diff --git "a/dataset1.query.intent.gdc.csv" "b/dataset1.query.intent.gdc.csv"
new file mode 100644--- /dev/null
+++ "b/dataset1.query.intent.gdc.csv"
@@ -0,0 +1,63757 @@
+,gene,mutation,cancer,questions,intent
+1,TNS1,G1362V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases have the TNS1 G1362V mutation?,ssm_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases have the TNS1 G1711V mutation?,ssm_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases have the TNS1 G1718V mutation?,ssm_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases have the TNS1 G1732V mutation?,ssm_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases have the TNS1 G1824V mutation?,ssm_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases have the TNS1 G1857V mutation?,ssm_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases have the TNS1 G843V mutation?,ssm_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases have the EVC2 E1067K mutation?,ssm_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases have the EVC2 E987K mutation?,ssm_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the CR1 V1108G mutation?,ssm_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the CR1 V1558G mutation?,ssm_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases have the TRPA1 S295I mutation?,ssm_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases have the TRPA1 S443I mutation?,ssm_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the TAF1C R299L mutation?,ssm_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the TAF1C R396L mutation?,ssm_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the TAF1C R634L mutation?,ssm_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the TAF1C R702L mutation?,ssm_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the TAF1C R728L mutation?,ssm_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the DPF3 R104W mutation?,ssm_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the DPF3 R149W mutation?,ssm_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the DPF3 R94W mutation?,ssm_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the OR2T4 P272H mutation?,ssm_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the OR2T4 P300H mutation?,ssm_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases have the FBN1 E2667K mutation?,ssm_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases have the MAD1L1 E396K mutation?,ssm_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases have the MAD1L1 E488K mutation?,ssm_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases have the MAD1L1 E78K mutation?,ssm_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the CCNG1 E22K mutation?,ssm_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases have the ANP32E N114T mutation?,ssm_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases have the ANP32E N64T mutation?,ssm_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases have the ANP32E N66T mutation?,ssm_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases have the ANP32E N73T mutation?,ssm_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases have the FRY S1888A mutation?,ssm_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases have the FRY S1937A mutation?,ssm_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases have the FRY S1938A mutation?,ssm_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases have the FRY S1983A mutation?,ssm_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the PAK3 E318K mutation?,ssm_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the PAK3 E319K mutation?,ssm_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the PAK3 E334K mutation?,ssm_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the PAK3 E340K mutation?,ssm_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the PAK3 E355K mutation?,ssm_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the MUC16 P7963L mutation?,ssm_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases have the ZFPM2 T498I mutation?,ssm_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases have the ZFPM2 T630I mutation?,ssm_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases have the PIK3C2B S1328C mutation?,ssm_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases have the PIK3C2B S1356C mutation?,ssm_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the ZNF804A S371Y mutation?,ssm_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the RELN A2371V mutation?,ssm_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the EFCAB12 R173C mutation?",ssm_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the EFCAB12 R23C mutation?",ssm_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the DEFB115 E53K mutation?,ssm_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases have the ANKDD1A S290F mutation?,ssm_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases have the ANKDD1A S322F mutation?,ssm_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases have the ANKDD1A S413F mutation?,ssm_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the HTR3B S146I mutation?,ssm_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the HTR3B S206I mutation?,ssm_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the HTR3B S217I mutation?,ssm_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the ABCC3 R758W mutation?,ssm_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the NOMO1 T204I mutation?,ssm_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the NOMO1 T371I mutation?,ssm_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases have the HYOU1 D298H mutation?,ssm_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the FMO4 R500Q mutation?,ssm_frequency
+140,BICC1,A372V,Exceptional Responders,What percentage of Exceptional Responders cases have the BICC1 A372V mutation?,ssm_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the ZMYM3 I920V mutation?,ssm_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the ZMYM3 I932V mutation?,ssm_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the ZMYM3 I934V mutation?,ssm_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the XKR4 R547W mutation?",ssm_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases have the ABCC2 V239L mutation?,ssm_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the OR8K5 R293G mutation?,ssm_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the SPTAN1 S1503F mutation?,ssm_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the SPTAN1 S1523F mutation?,ssm_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases have the SYT10 M484I mutation?,ssm_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the HSPA5 N457K mutation?,ssm_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the UNC5D L280V mutation?,ssm_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the UNC5D L635V mutation?,ssm_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the UNC5D L637V mutation?,ssm_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the UNC5D L699V mutation?,ssm_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the UNC5D L704V mutation?,ssm_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the UNC5D L709V mutation?,ssm_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma cases have the DOCK2 L1527H mutation?,ssm_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma cases have the ZNF627 A5V mutation?,ssm_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the CDC42BPA L823F mutation?,ssm_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the MRPL55 H27Y mutation?,ssm_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the MRPL55 H63Y mutation?,ssm_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases have the TMTC3 Q749K mutation?,ssm_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the EPRS1 K771I mutation?,ssm_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the EPRS1 K778I mutation?,ssm_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the GRTP1 A110V mutation?,ssm_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the GRTP1 A32V mutation?,ssm_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the TSHZ3 Q538K mutation?,ssm_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What percentage of HIV+ Tumor Molecular Characterization Project - Cervical Cancer cases have the TAS1R3 Q326H mutation?,ssm_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the PIAS3 S238C mutation?,ssm_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the PIAS3 S273C mutation?,ssm_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the ZNF274 P13R mutation?,ssm_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the SYNJ1 R795C mutation?,ssm_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the SYNJ1 R800C mutation?,ssm_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the SYNJ1 R839C mutation?,ssm_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases have the DSCAM V343M mutation?,ssm_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases have the DSCAM V426M mutation?,ssm_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases have the DSCAM V591M mutation?,ssm_frequency
+267,DGKD,R140H,Exceptional Responders,What percentage of Exceptional Responders cases have the DGKD R140H mutation?,ssm_frequency
+268,DGKD,R160H,Exceptional Responders,What percentage of Exceptional Responders cases have the DGKD R160H mutation?,ssm_frequency
+269,DGKD,R204H,Exceptional Responders,What percentage of Exceptional Responders cases have the DGKD R204H mutation?,ssm_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases have the PLEKHG6 D105Y mutation?,ssm_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases have the PLEKHG6 D543Y mutation?,ssm_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases have the PLEKHG6 D575Y mutation?,ssm_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the WNT2 D138N mutation?,ssm_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the GUCY2C G667R mutation?,ssm_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the C7orf31 P244H mutation?,ssm_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the ZKSCAN7 E64K mutation?",ssm_frequency
+299,OR5D14,M210L,Neuroblastoma,What percentage of Neuroblastoma cases have the OR5D14 M210L mutation?,ssm_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the SPATA22 K279E mutation?,ssm_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the SPATA22 K306E mutation?,ssm_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the SPATA22 K322E mutation?,ssm_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the LCN15 E21V mutation?,ssm_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the DCAF4L2 S129F mutation?,ssm_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the GUK1 R135P mutation?,ssm_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the GUK1 R137P mutation?,ssm_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the GUK1 R139P mutation?,ssm_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the GUK1 R158P mutation?,ssm_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the GUK1 R203P mutation?,ssm_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the MORF4L1 K29T mutation?,ssm_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the MORF4L1 K51T mutation?,ssm_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the MORF4L1 K61T mutation?,ssm_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the MORF4L1 K76T mutation?,ssm_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the MYO3B F594L mutation?,ssm_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the MYO3B F603L mutation?,ssm_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the TENT5A S320F mutation?,ssm_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the TENT5A S339F mutation?,ssm_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the TENT5A S401F mutation?,ssm_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma cases have the ZFAT S614L mutation?,ssm_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma cases have the ZFAT S664L mutation?,ssm_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma cases have the ZFAT S676L mutation?,ssm_frequency
+357,ZNF584,A211T,Sarcoma,What percentage of Sarcoma cases have the ZNF584 A211T mutation?,ssm_frequency
+358,ZNF584,A256T,Sarcoma,What percentage of Sarcoma cases have the ZNF584 A256T mutation?,ssm_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the LDOC1 R63W mutation?,ssm_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the PDGFC R201G mutation?,ssm_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the MSANTD4 R304C mutation?,ssm_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the NPSR1 S123L mutation?,ssm_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the PHLPP1 K1317E mutation?,ssm_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the COL6A3 G237S mutation?,ssm_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the COL6A3 G437S mutation?,ssm_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the COL6A3 G638S mutation?,ssm_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the COL6A3 G644S mutation?,ssm_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the COL6A3 G844S mutation?,ssm_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the ADRA1A R348G mutation?,ssm_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have the LAMB2 S1254F mutation?,ssm_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases have the POC1B I198T mutation?,ssm_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases have the POC1B I286T mutation?,ssm_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases have the POC1B I328T mutation?,ssm_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases have the POC1B S79P mutation?,ssm_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases have the USH2A G1451C mutation?,ssm_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases have the AQP7 T110S mutation?,ssm_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases have the AQP7 T166S mutation?,ssm_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases have the AQP7 T167S mutation?,ssm_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases have the AQP7 T75S mutation?,ssm_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases have the DCN R163C mutation?,ssm_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases have the DCN R203C mutation?,ssm_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases have the DCN R241C mutation?,ssm_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases have the DCN R350C mutation?,ssm_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases have the DCN R41C mutation?,ssm_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the CPS1 K1269N mutation?,ssm_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the CPS1 K1275N mutation?,ssm_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the CPS1 K818N mutation?,ssm_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases have the FCGR2C P122S mutation?,ssm_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases have the FCGR2C P123S mutation?,ssm_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the GRM1 R280M mutation?,ssm_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the SGCZ Q138H mutation?,ssm_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the SGCZ Q91H mutation?,ssm_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the SMO V15M mutation?,ssm_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the SMO V321M mutation?,ssm_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the CHODL G159E mutation?,ssm_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the CHODL G181E mutation?,ssm_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the CHODL G200E mutation?,ssm_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the MYO16 P399H mutation?,ssm_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the MYO16 P421H mutation?,ssm_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the CXCR2 A98V mutation?,ssm_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases have the TMEM225 L212V mutation?,ssm_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the MAOB N251T mutation?,ssm_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the GPRASP1 F580S mutation?,ssm_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the MRPL32 R181Q mutation?,ssm_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the TYROBP A29T mutation?,ssm_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the RAB40C A111V mutation?,ssm_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the RAB40C A143V mutation?,ssm_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the CTNNA2 S323R mutation?,ssm_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the CTNNA2 S339R mutation?,ssm_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the CTNNA2 S386R mutation?,ssm_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the CTNNA2 S707R mutation?,ssm_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases have the MYO15A S268R mutation?,ssm_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the GIMAP2 A167T mutation?,ssm_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases have the KIF20B N1160D mutation?,ssm_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases have the KIF20B N1200D mutation?,ssm_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the ADAM17 E583K mutation?,ssm_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the BCAT1 G16R mutation?,ssm_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the BCAT1 G17R mutation?,ssm_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the BCAT1 G29R mutation?,ssm_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the ERCC6 R1053H mutation?,ssm_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases have the DCC R320W mutation?,ssm_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases have the DCC R363W mutation?,ssm_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases have the DCC R386W mutation?,ssm_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases have the DCC R41W mutation?,ssm_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the FBXO15 D417N mutation?,ssm_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the FBXO15 D86N mutation?,ssm_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the GSTCD S528F mutation?,ssm_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the GSTCD S615F mutation?,ssm_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the OLFML3 P296S mutation?,ssm_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the OLFML3 P337S mutation?,ssm_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the OLFML3 P357S mutation?,ssm_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma cases have the CFAP61 E173V mutation?,ssm_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma cases have the CFAP61 E817V mutation?,ssm_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases have the HLA-DQA2 E51K mutation?,ssm_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the TENM2 H240Y mutation?,ssm_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the TENM2 H351Y mutation?,ssm_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the TENM2 H472Y mutation?,ssm_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the ANKRD24 A465T mutation?,ssm_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the ANKRD24 A494T mutation?,ssm_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the ANKRD24 A584T mutation?,ssm_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the ZCCHC14 V549M mutation?,ssm_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the ZCCHC14 V665M mutation?,ssm_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the ZCCHC14 V676M mutation?,ssm_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the ZCCHC14 V802M mutation?,ssm_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the SIK2 I265M mutation?,ssm_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the MYH11 T1336M mutation?,ssm_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the MYH11 T1343M mutation?,ssm_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the SLC6A4 S174F mutation?,ssm_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the SLC9C1 K102N mutation?,ssm_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the SLC9C1 K29N mutation?,ssm_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,What percentage of Brain Lower Grade Glioma cases have the OR2A12 A254T mutation?,ssm_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the PYHIN1 T325K mutation?,ssm_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the PYHIN1 T334K mutation?,ssm_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the JAML G191E mutation?,ssm_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the JAML G219E mutation?,ssm_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the JAML G220E mutation?,ssm_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the JAML G230E mutation?,ssm_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the TYK2 H1146R mutation?,ssm_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the TYK2 H23R mutation?,ssm_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the TYK2 H961R mutation?,ssm_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the CTCFL R208C mutation?,ssm_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the CTCFL R265C mutation?,ssm_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the CTCFL R420C mutation?,ssm_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the CTCFL R470C mutation?,ssm_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the CEP20 R31Q mutation?,ssm_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the CEP20 R58Q mutation?,ssm_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the RIMS2 R25W mutation?,ssm_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the RIMS2 R393W mutation?,ssm_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the RIMS2 R423W mutation?,ssm_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the RIMS2 R470W mutation?,ssm_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the RIMS2 R615W mutation?,ssm_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the RIMS2 R619W mutation?,ssm_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the RIMS2 R716W mutation?,ssm_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the PIK3C2G S551L mutation?,ssm_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the PIK3C2G S592L mutation?,ssm_frequency
+728,STK19,D341N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the STK19 D341N mutation?,ssm_frequency
+729,STK19,D345N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the STK19 D345N mutation?,ssm_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the REXO4 P60A mutation?,ssm_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the ZBTB34 P160S mutation?,ssm_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the ZBTB34 P164S mutation?,ssm_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases have the NCKAP5 E148K mutation?,ssm_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the SORCS1 D1052Y mutation?",ssm_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the SORCS1 D587Y mutation?",ssm_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the SORCS1 D67Y mutation?",ssm_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the SORCS1 D810Y mutation?",ssm_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma cases have the FGF8 T154M mutation?,ssm_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma cases have the FGF8 T165M mutation?,ssm_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma cases have the FGF8 T183M mutation?,ssm_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma cases have the FGF8 T194M mutation?,ssm_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma cases have the FGF8 T90M mutation?,ssm_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What percentage of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia cases have the TENM3 R1877W mutation?,ssm_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the AKT1 D44N mutation?,ssm_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have the CFAP298-TCP10L E11Q mutation?,ssm_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the GLRB E148D mutation?,ssm_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the TTN F7636L mutation?,ssm_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the TTN F8563L mutation?,ssm_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the TTN F8880L mutation?,ssm_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the ANKRD30A V798I mutation?,ssm_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the ANKRD30A V854I mutation?,ssm_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the ANKRD30A V973I mutation?,ssm_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the TRIM45 S177L mutation?,ssm_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the TRIM45 S224L mutation?,ssm_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the TRIM45 S281L mutation?,ssm_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the CACNA1F G727V mutation?,ssm_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the CACNA1F G781V mutation?,ssm_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the CACNA1F G792V mutation?,ssm_frequency
+817,KL,R594C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the KL R594C mutation?,ssm_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases have the GUF1 I243T mutation?,ssm_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the TAF1L A539V mutation?,ssm_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the TASOR2 S256F mutation?,ssm_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the TASOR2 S36F mutation?,ssm_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the TASOR2 S471F mutation?,ssm_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the KDM5C R1151C mutation?,ssm_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the KDM5C R1177C mutation?,ssm_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the KDM5C R1217C mutation?,ssm_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the KDM5C R1218C mutation?,ssm_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have the IL5RA L153F mutation?,ssm_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the DHX16 A29V mutation?,ssm_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the DHX16 A89V mutation?,ssm_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the GPR158 A644V mutation?,ssm_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the GPR158 A723V mutation?,ssm_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the EIF2B4 E108K mutation?",ssm_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the EIF2B4 E110K mutation?",ssm_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the EIF2B4 E111K mutation?",ssm_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the EIF2B4 E131K mutation?",ssm_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the EIF2B4 E132K mutation?",ssm_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the EIF2B4 E96K mutation?",ssm_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the AUTS2 P136S mutation?,ssm_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the AUTS2 P218S mutation?,ssm_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the AUTS2 P233S mutation?,ssm_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the AUTS2 P313S mutation?,ssm_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the AUTS2 P419S mutation?,ssm_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the AUTS2 P443S mutation?,ssm_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the AUTS2 P56S mutation?,ssm_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the AUTS2 P667S mutation?,ssm_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the AUTS2 P690S mutation?,ssm_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the AUTS2 P691S mutation?,ssm_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the ACTL7B D223N mutation?",ssm_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases have the PCDHGA1 R535W mutation?,ssm_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the TRAP1 R114W mutation?,ssm_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the TRAP1 R61W mutation?,ssm_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the PIK3C2A R1570Q mutation?,ssm_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases have the KANSL1 R139G mutation?,ssm_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the ANKRD52 Y594C mutation?,ssm_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the PAPPA G1580S mutation?,ssm_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases have the B3GALNT1 V270A mutation?,ssm_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the GABRA6 G115R mutation?,ssm_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the GABRA6 G122R mutation?,ssm_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the GABRA6 G165R mutation?,ssm_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the GABRA6 G175R mutation?,ssm_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the GABRA6 G70R mutation?,ssm_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the ZSCAN31 D9N mutation?,ssm_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the MED16 L126P mutation?",ssm_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the MED16 L868P mutation?",ssm_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases have the PTPRO E1060K mutation?,ssm_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases have the PTPRO E1088K mutation?,ssm_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases have the PTPRO E249K mutation?,ssm_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases have the PTPRO E265K mutation?,ssm_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases have the PTPRO E277K mutation?,ssm_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases have the PTPRO E67K mutation?,ssm_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases have the PTPRO E923K mutation?,ssm_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases have the PTPRO E940K mutation?,ssm_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the CHMP7 D397N mutation?,ssm_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the GPC3 I107N mutation?,ssm_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the GPC3 I161N mutation?,ssm_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have the TLK2 V430L mutation?,ssm_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have the TLK2 V515L mutation?,ssm_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have the TLK2 V547L mutation?,ssm_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have the TLK2 V579L mutation?,ssm_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have the TLK2 V601L mutation?,ssm_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the ZNF217 E209Q mutation?,ssm_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the SYT9 V275L mutation?,ssm_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the SYT9 V307L mutation?,ssm_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the PKHD1L1 S2830N mutation?,ssm_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the MYO3A Y1295C mutation?,ssm_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the VASN V318I mutation?",ssm_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the DNMT1 A1037T mutation?,ssm_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the DNMT1 A1053T mutation?,ssm_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the DNMT1 A934T mutation?,ssm_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the CA9 E402K mutation?,ssm_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the TTC17 R808Q mutation?,ssm_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the TTC17 R865Q mutation?,ssm_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases have the PSG2 P43L mutation?,ssm_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases have the RIPOR2 R470L mutation?,ssm_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases have the RIPOR2 R499L mutation?,ssm_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases have the RIPOR2 R504L mutation?,ssm_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases have the RIPOR2 R520L mutation?,ssm_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the DCLK3 V520I mutation?,ssm_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the DCLK3 V689I mutation?,ssm_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the MERTK G257A mutation?,ssm_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the MERTK G757A mutation?,ssm_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the MERTK G933A mutation?,ssm_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the ZFP42 R206K mutation?,ssm_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the OR13C3 M117I mutation?,ssm_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the OR13C3 M147I mutation?,ssm_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the SPAG1 I917M mutation?,ssm_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the CDKN2AIP Y92H mutation?,ssm_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the PXN H1016Y mutation?,ssm_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the PXN H359Y mutation?,ssm_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the PXN H492Y mutation?,ssm_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the PXN H524Y mutation?,ssm_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the PXN H526Y mutation?,ssm_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the PXN H540Y mutation?,ssm_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the TTYH2 S23L mutation?,ssm_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the TTYH2 S44L mutation?,ssm_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the TMEM255A N205S mutation?,ssm_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the TMEM255A N229S mutation?,ssm_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the TMEM255A N65S mutation?,ssm_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases have the TASOR2 H2271D mutation?,ssm_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases have the TASOR2 H2486D mutation?,ssm_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the ICE1 T1839M mutation?,ssm_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases have the MYT1 A558E mutation?,ssm_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases have the MYT1 A879E mutation?,ssm_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases have the MYT1 A906E mutation?,ssm_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the CX3CR1 P203L mutation?,ssm_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the CX3CR1 P235L mutation?,ssm_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases have the SPINDOC R197C mutation?,ssm_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the ART3 C251Y mutation?,ssm_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the ART3 C3Y mutation?,ssm_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases have the CYP1A2 R243G mutation?,ssm_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the ADRA1A G279S mutation?",ssm_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the CDH23 P2523R mutation?,ssm_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the CDH23 P283R mutation?,ssm_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the KRT39 P137S mutation?,ssm_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the PDHA2 S7F mutation?,ssm_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the SLC24A2 H200Q mutation?,ssm_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases have the PTPRN2 F153L mutation?,ssm_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases have the PTPRN2 F847L mutation?,ssm_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases have the PTPRN2 F856L mutation?,ssm_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases have the PTPRN2 F868L mutation?,ssm_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases have the PTPRN2 F885L mutation?,ssm_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the SOX21 R55L mutation?,ssm_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases have the CPA6 G166E mutation?,ssm_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the GRM5 E14K mutation?,ssm_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the CASZ1 R233Q mutation?",ssm_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the SGIP1 N122T mutation?,ssm_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the SGIP1 N420T mutation?,ssm_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the SGIP1 N617T mutation?,ssm_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the SGIP1 N648T mutation?,ssm_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the CARMIL1 V549L mutation?,ssm_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the CARMIL1 V949L mutation?,ssm_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the ZNF431 D121Y mutation?,ssm_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the ZNF431 D161Y mutation?,ssm_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the ZNF431 R128I mutation?,ssm_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the DNAH11 P2987S mutation?,ssm_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the DNAH11 P2994S mutation?,ssm_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the POLD1 Q461L mutation?,ssm_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases have the POLD1 Q85L mutation?,ssm_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the TTC12 D646H mutation?,ssm_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the TTC12 D652H mutation?,ssm_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases have the CNGB1 D967N mutation?,ssm_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases have the CNGB1 D973N mutation?,ssm_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the CTSC E214V mutation?,ssm_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the CTSC E291V mutation?,ssm_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the CTSC E322V mutation?,ssm_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the CTSC E324V mutation?,ssm_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the CTSC E335V mutation?,ssm_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the PRSS8 A179T mutation?,ssm_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the PRSS8 A233T mutation?,ssm_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the ARHGEF40 V864F mutation?,ssm_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases have the ACTB A138T mutation?,ssm_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases have the ACTB A217T mutation?,ssm_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases have the ACTB A244T mutation?,ssm_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases have the ACTB A260T mutation?,ssm_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases have the YY1AP1 V546D mutation?,ssm_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases have the YY1AP1 V557D mutation?,ssm_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases have the YY1AP1 V566D mutation?,ssm_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases have the YY1AP1 V577D mutation?,ssm_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases have the YY1AP1 V623D mutation?,ssm_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases have the YY1AP1 V695D mutation?,ssm_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases have the YY1AP1 V715D mutation?,ssm_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the FNDC7 D323N mutation?,ssm_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the FNDC7 D99N mutation?,ssm_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the TLCD5 G15V mutation?,ssm_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the TLCD5 G37V mutation?,ssm_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the POLR1G R498W mutation?,ssm_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the POLR1G R500W mutation?,ssm_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the DNAH14 N1186K mutation?,ssm_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the DNAH14 N2657K mutation?,ssm_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the DNAH14 N3460K mutation?,ssm_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the NEXN E73D mutation?,ssm_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases have the CYB5R2 G112R mutation?,ssm_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases have the CYB5R2 G172R mutation?,ssm_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the NRAP S808L mutation?,ssm_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the NRAP S816L mutation?,ssm_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the NRAP S843L mutation?,ssm_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the CCDC22 E179D mutation?,ssm_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the DCAF6 S402F mutation?,ssm_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the DCAF6 S433F mutation?,ssm_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the ZNF708 E389D mutation?,ssm_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the BFAR T103M mutation?,ssm_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the MAST4 P1237S mutation?,ssm_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the MAST4 P1986S mutation?,ssm_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the MAST4 P1991S mutation?,ssm_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the MAST4 P2001S mutation?,ssm_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the MAST4 P2180S mutation?,ssm_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the ARMC3 R169C mutation?,ssm_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the ARMC3 R432C mutation?,ssm_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma cases have the TET2 L757V mutation?,ssm_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma cases have the TET2 L778V mutation?,ssm_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the SERPINB10 A353P mutation?,ssm_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the STAT3 Y22H mutation?,ssm_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the MIEF1 A42T mutation?,ssm_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the ACVR1B D397N mutation?,ssm_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the ACVR1B D449N mutation?,ssm_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the ACVR1B D490N mutation?,ssm_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the EBF2 T104I mutation?,ssm_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the EBF2 T252I mutation?,ssm_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the VPS26B F266L mutation?,ssm_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the PGR M106I mutation?",ssm_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the PGR M38I mutation?",ssm_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the PGR M632I mutation?",ssm_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases have the ACTA2 P334L mutation?,ssm_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the THBS4 T852I mutation?,ssm_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the THBS4 T943I mutation?,ssm_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the PRSS1 S114T mutation?,ssm_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the PRSS1 S124T mutation?,ssm_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the PRSS1 S138T mutation?,ssm_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases have the PRSS1 S74T mutation?,ssm_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the PGF R126H mutation?,ssm_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases have the PGF R127H mutation?,ssm_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases have the ITPRID2 S351C mutation?,ssm_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases have the ITPRID2 S842C mutation?,ssm_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the HBB E8D mutation?,ssm_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the PCDHB2 R158C mutation?,ssm_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the PCDHB2 T15M mutation?,ssm_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases have the PCDHB2 T26M mutation?,ssm_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases have the UBR2 P1594S mutation?,ssm_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases have the FBXO42 A618D mutation?,ssm_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,How widespread are TNS1 G1362V mutations in Breast Invasive Carcinoma?,ssm_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,How widespread are TNS1 G1711V mutations in Breast Invasive Carcinoma?,ssm_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,How widespread are TNS1 G1718V mutations in Breast Invasive Carcinoma?,ssm_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,How widespread are TNS1 G1732V mutations in Breast Invasive Carcinoma?,ssm_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,How widespread are TNS1 G1824V mutations in Breast Invasive Carcinoma?,ssm_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,How widespread are TNS1 G1857V mutations in Breast Invasive Carcinoma?,ssm_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,How widespread are TNS1 G843V mutations in Breast Invasive Carcinoma?,ssm_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How widespread are EVC2 E1067K mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How widespread are EVC2 E987K mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How widespread are CR1 V1108G mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How widespread are CR1 V1558G mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,How widespread are TRPA1 S295I mutations in Rectum Adenocarcinoma?,ssm_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,How widespread are TRPA1 S443I mutations in Rectum Adenocarcinoma?,ssm_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,How widespread are TAF1C R299L mutations in Lung Adenocarcinoma?,ssm_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,How widespread are TAF1C R396L mutations in Lung Adenocarcinoma?,ssm_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,How widespread are TAF1C R634L mutations in Lung Adenocarcinoma?,ssm_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,How widespread are TAF1C R702L mutations in Lung Adenocarcinoma?,ssm_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,How widespread are TAF1C R728L mutations in Lung Adenocarcinoma?,ssm_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How widespread are DPF3 R104W mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How widespread are DPF3 R149W mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How widespread are DPF3 R94W mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,How widespread are OR2T4 P272H mutations in Lung Adenocarcinoma?,ssm_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,How widespread are OR2T4 P300H mutations in Lung Adenocarcinoma?,ssm_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How widespread are FBN1 E2667K mutations in Pancreatic Adenocarcinoma?,ssm_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How widespread are MAD1L1 E396K mutations in Prostate Adenocarcinoma?,ssm_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How widespread are MAD1L1 E488K mutations in Prostate Adenocarcinoma?,ssm_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How widespread are MAD1L1 E78K mutations in Prostate Adenocarcinoma?,ssm_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How widespread are CCNG1 E22K mutations in Skin Cutaneous Melanoma?,ssm_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How widespread are ANP32E N114T mutations in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How widespread are ANP32E N64T mutations in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How widespread are ANP32E N66T mutations in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How widespread are ANP32E N73T mutations in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How widespread are FRY S1888A mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How widespread are FRY S1937A mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How widespread are FRY S1938A mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How widespread are FRY S1983A mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,How widespread are PAK3 E318K mutations in Skin Cutaneous Melanoma?,ssm_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,How widespread are PAK3 E319K mutations in Skin Cutaneous Melanoma?,ssm_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,How widespread are PAK3 E334K mutations in Skin Cutaneous Melanoma?,ssm_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,How widespread are PAK3 E340K mutations in Skin Cutaneous Melanoma?,ssm_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,How widespread are PAK3 E355K mutations in Skin Cutaneous Melanoma?,ssm_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How widespread are MUC16 P7963L mutations in Skin Cutaneous Melanoma?,ssm_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How widespread are ZFPM2 T498I mutations in Liver Hepatocellular Carcinoma?,ssm_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How widespread are ZFPM2 T630I mutations in Liver Hepatocellular Carcinoma?,ssm_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How widespread are PIK3C2B S1328C mutations in Breast Invasive Carcinoma?,ssm_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How widespread are PIK3C2B S1356C mutations in Breast Invasive Carcinoma?,ssm_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How widespread are ZNF804A S371Y mutations in Colon Adenocarcinoma?,ssm_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,How widespread are RELN A2371V mutations in Stomach Adenocarcinoma?,ssm_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread are EFCAB12 R173C mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread are EFCAB12 R23C mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How widespread are DEFB115 E53K mutations in Skin Cutaneous Melanoma?,ssm_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How widespread are ANKDD1A S290F mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How widespread are ANKDD1A S322F mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How widespread are ANKDD1A S413F mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How widespread are HTR3B S146I mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How widespread are HTR3B S206I mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How widespread are HTR3B S217I mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,How widespread are ABCC3 R758W mutations in Stomach Adenocarcinoma?,ssm_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How widespread are NOMO1 T204I mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How widespread are NOMO1 T371I mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How widespread are HYOU1 D298H mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How widespread are FMO4 R500Q mutations in Skin Cutaneous Melanoma?,ssm_frequency
+140,BICC1,A372V,Exceptional Responders,How widespread are BICC1 A372V mutations in Exceptional Responders?,ssm_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How widespread are ZMYM3 I920V mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How widespread are ZMYM3 I932V mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How widespread are ZMYM3 I934V mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread are XKR4 R547W mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How widespread are ABCC2 V239L mutations in Liver Hepatocellular Carcinoma?,ssm_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,How widespread are OR8K5 R293G mutations in Lung Adenocarcinoma?,ssm_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How widespread are SPTAN1 S1503F mutations in Skin Cutaneous Melanoma?,ssm_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How widespread are SPTAN1 S1523F mutations in Skin Cutaneous Melanoma?,ssm_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,How widespread are SYT10 M484I mutations in Rectum Adenocarcinoma?,ssm_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How widespread are HSPA5 N457K mutations in Skin Cutaneous Melanoma?,ssm_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,How widespread are UNC5D L280V mutations in Lung Adenocarcinoma?,ssm_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,How widespread are UNC5D L635V mutations in Lung Adenocarcinoma?,ssm_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,How widespread are UNC5D L637V mutations in Lung Adenocarcinoma?,ssm_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,How widespread are UNC5D L699V mutations in Lung Adenocarcinoma?,ssm_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,How widespread are UNC5D L704V mutations in Lung Adenocarcinoma?,ssm_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,How widespread are UNC5D L709V mutations in Lung Adenocarcinoma?,ssm_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How widespread are DOCK2 L1527H mutations in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How widespread are ZNF627 A5V mutations in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How widespread are CDC42BPA L823F mutations in Skin Cutaneous Melanoma?,ssm_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,How widespread are MRPL55 H27Y mutations in Colon Adenocarcinoma?,ssm_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,How widespread are MRPL55 H63Y mutations in Colon Adenocarcinoma?,ssm_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How widespread are TMTC3 Q749K mutations in Breast Invasive Carcinoma?,ssm_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,How widespread are EPRS1 K771I mutations in Colon Adenocarcinoma?,ssm_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,How widespread are EPRS1 K778I mutations in Colon Adenocarcinoma?,ssm_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How widespread are GRTP1 A110V mutations in Skin Cutaneous Melanoma?,ssm_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How widespread are GRTP1 A32V mutations in Skin Cutaneous Melanoma?,ssm_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How widespread are TSHZ3 Q538K mutations in Stomach Adenocarcinoma?,ssm_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How widespread are TAS1R3 Q326H mutations in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,ssm_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How widespread are PIAS3 S238C mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How widespread are PIAS3 S273C mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,How widespread are ZNF274 P13R mutations in Stomach Adenocarcinoma?,ssm_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,How widespread are SYNJ1 R795C mutations in Colon Adenocarcinoma?,ssm_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,How widespread are SYNJ1 R800C mutations in Colon Adenocarcinoma?,ssm_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,How widespread are SYNJ1 R839C mutations in Colon Adenocarcinoma?,ssm_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,How widespread are DSCAM V343M mutations in Prostate Adenocarcinoma?,ssm_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,How widespread are DSCAM V426M mutations in Prostate Adenocarcinoma?,ssm_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,How widespread are DSCAM V591M mutations in Prostate Adenocarcinoma?,ssm_frequency
+267,DGKD,R140H,Exceptional Responders,How widespread are DGKD R140H mutations in Exceptional Responders?,ssm_frequency
+268,DGKD,R160H,Exceptional Responders,How widespread are DGKD R160H mutations in Exceptional Responders?,ssm_frequency
+269,DGKD,R204H,Exceptional Responders,How widespread are DGKD R204H mutations in Exceptional Responders?,ssm_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How widespread are PLEKHG6 D105Y mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How widespread are PLEKHG6 D543Y mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How widespread are PLEKHG6 D575Y mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,How widespread are WNT2 D138N mutations in Skin Cutaneous Melanoma?,ssm_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How widespread are GUCY2C G667R mutations in Skin Cutaneous Melanoma?,ssm_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How widespread are C7orf31 P244H mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread are ZKSCAN7 E64K mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+299,OR5D14,M210L,Neuroblastoma,How widespread are OR5D14 M210L mutations in Neuroblastoma?,ssm_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How widespread are SPATA22 K279E mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How widespread are SPATA22 K306E mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How widespread are SPATA22 K322E mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,How widespread are LCN15 E21V mutations in Stomach Adenocarcinoma?,ssm_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How widespread are DCAF4L2 S129F mutations in Skin Cutaneous Melanoma?,ssm_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How widespread are GUK1 R135P mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How widespread are GUK1 R137P mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How widespread are GUK1 R139P mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How widespread are GUK1 R158P mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How widespread are GUK1 R203P mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How widespread are MORF4L1 K29T mutations in Stomach Adenocarcinoma?,ssm_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How widespread are MORF4L1 K51T mutations in Stomach Adenocarcinoma?,ssm_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How widespread are MORF4L1 K61T mutations in Stomach Adenocarcinoma?,ssm_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How widespread are MORF4L1 K76T mutations in Stomach Adenocarcinoma?,ssm_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How widespread are MYO3B F594L mutations in Skin Cutaneous Melanoma?,ssm_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How widespread are MYO3B F603L mutations in Skin Cutaneous Melanoma?,ssm_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How widespread are TENT5A S320F mutations in Skin Cutaneous Melanoma?,ssm_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How widespread are TENT5A S339F mutations in Skin Cutaneous Melanoma?,ssm_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How widespread are TENT5A S401F mutations in Skin Cutaneous Melanoma?,ssm_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How widespread are ZFAT S614L mutations in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How widespread are ZFAT S664L mutations in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How widespread are ZFAT S676L mutations in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+357,ZNF584,A211T,Sarcoma,How widespread are ZNF584 A211T mutations in Sarcoma?,ssm_frequency
+358,ZNF584,A256T,Sarcoma,How widespread are ZNF584 A256T mutations in Sarcoma?,ssm_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How widespread are LDOC1 R63W mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How widespread are PDGFC R201G mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How widespread are MSANTD4 R304C mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How widespread are NPSR1 S123L mutations in Skin Cutaneous Melanoma?,ssm_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How widespread are PHLPP1 K1317E mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How widespread are COL6A3 G237S mutations in Skin Cutaneous Melanoma?,ssm_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How widespread are COL6A3 G437S mutations in Skin Cutaneous Melanoma?,ssm_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How widespread are COL6A3 G638S mutations in Skin Cutaneous Melanoma?,ssm_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How widespread are COL6A3 G644S mutations in Skin Cutaneous Melanoma?,ssm_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How widespread are COL6A3 G844S mutations in Skin Cutaneous Melanoma?,ssm_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How widespread are ADRA1A R348G mutations in Stomach Adenocarcinoma?,ssm_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread are LAMB2 S1254F mutations in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,How widespread are POC1B I198T mutations in Rectum Adenocarcinoma?,ssm_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,How widespread are POC1B I286T mutations in Rectum Adenocarcinoma?,ssm_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,How widespread are POC1B I328T mutations in Rectum Adenocarcinoma?,ssm_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,How widespread are POC1B S79P mutations in Rectum Adenocarcinoma?,ssm_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How widespread are USH2A G1451C mutations in Liver Hepatocellular Carcinoma?,ssm_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,How widespread are AQP7 T110S mutations in Rectum Adenocarcinoma?,ssm_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,How widespread are AQP7 T166S mutations in Rectum Adenocarcinoma?,ssm_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,How widespread are AQP7 T167S mutations in Rectum Adenocarcinoma?,ssm_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,How widespread are AQP7 T75S mutations in Rectum Adenocarcinoma?,ssm_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,How widespread are DCN R163C mutations in Rectum Adenocarcinoma?,ssm_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,How widespread are DCN R203C mutations in Rectum Adenocarcinoma?,ssm_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,How widespread are DCN R241C mutations in Rectum Adenocarcinoma?,ssm_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,How widespread are DCN R350C mutations in Rectum Adenocarcinoma?,ssm_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,How widespread are DCN R41C mutations in Rectum Adenocarcinoma?,ssm_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How widespread are CPS1 K1269N mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How widespread are CPS1 K1275N mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How widespread are CPS1 K818N mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How widespread are FCGR2C P122S mutations in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How widespread are FCGR2C P123S mutations in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How widespread are GRM1 R280M mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,How widespread are SGCZ Q138H mutations in Lung Adenocarcinoma?,ssm_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,How widespread are SGCZ Q91H mutations in Lung Adenocarcinoma?,ssm_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,How widespread are SMO V15M mutations in Stomach Adenocarcinoma?,ssm_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,How widespread are SMO V321M mutations in Stomach Adenocarcinoma?,ssm_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,How widespread are CHODL G159E mutations in Skin Cutaneous Melanoma?,ssm_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,How widespread are CHODL G181E mutations in Skin Cutaneous Melanoma?,ssm_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,How widespread are CHODL G200E mutations in Skin Cutaneous Melanoma?,ssm_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,How widespread are MYO16 P399H mutations in Colon Adenocarcinoma?,ssm_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,How widespread are MYO16 P421H mutations in Colon Adenocarcinoma?,ssm_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,How widespread are CXCR2 A98V mutations in Stomach Adenocarcinoma?,ssm_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How widespread are TMEM225 L212V mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How widespread are MAOB N251T mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How widespread are GPRASP1 F580S mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How widespread are MRPL32 R181Q mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How widespread are TYROBP A29T mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,How widespread are RAB40C A111V mutations in Lung Adenocarcinoma?,ssm_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,How widespread are RAB40C A143V mutations in Lung Adenocarcinoma?,ssm_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,How widespread are CTNNA2 S323R mutations in Lung Adenocarcinoma?,ssm_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,How widespread are CTNNA2 S339R mutations in Lung Adenocarcinoma?,ssm_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,How widespread are CTNNA2 S386R mutations in Lung Adenocarcinoma?,ssm_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,How widespread are CTNNA2 S707R mutations in Lung Adenocarcinoma?,ssm_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How widespread are MYO15A S268R mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How widespread are GIMAP2 A167T mutations in Skin Cutaneous Melanoma?,ssm_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,How widespread are KIF20B N1160D mutations in Glioblastoma Multiforme?,ssm_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,How widespread are KIF20B N1200D mutations in Glioblastoma Multiforme?,ssm_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How widespread are ADAM17 E583K mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How widespread are BCAT1 G16R mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How widespread are BCAT1 G17R mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How widespread are BCAT1 G29R mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,How widespread are ERCC6 R1053H mutations in Colon Adenocarcinoma?,ssm_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,How widespread are DCC R320W mutations in Breast Invasive Carcinoma?,ssm_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,How widespread are DCC R363W mutations in Breast Invasive Carcinoma?,ssm_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,How widespread are DCC R386W mutations in Breast Invasive Carcinoma?,ssm_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,How widespread are DCC R41W mutations in Breast Invasive Carcinoma?,ssm_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How widespread are FBXO15 D417N mutations in Skin Cutaneous Melanoma?,ssm_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How widespread are FBXO15 D86N mutations in Skin Cutaneous Melanoma?,ssm_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How widespread are GSTCD S528F mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How widespread are GSTCD S615F mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How widespread are OLFML3 P296S mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How widespread are OLFML3 P337S mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How widespread are OLFML3 P357S mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How widespread are CFAP61 E173V mutations in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How widespread are CFAP61 E817V mutations in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How widespread are HLA-DQA2 E51K mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How widespread are TENM2 H240Y mutations in Skin Cutaneous Melanoma?,ssm_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How widespread are TENM2 H351Y mutations in Skin Cutaneous Melanoma?,ssm_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How widespread are TENM2 H472Y mutations in Skin Cutaneous Melanoma?,ssm_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How widespread are ANKRD24 A465T mutations in Stomach Adenocarcinoma?,ssm_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How widespread are ANKRD24 A494T mutations in Stomach Adenocarcinoma?,ssm_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How widespread are ANKRD24 A584T mutations in Stomach Adenocarcinoma?,ssm_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How widespread are ZCCHC14 V549M mutations in Stomach Adenocarcinoma?,ssm_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How widespread are ZCCHC14 V665M mutations in Stomach Adenocarcinoma?,ssm_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How widespread are ZCCHC14 V676M mutations in Stomach Adenocarcinoma?,ssm_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How widespread are ZCCHC14 V802M mutations in Stomach Adenocarcinoma?,ssm_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,How widespread are SIK2 I265M mutations in Lung Adenocarcinoma?,ssm_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How widespread are MYH11 T1336M mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How widespread are MYH11 T1343M mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How widespread are SLC6A4 S174F mutations in Skin Cutaneous Melanoma?,ssm_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How widespread are SLC9C1 K102N mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How widespread are SLC9C1 K29N mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,How widespread are OR2A12 A254T mutations in Brain Lower Grade Glioma?,ssm_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,How widespread are PYHIN1 T325K mutations in Lung Adenocarcinoma?,ssm_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,How widespread are PYHIN1 T334K mutations in Lung Adenocarcinoma?,ssm_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,How widespread are JAML G191E mutations in Skin Cutaneous Melanoma?,ssm_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,How widespread are JAML G219E mutations in Skin Cutaneous Melanoma?,ssm_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,How widespread are JAML G220E mutations in Skin Cutaneous Melanoma?,ssm_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,How widespread are JAML G230E mutations in Skin Cutaneous Melanoma?,ssm_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,How widespread are TYK2 H1146R mutations in Stomach Adenocarcinoma?,ssm_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,How widespread are TYK2 H23R mutations in Stomach Adenocarcinoma?,ssm_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,How widespread are TYK2 H961R mutations in Stomach Adenocarcinoma?,ssm_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How widespread are CTCFL R208C mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How widespread are CTCFL R265C mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How widespread are CTCFL R420C mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How widespread are CTCFL R470C mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How widespread are CEP20 R31Q mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How widespread are CEP20 R58Q mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How widespread are RIMS2 R25W mutations in Skin Cutaneous Melanoma?,ssm_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How widespread are RIMS2 R393W mutations in Skin Cutaneous Melanoma?,ssm_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How widespread are RIMS2 R423W mutations in Skin Cutaneous Melanoma?,ssm_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How widespread are RIMS2 R470W mutations in Skin Cutaneous Melanoma?,ssm_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How widespread are RIMS2 R615W mutations in Skin Cutaneous Melanoma?,ssm_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How widespread are RIMS2 R619W mutations in Skin Cutaneous Melanoma?,ssm_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How widespread are RIMS2 R716W mutations in Skin Cutaneous Melanoma?,ssm_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How widespread are PIK3C2G S551L mutations in Skin Cutaneous Melanoma?,ssm_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How widespread are PIK3C2G S592L mutations in Skin Cutaneous Melanoma?,ssm_frequency
+728,STK19,D341N,Colon Adenocarcinoma,How widespread are STK19 D341N mutations in Colon Adenocarcinoma?,ssm_frequency
+729,STK19,D345N,Colon Adenocarcinoma,How widespread are STK19 D345N mutations in Colon Adenocarcinoma?,ssm_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,How widespread are REXO4 P60A mutations in Skin Cutaneous Melanoma?,ssm_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How widespread are ZBTB34 P160S mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How widespread are ZBTB34 P164S mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How widespread are NCKAP5 E148K mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread are SORCS1 D1052Y mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread are SORCS1 D587Y mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread are SORCS1 D67Y mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread are SORCS1 D810Y mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How widespread are FGF8 T154M mutations in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How widespread are FGF8 T165M mutations in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How widespread are FGF8 T183M mutations in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How widespread are FGF8 T194M mutations in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How widespread are FGF8 T90M mutations in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How widespread are TENM3 R1877W mutations in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,ssm_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How widespread are AKT1 D44N mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread are CFAP298-TCP10L E11Q mutations in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,How widespread are GLRB E148D mutations in Stomach Adenocarcinoma?,ssm_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,How widespread are TTN F7636L mutations in Colon Adenocarcinoma?,ssm_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,How widespread are TTN F8563L mutations in Colon Adenocarcinoma?,ssm_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,How widespread are TTN F8880L mutations in Colon Adenocarcinoma?,ssm_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How widespread are ANKRD30A V798I mutations in Colon Adenocarcinoma?,ssm_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How widespread are ANKRD30A V854I mutations in Colon Adenocarcinoma?,ssm_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How widespread are ANKRD30A V973I mutations in Colon Adenocarcinoma?,ssm_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,How widespread are TRIM45 S177L mutations in Colon Adenocarcinoma?,ssm_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,How widespread are TRIM45 S224L mutations in Colon Adenocarcinoma?,ssm_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,How widespread are TRIM45 S281L mutations in Colon Adenocarcinoma?,ssm_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How widespread are CACNA1F G727V mutations in Stomach Adenocarcinoma?,ssm_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How widespread are CACNA1F G781V mutations in Stomach Adenocarcinoma?,ssm_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How widespread are CACNA1F G792V mutations in Stomach Adenocarcinoma?,ssm_frequency
+817,KL,R594C,Colon Adenocarcinoma,How widespread are KL R594C mutations in Colon Adenocarcinoma?,ssm_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How widespread are GUF1 I243T mutations in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,How widespread are TAF1L A539V mutations in Colon Adenocarcinoma?,ssm_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How widespread are TASOR2 S256F mutations in Skin Cutaneous Melanoma?,ssm_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How widespread are TASOR2 S36F mutations in Skin Cutaneous Melanoma?,ssm_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How widespread are TASOR2 S471F mutations in Skin Cutaneous Melanoma?,ssm_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How widespread are KDM5C R1151C mutations in Skin Cutaneous Melanoma?,ssm_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How widespread are KDM5C R1177C mutations in Skin Cutaneous Melanoma?,ssm_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How widespread are KDM5C R1217C mutations in Skin Cutaneous Melanoma?,ssm_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How widespread are KDM5C R1218C mutations in Skin Cutaneous Melanoma?,ssm_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread are IL5RA L153F mutations in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,How widespread are DHX16 A29V mutations in Skin Cutaneous Melanoma?,ssm_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,How widespread are DHX16 A89V mutations in Skin Cutaneous Melanoma?,ssm_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,How widespread are GPR158 A644V mutations in Stomach Adenocarcinoma?,ssm_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,How widespread are GPR158 A723V mutations in Stomach Adenocarcinoma?,ssm_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread are EIF2B4 E108K mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread are EIF2B4 E110K mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread are EIF2B4 E111K mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread are EIF2B4 E131K mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread are EIF2B4 E132K mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread are EIF2B4 E96K mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How widespread are AUTS2 P136S mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How widespread are AUTS2 P218S mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How widespread are AUTS2 P233S mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How widespread are AUTS2 P313S mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How widespread are AUTS2 P419S mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How widespread are AUTS2 P443S mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How widespread are AUTS2 P56S mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How widespread are AUTS2 P667S mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How widespread are AUTS2 P690S mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How widespread are AUTS2 P691S mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread are ACTL7B D223N mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How widespread are PCDHGA1 R535W mutations in Glioblastoma Multiforme?,ssm_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,How widespread are TRAP1 R114W mutations in Stomach Adenocarcinoma?,ssm_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,How widespread are TRAP1 R61W mutations in Stomach Adenocarcinoma?,ssm_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How widespread are PIK3C2A R1570Q mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How widespread are KANSL1 R139G mutations in Liver Hepatocellular Carcinoma?,ssm_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How widespread are ANKRD52 Y594C mutations in Stomach Adenocarcinoma?,ssm_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How widespread are PAPPA G1580S mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How widespread are B3GALNT1 V270A mutations in Rectum Adenocarcinoma?,ssm_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,How widespread are GABRA6 G115R mutations in Lung Adenocarcinoma?,ssm_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,How widespread are GABRA6 G122R mutations in Lung Adenocarcinoma?,ssm_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,How widespread are GABRA6 G165R mutations in Lung Adenocarcinoma?,ssm_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,How widespread are GABRA6 G175R mutations in Lung Adenocarcinoma?,ssm_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,How widespread are GABRA6 G70R mutations in Lung Adenocarcinoma?,ssm_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How widespread are ZSCAN31 D9N mutations in Skin Cutaneous Melanoma?,ssm_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread are MED16 L126P mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread are MED16 L868P mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How widespread are PTPRO E1060K mutations in Pancreatic Adenocarcinoma?,ssm_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How widespread are PTPRO E1088K mutations in Pancreatic Adenocarcinoma?,ssm_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How widespread are PTPRO E249K mutations in Pancreatic Adenocarcinoma?,ssm_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How widespread are PTPRO E265K mutations in Pancreatic Adenocarcinoma?,ssm_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How widespread are PTPRO E277K mutations in Pancreatic Adenocarcinoma?,ssm_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How widespread are PTPRO E67K mutations in Pancreatic Adenocarcinoma?,ssm_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How widespread are PTPRO E923K mutations in Pancreatic Adenocarcinoma?,ssm_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How widespread are PTPRO E940K mutations in Pancreatic Adenocarcinoma?,ssm_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How widespread are CHMP7 D397N mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,How widespread are GPC3 I107N mutations in Stomach Adenocarcinoma?,ssm_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,How widespread are GPC3 I161N mutations in Stomach Adenocarcinoma?,ssm_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread are TLK2 V430L mutations in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread are TLK2 V515L mutations in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread are TLK2 V547L mutations in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread are TLK2 V579L mutations in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread are TLK2 V601L mutations in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How widespread are ZNF217 E209Q mutations in Lung Adenocarcinoma?,ssm_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,How widespread are SYT9 V275L mutations in Lung Adenocarcinoma?,ssm_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,How widespread are SYT9 V307L mutations in Lung Adenocarcinoma?,ssm_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How widespread are PKHD1L1 S2830N mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How widespread are MYO3A Y1295C mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread are VASN V318I mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How widespread are DNMT1 A1037T mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How widespread are DNMT1 A1053T mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How widespread are DNMT1 A934T mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,How widespread are CA9 E402K mutations in Colon Adenocarcinoma?,ssm_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How widespread are TTC17 R808Q mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How widespread are TTC17 R865Q mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,How widespread are PSG2 P43L mutations in Breast Invasive Carcinoma?,ssm_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How widespread are RIPOR2 R470L mutations in Breast Invasive Carcinoma?,ssm_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How widespread are RIPOR2 R499L mutations in Breast Invasive Carcinoma?,ssm_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How widespread are RIPOR2 R504L mutations in Breast Invasive Carcinoma?,ssm_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How widespread are RIPOR2 R520L mutations in Breast Invasive Carcinoma?,ssm_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How widespread are DCLK3 V520I mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How widespread are DCLK3 V689I mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How widespread are MERTK G257A mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How widespread are MERTK G757A mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How widespread are MERTK G933A mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How widespread are ZFP42 R206K mutations in Skin Cutaneous Melanoma?,ssm_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How widespread are OR13C3 M117I mutations in Skin Cutaneous Melanoma?,ssm_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How widespread are OR13C3 M147I mutations in Skin Cutaneous Melanoma?,ssm_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How widespread are SPAG1 I917M mutations in Stomach Adenocarcinoma?,ssm_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How widespread are CDKN2AIP Y92H mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,How widespread are PXN H1016Y mutations in Colon Adenocarcinoma?,ssm_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,How widespread are PXN H359Y mutations in Colon Adenocarcinoma?,ssm_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,How widespread are PXN H492Y mutations in Colon Adenocarcinoma?,ssm_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,How widespread are PXN H524Y mutations in Colon Adenocarcinoma?,ssm_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,How widespread are PXN H526Y mutations in Colon Adenocarcinoma?,ssm_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,How widespread are PXN H540Y mutations in Colon Adenocarcinoma?,ssm_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How widespread are TTYH2 S23L mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How widespread are TTYH2 S44L mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How widespread are TMEM255A N205S mutations in Colon Adenocarcinoma?,ssm_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How widespread are TMEM255A N229S mutations in Colon Adenocarcinoma?,ssm_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How widespread are TMEM255A N65S mutations in Colon Adenocarcinoma?,ssm_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How widespread are TASOR2 H2271D mutations in Breast Invasive Carcinoma?,ssm_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How widespread are TASOR2 H2486D mutations in Breast Invasive Carcinoma?,ssm_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How widespread are ICE1 T1839M mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,How widespread are MYT1 A558E mutations in Breast Invasive Carcinoma?,ssm_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,How widespread are MYT1 A879E mutations in Breast Invasive Carcinoma?,ssm_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,How widespread are MYT1 A906E mutations in Breast Invasive Carcinoma?,ssm_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How widespread are CX3CR1 P203L mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How widespread are CX3CR1 P235L mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How widespread are SPINDOC R197C mutations in Liver Hepatocellular Carcinoma?,ssm_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How widespread are ART3 C251Y mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How widespread are ART3 C3Y mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How widespread are CYP1A2 R243G mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread are ADRA1A G279S mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How widespread are CDH23 P2523R mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How widespread are CDH23 P283R mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How widespread are KRT39 P137S mutations in Skin Cutaneous Melanoma?,ssm_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How widespread are PDHA2 S7F mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How widespread are SLC24A2 H200Q mutations in Colon Adenocarcinoma?,ssm_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How widespread are PTPRN2 F153L mutations in Liver Hepatocellular Carcinoma?,ssm_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How widespread are PTPRN2 F847L mutations in Liver Hepatocellular Carcinoma?,ssm_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How widespread are PTPRN2 F856L mutations in Liver Hepatocellular Carcinoma?,ssm_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How widespread are PTPRN2 F868L mutations in Liver Hepatocellular Carcinoma?,ssm_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How widespread are PTPRN2 F885L mutations in Liver Hepatocellular Carcinoma?,ssm_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,How widespread are SOX21 R55L mutations in Lung Adenocarcinoma?,ssm_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How widespread are CPA6 G166E mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How widespread are GRM5 E14K mutations in Skin Cutaneous Melanoma?,ssm_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread are CASZ1 R233Q mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How widespread are SGIP1 N122T mutations in Stomach Adenocarcinoma?,ssm_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How widespread are SGIP1 N420T mutations in Stomach Adenocarcinoma?,ssm_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How widespread are SGIP1 N617T mutations in Stomach Adenocarcinoma?,ssm_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How widespread are SGIP1 N648T mutations in Stomach Adenocarcinoma?,ssm_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How widespread are CARMIL1 V549L mutations in Lung Adenocarcinoma?,ssm_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How widespread are CARMIL1 V949L mutations in Lung Adenocarcinoma?,ssm_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How widespread are ZNF431 D121Y mutations in Lung Adenocarcinoma?,ssm_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How widespread are ZNF431 D161Y mutations in Lung Adenocarcinoma?,ssm_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,How widespread are ZNF431 R128I mutations in Lung Adenocarcinoma?,ssm_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How widespread are DNAH11 P2987S mutations in Skin Cutaneous Melanoma?,ssm_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How widespread are DNAH11 P2994S mutations in Skin Cutaneous Melanoma?,ssm_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How widespread are POLD1 Q461L mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How widespread are POLD1 Q85L mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,How widespread are TTC12 D646H mutations in Lung Adenocarcinoma?,ssm_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,How widespread are TTC12 D652H mutations in Lung Adenocarcinoma?,ssm_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How widespread are CNGB1 D967N mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How widespread are CNGB1 D973N mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,How widespread are CTSC E214V mutations in Stomach Adenocarcinoma?,ssm_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,How widespread are CTSC E291V mutations in Stomach Adenocarcinoma?,ssm_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,How widespread are CTSC E322V mutations in Stomach Adenocarcinoma?,ssm_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,How widespread are CTSC E324V mutations in Stomach Adenocarcinoma?,ssm_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,How widespread are CTSC E335V mutations in Stomach Adenocarcinoma?,ssm_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How widespread are PRSS8 A179T mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How widespread are PRSS8 A233T mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How widespread are ARHGEF40 V864F mutations in Lung Adenocarcinoma?,ssm_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,How widespread are ACTB A138T mutations in Rectum Adenocarcinoma?,ssm_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,How widespread are ACTB A217T mutations in Rectum Adenocarcinoma?,ssm_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,How widespread are ACTB A244T mutations in Rectum Adenocarcinoma?,ssm_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,How widespread are ACTB A260T mutations in Rectum Adenocarcinoma?,ssm_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How widespread are YY1AP1 V546D mutations in Glioblastoma Multiforme?,ssm_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How widespread are YY1AP1 V557D mutations in Glioblastoma Multiforme?,ssm_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How widespread are YY1AP1 V566D mutations in Glioblastoma Multiforme?,ssm_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How widespread are YY1AP1 V577D mutations in Glioblastoma Multiforme?,ssm_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How widespread are YY1AP1 V623D mutations in Glioblastoma Multiforme?,ssm_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How widespread are YY1AP1 V695D mutations in Glioblastoma Multiforme?,ssm_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How widespread are YY1AP1 V715D mutations in Glioblastoma Multiforme?,ssm_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How widespread are FNDC7 D323N mutations in Skin Cutaneous Melanoma?,ssm_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How widespread are FNDC7 D99N mutations in Skin Cutaneous Melanoma?,ssm_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,How widespread are TLCD5 G15V mutations in Lung Adenocarcinoma?,ssm_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,How widespread are TLCD5 G37V mutations in Lung Adenocarcinoma?,ssm_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How widespread are POLR1G R498W mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How widespread are POLR1G R500W mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How widespread are DNAH14 N1186K mutations in Colon Adenocarcinoma?,ssm_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How widespread are DNAH14 N2657K mutations in Colon Adenocarcinoma?,ssm_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How widespread are DNAH14 N3460K mutations in Colon Adenocarcinoma?,ssm_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How widespread are NEXN E73D mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How widespread are CYB5R2 G112R mutations in Prostate Adenocarcinoma?,ssm_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How widespread are CYB5R2 G172R mutations in Prostate Adenocarcinoma?,ssm_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How widespread are NRAP S808L mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How widespread are NRAP S816L mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How widespread are NRAP S843L mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How widespread are CCDC22 E179D mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How widespread are DCAF6 S402F mutations in Skin Cutaneous Melanoma?,ssm_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How widespread are DCAF6 S433F mutations in Skin Cutaneous Melanoma?,ssm_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How widespread are ZNF708 E389D mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How widespread are BFAR T103M mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How widespread are MAST4 P1237S mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How widespread are MAST4 P1986S mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How widespread are MAST4 P1991S mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How widespread are MAST4 P2001S mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How widespread are MAST4 P2180S mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How widespread are ARMC3 R169C mutations in Stomach Adenocarcinoma?,ssm_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How widespread are ARMC3 R432C mutations in Stomach Adenocarcinoma?,ssm_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How widespread are TET2 L757V mutations in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How widespread are TET2 L778V mutations in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How widespread are SERPINB10 A353P mutations in Lung Adenocarcinoma?,ssm_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How widespread are STAT3 Y22H mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How widespread are MIEF1 A42T mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How widespread are ACVR1B D397N mutations in Colon Adenocarcinoma?,ssm_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How widespread are ACVR1B D449N mutations in Colon Adenocarcinoma?,ssm_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How widespread are ACVR1B D490N mutations in Colon Adenocarcinoma?,ssm_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,How widespread are EBF2 T104I mutations in Stomach Adenocarcinoma?,ssm_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,How widespread are EBF2 T252I mutations in Stomach Adenocarcinoma?,ssm_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How widespread are VPS26B F266L mutations in Stomach Adenocarcinoma?,ssm_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread are PGR M106I mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread are PGR M38I mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread are PGR M632I mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How widespread are ACTA2 P334L mutations in Skin Cutaneous Melanoma?,ssm_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How widespread are THBS4 T852I mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How widespread are THBS4 T943I mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,How widespread are PRSS1 S114T mutations in Lung Adenocarcinoma?,ssm_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,How widespread are PRSS1 S124T mutations in Lung Adenocarcinoma?,ssm_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,How widespread are PRSS1 S138T mutations in Lung Adenocarcinoma?,ssm_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,How widespread are PRSS1 S74T mutations in Lung Adenocarcinoma?,ssm_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,How widespread are PGF R126H mutations in Stomach Adenocarcinoma?,ssm_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,How widespread are PGF R127H mutations in Stomach Adenocarcinoma?,ssm_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How widespread are ITPRID2 S351C mutations in Breast Invasive Carcinoma?,ssm_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How widespread are ITPRID2 S842C mutations in Breast Invasive Carcinoma?,ssm_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How widespread are HBB E8D mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How widespread are PCDHB2 R158C mutations in Colon Adenocarcinoma?,ssm_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How widespread are PCDHB2 T15M mutations in Colon Adenocarcinoma?,ssm_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How widespread are PCDHB2 T26M mutations in Colon Adenocarcinoma?,ssm_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How widespread are UBR2 P1594S mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How widespread are FBXO42 A618D mutations in Rectum Adenocarcinoma?,ssm_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,How often is the TNS1 G1362V found in Breast Invasive Carcinoma?,ssm_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,How often is the TNS1 G1711V found in Breast Invasive Carcinoma?,ssm_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,How often is the TNS1 G1718V found in Breast Invasive Carcinoma?,ssm_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,How often is the TNS1 G1732V found in Breast Invasive Carcinoma?,ssm_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,How often is the TNS1 G1824V found in Breast Invasive Carcinoma?,ssm_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,How often is the TNS1 G1857V found in Breast Invasive Carcinoma?,ssm_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,How often is the TNS1 G843V found in Breast Invasive Carcinoma?,ssm_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How often is the EVC2 E1067K found in Bladder Urothelial Carcinoma?,ssm_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How often is the EVC2 E987K found in Bladder Urothelial Carcinoma?,ssm_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How often is the CR1 V1108G found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How often is the CR1 V1558G found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,How often is the TRPA1 S295I found in Rectum Adenocarcinoma?,ssm_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,How often is the TRPA1 S443I found in Rectum Adenocarcinoma?,ssm_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,How often is the TAF1C R299L found in Lung Adenocarcinoma?,ssm_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,How often is the TAF1C R396L found in Lung Adenocarcinoma?,ssm_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,How often is the TAF1C R634L found in Lung Adenocarcinoma?,ssm_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,How often is the TAF1C R702L found in Lung Adenocarcinoma?,ssm_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,How often is the TAF1C R728L found in Lung Adenocarcinoma?,ssm_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How often is the DPF3 R104W found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How often is the DPF3 R149W found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How often is the DPF3 R94W found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,How often is the OR2T4 P272H found in Lung Adenocarcinoma?,ssm_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,How often is the OR2T4 P300H found in Lung Adenocarcinoma?,ssm_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How often is the FBN1 E2667K found in Pancreatic Adenocarcinoma?,ssm_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How often is the MAD1L1 E396K found in Prostate Adenocarcinoma?,ssm_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How often is the MAD1L1 E488K found in Prostate Adenocarcinoma?,ssm_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How often is the MAD1L1 E78K found in Prostate Adenocarcinoma?,ssm_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How often is the CCNG1 E22K found in Skin Cutaneous Melanoma?,ssm_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How often is the ANP32E N114T found in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How often is the ANP32E N64T found in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How often is the ANP32E N66T found in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How often is the ANP32E N73T found in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How often is the FRY S1888A found in Bladder Urothelial Carcinoma?,ssm_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How often is the FRY S1937A found in Bladder Urothelial Carcinoma?,ssm_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How often is the FRY S1938A found in Bladder Urothelial Carcinoma?,ssm_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How often is the FRY S1983A found in Bladder Urothelial Carcinoma?,ssm_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,How often is the PAK3 E318K found in Skin Cutaneous Melanoma?,ssm_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,How often is the PAK3 E319K found in Skin Cutaneous Melanoma?,ssm_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,How often is the PAK3 E334K found in Skin Cutaneous Melanoma?,ssm_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,How often is the PAK3 E340K found in Skin Cutaneous Melanoma?,ssm_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,How often is the PAK3 E355K found in Skin Cutaneous Melanoma?,ssm_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How often is the MUC16 P7963L found in Skin Cutaneous Melanoma?,ssm_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How often is the ZFPM2 T498I found in Liver Hepatocellular Carcinoma?,ssm_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How often is the ZFPM2 T630I found in Liver Hepatocellular Carcinoma?,ssm_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How often is the PIK3C2B S1328C found in Breast Invasive Carcinoma?,ssm_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How often is the PIK3C2B S1356C found in Breast Invasive Carcinoma?,ssm_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How often is the ZNF804A S371Y found in Colon Adenocarcinoma?,ssm_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,How often is the RELN A2371V found in Stomach Adenocarcinoma?,ssm_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is the EFCAB12 R173C found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is the EFCAB12 R23C found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How often is the DEFB115 E53K found in Skin Cutaneous Melanoma?,ssm_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How often is the ANKDD1A S290F found in Bladder Urothelial Carcinoma?,ssm_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How often is the ANKDD1A S322F found in Bladder Urothelial Carcinoma?,ssm_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How often is the ANKDD1A S413F found in Bladder Urothelial Carcinoma?,ssm_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How often is the HTR3B S146I found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How often is the HTR3B S206I found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How often is the HTR3B S217I found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,How often is the ABCC3 R758W found in Stomach Adenocarcinoma?,ssm_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How often is the NOMO1 T204I found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How often is the NOMO1 T371I found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How often is the HYOU1 D298H found in Bladder Urothelial Carcinoma?,ssm_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How often is the FMO4 R500Q found in Skin Cutaneous Melanoma?,ssm_frequency
+140,BICC1,A372V,Exceptional Responders,How often is the BICC1 A372V found in Exceptional Responders?,ssm_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How often is the ZMYM3 I920V found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How often is the ZMYM3 I932V found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How often is the ZMYM3 I934V found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is the XKR4 R547W found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How often is the ABCC2 V239L found in Liver Hepatocellular Carcinoma?,ssm_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,How often is the OR8K5 R293G found in Lung Adenocarcinoma?,ssm_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How often is the SPTAN1 S1503F found in Skin Cutaneous Melanoma?,ssm_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How often is the SPTAN1 S1523F found in Skin Cutaneous Melanoma?,ssm_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,How often is the SYT10 M484I found in Rectum Adenocarcinoma?,ssm_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How often is the HSPA5 N457K found in Skin Cutaneous Melanoma?,ssm_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,How often is the UNC5D L280V found in Lung Adenocarcinoma?,ssm_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,How often is the UNC5D L635V found in Lung Adenocarcinoma?,ssm_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,How often is the UNC5D L637V found in Lung Adenocarcinoma?,ssm_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,How often is the UNC5D L699V found in Lung Adenocarcinoma?,ssm_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,How often is the UNC5D L704V found in Lung Adenocarcinoma?,ssm_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,How often is the UNC5D L709V found in Lung Adenocarcinoma?,ssm_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How often is the DOCK2 L1527H found in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How often is the ZNF627 A5V found in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How often is the CDC42BPA L823F found in Skin Cutaneous Melanoma?,ssm_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,How often is the MRPL55 H27Y found in Colon Adenocarcinoma?,ssm_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,How often is the MRPL55 H63Y found in Colon Adenocarcinoma?,ssm_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How often is the TMTC3 Q749K found in Breast Invasive Carcinoma?,ssm_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,How often is the EPRS1 K771I found in Colon Adenocarcinoma?,ssm_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,How often is the EPRS1 K778I found in Colon Adenocarcinoma?,ssm_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How often is the GRTP1 A110V found in Skin Cutaneous Melanoma?,ssm_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How often is the GRTP1 A32V found in Skin Cutaneous Melanoma?,ssm_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How often is the TSHZ3 Q538K found in Stomach Adenocarcinoma?,ssm_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How often is the TAS1R3 Q326H found in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,ssm_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How often is the PIAS3 S238C found in Lung Squamous Cell Carcinoma?,ssm_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How often is the PIAS3 S273C found in Lung Squamous Cell Carcinoma?,ssm_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,How often is the ZNF274 P13R found in Stomach Adenocarcinoma?,ssm_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,How often is the SYNJ1 R795C found in Colon Adenocarcinoma?,ssm_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,How often is the SYNJ1 R800C found in Colon Adenocarcinoma?,ssm_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,How often is the SYNJ1 R839C found in Colon Adenocarcinoma?,ssm_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,How often is the DSCAM V343M found in Prostate Adenocarcinoma?,ssm_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,How often is the DSCAM V426M found in Prostate Adenocarcinoma?,ssm_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,How often is the DSCAM V591M found in Prostate Adenocarcinoma?,ssm_frequency
+267,DGKD,R140H,Exceptional Responders,How often is the DGKD R140H found in Exceptional Responders?,ssm_frequency
+268,DGKD,R160H,Exceptional Responders,How often is the DGKD R160H found in Exceptional Responders?,ssm_frequency
+269,DGKD,R204H,Exceptional Responders,How often is the DGKD R204H found in Exceptional Responders?,ssm_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How often is the PLEKHG6 D105Y found in Bladder Urothelial Carcinoma?,ssm_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How often is the PLEKHG6 D543Y found in Bladder Urothelial Carcinoma?,ssm_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How often is the PLEKHG6 D575Y found in Bladder Urothelial Carcinoma?,ssm_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,How often is the WNT2 D138N found in Skin Cutaneous Melanoma?,ssm_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How often is the GUCY2C G667R found in Skin Cutaneous Melanoma?,ssm_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How often is the C7orf31 P244H found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is the ZKSCAN7 E64K found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+299,OR5D14,M210L,Neuroblastoma,How often is the OR5D14 M210L found in Neuroblastoma?,ssm_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How often is the SPATA22 K279E found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How often is the SPATA22 K306E found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How often is the SPATA22 K322E found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,How often is the LCN15 E21V found in Stomach Adenocarcinoma?,ssm_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How often is the DCAF4L2 S129F found in Skin Cutaneous Melanoma?,ssm_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How often is the GUK1 R135P found in Lung Squamous Cell Carcinoma?,ssm_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How often is the GUK1 R137P found in Lung Squamous Cell Carcinoma?,ssm_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How often is the GUK1 R139P found in Lung Squamous Cell Carcinoma?,ssm_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How often is the GUK1 R158P found in Lung Squamous Cell Carcinoma?,ssm_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How often is the GUK1 R203P found in Lung Squamous Cell Carcinoma?,ssm_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How often is the MORF4L1 K29T found in Stomach Adenocarcinoma?,ssm_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How often is the MORF4L1 K51T found in Stomach Adenocarcinoma?,ssm_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How often is the MORF4L1 K61T found in Stomach Adenocarcinoma?,ssm_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How often is the MORF4L1 K76T found in Stomach Adenocarcinoma?,ssm_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How often is the MYO3B F594L found in Skin Cutaneous Melanoma?,ssm_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How often is the MYO3B F603L found in Skin Cutaneous Melanoma?,ssm_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How often is the TENT5A S320F found in Skin Cutaneous Melanoma?,ssm_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How often is the TENT5A S339F found in Skin Cutaneous Melanoma?,ssm_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How often is the TENT5A S401F found in Skin Cutaneous Melanoma?,ssm_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How often is the ZFAT S614L found in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How often is the ZFAT S664L found in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How often is the ZFAT S676L found in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+357,ZNF584,A211T,Sarcoma,How often is the ZNF584 A211T found in Sarcoma?,ssm_frequency
+358,ZNF584,A256T,Sarcoma,How often is the ZNF584 A256T found in Sarcoma?,ssm_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How often is the LDOC1 R63W found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How often is the PDGFC R201G found in Lung Squamous Cell Carcinoma?,ssm_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How often is the MSANTD4 R304C found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How often is the NPSR1 S123L found in Skin Cutaneous Melanoma?,ssm_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How often is the PHLPP1 K1317E found in Lung Squamous Cell Carcinoma?,ssm_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How often is the COL6A3 G237S found in Skin Cutaneous Melanoma?,ssm_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How often is the COL6A3 G437S found in Skin Cutaneous Melanoma?,ssm_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How often is the COL6A3 G638S found in Skin Cutaneous Melanoma?,ssm_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How often is the COL6A3 G644S found in Skin Cutaneous Melanoma?,ssm_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How often is the COL6A3 G844S found in Skin Cutaneous Melanoma?,ssm_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How often is the ADRA1A R348G found in Stomach Adenocarcinoma?,ssm_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often is the LAMB2 S1254F found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,How often is the POC1B I198T found in Rectum Adenocarcinoma?,ssm_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,How often is the POC1B I286T found in Rectum Adenocarcinoma?,ssm_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,How often is the POC1B I328T found in Rectum Adenocarcinoma?,ssm_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,How often is the POC1B S79P found in Rectum Adenocarcinoma?,ssm_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How often is the USH2A G1451C found in Liver Hepatocellular Carcinoma?,ssm_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,How often is the AQP7 T110S found in Rectum Adenocarcinoma?,ssm_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,How often is the AQP7 T166S found in Rectum Adenocarcinoma?,ssm_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,How often is the AQP7 T167S found in Rectum Adenocarcinoma?,ssm_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,How often is the AQP7 T75S found in Rectum Adenocarcinoma?,ssm_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,How often is the DCN R163C found in Rectum Adenocarcinoma?,ssm_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,How often is the DCN R203C found in Rectum Adenocarcinoma?,ssm_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,How often is the DCN R241C found in Rectum Adenocarcinoma?,ssm_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,How often is the DCN R350C found in Rectum Adenocarcinoma?,ssm_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,How often is the DCN R41C found in Rectum Adenocarcinoma?,ssm_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How often is the CPS1 K1269N found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How often is the CPS1 K1275N found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How often is the CPS1 K818N found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How often is the FCGR2C P122S found in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How often is the FCGR2C P123S found in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How often is the GRM1 R280M found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,How often is the SGCZ Q138H found in Lung Adenocarcinoma?,ssm_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,How often is the SGCZ Q91H found in Lung Adenocarcinoma?,ssm_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,How often is the SMO V15M found in Stomach Adenocarcinoma?,ssm_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,How often is the SMO V321M found in Stomach Adenocarcinoma?,ssm_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,How often is the CHODL G159E found in Skin Cutaneous Melanoma?,ssm_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,How often is the CHODL G181E found in Skin Cutaneous Melanoma?,ssm_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,How often is the CHODL G200E found in Skin Cutaneous Melanoma?,ssm_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,How often is the MYO16 P399H found in Colon Adenocarcinoma?,ssm_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,How often is the MYO16 P421H found in Colon Adenocarcinoma?,ssm_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,How often is the CXCR2 A98V found in Stomach Adenocarcinoma?,ssm_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How often is the TMEM225 L212V found in Bladder Urothelial Carcinoma?,ssm_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How often is the MAOB N251T found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How often is the GPRASP1 F580S found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How often is the MRPL32 R181Q found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How often is the TYROBP A29T found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,How often is the RAB40C A111V found in Lung Adenocarcinoma?,ssm_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,How often is the RAB40C A143V found in Lung Adenocarcinoma?,ssm_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,How often is the CTNNA2 S323R found in Lung Adenocarcinoma?,ssm_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,How often is the CTNNA2 S339R found in Lung Adenocarcinoma?,ssm_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,How often is the CTNNA2 S386R found in Lung Adenocarcinoma?,ssm_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,How often is the CTNNA2 S707R found in Lung Adenocarcinoma?,ssm_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How often is the MYO15A S268R found in Bladder Urothelial Carcinoma?,ssm_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How often is the GIMAP2 A167T found in Skin Cutaneous Melanoma?,ssm_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,How often is the KIF20B N1160D found in Glioblastoma Multiforme?,ssm_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,How often is the KIF20B N1200D found in Glioblastoma Multiforme?,ssm_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How often is the ADAM17 E583K found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How often is the BCAT1 G16R found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How often is the BCAT1 G17R found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How often is the BCAT1 G29R found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,How often is the ERCC6 R1053H found in Colon Adenocarcinoma?,ssm_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,How often is the DCC R320W found in Breast Invasive Carcinoma?,ssm_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,How often is the DCC R363W found in Breast Invasive Carcinoma?,ssm_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,How often is the DCC R386W found in Breast Invasive Carcinoma?,ssm_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,How often is the DCC R41W found in Breast Invasive Carcinoma?,ssm_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How often is the FBXO15 D417N found in Skin Cutaneous Melanoma?,ssm_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How often is the FBXO15 D86N found in Skin Cutaneous Melanoma?,ssm_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How often is the GSTCD S528F found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How often is the GSTCD S615F found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How often is the OLFML3 P296S found in Lung Squamous Cell Carcinoma?,ssm_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How often is the OLFML3 P337S found in Lung Squamous Cell Carcinoma?,ssm_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How often is the OLFML3 P357S found in Lung Squamous Cell Carcinoma?,ssm_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How often is the CFAP61 E173V found in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How often is the CFAP61 E817V found in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How often is the HLA-DQA2 E51K found in Bladder Urothelial Carcinoma?,ssm_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How often is the TENM2 H240Y found in Skin Cutaneous Melanoma?,ssm_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How often is the TENM2 H351Y found in Skin Cutaneous Melanoma?,ssm_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How often is the TENM2 H472Y found in Skin Cutaneous Melanoma?,ssm_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How often is the ANKRD24 A465T found in Stomach Adenocarcinoma?,ssm_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How often is the ANKRD24 A494T found in Stomach Adenocarcinoma?,ssm_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How often is the ANKRD24 A584T found in Stomach Adenocarcinoma?,ssm_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How often is the ZCCHC14 V549M found in Stomach Adenocarcinoma?,ssm_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How often is the ZCCHC14 V665M found in Stomach Adenocarcinoma?,ssm_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How often is the ZCCHC14 V676M found in Stomach Adenocarcinoma?,ssm_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How often is the ZCCHC14 V802M found in Stomach Adenocarcinoma?,ssm_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,How often is the SIK2 I265M found in Lung Adenocarcinoma?,ssm_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How often is the MYH11 T1336M found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How often is the MYH11 T1343M found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How often is the SLC6A4 S174F found in Skin Cutaneous Melanoma?,ssm_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How often is the SLC9C1 K102N found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How often is the SLC9C1 K29N found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,How often is the OR2A12 A254T found in Brain Lower Grade Glioma?,ssm_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,How often is the PYHIN1 T325K found in Lung Adenocarcinoma?,ssm_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,How often is the PYHIN1 T334K found in Lung Adenocarcinoma?,ssm_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,How often is the JAML G191E found in Skin Cutaneous Melanoma?,ssm_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,How often is the JAML G219E found in Skin Cutaneous Melanoma?,ssm_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,How often is the JAML G220E found in Skin Cutaneous Melanoma?,ssm_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,How often is the JAML G230E found in Skin Cutaneous Melanoma?,ssm_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,How often is the TYK2 H1146R found in Stomach Adenocarcinoma?,ssm_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,How often is the TYK2 H23R found in Stomach Adenocarcinoma?,ssm_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,How often is the TYK2 H961R found in Stomach Adenocarcinoma?,ssm_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How often is the CTCFL R208C found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How often is the CTCFL R265C found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How often is the CTCFL R420C found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How often is the CTCFL R470C found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How often is the CEP20 R31Q found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How often is the CEP20 R58Q found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How often is the RIMS2 R25W found in Skin Cutaneous Melanoma?,ssm_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How often is the RIMS2 R393W found in Skin Cutaneous Melanoma?,ssm_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How often is the RIMS2 R423W found in Skin Cutaneous Melanoma?,ssm_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How often is the RIMS2 R470W found in Skin Cutaneous Melanoma?,ssm_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How often is the RIMS2 R615W found in Skin Cutaneous Melanoma?,ssm_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How often is the RIMS2 R619W found in Skin Cutaneous Melanoma?,ssm_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How often is the RIMS2 R716W found in Skin Cutaneous Melanoma?,ssm_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How often is the PIK3C2G S551L found in Skin Cutaneous Melanoma?,ssm_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How often is the PIK3C2G S592L found in Skin Cutaneous Melanoma?,ssm_frequency
+728,STK19,D341N,Colon Adenocarcinoma,How often is the STK19 D341N found in Colon Adenocarcinoma?,ssm_frequency
+729,STK19,D345N,Colon Adenocarcinoma,How often is the STK19 D345N found in Colon Adenocarcinoma?,ssm_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,How often is the REXO4 P60A found in Skin Cutaneous Melanoma?,ssm_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How often is the ZBTB34 P160S found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How often is the ZBTB34 P164S found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How often is the NCKAP5 E148K found in Bladder Urothelial Carcinoma?,ssm_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is the SORCS1 D1052Y found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is the SORCS1 D587Y found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is the SORCS1 D67Y found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is the SORCS1 D810Y found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How often is the FGF8 T154M found in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How often is the FGF8 T165M found in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How often is the FGF8 T183M found in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How often is the FGF8 T194M found in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How often is the FGF8 T90M found in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How often is the TENM3 R1877W found in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,ssm_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How often is the AKT1 D44N found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often is the CFAP298-TCP10L E11Q found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,How often is the GLRB E148D found in Stomach Adenocarcinoma?,ssm_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,How often is the TTN F7636L found in Colon Adenocarcinoma?,ssm_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,How often is the TTN F8563L found in Colon Adenocarcinoma?,ssm_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,How often is the TTN F8880L found in Colon Adenocarcinoma?,ssm_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How often is the ANKRD30A V798I found in Colon Adenocarcinoma?,ssm_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How often is the ANKRD30A V854I found in Colon Adenocarcinoma?,ssm_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How often is the ANKRD30A V973I found in Colon Adenocarcinoma?,ssm_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,How often is the TRIM45 S177L found in Colon Adenocarcinoma?,ssm_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,How often is the TRIM45 S224L found in Colon Adenocarcinoma?,ssm_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,How often is the TRIM45 S281L found in Colon Adenocarcinoma?,ssm_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How often is the CACNA1F G727V found in Stomach Adenocarcinoma?,ssm_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How often is the CACNA1F G781V found in Stomach Adenocarcinoma?,ssm_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How often is the CACNA1F G792V found in Stomach Adenocarcinoma?,ssm_frequency
+817,KL,R594C,Colon Adenocarcinoma,How often is the KL R594C found in Colon Adenocarcinoma?,ssm_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How often is the GUF1 I243T found in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,How often is the TAF1L A539V found in Colon Adenocarcinoma?,ssm_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How often is the TASOR2 S256F found in Skin Cutaneous Melanoma?,ssm_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How often is the TASOR2 S36F found in Skin Cutaneous Melanoma?,ssm_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How often is the TASOR2 S471F found in Skin Cutaneous Melanoma?,ssm_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How often is the KDM5C R1151C found in Skin Cutaneous Melanoma?,ssm_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How often is the KDM5C R1177C found in Skin Cutaneous Melanoma?,ssm_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How often is the KDM5C R1217C found in Skin Cutaneous Melanoma?,ssm_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How often is the KDM5C R1218C found in Skin Cutaneous Melanoma?,ssm_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often is the IL5RA L153F found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,How often is the DHX16 A29V found in Skin Cutaneous Melanoma?,ssm_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,How often is the DHX16 A89V found in Skin Cutaneous Melanoma?,ssm_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,How often is the GPR158 A644V found in Stomach Adenocarcinoma?,ssm_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,How often is the GPR158 A723V found in Stomach Adenocarcinoma?,ssm_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is the EIF2B4 E108K found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is the EIF2B4 E110K found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is the EIF2B4 E111K found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is the EIF2B4 E131K found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is the EIF2B4 E132K found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is the EIF2B4 E96K found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How often is the AUTS2 P136S found in Lung Squamous Cell Carcinoma?,ssm_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How often is the AUTS2 P218S found in Lung Squamous Cell Carcinoma?,ssm_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How often is the AUTS2 P233S found in Lung Squamous Cell Carcinoma?,ssm_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How often is the AUTS2 P313S found in Lung Squamous Cell Carcinoma?,ssm_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How often is the AUTS2 P419S found in Lung Squamous Cell Carcinoma?,ssm_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How often is the AUTS2 P443S found in Lung Squamous Cell Carcinoma?,ssm_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How often is the AUTS2 P56S found in Lung Squamous Cell Carcinoma?,ssm_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How often is the AUTS2 P667S found in Lung Squamous Cell Carcinoma?,ssm_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How often is the AUTS2 P690S found in Lung Squamous Cell Carcinoma?,ssm_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How often is the AUTS2 P691S found in Lung Squamous Cell Carcinoma?,ssm_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is the ACTL7B D223N found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How often is the PCDHGA1 R535W found in Glioblastoma Multiforme?,ssm_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,How often is the TRAP1 R114W found in Stomach Adenocarcinoma?,ssm_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,How often is the TRAP1 R61W found in Stomach Adenocarcinoma?,ssm_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How often is the PIK3C2A R1570Q found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How often is the KANSL1 R139G found in Liver Hepatocellular Carcinoma?,ssm_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How often is the ANKRD52 Y594C found in Stomach Adenocarcinoma?,ssm_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How often is the PAPPA G1580S found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How often is the B3GALNT1 V270A found in Rectum Adenocarcinoma?,ssm_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,How often is the GABRA6 G115R found in Lung Adenocarcinoma?,ssm_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,How often is the GABRA6 G122R found in Lung Adenocarcinoma?,ssm_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,How often is the GABRA6 G165R found in Lung Adenocarcinoma?,ssm_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,How often is the GABRA6 G175R found in Lung Adenocarcinoma?,ssm_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,How often is the GABRA6 G70R found in Lung Adenocarcinoma?,ssm_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How often is the ZSCAN31 D9N found in Skin Cutaneous Melanoma?,ssm_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is the MED16 L126P found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is the MED16 L868P found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How often is the PTPRO E1060K found in Pancreatic Adenocarcinoma?,ssm_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How often is the PTPRO E1088K found in Pancreatic Adenocarcinoma?,ssm_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How often is the PTPRO E249K found in Pancreatic Adenocarcinoma?,ssm_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How often is the PTPRO E265K found in Pancreatic Adenocarcinoma?,ssm_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How often is the PTPRO E277K found in Pancreatic Adenocarcinoma?,ssm_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How often is the PTPRO E67K found in Pancreatic Adenocarcinoma?,ssm_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How often is the PTPRO E923K found in Pancreatic Adenocarcinoma?,ssm_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How often is the PTPRO E940K found in Pancreatic Adenocarcinoma?,ssm_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How often is the CHMP7 D397N found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,How often is the GPC3 I107N found in Stomach Adenocarcinoma?,ssm_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,How often is the GPC3 I161N found in Stomach Adenocarcinoma?,ssm_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often is the TLK2 V430L found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often is the TLK2 V515L found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often is the TLK2 V547L found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often is the TLK2 V579L found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often is the TLK2 V601L found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How often is the ZNF217 E209Q found in Lung Adenocarcinoma?,ssm_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,How often is the SYT9 V275L found in Lung Adenocarcinoma?,ssm_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,How often is the SYT9 V307L found in Lung Adenocarcinoma?,ssm_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How often is the PKHD1L1 S2830N found in Lung Squamous Cell Carcinoma?,ssm_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How often is the MYO3A Y1295C found in Lung Squamous Cell Carcinoma?,ssm_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is the VASN V318I found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How often is the DNMT1 A1037T found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How often is the DNMT1 A1053T found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How often is the DNMT1 A934T found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,How often is the CA9 E402K found in Colon Adenocarcinoma?,ssm_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How often is the TTC17 R808Q found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How often is the TTC17 R865Q found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,How often is the PSG2 P43L found in Breast Invasive Carcinoma?,ssm_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How often is the RIPOR2 R470L found in Breast Invasive Carcinoma?,ssm_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How often is the RIPOR2 R499L found in Breast Invasive Carcinoma?,ssm_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How often is the RIPOR2 R504L found in Breast Invasive Carcinoma?,ssm_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How often is the RIPOR2 R520L found in Breast Invasive Carcinoma?,ssm_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How often is the DCLK3 V520I found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How often is the DCLK3 V689I found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How often is the MERTK G257A found in Lung Squamous Cell Carcinoma?,ssm_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How often is the MERTK G757A found in Lung Squamous Cell Carcinoma?,ssm_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How often is the MERTK G933A found in Lung Squamous Cell Carcinoma?,ssm_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How often is the ZFP42 R206K found in Skin Cutaneous Melanoma?,ssm_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How often is the OR13C3 M117I found in Skin Cutaneous Melanoma?,ssm_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How often is the OR13C3 M147I found in Skin Cutaneous Melanoma?,ssm_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How often is the SPAG1 I917M found in Stomach Adenocarcinoma?,ssm_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How often is the CDKN2AIP Y92H found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,How often is the PXN H1016Y found in Colon Adenocarcinoma?,ssm_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,How often is the PXN H359Y found in Colon Adenocarcinoma?,ssm_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,How often is the PXN H492Y found in Colon Adenocarcinoma?,ssm_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,How often is the PXN H524Y found in Colon Adenocarcinoma?,ssm_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,How often is the PXN H526Y found in Colon Adenocarcinoma?,ssm_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,How often is the PXN H540Y found in Colon Adenocarcinoma?,ssm_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How often is the TTYH2 S23L found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How often is the TTYH2 S44L found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How often is the TMEM255A N205S found in Colon Adenocarcinoma?,ssm_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How often is the TMEM255A N229S found in Colon Adenocarcinoma?,ssm_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How often is the TMEM255A N65S found in Colon Adenocarcinoma?,ssm_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How often is the TASOR2 H2271D found in Breast Invasive Carcinoma?,ssm_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How often is the TASOR2 H2486D found in Breast Invasive Carcinoma?,ssm_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How often is the ICE1 T1839M found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,How often is the MYT1 A558E found in Breast Invasive Carcinoma?,ssm_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,How often is the MYT1 A879E found in Breast Invasive Carcinoma?,ssm_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,How often is the MYT1 A906E found in Breast Invasive Carcinoma?,ssm_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How often is the CX3CR1 P203L found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How often is the CX3CR1 P235L found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How often is the SPINDOC R197C found in Liver Hepatocellular Carcinoma?,ssm_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How often is the ART3 C251Y found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How often is the ART3 C3Y found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How often is the CYP1A2 R243G found in Bladder Urothelial Carcinoma?,ssm_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is the ADRA1A G279S found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How often is the CDH23 P2523R found in Lung Squamous Cell Carcinoma?,ssm_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How often is the CDH23 P283R found in Lung Squamous Cell Carcinoma?,ssm_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How often is the KRT39 P137S found in Skin Cutaneous Melanoma?,ssm_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How often is the PDHA2 S7F found in Lung Squamous Cell Carcinoma?,ssm_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How often is the SLC24A2 H200Q found in Colon Adenocarcinoma?,ssm_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How often is the PTPRN2 F153L found in Liver Hepatocellular Carcinoma?,ssm_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How often is the PTPRN2 F847L found in Liver Hepatocellular Carcinoma?,ssm_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How often is the PTPRN2 F856L found in Liver Hepatocellular Carcinoma?,ssm_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How often is the PTPRN2 F868L found in Liver Hepatocellular Carcinoma?,ssm_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How often is the PTPRN2 F885L found in Liver Hepatocellular Carcinoma?,ssm_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,How often is the SOX21 R55L found in Lung Adenocarcinoma?,ssm_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How often is the CPA6 G166E found in Bladder Urothelial Carcinoma?,ssm_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How often is the GRM5 E14K found in Skin Cutaneous Melanoma?,ssm_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is the CASZ1 R233Q found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How often is the SGIP1 N122T found in Stomach Adenocarcinoma?,ssm_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How often is the SGIP1 N420T found in Stomach Adenocarcinoma?,ssm_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How often is the SGIP1 N617T found in Stomach Adenocarcinoma?,ssm_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How often is the SGIP1 N648T found in Stomach Adenocarcinoma?,ssm_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How often is the CARMIL1 V549L found in Lung Adenocarcinoma?,ssm_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How often is the CARMIL1 V949L found in Lung Adenocarcinoma?,ssm_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How often is the ZNF431 D121Y found in Lung Adenocarcinoma?,ssm_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How often is the ZNF431 D161Y found in Lung Adenocarcinoma?,ssm_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,How often is the ZNF431 R128I found in Lung Adenocarcinoma?,ssm_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How often is the DNAH11 P2987S found in Skin Cutaneous Melanoma?,ssm_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How often is the DNAH11 P2994S found in Skin Cutaneous Melanoma?,ssm_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How often is the POLD1 Q461L found in Lung Squamous Cell Carcinoma?,ssm_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How often is the POLD1 Q85L found in Lung Squamous Cell Carcinoma?,ssm_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,How often is the TTC12 D646H found in Lung Adenocarcinoma?,ssm_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,How often is the TTC12 D652H found in Lung Adenocarcinoma?,ssm_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How often is the CNGB1 D967N found in Bladder Urothelial Carcinoma?,ssm_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How often is the CNGB1 D973N found in Bladder Urothelial Carcinoma?,ssm_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,How often is the CTSC E214V found in Stomach Adenocarcinoma?,ssm_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,How often is the CTSC E291V found in Stomach Adenocarcinoma?,ssm_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,How often is the CTSC E322V found in Stomach Adenocarcinoma?,ssm_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,How often is the CTSC E324V found in Stomach Adenocarcinoma?,ssm_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,How often is the CTSC E335V found in Stomach Adenocarcinoma?,ssm_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How often is the PRSS8 A179T found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How often is the PRSS8 A233T found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How often is the ARHGEF40 V864F found in Lung Adenocarcinoma?,ssm_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,How often is the ACTB A138T found in Rectum Adenocarcinoma?,ssm_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,How often is the ACTB A217T found in Rectum Adenocarcinoma?,ssm_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,How often is the ACTB A244T found in Rectum Adenocarcinoma?,ssm_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,How often is the ACTB A260T found in Rectum Adenocarcinoma?,ssm_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How often is the YY1AP1 V546D found in Glioblastoma Multiforme?,ssm_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How often is the YY1AP1 V557D found in Glioblastoma Multiforme?,ssm_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How often is the YY1AP1 V566D found in Glioblastoma Multiforme?,ssm_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How often is the YY1AP1 V577D found in Glioblastoma Multiforme?,ssm_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How often is the YY1AP1 V623D found in Glioblastoma Multiforme?,ssm_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How often is the YY1AP1 V695D found in Glioblastoma Multiforme?,ssm_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How often is the YY1AP1 V715D found in Glioblastoma Multiforme?,ssm_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How often is the FNDC7 D323N found in Skin Cutaneous Melanoma?,ssm_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How often is the FNDC7 D99N found in Skin Cutaneous Melanoma?,ssm_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,How often is the TLCD5 G15V found in Lung Adenocarcinoma?,ssm_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,How often is the TLCD5 G37V found in Lung Adenocarcinoma?,ssm_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How often is the POLR1G R498W found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How often is the POLR1G R500W found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How often is the DNAH14 N1186K found in Colon Adenocarcinoma?,ssm_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How often is the DNAH14 N2657K found in Colon Adenocarcinoma?,ssm_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How often is the DNAH14 N3460K found in Colon Adenocarcinoma?,ssm_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How often is the NEXN E73D found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How often is the CYB5R2 G112R found in Prostate Adenocarcinoma?,ssm_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How often is the CYB5R2 G172R found in Prostate Adenocarcinoma?,ssm_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How often is the NRAP S808L found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How often is the NRAP S816L found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How often is the NRAP S843L found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How often is the CCDC22 E179D found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How often is the DCAF6 S402F found in Skin Cutaneous Melanoma?,ssm_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How often is the DCAF6 S433F found in Skin Cutaneous Melanoma?,ssm_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How often is the ZNF708 E389D found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How often is the BFAR T103M found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How often is the MAST4 P1237S found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How often is the MAST4 P1986S found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How often is the MAST4 P1991S found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How often is the MAST4 P2001S found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How often is the MAST4 P2180S found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How often is the ARMC3 R169C found in Stomach Adenocarcinoma?,ssm_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How often is the ARMC3 R432C found in Stomach Adenocarcinoma?,ssm_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How often is the TET2 L757V found in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How often is the TET2 L778V found in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How often is the SERPINB10 A353P found in Lung Adenocarcinoma?,ssm_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How often is the STAT3 Y22H found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How often is the MIEF1 A42T found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How often is the ACVR1B D397N found in Colon Adenocarcinoma?,ssm_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How often is the ACVR1B D449N found in Colon Adenocarcinoma?,ssm_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How often is the ACVR1B D490N found in Colon Adenocarcinoma?,ssm_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,How often is the EBF2 T104I found in Stomach Adenocarcinoma?,ssm_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,How often is the EBF2 T252I found in Stomach Adenocarcinoma?,ssm_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How often is the VPS26B F266L found in Stomach Adenocarcinoma?,ssm_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is the PGR M106I found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is the PGR M38I found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is the PGR M632I found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How often is the ACTA2 P334L found in Skin Cutaneous Melanoma?,ssm_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How often is the THBS4 T852I found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How often is the THBS4 T943I found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,How often is the PRSS1 S114T found in Lung Adenocarcinoma?,ssm_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,How often is the PRSS1 S124T found in Lung Adenocarcinoma?,ssm_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,How often is the PRSS1 S138T found in Lung Adenocarcinoma?,ssm_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,How often is the PRSS1 S74T found in Lung Adenocarcinoma?,ssm_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,How often is the PGF R126H found in Stomach Adenocarcinoma?,ssm_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,How often is the PGF R127H found in Stomach Adenocarcinoma?,ssm_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How often is the ITPRID2 S351C found in Breast Invasive Carcinoma?,ssm_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How often is the ITPRID2 S842C found in Breast Invasive Carcinoma?,ssm_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How often is the HBB E8D found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How often is the PCDHB2 R158C found in Colon Adenocarcinoma?,ssm_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How often is the PCDHB2 T15M found in Colon Adenocarcinoma?,ssm_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How often is the PCDHB2 T26M found in Colon Adenocarcinoma?,ssm_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How often is the UBR2 P1594S found in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How often is the FBXO42 A618D found in Rectum Adenocarcinoma?,ssm_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the occurrence rate of TNS1 G1362V in Breast Invasive Carcinoma patients?,ssm_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the occurrence rate of TNS1 G1711V in Breast Invasive Carcinoma patients?,ssm_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the occurrence rate of TNS1 G1718V in Breast Invasive Carcinoma patients?,ssm_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the occurrence rate of TNS1 G1732V in Breast Invasive Carcinoma patients?,ssm_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the occurrence rate of TNS1 G1824V in Breast Invasive Carcinoma patients?,ssm_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the occurrence rate of TNS1 G1857V in Breast Invasive Carcinoma patients?,ssm_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the occurrence rate of TNS1 G843V in Breast Invasive Carcinoma patients?,ssm_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the occurrence rate of EVC2 E1067K in Bladder Urothelial Carcinoma patients?,ssm_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the occurrence rate of EVC2 E987K in Bladder Urothelial Carcinoma patients?,ssm_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of CR1 V1108G in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of CR1 V1558G in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the occurrence rate of TRPA1 S295I in Rectum Adenocarcinoma patients?,ssm_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the occurrence rate of TRPA1 S443I in Rectum Adenocarcinoma patients?,ssm_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the occurrence rate of TAF1C R299L in Lung Adenocarcinoma patients?,ssm_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the occurrence rate of TAF1C R396L in Lung Adenocarcinoma patients?,ssm_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the occurrence rate of TAF1C R634L in Lung Adenocarcinoma patients?,ssm_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the occurrence rate of TAF1C R702L in Lung Adenocarcinoma patients?,ssm_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the occurrence rate of TAF1C R728L in Lung Adenocarcinoma patients?,ssm_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of DPF3 R104W in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of DPF3 R149W in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of DPF3 R94W in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the occurrence rate of OR2T4 P272H in Lung Adenocarcinoma patients?,ssm_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the occurrence rate of OR2T4 P300H in Lung Adenocarcinoma patients?,ssm_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the occurrence rate of FBN1 E2667K in Pancreatic Adenocarcinoma patients?,ssm_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the occurrence rate of MAD1L1 E396K in Prostate Adenocarcinoma patients?,ssm_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the occurrence rate of MAD1L1 E488K in Prostate Adenocarcinoma patients?,ssm_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the occurrence rate of MAD1L1 E78K in Prostate Adenocarcinoma patients?,ssm_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the occurrence rate of CCNG1 E22K in Skin Cutaneous Melanoma patients?,ssm_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the occurrence rate of ANP32E N114T in Kidney Renal Papillary Cell Carcinoma patients?,ssm_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the occurrence rate of ANP32E N64T in Kidney Renal Papillary Cell Carcinoma patients?,ssm_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the occurrence rate of ANP32E N66T in Kidney Renal Papillary Cell Carcinoma patients?,ssm_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the occurrence rate of ANP32E N73T in Kidney Renal Papillary Cell Carcinoma patients?,ssm_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the occurrence rate of FRY S1888A in Bladder Urothelial Carcinoma patients?,ssm_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the occurrence rate of FRY S1937A in Bladder Urothelial Carcinoma patients?,ssm_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the occurrence rate of FRY S1938A in Bladder Urothelial Carcinoma patients?,ssm_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the occurrence rate of FRY S1983A in Bladder Urothelial Carcinoma patients?,ssm_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the occurrence rate of PAK3 E318K in Skin Cutaneous Melanoma patients?,ssm_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the occurrence rate of PAK3 E319K in Skin Cutaneous Melanoma patients?,ssm_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the occurrence rate of PAK3 E334K in Skin Cutaneous Melanoma patients?,ssm_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the occurrence rate of PAK3 E340K in Skin Cutaneous Melanoma patients?,ssm_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the occurrence rate of PAK3 E355K in Skin Cutaneous Melanoma patients?,ssm_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the occurrence rate of MUC16 P7963L in Skin Cutaneous Melanoma patients?,ssm_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the occurrence rate of ZFPM2 T498I in Liver Hepatocellular Carcinoma patients?,ssm_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the occurrence rate of ZFPM2 T630I in Liver Hepatocellular Carcinoma patients?,ssm_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the occurrence rate of PIK3C2B S1328C in Breast Invasive Carcinoma patients?,ssm_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the occurrence rate of PIK3C2B S1356C in Breast Invasive Carcinoma patients?,ssm_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the occurrence rate of ZNF804A S371Y in Colon Adenocarcinoma patients?,ssm_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the occurrence rate of RELN A2371V in Stomach Adenocarcinoma patients?,ssm_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence rate of EFCAB12 R173C in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",ssm_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence rate of EFCAB12 R23C in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",ssm_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the occurrence rate of DEFB115 E53K in Skin Cutaneous Melanoma patients?,ssm_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the occurrence rate of ANKDD1A S290F in Bladder Urothelial Carcinoma patients?,ssm_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the occurrence rate of ANKDD1A S322F in Bladder Urothelial Carcinoma patients?,ssm_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the occurrence rate of ANKDD1A S413F in Bladder Urothelial Carcinoma patients?,ssm_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of HTR3B S146I in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of HTR3B S206I in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of HTR3B S217I in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the occurrence rate of ABCC3 R758W in Stomach Adenocarcinoma patients?,ssm_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of NOMO1 T204I in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of NOMO1 T371I in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the occurrence rate of HYOU1 D298H in Bladder Urothelial Carcinoma patients?,ssm_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the occurrence rate of FMO4 R500Q in Skin Cutaneous Melanoma patients?,ssm_frequency
+140,BICC1,A372V,Exceptional Responders,What is the occurrence rate of BICC1 A372V in Exceptional Responders patients?,ssm_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of ZMYM3 I920V in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of ZMYM3 I932V in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of ZMYM3 I934V in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence rate of XKR4 R547W in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",ssm_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the occurrence rate of ABCC2 V239L in Liver Hepatocellular Carcinoma patients?,ssm_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the occurrence rate of OR8K5 R293G in Lung Adenocarcinoma patients?,ssm_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the occurrence rate of SPTAN1 S1503F in Skin Cutaneous Melanoma patients?,ssm_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the occurrence rate of SPTAN1 S1523F in Skin Cutaneous Melanoma patients?,ssm_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the occurrence rate of SYT10 M484I in Rectum Adenocarcinoma patients?,ssm_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the occurrence rate of HSPA5 N457K in Skin Cutaneous Melanoma patients?,ssm_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the occurrence rate of UNC5D L280V in Lung Adenocarcinoma patients?,ssm_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the occurrence rate of UNC5D L635V in Lung Adenocarcinoma patients?,ssm_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the occurrence rate of UNC5D L637V in Lung Adenocarcinoma patients?,ssm_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the occurrence rate of UNC5D L699V in Lung Adenocarcinoma patients?,ssm_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the occurrence rate of UNC5D L704V in Lung Adenocarcinoma patients?,ssm_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the occurrence rate of UNC5D L709V in Lung Adenocarcinoma patients?,ssm_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the occurrence rate of DOCK2 L1527H in Kidney Renal Clear Cell Carcinoma patients?,ssm_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the occurrence rate of ZNF627 A5V in Kidney Renal Clear Cell Carcinoma patients?,ssm_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the occurrence rate of CDC42BPA L823F in Skin Cutaneous Melanoma patients?,ssm_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the occurrence rate of MRPL55 H27Y in Colon Adenocarcinoma patients?,ssm_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the occurrence rate of MRPL55 H63Y in Colon Adenocarcinoma patients?,ssm_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the occurrence rate of TMTC3 Q749K in Breast Invasive Carcinoma patients?,ssm_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the occurrence rate of EPRS1 K771I in Colon Adenocarcinoma patients?,ssm_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the occurrence rate of EPRS1 K778I in Colon Adenocarcinoma patients?,ssm_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the occurrence rate of GRTP1 A110V in Skin Cutaneous Melanoma patients?,ssm_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the occurrence rate of GRTP1 A32V in Skin Cutaneous Melanoma patients?,ssm_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the occurrence rate of TSHZ3 Q538K in Stomach Adenocarcinoma patients?,ssm_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the occurrence rate of TAS1R3 Q326H in HIV+ Tumor Molecular Characterization Project - Cervical Cancer patients?,ssm_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the occurrence rate of PIAS3 S238C in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the occurrence rate of PIAS3 S273C in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the occurrence rate of ZNF274 P13R in Stomach Adenocarcinoma patients?,ssm_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the occurrence rate of SYNJ1 R795C in Colon Adenocarcinoma patients?,ssm_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the occurrence rate of SYNJ1 R800C in Colon Adenocarcinoma patients?,ssm_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the occurrence rate of SYNJ1 R839C in Colon Adenocarcinoma patients?,ssm_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the occurrence rate of DSCAM V343M in Prostate Adenocarcinoma patients?,ssm_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the occurrence rate of DSCAM V426M in Prostate Adenocarcinoma patients?,ssm_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the occurrence rate of DSCAM V591M in Prostate Adenocarcinoma patients?,ssm_frequency
+267,DGKD,R140H,Exceptional Responders,What is the occurrence rate of DGKD R140H in Exceptional Responders patients?,ssm_frequency
+268,DGKD,R160H,Exceptional Responders,What is the occurrence rate of DGKD R160H in Exceptional Responders patients?,ssm_frequency
+269,DGKD,R204H,Exceptional Responders,What is the occurrence rate of DGKD R204H in Exceptional Responders patients?,ssm_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the occurrence rate of PLEKHG6 D105Y in Bladder Urothelial Carcinoma patients?,ssm_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the occurrence rate of PLEKHG6 D543Y in Bladder Urothelial Carcinoma patients?,ssm_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the occurrence rate of PLEKHG6 D575Y in Bladder Urothelial Carcinoma patients?,ssm_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the occurrence rate of WNT2 D138N in Skin Cutaneous Melanoma patients?,ssm_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the occurrence rate of GUCY2C G667R in Skin Cutaneous Melanoma patients?,ssm_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of C7orf31 P244H in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence rate of ZKSCAN7 E64K in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",ssm_frequency
+299,OR5D14,M210L,Neuroblastoma,What is the occurrence rate of OR5D14 M210L in Neuroblastoma patients?,ssm_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of SPATA22 K279E in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of SPATA22 K306E in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of SPATA22 K322E in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the occurrence rate of LCN15 E21V in Stomach Adenocarcinoma patients?,ssm_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the occurrence rate of DCAF4L2 S129F in Skin Cutaneous Melanoma patients?,ssm_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the occurrence rate of GUK1 R135P in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the occurrence rate of GUK1 R137P in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the occurrence rate of GUK1 R139P in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the occurrence rate of GUK1 R158P in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the occurrence rate of GUK1 R203P in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the occurrence rate of MORF4L1 K29T in Stomach Adenocarcinoma patients?,ssm_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the occurrence rate of MORF4L1 K51T in Stomach Adenocarcinoma patients?,ssm_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the occurrence rate of MORF4L1 K61T in Stomach Adenocarcinoma patients?,ssm_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the occurrence rate of MORF4L1 K76T in Stomach Adenocarcinoma patients?,ssm_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the occurrence rate of MYO3B F594L in Skin Cutaneous Melanoma patients?,ssm_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the occurrence rate of MYO3B F603L in Skin Cutaneous Melanoma patients?,ssm_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the occurrence rate of TENT5A S320F in Skin Cutaneous Melanoma patients?,ssm_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the occurrence rate of TENT5A S339F in Skin Cutaneous Melanoma patients?,ssm_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the occurrence rate of TENT5A S401F in Skin Cutaneous Melanoma patients?,ssm_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the occurrence rate of ZFAT S614L in Ovarian Serous Cystadenocarcinoma patients?,ssm_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the occurrence rate of ZFAT S664L in Ovarian Serous Cystadenocarcinoma patients?,ssm_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the occurrence rate of ZFAT S676L in Ovarian Serous Cystadenocarcinoma patients?,ssm_frequency
+357,ZNF584,A211T,Sarcoma,What is the occurrence rate of ZNF584 A211T in Sarcoma patients?,ssm_frequency
+358,ZNF584,A256T,Sarcoma,What is the occurrence rate of ZNF584 A256T in Sarcoma patients?,ssm_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of LDOC1 R63W in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the occurrence rate of PDGFC R201G in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of MSANTD4 R304C in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the occurrence rate of NPSR1 S123L in Skin Cutaneous Melanoma patients?,ssm_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the occurrence rate of PHLPP1 K1317E in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the occurrence rate of COL6A3 G237S in Skin Cutaneous Melanoma patients?,ssm_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the occurrence rate of COL6A3 G437S in Skin Cutaneous Melanoma patients?,ssm_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the occurrence rate of COL6A3 G638S in Skin Cutaneous Melanoma patients?,ssm_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the occurrence rate of COL6A3 G644S in Skin Cutaneous Melanoma patients?,ssm_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the occurrence rate of COL6A3 G844S in Skin Cutaneous Melanoma patients?,ssm_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the occurrence rate of ADRA1A R348G in Stomach Adenocarcinoma patients?,ssm_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the occurrence rate of LAMB2 S1254F in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,ssm_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the occurrence rate of POC1B I198T in Rectum Adenocarcinoma patients?,ssm_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the occurrence rate of POC1B I286T in Rectum Adenocarcinoma patients?,ssm_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the occurrence rate of POC1B I328T in Rectum Adenocarcinoma patients?,ssm_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the occurrence rate of POC1B S79P in Rectum Adenocarcinoma patients?,ssm_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the occurrence rate of USH2A G1451C in Liver Hepatocellular Carcinoma patients?,ssm_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the occurrence rate of AQP7 T110S in Rectum Adenocarcinoma patients?,ssm_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the occurrence rate of AQP7 T166S in Rectum Adenocarcinoma patients?,ssm_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the occurrence rate of AQP7 T167S in Rectum Adenocarcinoma patients?,ssm_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the occurrence rate of AQP7 T75S in Rectum Adenocarcinoma patients?,ssm_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,What is the occurrence rate of DCN R163C in Rectum Adenocarcinoma patients?,ssm_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,What is the occurrence rate of DCN R203C in Rectum Adenocarcinoma patients?,ssm_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,What is the occurrence rate of DCN R241C in Rectum Adenocarcinoma patients?,ssm_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,What is the occurrence rate of DCN R350C in Rectum Adenocarcinoma patients?,ssm_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,What is the occurrence rate of DCN R41C in Rectum Adenocarcinoma patients?,ssm_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of CPS1 K1269N in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of CPS1 K1275N in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of CPS1 K818N in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the occurrence rate of FCGR2C P122S in Kidney Renal Papillary Cell Carcinoma patients?,ssm_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the occurrence rate of FCGR2C P123S in Kidney Renal Papillary Cell Carcinoma patients?,ssm_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of GRM1 R280M in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the occurrence rate of SGCZ Q138H in Lung Adenocarcinoma patients?,ssm_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the occurrence rate of SGCZ Q91H in Lung Adenocarcinoma patients?,ssm_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,What is the occurrence rate of SMO V15M in Stomach Adenocarcinoma patients?,ssm_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,What is the occurrence rate of SMO V321M in Stomach Adenocarcinoma patients?,ssm_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the occurrence rate of CHODL G159E in Skin Cutaneous Melanoma patients?,ssm_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the occurrence rate of CHODL G181E in Skin Cutaneous Melanoma patients?,ssm_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the occurrence rate of CHODL G200E in Skin Cutaneous Melanoma patients?,ssm_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,What is the occurrence rate of MYO16 P399H in Colon Adenocarcinoma patients?,ssm_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,What is the occurrence rate of MYO16 P421H in Colon Adenocarcinoma patients?,ssm_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the occurrence rate of CXCR2 A98V in Stomach Adenocarcinoma patients?,ssm_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the occurrence rate of TMEM225 L212V in Bladder Urothelial Carcinoma patients?,ssm_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of MAOB N251T in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of GPRASP1 F580S in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of MRPL32 R181Q in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of TYROBP A29T in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the occurrence rate of RAB40C A111V in Lung Adenocarcinoma patients?,ssm_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the occurrence rate of RAB40C A143V in Lung Adenocarcinoma patients?,ssm_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the occurrence rate of CTNNA2 S323R in Lung Adenocarcinoma patients?,ssm_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the occurrence rate of CTNNA2 S339R in Lung Adenocarcinoma patients?,ssm_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the occurrence rate of CTNNA2 S386R in Lung Adenocarcinoma patients?,ssm_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the occurrence rate of CTNNA2 S707R in Lung Adenocarcinoma patients?,ssm_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the occurrence rate of MYO15A S268R in Bladder Urothelial Carcinoma patients?,ssm_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the occurrence rate of GIMAP2 A167T in Skin Cutaneous Melanoma patients?,ssm_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the occurrence rate of KIF20B N1160D in Glioblastoma Multiforme patients?,ssm_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the occurrence rate of KIF20B N1200D in Glioblastoma Multiforme patients?,ssm_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of ADAM17 E583K in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of BCAT1 G16R in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of BCAT1 G17R in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of BCAT1 G29R in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the occurrence rate of ERCC6 R1053H in Colon Adenocarcinoma patients?,ssm_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,What is the occurrence rate of DCC R320W in Breast Invasive Carcinoma patients?,ssm_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,What is the occurrence rate of DCC R363W in Breast Invasive Carcinoma patients?,ssm_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,What is the occurrence rate of DCC R386W in Breast Invasive Carcinoma patients?,ssm_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,What is the occurrence rate of DCC R41W in Breast Invasive Carcinoma patients?,ssm_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the occurrence rate of FBXO15 D417N in Skin Cutaneous Melanoma patients?,ssm_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the occurrence rate of FBXO15 D86N in Skin Cutaneous Melanoma patients?,ssm_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of GSTCD S528F in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of GSTCD S615F in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the occurrence rate of OLFML3 P296S in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the occurrence rate of OLFML3 P337S in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the occurrence rate of OLFML3 P357S in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the occurrence rate of CFAP61 E173V in Ovarian Serous Cystadenocarcinoma patients?,ssm_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the occurrence rate of CFAP61 E817V in Ovarian Serous Cystadenocarcinoma patients?,ssm_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the occurrence rate of HLA-DQA2 E51K in Bladder Urothelial Carcinoma patients?,ssm_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the occurrence rate of TENM2 H240Y in Skin Cutaneous Melanoma patients?,ssm_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the occurrence rate of TENM2 H351Y in Skin Cutaneous Melanoma patients?,ssm_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the occurrence rate of TENM2 H472Y in Skin Cutaneous Melanoma patients?,ssm_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the occurrence rate of ANKRD24 A465T in Stomach Adenocarcinoma patients?,ssm_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the occurrence rate of ANKRD24 A494T in Stomach Adenocarcinoma patients?,ssm_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the occurrence rate of ANKRD24 A584T in Stomach Adenocarcinoma patients?,ssm_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the occurrence rate of ZCCHC14 V549M in Stomach Adenocarcinoma patients?,ssm_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the occurrence rate of ZCCHC14 V665M in Stomach Adenocarcinoma patients?,ssm_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the occurrence rate of ZCCHC14 V676M in Stomach Adenocarcinoma patients?,ssm_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the occurrence rate of ZCCHC14 V802M in Stomach Adenocarcinoma patients?,ssm_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,What is the occurrence rate of SIK2 I265M in Lung Adenocarcinoma patients?,ssm_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of MYH11 T1336M in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of MYH11 T1343M in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the occurrence rate of SLC6A4 S174F in Skin Cutaneous Melanoma patients?,ssm_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of SLC9C1 K102N in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of SLC9C1 K29N in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the occurrence rate of OR2A12 A254T in Brain Lower Grade Glioma patients?,ssm_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the occurrence rate of PYHIN1 T325K in Lung Adenocarcinoma patients?,ssm_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the occurrence rate of PYHIN1 T334K in Lung Adenocarcinoma patients?,ssm_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the occurrence rate of JAML G191E in Skin Cutaneous Melanoma patients?,ssm_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the occurrence rate of JAML G219E in Skin Cutaneous Melanoma patients?,ssm_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the occurrence rate of JAML G220E in Skin Cutaneous Melanoma patients?,ssm_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the occurrence rate of JAML G230E in Skin Cutaneous Melanoma patients?,ssm_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the occurrence rate of TYK2 H1146R in Stomach Adenocarcinoma patients?,ssm_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the occurrence rate of TYK2 H23R in Stomach Adenocarcinoma patients?,ssm_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the occurrence rate of TYK2 H961R in Stomach Adenocarcinoma patients?,ssm_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of CTCFL R208C in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of CTCFL R265C in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of CTCFL R420C in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of CTCFL R470C in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of CEP20 R31Q in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of CEP20 R58Q in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the occurrence rate of RIMS2 R25W in Skin Cutaneous Melanoma patients?,ssm_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the occurrence rate of RIMS2 R393W in Skin Cutaneous Melanoma patients?,ssm_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the occurrence rate of RIMS2 R423W in Skin Cutaneous Melanoma patients?,ssm_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the occurrence rate of RIMS2 R470W in Skin Cutaneous Melanoma patients?,ssm_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the occurrence rate of RIMS2 R615W in Skin Cutaneous Melanoma patients?,ssm_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the occurrence rate of RIMS2 R619W in Skin Cutaneous Melanoma patients?,ssm_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the occurrence rate of RIMS2 R716W in Skin Cutaneous Melanoma patients?,ssm_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the occurrence rate of PIK3C2G S551L in Skin Cutaneous Melanoma patients?,ssm_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the occurrence rate of PIK3C2G S592L in Skin Cutaneous Melanoma patients?,ssm_frequency
+728,STK19,D341N,Colon Adenocarcinoma,What is the occurrence rate of STK19 D341N in Colon Adenocarcinoma patients?,ssm_frequency
+729,STK19,D345N,Colon Adenocarcinoma,What is the occurrence rate of STK19 D345N in Colon Adenocarcinoma patients?,ssm_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the occurrence rate of REXO4 P60A in Skin Cutaneous Melanoma patients?,ssm_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of ZBTB34 P160S in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of ZBTB34 P164S in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the occurrence rate of NCKAP5 E148K in Bladder Urothelial Carcinoma patients?,ssm_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence rate of SORCS1 D1052Y in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",ssm_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence rate of SORCS1 D587Y in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",ssm_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence rate of SORCS1 D67Y in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",ssm_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence rate of SORCS1 D810Y in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",ssm_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the occurrence rate of FGF8 T154M in Head and Neck Squamous Cell Carcinoma patients?,ssm_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the occurrence rate of FGF8 T165M in Head and Neck Squamous Cell Carcinoma patients?,ssm_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the occurrence rate of FGF8 T183M in Head and Neck Squamous Cell Carcinoma patients?,ssm_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the occurrence rate of FGF8 T194M in Head and Neck Squamous Cell Carcinoma patients?,ssm_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the occurrence rate of FGF8 T90M in Head and Neck Squamous Cell Carcinoma patients?,ssm_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the occurrence rate of TENM3 R1877W in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia patients?,ssm_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of AKT1 D44N in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the occurrence rate of CFAP298-TCP10L E11Q in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,ssm_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the occurrence rate of GLRB E148D in Stomach Adenocarcinoma patients?,ssm_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,What is the occurrence rate of TTN F7636L in Colon Adenocarcinoma patients?,ssm_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,What is the occurrence rate of TTN F8563L in Colon Adenocarcinoma patients?,ssm_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,What is the occurrence rate of TTN F8880L in Colon Adenocarcinoma patients?,ssm_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the occurrence rate of ANKRD30A V798I in Colon Adenocarcinoma patients?,ssm_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the occurrence rate of ANKRD30A V854I in Colon Adenocarcinoma patients?,ssm_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the occurrence rate of ANKRD30A V973I in Colon Adenocarcinoma patients?,ssm_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the occurrence rate of TRIM45 S177L in Colon Adenocarcinoma patients?,ssm_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the occurrence rate of TRIM45 S224L in Colon Adenocarcinoma patients?,ssm_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the occurrence rate of TRIM45 S281L in Colon Adenocarcinoma patients?,ssm_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the occurrence rate of CACNA1F G727V in Stomach Adenocarcinoma patients?,ssm_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the occurrence rate of CACNA1F G781V in Stomach Adenocarcinoma patients?,ssm_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the occurrence rate of CACNA1F G792V in Stomach Adenocarcinoma patients?,ssm_frequency
+817,KL,R594C,Colon Adenocarcinoma,What is the occurrence rate of KL R594C in Colon Adenocarcinoma patients?,ssm_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the occurrence rate of GUF1 I243T in Kidney Renal Papillary Cell Carcinoma patients?,ssm_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the occurrence rate of TAF1L A539V in Colon Adenocarcinoma patients?,ssm_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the occurrence rate of TASOR2 S256F in Skin Cutaneous Melanoma patients?,ssm_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the occurrence rate of TASOR2 S36F in Skin Cutaneous Melanoma patients?,ssm_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the occurrence rate of TASOR2 S471F in Skin Cutaneous Melanoma patients?,ssm_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the occurrence rate of KDM5C R1151C in Skin Cutaneous Melanoma patients?,ssm_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the occurrence rate of KDM5C R1177C in Skin Cutaneous Melanoma patients?,ssm_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the occurrence rate of KDM5C R1217C in Skin Cutaneous Melanoma patients?,ssm_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the occurrence rate of KDM5C R1218C in Skin Cutaneous Melanoma patients?,ssm_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the occurrence rate of IL5RA L153F in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,ssm_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the occurrence rate of DHX16 A29V in Skin Cutaneous Melanoma patients?,ssm_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the occurrence rate of DHX16 A89V in Skin Cutaneous Melanoma patients?,ssm_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the occurrence rate of GPR158 A644V in Stomach Adenocarcinoma patients?,ssm_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the occurrence rate of GPR158 A723V in Stomach Adenocarcinoma patients?,ssm_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence rate of EIF2B4 E108K in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",ssm_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence rate of EIF2B4 E110K in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",ssm_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence rate of EIF2B4 E111K in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",ssm_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence rate of EIF2B4 E131K in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",ssm_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence rate of EIF2B4 E132K in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",ssm_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence rate of EIF2B4 E96K in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",ssm_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the occurrence rate of AUTS2 P136S in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the occurrence rate of AUTS2 P218S in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the occurrence rate of AUTS2 P233S in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the occurrence rate of AUTS2 P313S in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the occurrence rate of AUTS2 P419S in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the occurrence rate of AUTS2 P443S in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the occurrence rate of AUTS2 P56S in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the occurrence rate of AUTS2 P667S in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the occurrence rate of AUTS2 P690S in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the occurrence rate of AUTS2 P691S in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence rate of ACTL7B D223N in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",ssm_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the occurrence rate of PCDHGA1 R535W in Glioblastoma Multiforme patients?,ssm_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the occurrence rate of TRAP1 R114W in Stomach Adenocarcinoma patients?,ssm_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the occurrence rate of TRAP1 R61W in Stomach Adenocarcinoma patients?,ssm_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of PIK3C2A R1570Q in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the occurrence rate of KANSL1 R139G in Liver Hepatocellular Carcinoma patients?,ssm_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the occurrence rate of ANKRD52 Y594C in Stomach Adenocarcinoma patients?,ssm_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of PAPPA G1580S in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the occurrence rate of B3GALNT1 V270A in Rectum Adenocarcinoma patients?,ssm_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the occurrence rate of GABRA6 G115R in Lung Adenocarcinoma patients?,ssm_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the occurrence rate of GABRA6 G122R in Lung Adenocarcinoma patients?,ssm_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the occurrence rate of GABRA6 G165R in Lung Adenocarcinoma patients?,ssm_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the occurrence rate of GABRA6 G175R in Lung Adenocarcinoma patients?,ssm_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the occurrence rate of GABRA6 G70R in Lung Adenocarcinoma patients?,ssm_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the occurrence rate of ZSCAN31 D9N in Skin Cutaneous Melanoma patients?,ssm_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence rate of MED16 L126P in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",ssm_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence rate of MED16 L868P in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",ssm_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the occurrence rate of PTPRO E1060K in Pancreatic Adenocarcinoma patients?,ssm_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the occurrence rate of PTPRO E1088K in Pancreatic Adenocarcinoma patients?,ssm_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the occurrence rate of PTPRO E249K in Pancreatic Adenocarcinoma patients?,ssm_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the occurrence rate of PTPRO E265K in Pancreatic Adenocarcinoma patients?,ssm_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the occurrence rate of PTPRO E277K in Pancreatic Adenocarcinoma patients?,ssm_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the occurrence rate of PTPRO E67K in Pancreatic Adenocarcinoma patients?,ssm_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the occurrence rate of PTPRO E923K in Pancreatic Adenocarcinoma patients?,ssm_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the occurrence rate of PTPRO E940K in Pancreatic Adenocarcinoma patients?,ssm_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of CHMP7 D397N in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the occurrence rate of GPC3 I107N in Stomach Adenocarcinoma patients?,ssm_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the occurrence rate of GPC3 I161N in Stomach Adenocarcinoma patients?,ssm_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the occurrence rate of TLK2 V430L in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,ssm_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the occurrence rate of TLK2 V515L in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,ssm_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the occurrence rate of TLK2 V547L in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,ssm_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the occurrence rate of TLK2 V579L in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,ssm_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the occurrence rate of TLK2 V601L in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,ssm_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the occurrence rate of ZNF217 E209Q in Lung Adenocarcinoma patients?,ssm_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the occurrence rate of SYT9 V275L in Lung Adenocarcinoma patients?,ssm_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the occurrence rate of SYT9 V307L in Lung Adenocarcinoma patients?,ssm_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the occurrence rate of PKHD1L1 S2830N in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the occurrence rate of MYO3A Y1295C in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence rate of VASN V318I in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",ssm_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of DNMT1 A1037T in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of DNMT1 A1053T in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of DNMT1 A934T in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,What is the occurrence rate of CA9 E402K in Colon Adenocarcinoma patients?,ssm_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of TTC17 R808Q in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of TTC17 R865Q in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the occurrence rate of PSG2 P43L in Breast Invasive Carcinoma patients?,ssm_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the occurrence rate of RIPOR2 R470L in Breast Invasive Carcinoma patients?,ssm_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the occurrence rate of RIPOR2 R499L in Breast Invasive Carcinoma patients?,ssm_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the occurrence rate of RIPOR2 R504L in Breast Invasive Carcinoma patients?,ssm_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the occurrence rate of RIPOR2 R520L in Breast Invasive Carcinoma patients?,ssm_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of DCLK3 V520I in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of DCLK3 V689I in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the occurrence rate of MERTK G257A in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the occurrence rate of MERTK G757A in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the occurrence rate of MERTK G933A in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the occurrence rate of ZFP42 R206K in Skin Cutaneous Melanoma patients?,ssm_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the occurrence rate of OR13C3 M117I in Skin Cutaneous Melanoma patients?,ssm_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the occurrence rate of OR13C3 M147I in Skin Cutaneous Melanoma patients?,ssm_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the occurrence rate of SPAG1 I917M in Stomach Adenocarcinoma patients?,ssm_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of CDKN2AIP Y92H in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the occurrence rate of PXN H1016Y in Colon Adenocarcinoma patients?,ssm_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the occurrence rate of PXN H359Y in Colon Adenocarcinoma patients?,ssm_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the occurrence rate of PXN H492Y in Colon Adenocarcinoma patients?,ssm_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the occurrence rate of PXN H524Y in Colon Adenocarcinoma patients?,ssm_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the occurrence rate of PXN H526Y in Colon Adenocarcinoma patients?,ssm_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the occurrence rate of PXN H540Y in Colon Adenocarcinoma patients?,ssm_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of TTYH2 S23L in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of TTYH2 S44L in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the occurrence rate of TMEM255A N205S in Colon Adenocarcinoma patients?,ssm_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the occurrence rate of TMEM255A N229S in Colon Adenocarcinoma patients?,ssm_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the occurrence rate of TMEM255A N65S in Colon Adenocarcinoma patients?,ssm_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the occurrence rate of TASOR2 H2271D in Breast Invasive Carcinoma patients?,ssm_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the occurrence rate of TASOR2 H2486D in Breast Invasive Carcinoma patients?,ssm_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of ICE1 T1839M in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the occurrence rate of MYT1 A558E in Breast Invasive Carcinoma patients?,ssm_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the occurrence rate of MYT1 A879E in Breast Invasive Carcinoma patients?,ssm_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the occurrence rate of MYT1 A906E in Breast Invasive Carcinoma patients?,ssm_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of CX3CR1 P203L in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of CX3CR1 P235L in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the occurrence rate of SPINDOC R197C in Liver Hepatocellular Carcinoma patients?,ssm_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of ART3 C251Y in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of ART3 C3Y in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the occurrence rate of CYP1A2 R243G in Bladder Urothelial Carcinoma patients?,ssm_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence rate of ADRA1A G279S in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",ssm_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the occurrence rate of CDH23 P2523R in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the occurrence rate of CDH23 P283R in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the occurrence rate of KRT39 P137S in Skin Cutaneous Melanoma patients?,ssm_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the occurrence rate of PDHA2 S7F in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the occurrence rate of SLC24A2 H200Q in Colon Adenocarcinoma patients?,ssm_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the occurrence rate of PTPRN2 F153L in Liver Hepatocellular Carcinoma patients?,ssm_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the occurrence rate of PTPRN2 F847L in Liver Hepatocellular Carcinoma patients?,ssm_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the occurrence rate of PTPRN2 F856L in Liver Hepatocellular Carcinoma patients?,ssm_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the occurrence rate of PTPRN2 F868L in Liver Hepatocellular Carcinoma patients?,ssm_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the occurrence rate of PTPRN2 F885L in Liver Hepatocellular Carcinoma patients?,ssm_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the occurrence rate of SOX21 R55L in Lung Adenocarcinoma patients?,ssm_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the occurrence rate of CPA6 G166E in Bladder Urothelial Carcinoma patients?,ssm_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the occurrence rate of GRM5 E14K in Skin Cutaneous Melanoma patients?,ssm_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence rate of CASZ1 R233Q in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",ssm_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the occurrence rate of SGIP1 N122T in Stomach Adenocarcinoma patients?,ssm_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the occurrence rate of SGIP1 N420T in Stomach Adenocarcinoma patients?,ssm_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the occurrence rate of SGIP1 N617T in Stomach Adenocarcinoma patients?,ssm_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the occurrence rate of SGIP1 N648T in Stomach Adenocarcinoma patients?,ssm_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the occurrence rate of CARMIL1 V549L in Lung Adenocarcinoma patients?,ssm_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the occurrence rate of CARMIL1 V949L in Lung Adenocarcinoma patients?,ssm_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the occurrence rate of ZNF431 D121Y in Lung Adenocarcinoma patients?,ssm_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the occurrence rate of ZNF431 D161Y in Lung Adenocarcinoma patients?,ssm_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the occurrence rate of ZNF431 R128I in Lung Adenocarcinoma patients?,ssm_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the occurrence rate of DNAH11 P2987S in Skin Cutaneous Melanoma patients?,ssm_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the occurrence rate of DNAH11 P2994S in Skin Cutaneous Melanoma patients?,ssm_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the occurrence rate of POLD1 Q461L in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the occurrence rate of POLD1 Q85L in Lung Squamous Cell Carcinoma patients?,ssm_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the occurrence rate of TTC12 D646H in Lung Adenocarcinoma patients?,ssm_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the occurrence rate of TTC12 D652H in Lung Adenocarcinoma patients?,ssm_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the occurrence rate of CNGB1 D967N in Bladder Urothelial Carcinoma patients?,ssm_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the occurrence rate of CNGB1 D973N in Bladder Urothelial Carcinoma patients?,ssm_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the occurrence rate of CTSC E214V in Stomach Adenocarcinoma patients?,ssm_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the occurrence rate of CTSC E291V in Stomach Adenocarcinoma patients?,ssm_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the occurrence rate of CTSC E322V in Stomach Adenocarcinoma patients?,ssm_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the occurrence rate of CTSC E324V in Stomach Adenocarcinoma patients?,ssm_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the occurrence rate of CTSC E335V in Stomach Adenocarcinoma patients?,ssm_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of PRSS8 A179T in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of PRSS8 A233T in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the occurrence rate of ARHGEF40 V864F in Lung Adenocarcinoma patients?,ssm_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the occurrence rate of ACTB A138T in Rectum Adenocarcinoma patients?,ssm_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the occurrence rate of ACTB A217T in Rectum Adenocarcinoma patients?,ssm_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the occurrence rate of ACTB A244T in Rectum Adenocarcinoma patients?,ssm_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the occurrence rate of ACTB A260T in Rectum Adenocarcinoma patients?,ssm_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the occurrence rate of YY1AP1 V546D in Glioblastoma Multiforme patients?,ssm_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the occurrence rate of YY1AP1 V557D in Glioblastoma Multiforme patients?,ssm_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the occurrence rate of YY1AP1 V566D in Glioblastoma Multiforme patients?,ssm_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the occurrence rate of YY1AP1 V577D in Glioblastoma Multiforme patients?,ssm_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the occurrence rate of YY1AP1 V623D in Glioblastoma Multiforme patients?,ssm_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the occurrence rate of YY1AP1 V695D in Glioblastoma Multiforme patients?,ssm_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the occurrence rate of YY1AP1 V715D in Glioblastoma Multiforme patients?,ssm_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the occurrence rate of FNDC7 D323N in Skin Cutaneous Melanoma patients?,ssm_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the occurrence rate of FNDC7 D99N in Skin Cutaneous Melanoma patients?,ssm_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the occurrence rate of TLCD5 G15V in Lung Adenocarcinoma patients?,ssm_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the occurrence rate of TLCD5 G37V in Lung Adenocarcinoma patients?,ssm_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of POLR1G R498W in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of POLR1G R500W in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the occurrence rate of DNAH14 N1186K in Colon Adenocarcinoma patients?,ssm_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the occurrence rate of DNAH14 N2657K in Colon Adenocarcinoma patients?,ssm_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the occurrence rate of DNAH14 N3460K in Colon Adenocarcinoma patients?,ssm_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of NEXN E73D in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the occurrence rate of CYB5R2 G112R in Prostate Adenocarcinoma patients?,ssm_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the occurrence rate of CYB5R2 G172R in Prostate Adenocarcinoma patients?,ssm_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of NRAP S808L in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of NRAP S816L in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of NRAP S843L in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of CCDC22 E179D in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the occurrence rate of DCAF6 S402F in Skin Cutaneous Melanoma patients?,ssm_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the occurrence rate of DCAF6 S433F in Skin Cutaneous Melanoma patients?,ssm_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of ZNF708 E389D in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of BFAR T103M in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of MAST4 P1237S in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of MAST4 P1986S in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of MAST4 P1991S in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of MAST4 P2001S in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of MAST4 P2180S in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the occurrence rate of ARMC3 R169C in Stomach Adenocarcinoma patients?,ssm_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the occurrence rate of ARMC3 R432C in Stomach Adenocarcinoma patients?,ssm_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the occurrence rate of TET2 L757V in Kidney Renal Clear Cell Carcinoma patients?,ssm_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the occurrence rate of TET2 L778V in Kidney Renal Clear Cell Carcinoma patients?,ssm_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the occurrence rate of SERPINB10 A353P in Lung Adenocarcinoma patients?,ssm_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of STAT3 Y22H in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of MIEF1 A42T in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the occurrence rate of ACVR1B D397N in Colon Adenocarcinoma patients?,ssm_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the occurrence rate of ACVR1B D449N in Colon Adenocarcinoma patients?,ssm_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the occurrence rate of ACVR1B D490N in Colon Adenocarcinoma patients?,ssm_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the occurrence rate of EBF2 T104I in Stomach Adenocarcinoma patients?,ssm_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the occurrence rate of EBF2 T252I in Stomach Adenocarcinoma patients?,ssm_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the occurrence rate of VPS26B F266L in Stomach Adenocarcinoma patients?,ssm_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence rate of PGR M106I in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",ssm_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence rate of PGR M38I in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",ssm_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence rate of PGR M632I in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",ssm_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the occurrence rate of ACTA2 P334L in Skin Cutaneous Melanoma patients?,ssm_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of THBS4 T852I in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of THBS4 T943I in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the occurrence rate of PRSS1 S114T in Lung Adenocarcinoma patients?,ssm_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the occurrence rate of PRSS1 S124T in Lung Adenocarcinoma patients?,ssm_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the occurrence rate of PRSS1 S138T in Lung Adenocarcinoma patients?,ssm_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the occurrence rate of PRSS1 S74T in Lung Adenocarcinoma patients?,ssm_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the occurrence rate of PGF R126H in Stomach Adenocarcinoma patients?,ssm_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the occurrence rate of PGF R127H in Stomach Adenocarcinoma patients?,ssm_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the occurrence rate of ITPRID2 S351C in Breast Invasive Carcinoma patients?,ssm_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the occurrence rate of ITPRID2 S842C in Breast Invasive Carcinoma patients?,ssm_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of HBB E8D in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the occurrence rate of PCDHB2 R158C in Colon Adenocarcinoma patients?,ssm_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the occurrence rate of PCDHB2 T15M in Colon Adenocarcinoma patients?,ssm_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the occurrence rate of PCDHB2 T26M in Colon Adenocarcinoma patients?,ssm_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the occurrence rate of UBR2 P1594S in Uterine Corpus Endometrial Carcinoma patients?,ssm_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the occurrence rate of FBXO42 A618D in Rectum Adenocarcinoma patients?,ssm_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,How prevalent is the TNS1 G1362V mutation in cases of Breast Invasive Carcinoma?,ssm_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,How prevalent is the TNS1 G1711V mutation in cases of Breast Invasive Carcinoma?,ssm_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,How prevalent is the TNS1 G1718V mutation in cases of Breast Invasive Carcinoma?,ssm_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,How prevalent is the TNS1 G1732V mutation in cases of Breast Invasive Carcinoma?,ssm_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,How prevalent is the TNS1 G1824V mutation in cases of Breast Invasive Carcinoma?,ssm_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,How prevalent is the TNS1 G1857V mutation in cases of Breast Invasive Carcinoma?,ssm_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,How prevalent is the TNS1 G843V mutation in cases of Breast Invasive Carcinoma?,ssm_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How prevalent is the EVC2 E1067K mutation in cases of Bladder Urothelial Carcinoma?,ssm_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How prevalent is the EVC2 E987K mutation in cases of Bladder Urothelial Carcinoma?,ssm_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How prevalent is the CR1 V1108G mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How prevalent is the CR1 V1558G mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,How prevalent is the TRPA1 S295I mutation in cases of Rectum Adenocarcinoma?,ssm_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,How prevalent is the TRPA1 S443I mutation in cases of Rectum Adenocarcinoma?,ssm_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,How prevalent is the TAF1C R299L mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,How prevalent is the TAF1C R396L mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,How prevalent is the TAF1C R634L mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,How prevalent is the TAF1C R702L mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,How prevalent is the TAF1C R728L mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How prevalent is the DPF3 R104W mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How prevalent is the DPF3 R149W mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How prevalent is the DPF3 R94W mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,How prevalent is the OR2T4 P272H mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,How prevalent is the OR2T4 P300H mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How prevalent is the FBN1 E2667K mutation in cases of Pancreatic Adenocarcinoma?,ssm_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How prevalent is the MAD1L1 E396K mutation in cases of Prostate Adenocarcinoma?,ssm_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How prevalent is the MAD1L1 E488K mutation in cases of Prostate Adenocarcinoma?,ssm_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How prevalent is the MAD1L1 E78K mutation in cases of Prostate Adenocarcinoma?,ssm_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How prevalent is the CCNG1 E22K mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How prevalent is the ANP32E N114T mutation in cases of Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How prevalent is the ANP32E N64T mutation in cases of Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How prevalent is the ANP32E N66T mutation in cases of Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How prevalent is the ANP32E N73T mutation in cases of Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How prevalent is the FRY S1888A mutation in cases of Bladder Urothelial Carcinoma?,ssm_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How prevalent is the FRY S1937A mutation in cases of Bladder Urothelial Carcinoma?,ssm_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How prevalent is the FRY S1938A mutation in cases of Bladder Urothelial Carcinoma?,ssm_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How prevalent is the FRY S1983A mutation in cases of Bladder Urothelial Carcinoma?,ssm_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,How prevalent is the PAK3 E318K mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,How prevalent is the PAK3 E319K mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,How prevalent is the PAK3 E334K mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,How prevalent is the PAK3 E340K mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,How prevalent is the PAK3 E355K mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How prevalent is the MUC16 P7963L mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How prevalent is the ZFPM2 T498I mutation in cases of Liver Hepatocellular Carcinoma?,ssm_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How prevalent is the ZFPM2 T630I mutation in cases of Liver Hepatocellular Carcinoma?,ssm_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How prevalent is the PIK3C2B S1328C mutation in cases of Breast Invasive Carcinoma?,ssm_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How prevalent is the PIK3C2B S1356C mutation in cases of Breast Invasive Carcinoma?,ssm_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How prevalent is the ZNF804A S371Y mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,How prevalent is the RELN A2371V mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the EFCAB12 R173C mutation in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the EFCAB12 R23C mutation in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How prevalent is the DEFB115 E53K mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How prevalent is the ANKDD1A S290F mutation in cases of Bladder Urothelial Carcinoma?,ssm_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How prevalent is the ANKDD1A S322F mutation in cases of Bladder Urothelial Carcinoma?,ssm_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How prevalent is the ANKDD1A S413F mutation in cases of Bladder Urothelial Carcinoma?,ssm_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How prevalent is the HTR3B S146I mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How prevalent is the HTR3B S206I mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How prevalent is the HTR3B S217I mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,How prevalent is the ABCC3 R758W mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How prevalent is the NOMO1 T204I mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How prevalent is the NOMO1 T371I mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How prevalent is the HYOU1 D298H mutation in cases of Bladder Urothelial Carcinoma?,ssm_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How prevalent is the FMO4 R500Q mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+140,BICC1,A372V,Exceptional Responders,How prevalent is the BICC1 A372V mutation in cases of Exceptional Responders?,ssm_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How prevalent is the ZMYM3 I920V mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How prevalent is the ZMYM3 I932V mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How prevalent is the ZMYM3 I934V mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the XKR4 R547W mutation in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How prevalent is the ABCC2 V239L mutation in cases of Liver Hepatocellular Carcinoma?,ssm_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,How prevalent is the OR8K5 R293G mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How prevalent is the SPTAN1 S1503F mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How prevalent is the SPTAN1 S1523F mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,How prevalent is the SYT10 M484I mutation in cases of Rectum Adenocarcinoma?,ssm_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How prevalent is the HSPA5 N457K mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,How prevalent is the UNC5D L280V mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,How prevalent is the UNC5D L635V mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,How prevalent is the UNC5D L637V mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,How prevalent is the UNC5D L699V mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,How prevalent is the UNC5D L704V mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,How prevalent is the UNC5D L709V mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How prevalent is the DOCK2 L1527H mutation in cases of Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How prevalent is the ZNF627 A5V mutation in cases of Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How prevalent is the CDC42BPA L823F mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,How prevalent is the MRPL55 H27Y mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,How prevalent is the MRPL55 H63Y mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How prevalent is the TMTC3 Q749K mutation in cases of Breast Invasive Carcinoma?,ssm_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,How prevalent is the EPRS1 K771I mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,How prevalent is the EPRS1 K778I mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How prevalent is the GRTP1 A110V mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How prevalent is the GRTP1 A32V mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How prevalent is the TSHZ3 Q538K mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How prevalent is the TAS1R3 Q326H mutation in cases of HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,ssm_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How prevalent is the PIAS3 S238C mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How prevalent is the PIAS3 S273C mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,How prevalent is the ZNF274 P13R mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,How prevalent is the SYNJ1 R795C mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,How prevalent is the SYNJ1 R800C mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,How prevalent is the SYNJ1 R839C mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,How prevalent is the DSCAM V343M mutation in cases of Prostate Adenocarcinoma?,ssm_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,How prevalent is the DSCAM V426M mutation in cases of Prostate Adenocarcinoma?,ssm_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,How prevalent is the DSCAM V591M mutation in cases of Prostate Adenocarcinoma?,ssm_frequency
+267,DGKD,R140H,Exceptional Responders,How prevalent is the DGKD R140H mutation in cases of Exceptional Responders?,ssm_frequency
+268,DGKD,R160H,Exceptional Responders,How prevalent is the DGKD R160H mutation in cases of Exceptional Responders?,ssm_frequency
+269,DGKD,R204H,Exceptional Responders,How prevalent is the DGKD R204H mutation in cases of Exceptional Responders?,ssm_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How prevalent is the PLEKHG6 D105Y mutation in cases of Bladder Urothelial Carcinoma?,ssm_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How prevalent is the PLEKHG6 D543Y mutation in cases of Bladder Urothelial Carcinoma?,ssm_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How prevalent is the PLEKHG6 D575Y mutation in cases of Bladder Urothelial Carcinoma?,ssm_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,How prevalent is the WNT2 D138N mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How prevalent is the GUCY2C G667R mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How prevalent is the C7orf31 P244H mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the ZKSCAN7 E64K mutation in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+299,OR5D14,M210L,Neuroblastoma,How prevalent is the OR5D14 M210L mutation in cases of Neuroblastoma?,ssm_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How prevalent is the SPATA22 K279E mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How prevalent is the SPATA22 K306E mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How prevalent is the SPATA22 K322E mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,How prevalent is the LCN15 E21V mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How prevalent is the DCAF4L2 S129F mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How prevalent is the GUK1 R135P mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How prevalent is the GUK1 R137P mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How prevalent is the GUK1 R139P mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How prevalent is the GUK1 R158P mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How prevalent is the GUK1 R203P mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How prevalent is the MORF4L1 K29T mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How prevalent is the MORF4L1 K51T mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How prevalent is the MORF4L1 K61T mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How prevalent is the MORF4L1 K76T mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How prevalent is the MYO3B F594L mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How prevalent is the MYO3B F603L mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How prevalent is the TENT5A S320F mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How prevalent is the TENT5A S339F mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How prevalent is the TENT5A S401F mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How prevalent is the ZFAT S614L mutation in cases of Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How prevalent is the ZFAT S664L mutation in cases of Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How prevalent is the ZFAT S676L mutation in cases of Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+357,ZNF584,A211T,Sarcoma,How prevalent is the ZNF584 A211T mutation in cases of Sarcoma?,ssm_frequency
+358,ZNF584,A256T,Sarcoma,How prevalent is the ZNF584 A256T mutation in cases of Sarcoma?,ssm_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How prevalent is the LDOC1 R63W mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How prevalent is the PDGFC R201G mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How prevalent is the MSANTD4 R304C mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How prevalent is the NPSR1 S123L mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How prevalent is the PHLPP1 K1317E mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How prevalent is the COL6A3 G237S mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How prevalent is the COL6A3 G437S mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How prevalent is the COL6A3 G638S mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How prevalent is the COL6A3 G644S mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How prevalent is the COL6A3 G844S mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How prevalent is the ADRA1A R348G mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is the LAMB2 S1254F mutation in cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,How prevalent is the POC1B I198T mutation in cases of Rectum Adenocarcinoma?,ssm_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,How prevalent is the POC1B I286T mutation in cases of Rectum Adenocarcinoma?,ssm_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,How prevalent is the POC1B I328T mutation in cases of Rectum Adenocarcinoma?,ssm_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,How prevalent is the POC1B S79P mutation in cases of Rectum Adenocarcinoma?,ssm_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How prevalent is the USH2A G1451C mutation in cases of Liver Hepatocellular Carcinoma?,ssm_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,How prevalent is the AQP7 T110S mutation in cases of Rectum Adenocarcinoma?,ssm_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,How prevalent is the AQP7 T166S mutation in cases of Rectum Adenocarcinoma?,ssm_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,How prevalent is the AQP7 T167S mutation in cases of Rectum Adenocarcinoma?,ssm_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,How prevalent is the AQP7 T75S mutation in cases of Rectum Adenocarcinoma?,ssm_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,How prevalent is the DCN R163C mutation in cases of Rectum Adenocarcinoma?,ssm_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,How prevalent is the DCN R203C mutation in cases of Rectum Adenocarcinoma?,ssm_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,How prevalent is the DCN R241C mutation in cases of Rectum Adenocarcinoma?,ssm_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,How prevalent is the DCN R350C mutation in cases of Rectum Adenocarcinoma?,ssm_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,How prevalent is the DCN R41C mutation in cases of Rectum Adenocarcinoma?,ssm_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How prevalent is the CPS1 K1269N mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How prevalent is the CPS1 K1275N mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How prevalent is the CPS1 K818N mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How prevalent is the FCGR2C P122S mutation in cases of Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How prevalent is the FCGR2C P123S mutation in cases of Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How prevalent is the GRM1 R280M mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,How prevalent is the SGCZ Q138H mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,How prevalent is the SGCZ Q91H mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,How prevalent is the SMO V15M mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,How prevalent is the SMO V321M mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,How prevalent is the CHODL G159E mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,How prevalent is the CHODL G181E mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,How prevalent is the CHODL G200E mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,How prevalent is the MYO16 P399H mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,How prevalent is the MYO16 P421H mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,How prevalent is the CXCR2 A98V mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How prevalent is the TMEM225 L212V mutation in cases of Bladder Urothelial Carcinoma?,ssm_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How prevalent is the MAOB N251T mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How prevalent is the GPRASP1 F580S mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How prevalent is the MRPL32 R181Q mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How prevalent is the TYROBP A29T mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,How prevalent is the RAB40C A111V mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,How prevalent is the RAB40C A143V mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,How prevalent is the CTNNA2 S323R mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,How prevalent is the CTNNA2 S339R mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,How prevalent is the CTNNA2 S386R mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,How prevalent is the CTNNA2 S707R mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How prevalent is the MYO15A S268R mutation in cases of Bladder Urothelial Carcinoma?,ssm_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How prevalent is the GIMAP2 A167T mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,How prevalent is the KIF20B N1160D mutation in cases of Glioblastoma Multiforme?,ssm_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,How prevalent is the KIF20B N1200D mutation in cases of Glioblastoma Multiforme?,ssm_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How prevalent is the ADAM17 E583K mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How prevalent is the BCAT1 G16R mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How prevalent is the BCAT1 G17R mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How prevalent is the BCAT1 G29R mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,How prevalent is the ERCC6 R1053H mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,How prevalent is the DCC R320W mutation in cases of Breast Invasive Carcinoma?,ssm_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,How prevalent is the DCC R363W mutation in cases of Breast Invasive Carcinoma?,ssm_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,How prevalent is the DCC R386W mutation in cases of Breast Invasive Carcinoma?,ssm_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,How prevalent is the DCC R41W mutation in cases of Breast Invasive Carcinoma?,ssm_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How prevalent is the FBXO15 D417N mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How prevalent is the FBXO15 D86N mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How prevalent is the GSTCD S528F mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How prevalent is the GSTCD S615F mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How prevalent is the OLFML3 P296S mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How prevalent is the OLFML3 P337S mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How prevalent is the OLFML3 P357S mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How prevalent is the CFAP61 E173V mutation in cases of Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How prevalent is the CFAP61 E817V mutation in cases of Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How prevalent is the HLA-DQA2 E51K mutation in cases of Bladder Urothelial Carcinoma?,ssm_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How prevalent is the TENM2 H240Y mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How prevalent is the TENM2 H351Y mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How prevalent is the TENM2 H472Y mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How prevalent is the ANKRD24 A465T mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How prevalent is the ANKRD24 A494T mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How prevalent is the ANKRD24 A584T mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How prevalent is the ZCCHC14 V549M mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How prevalent is the ZCCHC14 V665M mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How prevalent is the ZCCHC14 V676M mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How prevalent is the ZCCHC14 V802M mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,How prevalent is the SIK2 I265M mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How prevalent is the MYH11 T1336M mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How prevalent is the MYH11 T1343M mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How prevalent is the SLC6A4 S174F mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How prevalent is the SLC9C1 K102N mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How prevalent is the SLC9C1 K29N mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,How prevalent is the OR2A12 A254T mutation in cases of Brain Lower Grade Glioma?,ssm_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,How prevalent is the PYHIN1 T325K mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,How prevalent is the PYHIN1 T334K mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,How prevalent is the JAML G191E mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,How prevalent is the JAML G219E mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,How prevalent is the JAML G220E mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,How prevalent is the JAML G230E mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,How prevalent is the TYK2 H1146R mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,How prevalent is the TYK2 H23R mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,How prevalent is the TYK2 H961R mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How prevalent is the CTCFL R208C mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How prevalent is the CTCFL R265C mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How prevalent is the CTCFL R420C mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How prevalent is the CTCFL R470C mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How prevalent is the CEP20 R31Q mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How prevalent is the CEP20 R58Q mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How prevalent is the RIMS2 R25W mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How prevalent is the RIMS2 R393W mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How prevalent is the RIMS2 R423W mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How prevalent is the RIMS2 R470W mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How prevalent is the RIMS2 R615W mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How prevalent is the RIMS2 R619W mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How prevalent is the RIMS2 R716W mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How prevalent is the PIK3C2G S551L mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How prevalent is the PIK3C2G S592L mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+728,STK19,D341N,Colon Adenocarcinoma,How prevalent is the STK19 D341N mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+729,STK19,D345N,Colon Adenocarcinoma,How prevalent is the STK19 D345N mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,How prevalent is the REXO4 P60A mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How prevalent is the ZBTB34 P160S mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How prevalent is the ZBTB34 P164S mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How prevalent is the NCKAP5 E148K mutation in cases of Bladder Urothelial Carcinoma?,ssm_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the SORCS1 D1052Y mutation in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the SORCS1 D587Y mutation in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the SORCS1 D67Y mutation in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the SORCS1 D810Y mutation in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How prevalent is the FGF8 T154M mutation in cases of Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How prevalent is the FGF8 T165M mutation in cases of Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How prevalent is the FGF8 T183M mutation in cases of Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How prevalent is the FGF8 T194M mutation in cases of Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How prevalent is the FGF8 T90M mutation in cases of Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How prevalent is the TENM3 R1877W mutation in cases of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,ssm_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How prevalent is the AKT1 D44N mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is the CFAP298-TCP10L E11Q mutation in cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,How prevalent is the GLRB E148D mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,How prevalent is the TTN F7636L mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,How prevalent is the TTN F8563L mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,How prevalent is the TTN F8880L mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How prevalent is the ANKRD30A V798I mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How prevalent is the ANKRD30A V854I mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How prevalent is the ANKRD30A V973I mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,How prevalent is the TRIM45 S177L mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,How prevalent is the TRIM45 S224L mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,How prevalent is the TRIM45 S281L mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How prevalent is the CACNA1F G727V mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How prevalent is the CACNA1F G781V mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How prevalent is the CACNA1F G792V mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+817,KL,R594C,Colon Adenocarcinoma,How prevalent is the KL R594C mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How prevalent is the GUF1 I243T mutation in cases of Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,How prevalent is the TAF1L A539V mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How prevalent is the TASOR2 S256F mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How prevalent is the TASOR2 S36F mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How prevalent is the TASOR2 S471F mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How prevalent is the KDM5C R1151C mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How prevalent is the KDM5C R1177C mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How prevalent is the KDM5C R1217C mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How prevalent is the KDM5C R1218C mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is the IL5RA L153F mutation in cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,How prevalent is the DHX16 A29V mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,How prevalent is the DHX16 A89V mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,How prevalent is the GPR158 A644V mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,How prevalent is the GPR158 A723V mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the EIF2B4 E108K mutation in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the EIF2B4 E110K mutation in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the EIF2B4 E111K mutation in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the EIF2B4 E131K mutation in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the EIF2B4 E132K mutation in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the EIF2B4 E96K mutation in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How prevalent is the AUTS2 P136S mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How prevalent is the AUTS2 P218S mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How prevalent is the AUTS2 P233S mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How prevalent is the AUTS2 P313S mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How prevalent is the AUTS2 P419S mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How prevalent is the AUTS2 P443S mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How prevalent is the AUTS2 P56S mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How prevalent is the AUTS2 P667S mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How prevalent is the AUTS2 P690S mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How prevalent is the AUTS2 P691S mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the ACTL7B D223N mutation in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How prevalent is the PCDHGA1 R535W mutation in cases of Glioblastoma Multiforme?,ssm_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,How prevalent is the TRAP1 R114W mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,How prevalent is the TRAP1 R61W mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How prevalent is the PIK3C2A R1570Q mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How prevalent is the KANSL1 R139G mutation in cases of Liver Hepatocellular Carcinoma?,ssm_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How prevalent is the ANKRD52 Y594C mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How prevalent is the PAPPA G1580S mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How prevalent is the B3GALNT1 V270A mutation in cases of Rectum Adenocarcinoma?,ssm_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,How prevalent is the GABRA6 G115R mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,How prevalent is the GABRA6 G122R mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,How prevalent is the GABRA6 G165R mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,How prevalent is the GABRA6 G175R mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,How prevalent is the GABRA6 G70R mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How prevalent is the ZSCAN31 D9N mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the MED16 L126P mutation in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the MED16 L868P mutation in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How prevalent is the PTPRO E1060K mutation in cases of Pancreatic Adenocarcinoma?,ssm_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How prevalent is the PTPRO E1088K mutation in cases of Pancreatic Adenocarcinoma?,ssm_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How prevalent is the PTPRO E249K mutation in cases of Pancreatic Adenocarcinoma?,ssm_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How prevalent is the PTPRO E265K mutation in cases of Pancreatic Adenocarcinoma?,ssm_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How prevalent is the PTPRO E277K mutation in cases of Pancreatic Adenocarcinoma?,ssm_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How prevalent is the PTPRO E67K mutation in cases of Pancreatic Adenocarcinoma?,ssm_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How prevalent is the PTPRO E923K mutation in cases of Pancreatic Adenocarcinoma?,ssm_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How prevalent is the PTPRO E940K mutation in cases of Pancreatic Adenocarcinoma?,ssm_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How prevalent is the CHMP7 D397N mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,How prevalent is the GPC3 I107N mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,How prevalent is the GPC3 I161N mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is the TLK2 V430L mutation in cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is the TLK2 V515L mutation in cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is the TLK2 V547L mutation in cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is the TLK2 V579L mutation in cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is the TLK2 V601L mutation in cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How prevalent is the ZNF217 E209Q mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,How prevalent is the SYT9 V275L mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,How prevalent is the SYT9 V307L mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How prevalent is the PKHD1L1 S2830N mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How prevalent is the MYO3A Y1295C mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the VASN V318I mutation in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How prevalent is the DNMT1 A1037T mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How prevalent is the DNMT1 A1053T mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How prevalent is the DNMT1 A934T mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,How prevalent is the CA9 E402K mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How prevalent is the TTC17 R808Q mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How prevalent is the TTC17 R865Q mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,How prevalent is the PSG2 P43L mutation in cases of Breast Invasive Carcinoma?,ssm_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How prevalent is the RIPOR2 R470L mutation in cases of Breast Invasive Carcinoma?,ssm_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How prevalent is the RIPOR2 R499L mutation in cases of Breast Invasive Carcinoma?,ssm_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How prevalent is the RIPOR2 R504L mutation in cases of Breast Invasive Carcinoma?,ssm_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How prevalent is the RIPOR2 R520L mutation in cases of Breast Invasive Carcinoma?,ssm_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How prevalent is the DCLK3 V520I mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How prevalent is the DCLK3 V689I mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How prevalent is the MERTK G257A mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How prevalent is the MERTK G757A mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How prevalent is the MERTK G933A mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How prevalent is the ZFP42 R206K mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How prevalent is the OR13C3 M117I mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How prevalent is the OR13C3 M147I mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How prevalent is the SPAG1 I917M mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How prevalent is the CDKN2AIP Y92H mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,How prevalent is the PXN H1016Y mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,How prevalent is the PXN H359Y mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,How prevalent is the PXN H492Y mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,How prevalent is the PXN H524Y mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,How prevalent is the PXN H526Y mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,How prevalent is the PXN H540Y mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How prevalent is the TTYH2 S23L mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How prevalent is the TTYH2 S44L mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How prevalent is the TMEM255A N205S mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How prevalent is the TMEM255A N229S mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How prevalent is the TMEM255A N65S mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How prevalent is the TASOR2 H2271D mutation in cases of Breast Invasive Carcinoma?,ssm_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How prevalent is the TASOR2 H2486D mutation in cases of Breast Invasive Carcinoma?,ssm_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How prevalent is the ICE1 T1839M mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,How prevalent is the MYT1 A558E mutation in cases of Breast Invasive Carcinoma?,ssm_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,How prevalent is the MYT1 A879E mutation in cases of Breast Invasive Carcinoma?,ssm_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,How prevalent is the MYT1 A906E mutation in cases of Breast Invasive Carcinoma?,ssm_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How prevalent is the CX3CR1 P203L mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How prevalent is the CX3CR1 P235L mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How prevalent is the SPINDOC R197C mutation in cases of Liver Hepatocellular Carcinoma?,ssm_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How prevalent is the ART3 C251Y mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How prevalent is the ART3 C3Y mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How prevalent is the CYP1A2 R243G mutation in cases of Bladder Urothelial Carcinoma?,ssm_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the ADRA1A G279S mutation in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How prevalent is the CDH23 P2523R mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How prevalent is the CDH23 P283R mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How prevalent is the KRT39 P137S mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How prevalent is the PDHA2 S7F mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How prevalent is the SLC24A2 H200Q mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How prevalent is the PTPRN2 F153L mutation in cases of Liver Hepatocellular Carcinoma?,ssm_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How prevalent is the PTPRN2 F847L mutation in cases of Liver Hepatocellular Carcinoma?,ssm_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How prevalent is the PTPRN2 F856L mutation in cases of Liver Hepatocellular Carcinoma?,ssm_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How prevalent is the PTPRN2 F868L mutation in cases of Liver Hepatocellular Carcinoma?,ssm_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How prevalent is the PTPRN2 F885L mutation in cases of Liver Hepatocellular Carcinoma?,ssm_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,How prevalent is the SOX21 R55L mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How prevalent is the CPA6 G166E mutation in cases of Bladder Urothelial Carcinoma?,ssm_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How prevalent is the GRM5 E14K mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the CASZ1 R233Q mutation in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How prevalent is the SGIP1 N122T mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How prevalent is the SGIP1 N420T mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How prevalent is the SGIP1 N617T mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How prevalent is the SGIP1 N648T mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How prevalent is the CARMIL1 V549L mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How prevalent is the CARMIL1 V949L mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How prevalent is the ZNF431 D121Y mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How prevalent is the ZNF431 D161Y mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,How prevalent is the ZNF431 R128I mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How prevalent is the DNAH11 P2987S mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How prevalent is the DNAH11 P2994S mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How prevalent is the POLD1 Q461L mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How prevalent is the POLD1 Q85L mutation in cases of Lung Squamous Cell Carcinoma?,ssm_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,How prevalent is the TTC12 D646H mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,How prevalent is the TTC12 D652H mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How prevalent is the CNGB1 D967N mutation in cases of Bladder Urothelial Carcinoma?,ssm_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How prevalent is the CNGB1 D973N mutation in cases of Bladder Urothelial Carcinoma?,ssm_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,How prevalent is the CTSC E214V mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,How prevalent is the CTSC E291V mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,How prevalent is the CTSC E322V mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,How prevalent is the CTSC E324V mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,How prevalent is the CTSC E335V mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How prevalent is the PRSS8 A179T mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How prevalent is the PRSS8 A233T mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How prevalent is the ARHGEF40 V864F mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,How prevalent is the ACTB A138T mutation in cases of Rectum Adenocarcinoma?,ssm_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,How prevalent is the ACTB A217T mutation in cases of Rectum Adenocarcinoma?,ssm_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,How prevalent is the ACTB A244T mutation in cases of Rectum Adenocarcinoma?,ssm_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,How prevalent is the ACTB A260T mutation in cases of Rectum Adenocarcinoma?,ssm_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How prevalent is the YY1AP1 V546D mutation in cases of Glioblastoma Multiforme?,ssm_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How prevalent is the YY1AP1 V557D mutation in cases of Glioblastoma Multiforme?,ssm_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How prevalent is the YY1AP1 V566D mutation in cases of Glioblastoma Multiforme?,ssm_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How prevalent is the YY1AP1 V577D mutation in cases of Glioblastoma Multiforme?,ssm_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How prevalent is the YY1AP1 V623D mutation in cases of Glioblastoma Multiforme?,ssm_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How prevalent is the YY1AP1 V695D mutation in cases of Glioblastoma Multiforme?,ssm_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How prevalent is the YY1AP1 V715D mutation in cases of Glioblastoma Multiforme?,ssm_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How prevalent is the FNDC7 D323N mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How prevalent is the FNDC7 D99N mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,How prevalent is the TLCD5 G15V mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,How prevalent is the TLCD5 G37V mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How prevalent is the POLR1G R498W mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How prevalent is the POLR1G R500W mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How prevalent is the DNAH14 N1186K mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How prevalent is the DNAH14 N2657K mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How prevalent is the DNAH14 N3460K mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How prevalent is the NEXN E73D mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How prevalent is the CYB5R2 G112R mutation in cases of Prostate Adenocarcinoma?,ssm_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How prevalent is the CYB5R2 G172R mutation in cases of Prostate Adenocarcinoma?,ssm_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How prevalent is the NRAP S808L mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How prevalent is the NRAP S816L mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How prevalent is the NRAP S843L mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How prevalent is the CCDC22 E179D mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How prevalent is the DCAF6 S402F mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How prevalent is the DCAF6 S433F mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How prevalent is the ZNF708 E389D mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How prevalent is the BFAR T103M mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How prevalent is the MAST4 P1237S mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How prevalent is the MAST4 P1986S mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How prevalent is the MAST4 P1991S mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How prevalent is the MAST4 P2001S mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How prevalent is the MAST4 P2180S mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How prevalent is the ARMC3 R169C mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How prevalent is the ARMC3 R432C mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How prevalent is the TET2 L757V mutation in cases of Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How prevalent is the TET2 L778V mutation in cases of Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How prevalent is the SERPINB10 A353P mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How prevalent is the STAT3 Y22H mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How prevalent is the MIEF1 A42T mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How prevalent is the ACVR1B D397N mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How prevalent is the ACVR1B D449N mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How prevalent is the ACVR1B D490N mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,How prevalent is the EBF2 T104I mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,How prevalent is the EBF2 T252I mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How prevalent is the VPS26B F266L mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the PGR M106I mutation in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the PGR M38I mutation in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the PGR M632I mutation in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How prevalent is the ACTA2 P334L mutation in cases of Skin Cutaneous Melanoma?,ssm_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How prevalent is the THBS4 T852I mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How prevalent is the THBS4 T943I mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,How prevalent is the PRSS1 S114T mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,How prevalent is the PRSS1 S124T mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,How prevalent is the PRSS1 S138T mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,How prevalent is the PRSS1 S74T mutation in cases of Lung Adenocarcinoma?,ssm_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,How prevalent is the PGF R126H mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,How prevalent is the PGF R127H mutation in cases of Stomach Adenocarcinoma?,ssm_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How prevalent is the ITPRID2 S351C mutation in cases of Breast Invasive Carcinoma?,ssm_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How prevalent is the ITPRID2 S842C mutation in cases of Breast Invasive Carcinoma?,ssm_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How prevalent is the HBB E8D mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How prevalent is the PCDHB2 R158C mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How prevalent is the PCDHB2 T15M mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How prevalent is the PCDHB2 T26M mutation in cases of Colon Adenocarcinoma?,ssm_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How prevalent is the UBR2 P1594S mutation in cases of Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How prevalent is the FBXO42 A618D mutation in cases of Rectum Adenocarcinoma?,ssm_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the incidence of the TNS1 G1362V mutation in Breast Invasive Carcinoma?,ssm_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the incidence of the TNS1 G1711V mutation in Breast Invasive Carcinoma?,ssm_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the incidence of the TNS1 G1718V mutation in Breast Invasive Carcinoma?,ssm_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the incidence of the TNS1 G1732V mutation in Breast Invasive Carcinoma?,ssm_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the incidence of the TNS1 G1824V mutation in Breast Invasive Carcinoma?,ssm_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the incidence of the TNS1 G1857V mutation in Breast Invasive Carcinoma?,ssm_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the incidence of the TNS1 G843V mutation in Breast Invasive Carcinoma?,ssm_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the incidence of the EVC2 E1067K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the incidence of the EVC2 E987K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the incidence of the CR1 V1108G mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the incidence of the CR1 V1558G mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the incidence of the TRPA1 S295I mutation in Rectum Adenocarcinoma?,ssm_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the incidence of the TRPA1 S443I mutation in Rectum Adenocarcinoma?,ssm_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the incidence of the TAF1C R299L mutation in Lung Adenocarcinoma?,ssm_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the incidence of the TAF1C R396L mutation in Lung Adenocarcinoma?,ssm_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the incidence of the TAF1C R634L mutation in Lung Adenocarcinoma?,ssm_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the incidence of the TAF1C R702L mutation in Lung Adenocarcinoma?,ssm_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the incidence of the TAF1C R728L mutation in Lung Adenocarcinoma?,ssm_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the incidence of the DPF3 R104W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the incidence of the DPF3 R149W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the incidence of the DPF3 R94W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the incidence of the OR2T4 P272H mutation in Lung Adenocarcinoma?,ssm_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the incidence of the OR2T4 P300H mutation in Lung Adenocarcinoma?,ssm_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the incidence of the FBN1 E2667K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the incidence of the MAD1L1 E396K mutation in Prostate Adenocarcinoma?,ssm_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the incidence of the MAD1L1 E488K mutation in Prostate Adenocarcinoma?,ssm_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the incidence of the MAD1L1 E78K mutation in Prostate Adenocarcinoma?,ssm_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the incidence of the CCNG1 E22K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the incidence of the ANP32E N114T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the incidence of the ANP32E N64T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the incidence of the ANP32E N66T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the incidence of the ANP32E N73T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the incidence of the FRY S1888A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the incidence of the FRY S1937A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the incidence of the FRY S1938A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the incidence of the FRY S1983A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the incidence of the PAK3 E318K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the incidence of the PAK3 E319K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the incidence of the PAK3 E334K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the incidence of the PAK3 E340K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the incidence of the PAK3 E355K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the incidence of the MUC16 P7963L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the incidence of the ZFPM2 T498I mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the incidence of the ZFPM2 T630I mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the incidence of the PIK3C2B S1328C mutation in Breast Invasive Carcinoma?,ssm_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the incidence of the PIK3C2B S1356C mutation in Breast Invasive Carcinoma?,ssm_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the incidence of the ZNF804A S371Y mutation in Colon Adenocarcinoma?,ssm_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the incidence of the RELN A2371V mutation in Stomach Adenocarcinoma?,ssm_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of the EFCAB12 R173C mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of the EFCAB12 R23C mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the incidence of the DEFB115 E53K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the incidence of the ANKDD1A S290F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the incidence of the ANKDD1A S322F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the incidence of the ANKDD1A S413F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the incidence of the HTR3B S146I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the incidence of the HTR3B S206I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the incidence of the HTR3B S217I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the incidence of the ABCC3 R758W mutation in Stomach Adenocarcinoma?,ssm_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the incidence of the NOMO1 T204I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the incidence of the NOMO1 T371I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the incidence of the HYOU1 D298H mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the incidence of the FMO4 R500Q mutation in Skin Cutaneous Melanoma?,ssm_frequency
+140,BICC1,A372V,Exceptional Responders,What is the incidence of the BICC1 A372V mutation in Exceptional Responders?,ssm_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the incidence of the ZMYM3 I920V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the incidence of the ZMYM3 I932V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the incidence of the ZMYM3 I934V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of the XKR4 R547W mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the incidence of the ABCC2 V239L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the incidence of the OR8K5 R293G mutation in Lung Adenocarcinoma?,ssm_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the incidence of the SPTAN1 S1503F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the incidence of the SPTAN1 S1523F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the incidence of the SYT10 M484I mutation in Rectum Adenocarcinoma?,ssm_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the incidence of the HSPA5 N457K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the incidence of the UNC5D L280V mutation in Lung Adenocarcinoma?,ssm_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the incidence of the UNC5D L635V mutation in Lung Adenocarcinoma?,ssm_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the incidence of the UNC5D L637V mutation in Lung Adenocarcinoma?,ssm_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the incidence of the UNC5D L699V mutation in Lung Adenocarcinoma?,ssm_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the incidence of the UNC5D L704V mutation in Lung Adenocarcinoma?,ssm_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the incidence of the UNC5D L709V mutation in Lung Adenocarcinoma?,ssm_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the incidence of the DOCK2 L1527H mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the incidence of the ZNF627 A5V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the incidence of the CDC42BPA L823F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the incidence of the MRPL55 H27Y mutation in Colon Adenocarcinoma?,ssm_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the incidence of the MRPL55 H63Y mutation in Colon Adenocarcinoma?,ssm_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the incidence of the TMTC3 Q749K mutation in Breast Invasive Carcinoma?,ssm_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the incidence of the EPRS1 K771I mutation in Colon Adenocarcinoma?,ssm_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the incidence of the EPRS1 K778I mutation in Colon Adenocarcinoma?,ssm_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the incidence of the GRTP1 A110V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the incidence of the GRTP1 A32V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the incidence of the TSHZ3 Q538K mutation in Stomach Adenocarcinoma?,ssm_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the incidence of the TAS1R3 Q326H mutation in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,ssm_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the incidence of the PIAS3 S238C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the incidence of the PIAS3 S273C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the incidence of the ZNF274 P13R mutation in Stomach Adenocarcinoma?,ssm_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the incidence of the SYNJ1 R795C mutation in Colon Adenocarcinoma?,ssm_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the incidence of the SYNJ1 R800C mutation in Colon Adenocarcinoma?,ssm_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the incidence of the SYNJ1 R839C mutation in Colon Adenocarcinoma?,ssm_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the incidence of the DSCAM V343M mutation in Prostate Adenocarcinoma?,ssm_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the incidence of the DSCAM V426M mutation in Prostate Adenocarcinoma?,ssm_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the incidence of the DSCAM V591M mutation in Prostate Adenocarcinoma?,ssm_frequency
+267,DGKD,R140H,Exceptional Responders,What is the incidence of the DGKD R140H mutation in Exceptional Responders?,ssm_frequency
+268,DGKD,R160H,Exceptional Responders,What is the incidence of the DGKD R160H mutation in Exceptional Responders?,ssm_frequency
+269,DGKD,R204H,Exceptional Responders,What is the incidence of the DGKD R204H mutation in Exceptional Responders?,ssm_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the incidence of the PLEKHG6 D105Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the incidence of the PLEKHG6 D543Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the incidence of the PLEKHG6 D575Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the incidence of the WNT2 D138N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the incidence of the GUCY2C G667R mutation in Skin Cutaneous Melanoma?,ssm_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the incidence of the C7orf31 P244H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of the ZKSCAN7 E64K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+299,OR5D14,M210L,Neuroblastoma,What is the incidence of the OR5D14 M210L mutation in Neuroblastoma?,ssm_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the incidence of the SPATA22 K279E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the incidence of the SPATA22 K306E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the incidence of the SPATA22 K322E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the incidence of the LCN15 E21V mutation in Stomach Adenocarcinoma?,ssm_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the incidence of the DCAF4L2 S129F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the incidence of the GUK1 R135P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the incidence of the GUK1 R137P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the incidence of the GUK1 R139P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the incidence of the GUK1 R158P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the incidence of the GUK1 R203P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the incidence of the MORF4L1 K29T mutation in Stomach Adenocarcinoma?,ssm_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the incidence of the MORF4L1 K51T mutation in Stomach Adenocarcinoma?,ssm_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the incidence of the MORF4L1 K61T mutation in Stomach Adenocarcinoma?,ssm_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the incidence of the MORF4L1 K76T mutation in Stomach Adenocarcinoma?,ssm_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the incidence of the MYO3B F594L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the incidence of the MYO3B F603L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the incidence of the TENT5A S320F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the incidence of the TENT5A S339F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the incidence of the TENT5A S401F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the incidence of the ZFAT S614L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the incidence of the ZFAT S664L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the incidence of the ZFAT S676L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+357,ZNF584,A211T,Sarcoma,What is the incidence of the ZNF584 A211T mutation in Sarcoma?,ssm_frequency
+358,ZNF584,A256T,Sarcoma,What is the incidence of the ZNF584 A256T mutation in Sarcoma?,ssm_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the incidence of the LDOC1 R63W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the incidence of the PDGFC R201G mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the incidence of the MSANTD4 R304C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the incidence of the NPSR1 S123L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the incidence of the PHLPP1 K1317E mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the incidence of the COL6A3 G237S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the incidence of the COL6A3 G437S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the incidence of the COL6A3 G638S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the incidence of the COL6A3 G644S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the incidence of the COL6A3 G844S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the incidence of the ADRA1A R348G mutation in Stomach Adenocarcinoma?,ssm_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of the LAMB2 S1254F mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the incidence of the POC1B I198T mutation in Rectum Adenocarcinoma?,ssm_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the incidence of the POC1B I286T mutation in Rectum Adenocarcinoma?,ssm_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the incidence of the POC1B I328T mutation in Rectum Adenocarcinoma?,ssm_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the incidence of the POC1B S79P mutation in Rectum Adenocarcinoma?,ssm_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the incidence of the USH2A G1451C mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the incidence of the AQP7 T110S mutation in Rectum Adenocarcinoma?,ssm_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the incidence of the AQP7 T166S mutation in Rectum Adenocarcinoma?,ssm_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the incidence of the AQP7 T167S mutation in Rectum Adenocarcinoma?,ssm_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the incidence of the AQP7 T75S mutation in Rectum Adenocarcinoma?,ssm_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,What is the incidence of the DCN R163C mutation in Rectum Adenocarcinoma?,ssm_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,What is the incidence of the DCN R203C mutation in Rectum Adenocarcinoma?,ssm_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,What is the incidence of the DCN R241C mutation in Rectum Adenocarcinoma?,ssm_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,What is the incidence of the DCN R350C mutation in Rectum Adenocarcinoma?,ssm_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,What is the incidence of the DCN R41C mutation in Rectum Adenocarcinoma?,ssm_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the incidence of the CPS1 K1269N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the incidence of the CPS1 K1275N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the incidence of the CPS1 K818N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the incidence of the FCGR2C P122S mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the incidence of the FCGR2C P123S mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the incidence of the GRM1 R280M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the incidence of the SGCZ Q138H mutation in Lung Adenocarcinoma?,ssm_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the incidence of the SGCZ Q91H mutation in Lung Adenocarcinoma?,ssm_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,What is the incidence of the SMO V15M mutation in Stomach Adenocarcinoma?,ssm_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,What is the incidence of the SMO V321M mutation in Stomach Adenocarcinoma?,ssm_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the incidence of the CHODL G159E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the incidence of the CHODL G181E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the incidence of the CHODL G200E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,What is the incidence of the MYO16 P399H mutation in Colon Adenocarcinoma?,ssm_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,What is the incidence of the MYO16 P421H mutation in Colon Adenocarcinoma?,ssm_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the incidence of the CXCR2 A98V mutation in Stomach Adenocarcinoma?,ssm_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the incidence of the TMEM225 L212V mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the incidence of the MAOB N251T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the incidence of the GPRASP1 F580S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of the MRPL32 R181Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the incidence of the TYROBP A29T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the incidence of the RAB40C A111V mutation in Lung Adenocarcinoma?,ssm_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the incidence of the RAB40C A143V mutation in Lung Adenocarcinoma?,ssm_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the incidence of the CTNNA2 S323R mutation in Lung Adenocarcinoma?,ssm_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the incidence of the CTNNA2 S339R mutation in Lung Adenocarcinoma?,ssm_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the incidence of the CTNNA2 S386R mutation in Lung Adenocarcinoma?,ssm_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the incidence of the CTNNA2 S707R mutation in Lung Adenocarcinoma?,ssm_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the incidence of the MYO15A S268R mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the incidence of the GIMAP2 A167T mutation in Skin Cutaneous Melanoma?,ssm_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the incidence of the KIF20B N1160D mutation in Glioblastoma Multiforme?,ssm_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the incidence of the KIF20B N1200D mutation in Glioblastoma Multiforme?,ssm_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the incidence of the ADAM17 E583K mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the incidence of the BCAT1 G16R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the incidence of the BCAT1 G17R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the incidence of the BCAT1 G29R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the incidence of the ERCC6 R1053H mutation in Colon Adenocarcinoma?,ssm_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,What is the incidence of the DCC R320W mutation in Breast Invasive Carcinoma?,ssm_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,What is the incidence of the DCC R363W mutation in Breast Invasive Carcinoma?,ssm_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,What is the incidence of the DCC R386W mutation in Breast Invasive Carcinoma?,ssm_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,What is the incidence of the DCC R41W mutation in Breast Invasive Carcinoma?,ssm_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the incidence of the FBXO15 D417N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the incidence of the FBXO15 D86N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the incidence of the GSTCD S528F mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the incidence of the GSTCD S615F mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the incidence of the OLFML3 P296S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the incidence of the OLFML3 P337S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the incidence of the OLFML3 P357S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the incidence of the CFAP61 E173V mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the incidence of the CFAP61 E817V mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the incidence of the HLA-DQA2 E51K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the incidence of the TENM2 H240Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the incidence of the TENM2 H351Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the incidence of the TENM2 H472Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the incidence of the ANKRD24 A465T mutation in Stomach Adenocarcinoma?,ssm_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the incidence of the ANKRD24 A494T mutation in Stomach Adenocarcinoma?,ssm_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the incidence of the ANKRD24 A584T mutation in Stomach Adenocarcinoma?,ssm_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the incidence of the ZCCHC14 V549M mutation in Stomach Adenocarcinoma?,ssm_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the incidence of the ZCCHC14 V665M mutation in Stomach Adenocarcinoma?,ssm_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the incidence of the ZCCHC14 V676M mutation in Stomach Adenocarcinoma?,ssm_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the incidence of the ZCCHC14 V802M mutation in Stomach Adenocarcinoma?,ssm_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,What is the incidence of the SIK2 I265M mutation in Lung Adenocarcinoma?,ssm_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the incidence of the MYH11 T1336M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the incidence of the MYH11 T1343M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the incidence of the SLC6A4 S174F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the incidence of the SLC9C1 K102N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the incidence of the SLC9C1 K29N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the incidence of the OR2A12 A254T mutation in Brain Lower Grade Glioma?,ssm_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the incidence of the PYHIN1 T325K mutation in Lung Adenocarcinoma?,ssm_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the incidence of the PYHIN1 T334K mutation in Lung Adenocarcinoma?,ssm_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the incidence of the JAML G191E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the incidence of the JAML G219E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the incidence of the JAML G220E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the incidence of the JAML G230E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the incidence of the TYK2 H1146R mutation in Stomach Adenocarcinoma?,ssm_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the incidence of the TYK2 H23R mutation in Stomach Adenocarcinoma?,ssm_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the incidence of the TYK2 H961R mutation in Stomach Adenocarcinoma?,ssm_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the incidence of the CTCFL R208C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the incidence of the CTCFL R265C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the incidence of the CTCFL R420C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the incidence of the CTCFL R470C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of the CEP20 R31Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of the CEP20 R58Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the incidence of the RIMS2 R25W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the incidence of the RIMS2 R393W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the incidence of the RIMS2 R423W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the incidence of the RIMS2 R470W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the incidence of the RIMS2 R615W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the incidence of the RIMS2 R619W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the incidence of the RIMS2 R716W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the incidence of the PIK3C2G S551L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the incidence of the PIK3C2G S592L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+728,STK19,D341N,Colon Adenocarcinoma,What is the incidence of the STK19 D341N mutation in Colon Adenocarcinoma?,ssm_frequency
+729,STK19,D345N,Colon Adenocarcinoma,What is the incidence of the STK19 D345N mutation in Colon Adenocarcinoma?,ssm_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the incidence of the REXO4 P60A mutation in Skin Cutaneous Melanoma?,ssm_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the incidence of the ZBTB34 P160S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the incidence of the ZBTB34 P164S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the incidence of the NCKAP5 E148K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of the SORCS1 D1052Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of the SORCS1 D587Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of the SORCS1 D67Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of the SORCS1 D810Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the incidence of the FGF8 T154M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the incidence of the FGF8 T165M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the incidence of the FGF8 T183M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the incidence of the FGF8 T194M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the incidence of the FGF8 T90M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the incidence of the TENM3 R1877W mutation in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,ssm_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the incidence of the AKT1 D44N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of the CFAP298-TCP10L E11Q mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the incidence of the GLRB E148D mutation in Stomach Adenocarcinoma?,ssm_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,What is the incidence of the TTN F7636L mutation in Colon Adenocarcinoma?,ssm_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,What is the incidence of the TTN F8563L mutation in Colon Adenocarcinoma?,ssm_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,What is the incidence of the TTN F8880L mutation in Colon Adenocarcinoma?,ssm_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the incidence of the ANKRD30A V798I mutation in Colon Adenocarcinoma?,ssm_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the incidence of the ANKRD30A V854I mutation in Colon Adenocarcinoma?,ssm_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the incidence of the ANKRD30A V973I mutation in Colon Adenocarcinoma?,ssm_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the incidence of the TRIM45 S177L mutation in Colon Adenocarcinoma?,ssm_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the incidence of the TRIM45 S224L mutation in Colon Adenocarcinoma?,ssm_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the incidence of the TRIM45 S281L mutation in Colon Adenocarcinoma?,ssm_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the incidence of the CACNA1F G727V mutation in Stomach Adenocarcinoma?,ssm_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the incidence of the CACNA1F G781V mutation in Stomach Adenocarcinoma?,ssm_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the incidence of the CACNA1F G792V mutation in Stomach Adenocarcinoma?,ssm_frequency
+817,KL,R594C,Colon Adenocarcinoma,What is the incidence of the KL R594C mutation in Colon Adenocarcinoma?,ssm_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the incidence of the GUF1 I243T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the incidence of the TAF1L A539V mutation in Colon Adenocarcinoma?,ssm_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the incidence of the TASOR2 S256F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the incidence of the TASOR2 S36F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the incidence of the TASOR2 S471F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the incidence of the KDM5C R1151C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the incidence of the KDM5C R1177C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the incidence of the KDM5C R1217C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the incidence of the KDM5C R1218C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of the IL5RA L153F mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the incidence of the DHX16 A29V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the incidence of the DHX16 A89V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the incidence of the GPR158 A644V mutation in Stomach Adenocarcinoma?,ssm_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the incidence of the GPR158 A723V mutation in Stomach Adenocarcinoma?,ssm_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of the EIF2B4 E108K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of the EIF2B4 E110K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of the EIF2B4 E111K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of the EIF2B4 E131K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of the EIF2B4 E132K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of the EIF2B4 E96K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the incidence of the AUTS2 P136S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the incidence of the AUTS2 P218S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the incidence of the AUTS2 P233S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the incidence of the AUTS2 P313S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the incidence of the AUTS2 P419S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the incidence of the AUTS2 P443S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the incidence of the AUTS2 P56S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the incidence of the AUTS2 P667S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the incidence of the AUTS2 P690S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the incidence of the AUTS2 P691S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of the ACTL7B D223N mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the incidence of the PCDHGA1 R535W mutation in Glioblastoma Multiforme?,ssm_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the incidence of the TRAP1 R114W mutation in Stomach Adenocarcinoma?,ssm_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the incidence of the TRAP1 R61W mutation in Stomach Adenocarcinoma?,ssm_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of the PIK3C2A R1570Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the incidence of the KANSL1 R139G mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the incidence of the ANKRD52 Y594C mutation in Stomach Adenocarcinoma?,ssm_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the incidence of the PAPPA G1580S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the incidence of the B3GALNT1 V270A mutation in Rectum Adenocarcinoma?,ssm_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the incidence of the GABRA6 G115R mutation in Lung Adenocarcinoma?,ssm_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the incidence of the GABRA6 G122R mutation in Lung Adenocarcinoma?,ssm_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the incidence of the GABRA6 G165R mutation in Lung Adenocarcinoma?,ssm_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the incidence of the GABRA6 G175R mutation in Lung Adenocarcinoma?,ssm_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the incidence of the GABRA6 G70R mutation in Lung Adenocarcinoma?,ssm_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the incidence of the ZSCAN31 D9N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of the MED16 L126P mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of the MED16 L868P mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the incidence of the PTPRO E1060K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the incidence of the PTPRO E1088K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the incidence of the PTPRO E249K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the incidence of the PTPRO E265K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the incidence of the PTPRO E277K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the incidence of the PTPRO E67K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the incidence of the PTPRO E923K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the incidence of the PTPRO E940K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the incidence of the CHMP7 D397N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the incidence of the GPC3 I107N mutation in Stomach Adenocarcinoma?,ssm_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the incidence of the GPC3 I161N mutation in Stomach Adenocarcinoma?,ssm_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of the TLK2 V430L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of the TLK2 V515L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of the TLK2 V547L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of the TLK2 V579L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of the TLK2 V601L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the incidence of the ZNF217 E209Q mutation in Lung Adenocarcinoma?,ssm_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the incidence of the SYT9 V275L mutation in Lung Adenocarcinoma?,ssm_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the incidence of the SYT9 V307L mutation in Lung Adenocarcinoma?,ssm_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the incidence of the PKHD1L1 S2830N mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the incidence of the MYO3A Y1295C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of the VASN V318I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the incidence of the DNMT1 A1037T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the incidence of the DNMT1 A1053T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the incidence of the DNMT1 A934T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,What is the incidence of the CA9 E402K mutation in Colon Adenocarcinoma?,ssm_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of the TTC17 R808Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of the TTC17 R865Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the incidence of the PSG2 P43L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the incidence of the RIPOR2 R470L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the incidence of the RIPOR2 R499L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the incidence of the RIPOR2 R504L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the incidence of the RIPOR2 R520L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the incidence of the DCLK3 V520I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the incidence of the DCLK3 V689I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the incidence of the MERTK G257A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the incidence of the MERTK G757A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the incidence of the MERTK G933A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the incidence of the ZFP42 R206K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the incidence of the OR13C3 M117I mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the incidence of the OR13C3 M147I mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the incidence of the SPAG1 I917M mutation in Stomach Adenocarcinoma?,ssm_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the incidence of the CDKN2AIP Y92H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the incidence of the PXN H1016Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the incidence of the PXN H359Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the incidence of the PXN H492Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the incidence of the PXN H524Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the incidence of the PXN H526Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the incidence of the PXN H540Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the incidence of the TTYH2 S23L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the incidence of the TTYH2 S44L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the incidence of the TMEM255A N205S mutation in Colon Adenocarcinoma?,ssm_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the incidence of the TMEM255A N229S mutation in Colon Adenocarcinoma?,ssm_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the incidence of the TMEM255A N65S mutation in Colon Adenocarcinoma?,ssm_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the incidence of the TASOR2 H2271D mutation in Breast Invasive Carcinoma?,ssm_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the incidence of the TASOR2 H2486D mutation in Breast Invasive Carcinoma?,ssm_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the incidence of the ICE1 T1839M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the incidence of the MYT1 A558E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the incidence of the MYT1 A879E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the incidence of the MYT1 A906E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the incidence of the CX3CR1 P203L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the incidence of the CX3CR1 P235L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the incidence of the SPINDOC R197C mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the incidence of the ART3 C251Y mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the incidence of the ART3 C3Y mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the incidence of the CYP1A2 R243G mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of the ADRA1A G279S mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the incidence of the CDH23 P2523R mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the incidence of the CDH23 P283R mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the incidence of the KRT39 P137S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the incidence of the PDHA2 S7F mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the incidence of the SLC24A2 H200Q mutation in Colon Adenocarcinoma?,ssm_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the incidence of the PTPRN2 F153L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the incidence of the PTPRN2 F847L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the incidence of the PTPRN2 F856L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the incidence of the PTPRN2 F868L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the incidence of the PTPRN2 F885L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the incidence of the SOX21 R55L mutation in Lung Adenocarcinoma?,ssm_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the incidence of the CPA6 G166E mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the incidence of the GRM5 E14K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of the CASZ1 R233Q mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the incidence of the SGIP1 N122T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the incidence of the SGIP1 N420T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the incidence of the SGIP1 N617T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the incidence of the SGIP1 N648T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the incidence of the CARMIL1 V549L mutation in Lung Adenocarcinoma?,ssm_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the incidence of the CARMIL1 V949L mutation in Lung Adenocarcinoma?,ssm_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the incidence of the ZNF431 D121Y mutation in Lung Adenocarcinoma?,ssm_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the incidence of the ZNF431 D161Y mutation in Lung Adenocarcinoma?,ssm_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the incidence of the ZNF431 R128I mutation in Lung Adenocarcinoma?,ssm_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the incidence of the DNAH11 P2987S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the incidence of the DNAH11 P2994S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the incidence of the POLD1 Q461L mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the incidence of the POLD1 Q85L mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the incidence of the TTC12 D646H mutation in Lung Adenocarcinoma?,ssm_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the incidence of the TTC12 D652H mutation in Lung Adenocarcinoma?,ssm_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the incidence of the CNGB1 D967N mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the incidence of the CNGB1 D973N mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the incidence of the CTSC E214V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the incidence of the CTSC E291V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the incidence of the CTSC E322V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the incidence of the CTSC E324V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the incidence of the CTSC E335V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the incidence of the PRSS8 A179T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the incidence of the PRSS8 A233T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the incidence of the ARHGEF40 V864F mutation in Lung Adenocarcinoma?,ssm_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the incidence of the ACTB A138T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the incidence of the ACTB A217T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the incidence of the ACTB A244T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the incidence of the ACTB A260T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the incidence of the YY1AP1 V546D mutation in Glioblastoma Multiforme?,ssm_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the incidence of the YY1AP1 V557D mutation in Glioblastoma Multiforme?,ssm_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the incidence of the YY1AP1 V566D mutation in Glioblastoma Multiforme?,ssm_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the incidence of the YY1AP1 V577D mutation in Glioblastoma Multiforme?,ssm_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the incidence of the YY1AP1 V623D mutation in Glioblastoma Multiforme?,ssm_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the incidence of the YY1AP1 V695D mutation in Glioblastoma Multiforme?,ssm_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the incidence of the YY1AP1 V715D mutation in Glioblastoma Multiforme?,ssm_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the incidence of the FNDC7 D323N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the incidence of the FNDC7 D99N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the incidence of the TLCD5 G15V mutation in Lung Adenocarcinoma?,ssm_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the incidence of the TLCD5 G37V mutation in Lung Adenocarcinoma?,ssm_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the incidence of the POLR1G R498W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the incidence of the POLR1G R500W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the incidence of the DNAH14 N1186K mutation in Colon Adenocarcinoma?,ssm_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the incidence of the DNAH14 N2657K mutation in Colon Adenocarcinoma?,ssm_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the incidence of the DNAH14 N3460K mutation in Colon Adenocarcinoma?,ssm_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the incidence of the NEXN E73D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the incidence of the CYB5R2 G112R mutation in Prostate Adenocarcinoma?,ssm_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the incidence of the CYB5R2 G172R mutation in Prostate Adenocarcinoma?,ssm_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the incidence of the NRAP S808L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the incidence of the NRAP S816L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the incidence of the NRAP S843L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the incidence of the CCDC22 E179D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the incidence of the DCAF6 S402F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the incidence of the DCAF6 S433F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the incidence of the ZNF708 E389D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the incidence of the BFAR T103M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the incidence of the MAST4 P1237S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the incidence of the MAST4 P1986S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the incidence of the MAST4 P1991S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the incidence of the MAST4 P2001S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the incidence of the MAST4 P2180S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the incidence of the ARMC3 R169C mutation in Stomach Adenocarcinoma?,ssm_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the incidence of the ARMC3 R432C mutation in Stomach Adenocarcinoma?,ssm_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the incidence of the TET2 L757V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the incidence of the TET2 L778V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the incidence of the SERPINB10 A353P mutation in Lung Adenocarcinoma?,ssm_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the incidence of the STAT3 Y22H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the incidence of the MIEF1 A42T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the incidence of the ACVR1B D397N mutation in Colon Adenocarcinoma?,ssm_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the incidence of the ACVR1B D449N mutation in Colon Adenocarcinoma?,ssm_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the incidence of the ACVR1B D490N mutation in Colon Adenocarcinoma?,ssm_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the incidence of the EBF2 T104I mutation in Stomach Adenocarcinoma?,ssm_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the incidence of the EBF2 T252I mutation in Stomach Adenocarcinoma?,ssm_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the incidence of the VPS26B F266L mutation in Stomach Adenocarcinoma?,ssm_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of the PGR M106I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of the PGR M38I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of the PGR M632I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the incidence of the ACTA2 P334L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the incidence of the THBS4 T852I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the incidence of the THBS4 T943I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the incidence of the PRSS1 S114T mutation in Lung Adenocarcinoma?,ssm_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the incidence of the PRSS1 S124T mutation in Lung Adenocarcinoma?,ssm_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the incidence of the PRSS1 S138T mutation in Lung Adenocarcinoma?,ssm_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the incidence of the PRSS1 S74T mutation in Lung Adenocarcinoma?,ssm_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the incidence of the PGF R126H mutation in Stomach Adenocarcinoma?,ssm_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the incidence of the PGF R127H mutation in Stomach Adenocarcinoma?,ssm_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the incidence of the ITPRID2 S351C mutation in Breast Invasive Carcinoma?,ssm_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the incidence of the ITPRID2 S842C mutation in Breast Invasive Carcinoma?,ssm_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the incidence of the HBB E8D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the incidence of the PCDHB2 R158C mutation in Colon Adenocarcinoma?,ssm_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the incidence of the PCDHB2 T15M mutation in Colon Adenocarcinoma?,ssm_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the incidence of the PCDHB2 T26M mutation in Colon Adenocarcinoma?,ssm_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the incidence of the UBR2 P1594S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the incidence of the FBXO42 A618D mutation in Rectum Adenocarcinoma?,ssm_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the frequency of TNS1 G1362V mutation in Breast Invasive Carcinoma?,ssm_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the frequency of TNS1 G1711V mutation in Breast Invasive Carcinoma?,ssm_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the frequency of TNS1 G1718V mutation in Breast Invasive Carcinoma?,ssm_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the frequency of TNS1 G1732V mutation in Breast Invasive Carcinoma?,ssm_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the frequency of TNS1 G1824V mutation in Breast Invasive Carcinoma?,ssm_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the frequency of TNS1 G1857V mutation in Breast Invasive Carcinoma?,ssm_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the frequency of TNS1 G843V mutation in Breast Invasive Carcinoma?,ssm_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the frequency of EVC2 E1067K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the frequency of EVC2 E987K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the frequency of CR1 V1108G mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the frequency of CR1 V1558G mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the frequency of TRPA1 S295I mutation in Rectum Adenocarcinoma?,ssm_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the frequency of TRPA1 S443I mutation in Rectum Adenocarcinoma?,ssm_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the frequency of TAF1C R299L mutation in Lung Adenocarcinoma?,ssm_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the frequency of TAF1C R396L mutation in Lung Adenocarcinoma?,ssm_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the frequency of TAF1C R634L mutation in Lung Adenocarcinoma?,ssm_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the frequency of TAF1C R702L mutation in Lung Adenocarcinoma?,ssm_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the frequency of TAF1C R728L mutation in Lung Adenocarcinoma?,ssm_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the frequency of DPF3 R104W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the frequency of DPF3 R149W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the frequency of DPF3 R94W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the frequency of OR2T4 P272H mutation in Lung Adenocarcinoma?,ssm_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the frequency of OR2T4 P300H mutation in Lung Adenocarcinoma?,ssm_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the frequency of FBN1 E2667K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the frequency of MAD1L1 E396K mutation in Prostate Adenocarcinoma?,ssm_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the frequency of MAD1L1 E488K mutation in Prostate Adenocarcinoma?,ssm_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the frequency of MAD1L1 E78K mutation in Prostate Adenocarcinoma?,ssm_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the frequency of CCNG1 E22K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of ANP32E N114T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of ANP32E N64T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of ANP32E N66T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of ANP32E N73T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the frequency of FRY S1888A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the frequency of FRY S1937A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the frequency of FRY S1938A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the frequency of FRY S1983A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the frequency of PAK3 E318K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the frequency of PAK3 E319K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the frequency of PAK3 E334K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the frequency of PAK3 E340K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the frequency of PAK3 E355K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the frequency of MUC16 P7963L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the frequency of ZFPM2 T498I mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the frequency of ZFPM2 T630I mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the frequency of PIK3C2B S1328C mutation in Breast Invasive Carcinoma?,ssm_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the frequency of PIK3C2B S1356C mutation in Breast Invasive Carcinoma?,ssm_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the frequency of ZNF804A S371Y mutation in Colon Adenocarcinoma?,ssm_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the frequency of RELN A2371V mutation in Stomach Adenocarcinoma?,ssm_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of EFCAB12 R173C mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of EFCAB12 R23C mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the frequency of DEFB115 E53K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the frequency of ANKDD1A S290F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the frequency of ANKDD1A S322F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the frequency of ANKDD1A S413F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the frequency of HTR3B S146I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the frequency of HTR3B S206I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the frequency of HTR3B S217I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the frequency of ABCC3 R758W mutation in Stomach Adenocarcinoma?,ssm_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the frequency of NOMO1 T204I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the frequency of NOMO1 T371I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the frequency of HYOU1 D298H mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the frequency of FMO4 R500Q mutation in Skin Cutaneous Melanoma?,ssm_frequency
+140,BICC1,A372V,Exceptional Responders,What is the frequency of BICC1 A372V mutation in Exceptional Responders?,ssm_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the frequency of ZMYM3 I920V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the frequency of ZMYM3 I932V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the frequency of ZMYM3 I934V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of XKR4 R547W mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the frequency of ABCC2 V239L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the frequency of OR8K5 R293G mutation in Lung Adenocarcinoma?,ssm_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the frequency of SPTAN1 S1503F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the frequency of SPTAN1 S1523F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the frequency of SYT10 M484I mutation in Rectum Adenocarcinoma?,ssm_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the frequency of HSPA5 N457K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the frequency of UNC5D L280V mutation in Lung Adenocarcinoma?,ssm_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the frequency of UNC5D L635V mutation in Lung Adenocarcinoma?,ssm_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the frequency of UNC5D L637V mutation in Lung Adenocarcinoma?,ssm_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the frequency of UNC5D L699V mutation in Lung Adenocarcinoma?,ssm_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the frequency of UNC5D L704V mutation in Lung Adenocarcinoma?,ssm_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the frequency of UNC5D L709V mutation in Lung Adenocarcinoma?,ssm_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the frequency of DOCK2 L1527H mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the frequency of ZNF627 A5V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the frequency of CDC42BPA L823F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the frequency of MRPL55 H27Y mutation in Colon Adenocarcinoma?,ssm_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the frequency of MRPL55 H63Y mutation in Colon Adenocarcinoma?,ssm_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the frequency of TMTC3 Q749K mutation in Breast Invasive Carcinoma?,ssm_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the frequency of EPRS1 K771I mutation in Colon Adenocarcinoma?,ssm_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the frequency of EPRS1 K778I mutation in Colon Adenocarcinoma?,ssm_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the frequency of GRTP1 A110V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the frequency of GRTP1 A32V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the frequency of TSHZ3 Q538K mutation in Stomach Adenocarcinoma?,ssm_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the frequency of TAS1R3 Q326H mutation in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,ssm_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the frequency of PIAS3 S238C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the frequency of PIAS3 S273C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the frequency of ZNF274 P13R mutation in Stomach Adenocarcinoma?,ssm_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the frequency of SYNJ1 R795C mutation in Colon Adenocarcinoma?,ssm_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the frequency of SYNJ1 R800C mutation in Colon Adenocarcinoma?,ssm_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the frequency of SYNJ1 R839C mutation in Colon Adenocarcinoma?,ssm_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the frequency of DSCAM V343M mutation in Prostate Adenocarcinoma?,ssm_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the frequency of DSCAM V426M mutation in Prostate Adenocarcinoma?,ssm_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the frequency of DSCAM V591M mutation in Prostate Adenocarcinoma?,ssm_frequency
+267,DGKD,R140H,Exceptional Responders,What is the frequency of DGKD R140H mutation in Exceptional Responders?,ssm_frequency
+268,DGKD,R160H,Exceptional Responders,What is the frequency of DGKD R160H mutation in Exceptional Responders?,ssm_frequency
+269,DGKD,R204H,Exceptional Responders,What is the frequency of DGKD R204H mutation in Exceptional Responders?,ssm_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the frequency of PLEKHG6 D105Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the frequency of PLEKHG6 D543Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the frequency of PLEKHG6 D575Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the frequency of WNT2 D138N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the frequency of GUCY2C G667R mutation in Skin Cutaneous Melanoma?,ssm_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the frequency of C7orf31 P244H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of ZKSCAN7 E64K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+299,OR5D14,M210L,Neuroblastoma,What is the frequency of OR5D14 M210L mutation in Neuroblastoma?,ssm_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the frequency of SPATA22 K279E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the frequency of SPATA22 K306E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the frequency of SPATA22 K322E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the frequency of LCN15 E21V mutation in Stomach Adenocarcinoma?,ssm_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the frequency of DCAF4L2 S129F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the frequency of GUK1 R135P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the frequency of GUK1 R137P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the frequency of GUK1 R139P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the frequency of GUK1 R158P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the frequency of GUK1 R203P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the frequency of MORF4L1 K29T mutation in Stomach Adenocarcinoma?,ssm_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the frequency of MORF4L1 K51T mutation in Stomach Adenocarcinoma?,ssm_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the frequency of MORF4L1 K61T mutation in Stomach Adenocarcinoma?,ssm_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the frequency of MORF4L1 K76T mutation in Stomach Adenocarcinoma?,ssm_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the frequency of MYO3B F594L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the frequency of MYO3B F603L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the frequency of TENT5A S320F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the frequency of TENT5A S339F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the frequency of TENT5A S401F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the frequency of ZFAT S614L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the frequency of ZFAT S664L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the frequency of ZFAT S676L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+357,ZNF584,A211T,Sarcoma,What is the frequency of ZNF584 A211T mutation in Sarcoma?,ssm_frequency
+358,ZNF584,A256T,Sarcoma,What is the frequency of ZNF584 A256T mutation in Sarcoma?,ssm_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the frequency of LDOC1 R63W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the frequency of PDGFC R201G mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the frequency of MSANTD4 R304C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the frequency of NPSR1 S123L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the frequency of PHLPP1 K1317E mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the frequency of COL6A3 G237S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the frequency of COL6A3 G437S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the frequency of COL6A3 G638S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the frequency of COL6A3 G644S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the frequency of COL6A3 G844S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the frequency of ADRA1A R348G mutation in Stomach Adenocarcinoma?,ssm_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of LAMB2 S1254F mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the frequency of POC1B I198T mutation in Rectum Adenocarcinoma?,ssm_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the frequency of POC1B I286T mutation in Rectum Adenocarcinoma?,ssm_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the frequency of POC1B I328T mutation in Rectum Adenocarcinoma?,ssm_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the frequency of POC1B S79P mutation in Rectum Adenocarcinoma?,ssm_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the frequency of USH2A G1451C mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the frequency of AQP7 T110S mutation in Rectum Adenocarcinoma?,ssm_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the frequency of AQP7 T166S mutation in Rectum Adenocarcinoma?,ssm_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the frequency of AQP7 T167S mutation in Rectum Adenocarcinoma?,ssm_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the frequency of AQP7 T75S mutation in Rectum Adenocarcinoma?,ssm_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,What is the frequency of DCN R163C mutation in Rectum Adenocarcinoma?,ssm_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,What is the frequency of DCN R203C mutation in Rectum Adenocarcinoma?,ssm_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,What is the frequency of DCN R241C mutation in Rectum Adenocarcinoma?,ssm_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,What is the frequency of DCN R350C mutation in Rectum Adenocarcinoma?,ssm_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,What is the frequency of DCN R41C mutation in Rectum Adenocarcinoma?,ssm_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the frequency of CPS1 K1269N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the frequency of CPS1 K1275N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the frequency of CPS1 K818N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the frequency of FCGR2C P122S mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the frequency of FCGR2C P123S mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the frequency of GRM1 R280M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the frequency of SGCZ Q138H mutation in Lung Adenocarcinoma?,ssm_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the frequency of SGCZ Q91H mutation in Lung Adenocarcinoma?,ssm_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,What is the frequency of SMO V15M mutation in Stomach Adenocarcinoma?,ssm_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,What is the frequency of SMO V321M mutation in Stomach Adenocarcinoma?,ssm_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the frequency of CHODL G159E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the frequency of CHODL G181E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the frequency of CHODL G200E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,What is the frequency of MYO16 P399H mutation in Colon Adenocarcinoma?,ssm_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,What is the frequency of MYO16 P421H mutation in Colon Adenocarcinoma?,ssm_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the frequency of CXCR2 A98V mutation in Stomach Adenocarcinoma?,ssm_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the frequency of TMEM225 L212V mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the frequency of MAOB N251T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the frequency of GPRASP1 F580S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of MRPL32 R181Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the frequency of TYROBP A29T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the frequency of RAB40C A111V mutation in Lung Adenocarcinoma?,ssm_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the frequency of RAB40C A143V mutation in Lung Adenocarcinoma?,ssm_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the frequency of CTNNA2 S323R mutation in Lung Adenocarcinoma?,ssm_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the frequency of CTNNA2 S339R mutation in Lung Adenocarcinoma?,ssm_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the frequency of CTNNA2 S386R mutation in Lung Adenocarcinoma?,ssm_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the frequency of CTNNA2 S707R mutation in Lung Adenocarcinoma?,ssm_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the frequency of MYO15A S268R mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the frequency of GIMAP2 A167T mutation in Skin Cutaneous Melanoma?,ssm_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the frequency of KIF20B N1160D mutation in Glioblastoma Multiforme?,ssm_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the frequency of KIF20B N1200D mutation in Glioblastoma Multiforme?,ssm_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the frequency of ADAM17 E583K mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the frequency of BCAT1 G16R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the frequency of BCAT1 G17R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the frequency of BCAT1 G29R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the frequency of ERCC6 R1053H mutation in Colon Adenocarcinoma?,ssm_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,What is the frequency of DCC R320W mutation in Breast Invasive Carcinoma?,ssm_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,What is the frequency of DCC R363W mutation in Breast Invasive Carcinoma?,ssm_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,What is the frequency of DCC R386W mutation in Breast Invasive Carcinoma?,ssm_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,What is the frequency of DCC R41W mutation in Breast Invasive Carcinoma?,ssm_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the frequency of FBXO15 D417N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the frequency of FBXO15 D86N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the frequency of GSTCD S528F mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the frequency of GSTCD S615F mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the frequency of OLFML3 P296S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the frequency of OLFML3 P337S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the frequency of OLFML3 P357S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the frequency of CFAP61 E173V mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the frequency of CFAP61 E817V mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the frequency of HLA-DQA2 E51K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the frequency of TENM2 H240Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the frequency of TENM2 H351Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the frequency of TENM2 H472Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the frequency of ANKRD24 A465T mutation in Stomach Adenocarcinoma?,ssm_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the frequency of ANKRD24 A494T mutation in Stomach Adenocarcinoma?,ssm_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the frequency of ANKRD24 A584T mutation in Stomach Adenocarcinoma?,ssm_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the frequency of ZCCHC14 V549M mutation in Stomach Adenocarcinoma?,ssm_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the frequency of ZCCHC14 V665M mutation in Stomach Adenocarcinoma?,ssm_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the frequency of ZCCHC14 V676M mutation in Stomach Adenocarcinoma?,ssm_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the frequency of ZCCHC14 V802M mutation in Stomach Adenocarcinoma?,ssm_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,What is the frequency of SIK2 I265M mutation in Lung Adenocarcinoma?,ssm_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the frequency of MYH11 T1336M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the frequency of MYH11 T1343M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the frequency of SLC6A4 S174F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the frequency of SLC9C1 K102N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the frequency of SLC9C1 K29N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the frequency of OR2A12 A254T mutation in Brain Lower Grade Glioma?,ssm_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the frequency of PYHIN1 T325K mutation in Lung Adenocarcinoma?,ssm_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the frequency of PYHIN1 T334K mutation in Lung Adenocarcinoma?,ssm_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the frequency of JAML G191E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the frequency of JAML G219E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the frequency of JAML G220E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the frequency of JAML G230E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the frequency of TYK2 H1146R mutation in Stomach Adenocarcinoma?,ssm_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the frequency of TYK2 H23R mutation in Stomach Adenocarcinoma?,ssm_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the frequency of TYK2 H961R mutation in Stomach Adenocarcinoma?,ssm_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the frequency of CTCFL R208C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the frequency of CTCFL R265C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the frequency of CTCFL R420C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the frequency of CTCFL R470C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of CEP20 R31Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of CEP20 R58Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the frequency of RIMS2 R25W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the frequency of RIMS2 R393W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the frequency of RIMS2 R423W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the frequency of RIMS2 R470W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the frequency of RIMS2 R615W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the frequency of RIMS2 R619W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the frequency of RIMS2 R716W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the frequency of PIK3C2G S551L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the frequency of PIK3C2G S592L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+728,STK19,D341N,Colon Adenocarcinoma,What is the frequency of STK19 D341N mutation in Colon Adenocarcinoma?,ssm_frequency
+729,STK19,D345N,Colon Adenocarcinoma,What is the frequency of STK19 D345N mutation in Colon Adenocarcinoma?,ssm_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the frequency of REXO4 P60A mutation in Skin Cutaneous Melanoma?,ssm_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the frequency of ZBTB34 P160S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the frequency of ZBTB34 P164S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the frequency of NCKAP5 E148K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of SORCS1 D1052Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of SORCS1 D587Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of SORCS1 D67Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of SORCS1 D810Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the frequency of FGF8 T154M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the frequency of FGF8 T165M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the frequency of FGF8 T183M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the frequency of FGF8 T194M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the frequency of FGF8 T90M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the frequency of TENM3 R1877W mutation in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,ssm_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the frequency of AKT1 D44N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of CFAP298-TCP10L E11Q mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the frequency of GLRB E148D mutation in Stomach Adenocarcinoma?,ssm_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,What is the frequency of TTN F7636L mutation in Colon Adenocarcinoma?,ssm_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,What is the frequency of TTN F8563L mutation in Colon Adenocarcinoma?,ssm_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,What is the frequency of TTN F8880L mutation in Colon Adenocarcinoma?,ssm_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the frequency of ANKRD30A V798I mutation in Colon Adenocarcinoma?,ssm_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the frequency of ANKRD30A V854I mutation in Colon Adenocarcinoma?,ssm_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the frequency of ANKRD30A V973I mutation in Colon Adenocarcinoma?,ssm_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the frequency of TRIM45 S177L mutation in Colon Adenocarcinoma?,ssm_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the frequency of TRIM45 S224L mutation in Colon Adenocarcinoma?,ssm_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the frequency of TRIM45 S281L mutation in Colon Adenocarcinoma?,ssm_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the frequency of CACNA1F G727V mutation in Stomach Adenocarcinoma?,ssm_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the frequency of CACNA1F G781V mutation in Stomach Adenocarcinoma?,ssm_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the frequency of CACNA1F G792V mutation in Stomach Adenocarcinoma?,ssm_frequency
+817,KL,R594C,Colon Adenocarcinoma,What is the frequency of KL R594C mutation in Colon Adenocarcinoma?,ssm_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of GUF1 I243T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the frequency of TAF1L A539V mutation in Colon Adenocarcinoma?,ssm_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the frequency of TASOR2 S256F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the frequency of TASOR2 S36F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the frequency of TASOR2 S471F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the frequency of KDM5C R1151C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the frequency of KDM5C R1177C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the frequency of KDM5C R1217C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the frequency of KDM5C R1218C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of IL5RA L153F mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the frequency of DHX16 A29V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the frequency of DHX16 A89V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the frequency of GPR158 A644V mutation in Stomach Adenocarcinoma?,ssm_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the frequency of GPR158 A723V mutation in Stomach Adenocarcinoma?,ssm_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of EIF2B4 E108K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of EIF2B4 E110K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of EIF2B4 E111K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of EIF2B4 E131K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of EIF2B4 E132K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of EIF2B4 E96K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the frequency of AUTS2 P136S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the frequency of AUTS2 P218S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the frequency of AUTS2 P233S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the frequency of AUTS2 P313S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the frequency of AUTS2 P419S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the frequency of AUTS2 P443S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the frequency of AUTS2 P56S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the frequency of AUTS2 P667S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the frequency of AUTS2 P690S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the frequency of AUTS2 P691S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of ACTL7B D223N mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the frequency of PCDHGA1 R535W mutation in Glioblastoma Multiforme?,ssm_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the frequency of TRAP1 R114W mutation in Stomach Adenocarcinoma?,ssm_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the frequency of TRAP1 R61W mutation in Stomach Adenocarcinoma?,ssm_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of PIK3C2A R1570Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the frequency of KANSL1 R139G mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the frequency of ANKRD52 Y594C mutation in Stomach Adenocarcinoma?,ssm_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the frequency of PAPPA G1580S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the frequency of B3GALNT1 V270A mutation in Rectum Adenocarcinoma?,ssm_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the frequency of GABRA6 G115R mutation in Lung Adenocarcinoma?,ssm_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the frequency of GABRA6 G122R mutation in Lung Adenocarcinoma?,ssm_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the frequency of GABRA6 G165R mutation in Lung Adenocarcinoma?,ssm_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the frequency of GABRA6 G175R mutation in Lung Adenocarcinoma?,ssm_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the frequency of GABRA6 G70R mutation in Lung Adenocarcinoma?,ssm_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the frequency of ZSCAN31 D9N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of MED16 L126P mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of MED16 L868P mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the frequency of PTPRO E1060K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the frequency of PTPRO E1088K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the frequency of PTPRO E249K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the frequency of PTPRO E265K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the frequency of PTPRO E277K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the frequency of PTPRO E67K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the frequency of PTPRO E923K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the frequency of PTPRO E940K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the frequency of CHMP7 D397N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the frequency of GPC3 I107N mutation in Stomach Adenocarcinoma?,ssm_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the frequency of GPC3 I161N mutation in Stomach Adenocarcinoma?,ssm_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of TLK2 V430L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of TLK2 V515L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of TLK2 V547L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of TLK2 V579L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of TLK2 V601L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the frequency of ZNF217 E209Q mutation in Lung Adenocarcinoma?,ssm_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the frequency of SYT9 V275L mutation in Lung Adenocarcinoma?,ssm_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the frequency of SYT9 V307L mutation in Lung Adenocarcinoma?,ssm_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the frequency of PKHD1L1 S2830N mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the frequency of MYO3A Y1295C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of VASN V318I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the frequency of DNMT1 A1037T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the frequency of DNMT1 A1053T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the frequency of DNMT1 A934T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,What is the frequency of CA9 E402K mutation in Colon Adenocarcinoma?,ssm_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of TTC17 R808Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of TTC17 R865Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the frequency of PSG2 P43L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the frequency of RIPOR2 R470L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the frequency of RIPOR2 R499L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the frequency of RIPOR2 R504L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the frequency of RIPOR2 R520L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the frequency of DCLK3 V520I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the frequency of DCLK3 V689I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the frequency of MERTK G257A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the frequency of MERTK G757A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the frequency of MERTK G933A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the frequency of ZFP42 R206K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the frequency of OR13C3 M117I mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the frequency of OR13C3 M147I mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the frequency of SPAG1 I917M mutation in Stomach Adenocarcinoma?,ssm_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the frequency of CDKN2AIP Y92H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the frequency of PXN H1016Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the frequency of PXN H359Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the frequency of PXN H492Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the frequency of PXN H524Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the frequency of PXN H526Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the frequency of PXN H540Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the frequency of TTYH2 S23L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the frequency of TTYH2 S44L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the frequency of TMEM255A N205S mutation in Colon Adenocarcinoma?,ssm_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the frequency of TMEM255A N229S mutation in Colon Adenocarcinoma?,ssm_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the frequency of TMEM255A N65S mutation in Colon Adenocarcinoma?,ssm_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the frequency of TASOR2 H2271D mutation in Breast Invasive Carcinoma?,ssm_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the frequency of TASOR2 H2486D mutation in Breast Invasive Carcinoma?,ssm_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the frequency of ICE1 T1839M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the frequency of MYT1 A558E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the frequency of MYT1 A879E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the frequency of MYT1 A906E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the frequency of CX3CR1 P203L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the frequency of CX3CR1 P235L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the frequency of SPINDOC R197C mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the frequency of ART3 C251Y mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the frequency of ART3 C3Y mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the frequency of CYP1A2 R243G mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of ADRA1A G279S mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the frequency of CDH23 P2523R mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the frequency of CDH23 P283R mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the frequency of KRT39 P137S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the frequency of PDHA2 S7F mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the frequency of SLC24A2 H200Q mutation in Colon Adenocarcinoma?,ssm_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the frequency of PTPRN2 F153L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the frequency of PTPRN2 F847L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the frequency of PTPRN2 F856L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the frequency of PTPRN2 F868L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the frequency of PTPRN2 F885L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the frequency of SOX21 R55L mutation in Lung Adenocarcinoma?,ssm_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the frequency of CPA6 G166E mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the frequency of GRM5 E14K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of CASZ1 R233Q mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the frequency of SGIP1 N122T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the frequency of SGIP1 N420T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the frequency of SGIP1 N617T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the frequency of SGIP1 N648T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the frequency of CARMIL1 V549L mutation in Lung Adenocarcinoma?,ssm_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the frequency of CARMIL1 V949L mutation in Lung Adenocarcinoma?,ssm_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the frequency of ZNF431 D121Y mutation in Lung Adenocarcinoma?,ssm_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the frequency of ZNF431 D161Y mutation in Lung Adenocarcinoma?,ssm_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the frequency of ZNF431 R128I mutation in Lung Adenocarcinoma?,ssm_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the frequency of DNAH11 P2987S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the frequency of DNAH11 P2994S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the frequency of POLD1 Q461L mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the frequency of POLD1 Q85L mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the frequency of TTC12 D646H mutation in Lung Adenocarcinoma?,ssm_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the frequency of TTC12 D652H mutation in Lung Adenocarcinoma?,ssm_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the frequency of CNGB1 D967N mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the frequency of CNGB1 D973N mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the frequency of CTSC E214V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the frequency of CTSC E291V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the frequency of CTSC E322V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the frequency of CTSC E324V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the frequency of CTSC E335V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the frequency of PRSS8 A179T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the frequency of PRSS8 A233T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the frequency of ARHGEF40 V864F mutation in Lung Adenocarcinoma?,ssm_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the frequency of ACTB A138T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the frequency of ACTB A217T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the frequency of ACTB A244T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the frequency of ACTB A260T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the frequency of YY1AP1 V546D mutation in Glioblastoma Multiforme?,ssm_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the frequency of YY1AP1 V557D mutation in Glioblastoma Multiforme?,ssm_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the frequency of YY1AP1 V566D mutation in Glioblastoma Multiforme?,ssm_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the frequency of YY1AP1 V577D mutation in Glioblastoma Multiforme?,ssm_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the frequency of YY1AP1 V623D mutation in Glioblastoma Multiforme?,ssm_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the frequency of YY1AP1 V695D mutation in Glioblastoma Multiforme?,ssm_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the frequency of YY1AP1 V715D mutation in Glioblastoma Multiforme?,ssm_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the frequency of FNDC7 D323N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the frequency of FNDC7 D99N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the frequency of TLCD5 G15V mutation in Lung Adenocarcinoma?,ssm_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the frequency of TLCD5 G37V mutation in Lung Adenocarcinoma?,ssm_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the frequency of POLR1G R498W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the frequency of POLR1G R500W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the frequency of DNAH14 N1186K mutation in Colon Adenocarcinoma?,ssm_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the frequency of DNAH14 N2657K mutation in Colon Adenocarcinoma?,ssm_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the frequency of DNAH14 N3460K mutation in Colon Adenocarcinoma?,ssm_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the frequency of NEXN E73D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the frequency of CYB5R2 G112R mutation in Prostate Adenocarcinoma?,ssm_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the frequency of CYB5R2 G172R mutation in Prostate Adenocarcinoma?,ssm_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the frequency of NRAP S808L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the frequency of NRAP S816L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the frequency of NRAP S843L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the frequency of CCDC22 E179D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the frequency of DCAF6 S402F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the frequency of DCAF6 S433F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the frequency of ZNF708 E389D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the frequency of BFAR T103M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the frequency of MAST4 P1237S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the frequency of MAST4 P1986S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the frequency of MAST4 P1991S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the frequency of MAST4 P2001S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the frequency of MAST4 P2180S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the frequency of ARMC3 R169C mutation in Stomach Adenocarcinoma?,ssm_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the frequency of ARMC3 R432C mutation in Stomach Adenocarcinoma?,ssm_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the frequency of TET2 L757V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the frequency of TET2 L778V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the frequency of SERPINB10 A353P mutation in Lung Adenocarcinoma?,ssm_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the frequency of STAT3 Y22H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the frequency of MIEF1 A42T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the frequency of ACVR1B D397N mutation in Colon Adenocarcinoma?,ssm_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the frequency of ACVR1B D449N mutation in Colon Adenocarcinoma?,ssm_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the frequency of ACVR1B D490N mutation in Colon Adenocarcinoma?,ssm_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the frequency of EBF2 T104I mutation in Stomach Adenocarcinoma?,ssm_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the frequency of EBF2 T252I mutation in Stomach Adenocarcinoma?,ssm_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the frequency of VPS26B F266L mutation in Stomach Adenocarcinoma?,ssm_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of PGR M106I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of PGR M38I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of PGR M632I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the frequency of ACTA2 P334L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the frequency of THBS4 T852I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the frequency of THBS4 T943I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the frequency of PRSS1 S114T mutation in Lung Adenocarcinoma?,ssm_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the frequency of PRSS1 S124T mutation in Lung Adenocarcinoma?,ssm_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the frequency of PRSS1 S138T mutation in Lung Adenocarcinoma?,ssm_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the frequency of PRSS1 S74T mutation in Lung Adenocarcinoma?,ssm_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the frequency of PGF R126H mutation in Stomach Adenocarcinoma?,ssm_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the frequency of PGF R127H mutation in Stomach Adenocarcinoma?,ssm_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the frequency of ITPRID2 S351C mutation in Breast Invasive Carcinoma?,ssm_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the frequency of ITPRID2 S842C mutation in Breast Invasive Carcinoma?,ssm_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the frequency of HBB E8D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the frequency of PCDHB2 R158C mutation in Colon Adenocarcinoma?,ssm_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the frequency of PCDHB2 T15M mutation in Colon Adenocarcinoma?,ssm_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the frequency of PCDHB2 T26M mutation in Colon Adenocarcinoma?,ssm_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the frequency of UBR2 P1594S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the frequency of FBXO42 A618D mutation in Rectum Adenocarcinoma?,ssm_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,How common is the TNS1 G1362V mutation in Breast Invasive Carcinoma?,ssm_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,How common is the TNS1 G1711V mutation in Breast Invasive Carcinoma?,ssm_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,How common is the TNS1 G1718V mutation in Breast Invasive Carcinoma?,ssm_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,How common is the TNS1 G1732V mutation in Breast Invasive Carcinoma?,ssm_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,How common is the TNS1 G1824V mutation in Breast Invasive Carcinoma?,ssm_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,How common is the TNS1 G1857V mutation in Breast Invasive Carcinoma?,ssm_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,How common is the TNS1 G843V mutation in Breast Invasive Carcinoma?,ssm_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How common is the EVC2 E1067K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How common is the EVC2 E987K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How common is the CR1 V1108G mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How common is the CR1 V1558G mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,How common is the TRPA1 S295I mutation in Rectum Adenocarcinoma?,ssm_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,How common is the TRPA1 S443I mutation in Rectum Adenocarcinoma?,ssm_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,How common is the TAF1C R299L mutation in Lung Adenocarcinoma?,ssm_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,How common is the TAF1C R396L mutation in Lung Adenocarcinoma?,ssm_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,How common is the TAF1C R634L mutation in Lung Adenocarcinoma?,ssm_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,How common is the TAF1C R702L mutation in Lung Adenocarcinoma?,ssm_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,How common is the TAF1C R728L mutation in Lung Adenocarcinoma?,ssm_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How common is the DPF3 R104W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How common is the DPF3 R149W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How common is the DPF3 R94W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,How common is the OR2T4 P272H mutation in Lung Adenocarcinoma?,ssm_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,How common is the OR2T4 P300H mutation in Lung Adenocarcinoma?,ssm_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How common is the FBN1 E2667K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How common is the MAD1L1 E396K mutation in Prostate Adenocarcinoma?,ssm_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How common is the MAD1L1 E488K mutation in Prostate Adenocarcinoma?,ssm_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How common is the MAD1L1 E78K mutation in Prostate Adenocarcinoma?,ssm_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How common is the CCNG1 E22K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How common is the ANP32E N114T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How common is the ANP32E N64T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How common is the ANP32E N66T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How common is the ANP32E N73T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How common is the FRY S1888A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How common is the FRY S1937A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How common is the FRY S1938A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How common is the FRY S1983A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,How common is the PAK3 E318K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,How common is the PAK3 E319K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,How common is the PAK3 E334K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,How common is the PAK3 E340K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,How common is the PAK3 E355K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How common is the MUC16 P7963L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How common is the ZFPM2 T498I mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How common is the ZFPM2 T630I mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How common is the PIK3C2B S1328C mutation in Breast Invasive Carcinoma?,ssm_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How common is the PIK3C2B S1356C mutation in Breast Invasive Carcinoma?,ssm_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How common is the ZNF804A S371Y mutation in Colon Adenocarcinoma?,ssm_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,How common is the RELN A2371V mutation in Stomach Adenocarcinoma?,ssm_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is the EFCAB12 R173C mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is the EFCAB12 R23C mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How common is the DEFB115 E53K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How common is the ANKDD1A S290F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How common is the ANKDD1A S322F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How common is the ANKDD1A S413F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How common is the HTR3B S146I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How common is the HTR3B S206I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How common is the HTR3B S217I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,How common is the ABCC3 R758W mutation in Stomach Adenocarcinoma?,ssm_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How common is the NOMO1 T204I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How common is the NOMO1 T371I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How common is the HYOU1 D298H mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How common is the FMO4 R500Q mutation in Skin Cutaneous Melanoma?,ssm_frequency
+140,BICC1,A372V,Exceptional Responders,How common is the BICC1 A372V mutation in Exceptional Responders?,ssm_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How common is the ZMYM3 I920V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How common is the ZMYM3 I932V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How common is the ZMYM3 I934V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is the XKR4 R547W mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How common is the ABCC2 V239L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,How common is the OR8K5 R293G mutation in Lung Adenocarcinoma?,ssm_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How common is the SPTAN1 S1503F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How common is the SPTAN1 S1523F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,How common is the SYT10 M484I mutation in Rectum Adenocarcinoma?,ssm_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How common is the HSPA5 N457K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,How common is the UNC5D L280V mutation in Lung Adenocarcinoma?,ssm_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,How common is the UNC5D L635V mutation in Lung Adenocarcinoma?,ssm_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,How common is the UNC5D L637V mutation in Lung Adenocarcinoma?,ssm_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,How common is the UNC5D L699V mutation in Lung Adenocarcinoma?,ssm_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,How common is the UNC5D L704V mutation in Lung Adenocarcinoma?,ssm_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,How common is the UNC5D L709V mutation in Lung Adenocarcinoma?,ssm_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How common is the DOCK2 L1527H mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How common is the ZNF627 A5V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How common is the CDC42BPA L823F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,How common is the MRPL55 H27Y mutation in Colon Adenocarcinoma?,ssm_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,How common is the MRPL55 H63Y mutation in Colon Adenocarcinoma?,ssm_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How common is the TMTC3 Q749K mutation in Breast Invasive Carcinoma?,ssm_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,How common is the EPRS1 K771I mutation in Colon Adenocarcinoma?,ssm_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,How common is the EPRS1 K778I mutation in Colon Adenocarcinoma?,ssm_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How common is the GRTP1 A110V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How common is the GRTP1 A32V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How common is the TSHZ3 Q538K mutation in Stomach Adenocarcinoma?,ssm_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How common is the TAS1R3 Q326H mutation in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,ssm_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How common is the PIAS3 S238C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How common is the PIAS3 S273C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,How common is the ZNF274 P13R mutation in Stomach Adenocarcinoma?,ssm_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,How common is the SYNJ1 R795C mutation in Colon Adenocarcinoma?,ssm_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,How common is the SYNJ1 R800C mutation in Colon Adenocarcinoma?,ssm_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,How common is the SYNJ1 R839C mutation in Colon Adenocarcinoma?,ssm_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,How common is the DSCAM V343M mutation in Prostate Adenocarcinoma?,ssm_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,How common is the DSCAM V426M mutation in Prostate Adenocarcinoma?,ssm_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,How common is the DSCAM V591M mutation in Prostate Adenocarcinoma?,ssm_frequency
+267,DGKD,R140H,Exceptional Responders,How common is the DGKD R140H mutation in Exceptional Responders?,ssm_frequency
+268,DGKD,R160H,Exceptional Responders,How common is the DGKD R160H mutation in Exceptional Responders?,ssm_frequency
+269,DGKD,R204H,Exceptional Responders,How common is the DGKD R204H mutation in Exceptional Responders?,ssm_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How common is the PLEKHG6 D105Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How common is the PLEKHG6 D543Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How common is the PLEKHG6 D575Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,How common is the WNT2 D138N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How common is the GUCY2C G667R mutation in Skin Cutaneous Melanoma?,ssm_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How common is the C7orf31 P244H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is the ZKSCAN7 E64K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+299,OR5D14,M210L,Neuroblastoma,How common is the OR5D14 M210L mutation in Neuroblastoma?,ssm_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How common is the SPATA22 K279E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How common is the SPATA22 K306E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How common is the SPATA22 K322E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,How common is the LCN15 E21V mutation in Stomach Adenocarcinoma?,ssm_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How common is the DCAF4L2 S129F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How common is the GUK1 R135P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How common is the GUK1 R137P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How common is the GUK1 R139P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How common is the GUK1 R158P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How common is the GUK1 R203P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How common is the MORF4L1 K29T mutation in Stomach Adenocarcinoma?,ssm_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How common is the MORF4L1 K51T mutation in Stomach Adenocarcinoma?,ssm_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How common is the MORF4L1 K61T mutation in Stomach Adenocarcinoma?,ssm_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How common is the MORF4L1 K76T mutation in Stomach Adenocarcinoma?,ssm_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How common is the MYO3B F594L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How common is the MYO3B F603L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How common is the TENT5A S320F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How common is the TENT5A S339F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How common is the TENT5A S401F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How common is the ZFAT S614L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How common is the ZFAT S664L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How common is the ZFAT S676L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+357,ZNF584,A211T,Sarcoma,How common is the ZNF584 A211T mutation in Sarcoma?,ssm_frequency
+358,ZNF584,A256T,Sarcoma,How common is the ZNF584 A256T mutation in Sarcoma?,ssm_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How common is the LDOC1 R63W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How common is the PDGFC R201G mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How common is the MSANTD4 R304C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How common is the NPSR1 S123L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How common is the PHLPP1 K1317E mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How common is the COL6A3 G237S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How common is the COL6A3 G437S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How common is the COL6A3 G638S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How common is the COL6A3 G644S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How common is the COL6A3 G844S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How common is the ADRA1A R348G mutation in Stomach Adenocarcinoma?,ssm_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is the LAMB2 S1254F mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,How common is the POC1B I198T mutation in Rectum Adenocarcinoma?,ssm_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,How common is the POC1B I286T mutation in Rectum Adenocarcinoma?,ssm_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,How common is the POC1B I328T mutation in Rectum Adenocarcinoma?,ssm_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,How common is the POC1B S79P mutation in Rectum Adenocarcinoma?,ssm_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How common is the USH2A G1451C mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,How common is the AQP7 T110S mutation in Rectum Adenocarcinoma?,ssm_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,How common is the AQP7 T166S mutation in Rectum Adenocarcinoma?,ssm_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,How common is the AQP7 T167S mutation in Rectum Adenocarcinoma?,ssm_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,How common is the AQP7 T75S mutation in Rectum Adenocarcinoma?,ssm_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,How common is the DCN R163C mutation in Rectum Adenocarcinoma?,ssm_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,How common is the DCN R203C mutation in Rectum Adenocarcinoma?,ssm_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,How common is the DCN R241C mutation in Rectum Adenocarcinoma?,ssm_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,How common is the DCN R350C mutation in Rectum Adenocarcinoma?,ssm_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,How common is the DCN R41C mutation in Rectum Adenocarcinoma?,ssm_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How common is the CPS1 K1269N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How common is the CPS1 K1275N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How common is the CPS1 K818N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How common is the FCGR2C P122S mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How common is the FCGR2C P123S mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How common is the GRM1 R280M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,How common is the SGCZ Q138H mutation in Lung Adenocarcinoma?,ssm_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,How common is the SGCZ Q91H mutation in Lung Adenocarcinoma?,ssm_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,How common is the SMO V15M mutation in Stomach Adenocarcinoma?,ssm_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,How common is the SMO V321M mutation in Stomach Adenocarcinoma?,ssm_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,How common is the CHODL G159E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,How common is the CHODL G181E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,How common is the CHODL G200E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,How common is the MYO16 P399H mutation in Colon Adenocarcinoma?,ssm_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,How common is the MYO16 P421H mutation in Colon Adenocarcinoma?,ssm_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,How common is the CXCR2 A98V mutation in Stomach Adenocarcinoma?,ssm_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How common is the TMEM225 L212V mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How common is the MAOB N251T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How common is the GPRASP1 F580S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How common is the MRPL32 R181Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How common is the TYROBP A29T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,How common is the RAB40C A111V mutation in Lung Adenocarcinoma?,ssm_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,How common is the RAB40C A143V mutation in Lung Adenocarcinoma?,ssm_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,How common is the CTNNA2 S323R mutation in Lung Adenocarcinoma?,ssm_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,How common is the CTNNA2 S339R mutation in Lung Adenocarcinoma?,ssm_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,How common is the CTNNA2 S386R mutation in Lung Adenocarcinoma?,ssm_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,How common is the CTNNA2 S707R mutation in Lung Adenocarcinoma?,ssm_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How common is the MYO15A S268R mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How common is the GIMAP2 A167T mutation in Skin Cutaneous Melanoma?,ssm_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,How common is the KIF20B N1160D mutation in Glioblastoma Multiforme?,ssm_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,How common is the KIF20B N1200D mutation in Glioblastoma Multiforme?,ssm_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How common is the ADAM17 E583K mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How common is the BCAT1 G16R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How common is the BCAT1 G17R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How common is the BCAT1 G29R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,How common is the ERCC6 R1053H mutation in Colon Adenocarcinoma?,ssm_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,How common is the DCC R320W mutation in Breast Invasive Carcinoma?,ssm_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,How common is the DCC R363W mutation in Breast Invasive Carcinoma?,ssm_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,How common is the DCC R386W mutation in Breast Invasive Carcinoma?,ssm_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,How common is the DCC R41W mutation in Breast Invasive Carcinoma?,ssm_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How common is the FBXO15 D417N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How common is the FBXO15 D86N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How common is the GSTCD S528F mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How common is the GSTCD S615F mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How common is the OLFML3 P296S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How common is the OLFML3 P337S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How common is the OLFML3 P357S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How common is the CFAP61 E173V mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How common is the CFAP61 E817V mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How common is the HLA-DQA2 E51K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How common is the TENM2 H240Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How common is the TENM2 H351Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How common is the TENM2 H472Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How common is the ANKRD24 A465T mutation in Stomach Adenocarcinoma?,ssm_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How common is the ANKRD24 A494T mutation in Stomach Adenocarcinoma?,ssm_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How common is the ANKRD24 A584T mutation in Stomach Adenocarcinoma?,ssm_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How common is the ZCCHC14 V549M mutation in Stomach Adenocarcinoma?,ssm_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How common is the ZCCHC14 V665M mutation in Stomach Adenocarcinoma?,ssm_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How common is the ZCCHC14 V676M mutation in Stomach Adenocarcinoma?,ssm_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How common is the ZCCHC14 V802M mutation in Stomach Adenocarcinoma?,ssm_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,How common is the SIK2 I265M mutation in Lung Adenocarcinoma?,ssm_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How common is the MYH11 T1336M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How common is the MYH11 T1343M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How common is the SLC6A4 S174F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How common is the SLC9C1 K102N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How common is the SLC9C1 K29N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,How common is the OR2A12 A254T mutation in Brain Lower Grade Glioma?,ssm_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,How common is the PYHIN1 T325K mutation in Lung Adenocarcinoma?,ssm_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,How common is the PYHIN1 T334K mutation in Lung Adenocarcinoma?,ssm_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,How common is the JAML G191E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,How common is the JAML G219E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,How common is the JAML G220E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,How common is the JAML G230E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,How common is the TYK2 H1146R mutation in Stomach Adenocarcinoma?,ssm_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,How common is the TYK2 H23R mutation in Stomach Adenocarcinoma?,ssm_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,How common is the TYK2 H961R mutation in Stomach Adenocarcinoma?,ssm_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How common is the CTCFL R208C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How common is the CTCFL R265C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How common is the CTCFL R420C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How common is the CTCFL R470C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How common is the CEP20 R31Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How common is the CEP20 R58Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How common is the RIMS2 R25W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How common is the RIMS2 R393W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How common is the RIMS2 R423W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How common is the RIMS2 R470W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How common is the RIMS2 R615W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How common is the RIMS2 R619W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How common is the RIMS2 R716W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How common is the PIK3C2G S551L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How common is the PIK3C2G S592L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+728,STK19,D341N,Colon Adenocarcinoma,How common is the STK19 D341N mutation in Colon Adenocarcinoma?,ssm_frequency
+729,STK19,D345N,Colon Adenocarcinoma,How common is the STK19 D345N mutation in Colon Adenocarcinoma?,ssm_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,How common is the REXO4 P60A mutation in Skin Cutaneous Melanoma?,ssm_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How common is the ZBTB34 P160S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How common is the ZBTB34 P164S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How common is the NCKAP5 E148K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is the SORCS1 D1052Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is the SORCS1 D587Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is the SORCS1 D67Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is the SORCS1 D810Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How common is the FGF8 T154M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How common is the FGF8 T165M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How common is the FGF8 T183M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How common is the FGF8 T194M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How common is the FGF8 T90M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How common is the TENM3 R1877W mutation in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,ssm_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How common is the AKT1 D44N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is the CFAP298-TCP10L E11Q mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,How common is the GLRB E148D mutation in Stomach Adenocarcinoma?,ssm_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,How common is the TTN F7636L mutation in Colon Adenocarcinoma?,ssm_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,How common is the TTN F8563L mutation in Colon Adenocarcinoma?,ssm_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,How common is the TTN F8880L mutation in Colon Adenocarcinoma?,ssm_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How common is the ANKRD30A V798I mutation in Colon Adenocarcinoma?,ssm_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How common is the ANKRD30A V854I mutation in Colon Adenocarcinoma?,ssm_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How common is the ANKRD30A V973I mutation in Colon Adenocarcinoma?,ssm_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,How common is the TRIM45 S177L mutation in Colon Adenocarcinoma?,ssm_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,How common is the TRIM45 S224L mutation in Colon Adenocarcinoma?,ssm_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,How common is the TRIM45 S281L mutation in Colon Adenocarcinoma?,ssm_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How common is the CACNA1F G727V mutation in Stomach Adenocarcinoma?,ssm_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How common is the CACNA1F G781V mutation in Stomach Adenocarcinoma?,ssm_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How common is the CACNA1F G792V mutation in Stomach Adenocarcinoma?,ssm_frequency
+817,KL,R594C,Colon Adenocarcinoma,How common is the KL R594C mutation in Colon Adenocarcinoma?,ssm_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How common is the GUF1 I243T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,How common is the TAF1L A539V mutation in Colon Adenocarcinoma?,ssm_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How common is the TASOR2 S256F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How common is the TASOR2 S36F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How common is the TASOR2 S471F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How common is the KDM5C R1151C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How common is the KDM5C R1177C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How common is the KDM5C R1217C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How common is the KDM5C R1218C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is the IL5RA L153F mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,How common is the DHX16 A29V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,How common is the DHX16 A89V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,How common is the GPR158 A644V mutation in Stomach Adenocarcinoma?,ssm_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,How common is the GPR158 A723V mutation in Stomach Adenocarcinoma?,ssm_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is the EIF2B4 E108K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is the EIF2B4 E110K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is the EIF2B4 E111K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is the EIF2B4 E131K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is the EIF2B4 E132K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is the EIF2B4 E96K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How common is the AUTS2 P136S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How common is the AUTS2 P218S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How common is the AUTS2 P233S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How common is the AUTS2 P313S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How common is the AUTS2 P419S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How common is the AUTS2 P443S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How common is the AUTS2 P56S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How common is the AUTS2 P667S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How common is the AUTS2 P690S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How common is the AUTS2 P691S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is the ACTL7B D223N mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How common is the PCDHGA1 R535W mutation in Glioblastoma Multiforme?,ssm_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,How common is the TRAP1 R114W mutation in Stomach Adenocarcinoma?,ssm_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,How common is the TRAP1 R61W mutation in Stomach Adenocarcinoma?,ssm_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How common is the PIK3C2A R1570Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How common is the KANSL1 R139G mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How common is the ANKRD52 Y594C mutation in Stomach Adenocarcinoma?,ssm_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How common is the PAPPA G1580S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How common is the B3GALNT1 V270A mutation in Rectum Adenocarcinoma?,ssm_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,How common is the GABRA6 G115R mutation in Lung Adenocarcinoma?,ssm_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,How common is the GABRA6 G122R mutation in Lung Adenocarcinoma?,ssm_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,How common is the GABRA6 G165R mutation in Lung Adenocarcinoma?,ssm_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,How common is the GABRA6 G175R mutation in Lung Adenocarcinoma?,ssm_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,How common is the GABRA6 G70R mutation in Lung Adenocarcinoma?,ssm_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How common is the ZSCAN31 D9N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is the MED16 L126P mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is the MED16 L868P mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How common is the PTPRO E1060K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How common is the PTPRO E1088K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How common is the PTPRO E249K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How common is the PTPRO E265K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How common is the PTPRO E277K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How common is the PTPRO E67K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How common is the PTPRO E923K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How common is the PTPRO E940K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How common is the CHMP7 D397N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,How common is the GPC3 I107N mutation in Stomach Adenocarcinoma?,ssm_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,How common is the GPC3 I161N mutation in Stomach Adenocarcinoma?,ssm_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is the TLK2 V430L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is the TLK2 V515L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is the TLK2 V547L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is the TLK2 V579L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is the TLK2 V601L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How common is the ZNF217 E209Q mutation in Lung Adenocarcinoma?,ssm_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,How common is the SYT9 V275L mutation in Lung Adenocarcinoma?,ssm_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,How common is the SYT9 V307L mutation in Lung Adenocarcinoma?,ssm_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How common is the PKHD1L1 S2830N mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How common is the MYO3A Y1295C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is the VASN V318I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How common is the DNMT1 A1037T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How common is the DNMT1 A1053T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How common is the DNMT1 A934T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,How common is the CA9 E402K mutation in Colon Adenocarcinoma?,ssm_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How common is the TTC17 R808Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How common is the TTC17 R865Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,How common is the PSG2 P43L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How common is the RIPOR2 R470L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How common is the RIPOR2 R499L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How common is the RIPOR2 R504L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How common is the RIPOR2 R520L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How common is the DCLK3 V520I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How common is the DCLK3 V689I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How common is the MERTK G257A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How common is the MERTK G757A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How common is the MERTK G933A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How common is the ZFP42 R206K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How common is the OR13C3 M117I mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How common is the OR13C3 M147I mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How common is the SPAG1 I917M mutation in Stomach Adenocarcinoma?,ssm_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How common is the CDKN2AIP Y92H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,How common is the PXN H1016Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,How common is the PXN H359Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,How common is the PXN H492Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,How common is the PXN H524Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,How common is the PXN H526Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,How common is the PXN H540Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How common is the TTYH2 S23L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How common is the TTYH2 S44L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How common is the TMEM255A N205S mutation in Colon Adenocarcinoma?,ssm_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How common is the TMEM255A N229S mutation in Colon Adenocarcinoma?,ssm_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How common is the TMEM255A N65S mutation in Colon Adenocarcinoma?,ssm_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How common is the TASOR2 H2271D mutation in Breast Invasive Carcinoma?,ssm_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How common is the TASOR2 H2486D mutation in Breast Invasive Carcinoma?,ssm_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How common is the ICE1 T1839M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,How common is the MYT1 A558E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,How common is the MYT1 A879E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,How common is the MYT1 A906E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How common is the CX3CR1 P203L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How common is the CX3CR1 P235L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How common is the SPINDOC R197C mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How common is the ART3 C251Y mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How common is the ART3 C3Y mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How common is the CYP1A2 R243G mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is the ADRA1A G279S mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How common is the CDH23 P2523R mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How common is the CDH23 P283R mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How common is the KRT39 P137S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How common is the PDHA2 S7F mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How common is the SLC24A2 H200Q mutation in Colon Adenocarcinoma?,ssm_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How common is the PTPRN2 F153L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How common is the PTPRN2 F847L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How common is the PTPRN2 F856L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How common is the PTPRN2 F868L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How common is the PTPRN2 F885L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,How common is the SOX21 R55L mutation in Lung Adenocarcinoma?,ssm_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How common is the CPA6 G166E mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How common is the GRM5 E14K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is the CASZ1 R233Q mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How common is the SGIP1 N122T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How common is the SGIP1 N420T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How common is the SGIP1 N617T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How common is the SGIP1 N648T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How common is the CARMIL1 V549L mutation in Lung Adenocarcinoma?,ssm_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How common is the CARMIL1 V949L mutation in Lung Adenocarcinoma?,ssm_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How common is the ZNF431 D121Y mutation in Lung Adenocarcinoma?,ssm_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How common is the ZNF431 D161Y mutation in Lung Adenocarcinoma?,ssm_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,How common is the ZNF431 R128I mutation in Lung Adenocarcinoma?,ssm_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How common is the DNAH11 P2987S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How common is the DNAH11 P2994S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How common is the POLD1 Q461L mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How common is the POLD1 Q85L mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,How common is the TTC12 D646H mutation in Lung Adenocarcinoma?,ssm_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,How common is the TTC12 D652H mutation in Lung Adenocarcinoma?,ssm_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How common is the CNGB1 D967N mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How common is the CNGB1 D973N mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,How common is the CTSC E214V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,How common is the CTSC E291V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,How common is the CTSC E322V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,How common is the CTSC E324V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,How common is the CTSC E335V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How common is the PRSS8 A179T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How common is the PRSS8 A233T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How common is the ARHGEF40 V864F mutation in Lung Adenocarcinoma?,ssm_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,How common is the ACTB A138T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,How common is the ACTB A217T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,How common is the ACTB A244T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,How common is the ACTB A260T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How common is the YY1AP1 V546D mutation in Glioblastoma Multiforme?,ssm_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How common is the YY1AP1 V557D mutation in Glioblastoma Multiforme?,ssm_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How common is the YY1AP1 V566D mutation in Glioblastoma Multiforme?,ssm_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How common is the YY1AP1 V577D mutation in Glioblastoma Multiforme?,ssm_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How common is the YY1AP1 V623D mutation in Glioblastoma Multiforme?,ssm_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How common is the YY1AP1 V695D mutation in Glioblastoma Multiforme?,ssm_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How common is the YY1AP1 V715D mutation in Glioblastoma Multiforme?,ssm_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How common is the FNDC7 D323N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How common is the FNDC7 D99N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,How common is the TLCD5 G15V mutation in Lung Adenocarcinoma?,ssm_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,How common is the TLCD5 G37V mutation in Lung Adenocarcinoma?,ssm_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How common is the POLR1G R498W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How common is the POLR1G R500W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How common is the DNAH14 N1186K mutation in Colon Adenocarcinoma?,ssm_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How common is the DNAH14 N2657K mutation in Colon Adenocarcinoma?,ssm_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How common is the DNAH14 N3460K mutation in Colon Adenocarcinoma?,ssm_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How common is the NEXN E73D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How common is the CYB5R2 G112R mutation in Prostate Adenocarcinoma?,ssm_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How common is the CYB5R2 G172R mutation in Prostate Adenocarcinoma?,ssm_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How common is the NRAP S808L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How common is the NRAP S816L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How common is the NRAP S843L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How common is the CCDC22 E179D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How common is the DCAF6 S402F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How common is the DCAF6 S433F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How common is the ZNF708 E389D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How common is the BFAR T103M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How common is the MAST4 P1237S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How common is the MAST4 P1986S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How common is the MAST4 P1991S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How common is the MAST4 P2001S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How common is the MAST4 P2180S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How common is the ARMC3 R169C mutation in Stomach Adenocarcinoma?,ssm_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How common is the ARMC3 R432C mutation in Stomach Adenocarcinoma?,ssm_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How common is the TET2 L757V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How common is the TET2 L778V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How common is the SERPINB10 A353P mutation in Lung Adenocarcinoma?,ssm_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How common is the STAT3 Y22H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How common is the MIEF1 A42T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How common is the ACVR1B D397N mutation in Colon Adenocarcinoma?,ssm_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How common is the ACVR1B D449N mutation in Colon Adenocarcinoma?,ssm_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How common is the ACVR1B D490N mutation in Colon Adenocarcinoma?,ssm_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,How common is the EBF2 T104I mutation in Stomach Adenocarcinoma?,ssm_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,How common is the EBF2 T252I mutation in Stomach Adenocarcinoma?,ssm_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How common is the VPS26B F266L mutation in Stomach Adenocarcinoma?,ssm_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is the PGR M106I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is the PGR M38I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is the PGR M632I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How common is the ACTA2 P334L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How common is the THBS4 T852I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How common is the THBS4 T943I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,How common is the PRSS1 S114T mutation in Lung Adenocarcinoma?,ssm_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,How common is the PRSS1 S124T mutation in Lung Adenocarcinoma?,ssm_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,How common is the PRSS1 S138T mutation in Lung Adenocarcinoma?,ssm_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,How common is the PRSS1 S74T mutation in Lung Adenocarcinoma?,ssm_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,How common is the PGF R126H mutation in Stomach Adenocarcinoma?,ssm_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,How common is the PGF R127H mutation in Stomach Adenocarcinoma?,ssm_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How common is the ITPRID2 S351C mutation in Breast Invasive Carcinoma?,ssm_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How common is the ITPRID2 S842C mutation in Breast Invasive Carcinoma?,ssm_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How common is the HBB E8D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How common is the PCDHB2 R158C mutation in Colon Adenocarcinoma?,ssm_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How common is the PCDHB2 T15M mutation in Colon Adenocarcinoma?,ssm_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How common is the PCDHB2 T26M mutation in Colon Adenocarcinoma?,ssm_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How common is the UBR2 P1594S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How common is the FBXO42 A618D mutation in Rectum Adenocarcinoma?,ssm_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma patients have the TNS1 G1362V mutation?,ssm_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma patients have the TNS1 G1711V mutation?,ssm_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma patients have the TNS1 G1718V mutation?,ssm_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma patients have the TNS1 G1732V mutation?,ssm_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma patients have the TNS1 G1824V mutation?,ssm_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma patients have the TNS1 G1857V mutation?,ssm_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma patients have the TNS1 G843V mutation?,ssm_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma patients have the EVC2 E1067K mutation?,ssm_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma patients have the EVC2 E987K mutation?,ssm_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the CR1 V1108G mutation?,ssm_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the CR1 V1558G mutation?,ssm_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma patients have the TRPA1 S295I mutation?,ssm_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma patients have the TRPA1 S443I mutation?,ssm_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the TAF1C R299L mutation?,ssm_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the TAF1C R396L mutation?,ssm_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the TAF1C R634L mutation?,ssm_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the TAF1C R702L mutation?,ssm_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the TAF1C R728L mutation?,ssm_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the DPF3 R104W mutation?,ssm_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the DPF3 R149W mutation?,ssm_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the DPF3 R94W mutation?,ssm_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the OR2T4 P272H mutation?,ssm_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the OR2T4 P300H mutation?,ssm_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma patients have the FBN1 E2667K mutation?,ssm_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma patients have the MAD1L1 E396K mutation?,ssm_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma patients have the MAD1L1 E488K mutation?,ssm_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma patients have the MAD1L1 E78K mutation?,ssm_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the CCNG1 E22K mutation?,ssm_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What fraction of Kidney Renal Papillary Cell Carcinoma patients have the ANP32E N114T mutation?,ssm_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What fraction of Kidney Renal Papillary Cell Carcinoma patients have the ANP32E N64T mutation?,ssm_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What fraction of Kidney Renal Papillary Cell Carcinoma patients have the ANP32E N66T mutation?,ssm_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What fraction of Kidney Renal Papillary Cell Carcinoma patients have the ANP32E N73T mutation?,ssm_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma patients have the FRY S1888A mutation?,ssm_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma patients have the FRY S1937A mutation?,ssm_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma patients have the FRY S1938A mutation?,ssm_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma patients have the FRY S1983A mutation?,ssm_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the PAK3 E318K mutation?,ssm_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the PAK3 E319K mutation?,ssm_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the PAK3 E334K mutation?,ssm_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the PAK3 E340K mutation?,ssm_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the PAK3 E355K mutation?,ssm_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the MUC16 P7963L mutation?,ssm_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma patients have the ZFPM2 T498I mutation?,ssm_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma patients have the ZFPM2 T630I mutation?,ssm_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma patients have the PIK3C2B S1328C mutation?,ssm_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma patients have the PIK3C2B S1356C mutation?,ssm_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the ZNF804A S371Y mutation?,ssm_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the RELN A2371V mutation?,ssm_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have the EFCAB12 R173C mutation?",ssm_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have the EFCAB12 R23C mutation?",ssm_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the DEFB115 E53K mutation?,ssm_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma patients have the ANKDD1A S290F mutation?,ssm_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma patients have the ANKDD1A S322F mutation?,ssm_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma patients have the ANKDD1A S413F mutation?,ssm_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the HTR3B S146I mutation?,ssm_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the HTR3B S206I mutation?,ssm_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the HTR3B S217I mutation?,ssm_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the ABCC3 R758W mutation?,ssm_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the NOMO1 T204I mutation?,ssm_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the NOMO1 T371I mutation?,ssm_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma patients have the HYOU1 D298H mutation?,ssm_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the FMO4 R500Q mutation?,ssm_frequency
+140,BICC1,A372V,Exceptional Responders,What fraction of Exceptional Responders patients have the BICC1 A372V mutation?,ssm_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the ZMYM3 I920V mutation?,ssm_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the ZMYM3 I932V mutation?,ssm_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the ZMYM3 I934V mutation?,ssm_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have the XKR4 R547W mutation?",ssm_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma patients have the ABCC2 V239L mutation?,ssm_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the OR8K5 R293G mutation?,ssm_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the SPTAN1 S1503F mutation?,ssm_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the SPTAN1 S1523F mutation?,ssm_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma patients have the SYT10 M484I mutation?,ssm_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the HSPA5 N457K mutation?,ssm_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the UNC5D L280V mutation?,ssm_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the UNC5D L635V mutation?,ssm_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the UNC5D L637V mutation?,ssm_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the UNC5D L699V mutation?,ssm_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the UNC5D L704V mutation?,ssm_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the UNC5D L709V mutation?,ssm_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What fraction of Kidney Renal Clear Cell Carcinoma patients have the DOCK2 L1527H mutation?,ssm_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What fraction of Kidney Renal Clear Cell Carcinoma patients have the ZNF627 A5V mutation?,ssm_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the CDC42BPA L823F mutation?,ssm_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the MRPL55 H27Y mutation?,ssm_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the MRPL55 H63Y mutation?,ssm_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma patients have the TMTC3 Q749K mutation?,ssm_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the EPRS1 K771I mutation?,ssm_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the EPRS1 K778I mutation?,ssm_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the GRTP1 A110V mutation?,ssm_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the GRTP1 A32V mutation?,ssm_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the TSHZ3 Q538K mutation?,ssm_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What fraction of HIV+ Tumor Molecular Characterization Project - Cervical Cancer patients have the TAS1R3 Q326H mutation?,ssm_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the PIAS3 S238C mutation?,ssm_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the PIAS3 S273C mutation?,ssm_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the ZNF274 P13R mutation?,ssm_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the SYNJ1 R795C mutation?,ssm_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the SYNJ1 R800C mutation?,ssm_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the SYNJ1 R839C mutation?,ssm_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma patients have the DSCAM V343M mutation?,ssm_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma patients have the DSCAM V426M mutation?,ssm_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma patients have the DSCAM V591M mutation?,ssm_frequency
+267,DGKD,R140H,Exceptional Responders,What fraction of Exceptional Responders patients have the DGKD R140H mutation?,ssm_frequency
+268,DGKD,R160H,Exceptional Responders,What fraction of Exceptional Responders patients have the DGKD R160H mutation?,ssm_frequency
+269,DGKD,R204H,Exceptional Responders,What fraction of Exceptional Responders patients have the DGKD R204H mutation?,ssm_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma patients have the PLEKHG6 D105Y mutation?,ssm_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma patients have the PLEKHG6 D543Y mutation?,ssm_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma patients have the PLEKHG6 D575Y mutation?,ssm_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the WNT2 D138N mutation?,ssm_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the GUCY2C G667R mutation?,ssm_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the C7orf31 P244H mutation?,ssm_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have the ZKSCAN7 E64K mutation?",ssm_frequency
+299,OR5D14,M210L,Neuroblastoma,What fraction of Neuroblastoma patients have the OR5D14 M210L mutation?,ssm_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the SPATA22 K279E mutation?,ssm_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the SPATA22 K306E mutation?,ssm_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the SPATA22 K322E mutation?,ssm_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the LCN15 E21V mutation?,ssm_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the DCAF4L2 S129F mutation?,ssm_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the GUK1 R135P mutation?,ssm_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the GUK1 R137P mutation?,ssm_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the GUK1 R139P mutation?,ssm_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the GUK1 R158P mutation?,ssm_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the GUK1 R203P mutation?,ssm_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the MORF4L1 K29T mutation?,ssm_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the MORF4L1 K51T mutation?,ssm_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the MORF4L1 K61T mutation?,ssm_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the MORF4L1 K76T mutation?,ssm_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the MYO3B F594L mutation?,ssm_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the MYO3B F603L mutation?,ssm_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the TENT5A S320F mutation?,ssm_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the TENT5A S339F mutation?,ssm_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the TENT5A S401F mutation?,ssm_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What fraction of Ovarian Serous Cystadenocarcinoma patients have the ZFAT S614L mutation?,ssm_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What fraction of Ovarian Serous Cystadenocarcinoma patients have the ZFAT S664L mutation?,ssm_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What fraction of Ovarian Serous Cystadenocarcinoma patients have the ZFAT S676L mutation?,ssm_frequency
+357,ZNF584,A211T,Sarcoma,What fraction of Sarcoma patients have the ZNF584 A211T mutation?,ssm_frequency
+358,ZNF584,A256T,Sarcoma,What fraction of Sarcoma patients have the ZNF584 A256T mutation?,ssm_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the LDOC1 R63W mutation?,ssm_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the PDGFC R201G mutation?,ssm_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the MSANTD4 R304C mutation?,ssm_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the NPSR1 S123L mutation?,ssm_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the PHLPP1 K1317E mutation?,ssm_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the COL6A3 G237S mutation?,ssm_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the COL6A3 G437S mutation?,ssm_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the COL6A3 G638S mutation?,ssm_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the COL6A3 G644S mutation?,ssm_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the COL6A3 G844S mutation?,ssm_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the ADRA1A R348G mutation?,ssm_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have the LAMB2 S1254F mutation?,ssm_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma patients have the POC1B I198T mutation?,ssm_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma patients have the POC1B I286T mutation?,ssm_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma patients have the POC1B I328T mutation?,ssm_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma patients have the POC1B S79P mutation?,ssm_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma patients have the USH2A G1451C mutation?,ssm_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma patients have the AQP7 T110S mutation?,ssm_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma patients have the AQP7 T166S mutation?,ssm_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma patients have the AQP7 T167S mutation?,ssm_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma patients have the AQP7 T75S mutation?,ssm_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma patients have the DCN R163C mutation?,ssm_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma patients have the DCN R203C mutation?,ssm_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma patients have the DCN R241C mutation?,ssm_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma patients have the DCN R350C mutation?,ssm_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma patients have the DCN R41C mutation?,ssm_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the CPS1 K1269N mutation?,ssm_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the CPS1 K1275N mutation?,ssm_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the CPS1 K818N mutation?,ssm_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What fraction of Kidney Renal Papillary Cell Carcinoma patients have the FCGR2C P122S mutation?,ssm_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What fraction of Kidney Renal Papillary Cell Carcinoma patients have the FCGR2C P123S mutation?,ssm_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the GRM1 R280M mutation?,ssm_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the SGCZ Q138H mutation?,ssm_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the SGCZ Q91H mutation?,ssm_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the SMO V15M mutation?,ssm_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the SMO V321M mutation?,ssm_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the CHODL G159E mutation?,ssm_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the CHODL G181E mutation?,ssm_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the CHODL G200E mutation?,ssm_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the MYO16 P399H mutation?,ssm_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the MYO16 P421H mutation?,ssm_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the CXCR2 A98V mutation?,ssm_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma patients have the TMEM225 L212V mutation?,ssm_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the MAOB N251T mutation?,ssm_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the GPRASP1 F580S mutation?,ssm_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the MRPL32 R181Q mutation?,ssm_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the TYROBP A29T mutation?,ssm_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the RAB40C A111V mutation?,ssm_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the RAB40C A143V mutation?,ssm_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the CTNNA2 S323R mutation?,ssm_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the CTNNA2 S339R mutation?,ssm_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the CTNNA2 S386R mutation?,ssm_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the CTNNA2 S707R mutation?,ssm_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma patients have the MYO15A S268R mutation?,ssm_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the GIMAP2 A167T mutation?,ssm_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme patients have the KIF20B N1160D mutation?,ssm_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme patients have the KIF20B N1200D mutation?,ssm_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the ADAM17 E583K mutation?,ssm_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the BCAT1 G16R mutation?,ssm_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the BCAT1 G17R mutation?,ssm_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the BCAT1 G29R mutation?,ssm_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the ERCC6 R1053H mutation?,ssm_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma patients have the DCC R320W mutation?,ssm_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma patients have the DCC R363W mutation?,ssm_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma patients have the DCC R386W mutation?,ssm_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma patients have the DCC R41W mutation?,ssm_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the FBXO15 D417N mutation?,ssm_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the FBXO15 D86N mutation?,ssm_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the GSTCD S528F mutation?,ssm_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the GSTCD S615F mutation?,ssm_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the OLFML3 P296S mutation?,ssm_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the OLFML3 P337S mutation?,ssm_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the OLFML3 P357S mutation?,ssm_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What fraction of Ovarian Serous Cystadenocarcinoma patients have the CFAP61 E173V mutation?,ssm_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What fraction of Ovarian Serous Cystadenocarcinoma patients have the CFAP61 E817V mutation?,ssm_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma patients have the HLA-DQA2 E51K mutation?,ssm_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the TENM2 H240Y mutation?,ssm_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the TENM2 H351Y mutation?,ssm_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the TENM2 H472Y mutation?,ssm_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the ANKRD24 A465T mutation?,ssm_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the ANKRD24 A494T mutation?,ssm_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the ANKRD24 A584T mutation?,ssm_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the ZCCHC14 V549M mutation?,ssm_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the ZCCHC14 V665M mutation?,ssm_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the ZCCHC14 V676M mutation?,ssm_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the ZCCHC14 V802M mutation?,ssm_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the SIK2 I265M mutation?,ssm_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the MYH11 T1336M mutation?,ssm_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the MYH11 T1343M mutation?,ssm_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the SLC6A4 S174F mutation?,ssm_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the SLC9C1 K102N mutation?,ssm_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the SLC9C1 K29N mutation?,ssm_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,What fraction of Brain Lower Grade Glioma patients have the OR2A12 A254T mutation?,ssm_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the PYHIN1 T325K mutation?,ssm_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the PYHIN1 T334K mutation?,ssm_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the JAML G191E mutation?,ssm_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the JAML G219E mutation?,ssm_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the JAML G220E mutation?,ssm_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the JAML G230E mutation?,ssm_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the TYK2 H1146R mutation?,ssm_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the TYK2 H23R mutation?,ssm_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the TYK2 H961R mutation?,ssm_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the CTCFL R208C mutation?,ssm_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the CTCFL R265C mutation?,ssm_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the CTCFL R420C mutation?,ssm_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the CTCFL R470C mutation?,ssm_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the CEP20 R31Q mutation?,ssm_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the CEP20 R58Q mutation?,ssm_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the RIMS2 R25W mutation?,ssm_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the RIMS2 R393W mutation?,ssm_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the RIMS2 R423W mutation?,ssm_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the RIMS2 R470W mutation?,ssm_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the RIMS2 R615W mutation?,ssm_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the RIMS2 R619W mutation?,ssm_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the RIMS2 R716W mutation?,ssm_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the PIK3C2G S551L mutation?,ssm_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the PIK3C2G S592L mutation?,ssm_frequency
+728,STK19,D341N,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the STK19 D341N mutation?,ssm_frequency
+729,STK19,D345N,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the STK19 D345N mutation?,ssm_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the REXO4 P60A mutation?,ssm_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the ZBTB34 P160S mutation?,ssm_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the ZBTB34 P164S mutation?,ssm_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma patients have the NCKAP5 E148K mutation?,ssm_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have the SORCS1 D1052Y mutation?",ssm_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have the SORCS1 D587Y mutation?",ssm_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have the SORCS1 D67Y mutation?",ssm_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have the SORCS1 D810Y mutation?",ssm_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What fraction of Head and Neck Squamous Cell Carcinoma patients have the FGF8 T154M mutation?,ssm_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What fraction of Head and Neck Squamous Cell Carcinoma patients have the FGF8 T165M mutation?,ssm_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What fraction of Head and Neck Squamous Cell Carcinoma patients have the FGF8 T183M mutation?,ssm_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What fraction of Head and Neck Squamous Cell Carcinoma patients have the FGF8 T194M mutation?,ssm_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What fraction of Head and Neck Squamous Cell Carcinoma patients have the FGF8 T90M mutation?,ssm_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What fraction of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia patients have the TENM3 R1877W mutation?,ssm_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the AKT1 D44N mutation?,ssm_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have the CFAP298-TCP10L E11Q mutation?,ssm_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the GLRB E148D mutation?,ssm_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the TTN F7636L mutation?,ssm_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the TTN F8563L mutation?,ssm_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the TTN F8880L mutation?,ssm_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the ANKRD30A V798I mutation?,ssm_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the ANKRD30A V854I mutation?,ssm_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the ANKRD30A V973I mutation?,ssm_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the TRIM45 S177L mutation?,ssm_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the TRIM45 S224L mutation?,ssm_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the TRIM45 S281L mutation?,ssm_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the CACNA1F G727V mutation?,ssm_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the CACNA1F G781V mutation?,ssm_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the CACNA1F G792V mutation?,ssm_frequency
+817,KL,R594C,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the KL R594C mutation?,ssm_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What fraction of Kidney Renal Papillary Cell Carcinoma patients have the GUF1 I243T mutation?,ssm_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the TAF1L A539V mutation?,ssm_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the TASOR2 S256F mutation?,ssm_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the TASOR2 S36F mutation?,ssm_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the TASOR2 S471F mutation?,ssm_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the KDM5C R1151C mutation?,ssm_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the KDM5C R1177C mutation?,ssm_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the KDM5C R1217C mutation?,ssm_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the KDM5C R1218C mutation?,ssm_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have the IL5RA L153F mutation?,ssm_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the DHX16 A29V mutation?,ssm_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the DHX16 A89V mutation?,ssm_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the GPR158 A644V mutation?,ssm_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the GPR158 A723V mutation?,ssm_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have the EIF2B4 E108K mutation?",ssm_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have the EIF2B4 E110K mutation?",ssm_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have the EIF2B4 E111K mutation?",ssm_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have the EIF2B4 E131K mutation?",ssm_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have the EIF2B4 E132K mutation?",ssm_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have the EIF2B4 E96K mutation?",ssm_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the AUTS2 P136S mutation?,ssm_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the AUTS2 P218S mutation?,ssm_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the AUTS2 P233S mutation?,ssm_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the AUTS2 P313S mutation?,ssm_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the AUTS2 P419S mutation?,ssm_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the AUTS2 P443S mutation?,ssm_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the AUTS2 P56S mutation?,ssm_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the AUTS2 P667S mutation?,ssm_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the AUTS2 P690S mutation?,ssm_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the AUTS2 P691S mutation?,ssm_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have the ACTL7B D223N mutation?",ssm_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme patients have the PCDHGA1 R535W mutation?,ssm_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the TRAP1 R114W mutation?,ssm_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the TRAP1 R61W mutation?,ssm_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the PIK3C2A R1570Q mutation?,ssm_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma patients have the KANSL1 R139G mutation?,ssm_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the ANKRD52 Y594C mutation?,ssm_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the PAPPA G1580S mutation?,ssm_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma patients have the B3GALNT1 V270A mutation?,ssm_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the GABRA6 G115R mutation?,ssm_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the GABRA6 G122R mutation?,ssm_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the GABRA6 G165R mutation?,ssm_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the GABRA6 G175R mutation?,ssm_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the GABRA6 G70R mutation?,ssm_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the ZSCAN31 D9N mutation?,ssm_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have the MED16 L126P mutation?",ssm_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have the MED16 L868P mutation?",ssm_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma patients have the PTPRO E1060K mutation?,ssm_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma patients have the PTPRO E1088K mutation?,ssm_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma patients have the PTPRO E249K mutation?,ssm_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma patients have the PTPRO E265K mutation?,ssm_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma patients have the PTPRO E277K mutation?,ssm_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma patients have the PTPRO E67K mutation?,ssm_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma patients have the PTPRO E923K mutation?,ssm_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma patients have the PTPRO E940K mutation?,ssm_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the CHMP7 D397N mutation?,ssm_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the GPC3 I107N mutation?,ssm_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the GPC3 I161N mutation?,ssm_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have the TLK2 V430L mutation?,ssm_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have the TLK2 V515L mutation?,ssm_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have the TLK2 V547L mutation?,ssm_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have the TLK2 V579L mutation?,ssm_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have the TLK2 V601L mutation?,ssm_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the ZNF217 E209Q mutation?,ssm_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the SYT9 V275L mutation?,ssm_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the SYT9 V307L mutation?,ssm_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the PKHD1L1 S2830N mutation?,ssm_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the MYO3A Y1295C mutation?,ssm_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have the VASN V318I mutation?",ssm_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the DNMT1 A1037T mutation?,ssm_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the DNMT1 A1053T mutation?,ssm_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the DNMT1 A934T mutation?,ssm_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the CA9 E402K mutation?,ssm_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the TTC17 R808Q mutation?,ssm_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the TTC17 R865Q mutation?,ssm_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma patients have the PSG2 P43L mutation?,ssm_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma patients have the RIPOR2 R470L mutation?,ssm_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma patients have the RIPOR2 R499L mutation?,ssm_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma patients have the RIPOR2 R504L mutation?,ssm_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma patients have the RIPOR2 R520L mutation?,ssm_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the DCLK3 V520I mutation?,ssm_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the DCLK3 V689I mutation?,ssm_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the MERTK G257A mutation?,ssm_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the MERTK G757A mutation?,ssm_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the MERTK G933A mutation?,ssm_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the ZFP42 R206K mutation?,ssm_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the OR13C3 M117I mutation?,ssm_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the OR13C3 M147I mutation?,ssm_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the SPAG1 I917M mutation?,ssm_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the CDKN2AIP Y92H mutation?,ssm_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the PXN H1016Y mutation?,ssm_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the PXN H359Y mutation?,ssm_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the PXN H492Y mutation?,ssm_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the PXN H524Y mutation?,ssm_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the PXN H526Y mutation?,ssm_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the PXN H540Y mutation?,ssm_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the TTYH2 S23L mutation?,ssm_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the TTYH2 S44L mutation?,ssm_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the TMEM255A N205S mutation?,ssm_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the TMEM255A N229S mutation?,ssm_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the TMEM255A N65S mutation?,ssm_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma patients have the TASOR2 H2271D mutation?,ssm_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma patients have the TASOR2 H2486D mutation?,ssm_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the ICE1 T1839M mutation?,ssm_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma patients have the MYT1 A558E mutation?,ssm_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma patients have the MYT1 A879E mutation?,ssm_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma patients have the MYT1 A906E mutation?,ssm_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the CX3CR1 P203L mutation?,ssm_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the CX3CR1 P235L mutation?,ssm_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma patients have the SPINDOC R197C mutation?,ssm_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the ART3 C251Y mutation?,ssm_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the ART3 C3Y mutation?,ssm_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma patients have the CYP1A2 R243G mutation?,ssm_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have the ADRA1A G279S mutation?",ssm_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the CDH23 P2523R mutation?,ssm_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the CDH23 P283R mutation?,ssm_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the KRT39 P137S mutation?,ssm_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the PDHA2 S7F mutation?,ssm_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the SLC24A2 H200Q mutation?,ssm_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma patients have the PTPRN2 F153L mutation?,ssm_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma patients have the PTPRN2 F847L mutation?,ssm_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma patients have the PTPRN2 F856L mutation?,ssm_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma patients have the PTPRN2 F868L mutation?,ssm_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma patients have the PTPRN2 F885L mutation?,ssm_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the SOX21 R55L mutation?,ssm_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma patients have the CPA6 G166E mutation?,ssm_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the GRM5 E14K mutation?,ssm_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have the CASZ1 R233Q mutation?",ssm_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the SGIP1 N122T mutation?,ssm_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the SGIP1 N420T mutation?,ssm_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the SGIP1 N617T mutation?,ssm_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the SGIP1 N648T mutation?,ssm_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the CARMIL1 V549L mutation?,ssm_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the CARMIL1 V949L mutation?,ssm_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the ZNF431 D121Y mutation?,ssm_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the ZNF431 D161Y mutation?,ssm_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the ZNF431 R128I mutation?,ssm_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the DNAH11 P2987S mutation?,ssm_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the DNAH11 P2994S mutation?,ssm_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the POLD1 Q461L mutation?,ssm_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma patients have the POLD1 Q85L mutation?,ssm_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the TTC12 D646H mutation?,ssm_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the TTC12 D652H mutation?,ssm_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma patients have the CNGB1 D967N mutation?,ssm_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma patients have the CNGB1 D973N mutation?,ssm_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the CTSC E214V mutation?,ssm_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the CTSC E291V mutation?,ssm_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the CTSC E322V mutation?,ssm_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the CTSC E324V mutation?,ssm_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the CTSC E335V mutation?,ssm_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the PRSS8 A179T mutation?,ssm_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the PRSS8 A233T mutation?,ssm_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the ARHGEF40 V864F mutation?,ssm_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma patients have the ACTB A138T mutation?,ssm_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma patients have the ACTB A217T mutation?,ssm_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma patients have the ACTB A244T mutation?,ssm_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma patients have the ACTB A260T mutation?,ssm_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme patients have the YY1AP1 V546D mutation?,ssm_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme patients have the YY1AP1 V557D mutation?,ssm_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme patients have the YY1AP1 V566D mutation?,ssm_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme patients have the YY1AP1 V577D mutation?,ssm_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme patients have the YY1AP1 V623D mutation?,ssm_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme patients have the YY1AP1 V695D mutation?,ssm_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme patients have the YY1AP1 V715D mutation?,ssm_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the FNDC7 D323N mutation?,ssm_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the FNDC7 D99N mutation?,ssm_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the TLCD5 G15V mutation?,ssm_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the TLCD5 G37V mutation?,ssm_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the POLR1G R498W mutation?,ssm_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the POLR1G R500W mutation?,ssm_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the DNAH14 N1186K mutation?,ssm_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the DNAH14 N2657K mutation?,ssm_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the DNAH14 N3460K mutation?,ssm_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the NEXN E73D mutation?,ssm_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma patients have the CYB5R2 G112R mutation?,ssm_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma patients have the CYB5R2 G172R mutation?,ssm_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the NRAP S808L mutation?,ssm_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the NRAP S816L mutation?,ssm_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the NRAP S843L mutation?,ssm_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the CCDC22 E179D mutation?,ssm_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the DCAF6 S402F mutation?,ssm_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the DCAF6 S433F mutation?,ssm_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the ZNF708 E389D mutation?,ssm_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the BFAR T103M mutation?,ssm_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the MAST4 P1237S mutation?,ssm_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the MAST4 P1986S mutation?,ssm_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the MAST4 P1991S mutation?,ssm_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the MAST4 P2001S mutation?,ssm_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the MAST4 P2180S mutation?,ssm_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the ARMC3 R169C mutation?,ssm_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the ARMC3 R432C mutation?,ssm_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What fraction of Kidney Renal Clear Cell Carcinoma patients have the TET2 L757V mutation?,ssm_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What fraction of Kidney Renal Clear Cell Carcinoma patients have the TET2 L778V mutation?,ssm_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the SERPINB10 A353P mutation?,ssm_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the STAT3 Y22H mutation?,ssm_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the MIEF1 A42T mutation?,ssm_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the ACVR1B D397N mutation?,ssm_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the ACVR1B D449N mutation?,ssm_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the ACVR1B D490N mutation?,ssm_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the EBF2 T104I mutation?,ssm_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the EBF2 T252I mutation?,ssm_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the VPS26B F266L mutation?,ssm_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have the PGR M106I mutation?",ssm_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have the PGR M38I mutation?",ssm_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have the PGR M632I mutation?",ssm_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma patients have the ACTA2 P334L mutation?,ssm_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the THBS4 T852I mutation?,ssm_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the THBS4 T943I mutation?,ssm_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the PRSS1 S114T mutation?,ssm_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the PRSS1 S124T mutation?,ssm_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the PRSS1 S138T mutation?,ssm_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma patients have the PRSS1 S74T mutation?,ssm_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the PGF R126H mutation?,ssm_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma patients have the PGF R127H mutation?,ssm_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma patients have the ITPRID2 S351C mutation?,ssm_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma patients have the ITPRID2 S842C mutation?,ssm_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the HBB E8D mutation?,ssm_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the PCDHB2 R158C mutation?,ssm_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the PCDHB2 T15M mutation?,ssm_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma patients have the PCDHB2 T26M mutation?,ssm_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma patients have the UBR2 P1594S mutation?,ssm_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma patients have the FBXO42 A618D mutation?,ssm_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,How widespread is the TNS1 G1362V mutation in Breast Invasive Carcinoma?,ssm_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,How widespread is the TNS1 G1711V mutation in Breast Invasive Carcinoma?,ssm_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,How widespread is the TNS1 G1718V mutation in Breast Invasive Carcinoma?,ssm_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,How widespread is the TNS1 G1732V mutation in Breast Invasive Carcinoma?,ssm_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,How widespread is the TNS1 G1824V mutation in Breast Invasive Carcinoma?,ssm_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,How widespread is the TNS1 G1857V mutation in Breast Invasive Carcinoma?,ssm_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,How widespread is the TNS1 G843V mutation in Breast Invasive Carcinoma?,ssm_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How widespread is the EVC2 E1067K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How widespread is the EVC2 E987K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How widespread is the CR1 V1108G mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How widespread is the CR1 V1558G mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,How widespread is the TRPA1 S295I mutation in Rectum Adenocarcinoma?,ssm_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,How widespread is the TRPA1 S443I mutation in Rectum Adenocarcinoma?,ssm_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,How widespread is the TAF1C R299L mutation in Lung Adenocarcinoma?,ssm_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,How widespread is the TAF1C R396L mutation in Lung Adenocarcinoma?,ssm_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,How widespread is the TAF1C R634L mutation in Lung Adenocarcinoma?,ssm_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,How widespread is the TAF1C R702L mutation in Lung Adenocarcinoma?,ssm_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,How widespread is the TAF1C R728L mutation in Lung Adenocarcinoma?,ssm_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How widespread is the DPF3 R104W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How widespread is the DPF3 R149W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How widespread is the DPF3 R94W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,How widespread is the OR2T4 P272H mutation in Lung Adenocarcinoma?,ssm_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,How widespread is the OR2T4 P300H mutation in Lung Adenocarcinoma?,ssm_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How widespread is the FBN1 E2667K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How widespread is the MAD1L1 E396K mutation in Prostate Adenocarcinoma?,ssm_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How widespread is the MAD1L1 E488K mutation in Prostate Adenocarcinoma?,ssm_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How widespread is the MAD1L1 E78K mutation in Prostate Adenocarcinoma?,ssm_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How widespread is the CCNG1 E22K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How widespread is the ANP32E N114T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How widespread is the ANP32E N64T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How widespread is the ANP32E N66T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How widespread is the ANP32E N73T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How widespread is the FRY S1888A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How widespread is the FRY S1937A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How widespread is the FRY S1938A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How widespread is the FRY S1983A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,How widespread is the PAK3 E318K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,How widespread is the PAK3 E319K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,How widespread is the PAK3 E334K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,How widespread is the PAK3 E340K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,How widespread is the PAK3 E355K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How widespread is the MUC16 P7963L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How widespread is the ZFPM2 T498I mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How widespread is the ZFPM2 T630I mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How widespread is the PIK3C2B S1328C mutation in Breast Invasive Carcinoma?,ssm_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How widespread is the PIK3C2B S1356C mutation in Breast Invasive Carcinoma?,ssm_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How widespread is the ZNF804A S371Y mutation in Colon Adenocarcinoma?,ssm_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,How widespread is the RELN A2371V mutation in Stomach Adenocarcinoma?,ssm_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is the EFCAB12 R173C mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is the EFCAB12 R23C mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How widespread is the DEFB115 E53K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How widespread is the ANKDD1A S290F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How widespread is the ANKDD1A S322F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How widespread is the ANKDD1A S413F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How widespread is the HTR3B S146I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How widespread is the HTR3B S206I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How widespread is the HTR3B S217I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,How widespread is the ABCC3 R758W mutation in Stomach Adenocarcinoma?,ssm_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How widespread is the NOMO1 T204I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How widespread is the NOMO1 T371I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How widespread is the HYOU1 D298H mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How widespread is the FMO4 R500Q mutation in Skin Cutaneous Melanoma?,ssm_frequency
+140,BICC1,A372V,Exceptional Responders,How widespread is the BICC1 A372V mutation in Exceptional Responders?,ssm_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How widespread is the ZMYM3 I920V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How widespread is the ZMYM3 I932V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How widespread is the ZMYM3 I934V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is the XKR4 R547W mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How widespread is the ABCC2 V239L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,How widespread is the OR8K5 R293G mutation in Lung Adenocarcinoma?,ssm_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How widespread is the SPTAN1 S1503F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How widespread is the SPTAN1 S1523F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,How widespread is the SYT10 M484I mutation in Rectum Adenocarcinoma?,ssm_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How widespread is the HSPA5 N457K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,How widespread is the UNC5D L280V mutation in Lung Adenocarcinoma?,ssm_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,How widespread is the UNC5D L635V mutation in Lung Adenocarcinoma?,ssm_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,How widespread is the UNC5D L637V mutation in Lung Adenocarcinoma?,ssm_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,How widespread is the UNC5D L699V mutation in Lung Adenocarcinoma?,ssm_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,How widespread is the UNC5D L704V mutation in Lung Adenocarcinoma?,ssm_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,How widespread is the UNC5D L709V mutation in Lung Adenocarcinoma?,ssm_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How widespread is the DOCK2 L1527H mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How widespread is the ZNF627 A5V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How widespread is the CDC42BPA L823F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,How widespread is the MRPL55 H27Y mutation in Colon Adenocarcinoma?,ssm_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,How widespread is the MRPL55 H63Y mutation in Colon Adenocarcinoma?,ssm_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How widespread is the TMTC3 Q749K mutation in Breast Invasive Carcinoma?,ssm_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,How widespread is the EPRS1 K771I mutation in Colon Adenocarcinoma?,ssm_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,How widespread is the EPRS1 K778I mutation in Colon Adenocarcinoma?,ssm_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How widespread is the GRTP1 A110V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How widespread is the GRTP1 A32V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How widespread is the TSHZ3 Q538K mutation in Stomach Adenocarcinoma?,ssm_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How widespread is the TAS1R3 Q326H mutation in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,ssm_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How widespread is the PIAS3 S238C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How widespread is the PIAS3 S273C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,How widespread is the ZNF274 P13R mutation in Stomach Adenocarcinoma?,ssm_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,How widespread is the SYNJ1 R795C mutation in Colon Adenocarcinoma?,ssm_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,How widespread is the SYNJ1 R800C mutation in Colon Adenocarcinoma?,ssm_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,How widespread is the SYNJ1 R839C mutation in Colon Adenocarcinoma?,ssm_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,How widespread is the DSCAM V343M mutation in Prostate Adenocarcinoma?,ssm_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,How widespread is the DSCAM V426M mutation in Prostate Adenocarcinoma?,ssm_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,How widespread is the DSCAM V591M mutation in Prostate Adenocarcinoma?,ssm_frequency
+267,DGKD,R140H,Exceptional Responders,How widespread is the DGKD R140H mutation in Exceptional Responders?,ssm_frequency
+268,DGKD,R160H,Exceptional Responders,How widespread is the DGKD R160H mutation in Exceptional Responders?,ssm_frequency
+269,DGKD,R204H,Exceptional Responders,How widespread is the DGKD R204H mutation in Exceptional Responders?,ssm_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How widespread is the PLEKHG6 D105Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How widespread is the PLEKHG6 D543Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How widespread is the PLEKHG6 D575Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,How widespread is the WNT2 D138N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How widespread is the GUCY2C G667R mutation in Skin Cutaneous Melanoma?,ssm_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How widespread is the C7orf31 P244H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is the ZKSCAN7 E64K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+299,OR5D14,M210L,Neuroblastoma,How widespread is the OR5D14 M210L mutation in Neuroblastoma?,ssm_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How widespread is the SPATA22 K279E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How widespread is the SPATA22 K306E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How widespread is the SPATA22 K322E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,How widespread is the LCN15 E21V mutation in Stomach Adenocarcinoma?,ssm_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How widespread is the DCAF4L2 S129F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How widespread is the GUK1 R135P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How widespread is the GUK1 R137P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How widespread is the GUK1 R139P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How widespread is the GUK1 R158P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How widespread is the GUK1 R203P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How widespread is the MORF4L1 K29T mutation in Stomach Adenocarcinoma?,ssm_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How widespread is the MORF4L1 K51T mutation in Stomach Adenocarcinoma?,ssm_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How widespread is the MORF4L1 K61T mutation in Stomach Adenocarcinoma?,ssm_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How widespread is the MORF4L1 K76T mutation in Stomach Adenocarcinoma?,ssm_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How widespread is the MYO3B F594L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How widespread is the MYO3B F603L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How widespread is the TENT5A S320F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How widespread is the TENT5A S339F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How widespread is the TENT5A S401F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How widespread is the ZFAT S614L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How widespread is the ZFAT S664L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How widespread is the ZFAT S676L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+357,ZNF584,A211T,Sarcoma,How widespread is the ZNF584 A211T mutation in Sarcoma?,ssm_frequency
+358,ZNF584,A256T,Sarcoma,How widespread is the ZNF584 A256T mutation in Sarcoma?,ssm_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How widespread is the LDOC1 R63W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How widespread is the PDGFC R201G mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How widespread is the MSANTD4 R304C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How widespread is the NPSR1 S123L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How widespread is the PHLPP1 K1317E mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How widespread is the COL6A3 G237S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How widespread is the COL6A3 G437S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How widespread is the COL6A3 G638S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How widespread is the COL6A3 G644S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How widespread is the COL6A3 G844S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How widespread is the ADRA1A R348G mutation in Stomach Adenocarcinoma?,ssm_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread is the LAMB2 S1254F mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,How widespread is the POC1B I198T mutation in Rectum Adenocarcinoma?,ssm_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,How widespread is the POC1B I286T mutation in Rectum Adenocarcinoma?,ssm_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,How widespread is the POC1B I328T mutation in Rectum Adenocarcinoma?,ssm_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,How widespread is the POC1B S79P mutation in Rectum Adenocarcinoma?,ssm_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How widespread is the USH2A G1451C mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,How widespread is the AQP7 T110S mutation in Rectum Adenocarcinoma?,ssm_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,How widespread is the AQP7 T166S mutation in Rectum Adenocarcinoma?,ssm_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,How widespread is the AQP7 T167S mutation in Rectum Adenocarcinoma?,ssm_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,How widespread is the AQP7 T75S mutation in Rectum Adenocarcinoma?,ssm_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,How widespread is the DCN R163C mutation in Rectum Adenocarcinoma?,ssm_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,How widespread is the DCN R203C mutation in Rectum Adenocarcinoma?,ssm_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,How widespread is the DCN R241C mutation in Rectum Adenocarcinoma?,ssm_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,How widespread is the DCN R350C mutation in Rectum Adenocarcinoma?,ssm_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,How widespread is the DCN R41C mutation in Rectum Adenocarcinoma?,ssm_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How widespread is the CPS1 K1269N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How widespread is the CPS1 K1275N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How widespread is the CPS1 K818N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How widespread is the FCGR2C P122S mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How widespread is the FCGR2C P123S mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How widespread is the GRM1 R280M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,How widespread is the SGCZ Q138H mutation in Lung Adenocarcinoma?,ssm_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,How widespread is the SGCZ Q91H mutation in Lung Adenocarcinoma?,ssm_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,How widespread is the SMO V15M mutation in Stomach Adenocarcinoma?,ssm_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,How widespread is the SMO V321M mutation in Stomach Adenocarcinoma?,ssm_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,How widespread is the CHODL G159E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,How widespread is the CHODL G181E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,How widespread is the CHODL G200E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,How widespread is the MYO16 P399H mutation in Colon Adenocarcinoma?,ssm_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,How widespread is the MYO16 P421H mutation in Colon Adenocarcinoma?,ssm_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,How widespread is the CXCR2 A98V mutation in Stomach Adenocarcinoma?,ssm_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How widespread is the TMEM225 L212V mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How widespread is the MAOB N251T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How widespread is the GPRASP1 F580S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How widespread is the MRPL32 R181Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How widespread is the TYROBP A29T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,How widespread is the RAB40C A111V mutation in Lung Adenocarcinoma?,ssm_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,How widespread is the RAB40C A143V mutation in Lung Adenocarcinoma?,ssm_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,How widespread is the CTNNA2 S323R mutation in Lung Adenocarcinoma?,ssm_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,How widespread is the CTNNA2 S339R mutation in Lung Adenocarcinoma?,ssm_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,How widespread is the CTNNA2 S386R mutation in Lung Adenocarcinoma?,ssm_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,How widespread is the CTNNA2 S707R mutation in Lung Adenocarcinoma?,ssm_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How widespread is the MYO15A S268R mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How widespread is the GIMAP2 A167T mutation in Skin Cutaneous Melanoma?,ssm_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,How widespread is the KIF20B N1160D mutation in Glioblastoma Multiforme?,ssm_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,How widespread is the KIF20B N1200D mutation in Glioblastoma Multiforme?,ssm_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How widespread is the ADAM17 E583K mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How widespread is the BCAT1 G16R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How widespread is the BCAT1 G17R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How widespread is the BCAT1 G29R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,How widespread is the ERCC6 R1053H mutation in Colon Adenocarcinoma?,ssm_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,How widespread is the DCC R320W mutation in Breast Invasive Carcinoma?,ssm_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,How widespread is the DCC R363W mutation in Breast Invasive Carcinoma?,ssm_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,How widespread is the DCC R386W mutation in Breast Invasive Carcinoma?,ssm_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,How widespread is the DCC R41W mutation in Breast Invasive Carcinoma?,ssm_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How widespread is the FBXO15 D417N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How widespread is the FBXO15 D86N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How widespread is the GSTCD S528F mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How widespread is the GSTCD S615F mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How widespread is the OLFML3 P296S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How widespread is the OLFML3 P337S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How widespread is the OLFML3 P357S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How widespread is the CFAP61 E173V mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How widespread is the CFAP61 E817V mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How widespread is the HLA-DQA2 E51K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How widespread is the TENM2 H240Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How widespread is the TENM2 H351Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How widespread is the TENM2 H472Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How widespread is the ANKRD24 A465T mutation in Stomach Adenocarcinoma?,ssm_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How widespread is the ANKRD24 A494T mutation in Stomach Adenocarcinoma?,ssm_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How widespread is the ANKRD24 A584T mutation in Stomach Adenocarcinoma?,ssm_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How widespread is the ZCCHC14 V549M mutation in Stomach Adenocarcinoma?,ssm_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How widespread is the ZCCHC14 V665M mutation in Stomach Adenocarcinoma?,ssm_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How widespread is the ZCCHC14 V676M mutation in Stomach Adenocarcinoma?,ssm_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How widespread is the ZCCHC14 V802M mutation in Stomach Adenocarcinoma?,ssm_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,How widespread is the SIK2 I265M mutation in Lung Adenocarcinoma?,ssm_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How widespread is the MYH11 T1336M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How widespread is the MYH11 T1343M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How widespread is the SLC6A4 S174F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How widespread is the SLC9C1 K102N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How widespread is the SLC9C1 K29N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,How widespread is the OR2A12 A254T mutation in Brain Lower Grade Glioma?,ssm_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,How widespread is the PYHIN1 T325K mutation in Lung Adenocarcinoma?,ssm_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,How widespread is the PYHIN1 T334K mutation in Lung Adenocarcinoma?,ssm_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,How widespread is the JAML G191E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,How widespread is the JAML G219E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,How widespread is the JAML G220E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,How widespread is the JAML G230E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,How widespread is the TYK2 H1146R mutation in Stomach Adenocarcinoma?,ssm_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,How widespread is the TYK2 H23R mutation in Stomach Adenocarcinoma?,ssm_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,How widespread is the TYK2 H961R mutation in Stomach Adenocarcinoma?,ssm_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How widespread is the CTCFL R208C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How widespread is the CTCFL R265C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How widespread is the CTCFL R420C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How widespread is the CTCFL R470C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How widespread is the CEP20 R31Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How widespread is the CEP20 R58Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How widespread is the RIMS2 R25W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How widespread is the RIMS2 R393W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How widespread is the RIMS2 R423W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How widespread is the RIMS2 R470W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How widespread is the RIMS2 R615W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How widespread is the RIMS2 R619W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How widespread is the RIMS2 R716W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How widespread is the PIK3C2G S551L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How widespread is the PIK3C2G S592L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+728,STK19,D341N,Colon Adenocarcinoma,How widespread is the STK19 D341N mutation in Colon Adenocarcinoma?,ssm_frequency
+729,STK19,D345N,Colon Adenocarcinoma,How widespread is the STK19 D345N mutation in Colon Adenocarcinoma?,ssm_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,How widespread is the REXO4 P60A mutation in Skin Cutaneous Melanoma?,ssm_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How widespread is the ZBTB34 P160S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How widespread is the ZBTB34 P164S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How widespread is the NCKAP5 E148K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is the SORCS1 D1052Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is the SORCS1 D587Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is the SORCS1 D67Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is the SORCS1 D810Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How widespread is the FGF8 T154M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How widespread is the FGF8 T165M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How widespread is the FGF8 T183M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How widespread is the FGF8 T194M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How widespread is the FGF8 T90M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How widespread is the TENM3 R1877W mutation in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,ssm_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How widespread is the AKT1 D44N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread is the CFAP298-TCP10L E11Q mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,How widespread is the GLRB E148D mutation in Stomach Adenocarcinoma?,ssm_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,How widespread is the TTN F7636L mutation in Colon Adenocarcinoma?,ssm_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,How widespread is the TTN F8563L mutation in Colon Adenocarcinoma?,ssm_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,How widespread is the TTN F8880L mutation in Colon Adenocarcinoma?,ssm_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How widespread is the ANKRD30A V798I mutation in Colon Adenocarcinoma?,ssm_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How widespread is the ANKRD30A V854I mutation in Colon Adenocarcinoma?,ssm_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How widespread is the ANKRD30A V973I mutation in Colon Adenocarcinoma?,ssm_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,How widespread is the TRIM45 S177L mutation in Colon Adenocarcinoma?,ssm_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,How widespread is the TRIM45 S224L mutation in Colon Adenocarcinoma?,ssm_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,How widespread is the TRIM45 S281L mutation in Colon Adenocarcinoma?,ssm_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How widespread is the CACNA1F G727V mutation in Stomach Adenocarcinoma?,ssm_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How widespread is the CACNA1F G781V mutation in Stomach Adenocarcinoma?,ssm_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How widespread is the CACNA1F G792V mutation in Stomach Adenocarcinoma?,ssm_frequency
+817,KL,R594C,Colon Adenocarcinoma,How widespread is the KL R594C mutation in Colon Adenocarcinoma?,ssm_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How widespread is the GUF1 I243T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,How widespread is the TAF1L A539V mutation in Colon Adenocarcinoma?,ssm_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How widespread is the TASOR2 S256F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How widespread is the TASOR2 S36F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How widespread is the TASOR2 S471F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How widespread is the KDM5C R1151C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How widespread is the KDM5C R1177C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How widespread is the KDM5C R1217C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How widespread is the KDM5C R1218C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread is the IL5RA L153F mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,How widespread is the DHX16 A29V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,How widespread is the DHX16 A89V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,How widespread is the GPR158 A644V mutation in Stomach Adenocarcinoma?,ssm_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,How widespread is the GPR158 A723V mutation in Stomach Adenocarcinoma?,ssm_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is the EIF2B4 E108K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is the EIF2B4 E110K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is the EIF2B4 E111K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is the EIF2B4 E131K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is the EIF2B4 E132K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is the EIF2B4 E96K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How widespread is the AUTS2 P136S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How widespread is the AUTS2 P218S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How widespread is the AUTS2 P233S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How widespread is the AUTS2 P313S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How widespread is the AUTS2 P419S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How widespread is the AUTS2 P443S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How widespread is the AUTS2 P56S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How widespread is the AUTS2 P667S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How widespread is the AUTS2 P690S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How widespread is the AUTS2 P691S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is the ACTL7B D223N mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How widespread is the PCDHGA1 R535W mutation in Glioblastoma Multiforme?,ssm_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,How widespread is the TRAP1 R114W mutation in Stomach Adenocarcinoma?,ssm_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,How widespread is the TRAP1 R61W mutation in Stomach Adenocarcinoma?,ssm_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How widespread is the PIK3C2A R1570Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How widespread is the KANSL1 R139G mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How widespread is the ANKRD52 Y594C mutation in Stomach Adenocarcinoma?,ssm_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How widespread is the PAPPA G1580S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How widespread is the B3GALNT1 V270A mutation in Rectum Adenocarcinoma?,ssm_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,How widespread is the GABRA6 G115R mutation in Lung Adenocarcinoma?,ssm_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,How widespread is the GABRA6 G122R mutation in Lung Adenocarcinoma?,ssm_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,How widespread is the GABRA6 G165R mutation in Lung Adenocarcinoma?,ssm_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,How widespread is the GABRA6 G175R mutation in Lung Adenocarcinoma?,ssm_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,How widespread is the GABRA6 G70R mutation in Lung Adenocarcinoma?,ssm_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How widespread is the ZSCAN31 D9N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is the MED16 L126P mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is the MED16 L868P mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How widespread is the PTPRO E1060K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How widespread is the PTPRO E1088K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How widespread is the PTPRO E249K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How widespread is the PTPRO E265K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How widespread is the PTPRO E277K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How widespread is the PTPRO E67K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How widespread is the PTPRO E923K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How widespread is the PTPRO E940K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How widespread is the CHMP7 D397N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,How widespread is the GPC3 I107N mutation in Stomach Adenocarcinoma?,ssm_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,How widespread is the GPC3 I161N mutation in Stomach Adenocarcinoma?,ssm_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread is the TLK2 V430L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread is the TLK2 V515L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread is the TLK2 V547L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread is the TLK2 V579L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread is the TLK2 V601L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How widespread is the ZNF217 E209Q mutation in Lung Adenocarcinoma?,ssm_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,How widespread is the SYT9 V275L mutation in Lung Adenocarcinoma?,ssm_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,How widespread is the SYT9 V307L mutation in Lung Adenocarcinoma?,ssm_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How widespread is the PKHD1L1 S2830N mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How widespread is the MYO3A Y1295C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is the VASN V318I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How widespread is the DNMT1 A1037T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How widespread is the DNMT1 A1053T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How widespread is the DNMT1 A934T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,How widespread is the CA9 E402K mutation in Colon Adenocarcinoma?,ssm_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How widespread is the TTC17 R808Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How widespread is the TTC17 R865Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,How widespread is the PSG2 P43L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How widespread is the RIPOR2 R470L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How widespread is the RIPOR2 R499L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How widespread is the RIPOR2 R504L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How widespread is the RIPOR2 R520L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How widespread is the DCLK3 V520I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How widespread is the DCLK3 V689I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How widespread is the MERTK G257A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How widespread is the MERTK G757A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How widespread is the MERTK G933A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How widespread is the ZFP42 R206K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How widespread is the OR13C3 M117I mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How widespread is the OR13C3 M147I mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How widespread is the SPAG1 I917M mutation in Stomach Adenocarcinoma?,ssm_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How widespread is the CDKN2AIP Y92H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,How widespread is the PXN H1016Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,How widespread is the PXN H359Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,How widespread is the PXN H492Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,How widespread is the PXN H524Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,How widespread is the PXN H526Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,How widespread is the PXN H540Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How widespread is the TTYH2 S23L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How widespread is the TTYH2 S44L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How widespread is the TMEM255A N205S mutation in Colon Adenocarcinoma?,ssm_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How widespread is the TMEM255A N229S mutation in Colon Adenocarcinoma?,ssm_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How widespread is the TMEM255A N65S mutation in Colon Adenocarcinoma?,ssm_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How widespread is the TASOR2 H2271D mutation in Breast Invasive Carcinoma?,ssm_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How widespread is the TASOR2 H2486D mutation in Breast Invasive Carcinoma?,ssm_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How widespread is the ICE1 T1839M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,How widespread is the MYT1 A558E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,How widespread is the MYT1 A879E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,How widespread is the MYT1 A906E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How widespread is the CX3CR1 P203L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How widespread is the CX3CR1 P235L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How widespread is the SPINDOC R197C mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How widespread is the ART3 C251Y mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How widespread is the ART3 C3Y mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How widespread is the CYP1A2 R243G mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is the ADRA1A G279S mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How widespread is the CDH23 P2523R mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How widespread is the CDH23 P283R mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How widespread is the KRT39 P137S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How widespread is the PDHA2 S7F mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How widespread is the SLC24A2 H200Q mutation in Colon Adenocarcinoma?,ssm_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How widespread is the PTPRN2 F153L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How widespread is the PTPRN2 F847L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How widespread is the PTPRN2 F856L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How widespread is the PTPRN2 F868L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How widespread is the PTPRN2 F885L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,How widespread is the SOX21 R55L mutation in Lung Adenocarcinoma?,ssm_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How widespread is the CPA6 G166E mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How widespread is the GRM5 E14K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is the CASZ1 R233Q mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How widespread is the SGIP1 N122T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How widespread is the SGIP1 N420T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How widespread is the SGIP1 N617T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How widespread is the SGIP1 N648T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How widespread is the CARMIL1 V549L mutation in Lung Adenocarcinoma?,ssm_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How widespread is the CARMIL1 V949L mutation in Lung Adenocarcinoma?,ssm_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How widespread is the ZNF431 D121Y mutation in Lung Adenocarcinoma?,ssm_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How widespread is the ZNF431 D161Y mutation in Lung Adenocarcinoma?,ssm_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,How widespread is the ZNF431 R128I mutation in Lung Adenocarcinoma?,ssm_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How widespread is the DNAH11 P2987S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How widespread is the DNAH11 P2994S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How widespread is the POLD1 Q461L mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How widespread is the POLD1 Q85L mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,How widespread is the TTC12 D646H mutation in Lung Adenocarcinoma?,ssm_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,How widespread is the TTC12 D652H mutation in Lung Adenocarcinoma?,ssm_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How widespread is the CNGB1 D967N mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How widespread is the CNGB1 D973N mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,How widespread is the CTSC E214V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,How widespread is the CTSC E291V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,How widespread is the CTSC E322V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,How widespread is the CTSC E324V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,How widespread is the CTSC E335V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How widespread is the PRSS8 A179T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How widespread is the PRSS8 A233T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How widespread is the ARHGEF40 V864F mutation in Lung Adenocarcinoma?,ssm_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,How widespread is the ACTB A138T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,How widespread is the ACTB A217T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,How widespread is the ACTB A244T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,How widespread is the ACTB A260T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How widespread is the YY1AP1 V546D mutation in Glioblastoma Multiforme?,ssm_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How widespread is the YY1AP1 V557D mutation in Glioblastoma Multiforme?,ssm_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How widespread is the YY1AP1 V566D mutation in Glioblastoma Multiforme?,ssm_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How widespread is the YY1AP1 V577D mutation in Glioblastoma Multiforme?,ssm_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How widespread is the YY1AP1 V623D mutation in Glioblastoma Multiforme?,ssm_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How widespread is the YY1AP1 V695D mutation in Glioblastoma Multiforme?,ssm_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How widespread is the YY1AP1 V715D mutation in Glioblastoma Multiforme?,ssm_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How widespread is the FNDC7 D323N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How widespread is the FNDC7 D99N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,How widespread is the TLCD5 G15V mutation in Lung Adenocarcinoma?,ssm_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,How widespread is the TLCD5 G37V mutation in Lung Adenocarcinoma?,ssm_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How widespread is the POLR1G R498W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How widespread is the POLR1G R500W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How widespread is the DNAH14 N1186K mutation in Colon Adenocarcinoma?,ssm_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How widespread is the DNAH14 N2657K mutation in Colon Adenocarcinoma?,ssm_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How widespread is the DNAH14 N3460K mutation in Colon Adenocarcinoma?,ssm_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How widespread is the NEXN E73D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How widespread is the CYB5R2 G112R mutation in Prostate Adenocarcinoma?,ssm_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How widespread is the CYB5R2 G172R mutation in Prostate Adenocarcinoma?,ssm_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How widespread is the NRAP S808L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How widespread is the NRAP S816L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How widespread is the NRAP S843L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How widespread is the CCDC22 E179D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How widespread is the DCAF6 S402F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How widespread is the DCAF6 S433F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How widespread is the ZNF708 E389D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How widespread is the BFAR T103M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How widespread is the MAST4 P1237S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How widespread is the MAST4 P1986S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How widespread is the MAST4 P1991S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How widespread is the MAST4 P2001S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How widespread is the MAST4 P2180S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How widespread is the ARMC3 R169C mutation in Stomach Adenocarcinoma?,ssm_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How widespread is the ARMC3 R432C mutation in Stomach Adenocarcinoma?,ssm_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How widespread is the TET2 L757V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How widespread is the TET2 L778V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How widespread is the SERPINB10 A353P mutation in Lung Adenocarcinoma?,ssm_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How widespread is the STAT3 Y22H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How widespread is the MIEF1 A42T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How widespread is the ACVR1B D397N mutation in Colon Adenocarcinoma?,ssm_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How widespread is the ACVR1B D449N mutation in Colon Adenocarcinoma?,ssm_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How widespread is the ACVR1B D490N mutation in Colon Adenocarcinoma?,ssm_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,How widespread is the EBF2 T104I mutation in Stomach Adenocarcinoma?,ssm_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,How widespread is the EBF2 T252I mutation in Stomach Adenocarcinoma?,ssm_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How widespread is the VPS26B F266L mutation in Stomach Adenocarcinoma?,ssm_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is the PGR M106I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is the PGR M38I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is the PGR M632I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How widespread is the ACTA2 P334L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How widespread is the THBS4 T852I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How widespread is the THBS4 T943I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,How widespread is the PRSS1 S114T mutation in Lung Adenocarcinoma?,ssm_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,How widespread is the PRSS1 S124T mutation in Lung Adenocarcinoma?,ssm_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,How widespread is the PRSS1 S138T mutation in Lung Adenocarcinoma?,ssm_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,How widespread is the PRSS1 S74T mutation in Lung Adenocarcinoma?,ssm_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,How widespread is the PGF R126H mutation in Stomach Adenocarcinoma?,ssm_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,How widespread is the PGF R127H mutation in Stomach Adenocarcinoma?,ssm_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How widespread is the ITPRID2 S351C mutation in Breast Invasive Carcinoma?,ssm_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How widespread is the ITPRID2 S842C mutation in Breast Invasive Carcinoma?,ssm_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How widespread is the HBB E8D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How widespread is the PCDHB2 R158C mutation in Colon Adenocarcinoma?,ssm_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How widespread is the PCDHB2 T15M mutation in Colon Adenocarcinoma?,ssm_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How widespread is the PCDHB2 T26M mutation in Colon Adenocarcinoma?,ssm_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How widespread is the UBR2 P1594S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How widespread is the FBXO42 A618D mutation in Rectum Adenocarcinoma?,ssm_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the rate of occurrence of the TNS1 G1362V mutation in Breast Invasive Carcinoma?,ssm_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the rate of occurrence of the TNS1 G1711V mutation in Breast Invasive Carcinoma?,ssm_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the rate of occurrence of the TNS1 G1718V mutation in Breast Invasive Carcinoma?,ssm_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the rate of occurrence of the TNS1 G1732V mutation in Breast Invasive Carcinoma?,ssm_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the rate of occurrence of the TNS1 G1824V mutation in Breast Invasive Carcinoma?,ssm_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the rate of occurrence of the TNS1 G1857V mutation in Breast Invasive Carcinoma?,ssm_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the rate of occurrence of the TNS1 G843V mutation in Breast Invasive Carcinoma?,ssm_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the rate of occurrence of the EVC2 E1067K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the rate of occurrence of the EVC2 E987K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the CR1 V1108G mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the CR1 V1558G mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the rate of occurrence of the TRPA1 S295I mutation in Rectum Adenocarcinoma?,ssm_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the rate of occurrence of the TRPA1 S443I mutation in Rectum Adenocarcinoma?,ssm_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the rate of occurrence of the TAF1C R299L mutation in Lung Adenocarcinoma?,ssm_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the rate of occurrence of the TAF1C R396L mutation in Lung Adenocarcinoma?,ssm_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the rate of occurrence of the TAF1C R634L mutation in Lung Adenocarcinoma?,ssm_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the rate of occurrence of the TAF1C R702L mutation in Lung Adenocarcinoma?,ssm_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the rate of occurrence of the TAF1C R728L mutation in Lung Adenocarcinoma?,ssm_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the DPF3 R104W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the DPF3 R149W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the DPF3 R94W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the rate of occurrence of the OR2T4 P272H mutation in Lung Adenocarcinoma?,ssm_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the rate of occurrence of the OR2T4 P300H mutation in Lung Adenocarcinoma?,ssm_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the rate of occurrence of the FBN1 E2667K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the rate of occurrence of the MAD1L1 E396K mutation in Prostate Adenocarcinoma?,ssm_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the rate of occurrence of the MAD1L1 E488K mutation in Prostate Adenocarcinoma?,ssm_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the rate of occurrence of the MAD1L1 E78K mutation in Prostate Adenocarcinoma?,ssm_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the rate of occurrence of the CCNG1 E22K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the rate of occurrence of the ANP32E N114T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the rate of occurrence of the ANP32E N64T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the rate of occurrence of the ANP32E N66T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the rate of occurrence of the ANP32E N73T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the rate of occurrence of the FRY S1888A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the rate of occurrence of the FRY S1937A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the rate of occurrence of the FRY S1938A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the rate of occurrence of the FRY S1983A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the rate of occurrence of the PAK3 E318K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the rate of occurrence of the PAK3 E319K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the rate of occurrence of the PAK3 E334K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the rate of occurrence of the PAK3 E340K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the rate of occurrence of the PAK3 E355K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the rate of occurrence of the MUC16 P7963L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the rate of occurrence of the ZFPM2 T498I mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the rate of occurrence of the ZFPM2 T630I mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the rate of occurrence of the PIK3C2B S1328C mutation in Breast Invasive Carcinoma?,ssm_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the rate of occurrence of the PIK3C2B S1356C mutation in Breast Invasive Carcinoma?,ssm_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the rate of occurrence of the ZNF804A S371Y mutation in Colon Adenocarcinoma?,ssm_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the rate of occurrence of the RELN A2371V mutation in Stomach Adenocarcinoma?,ssm_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of occurrence of the EFCAB12 R173C mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of occurrence of the EFCAB12 R23C mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the rate of occurrence of the DEFB115 E53K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the rate of occurrence of the ANKDD1A S290F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the rate of occurrence of the ANKDD1A S322F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the rate of occurrence of the ANKDD1A S413F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the HTR3B S146I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the HTR3B S206I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the HTR3B S217I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the rate of occurrence of the ABCC3 R758W mutation in Stomach Adenocarcinoma?,ssm_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the NOMO1 T204I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the NOMO1 T371I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the rate of occurrence of the HYOU1 D298H mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the rate of occurrence of the FMO4 R500Q mutation in Skin Cutaneous Melanoma?,ssm_frequency
+140,BICC1,A372V,Exceptional Responders,What is the rate of occurrence of the BICC1 A372V mutation in Exceptional Responders?,ssm_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the ZMYM3 I920V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the ZMYM3 I932V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the ZMYM3 I934V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of occurrence of the XKR4 R547W mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the rate of occurrence of the ABCC2 V239L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the rate of occurrence of the OR8K5 R293G mutation in Lung Adenocarcinoma?,ssm_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the rate of occurrence of the SPTAN1 S1503F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the rate of occurrence of the SPTAN1 S1523F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the rate of occurrence of the SYT10 M484I mutation in Rectum Adenocarcinoma?,ssm_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the rate of occurrence of the HSPA5 N457K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the rate of occurrence of the UNC5D L280V mutation in Lung Adenocarcinoma?,ssm_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the rate of occurrence of the UNC5D L635V mutation in Lung Adenocarcinoma?,ssm_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the rate of occurrence of the UNC5D L637V mutation in Lung Adenocarcinoma?,ssm_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the rate of occurrence of the UNC5D L699V mutation in Lung Adenocarcinoma?,ssm_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the rate of occurrence of the UNC5D L704V mutation in Lung Adenocarcinoma?,ssm_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the rate of occurrence of the UNC5D L709V mutation in Lung Adenocarcinoma?,ssm_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the rate of occurrence of the DOCK2 L1527H mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the rate of occurrence of the ZNF627 A5V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the rate of occurrence of the CDC42BPA L823F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the rate of occurrence of the MRPL55 H27Y mutation in Colon Adenocarcinoma?,ssm_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the rate of occurrence of the MRPL55 H63Y mutation in Colon Adenocarcinoma?,ssm_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the rate of occurrence of the TMTC3 Q749K mutation in Breast Invasive Carcinoma?,ssm_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the rate of occurrence of the EPRS1 K771I mutation in Colon Adenocarcinoma?,ssm_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the rate of occurrence of the EPRS1 K778I mutation in Colon Adenocarcinoma?,ssm_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the rate of occurrence of the GRTP1 A110V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the rate of occurrence of the GRTP1 A32V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the rate of occurrence of the TSHZ3 Q538K mutation in Stomach Adenocarcinoma?,ssm_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the rate of occurrence of the TAS1R3 Q326H mutation in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,ssm_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the PIAS3 S238C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the PIAS3 S273C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the rate of occurrence of the ZNF274 P13R mutation in Stomach Adenocarcinoma?,ssm_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the rate of occurrence of the SYNJ1 R795C mutation in Colon Adenocarcinoma?,ssm_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the rate of occurrence of the SYNJ1 R800C mutation in Colon Adenocarcinoma?,ssm_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the rate of occurrence of the SYNJ1 R839C mutation in Colon Adenocarcinoma?,ssm_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the rate of occurrence of the DSCAM V343M mutation in Prostate Adenocarcinoma?,ssm_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the rate of occurrence of the DSCAM V426M mutation in Prostate Adenocarcinoma?,ssm_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the rate of occurrence of the DSCAM V591M mutation in Prostate Adenocarcinoma?,ssm_frequency
+267,DGKD,R140H,Exceptional Responders,What is the rate of occurrence of the DGKD R140H mutation in Exceptional Responders?,ssm_frequency
+268,DGKD,R160H,Exceptional Responders,What is the rate of occurrence of the DGKD R160H mutation in Exceptional Responders?,ssm_frequency
+269,DGKD,R204H,Exceptional Responders,What is the rate of occurrence of the DGKD R204H mutation in Exceptional Responders?,ssm_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the rate of occurrence of the PLEKHG6 D105Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the rate of occurrence of the PLEKHG6 D543Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the rate of occurrence of the PLEKHG6 D575Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the rate of occurrence of the WNT2 D138N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the rate of occurrence of the GUCY2C G667R mutation in Skin Cutaneous Melanoma?,ssm_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the C7orf31 P244H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of occurrence of the ZKSCAN7 E64K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+299,OR5D14,M210L,Neuroblastoma,What is the rate of occurrence of the OR5D14 M210L mutation in Neuroblastoma?,ssm_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the SPATA22 K279E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the SPATA22 K306E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the SPATA22 K322E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the rate of occurrence of the LCN15 E21V mutation in Stomach Adenocarcinoma?,ssm_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the rate of occurrence of the DCAF4L2 S129F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the GUK1 R135P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the GUK1 R137P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the GUK1 R139P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the GUK1 R158P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the GUK1 R203P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the rate of occurrence of the MORF4L1 K29T mutation in Stomach Adenocarcinoma?,ssm_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the rate of occurrence of the MORF4L1 K51T mutation in Stomach Adenocarcinoma?,ssm_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the rate of occurrence of the MORF4L1 K61T mutation in Stomach Adenocarcinoma?,ssm_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the rate of occurrence of the MORF4L1 K76T mutation in Stomach Adenocarcinoma?,ssm_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the rate of occurrence of the MYO3B F594L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the rate of occurrence of the MYO3B F603L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the rate of occurrence of the TENT5A S320F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the rate of occurrence of the TENT5A S339F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the rate of occurrence of the TENT5A S401F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the rate of occurrence of the ZFAT S614L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the rate of occurrence of the ZFAT S664L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the rate of occurrence of the ZFAT S676L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+357,ZNF584,A211T,Sarcoma,What is the rate of occurrence of the ZNF584 A211T mutation in Sarcoma?,ssm_frequency
+358,ZNF584,A256T,Sarcoma,What is the rate of occurrence of the ZNF584 A256T mutation in Sarcoma?,ssm_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the LDOC1 R63W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the PDGFC R201G mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the MSANTD4 R304C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the rate of occurrence of the NPSR1 S123L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the PHLPP1 K1317E mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the rate of occurrence of the COL6A3 G237S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the rate of occurrence of the COL6A3 G437S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the rate of occurrence of the COL6A3 G638S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the rate of occurrence of the COL6A3 G644S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the rate of occurrence of the COL6A3 G844S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the rate of occurrence of the ADRA1A R348G mutation in Stomach Adenocarcinoma?,ssm_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of occurrence of the LAMB2 S1254F mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the rate of occurrence of the POC1B I198T mutation in Rectum Adenocarcinoma?,ssm_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the rate of occurrence of the POC1B I286T mutation in Rectum Adenocarcinoma?,ssm_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the rate of occurrence of the POC1B I328T mutation in Rectum Adenocarcinoma?,ssm_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the rate of occurrence of the POC1B S79P mutation in Rectum Adenocarcinoma?,ssm_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the rate of occurrence of the USH2A G1451C mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the rate of occurrence of the AQP7 T110S mutation in Rectum Adenocarcinoma?,ssm_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the rate of occurrence of the AQP7 T166S mutation in Rectum Adenocarcinoma?,ssm_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the rate of occurrence of the AQP7 T167S mutation in Rectum Adenocarcinoma?,ssm_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the rate of occurrence of the AQP7 T75S mutation in Rectum Adenocarcinoma?,ssm_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,What is the rate of occurrence of the DCN R163C mutation in Rectum Adenocarcinoma?,ssm_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,What is the rate of occurrence of the DCN R203C mutation in Rectum Adenocarcinoma?,ssm_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,What is the rate of occurrence of the DCN R241C mutation in Rectum Adenocarcinoma?,ssm_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,What is the rate of occurrence of the DCN R350C mutation in Rectum Adenocarcinoma?,ssm_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,What is the rate of occurrence of the DCN R41C mutation in Rectum Adenocarcinoma?,ssm_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the CPS1 K1269N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the CPS1 K1275N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the CPS1 K818N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the rate of occurrence of the FCGR2C P122S mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the rate of occurrence of the FCGR2C P123S mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the GRM1 R280M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the rate of occurrence of the SGCZ Q138H mutation in Lung Adenocarcinoma?,ssm_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the rate of occurrence of the SGCZ Q91H mutation in Lung Adenocarcinoma?,ssm_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,What is the rate of occurrence of the SMO V15M mutation in Stomach Adenocarcinoma?,ssm_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,What is the rate of occurrence of the SMO V321M mutation in Stomach Adenocarcinoma?,ssm_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the rate of occurrence of the CHODL G159E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the rate of occurrence of the CHODL G181E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the rate of occurrence of the CHODL G200E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,What is the rate of occurrence of the MYO16 P399H mutation in Colon Adenocarcinoma?,ssm_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,What is the rate of occurrence of the MYO16 P421H mutation in Colon Adenocarcinoma?,ssm_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the rate of occurrence of the CXCR2 A98V mutation in Stomach Adenocarcinoma?,ssm_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the rate of occurrence of the TMEM225 L212V mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the MAOB N251T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the GPRASP1 F580S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the MRPL32 R181Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the TYROBP A29T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the rate of occurrence of the RAB40C A111V mutation in Lung Adenocarcinoma?,ssm_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the rate of occurrence of the RAB40C A143V mutation in Lung Adenocarcinoma?,ssm_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the rate of occurrence of the CTNNA2 S323R mutation in Lung Adenocarcinoma?,ssm_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the rate of occurrence of the CTNNA2 S339R mutation in Lung Adenocarcinoma?,ssm_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the rate of occurrence of the CTNNA2 S386R mutation in Lung Adenocarcinoma?,ssm_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the rate of occurrence of the CTNNA2 S707R mutation in Lung Adenocarcinoma?,ssm_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the rate of occurrence of the MYO15A S268R mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the rate of occurrence of the GIMAP2 A167T mutation in Skin Cutaneous Melanoma?,ssm_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the rate of occurrence of the KIF20B N1160D mutation in Glioblastoma Multiforme?,ssm_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the rate of occurrence of the KIF20B N1200D mutation in Glioblastoma Multiforme?,ssm_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the ADAM17 E583K mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the BCAT1 G16R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the BCAT1 G17R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the BCAT1 G29R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the rate of occurrence of the ERCC6 R1053H mutation in Colon Adenocarcinoma?,ssm_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,What is the rate of occurrence of the DCC R320W mutation in Breast Invasive Carcinoma?,ssm_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,What is the rate of occurrence of the DCC R363W mutation in Breast Invasive Carcinoma?,ssm_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,What is the rate of occurrence of the DCC R386W mutation in Breast Invasive Carcinoma?,ssm_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,What is the rate of occurrence of the DCC R41W mutation in Breast Invasive Carcinoma?,ssm_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the rate of occurrence of the FBXO15 D417N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the rate of occurrence of the FBXO15 D86N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the GSTCD S528F mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the GSTCD S615F mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the OLFML3 P296S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the OLFML3 P337S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the OLFML3 P357S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the rate of occurrence of the CFAP61 E173V mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the rate of occurrence of the CFAP61 E817V mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the rate of occurrence of the HLA-DQA2 E51K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the rate of occurrence of the TENM2 H240Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the rate of occurrence of the TENM2 H351Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the rate of occurrence of the TENM2 H472Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the rate of occurrence of the ANKRD24 A465T mutation in Stomach Adenocarcinoma?,ssm_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the rate of occurrence of the ANKRD24 A494T mutation in Stomach Adenocarcinoma?,ssm_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the rate of occurrence of the ANKRD24 A584T mutation in Stomach Adenocarcinoma?,ssm_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the rate of occurrence of the ZCCHC14 V549M mutation in Stomach Adenocarcinoma?,ssm_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the rate of occurrence of the ZCCHC14 V665M mutation in Stomach Adenocarcinoma?,ssm_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the rate of occurrence of the ZCCHC14 V676M mutation in Stomach Adenocarcinoma?,ssm_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the rate of occurrence of the ZCCHC14 V802M mutation in Stomach Adenocarcinoma?,ssm_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,What is the rate of occurrence of the SIK2 I265M mutation in Lung Adenocarcinoma?,ssm_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the MYH11 T1336M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the MYH11 T1343M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the rate of occurrence of the SLC6A4 S174F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the SLC9C1 K102N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the SLC9C1 K29N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the rate of occurrence of the OR2A12 A254T mutation in Brain Lower Grade Glioma?,ssm_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the rate of occurrence of the PYHIN1 T325K mutation in Lung Adenocarcinoma?,ssm_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the rate of occurrence of the PYHIN1 T334K mutation in Lung Adenocarcinoma?,ssm_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the rate of occurrence of the JAML G191E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the rate of occurrence of the JAML G219E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the rate of occurrence of the JAML G220E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the rate of occurrence of the JAML G230E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the rate of occurrence of the TYK2 H1146R mutation in Stomach Adenocarcinoma?,ssm_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the rate of occurrence of the TYK2 H23R mutation in Stomach Adenocarcinoma?,ssm_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the rate of occurrence of the TYK2 H961R mutation in Stomach Adenocarcinoma?,ssm_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the CTCFL R208C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the CTCFL R265C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the CTCFL R420C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the CTCFL R470C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the CEP20 R31Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the CEP20 R58Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the rate of occurrence of the RIMS2 R25W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the rate of occurrence of the RIMS2 R393W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the rate of occurrence of the RIMS2 R423W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the rate of occurrence of the RIMS2 R470W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the rate of occurrence of the RIMS2 R615W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the rate of occurrence of the RIMS2 R619W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the rate of occurrence of the RIMS2 R716W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the rate of occurrence of the PIK3C2G S551L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the rate of occurrence of the PIK3C2G S592L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+728,STK19,D341N,Colon Adenocarcinoma,What is the rate of occurrence of the STK19 D341N mutation in Colon Adenocarcinoma?,ssm_frequency
+729,STK19,D345N,Colon Adenocarcinoma,What is the rate of occurrence of the STK19 D345N mutation in Colon Adenocarcinoma?,ssm_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the rate of occurrence of the REXO4 P60A mutation in Skin Cutaneous Melanoma?,ssm_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the ZBTB34 P160S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the ZBTB34 P164S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the rate of occurrence of the NCKAP5 E148K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of occurrence of the SORCS1 D1052Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of occurrence of the SORCS1 D587Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of occurrence of the SORCS1 D67Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of occurrence of the SORCS1 D810Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the rate of occurrence of the FGF8 T154M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the rate of occurrence of the FGF8 T165M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the rate of occurrence of the FGF8 T183M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the rate of occurrence of the FGF8 T194M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the rate of occurrence of the FGF8 T90M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the rate of occurrence of the TENM3 R1877W mutation in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,ssm_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the AKT1 D44N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of occurrence of the CFAP298-TCP10L E11Q mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the rate of occurrence of the GLRB E148D mutation in Stomach Adenocarcinoma?,ssm_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,What is the rate of occurrence of the TTN F7636L mutation in Colon Adenocarcinoma?,ssm_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,What is the rate of occurrence of the TTN F8563L mutation in Colon Adenocarcinoma?,ssm_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,What is the rate of occurrence of the TTN F8880L mutation in Colon Adenocarcinoma?,ssm_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the rate of occurrence of the ANKRD30A V798I mutation in Colon Adenocarcinoma?,ssm_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the rate of occurrence of the ANKRD30A V854I mutation in Colon Adenocarcinoma?,ssm_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the rate of occurrence of the ANKRD30A V973I mutation in Colon Adenocarcinoma?,ssm_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the rate of occurrence of the TRIM45 S177L mutation in Colon Adenocarcinoma?,ssm_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the rate of occurrence of the TRIM45 S224L mutation in Colon Adenocarcinoma?,ssm_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the rate of occurrence of the TRIM45 S281L mutation in Colon Adenocarcinoma?,ssm_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the rate of occurrence of the CACNA1F G727V mutation in Stomach Adenocarcinoma?,ssm_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the rate of occurrence of the CACNA1F G781V mutation in Stomach Adenocarcinoma?,ssm_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the rate of occurrence of the CACNA1F G792V mutation in Stomach Adenocarcinoma?,ssm_frequency
+817,KL,R594C,Colon Adenocarcinoma,What is the rate of occurrence of the KL R594C mutation in Colon Adenocarcinoma?,ssm_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the rate of occurrence of the GUF1 I243T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the rate of occurrence of the TAF1L A539V mutation in Colon Adenocarcinoma?,ssm_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the rate of occurrence of the TASOR2 S256F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the rate of occurrence of the TASOR2 S36F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the rate of occurrence of the TASOR2 S471F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the rate of occurrence of the KDM5C R1151C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the rate of occurrence of the KDM5C R1177C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the rate of occurrence of the KDM5C R1217C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the rate of occurrence of the KDM5C R1218C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of occurrence of the IL5RA L153F mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the rate of occurrence of the DHX16 A29V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the rate of occurrence of the DHX16 A89V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the rate of occurrence of the GPR158 A644V mutation in Stomach Adenocarcinoma?,ssm_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the rate of occurrence of the GPR158 A723V mutation in Stomach Adenocarcinoma?,ssm_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of occurrence of the EIF2B4 E108K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of occurrence of the EIF2B4 E110K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of occurrence of the EIF2B4 E111K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of occurrence of the EIF2B4 E131K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of occurrence of the EIF2B4 E132K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of occurrence of the EIF2B4 E96K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the AUTS2 P136S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the AUTS2 P218S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the AUTS2 P233S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the AUTS2 P313S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the AUTS2 P419S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the AUTS2 P443S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the AUTS2 P56S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the AUTS2 P667S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the AUTS2 P690S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the AUTS2 P691S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of occurrence of the ACTL7B D223N mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the rate of occurrence of the PCDHGA1 R535W mutation in Glioblastoma Multiforme?,ssm_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the rate of occurrence of the TRAP1 R114W mutation in Stomach Adenocarcinoma?,ssm_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the rate of occurrence of the TRAP1 R61W mutation in Stomach Adenocarcinoma?,ssm_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the PIK3C2A R1570Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the rate of occurrence of the KANSL1 R139G mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the rate of occurrence of the ANKRD52 Y594C mutation in Stomach Adenocarcinoma?,ssm_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the PAPPA G1580S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the rate of occurrence of the B3GALNT1 V270A mutation in Rectum Adenocarcinoma?,ssm_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the rate of occurrence of the GABRA6 G115R mutation in Lung Adenocarcinoma?,ssm_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the rate of occurrence of the GABRA6 G122R mutation in Lung Adenocarcinoma?,ssm_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the rate of occurrence of the GABRA6 G165R mutation in Lung Adenocarcinoma?,ssm_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the rate of occurrence of the GABRA6 G175R mutation in Lung Adenocarcinoma?,ssm_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the rate of occurrence of the GABRA6 G70R mutation in Lung Adenocarcinoma?,ssm_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the rate of occurrence of the ZSCAN31 D9N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of occurrence of the MED16 L126P mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of occurrence of the MED16 L868P mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the rate of occurrence of the PTPRO E1060K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the rate of occurrence of the PTPRO E1088K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the rate of occurrence of the PTPRO E249K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the rate of occurrence of the PTPRO E265K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the rate of occurrence of the PTPRO E277K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the rate of occurrence of the PTPRO E67K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the rate of occurrence of the PTPRO E923K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the rate of occurrence of the PTPRO E940K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the CHMP7 D397N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the rate of occurrence of the GPC3 I107N mutation in Stomach Adenocarcinoma?,ssm_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the rate of occurrence of the GPC3 I161N mutation in Stomach Adenocarcinoma?,ssm_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of occurrence of the TLK2 V430L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of occurrence of the TLK2 V515L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of occurrence of the TLK2 V547L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of occurrence of the TLK2 V579L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of occurrence of the TLK2 V601L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the rate of occurrence of the ZNF217 E209Q mutation in Lung Adenocarcinoma?,ssm_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the rate of occurrence of the SYT9 V275L mutation in Lung Adenocarcinoma?,ssm_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the rate of occurrence of the SYT9 V307L mutation in Lung Adenocarcinoma?,ssm_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the PKHD1L1 S2830N mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the MYO3A Y1295C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of occurrence of the VASN V318I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the DNMT1 A1037T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the DNMT1 A1053T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the DNMT1 A934T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,What is the rate of occurrence of the CA9 E402K mutation in Colon Adenocarcinoma?,ssm_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the TTC17 R808Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the TTC17 R865Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the rate of occurrence of the PSG2 P43L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the rate of occurrence of the RIPOR2 R470L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the rate of occurrence of the RIPOR2 R499L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the rate of occurrence of the RIPOR2 R504L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the rate of occurrence of the RIPOR2 R520L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the DCLK3 V520I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the DCLK3 V689I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the MERTK G257A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the MERTK G757A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the MERTK G933A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the rate of occurrence of the ZFP42 R206K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the rate of occurrence of the OR13C3 M117I mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the rate of occurrence of the OR13C3 M147I mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the rate of occurrence of the SPAG1 I917M mutation in Stomach Adenocarcinoma?,ssm_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the CDKN2AIP Y92H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the rate of occurrence of the PXN H1016Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the rate of occurrence of the PXN H359Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the rate of occurrence of the PXN H492Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the rate of occurrence of the PXN H524Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the rate of occurrence of the PXN H526Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the rate of occurrence of the PXN H540Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the TTYH2 S23L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the TTYH2 S44L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the rate of occurrence of the TMEM255A N205S mutation in Colon Adenocarcinoma?,ssm_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the rate of occurrence of the TMEM255A N229S mutation in Colon Adenocarcinoma?,ssm_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the rate of occurrence of the TMEM255A N65S mutation in Colon Adenocarcinoma?,ssm_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the rate of occurrence of the TASOR2 H2271D mutation in Breast Invasive Carcinoma?,ssm_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the rate of occurrence of the TASOR2 H2486D mutation in Breast Invasive Carcinoma?,ssm_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the ICE1 T1839M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the rate of occurrence of the MYT1 A558E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the rate of occurrence of the MYT1 A879E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the rate of occurrence of the MYT1 A906E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the CX3CR1 P203L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the CX3CR1 P235L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the rate of occurrence of the SPINDOC R197C mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the ART3 C251Y mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the ART3 C3Y mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the rate of occurrence of the CYP1A2 R243G mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of occurrence of the ADRA1A G279S mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the CDH23 P2523R mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the CDH23 P283R mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the rate of occurrence of the KRT39 P137S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the PDHA2 S7F mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the rate of occurrence of the SLC24A2 H200Q mutation in Colon Adenocarcinoma?,ssm_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the rate of occurrence of the PTPRN2 F153L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the rate of occurrence of the PTPRN2 F847L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the rate of occurrence of the PTPRN2 F856L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the rate of occurrence of the PTPRN2 F868L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the rate of occurrence of the PTPRN2 F885L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the rate of occurrence of the SOX21 R55L mutation in Lung Adenocarcinoma?,ssm_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the rate of occurrence of the CPA6 G166E mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the rate of occurrence of the GRM5 E14K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of occurrence of the CASZ1 R233Q mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the rate of occurrence of the SGIP1 N122T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the rate of occurrence of the SGIP1 N420T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the rate of occurrence of the SGIP1 N617T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the rate of occurrence of the SGIP1 N648T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the rate of occurrence of the CARMIL1 V549L mutation in Lung Adenocarcinoma?,ssm_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the rate of occurrence of the CARMIL1 V949L mutation in Lung Adenocarcinoma?,ssm_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the rate of occurrence of the ZNF431 D121Y mutation in Lung Adenocarcinoma?,ssm_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the rate of occurrence of the ZNF431 D161Y mutation in Lung Adenocarcinoma?,ssm_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the rate of occurrence of the ZNF431 R128I mutation in Lung Adenocarcinoma?,ssm_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the rate of occurrence of the DNAH11 P2987S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the rate of occurrence of the DNAH11 P2994S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the POLD1 Q461L mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the rate of occurrence of the POLD1 Q85L mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the rate of occurrence of the TTC12 D646H mutation in Lung Adenocarcinoma?,ssm_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the rate of occurrence of the TTC12 D652H mutation in Lung Adenocarcinoma?,ssm_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the rate of occurrence of the CNGB1 D967N mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the rate of occurrence of the CNGB1 D973N mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the rate of occurrence of the CTSC E214V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the rate of occurrence of the CTSC E291V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the rate of occurrence of the CTSC E322V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the rate of occurrence of the CTSC E324V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the rate of occurrence of the CTSC E335V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the PRSS8 A179T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the PRSS8 A233T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the rate of occurrence of the ARHGEF40 V864F mutation in Lung Adenocarcinoma?,ssm_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the rate of occurrence of the ACTB A138T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the rate of occurrence of the ACTB A217T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the rate of occurrence of the ACTB A244T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the rate of occurrence of the ACTB A260T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the rate of occurrence of the YY1AP1 V546D mutation in Glioblastoma Multiforme?,ssm_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the rate of occurrence of the YY1AP1 V557D mutation in Glioblastoma Multiforme?,ssm_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the rate of occurrence of the YY1AP1 V566D mutation in Glioblastoma Multiforme?,ssm_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the rate of occurrence of the YY1AP1 V577D mutation in Glioblastoma Multiforme?,ssm_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the rate of occurrence of the YY1AP1 V623D mutation in Glioblastoma Multiforme?,ssm_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the rate of occurrence of the YY1AP1 V695D mutation in Glioblastoma Multiforme?,ssm_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the rate of occurrence of the YY1AP1 V715D mutation in Glioblastoma Multiforme?,ssm_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the rate of occurrence of the FNDC7 D323N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the rate of occurrence of the FNDC7 D99N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the rate of occurrence of the TLCD5 G15V mutation in Lung Adenocarcinoma?,ssm_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the rate of occurrence of the TLCD5 G37V mutation in Lung Adenocarcinoma?,ssm_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the POLR1G R498W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the POLR1G R500W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the rate of occurrence of the DNAH14 N1186K mutation in Colon Adenocarcinoma?,ssm_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the rate of occurrence of the DNAH14 N2657K mutation in Colon Adenocarcinoma?,ssm_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the rate of occurrence of the DNAH14 N3460K mutation in Colon Adenocarcinoma?,ssm_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the NEXN E73D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the rate of occurrence of the CYB5R2 G112R mutation in Prostate Adenocarcinoma?,ssm_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the rate of occurrence of the CYB5R2 G172R mutation in Prostate Adenocarcinoma?,ssm_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the NRAP S808L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the NRAP S816L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the NRAP S843L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the CCDC22 E179D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the rate of occurrence of the DCAF6 S402F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the rate of occurrence of the DCAF6 S433F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the ZNF708 E389D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the BFAR T103M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the MAST4 P1237S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the MAST4 P1986S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the MAST4 P1991S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the MAST4 P2001S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the MAST4 P2180S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the rate of occurrence of the ARMC3 R169C mutation in Stomach Adenocarcinoma?,ssm_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the rate of occurrence of the ARMC3 R432C mutation in Stomach Adenocarcinoma?,ssm_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the rate of occurrence of the TET2 L757V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the rate of occurrence of the TET2 L778V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the rate of occurrence of the SERPINB10 A353P mutation in Lung Adenocarcinoma?,ssm_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the STAT3 Y22H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the MIEF1 A42T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the rate of occurrence of the ACVR1B D397N mutation in Colon Adenocarcinoma?,ssm_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the rate of occurrence of the ACVR1B D449N mutation in Colon Adenocarcinoma?,ssm_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the rate of occurrence of the ACVR1B D490N mutation in Colon Adenocarcinoma?,ssm_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the rate of occurrence of the EBF2 T104I mutation in Stomach Adenocarcinoma?,ssm_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the rate of occurrence of the EBF2 T252I mutation in Stomach Adenocarcinoma?,ssm_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the rate of occurrence of the VPS26B F266L mutation in Stomach Adenocarcinoma?,ssm_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of occurrence of the PGR M106I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of occurrence of the PGR M38I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of occurrence of the PGR M632I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the rate of occurrence of the ACTA2 P334L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the THBS4 T852I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the THBS4 T943I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the rate of occurrence of the PRSS1 S114T mutation in Lung Adenocarcinoma?,ssm_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the rate of occurrence of the PRSS1 S124T mutation in Lung Adenocarcinoma?,ssm_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the rate of occurrence of the PRSS1 S138T mutation in Lung Adenocarcinoma?,ssm_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the rate of occurrence of the PRSS1 S74T mutation in Lung Adenocarcinoma?,ssm_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the rate of occurrence of the PGF R126H mutation in Stomach Adenocarcinoma?,ssm_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the rate of occurrence of the PGF R127H mutation in Stomach Adenocarcinoma?,ssm_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the rate of occurrence of the ITPRID2 S351C mutation in Breast Invasive Carcinoma?,ssm_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the rate of occurrence of the ITPRID2 S842C mutation in Breast Invasive Carcinoma?,ssm_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the HBB E8D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the rate of occurrence of the PCDHB2 R158C mutation in Colon Adenocarcinoma?,ssm_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the rate of occurrence of the PCDHB2 T15M mutation in Colon Adenocarcinoma?,ssm_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the rate of occurrence of the PCDHB2 T26M mutation in Colon Adenocarcinoma?,ssm_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the rate of occurrence of the UBR2 P1594S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the rate of occurrence of the FBXO42 A618D mutation in Rectum Adenocarcinoma?,ssm_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,How frequently is the TNS1 G1362V mutation detected in Breast Invasive Carcinoma?,ssm_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,How frequently is the TNS1 G1711V mutation detected in Breast Invasive Carcinoma?,ssm_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,How frequently is the TNS1 G1718V mutation detected in Breast Invasive Carcinoma?,ssm_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,How frequently is the TNS1 G1732V mutation detected in Breast Invasive Carcinoma?,ssm_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,How frequently is the TNS1 G1824V mutation detected in Breast Invasive Carcinoma?,ssm_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,How frequently is the TNS1 G1857V mutation detected in Breast Invasive Carcinoma?,ssm_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,How frequently is the TNS1 G843V mutation detected in Breast Invasive Carcinoma?,ssm_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How frequently is the EVC2 E1067K mutation detected in Bladder Urothelial Carcinoma?,ssm_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How frequently is the EVC2 E987K mutation detected in Bladder Urothelial Carcinoma?,ssm_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How frequently is the CR1 V1108G mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How frequently is the CR1 V1558G mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,How frequently is the TRPA1 S295I mutation detected in Rectum Adenocarcinoma?,ssm_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,How frequently is the TRPA1 S443I mutation detected in Rectum Adenocarcinoma?,ssm_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,How frequently is the TAF1C R299L mutation detected in Lung Adenocarcinoma?,ssm_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,How frequently is the TAF1C R396L mutation detected in Lung Adenocarcinoma?,ssm_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,How frequently is the TAF1C R634L mutation detected in Lung Adenocarcinoma?,ssm_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,How frequently is the TAF1C R702L mutation detected in Lung Adenocarcinoma?,ssm_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,How frequently is the TAF1C R728L mutation detected in Lung Adenocarcinoma?,ssm_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How frequently is the DPF3 R104W mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How frequently is the DPF3 R149W mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How frequently is the DPF3 R94W mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,How frequently is the OR2T4 P272H mutation detected in Lung Adenocarcinoma?,ssm_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,How frequently is the OR2T4 P300H mutation detected in Lung Adenocarcinoma?,ssm_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How frequently is the FBN1 E2667K mutation detected in Pancreatic Adenocarcinoma?,ssm_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How frequently is the MAD1L1 E396K mutation detected in Prostate Adenocarcinoma?,ssm_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How frequently is the MAD1L1 E488K mutation detected in Prostate Adenocarcinoma?,ssm_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How frequently is the MAD1L1 E78K mutation detected in Prostate Adenocarcinoma?,ssm_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How frequently is the CCNG1 E22K mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How frequently is the ANP32E N114T mutation detected in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How frequently is the ANP32E N64T mutation detected in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How frequently is the ANP32E N66T mutation detected in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How frequently is the ANP32E N73T mutation detected in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How frequently is the FRY S1888A mutation detected in Bladder Urothelial Carcinoma?,ssm_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How frequently is the FRY S1937A mutation detected in Bladder Urothelial Carcinoma?,ssm_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How frequently is the FRY S1938A mutation detected in Bladder Urothelial Carcinoma?,ssm_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How frequently is the FRY S1983A mutation detected in Bladder Urothelial Carcinoma?,ssm_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,How frequently is the PAK3 E318K mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,How frequently is the PAK3 E319K mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,How frequently is the PAK3 E334K mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,How frequently is the PAK3 E340K mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,How frequently is the PAK3 E355K mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How frequently is the MUC16 P7963L mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How frequently is the ZFPM2 T498I mutation detected in Liver Hepatocellular Carcinoma?,ssm_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How frequently is the ZFPM2 T630I mutation detected in Liver Hepatocellular Carcinoma?,ssm_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How frequently is the PIK3C2B S1328C mutation detected in Breast Invasive Carcinoma?,ssm_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How frequently is the PIK3C2B S1356C mutation detected in Breast Invasive Carcinoma?,ssm_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How frequently is the ZNF804A S371Y mutation detected in Colon Adenocarcinoma?,ssm_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,How frequently is the RELN A2371V mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is the EFCAB12 R173C mutation detected in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is the EFCAB12 R23C mutation detected in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How frequently is the DEFB115 E53K mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How frequently is the ANKDD1A S290F mutation detected in Bladder Urothelial Carcinoma?,ssm_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How frequently is the ANKDD1A S322F mutation detected in Bladder Urothelial Carcinoma?,ssm_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How frequently is the ANKDD1A S413F mutation detected in Bladder Urothelial Carcinoma?,ssm_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How frequently is the HTR3B S146I mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How frequently is the HTR3B S206I mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How frequently is the HTR3B S217I mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,How frequently is the ABCC3 R758W mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How frequently is the NOMO1 T204I mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How frequently is the NOMO1 T371I mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How frequently is the HYOU1 D298H mutation detected in Bladder Urothelial Carcinoma?,ssm_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How frequently is the FMO4 R500Q mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+140,BICC1,A372V,Exceptional Responders,How frequently is the BICC1 A372V mutation detected in Exceptional Responders?,ssm_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How frequently is the ZMYM3 I920V mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How frequently is the ZMYM3 I932V mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How frequently is the ZMYM3 I934V mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is the XKR4 R547W mutation detected in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How frequently is the ABCC2 V239L mutation detected in Liver Hepatocellular Carcinoma?,ssm_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,How frequently is the OR8K5 R293G mutation detected in Lung Adenocarcinoma?,ssm_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How frequently is the SPTAN1 S1503F mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How frequently is the SPTAN1 S1523F mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,How frequently is the SYT10 M484I mutation detected in Rectum Adenocarcinoma?,ssm_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How frequently is the HSPA5 N457K mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,How frequently is the UNC5D L280V mutation detected in Lung Adenocarcinoma?,ssm_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,How frequently is the UNC5D L635V mutation detected in Lung Adenocarcinoma?,ssm_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,How frequently is the UNC5D L637V mutation detected in Lung Adenocarcinoma?,ssm_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,How frequently is the UNC5D L699V mutation detected in Lung Adenocarcinoma?,ssm_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,How frequently is the UNC5D L704V mutation detected in Lung Adenocarcinoma?,ssm_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,How frequently is the UNC5D L709V mutation detected in Lung Adenocarcinoma?,ssm_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How frequently is the DOCK2 L1527H mutation detected in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How frequently is the ZNF627 A5V mutation detected in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How frequently is the CDC42BPA L823F mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,How frequently is the MRPL55 H27Y mutation detected in Colon Adenocarcinoma?,ssm_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,How frequently is the MRPL55 H63Y mutation detected in Colon Adenocarcinoma?,ssm_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How frequently is the TMTC3 Q749K mutation detected in Breast Invasive Carcinoma?,ssm_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,How frequently is the EPRS1 K771I mutation detected in Colon Adenocarcinoma?,ssm_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,How frequently is the EPRS1 K778I mutation detected in Colon Adenocarcinoma?,ssm_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How frequently is the GRTP1 A110V mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How frequently is the GRTP1 A32V mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How frequently is the TSHZ3 Q538K mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How frequently is the TAS1R3 Q326H mutation detected in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,ssm_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How frequently is the PIAS3 S238C mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How frequently is the PIAS3 S273C mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,How frequently is the ZNF274 P13R mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,How frequently is the SYNJ1 R795C mutation detected in Colon Adenocarcinoma?,ssm_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,How frequently is the SYNJ1 R800C mutation detected in Colon Adenocarcinoma?,ssm_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,How frequently is the SYNJ1 R839C mutation detected in Colon Adenocarcinoma?,ssm_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,How frequently is the DSCAM V343M mutation detected in Prostate Adenocarcinoma?,ssm_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,How frequently is the DSCAM V426M mutation detected in Prostate Adenocarcinoma?,ssm_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,How frequently is the DSCAM V591M mutation detected in Prostate Adenocarcinoma?,ssm_frequency
+267,DGKD,R140H,Exceptional Responders,How frequently is the DGKD R140H mutation detected in Exceptional Responders?,ssm_frequency
+268,DGKD,R160H,Exceptional Responders,How frequently is the DGKD R160H mutation detected in Exceptional Responders?,ssm_frequency
+269,DGKD,R204H,Exceptional Responders,How frequently is the DGKD R204H mutation detected in Exceptional Responders?,ssm_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How frequently is the PLEKHG6 D105Y mutation detected in Bladder Urothelial Carcinoma?,ssm_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How frequently is the PLEKHG6 D543Y mutation detected in Bladder Urothelial Carcinoma?,ssm_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How frequently is the PLEKHG6 D575Y mutation detected in Bladder Urothelial Carcinoma?,ssm_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,How frequently is the WNT2 D138N mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How frequently is the GUCY2C G667R mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How frequently is the C7orf31 P244H mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is the ZKSCAN7 E64K mutation detected in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+299,OR5D14,M210L,Neuroblastoma,How frequently is the OR5D14 M210L mutation detected in Neuroblastoma?,ssm_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How frequently is the SPATA22 K279E mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How frequently is the SPATA22 K306E mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How frequently is the SPATA22 K322E mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,How frequently is the LCN15 E21V mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How frequently is the DCAF4L2 S129F mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How frequently is the GUK1 R135P mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How frequently is the GUK1 R137P mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How frequently is the GUK1 R139P mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How frequently is the GUK1 R158P mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How frequently is the GUK1 R203P mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How frequently is the MORF4L1 K29T mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How frequently is the MORF4L1 K51T mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How frequently is the MORF4L1 K61T mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How frequently is the MORF4L1 K76T mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How frequently is the MYO3B F594L mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How frequently is the MYO3B F603L mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How frequently is the TENT5A S320F mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How frequently is the TENT5A S339F mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How frequently is the TENT5A S401F mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How frequently is the ZFAT S614L mutation detected in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How frequently is the ZFAT S664L mutation detected in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How frequently is the ZFAT S676L mutation detected in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+357,ZNF584,A211T,Sarcoma,How frequently is the ZNF584 A211T mutation detected in Sarcoma?,ssm_frequency
+358,ZNF584,A256T,Sarcoma,How frequently is the ZNF584 A256T mutation detected in Sarcoma?,ssm_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How frequently is the LDOC1 R63W mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How frequently is the PDGFC R201G mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How frequently is the MSANTD4 R304C mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How frequently is the NPSR1 S123L mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How frequently is the PHLPP1 K1317E mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How frequently is the COL6A3 G237S mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How frequently is the COL6A3 G437S mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How frequently is the COL6A3 G638S mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How frequently is the COL6A3 G644S mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How frequently is the COL6A3 G844S mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How frequently is the ADRA1A R348G mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently is the LAMB2 S1254F mutation detected in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,How frequently is the POC1B I198T mutation detected in Rectum Adenocarcinoma?,ssm_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,How frequently is the POC1B I286T mutation detected in Rectum Adenocarcinoma?,ssm_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,How frequently is the POC1B I328T mutation detected in Rectum Adenocarcinoma?,ssm_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,How frequently is the POC1B S79P mutation detected in Rectum Adenocarcinoma?,ssm_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How frequently is the USH2A G1451C mutation detected in Liver Hepatocellular Carcinoma?,ssm_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,How frequently is the AQP7 T110S mutation detected in Rectum Adenocarcinoma?,ssm_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,How frequently is the AQP7 T166S mutation detected in Rectum Adenocarcinoma?,ssm_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,How frequently is the AQP7 T167S mutation detected in Rectum Adenocarcinoma?,ssm_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,How frequently is the AQP7 T75S mutation detected in Rectum Adenocarcinoma?,ssm_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,How frequently is the DCN R163C mutation detected in Rectum Adenocarcinoma?,ssm_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,How frequently is the DCN R203C mutation detected in Rectum Adenocarcinoma?,ssm_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,How frequently is the DCN R241C mutation detected in Rectum Adenocarcinoma?,ssm_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,How frequently is the DCN R350C mutation detected in Rectum Adenocarcinoma?,ssm_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,How frequently is the DCN R41C mutation detected in Rectum Adenocarcinoma?,ssm_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How frequently is the CPS1 K1269N mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How frequently is the CPS1 K1275N mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How frequently is the CPS1 K818N mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How frequently is the FCGR2C P122S mutation detected in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How frequently is the FCGR2C P123S mutation detected in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How frequently is the GRM1 R280M mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,How frequently is the SGCZ Q138H mutation detected in Lung Adenocarcinoma?,ssm_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,How frequently is the SGCZ Q91H mutation detected in Lung Adenocarcinoma?,ssm_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,How frequently is the SMO V15M mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,How frequently is the SMO V321M mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,How frequently is the CHODL G159E mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,How frequently is the CHODL G181E mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,How frequently is the CHODL G200E mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,How frequently is the MYO16 P399H mutation detected in Colon Adenocarcinoma?,ssm_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,How frequently is the MYO16 P421H mutation detected in Colon Adenocarcinoma?,ssm_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,How frequently is the CXCR2 A98V mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How frequently is the TMEM225 L212V mutation detected in Bladder Urothelial Carcinoma?,ssm_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How frequently is the MAOB N251T mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How frequently is the GPRASP1 F580S mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How frequently is the MRPL32 R181Q mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How frequently is the TYROBP A29T mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,How frequently is the RAB40C A111V mutation detected in Lung Adenocarcinoma?,ssm_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,How frequently is the RAB40C A143V mutation detected in Lung Adenocarcinoma?,ssm_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,How frequently is the CTNNA2 S323R mutation detected in Lung Adenocarcinoma?,ssm_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,How frequently is the CTNNA2 S339R mutation detected in Lung Adenocarcinoma?,ssm_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,How frequently is the CTNNA2 S386R mutation detected in Lung Adenocarcinoma?,ssm_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,How frequently is the CTNNA2 S707R mutation detected in Lung Adenocarcinoma?,ssm_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How frequently is the MYO15A S268R mutation detected in Bladder Urothelial Carcinoma?,ssm_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How frequently is the GIMAP2 A167T mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,How frequently is the KIF20B N1160D mutation detected in Glioblastoma Multiforme?,ssm_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,How frequently is the KIF20B N1200D mutation detected in Glioblastoma Multiforme?,ssm_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How frequently is the ADAM17 E583K mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How frequently is the BCAT1 G16R mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How frequently is the BCAT1 G17R mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How frequently is the BCAT1 G29R mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,How frequently is the ERCC6 R1053H mutation detected in Colon Adenocarcinoma?,ssm_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,How frequently is the DCC R320W mutation detected in Breast Invasive Carcinoma?,ssm_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,How frequently is the DCC R363W mutation detected in Breast Invasive Carcinoma?,ssm_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,How frequently is the DCC R386W mutation detected in Breast Invasive Carcinoma?,ssm_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,How frequently is the DCC R41W mutation detected in Breast Invasive Carcinoma?,ssm_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How frequently is the FBXO15 D417N mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How frequently is the FBXO15 D86N mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How frequently is the GSTCD S528F mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How frequently is the GSTCD S615F mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How frequently is the OLFML3 P296S mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How frequently is the OLFML3 P337S mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How frequently is the OLFML3 P357S mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How frequently is the CFAP61 E173V mutation detected in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How frequently is the CFAP61 E817V mutation detected in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How frequently is the HLA-DQA2 E51K mutation detected in Bladder Urothelial Carcinoma?,ssm_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How frequently is the TENM2 H240Y mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How frequently is the TENM2 H351Y mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How frequently is the TENM2 H472Y mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How frequently is the ANKRD24 A465T mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How frequently is the ANKRD24 A494T mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How frequently is the ANKRD24 A584T mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How frequently is the ZCCHC14 V549M mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How frequently is the ZCCHC14 V665M mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How frequently is the ZCCHC14 V676M mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How frequently is the ZCCHC14 V802M mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,How frequently is the SIK2 I265M mutation detected in Lung Adenocarcinoma?,ssm_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How frequently is the MYH11 T1336M mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How frequently is the MYH11 T1343M mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How frequently is the SLC6A4 S174F mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How frequently is the SLC9C1 K102N mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How frequently is the SLC9C1 K29N mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,How frequently is the OR2A12 A254T mutation detected in Brain Lower Grade Glioma?,ssm_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,How frequently is the PYHIN1 T325K mutation detected in Lung Adenocarcinoma?,ssm_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,How frequently is the PYHIN1 T334K mutation detected in Lung Adenocarcinoma?,ssm_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,How frequently is the JAML G191E mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,How frequently is the JAML G219E mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,How frequently is the JAML G220E mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,How frequently is the JAML G230E mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,How frequently is the TYK2 H1146R mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,How frequently is the TYK2 H23R mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,How frequently is the TYK2 H961R mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How frequently is the CTCFL R208C mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How frequently is the CTCFL R265C mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How frequently is the CTCFL R420C mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How frequently is the CTCFL R470C mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How frequently is the CEP20 R31Q mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How frequently is the CEP20 R58Q mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How frequently is the RIMS2 R25W mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How frequently is the RIMS2 R393W mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How frequently is the RIMS2 R423W mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How frequently is the RIMS2 R470W mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How frequently is the RIMS2 R615W mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How frequently is the RIMS2 R619W mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How frequently is the RIMS2 R716W mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How frequently is the PIK3C2G S551L mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How frequently is the PIK3C2G S592L mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+728,STK19,D341N,Colon Adenocarcinoma,How frequently is the STK19 D341N mutation detected in Colon Adenocarcinoma?,ssm_frequency
+729,STK19,D345N,Colon Adenocarcinoma,How frequently is the STK19 D345N mutation detected in Colon Adenocarcinoma?,ssm_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,How frequently is the REXO4 P60A mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How frequently is the ZBTB34 P160S mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How frequently is the ZBTB34 P164S mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How frequently is the NCKAP5 E148K mutation detected in Bladder Urothelial Carcinoma?,ssm_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is the SORCS1 D1052Y mutation detected in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is the SORCS1 D587Y mutation detected in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is the SORCS1 D67Y mutation detected in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is the SORCS1 D810Y mutation detected in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How frequently is the FGF8 T154M mutation detected in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How frequently is the FGF8 T165M mutation detected in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How frequently is the FGF8 T183M mutation detected in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How frequently is the FGF8 T194M mutation detected in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How frequently is the FGF8 T90M mutation detected in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How frequently is the TENM3 R1877W mutation detected in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,ssm_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How frequently is the AKT1 D44N mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently is the CFAP298-TCP10L E11Q mutation detected in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,How frequently is the GLRB E148D mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,How frequently is the TTN F7636L mutation detected in Colon Adenocarcinoma?,ssm_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,How frequently is the TTN F8563L mutation detected in Colon Adenocarcinoma?,ssm_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,How frequently is the TTN F8880L mutation detected in Colon Adenocarcinoma?,ssm_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How frequently is the ANKRD30A V798I mutation detected in Colon Adenocarcinoma?,ssm_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How frequently is the ANKRD30A V854I mutation detected in Colon Adenocarcinoma?,ssm_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How frequently is the ANKRD30A V973I mutation detected in Colon Adenocarcinoma?,ssm_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,How frequently is the TRIM45 S177L mutation detected in Colon Adenocarcinoma?,ssm_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,How frequently is the TRIM45 S224L mutation detected in Colon Adenocarcinoma?,ssm_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,How frequently is the TRIM45 S281L mutation detected in Colon Adenocarcinoma?,ssm_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How frequently is the CACNA1F G727V mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How frequently is the CACNA1F G781V mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How frequently is the CACNA1F G792V mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+817,KL,R594C,Colon Adenocarcinoma,How frequently is the KL R594C mutation detected in Colon Adenocarcinoma?,ssm_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How frequently is the GUF1 I243T mutation detected in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,How frequently is the TAF1L A539V mutation detected in Colon Adenocarcinoma?,ssm_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How frequently is the TASOR2 S256F mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How frequently is the TASOR2 S36F mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How frequently is the TASOR2 S471F mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How frequently is the KDM5C R1151C mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How frequently is the KDM5C R1177C mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How frequently is the KDM5C R1217C mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How frequently is the KDM5C R1218C mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently is the IL5RA L153F mutation detected in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,How frequently is the DHX16 A29V mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,How frequently is the DHX16 A89V mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,How frequently is the GPR158 A644V mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,How frequently is the GPR158 A723V mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is the EIF2B4 E108K mutation detected in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is the EIF2B4 E110K mutation detected in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is the EIF2B4 E111K mutation detected in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is the EIF2B4 E131K mutation detected in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is the EIF2B4 E132K mutation detected in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is the EIF2B4 E96K mutation detected in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How frequently is the AUTS2 P136S mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How frequently is the AUTS2 P218S mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How frequently is the AUTS2 P233S mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How frequently is the AUTS2 P313S mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How frequently is the AUTS2 P419S mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How frequently is the AUTS2 P443S mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How frequently is the AUTS2 P56S mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How frequently is the AUTS2 P667S mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How frequently is the AUTS2 P690S mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How frequently is the AUTS2 P691S mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is the ACTL7B D223N mutation detected in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How frequently is the PCDHGA1 R535W mutation detected in Glioblastoma Multiforme?,ssm_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,How frequently is the TRAP1 R114W mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,How frequently is the TRAP1 R61W mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How frequently is the PIK3C2A R1570Q mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How frequently is the KANSL1 R139G mutation detected in Liver Hepatocellular Carcinoma?,ssm_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How frequently is the ANKRD52 Y594C mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How frequently is the PAPPA G1580S mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How frequently is the B3GALNT1 V270A mutation detected in Rectum Adenocarcinoma?,ssm_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,How frequently is the GABRA6 G115R mutation detected in Lung Adenocarcinoma?,ssm_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,How frequently is the GABRA6 G122R mutation detected in Lung Adenocarcinoma?,ssm_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,How frequently is the GABRA6 G165R mutation detected in Lung Adenocarcinoma?,ssm_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,How frequently is the GABRA6 G175R mutation detected in Lung Adenocarcinoma?,ssm_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,How frequently is the GABRA6 G70R mutation detected in Lung Adenocarcinoma?,ssm_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How frequently is the ZSCAN31 D9N mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is the MED16 L126P mutation detected in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is the MED16 L868P mutation detected in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How frequently is the PTPRO E1060K mutation detected in Pancreatic Adenocarcinoma?,ssm_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How frequently is the PTPRO E1088K mutation detected in Pancreatic Adenocarcinoma?,ssm_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How frequently is the PTPRO E249K mutation detected in Pancreatic Adenocarcinoma?,ssm_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How frequently is the PTPRO E265K mutation detected in Pancreatic Adenocarcinoma?,ssm_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How frequently is the PTPRO E277K mutation detected in Pancreatic Adenocarcinoma?,ssm_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How frequently is the PTPRO E67K mutation detected in Pancreatic Adenocarcinoma?,ssm_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How frequently is the PTPRO E923K mutation detected in Pancreatic Adenocarcinoma?,ssm_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How frequently is the PTPRO E940K mutation detected in Pancreatic Adenocarcinoma?,ssm_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How frequently is the CHMP7 D397N mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,How frequently is the GPC3 I107N mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,How frequently is the GPC3 I161N mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently is the TLK2 V430L mutation detected in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently is the TLK2 V515L mutation detected in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently is the TLK2 V547L mutation detected in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently is the TLK2 V579L mutation detected in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently is the TLK2 V601L mutation detected in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How frequently is the ZNF217 E209Q mutation detected in Lung Adenocarcinoma?,ssm_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,How frequently is the SYT9 V275L mutation detected in Lung Adenocarcinoma?,ssm_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,How frequently is the SYT9 V307L mutation detected in Lung Adenocarcinoma?,ssm_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How frequently is the PKHD1L1 S2830N mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How frequently is the MYO3A Y1295C mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is the VASN V318I mutation detected in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How frequently is the DNMT1 A1037T mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How frequently is the DNMT1 A1053T mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How frequently is the DNMT1 A934T mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,How frequently is the CA9 E402K mutation detected in Colon Adenocarcinoma?,ssm_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How frequently is the TTC17 R808Q mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How frequently is the TTC17 R865Q mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,How frequently is the PSG2 P43L mutation detected in Breast Invasive Carcinoma?,ssm_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How frequently is the RIPOR2 R470L mutation detected in Breast Invasive Carcinoma?,ssm_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How frequently is the RIPOR2 R499L mutation detected in Breast Invasive Carcinoma?,ssm_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How frequently is the RIPOR2 R504L mutation detected in Breast Invasive Carcinoma?,ssm_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How frequently is the RIPOR2 R520L mutation detected in Breast Invasive Carcinoma?,ssm_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How frequently is the DCLK3 V520I mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How frequently is the DCLK3 V689I mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How frequently is the MERTK G257A mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How frequently is the MERTK G757A mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How frequently is the MERTK G933A mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How frequently is the ZFP42 R206K mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How frequently is the OR13C3 M117I mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How frequently is the OR13C3 M147I mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How frequently is the SPAG1 I917M mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How frequently is the CDKN2AIP Y92H mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,How frequently is the PXN H1016Y mutation detected in Colon Adenocarcinoma?,ssm_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,How frequently is the PXN H359Y mutation detected in Colon Adenocarcinoma?,ssm_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,How frequently is the PXN H492Y mutation detected in Colon Adenocarcinoma?,ssm_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,How frequently is the PXN H524Y mutation detected in Colon Adenocarcinoma?,ssm_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,How frequently is the PXN H526Y mutation detected in Colon Adenocarcinoma?,ssm_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,How frequently is the PXN H540Y mutation detected in Colon Adenocarcinoma?,ssm_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How frequently is the TTYH2 S23L mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How frequently is the TTYH2 S44L mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How frequently is the TMEM255A N205S mutation detected in Colon Adenocarcinoma?,ssm_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How frequently is the TMEM255A N229S mutation detected in Colon Adenocarcinoma?,ssm_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How frequently is the TMEM255A N65S mutation detected in Colon Adenocarcinoma?,ssm_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How frequently is the TASOR2 H2271D mutation detected in Breast Invasive Carcinoma?,ssm_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How frequently is the TASOR2 H2486D mutation detected in Breast Invasive Carcinoma?,ssm_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How frequently is the ICE1 T1839M mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,How frequently is the MYT1 A558E mutation detected in Breast Invasive Carcinoma?,ssm_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,How frequently is the MYT1 A879E mutation detected in Breast Invasive Carcinoma?,ssm_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,How frequently is the MYT1 A906E mutation detected in Breast Invasive Carcinoma?,ssm_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How frequently is the CX3CR1 P203L mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How frequently is the CX3CR1 P235L mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How frequently is the SPINDOC R197C mutation detected in Liver Hepatocellular Carcinoma?,ssm_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How frequently is the ART3 C251Y mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How frequently is the ART3 C3Y mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How frequently is the CYP1A2 R243G mutation detected in Bladder Urothelial Carcinoma?,ssm_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is the ADRA1A G279S mutation detected in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How frequently is the CDH23 P2523R mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How frequently is the CDH23 P283R mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How frequently is the KRT39 P137S mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How frequently is the PDHA2 S7F mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How frequently is the SLC24A2 H200Q mutation detected in Colon Adenocarcinoma?,ssm_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How frequently is the PTPRN2 F153L mutation detected in Liver Hepatocellular Carcinoma?,ssm_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How frequently is the PTPRN2 F847L mutation detected in Liver Hepatocellular Carcinoma?,ssm_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How frequently is the PTPRN2 F856L mutation detected in Liver Hepatocellular Carcinoma?,ssm_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How frequently is the PTPRN2 F868L mutation detected in Liver Hepatocellular Carcinoma?,ssm_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How frequently is the PTPRN2 F885L mutation detected in Liver Hepatocellular Carcinoma?,ssm_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,How frequently is the SOX21 R55L mutation detected in Lung Adenocarcinoma?,ssm_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How frequently is the CPA6 G166E mutation detected in Bladder Urothelial Carcinoma?,ssm_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How frequently is the GRM5 E14K mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is the CASZ1 R233Q mutation detected in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How frequently is the SGIP1 N122T mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How frequently is the SGIP1 N420T mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How frequently is the SGIP1 N617T mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How frequently is the SGIP1 N648T mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How frequently is the CARMIL1 V549L mutation detected in Lung Adenocarcinoma?,ssm_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How frequently is the CARMIL1 V949L mutation detected in Lung Adenocarcinoma?,ssm_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How frequently is the ZNF431 D121Y mutation detected in Lung Adenocarcinoma?,ssm_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How frequently is the ZNF431 D161Y mutation detected in Lung Adenocarcinoma?,ssm_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,How frequently is the ZNF431 R128I mutation detected in Lung Adenocarcinoma?,ssm_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How frequently is the DNAH11 P2987S mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How frequently is the DNAH11 P2994S mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How frequently is the POLD1 Q461L mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How frequently is the POLD1 Q85L mutation detected in Lung Squamous Cell Carcinoma?,ssm_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,How frequently is the TTC12 D646H mutation detected in Lung Adenocarcinoma?,ssm_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,How frequently is the TTC12 D652H mutation detected in Lung Adenocarcinoma?,ssm_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How frequently is the CNGB1 D967N mutation detected in Bladder Urothelial Carcinoma?,ssm_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How frequently is the CNGB1 D973N mutation detected in Bladder Urothelial Carcinoma?,ssm_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,How frequently is the CTSC E214V mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,How frequently is the CTSC E291V mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,How frequently is the CTSC E322V mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,How frequently is the CTSC E324V mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,How frequently is the CTSC E335V mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How frequently is the PRSS8 A179T mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How frequently is the PRSS8 A233T mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How frequently is the ARHGEF40 V864F mutation detected in Lung Adenocarcinoma?,ssm_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,How frequently is the ACTB A138T mutation detected in Rectum Adenocarcinoma?,ssm_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,How frequently is the ACTB A217T mutation detected in Rectum Adenocarcinoma?,ssm_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,How frequently is the ACTB A244T mutation detected in Rectum Adenocarcinoma?,ssm_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,How frequently is the ACTB A260T mutation detected in Rectum Adenocarcinoma?,ssm_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How frequently is the YY1AP1 V546D mutation detected in Glioblastoma Multiforme?,ssm_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How frequently is the YY1AP1 V557D mutation detected in Glioblastoma Multiforme?,ssm_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How frequently is the YY1AP1 V566D mutation detected in Glioblastoma Multiforme?,ssm_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How frequently is the YY1AP1 V577D mutation detected in Glioblastoma Multiforme?,ssm_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How frequently is the YY1AP1 V623D mutation detected in Glioblastoma Multiforme?,ssm_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How frequently is the YY1AP1 V695D mutation detected in Glioblastoma Multiforme?,ssm_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How frequently is the YY1AP1 V715D mutation detected in Glioblastoma Multiforme?,ssm_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How frequently is the FNDC7 D323N mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How frequently is the FNDC7 D99N mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,How frequently is the TLCD5 G15V mutation detected in Lung Adenocarcinoma?,ssm_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,How frequently is the TLCD5 G37V mutation detected in Lung Adenocarcinoma?,ssm_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How frequently is the POLR1G R498W mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How frequently is the POLR1G R500W mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How frequently is the DNAH14 N1186K mutation detected in Colon Adenocarcinoma?,ssm_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How frequently is the DNAH14 N2657K mutation detected in Colon Adenocarcinoma?,ssm_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How frequently is the DNAH14 N3460K mutation detected in Colon Adenocarcinoma?,ssm_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How frequently is the NEXN E73D mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How frequently is the CYB5R2 G112R mutation detected in Prostate Adenocarcinoma?,ssm_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How frequently is the CYB5R2 G172R mutation detected in Prostate Adenocarcinoma?,ssm_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How frequently is the NRAP S808L mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How frequently is the NRAP S816L mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How frequently is the NRAP S843L mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How frequently is the CCDC22 E179D mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How frequently is the DCAF6 S402F mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How frequently is the DCAF6 S433F mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How frequently is the ZNF708 E389D mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How frequently is the BFAR T103M mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How frequently is the MAST4 P1237S mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How frequently is the MAST4 P1986S mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How frequently is the MAST4 P1991S mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How frequently is the MAST4 P2001S mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How frequently is the MAST4 P2180S mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How frequently is the ARMC3 R169C mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How frequently is the ARMC3 R432C mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How frequently is the TET2 L757V mutation detected in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How frequently is the TET2 L778V mutation detected in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How frequently is the SERPINB10 A353P mutation detected in Lung Adenocarcinoma?,ssm_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How frequently is the STAT3 Y22H mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How frequently is the MIEF1 A42T mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How frequently is the ACVR1B D397N mutation detected in Colon Adenocarcinoma?,ssm_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How frequently is the ACVR1B D449N mutation detected in Colon Adenocarcinoma?,ssm_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How frequently is the ACVR1B D490N mutation detected in Colon Adenocarcinoma?,ssm_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,How frequently is the EBF2 T104I mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,How frequently is the EBF2 T252I mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How frequently is the VPS26B F266L mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is the PGR M106I mutation detected in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is the PGR M38I mutation detected in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is the PGR M632I mutation detected in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How frequently is the ACTA2 P334L mutation detected in Skin Cutaneous Melanoma?,ssm_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How frequently is the THBS4 T852I mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How frequently is the THBS4 T943I mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,How frequently is the PRSS1 S114T mutation detected in Lung Adenocarcinoma?,ssm_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,How frequently is the PRSS1 S124T mutation detected in Lung Adenocarcinoma?,ssm_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,How frequently is the PRSS1 S138T mutation detected in Lung Adenocarcinoma?,ssm_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,How frequently is the PRSS1 S74T mutation detected in Lung Adenocarcinoma?,ssm_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,How frequently is the PGF R126H mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,How frequently is the PGF R127H mutation detected in Stomach Adenocarcinoma?,ssm_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How frequently is the ITPRID2 S351C mutation detected in Breast Invasive Carcinoma?,ssm_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How frequently is the ITPRID2 S842C mutation detected in Breast Invasive Carcinoma?,ssm_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How frequently is the HBB E8D mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How frequently is the PCDHB2 R158C mutation detected in Colon Adenocarcinoma?,ssm_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How frequently is the PCDHB2 T15M mutation detected in Colon Adenocarcinoma?,ssm_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How frequently is the PCDHB2 T26M mutation detected in Colon Adenocarcinoma?,ssm_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How frequently is the UBR2 P1594S mutation detected in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How frequently is the FBXO42 A618D mutation detected in Rectum Adenocarcinoma?,ssm_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,what percentage of cases have mutations in both TNS1 G1362V and MYH11 P313S mutations in Breast Invasive Carcinoma?,ssm_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,what percentage of cases have mutations in both TNS1 G1711V and MORF4L1 Q138H mutations in Breast Invasive Carcinoma?,ssm_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,what percentage of cases have mutations in both TNS1 G1718V and POC1B K279E mutations in Breast Invasive Carcinoma?,ssm_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,what percentage of cases have mutations in both TNS1 G1732V and MORF4L1 R299L mutations in Breast Invasive Carcinoma?,ssm_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,what percentage of cases have mutations in both TNS1 G1824V and SORCS1 A217T mutations in Breast Invasive Carcinoma?,ssm_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,what percentage of cases have mutations in both TNS1 G1857V and EVC2 E940K mutations in Breast Invasive Carcinoma?,ssm_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,what percentage of cases have mutations in both TNS1 G843V and FBXO15 P1991S mutations in Breast Invasive Carcinoma?,ssm_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,what percentage of cases have mutations in both EVC2 E1067K and CX3CR1 P137S mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,what percentage of cases have mutations in both EVC2 E987K and SPTAN1 E355K mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both CR1 V1108G and MYT1 G159E mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both CR1 V1558G and ZNF431 N420T mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,what percentage of cases have mutations in both TRPA1 S295I and DNAH11 S79P mutations in Rectum Adenocarcinoma?,ssm_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,what percentage of cases have mutations in both TRPA1 S443I and POC1B D323N mutations in Rectum Adenocarcinoma?,ssm_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,what percentage of cases have mutations in both TAF1C R299L and TYROBP E8D mutations in Lung Adenocarcinoma?,ssm_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,what percentage of cases have mutations in both TAF1C R396L and KDM5C F266L mutations in Lung Adenocarcinoma?,ssm_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,what percentage of cases have mutations in both TAF1C R634L and FRY P1991S mutations in Lung Adenocarcinoma?,ssm_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,what percentage of cases have mutations in both TAF1C R702L and DEFB115 I265M mutations in Lung Adenocarcinoma?,ssm_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,what percentage of cases have mutations in both TAF1C R728L and CARMIL1 K1269N mutations in Lung Adenocarcinoma?,ssm_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both DPF3 R104W and MORF4L1 A539V mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both DPF3 R149W and DNAH14 D543Y mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both DPF3 R94W and TRPA1 T334K mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,what percentage of cases have mutations in both OR2T4 P272H and PAPPA T15M mutations in Lung Adenocarcinoma?,ssm_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,what percentage of cases have mutations in both OR2T4 P300H and CTCFL G175R mutations in Lung Adenocarcinoma?,ssm_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,what percentage of cases have mutations in both FBN1 E2667K and KRT39 G1732V mutations in Pancreatic Adenocarcinoma?,ssm_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,what percentage of cases have mutations in both MAD1L1 E396K and DCAF6 P244H mutations in Prostate Adenocarcinoma?,ssm_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,what percentage of cases have mutations in both MAD1L1 E488K and DCLK3 S124T mutations in Prostate Adenocarcinoma?,ssm_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,what percentage of cases have mutations in both MAD1L1 E78K and ZCCHC14 R63W mutations in Prostate Adenocarcinoma?,ssm_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,what percentage of cases have mutations in both CCNG1 E22K and RELN D67Y mutations in Skin Cutaneous Melanoma?,ssm_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,what percentage of cases have mutations in both ANP32E N114T and CTNNA2 R634L mutations in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,what percentage of cases have mutations in both ANP32E N64T and DPF3 A584T mutations in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,what percentage of cases have mutations in both ANP32E N66T and PAK3 N1186K mutations in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,what percentage of cases have mutations in both ANP32E N73T and PCDHB2 V623D mutations in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,what percentage of cases have mutations in both FRY S1888A and ADRA1A R470C mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,what percentage of cases have mutations in both FRY S1937A and SLC24A2 M632I mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,what percentage of cases have mutations in both FRY S1938A and POLD1 S290F mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,what percentage of cases have mutations in both FRY S1983A and POC1B N251T mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,what percentage of cases have mutations in both PAK3 E318K and SLC9C1 P1991S mutations in Skin Cutaneous Melanoma?,ssm_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,what percentage of cases have mutations in both PAK3 E319K and STK19 S320F mutations in Skin Cutaneous Melanoma?,ssm_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,what percentage of cases have mutations in both PAK3 E334K and PRSS8 N66T mutations in Skin Cutaneous Melanoma?,ssm_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,what percentage of cases have mutations in both PAK3 E340K and TENM2 Y1295C mutations in Skin Cutaneous Melanoma?,ssm_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,what percentage of cases have mutations in both PAK3 E355K and GABRA6 R547W mutations in Skin Cutaneous Melanoma?,ssm_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,what percentage of cases have mutations in both MUC16 P7963L and TENT5A R127H mutations in Skin Cutaneous Melanoma?,ssm_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,what percentage of cases have mutations in both ZFPM2 T498I and TRPA1 K322E mutations in Liver Hepatocellular Carcinoma?,ssm_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,what percentage of cases have mutations in both ZFPM2 T630I and SPAG1 P443S mutations in Liver Hepatocellular Carcinoma?,ssm_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,what percentage of cases have mutations in both PIK3C2B S1328C and DOCK2 D587Y mutations in Breast Invasive Carcinoma?,ssm_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,what percentage of cases have mutations in both PIK3C2B S1356C and MYH11 T204I mutations in Breast Invasive Carcinoma?,ssm_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,what percentage of cases have mutations in both ZNF804A S371Y and MYO3B P283R mutations in Colon Adenocarcinoma?,ssm_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,what percentage of cases have mutations in both RELN A2371V and PTPRN2 T371I mutations in Stomach Adenocarcinoma?,ssm_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what percentage of cases have mutations in both EFCAB12 R173C and HTR3B D397N mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what percentage of cases have mutations in both EFCAB12 R23C and OR2A12 A244T mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,what percentage of cases have mutations in both DEFB115 E53K and ZCCHC14 A211T mutations in Skin Cutaneous Melanoma?,ssm_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,what percentage of cases have mutations in both ANKDD1A S290F and ANKDD1A R423W mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,what percentage of cases have mutations in both ANKDD1A S322F and CACNA1F H2271D mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,what percentage of cases have mutations in both ANKDD1A S413F and ANKRD30A A644V mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both HTR3B S146I and CEP20 Q461L mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both HTR3B S206I and PTPRO S224L mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both HTR3B S217I and B3GALNT1 D1052Y mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,what percentage of cases have mutations in both ABCC3 R758W and MERTK R1053H mutations in Stomach Adenocarcinoma?,ssm_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both NOMO1 T204I and TRAP1 E22K mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both NOMO1 T371I and ZNF804A F8880L mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,what percentage of cases have mutations in both HYOU1 D298H and MYT1 G29R mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,what percentage of cases have mutations in both FMO4 R500Q and RIPOR2 T252I mutations in Skin Cutaneous Melanoma?,ssm_frequency
+140,BICC1,A372V,Exceptional Responders,what percentage of cases have mutations in both BICC1 A372V and AUTS2 S1356C mutations in Exceptional Responders?,ssm_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both ZMYM3 I920V and FGF8 T165M mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both ZMYM3 I932V and POC1B E51K mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both ZMYM3 I934V and NRAP T166S mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what percentage of cases have mutations in both XKR4 R547W and BCAT1 K29N mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,what percentage of cases have mutations in both ABCC2 V239L and DPF3 A906E mutations in Liver Hepatocellular Carcinoma?,ssm_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,what percentage of cases have mutations in both OR8K5 R293G and KRT39 A584T mutations in Lung Adenocarcinoma?,ssm_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,what percentage of cases have mutations in both SPTAN1 S1503F and DCN S273C mutations in Skin Cutaneous Melanoma?,ssm_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,what percentage of cases have mutations in both SPTAN1 S1523F and ACTA2 P160S mutations in Skin Cutaneous Melanoma?,ssm_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,what percentage of cases have mutations in both SYT10 M484I and BCAT1 S1937A mutations in Rectum Adenocarcinoma?,ssm_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,what percentage of cases have mutations in both HSPA5 N457K and EIF2B4 D652H mutations in Skin Cutaneous Melanoma?,ssm_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,what percentage of cases have mutations in both UNC5D L280V and CACNA1F A211T mutations in Lung Adenocarcinoma?,ssm_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,what percentage of cases have mutations in both UNC5D L635V and TLK2 E148K mutations in Lung Adenocarcinoma?,ssm_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,what percentage of cases have mutations in both UNC5D L637V and TLK2 H492Y mutations in Lung Adenocarcinoma?,ssm_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,what percentage of cases have mutations in both UNC5D L699V and ZNF584 T630I mutations in Lung Adenocarcinoma?,ssm_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,what percentage of cases have mutations in both UNC5D L704V and SORCS1 E108K mutations in Lung Adenocarcinoma?,ssm_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,what percentage of cases have mutations in both UNC5D L709V and SGIP1 P233S mutations in Lung Adenocarcinoma?,ssm_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,what percentage of cases have mutations in both DOCK2 L1527H and TAF1C D44N mutations in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,what percentage of cases have mutations in both ZNF627 A5V and PTPRO R393W mutations in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,what percentage of cases have mutations in both CDC42BPA L823F and SPINDOC E318K mutations in Skin Cutaneous Melanoma?,ssm_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,what percentage of cases have mutations in both MRPL55 H27Y and PHLPP1 R203P mutations in Colon Adenocarcinoma?,ssm_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,what percentage of cases have mutations in both MRPL55 H63Y and GLRB P244H mutations in Colon Adenocarcinoma?,ssm_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,what percentage of cases have mutations in both TMTC3 Q749K and ZMYM3 H961R mutations in Breast Invasive Carcinoma?,ssm_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,what percentage of cases have mutations in both EPRS1 K771I and CXCR2 N3460K mutations in Colon Adenocarcinoma?,ssm_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,what percentage of cases have mutations in both EPRS1 K778I and MSANTD4 Q326H mutations in Colon Adenocarcinoma?,ssm_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,what percentage of cases have mutations in both GRTP1 A110V and RIMS2 G933A mutations in Skin Cutaneous Melanoma?,ssm_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,what percentage of cases have mutations in both GRTP1 A32V and EFCAB12 P296S mutations in Skin Cutaneous Melanoma?,ssm_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,what percentage of cases have mutations in both TSHZ3 Q538K and FNDC7 L280V mutations in Stomach Adenocarcinoma?,ssm_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,what percentage of cases have mutations in both TAS1R3 Q326H and ANKDD1A S528F mutations in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,ssm_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both PIAS3 S238C and ZCCHC14 M632I mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both PIAS3 S273C and SORCS1 P272H mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,what percentage of cases have mutations in both ZNF274 P13R and MYT1 R181Q mutations in Stomach Adenocarcinoma?,ssm_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,what percentage of cases have mutations in both SYNJ1 R795C and TAF1C L1527H mutations in Colon Adenocarcinoma?,ssm_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,what percentage of cases have mutations in both SYNJ1 R800C and TLCD5 T165M mutations in Colon Adenocarcinoma?,ssm_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,what percentage of cases have mutations in both SYNJ1 R839C and CEP20 D397N mutations in Colon Adenocarcinoma?,ssm_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,what percentage of cases have mutations in both DSCAM V343M and PAK3 E148D mutations in Prostate Adenocarcinoma?,ssm_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,what percentage of cases have mutations in both DSCAM V426M and MAD1L1 S615F mutations in Prostate Adenocarcinoma?,ssm_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,what percentage of cases have mutations in both DSCAM V591M and AQP7 S1328C mutations in Prostate Adenocarcinoma?,ssm_frequency
+267,DGKD,R140H,Exceptional Responders,what percentage of cases have mutations in both DGKD R140H and POC1B P235L mutations in Exceptional Responders?,ssm_frequency
+268,DGKD,R160H,Exceptional Responders,what percentage of cases have mutations in both DGKD R160H and ZMYM3 S1503F mutations in Exceptional Responders?,ssm_frequency
+269,DGKD,R204H,Exceptional Responders,what percentage of cases have mutations in both DGKD R204H and NEXN R140H mutations in Exceptional Responders?,ssm_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,what percentage of cases have mutations in both PLEKHG6 D105Y and PTPRN2 G1580S mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,what percentage of cases have mutations in both PLEKHG6 D543Y and OR13C3 P160S mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,what percentage of cases have mutations in both PLEKHG6 D575Y and DNAH11 R135P mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,what percentage of cases have mutations in both WNT2 D138N and ANKDD1A V601L mutations in Skin Cutaneous Melanoma?,ssm_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,what percentage of cases have mutations in both GUCY2C G667R and BFAR K306E mutations in Skin Cutaneous Melanoma?,ssm_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both C7orf31 P244H and CACNA1F L709V mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what percentage of cases have mutations in both ZKSCAN7 E64K and YY1AP1 S816L mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+299,OR5D14,M210L,Neuroblastoma,what percentage of cases have mutations in both OR5D14 M210L and SGIP1 S842C mutations in Neuroblastoma?,ssm_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both SPATA22 K279E and ERCC6 E148D mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both SPATA22 K306E and ABCC2 H524Y mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both SPATA22 K322E and JAML R520L mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,what percentage of cases have mutations in both LCN15 E21V and TRIM45 L637V mutations in Stomach Adenocarcinoma?,ssm_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,what percentage of cases have mutations in both DCAF4L2 S129F and ZNF431 R127H mutations in Skin Cutaneous Melanoma?,ssm_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both GUK1 R135P and GRM5 K51T mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both GUK1 R137P and CNGB1 G191E mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both GUK1 R139P and CR1 C3Y mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both GUK1 R158P and FRY T204I mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both GUK1 R203P and ADAM17 D810Y mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,what percentage of cases have mutations in both MORF4L1 K29T and PTPRN2 G1711V mutations in Stomach Adenocarcinoma?,ssm_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,what percentage of cases have mutations in both MORF4L1 K51T and GRM5 D1052Y mutations in Stomach Adenocarcinoma?,ssm_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,what percentage of cases have mutations in both MORF4L1 K61T and SLC24A2 R728L mutations in Stomach Adenocarcinoma?,ssm_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,what percentage of cases have mutations in both MORF4L1 K76T and PYHIN1 R615W mutations in Stomach Adenocarcinoma?,ssm_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,what percentage of cases have mutations in both MYO3B F594L and BCAT1 R470W mutations in Skin Cutaneous Melanoma?,ssm_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,what percentage of cases have mutations in both MYO3B F603L and CHMP7 E987K mutations in Skin Cutaneous Melanoma?,ssm_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,what percentage of cases have mutations in both TENT5A S320F and TLK2 S129F mutations in Skin Cutaneous Melanoma?,ssm_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,what percentage of cases have mutations in both TENT5A S339F and AUTS2 H359Y mutations in Skin Cutaneous Melanoma?,ssm_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,what percentage of cases have mutations in both TENT5A S401F and POLR1G S36F mutations in Skin Cutaneous Melanoma?,ssm_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,what percentage of cases have mutations in both ZFAT S614L and FGF8 E322V mutations in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,what percentage of cases have mutations in both ZFAT S664L and YY1AP1 K818N mutations in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,what percentage of cases have mutations in both ZFAT S676L and CTNNA2 K51T mutations in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+357,ZNF584,A211T,Sarcoma,what percentage of cases have mutations in both ZNF584 A211T and PGR D543Y mutations in Sarcoma?,ssm_frequency
+358,ZNF584,A256T,Sarcoma,what percentage of cases have mutations in both ZNF584 A256T and OR2A12 S138T mutations in Sarcoma?,ssm_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both LDOC1 R63W and PTPRN2 G644S mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both PDGFC R201G and GPR158 R127H mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both MSANTD4 R304C and ART3 I917M mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,what percentage of cases have mutations in both NPSR1 S123L and MORF4L1 P160S mutations in Skin Cutaneous Melanoma?,ssm_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both PHLPP1 K1317E and KANSL1 G165R mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,what percentage of cases have mutations in both COL6A3 G237S and TAF1C P43L mutations in Skin Cutaneous Melanoma?,ssm_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,what percentage of cases have mutations in both COL6A3 G437S and ACTB V557D mutations in Skin Cutaneous Melanoma?,ssm_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,what percentage of cases have mutations in both COL6A3 G638S and CEP20 E355K mutations in Skin Cutaneous Melanoma?,ssm_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,what percentage of cases have mutations in both COL6A3 G644S and AUTS2 S123L mutations in Skin Cutaneous Melanoma?,ssm_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,what percentage of cases have mutations in both COL6A3 G844S and RIMS2 Q326H mutations in Skin Cutaneous Melanoma?,ssm_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,what percentage of cases have mutations in both ADRA1A R348G and POLD1 E179D mutations in Stomach Adenocarcinoma?,ssm_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what percentage of cases have mutations in both LAMB2 S1254F and DCN S676L mutations in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,what percentage of cases have mutations in both POC1B I198T and ACTB S592L mutations in Rectum Adenocarcinoma?,ssm_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,what percentage of cases have mutations in both POC1B I286T and SLC6A4 D161Y mutations in Rectum Adenocarcinoma?,ssm_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,what percentage of cases have mutations in both POC1B I328T and SORCS1 V15M mutations in Rectum Adenocarcinoma?,ssm_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,what percentage of cases have mutations in both POC1B S79P and CYB5R2 V547L mutations in Rectum Adenocarcinoma?,ssm_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,what percentage of cases have mutations in both USH2A G1451C and SPATA22 R181Q mutations in Liver Hepatocellular Carcinoma?,ssm_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,what percentage of cases have mutations in both AQP7 T110S and EFCAB12 S664L mutations in Rectum Adenocarcinoma?,ssm_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,what percentage of cases have mutations in both AQP7 T166S and DCC D587Y mutations in Rectum Adenocarcinoma?,ssm_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,what percentage of cases have mutations in both AQP7 T167S and CTSC R594C mutations in Rectum Adenocarcinoma?,ssm_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,what percentage of cases have mutations in both AQP7 T75S and ZSCAN31 E277K mutations in Rectum Adenocarcinoma?,ssm_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,what percentage of cases have mutations in both DCN R163C and HSPA5 E1088K mutations in Rectum Adenocarcinoma?,ssm_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,what percentage of cases have mutations in both DCN R203C and GPR158 T194M mutations in Rectum Adenocarcinoma?,ssm_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,what percentage of cases have mutations in both DCN R241C and CTNNA2 S339F mutations in Rectum Adenocarcinoma?,ssm_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,what percentage of cases have mutations in both DCN R350C and SGCZ E22K mutations in Rectum Adenocarcinoma?,ssm_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,what percentage of cases have mutations in both DCN R41C and DNMT1 E817V mutations in Rectum Adenocarcinoma?,ssm_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both CPS1 K1269N and SGIP1 E583K mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both CPS1 K1275N and ZFAT G279S mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both CPS1 K818N and COL6A3 I198T mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,what percentage of cases have mutations in both FCGR2C P122S and RIMS2 K29N mutations in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,what percentage of cases have mutations in both FCGR2C P123S and PTPRN2 S1938A mutations in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both GRM1 R280M and FBN1 H472Y mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,what percentage of cases have mutations in both SGCZ Q138H and SLC6A4 K29N mutations in Lung Adenocarcinoma?,ssm_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,what percentage of cases have mutations in both SGCZ Q91H and EBF2 R128I mutations in Lung Adenocarcinoma?,ssm_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,what percentage of cases have mutations in both SMO V15M and MED16 E817V mutations in Stomach Adenocarcinoma?,ssm_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,what percentage of cases have mutations in both SMO V321M and TRAP1 H2271D mutations in Stomach Adenocarcinoma?,ssm_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,what percentage of cases have mutations in both CHODL G159E and ACTL7B E22K mutations in Skin Cutaneous Melanoma?,ssm_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,what percentage of cases have mutations in both CHODL G181E and CTCFL R547W mutations in Skin Cutaneous Melanoma?,ssm_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,what percentage of cases have mutations in both CHODL G200E and PIK3C2G G17R mutations in Skin Cutaneous Melanoma?,ssm_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,what percentage of cases have mutations in both MYO16 P399H and ZCCHC14 G175R mutations in Colon Adenocarcinoma?,ssm_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,what percentage of cases have mutations in both MYO16 P421H and FRY T371I mutations in Colon Adenocarcinoma?,ssm_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,what percentage of cases have mutations in both CXCR2 A98V and MERTK V798I mutations in Stomach Adenocarcinoma?,ssm_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,what percentage of cases have mutations in both TMEM225 L212V and CX3CR1 V520I mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both MAOB N251T and POC1B I934V mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both GPRASP1 F580S and MAST4 R204H mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both MRPL32 R181Q and MYO16 A1037T mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both TYROBP A29T and GABRA6 K1317E mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,what percentage of cases have mutations in both RAB40C A111V and GPC3 E940K mutations in Lung Adenocarcinoma?,ssm_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,what percentage of cases have mutations in both RAB40C A143V and RIMS2 A143V mutations in Lung Adenocarcinoma?,ssm_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,what percentage of cases have mutations in both CTNNA2 S323R and CFAP298-TCP10L R535W mutations in Lung Adenocarcinoma?,ssm_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,what percentage of cases have mutations in both CTNNA2 S339R and TENT5A I198T mutations in Lung Adenocarcinoma?,ssm_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,what percentage of cases have mutations in both CTNNA2 S386R and MAST4 S217I mutations in Lung Adenocarcinoma?,ssm_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,what percentage of cases have mutations in both CTNNA2 S707R and BCAT1 R363W mutations in Lung Adenocarcinoma?,ssm_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,what percentage of cases have mutations in both MYO15A S268R and PTPRN2 A89V mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,what percentage of cases have mutations in both GIMAP2 A167T and EIF2B4 R293G mutations in Skin Cutaneous Melanoma?,ssm_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,what percentage of cases have mutations in both KIF20B N1160D and RELN D1052Y mutations in Glioblastoma Multiforme?,ssm_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,what percentage of cases have mutations in both KIF20B N1200D and NOMO1 A217T mutations in Glioblastoma Multiforme?,ssm_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both ADAM17 E583K and DHX16 E209Q mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both BCAT1 G16R and CR1 E132K mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both BCAT1 G17R and DCN I920V mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both BCAT1 G29R and CDC42BPA F580S mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,what percentage of cases have mutations in both ERCC6 R1053H and PLEKHG6 S433F mutations in Colon Adenocarcinoma?,ssm_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,what percentage of cases have mutations in both DCC R320W and MRPL55 L704V mutations in Breast Invasive Carcinoma?,ssm_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,what percentage of cases have mutations in both DCC R363W and REXO4 R140H mutations in Breast Invasive Carcinoma?,ssm_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,what percentage of cases have mutations in both DCC R386W and CTCFL V239L mutations in Breast Invasive Carcinoma?,ssm_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,what percentage of cases have mutations in both DCC R41W and CACNA1F P2994S mutations in Breast Invasive Carcinoma?,ssm_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,what percentage of cases have mutations in both FBXO15 D417N and GABRA6 P2180S mutations in Skin Cutaneous Melanoma?,ssm_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,what percentage of cases have mutations in both FBXO15 D86N and DPF3 S79P mutations in Skin Cutaneous Melanoma?,ssm_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both GSTCD S528F and AUTS2 A211T mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both GSTCD S615F and PLEKHG6 S206I mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both OLFML3 P296S and SGIP1 K1275N mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both OLFML3 P337S and NRAP R386W mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both OLFML3 P357S and DCLK3 R393W mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,what percentage of cases have mutations in both CFAP61 E173V and TAF1L G1711V mutations in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,what percentage of cases have mutations in both CFAP61 E817V and GABRA6 E318K mutations in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,what percentage of cases have mutations in both HLA-DQA2 E51K and POC1B G257A mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,what percentage of cases have mutations in both TENM2 H240Y and CTSC R396L mutations in Skin Cutaneous Melanoma?,ssm_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,what percentage of cases have mutations in both TENM2 H351Y and TTN E987K mutations in Skin Cutaneous Melanoma?,ssm_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,what percentage of cases have mutations in both TENM2 H472Y and OR2T4 A644V mutations in Skin Cutaneous Melanoma?,ssm_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,what percentage of cases have mutations in both ANKRD24 A465T and SLC9C1 V426M mutations in Stomach Adenocarcinoma?,ssm_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,what percentage of cases have mutations in both ANKRD24 A494T and AQP7 R208C mutations in Stomach Adenocarcinoma?,ssm_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,what percentage of cases have mutations in both ANKRD24 A584T and DGKD S443I mutations in Stomach Adenocarcinoma?,ssm_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,what percentage of cases have mutations in both ZCCHC14 V549M and SIK2 A217T mutations in Stomach Adenocarcinoma?,ssm_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,what percentage of cases have mutations in both ZCCHC14 V665M and OR13C3 G175R mutations in Stomach Adenocarcinoma?,ssm_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,what percentage of cases have mutations in both ZCCHC14 V676M and TTC12 N65S mutations in Stomach Adenocarcinoma?,ssm_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,what percentage of cases have mutations in both ZCCHC14 V802M and ANKRD24 V343M mutations in Stomach Adenocarcinoma?,ssm_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,what percentage of cases have mutations in both SIK2 I265M and TASOR2 N1200D mutations in Lung Adenocarcinoma?,ssm_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both MYH11 T1336M and GIMAP2 R504L mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both MYH11 T1343M and MYT1 R520L mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,what percentage of cases have mutations in both SLC6A4 S174F and MYO16 V579L mutations in Skin Cutaneous Melanoma?,ssm_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both SLC9C1 K102N and HYOU1 R41W mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both SLC9C1 K29N and EIF2B4 N648T mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,what percentage of cases have mutations in both OR2A12 A254T and STK19 H1016Y mutations in Brain Lower Grade Glioma?,ssm_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,what percentage of cases have mutations in both PYHIN1 T325K and PCDHB2 R149W mutations in Lung Adenocarcinoma?,ssm_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,what percentage of cases have mutations in both PYHIN1 T334K and GABRA6 D646H mutations in Lung Adenocarcinoma?,ssm_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,what percentage of cases have mutations in both JAML G191E and GUF1 I265M mutations in Skin Cutaneous Melanoma?,ssm_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,what percentage of cases have mutations in both JAML G219E and CXCR2 E11Q mutations in Skin Cutaneous Melanoma?,ssm_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,what percentage of cases have mutations in both JAML G220E and OR13C3 R839C mutations in Skin Cutaneous Melanoma?,ssm_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,what percentage of cases have mutations in both JAML G230E and CTNNA2 F580S mutations in Skin Cutaneous Melanoma?,ssm_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,what percentage of cases have mutations in both TYK2 H1146R and PYHIN1 S295I mutations in Stomach Adenocarcinoma?,ssm_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,what percentage of cases have mutations in both TYK2 H23R and MYO3A S74T mutations in Stomach Adenocarcinoma?,ssm_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,what percentage of cases have mutations in both TYK2 H961R and LAMB2 Y1295C mutations in Stomach Adenocarcinoma?,ssm_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both CTCFL R208C and KDM5C P334L mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both CTCFL R265C and EBF2 V321M mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both CTCFL R420C and KIF20B G1857V mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both CTCFL R470C and CNGB1 S1888A mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both CEP20 R31Q and DCC R31Q mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both CEP20 R58Q and DCAF6 G1580S mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,what percentage of cases have mutations in both RIMS2 R25W and SMO D575Y mutations in Skin Cutaneous Melanoma?,ssm_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,what percentage of cases have mutations in both RIMS2 R393W and TASOR2 V321M mutations in Skin Cutaneous Melanoma?,ssm_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,what percentage of cases have mutations in both RIMS2 R423W and VASN G16R mutations in Skin Cutaneous Melanoma?,ssm_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,what percentage of cases have mutations in both RIMS2 R470W and C7orf31 A138T mutations in Skin Cutaneous Melanoma?,ssm_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,what percentage of cases have mutations in both RIMS2 R615W and DCN R504L mutations in Skin Cutaneous Melanoma?,ssm_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,what percentage of cases have mutations in both RIMS2 R619W and RAB40C K771I mutations in Skin Cutaneous Melanoma?,ssm_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,what percentage of cases have mutations in both RIMS2 R716W and DNAH14 F594L mutations in Skin Cutaneous Melanoma?,ssm_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,what percentage of cases have mutations in both PIK3C2G S551L and GRM5 V798I mutations in Skin Cutaneous Melanoma?,ssm_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,what percentage of cases have mutations in both PIK3C2G S592L and DNAH14 E111K mutations in Skin Cutaneous Melanoma?,ssm_frequency
+728,STK19,D341N,Colon Adenocarcinoma,what percentage of cases have mutations in both STK19 D341N and RIPOR2 L704V mutations in Colon Adenocarcinoma?,ssm_frequency
+729,STK19,D345N,Colon Adenocarcinoma,what percentage of cases have mutations in both STK19 D345N and MYH11 E402K mutations in Colon Adenocarcinoma?,ssm_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,what percentage of cases have mutations in both REXO4 P60A and ITPRID2 E132K mutations in Skin Cutaneous Melanoma?,ssm_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both ZBTB34 P160S and SLC9C1 L153F mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both ZBTB34 P164S and TAF1C A256T mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,what percentage of cases have mutations in both NCKAP5 E148K and AUTS2 R265C mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what percentage of cases have mutations in both SORCS1 D1052Y and MYH11 A2371V mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what percentage of cases have mutations in both SORCS1 D587Y and TASOR2 S551L mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what percentage of cases have mutations in both SORCS1 D67Y and CEP20 N73T mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what percentage of cases have mutations in both SORCS1 D810Y and MERTK G122R mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,what percentage of cases have mutations in both FGF8 T154M and CEP20 P399H mutations in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,what percentage of cases have mutations in both FGF8 T165M and AUTS2 V623D mutations in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,what percentage of cases have mutations in both FGF8 T183M and TASOR2 R386W mutations in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,what percentage of cases have mutations in both FGF8 T194M and TNS1 D9N mutations in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,what percentage of cases have mutations in both FGF8 T90M and OR13C3 F7636L mutations in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,what percentage of cases have mutations in both TENM3 R1877W and SORCS1 Q85L mutations in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,ssm_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both AKT1 D44N and SLC9C1 G115R mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what percentage of cases have mutations in both CFAP298-TCP10L E11Q and DGKD R619W mutations in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,what percentage of cases have mutations in both GLRB E148D and ZNF431 G257A mutations in Stomach Adenocarcinoma?,ssm_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,what percentage of cases have mutations in both TTN F7636L and MYO3B P137S mutations in Colon Adenocarcinoma?,ssm_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,what percentage of cases have mutations in both TTN F8563L and RIMS2 D397N mutations in Colon Adenocarcinoma?,ssm_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,what percentage of cases have mutations in both TTN F8880L and AUTS2 P419S mutations in Colon Adenocarcinoma?,ssm_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,what percentage of cases have mutations in both ANKRD30A V798I and DNAH14 S339F mutations in Colon Adenocarcinoma?,ssm_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,what percentage of cases have mutations in both ANKRD30A V854I and PIK3C2B R500Q mutations in Colon Adenocarcinoma?,ssm_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,what percentage of cases have mutations in both ANKRD30A V973I and MED16 S371Y mutations in Colon Adenocarcinoma?,ssm_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,what percentage of cases have mutations in both TRIM45 S177L and MIEF1 T110S mutations in Colon Adenocarcinoma?,ssm_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,what percentage of cases have mutations in both TRIM45 S224L and CDH23 A32V mutations in Colon Adenocarcinoma?,ssm_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,what percentage of cases have mutations in both TRIM45 S281L and CHMP7 G17R mutations in Colon Adenocarcinoma?,ssm_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,what percentage of cases have mutations in both CACNA1F G727V and DCN Q749K mutations in Stomach Adenocarcinoma?,ssm_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,what percentage of cases have mutations in both CACNA1F G781V and DOCK2 K61T mutations in Stomach Adenocarcinoma?,ssm_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,what percentage of cases have mutations in both CACNA1F G792V and RIMS2 H524Y mutations in Stomach Adenocarcinoma?,ssm_frequency
+817,KL,R594C,Colon Adenocarcinoma,what percentage of cases have mutations in both KL R594C and DCC D646H mutations in Colon Adenocarcinoma?,ssm_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,what percentage of cases have mutations in both GUF1 I243T and TTYH2 E173V mutations in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,what percentage of cases have mutations in both TAF1L A539V and EIF2B4 S138T mutations in Colon Adenocarcinoma?,ssm_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,what percentage of cases have mutations in both TASOR2 S256F and KDM5C A29V mutations in Skin Cutaneous Melanoma?,ssm_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,what percentage of cases have mutations in both TASOR2 S36F and AQP7 S7F mutations in Skin Cutaneous Melanoma?,ssm_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,what percentage of cases have mutations in both TASOR2 S471F and SYNJ1 A244T mutations in Skin Cutaneous Melanoma?,ssm_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,what percentage of cases have mutations in both KDM5C R1151C and RIPOR2 V676M mutations in Skin Cutaneous Melanoma?,ssm_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,what percentage of cases have mutations in both KDM5C R1177C and DCLK3 F856L mutations in Skin Cutaneous Melanoma?,ssm_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,what percentage of cases have mutations in both KDM5C R1217C and OLFML3 A1053T mutations in Skin Cutaneous Melanoma?,ssm_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,what percentage of cases have mutations in both KDM5C R1218C and GSTCD T166S mutations in Skin Cutaneous Melanoma?,ssm_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what percentage of cases have mutations in both IL5RA L153F and PGR R1053H mutations in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,what percentage of cases have mutations in both DHX16 A29V and PCDHB2 R201G mutations in Skin Cutaneous Melanoma?,ssm_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,what percentage of cases have mutations in both DHX16 A89V and PTPRN2 P160S mutations in Skin Cutaneous Melanoma?,ssm_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,what percentage of cases have mutations in both GPR158 A644V and TRIM45 G844S mutations in Stomach Adenocarcinoma?,ssm_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,what percentage of cases have mutations in both GPR158 A723V and RIMS2 S413F mutations in Stomach Adenocarcinoma?,ssm_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what percentage of cases have mutations in both EIF2B4 E108K and GRM5 R104W mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what percentage of cases have mutations in both EIF2B4 E110K and PAPPA E277K mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what percentage of cases have mutations in both EIF2B4 E111K and DNMT1 S339R mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what percentage of cases have mutations in both EIF2B4 E131K and UNC5D R758W mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what percentage of cases have mutations in both EIF2B4 E132K and TNS1 V579L mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what percentage of cases have mutations in both EIF2B4 E96K and DCN H1146R mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both AUTS2 P136S and FRY S402F mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both AUTS2 P218S and FRY S268R mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both AUTS2 P233S and MRPL55 C3Y mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both AUTS2 P313S and CR1 V239L mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both AUTS2 P419S and PAK3 E322V mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both AUTS2 P443S and CTNNA2 G237S mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both AUTS2 P56S and RIMS2 R58Q mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both AUTS2 P667S and ADRA1A A644V mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both AUTS2 P690S and ANKRD30A F868L mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both AUTS2 P691S and SGIP1 P2994S mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what percentage of cases have mutations in both ACTL7B D223N and TLK2 R800C mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,what percentage of cases have mutations in both PCDHGA1 R535W and PRSS8 G219E mutations in Glioblastoma Multiforme?,ssm_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,what percentage of cases have mutations in both TRAP1 R114W and GUCY2C G17R mutations in Stomach Adenocarcinoma?,ssm_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,what percentage of cases have mutations in both TRAP1 R61W and AUTS2 M106I mutations in Stomach Adenocarcinoma?,ssm_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both PIK3C2A R1570Q and GSTCD G1711V mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,what percentage of cases have mutations in both KANSL1 R139G and OLFML3 E11Q mutations in Liver Hepatocellular Carcinoma?,ssm_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,what percentage of cases have mutations in both ANKRD52 Y594C and PTPRO L757V mutations in Stomach Adenocarcinoma?,ssm_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both PAPPA G1580S and NRAP K771I mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,what percentage of cases have mutations in both B3GALNT1 V270A and ACTB S1523F mutations in Rectum Adenocarcinoma?,ssm_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,what percentage of cases have mutations in both GABRA6 G115R and ZFAT S551L mutations in Lung Adenocarcinoma?,ssm_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,what percentage of cases have mutations in both GABRA6 G122R and MYH11 N1160D mutations in Lung Adenocarcinoma?,ssm_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,what percentage of cases have mutations in both GABRA6 G165R and PIAS3 G175R mutations in Lung Adenocarcinoma?,ssm_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,what percentage of cases have mutations in both GABRA6 G175R and MAD1L1 P160S mutations in Lung Adenocarcinoma?,ssm_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,what percentage of cases have mutations in both GABRA6 G70R and ZNF708 Q91H mutations in Lung Adenocarcinoma?,ssm_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,what percentage of cases have mutations in both ZSCAN31 D9N and FMO4 R396L mutations in Skin Cutaneous Melanoma?,ssm_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what percentage of cases have mutations in both MED16 L126P and KL G1857V mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what percentage of cases have mutations in both MED16 L868P and DNAH14 S206I mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,what percentage of cases have mutations in both PTPRO E1060K and CPS1 G16R mutations in Pancreatic Adenocarcinoma?,ssm_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,what percentage of cases have mutations in both PTPRO E1088K and TMTC3 H2271D mutations in Pancreatic Adenocarcinoma?,ssm_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,what percentage of cases have mutations in both PTPRO E249K and FGF8 F7636L mutations in Pancreatic Adenocarcinoma?,ssm_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,what percentage of cases have mutations in both PTPRO E265K and FGF8 H1146R mutations in Pancreatic Adenocarcinoma?,ssm_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,what percentage of cases have mutations in both PTPRO E277K and MED16 P2994S mutations in Pancreatic Adenocarcinoma?,ssm_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,what percentage of cases have mutations in both PTPRO E67K and ZNF431 E67K mutations in Pancreatic Adenocarcinoma?,ssm_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,what percentage of cases have mutations in both PTPRO E923K and SGIP1 I265M mutations in Pancreatic Adenocarcinoma?,ssm_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,what percentage of cases have mutations in both PTPRO E940K and AUTS2 F856L mutations in Pancreatic Adenocarcinoma?,ssm_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both CHMP7 D397N and MORF4L1 E319K mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,what percentage of cases have mutations in both GPC3 I107N and ACTL7B V307L mutations in Stomach Adenocarcinoma?,ssm_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,what percentage of cases have mutations in both GPC3 I161N and ACTB E21V mutations in Stomach Adenocarcinoma?,ssm_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what percentage of cases have mutations in both TLK2 V430L and ZNF217 T104I mutations in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what percentage of cases have mutations in both TLK2 V515L and ZNF217 I161N mutations in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what percentage of cases have mutations in both TLK2 V547L and TNS1 S1937A mutations in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what percentage of cases have mutations in both TLK2 V579L and ICE1 P203L mutations in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what percentage of cases have mutations in both TLK2 V601L and EIF2B4 E940K mutations in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,what percentage of cases have mutations in both ZNF217 E209Q and FBXO15 G757A mutations in Lung Adenocarcinoma?,ssm_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,what percentage of cases have mutations in both SYT9 V275L and KRT39 F153L mutations in Lung Adenocarcinoma?,ssm_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,what percentage of cases have mutations in both SYT9 V307L and TET2 V275L mutations in Lung Adenocarcinoma?,ssm_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both PKHD1L1 S2830N and GRM5 G844S mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both MYO3A Y1295C and SPATA22 F868L mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what percentage of cases have mutations in both VASN V318I and SGIP1 P272H mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both DNMT1 A1037T and SYT9 N457K mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both DNMT1 A1053T and HTR3B N122T mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both DNMT1 A934T and GUK1 P313S mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,what percentage of cases have mutations in both CA9 E402K and MORF4L1 R716W mutations in Colon Adenocarcinoma?,ssm_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both TTC17 R808Q and BICC1 G644S mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both TTC17 R865Q and SPTAN1 R393W mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,what percentage of cases have mutations in both PSG2 P43L and HTR3B H1016Y mutations in Breast Invasive Carcinoma?,ssm_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,what percentage of cases have mutations in both RIPOR2 R470L and SPATA22 R615W mutations in Breast Invasive Carcinoma?,ssm_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,what percentage of cases have mutations in both RIPOR2 R499L and MAST4 N229S mutations in Breast Invasive Carcinoma?,ssm_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,what percentage of cases have mutations in both RIPOR2 R504L and DPF3 N65S mutations in Breast Invasive Carcinoma?,ssm_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,what percentage of cases have mutations in both RIPOR2 R520L and FBXO15 R808Q mutations in Breast Invasive Carcinoma?,ssm_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both DCLK3 V520I and GUK1 R470W mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both DCLK3 V689I and ADRA1A A2371V mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both MERTK G257A and SYNJ1 R535W mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both MERTK G757A and CPS1 S174F mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both MERTK G933A and ACTL7B D575Y mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,what percentage of cases have mutations in both ZFP42 R206K and SGCZ S443I mutations in Skin Cutaneous Melanoma?,ssm_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,what percentage of cases have mutations in both OR13C3 M117I and COL6A3 A211T mutations in Skin Cutaneous Melanoma?,ssm_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,what percentage of cases have mutations in both OR13C3 M147I and CTSC K51T mutations in Skin Cutaneous Melanoma?,ssm_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,what percentage of cases have mutations in both SPAG1 I917M and ADRA1A G644S mutations in Stomach Adenocarcinoma?,ssm_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both CDKN2AIP Y92H and BCAT1 A98V mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,what percentage of cases have mutations in both PXN H1016Y and CEP20 S295I mutations in Colon Adenocarcinoma?,ssm_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,what percentage of cases have mutations in both PXN H359Y and SGCZ A29V mutations in Colon Adenocarcinoma?,ssm_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,what percentage of cases have mutations in both PXN H492Y and RIPOR2 M117I mutations in Colon Adenocarcinoma?,ssm_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,what percentage of cases have mutations in both PXN H524Y and PGF D967N mutations in Colon Adenocarcinoma?,ssm_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,what percentage of cases have mutations in both PXN H526Y and ANP32E V557D mutations in Colon Adenocarcinoma?,ssm_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,what percentage of cases have mutations in both PXN H540Y and ACTL7B D575Y mutations in Colon Adenocarcinoma?,ssm_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both TTYH2 S23L and PRSS8 R808Q mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both TTYH2 S44L and ABCC2 I328T mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,what percentage of cases have mutations in both TMEM255A N205S and MORF4L1 P2001S mutations in Colon Adenocarcinoma?,ssm_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,what percentage of cases have mutations in both TMEM255A N229S and CACNA1F R1570Q mutations in Colon Adenocarcinoma?,ssm_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,what percentage of cases have mutations in both TMEM255A N65S and NEXN S2830N mutations in Colon Adenocarcinoma?,ssm_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,what percentage of cases have mutations in both TASOR2 H2271D and MYO16 A29T mutations in Breast Invasive Carcinoma?,ssm_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,what percentage of cases have mutations in both TASOR2 H2486D and DNMT1 C251Y mutations in Breast Invasive Carcinoma?,ssm_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both ICE1 T1839M and GABRA6 S79P mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,what percentage of cases have mutations in both MYT1 A558E and CX3CR1 V601L mutations in Breast Invasive Carcinoma?,ssm_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,what percentage of cases have mutations in both MYT1 A879E and SPATA22 R547W mutations in Breast Invasive Carcinoma?,ssm_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,what percentage of cases have mutations in both MYT1 A906E and GUK1 K778I mutations in Breast Invasive Carcinoma?,ssm_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both CX3CR1 P203L and SOX21 F266L mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both CX3CR1 P235L and HTR3B H472Y mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,what percentage of cases have mutations in both SPINDOC R197C and ZNF804A D575Y mutations in Liver Hepatocellular Carcinoma?,ssm_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both ART3 C251Y and ACTL7B A558E mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both ART3 C3Y and CR1 V307L mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,what percentage of cases have mutations in both CYP1A2 R243G and PHLPP1 V676M mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what percentage of cases have mutations in both ADRA1A G279S and DCN E132K mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both CDH23 P2523R and UNC5D E318K mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both CDH23 P283R and POLD1 V798I mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,what percentage of cases have mutations in both KRT39 P137S and AUTS2 V318I mutations in Skin Cutaneous Melanoma?,ssm_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both PDHA2 S7F and ZMYM3 L1527H mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,what percentage of cases have mutations in both SLC24A2 H200Q and PCDHB2 S842C mutations in Colon Adenocarcinoma?,ssm_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,what percentage of cases have mutations in both PTPRN2 F153L and ZNF627 V239L mutations in Liver Hepatocellular Carcinoma?,ssm_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,what percentage of cases have mutations in both PTPRN2 F847L and CEP20 R206K mutations in Liver Hepatocellular Carcinoma?,ssm_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,what percentage of cases have mutations in both PTPRN2 F856L and CTNNA2 P2987S mutations in Liver Hepatocellular Carcinoma?,ssm_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,what percentage of cases have mutations in both PTPRN2 F868L and TTN R839C mutations in Liver Hepatocellular Carcinoma?,ssm_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,what percentage of cases have mutations in both PTPRN2 F885L and SPATA22 G219E mutations in Liver Hepatocellular Carcinoma?,ssm_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,what percentage of cases have mutations in both SOX21 R55L and TLK2 S551L mutations in Lung Adenocarcinoma?,ssm_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,what percentage of cases have mutations in both CPA6 G166E and HTR3B E8D mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,what percentage of cases have mutations in both GRM5 E14K and MUC16 K1317E mutations in Skin Cutaneous Melanoma?,ssm_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what percentage of cases have mutations in both CASZ1 R233Q and ZNF431 R423W mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,what percentage of cases have mutations in both SGIP1 N122T and SMO N73T mutations in Stomach Adenocarcinoma?,ssm_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,what percentage of cases have mutations in both SGIP1 N420T and ADRA1A P2994S mutations in Stomach Adenocarcinoma?,ssm_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,what percentage of cases have mutations in both SGIP1 N617T and PYHIN1 G191E mutations in Stomach Adenocarcinoma?,ssm_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,what percentage of cases have mutations in both SGIP1 N648T and RIMS2 R304C mutations in Stomach Adenocarcinoma?,ssm_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,what percentage of cases have mutations in both CARMIL1 V549L and KDM5C K322E mutations in Lung Adenocarcinoma?,ssm_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,what percentage of cases have mutations in both CARMIL1 V949L and CACNA1F P203L mutations in Lung Adenocarcinoma?,ssm_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,what percentage of cases have mutations in both ZNF431 D121Y and TYK2 P203L mutations in Lung Adenocarcinoma?,ssm_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,what percentage of cases have mutations in both ZNF431 D161Y and PAPPA E396K mutations in Lung Adenocarcinoma?,ssm_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,what percentage of cases have mutations in both ZNF431 R128I and TTYH2 M484I mutations in Lung Adenocarcinoma?,ssm_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,what percentage of cases have mutations in both DNAH11 P2987S and ZNF708 D67Y mutations in Skin Cutaneous Melanoma?,ssm_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,what percentage of cases have mutations in both DNAH11 P2994S and ACTB L1527H mutations in Skin Cutaneous Melanoma?,ssm_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both POLD1 Q461L and TLCD5 F856L mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,what percentage of cases have mutations in both POLD1 Q85L and EPRS1 F580S mutations in Lung Squamous Cell Carcinoma?,ssm_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,what percentage of cases have mutations in both TTC12 D646H and YY1AP1 S615F mutations in Lung Adenocarcinoma?,ssm_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,what percentage of cases have mutations in both TTC12 D652H and TLK2 R470C mutations in Lung Adenocarcinoma?,ssm_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,what percentage of cases have mutations in both CNGB1 D967N and FRY A233T mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,what percentage of cases have mutations in both CNGB1 D973N and DHX16 E148K mutations in Bladder Urothelial Carcinoma?,ssm_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,what percentage of cases have mutations in both CTSC E214V and NOMO1 T167S mutations in Stomach Adenocarcinoma?,ssm_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,what percentage of cases have mutations in both CTSC E291V and SLC6A4 E53K mutations in Stomach Adenocarcinoma?,ssm_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,what percentage of cases have mutations in both CTSC E322V and DGKD N420T mutations in Stomach Adenocarcinoma?,ssm_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,what percentage of cases have mutations in both CTSC E324V and ZNF708 E209Q mutations in Stomach Adenocarcinoma?,ssm_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,what percentage of cases have mutations in both CTSC E335V and NRAP S256F mutations in Stomach Adenocarcinoma?,ssm_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both PRSS8 A179T and ACTB P56S mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both PRSS8 A233T and SORCS1 E1060K mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,what percentage of cases have mutations in both ARHGEF40 V864F and FNDC7 R169C mutations in Lung Adenocarcinoma?,ssm_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,what percentage of cases have mutations in both ACTB A138T and OR8K5 Y92H mutations in Rectum Adenocarcinoma?,ssm_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,what percentage of cases have mutations in both ACTB A217T and GUK1 R63W mutations in Rectum Adenocarcinoma?,ssm_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,what percentage of cases have mutations in both ACTB A244T and SMO V715D mutations in Rectum Adenocarcinoma?,ssm_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,what percentage of cases have mutations in both ACTB A260T and SORCS1 G165R mutations in Rectum Adenocarcinoma?,ssm_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,what percentage of cases have mutations in both YY1AP1 V546D and JAML R203P mutations in Glioblastoma Multiforme?,ssm_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,what percentage of cases have mutations in both YY1AP1 V557D and AUTS2 S707R mutations in Glioblastoma Multiforme?,ssm_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,what percentage of cases have mutations in both YY1AP1 V566D and MED16 G1857V mutations in Glioblastoma Multiforme?,ssm_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,what percentage of cases have mutations in both YY1AP1 V577D and USH2A A1053T mutations in Glioblastoma Multiforme?,ssm_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,what percentage of cases have mutations in both YY1AP1 V623D and TNS1 V623D mutations in Glioblastoma Multiforme?,ssm_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,what percentage of cases have mutations in both YY1AP1 V695D and RIPOR2 V577D mutations in Glioblastoma Multiforme?,ssm_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,what percentage of cases have mutations in both YY1AP1 V715D and TENM3 R499L mutations in Glioblastoma Multiforme?,ssm_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,what percentage of cases have mutations in both FNDC7 D323N and MORF4L1 P244H mutations in Skin Cutaneous Melanoma?,ssm_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,what percentage of cases have mutations in both FNDC7 D99N and TRPA1 P2001S mutations in Skin Cutaneous Melanoma?,ssm_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,what percentage of cases have mutations in both TLCD5 G15V and DPF3 R203C mutations in Lung Adenocarcinoma?,ssm_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,what percentage of cases have mutations in both TLCD5 G37V and KIF20B L1527H mutations in Lung Adenocarcinoma?,ssm_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both POLR1G R498W and ADAM17 R160H mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both POLR1G R500W and NOMO1 S1937A mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,what percentage of cases have mutations in both DNAH14 N1186K and NRAP R839C mutations in Colon Adenocarcinoma?,ssm_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,what percentage of cases have mutations in both DNAH14 N2657K and PTPRO L280V mutations in Colon Adenocarcinoma?,ssm_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,what percentage of cases have mutations in both DNAH14 N3460K and CFAP61 P2180S mutations in Colon Adenocarcinoma?,ssm_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both NEXN E73D and COL6A3 G181E mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,what percentage of cases have mutations in both CYB5R2 G112R and TTN R163C mutations in Prostate Adenocarcinoma?,ssm_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,what percentage of cases have mutations in both CYB5R2 G172R and DNMT1 E277K mutations in Prostate Adenocarcinoma?,ssm_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both NRAP S808L and EFCAB12 V601L mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both NRAP S816L and DCAF6 R520L mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both NRAP S843L and DSCAM R139P mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both CCDC22 E179D and SGIP1 N3460K mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,what percentage of cases have mutations in both DCAF6 S402F and AUTS2 S1254F mutations in Skin Cutaneous Melanoma?,ssm_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,what percentage of cases have mutations in both DCAF6 S433F and POC1B E923K mutations in Skin Cutaneous Melanoma?,ssm_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both ZNF708 E389D and EIF2B4 R865Q mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both BFAR T103M and BCAT1 R158P mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both MAST4 P1237S and TRIM45 R470L mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both MAST4 P1986S and GPRASP1 S256F mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both MAST4 P1991S and ZCCHC14 S177L mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both MAST4 P2001S and CTNNA2 V949L mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both MAST4 P2180S and DSCAM E96K mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,what percentage of cases have mutations in both ARMC3 R169C and YY1AP1 A2371V mutations in Stomach Adenocarcinoma?,ssm_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,what percentage of cases have mutations in both ARMC3 R432C and AUTS2 S273C mutations in Stomach Adenocarcinoma?,ssm_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,what percentage of cases have mutations in both TET2 L757V and PXN G115R mutations in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,what percentage of cases have mutations in both TET2 L778V and ZCCHC14 G1711V mutations in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,what percentage of cases have mutations in both SERPINB10 A353P and PTPRO K322E mutations in Lung Adenocarcinoma?,ssm_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both STAT3 Y22H and PLEKHG6 V577D mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both MIEF1 A42T and GPR158 R304C mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,what percentage of cases have mutations in both ACVR1B D397N and AQP7 T371I mutations in Colon Adenocarcinoma?,ssm_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,what percentage of cases have mutations in both ACVR1B D449N and SPATA22 L212V mutations in Colon Adenocarcinoma?,ssm_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,what percentage of cases have mutations in both ACVR1B D490N and TNS1 K76T mutations in Colon Adenocarcinoma?,ssm_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,what percentage of cases have mutations in both EBF2 T104I and PTPRO P60A mutations in Stomach Adenocarcinoma?,ssm_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,what percentage of cases have mutations in both EBF2 T252I and GABRA6 D490N mutations in Stomach Adenocarcinoma?,ssm_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,what percentage of cases have mutations in both VPS26B F266L and DGKD L699V mutations in Stomach Adenocarcinoma?,ssm_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what percentage of cases have mutations in both PGR M106I and DNMT1 D973N mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what percentage of cases have mutations in both PGR M38I and TNS1 P667S mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what percentage of cases have mutations in both PGR M632I and OR5D14 L868P mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,what percentage of cases have mutations in both ACTA2 P334L and GPR158 R61W mutations in Skin Cutaneous Melanoma?,ssm_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both THBS4 T852I and CTCFL S273C mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both THBS4 T943I and SYNJ1 A1053T mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,what percentage of cases have mutations in both PRSS1 S114T and AUTS2 G1711V mutations in Lung Adenocarcinoma?,ssm_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,what percentage of cases have mutations in both PRSS1 S124T and DNMT1 S124T mutations in Lung Adenocarcinoma?,ssm_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,what percentage of cases have mutations in both PRSS1 S138T and OR2T4 R181Q mutations in Lung Adenocarcinoma?,ssm_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,what percentage of cases have mutations in both PRSS1 S74T and MAST4 F580S mutations in Lung Adenocarcinoma?,ssm_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,what percentage of cases have mutations in both PGF R126H and EIF2B4 R173C mutations in Stomach Adenocarcinoma?,ssm_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,what percentage of cases have mutations in both PGF R127H and ZNF708 F594L mutations in Stomach Adenocarcinoma?,ssm_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,what percentage of cases have mutations in both ITPRID2 S351C and PYHIN1 P283R mutations in Breast Invasive Carcinoma?,ssm_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,what percentage of cases have mutations in both ITPRID2 S842C and GLRB R500Q mutations in Breast Invasive Carcinoma?,ssm_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both HBB E8D and CFAP298-TCP10L I161N mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,what percentage of cases have mutations in both PCDHB2 R158C and NRAP E132K mutations in Colon Adenocarcinoma?,ssm_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,what percentage of cases have mutations in both PCDHB2 T15M and ADRA1A R1053H mutations in Colon Adenocarcinoma?,ssm_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,what percentage of cases have mutations in both PCDHB2 T26M and ACVR1B P244H mutations in Colon Adenocarcinoma?,ssm_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,what percentage of cases have mutations in both UBR2 P1594S and ZMYM3 E583K mutations in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,what percentage of cases have mutations in both FBXO42 A618D and POLD1 R363W mutations in Rectum Adenocarcinoma?,ssm_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,what proportion of Breast Invasive Carcinoma patients have mutations in both TNS1 G1362V and MERTK G122R?,ssm_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,what proportion of Breast Invasive Carcinoma patients have mutations in both TNS1 G1711V and NOMO1 R800C?,ssm_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,what proportion of Breast Invasive Carcinoma patients have mutations in both TNS1 G1718V and CTCFL F153L?,ssm_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,what proportion of Breast Invasive Carcinoma patients have mutations in both TNS1 G1732V and VPS26B A1037T?,ssm_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,what proportion of Breast Invasive Carcinoma patients have mutations in both TNS1 G1824V and DCC L704V?,ssm_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,what proportion of Breast Invasive Carcinoma patients have mutations in both TNS1 G1857V and PCDHB2 P334L?,ssm_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,what proportion of Breast Invasive Carcinoma patients have mutations in both TNS1 G843V and DSCAM K102N?,ssm_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,what proportion of Bladder Urothelial Carcinoma patients have mutations in both EVC2 E1067K and KANSL1 K29T?,ssm_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,what proportion of Bladder Urothelial Carcinoma patients have mutations in both EVC2 E987K and SPINDOC N122T?,ssm_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both CR1 V1108G and COL6A3 R169C?,ssm_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both CR1 V1558G and MYO15A G165R?,ssm_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,what proportion of Rectum Adenocarcinoma patients have mutations in both TRPA1 S295I and TMEM255A H27Y?,ssm_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,what proportion of Rectum Adenocarcinoma patients have mutations in both TRPA1 S443I and ANKRD30A I265M?,ssm_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both TAF1C R299L and KDM5C A138T?,ssm_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both TAF1C R396L and MRPL55 P13R?,ssm_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both TAF1C R634L and TAF1C R299L?,ssm_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both TAF1C R702L and BCAT1 A2371V?,ssm_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both TAF1C R728L and SPTAN1 A42T?,ssm_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both DPF3 R104W and NCKAP5 G159E?,ssm_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both DPF3 R149W and OR8K5 S401F?,ssm_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both DPF3 R94W and FRY S1503F?,ssm_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both OR2T4 P272H and CCDC22 R139G?,ssm_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both OR2T4 P300H and CTSC L868P?,ssm_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,what proportion of Pancreatic Adenocarcinoma patients have mutations in both FBN1 E2667K and ZFAT K76T?,ssm_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,what proportion of Prostate Adenocarcinoma patients have mutations in both MAD1L1 E396K and RAB40C P123S?,ssm_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,what proportion of Prostate Adenocarcinoma patients have mutations in both MAD1L1 E488K and ZBTB34 S402F?,ssm_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,what proportion of Prostate Adenocarcinoma patients have mutations in both MAD1L1 E78K and CNGB1 E987K?,ssm_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both CCNG1 E22K and AQP7 E131K?,ssm_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,what proportion of Kidney Renal Papillary Cell Carcinoma patients have mutations in both ANP32E N114T and EIF2B4 S1888A?,ssm_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,what proportion of Kidney Renal Papillary Cell Carcinoma patients have mutations in both ANP32E N64T and THBS4 P136S?,ssm_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,what proportion of Kidney Renal Papillary Cell Carcinoma patients have mutations in both ANP32E N66T and TAF1C G667R?,ssm_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,what proportion of Kidney Renal Papillary Cell Carcinoma patients have mutations in both ANP32E N73T and SLC9C1 R504L?,ssm_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,what proportion of Bladder Urothelial Carcinoma patients have mutations in both FRY S1888A and TYROBP A138T?,ssm_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,what proportion of Bladder Urothelial Carcinoma patients have mutations in both FRY S1937A and THBS4 T252I?,ssm_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,what proportion of Bladder Urothelial Carcinoma patients have mutations in both FRY S1938A and CTCFL E355K?,ssm_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,what proportion of Bladder Urothelial Carcinoma patients have mutations in both FRY S1983A and TMEM255A L153F?,ssm_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both PAK3 E318K and YY1AP1 L778V?,ssm_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both PAK3 E319K and DPF3 G844S?,ssm_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both PAK3 E334K and TRPA1 S268R?,ssm_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both PAK3 E340K and VASN H23R?,ssm_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both PAK3 E355K and FRY P419S?,ssm_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both MUC16 P7963L and FRY N66T?,ssm_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,what proportion of Liver Hepatocellular Carcinoma patients have mutations in both ZFPM2 T498I and SIK2 D646H?,ssm_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,what proportion of Liver Hepatocellular Carcinoma patients have mutations in both ZFPM2 T630I and ZBTB34 R499L?,ssm_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,what proportion of Breast Invasive Carcinoma patients have mutations in both PIK3C2B S1328C and CTSC R396L?,ssm_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,what proportion of Breast Invasive Carcinoma patients have mutations in both PIK3C2B S1356C and FMO4 A256T?,ssm_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both ZNF804A S371Y and POLR1G G181E?,ssm_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both RELN A2371V and TRPA1 N114T?,ssm_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have mutations in both EFCAB12 R173C and GABRA6 R204H?",ssm_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have mutations in both EFCAB12 R23C and ACVR1B N648T?",ssm_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both DEFB115 E53K and GSTCD R233Q?,ssm_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,what proportion of Bladder Urothelial Carcinoma patients have mutations in both ANKDD1A S290F and MAST4 D44N?,ssm_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,what proportion of Bladder Urothelial Carcinoma patients have mutations in both ANKDD1A S322F and EPRS1 R127H?,ssm_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,what proportion of Bladder Urothelial Carcinoma patients have mutations in both ANKDD1A S413F and CA9 S551L?,ssm_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both HTR3B S146I and DPF3 P203L?,ssm_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both HTR3B S206I and FGF8 S281L?,ssm_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both HTR3B S217I and SPTAN1 D397N?,ssm_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both ABCC3 R758W and OR2T4 F580S?,ssm_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both NOMO1 T204I and ZNF804A R808Q?,ssm_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both NOMO1 T371I and PCDHGA1 D1052Y?,ssm_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,what proportion of Bladder Urothelial Carcinoma patients have mutations in both HYOU1 D298H and ZCCHC14 R1053H?,ssm_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both FMO4 R500Q and MAD1L1 R634L?,ssm_frequency
+140,BICC1,A372V,Exceptional Responders,what proportion of Exceptional Responders patients have mutations in both BICC1 A372V and MAST4 P1991S?,ssm_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both ZMYM3 I920V and MYO3A G1718V?,ssm_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both ZMYM3 I932V and COL6A3 A211T?,ssm_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both ZMYM3 I934V and CTSC G200E?,ssm_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have mutations in both XKR4 R547W and BCAT1 A5V?",ssm_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,what proportion of Liver Hepatocellular Carcinoma patients have mutations in both ABCC2 V239L and GUCY2C E319K?,ssm_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both OR8K5 R293G and CHODL E987K?,ssm_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both SPTAN1 S1503F and MYT1 H240Y?,ssm_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both SPTAN1 S1523F and ICE1 P300H?,ssm_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,what proportion of Rectum Adenocarcinoma patients have mutations in both SYT10 M484I and ACTB A89V?,ssm_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both HSPA5 N457K and SGCZ R728L?,ssm_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both UNC5D L280V and DCAF4L2 D223N?,ssm_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both UNC5D L635V and GUK1 S816L?,ssm_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both UNC5D L637V and POC1B S174F?,ssm_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both UNC5D L699V and GABRA6 V430L?,ssm_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both UNC5D L704V and DCN M117I?,ssm_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both UNC5D L709V and ANP32E R63W?,ssm_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,what proportion of Kidney Renal Clear Cell Carcinoma patients have mutations in both DOCK2 L1527H and TAF1C S36F?,ssm_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,what proportion of Kidney Renal Clear Cell Carcinoma patients have mutations in both ZNF627 A5V and PAK3 E277K?,ssm_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both CDC42BPA L823F and CARMIL1 A260T?,ssm_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both MRPL55 H27Y and JAML A618D?,ssm_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both MRPL55 H63Y and ITPRID2 R173C?,ssm_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,what proportion of Breast Invasive Carcinoma patients have mutations in both TMTC3 Q749K and KIF20B P122S?,ssm_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both EPRS1 K771I and PTPRO E214V?,ssm_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both EPRS1 K778I and ANKDD1A P283R?,ssm_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both GRTP1 A110V and SMO H472Y?,ssm_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both GRTP1 A32V and AUTS2 I107N?,ssm_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both TSHZ3 Q538K and FBXO42 D397N?,ssm_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,what proportion of HIV+ Tumor Molecular Characterization Project - Cervical Cancer patients have mutations in both TAS1R3 Q326H and ZNF627 G237S?,ssm_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both PIAS3 S238C and AUTS2 H1016Y?,ssm_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both PIAS3 S273C and ANKRD30A I198T?,ssm_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both ZNF274 P13R and HTR3B S351C?,ssm_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both SYNJ1 R795C and SPATA22 E131K?,ssm_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both SYNJ1 R800C and EVC2 C251Y?,ssm_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both SYNJ1 R839C and AKT1 A167T?,ssm_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,what proportion of Prostate Adenocarcinoma patients have mutations in both DSCAM V343M and FBXO42 H351Y?,ssm_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,what proportion of Prostate Adenocarcinoma patients have mutations in both DSCAM V426M and TYROBP A1037T?,ssm_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,what proportion of Prostate Adenocarcinoma patients have mutations in both DSCAM V591M and POLR1G S123L?,ssm_frequency
+267,DGKD,R140H,Exceptional Responders,what proportion of Exceptional Responders patients have mutations in both DGKD R140H and EBF2 G15V?,ssm_frequency
+268,DGKD,R160H,Exceptional Responders,what proportion of Exceptional Responders patients have mutations in both DGKD R160H and PAK3 T498I?,ssm_frequency
+269,DGKD,R204H,Exceptional Responders,what proportion of Exceptional Responders patients have mutations in both DGKD R204H and TLCD5 G844S?,ssm_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,what proportion of Bladder Urothelial Carcinoma patients have mutations in both PLEKHG6 D105Y and CTSC E291V?,ssm_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,what proportion of Bladder Urothelial Carcinoma patients have mutations in both PLEKHG6 D543Y and TRPA1 M484I?,ssm_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,what proportion of Bladder Urothelial Carcinoma patients have mutations in both PLEKHG6 D575Y and SGCZ K306E?,ssm_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both WNT2 D138N and CTCFL P421H?,ssm_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both GUCY2C G667R and PHLPP1 G219E?,ssm_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both C7orf31 P244H and DNAH14 E389D?,ssm_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have mutations in both ZKSCAN7 E64K and SPINDOC V601L?",ssm_frequency
+299,OR5D14,M210L,Neuroblastoma,what proportion of Neuroblastoma patients have mutations in both OR5D14 M210L and PGR N251T?,ssm_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both SPATA22 K279E and LAMB2 A372V?,ssm_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both SPATA22 K306E and HTR3B S322F?,ssm_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both SPATA22 K322E and GUCY2C K1317E?,ssm_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both LCN15 E21V and PRSS1 G165R?,ssm_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both DCAF4L2 S129F and MYT1 S273C?,ssm_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both GUK1 R135P and TMEM255A A584T?,ssm_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both GUK1 R137P and DCAF4L2 N457K?,ssm_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both GUK1 R139P and TENM2 F885L?,ssm_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both GUK1 R158P and SORCS1 R158C?,ssm_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both GUK1 R203P and TENT5A S843L?,ssm_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both MORF4L1 K29T and HLA-DQA2 T75S?,ssm_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both MORF4L1 K51T and JAML G257A?,ssm_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both MORF4L1 K61T and MYT1 S1356C?,ssm_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both MORF4L1 K76T and ARMC3 A110V?,ssm_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both MYO3B F594L and TTC12 N3460K?,ssm_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both MYO3B F603L and EIF2B4 N114T?,ssm_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both TENT5A S320F and EPRS1 I198T?,ssm_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both TENT5A S339F and GUCY2C G843V?,ssm_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both TENT5A S401F and PTPRO R41W?,ssm_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,what proportion of Ovarian Serous Cystadenocarcinoma patients have mutations in both ZFAT S614L and OR13C3 R348G?,ssm_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,what proportion of Ovarian Serous Cystadenocarcinoma patients have mutations in both ZFAT S664L and PAK3 S74T?,ssm_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,what proportion of Ovarian Serous Cystadenocarcinoma patients have mutations in both ZFAT S676L and PTPRO R363W?,ssm_frequency
+357,ZNF584,A211T,Sarcoma,what proportion of Sarcoma patients have mutations in both ZNF584 A211T and RIMS2 P203L?,ssm_frequency
+358,ZNF584,A256T,Sarcoma,what proportion of Sarcoma patients have mutations in both ZNF584 A256T and FCGR2C R265C?,ssm_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both LDOC1 R63W and GSTCD I932V?,ssm_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both PDGFC R201G and PRSS1 K29N?,ssm_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both MSANTD4 R304C and MSANTD4 R94W?,ssm_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both NPSR1 S123L and ACTA2 P296S?,ssm_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both PHLPP1 K1317E and TAF1C L699V?,ssm_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both COL6A3 G237S and PCDHB2 G792V?,ssm_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both COL6A3 G437S and ZFAT S371Y?,ssm_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both COL6A3 G638S and TYK2 E249K?,ssm_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both COL6A3 G644S and SGIP1 S2830N?,ssm_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both COL6A3 G844S and ACTA2 E249K?,ssm_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both ADRA1A R348G and TASOR2 R1877W?,ssm_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have mutations in both LAMB2 S1254F and ACTB G1824V?,ssm_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,what proportion of Rectum Adenocarcinoma patients have mutations in both POC1B I198T and RAB40C E8D?,ssm_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,what proportion of Rectum Adenocarcinoma patients have mutations in both POC1B I286T and FGF8 R808Q?,ssm_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,what proportion of Rectum Adenocarcinoma patients have mutations in both POC1B I328T and PXN Q326H?,ssm_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,what proportion of Rectum Adenocarcinoma patients have mutations in both POC1B S79P and ANKDD1A R126H?,ssm_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,what proportion of Liver Hepatocellular Carcinoma patients have mutations in both USH2A G1451C and SPTAN1 R499L?,ssm_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,what proportion of Rectum Adenocarcinoma patients have mutations in both AQP7 T110S and SMO V601L?,ssm_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,what proportion of Rectum Adenocarcinoma patients have mutations in both AQP7 T166S and TYK2 R520L?,ssm_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,what proportion of Rectum Adenocarcinoma patients have mutations in both AQP7 T167S and MAST4 G165R?,ssm_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,what proportion of Rectum Adenocarcinoma patients have mutations in both AQP7 T75S and SPTAN1 G16R?,ssm_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,what proportion of Rectum Adenocarcinoma patients have mutations in both DCN R163C and SLC9C1 G933A?,ssm_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,what proportion of Rectum Adenocarcinoma patients have mutations in both DCN R203C and UNC5D D397N?,ssm_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,what proportion of Rectum Adenocarcinoma patients have mutations in both DCN R241C and DNAH14 A138T?,ssm_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,what proportion of Rectum Adenocarcinoma patients have mutations in both DCN R350C and ACTB E14K?,ssm_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,what proportion of Rectum Adenocarcinoma patients have mutations in both DCN R41C and CEP20 N64T?,ssm_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both CPS1 K1269N and EIF2B4 E987K?,ssm_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both CPS1 K1275N and CEP20 R104W?,ssm_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both CPS1 K818N and PIAS3 L1527H?,ssm_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,what proportion of Kidney Renal Papillary Cell Carcinoma patients have mutations in both FCGR2C P122S and ICE1 V307L?,ssm_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,what proportion of Kidney Renal Papillary Cell Carcinoma patients have mutations in both FCGR2C P123S and ANKRD30A D323N?,ssm_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both GRM1 R280M and DHX16 H526Y?,ssm_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both SGCZ Q138H and BCAT1 S471F?,ssm_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both SGCZ Q91H and AUTS2 V566D?,ssm_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both SMO V15M and ANP32E A244T?,ssm_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both SMO V321M and ZNF584 S614L?,ssm_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both CHODL G159E and TAF1C S256F?,ssm_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both CHODL G181E and AQP7 A539V?,ssm_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both CHODL G200E and PCDHB2 D138N?,ssm_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both MYO16 P399H and HBB Q326H?,ssm_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both MYO16 P421H and MAOB M117I?,ssm_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both CXCR2 A98V and SGCZ E1067K?,ssm_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,what proportion of Bladder Urothelial Carcinoma patients have mutations in both TMEM225 L212V and TNS1 I917M?,ssm_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both MAOB N251T and PCDHB2 R41C?,ssm_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both GPRASP1 F580S and ZFP42 L126P?,ssm_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both MRPL32 R181Q and ZMYM3 A110V?,ssm_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both TYROBP A29T and ZNF584 S1983A?,ssm_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both RAB40C A111V and MAST4 S707R?,ssm_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both RAB40C A143V and HBB L757V?,ssm_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both CTNNA2 S323R and SERPINB10 P357S?,ssm_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both CTNNA2 S339R and JAML R423W?,ssm_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both CTNNA2 S386R and TNS1 F594L?,ssm_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both CTNNA2 S707R and AUTS2 L699V?,ssm_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,what proportion of Bladder Urothelial Carcinoma patients have mutations in both MYO15A S268R and TAF1L S1523F?,ssm_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both GIMAP2 A167T and JAML A558E?,ssm_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,what proportion of Glioblastoma Multiforme patients have mutations in both KIF20B N1160D and TNS1 G1857V?,ssm_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,what proportion of Glioblastoma Multiforme patients have mutations in both KIF20B N1200D and LDOC1 V1108G?,ssm_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both ADAM17 E583K and OLFML3 L1527H?,ssm_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both BCAT1 G16R and ACTB V1108G?,ssm_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both BCAT1 G17R and DPF3 L823F?,ssm_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both BCAT1 G29R and SPATA22 V601L?,ssm_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both ERCC6 R1053H and SLC24A2 R280M?,ssm_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,what proportion of Breast Invasive Carcinoma patients have mutations in both DCC R320W and TENT5A G29R?,ssm_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,what proportion of Breast Invasive Carcinoma patients have mutations in both DCC R363W and ART3 T371I?,ssm_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,what proportion of Breast Invasive Carcinoma patients have mutations in both DCC R386W and ANKDD1A E22K?,ssm_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,what proportion of Breast Invasive Carcinoma patients have mutations in both DCC R41W and TLK2 T15M?,ssm_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both FBXO15 D417N and GRTP1 D652H?,ssm_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both FBXO15 D86N and MYO15A F8880L?,ssm_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both GSTCD S528F and BICC1 P2180S?,ssm_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both GSTCD S615F and PRSS8 L637V?,ssm_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both OLFML3 P296S and DCN R61W?,ssm_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both OLFML3 P337S and ITPRID2 P2523R?,ssm_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both OLFML3 P357S and REXO4 H492Y?,ssm_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,what proportion of Ovarian Serous Cystadenocarcinoma patients have mutations in both CFAP61 E173V and ABCC2 M210L?,ssm_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,what proportion of Ovarian Serous Cystadenocarcinoma patients have mutations in both CFAP61 E817V and HLA-DQA2 V275L?,ssm_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,what proportion of Bladder Urothelial Carcinoma patients have mutations in both HLA-DQA2 E51K and SYT9 S707R?,ssm_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both TENM2 H240Y and CDKN2AIP R350C?,ssm_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both TENM2 H351Y and RAB40C P357S?,ssm_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both TENM2 H472Y and RIMS2 R280M?,ssm_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both ANKRD24 A465T and CTSC S7F?,ssm_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both ANKRD24 A494T and ART3 V949L?,ssm_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both ANKRD24 A584T and TMEM255A K1317E?,ssm_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both ZCCHC14 V549M and CARMIL1 F885L?,ssm_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both ZCCHC14 V665M and PGF L153F?,ssm_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both ZCCHC14 V676M and TLK2 D575Y?,ssm_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both ZCCHC14 V802M and MORF4L1 R619W?,ssm_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both SIK2 I265M and CX3CR1 L637V?,ssm_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both MYH11 T1336M and ANKRD24 I917M?,ssm_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both MYH11 T1343M and BCAT1 E22K?,ssm_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both SLC6A4 S174F and PAK3 F856L?,ssm_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both SLC9C1 K102N and ZMYM3 A211T?,ssm_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both SLC9C1 K29N and KIF20B P60A?,ssm_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,what proportion of Brain Lower Grade Glioma patients have mutations in both OR2A12 A254T and PRSS1 R208C?,ssm_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both PYHIN1 T325K and SORCS1 D161Y?,ssm_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both PYHIN1 T334K and DNMT1 H27Y?,ssm_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both JAML G191E and UNC5D S273C?,ssm_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both JAML G219E and TSHZ3 T498I?,ssm_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both JAML G220E and MRPL55 R280M?,ssm_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both JAML G230E and CCDC22 G115R?,ssm_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both TYK2 H1146R and KIF20B R241C?,ssm_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both TYK2 H23R and ACTB R158C?,ssm_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both TYK2 H961R and YY1AP1 G172R?,ssm_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both CTCFL R208C and ZFAT E817V?,ssm_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both CTCFL R265C and DNAH11 S224L?,ssm_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both CTCFL R420C and C7orf31 R293G?,ssm_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both CTCFL R470C and FCGR2C N66T?,ssm_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both CEP20 R31Q and KL D449N?,ssm_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both CEP20 R58Q and OR2T4 D67Y?,ssm_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both RIMS2 R25W and ZNF217 M484I?,ssm_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both RIMS2 R393W and TTN A89V?,ssm_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both RIMS2 R423W and PIAS3 N2657K?,ssm_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both RIMS2 R470W and TMEM255A K29T?,ssm_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both RIMS2 R615W and RELN P218S?,ssm_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both RIMS2 R619W and GPR158 I198T?,ssm_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both RIMS2 R716W and DGKD C3Y?,ssm_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both PIK3C2G S551L and TENT5A S808L?,ssm_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both PIK3C2G S592L and AUTS2 G220E?,ssm_frequency
+728,STK19,D341N,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both STK19 D341N and KRT39 V549L?,ssm_frequency
+729,STK19,D345N,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both STK19 D345N and TLK2 A138T?,ssm_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both REXO4 P60A and ANKRD24 R140H?,ssm_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both ZBTB34 P160S and DCLK3 R31Q?,ssm_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both ZBTB34 P164S and AUTS2 R63W?,ssm_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,what proportion of Bladder Urothelial Carcinoma patients have mutations in both NCKAP5 E148K and GPR158 R702L?,ssm_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have mutations in both SORCS1 D1052Y and GABRA6 N420T?",ssm_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have mutations in both SORCS1 D587Y and THBS4 R149W?",ssm_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have mutations in both SORCS1 D67Y and EBF2 K76T?",ssm_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have mutations in both SORCS1 D810Y and ZBTB34 E318K?",ssm_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,what proportion of Head and Neck Squamous Cell Carcinoma patients have mutations in both FGF8 T154M and CTCFL A906E?,ssm_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,what proportion of Head and Neck Squamous Cell Carcinoma patients have mutations in both FGF8 T165M and PTPRO E324V?,ssm_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,what proportion of Head and Neck Squamous Cell Carcinoma patients have mutations in both FGF8 T183M and HTR3B R206K?,ssm_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,what proportion of Head and Neck Squamous Cell Carcinoma patients have mutations in both FGF8 T194M and SPTAN1 R243G?,ssm_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,what proportion of Head and Neck Squamous Cell Carcinoma patients have mutations in both FGF8 T90M and TAF1C R58Q?,ssm_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,what proportion of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia patients have mutations in both TENM3 R1877W and ANKRD24 V676M?,ssm_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both AKT1 D44N and TTC17 T75S?,ssm_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have mutations in both CFAP298-TCP10L E11Q and ART3 V1558G?,ssm_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both GLRB E148D and CFAP298-TCP10L I265M?,ssm_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both TTN F7636L and OR2T4 M38I?,ssm_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both TTN F8563L and GRM1 E67K?,ssm_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both TTN F8880L and ICE1 P1237S?,ssm_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both ANKRD30A V798I and DNMT1 D543Y?,ssm_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both ANKRD30A V854I and RIMS2 M106I?,ssm_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both ANKRD30A V973I and TRIM45 E940K?,ssm_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both TRIM45 S177L and PDHA2 A256T?,ssm_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both TRIM45 S224L and FGF8 P218S?,ssm_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both TRIM45 S281L and CARMIL1 E1067K?,ssm_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both CACNA1F G727V and ANKRD24 E22K?,ssm_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both CACNA1F G781V and SLC6A4 P13R?,ssm_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both CACNA1F G792V and SERPINB10 D345N?,ssm_frequency
+817,KL,R594C,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both KL R594C and CYP1A2 E987K?,ssm_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,what proportion of Kidney Renal Papillary Cell Carcinoma patients have mutations in both GUF1 I243T and RIMS2 R348G?,ssm_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both TAF1L A539V and STK19 S402F?,ssm_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both TASOR2 S256F and MYO3B S551L?,ssm_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both TASOR2 S36F and EIF2B4 R126H?,ssm_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both TASOR2 S471F and PXN R293G?,ssm_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both KDM5C R1151C and PIAS3 G1580S?,ssm_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both KDM5C R1177C and DCN R126H?,ssm_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both KDM5C R1217C and CPS1 H526Y?,ssm_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both KDM5C R1218C and SERPINB10 A879E?,ssm_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have mutations in both IL5RA L153F and FNDC7 G172R?,ssm_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both DHX16 A29V and EVC2 E14K?,ssm_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both DHX16 A89V and ANKRD24 M484I?,ssm_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both GPR158 A644V and CHODL H1016Y?,ssm_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both GPR158 A723V and MUC16 A29V?,ssm_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have mutations in both EIF2B4 E108K and TRIM45 C3Y?",ssm_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have mutations in both EIF2B4 E110K and MRPL32 G200E?",ssm_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have mutations in both EIF2B4 E111K and TENT5A L709V?",ssm_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have mutations in both EIF2B4 E131K and MED16 R1877W?",ssm_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have mutations in both EIF2B4 E132K and THBS4 G115R?",ssm_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have mutations in both EIF2B4 E96K and DCN K29T?",ssm_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both AUTS2 P136S and STK19 A138T?,ssm_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both AUTS2 P218S and SLC9C1 H540Y?,ssm_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both AUTS2 P233S and POC1B G644S?,ssm_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both AUTS2 P313S and EFCAB12 D490N?,ssm_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both AUTS2 P419S and SIK2 T498I?,ssm_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both AUTS2 P443S and PGR Y22H?,ssm_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both AUTS2 P56S and PTPRN2 Q749K?,ssm_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both AUTS2 P667S and TLCD5 K279E?,ssm_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both AUTS2 P690S and DNAH11 P136S?,ssm_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both AUTS2 P691S and GRM5 V343M?,ssm_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have mutations in both ACTL7B D223N and COL6A3 N251T?",ssm_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,what proportion of Glioblastoma Multiforme patients have mutations in both PCDHGA1 R535W and PAK3 E335V?,ssm_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both TRAP1 R114W and ZNF584 E2667K?,ssm_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both TRAP1 R61W and DCLK3 K818N?,ssm_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both PIK3C2A R1570Q and PDHA2 S1328C?,ssm_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,what proportion of Liver Hepatocellular Carcinoma patients have mutations in both KANSL1 R139G and EBF2 S1503F?,ssm_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both ANKRD52 Y594C and PAK3 A353P?,ssm_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both PAPPA G1580S and TENT5A R160H?,ssm_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,what proportion of Rectum Adenocarcinoma patients have mutations in both B3GALNT1 V270A and TENM3 S224L?,ssm_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both GABRA6 G115R and CPS1 G638S?,ssm_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both GABRA6 G122R and REXO4 T943I?,ssm_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both GABRA6 G165R and FBN1 E131K?,ssm_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both GABRA6 G175R and GSTCD E73D?,ssm_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both GABRA6 G70R and PYHIN1 S664L?,ssm_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both ZSCAN31 D9N and DCAF4L2 S614L?,ssm_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have mutations in both MED16 L126P and CNGB1 R58Q?",ssm_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have mutations in both MED16 L868P and MORF4L1 R293G?",ssm_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,what proportion of Pancreatic Adenocarcinoma patients have mutations in both PTPRO E1060K and MED16 A256T?,ssm_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,what proportion of Pancreatic Adenocarcinoma patients have mutations in both PTPRO E1088K and PCDHB2 G17R?,ssm_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,what proportion of Pancreatic Adenocarcinoma patients have mutations in both PTPRO E249K and PAPPA G237S?,ssm_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,what proportion of Pancreatic Adenocarcinoma patients have mutations in both PTPRO E265K and UNC5D N457K?,ssm_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,what proportion of Pancreatic Adenocarcinoma patients have mutations in both PTPRO E277K and DNAH14 R499L?,ssm_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,what proportion of Pancreatic Adenocarcinoma patients have mutations in both PTPRO E67K and SPATA22 G437S?,ssm_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,what proportion of Pancreatic Adenocarcinoma patients have mutations in both PTPRO E923K and SMO V547L?,ssm_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,what proportion of Pancreatic Adenocarcinoma patients have mutations in both PTPRO E940K and PCDHGA1 E11Q?,ssm_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both CHMP7 D397N and PGR G220E?,ssm_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both GPC3 I107N and TENM2 E940K?,ssm_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both GPC3 I161N and GABRA6 S816L?,ssm_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have mutations in both TLK2 V430L and SGCZ V430L?,ssm_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have mutations in both TLK2 V515L and MED16 E249K?,ssm_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have mutations in both TLK2 V547L and TLK2 K322E?,ssm_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have mutations in both TLK2 V579L and CHMP7 V566D?,ssm_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have mutations in both TLK2 V601L and GLRB A167T?,ssm_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both ZNF217 E209Q and ICE1 S433F?,ssm_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both SYT9 V275L and ZNF431 A167T?,ssm_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both SYT9 V307L and MORF4L1 E2667K?,ssm_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both PKHD1L1 S2830N and BFAR L280V?,ssm_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both MYO3A Y1295C and CX3CR1 E265K?,ssm_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have mutations in both VASN V318I and FBXO42 S443I?",ssm_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both DNMT1 A1037T and PAK3 G172R?,ssm_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both DNMT1 A1053T and VASN V715D?,ssm_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both DNMT1 A934T and ZNF431 D1052Y?,ssm_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both CA9 E402K and VASN G112R?,ssm_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both TTC17 R808Q and EPRS1 N229S?,ssm_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both TTC17 R865Q and CDH23 G237S?,ssm_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,what proportion of Breast Invasive Carcinoma patients have mutations in both PSG2 P43L and AUTS2 R197C?,ssm_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,what proportion of Breast Invasive Carcinoma patients have mutations in both RIPOR2 R470L and CR1 P421H?,ssm_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,what proportion of Breast Invasive Carcinoma patients have mutations in both RIPOR2 R499L and MED16 R25W?,ssm_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,what proportion of Breast Invasive Carcinoma patients have mutations in both RIPOR2 R504L and ACTL7B S676L?,ssm_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,what proportion of Breast Invasive Carcinoma patients have mutations in both RIPOR2 R520L and NOMO1 M484I?,ssm_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both DCLK3 V520I and ANKRD24 G112R?,ssm_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both DCLK3 V689I and TMEM255A R158C?,ssm_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both MERTK G257A and ART3 P13R?,ssm_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both MERTK G757A and SGIP1 F153L?,ssm_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both MERTK G933A and DCN E22K?,ssm_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both ZFP42 R206K and HTR3B R241C?,ssm_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both OR13C3 M117I and OLFML3 D810Y?,ssm_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both OR13C3 M147I and MED16 P60A?,ssm_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both SPAG1 I917M and PCDHGA1 S268R?,ssm_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both CDKN2AIP Y92H and KRT39 S217I?,ssm_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both PXN H1016Y and CPA6 R128I?,ssm_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both PXN H359Y and PHLPP1 P1986S?,ssm_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both PXN H492Y and GPRASP1 P203L?,ssm_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both PXN H524Y and GABRA6 A167T?,ssm_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both PXN H526Y and ITPRID2 N1200D?,ssm_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both PXN H540Y and ZNF217 V798I?,ssm_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both TTYH2 S23L and MUC16 A217T?,ssm_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both TTYH2 S44L and AUTS2 R1877W?,ssm_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both TMEM255A N205S and FCGR2C T103M?,ssm_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both TMEM255A N229S and RIMS2 R386W?,ssm_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both TMEM255A N65S and PRSS1 H1146R?,ssm_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,what proportion of Breast Invasive Carcinoma patients have mutations in both TASOR2 H2271D and EPRS1 V695D?,ssm_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,what proportion of Breast Invasive Carcinoma patients have mutations in both TASOR2 H2486D and CACNA1F D397N?,ssm_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both ICE1 T1839M and ADAM17 H63Y?,ssm_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,what proportion of Breast Invasive Carcinoma patients have mutations in both MYT1 A558E and PIK3C2G A723V?,ssm_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,what proportion of Breast Invasive Carcinoma patients have mutations in both MYT1 A879E and CTNNA2 G1824V?,ssm_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,what proportion of Breast Invasive Carcinoma patients have mutations in both MYT1 A906E and AQP7 R114W?,ssm_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both CX3CR1 P203L and OR13C3 G933A?,ssm_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both CX3CR1 P235L and BCAT1 P1237S?,ssm_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,what proportion of Liver Hepatocellular Carcinoma patients have mutations in both SPINDOC R197C and PIAS3 E110K?,ssm_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both ART3 C251Y and OR2T4 R58Q?,ssm_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both ART3 C3Y and JAML L757V?,ssm_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,what proportion of Bladder Urothelial Carcinoma patients have mutations in both CYP1A2 R243G and TASOR2 R63W?,ssm_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have mutations in both ADRA1A G279S and GABRA6 T371I?",ssm_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both CDH23 P2523R and DNAH14 D138N?,ssm_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both CDH23 P283R and ART3 R500Q?,ssm_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both KRT39 P137S and GRTP1 S320F?,ssm_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both PDHA2 S7F and ACVR1B G781V?,ssm_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both SLC24A2 H200Q and CDKN2AIP R1053H?,ssm_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,what proportion of Liver Hepatocellular Carcinoma patients have mutations in both PTPRN2 F153L and ACTB P2180S?,ssm_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,what proportion of Liver Hepatocellular Carcinoma patients have mutations in both PTPRN2 F847L and DGKD S351C?,ssm_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,what proportion of Liver Hepatocellular Carcinoma patients have mutations in both PTPRN2 F856L and PTPRO S129F?,ssm_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,what proportion of Liver Hepatocellular Carcinoma patients have mutations in both PTPRN2 F868L and ACTB A256T?,ssm_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,what proportion of Liver Hepatocellular Carcinoma patients have mutations in both PTPRN2 F885L and ART3 D490N?,ssm_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both SOX21 R55L and DNAH14 E940K?,ssm_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,what proportion of Bladder Urothelial Carcinoma patients have mutations in both CPA6 G166E and TAF1C E817V?,ssm_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both GRM5 E14K and TMEM225 A89V?,ssm_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have mutations in both CASZ1 R233Q and SYNJ1 T165M?",ssm_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both SGIP1 N122T and SPTAN1 G667R?,ssm_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both SGIP1 N420T and PIK3C2A P1237S?,ssm_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both SGIP1 N617T and EBF2 R504L?,ssm_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both SGIP1 N648T and PLEKHG6 S1937A?,ssm_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both CARMIL1 V549L and CTNNA2 G843V?,ssm_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both CARMIL1 V949L and KDM5C G181E?,ssm_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both ZNF431 D121Y and TMEM255A G115R?,ssm_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both ZNF431 D161Y and CYP1A2 K29T?,ssm_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both ZNF431 R128I and MERTK R149W?,ssm_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both DNAH11 P2987S and DCN L868P?,ssm_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both DNAH11 P2994S and PKHD1L1 R293G?,ssm_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both POLD1 Q461L and GRM1 R201G?,ssm_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,what proportion of Lung Squamous Cell Carcinoma patients have mutations in both POLD1 Q85L and TTC12 R702L?,ssm_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both TTC12 D646H and YY1AP1 Y92H?,ssm_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both TTC12 D652H and PGF E1088K?,ssm_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,what proportion of Bladder Urothelial Carcinoma patients have mutations in both CNGB1 D967N and DCC D1052Y?,ssm_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,what proportion of Bladder Urothelial Carcinoma patients have mutations in both CNGB1 D973N and FRY R181Q?,ssm_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both CTSC E214V and TLCD5 G644S?,ssm_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both CTSC E291V and CTSC D397N?,ssm_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both CTSC E322V and HTR3B V973I?,ssm_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both CTSC E324V and POLD1 N251T?,ssm_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both CTSC E335V and DSCAM P136S?,ssm_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both PRSS8 A179T and ZMYM3 F580S?,ssm_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both PRSS8 A233T and DEFB115 M210L?,ssm_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both ARHGEF40 V864F and PGR T371I?,ssm_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,what proportion of Rectum Adenocarcinoma patients have mutations in both ACTB A138T and SLC6A4 R158P?,ssm_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,what proportion of Rectum Adenocarcinoma patients have mutations in both ACTB A217T and HTR3B E817V?,ssm_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,what proportion of Rectum Adenocarcinoma patients have mutations in both ACTB A244T and TTC17 R293G?,ssm_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,what proportion of Rectum Adenocarcinoma patients have mutations in both ACTB A260T and DPF3 R203C?,ssm_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,what proportion of Glioblastoma Multiforme patients have mutations in both YY1AP1 V546D and TENM3 D67Y?,ssm_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,what proportion of Glioblastoma Multiforme patients have mutations in both YY1AP1 V557D and HTR3B F153L?,ssm_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,what proportion of Glioblastoma Multiforme patients have mutations in both YY1AP1 V566D and ACVR1B H200Q?,ssm_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,what proportion of Glioblastoma Multiforme patients have mutations in both YY1AP1 V577D and GRTP1 Y594C?,ssm_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,what proportion of Glioblastoma Multiforme patients have mutations in both YY1AP1 V623D and GUK1 A29T?,ssm_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,what proportion of Glioblastoma Multiforme patients have mutations in both YY1AP1 V695D and DNAH14 P218S?,ssm_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,what proportion of Glioblastoma Multiforme patients have mutations in both YY1AP1 V715D and TMTC3 R500W?,ssm_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both FNDC7 D323N and ZNF274 D138N?,ssm_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both FNDC7 D99N and ZMYM3 E73D?,ssm_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both TLCD5 G15V and CACNA1F S1888A?,ssm_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both TLCD5 G37V and KIF20B S124T?,ssm_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both POLR1G R498W and YY1AP1 L757V?,ssm_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both POLR1G R500W and SOX21 E322V?,ssm_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both DNAH14 N1186K and GPR158 A111V?,ssm_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both DNAH14 N2657K and MYT1 R432C?,ssm_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both DNAH14 N3460K and TENM2 H492Y?,ssm_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both NEXN E73D and TAS1R3 G279S?,ssm_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,what proportion of Prostate Adenocarcinoma patients have mutations in both CYB5R2 G112R and FCGR2C A723V?,ssm_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,what proportion of Prostate Adenocarcinoma patients have mutations in both CYB5R2 G172R and TET2 T334K?,ssm_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both NRAP S808L and TYK2 D86N?,ssm_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both NRAP S816L and DSCAM Y22H?,ssm_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both NRAP S843L and MRPL55 R547W?,ssm_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both CCDC22 E179D and CEP20 L868P?,ssm_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both DCAF6 S402F and SORCS1 N229S?,ssm_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both DCAF6 S433F and PDHA2 V577D?,ssm_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both ZNF708 E389D and EIF2B4 A906E?,ssm_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both BFAR T103M and ZNF627 F580S?,ssm_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both MAST4 P1237S and PIK3C2G D490N?,ssm_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both MAST4 P1986S and CACNA1F F885L?,ssm_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both MAST4 P1991S and GUK1 E583K?,ssm_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both MAST4 P2001S and RIMS2 E22K?,ssm_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both MAST4 P2180S and TSHZ3 K1317E?,ssm_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both ARMC3 R169C and PTPRN2 R173C?,ssm_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both ARMC3 R432C and DPF3 T90M?,ssm_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,what proportion of Kidney Renal Clear Cell Carcinoma patients have mutations in both TET2 L757V and ADRA1A A256T?,ssm_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,what proportion of Kidney Renal Clear Cell Carcinoma patients have mutations in both TET2 L778V and TYROBP V515L?,ssm_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both SERPINB10 A353P and ZMYM3 T852I?,ssm_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both STAT3 Y22H and TAF1L G257A?,ssm_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both MIEF1 A42T and MERTK D67Y?,ssm_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both ACVR1B D397N and THBS4 R41W?,ssm_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both ACVR1B D449N and JAML T110S?,ssm_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both ACVR1B D490N and MRPL32 T167S?,ssm_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both EBF2 T104I and PXN S443I?,ssm_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both EBF2 T252I and KDM5C R363W?,ssm_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both VPS26B F266L and GPC3 R169C?,ssm_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have mutations in both PGR M106I and MYO15A G181E?",ssm_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have mutations in both PGR M38I and ADRA1A E817V?",ssm_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have mutations in both PGR M632I and TTYH2 E73D?",ssm_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,what proportion of Skin Cutaneous Melanoma patients have mutations in both ACTA2 P334L and FRY G166E?,ssm_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both THBS4 T852I and MYT1 S177L?,ssm_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both THBS4 T943I and DSCAM A934T?,ssm_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both PRSS1 S114T and SMO Q85L?,ssm_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both PRSS1 S124T and GPC3 G933A?,ssm_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both PRSS1 S138T and CTCFL E110K?,ssm_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,what proportion of Lung Adenocarcinoma patients have mutations in both PRSS1 S74T and THBS4 V547L?,ssm_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both PGF R126H and ZNF274 V695D?,ssm_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,what proportion of Stomach Adenocarcinoma patients have mutations in both PGF R127H and EBF2 T167S?,ssm_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,what proportion of Breast Invasive Carcinoma patients have mutations in both ITPRID2 S351C and SERPINB10 V566D?,ssm_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,what proportion of Breast Invasive Carcinoma patients have mutations in both ITPRID2 S842C and REXO4 S36F?,ssm_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both HBB E8D and CPS1 V566D?,ssm_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both PCDHB2 R158C and GSTCD A42T?,ssm_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both PCDHB2 T15M and PCDHB2 Q85L?,ssm_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,what proportion of Colon Adenocarcinoma patients have mutations in both PCDHB2 T26M and FRY S402F?,ssm_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,what proportion of Uterine Corpus Endometrial Carcinoma patients have mutations in both UBR2 P1594S and FGF8 R280M?,ssm_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,what proportion of Rectum Adenocarcinoma patients have mutations in both FBXO42 A618D and SOX21 H472Y?,ssm_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma patients exhibit the TNS1 G1362V mutation?,ssm_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma patients exhibit the TNS1 G1711V mutation?,ssm_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma patients exhibit the TNS1 G1718V mutation?,ssm_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma patients exhibit the TNS1 G1732V mutation?,ssm_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma patients exhibit the TNS1 G1824V mutation?,ssm_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma patients exhibit the TNS1 G1857V mutation?,ssm_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma patients exhibit the TNS1 G843V mutation?,ssm_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma patients exhibit the EVC2 E1067K mutation?,ssm_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma patients exhibit the EVC2 E987K mutation?,ssm_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the CR1 V1108G mutation?,ssm_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the CR1 V1558G mutation?,ssm_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma patients exhibit the TRPA1 S295I mutation?,ssm_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma patients exhibit the TRPA1 S443I mutation?,ssm_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the TAF1C R299L mutation?,ssm_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the TAF1C R396L mutation?,ssm_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the TAF1C R634L mutation?,ssm_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the TAF1C R702L mutation?,ssm_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the TAF1C R728L mutation?,ssm_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the DPF3 R104W mutation?,ssm_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the DPF3 R149W mutation?,ssm_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the DPF3 R94W mutation?,ssm_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the OR2T4 P272H mutation?,ssm_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the OR2T4 P300H mutation?,ssm_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma patients exhibit the FBN1 E2667K mutation?,ssm_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma patients exhibit the MAD1L1 E396K mutation?,ssm_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma patients exhibit the MAD1L1 E488K mutation?,ssm_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma patients exhibit the MAD1L1 E78K mutation?,ssm_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the CCNG1 E22K mutation?,ssm_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma patients exhibit the ANP32E N114T mutation?,ssm_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma patients exhibit the ANP32E N64T mutation?,ssm_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma patients exhibit the ANP32E N66T mutation?,ssm_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma patients exhibit the ANP32E N73T mutation?,ssm_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma patients exhibit the FRY S1888A mutation?,ssm_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma patients exhibit the FRY S1937A mutation?,ssm_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma patients exhibit the FRY S1938A mutation?,ssm_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma patients exhibit the FRY S1983A mutation?,ssm_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the PAK3 E318K mutation?,ssm_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the PAK3 E319K mutation?,ssm_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the PAK3 E334K mutation?,ssm_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the PAK3 E340K mutation?,ssm_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the PAK3 E355K mutation?,ssm_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the MUC16 P7963L mutation?,ssm_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma patients exhibit the ZFPM2 T498I mutation?,ssm_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma patients exhibit the ZFPM2 T630I mutation?,ssm_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma patients exhibit the PIK3C2B S1328C mutation?,ssm_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma patients exhibit the PIK3C2B S1356C mutation?,ssm_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the ZNF804A S371Y mutation?,ssm_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the RELN A2371V mutation?,ssm_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit the EFCAB12 R173C mutation?",ssm_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit the EFCAB12 R23C mutation?",ssm_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the DEFB115 E53K mutation?,ssm_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma patients exhibit the ANKDD1A S290F mutation?,ssm_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma patients exhibit the ANKDD1A S322F mutation?,ssm_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma patients exhibit the ANKDD1A S413F mutation?,ssm_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the HTR3B S146I mutation?,ssm_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the HTR3B S206I mutation?,ssm_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the HTR3B S217I mutation?,ssm_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the ABCC3 R758W mutation?,ssm_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the NOMO1 T204I mutation?,ssm_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the NOMO1 T371I mutation?,ssm_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma patients exhibit the HYOU1 D298H mutation?,ssm_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the FMO4 R500Q mutation?,ssm_frequency
+140,BICC1,A372V,Exceptional Responders,What proportion of Exceptional Responders patients exhibit the BICC1 A372V mutation?,ssm_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the ZMYM3 I920V mutation?,ssm_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the ZMYM3 I932V mutation?,ssm_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the ZMYM3 I934V mutation?,ssm_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit the XKR4 R547W mutation?",ssm_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma patients exhibit the ABCC2 V239L mutation?,ssm_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the OR8K5 R293G mutation?,ssm_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the SPTAN1 S1503F mutation?,ssm_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the SPTAN1 S1523F mutation?,ssm_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma patients exhibit the SYT10 M484I mutation?,ssm_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the HSPA5 N457K mutation?,ssm_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the UNC5D L280V mutation?,ssm_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the UNC5D L635V mutation?,ssm_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the UNC5D L637V mutation?,ssm_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the UNC5D L699V mutation?,ssm_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the UNC5D L704V mutation?,ssm_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the UNC5D L709V mutation?,ssm_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What proportion of Kidney Renal Clear Cell Carcinoma patients exhibit the DOCK2 L1527H mutation?,ssm_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What proportion of Kidney Renal Clear Cell Carcinoma patients exhibit the ZNF627 A5V mutation?,ssm_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the CDC42BPA L823F mutation?,ssm_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the MRPL55 H27Y mutation?,ssm_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the MRPL55 H63Y mutation?,ssm_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma patients exhibit the TMTC3 Q749K mutation?,ssm_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the EPRS1 K771I mutation?,ssm_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the EPRS1 K778I mutation?,ssm_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the GRTP1 A110V mutation?,ssm_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the GRTP1 A32V mutation?,ssm_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the TSHZ3 Q538K mutation?,ssm_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What proportion of HIV+ Tumor Molecular Characterization Project - Cervical Cancer patients exhibit the TAS1R3 Q326H mutation?,ssm_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the PIAS3 S238C mutation?,ssm_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the PIAS3 S273C mutation?,ssm_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the ZNF274 P13R mutation?,ssm_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the SYNJ1 R795C mutation?,ssm_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the SYNJ1 R800C mutation?,ssm_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the SYNJ1 R839C mutation?,ssm_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma patients exhibit the DSCAM V343M mutation?,ssm_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma patients exhibit the DSCAM V426M mutation?,ssm_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma patients exhibit the DSCAM V591M mutation?,ssm_frequency
+267,DGKD,R140H,Exceptional Responders,What proportion of Exceptional Responders patients exhibit the DGKD R140H mutation?,ssm_frequency
+268,DGKD,R160H,Exceptional Responders,What proportion of Exceptional Responders patients exhibit the DGKD R160H mutation?,ssm_frequency
+269,DGKD,R204H,Exceptional Responders,What proportion of Exceptional Responders patients exhibit the DGKD R204H mutation?,ssm_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma patients exhibit the PLEKHG6 D105Y mutation?,ssm_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma patients exhibit the PLEKHG6 D543Y mutation?,ssm_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma patients exhibit the PLEKHG6 D575Y mutation?,ssm_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the WNT2 D138N mutation?,ssm_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the GUCY2C G667R mutation?,ssm_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the C7orf31 P244H mutation?,ssm_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit the ZKSCAN7 E64K mutation?",ssm_frequency
+299,OR5D14,M210L,Neuroblastoma,What proportion of Neuroblastoma patients exhibit the OR5D14 M210L mutation?,ssm_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the SPATA22 K279E mutation?,ssm_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the SPATA22 K306E mutation?,ssm_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the SPATA22 K322E mutation?,ssm_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the LCN15 E21V mutation?,ssm_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the DCAF4L2 S129F mutation?,ssm_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the GUK1 R135P mutation?,ssm_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the GUK1 R137P mutation?,ssm_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the GUK1 R139P mutation?,ssm_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the GUK1 R158P mutation?,ssm_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the GUK1 R203P mutation?,ssm_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the MORF4L1 K29T mutation?,ssm_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the MORF4L1 K51T mutation?,ssm_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the MORF4L1 K61T mutation?,ssm_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the MORF4L1 K76T mutation?,ssm_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the MYO3B F594L mutation?,ssm_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the MYO3B F603L mutation?,ssm_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the TENT5A S320F mutation?,ssm_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the TENT5A S339F mutation?,ssm_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the TENT5A S401F mutation?,ssm_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What proportion of Ovarian Serous Cystadenocarcinoma patients exhibit the ZFAT S614L mutation?,ssm_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What proportion of Ovarian Serous Cystadenocarcinoma patients exhibit the ZFAT S664L mutation?,ssm_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What proportion of Ovarian Serous Cystadenocarcinoma patients exhibit the ZFAT S676L mutation?,ssm_frequency
+357,ZNF584,A211T,Sarcoma,What proportion of Sarcoma patients exhibit the ZNF584 A211T mutation?,ssm_frequency
+358,ZNF584,A256T,Sarcoma,What proportion of Sarcoma patients exhibit the ZNF584 A256T mutation?,ssm_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the LDOC1 R63W mutation?,ssm_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the PDGFC R201G mutation?,ssm_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the MSANTD4 R304C mutation?,ssm_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the NPSR1 S123L mutation?,ssm_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the PHLPP1 K1317E mutation?,ssm_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the COL6A3 G237S mutation?,ssm_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the COL6A3 G437S mutation?,ssm_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the COL6A3 G638S mutation?,ssm_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the COL6A3 G644S mutation?,ssm_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the COL6A3 G844S mutation?,ssm_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the ADRA1A R348G mutation?,ssm_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients exhibit the LAMB2 S1254F mutation?,ssm_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma patients exhibit the POC1B I198T mutation?,ssm_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma patients exhibit the POC1B I286T mutation?,ssm_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma patients exhibit the POC1B I328T mutation?,ssm_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma patients exhibit the POC1B S79P mutation?,ssm_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma patients exhibit the USH2A G1451C mutation?,ssm_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma patients exhibit the AQP7 T110S mutation?,ssm_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma patients exhibit the AQP7 T166S mutation?,ssm_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma patients exhibit the AQP7 T167S mutation?,ssm_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma patients exhibit the AQP7 T75S mutation?,ssm_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma patients exhibit the DCN R163C mutation?,ssm_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma patients exhibit the DCN R203C mutation?,ssm_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma patients exhibit the DCN R241C mutation?,ssm_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma patients exhibit the DCN R350C mutation?,ssm_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma patients exhibit the DCN R41C mutation?,ssm_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the CPS1 K1269N mutation?,ssm_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the CPS1 K1275N mutation?,ssm_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the CPS1 K818N mutation?,ssm_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma patients exhibit the FCGR2C P122S mutation?,ssm_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma patients exhibit the FCGR2C P123S mutation?,ssm_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the GRM1 R280M mutation?,ssm_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the SGCZ Q138H mutation?,ssm_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the SGCZ Q91H mutation?,ssm_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the SMO V15M mutation?,ssm_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the SMO V321M mutation?,ssm_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the CHODL G159E mutation?,ssm_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the CHODL G181E mutation?,ssm_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the CHODL G200E mutation?,ssm_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the MYO16 P399H mutation?,ssm_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the MYO16 P421H mutation?,ssm_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the CXCR2 A98V mutation?,ssm_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma patients exhibit the TMEM225 L212V mutation?,ssm_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the MAOB N251T mutation?,ssm_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the GPRASP1 F580S mutation?,ssm_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the MRPL32 R181Q mutation?,ssm_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the TYROBP A29T mutation?,ssm_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the RAB40C A111V mutation?,ssm_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the RAB40C A143V mutation?,ssm_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the CTNNA2 S323R mutation?,ssm_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the CTNNA2 S339R mutation?,ssm_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the CTNNA2 S386R mutation?,ssm_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the CTNNA2 S707R mutation?,ssm_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma patients exhibit the MYO15A S268R mutation?,ssm_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the GIMAP2 A167T mutation?,ssm_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme patients exhibit the KIF20B N1160D mutation?,ssm_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme patients exhibit the KIF20B N1200D mutation?,ssm_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the ADAM17 E583K mutation?,ssm_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the BCAT1 G16R mutation?,ssm_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the BCAT1 G17R mutation?,ssm_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the BCAT1 G29R mutation?,ssm_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the ERCC6 R1053H mutation?,ssm_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma patients exhibit the DCC R320W mutation?,ssm_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma patients exhibit the DCC R363W mutation?,ssm_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma patients exhibit the DCC R386W mutation?,ssm_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma patients exhibit the DCC R41W mutation?,ssm_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the FBXO15 D417N mutation?,ssm_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the FBXO15 D86N mutation?,ssm_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the GSTCD S528F mutation?,ssm_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the GSTCD S615F mutation?,ssm_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the OLFML3 P296S mutation?,ssm_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the OLFML3 P337S mutation?,ssm_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the OLFML3 P357S mutation?,ssm_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What proportion of Ovarian Serous Cystadenocarcinoma patients exhibit the CFAP61 E173V mutation?,ssm_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What proportion of Ovarian Serous Cystadenocarcinoma patients exhibit the CFAP61 E817V mutation?,ssm_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma patients exhibit the HLA-DQA2 E51K mutation?,ssm_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the TENM2 H240Y mutation?,ssm_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the TENM2 H351Y mutation?,ssm_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the TENM2 H472Y mutation?,ssm_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the ANKRD24 A465T mutation?,ssm_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the ANKRD24 A494T mutation?,ssm_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the ANKRD24 A584T mutation?,ssm_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the ZCCHC14 V549M mutation?,ssm_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the ZCCHC14 V665M mutation?,ssm_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the ZCCHC14 V676M mutation?,ssm_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the ZCCHC14 V802M mutation?,ssm_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the SIK2 I265M mutation?,ssm_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the MYH11 T1336M mutation?,ssm_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the MYH11 T1343M mutation?,ssm_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the SLC6A4 S174F mutation?,ssm_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the SLC9C1 K102N mutation?,ssm_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the SLC9C1 K29N mutation?,ssm_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,What proportion of Brain Lower Grade Glioma patients exhibit the OR2A12 A254T mutation?,ssm_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the PYHIN1 T325K mutation?,ssm_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the PYHIN1 T334K mutation?,ssm_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the JAML G191E mutation?,ssm_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the JAML G219E mutation?,ssm_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the JAML G220E mutation?,ssm_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the JAML G230E mutation?,ssm_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the TYK2 H1146R mutation?,ssm_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the TYK2 H23R mutation?,ssm_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the TYK2 H961R mutation?,ssm_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the CTCFL R208C mutation?,ssm_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the CTCFL R265C mutation?,ssm_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the CTCFL R420C mutation?,ssm_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the CTCFL R470C mutation?,ssm_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the CEP20 R31Q mutation?,ssm_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the CEP20 R58Q mutation?,ssm_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the RIMS2 R25W mutation?,ssm_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the RIMS2 R393W mutation?,ssm_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the RIMS2 R423W mutation?,ssm_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the RIMS2 R470W mutation?,ssm_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the RIMS2 R615W mutation?,ssm_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the RIMS2 R619W mutation?,ssm_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the RIMS2 R716W mutation?,ssm_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the PIK3C2G S551L mutation?,ssm_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the PIK3C2G S592L mutation?,ssm_frequency
+728,STK19,D341N,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the STK19 D341N mutation?,ssm_frequency
+729,STK19,D345N,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the STK19 D345N mutation?,ssm_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the REXO4 P60A mutation?,ssm_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the ZBTB34 P160S mutation?,ssm_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the ZBTB34 P164S mutation?,ssm_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma patients exhibit the NCKAP5 E148K mutation?,ssm_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit the SORCS1 D1052Y mutation?",ssm_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit the SORCS1 D587Y mutation?",ssm_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit the SORCS1 D67Y mutation?",ssm_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit the SORCS1 D810Y mutation?",ssm_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What proportion of Head and Neck Squamous Cell Carcinoma patients exhibit the FGF8 T154M mutation?,ssm_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What proportion of Head and Neck Squamous Cell Carcinoma patients exhibit the FGF8 T165M mutation?,ssm_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What proportion of Head and Neck Squamous Cell Carcinoma patients exhibit the FGF8 T183M mutation?,ssm_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What proportion of Head and Neck Squamous Cell Carcinoma patients exhibit the FGF8 T194M mutation?,ssm_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What proportion of Head and Neck Squamous Cell Carcinoma patients exhibit the FGF8 T90M mutation?,ssm_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What proportion of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia patients exhibit the TENM3 R1877W mutation?,ssm_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the AKT1 D44N mutation?,ssm_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients exhibit the CFAP298-TCP10L E11Q mutation?,ssm_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the GLRB E148D mutation?,ssm_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the TTN F7636L mutation?,ssm_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the TTN F8563L mutation?,ssm_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the TTN F8880L mutation?,ssm_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the ANKRD30A V798I mutation?,ssm_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the ANKRD30A V854I mutation?,ssm_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the ANKRD30A V973I mutation?,ssm_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the TRIM45 S177L mutation?,ssm_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the TRIM45 S224L mutation?,ssm_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the TRIM45 S281L mutation?,ssm_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the CACNA1F G727V mutation?,ssm_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the CACNA1F G781V mutation?,ssm_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the CACNA1F G792V mutation?,ssm_frequency
+817,KL,R594C,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the KL R594C mutation?,ssm_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma patients exhibit the GUF1 I243T mutation?,ssm_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the TAF1L A539V mutation?,ssm_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the TASOR2 S256F mutation?,ssm_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the TASOR2 S36F mutation?,ssm_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the TASOR2 S471F mutation?,ssm_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the KDM5C R1151C mutation?,ssm_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the KDM5C R1177C mutation?,ssm_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the KDM5C R1217C mutation?,ssm_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the KDM5C R1218C mutation?,ssm_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients exhibit the IL5RA L153F mutation?,ssm_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the DHX16 A29V mutation?,ssm_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the DHX16 A89V mutation?,ssm_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the GPR158 A644V mutation?,ssm_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the GPR158 A723V mutation?,ssm_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit the EIF2B4 E108K mutation?",ssm_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit the EIF2B4 E110K mutation?",ssm_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit the EIF2B4 E111K mutation?",ssm_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit the EIF2B4 E131K mutation?",ssm_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit the EIF2B4 E132K mutation?",ssm_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit the EIF2B4 E96K mutation?",ssm_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the AUTS2 P136S mutation?,ssm_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the AUTS2 P218S mutation?,ssm_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the AUTS2 P233S mutation?,ssm_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the AUTS2 P313S mutation?,ssm_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the AUTS2 P419S mutation?,ssm_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the AUTS2 P443S mutation?,ssm_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the AUTS2 P56S mutation?,ssm_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the AUTS2 P667S mutation?,ssm_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the AUTS2 P690S mutation?,ssm_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the AUTS2 P691S mutation?,ssm_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit the ACTL7B D223N mutation?",ssm_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme patients exhibit the PCDHGA1 R535W mutation?,ssm_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the TRAP1 R114W mutation?,ssm_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the TRAP1 R61W mutation?,ssm_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the PIK3C2A R1570Q mutation?,ssm_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma patients exhibit the KANSL1 R139G mutation?,ssm_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the ANKRD52 Y594C mutation?,ssm_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the PAPPA G1580S mutation?,ssm_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma patients exhibit the B3GALNT1 V270A mutation?,ssm_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the GABRA6 G115R mutation?,ssm_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the GABRA6 G122R mutation?,ssm_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the GABRA6 G165R mutation?,ssm_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the GABRA6 G175R mutation?,ssm_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the GABRA6 G70R mutation?,ssm_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the ZSCAN31 D9N mutation?,ssm_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit the MED16 L126P mutation?",ssm_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit the MED16 L868P mutation?",ssm_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma patients exhibit the PTPRO E1060K mutation?,ssm_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma patients exhibit the PTPRO E1088K mutation?,ssm_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma patients exhibit the PTPRO E249K mutation?,ssm_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma patients exhibit the PTPRO E265K mutation?,ssm_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma patients exhibit the PTPRO E277K mutation?,ssm_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma patients exhibit the PTPRO E67K mutation?,ssm_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma patients exhibit the PTPRO E923K mutation?,ssm_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma patients exhibit the PTPRO E940K mutation?,ssm_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the CHMP7 D397N mutation?,ssm_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the GPC3 I107N mutation?,ssm_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the GPC3 I161N mutation?,ssm_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients exhibit the TLK2 V430L mutation?,ssm_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients exhibit the TLK2 V515L mutation?,ssm_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients exhibit the TLK2 V547L mutation?,ssm_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients exhibit the TLK2 V579L mutation?,ssm_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients exhibit the TLK2 V601L mutation?,ssm_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the ZNF217 E209Q mutation?,ssm_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the SYT9 V275L mutation?,ssm_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the SYT9 V307L mutation?,ssm_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the PKHD1L1 S2830N mutation?,ssm_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the MYO3A Y1295C mutation?,ssm_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit the VASN V318I mutation?",ssm_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the DNMT1 A1037T mutation?,ssm_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the DNMT1 A1053T mutation?,ssm_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the DNMT1 A934T mutation?,ssm_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the CA9 E402K mutation?,ssm_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the TTC17 R808Q mutation?,ssm_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the TTC17 R865Q mutation?,ssm_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma patients exhibit the PSG2 P43L mutation?,ssm_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma patients exhibit the RIPOR2 R470L mutation?,ssm_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma patients exhibit the RIPOR2 R499L mutation?,ssm_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma patients exhibit the RIPOR2 R504L mutation?,ssm_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma patients exhibit the RIPOR2 R520L mutation?,ssm_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the DCLK3 V520I mutation?,ssm_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the DCLK3 V689I mutation?,ssm_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the MERTK G257A mutation?,ssm_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the MERTK G757A mutation?,ssm_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the MERTK G933A mutation?,ssm_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the ZFP42 R206K mutation?,ssm_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the OR13C3 M117I mutation?,ssm_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the OR13C3 M147I mutation?,ssm_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the SPAG1 I917M mutation?,ssm_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the CDKN2AIP Y92H mutation?,ssm_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the PXN H1016Y mutation?,ssm_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the PXN H359Y mutation?,ssm_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the PXN H492Y mutation?,ssm_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the PXN H524Y mutation?,ssm_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the PXN H526Y mutation?,ssm_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the PXN H540Y mutation?,ssm_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the TTYH2 S23L mutation?,ssm_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the TTYH2 S44L mutation?,ssm_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the TMEM255A N205S mutation?,ssm_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the TMEM255A N229S mutation?,ssm_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the TMEM255A N65S mutation?,ssm_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma patients exhibit the TASOR2 H2271D mutation?,ssm_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma patients exhibit the TASOR2 H2486D mutation?,ssm_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the ICE1 T1839M mutation?,ssm_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma patients exhibit the MYT1 A558E mutation?,ssm_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma patients exhibit the MYT1 A879E mutation?,ssm_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma patients exhibit the MYT1 A906E mutation?,ssm_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the CX3CR1 P203L mutation?,ssm_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the CX3CR1 P235L mutation?,ssm_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma patients exhibit the SPINDOC R197C mutation?,ssm_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the ART3 C251Y mutation?,ssm_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the ART3 C3Y mutation?,ssm_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma patients exhibit the CYP1A2 R243G mutation?,ssm_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit the ADRA1A G279S mutation?",ssm_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the CDH23 P2523R mutation?,ssm_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the CDH23 P283R mutation?,ssm_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the KRT39 P137S mutation?,ssm_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the PDHA2 S7F mutation?,ssm_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the SLC24A2 H200Q mutation?,ssm_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma patients exhibit the PTPRN2 F153L mutation?,ssm_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma patients exhibit the PTPRN2 F847L mutation?,ssm_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma patients exhibit the PTPRN2 F856L mutation?,ssm_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma patients exhibit the PTPRN2 F868L mutation?,ssm_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma patients exhibit the PTPRN2 F885L mutation?,ssm_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the SOX21 R55L mutation?,ssm_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma patients exhibit the CPA6 G166E mutation?,ssm_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the GRM5 E14K mutation?,ssm_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit the CASZ1 R233Q mutation?",ssm_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the SGIP1 N122T mutation?,ssm_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the SGIP1 N420T mutation?,ssm_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the SGIP1 N617T mutation?,ssm_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the SGIP1 N648T mutation?,ssm_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the CARMIL1 V549L mutation?,ssm_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the CARMIL1 V949L mutation?,ssm_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the ZNF431 D121Y mutation?,ssm_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the ZNF431 D161Y mutation?,ssm_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the ZNF431 R128I mutation?,ssm_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the DNAH11 P2987S mutation?,ssm_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the DNAH11 P2994S mutation?,ssm_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the POLD1 Q461L mutation?,ssm_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma patients exhibit the POLD1 Q85L mutation?,ssm_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the TTC12 D646H mutation?,ssm_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the TTC12 D652H mutation?,ssm_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma patients exhibit the CNGB1 D967N mutation?,ssm_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma patients exhibit the CNGB1 D973N mutation?,ssm_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the CTSC E214V mutation?,ssm_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the CTSC E291V mutation?,ssm_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the CTSC E322V mutation?,ssm_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the CTSC E324V mutation?,ssm_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the CTSC E335V mutation?,ssm_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the PRSS8 A179T mutation?,ssm_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the PRSS8 A233T mutation?,ssm_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the ARHGEF40 V864F mutation?,ssm_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma patients exhibit the ACTB A138T mutation?,ssm_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma patients exhibit the ACTB A217T mutation?,ssm_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma patients exhibit the ACTB A244T mutation?,ssm_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma patients exhibit the ACTB A260T mutation?,ssm_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme patients exhibit the YY1AP1 V546D mutation?,ssm_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme patients exhibit the YY1AP1 V557D mutation?,ssm_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme patients exhibit the YY1AP1 V566D mutation?,ssm_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme patients exhibit the YY1AP1 V577D mutation?,ssm_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme patients exhibit the YY1AP1 V623D mutation?,ssm_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme patients exhibit the YY1AP1 V695D mutation?,ssm_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme patients exhibit the YY1AP1 V715D mutation?,ssm_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the FNDC7 D323N mutation?,ssm_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the FNDC7 D99N mutation?,ssm_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the TLCD5 G15V mutation?,ssm_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the TLCD5 G37V mutation?,ssm_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the POLR1G R498W mutation?,ssm_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the POLR1G R500W mutation?,ssm_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the DNAH14 N1186K mutation?,ssm_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the DNAH14 N2657K mutation?,ssm_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the DNAH14 N3460K mutation?,ssm_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the NEXN E73D mutation?,ssm_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma patients exhibit the CYB5R2 G112R mutation?,ssm_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma patients exhibit the CYB5R2 G172R mutation?,ssm_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the NRAP S808L mutation?,ssm_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the NRAP S816L mutation?,ssm_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the NRAP S843L mutation?,ssm_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the CCDC22 E179D mutation?,ssm_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the DCAF6 S402F mutation?,ssm_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the DCAF6 S433F mutation?,ssm_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the ZNF708 E389D mutation?,ssm_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the BFAR T103M mutation?,ssm_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the MAST4 P1237S mutation?,ssm_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the MAST4 P1986S mutation?,ssm_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the MAST4 P1991S mutation?,ssm_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the MAST4 P2001S mutation?,ssm_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the MAST4 P2180S mutation?,ssm_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the ARMC3 R169C mutation?,ssm_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the ARMC3 R432C mutation?,ssm_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What proportion of Kidney Renal Clear Cell Carcinoma patients exhibit the TET2 L757V mutation?,ssm_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What proportion of Kidney Renal Clear Cell Carcinoma patients exhibit the TET2 L778V mutation?,ssm_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the SERPINB10 A353P mutation?,ssm_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the STAT3 Y22H mutation?,ssm_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the MIEF1 A42T mutation?,ssm_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the ACVR1B D397N mutation?,ssm_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the ACVR1B D449N mutation?,ssm_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the ACVR1B D490N mutation?,ssm_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the EBF2 T104I mutation?,ssm_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the EBF2 T252I mutation?,ssm_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the VPS26B F266L mutation?,ssm_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit the PGR M106I mutation?",ssm_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit the PGR M38I mutation?",ssm_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit the PGR M632I mutation?",ssm_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma patients exhibit the ACTA2 P334L mutation?,ssm_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the THBS4 T852I mutation?,ssm_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the THBS4 T943I mutation?,ssm_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the PRSS1 S114T mutation?,ssm_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the PRSS1 S124T mutation?,ssm_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the PRSS1 S138T mutation?,ssm_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma patients exhibit the PRSS1 S74T mutation?,ssm_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the PGF R126H mutation?,ssm_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma patients exhibit the PGF R127H mutation?,ssm_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma patients exhibit the ITPRID2 S351C mutation?,ssm_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma patients exhibit the ITPRID2 S842C mutation?,ssm_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the HBB E8D mutation?,ssm_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the PCDHB2 R158C mutation?,ssm_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the PCDHB2 T15M mutation?,ssm_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma patients exhibit the PCDHB2 T26M mutation?,ssm_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma patients exhibit the UBR2 P1594S mutation?,ssm_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma patients exhibit the FBXO42 A618D mutation?,ssm_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,Can you tell me the rate of TNS1 G1362V mutation in Breast Invasive Carcinoma?,ssm_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,Can you tell me the rate of TNS1 G1711V mutation in Breast Invasive Carcinoma?,ssm_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,Can you tell me the rate of TNS1 G1718V mutation in Breast Invasive Carcinoma?,ssm_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,Can you tell me the rate of TNS1 G1732V mutation in Breast Invasive Carcinoma?,ssm_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,Can you tell me the rate of TNS1 G1824V mutation in Breast Invasive Carcinoma?,ssm_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,Can you tell me the rate of TNS1 G1857V mutation in Breast Invasive Carcinoma?,ssm_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,Can you tell me the rate of TNS1 G843V mutation in Breast Invasive Carcinoma?,ssm_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,Can you tell me the rate of EVC2 E1067K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,Can you tell me the rate of EVC2 E987K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of CR1 V1108G mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of CR1 V1558G mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,Can you tell me the rate of TRPA1 S295I mutation in Rectum Adenocarcinoma?,ssm_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,Can you tell me the rate of TRPA1 S443I mutation in Rectum Adenocarcinoma?,ssm_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,Can you tell me the rate of TAF1C R299L mutation in Lung Adenocarcinoma?,ssm_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,Can you tell me the rate of TAF1C R396L mutation in Lung Adenocarcinoma?,ssm_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,Can you tell me the rate of TAF1C R634L mutation in Lung Adenocarcinoma?,ssm_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,Can you tell me the rate of TAF1C R702L mutation in Lung Adenocarcinoma?,ssm_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,Can you tell me the rate of TAF1C R728L mutation in Lung Adenocarcinoma?,ssm_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of DPF3 R104W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of DPF3 R149W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of DPF3 R94W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,Can you tell me the rate of OR2T4 P272H mutation in Lung Adenocarcinoma?,ssm_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,Can you tell me the rate of OR2T4 P300H mutation in Lung Adenocarcinoma?,ssm_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,Can you tell me the rate of FBN1 E2667K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,Can you tell me the rate of MAD1L1 E396K mutation in Prostate Adenocarcinoma?,ssm_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,Can you tell me the rate of MAD1L1 E488K mutation in Prostate Adenocarcinoma?,ssm_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,Can you tell me the rate of MAD1L1 E78K mutation in Prostate Adenocarcinoma?,ssm_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,Can you tell me the rate of CCNG1 E22K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,Can you tell me the rate of ANP32E N114T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,Can you tell me the rate of ANP32E N64T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,Can you tell me the rate of ANP32E N66T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,Can you tell me the rate of ANP32E N73T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,Can you tell me the rate of FRY S1888A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,Can you tell me the rate of FRY S1937A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,Can you tell me the rate of FRY S1938A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,Can you tell me the rate of FRY S1983A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,Can you tell me the rate of PAK3 E318K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,Can you tell me the rate of PAK3 E319K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,Can you tell me the rate of PAK3 E334K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,Can you tell me the rate of PAK3 E340K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,Can you tell me the rate of PAK3 E355K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,Can you tell me the rate of MUC16 P7963L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,Can you tell me the rate of ZFPM2 T498I mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,Can you tell me the rate of ZFPM2 T630I mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,Can you tell me the rate of PIK3C2B S1328C mutation in Breast Invasive Carcinoma?,ssm_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,Can you tell me the rate of PIK3C2B S1356C mutation in Breast Invasive Carcinoma?,ssm_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,Can you tell me the rate of ZNF804A S371Y mutation in Colon Adenocarcinoma?,ssm_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,Can you tell me the rate of RELN A2371V mutation in Stomach Adenocarcinoma?,ssm_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the rate of EFCAB12 R173C mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the rate of EFCAB12 R23C mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,Can you tell me the rate of DEFB115 E53K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,Can you tell me the rate of ANKDD1A S290F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,Can you tell me the rate of ANKDD1A S322F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,Can you tell me the rate of ANKDD1A S413F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of HTR3B S146I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of HTR3B S206I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of HTR3B S217I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,Can you tell me the rate of ABCC3 R758W mutation in Stomach Adenocarcinoma?,ssm_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of NOMO1 T204I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of NOMO1 T371I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,Can you tell me the rate of HYOU1 D298H mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,Can you tell me the rate of FMO4 R500Q mutation in Skin Cutaneous Melanoma?,ssm_frequency
+140,BICC1,A372V,Exceptional Responders,Can you tell me the rate of BICC1 A372V mutation in Exceptional Responders?,ssm_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of ZMYM3 I920V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of ZMYM3 I932V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of ZMYM3 I934V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the rate of XKR4 R547W mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,Can you tell me the rate of ABCC2 V239L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,Can you tell me the rate of OR8K5 R293G mutation in Lung Adenocarcinoma?,ssm_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,Can you tell me the rate of SPTAN1 S1503F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,Can you tell me the rate of SPTAN1 S1523F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,Can you tell me the rate of SYT10 M484I mutation in Rectum Adenocarcinoma?,ssm_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,Can you tell me the rate of HSPA5 N457K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,Can you tell me the rate of UNC5D L280V mutation in Lung Adenocarcinoma?,ssm_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,Can you tell me the rate of UNC5D L635V mutation in Lung Adenocarcinoma?,ssm_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,Can you tell me the rate of UNC5D L637V mutation in Lung Adenocarcinoma?,ssm_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,Can you tell me the rate of UNC5D L699V mutation in Lung Adenocarcinoma?,ssm_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,Can you tell me the rate of UNC5D L704V mutation in Lung Adenocarcinoma?,ssm_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,Can you tell me the rate of UNC5D L709V mutation in Lung Adenocarcinoma?,ssm_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,Can you tell me the rate of DOCK2 L1527H mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,Can you tell me the rate of ZNF627 A5V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,Can you tell me the rate of CDC42BPA L823F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,Can you tell me the rate of MRPL55 H27Y mutation in Colon Adenocarcinoma?,ssm_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,Can you tell me the rate of MRPL55 H63Y mutation in Colon Adenocarcinoma?,ssm_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,Can you tell me the rate of TMTC3 Q749K mutation in Breast Invasive Carcinoma?,ssm_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,Can you tell me the rate of EPRS1 K771I mutation in Colon Adenocarcinoma?,ssm_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,Can you tell me the rate of EPRS1 K778I mutation in Colon Adenocarcinoma?,ssm_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,Can you tell me the rate of GRTP1 A110V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,Can you tell me the rate of GRTP1 A32V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,Can you tell me the rate of TSHZ3 Q538K mutation in Stomach Adenocarcinoma?,ssm_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,Can you tell me the rate of TAS1R3 Q326H mutation in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,ssm_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,Can you tell me the rate of PIAS3 S238C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,Can you tell me the rate of PIAS3 S273C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,Can you tell me the rate of ZNF274 P13R mutation in Stomach Adenocarcinoma?,ssm_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,Can you tell me the rate of SYNJ1 R795C mutation in Colon Adenocarcinoma?,ssm_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,Can you tell me the rate of SYNJ1 R800C mutation in Colon Adenocarcinoma?,ssm_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,Can you tell me the rate of SYNJ1 R839C mutation in Colon Adenocarcinoma?,ssm_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,Can you tell me the rate of DSCAM V343M mutation in Prostate Adenocarcinoma?,ssm_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,Can you tell me the rate of DSCAM V426M mutation in Prostate Adenocarcinoma?,ssm_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,Can you tell me the rate of DSCAM V591M mutation in Prostate Adenocarcinoma?,ssm_frequency
+267,DGKD,R140H,Exceptional Responders,Can you tell me the rate of DGKD R140H mutation in Exceptional Responders?,ssm_frequency
+268,DGKD,R160H,Exceptional Responders,Can you tell me the rate of DGKD R160H mutation in Exceptional Responders?,ssm_frequency
+269,DGKD,R204H,Exceptional Responders,Can you tell me the rate of DGKD R204H mutation in Exceptional Responders?,ssm_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,Can you tell me the rate of PLEKHG6 D105Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,Can you tell me the rate of PLEKHG6 D543Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,Can you tell me the rate of PLEKHG6 D575Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,Can you tell me the rate of WNT2 D138N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,Can you tell me the rate of GUCY2C G667R mutation in Skin Cutaneous Melanoma?,ssm_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of C7orf31 P244H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the rate of ZKSCAN7 E64K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+299,OR5D14,M210L,Neuroblastoma,Can you tell me the rate of OR5D14 M210L mutation in Neuroblastoma?,ssm_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of SPATA22 K279E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of SPATA22 K306E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of SPATA22 K322E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,Can you tell me the rate of LCN15 E21V mutation in Stomach Adenocarcinoma?,ssm_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,Can you tell me the rate of DCAF4L2 S129F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,Can you tell me the rate of GUK1 R135P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,Can you tell me the rate of GUK1 R137P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,Can you tell me the rate of GUK1 R139P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,Can you tell me the rate of GUK1 R158P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,Can you tell me the rate of GUK1 R203P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,Can you tell me the rate of MORF4L1 K29T mutation in Stomach Adenocarcinoma?,ssm_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,Can you tell me the rate of MORF4L1 K51T mutation in Stomach Adenocarcinoma?,ssm_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,Can you tell me the rate of MORF4L1 K61T mutation in Stomach Adenocarcinoma?,ssm_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,Can you tell me the rate of MORF4L1 K76T mutation in Stomach Adenocarcinoma?,ssm_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,Can you tell me the rate of MYO3B F594L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,Can you tell me the rate of MYO3B F603L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,Can you tell me the rate of TENT5A S320F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,Can you tell me the rate of TENT5A S339F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,Can you tell me the rate of TENT5A S401F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,Can you tell me the rate of ZFAT S614L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,Can you tell me the rate of ZFAT S664L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,Can you tell me the rate of ZFAT S676L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+357,ZNF584,A211T,Sarcoma,Can you tell me the rate of ZNF584 A211T mutation in Sarcoma?,ssm_frequency
+358,ZNF584,A256T,Sarcoma,Can you tell me the rate of ZNF584 A256T mutation in Sarcoma?,ssm_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of LDOC1 R63W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,Can you tell me the rate of PDGFC R201G mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of MSANTD4 R304C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,Can you tell me the rate of NPSR1 S123L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,Can you tell me the rate of PHLPP1 K1317E mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,Can you tell me the rate of COL6A3 G237S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,Can you tell me the rate of COL6A3 G437S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,Can you tell me the rate of COL6A3 G638S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,Can you tell me the rate of COL6A3 G644S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,Can you tell me the rate of COL6A3 G844S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,Can you tell me the rate of ADRA1A R348G mutation in Stomach Adenocarcinoma?,ssm_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me the rate of LAMB2 S1254F mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,Can you tell me the rate of POC1B I198T mutation in Rectum Adenocarcinoma?,ssm_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,Can you tell me the rate of POC1B I286T mutation in Rectum Adenocarcinoma?,ssm_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,Can you tell me the rate of POC1B I328T mutation in Rectum Adenocarcinoma?,ssm_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,Can you tell me the rate of POC1B S79P mutation in Rectum Adenocarcinoma?,ssm_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,Can you tell me the rate of USH2A G1451C mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,Can you tell me the rate of AQP7 T110S mutation in Rectum Adenocarcinoma?,ssm_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,Can you tell me the rate of AQP7 T166S mutation in Rectum Adenocarcinoma?,ssm_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,Can you tell me the rate of AQP7 T167S mutation in Rectum Adenocarcinoma?,ssm_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,Can you tell me the rate of AQP7 T75S mutation in Rectum Adenocarcinoma?,ssm_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,Can you tell me the rate of DCN R163C mutation in Rectum Adenocarcinoma?,ssm_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,Can you tell me the rate of DCN R203C mutation in Rectum Adenocarcinoma?,ssm_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,Can you tell me the rate of DCN R241C mutation in Rectum Adenocarcinoma?,ssm_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,Can you tell me the rate of DCN R350C mutation in Rectum Adenocarcinoma?,ssm_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,Can you tell me the rate of DCN R41C mutation in Rectum Adenocarcinoma?,ssm_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of CPS1 K1269N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of CPS1 K1275N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of CPS1 K818N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,Can you tell me the rate of FCGR2C P122S mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,Can you tell me the rate of FCGR2C P123S mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of GRM1 R280M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,Can you tell me the rate of SGCZ Q138H mutation in Lung Adenocarcinoma?,ssm_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,Can you tell me the rate of SGCZ Q91H mutation in Lung Adenocarcinoma?,ssm_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,Can you tell me the rate of SMO V15M mutation in Stomach Adenocarcinoma?,ssm_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,Can you tell me the rate of SMO V321M mutation in Stomach Adenocarcinoma?,ssm_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,Can you tell me the rate of CHODL G159E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,Can you tell me the rate of CHODL G181E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,Can you tell me the rate of CHODL G200E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,Can you tell me the rate of MYO16 P399H mutation in Colon Adenocarcinoma?,ssm_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,Can you tell me the rate of MYO16 P421H mutation in Colon Adenocarcinoma?,ssm_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,Can you tell me the rate of CXCR2 A98V mutation in Stomach Adenocarcinoma?,ssm_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,Can you tell me the rate of TMEM225 L212V mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of MAOB N251T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of GPRASP1 F580S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of MRPL32 R181Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of TYROBP A29T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,Can you tell me the rate of RAB40C A111V mutation in Lung Adenocarcinoma?,ssm_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,Can you tell me the rate of RAB40C A143V mutation in Lung Adenocarcinoma?,ssm_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,Can you tell me the rate of CTNNA2 S323R mutation in Lung Adenocarcinoma?,ssm_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,Can you tell me the rate of CTNNA2 S339R mutation in Lung Adenocarcinoma?,ssm_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,Can you tell me the rate of CTNNA2 S386R mutation in Lung Adenocarcinoma?,ssm_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,Can you tell me the rate of CTNNA2 S707R mutation in Lung Adenocarcinoma?,ssm_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,Can you tell me the rate of MYO15A S268R mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,Can you tell me the rate of GIMAP2 A167T mutation in Skin Cutaneous Melanoma?,ssm_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,Can you tell me the rate of KIF20B N1160D mutation in Glioblastoma Multiforme?,ssm_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,Can you tell me the rate of KIF20B N1200D mutation in Glioblastoma Multiforme?,ssm_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of ADAM17 E583K mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of BCAT1 G16R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of BCAT1 G17R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of BCAT1 G29R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,Can you tell me the rate of ERCC6 R1053H mutation in Colon Adenocarcinoma?,ssm_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,Can you tell me the rate of DCC R320W mutation in Breast Invasive Carcinoma?,ssm_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,Can you tell me the rate of DCC R363W mutation in Breast Invasive Carcinoma?,ssm_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,Can you tell me the rate of DCC R386W mutation in Breast Invasive Carcinoma?,ssm_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,Can you tell me the rate of DCC R41W mutation in Breast Invasive Carcinoma?,ssm_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,Can you tell me the rate of FBXO15 D417N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,Can you tell me the rate of FBXO15 D86N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of GSTCD S528F mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of GSTCD S615F mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,Can you tell me the rate of OLFML3 P296S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,Can you tell me the rate of OLFML3 P337S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,Can you tell me the rate of OLFML3 P357S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,Can you tell me the rate of CFAP61 E173V mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,Can you tell me the rate of CFAP61 E817V mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,Can you tell me the rate of HLA-DQA2 E51K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,Can you tell me the rate of TENM2 H240Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,Can you tell me the rate of TENM2 H351Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,Can you tell me the rate of TENM2 H472Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,Can you tell me the rate of ANKRD24 A465T mutation in Stomach Adenocarcinoma?,ssm_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,Can you tell me the rate of ANKRD24 A494T mutation in Stomach Adenocarcinoma?,ssm_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,Can you tell me the rate of ANKRD24 A584T mutation in Stomach Adenocarcinoma?,ssm_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,Can you tell me the rate of ZCCHC14 V549M mutation in Stomach Adenocarcinoma?,ssm_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,Can you tell me the rate of ZCCHC14 V665M mutation in Stomach Adenocarcinoma?,ssm_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,Can you tell me the rate of ZCCHC14 V676M mutation in Stomach Adenocarcinoma?,ssm_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,Can you tell me the rate of ZCCHC14 V802M mutation in Stomach Adenocarcinoma?,ssm_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,Can you tell me the rate of SIK2 I265M mutation in Lung Adenocarcinoma?,ssm_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of MYH11 T1336M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of MYH11 T1343M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,Can you tell me the rate of SLC6A4 S174F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of SLC9C1 K102N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of SLC9C1 K29N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,Can you tell me the rate of OR2A12 A254T mutation in Brain Lower Grade Glioma?,ssm_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,Can you tell me the rate of PYHIN1 T325K mutation in Lung Adenocarcinoma?,ssm_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,Can you tell me the rate of PYHIN1 T334K mutation in Lung Adenocarcinoma?,ssm_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,Can you tell me the rate of JAML G191E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,Can you tell me the rate of JAML G219E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,Can you tell me the rate of JAML G220E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,Can you tell me the rate of JAML G230E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,Can you tell me the rate of TYK2 H1146R mutation in Stomach Adenocarcinoma?,ssm_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,Can you tell me the rate of TYK2 H23R mutation in Stomach Adenocarcinoma?,ssm_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,Can you tell me the rate of TYK2 H961R mutation in Stomach Adenocarcinoma?,ssm_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of CTCFL R208C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of CTCFL R265C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of CTCFL R420C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of CTCFL R470C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of CEP20 R31Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of CEP20 R58Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,Can you tell me the rate of RIMS2 R25W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,Can you tell me the rate of RIMS2 R393W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,Can you tell me the rate of RIMS2 R423W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,Can you tell me the rate of RIMS2 R470W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,Can you tell me the rate of RIMS2 R615W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,Can you tell me the rate of RIMS2 R619W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,Can you tell me the rate of RIMS2 R716W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,Can you tell me the rate of PIK3C2G S551L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,Can you tell me the rate of PIK3C2G S592L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+728,STK19,D341N,Colon Adenocarcinoma,Can you tell me the rate of STK19 D341N mutation in Colon Adenocarcinoma?,ssm_frequency
+729,STK19,D345N,Colon Adenocarcinoma,Can you tell me the rate of STK19 D345N mutation in Colon Adenocarcinoma?,ssm_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,Can you tell me the rate of REXO4 P60A mutation in Skin Cutaneous Melanoma?,ssm_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of ZBTB34 P160S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of ZBTB34 P164S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,Can you tell me the rate of NCKAP5 E148K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the rate of SORCS1 D1052Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the rate of SORCS1 D587Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the rate of SORCS1 D67Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the rate of SORCS1 D810Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,Can you tell me the rate of FGF8 T154M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,Can you tell me the rate of FGF8 T165M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,Can you tell me the rate of FGF8 T183M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,Can you tell me the rate of FGF8 T194M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,Can you tell me the rate of FGF8 T90M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,Can you tell me the rate of TENM3 R1877W mutation in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,ssm_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of AKT1 D44N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me the rate of CFAP298-TCP10L E11Q mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,Can you tell me the rate of GLRB E148D mutation in Stomach Adenocarcinoma?,ssm_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,Can you tell me the rate of TTN F7636L mutation in Colon Adenocarcinoma?,ssm_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,Can you tell me the rate of TTN F8563L mutation in Colon Adenocarcinoma?,ssm_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,Can you tell me the rate of TTN F8880L mutation in Colon Adenocarcinoma?,ssm_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,Can you tell me the rate of ANKRD30A V798I mutation in Colon Adenocarcinoma?,ssm_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,Can you tell me the rate of ANKRD30A V854I mutation in Colon Adenocarcinoma?,ssm_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,Can you tell me the rate of ANKRD30A V973I mutation in Colon Adenocarcinoma?,ssm_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,Can you tell me the rate of TRIM45 S177L mutation in Colon Adenocarcinoma?,ssm_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,Can you tell me the rate of TRIM45 S224L mutation in Colon Adenocarcinoma?,ssm_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,Can you tell me the rate of TRIM45 S281L mutation in Colon Adenocarcinoma?,ssm_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,Can you tell me the rate of CACNA1F G727V mutation in Stomach Adenocarcinoma?,ssm_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,Can you tell me the rate of CACNA1F G781V mutation in Stomach Adenocarcinoma?,ssm_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,Can you tell me the rate of CACNA1F G792V mutation in Stomach Adenocarcinoma?,ssm_frequency
+817,KL,R594C,Colon Adenocarcinoma,Can you tell me the rate of KL R594C mutation in Colon Adenocarcinoma?,ssm_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,Can you tell me the rate of GUF1 I243T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,Can you tell me the rate of TAF1L A539V mutation in Colon Adenocarcinoma?,ssm_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,Can you tell me the rate of TASOR2 S256F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,Can you tell me the rate of TASOR2 S36F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,Can you tell me the rate of TASOR2 S471F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,Can you tell me the rate of KDM5C R1151C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,Can you tell me the rate of KDM5C R1177C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,Can you tell me the rate of KDM5C R1217C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,Can you tell me the rate of KDM5C R1218C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me the rate of IL5RA L153F mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,Can you tell me the rate of DHX16 A29V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,Can you tell me the rate of DHX16 A89V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,Can you tell me the rate of GPR158 A644V mutation in Stomach Adenocarcinoma?,ssm_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,Can you tell me the rate of GPR158 A723V mutation in Stomach Adenocarcinoma?,ssm_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the rate of EIF2B4 E108K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the rate of EIF2B4 E110K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the rate of EIF2B4 E111K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the rate of EIF2B4 E131K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the rate of EIF2B4 E132K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the rate of EIF2B4 E96K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,Can you tell me the rate of AUTS2 P136S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,Can you tell me the rate of AUTS2 P218S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,Can you tell me the rate of AUTS2 P233S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,Can you tell me the rate of AUTS2 P313S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,Can you tell me the rate of AUTS2 P419S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,Can you tell me the rate of AUTS2 P443S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,Can you tell me the rate of AUTS2 P56S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,Can you tell me the rate of AUTS2 P667S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,Can you tell me the rate of AUTS2 P690S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,Can you tell me the rate of AUTS2 P691S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the rate of ACTL7B D223N mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,Can you tell me the rate of PCDHGA1 R535W mutation in Glioblastoma Multiforme?,ssm_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,Can you tell me the rate of TRAP1 R114W mutation in Stomach Adenocarcinoma?,ssm_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,Can you tell me the rate of TRAP1 R61W mutation in Stomach Adenocarcinoma?,ssm_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of PIK3C2A R1570Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,Can you tell me the rate of KANSL1 R139G mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,Can you tell me the rate of ANKRD52 Y594C mutation in Stomach Adenocarcinoma?,ssm_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of PAPPA G1580S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,Can you tell me the rate of B3GALNT1 V270A mutation in Rectum Adenocarcinoma?,ssm_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,Can you tell me the rate of GABRA6 G115R mutation in Lung Adenocarcinoma?,ssm_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,Can you tell me the rate of GABRA6 G122R mutation in Lung Adenocarcinoma?,ssm_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,Can you tell me the rate of GABRA6 G165R mutation in Lung Adenocarcinoma?,ssm_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,Can you tell me the rate of GABRA6 G175R mutation in Lung Adenocarcinoma?,ssm_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,Can you tell me the rate of GABRA6 G70R mutation in Lung Adenocarcinoma?,ssm_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,Can you tell me the rate of ZSCAN31 D9N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the rate of MED16 L126P mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the rate of MED16 L868P mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,Can you tell me the rate of PTPRO E1060K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,Can you tell me the rate of PTPRO E1088K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,Can you tell me the rate of PTPRO E249K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,Can you tell me the rate of PTPRO E265K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,Can you tell me the rate of PTPRO E277K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,Can you tell me the rate of PTPRO E67K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,Can you tell me the rate of PTPRO E923K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,Can you tell me the rate of PTPRO E940K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of CHMP7 D397N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,Can you tell me the rate of GPC3 I107N mutation in Stomach Adenocarcinoma?,ssm_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,Can you tell me the rate of GPC3 I161N mutation in Stomach Adenocarcinoma?,ssm_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me the rate of TLK2 V430L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me the rate of TLK2 V515L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me the rate of TLK2 V547L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me the rate of TLK2 V579L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me the rate of TLK2 V601L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,Can you tell me the rate of ZNF217 E209Q mutation in Lung Adenocarcinoma?,ssm_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,Can you tell me the rate of SYT9 V275L mutation in Lung Adenocarcinoma?,ssm_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,Can you tell me the rate of SYT9 V307L mutation in Lung Adenocarcinoma?,ssm_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,Can you tell me the rate of PKHD1L1 S2830N mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,Can you tell me the rate of MYO3A Y1295C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the rate of VASN V318I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of DNMT1 A1037T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of DNMT1 A1053T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of DNMT1 A934T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,Can you tell me the rate of CA9 E402K mutation in Colon Adenocarcinoma?,ssm_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of TTC17 R808Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of TTC17 R865Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,Can you tell me the rate of PSG2 P43L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,Can you tell me the rate of RIPOR2 R470L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,Can you tell me the rate of RIPOR2 R499L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,Can you tell me the rate of RIPOR2 R504L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,Can you tell me the rate of RIPOR2 R520L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of DCLK3 V520I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of DCLK3 V689I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,Can you tell me the rate of MERTK G257A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,Can you tell me the rate of MERTK G757A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,Can you tell me the rate of MERTK G933A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,Can you tell me the rate of ZFP42 R206K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,Can you tell me the rate of OR13C3 M117I mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,Can you tell me the rate of OR13C3 M147I mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,Can you tell me the rate of SPAG1 I917M mutation in Stomach Adenocarcinoma?,ssm_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of CDKN2AIP Y92H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,Can you tell me the rate of PXN H1016Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,Can you tell me the rate of PXN H359Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,Can you tell me the rate of PXN H492Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,Can you tell me the rate of PXN H524Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,Can you tell me the rate of PXN H526Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,Can you tell me the rate of PXN H540Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of TTYH2 S23L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of TTYH2 S44L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,Can you tell me the rate of TMEM255A N205S mutation in Colon Adenocarcinoma?,ssm_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,Can you tell me the rate of TMEM255A N229S mutation in Colon Adenocarcinoma?,ssm_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,Can you tell me the rate of TMEM255A N65S mutation in Colon Adenocarcinoma?,ssm_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,Can you tell me the rate of TASOR2 H2271D mutation in Breast Invasive Carcinoma?,ssm_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,Can you tell me the rate of TASOR2 H2486D mutation in Breast Invasive Carcinoma?,ssm_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of ICE1 T1839M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,Can you tell me the rate of MYT1 A558E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,Can you tell me the rate of MYT1 A879E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,Can you tell me the rate of MYT1 A906E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of CX3CR1 P203L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of CX3CR1 P235L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,Can you tell me the rate of SPINDOC R197C mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of ART3 C251Y mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of ART3 C3Y mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,Can you tell me the rate of CYP1A2 R243G mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the rate of ADRA1A G279S mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,Can you tell me the rate of CDH23 P2523R mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,Can you tell me the rate of CDH23 P283R mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,Can you tell me the rate of KRT39 P137S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,Can you tell me the rate of PDHA2 S7F mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,Can you tell me the rate of SLC24A2 H200Q mutation in Colon Adenocarcinoma?,ssm_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,Can you tell me the rate of PTPRN2 F153L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,Can you tell me the rate of PTPRN2 F847L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,Can you tell me the rate of PTPRN2 F856L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,Can you tell me the rate of PTPRN2 F868L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,Can you tell me the rate of PTPRN2 F885L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,Can you tell me the rate of SOX21 R55L mutation in Lung Adenocarcinoma?,ssm_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,Can you tell me the rate of CPA6 G166E mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,Can you tell me the rate of GRM5 E14K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the rate of CASZ1 R233Q mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,Can you tell me the rate of SGIP1 N122T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,Can you tell me the rate of SGIP1 N420T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,Can you tell me the rate of SGIP1 N617T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,Can you tell me the rate of SGIP1 N648T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,Can you tell me the rate of CARMIL1 V549L mutation in Lung Adenocarcinoma?,ssm_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,Can you tell me the rate of CARMIL1 V949L mutation in Lung Adenocarcinoma?,ssm_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,Can you tell me the rate of ZNF431 D121Y mutation in Lung Adenocarcinoma?,ssm_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,Can you tell me the rate of ZNF431 D161Y mutation in Lung Adenocarcinoma?,ssm_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,Can you tell me the rate of ZNF431 R128I mutation in Lung Adenocarcinoma?,ssm_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,Can you tell me the rate of DNAH11 P2987S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,Can you tell me the rate of DNAH11 P2994S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,Can you tell me the rate of POLD1 Q461L mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,Can you tell me the rate of POLD1 Q85L mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,Can you tell me the rate of TTC12 D646H mutation in Lung Adenocarcinoma?,ssm_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,Can you tell me the rate of TTC12 D652H mutation in Lung Adenocarcinoma?,ssm_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,Can you tell me the rate of CNGB1 D967N mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,Can you tell me the rate of CNGB1 D973N mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,Can you tell me the rate of CTSC E214V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,Can you tell me the rate of CTSC E291V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,Can you tell me the rate of CTSC E322V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,Can you tell me the rate of CTSC E324V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,Can you tell me the rate of CTSC E335V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of PRSS8 A179T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of PRSS8 A233T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,Can you tell me the rate of ARHGEF40 V864F mutation in Lung Adenocarcinoma?,ssm_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,Can you tell me the rate of ACTB A138T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,Can you tell me the rate of ACTB A217T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,Can you tell me the rate of ACTB A244T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,Can you tell me the rate of ACTB A260T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,Can you tell me the rate of YY1AP1 V546D mutation in Glioblastoma Multiforme?,ssm_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,Can you tell me the rate of YY1AP1 V557D mutation in Glioblastoma Multiforme?,ssm_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,Can you tell me the rate of YY1AP1 V566D mutation in Glioblastoma Multiforme?,ssm_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,Can you tell me the rate of YY1AP1 V577D mutation in Glioblastoma Multiforme?,ssm_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,Can you tell me the rate of YY1AP1 V623D mutation in Glioblastoma Multiforme?,ssm_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,Can you tell me the rate of YY1AP1 V695D mutation in Glioblastoma Multiforme?,ssm_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,Can you tell me the rate of YY1AP1 V715D mutation in Glioblastoma Multiforme?,ssm_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,Can you tell me the rate of FNDC7 D323N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,Can you tell me the rate of FNDC7 D99N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,Can you tell me the rate of TLCD5 G15V mutation in Lung Adenocarcinoma?,ssm_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,Can you tell me the rate of TLCD5 G37V mutation in Lung Adenocarcinoma?,ssm_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of POLR1G R498W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of POLR1G R500W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,Can you tell me the rate of DNAH14 N1186K mutation in Colon Adenocarcinoma?,ssm_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,Can you tell me the rate of DNAH14 N2657K mutation in Colon Adenocarcinoma?,ssm_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,Can you tell me the rate of DNAH14 N3460K mutation in Colon Adenocarcinoma?,ssm_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of NEXN E73D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,Can you tell me the rate of CYB5R2 G112R mutation in Prostate Adenocarcinoma?,ssm_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,Can you tell me the rate of CYB5R2 G172R mutation in Prostate Adenocarcinoma?,ssm_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of NRAP S808L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of NRAP S816L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of NRAP S843L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of CCDC22 E179D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,Can you tell me the rate of DCAF6 S402F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,Can you tell me the rate of DCAF6 S433F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of ZNF708 E389D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of BFAR T103M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of MAST4 P1237S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of MAST4 P1986S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of MAST4 P1991S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of MAST4 P2001S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of MAST4 P2180S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,Can you tell me the rate of ARMC3 R169C mutation in Stomach Adenocarcinoma?,ssm_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,Can you tell me the rate of ARMC3 R432C mutation in Stomach Adenocarcinoma?,ssm_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,Can you tell me the rate of TET2 L757V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,Can you tell me the rate of TET2 L778V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,Can you tell me the rate of SERPINB10 A353P mutation in Lung Adenocarcinoma?,ssm_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of STAT3 Y22H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of MIEF1 A42T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,Can you tell me the rate of ACVR1B D397N mutation in Colon Adenocarcinoma?,ssm_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,Can you tell me the rate of ACVR1B D449N mutation in Colon Adenocarcinoma?,ssm_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,Can you tell me the rate of ACVR1B D490N mutation in Colon Adenocarcinoma?,ssm_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,Can you tell me the rate of EBF2 T104I mutation in Stomach Adenocarcinoma?,ssm_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,Can you tell me the rate of EBF2 T252I mutation in Stomach Adenocarcinoma?,ssm_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,Can you tell me the rate of VPS26B F266L mutation in Stomach Adenocarcinoma?,ssm_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the rate of PGR M106I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the rate of PGR M38I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the rate of PGR M632I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,Can you tell me the rate of ACTA2 P334L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of THBS4 T852I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of THBS4 T943I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,Can you tell me the rate of PRSS1 S114T mutation in Lung Adenocarcinoma?,ssm_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,Can you tell me the rate of PRSS1 S124T mutation in Lung Adenocarcinoma?,ssm_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,Can you tell me the rate of PRSS1 S138T mutation in Lung Adenocarcinoma?,ssm_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,Can you tell me the rate of PRSS1 S74T mutation in Lung Adenocarcinoma?,ssm_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,Can you tell me the rate of PGF R126H mutation in Stomach Adenocarcinoma?,ssm_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,Can you tell me the rate of PGF R127H mutation in Stomach Adenocarcinoma?,ssm_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,Can you tell me the rate of ITPRID2 S351C mutation in Breast Invasive Carcinoma?,ssm_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,Can you tell me the rate of ITPRID2 S842C mutation in Breast Invasive Carcinoma?,ssm_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of HBB E8D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,Can you tell me the rate of PCDHB2 R158C mutation in Colon Adenocarcinoma?,ssm_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,Can you tell me the rate of PCDHB2 T15M mutation in Colon Adenocarcinoma?,ssm_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,Can you tell me the rate of PCDHB2 T26M mutation in Colon Adenocarcinoma?,ssm_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,Can you tell me the rate of UBR2 P1594S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,Can you tell me the rate of FBXO42 A618D mutation in Rectum Adenocarcinoma?,ssm_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the percentage of Breast Invasive Carcinoma tumors with the TNS1 G1362V mutation?,ssm_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the percentage of Breast Invasive Carcinoma tumors with the TNS1 G1711V mutation?,ssm_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the percentage of Breast Invasive Carcinoma tumors with the TNS1 G1718V mutation?,ssm_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the percentage of Breast Invasive Carcinoma tumors with the TNS1 G1732V mutation?,ssm_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the percentage of Breast Invasive Carcinoma tumors with the TNS1 G1824V mutation?,ssm_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the percentage of Breast Invasive Carcinoma tumors with the TNS1 G1857V mutation?,ssm_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the percentage of Breast Invasive Carcinoma tumors with the TNS1 G843V mutation?,ssm_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the percentage of Bladder Urothelial Carcinoma tumors with the EVC2 E1067K mutation?,ssm_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the percentage of Bladder Urothelial Carcinoma tumors with the EVC2 E987K mutation?,ssm_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the CR1 V1108G mutation?,ssm_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the CR1 V1558G mutation?,ssm_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the percentage of Rectum Adenocarcinoma tumors with the TRPA1 S295I mutation?,ssm_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the percentage of Rectum Adenocarcinoma tumors with the TRPA1 S443I mutation?,ssm_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the TAF1C R299L mutation?,ssm_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the TAF1C R396L mutation?,ssm_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the TAF1C R634L mutation?,ssm_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the TAF1C R702L mutation?,ssm_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the TAF1C R728L mutation?,ssm_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the DPF3 R104W mutation?,ssm_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the DPF3 R149W mutation?,ssm_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the DPF3 R94W mutation?,ssm_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the OR2T4 P272H mutation?,ssm_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the OR2T4 P300H mutation?,ssm_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the percentage of Pancreatic Adenocarcinoma tumors with the FBN1 E2667K mutation?,ssm_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the percentage of Prostate Adenocarcinoma tumors with the MAD1L1 E396K mutation?,ssm_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the percentage of Prostate Adenocarcinoma tumors with the MAD1L1 E488K mutation?,ssm_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the percentage of Prostate Adenocarcinoma tumors with the MAD1L1 E78K mutation?,ssm_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the CCNG1 E22K mutation?,ssm_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the percentage of Kidney Renal Papillary Cell Carcinoma tumors with the ANP32E N114T mutation?,ssm_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the percentage of Kidney Renal Papillary Cell Carcinoma tumors with the ANP32E N64T mutation?,ssm_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the percentage of Kidney Renal Papillary Cell Carcinoma tumors with the ANP32E N66T mutation?,ssm_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the percentage of Kidney Renal Papillary Cell Carcinoma tumors with the ANP32E N73T mutation?,ssm_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the percentage of Bladder Urothelial Carcinoma tumors with the FRY S1888A mutation?,ssm_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the percentage of Bladder Urothelial Carcinoma tumors with the FRY S1937A mutation?,ssm_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the percentage of Bladder Urothelial Carcinoma tumors with the FRY S1938A mutation?,ssm_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the percentage of Bladder Urothelial Carcinoma tumors with the FRY S1983A mutation?,ssm_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the PAK3 E318K mutation?,ssm_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the PAK3 E319K mutation?,ssm_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the PAK3 E334K mutation?,ssm_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the PAK3 E340K mutation?,ssm_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the PAK3 E355K mutation?,ssm_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the MUC16 P7963L mutation?,ssm_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the percentage of Liver Hepatocellular Carcinoma tumors with the ZFPM2 T498I mutation?,ssm_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the percentage of Liver Hepatocellular Carcinoma tumors with the ZFPM2 T630I mutation?,ssm_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the percentage of Breast Invasive Carcinoma tumors with the PIK3C2B S1328C mutation?,ssm_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the percentage of Breast Invasive Carcinoma tumors with the PIK3C2B S1356C mutation?,ssm_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the ZNF804A S371Y mutation?,ssm_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the RELN A2371V mutation?,ssm_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors with the EFCAB12 R173C mutation?",ssm_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors with the EFCAB12 R23C mutation?",ssm_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the DEFB115 E53K mutation?,ssm_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the percentage of Bladder Urothelial Carcinoma tumors with the ANKDD1A S290F mutation?,ssm_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the percentage of Bladder Urothelial Carcinoma tumors with the ANKDD1A S322F mutation?,ssm_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the percentage of Bladder Urothelial Carcinoma tumors with the ANKDD1A S413F mutation?,ssm_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the HTR3B S146I mutation?,ssm_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the HTR3B S206I mutation?,ssm_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the HTR3B S217I mutation?,ssm_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the ABCC3 R758W mutation?,ssm_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the NOMO1 T204I mutation?,ssm_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the NOMO1 T371I mutation?,ssm_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the percentage of Bladder Urothelial Carcinoma tumors with the HYOU1 D298H mutation?,ssm_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the FMO4 R500Q mutation?,ssm_frequency
+140,BICC1,A372V,Exceptional Responders,What is the percentage of Exceptional Responders tumors with the BICC1 A372V mutation?,ssm_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the ZMYM3 I920V mutation?,ssm_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the ZMYM3 I932V mutation?,ssm_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the ZMYM3 I934V mutation?,ssm_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors with the XKR4 R547W mutation?",ssm_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the percentage of Liver Hepatocellular Carcinoma tumors with the ABCC2 V239L mutation?,ssm_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the OR8K5 R293G mutation?,ssm_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the SPTAN1 S1503F mutation?,ssm_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the SPTAN1 S1523F mutation?,ssm_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the percentage of Rectum Adenocarcinoma tumors with the SYT10 M484I mutation?,ssm_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the HSPA5 N457K mutation?,ssm_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the UNC5D L280V mutation?,ssm_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the UNC5D L635V mutation?,ssm_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the UNC5D L637V mutation?,ssm_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the UNC5D L699V mutation?,ssm_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the UNC5D L704V mutation?,ssm_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the UNC5D L709V mutation?,ssm_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the percentage of Kidney Renal Clear Cell Carcinoma tumors with the DOCK2 L1527H mutation?,ssm_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the percentage of Kidney Renal Clear Cell Carcinoma tumors with the ZNF627 A5V mutation?,ssm_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the CDC42BPA L823F mutation?,ssm_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the MRPL55 H27Y mutation?,ssm_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the MRPL55 H63Y mutation?,ssm_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the percentage of Breast Invasive Carcinoma tumors with the TMTC3 Q749K mutation?,ssm_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the EPRS1 K771I mutation?,ssm_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the EPRS1 K778I mutation?,ssm_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the GRTP1 A110V mutation?,ssm_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the GRTP1 A32V mutation?,ssm_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the TSHZ3 Q538K mutation?,ssm_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the percentage of HIV+ Tumor Molecular Characterization Project - Cervical Cancer tumors with the TAS1R3 Q326H mutation?,ssm_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the PIAS3 S238C mutation?,ssm_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the PIAS3 S273C mutation?,ssm_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the ZNF274 P13R mutation?,ssm_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the SYNJ1 R795C mutation?,ssm_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the SYNJ1 R800C mutation?,ssm_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the SYNJ1 R839C mutation?,ssm_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the percentage of Prostate Adenocarcinoma tumors with the DSCAM V343M mutation?,ssm_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the percentage of Prostate Adenocarcinoma tumors with the DSCAM V426M mutation?,ssm_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the percentage of Prostate Adenocarcinoma tumors with the DSCAM V591M mutation?,ssm_frequency
+267,DGKD,R140H,Exceptional Responders,What is the percentage of Exceptional Responders tumors with the DGKD R140H mutation?,ssm_frequency
+268,DGKD,R160H,Exceptional Responders,What is the percentage of Exceptional Responders tumors with the DGKD R160H mutation?,ssm_frequency
+269,DGKD,R204H,Exceptional Responders,What is the percentage of Exceptional Responders tumors with the DGKD R204H mutation?,ssm_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the percentage of Bladder Urothelial Carcinoma tumors with the PLEKHG6 D105Y mutation?,ssm_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the percentage of Bladder Urothelial Carcinoma tumors with the PLEKHG6 D543Y mutation?,ssm_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the percentage of Bladder Urothelial Carcinoma tumors with the PLEKHG6 D575Y mutation?,ssm_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the WNT2 D138N mutation?,ssm_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the GUCY2C G667R mutation?,ssm_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the C7orf31 P244H mutation?,ssm_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors with the ZKSCAN7 E64K mutation?",ssm_frequency
+299,OR5D14,M210L,Neuroblastoma,What is the percentage of Neuroblastoma tumors with the OR5D14 M210L mutation?,ssm_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the SPATA22 K279E mutation?,ssm_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the SPATA22 K306E mutation?,ssm_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the SPATA22 K322E mutation?,ssm_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the LCN15 E21V mutation?,ssm_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the DCAF4L2 S129F mutation?,ssm_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the GUK1 R135P mutation?,ssm_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the GUK1 R137P mutation?,ssm_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the GUK1 R139P mutation?,ssm_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the GUK1 R158P mutation?,ssm_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the GUK1 R203P mutation?,ssm_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the MORF4L1 K29T mutation?,ssm_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the MORF4L1 K51T mutation?,ssm_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the MORF4L1 K61T mutation?,ssm_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the MORF4L1 K76T mutation?,ssm_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the MYO3B F594L mutation?,ssm_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the MYO3B F603L mutation?,ssm_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the TENT5A S320F mutation?,ssm_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the TENT5A S339F mutation?,ssm_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the TENT5A S401F mutation?,ssm_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the percentage of Ovarian Serous Cystadenocarcinoma tumors with the ZFAT S614L mutation?,ssm_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the percentage of Ovarian Serous Cystadenocarcinoma tumors with the ZFAT S664L mutation?,ssm_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the percentage of Ovarian Serous Cystadenocarcinoma tumors with the ZFAT S676L mutation?,ssm_frequency
+357,ZNF584,A211T,Sarcoma,What is the percentage of Sarcoma tumors with the ZNF584 A211T mutation?,ssm_frequency
+358,ZNF584,A256T,Sarcoma,What is the percentage of Sarcoma tumors with the ZNF584 A256T mutation?,ssm_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the LDOC1 R63W mutation?,ssm_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the PDGFC R201G mutation?,ssm_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the MSANTD4 R304C mutation?,ssm_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the NPSR1 S123L mutation?,ssm_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the PHLPP1 K1317E mutation?,ssm_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the COL6A3 G237S mutation?,ssm_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the COL6A3 G437S mutation?,ssm_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the COL6A3 G638S mutation?,ssm_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the COL6A3 G644S mutation?,ssm_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the COL6A3 G844S mutation?,ssm_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the ADRA1A R348G mutation?,ssm_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma tumors with the LAMB2 S1254F mutation?,ssm_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the percentage of Rectum Adenocarcinoma tumors with the POC1B I198T mutation?,ssm_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the percentage of Rectum Adenocarcinoma tumors with the POC1B I286T mutation?,ssm_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the percentage of Rectum Adenocarcinoma tumors with the POC1B I328T mutation?,ssm_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the percentage of Rectum Adenocarcinoma tumors with the POC1B S79P mutation?,ssm_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the percentage of Liver Hepatocellular Carcinoma tumors with the USH2A G1451C mutation?,ssm_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the percentage of Rectum Adenocarcinoma tumors with the AQP7 T110S mutation?,ssm_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the percentage of Rectum Adenocarcinoma tumors with the AQP7 T166S mutation?,ssm_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the percentage of Rectum Adenocarcinoma tumors with the AQP7 T167S mutation?,ssm_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the percentage of Rectum Adenocarcinoma tumors with the AQP7 T75S mutation?,ssm_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,What is the percentage of Rectum Adenocarcinoma tumors with the DCN R163C mutation?,ssm_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,What is the percentage of Rectum Adenocarcinoma tumors with the DCN R203C mutation?,ssm_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,What is the percentage of Rectum Adenocarcinoma tumors with the DCN R241C mutation?,ssm_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,What is the percentage of Rectum Adenocarcinoma tumors with the DCN R350C mutation?,ssm_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,What is the percentage of Rectum Adenocarcinoma tumors with the DCN R41C mutation?,ssm_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the CPS1 K1269N mutation?,ssm_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the CPS1 K1275N mutation?,ssm_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the CPS1 K818N mutation?,ssm_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the percentage of Kidney Renal Papillary Cell Carcinoma tumors with the FCGR2C P122S mutation?,ssm_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the percentage of Kidney Renal Papillary Cell Carcinoma tumors with the FCGR2C P123S mutation?,ssm_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the GRM1 R280M mutation?,ssm_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the SGCZ Q138H mutation?,ssm_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the SGCZ Q91H mutation?,ssm_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the SMO V15M mutation?,ssm_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the SMO V321M mutation?,ssm_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the CHODL G159E mutation?,ssm_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the CHODL G181E mutation?,ssm_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the CHODL G200E mutation?,ssm_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the MYO16 P399H mutation?,ssm_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the MYO16 P421H mutation?,ssm_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the CXCR2 A98V mutation?,ssm_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the percentage of Bladder Urothelial Carcinoma tumors with the TMEM225 L212V mutation?,ssm_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the MAOB N251T mutation?,ssm_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the GPRASP1 F580S mutation?,ssm_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the MRPL32 R181Q mutation?,ssm_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the TYROBP A29T mutation?,ssm_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the RAB40C A111V mutation?,ssm_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the RAB40C A143V mutation?,ssm_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the CTNNA2 S323R mutation?,ssm_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the CTNNA2 S339R mutation?,ssm_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the CTNNA2 S386R mutation?,ssm_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the CTNNA2 S707R mutation?,ssm_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the percentage of Bladder Urothelial Carcinoma tumors with the MYO15A S268R mutation?,ssm_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the GIMAP2 A167T mutation?,ssm_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the percentage of Glioblastoma Multiforme tumors with the KIF20B N1160D mutation?,ssm_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the percentage of Glioblastoma Multiforme tumors with the KIF20B N1200D mutation?,ssm_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the ADAM17 E583K mutation?,ssm_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the BCAT1 G16R mutation?,ssm_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the BCAT1 G17R mutation?,ssm_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the BCAT1 G29R mutation?,ssm_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the ERCC6 R1053H mutation?,ssm_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,What is the percentage of Breast Invasive Carcinoma tumors with the DCC R320W mutation?,ssm_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,What is the percentage of Breast Invasive Carcinoma tumors with the DCC R363W mutation?,ssm_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,What is the percentage of Breast Invasive Carcinoma tumors with the DCC R386W mutation?,ssm_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,What is the percentage of Breast Invasive Carcinoma tumors with the DCC R41W mutation?,ssm_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the FBXO15 D417N mutation?,ssm_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the FBXO15 D86N mutation?,ssm_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the GSTCD S528F mutation?,ssm_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the GSTCD S615F mutation?,ssm_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the OLFML3 P296S mutation?,ssm_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the OLFML3 P337S mutation?,ssm_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the OLFML3 P357S mutation?,ssm_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the percentage of Ovarian Serous Cystadenocarcinoma tumors with the CFAP61 E173V mutation?,ssm_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the percentage of Ovarian Serous Cystadenocarcinoma tumors with the CFAP61 E817V mutation?,ssm_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the percentage of Bladder Urothelial Carcinoma tumors with the HLA-DQA2 E51K mutation?,ssm_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the TENM2 H240Y mutation?,ssm_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the TENM2 H351Y mutation?,ssm_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the TENM2 H472Y mutation?,ssm_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the ANKRD24 A465T mutation?,ssm_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the ANKRD24 A494T mutation?,ssm_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the ANKRD24 A584T mutation?,ssm_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the ZCCHC14 V549M mutation?,ssm_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the ZCCHC14 V665M mutation?,ssm_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the ZCCHC14 V676M mutation?,ssm_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the ZCCHC14 V802M mutation?,ssm_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the SIK2 I265M mutation?,ssm_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the MYH11 T1336M mutation?,ssm_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the MYH11 T1343M mutation?,ssm_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the SLC6A4 S174F mutation?,ssm_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the SLC9C1 K102N mutation?,ssm_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the SLC9C1 K29N mutation?,ssm_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the percentage of Brain Lower Grade Glioma tumors with the OR2A12 A254T mutation?,ssm_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the PYHIN1 T325K mutation?,ssm_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the PYHIN1 T334K mutation?,ssm_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the JAML G191E mutation?,ssm_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the JAML G219E mutation?,ssm_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the JAML G220E mutation?,ssm_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the JAML G230E mutation?,ssm_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the TYK2 H1146R mutation?,ssm_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the TYK2 H23R mutation?,ssm_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the TYK2 H961R mutation?,ssm_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the CTCFL R208C mutation?,ssm_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the CTCFL R265C mutation?,ssm_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the CTCFL R420C mutation?,ssm_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the CTCFL R470C mutation?,ssm_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the CEP20 R31Q mutation?,ssm_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the CEP20 R58Q mutation?,ssm_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the RIMS2 R25W mutation?,ssm_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the RIMS2 R393W mutation?,ssm_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the RIMS2 R423W mutation?,ssm_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the RIMS2 R470W mutation?,ssm_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the RIMS2 R615W mutation?,ssm_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the RIMS2 R619W mutation?,ssm_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the RIMS2 R716W mutation?,ssm_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the PIK3C2G S551L mutation?,ssm_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the PIK3C2G S592L mutation?,ssm_frequency
+728,STK19,D341N,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the STK19 D341N mutation?,ssm_frequency
+729,STK19,D345N,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the STK19 D345N mutation?,ssm_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the REXO4 P60A mutation?,ssm_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the ZBTB34 P160S mutation?,ssm_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the ZBTB34 P164S mutation?,ssm_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the percentage of Bladder Urothelial Carcinoma tumors with the NCKAP5 E148K mutation?,ssm_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors with the SORCS1 D1052Y mutation?",ssm_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors with the SORCS1 D587Y mutation?",ssm_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors with the SORCS1 D67Y mutation?",ssm_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors with the SORCS1 D810Y mutation?",ssm_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the percentage of Head and Neck Squamous Cell Carcinoma tumors with the FGF8 T154M mutation?,ssm_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the percentage of Head and Neck Squamous Cell Carcinoma tumors with the FGF8 T165M mutation?,ssm_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the percentage of Head and Neck Squamous Cell Carcinoma tumors with the FGF8 T183M mutation?,ssm_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the percentage of Head and Neck Squamous Cell Carcinoma tumors with the FGF8 T194M mutation?,ssm_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the percentage of Head and Neck Squamous Cell Carcinoma tumors with the FGF8 T90M mutation?,ssm_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the percentage of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia tumors with the TENM3 R1877W mutation?,ssm_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the AKT1 D44N mutation?,ssm_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma tumors with the CFAP298-TCP10L E11Q mutation?,ssm_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the GLRB E148D mutation?,ssm_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the TTN F7636L mutation?,ssm_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the TTN F8563L mutation?,ssm_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the TTN F8880L mutation?,ssm_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the ANKRD30A V798I mutation?,ssm_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the ANKRD30A V854I mutation?,ssm_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the ANKRD30A V973I mutation?,ssm_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the TRIM45 S177L mutation?,ssm_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the TRIM45 S224L mutation?,ssm_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the TRIM45 S281L mutation?,ssm_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the CACNA1F G727V mutation?,ssm_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the CACNA1F G781V mutation?,ssm_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the CACNA1F G792V mutation?,ssm_frequency
+817,KL,R594C,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the KL R594C mutation?,ssm_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the percentage of Kidney Renal Papillary Cell Carcinoma tumors with the GUF1 I243T mutation?,ssm_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the TAF1L A539V mutation?,ssm_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the TASOR2 S256F mutation?,ssm_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the TASOR2 S36F mutation?,ssm_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the TASOR2 S471F mutation?,ssm_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the KDM5C R1151C mutation?,ssm_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the KDM5C R1177C mutation?,ssm_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the KDM5C R1217C mutation?,ssm_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the KDM5C R1218C mutation?,ssm_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma tumors with the IL5RA L153F mutation?,ssm_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the DHX16 A29V mutation?,ssm_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the DHX16 A89V mutation?,ssm_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the GPR158 A644V mutation?,ssm_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the GPR158 A723V mutation?,ssm_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors with the EIF2B4 E108K mutation?",ssm_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors with the EIF2B4 E110K mutation?",ssm_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors with the EIF2B4 E111K mutation?",ssm_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors with the EIF2B4 E131K mutation?",ssm_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors with the EIF2B4 E132K mutation?",ssm_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors with the EIF2B4 E96K mutation?",ssm_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the AUTS2 P136S mutation?,ssm_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the AUTS2 P218S mutation?,ssm_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the AUTS2 P233S mutation?,ssm_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the AUTS2 P313S mutation?,ssm_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the AUTS2 P419S mutation?,ssm_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the AUTS2 P443S mutation?,ssm_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the AUTS2 P56S mutation?,ssm_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the AUTS2 P667S mutation?,ssm_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the AUTS2 P690S mutation?,ssm_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the AUTS2 P691S mutation?,ssm_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors with the ACTL7B D223N mutation?",ssm_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the percentage of Glioblastoma Multiforme tumors with the PCDHGA1 R535W mutation?,ssm_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the TRAP1 R114W mutation?,ssm_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the TRAP1 R61W mutation?,ssm_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the PIK3C2A R1570Q mutation?,ssm_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the percentage of Liver Hepatocellular Carcinoma tumors with the KANSL1 R139G mutation?,ssm_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the ANKRD52 Y594C mutation?,ssm_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the PAPPA G1580S mutation?,ssm_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the percentage of Rectum Adenocarcinoma tumors with the B3GALNT1 V270A mutation?,ssm_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the GABRA6 G115R mutation?,ssm_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the GABRA6 G122R mutation?,ssm_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the GABRA6 G165R mutation?,ssm_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the GABRA6 G175R mutation?,ssm_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the GABRA6 G70R mutation?,ssm_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the ZSCAN31 D9N mutation?,ssm_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors with the MED16 L126P mutation?",ssm_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors with the MED16 L868P mutation?",ssm_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the percentage of Pancreatic Adenocarcinoma tumors with the PTPRO E1060K mutation?,ssm_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the percentage of Pancreatic Adenocarcinoma tumors with the PTPRO E1088K mutation?,ssm_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the percentage of Pancreatic Adenocarcinoma tumors with the PTPRO E249K mutation?,ssm_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the percentage of Pancreatic Adenocarcinoma tumors with the PTPRO E265K mutation?,ssm_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the percentage of Pancreatic Adenocarcinoma tumors with the PTPRO E277K mutation?,ssm_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the percentage of Pancreatic Adenocarcinoma tumors with the PTPRO E67K mutation?,ssm_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the percentage of Pancreatic Adenocarcinoma tumors with the PTPRO E923K mutation?,ssm_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the percentage of Pancreatic Adenocarcinoma tumors with the PTPRO E940K mutation?,ssm_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the CHMP7 D397N mutation?,ssm_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the GPC3 I107N mutation?,ssm_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the GPC3 I161N mutation?,ssm_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma tumors with the TLK2 V430L mutation?,ssm_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma tumors with the TLK2 V515L mutation?,ssm_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma tumors with the TLK2 V547L mutation?,ssm_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma tumors with the TLK2 V579L mutation?,ssm_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma tumors with the TLK2 V601L mutation?,ssm_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the ZNF217 E209Q mutation?,ssm_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the SYT9 V275L mutation?,ssm_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the SYT9 V307L mutation?,ssm_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the PKHD1L1 S2830N mutation?,ssm_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the MYO3A Y1295C mutation?,ssm_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors with the VASN V318I mutation?",ssm_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the DNMT1 A1037T mutation?,ssm_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the DNMT1 A1053T mutation?,ssm_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the DNMT1 A934T mutation?,ssm_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the CA9 E402K mutation?,ssm_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the TTC17 R808Q mutation?,ssm_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the TTC17 R865Q mutation?,ssm_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the percentage of Breast Invasive Carcinoma tumors with the PSG2 P43L mutation?,ssm_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the percentage of Breast Invasive Carcinoma tumors with the RIPOR2 R470L mutation?,ssm_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the percentage of Breast Invasive Carcinoma tumors with the RIPOR2 R499L mutation?,ssm_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the percentage of Breast Invasive Carcinoma tumors with the RIPOR2 R504L mutation?,ssm_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the percentage of Breast Invasive Carcinoma tumors with the RIPOR2 R520L mutation?,ssm_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the DCLK3 V520I mutation?,ssm_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the DCLK3 V689I mutation?,ssm_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the MERTK G257A mutation?,ssm_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the MERTK G757A mutation?,ssm_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the MERTK G933A mutation?,ssm_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the ZFP42 R206K mutation?,ssm_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the OR13C3 M117I mutation?,ssm_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the OR13C3 M147I mutation?,ssm_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the SPAG1 I917M mutation?,ssm_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the CDKN2AIP Y92H mutation?,ssm_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the PXN H1016Y mutation?,ssm_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the PXN H359Y mutation?,ssm_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the PXN H492Y mutation?,ssm_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the PXN H524Y mutation?,ssm_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the PXN H526Y mutation?,ssm_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the PXN H540Y mutation?,ssm_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the TTYH2 S23L mutation?,ssm_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the TTYH2 S44L mutation?,ssm_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the TMEM255A N205S mutation?,ssm_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the TMEM255A N229S mutation?,ssm_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the TMEM255A N65S mutation?,ssm_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the percentage of Breast Invasive Carcinoma tumors with the TASOR2 H2271D mutation?,ssm_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the percentage of Breast Invasive Carcinoma tumors with the TASOR2 H2486D mutation?,ssm_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the ICE1 T1839M mutation?,ssm_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the percentage of Breast Invasive Carcinoma tumors with the MYT1 A558E mutation?,ssm_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the percentage of Breast Invasive Carcinoma tumors with the MYT1 A879E mutation?,ssm_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the percentage of Breast Invasive Carcinoma tumors with the MYT1 A906E mutation?,ssm_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the CX3CR1 P203L mutation?,ssm_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the CX3CR1 P235L mutation?,ssm_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the percentage of Liver Hepatocellular Carcinoma tumors with the SPINDOC R197C mutation?,ssm_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the ART3 C251Y mutation?,ssm_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the ART3 C3Y mutation?,ssm_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the percentage of Bladder Urothelial Carcinoma tumors with the CYP1A2 R243G mutation?,ssm_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors with the ADRA1A G279S mutation?",ssm_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the CDH23 P2523R mutation?,ssm_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the CDH23 P283R mutation?,ssm_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the KRT39 P137S mutation?,ssm_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the PDHA2 S7F mutation?,ssm_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the SLC24A2 H200Q mutation?,ssm_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the percentage of Liver Hepatocellular Carcinoma tumors with the PTPRN2 F153L mutation?,ssm_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the percentage of Liver Hepatocellular Carcinoma tumors with the PTPRN2 F847L mutation?,ssm_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the percentage of Liver Hepatocellular Carcinoma tumors with the PTPRN2 F856L mutation?,ssm_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the percentage of Liver Hepatocellular Carcinoma tumors with the PTPRN2 F868L mutation?,ssm_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the percentage of Liver Hepatocellular Carcinoma tumors with the PTPRN2 F885L mutation?,ssm_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the SOX21 R55L mutation?,ssm_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the percentage of Bladder Urothelial Carcinoma tumors with the CPA6 G166E mutation?,ssm_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the GRM5 E14K mutation?,ssm_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors with the CASZ1 R233Q mutation?",ssm_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the SGIP1 N122T mutation?,ssm_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the SGIP1 N420T mutation?,ssm_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the SGIP1 N617T mutation?,ssm_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the SGIP1 N648T mutation?,ssm_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the CARMIL1 V549L mutation?,ssm_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the CARMIL1 V949L mutation?,ssm_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the ZNF431 D121Y mutation?,ssm_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the ZNF431 D161Y mutation?,ssm_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the ZNF431 R128I mutation?,ssm_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the DNAH11 P2987S mutation?,ssm_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the DNAH11 P2994S mutation?,ssm_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the POLD1 Q461L mutation?,ssm_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the percentage of Lung Squamous Cell Carcinoma tumors with the POLD1 Q85L mutation?,ssm_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the TTC12 D646H mutation?,ssm_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the TTC12 D652H mutation?,ssm_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the percentage of Bladder Urothelial Carcinoma tumors with the CNGB1 D967N mutation?,ssm_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the percentage of Bladder Urothelial Carcinoma tumors with the CNGB1 D973N mutation?,ssm_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the CTSC E214V mutation?,ssm_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the CTSC E291V mutation?,ssm_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the CTSC E322V mutation?,ssm_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the CTSC E324V mutation?,ssm_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the CTSC E335V mutation?,ssm_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the PRSS8 A179T mutation?,ssm_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the PRSS8 A233T mutation?,ssm_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the ARHGEF40 V864F mutation?,ssm_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the percentage of Rectum Adenocarcinoma tumors with the ACTB A138T mutation?,ssm_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the percentage of Rectum Adenocarcinoma tumors with the ACTB A217T mutation?,ssm_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the percentage of Rectum Adenocarcinoma tumors with the ACTB A244T mutation?,ssm_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the percentage of Rectum Adenocarcinoma tumors with the ACTB A260T mutation?,ssm_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the percentage of Glioblastoma Multiforme tumors with the YY1AP1 V546D mutation?,ssm_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the percentage of Glioblastoma Multiforme tumors with the YY1AP1 V557D mutation?,ssm_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the percentage of Glioblastoma Multiforme tumors with the YY1AP1 V566D mutation?,ssm_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the percentage of Glioblastoma Multiforme tumors with the YY1AP1 V577D mutation?,ssm_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the percentage of Glioblastoma Multiforme tumors with the YY1AP1 V623D mutation?,ssm_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the percentage of Glioblastoma Multiforme tumors with the YY1AP1 V695D mutation?,ssm_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the percentage of Glioblastoma Multiforme tumors with the YY1AP1 V715D mutation?,ssm_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the FNDC7 D323N mutation?,ssm_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the FNDC7 D99N mutation?,ssm_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the TLCD5 G15V mutation?,ssm_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the TLCD5 G37V mutation?,ssm_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the POLR1G R498W mutation?,ssm_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the POLR1G R500W mutation?,ssm_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the DNAH14 N1186K mutation?,ssm_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the DNAH14 N2657K mutation?,ssm_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the DNAH14 N3460K mutation?,ssm_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the NEXN E73D mutation?,ssm_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the percentage of Prostate Adenocarcinoma tumors with the CYB5R2 G112R mutation?,ssm_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the percentage of Prostate Adenocarcinoma tumors with the CYB5R2 G172R mutation?,ssm_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the NRAP S808L mutation?,ssm_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the NRAP S816L mutation?,ssm_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the NRAP S843L mutation?,ssm_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the CCDC22 E179D mutation?,ssm_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the DCAF6 S402F mutation?,ssm_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the DCAF6 S433F mutation?,ssm_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the ZNF708 E389D mutation?,ssm_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the BFAR T103M mutation?,ssm_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the MAST4 P1237S mutation?,ssm_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the MAST4 P1986S mutation?,ssm_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the MAST4 P1991S mutation?,ssm_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the MAST4 P2001S mutation?,ssm_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the MAST4 P2180S mutation?,ssm_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the ARMC3 R169C mutation?,ssm_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the ARMC3 R432C mutation?,ssm_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the percentage of Kidney Renal Clear Cell Carcinoma tumors with the TET2 L757V mutation?,ssm_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the percentage of Kidney Renal Clear Cell Carcinoma tumors with the TET2 L778V mutation?,ssm_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the SERPINB10 A353P mutation?,ssm_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the STAT3 Y22H mutation?,ssm_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the MIEF1 A42T mutation?,ssm_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the ACVR1B D397N mutation?,ssm_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the ACVR1B D449N mutation?,ssm_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the ACVR1B D490N mutation?,ssm_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the EBF2 T104I mutation?,ssm_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the EBF2 T252I mutation?,ssm_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the VPS26B F266L mutation?,ssm_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors with the PGR M106I mutation?",ssm_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors with the PGR M38I mutation?",ssm_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors with the PGR M632I mutation?",ssm_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the percentage of Skin Cutaneous Melanoma tumors with the ACTA2 P334L mutation?,ssm_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the THBS4 T852I mutation?,ssm_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the THBS4 T943I mutation?,ssm_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the PRSS1 S114T mutation?,ssm_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the PRSS1 S124T mutation?,ssm_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the PRSS1 S138T mutation?,ssm_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the percentage of Lung Adenocarcinoma tumors with the PRSS1 S74T mutation?,ssm_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the PGF R126H mutation?,ssm_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the percentage of Stomach Adenocarcinoma tumors with the PGF R127H mutation?,ssm_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the percentage of Breast Invasive Carcinoma tumors with the ITPRID2 S351C mutation?,ssm_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the percentage of Breast Invasive Carcinoma tumors with the ITPRID2 S842C mutation?,ssm_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the HBB E8D mutation?,ssm_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the PCDHB2 R158C mutation?,ssm_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the PCDHB2 T15M mutation?,ssm_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the percentage of Colon Adenocarcinoma tumors with the PCDHB2 T26M mutation?,ssm_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the percentage of Uterine Corpus Endometrial Carcinoma tumors with the UBR2 P1594S mutation?,ssm_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the percentage of Rectum Adenocarcinoma tumors with the FBXO42 A618D mutation?,ssm_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the prevalence rate of TNS1 G1362V mutation in Breast Invasive Carcinoma?,ssm_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the prevalence rate of TNS1 G1711V mutation in Breast Invasive Carcinoma?,ssm_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the prevalence rate of TNS1 G1718V mutation in Breast Invasive Carcinoma?,ssm_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the prevalence rate of TNS1 G1732V mutation in Breast Invasive Carcinoma?,ssm_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the prevalence rate of TNS1 G1824V mutation in Breast Invasive Carcinoma?,ssm_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the prevalence rate of TNS1 G1857V mutation in Breast Invasive Carcinoma?,ssm_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the prevalence rate of TNS1 G843V mutation in Breast Invasive Carcinoma?,ssm_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the prevalence rate of EVC2 E1067K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the prevalence rate of EVC2 E987K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of CR1 V1108G mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of CR1 V1558G mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the prevalence rate of TRPA1 S295I mutation in Rectum Adenocarcinoma?,ssm_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the prevalence rate of TRPA1 S443I mutation in Rectum Adenocarcinoma?,ssm_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the prevalence rate of TAF1C R299L mutation in Lung Adenocarcinoma?,ssm_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the prevalence rate of TAF1C R396L mutation in Lung Adenocarcinoma?,ssm_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the prevalence rate of TAF1C R634L mutation in Lung Adenocarcinoma?,ssm_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the prevalence rate of TAF1C R702L mutation in Lung Adenocarcinoma?,ssm_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the prevalence rate of TAF1C R728L mutation in Lung Adenocarcinoma?,ssm_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of DPF3 R104W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of DPF3 R149W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of DPF3 R94W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the prevalence rate of OR2T4 P272H mutation in Lung Adenocarcinoma?,ssm_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the prevalence rate of OR2T4 P300H mutation in Lung Adenocarcinoma?,ssm_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the prevalence rate of FBN1 E2667K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the prevalence rate of MAD1L1 E396K mutation in Prostate Adenocarcinoma?,ssm_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the prevalence rate of MAD1L1 E488K mutation in Prostate Adenocarcinoma?,ssm_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the prevalence rate of MAD1L1 E78K mutation in Prostate Adenocarcinoma?,ssm_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the prevalence rate of CCNG1 E22K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the prevalence rate of ANP32E N114T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the prevalence rate of ANP32E N64T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the prevalence rate of ANP32E N66T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the prevalence rate of ANP32E N73T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the prevalence rate of FRY S1888A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the prevalence rate of FRY S1937A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the prevalence rate of FRY S1938A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the prevalence rate of FRY S1983A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the prevalence rate of PAK3 E318K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the prevalence rate of PAK3 E319K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the prevalence rate of PAK3 E334K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the prevalence rate of PAK3 E340K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the prevalence rate of PAK3 E355K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the prevalence rate of MUC16 P7963L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the prevalence rate of ZFPM2 T498I mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the prevalence rate of ZFPM2 T630I mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the prevalence rate of PIK3C2B S1328C mutation in Breast Invasive Carcinoma?,ssm_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the prevalence rate of PIK3C2B S1356C mutation in Breast Invasive Carcinoma?,ssm_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the prevalence rate of ZNF804A S371Y mutation in Colon Adenocarcinoma?,ssm_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the prevalence rate of RELN A2371V mutation in Stomach Adenocarcinoma?,ssm_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of EFCAB12 R173C mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of EFCAB12 R23C mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the prevalence rate of DEFB115 E53K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the prevalence rate of ANKDD1A S290F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the prevalence rate of ANKDD1A S322F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the prevalence rate of ANKDD1A S413F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of HTR3B S146I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of HTR3B S206I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of HTR3B S217I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the prevalence rate of ABCC3 R758W mutation in Stomach Adenocarcinoma?,ssm_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of NOMO1 T204I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of NOMO1 T371I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the prevalence rate of HYOU1 D298H mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the prevalence rate of FMO4 R500Q mutation in Skin Cutaneous Melanoma?,ssm_frequency
+140,BICC1,A372V,Exceptional Responders,What is the prevalence rate of BICC1 A372V mutation in Exceptional Responders?,ssm_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of ZMYM3 I920V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of ZMYM3 I932V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of ZMYM3 I934V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of XKR4 R547W mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the prevalence rate of ABCC2 V239L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the prevalence rate of OR8K5 R293G mutation in Lung Adenocarcinoma?,ssm_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the prevalence rate of SPTAN1 S1503F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the prevalence rate of SPTAN1 S1523F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the prevalence rate of SYT10 M484I mutation in Rectum Adenocarcinoma?,ssm_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the prevalence rate of HSPA5 N457K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the prevalence rate of UNC5D L280V mutation in Lung Adenocarcinoma?,ssm_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the prevalence rate of UNC5D L635V mutation in Lung Adenocarcinoma?,ssm_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the prevalence rate of UNC5D L637V mutation in Lung Adenocarcinoma?,ssm_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the prevalence rate of UNC5D L699V mutation in Lung Adenocarcinoma?,ssm_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the prevalence rate of UNC5D L704V mutation in Lung Adenocarcinoma?,ssm_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the prevalence rate of UNC5D L709V mutation in Lung Adenocarcinoma?,ssm_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the prevalence rate of DOCK2 L1527H mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the prevalence rate of ZNF627 A5V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the prevalence rate of CDC42BPA L823F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the prevalence rate of MRPL55 H27Y mutation in Colon Adenocarcinoma?,ssm_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the prevalence rate of MRPL55 H63Y mutation in Colon Adenocarcinoma?,ssm_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the prevalence rate of TMTC3 Q749K mutation in Breast Invasive Carcinoma?,ssm_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the prevalence rate of EPRS1 K771I mutation in Colon Adenocarcinoma?,ssm_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the prevalence rate of EPRS1 K778I mutation in Colon Adenocarcinoma?,ssm_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the prevalence rate of GRTP1 A110V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the prevalence rate of GRTP1 A32V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the prevalence rate of TSHZ3 Q538K mutation in Stomach Adenocarcinoma?,ssm_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the prevalence rate of TAS1R3 Q326H mutation in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,ssm_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the prevalence rate of PIAS3 S238C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the prevalence rate of PIAS3 S273C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the prevalence rate of ZNF274 P13R mutation in Stomach Adenocarcinoma?,ssm_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the prevalence rate of SYNJ1 R795C mutation in Colon Adenocarcinoma?,ssm_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the prevalence rate of SYNJ1 R800C mutation in Colon Adenocarcinoma?,ssm_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the prevalence rate of SYNJ1 R839C mutation in Colon Adenocarcinoma?,ssm_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the prevalence rate of DSCAM V343M mutation in Prostate Adenocarcinoma?,ssm_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the prevalence rate of DSCAM V426M mutation in Prostate Adenocarcinoma?,ssm_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the prevalence rate of DSCAM V591M mutation in Prostate Adenocarcinoma?,ssm_frequency
+267,DGKD,R140H,Exceptional Responders,What is the prevalence rate of DGKD R140H mutation in Exceptional Responders?,ssm_frequency
+268,DGKD,R160H,Exceptional Responders,What is the prevalence rate of DGKD R160H mutation in Exceptional Responders?,ssm_frequency
+269,DGKD,R204H,Exceptional Responders,What is the prevalence rate of DGKD R204H mutation in Exceptional Responders?,ssm_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the prevalence rate of PLEKHG6 D105Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the prevalence rate of PLEKHG6 D543Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the prevalence rate of PLEKHG6 D575Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the prevalence rate of WNT2 D138N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the prevalence rate of GUCY2C G667R mutation in Skin Cutaneous Melanoma?,ssm_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of C7orf31 P244H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of ZKSCAN7 E64K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+299,OR5D14,M210L,Neuroblastoma,What is the prevalence rate of OR5D14 M210L mutation in Neuroblastoma?,ssm_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of SPATA22 K279E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of SPATA22 K306E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of SPATA22 K322E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the prevalence rate of LCN15 E21V mutation in Stomach Adenocarcinoma?,ssm_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the prevalence rate of DCAF4L2 S129F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the prevalence rate of GUK1 R135P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the prevalence rate of GUK1 R137P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the prevalence rate of GUK1 R139P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the prevalence rate of GUK1 R158P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the prevalence rate of GUK1 R203P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the prevalence rate of MORF4L1 K29T mutation in Stomach Adenocarcinoma?,ssm_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the prevalence rate of MORF4L1 K51T mutation in Stomach Adenocarcinoma?,ssm_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the prevalence rate of MORF4L1 K61T mutation in Stomach Adenocarcinoma?,ssm_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the prevalence rate of MORF4L1 K76T mutation in Stomach Adenocarcinoma?,ssm_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the prevalence rate of MYO3B F594L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the prevalence rate of MYO3B F603L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the prevalence rate of TENT5A S320F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the prevalence rate of TENT5A S339F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the prevalence rate of TENT5A S401F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the prevalence rate of ZFAT S614L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the prevalence rate of ZFAT S664L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the prevalence rate of ZFAT S676L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+357,ZNF584,A211T,Sarcoma,What is the prevalence rate of ZNF584 A211T mutation in Sarcoma?,ssm_frequency
+358,ZNF584,A256T,Sarcoma,What is the prevalence rate of ZNF584 A256T mutation in Sarcoma?,ssm_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of LDOC1 R63W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the prevalence rate of PDGFC R201G mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of MSANTD4 R304C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the prevalence rate of NPSR1 S123L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the prevalence rate of PHLPP1 K1317E mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the prevalence rate of COL6A3 G237S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the prevalence rate of COL6A3 G437S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the prevalence rate of COL6A3 G638S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the prevalence rate of COL6A3 G644S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the prevalence rate of COL6A3 G844S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the prevalence rate of ADRA1A R348G mutation in Stomach Adenocarcinoma?,ssm_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence rate of LAMB2 S1254F mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the prevalence rate of POC1B I198T mutation in Rectum Adenocarcinoma?,ssm_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the prevalence rate of POC1B I286T mutation in Rectum Adenocarcinoma?,ssm_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the prevalence rate of POC1B I328T mutation in Rectum Adenocarcinoma?,ssm_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the prevalence rate of POC1B S79P mutation in Rectum Adenocarcinoma?,ssm_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the prevalence rate of USH2A G1451C mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the prevalence rate of AQP7 T110S mutation in Rectum Adenocarcinoma?,ssm_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the prevalence rate of AQP7 T166S mutation in Rectum Adenocarcinoma?,ssm_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the prevalence rate of AQP7 T167S mutation in Rectum Adenocarcinoma?,ssm_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the prevalence rate of AQP7 T75S mutation in Rectum Adenocarcinoma?,ssm_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,What is the prevalence rate of DCN R163C mutation in Rectum Adenocarcinoma?,ssm_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,What is the prevalence rate of DCN R203C mutation in Rectum Adenocarcinoma?,ssm_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,What is the prevalence rate of DCN R241C mutation in Rectum Adenocarcinoma?,ssm_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,What is the prevalence rate of DCN R350C mutation in Rectum Adenocarcinoma?,ssm_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,What is the prevalence rate of DCN R41C mutation in Rectum Adenocarcinoma?,ssm_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of CPS1 K1269N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of CPS1 K1275N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of CPS1 K818N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the prevalence rate of FCGR2C P122S mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the prevalence rate of FCGR2C P123S mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of GRM1 R280M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the prevalence rate of SGCZ Q138H mutation in Lung Adenocarcinoma?,ssm_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the prevalence rate of SGCZ Q91H mutation in Lung Adenocarcinoma?,ssm_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,What is the prevalence rate of SMO V15M mutation in Stomach Adenocarcinoma?,ssm_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,What is the prevalence rate of SMO V321M mutation in Stomach Adenocarcinoma?,ssm_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the prevalence rate of CHODL G159E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the prevalence rate of CHODL G181E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the prevalence rate of CHODL G200E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,What is the prevalence rate of MYO16 P399H mutation in Colon Adenocarcinoma?,ssm_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,What is the prevalence rate of MYO16 P421H mutation in Colon Adenocarcinoma?,ssm_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the prevalence rate of CXCR2 A98V mutation in Stomach Adenocarcinoma?,ssm_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the prevalence rate of TMEM225 L212V mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of MAOB N251T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of GPRASP1 F580S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of MRPL32 R181Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of TYROBP A29T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the prevalence rate of RAB40C A111V mutation in Lung Adenocarcinoma?,ssm_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the prevalence rate of RAB40C A143V mutation in Lung Adenocarcinoma?,ssm_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the prevalence rate of CTNNA2 S323R mutation in Lung Adenocarcinoma?,ssm_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the prevalence rate of CTNNA2 S339R mutation in Lung Adenocarcinoma?,ssm_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the prevalence rate of CTNNA2 S386R mutation in Lung Adenocarcinoma?,ssm_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the prevalence rate of CTNNA2 S707R mutation in Lung Adenocarcinoma?,ssm_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the prevalence rate of MYO15A S268R mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the prevalence rate of GIMAP2 A167T mutation in Skin Cutaneous Melanoma?,ssm_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the prevalence rate of KIF20B N1160D mutation in Glioblastoma Multiforme?,ssm_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the prevalence rate of KIF20B N1200D mutation in Glioblastoma Multiforme?,ssm_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of ADAM17 E583K mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of BCAT1 G16R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of BCAT1 G17R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of BCAT1 G29R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the prevalence rate of ERCC6 R1053H mutation in Colon Adenocarcinoma?,ssm_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,What is the prevalence rate of DCC R320W mutation in Breast Invasive Carcinoma?,ssm_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,What is the prevalence rate of DCC R363W mutation in Breast Invasive Carcinoma?,ssm_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,What is the prevalence rate of DCC R386W mutation in Breast Invasive Carcinoma?,ssm_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,What is the prevalence rate of DCC R41W mutation in Breast Invasive Carcinoma?,ssm_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the prevalence rate of FBXO15 D417N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the prevalence rate of FBXO15 D86N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of GSTCD S528F mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of GSTCD S615F mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the prevalence rate of OLFML3 P296S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the prevalence rate of OLFML3 P337S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the prevalence rate of OLFML3 P357S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the prevalence rate of CFAP61 E173V mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the prevalence rate of CFAP61 E817V mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the prevalence rate of HLA-DQA2 E51K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the prevalence rate of TENM2 H240Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the prevalence rate of TENM2 H351Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the prevalence rate of TENM2 H472Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the prevalence rate of ANKRD24 A465T mutation in Stomach Adenocarcinoma?,ssm_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the prevalence rate of ANKRD24 A494T mutation in Stomach Adenocarcinoma?,ssm_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the prevalence rate of ANKRD24 A584T mutation in Stomach Adenocarcinoma?,ssm_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the prevalence rate of ZCCHC14 V549M mutation in Stomach Adenocarcinoma?,ssm_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the prevalence rate of ZCCHC14 V665M mutation in Stomach Adenocarcinoma?,ssm_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the prevalence rate of ZCCHC14 V676M mutation in Stomach Adenocarcinoma?,ssm_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the prevalence rate of ZCCHC14 V802M mutation in Stomach Adenocarcinoma?,ssm_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,What is the prevalence rate of SIK2 I265M mutation in Lung Adenocarcinoma?,ssm_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of MYH11 T1336M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of MYH11 T1343M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the prevalence rate of SLC6A4 S174F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of SLC9C1 K102N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of SLC9C1 K29N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the prevalence rate of OR2A12 A254T mutation in Brain Lower Grade Glioma?,ssm_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the prevalence rate of PYHIN1 T325K mutation in Lung Adenocarcinoma?,ssm_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the prevalence rate of PYHIN1 T334K mutation in Lung Adenocarcinoma?,ssm_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the prevalence rate of JAML G191E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the prevalence rate of JAML G219E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the prevalence rate of JAML G220E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the prevalence rate of JAML G230E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the prevalence rate of TYK2 H1146R mutation in Stomach Adenocarcinoma?,ssm_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the prevalence rate of TYK2 H23R mutation in Stomach Adenocarcinoma?,ssm_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the prevalence rate of TYK2 H961R mutation in Stomach Adenocarcinoma?,ssm_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of CTCFL R208C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of CTCFL R265C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of CTCFL R420C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of CTCFL R470C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of CEP20 R31Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of CEP20 R58Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the prevalence rate of RIMS2 R25W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the prevalence rate of RIMS2 R393W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the prevalence rate of RIMS2 R423W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the prevalence rate of RIMS2 R470W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the prevalence rate of RIMS2 R615W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the prevalence rate of RIMS2 R619W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the prevalence rate of RIMS2 R716W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the prevalence rate of PIK3C2G S551L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the prevalence rate of PIK3C2G S592L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+728,STK19,D341N,Colon Adenocarcinoma,What is the prevalence rate of STK19 D341N mutation in Colon Adenocarcinoma?,ssm_frequency
+729,STK19,D345N,Colon Adenocarcinoma,What is the prevalence rate of STK19 D345N mutation in Colon Adenocarcinoma?,ssm_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the prevalence rate of REXO4 P60A mutation in Skin Cutaneous Melanoma?,ssm_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of ZBTB34 P160S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of ZBTB34 P164S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the prevalence rate of NCKAP5 E148K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of SORCS1 D1052Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of SORCS1 D587Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of SORCS1 D67Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of SORCS1 D810Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the prevalence rate of FGF8 T154M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the prevalence rate of FGF8 T165M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the prevalence rate of FGF8 T183M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the prevalence rate of FGF8 T194M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the prevalence rate of FGF8 T90M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the prevalence rate of TENM3 R1877W mutation in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,ssm_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of AKT1 D44N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence rate of CFAP298-TCP10L E11Q mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the prevalence rate of GLRB E148D mutation in Stomach Adenocarcinoma?,ssm_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,What is the prevalence rate of TTN F7636L mutation in Colon Adenocarcinoma?,ssm_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,What is the prevalence rate of TTN F8563L mutation in Colon Adenocarcinoma?,ssm_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,What is the prevalence rate of TTN F8880L mutation in Colon Adenocarcinoma?,ssm_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the prevalence rate of ANKRD30A V798I mutation in Colon Adenocarcinoma?,ssm_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the prevalence rate of ANKRD30A V854I mutation in Colon Adenocarcinoma?,ssm_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the prevalence rate of ANKRD30A V973I mutation in Colon Adenocarcinoma?,ssm_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the prevalence rate of TRIM45 S177L mutation in Colon Adenocarcinoma?,ssm_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the prevalence rate of TRIM45 S224L mutation in Colon Adenocarcinoma?,ssm_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the prevalence rate of TRIM45 S281L mutation in Colon Adenocarcinoma?,ssm_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the prevalence rate of CACNA1F G727V mutation in Stomach Adenocarcinoma?,ssm_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the prevalence rate of CACNA1F G781V mutation in Stomach Adenocarcinoma?,ssm_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the prevalence rate of CACNA1F G792V mutation in Stomach Adenocarcinoma?,ssm_frequency
+817,KL,R594C,Colon Adenocarcinoma,What is the prevalence rate of KL R594C mutation in Colon Adenocarcinoma?,ssm_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the prevalence rate of GUF1 I243T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the prevalence rate of TAF1L A539V mutation in Colon Adenocarcinoma?,ssm_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the prevalence rate of TASOR2 S256F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the prevalence rate of TASOR2 S36F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the prevalence rate of TASOR2 S471F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the prevalence rate of KDM5C R1151C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the prevalence rate of KDM5C R1177C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the prevalence rate of KDM5C R1217C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the prevalence rate of KDM5C R1218C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence rate of IL5RA L153F mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the prevalence rate of DHX16 A29V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the prevalence rate of DHX16 A89V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the prevalence rate of GPR158 A644V mutation in Stomach Adenocarcinoma?,ssm_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the prevalence rate of GPR158 A723V mutation in Stomach Adenocarcinoma?,ssm_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of EIF2B4 E108K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of EIF2B4 E110K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of EIF2B4 E111K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of EIF2B4 E131K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of EIF2B4 E132K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of EIF2B4 E96K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the prevalence rate of AUTS2 P136S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the prevalence rate of AUTS2 P218S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the prevalence rate of AUTS2 P233S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the prevalence rate of AUTS2 P313S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the prevalence rate of AUTS2 P419S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the prevalence rate of AUTS2 P443S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the prevalence rate of AUTS2 P56S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the prevalence rate of AUTS2 P667S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the prevalence rate of AUTS2 P690S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the prevalence rate of AUTS2 P691S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of ACTL7B D223N mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the prevalence rate of PCDHGA1 R535W mutation in Glioblastoma Multiforme?,ssm_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the prevalence rate of TRAP1 R114W mutation in Stomach Adenocarcinoma?,ssm_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the prevalence rate of TRAP1 R61W mutation in Stomach Adenocarcinoma?,ssm_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of PIK3C2A R1570Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the prevalence rate of KANSL1 R139G mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the prevalence rate of ANKRD52 Y594C mutation in Stomach Adenocarcinoma?,ssm_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of PAPPA G1580S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the prevalence rate of B3GALNT1 V270A mutation in Rectum Adenocarcinoma?,ssm_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the prevalence rate of GABRA6 G115R mutation in Lung Adenocarcinoma?,ssm_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the prevalence rate of GABRA6 G122R mutation in Lung Adenocarcinoma?,ssm_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the prevalence rate of GABRA6 G165R mutation in Lung Adenocarcinoma?,ssm_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the prevalence rate of GABRA6 G175R mutation in Lung Adenocarcinoma?,ssm_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the prevalence rate of GABRA6 G70R mutation in Lung Adenocarcinoma?,ssm_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the prevalence rate of ZSCAN31 D9N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of MED16 L126P mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of MED16 L868P mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the prevalence rate of PTPRO E1060K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the prevalence rate of PTPRO E1088K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the prevalence rate of PTPRO E249K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the prevalence rate of PTPRO E265K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the prevalence rate of PTPRO E277K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the prevalence rate of PTPRO E67K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the prevalence rate of PTPRO E923K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the prevalence rate of PTPRO E940K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of CHMP7 D397N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the prevalence rate of GPC3 I107N mutation in Stomach Adenocarcinoma?,ssm_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the prevalence rate of GPC3 I161N mutation in Stomach Adenocarcinoma?,ssm_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence rate of TLK2 V430L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence rate of TLK2 V515L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence rate of TLK2 V547L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence rate of TLK2 V579L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence rate of TLK2 V601L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the prevalence rate of ZNF217 E209Q mutation in Lung Adenocarcinoma?,ssm_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the prevalence rate of SYT9 V275L mutation in Lung Adenocarcinoma?,ssm_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the prevalence rate of SYT9 V307L mutation in Lung Adenocarcinoma?,ssm_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the prevalence rate of PKHD1L1 S2830N mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the prevalence rate of MYO3A Y1295C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of VASN V318I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of DNMT1 A1037T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of DNMT1 A1053T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of DNMT1 A934T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,What is the prevalence rate of CA9 E402K mutation in Colon Adenocarcinoma?,ssm_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of TTC17 R808Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of TTC17 R865Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the prevalence rate of PSG2 P43L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the prevalence rate of RIPOR2 R470L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the prevalence rate of RIPOR2 R499L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the prevalence rate of RIPOR2 R504L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the prevalence rate of RIPOR2 R520L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of DCLK3 V520I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of DCLK3 V689I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the prevalence rate of MERTK G257A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the prevalence rate of MERTK G757A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the prevalence rate of MERTK G933A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the prevalence rate of ZFP42 R206K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the prevalence rate of OR13C3 M117I mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the prevalence rate of OR13C3 M147I mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the prevalence rate of SPAG1 I917M mutation in Stomach Adenocarcinoma?,ssm_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of CDKN2AIP Y92H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the prevalence rate of PXN H1016Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the prevalence rate of PXN H359Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the prevalence rate of PXN H492Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the prevalence rate of PXN H524Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the prevalence rate of PXN H526Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the prevalence rate of PXN H540Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of TTYH2 S23L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of TTYH2 S44L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the prevalence rate of TMEM255A N205S mutation in Colon Adenocarcinoma?,ssm_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the prevalence rate of TMEM255A N229S mutation in Colon Adenocarcinoma?,ssm_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the prevalence rate of TMEM255A N65S mutation in Colon Adenocarcinoma?,ssm_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the prevalence rate of TASOR2 H2271D mutation in Breast Invasive Carcinoma?,ssm_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the prevalence rate of TASOR2 H2486D mutation in Breast Invasive Carcinoma?,ssm_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of ICE1 T1839M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the prevalence rate of MYT1 A558E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the prevalence rate of MYT1 A879E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the prevalence rate of MYT1 A906E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of CX3CR1 P203L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of CX3CR1 P235L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the prevalence rate of SPINDOC R197C mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of ART3 C251Y mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of ART3 C3Y mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the prevalence rate of CYP1A2 R243G mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of ADRA1A G279S mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the prevalence rate of CDH23 P2523R mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the prevalence rate of CDH23 P283R mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the prevalence rate of KRT39 P137S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the prevalence rate of PDHA2 S7F mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the prevalence rate of SLC24A2 H200Q mutation in Colon Adenocarcinoma?,ssm_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the prevalence rate of PTPRN2 F153L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the prevalence rate of PTPRN2 F847L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the prevalence rate of PTPRN2 F856L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the prevalence rate of PTPRN2 F868L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the prevalence rate of PTPRN2 F885L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the prevalence rate of SOX21 R55L mutation in Lung Adenocarcinoma?,ssm_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the prevalence rate of CPA6 G166E mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the prevalence rate of GRM5 E14K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of CASZ1 R233Q mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the prevalence rate of SGIP1 N122T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the prevalence rate of SGIP1 N420T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the prevalence rate of SGIP1 N617T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the prevalence rate of SGIP1 N648T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the prevalence rate of CARMIL1 V549L mutation in Lung Adenocarcinoma?,ssm_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the prevalence rate of CARMIL1 V949L mutation in Lung Adenocarcinoma?,ssm_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the prevalence rate of ZNF431 D121Y mutation in Lung Adenocarcinoma?,ssm_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the prevalence rate of ZNF431 D161Y mutation in Lung Adenocarcinoma?,ssm_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the prevalence rate of ZNF431 R128I mutation in Lung Adenocarcinoma?,ssm_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the prevalence rate of DNAH11 P2987S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the prevalence rate of DNAH11 P2994S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the prevalence rate of POLD1 Q461L mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the prevalence rate of POLD1 Q85L mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the prevalence rate of TTC12 D646H mutation in Lung Adenocarcinoma?,ssm_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the prevalence rate of TTC12 D652H mutation in Lung Adenocarcinoma?,ssm_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the prevalence rate of CNGB1 D967N mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the prevalence rate of CNGB1 D973N mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the prevalence rate of CTSC E214V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the prevalence rate of CTSC E291V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the prevalence rate of CTSC E322V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the prevalence rate of CTSC E324V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the prevalence rate of CTSC E335V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of PRSS8 A179T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of PRSS8 A233T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the prevalence rate of ARHGEF40 V864F mutation in Lung Adenocarcinoma?,ssm_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the prevalence rate of ACTB A138T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the prevalence rate of ACTB A217T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the prevalence rate of ACTB A244T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the prevalence rate of ACTB A260T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the prevalence rate of YY1AP1 V546D mutation in Glioblastoma Multiforme?,ssm_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the prevalence rate of YY1AP1 V557D mutation in Glioblastoma Multiforme?,ssm_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the prevalence rate of YY1AP1 V566D mutation in Glioblastoma Multiforme?,ssm_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the prevalence rate of YY1AP1 V577D mutation in Glioblastoma Multiforme?,ssm_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the prevalence rate of YY1AP1 V623D mutation in Glioblastoma Multiforme?,ssm_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the prevalence rate of YY1AP1 V695D mutation in Glioblastoma Multiforme?,ssm_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the prevalence rate of YY1AP1 V715D mutation in Glioblastoma Multiforme?,ssm_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the prevalence rate of FNDC7 D323N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the prevalence rate of FNDC7 D99N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the prevalence rate of TLCD5 G15V mutation in Lung Adenocarcinoma?,ssm_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the prevalence rate of TLCD5 G37V mutation in Lung Adenocarcinoma?,ssm_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of POLR1G R498W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of POLR1G R500W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the prevalence rate of DNAH14 N1186K mutation in Colon Adenocarcinoma?,ssm_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the prevalence rate of DNAH14 N2657K mutation in Colon Adenocarcinoma?,ssm_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the prevalence rate of DNAH14 N3460K mutation in Colon Adenocarcinoma?,ssm_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of NEXN E73D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the prevalence rate of CYB5R2 G112R mutation in Prostate Adenocarcinoma?,ssm_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the prevalence rate of CYB5R2 G172R mutation in Prostate Adenocarcinoma?,ssm_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of NRAP S808L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of NRAP S816L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of NRAP S843L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of CCDC22 E179D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the prevalence rate of DCAF6 S402F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the prevalence rate of DCAF6 S433F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of ZNF708 E389D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of BFAR T103M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of MAST4 P1237S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of MAST4 P1986S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of MAST4 P1991S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of MAST4 P2001S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of MAST4 P2180S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the prevalence rate of ARMC3 R169C mutation in Stomach Adenocarcinoma?,ssm_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the prevalence rate of ARMC3 R432C mutation in Stomach Adenocarcinoma?,ssm_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the prevalence rate of TET2 L757V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the prevalence rate of TET2 L778V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the prevalence rate of SERPINB10 A353P mutation in Lung Adenocarcinoma?,ssm_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of STAT3 Y22H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of MIEF1 A42T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the prevalence rate of ACVR1B D397N mutation in Colon Adenocarcinoma?,ssm_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the prevalence rate of ACVR1B D449N mutation in Colon Adenocarcinoma?,ssm_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the prevalence rate of ACVR1B D490N mutation in Colon Adenocarcinoma?,ssm_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the prevalence rate of EBF2 T104I mutation in Stomach Adenocarcinoma?,ssm_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the prevalence rate of EBF2 T252I mutation in Stomach Adenocarcinoma?,ssm_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the prevalence rate of VPS26B F266L mutation in Stomach Adenocarcinoma?,ssm_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of PGR M106I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of PGR M38I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of PGR M632I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the prevalence rate of ACTA2 P334L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of THBS4 T852I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of THBS4 T943I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the prevalence rate of PRSS1 S114T mutation in Lung Adenocarcinoma?,ssm_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the prevalence rate of PRSS1 S124T mutation in Lung Adenocarcinoma?,ssm_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the prevalence rate of PRSS1 S138T mutation in Lung Adenocarcinoma?,ssm_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the prevalence rate of PRSS1 S74T mutation in Lung Adenocarcinoma?,ssm_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the prevalence rate of PGF R126H mutation in Stomach Adenocarcinoma?,ssm_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the prevalence rate of PGF R127H mutation in Stomach Adenocarcinoma?,ssm_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the prevalence rate of ITPRID2 S351C mutation in Breast Invasive Carcinoma?,ssm_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the prevalence rate of ITPRID2 S842C mutation in Breast Invasive Carcinoma?,ssm_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of HBB E8D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the prevalence rate of PCDHB2 R158C mutation in Colon Adenocarcinoma?,ssm_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the prevalence rate of PCDHB2 T15M mutation in Colon Adenocarcinoma?,ssm_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the prevalence rate of PCDHB2 T26M mutation in Colon Adenocarcinoma?,ssm_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of UBR2 P1594S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the prevalence rate of FBXO42 A618D mutation in Rectum Adenocarcinoma?,ssm_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases have the TNS1 G1362V mutation?,ssm_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases have the TNS1 G1711V mutation?,ssm_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases have the TNS1 G1718V mutation?,ssm_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases have the TNS1 G1732V mutation?,ssm_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases have the TNS1 G1824V mutation?,ssm_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases have the TNS1 G1857V mutation?,ssm_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases have the TNS1 G843V mutation?,ssm_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases have the EVC2 E1067K mutation?,ssm_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases have the EVC2 E987K mutation?,ssm_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the CR1 V1108G mutation?,ssm_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the CR1 V1558G mutation?,ssm_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases have the TRPA1 S295I mutation?,ssm_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases have the TRPA1 S443I mutation?,ssm_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the TAF1C R299L mutation?,ssm_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the TAF1C R396L mutation?,ssm_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the TAF1C R634L mutation?,ssm_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the TAF1C R702L mutation?,ssm_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the TAF1C R728L mutation?,ssm_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the DPF3 R104W mutation?,ssm_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the DPF3 R149W mutation?,ssm_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the DPF3 R94W mutation?,ssm_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the OR2T4 P272H mutation?,ssm_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the OR2T4 P300H mutation?,ssm_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma cases have the FBN1 E2667K mutation?,ssm_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma cases have the MAD1L1 E396K mutation?,ssm_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma cases have the MAD1L1 E488K mutation?,ssm_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma cases have the MAD1L1 E78K mutation?,ssm_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the CCNG1 E22K mutation?,ssm_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma cases have the ANP32E N114T mutation?,ssm_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma cases have the ANP32E N64T mutation?,ssm_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma cases have the ANP32E N66T mutation?,ssm_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma cases have the ANP32E N73T mutation?,ssm_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases have the FRY S1888A mutation?,ssm_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases have the FRY S1937A mutation?,ssm_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases have the FRY S1938A mutation?,ssm_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases have the FRY S1983A mutation?,ssm_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the PAK3 E318K mutation?,ssm_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the PAK3 E319K mutation?,ssm_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the PAK3 E334K mutation?,ssm_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the PAK3 E340K mutation?,ssm_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the PAK3 E355K mutation?,ssm_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the MUC16 P7963L mutation?,ssm_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma cases have the ZFPM2 T498I mutation?,ssm_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma cases have the ZFPM2 T630I mutation?,ssm_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases have the PIK3C2B S1328C mutation?,ssm_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases have the PIK3C2B S1356C mutation?,ssm_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the ZNF804A S371Y mutation?,ssm_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the RELN A2371V mutation?,ssm_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the EFCAB12 R173C mutation?",ssm_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the EFCAB12 R23C mutation?",ssm_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the DEFB115 E53K mutation?,ssm_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases have the ANKDD1A S290F mutation?,ssm_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases have the ANKDD1A S322F mutation?,ssm_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases have the ANKDD1A S413F mutation?,ssm_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the HTR3B S146I mutation?,ssm_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the HTR3B S206I mutation?,ssm_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the HTR3B S217I mutation?,ssm_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the ABCC3 R758W mutation?,ssm_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the NOMO1 T204I mutation?,ssm_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the NOMO1 T371I mutation?,ssm_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases have the HYOU1 D298H mutation?,ssm_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the FMO4 R500Q mutation?,ssm_frequency
+140,BICC1,A372V,Exceptional Responders,How many Exceptional Responders cases have the BICC1 A372V mutation?,ssm_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the ZMYM3 I920V mutation?,ssm_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the ZMYM3 I932V mutation?,ssm_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the ZMYM3 I934V mutation?,ssm_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the XKR4 R547W mutation?",ssm_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma cases have the ABCC2 V239L mutation?,ssm_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the OR8K5 R293G mutation?,ssm_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the SPTAN1 S1503F mutation?,ssm_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the SPTAN1 S1523F mutation?,ssm_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases have the SYT10 M484I mutation?,ssm_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the HSPA5 N457K mutation?,ssm_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the UNC5D L280V mutation?,ssm_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the UNC5D L635V mutation?,ssm_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the UNC5D L637V mutation?,ssm_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the UNC5D L699V mutation?,ssm_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the UNC5D L704V mutation?,ssm_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the UNC5D L709V mutation?,ssm_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How many Kidney Renal Clear Cell Carcinoma cases have the DOCK2 L1527H mutation?,ssm_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How many Kidney Renal Clear Cell Carcinoma cases have the ZNF627 A5V mutation?,ssm_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the CDC42BPA L823F mutation?,ssm_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the MRPL55 H27Y mutation?,ssm_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the MRPL55 H63Y mutation?,ssm_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases have the TMTC3 Q749K mutation?,ssm_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the EPRS1 K771I mutation?,ssm_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the EPRS1 K778I mutation?,ssm_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the GRTP1 A110V mutation?,ssm_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the GRTP1 A32V mutation?,ssm_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the TSHZ3 Q538K mutation?,ssm_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How many HIV+ Tumor Molecular Characterization Project - Cervical Cancer cases have the TAS1R3 Q326H mutation?,ssm_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the PIAS3 S238C mutation?,ssm_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the PIAS3 S273C mutation?,ssm_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the ZNF274 P13R mutation?,ssm_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the SYNJ1 R795C mutation?,ssm_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the SYNJ1 R800C mutation?,ssm_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the SYNJ1 R839C mutation?,ssm_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma cases have the DSCAM V343M mutation?,ssm_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma cases have the DSCAM V426M mutation?,ssm_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma cases have the DSCAM V591M mutation?,ssm_frequency
+267,DGKD,R140H,Exceptional Responders,How many Exceptional Responders cases have the DGKD R140H mutation?,ssm_frequency
+268,DGKD,R160H,Exceptional Responders,How many Exceptional Responders cases have the DGKD R160H mutation?,ssm_frequency
+269,DGKD,R204H,Exceptional Responders,How many Exceptional Responders cases have the DGKD R204H mutation?,ssm_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases have the PLEKHG6 D105Y mutation?,ssm_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases have the PLEKHG6 D543Y mutation?,ssm_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases have the PLEKHG6 D575Y mutation?,ssm_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the WNT2 D138N mutation?,ssm_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the GUCY2C G667R mutation?,ssm_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the C7orf31 P244H mutation?,ssm_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the ZKSCAN7 E64K mutation?",ssm_frequency
+299,OR5D14,M210L,Neuroblastoma,How many Neuroblastoma cases have the OR5D14 M210L mutation?,ssm_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the SPATA22 K279E mutation?,ssm_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the SPATA22 K306E mutation?,ssm_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the SPATA22 K322E mutation?,ssm_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the LCN15 E21V mutation?,ssm_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the DCAF4L2 S129F mutation?,ssm_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the GUK1 R135P mutation?,ssm_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the GUK1 R137P mutation?,ssm_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the GUK1 R139P mutation?,ssm_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the GUK1 R158P mutation?,ssm_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the GUK1 R203P mutation?,ssm_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the MORF4L1 K29T mutation?,ssm_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the MORF4L1 K51T mutation?,ssm_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the MORF4L1 K61T mutation?,ssm_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the MORF4L1 K76T mutation?,ssm_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the MYO3B F594L mutation?,ssm_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the MYO3B F603L mutation?,ssm_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the TENT5A S320F mutation?,ssm_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the TENT5A S339F mutation?,ssm_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the TENT5A S401F mutation?,ssm_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How many Ovarian Serous Cystadenocarcinoma cases have the ZFAT S614L mutation?,ssm_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How many Ovarian Serous Cystadenocarcinoma cases have the ZFAT S664L mutation?,ssm_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How many Ovarian Serous Cystadenocarcinoma cases have the ZFAT S676L mutation?,ssm_frequency
+357,ZNF584,A211T,Sarcoma,How many Sarcoma cases have the ZNF584 A211T mutation?,ssm_frequency
+358,ZNF584,A256T,Sarcoma,How many Sarcoma cases have the ZNF584 A256T mutation?,ssm_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the LDOC1 R63W mutation?,ssm_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the PDGFC R201G mutation?,ssm_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the MSANTD4 R304C mutation?,ssm_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the NPSR1 S123L mutation?,ssm_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the PHLPP1 K1317E mutation?,ssm_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the COL6A3 G237S mutation?,ssm_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the COL6A3 G437S mutation?,ssm_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the COL6A3 G638S mutation?,ssm_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the COL6A3 G644S mutation?,ssm_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the COL6A3 G844S mutation?,ssm_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the ADRA1A R348G mutation?,ssm_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have the LAMB2 S1254F mutation?,ssm_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases have the POC1B I198T mutation?,ssm_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases have the POC1B I286T mutation?,ssm_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases have the POC1B I328T mutation?,ssm_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases have the POC1B S79P mutation?,ssm_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma cases have the USH2A G1451C mutation?,ssm_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases have the AQP7 T110S mutation?,ssm_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases have the AQP7 T166S mutation?,ssm_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases have the AQP7 T167S mutation?,ssm_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases have the AQP7 T75S mutation?,ssm_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases have the DCN R163C mutation?,ssm_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases have the DCN R203C mutation?,ssm_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases have the DCN R241C mutation?,ssm_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases have the DCN R350C mutation?,ssm_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases have the DCN R41C mutation?,ssm_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the CPS1 K1269N mutation?,ssm_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the CPS1 K1275N mutation?,ssm_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the CPS1 K818N mutation?,ssm_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma cases have the FCGR2C P122S mutation?,ssm_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma cases have the FCGR2C P123S mutation?,ssm_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the GRM1 R280M mutation?,ssm_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the SGCZ Q138H mutation?,ssm_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the SGCZ Q91H mutation?,ssm_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the SMO V15M mutation?,ssm_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the SMO V321M mutation?,ssm_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the CHODL G159E mutation?,ssm_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the CHODL G181E mutation?,ssm_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the CHODL G200E mutation?,ssm_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the MYO16 P399H mutation?,ssm_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the MYO16 P421H mutation?,ssm_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the CXCR2 A98V mutation?,ssm_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases have the TMEM225 L212V mutation?,ssm_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the MAOB N251T mutation?,ssm_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the GPRASP1 F580S mutation?,ssm_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the MRPL32 R181Q mutation?,ssm_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the TYROBP A29T mutation?,ssm_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the RAB40C A111V mutation?,ssm_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the RAB40C A143V mutation?,ssm_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the CTNNA2 S323R mutation?,ssm_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the CTNNA2 S339R mutation?,ssm_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the CTNNA2 S386R mutation?,ssm_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the CTNNA2 S707R mutation?,ssm_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases have the MYO15A S268R mutation?,ssm_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the GIMAP2 A167T mutation?,ssm_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,How many Glioblastoma Multiforme cases have the KIF20B N1160D mutation?,ssm_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,How many Glioblastoma Multiforme cases have the KIF20B N1200D mutation?,ssm_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the ADAM17 E583K mutation?,ssm_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the BCAT1 G16R mutation?,ssm_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the BCAT1 G17R mutation?,ssm_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the BCAT1 G29R mutation?,ssm_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the ERCC6 R1053H mutation?,ssm_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases have the DCC R320W mutation?,ssm_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases have the DCC R363W mutation?,ssm_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases have the DCC R386W mutation?,ssm_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases have the DCC R41W mutation?,ssm_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the FBXO15 D417N mutation?,ssm_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the FBXO15 D86N mutation?,ssm_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the GSTCD S528F mutation?,ssm_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the GSTCD S615F mutation?,ssm_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the OLFML3 P296S mutation?,ssm_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the OLFML3 P337S mutation?,ssm_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the OLFML3 P357S mutation?,ssm_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How many Ovarian Serous Cystadenocarcinoma cases have the CFAP61 E173V mutation?,ssm_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How many Ovarian Serous Cystadenocarcinoma cases have the CFAP61 E817V mutation?,ssm_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases have the HLA-DQA2 E51K mutation?,ssm_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the TENM2 H240Y mutation?,ssm_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the TENM2 H351Y mutation?,ssm_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the TENM2 H472Y mutation?,ssm_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the ANKRD24 A465T mutation?,ssm_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the ANKRD24 A494T mutation?,ssm_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the ANKRD24 A584T mutation?,ssm_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the ZCCHC14 V549M mutation?,ssm_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the ZCCHC14 V665M mutation?,ssm_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the ZCCHC14 V676M mutation?,ssm_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the ZCCHC14 V802M mutation?,ssm_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the SIK2 I265M mutation?,ssm_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the MYH11 T1336M mutation?,ssm_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the MYH11 T1343M mutation?,ssm_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the SLC6A4 S174F mutation?,ssm_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the SLC9C1 K102N mutation?,ssm_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the SLC9C1 K29N mutation?,ssm_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,How many Brain Lower Grade Glioma cases have the OR2A12 A254T mutation?,ssm_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the PYHIN1 T325K mutation?,ssm_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the PYHIN1 T334K mutation?,ssm_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the JAML G191E mutation?,ssm_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the JAML G219E mutation?,ssm_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the JAML G220E mutation?,ssm_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the JAML G230E mutation?,ssm_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the TYK2 H1146R mutation?,ssm_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the TYK2 H23R mutation?,ssm_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the TYK2 H961R mutation?,ssm_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the CTCFL R208C mutation?,ssm_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the CTCFL R265C mutation?,ssm_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the CTCFL R420C mutation?,ssm_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the CTCFL R470C mutation?,ssm_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the CEP20 R31Q mutation?,ssm_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the CEP20 R58Q mutation?,ssm_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the RIMS2 R25W mutation?,ssm_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the RIMS2 R393W mutation?,ssm_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the RIMS2 R423W mutation?,ssm_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the RIMS2 R470W mutation?,ssm_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the RIMS2 R615W mutation?,ssm_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the RIMS2 R619W mutation?,ssm_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the RIMS2 R716W mutation?,ssm_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the PIK3C2G S551L mutation?,ssm_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the PIK3C2G S592L mutation?,ssm_frequency
+728,STK19,D341N,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the STK19 D341N mutation?,ssm_frequency
+729,STK19,D345N,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the STK19 D345N mutation?,ssm_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the REXO4 P60A mutation?,ssm_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the ZBTB34 P160S mutation?,ssm_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the ZBTB34 P164S mutation?,ssm_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases have the NCKAP5 E148K mutation?,ssm_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the SORCS1 D1052Y mutation?",ssm_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the SORCS1 D587Y mutation?",ssm_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the SORCS1 D67Y mutation?",ssm_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the SORCS1 D810Y mutation?",ssm_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How many Head and Neck Squamous Cell Carcinoma cases have the FGF8 T154M mutation?,ssm_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How many Head and Neck Squamous Cell Carcinoma cases have the FGF8 T165M mutation?,ssm_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How many Head and Neck Squamous Cell Carcinoma cases have the FGF8 T183M mutation?,ssm_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How many Head and Neck Squamous Cell Carcinoma cases have the FGF8 T194M mutation?,ssm_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How many Head and Neck Squamous Cell Carcinoma cases have the FGF8 T90M mutation?,ssm_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How many Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia cases have the TENM3 R1877W mutation?,ssm_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the AKT1 D44N mutation?,ssm_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have the CFAP298-TCP10L E11Q mutation?,ssm_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the GLRB E148D mutation?,ssm_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the TTN F7636L mutation?,ssm_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the TTN F8563L mutation?,ssm_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the TTN F8880L mutation?,ssm_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the ANKRD30A V798I mutation?,ssm_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the ANKRD30A V854I mutation?,ssm_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the ANKRD30A V973I mutation?,ssm_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the TRIM45 S177L mutation?,ssm_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the TRIM45 S224L mutation?,ssm_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the TRIM45 S281L mutation?,ssm_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the CACNA1F G727V mutation?,ssm_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the CACNA1F G781V mutation?,ssm_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the CACNA1F G792V mutation?,ssm_frequency
+817,KL,R594C,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the KL R594C mutation?,ssm_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma cases have the GUF1 I243T mutation?,ssm_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the TAF1L A539V mutation?,ssm_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the TASOR2 S256F mutation?,ssm_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the TASOR2 S36F mutation?,ssm_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the TASOR2 S471F mutation?,ssm_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the KDM5C R1151C mutation?,ssm_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the KDM5C R1177C mutation?,ssm_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the KDM5C R1217C mutation?,ssm_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the KDM5C R1218C mutation?,ssm_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have the IL5RA L153F mutation?,ssm_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the DHX16 A29V mutation?,ssm_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the DHX16 A89V mutation?,ssm_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the GPR158 A644V mutation?,ssm_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the GPR158 A723V mutation?,ssm_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the EIF2B4 E108K mutation?",ssm_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the EIF2B4 E110K mutation?",ssm_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the EIF2B4 E111K mutation?",ssm_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the EIF2B4 E131K mutation?",ssm_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the EIF2B4 E132K mutation?",ssm_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the EIF2B4 E96K mutation?",ssm_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the AUTS2 P136S mutation?,ssm_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the AUTS2 P218S mutation?,ssm_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the AUTS2 P233S mutation?,ssm_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the AUTS2 P313S mutation?,ssm_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the AUTS2 P419S mutation?,ssm_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the AUTS2 P443S mutation?,ssm_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the AUTS2 P56S mutation?,ssm_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the AUTS2 P667S mutation?,ssm_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the AUTS2 P690S mutation?,ssm_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the AUTS2 P691S mutation?,ssm_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the ACTL7B D223N mutation?",ssm_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How many Glioblastoma Multiforme cases have the PCDHGA1 R535W mutation?,ssm_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the TRAP1 R114W mutation?,ssm_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the TRAP1 R61W mutation?,ssm_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the PIK3C2A R1570Q mutation?,ssm_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma cases have the KANSL1 R139G mutation?,ssm_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the ANKRD52 Y594C mutation?,ssm_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the PAPPA G1580S mutation?,ssm_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases have the B3GALNT1 V270A mutation?,ssm_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the GABRA6 G115R mutation?,ssm_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the GABRA6 G122R mutation?,ssm_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the GABRA6 G165R mutation?,ssm_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the GABRA6 G175R mutation?,ssm_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the GABRA6 G70R mutation?,ssm_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the ZSCAN31 D9N mutation?,ssm_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the MED16 L126P mutation?",ssm_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the MED16 L868P mutation?",ssm_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma cases have the PTPRO E1060K mutation?,ssm_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma cases have the PTPRO E1088K mutation?,ssm_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma cases have the PTPRO E249K mutation?,ssm_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma cases have the PTPRO E265K mutation?,ssm_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma cases have the PTPRO E277K mutation?,ssm_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma cases have the PTPRO E67K mutation?,ssm_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma cases have the PTPRO E923K mutation?,ssm_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma cases have the PTPRO E940K mutation?,ssm_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the CHMP7 D397N mutation?,ssm_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the GPC3 I107N mutation?,ssm_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the GPC3 I161N mutation?,ssm_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have the TLK2 V430L mutation?,ssm_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have the TLK2 V515L mutation?,ssm_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have the TLK2 V547L mutation?,ssm_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have the TLK2 V579L mutation?,ssm_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have the TLK2 V601L mutation?,ssm_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the ZNF217 E209Q mutation?,ssm_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the SYT9 V275L mutation?,ssm_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the SYT9 V307L mutation?,ssm_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the PKHD1L1 S2830N mutation?,ssm_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the MYO3A Y1295C mutation?,ssm_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the VASN V318I mutation?",ssm_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the DNMT1 A1037T mutation?,ssm_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the DNMT1 A1053T mutation?,ssm_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the DNMT1 A934T mutation?,ssm_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the CA9 E402K mutation?,ssm_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the TTC17 R808Q mutation?,ssm_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the TTC17 R865Q mutation?,ssm_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases have the PSG2 P43L mutation?,ssm_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases have the RIPOR2 R470L mutation?,ssm_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases have the RIPOR2 R499L mutation?,ssm_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases have the RIPOR2 R504L mutation?,ssm_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases have the RIPOR2 R520L mutation?,ssm_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the DCLK3 V520I mutation?,ssm_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the DCLK3 V689I mutation?,ssm_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the MERTK G257A mutation?,ssm_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the MERTK G757A mutation?,ssm_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the MERTK G933A mutation?,ssm_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the ZFP42 R206K mutation?,ssm_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the OR13C3 M117I mutation?,ssm_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the OR13C3 M147I mutation?,ssm_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the SPAG1 I917M mutation?,ssm_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the CDKN2AIP Y92H mutation?,ssm_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the PXN H1016Y mutation?,ssm_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the PXN H359Y mutation?,ssm_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the PXN H492Y mutation?,ssm_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the PXN H524Y mutation?,ssm_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the PXN H526Y mutation?,ssm_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the PXN H540Y mutation?,ssm_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the TTYH2 S23L mutation?,ssm_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the TTYH2 S44L mutation?,ssm_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the TMEM255A N205S mutation?,ssm_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the TMEM255A N229S mutation?,ssm_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the TMEM255A N65S mutation?,ssm_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases have the TASOR2 H2271D mutation?,ssm_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases have the TASOR2 H2486D mutation?,ssm_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the ICE1 T1839M mutation?,ssm_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases have the MYT1 A558E mutation?,ssm_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases have the MYT1 A879E mutation?,ssm_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases have the MYT1 A906E mutation?,ssm_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the CX3CR1 P203L mutation?,ssm_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the CX3CR1 P235L mutation?,ssm_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma cases have the SPINDOC R197C mutation?,ssm_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the ART3 C251Y mutation?,ssm_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the ART3 C3Y mutation?,ssm_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases have the CYP1A2 R243G mutation?,ssm_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the ADRA1A G279S mutation?",ssm_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the CDH23 P2523R mutation?,ssm_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the CDH23 P283R mutation?,ssm_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the KRT39 P137S mutation?,ssm_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the PDHA2 S7F mutation?,ssm_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the SLC24A2 H200Q mutation?,ssm_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma cases have the PTPRN2 F153L mutation?,ssm_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma cases have the PTPRN2 F847L mutation?,ssm_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma cases have the PTPRN2 F856L mutation?,ssm_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma cases have the PTPRN2 F868L mutation?,ssm_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma cases have the PTPRN2 F885L mutation?,ssm_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the SOX21 R55L mutation?,ssm_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases have the CPA6 G166E mutation?,ssm_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the GRM5 E14K mutation?,ssm_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the CASZ1 R233Q mutation?",ssm_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the SGIP1 N122T mutation?,ssm_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the SGIP1 N420T mutation?,ssm_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the SGIP1 N617T mutation?,ssm_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the SGIP1 N648T mutation?,ssm_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the CARMIL1 V549L mutation?,ssm_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the CARMIL1 V949L mutation?,ssm_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the ZNF431 D121Y mutation?,ssm_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the ZNF431 D161Y mutation?,ssm_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the ZNF431 R128I mutation?,ssm_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the DNAH11 P2987S mutation?,ssm_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the DNAH11 P2994S mutation?,ssm_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the POLD1 Q461L mutation?,ssm_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases have the POLD1 Q85L mutation?,ssm_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the TTC12 D646H mutation?,ssm_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the TTC12 D652H mutation?,ssm_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases have the CNGB1 D967N mutation?,ssm_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases have the CNGB1 D973N mutation?,ssm_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the CTSC E214V mutation?,ssm_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the CTSC E291V mutation?,ssm_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the CTSC E322V mutation?,ssm_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the CTSC E324V mutation?,ssm_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the CTSC E335V mutation?,ssm_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the PRSS8 A179T mutation?,ssm_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the PRSS8 A233T mutation?,ssm_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the ARHGEF40 V864F mutation?,ssm_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases have the ACTB A138T mutation?,ssm_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases have the ACTB A217T mutation?,ssm_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases have the ACTB A244T mutation?,ssm_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases have the ACTB A260T mutation?,ssm_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How many Glioblastoma Multiforme cases have the YY1AP1 V546D mutation?,ssm_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How many Glioblastoma Multiforme cases have the YY1AP1 V557D mutation?,ssm_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How many Glioblastoma Multiforme cases have the YY1AP1 V566D mutation?,ssm_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How many Glioblastoma Multiforme cases have the YY1AP1 V577D mutation?,ssm_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How many Glioblastoma Multiforme cases have the YY1AP1 V623D mutation?,ssm_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How many Glioblastoma Multiforme cases have the YY1AP1 V695D mutation?,ssm_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How many Glioblastoma Multiforme cases have the YY1AP1 V715D mutation?,ssm_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the FNDC7 D323N mutation?,ssm_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the FNDC7 D99N mutation?,ssm_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the TLCD5 G15V mutation?,ssm_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the TLCD5 G37V mutation?,ssm_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the POLR1G R498W mutation?,ssm_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the POLR1G R500W mutation?,ssm_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the DNAH14 N1186K mutation?,ssm_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the DNAH14 N2657K mutation?,ssm_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the DNAH14 N3460K mutation?,ssm_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the NEXN E73D mutation?,ssm_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma cases have the CYB5R2 G112R mutation?,ssm_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma cases have the CYB5R2 G172R mutation?,ssm_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the NRAP S808L mutation?,ssm_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the NRAP S816L mutation?,ssm_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the NRAP S843L mutation?,ssm_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the CCDC22 E179D mutation?,ssm_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the DCAF6 S402F mutation?,ssm_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the DCAF6 S433F mutation?,ssm_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the ZNF708 E389D mutation?,ssm_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the BFAR T103M mutation?,ssm_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the MAST4 P1237S mutation?,ssm_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the MAST4 P1986S mutation?,ssm_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the MAST4 P1991S mutation?,ssm_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the MAST4 P2001S mutation?,ssm_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the MAST4 P2180S mutation?,ssm_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the ARMC3 R169C mutation?,ssm_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the ARMC3 R432C mutation?,ssm_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How many Kidney Renal Clear Cell Carcinoma cases have the TET2 L757V mutation?,ssm_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How many Kidney Renal Clear Cell Carcinoma cases have the TET2 L778V mutation?,ssm_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the SERPINB10 A353P mutation?,ssm_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the STAT3 Y22H mutation?,ssm_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the MIEF1 A42T mutation?,ssm_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the ACVR1B D397N mutation?,ssm_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the ACVR1B D449N mutation?,ssm_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the ACVR1B D490N mutation?,ssm_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the EBF2 T104I mutation?,ssm_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the EBF2 T252I mutation?,ssm_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the VPS26B F266L mutation?,ssm_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the PGR M106I mutation?",ssm_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the PGR M38I mutation?",ssm_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have the PGR M632I mutation?",ssm_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases have the ACTA2 P334L mutation?,ssm_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the THBS4 T852I mutation?,ssm_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the THBS4 T943I mutation?,ssm_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the PRSS1 S114T mutation?,ssm_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the PRSS1 S124T mutation?,ssm_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the PRSS1 S138T mutation?,ssm_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases have the PRSS1 S74T mutation?,ssm_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the PGF R126H mutation?,ssm_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases have the PGF R127H mutation?,ssm_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases have the ITPRID2 S351C mutation?,ssm_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases have the ITPRID2 S842C mutation?,ssm_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the HBB E8D mutation?,ssm_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the PCDHB2 R158C mutation?,ssm_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the PCDHB2 T15M mutation?,ssm_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases have the PCDHB2 T26M mutation?,ssm_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases have the UBR2 P1594S mutation?,ssm_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases have the FBXO42 A618D mutation?,ssm_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the prevalence rate of the TNS1 G1362V mutation in Breast Invasive Carcinoma?,ssm_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the prevalence rate of the TNS1 G1711V mutation in Breast Invasive Carcinoma?,ssm_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the prevalence rate of the TNS1 G1718V mutation in Breast Invasive Carcinoma?,ssm_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the prevalence rate of the TNS1 G1732V mutation in Breast Invasive Carcinoma?,ssm_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the prevalence rate of the TNS1 G1824V mutation in Breast Invasive Carcinoma?,ssm_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the prevalence rate of the TNS1 G1857V mutation in Breast Invasive Carcinoma?,ssm_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the prevalence rate of the TNS1 G843V mutation in Breast Invasive Carcinoma?,ssm_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the prevalence rate of the EVC2 E1067K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the prevalence rate of the EVC2 E987K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the CR1 V1108G mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the CR1 V1558G mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the prevalence rate of the TRPA1 S295I mutation in Rectum Adenocarcinoma?,ssm_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the prevalence rate of the TRPA1 S443I mutation in Rectum Adenocarcinoma?,ssm_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the prevalence rate of the TAF1C R299L mutation in Lung Adenocarcinoma?,ssm_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the prevalence rate of the TAF1C R396L mutation in Lung Adenocarcinoma?,ssm_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the prevalence rate of the TAF1C R634L mutation in Lung Adenocarcinoma?,ssm_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the prevalence rate of the TAF1C R702L mutation in Lung Adenocarcinoma?,ssm_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the prevalence rate of the TAF1C R728L mutation in Lung Adenocarcinoma?,ssm_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the DPF3 R104W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the DPF3 R149W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the DPF3 R94W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the prevalence rate of the OR2T4 P272H mutation in Lung Adenocarcinoma?,ssm_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the prevalence rate of the OR2T4 P300H mutation in Lung Adenocarcinoma?,ssm_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the prevalence rate of the FBN1 E2667K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the prevalence rate of the MAD1L1 E396K mutation in Prostate Adenocarcinoma?,ssm_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the prevalence rate of the MAD1L1 E488K mutation in Prostate Adenocarcinoma?,ssm_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the prevalence rate of the MAD1L1 E78K mutation in Prostate Adenocarcinoma?,ssm_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the prevalence rate of the CCNG1 E22K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the prevalence rate of the ANP32E N114T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the prevalence rate of the ANP32E N64T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the prevalence rate of the ANP32E N66T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the prevalence rate of the ANP32E N73T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the prevalence rate of the FRY S1888A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the prevalence rate of the FRY S1937A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the prevalence rate of the FRY S1938A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the prevalence rate of the FRY S1983A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the prevalence rate of the PAK3 E318K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the prevalence rate of the PAK3 E319K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the prevalence rate of the PAK3 E334K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the prevalence rate of the PAK3 E340K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the prevalence rate of the PAK3 E355K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the prevalence rate of the MUC16 P7963L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the prevalence rate of the ZFPM2 T498I mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the prevalence rate of the ZFPM2 T630I mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the prevalence rate of the PIK3C2B S1328C mutation in Breast Invasive Carcinoma?,ssm_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the prevalence rate of the PIK3C2B S1356C mutation in Breast Invasive Carcinoma?,ssm_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the prevalence rate of the ZNF804A S371Y mutation in Colon Adenocarcinoma?,ssm_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the prevalence rate of the RELN A2371V mutation in Stomach Adenocarcinoma?,ssm_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of the EFCAB12 R173C mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of the EFCAB12 R23C mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the prevalence rate of the DEFB115 E53K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the prevalence rate of the ANKDD1A S290F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the prevalence rate of the ANKDD1A S322F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the prevalence rate of the ANKDD1A S413F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the HTR3B S146I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the HTR3B S206I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the HTR3B S217I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the prevalence rate of the ABCC3 R758W mutation in Stomach Adenocarcinoma?,ssm_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the NOMO1 T204I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the NOMO1 T371I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the prevalence rate of the HYOU1 D298H mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the prevalence rate of the FMO4 R500Q mutation in Skin Cutaneous Melanoma?,ssm_frequency
+140,BICC1,A372V,Exceptional Responders,What is the prevalence rate of the BICC1 A372V mutation in Exceptional Responders?,ssm_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the ZMYM3 I920V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the ZMYM3 I932V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the ZMYM3 I934V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of the XKR4 R547W mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the prevalence rate of the ABCC2 V239L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the prevalence rate of the OR8K5 R293G mutation in Lung Adenocarcinoma?,ssm_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the prevalence rate of the SPTAN1 S1503F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the prevalence rate of the SPTAN1 S1523F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the prevalence rate of the SYT10 M484I mutation in Rectum Adenocarcinoma?,ssm_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the prevalence rate of the HSPA5 N457K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the prevalence rate of the UNC5D L280V mutation in Lung Adenocarcinoma?,ssm_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the prevalence rate of the UNC5D L635V mutation in Lung Adenocarcinoma?,ssm_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the prevalence rate of the UNC5D L637V mutation in Lung Adenocarcinoma?,ssm_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the prevalence rate of the UNC5D L699V mutation in Lung Adenocarcinoma?,ssm_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the prevalence rate of the UNC5D L704V mutation in Lung Adenocarcinoma?,ssm_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the prevalence rate of the UNC5D L709V mutation in Lung Adenocarcinoma?,ssm_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the prevalence rate of the DOCK2 L1527H mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the prevalence rate of the ZNF627 A5V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the prevalence rate of the CDC42BPA L823F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the prevalence rate of the MRPL55 H27Y mutation in Colon Adenocarcinoma?,ssm_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the prevalence rate of the MRPL55 H63Y mutation in Colon Adenocarcinoma?,ssm_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the prevalence rate of the TMTC3 Q749K mutation in Breast Invasive Carcinoma?,ssm_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the prevalence rate of the EPRS1 K771I mutation in Colon Adenocarcinoma?,ssm_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the prevalence rate of the EPRS1 K778I mutation in Colon Adenocarcinoma?,ssm_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the prevalence rate of the GRTP1 A110V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the prevalence rate of the GRTP1 A32V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the prevalence rate of the TSHZ3 Q538K mutation in Stomach Adenocarcinoma?,ssm_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the prevalence rate of the TAS1R3 Q326H mutation in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,ssm_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the prevalence rate of the PIAS3 S238C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the prevalence rate of the PIAS3 S273C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the prevalence rate of the ZNF274 P13R mutation in Stomach Adenocarcinoma?,ssm_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the prevalence rate of the SYNJ1 R795C mutation in Colon Adenocarcinoma?,ssm_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the prevalence rate of the SYNJ1 R800C mutation in Colon Adenocarcinoma?,ssm_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the prevalence rate of the SYNJ1 R839C mutation in Colon Adenocarcinoma?,ssm_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the prevalence rate of the DSCAM V343M mutation in Prostate Adenocarcinoma?,ssm_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the prevalence rate of the DSCAM V426M mutation in Prostate Adenocarcinoma?,ssm_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the prevalence rate of the DSCAM V591M mutation in Prostate Adenocarcinoma?,ssm_frequency
+267,DGKD,R140H,Exceptional Responders,What is the prevalence rate of the DGKD R140H mutation in Exceptional Responders?,ssm_frequency
+268,DGKD,R160H,Exceptional Responders,What is the prevalence rate of the DGKD R160H mutation in Exceptional Responders?,ssm_frequency
+269,DGKD,R204H,Exceptional Responders,What is the prevalence rate of the DGKD R204H mutation in Exceptional Responders?,ssm_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the prevalence rate of the PLEKHG6 D105Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the prevalence rate of the PLEKHG6 D543Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the prevalence rate of the PLEKHG6 D575Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the prevalence rate of the WNT2 D138N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the prevalence rate of the GUCY2C G667R mutation in Skin Cutaneous Melanoma?,ssm_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the C7orf31 P244H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of the ZKSCAN7 E64K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+299,OR5D14,M210L,Neuroblastoma,What is the prevalence rate of the OR5D14 M210L mutation in Neuroblastoma?,ssm_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the SPATA22 K279E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the SPATA22 K306E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the SPATA22 K322E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the prevalence rate of the LCN15 E21V mutation in Stomach Adenocarcinoma?,ssm_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the prevalence rate of the DCAF4L2 S129F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the prevalence rate of the GUK1 R135P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the prevalence rate of the GUK1 R137P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the prevalence rate of the GUK1 R139P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the prevalence rate of the GUK1 R158P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the prevalence rate of the GUK1 R203P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the prevalence rate of the MORF4L1 K29T mutation in Stomach Adenocarcinoma?,ssm_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the prevalence rate of the MORF4L1 K51T mutation in Stomach Adenocarcinoma?,ssm_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the prevalence rate of the MORF4L1 K61T mutation in Stomach Adenocarcinoma?,ssm_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the prevalence rate of the MORF4L1 K76T mutation in Stomach Adenocarcinoma?,ssm_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the prevalence rate of the MYO3B F594L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the prevalence rate of the MYO3B F603L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the prevalence rate of the TENT5A S320F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the prevalence rate of the TENT5A S339F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the prevalence rate of the TENT5A S401F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the prevalence rate of the ZFAT S614L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the prevalence rate of the ZFAT S664L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the prevalence rate of the ZFAT S676L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+357,ZNF584,A211T,Sarcoma,What is the prevalence rate of the ZNF584 A211T mutation in Sarcoma?,ssm_frequency
+358,ZNF584,A256T,Sarcoma,What is the prevalence rate of the ZNF584 A256T mutation in Sarcoma?,ssm_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the LDOC1 R63W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the prevalence rate of the PDGFC R201G mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the MSANTD4 R304C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the prevalence rate of the NPSR1 S123L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the prevalence rate of the PHLPP1 K1317E mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the prevalence rate of the COL6A3 G237S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the prevalence rate of the COL6A3 G437S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the prevalence rate of the COL6A3 G638S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the prevalence rate of the COL6A3 G644S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the prevalence rate of the COL6A3 G844S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the prevalence rate of the ADRA1A R348G mutation in Stomach Adenocarcinoma?,ssm_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence rate of the LAMB2 S1254F mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the prevalence rate of the POC1B I198T mutation in Rectum Adenocarcinoma?,ssm_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the prevalence rate of the POC1B I286T mutation in Rectum Adenocarcinoma?,ssm_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the prevalence rate of the POC1B I328T mutation in Rectum Adenocarcinoma?,ssm_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the prevalence rate of the POC1B S79P mutation in Rectum Adenocarcinoma?,ssm_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the prevalence rate of the USH2A G1451C mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the prevalence rate of the AQP7 T110S mutation in Rectum Adenocarcinoma?,ssm_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the prevalence rate of the AQP7 T166S mutation in Rectum Adenocarcinoma?,ssm_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the prevalence rate of the AQP7 T167S mutation in Rectum Adenocarcinoma?,ssm_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the prevalence rate of the AQP7 T75S mutation in Rectum Adenocarcinoma?,ssm_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,What is the prevalence rate of the DCN R163C mutation in Rectum Adenocarcinoma?,ssm_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,What is the prevalence rate of the DCN R203C mutation in Rectum Adenocarcinoma?,ssm_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,What is the prevalence rate of the DCN R241C mutation in Rectum Adenocarcinoma?,ssm_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,What is the prevalence rate of the DCN R350C mutation in Rectum Adenocarcinoma?,ssm_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,What is the prevalence rate of the DCN R41C mutation in Rectum Adenocarcinoma?,ssm_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the CPS1 K1269N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the CPS1 K1275N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the CPS1 K818N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the prevalence rate of the FCGR2C P122S mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the prevalence rate of the FCGR2C P123S mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the GRM1 R280M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the prevalence rate of the SGCZ Q138H mutation in Lung Adenocarcinoma?,ssm_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the prevalence rate of the SGCZ Q91H mutation in Lung Adenocarcinoma?,ssm_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,What is the prevalence rate of the SMO V15M mutation in Stomach Adenocarcinoma?,ssm_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,What is the prevalence rate of the SMO V321M mutation in Stomach Adenocarcinoma?,ssm_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the prevalence rate of the CHODL G159E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the prevalence rate of the CHODL G181E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the prevalence rate of the CHODL G200E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,What is the prevalence rate of the MYO16 P399H mutation in Colon Adenocarcinoma?,ssm_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,What is the prevalence rate of the MYO16 P421H mutation in Colon Adenocarcinoma?,ssm_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the prevalence rate of the CXCR2 A98V mutation in Stomach Adenocarcinoma?,ssm_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the prevalence rate of the TMEM225 L212V mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the MAOB N251T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the GPRASP1 F580S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the MRPL32 R181Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the TYROBP A29T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the prevalence rate of the RAB40C A111V mutation in Lung Adenocarcinoma?,ssm_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the prevalence rate of the RAB40C A143V mutation in Lung Adenocarcinoma?,ssm_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the prevalence rate of the CTNNA2 S323R mutation in Lung Adenocarcinoma?,ssm_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the prevalence rate of the CTNNA2 S339R mutation in Lung Adenocarcinoma?,ssm_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the prevalence rate of the CTNNA2 S386R mutation in Lung Adenocarcinoma?,ssm_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the prevalence rate of the CTNNA2 S707R mutation in Lung Adenocarcinoma?,ssm_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the prevalence rate of the MYO15A S268R mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the prevalence rate of the GIMAP2 A167T mutation in Skin Cutaneous Melanoma?,ssm_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the prevalence rate of the KIF20B N1160D mutation in Glioblastoma Multiforme?,ssm_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the prevalence rate of the KIF20B N1200D mutation in Glioblastoma Multiforme?,ssm_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the ADAM17 E583K mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the BCAT1 G16R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the BCAT1 G17R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the BCAT1 G29R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the prevalence rate of the ERCC6 R1053H mutation in Colon Adenocarcinoma?,ssm_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,What is the prevalence rate of the DCC R320W mutation in Breast Invasive Carcinoma?,ssm_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,What is the prevalence rate of the DCC R363W mutation in Breast Invasive Carcinoma?,ssm_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,What is the prevalence rate of the DCC R386W mutation in Breast Invasive Carcinoma?,ssm_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,What is the prevalence rate of the DCC R41W mutation in Breast Invasive Carcinoma?,ssm_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the prevalence rate of the FBXO15 D417N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the prevalence rate of the FBXO15 D86N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the GSTCD S528F mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the GSTCD S615F mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the prevalence rate of the OLFML3 P296S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the prevalence rate of the OLFML3 P337S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the prevalence rate of the OLFML3 P357S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the prevalence rate of the CFAP61 E173V mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the prevalence rate of the CFAP61 E817V mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the prevalence rate of the HLA-DQA2 E51K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the prevalence rate of the TENM2 H240Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the prevalence rate of the TENM2 H351Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the prevalence rate of the TENM2 H472Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the prevalence rate of the ANKRD24 A465T mutation in Stomach Adenocarcinoma?,ssm_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the prevalence rate of the ANKRD24 A494T mutation in Stomach Adenocarcinoma?,ssm_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the prevalence rate of the ANKRD24 A584T mutation in Stomach Adenocarcinoma?,ssm_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the prevalence rate of the ZCCHC14 V549M mutation in Stomach Adenocarcinoma?,ssm_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the prevalence rate of the ZCCHC14 V665M mutation in Stomach Adenocarcinoma?,ssm_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the prevalence rate of the ZCCHC14 V676M mutation in Stomach Adenocarcinoma?,ssm_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the prevalence rate of the ZCCHC14 V802M mutation in Stomach Adenocarcinoma?,ssm_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,What is the prevalence rate of the SIK2 I265M mutation in Lung Adenocarcinoma?,ssm_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the MYH11 T1336M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the MYH11 T1343M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the prevalence rate of the SLC6A4 S174F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the SLC9C1 K102N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the SLC9C1 K29N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the prevalence rate of the OR2A12 A254T mutation in Brain Lower Grade Glioma?,ssm_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the prevalence rate of the PYHIN1 T325K mutation in Lung Adenocarcinoma?,ssm_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the prevalence rate of the PYHIN1 T334K mutation in Lung Adenocarcinoma?,ssm_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the prevalence rate of the JAML G191E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the prevalence rate of the JAML G219E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the prevalence rate of the JAML G220E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the prevalence rate of the JAML G230E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the prevalence rate of the TYK2 H1146R mutation in Stomach Adenocarcinoma?,ssm_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the prevalence rate of the TYK2 H23R mutation in Stomach Adenocarcinoma?,ssm_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the prevalence rate of the TYK2 H961R mutation in Stomach Adenocarcinoma?,ssm_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the CTCFL R208C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the CTCFL R265C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the CTCFL R420C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the CTCFL R470C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the CEP20 R31Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the CEP20 R58Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the prevalence rate of the RIMS2 R25W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the prevalence rate of the RIMS2 R393W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the prevalence rate of the RIMS2 R423W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the prevalence rate of the RIMS2 R470W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the prevalence rate of the RIMS2 R615W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the prevalence rate of the RIMS2 R619W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the prevalence rate of the RIMS2 R716W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the prevalence rate of the PIK3C2G S551L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the prevalence rate of the PIK3C2G S592L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+728,STK19,D341N,Colon Adenocarcinoma,What is the prevalence rate of the STK19 D341N mutation in Colon Adenocarcinoma?,ssm_frequency
+729,STK19,D345N,Colon Adenocarcinoma,What is the prevalence rate of the STK19 D345N mutation in Colon Adenocarcinoma?,ssm_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the prevalence rate of the REXO4 P60A mutation in Skin Cutaneous Melanoma?,ssm_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the ZBTB34 P160S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the ZBTB34 P164S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the prevalence rate of the NCKAP5 E148K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of the SORCS1 D1052Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of the SORCS1 D587Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of the SORCS1 D67Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of the SORCS1 D810Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the prevalence rate of the FGF8 T154M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the prevalence rate of the FGF8 T165M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the prevalence rate of the FGF8 T183M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the prevalence rate of the FGF8 T194M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the prevalence rate of the FGF8 T90M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the prevalence rate of the TENM3 R1877W mutation in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,ssm_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the AKT1 D44N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence rate of the CFAP298-TCP10L E11Q mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the prevalence rate of the GLRB E148D mutation in Stomach Adenocarcinoma?,ssm_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,What is the prevalence rate of the TTN F7636L mutation in Colon Adenocarcinoma?,ssm_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,What is the prevalence rate of the TTN F8563L mutation in Colon Adenocarcinoma?,ssm_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,What is the prevalence rate of the TTN F8880L mutation in Colon Adenocarcinoma?,ssm_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the prevalence rate of the ANKRD30A V798I mutation in Colon Adenocarcinoma?,ssm_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the prevalence rate of the ANKRD30A V854I mutation in Colon Adenocarcinoma?,ssm_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the prevalence rate of the ANKRD30A V973I mutation in Colon Adenocarcinoma?,ssm_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the prevalence rate of the TRIM45 S177L mutation in Colon Adenocarcinoma?,ssm_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the prevalence rate of the TRIM45 S224L mutation in Colon Adenocarcinoma?,ssm_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the prevalence rate of the TRIM45 S281L mutation in Colon Adenocarcinoma?,ssm_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the prevalence rate of the CACNA1F G727V mutation in Stomach Adenocarcinoma?,ssm_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the prevalence rate of the CACNA1F G781V mutation in Stomach Adenocarcinoma?,ssm_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the prevalence rate of the CACNA1F G792V mutation in Stomach Adenocarcinoma?,ssm_frequency
+817,KL,R594C,Colon Adenocarcinoma,What is the prevalence rate of the KL R594C mutation in Colon Adenocarcinoma?,ssm_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the prevalence rate of the GUF1 I243T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the prevalence rate of the TAF1L A539V mutation in Colon Adenocarcinoma?,ssm_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the prevalence rate of the TASOR2 S256F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the prevalence rate of the TASOR2 S36F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the prevalence rate of the TASOR2 S471F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the prevalence rate of the KDM5C R1151C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the prevalence rate of the KDM5C R1177C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the prevalence rate of the KDM5C R1217C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the prevalence rate of the KDM5C R1218C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence rate of the IL5RA L153F mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the prevalence rate of the DHX16 A29V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the prevalence rate of the DHX16 A89V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the prevalence rate of the GPR158 A644V mutation in Stomach Adenocarcinoma?,ssm_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the prevalence rate of the GPR158 A723V mutation in Stomach Adenocarcinoma?,ssm_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of the EIF2B4 E108K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of the EIF2B4 E110K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of the EIF2B4 E111K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of the EIF2B4 E131K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of the EIF2B4 E132K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of the EIF2B4 E96K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the prevalence rate of the AUTS2 P136S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the prevalence rate of the AUTS2 P218S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the prevalence rate of the AUTS2 P233S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the prevalence rate of the AUTS2 P313S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the prevalence rate of the AUTS2 P419S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the prevalence rate of the AUTS2 P443S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the prevalence rate of the AUTS2 P56S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the prevalence rate of the AUTS2 P667S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the prevalence rate of the AUTS2 P690S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the prevalence rate of the AUTS2 P691S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of the ACTL7B D223N mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the prevalence rate of the PCDHGA1 R535W mutation in Glioblastoma Multiforme?,ssm_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the prevalence rate of the TRAP1 R114W mutation in Stomach Adenocarcinoma?,ssm_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the prevalence rate of the TRAP1 R61W mutation in Stomach Adenocarcinoma?,ssm_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the PIK3C2A R1570Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the prevalence rate of the KANSL1 R139G mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the prevalence rate of the ANKRD52 Y594C mutation in Stomach Adenocarcinoma?,ssm_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the PAPPA G1580S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the prevalence rate of the B3GALNT1 V270A mutation in Rectum Adenocarcinoma?,ssm_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the prevalence rate of the GABRA6 G115R mutation in Lung Adenocarcinoma?,ssm_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the prevalence rate of the GABRA6 G122R mutation in Lung Adenocarcinoma?,ssm_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the prevalence rate of the GABRA6 G165R mutation in Lung Adenocarcinoma?,ssm_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the prevalence rate of the GABRA6 G175R mutation in Lung Adenocarcinoma?,ssm_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the prevalence rate of the GABRA6 G70R mutation in Lung Adenocarcinoma?,ssm_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the prevalence rate of the ZSCAN31 D9N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of the MED16 L126P mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of the MED16 L868P mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the prevalence rate of the PTPRO E1060K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the prevalence rate of the PTPRO E1088K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the prevalence rate of the PTPRO E249K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the prevalence rate of the PTPRO E265K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the prevalence rate of the PTPRO E277K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the prevalence rate of the PTPRO E67K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the prevalence rate of the PTPRO E923K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the prevalence rate of the PTPRO E940K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the CHMP7 D397N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the prevalence rate of the GPC3 I107N mutation in Stomach Adenocarcinoma?,ssm_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the prevalence rate of the GPC3 I161N mutation in Stomach Adenocarcinoma?,ssm_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence rate of the TLK2 V430L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence rate of the TLK2 V515L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence rate of the TLK2 V547L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence rate of the TLK2 V579L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence rate of the TLK2 V601L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the prevalence rate of the ZNF217 E209Q mutation in Lung Adenocarcinoma?,ssm_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the prevalence rate of the SYT9 V275L mutation in Lung Adenocarcinoma?,ssm_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the prevalence rate of the SYT9 V307L mutation in Lung Adenocarcinoma?,ssm_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the prevalence rate of the PKHD1L1 S2830N mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the prevalence rate of the MYO3A Y1295C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of the VASN V318I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the DNMT1 A1037T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the DNMT1 A1053T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the DNMT1 A934T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,What is the prevalence rate of the CA9 E402K mutation in Colon Adenocarcinoma?,ssm_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the TTC17 R808Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the TTC17 R865Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the prevalence rate of the PSG2 P43L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the prevalence rate of the RIPOR2 R470L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the prevalence rate of the RIPOR2 R499L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the prevalence rate of the RIPOR2 R504L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the prevalence rate of the RIPOR2 R520L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the DCLK3 V520I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the DCLK3 V689I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the prevalence rate of the MERTK G257A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the prevalence rate of the MERTK G757A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the prevalence rate of the MERTK G933A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the prevalence rate of the ZFP42 R206K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the prevalence rate of the OR13C3 M117I mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the prevalence rate of the OR13C3 M147I mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the prevalence rate of the SPAG1 I917M mutation in Stomach Adenocarcinoma?,ssm_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the CDKN2AIP Y92H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the prevalence rate of the PXN H1016Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the prevalence rate of the PXN H359Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the prevalence rate of the PXN H492Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the prevalence rate of the PXN H524Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the prevalence rate of the PXN H526Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the prevalence rate of the PXN H540Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the TTYH2 S23L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the TTYH2 S44L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the prevalence rate of the TMEM255A N205S mutation in Colon Adenocarcinoma?,ssm_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the prevalence rate of the TMEM255A N229S mutation in Colon Adenocarcinoma?,ssm_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the prevalence rate of the TMEM255A N65S mutation in Colon Adenocarcinoma?,ssm_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the prevalence rate of the TASOR2 H2271D mutation in Breast Invasive Carcinoma?,ssm_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the prevalence rate of the TASOR2 H2486D mutation in Breast Invasive Carcinoma?,ssm_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the ICE1 T1839M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the prevalence rate of the MYT1 A558E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the prevalence rate of the MYT1 A879E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the prevalence rate of the MYT1 A906E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the CX3CR1 P203L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the CX3CR1 P235L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the prevalence rate of the SPINDOC R197C mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the ART3 C251Y mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the ART3 C3Y mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the prevalence rate of the CYP1A2 R243G mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of the ADRA1A G279S mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the prevalence rate of the CDH23 P2523R mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the prevalence rate of the CDH23 P283R mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the prevalence rate of the KRT39 P137S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the prevalence rate of the PDHA2 S7F mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the prevalence rate of the SLC24A2 H200Q mutation in Colon Adenocarcinoma?,ssm_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the prevalence rate of the PTPRN2 F153L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the prevalence rate of the PTPRN2 F847L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the prevalence rate of the PTPRN2 F856L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the prevalence rate of the PTPRN2 F868L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the prevalence rate of the PTPRN2 F885L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the prevalence rate of the SOX21 R55L mutation in Lung Adenocarcinoma?,ssm_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the prevalence rate of the CPA6 G166E mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the prevalence rate of the GRM5 E14K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of the CASZ1 R233Q mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the prevalence rate of the SGIP1 N122T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the prevalence rate of the SGIP1 N420T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the prevalence rate of the SGIP1 N617T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the prevalence rate of the SGIP1 N648T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the prevalence rate of the CARMIL1 V549L mutation in Lung Adenocarcinoma?,ssm_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the prevalence rate of the CARMIL1 V949L mutation in Lung Adenocarcinoma?,ssm_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the prevalence rate of the ZNF431 D121Y mutation in Lung Adenocarcinoma?,ssm_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the prevalence rate of the ZNF431 D161Y mutation in Lung Adenocarcinoma?,ssm_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the prevalence rate of the ZNF431 R128I mutation in Lung Adenocarcinoma?,ssm_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the prevalence rate of the DNAH11 P2987S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the prevalence rate of the DNAH11 P2994S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the prevalence rate of the POLD1 Q461L mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the prevalence rate of the POLD1 Q85L mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the prevalence rate of the TTC12 D646H mutation in Lung Adenocarcinoma?,ssm_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the prevalence rate of the TTC12 D652H mutation in Lung Adenocarcinoma?,ssm_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the prevalence rate of the CNGB1 D967N mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the prevalence rate of the CNGB1 D973N mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the prevalence rate of the CTSC E214V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the prevalence rate of the CTSC E291V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the prevalence rate of the CTSC E322V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the prevalence rate of the CTSC E324V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the prevalence rate of the CTSC E335V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the PRSS8 A179T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the PRSS8 A233T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the prevalence rate of the ARHGEF40 V864F mutation in Lung Adenocarcinoma?,ssm_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the prevalence rate of the ACTB A138T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the prevalence rate of the ACTB A217T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the prevalence rate of the ACTB A244T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the prevalence rate of the ACTB A260T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the prevalence rate of the YY1AP1 V546D mutation in Glioblastoma Multiforme?,ssm_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the prevalence rate of the YY1AP1 V557D mutation in Glioblastoma Multiforme?,ssm_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the prevalence rate of the YY1AP1 V566D mutation in Glioblastoma Multiforme?,ssm_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the prevalence rate of the YY1AP1 V577D mutation in Glioblastoma Multiforme?,ssm_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the prevalence rate of the YY1AP1 V623D mutation in Glioblastoma Multiforme?,ssm_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the prevalence rate of the YY1AP1 V695D mutation in Glioblastoma Multiforme?,ssm_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the prevalence rate of the YY1AP1 V715D mutation in Glioblastoma Multiforme?,ssm_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the prevalence rate of the FNDC7 D323N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the prevalence rate of the FNDC7 D99N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the prevalence rate of the TLCD5 G15V mutation in Lung Adenocarcinoma?,ssm_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the prevalence rate of the TLCD5 G37V mutation in Lung Adenocarcinoma?,ssm_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the POLR1G R498W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the POLR1G R500W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the prevalence rate of the DNAH14 N1186K mutation in Colon Adenocarcinoma?,ssm_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the prevalence rate of the DNAH14 N2657K mutation in Colon Adenocarcinoma?,ssm_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the prevalence rate of the DNAH14 N3460K mutation in Colon Adenocarcinoma?,ssm_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the NEXN E73D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the prevalence rate of the CYB5R2 G112R mutation in Prostate Adenocarcinoma?,ssm_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the prevalence rate of the CYB5R2 G172R mutation in Prostate Adenocarcinoma?,ssm_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the NRAP S808L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the NRAP S816L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the NRAP S843L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the CCDC22 E179D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the prevalence rate of the DCAF6 S402F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the prevalence rate of the DCAF6 S433F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the ZNF708 E389D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the BFAR T103M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the MAST4 P1237S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the MAST4 P1986S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the MAST4 P1991S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the MAST4 P2001S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the MAST4 P2180S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the prevalence rate of the ARMC3 R169C mutation in Stomach Adenocarcinoma?,ssm_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the prevalence rate of the ARMC3 R432C mutation in Stomach Adenocarcinoma?,ssm_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the prevalence rate of the TET2 L757V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the prevalence rate of the TET2 L778V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the prevalence rate of the SERPINB10 A353P mutation in Lung Adenocarcinoma?,ssm_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the STAT3 Y22H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the MIEF1 A42T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the prevalence rate of the ACVR1B D397N mutation in Colon Adenocarcinoma?,ssm_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the prevalence rate of the ACVR1B D449N mutation in Colon Adenocarcinoma?,ssm_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the prevalence rate of the ACVR1B D490N mutation in Colon Adenocarcinoma?,ssm_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the prevalence rate of the EBF2 T104I mutation in Stomach Adenocarcinoma?,ssm_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the prevalence rate of the EBF2 T252I mutation in Stomach Adenocarcinoma?,ssm_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the prevalence rate of the VPS26B F266L mutation in Stomach Adenocarcinoma?,ssm_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of the PGR M106I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of the PGR M38I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence rate of the PGR M632I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the prevalence rate of the ACTA2 P334L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the THBS4 T852I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the THBS4 T943I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the prevalence rate of the PRSS1 S114T mutation in Lung Adenocarcinoma?,ssm_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the prevalence rate of the PRSS1 S124T mutation in Lung Adenocarcinoma?,ssm_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the prevalence rate of the PRSS1 S138T mutation in Lung Adenocarcinoma?,ssm_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the prevalence rate of the PRSS1 S74T mutation in Lung Adenocarcinoma?,ssm_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the prevalence rate of the PGF R126H mutation in Stomach Adenocarcinoma?,ssm_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the prevalence rate of the PGF R127H mutation in Stomach Adenocarcinoma?,ssm_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the prevalence rate of the ITPRID2 S351C mutation in Breast Invasive Carcinoma?,ssm_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the prevalence rate of the ITPRID2 S842C mutation in Breast Invasive Carcinoma?,ssm_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the HBB E8D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the prevalence rate of the PCDHB2 R158C mutation in Colon Adenocarcinoma?,ssm_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the prevalence rate of the PCDHB2 T15M mutation in Colon Adenocarcinoma?,ssm_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the prevalence rate of the PCDHB2 T26M mutation in Colon Adenocarcinoma?,ssm_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the prevalence rate of the UBR2 P1594S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the prevalence rate of the FBXO42 A618D mutation in Rectum Adenocarcinoma?,ssm_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the distribution of the TNS1 G1362V mutation in Breast Invasive Carcinoma?,ssm_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the distribution of the TNS1 G1711V mutation in Breast Invasive Carcinoma?,ssm_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the distribution of the TNS1 G1718V mutation in Breast Invasive Carcinoma?,ssm_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the distribution of the TNS1 G1732V mutation in Breast Invasive Carcinoma?,ssm_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the distribution of the TNS1 G1824V mutation in Breast Invasive Carcinoma?,ssm_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the distribution of the TNS1 G1857V mutation in Breast Invasive Carcinoma?,ssm_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the distribution of the TNS1 G843V mutation in Breast Invasive Carcinoma?,ssm_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the distribution of the EVC2 E1067K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the distribution of the EVC2 E987K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the distribution of the CR1 V1108G mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the distribution of the CR1 V1558G mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the distribution of the TRPA1 S295I mutation in Rectum Adenocarcinoma?,ssm_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the distribution of the TRPA1 S443I mutation in Rectum Adenocarcinoma?,ssm_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the distribution of the TAF1C R299L mutation in Lung Adenocarcinoma?,ssm_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the distribution of the TAF1C R396L mutation in Lung Adenocarcinoma?,ssm_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the distribution of the TAF1C R634L mutation in Lung Adenocarcinoma?,ssm_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the distribution of the TAF1C R702L mutation in Lung Adenocarcinoma?,ssm_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the distribution of the TAF1C R728L mutation in Lung Adenocarcinoma?,ssm_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the distribution of the DPF3 R104W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the distribution of the DPF3 R149W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the distribution of the DPF3 R94W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the distribution of the OR2T4 P272H mutation in Lung Adenocarcinoma?,ssm_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the distribution of the OR2T4 P300H mutation in Lung Adenocarcinoma?,ssm_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the distribution of the FBN1 E2667K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the distribution of the MAD1L1 E396K mutation in Prostate Adenocarcinoma?,ssm_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the distribution of the MAD1L1 E488K mutation in Prostate Adenocarcinoma?,ssm_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the distribution of the MAD1L1 E78K mutation in Prostate Adenocarcinoma?,ssm_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the distribution of the CCNG1 E22K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the distribution of the ANP32E N114T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the distribution of the ANP32E N64T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the distribution of the ANP32E N66T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the distribution of the ANP32E N73T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the distribution of the FRY S1888A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the distribution of the FRY S1937A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the distribution of the FRY S1938A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the distribution of the FRY S1983A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the distribution of the PAK3 E318K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the distribution of the PAK3 E319K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the distribution of the PAK3 E334K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the distribution of the PAK3 E340K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the distribution of the PAK3 E355K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the distribution of the MUC16 P7963L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the distribution of the ZFPM2 T498I mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the distribution of the ZFPM2 T630I mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the distribution of the PIK3C2B S1328C mutation in Breast Invasive Carcinoma?,ssm_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the distribution of the PIK3C2B S1356C mutation in Breast Invasive Carcinoma?,ssm_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the distribution of the ZNF804A S371Y mutation in Colon Adenocarcinoma?,ssm_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the distribution of the RELN A2371V mutation in Stomach Adenocarcinoma?,ssm_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution of the EFCAB12 R173C mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution of the EFCAB12 R23C mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the distribution of the DEFB115 E53K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the distribution of the ANKDD1A S290F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the distribution of the ANKDD1A S322F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the distribution of the ANKDD1A S413F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the distribution of the HTR3B S146I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the distribution of the HTR3B S206I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the distribution of the HTR3B S217I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the distribution of the ABCC3 R758W mutation in Stomach Adenocarcinoma?,ssm_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the distribution of the NOMO1 T204I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the distribution of the NOMO1 T371I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the distribution of the HYOU1 D298H mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the distribution of the FMO4 R500Q mutation in Skin Cutaneous Melanoma?,ssm_frequency
+140,BICC1,A372V,Exceptional Responders,What is the distribution of the BICC1 A372V mutation in Exceptional Responders?,ssm_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the distribution of the ZMYM3 I920V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the distribution of the ZMYM3 I932V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the distribution of the ZMYM3 I934V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution of the XKR4 R547W mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the distribution of the ABCC2 V239L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the distribution of the OR8K5 R293G mutation in Lung Adenocarcinoma?,ssm_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the distribution of the SPTAN1 S1503F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the distribution of the SPTAN1 S1523F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the distribution of the SYT10 M484I mutation in Rectum Adenocarcinoma?,ssm_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the distribution of the HSPA5 N457K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the distribution of the UNC5D L280V mutation in Lung Adenocarcinoma?,ssm_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the distribution of the UNC5D L635V mutation in Lung Adenocarcinoma?,ssm_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the distribution of the UNC5D L637V mutation in Lung Adenocarcinoma?,ssm_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the distribution of the UNC5D L699V mutation in Lung Adenocarcinoma?,ssm_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the distribution of the UNC5D L704V mutation in Lung Adenocarcinoma?,ssm_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the distribution of the UNC5D L709V mutation in Lung Adenocarcinoma?,ssm_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the distribution of the DOCK2 L1527H mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the distribution of the ZNF627 A5V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the distribution of the CDC42BPA L823F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the distribution of the MRPL55 H27Y mutation in Colon Adenocarcinoma?,ssm_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the distribution of the MRPL55 H63Y mutation in Colon Adenocarcinoma?,ssm_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the distribution of the TMTC3 Q749K mutation in Breast Invasive Carcinoma?,ssm_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the distribution of the EPRS1 K771I mutation in Colon Adenocarcinoma?,ssm_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the distribution of the EPRS1 K778I mutation in Colon Adenocarcinoma?,ssm_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the distribution of the GRTP1 A110V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the distribution of the GRTP1 A32V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the distribution of the TSHZ3 Q538K mutation in Stomach Adenocarcinoma?,ssm_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the distribution of the TAS1R3 Q326H mutation in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,ssm_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the distribution of the PIAS3 S238C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the distribution of the PIAS3 S273C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the distribution of the ZNF274 P13R mutation in Stomach Adenocarcinoma?,ssm_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the distribution of the SYNJ1 R795C mutation in Colon Adenocarcinoma?,ssm_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the distribution of the SYNJ1 R800C mutation in Colon Adenocarcinoma?,ssm_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the distribution of the SYNJ1 R839C mutation in Colon Adenocarcinoma?,ssm_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the distribution of the DSCAM V343M mutation in Prostate Adenocarcinoma?,ssm_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the distribution of the DSCAM V426M mutation in Prostate Adenocarcinoma?,ssm_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the distribution of the DSCAM V591M mutation in Prostate Adenocarcinoma?,ssm_frequency
+267,DGKD,R140H,Exceptional Responders,What is the distribution of the DGKD R140H mutation in Exceptional Responders?,ssm_frequency
+268,DGKD,R160H,Exceptional Responders,What is the distribution of the DGKD R160H mutation in Exceptional Responders?,ssm_frequency
+269,DGKD,R204H,Exceptional Responders,What is the distribution of the DGKD R204H mutation in Exceptional Responders?,ssm_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the distribution of the PLEKHG6 D105Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the distribution of the PLEKHG6 D543Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the distribution of the PLEKHG6 D575Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the distribution of the WNT2 D138N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the distribution of the GUCY2C G667R mutation in Skin Cutaneous Melanoma?,ssm_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the distribution of the C7orf31 P244H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution of the ZKSCAN7 E64K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+299,OR5D14,M210L,Neuroblastoma,What is the distribution of the OR5D14 M210L mutation in Neuroblastoma?,ssm_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the distribution of the SPATA22 K279E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the distribution of the SPATA22 K306E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the distribution of the SPATA22 K322E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the distribution of the LCN15 E21V mutation in Stomach Adenocarcinoma?,ssm_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the distribution of the DCAF4L2 S129F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the distribution of the GUK1 R135P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the distribution of the GUK1 R137P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the distribution of the GUK1 R139P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the distribution of the GUK1 R158P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the distribution of the GUK1 R203P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the distribution of the MORF4L1 K29T mutation in Stomach Adenocarcinoma?,ssm_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the distribution of the MORF4L1 K51T mutation in Stomach Adenocarcinoma?,ssm_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the distribution of the MORF4L1 K61T mutation in Stomach Adenocarcinoma?,ssm_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the distribution of the MORF4L1 K76T mutation in Stomach Adenocarcinoma?,ssm_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the distribution of the MYO3B F594L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the distribution of the MYO3B F603L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the distribution of the TENT5A S320F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the distribution of the TENT5A S339F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the distribution of the TENT5A S401F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the distribution of the ZFAT S614L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the distribution of the ZFAT S664L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the distribution of the ZFAT S676L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+357,ZNF584,A211T,Sarcoma,What is the distribution of the ZNF584 A211T mutation in Sarcoma?,ssm_frequency
+358,ZNF584,A256T,Sarcoma,What is the distribution of the ZNF584 A256T mutation in Sarcoma?,ssm_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the distribution of the LDOC1 R63W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the distribution of the PDGFC R201G mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the distribution of the MSANTD4 R304C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the distribution of the NPSR1 S123L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the distribution of the PHLPP1 K1317E mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the distribution of the COL6A3 G237S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the distribution of the COL6A3 G437S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the distribution of the COL6A3 G638S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the distribution of the COL6A3 G644S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the distribution of the COL6A3 G844S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the distribution of the ADRA1A R348G mutation in Stomach Adenocarcinoma?,ssm_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the distribution of the LAMB2 S1254F mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the distribution of the POC1B I198T mutation in Rectum Adenocarcinoma?,ssm_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the distribution of the POC1B I286T mutation in Rectum Adenocarcinoma?,ssm_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the distribution of the POC1B I328T mutation in Rectum Adenocarcinoma?,ssm_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the distribution of the POC1B S79P mutation in Rectum Adenocarcinoma?,ssm_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the distribution of the USH2A G1451C mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the distribution of the AQP7 T110S mutation in Rectum Adenocarcinoma?,ssm_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the distribution of the AQP7 T166S mutation in Rectum Adenocarcinoma?,ssm_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the distribution of the AQP7 T167S mutation in Rectum Adenocarcinoma?,ssm_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the distribution of the AQP7 T75S mutation in Rectum Adenocarcinoma?,ssm_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,What is the distribution of the DCN R163C mutation in Rectum Adenocarcinoma?,ssm_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,What is the distribution of the DCN R203C mutation in Rectum Adenocarcinoma?,ssm_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,What is the distribution of the DCN R241C mutation in Rectum Adenocarcinoma?,ssm_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,What is the distribution of the DCN R350C mutation in Rectum Adenocarcinoma?,ssm_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,What is the distribution of the DCN R41C mutation in Rectum Adenocarcinoma?,ssm_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the distribution of the CPS1 K1269N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the distribution of the CPS1 K1275N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the distribution of the CPS1 K818N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the distribution of the FCGR2C P122S mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the distribution of the FCGR2C P123S mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the distribution of the GRM1 R280M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the distribution of the SGCZ Q138H mutation in Lung Adenocarcinoma?,ssm_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the distribution of the SGCZ Q91H mutation in Lung Adenocarcinoma?,ssm_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,What is the distribution of the SMO V15M mutation in Stomach Adenocarcinoma?,ssm_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,What is the distribution of the SMO V321M mutation in Stomach Adenocarcinoma?,ssm_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the distribution of the CHODL G159E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the distribution of the CHODL G181E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the distribution of the CHODL G200E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,What is the distribution of the MYO16 P399H mutation in Colon Adenocarcinoma?,ssm_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,What is the distribution of the MYO16 P421H mutation in Colon Adenocarcinoma?,ssm_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the distribution of the CXCR2 A98V mutation in Stomach Adenocarcinoma?,ssm_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the distribution of the TMEM225 L212V mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the distribution of the MAOB N251T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the distribution of the GPRASP1 F580S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the distribution of the MRPL32 R181Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the distribution of the TYROBP A29T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the distribution of the RAB40C A111V mutation in Lung Adenocarcinoma?,ssm_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the distribution of the RAB40C A143V mutation in Lung Adenocarcinoma?,ssm_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the distribution of the CTNNA2 S323R mutation in Lung Adenocarcinoma?,ssm_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the distribution of the CTNNA2 S339R mutation in Lung Adenocarcinoma?,ssm_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the distribution of the CTNNA2 S386R mutation in Lung Adenocarcinoma?,ssm_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the distribution of the CTNNA2 S707R mutation in Lung Adenocarcinoma?,ssm_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the distribution of the MYO15A S268R mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the distribution of the GIMAP2 A167T mutation in Skin Cutaneous Melanoma?,ssm_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the distribution of the KIF20B N1160D mutation in Glioblastoma Multiforme?,ssm_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the distribution of the KIF20B N1200D mutation in Glioblastoma Multiforme?,ssm_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the distribution of the ADAM17 E583K mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the distribution of the BCAT1 G16R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the distribution of the BCAT1 G17R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the distribution of the BCAT1 G29R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the distribution of the ERCC6 R1053H mutation in Colon Adenocarcinoma?,ssm_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,What is the distribution of the DCC R320W mutation in Breast Invasive Carcinoma?,ssm_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,What is the distribution of the DCC R363W mutation in Breast Invasive Carcinoma?,ssm_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,What is the distribution of the DCC R386W mutation in Breast Invasive Carcinoma?,ssm_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,What is the distribution of the DCC R41W mutation in Breast Invasive Carcinoma?,ssm_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the distribution of the FBXO15 D417N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the distribution of the FBXO15 D86N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the distribution of the GSTCD S528F mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the distribution of the GSTCD S615F mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the distribution of the OLFML3 P296S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the distribution of the OLFML3 P337S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the distribution of the OLFML3 P357S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the distribution of the CFAP61 E173V mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the distribution of the CFAP61 E817V mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the distribution of the HLA-DQA2 E51K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the distribution of the TENM2 H240Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the distribution of the TENM2 H351Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the distribution of the TENM2 H472Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the distribution of the ANKRD24 A465T mutation in Stomach Adenocarcinoma?,ssm_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the distribution of the ANKRD24 A494T mutation in Stomach Adenocarcinoma?,ssm_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the distribution of the ANKRD24 A584T mutation in Stomach Adenocarcinoma?,ssm_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the distribution of the ZCCHC14 V549M mutation in Stomach Adenocarcinoma?,ssm_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the distribution of the ZCCHC14 V665M mutation in Stomach Adenocarcinoma?,ssm_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the distribution of the ZCCHC14 V676M mutation in Stomach Adenocarcinoma?,ssm_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the distribution of the ZCCHC14 V802M mutation in Stomach Adenocarcinoma?,ssm_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,What is the distribution of the SIK2 I265M mutation in Lung Adenocarcinoma?,ssm_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the distribution of the MYH11 T1336M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the distribution of the MYH11 T1343M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the distribution of the SLC6A4 S174F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the distribution of the SLC9C1 K102N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the distribution of the SLC9C1 K29N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the distribution of the OR2A12 A254T mutation in Brain Lower Grade Glioma?,ssm_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the distribution of the PYHIN1 T325K mutation in Lung Adenocarcinoma?,ssm_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the distribution of the PYHIN1 T334K mutation in Lung Adenocarcinoma?,ssm_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the distribution of the JAML G191E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the distribution of the JAML G219E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the distribution of the JAML G220E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the distribution of the JAML G230E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the distribution of the TYK2 H1146R mutation in Stomach Adenocarcinoma?,ssm_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the distribution of the TYK2 H23R mutation in Stomach Adenocarcinoma?,ssm_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the distribution of the TYK2 H961R mutation in Stomach Adenocarcinoma?,ssm_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the distribution of the CTCFL R208C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the distribution of the CTCFL R265C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the distribution of the CTCFL R420C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the distribution of the CTCFL R470C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the distribution of the CEP20 R31Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the distribution of the CEP20 R58Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the distribution of the RIMS2 R25W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the distribution of the RIMS2 R393W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the distribution of the RIMS2 R423W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the distribution of the RIMS2 R470W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the distribution of the RIMS2 R615W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the distribution of the RIMS2 R619W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the distribution of the RIMS2 R716W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the distribution of the PIK3C2G S551L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the distribution of the PIK3C2G S592L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+728,STK19,D341N,Colon Adenocarcinoma,What is the distribution of the STK19 D341N mutation in Colon Adenocarcinoma?,ssm_frequency
+729,STK19,D345N,Colon Adenocarcinoma,What is the distribution of the STK19 D345N mutation in Colon Adenocarcinoma?,ssm_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the distribution of the REXO4 P60A mutation in Skin Cutaneous Melanoma?,ssm_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the distribution of the ZBTB34 P160S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the distribution of the ZBTB34 P164S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the distribution of the NCKAP5 E148K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution of the SORCS1 D1052Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution of the SORCS1 D587Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution of the SORCS1 D67Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution of the SORCS1 D810Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the distribution of the FGF8 T154M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the distribution of the FGF8 T165M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the distribution of the FGF8 T183M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the distribution of the FGF8 T194M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the distribution of the FGF8 T90M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the distribution of the TENM3 R1877W mutation in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,ssm_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the distribution of the AKT1 D44N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the distribution of the CFAP298-TCP10L E11Q mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the distribution of the GLRB E148D mutation in Stomach Adenocarcinoma?,ssm_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,What is the distribution of the TTN F7636L mutation in Colon Adenocarcinoma?,ssm_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,What is the distribution of the TTN F8563L mutation in Colon Adenocarcinoma?,ssm_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,What is the distribution of the TTN F8880L mutation in Colon Adenocarcinoma?,ssm_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the distribution of the ANKRD30A V798I mutation in Colon Adenocarcinoma?,ssm_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the distribution of the ANKRD30A V854I mutation in Colon Adenocarcinoma?,ssm_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the distribution of the ANKRD30A V973I mutation in Colon Adenocarcinoma?,ssm_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the distribution of the TRIM45 S177L mutation in Colon Adenocarcinoma?,ssm_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the distribution of the TRIM45 S224L mutation in Colon Adenocarcinoma?,ssm_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the distribution of the TRIM45 S281L mutation in Colon Adenocarcinoma?,ssm_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the distribution of the CACNA1F G727V mutation in Stomach Adenocarcinoma?,ssm_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the distribution of the CACNA1F G781V mutation in Stomach Adenocarcinoma?,ssm_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the distribution of the CACNA1F G792V mutation in Stomach Adenocarcinoma?,ssm_frequency
+817,KL,R594C,Colon Adenocarcinoma,What is the distribution of the KL R594C mutation in Colon Adenocarcinoma?,ssm_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the distribution of the GUF1 I243T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the distribution of the TAF1L A539V mutation in Colon Adenocarcinoma?,ssm_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the distribution of the TASOR2 S256F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the distribution of the TASOR2 S36F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the distribution of the TASOR2 S471F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the distribution of the KDM5C R1151C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the distribution of the KDM5C R1177C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the distribution of the KDM5C R1217C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the distribution of the KDM5C R1218C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the distribution of the IL5RA L153F mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the distribution of the DHX16 A29V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the distribution of the DHX16 A89V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the distribution of the GPR158 A644V mutation in Stomach Adenocarcinoma?,ssm_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the distribution of the GPR158 A723V mutation in Stomach Adenocarcinoma?,ssm_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution of the EIF2B4 E108K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution of the EIF2B4 E110K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution of the EIF2B4 E111K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution of the EIF2B4 E131K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution of the EIF2B4 E132K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution of the EIF2B4 E96K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the distribution of the AUTS2 P136S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the distribution of the AUTS2 P218S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the distribution of the AUTS2 P233S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the distribution of the AUTS2 P313S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the distribution of the AUTS2 P419S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the distribution of the AUTS2 P443S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the distribution of the AUTS2 P56S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the distribution of the AUTS2 P667S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the distribution of the AUTS2 P690S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the distribution of the AUTS2 P691S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution of the ACTL7B D223N mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the distribution of the PCDHGA1 R535W mutation in Glioblastoma Multiforme?,ssm_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the distribution of the TRAP1 R114W mutation in Stomach Adenocarcinoma?,ssm_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the distribution of the TRAP1 R61W mutation in Stomach Adenocarcinoma?,ssm_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the distribution of the PIK3C2A R1570Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the distribution of the KANSL1 R139G mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the distribution of the ANKRD52 Y594C mutation in Stomach Adenocarcinoma?,ssm_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the distribution of the PAPPA G1580S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the distribution of the B3GALNT1 V270A mutation in Rectum Adenocarcinoma?,ssm_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the distribution of the GABRA6 G115R mutation in Lung Adenocarcinoma?,ssm_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the distribution of the GABRA6 G122R mutation in Lung Adenocarcinoma?,ssm_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the distribution of the GABRA6 G165R mutation in Lung Adenocarcinoma?,ssm_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the distribution of the GABRA6 G175R mutation in Lung Adenocarcinoma?,ssm_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the distribution of the GABRA6 G70R mutation in Lung Adenocarcinoma?,ssm_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the distribution of the ZSCAN31 D9N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution of the MED16 L126P mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution of the MED16 L868P mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the distribution of the PTPRO E1060K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the distribution of the PTPRO E1088K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the distribution of the PTPRO E249K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the distribution of the PTPRO E265K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the distribution of the PTPRO E277K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the distribution of the PTPRO E67K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the distribution of the PTPRO E923K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the distribution of the PTPRO E940K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the distribution of the CHMP7 D397N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the distribution of the GPC3 I107N mutation in Stomach Adenocarcinoma?,ssm_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the distribution of the GPC3 I161N mutation in Stomach Adenocarcinoma?,ssm_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the distribution of the TLK2 V430L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the distribution of the TLK2 V515L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the distribution of the TLK2 V547L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the distribution of the TLK2 V579L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the distribution of the TLK2 V601L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the distribution of the ZNF217 E209Q mutation in Lung Adenocarcinoma?,ssm_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the distribution of the SYT9 V275L mutation in Lung Adenocarcinoma?,ssm_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the distribution of the SYT9 V307L mutation in Lung Adenocarcinoma?,ssm_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the distribution of the PKHD1L1 S2830N mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the distribution of the MYO3A Y1295C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution of the VASN V318I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the distribution of the DNMT1 A1037T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the distribution of the DNMT1 A1053T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the distribution of the DNMT1 A934T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,What is the distribution of the CA9 E402K mutation in Colon Adenocarcinoma?,ssm_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the distribution of the TTC17 R808Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the distribution of the TTC17 R865Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the distribution of the PSG2 P43L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the distribution of the RIPOR2 R470L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the distribution of the RIPOR2 R499L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the distribution of the RIPOR2 R504L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the distribution of the RIPOR2 R520L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the distribution of the DCLK3 V520I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the distribution of the DCLK3 V689I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the distribution of the MERTK G257A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the distribution of the MERTK G757A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the distribution of the MERTK G933A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the distribution of the ZFP42 R206K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the distribution of the OR13C3 M117I mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the distribution of the OR13C3 M147I mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the distribution of the SPAG1 I917M mutation in Stomach Adenocarcinoma?,ssm_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the distribution of the CDKN2AIP Y92H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the distribution of the PXN H1016Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the distribution of the PXN H359Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the distribution of the PXN H492Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the distribution of the PXN H524Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the distribution of the PXN H526Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the distribution of the PXN H540Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the distribution of the TTYH2 S23L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the distribution of the TTYH2 S44L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the distribution of the TMEM255A N205S mutation in Colon Adenocarcinoma?,ssm_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the distribution of the TMEM255A N229S mutation in Colon Adenocarcinoma?,ssm_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the distribution of the TMEM255A N65S mutation in Colon Adenocarcinoma?,ssm_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the distribution of the TASOR2 H2271D mutation in Breast Invasive Carcinoma?,ssm_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the distribution of the TASOR2 H2486D mutation in Breast Invasive Carcinoma?,ssm_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the distribution of the ICE1 T1839M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the distribution of the MYT1 A558E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the distribution of the MYT1 A879E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the distribution of the MYT1 A906E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the distribution of the CX3CR1 P203L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the distribution of the CX3CR1 P235L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the distribution of the SPINDOC R197C mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the distribution of the ART3 C251Y mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the distribution of the ART3 C3Y mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the distribution of the CYP1A2 R243G mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution of the ADRA1A G279S mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the distribution of the CDH23 P2523R mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the distribution of the CDH23 P283R mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the distribution of the KRT39 P137S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the distribution of the PDHA2 S7F mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the distribution of the SLC24A2 H200Q mutation in Colon Adenocarcinoma?,ssm_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the distribution of the PTPRN2 F153L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the distribution of the PTPRN2 F847L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the distribution of the PTPRN2 F856L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the distribution of the PTPRN2 F868L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the distribution of the PTPRN2 F885L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the distribution of the SOX21 R55L mutation in Lung Adenocarcinoma?,ssm_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the distribution of the CPA6 G166E mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the distribution of the GRM5 E14K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution of the CASZ1 R233Q mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the distribution of the SGIP1 N122T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the distribution of the SGIP1 N420T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the distribution of the SGIP1 N617T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the distribution of the SGIP1 N648T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the distribution of the CARMIL1 V549L mutation in Lung Adenocarcinoma?,ssm_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the distribution of the CARMIL1 V949L mutation in Lung Adenocarcinoma?,ssm_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the distribution of the ZNF431 D121Y mutation in Lung Adenocarcinoma?,ssm_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the distribution of the ZNF431 D161Y mutation in Lung Adenocarcinoma?,ssm_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the distribution of the ZNF431 R128I mutation in Lung Adenocarcinoma?,ssm_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the distribution of the DNAH11 P2987S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the distribution of the DNAH11 P2994S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the distribution of the POLD1 Q461L mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the distribution of the POLD1 Q85L mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the distribution of the TTC12 D646H mutation in Lung Adenocarcinoma?,ssm_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the distribution of the TTC12 D652H mutation in Lung Adenocarcinoma?,ssm_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the distribution of the CNGB1 D967N mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the distribution of the CNGB1 D973N mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the distribution of the CTSC E214V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the distribution of the CTSC E291V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the distribution of the CTSC E322V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the distribution of the CTSC E324V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the distribution of the CTSC E335V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the distribution of the PRSS8 A179T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the distribution of the PRSS8 A233T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the distribution of the ARHGEF40 V864F mutation in Lung Adenocarcinoma?,ssm_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the distribution of the ACTB A138T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the distribution of the ACTB A217T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the distribution of the ACTB A244T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the distribution of the ACTB A260T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the distribution of the YY1AP1 V546D mutation in Glioblastoma Multiforme?,ssm_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the distribution of the YY1AP1 V557D mutation in Glioblastoma Multiforme?,ssm_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the distribution of the YY1AP1 V566D mutation in Glioblastoma Multiforme?,ssm_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the distribution of the YY1AP1 V577D mutation in Glioblastoma Multiforme?,ssm_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the distribution of the YY1AP1 V623D mutation in Glioblastoma Multiforme?,ssm_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the distribution of the YY1AP1 V695D mutation in Glioblastoma Multiforme?,ssm_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the distribution of the YY1AP1 V715D mutation in Glioblastoma Multiforme?,ssm_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the distribution of the FNDC7 D323N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the distribution of the FNDC7 D99N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the distribution of the TLCD5 G15V mutation in Lung Adenocarcinoma?,ssm_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the distribution of the TLCD5 G37V mutation in Lung Adenocarcinoma?,ssm_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the distribution of the POLR1G R498W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the distribution of the POLR1G R500W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the distribution of the DNAH14 N1186K mutation in Colon Adenocarcinoma?,ssm_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the distribution of the DNAH14 N2657K mutation in Colon Adenocarcinoma?,ssm_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the distribution of the DNAH14 N3460K mutation in Colon Adenocarcinoma?,ssm_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the distribution of the NEXN E73D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the distribution of the CYB5R2 G112R mutation in Prostate Adenocarcinoma?,ssm_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the distribution of the CYB5R2 G172R mutation in Prostate Adenocarcinoma?,ssm_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the distribution of the NRAP S808L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the distribution of the NRAP S816L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the distribution of the NRAP S843L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the distribution of the CCDC22 E179D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the distribution of the DCAF6 S402F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the distribution of the DCAF6 S433F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the distribution of the ZNF708 E389D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the distribution of the BFAR T103M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the distribution of the MAST4 P1237S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the distribution of the MAST4 P1986S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the distribution of the MAST4 P1991S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the distribution of the MAST4 P2001S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the distribution of the MAST4 P2180S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the distribution of the ARMC3 R169C mutation in Stomach Adenocarcinoma?,ssm_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the distribution of the ARMC3 R432C mutation in Stomach Adenocarcinoma?,ssm_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the distribution of the TET2 L757V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the distribution of the TET2 L778V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the distribution of the SERPINB10 A353P mutation in Lung Adenocarcinoma?,ssm_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the distribution of the STAT3 Y22H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the distribution of the MIEF1 A42T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the distribution of the ACVR1B D397N mutation in Colon Adenocarcinoma?,ssm_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the distribution of the ACVR1B D449N mutation in Colon Adenocarcinoma?,ssm_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the distribution of the ACVR1B D490N mutation in Colon Adenocarcinoma?,ssm_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the distribution of the EBF2 T104I mutation in Stomach Adenocarcinoma?,ssm_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the distribution of the EBF2 T252I mutation in Stomach Adenocarcinoma?,ssm_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the distribution of the VPS26B F266L mutation in Stomach Adenocarcinoma?,ssm_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution of the PGR M106I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution of the PGR M38I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution of the PGR M632I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the distribution of the ACTA2 P334L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the distribution of the THBS4 T852I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the distribution of the THBS4 T943I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the distribution of the PRSS1 S114T mutation in Lung Adenocarcinoma?,ssm_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the distribution of the PRSS1 S124T mutation in Lung Adenocarcinoma?,ssm_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the distribution of the PRSS1 S138T mutation in Lung Adenocarcinoma?,ssm_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the distribution of the PRSS1 S74T mutation in Lung Adenocarcinoma?,ssm_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the distribution of the PGF R126H mutation in Stomach Adenocarcinoma?,ssm_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the distribution of the PGF R127H mutation in Stomach Adenocarcinoma?,ssm_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the distribution of the ITPRID2 S351C mutation in Breast Invasive Carcinoma?,ssm_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the distribution of the ITPRID2 S842C mutation in Breast Invasive Carcinoma?,ssm_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the distribution of the HBB E8D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the distribution of the PCDHB2 R158C mutation in Colon Adenocarcinoma?,ssm_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the distribution of the PCDHB2 T15M mutation in Colon Adenocarcinoma?,ssm_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the distribution of the PCDHB2 T26M mutation in Colon Adenocarcinoma?,ssm_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the distribution of the UBR2 P1594S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the distribution of the FBXO42 A618D mutation in Rectum Adenocarcinoma?,ssm_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,How high is the prevalence of the TNS1 G1362V mutation in Breast Invasive Carcinoma?,ssm_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,How high is the prevalence of the TNS1 G1711V mutation in Breast Invasive Carcinoma?,ssm_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,How high is the prevalence of the TNS1 G1718V mutation in Breast Invasive Carcinoma?,ssm_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,How high is the prevalence of the TNS1 G1732V mutation in Breast Invasive Carcinoma?,ssm_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,How high is the prevalence of the TNS1 G1824V mutation in Breast Invasive Carcinoma?,ssm_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,How high is the prevalence of the TNS1 G1857V mutation in Breast Invasive Carcinoma?,ssm_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,How high is the prevalence of the TNS1 G843V mutation in Breast Invasive Carcinoma?,ssm_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How high is the prevalence of the EVC2 E1067K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How high is the prevalence of the EVC2 E987K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the CR1 V1108G mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the CR1 V1558G mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,How high is the prevalence of the TRPA1 S295I mutation in Rectum Adenocarcinoma?,ssm_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,How high is the prevalence of the TRPA1 S443I mutation in Rectum Adenocarcinoma?,ssm_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,How high is the prevalence of the TAF1C R299L mutation in Lung Adenocarcinoma?,ssm_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,How high is the prevalence of the TAF1C R396L mutation in Lung Adenocarcinoma?,ssm_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,How high is the prevalence of the TAF1C R634L mutation in Lung Adenocarcinoma?,ssm_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,How high is the prevalence of the TAF1C R702L mutation in Lung Adenocarcinoma?,ssm_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,How high is the prevalence of the TAF1C R728L mutation in Lung Adenocarcinoma?,ssm_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the DPF3 R104W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the DPF3 R149W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the DPF3 R94W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,How high is the prevalence of the OR2T4 P272H mutation in Lung Adenocarcinoma?,ssm_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,How high is the prevalence of the OR2T4 P300H mutation in Lung Adenocarcinoma?,ssm_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How high is the prevalence of the FBN1 E2667K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How high is the prevalence of the MAD1L1 E396K mutation in Prostate Adenocarcinoma?,ssm_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How high is the prevalence of the MAD1L1 E488K mutation in Prostate Adenocarcinoma?,ssm_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How high is the prevalence of the MAD1L1 E78K mutation in Prostate Adenocarcinoma?,ssm_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How high is the prevalence of the CCNG1 E22K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How high is the prevalence of the ANP32E N114T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How high is the prevalence of the ANP32E N64T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How high is the prevalence of the ANP32E N66T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How high is the prevalence of the ANP32E N73T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How high is the prevalence of the FRY S1888A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How high is the prevalence of the FRY S1937A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How high is the prevalence of the FRY S1938A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How high is the prevalence of the FRY S1983A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,How high is the prevalence of the PAK3 E318K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,How high is the prevalence of the PAK3 E319K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,How high is the prevalence of the PAK3 E334K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,How high is the prevalence of the PAK3 E340K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,How high is the prevalence of the PAK3 E355K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How high is the prevalence of the MUC16 P7963L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How high is the prevalence of the ZFPM2 T498I mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How high is the prevalence of the ZFPM2 T630I mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How high is the prevalence of the PIK3C2B S1328C mutation in Breast Invasive Carcinoma?,ssm_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How high is the prevalence of the PIK3C2B S1356C mutation in Breast Invasive Carcinoma?,ssm_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How high is the prevalence of the ZNF804A S371Y mutation in Colon Adenocarcinoma?,ssm_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,How high is the prevalence of the RELN A2371V mutation in Stomach Adenocarcinoma?,ssm_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How high is the prevalence of the EFCAB12 R173C mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How high is the prevalence of the EFCAB12 R23C mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How high is the prevalence of the DEFB115 E53K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How high is the prevalence of the ANKDD1A S290F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How high is the prevalence of the ANKDD1A S322F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How high is the prevalence of the ANKDD1A S413F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the HTR3B S146I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the HTR3B S206I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the HTR3B S217I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,How high is the prevalence of the ABCC3 R758W mutation in Stomach Adenocarcinoma?,ssm_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the NOMO1 T204I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the NOMO1 T371I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How high is the prevalence of the HYOU1 D298H mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How high is the prevalence of the FMO4 R500Q mutation in Skin Cutaneous Melanoma?,ssm_frequency
+140,BICC1,A372V,Exceptional Responders,How high is the prevalence of the BICC1 A372V mutation in Exceptional Responders?,ssm_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the ZMYM3 I920V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the ZMYM3 I932V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the ZMYM3 I934V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How high is the prevalence of the XKR4 R547W mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How high is the prevalence of the ABCC2 V239L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,How high is the prevalence of the OR8K5 R293G mutation in Lung Adenocarcinoma?,ssm_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How high is the prevalence of the SPTAN1 S1503F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How high is the prevalence of the SPTAN1 S1523F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,How high is the prevalence of the SYT10 M484I mutation in Rectum Adenocarcinoma?,ssm_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How high is the prevalence of the HSPA5 N457K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,How high is the prevalence of the UNC5D L280V mutation in Lung Adenocarcinoma?,ssm_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,How high is the prevalence of the UNC5D L635V mutation in Lung Adenocarcinoma?,ssm_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,How high is the prevalence of the UNC5D L637V mutation in Lung Adenocarcinoma?,ssm_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,How high is the prevalence of the UNC5D L699V mutation in Lung Adenocarcinoma?,ssm_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,How high is the prevalence of the UNC5D L704V mutation in Lung Adenocarcinoma?,ssm_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,How high is the prevalence of the UNC5D L709V mutation in Lung Adenocarcinoma?,ssm_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How high is the prevalence of the DOCK2 L1527H mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How high is the prevalence of the ZNF627 A5V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How high is the prevalence of the CDC42BPA L823F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,How high is the prevalence of the MRPL55 H27Y mutation in Colon Adenocarcinoma?,ssm_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,How high is the prevalence of the MRPL55 H63Y mutation in Colon Adenocarcinoma?,ssm_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How high is the prevalence of the TMTC3 Q749K mutation in Breast Invasive Carcinoma?,ssm_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,How high is the prevalence of the EPRS1 K771I mutation in Colon Adenocarcinoma?,ssm_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,How high is the prevalence of the EPRS1 K778I mutation in Colon Adenocarcinoma?,ssm_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How high is the prevalence of the GRTP1 A110V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How high is the prevalence of the GRTP1 A32V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How high is the prevalence of the TSHZ3 Q538K mutation in Stomach Adenocarcinoma?,ssm_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How high is the prevalence of the TAS1R3 Q326H mutation in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,ssm_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How high is the prevalence of the PIAS3 S238C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How high is the prevalence of the PIAS3 S273C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,How high is the prevalence of the ZNF274 P13R mutation in Stomach Adenocarcinoma?,ssm_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,How high is the prevalence of the SYNJ1 R795C mutation in Colon Adenocarcinoma?,ssm_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,How high is the prevalence of the SYNJ1 R800C mutation in Colon Adenocarcinoma?,ssm_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,How high is the prevalence of the SYNJ1 R839C mutation in Colon Adenocarcinoma?,ssm_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,How high is the prevalence of the DSCAM V343M mutation in Prostate Adenocarcinoma?,ssm_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,How high is the prevalence of the DSCAM V426M mutation in Prostate Adenocarcinoma?,ssm_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,How high is the prevalence of the DSCAM V591M mutation in Prostate Adenocarcinoma?,ssm_frequency
+267,DGKD,R140H,Exceptional Responders,How high is the prevalence of the DGKD R140H mutation in Exceptional Responders?,ssm_frequency
+268,DGKD,R160H,Exceptional Responders,How high is the prevalence of the DGKD R160H mutation in Exceptional Responders?,ssm_frequency
+269,DGKD,R204H,Exceptional Responders,How high is the prevalence of the DGKD R204H mutation in Exceptional Responders?,ssm_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How high is the prevalence of the PLEKHG6 D105Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How high is the prevalence of the PLEKHG6 D543Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How high is the prevalence of the PLEKHG6 D575Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,How high is the prevalence of the WNT2 D138N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How high is the prevalence of the GUCY2C G667R mutation in Skin Cutaneous Melanoma?,ssm_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the C7orf31 P244H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How high is the prevalence of the ZKSCAN7 E64K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+299,OR5D14,M210L,Neuroblastoma,How high is the prevalence of the OR5D14 M210L mutation in Neuroblastoma?,ssm_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the SPATA22 K279E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the SPATA22 K306E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the SPATA22 K322E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,How high is the prevalence of the LCN15 E21V mutation in Stomach Adenocarcinoma?,ssm_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How high is the prevalence of the DCAF4L2 S129F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How high is the prevalence of the GUK1 R135P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How high is the prevalence of the GUK1 R137P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How high is the prevalence of the GUK1 R139P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How high is the prevalence of the GUK1 R158P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How high is the prevalence of the GUK1 R203P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How high is the prevalence of the MORF4L1 K29T mutation in Stomach Adenocarcinoma?,ssm_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How high is the prevalence of the MORF4L1 K51T mutation in Stomach Adenocarcinoma?,ssm_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How high is the prevalence of the MORF4L1 K61T mutation in Stomach Adenocarcinoma?,ssm_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How high is the prevalence of the MORF4L1 K76T mutation in Stomach Adenocarcinoma?,ssm_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How high is the prevalence of the MYO3B F594L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How high is the prevalence of the MYO3B F603L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How high is the prevalence of the TENT5A S320F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How high is the prevalence of the TENT5A S339F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How high is the prevalence of the TENT5A S401F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How high is the prevalence of the ZFAT S614L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How high is the prevalence of the ZFAT S664L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How high is the prevalence of the ZFAT S676L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+357,ZNF584,A211T,Sarcoma,How high is the prevalence of the ZNF584 A211T mutation in Sarcoma?,ssm_frequency
+358,ZNF584,A256T,Sarcoma,How high is the prevalence of the ZNF584 A256T mutation in Sarcoma?,ssm_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the LDOC1 R63W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How high is the prevalence of the PDGFC R201G mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the MSANTD4 R304C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How high is the prevalence of the NPSR1 S123L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How high is the prevalence of the PHLPP1 K1317E mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How high is the prevalence of the COL6A3 G237S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How high is the prevalence of the COL6A3 G437S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How high is the prevalence of the COL6A3 G638S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How high is the prevalence of the COL6A3 G644S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How high is the prevalence of the COL6A3 G844S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How high is the prevalence of the ADRA1A R348G mutation in Stomach Adenocarcinoma?,ssm_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How high is the prevalence of the LAMB2 S1254F mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,How high is the prevalence of the POC1B I198T mutation in Rectum Adenocarcinoma?,ssm_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,How high is the prevalence of the POC1B I286T mutation in Rectum Adenocarcinoma?,ssm_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,How high is the prevalence of the POC1B I328T mutation in Rectum Adenocarcinoma?,ssm_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,How high is the prevalence of the POC1B S79P mutation in Rectum Adenocarcinoma?,ssm_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How high is the prevalence of the USH2A G1451C mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,How high is the prevalence of the AQP7 T110S mutation in Rectum Adenocarcinoma?,ssm_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,How high is the prevalence of the AQP7 T166S mutation in Rectum Adenocarcinoma?,ssm_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,How high is the prevalence of the AQP7 T167S mutation in Rectum Adenocarcinoma?,ssm_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,How high is the prevalence of the AQP7 T75S mutation in Rectum Adenocarcinoma?,ssm_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,How high is the prevalence of the DCN R163C mutation in Rectum Adenocarcinoma?,ssm_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,How high is the prevalence of the DCN R203C mutation in Rectum Adenocarcinoma?,ssm_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,How high is the prevalence of the DCN R241C mutation in Rectum Adenocarcinoma?,ssm_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,How high is the prevalence of the DCN R350C mutation in Rectum Adenocarcinoma?,ssm_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,How high is the prevalence of the DCN R41C mutation in Rectum Adenocarcinoma?,ssm_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the CPS1 K1269N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the CPS1 K1275N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the CPS1 K818N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How high is the prevalence of the FCGR2C P122S mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How high is the prevalence of the FCGR2C P123S mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the GRM1 R280M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,How high is the prevalence of the SGCZ Q138H mutation in Lung Adenocarcinoma?,ssm_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,How high is the prevalence of the SGCZ Q91H mutation in Lung Adenocarcinoma?,ssm_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,How high is the prevalence of the SMO V15M mutation in Stomach Adenocarcinoma?,ssm_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,How high is the prevalence of the SMO V321M mutation in Stomach Adenocarcinoma?,ssm_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,How high is the prevalence of the CHODL G159E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,How high is the prevalence of the CHODL G181E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,How high is the prevalence of the CHODL G200E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,How high is the prevalence of the MYO16 P399H mutation in Colon Adenocarcinoma?,ssm_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,How high is the prevalence of the MYO16 P421H mutation in Colon Adenocarcinoma?,ssm_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,How high is the prevalence of the CXCR2 A98V mutation in Stomach Adenocarcinoma?,ssm_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How high is the prevalence of the TMEM225 L212V mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the MAOB N251T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the GPRASP1 F580S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the MRPL32 R181Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the TYROBP A29T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,How high is the prevalence of the RAB40C A111V mutation in Lung Adenocarcinoma?,ssm_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,How high is the prevalence of the RAB40C A143V mutation in Lung Adenocarcinoma?,ssm_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,How high is the prevalence of the CTNNA2 S323R mutation in Lung Adenocarcinoma?,ssm_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,How high is the prevalence of the CTNNA2 S339R mutation in Lung Adenocarcinoma?,ssm_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,How high is the prevalence of the CTNNA2 S386R mutation in Lung Adenocarcinoma?,ssm_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,How high is the prevalence of the CTNNA2 S707R mutation in Lung Adenocarcinoma?,ssm_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How high is the prevalence of the MYO15A S268R mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How high is the prevalence of the GIMAP2 A167T mutation in Skin Cutaneous Melanoma?,ssm_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,How high is the prevalence of the KIF20B N1160D mutation in Glioblastoma Multiforme?,ssm_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,How high is the prevalence of the KIF20B N1200D mutation in Glioblastoma Multiforme?,ssm_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the ADAM17 E583K mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the BCAT1 G16R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the BCAT1 G17R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the BCAT1 G29R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,How high is the prevalence of the ERCC6 R1053H mutation in Colon Adenocarcinoma?,ssm_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,How high is the prevalence of the DCC R320W mutation in Breast Invasive Carcinoma?,ssm_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,How high is the prevalence of the DCC R363W mutation in Breast Invasive Carcinoma?,ssm_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,How high is the prevalence of the DCC R386W mutation in Breast Invasive Carcinoma?,ssm_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,How high is the prevalence of the DCC R41W mutation in Breast Invasive Carcinoma?,ssm_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How high is the prevalence of the FBXO15 D417N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How high is the prevalence of the FBXO15 D86N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the GSTCD S528F mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the GSTCD S615F mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How high is the prevalence of the OLFML3 P296S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How high is the prevalence of the OLFML3 P337S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How high is the prevalence of the OLFML3 P357S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How high is the prevalence of the CFAP61 E173V mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How high is the prevalence of the CFAP61 E817V mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How high is the prevalence of the HLA-DQA2 E51K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How high is the prevalence of the TENM2 H240Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How high is the prevalence of the TENM2 H351Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How high is the prevalence of the TENM2 H472Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How high is the prevalence of the ANKRD24 A465T mutation in Stomach Adenocarcinoma?,ssm_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How high is the prevalence of the ANKRD24 A494T mutation in Stomach Adenocarcinoma?,ssm_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How high is the prevalence of the ANKRD24 A584T mutation in Stomach Adenocarcinoma?,ssm_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How high is the prevalence of the ZCCHC14 V549M mutation in Stomach Adenocarcinoma?,ssm_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How high is the prevalence of the ZCCHC14 V665M mutation in Stomach Adenocarcinoma?,ssm_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How high is the prevalence of the ZCCHC14 V676M mutation in Stomach Adenocarcinoma?,ssm_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How high is the prevalence of the ZCCHC14 V802M mutation in Stomach Adenocarcinoma?,ssm_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,How high is the prevalence of the SIK2 I265M mutation in Lung Adenocarcinoma?,ssm_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the MYH11 T1336M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the MYH11 T1343M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How high is the prevalence of the SLC6A4 S174F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the SLC9C1 K102N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the SLC9C1 K29N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,How high is the prevalence of the OR2A12 A254T mutation in Brain Lower Grade Glioma?,ssm_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,How high is the prevalence of the PYHIN1 T325K mutation in Lung Adenocarcinoma?,ssm_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,How high is the prevalence of the PYHIN1 T334K mutation in Lung Adenocarcinoma?,ssm_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,How high is the prevalence of the JAML G191E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,How high is the prevalence of the JAML G219E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,How high is the prevalence of the JAML G220E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,How high is the prevalence of the JAML G230E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,How high is the prevalence of the TYK2 H1146R mutation in Stomach Adenocarcinoma?,ssm_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,How high is the prevalence of the TYK2 H23R mutation in Stomach Adenocarcinoma?,ssm_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,How high is the prevalence of the TYK2 H961R mutation in Stomach Adenocarcinoma?,ssm_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the CTCFL R208C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the CTCFL R265C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the CTCFL R420C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the CTCFL R470C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the CEP20 R31Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the CEP20 R58Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How high is the prevalence of the RIMS2 R25W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How high is the prevalence of the RIMS2 R393W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How high is the prevalence of the RIMS2 R423W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How high is the prevalence of the RIMS2 R470W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How high is the prevalence of the RIMS2 R615W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How high is the prevalence of the RIMS2 R619W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How high is the prevalence of the RIMS2 R716W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How high is the prevalence of the PIK3C2G S551L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How high is the prevalence of the PIK3C2G S592L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+728,STK19,D341N,Colon Adenocarcinoma,How high is the prevalence of the STK19 D341N mutation in Colon Adenocarcinoma?,ssm_frequency
+729,STK19,D345N,Colon Adenocarcinoma,How high is the prevalence of the STK19 D345N mutation in Colon Adenocarcinoma?,ssm_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,How high is the prevalence of the REXO4 P60A mutation in Skin Cutaneous Melanoma?,ssm_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the ZBTB34 P160S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the ZBTB34 P164S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How high is the prevalence of the NCKAP5 E148K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How high is the prevalence of the SORCS1 D1052Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How high is the prevalence of the SORCS1 D587Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How high is the prevalence of the SORCS1 D67Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How high is the prevalence of the SORCS1 D810Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How high is the prevalence of the FGF8 T154M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How high is the prevalence of the FGF8 T165M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How high is the prevalence of the FGF8 T183M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How high is the prevalence of the FGF8 T194M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How high is the prevalence of the FGF8 T90M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How high is the prevalence of the TENM3 R1877W mutation in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,ssm_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the AKT1 D44N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How high is the prevalence of the CFAP298-TCP10L E11Q mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,How high is the prevalence of the GLRB E148D mutation in Stomach Adenocarcinoma?,ssm_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,How high is the prevalence of the TTN F7636L mutation in Colon Adenocarcinoma?,ssm_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,How high is the prevalence of the TTN F8563L mutation in Colon Adenocarcinoma?,ssm_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,How high is the prevalence of the TTN F8880L mutation in Colon Adenocarcinoma?,ssm_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How high is the prevalence of the ANKRD30A V798I mutation in Colon Adenocarcinoma?,ssm_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How high is the prevalence of the ANKRD30A V854I mutation in Colon Adenocarcinoma?,ssm_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How high is the prevalence of the ANKRD30A V973I mutation in Colon Adenocarcinoma?,ssm_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,How high is the prevalence of the TRIM45 S177L mutation in Colon Adenocarcinoma?,ssm_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,How high is the prevalence of the TRIM45 S224L mutation in Colon Adenocarcinoma?,ssm_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,How high is the prevalence of the TRIM45 S281L mutation in Colon Adenocarcinoma?,ssm_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How high is the prevalence of the CACNA1F G727V mutation in Stomach Adenocarcinoma?,ssm_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How high is the prevalence of the CACNA1F G781V mutation in Stomach Adenocarcinoma?,ssm_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How high is the prevalence of the CACNA1F G792V mutation in Stomach Adenocarcinoma?,ssm_frequency
+817,KL,R594C,Colon Adenocarcinoma,How high is the prevalence of the KL R594C mutation in Colon Adenocarcinoma?,ssm_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How high is the prevalence of the GUF1 I243T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,How high is the prevalence of the TAF1L A539V mutation in Colon Adenocarcinoma?,ssm_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How high is the prevalence of the TASOR2 S256F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How high is the prevalence of the TASOR2 S36F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How high is the prevalence of the TASOR2 S471F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How high is the prevalence of the KDM5C R1151C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How high is the prevalence of the KDM5C R1177C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How high is the prevalence of the KDM5C R1217C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How high is the prevalence of the KDM5C R1218C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How high is the prevalence of the IL5RA L153F mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,How high is the prevalence of the DHX16 A29V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,How high is the prevalence of the DHX16 A89V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,How high is the prevalence of the GPR158 A644V mutation in Stomach Adenocarcinoma?,ssm_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,How high is the prevalence of the GPR158 A723V mutation in Stomach Adenocarcinoma?,ssm_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How high is the prevalence of the EIF2B4 E108K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How high is the prevalence of the EIF2B4 E110K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How high is the prevalence of the EIF2B4 E111K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How high is the prevalence of the EIF2B4 E131K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How high is the prevalence of the EIF2B4 E132K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How high is the prevalence of the EIF2B4 E96K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How high is the prevalence of the AUTS2 P136S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How high is the prevalence of the AUTS2 P218S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How high is the prevalence of the AUTS2 P233S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How high is the prevalence of the AUTS2 P313S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How high is the prevalence of the AUTS2 P419S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How high is the prevalence of the AUTS2 P443S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How high is the prevalence of the AUTS2 P56S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How high is the prevalence of the AUTS2 P667S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How high is the prevalence of the AUTS2 P690S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How high is the prevalence of the AUTS2 P691S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How high is the prevalence of the ACTL7B D223N mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How high is the prevalence of the PCDHGA1 R535W mutation in Glioblastoma Multiforme?,ssm_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,How high is the prevalence of the TRAP1 R114W mutation in Stomach Adenocarcinoma?,ssm_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,How high is the prevalence of the TRAP1 R61W mutation in Stomach Adenocarcinoma?,ssm_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the PIK3C2A R1570Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How high is the prevalence of the KANSL1 R139G mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How high is the prevalence of the ANKRD52 Y594C mutation in Stomach Adenocarcinoma?,ssm_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the PAPPA G1580S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How high is the prevalence of the B3GALNT1 V270A mutation in Rectum Adenocarcinoma?,ssm_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,How high is the prevalence of the GABRA6 G115R mutation in Lung Adenocarcinoma?,ssm_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,How high is the prevalence of the GABRA6 G122R mutation in Lung Adenocarcinoma?,ssm_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,How high is the prevalence of the GABRA6 G165R mutation in Lung Adenocarcinoma?,ssm_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,How high is the prevalence of the GABRA6 G175R mutation in Lung Adenocarcinoma?,ssm_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,How high is the prevalence of the GABRA6 G70R mutation in Lung Adenocarcinoma?,ssm_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How high is the prevalence of the ZSCAN31 D9N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How high is the prevalence of the MED16 L126P mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How high is the prevalence of the MED16 L868P mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How high is the prevalence of the PTPRO E1060K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How high is the prevalence of the PTPRO E1088K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How high is the prevalence of the PTPRO E249K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How high is the prevalence of the PTPRO E265K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How high is the prevalence of the PTPRO E277K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How high is the prevalence of the PTPRO E67K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How high is the prevalence of the PTPRO E923K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How high is the prevalence of the PTPRO E940K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the CHMP7 D397N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,How high is the prevalence of the GPC3 I107N mutation in Stomach Adenocarcinoma?,ssm_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,How high is the prevalence of the GPC3 I161N mutation in Stomach Adenocarcinoma?,ssm_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How high is the prevalence of the TLK2 V430L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How high is the prevalence of the TLK2 V515L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How high is the prevalence of the TLK2 V547L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How high is the prevalence of the TLK2 V579L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How high is the prevalence of the TLK2 V601L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How high is the prevalence of the ZNF217 E209Q mutation in Lung Adenocarcinoma?,ssm_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,How high is the prevalence of the SYT9 V275L mutation in Lung Adenocarcinoma?,ssm_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,How high is the prevalence of the SYT9 V307L mutation in Lung Adenocarcinoma?,ssm_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How high is the prevalence of the PKHD1L1 S2830N mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How high is the prevalence of the MYO3A Y1295C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How high is the prevalence of the VASN V318I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the DNMT1 A1037T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the DNMT1 A1053T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the DNMT1 A934T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,How high is the prevalence of the CA9 E402K mutation in Colon Adenocarcinoma?,ssm_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the TTC17 R808Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the TTC17 R865Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,How high is the prevalence of the PSG2 P43L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How high is the prevalence of the RIPOR2 R470L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How high is the prevalence of the RIPOR2 R499L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How high is the prevalence of the RIPOR2 R504L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How high is the prevalence of the RIPOR2 R520L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the DCLK3 V520I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the DCLK3 V689I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How high is the prevalence of the MERTK G257A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How high is the prevalence of the MERTK G757A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How high is the prevalence of the MERTK G933A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How high is the prevalence of the ZFP42 R206K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How high is the prevalence of the OR13C3 M117I mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How high is the prevalence of the OR13C3 M147I mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How high is the prevalence of the SPAG1 I917M mutation in Stomach Adenocarcinoma?,ssm_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the CDKN2AIP Y92H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,How high is the prevalence of the PXN H1016Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,How high is the prevalence of the PXN H359Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,How high is the prevalence of the PXN H492Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,How high is the prevalence of the PXN H524Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,How high is the prevalence of the PXN H526Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,How high is the prevalence of the PXN H540Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the TTYH2 S23L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the TTYH2 S44L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How high is the prevalence of the TMEM255A N205S mutation in Colon Adenocarcinoma?,ssm_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How high is the prevalence of the TMEM255A N229S mutation in Colon Adenocarcinoma?,ssm_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How high is the prevalence of the TMEM255A N65S mutation in Colon Adenocarcinoma?,ssm_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How high is the prevalence of the TASOR2 H2271D mutation in Breast Invasive Carcinoma?,ssm_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How high is the prevalence of the TASOR2 H2486D mutation in Breast Invasive Carcinoma?,ssm_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the ICE1 T1839M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,How high is the prevalence of the MYT1 A558E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,How high is the prevalence of the MYT1 A879E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,How high is the prevalence of the MYT1 A906E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the CX3CR1 P203L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the CX3CR1 P235L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How high is the prevalence of the SPINDOC R197C mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the ART3 C251Y mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the ART3 C3Y mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How high is the prevalence of the CYP1A2 R243G mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How high is the prevalence of the ADRA1A G279S mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How high is the prevalence of the CDH23 P2523R mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How high is the prevalence of the CDH23 P283R mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How high is the prevalence of the KRT39 P137S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How high is the prevalence of the PDHA2 S7F mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How high is the prevalence of the SLC24A2 H200Q mutation in Colon Adenocarcinoma?,ssm_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How high is the prevalence of the PTPRN2 F153L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How high is the prevalence of the PTPRN2 F847L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How high is the prevalence of the PTPRN2 F856L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How high is the prevalence of the PTPRN2 F868L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How high is the prevalence of the PTPRN2 F885L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,How high is the prevalence of the SOX21 R55L mutation in Lung Adenocarcinoma?,ssm_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How high is the prevalence of the CPA6 G166E mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How high is the prevalence of the GRM5 E14K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How high is the prevalence of the CASZ1 R233Q mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How high is the prevalence of the SGIP1 N122T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How high is the prevalence of the SGIP1 N420T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How high is the prevalence of the SGIP1 N617T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How high is the prevalence of the SGIP1 N648T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How high is the prevalence of the CARMIL1 V549L mutation in Lung Adenocarcinoma?,ssm_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How high is the prevalence of the CARMIL1 V949L mutation in Lung Adenocarcinoma?,ssm_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How high is the prevalence of the ZNF431 D121Y mutation in Lung Adenocarcinoma?,ssm_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How high is the prevalence of the ZNF431 D161Y mutation in Lung Adenocarcinoma?,ssm_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,How high is the prevalence of the ZNF431 R128I mutation in Lung Adenocarcinoma?,ssm_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How high is the prevalence of the DNAH11 P2987S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How high is the prevalence of the DNAH11 P2994S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How high is the prevalence of the POLD1 Q461L mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How high is the prevalence of the POLD1 Q85L mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,How high is the prevalence of the TTC12 D646H mutation in Lung Adenocarcinoma?,ssm_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,How high is the prevalence of the TTC12 D652H mutation in Lung Adenocarcinoma?,ssm_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How high is the prevalence of the CNGB1 D967N mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How high is the prevalence of the CNGB1 D973N mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,How high is the prevalence of the CTSC E214V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,How high is the prevalence of the CTSC E291V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,How high is the prevalence of the CTSC E322V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,How high is the prevalence of the CTSC E324V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,How high is the prevalence of the CTSC E335V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the PRSS8 A179T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the PRSS8 A233T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How high is the prevalence of the ARHGEF40 V864F mutation in Lung Adenocarcinoma?,ssm_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,How high is the prevalence of the ACTB A138T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,How high is the prevalence of the ACTB A217T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,How high is the prevalence of the ACTB A244T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,How high is the prevalence of the ACTB A260T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How high is the prevalence of the YY1AP1 V546D mutation in Glioblastoma Multiforme?,ssm_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How high is the prevalence of the YY1AP1 V557D mutation in Glioblastoma Multiforme?,ssm_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How high is the prevalence of the YY1AP1 V566D mutation in Glioblastoma Multiforme?,ssm_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How high is the prevalence of the YY1AP1 V577D mutation in Glioblastoma Multiforme?,ssm_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How high is the prevalence of the YY1AP1 V623D mutation in Glioblastoma Multiforme?,ssm_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How high is the prevalence of the YY1AP1 V695D mutation in Glioblastoma Multiforme?,ssm_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How high is the prevalence of the YY1AP1 V715D mutation in Glioblastoma Multiforme?,ssm_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How high is the prevalence of the FNDC7 D323N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How high is the prevalence of the FNDC7 D99N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,How high is the prevalence of the TLCD5 G15V mutation in Lung Adenocarcinoma?,ssm_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,How high is the prevalence of the TLCD5 G37V mutation in Lung Adenocarcinoma?,ssm_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the POLR1G R498W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the POLR1G R500W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How high is the prevalence of the DNAH14 N1186K mutation in Colon Adenocarcinoma?,ssm_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How high is the prevalence of the DNAH14 N2657K mutation in Colon Adenocarcinoma?,ssm_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How high is the prevalence of the DNAH14 N3460K mutation in Colon Adenocarcinoma?,ssm_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the NEXN E73D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How high is the prevalence of the CYB5R2 G112R mutation in Prostate Adenocarcinoma?,ssm_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How high is the prevalence of the CYB5R2 G172R mutation in Prostate Adenocarcinoma?,ssm_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the NRAP S808L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the NRAP S816L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the NRAP S843L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the CCDC22 E179D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How high is the prevalence of the DCAF6 S402F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How high is the prevalence of the DCAF6 S433F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the ZNF708 E389D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the BFAR T103M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the MAST4 P1237S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the MAST4 P1986S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the MAST4 P1991S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the MAST4 P2001S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the MAST4 P2180S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How high is the prevalence of the ARMC3 R169C mutation in Stomach Adenocarcinoma?,ssm_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How high is the prevalence of the ARMC3 R432C mutation in Stomach Adenocarcinoma?,ssm_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How high is the prevalence of the TET2 L757V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How high is the prevalence of the TET2 L778V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How high is the prevalence of the SERPINB10 A353P mutation in Lung Adenocarcinoma?,ssm_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the STAT3 Y22H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the MIEF1 A42T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How high is the prevalence of the ACVR1B D397N mutation in Colon Adenocarcinoma?,ssm_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How high is the prevalence of the ACVR1B D449N mutation in Colon Adenocarcinoma?,ssm_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How high is the prevalence of the ACVR1B D490N mutation in Colon Adenocarcinoma?,ssm_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,How high is the prevalence of the EBF2 T104I mutation in Stomach Adenocarcinoma?,ssm_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,How high is the prevalence of the EBF2 T252I mutation in Stomach Adenocarcinoma?,ssm_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How high is the prevalence of the VPS26B F266L mutation in Stomach Adenocarcinoma?,ssm_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How high is the prevalence of the PGR M106I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How high is the prevalence of the PGR M38I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How high is the prevalence of the PGR M632I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How high is the prevalence of the ACTA2 P334L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the THBS4 T852I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the THBS4 T943I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,How high is the prevalence of the PRSS1 S114T mutation in Lung Adenocarcinoma?,ssm_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,How high is the prevalence of the PRSS1 S124T mutation in Lung Adenocarcinoma?,ssm_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,How high is the prevalence of the PRSS1 S138T mutation in Lung Adenocarcinoma?,ssm_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,How high is the prevalence of the PRSS1 S74T mutation in Lung Adenocarcinoma?,ssm_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,How high is the prevalence of the PGF R126H mutation in Stomach Adenocarcinoma?,ssm_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,How high is the prevalence of the PGF R127H mutation in Stomach Adenocarcinoma?,ssm_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How high is the prevalence of the ITPRID2 S351C mutation in Breast Invasive Carcinoma?,ssm_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How high is the prevalence of the ITPRID2 S842C mutation in Breast Invasive Carcinoma?,ssm_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the HBB E8D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How high is the prevalence of the PCDHB2 R158C mutation in Colon Adenocarcinoma?,ssm_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How high is the prevalence of the PCDHB2 T15M mutation in Colon Adenocarcinoma?,ssm_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How high is the prevalence of the PCDHB2 T26M mutation in Colon Adenocarcinoma?,ssm_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How high is the prevalence of the UBR2 P1594S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How high is the prevalence of the FBXO42 A618D mutation in Rectum Adenocarcinoma?,ssm_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the presence rate of the TNS1 G1362V mutation in Breast Invasive Carcinoma?,ssm_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the presence rate of the TNS1 G1711V mutation in Breast Invasive Carcinoma?,ssm_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the presence rate of the TNS1 G1718V mutation in Breast Invasive Carcinoma?,ssm_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the presence rate of the TNS1 G1732V mutation in Breast Invasive Carcinoma?,ssm_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the presence rate of the TNS1 G1824V mutation in Breast Invasive Carcinoma?,ssm_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the presence rate of the TNS1 G1857V mutation in Breast Invasive Carcinoma?,ssm_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the presence rate of the TNS1 G843V mutation in Breast Invasive Carcinoma?,ssm_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the presence rate of the EVC2 E1067K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the presence rate of the EVC2 E987K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the CR1 V1108G mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the CR1 V1558G mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the presence rate of the TRPA1 S295I mutation in Rectum Adenocarcinoma?,ssm_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the presence rate of the TRPA1 S443I mutation in Rectum Adenocarcinoma?,ssm_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the presence rate of the TAF1C R299L mutation in Lung Adenocarcinoma?,ssm_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the presence rate of the TAF1C R396L mutation in Lung Adenocarcinoma?,ssm_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the presence rate of the TAF1C R634L mutation in Lung Adenocarcinoma?,ssm_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the presence rate of the TAF1C R702L mutation in Lung Adenocarcinoma?,ssm_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the presence rate of the TAF1C R728L mutation in Lung Adenocarcinoma?,ssm_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the DPF3 R104W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the DPF3 R149W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the DPF3 R94W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the presence rate of the OR2T4 P272H mutation in Lung Adenocarcinoma?,ssm_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the presence rate of the OR2T4 P300H mutation in Lung Adenocarcinoma?,ssm_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the presence rate of the FBN1 E2667K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the presence rate of the MAD1L1 E396K mutation in Prostate Adenocarcinoma?,ssm_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the presence rate of the MAD1L1 E488K mutation in Prostate Adenocarcinoma?,ssm_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the presence rate of the MAD1L1 E78K mutation in Prostate Adenocarcinoma?,ssm_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the presence rate of the CCNG1 E22K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the presence rate of the ANP32E N114T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the presence rate of the ANP32E N64T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the presence rate of the ANP32E N66T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the presence rate of the ANP32E N73T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the presence rate of the FRY S1888A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the presence rate of the FRY S1937A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the presence rate of the FRY S1938A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the presence rate of the FRY S1983A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the presence rate of the PAK3 E318K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the presence rate of the PAK3 E319K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the presence rate of the PAK3 E334K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the presence rate of the PAK3 E340K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the presence rate of the PAK3 E355K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the presence rate of the MUC16 P7963L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the presence rate of the ZFPM2 T498I mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the presence rate of the ZFPM2 T630I mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the presence rate of the PIK3C2B S1328C mutation in Breast Invasive Carcinoma?,ssm_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the presence rate of the PIK3C2B S1356C mutation in Breast Invasive Carcinoma?,ssm_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the presence rate of the ZNF804A S371Y mutation in Colon Adenocarcinoma?,ssm_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the presence rate of the RELN A2371V mutation in Stomach Adenocarcinoma?,ssm_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the presence rate of the EFCAB12 R173C mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the presence rate of the EFCAB12 R23C mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the presence rate of the DEFB115 E53K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the presence rate of the ANKDD1A S290F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the presence rate of the ANKDD1A S322F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the presence rate of the ANKDD1A S413F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the HTR3B S146I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the HTR3B S206I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the HTR3B S217I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the presence rate of the ABCC3 R758W mutation in Stomach Adenocarcinoma?,ssm_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the NOMO1 T204I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the NOMO1 T371I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the presence rate of the HYOU1 D298H mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the presence rate of the FMO4 R500Q mutation in Skin Cutaneous Melanoma?,ssm_frequency
+140,BICC1,A372V,Exceptional Responders,What is the presence rate of the BICC1 A372V mutation in Exceptional Responders?,ssm_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the ZMYM3 I920V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the ZMYM3 I932V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the ZMYM3 I934V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the presence rate of the XKR4 R547W mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the presence rate of the ABCC2 V239L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the presence rate of the OR8K5 R293G mutation in Lung Adenocarcinoma?,ssm_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the presence rate of the SPTAN1 S1503F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the presence rate of the SPTAN1 S1523F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the presence rate of the SYT10 M484I mutation in Rectum Adenocarcinoma?,ssm_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the presence rate of the HSPA5 N457K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the presence rate of the UNC5D L280V mutation in Lung Adenocarcinoma?,ssm_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the presence rate of the UNC5D L635V mutation in Lung Adenocarcinoma?,ssm_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the presence rate of the UNC5D L637V mutation in Lung Adenocarcinoma?,ssm_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the presence rate of the UNC5D L699V mutation in Lung Adenocarcinoma?,ssm_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the presence rate of the UNC5D L704V mutation in Lung Adenocarcinoma?,ssm_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the presence rate of the UNC5D L709V mutation in Lung Adenocarcinoma?,ssm_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the presence rate of the DOCK2 L1527H mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the presence rate of the ZNF627 A5V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the presence rate of the CDC42BPA L823F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the presence rate of the MRPL55 H27Y mutation in Colon Adenocarcinoma?,ssm_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the presence rate of the MRPL55 H63Y mutation in Colon Adenocarcinoma?,ssm_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the presence rate of the TMTC3 Q749K mutation in Breast Invasive Carcinoma?,ssm_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the presence rate of the EPRS1 K771I mutation in Colon Adenocarcinoma?,ssm_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the presence rate of the EPRS1 K778I mutation in Colon Adenocarcinoma?,ssm_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the presence rate of the GRTP1 A110V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the presence rate of the GRTP1 A32V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the presence rate of the TSHZ3 Q538K mutation in Stomach Adenocarcinoma?,ssm_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the presence rate of the TAS1R3 Q326H mutation in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,ssm_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the presence rate of the PIAS3 S238C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the presence rate of the PIAS3 S273C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the presence rate of the ZNF274 P13R mutation in Stomach Adenocarcinoma?,ssm_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the presence rate of the SYNJ1 R795C mutation in Colon Adenocarcinoma?,ssm_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the presence rate of the SYNJ1 R800C mutation in Colon Adenocarcinoma?,ssm_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the presence rate of the SYNJ1 R839C mutation in Colon Adenocarcinoma?,ssm_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the presence rate of the DSCAM V343M mutation in Prostate Adenocarcinoma?,ssm_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the presence rate of the DSCAM V426M mutation in Prostate Adenocarcinoma?,ssm_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the presence rate of the DSCAM V591M mutation in Prostate Adenocarcinoma?,ssm_frequency
+267,DGKD,R140H,Exceptional Responders,What is the presence rate of the DGKD R140H mutation in Exceptional Responders?,ssm_frequency
+268,DGKD,R160H,Exceptional Responders,What is the presence rate of the DGKD R160H mutation in Exceptional Responders?,ssm_frequency
+269,DGKD,R204H,Exceptional Responders,What is the presence rate of the DGKD R204H mutation in Exceptional Responders?,ssm_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the presence rate of the PLEKHG6 D105Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the presence rate of the PLEKHG6 D543Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the presence rate of the PLEKHG6 D575Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the presence rate of the WNT2 D138N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the presence rate of the GUCY2C G667R mutation in Skin Cutaneous Melanoma?,ssm_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the C7orf31 P244H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the presence rate of the ZKSCAN7 E64K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+299,OR5D14,M210L,Neuroblastoma,What is the presence rate of the OR5D14 M210L mutation in Neuroblastoma?,ssm_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the SPATA22 K279E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the SPATA22 K306E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the SPATA22 K322E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the presence rate of the LCN15 E21V mutation in Stomach Adenocarcinoma?,ssm_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the presence rate of the DCAF4L2 S129F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the presence rate of the GUK1 R135P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the presence rate of the GUK1 R137P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the presence rate of the GUK1 R139P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the presence rate of the GUK1 R158P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the presence rate of the GUK1 R203P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the presence rate of the MORF4L1 K29T mutation in Stomach Adenocarcinoma?,ssm_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the presence rate of the MORF4L1 K51T mutation in Stomach Adenocarcinoma?,ssm_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the presence rate of the MORF4L1 K61T mutation in Stomach Adenocarcinoma?,ssm_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the presence rate of the MORF4L1 K76T mutation in Stomach Adenocarcinoma?,ssm_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the presence rate of the MYO3B F594L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the presence rate of the MYO3B F603L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the presence rate of the TENT5A S320F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the presence rate of the TENT5A S339F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the presence rate of the TENT5A S401F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the presence rate of the ZFAT S614L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the presence rate of the ZFAT S664L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the presence rate of the ZFAT S676L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+357,ZNF584,A211T,Sarcoma,What is the presence rate of the ZNF584 A211T mutation in Sarcoma?,ssm_frequency
+358,ZNF584,A256T,Sarcoma,What is the presence rate of the ZNF584 A256T mutation in Sarcoma?,ssm_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the LDOC1 R63W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the presence rate of the PDGFC R201G mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the MSANTD4 R304C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the presence rate of the NPSR1 S123L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the presence rate of the PHLPP1 K1317E mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the presence rate of the COL6A3 G237S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the presence rate of the COL6A3 G437S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the presence rate of the COL6A3 G638S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the presence rate of the COL6A3 G644S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the presence rate of the COL6A3 G844S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the presence rate of the ADRA1A R348G mutation in Stomach Adenocarcinoma?,ssm_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the presence rate of the LAMB2 S1254F mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the presence rate of the POC1B I198T mutation in Rectum Adenocarcinoma?,ssm_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the presence rate of the POC1B I286T mutation in Rectum Adenocarcinoma?,ssm_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the presence rate of the POC1B I328T mutation in Rectum Adenocarcinoma?,ssm_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the presence rate of the POC1B S79P mutation in Rectum Adenocarcinoma?,ssm_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the presence rate of the USH2A G1451C mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the presence rate of the AQP7 T110S mutation in Rectum Adenocarcinoma?,ssm_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the presence rate of the AQP7 T166S mutation in Rectum Adenocarcinoma?,ssm_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the presence rate of the AQP7 T167S mutation in Rectum Adenocarcinoma?,ssm_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the presence rate of the AQP7 T75S mutation in Rectum Adenocarcinoma?,ssm_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,What is the presence rate of the DCN R163C mutation in Rectum Adenocarcinoma?,ssm_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,What is the presence rate of the DCN R203C mutation in Rectum Adenocarcinoma?,ssm_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,What is the presence rate of the DCN R241C mutation in Rectum Adenocarcinoma?,ssm_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,What is the presence rate of the DCN R350C mutation in Rectum Adenocarcinoma?,ssm_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,What is the presence rate of the DCN R41C mutation in Rectum Adenocarcinoma?,ssm_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the CPS1 K1269N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the CPS1 K1275N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the CPS1 K818N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the presence rate of the FCGR2C P122S mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the presence rate of the FCGR2C P123S mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the GRM1 R280M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the presence rate of the SGCZ Q138H mutation in Lung Adenocarcinoma?,ssm_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the presence rate of the SGCZ Q91H mutation in Lung Adenocarcinoma?,ssm_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,What is the presence rate of the SMO V15M mutation in Stomach Adenocarcinoma?,ssm_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,What is the presence rate of the SMO V321M mutation in Stomach Adenocarcinoma?,ssm_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the presence rate of the CHODL G159E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the presence rate of the CHODL G181E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the presence rate of the CHODL G200E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,What is the presence rate of the MYO16 P399H mutation in Colon Adenocarcinoma?,ssm_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,What is the presence rate of the MYO16 P421H mutation in Colon Adenocarcinoma?,ssm_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the presence rate of the CXCR2 A98V mutation in Stomach Adenocarcinoma?,ssm_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the presence rate of the TMEM225 L212V mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the MAOB N251T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the GPRASP1 F580S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the MRPL32 R181Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the TYROBP A29T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the presence rate of the RAB40C A111V mutation in Lung Adenocarcinoma?,ssm_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the presence rate of the RAB40C A143V mutation in Lung Adenocarcinoma?,ssm_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the presence rate of the CTNNA2 S323R mutation in Lung Adenocarcinoma?,ssm_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the presence rate of the CTNNA2 S339R mutation in Lung Adenocarcinoma?,ssm_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the presence rate of the CTNNA2 S386R mutation in Lung Adenocarcinoma?,ssm_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the presence rate of the CTNNA2 S707R mutation in Lung Adenocarcinoma?,ssm_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the presence rate of the MYO15A S268R mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the presence rate of the GIMAP2 A167T mutation in Skin Cutaneous Melanoma?,ssm_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the presence rate of the KIF20B N1160D mutation in Glioblastoma Multiforme?,ssm_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the presence rate of the KIF20B N1200D mutation in Glioblastoma Multiforme?,ssm_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the ADAM17 E583K mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the BCAT1 G16R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the BCAT1 G17R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the BCAT1 G29R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the presence rate of the ERCC6 R1053H mutation in Colon Adenocarcinoma?,ssm_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,What is the presence rate of the DCC R320W mutation in Breast Invasive Carcinoma?,ssm_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,What is the presence rate of the DCC R363W mutation in Breast Invasive Carcinoma?,ssm_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,What is the presence rate of the DCC R386W mutation in Breast Invasive Carcinoma?,ssm_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,What is the presence rate of the DCC R41W mutation in Breast Invasive Carcinoma?,ssm_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the presence rate of the FBXO15 D417N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the presence rate of the FBXO15 D86N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the GSTCD S528F mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the GSTCD S615F mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the presence rate of the OLFML3 P296S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the presence rate of the OLFML3 P337S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the presence rate of the OLFML3 P357S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the presence rate of the CFAP61 E173V mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the presence rate of the CFAP61 E817V mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the presence rate of the HLA-DQA2 E51K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the presence rate of the TENM2 H240Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the presence rate of the TENM2 H351Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the presence rate of the TENM2 H472Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the presence rate of the ANKRD24 A465T mutation in Stomach Adenocarcinoma?,ssm_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the presence rate of the ANKRD24 A494T mutation in Stomach Adenocarcinoma?,ssm_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the presence rate of the ANKRD24 A584T mutation in Stomach Adenocarcinoma?,ssm_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the presence rate of the ZCCHC14 V549M mutation in Stomach Adenocarcinoma?,ssm_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the presence rate of the ZCCHC14 V665M mutation in Stomach Adenocarcinoma?,ssm_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the presence rate of the ZCCHC14 V676M mutation in Stomach Adenocarcinoma?,ssm_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the presence rate of the ZCCHC14 V802M mutation in Stomach Adenocarcinoma?,ssm_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,What is the presence rate of the SIK2 I265M mutation in Lung Adenocarcinoma?,ssm_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the MYH11 T1336M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the MYH11 T1343M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the presence rate of the SLC6A4 S174F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the SLC9C1 K102N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the SLC9C1 K29N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the presence rate of the OR2A12 A254T mutation in Brain Lower Grade Glioma?,ssm_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the presence rate of the PYHIN1 T325K mutation in Lung Adenocarcinoma?,ssm_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the presence rate of the PYHIN1 T334K mutation in Lung Adenocarcinoma?,ssm_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the presence rate of the JAML G191E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the presence rate of the JAML G219E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the presence rate of the JAML G220E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the presence rate of the JAML G230E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the presence rate of the TYK2 H1146R mutation in Stomach Adenocarcinoma?,ssm_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the presence rate of the TYK2 H23R mutation in Stomach Adenocarcinoma?,ssm_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the presence rate of the TYK2 H961R mutation in Stomach Adenocarcinoma?,ssm_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the CTCFL R208C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the CTCFL R265C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the CTCFL R420C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the CTCFL R470C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the CEP20 R31Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the CEP20 R58Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the presence rate of the RIMS2 R25W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the presence rate of the RIMS2 R393W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the presence rate of the RIMS2 R423W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the presence rate of the RIMS2 R470W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the presence rate of the RIMS2 R615W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the presence rate of the RIMS2 R619W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the presence rate of the RIMS2 R716W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the presence rate of the PIK3C2G S551L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the presence rate of the PIK3C2G S592L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+728,STK19,D341N,Colon Adenocarcinoma,What is the presence rate of the STK19 D341N mutation in Colon Adenocarcinoma?,ssm_frequency
+729,STK19,D345N,Colon Adenocarcinoma,What is the presence rate of the STK19 D345N mutation in Colon Adenocarcinoma?,ssm_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the presence rate of the REXO4 P60A mutation in Skin Cutaneous Melanoma?,ssm_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the ZBTB34 P160S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the ZBTB34 P164S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the presence rate of the NCKAP5 E148K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the presence rate of the SORCS1 D1052Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the presence rate of the SORCS1 D587Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the presence rate of the SORCS1 D67Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the presence rate of the SORCS1 D810Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the presence rate of the FGF8 T154M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the presence rate of the FGF8 T165M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the presence rate of the FGF8 T183M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the presence rate of the FGF8 T194M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the presence rate of the FGF8 T90M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the presence rate of the TENM3 R1877W mutation in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,ssm_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the AKT1 D44N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the presence rate of the CFAP298-TCP10L E11Q mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the presence rate of the GLRB E148D mutation in Stomach Adenocarcinoma?,ssm_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,What is the presence rate of the TTN F7636L mutation in Colon Adenocarcinoma?,ssm_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,What is the presence rate of the TTN F8563L mutation in Colon Adenocarcinoma?,ssm_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,What is the presence rate of the TTN F8880L mutation in Colon Adenocarcinoma?,ssm_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the presence rate of the ANKRD30A V798I mutation in Colon Adenocarcinoma?,ssm_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the presence rate of the ANKRD30A V854I mutation in Colon Adenocarcinoma?,ssm_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the presence rate of the ANKRD30A V973I mutation in Colon Adenocarcinoma?,ssm_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the presence rate of the TRIM45 S177L mutation in Colon Adenocarcinoma?,ssm_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the presence rate of the TRIM45 S224L mutation in Colon Adenocarcinoma?,ssm_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the presence rate of the TRIM45 S281L mutation in Colon Adenocarcinoma?,ssm_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the presence rate of the CACNA1F G727V mutation in Stomach Adenocarcinoma?,ssm_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the presence rate of the CACNA1F G781V mutation in Stomach Adenocarcinoma?,ssm_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the presence rate of the CACNA1F G792V mutation in Stomach Adenocarcinoma?,ssm_frequency
+817,KL,R594C,Colon Adenocarcinoma,What is the presence rate of the KL R594C mutation in Colon Adenocarcinoma?,ssm_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the presence rate of the GUF1 I243T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the presence rate of the TAF1L A539V mutation in Colon Adenocarcinoma?,ssm_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the presence rate of the TASOR2 S256F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the presence rate of the TASOR2 S36F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the presence rate of the TASOR2 S471F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the presence rate of the KDM5C R1151C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the presence rate of the KDM5C R1177C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the presence rate of the KDM5C R1217C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the presence rate of the KDM5C R1218C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the presence rate of the IL5RA L153F mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the presence rate of the DHX16 A29V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the presence rate of the DHX16 A89V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the presence rate of the GPR158 A644V mutation in Stomach Adenocarcinoma?,ssm_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the presence rate of the GPR158 A723V mutation in Stomach Adenocarcinoma?,ssm_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the presence rate of the EIF2B4 E108K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the presence rate of the EIF2B4 E110K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the presence rate of the EIF2B4 E111K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the presence rate of the EIF2B4 E131K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the presence rate of the EIF2B4 E132K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the presence rate of the EIF2B4 E96K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the presence rate of the AUTS2 P136S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the presence rate of the AUTS2 P218S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the presence rate of the AUTS2 P233S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the presence rate of the AUTS2 P313S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the presence rate of the AUTS2 P419S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the presence rate of the AUTS2 P443S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the presence rate of the AUTS2 P56S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the presence rate of the AUTS2 P667S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the presence rate of the AUTS2 P690S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the presence rate of the AUTS2 P691S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the presence rate of the ACTL7B D223N mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the presence rate of the PCDHGA1 R535W mutation in Glioblastoma Multiforme?,ssm_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the presence rate of the TRAP1 R114W mutation in Stomach Adenocarcinoma?,ssm_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the presence rate of the TRAP1 R61W mutation in Stomach Adenocarcinoma?,ssm_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the PIK3C2A R1570Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the presence rate of the KANSL1 R139G mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the presence rate of the ANKRD52 Y594C mutation in Stomach Adenocarcinoma?,ssm_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the PAPPA G1580S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the presence rate of the B3GALNT1 V270A mutation in Rectum Adenocarcinoma?,ssm_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the presence rate of the GABRA6 G115R mutation in Lung Adenocarcinoma?,ssm_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the presence rate of the GABRA6 G122R mutation in Lung Adenocarcinoma?,ssm_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the presence rate of the GABRA6 G165R mutation in Lung Adenocarcinoma?,ssm_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the presence rate of the GABRA6 G175R mutation in Lung Adenocarcinoma?,ssm_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the presence rate of the GABRA6 G70R mutation in Lung Adenocarcinoma?,ssm_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the presence rate of the ZSCAN31 D9N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the presence rate of the MED16 L126P mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the presence rate of the MED16 L868P mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the presence rate of the PTPRO E1060K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the presence rate of the PTPRO E1088K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the presence rate of the PTPRO E249K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the presence rate of the PTPRO E265K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the presence rate of the PTPRO E277K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the presence rate of the PTPRO E67K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the presence rate of the PTPRO E923K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the presence rate of the PTPRO E940K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the CHMP7 D397N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the presence rate of the GPC3 I107N mutation in Stomach Adenocarcinoma?,ssm_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the presence rate of the GPC3 I161N mutation in Stomach Adenocarcinoma?,ssm_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the presence rate of the TLK2 V430L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the presence rate of the TLK2 V515L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the presence rate of the TLK2 V547L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the presence rate of the TLK2 V579L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the presence rate of the TLK2 V601L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the presence rate of the ZNF217 E209Q mutation in Lung Adenocarcinoma?,ssm_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the presence rate of the SYT9 V275L mutation in Lung Adenocarcinoma?,ssm_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the presence rate of the SYT9 V307L mutation in Lung Adenocarcinoma?,ssm_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the presence rate of the PKHD1L1 S2830N mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the presence rate of the MYO3A Y1295C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the presence rate of the VASN V318I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the DNMT1 A1037T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the DNMT1 A1053T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the DNMT1 A934T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,What is the presence rate of the CA9 E402K mutation in Colon Adenocarcinoma?,ssm_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the TTC17 R808Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the TTC17 R865Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the presence rate of the PSG2 P43L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the presence rate of the RIPOR2 R470L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the presence rate of the RIPOR2 R499L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the presence rate of the RIPOR2 R504L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the presence rate of the RIPOR2 R520L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the DCLK3 V520I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the DCLK3 V689I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the presence rate of the MERTK G257A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the presence rate of the MERTK G757A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the presence rate of the MERTK G933A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the presence rate of the ZFP42 R206K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the presence rate of the OR13C3 M117I mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the presence rate of the OR13C3 M147I mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the presence rate of the SPAG1 I917M mutation in Stomach Adenocarcinoma?,ssm_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the CDKN2AIP Y92H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the presence rate of the PXN H1016Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the presence rate of the PXN H359Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the presence rate of the PXN H492Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the presence rate of the PXN H524Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the presence rate of the PXN H526Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the presence rate of the PXN H540Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the TTYH2 S23L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the TTYH2 S44L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the presence rate of the TMEM255A N205S mutation in Colon Adenocarcinoma?,ssm_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the presence rate of the TMEM255A N229S mutation in Colon Adenocarcinoma?,ssm_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the presence rate of the TMEM255A N65S mutation in Colon Adenocarcinoma?,ssm_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the presence rate of the TASOR2 H2271D mutation in Breast Invasive Carcinoma?,ssm_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the presence rate of the TASOR2 H2486D mutation in Breast Invasive Carcinoma?,ssm_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the ICE1 T1839M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the presence rate of the MYT1 A558E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the presence rate of the MYT1 A879E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the presence rate of the MYT1 A906E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the CX3CR1 P203L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the CX3CR1 P235L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the presence rate of the SPINDOC R197C mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the ART3 C251Y mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the ART3 C3Y mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the presence rate of the CYP1A2 R243G mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the presence rate of the ADRA1A G279S mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the presence rate of the CDH23 P2523R mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the presence rate of the CDH23 P283R mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the presence rate of the KRT39 P137S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the presence rate of the PDHA2 S7F mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the presence rate of the SLC24A2 H200Q mutation in Colon Adenocarcinoma?,ssm_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the presence rate of the PTPRN2 F153L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the presence rate of the PTPRN2 F847L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the presence rate of the PTPRN2 F856L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the presence rate of the PTPRN2 F868L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the presence rate of the PTPRN2 F885L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the presence rate of the SOX21 R55L mutation in Lung Adenocarcinoma?,ssm_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the presence rate of the CPA6 G166E mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the presence rate of the GRM5 E14K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the presence rate of the CASZ1 R233Q mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the presence rate of the SGIP1 N122T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the presence rate of the SGIP1 N420T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the presence rate of the SGIP1 N617T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the presence rate of the SGIP1 N648T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the presence rate of the CARMIL1 V549L mutation in Lung Adenocarcinoma?,ssm_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the presence rate of the CARMIL1 V949L mutation in Lung Adenocarcinoma?,ssm_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the presence rate of the ZNF431 D121Y mutation in Lung Adenocarcinoma?,ssm_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the presence rate of the ZNF431 D161Y mutation in Lung Adenocarcinoma?,ssm_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the presence rate of the ZNF431 R128I mutation in Lung Adenocarcinoma?,ssm_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the presence rate of the DNAH11 P2987S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the presence rate of the DNAH11 P2994S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the presence rate of the POLD1 Q461L mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the presence rate of the POLD1 Q85L mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the presence rate of the TTC12 D646H mutation in Lung Adenocarcinoma?,ssm_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the presence rate of the TTC12 D652H mutation in Lung Adenocarcinoma?,ssm_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the presence rate of the CNGB1 D967N mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the presence rate of the CNGB1 D973N mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the presence rate of the CTSC E214V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the presence rate of the CTSC E291V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the presence rate of the CTSC E322V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the presence rate of the CTSC E324V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the presence rate of the CTSC E335V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the PRSS8 A179T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the PRSS8 A233T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the presence rate of the ARHGEF40 V864F mutation in Lung Adenocarcinoma?,ssm_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the presence rate of the ACTB A138T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the presence rate of the ACTB A217T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the presence rate of the ACTB A244T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the presence rate of the ACTB A260T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the presence rate of the YY1AP1 V546D mutation in Glioblastoma Multiforme?,ssm_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the presence rate of the YY1AP1 V557D mutation in Glioblastoma Multiforme?,ssm_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the presence rate of the YY1AP1 V566D mutation in Glioblastoma Multiforme?,ssm_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the presence rate of the YY1AP1 V577D mutation in Glioblastoma Multiforme?,ssm_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the presence rate of the YY1AP1 V623D mutation in Glioblastoma Multiforme?,ssm_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the presence rate of the YY1AP1 V695D mutation in Glioblastoma Multiforme?,ssm_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the presence rate of the YY1AP1 V715D mutation in Glioblastoma Multiforme?,ssm_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the presence rate of the FNDC7 D323N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the presence rate of the FNDC7 D99N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the presence rate of the TLCD5 G15V mutation in Lung Adenocarcinoma?,ssm_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the presence rate of the TLCD5 G37V mutation in Lung Adenocarcinoma?,ssm_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the POLR1G R498W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the POLR1G R500W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the presence rate of the DNAH14 N1186K mutation in Colon Adenocarcinoma?,ssm_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the presence rate of the DNAH14 N2657K mutation in Colon Adenocarcinoma?,ssm_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the presence rate of the DNAH14 N3460K mutation in Colon Adenocarcinoma?,ssm_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the NEXN E73D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the presence rate of the CYB5R2 G112R mutation in Prostate Adenocarcinoma?,ssm_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the presence rate of the CYB5R2 G172R mutation in Prostate Adenocarcinoma?,ssm_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the NRAP S808L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the NRAP S816L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the NRAP S843L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the CCDC22 E179D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the presence rate of the DCAF6 S402F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the presence rate of the DCAF6 S433F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the ZNF708 E389D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the BFAR T103M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the MAST4 P1237S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the MAST4 P1986S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the MAST4 P1991S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the MAST4 P2001S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the MAST4 P2180S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the presence rate of the ARMC3 R169C mutation in Stomach Adenocarcinoma?,ssm_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the presence rate of the ARMC3 R432C mutation in Stomach Adenocarcinoma?,ssm_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the presence rate of the TET2 L757V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the presence rate of the TET2 L778V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the presence rate of the SERPINB10 A353P mutation in Lung Adenocarcinoma?,ssm_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the STAT3 Y22H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the MIEF1 A42T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the presence rate of the ACVR1B D397N mutation in Colon Adenocarcinoma?,ssm_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the presence rate of the ACVR1B D449N mutation in Colon Adenocarcinoma?,ssm_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the presence rate of the ACVR1B D490N mutation in Colon Adenocarcinoma?,ssm_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the presence rate of the EBF2 T104I mutation in Stomach Adenocarcinoma?,ssm_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the presence rate of the EBF2 T252I mutation in Stomach Adenocarcinoma?,ssm_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the presence rate of the VPS26B F266L mutation in Stomach Adenocarcinoma?,ssm_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the presence rate of the PGR M106I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the presence rate of the PGR M38I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the presence rate of the PGR M632I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the presence rate of the ACTA2 P334L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the THBS4 T852I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the THBS4 T943I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the presence rate of the PRSS1 S114T mutation in Lung Adenocarcinoma?,ssm_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the presence rate of the PRSS1 S124T mutation in Lung Adenocarcinoma?,ssm_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the presence rate of the PRSS1 S138T mutation in Lung Adenocarcinoma?,ssm_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the presence rate of the PRSS1 S74T mutation in Lung Adenocarcinoma?,ssm_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the presence rate of the PGF R126H mutation in Stomach Adenocarcinoma?,ssm_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the presence rate of the PGF R127H mutation in Stomach Adenocarcinoma?,ssm_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the presence rate of the ITPRID2 S351C mutation in Breast Invasive Carcinoma?,ssm_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the presence rate of the ITPRID2 S842C mutation in Breast Invasive Carcinoma?,ssm_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the HBB E8D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the presence rate of the PCDHB2 R158C mutation in Colon Adenocarcinoma?,ssm_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the presence rate of the PCDHB2 T15M mutation in Colon Adenocarcinoma?,ssm_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the presence rate of the PCDHB2 T26M mutation in Colon Adenocarcinoma?,ssm_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the presence rate of the UBR2 P1594S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the presence rate of the FBXO42 A618D mutation in Rectum Adenocarcinoma?,ssm_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,How pervasively is the TNS1 G1362V mutation present in Breast Invasive Carcinoma?,ssm_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,How pervasively is the TNS1 G1711V mutation present in Breast Invasive Carcinoma?,ssm_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,How pervasively is the TNS1 G1718V mutation present in Breast Invasive Carcinoma?,ssm_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,How pervasively is the TNS1 G1732V mutation present in Breast Invasive Carcinoma?,ssm_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,How pervasively is the TNS1 G1824V mutation present in Breast Invasive Carcinoma?,ssm_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,How pervasively is the TNS1 G1857V mutation present in Breast Invasive Carcinoma?,ssm_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,How pervasively is the TNS1 G843V mutation present in Breast Invasive Carcinoma?,ssm_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How pervasively is the EVC2 E1067K mutation present in Bladder Urothelial Carcinoma?,ssm_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How pervasively is the EVC2 E987K mutation present in Bladder Urothelial Carcinoma?,ssm_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How pervasively is the CR1 V1108G mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How pervasively is the CR1 V1558G mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,How pervasively is the TRPA1 S295I mutation present in Rectum Adenocarcinoma?,ssm_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,How pervasively is the TRPA1 S443I mutation present in Rectum Adenocarcinoma?,ssm_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,How pervasively is the TAF1C R299L mutation present in Lung Adenocarcinoma?,ssm_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,How pervasively is the TAF1C R396L mutation present in Lung Adenocarcinoma?,ssm_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,How pervasively is the TAF1C R634L mutation present in Lung Adenocarcinoma?,ssm_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,How pervasively is the TAF1C R702L mutation present in Lung Adenocarcinoma?,ssm_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,How pervasively is the TAF1C R728L mutation present in Lung Adenocarcinoma?,ssm_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How pervasively is the DPF3 R104W mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How pervasively is the DPF3 R149W mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How pervasively is the DPF3 R94W mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,How pervasively is the OR2T4 P272H mutation present in Lung Adenocarcinoma?,ssm_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,How pervasively is the OR2T4 P300H mutation present in Lung Adenocarcinoma?,ssm_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How pervasively is the FBN1 E2667K mutation present in Pancreatic Adenocarcinoma?,ssm_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How pervasively is the MAD1L1 E396K mutation present in Prostate Adenocarcinoma?,ssm_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How pervasively is the MAD1L1 E488K mutation present in Prostate Adenocarcinoma?,ssm_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How pervasively is the MAD1L1 E78K mutation present in Prostate Adenocarcinoma?,ssm_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How pervasively is the CCNG1 E22K mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How pervasively is the ANP32E N114T mutation present in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How pervasively is the ANP32E N64T mutation present in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How pervasively is the ANP32E N66T mutation present in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How pervasively is the ANP32E N73T mutation present in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How pervasively is the FRY S1888A mutation present in Bladder Urothelial Carcinoma?,ssm_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How pervasively is the FRY S1937A mutation present in Bladder Urothelial Carcinoma?,ssm_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How pervasively is the FRY S1938A mutation present in Bladder Urothelial Carcinoma?,ssm_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How pervasively is the FRY S1983A mutation present in Bladder Urothelial Carcinoma?,ssm_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,How pervasively is the PAK3 E318K mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,How pervasively is the PAK3 E319K mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,How pervasively is the PAK3 E334K mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,How pervasively is the PAK3 E340K mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,How pervasively is the PAK3 E355K mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How pervasively is the MUC16 P7963L mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How pervasively is the ZFPM2 T498I mutation present in Liver Hepatocellular Carcinoma?,ssm_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How pervasively is the ZFPM2 T630I mutation present in Liver Hepatocellular Carcinoma?,ssm_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How pervasively is the PIK3C2B S1328C mutation present in Breast Invasive Carcinoma?,ssm_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How pervasively is the PIK3C2B S1356C mutation present in Breast Invasive Carcinoma?,ssm_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How pervasively is the ZNF804A S371Y mutation present in Colon Adenocarcinoma?,ssm_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,How pervasively is the RELN A2371V mutation present in Stomach Adenocarcinoma?,ssm_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How pervasively is the EFCAB12 R173C mutation present in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How pervasively is the EFCAB12 R23C mutation present in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How pervasively is the DEFB115 E53K mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How pervasively is the ANKDD1A S290F mutation present in Bladder Urothelial Carcinoma?,ssm_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How pervasively is the ANKDD1A S322F mutation present in Bladder Urothelial Carcinoma?,ssm_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How pervasively is the ANKDD1A S413F mutation present in Bladder Urothelial Carcinoma?,ssm_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How pervasively is the HTR3B S146I mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How pervasively is the HTR3B S206I mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How pervasively is the HTR3B S217I mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,How pervasively is the ABCC3 R758W mutation present in Stomach Adenocarcinoma?,ssm_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How pervasively is the NOMO1 T204I mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How pervasively is the NOMO1 T371I mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How pervasively is the HYOU1 D298H mutation present in Bladder Urothelial Carcinoma?,ssm_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How pervasively is the FMO4 R500Q mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+140,BICC1,A372V,Exceptional Responders,How pervasively is the BICC1 A372V mutation present in Exceptional Responders?,ssm_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How pervasively is the ZMYM3 I920V mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How pervasively is the ZMYM3 I932V mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How pervasively is the ZMYM3 I934V mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How pervasively is the XKR4 R547W mutation present in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How pervasively is the ABCC2 V239L mutation present in Liver Hepatocellular Carcinoma?,ssm_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,How pervasively is the OR8K5 R293G mutation present in Lung Adenocarcinoma?,ssm_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How pervasively is the SPTAN1 S1503F mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How pervasively is the SPTAN1 S1523F mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,How pervasively is the SYT10 M484I mutation present in Rectum Adenocarcinoma?,ssm_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How pervasively is the HSPA5 N457K mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,How pervasively is the UNC5D L280V mutation present in Lung Adenocarcinoma?,ssm_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,How pervasively is the UNC5D L635V mutation present in Lung Adenocarcinoma?,ssm_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,How pervasively is the UNC5D L637V mutation present in Lung Adenocarcinoma?,ssm_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,How pervasively is the UNC5D L699V mutation present in Lung Adenocarcinoma?,ssm_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,How pervasively is the UNC5D L704V mutation present in Lung Adenocarcinoma?,ssm_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,How pervasively is the UNC5D L709V mutation present in Lung Adenocarcinoma?,ssm_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How pervasively is the DOCK2 L1527H mutation present in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How pervasively is the ZNF627 A5V mutation present in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How pervasively is the CDC42BPA L823F mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,How pervasively is the MRPL55 H27Y mutation present in Colon Adenocarcinoma?,ssm_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,How pervasively is the MRPL55 H63Y mutation present in Colon Adenocarcinoma?,ssm_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How pervasively is the TMTC3 Q749K mutation present in Breast Invasive Carcinoma?,ssm_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,How pervasively is the EPRS1 K771I mutation present in Colon Adenocarcinoma?,ssm_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,How pervasively is the EPRS1 K778I mutation present in Colon Adenocarcinoma?,ssm_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How pervasively is the GRTP1 A110V mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How pervasively is the GRTP1 A32V mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How pervasively is the TSHZ3 Q538K mutation present in Stomach Adenocarcinoma?,ssm_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How pervasively is the TAS1R3 Q326H mutation present in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,ssm_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How pervasively is the PIAS3 S238C mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How pervasively is the PIAS3 S273C mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,How pervasively is the ZNF274 P13R mutation present in Stomach Adenocarcinoma?,ssm_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,How pervasively is the SYNJ1 R795C mutation present in Colon Adenocarcinoma?,ssm_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,How pervasively is the SYNJ1 R800C mutation present in Colon Adenocarcinoma?,ssm_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,How pervasively is the SYNJ1 R839C mutation present in Colon Adenocarcinoma?,ssm_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,How pervasively is the DSCAM V343M mutation present in Prostate Adenocarcinoma?,ssm_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,How pervasively is the DSCAM V426M mutation present in Prostate Adenocarcinoma?,ssm_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,How pervasively is the DSCAM V591M mutation present in Prostate Adenocarcinoma?,ssm_frequency
+267,DGKD,R140H,Exceptional Responders,How pervasively is the DGKD R140H mutation present in Exceptional Responders?,ssm_frequency
+268,DGKD,R160H,Exceptional Responders,How pervasively is the DGKD R160H mutation present in Exceptional Responders?,ssm_frequency
+269,DGKD,R204H,Exceptional Responders,How pervasively is the DGKD R204H mutation present in Exceptional Responders?,ssm_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How pervasively is the PLEKHG6 D105Y mutation present in Bladder Urothelial Carcinoma?,ssm_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How pervasively is the PLEKHG6 D543Y mutation present in Bladder Urothelial Carcinoma?,ssm_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How pervasively is the PLEKHG6 D575Y mutation present in Bladder Urothelial Carcinoma?,ssm_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,How pervasively is the WNT2 D138N mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How pervasively is the GUCY2C G667R mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How pervasively is the C7orf31 P244H mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How pervasively is the ZKSCAN7 E64K mutation present in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+299,OR5D14,M210L,Neuroblastoma,How pervasively is the OR5D14 M210L mutation present in Neuroblastoma?,ssm_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How pervasively is the SPATA22 K279E mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How pervasively is the SPATA22 K306E mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How pervasively is the SPATA22 K322E mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,How pervasively is the LCN15 E21V mutation present in Stomach Adenocarcinoma?,ssm_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How pervasively is the DCAF4L2 S129F mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How pervasively is the GUK1 R135P mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How pervasively is the GUK1 R137P mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How pervasively is the GUK1 R139P mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How pervasively is the GUK1 R158P mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How pervasively is the GUK1 R203P mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How pervasively is the MORF4L1 K29T mutation present in Stomach Adenocarcinoma?,ssm_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How pervasively is the MORF4L1 K51T mutation present in Stomach Adenocarcinoma?,ssm_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How pervasively is the MORF4L1 K61T mutation present in Stomach Adenocarcinoma?,ssm_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How pervasively is the MORF4L1 K76T mutation present in Stomach Adenocarcinoma?,ssm_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How pervasively is the MYO3B F594L mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How pervasively is the MYO3B F603L mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How pervasively is the TENT5A S320F mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How pervasively is the TENT5A S339F mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How pervasively is the TENT5A S401F mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How pervasively is the ZFAT S614L mutation present in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How pervasively is the ZFAT S664L mutation present in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How pervasively is the ZFAT S676L mutation present in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+357,ZNF584,A211T,Sarcoma,How pervasively is the ZNF584 A211T mutation present in Sarcoma?,ssm_frequency
+358,ZNF584,A256T,Sarcoma,How pervasively is the ZNF584 A256T mutation present in Sarcoma?,ssm_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How pervasively is the LDOC1 R63W mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How pervasively is the PDGFC R201G mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How pervasively is the MSANTD4 R304C mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How pervasively is the NPSR1 S123L mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How pervasively is the PHLPP1 K1317E mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How pervasively is the COL6A3 G237S mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How pervasively is the COL6A3 G437S mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How pervasively is the COL6A3 G638S mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How pervasively is the COL6A3 G644S mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How pervasively is the COL6A3 G844S mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How pervasively is the ADRA1A R348G mutation present in Stomach Adenocarcinoma?,ssm_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How pervasively is the LAMB2 S1254F mutation present in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,How pervasively is the POC1B I198T mutation present in Rectum Adenocarcinoma?,ssm_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,How pervasively is the POC1B I286T mutation present in Rectum Adenocarcinoma?,ssm_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,How pervasively is the POC1B I328T mutation present in Rectum Adenocarcinoma?,ssm_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,How pervasively is the POC1B S79P mutation present in Rectum Adenocarcinoma?,ssm_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How pervasively is the USH2A G1451C mutation present in Liver Hepatocellular Carcinoma?,ssm_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,How pervasively is the AQP7 T110S mutation present in Rectum Adenocarcinoma?,ssm_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,How pervasively is the AQP7 T166S mutation present in Rectum Adenocarcinoma?,ssm_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,How pervasively is the AQP7 T167S mutation present in Rectum Adenocarcinoma?,ssm_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,How pervasively is the AQP7 T75S mutation present in Rectum Adenocarcinoma?,ssm_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,How pervasively is the DCN R163C mutation present in Rectum Adenocarcinoma?,ssm_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,How pervasively is the DCN R203C mutation present in Rectum Adenocarcinoma?,ssm_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,How pervasively is the DCN R241C mutation present in Rectum Adenocarcinoma?,ssm_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,How pervasively is the DCN R350C mutation present in Rectum Adenocarcinoma?,ssm_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,How pervasively is the DCN R41C mutation present in Rectum Adenocarcinoma?,ssm_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How pervasively is the CPS1 K1269N mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How pervasively is the CPS1 K1275N mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How pervasively is the CPS1 K818N mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How pervasively is the FCGR2C P122S mutation present in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How pervasively is the FCGR2C P123S mutation present in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How pervasively is the GRM1 R280M mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,How pervasively is the SGCZ Q138H mutation present in Lung Adenocarcinoma?,ssm_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,How pervasively is the SGCZ Q91H mutation present in Lung Adenocarcinoma?,ssm_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,How pervasively is the SMO V15M mutation present in Stomach Adenocarcinoma?,ssm_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,How pervasively is the SMO V321M mutation present in Stomach Adenocarcinoma?,ssm_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,How pervasively is the CHODL G159E mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,How pervasively is the CHODL G181E mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,How pervasively is the CHODL G200E mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,How pervasively is the MYO16 P399H mutation present in Colon Adenocarcinoma?,ssm_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,How pervasively is the MYO16 P421H mutation present in Colon Adenocarcinoma?,ssm_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,How pervasively is the CXCR2 A98V mutation present in Stomach Adenocarcinoma?,ssm_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How pervasively is the TMEM225 L212V mutation present in Bladder Urothelial Carcinoma?,ssm_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How pervasively is the MAOB N251T mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How pervasively is the GPRASP1 F580S mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How pervasively is the MRPL32 R181Q mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How pervasively is the TYROBP A29T mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,How pervasively is the RAB40C A111V mutation present in Lung Adenocarcinoma?,ssm_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,How pervasively is the RAB40C A143V mutation present in Lung Adenocarcinoma?,ssm_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,How pervasively is the CTNNA2 S323R mutation present in Lung Adenocarcinoma?,ssm_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,How pervasively is the CTNNA2 S339R mutation present in Lung Adenocarcinoma?,ssm_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,How pervasively is the CTNNA2 S386R mutation present in Lung Adenocarcinoma?,ssm_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,How pervasively is the CTNNA2 S707R mutation present in Lung Adenocarcinoma?,ssm_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How pervasively is the MYO15A S268R mutation present in Bladder Urothelial Carcinoma?,ssm_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How pervasively is the GIMAP2 A167T mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,How pervasively is the KIF20B N1160D mutation present in Glioblastoma Multiforme?,ssm_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,How pervasively is the KIF20B N1200D mutation present in Glioblastoma Multiforme?,ssm_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How pervasively is the ADAM17 E583K mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How pervasively is the BCAT1 G16R mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How pervasively is the BCAT1 G17R mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How pervasively is the BCAT1 G29R mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,How pervasively is the ERCC6 R1053H mutation present in Colon Adenocarcinoma?,ssm_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,How pervasively is the DCC R320W mutation present in Breast Invasive Carcinoma?,ssm_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,How pervasively is the DCC R363W mutation present in Breast Invasive Carcinoma?,ssm_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,How pervasively is the DCC R386W mutation present in Breast Invasive Carcinoma?,ssm_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,How pervasively is the DCC R41W mutation present in Breast Invasive Carcinoma?,ssm_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How pervasively is the FBXO15 D417N mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How pervasively is the FBXO15 D86N mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How pervasively is the GSTCD S528F mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How pervasively is the GSTCD S615F mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How pervasively is the OLFML3 P296S mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How pervasively is the OLFML3 P337S mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How pervasively is the OLFML3 P357S mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How pervasively is the CFAP61 E173V mutation present in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How pervasively is the CFAP61 E817V mutation present in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How pervasively is the HLA-DQA2 E51K mutation present in Bladder Urothelial Carcinoma?,ssm_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How pervasively is the TENM2 H240Y mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How pervasively is the TENM2 H351Y mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How pervasively is the TENM2 H472Y mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How pervasively is the ANKRD24 A465T mutation present in Stomach Adenocarcinoma?,ssm_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How pervasively is the ANKRD24 A494T mutation present in Stomach Adenocarcinoma?,ssm_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How pervasively is the ANKRD24 A584T mutation present in Stomach Adenocarcinoma?,ssm_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How pervasively is the ZCCHC14 V549M mutation present in Stomach Adenocarcinoma?,ssm_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How pervasively is the ZCCHC14 V665M mutation present in Stomach Adenocarcinoma?,ssm_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How pervasively is the ZCCHC14 V676M mutation present in Stomach Adenocarcinoma?,ssm_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How pervasively is the ZCCHC14 V802M mutation present in Stomach Adenocarcinoma?,ssm_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,How pervasively is the SIK2 I265M mutation present in Lung Adenocarcinoma?,ssm_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How pervasively is the MYH11 T1336M mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How pervasively is the MYH11 T1343M mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How pervasively is the SLC6A4 S174F mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How pervasively is the SLC9C1 K102N mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How pervasively is the SLC9C1 K29N mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,How pervasively is the OR2A12 A254T mutation present in Brain Lower Grade Glioma?,ssm_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,How pervasively is the PYHIN1 T325K mutation present in Lung Adenocarcinoma?,ssm_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,How pervasively is the PYHIN1 T334K mutation present in Lung Adenocarcinoma?,ssm_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,How pervasively is the JAML G191E mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,How pervasively is the JAML G219E mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,How pervasively is the JAML G220E mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,How pervasively is the JAML G230E mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,How pervasively is the TYK2 H1146R mutation present in Stomach Adenocarcinoma?,ssm_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,How pervasively is the TYK2 H23R mutation present in Stomach Adenocarcinoma?,ssm_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,How pervasively is the TYK2 H961R mutation present in Stomach Adenocarcinoma?,ssm_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How pervasively is the CTCFL R208C mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How pervasively is the CTCFL R265C mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How pervasively is the CTCFL R420C mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How pervasively is the CTCFL R470C mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How pervasively is the CEP20 R31Q mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How pervasively is the CEP20 R58Q mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How pervasively is the RIMS2 R25W mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How pervasively is the RIMS2 R393W mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How pervasively is the RIMS2 R423W mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How pervasively is the RIMS2 R470W mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How pervasively is the RIMS2 R615W mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How pervasively is the RIMS2 R619W mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How pervasively is the RIMS2 R716W mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How pervasively is the PIK3C2G S551L mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How pervasively is the PIK3C2G S592L mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+728,STK19,D341N,Colon Adenocarcinoma,How pervasively is the STK19 D341N mutation present in Colon Adenocarcinoma?,ssm_frequency
+729,STK19,D345N,Colon Adenocarcinoma,How pervasively is the STK19 D345N mutation present in Colon Adenocarcinoma?,ssm_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,How pervasively is the REXO4 P60A mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How pervasively is the ZBTB34 P160S mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How pervasively is the ZBTB34 P164S mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How pervasively is the NCKAP5 E148K mutation present in Bladder Urothelial Carcinoma?,ssm_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How pervasively is the SORCS1 D1052Y mutation present in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How pervasively is the SORCS1 D587Y mutation present in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How pervasively is the SORCS1 D67Y mutation present in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How pervasively is the SORCS1 D810Y mutation present in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How pervasively is the FGF8 T154M mutation present in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How pervasively is the FGF8 T165M mutation present in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How pervasively is the FGF8 T183M mutation present in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How pervasively is the FGF8 T194M mutation present in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How pervasively is the FGF8 T90M mutation present in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How pervasively is the TENM3 R1877W mutation present in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,ssm_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How pervasively is the AKT1 D44N mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How pervasively is the CFAP298-TCP10L E11Q mutation present in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,How pervasively is the GLRB E148D mutation present in Stomach Adenocarcinoma?,ssm_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,How pervasively is the TTN F7636L mutation present in Colon Adenocarcinoma?,ssm_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,How pervasively is the TTN F8563L mutation present in Colon Adenocarcinoma?,ssm_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,How pervasively is the TTN F8880L mutation present in Colon Adenocarcinoma?,ssm_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How pervasively is the ANKRD30A V798I mutation present in Colon Adenocarcinoma?,ssm_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How pervasively is the ANKRD30A V854I mutation present in Colon Adenocarcinoma?,ssm_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How pervasively is the ANKRD30A V973I mutation present in Colon Adenocarcinoma?,ssm_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,How pervasively is the TRIM45 S177L mutation present in Colon Adenocarcinoma?,ssm_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,How pervasively is the TRIM45 S224L mutation present in Colon Adenocarcinoma?,ssm_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,How pervasively is the TRIM45 S281L mutation present in Colon Adenocarcinoma?,ssm_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How pervasively is the CACNA1F G727V mutation present in Stomach Adenocarcinoma?,ssm_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How pervasively is the CACNA1F G781V mutation present in Stomach Adenocarcinoma?,ssm_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How pervasively is the CACNA1F G792V mutation present in Stomach Adenocarcinoma?,ssm_frequency
+817,KL,R594C,Colon Adenocarcinoma,How pervasively is the KL R594C mutation present in Colon Adenocarcinoma?,ssm_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How pervasively is the GUF1 I243T mutation present in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,How pervasively is the TAF1L A539V mutation present in Colon Adenocarcinoma?,ssm_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How pervasively is the TASOR2 S256F mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How pervasively is the TASOR2 S36F mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How pervasively is the TASOR2 S471F mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How pervasively is the KDM5C R1151C mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How pervasively is the KDM5C R1177C mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How pervasively is the KDM5C R1217C mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How pervasively is the KDM5C R1218C mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How pervasively is the IL5RA L153F mutation present in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,How pervasively is the DHX16 A29V mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,How pervasively is the DHX16 A89V mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,How pervasively is the GPR158 A644V mutation present in Stomach Adenocarcinoma?,ssm_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,How pervasively is the GPR158 A723V mutation present in Stomach Adenocarcinoma?,ssm_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How pervasively is the EIF2B4 E108K mutation present in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How pervasively is the EIF2B4 E110K mutation present in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How pervasively is the EIF2B4 E111K mutation present in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How pervasively is the EIF2B4 E131K mutation present in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How pervasively is the EIF2B4 E132K mutation present in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How pervasively is the EIF2B4 E96K mutation present in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How pervasively is the AUTS2 P136S mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How pervasively is the AUTS2 P218S mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How pervasively is the AUTS2 P233S mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How pervasively is the AUTS2 P313S mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How pervasively is the AUTS2 P419S mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How pervasively is the AUTS2 P443S mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How pervasively is the AUTS2 P56S mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How pervasively is the AUTS2 P667S mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How pervasively is the AUTS2 P690S mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How pervasively is the AUTS2 P691S mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How pervasively is the ACTL7B D223N mutation present in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How pervasively is the PCDHGA1 R535W mutation present in Glioblastoma Multiforme?,ssm_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,How pervasively is the TRAP1 R114W mutation present in Stomach Adenocarcinoma?,ssm_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,How pervasively is the TRAP1 R61W mutation present in Stomach Adenocarcinoma?,ssm_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How pervasively is the PIK3C2A R1570Q mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How pervasively is the KANSL1 R139G mutation present in Liver Hepatocellular Carcinoma?,ssm_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How pervasively is the ANKRD52 Y594C mutation present in Stomach Adenocarcinoma?,ssm_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How pervasively is the PAPPA G1580S mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How pervasively is the B3GALNT1 V270A mutation present in Rectum Adenocarcinoma?,ssm_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,How pervasively is the GABRA6 G115R mutation present in Lung Adenocarcinoma?,ssm_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,How pervasively is the GABRA6 G122R mutation present in Lung Adenocarcinoma?,ssm_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,How pervasively is the GABRA6 G165R mutation present in Lung Adenocarcinoma?,ssm_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,How pervasively is the GABRA6 G175R mutation present in Lung Adenocarcinoma?,ssm_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,How pervasively is the GABRA6 G70R mutation present in Lung Adenocarcinoma?,ssm_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How pervasively is the ZSCAN31 D9N mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How pervasively is the MED16 L126P mutation present in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How pervasively is the MED16 L868P mutation present in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How pervasively is the PTPRO E1060K mutation present in Pancreatic Adenocarcinoma?,ssm_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How pervasively is the PTPRO E1088K mutation present in Pancreatic Adenocarcinoma?,ssm_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How pervasively is the PTPRO E249K mutation present in Pancreatic Adenocarcinoma?,ssm_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How pervasively is the PTPRO E265K mutation present in Pancreatic Adenocarcinoma?,ssm_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How pervasively is the PTPRO E277K mutation present in Pancreatic Adenocarcinoma?,ssm_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How pervasively is the PTPRO E67K mutation present in Pancreatic Adenocarcinoma?,ssm_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How pervasively is the PTPRO E923K mutation present in Pancreatic Adenocarcinoma?,ssm_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How pervasively is the PTPRO E940K mutation present in Pancreatic Adenocarcinoma?,ssm_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How pervasively is the CHMP7 D397N mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,How pervasively is the GPC3 I107N mutation present in Stomach Adenocarcinoma?,ssm_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,How pervasively is the GPC3 I161N mutation present in Stomach Adenocarcinoma?,ssm_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How pervasively is the TLK2 V430L mutation present in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How pervasively is the TLK2 V515L mutation present in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How pervasively is the TLK2 V547L mutation present in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How pervasively is the TLK2 V579L mutation present in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How pervasively is the TLK2 V601L mutation present in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How pervasively is the ZNF217 E209Q mutation present in Lung Adenocarcinoma?,ssm_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,How pervasively is the SYT9 V275L mutation present in Lung Adenocarcinoma?,ssm_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,How pervasively is the SYT9 V307L mutation present in Lung Adenocarcinoma?,ssm_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How pervasively is the PKHD1L1 S2830N mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How pervasively is the MYO3A Y1295C mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How pervasively is the VASN V318I mutation present in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How pervasively is the DNMT1 A1037T mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How pervasively is the DNMT1 A1053T mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How pervasively is the DNMT1 A934T mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,How pervasively is the CA9 E402K mutation present in Colon Adenocarcinoma?,ssm_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How pervasively is the TTC17 R808Q mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How pervasively is the TTC17 R865Q mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,How pervasively is the PSG2 P43L mutation present in Breast Invasive Carcinoma?,ssm_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How pervasively is the RIPOR2 R470L mutation present in Breast Invasive Carcinoma?,ssm_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How pervasively is the RIPOR2 R499L mutation present in Breast Invasive Carcinoma?,ssm_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How pervasively is the RIPOR2 R504L mutation present in Breast Invasive Carcinoma?,ssm_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How pervasively is the RIPOR2 R520L mutation present in Breast Invasive Carcinoma?,ssm_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How pervasively is the DCLK3 V520I mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How pervasively is the DCLK3 V689I mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How pervasively is the MERTK G257A mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How pervasively is the MERTK G757A mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How pervasively is the MERTK G933A mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How pervasively is the ZFP42 R206K mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How pervasively is the OR13C3 M117I mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How pervasively is the OR13C3 M147I mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How pervasively is the SPAG1 I917M mutation present in Stomach Adenocarcinoma?,ssm_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How pervasively is the CDKN2AIP Y92H mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,How pervasively is the PXN H1016Y mutation present in Colon Adenocarcinoma?,ssm_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,How pervasively is the PXN H359Y mutation present in Colon Adenocarcinoma?,ssm_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,How pervasively is the PXN H492Y mutation present in Colon Adenocarcinoma?,ssm_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,How pervasively is the PXN H524Y mutation present in Colon Adenocarcinoma?,ssm_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,How pervasively is the PXN H526Y mutation present in Colon Adenocarcinoma?,ssm_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,How pervasively is the PXN H540Y mutation present in Colon Adenocarcinoma?,ssm_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How pervasively is the TTYH2 S23L mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How pervasively is the TTYH2 S44L mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How pervasively is the TMEM255A N205S mutation present in Colon Adenocarcinoma?,ssm_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How pervasively is the TMEM255A N229S mutation present in Colon Adenocarcinoma?,ssm_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How pervasively is the TMEM255A N65S mutation present in Colon Adenocarcinoma?,ssm_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How pervasively is the TASOR2 H2271D mutation present in Breast Invasive Carcinoma?,ssm_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How pervasively is the TASOR2 H2486D mutation present in Breast Invasive Carcinoma?,ssm_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How pervasively is the ICE1 T1839M mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,How pervasively is the MYT1 A558E mutation present in Breast Invasive Carcinoma?,ssm_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,How pervasively is the MYT1 A879E mutation present in Breast Invasive Carcinoma?,ssm_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,How pervasively is the MYT1 A906E mutation present in Breast Invasive Carcinoma?,ssm_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How pervasively is the CX3CR1 P203L mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How pervasively is the CX3CR1 P235L mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How pervasively is the SPINDOC R197C mutation present in Liver Hepatocellular Carcinoma?,ssm_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How pervasively is the ART3 C251Y mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How pervasively is the ART3 C3Y mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How pervasively is the CYP1A2 R243G mutation present in Bladder Urothelial Carcinoma?,ssm_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How pervasively is the ADRA1A G279S mutation present in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How pervasively is the CDH23 P2523R mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How pervasively is the CDH23 P283R mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How pervasively is the KRT39 P137S mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How pervasively is the PDHA2 S7F mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How pervasively is the SLC24A2 H200Q mutation present in Colon Adenocarcinoma?,ssm_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How pervasively is the PTPRN2 F153L mutation present in Liver Hepatocellular Carcinoma?,ssm_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How pervasively is the PTPRN2 F847L mutation present in Liver Hepatocellular Carcinoma?,ssm_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How pervasively is the PTPRN2 F856L mutation present in Liver Hepatocellular Carcinoma?,ssm_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How pervasively is the PTPRN2 F868L mutation present in Liver Hepatocellular Carcinoma?,ssm_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How pervasively is the PTPRN2 F885L mutation present in Liver Hepatocellular Carcinoma?,ssm_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,How pervasively is the SOX21 R55L mutation present in Lung Adenocarcinoma?,ssm_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How pervasively is the CPA6 G166E mutation present in Bladder Urothelial Carcinoma?,ssm_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How pervasively is the GRM5 E14K mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How pervasively is the CASZ1 R233Q mutation present in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How pervasively is the SGIP1 N122T mutation present in Stomach Adenocarcinoma?,ssm_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How pervasively is the SGIP1 N420T mutation present in Stomach Adenocarcinoma?,ssm_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How pervasively is the SGIP1 N617T mutation present in Stomach Adenocarcinoma?,ssm_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How pervasively is the SGIP1 N648T mutation present in Stomach Adenocarcinoma?,ssm_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How pervasively is the CARMIL1 V549L mutation present in Lung Adenocarcinoma?,ssm_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How pervasively is the CARMIL1 V949L mutation present in Lung Adenocarcinoma?,ssm_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How pervasively is the ZNF431 D121Y mutation present in Lung Adenocarcinoma?,ssm_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How pervasively is the ZNF431 D161Y mutation present in Lung Adenocarcinoma?,ssm_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,How pervasively is the ZNF431 R128I mutation present in Lung Adenocarcinoma?,ssm_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How pervasively is the DNAH11 P2987S mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How pervasively is the DNAH11 P2994S mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How pervasively is the POLD1 Q461L mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How pervasively is the POLD1 Q85L mutation present in Lung Squamous Cell Carcinoma?,ssm_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,How pervasively is the TTC12 D646H mutation present in Lung Adenocarcinoma?,ssm_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,How pervasively is the TTC12 D652H mutation present in Lung Adenocarcinoma?,ssm_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How pervasively is the CNGB1 D967N mutation present in Bladder Urothelial Carcinoma?,ssm_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How pervasively is the CNGB1 D973N mutation present in Bladder Urothelial Carcinoma?,ssm_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,How pervasively is the CTSC E214V mutation present in Stomach Adenocarcinoma?,ssm_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,How pervasively is the CTSC E291V mutation present in Stomach Adenocarcinoma?,ssm_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,How pervasively is the CTSC E322V mutation present in Stomach Adenocarcinoma?,ssm_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,How pervasively is the CTSC E324V mutation present in Stomach Adenocarcinoma?,ssm_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,How pervasively is the CTSC E335V mutation present in Stomach Adenocarcinoma?,ssm_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How pervasively is the PRSS8 A179T mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How pervasively is the PRSS8 A233T mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How pervasively is the ARHGEF40 V864F mutation present in Lung Adenocarcinoma?,ssm_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,How pervasively is the ACTB A138T mutation present in Rectum Adenocarcinoma?,ssm_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,How pervasively is the ACTB A217T mutation present in Rectum Adenocarcinoma?,ssm_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,How pervasively is the ACTB A244T mutation present in Rectum Adenocarcinoma?,ssm_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,How pervasively is the ACTB A260T mutation present in Rectum Adenocarcinoma?,ssm_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How pervasively is the YY1AP1 V546D mutation present in Glioblastoma Multiforme?,ssm_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How pervasively is the YY1AP1 V557D mutation present in Glioblastoma Multiforme?,ssm_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How pervasively is the YY1AP1 V566D mutation present in Glioblastoma Multiforme?,ssm_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How pervasively is the YY1AP1 V577D mutation present in Glioblastoma Multiforme?,ssm_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How pervasively is the YY1AP1 V623D mutation present in Glioblastoma Multiforme?,ssm_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How pervasively is the YY1AP1 V695D mutation present in Glioblastoma Multiforme?,ssm_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How pervasively is the YY1AP1 V715D mutation present in Glioblastoma Multiforme?,ssm_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How pervasively is the FNDC7 D323N mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How pervasively is the FNDC7 D99N mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,How pervasively is the TLCD5 G15V mutation present in Lung Adenocarcinoma?,ssm_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,How pervasively is the TLCD5 G37V mutation present in Lung Adenocarcinoma?,ssm_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How pervasively is the POLR1G R498W mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How pervasively is the POLR1G R500W mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How pervasively is the DNAH14 N1186K mutation present in Colon Adenocarcinoma?,ssm_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How pervasively is the DNAH14 N2657K mutation present in Colon Adenocarcinoma?,ssm_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How pervasively is the DNAH14 N3460K mutation present in Colon Adenocarcinoma?,ssm_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How pervasively is the NEXN E73D mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How pervasively is the CYB5R2 G112R mutation present in Prostate Adenocarcinoma?,ssm_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How pervasively is the CYB5R2 G172R mutation present in Prostate Adenocarcinoma?,ssm_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How pervasively is the NRAP S808L mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How pervasively is the NRAP S816L mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How pervasively is the NRAP S843L mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How pervasively is the CCDC22 E179D mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How pervasively is the DCAF6 S402F mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How pervasively is the DCAF6 S433F mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How pervasively is the ZNF708 E389D mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How pervasively is the BFAR T103M mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How pervasively is the MAST4 P1237S mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How pervasively is the MAST4 P1986S mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How pervasively is the MAST4 P1991S mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How pervasively is the MAST4 P2001S mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How pervasively is the MAST4 P2180S mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How pervasively is the ARMC3 R169C mutation present in Stomach Adenocarcinoma?,ssm_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How pervasively is the ARMC3 R432C mutation present in Stomach Adenocarcinoma?,ssm_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How pervasively is the TET2 L757V mutation present in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How pervasively is the TET2 L778V mutation present in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How pervasively is the SERPINB10 A353P mutation present in Lung Adenocarcinoma?,ssm_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How pervasively is the STAT3 Y22H mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How pervasively is the MIEF1 A42T mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How pervasively is the ACVR1B D397N mutation present in Colon Adenocarcinoma?,ssm_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How pervasively is the ACVR1B D449N mutation present in Colon Adenocarcinoma?,ssm_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How pervasively is the ACVR1B D490N mutation present in Colon Adenocarcinoma?,ssm_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,How pervasively is the EBF2 T104I mutation present in Stomach Adenocarcinoma?,ssm_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,How pervasively is the EBF2 T252I mutation present in Stomach Adenocarcinoma?,ssm_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How pervasively is the VPS26B F266L mutation present in Stomach Adenocarcinoma?,ssm_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How pervasively is the PGR M106I mutation present in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How pervasively is the PGR M38I mutation present in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How pervasively is the PGR M632I mutation present in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How pervasively is the ACTA2 P334L mutation present in Skin Cutaneous Melanoma?,ssm_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How pervasively is the THBS4 T852I mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How pervasively is the THBS4 T943I mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,How pervasively is the PRSS1 S114T mutation present in Lung Adenocarcinoma?,ssm_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,How pervasively is the PRSS1 S124T mutation present in Lung Adenocarcinoma?,ssm_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,How pervasively is the PRSS1 S138T mutation present in Lung Adenocarcinoma?,ssm_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,How pervasively is the PRSS1 S74T mutation present in Lung Adenocarcinoma?,ssm_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,How pervasively is the PGF R126H mutation present in Stomach Adenocarcinoma?,ssm_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,How pervasively is the PGF R127H mutation present in Stomach Adenocarcinoma?,ssm_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How pervasively is the ITPRID2 S351C mutation present in Breast Invasive Carcinoma?,ssm_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How pervasively is the ITPRID2 S842C mutation present in Breast Invasive Carcinoma?,ssm_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How pervasively is the HBB E8D mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How pervasively is the PCDHB2 R158C mutation present in Colon Adenocarcinoma?,ssm_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How pervasively is the PCDHB2 T15M mutation present in Colon Adenocarcinoma?,ssm_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How pervasively is the PCDHB2 T26M mutation present in Colon Adenocarcinoma?,ssm_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How pervasively is the UBR2 P1594S mutation present in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How pervasively is the FBXO42 A618D mutation present in Rectum Adenocarcinoma?,ssm_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the occurrence of TNS1 G1362V mutation in Breast Invasive Carcinoma?,ssm_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the occurrence of TNS1 G1711V mutation in Breast Invasive Carcinoma?,ssm_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the occurrence of TNS1 G1718V mutation in Breast Invasive Carcinoma?,ssm_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the occurrence of TNS1 G1732V mutation in Breast Invasive Carcinoma?,ssm_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the occurrence of TNS1 G1824V mutation in Breast Invasive Carcinoma?,ssm_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the occurrence of TNS1 G1857V mutation in Breast Invasive Carcinoma?,ssm_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the occurrence of TNS1 G843V mutation in Breast Invasive Carcinoma?,ssm_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the occurrence of EVC2 E1067K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the occurrence of EVC2 E987K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CR1 V1108G mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CR1 V1558G mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the occurrence of TRPA1 S295I mutation in Rectum Adenocarcinoma?,ssm_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the occurrence of TRPA1 S443I mutation in Rectum Adenocarcinoma?,ssm_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the occurrence of TAF1C R299L mutation in Lung Adenocarcinoma?,ssm_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the occurrence of TAF1C R396L mutation in Lung Adenocarcinoma?,ssm_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the occurrence of TAF1C R634L mutation in Lung Adenocarcinoma?,ssm_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the occurrence of TAF1C R702L mutation in Lung Adenocarcinoma?,ssm_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the occurrence of TAF1C R728L mutation in Lung Adenocarcinoma?,ssm_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the occurrence of DPF3 R104W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the occurrence of DPF3 R149W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the occurrence of DPF3 R94W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the occurrence of OR2T4 P272H mutation in Lung Adenocarcinoma?,ssm_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the occurrence of OR2T4 P300H mutation in Lung Adenocarcinoma?,ssm_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the occurrence of FBN1 E2667K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the occurrence of MAD1L1 E396K mutation in Prostate Adenocarcinoma?,ssm_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the occurrence of MAD1L1 E488K mutation in Prostate Adenocarcinoma?,ssm_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the occurrence of MAD1L1 E78K mutation in Prostate Adenocarcinoma?,ssm_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the occurrence of CCNG1 E22K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the occurrence of ANP32E N114T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the occurrence of ANP32E N64T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the occurrence of ANP32E N66T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the occurrence of ANP32E N73T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the occurrence of FRY S1888A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the occurrence of FRY S1937A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the occurrence of FRY S1938A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the occurrence of FRY S1983A mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the occurrence of PAK3 E318K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the occurrence of PAK3 E319K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the occurrence of PAK3 E334K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the occurrence of PAK3 E340K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the occurrence of PAK3 E355K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the occurrence of MUC16 P7963L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the occurrence of ZFPM2 T498I mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the occurrence of ZFPM2 T630I mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the occurrence of PIK3C2B S1328C mutation in Breast Invasive Carcinoma?,ssm_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the occurrence of PIK3C2B S1356C mutation in Breast Invasive Carcinoma?,ssm_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the occurrence of ZNF804A S371Y mutation in Colon Adenocarcinoma?,ssm_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the occurrence of RELN A2371V mutation in Stomach Adenocarcinoma?,ssm_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of EFCAB12 R173C mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of EFCAB12 R23C mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the occurrence of DEFB115 E53K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the occurrence of ANKDD1A S290F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the occurrence of ANKDD1A S322F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the occurrence of ANKDD1A S413F mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the occurrence of HTR3B S146I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the occurrence of HTR3B S206I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the occurrence of HTR3B S217I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the occurrence of ABCC3 R758W mutation in Stomach Adenocarcinoma?,ssm_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the occurrence of NOMO1 T204I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the occurrence of NOMO1 T371I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the occurrence of HYOU1 D298H mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the occurrence of FMO4 R500Q mutation in Skin Cutaneous Melanoma?,ssm_frequency
+140,BICC1,A372V,Exceptional Responders,What is the occurrence of BICC1 A372V mutation in Exceptional Responders?,ssm_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the occurrence of ZMYM3 I920V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the occurrence of ZMYM3 I932V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the occurrence of ZMYM3 I934V mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of XKR4 R547W mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the occurrence of ABCC2 V239L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the occurrence of OR8K5 R293G mutation in Lung Adenocarcinoma?,ssm_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the occurrence of SPTAN1 S1503F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the occurrence of SPTAN1 S1523F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the occurrence of SYT10 M484I mutation in Rectum Adenocarcinoma?,ssm_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the occurrence of HSPA5 N457K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the occurrence of UNC5D L280V mutation in Lung Adenocarcinoma?,ssm_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the occurrence of UNC5D L635V mutation in Lung Adenocarcinoma?,ssm_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the occurrence of UNC5D L637V mutation in Lung Adenocarcinoma?,ssm_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the occurrence of UNC5D L699V mutation in Lung Adenocarcinoma?,ssm_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the occurrence of UNC5D L704V mutation in Lung Adenocarcinoma?,ssm_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the occurrence of UNC5D L709V mutation in Lung Adenocarcinoma?,ssm_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the occurrence of DOCK2 L1527H mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the occurrence of ZNF627 A5V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the occurrence of CDC42BPA L823F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the occurrence of MRPL55 H27Y mutation in Colon Adenocarcinoma?,ssm_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the occurrence of MRPL55 H63Y mutation in Colon Adenocarcinoma?,ssm_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the occurrence of TMTC3 Q749K mutation in Breast Invasive Carcinoma?,ssm_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the occurrence of EPRS1 K771I mutation in Colon Adenocarcinoma?,ssm_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the occurrence of EPRS1 K778I mutation in Colon Adenocarcinoma?,ssm_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the occurrence of GRTP1 A110V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the occurrence of GRTP1 A32V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the occurrence of TSHZ3 Q538K mutation in Stomach Adenocarcinoma?,ssm_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the occurrence of TAS1R3 Q326H mutation in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,ssm_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the occurrence of PIAS3 S238C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the occurrence of PIAS3 S273C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the occurrence of ZNF274 P13R mutation in Stomach Adenocarcinoma?,ssm_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the occurrence of SYNJ1 R795C mutation in Colon Adenocarcinoma?,ssm_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the occurrence of SYNJ1 R800C mutation in Colon Adenocarcinoma?,ssm_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the occurrence of SYNJ1 R839C mutation in Colon Adenocarcinoma?,ssm_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the occurrence of DSCAM V343M mutation in Prostate Adenocarcinoma?,ssm_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the occurrence of DSCAM V426M mutation in Prostate Adenocarcinoma?,ssm_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the occurrence of DSCAM V591M mutation in Prostate Adenocarcinoma?,ssm_frequency
+267,DGKD,R140H,Exceptional Responders,What is the occurrence of DGKD R140H mutation in Exceptional Responders?,ssm_frequency
+268,DGKD,R160H,Exceptional Responders,What is the occurrence of DGKD R160H mutation in Exceptional Responders?,ssm_frequency
+269,DGKD,R204H,Exceptional Responders,What is the occurrence of DGKD R204H mutation in Exceptional Responders?,ssm_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the occurrence of PLEKHG6 D105Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the occurrence of PLEKHG6 D543Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the occurrence of PLEKHG6 D575Y mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the occurrence of WNT2 D138N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the occurrence of GUCY2C G667R mutation in Skin Cutaneous Melanoma?,ssm_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the occurrence of C7orf31 P244H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of ZKSCAN7 E64K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+299,OR5D14,M210L,Neuroblastoma,What is the occurrence of OR5D14 M210L mutation in Neuroblastoma?,ssm_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the occurrence of SPATA22 K279E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the occurrence of SPATA22 K306E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the occurrence of SPATA22 K322E mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the occurrence of LCN15 E21V mutation in Stomach Adenocarcinoma?,ssm_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the occurrence of DCAF4L2 S129F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the occurrence of GUK1 R135P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the occurrence of GUK1 R137P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the occurrence of GUK1 R139P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the occurrence of GUK1 R158P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the occurrence of GUK1 R203P mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the occurrence of MORF4L1 K29T mutation in Stomach Adenocarcinoma?,ssm_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the occurrence of MORF4L1 K51T mutation in Stomach Adenocarcinoma?,ssm_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the occurrence of MORF4L1 K61T mutation in Stomach Adenocarcinoma?,ssm_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the occurrence of MORF4L1 K76T mutation in Stomach Adenocarcinoma?,ssm_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the occurrence of MYO3B F594L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the occurrence of MYO3B F603L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the occurrence of TENT5A S320F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the occurrence of TENT5A S339F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the occurrence of TENT5A S401F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the occurrence of ZFAT S614L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the occurrence of ZFAT S664L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the occurrence of ZFAT S676L mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+357,ZNF584,A211T,Sarcoma,What is the occurrence of ZNF584 A211T mutation in Sarcoma?,ssm_frequency
+358,ZNF584,A256T,Sarcoma,What is the occurrence of ZNF584 A256T mutation in Sarcoma?,ssm_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the occurrence of LDOC1 R63W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the occurrence of PDGFC R201G mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the occurrence of MSANTD4 R304C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the occurrence of NPSR1 S123L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the occurrence of PHLPP1 K1317E mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the occurrence of COL6A3 G237S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the occurrence of COL6A3 G437S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the occurrence of COL6A3 G638S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the occurrence of COL6A3 G644S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the occurrence of COL6A3 G844S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the occurrence of ADRA1A R348G mutation in Stomach Adenocarcinoma?,ssm_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the occurrence of LAMB2 S1254F mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the occurrence of POC1B I198T mutation in Rectum Adenocarcinoma?,ssm_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the occurrence of POC1B I286T mutation in Rectum Adenocarcinoma?,ssm_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the occurrence of POC1B I328T mutation in Rectum Adenocarcinoma?,ssm_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the occurrence of POC1B S79P mutation in Rectum Adenocarcinoma?,ssm_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the occurrence of USH2A G1451C mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the occurrence of AQP7 T110S mutation in Rectum Adenocarcinoma?,ssm_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the occurrence of AQP7 T166S mutation in Rectum Adenocarcinoma?,ssm_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the occurrence of AQP7 T167S mutation in Rectum Adenocarcinoma?,ssm_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the occurrence of AQP7 T75S mutation in Rectum Adenocarcinoma?,ssm_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,What is the occurrence of DCN R163C mutation in Rectum Adenocarcinoma?,ssm_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,What is the occurrence of DCN R203C mutation in Rectum Adenocarcinoma?,ssm_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,What is the occurrence of DCN R241C mutation in Rectum Adenocarcinoma?,ssm_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,What is the occurrence of DCN R350C mutation in Rectum Adenocarcinoma?,ssm_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,What is the occurrence of DCN R41C mutation in Rectum Adenocarcinoma?,ssm_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CPS1 K1269N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CPS1 K1275N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CPS1 K818N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the occurrence of FCGR2C P122S mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the occurrence of FCGR2C P123S mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the occurrence of GRM1 R280M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the occurrence of SGCZ Q138H mutation in Lung Adenocarcinoma?,ssm_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the occurrence of SGCZ Q91H mutation in Lung Adenocarcinoma?,ssm_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,What is the occurrence of SMO V15M mutation in Stomach Adenocarcinoma?,ssm_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,What is the occurrence of SMO V321M mutation in Stomach Adenocarcinoma?,ssm_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the occurrence of CHODL G159E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the occurrence of CHODL G181E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the occurrence of CHODL G200E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,What is the occurrence of MYO16 P399H mutation in Colon Adenocarcinoma?,ssm_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,What is the occurrence of MYO16 P421H mutation in Colon Adenocarcinoma?,ssm_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the occurrence of CXCR2 A98V mutation in Stomach Adenocarcinoma?,ssm_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the occurrence of TMEM225 L212V mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the occurrence of MAOB N251T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the occurrence of GPRASP1 F580S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the occurrence of MRPL32 R181Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the occurrence of TYROBP A29T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the occurrence of RAB40C A111V mutation in Lung Adenocarcinoma?,ssm_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the occurrence of RAB40C A143V mutation in Lung Adenocarcinoma?,ssm_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the occurrence of CTNNA2 S323R mutation in Lung Adenocarcinoma?,ssm_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the occurrence of CTNNA2 S339R mutation in Lung Adenocarcinoma?,ssm_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the occurrence of CTNNA2 S386R mutation in Lung Adenocarcinoma?,ssm_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the occurrence of CTNNA2 S707R mutation in Lung Adenocarcinoma?,ssm_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the occurrence of MYO15A S268R mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the occurrence of GIMAP2 A167T mutation in Skin Cutaneous Melanoma?,ssm_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the occurrence of KIF20B N1160D mutation in Glioblastoma Multiforme?,ssm_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the occurrence of KIF20B N1200D mutation in Glioblastoma Multiforme?,ssm_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the occurrence of ADAM17 E583K mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the occurrence of BCAT1 G16R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the occurrence of BCAT1 G17R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the occurrence of BCAT1 G29R mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the occurrence of ERCC6 R1053H mutation in Colon Adenocarcinoma?,ssm_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,What is the occurrence of DCC R320W mutation in Breast Invasive Carcinoma?,ssm_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,What is the occurrence of DCC R363W mutation in Breast Invasive Carcinoma?,ssm_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,What is the occurrence of DCC R386W mutation in Breast Invasive Carcinoma?,ssm_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,What is the occurrence of DCC R41W mutation in Breast Invasive Carcinoma?,ssm_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the occurrence of FBXO15 D417N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the occurrence of FBXO15 D86N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the occurrence of GSTCD S528F mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the occurrence of GSTCD S615F mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the occurrence of OLFML3 P296S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the occurrence of OLFML3 P337S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the occurrence of OLFML3 P357S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the occurrence of CFAP61 E173V mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the occurrence of CFAP61 E817V mutation in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the occurrence of HLA-DQA2 E51K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the occurrence of TENM2 H240Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the occurrence of TENM2 H351Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the occurrence of TENM2 H472Y mutation in Skin Cutaneous Melanoma?,ssm_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the occurrence of ANKRD24 A465T mutation in Stomach Adenocarcinoma?,ssm_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the occurrence of ANKRD24 A494T mutation in Stomach Adenocarcinoma?,ssm_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the occurrence of ANKRD24 A584T mutation in Stomach Adenocarcinoma?,ssm_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the occurrence of ZCCHC14 V549M mutation in Stomach Adenocarcinoma?,ssm_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the occurrence of ZCCHC14 V665M mutation in Stomach Adenocarcinoma?,ssm_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the occurrence of ZCCHC14 V676M mutation in Stomach Adenocarcinoma?,ssm_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the occurrence of ZCCHC14 V802M mutation in Stomach Adenocarcinoma?,ssm_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,What is the occurrence of SIK2 I265M mutation in Lung Adenocarcinoma?,ssm_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the occurrence of MYH11 T1336M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the occurrence of MYH11 T1343M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the occurrence of SLC6A4 S174F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the occurrence of SLC9C1 K102N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the occurrence of SLC9C1 K29N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the occurrence of OR2A12 A254T mutation in Brain Lower Grade Glioma?,ssm_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the occurrence of PYHIN1 T325K mutation in Lung Adenocarcinoma?,ssm_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the occurrence of PYHIN1 T334K mutation in Lung Adenocarcinoma?,ssm_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the occurrence of JAML G191E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the occurrence of JAML G219E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the occurrence of JAML G220E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the occurrence of JAML G230E mutation in Skin Cutaneous Melanoma?,ssm_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the occurrence of TYK2 H1146R mutation in Stomach Adenocarcinoma?,ssm_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the occurrence of TYK2 H23R mutation in Stomach Adenocarcinoma?,ssm_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the occurrence of TYK2 H961R mutation in Stomach Adenocarcinoma?,ssm_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CTCFL R208C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CTCFL R265C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CTCFL R420C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CTCFL R470C mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CEP20 R31Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CEP20 R58Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the occurrence of RIMS2 R25W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the occurrence of RIMS2 R393W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the occurrence of RIMS2 R423W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the occurrence of RIMS2 R470W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the occurrence of RIMS2 R615W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the occurrence of RIMS2 R619W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the occurrence of RIMS2 R716W mutation in Skin Cutaneous Melanoma?,ssm_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the occurrence of PIK3C2G S551L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the occurrence of PIK3C2G S592L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+728,STK19,D341N,Colon Adenocarcinoma,What is the occurrence of STK19 D341N mutation in Colon Adenocarcinoma?,ssm_frequency
+729,STK19,D345N,Colon Adenocarcinoma,What is the occurrence of STK19 D345N mutation in Colon Adenocarcinoma?,ssm_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the occurrence of REXO4 P60A mutation in Skin Cutaneous Melanoma?,ssm_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the occurrence of ZBTB34 P160S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the occurrence of ZBTB34 P164S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the occurrence of NCKAP5 E148K mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of SORCS1 D1052Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of SORCS1 D587Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of SORCS1 D67Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of SORCS1 D810Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the occurrence of FGF8 T154M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the occurrence of FGF8 T165M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the occurrence of FGF8 T183M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the occurrence of FGF8 T194M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the occurrence of FGF8 T90M mutation in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the occurrence of TENM3 R1877W mutation in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,ssm_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the occurrence of AKT1 D44N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the occurrence of CFAP298-TCP10L E11Q mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the occurrence of GLRB E148D mutation in Stomach Adenocarcinoma?,ssm_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,What is the occurrence of TTN F7636L mutation in Colon Adenocarcinoma?,ssm_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,What is the occurrence of TTN F8563L mutation in Colon Adenocarcinoma?,ssm_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,What is the occurrence of TTN F8880L mutation in Colon Adenocarcinoma?,ssm_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the occurrence of ANKRD30A V798I mutation in Colon Adenocarcinoma?,ssm_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the occurrence of ANKRD30A V854I mutation in Colon Adenocarcinoma?,ssm_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the occurrence of ANKRD30A V973I mutation in Colon Adenocarcinoma?,ssm_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the occurrence of TRIM45 S177L mutation in Colon Adenocarcinoma?,ssm_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the occurrence of TRIM45 S224L mutation in Colon Adenocarcinoma?,ssm_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the occurrence of TRIM45 S281L mutation in Colon Adenocarcinoma?,ssm_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the occurrence of CACNA1F G727V mutation in Stomach Adenocarcinoma?,ssm_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the occurrence of CACNA1F G781V mutation in Stomach Adenocarcinoma?,ssm_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the occurrence of CACNA1F G792V mutation in Stomach Adenocarcinoma?,ssm_frequency
+817,KL,R594C,Colon Adenocarcinoma,What is the occurrence of KL R594C mutation in Colon Adenocarcinoma?,ssm_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the occurrence of GUF1 I243T mutation in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the occurrence of TAF1L A539V mutation in Colon Adenocarcinoma?,ssm_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the occurrence of TASOR2 S256F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the occurrence of TASOR2 S36F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the occurrence of TASOR2 S471F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the occurrence of KDM5C R1151C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the occurrence of KDM5C R1177C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the occurrence of KDM5C R1217C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the occurrence of KDM5C R1218C mutation in Skin Cutaneous Melanoma?,ssm_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the occurrence of IL5RA L153F mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the occurrence of DHX16 A29V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the occurrence of DHX16 A89V mutation in Skin Cutaneous Melanoma?,ssm_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the occurrence of GPR158 A644V mutation in Stomach Adenocarcinoma?,ssm_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the occurrence of GPR158 A723V mutation in Stomach Adenocarcinoma?,ssm_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of EIF2B4 E108K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of EIF2B4 E110K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of EIF2B4 E111K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of EIF2B4 E131K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of EIF2B4 E132K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of EIF2B4 E96K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the occurrence of AUTS2 P136S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the occurrence of AUTS2 P218S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the occurrence of AUTS2 P233S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the occurrence of AUTS2 P313S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the occurrence of AUTS2 P419S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the occurrence of AUTS2 P443S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the occurrence of AUTS2 P56S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the occurrence of AUTS2 P667S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the occurrence of AUTS2 P690S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the occurrence of AUTS2 P691S mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of ACTL7B D223N mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the occurrence of PCDHGA1 R535W mutation in Glioblastoma Multiforme?,ssm_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the occurrence of TRAP1 R114W mutation in Stomach Adenocarcinoma?,ssm_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the occurrence of TRAP1 R61W mutation in Stomach Adenocarcinoma?,ssm_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the occurrence of PIK3C2A R1570Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the occurrence of KANSL1 R139G mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the occurrence of ANKRD52 Y594C mutation in Stomach Adenocarcinoma?,ssm_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the occurrence of PAPPA G1580S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the occurrence of B3GALNT1 V270A mutation in Rectum Adenocarcinoma?,ssm_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the occurrence of GABRA6 G115R mutation in Lung Adenocarcinoma?,ssm_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the occurrence of GABRA6 G122R mutation in Lung Adenocarcinoma?,ssm_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the occurrence of GABRA6 G165R mutation in Lung Adenocarcinoma?,ssm_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the occurrence of GABRA6 G175R mutation in Lung Adenocarcinoma?,ssm_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the occurrence of GABRA6 G70R mutation in Lung Adenocarcinoma?,ssm_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the occurrence of ZSCAN31 D9N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of MED16 L126P mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of MED16 L868P mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the occurrence of PTPRO E1060K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the occurrence of PTPRO E1088K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the occurrence of PTPRO E249K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the occurrence of PTPRO E265K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the occurrence of PTPRO E277K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the occurrence of PTPRO E67K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the occurrence of PTPRO E923K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the occurrence of PTPRO E940K mutation in Pancreatic Adenocarcinoma?,ssm_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CHMP7 D397N mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the occurrence of GPC3 I107N mutation in Stomach Adenocarcinoma?,ssm_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the occurrence of GPC3 I161N mutation in Stomach Adenocarcinoma?,ssm_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the occurrence of TLK2 V430L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the occurrence of TLK2 V515L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the occurrence of TLK2 V547L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the occurrence of TLK2 V579L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the occurrence of TLK2 V601L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the occurrence of ZNF217 E209Q mutation in Lung Adenocarcinoma?,ssm_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the occurrence of SYT9 V275L mutation in Lung Adenocarcinoma?,ssm_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the occurrence of SYT9 V307L mutation in Lung Adenocarcinoma?,ssm_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the occurrence of PKHD1L1 S2830N mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the occurrence of MYO3A Y1295C mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of VASN V318I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the occurrence of DNMT1 A1037T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the occurrence of DNMT1 A1053T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the occurrence of DNMT1 A934T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,What is the occurrence of CA9 E402K mutation in Colon Adenocarcinoma?,ssm_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the occurrence of TTC17 R808Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the occurrence of TTC17 R865Q mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the occurrence of PSG2 P43L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the occurrence of RIPOR2 R470L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the occurrence of RIPOR2 R499L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the occurrence of RIPOR2 R504L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the occurrence of RIPOR2 R520L mutation in Breast Invasive Carcinoma?,ssm_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the occurrence of DCLK3 V520I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the occurrence of DCLK3 V689I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the occurrence of MERTK G257A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the occurrence of MERTK G757A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the occurrence of MERTK G933A mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the occurrence of ZFP42 R206K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the occurrence of OR13C3 M117I mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the occurrence of OR13C3 M147I mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the occurrence of SPAG1 I917M mutation in Stomach Adenocarcinoma?,ssm_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CDKN2AIP Y92H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the occurrence of PXN H1016Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the occurrence of PXN H359Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the occurrence of PXN H492Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the occurrence of PXN H524Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the occurrence of PXN H526Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the occurrence of PXN H540Y mutation in Colon Adenocarcinoma?,ssm_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the occurrence of TTYH2 S23L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the occurrence of TTYH2 S44L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the occurrence of TMEM255A N205S mutation in Colon Adenocarcinoma?,ssm_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the occurrence of TMEM255A N229S mutation in Colon Adenocarcinoma?,ssm_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the occurrence of TMEM255A N65S mutation in Colon Adenocarcinoma?,ssm_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the occurrence of TASOR2 H2271D mutation in Breast Invasive Carcinoma?,ssm_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the occurrence of TASOR2 H2486D mutation in Breast Invasive Carcinoma?,ssm_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the occurrence of ICE1 T1839M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the occurrence of MYT1 A558E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the occurrence of MYT1 A879E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the occurrence of MYT1 A906E mutation in Breast Invasive Carcinoma?,ssm_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CX3CR1 P203L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CX3CR1 P235L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the occurrence of SPINDOC R197C mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the occurrence of ART3 C251Y mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the occurrence of ART3 C3Y mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the occurrence of CYP1A2 R243G mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of ADRA1A G279S mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the occurrence of CDH23 P2523R mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the occurrence of CDH23 P283R mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the occurrence of KRT39 P137S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the occurrence of PDHA2 S7F mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the occurrence of SLC24A2 H200Q mutation in Colon Adenocarcinoma?,ssm_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the occurrence of PTPRN2 F153L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the occurrence of PTPRN2 F847L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the occurrence of PTPRN2 F856L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the occurrence of PTPRN2 F868L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the occurrence of PTPRN2 F885L mutation in Liver Hepatocellular Carcinoma?,ssm_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the occurrence of SOX21 R55L mutation in Lung Adenocarcinoma?,ssm_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the occurrence of CPA6 G166E mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the occurrence of GRM5 E14K mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of CASZ1 R233Q mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the occurrence of SGIP1 N122T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the occurrence of SGIP1 N420T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the occurrence of SGIP1 N617T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the occurrence of SGIP1 N648T mutation in Stomach Adenocarcinoma?,ssm_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the occurrence of CARMIL1 V549L mutation in Lung Adenocarcinoma?,ssm_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the occurrence of CARMIL1 V949L mutation in Lung Adenocarcinoma?,ssm_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the occurrence of ZNF431 D121Y mutation in Lung Adenocarcinoma?,ssm_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the occurrence of ZNF431 D161Y mutation in Lung Adenocarcinoma?,ssm_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the occurrence of ZNF431 R128I mutation in Lung Adenocarcinoma?,ssm_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the occurrence of DNAH11 P2987S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the occurrence of DNAH11 P2994S mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the occurrence of POLD1 Q461L mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the occurrence of POLD1 Q85L mutation in Lung Squamous Cell Carcinoma?,ssm_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the occurrence of TTC12 D646H mutation in Lung Adenocarcinoma?,ssm_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the occurrence of TTC12 D652H mutation in Lung Adenocarcinoma?,ssm_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the occurrence of CNGB1 D967N mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the occurrence of CNGB1 D973N mutation in Bladder Urothelial Carcinoma?,ssm_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the occurrence of CTSC E214V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the occurrence of CTSC E291V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the occurrence of CTSC E322V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the occurrence of CTSC E324V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the occurrence of CTSC E335V mutation in Stomach Adenocarcinoma?,ssm_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the occurrence of PRSS8 A179T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the occurrence of PRSS8 A233T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the occurrence of ARHGEF40 V864F mutation in Lung Adenocarcinoma?,ssm_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the occurrence of ACTB A138T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the occurrence of ACTB A217T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the occurrence of ACTB A244T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the occurrence of ACTB A260T mutation in Rectum Adenocarcinoma?,ssm_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the occurrence of YY1AP1 V546D mutation in Glioblastoma Multiforme?,ssm_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the occurrence of YY1AP1 V557D mutation in Glioblastoma Multiforme?,ssm_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the occurrence of YY1AP1 V566D mutation in Glioblastoma Multiforme?,ssm_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the occurrence of YY1AP1 V577D mutation in Glioblastoma Multiforme?,ssm_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the occurrence of YY1AP1 V623D mutation in Glioblastoma Multiforme?,ssm_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the occurrence of YY1AP1 V695D mutation in Glioblastoma Multiforme?,ssm_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the occurrence of YY1AP1 V715D mutation in Glioblastoma Multiforme?,ssm_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the occurrence of FNDC7 D323N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the occurrence of FNDC7 D99N mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the occurrence of TLCD5 G15V mutation in Lung Adenocarcinoma?,ssm_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the occurrence of TLCD5 G37V mutation in Lung Adenocarcinoma?,ssm_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the occurrence of POLR1G R498W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the occurrence of POLR1G R500W mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the occurrence of DNAH14 N1186K mutation in Colon Adenocarcinoma?,ssm_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the occurrence of DNAH14 N2657K mutation in Colon Adenocarcinoma?,ssm_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the occurrence of DNAH14 N3460K mutation in Colon Adenocarcinoma?,ssm_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the occurrence of NEXN E73D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the occurrence of CYB5R2 G112R mutation in Prostate Adenocarcinoma?,ssm_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the occurrence of CYB5R2 G172R mutation in Prostate Adenocarcinoma?,ssm_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the occurrence of NRAP S808L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the occurrence of NRAP S816L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the occurrence of NRAP S843L mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CCDC22 E179D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the occurrence of DCAF6 S402F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the occurrence of DCAF6 S433F mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the occurrence of ZNF708 E389D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the occurrence of BFAR T103M mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the occurrence of MAST4 P1237S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the occurrence of MAST4 P1986S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the occurrence of MAST4 P1991S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the occurrence of MAST4 P2001S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the occurrence of MAST4 P2180S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the occurrence of ARMC3 R169C mutation in Stomach Adenocarcinoma?,ssm_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the occurrence of ARMC3 R432C mutation in Stomach Adenocarcinoma?,ssm_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the occurrence of TET2 L757V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the occurrence of TET2 L778V mutation in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the occurrence of SERPINB10 A353P mutation in Lung Adenocarcinoma?,ssm_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the occurrence of STAT3 Y22H mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the occurrence of MIEF1 A42T mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the occurrence of ACVR1B D397N mutation in Colon Adenocarcinoma?,ssm_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the occurrence of ACVR1B D449N mutation in Colon Adenocarcinoma?,ssm_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the occurrence of ACVR1B D490N mutation in Colon Adenocarcinoma?,ssm_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the occurrence of EBF2 T104I mutation in Stomach Adenocarcinoma?,ssm_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the occurrence of EBF2 T252I mutation in Stomach Adenocarcinoma?,ssm_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the occurrence of VPS26B F266L mutation in Stomach Adenocarcinoma?,ssm_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of PGR M106I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of PGR M38I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of PGR M632I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the occurrence of ACTA2 P334L mutation in Skin Cutaneous Melanoma?,ssm_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the occurrence of THBS4 T852I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the occurrence of THBS4 T943I mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the occurrence of PRSS1 S114T mutation in Lung Adenocarcinoma?,ssm_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the occurrence of PRSS1 S124T mutation in Lung Adenocarcinoma?,ssm_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the occurrence of PRSS1 S138T mutation in Lung Adenocarcinoma?,ssm_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the occurrence of PRSS1 S74T mutation in Lung Adenocarcinoma?,ssm_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the occurrence of PGF R126H mutation in Stomach Adenocarcinoma?,ssm_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the occurrence of PGF R127H mutation in Stomach Adenocarcinoma?,ssm_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the occurrence of ITPRID2 S351C mutation in Breast Invasive Carcinoma?,ssm_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the occurrence of ITPRID2 S842C mutation in Breast Invasive Carcinoma?,ssm_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the occurrence of HBB E8D mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the occurrence of PCDHB2 R158C mutation in Colon Adenocarcinoma?,ssm_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the occurrence of PCDHB2 T15M mutation in Colon Adenocarcinoma?,ssm_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the occurrence of PCDHB2 T26M mutation in Colon Adenocarcinoma?,ssm_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the occurrence of UBR2 P1594S mutation in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the occurrence of FBXO42 A618D mutation in Rectum Adenocarcinoma?,ssm_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the TNS1 G1362V mutation rate in Breast Invasive Carcinoma?,ssm_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the TNS1 G1711V mutation rate in Breast Invasive Carcinoma?,ssm_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the TNS1 G1718V mutation rate in Breast Invasive Carcinoma?,ssm_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the TNS1 G1732V mutation rate in Breast Invasive Carcinoma?,ssm_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the TNS1 G1824V mutation rate in Breast Invasive Carcinoma?,ssm_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the TNS1 G1857V mutation rate in Breast Invasive Carcinoma?,ssm_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the TNS1 G843V mutation rate in Breast Invasive Carcinoma?,ssm_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the EVC2 E1067K mutation rate in Bladder Urothelial Carcinoma?,ssm_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the EVC2 E987K mutation rate in Bladder Urothelial Carcinoma?,ssm_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the CR1 V1108G mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the CR1 V1558G mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the TRPA1 S295I mutation rate in Rectum Adenocarcinoma?,ssm_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the TRPA1 S443I mutation rate in Rectum Adenocarcinoma?,ssm_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the TAF1C R299L mutation rate in Lung Adenocarcinoma?,ssm_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the TAF1C R396L mutation rate in Lung Adenocarcinoma?,ssm_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the TAF1C R634L mutation rate in Lung Adenocarcinoma?,ssm_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the TAF1C R702L mutation rate in Lung Adenocarcinoma?,ssm_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the TAF1C R728L mutation rate in Lung Adenocarcinoma?,ssm_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the DPF3 R104W mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the DPF3 R149W mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the DPF3 R94W mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the OR2T4 P272H mutation rate in Lung Adenocarcinoma?,ssm_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the OR2T4 P300H mutation rate in Lung Adenocarcinoma?,ssm_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the FBN1 E2667K mutation rate in Pancreatic Adenocarcinoma?,ssm_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the MAD1L1 E396K mutation rate in Prostate Adenocarcinoma?,ssm_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the MAD1L1 E488K mutation rate in Prostate Adenocarcinoma?,ssm_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the MAD1L1 E78K mutation rate in Prostate Adenocarcinoma?,ssm_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the CCNG1 E22K mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the ANP32E N114T mutation rate in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the ANP32E N64T mutation rate in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the ANP32E N66T mutation rate in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the ANP32E N73T mutation rate in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the FRY S1888A mutation rate in Bladder Urothelial Carcinoma?,ssm_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the FRY S1937A mutation rate in Bladder Urothelial Carcinoma?,ssm_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the FRY S1938A mutation rate in Bladder Urothelial Carcinoma?,ssm_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the FRY S1983A mutation rate in Bladder Urothelial Carcinoma?,ssm_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the PAK3 E318K mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the PAK3 E319K mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the PAK3 E334K mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the PAK3 E340K mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the PAK3 E355K mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the MUC16 P7963L mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the ZFPM2 T498I mutation rate in Liver Hepatocellular Carcinoma?,ssm_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the ZFPM2 T630I mutation rate in Liver Hepatocellular Carcinoma?,ssm_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the PIK3C2B S1328C mutation rate in Breast Invasive Carcinoma?,ssm_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the PIK3C2B S1356C mutation rate in Breast Invasive Carcinoma?,ssm_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the ZNF804A S371Y mutation rate in Colon Adenocarcinoma?,ssm_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the RELN A2371V mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the EFCAB12 R173C mutation rate in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the EFCAB12 R23C mutation rate in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the DEFB115 E53K mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the ANKDD1A S290F mutation rate in Bladder Urothelial Carcinoma?,ssm_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the ANKDD1A S322F mutation rate in Bladder Urothelial Carcinoma?,ssm_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the ANKDD1A S413F mutation rate in Bladder Urothelial Carcinoma?,ssm_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the HTR3B S146I mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the HTR3B S206I mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the HTR3B S217I mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the ABCC3 R758W mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the NOMO1 T204I mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the NOMO1 T371I mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the HYOU1 D298H mutation rate in Bladder Urothelial Carcinoma?,ssm_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the FMO4 R500Q mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+140,BICC1,A372V,Exceptional Responders,What is the BICC1 A372V mutation rate in Exceptional Responders?,ssm_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the ZMYM3 I920V mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the ZMYM3 I932V mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the ZMYM3 I934V mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the XKR4 R547W mutation rate in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the ABCC2 V239L mutation rate in Liver Hepatocellular Carcinoma?,ssm_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the OR8K5 R293G mutation rate in Lung Adenocarcinoma?,ssm_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the SPTAN1 S1503F mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the SPTAN1 S1523F mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the SYT10 M484I mutation rate in Rectum Adenocarcinoma?,ssm_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the HSPA5 N457K mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the UNC5D L280V mutation rate in Lung Adenocarcinoma?,ssm_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the UNC5D L635V mutation rate in Lung Adenocarcinoma?,ssm_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the UNC5D L637V mutation rate in Lung Adenocarcinoma?,ssm_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the UNC5D L699V mutation rate in Lung Adenocarcinoma?,ssm_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the UNC5D L704V mutation rate in Lung Adenocarcinoma?,ssm_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the UNC5D L709V mutation rate in Lung Adenocarcinoma?,ssm_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the DOCK2 L1527H mutation rate in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the ZNF627 A5V mutation rate in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the CDC42BPA L823F mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the MRPL55 H27Y mutation rate in Colon Adenocarcinoma?,ssm_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the MRPL55 H63Y mutation rate in Colon Adenocarcinoma?,ssm_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the TMTC3 Q749K mutation rate in Breast Invasive Carcinoma?,ssm_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the EPRS1 K771I mutation rate in Colon Adenocarcinoma?,ssm_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the EPRS1 K778I mutation rate in Colon Adenocarcinoma?,ssm_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the GRTP1 A110V mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the GRTP1 A32V mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the TSHZ3 Q538K mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the TAS1R3 Q326H mutation rate in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,ssm_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the PIAS3 S238C mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the PIAS3 S273C mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the ZNF274 P13R mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the SYNJ1 R795C mutation rate in Colon Adenocarcinoma?,ssm_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the SYNJ1 R800C mutation rate in Colon Adenocarcinoma?,ssm_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the SYNJ1 R839C mutation rate in Colon Adenocarcinoma?,ssm_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the DSCAM V343M mutation rate in Prostate Adenocarcinoma?,ssm_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the DSCAM V426M mutation rate in Prostate Adenocarcinoma?,ssm_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the DSCAM V591M mutation rate in Prostate Adenocarcinoma?,ssm_frequency
+267,DGKD,R140H,Exceptional Responders,What is the DGKD R140H mutation rate in Exceptional Responders?,ssm_frequency
+268,DGKD,R160H,Exceptional Responders,What is the DGKD R160H mutation rate in Exceptional Responders?,ssm_frequency
+269,DGKD,R204H,Exceptional Responders,What is the DGKD R204H mutation rate in Exceptional Responders?,ssm_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the PLEKHG6 D105Y mutation rate in Bladder Urothelial Carcinoma?,ssm_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the PLEKHG6 D543Y mutation rate in Bladder Urothelial Carcinoma?,ssm_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the PLEKHG6 D575Y mutation rate in Bladder Urothelial Carcinoma?,ssm_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the WNT2 D138N mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the GUCY2C G667R mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the C7orf31 P244H mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the ZKSCAN7 E64K mutation rate in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+299,OR5D14,M210L,Neuroblastoma,What is the OR5D14 M210L mutation rate in Neuroblastoma?,ssm_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the SPATA22 K279E mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the SPATA22 K306E mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the SPATA22 K322E mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the LCN15 E21V mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the DCAF4L2 S129F mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the GUK1 R135P mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the GUK1 R137P mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the GUK1 R139P mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the GUK1 R158P mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the GUK1 R203P mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the MORF4L1 K29T mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the MORF4L1 K51T mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the MORF4L1 K61T mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the MORF4L1 K76T mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the MYO3B F594L mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the MYO3B F603L mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the TENT5A S320F mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the TENT5A S339F mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the TENT5A S401F mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the ZFAT S614L mutation rate in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the ZFAT S664L mutation rate in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the ZFAT S676L mutation rate in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+357,ZNF584,A211T,Sarcoma,What is the ZNF584 A211T mutation rate in Sarcoma?,ssm_frequency
+358,ZNF584,A256T,Sarcoma,What is the ZNF584 A256T mutation rate in Sarcoma?,ssm_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the LDOC1 R63W mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the PDGFC R201G mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the MSANTD4 R304C mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the NPSR1 S123L mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the PHLPP1 K1317E mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the COL6A3 G237S mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the COL6A3 G437S mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the COL6A3 G638S mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the COL6A3 G644S mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the COL6A3 G844S mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the ADRA1A R348G mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the LAMB2 S1254F mutation rate in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the POC1B I198T mutation rate in Rectum Adenocarcinoma?,ssm_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the POC1B I286T mutation rate in Rectum Adenocarcinoma?,ssm_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the POC1B I328T mutation rate in Rectum Adenocarcinoma?,ssm_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the POC1B S79P mutation rate in Rectum Adenocarcinoma?,ssm_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the USH2A G1451C mutation rate in Liver Hepatocellular Carcinoma?,ssm_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the AQP7 T110S mutation rate in Rectum Adenocarcinoma?,ssm_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the AQP7 T166S mutation rate in Rectum Adenocarcinoma?,ssm_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the AQP7 T167S mutation rate in Rectum Adenocarcinoma?,ssm_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the AQP7 T75S mutation rate in Rectum Adenocarcinoma?,ssm_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,What is the DCN R163C mutation rate in Rectum Adenocarcinoma?,ssm_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,What is the DCN R203C mutation rate in Rectum Adenocarcinoma?,ssm_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,What is the DCN R241C mutation rate in Rectum Adenocarcinoma?,ssm_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,What is the DCN R350C mutation rate in Rectum Adenocarcinoma?,ssm_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,What is the DCN R41C mutation rate in Rectum Adenocarcinoma?,ssm_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the CPS1 K1269N mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the CPS1 K1275N mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the CPS1 K818N mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the FCGR2C P122S mutation rate in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the FCGR2C P123S mutation rate in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the GRM1 R280M mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the SGCZ Q138H mutation rate in Lung Adenocarcinoma?,ssm_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the SGCZ Q91H mutation rate in Lung Adenocarcinoma?,ssm_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,What is the SMO V15M mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,What is the SMO V321M mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the CHODL G159E mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the CHODL G181E mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the CHODL G200E mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,What is the MYO16 P399H mutation rate in Colon Adenocarcinoma?,ssm_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,What is the MYO16 P421H mutation rate in Colon Adenocarcinoma?,ssm_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the CXCR2 A98V mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the TMEM225 L212V mutation rate in Bladder Urothelial Carcinoma?,ssm_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the MAOB N251T mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the GPRASP1 F580S mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the MRPL32 R181Q mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the TYROBP A29T mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the RAB40C A111V mutation rate in Lung Adenocarcinoma?,ssm_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the RAB40C A143V mutation rate in Lung Adenocarcinoma?,ssm_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the CTNNA2 S323R mutation rate in Lung Adenocarcinoma?,ssm_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the CTNNA2 S339R mutation rate in Lung Adenocarcinoma?,ssm_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the CTNNA2 S386R mutation rate in Lung Adenocarcinoma?,ssm_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the CTNNA2 S707R mutation rate in Lung Adenocarcinoma?,ssm_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the MYO15A S268R mutation rate in Bladder Urothelial Carcinoma?,ssm_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the GIMAP2 A167T mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the KIF20B N1160D mutation rate in Glioblastoma Multiforme?,ssm_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the KIF20B N1200D mutation rate in Glioblastoma Multiforme?,ssm_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the ADAM17 E583K mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the BCAT1 G16R mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the BCAT1 G17R mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the BCAT1 G29R mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the ERCC6 R1053H mutation rate in Colon Adenocarcinoma?,ssm_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,What is the DCC R320W mutation rate in Breast Invasive Carcinoma?,ssm_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,What is the DCC R363W mutation rate in Breast Invasive Carcinoma?,ssm_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,What is the DCC R386W mutation rate in Breast Invasive Carcinoma?,ssm_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,What is the DCC R41W mutation rate in Breast Invasive Carcinoma?,ssm_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the FBXO15 D417N mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the FBXO15 D86N mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the GSTCD S528F mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the GSTCD S615F mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the OLFML3 P296S mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the OLFML3 P337S mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the OLFML3 P357S mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the CFAP61 E173V mutation rate in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the CFAP61 E817V mutation rate in Ovarian Serous Cystadenocarcinoma?,ssm_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the HLA-DQA2 E51K mutation rate in Bladder Urothelial Carcinoma?,ssm_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the TENM2 H240Y mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the TENM2 H351Y mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the TENM2 H472Y mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the ANKRD24 A465T mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the ANKRD24 A494T mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the ANKRD24 A584T mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the ZCCHC14 V549M mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the ZCCHC14 V665M mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the ZCCHC14 V676M mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the ZCCHC14 V802M mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,What is the SIK2 I265M mutation rate in Lung Adenocarcinoma?,ssm_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the MYH11 T1336M mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the MYH11 T1343M mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the SLC6A4 S174F mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the SLC9C1 K102N mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the SLC9C1 K29N mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the OR2A12 A254T mutation rate in Brain Lower Grade Glioma?,ssm_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the PYHIN1 T325K mutation rate in Lung Adenocarcinoma?,ssm_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the PYHIN1 T334K mutation rate in Lung Adenocarcinoma?,ssm_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the JAML G191E mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the JAML G219E mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the JAML G220E mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the JAML G230E mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the TYK2 H1146R mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the TYK2 H23R mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the TYK2 H961R mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the CTCFL R208C mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the CTCFL R265C mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the CTCFL R420C mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the CTCFL R470C mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the CEP20 R31Q mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the CEP20 R58Q mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the RIMS2 R25W mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the RIMS2 R393W mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the RIMS2 R423W mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the RIMS2 R470W mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the RIMS2 R615W mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the RIMS2 R619W mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the RIMS2 R716W mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the PIK3C2G S551L mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the PIK3C2G S592L mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+728,STK19,D341N,Colon Adenocarcinoma,What is the STK19 D341N mutation rate in Colon Adenocarcinoma?,ssm_frequency
+729,STK19,D345N,Colon Adenocarcinoma,What is the STK19 D345N mutation rate in Colon Adenocarcinoma?,ssm_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the REXO4 P60A mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the ZBTB34 P160S mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the ZBTB34 P164S mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the NCKAP5 E148K mutation rate in Bladder Urothelial Carcinoma?,ssm_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the SORCS1 D1052Y mutation rate in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the SORCS1 D587Y mutation rate in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the SORCS1 D67Y mutation rate in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the SORCS1 D810Y mutation rate in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the FGF8 T154M mutation rate in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the FGF8 T165M mutation rate in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the FGF8 T183M mutation rate in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the FGF8 T194M mutation rate in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the FGF8 T90M mutation rate in Head and Neck Squamous Cell Carcinoma?,ssm_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the TENM3 R1877W mutation rate in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,ssm_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the AKT1 D44N mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the CFAP298-TCP10L E11Q mutation rate in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the GLRB E148D mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,What is the TTN F7636L mutation rate in Colon Adenocarcinoma?,ssm_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,What is the TTN F8563L mutation rate in Colon Adenocarcinoma?,ssm_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,What is the TTN F8880L mutation rate in Colon Adenocarcinoma?,ssm_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the ANKRD30A V798I mutation rate in Colon Adenocarcinoma?,ssm_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the ANKRD30A V854I mutation rate in Colon Adenocarcinoma?,ssm_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the ANKRD30A V973I mutation rate in Colon Adenocarcinoma?,ssm_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the TRIM45 S177L mutation rate in Colon Adenocarcinoma?,ssm_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the TRIM45 S224L mutation rate in Colon Adenocarcinoma?,ssm_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the TRIM45 S281L mutation rate in Colon Adenocarcinoma?,ssm_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the CACNA1F G727V mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the CACNA1F G781V mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the CACNA1F G792V mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+817,KL,R594C,Colon Adenocarcinoma,What is the KL R594C mutation rate in Colon Adenocarcinoma?,ssm_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the GUF1 I243T mutation rate in Kidney Renal Papillary Cell Carcinoma?,ssm_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the TAF1L A539V mutation rate in Colon Adenocarcinoma?,ssm_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the TASOR2 S256F mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the TASOR2 S36F mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the TASOR2 S471F mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the KDM5C R1151C mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the KDM5C R1177C mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the KDM5C R1217C mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the KDM5C R1218C mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the IL5RA L153F mutation rate in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the DHX16 A29V mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the DHX16 A89V mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the GPR158 A644V mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the GPR158 A723V mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the EIF2B4 E108K mutation rate in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the EIF2B4 E110K mutation rate in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the EIF2B4 E111K mutation rate in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the EIF2B4 E131K mutation rate in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the EIF2B4 E132K mutation rate in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the EIF2B4 E96K mutation rate in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the AUTS2 P136S mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the AUTS2 P218S mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the AUTS2 P233S mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the AUTS2 P313S mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the AUTS2 P419S mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the AUTS2 P443S mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the AUTS2 P56S mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the AUTS2 P667S mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the AUTS2 P690S mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the AUTS2 P691S mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the ACTL7B D223N mutation rate in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the PCDHGA1 R535W mutation rate in Glioblastoma Multiforme?,ssm_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the TRAP1 R114W mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the TRAP1 R61W mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the PIK3C2A R1570Q mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the KANSL1 R139G mutation rate in Liver Hepatocellular Carcinoma?,ssm_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the ANKRD52 Y594C mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the PAPPA G1580S mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the B3GALNT1 V270A mutation rate in Rectum Adenocarcinoma?,ssm_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the GABRA6 G115R mutation rate in Lung Adenocarcinoma?,ssm_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the GABRA6 G122R mutation rate in Lung Adenocarcinoma?,ssm_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the GABRA6 G165R mutation rate in Lung Adenocarcinoma?,ssm_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the GABRA6 G175R mutation rate in Lung Adenocarcinoma?,ssm_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the GABRA6 G70R mutation rate in Lung Adenocarcinoma?,ssm_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the ZSCAN31 D9N mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the MED16 L126P mutation rate in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the MED16 L868P mutation rate in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the PTPRO E1060K mutation rate in Pancreatic Adenocarcinoma?,ssm_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the PTPRO E1088K mutation rate in Pancreatic Adenocarcinoma?,ssm_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the PTPRO E249K mutation rate in Pancreatic Adenocarcinoma?,ssm_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the PTPRO E265K mutation rate in Pancreatic Adenocarcinoma?,ssm_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the PTPRO E277K mutation rate in Pancreatic Adenocarcinoma?,ssm_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the PTPRO E67K mutation rate in Pancreatic Adenocarcinoma?,ssm_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the PTPRO E923K mutation rate in Pancreatic Adenocarcinoma?,ssm_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the PTPRO E940K mutation rate in Pancreatic Adenocarcinoma?,ssm_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the CHMP7 D397N mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the GPC3 I107N mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the GPC3 I161N mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the TLK2 V430L mutation rate in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the TLK2 V515L mutation rate in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the TLK2 V547L mutation rate in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the TLK2 V579L mutation rate in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the TLK2 V601L mutation rate in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,ssm_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the ZNF217 E209Q mutation rate in Lung Adenocarcinoma?,ssm_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the SYT9 V275L mutation rate in Lung Adenocarcinoma?,ssm_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the SYT9 V307L mutation rate in Lung Adenocarcinoma?,ssm_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the PKHD1L1 S2830N mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the MYO3A Y1295C mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the VASN V318I mutation rate in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the DNMT1 A1037T mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the DNMT1 A1053T mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the DNMT1 A934T mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,What is the CA9 E402K mutation rate in Colon Adenocarcinoma?,ssm_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the TTC17 R808Q mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the TTC17 R865Q mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the PSG2 P43L mutation rate in Breast Invasive Carcinoma?,ssm_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the RIPOR2 R470L mutation rate in Breast Invasive Carcinoma?,ssm_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the RIPOR2 R499L mutation rate in Breast Invasive Carcinoma?,ssm_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the RIPOR2 R504L mutation rate in Breast Invasive Carcinoma?,ssm_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the RIPOR2 R520L mutation rate in Breast Invasive Carcinoma?,ssm_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the DCLK3 V520I mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the DCLK3 V689I mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the MERTK G257A mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the MERTK G757A mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the MERTK G933A mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the ZFP42 R206K mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the OR13C3 M117I mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the OR13C3 M147I mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the SPAG1 I917M mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the CDKN2AIP Y92H mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the PXN H1016Y mutation rate in Colon Adenocarcinoma?,ssm_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the PXN H359Y mutation rate in Colon Adenocarcinoma?,ssm_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the PXN H492Y mutation rate in Colon Adenocarcinoma?,ssm_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the PXN H524Y mutation rate in Colon Adenocarcinoma?,ssm_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the PXN H526Y mutation rate in Colon Adenocarcinoma?,ssm_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the PXN H540Y mutation rate in Colon Adenocarcinoma?,ssm_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the TTYH2 S23L mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the TTYH2 S44L mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the TMEM255A N205S mutation rate in Colon Adenocarcinoma?,ssm_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the TMEM255A N229S mutation rate in Colon Adenocarcinoma?,ssm_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the TMEM255A N65S mutation rate in Colon Adenocarcinoma?,ssm_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the TASOR2 H2271D mutation rate in Breast Invasive Carcinoma?,ssm_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the TASOR2 H2486D mutation rate in Breast Invasive Carcinoma?,ssm_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the ICE1 T1839M mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the MYT1 A558E mutation rate in Breast Invasive Carcinoma?,ssm_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the MYT1 A879E mutation rate in Breast Invasive Carcinoma?,ssm_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the MYT1 A906E mutation rate in Breast Invasive Carcinoma?,ssm_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the CX3CR1 P203L mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the CX3CR1 P235L mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the SPINDOC R197C mutation rate in Liver Hepatocellular Carcinoma?,ssm_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the ART3 C251Y mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the ART3 C3Y mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the CYP1A2 R243G mutation rate in Bladder Urothelial Carcinoma?,ssm_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the ADRA1A G279S mutation rate in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the CDH23 P2523R mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the CDH23 P283R mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the KRT39 P137S mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the PDHA2 S7F mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the SLC24A2 H200Q mutation rate in Colon Adenocarcinoma?,ssm_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the PTPRN2 F153L mutation rate in Liver Hepatocellular Carcinoma?,ssm_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the PTPRN2 F847L mutation rate in Liver Hepatocellular Carcinoma?,ssm_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the PTPRN2 F856L mutation rate in Liver Hepatocellular Carcinoma?,ssm_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the PTPRN2 F868L mutation rate in Liver Hepatocellular Carcinoma?,ssm_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the PTPRN2 F885L mutation rate in Liver Hepatocellular Carcinoma?,ssm_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the SOX21 R55L mutation rate in Lung Adenocarcinoma?,ssm_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the CPA6 G166E mutation rate in Bladder Urothelial Carcinoma?,ssm_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the GRM5 E14K mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the CASZ1 R233Q mutation rate in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the SGIP1 N122T mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the SGIP1 N420T mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the SGIP1 N617T mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the SGIP1 N648T mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the CARMIL1 V549L mutation rate in Lung Adenocarcinoma?,ssm_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the CARMIL1 V949L mutation rate in Lung Adenocarcinoma?,ssm_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the ZNF431 D121Y mutation rate in Lung Adenocarcinoma?,ssm_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the ZNF431 D161Y mutation rate in Lung Adenocarcinoma?,ssm_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the ZNF431 R128I mutation rate in Lung Adenocarcinoma?,ssm_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the DNAH11 P2987S mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the DNAH11 P2994S mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the POLD1 Q461L mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the POLD1 Q85L mutation rate in Lung Squamous Cell Carcinoma?,ssm_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the TTC12 D646H mutation rate in Lung Adenocarcinoma?,ssm_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the TTC12 D652H mutation rate in Lung Adenocarcinoma?,ssm_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the CNGB1 D967N mutation rate in Bladder Urothelial Carcinoma?,ssm_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the CNGB1 D973N mutation rate in Bladder Urothelial Carcinoma?,ssm_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the CTSC E214V mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the CTSC E291V mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the CTSC E322V mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the CTSC E324V mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the CTSC E335V mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the PRSS8 A179T mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the PRSS8 A233T mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the ARHGEF40 V864F mutation rate in Lung Adenocarcinoma?,ssm_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the ACTB A138T mutation rate in Rectum Adenocarcinoma?,ssm_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the ACTB A217T mutation rate in Rectum Adenocarcinoma?,ssm_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the ACTB A244T mutation rate in Rectum Adenocarcinoma?,ssm_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the ACTB A260T mutation rate in Rectum Adenocarcinoma?,ssm_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the YY1AP1 V546D mutation rate in Glioblastoma Multiforme?,ssm_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the YY1AP1 V557D mutation rate in Glioblastoma Multiforme?,ssm_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the YY1AP1 V566D mutation rate in Glioblastoma Multiforme?,ssm_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the YY1AP1 V577D mutation rate in Glioblastoma Multiforme?,ssm_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the YY1AP1 V623D mutation rate in Glioblastoma Multiforme?,ssm_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the YY1AP1 V695D mutation rate in Glioblastoma Multiforme?,ssm_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the YY1AP1 V715D mutation rate in Glioblastoma Multiforme?,ssm_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the FNDC7 D323N mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the FNDC7 D99N mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the TLCD5 G15V mutation rate in Lung Adenocarcinoma?,ssm_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the TLCD5 G37V mutation rate in Lung Adenocarcinoma?,ssm_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the POLR1G R498W mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the POLR1G R500W mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the DNAH14 N1186K mutation rate in Colon Adenocarcinoma?,ssm_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the DNAH14 N2657K mutation rate in Colon Adenocarcinoma?,ssm_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the DNAH14 N3460K mutation rate in Colon Adenocarcinoma?,ssm_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the NEXN E73D mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the CYB5R2 G112R mutation rate in Prostate Adenocarcinoma?,ssm_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the CYB5R2 G172R mutation rate in Prostate Adenocarcinoma?,ssm_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the NRAP S808L mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the NRAP S816L mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the NRAP S843L mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the CCDC22 E179D mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the DCAF6 S402F mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the DCAF6 S433F mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the ZNF708 E389D mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the BFAR T103M mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the MAST4 P1237S mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the MAST4 P1986S mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the MAST4 P1991S mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the MAST4 P2001S mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the MAST4 P2180S mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the ARMC3 R169C mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the ARMC3 R432C mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the TET2 L757V mutation rate in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the TET2 L778V mutation rate in Kidney Renal Clear Cell Carcinoma?,ssm_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the SERPINB10 A353P mutation rate in Lung Adenocarcinoma?,ssm_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the STAT3 Y22H mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the MIEF1 A42T mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the ACVR1B D397N mutation rate in Colon Adenocarcinoma?,ssm_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the ACVR1B D449N mutation rate in Colon Adenocarcinoma?,ssm_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the ACVR1B D490N mutation rate in Colon Adenocarcinoma?,ssm_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the EBF2 T104I mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the EBF2 T252I mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the VPS26B F266L mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the PGR M106I mutation rate in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the PGR M38I mutation rate in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the PGR M632I mutation rate in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",ssm_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the ACTA2 P334L mutation rate in Skin Cutaneous Melanoma?,ssm_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the THBS4 T852I mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the THBS4 T943I mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the PRSS1 S114T mutation rate in Lung Adenocarcinoma?,ssm_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the PRSS1 S124T mutation rate in Lung Adenocarcinoma?,ssm_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the PRSS1 S138T mutation rate in Lung Adenocarcinoma?,ssm_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the PRSS1 S74T mutation rate in Lung Adenocarcinoma?,ssm_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the PGF R126H mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the PGF R127H mutation rate in Stomach Adenocarcinoma?,ssm_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the ITPRID2 S351C mutation rate in Breast Invasive Carcinoma?,ssm_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the ITPRID2 S842C mutation rate in Breast Invasive Carcinoma?,ssm_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the HBB E8D mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the PCDHB2 R158C mutation rate in Colon Adenocarcinoma?,ssm_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the PCDHB2 T15M mutation rate in Colon Adenocarcinoma?,ssm_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the PCDHB2 T26M mutation rate in Colon Adenocarcinoma?,ssm_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the UBR2 P1594S mutation rate in Uterine Corpus Endometrial Carcinoma?,ssm_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the FBXO42 A618D mutation rate in Rectum Adenocarcinoma?,ssm_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,How frequent is the TNS1 G1362V mutation in Breast Invasive Carcinoma cases?,ssm_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,How frequent is the TNS1 G1711V mutation in Breast Invasive Carcinoma cases?,ssm_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,How frequent is the TNS1 G1718V mutation in Breast Invasive Carcinoma cases?,ssm_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,How frequent is the TNS1 G1732V mutation in Breast Invasive Carcinoma cases?,ssm_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,How frequent is the TNS1 G1824V mutation in Breast Invasive Carcinoma cases?,ssm_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,How frequent is the TNS1 G1857V mutation in Breast Invasive Carcinoma cases?,ssm_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,How frequent is the TNS1 G843V mutation in Breast Invasive Carcinoma cases?,ssm_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How frequent is the EVC2 E1067K mutation in Bladder Urothelial Carcinoma cases?,ssm_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How frequent is the EVC2 E987K mutation in Bladder Urothelial Carcinoma cases?,ssm_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How frequent is the CR1 V1108G mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How frequent is the CR1 V1558G mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,How frequent is the TRPA1 S295I mutation in Rectum Adenocarcinoma cases?,ssm_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,How frequent is the TRPA1 S443I mutation in Rectum Adenocarcinoma cases?,ssm_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,How frequent is the TAF1C R299L mutation in Lung Adenocarcinoma cases?,ssm_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,How frequent is the TAF1C R396L mutation in Lung Adenocarcinoma cases?,ssm_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,How frequent is the TAF1C R634L mutation in Lung Adenocarcinoma cases?,ssm_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,How frequent is the TAF1C R702L mutation in Lung Adenocarcinoma cases?,ssm_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,How frequent is the TAF1C R728L mutation in Lung Adenocarcinoma cases?,ssm_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How frequent is the DPF3 R104W mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How frequent is the DPF3 R149W mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How frequent is the DPF3 R94W mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,How frequent is the OR2T4 P272H mutation in Lung Adenocarcinoma cases?,ssm_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,How frequent is the OR2T4 P300H mutation in Lung Adenocarcinoma cases?,ssm_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How frequent is the FBN1 E2667K mutation in Pancreatic Adenocarcinoma cases?,ssm_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How frequent is the MAD1L1 E396K mutation in Prostate Adenocarcinoma cases?,ssm_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How frequent is the MAD1L1 E488K mutation in Prostate Adenocarcinoma cases?,ssm_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How frequent is the MAD1L1 E78K mutation in Prostate Adenocarcinoma cases?,ssm_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How frequent is the CCNG1 E22K mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How frequent is the ANP32E N114T mutation in Kidney Renal Papillary Cell Carcinoma cases?,ssm_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How frequent is the ANP32E N64T mutation in Kidney Renal Papillary Cell Carcinoma cases?,ssm_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How frequent is the ANP32E N66T mutation in Kidney Renal Papillary Cell Carcinoma cases?,ssm_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How frequent is the ANP32E N73T mutation in Kidney Renal Papillary Cell Carcinoma cases?,ssm_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How frequent is the FRY S1888A mutation in Bladder Urothelial Carcinoma cases?,ssm_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How frequent is the FRY S1937A mutation in Bladder Urothelial Carcinoma cases?,ssm_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How frequent is the FRY S1938A mutation in Bladder Urothelial Carcinoma cases?,ssm_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How frequent is the FRY S1983A mutation in Bladder Urothelial Carcinoma cases?,ssm_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,How frequent is the PAK3 E318K mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,How frequent is the PAK3 E319K mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,How frequent is the PAK3 E334K mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,How frequent is the PAK3 E340K mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,How frequent is the PAK3 E355K mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How frequent is the MUC16 P7963L mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How frequent is the ZFPM2 T498I mutation in Liver Hepatocellular Carcinoma cases?,ssm_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How frequent is the ZFPM2 T630I mutation in Liver Hepatocellular Carcinoma cases?,ssm_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How frequent is the PIK3C2B S1328C mutation in Breast Invasive Carcinoma cases?,ssm_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How frequent is the PIK3C2B S1356C mutation in Breast Invasive Carcinoma cases?,ssm_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How frequent is the ZNF804A S371Y mutation in Colon Adenocarcinoma cases?,ssm_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,How frequent is the RELN A2371V mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequent is the EFCAB12 R173C mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",ssm_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequent is the EFCAB12 R23C mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",ssm_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How frequent is the DEFB115 E53K mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How frequent is the ANKDD1A S290F mutation in Bladder Urothelial Carcinoma cases?,ssm_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How frequent is the ANKDD1A S322F mutation in Bladder Urothelial Carcinoma cases?,ssm_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How frequent is the ANKDD1A S413F mutation in Bladder Urothelial Carcinoma cases?,ssm_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How frequent is the HTR3B S146I mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How frequent is the HTR3B S206I mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How frequent is the HTR3B S217I mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,How frequent is the ABCC3 R758W mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How frequent is the NOMO1 T204I mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How frequent is the NOMO1 T371I mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How frequent is the HYOU1 D298H mutation in Bladder Urothelial Carcinoma cases?,ssm_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How frequent is the FMO4 R500Q mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+140,BICC1,A372V,Exceptional Responders,How frequent is the BICC1 A372V mutation in Exceptional Responders cases?,ssm_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How frequent is the ZMYM3 I920V mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How frequent is the ZMYM3 I932V mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How frequent is the ZMYM3 I934V mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequent is the XKR4 R547W mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",ssm_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How frequent is the ABCC2 V239L mutation in Liver Hepatocellular Carcinoma cases?,ssm_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,How frequent is the OR8K5 R293G mutation in Lung Adenocarcinoma cases?,ssm_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How frequent is the SPTAN1 S1503F mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How frequent is the SPTAN1 S1523F mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,How frequent is the SYT10 M484I mutation in Rectum Adenocarcinoma cases?,ssm_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How frequent is the HSPA5 N457K mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,How frequent is the UNC5D L280V mutation in Lung Adenocarcinoma cases?,ssm_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,How frequent is the UNC5D L635V mutation in Lung Adenocarcinoma cases?,ssm_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,How frequent is the UNC5D L637V mutation in Lung Adenocarcinoma cases?,ssm_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,How frequent is the UNC5D L699V mutation in Lung Adenocarcinoma cases?,ssm_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,How frequent is the UNC5D L704V mutation in Lung Adenocarcinoma cases?,ssm_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,How frequent is the UNC5D L709V mutation in Lung Adenocarcinoma cases?,ssm_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How frequent is the DOCK2 L1527H mutation in Kidney Renal Clear Cell Carcinoma cases?,ssm_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How frequent is the ZNF627 A5V mutation in Kidney Renal Clear Cell Carcinoma cases?,ssm_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How frequent is the CDC42BPA L823F mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,How frequent is the MRPL55 H27Y mutation in Colon Adenocarcinoma cases?,ssm_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,How frequent is the MRPL55 H63Y mutation in Colon Adenocarcinoma cases?,ssm_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How frequent is the TMTC3 Q749K mutation in Breast Invasive Carcinoma cases?,ssm_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,How frequent is the EPRS1 K771I mutation in Colon Adenocarcinoma cases?,ssm_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,How frequent is the EPRS1 K778I mutation in Colon Adenocarcinoma cases?,ssm_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How frequent is the GRTP1 A110V mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How frequent is the GRTP1 A32V mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How frequent is the TSHZ3 Q538K mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How frequent is the TAS1R3 Q326H mutation in HIV+ Tumor Molecular Characterization Project - Cervical Cancer cases?,ssm_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How frequent is the PIAS3 S238C mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How frequent is the PIAS3 S273C mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,How frequent is the ZNF274 P13R mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,How frequent is the SYNJ1 R795C mutation in Colon Adenocarcinoma cases?,ssm_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,How frequent is the SYNJ1 R800C mutation in Colon Adenocarcinoma cases?,ssm_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,How frequent is the SYNJ1 R839C mutation in Colon Adenocarcinoma cases?,ssm_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,How frequent is the DSCAM V343M mutation in Prostate Adenocarcinoma cases?,ssm_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,How frequent is the DSCAM V426M mutation in Prostate Adenocarcinoma cases?,ssm_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,How frequent is the DSCAM V591M mutation in Prostate Adenocarcinoma cases?,ssm_frequency
+267,DGKD,R140H,Exceptional Responders,How frequent is the DGKD R140H mutation in Exceptional Responders cases?,ssm_frequency
+268,DGKD,R160H,Exceptional Responders,How frequent is the DGKD R160H mutation in Exceptional Responders cases?,ssm_frequency
+269,DGKD,R204H,Exceptional Responders,How frequent is the DGKD R204H mutation in Exceptional Responders cases?,ssm_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How frequent is the PLEKHG6 D105Y mutation in Bladder Urothelial Carcinoma cases?,ssm_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How frequent is the PLEKHG6 D543Y mutation in Bladder Urothelial Carcinoma cases?,ssm_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How frequent is the PLEKHG6 D575Y mutation in Bladder Urothelial Carcinoma cases?,ssm_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,How frequent is the WNT2 D138N mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How frequent is the GUCY2C G667R mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How frequent is the C7orf31 P244H mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequent is the ZKSCAN7 E64K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",ssm_frequency
+299,OR5D14,M210L,Neuroblastoma,How frequent is the OR5D14 M210L mutation in Neuroblastoma cases?,ssm_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How frequent is the SPATA22 K279E mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How frequent is the SPATA22 K306E mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How frequent is the SPATA22 K322E mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,How frequent is the LCN15 E21V mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How frequent is the DCAF4L2 S129F mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How frequent is the GUK1 R135P mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How frequent is the GUK1 R137P mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How frequent is the GUK1 R139P mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How frequent is the GUK1 R158P mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How frequent is the GUK1 R203P mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How frequent is the MORF4L1 K29T mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How frequent is the MORF4L1 K51T mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How frequent is the MORF4L1 K61T mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How frequent is the MORF4L1 K76T mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How frequent is the MYO3B F594L mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How frequent is the MYO3B F603L mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How frequent is the TENT5A S320F mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How frequent is the TENT5A S339F mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How frequent is the TENT5A S401F mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How frequent is the ZFAT S614L mutation in Ovarian Serous Cystadenocarcinoma cases?,ssm_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How frequent is the ZFAT S664L mutation in Ovarian Serous Cystadenocarcinoma cases?,ssm_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How frequent is the ZFAT S676L mutation in Ovarian Serous Cystadenocarcinoma cases?,ssm_frequency
+357,ZNF584,A211T,Sarcoma,How frequent is the ZNF584 A211T mutation in Sarcoma cases?,ssm_frequency
+358,ZNF584,A256T,Sarcoma,How frequent is the ZNF584 A256T mutation in Sarcoma cases?,ssm_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How frequent is the LDOC1 R63W mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How frequent is the PDGFC R201G mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How frequent is the MSANTD4 R304C mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How frequent is the NPSR1 S123L mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How frequent is the PHLPP1 K1317E mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How frequent is the COL6A3 G237S mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How frequent is the COL6A3 G437S mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How frequent is the COL6A3 G638S mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How frequent is the COL6A3 G644S mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How frequent is the COL6A3 G844S mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How frequent is the ADRA1A R348G mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequent is the LAMB2 S1254F mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,ssm_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,How frequent is the POC1B I198T mutation in Rectum Adenocarcinoma cases?,ssm_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,How frequent is the POC1B I286T mutation in Rectum Adenocarcinoma cases?,ssm_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,How frequent is the POC1B I328T mutation in Rectum Adenocarcinoma cases?,ssm_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,How frequent is the POC1B S79P mutation in Rectum Adenocarcinoma cases?,ssm_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How frequent is the USH2A G1451C mutation in Liver Hepatocellular Carcinoma cases?,ssm_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,How frequent is the AQP7 T110S mutation in Rectum Adenocarcinoma cases?,ssm_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,How frequent is the AQP7 T166S mutation in Rectum Adenocarcinoma cases?,ssm_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,How frequent is the AQP7 T167S mutation in Rectum Adenocarcinoma cases?,ssm_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,How frequent is the AQP7 T75S mutation in Rectum Adenocarcinoma cases?,ssm_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,How frequent is the DCN R163C mutation in Rectum Adenocarcinoma cases?,ssm_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,How frequent is the DCN R203C mutation in Rectum Adenocarcinoma cases?,ssm_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,How frequent is the DCN R241C mutation in Rectum Adenocarcinoma cases?,ssm_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,How frequent is the DCN R350C mutation in Rectum Adenocarcinoma cases?,ssm_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,How frequent is the DCN R41C mutation in Rectum Adenocarcinoma cases?,ssm_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How frequent is the CPS1 K1269N mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How frequent is the CPS1 K1275N mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How frequent is the CPS1 K818N mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How frequent is the FCGR2C P122S mutation in Kidney Renal Papillary Cell Carcinoma cases?,ssm_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How frequent is the FCGR2C P123S mutation in Kidney Renal Papillary Cell Carcinoma cases?,ssm_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How frequent is the GRM1 R280M mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,How frequent is the SGCZ Q138H mutation in Lung Adenocarcinoma cases?,ssm_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,How frequent is the SGCZ Q91H mutation in Lung Adenocarcinoma cases?,ssm_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,How frequent is the SMO V15M mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,How frequent is the SMO V321M mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,How frequent is the CHODL G159E mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,How frequent is the CHODL G181E mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,How frequent is the CHODL G200E mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,How frequent is the MYO16 P399H mutation in Colon Adenocarcinoma cases?,ssm_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,How frequent is the MYO16 P421H mutation in Colon Adenocarcinoma cases?,ssm_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,How frequent is the CXCR2 A98V mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How frequent is the TMEM225 L212V mutation in Bladder Urothelial Carcinoma cases?,ssm_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How frequent is the MAOB N251T mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How frequent is the GPRASP1 F580S mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How frequent is the MRPL32 R181Q mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How frequent is the TYROBP A29T mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,How frequent is the RAB40C A111V mutation in Lung Adenocarcinoma cases?,ssm_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,How frequent is the RAB40C A143V mutation in Lung Adenocarcinoma cases?,ssm_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,How frequent is the CTNNA2 S323R mutation in Lung Adenocarcinoma cases?,ssm_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,How frequent is the CTNNA2 S339R mutation in Lung Adenocarcinoma cases?,ssm_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,How frequent is the CTNNA2 S386R mutation in Lung Adenocarcinoma cases?,ssm_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,How frequent is the CTNNA2 S707R mutation in Lung Adenocarcinoma cases?,ssm_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How frequent is the MYO15A S268R mutation in Bladder Urothelial Carcinoma cases?,ssm_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How frequent is the GIMAP2 A167T mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,How frequent is the KIF20B N1160D mutation in Glioblastoma Multiforme cases?,ssm_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,How frequent is the KIF20B N1200D mutation in Glioblastoma Multiforme cases?,ssm_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How frequent is the ADAM17 E583K mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How frequent is the BCAT1 G16R mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How frequent is the BCAT1 G17R mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How frequent is the BCAT1 G29R mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,How frequent is the ERCC6 R1053H mutation in Colon Adenocarcinoma cases?,ssm_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,How frequent is the DCC R320W mutation in Breast Invasive Carcinoma cases?,ssm_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,How frequent is the DCC R363W mutation in Breast Invasive Carcinoma cases?,ssm_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,How frequent is the DCC R386W mutation in Breast Invasive Carcinoma cases?,ssm_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,How frequent is the DCC R41W mutation in Breast Invasive Carcinoma cases?,ssm_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How frequent is the FBXO15 D417N mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How frequent is the FBXO15 D86N mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How frequent is the GSTCD S528F mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How frequent is the GSTCD S615F mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How frequent is the OLFML3 P296S mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How frequent is the OLFML3 P337S mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How frequent is the OLFML3 P357S mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How frequent is the CFAP61 E173V mutation in Ovarian Serous Cystadenocarcinoma cases?,ssm_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How frequent is the CFAP61 E817V mutation in Ovarian Serous Cystadenocarcinoma cases?,ssm_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How frequent is the HLA-DQA2 E51K mutation in Bladder Urothelial Carcinoma cases?,ssm_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How frequent is the TENM2 H240Y mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How frequent is the TENM2 H351Y mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How frequent is the TENM2 H472Y mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How frequent is the ANKRD24 A465T mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How frequent is the ANKRD24 A494T mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How frequent is the ANKRD24 A584T mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How frequent is the ZCCHC14 V549M mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How frequent is the ZCCHC14 V665M mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How frequent is the ZCCHC14 V676M mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How frequent is the ZCCHC14 V802M mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,How frequent is the SIK2 I265M mutation in Lung Adenocarcinoma cases?,ssm_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How frequent is the MYH11 T1336M mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How frequent is the MYH11 T1343M mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How frequent is the SLC6A4 S174F mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How frequent is the SLC9C1 K102N mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How frequent is the SLC9C1 K29N mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,How frequent is the OR2A12 A254T mutation in Brain Lower Grade Glioma cases?,ssm_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,How frequent is the PYHIN1 T325K mutation in Lung Adenocarcinoma cases?,ssm_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,How frequent is the PYHIN1 T334K mutation in Lung Adenocarcinoma cases?,ssm_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,How frequent is the JAML G191E mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,How frequent is the JAML G219E mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,How frequent is the JAML G220E mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,How frequent is the JAML G230E mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,How frequent is the TYK2 H1146R mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,How frequent is the TYK2 H23R mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,How frequent is the TYK2 H961R mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How frequent is the CTCFL R208C mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How frequent is the CTCFL R265C mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How frequent is the CTCFL R420C mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How frequent is the CTCFL R470C mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How frequent is the CEP20 R31Q mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How frequent is the CEP20 R58Q mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How frequent is the RIMS2 R25W mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How frequent is the RIMS2 R393W mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How frequent is the RIMS2 R423W mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How frequent is the RIMS2 R470W mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How frequent is the RIMS2 R615W mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How frequent is the RIMS2 R619W mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How frequent is the RIMS2 R716W mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How frequent is the PIK3C2G S551L mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How frequent is the PIK3C2G S592L mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+728,STK19,D341N,Colon Adenocarcinoma,How frequent is the STK19 D341N mutation in Colon Adenocarcinoma cases?,ssm_frequency
+729,STK19,D345N,Colon Adenocarcinoma,How frequent is the STK19 D345N mutation in Colon Adenocarcinoma cases?,ssm_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,How frequent is the REXO4 P60A mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How frequent is the ZBTB34 P160S mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How frequent is the ZBTB34 P164S mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How frequent is the NCKAP5 E148K mutation in Bladder Urothelial Carcinoma cases?,ssm_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequent is the SORCS1 D1052Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",ssm_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequent is the SORCS1 D587Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",ssm_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequent is the SORCS1 D67Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",ssm_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequent is the SORCS1 D810Y mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",ssm_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How frequent is the FGF8 T154M mutation in Head and Neck Squamous Cell Carcinoma cases?,ssm_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How frequent is the FGF8 T165M mutation in Head and Neck Squamous Cell Carcinoma cases?,ssm_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How frequent is the FGF8 T183M mutation in Head and Neck Squamous Cell Carcinoma cases?,ssm_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How frequent is the FGF8 T194M mutation in Head and Neck Squamous Cell Carcinoma cases?,ssm_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How frequent is the FGF8 T90M mutation in Head and Neck Squamous Cell Carcinoma cases?,ssm_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How frequent is the TENM3 R1877W mutation in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia cases?,ssm_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How frequent is the AKT1 D44N mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequent is the CFAP298-TCP10L E11Q mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,ssm_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,How frequent is the GLRB E148D mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,How frequent is the TTN F7636L mutation in Colon Adenocarcinoma cases?,ssm_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,How frequent is the TTN F8563L mutation in Colon Adenocarcinoma cases?,ssm_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,How frequent is the TTN F8880L mutation in Colon Adenocarcinoma cases?,ssm_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How frequent is the ANKRD30A V798I mutation in Colon Adenocarcinoma cases?,ssm_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How frequent is the ANKRD30A V854I mutation in Colon Adenocarcinoma cases?,ssm_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How frequent is the ANKRD30A V973I mutation in Colon Adenocarcinoma cases?,ssm_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,How frequent is the TRIM45 S177L mutation in Colon Adenocarcinoma cases?,ssm_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,How frequent is the TRIM45 S224L mutation in Colon Adenocarcinoma cases?,ssm_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,How frequent is the TRIM45 S281L mutation in Colon Adenocarcinoma cases?,ssm_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How frequent is the CACNA1F G727V mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How frequent is the CACNA1F G781V mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How frequent is the CACNA1F G792V mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+817,KL,R594C,Colon Adenocarcinoma,How frequent is the KL R594C mutation in Colon Adenocarcinoma cases?,ssm_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How frequent is the GUF1 I243T mutation in Kidney Renal Papillary Cell Carcinoma cases?,ssm_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,How frequent is the TAF1L A539V mutation in Colon Adenocarcinoma cases?,ssm_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How frequent is the TASOR2 S256F mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How frequent is the TASOR2 S36F mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How frequent is the TASOR2 S471F mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How frequent is the KDM5C R1151C mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How frequent is the KDM5C R1177C mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How frequent is the KDM5C R1217C mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How frequent is the KDM5C R1218C mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequent is the IL5RA L153F mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,ssm_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,How frequent is the DHX16 A29V mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,How frequent is the DHX16 A89V mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,How frequent is the GPR158 A644V mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,How frequent is the GPR158 A723V mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequent is the EIF2B4 E108K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",ssm_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequent is the EIF2B4 E110K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",ssm_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequent is the EIF2B4 E111K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",ssm_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequent is the EIF2B4 E131K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",ssm_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequent is the EIF2B4 E132K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",ssm_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequent is the EIF2B4 E96K mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",ssm_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How frequent is the AUTS2 P136S mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How frequent is the AUTS2 P218S mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How frequent is the AUTS2 P233S mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How frequent is the AUTS2 P313S mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How frequent is the AUTS2 P419S mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How frequent is the AUTS2 P443S mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How frequent is the AUTS2 P56S mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How frequent is the AUTS2 P667S mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How frequent is the AUTS2 P690S mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How frequent is the AUTS2 P691S mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequent is the ACTL7B D223N mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",ssm_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How frequent is the PCDHGA1 R535W mutation in Glioblastoma Multiforme cases?,ssm_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,How frequent is the TRAP1 R114W mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,How frequent is the TRAP1 R61W mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How frequent is the PIK3C2A R1570Q mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How frequent is the KANSL1 R139G mutation in Liver Hepatocellular Carcinoma cases?,ssm_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How frequent is the ANKRD52 Y594C mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How frequent is the PAPPA G1580S mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How frequent is the B3GALNT1 V270A mutation in Rectum Adenocarcinoma cases?,ssm_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,How frequent is the GABRA6 G115R mutation in Lung Adenocarcinoma cases?,ssm_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,How frequent is the GABRA6 G122R mutation in Lung Adenocarcinoma cases?,ssm_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,How frequent is the GABRA6 G165R mutation in Lung Adenocarcinoma cases?,ssm_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,How frequent is the GABRA6 G175R mutation in Lung Adenocarcinoma cases?,ssm_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,How frequent is the GABRA6 G70R mutation in Lung Adenocarcinoma cases?,ssm_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How frequent is the ZSCAN31 D9N mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequent is the MED16 L126P mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",ssm_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequent is the MED16 L868P mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",ssm_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How frequent is the PTPRO E1060K mutation in Pancreatic Adenocarcinoma cases?,ssm_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How frequent is the PTPRO E1088K mutation in Pancreatic Adenocarcinoma cases?,ssm_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How frequent is the PTPRO E249K mutation in Pancreatic Adenocarcinoma cases?,ssm_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How frequent is the PTPRO E265K mutation in Pancreatic Adenocarcinoma cases?,ssm_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How frequent is the PTPRO E277K mutation in Pancreatic Adenocarcinoma cases?,ssm_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How frequent is the PTPRO E67K mutation in Pancreatic Adenocarcinoma cases?,ssm_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How frequent is the PTPRO E923K mutation in Pancreatic Adenocarcinoma cases?,ssm_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How frequent is the PTPRO E940K mutation in Pancreatic Adenocarcinoma cases?,ssm_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How frequent is the CHMP7 D397N mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,How frequent is the GPC3 I107N mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,How frequent is the GPC3 I161N mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequent is the TLK2 V430L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,ssm_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequent is the TLK2 V515L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,ssm_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequent is the TLK2 V547L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,ssm_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequent is the TLK2 V579L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,ssm_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequent is the TLK2 V601L mutation in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,ssm_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How frequent is the ZNF217 E209Q mutation in Lung Adenocarcinoma cases?,ssm_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,How frequent is the SYT9 V275L mutation in Lung Adenocarcinoma cases?,ssm_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,How frequent is the SYT9 V307L mutation in Lung Adenocarcinoma cases?,ssm_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How frequent is the PKHD1L1 S2830N mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How frequent is the MYO3A Y1295C mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequent is the VASN V318I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",ssm_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How frequent is the DNMT1 A1037T mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How frequent is the DNMT1 A1053T mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How frequent is the DNMT1 A934T mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,How frequent is the CA9 E402K mutation in Colon Adenocarcinoma cases?,ssm_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How frequent is the TTC17 R808Q mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How frequent is the TTC17 R865Q mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,How frequent is the PSG2 P43L mutation in Breast Invasive Carcinoma cases?,ssm_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How frequent is the RIPOR2 R470L mutation in Breast Invasive Carcinoma cases?,ssm_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How frequent is the RIPOR2 R499L mutation in Breast Invasive Carcinoma cases?,ssm_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How frequent is the RIPOR2 R504L mutation in Breast Invasive Carcinoma cases?,ssm_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How frequent is the RIPOR2 R520L mutation in Breast Invasive Carcinoma cases?,ssm_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How frequent is the DCLK3 V520I mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How frequent is the DCLK3 V689I mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How frequent is the MERTK G257A mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How frequent is the MERTK G757A mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How frequent is the MERTK G933A mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How frequent is the ZFP42 R206K mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How frequent is the OR13C3 M117I mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How frequent is the OR13C3 M147I mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How frequent is the SPAG1 I917M mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How frequent is the CDKN2AIP Y92H mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,How frequent is the PXN H1016Y mutation in Colon Adenocarcinoma cases?,ssm_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,How frequent is the PXN H359Y mutation in Colon Adenocarcinoma cases?,ssm_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,How frequent is the PXN H492Y mutation in Colon Adenocarcinoma cases?,ssm_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,How frequent is the PXN H524Y mutation in Colon Adenocarcinoma cases?,ssm_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,How frequent is the PXN H526Y mutation in Colon Adenocarcinoma cases?,ssm_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,How frequent is the PXN H540Y mutation in Colon Adenocarcinoma cases?,ssm_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How frequent is the TTYH2 S23L mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How frequent is the TTYH2 S44L mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How frequent is the TMEM255A N205S mutation in Colon Adenocarcinoma cases?,ssm_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How frequent is the TMEM255A N229S mutation in Colon Adenocarcinoma cases?,ssm_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How frequent is the TMEM255A N65S mutation in Colon Adenocarcinoma cases?,ssm_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How frequent is the TASOR2 H2271D mutation in Breast Invasive Carcinoma cases?,ssm_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How frequent is the TASOR2 H2486D mutation in Breast Invasive Carcinoma cases?,ssm_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How frequent is the ICE1 T1839M mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,How frequent is the MYT1 A558E mutation in Breast Invasive Carcinoma cases?,ssm_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,How frequent is the MYT1 A879E mutation in Breast Invasive Carcinoma cases?,ssm_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,How frequent is the MYT1 A906E mutation in Breast Invasive Carcinoma cases?,ssm_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How frequent is the CX3CR1 P203L mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How frequent is the CX3CR1 P235L mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How frequent is the SPINDOC R197C mutation in Liver Hepatocellular Carcinoma cases?,ssm_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How frequent is the ART3 C251Y mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How frequent is the ART3 C3Y mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How frequent is the CYP1A2 R243G mutation in Bladder Urothelial Carcinoma cases?,ssm_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequent is the ADRA1A G279S mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",ssm_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How frequent is the CDH23 P2523R mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How frequent is the CDH23 P283R mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How frequent is the KRT39 P137S mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How frequent is the PDHA2 S7F mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How frequent is the SLC24A2 H200Q mutation in Colon Adenocarcinoma cases?,ssm_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How frequent is the PTPRN2 F153L mutation in Liver Hepatocellular Carcinoma cases?,ssm_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How frequent is the PTPRN2 F847L mutation in Liver Hepatocellular Carcinoma cases?,ssm_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How frequent is the PTPRN2 F856L mutation in Liver Hepatocellular Carcinoma cases?,ssm_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How frequent is the PTPRN2 F868L mutation in Liver Hepatocellular Carcinoma cases?,ssm_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How frequent is the PTPRN2 F885L mutation in Liver Hepatocellular Carcinoma cases?,ssm_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,How frequent is the SOX21 R55L mutation in Lung Adenocarcinoma cases?,ssm_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How frequent is the CPA6 G166E mutation in Bladder Urothelial Carcinoma cases?,ssm_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How frequent is the GRM5 E14K mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequent is the CASZ1 R233Q mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",ssm_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How frequent is the SGIP1 N122T mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How frequent is the SGIP1 N420T mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How frequent is the SGIP1 N617T mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How frequent is the SGIP1 N648T mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How frequent is the CARMIL1 V549L mutation in Lung Adenocarcinoma cases?,ssm_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How frequent is the CARMIL1 V949L mutation in Lung Adenocarcinoma cases?,ssm_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How frequent is the ZNF431 D121Y mutation in Lung Adenocarcinoma cases?,ssm_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How frequent is the ZNF431 D161Y mutation in Lung Adenocarcinoma cases?,ssm_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,How frequent is the ZNF431 R128I mutation in Lung Adenocarcinoma cases?,ssm_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How frequent is the DNAH11 P2987S mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How frequent is the DNAH11 P2994S mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How frequent is the POLD1 Q461L mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How frequent is the POLD1 Q85L mutation in Lung Squamous Cell Carcinoma cases?,ssm_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,How frequent is the TTC12 D646H mutation in Lung Adenocarcinoma cases?,ssm_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,How frequent is the TTC12 D652H mutation in Lung Adenocarcinoma cases?,ssm_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How frequent is the CNGB1 D967N mutation in Bladder Urothelial Carcinoma cases?,ssm_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How frequent is the CNGB1 D973N mutation in Bladder Urothelial Carcinoma cases?,ssm_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,How frequent is the CTSC E214V mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,How frequent is the CTSC E291V mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,How frequent is the CTSC E322V mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,How frequent is the CTSC E324V mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,How frequent is the CTSC E335V mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How frequent is the PRSS8 A179T mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How frequent is the PRSS8 A233T mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How frequent is the ARHGEF40 V864F mutation in Lung Adenocarcinoma cases?,ssm_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,How frequent is the ACTB A138T mutation in Rectum Adenocarcinoma cases?,ssm_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,How frequent is the ACTB A217T mutation in Rectum Adenocarcinoma cases?,ssm_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,How frequent is the ACTB A244T mutation in Rectum Adenocarcinoma cases?,ssm_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,How frequent is the ACTB A260T mutation in Rectum Adenocarcinoma cases?,ssm_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How frequent is the YY1AP1 V546D mutation in Glioblastoma Multiforme cases?,ssm_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How frequent is the YY1AP1 V557D mutation in Glioblastoma Multiforme cases?,ssm_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How frequent is the YY1AP1 V566D mutation in Glioblastoma Multiforme cases?,ssm_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How frequent is the YY1AP1 V577D mutation in Glioblastoma Multiforme cases?,ssm_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How frequent is the YY1AP1 V623D mutation in Glioblastoma Multiforme cases?,ssm_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How frequent is the YY1AP1 V695D mutation in Glioblastoma Multiforme cases?,ssm_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How frequent is the YY1AP1 V715D mutation in Glioblastoma Multiforme cases?,ssm_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How frequent is the FNDC7 D323N mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How frequent is the FNDC7 D99N mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,How frequent is the TLCD5 G15V mutation in Lung Adenocarcinoma cases?,ssm_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,How frequent is the TLCD5 G37V mutation in Lung Adenocarcinoma cases?,ssm_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How frequent is the POLR1G R498W mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How frequent is the POLR1G R500W mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How frequent is the DNAH14 N1186K mutation in Colon Adenocarcinoma cases?,ssm_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How frequent is the DNAH14 N2657K mutation in Colon Adenocarcinoma cases?,ssm_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How frequent is the DNAH14 N3460K mutation in Colon Adenocarcinoma cases?,ssm_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How frequent is the NEXN E73D mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How frequent is the CYB5R2 G112R mutation in Prostate Adenocarcinoma cases?,ssm_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How frequent is the CYB5R2 G172R mutation in Prostate Adenocarcinoma cases?,ssm_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How frequent is the NRAP S808L mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How frequent is the NRAP S816L mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How frequent is the NRAP S843L mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How frequent is the CCDC22 E179D mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How frequent is the DCAF6 S402F mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How frequent is the DCAF6 S433F mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How frequent is the ZNF708 E389D mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How frequent is the BFAR T103M mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How frequent is the MAST4 P1237S mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How frequent is the MAST4 P1986S mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How frequent is the MAST4 P1991S mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How frequent is the MAST4 P2001S mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How frequent is the MAST4 P2180S mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How frequent is the ARMC3 R169C mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How frequent is the ARMC3 R432C mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How frequent is the TET2 L757V mutation in Kidney Renal Clear Cell Carcinoma cases?,ssm_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How frequent is the TET2 L778V mutation in Kidney Renal Clear Cell Carcinoma cases?,ssm_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How frequent is the SERPINB10 A353P mutation in Lung Adenocarcinoma cases?,ssm_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How frequent is the STAT3 Y22H mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How frequent is the MIEF1 A42T mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How frequent is the ACVR1B D397N mutation in Colon Adenocarcinoma cases?,ssm_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How frequent is the ACVR1B D449N mutation in Colon Adenocarcinoma cases?,ssm_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How frequent is the ACVR1B D490N mutation in Colon Adenocarcinoma cases?,ssm_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,How frequent is the EBF2 T104I mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,How frequent is the EBF2 T252I mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How frequent is the VPS26B F266L mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequent is the PGR M106I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",ssm_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequent is the PGR M38I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",ssm_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequent is the PGR M632I mutation in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",ssm_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How frequent is the ACTA2 P334L mutation in Skin Cutaneous Melanoma cases?,ssm_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How frequent is the THBS4 T852I mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How frequent is the THBS4 T943I mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,How frequent is the PRSS1 S114T mutation in Lung Adenocarcinoma cases?,ssm_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,How frequent is the PRSS1 S124T mutation in Lung Adenocarcinoma cases?,ssm_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,How frequent is the PRSS1 S138T mutation in Lung Adenocarcinoma cases?,ssm_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,How frequent is the PRSS1 S74T mutation in Lung Adenocarcinoma cases?,ssm_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,How frequent is the PGF R126H mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,How frequent is the PGF R127H mutation in Stomach Adenocarcinoma cases?,ssm_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How frequent is the ITPRID2 S351C mutation in Breast Invasive Carcinoma cases?,ssm_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How frequent is the ITPRID2 S842C mutation in Breast Invasive Carcinoma cases?,ssm_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How frequent is the HBB E8D mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How frequent is the PCDHB2 R158C mutation in Colon Adenocarcinoma cases?,ssm_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How frequent is the PCDHB2 T15M mutation in Colon Adenocarcinoma cases?,ssm_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How frequent is the PCDHB2 T26M mutation in Colon Adenocarcinoma cases?,ssm_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How frequent is the UBR2 P1594S mutation in Uterine Corpus Endometrial Carcinoma cases?,ssm_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How frequent is the FBXO42 A618D mutation in Rectum Adenocarcinoma cases?,ssm_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the frequency of microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the frequency of microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the frequency of microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the frequency of microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the frequency of microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the frequency of microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the frequency of microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the frequency of microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the frequency of microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the frequency of microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the frequency of microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the frequency of microsatellite instability-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the frequency of microsatellite instability-high in Prostate Adenocarcinoma?,msi_h_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the frequency of microsatellite instability-high in Prostate Adenocarcinoma?,msi_h_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the frequency of microsatellite instability-high in Prostate Adenocarcinoma?,msi_h_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the frequency of microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the frequency of microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the frequency of microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the frequency of microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the frequency of microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the frequency of microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the frequency of microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the frequency of microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the frequency of microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the frequency of microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the frequency of microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the frequency of microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+140,BICC1,A372V,Exceptional Responders,What is the frequency of microsatellite instability-high in Exceptional Responders?,msi_h_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the frequency of microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the frequency of microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the frequency of microsatellite instability-high in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the frequency of microsatellite instability-high in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the frequency of microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the frequency of microsatellite instability-high in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,msi_h_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the frequency of microsatellite instability-high in Prostate Adenocarcinoma?,msi_h_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the frequency of microsatellite instability-high in Prostate Adenocarcinoma?,msi_h_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the frequency of microsatellite instability-high in Prostate Adenocarcinoma?,msi_h_frequency
+267,DGKD,R140H,Exceptional Responders,What is the frequency of microsatellite instability-high in Exceptional Responders?,msi_h_frequency
+268,DGKD,R160H,Exceptional Responders,What is the frequency of microsatellite instability-high in Exceptional Responders?,msi_h_frequency
+269,DGKD,R204H,Exceptional Responders,What is the frequency of microsatellite instability-high in Exceptional Responders?,msi_h_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the frequency of microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the frequency of microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the frequency of microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+299,OR5D14,M210L,Neuroblastoma,What is the frequency of microsatellite instability-high in Neuroblastoma?,msi_h_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the frequency of microsatellite instability-high in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the frequency of microsatellite instability-high in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the frequency of microsatellite instability-high in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+357,ZNF584,A211T,Sarcoma,What is the frequency of microsatellite instability-high in Sarcoma?,msi_h_frequency
+358,ZNF584,A256T,Sarcoma,What is the frequency of microsatellite instability-high in Sarcoma?,msi_h_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the frequency of microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the frequency of microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the frequency of microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the frequency of microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the frequency of microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the frequency of microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the frequency of microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the frequency of microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the frequency of microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,What is the frequency of microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,What is the frequency of microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,What is the frequency of microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,What is the frequency of microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,What is the frequency of microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the frequency of microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the frequency of microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the frequency of microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the frequency of microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the frequency of microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the frequency of microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,What is the frequency of microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,What is the frequency of microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,What is the frequency of microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,What is the frequency of microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the frequency of microsatellite instability-high in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the frequency of microsatellite instability-high in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the frequency of microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the frequency of microsatellite instability-high in Brain Lower Grade Glioma?,msi_h_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+728,STK19,D341N,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+729,STK19,D345N,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the frequency of microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the frequency of microsatellite instability-high in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,msi_h_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+817,KL,R594C,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the frequency of microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the frequency of microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the frequency of microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the frequency of microsatellite instability-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the frequency of microsatellite instability-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the frequency of microsatellite instability-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the frequency of microsatellite instability-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the frequency of microsatellite instability-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the frequency of microsatellite instability-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the frequency of microsatellite instability-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the frequency of microsatellite instability-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the frequency of microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the frequency of microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the frequency of microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the frequency of microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the frequency of microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the frequency of microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the frequency of microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the frequency of microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the frequency of microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the frequency of microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the frequency of microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the frequency of microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the frequency of microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the frequency of microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the frequency of microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the frequency of microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the frequency of microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the frequency of microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the frequency of microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the frequency of microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the frequency of microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the frequency of microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the frequency of microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the frequency of microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the frequency of microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the frequency of microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the frequency of microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the frequency of microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the frequency of microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the frequency of microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the frequency of microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the frequency of microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the frequency of microsatellite instability-high in Prostate Adenocarcinoma?,msi_h_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the frequency of microsatellite instability-high in Prostate Adenocarcinoma?,msi_h_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the frequency of microsatellite instability-high in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the frequency of microsatellite instability-high in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the frequency of microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the frequency of microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the frequency of microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the frequency of microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the frequency of microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the frequency of microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the frequency of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the frequency of microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,How common is MSI-H in Breast Invasive Carcinoma cases?,msi_h_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,How common is MSI-H in Breast Invasive Carcinoma cases?,msi_h_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,How common is MSI-H in Breast Invasive Carcinoma cases?,msi_h_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,How common is MSI-H in Breast Invasive Carcinoma cases?,msi_h_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,How common is MSI-H in Breast Invasive Carcinoma cases?,msi_h_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,How common is MSI-H in Breast Invasive Carcinoma cases?,msi_h_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,How common is MSI-H in Breast Invasive Carcinoma cases?,msi_h_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How common is MSI-H in Bladder Urothelial Carcinoma cases?,msi_h_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How common is MSI-H in Bladder Urothelial Carcinoma cases?,msi_h_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,How common is MSI-H in Rectum Adenocarcinoma cases?,msi_h_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,How common is MSI-H in Rectum Adenocarcinoma cases?,msi_h_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How common is MSI-H in Pancreatic Adenocarcinoma cases?,msi_h_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How common is MSI-H in Prostate Adenocarcinoma cases?,msi_h_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How common is MSI-H in Prostate Adenocarcinoma cases?,msi_h_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How common is MSI-H in Prostate Adenocarcinoma cases?,msi_h_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How common is MSI-H in Kidney Renal Papillary Cell Carcinoma cases?,msi_h_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How common is MSI-H in Kidney Renal Papillary Cell Carcinoma cases?,msi_h_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How common is MSI-H in Kidney Renal Papillary Cell Carcinoma cases?,msi_h_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How common is MSI-H in Kidney Renal Papillary Cell Carcinoma cases?,msi_h_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How common is MSI-H in Bladder Urothelial Carcinoma cases?,msi_h_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How common is MSI-H in Bladder Urothelial Carcinoma cases?,msi_h_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How common is MSI-H in Bladder Urothelial Carcinoma cases?,msi_h_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How common is MSI-H in Bladder Urothelial Carcinoma cases?,msi_h_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How common is MSI-H in Liver Hepatocellular Carcinoma cases?,msi_h_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How common is MSI-H in Liver Hepatocellular Carcinoma cases?,msi_h_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How common is MSI-H in Breast Invasive Carcinoma cases?,msi_h_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How common is MSI-H in Breast Invasive Carcinoma cases?,msi_h_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",msi_h_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",msi_h_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How common is MSI-H in Bladder Urothelial Carcinoma cases?,msi_h_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How common is MSI-H in Bladder Urothelial Carcinoma cases?,msi_h_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How common is MSI-H in Bladder Urothelial Carcinoma cases?,msi_h_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How common is MSI-H in Bladder Urothelial Carcinoma cases?,msi_h_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+140,BICC1,A372V,Exceptional Responders,How common is MSI-H in Exceptional Responders cases?,msi_h_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",msi_h_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How common is MSI-H in Liver Hepatocellular Carcinoma cases?,msi_h_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,How common is MSI-H in Rectum Adenocarcinoma cases?,msi_h_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How common is MSI-H in Kidney Renal Clear Cell Carcinoma cases?,msi_h_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How common is MSI-H in Kidney Renal Clear Cell Carcinoma cases?,msi_h_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How common is MSI-H in Breast Invasive Carcinoma cases?,msi_h_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How common is MSI-H in HIV+ Tumor Molecular Characterization Project - Cervical Cancer cases?,msi_h_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,How common is MSI-H in Prostate Adenocarcinoma cases?,msi_h_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,How common is MSI-H in Prostate Adenocarcinoma cases?,msi_h_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,How common is MSI-H in Prostate Adenocarcinoma cases?,msi_h_frequency
+267,DGKD,R140H,Exceptional Responders,How common is MSI-H in Exceptional Responders cases?,msi_h_frequency
+268,DGKD,R160H,Exceptional Responders,How common is MSI-H in Exceptional Responders cases?,msi_h_frequency
+269,DGKD,R204H,Exceptional Responders,How common is MSI-H in Exceptional Responders cases?,msi_h_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How common is MSI-H in Bladder Urothelial Carcinoma cases?,msi_h_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How common is MSI-H in Bladder Urothelial Carcinoma cases?,msi_h_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How common is MSI-H in Bladder Urothelial Carcinoma cases?,msi_h_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",msi_h_frequency
+299,OR5D14,M210L,Neuroblastoma,How common is MSI-H in Neuroblastoma cases?,msi_h_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How common is MSI-H in Ovarian Serous Cystadenocarcinoma cases?,msi_h_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How common is MSI-H in Ovarian Serous Cystadenocarcinoma cases?,msi_h_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How common is MSI-H in Ovarian Serous Cystadenocarcinoma cases?,msi_h_frequency
+357,ZNF584,A211T,Sarcoma,How common is MSI-H in Sarcoma cases?,msi_h_frequency
+358,ZNF584,A256T,Sarcoma,How common is MSI-H in Sarcoma cases?,msi_h_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is MSI-H in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,msi_h_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,How common is MSI-H in Rectum Adenocarcinoma cases?,msi_h_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,How common is MSI-H in Rectum Adenocarcinoma cases?,msi_h_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,How common is MSI-H in Rectum Adenocarcinoma cases?,msi_h_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,How common is MSI-H in Rectum Adenocarcinoma cases?,msi_h_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How common is MSI-H in Liver Hepatocellular Carcinoma cases?,msi_h_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,How common is MSI-H in Rectum Adenocarcinoma cases?,msi_h_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,How common is MSI-H in Rectum Adenocarcinoma cases?,msi_h_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,How common is MSI-H in Rectum Adenocarcinoma cases?,msi_h_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,How common is MSI-H in Rectum Adenocarcinoma cases?,msi_h_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,How common is MSI-H in Rectum Adenocarcinoma cases?,msi_h_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,How common is MSI-H in Rectum Adenocarcinoma cases?,msi_h_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,How common is MSI-H in Rectum Adenocarcinoma cases?,msi_h_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,How common is MSI-H in Rectum Adenocarcinoma cases?,msi_h_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,How common is MSI-H in Rectum Adenocarcinoma cases?,msi_h_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How common is MSI-H in Kidney Renal Papillary Cell Carcinoma cases?,msi_h_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How common is MSI-H in Kidney Renal Papillary Cell Carcinoma cases?,msi_h_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How common is MSI-H in Bladder Urothelial Carcinoma cases?,msi_h_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How common is MSI-H in Bladder Urothelial Carcinoma cases?,msi_h_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,How common is MSI-H in Glioblastoma Multiforme cases?,msi_h_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,How common is MSI-H in Glioblastoma Multiforme cases?,msi_h_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,How common is MSI-H in Breast Invasive Carcinoma cases?,msi_h_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,How common is MSI-H in Breast Invasive Carcinoma cases?,msi_h_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,How common is MSI-H in Breast Invasive Carcinoma cases?,msi_h_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,How common is MSI-H in Breast Invasive Carcinoma cases?,msi_h_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How common is MSI-H in Ovarian Serous Cystadenocarcinoma cases?,msi_h_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How common is MSI-H in Ovarian Serous Cystadenocarcinoma cases?,msi_h_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How common is MSI-H in Bladder Urothelial Carcinoma cases?,msi_h_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,How common is MSI-H in Brain Lower Grade Glioma cases?,msi_h_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+728,STK19,D341N,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+729,STK19,D345N,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How common is MSI-H in Bladder Urothelial Carcinoma cases?,msi_h_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",msi_h_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",msi_h_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",msi_h_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",msi_h_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How common is MSI-H in Head and Neck Squamous Cell Carcinoma cases?,msi_h_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How common is MSI-H in Head and Neck Squamous Cell Carcinoma cases?,msi_h_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How common is MSI-H in Head and Neck Squamous Cell Carcinoma cases?,msi_h_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How common is MSI-H in Head and Neck Squamous Cell Carcinoma cases?,msi_h_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How common is MSI-H in Head and Neck Squamous Cell Carcinoma cases?,msi_h_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How common is MSI-H in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia cases?,msi_h_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is MSI-H in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,msi_h_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+817,KL,R594C,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How common is MSI-H in Kidney Renal Papillary Cell Carcinoma cases?,msi_h_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is MSI-H in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,msi_h_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",msi_h_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",msi_h_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",msi_h_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",msi_h_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",msi_h_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",msi_h_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",msi_h_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How common is MSI-H in Glioblastoma Multiforme cases?,msi_h_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How common is MSI-H in Liver Hepatocellular Carcinoma cases?,msi_h_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How common is MSI-H in Rectum Adenocarcinoma cases?,msi_h_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",msi_h_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",msi_h_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How common is MSI-H in Pancreatic Adenocarcinoma cases?,msi_h_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How common is MSI-H in Pancreatic Adenocarcinoma cases?,msi_h_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How common is MSI-H in Pancreatic Adenocarcinoma cases?,msi_h_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How common is MSI-H in Pancreatic Adenocarcinoma cases?,msi_h_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How common is MSI-H in Pancreatic Adenocarcinoma cases?,msi_h_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How common is MSI-H in Pancreatic Adenocarcinoma cases?,msi_h_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How common is MSI-H in Pancreatic Adenocarcinoma cases?,msi_h_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How common is MSI-H in Pancreatic Adenocarcinoma cases?,msi_h_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is MSI-H in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,msi_h_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is MSI-H in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,msi_h_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is MSI-H in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,msi_h_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is MSI-H in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,msi_h_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is MSI-H in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,msi_h_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",msi_h_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,How common is MSI-H in Breast Invasive Carcinoma cases?,msi_h_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How common is MSI-H in Breast Invasive Carcinoma cases?,msi_h_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How common is MSI-H in Breast Invasive Carcinoma cases?,msi_h_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How common is MSI-H in Breast Invasive Carcinoma cases?,msi_h_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How common is MSI-H in Breast Invasive Carcinoma cases?,msi_h_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How common is MSI-H in Breast Invasive Carcinoma cases?,msi_h_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How common is MSI-H in Breast Invasive Carcinoma cases?,msi_h_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,How common is MSI-H in Breast Invasive Carcinoma cases?,msi_h_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,How common is MSI-H in Breast Invasive Carcinoma cases?,msi_h_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,How common is MSI-H in Breast Invasive Carcinoma cases?,msi_h_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How common is MSI-H in Liver Hepatocellular Carcinoma cases?,msi_h_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How common is MSI-H in Bladder Urothelial Carcinoma cases?,msi_h_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",msi_h_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How common is MSI-H in Liver Hepatocellular Carcinoma cases?,msi_h_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How common is MSI-H in Liver Hepatocellular Carcinoma cases?,msi_h_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How common is MSI-H in Liver Hepatocellular Carcinoma cases?,msi_h_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How common is MSI-H in Liver Hepatocellular Carcinoma cases?,msi_h_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How common is MSI-H in Liver Hepatocellular Carcinoma cases?,msi_h_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How common is MSI-H in Bladder Urothelial Carcinoma cases?,msi_h_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",msi_h_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How common is MSI-H in Lung Squamous Cell Carcinoma cases?,msi_h_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How common is MSI-H in Bladder Urothelial Carcinoma cases?,msi_h_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How common is MSI-H in Bladder Urothelial Carcinoma cases?,msi_h_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,How common is MSI-H in Rectum Adenocarcinoma cases?,msi_h_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,How common is MSI-H in Rectum Adenocarcinoma cases?,msi_h_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,How common is MSI-H in Rectum Adenocarcinoma cases?,msi_h_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,How common is MSI-H in Rectum Adenocarcinoma cases?,msi_h_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How common is MSI-H in Glioblastoma Multiforme cases?,msi_h_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How common is MSI-H in Glioblastoma Multiforme cases?,msi_h_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How common is MSI-H in Glioblastoma Multiforme cases?,msi_h_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How common is MSI-H in Glioblastoma Multiforme cases?,msi_h_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How common is MSI-H in Glioblastoma Multiforme cases?,msi_h_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How common is MSI-H in Glioblastoma Multiforme cases?,msi_h_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How common is MSI-H in Glioblastoma Multiforme cases?,msi_h_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How common is MSI-H in Prostate Adenocarcinoma cases?,msi_h_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How common is MSI-H in Prostate Adenocarcinoma cases?,msi_h_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How common is MSI-H in Kidney Renal Clear Cell Carcinoma cases?,msi_h_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How common is MSI-H in Kidney Renal Clear Cell Carcinoma cases?,msi_h_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",msi_h_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",msi_h_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",msi_h_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How common is MSI-H in Skin Cutaneous Melanoma cases?,msi_h_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,How common is MSI-H in Lung Adenocarcinoma cases?,msi_h_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,How common is MSI-H in Stomach Adenocarcinoma cases?,msi_h_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How common is MSI-H in Breast Invasive Carcinoma cases?,msi_h_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How common is MSI-H in Breast Invasive Carcinoma cases?,msi_h_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How common is MSI-H in Colon Adenocarcinoma cases?,msi_h_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How common is MSI-H in Uterine Corpus Endometrial Carcinoma cases?,msi_h_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How common is MSI-H in Rectum Adenocarcinoma cases?,msi_h_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,Can you provide the prevalence of microsatellite instability-high in Breast Invasive Carcinoma patients?,msi_h_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,Can you provide the prevalence of microsatellite instability-high in Breast Invasive Carcinoma patients?,msi_h_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,Can you provide the prevalence of microsatellite instability-high in Breast Invasive Carcinoma patients?,msi_h_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,Can you provide the prevalence of microsatellite instability-high in Breast Invasive Carcinoma patients?,msi_h_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,Can you provide the prevalence of microsatellite instability-high in Breast Invasive Carcinoma patients?,msi_h_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,Can you provide the prevalence of microsatellite instability-high in Breast Invasive Carcinoma patients?,msi_h_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,Can you provide the prevalence of microsatellite instability-high in Breast Invasive Carcinoma patients?,msi_h_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Rectum Adenocarcinoma patients?,msi_h_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Rectum Adenocarcinoma patients?,msi_h_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Pancreatic Adenocarcinoma patients?,msi_h_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Prostate Adenocarcinoma patients?,msi_h_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Prostate Adenocarcinoma patients?,msi_h_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Prostate Adenocarcinoma patients?,msi_h_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma patients?,msi_h_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma patients?,msi_h_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma patients?,msi_h_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma patients?,msi_h_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,Can you provide the prevalence of microsatellite instability-high in Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,Can you provide the prevalence of microsatellite instability-high in Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,Can you provide the prevalence of microsatellite instability-high in Breast Invasive Carcinoma patients?,msi_h_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,Can you provide the prevalence of microsatellite instability-high in Breast Invasive Carcinoma patients?,msi_h_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you provide the prevalence of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you provide the prevalence of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+140,BICC1,A372V,Exceptional Responders,Can you provide the prevalence of microsatellite instability-high in Exceptional Responders patients?,msi_h_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you provide the prevalence of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,Can you provide the prevalence of microsatellite instability-high in Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Rectum Adenocarcinoma patients?,msi_h_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Kidney Renal Clear Cell Carcinoma patients?,msi_h_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Kidney Renal Clear Cell Carcinoma patients?,msi_h_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,Can you provide the prevalence of microsatellite instability-high in Breast Invasive Carcinoma patients?,msi_h_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,Can you provide the prevalence of microsatellite instability-high in HIV+ Tumor Molecular Characterization Project - Cervical Cancer patients?,msi_h_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Prostate Adenocarcinoma patients?,msi_h_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Prostate Adenocarcinoma patients?,msi_h_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Prostate Adenocarcinoma patients?,msi_h_frequency
+267,DGKD,R140H,Exceptional Responders,Can you provide the prevalence of microsatellite instability-high in Exceptional Responders patients?,msi_h_frequency
+268,DGKD,R160H,Exceptional Responders,Can you provide the prevalence of microsatellite instability-high in Exceptional Responders patients?,msi_h_frequency
+269,DGKD,R204H,Exceptional Responders,Can you provide the prevalence of microsatellite instability-high in Exceptional Responders patients?,msi_h_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you provide the prevalence of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+299,OR5D14,M210L,Neuroblastoma,Can you provide the prevalence of microsatellite instability-high in Neuroblastoma patients?,msi_h_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Ovarian Serous Cystadenocarcinoma patients?,msi_h_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Ovarian Serous Cystadenocarcinoma patients?,msi_h_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Ovarian Serous Cystadenocarcinoma patients?,msi_h_frequency
+357,ZNF584,A211T,Sarcoma,Can you provide the prevalence of microsatellite instability-high in Sarcoma patients?,msi_h_frequency
+358,ZNF584,A256T,Sarcoma,Can you provide the prevalence of microsatellite instability-high in Sarcoma patients?,msi_h_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,msi_h_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Rectum Adenocarcinoma patients?,msi_h_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Rectum Adenocarcinoma patients?,msi_h_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Rectum Adenocarcinoma patients?,msi_h_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Rectum Adenocarcinoma patients?,msi_h_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,Can you provide the prevalence of microsatellite instability-high in Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Rectum Adenocarcinoma patients?,msi_h_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Rectum Adenocarcinoma patients?,msi_h_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Rectum Adenocarcinoma patients?,msi_h_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Rectum Adenocarcinoma patients?,msi_h_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Rectum Adenocarcinoma patients?,msi_h_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Rectum Adenocarcinoma patients?,msi_h_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Rectum Adenocarcinoma patients?,msi_h_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Rectum Adenocarcinoma patients?,msi_h_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Rectum Adenocarcinoma patients?,msi_h_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma patients?,msi_h_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma patients?,msi_h_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,Can you provide the prevalence of microsatellite instability-high in Glioblastoma Multiforme patients?,msi_h_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,Can you provide the prevalence of microsatellite instability-high in Glioblastoma Multiforme patients?,msi_h_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,Can you provide the prevalence of microsatellite instability-high in Breast Invasive Carcinoma patients?,msi_h_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,Can you provide the prevalence of microsatellite instability-high in Breast Invasive Carcinoma patients?,msi_h_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,Can you provide the prevalence of microsatellite instability-high in Breast Invasive Carcinoma patients?,msi_h_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,Can you provide the prevalence of microsatellite instability-high in Breast Invasive Carcinoma patients?,msi_h_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Ovarian Serous Cystadenocarcinoma patients?,msi_h_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Ovarian Serous Cystadenocarcinoma patients?,msi_h_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,Can you provide the prevalence of microsatellite instability-high in Brain Lower Grade Glioma patients?,msi_h_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+728,STK19,D341N,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+729,STK19,D345N,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you provide the prevalence of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you provide the prevalence of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you provide the prevalence of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you provide the prevalence of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Head and Neck Squamous Cell Carcinoma patients?,msi_h_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Head and Neck Squamous Cell Carcinoma patients?,msi_h_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Head and Neck Squamous Cell Carcinoma patients?,msi_h_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Head and Neck Squamous Cell Carcinoma patients?,msi_h_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Head and Neck Squamous Cell Carcinoma patients?,msi_h_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,Can you provide the prevalence of microsatellite instability-high in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia patients?,msi_h_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,msi_h_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+817,KL,R594C,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma patients?,msi_h_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,msi_h_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you provide the prevalence of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you provide the prevalence of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you provide the prevalence of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you provide the prevalence of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you provide the prevalence of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you provide the prevalence of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you provide the prevalence of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,Can you provide the prevalence of microsatellite instability-high in Glioblastoma Multiforme patients?,msi_h_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,Can you provide the prevalence of microsatellite instability-high in Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Rectum Adenocarcinoma patients?,msi_h_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you provide the prevalence of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you provide the prevalence of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Pancreatic Adenocarcinoma patients?,msi_h_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Pancreatic Adenocarcinoma patients?,msi_h_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Pancreatic Adenocarcinoma patients?,msi_h_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Pancreatic Adenocarcinoma patients?,msi_h_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Pancreatic Adenocarcinoma patients?,msi_h_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Pancreatic Adenocarcinoma patients?,msi_h_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Pancreatic Adenocarcinoma patients?,msi_h_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Pancreatic Adenocarcinoma patients?,msi_h_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,msi_h_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,msi_h_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,msi_h_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,msi_h_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,msi_h_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you provide the prevalence of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,Can you provide the prevalence of microsatellite instability-high in Breast Invasive Carcinoma patients?,msi_h_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,Can you provide the prevalence of microsatellite instability-high in Breast Invasive Carcinoma patients?,msi_h_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,Can you provide the prevalence of microsatellite instability-high in Breast Invasive Carcinoma patients?,msi_h_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,Can you provide the prevalence of microsatellite instability-high in Breast Invasive Carcinoma patients?,msi_h_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,Can you provide the prevalence of microsatellite instability-high in Breast Invasive Carcinoma patients?,msi_h_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,Can you provide the prevalence of microsatellite instability-high in Breast Invasive Carcinoma patients?,msi_h_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,Can you provide the prevalence of microsatellite instability-high in Breast Invasive Carcinoma patients?,msi_h_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,Can you provide the prevalence of microsatellite instability-high in Breast Invasive Carcinoma patients?,msi_h_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,Can you provide the prevalence of microsatellite instability-high in Breast Invasive Carcinoma patients?,msi_h_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,Can you provide the prevalence of microsatellite instability-high in Breast Invasive Carcinoma patients?,msi_h_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,Can you provide the prevalence of microsatellite instability-high in Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you provide the prevalence of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,Can you provide the prevalence of microsatellite instability-high in Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,Can you provide the prevalence of microsatellite instability-high in Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,Can you provide the prevalence of microsatellite instability-high in Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,Can you provide the prevalence of microsatellite instability-high in Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,Can you provide the prevalence of microsatellite instability-high in Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you provide the prevalence of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Rectum Adenocarcinoma patients?,msi_h_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Rectum Adenocarcinoma patients?,msi_h_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Rectum Adenocarcinoma patients?,msi_h_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Rectum Adenocarcinoma patients?,msi_h_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,Can you provide the prevalence of microsatellite instability-high in Glioblastoma Multiforme patients?,msi_h_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,Can you provide the prevalence of microsatellite instability-high in Glioblastoma Multiforme patients?,msi_h_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,Can you provide the prevalence of microsatellite instability-high in Glioblastoma Multiforme patients?,msi_h_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,Can you provide the prevalence of microsatellite instability-high in Glioblastoma Multiforme patients?,msi_h_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,Can you provide the prevalence of microsatellite instability-high in Glioblastoma Multiforme patients?,msi_h_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,Can you provide the prevalence of microsatellite instability-high in Glioblastoma Multiforme patients?,msi_h_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,Can you provide the prevalence of microsatellite instability-high in Glioblastoma Multiforme patients?,msi_h_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Prostate Adenocarcinoma patients?,msi_h_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Prostate Adenocarcinoma patients?,msi_h_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Kidney Renal Clear Cell Carcinoma patients?,msi_h_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,Can you provide the prevalence of microsatellite instability-high in Kidney Renal Clear Cell Carcinoma patients?,msi_h_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you provide the prevalence of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you provide the prevalence of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you provide the prevalence of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,Can you provide the prevalence of microsatellite instability-high in Skin Cutaneous Melanoma patients?,msi_h_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Lung Adenocarcinoma patients?,msi_h_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Stomach Adenocarcinoma patients?,msi_h_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,Can you provide the prevalence of microsatellite instability-high in Breast Invasive Carcinoma patients?,msi_h_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,Can you provide the prevalence of microsatellite instability-high in Breast Invasive Carcinoma patients?,msi_h_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Colon Adenocarcinoma patients?,msi_h_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,Can you provide the prevalence of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,Can you provide the prevalence of microsatellite instability-high in Rectum Adenocarcinoma patients?,msi_h_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have MSI-H?,msi_h_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have MSI-H?,msi_h_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have MSI-H?,msi_h_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have MSI-H?,msi_h_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have MSI-H?,msi_h_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have MSI-H?,msi_h_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have MSI-H?,msi_h_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have MSI-H?,msi_h_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have MSI-H?,msi_h_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have MSI-H?,msi_h_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have MSI-H?,msi_h_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma patients have MSI-H?,msi_h_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma patients have MSI-H?,msi_h_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma patients have MSI-H?,msi_h_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma patients have MSI-H?,msi_h_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma patients have MSI-H?,msi_h_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma patients have MSI-H?,msi_h_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma patients have MSI-H?,msi_h_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma patients have MSI-H?,msi_h_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have MSI-H?,msi_h_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have MSI-H?,msi_h_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have MSI-H?,msi_h_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have MSI-H?,msi_h_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma patients have MSI-H?,msi_h_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma patients have MSI-H?,msi_h_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have MSI-H?,msi_h_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have MSI-H?,msi_h_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have MSI-H?",msi_h_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have MSI-H?",msi_h_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have MSI-H?,msi_h_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have MSI-H?,msi_h_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have MSI-H?,msi_h_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have MSI-H?,msi_h_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+140,BICC1,A372V,Exceptional Responders,What percentage of Exceptional Responders patients have MSI-H?,msi_h_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have MSI-H?",msi_h_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma patients have MSI-H?,msi_h_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have MSI-H?,msi_h_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma patients have MSI-H?,msi_h_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma patients have MSI-H?,msi_h_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have MSI-H?,msi_h_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What percentage of HIV+ Tumor Molecular Characterization Project - Cervical Cancer patients have MSI-H?,msi_h_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma patients have MSI-H?,msi_h_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma patients have MSI-H?,msi_h_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma patients have MSI-H?,msi_h_frequency
+267,DGKD,R140H,Exceptional Responders,What percentage of Exceptional Responders patients have MSI-H?,msi_h_frequency
+268,DGKD,R160H,Exceptional Responders,What percentage of Exceptional Responders patients have MSI-H?,msi_h_frequency
+269,DGKD,R204H,Exceptional Responders,What percentage of Exceptional Responders patients have MSI-H?,msi_h_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have MSI-H?,msi_h_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have MSI-H?,msi_h_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have MSI-H?,msi_h_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have MSI-H?",msi_h_frequency
+299,OR5D14,M210L,Neuroblastoma,What percentage of Neuroblastoma patients have MSI-H?,msi_h_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma patients have MSI-H?,msi_h_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma patients have MSI-H?,msi_h_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma patients have MSI-H?,msi_h_frequency
+357,ZNF584,A211T,Sarcoma,What percentage of Sarcoma patients have MSI-H?,msi_h_frequency
+358,ZNF584,A256T,Sarcoma,What percentage of Sarcoma patients have MSI-H?,msi_h_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have MSI-H?,msi_h_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have MSI-H?,msi_h_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have MSI-H?,msi_h_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have MSI-H?,msi_h_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have MSI-H?,msi_h_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma patients have MSI-H?,msi_h_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have MSI-H?,msi_h_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have MSI-H?,msi_h_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have MSI-H?,msi_h_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have MSI-H?,msi_h_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have MSI-H?,msi_h_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have MSI-H?,msi_h_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have MSI-H?,msi_h_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have MSI-H?,msi_h_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have MSI-H?,msi_h_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma patients have MSI-H?,msi_h_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma patients have MSI-H?,msi_h_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have MSI-H?,msi_h_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have MSI-H?,msi_h_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme patients have MSI-H?,msi_h_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme patients have MSI-H?,msi_h_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have MSI-H?,msi_h_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have MSI-H?,msi_h_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have MSI-H?,msi_h_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have MSI-H?,msi_h_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma patients have MSI-H?,msi_h_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma patients have MSI-H?,msi_h_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have MSI-H?,msi_h_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,What percentage of Brain Lower Grade Glioma patients have MSI-H?,msi_h_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+728,STK19,D341N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+729,STK19,D345N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have MSI-H?,msi_h_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have MSI-H?",msi_h_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have MSI-H?",msi_h_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have MSI-H?",msi_h_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have MSI-H?",msi_h_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What percentage of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia patients have MSI-H?,msi_h_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have MSI-H?,msi_h_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+817,KL,R594C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma patients have MSI-H?,msi_h_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have MSI-H?,msi_h_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have MSI-H?",msi_h_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have MSI-H?",msi_h_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have MSI-H?",msi_h_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have MSI-H?",msi_h_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have MSI-H?",msi_h_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have MSI-H?",msi_h_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have MSI-H?",msi_h_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme patients have MSI-H?,msi_h_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma patients have MSI-H?,msi_h_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have MSI-H?,msi_h_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have MSI-H?",msi_h_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have MSI-H?",msi_h_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma patients have MSI-H?,msi_h_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma patients have MSI-H?,msi_h_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma patients have MSI-H?,msi_h_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma patients have MSI-H?,msi_h_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma patients have MSI-H?,msi_h_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have MSI-H?",msi_h_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have MSI-H?,msi_h_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have MSI-H?,msi_h_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have MSI-H?,msi_h_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have MSI-H?,msi_h_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have MSI-H?,msi_h_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have MSI-H?,msi_h_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have MSI-H?,msi_h_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have MSI-H?,msi_h_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have MSI-H?,msi_h_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have MSI-H?,msi_h_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma patients have MSI-H?,msi_h_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have MSI-H?,msi_h_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have MSI-H?",msi_h_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma patients have MSI-H?,msi_h_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma patients have MSI-H?,msi_h_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma patients have MSI-H?,msi_h_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma patients have MSI-H?,msi_h_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma patients have MSI-H?,msi_h_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have MSI-H?,msi_h_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have MSI-H?",msi_h_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have MSI-H?,msi_h_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have MSI-H?,msi_h_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have MSI-H?,msi_h_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme patients have MSI-H?,msi_h_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme patients have MSI-H?,msi_h_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme patients have MSI-H?,msi_h_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme patients have MSI-H?,msi_h_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme patients have MSI-H?,msi_h_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme patients have MSI-H?,msi_h_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme patients have MSI-H?,msi_h_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma patients have MSI-H?,msi_h_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma patients have MSI-H?,msi_h_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have MSI-H?",msi_h_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have MSI-H?",msi_h_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have MSI-H?",msi_h_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have MSI-H?,msi_h_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have MSI-H?,msi_h_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have MSI-H?,msi_h_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have MSI-H?,msi_h_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have MSI-H?,msi_h_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,How often is microsatellite instability-high observed in Breast Invasive Carcinoma?,msi_h_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,How often is microsatellite instability-high observed in Breast Invasive Carcinoma?,msi_h_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,How often is microsatellite instability-high observed in Breast Invasive Carcinoma?,msi_h_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,How often is microsatellite instability-high observed in Breast Invasive Carcinoma?,msi_h_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,How often is microsatellite instability-high observed in Breast Invasive Carcinoma?,msi_h_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,How often is microsatellite instability-high observed in Breast Invasive Carcinoma?,msi_h_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,How often is microsatellite instability-high observed in Breast Invasive Carcinoma?,msi_h_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How often is microsatellite instability-high observed in Bladder Urothelial Carcinoma?,msi_h_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How often is microsatellite instability-high observed in Bladder Urothelial Carcinoma?,msi_h_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,How often is microsatellite instability-high observed in Rectum Adenocarcinoma?,msi_h_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,How often is microsatellite instability-high observed in Rectum Adenocarcinoma?,msi_h_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How often is microsatellite instability-high observed in Pancreatic Adenocarcinoma?,msi_h_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How often is microsatellite instability-high observed in Prostate Adenocarcinoma?,msi_h_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How often is microsatellite instability-high observed in Prostate Adenocarcinoma?,msi_h_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How often is microsatellite instability-high observed in Prostate Adenocarcinoma?,msi_h_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How often is microsatellite instability-high observed in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How often is microsatellite instability-high observed in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How often is microsatellite instability-high observed in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How often is microsatellite instability-high observed in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How often is microsatellite instability-high observed in Bladder Urothelial Carcinoma?,msi_h_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How often is microsatellite instability-high observed in Bladder Urothelial Carcinoma?,msi_h_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How often is microsatellite instability-high observed in Bladder Urothelial Carcinoma?,msi_h_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How often is microsatellite instability-high observed in Bladder Urothelial Carcinoma?,msi_h_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How often is microsatellite instability-high observed in Liver Hepatocellular Carcinoma?,msi_h_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How often is microsatellite instability-high observed in Liver Hepatocellular Carcinoma?,msi_h_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How often is microsatellite instability-high observed in Breast Invasive Carcinoma?,msi_h_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How often is microsatellite instability-high observed in Breast Invasive Carcinoma?,msi_h_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is microsatellite instability-high observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is microsatellite instability-high observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How often is microsatellite instability-high observed in Bladder Urothelial Carcinoma?,msi_h_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How often is microsatellite instability-high observed in Bladder Urothelial Carcinoma?,msi_h_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How often is microsatellite instability-high observed in Bladder Urothelial Carcinoma?,msi_h_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How often is microsatellite instability-high observed in Bladder Urothelial Carcinoma?,msi_h_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+140,BICC1,A372V,Exceptional Responders,How often is microsatellite instability-high observed in Exceptional Responders?,msi_h_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is microsatellite instability-high observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How often is microsatellite instability-high observed in Liver Hepatocellular Carcinoma?,msi_h_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,How often is microsatellite instability-high observed in Rectum Adenocarcinoma?,msi_h_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How often is microsatellite instability-high observed in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How often is microsatellite instability-high observed in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How often is microsatellite instability-high observed in Breast Invasive Carcinoma?,msi_h_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How often is microsatellite instability-high observed in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,msi_h_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,How often is microsatellite instability-high observed in Prostate Adenocarcinoma?,msi_h_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,How often is microsatellite instability-high observed in Prostate Adenocarcinoma?,msi_h_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,How often is microsatellite instability-high observed in Prostate Adenocarcinoma?,msi_h_frequency
+267,DGKD,R140H,Exceptional Responders,How often is microsatellite instability-high observed in Exceptional Responders?,msi_h_frequency
+268,DGKD,R160H,Exceptional Responders,How often is microsatellite instability-high observed in Exceptional Responders?,msi_h_frequency
+269,DGKD,R204H,Exceptional Responders,How often is microsatellite instability-high observed in Exceptional Responders?,msi_h_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How often is microsatellite instability-high observed in Bladder Urothelial Carcinoma?,msi_h_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How often is microsatellite instability-high observed in Bladder Urothelial Carcinoma?,msi_h_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How often is microsatellite instability-high observed in Bladder Urothelial Carcinoma?,msi_h_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is microsatellite instability-high observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+299,OR5D14,M210L,Neuroblastoma,How often is microsatellite instability-high observed in Neuroblastoma?,msi_h_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How often is microsatellite instability-high observed in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How often is microsatellite instability-high observed in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How often is microsatellite instability-high observed in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+357,ZNF584,A211T,Sarcoma,How often is microsatellite instability-high observed in Sarcoma?,msi_h_frequency
+358,ZNF584,A256T,Sarcoma,How often is microsatellite instability-high observed in Sarcoma?,msi_h_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often is microsatellite instability-high observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,How often is microsatellite instability-high observed in Rectum Adenocarcinoma?,msi_h_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,How often is microsatellite instability-high observed in Rectum Adenocarcinoma?,msi_h_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,How often is microsatellite instability-high observed in Rectum Adenocarcinoma?,msi_h_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,How often is microsatellite instability-high observed in Rectum Adenocarcinoma?,msi_h_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How often is microsatellite instability-high observed in Liver Hepatocellular Carcinoma?,msi_h_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,How often is microsatellite instability-high observed in Rectum Adenocarcinoma?,msi_h_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,How often is microsatellite instability-high observed in Rectum Adenocarcinoma?,msi_h_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,How often is microsatellite instability-high observed in Rectum Adenocarcinoma?,msi_h_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,How often is microsatellite instability-high observed in Rectum Adenocarcinoma?,msi_h_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,How often is microsatellite instability-high observed in Rectum Adenocarcinoma?,msi_h_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,How often is microsatellite instability-high observed in Rectum Adenocarcinoma?,msi_h_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,How often is microsatellite instability-high observed in Rectum Adenocarcinoma?,msi_h_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,How often is microsatellite instability-high observed in Rectum Adenocarcinoma?,msi_h_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,How often is microsatellite instability-high observed in Rectum Adenocarcinoma?,msi_h_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How often is microsatellite instability-high observed in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How often is microsatellite instability-high observed in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How often is microsatellite instability-high observed in Bladder Urothelial Carcinoma?,msi_h_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How often is microsatellite instability-high observed in Bladder Urothelial Carcinoma?,msi_h_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,How often is microsatellite instability-high observed in Glioblastoma Multiforme?,msi_h_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,How often is microsatellite instability-high observed in Glioblastoma Multiforme?,msi_h_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,How often is microsatellite instability-high observed in Breast Invasive Carcinoma?,msi_h_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,How often is microsatellite instability-high observed in Breast Invasive Carcinoma?,msi_h_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,How often is microsatellite instability-high observed in Breast Invasive Carcinoma?,msi_h_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,How often is microsatellite instability-high observed in Breast Invasive Carcinoma?,msi_h_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How often is microsatellite instability-high observed in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How often is microsatellite instability-high observed in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How often is microsatellite instability-high observed in Bladder Urothelial Carcinoma?,msi_h_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,How often is microsatellite instability-high observed in Brain Lower Grade Glioma?,msi_h_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+728,STK19,D341N,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+729,STK19,D345N,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How often is microsatellite instability-high observed in Bladder Urothelial Carcinoma?,msi_h_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is microsatellite instability-high observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is microsatellite instability-high observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is microsatellite instability-high observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is microsatellite instability-high observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How often is microsatellite instability-high observed in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,msi_h_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often is microsatellite instability-high observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+817,KL,R594C,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How often is microsatellite instability-high observed in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often is microsatellite instability-high observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is microsatellite instability-high observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is microsatellite instability-high observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is microsatellite instability-high observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is microsatellite instability-high observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is microsatellite instability-high observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is microsatellite instability-high observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is microsatellite instability-high observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How often is microsatellite instability-high observed in Glioblastoma Multiforme?,msi_h_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How often is microsatellite instability-high observed in Liver Hepatocellular Carcinoma?,msi_h_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How often is microsatellite instability-high observed in Rectum Adenocarcinoma?,msi_h_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is microsatellite instability-high observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is microsatellite instability-high observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How often is microsatellite instability-high observed in Pancreatic Adenocarcinoma?,msi_h_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How often is microsatellite instability-high observed in Pancreatic Adenocarcinoma?,msi_h_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How often is microsatellite instability-high observed in Pancreatic Adenocarcinoma?,msi_h_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How often is microsatellite instability-high observed in Pancreatic Adenocarcinoma?,msi_h_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How often is microsatellite instability-high observed in Pancreatic Adenocarcinoma?,msi_h_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How often is microsatellite instability-high observed in Pancreatic Adenocarcinoma?,msi_h_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How often is microsatellite instability-high observed in Pancreatic Adenocarcinoma?,msi_h_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How often is microsatellite instability-high observed in Pancreatic Adenocarcinoma?,msi_h_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often is microsatellite instability-high observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often is microsatellite instability-high observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often is microsatellite instability-high observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often is microsatellite instability-high observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often is microsatellite instability-high observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is microsatellite instability-high observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,How often is microsatellite instability-high observed in Breast Invasive Carcinoma?,msi_h_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How often is microsatellite instability-high observed in Breast Invasive Carcinoma?,msi_h_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How often is microsatellite instability-high observed in Breast Invasive Carcinoma?,msi_h_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How often is microsatellite instability-high observed in Breast Invasive Carcinoma?,msi_h_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How often is microsatellite instability-high observed in Breast Invasive Carcinoma?,msi_h_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How often is microsatellite instability-high observed in Breast Invasive Carcinoma?,msi_h_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How often is microsatellite instability-high observed in Breast Invasive Carcinoma?,msi_h_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,How often is microsatellite instability-high observed in Breast Invasive Carcinoma?,msi_h_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,How often is microsatellite instability-high observed in Breast Invasive Carcinoma?,msi_h_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,How often is microsatellite instability-high observed in Breast Invasive Carcinoma?,msi_h_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How often is microsatellite instability-high observed in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How often is microsatellite instability-high observed in Bladder Urothelial Carcinoma?,msi_h_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is microsatellite instability-high observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How often is microsatellite instability-high observed in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How often is microsatellite instability-high observed in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How often is microsatellite instability-high observed in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How often is microsatellite instability-high observed in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How often is microsatellite instability-high observed in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How often is microsatellite instability-high observed in Bladder Urothelial Carcinoma?,msi_h_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is microsatellite instability-high observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How often is microsatellite instability-high observed in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How often is microsatellite instability-high observed in Bladder Urothelial Carcinoma?,msi_h_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How often is microsatellite instability-high observed in Bladder Urothelial Carcinoma?,msi_h_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,How often is microsatellite instability-high observed in Rectum Adenocarcinoma?,msi_h_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,How often is microsatellite instability-high observed in Rectum Adenocarcinoma?,msi_h_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,How often is microsatellite instability-high observed in Rectum Adenocarcinoma?,msi_h_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,How often is microsatellite instability-high observed in Rectum Adenocarcinoma?,msi_h_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How often is microsatellite instability-high observed in Glioblastoma Multiforme?,msi_h_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How often is microsatellite instability-high observed in Glioblastoma Multiforme?,msi_h_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How often is microsatellite instability-high observed in Glioblastoma Multiforme?,msi_h_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How often is microsatellite instability-high observed in Glioblastoma Multiforme?,msi_h_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How often is microsatellite instability-high observed in Glioblastoma Multiforme?,msi_h_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How often is microsatellite instability-high observed in Glioblastoma Multiforme?,msi_h_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How often is microsatellite instability-high observed in Glioblastoma Multiforme?,msi_h_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How often is microsatellite instability-high observed in Prostate Adenocarcinoma?,msi_h_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How often is microsatellite instability-high observed in Prostate Adenocarcinoma?,msi_h_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How often is microsatellite instability-high observed in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How often is microsatellite instability-high observed in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is microsatellite instability-high observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is microsatellite instability-high observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is microsatellite instability-high observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How often is microsatellite instability-high observed in Skin Cutaneous Melanoma?,msi_h_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,How often is microsatellite instability-high observed in Lung Adenocarcinoma?,msi_h_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,How often is microsatellite instability-high observed in Stomach Adenocarcinoma?,msi_h_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How often is microsatellite instability-high observed in Breast Invasive Carcinoma?,msi_h_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How often is microsatellite instability-high observed in Breast Invasive Carcinoma?,msi_h_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How often is microsatellite instability-high observed in Colon Adenocarcinoma?,msi_h_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How often is microsatellite instability-high observed in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How often is microsatellite instability-high observed in Rectum Adenocarcinoma?,msi_h_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,"In Pancreatic Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,"In Prostate Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,"In Prostate Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,"In Prostate Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,"In Kidney Renal Papillary Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,"In Kidney Renal Papillary Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,"In Kidney Renal Papillary Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,"In Kidney Renal Papillary Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,"In Liver Hepatocellular Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,"In Liver Hepatocellular Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of MSI-H?",msi_h_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of MSI-H?",msi_h_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+140,BICC1,A372V,Exceptional Responders,"In Exceptional Responders, what is the occurrence rate of MSI-H?",msi_h_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of MSI-H?",msi_h_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,"In Liver Hepatocellular Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,"In Kidney Renal Clear Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,"In Kidney Renal Clear Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,"In HIV+ Tumor Molecular Characterization Project - Cervical Cancer, what is the occurrence rate of MSI-H?",msi_h_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,"In Prostate Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,"In Prostate Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,"In Prostate Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+267,DGKD,R140H,Exceptional Responders,"In Exceptional Responders, what is the occurrence rate of MSI-H?",msi_h_frequency
+268,DGKD,R160H,Exceptional Responders,"In Exceptional Responders, what is the occurrence rate of MSI-H?",msi_h_frequency
+269,DGKD,R204H,Exceptional Responders,"In Exceptional Responders, what is the occurrence rate of MSI-H?",msi_h_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of MSI-H?",msi_h_frequency
+299,OR5D14,M210L,Neuroblastoma,"In Neuroblastoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,"In Ovarian Serous Cystadenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,"In Ovarian Serous Cystadenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,"In Ovarian Serous Cystadenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+357,ZNF584,A211T,Sarcoma,"In Sarcoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+358,ZNF584,A256T,Sarcoma,"In Sarcoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,"In Liver Hepatocellular Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,"In Kidney Renal Papillary Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,"In Kidney Renal Papillary Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,"In Glioblastoma Multiforme, what is the occurrence rate of MSI-H?",msi_h_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,"In Glioblastoma Multiforme, what is the occurrence rate of MSI-H?",msi_h_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,"In Ovarian Serous Cystadenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,"In Ovarian Serous Cystadenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,"In Brain Lower Grade Glioma, what is the occurrence rate of MSI-H?",msi_h_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+728,STK19,D341N,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+729,STK19,D345N,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of MSI-H?",msi_h_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of MSI-H?",msi_h_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of MSI-H?",msi_h_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of MSI-H?",msi_h_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,"In Head and Neck Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,"In Head and Neck Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,"In Head and Neck Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,"In Head and Neck Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,"In Head and Neck Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,"In Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia, what is the occurrence rate of MSI-H?",msi_h_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+817,KL,R594C,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,"In Kidney Renal Papillary Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of MSI-H?",msi_h_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of MSI-H?",msi_h_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of MSI-H?",msi_h_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of MSI-H?",msi_h_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of MSI-H?",msi_h_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of MSI-H?",msi_h_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of MSI-H?",msi_h_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,"In Glioblastoma Multiforme, what is the occurrence rate of MSI-H?",msi_h_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,"In Liver Hepatocellular Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of MSI-H?",msi_h_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of MSI-H?",msi_h_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,"In Pancreatic Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,"In Pancreatic Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,"In Pancreatic Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,"In Pancreatic Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,"In Pancreatic Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,"In Pancreatic Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,"In Pancreatic Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,"In Pancreatic Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of MSI-H?",msi_h_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,"In Liver Hepatocellular Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of MSI-H?",msi_h_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,"In Liver Hepatocellular Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,"In Liver Hepatocellular Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,"In Liver Hepatocellular Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,"In Liver Hepatocellular Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,"In Liver Hepatocellular Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of MSI-H?",msi_h_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,"In Glioblastoma Multiforme, what is the occurrence rate of MSI-H?",msi_h_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,"In Glioblastoma Multiforme, what is the occurrence rate of MSI-H?",msi_h_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,"In Glioblastoma Multiforme, what is the occurrence rate of MSI-H?",msi_h_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,"In Glioblastoma Multiforme, what is the occurrence rate of MSI-H?",msi_h_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,"In Glioblastoma Multiforme, what is the occurrence rate of MSI-H?",msi_h_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,"In Glioblastoma Multiforme, what is the occurrence rate of MSI-H?",msi_h_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,"In Glioblastoma Multiforme, what is the occurrence rate of MSI-H?",msi_h_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,"In Prostate Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,"In Prostate Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,"In Kidney Renal Clear Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,"In Kidney Renal Clear Cell Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of MSI-H?",msi_h_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of MSI-H?",msi_h_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of MSI-H?",msi_h_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of MSI-H?",msi_h_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the incidence of MSI-H in Breast Invasive Carcinoma?,msi_h_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the incidence of MSI-H in Breast Invasive Carcinoma?,msi_h_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the incidence of MSI-H in Breast Invasive Carcinoma?,msi_h_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the incidence of MSI-H in Breast Invasive Carcinoma?,msi_h_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the incidence of MSI-H in Breast Invasive Carcinoma?,msi_h_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the incidence of MSI-H in Breast Invasive Carcinoma?,msi_h_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the incidence of MSI-H in Breast Invasive Carcinoma?,msi_h_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the incidence of MSI-H in Bladder Urothelial Carcinoma?,msi_h_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the incidence of MSI-H in Bladder Urothelial Carcinoma?,msi_h_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the incidence of MSI-H in Rectum Adenocarcinoma?,msi_h_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the incidence of MSI-H in Rectum Adenocarcinoma?,msi_h_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the incidence of MSI-H in Pancreatic Adenocarcinoma?,msi_h_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the incidence of MSI-H in Prostate Adenocarcinoma?,msi_h_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the incidence of MSI-H in Prostate Adenocarcinoma?,msi_h_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the incidence of MSI-H in Prostate Adenocarcinoma?,msi_h_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the incidence of MSI-H in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the incidence of MSI-H in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the incidence of MSI-H in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the incidence of MSI-H in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the incidence of MSI-H in Bladder Urothelial Carcinoma?,msi_h_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the incidence of MSI-H in Bladder Urothelial Carcinoma?,msi_h_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the incidence of MSI-H in Bladder Urothelial Carcinoma?,msi_h_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the incidence of MSI-H in Bladder Urothelial Carcinoma?,msi_h_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the incidence of MSI-H in Liver Hepatocellular Carcinoma?,msi_h_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the incidence of MSI-H in Liver Hepatocellular Carcinoma?,msi_h_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the incidence of MSI-H in Breast Invasive Carcinoma?,msi_h_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the incidence of MSI-H in Breast Invasive Carcinoma?,msi_h_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the incidence of MSI-H in Bladder Urothelial Carcinoma?,msi_h_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the incidence of MSI-H in Bladder Urothelial Carcinoma?,msi_h_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the incidence of MSI-H in Bladder Urothelial Carcinoma?,msi_h_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the incidence of MSI-H in Bladder Urothelial Carcinoma?,msi_h_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+140,BICC1,A372V,Exceptional Responders,What is the incidence of MSI-H in Exceptional Responders?,msi_h_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the incidence of MSI-H in Liver Hepatocellular Carcinoma?,msi_h_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the incidence of MSI-H in Rectum Adenocarcinoma?,msi_h_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the incidence of MSI-H in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the incidence of MSI-H in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the incidence of MSI-H in Breast Invasive Carcinoma?,msi_h_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the incidence of MSI-H in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,msi_h_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the incidence of MSI-H in Prostate Adenocarcinoma?,msi_h_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the incidence of MSI-H in Prostate Adenocarcinoma?,msi_h_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the incidence of MSI-H in Prostate Adenocarcinoma?,msi_h_frequency
+267,DGKD,R140H,Exceptional Responders,What is the incidence of MSI-H in Exceptional Responders?,msi_h_frequency
+268,DGKD,R160H,Exceptional Responders,What is the incidence of MSI-H in Exceptional Responders?,msi_h_frequency
+269,DGKD,R204H,Exceptional Responders,What is the incidence of MSI-H in Exceptional Responders?,msi_h_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the incidence of MSI-H in Bladder Urothelial Carcinoma?,msi_h_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the incidence of MSI-H in Bladder Urothelial Carcinoma?,msi_h_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the incidence of MSI-H in Bladder Urothelial Carcinoma?,msi_h_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+299,OR5D14,M210L,Neuroblastoma,What is the incidence of MSI-H in Neuroblastoma?,msi_h_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the incidence of MSI-H in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the incidence of MSI-H in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the incidence of MSI-H in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+357,ZNF584,A211T,Sarcoma,What is the incidence of MSI-H in Sarcoma?,msi_h_frequency
+358,ZNF584,A256T,Sarcoma,What is the incidence of MSI-H in Sarcoma?,msi_h_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of MSI-H in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the incidence of MSI-H in Rectum Adenocarcinoma?,msi_h_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the incidence of MSI-H in Rectum Adenocarcinoma?,msi_h_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the incidence of MSI-H in Rectum Adenocarcinoma?,msi_h_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the incidence of MSI-H in Rectum Adenocarcinoma?,msi_h_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the incidence of MSI-H in Liver Hepatocellular Carcinoma?,msi_h_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the incidence of MSI-H in Rectum Adenocarcinoma?,msi_h_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the incidence of MSI-H in Rectum Adenocarcinoma?,msi_h_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the incidence of MSI-H in Rectum Adenocarcinoma?,msi_h_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the incidence of MSI-H in Rectum Adenocarcinoma?,msi_h_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,What is the incidence of MSI-H in Rectum Adenocarcinoma?,msi_h_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,What is the incidence of MSI-H in Rectum Adenocarcinoma?,msi_h_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,What is the incidence of MSI-H in Rectum Adenocarcinoma?,msi_h_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,What is the incidence of MSI-H in Rectum Adenocarcinoma?,msi_h_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,What is the incidence of MSI-H in Rectum Adenocarcinoma?,msi_h_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the incidence of MSI-H in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the incidence of MSI-H in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the incidence of MSI-H in Bladder Urothelial Carcinoma?,msi_h_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the incidence of MSI-H in Bladder Urothelial Carcinoma?,msi_h_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the incidence of MSI-H in Glioblastoma Multiforme?,msi_h_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the incidence of MSI-H in Glioblastoma Multiforme?,msi_h_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,What is the incidence of MSI-H in Breast Invasive Carcinoma?,msi_h_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,What is the incidence of MSI-H in Breast Invasive Carcinoma?,msi_h_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,What is the incidence of MSI-H in Breast Invasive Carcinoma?,msi_h_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,What is the incidence of MSI-H in Breast Invasive Carcinoma?,msi_h_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the incidence of MSI-H in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the incidence of MSI-H in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the incidence of MSI-H in Bladder Urothelial Carcinoma?,msi_h_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the incidence of MSI-H in Brain Lower Grade Glioma?,msi_h_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+728,STK19,D341N,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+729,STK19,D345N,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the incidence of MSI-H in Bladder Urothelial Carcinoma?,msi_h_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the incidence of MSI-H in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the incidence of MSI-H in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the incidence of MSI-H in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the incidence of MSI-H in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the incidence of MSI-H in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the incidence of MSI-H in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,msi_h_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of MSI-H in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+817,KL,R594C,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the incidence of MSI-H in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of MSI-H in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the incidence of MSI-H in Glioblastoma Multiforme?,msi_h_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the incidence of MSI-H in Liver Hepatocellular Carcinoma?,msi_h_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the incidence of MSI-H in Rectum Adenocarcinoma?,msi_h_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the incidence of MSI-H in Pancreatic Adenocarcinoma?,msi_h_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the incidence of MSI-H in Pancreatic Adenocarcinoma?,msi_h_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the incidence of MSI-H in Pancreatic Adenocarcinoma?,msi_h_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the incidence of MSI-H in Pancreatic Adenocarcinoma?,msi_h_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the incidence of MSI-H in Pancreatic Adenocarcinoma?,msi_h_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the incidence of MSI-H in Pancreatic Adenocarcinoma?,msi_h_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the incidence of MSI-H in Pancreatic Adenocarcinoma?,msi_h_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the incidence of MSI-H in Pancreatic Adenocarcinoma?,msi_h_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of MSI-H in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of MSI-H in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of MSI-H in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of MSI-H in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of MSI-H in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the incidence of MSI-H in Breast Invasive Carcinoma?,msi_h_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the incidence of MSI-H in Breast Invasive Carcinoma?,msi_h_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the incidence of MSI-H in Breast Invasive Carcinoma?,msi_h_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the incidence of MSI-H in Breast Invasive Carcinoma?,msi_h_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the incidence of MSI-H in Breast Invasive Carcinoma?,msi_h_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the incidence of MSI-H in Breast Invasive Carcinoma?,msi_h_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the incidence of MSI-H in Breast Invasive Carcinoma?,msi_h_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the incidence of MSI-H in Breast Invasive Carcinoma?,msi_h_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the incidence of MSI-H in Breast Invasive Carcinoma?,msi_h_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the incidence of MSI-H in Breast Invasive Carcinoma?,msi_h_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the incidence of MSI-H in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the incidence of MSI-H in Bladder Urothelial Carcinoma?,msi_h_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the incidence of MSI-H in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the incidence of MSI-H in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the incidence of MSI-H in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the incidence of MSI-H in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the incidence of MSI-H in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the incidence of MSI-H in Bladder Urothelial Carcinoma?,msi_h_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the incidence of MSI-H in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the incidence of MSI-H in Bladder Urothelial Carcinoma?,msi_h_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the incidence of MSI-H in Bladder Urothelial Carcinoma?,msi_h_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the incidence of MSI-H in Rectum Adenocarcinoma?,msi_h_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the incidence of MSI-H in Rectum Adenocarcinoma?,msi_h_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the incidence of MSI-H in Rectum Adenocarcinoma?,msi_h_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the incidence of MSI-H in Rectum Adenocarcinoma?,msi_h_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the incidence of MSI-H in Glioblastoma Multiforme?,msi_h_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the incidence of MSI-H in Glioblastoma Multiforme?,msi_h_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the incidence of MSI-H in Glioblastoma Multiforme?,msi_h_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the incidence of MSI-H in Glioblastoma Multiforme?,msi_h_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the incidence of MSI-H in Glioblastoma Multiforme?,msi_h_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the incidence of MSI-H in Glioblastoma Multiforme?,msi_h_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the incidence of MSI-H in Glioblastoma Multiforme?,msi_h_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the incidence of MSI-H in Prostate Adenocarcinoma?,msi_h_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the incidence of MSI-H in Prostate Adenocarcinoma?,msi_h_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the incidence of MSI-H in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the incidence of MSI-H in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of MSI-H in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the incidence of MSI-H in Skin Cutaneous Melanoma?,msi_h_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the incidence of MSI-H in Lung Adenocarcinoma?,msi_h_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the incidence of MSI-H in Stomach Adenocarcinoma?,msi_h_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the incidence of MSI-H in Breast Invasive Carcinoma?,msi_h_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the incidence of MSI-H in Breast Invasive Carcinoma?,msi_h_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the incidence of MSI-H in Colon Adenocarcinoma?,msi_h_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSI-H in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the incidence of MSI-H in Rectum Adenocarcinoma?,msi_h_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,How prevalent is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,How prevalent is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,How prevalent is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,How prevalent is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,How prevalent is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,How prevalent is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,How prevalent is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How prevalent is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How prevalent is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,How prevalent is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,How prevalent is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How prevalent is microsatellite instability-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How prevalent is microsatellite instability-high in Prostate Adenocarcinoma?,msi_h_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How prevalent is microsatellite instability-high in Prostate Adenocarcinoma?,msi_h_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How prevalent is microsatellite instability-high in Prostate Adenocarcinoma?,msi_h_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How prevalent is microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How prevalent is microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How prevalent is microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How prevalent is microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How prevalent is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How prevalent is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How prevalent is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How prevalent is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How prevalent is microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How prevalent is microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How prevalent is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How prevalent is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How prevalent is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How prevalent is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How prevalent is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How prevalent is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+140,BICC1,A372V,Exceptional Responders,How prevalent is microsatellite instability-high in Exceptional Responders?,msi_h_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How prevalent is microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,How prevalent is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How prevalent is microsatellite instability-high in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How prevalent is microsatellite instability-high in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How prevalent is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How prevalent is microsatellite instability-high in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,msi_h_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,How prevalent is microsatellite instability-high in Prostate Adenocarcinoma?,msi_h_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,How prevalent is microsatellite instability-high in Prostate Adenocarcinoma?,msi_h_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,How prevalent is microsatellite instability-high in Prostate Adenocarcinoma?,msi_h_frequency
+267,DGKD,R140H,Exceptional Responders,How prevalent is microsatellite instability-high in Exceptional Responders?,msi_h_frequency
+268,DGKD,R160H,Exceptional Responders,How prevalent is microsatellite instability-high in Exceptional Responders?,msi_h_frequency
+269,DGKD,R204H,Exceptional Responders,How prevalent is microsatellite instability-high in Exceptional Responders?,msi_h_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How prevalent is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How prevalent is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How prevalent is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+299,OR5D14,M210L,Neuroblastoma,How prevalent is microsatellite instability-high in Neuroblastoma?,msi_h_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How prevalent is microsatellite instability-high in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How prevalent is microsatellite instability-high in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How prevalent is microsatellite instability-high in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+357,ZNF584,A211T,Sarcoma,How prevalent is microsatellite instability-high in Sarcoma?,msi_h_frequency
+358,ZNF584,A256T,Sarcoma,How prevalent is microsatellite instability-high in Sarcoma?,msi_h_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,How prevalent is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,How prevalent is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,How prevalent is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,How prevalent is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How prevalent is microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,How prevalent is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,How prevalent is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,How prevalent is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,How prevalent is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,How prevalent is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,How prevalent is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,How prevalent is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,How prevalent is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,How prevalent is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How prevalent is microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How prevalent is microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How prevalent is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How prevalent is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,How prevalent is microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,How prevalent is microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,How prevalent is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,How prevalent is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,How prevalent is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,How prevalent is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How prevalent is microsatellite instability-high in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How prevalent is microsatellite instability-high in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How prevalent is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,How prevalent is microsatellite instability-high in Brain Lower Grade Glioma?,msi_h_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+728,STK19,D341N,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+729,STK19,D345N,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How prevalent is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How prevalent is microsatellite instability-high in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,msi_h_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+817,KL,R594C,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How prevalent is microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How prevalent is microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How prevalent is microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How prevalent is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How prevalent is microsatellite instability-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How prevalent is microsatellite instability-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How prevalent is microsatellite instability-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How prevalent is microsatellite instability-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How prevalent is microsatellite instability-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How prevalent is microsatellite instability-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How prevalent is microsatellite instability-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How prevalent is microsatellite instability-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,How prevalent is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How prevalent is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How prevalent is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How prevalent is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How prevalent is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How prevalent is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How prevalent is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,How prevalent is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,How prevalent is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,How prevalent is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How prevalent is microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How prevalent is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How prevalent is microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How prevalent is microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How prevalent is microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How prevalent is microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How prevalent is microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How prevalent is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How prevalent is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How prevalent is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How prevalent is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,How prevalent is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,How prevalent is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,How prevalent is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,How prevalent is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How prevalent is microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How prevalent is microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How prevalent is microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How prevalent is microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How prevalent is microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How prevalent is microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How prevalent is microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How prevalent is microsatellite instability-high in Prostate Adenocarcinoma?,msi_h_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How prevalent is microsatellite instability-high in Prostate Adenocarcinoma?,msi_h_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How prevalent is microsatellite instability-high in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How prevalent is microsatellite instability-high in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How prevalent is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,How prevalent is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,How prevalent is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How prevalent is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How prevalent is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How prevalent is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How prevalent is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How prevalent is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit MSI-H?,msi_h_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit MSI-H?,msi_h_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit MSI-H?,msi_h_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit MSI-H?,msi_h_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit MSI-H?,msi_h_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit MSI-H?,msi_h_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit MSI-H?,msi_h_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases exhibit MSI-H?,msi_h_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases exhibit MSI-H?,msi_h_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit MSI-H?,msi_h_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit MSI-H?,msi_h_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit MSI-H?",msi_h_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit MSI-H?",msi_h_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+140,BICC1,A372V,Exceptional Responders,What proportion of Exceptional Responders cases exhibit MSI-H?,msi_h_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit MSI-H?",msi_h_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases exhibit MSI-H?,msi_h_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What proportion of Kidney Renal Clear Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What proportion of Kidney Renal Clear Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit MSI-H?,msi_h_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What proportion of HIV+ Tumor Molecular Characterization Project - Cervical Cancer cases exhibit MSI-H?,msi_h_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+267,DGKD,R140H,Exceptional Responders,What proportion of Exceptional Responders cases exhibit MSI-H?,msi_h_frequency
+268,DGKD,R160H,Exceptional Responders,What proportion of Exceptional Responders cases exhibit MSI-H?,msi_h_frequency
+269,DGKD,R204H,Exceptional Responders,What proportion of Exceptional Responders cases exhibit MSI-H?,msi_h_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit MSI-H?",msi_h_frequency
+299,OR5D14,M210L,Neuroblastoma,What proportion of Neuroblastoma cases exhibit MSI-H?,msi_h_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What proportion of Ovarian Serous Cystadenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What proportion of Ovarian Serous Cystadenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What proportion of Ovarian Serous Cystadenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+357,ZNF584,A211T,Sarcoma,What proportion of Sarcoma cases exhibit MSI-H?,msi_h_frequency
+358,ZNF584,A256T,Sarcoma,What proportion of Sarcoma cases exhibit MSI-H?,msi_h_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases exhibit MSI-H?,msi_h_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases exhibit MSI-H?,msi_h_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases exhibit MSI-H?,msi_h_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit MSI-H?,msi_h_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit MSI-H?,msi_h_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit MSI-H?,msi_h_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit MSI-H?,msi_h_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What proportion of Ovarian Serous Cystadenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What proportion of Ovarian Serous Cystadenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,What proportion of Brain Lower Grade Glioma cases exhibit MSI-H?,msi_h_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+728,STK19,D341N,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+729,STK19,D345N,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit MSI-H?",msi_h_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit MSI-H?",msi_h_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit MSI-H?",msi_h_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit MSI-H?",msi_h_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What proportion of Head and Neck Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What proportion of Head and Neck Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What proportion of Head and Neck Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What proportion of Head and Neck Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What proportion of Head and Neck Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What proportion of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia cases exhibit MSI-H?,msi_h_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+817,KL,R594C,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit MSI-H?",msi_h_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit MSI-H?",msi_h_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit MSI-H?",msi_h_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit MSI-H?",msi_h_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit MSI-H?",msi_h_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit MSI-H?",msi_h_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit MSI-H?",msi_h_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases exhibit MSI-H?,msi_h_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases exhibit MSI-H?,msi_h_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit MSI-H?",msi_h_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit MSI-H?",msi_h_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit MSI-H?",msi_h_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit MSI-H?",msi_h_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit MSI-H?",msi_h_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases exhibit MSI-H?,msi_h_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases exhibit MSI-H?,msi_h_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases exhibit MSI-H?,msi_h_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases exhibit MSI-H?,msi_h_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases exhibit MSI-H?,msi_h_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases exhibit MSI-H?,msi_h_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases exhibit MSI-H?,msi_h_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What proportion of Kidney Renal Clear Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What proportion of Kidney Renal Clear Cell Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit MSI-H?",msi_h_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit MSI-H?",msi_h_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit MSI-H?",msi_h_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MSI-H?,msi_h_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSI-H?,msi_h_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit MSI-H?,msi_h_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,How frequently is MSI High found in Breast Invasive Carcinoma?,msi_h_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,How frequently is MSI High found in Breast Invasive Carcinoma?,msi_h_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,How frequently is MSI High found in Breast Invasive Carcinoma?,msi_h_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,How frequently is MSI High found in Breast Invasive Carcinoma?,msi_h_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,How frequently is MSI High found in Breast Invasive Carcinoma?,msi_h_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,How frequently is MSI High found in Breast Invasive Carcinoma?,msi_h_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,How frequently is MSI High found in Breast Invasive Carcinoma?,msi_h_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How frequently is MSI High found in Bladder Urothelial Carcinoma?,msi_h_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How frequently is MSI High found in Bladder Urothelial Carcinoma?,msi_h_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,How frequently is MSI High found in Rectum Adenocarcinoma?,msi_h_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,How frequently is MSI High found in Rectum Adenocarcinoma?,msi_h_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How frequently is MSI High found in Pancreatic Adenocarcinoma?,msi_h_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How frequently is MSI High found in Prostate Adenocarcinoma?,msi_h_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How frequently is MSI High found in Prostate Adenocarcinoma?,msi_h_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How frequently is MSI High found in Prostate Adenocarcinoma?,msi_h_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How frequently is MSI High found in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How frequently is MSI High found in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How frequently is MSI High found in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How frequently is MSI High found in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How frequently is MSI High found in Bladder Urothelial Carcinoma?,msi_h_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How frequently is MSI High found in Bladder Urothelial Carcinoma?,msi_h_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How frequently is MSI High found in Bladder Urothelial Carcinoma?,msi_h_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How frequently is MSI High found in Bladder Urothelial Carcinoma?,msi_h_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How frequently is MSI High found in Liver Hepatocellular Carcinoma?,msi_h_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How frequently is MSI High found in Liver Hepatocellular Carcinoma?,msi_h_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How frequently is MSI High found in Breast Invasive Carcinoma?,msi_h_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How frequently is MSI High found in Breast Invasive Carcinoma?,msi_h_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is MSI High found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is MSI High found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How frequently is MSI High found in Bladder Urothelial Carcinoma?,msi_h_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How frequently is MSI High found in Bladder Urothelial Carcinoma?,msi_h_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How frequently is MSI High found in Bladder Urothelial Carcinoma?,msi_h_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How frequently is MSI High found in Bladder Urothelial Carcinoma?,msi_h_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+140,BICC1,A372V,Exceptional Responders,How frequently is MSI High found in Exceptional Responders?,msi_h_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is MSI High found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How frequently is MSI High found in Liver Hepatocellular Carcinoma?,msi_h_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,How frequently is MSI High found in Rectum Adenocarcinoma?,msi_h_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How frequently is MSI High found in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How frequently is MSI High found in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How frequently is MSI High found in Breast Invasive Carcinoma?,msi_h_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How frequently is MSI High found in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,msi_h_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,How frequently is MSI High found in Prostate Adenocarcinoma?,msi_h_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,How frequently is MSI High found in Prostate Adenocarcinoma?,msi_h_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,How frequently is MSI High found in Prostate Adenocarcinoma?,msi_h_frequency
+267,DGKD,R140H,Exceptional Responders,How frequently is MSI High found in Exceptional Responders?,msi_h_frequency
+268,DGKD,R160H,Exceptional Responders,How frequently is MSI High found in Exceptional Responders?,msi_h_frequency
+269,DGKD,R204H,Exceptional Responders,How frequently is MSI High found in Exceptional Responders?,msi_h_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How frequently is MSI High found in Bladder Urothelial Carcinoma?,msi_h_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How frequently is MSI High found in Bladder Urothelial Carcinoma?,msi_h_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How frequently is MSI High found in Bladder Urothelial Carcinoma?,msi_h_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is MSI High found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+299,OR5D14,M210L,Neuroblastoma,How frequently is MSI High found in Neuroblastoma?,msi_h_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How frequently is MSI High found in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How frequently is MSI High found in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How frequently is MSI High found in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+357,ZNF584,A211T,Sarcoma,How frequently is MSI High found in Sarcoma?,msi_h_frequency
+358,ZNF584,A256T,Sarcoma,How frequently is MSI High found in Sarcoma?,msi_h_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently is MSI High found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,How frequently is MSI High found in Rectum Adenocarcinoma?,msi_h_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,How frequently is MSI High found in Rectum Adenocarcinoma?,msi_h_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,How frequently is MSI High found in Rectum Adenocarcinoma?,msi_h_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,How frequently is MSI High found in Rectum Adenocarcinoma?,msi_h_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How frequently is MSI High found in Liver Hepatocellular Carcinoma?,msi_h_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,How frequently is MSI High found in Rectum Adenocarcinoma?,msi_h_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,How frequently is MSI High found in Rectum Adenocarcinoma?,msi_h_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,How frequently is MSI High found in Rectum Adenocarcinoma?,msi_h_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,How frequently is MSI High found in Rectum Adenocarcinoma?,msi_h_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,How frequently is MSI High found in Rectum Adenocarcinoma?,msi_h_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,How frequently is MSI High found in Rectum Adenocarcinoma?,msi_h_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,How frequently is MSI High found in Rectum Adenocarcinoma?,msi_h_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,How frequently is MSI High found in Rectum Adenocarcinoma?,msi_h_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,How frequently is MSI High found in Rectum Adenocarcinoma?,msi_h_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How frequently is MSI High found in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How frequently is MSI High found in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How frequently is MSI High found in Bladder Urothelial Carcinoma?,msi_h_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How frequently is MSI High found in Bladder Urothelial Carcinoma?,msi_h_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,How frequently is MSI High found in Glioblastoma Multiforme?,msi_h_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,How frequently is MSI High found in Glioblastoma Multiforme?,msi_h_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,How frequently is MSI High found in Breast Invasive Carcinoma?,msi_h_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,How frequently is MSI High found in Breast Invasive Carcinoma?,msi_h_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,How frequently is MSI High found in Breast Invasive Carcinoma?,msi_h_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,How frequently is MSI High found in Breast Invasive Carcinoma?,msi_h_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How frequently is MSI High found in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How frequently is MSI High found in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How frequently is MSI High found in Bladder Urothelial Carcinoma?,msi_h_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,How frequently is MSI High found in Brain Lower Grade Glioma?,msi_h_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+728,STK19,D341N,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+729,STK19,D345N,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How frequently is MSI High found in Bladder Urothelial Carcinoma?,msi_h_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is MSI High found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is MSI High found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is MSI High found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is MSI High found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How frequently is MSI High found in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How frequently is MSI High found in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How frequently is MSI High found in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How frequently is MSI High found in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How frequently is MSI High found in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How frequently is MSI High found in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,msi_h_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently is MSI High found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+817,KL,R594C,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How frequently is MSI High found in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently is MSI High found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is MSI High found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is MSI High found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is MSI High found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is MSI High found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is MSI High found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is MSI High found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is MSI High found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How frequently is MSI High found in Glioblastoma Multiforme?,msi_h_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How frequently is MSI High found in Liver Hepatocellular Carcinoma?,msi_h_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How frequently is MSI High found in Rectum Adenocarcinoma?,msi_h_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is MSI High found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is MSI High found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How frequently is MSI High found in Pancreatic Adenocarcinoma?,msi_h_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How frequently is MSI High found in Pancreatic Adenocarcinoma?,msi_h_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How frequently is MSI High found in Pancreatic Adenocarcinoma?,msi_h_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How frequently is MSI High found in Pancreatic Adenocarcinoma?,msi_h_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How frequently is MSI High found in Pancreatic Adenocarcinoma?,msi_h_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How frequently is MSI High found in Pancreatic Adenocarcinoma?,msi_h_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How frequently is MSI High found in Pancreatic Adenocarcinoma?,msi_h_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How frequently is MSI High found in Pancreatic Adenocarcinoma?,msi_h_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently is MSI High found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently is MSI High found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently is MSI High found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently is MSI High found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently is MSI High found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is MSI High found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,How frequently is MSI High found in Breast Invasive Carcinoma?,msi_h_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How frequently is MSI High found in Breast Invasive Carcinoma?,msi_h_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How frequently is MSI High found in Breast Invasive Carcinoma?,msi_h_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How frequently is MSI High found in Breast Invasive Carcinoma?,msi_h_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How frequently is MSI High found in Breast Invasive Carcinoma?,msi_h_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How frequently is MSI High found in Breast Invasive Carcinoma?,msi_h_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How frequently is MSI High found in Breast Invasive Carcinoma?,msi_h_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,How frequently is MSI High found in Breast Invasive Carcinoma?,msi_h_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,How frequently is MSI High found in Breast Invasive Carcinoma?,msi_h_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,How frequently is MSI High found in Breast Invasive Carcinoma?,msi_h_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How frequently is MSI High found in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How frequently is MSI High found in Bladder Urothelial Carcinoma?,msi_h_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is MSI High found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How frequently is MSI High found in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How frequently is MSI High found in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How frequently is MSI High found in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How frequently is MSI High found in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How frequently is MSI High found in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How frequently is MSI High found in Bladder Urothelial Carcinoma?,msi_h_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is MSI High found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How frequently is MSI High found in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How frequently is MSI High found in Bladder Urothelial Carcinoma?,msi_h_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How frequently is MSI High found in Bladder Urothelial Carcinoma?,msi_h_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,How frequently is MSI High found in Rectum Adenocarcinoma?,msi_h_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,How frequently is MSI High found in Rectum Adenocarcinoma?,msi_h_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,How frequently is MSI High found in Rectum Adenocarcinoma?,msi_h_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,How frequently is MSI High found in Rectum Adenocarcinoma?,msi_h_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How frequently is MSI High found in Glioblastoma Multiforme?,msi_h_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How frequently is MSI High found in Glioblastoma Multiforme?,msi_h_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How frequently is MSI High found in Glioblastoma Multiforme?,msi_h_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How frequently is MSI High found in Glioblastoma Multiforme?,msi_h_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How frequently is MSI High found in Glioblastoma Multiforme?,msi_h_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How frequently is MSI High found in Glioblastoma Multiforme?,msi_h_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How frequently is MSI High found in Glioblastoma Multiforme?,msi_h_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How frequently is MSI High found in Prostate Adenocarcinoma?,msi_h_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How frequently is MSI High found in Prostate Adenocarcinoma?,msi_h_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How frequently is MSI High found in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How frequently is MSI High found in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is MSI High found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is MSI High found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is MSI High found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How frequently is MSI High found in Skin Cutaneous Melanoma?,msi_h_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,How frequently is MSI High found in Lung Adenocarcinoma?,msi_h_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,How frequently is MSI High found in Stomach Adenocarcinoma?,msi_h_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How frequently is MSI High found in Breast Invasive Carcinoma?,msi_h_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How frequently is MSI High found in Breast Invasive Carcinoma?,msi_h_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How frequently is MSI High found in Colon Adenocarcinoma?,msi_h_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How frequently is MSI High found in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How frequently is MSI High found in Rectum Adenocarcinoma?,msi_h_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the distribution rate of microsatellite instability-high among Breast Invasive Carcinoma patients?,msi_h_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the distribution rate of microsatellite instability-high among Breast Invasive Carcinoma patients?,msi_h_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the distribution rate of microsatellite instability-high among Breast Invasive Carcinoma patients?,msi_h_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the distribution rate of microsatellite instability-high among Breast Invasive Carcinoma patients?,msi_h_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the distribution rate of microsatellite instability-high among Breast Invasive Carcinoma patients?,msi_h_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the distribution rate of microsatellite instability-high among Breast Invasive Carcinoma patients?,msi_h_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the distribution rate of microsatellite instability-high among Breast Invasive Carcinoma patients?,msi_h_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the distribution rate of microsatellite instability-high among Bladder Urothelial Carcinoma patients?,msi_h_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the distribution rate of microsatellite instability-high among Bladder Urothelial Carcinoma patients?,msi_h_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Rectum Adenocarcinoma patients?,msi_h_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Rectum Adenocarcinoma patients?,msi_h_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Pancreatic Adenocarcinoma patients?,msi_h_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Prostate Adenocarcinoma patients?,msi_h_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Prostate Adenocarcinoma patients?,msi_h_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Prostate Adenocarcinoma patients?,msi_h_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Kidney Renal Papillary Cell Carcinoma patients?,msi_h_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Kidney Renal Papillary Cell Carcinoma patients?,msi_h_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Kidney Renal Papillary Cell Carcinoma patients?,msi_h_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Kidney Renal Papillary Cell Carcinoma patients?,msi_h_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the distribution rate of microsatellite instability-high among Bladder Urothelial Carcinoma patients?,msi_h_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the distribution rate of microsatellite instability-high among Bladder Urothelial Carcinoma patients?,msi_h_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the distribution rate of microsatellite instability-high among Bladder Urothelial Carcinoma patients?,msi_h_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the distribution rate of microsatellite instability-high among Bladder Urothelial Carcinoma patients?,msi_h_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the distribution rate of microsatellite instability-high among Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the distribution rate of microsatellite instability-high among Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the distribution rate of microsatellite instability-high among Breast Invasive Carcinoma patients?,msi_h_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the distribution rate of microsatellite instability-high among Breast Invasive Carcinoma patients?,msi_h_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of microsatellite instability-high among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of microsatellite instability-high among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the distribution rate of microsatellite instability-high among Bladder Urothelial Carcinoma patients?,msi_h_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the distribution rate of microsatellite instability-high among Bladder Urothelial Carcinoma patients?,msi_h_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the distribution rate of microsatellite instability-high among Bladder Urothelial Carcinoma patients?,msi_h_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the distribution rate of microsatellite instability-high among Bladder Urothelial Carcinoma patients?,msi_h_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+140,BICC1,A372V,Exceptional Responders,What is the distribution rate of microsatellite instability-high among Exceptional Responders patients?,msi_h_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of microsatellite instability-high among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the distribution rate of microsatellite instability-high among Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Rectum Adenocarcinoma patients?,msi_h_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Kidney Renal Clear Cell Carcinoma patients?,msi_h_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Kidney Renal Clear Cell Carcinoma patients?,msi_h_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the distribution rate of microsatellite instability-high among Breast Invasive Carcinoma patients?,msi_h_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the distribution rate of microsatellite instability-high among HIV+ Tumor Molecular Characterization Project - Cervical Cancer patients?,msi_h_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Prostate Adenocarcinoma patients?,msi_h_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Prostate Adenocarcinoma patients?,msi_h_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Prostate Adenocarcinoma patients?,msi_h_frequency
+267,DGKD,R140H,Exceptional Responders,What is the distribution rate of microsatellite instability-high among Exceptional Responders patients?,msi_h_frequency
+268,DGKD,R160H,Exceptional Responders,What is the distribution rate of microsatellite instability-high among Exceptional Responders patients?,msi_h_frequency
+269,DGKD,R204H,Exceptional Responders,What is the distribution rate of microsatellite instability-high among Exceptional Responders patients?,msi_h_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the distribution rate of microsatellite instability-high among Bladder Urothelial Carcinoma patients?,msi_h_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the distribution rate of microsatellite instability-high among Bladder Urothelial Carcinoma patients?,msi_h_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the distribution rate of microsatellite instability-high among Bladder Urothelial Carcinoma patients?,msi_h_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of microsatellite instability-high among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+299,OR5D14,M210L,Neuroblastoma,What is the distribution rate of microsatellite instability-high among Neuroblastoma patients?,msi_h_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the distribution rate of microsatellite instability-high among Ovarian Serous Cystadenocarcinoma patients?,msi_h_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the distribution rate of microsatellite instability-high among Ovarian Serous Cystadenocarcinoma patients?,msi_h_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the distribution rate of microsatellite instability-high among Ovarian Serous Cystadenocarcinoma patients?,msi_h_frequency
+357,ZNF584,A211T,Sarcoma,What is the distribution rate of microsatellite instability-high among Sarcoma patients?,msi_h_frequency
+358,ZNF584,A256T,Sarcoma,What is the distribution rate of microsatellite instability-high among Sarcoma patients?,msi_h_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,msi_h_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Rectum Adenocarcinoma patients?,msi_h_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Rectum Adenocarcinoma patients?,msi_h_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Rectum Adenocarcinoma patients?,msi_h_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Rectum Adenocarcinoma patients?,msi_h_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the distribution rate of microsatellite instability-high among Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Rectum Adenocarcinoma patients?,msi_h_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Rectum Adenocarcinoma patients?,msi_h_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Rectum Adenocarcinoma patients?,msi_h_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Rectum Adenocarcinoma patients?,msi_h_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Rectum Adenocarcinoma patients?,msi_h_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Rectum Adenocarcinoma patients?,msi_h_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Rectum Adenocarcinoma patients?,msi_h_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Rectum Adenocarcinoma patients?,msi_h_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Rectum Adenocarcinoma patients?,msi_h_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Kidney Renal Papillary Cell Carcinoma patients?,msi_h_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Kidney Renal Papillary Cell Carcinoma patients?,msi_h_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the distribution rate of microsatellite instability-high among Bladder Urothelial Carcinoma patients?,msi_h_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the distribution rate of microsatellite instability-high among Bladder Urothelial Carcinoma patients?,msi_h_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the distribution rate of microsatellite instability-high among Glioblastoma Multiforme patients?,msi_h_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the distribution rate of microsatellite instability-high among Glioblastoma Multiforme patients?,msi_h_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,What is the distribution rate of microsatellite instability-high among Breast Invasive Carcinoma patients?,msi_h_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,What is the distribution rate of microsatellite instability-high among Breast Invasive Carcinoma patients?,msi_h_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,What is the distribution rate of microsatellite instability-high among Breast Invasive Carcinoma patients?,msi_h_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,What is the distribution rate of microsatellite instability-high among Breast Invasive Carcinoma patients?,msi_h_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the distribution rate of microsatellite instability-high among Ovarian Serous Cystadenocarcinoma patients?,msi_h_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the distribution rate of microsatellite instability-high among Ovarian Serous Cystadenocarcinoma patients?,msi_h_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the distribution rate of microsatellite instability-high among Bladder Urothelial Carcinoma patients?,msi_h_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the distribution rate of microsatellite instability-high among Brain Lower Grade Glioma patients?,msi_h_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+728,STK19,D341N,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+729,STK19,D345N,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the distribution rate of microsatellite instability-high among Bladder Urothelial Carcinoma patients?,msi_h_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of microsatellite instability-high among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of microsatellite instability-high among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of microsatellite instability-high among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of microsatellite instability-high among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Head and Neck Squamous Cell Carcinoma patients?,msi_h_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Head and Neck Squamous Cell Carcinoma patients?,msi_h_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Head and Neck Squamous Cell Carcinoma patients?,msi_h_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Head and Neck Squamous Cell Carcinoma patients?,msi_h_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Head and Neck Squamous Cell Carcinoma patients?,msi_h_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the distribution rate of microsatellite instability-high among Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia patients?,msi_h_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,msi_h_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+817,KL,R594C,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Kidney Renal Papillary Cell Carcinoma patients?,msi_h_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,msi_h_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of microsatellite instability-high among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of microsatellite instability-high among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of microsatellite instability-high among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of microsatellite instability-high among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of microsatellite instability-high among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of microsatellite instability-high among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of microsatellite instability-high among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the distribution rate of microsatellite instability-high among Glioblastoma Multiforme patients?,msi_h_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the distribution rate of microsatellite instability-high among Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Rectum Adenocarcinoma patients?,msi_h_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of microsatellite instability-high among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of microsatellite instability-high among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Pancreatic Adenocarcinoma patients?,msi_h_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Pancreatic Adenocarcinoma patients?,msi_h_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Pancreatic Adenocarcinoma patients?,msi_h_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Pancreatic Adenocarcinoma patients?,msi_h_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Pancreatic Adenocarcinoma patients?,msi_h_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Pancreatic Adenocarcinoma patients?,msi_h_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Pancreatic Adenocarcinoma patients?,msi_h_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Pancreatic Adenocarcinoma patients?,msi_h_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,msi_h_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,msi_h_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,msi_h_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,msi_h_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,msi_h_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of microsatellite instability-high among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the distribution rate of microsatellite instability-high among Breast Invasive Carcinoma patients?,msi_h_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the distribution rate of microsatellite instability-high among Breast Invasive Carcinoma patients?,msi_h_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the distribution rate of microsatellite instability-high among Breast Invasive Carcinoma patients?,msi_h_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the distribution rate of microsatellite instability-high among Breast Invasive Carcinoma patients?,msi_h_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the distribution rate of microsatellite instability-high among Breast Invasive Carcinoma patients?,msi_h_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the distribution rate of microsatellite instability-high among Breast Invasive Carcinoma patients?,msi_h_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the distribution rate of microsatellite instability-high among Breast Invasive Carcinoma patients?,msi_h_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the distribution rate of microsatellite instability-high among Breast Invasive Carcinoma patients?,msi_h_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the distribution rate of microsatellite instability-high among Breast Invasive Carcinoma patients?,msi_h_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the distribution rate of microsatellite instability-high among Breast Invasive Carcinoma patients?,msi_h_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the distribution rate of microsatellite instability-high among Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the distribution rate of microsatellite instability-high among Bladder Urothelial Carcinoma patients?,msi_h_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of microsatellite instability-high among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the distribution rate of microsatellite instability-high among Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the distribution rate of microsatellite instability-high among Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the distribution rate of microsatellite instability-high among Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the distribution rate of microsatellite instability-high among Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the distribution rate of microsatellite instability-high among Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the distribution rate of microsatellite instability-high among Bladder Urothelial Carcinoma patients?,msi_h_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of microsatellite instability-high among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the distribution rate of microsatellite instability-high among Bladder Urothelial Carcinoma patients?,msi_h_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the distribution rate of microsatellite instability-high among Bladder Urothelial Carcinoma patients?,msi_h_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Rectum Adenocarcinoma patients?,msi_h_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Rectum Adenocarcinoma patients?,msi_h_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Rectum Adenocarcinoma patients?,msi_h_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Rectum Adenocarcinoma patients?,msi_h_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the distribution rate of microsatellite instability-high among Glioblastoma Multiforme patients?,msi_h_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the distribution rate of microsatellite instability-high among Glioblastoma Multiforme patients?,msi_h_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the distribution rate of microsatellite instability-high among Glioblastoma Multiforme patients?,msi_h_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the distribution rate of microsatellite instability-high among Glioblastoma Multiforme patients?,msi_h_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the distribution rate of microsatellite instability-high among Glioblastoma Multiforme patients?,msi_h_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the distribution rate of microsatellite instability-high among Glioblastoma Multiforme patients?,msi_h_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the distribution rate of microsatellite instability-high among Glioblastoma Multiforme patients?,msi_h_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Prostate Adenocarcinoma patients?,msi_h_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Prostate Adenocarcinoma patients?,msi_h_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Kidney Renal Clear Cell Carcinoma patients?,msi_h_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the distribution rate of microsatellite instability-high among Kidney Renal Clear Cell Carcinoma patients?,msi_h_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of microsatellite instability-high among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of microsatellite instability-high among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of microsatellite instability-high among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the distribution rate of microsatellite instability-high among Skin Cutaneous Melanoma patients?,msi_h_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Lung Adenocarcinoma patients?,msi_h_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Stomach Adenocarcinoma patients?,msi_h_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the distribution rate of microsatellite instability-high among Breast Invasive Carcinoma patients?,msi_h_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the distribution rate of microsatellite instability-high among Breast Invasive Carcinoma patients?,msi_h_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Colon Adenocarcinoma patients?,msi_h_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of microsatellite instability-high among Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the distribution rate of microsatellite instability-high among Rectum Adenocarcinoma patients?,msi_h_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,How widespread is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,How widespread is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,How widespread is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,How widespread is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,How widespread is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,How widespread is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,How widespread is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How widespread is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How widespread is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,How widespread is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,How widespread is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How widespread is microsatellite instability-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How widespread is microsatellite instability-high in Prostate Adenocarcinoma?,msi_h_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How widespread is microsatellite instability-high in Prostate Adenocarcinoma?,msi_h_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How widespread is microsatellite instability-high in Prostate Adenocarcinoma?,msi_h_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How widespread is microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How widespread is microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How widespread is microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How widespread is microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How widespread is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How widespread is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How widespread is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How widespread is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How widespread is microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How widespread is microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How widespread is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How widespread is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How widespread is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How widespread is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How widespread is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How widespread is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+140,BICC1,A372V,Exceptional Responders,How widespread is microsatellite instability-high in Exceptional Responders?,msi_h_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How widespread is microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,How widespread is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How widespread is microsatellite instability-high in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How widespread is microsatellite instability-high in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How widespread is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How widespread is microsatellite instability-high in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,msi_h_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,How widespread is microsatellite instability-high in Prostate Adenocarcinoma?,msi_h_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,How widespread is microsatellite instability-high in Prostate Adenocarcinoma?,msi_h_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,How widespread is microsatellite instability-high in Prostate Adenocarcinoma?,msi_h_frequency
+267,DGKD,R140H,Exceptional Responders,How widespread is microsatellite instability-high in Exceptional Responders?,msi_h_frequency
+268,DGKD,R160H,Exceptional Responders,How widespread is microsatellite instability-high in Exceptional Responders?,msi_h_frequency
+269,DGKD,R204H,Exceptional Responders,How widespread is microsatellite instability-high in Exceptional Responders?,msi_h_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How widespread is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How widespread is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How widespread is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+299,OR5D14,M210L,Neuroblastoma,How widespread is microsatellite instability-high in Neuroblastoma?,msi_h_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How widespread is microsatellite instability-high in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How widespread is microsatellite instability-high in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How widespread is microsatellite instability-high in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+357,ZNF584,A211T,Sarcoma,How widespread is microsatellite instability-high in Sarcoma?,msi_h_frequency
+358,ZNF584,A256T,Sarcoma,How widespread is microsatellite instability-high in Sarcoma?,msi_h_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread is microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,How widespread is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,How widespread is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,How widespread is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,How widespread is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How widespread is microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,How widespread is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,How widespread is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,How widespread is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,How widespread is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,How widespread is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,How widespread is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,How widespread is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,How widespread is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,How widespread is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How widespread is microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How widespread is microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How widespread is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How widespread is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,How widespread is microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,How widespread is microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,How widespread is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,How widespread is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,How widespread is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,How widespread is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How widespread is microsatellite instability-high in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How widespread is microsatellite instability-high in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How widespread is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,How widespread is microsatellite instability-high in Brain Lower Grade Glioma?,msi_h_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+728,STK19,D341N,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+729,STK19,D345N,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How widespread is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How widespread is microsatellite instability-high in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,msi_h_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread is microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+817,KL,R594C,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How widespread is microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread is microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How widespread is microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How widespread is microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How widespread is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How widespread is microsatellite instability-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How widespread is microsatellite instability-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How widespread is microsatellite instability-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How widespread is microsatellite instability-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How widespread is microsatellite instability-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How widespread is microsatellite instability-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How widespread is microsatellite instability-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How widespread is microsatellite instability-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread is microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread is microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread is microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread is microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread is microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,How widespread is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How widespread is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How widespread is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How widespread is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How widespread is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How widespread is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How widespread is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,How widespread is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,How widespread is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,How widespread is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How widespread is microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How widespread is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How widespread is microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How widespread is microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How widespread is microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How widespread is microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How widespread is microsatellite instability-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How widespread is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How widespread is microsatellite instability-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How widespread is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How widespread is microsatellite instability-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,How widespread is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,How widespread is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,How widespread is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,How widespread is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How widespread is microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How widespread is microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How widespread is microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How widespread is microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How widespread is microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How widespread is microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How widespread is microsatellite instability-high in Glioblastoma Multiforme?,msi_h_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How widespread is microsatellite instability-high in Prostate Adenocarcinoma?,msi_h_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How widespread is microsatellite instability-high in Prostate Adenocarcinoma?,msi_h_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How widespread is microsatellite instability-high in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How widespread is microsatellite instability-high in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How widespread is microsatellite instability-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,How widespread is microsatellite instability-high in Lung Adenocarcinoma?,msi_h_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,How widespread is microsatellite instability-high in Stomach Adenocarcinoma?,msi_h_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How widespread is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How widespread is microsatellite instability-high in Breast Invasive Carcinoma?,msi_h_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How widespread is microsatellite instability-high in Colon Adenocarcinoma?,msi_h_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How widespread is microsatellite instability-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How widespread is microsatellite instability-high in Rectum Adenocarcinoma?,msi_h_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,Can you tell me how prevalent MSI High is in Breast Invasive Carcinoma?,msi_h_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,Can you tell me how prevalent MSI High is in Breast Invasive Carcinoma?,msi_h_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,Can you tell me how prevalent MSI High is in Breast Invasive Carcinoma?,msi_h_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,Can you tell me how prevalent MSI High is in Breast Invasive Carcinoma?,msi_h_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,Can you tell me how prevalent MSI High is in Breast Invasive Carcinoma?,msi_h_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,Can you tell me how prevalent MSI High is in Breast Invasive Carcinoma?,msi_h_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,Can you tell me how prevalent MSI High is in Breast Invasive Carcinoma?,msi_h_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,Can you tell me how prevalent MSI High is in Bladder Urothelial Carcinoma?,msi_h_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,Can you tell me how prevalent MSI High is in Bladder Urothelial Carcinoma?,msi_h_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,Can you tell me how prevalent MSI High is in Rectum Adenocarcinoma?,msi_h_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,Can you tell me how prevalent MSI High is in Rectum Adenocarcinoma?,msi_h_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,Can you tell me how prevalent MSI High is in Pancreatic Adenocarcinoma?,msi_h_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,Can you tell me how prevalent MSI High is in Prostate Adenocarcinoma?,msi_h_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,Can you tell me how prevalent MSI High is in Prostate Adenocarcinoma?,msi_h_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,Can you tell me how prevalent MSI High is in Prostate Adenocarcinoma?,msi_h_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,Can you tell me how prevalent MSI High is in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,Can you tell me how prevalent MSI High is in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,Can you tell me how prevalent MSI High is in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,Can you tell me how prevalent MSI High is in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,Can you tell me how prevalent MSI High is in Bladder Urothelial Carcinoma?,msi_h_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,Can you tell me how prevalent MSI High is in Bladder Urothelial Carcinoma?,msi_h_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,Can you tell me how prevalent MSI High is in Bladder Urothelial Carcinoma?,msi_h_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,Can you tell me how prevalent MSI High is in Bladder Urothelial Carcinoma?,msi_h_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,Can you tell me how prevalent MSI High is in Liver Hepatocellular Carcinoma?,msi_h_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,Can you tell me how prevalent MSI High is in Liver Hepatocellular Carcinoma?,msi_h_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,Can you tell me how prevalent MSI High is in Breast Invasive Carcinoma?,msi_h_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,Can you tell me how prevalent MSI High is in Breast Invasive Carcinoma?,msi_h_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent MSI High is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent MSI High is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,Can you tell me how prevalent MSI High is in Bladder Urothelial Carcinoma?,msi_h_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,Can you tell me how prevalent MSI High is in Bladder Urothelial Carcinoma?,msi_h_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,Can you tell me how prevalent MSI High is in Bladder Urothelial Carcinoma?,msi_h_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,Can you tell me how prevalent MSI High is in Bladder Urothelial Carcinoma?,msi_h_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+140,BICC1,A372V,Exceptional Responders,Can you tell me how prevalent MSI High is in Exceptional Responders?,msi_h_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent MSI High is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,Can you tell me how prevalent MSI High is in Liver Hepatocellular Carcinoma?,msi_h_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,Can you tell me how prevalent MSI High is in Rectum Adenocarcinoma?,msi_h_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,Can you tell me how prevalent MSI High is in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,Can you tell me how prevalent MSI High is in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,Can you tell me how prevalent MSI High is in Breast Invasive Carcinoma?,msi_h_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,Can you tell me how prevalent MSI High is in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,msi_h_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,Can you tell me how prevalent MSI High is in Prostate Adenocarcinoma?,msi_h_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,Can you tell me how prevalent MSI High is in Prostate Adenocarcinoma?,msi_h_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,Can you tell me how prevalent MSI High is in Prostate Adenocarcinoma?,msi_h_frequency
+267,DGKD,R140H,Exceptional Responders,Can you tell me how prevalent MSI High is in Exceptional Responders?,msi_h_frequency
+268,DGKD,R160H,Exceptional Responders,Can you tell me how prevalent MSI High is in Exceptional Responders?,msi_h_frequency
+269,DGKD,R204H,Exceptional Responders,Can you tell me how prevalent MSI High is in Exceptional Responders?,msi_h_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,Can you tell me how prevalent MSI High is in Bladder Urothelial Carcinoma?,msi_h_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,Can you tell me how prevalent MSI High is in Bladder Urothelial Carcinoma?,msi_h_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,Can you tell me how prevalent MSI High is in Bladder Urothelial Carcinoma?,msi_h_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent MSI High is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+299,OR5D14,M210L,Neuroblastoma,Can you tell me how prevalent MSI High is in Neuroblastoma?,msi_h_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,Can you tell me how prevalent MSI High is in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,Can you tell me how prevalent MSI High is in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,Can you tell me how prevalent MSI High is in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+357,ZNF584,A211T,Sarcoma,Can you tell me how prevalent MSI High is in Sarcoma?,msi_h_frequency
+358,ZNF584,A256T,Sarcoma,Can you tell me how prevalent MSI High is in Sarcoma?,msi_h_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me how prevalent MSI High is in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,Can you tell me how prevalent MSI High is in Rectum Adenocarcinoma?,msi_h_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,Can you tell me how prevalent MSI High is in Rectum Adenocarcinoma?,msi_h_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,Can you tell me how prevalent MSI High is in Rectum Adenocarcinoma?,msi_h_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,Can you tell me how prevalent MSI High is in Rectum Adenocarcinoma?,msi_h_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,Can you tell me how prevalent MSI High is in Liver Hepatocellular Carcinoma?,msi_h_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,Can you tell me how prevalent MSI High is in Rectum Adenocarcinoma?,msi_h_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,Can you tell me how prevalent MSI High is in Rectum Adenocarcinoma?,msi_h_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,Can you tell me how prevalent MSI High is in Rectum Adenocarcinoma?,msi_h_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,Can you tell me how prevalent MSI High is in Rectum Adenocarcinoma?,msi_h_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,Can you tell me how prevalent MSI High is in Rectum Adenocarcinoma?,msi_h_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,Can you tell me how prevalent MSI High is in Rectum Adenocarcinoma?,msi_h_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,Can you tell me how prevalent MSI High is in Rectum Adenocarcinoma?,msi_h_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,Can you tell me how prevalent MSI High is in Rectum Adenocarcinoma?,msi_h_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,Can you tell me how prevalent MSI High is in Rectum Adenocarcinoma?,msi_h_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,Can you tell me how prevalent MSI High is in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,Can you tell me how prevalent MSI High is in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,Can you tell me how prevalent MSI High is in Bladder Urothelial Carcinoma?,msi_h_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,Can you tell me how prevalent MSI High is in Bladder Urothelial Carcinoma?,msi_h_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,Can you tell me how prevalent MSI High is in Glioblastoma Multiforme?,msi_h_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,Can you tell me how prevalent MSI High is in Glioblastoma Multiforme?,msi_h_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,Can you tell me how prevalent MSI High is in Breast Invasive Carcinoma?,msi_h_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,Can you tell me how prevalent MSI High is in Breast Invasive Carcinoma?,msi_h_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,Can you tell me how prevalent MSI High is in Breast Invasive Carcinoma?,msi_h_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,Can you tell me how prevalent MSI High is in Breast Invasive Carcinoma?,msi_h_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,Can you tell me how prevalent MSI High is in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,Can you tell me how prevalent MSI High is in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,Can you tell me how prevalent MSI High is in Bladder Urothelial Carcinoma?,msi_h_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,Can you tell me how prevalent MSI High is in Brain Lower Grade Glioma?,msi_h_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+728,STK19,D341N,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+729,STK19,D345N,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,Can you tell me how prevalent MSI High is in Bladder Urothelial Carcinoma?,msi_h_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent MSI High is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent MSI High is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent MSI High is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent MSI High is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,Can you tell me how prevalent MSI High is in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,msi_h_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me how prevalent MSI High is in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+817,KL,R594C,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,Can you tell me how prevalent MSI High is in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me how prevalent MSI High is in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent MSI High is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent MSI High is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent MSI High is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent MSI High is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent MSI High is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent MSI High is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent MSI High is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,Can you tell me how prevalent MSI High is in Glioblastoma Multiforme?,msi_h_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,Can you tell me how prevalent MSI High is in Liver Hepatocellular Carcinoma?,msi_h_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,Can you tell me how prevalent MSI High is in Rectum Adenocarcinoma?,msi_h_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent MSI High is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent MSI High is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,Can you tell me how prevalent MSI High is in Pancreatic Adenocarcinoma?,msi_h_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,Can you tell me how prevalent MSI High is in Pancreatic Adenocarcinoma?,msi_h_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,Can you tell me how prevalent MSI High is in Pancreatic Adenocarcinoma?,msi_h_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,Can you tell me how prevalent MSI High is in Pancreatic Adenocarcinoma?,msi_h_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,Can you tell me how prevalent MSI High is in Pancreatic Adenocarcinoma?,msi_h_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,Can you tell me how prevalent MSI High is in Pancreatic Adenocarcinoma?,msi_h_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,Can you tell me how prevalent MSI High is in Pancreatic Adenocarcinoma?,msi_h_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,Can you tell me how prevalent MSI High is in Pancreatic Adenocarcinoma?,msi_h_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me how prevalent MSI High is in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me how prevalent MSI High is in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me how prevalent MSI High is in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me how prevalent MSI High is in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me how prevalent MSI High is in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent MSI High is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,Can you tell me how prevalent MSI High is in Breast Invasive Carcinoma?,msi_h_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,Can you tell me how prevalent MSI High is in Breast Invasive Carcinoma?,msi_h_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,Can you tell me how prevalent MSI High is in Breast Invasive Carcinoma?,msi_h_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,Can you tell me how prevalent MSI High is in Breast Invasive Carcinoma?,msi_h_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,Can you tell me how prevalent MSI High is in Breast Invasive Carcinoma?,msi_h_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,Can you tell me how prevalent MSI High is in Breast Invasive Carcinoma?,msi_h_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,Can you tell me how prevalent MSI High is in Breast Invasive Carcinoma?,msi_h_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,Can you tell me how prevalent MSI High is in Breast Invasive Carcinoma?,msi_h_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,Can you tell me how prevalent MSI High is in Breast Invasive Carcinoma?,msi_h_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,Can you tell me how prevalent MSI High is in Breast Invasive Carcinoma?,msi_h_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,Can you tell me how prevalent MSI High is in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,Can you tell me how prevalent MSI High is in Bladder Urothelial Carcinoma?,msi_h_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent MSI High is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,Can you tell me how prevalent MSI High is in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,Can you tell me how prevalent MSI High is in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,Can you tell me how prevalent MSI High is in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,Can you tell me how prevalent MSI High is in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,Can you tell me how prevalent MSI High is in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,Can you tell me how prevalent MSI High is in Bladder Urothelial Carcinoma?,msi_h_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent MSI High is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MSI High is in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,Can you tell me how prevalent MSI High is in Bladder Urothelial Carcinoma?,msi_h_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,Can you tell me how prevalent MSI High is in Bladder Urothelial Carcinoma?,msi_h_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,Can you tell me how prevalent MSI High is in Rectum Adenocarcinoma?,msi_h_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,Can you tell me how prevalent MSI High is in Rectum Adenocarcinoma?,msi_h_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,Can you tell me how prevalent MSI High is in Rectum Adenocarcinoma?,msi_h_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,Can you tell me how prevalent MSI High is in Rectum Adenocarcinoma?,msi_h_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,Can you tell me how prevalent MSI High is in Glioblastoma Multiforme?,msi_h_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,Can you tell me how prevalent MSI High is in Glioblastoma Multiforme?,msi_h_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,Can you tell me how prevalent MSI High is in Glioblastoma Multiforme?,msi_h_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,Can you tell me how prevalent MSI High is in Glioblastoma Multiforme?,msi_h_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,Can you tell me how prevalent MSI High is in Glioblastoma Multiforme?,msi_h_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,Can you tell me how prevalent MSI High is in Glioblastoma Multiforme?,msi_h_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,Can you tell me how prevalent MSI High is in Glioblastoma Multiforme?,msi_h_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,Can you tell me how prevalent MSI High is in Prostate Adenocarcinoma?,msi_h_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,Can you tell me how prevalent MSI High is in Prostate Adenocarcinoma?,msi_h_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,Can you tell me how prevalent MSI High is in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,Can you tell me how prevalent MSI High is in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent MSI High is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent MSI High is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent MSI High is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,Can you tell me how prevalent MSI High is in Skin Cutaneous Melanoma?,msi_h_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,Can you tell me how prevalent MSI High is in Lung Adenocarcinoma?,msi_h_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,Can you tell me how prevalent MSI High is in Stomach Adenocarcinoma?,msi_h_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,Can you tell me how prevalent MSI High is in Breast Invasive Carcinoma?,msi_h_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,Can you tell me how prevalent MSI High is in Breast Invasive Carcinoma?,msi_h_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,Can you tell me how prevalent MSI High is in Colon Adenocarcinoma?,msi_h_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSI High is in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,Can you tell me how prevalent MSI High is in Rectum Adenocarcinoma?,msi_h_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases are characterized by microsatellite instability-high (MSI-H)?",msi_h_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases are characterized by microsatellite instability-high (MSI-H)?",msi_h_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+140,BICC1,A372V,Exceptional Responders,What percentage of Exceptional Responders cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases are characterized by microsatellite instability-high (MSI-H)?",msi_h_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What percentage of HIV+ Tumor Molecular Characterization Project - Cervical Cancer cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+267,DGKD,R140H,Exceptional Responders,What percentage of Exceptional Responders cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+268,DGKD,R160H,Exceptional Responders,What percentage of Exceptional Responders cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+269,DGKD,R204H,Exceptional Responders,What percentage of Exceptional Responders cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases are characterized by microsatellite instability-high (MSI-H)?",msi_h_frequency
+299,OR5D14,M210L,Neuroblastoma,What percentage of Neuroblastoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+357,ZNF584,A211T,Sarcoma,What percentage of Sarcoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+358,ZNF584,A256T,Sarcoma,What percentage of Sarcoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,What percentage of Brain Lower Grade Glioma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+728,STK19,D341N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+729,STK19,D345N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases are characterized by microsatellite instability-high (MSI-H)?",msi_h_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases are characterized by microsatellite instability-high (MSI-H)?",msi_h_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases are characterized by microsatellite instability-high (MSI-H)?",msi_h_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases are characterized by microsatellite instability-high (MSI-H)?",msi_h_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What percentage of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+817,KL,R594C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases are characterized by microsatellite instability-high (MSI-H)?",msi_h_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases are characterized by microsatellite instability-high (MSI-H)?",msi_h_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases are characterized by microsatellite instability-high (MSI-H)?",msi_h_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases are characterized by microsatellite instability-high (MSI-H)?",msi_h_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases are characterized by microsatellite instability-high (MSI-H)?",msi_h_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases are characterized by microsatellite instability-high (MSI-H)?",msi_h_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases are characterized by microsatellite instability-high (MSI-H)?",msi_h_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases are characterized by microsatellite instability-high (MSI-H)?",msi_h_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases are characterized by microsatellite instability-high (MSI-H)?",msi_h_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases are characterized by microsatellite instability-high (MSI-H)?",msi_h_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases are characterized by microsatellite instability-high (MSI-H)?",msi_h_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases are characterized by microsatellite instability-high (MSI-H)?",msi_h_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases are characterized by microsatellite instability-high (MSI-H)?",msi_h_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases are characterized by microsatellite instability-high (MSI-H)?",msi_h_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases are characterized by microsatellite instability-high (MSI-H)?",msi_h_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases are characterized by microsatellite instability-high (MSI-H)?,msi_h_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,How common is MSI High status in cases of Breast Invasive Carcinoma?,msi_h_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,How common is MSI High status in cases of Breast Invasive Carcinoma?,msi_h_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,How common is MSI High status in cases of Breast Invasive Carcinoma?,msi_h_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,How common is MSI High status in cases of Breast Invasive Carcinoma?,msi_h_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,How common is MSI High status in cases of Breast Invasive Carcinoma?,msi_h_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,How common is MSI High status in cases of Breast Invasive Carcinoma?,msi_h_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,How common is MSI High status in cases of Breast Invasive Carcinoma?,msi_h_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How common is MSI High status in cases of Bladder Urothelial Carcinoma?,msi_h_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How common is MSI High status in cases of Bladder Urothelial Carcinoma?,msi_h_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,How common is MSI High status in cases of Rectum Adenocarcinoma?,msi_h_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,How common is MSI High status in cases of Rectum Adenocarcinoma?,msi_h_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How common is MSI High status in cases of Pancreatic Adenocarcinoma?,msi_h_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How common is MSI High status in cases of Prostate Adenocarcinoma?,msi_h_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How common is MSI High status in cases of Prostate Adenocarcinoma?,msi_h_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How common is MSI High status in cases of Prostate Adenocarcinoma?,msi_h_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How common is MSI High status in cases of Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How common is MSI High status in cases of Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How common is MSI High status in cases of Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How common is MSI High status in cases of Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How common is MSI High status in cases of Bladder Urothelial Carcinoma?,msi_h_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How common is MSI High status in cases of Bladder Urothelial Carcinoma?,msi_h_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How common is MSI High status in cases of Bladder Urothelial Carcinoma?,msi_h_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How common is MSI High status in cases of Bladder Urothelial Carcinoma?,msi_h_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How common is MSI High status in cases of Liver Hepatocellular Carcinoma?,msi_h_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How common is MSI High status in cases of Liver Hepatocellular Carcinoma?,msi_h_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How common is MSI High status in cases of Breast Invasive Carcinoma?,msi_h_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How common is MSI High status in cases of Breast Invasive Carcinoma?,msi_h_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI High status in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI High status in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How common is MSI High status in cases of Bladder Urothelial Carcinoma?,msi_h_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How common is MSI High status in cases of Bladder Urothelial Carcinoma?,msi_h_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How common is MSI High status in cases of Bladder Urothelial Carcinoma?,msi_h_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How common is MSI High status in cases of Bladder Urothelial Carcinoma?,msi_h_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+140,BICC1,A372V,Exceptional Responders,How common is MSI High status in cases of Exceptional Responders?,msi_h_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI High status in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How common is MSI High status in cases of Liver Hepatocellular Carcinoma?,msi_h_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,How common is MSI High status in cases of Rectum Adenocarcinoma?,msi_h_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How common is MSI High status in cases of Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How common is MSI High status in cases of Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How common is MSI High status in cases of Breast Invasive Carcinoma?,msi_h_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How common is MSI High status in cases of HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,msi_h_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,How common is MSI High status in cases of Prostate Adenocarcinoma?,msi_h_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,How common is MSI High status in cases of Prostate Adenocarcinoma?,msi_h_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,How common is MSI High status in cases of Prostate Adenocarcinoma?,msi_h_frequency
+267,DGKD,R140H,Exceptional Responders,How common is MSI High status in cases of Exceptional Responders?,msi_h_frequency
+268,DGKD,R160H,Exceptional Responders,How common is MSI High status in cases of Exceptional Responders?,msi_h_frequency
+269,DGKD,R204H,Exceptional Responders,How common is MSI High status in cases of Exceptional Responders?,msi_h_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How common is MSI High status in cases of Bladder Urothelial Carcinoma?,msi_h_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How common is MSI High status in cases of Bladder Urothelial Carcinoma?,msi_h_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How common is MSI High status in cases of Bladder Urothelial Carcinoma?,msi_h_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI High status in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+299,OR5D14,M210L,Neuroblastoma,How common is MSI High status in cases of Neuroblastoma?,msi_h_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How common is MSI High status in cases of Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How common is MSI High status in cases of Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How common is MSI High status in cases of Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+357,ZNF584,A211T,Sarcoma,How common is MSI High status in cases of Sarcoma?,msi_h_frequency
+358,ZNF584,A256T,Sarcoma,How common is MSI High status in cases of Sarcoma?,msi_h_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is MSI High status in cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,How common is MSI High status in cases of Rectum Adenocarcinoma?,msi_h_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,How common is MSI High status in cases of Rectum Adenocarcinoma?,msi_h_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,How common is MSI High status in cases of Rectum Adenocarcinoma?,msi_h_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,How common is MSI High status in cases of Rectum Adenocarcinoma?,msi_h_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How common is MSI High status in cases of Liver Hepatocellular Carcinoma?,msi_h_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,How common is MSI High status in cases of Rectum Adenocarcinoma?,msi_h_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,How common is MSI High status in cases of Rectum Adenocarcinoma?,msi_h_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,How common is MSI High status in cases of Rectum Adenocarcinoma?,msi_h_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,How common is MSI High status in cases of Rectum Adenocarcinoma?,msi_h_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,How common is MSI High status in cases of Rectum Adenocarcinoma?,msi_h_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,How common is MSI High status in cases of Rectum Adenocarcinoma?,msi_h_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,How common is MSI High status in cases of Rectum Adenocarcinoma?,msi_h_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,How common is MSI High status in cases of Rectum Adenocarcinoma?,msi_h_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,How common is MSI High status in cases of Rectum Adenocarcinoma?,msi_h_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How common is MSI High status in cases of Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How common is MSI High status in cases of Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How common is MSI High status in cases of Bladder Urothelial Carcinoma?,msi_h_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How common is MSI High status in cases of Bladder Urothelial Carcinoma?,msi_h_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,How common is MSI High status in cases of Glioblastoma Multiforme?,msi_h_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,How common is MSI High status in cases of Glioblastoma Multiforme?,msi_h_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,How common is MSI High status in cases of Breast Invasive Carcinoma?,msi_h_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,How common is MSI High status in cases of Breast Invasive Carcinoma?,msi_h_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,How common is MSI High status in cases of Breast Invasive Carcinoma?,msi_h_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,How common is MSI High status in cases of Breast Invasive Carcinoma?,msi_h_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How common is MSI High status in cases of Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How common is MSI High status in cases of Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How common is MSI High status in cases of Bladder Urothelial Carcinoma?,msi_h_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,How common is MSI High status in cases of Brain Lower Grade Glioma?,msi_h_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+728,STK19,D341N,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+729,STK19,D345N,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How common is MSI High status in cases of Bladder Urothelial Carcinoma?,msi_h_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI High status in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI High status in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI High status in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI High status in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How common is MSI High status in cases of Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How common is MSI High status in cases of Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How common is MSI High status in cases of Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How common is MSI High status in cases of Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How common is MSI High status in cases of Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How common is MSI High status in cases of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,msi_h_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is MSI High status in cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+817,KL,R594C,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How common is MSI High status in cases of Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is MSI High status in cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI High status in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI High status in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI High status in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI High status in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI High status in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI High status in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI High status in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How common is MSI High status in cases of Glioblastoma Multiforme?,msi_h_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How common is MSI High status in cases of Liver Hepatocellular Carcinoma?,msi_h_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How common is MSI High status in cases of Rectum Adenocarcinoma?,msi_h_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI High status in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI High status in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How common is MSI High status in cases of Pancreatic Adenocarcinoma?,msi_h_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How common is MSI High status in cases of Pancreatic Adenocarcinoma?,msi_h_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How common is MSI High status in cases of Pancreatic Adenocarcinoma?,msi_h_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How common is MSI High status in cases of Pancreatic Adenocarcinoma?,msi_h_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How common is MSI High status in cases of Pancreatic Adenocarcinoma?,msi_h_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How common is MSI High status in cases of Pancreatic Adenocarcinoma?,msi_h_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How common is MSI High status in cases of Pancreatic Adenocarcinoma?,msi_h_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How common is MSI High status in cases of Pancreatic Adenocarcinoma?,msi_h_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is MSI High status in cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is MSI High status in cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is MSI High status in cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is MSI High status in cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is MSI High status in cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI High status in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,How common is MSI High status in cases of Breast Invasive Carcinoma?,msi_h_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How common is MSI High status in cases of Breast Invasive Carcinoma?,msi_h_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How common is MSI High status in cases of Breast Invasive Carcinoma?,msi_h_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How common is MSI High status in cases of Breast Invasive Carcinoma?,msi_h_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How common is MSI High status in cases of Breast Invasive Carcinoma?,msi_h_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How common is MSI High status in cases of Breast Invasive Carcinoma?,msi_h_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How common is MSI High status in cases of Breast Invasive Carcinoma?,msi_h_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,How common is MSI High status in cases of Breast Invasive Carcinoma?,msi_h_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,How common is MSI High status in cases of Breast Invasive Carcinoma?,msi_h_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,How common is MSI High status in cases of Breast Invasive Carcinoma?,msi_h_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How common is MSI High status in cases of Liver Hepatocellular Carcinoma?,msi_h_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How common is MSI High status in cases of Bladder Urothelial Carcinoma?,msi_h_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI High status in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How common is MSI High status in cases of Liver Hepatocellular Carcinoma?,msi_h_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How common is MSI High status in cases of Liver Hepatocellular Carcinoma?,msi_h_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How common is MSI High status in cases of Liver Hepatocellular Carcinoma?,msi_h_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How common is MSI High status in cases of Liver Hepatocellular Carcinoma?,msi_h_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How common is MSI High status in cases of Liver Hepatocellular Carcinoma?,msi_h_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How common is MSI High status in cases of Bladder Urothelial Carcinoma?,msi_h_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI High status in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How common is MSI High status in cases of Lung Squamous Cell Carcinoma?,msi_h_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How common is MSI High status in cases of Bladder Urothelial Carcinoma?,msi_h_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How common is MSI High status in cases of Bladder Urothelial Carcinoma?,msi_h_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,How common is MSI High status in cases of Rectum Adenocarcinoma?,msi_h_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,How common is MSI High status in cases of Rectum Adenocarcinoma?,msi_h_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,How common is MSI High status in cases of Rectum Adenocarcinoma?,msi_h_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,How common is MSI High status in cases of Rectum Adenocarcinoma?,msi_h_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How common is MSI High status in cases of Glioblastoma Multiforme?,msi_h_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How common is MSI High status in cases of Glioblastoma Multiforme?,msi_h_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How common is MSI High status in cases of Glioblastoma Multiforme?,msi_h_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How common is MSI High status in cases of Glioblastoma Multiforme?,msi_h_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How common is MSI High status in cases of Glioblastoma Multiforme?,msi_h_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How common is MSI High status in cases of Glioblastoma Multiforme?,msi_h_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How common is MSI High status in cases of Glioblastoma Multiforme?,msi_h_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How common is MSI High status in cases of Prostate Adenocarcinoma?,msi_h_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How common is MSI High status in cases of Prostate Adenocarcinoma?,msi_h_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How common is MSI High status in cases of Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How common is MSI High status in cases of Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI High status in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI High status in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MSI High status in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How common is MSI High status in cases of Skin Cutaneous Melanoma?,msi_h_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,How common is MSI High status in cases of Lung Adenocarcinoma?,msi_h_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,How common is MSI High status in cases of Stomach Adenocarcinoma?,msi_h_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How common is MSI High status in cases of Breast Invasive Carcinoma?,msi_h_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How common is MSI High status in cases of Breast Invasive Carcinoma?,msi_h_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How common is MSI High status in cases of Colon Adenocarcinoma?,msi_h_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How common is MSI High status in cases of Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How common is MSI High status in cases of Rectum Adenocarcinoma?,msi_h_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the rate of microsatellite instability-high in Breast Invasive Carcinoma diagnoses?,msi_h_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the rate of microsatellite instability-high in Breast Invasive Carcinoma diagnoses?,msi_h_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the rate of microsatellite instability-high in Breast Invasive Carcinoma diagnoses?,msi_h_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the rate of microsatellite instability-high in Breast Invasive Carcinoma diagnoses?,msi_h_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the rate of microsatellite instability-high in Breast Invasive Carcinoma diagnoses?,msi_h_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the rate of microsatellite instability-high in Breast Invasive Carcinoma diagnoses?,msi_h_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the rate of microsatellite instability-high in Breast Invasive Carcinoma diagnoses?,msi_h_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the rate of microsatellite instability-high in Bladder Urothelial Carcinoma diagnoses?,msi_h_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the rate of microsatellite instability-high in Bladder Urothelial Carcinoma diagnoses?,msi_h_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the rate of microsatellite instability-high in Rectum Adenocarcinoma diagnoses?,msi_h_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the rate of microsatellite instability-high in Rectum Adenocarcinoma diagnoses?,msi_h_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the rate of microsatellite instability-high in Pancreatic Adenocarcinoma diagnoses?,msi_h_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the rate of microsatellite instability-high in Prostate Adenocarcinoma diagnoses?,msi_h_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the rate of microsatellite instability-high in Prostate Adenocarcinoma diagnoses?,msi_h_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the rate of microsatellite instability-high in Prostate Adenocarcinoma diagnoses?,msi_h_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the rate of microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma diagnoses?,msi_h_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the rate of microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma diagnoses?,msi_h_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the rate of microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma diagnoses?,msi_h_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the rate of microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma diagnoses?,msi_h_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the rate of microsatellite instability-high in Bladder Urothelial Carcinoma diagnoses?,msi_h_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the rate of microsatellite instability-high in Bladder Urothelial Carcinoma diagnoses?,msi_h_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the rate of microsatellite instability-high in Bladder Urothelial Carcinoma diagnoses?,msi_h_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the rate of microsatellite instability-high in Bladder Urothelial Carcinoma diagnoses?,msi_h_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the rate of microsatellite instability-high in Liver Hepatocellular Carcinoma diagnoses?,msi_h_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the rate of microsatellite instability-high in Liver Hepatocellular Carcinoma diagnoses?,msi_h_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the rate of microsatellite instability-high in Breast Invasive Carcinoma diagnoses?,msi_h_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the rate of microsatellite instability-high in Breast Invasive Carcinoma diagnoses?,msi_h_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",msi_h_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",msi_h_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the rate of microsatellite instability-high in Bladder Urothelial Carcinoma diagnoses?,msi_h_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the rate of microsatellite instability-high in Bladder Urothelial Carcinoma diagnoses?,msi_h_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the rate of microsatellite instability-high in Bladder Urothelial Carcinoma diagnoses?,msi_h_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the rate of microsatellite instability-high in Bladder Urothelial Carcinoma diagnoses?,msi_h_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+140,BICC1,A372V,Exceptional Responders,What is the rate of microsatellite instability-high in Exceptional Responders diagnoses?,msi_h_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",msi_h_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the rate of microsatellite instability-high in Liver Hepatocellular Carcinoma diagnoses?,msi_h_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the rate of microsatellite instability-high in Rectum Adenocarcinoma diagnoses?,msi_h_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the rate of microsatellite instability-high in Kidney Renal Clear Cell Carcinoma diagnoses?,msi_h_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the rate of microsatellite instability-high in Kidney Renal Clear Cell Carcinoma diagnoses?,msi_h_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the rate of microsatellite instability-high in Breast Invasive Carcinoma diagnoses?,msi_h_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the rate of microsatellite instability-high in HIV+ Tumor Molecular Characterization Project - Cervical Cancer diagnoses?,msi_h_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the rate of microsatellite instability-high in Prostate Adenocarcinoma diagnoses?,msi_h_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the rate of microsatellite instability-high in Prostate Adenocarcinoma diagnoses?,msi_h_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the rate of microsatellite instability-high in Prostate Adenocarcinoma diagnoses?,msi_h_frequency
+267,DGKD,R140H,Exceptional Responders,What is the rate of microsatellite instability-high in Exceptional Responders diagnoses?,msi_h_frequency
+268,DGKD,R160H,Exceptional Responders,What is the rate of microsatellite instability-high in Exceptional Responders diagnoses?,msi_h_frequency
+269,DGKD,R204H,Exceptional Responders,What is the rate of microsatellite instability-high in Exceptional Responders diagnoses?,msi_h_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the rate of microsatellite instability-high in Bladder Urothelial Carcinoma diagnoses?,msi_h_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the rate of microsatellite instability-high in Bladder Urothelial Carcinoma diagnoses?,msi_h_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the rate of microsatellite instability-high in Bladder Urothelial Carcinoma diagnoses?,msi_h_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",msi_h_frequency
+299,OR5D14,M210L,Neuroblastoma,What is the rate of microsatellite instability-high in Neuroblastoma diagnoses?,msi_h_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the rate of microsatellite instability-high in Ovarian Serous Cystadenocarcinoma diagnoses?,msi_h_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the rate of microsatellite instability-high in Ovarian Serous Cystadenocarcinoma diagnoses?,msi_h_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the rate of microsatellite instability-high in Ovarian Serous Cystadenocarcinoma diagnoses?,msi_h_frequency
+357,ZNF584,A211T,Sarcoma,What is the rate of microsatellite instability-high in Sarcoma diagnoses?,msi_h_frequency
+358,ZNF584,A256T,Sarcoma,What is the rate of microsatellite instability-high in Sarcoma diagnoses?,msi_h_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma diagnoses?,msi_h_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the rate of microsatellite instability-high in Rectum Adenocarcinoma diagnoses?,msi_h_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the rate of microsatellite instability-high in Rectum Adenocarcinoma diagnoses?,msi_h_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the rate of microsatellite instability-high in Rectum Adenocarcinoma diagnoses?,msi_h_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the rate of microsatellite instability-high in Rectum Adenocarcinoma diagnoses?,msi_h_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the rate of microsatellite instability-high in Liver Hepatocellular Carcinoma diagnoses?,msi_h_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the rate of microsatellite instability-high in Rectum Adenocarcinoma diagnoses?,msi_h_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the rate of microsatellite instability-high in Rectum Adenocarcinoma diagnoses?,msi_h_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the rate of microsatellite instability-high in Rectum Adenocarcinoma diagnoses?,msi_h_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the rate of microsatellite instability-high in Rectum Adenocarcinoma diagnoses?,msi_h_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,What is the rate of microsatellite instability-high in Rectum Adenocarcinoma diagnoses?,msi_h_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,What is the rate of microsatellite instability-high in Rectum Adenocarcinoma diagnoses?,msi_h_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,What is the rate of microsatellite instability-high in Rectum Adenocarcinoma diagnoses?,msi_h_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,What is the rate of microsatellite instability-high in Rectum Adenocarcinoma diagnoses?,msi_h_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,What is the rate of microsatellite instability-high in Rectum Adenocarcinoma diagnoses?,msi_h_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the rate of microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma diagnoses?,msi_h_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the rate of microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma diagnoses?,msi_h_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the rate of microsatellite instability-high in Bladder Urothelial Carcinoma diagnoses?,msi_h_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the rate of microsatellite instability-high in Bladder Urothelial Carcinoma diagnoses?,msi_h_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the rate of microsatellite instability-high in Glioblastoma Multiforme diagnoses?,msi_h_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the rate of microsatellite instability-high in Glioblastoma Multiforme diagnoses?,msi_h_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,What is the rate of microsatellite instability-high in Breast Invasive Carcinoma diagnoses?,msi_h_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,What is the rate of microsatellite instability-high in Breast Invasive Carcinoma diagnoses?,msi_h_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,What is the rate of microsatellite instability-high in Breast Invasive Carcinoma diagnoses?,msi_h_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,What is the rate of microsatellite instability-high in Breast Invasive Carcinoma diagnoses?,msi_h_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the rate of microsatellite instability-high in Ovarian Serous Cystadenocarcinoma diagnoses?,msi_h_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the rate of microsatellite instability-high in Ovarian Serous Cystadenocarcinoma diagnoses?,msi_h_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the rate of microsatellite instability-high in Bladder Urothelial Carcinoma diagnoses?,msi_h_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the rate of microsatellite instability-high in Brain Lower Grade Glioma diagnoses?,msi_h_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+728,STK19,D341N,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+729,STK19,D345N,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the rate of microsatellite instability-high in Bladder Urothelial Carcinoma diagnoses?,msi_h_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",msi_h_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",msi_h_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",msi_h_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",msi_h_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Head and Neck Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Head and Neck Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Head and Neck Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Head and Neck Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Head and Neck Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the rate of microsatellite instability-high in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia diagnoses?,msi_h_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma diagnoses?,msi_h_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+817,KL,R594C,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the rate of microsatellite instability-high in Kidney Renal Papillary Cell Carcinoma diagnoses?,msi_h_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma diagnoses?,msi_h_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",msi_h_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",msi_h_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",msi_h_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",msi_h_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",msi_h_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",msi_h_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",msi_h_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the rate of microsatellite instability-high in Glioblastoma Multiforme diagnoses?,msi_h_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the rate of microsatellite instability-high in Liver Hepatocellular Carcinoma diagnoses?,msi_h_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the rate of microsatellite instability-high in Rectum Adenocarcinoma diagnoses?,msi_h_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",msi_h_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",msi_h_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the rate of microsatellite instability-high in Pancreatic Adenocarcinoma diagnoses?,msi_h_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the rate of microsatellite instability-high in Pancreatic Adenocarcinoma diagnoses?,msi_h_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the rate of microsatellite instability-high in Pancreatic Adenocarcinoma diagnoses?,msi_h_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the rate of microsatellite instability-high in Pancreatic Adenocarcinoma diagnoses?,msi_h_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the rate of microsatellite instability-high in Pancreatic Adenocarcinoma diagnoses?,msi_h_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the rate of microsatellite instability-high in Pancreatic Adenocarcinoma diagnoses?,msi_h_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the rate of microsatellite instability-high in Pancreatic Adenocarcinoma diagnoses?,msi_h_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the rate of microsatellite instability-high in Pancreatic Adenocarcinoma diagnoses?,msi_h_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma diagnoses?,msi_h_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma diagnoses?,msi_h_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma diagnoses?,msi_h_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma diagnoses?,msi_h_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of microsatellite instability-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma diagnoses?,msi_h_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",msi_h_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the rate of microsatellite instability-high in Breast Invasive Carcinoma diagnoses?,msi_h_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the rate of microsatellite instability-high in Breast Invasive Carcinoma diagnoses?,msi_h_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the rate of microsatellite instability-high in Breast Invasive Carcinoma diagnoses?,msi_h_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the rate of microsatellite instability-high in Breast Invasive Carcinoma diagnoses?,msi_h_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the rate of microsatellite instability-high in Breast Invasive Carcinoma diagnoses?,msi_h_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the rate of microsatellite instability-high in Breast Invasive Carcinoma diagnoses?,msi_h_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the rate of microsatellite instability-high in Breast Invasive Carcinoma diagnoses?,msi_h_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the rate of microsatellite instability-high in Breast Invasive Carcinoma diagnoses?,msi_h_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the rate of microsatellite instability-high in Breast Invasive Carcinoma diagnoses?,msi_h_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the rate of microsatellite instability-high in Breast Invasive Carcinoma diagnoses?,msi_h_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the rate of microsatellite instability-high in Liver Hepatocellular Carcinoma diagnoses?,msi_h_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the rate of microsatellite instability-high in Bladder Urothelial Carcinoma diagnoses?,msi_h_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",msi_h_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the rate of microsatellite instability-high in Liver Hepatocellular Carcinoma diagnoses?,msi_h_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the rate of microsatellite instability-high in Liver Hepatocellular Carcinoma diagnoses?,msi_h_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the rate of microsatellite instability-high in Liver Hepatocellular Carcinoma diagnoses?,msi_h_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the rate of microsatellite instability-high in Liver Hepatocellular Carcinoma diagnoses?,msi_h_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the rate of microsatellite instability-high in Liver Hepatocellular Carcinoma diagnoses?,msi_h_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the rate of microsatellite instability-high in Bladder Urothelial Carcinoma diagnoses?,msi_h_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",msi_h_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the rate of microsatellite instability-high in Lung Squamous Cell Carcinoma diagnoses?,msi_h_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the rate of microsatellite instability-high in Bladder Urothelial Carcinoma diagnoses?,msi_h_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the rate of microsatellite instability-high in Bladder Urothelial Carcinoma diagnoses?,msi_h_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the rate of microsatellite instability-high in Rectum Adenocarcinoma diagnoses?,msi_h_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the rate of microsatellite instability-high in Rectum Adenocarcinoma diagnoses?,msi_h_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the rate of microsatellite instability-high in Rectum Adenocarcinoma diagnoses?,msi_h_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the rate of microsatellite instability-high in Rectum Adenocarcinoma diagnoses?,msi_h_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the rate of microsatellite instability-high in Glioblastoma Multiforme diagnoses?,msi_h_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the rate of microsatellite instability-high in Glioblastoma Multiforme diagnoses?,msi_h_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the rate of microsatellite instability-high in Glioblastoma Multiforme diagnoses?,msi_h_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the rate of microsatellite instability-high in Glioblastoma Multiforme diagnoses?,msi_h_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the rate of microsatellite instability-high in Glioblastoma Multiforme diagnoses?,msi_h_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the rate of microsatellite instability-high in Glioblastoma Multiforme diagnoses?,msi_h_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the rate of microsatellite instability-high in Glioblastoma Multiforme diagnoses?,msi_h_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the rate of microsatellite instability-high in Prostate Adenocarcinoma diagnoses?,msi_h_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the rate of microsatellite instability-high in Prostate Adenocarcinoma diagnoses?,msi_h_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the rate of microsatellite instability-high in Kidney Renal Clear Cell Carcinoma diagnoses?,msi_h_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the rate of microsatellite instability-high in Kidney Renal Clear Cell Carcinoma diagnoses?,msi_h_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",msi_h_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",msi_h_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of microsatellite instability-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",msi_h_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the rate of microsatellite instability-high in Skin Cutaneous Melanoma diagnoses?,msi_h_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the rate of microsatellite instability-high in Lung Adenocarcinoma diagnoses?,msi_h_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the rate of microsatellite instability-high in Stomach Adenocarcinoma diagnoses?,msi_h_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the rate of microsatellite instability-high in Breast Invasive Carcinoma diagnoses?,msi_h_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the rate of microsatellite instability-high in Breast Invasive Carcinoma diagnoses?,msi_h_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the rate of microsatellite instability-high in Colon Adenocarcinoma diagnoses?,msi_h_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the rate of microsatellite instability-high in Uterine Corpus Endometrial Carcinoma diagnoses?,msi_h_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the rate of microsatellite instability-high in Rectum Adenocarcinoma diagnoses?,msi_h_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,"Among Pancreatic Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,"Among Prostate Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,"Among Prostate Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,"Among Prostate Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,"Among Kidney Renal Papillary Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,"Among Kidney Renal Papillary Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,"Among Kidney Renal Papillary Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,"Among Kidney Renal Papillary Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,"Among Liver Hepatocellular Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,"Among Liver Hepatocellular Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of msi-h?",msi_h_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of msi-h?",msi_h_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+140,BICC1,A372V,Exceptional Responders,"Among Exceptional Responders patients, what is the frequency of msi-h?",msi_h_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of msi-h?",msi_h_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,"Among Liver Hepatocellular Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,"Among Kidney Renal Clear Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,"Among Kidney Renal Clear Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,"Among HIV+ Tumor Molecular Characterization Project - Cervical Cancer patients, what is the frequency of msi-h?",msi_h_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,"Among Prostate Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,"Among Prostate Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,"Among Prostate Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+267,DGKD,R140H,Exceptional Responders,"Among Exceptional Responders patients, what is the frequency of msi-h?",msi_h_frequency
+268,DGKD,R160H,Exceptional Responders,"Among Exceptional Responders patients, what is the frequency of msi-h?",msi_h_frequency
+269,DGKD,R204H,Exceptional Responders,"Among Exceptional Responders patients, what is the frequency of msi-h?",msi_h_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of msi-h?",msi_h_frequency
+299,OR5D14,M210L,Neuroblastoma,"Among Neuroblastoma patients, what is the frequency of msi-h?",msi_h_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,"Among Ovarian Serous Cystadenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,"Among Ovarian Serous Cystadenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,"Among Ovarian Serous Cystadenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+357,ZNF584,A211T,Sarcoma,"Among Sarcoma patients, what is the frequency of msi-h?",msi_h_frequency
+358,ZNF584,A256T,Sarcoma,"Among Sarcoma patients, what is the frequency of msi-h?",msi_h_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"Among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,"Among Liver Hepatocellular Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,"Among Kidney Renal Papillary Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,"Among Kidney Renal Papillary Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,"Among Glioblastoma Multiforme patients, what is the frequency of msi-h?",msi_h_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,"Among Glioblastoma Multiforme patients, what is the frequency of msi-h?",msi_h_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,"Among Ovarian Serous Cystadenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,"Among Ovarian Serous Cystadenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,"Among Brain Lower Grade Glioma patients, what is the frequency of msi-h?",msi_h_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+728,STK19,D341N,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+729,STK19,D345N,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of msi-h?",msi_h_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of msi-h?",msi_h_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of msi-h?",msi_h_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of msi-h?",msi_h_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,"Among Head and Neck Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,"Among Head and Neck Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,"Among Head and Neck Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,"Among Head and Neck Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,"Among Head and Neck Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,"Among Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia patients, what is the frequency of msi-h?",msi_h_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"Among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+817,KL,R594C,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,"Among Kidney Renal Papillary Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"Among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of msi-h?",msi_h_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of msi-h?",msi_h_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of msi-h?",msi_h_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of msi-h?",msi_h_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of msi-h?",msi_h_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of msi-h?",msi_h_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of msi-h?",msi_h_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,"Among Glioblastoma Multiforme patients, what is the frequency of msi-h?",msi_h_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,"Among Liver Hepatocellular Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of msi-h?",msi_h_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of msi-h?",msi_h_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,"Among Pancreatic Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,"Among Pancreatic Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,"Among Pancreatic Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,"Among Pancreatic Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,"Among Pancreatic Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,"Among Pancreatic Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,"Among Pancreatic Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,"Among Pancreatic Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"Among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"Among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"Among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"Among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"Among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of msi-h?",msi_h_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,"Among Liver Hepatocellular Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of msi-h?",msi_h_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,"Among Liver Hepatocellular Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,"Among Liver Hepatocellular Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,"Among Liver Hepatocellular Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,"Among Liver Hepatocellular Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,"Among Liver Hepatocellular Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of msi-h?",msi_h_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,"Among Glioblastoma Multiforme patients, what is the frequency of msi-h?",msi_h_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,"Among Glioblastoma Multiforme patients, what is the frequency of msi-h?",msi_h_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,"Among Glioblastoma Multiforme patients, what is the frequency of msi-h?",msi_h_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,"Among Glioblastoma Multiforme patients, what is the frequency of msi-h?",msi_h_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,"Among Glioblastoma Multiforme patients, what is the frequency of msi-h?",msi_h_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,"Among Glioblastoma Multiforme patients, what is the frequency of msi-h?",msi_h_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,"Among Glioblastoma Multiforme patients, what is the frequency of msi-h?",msi_h_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,"Among Prostate Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,"Among Prostate Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,"Among Kidney Renal Clear Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,"Among Kidney Renal Clear Cell Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of msi-h?",msi_h_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of msi-h?",msi_h_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of msi-h?",msi_h_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of msi-h?",msi_h_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of msi-h?",msi_h_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,How often does msi-h occur in Breast Invasive Carcinoma patients?,msi_h_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,How often does msi-h occur in Breast Invasive Carcinoma patients?,msi_h_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,How often does msi-h occur in Breast Invasive Carcinoma patients?,msi_h_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,How often does msi-h occur in Breast Invasive Carcinoma patients?,msi_h_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,How often does msi-h occur in Breast Invasive Carcinoma patients?,msi_h_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,How often does msi-h occur in Breast Invasive Carcinoma patients?,msi_h_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,How often does msi-h occur in Breast Invasive Carcinoma patients?,msi_h_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How often does msi-h occur in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How often does msi-h occur in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,How often does msi-h occur in Rectum Adenocarcinoma patients?,msi_h_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,How often does msi-h occur in Rectum Adenocarcinoma patients?,msi_h_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How often does msi-h occur in Pancreatic Adenocarcinoma patients?,msi_h_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How often does msi-h occur in Prostate Adenocarcinoma patients?,msi_h_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How often does msi-h occur in Prostate Adenocarcinoma patients?,msi_h_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How often does msi-h occur in Prostate Adenocarcinoma patients?,msi_h_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How often does msi-h occur in Kidney Renal Papillary Cell Carcinoma patients?,msi_h_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How often does msi-h occur in Kidney Renal Papillary Cell Carcinoma patients?,msi_h_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How often does msi-h occur in Kidney Renal Papillary Cell Carcinoma patients?,msi_h_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How often does msi-h occur in Kidney Renal Papillary Cell Carcinoma patients?,msi_h_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How often does msi-h occur in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How often does msi-h occur in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How often does msi-h occur in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How often does msi-h occur in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How often does msi-h occur in Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How often does msi-h occur in Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How often does msi-h occur in Breast Invasive Carcinoma patients?,msi_h_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How often does msi-h occur in Breast Invasive Carcinoma patients?,msi_h_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does msi-h occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does msi-h occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How often does msi-h occur in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How often does msi-h occur in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How often does msi-h occur in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How often does msi-h occur in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+140,BICC1,A372V,Exceptional Responders,How often does msi-h occur in Exceptional Responders patients?,msi_h_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does msi-h occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How often does msi-h occur in Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,How often does msi-h occur in Rectum Adenocarcinoma patients?,msi_h_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How often does msi-h occur in Kidney Renal Clear Cell Carcinoma patients?,msi_h_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How often does msi-h occur in Kidney Renal Clear Cell Carcinoma patients?,msi_h_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How often does msi-h occur in Breast Invasive Carcinoma patients?,msi_h_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How often does msi-h occur in HIV+ Tumor Molecular Characterization Project - Cervical Cancer patients?,msi_h_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,How often does msi-h occur in Prostate Adenocarcinoma patients?,msi_h_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,How often does msi-h occur in Prostate Adenocarcinoma patients?,msi_h_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,How often does msi-h occur in Prostate Adenocarcinoma patients?,msi_h_frequency
+267,DGKD,R140H,Exceptional Responders,How often does msi-h occur in Exceptional Responders patients?,msi_h_frequency
+268,DGKD,R160H,Exceptional Responders,How often does msi-h occur in Exceptional Responders patients?,msi_h_frequency
+269,DGKD,R204H,Exceptional Responders,How often does msi-h occur in Exceptional Responders patients?,msi_h_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How often does msi-h occur in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How often does msi-h occur in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How often does msi-h occur in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does msi-h occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+299,OR5D14,M210L,Neuroblastoma,How often does msi-h occur in Neuroblastoma patients?,msi_h_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How often does msi-h occur in Ovarian Serous Cystadenocarcinoma patients?,msi_h_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How often does msi-h occur in Ovarian Serous Cystadenocarcinoma patients?,msi_h_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How often does msi-h occur in Ovarian Serous Cystadenocarcinoma patients?,msi_h_frequency
+357,ZNF584,A211T,Sarcoma,How often does msi-h occur in Sarcoma patients?,msi_h_frequency
+358,ZNF584,A256T,Sarcoma,How often does msi-h occur in Sarcoma patients?,msi_h_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often does msi-h occur in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,msi_h_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,How often does msi-h occur in Rectum Adenocarcinoma patients?,msi_h_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,How often does msi-h occur in Rectum Adenocarcinoma patients?,msi_h_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,How often does msi-h occur in Rectum Adenocarcinoma patients?,msi_h_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,How often does msi-h occur in Rectum Adenocarcinoma patients?,msi_h_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How often does msi-h occur in Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,How often does msi-h occur in Rectum Adenocarcinoma patients?,msi_h_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,How often does msi-h occur in Rectum Adenocarcinoma patients?,msi_h_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,How often does msi-h occur in Rectum Adenocarcinoma patients?,msi_h_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,How often does msi-h occur in Rectum Adenocarcinoma patients?,msi_h_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,How often does msi-h occur in Rectum Adenocarcinoma patients?,msi_h_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,How often does msi-h occur in Rectum Adenocarcinoma patients?,msi_h_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,How often does msi-h occur in Rectum Adenocarcinoma patients?,msi_h_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,How often does msi-h occur in Rectum Adenocarcinoma patients?,msi_h_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,How often does msi-h occur in Rectum Adenocarcinoma patients?,msi_h_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How often does msi-h occur in Kidney Renal Papillary Cell Carcinoma patients?,msi_h_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How often does msi-h occur in Kidney Renal Papillary Cell Carcinoma patients?,msi_h_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How often does msi-h occur in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How often does msi-h occur in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,How often does msi-h occur in Glioblastoma Multiforme patients?,msi_h_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,How often does msi-h occur in Glioblastoma Multiforme patients?,msi_h_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,How often does msi-h occur in Breast Invasive Carcinoma patients?,msi_h_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,How often does msi-h occur in Breast Invasive Carcinoma patients?,msi_h_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,How often does msi-h occur in Breast Invasive Carcinoma patients?,msi_h_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,How often does msi-h occur in Breast Invasive Carcinoma patients?,msi_h_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How often does msi-h occur in Ovarian Serous Cystadenocarcinoma patients?,msi_h_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How often does msi-h occur in Ovarian Serous Cystadenocarcinoma patients?,msi_h_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How often does msi-h occur in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,How often does msi-h occur in Brain Lower Grade Glioma patients?,msi_h_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+728,STK19,D341N,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+729,STK19,D345N,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How often does msi-h occur in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does msi-h occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does msi-h occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does msi-h occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does msi-h occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How often does msi-h occur in Head and Neck Squamous Cell Carcinoma patients?,msi_h_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How often does msi-h occur in Head and Neck Squamous Cell Carcinoma patients?,msi_h_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How often does msi-h occur in Head and Neck Squamous Cell Carcinoma patients?,msi_h_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How often does msi-h occur in Head and Neck Squamous Cell Carcinoma patients?,msi_h_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How often does msi-h occur in Head and Neck Squamous Cell Carcinoma patients?,msi_h_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How often does msi-h occur in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia patients?,msi_h_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often does msi-h occur in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,msi_h_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+817,KL,R594C,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How often does msi-h occur in Kidney Renal Papillary Cell Carcinoma patients?,msi_h_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often does msi-h occur in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,msi_h_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does msi-h occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does msi-h occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does msi-h occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does msi-h occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does msi-h occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does msi-h occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does msi-h occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How often does msi-h occur in Glioblastoma Multiforme patients?,msi_h_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How often does msi-h occur in Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How often does msi-h occur in Rectum Adenocarcinoma patients?,msi_h_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does msi-h occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does msi-h occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How often does msi-h occur in Pancreatic Adenocarcinoma patients?,msi_h_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How often does msi-h occur in Pancreatic Adenocarcinoma patients?,msi_h_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How often does msi-h occur in Pancreatic Adenocarcinoma patients?,msi_h_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How often does msi-h occur in Pancreatic Adenocarcinoma patients?,msi_h_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How often does msi-h occur in Pancreatic Adenocarcinoma patients?,msi_h_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How often does msi-h occur in Pancreatic Adenocarcinoma patients?,msi_h_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How often does msi-h occur in Pancreatic Adenocarcinoma patients?,msi_h_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How often does msi-h occur in Pancreatic Adenocarcinoma patients?,msi_h_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often does msi-h occur in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,msi_h_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often does msi-h occur in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,msi_h_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often does msi-h occur in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,msi_h_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often does msi-h occur in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,msi_h_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often does msi-h occur in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,msi_h_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does msi-h occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,How often does msi-h occur in Breast Invasive Carcinoma patients?,msi_h_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How often does msi-h occur in Breast Invasive Carcinoma patients?,msi_h_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How often does msi-h occur in Breast Invasive Carcinoma patients?,msi_h_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How often does msi-h occur in Breast Invasive Carcinoma patients?,msi_h_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How often does msi-h occur in Breast Invasive Carcinoma patients?,msi_h_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How often does msi-h occur in Breast Invasive Carcinoma patients?,msi_h_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How often does msi-h occur in Breast Invasive Carcinoma patients?,msi_h_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,How often does msi-h occur in Breast Invasive Carcinoma patients?,msi_h_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,How often does msi-h occur in Breast Invasive Carcinoma patients?,msi_h_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,How often does msi-h occur in Breast Invasive Carcinoma patients?,msi_h_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How often does msi-h occur in Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How often does msi-h occur in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does msi-h occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How often does msi-h occur in Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How often does msi-h occur in Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How often does msi-h occur in Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How often does msi-h occur in Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How often does msi-h occur in Liver Hepatocellular Carcinoma patients?,msi_h_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How often does msi-h occur in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does msi-h occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How often does msi-h occur in Lung Squamous Cell Carcinoma patients?,msi_h_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How often does msi-h occur in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How often does msi-h occur in Bladder Urothelial Carcinoma patients?,msi_h_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,How often does msi-h occur in Rectum Adenocarcinoma patients?,msi_h_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,How often does msi-h occur in Rectum Adenocarcinoma patients?,msi_h_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,How often does msi-h occur in Rectum Adenocarcinoma patients?,msi_h_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,How often does msi-h occur in Rectum Adenocarcinoma patients?,msi_h_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How often does msi-h occur in Glioblastoma Multiforme patients?,msi_h_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How often does msi-h occur in Glioblastoma Multiforme patients?,msi_h_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How often does msi-h occur in Glioblastoma Multiforme patients?,msi_h_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How often does msi-h occur in Glioblastoma Multiforme patients?,msi_h_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How often does msi-h occur in Glioblastoma Multiforme patients?,msi_h_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How often does msi-h occur in Glioblastoma Multiforme patients?,msi_h_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How often does msi-h occur in Glioblastoma Multiforme patients?,msi_h_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How often does msi-h occur in Prostate Adenocarcinoma patients?,msi_h_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How often does msi-h occur in Prostate Adenocarcinoma patients?,msi_h_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How often does msi-h occur in Kidney Renal Clear Cell Carcinoma patients?,msi_h_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How often does msi-h occur in Kidney Renal Clear Cell Carcinoma patients?,msi_h_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does msi-h occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does msi-h occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does msi-h occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",msi_h_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How often does msi-h occur in Skin Cutaneous Melanoma patients?,msi_h_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,How often does msi-h occur in Lung Adenocarcinoma patients?,msi_h_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,How often does msi-h occur in Stomach Adenocarcinoma patients?,msi_h_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How often does msi-h occur in Breast Invasive Carcinoma patients?,msi_h_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How often does msi-h occur in Breast Invasive Carcinoma patients?,msi_h_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How often does msi-h occur in Colon Adenocarcinoma patients?,msi_h_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How often does msi-h occur in Uterine Corpus Endometrial Carcinoma patients?,msi_h_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How often does msi-h occur in Rectum Adenocarcinoma patients?,msi_h_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the detection rate of msi-h in Breast Invasive Carcinoma?,msi_h_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the detection rate of msi-h in Breast Invasive Carcinoma?,msi_h_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the detection rate of msi-h in Breast Invasive Carcinoma?,msi_h_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the detection rate of msi-h in Breast Invasive Carcinoma?,msi_h_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the detection rate of msi-h in Breast Invasive Carcinoma?,msi_h_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the detection rate of msi-h in Breast Invasive Carcinoma?,msi_h_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the detection rate of msi-h in Breast Invasive Carcinoma?,msi_h_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the detection rate of msi-h in Bladder Urothelial Carcinoma?,msi_h_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the detection rate of msi-h in Bladder Urothelial Carcinoma?,msi_h_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the detection rate of msi-h in Rectum Adenocarcinoma?,msi_h_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the detection rate of msi-h in Rectum Adenocarcinoma?,msi_h_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the detection rate of msi-h in Pancreatic Adenocarcinoma?,msi_h_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the detection rate of msi-h in Prostate Adenocarcinoma?,msi_h_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the detection rate of msi-h in Prostate Adenocarcinoma?,msi_h_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the detection rate of msi-h in Prostate Adenocarcinoma?,msi_h_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the detection rate of msi-h in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the detection rate of msi-h in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the detection rate of msi-h in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the detection rate of msi-h in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the detection rate of msi-h in Bladder Urothelial Carcinoma?,msi_h_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the detection rate of msi-h in Bladder Urothelial Carcinoma?,msi_h_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the detection rate of msi-h in Bladder Urothelial Carcinoma?,msi_h_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the detection rate of msi-h in Bladder Urothelial Carcinoma?,msi_h_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the detection rate of msi-h in Liver Hepatocellular Carcinoma?,msi_h_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the detection rate of msi-h in Liver Hepatocellular Carcinoma?,msi_h_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the detection rate of msi-h in Breast Invasive Carcinoma?,msi_h_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the detection rate of msi-h in Breast Invasive Carcinoma?,msi_h_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of msi-h in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of msi-h in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the detection rate of msi-h in Bladder Urothelial Carcinoma?,msi_h_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the detection rate of msi-h in Bladder Urothelial Carcinoma?,msi_h_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the detection rate of msi-h in Bladder Urothelial Carcinoma?,msi_h_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the detection rate of msi-h in Bladder Urothelial Carcinoma?,msi_h_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+140,BICC1,A372V,Exceptional Responders,What is the detection rate of msi-h in Exceptional Responders?,msi_h_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of msi-h in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the detection rate of msi-h in Liver Hepatocellular Carcinoma?,msi_h_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the detection rate of msi-h in Rectum Adenocarcinoma?,msi_h_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the detection rate of msi-h in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the detection rate of msi-h in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the detection rate of msi-h in Breast Invasive Carcinoma?,msi_h_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the detection rate of msi-h in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,msi_h_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the detection rate of msi-h in Prostate Adenocarcinoma?,msi_h_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the detection rate of msi-h in Prostate Adenocarcinoma?,msi_h_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the detection rate of msi-h in Prostate Adenocarcinoma?,msi_h_frequency
+267,DGKD,R140H,Exceptional Responders,What is the detection rate of msi-h in Exceptional Responders?,msi_h_frequency
+268,DGKD,R160H,Exceptional Responders,What is the detection rate of msi-h in Exceptional Responders?,msi_h_frequency
+269,DGKD,R204H,Exceptional Responders,What is the detection rate of msi-h in Exceptional Responders?,msi_h_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the detection rate of msi-h in Bladder Urothelial Carcinoma?,msi_h_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the detection rate of msi-h in Bladder Urothelial Carcinoma?,msi_h_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the detection rate of msi-h in Bladder Urothelial Carcinoma?,msi_h_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of msi-h in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+299,OR5D14,M210L,Neuroblastoma,What is the detection rate of msi-h in Neuroblastoma?,msi_h_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the detection rate of msi-h in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the detection rate of msi-h in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the detection rate of msi-h in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+357,ZNF584,A211T,Sarcoma,What is the detection rate of msi-h in Sarcoma?,msi_h_frequency
+358,ZNF584,A256T,Sarcoma,What is the detection rate of msi-h in Sarcoma?,msi_h_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the detection rate of msi-h in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the detection rate of msi-h in Rectum Adenocarcinoma?,msi_h_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the detection rate of msi-h in Rectum Adenocarcinoma?,msi_h_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the detection rate of msi-h in Rectum Adenocarcinoma?,msi_h_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the detection rate of msi-h in Rectum Adenocarcinoma?,msi_h_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the detection rate of msi-h in Liver Hepatocellular Carcinoma?,msi_h_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the detection rate of msi-h in Rectum Adenocarcinoma?,msi_h_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the detection rate of msi-h in Rectum Adenocarcinoma?,msi_h_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the detection rate of msi-h in Rectum Adenocarcinoma?,msi_h_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the detection rate of msi-h in Rectum Adenocarcinoma?,msi_h_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,What is the detection rate of msi-h in Rectum Adenocarcinoma?,msi_h_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,What is the detection rate of msi-h in Rectum Adenocarcinoma?,msi_h_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,What is the detection rate of msi-h in Rectum Adenocarcinoma?,msi_h_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,What is the detection rate of msi-h in Rectum Adenocarcinoma?,msi_h_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,What is the detection rate of msi-h in Rectum Adenocarcinoma?,msi_h_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the detection rate of msi-h in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the detection rate of msi-h in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the detection rate of msi-h in Bladder Urothelial Carcinoma?,msi_h_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the detection rate of msi-h in Bladder Urothelial Carcinoma?,msi_h_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the detection rate of msi-h in Glioblastoma Multiforme?,msi_h_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the detection rate of msi-h in Glioblastoma Multiforme?,msi_h_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,What is the detection rate of msi-h in Breast Invasive Carcinoma?,msi_h_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,What is the detection rate of msi-h in Breast Invasive Carcinoma?,msi_h_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,What is the detection rate of msi-h in Breast Invasive Carcinoma?,msi_h_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,What is the detection rate of msi-h in Breast Invasive Carcinoma?,msi_h_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the detection rate of msi-h in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the detection rate of msi-h in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the detection rate of msi-h in Bladder Urothelial Carcinoma?,msi_h_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the detection rate of msi-h in Brain Lower Grade Glioma?,msi_h_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+728,STK19,D341N,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+729,STK19,D345N,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the detection rate of msi-h in Bladder Urothelial Carcinoma?,msi_h_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of msi-h in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of msi-h in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of msi-h in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of msi-h in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the detection rate of msi-h in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the detection rate of msi-h in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the detection rate of msi-h in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the detection rate of msi-h in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the detection rate of msi-h in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the detection rate of msi-h in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,msi_h_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the detection rate of msi-h in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+817,KL,R594C,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the detection rate of msi-h in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the detection rate of msi-h in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of msi-h in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of msi-h in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of msi-h in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of msi-h in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of msi-h in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of msi-h in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of msi-h in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the detection rate of msi-h in Glioblastoma Multiforme?,msi_h_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the detection rate of msi-h in Liver Hepatocellular Carcinoma?,msi_h_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the detection rate of msi-h in Rectum Adenocarcinoma?,msi_h_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of msi-h in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of msi-h in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the detection rate of msi-h in Pancreatic Adenocarcinoma?,msi_h_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the detection rate of msi-h in Pancreatic Adenocarcinoma?,msi_h_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the detection rate of msi-h in Pancreatic Adenocarcinoma?,msi_h_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the detection rate of msi-h in Pancreatic Adenocarcinoma?,msi_h_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the detection rate of msi-h in Pancreatic Adenocarcinoma?,msi_h_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the detection rate of msi-h in Pancreatic Adenocarcinoma?,msi_h_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the detection rate of msi-h in Pancreatic Adenocarcinoma?,msi_h_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the detection rate of msi-h in Pancreatic Adenocarcinoma?,msi_h_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the detection rate of msi-h in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the detection rate of msi-h in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the detection rate of msi-h in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the detection rate of msi-h in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the detection rate of msi-h in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of msi-h in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the detection rate of msi-h in Breast Invasive Carcinoma?,msi_h_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the detection rate of msi-h in Breast Invasive Carcinoma?,msi_h_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the detection rate of msi-h in Breast Invasive Carcinoma?,msi_h_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the detection rate of msi-h in Breast Invasive Carcinoma?,msi_h_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the detection rate of msi-h in Breast Invasive Carcinoma?,msi_h_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the detection rate of msi-h in Breast Invasive Carcinoma?,msi_h_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the detection rate of msi-h in Breast Invasive Carcinoma?,msi_h_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the detection rate of msi-h in Breast Invasive Carcinoma?,msi_h_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the detection rate of msi-h in Breast Invasive Carcinoma?,msi_h_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the detection rate of msi-h in Breast Invasive Carcinoma?,msi_h_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the detection rate of msi-h in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the detection rate of msi-h in Bladder Urothelial Carcinoma?,msi_h_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of msi-h in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the detection rate of msi-h in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the detection rate of msi-h in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the detection rate of msi-h in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the detection rate of msi-h in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the detection rate of msi-h in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the detection rate of msi-h in Bladder Urothelial Carcinoma?,msi_h_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of msi-h in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the detection rate of msi-h in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the detection rate of msi-h in Bladder Urothelial Carcinoma?,msi_h_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the detection rate of msi-h in Bladder Urothelial Carcinoma?,msi_h_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the detection rate of msi-h in Rectum Adenocarcinoma?,msi_h_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the detection rate of msi-h in Rectum Adenocarcinoma?,msi_h_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the detection rate of msi-h in Rectum Adenocarcinoma?,msi_h_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the detection rate of msi-h in Rectum Adenocarcinoma?,msi_h_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the detection rate of msi-h in Glioblastoma Multiforme?,msi_h_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the detection rate of msi-h in Glioblastoma Multiforme?,msi_h_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the detection rate of msi-h in Glioblastoma Multiforme?,msi_h_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the detection rate of msi-h in Glioblastoma Multiforme?,msi_h_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the detection rate of msi-h in Glioblastoma Multiforme?,msi_h_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the detection rate of msi-h in Glioblastoma Multiforme?,msi_h_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the detection rate of msi-h in Glioblastoma Multiforme?,msi_h_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the detection rate of msi-h in Prostate Adenocarcinoma?,msi_h_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the detection rate of msi-h in Prostate Adenocarcinoma?,msi_h_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the detection rate of msi-h in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the detection rate of msi-h in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of msi-h in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of msi-h in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of msi-h in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the detection rate of msi-h in Skin Cutaneous Melanoma?,msi_h_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the detection rate of msi-h in Lung Adenocarcinoma?,msi_h_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the detection rate of msi-h in Stomach Adenocarcinoma?,msi_h_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the detection rate of msi-h in Breast Invasive Carcinoma?,msi_h_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the detection rate of msi-h in Breast Invasive Carcinoma?,msi_h_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the detection rate of msi-h in Colon Adenocarcinoma?,msi_h_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the detection rate of msi-h in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the detection rate of msi-h in Rectum Adenocarcinoma?,msi_h_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit microsatellite instability-high?",msi_h_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit microsatellite instability-high?",msi_h_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+140,BICC1,A372V,Exceptional Responders,How many Exceptional Responders patients exhibit microsatellite instability-high?,msi_h_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit microsatellite instability-high?",msi_h_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How many Kidney Renal Clear Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How many Kidney Renal Clear Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How many HIV+ Tumor Molecular Characterization Project - Cervical Cancer patients exhibit microsatellite instability-high?,msi_h_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+267,DGKD,R140H,Exceptional Responders,How many Exceptional Responders patients exhibit microsatellite instability-high?,msi_h_frequency
+268,DGKD,R160H,Exceptional Responders,How many Exceptional Responders patients exhibit microsatellite instability-high?,msi_h_frequency
+269,DGKD,R204H,Exceptional Responders,How many Exceptional Responders patients exhibit microsatellite instability-high?,msi_h_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit microsatellite instability-high?",msi_h_frequency
+299,OR5D14,M210L,Neuroblastoma,How many Neuroblastoma patients exhibit microsatellite instability-high?,msi_h_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How many Ovarian Serous Cystadenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How many Ovarian Serous Cystadenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How many Ovarian Serous Cystadenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+357,ZNF584,A211T,Sarcoma,How many Sarcoma patients exhibit microsatellite instability-high?,msi_h_frequency
+358,ZNF584,A256T,Sarcoma,How many Sarcoma patients exhibit microsatellite instability-high?,msi_h_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients exhibit microsatellite instability-high?,msi_h_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients exhibit microsatellite instability-high?,msi_h_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How many Ovarian Serous Cystadenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How many Ovarian Serous Cystadenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,How many Brain Lower Grade Glioma patients exhibit microsatellite instability-high?,msi_h_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+728,STK19,D341N,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+729,STK19,D345N,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit microsatellite instability-high?",msi_h_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit microsatellite instability-high?",msi_h_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit microsatellite instability-high?",msi_h_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit microsatellite instability-high?",msi_h_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How many Head and Neck Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How many Head and Neck Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How many Head and Neck Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How many Head and Neck Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How many Head and Neck Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How many Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia patients exhibit microsatellite instability-high?,msi_h_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+817,KL,R594C,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit microsatellite instability-high?",msi_h_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit microsatellite instability-high?",msi_h_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit microsatellite instability-high?",msi_h_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit microsatellite instability-high?",msi_h_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit microsatellite instability-high?",msi_h_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit microsatellite instability-high?",msi_h_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit microsatellite instability-high?",msi_h_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients exhibit microsatellite instability-high?,msi_h_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit microsatellite instability-high?",msi_h_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit microsatellite instability-high?",msi_h_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit microsatellite instability-high?",msi_h_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit microsatellite instability-high?",msi_h_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit microsatellite instability-high?",msi_h_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients exhibit microsatellite instability-high?,msi_h_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients exhibit microsatellite instability-high?,msi_h_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients exhibit microsatellite instability-high?,msi_h_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients exhibit microsatellite instability-high?,msi_h_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients exhibit microsatellite instability-high?,msi_h_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients exhibit microsatellite instability-high?,msi_h_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients exhibit microsatellite instability-high?,msi_h_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How many Kidney Renal Clear Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How many Kidney Renal Clear Cell Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit microsatellite instability-high?",msi_h_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit microsatellite instability-high?",msi_h_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit microsatellite instability-high?",msi_h_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit microsatellite instability-high?,msi_h_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the percentage occurrence of MSI High in Breast Invasive Carcinoma?,msi_h_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the percentage occurrence of MSI High in Breast Invasive Carcinoma?,msi_h_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the percentage occurrence of MSI High in Breast Invasive Carcinoma?,msi_h_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the percentage occurrence of MSI High in Breast Invasive Carcinoma?,msi_h_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the percentage occurrence of MSI High in Breast Invasive Carcinoma?,msi_h_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the percentage occurrence of MSI High in Breast Invasive Carcinoma?,msi_h_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the percentage occurrence of MSI High in Breast Invasive Carcinoma?,msi_h_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the percentage occurrence of MSI High in Bladder Urothelial Carcinoma?,msi_h_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the percentage occurrence of MSI High in Bladder Urothelial Carcinoma?,msi_h_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the percentage occurrence of MSI High in Rectum Adenocarcinoma?,msi_h_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the percentage occurrence of MSI High in Rectum Adenocarcinoma?,msi_h_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the percentage occurrence of MSI High in Pancreatic Adenocarcinoma?,msi_h_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the percentage occurrence of MSI High in Prostate Adenocarcinoma?,msi_h_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the percentage occurrence of MSI High in Prostate Adenocarcinoma?,msi_h_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the percentage occurrence of MSI High in Prostate Adenocarcinoma?,msi_h_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the percentage occurrence of MSI High in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the percentage occurrence of MSI High in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the percentage occurrence of MSI High in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the percentage occurrence of MSI High in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the percentage occurrence of MSI High in Bladder Urothelial Carcinoma?,msi_h_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the percentage occurrence of MSI High in Bladder Urothelial Carcinoma?,msi_h_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the percentage occurrence of MSI High in Bladder Urothelial Carcinoma?,msi_h_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the percentage occurrence of MSI High in Bladder Urothelial Carcinoma?,msi_h_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the percentage occurrence of MSI High in Liver Hepatocellular Carcinoma?,msi_h_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the percentage occurrence of MSI High in Liver Hepatocellular Carcinoma?,msi_h_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the percentage occurrence of MSI High in Breast Invasive Carcinoma?,msi_h_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the percentage occurrence of MSI High in Breast Invasive Carcinoma?,msi_h_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of MSI High in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of MSI High in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the percentage occurrence of MSI High in Bladder Urothelial Carcinoma?,msi_h_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the percentage occurrence of MSI High in Bladder Urothelial Carcinoma?,msi_h_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the percentage occurrence of MSI High in Bladder Urothelial Carcinoma?,msi_h_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the percentage occurrence of MSI High in Bladder Urothelial Carcinoma?,msi_h_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+140,BICC1,A372V,Exceptional Responders,What is the percentage occurrence of MSI High in Exceptional Responders?,msi_h_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of MSI High in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the percentage occurrence of MSI High in Liver Hepatocellular Carcinoma?,msi_h_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the percentage occurrence of MSI High in Rectum Adenocarcinoma?,msi_h_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the percentage occurrence of MSI High in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the percentage occurrence of MSI High in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the percentage occurrence of MSI High in Breast Invasive Carcinoma?,msi_h_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the percentage occurrence of MSI High in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,msi_h_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the percentage occurrence of MSI High in Prostate Adenocarcinoma?,msi_h_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the percentage occurrence of MSI High in Prostate Adenocarcinoma?,msi_h_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the percentage occurrence of MSI High in Prostate Adenocarcinoma?,msi_h_frequency
+267,DGKD,R140H,Exceptional Responders,What is the percentage occurrence of MSI High in Exceptional Responders?,msi_h_frequency
+268,DGKD,R160H,Exceptional Responders,What is the percentage occurrence of MSI High in Exceptional Responders?,msi_h_frequency
+269,DGKD,R204H,Exceptional Responders,What is the percentage occurrence of MSI High in Exceptional Responders?,msi_h_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the percentage occurrence of MSI High in Bladder Urothelial Carcinoma?,msi_h_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the percentage occurrence of MSI High in Bladder Urothelial Carcinoma?,msi_h_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the percentage occurrence of MSI High in Bladder Urothelial Carcinoma?,msi_h_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of MSI High in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+299,OR5D14,M210L,Neuroblastoma,What is the percentage occurrence of MSI High in Neuroblastoma?,msi_h_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the percentage occurrence of MSI High in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the percentage occurrence of MSI High in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the percentage occurrence of MSI High in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+357,ZNF584,A211T,Sarcoma,What is the percentage occurrence of MSI High in Sarcoma?,msi_h_frequency
+358,ZNF584,A256T,Sarcoma,What is the percentage occurrence of MSI High in Sarcoma?,msi_h_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the percentage occurrence of MSI High in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the percentage occurrence of MSI High in Rectum Adenocarcinoma?,msi_h_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the percentage occurrence of MSI High in Rectum Adenocarcinoma?,msi_h_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the percentage occurrence of MSI High in Rectum Adenocarcinoma?,msi_h_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the percentage occurrence of MSI High in Rectum Adenocarcinoma?,msi_h_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the percentage occurrence of MSI High in Liver Hepatocellular Carcinoma?,msi_h_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the percentage occurrence of MSI High in Rectum Adenocarcinoma?,msi_h_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the percentage occurrence of MSI High in Rectum Adenocarcinoma?,msi_h_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the percentage occurrence of MSI High in Rectum Adenocarcinoma?,msi_h_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the percentage occurrence of MSI High in Rectum Adenocarcinoma?,msi_h_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,What is the percentage occurrence of MSI High in Rectum Adenocarcinoma?,msi_h_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,What is the percentage occurrence of MSI High in Rectum Adenocarcinoma?,msi_h_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,What is the percentage occurrence of MSI High in Rectum Adenocarcinoma?,msi_h_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,What is the percentage occurrence of MSI High in Rectum Adenocarcinoma?,msi_h_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,What is the percentage occurrence of MSI High in Rectum Adenocarcinoma?,msi_h_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the percentage occurrence of MSI High in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the percentage occurrence of MSI High in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the percentage occurrence of MSI High in Bladder Urothelial Carcinoma?,msi_h_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the percentage occurrence of MSI High in Bladder Urothelial Carcinoma?,msi_h_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the percentage occurrence of MSI High in Glioblastoma Multiforme?,msi_h_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the percentage occurrence of MSI High in Glioblastoma Multiforme?,msi_h_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,What is the percentage occurrence of MSI High in Breast Invasive Carcinoma?,msi_h_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,What is the percentage occurrence of MSI High in Breast Invasive Carcinoma?,msi_h_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,What is the percentage occurrence of MSI High in Breast Invasive Carcinoma?,msi_h_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,What is the percentage occurrence of MSI High in Breast Invasive Carcinoma?,msi_h_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the percentage occurrence of MSI High in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the percentage occurrence of MSI High in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the percentage occurrence of MSI High in Bladder Urothelial Carcinoma?,msi_h_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the percentage occurrence of MSI High in Brain Lower Grade Glioma?,msi_h_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+728,STK19,D341N,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+729,STK19,D345N,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the percentage occurrence of MSI High in Bladder Urothelial Carcinoma?,msi_h_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of MSI High in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of MSI High in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of MSI High in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of MSI High in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the percentage occurrence of MSI High in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,msi_h_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the percentage occurrence of MSI High in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+817,KL,R594C,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the percentage occurrence of MSI High in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the percentage occurrence of MSI High in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of MSI High in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of MSI High in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of MSI High in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of MSI High in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of MSI High in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of MSI High in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of MSI High in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the percentage occurrence of MSI High in Glioblastoma Multiforme?,msi_h_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the percentage occurrence of MSI High in Liver Hepatocellular Carcinoma?,msi_h_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the percentage occurrence of MSI High in Rectum Adenocarcinoma?,msi_h_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of MSI High in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of MSI High in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the percentage occurrence of MSI High in Pancreatic Adenocarcinoma?,msi_h_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the percentage occurrence of MSI High in Pancreatic Adenocarcinoma?,msi_h_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the percentage occurrence of MSI High in Pancreatic Adenocarcinoma?,msi_h_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the percentage occurrence of MSI High in Pancreatic Adenocarcinoma?,msi_h_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the percentage occurrence of MSI High in Pancreatic Adenocarcinoma?,msi_h_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the percentage occurrence of MSI High in Pancreatic Adenocarcinoma?,msi_h_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the percentage occurrence of MSI High in Pancreatic Adenocarcinoma?,msi_h_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the percentage occurrence of MSI High in Pancreatic Adenocarcinoma?,msi_h_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the percentage occurrence of MSI High in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the percentage occurrence of MSI High in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the percentage occurrence of MSI High in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the percentage occurrence of MSI High in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the percentage occurrence of MSI High in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of MSI High in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the percentage occurrence of MSI High in Breast Invasive Carcinoma?,msi_h_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the percentage occurrence of MSI High in Breast Invasive Carcinoma?,msi_h_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the percentage occurrence of MSI High in Breast Invasive Carcinoma?,msi_h_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the percentage occurrence of MSI High in Breast Invasive Carcinoma?,msi_h_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the percentage occurrence of MSI High in Breast Invasive Carcinoma?,msi_h_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the percentage occurrence of MSI High in Breast Invasive Carcinoma?,msi_h_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the percentage occurrence of MSI High in Breast Invasive Carcinoma?,msi_h_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the percentage occurrence of MSI High in Breast Invasive Carcinoma?,msi_h_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the percentage occurrence of MSI High in Breast Invasive Carcinoma?,msi_h_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the percentage occurrence of MSI High in Breast Invasive Carcinoma?,msi_h_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the percentage occurrence of MSI High in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the percentage occurrence of MSI High in Bladder Urothelial Carcinoma?,msi_h_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of MSI High in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the percentage occurrence of MSI High in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the percentage occurrence of MSI High in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the percentage occurrence of MSI High in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the percentage occurrence of MSI High in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the percentage occurrence of MSI High in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the percentage occurrence of MSI High in Bladder Urothelial Carcinoma?,msi_h_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of MSI High in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MSI High in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the percentage occurrence of MSI High in Bladder Urothelial Carcinoma?,msi_h_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the percentage occurrence of MSI High in Bladder Urothelial Carcinoma?,msi_h_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the percentage occurrence of MSI High in Rectum Adenocarcinoma?,msi_h_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the percentage occurrence of MSI High in Rectum Adenocarcinoma?,msi_h_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the percentage occurrence of MSI High in Rectum Adenocarcinoma?,msi_h_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the percentage occurrence of MSI High in Rectum Adenocarcinoma?,msi_h_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the percentage occurrence of MSI High in Glioblastoma Multiforme?,msi_h_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the percentage occurrence of MSI High in Glioblastoma Multiforme?,msi_h_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the percentage occurrence of MSI High in Glioblastoma Multiforme?,msi_h_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the percentage occurrence of MSI High in Glioblastoma Multiforme?,msi_h_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the percentage occurrence of MSI High in Glioblastoma Multiforme?,msi_h_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the percentage occurrence of MSI High in Glioblastoma Multiforme?,msi_h_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the percentage occurrence of MSI High in Glioblastoma Multiforme?,msi_h_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the percentage occurrence of MSI High in Prostate Adenocarcinoma?,msi_h_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the percentage occurrence of MSI High in Prostate Adenocarcinoma?,msi_h_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the percentage occurrence of MSI High in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the percentage occurrence of MSI High in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of MSI High in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of MSI High in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of MSI High in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the percentage occurrence of MSI High in Skin Cutaneous Melanoma?,msi_h_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the percentage occurrence of MSI High in Lung Adenocarcinoma?,msi_h_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the percentage occurrence of MSI High in Stomach Adenocarcinoma?,msi_h_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the percentage occurrence of MSI High in Breast Invasive Carcinoma?,msi_h_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the percentage occurrence of MSI High in Breast Invasive Carcinoma?,msi_h_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the percentage occurrence of MSI High in Colon Adenocarcinoma?,msi_h_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MSI High in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the percentage occurrence of MSI High in Rectum Adenocarcinoma?,msi_h_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How frequently do Pancreatic Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How frequently do Prostate Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How frequently do Prostate Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How frequently do Prostate Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How frequently do Kidney Renal Papillary Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How frequently do Kidney Renal Papillary Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How frequently do Kidney Renal Papillary Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How frequently do Kidney Renal Papillary Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How frequently do Liver Hepatocellular Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How frequently do Liver Hepatocellular Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with microsatellite instability-high?",msi_h_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with microsatellite instability-high?",msi_h_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+140,BICC1,A372V,Exceptional Responders,How frequently do Exceptional Responders patients present with microsatellite instability-high?,msi_h_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with microsatellite instability-high?",msi_h_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How frequently do Liver Hepatocellular Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How frequently do Kidney Renal Clear Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How frequently do Kidney Renal Clear Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How frequently do HIV+ Tumor Molecular Characterization Project - Cervical Cancer patients present with microsatellite instability-high?,msi_h_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,How frequently do Prostate Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,How frequently do Prostate Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,How frequently do Prostate Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+267,DGKD,R140H,Exceptional Responders,How frequently do Exceptional Responders patients present with microsatellite instability-high?,msi_h_frequency
+268,DGKD,R160H,Exceptional Responders,How frequently do Exceptional Responders patients present with microsatellite instability-high?,msi_h_frequency
+269,DGKD,R204H,Exceptional Responders,How frequently do Exceptional Responders patients present with microsatellite instability-high?,msi_h_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with microsatellite instability-high?",msi_h_frequency
+299,OR5D14,M210L,Neuroblastoma,How frequently do Neuroblastoma patients present with microsatellite instability-high?,msi_h_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How frequently do Ovarian Serous Cystadenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How frequently do Ovarian Serous Cystadenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How frequently do Ovarian Serous Cystadenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+357,ZNF584,A211T,Sarcoma,How frequently do Sarcoma patients present with microsatellite instability-high?,msi_h_frequency
+358,ZNF584,A256T,Sarcoma,How frequently do Sarcoma patients present with microsatellite instability-high?,msi_h_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently do Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How frequently do Liver Hepatocellular Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How frequently do Kidney Renal Papillary Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How frequently do Kidney Renal Papillary Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,How frequently do Glioblastoma Multiforme patients present with microsatellite instability-high?,msi_h_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,How frequently do Glioblastoma Multiforme patients present with microsatellite instability-high?,msi_h_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How frequently do Ovarian Serous Cystadenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How frequently do Ovarian Serous Cystadenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,How frequently do Brain Lower Grade Glioma patients present with microsatellite instability-high?,msi_h_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+728,STK19,D341N,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+729,STK19,D345N,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with microsatellite instability-high?",msi_h_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with microsatellite instability-high?",msi_h_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with microsatellite instability-high?",msi_h_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with microsatellite instability-high?",msi_h_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How frequently do Head and Neck Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How frequently do Head and Neck Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How frequently do Head and Neck Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How frequently do Head and Neck Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How frequently do Head and Neck Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How frequently do Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia patients present with microsatellite instability-high?,msi_h_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently do Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+817,KL,R594C,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How frequently do Kidney Renal Papillary Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently do Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with microsatellite instability-high?",msi_h_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with microsatellite instability-high?",msi_h_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with microsatellite instability-high?",msi_h_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with microsatellite instability-high?",msi_h_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with microsatellite instability-high?",msi_h_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with microsatellite instability-high?",msi_h_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with microsatellite instability-high?",msi_h_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How frequently do Glioblastoma Multiforme patients present with microsatellite instability-high?,msi_h_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How frequently do Liver Hepatocellular Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with microsatellite instability-high?",msi_h_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with microsatellite instability-high?",msi_h_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How frequently do Pancreatic Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How frequently do Pancreatic Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How frequently do Pancreatic Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How frequently do Pancreatic Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How frequently do Pancreatic Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How frequently do Pancreatic Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How frequently do Pancreatic Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How frequently do Pancreatic Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently do Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently do Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently do Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently do Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently do Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with microsatellite instability-high?",msi_h_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How frequently do Liver Hepatocellular Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with microsatellite instability-high?",msi_h_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How frequently do Liver Hepatocellular Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How frequently do Liver Hepatocellular Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How frequently do Liver Hepatocellular Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How frequently do Liver Hepatocellular Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How frequently do Liver Hepatocellular Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with microsatellite instability-high?",msi_h_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How frequently do Glioblastoma Multiforme patients present with microsatellite instability-high?,msi_h_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How frequently do Glioblastoma Multiforme patients present with microsatellite instability-high?,msi_h_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How frequently do Glioblastoma Multiforme patients present with microsatellite instability-high?,msi_h_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How frequently do Glioblastoma Multiforme patients present with microsatellite instability-high?,msi_h_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How frequently do Glioblastoma Multiforme patients present with microsatellite instability-high?,msi_h_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How frequently do Glioblastoma Multiforme patients present with microsatellite instability-high?,msi_h_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How frequently do Glioblastoma Multiforme patients present with microsatellite instability-high?,msi_h_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How frequently do Prostate Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How frequently do Prostate Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How frequently do Kidney Renal Clear Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How frequently do Kidney Renal Clear Cell Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with microsatellite instability-high?",msi_h_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with microsatellite instability-high?",msi_h_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with microsatellite instability-high?",msi_h_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with microsatellite instability-high?,msi_h_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with microsatellite instability-high?,msi_h_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the proportion of MSI High tumors in Breast Invasive Carcinoma?,msi_h_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the proportion of MSI High tumors in Breast Invasive Carcinoma?,msi_h_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the proportion of MSI High tumors in Breast Invasive Carcinoma?,msi_h_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the proportion of MSI High tumors in Breast Invasive Carcinoma?,msi_h_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the proportion of MSI High tumors in Breast Invasive Carcinoma?,msi_h_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the proportion of MSI High tumors in Breast Invasive Carcinoma?,msi_h_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the proportion of MSI High tumors in Breast Invasive Carcinoma?,msi_h_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the proportion of MSI High tumors in Bladder Urothelial Carcinoma?,msi_h_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the proportion of MSI High tumors in Bladder Urothelial Carcinoma?,msi_h_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the proportion of MSI High tumors in Rectum Adenocarcinoma?,msi_h_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the proportion of MSI High tumors in Rectum Adenocarcinoma?,msi_h_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the proportion of MSI High tumors in Pancreatic Adenocarcinoma?,msi_h_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the proportion of MSI High tumors in Prostate Adenocarcinoma?,msi_h_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the proportion of MSI High tumors in Prostate Adenocarcinoma?,msi_h_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the proportion of MSI High tumors in Prostate Adenocarcinoma?,msi_h_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the proportion of MSI High tumors in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the proportion of MSI High tumors in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the proportion of MSI High tumors in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the proportion of MSI High tumors in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the proportion of MSI High tumors in Bladder Urothelial Carcinoma?,msi_h_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the proportion of MSI High tumors in Bladder Urothelial Carcinoma?,msi_h_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the proportion of MSI High tumors in Bladder Urothelial Carcinoma?,msi_h_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the proportion of MSI High tumors in Bladder Urothelial Carcinoma?,msi_h_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the proportion of MSI High tumors in Liver Hepatocellular Carcinoma?,msi_h_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the proportion of MSI High tumors in Liver Hepatocellular Carcinoma?,msi_h_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the proportion of MSI High tumors in Breast Invasive Carcinoma?,msi_h_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the proportion of MSI High tumors in Breast Invasive Carcinoma?,msi_h_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of MSI High tumors in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of MSI High tumors in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the proportion of MSI High tumors in Bladder Urothelial Carcinoma?,msi_h_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the proportion of MSI High tumors in Bladder Urothelial Carcinoma?,msi_h_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the proportion of MSI High tumors in Bladder Urothelial Carcinoma?,msi_h_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the proportion of MSI High tumors in Bladder Urothelial Carcinoma?,msi_h_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+140,BICC1,A372V,Exceptional Responders,What is the proportion of MSI High tumors in Exceptional Responders?,msi_h_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of MSI High tumors in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the proportion of MSI High tumors in Liver Hepatocellular Carcinoma?,msi_h_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the proportion of MSI High tumors in Rectum Adenocarcinoma?,msi_h_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the proportion of MSI High tumors in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the proportion of MSI High tumors in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the proportion of MSI High tumors in Breast Invasive Carcinoma?,msi_h_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the proportion of MSI High tumors in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,msi_h_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the proportion of MSI High tumors in Prostate Adenocarcinoma?,msi_h_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the proportion of MSI High tumors in Prostate Adenocarcinoma?,msi_h_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the proportion of MSI High tumors in Prostate Adenocarcinoma?,msi_h_frequency
+267,DGKD,R140H,Exceptional Responders,What is the proportion of MSI High tumors in Exceptional Responders?,msi_h_frequency
+268,DGKD,R160H,Exceptional Responders,What is the proportion of MSI High tumors in Exceptional Responders?,msi_h_frequency
+269,DGKD,R204H,Exceptional Responders,What is the proportion of MSI High tumors in Exceptional Responders?,msi_h_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the proportion of MSI High tumors in Bladder Urothelial Carcinoma?,msi_h_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the proportion of MSI High tumors in Bladder Urothelial Carcinoma?,msi_h_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the proportion of MSI High tumors in Bladder Urothelial Carcinoma?,msi_h_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of MSI High tumors in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+299,OR5D14,M210L,Neuroblastoma,What is the proportion of MSI High tumors in Neuroblastoma?,msi_h_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the proportion of MSI High tumors in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the proportion of MSI High tumors in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the proportion of MSI High tumors in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+357,ZNF584,A211T,Sarcoma,What is the proportion of MSI High tumors in Sarcoma?,msi_h_frequency
+358,ZNF584,A256T,Sarcoma,What is the proportion of MSI High tumors in Sarcoma?,msi_h_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the proportion of MSI High tumors in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the proportion of MSI High tumors in Rectum Adenocarcinoma?,msi_h_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the proportion of MSI High tumors in Rectum Adenocarcinoma?,msi_h_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the proportion of MSI High tumors in Rectum Adenocarcinoma?,msi_h_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the proportion of MSI High tumors in Rectum Adenocarcinoma?,msi_h_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the proportion of MSI High tumors in Liver Hepatocellular Carcinoma?,msi_h_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the proportion of MSI High tumors in Rectum Adenocarcinoma?,msi_h_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the proportion of MSI High tumors in Rectum Adenocarcinoma?,msi_h_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the proportion of MSI High tumors in Rectum Adenocarcinoma?,msi_h_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the proportion of MSI High tumors in Rectum Adenocarcinoma?,msi_h_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,What is the proportion of MSI High tumors in Rectum Adenocarcinoma?,msi_h_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,What is the proportion of MSI High tumors in Rectum Adenocarcinoma?,msi_h_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,What is the proportion of MSI High tumors in Rectum Adenocarcinoma?,msi_h_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,What is the proportion of MSI High tumors in Rectum Adenocarcinoma?,msi_h_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,What is the proportion of MSI High tumors in Rectum Adenocarcinoma?,msi_h_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the proportion of MSI High tumors in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the proportion of MSI High tumors in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the proportion of MSI High tumors in Bladder Urothelial Carcinoma?,msi_h_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the proportion of MSI High tumors in Bladder Urothelial Carcinoma?,msi_h_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the proportion of MSI High tumors in Glioblastoma Multiforme?,msi_h_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the proportion of MSI High tumors in Glioblastoma Multiforme?,msi_h_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,What is the proportion of MSI High tumors in Breast Invasive Carcinoma?,msi_h_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,What is the proportion of MSI High tumors in Breast Invasive Carcinoma?,msi_h_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,What is the proportion of MSI High tumors in Breast Invasive Carcinoma?,msi_h_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,What is the proportion of MSI High tumors in Breast Invasive Carcinoma?,msi_h_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the proportion of MSI High tumors in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the proportion of MSI High tumors in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the proportion of MSI High tumors in Bladder Urothelial Carcinoma?,msi_h_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the proportion of MSI High tumors in Brain Lower Grade Glioma?,msi_h_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+728,STK19,D341N,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+729,STK19,D345N,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the proportion of MSI High tumors in Bladder Urothelial Carcinoma?,msi_h_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of MSI High tumors in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of MSI High tumors in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of MSI High tumors in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of MSI High tumors in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the proportion of MSI High tumors in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,msi_h_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the proportion of MSI High tumors in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+817,KL,R594C,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the proportion of MSI High tumors in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the proportion of MSI High tumors in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of MSI High tumors in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of MSI High tumors in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of MSI High tumors in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of MSI High tumors in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of MSI High tumors in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of MSI High tumors in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of MSI High tumors in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the proportion of MSI High tumors in Glioblastoma Multiforme?,msi_h_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the proportion of MSI High tumors in Liver Hepatocellular Carcinoma?,msi_h_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the proportion of MSI High tumors in Rectum Adenocarcinoma?,msi_h_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of MSI High tumors in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of MSI High tumors in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the proportion of MSI High tumors in Pancreatic Adenocarcinoma?,msi_h_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the proportion of MSI High tumors in Pancreatic Adenocarcinoma?,msi_h_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the proportion of MSI High tumors in Pancreatic Adenocarcinoma?,msi_h_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the proportion of MSI High tumors in Pancreatic Adenocarcinoma?,msi_h_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the proportion of MSI High tumors in Pancreatic Adenocarcinoma?,msi_h_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the proportion of MSI High tumors in Pancreatic Adenocarcinoma?,msi_h_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the proportion of MSI High tumors in Pancreatic Adenocarcinoma?,msi_h_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the proportion of MSI High tumors in Pancreatic Adenocarcinoma?,msi_h_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the proportion of MSI High tumors in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the proportion of MSI High tumors in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the proportion of MSI High tumors in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the proportion of MSI High tumors in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the proportion of MSI High tumors in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of MSI High tumors in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the proportion of MSI High tumors in Breast Invasive Carcinoma?,msi_h_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the proportion of MSI High tumors in Breast Invasive Carcinoma?,msi_h_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the proportion of MSI High tumors in Breast Invasive Carcinoma?,msi_h_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the proportion of MSI High tumors in Breast Invasive Carcinoma?,msi_h_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the proportion of MSI High tumors in Breast Invasive Carcinoma?,msi_h_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the proportion of MSI High tumors in Breast Invasive Carcinoma?,msi_h_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the proportion of MSI High tumors in Breast Invasive Carcinoma?,msi_h_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the proportion of MSI High tumors in Breast Invasive Carcinoma?,msi_h_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the proportion of MSI High tumors in Breast Invasive Carcinoma?,msi_h_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the proportion of MSI High tumors in Breast Invasive Carcinoma?,msi_h_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the proportion of MSI High tumors in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the proportion of MSI High tumors in Bladder Urothelial Carcinoma?,msi_h_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of MSI High tumors in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the proportion of MSI High tumors in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the proportion of MSI High tumors in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the proportion of MSI High tumors in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the proportion of MSI High tumors in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the proportion of MSI High tumors in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the proportion of MSI High tumors in Bladder Urothelial Carcinoma?,msi_h_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of MSI High tumors in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the proportion of MSI High tumors in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the proportion of MSI High tumors in Bladder Urothelial Carcinoma?,msi_h_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the proportion of MSI High tumors in Bladder Urothelial Carcinoma?,msi_h_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the proportion of MSI High tumors in Rectum Adenocarcinoma?,msi_h_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the proportion of MSI High tumors in Rectum Adenocarcinoma?,msi_h_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the proportion of MSI High tumors in Rectum Adenocarcinoma?,msi_h_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the proportion of MSI High tumors in Rectum Adenocarcinoma?,msi_h_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the proportion of MSI High tumors in Glioblastoma Multiforme?,msi_h_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the proportion of MSI High tumors in Glioblastoma Multiforme?,msi_h_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the proportion of MSI High tumors in Glioblastoma Multiforme?,msi_h_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the proportion of MSI High tumors in Glioblastoma Multiforme?,msi_h_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the proportion of MSI High tumors in Glioblastoma Multiforme?,msi_h_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the proportion of MSI High tumors in Glioblastoma Multiforme?,msi_h_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the proportion of MSI High tumors in Glioblastoma Multiforme?,msi_h_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the proportion of MSI High tumors in Prostate Adenocarcinoma?,msi_h_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the proportion of MSI High tumors in Prostate Adenocarcinoma?,msi_h_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the proportion of MSI High tumors in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the proportion of MSI High tumors in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of MSI High tumors in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of MSI High tumors in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of MSI High tumors in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the proportion of MSI High tumors in Skin Cutaneous Melanoma?,msi_h_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the proportion of MSI High tumors in Lung Adenocarcinoma?,msi_h_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the proportion of MSI High tumors in Stomach Adenocarcinoma?,msi_h_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the proportion of MSI High tumors in Breast Invasive Carcinoma?,msi_h_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the proportion of MSI High tumors in Breast Invasive Carcinoma?,msi_h_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the proportion of MSI High tumors in Colon Adenocarcinoma?,msi_h_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSI High tumors in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the proportion of MSI High tumors in Rectum Adenocarcinoma?,msi_h_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,Can you share the incidence rate of msi-high in Breast Invasive Carcinoma?,msi_h_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,Can you share the incidence rate of msi-high in Breast Invasive Carcinoma?,msi_h_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,Can you share the incidence rate of msi-high in Breast Invasive Carcinoma?,msi_h_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,Can you share the incidence rate of msi-high in Breast Invasive Carcinoma?,msi_h_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,Can you share the incidence rate of msi-high in Breast Invasive Carcinoma?,msi_h_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,Can you share the incidence rate of msi-high in Breast Invasive Carcinoma?,msi_h_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,Can you share the incidence rate of msi-high in Breast Invasive Carcinoma?,msi_h_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,Can you share the incidence rate of msi-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,Can you share the incidence rate of msi-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,Can you share the incidence rate of msi-high in Rectum Adenocarcinoma?,msi_h_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,Can you share the incidence rate of msi-high in Rectum Adenocarcinoma?,msi_h_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,Can you share the incidence rate of msi-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,Can you share the incidence rate of msi-high in Prostate Adenocarcinoma?,msi_h_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,Can you share the incidence rate of msi-high in Prostate Adenocarcinoma?,msi_h_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,Can you share the incidence rate of msi-high in Prostate Adenocarcinoma?,msi_h_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,Can you share the incidence rate of msi-high in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,Can you share the incidence rate of msi-high in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,Can you share the incidence rate of msi-high in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,Can you share the incidence rate of msi-high in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,Can you share the incidence rate of msi-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,Can you share the incidence rate of msi-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,Can you share the incidence rate of msi-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,Can you share the incidence rate of msi-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,Can you share the incidence rate of msi-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,Can you share the incidence rate of msi-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,Can you share the incidence rate of msi-high in Breast Invasive Carcinoma?,msi_h_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,Can you share the incidence rate of msi-high in Breast Invasive Carcinoma?,msi_h_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of msi-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of msi-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,Can you share the incidence rate of msi-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,Can you share the incidence rate of msi-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,Can you share the incidence rate of msi-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,Can you share the incidence rate of msi-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+140,BICC1,A372V,Exceptional Responders,Can you share the incidence rate of msi-high in Exceptional Responders?,msi_h_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of msi-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,Can you share the incidence rate of msi-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,Can you share the incidence rate of msi-high in Rectum Adenocarcinoma?,msi_h_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,Can you share the incidence rate of msi-high in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,Can you share the incidence rate of msi-high in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,Can you share the incidence rate of msi-high in Breast Invasive Carcinoma?,msi_h_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,Can you share the incidence rate of msi-high in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,msi_h_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,Can you share the incidence rate of msi-high in Prostate Adenocarcinoma?,msi_h_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,Can you share the incidence rate of msi-high in Prostate Adenocarcinoma?,msi_h_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,Can you share the incidence rate of msi-high in Prostate Adenocarcinoma?,msi_h_frequency
+267,DGKD,R140H,Exceptional Responders,Can you share the incidence rate of msi-high in Exceptional Responders?,msi_h_frequency
+268,DGKD,R160H,Exceptional Responders,Can you share the incidence rate of msi-high in Exceptional Responders?,msi_h_frequency
+269,DGKD,R204H,Exceptional Responders,Can you share the incidence rate of msi-high in Exceptional Responders?,msi_h_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,Can you share the incidence rate of msi-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,Can you share the incidence rate of msi-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,Can you share the incidence rate of msi-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of msi-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+299,OR5D14,M210L,Neuroblastoma,Can you share the incidence rate of msi-high in Neuroblastoma?,msi_h_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,Can you share the incidence rate of msi-high in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,Can you share the incidence rate of msi-high in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,Can you share the incidence rate of msi-high in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+357,ZNF584,A211T,Sarcoma,Can you share the incidence rate of msi-high in Sarcoma?,msi_h_frequency
+358,ZNF584,A256T,Sarcoma,Can you share the incidence rate of msi-high in Sarcoma?,msi_h_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you share the incidence rate of msi-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,Can you share the incidence rate of msi-high in Rectum Adenocarcinoma?,msi_h_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,Can you share the incidence rate of msi-high in Rectum Adenocarcinoma?,msi_h_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,Can you share the incidence rate of msi-high in Rectum Adenocarcinoma?,msi_h_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,Can you share the incidence rate of msi-high in Rectum Adenocarcinoma?,msi_h_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,Can you share the incidence rate of msi-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,Can you share the incidence rate of msi-high in Rectum Adenocarcinoma?,msi_h_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,Can you share the incidence rate of msi-high in Rectum Adenocarcinoma?,msi_h_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,Can you share the incidence rate of msi-high in Rectum Adenocarcinoma?,msi_h_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,Can you share the incidence rate of msi-high in Rectum Adenocarcinoma?,msi_h_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,Can you share the incidence rate of msi-high in Rectum Adenocarcinoma?,msi_h_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,Can you share the incidence rate of msi-high in Rectum Adenocarcinoma?,msi_h_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,Can you share the incidence rate of msi-high in Rectum Adenocarcinoma?,msi_h_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,Can you share the incidence rate of msi-high in Rectum Adenocarcinoma?,msi_h_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,Can you share the incidence rate of msi-high in Rectum Adenocarcinoma?,msi_h_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,Can you share the incidence rate of msi-high in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,Can you share the incidence rate of msi-high in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,Can you share the incidence rate of msi-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,Can you share the incidence rate of msi-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,Can you share the incidence rate of msi-high in Glioblastoma Multiforme?,msi_h_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,Can you share the incidence rate of msi-high in Glioblastoma Multiforme?,msi_h_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,Can you share the incidence rate of msi-high in Breast Invasive Carcinoma?,msi_h_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,Can you share the incidence rate of msi-high in Breast Invasive Carcinoma?,msi_h_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,Can you share the incidence rate of msi-high in Breast Invasive Carcinoma?,msi_h_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,Can you share the incidence rate of msi-high in Breast Invasive Carcinoma?,msi_h_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,Can you share the incidence rate of msi-high in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,Can you share the incidence rate of msi-high in Ovarian Serous Cystadenocarcinoma?,msi_h_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,Can you share the incidence rate of msi-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,Can you share the incidence rate of msi-high in Brain Lower Grade Glioma?,msi_h_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+728,STK19,D341N,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+729,STK19,D345N,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,Can you share the incidence rate of msi-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of msi-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of msi-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of msi-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of msi-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Head and Neck Squamous Cell Carcinoma?,msi_h_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,Can you share the incidence rate of msi-high in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,msi_h_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you share the incidence rate of msi-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+817,KL,R594C,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,Can you share the incidence rate of msi-high in Kidney Renal Papillary Cell Carcinoma?,msi_h_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you share the incidence rate of msi-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of msi-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of msi-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of msi-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of msi-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of msi-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of msi-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of msi-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,Can you share the incidence rate of msi-high in Glioblastoma Multiforme?,msi_h_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,Can you share the incidence rate of msi-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,Can you share the incidence rate of msi-high in Rectum Adenocarcinoma?,msi_h_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of msi-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of msi-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,Can you share the incidence rate of msi-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,Can you share the incidence rate of msi-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,Can you share the incidence rate of msi-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,Can you share the incidence rate of msi-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,Can you share the incidence rate of msi-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,Can you share the incidence rate of msi-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,Can you share the incidence rate of msi-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,Can you share the incidence rate of msi-high in Pancreatic Adenocarcinoma?,msi_h_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you share the incidence rate of msi-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you share the incidence rate of msi-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you share the incidence rate of msi-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you share the incidence rate of msi-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you share the incidence rate of msi-high in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,msi_h_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of msi-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,Can you share the incidence rate of msi-high in Breast Invasive Carcinoma?,msi_h_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,Can you share the incidence rate of msi-high in Breast Invasive Carcinoma?,msi_h_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,Can you share the incidence rate of msi-high in Breast Invasive Carcinoma?,msi_h_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,Can you share the incidence rate of msi-high in Breast Invasive Carcinoma?,msi_h_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,Can you share the incidence rate of msi-high in Breast Invasive Carcinoma?,msi_h_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,Can you share the incidence rate of msi-high in Breast Invasive Carcinoma?,msi_h_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,Can you share the incidence rate of msi-high in Breast Invasive Carcinoma?,msi_h_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,Can you share the incidence rate of msi-high in Breast Invasive Carcinoma?,msi_h_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,Can you share the incidence rate of msi-high in Breast Invasive Carcinoma?,msi_h_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,Can you share the incidence rate of msi-high in Breast Invasive Carcinoma?,msi_h_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,Can you share the incidence rate of msi-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,Can you share the incidence rate of msi-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of msi-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,Can you share the incidence rate of msi-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,Can you share the incidence rate of msi-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,Can you share the incidence rate of msi-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,Can you share the incidence rate of msi-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,Can you share the incidence rate of msi-high in Liver Hepatocellular Carcinoma?,msi_h_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,Can you share the incidence rate of msi-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of msi-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,Can you share the incidence rate of msi-high in Lung Squamous Cell Carcinoma?,msi_h_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,Can you share the incidence rate of msi-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,Can you share the incidence rate of msi-high in Bladder Urothelial Carcinoma?,msi_h_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,Can you share the incidence rate of msi-high in Rectum Adenocarcinoma?,msi_h_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,Can you share the incidence rate of msi-high in Rectum Adenocarcinoma?,msi_h_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,Can you share the incidence rate of msi-high in Rectum Adenocarcinoma?,msi_h_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,Can you share the incidence rate of msi-high in Rectum Adenocarcinoma?,msi_h_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,Can you share the incidence rate of msi-high in Glioblastoma Multiforme?,msi_h_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,Can you share the incidence rate of msi-high in Glioblastoma Multiforme?,msi_h_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,Can you share the incidence rate of msi-high in Glioblastoma Multiforme?,msi_h_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,Can you share the incidence rate of msi-high in Glioblastoma Multiforme?,msi_h_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,Can you share the incidence rate of msi-high in Glioblastoma Multiforme?,msi_h_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,Can you share the incidence rate of msi-high in Glioblastoma Multiforme?,msi_h_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,Can you share the incidence rate of msi-high in Glioblastoma Multiforme?,msi_h_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,Can you share the incidence rate of msi-high in Prostate Adenocarcinoma?,msi_h_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,Can you share the incidence rate of msi-high in Prostate Adenocarcinoma?,msi_h_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,Can you share the incidence rate of msi-high in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,Can you share the incidence rate of msi-high in Kidney Renal Clear Cell Carcinoma?,msi_h_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of msi-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of msi-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of msi-high in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",msi_h_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,Can you share the incidence rate of msi-high in Skin Cutaneous Melanoma?,msi_h_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,Can you share the incidence rate of msi-high in Lung Adenocarcinoma?,msi_h_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,Can you share the incidence rate of msi-high in Stomach Adenocarcinoma?,msi_h_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,Can you share the incidence rate of msi-high in Breast Invasive Carcinoma?,msi_h_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,Can you share the incidence rate of msi-high in Breast Invasive Carcinoma?,msi_h_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,Can you share the incidence rate of msi-high in Colon Adenocarcinoma?,msi_h_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of msi-high in Uterine Corpus Endometrial Carcinoma?,msi_h_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,Can you share the incidence rate of msi-high in Rectum Adenocarcinoma?,msi_h_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve msi-high?,msi_h_frequency
+2,TNS1,G1711V,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve msi-high?,msi_h_frequency
+3,TNS1,G1718V,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve msi-high?,msi_h_frequency
+4,TNS1,G1732V,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve msi-high?,msi_h_frequency
+5,TNS1,G1824V,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve msi-high?,msi_h_frequency
+6,TNS1,G1857V,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve msi-high?,msi_h_frequency
+7,TNS1,G843V,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve msi-high?,msi_h_frequency
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve msi-high?,msi_h_frequency
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve msi-high?,msi_h_frequency
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+22,TRPA1,S295I,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve msi-high?,msi_h_frequency
+23,TRPA1,S443I,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve msi-high?,msi_h_frequency
+24,TAF1C,R299L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+25,TAF1C,R396L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+26,TAF1C,R634L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+27,TAF1C,R702L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+28,TAF1C,R728L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+42,OR2T4,P272H,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+43,OR2T4,P300H,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma cases involve msi-high?,msi_h_frequency
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma cases involve msi-high?,msi_h_frequency
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma cases involve msi-high?,msi_h_frequency
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma cases involve msi-high?,msi_h_frequency
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What fraction of Kidney Renal Papillary Cell Carcinoma cases involve msi-high?,msi_h_frequency
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What fraction of Kidney Renal Papillary Cell Carcinoma cases involve msi-high?,msi_h_frequency
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What fraction of Kidney Renal Papillary Cell Carcinoma cases involve msi-high?,msi_h_frequency
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What fraction of Kidney Renal Papillary Cell Carcinoma cases involve msi-high?,msi_h_frequency
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve msi-high?,msi_h_frequency
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve msi-high?,msi_h_frequency
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve msi-high?,msi_h_frequency
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve msi-high?,msi_h_frequency
+70,PAK3,E318K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+71,PAK3,E319K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+72,PAK3,E334K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+73,PAK3,E340K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+74,PAK3,E355K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases involve msi-high?,msi_h_frequency
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases involve msi-high?,msi_h_frequency
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve msi-high?,msi_h_frequency
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve msi-high?,msi_h_frequency
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+116,RELN,A2371V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve msi-high?",msi_h_frequency
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve msi-high?",msi_h_frequency
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve msi-high?,msi_h_frequency
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve msi-high?,msi_h_frequency
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve msi-high?,msi_h_frequency
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+129,ABCC3,R758W,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve msi-high?,msi_h_frequency
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+140,BICC1,A372V,Exceptional Responders,What fraction of Exceptional Responders cases involve msi-high?,msi_h_frequency
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve msi-high?",msi_h_frequency
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases involve msi-high?,msi_h_frequency
+157,OR8K5,R293G,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+164,SYT10,M484I,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve msi-high?,msi_h_frequency
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+175,UNC5D,L280V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+176,UNC5D,L635V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+177,UNC5D,L637V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+178,UNC5D,L699V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+179,UNC5D,L704V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+180,UNC5D,L709V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What fraction of Kidney Renal Clear Cell Carcinoma cases involve msi-high?,msi_h_frequency
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What fraction of Kidney Renal Clear Cell Carcinoma cases involve msi-high?,msi_h_frequency
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+193,MRPL55,H27Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+194,MRPL55,H63Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve msi-high?,msi_h_frequency
+198,EPRS1,K771I,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+199,EPRS1,K778I,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What fraction of HIV+ Tumor Molecular Characterization Project - Cervical Cancer cases involve msi-high?,msi_h_frequency
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+251,ZNF274,P13R,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+253,SYNJ1,R795C,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+254,SYNJ1,R800C,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+255,SYNJ1,R839C,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+261,DSCAM,V343M,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma cases involve msi-high?,msi_h_frequency
+262,DSCAM,V426M,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma cases involve msi-high?,msi_h_frequency
+263,DSCAM,V591M,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma cases involve msi-high?,msi_h_frequency
+267,DGKD,R140H,Exceptional Responders,What fraction of Exceptional Responders cases involve msi-high?,msi_h_frequency
+268,DGKD,R160H,Exceptional Responders,What fraction of Exceptional Responders cases involve msi-high?,msi_h_frequency
+269,DGKD,R204H,Exceptional Responders,What fraction of Exceptional Responders cases involve msi-high?,msi_h_frequency
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve msi-high?,msi_h_frequency
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve msi-high?,msi_h_frequency
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve msi-high?,msi_h_frequency
+279,WNT2,D138N,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve msi-high?",msi_h_frequency
+299,OR5D14,M210L,Neuroblastoma,What fraction of Neuroblastoma cases involve msi-high?,msi_h_frequency
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+310,LCN15,E21V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What fraction of Ovarian Serous Cystadenocarcinoma cases involve msi-high?,msi_h_frequency
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What fraction of Ovarian Serous Cystadenocarcinoma cases involve msi-high?,msi_h_frequency
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What fraction of Ovarian Serous Cystadenocarcinoma cases involve msi-high?,msi_h_frequency
+357,ZNF584,A211T,Sarcoma,What fraction of Sarcoma cases involve msi-high?,msi_h_frequency
+358,ZNF584,A256T,Sarcoma,What fraction of Sarcoma cases involve msi-high?,msi_h_frequency
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases involve msi-high?,msi_h_frequency
+406,POC1B,I198T,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve msi-high?,msi_h_frequency
+407,POC1B,I286T,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve msi-high?,msi_h_frequency
+408,POC1B,I328T,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve msi-high?,msi_h_frequency
+409,POC1B,S79P,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve msi-high?,msi_h_frequency
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases involve msi-high?,msi_h_frequency
+414,AQP7,T110S,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve msi-high?,msi_h_frequency
+415,AQP7,T166S,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve msi-high?,msi_h_frequency
+416,AQP7,T167S,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve msi-high?,msi_h_frequency
+417,AQP7,T75S,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve msi-high?,msi_h_frequency
+430,DCN,R163C,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve msi-high?,msi_h_frequency
+431,DCN,R203C,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve msi-high?,msi_h_frequency
+432,DCN,R241C,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve msi-high?,msi_h_frequency
+433,DCN,R350C,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve msi-high?,msi_h_frequency
+434,DCN,R41C,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve msi-high?,msi_h_frequency
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What fraction of Kidney Renal Papillary Cell Carcinoma cases involve msi-high?,msi_h_frequency
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What fraction of Kidney Renal Papillary Cell Carcinoma cases involve msi-high?,msi_h_frequency
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+482,SGCZ,Q138H,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+483,SGCZ,Q91H,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+485,SMO,V15M,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+486,SMO,V321M,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+488,CHODL,G159E,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+489,CHODL,G181E,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+490,CHODL,G200E,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+494,MYO16,P399H,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+495,MYO16,P421H,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+498,CXCR2,A98V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve msi-high?,msi_h_frequency
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+510,RAB40C,A111V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+511,RAB40C,A143V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+512,CTNNA2,S323R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+513,CTNNA2,S339R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+514,CTNNA2,S386R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+515,CTNNA2,S707R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve msi-high?,msi_h_frequency
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+532,KIF20B,N1160D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases involve msi-high?,msi_h_frequency
+533,KIF20B,N1200D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases involve msi-high?,msi_h_frequency
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+540,ERCC6,R1053H,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+541,DCC,R320W,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve msi-high?,msi_h_frequency
+542,DCC,R363W,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve msi-high?,msi_h_frequency
+543,DCC,R386W,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve msi-high?,msi_h_frequency
+544,DCC,R41W,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve msi-high?,msi_h_frequency
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What fraction of Ovarian Serous Cystadenocarcinoma cases involve msi-high?,msi_h_frequency
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What fraction of Ovarian Serous Cystadenocarcinoma cases involve msi-high?,msi_h_frequency
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve msi-high?,msi_h_frequency
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+625,SIK2,I265M,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+644,OR2A12,A254T,Brain Lower Grade Glioma,What fraction of Brain Lower Grade Glioma cases involve msi-high?,msi_h_frequency
+646,PYHIN1,T325K,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+647,PYHIN1,T334K,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+650,JAML,G191E,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+651,JAML,G219E,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+652,JAML,G220E,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+653,JAML,G230E,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+658,TYK2,H1146R,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+659,TYK2,H23R,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+660,TYK2,H961R,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+728,STK19,D341N,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+729,STK19,D345N,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+730,REXO4,P60A,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve msi-high?,msi_h_frequency
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve msi-high?",msi_h_frequency
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve msi-high?",msi_h_frequency
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve msi-high?",msi_h_frequency
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve msi-high?",msi_h_frequency
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What fraction of Head and Neck Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What fraction of Head and Neck Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What fraction of Head and Neck Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What fraction of Head and Neck Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What fraction of Head and Neck Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What fraction of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia cases involve msi-high?,msi_h_frequency
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases involve msi-high?,msi_h_frequency
+792,GLRB,E148D,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+793,TTN,F7636L,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+794,TTN,F8563L,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+795,TTN,F8880L,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+809,TRIM45,S177L,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+810,TRIM45,S224L,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+811,TRIM45,S281L,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+817,KL,R594C,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What fraction of Kidney Renal Papillary Cell Carcinoma cases involve msi-high?,msi_h_frequency
+822,TAF1L,A539V,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases involve msi-high?,msi_h_frequency
+843,DHX16,A29V,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+844,DHX16,A89V,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+902,GPR158,A644V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+903,GPR158,A723V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve msi-high?",msi_h_frequency
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve msi-high?",msi_h_frequency
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve msi-high?",msi_h_frequency
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve msi-high?",msi_h_frequency
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve msi-high?",msi_h_frequency
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve msi-high?",msi_h_frequency
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve msi-high?",msi_h_frequency
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases involve msi-high?,msi_h_frequency
+954,TRAP1,R114W,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+955,TRAP1,R61W,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases involve msi-high?,msi_h_frequency
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve msi-high?,msi_h_frequency
+982,GABRA6,G115R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+983,GABRA6,G122R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+984,GABRA6,G165R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+985,GABRA6,G175R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+986,GABRA6,G70R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve msi-high?",msi_h_frequency
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve msi-high?",msi_h_frequency
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma cases involve msi-high?,msi_h_frequency
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma cases involve msi-high?,msi_h_frequency
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma cases involve msi-high?,msi_h_frequency
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma cases involve msi-high?,msi_h_frequency
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma cases involve msi-high?,msi_h_frequency
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1017,GPC3,I107N,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1018,GPC3,I161N,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1038,SYT9,V275L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1039,SYT9,V307L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve msi-high?",msi_h_frequency
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1056,CA9,E402K,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1065,PSG2,P43L,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve msi-high?,msi_h_frequency
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve msi-high?,msi_h_frequency
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve msi-high?,msi_h_frequency
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve msi-high?,msi_h_frequency
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve msi-high?,msi_h_frequency
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1093,PXN,H1016Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1094,PXN,H359Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1095,PXN,H492Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1096,PXN,H524Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1097,PXN,H526Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1098,PXN,H540Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve msi-high?,msi_h_frequency
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve msi-high?,msi_h_frequency
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1112,MYT1,A558E,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve msi-high?,msi_h_frequency
+1113,MYT1,A879E,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve msi-high?,msi_h_frequency
+1114,MYT1,A906E,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve msi-high?,msi_h_frequency
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases involve msi-high?,msi_h_frequency
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve msi-high?,msi_h_frequency
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve msi-high?",msi_h_frequency
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases involve msi-high?,msi_h_frequency
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases involve msi-high?,msi_h_frequency
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases involve msi-high?,msi_h_frequency
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases involve msi-high?,msi_h_frequency
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases involve msi-high?,msi_h_frequency
+1188,SOX21,R55L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve msi-high?,msi_h_frequency
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve msi-high?",msi_h_frequency
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1234,ZNF431,R128I,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve msi-high?,msi_h_frequency
+1248,TTC12,D646H,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1249,TTC12,D652H,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve msi-high?,msi_h_frequency
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve msi-high?,msi_h_frequency
+1254,CTSC,E214V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1255,CTSC,E291V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1256,CTSC,E322V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1257,CTSC,E324V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1258,CTSC,E335V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1264,ACTB,A138T,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1265,ACTB,A217T,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1266,ACTB,A244T,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1267,ACTB,A260T,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases involve msi-high?,msi_h_frequency
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases involve msi-high?,msi_h_frequency
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases involve msi-high?,msi_h_frequency
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases involve msi-high?,msi_h_frequency
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases involve msi-high?,msi_h_frequency
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases involve msi-high?,msi_h_frequency
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases involve msi-high?,msi_h_frequency
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+1299,TLCD5,G15V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1300,TLCD5,G37V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What fraction of Kidney Renal Clear Cell Carcinoma cases involve msi-high?,msi_h_frequency
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What fraction of Kidney Renal Clear Cell Carcinoma cases involve msi-high?,msi_h_frequency
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1393,EBF2,T104I,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1394,EBF2,T252I,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve msi-high?",msi_h_frequency
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve msi-high?",msi_h_frequency
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve msi-high?",msi_h_frequency
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve msi-high?,msi_h_frequency
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1413,PRSS1,S114T,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1414,PRSS1,S124T,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1415,PRSS1,S138T,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1416,PRSS1,S74T,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1417,PGF,R126H,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1418,PGF,R127H,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve msi-high?,msi_h_frequency
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve msi-high?,msi_h_frequency
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve msi-high?,msi_h_frequency
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve msi-high?,msi_h_frequency
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the incidence of TNS1 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the incidence of TNS1 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the incidence of TNS1 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the incidence of TNS1 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the incidence of TNS1 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the incidence of TNS1 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the incidence of TNS1 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the incidence of EVC2 loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the incidence of EVC2 loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the incidence of CR1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the incidence of CR1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the incidence of TRPA1 loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the incidence of TRPA1 loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the incidence of TAF1C loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the incidence of TAF1C loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the incidence of TAF1C loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the incidence of TAF1C loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the incidence of TAF1C loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the incidence of DPF3 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the incidence of DPF3 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the incidence of DPF3 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the incidence of OR2T4 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the incidence of OR2T4 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the incidence of FBN1 loss in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the incidence of MAD1L1 loss in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the incidence of MAD1L1 loss in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the incidence of MAD1L1 loss in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the incidence of CCNG1 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the incidence of ANP32E loss in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the incidence of ANP32E loss in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the incidence of ANP32E loss in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the incidence of ANP32E loss in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the incidence of FRY loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the incidence of FRY loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the incidence of FRY loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the incidence of FRY loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the incidence of PAK3 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the incidence of PAK3 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the incidence of PAK3 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the incidence of PAK3 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the incidence of PAK3 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the incidence of MUC16 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the incidence of ZFPM2 loss in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the incidence of ZFPM2 loss in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the incidence of PIK3C2B loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the incidence of PIK3C2B loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the incidence of ZNF804A loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the incidence of RELN loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of EFCAB12 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of EFCAB12 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the incidence of DEFB115 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the incidence of ANKDD1A loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the incidence of ANKDD1A loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the incidence of ANKDD1A loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the incidence of HTR3B loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the incidence of HTR3B loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the incidence of HTR3B loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the incidence of ABCC3 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the incidence of NOMO1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the incidence of NOMO1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the incidence of HYOU1 loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the incidence of FMO4 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+140,BICC1,A372V,Exceptional Responders,What is the incidence of BICC1 loss in Exceptional Responders?,freq_cnv_loss_or_gain
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the incidence of ZMYM3 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the incidence of ZMYM3 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the incidence of ZMYM3 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of XKR4 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the incidence of ABCC2 loss in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the incidence of OR8K5 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the incidence of SPTAN1 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the incidence of SPTAN1 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the incidence of SYT10 loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the incidence of HSPA5 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the incidence of UNC5D loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the incidence of UNC5D loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the incidence of UNC5D loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the incidence of UNC5D loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the incidence of UNC5D loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the incidence of UNC5D loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the incidence of DOCK2 loss in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the incidence of ZNF627 loss in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the incidence of CDC42BPA loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the incidence of MRPL55 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the incidence of MRPL55 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the incidence of TMTC3 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the incidence of EPRS1 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the incidence of EPRS1 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the incidence of GRTP1 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the incidence of GRTP1 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the incidence of TSHZ3 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the incidence of TAS1R3 loss in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,freq_cnv_loss_or_gain
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the incidence of PIAS3 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the incidence of PIAS3 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the incidence of ZNF274 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the incidence of SYNJ1 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the incidence of SYNJ1 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the incidence of SYNJ1 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the incidence of DSCAM loss in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the incidence of DSCAM loss in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the incidence of DSCAM loss in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+267,DGKD,R140H,Exceptional Responders,What is the incidence of DGKD loss in Exceptional Responders?,freq_cnv_loss_or_gain
+268,DGKD,R160H,Exceptional Responders,What is the incidence of DGKD loss in Exceptional Responders?,freq_cnv_loss_or_gain
+269,DGKD,R204H,Exceptional Responders,What is the incidence of DGKD loss in Exceptional Responders?,freq_cnv_loss_or_gain
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the incidence of PLEKHG6 loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the incidence of PLEKHG6 loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the incidence of PLEKHG6 loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the incidence of WNT2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the incidence of GUCY2C loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the incidence of C7orf31 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of ZKSCAN7 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+299,OR5D14,M210L,Neuroblastoma,What is the incidence of OR5D14 loss in Neuroblastoma?,freq_cnv_loss_or_gain
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the incidence of SPATA22 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the incidence of SPATA22 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the incidence of SPATA22 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the incidence of LCN15 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the incidence of DCAF4L2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the incidence of GUK1 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the incidence of GUK1 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the incidence of GUK1 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the incidence of GUK1 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the incidence of GUK1 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the incidence of MORF4L1 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the incidence of MORF4L1 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the incidence of MORF4L1 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the incidence of MORF4L1 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the incidence of MYO3B loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the incidence of MYO3B loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the incidence of TENT5A loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the incidence of TENT5A loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the incidence of TENT5A loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the incidence of ZFAT loss in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the incidence of ZFAT loss in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the incidence of ZFAT loss in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+357,ZNF584,A211T,Sarcoma,What is the incidence of ZNF584 loss in Sarcoma?,freq_cnv_loss_or_gain
+358,ZNF584,A256T,Sarcoma,What is the incidence of ZNF584 loss in Sarcoma?,freq_cnv_loss_or_gain
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the incidence of LDOC1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the incidence of PDGFC loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSANTD4 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the incidence of NPSR1 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the incidence of PHLPP1 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the incidence of COL6A3 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the incidence of COL6A3 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the incidence of COL6A3 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the incidence of COL6A3 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the incidence of COL6A3 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the incidence of ADRA1A loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of LAMB2 loss in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the incidence of POC1B loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the incidence of POC1B loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the incidence of POC1B loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the incidence of POC1B loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the incidence of USH2A loss in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the incidence of AQP7 loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the incidence of AQP7 loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the incidence of AQP7 loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the incidence of AQP7 loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+430,DCN,R163C,Rectum Adenocarcinoma,What is the incidence of DCN loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+431,DCN,R203C,Rectum Adenocarcinoma,What is the incidence of DCN loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+432,DCN,R241C,Rectum Adenocarcinoma,What is the incidence of DCN loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+433,DCN,R350C,Rectum Adenocarcinoma,What is the incidence of DCN loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+434,DCN,R41C,Rectum Adenocarcinoma,What is the incidence of DCN loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the incidence of CPS1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the incidence of CPS1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the incidence of CPS1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the incidence of FCGR2C loss in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the incidence of FCGR2C loss in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the incidence of GRM1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the incidence of SGCZ loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the incidence of SGCZ loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+485,SMO,V15M,Stomach Adenocarcinoma,What is the incidence of SMO loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+486,SMO,V321M,Stomach Adenocarcinoma,What is the incidence of SMO loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the incidence of CHODL loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the incidence of CHODL loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the incidence of CHODL loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+494,MYO16,P399H,Colon Adenocarcinoma,What is the incidence of MYO16 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+495,MYO16,P421H,Colon Adenocarcinoma,What is the incidence of MYO16 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the incidence of CXCR2 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the incidence of TMEM225 loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the incidence of MAOB loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the incidence of GPRASP1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of MRPL32 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the incidence of TYROBP loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the incidence of RAB40C loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the incidence of RAB40C loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the incidence of CTNNA2 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the incidence of CTNNA2 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the incidence of CTNNA2 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the incidence of CTNNA2 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the incidence of MYO15A loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the incidence of GIMAP2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the incidence of KIF20B loss in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the incidence of KIF20B loss in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the incidence of ADAM17 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the incidence of BCAT1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the incidence of BCAT1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the incidence of BCAT1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the incidence of ERCC6 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+541,DCC,R320W,Breast Invasive Carcinoma,What is the incidence of DCC loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+542,DCC,R363W,Breast Invasive Carcinoma,What is the incidence of DCC loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+543,DCC,R386W,Breast Invasive Carcinoma,What is the incidence of DCC loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+544,DCC,R41W,Breast Invasive Carcinoma,What is the incidence of DCC loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the incidence of FBXO15 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the incidence of FBXO15 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the incidence of GSTCD loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the incidence of GSTCD loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the incidence of OLFML3 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the incidence of OLFML3 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the incidence of OLFML3 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the incidence of CFAP61 loss in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the incidence of CFAP61 loss in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the incidence of HLA-DQA2 loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the incidence of TENM2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the incidence of TENM2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the incidence of TENM2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the incidence of ANKRD24 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the incidence of ANKRD24 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the incidence of ANKRD24 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the incidence of ZCCHC14 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the incidence of ZCCHC14 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the incidence of ZCCHC14 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the incidence of ZCCHC14 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+625,SIK2,I265M,Lung Adenocarcinoma,What is the incidence of SIK2 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the incidence of MYH11 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the incidence of MYH11 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the incidence of SLC6A4 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the incidence of SLC9C1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the incidence of SLC9C1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the incidence of OR2A12 loss in Brain Lower Grade Glioma?,freq_cnv_loss_or_gain
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the incidence of PYHIN1 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the incidence of PYHIN1 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the incidence of JAML loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the incidence of JAML loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the incidence of JAML loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the incidence of JAML loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the incidence of TYK2 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the incidence of TYK2 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the incidence of TYK2 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the incidence of CTCFL loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the incidence of CTCFL loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the incidence of CTCFL loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the incidence of CTCFL loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of CEP20 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of CEP20 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the incidence of RIMS2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the incidence of RIMS2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the incidence of RIMS2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the incidence of RIMS2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the incidence of RIMS2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the incidence of RIMS2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the incidence of RIMS2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the incidence of PIK3C2G loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the incidence of PIK3C2G loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+728,STK19,D341N,Colon Adenocarcinoma,What is the incidence of STK19 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+729,STK19,D345N,Colon Adenocarcinoma,What is the incidence of STK19 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the incidence of REXO4 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the incidence of ZBTB34 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the incidence of ZBTB34 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the incidence of NCKAP5 loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of SORCS1 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of SORCS1 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of SORCS1 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of SORCS1 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the incidence of FGF8 loss in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the incidence of FGF8 loss in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the incidence of FGF8 loss in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the incidence of FGF8 loss in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the incidence of FGF8 loss in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the incidence of TENM3 loss in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,freq_cnv_loss_or_gain
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the incidence of AKT1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of CFAP298-TCP10L loss in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the incidence of GLRB loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+793,TTN,F7636L,Colon Adenocarcinoma,What is the incidence of TTN loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+794,TTN,F8563L,Colon Adenocarcinoma,What is the incidence of TTN loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+795,TTN,F8880L,Colon Adenocarcinoma,What is the incidence of TTN loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the incidence of ANKRD30A loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the incidence of ANKRD30A loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the incidence of ANKRD30A loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the incidence of TRIM45 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the incidence of TRIM45 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the incidence of TRIM45 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the incidence of CACNA1F loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the incidence of CACNA1F loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the incidence of CACNA1F loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+817,KL,R594C,Colon Adenocarcinoma,What is the incidence of KL loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the incidence of GUF1 loss in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the incidence of TAF1L loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the incidence of TASOR2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the incidence of TASOR2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the incidence of TASOR2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the incidence of KDM5C loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the incidence of KDM5C loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the incidence of KDM5C loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the incidence of KDM5C loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of IL5RA loss in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the incidence of DHX16 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the incidence of DHX16 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the incidence of GPR158 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the incidence of GPR158 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of EIF2B4 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of EIF2B4 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of EIF2B4 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of EIF2B4 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of EIF2B4 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of EIF2B4 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of ACTL7B loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the incidence of PCDHGA1 loss in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the incidence of TRAP1 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the incidence of TRAP1 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of PIK3C2A loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the incidence of KANSL1 loss in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the incidence of ANKRD52 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the incidence of PAPPA loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the incidence of B3GALNT1 loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the incidence of GABRA6 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the incidence of GABRA6 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the incidence of GABRA6 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the incidence of GABRA6 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the incidence of GABRA6 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the incidence of ZSCAN31 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of MED16 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of MED16 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the incidence of PTPRO loss in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the incidence of PTPRO loss in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the incidence of PTPRO loss in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the incidence of PTPRO loss in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the incidence of PTPRO loss in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the incidence of PTPRO loss in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the incidence of PTPRO loss in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the incidence of PTPRO loss in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the incidence of CHMP7 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the incidence of GPC3 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the incidence of GPC3 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of TLK2 loss in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of TLK2 loss in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of TLK2 loss in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of TLK2 loss in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of TLK2 loss in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the incidence of ZNF217 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the incidence of SYT9 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the incidence of SYT9 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the incidence of PKHD1L1 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the incidence of MYO3A loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of VASN loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the incidence of DNMT1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the incidence of DNMT1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the incidence of DNMT1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1056,CA9,E402K,Colon Adenocarcinoma,What is the incidence of CA9 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of TTC17 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of TTC17 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the incidence of PSG2 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the incidence of RIPOR2 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the incidence of RIPOR2 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the incidence of RIPOR2 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the incidence of RIPOR2 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the incidence of DCLK3 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the incidence of DCLK3 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the incidence of MERTK loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the incidence of MERTK loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the incidence of MERTK loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the incidence of ZFP42 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the incidence of OR13C3 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the incidence of OR13C3 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the incidence of SPAG1 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the incidence of CDKN2AIP loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the incidence of PXN loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the incidence of PXN loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the incidence of PXN loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the incidence of PXN loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the incidence of PXN loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the incidence of PXN loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the incidence of TTYH2 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the incidence of TTYH2 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the incidence of TMEM255A loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the incidence of TMEM255A loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the incidence of TMEM255A loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the incidence of TASOR2 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the incidence of TASOR2 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the incidence of ICE1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the incidence of MYT1 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the incidence of MYT1 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the incidence of MYT1 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the incidence of CX3CR1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the incidence of CX3CR1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the incidence of SPINDOC loss in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the incidence of ART3 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the incidence of ART3 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the incidence of CYP1A2 loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of ADRA1A loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the incidence of CDH23 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the incidence of CDH23 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the incidence of KRT39 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the incidence of PDHA2 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the incidence of SLC24A2 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the incidence of PTPRN2 loss in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the incidence of PTPRN2 loss in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the incidence of PTPRN2 loss in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the incidence of PTPRN2 loss in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the incidence of PTPRN2 loss in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the incidence of SOX21 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the incidence of CPA6 loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the incidence of GRM5 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of CASZ1 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the incidence of SGIP1 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the incidence of SGIP1 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the incidence of SGIP1 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the incidence of SGIP1 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the incidence of CARMIL1 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the incidence of CARMIL1 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the incidence of ZNF431 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the incidence of ZNF431 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the incidence of ZNF431 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the incidence of DNAH11 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the incidence of DNAH11 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the incidence of POLD1 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the incidence of POLD1 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the incidence of TTC12 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the incidence of TTC12 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the incidence of CNGB1 loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the incidence of CNGB1 loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the incidence of CTSC loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the incidence of CTSC loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the incidence of CTSC loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the incidence of CTSC loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the incidence of CTSC loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the incidence of PRSS8 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the incidence of PRSS8 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the incidence of ARHGEF40 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the incidence of ACTB loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the incidence of ACTB loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the incidence of ACTB loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the incidence of ACTB loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the incidence of YY1AP1 loss in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the incidence of YY1AP1 loss in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the incidence of YY1AP1 loss in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the incidence of YY1AP1 loss in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the incidence of YY1AP1 loss in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the incidence of YY1AP1 loss in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the incidence of YY1AP1 loss in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the incidence of FNDC7 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the incidence of FNDC7 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the incidence of TLCD5 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the incidence of TLCD5 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the incidence of POLR1G loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the incidence of POLR1G loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the incidence of DNAH14 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the incidence of DNAH14 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the incidence of DNAH14 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the incidence of NEXN loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the incidence of CYB5R2 loss in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the incidence of CYB5R2 loss in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the incidence of NRAP loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the incidence of NRAP loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the incidence of NRAP loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the incidence of CCDC22 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the incidence of DCAF6 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the incidence of DCAF6 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the incidence of ZNF708 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the incidence of BFAR loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the incidence of MAST4 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the incidence of MAST4 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the incidence of MAST4 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the incidence of MAST4 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the incidence of MAST4 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the incidence of ARMC3 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the incidence of ARMC3 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the incidence of TET2 loss in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the incidence of TET2 loss in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the incidence of SERPINB10 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the incidence of STAT3 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the incidence of MIEF1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the incidence of ACVR1B loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the incidence of ACVR1B loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the incidence of ACVR1B loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the incidence of EBF2 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the incidence of EBF2 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the incidence of VPS26B loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of PGR loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of PGR loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of PGR loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the incidence of ACTA2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the incidence of THBS4 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the incidence of THBS4 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the incidence of PRSS1 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the incidence of PRSS1 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the incidence of PRSS1 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the incidence of PRSS1 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the incidence of PGF loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the incidence of PGF loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the incidence of ITPRID2 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the incidence of ITPRID2 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the incidence of HBB loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the incidence of PCDHB2 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the incidence of PCDHB2 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the incidence of PCDHB2 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the incidence of UBR2 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the incidence of FBXO42 loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the frequency of somatic TNS1 heterozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the frequency of somatic TNS1 heterozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the frequency of somatic TNS1 heterozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the frequency of somatic TNS1 heterozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the frequency of somatic TNS1 heterozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the frequency of somatic TNS1 heterozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the frequency of somatic TNS1 heterozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the frequency of somatic EVC2 heterozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the frequency of somatic EVC2 heterozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CR1 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CR1 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the frequency of somatic TRPA1 heterozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the frequency of somatic TRPA1 heterozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the frequency of somatic TAF1C heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the frequency of somatic TAF1C heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the frequency of somatic TAF1C heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the frequency of somatic TAF1C heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the frequency of somatic TAF1C heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic DPF3 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic DPF3 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic DPF3 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the frequency of somatic OR2T4 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the frequency of somatic OR2T4 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the frequency of somatic FBN1 heterozygous deletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the frequency of somatic MAD1L1 heterozygous deletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the frequency of somatic MAD1L1 heterozygous deletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the frequency of somatic MAD1L1 heterozygous deletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the frequency of somatic CCNG1 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of somatic ANP32E heterozygous deletion in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of somatic ANP32E heterozygous deletion in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of somatic ANP32E heterozygous deletion in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of somatic ANP32E heterozygous deletion in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the frequency of somatic FRY heterozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the frequency of somatic FRY heterozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the frequency of somatic FRY heterozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the frequency of somatic FRY heterozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the frequency of somatic PAK3 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the frequency of somatic PAK3 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the frequency of somatic PAK3 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the frequency of somatic PAK3 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the frequency of somatic PAK3 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the frequency of somatic MUC16 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the frequency of somatic ZFPM2 heterozygous deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the frequency of somatic ZFPM2 heterozygous deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the frequency of somatic PIK3C2B heterozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the frequency of somatic PIK3C2B heterozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the frequency of somatic ZNF804A heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the frequency of somatic RELN heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic EFCAB12 heterozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic EFCAB12 heterozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the frequency of somatic DEFB115 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the frequency of somatic ANKDD1A heterozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the frequency of somatic ANKDD1A heterozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the frequency of somatic ANKDD1A heterozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic HTR3B heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic HTR3B heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic HTR3B heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the frequency of somatic ABCC3 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic NOMO1 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic NOMO1 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the frequency of somatic HYOU1 heterozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the frequency of somatic FMO4 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+140,BICC1,A372V,Exceptional Responders,What is the frequency of somatic BICC1 heterozygous deletion in Exceptional Responders?,freq_cnv_loss_or_gain
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ZMYM3 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ZMYM3 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ZMYM3 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic XKR4 heterozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the frequency of somatic ABCC2 heterozygous deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the frequency of somatic OR8K5 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the frequency of somatic SPTAN1 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the frequency of somatic SPTAN1 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the frequency of somatic SYT10 heterozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the frequency of somatic HSPA5 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the frequency of somatic UNC5D heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the frequency of somatic UNC5D heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the frequency of somatic UNC5D heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the frequency of somatic UNC5D heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the frequency of somatic UNC5D heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the frequency of somatic UNC5D heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the frequency of somatic DOCK2 heterozygous deletion in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the frequency of somatic ZNF627 heterozygous deletion in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the frequency of somatic CDC42BPA heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the frequency of somatic MRPL55 heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the frequency of somatic MRPL55 heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the frequency of somatic TMTC3 heterozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the frequency of somatic EPRS1 heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the frequency of somatic EPRS1 heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the frequency of somatic GRTP1 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the frequency of somatic GRTP1 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the frequency of somatic TSHZ3 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the frequency of somatic TAS1R3 heterozygous deletion in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,freq_cnv_loss_or_gain
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the frequency of somatic PIAS3 heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the frequency of somatic PIAS3 heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the frequency of somatic ZNF274 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the frequency of somatic SYNJ1 heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the frequency of somatic SYNJ1 heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the frequency of somatic SYNJ1 heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the frequency of somatic DSCAM heterozygous deletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the frequency of somatic DSCAM heterozygous deletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the frequency of somatic DSCAM heterozygous deletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+267,DGKD,R140H,Exceptional Responders,What is the frequency of somatic DGKD heterozygous deletion in Exceptional Responders?,freq_cnv_loss_or_gain
+268,DGKD,R160H,Exceptional Responders,What is the frequency of somatic DGKD heterozygous deletion in Exceptional Responders?,freq_cnv_loss_or_gain
+269,DGKD,R204H,Exceptional Responders,What is the frequency of somatic DGKD heterozygous deletion in Exceptional Responders?,freq_cnv_loss_or_gain
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the frequency of somatic PLEKHG6 heterozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the frequency of somatic PLEKHG6 heterozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the frequency of somatic PLEKHG6 heterozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the frequency of somatic WNT2 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the frequency of somatic GUCY2C heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic C7orf31 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic ZKSCAN7 heterozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+299,OR5D14,M210L,Neuroblastoma,What is the frequency of somatic OR5D14 heterozygous deletion in Neuroblastoma?,freq_cnv_loss_or_gain
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic SPATA22 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic SPATA22 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic SPATA22 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the frequency of somatic LCN15 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the frequency of somatic DCAF4L2 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the frequency of somatic GUK1 heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the frequency of somatic GUK1 heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the frequency of somatic GUK1 heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the frequency of somatic GUK1 heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the frequency of somatic GUK1 heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the frequency of somatic MORF4L1 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the frequency of somatic MORF4L1 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the frequency of somatic MORF4L1 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the frequency of somatic MORF4L1 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the frequency of somatic MYO3B heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the frequency of somatic MYO3B heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the frequency of somatic TENT5A heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the frequency of somatic TENT5A heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the frequency of somatic TENT5A heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the frequency of somatic ZFAT heterozygous deletion in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the frequency of somatic ZFAT heterozygous deletion in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the frequency of somatic ZFAT heterozygous deletion in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+357,ZNF584,A211T,Sarcoma,What is the frequency of somatic ZNF584 heterozygous deletion in Sarcoma?,freq_cnv_loss_or_gain
+358,ZNF584,A256T,Sarcoma,What is the frequency of somatic ZNF584 heterozygous deletion in Sarcoma?,freq_cnv_loss_or_gain
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic LDOC1 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the frequency of somatic PDGFC heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MSANTD4 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the frequency of somatic NPSR1 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the frequency of somatic PHLPP1 heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the frequency of somatic COL6A3 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the frequency of somatic COL6A3 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the frequency of somatic COL6A3 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the frequency of somatic COL6A3 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the frequency of somatic COL6A3 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the frequency of somatic ADRA1A heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of somatic LAMB2 heterozygous deletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the frequency of somatic POC1B heterozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the frequency of somatic POC1B heterozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the frequency of somatic POC1B heterozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the frequency of somatic POC1B heterozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the frequency of somatic USH2A heterozygous deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the frequency of somatic AQP7 heterozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the frequency of somatic AQP7 heterozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the frequency of somatic AQP7 heterozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the frequency of somatic AQP7 heterozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+430,DCN,R163C,Rectum Adenocarcinoma,What is the frequency of somatic DCN heterozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+431,DCN,R203C,Rectum Adenocarcinoma,What is the frequency of somatic DCN heterozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+432,DCN,R241C,Rectum Adenocarcinoma,What is the frequency of somatic DCN heterozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+433,DCN,R350C,Rectum Adenocarcinoma,What is the frequency of somatic DCN heterozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+434,DCN,R41C,Rectum Adenocarcinoma,What is the frequency of somatic DCN heterozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CPS1 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CPS1 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CPS1 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the frequency of somatic FCGR2C heterozygous deletion in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the frequency of somatic FCGR2C heterozygous deletion in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic GRM1 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the frequency of somatic SGCZ heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the frequency of somatic SGCZ heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+485,SMO,V15M,Stomach Adenocarcinoma,What is the frequency of somatic SMO heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+486,SMO,V321M,Stomach Adenocarcinoma,What is the frequency of somatic SMO heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the frequency of somatic CHODL heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the frequency of somatic CHODL heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the frequency of somatic CHODL heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+494,MYO16,P399H,Colon Adenocarcinoma,What is the frequency of somatic MYO16 heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+495,MYO16,P421H,Colon Adenocarcinoma,What is the frequency of somatic MYO16 heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the frequency of somatic CXCR2 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the frequency of somatic TMEM225 heterozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MAOB heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic GPRASP1 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MRPL32 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic TYROBP heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the frequency of somatic RAB40C heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the frequency of somatic RAB40C heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the frequency of somatic CTNNA2 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the frequency of somatic CTNNA2 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the frequency of somatic CTNNA2 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the frequency of somatic CTNNA2 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the frequency of somatic MYO15A heterozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the frequency of somatic GIMAP2 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the frequency of somatic KIF20B heterozygous deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the frequency of somatic KIF20B heterozygous deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ADAM17 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic BCAT1 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic BCAT1 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic BCAT1 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the frequency of somatic ERCC6 heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+541,DCC,R320W,Breast Invasive Carcinoma,What is the frequency of somatic DCC heterozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+542,DCC,R363W,Breast Invasive Carcinoma,What is the frequency of somatic DCC heterozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+543,DCC,R386W,Breast Invasive Carcinoma,What is the frequency of somatic DCC heterozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+544,DCC,R41W,Breast Invasive Carcinoma,What is the frequency of somatic DCC heterozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the frequency of somatic FBXO15 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the frequency of somatic FBXO15 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic GSTCD heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic GSTCD heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the frequency of somatic OLFML3 heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the frequency of somatic OLFML3 heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the frequency of somatic OLFML3 heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the frequency of somatic CFAP61 heterozygous deletion in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the frequency of somatic CFAP61 heterozygous deletion in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the frequency of somatic HLA-DQA2 heterozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the frequency of somatic TENM2 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the frequency of somatic TENM2 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the frequency of somatic TENM2 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the frequency of somatic ANKRD24 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the frequency of somatic ANKRD24 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the frequency of somatic ANKRD24 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the frequency of somatic ZCCHC14 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the frequency of somatic ZCCHC14 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the frequency of somatic ZCCHC14 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the frequency of somatic ZCCHC14 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+625,SIK2,I265M,Lung Adenocarcinoma,What is the frequency of somatic SIK2 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MYH11 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MYH11 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the frequency of somatic SLC6A4 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic SLC9C1 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic SLC9C1 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the frequency of somatic OR2A12 heterozygous deletion in Brain Lower Grade Glioma?,freq_cnv_loss_or_gain
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the frequency of somatic PYHIN1 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the frequency of somatic PYHIN1 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the frequency of somatic JAML heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the frequency of somatic JAML heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the frequency of somatic JAML heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the frequency of somatic JAML heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the frequency of somatic TYK2 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the frequency of somatic TYK2 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the frequency of somatic TYK2 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CTCFL heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CTCFL heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CTCFL heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CTCFL heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CEP20 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CEP20 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the frequency of somatic RIMS2 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the frequency of somatic RIMS2 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the frequency of somatic RIMS2 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the frequency of somatic RIMS2 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the frequency of somatic RIMS2 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the frequency of somatic RIMS2 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the frequency of somatic RIMS2 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the frequency of somatic PIK3C2G heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the frequency of somatic PIK3C2G heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+728,STK19,D341N,Colon Adenocarcinoma,What is the frequency of somatic STK19 heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+729,STK19,D345N,Colon Adenocarcinoma,What is the frequency of somatic STK19 heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the frequency of somatic REXO4 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ZBTB34 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ZBTB34 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the frequency of somatic NCKAP5 heterozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic SORCS1 heterozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic SORCS1 heterozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic SORCS1 heterozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic SORCS1 heterozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the frequency of somatic FGF8 heterozygous deletion in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the frequency of somatic FGF8 heterozygous deletion in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the frequency of somatic FGF8 heterozygous deletion in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the frequency of somatic FGF8 heterozygous deletion in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the frequency of somatic FGF8 heterozygous deletion in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the frequency of somatic TENM3 heterozygous deletion in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,freq_cnv_loss_or_gain
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic AKT1 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of somatic CFAP298-TCP10L heterozygous deletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the frequency of somatic GLRB heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+793,TTN,F7636L,Colon Adenocarcinoma,What is the frequency of somatic TTN heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+794,TTN,F8563L,Colon Adenocarcinoma,What is the frequency of somatic TTN heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+795,TTN,F8880L,Colon Adenocarcinoma,What is the frequency of somatic TTN heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the frequency of somatic ANKRD30A heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the frequency of somatic ANKRD30A heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the frequency of somatic ANKRD30A heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the frequency of somatic TRIM45 heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the frequency of somatic TRIM45 heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the frequency of somatic TRIM45 heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the frequency of somatic CACNA1F heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the frequency of somatic CACNA1F heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the frequency of somatic CACNA1F heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+817,KL,R594C,Colon Adenocarcinoma,What is the frequency of somatic KL heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of somatic GUF1 heterozygous deletion in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the frequency of somatic TAF1L heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the frequency of somatic TASOR2 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the frequency of somatic TASOR2 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the frequency of somatic TASOR2 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the frequency of somatic KDM5C heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the frequency of somatic KDM5C heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the frequency of somatic KDM5C heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the frequency of somatic KDM5C heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of somatic IL5RA heterozygous deletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the frequency of somatic DHX16 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the frequency of somatic DHX16 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the frequency of somatic GPR158 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the frequency of somatic GPR158 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic EIF2B4 heterozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic EIF2B4 heterozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic EIF2B4 heterozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic EIF2B4 heterozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic EIF2B4 heterozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic EIF2B4 heterozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic ACTL7B heterozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the frequency of somatic PCDHGA1 heterozygous deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the frequency of somatic TRAP1 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the frequency of somatic TRAP1 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic PIK3C2A heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the frequency of somatic KANSL1 heterozygous deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the frequency of somatic ANKRD52 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic PAPPA heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the frequency of somatic B3GALNT1 heterozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the frequency of somatic GABRA6 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the frequency of somatic GABRA6 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the frequency of somatic GABRA6 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the frequency of somatic GABRA6 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the frequency of somatic GABRA6 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the frequency of somatic ZSCAN31 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic MED16 heterozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic MED16 heterozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the frequency of somatic PTPRO heterozygous deletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the frequency of somatic PTPRO heterozygous deletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the frequency of somatic PTPRO heterozygous deletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the frequency of somatic PTPRO heterozygous deletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the frequency of somatic PTPRO heterozygous deletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the frequency of somatic PTPRO heterozygous deletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the frequency of somatic PTPRO heterozygous deletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the frequency of somatic PTPRO heterozygous deletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CHMP7 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the frequency of somatic GPC3 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the frequency of somatic GPC3 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of somatic TLK2 heterozygous deletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of somatic TLK2 heterozygous deletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of somatic TLK2 heterozygous deletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of somatic TLK2 heterozygous deletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of somatic TLK2 heterozygous deletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the frequency of somatic ZNF217 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the frequency of somatic SYT9 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the frequency of somatic SYT9 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the frequency of somatic PKHD1L1 heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the frequency of somatic MYO3A heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic VASN heterozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic DNMT1 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic DNMT1 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic DNMT1 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1056,CA9,E402K,Colon Adenocarcinoma,What is the frequency of somatic CA9 heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic TTC17 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic TTC17 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the frequency of somatic PSG2 heterozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the frequency of somatic RIPOR2 heterozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the frequency of somatic RIPOR2 heterozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the frequency of somatic RIPOR2 heterozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the frequency of somatic RIPOR2 heterozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic DCLK3 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic DCLK3 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the frequency of somatic MERTK heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the frequency of somatic MERTK heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the frequency of somatic MERTK heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the frequency of somatic ZFP42 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the frequency of somatic OR13C3 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the frequency of somatic OR13C3 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the frequency of somatic SPAG1 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CDKN2AIP heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the frequency of somatic PXN heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the frequency of somatic PXN heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the frequency of somatic PXN heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the frequency of somatic PXN heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the frequency of somatic PXN heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the frequency of somatic PXN heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic TTYH2 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic TTYH2 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the frequency of somatic TMEM255A heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the frequency of somatic TMEM255A heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the frequency of somatic TMEM255A heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the frequency of somatic TASOR2 heterozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the frequency of somatic TASOR2 heterozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ICE1 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the frequency of somatic MYT1 heterozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the frequency of somatic MYT1 heterozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the frequency of somatic MYT1 heterozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CX3CR1 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CX3CR1 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the frequency of somatic SPINDOC heterozygous deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ART3 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ART3 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the frequency of somatic CYP1A2 heterozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic ADRA1A heterozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the frequency of somatic CDH23 heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the frequency of somatic CDH23 heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the frequency of somatic KRT39 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the frequency of somatic PDHA2 heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the frequency of somatic SLC24A2 heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the frequency of somatic PTPRN2 heterozygous deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the frequency of somatic PTPRN2 heterozygous deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the frequency of somatic PTPRN2 heterozygous deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the frequency of somatic PTPRN2 heterozygous deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the frequency of somatic PTPRN2 heterozygous deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the frequency of somatic SOX21 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the frequency of somatic CPA6 heterozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the frequency of somatic GRM5 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic CASZ1 heterozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the frequency of somatic SGIP1 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the frequency of somatic SGIP1 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the frequency of somatic SGIP1 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the frequency of somatic SGIP1 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the frequency of somatic CARMIL1 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the frequency of somatic CARMIL1 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the frequency of somatic ZNF431 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the frequency of somatic ZNF431 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the frequency of somatic ZNF431 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the frequency of somatic DNAH11 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the frequency of somatic DNAH11 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the frequency of somatic POLD1 heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the frequency of somatic POLD1 heterozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the frequency of somatic TTC12 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the frequency of somatic TTC12 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the frequency of somatic CNGB1 heterozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the frequency of somatic CNGB1 heterozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the frequency of somatic CTSC heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the frequency of somatic CTSC heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the frequency of somatic CTSC heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the frequency of somatic CTSC heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the frequency of somatic CTSC heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic PRSS8 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic PRSS8 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the frequency of somatic ARHGEF40 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the frequency of somatic ACTB heterozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the frequency of somatic ACTB heterozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the frequency of somatic ACTB heterozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the frequency of somatic ACTB heterozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the frequency of somatic YY1AP1 heterozygous deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the frequency of somatic YY1AP1 heterozygous deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the frequency of somatic YY1AP1 heterozygous deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the frequency of somatic YY1AP1 heterozygous deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the frequency of somatic YY1AP1 heterozygous deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the frequency of somatic YY1AP1 heterozygous deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the frequency of somatic YY1AP1 heterozygous deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the frequency of somatic FNDC7 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the frequency of somatic FNDC7 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the frequency of somatic TLCD5 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the frequency of somatic TLCD5 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic POLR1G heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic POLR1G heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the frequency of somatic DNAH14 heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the frequency of somatic DNAH14 heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the frequency of somatic DNAH14 heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic NEXN heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the frequency of somatic CYB5R2 heterozygous deletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the frequency of somatic CYB5R2 heterozygous deletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic NRAP heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic NRAP heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic NRAP heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CCDC22 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the frequency of somatic DCAF6 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the frequency of somatic DCAF6 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ZNF708 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic BFAR heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MAST4 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MAST4 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MAST4 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MAST4 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MAST4 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the frequency of somatic ARMC3 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the frequency of somatic ARMC3 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the frequency of somatic TET2 heterozygous deletion in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the frequency of somatic TET2 heterozygous deletion in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the frequency of somatic SERPINB10 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic STAT3 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MIEF1 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the frequency of somatic ACVR1B heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the frequency of somatic ACVR1B heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the frequency of somatic ACVR1B heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the frequency of somatic EBF2 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the frequency of somatic EBF2 heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the frequency of somatic VPS26B heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic PGR heterozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic PGR heterozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic PGR heterozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the frequency of somatic ACTA2 heterozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic THBS4 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic THBS4 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the frequency of somatic PRSS1 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the frequency of somatic PRSS1 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the frequency of somatic PRSS1 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the frequency of somatic PRSS1 heterozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the frequency of somatic PGF heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the frequency of somatic PGF heterozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the frequency of somatic ITPRID2 heterozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the frequency of somatic ITPRID2 heterozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic HBB heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the frequency of somatic PCDHB2 heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the frequency of somatic PCDHB2 heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the frequency of somatic PCDHB2 heterozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic UBR2 heterozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the frequency of somatic FBXO42 heterozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the frequency of somatic TNS1 homozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the frequency of somatic TNS1 homozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the frequency of somatic TNS1 homozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the frequency of somatic TNS1 homozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the frequency of somatic TNS1 homozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the frequency of somatic TNS1 homozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the frequency of somatic TNS1 homozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the frequency of somatic EVC2 homozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the frequency of somatic EVC2 homozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CR1 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CR1 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the frequency of somatic TRPA1 homozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the frequency of somatic TRPA1 homozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the frequency of somatic TAF1C homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the frequency of somatic TAF1C homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the frequency of somatic TAF1C homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the frequency of somatic TAF1C homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the frequency of somatic TAF1C homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic DPF3 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic DPF3 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic DPF3 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the frequency of somatic OR2T4 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the frequency of somatic OR2T4 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the frequency of somatic FBN1 homozygous deletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the frequency of somatic MAD1L1 homozygous deletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the frequency of somatic MAD1L1 homozygous deletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the frequency of somatic MAD1L1 homozygous deletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the frequency of somatic CCNG1 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of somatic ANP32E homozygous deletion in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of somatic ANP32E homozygous deletion in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of somatic ANP32E homozygous deletion in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of somatic ANP32E homozygous deletion in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the frequency of somatic FRY homozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the frequency of somatic FRY homozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the frequency of somatic FRY homozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the frequency of somatic FRY homozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the frequency of somatic PAK3 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the frequency of somatic PAK3 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the frequency of somatic PAK3 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the frequency of somatic PAK3 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the frequency of somatic PAK3 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the frequency of somatic MUC16 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the frequency of somatic ZFPM2 homozygous deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the frequency of somatic ZFPM2 homozygous deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the frequency of somatic PIK3C2B homozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the frequency of somatic PIK3C2B homozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the frequency of somatic ZNF804A homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the frequency of somatic RELN homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic EFCAB12 homozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic EFCAB12 homozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the frequency of somatic DEFB115 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the frequency of somatic ANKDD1A homozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the frequency of somatic ANKDD1A homozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the frequency of somatic ANKDD1A homozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic HTR3B homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic HTR3B homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic HTR3B homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the frequency of somatic ABCC3 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic NOMO1 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic NOMO1 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the frequency of somatic HYOU1 homozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the frequency of somatic FMO4 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+140,BICC1,A372V,Exceptional Responders,What is the frequency of somatic BICC1 homozygous deletion in Exceptional Responders?,freq_cnv_loss_or_gain
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ZMYM3 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ZMYM3 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ZMYM3 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic XKR4 homozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the frequency of somatic ABCC2 homozygous deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the frequency of somatic OR8K5 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the frequency of somatic SPTAN1 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the frequency of somatic SPTAN1 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the frequency of somatic SYT10 homozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the frequency of somatic HSPA5 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the frequency of somatic UNC5D homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the frequency of somatic UNC5D homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the frequency of somatic UNC5D homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the frequency of somatic UNC5D homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the frequency of somatic UNC5D homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the frequency of somatic UNC5D homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the frequency of somatic DOCK2 homozygous deletion in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the frequency of somatic ZNF627 homozygous deletion in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the frequency of somatic CDC42BPA homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the frequency of somatic MRPL55 homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the frequency of somatic MRPL55 homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the frequency of somatic TMTC3 homozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the frequency of somatic EPRS1 homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the frequency of somatic EPRS1 homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the frequency of somatic GRTP1 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the frequency of somatic GRTP1 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the frequency of somatic TSHZ3 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the frequency of somatic TAS1R3 homozygous deletion in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,freq_cnv_loss_or_gain
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the frequency of somatic PIAS3 homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the frequency of somatic PIAS3 homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the frequency of somatic ZNF274 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the frequency of somatic SYNJ1 homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the frequency of somatic SYNJ1 homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the frequency of somatic SYNJ1 homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the frequency of somatic DSCAM homozygous deletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the frequency of somatic DSCAM homozygous deletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the frequency of somatic DSCAM homozygous deletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+267,DGKD,R140H,Exceptional Responders,What is the frequency of somatic DGKD homozygous deletion in Exceptional Responders?,freq_cnv_loss_or_gain
+268,DGKD,R160H,Exceptional Responders,What is the frequency of somatic DGKD homozygous deletion in Exceptional Responders?,freq_cnv_loss_or_gain
+269,DGKD,R204H,Exceptional Responders,What is the frequency of somatic DGKD homozygous deletion in Exceptional Responders?,freq_cnv_loss_or_gain
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the frequency of somatic PLEKHG6 homozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the frequency of somatic PLEKHG6 homozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the frequency of somatic PLEKHG6 homozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the frequency of somatic WNT2 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the frequency of somatic GUCY2C homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic C7orf31 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic ZKSCAN7 homozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+299,OR5D14,M210L,Neuroblastoma,What is the frequency of somatic OR5D14 homozygous deletion in Neuroblastoma?,freq_cnv_loss_or_gain
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic SPATA22 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic SPATA22 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic SPATA22 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the frequency of somatic LCN15 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the frequency of somatic DCAF4L2 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the frequency of somatic GUK1 homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the frequency of somatic GUK1 homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the frequency of somatic GUK1 homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the frequency of somatic GUK1 homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the frequency of somatic GUK1 homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the frequency of somatic MORF4L1 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the frequency of somatic MORF4L1 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the frequency of somatic MORF4L1 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the frequency of somatic MORF4L1 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the frequency of somatic MYO3B homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the frequency of somatic MYO3B homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the frequency of somatic TENT5A homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the frequency of somatic TENT5A homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the frequency of somatic TENT5A homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the frequency of somatic ZFAT homozygous deletion in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the frequency of somatic ZFAT homozygous deletion in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the frequency of somatic ZFAT homozygous deletion in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+357,ZNF584,A211T,Sarcoma,What is the frequency of somatic ZNF584 homozygous deletion in Sarcoma?,freq_cnv_loss_or_gain
+358,ZNF584,A256T,Sarcoma,What is the frequency of somatic ZNF584 homozygous deletion in Sarcoma?,freq_cnv_loss_or_gain
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic LDOC1 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the frequency of somatic PDGFC homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MSANTD4 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the frequency of somatic NPSR1 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the frequency of somatic PHLPP1 homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the frequency of somatic COL6A3 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the frequency of somatic COL6A3 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the frequency of somatic COL6A3 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the frequency of somatic COL6A3 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the frequency of somatic COL6A3 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the frequency of somatic ADRA1A homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of somatic LAMB2 homozygous deletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the frequency of somatic POC1B homozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the frequency of somatic POC1B homozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the frequency of somatic POC1B homozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the frequency of somatic POC1B homozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the frequency of somatic USH2A homozygous deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the frequency of somatic AQP7 homozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the frequency of somatic AQP7 homozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the frequency of somatic AQP7 homozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the frequency of somatic AQP7 homozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+430,DCN,R163C,Rectum Adenocarcinoma,What is the frequency of somatic DCN homozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+431,DCN,R203C,Rectum Adenocarcinoma,What is the frequency of somatic DCN homozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+432,DCN,R241C,Rectum Adenocarcinoma,What is the frequency of somatic DCN homozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+433,DCN,R350C,Rectum Adenocarcinoma,What is the frequency of somatic DCN homozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+434,DCN,R41C,Rectum Adenocarcinoma,What is the frequency of somatic DCN homozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CPS1 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CPS1 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CPS1 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the frequency of somatic FCGR2C homozygous deletion in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the frequency of somatic FCGR2C homozygous deletion in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic GRM1 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the frequency of somatic SGCZ homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the frequency of somatic SGCZ homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+485,SMO,V15M,Stomach Adenocarcinoma,What is the frequency of somatic SMO homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+486,SMO,V321M,Stomach Adenocarcinoma,What is the frequency of somatic SMO homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the frequency of somatic CHODL homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the frequency of somatic CHODL homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the frequency of somatic CHODL homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+494,MYO16,P399H,Colon Adenocarcinoma,What is the frequency of somatic MYO16 homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+495,MYO16,P421H,Colon Adenocarcinoma,What is the frequency of somatic MYO16 homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the frequency of somatic CXCR2 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the frequency of somatic TMEM225 homozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MAOB homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic GPRASP1 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MRPL32 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic TYROBP homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the frequency of somatic RAB40C homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the frequency of somatic RAB40C homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the frequency of somatic CTNNA2 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the frequency of somatic CTNNA2 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the frequency of somatic CTNNA2 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the frequency of somatic CTNNA2 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the frequency of somatic MYO15A homozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the frequency of somatic GIMAP2 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the frequency of somatic KIF20B homozygous deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the frequency of somatic KIF20B homozygous deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ADAM17 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic BCAT1 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic BCAT1 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic BCAT1 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the frequency of somatic ERCC6 homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+541,DCC,R320W,Breast Invasive Carcinoma,What is the frequency of somatic DCC homozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+542,DCC,R363W,Breast Invasive Carcinoma,What is the frequency of somatic DCC homozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+543,DCC,R386W,Breast Invasive Carcinoma,What is the frequency of somatic DCC homozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+544,DCC,R41W,Breast Invasive Carcinoma,What is the frequency of somatic DCC homozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the frequency of somatic FBXO15 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the frequency of somatic FBXO15 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic GSTCD homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic GSTCD homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the frequency of somatic OLFML3 homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the frequency of somatic OLFML3 homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the frequency of somatic OLFML3 homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the frequency of somatic CFAP61 homozygous deletion in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the frequency of somatic CFAP61 homozygous deletion in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the frequency of somatic HLA-DQA2 homozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the frequency of somatic TENM2 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the frequency of somatic TENM2 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the frequency of somatic TENM2 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the frequency of somatic ANKRD24 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the frequency of somatic ANKRD24 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the frequency of somatic ANKRD24 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the frequency of somatic ZCCHC14 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the frequency of somatic ZCCHC14 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the frequency of somatic ZCCHC14 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the frequency of somatic ZCCHC14 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+625,SIK2,I265M,Lung Adenocarcinoma,What is the frequency of somatic SIK2 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MYH11 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MYH11 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the frequency of somatic SLC6A4 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic SLC9C1 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic SLC9C1 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the frequency of somatic OR2A12 homozygous deletion in Brain Lower Grade Glioma?,freq_cnv_loss_or_gain
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the frequency of somatic PYHIN1 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the frequency of somatic PYHIN1 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the frequency of somatic JAML homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the frequency of somatic JAML homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the frequency of somatic JAML homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the frequency of somatic JAML homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the frequency of somatic TYK2 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the frequency of somatic TYK2 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the frequency of somatic TYK2 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CTCFL homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CTCFL homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CTCFL homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CTCFL homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CEP20 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CEP20 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the frequency of somatic RIMS2 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the frequency of somatic RIMS2 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the frequency of somatic RIMS2 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the frequency of somatic RIMS2 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the frequency of somatic RIMS2 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the frequency of somatic RIMS2 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the frequency of somatic RIMS2 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the frequency of somatic PIK3C2G homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the frequency of somatic PIK3C2G homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+728,STK19,D341N,Colon Adenocarcinoma,What is the frequency of somatic STK19 homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+729,STK19,D345N,Colon Adenocarcinoma,What is the frequency of somatic STK19 homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the frequency of somatic REXO4 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ZBTB34 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ZBTB34 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the frequency of somatic NCKAP5 homozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic SORCS1 homozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic SORCS1 homozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic SORCS1 homozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic SORCS1 homozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the frequency of somatic FGF8 homozygous deletion in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the frequency of somatic FGF8 homozygous deletion in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the frequency of somatic FGF8 homozygous deletion in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the frequency of somatic FGF8 homozygous deletion in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the frequency of somatic FGF8 homozygous deletion in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the frequency of somatic TENM3 homozygous deletion in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,freq_cnv_loss_or_gain
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic AKT1 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of somatic CFAP298-TCP10L homozygous deletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the frequency of somatic GLRB homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+793,TTN,F7636L,Colon Adenocarcinoma,What is the frequency of somatic TTN homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+794,TTN,F8563L,Colon Adenocarcinoma,What is the frequency of somatic TTN homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+795,TTN,F8880L,Colon Adenocarcinoma,What is the frequency of somatic TTN homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the frequency of somatic ANKRD30A homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the frequency of somatic ANKRD30A homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the frequency of somatic ANKRD30A homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the frequency of somatic TRIM45 homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the frequency of somatic TRIM45 homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the frequency of somatic TRIM45 homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the frequency of somatic CACNA1F homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the frequency of somatic CACNA1F homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the frequency of somatic CACNA1F homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+817,KL,R594C,Colon Adenocarcinoma,What is the frequency of somatic KL homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of somatic GUF1 homozygous deletion in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the frequency of somatic TAF1L homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the frequency of somatic TASOR2 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the frequency of somatic TASOR2 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the frequency of somatic TASOR2 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the frequency of somatic KDM5C homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the frequency of somatic KDM5C homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the frequency of somatic KDM5C homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the frequency of somatic KDM5C homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of somatic IL5RA homozygous deletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the frequency of somatic DHX16 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the frequency of somatic DHX16 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the frequency of somatic GPR158 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the frequency of somatic GPR158 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic EIF2B4 homozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic EIF2B4 homozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic EIF2B4 homozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic EIF2B4 homozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic EIF2B4 homozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic EIF2B4 homozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic ACTL7B homozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the frequency of somatic PCDHGA1 homozygous deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the frequency of somatic TRAP1 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the frequency of somatic TRAP1 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic PIK3C2A homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the frequency of somatic KANSL1 homozygous deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the frequency of somatic ANKRD52 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic PAPPA homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the frequency of somatic B3GALNT1 homozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the frequency of somatic GABRA6 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the frequency of somatic GABRA6 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the frequency of somatic GABRA6 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the frequency of somatic GABRA6 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the frequency of somatic GABRA6 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the frequency of somatic ZSCAN31 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic MED16 homozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic MED16 homozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the frequency of somatic PTPRO homozygous deletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the frequency of somatic PTPRO homozygous deletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the frequency of somatic PTPRO homozygous deletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the frequency of somatic PTPRO homozygous deletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the frequency of somatic PTPRO homozygous deletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the frequency of somatic PTPRO homozygous deletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the frequency of somatic PTPRO homozygous deletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the frequency of somatic PTPRO homozygous deletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CHMP7 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the frequency of somatic GPC3 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the frequency of somatic GPC3 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of somatic TLK2 homozygous deletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of somatic TLK2 homozygous deletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of somatic TLK2 homozygous deletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of somatic TLK2 homozygous deletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of somatic TLK2 homozygous deletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the frequency of somatic ZNF217 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the frequency of somatic SYT9 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the frequency of somatic SYT9 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the frequency of somatic PKHD1L1 homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the frequency of somatic MYO3A homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic VASN homozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic DNMT1 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic DNMT1 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic DNMT1 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1056,CA9,E402K,Colon Adenocarcinoma,What is the frequency of somatic CA9 homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic TTC17 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic TTC17 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the frequency of somatic PSG2 homozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the frequency of somatic RIPOR2 homozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the frequency of somatic RIPOR2 homozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the frequency of somatic RIPOR2 homozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the frequency of somatic RIPOR2 homozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic DCLK3 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic DCLK3 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the frequency of somatic MERTK homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the frequency of somatic MERTK homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the frequency of somatic MERTK homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the frequency of somatic ZFP42 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the frequency of somatic OR13C3 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the frequency of somatic OR13C3 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the frequency of somatic SPAG1 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CDKN2AIP homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the frequency of somatic PXN homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the frequency of somatic PXN homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the frequency of somatic PXN homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the frequency of somatic PXN homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the frequency of somatic PXN homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the frequency of somatic PXN homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic TTYH2 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic TTYH2 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the frequency of somatic TMEM255A homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the frequency of somatic TMEM255A homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the frequency of somatic TMEM255A homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the frequency of somatic TASOR2 homozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the frequency of somatic TASOR2 homozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ICE1 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the frequency of somatic MYT1 homozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the frequency of somatic MYT1 homozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the frequency of somatic MYT1 homozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CX3CR1 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CX3CR1 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the frequency of somatic SPINDOC homozygous deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ART3 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ART3 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the frequency of somatic CYP1A2 homozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic ADRA1A homozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the frequency of somatic CDH23 homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the frequency of somatic CDH23 homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the frequency of somatic KRT39 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the frequency of somatic PDHA2 homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the frequency of somatic SLC24A2 homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the frequency of somatic PTPRN2 homozygous deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the frequency of somatic PTPRN2 homozygous deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the frequency of somatic PTPRN2 homozygous deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the frequency of somatic PTPRN2 homozygous deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the frequency of somatic PTPRN2 homozygous deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the frequency of somatic SOX21 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the frequency of somatic CPA6 homozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the frequency of somatic GRM5 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic CASZ1 homozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the frequency of somatic SGIP1 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the frequency of somatic SGIP1 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the frequency of somatic SGIP1 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the frequency of somatic SGIP1 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the frequency of somatic CARMIL1 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the frequency of somatic CARMIL1 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the frequency of somatic ZNF431 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the frequency of somatic ZNF431 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the frequency of somatic ZNF431 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the frequency of somatic DNAH11 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the frequency of somatic DNAH11 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the frequency of somatic POLD1 homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the frequency of somatic POLD1 homozygous deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the frequency of somatic TTC12 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the frequency of somatic TTC12 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the frequency of somatic CNGB1 homozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the frequency of somatic CNGB1 homozygous deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the frequency of somatic CTSC homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the frequency of somatic CTSC homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the frequency of somatic CTSC homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the frequency of somatic CTSC homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the frequency of somatic CTSC homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic PRSS8 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic PRSS8 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the frequency of somatic ARHGEF40 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the frequency of somatic ACTB homozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the frequency of somatic ACTB homozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the frequency of somatic ACTB homozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the frequency of somatic ACTB homozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the frequency of somatic YY1AP1 homozygous deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the frequency of somatic YY1AP1 homozygous deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the frequency of somatic YY1AP1 homozygous deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the frequency of somatic YY1AP1 homozygous deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the frequency of somatic YY1AP1 homozygous deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the frequency of somatic YY1AP1 homozygous deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the frequency of somatic YY1AP1 homozygous deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the frequency of somatic FNDC7 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the frequency of somatic FNDC7 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the frequency of somatic TLCD5 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the frequency of somatic TLCD5 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic POLR1G homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic POLR1G homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the frequency of somatic DNAH14 homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the frequency of somatic DNAH14 homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the frequency of somatic DNAH14 homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic NEXN homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the frequency of somatic CYB5R2 homozygous deletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the frequency of somatic CYB5R2 homozygous deletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic NRAP homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic NRAP homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic NRAP homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CCDC22 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the frequency of somatic DCAF6 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the frequency of somatic DCAF6 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ZNF708 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic BFAR homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MAST4 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MAST4 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MAST4 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MAST4 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MAST4 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the frequency of somatic ARMC3 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the frequency of somatic ARMC3 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the frequency of somatic TET2 homozygous deletion in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the frequency of somatic TET2 homozygous deletion in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the frequency of somatic SERPINB10 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic STAT3 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MIEF1 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the frequency of somatic ACVR1B homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the frequency of somatic ACVR1B homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the frequency of somatic ACVR1B homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the frequency of somatic EBF2 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the frequency of somatic EBF2 homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the frequency of somatic VPS26B homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic PGR homozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic PGR homozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic PGR homozygous deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the frequency of somatic ACTA2 homozygous deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic THBS4 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic THBS4 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the frequency of somatic PRSS1 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the frequency of somatic PRSS1 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the frequency of somatic PRSS1 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the frequency of somatic PRSS1 homozygous deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the frequency of somatic PGF homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the frequency of somatic PGF homozygous deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the frequency of somatic ITPRID2 homozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the frequency of somatic ITPRID2 homozygous deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic HBB homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the frequency of somatic PCDHB2 homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the frequency of somatic PCDHB2 homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the frequency of somatic PCDHB2 homozygous deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic UBR2 homozygous deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the frequency of somatic FBXO42 homozygous deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1,TNS1,G1362V,Breast Invasive Carcinoma,How common is TNS1 and UNC5D codeletion in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+2,TNS1,G1711V,Breast Invasive Carcinoma,How common is TNS1 and MYO16 codeletion in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+3,TNS1,G1718V,Breast Invasive Carcinoma,How common is TNS1 and MYO3B codeletion in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+4,TNS1,G1732V,Breast Invasive Carcinoma,How common is TNS1 and CHODL codeletion in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+5,TNS1,G1824V,Breast Invasive Carcinoma,How common is TNS1 and DPF3 codeletion in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+6,TNS1,G1857V,Breast Invasive Carcinoma,How common is TNS1 and GUF1 codeletion in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+7,TNS1,G843V,Breast Invasive Carcinoma,How common is TNS1 and DOCK2 codeletion in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How common is EVC2 and SLC9C1 codeletion in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How common is EVC2 and PAPPA codeletion in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How common is CR1 and PXN codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How common is CR1 and MUC16 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+22,TRPA1,S295I,Rectum Adenocarcinoma,How common is TRPA1 and ANKRD52 codeletion in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+23,TRPA1,S443I,Rectum Adenocarcinoma,How common is TRPA1 and ZCCHC14 codeletion in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+24,TAF1C,R299L,Lung Adenocarcinoma,How common is TAF1C and ACTB codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+25,TAF1C,R396L,Lung Adenocarcinoma,How common is TAF1C and EPRS1 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+26,TAF1C,R634L,Lung Adenocarcinoma,How common is TAF1C and SYT9 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+27,TAF1C,R702L,Lung Adenocarcinoma,How common is TAF1C and YY1AP1 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+28,TAF1C,R728L,Lung Adenocarcinoma,How common is TAF1C and PTPRO codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How common is DPF3 and YY1AP1 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How common is DPF3 and DNAH14 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How common is DPF3 and ANKDD1A codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+42,OR2T4,P272H,Lung Adenocarcinoma,How common is OR2T4 and TLK2 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+43,OR2T4,P300H,Lung Adenocarcinoma,How common is OR2T4 and KDM5C codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How common is FBN1 and OR13C3 codeletion in Pancreatic Adenocarcinoma cases?,freq_cnv_loss_or_gain
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How common is MAD1L1 and ZFPM2 codeletion in Prostate Adenocarcinoma cases?,freq_cnv_loss_or_gain
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How common is MAD1L1 and TNS1 codeletion in Prostate Adenocarcinoma cases?,freq_cnv_loss_or_gain
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How common is MAD1L1 and POLR1G codeletion in Prostate Adenocarcinoma cases?,freq_cnv_loss_or_gain
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How common is CCNG1 and AUTS2 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How common is ANP32E and SGCZ codeletion in Kidney Renal Papillary Cell Carcinoma cases?,freq_cnv_loss_or_gain
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How common is ANP32E and AUTS2 codeletion in Kidney Renal Papillary Cell Carcinoma cases?,freq_cnv_loss_or_gain
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How common is ANP32E and FMO4 codeletion in Kidney Renal Papillary Cell Carcinoma cases?,freq_cnv_loss_or_gain
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How common is ANP32E and TMEM255A codeletion in Kidney Renal Papillary Cell Carcinoma cases?,freq_cnv_loss_or_gain
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How common is FRY and PCDHB2 codeletion in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How common is FRY and PXN codeletion in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How common is FRY and PIAS3 codeletion in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How common is FRY and DNAH14 codeletion in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+70,PAK3,E318K,Skin Cutaneous Melanoma,How common is PAK3 and POLR1G codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+71,PAK3,E319K,Skin Cutaneous Melanoma,How common is PAK3 and CNGB1 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+72,PAK3,E334K,Skin Cutaneous Melanoma,How common is PAK3 and ZSCAN31 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+73,PAK3,E340K,Skin Cutaneous Melanoma,How common is PAK3 and DCC codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+74,PAK3,E355K,Skin Cutaneous Melanoma,How common is PAK3 and TET2 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How common is MUC16 and TTN codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How common is ZFPM2 and MYO3A codeletion in Liver Hepatocellular Carcinoma cases?,freq_cnv_loss_or_gain
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How common is ZFPM2 and OR13C3 codeletion in Liver Hepatocellular Carcinoma cases?,freq_cnv_loss_or_gain
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How common is PIK3C2B and EIF2B4 codeletion in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How common is PIK3C2B and POC1B codeletion in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How common is ZNF804A and RIMS2 codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+116,RELN,A2371V,Stomach Adenocarcinoma,How common is RELN and KDM5C codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is EFCAB12 and ANKRD52 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is EFCAB12 and MYT1 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How common is DEFB115 and ANP32E codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How common is ANKDD1A and PAK3 codeletion in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How common is ANKDD1A and TRPA1 codeletion in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How common is ANKDD1A and RELN codeletion in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How common is HTR3B and FRY codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How common is HTR3B and PLEKHG6 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How common is HTR3B and NEXN codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+129,ABCC3,R758W,Stomach Adenocarcinoma,How common is ABCC3 and PGF codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How common is NOMO1 and MRPL32 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How common is NOMO1 and TLK2 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How common is HYOU1 and MRPL55 codeletion in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How common is FMO4 and ZNF431 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+140,BICC1,A372V,Exceptional Responders,How common is BICC1 and RIMS2 codeletion in Exceptional Responders cases?,freq_cnv_loss_or_gain
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How common is ZMYM3 and AUTS2 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How common is ZMYM3 and HTR3B codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How common is ZMYM3 and TLK2 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is XKR4 and MORF4L1 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How common is ABCC2 and AUTS2 codeletion in Liver Hepatocellular Carcinoma cases?,freq_cnv_loss_or_gain
+157,OR8K5,R293G,Lung Adenocarcinoma,How common is OR8K5 and TMEM255A codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How common is SPTAN1 and GABRA6 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How common is SPTAN1 and PLEKHG6 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+164,SYT10,M484I,Rectum Adenocarcinoma,How common is SYT10 and EIF2B4 codeletion in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How common is HSPA5 and MRPL55 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+175,UNC5D,L280V,Lung Adenocarcinoma,How common is UNC5D and TENM2 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+176,UNC5D,L635V,Lung Adenocarcinoma,How common is UNC5D and TYROBP codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+177,UNC5D,L637V,Lung Adenocarcinoma,How common is UNC5D and ZNF708 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+178,UNC5D,L699V,Lung Adenocarcinoma,How common is UNC5D and EPRS1 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+179,UNC5D,L704V,Lung Adenocarcinoma,How common is UNC5D and PRSS1 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+180,UNC5D,L709V,Lung Adenocarcinoma,How common is UNC5D and XKR4 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How common is DOCK2 and GLRB codeletion in Kidney Renal Clear Cell Carcinoma cases?,freq_cnv_loss_or_gain
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How common is ZNF627 and FCGR2C codeletion in Kidney Renal Clear Cell Carcinoma cases?,freq_cnv_loss_or_gain
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How common is CDC42BPA and CX3CR1 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+193,MRPL55,H27Y,Colon Adenocarcinoma,How common is MRPL55 and VASN codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+194,MRPL55,H63Y,Colon Adenocarcinoma,How common is MRPL55 and PGF codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How common is TMTC3 and GABRA6 codeletion in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+198,EPRS1,K771I,Colon Adenocarcinoma,How common is EPRS1 and MORF4L1 codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+199,EPRS1,K778I,Colon Adenocarcinoma,How common is EPRS1 and STK19 codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How common is GRTP1 and PTPRO codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How common is GRTP1 and TTYH2 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How common is TSHZ3 and ACTB codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How common is TAS1R3 and NRAP codeletion in HIV+ Tumor Molecular Characterization Project - Cervical Cancer cases?,freq_cnv_loss_or_gain
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How common is PIAS3 and NCKAP5 codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How common is PIAS3 and GRTP1 codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+251,ZNF274,P13R,Stomach Adenocarcinoma,How common is ZNF274 and ZNF431 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+253,SYNJ1,R795C,Colon Adenocarcinoma,How common is SYNJ1 and CTSC codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+254,SYNJ1,R800C,Colon Adenocarcinoma,How common is SYNJ1 and RIMS2 codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+255,SYNJ1,R839C,Colon Adenocarcinoma,How common is SYNJ1 and FMO4 codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+261,DSCAM,V343M,Prostate Adenocarcinoma,How common is DSCAM and SPTAN1 codeletion in Prostate Adenocarcinoma cases?,freq_cnv_loss_or_gain
+262,DSCAM,V426M,Prostate Adenocarcinoma,How common is DSCAM and SGIP1 codeletion in Prostate Adenocarcinoma cases?,freq_cnv_loss_or_gain
+263,DSCAM,V591M,Prostate Adenocarcinoma,How common is DSCAM and PTPRN2 codeletion in Prostate Adenocarcinoma cases?,freq_cnv_loss_or_gain
+267,DGKD,R140H,Exceptional Responders,How common is DGKD and GPRASP1 codeletion in Exceptional Responders cases?,freq_cnv_loss_or_gain
+268,DGKD,R160H,Exceptional Responders,How common is DGKD and HLA-DQA2 codeletion in Exceptional Responders cases?,freq_cnv_loss_or_gain
+269,DGKD,R204H,Exceptional Responders,How common is DGKD and YY1AP1 codeletion in Exceptional Responders cases?,freq_cnv_loss_or_gain
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How common is PLEKHG6 and CTSC codeletion in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How common is PLEKHG6 and SYNJ1 codeletion in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How common is PLEKHG6 and DCN codeletion in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+279,WNT2,D138N,Skin Cutaneous Melanoma,How common is WNT2 and KL codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How common is GUCY2C and TNS1 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How common is C7orf31 and TRAP1 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is ZKSCAN7 and GPRASP1 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+299,OR5D14,M210L,Neuroblastoma,How common is OR5D14 and PTPRO codeletion in Neuroblastoma cases?,freq_cnv_loss_or_gain
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How common is SPATA22 and AUTS2 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How common is SPATA22 and ZFPM2 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How common is SPATA22 and TRIM45 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+310,LCN15,E21V,Stomach Adenocarcinoma,How common is LCN15 and SMO codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How common is DCAF4L2 and TTC12 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How common is GUK1 and OR13C3 codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How common is GUK1 and PXN codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How common is GUK1 and GUK1 codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How common is GUK1 and SGIP1 codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How common is GUK1 and IL5RA codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How common is MORF4L1 and TLK2 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How common is MORF4L1 and CTCFL codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How common is MORF4L1 and PDGFC codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How common is MORF4L1 and GABRA6 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How common is MYO3B and CASZ1 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How common is MYO3B and BICC1 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How common is TENT5A and POLD1 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How common is TENT5A and ADRA1A codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How common is TENT5A and ZCCHC14 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How common is ZFAT and JAML codeletion in Ovarian Serous Cystadenocarcinoma cases?,freq_cnv_loss_or_gain
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How common is ZFAT and PLEKHG6 codeletion in Ovarian Serous Cystadenocarcinoma cases?,freq_cnv_loss_or_gain
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How common is ZFAT and DGKD codeletion in Ovarian Serous Cystadenocarcinoma cases?,freq_cnv_loss_or_gain
+357,ZNF584,A211T,Sarcoma,How common is ZNF584 and CR1 codeletion in Sarcoma cases?,freq_cnv_loss_or_gain
+358,ZNF584,A256T,Sarcoma,How common is ZNF584 and ZNF274 codeletion in Sarcoma cases?,freq_cnv_loss_or_gain
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How common is LDOC1 and TTYH2 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How common is PDGFC and ACTA2 codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How common is MSANTD4 and MUC16 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How common is NPSR1 and NRAP codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How common is PHLPP1 and CDH23 codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How common is COL6A3 and ABCC3 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How common is COL6A3 and DCAF6 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How common is COL6A3 and DPF3 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How common is COL6A3 and MYH11 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How common is COL6A3 and YY1AP1 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How common is ADRA1A and AKT1 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is LAMB2 and KRT39 codeletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,freq_cnv_loss_or_gain
+406,POC1B,I198T,Rectum Adenocarcinoma,How common is POC1B and DNMT1 codeletion in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+407,POC1B,I286T,Rectum Adenocarcinoma,How common is POC1B and UNC5D codeletion in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+408,POC1B,I328T,Rectum Adenocarcinoma,How common is POC1B and DCN codeletion in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+409,POC1B,S79P,Rectum Adenocarcinoma,How common is POC1B and DCLK3 codeletion in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How common is USH2A and ZFAT codeletion in Liver Hepatocellular Carcinoma cases?,freq_cnv_loss_or_gain
+414,AQP7,T110S,Rectum Adenocarcinoma,How common is AQP7 and BCAT1 codeletion in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+415,AQP7,T166S,Rectum Adenocarcinoma,How common is AQP7 and PIK3C2B codeletion in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+416,AQP7,T167S,Rectum Adenocarcinoma,How common is AQP7 and STK19 codeletion in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+417,AQP7,T75S,Rectum Adenocarcinoma,How common is AQP7 and ZCCHC14 codeletion in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+430,DCN,R163C,Rectum Adenocarcinoma,How common is DCN and GUK1 codeletion in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+431,DCN,R203C,Rectum Adenocarcinoma,How common is DCN and TNS1 codeletion in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+432,DCN,R241C,Rectum Adenocarcinoma,How common is DCN and GPC3 codeletion in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+433,DCN,R350C,Rectum Adenocarcinoma,How common is DCN and RIPOR2 codeletion in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+434,DCN,R41C,Rectum Adenocarcinoma,How common is DCN and MERTK codeletion in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How common is CPS1 and PGR codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How common is CPS1 and PIK3C2B codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How common is CPS1 and CTCFL codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How common is FCGR2C and ZKSCAN7 codeletion in Kidney Renal Papillary Cell Carcinoma cases?,freq_cnv_loss_or_gain
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How common is FCGR2C and VASN codeletion in Kidney Renal Papillary Cell Carcinoma cases?,freq_cnv_loss_or_gain
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How common is GRM1 and PTPRO codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+482,SGCZ,Q138H,Lung Adenocarcinoma,How common is SGCZ and MAST4 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+483,SGCZ,Q91H,Lung Adenocarcinoma,How common is SGCZ and ZKSCAN7 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+485,SMO,V15M,Stomach Adenocarcinoma,How common is SMO and GPC3 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+486,SMO,V321M,Stomach Adenocarcinoma,How common is SMO and ANKRD24 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+488,CHODL,G159E,Skin Cutaneous Melanoma,How common is CHODL and MYT1 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+489,CHODL,G181E,Skin Cutaneous Melanoma,How common is CHODL and JAML codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+490,CHODL,G200E,Skin Cutaneous Melanoma,How common is CHODL and YY1AP1 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+494,MYO16,P399H,Colon Adenocarcinoma,How common is MYO16 and MERTK codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+495,MYO16,P421H,Colon Adenocarcinoma,How common is MYO16 and CHMP7 codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+498,CXCR2,A98V,Stomach Adenocarcinoma,How common is CXCR2 and PGF codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How common is TMEM225 and SLC9C1 codeletion in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How common is MAOB and ANKRD52 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How common is GPRASP1 and FGF8 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How common is MRPL32 and DGKD codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How common is TYROBP and MAST4 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+510,RAB40C,A111V,Lung Adenocarcinoma,How common is RAB40C and AUTS2 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+511,RAB40C,A143V,Lung Adenocarcinoma,How common is RAB40C and DNAH14 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+512,CTNNA2,S323R,Lung Adenocarcinoma,How common is CTNNA2 and AUTS2 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+513,CTNNA2,S339R,Lung Adenocarcinoma,How common is CTNNA2 and PTPRO codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+514,CTNNA2,S386R,Lung Adenocarcinoma,How common is CTNNA2 and SPATA22 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+515,CTNNA2,S707R,Lung Adenocarcinoma,How common is CTNNA2 and TNS1 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How common is MYO15A and SORCS1 codeletion in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How common is GIMAP2 and ZCCHC14 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+532,KIF20B,N1160D,Glioblastoma Multiforme,How common is KIF20B and MAD1L1 codeletion in Glioblastoma Multiforme cases?,freq_cnv_loss_or_gain
+533,KIF20B,N1200D,Glioblastoma Multiforme,How common is KIF20B and DNAH14 codeletion in Glioblastoma Multiforme cases?,freq_cnv_loss_or_gain
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How common is ADAM17 and CHODL codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How common is BCAT1 and BCAT1 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How common is BCAT1 and ZNF431 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How common is BCAT1 and ZNF431 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+540,ERCC6,R1053H,Colon Adenocarcinoma,How common is ERCC6 and TNS1 codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+541,DCC,R320W,Breast Invasive Carcinoma,How common is DCC and PXN codeletion in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+542,DCC,R363W,Breast Invasive Carcinoma,How common is DCC and DSCAM codeletion in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+543,DCC,R386W,Breast Invasive Carcinoma,How common is DCC and TSHZ3 codeletion in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+544,DCC,R41W,Breast Invasive Carcinoma,How common is DCC and EIF2B4 codeletion in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How common is FBXO15 and TAF1L codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How common is FBXO15 and DPF3 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How common is GSTCD and YY1AP1 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How common is GSTCD and TNS1 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How common is OLFML3 and ZNF431 codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How common is OLFML3 and PIK3C2G codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How common is OLFML3 and JAML codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How common is CFAP61 and TNS1 codeletion in Ovarian Serous Cystadenocarcinoma cases?,freq_cnv_loss_or_gain
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How common is CFAP61 and DNMT1 codeletion in Ovarian Serous Cystadenocarcinoma cases?,freq_cnv_loss_or_gain
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How common is HLA-DQA2 and CYB5R2 codeletion in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How common is TENM2 and ART3 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How common is TENM2 and TTN codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How common is TENM2 and DPF3 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How common is ANKRD24 and PGR codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How common is ANKRD24 and CCNG1 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How common is ANKRD24 and PTPRN2 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How common is ZCCHC14 and TET2 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How common is ZCCHC14 and FNDC7 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How common is ZCCHC14 and CYP1A2 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How common is ZCCHC14 and PAK3 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+625,SIK2,I265M,Lung Adenocarcinoma,How common is SIK2 and DCC codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How common is MYH11 and AQP7 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How common is MYH11 and POLD1 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How common is SLC6A4 and CARMIL1 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How common is SLC9C1 and DSCAM codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How common is SLC9C1 and LCN15 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+644,OR2A12,A254T,Brain Lower Grade Glioma,How common is OR2A12 and DGKD codeletion in Brain Lower Grade Glioma cases?,freq_cnv_loss_or_gain
+646,PYHIN1,T325K,Lung Adenocarcinoma,How common is PYHIN1 and AQP7 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+647,PYHIN1,T334K,Lung Adenocarcinoma,How common is PYHIN1 and HYOU1 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+650,JAML,G191E,Skin Cutaneous Melanoma,How common is JAML and KRT39 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+651,JAML,G219E,Skin Cutaneous Melanoma,How common is JAML and SYNJ1 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+652,JAML,G220E,Skin Cutaneous Melanoma,How common is JAML and KIF20B codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+653,JAML,G230E,Skin Cutaneous Melanoma,How common is JAML and MERTK codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+658,TYK2,H1146R,Stomach Adenocarcinoma,How common is TYK2 and TENT5A codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+659,TYK2,H23R,Stomach Adenocarcinoma,How common is TYK2 and DCC codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+660,TYK2,H961R,Stomach Adenocarcinoma,How common is TYK2 and STK19 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How common is CTCFL and WNT2 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How common is CTCFL and PAK3 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How common is CTCFL and RAB40C codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How common is CTCFL and SPATA22 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How common is CEP20 and TYK2 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How common is CEP20 and YY1AP1 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How common is RIMS2 and RIPOR2 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How common is RIMS2 and MRPL55 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How common is RIMS2 and FBXO42 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How common is RIMS2 and YY1AP1 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How common is RIMS2 and AQP7 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How common is RIMS2 and TENT5A codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How common is RIMS2 and PAK3 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How common is PIK3C2G and RIPOR2 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How common is PIK3C2G and SLC9C1 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+728,STK19,D341N,Colon Adenocarcinoma,How common is STK19 and PTPRO codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+729,STK19,D345N,Colon Adenocarcinoma,How common is STK19 and MAST4 codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+730,REXO4,P60A,Skin Cutaneous Melanoma,How common is REXO4 and MYH11 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How common is ZBTB34 and GUK1 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How common is ZBTB34 and PCDHB2 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How common is NCKAP5 and ANKRD24 codeletion in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is SORCS1 and CDKN2AIP codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is SORCS1 and AKT1 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is SORCS1 and OR2A12 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is SORCS1 and ZCCHC14 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How common is FGF8 and MAOB codeletion in Head and Neck Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How common is FGF8 and SMO codeletion in Head and Neck Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How common is FGF8 and ANKRD30A codeletion in Head and Neck Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How common is FGF8 and ADAM17 codeletion in Head and Neck Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How common is FGF8 and TLK2 codeletion in Head and Neck Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How common is TENM3 and ZNF627 codeletion in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia cases?,freq_cnv_loss_or_gain
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How common is AKT1 and PRSS8 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is CFAP298-TCP10L and PRSS1 codeletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,freq_cnv_loss_or_gain
+792,GLRB,E148D,Stomach Adenocarcinoma,How common is GLRB and PGR codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+793,TTN,F7636L,Colon Adenocarcinoma,How common is TTN and CYB5R2 codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+794,TTN,F8563L,Colon Adenocarcinoma,How common is TTN and GPR158 codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+795,TTN,F8880L,Colon Adenocarcinoma,How common is TTN and CDC42BPA codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How common is ANKRD30A and TMEM255A codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How common is ANKRD30A and PXN codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How common is ANKRD30A and ANKRD24 codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+809,TRIM45,S177L,Colon Adenocarcinoma,How common is TRIM45 and MYH11 codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+810,TRIM45,S224L,Colon Adenocarcinoma,How common is TRIM45 and HTR3B codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+811,TRIM45,S281L,Colon Adenocarcinoma,How common is TRIM45 and NRAP codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How common is CACNA1F and CA9 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How common is CACNA1F and EBF2 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How common is CACNA1F and GRM1 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+817,KL,R594C,Colon Adenocarcinoma,How common is KL and SYT9 codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How common is GUF1 and AUTS2 codeletion in Kidney Renal Papillary Cell Carcinoma cases?,freq_cnv_loss_or_gain
+822,TAF1L,A539V,Colon Adenocarcinoma,How common is TAF1L and FRY codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How common is TASOR2 and DCLK3 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How common is TASOR2 and PGR codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How common is TASOR2 and TYK2 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How common is KDM5C and TTN codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How common is KDM5C and DCAF6 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How common is KDM5C and RIMS2 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How common is KDM5C and VASN codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is IL5RA and RIPOR2 codeletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,freq_cnv_loss_or_gain
+843,DHX16,A29V,Skin Cutaneous Melanoma,How common is DHX16 and GLRB codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+844,DHX16,A89V,Skin Cutaneous Melanoma,How common is DHX16 and TAF1C codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+902,GPR158,A644V,Stomach Adenocarcinoma,How common is GPR158 and SORCS1 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+903,GPR158,A723V,Stomach Adenocarcinoma,How common is GPR158 and PHLPP1 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is EIF2B4 and GUF1 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is EIF2B4 and PAPPA codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is EIF2B4 and KRT39 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is EIF2B4 and ICE1 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is EIF2B4 and TRIM45 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is EIF2B4 and PCDHB2 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How common is AUTS2 and PSG2 codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How common is AUTS2 and ACTB codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How common is AUTS2 and TASOR2 codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How common is AUTS2 and PXN codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How common is AUTS2 and SYT9 codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How common is AUTS2 and CARMIL1 codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How common is AUTS2 and ZNF584 codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How common is AUTS2 and SOX21 codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How common is AUTS2 and ANP32E codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How common is AUTS2 and CTNNA2 codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is ACTL7B and DCN codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How common is PCDHGA1 and RIPOR2 codeletion in Glioblastoma Multiforme cases?,freq_cnv_loss_or_gain
+954,TRAP1,R114W,Stomach Adenocarcinoma,How common is TRAP1 and SIK2 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+955,TRAP1,R61W,Stomach Adenocarcinoma,How common is TRAP1 and OR5D14 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How common is PIK3C2A and GPC3 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How common is KANSL1 and OR8K5 codeletion in Liver Hepatocellular Carcinoma cases?,freq_cnv_loss_or_gain
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How common is ANKRD52 and ZFPM2 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How common is PAPPA and CARMIL1 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How common is B3GALNT1 and EIF2B4 codeletion in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+982,GABRA6,G115R,Lung Adenocarcinoma,How common is GABRA6 and DGKD codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+983,GABRA6,G122R,Lung Adenocarcinoma,How common is GABRA6 and PTPRN2 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+984,GABRA6,G165R,Lung Adenocarcinoma,How common is GABRA6 and CEP20 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+985,GABRA6,G175R,Lung Adenocarcinoma,How common is GABRA6 and KDM5C codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+986,GABRA6,G70R,Lung Adenocarcinoma,How common is GABRA6 and TLK2 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How common is ZSCAN31 and ZNF274 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MED16 and BFAR codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MED16 and CTNNA2 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How common is PTPRO and TYK2 codeletion in Pancreatic Adenocarcinoma cases?,freq_cnv_loss_or_gain
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How common is PTPRO and THBS4 codeletion in Pancreatic Adenocarcinoma cases?,freq_cnv_loss_or_gain
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How common is PTPRO and MYO3B codeletion in Pancreatic Adenocarcinoma cases?,freq_cnv_loss_or_gain
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How common is PTPRO and CHODL codeletion in Pancreatic Adenocarcinoma cases?,freq_cnv_loss_or_gain
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How common is PTPRO and MYO16 codeletion in Pancreatic Adenocarcinoma cases?,freq_cnv_loss_or_gain
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How common is PTPRO and TAF1C codeletion in Pancreatic Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How common is PTPRO and EIF2B4 codeletion in Pancreatic Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How common is PTPRO and DCN codeletion in Pancreatic Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How common is CHMP7 and OR2T4 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1017,GPC3,I107N,Stomach Adenocarcinoma,How common is GPC3 and STK19 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1018,GPC3,I161N,Stomach Adenocarcinoma,How common is GPC3 and DSCAM codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is TLK2 and SERPINB10 codeletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is TLK2 and KDM5C codeletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is TLK2 and OR2T4 codeletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is TLK2 and TYROBP codeletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is TLK2 and PRSS8 codeletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How common is ZNF217 and GPRASP1 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1038,SYT9,V275L,Lung Adenocarcinoma,How common is SYT9 and POC1B codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1039,SYT9,V307L,Lung Adenocarcinoma,How common is SYT9 and DGKD codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How common is PKHD1L1 and VPS26B codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How common is MYO3A and OR13C3 codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is VASN and TENT5A codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How common is DNMT1 and ADRA1A codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How common is DNMT1 and TTN codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How common is DNMT1 and AQP7 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1056,CA9,E402K,Colon Adenocarcinoma,How common is CA9 and FGF8 codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How common is TTC17 and SLC9C1 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How common is TTC17 and SPTAN1 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1065,PSG2,P43L,Breast Invasive Carcinoma,How common is PSG2 and TMEM255A codeletion in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How common is RIPOR2 and PDGFC codeletion in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How common is RIPOR2 and FBXO42 codeletion in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How common is RIPOR2 and BCAT1 codeletion in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How common is RIPOR2 and CPS1 codeletion in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How common is DCLK3 and CYB5R2 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How common is DCLK3 and HBB codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How common is MERTK and STAT3 codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How common is MERTK and FBN1 codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How common is MERTK and PLEKHG6 codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How common is ZFP42 and CPS1 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How common is OR13C3 and ACVR1B codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How common is OR13C3 and PAK3 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How common is SPAG1 and CEP20 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How common is CDKN2AIP and TAF1L codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1093,PXN,H1016Y,Colon Adenocarcinoma,How common is PXN and NCKAP5 codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1094,PXN,H359Y,Colon Adenocarcinoma,How common is PXN and GUK1 codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1095,PXN,H492Y,Colon Adenocarcinoma,How common is PXN and DCN codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1096,PXN,H524Y,Colon Adenocarcinoma,How common is PXN and PCDHB2 codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1097,PXN,H526Y,Colon Adenocarcinoma,How common is PXN and MAD1L1 codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1098,PXN,H540Y,Colon Adenocarcinoma,How common is PXN and TYK2 codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How common is TTYH2 and CNGB1 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How common is TTYH2 and PGR codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How common is TMEM255A and PXN codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How common is TMEM255A and TMEM255A codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How common is TMEM255A and CHODL codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How common is TASOR2 and EPRS1 codeletion in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How common is TASOR2 and SGIP1 codeletion in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How common is ICE1 and CACNA1F codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1112,MYT1,A558E,Breast Invasive Carcinoma,How common is MYT1 and CEP20 codeletion in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+1113,MYT1,A879E,Breast Invasive Carcinoma,How common is MYT1 and MYO15A codeletion in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+1114,MYT1,A906E,Breast Invasive Carcinoma,How common is MYT1 and SPTAN1 codeletion in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How common is CX3CR1 and PYHIN1 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How common is CX3CR1 and CASZ1 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How common is SPINDOC and UNC5D codeletion in Liver Hepatocellular Carcinoma cases?,freq_cnv_loss_or_gain
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How common is ART3 and ZNF217 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How common is ART3 and ANKRD30A codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How common is CYP1A2 and CDH23 codeletion in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is ADRA1A and SORCS1 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How common is CDH23 and ADAM17 codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How common is CDH23 and CHMP7 codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How common is KRT39 and PRSS8 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How common is PDHA2 and MAD1L1 codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How common is SLC24A2 and MAD1L1 codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How common is PTPRN2 and MED16 codeletion in Liver Hepatocellular Carcinoma cases?,freq_cnv_loss_or_gain
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How common is PTPRN2 and PTPRN2 codeletion in Liver Hepatocellular Carcinoma cases?,freq_cnv_loss_or_gain
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How common is PTPRN2 and CARMIL1 codeletion in Liver Hepatocellular Carcinoma cases?,freq_cnv_loss_or_gain
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How common is PTPRN2 and ANKDD1A codeletion in Liver Hepatocellular Carcinoma cases?,freq_cnv_loss_or_gain
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How common is PTPRN2 and ZNF431 codeletion in Liver Hepatocellular Carcinoma cases?,freq_cnv_loss_or_gain
+1188,SOX21,R55L,Lung Adenocarcinoma,How common is SOX21 and SLC9C1 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How common is CPA6 and CTNNA2 codeletion in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How common is GRM5 and EPRS1 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is CASZ1 and DCLK3 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How common is SGIP1 and YY1AP1 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How common is SGIP1 and PTPRO codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How common is SGIP1 and FGF8 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How common is SGIP1 and TRIM45 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How common is CARMIL1 and EBF2 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How common is CARMIL1 and TTC17 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How common is ZNF431 and NPSR1 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How common is ZNF431 and DNAH14 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1234,ZNF431,R128I,Lung Adenocarcinoma,How common is ZNF431 and CNGB1 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How common is DNAH11 and PGR codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How common is DNAH11 and DEFB115 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How common is POLD1 and PXN codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How common is POLD1 and ZNF431 codeletion in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+1248,TTC12,D646H,Lung Adenocarcinoma,How common is TTC12 and TTN codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1249,TTC12,D652H,Lung Adenocarcinoma,How common is TTC12 and SGIP1 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How common is CNGB1 and SGIP1 codeletion in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How common is CNGB1 and CHODL codeletion in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+1254,CTSC,E214V,Stomach Adenocarcinoma,How common is CTSC and RIMS2 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1255,CTSC,E291V,Stomach Adenocarcinoma,How common is CTSC and FCGR2C codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1256,CTSC,E322V,Stomach Adenocarcinoma,How common is CTSC and PAPPA codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1257,CTSC,E324V,Stomach Adenocarcinoma,How common is CTSC and RELN codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1258,CTSC,E335V,Stomach Adenocarcinoma,How common is CTSC and POLR1G codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How common is PRSS8 and GUK1 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How common is PRSS8 and OR13C3 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How common is ARHGEF40 and GPC3 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1264,ACTB,A138T,Rectum Adenocarcinoma,How common is ACTB and LCN15 codeletion in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1265,ACTB,A217T,Rectum Adenocarcinoma,How common is ACTB and STAT3 codeletion in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1266,ACTB,A244T,Rectum Adenocarcinoma,How common is ACTB and CTCFL codeletion in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1267,ACTB,A260T,Rectum Adenocarcinoma,How common is ACTB and POLD1 codeletion in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How common is YY1AP1 and PXN codeletion in Glioblastoma Multiforme cases?,freq_cnv_loss_or_gain
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How common is YY1AP1 and TET2 codeletion in Glioblastoma Multiforme cases?,freq_cnv_loss_or_gain
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How common is YY1AP1 and RIMS2 codeletion in Glioblastoma Multiforme cases?,freq_cnv_loss_or_gain
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How common is YY1AP1 and CACNA1F codeletion in Glioblastoma Multiforme cases?,freq_cnv_loss_or_gain
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How common is YY1AP1 and SLC9C1 codeletion in Glioblastoma Multiforme cases?,freq_cnv_loss_or_gain
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How common is YY1AP1 and ZNF431 codeletion in Glioblastoma Multiforme cases?,freq_cnv_loss_or_gain
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How common is YY1AP1 and TAF1C codeletion in Glioblastoma Multiforme cases?,freq_cnv_loss_or_gain
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How common is FNDC7 and TENM2 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How common is FNDC7 and PTPRN2 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+1299,TLCD5,G15V,Lung Adenocarcinoma,How common is TLCD5 and POC1B codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1300,TLCD5,G37V,Lung Adenocarcinoma,How common is TLCD5 and TLK2 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How common is POLR1G and DCN codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How common is POLR1G and DPF3 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How common is DNAH14 and GIMAP2 codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How common is DNAH14 and ANKRD24 codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How common is DNAH14 and OLFML3 codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How common is NEXN and SIK2 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How common is CYB5R2 and DGKD codeletion in Prostate Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How common is CYB5R2 and PLEKHG6 codeletion in Prostate Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How common is NRAP and MYO3A codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How common is NRAP and CARMIL1 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How common is NRAP and PGR codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How common is CCDC22 and TTYH2 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How common is DCAF6 and NPSR1 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How common is DCAF6 and TMTC3 codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How common is ZNF708 and PAK3 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How common is BFAR and TSHZ3 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How common is MAST4 and TRPA1 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How common is MAST4 and STAT3 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How common is MAST4 and FGF8 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How common is MAST4 and DNMT1 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How common is MAST4 and PGR codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How common is ARMC3 and TENT5A codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How common is ARMC3 and GUF1 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How common is TET2 and ZNF708 codeletion in Kidney Renal Clear Cell Carcinoma cases?,freq_cnv_loss_or_gain
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How common is TET2 and FNDC7 codeletion in Kidney Renal Clear Cell Carcinoma cases?,freq_cnv_loss_or_gain
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How common is SERPINB10 and JAML codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How common is STAT3 and ANP32E codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How common is MIEF1 and SORCS1 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How common is ACVR1B and UNC5D codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How common is ACVR1B and REXO4 codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How common is ACVR1B and KANSL1 codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1393,EBF2,T104I,Stomach Adenocarcinoma,How common is EBF2 and RIMS2 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1394,EBF2,T252I,Stomach Adenocarcinoma,How common is EBF2 and ZNF584 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How common is VPS26B and CX3CR1 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is PGR and BCAT1 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is PGR and RIPOR2 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is PGR and RIPOR2 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How common is ACTA2 and SMO codeletion in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How common is THBS4 and GRTP1 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How common is THBS4 and EIF2B4 codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1413,PRSS1,S114T,Lung Adenocarcinoma,How common is PRSS1 and SORCS1 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1414,PRSS1,S124T,Lung Adenocarcinoma,How common is PRSS1 and TAF1C codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1415,PRSS1,S138T,Lung Adenocarcinoma,How common is PRSS1 and UNC5D codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1416,PRSS1,S74T,Lung Adenocarcinoma,How common is PRSS1 and TASOR2 codeletion in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1417,PGF,R126H,Stomach Adenocarcinoma,How common is PGF and CASZ1 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1418,PGF,R127H,Stomach Adenocarcinoma,How common is PGF and PIAS3 codeletion in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How common is ITPRID2 and OR8K5 codeletion in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How common is ITPRID2 and MYH11 codeletion in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How common is HBB and ACTB codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How common is PCDHB2 and TTN codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How common is PCDHB2 and YY1AP1 codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How common is PCDHB2 and PIK3C2A codeletion in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How common is UBR2 and IL5RA codeletion in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How common is FBXO42 and TRAP1 codeletion in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1,TNS1,G1362V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have somatic TNS1 LOH?,freq_cnv_loss_or_gain
+2,TNS1,G1711V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have somatic TNS1 LOH?,freq_cnv_loss_or_gain
+3,TNS1,G1718V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have somatic TNS1 LOH?,freq_cnv_loss_or_gain
+4,TNS1,G1732V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have somatic TNS1 LOH?,freq_cnv_loss_or_gain
+5,TNS1,G1824V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have somatic TNS1 LOH?,freq_cnv_loss_or_gain
+6,TNS1,G1857V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have somatic TNS1 LOH?,freq_cnv_loss_or_gain
+7,TNS1,G843V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have somatic TNS1 LOH?,freq_cnv_loss_or_gain
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have somatic EVC2 LOH?,freq_cnv_loss_or_gain
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have somatic EVC2 LOH?,freq_cnv_loss_or_gain
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic CR1 LOH?,freq_cnv_loss_or_gain
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic CR1 LOH?,freq_cnv_loss_or_gain
+22,TRPA1,S295I,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have somatic TRPA1 LOH?,freq_cnv_loss_or_gain
+23,TRPA1,S443I,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have somatic TRPA1 LOH?,freq_cnv_loss_or_gain
+24,TAF1C,R299L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic TAF1C LOH?,freq_cnv_loss_or_gain
+25,TAF1C,R396L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic TAF1C LOH?,freq_cnv_loss_or_gain
+26,TAF1C,R634L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic TAF1C LOH?,freq_cnv_loss_or_gain
+27,TAF1C,R702L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic TAF1C LOH?,freq_cnv_loss_or_gain
+28,TAF1C,R728L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic TAF1C LOH?,freq_cnv_loss_or_gain
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic DPF3 LOH?,freq_cnv_loss_or_gain
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic DPF3 LOH?,freq_cnv_loss_or_gain
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic DPF3 LOH?,freq_cnv_loss_or_gain
+42,OR2T4,P272H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic OR2T4 LOH?,freq_cnv_loss_or_gain
+43,OR2T4,P300H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic OR2T4 LOH?,freq_cnv_loss_or_gain
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma patients have somatic FBN1 LOH?,freq_cnv_loss_or_gain
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma patients have somatic MAD1L1 LOH?,freq_cnv_loss_or_gain
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma patients have somatic MAD1L1 LOH?,freq_cnv_loss_or_gain
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma patients have somatic MAD1L1 LOH?,freq_cnv_loss_or_gain
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic CCNG1 LOH?,freq_cnv_loss_or_gain
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma patients have somatic ANP32E LOH?,freq_cnv_loss_or_gain
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma patients have somatic ANP32E LOH?,freq_cnv_loss_or_gain
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma patients have somatic ANP32E LOH?,freq_cnv_loss_or_gain
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma patients have somatic ANP32E LOH?,freq_cnv_loss_or_gain
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have somatic FRY LOH?,freq_cnv_loss_or_gain
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have somatic FRY LOH?,freq_cnv_loss_or_gain
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have somatic FRY LOH?,freq_cnv_loss_or_gain
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have somatic FRY LOH?,freq_cnv_loss_or_gain
+70,PAK3,E318K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic PAK3 LOH?,freq_cnv_loss_or_gain
+71,PAK3,E319K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic PAK3 LOH?,freq_cnv_loss_or_gain
+72,PAK3,E334K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic PAK3 LOH?,freq_cnv_loss_or_gain
+73,PAK3,E340K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic PAK3 LOH?,freq_cnv_loss_or_gain
+74,PAK3,E355K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic PAK3 LOH?,freq_cnv_loss_or_gain
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic MUC16 LOH?,freq_cnv_loss_or_gain
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma patients have somatic ZFPM2 LOH?,freq_cnv_loss_or_gain
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma patients have somatic ZFPM2 LOH?,freq_cnv_loss_or_gain
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have somatic PIK3C2B LOH?,freq_cnv_loss_or_gain
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have somatic PIK3C2B LOH?,freq_cnv_loss_or_gain
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic ZNF804A LOH?,freq_cnv_loss_or_gain
+116,RELN,A2371V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic RELN LOH?,freq_cnv_loss_or_gain
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have somatic EFCAB12 LOH?",freq_cnv_loss_or_gain
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have somatic EFCAB12 LOH?",freq_cnv_loss_or_gain
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic DEFB115 LOH?,freq_cnv_loss_or_gain
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have somatic ANKDD1A LOH?,freq_cnv_loss_or_gain
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have somatic ANKDD1A LOH?,freq_cnv_loss_or_gain
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have somatic ANKDD1A LOH?,freq_cnv_loss_or_gain
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic HTR3B LOH?,freq_cnv_loss_or_gain
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic HTR3B LOH?,freq_cnv_loss_or_gain
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic HTR3B LOH?,freq_cnv_loss_or_gain
+129,ABCC3,R758W,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic ABCC3 LOH?,freq_cnv_loss_or_gain
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic NOMO1 LOH?,freq_cnv_loss_or_gain
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic NOMO1 LOH?,freq_cnv_loss_or_gain
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have somatic HYOU1 LOH?,freq_cnv_loss_or_gain
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic FMO4 LOH?,freq_cnv_loss_or_gain
+140,BICC1,A372V,Exceptional Responders,What percentage of Exceptional Responders patients have somatic BICC1 LOH?,freq_cnv_loss_or_gain
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic ZMYM3 LOH?,freq_cnv_loss_or_gain
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic ZMYM3 LOH?,freq_cnv_loss_or_gain
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic ZMYM3 LOH?,freq_cnv_loss_or_gain
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have somatic XKR4 LOH?",freq_cnv_loss_or_gain
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma patients have somatic ABCC2 LOH?,freq_cnv_loss_or_gain
+157,OR8K5,R293G,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic OR8K5 LOH?,freq_cnv_loss_or_gain
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic SPTAN1 LOH?,freq_cnv_loss_or_gain
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic SPTAN1 LOH?,freq_cnv_loss_or_gain
+164,SYT10,M484I,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have somatic SYT10 LOH?,freq_cnv_loss_or_gain
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic HSPA5 LOH?,freq_cnv_loss_or_gain
+175,UNC5D,L280V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic UNC5D LOH?,freq_cnv_loss_or_gain
+176,UNC5D,L635V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic UNC5D LOH?,freq_cnv_loss_or_gain
+177,UNC5D,L637V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic UNC5D LOH?,freq_cnv_loss_or_gain
+178,UNC5D,L699V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic UNC5D LOH?,freq_cnv_loss_or_gain
+179,UNC5D,L704V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic UNC5D LOH?,freq_cnv_loss_or_gain
+180,UNC5D,L709V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic UNC5D LOH?,freq_cnv_loss_or_gain
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma patients have somatic DOCK2 LOH?,freq_cnv_loss_or_gain
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma patients have somatic ZNF627 LOH?,freq_cnv_loss_or_gain
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic CDC42BPA LOH?,freq_cnv_loss_or_gain
+193,MRPL55,H27Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic MRPL55 LOH?,freq_cnv_loss_or_gain
+194,MRPL55,H63Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic MRPL55 LOH?,freq_cnv_loss_or_gain
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have somatic TMTC3 LOH?,freq_cnv_loss_or_gain
+198,EPRS1,K771I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic EPRS1 LOH?,freq_cnv_loss_or_gain
+199,EPRS1,K778I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic EPRS1 LOH?,freq_cnv_loss_or_gain
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic GRTP1 LOH?,freq_cnv_loss_or_gain
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic GRTP1 LOH?,freq_cnv_loss_or_gain
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic TSHZ3 LOH?,freq_cnv_loss_or_gain
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What percentage of HIV+ Tumor Molecular Characterization Project - Cervical Cancer patients have somatic TAS1R3 LOH?,freq_cnv_loss_or_gain
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic PIAS3 LOH?,freq_cnv_loss_or_gain
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic PIAS3 LOH?,freq_cnv_loss_or_gain
+251,ZNF274,P13R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic ZNF274 LOH?,freq_cnv_loss_or_gain
+253,SYNJ1,R795C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic SYNJ1 LOH?,freq_cnv_loss_or_gain
+254,SYNJ1,R800C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic SYNJ1 LOH?,freq_cnv_loss_or_gain
+255,SYNJ1,R839C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic SYNJ1 LOH?,freq_cnv_loss_or_gain
+261,DSCAM,V343M,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma patients have somatic DSCAM LOH?,freq_cnv_loss_or_gain
+262,DSCAM,V426M,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma patients have somatic DSCAM LOH?,freq_cnv_loss_or_gain
+263,DSCAM,V591M,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma patients have somatic DSCAM LOH?,freq_cnv_loss_or_gain
+267,DGKD,R140H,Exceptional Responders,What percentage of Exceptional Responders patients have somatic DGKD LOH?,freq_cnv_loss_or_gain
+268,DGKD,R160H,Exceptional Responders,What percentage of Exceptional Responders patients have somatic DGKD LOH?,freq_cnv_loss_or_gain
+269,DGKD,R204H,Exceptional Responders,What percentage of Exceptional Responders patients have somatic DGKD LOH?,freq_cnv_loss_or_gain
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have somatic PLEKHG6 LOH?,freq_cnv_loss_or_gain
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have somatic PLEKHG6 LOH?,freq_cnv_loss_or_gain
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have somatic PLEKHG6 LOH?,freq_cnv_loss_or_gain
+279,WNT2,D138N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic WNT2 LOH?,freq_cnv_loss_or_gain
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic GUCY2C LOH?,freq_cnv_loss_or_gain
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic C7orf31 LOH?,freq_cnv_loss_or_gain
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have somatic ZKSCAN7 LOH?",freq_cnv_loss_or_gain
+299,OR5D14,M210L,Neuroblastoma,What percentage of Neuroblastoma patients have somatic OR5D14 LOH?,freq_cnv_loss_or_gain
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic SPATA22 LOH?,freq_cnv_loss_or_gain
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic SPATA22 LOH?,freq_cnv_loss_or_gain
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic SPATA22 LOH?,freq_cnv_loss_or_gain
+310,LCN15,E21V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic LCN15 LOH?,freq_cnv_loss_or_gain
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic DCAF4L2 LOH?,freq_cnv_loss_or_gain
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic GUK1 LOH?,freq_cnv_loss_or_gain
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic GUK1 LOH?,freq_cnv_loss_or_gain
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic GUK1 LOH?,freq_cnv_loss_or_gain
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic GUK1 LOH?,freq_cnv_loss_or_gain
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic GUK1 LOH?,freq_cnv_loss_or_gain
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic MORF4L1 LOH?,freq_cnv_loss_or_gain
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic MORF4L1 LOH?,freq_cnv_loss_or_gain
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic MORF4L1 LOH?,freq_cnv_loss_or_gain
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic MORF4L1 LOH?,freq_cnv_loss_or_gain
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic MYO3B LOH?,freq_cnv_loss_or_gain
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic MYO3B LOH?,freq_cnv_loss_or_gain
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic TENT5A LOH?,freq_cnv_loss_or_gain
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic TENT5A LOH?,freq_cnv_loss_or_gain
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic TENT5A LOH?,freq_cnv_loss_or_gain
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma patients have somatic ZFAT LOH?,freq_cnv_loss_or_gain
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma patients have somatic ZFAT LOH?,freq_cnv_loss_or_gain
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma patients have somatic ZFAT LOH?,freq_cnv_loss_or_gain
+357,ZNF584,A211T,Sarcoma,What percentage of Sarcoma patients have somatic ZNF584 LOH?,freq_cnv_loss_or_gain
+358,ZNF584,A256T,Sarcoma,What percentage of Sarcoma patients have somatic ZNF584 LOH?,freq_cnv_loss_or_gain
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic LDOC1 LOH?,freq_cnv_loss_or_gain
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic PDGFC LOH?,freq_cnv_loss_or_gain
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic MSANTD4 LOH?,freq_cnv_loss_or_gain
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic NPSR1 LOH?,freq_cnv_loss_or_gain
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic PHLPP1 LOH?,freq_cnv_loss_or_gain
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic COL6A3 LOH?,freq_cnv_loss_or_gain
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic COL6A3 LOH?,freq_cnv_loss_or_gain
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic COL6A3 LOH?,freq_cnv_loss_or_gain
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic COL6A3 LOH?,freq_cnv_loss_or_gain
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic COL6A3 LOH?,freq_cnv_loss_or_gain
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic ADRA1A LOH?,freq_cnv_loss_or_gain
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have somatic LAMB2 LOH?,freq_cnv_loss_or_gain
+406,POC1B,I198T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have somatic POC1B LOH?,freq_cnv_loss_or_gain
+407,POC1B,I286T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have somatic POC1B LOH?,freq_cnv_loss_or_gain
+408,POC1B,I328T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have somatic POC1B LOH?,freq_cnv_loss_or_gain
+409,POC1B,S79P,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have somatic POC1B LOH?,freq_cnv_loss_or_gain
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma patients have somatic USH2A LOH?,freq_cnv_loss_or_gain
+414,AQP7,T110S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have somatic AQP7 LOH?,freq_cnv_loss_or_gain
+415,AQP7,T166S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have somatic AQP7 LOH?,freq_cnv_loss_or_gain
+416,AQP7,T167S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have somatic AQP7 LOH?,freq_cnv_loss_or_gain
+417,AQP7,T75S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have somatic AQP7 LOH?,freq_cnv_loss_or_gain
+430,DCN,R163C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have somatic DCN LOH?,freq_cnv_loss_or_gain
+431,DCN,R203C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have somatic DCN LOH?,freq_cnv_loss_or_gain
+432,DCN,R241C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have somatic DCN LOH?,freq_cnv_loss_or_gain
+433,DCN,R350C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have somatic DCN LOH?,freq_cnv_loss_or_gain
+434,DCN,R41C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have somatic DCN LOH?,freq_cnv_loss_or_gain
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic CPS1 LOH?,freq_cnv_loss_or_gain
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic CPS1 LOH?,freq_cnv_loss_or_gain
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic CPS1 LOH?,freq_cnv_loss_or_gain
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma patients have somatic FCGR2C LOH?,freq_cnv_loss_or_gain
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma patients have somatic FCGR2C LOH?,freq_cnv_loss_or_gain
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic GRM1 LOH?,freq_cnv_loss_or_gain
+482,SGCZ,Q138H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic SGCZ LOH?,freq_cnv_loss_or_gain
+483,SGCZ,Q91H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic SGCZ LOH?,freq_cnv_loss_or_gain
+485,SMO,V15M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic SMO LOH?,freq_cnv_loss_or_gain
+486,SMO,V321M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic SMO LOH?,freq_cnv_loss_or_gain
+488,CHODL,G159E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic CHODL LOH?,freq_cnv_loss_or_gain
+489,CHODL,G181E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic CHODL LOH?,freq_cnv_loss_or_gain
+490,CHODL,G200E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic CHODL LOH?,freq_cnv_loss_or_gain
+494,MYO16,P399H,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic MYO16 LOH?,freq_cnv_loss_or_gain
+495,MYO16,P421H,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic MYO16 LOH?,freq_cnv_loss_or_gain
+498,CXCR2,A98V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic CXCR2 LOH?,freq_cnv_loss_or_gain
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have somatic TMEM225 LOH?,freq_cnv_loss_or_gain
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic MAOB LOH?,freq_cnv_loss_or_gain
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic GPRASP1 LOH?,freq_cnv_loss_or_gain
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic MRPL32 LOH?,freq_cnv_loss_or_gain
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic TYROBP LOH?,freq_cnv_loss_or_gain
+510,RAB40C,A111V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic RAB40C LOH?,freq_cnv_loss_or_gain
+511,RAB40C,A143V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic RAB40C LOH?,freq_cnv_loss_or_gain
+512,CTNNA2,S323R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic CTNNA2 LOH?,freq_cnv_loss_or_gain
+513,CTNNA2,S339R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic CTNNA2 LOH?,freq_cnv_loss_or_gain
+514,CTNNA2,S386R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic CTNNA2 LOH?,freq_cnv_loss_or_gain
+515,CTNNA2,S707R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic CTNNA2 LOH?,freq_cnv_loss_or_gain
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have somatic MYO15A LOH?,freq_cnv_loss_or_gain
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic GIMAP2 LOH?,freq_cnv_loss_or_gain
+532,KIF20B,N1160D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme patients have somatic KIF20B LOH?,freq_cnv_loss_or_gain
+533,KIF20B,N1200D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme patients have somatic KIF20B LOH?,freq_cnv_loss_or_gain
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic ADAM17 LOH?,freq_cnv_loss_or_gain
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic BCAT1 LOH?,freq_cnv_loss_or_gain
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic BCAT1 LOH?,freq_cnv_loss_or_gain
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic BCAT1 LOH?,freq_cnv_loss_or_gain
+540,ERCC6,R1053H,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic ERCC6 LOH?,freq_cnv_loss_or_gain
+541,DCC,R320W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have somatic DCC LOH?,freq_cnv_loss_or_gain
+542,DCC,R363W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have somatic DCC LOH?,freq_cnv_loss_or_gain
+543,DCC,R386W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have somatic DCC LOH?,freq_cnv_loss_or_gain
+544,DCC,R41W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have somatic DCC LOH?,freq_cnv_loss_or_gain
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic FBXO15 LOH?,freq_cnv_loss_or_gain
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic FBXO15 LOH?,freq_cnv_loss_or_gain
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic GSTCD LOH?,freq_cnv_loss_or_gain
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic GSTCD LOH?,freq_cnv_loss_or_gain
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic OLFML3 LOH?,freq_cnv_loss_or_gain
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic OLFML3 LOH?,freq_cnv_loss_or_gain
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic OLFML3 LOH?,freq_cnv_loss_or_gain
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma patients have somatic CFAP61 LOH?,freq_cnv_loss_or_gain
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma patients have somatic CFAP61 LOH?,freq_cnv_loss_or_gain
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have somatic HLA-DQA2 LOH?,freq_cnv_loss_or_gain
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic TENM2 LOH?,freq_cnv_loss_or_gain
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic TENM2 LOH?,freq_cnv_loss_or_gain
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic TENM2 LOH?,freq_cnv_loss_or_gain
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic ANKRD24 LOH?,freq_cnv_loss_or_gain
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic ANKRD24 LOH?,freq_cnv_loss_or_gain
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic ANKRD24 LOH?,freq_cnv_loss_or_gain
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic ZCCHC14 LOH?,freq_cnv_loss_or_gain
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic ZCCHC14 LOH?,freq_cnv_loss_or_gain
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic ZCCHC14 LOH?,freq_cnv_loss_or_gain
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic ZCCHC14 LOH?,freq_cnv_loss_or_gain
+625,SIK2,I265M,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic SIK2 LOH?,freq_cnv_loss_or_gain
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic MYH11 LOH?,freq_cnv_loss_or_gain
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic MYH11 LOH?,freq_cnv_loss_or_gain
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic SLC6A4 LOH?,freq_cnv_loss_or_gain
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic SLC9C1 LOH?,freq_cnv_loss_or_gain
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic SLC9C1 LOH?,freq_cnv_loss_or_gain
+644,OR2A12,A254T,Brain Lower Grade Glioma,What percentage of Brain Lower Grade Glioma patients have somatic OR2A12 LOH?,freq_cnv_loss_or_gain
+646,PYHIN1,T325K,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic PYHIN1 LOH?,freq_cnv_loss_or_gain
+647,PYHIN1,T334K,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic PYHIN1 LOH?,freq_cnv_loss_or_gain
+650,JAML,G191E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic JAML LOH?,freq_cnv_loss_or_gain
+651,JAML,G219E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic JAML LOH?,freq_cnv_loss_or_gain
+652,JAML,G220E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic JAML LOH?,freq_cnv_loss_or_gain
+653,JAML,G230E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic JAML LOH?,freq_cnv_loss_or_gain
+658,TYK2,H1146R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic TYK2 LOH?,freq_cnv_loss_or_gain
+659,TYK2,H23R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic TYK2 LOH?,freq_cnv_loss_or_gain
+660,TYK2,H961R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic TYK2 LOH?,freq_cnv_loss_or_gain
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic CTCFL LOH?,freq_cnv_loss_or_gain
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic CTCFL LOH?,freq_cnv_loss_or_gain
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic CTCFL LOH?,freq_cnv_loss_or_gain
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic CTCFL LOH?,freq_cnv_loss_or_gain
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic CEP20 LOH?,freq_cnv_loss_or_gain
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic CEP20 LOH?,freq_cnv_loss_or_gain
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic RIMS2 LOH?,freq_cnv_loss_or_gain
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic RIMS2 LOH?,freq_cnv_loss_or_gain
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic RIMS2 LOH?,freq_cnv_loss_or_gain
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic RIMS2 LOH?,freq_cnv_loss_or_gain
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic RIMS2 LOH?,freq_cnv_loss_or_gain
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic RIMS2 LOH?,freq_cnv_loss_or_gain
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic RIMS2 LOH?,freq_cnv_loss_or_gain
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic PIK3C2G LOH?,freq_cnv_loss_or_gain
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic PIK3C2G LOH?,freq_cnv_loss_or_gain
+728,STK19,D341N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic STK19 LOH?,freq_cnv_loss_or_gain
+729,STK19,D345N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic STK19 LOH?,freq_cnv_loss_or_gain
+730,REXO4,P60A,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic REXO4 LOH?,freq_cnv_loss_or_gain
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic ZBTB34 LOH?,freq_cnv_loss_or_gain
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic ZBTB34 LOH?,freq_cnv_loss_or_gain
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have somatic NCKAP5 LOH?,freq_cnv_loss_or_gain
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have somatic SORCS1 LOH?",freq_cnv_loss_or_gain
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have somatic SORCS1 LOH?",freq_cnv_loss_or_gain
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have somatic SORCS1 LOH?",freq_cnv_loss_or_gain
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have somatic SORCS1 LOH?",freq_cnv_loss_or_gain
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma patients have somatic FGF8 LOH?,freq_cnv_loss_or_gain
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma patients have somatic FGF8 LOH?,freq_cnv_loss_or_gain
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma patients have somatic FGF8 LOH?,freq_cnv_loss_or_gain
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma patients have somatic FGF8 LOH?,freq_cnv_loss_or_gain
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma patients have somatic FGF8 LOH?,freq_cnv_loss_or_gain
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What percentage of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia patients have somatic TENM3 LOH?,freq_cnv_loss_or_gain
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic AKT1 LOH?,freq_cnv_loss_or_gain
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have somatic CFAP298-TCP10L LOH?,freq_cnv_loss_or_gain
+792,GLRB,E148D,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic GLRB LOH?,freq_cnv_loss_or_gain
+793,TTN,F7636L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic TTN LOH?,freq_cnv_loss_or_gain
+794,TTN,F8563L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic TTN LOH?,freq_cnv_loss_or_gain
+795,TTN,F8880L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic TTN LOH?,freq_cnv_loss_or_gain
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic ANKRD30A LOH?,freq_cnv_loss_or_gain
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic ANKRD30A LOH?,freq_cnv_loss_or_gain
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic ANKRD30A LOH?,freq_cnv_loss_or_gain
+809,TRIM45,S177L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic TRIM45 LOH?,freq_cnv_loss_or_gain
+810,TRIM45,S224L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic TRIM45 LOH?,freq_cnv_loss_or_gain
+811,TRIM45,S281L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic TRIM45 LOH?,freq_cnv_loss_or_gain
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic CACNA1F LOH?,freq_cnv_loss_or_gain
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic CACNA1F LOH?,freq_cnv_loss_or_gain
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic CACNA1F LOH?,freq_cnv_loss_or_gain
+817,KL,R594C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic KL LOH?,freq_cnv_loss_or_gain
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma patients have somatic GUF1 LOH?,freq_cnv_loss_or_gain
+822,TAF1L,A539V,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic TAF1L LOH?,freq_cnv_loss_or_gain
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic TASOR2 LOH?,freq_cnv_loss_or_gain
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic TASOR2 LOH?,freq_cnv_loss_or_gain
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic TASOR2 LOH?,freq_cnv_loss_or_gain
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic KDM5C LOH?,freq_cnv_loss_or_gain
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic KDM5C LOH?,freq_cnv_loss_or_gain
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic KDM5C LOH?,freq_cnv_loss_or_gain
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic KDM5C LOH?,freq_cnv_loss_or_gain
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have somatic IL5RA LOH?,freq_cnv_loss_or_gain
+843,DHX16,A29V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic DHX16 LOH?,freq_cnv_loss_or_gain
+844,DHX16,A89V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic DHX16 LOH?,freq_cnv_loss_or_gain
+902,GPR158,A644V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic GPR158 LOH?,freq_cnv_loss_or_gain
+903,GPR158,A723V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic GPR158 LOH?,freq_cnv_loss_or_gain
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have somatic EIF2B4 LOH?",freq_cnv_loss_or_gain
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have somatic EIF2B4 LOH?",freq_cnv_loss_or_gain
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have somatic EIF2B4 LOH?",freq_cnv_loss_or_gain
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have somatic EIF2B4 LOH?",freq_cnv_loss_or_gain
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have somatic EIF2B4 LOH?",freq_cnv_loss_or_gain
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have somatic EIF2B4 LOH?",freq_cnv_loss_or_gain
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic AUTS2 LOH?,freq_cnv_loss_or_gain
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic AUTS2 LOH?,freq_cnv_loss_or_gain
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic AUTS2 LOH?,freq_cnv_loss_or_gain
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic AUTS2 LOH?,freq_cnv_loss_or_gain
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic AUTS2 LOH?,freq_cnv_loss_or_gain
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic AUTS2 LOH?,freq_cnv_loss_or_gain
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic AUTS2 LOH?,freq_cnv_loss_or_gain
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic AUTS2 LOH?,freq_cnv_loss_or_gain
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic AUTS2 LOH?,freq_cnv_loss_or_gain
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic AUTS2 LOH?,freq_cnv_loss_or_gain
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have somatic ACTL7B LOH?",freq_cnv_loss_or_gain
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme patients have somatic PCDHGA1 LOH?,freq_cnv_loss_or_gain
+954,TRAP1,R114W,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic TRAP1 LOH?,freq_cnv_loss_or_gain
+955,TRAP1,R61W,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic TRAP1 LOH?,freq_cnv_loss_or_gain
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic PIK3C2A LOH?,freq_cnv_loss_or_gain
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma patients have somatic KANSL1 LOH?,freq_cnv_loss_or_gain
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic ANKRD52 LOH?,freq_cnv_loss_or_gain
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic PAPPA LOH?,freq_cnv_loss_or_gain
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have somatic B3GALNT1 LOH?,freq_cnv_loss_or_gain
+982,GABRA6,G115R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic GABRA6 LOH?,freq_cnv_loss_or_gain
+983,GABRA6,G122R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic GABRA6 LOH?,freq_cnv_loss_or_gain
+984,GABRA6,G165R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic GABRA6 LOH?,freq_cnv_loss_or_gain
+985,GABRA6,G175R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic GABRA6 LOH?,freq_cnv_loss_or_gain
+986,GABRA6,G70R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic GABRA6 LOH?,freq_cnv_loss_or_gain
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic ZSCAN31 LOH?,freq_cnv_loss_or_gain
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have somatic MED16 LOH?",freq_cnv_loss_or_gain
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have somatic MED16 LOH?",freq_cnv_loss_or_gain
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma patients have somatic PTPRO LOH?,freq_cnv_loss_or_gain
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma patients have somatic PTPRO LOH?,freq_cnv_loss_or_gain
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma patients have somatic PTPRO LOH?,freq_cnv_loss_or_gain
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma patients have somatic PTPRO LOH?,freq_cnv_loss_or_gain
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma patients have somatic PTPRO LOH?,freq_cnv_loss_or_gain
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma patients have somatic PTPRO LOH?,freq_cnv_loss_or_gain
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma patients have somatic PTPRO LOH?,freq_cnv_loss_or_gain
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma patients have somatic PTPRO LOH?,freq_cnv_loss_or_gain
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic CHMP7 LOH?,freq_cnv_loss_or_gain
+1017,GPC3,I107N,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic GPC3 LOH?,freq_cnv_loss_or_gain
+1018,GPC3,I161N,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic GPC3 LOH?,freq_cnv_loss_or_gain
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have somatic TLK2 LOH?,freq_cnv_loss_or_gain
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have somatic TLK2 LOH?,freq_cnv_loss_or_gain
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have somatic TLK2 LOH?,freq_cnv_loss_or_gain
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have somatic TLK2 LOH?,freq_cnv_loss_or_gain
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients have somatic TLK2 LOH?,freq_cnv_loss_or_gain
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic ZNF217 LOH?,freq_cnv_loss_or_gain
+1038,SYT9,V275L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic SYT9 LOH?,freq_cnv_loss_or_gain
+1039,SYT9,V307L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic SYT9 LOH?,freq_cnv_loss_or_gain
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic PKHD1L1 LOH?,freq_cnv_loss_or_gain
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic MYO3A LOH?,freq_cnv_loss_or_gain
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have somatic VASN LOH?",freq_cnv_loss_or_gain
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic DNMT1 LOH?,freq_cnv_loss_or_gain
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic DNMT1 LOH?,freq_cnv_loss_or_gain
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic DNMT1 LOH?,freq_cnv_loss_or_gain
+1056,CA9,E402K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic CA9 LOH?,freq_cnv_loss_or_gain
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic TTC17 LOH?,freq_cnv_loss_or_gain
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic TTC17 LOH?,freq_cnv_loss_or_gain
+1065,PSG2,P43L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have somatic PSG2 LOH?,freq_cnv_loss_or_gain
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have somatic RIPOR2 LOH?,freq_cnv_loss_or_gain
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have somatic RIPOR2 LOH?,freq_cnv_loss_or_gain
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have somatic RIPOR2 LOH?,freq_cnv_loss_or_gain
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have somatic RIPOR2 LOH?,freq_cnv_loss_or_gain
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic DCLK3 LOH?,freq_cnv_loss_or_gain
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic DCLK3 LOH?,freq_cnv_loss_or_gain
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic MERTK LOH?,freq_cnv_loss_or_gain
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic MERTK LOH?,freq_cnv_loss_or_gain
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic MERTK LOH?,freq_cnv_loss_or_gain
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic ZFP42 LOH?,freq_cnv_loss_or_gain
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic OR13C3 LOH?,freq_cnv_loss_or_gain
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic OR13C3 LOH?,freq_cnv_loss_or_gain
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic SPAG1 LOH?,freq_cnv_loss_or_gain
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic CDKN2AIP LOH?,freq_cnv_loss_or_gain
+1093,PXN,H1016Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic PXN LOH?,freq_cnv_loss_or_gain
+1094,PXN,H359Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic PXN LOH?,freq_cnv_loss_or_gain
+1095,PXN,H492Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic PXN LOH?,freq_cnv_loss_or_gain
+1096,PXN,H524Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic PXN LOH?,freq_cnv_loss_or_gain
+1097,PXN,H526Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic PXN LOH?,freq_cnv_loss_or_gain
+1098,PXN,H540Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic PXN LOH?,freq_cnv_loss_or_gain
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic TTYH2 LOH?,freq_cnv_loss_or_gain
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic TTYH2 LOH?,freq_cnv_loss_or_gain
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic TMEM255A LOH?,freq_cnv_loss_or_gain
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic TMEM255A LOH?,freq_cnv_loss_or_gain
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic TMEM255A LOH?,freq_cnv_loss_or_gain
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have somatic TASOR2 LOH?,freq_cnv_loss_or_gain
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have somatic TASOR2 LOH?,freq_cnv_loss_or_gain
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic ICE1 LOH?,freq_cnv_loss_or_gain
+1112,MYT1,A558E,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have somatic MYT1 LOH?,freq_cnv_loss_or_gain
+1113,MYT1,A879E,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have somatic MYT1 LOH?,freq_cnv_loss_or_gain
+1114,MYT1,A906E,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have somatic MYT1 LOH?,freq_cnv_loss_or_gain
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic CX3CR1 LOH?,freq_cnv_loss_or_gain
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic CX3CR1 LOH?,freq_cnv_loss_or_gain
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma patients have somatic SPINDOC LOH?,freq_cnv_loss_or_gain
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic ART3 LOH?,freq_cnv_loss_or_gain
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic ART3 LOH?,freq_cnv_loss_or_gain
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have somatic CYP1A2 LOH?,freq_cnv_loss_or_gain
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have somatic ADRA1A LOH?",freq_cnv_loss_or_gain
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic CDH23 LOH?,freq_cnv_loss_or_gain
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic CDH23 LOH?,freq_cnv_loss_or_gain
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic KRT39 LOH?,freq_cnv_loss_or_gain
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic PDHA2 LOH?,freq_cnv_loss_or_gain
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic SLC24A2 LOH?,freq_cnv_loss_or_gain
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma patients have somatic PTPRN2 LOH?,freq_cnv_loss_or_gain
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma patients have somatic PTPRN2 LOH?,freq_cnv_loss_or_gain
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma patients have somatic PTPRN2 LOH?,freq_cnv_loss_or_gain
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma patients have somatic PTPRN2 LOH?,freq_cnv_loss_or_gain
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma patients have somatic PTPRN2 LOH?,freq_cnv_loss_or_gain
+1188,SOX21,R55L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic SOX21 LOH?,freq_cnv_loss_or_gain
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have somatic CPA6 LOH?,freq_cnv_loss_or_gain
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic GRM5 LOH?,freq_cnv_loss_or_gain
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have somatic CASZ1 LOH?",freq_cnv_loss_or_gain
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic SGIP1 LOH?,freq_cnv_loss_or_gain
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic SGIP1 LOH?,freq_cnv_loss_or_gain
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic SGIP1 LOH?,freq_cnv_loss_or_gain
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic SGIP1 LOH?,freq_cnv_loss_or_gain
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic CARMIL1 LOH?,freq_cnv_loss_or_gain
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic CARMIL1 LOH?,freq_cnv_loss_or_gain
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic ZNF431 LOH?,freq_cnv_loss_or_gain
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic ZNF431 LOH?,freq_cnv_loss_or_gain
+1234,ZNF431,R128I,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic ZNF431 LOH?,freq_cnv_loss_or_gain
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic DNAH11 LOH?,freq_cnv_loss_or_gain
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic DNAH11 LOH?,freq_cnv_loss_or_gain
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic POLD1 LOH?,freq_cnv_loss_or_gain
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma patients have somatic POLD1 LOH?,freq_cnv_loss_or_gain
+1248,TTC12,D646H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic TTC12 LOH?,freq_cnv_loss_or_gain
+1249,TTC12,D652H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic TTC12 LOH?,freq_cnv_loss_or_gain
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have somatic CNGB1 LOH?,freq_cnv_loss_or_gain
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma patients have somatic CNGB1 LOH?,freq_cnv_loss_or_gain
+1254,CTSC,E214V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic CTSC LOH?,freq_cnv_loss_or_gain
+1255,CTSC,E291V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic CTSC LOH?,freq_cnv_loss_or_gain
+1256,CTSC,E322V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic CTSC LOH?,freq_cnv_loss_or_gain
+1257,CTSC,E324V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic CTSC LOH?,freq_cnv_loss_or_gain
+1258,CTSC,E335V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic CTSC LOH?,freq_cnv_loss_or_gain
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic PRSS8 LOH?,freq_cnv_loss_or_gain
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic PRSS8 LOH?,freq_cnv_loss_or_gain
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic ARHGEF40 LOH?,freq_cnv_loss_or_gain
+1264,ACTB,A138T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have somatic ACTB LOH?,freq_cnv_loss_or_gain
+1265,ACTB,A217T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have somatic ACTB LOH?,freq_cnv_loss_or_gain
+1266,ACTB,A244T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have somatic ACTB LOH?,freq_cnv_loss_or_gain
+1267,ACTB,A260T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have somatic ACTB LOH?,freq_cnv_loss_or_gain
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme patients have somatic YY1AP1 LOH?,freq_cnv_loss_or_gain
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme patients have somatic YY1AP1 LOH?,freq_cnv_loss_or_gain
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme patients have somatic YY1AP1 LOH?,freq_cnv_loss_or_gain
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme patients have somatic YY1AP1 LOH?,freq_cnv_loss_or_gain
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme patients have somatic YY1AP1 LOH?,freq_cnv_loss_or_gain
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme patients have somatic YY1AP1 LOH?,freq_cnv_loss_or_gain
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme patients have somatic YY1AP1 LOH?,freq_cnv_loss_or_gain
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic FNDC7 LOH?,freq_cnv_loss_or_gain
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic FNDC7 LOH?,freq_cnv_loss_or_gain
+1299,TLCD5,G15V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic TLCD5 LOH?,freq_cnv_loss_or_gain
+1300,TLCD5,G37V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic TLCD5 LOH?,freq_cnv_loss_or_gain
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic POLR1G LOH?,freq_cnv_loss_or_gain
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic POLR1G LOH?,freq_cnv_loss_or_gain
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic DNAH14 LOH?,freq_cnv_loss_or_gain
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic DNAH14 LOH?,freq_cnv_loss_or_gain
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic DNAH14 LOH?,freq_cnv_loss_or_gain
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic NEXN LOH?,freq_cnv_loss_or_gain
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma patients have somatic CYB5R2 LOH?,freq_cnv_loss_or_gain
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma patients have somatic CYB5R2 LOH?,freq_cnv_loss_or_gain
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic NRAP LOH?,freq_cnv_loss_or_gain
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic NRAP LOH?,freq_cnv_loss_or_gain
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic NRAP LOH?,freq_cnv_loss_or_gain
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic CCDC22 LOH?,freq_cnv_loss_or_gain
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic DCAF6 LOH?,freq_cnv_loss_or_gain
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic DCAF6 LOH?,freq_cnv_loss_or_gain
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic ZNF708 LOH?,freq_cnv_loss_or_gain
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic BFAR LOH?,freq_cnv_loss_or_gain
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic MAST4 LOH?,freq_cnv_loss_or_gain
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic MAST4 LOH?,freq_cnv_loss_or_gain
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic MAST4 LOH?,freq_cnv_loss_or_gain
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic MAST4 LOH?,freq_cnv_loss_or_gain
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic MAST4 LOH?,freq_cnv_loss_or_gain
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic ARMC3 LOH?,freq_cnv_loss_or_gain
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic ARMC3 LOH?,freq_cnv_loss_or_gain
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma patients have somatic TET2 LOH?,freq_cnv_loss_or_gain
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma patients have somatic TET2 LOH?,freq_cnv_loss_or_gain
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic SERPINB10 LOH?,freq_cnv_loss_or_gain
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic STAT3 LOH?,freq_cnv_loss_or_gain
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic MIEF1 LOH?,freq_cnv_loss_or_gain
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic ACVR1B LOH?,freq_cnv_loss_or_gain
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic ACVR1B LOH?,freq_cnv_loss_or_gain
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic ACVR1B LOH?,freq_cnv_loss_or_gain
+1393,EBF2,T104I,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic EBF2 LOH?,freq_cnv_loss_or_gain
+1394,EBF2,T252I,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic EBF2 LOH?,freq_cnv_loss_or_gain
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic VPS26B LOH?,freq_cnv_loss_or_gain
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have somatic PGR LOH?",freq_cnv_loss_or_gain
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have somatic PGR LOH?",freq_cnv_loss_or_gain
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients have somatic PGR LOH?",freq_cnv_loss_or_gain
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma patients have somatic ACTA2 LOH?,freq_cnv_loss_or_gain
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic THBS4 LOH?,freq_cnv_loss_or_gain
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic THBS4 LOH?,freq_cnv_loss_or_gain
+1413,PRSS1,S114T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic PRSS1 LOH?,freq_cnv_loss_or_gain
+1414,PRSS1,S124T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic PRSS1 LOH?,freq_cnv_loss_or_gain
+1415,PRSS1,S138T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic PRSS1 LOH?,freq_cnv_loss_or_gain
+1416,PRSS1,S74T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma patients have somatic PRSS1 LOH?,freq_cnv_loss_or_gain
+1417,PGF,R126H,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic PGF LOH?,freq_cnv_loss_or_gain
+1418,PGF,R127H,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma patients have somatic PGF LOH?,freq_cnv_loss_or_gain
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have somatic ITPRID2 LOH?,freq_cnv_loss_or_gain
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma patients have somatic ITPRID2 LOH?,freq_cnv_loss_or_gain
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic HBB LOH?,freq_cnv_loss_or_gain
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic PCDHB2 LOH?,freq_cnv_loss_or_gain
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic PCDHB2 LOH?,freq_cnv_loss_or_gain
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma patients have somatic PCDHB2 LOH?,freq_cnv_loss_or_gain
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma patients have somatic UBR2 LOH?,freq_cnv_loss_or_gain
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma patients have somatic FBXO42 LOH?,freq_cnv_loss_or_gain
+1,TNS1,G1362V,Breast Invasive Carcinoma,How often is TNS1 LOH observed in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+2,TNS1,G1711V,Breast Invasive Carcinoma,How often is TNS1 LOH observed in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+3,TNS1,G1718V,Breast Invasive Carcinoma,How often is TNS1 LOH observed in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+4,TNS1,G1732V,Breast Invasive Carcinoma,How often is TNS1 LOH observed in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+5,TNS1,G1824V,Breast Invasive Carcinoma,How often is TNS1 LOH observed in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+6,TNS1,G1857V,Breast Invasive Carcinoma,How often is TNS1 LOH observed in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+7,TNS1,G843V,Breast Invasive Carcinoma,How often is TNS1 LOH observed in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How often is EVC2 LOH observed in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How often is EVC2 LOH observed in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How often is CR1 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How often is CR1 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+22,TRPA1,S295I,Rectum Adenocarcinoma,How often is TRPA1 LOH observed in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+23,TRPA1,S443I,Rectum Adenocarcinoma,How often is TRPA1 LOH observed in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+24,TAF1C,R299L,Lung Adenocarcinoma,How often is TAF1C LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+25,TAF1C,R396L,Lung Adenocarcinoma,How often is TAF1C LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+26,TAF1C,R634L,Lung Adenocarcinoma,How often is TAF1C LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+27,TAF1C,R702L,Lung Adenocarcinoma,How often is TAF1C LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+28,TAF1C,R728L,Lung Adenocarcinoma,How often is TAF1C LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How often is DPF3 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How often is DPF3 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How often is DPF3 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+42,OR2T4,P272H,Lung Adenocarcinoma,How often is OR2T4 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+43,OR2T4,P300H,Lung Adenocarcinoma,How often is OR2T4 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How often is FBN1 LOH observed in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How often is MAD1L1 LOH observed in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How often is MAD1L1 LOH observed in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How often is MAD1L1 LOH observed in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How often is CCNG1 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How often is ANP32E LOH observed in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How often is ANP32E LOH observed in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How often is ANP32E LOH observed in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How often is ANP32E LOH observed in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How often is FRY LOH observed in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How often is FRY LOH observed in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How often is FRY LOH observed in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How often is FRY LOH observed in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+70,PAK3,E318K,Skin Cutaneous Melanoma,How often is PAK3 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+71,PAK3,E319K,Skin Cutaneous Melanoma,How often is PAK3 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+72,PAK3,E334K,Skin Cutaneous Melanoma,How often is PAK3 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+73,PAK3,E340K,Skin Cutaneous Melanoma,How often is PAK3 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+74,PAK3,E355K,Skin Cutaneous Melanoma,How often is PAK3 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How often is MUC16 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How often is ZFPM2 LOH observed in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How often is ZFPM2 LOH observed in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How often is PIK3C2B LOH observed in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How often is PIK3C2B LOH observed in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How often is ZNF804A LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+116,RELN,A2371V,Stomach Adenocarcinoma,How often is RELN LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is EFCAB12 LOH observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is EFCAB12 LOH observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How often is DEFB115 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How often is ANKDD1A LOH observed in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How often is ANKDD1A LOH observed in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How often is ANKDD1A LOH observed in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How often is HTR3B LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How often is HTR3B LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How often is HTR3B LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+129,ABCC3,R758W,Stomach Adenocarcinoma,How often is ABCC3 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How often is NOMO1 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How often is NOMO1 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How often is HYOU1 LOH observed in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How often is FMO4 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+140,BICC1,A372V,Exceptional Responders,How often is BICC1 LOH observed in Exceptional Responders?,freq_cnv_loss_or_gain
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How often is ZMYM3 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How often is ZMYM3 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How often is ZMYM3 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is XKR4 LOH observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How often is ABCC2 LOH observed in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+157,OR8K5,R293G,Lung Adenocarcinoma,How often is OR8K5 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How often is SPTAN1 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How often is SPTAN1 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+164,SYT10,M484I,Rectum Adenocarcinoma,How often is SYT10 LOH observed in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How often is HSPA5 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+175,UNC5D,L280V,Lung Adenocarcinoma,How often is UNC5D LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+176,UNC5D,L635V,Lung Adenocarcinoma,How often is UNC5D LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+177,UNC5D,L637V,Lung Adenocarcinoma,How often is UNC5D LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+178,UNC5D,L699V,Lung Adenocarcinoma,How often is UNC5D LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+179,UNC5D,L704V,Lung Adenocarcinoma,How often is UNC5D LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+180,UNC5D,L709V,Lung Adenocarcinoma,How often is UNC5D LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How often is DOCK2 LOH observed in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How often is ZNF627 LOH observed in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How often is CDC42BPA LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+193,MRPL55,H27Y,Colon Adenocarcinoma,How often is MRPL55 LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+194,MRPL55,H63Y,Colon Adenocarcinoma,How often is MRPL55 LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How often is TMTC3 LOH observed in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+198,EPRS1,K771I,Colon Adenocarcinoma,How often is EPRS1 LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+199,EPRS1,K778I,Colon Adenocarcinoma,How often is EPRS1 LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How often is GRTP1 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How often is GRTP1 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How often is TSHZ3 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How often is TAS1R3 LOH observed in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,freq_cnv_loss_or_gain
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How often is PIAS3 LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How often is PIAS3 LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+251,ZNF274,P13R,Stomach Adenocarcinoma,How often is ZNF274 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+253,SYNJ1,R795C,Colon Adenocarcinoma,How often is SYNJ1 LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+254,SYNJ1,R800C,Colon Adenocarcinoma,How often is SYNJ1 LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+255,SYNJ1,R839C,Colon Adenocarcinoma,How often is SYNJ1 LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+261,DSCAM,V343M,Prostate Adenocarcinoma,How often is DSCAM LOH observed in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+262,DSCAM,V426M,Prostate Adenocarcinoma,How often is DSCAM LOH observed in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+263,DSCAM,V591M,Prostate Adenocarcinoma,How often is DSCAM LOH observed in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+267,DGKD,R140H,Exceptional Responders,How often is DGKD LOH observed in Exceptional Responders?,freq_cnv_loss_or_gain
+268,DGKD,R160H,Exceptional Responders,How often is DGKD LOH observed in Exceptional Responders?,freq_cnv_loss_or_gain
+269,DGKD,R204H,Exceptional Responders,How often is DGKD LOH observed in Exceptional Responders?,freq_cnv_loss_or_gain
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How often is PLEKHG6 LOH observed in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How often is PLEKHG6 LOH observed in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How often is PLEKHG6 LOH observed in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+279,WNT2,D138N,Skin Cutaneous Melanoma,How often is WNT2 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How often is GUCY2C LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How often is C7orf31 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is ZKSCAN7 LOH observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+299,OR5D14,M210L,Neuroblastoma,How often is OR5D14 LOH observed in Neuroblastoma?,freq_cnv_loss_or_gain
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How often is SPATA22 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How often is SPATA22 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How often is SPATA22 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+310,LCN15,E21V,Stomach Adenocarcinoma,How often is LCN15 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How often is DCAF4L2 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How often is GUK1 LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How often is GUK1 LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How often is GUK1 LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How often is GUK1 LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How often is GUK1 LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How often is MORF4L1 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How often is MORF4L1 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How often is MORF4L1 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How often is MORF4L1 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How often is MYO3B LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How often is MYO3B LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How often is TENT5A LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How often is TENT5A LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How often is TENT5A LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How often is ZFAT LOH observed in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How often is ZFAT LOH observed in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How often is ZFAT LOH observed in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+357,ZNF584,A211T,Sarcoma,How often is ZNF584 LOH observed in Sarcoma?,freq_cnv_loss_or_gain
+358,ZNF584,A256T,Sarcoma,How often is ZNF584 LOH observed in Sarcoma?,freq_cnv_loss_or_gain
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How often is LDOC1 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How often is PDGFC LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How often is MSANTD4 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How often is NPSR1 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How often is PHLPP1 LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How often is COL6A3 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How often is COL6A3 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How often is COL6A3 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How often is COL6A3 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How often is COL6A3 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How often is ADRA1A LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often is LAMB2 LOH observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+406,POC1B,I198T,Rectum Adenocarcinoma,How often is POC1B LOH observed in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+407,POC1B,I286T,Rectum Adenocarcinoma,How often is POC1B LOH observed in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+408,POC1B,I328T,Rectum Adenocarcinoma,How often is POC1B LOH observed in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+409,POC1B,S79P,Rectum Adenocarcinoma,How often is POC1B LOH observed in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How often is USH2A LOH observed in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+414,AQP7,T110S,Rectum Adenocarcinoma,How often is AQP7 LOH observed in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+415,AQP7,T166S,Rectum Adenocarcinoma,How often is AQP7 LOH observed in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+416,AQP7,T167S,Rectum Adenocarcinoma,How often is AQP7 LOH observed in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+417,AQP7,T75S,Rectum Adenocarcinoma,How often is AQP7 LOH observed in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+430,DCN,R163C,Rectum Adenocarcinoma,How often is DCN LOH observed in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+431,DCN,R203C,Rectum Adenocarcinoma,How often is DCN LOH observed in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+432,DCN,R241C,Rectum Adenocarcinoma,How often is DCN LOH observed in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+433,DCN,R350C,Rectum Adenocarcinoma,How often is DCN LOH observed in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+434,DCN,R41C,Rectum Adenocarcinoma,How often is DCN LOH observed in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How often is CPS1 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How often is CPS1 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How often is CPS1 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How often is FCGR2C LOH observed in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How often is FCGR2C LOH observed in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How often is GRM1 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+482,SGCZ,Q138H,Lung Adenocarcinoma,How often is SGCZ LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+483,SGCZ,Q91H,Lung Adenocarcinoma,How often is SGCZ LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+485,SMO,V15M,Stomach Adenocarcinoma,How often is SMO LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+486,SMO,V321M,Stomach Adenocarcinoma,How often is SMO LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+488,CHODL,G159E,Skin Cutaneous Melanoma,How often is CHODL LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+489,CHODL,G181E,Skin Cutaneous Melanoma,How often is CHODL LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+490,CHODL,G200E,Skin Cutaneous Melanoma,How often is CHODL LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+494,MYO16,P399H,Colon Adenocarcinoma,How often is MYO16 LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+495,MYO16,P421H,Colon Adenocarcinoma,How often is MYO16 LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+498,CXCR2,A98V,Stomach Adenocarcinoma,How often is CXCR2 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How often is TMEM225 LOH observed in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How often is MAOB LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How often is GPRASP1 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How often is MRPL32 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How often is TYROBP LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+510,RAB40C,A111V,Lung Adenocarcinoma,How often is RAB40C LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+511,RAB40C,A143V,Lung Adenocarcinoma,How often is RAB40C LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+512,CTNNA2,S323R,Lung Adenocarcinoma,How often is CTNNA2 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+513,CTNNA2,S339R,Lung Adenocarcinoma,How often is CTNNA2 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+514,CTNNA2,S386R,Lung Adenocarcinoma,How often is CTNNA2 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+515,CTNNA2,S707R,Lung Adenocarcinoma,How often is CTNNA2 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How often is MYO15A LOH observed in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How often is GIMAP2 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+532,KIF20B,N1160D,Glioblastoma Multiforme,How often is KIF20B LOH observed in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+533,KIF20B,N1200D,Glioblastoma Multiforme,How often is KIF20B LOH observed in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How often is ADAM17 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How often is BCAT1 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How often is BCAT1 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How often is BCAT1 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+540,ERCC6,R1053H,Colon Adenocarcinoma,How often is ERCC6 LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+541,DCC,R320W,Breast Invasive Carcinoma,How often is DCC LOH observed in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+542,DCC,R363W,Breast Invasive Carcinoma,How often is DCC LOH observed in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+543,DCC,R386W,Breast Invasive Carcinoma,How often is DCC LOH observed in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+544,DCC,R41W,Breast Invasive Carcinoma,How often is DCC LOH observed in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How often is FBXO15 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How often is FBXO15 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How often is GSTCD LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How often is GSTCD LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How often is OLFML3 LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How often is OLFML3 LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How often is OLFML3 LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How often is CFAP61 LOH observed in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How often is CFAP61 LOH observed in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How often is HLA-DQA2 LOH observed in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How often is TENM2 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How often is TENM2 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How often is TENM2 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How often is ANKRD24 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How often is ANKRD24 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How often is ANKRD24 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How often is ZCCHC14 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How often is ZCCHC14 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How often is ZCCHC14 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How often is ZCCHC14 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+625,SIK2,I265M,Lung Adenocarcinoma,How often is SIK2 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How often is MYH11 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How often is MYH11 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How often is SLC6A4 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How often is SLC9C1 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How often is SLC9C1 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+644,OR2A12,A254T,Brain Lower Grade Glioma,How often is OR2A12 LOH observed in Brain Lower Grade Glioma?,freq_cnv_loss_or_gain
+646,PYHIN1,T325K,Lung Adenocarcinoma,How often is PYHIN1 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+647,PYHIN1,T334K,Lung Adenocarcinoma,How often is PYHIN1 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+650,JAML,G191E,Skin Cutaneous Melanoma,How often is JAML LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+651,JAML,G219E,Skin Cutaneous Melanoma,How often is JAML LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+652,JAML,G220E,Skin Cutaneous Melanoma,How often is JAML LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+653,JAML,G230E,Skin Cutaneous Melanoma,How often is JAML LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+658,TYK2,H1146R,Stomach Adenocarcinoma,How often is TYK2 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+659,TYK2,H23R,Stomach Adenocarcinoma,How often is TYK2 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+660,TYK2,H961R,Stomach Adenocarcinoma,How often is TYK2 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How often is CTCFL LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How often is CTCFL LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How often is CTCFL LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How often is CTCFL LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How often is CEP20 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How often is CEP20 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How often is RIMS2 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How often is RIMS2 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How often is RIMS2 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How often is RIMS2 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How often is RIMS2 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How often is RIMS2 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How often is RIMS2 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How often is PIK3C2G LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How often is PIK3C2G LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+728,STK19,D341N,Colon Adenocarcinoma,How often is STK19 LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+729,STK19,D345N,Colon Adenocarcinoma,How often is STK19 LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+730,REXO4,P60A,Skin Cutaneous Melanoma,How often is REXO4 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How often is ZBTB34 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How often is ZBTB34 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How often is NCKAP5 LOH observed in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is SORCS1 LOH observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is SORCS1 LOH observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is SORCS1 LOH observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is SORCS1 LOH observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How often is FGF8 LOH observed in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How often is FGF8 LOH observed in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How often is FGF8 LOH observed in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How often is FGF8 LOH observed in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How often is FGF8 LOH observed in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How often is TENM3 LOH observed in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,freq_cnv_loss_or_gain
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How often is AKT1 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often is CFAP298-TCP10L LOH observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+792,GLRB,E148D,Stomach Adenocarcinoma,How often is GLRB LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+793,TTN,F7636L,Colon Adenocarcinoma,How often is TTN LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+794,TTN,F8563L,Colon Adenocarcinoma,How often is TTN LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+795,TTN,F8880L,Colon Adenocarcinoma,How often is TTN LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How often is ANKRD30A LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How often is ANKRD30A LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How often is ANKRD30A LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+809,TRIM45,S177L,Colon Adenocarcinoma,How often is TRIM45 LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+810,TRIM45,S224L,Colon Adenocarcinoma,How often is TRIM45 LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+811,TRIM45,S281L,Colon Adenocarcinoma,How often is TRIM45 LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How often is CACNA1F LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How often is CACNA1F LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How often is CACNA1F LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+817,KL,R594C,Colon Adenocarcinoma,How often is KL LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How often is GUF1 LOH observed in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+822,TAF1L,A539V,Colon Adenocarcinoma,How often is TAF1L LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How often is TASOR2 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How often is TASOR2 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How often is TASOR2 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How often is KDM5C LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How often is KDM5C LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How often is KDM5C LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How often is KDM5C LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often is IL5RA LOH observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+843,DHX16,A29V,Skin Cutaneous Melanoma,How often is DHX16 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+844,DHX16,A89V,Skin Cutaneous Melanoma,How often is DHX16 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+902,GPR158,A644V,Stomach Adenocarcinoma,How often is GPR158 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+903,GPR158,A723V,Stomach Adenocarcinoma,How often is GPR158 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is EIF2B4 LOH observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is EIF2B4 LOH observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is EIF2B4 LOH observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is EIF2B4 LOH observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is EIF2B4 LOH observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is EIF2B4 LOH observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How often is AUTS2 LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How often is AUTS2 LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How often is AUTS2 LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How often is AUTS2 LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How often is AUTS2 LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How often is AUTS2 LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How often is AUTS2 LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How often is AUTS2 LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How often is AUTS2 LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How often is AUTS2 LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is ACTL7B LOH observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How often is PCDHGA1 LOH observed in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+954,TRAP1,R114W,Stomach Adenocarcinoma,How often is TRAP1 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+955,TRAP1,R61W,Stomach Adenocarcinoma,How often is TRAP1 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How often is PIK3C2A LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How often is KANSL1 LOH observed in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How often is ANKRD52 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How often is PAPPA LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How often is B3GALNT1 LOH observed in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+982,GABRA6,G115R,Lung Adenocarcinoma,How often is GABRA6 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+983,GABRA6,G122R,Lung Adenocarcinoma,How often is GABRA6 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+984,GABRA6,G165R,Lung Adenocarcinoma,How often is GABRA6 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+985,GABRA6,G175R,Lung Adenocarcinoma,How often is GABRA6 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+986,GABRA6,G70R,Lung Adenocarcinoma,How often is GABRA6 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How often is ZSCAN31 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is MED16 LOH observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is MED16 LOH observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How often is PTPRO LOH observed in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How often is PTPRO LOH observed in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How often is PTPRO LOH observed in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How often is PTPRO LOH observed in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How often is PTPRO LOH observed in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How often is PTPRO LOH observed in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How often is PTPRO LOH observed in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How often is PTPRO LOH observed in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How often is CHMP7 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1017,GPC3,I107N,Stomach Adenocarcinoma,How often is GPC3 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1018,GPC3,I161N,Stomach Adenocarcinoma,How often is GPC3 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often is TLK2 LOH observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often is TLK2 LOH observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often is TLK2 LOH observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often is TLK2 LOH observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often is TLK2 LOH observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How often is ZNF217 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1038,SYT9,V275L,Lung Adenocarcinoma,How often is SYT9 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1039,SYT9,V307L,Lung Adenocarcinoma,How often is SYT9 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How often is PKHD1L1 LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How often is MYO3A LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is VASN LOH observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How often is DNMT1 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How often is DNMT1 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How often is DNMT1 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1056,CA9,E402K,Colon Adenocarcinoma,How often is CA9 LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How often is TTC17 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How often is TTC17 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1065,PSG2,P43L,Breast Invasive Carcinoma,How often is PSG2 LOH observed in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How often is RIPOR2 LOH observed in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How often is RIPOR2 LOH observed in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How often is RIPOR2 LOH observed in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How often is RIPOR2 LOH observed in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How often is DCLK3 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How often is DCLK3 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How often is MERTK LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How often is MERTK LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How often is MERTK LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How often is ZFP42 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How often is OR13C3 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How often is OR13C3 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How often is SPAG1 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How often is CDKN2AIP LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1093,PXN,H1016Y,Colon Adenocarcinoma,How often is PXN LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1094,PXN,H359Y,Colon Adenocarcinoma,How often is PXN LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1095,PXN,H492Y,Colon Adenocarcinoma,How often is PXN LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1096,PXN,H524Y,Colon Adenocarcinoma,How often is PXN LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1097,PXN,H526Y,Colon Adenocarcinoma,How often is PXN LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1098,PXN,H540Y,Colon Adenocarcinoma,How often is PXN LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How often is TTYH2 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How often is TTYH2 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How often is TMEM255A LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How often is TMEM255A LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How often is TMEM255A LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How often is TASOR2 LOH observed in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How often is TASOR2 LOH observed in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How often is ICE1 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1112,MYT1,A558E,Breast Invasive Carcinoma,How often is MYT1 LOH observed in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1113,MYT1,A879E,Breast Invasive Carcinoma,How often is MYT1 LOH observed in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1114,MYT1,A906E,Breast Invasive Carcinoma,How often is MYT1 LOH observed in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How often is CX3CR1 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How often is CX3CR1 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How often is SPINDOC LOH observed in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How often is ART3 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How often is ART3 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How often is CYP1A2 LOH observed in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is ADRA1A LOH observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How often is CDH23 LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How often is CDH23 LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How often is KRT39 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How often is PDHA2 LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How often is SLC24A2 LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How often is PTPRN2 LOH observed in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How often is PTPRN2 LOH observed in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How often is PTPRN2 LOH observed in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How often is PTPRN2 LOH observed in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How often is PTPRN2 LOH observed in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1188,SOX21,R55L,Lung Adenocarcinoma,How often is SOX21 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How often is CPA6 LOH observed in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How often is GRM5 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is CASZ1 LOH observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How often is SGIP1 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How often is SGIP1 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How often is SGIP1 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How often is SGIP1 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How often is CARMIL1 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How often is CARMIL1 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How often is ZNF431 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How often is ZNF431 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1234,ZNF431,R128I,Lung Adenocarcinoma,How often is ZNF431 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How often is DNAH11 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How often is DNAH11 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How often is POLD1 LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How often is POLD1 LOH observed in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1248,TTC12,D646H,Lung Adenocarcinoma,How often is TTC12 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1249,TTC12,D652H,Lung Adenocarcinoma,How often is TTC12 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How often is CNGB1 LOH observed in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How often is CNGB1 LOH observed in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1254,CTSC,E214V,Stomach Adenocarcinoma,How often is CTSC LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1255,CTSC,E291V,Stomach Adenocarcinoma,How often is CTSC LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1256,CTSC,E322V,Stomach Adenocarcinoma,How often is CTSC LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1257,CTSC,E324V,Stomach Adenocarcinoma,How often is CTSC LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1258,CTSC,E335V,Stomach Adenocarcinoma,How often is CTSC LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How often is PRSS8 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How often is PRSS8 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How often is ARHGEF40 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1264,ACTB,A138T,Rectum Adenocarcinoma,How often is ACTB LOH observed in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1265,ACTB,A217T,Rectum Adenocarcinoma,How often is ACTB LOH observed in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1266,ACTB,A244T,Rectum Adenocarcinoma,How often is ACTB LOH observed in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1267,ACTB,A260T,Rectum Adenocarcinoma,How often is ACTB LOH observed in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How often is YY1AP1 LOH observed in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How often is YY1AP1 LOH observed in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How often is YY1AP1 LOH observed in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How often is YY1AP1 LOH observed in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How often is YY1AP1 LOH observed in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How often is YY1AP1 LOH observed in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How often is YY1AP1 LOH observed in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How often is FNDC7 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How often is FNDC7 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1299,TLCD5,G15V,Lung Adenocarcinoma,How often is TLCD5 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1300,TLCD5,G37V,Lung Adenocarcinoma,How often is TLCD5 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How often is POLR1G LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How often is POLR1G LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How often is DNAH14 LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How often is DNAH14 LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How often is DNAH14 LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How often is NEXN LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How often is CYB5R2 LOH observed in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How often is CYB5R2 LOH observed in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How often is NRAP LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How often is NRAP LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How often is NRAP LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How often is CCDC22 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How often is DCAF6 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How often is DCAF6 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How often is ZNF708 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How often is BFAR LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How often is MAST4 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How often is MAST4 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How often is MAST4 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How often is MAST4 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How often is MAST4 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How often is ARMC3 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How often is ARMC3 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How often is TET2 LOH observed in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How often is TET2 LOH observed in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How often is SERPINB10 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How often is STAT3 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How often is MIEF1 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How often is ACVR1B LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How often is ACVR1B LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How often is ACVR1B LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1393,EBF2,T104I,Stomach Adenocarcinoma,How often is EBF2 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1394,EBF2,T252I,Stomach Adenocarcinoma,How often is EBF2 LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How often is VPS26B LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is PGR LOH observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is PGR LOH observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often is PGR LOH observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How often is ACTA2 LOH observed in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How often is THBS4 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How often is THBS4 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1413,PRSS1,S114T,Lung Adenocarcinoma,How often is PRSS1 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1414,PRSS1,S124T,Lung Adenocarcinoma,How often is PRSS1 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1415,PRSS1,S138T,Lung Adenocarcinoma,How often is PRSS1 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1416,PRSS1,S74T,Lung Adenocarcinoma,How often is PRSS1 LOH observed in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1417,PGF,R126H,Stomach Adenocarcinoma,How often is PGF LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1418,PGF,R127H,Stomach Adenocarcinoma,How often is PGF LOH observed in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How often is ITPRID2 LOH observed in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How often is ITPRID2 LOH observed in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How often is HBB LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How often is PCDHB2 LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How often is PCDHB2 LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How often is PCDHB2 LOH observed in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How often is UBR2 LOH observed in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How often is FBXO42 LOH observed in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1,TNS1,G1362V,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of TNS1 loss?",freq_cnv_loss_or_gain
+2,TNS1,G1711V,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of TNS1 loss?",freq_cnv_loss_or_gain
+3,TNS1,G1718V,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of TNS1 loss?",freq_cnv_loss_or_gain
+4,TNS1,G1732V,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of TNS1 loss?",freq_cnv_loss_or_gain
+5,TNS1,G1824V,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of TNS1 loss?",freq_cnv_loss_or_gain
+6,TNS1,G1857V,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of TNS1 loss?",freq_cnv_loss_or_gain
+7,TNS1,G843V,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of TNS1 loss?",freq_cnv_loss_or_gain
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of EVC2 loss?",freq_cnv_loss_or_gain
+15,EVC2,E987K,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of EVC2 loss?",freq_cnv_loss_or_gain
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of CR1 loss?",freq_cnv_loss_or_gain
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of CR1 loss?",freq_cnv_loss_or_gain
+22,TRPA1,S295I,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of TRPA1 loss?",freq_cnv_loss_or_gain
+23,TRPA1,S443I,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of TRPA1 loss?",freq_cnv_loss_or_gain
+24,TAF1C,R299L,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of TAF1C loss?",freq_cnv_loss_or_gain
+25,TAF1C,R396L,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of TAF1C loss?",freq_cnv_loss_or_gain
+26,TAF1C,R634L,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of TAF1C loss?",freq_cnv_loss_or_gain
+27,TAF1C,R702L,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of TAF1C loss?",freq_cnv_loss_or_gain
+28,TAF1C,R728L,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of TAF1C loss?",freq_cnv_loss_or_gain
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of DPF3 loss?",freq_cnv_loss_or_gain
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of DPF3 loss?",freq_cnv_loss_or_gain
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of DPF3 loss?",freq_cnv_loss_or_gain
+42,OR2T4,P272H,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of OR2T4 loss?",freq_cnv_loss_or_gain
+43,OR2T4,P300H,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of OR2T4 loss?",freq_cnv_loss_or_gain
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,"In Pancreatic Adenocarcinoma, what is the occurrence rate of FBN1 loss?",freq_cnv_loss_or_gain
+45,MAD1L1,E396K,Prostate Adenocarcinoma,"In Prostate Adenocarcinoma, what is the occurrence rate of MAD1L1 loss?",freq_cnv_loss_or_gain
+46,MAD1L1,E488K,Prostate Adenocarcinoma,"In Prostate Adenocarcinoma, what is the occurrence rate of MAD1L1 loss?",freq_cnv_loss_or_gain
+47,MAD1L1,E78K,Prostate Adenocarcinoma,"In Prostate Adenocarcinoma, what is the occurrence rate of MAD1L1 loss?",freq_cnv_loss_or_gain
+61,CCNG1,E22K,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of CCNG1 loss?",freq_cnv_loss_or_gain
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,"In Kidney Renal Papillary Cell Carcinoma, what is the occurrence rate of ANP32E loss?",freq_cnv_loss_or_gain
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,"In Kidney Renal Papillary Cell Carcinoma, what is the occurrence rate of ANP32E loss?",freq_cnv_loss_or_gain
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,"In Kidney Renal Papillary Cell Carcinoma, what is the occurrence rate of ANP32E loss?",freq_cnv_loss_or_gain
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,"In Kidney Renal Papillary Cell Carcinoma, what is the occurrence rate of ANP32E loss?",freq_cnv_loss_or_gain
+66,FRY,S1888A,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of FRY loss?",freq_cnv_loss_or_gain
+67,FRY,S1937A,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of FRY loss?",freq_cnv_loss_or_gain
+68,FRY,S1938A,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of FRY loss?",freq_cnv_loss_or_gain
+69,FRY,S1983A,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of FRY loss?",freq_cnv_loss_or_gain
+70,PAK3,E318K,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of PAK3 loss?",freq_cnv_loss_or_gain
+71,PAK3,E319K,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of PAK3 loss?",freq_cnv_loss_or_gain
+72,PAK3,E334K,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of PAK3 loss?",freq_cnv_loss_or_gain
+73,PAK3,E340K,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of PAK3 loss?",freq_cnv_loss_or_gain
+74,PAK3,E355K,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of PAK3 loss?",freq_cnv_loss_or_gain
+80,MUC16,P7963L,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MUC16 loss?",freq_cnv_loss_or_gain
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,"In Liver Hepatocellular Carcinoma, what is the occurrence rate of ZFPM2 loss?",freq_cnv_loss_or_gain
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,"In Liver Hepatocellular Carcinoma, what is the occurrence rate of ZFPM2 loss?",freq_cnv_loss_or_gain
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of PIK3C2B loss?",freq_cnv_loss_or_gain
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of PIK3C2B loss?",freq_cnv_loss_or_gain
+114,ZNF804A,S371Y,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of ZNF804A loss?",freq_cnv_loss_or_gain
+116,RELN,A2371V,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of RELN loss?",freq_cnv_loss_or_gain
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of EFCAB12 loss?",freq_cnv_loss_or_gain
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of EFCAB12 loss?",freq_cnv_loss_or_gain
+120,DEFB115,E53K,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of DEFB115 loss?",freq_cnv_loss_or_gain
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of ANKDD1A loss?",freq_cnv_loss_or_gain
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of ANKDD1A loss?",freq_cnv_loss_or_gain
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of ANKDD1A loss?",freq_cnv_loss_or_gain
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of HTR3B loss?",freq_cnv_loss_or_gain
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of HTR3B loss?",freq_cnv_loss_or_gain
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of HTR3B loss?",freq_cnv_loss_or_gain
+129,ABCC3,R758W,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of ABCC3 loss?",freq_cnv_loss_or_gain
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of NOMO1 loss?",freq_cnv_loss_or_gain
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of NOMO1 loss?",freq_cnv_loss_or_gain
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of HYOU1 loss?",freq_cnv_loss_or_gain
+139,FMO4,R500Q,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of FMO4 loss?",freq_cnv_loss_or_gain
+140,BICC1,A372V,Exceptional Responders,"In Exceptional Responders, what is the occurrence rate of BICC1 loss?",freq_cnv_loss_or_gain
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of ZMYM3 loss?",freq_cnv_loss_or_gain
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of ZMYM3 loss?",freq_cnv_loss_or_gain
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of ZMYM3 loss?",freq_cnv_loss_or_gain
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of XKR4 loss?",freq_cnv_loss_or_gain
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,"In Liver Hepatocellular Carcinoma, what is the occurrence rate of ABCC2 loss?",freq_cnv_loss_or_gain
+157,OR8K5,R293G,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of OR8K5 loss?",freq_cnv_loss_or_gain
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of SPTAN1 loss?",freq_cnv_loss_or_gain
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of SPTAN1 loss?",freq_cnv_loss_or_gain
+164,SYT10,M484I,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of SYT10 loss?",freq_cnv_loss_or_gain
+174,HSPA5,N457K,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of HSPA5 loss?",freq_cnv_loss_or_gain
+175,UNC5D,L280V,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of UNC5D loss?",freq_cnv_loss_or_gain
+176,UNC5D,L635V,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of UNC5D loss?",freq_cnv_loss_or_gain
+177,UNC5D,L637V,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of UNC5D loss?",freq_cnv_loss_or_gain
+178,UNC5D,L699V,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of UNC5D loss?",freq_cnv_loss_or_gain
+179,UNC5D,L704V,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of UNC5D loss?",freq_cnv_loss_or_gain
+180,UNC5D,L709V,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of UNC5D loss?",freq_cnv_loss_or_gain
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,"In Kidney Renal Clear Cell Carcinoma, what is the occurrence rate of DOCK2 loss?",freq_cnv_loss_or_gain
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,"In Kidney Renal Clear Cell Carcinoma, what is the occurrence rate of ZNF627 loss?",freq_cnv_loss_or_gain
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of CDC42BPA loss?",freq_cnv_loss_or_gain
+193,MRPL55,H27Y,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MRPL55 loss?",freq_cnv_loss_or_gain
+194,MRPL55,H63Y,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MRPL55 loss?",freq_cnv_loss_or_gain
+197,TMTC3,Q749K,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of TMTC3 loss?",freq_cnv_loss_or_gain
+198,EPRS1,K771I,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of EPRS1 loss?",freq_cnv_loss_or_gain
+199,EPRS1,K778I,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of EPRS1 loss?",freq_cnv_loss_or_gain
+201,GRTP1,A110V,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of GRTP1 loss?",freq_cnv_loss_or_gain
+202,GRTP1,A32V,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of GRTP1 loss?",freq_cnv_loss_or_gain
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of TSHZ3 loss?",freq_cnv_loss_or_gain
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,"In HIV+ Tumor Molecular Characterization Project - Cervical Cancer, what is the occurrence rate of TAS1R3 loss?",freq_cnv_loss_or_gain
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of PIAS3 loss?",freq_cnv_loss_or_gain
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of PIAS3 loss?",freq_cnv_loss_or_gain
+251,ZNF274,P13R,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of ZNF274 loss?",freq_cnv_loss_or_gain
+253,SYNJ1,R795C,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of SYNJ1 loss?",freq_cnv_loss_or_gain
+254,SYNJ1,R800C,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of SYNJ1 loss?",freq_cnv_loss_or_gain
+255,SYNJ1,R839C,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of SYNJ1 loss?",freq_cnv_loss_or_gain
+261,DSCAM,V343M,Prostate Adenocarcinoma,"In Prostate Adenocarcinoma, what is the occurrence rate of DSCAM loss?",freq_cnv_loss_or_gain
+262,DSCAM,V426M,Prostate Adenocarcinoma,"In Prostate Adenocarcinoma, what is the occurrence rate of DSCAM loss?",freq_cnv_loss_or_gain
+263,DSCAM,V591M,Prostate Adenocarcinoma,"In Prostate Adenocarcinoma, what is the occurrence rate of DSCAM loss?",freq_cnv_loss_or_gain
+267,DGKD,R140H,Exceptional Responders,"In Exceptional Responders, what is the occurrence rate of DGKD loss?",freq_cnv_loss_or_gain
+268,DGKD,R160H,Exceptional Responders,"In Exceptional Responders, what is the occurrence rate of DGKD loss?",freq_cnv_loss_or_gain
+269,DGKD,R204H,Exceptional Responders,"In Exceptional Responders, what is the occurrence rate of DGKD loss?",freq_cnv_loss_or_gain
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of PLEKHG6 loss?",freq_cnv_loss_or_gain
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of PLEKHG6 loss?",freq_cnv_loss_or_gain
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of PLEKHG6 loss?",freq_cnv_loss_or_gain
+279,WNT2,D138N,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of WNT2 loss?",freq_cnv_loss_or_gain
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of GUCY2C loss?",freq_cnv_loss_or_gain
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of C7orf31 loss?",freq_cnv_loss_or_gain
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of ZKSCAN7 loss?",freq_cnv_loss_or_gain
+299,OR5D14,M210L,Neuroblastoma,"In Neuroblastoma, what is the occurrence rate of OR5D14 loss?",freq_cnv_loss_or_gain
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of SPATA22 loss?",freq_cnv_loss_or_gain
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of SPATA22 loss?",freq_cnv_loss_or_gain
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of SPATA22 loss?",freq_cnv_loss_or_gain
+310,LCN15,E21V,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of LCN15 loss?",freq_cnv_loss_or_gain
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of DCAF4L2 loss?",freq_cnv_loss_or_gain
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of GUK1 loss?",freq_cnv_loss_or_gain
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of GUK1 loss?",freq_cnv_loss_or_gain
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of GUK1 loss?",freq_cnv_loss_or_gain
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of GUK1 loss?",freq_cnv_loss_or_gain
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of GUK1 loss?",freq_cnv_loss_or_gain
+328,MORF4L1,K29T,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MORF4L1 loss?",freq_cnv_loss_or_gain
+329,MORF4L1,K51T,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MORF4L1 loss?",freq_cnv_loss_or_gain
+330,MORF4L1,K61T,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MORF4L1 loss?",freq_cnv_loss_or_gain
+331,MORF4L1,K76T,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of MORF4L1 loss?",freq_cnv_loss_or_gain
+335,MYO3B,F594L,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MYO3B loss?",freq_cnv_loss_or_gain
+336,MYO3B,F603L,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of MYO3B loss?",freq_cnv_loss_or_gain
+339,TENT5A,S320F,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of TENT5A loss?",freq_cnv_loss_or_gain
+340,TENT5A,S339F,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of TENT5A loss?",freq_cnv_loss_or_gain
+341,TENT5A,S401F,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of TENT5A loss?",freq_cnv_loss_or_gain
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,"In Ovarian Serous Cystadenocarcinoma, what is the occurrence rate of ZFAT loss?",freq_cnv_loss_or_gain
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,"In Ovarian Serous Cystadenocarcinoma, what is the occurrence rate of ZFAT loss?",freq_cnv_loss_or_gain
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,"In Ovarian Serous Cystadenocarcinoma, what is the occurrence rate of ZFAT loss?",freq_cnv_loss_or_gain
+357,ZNF584,A211T,Sarcoma,"In Sarcoma, what is the occurrence rate of ZNF584 loss?",freq_cnv_loss_or_gain
+358,ZNF584,A256T,Sarcoma,"In Sarcoma, what is the occurrence rate of ZNF584 loss?",freq_cnv_loss_or_gain
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of LDOC1 loss?",freq_cnv_loss_or_gain
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of PDGFC loss?",freq_cnv_loss_or_gain
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MSANTD4 loss?",freq_cnv_loss_or_gain
+374,NPSR1,S123L,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of NPSR1 loss?",freq_cnv_loss_or_gain
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of PHLPP1 loss?",freq_cnv_loss_or_gain
+385,COL6A3,G237S,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of COL6A3 loss?",freq_cnv_loss_or_gain
+386,COL6A3,G437S,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of COL6A3 loss?",freq_cnv_loss_or_gain
+387,COL6A3,G638S,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of COL6A3 loss?",freq_cnv_loss_or_gain
+388,COL6A3,G644S,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of COL6A3 loss?",freq_cnv_loss_or_gain
+389,COL6A3,G844S,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of COL6A3 loss?",freq_cnv_loss_or_gain
+395,ADRA1A,R348G,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of ADRA1A loss?",freq_cnv_loss_or_gain
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, what is the occurrence rate of LAMB2 loss?",freq_cnv_loss_or_gain
+406,POC1B,I198T,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of POC1B loss?",freq_cnv_loss_or_gain
+407,POC1B,I286T,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of POC1B loss?",freq_cnv_loss_or_gain
+408,POC1B,I328T,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of POC1B loss?",freq_cnv_loss_or_gain
+409,POC1B,S79P,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of POC1B loss?",freq_cnv_loss_or_gain
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,"In Liver Hepatocellular Carcinoma, what is the occurrence rate of USH2A loss?",freq_cnv_loss_or_gain
+414,AQP7,T110S,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of AQP7 loss?",freq_cnv_loss_or_gain
+415,AQP7,T166S,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of AQP7 loss?",freq_cnv_loss_or_gain
+416,AQP7,T167S,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of AQP7 loss?",freq_cnv_loss_or_gain
+417,AQP7,T75S,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of AQP7 loss?",freq_cnv_loss_or_gain
+430,DCN,R163C,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of DCN loss?",freq_cnv_loss_or_gain
+431,DCN,R203C,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of DCN loss?",freq_cnv_loss_or_gain
+432,DCN,R241C,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of DCN loss?",freq_cnv_loss_or_gain
+433,DCN,R350C,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of DCN loss?",freq_cnv_loss_or_gain
+434,DCN,R41C,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of DCN loss?",freq_cnv_loss_or_gain
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of CPS1 loss?",freq_cnv_loss_or_gain
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of CPS1 loss?",freq_cnv_loss_or_gain
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of CPS1 loss?",freq_cnv_loss_or_gain
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,"In Kidney Renal Papillary Cell Carcinoma, what is the occurrence rate of FCGR2C loss?",freq_cnv_loss_or_gain
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,"In Kidney Renal Papillary Cell Carcinoma, what is the occurrence rate of FCGR2C loss?",freq_cnv_loss_or_gain
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of GRM1 loss?",freq_cnv_loss_or_gain
+482,SGCZ,Q138H,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of SGCZ loss?",freq_cnv_loss_or_gain
+483,SGCZ,Q91H,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of SGCZ loss?",freq_cnv_loss_or_gain
+485,SMO,V15M,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of SMO loss?",freq_cnv_loss_or_gain
+486,SMO,V321M,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of SMO loss?",freq_cnv_loss_or_gain
+488,CHODL,G159E,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of CHODL loss?",freq_cnv_loss_or_gain
+489,CHODL,G181E,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of CHODL loss?",freq_cnv_loss_or_gain
+490,CHODL,G200E,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of CHODL loss?",freq_cnv_loss_or_gain
+494,MYO16,P399H,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MYO16 loss?",freq_cnv_loss_or_gain
+495,MYO16,P421H,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of MYO16 loss?",freq_cnv_loss_or_gain
+498,CXCR2,A98V,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of CXCR2 loss?",freq_cnv_loss_or_gain
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of TMEM225 loss?",freq_cnv_loss_or_gain
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MAOB loss?",freq_cnv_loss_or_gain
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of GPRASP1 loss?",freq_cnv_loss_or_gain
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MRPL32 loss?",freq_cnv_loss_or_gain
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of TYROBP loss?",freq_cnv_loss_or_gain
+510,RAB40C,A111V,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of RAB40C loss?",freq_cnv_loss_or_gain
+511,RAB40C,A143V,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of RAB40C loss?",freq_cnv_loss_or_gain
+512,CTNNA2,S323R,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of CTNNA2 loss?",freq_cnv_loss_or_gain
+513,CTNNA2,S339R,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of CTNNA2 loss?",freq_cnv_loss_or_gain
+514,CTNNA2,S386R,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of CTNNA2 loss?",freq_cnv_loss_or_gain
+515,CTNNA2,S707R,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of CTNNA2 loss?",freq_cnv_loss_or_gain
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of MYO15A loss?",freq_cnv_loss_or_gain
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of GIMAP2 loss?",freq_cnv_loss_or_gain
+532,KIF20B,N1160D,Glioblastoma Multiforme,"In Glioblastoma Multiforme, what is the occurrence rate of KIF20B loss?",freq_cnv_loss_or_gain
+533,KIF20B,N1200D,Glioblastoma Multiforme,"In Glioblastoma Multiforme, what is the occurrence rate of KIF20B loss?",freq_cnv_loss_or_gain
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of ADAM17 loss?",freq_cnv_loss_or_gain
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of BCAT1 loss?",freq_cnv_loss_or_gain
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of BCAT1 loss?",freq_cnv_loss_or_gain
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of BCAT1 loss?",freq_cnv_loss_or_gain
+540,ERCC6,R1053H,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of ERCC6 loss?",freq_cnv_loss_or_gain
+541,DCC,R320W,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of DCC loss?",freq_cnv_loss_or_gain
+542,DCC,R363W,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of DCC loss?",freq_cnv_loss_or_gain
+543,DCC,R386W,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of DCC loss?",freq_cnv_loss_or_gain
+544,DCC,R41W,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of DCC loss?",freq_cnv_loss_or_gain
+549,FBXO15,D417N,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of FBXO15 loss?",freq_cnv_loss_or_gain
+550,FBXO15,D86N,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of FBXO15 loss?",freq_cnv_loss_or_gain
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of GSTCD loss?",freq_cnv_loss_or_gain
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of GSTCD loss?",freq_cnv_loss_or_gain
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of OLFML3 loss?",freq_cnv_loss_or_gain
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of OLFML3 loss?",freq_cnv_loss_or_gain
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of OLFML3 loss?",freq_cnv_loss_or_gain
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,"In Ovarian Serous Cystadenocarcinoma, what is the occurrence rate of CFAP61 loss?",freq_cnv_loss_or_gain
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,"In Ovarian Serous Cystadenocarcinoma, what is the occurrence rate of CFAP61 loss?",freq_cnv_loss_or_gain
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of HLA-DQA2 loss?",freq_cnv_loss_or_gain
+582,TENM2,H240Y,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of TENM2 loss?",freq_cnv_loss_or_gain
+583,TENM2,H351Y,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of TENM2 loss?",freq_cnv_loss_or_gain
+584,TENM2,H472Y,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of TENM2 loss?",freq_cnv_loss_or_gain
+600,ANKRD24,A465T,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of ANKRD24 loss?",freq_cnv_loss_or_gain
+601,ANKRD24,A494T,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of ANKRD24 loss?",freq_cnv_loss_or_gain
+602,ANKRD24,A584T,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of ANKRD24 loss?",freq_cnv_loss_or_gain
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of ZCCHC14 loss?",freq_cnv_loss_or_gain
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of ZCCHC14 loss?",freq_cnv_loss_or_gain
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of ZCCHC14 loss?",freq_cnv_loss_or_gain
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of ZCCHC14 loss?",freq_cnv_loss_or_gain
+625,SIK2,I265M,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of SIK2 loss?",freq_cnv_loss_or_gain
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MYH11 loss?",freq_cnv_loss_or_gain
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MYH11 loss?",freq_cnv_loss_or_gain
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of SLC6A4 loss?",freq_cnv_loss_or_gain
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of SLC9C1 loss?",freq_cnv_loss_or_gain
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of SLC9C1 loss?",freq_cnv_loss_or_gain
+644,OR2A12,A254T,Brain Lower Grade Glioma,"In Brain Lower Grade Glioma, what is the occurrence rate of OR2A12 loss?",freq_cnv_loss_or_gain
+646,PYHIN1,T325K,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of PYHIN1 loss?",freq_cnv_loss_or_gain
+647,PYHIN1,T334K,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of PYHIN1 loss?",freq_cnv_loss_or_gain
+650,JAML,G191E,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of JAML loss?",freq_cnv_loss_or_gain
+651,JAML,G219E,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of JAML loss?",freq_cnv_loss_or_gain
+652,JAML,G220E,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of JAML loss?",freq_cnv_loss_or_gain
+653,JAML,G230E,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of JAML loss?",freq_cnv_loss_or_gain
+658,TYK2,H1146R,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of TYK2 loss?",freq_cnv_loss_or_gain
+659,TYK2,H23R,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of TYK2 loss?",freq_cnv_loss_or_gain
+660,TYK2,H961R,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of TYK2 loss?",freq_cnv_loss_or_gain
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of CTCFL loss?",freq_cnv_loss_or_gain
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of CTCFL loss?",freq_cnv_loss_or_gain
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of CTCFL loss?",freq_cnv_loss_or_gain
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of CTCFL loss?",freq_cnv_loss_or_gain
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of CEP20 loss?",freq_cnv_loss_or_gain
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of CEP20 loss?",freq_cnv_loss_or_gain
+689,RIMS2,R25W,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of RIMS2 loss?",freq_cnv_loss_or_gain
+690,RIMS2,R393W,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of RIMS2 loss?",freq_cnv_loss_or_gain
+691,RIMS2,R423W,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of RIMS2 loss?",freq_cnv_loss_or_gain
+692,RIMS2,R470W,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of RIMS2 loss?",freq_cnv_loss_or_gain
+693,RIMS2,R615W,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of RIMS2 loss?",freq_cnv_loss_or_gain
+694,RIMS2,R619W,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of RIMS2 loss?",freq_cnv_loss_or_gain
+695,RIMS2,R716W,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of RIMS2 loss?",freq_cnv_loss_or_gain
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of PIK3C2G loss?",freq_cnv_loss_or_gain
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of PIK3C2G loss?",freq_cnv_loss_or_gain
+728,STK19,D341N,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of STK19 loss?",freq_cnv_loss_or_gain
+729,STK19,D345N,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of STK19 loss?",freq_cnv_loss_or_gain
+730,REXO4,P60A,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of REXO4 loss?",freq_cnv_loss_or_gain
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of ZBTB34 loss?",freq_cnv_loss_or_gain
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of ZBTB34 loss?",freq_cnv_loss_or_gain
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of NCKAP5 loss?",freq_cnv_loss_or_gain
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of SORCS1 loss?",freq_cnv_loss_or_gain
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of SORCS1 loss?",freq_cnv_loss_or_gain
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of SORCS1 loss?",freq_cnv_loss_or_gain
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of SORCS1 loss?",freq_cnv_loss_or_gain
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,"In Head and Neck Squamous Cell Carcinoma, what is the occurrence rate of FGF8 loss?",freq_cnv_loss_or_gain
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,"In Head and Neck Squamous Cell Carcinoma, what is the occurrence rate of FGF8 loss?",freq_cnv_loss_or_gain
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,"In Head and Neck Squamous Cell Carcinoma, what is the occurrence rate of FGF8 loss?",freq_cnv_loss_or_gain
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,"In Head and Neck Squamous Cell Carcinoma, what is the occurrence rate of FGF8 loss?",freq_cnv_loss_or_gain
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,"In Head and Neck Squamous Cell Carcinoma, what is the occurrence rate of FGF8 loss?",freq_cnv_loss_or_gain
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,"In Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia, what is the occurrence rate of TENM3 loss?",freq_cnv_loss_or_gain
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of AKT1 loss?",freq_cnv_loss_or_gain
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, what is the occurrence rate of CFAP298-TCP10L loss?",freq_cnv_loss_or_gain
+792,GLRB,E148D,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of GLRB loss?",freq_cnv_loss_or_gain
+793,TTN,F7636L,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of TTN loss?",freq_cnv_loss_or_gain
+794,TTN,F8563L,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of TTN loss?",freq_cnv_loss_or_gain
+795,TTN,F8880L,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of TTN loss?",freq_cnv_loss_or_gain
+799,ANKRD30A,V798I,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of ANKRD30A loss?",freq_cnv_loss_or_gain
+800,ANKRD30A,V854I,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of ANKRD30A loss?",freq_cnv_loss_or_gain
+801,ANKRD30A,V973I,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of ANKRD30A loss?",freq_cnv_loss_or_gain
+809,TRIM45,S177L,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of TRIM45 loss?",freq_cnv_loss_or_gain
+810,TRIM45,S224L,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of TRIM45 loss?",freq_cnv_loss_or_gain
+811,TRIM45,S281L,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of TRIM45 loss?",freq_cnv_loss_or_gain
+812,CACNA1F,G727V,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of CACNA1F loss?",freq_cnv_loss_or_gain
+813,CACNA1F,G781V,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of CACNA1F loss?",freq_cnv_loss_or_gain
+814,CACNA1F,G792V,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of CACNA1F loss?",freq_cnv_loss_or_gain
+817,KL,R594C,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of KL loss?",freq_cnv_loss_or_gain
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,"In Kidney Renal Papillary Cell Carcinoma, what is the occurrence rate of GUF1 loss?",freq_cnv_loss_or_gain
+822,TAF1L,A539V,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of TAF1L loss?",freq_cnv_loss_or_gain
+823,TASOR2,S256F,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of TASOR2 loss?",freq_cnv_loss_or_gain
+824,TASOR2,S36F,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of TASOR2 loss?",freq_cnv_loss_or_gain
+825,TASOR2,S471F,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of TASOR2 loss?",freq_cnv_loss_or_gain
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of KDM5C loss?",freq_cnv_loss_or_gain
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of KDM5C loss?",freq_cnv_loss_or_gain
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of KDM5C loss?",freq_cnv_loss_or_gain
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of KDM5C loss?",freq_cnv_loss_or_gain
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, what is the occurrence rate of IL5RA loss?",freq_cnv_loss_or_gain
+843,DHX16,A29V,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of DHX16 loss?",freq_cnv_loss_or_gain
+844,DHX16,A89V,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of DHX16 loss?",freq_cnv_loss_or_gain
+902,GPR158,A644V,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of GPR158 loss?",freq_cnv_loss_or_gain
+903,GPR158,A723V,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of GPR158 loss?",freq_cnv_loss_or_gain
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of EIF2B4 loss?",freq_cnv_loss_or_gain
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of EIF2B4 loss?",freq_cnv_loss_or_gain
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of EIF2B4 loss?",freq_cnv_loss_or_gain
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of EIF2B4 loss?",freq_cnv_loss_or_gain
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of EIF2B4 loss?",freq_cnv_loss_or_gain
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of EIF2B4 loss?",freq_cnv_loss_or_gain
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of AUTS2 loss?",freq_cnv_loss_or_gain
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of AUTS2 loss?",freq_cnv_loss_or_gain
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of AUTS2 loss?",freq_cnv_loss_or_gain
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of AUTS2 loss?",freq_cnv_loss_or_gain
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of AUTS2 loss?",freq_cnv_loss_or_gain
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of AUTS2 loss?",freq_cnv_loss_or_gain
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of AUTS2 loss?",freq_cnv_loss_or_gain
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of AUTS2 loss?",freq_cnv_loss_or_gain
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of AUTS2 loss?",freq_cnv_loss_or_gain
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of AUTS2 loss?",freq_cnv_loss_or_gain
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of ACTL7B loss?",freq_cnv_loss_or_gain
+952,PCDHGA1,R535W,Glioblastoma Multiforme,"In Glioblastoma Multiforme, what is the occurrence rate of PCDHGA1 loss?",freq_cnv_loss_or_gain
+954,TRAP1,R114W,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of TRAP1 loss?",freq_cnv_loss_or_gain
+955,TRAP1,R61W,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of TRAP1 loss?",freq_cnv_loss_or_gain
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of PIK3C2A loss?",freq_cnv_loss_or_gain
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,"In Liver Hepatocellular Carcinoma, what is the occurrence rate of KANSL1 loss?",freq_cnv_loss_or_gain
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of ANKRD52 loss?",freq_cnv_loss_or_gain
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of PAPPA loss?",freq_cnv_loss_or_gain
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of B3GALNT1 loss?",freq_cnv_loss_or_gain
+982,GABRA6,G115R,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of GABRA6 loss?",freq_cnv_loss_or_gain
+983,GABRA6,G122R,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of GABRA6 loss?",freq_cnv_loss_or_gain
+984,GABRA6,G165R,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of GABRA6 loss?",freq_cnv_loss_or_gain
+985,GABRA6,G175R,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of GABRA6 loss?",freq_cnv_loss_or_gain
+986,GABRA6,G70R,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of GABRA6 loss?",freq_cnv_loss_or_gain
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of ZSCAN31 loss?",freq_cnv_loss_or_gain
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of MED16 loss?",freq_cnv_loss_or_gain
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of MED16 loss?",freq_cnv_loss_or_gain
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,"In Pancreatic Adenocarcinoma, what is the occurrence rate of PTPRO loss?",freq_cnv_loss_or_gain
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,"In Pancreatic Adenocarcinoma, what is the occurrence rate of PTPRO loss?",freq_cnv_loss_or_gain
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,"In Pancreatic Adenocarcinoma, what is the occurrence rate of PTPRO loss?",freq_cnv_loss_or_gain
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,"In Pancreatic Adenocarcinoma, what is the occurrence rate of PTPRO loss?",freq_cnv_loss_or_gain
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,"In Pancreatic Adenocarcinoma, what is the occurrence rate of PTPRO loss?",freq_cnv_loss_or_gain
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,"In Pancreatic Adenocarcinoma, what is the occurrence rate of PTPRO loss?",freq_cnv_loss_or_gain
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,"In Pancreatic Adenocarcinoma, what is the occurrence rate of PTPRO loss?",freq_cnv_loss_or_gain
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,"In Pancreatic Adenocarcinoma, what is the occurrence rate of PTPRO loss?",freq_cnv_loss_or_gain
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of CHMP7 loss?",freq_cnv_loss_or_gain
+1017,GPC3,I107N,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of GPC3 loss?",freq_cnv_loss_or_gain
+1018,GPC3,I161N,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of GPC3 loss?",freq_cnv_loss_or_gain
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, what is the occurrence rate of TLK2 loss?",freq_cnv_loss_or_gain
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, what is the occurrence rate of TLK2 loss?",freq_cnv_loss_or_gain
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, what is the occurrence rate of TLK2 loss?",freq_cnv_loss_or_gain
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, what is the occurrence rate of TLK2 loss?",freq_cnv_loss_or_gain
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, what is the occurrence rate of TLK2 loss?",freq_cnv_loss_or_gain
+1036,ZNF217,E209Q,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of ZNF217 loss?",freq_cnv_loss_or_gain
+1038,SYT9,V275L,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of SYT9 loss?",freq_cnv_loss_or_gain
+1039,SYT9,V307L,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of SYT9 loss?",freq_cnv_loss_or_gain
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of PKHD1L1 loss?",freq_cnv_loss_or_gain
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MYO3A loss?",freq_cnv_loss_or_gain
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of VASN loss?",freq_cnv_loss_or_gain
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of DNMT1 loss?",freq_cnv_loss_or_gain
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of DNMT1 loss?",freq_cnv_loss_or_gain
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of DNMT1 loss?",freq_cnv_loss_or_gain
+1056,CA9,E402K,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of CA9 loss?",freq_cnv_loss_or_gain
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of TTC17 loss?",freq_cnv_loss_or_gain
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of TTC17 loss?",freq_cnv_loss_or_gain
+1065,PSG2,P43L,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of PSG2 loss?",freq_cnv_loss_or_gain
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of RIPOR2 loss?",freq_cnv_loss_or_gain
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of RIPOR2 loss?",freq_cnv_loss_or_gain
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of RIPOR2 loss?",freq_cnv_loss_or_gain
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of RIPOR2 loss?",freq_cnv_loss_or_gain
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of DCLK3 loss?",freq_cnv_loss_or_gain
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of DCLK3 loss?",freq_cnv_loss_or_gain
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MERTK loss?",freq_cnv_loss_or_gain
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MERTK loss?",freq_cnv_loss_or_gain
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of MERTK loss?",freq_cnv_loss_or_gain
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of ZFP42 loss?",freq_cnv_loss_or_gain
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of OR13C3 loss?",freq_cnv_loss_or_gain
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of OR13C3 loss?",freq_cnv_loss_or_gain
+1091,SPAG1,I917M,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of SPAG1 loss?",freq_cnv_loss_or_gain
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of CDKN2AIP loss?",freq_cnv_loss_or_gain
+1093,PXN,H1016Y,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of PXN loss?",freq_cnv_loss_or_gain
+1094,PXN,H359Y,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of PXN loss?",freq_cnv_loss_or_gain
+1095,PXN,H492Y,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of PXN loss?",freq_cnv_loss_or_gain
+1096,PXN,H524Y,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of PXN loss?",freq_cnv_loss_or_gain
+1097,PXN,H526Y,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of PXN loss?",freq_cnv_loss_or_gain
+1098,PXN,H540Y,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of PXN loss?",freq_cnv_loss_or_gain
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of TTYH2 loss?",freq_cnv_loss_or_gain
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of TTYH2 loss?",freq_cnv_loss_or_gain
+1106,TMEM255A,N205S,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of TMEM255A loss?",freq_cnv_loss_or_gain
+1107,TMEM255A,N229S,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of TMEM255A loss?",freq_cnv_loss_or_gain
+1108,TMEM255A,N65S,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of TMEM255A loss?",freq_cnv_loss_or_gain
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of TASOR2 loss?",freq_cnv_loss_or_gain
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of TASOR2 loss?",freq_cnv_loss_or_gain
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of ICE1 loss?",freq_cnv_loss_or_gain
+1112,MYT1,A558E,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of MYT1 loss?",freq_cnv_loss_or_gain
+1113,MYT1,A879E,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of MYT1 loss?",freq_cnv_loss_or_gain
+1114,MYT1,A906E,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of MYT1 loss?",freq_cnv_loss_or_gain
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of CX3CR1 loss?",freq_cnv_loss_or_gain
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of CX3CR1 loss?",freq_cnv_loss_or_gain
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,"In Liver Hepatocellular Carcinoma, what is the occurrence rate of SPINDOC loss?",freq_cnv_loss_or_gain
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of ART3 loss?",freq_cnv_loss_or_gain
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of ART3 loss?",freq_cnv_loss_or_gain
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of CYP1A2 loss?",freq_cnv_loss_or_gain
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of ADRA1A loss?",freq_cnv_loss_or_gain
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of CDH23 loss?",freq_cnv_loss_or_gain
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of CDH23 loss?",freq_cnv_loss_or_gain
+1148,KRT39,P137S,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of KRT39 loss?",freq_cnv_loss_or_gain
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of PDHA2 loss?",freq_cnv_loss_or_gain
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of SLC24A2 loss?",freq_cnv_loss_or_gain
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,"In Liver Hepatocellular Carcinoma, what is the occurrence rate of PTPRN2 loss?",freq_cnv_loss_or_gain
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,"In Liver Hepatocellular Carcinoma, what is the occurrence rate of PTPRN2 loss?",freq_cnv_loss_or_gain
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,"In Liver Hepatocellular Carcinoma, what is the occurrence rate of PTPRN2 loss?",freq_cnv_loss_or_gain
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,"In Liver Hepatocellular Carcinoma, what is the occurrence rate of PTPRN2 loss?",freq_cnv_loss_or_gain
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,"In Liver Hepatocellular Carcinoma, what is the occurrence rate of PTPRN2 loss?",freq_cnv_loss_or_gain
+1188,SOX21,R55L,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of SOX21 loss?",freq_cnv_loss_or_gain
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of CPA6 loss?",freq_cnv_loss_or_gain
+1206,GRM5,E14K,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of GRM5 loss?",freq_cnv_loss_or_gain
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of CASZ1 loss?",freq_cnv_loss_or_gain
+1210,SGIP1,N122T,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of SGIP1 loss?",freq_cnv_loss_or_gain
+1211,SGIP1,N420T,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of SGIP1 loss?",freq_cnv_loss_or_gain
+1212,SGIP1,N617T,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of SGIP1 loss?",freq_cnv_loss_or_gain
+1213,SGIP1,N648T,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of SGIP1 loss?",freq_cnv_loss_or_gain
+1227,CARMIL1,V549L,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of CARMIL1 loss?",freq_cnv_loss_or_gain
+1228,CARMIL1,V949L,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of CARMIL1 loss?",freq_cnv_loss_or_gain
+1232,ZNF431,D121Y,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of ZNF431 loss?",freq_cnv_loss_or_gain
+1233,ZNF431,D161Y,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of ZNF431 loss?",freq_cnv_loss_or_gain
+1234,ZNF431,R128I,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of ZNF431 loss?",freq_cnv_loss_or_gain
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of DNAH11 loss?",freq_cnv_loss_or_gain
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of DNAH11 loss?",freq_cnv_loss_or_gain
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of POLD1 loss?",freq_cnv_loss_or_gain
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,"In Lung Squamous Cell Carcinoma, what is the occurrence rate of POLD1 loss?",freq_cnv_loss_or_gain
+1248,TTC12,D646H,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of TTC12 loss?",freq_cnv_loss_or_gain
+1249,TTC12,D652H,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of TTC12 loss?",freq_cnv_loss_or_gain
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of CNGB1 loss?",freq_cnv_loss_or_gain
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,"In Bladder Urothelial Carcinoma, what is the occurrence rate of CNGB1 loss?",freq_cnv_loss_or_gain
+1254,CTSC,E214V,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of CTSC loss?",freq_cnv_loss_or_gain
+1255,CTSC,E291V,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of CTSC loss?",freq_cnv_loss_or_gain
+1256,CTSC,E322V,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of CTSC loss?",freq_cnv_loss_or_gain
+1257,CTSC,E324V,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of CTSC loss?",freq_cnv_loss_or_gain
+1258,CTSC,E335V,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of CTSC loss?",freq_cnv_loss_or_gain
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of PRSS8 loss?",freq_cnv_loss_or_gain
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of PRSS8 loss?",freq_cnv_loss_or_gain
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of ARHGEF40 loss?",freq_cnv_loss_or_gain
+1264,ACTB,A138T,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of ACTB loss?",freq_cnv_loss_or_gain
+1265,ACTB,A217T,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of ACTB loss?",freq_cnv_loss_or_gain
+1266,ACTB,A244T,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of ACTB loss?",freq_cnv_loss_or_gain
+1267,ACTB,A260T,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of ACTB loss?",freq_cnv_loss_or_gain
+1268,YY1AP1,V546D,Glioblastoma Multiforme,"In Glioblastoma Multiforme, what is the occurrence rate of YY1AP1 loss?",freq_cnv_loss_or_gain
+1269,YY1AP1,V557D,Glioblastoma Multiforme,"In Glioblastoma Multiforme, what is the occurrence rate of YY1AP1 loss?",freq_cnv_loss_or_gain
+1270,YY1AP1,V566D,Glioblastoma Multiforme,"In Glioblastoma Multiforme, what is the occurrence rate of YY1AP1 loss?",freq_cnv_loss_or_gain
+1271,YY1AP1,V577D,Glioblastoma Multiforme,"In Glioblastoma Multiforme, what is the occurrence rate of YY1AP1 loss?",freq_cnv_loss_or_gain
+1272,YY1AP1,V623D,Glioblastoma Multiforme,"In Glioblastoma Multiforme, what is the occurrence rate of YY1AP1 loss?",freq_cnv_loss_or_gain
+1273,YY1AP1,V695D,Glioblastoma Multiforme,"In Glioblastoma Multiforme, what is the occurrence rate of YY1AP1 loss?",freq_cnv_loss_or_gain
+1274,YY1AP1,V715D,Glioblastoma Multiforme,"In Glioblastoma Multiforme, what is the occurrence rate of YY1AP1 loss?",freq_cnv_loss_or_gain
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of FNDC7 loss?",freq_cnv_loss_or_gain
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of FNDC7 loss?",freq_cnv_loss_or_gain
+1299,TLCD5,G15V,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of TLCD5 loss?",freq_cnv_loss_or_gain
+1300,TLCD5,G37V,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of TLCD5 loss?",freq_cnv_loss_or_gain
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of POLR1G loss?",freq_cnv_loss_or_gain
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of POLR1G loss?",freq_cnv_loss_or_gain
+1308,DNAH14,N1186K,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of DNAH14 loss?",freq_cnv_loss_or_gain
+1309,DNAH14,N2657K,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of DNAH14 loss?",freq_cnv_loss_or_gain
+1310,DNAH14,N3460K,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of DNAH14 loss?",freq_cnv_loss_or_gain
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of NEXN loss?",freq_cnv_loss_or_gain
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,"In Prostate Adenocarcinoma, what is the occurrence rate of CYB5R2 loss?",freq_cnv_loss_or_gain
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,"In Prostate Adenocarcinoma, what is the occurrence rate of CYB5R2 loss?",freq_cnv_loss_or_gain
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of NRAP loss?",freq_cnv_loss_or_gain
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of NRAP loss?",freq_cnv_loss_or_gain
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of NRAP loss?",freq_cnv_loss_or_gain
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of CCDC22 loss?",freq_cnv_loss_or_gain
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of DCAF6 loss?",freq_cnv_loss_or_gain
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of DCAF6 loss?",freq_cnv_loss_or_gain
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of ZNF708 loss?",freq_cnv_loss_or_gain
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of BFAR loss?",freq_cnv_loss_or_gain
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MAST4 loss?",freq_cnv_loss_or_gain
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MAST4 loss?",freq_cnv_loss_or_gain
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MAST4 loss?",freq_cnv_loss_or_gain
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MAST4 loss?",freq_cnv_loss_or_gain
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MAST4 loss?",freq_cnv_loss_or_gain
+1363,ARMC3,R169C,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of ARMC3 loss?",freq_cnv_loss_or_gain
+1364,ARMC3,R432C,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of ARMC3 loss?",freq_cnv_loss_or_gain
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,"In Kidney Renal Clear Cell Carcinoma, what is the occurrence rate of TET2 loss?",freq_cnv_loss_or_gain
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,"In Kidney Renal Clear Cell Carcinoma, what is the occurrence rate of TET2 loss?",freq_cnv_loss_or_gain
+1369,SERPINB10,A353P,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of SERPINB10 loss?",freq_cnv_loss_or_gain
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of STAT3 loss?",freq_cnv_loss_or_gain
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of MIEF1 loss?",freq_cnv_loss_or_gain
+1381,ACVR1B,D397N,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of ACVR1B loss?",freq_cnv_loss_or_gain
+1382,ACVR1B,D449N,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of ACVR1B loss?",freq_cnv_loss_or_gain
+1383,ACVR1B,D490N,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of ACVR1B loss?",freq_cnv_loss_or_gain
+1393,EBF2,T104I,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of EBF2 loss?",freq_cnv_loss_or_gain
+1394,EBF2,T252I,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of EBF2 loss?",freq_cnv_loss_or_gain
+1402,VPS26B,F266L,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of VPS26B loss?",freq_cnv_loss_or_gain
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of PGR loss?",freq_cnv_loss_or_gain
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of PGR loss?",freq_cnv_loss_or_gain
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, what is the occurrence rate of PGR loss?",freq_cnv_loss_or_gain
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,"In Skin Cutaneous Melanoma, what is the occurrence rate of ACTA2 loss?",freq_cnv_loss_or_gain
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of THBS4 loss?",freq_cnv_loss_or_gain
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of THBS4 loss?",freq_cnv_loss_or_gain
+1413,PRSS1,S114T,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of PRSS1 loss?",freq_cnv_loss_or_gain
+1414,PRSS1,S124T,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of PRSS1 loss?",freq_cnv_loss_or_gain
+1415,PRSS1,S138T,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of PRSS1 loss?",freq_cnv_loss_or_gain
+1416,PRSS1,S74T,Lung Adenocarcinoma,"In Lung Adenocarcinoma, what is the occurrence rate of PRSS1 loss?",freq_cnv_loss_or_gain
+1417,PGF,R126H,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of PGF loss?",freq_cnv_loss_or_gain
+1418,PGF,R127H,Stomach Adenocarcinoma,"In Stomach Adenocarcinoma, what is the occurrence rate of PGF loss?",freq_cnv_loss_or_gain
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of ITPRID2 loss?",freq_cnv_loss_or_gain
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,"In Breast Invasive Carcinoma, what is the occurrence rate of ITPRID2 loss?",freq_cnv_loss_or_gain
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of HBB loss?",freq_cnv_loss_or_gain
+1441,PCDHB2,R158C,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of PCDHB2 loss?",freq_cnv_loss_or_gain
+1442,PCDHB2,T15M,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of PCDHB2 loss?",freq_cnv_loss_or_gain
+1443,PCDHB2,T26M,Colon Adenocarcinoma,"In Colon Adenocarcinoma, what is the occurrence rate of PCDHB2 loss?",freq_cnv_loss_or_gain
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,"In Uterine Corpus Endometrial Carcinoma, what is the occurrence rate of UBR2 loss?",freq_cnv_loss_or_gain
+1452,FBXO42,A618D,Rectum Adenocarcinoma,"In Rectum Adenocarcinoma, what is the occurrence rate of FBXO42 loss?",freq_cnv_loss_or_gain
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the prevalence of TNS1 and KDM5C loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the prevalence of TNS1 and CPS1 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the prevalence of TNS1 and VASN loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the prevalence of TNS1 and DCN loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the prevalence of TNS1 and MAST4 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the prevalence of TNS1 and PCDHB2 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the prevalence of TNS1 and REXO4 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the prevalence of EVC2 and OLFML3 loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the prevalence of EVC2 and ZNF274 loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CR1 and ACTB loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CR1 and SLC6A4 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the prevalence of TRPA1 and TYK2 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the prevalence of TRPA1 and FBXO15 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the prevalence of TAF1C and EPRS1 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the prevalence of TAF1C and EIF2B4 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the prevalence of TAF1C and TTC12 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the prevalence of TAF1C and GUK1 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the prevalence of TAF1C and PIK3C2G loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the prevalence of DPF3 and ZNF708 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the prevalence of DPF3 and KDM5C loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the prevalence of DPF3 and TTN loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the prevalence of OR2T4 and CTNNA2 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the prevalence of OR2T4 and PTPRN2 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the prevalence of FBN1 and TYROBP loss of heterozygosity in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the prevalence of MAD1L1 and PTPRN2 loss of heterozygosity in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the prevalence of MAD1L1 and ZMYM3 loss of heterozygosity in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the prevalence of MAD1L1 and ANKRD52 loss of heterozygosity in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the prevalence of CCNG1 and CR1 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the prevalence of ANP32E and MAST4 loss of heterozygosity in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the prevalence of ANP32E and CTCFL loss of heterozygosity in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the prevalence of ANP32E and EVC2 loss of heterozygosity in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the prevalence of ANP32E and BICC1 loss of heterozygosity in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the prevalence of FRY and GPC3 loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the prevalence of FRY and ZNF217 loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the prevalence of FRY and CTSC loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the prevalence of FRY and PIK3C2B loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the prevalence of PAK3 and ZFAT loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the prevalence of PAK3 and PYHIN1 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the prevalence of PAK3 and DCN loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the prevalence of PAK3 and ZNF708 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the prevalence of PAK3 and GRTP1 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the prevalence of MUC16 and STK19 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the prevalence of ZFPM2 and GIMAP2 loss of heterozygosity in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the prevalence of ZFPM2 and CNGB1 loss of heterozygosity in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the prevalence of PIK3C2B and TRIM45 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the prevalence of PIK3C2B and FRY loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the prevalence of ZNF804A and PAK3 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the prevalence of RELN and CHODL loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of EFCAB12 and ANP32E loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of EFCAB12 and TAF1C loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the prevalence of DEFB115 and MIEF1 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the prevalence of ANKDD1A and GPR158 loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the prevalence of ANKDD1A and PAPPA loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the prevalence of ANKDD1A and CHODL loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the prevalence of HTR3B and ZNF217 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the prevalence of HTR3B and AQP7 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the prevalence of HTR3B and CR1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the prevalence of ABCC3 and PTPRO loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the prevalence of NOMO1 and PYHIN1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the prevalence of NOMO1 and OR5D14 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the prevalence of HYOU1 and ABCC3 loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the prevalence of FMO4 and BFAR loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+140,BICC1,A372V,Exceptional Responders,What is the prevalence of BICC1 and ZFPM2 loss of heterozygosity in Exceptional Responders?,freq_cnv_loss_or_gain
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the prevalence of ZMYM3 and RIMS2 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the prevalence of ZMYM3 and DCLK3 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the prevalence of ZMYM3 and DSCAM loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of XKR4 and PTPRO loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the prevalence of ABCC2 and RAB40C loss of heterozygosity in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the prevalence of OR8K5 and TASOR2 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the prevalence of SPTAN1 and GUCY2C loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the prevalence of SPTAN1 and PIK3C2G loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the prevalence of SYT10 and ZBTB34 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the prevalence of HSPA5 and TENT5A loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the prevalence of UNC5D and GUK1 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the prevalence of UNC5D and BCAT1 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the prevalence of UNC5D and BCAT1 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the prevalence of UNC5D and CR1 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the prevalence of UNC5D and MORF4L1 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the prevalence of UNC5D and TRAP1 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the prevalence of DOCK2 and ZFAT loss of heterozygosity in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the prevalence of ZNF627 and RIPOR2 loss of heterozygosity in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the prevalence of CDC42BPA and SPATA22 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the prevalence of MRPL55 and TRIM45 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the prevalence of MRPL55 and TAF1C loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the prevalence of TMTC3 and KIF20B loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the prevalence of EPRS1 and TRAP1 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the prevalence of EPRS1 and CHODL loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the prevalence of GRTP1 and DNAH14 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the prevalence of GRTP1 and DNAH11 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the prevalence of TSHZ3 and SPTAN1 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the prevalence of TAS1R3 and TAF1L loss of heterozygosity in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,freq_cnv_loss_or_gain
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the prevalence of PIAS3 and TAF1C loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the prevalence of PIAS3 and UNC5D loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the prevalence of ZNF274 and ZNF431 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the prevalence of SYNJ1 and ZNF217 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the prevalence of SYNJ1 and TMEM255A loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the prevalence of SYNJ1 and SGCZ loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the prevalence of DSCAM and HLA-DQA2 loss of heterozygosity in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the prevalence of DSCAM and MORF4L1 loss of heterozygosity in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the prevalence of DSCAM and SERPINB10 loss of heterozygosity in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+267,DGKD,R140H,Exceptional Responders,What is the prevalence of DGKD and FGF8 loss of heterozygosity in Exceptional Responders?,freq_cnv_loss_or_gain
+268,DGKD,R160H,Exceptional Responders,What is the prevalence of DGKD and PGR loss of heterozygosity in Exceptional Responders?,freq_cnv_loss_or_gain
+269,DGKD,R204H,Exceptional Responders,What is the prevalence of DGKD and MYT1 loss of heterozygosity in Exceptional Responders?,freq_cnv_loss_or_gain
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the prevalence of PLEKHG6 and UNC5D loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the prevalence of PLEKHG6 and PRSS8 loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the prevalence of PLEKHG6 and MERTK loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the prevalence of WNT2 and ZCCHC14 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the prevalence of GUCY2C and GUK1 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the prevalence of C7orf31 and RAB40C loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of ZKSCAN7 and MSANTD4 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+299,OR5D14,M210L,Neuroblastoma,What is the prevalence of OR5D14 and PTPRN2 loss of heterozygosity in Neuroblastoma?,freq_cnv_loss_or_gain
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the prevalence of SPATA22 and CARMIL1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the prevalence of SPATA22 and NCKAP5 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the prevalence of SPATA22 and PAK3 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the prevalence of LCN15 and PXN loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the prevalence of DCAF4L2 and ARMC3 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the prevalence of GUK1 and SORCS1 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the prevalence of GUK1 and POLD1 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the prevalence of GUK1 and PIK3C2B loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the prevalence of GUK1 and AUTS2 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the prevalence of GUK1 and CR1 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the prevalence of MORF4L1 and ITPRID2 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the prevalence of MORF4L1 and CDH23 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the prevalence of MORF4L1 and ZBTB34 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the prevalence of MORF4L1 and MYO15A loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the prevalence of MYO3B and DEFB115 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the prevalence of MYO3B and KL loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the prevalence of TENT5A and OR2T4 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the prevalence of TENT5A and SMO loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the prevalence of TENT5A and ANKDD1A loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the prevalence of ZFAT and ZNF804A loss of heterozygosity in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the prevalence of ZFAT and GPC3 loss of heterozygosity in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the prevalence of ZFAT and ZFPM2 loss of heterozygosity in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+357,ZNF584,A211T,Sarcoma,What is the prevalence of ZNF584 and PTPRO loss of heterozygosity in Sarcoma?,freq_cnv_loss_or_gain
+358,ZNF584,A256T,Sarcoma,What is the prevalence of ZNF584 and UNC5D loss of heterozygosity in Sarcoma?,freq_cnv_loss_or_gain
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the prevalence of LDOC1 and ACVR1B loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the prevalence of PDGFC and ITPRID2 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the prevalence of MSANTD4 and HYOU1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the prevalence of NPSR1 and RIPOR2 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the prevalence of PHLPP1 and CHODL loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the prevalence of COL6A3 and PGR loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the prevalence of COL6A3 and ART3 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the prevalence of COL6A3 and OLFML3 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the prevalence of COL6A3 and DEFB115 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the prevalence of COL6A3 and SYNJ1 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the prevalence of ADRA1A and GPC3 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence of LAMB2 and PRSS1 loss of heterozygosity in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the prevalence of POC1B and TRIM45 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the prevalence of POC1B and ZNF804A loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the prevalence of POC1B and EPRS1 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the prevalence of POC1B and SPTAN1 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the prevalence of USH2A and DCN loss of heterozygosity in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the prevalence of AQP7 and AQP7 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the prevalence of AQP7 and SMO loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the prevalence of AQP7 and MYO15A loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the prevalence of AQP7 and HTR3B loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+430,DCN,R163C,Rectum Adenocarcinoma,What is the prevalence of DCN and DCLK3 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+431,DCN,R203C,Rectum Adenocarcinoma,What is the prevalence of DCN and AUTS2 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+432,DCN,R241C,Rectum Adenocarcinoma,What is the prevalence of DCN and MRPL32 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+433,DCN,R350C,Rectum Adenocarcinoma,What is the prevalence of DCN and TNS1 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+434,DCN,R41C,Rectum Adenocarcinoma,What is the prevalence of DCN and PLEKHG6 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CPS1 and CACNA1F loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CPS1 and CTNNA2 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CPS1 and AQP7 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the prevalence of FCGR2C and PIK3C2B loss of heterozygosity in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the prevalence of FCGR2C and AQP7 loss of heterozygosity in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the prevalence of GRM1 and DCN loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the prevalence of SGCZ and ACVR1B loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the prevalence of SGCZ and CXCR2 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+485,SMO,V15M,Stomach Adenocarcinoma,What is the prevalence of SMO and ZFAT loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+486,SMO,V321M,Stomach Adenocarcinoma,What is the prevalence of SMO and YY1AP1 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the prevalence of CHODL and CXCR2 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the prevalence of CHODL and TTYH2 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the prevalence of CHODL and PLEKHG6 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+494,MYO16,P399H,Colon Adenocarcinoma,What is the prevalence of MYO16 and MYO16 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+495,MYO16,P421H,Colon Adenocarcinoma,What is the prevalence of MYO16 and PTPRN2 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the prevalence of CXCR2 and MYT1 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the prevalence of TMEM225 and DNMT1 loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the prevalence of MAOB and DNMT1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of GPRASP1 and TRAP1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence of MRPL32 and ABCC2 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the prevalence of TYROBP and EIF2B4 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the prevalence of RAB40C and SLC24A2 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the prevalence of RAB40C and PTPRN2 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the prevalence of CTNNA2 and ITPRID2 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the prevalence of CTNNA2 and PXN loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the prevalence of CTNNA2 and SPATA22 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the prevalence of CTNNA2 and OLFML3 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the prevalence of MYO15A and YY1AP1 loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the prevalence of GIMAP2 and B3GALNT1 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the prevalence of KIF20B and DCN loss of heterozygosity in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the prevalence of KIF20B and ZFAT loss of heterozygosity in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the prevalence of ADAM17 and JAML loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the prevalence of BCAT1 and ZMYM3 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the prevalence of BCAT1 and PTPRO loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the prevalence of BCAT1 and GABRA6 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the prevalence of ERCC6 and GUK1 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+541,DCC,R320W,Breast Invasive Carcinoma,What is the prevalence of DCC and SGIP1 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+542,DCC,R363W,Breast Invasive Carcinoma,What is the prevalence of DCC and ERCC6 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+543,DCC,R386W,Breast Invasive Carcinoma,What is the prevalence of DCC and TLK2 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+544,DCC,R41W,Breast Invasive Carcinoma,What is the prevalence of DCC and CACNA1F loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the prevalence of FBXO15 and MYT1 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the prevalence of FBXO15 and PLEKHG6 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the prevalence of GSTCD and GUK1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the prevalence of GSTCD and AQP7 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the prevalence of OLFML3 and SORCS1 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the prevalence of OLFML3 and MYO16 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the prevalence of OLFML3 and TRPA1 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the prevalence of CFAP61 and CTSC loss of heterozygosity in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the prevalence of CFAP61 and ANKRD24 loss of heterozygosity in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the prevalence of HLA-DQA2 and NRAP loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the prevalence of TENM2 and ZNF584 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the prevalence of TENM2 and ERCC6 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the prevalence of TENM2 and PGR loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the prevalence of ANKRD24 and FBXO15 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the prevalence of ANKRD24 and YY1AP1 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the prevalence of ANKRD24 and ICE1 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the prevalence of ZCCHC14 and DCC loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the prevalence of ZCCHC14 and MORF4L1 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the prevalence of ZCCHC14 and ZBTB34 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the prevalence of ZCCHC14 and DHX16 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+625,SIK2,I265M,Lung Adenocarcinoma,What is the prevalence of SIK2 and YY1AP1 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the prevalence of MYH11 and TLCD5 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the prevalence of MYH11 and NRAP loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the prevalence of SLC6A4 and MRPL32 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the prevalence of SLC9C1 and MYO3A loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the prevalence of SLC9C1 and ACTA2 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the prevalence of OR2A12 and ZNF431 loss of heterozygosity in Brain Lower Grade Glioma?,freq_cnv_loss_or_gain
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the prevalence of PYHIN1 and ZFP42 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the prevalence of PYHIN1 and REXO4 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the prevalence of JAML and CYB5R2 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the prevalence of JAML and GPR158 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the prevalence of JAML and PRSS1 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the prevalence of JAML and ARMC3 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the prevalence of TYK2 and CFAP61 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the prevalence of TYK2 and NCKAP5 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the prevalence of TYK2 and ICE1 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CTCFL and TENM2 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CTCFL and ZCCHC14 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CTCFL and UBR2 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CTCFL and PIK3C2G loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CEP20 and TTC17 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CEP20 and DGKD loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the prevalence of RIMS2 and NRAP loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the prevalence of RIMS2 and MIEF1 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the prevalence of RIMS2 and OR2T4 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the prevalence of RIMS2 and MYO16 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the prevalence of RIMS2 and TASOR2 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the prevalence of RIMS2 and EBF2 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the prevalence of RIMS2 and AUTS2 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the prevalence of PIK3C2G and DGKD loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the prevalence of PIK3C2G and ART3 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+728,STK19,D341N,Colon Adenocarcinoma,What is the prevalence of STK19 and MYT1 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+729,STK19,D345N,Colon Adenocarcinoma,What is the prevalence of STK19 and ZSCAN31 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the prevalence of REXO4 and KL loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of ZBTB34 and MYH11 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of ZBTB34 and KDM5C loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the prevalence of NCKAP5 and EBF2 loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of SORCS1 and TLK2 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of SORCS1 and TRIM45 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of SORCS1 and NOMO1 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of SORCS1 and UNC5D loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the prevalence of FGF8 and HTR3B loss of heterozygosity in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the prevalence of FGF8 and PRSS8 loss of heterozygosity in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the prevalence of FGF8 and FGF8 loss of heterozygosity in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the prevalence of FGF8 and PIAS3 loss of heterozygosity in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the prevalence of FGF8 and PKHD1L1 loss of heterozygosity in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the prevalence of TENM3 and ANKRD24 loss of heterozygosity in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,freq_cnv_loss_or_gain
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the prevalence of AKT1 and TAS1R3 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence of CFAP298-TCP10L and CTCFL loss of heterozygosity in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the prevalence of GLRB and GRTP1 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+793,TTN,F7636L,Colon Adenocarcinoma,What is the prevalence of TTN and EIF2B4 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+794,TTN,F8563L,Colon Adenocarcinoma,What is the prevalence of TTN and CTSC loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+795,TTN,F8880L,Colon Adenocarcinoma,What is the prevalence of TTN and YY1AP1 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the prevalence of ANKRD30A and NRAP loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the prevalence of ANKRD30A and CTNNA2 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the prevalence of ANKRD30A and GIMAP2 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the prevalence of TRIM45 and MAOB loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the prevalence of TRIM45 and TRIM45 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the prevalence of TRIM45 and CEP20 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the prevalence of CACNA1F and EVC2 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the prevalence of CACNA1F and MUC16 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the prevalence of CACNA1F and FRY loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+817,KL,R594C,Colon Adenocarcinoma,What is the prevalence of KL and PTPRO loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the prevalence of GUF1 and PLEKHG6 loss of heterozygosity in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the prevalence of TAF1L and TENM2 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the prevalence of TASOR2 and GABRA6 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the prevalence of TASOR2 and ACTB loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the prevalence of TASOR2 and HYOU1 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the prevalence of KDM5C and MERTK loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the prevalence of KDM5C and RIMS2 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the prevalence of KDM5C and TLCD5 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the prevalence of KDM5C and DGKD loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence of IL5RA and TNS1 loss of heterozygosity in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the prevalence of DHX16 and TYROBP loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the prevalence of DHX16 and GRM1 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the prevalence of GPR158 and EPRS1 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the prevalence of GPR158 and RIMS2 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of EIF2B4 and EPRS1 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of EIF2B4 and SGIP1 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of EIF2B4 and DSCAM loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of EIF2B4 and PCDHB2 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of EIF2B4 and ZFAT loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of EIF2B4 and PTPRN2 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the prevalence of AUTS2 and RIPOR2 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the prevalence of AUTS2 and ANP32E loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the prevalence of AUTS2 and ZMYM3 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the prevalence of AUTS2 and STK19 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the prevalence of AUTS2 and NEXN loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the prevalence of AUTS2 and FCGR2C loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the prevalence of AUTS2 and PTPRO loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the prevalence of AUTS2 and TAS1R3 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the prevalence of AUTS2 and TAF1C loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the prevalence of AUTS2 and NPSR1 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of ACTL7B and GABRA6 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the prevalence of PCDHGA1 and TASOR2 loss of heterozygosity in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the prevalence of TRAP1 and ZSCAN31 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the prevalence of TRAP1 and PTPRO loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence of PIK3C2A and MAOB loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the prevalence of KANSL1 and FRY loss of heterozygosity in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the prevalence of ANKRD52 and PAK3 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of PAPPA and PTPRO loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the prevalence of B3GALNT1 and RIPOR2 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the prevalence of GABRA6 and UNC5D loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the prevalence of GABRA6 and RIMS2 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the prevalence of GABRA6 and DPF3 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the prevalence of GABRA6 and RIMS2 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the prevalence of GABRA6 and DCC loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the prevalence of ZSCAN31 and DCC loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of MED16 and SYNJ1 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of MED16 and CR1 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the prevalence of PTPRO and ARMC3 loss of heterozygosity in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the prevalence of PTPRO and MAST4 loss of heterozygosity in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the prevalence of PTPRO and CTNNA2 loss of heterozygosity in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the prevalence of PTPRO and RIMS2 loss of heterozygosity in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the prevalence of PTPRO and CTNNA2 loss of heterozygosity in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the prevalence of PTPRO and PRSS8 loss of heterozygosity in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the prevalence of PTPRO and PYHIN1 loss of heterozygosity in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the prevalence of PTPRO and PTPRN2 loss of heterozygosity in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CHMP7 and ACTB loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the prevalence of GPC3 and XKR4 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the prevalence of GPC3 and NPSR1 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence of TLK2 and OR13C3 loss of heterozygosity in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence of TLK2 and RIPOR2 loss of heterozygosity in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence of TLK2 and MORF4L1 loss of heterozygosity in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence of TLK2 and PIK3C2B loss of heterozygosity in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence of TLK2 and DEFB115 loss of heterozygosity in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the prevalence of ZNF217 and TTN loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the prevalence of SYT9 and ANKRD24 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the prevalence of SYT9 and GSTCD loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the prevalence of PKHD1L1 and MAST4 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the prevalence of MYO3A and TLK2 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of VASN and PAPPA loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the prevalence of DNMT1 and CHODL loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the prevalence of DNMT1 and PXN loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the prevalence of DNMT1 and MAD1L1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1056,CA9,E402K,Colon Adenocarcinoma,What is the prevalence of CA9 and AUTS2 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence of TTC17 and DCC loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence of TTC17 and PRSS1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the prevalence of PSG2 and PIK3C2G loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the prevalence of RIPOR2 and TAF1C loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the prevalence of RIPOR2 and PIAS3 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the prevalence of RIPOR2 and PKHD1L1 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the prevalence of RIPOR2 and PTPRO loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the prevalence of DCLK3 and CCNG1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the prevalence of DCLK3 and SGCZ loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the prevalence of MERTK and BCAT1 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the prevalence of MERTK and CR1 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the prevalence of MERTK and GUK1 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the prevalence of ZFP42 and ANP32E loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the prevalence of OR13C3 and FGF8 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the prevalence of OR13C3 and ANP32E loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the prevalence of SPAG1 and ZCCHC14 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CDKN2AIP and SPATA22 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the prevalence of PXN and RIMS2 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the prevalence of PXN and CYB5R2 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the prevalence of PXN and TET2 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the prevalence of PXN and TSHZ3 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the prevalence of PXN and YY1AP1 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the prevalence of PXN and ANP32E loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the prevalence of TTYH2 and ARMC3 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the prevalence of TTYH2 and MAD1L1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the prevalence of TMEM255A and ADAM17 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the prevalence of TMEM255A and POC1B loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the prevalence of TMEM255A and AKT1 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the prevalence of TASOR2 and OR8K5 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the prevalence of TASOR2 and CDH23 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the prevalence of ICE1 and PTPRO loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the prevalence of MYT1 and UNC5D loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the prevalence of MYT1 and SPTAN1 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the prevalence of MYT1 and RIMS2 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CX3CR1 and PGR loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CX3CR1 and TMEM225 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the prevalence of SPINDOC and RIMS2 loss of heterozygosity in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the prevalence of ART3 and MYT1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the prevalence of ART3 and NRAP loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the prevalence of CYP1A2 and FRY loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of ADRA1A and AUTS2 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the prevalence of CDH23 and MYH11 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the prevalence of CDH23 and TAF1L loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the prevalence of KRT39 and TRIM45 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the prevalence of PDHA2 and DNAH14 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the prevalence of SLC24A2 and HYOU1 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the prevalence of PTPRN2 and CCDC22 loss of heterozygosity in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the prevalence of PTPRN2 and PAPPA loss of heterozygosity in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the prevalence of PTPRN2 and MORF4L1 loss of heterozygosity in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the prevalence of PTPRN2 and PAK3 loss of heterozygosity in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the prevalence of PTPRN2 and ANKDD1A loss of heterozygosity in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the prevalence of SOX21 and ZNF584 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the prevalence of CPA6 and CYP1A2 loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the prevalence of GRM5 and DNMT1 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of CASZ1 and MRPL55 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the prevalence of SGIP1 and OR13C3 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the prevalence of SGIP1 and CFAP298-TCP10L loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the prevalence of SGIP1 and DNAH14 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the prevalence of SGIP1 and GUF1 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the prevalence of CARMIL1 and BCAT1 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the prevalence of CARMIL1 and PCDHB2 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the prevalence of ZNF431 and MERTK loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the prevalence of ZNF431 and TNS1 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the prevalence of ZNF431 and OR8K5 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the prevalence of DNAH11 and BCAT1 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the prevalence of DNAH11 and GUK1 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the prevalence of POLD1 and ARMC3 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the prevalence of POLD1 and GRM5 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the prevalence of TTC12 and GPRASP1 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the prevalence of TTC12 and GABRA6 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the prevalence of CNGB1 and GUK1 loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the prevalence of CNGB1 and STK19 loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the prevalence of CTSC and OLFML3 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the prevalence of CTSC and PTPRO loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the prevalence of CTSC and PTPRO loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the prevalence of CTSC and SMO loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the prevalence of CTSC and DHX16 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the prevalence of PRSS8 and FBN1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the prevalence of PRSS8 and MAST4 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the prevalence of ARHGEF40 and SPTAN1 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the prevalence of ACTB and ANP32E loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the prevalence of ACTB and DCN loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the prevalence of ACTB and TRPA1 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the prevalence of ACTB and GUK1 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the prevalence of YY1AP1 and NPSR1 loss of heterozygosity in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the prevalence of YY1AP1 and HBB loss of heterozygosity in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the prevalence of YY1AP1 and SPTAN1 loss of heterozygosity in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the prevalence of YY1AP1 and OR8K5 loss of heterozygosity in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the prevalence of YY1AP1 and KIF20B loss of heterozygosity in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the prevalence of YY1AP1 and CTSC loss of heterozygosity in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the prevalence of YY1AP1 and AUTS2 loss of heterozygosity in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the prevalence of FNDC7 and GLRB loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the prevalence of FNDC7 and POC1B loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the prevalence of TLCD5 and XKR4 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the prevalence of TLCD5 and ACTB loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the prevalence of POLR1G and EIF2B4 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the prevalence of POLR1G and PYHIN1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the prevalence of DNAH14 and CFAP298-TCP10L loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the prevalence of DNAH14 and CA9 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the prevalence of DNAH14 and TYK2 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the prevalence of NEXN and AKT1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the prevalence of CYB5R2 and EBF2 loss of heterozygosity in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the prevalence of CYB5R2 and UNC5D loss of heterozygosity in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the prevalence of NRAP and UNC5D loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the prevalence of NRAP and GSTCD loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the prevalence of NRAP and EIF2B4 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CCDC22 and XKR4 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the prevalence of DCAF6 and PGR loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the prevalence of DCAF6 and EIF2B4 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the prevalence of ZNF708 and CNGB1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the prevalence of BFAR and AQP7 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of MAST4 and JAML loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of MAST4 and SYNJ1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of MAST4 and CHODL loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of MAST4 and RIMS2 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of MAST4 and PAPPA loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the prevalence of ARMC3 and CNGB1 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the prevalence of ARMC3 and NCKAP5 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the prevalence of TET2 and MYO16 loss of heterozygosity in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the prevalence of TET2 and PGF loss of heterozygosity in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the prevalence of SERPINB10 and ACTB loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the prevalence of STAT3 and GLRB loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the prevalence of MIEF1 and RELN loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the prevalence of ACVR1B and ZBTB34 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the prevalence of ACVR1B and PTPRO loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the prevalence of ACVR1B and CEP20 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the prevalence of EBF2 and DGKD loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the prevalence of EBF2 and ANP32E loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the prevalence of VPS26B and EVC2 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of PGR and BFAR loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of PGR and ICE1 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of PGR and TYROBP loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the prevalence of ACTA2 and CR1 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the prevalence of THBS4 and TASOR2 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the prevalence of THBS4 and CTCFL loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the prevalence of PRSS1 and NPSR1 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the prevalence of PRSS1 and CDH23 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the prevalence of PRSS1 and DCLK3 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the prevalence of PRSS1 and PCDHB2 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the prevalence of PGF and DEFB115 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the prevalence of PGF and TNS1 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the prevalence of ITPRID2 and ACTB loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the prevalence of ITPRID2 and CARMIL1 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the prevalence of HBB and PTPRN2 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the prevalence of PCDHB2 and KANSL1 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the prevalence of PCDHB2 and ANP32E loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the prevalence of PCDHB2 and EIF2B4 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of UBR2 and TRIM45 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the prevalence of FBXO42 and YY1AP1 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1,TNS1,G1362V,Breast Invasive Carcinoma,How prevalent is TNS1 gain in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+2,TNS1,G1711V,Breast Invasive Carcinoma,How prevalent is TNS1 gain in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+3,TNS1,G1718V,Breast Invasive Carcinoma,How prevalent is TNS1 gain in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+4,TNS1,G1732V,Breast Invasive Carcinoma,How prevalent is TNS1 gain in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+5,TNS1,G1824V,Breast Invasive Carcinoma,How prevalent is TNS1 gain in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+6,TNS1,G1857V,Breast Invasive Carcinoma,How prevalent is TNS1 gain in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+7,TNS1,G843V,Breast Invasive Carcinoma,How prevalent is TNS1 gain in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How prevalent is EVC2 gain in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How prevalent is EVC2 gain in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How prevalent is CR1 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How prevalent is CR1 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+22,TRPA1,S295I,Rectum Adenocarcinoma,How prevalent is TRPA1 gain in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+23,TRPA1,S443I,Rectum Adenocarcinoma,How prevalent is TRPA1 gain in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+24,TAF1C,R299L,Lung Adenocarcinoma,How prevalent is TAF1C gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+25,TAF1C,R396L,Lung Adenocarcinoma,How prevalent is TAF1C gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+26,TAF1C,R634L,Lung Adenocarcinoma,How prevalent is TAF1C gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+27,TAF1C,R702L,Lung Adenocarcinoma,How prevalent is TAF1C gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+28,TAF1C,R728L,Lung Adenocarcinoma,How prevalent is TAF1C gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How prevalent is DPF3 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How prevalent is DPF3 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How prevalent is DPF3 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+42,OR2T4,P272H,Lung Adenocarcinoma,How prevalent is OR2T4 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+43,OR2T4,P300H,Lung Adenocarcinoma,How prevalent is OR2T4 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How prevalent is FBN1 gain in Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How prevalent is MAD1L1 gain in Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How prevalent is MAD1L1 gain in Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How prevalent is MAD1L1 gain in Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How prevalent is CCNG1 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How prevalent is ANP32E gain in Kidney Renal Papillary Cell Carcinoma patients?,freq_cnv_loss_or_gain
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How prevalent is ANP32E gain in Kidney Renal Papillary Cell Carcinoma patients?,freq_cnv_loss_or_gain
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How prevalent is ANP32E gain in Kidney Renal Papillary Cell Carcinoma patients?,freq_cnv_loss_or_gain
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How prevalent is ANP32E gain in Kidney Renal Papillary Cell Carcinoma patients?,freq_cnv_loss_or_gain
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How prevalent is FRY gain in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How prevalent is FRY gain in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How prevalent is FRY gain in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How prevalent is FRY gain in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+70,PAK3,E318K,Skin Cutaneous Melanoma,How prevalent is PAK3 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+71,PAK3,E319K,Skin Cutaneous Melanoma,How prevalent is PAK3 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+72,PAK3,E334K,Skin Cutaneous Melanoma,How prevalent is PAK3 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+73,PAK3,E340K,Skin Cutaneous Melanoma,How prevalent is PAK3 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+74,PAK3,E355K,Skin Cutaneous Melanoma,How prevalent is PAK3 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How prevalent is MUC16 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How prevalent is ZFPM2 gain in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How prevalent is ZFPM2 gain in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How prevalent is PIK3C2B gain in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How prevalent is PIK3C2B gain in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How prevalent is ZNF804A gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+116,RELN,A2371V,Stomach Adenocarcinoma,How prevalent is RELN gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is EFCAB12 gain in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is EFCAB12 gain in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How prevalent is DEFB115 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How prevalent is ANKDD1A gain in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How prevalent is ANKDD1A gain in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How prevalent is ANKDD1A gain in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How prevalent is HTR3B gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How prevalent is HTR3B gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How prevalent is HTR3B gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+129,ABCC3,R758W,Stomach Adenocarcinoma,How prevalent is ABCC3 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How prevalent is NOMO1 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How prevalent is NOMO1 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How prevalent is HYOU1 gain in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How prevalent is FMO4 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+140,BICC1,A372V,Exceptional Responders,How prevalent is BICC1 gain in Exceptional Responders patients?,freq_cnv_loss_or_gain
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How prevalent is ZMYM3 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How prevalent is ZMYM3 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How prevalent is ZMYM3 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is XKR4 gain in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How prevalent is ABCC2 gain in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+157,OR8K5,R293G,Lung Adenocarcinoma,How prevalent is OR8K5 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How prevalent is SPTAN1 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How prevalent is SPTAN1 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+164,SYT10,M484I,Rectum Adenocarcinoma,How prevalent is SYT10 gain in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How prevalent is HSPA5 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+175,UNC5D,L280V,Lung Adenocarcinoma,How prevalent is UNC5D gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+176,UNC5D,L635V,Lung Adenocarcinoma,How prevalent is UNC5D gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+177,UNC5D,L637V,Lung Adenocarcinoma,How prevalent is UNC5D gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+178,UNC5D,L699V,Lung Adenocarcinoma,How prevalent is UNC5D gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+179,UNC5D,L704V,Lung Adenocarcinoma,How prevalent is UNC5D gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+180,UNC5D,L709V,Lung Adenocarcinoma,How prevalent is UNC5D gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How prevalent is DOCK2 gain in Kidney Renal Clear Cell Carcinoma patients?,freq_cnv_loss_or_gain
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How prevalent is ZNF627 gain in Kidney Renal Clear Cell Carcinoma patients?,freq_cnv_loss_or_gain
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How prevalent is CDC42BPA gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+193,MRPL55,H27Y,Colon Adenocarcinoma,How prevalent is MRPL55 gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+194,MRPL55,H63Y,Colon Adenocarcinoma,How prevalent is MRPL55 gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How prevalent is TMTC3 gain in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+198,EPRS1,K771I,Colon Adenocarcinoma,How prevalent is EPRS1 gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+199,EPRS1,K778I,Colon Adenocarcinoma,How prevalent is EPRS1 gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How prevalent is GRTP1 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How prevalent is GRTP1 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How prevalent is TSHZ3 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How prevalent is TAS1R3 gain in HIV+ Tumor Molecular Characterization Project - Cervical Cancer patients?,freq_cnv_loss_or_gain
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How prevalent is PIAS3 gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How prevalent is PIAS3 gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+251,ZNF274,P13R,Stomach Adenocarcinoma,How prevalent is ZNF274 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+253,SYNJ1,R795C,Colon Adenocarcinoma,How prevalent is SYNJ1 gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+254,SYNJ1,R800C,Colon Adenocarcinoma,How prevalent is SYNJ1 gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+255,SYNJ1,R839C,Colon Adenocarcinoma,How prevalent is SYNJ1 gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+261,DSCAM,V343M,Prostate Adenocarcinoma,How prevalent is DSCAM gain in Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+262,DSCAM,V426M,Prostate Adenocarcinoma,How prevalent is DSCAM gain in Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+263,DSCAM,V591M,Prostate Adenocarcinoma,How prevalent is DSCAM gain in Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+267,DGKD,R140H,Exceptional Responders,How prevalent is DGKD gain in Exceptional Responders patients?,freq_cnv_loss_or_gain
+268,DGKD,R160H,Exceptional Responders,How prevalent is DGKD gain in Exceptional Responders patients?,freq_cnv_loss_or_gain
+269,DGKD,R204H,Exceptional Responders,How prevalent is DGKD gain in Exceptional Responders patients?,freq_cnv_loss_or_gain
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How prevalent is PLEKHG6 gain in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How prevalent is PLEKHG6 gain in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How prevalent is PLEKHG6 gain in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+279,WNT2,D138N,Skin Cutaneous Melanoma,How prevalent is WNT2 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How prevalent is GUCY2C gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How prevalent is C7orf31 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is ZKSCAN7 gain in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+299,OR5D14,M210L,Neuroblastoma,How prevalent is OR5D14 gain in Neuroblastoma patients?,freq_cnv_loss_or_gain
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How prevalent is SPATA22 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How prevalent is SPATA22 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How prevalent is SPATA22 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+310,LCN15,E21V,Stomach Adenocarcinoma,How prevalent is LCN15 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How prevalent is DCAF4L2 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How prevalent is GUK1 gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How prevalent is GUK1 gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How prevalent is GUK1 gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How prevalent is GUK1 gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How prevalent is GUK1 gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How prevalent is MORF4L1 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How prevalent is MORF4L1 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How prevalent is MORF4L1 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How prevalent is MORF4L1 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How prevalent is MYO3B gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How prevalent is MYO3B gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How prevalent is TENT5A gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How prevalent is TENT5A gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How prevalent is TENT5A gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How prevalent is ZFAT gain in Ovarian Serous Cystadenocarcinoma patients?,freq_cnv_loss_or_gain
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How prevalent is ZFAT gain in Ovarian Serous Cystadenocarcinoma patients?,freq_cnv_loss_or_gain
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How prevalent is ZFAT gain in Ovarian Serous Cystadenocarcinoma patients?,freq_cnv_loss_or_gain
+357,ZNF584,A211T,Sarcoma,How prevalent is ZNF584 gain in Sarcoma patients?,freq_cnv_loss_or_gain
+358,ZNF584,A256T,Sarcoma,How prevalent is ZNF584 gain in Sarcoma patients?,freq_cnv_loss_or_gain
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How prevalent is LDOC1 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How prevalent is PDGFC gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How prevalent is MSANTD4 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How prevalent is NPSR1 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How prevalent is PHLPP1 gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How prevalent is COL6A3 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How prevalent is COL6A3 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How prevalent is COL6A3 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How prevalent is COL6A3 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How prevalent is COL6A3 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How prevalent is ADRA1A gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is LAMB2 gain in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+406,POC1B,I198T,Rectum Adenocarcinoma,How prevalent is POC1B gain in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+407,POC1B,I286T,Rectum Adenocarcinoma,How prevalent is POC1B gain in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+408,POC1B,I328T,Rectum Adenocarcinoma,How prevalent is POC1B gain in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+409,POC1B,S79P,Rectum Adenocarcinoma,How prevalent is POC1B gain in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How prevalent is USH2A gain in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+414,AQP7,T110S,Rectum Adenocarcinoma,How prevalent is AQP7 gain in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+415,AQP7,T166S,Rectum Adenocarcinoma,How prevalent is AQP7 gain in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+416,AQP7,T167S,Rectum Adenocarcinoma,How prevalent is AQP7 gain in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+417,AQP7,T75S,Rectum Adenocarcinoma,How prevalent is AQP7 gain in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+430,DCN,R163C,Rectum Adenocarcinoma,How prevalent is DCN gain in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+431,DCN,R203C,Rectum Adenocarcinoma,How prevalent is DCN gain in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+432,DCN,R241C,Rectum Adenocarcinoma,How prevalent is DCN gain in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+433,DCN,R350C,Rectum Adenocarcinoma,How prevalent is DCN gain in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+434,DCN,R41C,Rectum Adenocarcinoma,How prevalent is DCN gain in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How prevalent is CPS1 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How prevalent is CPS1 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How prevalent is CPS1 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How prevalent is FCGR2C gain in Kidney Renal Papillary Cell Carcinoma patients?,freq_cnv_loss_or_gain
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How prevalent is FCGR2C gain in Kidney Renal Papillary Cell Carcinoma patients?,freq_cnv_loss_or_gain
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How prevalent is GRM1 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+482,SGCZ,Q138H,Lung Adenocarcinoma,How prevalent is SGCZ gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+483,SGCZ,Q91H,Lung Adenocarcinoma,How prevalent is SGCZ gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+485,SMO,V15M,Stomach Adenocarcinoma,How prevalent is SMO gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+486,SMO,V321M,Stomach Adenocarcinoma,How prevalent is SMO gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+488,CHODL,G159E,Skin Cutaneous Melanoma,How prevalent is CHODL gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+489,CHODL,G181E,Skin Cutaneous Melanoma,How prevalent is CHODL gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+490,CHODL,G200E,Skin Cutaneous Melanoma,How prevalent is CHODL gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+494,MYO16,P399H,Colon Adenocarcinoma,How prevalent is MYO16 gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+495,MYO16,P421H,Colon Adenocarcinoma,How prevalent is MYO16 gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+498,CXCR2,A98V,Stomach Adenocarcinoma,How prevalent is CXCR2 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How prevalent is TMEM225 gain in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How prevalent is MAOB gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How prevalent is GPRASP1 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How prevalent is MRPL32 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How prevalent is TYROBP gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+510,RAB40C,A111V,Lung Adenocarcinoma,How prevalent is RAB40C gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+511,RAB40C,A143V,Lung Adenocarcinoma,How prevalent is RAB40C gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+512,CTNNA2,S323R,Lung Adenocarcinoma,How prevalent is CTNNA2 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+513,CTNNA2,S339R,Lung Adenocarcinoma,How prevalent is CTNNA2 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+514,CTNNA2,S386R,Lung Adenocarcinoma,How prevalent is CTNNA2 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+515,CTNNA2,S707R,Lung Adenocarcinoma,How prevalent is CTNNA2 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How prevalent is MYO15A gain in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How prevalent is GIMAP2 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+532,KIF20B,N1160D,Glioblastoma Multiforme,How prevalent is KIF20B gain in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+533,KIF20B,N1200D,Glioblastoma Multiforme,How prevalent is KIF20B gain in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How prevalent is ADAM17 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How prevalent is BCAT1 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How prevalent is BCAT1 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How prevalent is BCAT1 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+540,ERCC6,R1053H,Colon Adenocarcinoma,How prevalent is ERCC6 gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+541,DCC,R320W,Breast Invasive Carcinoma,How prevalent is DCC gain in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+542,DCC,R363W,Breast Invasive Carcinoma,How prevalent is DCC gain in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+543,DCC,R386W,Breast Invasive Carcinoma,How prevalent is DCC gain in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+544,DCC,R41W,Breast Invasive Carcinoma,How prevalent is DCC gain in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How prevalent is FBXO15 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How prevalent is FBXO15 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How prevalent is GSTCD gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How prevalent is GSTCD gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How prevalent is OLFML3 gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How prevalent is OLFML3 gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How prevalent is OLFML3 gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How prevalent is CFAP61 gain in Ovarian Serous Cystadenocarcinoma patients?,freq_cnv_loss_or_gain
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How prevalent is CFAP61 gain in Ovarian Serous Cystadenocarcinoma patients?,freq_cnv_loss_or_gain
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How prevalent is HLA-DQA2 gain in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How prevalent is TENM2 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How prevalent is TENM2 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How prevalent is TENM2 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How prevalent is ANKRD24 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How prevalent is ANKRD24 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How prevalent is ANKRD24 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How prevalent is ZCCHC14 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How prevalent is ZCCHC14 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How prevalent is ZCCHC14 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How prevalent is ZCCHC14 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+625,SIK2,I265M,Lung Adenocarcinoma,How prevalent is SIK2 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How prevalent is MYH11 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How prevalent is MYH11 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How prevalent is SLC6A4 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How prevalent is SLC9C1 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How prevalent is SLC9C1 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+644,OR2A12,A254T,Brain Lower Grade Glioma,How prevalent is OR2A12 gain in Brain Lower Grade Glioma patients?,freq_cnv_loss_or_gain
+646,PYHIN1,T325K,Lung Adenocarcinoma,How prevalent is PYHIN1 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+647,PYHIN1,T334K,Lung Adenocarcinoma,How prevalent is PYHIN1 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+650,JAML,G191E,Skin Cutaneous Melanoma,How prevalent is JAML gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+651,JAML,G219E,Skin Cutaneous Melanoma,How prevalent is JAML gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+652,JAML,G220E,Skin Cutaneous Melanoma,How prevalent is JAML gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+653,JAML,G230E,Skin Cutaneous Melanoma,How prevalent is JAML gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+658,TYK2,H1146R,Stomach Adenocarcinoma,How prevalent is TYK2 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+659,TYK2,H23R,Stomach Adenocarcinoma,How prevalent is TYK2 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+660,TYK2,H961R,Stomach Adenocarcinoma,How prevalent is TYK2 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How prevalent is CTCFL gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How prevalent is CTCFL gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How prevalent is CTCFL gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How prevalent is CTCFL gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How prevalent is CEP20 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How prevalent is CEP20 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How prevalent is RIMS2 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How prevalent is RIMS2 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How prevalent is RIMS2 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How prevalent is RIMS2 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How prevalent is RIMS2 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How prevalent is RIMS2 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How prevalent is RIMS2 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How prevalent is PIK3C2G gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How prevalent is PIK3C2G gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+728,STK19,D341N,Colon Adenocarcinoma,How prevalent is STK19 gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+729,STK19,D345N,Colon Adenocarcinoma,How prevalent is STK19 gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+730,REXO4,P60A,Skin Cutaneous Melanoma,How prevalent is REXO4 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How prevalent is ZBTB34 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How prevalent is ZBTB34 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How prevalent is NCKAP5 gain in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is SORCS1 gain in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is SORCS1 gain in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is SORCS1 gain in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is SORCS1 gain in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How prevalent is FGF8 gain in Head and Neck Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How prevalent is FGF8 gain in Head and Neck Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How prevalent is FGF8 gain in Head and Neck Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How prevalent is FGF8 gain in Head and Neck Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How prevalent is FGF8 gain in Head and Neck Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How prevalent is TENM3 gain in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia patients?,freq_cnv_loss_or_gain
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How prevalent is AKT1 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is CFAP298-TCP10L gain in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+792,GLRB,E148D,Stomach Adenocarcinoma,How prevalent is GLRB gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+793,TTN,F7636L,Colon Adenocarcinoma,How prevalent is TTN gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+794,TTN,F8563L,Colon Adenocarcinoma,How prevalent is TTN gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+795,TTN,F8880L,Colon Adenocarcinoma,How prevalent is TTN gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How prevalent is ANKRD30A gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How prevalent is ANKRD30A gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How prevalent is ANKRD30A gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+809,TRIM45,S177L,Colon Adenocarcinoma,How prevalent is TRIM45 gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+810,TRIM45,S224L,Colon Adenocarcinoma,How prevalent is TRIM45 gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+811,TRIM45,S281L,Colon Adenocarcinoma,How prevalent is TRIM45 gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How prevalent is CACNA1F gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How prevalent is CACNA1F gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How prevalent is CACNA1F gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+817,KL,R594C,Colon Adenocarcinoma,How prevalent is KL gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How prevalent is GUF1 gain in Kidney Renal Papillary Cell Carcinoma patients?,freq_cnv_loss_or_gain
+822,TAF1L,A539V,Colon Adenocarcinoma,How prevalent is TAF1L gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How prevalent is TASOR2 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How prevalent is TASOR2 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How prevalent is TASOR2 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How prevalent is KDM5C gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How prevalent is KDM5C gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How prevalent is KDM5C gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How prevalent is KDM5C gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is IL5RA gain in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+843,DHX16,A29V,Skin Cutaneous Melanoma,How prevalent is DHX16 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+844,DHX16,A89V,Skin Cutaneous Melanoma,How prevalent is DHX16 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+902,GPR158,A644V,Stomach Adenocarcinoma,How prevalent is GPR158 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+903,GPR158,A723V,Stomach Adenocarcinoma,How prevalent is GPR158 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is EIF2B4 gain in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is EIF2B4 gain in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is EIF2B4 gain in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is EIF2B4 gain in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is EIF2B4 gain in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is EIF2B4 gain in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How prevalent is AUTS2 gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How prevalent is AUTS2 gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How prevalent is AUTS2 gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How prevalent is AUTS2 gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How prevalent is AUTS2 gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How prevalent is AUTS2 gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How prevalent is AUTS2 gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How prevalent is AUTS2 gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How prevalent is AUTS2 gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How prevalent is AUTS2 gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is ACTL7B gain in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How prevalent is PCDHGA1 gain in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+954,TRAP1,R114W,Stomach Adenocarcinoma,How prevalent is TRAP1 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+955,TRAP1,R61W,Stomach Adenocarcinoma,How prevalent is TRAP1 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How prevalent is PIK3C2A gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How prevalent is KANSL1 gain in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How prevalent is ANKRD52 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How prevalent is PAPPA gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How prevalent is B3GALNT1 gain in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+982,GABRA6,G115R,Lung Adenocarcinoma,How prevalent is GABRA6 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+983,GABRA6,G122R,Lung Adenocarcinoma,How prevalent is GABRA6 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+984,GABRA6,G165R,Lung Adenocarcinoma,How prevalent is GABRA6 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+985,GABRA6,G175R,Lung Adenocarcinoma,How prevalent is GABRA6 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+986,GABRA6,G70R,Lung Adenocarcinoma,How prevalent is GABRA6 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How prevalent is ZSCAN31 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is MED16 gain in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is MED16 gain in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How prevalent is PTPRO gain in Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How prevalent is PTPRO gain in Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How prevalent is PTPRO gain in Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How prevalent is PTPRO gain in Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How prevalent is PTPRO gain in Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How prevalent is PTPRO gain in Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How prevalent is PTPRO gain in Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How prevalent is PTPRO gain in Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How prevalent is CHMP7 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1017,GPC3,I107N,Stomach Adenocarcinoma,How prevalent is GPC3 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1018,GPC3,I161N,Stomach Adenocarcinoma,How prevalent is GPC3 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is TLK2 gain in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is TLK2 gain in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is TLK2 gain in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is TLK2 gain in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is TLK2 gain in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How prevalent is ZNF217 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1038,SYT9,V275L,Lung Adenocarcinoma,How prevalent is SYT9 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1039,SYT9,V307L,Lung Adenocarcinoma,How prevalent is SYT9 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How prevalent is PKHD1L1 gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How prevalent is MYO3A gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is VASN gain in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How prevalent is DNMT1 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How prevalent is DNMT1 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How prevalent is DNMT1 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1056,CA9,E402K,Colon Adenocarcinoma,How prevalent is CA9 gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How prevalent is TTC17 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How prevalent is TTC17 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1065,PSG2,P43L,Breast Invasive Carcinoma,How prevalent is PSG2 gain in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How prevalent is RIPOR2 gain in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How prevalent is RIPOR2 gain in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How prevalent is RIPOR2 gain in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How prevalent is RIPOR2 gain in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How prevalent is DCLK3 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How prevalent is DCLK3 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How prevalent is MERTK gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How prevalent is MERTK gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How prevalent is MERTK gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How prevalent is ZFP42 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How prevalent is OR13C3 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How prevalent is OR13C3 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How prevalent is SPAG1 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How prevalent is CDKN2AIP gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1093,PXN,H1016Y,Colon Adenocarcinoma,How prevalent is PXN gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1094,PXN,H359Y,Colon Adenocarcinoma,How prevalent is PXN gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1095,PXN,H492Y,Colon Adenocarcinoma,How prevalent is PXN gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1096,PXN,H524Y,Colon Adenocarcinoma,How prevalent is PXN gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1097,PXN,H526Y,Colon Adenocarcinoma,How prevalent is PXN gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1098,PXN,H540Y,Colon Adenocarcinoma,How prevalent is PXN gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How prevalent is TTYH2 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How prevalent is TTYH2 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How prevalent is TMEM255A gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How prevalent is TMEM255A gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How prevalent is TMEM255A gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How prevalent is TASOR2 gain in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How prevalent is TASOR2 gain in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How prevalent is ICE1 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1112,MYT1,A558E,Breast Invasive Carcinoma,How prevalent is MYT1 gain in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1113,MYT1,A879E,Breast Invasive Carcinoma,How prevalent is MYT1 gain in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1114,MYT1,A906E,Breast Invasive Carcinoma,How prevalent is MYT1 gain in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How prevalent is CX3CR1 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How prevalent is CX3CR1 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How prevalent is SPINDOC gain in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How prevalent is ART3 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How prevalent is ART3 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How prevalent is CYP1A2 gain in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is ADRA1A gain in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How prevalent is CDH23 gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How prevalent is CDH23 gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How prevalent is KRT39 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How prevalent is PDHA2 gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How prevalent is SLC24A2 gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How prevalent is PTPRN2 gain in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How prevalent is PTPRN2 gain in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How prevalent is PTPRN2 gain in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How prevalent is PTPRN2 gain in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How prevalent is PTPRN2 gain in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+1188,SOX21,R55L,Lung Adenocarcinoma,How prevalent is SOX21 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How prevalent is CPA6 gain in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How prevalent is GRM5 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is CASZ1 gain in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How prevalent is SGIP1 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How prevalent is SGIP1 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How prevalent is SGIP1 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How prevalent is SGIP1 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How prevalent is CARMIL1 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How prevalent is CARMIL1 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How prevalent is ZNF431 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How prevalent is ZNF431 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1234,ZNF431,R128I,Lung Adenocarcinoma,How prevalent is ZNF431 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How prevalent is DNAH11 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How prevalent is DNAH11 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How prevalent is POLD1 gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How prevalent is POLD1 gain in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1248,TTC12,D646H,Lung Adenocarcinoma,How prevalent is TTC12 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1249,TTC12,D652H,Lung Adenocarcinoma,How prevalent is TTC12 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How prevalent is CNGB1 gain in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How prevalent is CNGB1 gain in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+1254,CTSC,E214V,Stomach Adenocarcinoma,How prevalent is CTSC gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1255,CTSC,E291V,Stomach Adenocarcinoma,How prevalent is CTSC gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1256,CTSC,E322V,Stomach Adenocarcinoma,How prevalent is CTSC gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1257,CTSC,E324V,Stomach Adenocarcinoma,How prevalent is CTSC gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1258,CTSC,E335V,Stomach Adenocarcinoma,How prevalent is CTSC gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How prevalent is PRSS8 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How prevalent is PRSS8 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How prevalent is ARHGEF40 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1264,ACTB,A138T,Rectum Adenocarcinoma,How prevalent is ACTB gain in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1265,ACTB,A217T,Rectum Adenocarcinoma,How prevalent is ACTB gain in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1266,ACTB,A244T,Rectum Adenocarcinoma,How prevalent is ACTB gain in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1267,ACTB,A260T,Rectum Adenocarcinoma,How prevalent is ACTB gain in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How prevalent is YY1AP1 gain in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How prevalent is YY1AP1 gain in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How prevalent is YY1AP1 gain in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How prevalent is YY1AP1 gain in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How prevalent is YY1AP1 gain in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How prevalent is YY1AP1 gain in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How prevalent is YY1AP1 gain in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How prevalent is FNDC7 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How prevalent is FNDC7 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1299,TLCD5,G15V,Lung Adenocarcinoma,How prevalent is TLCD5 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1300,TLCD5,G37V,Lung Adenocarcinoma,How prevalent is TLCD5 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How prevalent is POLR1G gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How prevalent is POLR1G gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How prevalent is DNAH14 gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How prevalent is DNAH14 gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How prevalent is DNAH14 gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How prevalent is NEXN gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How prevalent is CYB5R2 gain in Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How prevalent is CYB5R2 gain in Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How prevalent is NRAP gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How prevalent is NRAP gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How prevalent is NRAP gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How prevalent is CCDC22 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How prevalent is DCAF6 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How prevalent is DCAF6 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How prevalent is ZNF708 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How prevalent is BFAR gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How prevalent is MAST4 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How prevalent is MAST4 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How prevalent is MAST4 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How prevalent is MAST4 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How prevalent is MAST4 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How prevalent is ARMC3 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How prevalent is ARMC3 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How prevalent is TET2 gain in Kidney Renal Clear Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How prevalent is TET2 gain in Kidney Renal Clear Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How prevalent is SERPINB10 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How prevalent is STAT3 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How prevalent is MIEF1 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How prevalent is ACVR1B gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How prevalent is ACVR1B gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How prevalent is ACVR1B gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1393,EBF2,T104I,Stomach Adenocarcinoma,How prevalent is EBF2 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1394,EBF2,T252I,Stomach Adenocarcinoma,How prevalent is EBF2 gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How prevalent is VPS26B gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is PGR gain in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is PGR gain in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is PGR gain in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How prevalent is ACTA2 gain in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How prevalent is THBS4 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How prevalent is THBS4 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1413,PRSS1,S114T,Lung Adenocarcinoma,How prevalent is PRSS1 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1414,PRSS1,S124T,Lung Adenocarcinoma,How prevalent is PRSS1 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1415,PRSS1,S138T,Lung Adenocarcinoma,How prevalent is PRSS1 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1416,PRSS1,S74T,Lung Adenocarcinoma,How prevalent is PRSS1 gain in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1417,PGF,R126H,Stomach Adenocarcinoma,How prevalent is PGF gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1418,PGF,R127H,Stomach Adenocarcinoma,How prevalent is PGF gain in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How prevalent is ITPRID2 gain in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How prevalent is ITPRID2 gain in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How prevalent is HBB gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How prevalent is PCDHB2 gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How prevalent is PCDHB2 gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How prevalent is PCDHB2 gain in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How prevalent is UBR2 gain in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How prevalent is FBXO42 gain in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1,TNS1,G1362V,Breast Invasive Carcinoma,How prevalent is somatic TNS1 amplification in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+2,TNS1,G1711V,Breast Invasive Carcinoma,How prevalent is somatic TNS1 amplification in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+3,TNS1,G1718V,Breast Invasive Carcinoma,How prevalent is somatic TNS1 amplification in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+4,TNS1,G1732V,Breast Invasive Carcinoma,How prevalent is somatic TNS1 amplification in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+5,TNS1,G1824V,Breast Invasive Carcinoma,How prevalent is somatic TNS1 amplification in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+6,TNS1,G1857V,Breast Invasive Carcinoma,How prevalent is somatic TNS1 amplification in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+7,TNS1,G843V,Breast Invasive Carcinoma,How prevalent is somatic TNS1 amplification in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How prevalent is somatic EVC2 amplification in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How prevalent is somatic EVC2 amplification in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic CR1 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic CR1 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+22,TRPA1,S295I,Rectum Adenocarcinoma,How prevalent is somatic TRPA1 amplification in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+23,TRPA1,S443I,Rectum Adenocarcinoma,How prevalent is somatic TRPA1 amplification in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+24,TAF1C,R299L,Lung Adenocarcinoma,How prevalent is somatic TAF1C amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+25,TAF1C,R396L,Lung Adenocarcinoma,How prevalent is somatic TAF1C amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+26,TAF1C,R634L,Lung Adenocarcinoma,How prevalent is somatic TAF1C amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+27,TAF1C,R702L,Lung Adenocarcinoma,How prevalent is somatic TAF1C amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+28,TAF1C,R728L,Lung Adenocarcinoma,How prevalent is somatic TAF1C amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic DPF3 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic DPF3 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic DPF3 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+42,OR2T4,P272H,Lung Adenocarcinoma,How prevalent is somatic OR2T4 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+43,OR2T4,P300H,Lung Adenocarcinoma,How prevalent is somatic OR2T4 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How prevalent is somatic FBN1 amplification in Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How prevalent is somatic MAD1L1 amplification in Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How prevalent is somatic MAD1L1 amplification in Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How prevalent is somatic MAD1L1 amplification in Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How prevalent is somatic CCNG1 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How prevalent is somatic ANP32E amplification in Kidney Renal Papillary Cell Carcinoma patients?,freq_cnv_loss_or_gain
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How prevalent is somatic ANP32E amplification in Kidney Renal Papillary Cell Carcinoma patients?,freq_cnv_loss_or_gain
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How prevalent is somatic ANP32E amplification in Kidney Renal Papillary Cell Carcinoma patients?,freq_cnv_loss_or_gain
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How prevalent is somatic ANP32E amplification in Kidney Renal Papillary Cell Carcinoma patients?,freq_cnv_loss_or_gain
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How prevalent is somatic FRY amplification in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How prevalent is somatic FRY amplification in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How prevalent is somatic FRY amplification in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How prevalent is somatic FRY amplification in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+70,PAK3,E318K,Skin Cutaneous Melanoma,How prevalent is somatic PAK3 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+71,PAK3,E319K,Skin Cutaneous Melanoma,How prevalent is somatic PAK3 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+72,PAK3,E334K,Skin Cutaneous Melanoma,How prevalent is somatic PAK3 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+73,PAK3,E340K,Skin Cutaneous Melanoma,How prevalent is somatic PAK3 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+74,PAK3,E355K,Skin Cutaneous Melanoma,How prevalent is somatic PAK3 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How prevalent is somatic MUC16 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How prevalent is somatic ZFPM2 amplification in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How prevalent is somatic ZFPM2 amplification in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How prevalent is somatic PIK3C2B amplification in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How prevalent is somatic PIK3C2B amplification in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How prevalent is somatic ZNF804A amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+116,RELN,A2371V,Stomach Adenocarcinoma,How prevalent is somatic RELN amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is somatic EFCAB12 amplification in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is somatic EFCAB12 amplification in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How prevalent is somatic DEFB115 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How prevalent is somatic ANKDD1A amplification in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How prevalent is somatic ANKDD1A amplification in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How prevalent is somatic ANKDD1A amplification in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic HTR3B amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic HTR3B amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic HTR3B amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+129,ABCC3,R758W,Stomach Adenocarcinoma,How prevalent is somatic ABCC3 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic NOMO1 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic NOMO1 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How prevalent is somatic HYOU1 amplification in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How prevalent is somatic FMO4 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+140,BICC1,A372V,Exceptional Responders,How prevalent is somatic BICC1 amplification in Exceptional Responders patients?,freq_cnv_loss_or_gain
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic ZMYM3 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic ZMYM3 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic ZMYM3 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is somatic XKR4 amplification in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How prevalent is somatic ABCC2 amplification in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+157,OR8K5,R293G,Lung Adenocarcinoma,How prevalent is somatic OR8K5 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How prevalent is somatic SPTAN1 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How prevalent is somatic SPTAN1 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+164,SYT10,M484I,Rectum Adenocarcinoma,How prevalent is somatic SYT10 amplification in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How prevalent is somatic HSPA5 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+175,UNC5D,L280V,Lung Adenocarcinoma,How prevalent is somatic UNC5D amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+176,UNC5D,L635V,Lung Adenocarcinoma,How prevalent is somatic UNC5D amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+177,UNC5D,L637V,Lung Adenocarcinoma,How prevalent is somatic UNC5D amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+178,UNC5D,L699V,Lung Adenocarcinoma,How prevalent is somatic UNC5D amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+179,UNC5D,L704V,Lung Adenocarcinoma,How prevalent is somatic UNC5D amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+180,UNC5D,L709V,Lung Adenocarcinoma,How prevalent is somatic UNC5D amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How prevalent is somatic DOCK2 amplification in Kidney Renal Clear Cell Carcinoma patients?,freq_cnv_loss_or_gain
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How prevalent is somatic ZNF627 amplification in Kidney Renal Clear Cell Carcinoma patients?,freq_cnv_loss_or_gain
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How prevalent is somatic CDC42BPA amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+193,MRPL55,H27Y,Colon Adenocarcinoma,How prevalent is somatic MRPL55 amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+194,MRPL55,H63Y,Colon Adenocarcinoma,How prevalent is somatic MRPL55 amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How prevalent is somatic TMTC3 amplification in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+198,EPRS1,K771I,Colon Adenocarcinoma,How prevalent is somatic EPRS1 amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+199,EPRS1,K778I,Colon Adenocarcinoma,How prevalent is somatic EPRS1 amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How prevalent is somatic GRTP1 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How prevalent is somatic GRTP1 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How prevalent is somatic TSHZ3 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How prevalent is somatic TAS1R3 amplification in HIV+ Tumor Molecular Characterization Project - Cervical Cancer patients?,freq_cnv_loss_or_gain
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How prevalent is somatic PIAS3 amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How prevalent is somatic PIAS3 amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+251,ZNF274,P13R,Stomach Adenocarcinoma,How prevalent is somatic ZNF274 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+253,SYNJ1,R795C,Colon Adenocarcinoma,How prevalent is somatic SYNJ1 amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+254,SYNJ1,R800C,Colon Adenocarcinoma,How prevalent is somatic SYNJ1 amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+255,SYNJ1,R839C,Colon Adenocarcinoma,How prevalent is somatic SYNJ1 amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+261,DSCAM,V343M,Prostate Adenocarcinoma,How prevalent is somatic DSCAM amplification in Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+262,DSCAM,V426M,Prostate Adenocarcinoma,How prevalent is somatic DSCAM amplification in Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+263,DSCAM,V591M,Prostate Adenocarcinoma,How prevalent is somatic DSCAM amplification in Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+267,DGKD,R140H,Exceptional Responders,How prevalent is somatic DGKD amplification in Exceptional Responders patients?,freq_cnv_loss_or_gain
+268,DGKD,R160H,Exceptional Responders,How prevalent is somatic DGKD amplification in Exceptional Responders patients?,freq_cnv_loss_or_gain
+269,DGKD,R204H,Exceptional Responders,How prevalent is somatic DGKD amplification in Exceptional Responders patients?,freq_cnv_loss_or_gain
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How prevalent is somatic PLEKHG6 amplification in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How prevalent is somatic PLEKHG6 amplification in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How prevalent is somatic PLEKHG6 amplification in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+279,WNT2,D138N,Skin Cutaneous Melanoma,How prevalent is somatic WNT2 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How prevalent is somatic GUCY2C amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic C7orf31 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is somatic ZKSCAN7 amplification in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+299,OR5D14,M210L,Neuroblastoma,How prevalent is somatic OR5D14 amplification in Neuroblastoma patients?,freq_cnv_loss_or_gain
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic SPATA22 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic SPATA22 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic SPATA22 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+310,LCN15,E21V,Stomach Adenocarcinoma,How prevalent is somatic LCN15 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How prevalent is somatic DCAF4L2 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How prevalent is somatic GUK1 amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How prevalent is somatic GUK1 amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How prevalent is somatic GUK1 amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How prevalent is somatic GUK1 amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How prevalent is somatic GUK1 amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How prevalent is somatic MORF4L1 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How prevalent is somatic MORF4L1 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How prevalent is somatic MORF4L1 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How prevalent is somatic MORF4L1 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How prevalent is somatic MYO3B amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How prevalent is somatic MYO3B amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How prevalent is somatic TENT5A amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How prevalent is somatic TENT5A amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How prevalent is somatic TENT5A amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How prevalent is somatic ZFAT amplification in Ovarian Serous Cystadenocarcinoma patients?,freq_cnv_loss_or_gain
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How prevalent is somatic ZFAT amplification in Ovarian Serous Cystadenocarcinoma patients?,freq_cnv_loss_or_gain
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How prevalent is somatic ZFAT amplification in Ovarian Serous Cystadenocarcinoma patients?,freq_cnv_loss_or_gain
+357,ZNF584,A211T,Sarcoma,How prevalent is somatic ZNF584 amplification in Sarcoma patients?,freq_cnv_loss_or_gain
+358,ZNF584,A256T,Sarcoma,How prevalent is somatic ZNF584 amplification in Sarcoma patients?,freq_cnv_loss_or_gain
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic LDOC1 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How prevalent is somatic PDGFC amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic MSANTD4 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How prevalent is somatic NPSR1 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How prevalent is somatic PHLPP1 amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How prevalent is somatic COL6A3 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How prevalent is somatic COL6A3 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How prevalent is somatic COL6A3 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How prevalent is somatic COL6A3 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How prevalent is somatic COL6A3 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How prevalent is somatic ADRA1A amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is somatic LAMB2 amplification in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+406,POC1B,I198T,Rectum Adenocarcinoma,How prevalent is somatic POC1B amplification in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+407,POC1B,I286T,Rectum Adenocarcinoma,How prevalent is somatic POC1B amplification in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+408,POC1B,I328T,Rectum Adenocarcinoma,How prevalent is somatic POC1B amplification in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+409,POC1B,S79P,Rectum Adenocarcinoma,How prevalent is somatic POC1B amplification in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How prevalent is somatic USH2A amplification in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+414,AQP7,T110S,Rectum Adenocarcinoma,How prevalent is somatic AQP7 amplification in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+415,AQP7,T166S,Rectum Adenocarcinoma,How prevalent is somatic AQP7 amplification in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+416,AQP7,T167S,Rectum Adenocarcinoma,How prevalent is somatic AQP7 amplification in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+417,AQP7,T75S,Rectum Adenocarcinoma,How prevalent is somatic AQP7 amplification in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+430,DCN,R163C,Rectum Adenocarcinoma,How prevalent is somatic DCN amplification in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+431,DCN,R203C,Rectum Adenocarcinoma,How prevalent is somatic DCN amplification in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+432,DCN,R241C,Rectum Adenocarcinoma,How prevalent is somatic DCN amplification in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+433,DCN,R350C,Rectum Adenocarcinoma,How prevalent is somatic DCN amplification in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+434,DCN,R41C,Rectum Adenocarcinoma,How prevalent is somatic DCN amplification in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic CPS1 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic CPS1 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic CPS1 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How prevalent is somatic FCGR2C amplification in Kidney Renal Papillary Cell Carcinoma patients?,freq_cnv_loss_or_gain
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How prevalent is somatic FCGR2C amplification in Kidney Renal Papillary Cell Carcinoma patients?,freq_cnv_loss_or_gain
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic GRM1 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+482,SGCZ,Q138H,Lung Adenocarcinoma,How prevalent is somatic SGCZ amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+483,SGCZ,Q91H,Lung Adenocarcinoma,How prevalent is somatic SGCZ amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+485,SMO,V15M,Stomach Adenocarcinoma,How prevalent is somatic SMO amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+486,SMO,V321M,Stomach Adenocarcinoma,How prevalent is somatic SMO amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+488,CHODL,G159E,Skin Cutaneous Melanoma,How prevalent is somatic CHODL amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+489,CHODL,G181E,Skin Cutaneous Melanoma,How prevalent is somatic CHODL amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+490,CHODL,G200E,Skin Cutaneous Melanoma,How prevalent is somatic CHODL amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+494,MYO16,P399H,Colon Adenocarcinoma,How prevalent is somatic MYO16 amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+495,MYO16,P421H,Colon Adenocarcinoma,How prevalent is somatic MYO16 amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+498,CXCR2,A98V,Stomach Adenocarcinoma,How prevalent is somatic CXCR2 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How prevalent is somatic TMEM225 amplification in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic MAOB amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic GPRASP1 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic MRPL32 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic TYROBP amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+510,RAB40C,A111V,Lung Adenocarcinoma,How prevalent is somatic RAB40C amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+511,RAB40C,A143V,Lung Adenocarcinoma,How prevalent is somatic RAB40C amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+512,CTNNA2,S323R,Lung Adenocarcinoma,How prevalent is somatic CTNNA2 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+513,CTNNA2,S339R,Lung Adenocarcinoma,How prevalent is somatic CTNNA2 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+514,CTNNA2,S386R,Lung Adenocarcinoma,How prevalent is somatic CTNNA2 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+515,CTNNA2,S707R,Lung Adenocarcinoma,How prevalent is somatic CTNNA2 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How prevalent is somatic MYO15A amplification in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How prevalent is somatic GIMAP2 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+532,KIF20B,N1160D,Glioblastoma Multiforme,How prevalent is somatic KIF20B amplification in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+533,KIF20B,N1200D,Glioblastoma Multiforme,How prevalent is somatic KIF20B amplification in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic ADAM17 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic BCAT1 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic BCAT1 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic BCAT1 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+540,ERCC6,R1053H,Colon Adenocarcinoma,How prevalent is somatic ERCC6 amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+541,DCC,R320W,Breast Invasive Carcinoma,How prevalent is somatic DCC amplification in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+542,DCC,R363W,Breast Invasive Carcinoma,How prevalent is somatic DCC amplification in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+543,DCC,R386W,Breast Invasive Carcinoma,How prevalent is somatic DCC amplification in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+544,DCC,R41W,Breast Invasive Carcinoma,How prevalent is somatic DCC amplification in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How prevalent is somatic FBXO15 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How prevalent is somatic FBXO15 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic GSTCD amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic GSTCD amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How prevalent is somatic OLFML3 amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How prevalent is somatic OLFML3 amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How prevalent is somatic OLFML3 amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How prevalent is somatic CFAP61 amplification in Ovarian Serous Cystadenocarcinoma patients?,freq_cnv_loss_or_gain
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How prevalent is somatic CFAP61 amplification in Ovarian Serous Cystadenocarcinoma patients?,freq_cnv_loss_or_gain
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How prevalent is somatic HLA-DQA2 amplification in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How prevalent is somatic TENM2 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How prevalent is somatic TENM2 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How prevalent is somatic TENM2 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How prevalent is somatic ANKRD24 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How prevalent is somatic ANKRD24 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How prevalent is somatic ANKRD24 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How prevalent is somatic ZCCHC14 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How prevalent is somatic ZCCHC14 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How prevalent is somatic ZCCHC14 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How prevalent is somatic ZCCHC14 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+625,SIK2,I265M,Lung Adenocarcinoma,How prevalent is somatic SIK2 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic MYH11 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic MYH11 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How prevalent is somatic SLC6A4 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic SLC9C1 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic SLC9C1 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+644,OR2A12,A254T,Brain Lower Grade Glioma,How prevalent is somatic OR2A12 amplification in Brain Lower Grade Glioma patients?,freq_cnv_loss_or_gain
+646,PYHIN1,T325K,Lung Adenocarcinoma,How prevalent is somatic PYHIN1 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+647,PYHIN1,T334K,Lung Adenocarcinoma,How prevalent is somatic PYHIN1 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+650,JAML,G191E,Skin Cutaneous Melanoma,How prevalent is somatic JAML amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+651,JAML,G219E,Skin Cutaneous Melanoma,How prevalent is somatic JAML amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+652,JAML,G220E,Skin Cutaneous Melanoma,How prevalent is somatic JAML amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+653,JAML,G230E,Skin Cutaneous Melanoma,How prevalent is somatic JAML amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+658,TYK2,H1146R,Stomach Adenocarcinoma,How prevalent is somatic TYK2 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+659,TYK2,H23R,Stomach Adenocarcinoma,How prevalent is somatic TYK2 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+660,TYK2,H961R,Stomach Adenocarcinoma,How prevalent is somatic TYK2 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic CTCFL amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic CTCFL amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic CTCFL amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic CTCFL amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic CEP20 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic CEP20 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How prevalent is somatic RIMS2 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How prevalent is somatic RIMS2 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How prevalent is somatic RIMS2 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How prevalent is somatic RIMS2 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How prevalent is somatic RIMS2 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How prevalent is somatic RIMS2 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How prevalent is somatic RIMS2 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How prevalent is somatic PIK3C2G amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How prevalent is somatic PIK3C2G amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+728,STK19,D341N,Colon Adenocarcinoma,How prevalent is somatic STK19 amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+729,STK19,D345N,Colon Adenocarcinoma,How prevalent is somatic STK19 amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+730,REXO4,P60A,Skin Cutaneous Melanoma,How prevalent is somatic REXO4 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic ZBTB34 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic ZBTB34 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How prevalent is somatic NCKAP5 amplification in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is somatic SORCS1 amplification in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is somatic SORCS1 amplification in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is somatic SORCS1 amplification in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is somatic SORCS1 amplification in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How prevalent is somatic FGF8 amplification in Head and Neck Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How prevalent is somatic FGF8 amplification in Head and Neck Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How prevalent is somatic FGF8 amplification in Head and Neck Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How prevalent is somatic FGF8 amplification in Head and Neck Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How prevalent is somatic FGF8 amplification in Head and Neck Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How prevalent is somatic TENM3 amplification in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia patients?,freq_cnv_loss_or_gain
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic AKT1 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is somatic CFAP298-TCP10L amplification in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+792,GLRB,E148D,Stomach Adenocarcinoma,How prevalent is somatic GLRB amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+793,TTN,F7636L,Colon Adenocarcinoma,How prevalent is somatic TTN amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+794,TTN,F8563L,Colon Adenocarcinoma,How prevalent is somatic TTN amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+795,TTN,F8880L,Colon Adenocarcinoma,How prevalent is somatic TTN amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How prevalent is somatic ANKRD30A amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How prevalent is somatic ANKRD30A amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How prevalent is somatic ANKRD30A amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+809,TRIM45,S177L,Colon Adenocarcinoma,How prevalent is somatic TRIM45 amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+810,TRIM45,S224L,Colon Adenocarcinoma,How prevalent is somatic TRIM45 amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+811,TRIM45,S281L,Colon Adenocarcinoma,How prevalent is somatic TRIM45 amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How prevalent is somatic CACNA1F amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How prevalent is somatic CACNA1F amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How prevalent is somatic CACNA1F amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+817,KL,R594C,Colon Adenocarcinoma,How prevalent is somatic KL amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How prevalent is somatic GUF1 amplification in Kidney Renal Papillary Cell Carcinoma patients?,freq_cnv_loss_or_gain
+822,TAF1L,A539V,Colon Adenocarcinoma,How prevalent is somatic TAF1L amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How prevalent is somatic TASOR2 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How prevalent is somatic TASOR2 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How prevalent is somatic TASOR2 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How prevalent is somatic KDM5C amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How prevalent is somatic KDM5C amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How prevalent is somatic KDM5C amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How prevalent is somatic KDM5C amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is somatic IL5RA amplification in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+843,DHX16,A29V,Skin Cutaneous Melanoma,How prevalent is somatic DHX16 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+844,DHX16,A89V,Skin Cutaneous Melanoma,How prevalent is somatic DHX16 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+902,GPR158,A644V,Stomach Adenocarcinoma,How prevalent is somatic GPR158 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+903,GPR158,A723V,Stomach Adenocarcinoma,How prevalent is somatic GPR158 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is somatic EIF2B4 amplification in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is somatic EIF2B4 amplification in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is somatic EIF2B4 amplification in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is somatic EIF2B4 amplification in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is somatic EIF2B4 amplification in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is somatic EIF2B4 amplification in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How prevalent is somatic AUTS2 amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How prevalent is somatic AUTS2 amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How prevalent is somatic AUTS2 amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How prevalent is somatic AUTS2 amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How prevalent is somatic AUTS2 amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How prevalent is somatic AUTS2 amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How prevalent is somatic AUTS2 amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How prevalent is somatic AUTS2 amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How prevalent is somatic AUTS2 amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How prevalent is somatic AUTS2 amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is somatic ACTL7B amplification in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How prevalent is somatic PCDHGA1 amplification in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+954,TRAP1,R114W,Stomach Adenocarcinoma,How prevalent is somatic TRAP1 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+955,TRAP1,R61W,Stomach Adenocarcinoma,How prevalent is somatic TRAP1 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic PIK3C2A amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How prevalent is somatic KANSL1 amplification in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How prevalent is somatic ANKRD52 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic PAPPA amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How prevalent is somatic B3GALNT1 amplification in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+982,GABRA6,G115R,Lung Adenocarcinoma,How prevalent is somatic GABRA6 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+983,GABRA6,G122R,Lung Adenocarcinoma,How prevalent is somatic GABRA6 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+984,GABRA6,G165R,Lung Adenocarcinoma,How prevalent is somatic GABRA6 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+985,GABRA6,G175R,Lung Adenocarcinoma,How prevalent is somatic GABRA6 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+986,GABRA6,G70R,Lung Adenocarcinoma,How prevalent is somatic GABRA6 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How prevalent is somatic ZSCAN31 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is somatic MED16 amplification in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is somatic MED16 amplification in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How prevalent is somatic PTPRO amplification in Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How prevalent is somatic PTPRO amplification in Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How prevalent is somatic PTPRO amplification in Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How prevalent is somatic PTPRO amplification in Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How prevalent is somatic PTPRO amplification in Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How prevalent is somatic PTPRO amplification in Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How prevalent is somatic PTPRO amplification in Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How prevalent is somatic PTPRO amplification in Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic CHMP7 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1017,GPC3,I107N,Stomach Adenocarcinoma,How prevalent is somatic GPC3 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1018,GPC3,I161N,Stomach Adenocarcinoma,How prevalent is somatic GPC3 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is somatic TLK2 amplification in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is somatic TLK2 amplification in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is somatic TLK2 amplification in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is somatic TLK2 amplification in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is somatic TLK2 amplification in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How prevalent is somatic ZNF217 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1038,SYT9,V275L,Lung Adenocarcinoma,How prevalent is somatic SYT9 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1039,SYT9,V307L,Lung Adenocarcinoma,How prevalent is somatic SYT9 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How prevalent is somatic PKHD1L1 amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How prevalent is somatic MYO3A amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is somatic VASN amplification in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic DNMT1 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic DNMT1 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic DNMT1 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1056,CA9,E402K,Colon Adenocarcinoma,How prevalent is somatic CA9 amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic TTC17 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic TTC17 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1065,PSG2,P43L,Breast Invasive Carcinoma,How prevalent is somatic PSG2 amplification in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How prevalent is somatic RIPOR2 amplification in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How prevalent is somatic RIPOR2 amplification in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How prevalent is somatic RIPOR2 amplification in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How prevalent is somatic RIPOR2 amplification in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic DCLK3 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic DCLK3 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How prevalent is somatic MERTK amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How prevalent is somatic MERTK amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How prevalent is somatic MERTK amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How prevalent is somatic ZFP42 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How prevalent is somatic OR13C3 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How prevalent is somatic OR13C3 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How prevalent is somatic SPAG1 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic CDKN2AIP amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1093,PXN,H1016Y,Colon Adenocarcinoma,How prevalent is somatic PXN amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1094,PXN,H359Y,Colon Adenocarcinoma,How prevalent is somatic PXN amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1095,PXN,H492Y,Colon Adenocarcinoma,How prevalent is somatic PXN amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1096,PXN,H524Y,Colon Adenocarcinoma,How prevalent is somatic PXN amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1097,PXN,H526Y,Colon Adenocarcinoma,How prevalent is somatic PXN amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1098,PXN,H540Y,Colon Adenocarcinoma,How prevalent is somatic PXN amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic TTYH2 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic TTYH2 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How prevalent is somatic TMEM255A amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How prevalent is somatic TMEM255A amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How prevalent is somatic TMEM255A amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How prevalent is somatic TASOR2 amplification in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How prevalent is somatic TASOR2 amplification in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic ICE1 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1112,MYT1,A558E,Breast Invasive Carcinoma,How prevalent is somatic MYT1 amplification in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1113,MYT1,A879E,Breast Invasive Carcinoma,How prevalent is somatic MYT1 amplification in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1114,MYT1,A906E,Breast Invasive Carcinoma,How prevalent is somatic MYT1 amplification in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic CX3CR1 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic CX3CR1 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How prevalent is somatic SPINDOC amplification in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic ART3 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic ART3 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How prevalent is somatic CYP1A2 amplification in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is somatic ADRA1A amplification in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How prevalent is somatic CDH23 amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How prevalent is somatic CDH23 amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How prevalent is somatic KRT39 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How prevalent is somatic PDHA2 amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How prevalent is somatic SLC24A2 amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How prevalent is somatic PTPRN2 amplification in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How prevalent is somatic PTPRN2 amplification in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How prevalent is somatic PTPRN2 amplification in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How prevalent is somatic PTPRN2 amplification in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How prevalent is somatic PTPRN2 amplification in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+1188,SOX21,R55L,Lung Adenocarcinoma,How prevalent is somatic SOX21 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How prevalent is somatic CPA6 amplification in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How prevalent is somatic GRM5 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is somatic CASZ1 amplification in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How prevalent is somatic SGIP1 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How prevalent is somatic SGIP1 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How prevalent is somatic SGIP1 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How prevalent is somatic SGIP1 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How prevalent is somatic CARMIL1 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How prevalent is somatic CARMIL1 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How prevalent is somatic ZNF431 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How prevalent is somatic ZNF431 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1234,ZNF431,R128I,Lung Adenocarcinoma,How prevalent is somatic ZNF431 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How prevalent is somatic DNAH11 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How prevalent is somatic DNAH11 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How prevalent is somatic POLD1 amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How prevalent is somatic POLD1 amplification in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1248,TTC12,D646H,Lung Adenocarcinoma,How prevalent is somatic TTC12 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1249,TTC12,D652H,Lung Adenocarcinoma,How prevalent is somatic TTC12 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How prevalent is somatic CNGB1 amplification in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How prevalent is somatic CNGB1 amplification in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+1254,CTSC,E214V,Stomach Adenocarcinoma,How prevalent is somatic CTSC amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1255,CTSC,E291V,Stomach Adenocarcinoma,How prevalent is somatic CTSC amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1256,CTSC,E322V,Stomach Adenocarcinoma,How prevalent is somatic CTSC amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1257,CTSC,E324V,Stomach Adenocarcinoma,How prevalent is somatic CTSC amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1258,CTSC,E335V,Stomach Adenocarcinoma,How prevalent is somatic CTSC amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic PRSS8 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic PRSS8 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How prevalent is somatic ARHGEF40 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1264,ACTB,A138T,Rectum Adenocarcinoma,How prevalent is somatic ACTB amplification in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1265,ACTB,A217T,Rectum Adenocarcinoma,How prevalent is somatic ACTB amplification in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1266,ACTB,A244T,Rectum Adenocarcinoma,How prevalent is somatic ACTB amplification in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1267,ACTB,A260T,Rectum Adenocarcinoma,How prevalent is somatic ACTB amplification in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How prevalent is somatic YY1AP1 amplification in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How prevalent is somatic YY1AP1 amplification in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How prevalent is somatic YY1AP1 amplification in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How prevalent is somatic YY1AP1 amplification in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How prevalent is somatic YY1AP1 amplification in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How prevalent is somatic YY1AP1 amplification in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How prevalent is somatic YY1AP1 amplification in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How prevalent is somatic FNDC7 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How prevalent is somatic FNDC7 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1299,TLCD5,G15V,Lung Adenocarcinoma,How prevalent is somatic TLCD5 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1300,TLCD5,G37V,Lung Adenocarcinoma,How prevalent is somatic TLCD5 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic POLR1G amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic POLR1G amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How prevalent is somatic DNAH14 amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How prevalent is somatic DNAH14 amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How prevalent is somatic DNAH14 amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic NEXN amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How prevalent is somatic CYB5R2 amplification in Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How prevalent is somatic CYB5R2 amplification in Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic NRAP amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic NRAP amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic NRAP amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic CCDC22 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How prevalent is somatic DCAF6 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How prevalent is somatic DCAF6 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic ZNF708 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic BFAR amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic MAST4 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic MAST4 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic MAST4 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic MAST4 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic MAST4 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How prevalent is somatic ARMC3 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How prevalent is somatic ARMC3 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How prevalent is somatic TET2 amplification in Kidney Renal Clear Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How prevalent is somatic TET2 amplification in Kidney Renal Clear Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How prevalent is somatic SERPINB10 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic STAT3 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic MIEF1 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How prevalent is somatic ACVR1B amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How prevalent is somatic ACVR1B amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How prevalent is somatic ACVR1B amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1393,EBF2,T104I,Stomach Adenocarcinoma,How prevalent is somatic EBF2 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1394,EBF2,T252I,Stomach Adenocarcinoma,How prevalent is somatic EBF2 amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How prevalent is somatic VPS26B amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is somatic PGR amplification in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is somatic PGR amplification in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is somatic PGR amplification in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How prevalent is somatic ACTA2 amplification in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic THBS4 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic THBS4 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1413,PRSS1,S114T,Lung Adenocarcinoma,How prevalent is somatic PRSS1 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1414,PRSS1,S124T,Lung Adenocarcinoma,How prevalent is somatic PRSS1 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1415,PRSS1,S138T,Lung Adenocarcinoma,How prevalent is somatic PRSS1 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1416,PRSS1,S74T,Lung Adenocarcinoma,How prevalent is somatic PRSS1 amplification in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1417,PGF,R126H,Stomach Adenocarcinoma,How prevalent is somatic PGF amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1418,PGF,R127H,Stomach Adenocarcinoma,How prevalent is somatic PGF amplification in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How prevalent is somatic ITPRID2 amplification in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How prevalent is somatic ITPRID2 amplification in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic HBB amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How prevalent is somatic PCDHB2 amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How prevalent is somatic PCDHB2 amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How prevalent is somatic PCDHB2 amplification in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How prevalent is somatic UBR2 amplification in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How prevalent is somatic FBXO42 amplification in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1,TNS1,G1362V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit TNS1 and SORCS1 codeletion?,freq_cnv_loss_or_gain
+2,TNS1,G1711V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit TNS1 and OR2A12 codeletion?,freq_cnv_loss_or_gain
+3,TNS1,G1718V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit TNS1 and MAD1L1 codeletion?,freq_cnv_loss_or_gain
+4,TNS1,G1732V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit TNS1 and RIMS2 codeletion?,freq_cnv_loss_or_gain
+5,TNS1,G1824V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit TNS1 and RIMS2 codeletion?,freq_cnv_loss_or_gain
+6,TNS1,G1857V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit TNS1 and TRIM45 codeletion?,freq_cnv_loss_or_gain
+7,TNS1,G843V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit TNS1 and DSCAM codeletion?,freq_cnv_loss_or_gain
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit EVC2 and PRSS8 codeletion?,freq_cnv_loss_or_gain
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit EVC2 and ZFP42 codeletion?,freq_cnv_loss_or_gain
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit CR1 and GRTP1 codeletion?,freq_cnv_loss_or_gain
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit CR1 and PGR codeletion?,freq_cnv_loss_or_gain
+22,TRPA1,S295I,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit TRPA1 and PAPPA codeletion?,freq_cnv_loss_or_gain
+23,TRPA1,S443I,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit TRPA1 and FBXO42 codeletion?,freq_cnv_loss_or_gain
+24,TAF1C,R299L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit TAF1C and EIF2B4 codeletion?,freq_cnv_loss_or_gain
+25,TAF1C,R396L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit TAF1C and ZMYM3 codeletion?,freq_cnv_loss_or_gain
+26,TAF1C,R634L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit TAF1C and FBN1 codeletion?,freq_cnv_loss_or_gain
+27,TAF1C,R702L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit TAF1C and RIMS2 codeletion?,freq_cnv_loss_or_gain
+28,TAF1C,R728L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit TAF1C and CCNG1 codeletion?,freq_cnv_loss_or_gain
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit DPF3 and FGF8 codeletion?,freq_cnv_loss_or_gain
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit DPF3 and ZCCHC14 codeletion?,freq_cnv_loss_or_gain
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit DPF3 and MAST4 codeletion?,freq_cnv_loss_or_gain
+42,OR2T4,P272H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit OR2T4 and PCDHB2 codeletion?,freq_cnv_loss_or_gain
+43,OR2T4,P300H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit OR2T4 and EVC2 codeletion?,freq_cnv_loss_or_gain
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma cases exhibit FBN1 and PTPRO codeletion?,freq_cnv_loss_or_gain
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma cases exhibit MAD1L1 and GUK1 codeletion?,freq_cnv_loss_or_gain
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma cases exhibit MAD1L1 and CYB5R2 codeletion?,freq_cnv_loss_or_gain
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma cases exhibit MAD1L1 and PDHA2 codeletion?,freq_cnv_loss_or_gain
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit CCNG1 and CDC42BPA codeletion?,freq_cnv_loss_or_gain
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma cases exhibit ANP32E and PXN codeletion?,freq_cnv_loss_or_gain
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma cases exhibit ANP32E and PTPRO codeletion?,freq_cnv_loss_or_gain
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma cases exhibit ANP32E and TAF1C codeletion?,freq_cnv_loss_or_gain
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma cases exhibit ANP32E and PXN codeletion?,freq_cnv_loss_or_gain
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit FRY and TNS1 codeletion?,freq_cnv_loss_or_gain
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit FRY and GABRA6 codeletion?,freq_cnv_loss_or_gain
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit FRY and POC1B codeletion?,freq_cnv_loss_or_gain
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit FRY and BCAT1 codeletion?,freq_cnv_loss_or_gain
+70,PAK3,E318K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit PAK3 and AKT1 codeletion?,freq_cnv_loss_or_gain
+71,PAK3,E319K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit PAK3 and OR2T4 codeletion?,freq_cnv_loss_or_gain
+72,PAK3,E334K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit PAK3 and COL6A3 codeletion?,freq_cnv_loss_or_gain
+73,PAK3,E340K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit PAK3 and TSHZ3 codeletion?,freq_cnv_loss_or_gain
+74,PAK3,E355K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit PAK3 and KIF20B codeletion?,freq_cnv_loss_or_gain
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MUC16 and SERPINB10 codeletion?,freq_cnv_loss_or_gain
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases exhibit ZFPM2 and CTSC codeletion?,freq_cnv_loss_or_gain
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases exhibit ZFPM2 and TASOR2 codeletion?,freq_cnv_loss_or_gain
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit PIK3C2B and ART3 codeletion?,freq_cnv_loss_or_gain
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit PIK3C2B and TASOR2 codeletion?,freq_cnv_loss_or_gain
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit ZNF804A and PTPRO codeletion?,freq_cnv_loss_or_gain
+116,RELN,A2371V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit RELN and FGF8 codeletion?,freq_cnv_loss_or_gain
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit EFCAB12 and CTSC codeletion?",freq_cnv_loss_or_gain
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit EFCAB12 and ZBTB34 codeletion?",freq_cnv_loss_or_gain
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit DEFB115 and NRAP codeletion?,freq_cnv_loss_or_gain
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit ANKDD1A and TMEM255A codeletion?,freq_cnv_loss_or_gain
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit ANKDD1A and ABCC3 codeletion?,freq_cnv_loss_or_gain
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit ANKDD1A and NEXN codeletion?,freq_cnv_loss_or_gain
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit HTR3B and TMEM255A codeletion?,freq_cnv_loss_or_gain
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit HTR3B and ZNF431 codeletion?,freq_cnv_loss_or_gain
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit HTR3B and ZFPM2 codeletion?,freq_cnv_loss_or_gain
+129,ABCC3,R758W,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit ABCC3 and CTCFL codeletion?,freq_cnv_loss_or_gain
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit NOMO1 and NRAP codeletion?,freq_cnv_loss_or_gain
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit NOMO1 and TTN codeletion?,freq_cnv_loss_or_gain
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit HYOU1 and COL6A3 codeletion?,freq_cnv_loss_or_gain
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit FMO4 and CDH23 codeletion?,freq_cnv_loss_or_gain
+140,BICC1,A372V,Exceptional Responders,What proportion of Exceptional Responders cases exhibit BICC1 and MAD1L1 codeletion?,freq_cnv_loss_or_gain
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit ZMYM3 and POC1B codeletion?,freq_cnv_loss_or_gain
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit ZMYM3 and ADRA1A codeletion?,freq_cnv_loss_or_gain
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit ZMYM3 and KRT39 codeletion?,freq_cnv_loss_or_gain
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit XKR4 and PIAS3 codeletion?",freq_cnv_loss_or_gain
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases exhibit ABCC2 and EFCAB12 codeletion?,freq_cnv_loss_or_gain
+157,OR8K5,R293G,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit OR8K5 and FCGR2C codeletion?,freq_cnv_loss_or_gain
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit SPTAN1 and PTPRO codeletion?,freq_cnv_loss_or_gain
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit SPTAN1 and PIK3C2G codeletion?,freq_cnv_loss_or_gain
+164,SYT10,M484I,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit SYT10 and XKR4 codeletion?,freq_cnv_loss_or_gain
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit HSPA5 and TMEM225 codeletion?,freq_cnv_loss_or_gain
+175,UNC5D,L280V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit UNC5D and GABRA6 codeletion?,freq_cnv_loss_or_gain
+176,UNC5D,L635V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit UNC5D and MORF4L1 codeletion?,freq_cnv_loss_or_gain
+177,UNC5D,L637V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit UNC5D and PIK3C2A codeletion?,freq_cnv_loss_or_gain
+178,UNC5D,L699V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit UNC5D and PIK3C2A codeletion?,freq_cnv_loss_or_gain
+179,UNC5D,L704V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit UNC5D and CTSC codeletion?,freq_cnv_loss_or_gain
+180,UNC5D,L709V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit UNC5D and DCC codeletion?,freq_cnv_loss_or_gain
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What proportion of Kidney Renal Clear Cell Carcinoma cases exhibit DOCK2 and GSTCD codeletion?,freq_cnv_loss_or_gain
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What proportion of Kidney Renal Clear Cell Carcinoma cases exhibit ZNF627 and GABRA6 codeletion?,freq_cnv_loss_or_gain
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit CDC42BPA and RAB40C codeletion?,freq_cnv_loss_or_gain
+193,MRPL55,H27Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MRPL55 and PCDHB2 codeletion?,freq_cnv_loss_or_gain
+194,MRPL55,H63Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MRPL55 and XKR4 codeletion?,freq_cnv_loss_or_gain
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit TMTC3 and LAMB2 codeletion?,freq_cnv_loss_or_gain
+198,EPRS1,K771I,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit EPRS1 and EPRS1 codeletion?,freq_cnv_loss_or_gain
+199,EPRS1,K778I,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit EPRS1 and RIMS2 codeletion?,freq_cnv_loss_or_gain
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit GRTP1 and ERCC6 codeletion?,freq_cnv_loss_or_gain
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit GRTP1 and DCN codeletion?,freq_cnv_loss_or_gain
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit TSHZ3 and FGF8 codeletion?,freq_cnv_loss_or_gain
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What proportion of HIV+ Tumor Molecular Characterization Project - Cervical Cancer cases exhibit TAS1R3 and TAF1C codeletion?,freq_cnv_loss_or_gain
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit PIAS3 and PTPRN2 codeletion?,freq_cnv_loss_or_gain
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit PIAS3 and DNMT1 codeletion?,freq_cnv_loss_or_gain
+251,ZNF274,P13R,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit ZNF274 and TTC17 codeletion?,freq_cnv_loss_or_gain
+253,SYNJ1,R795C,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit SYNJ1 and ERCC6 codeletion?,freq_cnv_loss_or_gain
+254,SYNJ1,R800C,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit SYNJ1 and GRM1 codeletion?,freq_cnv_loss_or_gain
+255,SYNJ1,R839C,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit SYNJ1 and MRPL55 codeletion?,freq_cnv_loss_or_gain
+261,DSCAM,V343M,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma cases exhibit DSCAM and DCN codeletion?,freq_cnv_loss_or_gain
+262,DSCAM,V426M,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma cases exhibit DSCAM and EVC2 codeletion?,freq_cnv_loss_or_gain
+263,DSCAM,V591M,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma cases exhibit DSCAM and GIMAP2 codeletion?,freq_cnv_loss_or_gain
+267,DGKD,R140H,Exceptional Responders,What proportion of Exceptional Responders cases exhibit DGKD and ARHGEF40 codeletion?,freq_cnv_loss_or_gain
+268,DGKD,R160H,Exceptional Responders,What proportion of Exceptional Responders cases exhibit DGKD and CXCR2 codeletion?,freq_cnv_loss_or_gain
+269,DGKD,R204H,Exceptional Responders,What proportion of Exceptional Responders cases exhibit DGKD and THBS4 codeletion?,freq_cnv_loss_or_gain
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit PLEKHG6 and PTPRO codeletion?,freq_cnv_loss_or_gain
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit PLEKHG6 and CASZ1 codeletion?,freq_cnv_loss_or_gain
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit PLEKHG6 and ZBTB34 codeletion?,freq_cnv_loss_or_gain
+279,WNT2,D138N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit WNT2 and YY1AP1 codeletion?,freq_cnv_loss_or_gain
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit GUCY2C and ZSCAN31 codeletion?,freq_cnv_loss_or_gain
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit C7orf31 and PYHIN1 codeletion?,freq_cnv_loss_or_gain
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit ZKSCAN7 and PCDHGA1 codeletion?",freq_cnv_loss_or_gain
+299,OR5D14,M210L,Neuroblastoma,What proportion of Neuroblastoma cases exhibit OR5D14 and TAF1C codeletion?,freq_cnv_loss_or_gain
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit SPATA22 and KIF20B codeletion?,freq_cnv_loss_or_gain
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit SPATA22 and AUTS2 codeletion?,freq_cnv_loss_or_gain
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit SPATA22 and NPSR1 codeletion?,freq_cnv_loss_or_gain
+310,LCN15,E21V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit LCN15 and BCAT1 codeletion?,freq_cnv_loss_or_gain
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit DCAF4L2 and SIK2 codeletion?,freq_cnv_loss_or_gain
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit GUK1 and CPS1 codeletion?,freq_cnv_loss_or_gain
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit GUK1 and BCAT1 codeletion?,freq_cnv_loss_or_gain
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit GUK1 and TNS1 codeletion?,freq_cnv_loss_or_gain
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit GUK1 and ZNF627 codeletion?,freq_cnv_loss_or_gain
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit GUK1 and ZCCHC14 codeletion?,freq_cnv_loss_or_gain
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MORF4L1 and PTPRO codeletion?,freq_cnv_loss_or_gain
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MORF4L1 and PGF codeletion?,freq_cnv_loss_or_gain
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MORF4L1 and PSG2 codeletion?,freq_cnv_loss_or_gain
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit MORF4L1 and ANP32E codeletion?,freq_cnv_loss_or_gain
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MYO3B and CTCFL codeletion?,freq_cnv_loss_or_gain
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit MYO3B and PRSS1 codeletion?,freq_cnv_loss_or_gain
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit TENT5A and SGIP1 codeletion?,freq_cnv_loss_or_gain
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit TENT5A and ZFP42 codeletion?,freq_cnv_loss_or_gain
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit TENT5A and ZNF627 codeletion?,freq_cnv_loss_or_gain
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What proportion of Ovarian Serous Cystadenocarcinoma cases exhibit ZFAT and NEXN codeletion?,freq_cnv_loss_or_gain
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What proportion of Ovarian Serous Cystadenocarcinoma cases exhibit ZFAT and PYHIN1 codeletion?,freq_cnv_loss_or_gain
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What proportion of Ovarian Serous Cystadenocarcinoma cases exhibit ZFAT and PLEKHG6 codeletion?,freq_cnv_loss_or_gain
+357,ZNF584,A211T,Sarcoma,What proportion of Sarcoma cases exhibit ZNF584 and GLRB codeletion?,freq_cnv_loss_or_gain
+358,ZNF584,A256T,Sarcoma,What proportion of Sarcoma cases exhibit ZNF584 and MYO3A codeletion?,freq_cnv_loss_or_gain
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit LDOC1 and SPTAN1 codeletion?,freq_cnv_loss_or_gain
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit PDGFC and POC1B codeletion?,freq_cnv_loss_or_gain
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MSANTD4 and PAK3 codeletion?,freq_cnv_loss_or_gain
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit NPSR1 and VASN codeletion?,freq_cnv_loss_or_gain
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit PHLPP1 and DCLK3 codeletion?,freq_cnv_loss_or_gain
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit COL6A3 and DCN codeletion?,freq_cnv_loss_or_gain
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit COL6A3 and TENM2 codeletion?,freq_cnv_loss_or_gain
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit COL6A3 and RIPOR2 codeletion?,freq_cnv_loss_or_gain
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit COL6A3 and DGKD codeletion?,freq_cnv_loss_or_gain
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit COL6A3 and DCLK3 codeletion?,freq_cnv_loss_or_gain
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit ADRA1A and OR5D14 codeletion?,freq_cnv_loss_or_gain
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases exhibit LAMB2 and CYB5R2 codeletion?,freq_cnv_loss_or_gain
+406,POC1B,I198T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit POC1B and DSCAM codeletion?,freq_cnv_loss_or_gain
+407,POC1B,I286T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit POC1B and CHODL codeletion?,freq_cnv_loss_or_gain
+408,POC1B,I328T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit POC1B and PXN codeletion?,freq_cnv_loss_or_gain
+409,POC1B,S79P,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit POC1B and ANKRD24 codeletion?,freq_cnv_loss_or_gain
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases exhibit USH2A and OR2A12 codeletion?,freq_cnv_loss_or_gain
+414,AQP7,T110S,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit AQP7 and LDOC1 codeletion?,freq_cnv_loss_or_gain
+415,AQP7,T166S,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit AQP7 and MYO3A codeletion?,freq_cnv_loss_or_gain
+416,AQP7,T167S,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit AQP7 and SLC9C1 codeletion?,freq_cnv_loss_or_gain
+417,AQP7,T75S,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit AQP7 and KDM5C codeletion?,freq_cnv_loss_or_gain
+430,DCN,R163C,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit DCN and TTN codeletion?,freq_cnv_loss_or_gain
+431,DCN,R203C,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit DCN and GRTP1 codeletion?,freq_cnv_loss_or_gain
+432,DCN,R241C,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit DCN and CTCFL codeletion?,freq_cnv_loss_or_gain
+433,DCN,R350C,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit DCN and PXN codeletion?,freq_cnv_loss_or_gain
+434,DCN,R41C,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit DCN and ARHGEF40 codeletion?,freq_cnv_loss_or_gain
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit CPS1 and KANSL1 codeletion?,freq_cnv_loss_or_gain
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit CPS1 and SYNJ1 codeletion?,freq_cnv_loss_or_gain
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit CPS1 and TMTC3 codeletion?,freq_cnv_loss_or_gain
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma cases exhibit FCGR2C and CYP1A2 codeletion?,freq_cnv_loss_or_gain
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma cases exhibit FCGR2C and COL6A3 codeletion?,freq_cnv_loss_or_gain
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit GRM1 and ZKSCAN7 codeletion?,freq_cnv_loss_or_gain
+482,SGCZ,Q138H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit SGCZ and GPRASP1 codeletion?,freq_cnv_loss_or_gain
+483,SGCZ,Q91H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit SGCZ and MORF4L1 codeletion?,freq_cnv_loss_or_gain
+485,SMO,V15M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit SMO and CACNA1F codeletion?,freq_cnv_loss_or_gain
+486,SMO,V321M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit SMO and NOMO1 codeletion?,freq_cnv_loss_or_gain
+488,CHODL,G159E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit CHODL and ZMYM3 codeletion?,freq_cnv_loss_or_gain
+489,CHODL,G181E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit CHODL and BCAT1 codeletion?,freq_cnv_loss_or_gain
+490,CHODL,G200E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit CHODL and MAST4 codeletion?,freq_cnv_loss_or_gain
+494,MYO16,P399H,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MYO16 and PRSS1 codeletion?,freq_cnv_loss_or_gain
+495,MYO16,P421H,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit MYO16 and TASOR2 codeletion?,freq_cnv_loss_or_gain
+498,CXCR2,A98V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit CXCR2 and UNC5D codeletion?,freq_cnv_loss_or_gain
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit TMEM225 and FBXO42 codeletion?,freq_cnv_loss_or_gain
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MAOB and UNC5D codeletion?,freq_cnv_loss_or_gain
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit GPRASP1 and TMEM255A codeletion?,freq_cnv_loss_or_gain
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MRPL32 and MORF4L1 codeletion?,freq_cnv_loss_or_gain
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit TYROBP and TNS1 codeletion?,freq_cnv_loss_or_gain
+510,RAB40C,A111V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit RAB40C and NOMO1 codeletion?,freq_cnv_loss_or_gain
+511,RAB40C,A143V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit RAB40C and CXCR2 codeletion?,freq_cnv_loss_or_gain
+512,CTNNA2,S323R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit CTNNA2 and PLEKHG6 codeletion?,freq_cnv_loss_or_gain
+513,CTNNA2,S339R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit CTNNA2 and KIF20B codeletion?,freq_cnv_loss_or_gain
+514,CTNNA2,S386R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit CTNNA2 and EIF2B4 codeletion?,freq_cnv_loss_or_gain
+515,CTNNA2,S707R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit CTNNA2 and AQP7 codeletion?,freq_cnv_loss_or_gain
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit MYO15A and ZSCAN31 codeletion?,freq_cnv_loss_or_gain
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit GIMAP2 and CARMIL1 codeletion?,freq_cnv_loss_or_gain
+532,KIF20B,N1160D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases exhibit KIF20B and BCAT1 codeletion?,freq_cnv_loss_or_gain
+533,KIF20B,N1200D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases exhibit KIF20B and TMEM255A codeletion?,freq_cnv_loss_or_gain
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit ADAM17 and AQP7 codeletion?,freq_cnv_loss_or_gain
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit BCAT1 and ERCC6 codeletion?,freq_cnv_loss_or_gain
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit BCAT1 and ABCC2 codeletion?,freq_cnv_loss_or_gain
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit BCAT1 and DGKD codeletion?,freq_cnv_loss_or_gain
+540,ERCC6,R1053H,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit ERCC6 and POC1B codeletion?,freq_cnv_loss_or_gain
+541,DCC,R320W,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit DCC and POLD1 codeletion?,freq_cnv_loss_or_gain
+542,DCC,R363W,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit DCC and GABRA6 codeletion?,freq_cnv_loss_or_gain
+543,DCC,R386W,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit DCC and COL6A3 codeletion?,freq_cnv_loss_or_gain
+544,DCC,R41W,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit DCC and AUTS2 codeletion?,freq_cnv_loss_or_gain
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit FBXO15 and TRAP1 codeletion?,freq_cnv_loss_or_gain
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit FBXO15 and SERPINB10 codeletion?,freq_cnv_loss_or_gain
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit GSTCD and BICC1 codeletion?,freq_cnv_loss_or_gain
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit GSTCD and SPINDOC codeletion?,freq_cnv_loss_or_gain
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit OLFML3 and DEFB115 codeletion?,freq_cnv_loss_or_gain
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit OLFML3 and PIK3C2A codeletion?,freq_cnv_loss_or_gain
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit OLFML3 and SYNJ1 codeletion?,freq_cnv_loss_or_gain
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What proportion of Ovarian Serous Cystadenocarcinoma cases exhibit CFAP61 and ACTA2 codeletion?,freq_cnv_loss_or_gain
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What proportion of Ovarian Serous Cystadenocarcinoma cases exhibit CFAP61 and EVC2 codeletion?,freq_cnv_loss_or_gain
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit HLA-DQA2 and NRAP codeletion?,freq_cnv_loss_or_gain
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit TENM2 and KDM5C codeletion?,freq_cnv_loss_or_gain
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit TENM2 and DPF3 codeletion?,freq_cnv_loss_or_gain
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit TENM2 and HTR3B codeletion?,freq_cnv_loss_or_gain
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit ANKRD24 and MAST4 codeletion?,freq_cnv_loss_or_gain
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit ANKRD24 and MRPL32 codeletion?,freq_cnv_loss_or_gain
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit ANKRD24 and ZNF274 codeletion?,freq_cnv_loss_or_gain
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit ZCCHC14 and ANKDD1A codeletion?,freq_cnv_loss_or_gain
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit ZCCHC14 and SGIP1 codeletion?,freq_cnv_loss_or_gain
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit ZCCHC14 and OR2A12 codeletion?,freq_cnv_loss_or_gain
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit ZCCHC14 and RELN codeletion?,freq_cnv_loss_or_gain
+625,SIK2,I265M,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit SIK2 and RELN codeletion?,freq_cnv_loss_or_gain
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MYH11 and EFCAB12 codeletion?,freq_cnv_loss_or_gain
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MYH11 and DSCAM codeletion?,freq_cnv_loss_or_gain
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit SLC6A4 and CPS1 codeletion?,freq_cnv_loss_or_gain
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit SLC9C1 and ARMC3 codeletion?,freq_cnv_loss_or_gain
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit SLC9C1 and SERPINB10 codeletion?,freq_cnv_loss_or_gain
+644,OR2A12,A254T,Brain Lower Grade Glioma,What proportion of Brain Lower Grade Glioma cases exhibit OR2A12 and ZNF708 codeletion?,freq_cnv_loss_or_gain
+646,PYHIN1,T325K,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit PYHIN1 and KIF20B codeletion?,freq_cnv_loss_or_gain
+647,PYHIN1,T334K,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit PYHIN1 and TRIM45 codeletion?,freq_cnv_loss_or_gain
+650,JAML,G191E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit JAML and DHX16 codeletion?,freq_cnv_loss_or_gain
+651,JAML,G219E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit JAML and NOMO1 codeletion?,freq_cnv_loss_or_gain
+652,JAML,G220E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit JAML and ANKDD1A codeletion?,freq_cnv_loss_or_gain
+653,JAML,G230E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit JAML and FRY codeletion?,freq_cnv_loss_or_gain
+658,TYK2,H1146R,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit TYK2 and CNGB1 codeletion?,freq_cnv_loss_or_gain
+659,TYK2,H23R,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit TYK2 and DSCAM codeletion?,freq_cnv_loss_or_gain
+660,TYK2,H961R,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit TYK2 and PRSS1 codeletion?,freq_cnv_loss_or_gain
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit CTCFL and ANKDD1A codeletion?,freq_cnv_loss_or_gain
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit CTCFL and GPR158 codeletion?,freq_cnv_loss_or_gain
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit CTCFL and KDM5C codeletion?,freq_cnv_loss_or_gain
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit CTCFL and CDH23 codeletion?,freq_cnv_loss_or_gain
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit CEP20 and CTSC codeletion?,freq_cnv_loss_or_gain
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit CEP20 and DGKD codeletion?,freq_cnv_loss_or_gain
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit RIMS2 and TYK2 codeletion?,freq_cnv_loss_or_gain
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit RIMS2 and OR5D14 codeletion?,freq_cnv_loss_or_gain
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit RIMS2 and PAPPA codeletion?,freq_cnv_loss_or_gain
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit RIMS2 and FRY codeletion?,freq_cnv_loss_or_gain
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit RIMS2 and CTCFL codeletion?,freq_cnv_loss_or_gain
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit RIMS2 and SPATA22 codeletion?,freq_cnv_loss_or_gain
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit RIMS2 and SMO codeletion?,freq_cnv_loss_or_gain
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit PIK3C2G and CEP20 codeletion?,freq_cnv_loss_or_gain
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit PIK3C2G and UNC5D codeletion?,freq_cnv_loss_or_gain
+728,STK19,D341N,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit STK19 and MYO3B codeletion?,freq_cnv_loss_or_gain
+729,STK19,D345N,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit STK19 and RIMS2 codeletion?,freq_cnv_loss_or_gain
+730,REXO4,P60A,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit REXO4 and PLEKHG6 codeletion?,freq_cnv_loss_or_gain
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit ZBTB34 and RIMS2 codeletion?,freq_cnv_loss_or_gain
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit ZBTB34 and GUCY2C codeletion?,freq_cnv_loss_or_gain
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit NCKAP5 and ACTB codeletion?,freq_cnv_loss_or_gain
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit SORCS1 and PSG2 codeletion?",freq_cnv_loss_or_gain
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit SORCS1 and SORCS1 codeletion?",freq_cnv_loss_or_gain
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit SORCS1 and DNAH14 codeletion?",freq_cnv_loss_or_gain
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit SORCS1 and MYO16 codeletion?",freq_cnv_loss_or_gain
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What proportion of Head and Neck Squamous Cell Carcinoma cases exhibit FGF8 and ZCCHC14 codeletion?,freq_cnv_loss_or_gain
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What proportion of Head and Neck Squamous Cell Carcinoma cases exhibit FGF8 and DCAF6 codeletion?,freq_cnv_loss_or_gain
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What proportion of Head and Neck Squamous Cell Carcinoma cases exhibit FGF8 and DNAH14 codeletion?,freq_cnv_loss_or_gain
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What proportion of Head and Neck Squamous Cell Carcinoma cases exhibit FGF8 and PAPPA codeletion?,freq_cnv_loss_or_gain
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What proportion of Head and Neck Squamous Cell Carcinoma cases exhibit FGF8 and TASOR2 codeletion?,freq_cnv_loss_or_gain
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What proportion of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia cases exhibit TENM3 and ZFP42 codeletion?,freq_cnv_loss_or_gain
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit AKT1 and CEP20 codeletion?,freq_cnv_loss_or_gain
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases exhibit CFAP298-TCP10L and SPATA22 codeletion?,freq_cnv_loss_or_gain
+792,GLRB,E148D,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit GLRB and GUK1 codeletion?,freq_cnv_loss_or_gain
+793,TTN,F7636L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit TTN and TNS1 codeletion?,freq_cnv_loss_or_gain
+794,TTN,F8563L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit TTN and DNMT1 codeletion?,freq_cnv_loss_or_gain
+795,TTN,F8880L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit TTN and ANP32E codeletion?,freq_cnv_loss_or_gain
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit ANKRD30A and SLC24A2 codeletion?,freq_cnv_loss_or_gain
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit ANKRD30A and TNS1 codeletion?,freq_cnv_loss_or_gain
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit ANKRD30A and AUTS2 codeletion?,freq_cnv_loss_or_gain
+809,TRIM45,S177L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit TRIM45 and VASN codeletion?,freq_cnv_loss_or_gain
+810,TRIM45,S224L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit TRIM45 and PXN codeletion?,freq_cnv_loss_or_gain
+811,TRIM45,S281L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit TRIM45 and AQP7 codeletion?,freq_cnv_loss_or_gain
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit CACNA1F and ANKDD1A codeletion?,freq_cnv_loss_or_gain
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit CACNA1F and PGR codeletion?,freq_cnv_loss_or_gain
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit CACNA1F and PTPRN2 codeletion?,freq_cnv_loss_or_gain
+817,KL,R594C,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit KL and AUTS2 codeletion?,freq_cnv_loss_or_gain
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma cases exhibit GUF1 and NRAP codeletion?,freq_cnv_loss_or_gain
+822,TAF1L,A539V,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit TAF1L and CPS1 codeletion?,freq_cnv_loss_or_gain
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit TASOR2 and GABRA6 codeletion?,freq_cnv_loss_or_gain
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit TASOR2 and GLRB codeletion?,freq_cnv_loss_or_gain
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit TASOR2 and ACTB codeletion?,freq_cnv_loss_or_gain
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit KDM5C and PYHIN1 codeletion?,freq_cnv_loss_or_gain
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit KDM5C and GABRA6 codeletion?,freq_cnv_loss_or_gain
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit KDM5C and CARMIL1 codeletion?,freq_cnv_loss_or_gain
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit KDM5C and CYB5R2 codeletion?,freq_cnv_loss_or_gain
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases exhibit IL5RA and POLD1 codeletion?,freq_cnv_loss_or_gain
+843,DHX16,A29V,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit DHX16 and PKHD1L1 codeletion?,freq_cnv_loss_or_gain
+844,DHX16,A89V,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit DHX16 and ANKRD30A codeletion?,freq_cnv_loss_or_gain
+902,GPR158,A644V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit GPR158 and DCAF6 codeletion?,freq_cnv_loss_or_gain
+903,GPR158,A723V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit GPR158 and PAPPA codeletion?,freq_cnv_loss_or_gain
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit EIF2B4 and GRM5 codeletion?",freq_cnv_loss_or_gain
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit EIF2B4 and PGR codeletion?",freq_cnv_loss_or_gain
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit EIF2B4 and SMO codeletion?",freq_cnv_loss_or_gain
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit EIF2B4 and MYH11 codeletion?",freq_cnv_loss_or_gain
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit EIF2B4 and ANKRD24 codeletion?",freq_cnv_loss_or_gain
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit EIF2B4 and GPR158 codeletion?",freq_cnv_loss_or_gain
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit AUTS2 and PXN codeletion?,freq_cnv_loss_or_gain
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit AUTS2 and ZNF627 codeletion?,freq_cnv_loss_or_gain
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit AUTS2 and DSCAM codeletion?,freq_cnv_loss_or_gain
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit AUTS2 and PTPRO codeletion?,freq_cnv_loss_or_gain
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit AUTS2 and ACTB codeletion?,freq_cnv_loss_or_gain
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit AUTS2 and ZFAT codeletion?,freq_cnv_loss_or_gain
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit AUTS2 and TNS1 codeletion?,freq_cnv_loss_or_gain
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit AUTS2 and TTC17 codeletion?,freq_cnv_loss_or_gain
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit AUTS2 and TAF1C codeletion?,freq_cnv_loss_or_gain
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit AUTS2 and MAD1L1 codeletion?,freq_cnv_loss_or_gain
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit ACTL7B and PIK3C2G codeletion?",freq_cnv_loss_or_gain
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases exhibit PCDHGA1 and ZFPM2 codeletion?,freq_cnv_loss_or_gain
+954,TRAP1,R114W,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit TRAP1 and TTN codeletion?,freq_cnv_loss_or_gain
+955,TRAP1,R61W,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit TRAP1 and SYT9 codeletion?,freq_cnv_loss_or_gain
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit PIK3C2A and TRPA1 codeletion?,freq_cnv_loss_or_gain
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases exhibit KANSL1 and CPS1 codeletion?,freq_cnv_loss_or_gain
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit ANKRD52 and EFCAB12 codeletion?,freq_cnv_loss_or_gain
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit PAPPA and BFAR codeletion?,freq_cnv_loss_or_gain
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit B3GALNT1 and DCLK3 codeletion?,freq_cnv_loss_or_gain
+982,GABRA6,G115R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit GABRA6 and YY1AP1 codeletion?,freq_cnv_loss_or_gain
+983,GABRA6,G122R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit GABRA6 and PRSS1 codeletion?,freq_cnv_loss_or_gain
+984,GABRA6,G165R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit GABRA6 and ZFAT codeletion?,freq_cnv_loss_or_gain
+985,GABRA6,G175R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit GABRA6 and PXN codeletion?,freq_cnv_loss_or_gain
+986,GABRA6,G70R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit GABRA6 and SORCS1 codeletion?,freq_cnv_loss_or_gain
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit ZSCAN31 and ZNF274 codeletion?,freq_cnv_loss_or_gain
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit MED16 and SYT9 codeletion?",freq_cnv_loss_or_gain
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit MED16 and RELN codeletion?",freq_cnv_loss_or_gain
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma cases exhibit PTPRO and SGCZ codeletion?,freq_cnv_loss_or_gain
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma cases exhibit PTPRO and TASOR2 codeletion?,freq_cnv_loss_or_gain
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma cases exhibit PTPRO and POC1B codeletion?,freq_cnv_loss_or_gain
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma cases exhibit PTPRO and CDKN2AIP codeletion?,freq_cnv_loss_or_gain
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma cases exhibit PTPRO and CACNA1F codeletion?,freq_cnv_loss_or_gain
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma cases exhibit PTPRO and NOMO1 codeletion?,freq_cnv_loss_or_gain
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma cases exhibit PTPRO and NRAP codeletion?,freq_cnv_loss_or_gain
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma cases exhibit PTPRO and OLFML3 codeletion?,freq_cnv_loss_or_gain
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit CHMP7 and TENT5A codeletion?,freq_cnv_loss_or_gain
+1017,GPC3,I107N,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit GPC3 and CFAP61 codeletion?,freq_cnv_loss_or_gain
+1018,GPC3,I161N,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit GPC3 and MED16 codeletion?,freq_cnv_loss_or_gain
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases exhibit TLK2 and MAST4 codeletion?,freq_cnv_loss_or_gain
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases exhibit TLK2 and TENT5A codeletion?,freq_cnv_loss_or_gain
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases exhibit TLK2 and COL6A3 codeletion?,freq_cnv_loss_or_gain
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases exhibit TLK2 and CPA6 codeletion?,freq_cnv_loss_or_gain
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases exhibit TLK2 and DGKD codeletion?,freq_cnv_loss_or_gain
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit ZNF217 and RIPOR2 codeletion?,freq_cnv_loss_or_gain
+1038,SYT9,V275L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit SYT9 and ZCCHC14 codeletion?,freq_cnv_loss_or_gain
+1039,SYT9,V307L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit SYT9 and PIK3C2G codeletion?,freq_cnv_loss_or_gain
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit PKHD1L1 and DPF3 codeletion?,freq_cnv_loss_or_gain
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MYO3A and ANKRD30A codeletion?,freq_cnv_loss_or_gain
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit VASN and GABRA6 codeletion?",freq_cnv_loss_or_gain
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit DNMT1 and PRSS8 codeletion?,freq_cnv_loss_or_gain
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit DNMT1 and RAB40C codeletion?,freq_cnv_loss_or_gain
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit DNMT1 and EIF2B4 codeletion?,freq_cnv_loss_or_gain
+1056,CA9,E402K,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit CA9 and FGF8 codeletion?,freq_cnv_loss_or_gain
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit TTC17 and GUK1 codeletion?,freq_cnv_loss_or_gain
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit TTC17 and UNC5D codeletion?,freq_cnv_loss_or_gain
+1065,PSG2,P43L,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit PSG2 and SPINDOC codeletion?,freq_cnv_loss_or_gain
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit RIPOR2 and PAK3 codeletion?,freq_cnv_loss_or_gain
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit RIPOR2 and GLRB codeletion?,freq_cnv_loss_or_gain
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit RIPOR2 and DNMT1 codeletion?,freq_cnv_loss_or_gain
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit RIPOR2 and ACTB codeletion?,freq_cnv_loss_or_gain
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit DCLK3 and PTPRO codeletion?,freq_cnv_loss_or_gain
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit DCLK3 and ZFAT codeletion?,freq_cnv_loss_or_gain
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MERTK and ACVR1B codeletion?,freq_cnv_loss_or_gain
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MERTK and RIMS2 codeletion?,freq_cnv_loss_or_gain
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit MERTK and KDM5C codeletion?,freq_cnv_loss_or_gain
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit ZFP42 and ANKRD30A codeletion?,freq_cnv_loss_or_gain
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit OR13C3 and DNAH14 codeletion?,freq_cnv_loss_or_gain
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit OR13C3 and EIF2B4 codeletion?,freq_cnv_loss_or_gain
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit SPAG1 and ANKRD24 codeletion?,freq_cnv_loss_or_gain
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit CDKN2AIP and TMEM255A codeletion?,freq_cnv_loss_or_gain
+1093,PXN,H1016Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit PXN and TAF1C codeletion?,freq_cnv_loss_or_gain
+1094,PXN,H359Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit PXN and FMO4 codeletion?,freq_cnv_loss_or_gain
+1095,PXN,H492Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit PXN and TENM2 codeletion?,freq_cnv_loss_or_gain
+1096,PXN,H524Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit PXN and PCDHGA1 codeletion?,freq_cnv_loss_or_gain
+1097,PXN,H526Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit PXN and SPINDOC codeletion?,freq_cnv_loss_or_gain
+1098,PXN,H540Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit PXN and ZBTB34 codeletion?,freq_cnv_loss_or_gain
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit TTYH2 and FCGR2C codeletion?,freq_cnv_loss_or_gain
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit TTYH2 and DCN codeletion?,freq_cnv_loss_or_gain
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit TMEM255A and TNS1 codeletion?,freq_cnv_loss_or_gain
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit TMEM255A and PXN codeletion?,freq_cnv_loss_or_gain
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit TMEM255A and ZCCHC14 codeletion?,freq_cnv_loss_or_gain
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit TASOR2 and CTCFL codeletion?,freq_cnv_loss_or_gain
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit TASOR2 and NPSR1 codeletion?,freq_cnv_loss_or_gain
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit ICE1 and TRPA1 codeletion?,freq_cnv_loss_or_gain
+1112,MYT1,A558E,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit MYT1 and CPS1 codeletion?,freq_cnv_loss_or_gain
+1113,MYT1,A879E,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit MYT1 and NOMO1 codeletion?,freq_cnv_loss_or_gain
+1114,MYT1,A906E,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit MYT1 and GABRA6 codeletion?,freq_cnv_loss_or_gain
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit CX3CR1 and STK19 codeletion?,freq_cnv_loss_or_gain
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit CX3CR1 and YY1AP1 codeletion?,freq_cnv_loss_or_gain
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases exhibit SPINDOC and TASOR2 codeletion?,freq_cnv_loss_or_gain
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit ART3 and TMEM225 codeletion?,freq_cnv_loss_or_gain
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit ART3 and DHX16 codeletion?,freq_cnv_loss_or_gain
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit CYP1A2 and GABRA6 codeletion?,freq_cnv_loss_or_gain
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit ADRA1A and ABCC3 codeletion?",freq_cnv_loss_or_gain
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit CDH23 and EIF2B4 codeletion?,freq_cnv_loss_or_gain
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit CDH23 and MYT1 codeletion?,freq_cnv_loss_or_gain
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit KRT39 and YY1AP1 codeletion?,freq_cnv_loss_or_gain
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit PDHA2 and MAOB codeletion?,freq_cnv_loss_or_gain
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit SLC24A2 and ADRA1A codeletion?,freq_cnv_loss_or_gain
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases exhibit PTPRN2 and DGKD codeletion?,freq_cnv_loss_or_gain
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases exhibit PTPRN2 and ANP32E codeletion?,freq_cnv_loss_or_gain
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases exhibit PTPRN2 and CYB5R2 codeletion?,freq_cnv_loss_or_gain
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases exhibit PTPRN2 and YY1AP1 codeletion?,freq_cnv_loss_or_gain
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases exhibit PTPRN2 and MORF4L1 codeletion?,freq_cnv_loss_or_gain
+1188,SOX21,R55L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit SOX21 and ZSCAN31 codeletion?,freq_cnv_loss_or_gain
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit CPA6 and TRIM45 codeletion?,freq_cnv_loss_or_gain
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit GRM5 and PIK3C2G codeletion?,freq_cnv_loss_or_gain
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit CASZ1 and CPA6 codeletion?",freq_cnv_loss_or_gain
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit SGIP1 and PRSS8 codeletion?,freq_cnv_loss_or_gain
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit SGIP1 and MED16 codeletion?,freq_cnv_loss_or_gain
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit SGIP1 and EVC2 codeletion?,freq_cnv_loss_or_gain
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit SGIP1 and OR13C3 codeletion?,freq_cnv_loss_or_gain
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit CARMIL1 and CEP20 codeletion?,freq_cnv_loss_or_gain
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit CARMIL1 and MED16 codeletion?,freq_cnv_loss_or_gain
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit ZNF431 and ICE1 codeletion?,freq_cnv_loss_or_gain
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit ZNF431 and ACVR1B codeletion?,freq_cnv_loss_or_gain
+1234,ZNF431,R128I,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit ZNF431 and UNC5D codeletion?,freq_cnv_loss_or_gain
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit DNAH11 and DCAF6 codeletion?,freq_cnv_loss_or_gain
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit DNAH11 and TTN codeletion?,freq_cnv_loss_or_gain
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit POLD1 and PTPRO codeletion?,freq_cnv_loss_or_gain
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases exhibit POLD1 and TAF1C codeletion?,freq_cnv_loss_or_gain
+1248,TTC12,D646H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit TTC12 and MED16 codeletion?,freq_cnv_loss_or_gain
+1249,TTC12,D652H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit TTC12 and DCN codeletion?,freq_cnv_loss_or_gain
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit CNGB1 and JAML codeletion?,freq_cnv_loss_or_gain
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases exhibit CNGB1 and CTSC codeletion?,freq_cnv_loss_or_gain
+1254,CTSC,E214V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit CTSC and POC1B codeletion?,freq_cnv_loss_or_gain
+1255,CTSC,E291V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit CTSC and NEXN codeletion?,freq_cnv_loss_or_gain
+1256,CTSC,E322V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit CTSC and VPS26B codeletion?,freq_cnv_loss_or_gain
+1257,CTSC,E324V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit CTSC and OR8K5 codeletion?,freq_cnv_loss_or_gain
+1258,CTSC,E335V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit CTSC and OLFML3 codeletion?,freq_cnv_loss_or_gain
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit PRSS8 and PCDHGA1 codeletion?,freq_cnv_loss_or_gain
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit PRSS8 and PRSS8 codeletion?,freq_cnv_loss_or_gain
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit ARHGEF40 and TASOR2 codeletion?,freq_cnv_loss_or_gain
+1264,ACTB,A138T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit ACTB and JAML codeletion?,freq_cnv_loss_or_gain
+1265,ACTB,A217T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit ACTB and TMEM225 codeletion?,freq_cnv_loss_or_gain
+1266,ACTB,A244T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit ACTB and CTNNA2 codeletion?,freq_cnv_loss_or_gain
+1267,ACTB,A260T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit ACTB and HBB codeletion?,freq_cnv_loss_or_gain
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases exhibit YY1AP1 and DGKD codeletion?,freq_cnv_loss_or_gain
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases exhibit YY1AP1 and DNMT1 codeletion?,freq_cnv_loss_or_gain
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases exhibit YY1AP1 and PXN codeletion?,freq_cnv_loss_or_gain
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases exhibit YY1AP1 and ZCCHC14 codeletion?,freq_cnv_loss_or_gain
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases exhibit YY1AP1 and MYH11 codeletion?,freq_cnv_loss_or_gain
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases exhibit YY1AP1 and EFCAB12 codeletion?,freq_cnv_loss_or_gain
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases exhibit YY1AP1 and HTR3B codeletion?,freq_cnv_loss_or_gain
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit FNDC7 and ZMYM3 codeletion?,freq_cnv_loss_or_gain
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit FNDC7 and OR8K5 codeletion?,freq_cnv_loss_or_gain
+1299,TLCD5,G15V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit TLCD5 and HTR3B codeletion?,freq_cnv_loss_or_gain
+1300,TLCD5,G37V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit TLCD5 and PTPRO codeletion?,freq_cnv_loss_or_gain
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit POLR1G and FGF8 codeletion?,freq_cnv_loss_or_gain
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit POLR1G and PSG2 codeletion?,freq_cnv_loss_or_gain
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit DNAH14 and GUK1 codeletion?,freq_cnv_loss_or_gain
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit DNAH14 and PCDHB2 codeletion?,freq_cnv_loss_or_gain
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit DNAH14 and CR1 codeletion?,freq_cnv_loss_or_gain
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit NEXN and PXN codeletion?,freq_cnv_loss_or_gain
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma cases exhibit CYB5R2 and TAF1C codeletion?,freq_cnv_loss_or_gain
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma cases exhibit CYB5R2 and PTPRN2 codeletion?,freq_cnv_loss_or_gain
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit NRAP and TNS1 codeletion?,freq_cnv_loss_or_gain
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit NRAP and EPRS1 codeletion?,freq_cnv_loss_or_gain
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit NRAP and DCLK3 codeletion?,freq_cnv_loss_or_gain
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit CCDC22 and PGR codeletion?,freq_cnv_loss_or_gain
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit DCAF6 and HSPA5 codeletion?,freq_cnv_loss_or_gain
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit DCAF6 and RAB40C codeletion?,freq_cnv_loss_or_gain
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit ZNF708 and CFAP61 codeletion?,freq_cnv_loss_or_gain
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit BFAR and PXN codeletion?,freq_cnv_loss_or_gain
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MAST4 and AUTS2 codeletion?,freq_cnv_loss_or_gain
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MAST4 and TAF1C codeletion?,freq_cnv_loss_or_gain
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MAST4 and ARMC3 codeletion?,freq_cnv_loss_or_gain
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MAST4 and OR8K5 codeletion?,freq_cnv_loss_or_gain
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MAST4 and PYHIN1 codeletion?,freq_cnv_loss_or_gain
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit ARMC3 and CACNA1F codeletion?,freq_cnv_loss_or_gain
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit ARMC3 and PCDHB2 codeletion?,freq_cnv_loss_or_gain
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What proportion of Kidney Renal Clear Cell Carcinoma cases exhibit TET2 and TENM3 codeletion?,freq_cnv_loss_or_gain
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What proportion of Kidney Renal Clear Cell Carcinoma cases exhibit TET2 and MERTK codeletion?,freq_cnv_loss_or_gain
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit SERPINB10 and DOCK2 codeletion?,freq_cnv_loss_or_gain
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit STAT3 and ITPRID2 codeletion?,freq_cnv_loss_or_gain
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit MIEF1 and PGF codeletion?,freq_cnv_loss_or_gain
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit ACVR1B and TENM2 codeletion?,freq_cnv_loss_or_gain
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit ACVR1B and PXN codeletion?,freq_cnv_loss_or_gain
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit ACVR1B and CASZ1 codeletion?,freq_cnv_loss_or_gain
+1393,EBF2,T104I,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit EBF2 and ACTA2 codeletion?,freq_cnv_loss_or_gain
+1394,EBF2,T252I,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit EBF2 and UNC5D codeletion?,freq_cnv_loss_or_gain
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit VPS26B and GUK1 codeletion?,freq_cnv_loss_or_gain
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit PGR and RELN codeletion?",freq_cnv_loss_or_gain
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit PGR and TASOR2 codeletion?",freq_cnv_loss_or_gain
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit PGR and LAMB2 codeletion?",freq_cnv_loss_or_gain
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases exhibit ACTA2 and RIPOR2 codeletion?,freq_cnv_loss_or_gain
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit THBS4 and EIF2B4 codeletion?,freq_cnv_loss_or_gain
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit THBS4 and ZFPM2 codeletion?,freq_cnv_loss_or_gain
+1413,PRSS1,S114T,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit PRSS1 and SORCS1 codeletion?,freq_cnv_loss_or_gain
+1414,PRSS1,S124T,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit PRSS1 and FBXO15 codeletion?,freq_cnv_loss_or_gain
+1415,PRSS1,S138T,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit PRSS1 and PYHIN1 codeletion?,freq_cnv_loss_or_gain
+1416,PRSS1,S74T,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases exhibit PRSS1 and PRSS1 codeletion?,freq_cnv_loss_or_gain
+1417,PGF,R126H,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit PGF and ARMC3 codeletion?,freq_cnv_loss_or_gain
+1418,PGF,R127H,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases exhibit PGF and GRTP1 codeletion?,freq_cnv_loss_or_gain
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit ITPRID2 and SMO codeletion?,freq_cnv_loss_or_gain
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases exhibit ITPRID2 and DCAF4L2 codeletion?,freq_cnv_loss_or_gain
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit HBB and ARHGEF40 codeletion?,freq_cnv_loss_or_gain
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit PCDHB2 and RIMS2 codeletion?,freq_cnv_loss_or_gain
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit PCDHB2 and ACTB codeletion?,freq_cnv_loss_or_gain
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases exhibit PCDHB2 and KIF20B codeletion?,freq_cnv_loss_or_gain
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases exhibit UBR2 and MAST4 codeletion?,freq_cnv_loss_or_gain
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases exhibit FBXO42 and TAF1C codeletion?,freq_cnv_loss_or_gain
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the joint frequency of somatic TNS1 and TASOR2 homozygous deletions in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the joint frequency of somatic TNS1 and NEXN homozygous deletions in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the joint frequency of somatic TNS1 and YY1AP1 homozygous deletions in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the joint frequency of somatic TNS1 and AUTS2 homozygous deletions in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the joint frequency of somatic TNS1 and PTPRO homozygous deletions in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the joint frequency of somatic TNS1 and GPR158 homozygous deletions in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the joint frequency of somatic TNS1 and DCAF4L2 homozygous deletions in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the joint frequency of somatic EVC2 and C7orf31 homozygous deletions in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the joint frequency of somatic EVC2 and CARMIL1 homozygous deletions in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CR1 and DHX16 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CR1 and PAPPA homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the joint frequency of somatic TRPA1 and PTPRO homozygous deletions in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the joint frequency of somatic TRPA1 and TSHZ3 homozygous deletions in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the joint frequency of somatic TAF1C and TLK2 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the joint frequency of somatic TAF1C and PCDHB2 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the joint frequency of somatic TAF1C and ART3 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the joint frequency of somatic TAF1C and CFAP298-TCP10L homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the joint frequency of somatic TAF1C and PHLPP1 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic DPF3 and ZFP42 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic DPF3 and REXO4 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic DPF3 and PSG2 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the joint frequency of somatic OR2T4 and VPS26B homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the joint frequency of somatic OR2T4 and CARMIL1 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the joint frequency of somatic FBN1 and UNC5D homozygous deletions in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the joint frequency of somatic MAD1L1 and TASOR2 homozygous deletions in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the joint frequency of somatic MAD1L1 and ADAM17 homozygous deletions in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the joint frequency of somatic MAD1L1 and OLFML3 homozygous deletions in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the joint frequency of somatic CCNG1 and HLA-DQA2 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the joint frequency of somatic ANP32E and ZCCHC14 homozygous deletions in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the joint frequency of somatic ANP32E and NCKAP5 homozygous deletions in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the joint frequency of somatic ANP32E and EIF2B4 homozygous deletions in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the joint frequency of somatic ANP32E and OR2A12 homozygous deletions in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the joint frequency of somatic FRY and CPS1 homozygous deletions in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the joint frequency of somatic FRY and PIK3C2G homozygous deletions in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the joint frequency of somatic FRY and TMEM225 homozygous deletions in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the joint frequency of somatic FRY and PYHIN1 homozygous deletions in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the joint frequency of somatic PAK3 and PIAS3 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the joint frequency of somatic PAK3 and ANKRD24 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the joint frequency of somatic PAK3 and ACTA2 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the joint frequency of somatic PAK3 and ACVR1B homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the joint frequency of somatic PAK3 and MORF4L1 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the joint frequency of somatic MUC16 and DCN homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the joint frequency of somatic ZFPM2 and TAF1C homozygous deletions in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the joint frequency of somatic ZFPM2 and PRSS8 homozygous deletions in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the joint frequency of somatic PIK3C2B and FCGR2C homozygous deletions in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the joint frequency of somatic PIK3C2B and CXCR2 homozygous deletions in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the joint frequency of somatic ZNF804A and DPF3 homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the joint frequency of somatic RELN and MAOB homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic EFCAB12 and CFAP61 homozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic EFCAB12 and TTC12 homozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the joint frequency of somatic DEFB115 and SORCS1 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the joint frequency of somatic ANKDD1A and DCLK3 homozygous deletions in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the joint frequency of somatic ANKDD1A and CHODL homozygous deletions in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the joint frequency of somatic ANKDD1A and SMO homozygous deletions in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic HTR3B and RAB40C homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic HTR3B and TRIM45 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic HTR3B and ARMC3 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the joint frequency of somatic ABCC3 and MORF4L1 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic NOMO1 and TET2 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic NOMO1 and B3GALNT1 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the joint frequency of somatic HYOU1 and CHODL homozygous deletions in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the joint frequency of somatic FMO4 and TASOR2 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+140,BICC1,A372V,Exceptional Responders,What is the joint frequency of somatic BICC1 and CYP1A2 homozygous deletions in Exceptional Responders?,freq_cnv_loss_or_gain
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic ZMYM3 and RIPOR2 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic ZMYM3 and ZFAT homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic ZMYM3 and POC1B homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic XKR4 and TNS1 homozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the joint frequency of somatic ABCC2 and DCC homozygous deletions in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the joint frequency of somatic OR8K5 and ITPRID2 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the joint frequency of somatic SPTAN1 and ANKRD30A homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the joint frequency of somatic SPTAN1 and SLC9C1 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the joint frequency of somatic SYT10 and COL6A3 homozygous deletions in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the joint frequency of somatic HSPA5 and PTPRN2 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the joint frequency of somatic UNC5D and EIF2B4 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the joint frequency of somatic UNC5D and GABRA6 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the joint frequency of somatic UNC5D and TMEM255A homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the joint frequency of somatic UNC5D and NRAP homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the joint frequency of somatic UNC5D and GLRB homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the joint frequency of somatic UNC5D and SLC24A2 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the joint frequency of somatic DOCK2 and ACTA2 homozygous deletions in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the joint frequency of somatic ZNF627 and MAD1L1 homozygous deletions in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the joint frequency of somatic CDC42BPA and DNMT1 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the joint frequency of somatic MRPL55 and CTCFL homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the joint frequency of somatic MRPL55 and ZNF584 homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the joint frequency of somatic TMTC3 and ANKDD1A homozygous deletions in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the joint frequency of somatic EPRS1 and POC1B homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the joint frequency of somatic EPRS1 and EIF2B4 homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the joint frequency of somatic GRTP1 and GRM1 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the joint frequency of somatic GRTP1 and MRPL55 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the joint frequency of somatic TSHZ3 and GRTP1 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the joint frequency of somatic TAS1R3 and DCC homozygous deletions in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,freq_cnv_loss_or_gain
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic PIAS3 and POC1B homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic PIAS3 and ZFP42 homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the joint frequency of somatic ZNF274 and AUTS2 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the joint frequency of somatic SYNJ1 and SPTAN1 homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the joint frequency of somatic SYNJ1 and CTCFL homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the joint frequency of somatic SYNJ1 and ITPRID2 homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the joint frequency of somatic DSCAM and SGIP1 homozygous deletions in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the joint frequency of somatic DSCAM and TLK2 homozygous deletions in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the joint frequency of somatic DSCAM and DCC homozygous deletions in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+267,DGKD,R140H,Exceptional Responders,What is the joint frequency of somatic DGKD and CACNA1F homozygous deletions in Exceptional Responders?,freq_cnv_loss_or_gain
+268,DGKD,R160H,Exceptional Responders,What is the joint frequency of somatic DGKD and MED16 homozygous deletions in Exceptional Responders?,freq_cnv_loss_or_gain
+269,DGKD,R204H,Exceptional Responders,What is the joint frequency of somatic DGKD and OLFML3 homozygous deletions in Exceptional Responders?,freq_cnv_loss_or_gain
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the joint frequency of somatic PLEKHG6 and RAB40C homozygous deletions in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the joint frequency of somatic PLEKHG6 and SERPINB10 homozygous deletions in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the joint frequency of somatic PLEKHG6 and ANKRD24 homozygous deletions in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the joint frequency of somatic WNT2 and PAK3 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the joint frequency of somatic GUCY2C and DNAH11 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic C7orf31 and TET2 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic ZKSCAN7 and COL6A3 homozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+299,OR5D14,M210L,Neuroblastoma,What is the joint frequency of somatic OR5D14 and RIMS2 homozygous deletions in Neuroblastoma?,freq_cnv_loss_or_gain
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic SPATA22 and KL homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic SPATA22 and PRSS1 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic SPATA22 and TRPA1 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the joint frequency of somatic LCN15 and AUTS2 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the joint frequency of somatic DCAF4L2 and NRAP homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic GUK1 and ANKDD1A homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic GUK1 and TRIM45 homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic GUK1 and CPA6 homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic GUK1 and SPATA22 homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic GUK1 and SORCS1 homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the joint frequency of somatic MORF4L1 and REXO4 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the joint frequency of somatic MORF4L1 and PAK3 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the joint frequency of somatic MORF4L1 and NOMO1 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the joint frequency of somatic MORF4L1 and KIF20B homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the joint frequency of somatic MYO3B and GLRB homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the joint frequency of somatic MYO3B and CDH23 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the joint frequency of somatic TENT5A and TYK2 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the joint frequency of somatic TENT5A and ADAM17 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the joint frequency of somatic TENT5A and SPATA22 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the joint frequency of somatic ZFAT and HTR3B homozygous deletions in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the joint frequency of somatic ZFAT and PGR homozygous deletions in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the joint frequency of somatic ZFAT and POC1B homozygous deletions in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+357,ZNF584,A211T,Sarcoma,What is the joint frequency of somatic ZNF584 and KDM5C homozygous deletions in Sarcoma?,freq_cnv_loss_or_gain
+358,ZNF584,A256T,Sarcoma,What is the joint frequency of somatic ZNF584 and TLK2 homozygous deletions in Sarcoma?,freq_cnv_loss_or_gain
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic LDOC1 and TET2 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic PDGFC and CYB5R2 homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic MSANTD4 and MAST4 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the joint frequency of somatic NPSR1 and SYNJ1 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic PHLPP1 and TENM2 homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the joint frequency of somatic COL6A3 and SOX21 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the joint frequency of somatic COL6A3 and BICC1 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the joint frequency of somatic COL6A3 and ZMYM3 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the joint frequency of somatic COL6A3 and FBN1 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the joint frequency of somatic COL6A3 and OR5D14 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the joint frequency of somatic ADRA1A and YY1AP1 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the joint frequency of somatic LAMB2 and BFAR homozygous deletions in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the joint frequency of somatic POC1B and CTSC homozygous deletions in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the joint frequency of somatic POC1B and DCN homozygous deletions in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the joint frequency of somatic POC1B and POLR1G homozygous deletions in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the joint frequency of somatic POC1B and SGIP1 homozygous deletions in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the joint frequency of somatic USH2A and RIMS2 homozygous deletions in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the joint frequency of somatic AQP7 and RIMS2 homozygous deletions in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the joint frequency of somatic AQP7 and HTR3B homozygous deletions in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the joint frequency of somatic AQP7 and DCC homozygous deletions in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the joint frequency of somatic AQP7 and LDOC1 homozygous deletions in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+430,DCN,R163C,Rectum Adenocarcinoma,What is the joint frequency of somatic DCN and NRAP homozygous deletions in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+431,DCN,R203C,Rectum Adenocarcinoma,What is the joint frequency of somatic DCN and EVC2 homozygous deletions in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+432,DCN,R241C,Rectum Adenocarcinoma,What is the joint frequency of somatic DCN and TLCD5 homozygous deletions in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+433,DCN,R350C,Rectum Adenocarcinoma,What is the joint frequency of somatic DCN and ZMYM3 homozygous deletions in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+434,DCN,R41C,Rectum Adenocarcinoma,What is the joint frequency of somatic DCN and CTSC homozygous deletions in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CPS1 and TMEM255A homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CPS1 and ADAM17 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CPS1 and GIMAP2 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the joint frequency of somatic FCGR2C and PTPRO homozygous deletions in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the joint frequency of somatic FCGR2C and OLFML3 homozygous deletions in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic GRM1 and PTPRO homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the joint frequency of somatic SGCZ and MAST4 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the joint frequency of somatic SGCZ and CTNNA2 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+485,SMO,V15M,Stomach Adenocarcinoma,What is the joint frequency of somatic SMO and TAF1C homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+486,SMO,V321M,Stomach Adenocarcinoma,What is the joint frequency of somatic SMO and CPS1 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the joint frequency of somatic CHODL and TMEM255A homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the joint frequency of somatic CHODL and SPINDOC homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the joint frequency of somatic CHODL and RIPOR2 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+494,MYO16,P399H,Colon Adenocarcinoma,What is the joint frequency of somatic MYO16 and FRY homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+495,MYO16,P421H,Colon Adenocarcinoma,What is the joint frequency of somatic MYO16 and TRAP1 homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the joint frequency of somatic CXCR2 and CHODL homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the joint frequency of somatic TMEM225 and TAF1C homozygous deletions in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic MAOB and NRAP homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic GPRASP1 and AUTS2 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic MRPL32 and UNC5D homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic TYROBP and CHODL homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the joint frequency of somatic RAB40C and GSTCD homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the joint frequency of somatic RAB40C and ZNF217 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the joint frequency of somatic CTNNA2 and UNC5D homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the joint frequency of somatic CTNNA2 and PAK3 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the joint frequency of somatic CTNNA2 and COL6A3 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the joint frequency of somatic CTNNA2 and CTCFL homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the joint frequency of somatic MYO15A and ZNF431 homozygous deletions in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the joint frequency of somatic GIMAP2 and DCC homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the joint frequency of somatic KIF20B and MYO3B homozygous deletions in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the joint frequency of somatic KIF20B and TAF1C homozygous deletions in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic ADAM17 and GABRA6 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic BCAT1 and PTPRN2 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic BCAT1 and LCN15 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic BCAT1 and TASOR2 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the joint frequency of somatic ERCC6 and EPRS1 homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+541,DCC,R320W,Breast Invasive Carcinoma,What is the joint frequency of somatic DCC and POLR1G homozygous deletions in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+542,DCC,R363W,Breast Invasive Carcinoma,What is the joint frequency of somatic DCC and CARMIL1 homozygous deletions in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+543,DCC,R386W,Breast Invasive Carcinoma,What is the joint frequency of somatic DCC and CACNA1F homozygous deletions in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+544,DCC,R41W,Breast Invasive Carcinoma,What is the joint frequency of somatic DCC and OLFML3 homozygous deletions in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the joint frequency of somatic FBXO15 and ART3 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the joint frequency of somatic FBXO15 and ABCC2 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic GSTCD and HTR3B homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic GSTCD and AUTS2 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic OLFML3 and PGF homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic OLFML3 and ZFP42 homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic OLFML3 and SPATA22 homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the joint frequency of somatic CFAP61 and NOMO1 homozygous deletions in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the joint frequency of somatic CFAP61 and JAML homozygous deletions in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the joint frequency of somatic HLA-DQA2 and TNS1 homozygous deletions in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the joint frequency of somatic TENM2 and TRIM45 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the joint frequency of somatic TENM2 and SGCZ homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the joint frequency of somatic TENM2 and ANKDD1A homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the joint frequency of somatic ANKRD24 and NRAP homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the joint frequency of somatic ANKRD24 and PHLPP1 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the joint frequency of somatic ANKRD24 and RAB40C homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the joint frequency of somatic ZCCHC14 and YY1AP1 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the joint frequency of somatic ZCCHC14 and JAML homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the joint frequency of somatic ZCCHC14 and SMO homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the joint frequency of somatic ZCCHC14 and GLRB homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+625,SIK2,I265M,Lung Adenocarcinoma,What is the joint frequency of somatic SIK2 and ZCCHC14 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic MYH11 and DCLK3 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic MYH11 and KDM5C homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the joint frequency of somatic SLC6A4 and TTC12 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic SLC9C1 and CA9 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic SLC9C1 and EIF2B4 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the joint frequency of somatic OR2A12 and DHX16 homozygous deletions in Brain Lower Grade Glioma?,freq_cnv_loss_or_gain
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the joint frequency of somatic PYHIN1 and ACTB homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the joint frequency of somatic PYHIN1 and FBXO15 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the joint frequency of somatic JAML and KANSL1 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the joint frequency of somatic JAML and MAST4 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the joint frequency of somatic JAML and PIK3C2B homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the joint frequency of somatic JAML and PXN homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the joint frequency of somatic TYK2 and MRPL32 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the joint frequency of somatic TYK2 and GABRA6 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the joint frequency of somatic TYK2 and MORF4L1 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CTCFL and CTCFL homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CTCFL and SGIP1 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CTCFL and ACVR1B homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CTCFL and ANKRD30A homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CEP20 and OLFML3 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CEP20 and TASOR2 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the joint frequency of somatic RIMS2 and ZMYM3 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the joint frequency of somatic RIMS2 and REXO4 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the joint frequency of somatic RIMS2 and ART3 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the joint frequency of somatic RIMS2 and MYO3A homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the joint frequency of somatic RIMS2 and TASOR2 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the joint frequency of somatic RIMS2 and PRSS8 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the joint frequency of somatic RIMS2 and TET2 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the joint frequency of somatic PIK3C2G and SGCZ homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the joint frequency of somatic PIK3C2G and MAD1L1 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+728,STK19,D341N,Colon Adenocarcinoma,What is the joint frequency of somatic STK19 and MERTK homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+729,STK19,D345N,Colon Adenocarcinoma,What is the joint frequency of somatic STK19 and DNMT1 homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the joint frequency of somatic REXO4 and TTYH2 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic ZBTB34 and ZCCHC14 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic ZBTB34 and PGR homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the joint frequency of somatic NCKAP5 and PCDHB2 homozygous deletions in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic SORCS1 and SMO homozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic SORCS1 and TAF1C homozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic SORCS1 and SORCS1 homozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic SORCS1 and FGF8 homozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the joint frequency of somatic FGF8 and ZFPM2 homozygous deletions in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the joint frequency of somatic FGF8 and GUF1 homozygous deletions in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the joint frequency of somatic FGF8 and ACVR1B homozygous deletions in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the joint frequency of somatic FGF8 and CTSC homozygous deletions in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the joint frequency of somatic FGF8 and FGF8 homozygous deletions in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the joint frequency of somatic TENM3 and ZNF708 homozygous deletions in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,freq_cnv_loss_or_gain
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic AKT1 and RIMS2 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the joint frequency of somatic CFAP298-TCP10L and GPR158 homozygous deletions in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the joint frequency of somatic GLRB and MAD1L1 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+793,TTN,F7636L,Colon Adenocarcinoma,What is the joint frequency of somatic TTN and PAK3 homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+794,TTN,F8563L,Colon Adenocarcinoma,What is the joint frequency of somatic TTN and ART3 homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+795,TTN,F8880L,Colon Adenocarcinoma,What is the joint frequency of somatic TTN and CEP20 homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the joint frequency of somatic ANKRD30A and SYT10 homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the joint frequency of somatic ANKRD30A and DCC homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the joint frequency of somatic ANKRD30A and TRPA1 homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the joint frequency of somatic TRIM45 and PAK3 homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the joint frequency of somatic TRIM45 and NPSR1 homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the joint frequency of somatic TRIM45 and YY1AP1 homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the joint frequency of somatic CACNA1F and ZMYM3 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the joint frequency of somatic CACNA1F and TTN homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the joint frequency of somatic CACNA1F and GABRA6 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+817,KL,R594C,Colon Adenocarcinoma,What is the joint frequency of somatic KL and YY1AP1 homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the joint frequency of somatic GUF1 and FGF8 homozygous deletions in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the joint frequency of somatic TAF1L and TMEM255A homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the joint frequency of somatic TASOR2 and TAF1C homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the joint frequency of somatic TASOR2 and CTNNA2 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the joint frequency of somatic TASOR2 and FNDC7 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the joint frequency of somatic KDM5C and ADRA1A homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the joint frequency of somatic KDM5C and ZFPM2 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the joint frequency of somatic KDM5C and CACNA1F homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the joint frequency of somatic KDM5C and DPF3 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the joint frequency of somatic IL5RA and LCN15 homozygous deletions in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the joint frequency of somatic DHX16 and CEP20 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the joint frequency of somatic DHX16 and PXN homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the joint frequency of somatic GPR158 and MYO3A homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the joint frequency of somatic GPR158 and ZFAT homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic EIF2B4 and AUTS2 homozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic EIF2B4 and FCGR2C homozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic EIF2B4 and CTCFL homozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic EIF2B4 and TMEM255A homozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic EIF2B4 and EVC2 homozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic EIF2B4 and ANKDD1A homozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic AUTS2 and LCN15 homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic AUTS2 and MERTK homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic AUTS2 and GPC3 homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic AUTS2 and CTSC homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic AUTS2 and ANKDD1A homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic AUTS2 and GPC3 homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic AUTS2 and FGF8 homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic AUTS2 and ZSCAN31 homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic AUTS2 and TYK2 homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic AUTS2 and RAB40C homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic ACTL7B and TTYH2 homozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the joint frequency of somatic PCDHGA1 and ZNF627 homozygous deletions in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the joint frequency of somatic TRAP1 and DCC homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the joint frequency of somatic TRAP1 and TYK2 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic PIK3C2A and CEP20 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the joint frequency of somatic KANSL1 and CTNNA2 homozygous deletions in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the joint frequency of somatic ANKRD52 and CXCR2 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic PAPPA and EIF2B4 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the joint frequency of somatic B3GALNT1 and ANKRD24 homozygous deletions in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the joint frequency of somatic GABRA6 and THBS4 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the joint frequency of somatic GABRA6 and CDH23 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the joint frequency of somatic GABRA6 and MAOB homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the joint frequency of somatic GABRA6 and TAF1C homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the joint frequency of somatic GABRA6 and TASOR2 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the joint frequency of somatic ZSCAN31 and ANKRD24 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic MED16 and SMO homozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic MED16 and MERTK homozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the joint frequency of somatic PTPRO and STK19 homozygous deletions in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the joint frequency of somatic PTPRO and RELN homozygous deletions in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the joint frequency of somatic PTPRO and PIK3C2B homozygous deletions in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the joint frequency of somatic PTPRO and C7orf31 homozygous deletions in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the joint frequency of somatic PTPRO and GPC3 homozygous deletions in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the joint frequency of somatic PTPRO and ZFAT homozygous deletions in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the joint frequency of somatic PTPRO and TLK2 homozygous deletions in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the joint frequency of somatic PTPRO and SIK2 homozygous deletions in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CHMP7 and MED16 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the joint frequency of somatic GPC3 and SLC9C1 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the joint frequency of somatic GPC3 and TTYH2 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the joint frequency of somatic TLK2 and TNS1 homozygous deletions in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the joint frequency of somatic TLK2 and AUTS2 homozygous deletions in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the joint frequency of somatic TLK2 and PGR homozygous deletions in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the joint frequency of somatic TLK2 and TMTC3 homozygous deletions in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the joint frequency of somatic TLK2 and RIMS2 homozygous deletions in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the joint frequency of somatic ZNF217 and PLEKHG6 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the joint frequency of somatic SYT9 and CCDC22 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the joint frequency of somatic SYT9 and CYB5R2 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic PKHD1L1 and MORF4L1 homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic MYO3A and DPF3 homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic VASN and TET2 homozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic DNMT1 and TENM2 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic DNMT1 and CNGB1 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic DNMT1 and YY1AP1 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1056,CA9,E402K,Colon Adenocarcinoma,What is the joint frequency of somatic CA9 and ZFAT homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic TTC17 and CNGB1 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic TTC17 and GRTP1 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the joint frequency of somatic PSG2 and CTNNA2 homozygous deletions in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the joint frequency of somatic RIPOR2 and FBN1 homozygous deletions in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the joint frequency of somatic RIPOR2 and PRSS8 homozygous deletions in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the joint frequency of somatic RIPOR2 and FRY homozygous deletions in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the joint frequency of somatic RIPOR2 and MED16 homozygous deletions in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic DCLK3 and RIMS2 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic DCLK3 and ZNF217 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic MERTK and PRSS8 homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic MERTK and DCAF6 homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic MERTK and TLCD5 homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the joint frequency of somatic ZFP42 and TSHZ3 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the joint frequency of somatic OR13C3 and DCAF4L2 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the joint frequency of somatic OR13C3 and TASOR2 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the joint frequency of somatic SPAG1 and MSANTD4 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CDKN2AIP and DNMT1 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the joint frequency of somatic PXN and PLEKHG6 homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the joint frequency of somatic PXN and ZKSCAN7 homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the joint frequency of somatic PXN and EBF2 homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the joint frequency of somatic PXN and DCC homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the joint frequency of somatic PXN and RIMS2 homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the joint frequency of somatic PXN and PGR homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic TTYH2 and CHMP7 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic TTYH2 and PAK3 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the joint frequency of somatic TMEM255A and DHX16 homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the joint frequency of somatic TMEM255A and ZNF708 homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the joint frequency of somatic TMEM255A and MYT1 homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the joint frequency of somatic TASOR2 and CFAP61 homozygous deletions in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the joint frequency of somatic TASOR2 and MERTK homozygous deletions in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic ICE1 and TMEM255A homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the joint frequency of somatic MYT1 and ANKRD30A homozygous deletions in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the joint frequency of somatic MYT1 and EIF2B4 homozygous deletions in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the joint frequency of somatic MYT1 and IL5RA homozygous deletions in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CX3CR1 and TTC17 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CX3CR1 and PRSS1 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the joint frequency of somatic SPINDOC and ARMC3 homozygous deletions in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic ART3 and TMEM255A homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic ART3 and ANKRD30A homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the joint frequency of somatic CYP1A2 and KDM5C homozygous deletions in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic ADRA1A and CPS1 homozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic CDH23 and TNS1 homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic CDH23 and ZFPM2 homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the joint frequency of somatic KRT39 and CNGB1 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic PDHA2 and DCN homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the joint frequency of somatic SLC24A2 and PDGFC homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the joint frequency of somatic PTPRN2 and GPC3 homozygous deletions in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the joint frequency of somatic PTPRN2 and TYK2 homozygous deletions in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the joint frequency of somatic PTPRN2 and EPRS1 homozygous deletions in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the joint frequency of somatic PTPRN2 and TAF1L homozygous deletions in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the joint frequency of somatic PTPRN2 and AUTS2 homozygous deletions in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the joint frequency of somatic SOX21 and REXO4 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the joint frequency of somatic CPA6 and PCDHB2 homozygous deletions in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the joint frequency of somatic GRM5 and TTC17 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic CASZ1 and ZKSCAN7 homozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the joint frequency of somatic SGIP1 and PIK3C2G homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the joint frequency of somatic SGIP1 and MAST4 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the joint frequency of somatic SGIP1 and PRSS8 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the joint frequency of somatic SGIP1 and EPRS1 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the joint frequency of somatic CARMIL1 and ZCCHC14 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the joint frequency of somatic CARMIL1 and JAML homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the joint frequency of somatic ZNF431 and TASOR2 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the joint frequency of somatic ZNF431 and OLFML3 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the joint frequency of somatic ZNF431 and JAML homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the joint frequency of somatic DNAH11 and CNGB1 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the joint frequency of somatic DNAH11 and CACNA1F homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic POLD1 and COL6A3 homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic POLD1 and DNMT1 homozygous deletions in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the joint frequency of somatic TTC12 and PXN homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the joint frequency of somatic TTC12 and NEXN homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the joint frequency of somatic CNGB1 and SLC9C1 homozygous deletions in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the joint frequency of somatic CNGB1 and AUTS2 homozygous deletions in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the joint frequency of somatic CTSC and ZFP42 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the joint frequency of somatic CTSC and CCDC22 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the joint frequency of somatic CTSC and HSPA5 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the joint frequency of somatic CTSC and HYOU1 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the joint frequency of somatic CTSC and TTN homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic PRSS8 and GUK1 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic PRSS8 and BICC1 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the joint frequency of somatic ARHGEF40 and TTC17 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the joint frequency of somatic ACTB and MAST4 homozygous deletions in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the joint frequency of somatic ACTB and TENM2 homozygous deletions in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the joint frequency of somatic ACTB and AUTS2 homozygous deletions in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the joint frequency of somatic ACTB and RIMS2 homozygous deletions in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the joint frequency of somatic YY1AP1 and GABRA6 homozygous deletions in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the joint frequency of somatic YY1AP1 and ART3 homozygous deletions in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the joint frequency of somatic YY1AP1 and FGF8 homozygous deletions in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the joint frequency of somatic YY1AP1 and TAS1R3 homozygous deletions in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the joint frequency of somatic YY1AP1 and DNAH11 homozygous deletions in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the joint frequency of somatic YY1AP1 and TASOR2 homozygous deletions in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the joint frequency of somatic YY1AP1 and TRAP1 homozygous deletions in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the joint frequency of somatic FNDC7 and THBS4 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the joint frequency of somatic FNDC7 and ANKDD1A homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the joint frequency of somatic TLCD5 and CACNA1F homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the joint frequency of somatic TLCD5 and EVC2 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic POLR1G and ZFAT homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic POLR1G and SGIP1 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the joint frequency of somatic DNAH14 and PIAS3 homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the joint frequency of somatic DNAH14 and VPS26B homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the joint frequency of somatic DNAH14 and POC1B homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic NEXN and GABRA6 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the joint frequency of somatic CYB5R2 and YY1AP1 homozygous deletions in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the joint frequency of somatic CYB5R2 and DNAH11 homozygous deletions in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic NRAP and ACVR1B homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic NRAP and TTC17 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic NRAP and MAD1L1 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CCDC22 and ARMC3 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the joint frequency of somatic DCAF6 and LDOC1 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the joint frequency of somatic DCAF6 and TASOR2 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic ZNF708 and KDM5C homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic BFAR and ANKRD24 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic MAST4 and SLC24A2 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic MAST4 and CTNNA2 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic MAST4 and TAF1C homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic MAST4 and GUK1 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic MAST4 and ZFPM2 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the joint frequency of somatic ARMC3 and ANKRD30A homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the joint frequency of somatic ARMC3 and PRSS8 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the joint frequency of somatic TET2 and AUTS2 homozygous deletions in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the joint frequency of somatic TET2 and TLK2 homozygous deletions in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the joint frequency of somatic SERPINB10 and ZNF274 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic STAT3 and TLK2 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic MIEF1 and PYHIN1 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the joint frequency of somatic ACVR1B and POLD1 homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the joint frequency of somatic ACVR1B and SGCZ homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the joint frequency of somatic ACVR1B and ZFP42 homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the joint frequency of somatic EBF2 and TRAP1 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the joint frequency of somatic EBF2 and C7orf31 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the joint frequency of somatic VPS26B and CHODL homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic PGR and CPS1 homozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic PGR and ZBTB34 homozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic PGR and CFAP61 homozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the joint frequency of somatic ACTA2 and CFAP61 homozygous deletions in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic THBS4 and PXN homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic THBS4 and MYO15A homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the joint frequency of somatic PRSS1 and MYO16 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the joint frequency of somatic PRSS1 and ZFAT homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the joint frequency of somatic PRSS1 and PIK3C2A homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the joint frequency of somatic PRSS1 and B3GALNT1 homozygous deletions in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the joint frequency of somatic PGF and EIF2B4 homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the joint frequency of somatic PGF and DSCAM homozygous deletions in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the joint frequency of somatic ITPRID2 and DPF3 homozygous deletions in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the joint frequency of somatic ITPRID2 and HYOU1 homozygous deletions in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic HBB and SYNJ1 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the joint frequency of somatic PCDHB2 and COL6A3 homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the joint frequency of somatic PCDHB2 and PXN homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the joint frequency of somatic PCDHB2 and OR2A12 homozygous deletions in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic UBR2 and CDH23 homozygous deletions in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the joint frequency of somatic FBXO42 and SERPINB10 homozygous deletions in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the frequency of somatic TNS1 and JAML heterozygous co-deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the frequency of somatic TNS1 and PIK3C2G heterozygous co-deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the frequency of somatic TNS1 and HLA-DQA2 heterozygous co-deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the frequency of somatic TNS1 and ANP32E heterozygous co-deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the frequency of somatic TNS1 and POC1B heterozygous co-deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the frequency of somatic TNS1 and TENT5A heterozygous co-deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the frequency of somatic TNS1 and ACVR1B heterozygous co-deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the frequency of somatic EVC2 and MED16 heterozygous co-deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the frequency of somatic EVC2 and PDHA2 heterozygous co-deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CR1 and EBF2 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CR1 and TMEM255A heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the frequency of somatic TRPA1 and COL6A3 heterozygous co-deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the frequency of somatic TRPA1 and CDH23 heterozygous co-deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the frequency of somatic TAF1C and GUK1 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the frequency of somatic TAF1C and GRTP1 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the frequency of somatic TAF1C and SPINDOC heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the frequency of somatic TAF1C and MAST4 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the frequency of somatic TAF1C and TTN heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic DPF3 and DCN heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic DPF3 and TAF1C heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic DPF3 and SGCZ heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the frequency of somatic OR2T4 and PTPRO heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the frequency of somatic OR2T4 and PTPRO heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the frequency of somatic FBN1 and TMEM255A heterozygous co-deletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the frequency of somatic MAD1L1 and CHODL heterozygous co-deletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the frequency of somatic MAD1L1 and MYO3A heterozygous co-deletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the frequency of somatic MAD1L1 and NOMO1 heterozygous co-deletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the frequency of somatic CCNG1 and AUTS2 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of somatic ANP32E and GUK1 heterozygous co-deletion in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of somatic ANP32E and TENT5A heterozygous co-deletion in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of somatic ANP32E and CPS1 heterozygous co-deletion in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of somatic ANP32E and SYNJ1 heterozygous co-deletion in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the frequency of somatic FRY and HTR3B heterozygous co-deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the frequency of somatic FRY and RIPOR2 heterozygous co-deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the frequency of somatic FRY and AUTS2 heterozygous co-deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the frequency of somatic FRY and DHX16 heterozygous co-deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the frequency of somatic PAK3 and KDM5C heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the frequency of somatic PAK3 and TAF1L heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the frequency of somatic PAK3 and TAF1C heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the frequency of somatic PAK3 and CCDC22 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the frequency of somatic PAK3 and ADRA1A heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the frequency of somatic MUC16 and FGF8 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the frequency of somatic ZFPM2 and MYO16 heterozygous co-deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the frequency of somatic ZFPM2 and GSTCD heterozygous co-deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the frequency of somatic PIK3C2B and AUTS2 heterozygous co-deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the frequency of somatic PIK3C2B and AUTS2 heterozygous co-deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the frequency of somatic ZNF804A and MYO16 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the frequency of somatic RELN and ARMC3 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic EFCAB12 and UNC5D heterozygous co-deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic EFCAB12 and CTNNA2 heterozygous co-deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the frequency of somatic DEFB115 and SGIP1 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the frequency of somatic ANKDD1A and TRIM45 heterozygous co-deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the frequency of somatic ANKDD1A and ART3 heterozygous co-deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the frequency of somatic ANKDD1A and UNC5D heterozygous co-deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic HTR3B and AUTS2 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic HTR3B and CX3CR1 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic HTR3B and GABRA6 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the frequency of somatic ABCC3 and ABCC3 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic NOMO1 and TMEM225 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic NOMO1 and ICE1 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the frequency of somatic HYOU1 and ZBTB34 heterozygous co-deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the frequency of somatic FMO4 and SERPINB10 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+140,BICC1,A372V,Exceptional Responders,What is the frequency of somatic BICC1 and KIF20B heterozygous co-deletion in Exceptional Responders?,freq_cnv_loss_or_gain
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ZMYM3 and TAF1C heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ZMYM3 and MAST4 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ZMYM3 and MUC16 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic XKR4 and CX3CR1 heterozygous co-deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the frequency of somatic ABCC2 and RIMS2 heterozygous co-deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the frequency of somatic OR8K5 and ARMC3 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the frequency of somatic SPTAN1 and ADRA1A heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the frequency of somatic SPTAN1 and DEFB115 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the frequency of somatic SYT10 and MERTK heterozygous co-deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the frequency of somatic HSPA5 and SLC6A4 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the frequency of somatic UNC5D and KIF20B heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the frequency of somatic UNC5D and CA9 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the frequency of somatic UNC5D and ZNF217 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the frequency of somatic UNC5D and SYNJ1 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the frequency of somatic UNC5D and ANKDD1A heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the frequency of somatic UNC5D and ZBTB34 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the frequency of somatic DOCK2 and KRT39 heterozygous co-deletion in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the frequency of somatic ZNF627 and NRAP heterozygous co-deletion in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the frequency of somatic CDC42BPA and AUTS2 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the frequency of somatic MRPL55 and NCKAP5 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the frequency of somatic MRPL55 and SMO heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the frequency of somatic TMTC3 and CTNNA2 heterozygous co-deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the frequency of somatic EPRS1 and RIPOR2 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the frequency of somatic EPRS1 and TAF1C heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the frequency of somatic GRTP1 and MYT1 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the frequency of somatic GRTP1 and THBS4 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the frequency of somatic TSHZ3 and ACTB heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the frequency of somatic TAS1R3 and TENM2 heterozygous co-deletion in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,freq_cnv_loss_or_gain
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the frequency of somatic PIAS3 and SERPINB10 heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the frequency of somatic PIAS3 and PTPRO heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the frequency of somatic ZNF274 and SGIP1 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the frequency of somatic SYNJ1 and SORCS1 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the frequency of somatic SYNJ1 and DCAF4L2 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the frequency of somatic SYNJ1 and HLA-DQA2 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the frequency of somatic DSCAM and RIMS2 heterozygous co-deletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the frequency of somatic DSCAM and TRPA1 heterozygous co-deletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the frequency of somatic DSCAM and TAS1R3 heterozygous co-deletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+267,DGKD,R140H,Exceptional Responders,What is the frequency of somatic DGKD and FGF8 heterozygous co-deletion in Exceptional Responders?,freq_cnv_loss_or_gain
+268,DGKD,R160H,Exceptional Responders,What is the frequency of somatic DGKD and PTPRO heterozygous co-deletion in Exceptional Responders?,freq_cnv_loss_or_gain
+269,DGKD,R204H,Exceptional Responders,What is the frequency of somatic DGKD and POLR1G heterozygous co-deletion in Exceptional Responders?,freq_cnv_loss_or_gain
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the frequency of somatic PLEKHG6 and ZKSCAN7 heterozygous co-deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the frequency of somatic PLEKHG6 and SYT9 heterozygous co-deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the frequency of somatic PLEKHG6 and AUTS2 heterozygous co-deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the frequency of somatic WNT2 and WNT2 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the frequency of somatic GUCY2C and CA9 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic C7orf31 and KDM5C heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic ZKSCAN7 and OLFML3 heterozygous co-deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+299,OR5D14,M210L,Neuroblastoma,What is the frequency of somatic OR5D14 and PGF heterozygous co-deletion in Neuroblastoma?,freq_cnv_loss_or_gain
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic SPATA22 and TTYH2 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic SPATA22 and TENT5A heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic SPATA22 and ZCCHC14 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the frequency of somatic LCN15 and DCN heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the frequency of somatic DCAF4L2 and PTPRO heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the frequency of somatic GUK1 and MERTK heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the frequency of somatic GUK1 and CASZ1 heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the frequency of somatic GUK1 and CYP1A2 heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the frequency of somatic GUK1 and MED16 heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the frequency of somatic GUK1 and PGR heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the frequency of somatic MORF4L1 and POLD1 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the frequency of somatic MORF4L1 and GPR158 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the frequency of somatic MORF4L1 and MAST4 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the frequency of somatic MORF4L1 and UNC5D heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the frequency of somatic MYO3B and ABCC2 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the frequency of somatic MYO3B and ACTA2 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the frequency of somatic TENT5A and FRY heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the frequency of somatic TENT5A and TLK2 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the frequency of somatic TENT5A and UNC5D heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the frequency of somatic ZFAT and ZNF804A heterozygous co-deletion in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the frequency of somatic ZFAT and PLEKHG6 heterozygous co-deletion in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the frequency of somatic ZFAT and TTYH2 heterozygous co-deletion in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+357,ZNF584,A211T,Sarcoma,What is the frequency of somatic ZNF584 and SGIP1 heterozygous co-deletion in Sarcoma?,freq_cnv_loss_or_gain
+358,ZNF584,A256T,Sarcoma,What is the frequency of somatic ZNF584 and MYT1 heterozygous co-deletion in Sarcoma?,freq_cnv_loss_or_gain
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic LDOC1 and CCDC22 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the frequency of somatic PDGFC and NRAP heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MSANTD4 and SGIP1 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the frequency of somatic NPSR1 and CR1 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the frequency of somatic PHLPP1 and AUTS2 heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the frequency of somatic COL6A3 and EPRS1 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the frequency of somatic COL6A3 and ZCCHC14 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the frequency of somatic COL6A3 and TASOR2 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the frequency of somatic COL6A3 and MAD1L1 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the frequency of somatic COL6A3 and TTC12 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the frequency of somatic ADRA1A and MYO16 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of somatic LAMB2 and NOMO1 heterozygous co-deletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the frequency of somatic POC1B and ACVR1B heterozygous co-deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the frequency of somatic POC1B and CTNNA2 heterozygous co-deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the frequency of somatic POC1B and KL heterozygous co-deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the frequency of somatic POC1B and RIMS2 heterozygous co-deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the frequency of somatic USH2A and SYNJ1 heterozygous co-deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the frequency of somatic AQP7 and ZBTB34 heterozygous co-deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the frequency of somatic AQP7 and SPTAN1 heterozygous co-deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the frequency of somatic AQP7 and PXN heterozygous co-deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the frequency of somatic AQP7 and UBR2 heterozygous co-deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+430,DCN,R163C,Rectum Adenocarcinoma,What is the frequency of somatic DCN and SLC9C1 heterozygous co-deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+431,DCN,R203C,Rectum Adenocarcinoma,What is the frequency of somatic DCN and MAD1L1 heterozygous co-deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+432,DCN,R241C,Rectum Adenocarcinoma,What is the frequency of somatic DCN and TTYH2 heterozygous co-deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+433,DCN,R350C,Rectum Adenocarcinoma,What is the frequency of somatic DCN and PLEKHG6 heterozygous co-deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+434,DCN,R41C,Rectum Adenocarcinoma,What is the frequency of somatic DCN and AQP7 heterozygous co-deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CPS1 and COL6A3 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CPS1 and PRSS8 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CPS1 and GPC3 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the frequency of somatic FCGR2C and MYO16 heterozygous co-deletion in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the frequency of somatic FCGR2C and ANKRD30A heterozygous co-deletion in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic GRM1 and ZMYM3 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the frequency of somatic SGCZ and PGF heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the frequency of somatic SGCZ and GIMAP2 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+485,SMO,V15M,Stomach Adenocarcinoma,What is the frequency of somatic SMO and PGF heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+486,SMO,V321M,Stomach Adenocarcinoma,What is the frequency of somatic SMO and DCAF4L2 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the frequency of somatic CHODL and DCC heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the frequency of somatic CHODL and MYH11 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the frequency of somatic CHODL and POLR1G heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+494,MYO16,P399H,Colon Adenocarcinoma,What is the frequency of somatic MYO16 and PSG2 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+495,MYO16,P421H,Colon Adenocarcinoma,What is the frequency of somatic MYO16 and FGF8 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the frequency of somatic CXCR2 and GUK1 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the frequency of somatic TMEM225 and ACTB heterozygous co-deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MAOB and DSCAM heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic GPRASP1 and JAML heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MRPL32 and CARMIL1 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic TYROBP and EFCAB12 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the frequency of somatic RAB40C and PIAS3 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the frequency of somatic RAB40C and AUTS2 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the frequency of somatic CTNNA2 and COL6A3 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the frequency of somatic CTNNA2 and YY1AP1 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the frequency of somatic CTNNA2 and CPS1 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the frequency of somatic CTNNA2 and GPR158 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the frequency of somatic MYO15A and HTR3B heterozygous co-deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the frequency of somatic GIMAP2 and ZMYM3 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the frequency of somatic KIF20B and RIPOR2 heterozygous co-deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the frequency of somatic KIF20B and YY1AP1 heterozygous co-deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ADAM17 and FGF8 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic BCAT1 and CHODL heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic BCAT1 and PGF heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic BCAT1 and LAMB2 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the frequency of somatic ERCC6 and MRPL32 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+541,DCC,R320W,Breast Invasive Carcinoma,What is the frequency of somatic DCC and UNC5D heterozygous co-deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+542,DCC,R363W,Breast Invasive Carcinoma,What is the frequency of somatic DCC and TENT5A heterozygous co-deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+543,DCC,R386W,Breast Invasive Carcinoma,What is the frequency of somatic DCC and PGR heterozygous co-deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+544,DCC,R41W,Breast Invasive Carcinoma,What is the frequency of somatic DCC and PTPRO heterozygous co-deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the frequency of somatic FBXO15 and MAST4 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the frequency of somatic FBXO15 and TASOR2 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic GSTCD and TENT5A heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic GSTCD and CFAP61 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the frequency of somatic OLFML3 and BICC1 heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the frequency of somatic OLFML3 and TASOR2 heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the frequency of somatic OLFML3 and TRPA1 heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the frequency of somatic CFAP61 and UNC5D heterozygous co-deletion in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the frequency of somatic CFAP61 and PXN heterozygous co-deletion in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the frequency of somatic HLA-DQA2 and DCLK3 heterozygous co-deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the frequency of somatic TENM2 and TAS1R3 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the frequency of somatic TENM2 and GRM5 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the frequency of somatic TENM2 and DCN heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the frequency of somatic ANKRD24 and EPRS1 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the frequency of somatic ANKRD24 and ART3 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the frequency of somatic ANKRD24 and TTC12 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the frequency of somatic ZCCHC14 and MUC16 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the frequency of somatic ZCCHC14 and TET2 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the frequency of somatic ZCCHC14 and CXCR2 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the frequency of somatic ZCCHC14 and AUTS2 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+625,SIK2,I265M,Lung Adenocarcinoma,What is the frequency of somatic SIK2 and HTR3B heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MYH11 and BCAT1 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MYH11 and ZNF627 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the frequency of somatic SLC6A4 and TRPA1 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic SLC9C1 and MUC16 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic SLC9C1 and PTPRN2 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the frequency of somatic OR2A12 and OR13C3 heterozygous co-deletion in Brain Lower Grade Glioma?,freq_cnv_loss_or_gain
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the frequency of somatic PYHIN1 and SGIP1 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the frequency of somatic PYHIN1 and GRTP1 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the frequency of somatic JAML and CYB5R2 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the frequency of somatic JAML and PXN heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the frequency of somatic JAML and NEXN heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the frequency of somatic JAML and AQP7 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the frequency of somatic TYK2 and MERTK heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the frequency of somatic TYK2 and CDH23 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the frequency of somatic TYK2 and PIK3C2B heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CTCFL and PRSS1 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CTCFL and SERPINB10 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CTCFL and TTC17 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CTCFL and YY1AP1 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CEP20 and ZFAT heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CEP20 and ERCC6 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the frequency of somatic RIMS2 and DCC heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the frequency of somatic RIMS2 and OR2T4 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the frequency of somatic RIMS2 and MORF4L1 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the frequency of somatic RIMS2 and HTR3B heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the frequency of somatic RIMS2 and ICE1 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the frequency of somatic RIMS2 and MERTK heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the frequency of somatic RIMS2 and ACTB heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the frequency of somatic PIK3C2G and OR8K5 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the frequency of somatic PIK3C2G and DCN heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+728,STK19,D341N,Colon Adenocarcinoma,What is the frequency of somatic STK19 and ADRA1A heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+729,STK19,D345N,Colon Adenocarcinoma,What is the frequency of somatic STK19 and TTC17 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the frequency of somatic REXO4 and SORCS1 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ZBTB34 and TAF1C heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ZBTB34 and TLK2 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the frequency of somatic NCKAP5 and ACTB heterozygous co-deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic SORCS1 and TNS1 heterozygous co-deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic SORCS1 and PIK3C2G heterozygous co-deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic SORCS1 and ZCCHC14 heterozygous co-deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic SORCS1 and PIK3C2B heterozygous co-deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the frequency of somatic FGF8 and PAK3 heterozygous co-deletion in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the frequency of somatic FGF8 and EVC2 heterozygous co-deletion in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the frequency of somatic FGF8 and TNS1 heterozygous co-deletion in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the frequency of somatic FGF8 and ANKRD30A heterozygous co-deletion in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the frequency of somatic FGF8 and TASOR2 heterozygous co-deletion in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the frequency of somatic TENM3 and TTYH2 heterozygous co-deletion in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,freq_cnv_loss_or_gain
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic AKT1 and DCC heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of somatic CFAP298-TCP10L and HYOU1 heterozygous co-deletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the frequency of somatic GLRB and TET2 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+793,TTN,F7636L,Colon Adenocarcinoma,What is the frequency of somatic TTN and ERCC6 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+794,TTN,F8563L,Colon Adenocarcinoma,What is the frequency of somatic TTN and MYH11 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+795,TTN,F8880L,Colon Adenocarcinoma,What is the frequency of somatic TTN and AUTS2 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the frequency of somatic ANKRD30A and PRSS1 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the frequency of somatic ANKRD30A and FNDC7 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the frequency of somatic ANKRD30A and TET2 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the frequency of somatic TRIM45 and XKR4 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the frequency of somatic TRIM45 and PTPRN2 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the frequency of somatic TRIM45 and CTSC heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the frequency of somatic CACNA1F and NRAP heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the frequency of somatic CACNA1F and GPC3 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the frequency of somatic CACNA1F and ZSCAN31 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+817,KL,R594C,Colon Adenocarcinoma,What is the frequency of somatic KL and TMEM255A heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of somatic GUF1 and ABCC2 heterozygous co-deletion in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the frequency of somatic TAF1L and TENT5A heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the frequency of somatic TASOR2 and AQP7 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the frequency of somatic TASOR2 and MAST4 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the frequency of somatic TASOR2 and CHODL heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the frequency of somatic KDM5C and TRPA1 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the frequency of somatic KDM5C and CYB5R2 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the frequency of somatic KDM5C and MAD1L1 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the frequency of somatic KDM5C and STK19 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of somatic IL5RA and MAOB heterozygous co-deletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the frequency of somatic DHX16 and FMO4 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the frequency of somatic DHX16 and ACTB heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the frequency of somatic GPR158 and CTNNA2 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the frequency of somatic GPR158 and OR2T4 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic EIF2B4 and ADRA1A heterozygous co-deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic EIF2B4 and MIEF1 heterozygous co-deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic EIF2B4 and DNMT1 heterozygous co-deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic EIF2B4 and ANP32E heterozygous co-deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic EIF2B4 and ZNF431 heterozygous co-deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic EIF2B4 and MRPL32 heterozygous co-deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 and CEP20 heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 and MAOB heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 and AQP7 heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 and DNMT1 heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 and TNS1 heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 and ZNF584 heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 and ANKDD1A heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 and SLC9C1 heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 and MAST4 heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the frequency of somatic AUTS2 and DCC heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic ACTL7B and GABRA6 heterozygous co-deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the frequency of somatic PCDHGA1 and ABCC3 heterozygous co-deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the frequency of somatic TRAP1 and PCDHB2 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the frequency of somatic TRAP1 and FNDC7 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic PIK3C2A and TMEM255A heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the frequency of somatic KANSL1 and MED16 heterozygous co-deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the frequency of somatic ANKRD52 and PAK3 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic PAPPA and KIF20B heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the frequency of somatic B3GALNT1 and TTC12 heterozygous co-deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the frequency of somatic GABRA6 and STAT3 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the frequency of somatic GABRA6 and MERTK heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the frequency of somatic GABRA6 and ANKRD30A heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the frequency of somatic GABRA6 and PLEKHG6 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the frequency of somatic GABRA6 and ITPRID2 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the frequency of somatic ZSCAN31 and ANP32E heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic MED16 and FGF8 heterozygous co-deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic MED16 and THBS4 heterozygous co-deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the frequency of somatic PTPRO and JAML heterozygous co-deletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the frequency of somatic PTPRO and HLA-DQA2 heterozygous co-deletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the frequency of somatic PTPRO and COL6A3 heterozygous co-deletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the frequency of somatic PTPRO and DGKD heterozygous co-deletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the frequency of somatic PTPRO and NPSR1 heterozygous co-deletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the frequency of somatic PTPRO and STAT3 heterozygous co-deletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the frequency of somatic PTPRO and STAT3 heterozygous co-deletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the frequency of somatic PTPRO and PIAS3 heterozygous co-deletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CHMP7 and SMO heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the frequency of somatic GPC3 and PCDHB2 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the frequency of somatic GPC3 and GABRA6 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of somatic TLK2 and TAS1R3 heterozygous co-deletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of somatic TLK2 and FNDC7 heterozygous co-deletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of somatic TLK2 and ZNF431 heterozygous co-deletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of somatic TLK2 and ANP32E heterozygous co-deletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of somatic TLK2 and SPATA22 heterozygous co-deletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the frequency of somatic ZNF217 and ABCC3 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the frequency of somatic SYT9 and GPC3 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the frequency of somatic SYT9 and TNS1 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the frequency of somatic PKHD1L1 and MAST4 heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the frequency of somatic MYO3A and PIAS3 heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic VASN and KDM5C heterozygous co-deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic DNMT1 and SGCZ heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic DNMT1 and ITPRID2 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic DNMT1 and EIF2B4 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1056,CA9,E402K,Colon Adenocarcinoma,What is the frequency of somatic CA9 and ANKRD30A heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic TTC17 and RIMS2 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic TTC17 and ANP32E heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the frequency of somatic PSG2 and TTN heterozygous co-deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the frequency of somatic RIPOR2 and DHX16 heterozygous co-deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the frequency of somatic RIPOR2 and MYT1 heterozygous co-deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the frequency of somatic RIPOR2 and PRSS1 heterozygous co-deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the frequency of somatic RIPOR2 and COL6A3 heterozygous co-deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic DCLK3 and STAT3 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic DCLK3 and MIEF1 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the frequency of somatic MERTK and POC1B heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the frequency of somatic MERTK and GIMAP2 heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the frequency of somatic MERTK and MORF4L1 heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the frequency of somatic ZFP42 and SGIP1 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the frequency of somatic OR13C3 and YY1AP1 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the frequency of somatic OR13C3 and GABRA6 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the frequency of somatic SPAG1 and ZFAT heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CDKN2AIP and YY1AP1 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the frequency of somatic PXN and TAF1C heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the frequency of somatic PXN and BCAT1 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the frequency of somatic PXN and CPS1 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the frequency of somatic PXN and TENM2 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the frequency of somatic PXN and MYO3B heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the frequency of somatic PXN and PYHIN1 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic TTYH2 and GABRA6 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic TTYH2 and CPS1 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the frequency of somatic TMEM255A and TTC12 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the frequency of somatic TMEM255A and EIF2B4 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the frequency of somatic TMEM255A and TYK2 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the frequency of somatic TASOR2 and PCDHB2 heterozygous co-deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the frequency of somatic TASOR2 and TAS1R3 heterozygous co-deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ICE1 and MYO3B heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the frequency of somatic MYT1 and OR5D14 heterozygous co-deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the frequency of somatic MYT1 and ANKDD1A heterozygous co-deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the frequency of somatic MYT1 and GABRA6 heterozygous co-deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CX3CR1 and PTPRO heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CX3CR1 and TNS1 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the frequency of somatic SPINDOC and TLK2 heterozygous co-deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ART3 and DHX16 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ART3 and EIF2B4 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the frequency of somatic CYP1A2 and GRM1 heterozygous co-deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic ADRA1A and TAF1C heterozygous co-deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the frequency of somatic CDH23 and SYT9 heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the frequency of somatic CDH23 and PXN heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the frequency of somatic KRT39 and JAML heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the frequency of somatic PDHA2 and ZNF431 heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the frequency of somatic SLC24A2 and PAPPA heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the frequency of somatic PTPRN2 and PCDHB2 heterozygous co-deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the frequency of somatic PTPRN2 and MAST4 heterozygous co-deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the frequency of somatic PTPRN2 and PHLPP1 heterozygous co-deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the frequency of somatic PTPRN2 and MAST4 heterozygous co-deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the frequency of somatic PTPRN2 and KDM5C heterozygous co-deletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the frequency of somatic SOX21 and ART3 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the frequency of somatic CPA6 and CACNA1F heterozygous co-deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the frequency of somatic GRM5 and ZBTB34 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic CASZ1 and CARMIL1 heterozygous co-deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the frequency of somatic SGIP1 and ADRA1A heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the frequency of somatic SGIP1 and STAT3 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the frequency of somatic SGIP1 and ANKDD1A heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the frequency of somatic SGIP1 and ZSCAN31 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the frequency of somatic CARMIL1 and GPRASP1 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the frequency of somatic CARMIL1 and TLCD5 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the frequency of somatic ZNF431 and JAML heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the frequency of somatic ZNF431 and VASN heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the frequency of somatic ZNF431 and TLK2 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the frequency of somatic DNAH11 and ZFAT heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the frequency of somatic DNAH11 and EFCAB12 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the frequency of somatic POLD1 and JAML heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the frequency of somatic POLD1 and TENM3 heterozygous co-deletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the frequency of somatic TTC12 and TENT5A heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the frequency of somatic TTC12 and POLR1G heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the frequency of somatic CNGB1 and POLR1G heterozygous co-deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the frequency of somatic CNGB1 and RIPOR2 heterozygous co-deletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the frequency of somatic CTSC and SPATA22 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the frequency of somatic CTSC and DNMT1 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the frequency of somatic CTSC and PXN heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the frequency of somatic CTSC and ZNF431 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the frequency of somatic CTSC and MYT1 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic PRSS8 and ABCC3 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic PRSS8 and ACTA2 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the frequency of somatic ARHGEF40 and ANKRD24 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the frequency of somatic ACTB and SYNJ1 heterozygous co-deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the frequency of somatic ACTB and TAS1R3 heterozygous co-deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the frequency of somatic ACTB and PIAS3 heterozygous co-deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the frequency of somatic ACTB and ANKRD24 heterozygous co-deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the frequency of somatic YY1AP1 and MORF4L1 heterozygous co-deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the frequency of somatic YY1AP1 and SLC9C1 heterozygous co-deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the frequency of somatic YY1AP1 and UBR2 heterozygous co-deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the frequency of somatic YY1AP1 and TAF1C heterozygous co-deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the frequency of somatic YY1AP1 and ZMYM3 heterozygous co-deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the frequency of somatic YY1AP1 and POLD1 heterozygous co-deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the frequency of somatic YY1AP1 and VPS26B heterozygous co-deletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the frequency of somatic FNDC7 and PCDHB2 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the frequency of somatic FNDC7 and PIK3C2G heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the frequency of somatic TLCD5 and TTC17 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the frequency of somatic TLCD5 and EBF2 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic POLR1G and CPS1 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic POLR1G and GABRA6 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the frequency of somatic DNAH14 and PAK3 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the frequency of somatic DNAH14 and MYH11 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the frequency of somatic DNAH14 and NPSR1 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic NEXN and TASOR2 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the frequency of somatic CYB5R2 and ZFPM2 heterozygous co-deletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the frequency of somatic CYB5R2 and PXN heterozygous co-deletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic NRAP and GUF1 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic NRAP and EPRS1 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic NRAP and NRAP heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic CCDC22 and MYT1 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the frequency of somatic DCAF6 and MAD1L1 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the frequency of somatic DCAF6 and PIK3C2B heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic ZNF708 and AUTS2 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic BFAR and ANKDD1A heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MAST4 and TENT5A heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MAST4 and AUTS2 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MAST4 and HBB heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MAST4 and KDM5C heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MAST4 and CCNG1 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the frequency of somatic ARMC3 and GABRA6 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the frequency of somatic ARMC3 and JAML heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the frequency of somatic TET2 and TLCD5 heterozygous co-deletion in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the frequency of somatic TET2 and TRAP1 heterozygous co-deletion in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the frequency of somatic SERPINB10 and SLC9C1 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic STAT3 and VASN heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic MIEF1 and TENT5A heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the frequency of somatic ACVR1B and GUK1 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the frequency of somatic ACVR1B and FNDC7 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the frequency of somatic ACVR1B and NEXN heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the frequency of somatic EBF2 and KL heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the frequency of somatic EBF2 and COL6A3 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the frequency of somatic VPS26B and CTCFL heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic PGR and CFAP61 heterozygous co-deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic PGR and DCN heterozygous co-deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of somatic PGR and STAT3 heterozygous co-deletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the frequency of somatic ACTA2 and TNS1 heterozygous co-deletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic THBS4 and LCN15 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic THBS4 and DNAH11 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the frequency of somatic PRSS1 and PCDHB2 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the frequency of somatic PRSS1 and TRPA1 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the frequency of somatic PRSS1 and MAST4 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the frequency of somatic PRSS1 and CFAP61 heterozygous co-deletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the frequency of somatic PGF and TAF1C heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the frequency of somatic PGF and TASOR2 heterozygous co-deletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the frequency of somatic ITPRID2 and RIMS2 heterozygous co-deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the frequency of somatic ITPRID2 and DCC heterozygous co-deletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic HBB and PDGFC heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the frequency of somatic PCDHB2 and DNAH14 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the frequency of somatic PCDHB2 and FGF8 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the frequency of somatic PCDHB2 and MRPL32 heterozygous co-deletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the frequency of somatic UBR2 and HLA-DQA2 heterozygous co-deletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the frequency of somatic FBXO42 and PTPRN2 heterozygous co-deletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1,TNS1,G1362V,Breast Invasive Carcinoma,How frequently is TNS1 LOH found in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+2,TNS1,G1711V,Breast Invasive Carcinoma,How frequently is TNS1 LOH found in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+3,TNS1,G1718V,Breast Invasive Carcinoma,How frequently is TNS1 LOH found in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+4,TNS1,G1732V,Breast Invasive Carcinoma,How frequently is TNS1 LOH found in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+5,TNS1,G1824V,Breast Invasive Carcinoma,How frequently is TNS1 LOH found in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+6,TNS1,G1857V,Breast Invasive Carcinoma,How frequently is TNS1 LOH found in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+7,TNS1,G843V,Breast Invasive Carcinoma,How frequently is TNS1 LOH found in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How frequently is EVC2 LOH found in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How frequently is EVC2 LOH found in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How frequently is CR1 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How frequently is CR1 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+22,TRPA1,S295I,Rectum Adenocarcinoma,How frequently is TRPA1 LOH found in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+23,TRPA1,S443I,Rectum Adenocarcinoma,How frequently is TRPA1 LOH found in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+24,TAF1C,R299L,Lung Adenocarcinoma,How frequently is TAF1C LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+25,TAF1C,R396L,Lung Adenocarcinoma,How frequently is TAF1C LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+26,TAF1C,R634L,Lung Adenocarcinoma,How frequently is TAF1C LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+27,TAF1C,R702L,Lung Adenocarcinoma,How frequently is TAF1C LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+28,TAF1C,R728L,Lung Adenocarcinoma,How frequently is TAF1C LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How frequently is DPF3 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How frequently is DPF3 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How frequently is DPF3 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+42,OR2T4,P272H,Lung Adenocarcinoma,How frequently is OR2T4 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+43,OR2T4,P300H,Lung Adenocarcinoma,How frequently is OR2T4 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How frequently is FBN1 LOH found in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How frequently is MAD1L1 LOH found in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How frequently is MAD1L1 LOH found in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How frequently is MAD1L1 LOH found in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How frequently is CCNG1 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How frequently is ANP32E LOH found in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How frequently is ANP32E LOH found in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How frequently is ANP32E LOH found in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How frequently is ANP32E LOH found in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How frequently is FRY LOH found in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How frequently is FRY LOH found in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How frequently is FRY LOH found in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How frequently is FRY LOH found in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+70,PAK3,E318K,Skin Cutaneous Melanoma,How frequently is PAK3 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+71,PAK3,E319K,Skin Cutaneous Melanoma,How frequently is PAK3 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+72,PAK3,E334K,Skin Cutaneous Melanoma,How frequently is PAK3 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+73,PAK3,E340K,Skin Cutaneous Melanoma,How frequently is PAK3 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+74,PAK3,E355K,Skin Cutaneous Melanoma,How frequently is PAK3 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How frequently is MUC16 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How frequently is ZFPM2 LOH found in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How frequently is ZFPM2 LOH found in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How frequently is PIK3C2B LOH found in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How frequently is PIK3C2B LOH found in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How frequently is ZNF804A LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+116,RELN,A2371V,Stomach Adenocarcinoma,How frequently is RELN LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is EFCAB12 LOH found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is EFCAB12 LOH found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How frequently is DEFB115 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How frequently is ANKDD1A LOH found in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How frequently is ANKDD1A LOH found in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How frequently is ANKDD1A LOH found in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How frequently is HTR3B LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How frequently is HTR3B LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How frequently is HTR3B LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+129,ABCC3,R758W,Stomach Adenocarcinoma,How frequently is ABCC3 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How frequently is NOMO1 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How frequently is NOMO1 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How frequently is HYOU1 LOH found in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How frequently is FMO4 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+140,BICC1,A372V,Exceptional Responders,How frequently is BICC1 LOH found in Exceptional Responders?,freq_cnv_loss_or_gain
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How frequently is ZMYM3 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How frequently is ZMYM3 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How frequently is ZMYM3 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is XKR4 LOH found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How frequently is ABCC2 LOH found in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+157,OR8K5,R293G,Lung Adenocarcinoma,How frequently is OR8K5 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How frequently is SPTAN1 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How frequently is SPTAN1 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+164,SYT10,M484I,Rectum Adenocarcinoma,How frequently is SYT10 LOH found in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How frequently is HSPA5 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+175,UNC5D,L280V,Lung Adenocarcinoma,How frequently is UNC5D LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+176,UNC5D,L635V,Lung Adenocarcinoma,How frequently is UNC5D LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+177,UNC5D,L637V,Lung Adenocarcinoma,How frequently is UNC5D LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+178,UNC5D,L699V,Lung Adenocarcinoma,How frequently is UNC5D LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+179,UNC5D,L704V,Lung Adenocarcinoma,How frequently is UNC5D LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+180,UNC5D,L709V,Lung Adenocarcinoma,How frequently is UNC5D LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How frequently is DOCK2 LOH found in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How frequently is ZNF627 LOH found in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How frequently is CDC42BPA LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+193,MRPL55,H27Y,Colon Adenocarcinoma,How frequently is MRPL55 LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+194,MRPL55,H63Y,Colon Adenocarcinoma,How frequently is MRPL55 LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How frequently is TMTC3 LOH found in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+198,EPRS1,K771I,Colon Adenocarcinoma,How frequently is EPRS1 LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+199,EPRS1,K778I,Colon Adenocarcinoma,How frequently is EPRS1 LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How frequently is GRTP1 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How frequently is GRTP1 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How frequently is TSHZ3 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How frequently is TAS1R3 LOH found in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,freq_cnv_loss_or_gain
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How frequently is PIAS3 LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How frequently is PIAS3 LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+251,ZNF274,P13R,Stomach Adenocarcinoma,How frequently is ZNF274 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+253,SYNJ1,R795C,Colon Adenocarcinoma,How frequently is SYNJ1 LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+254,SYNJ1,R800C,Colon Adenocarcinoma,How frequently is SYNJ1 LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+255,SYNJ1,R839C,Colon Adenocarcinoma,How frequently is SYNJ1 LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+261,DSCAM,V343M,Prostate Adenocarcinoma,How frequently is DSCAM LOH found in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+262,DSCAM,V426M,Prostate Adenocarcinoma,How frequently is DSCAM LOH found in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+263,DSCAM,V591M,Prostate Adenocarcinoma,How frequently is DSCAM LOH found in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+267,DGKD,R140H,Exceptional Responders,How frequently is DGKD LOH found in Exceptional Responders?,freq_cnv_loss_or_gain
+268,DGKD,R160H,Exceptional Responders,How frequently is DGKD LOH found in Exceptional Responders?,freq_cnv_loss_or_gain
+269,DGKD,R204H,Exceptional Responders,How frequently is DGKD LOH found in Exceptional Responders?,freq_cnv_loss_or_gain
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How frequently is PLEKHG6 LOH found in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How frequently is PLEKHG6 LOH found in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How frequently is PLEKHG6 LOH found in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+279,WNT2,D138N,Skin Cutaneous Melanoma,How frequently is WNT2 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How frequently is GUCY2C LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How frequently is C7orf31 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is ZKSCAN7 LOH found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+299,OR5D14,M210L,Neuroblastoma,How frequently is OR5D14 LOH found in Neuroblastoma?,freq_cnv_loss_or_gain
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How frequently is SPATA22 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How frequently is SPATA22 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How frequently is SPATA22 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+310,LCN15,E21V,Stomach Adenocarcinoma,How frequently is LCN15 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How frequently is DCAF4L2 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How frequently is GUK1 LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How frequently is GUK1 LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How frequently is GUK1 LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How frequently is GUK1 LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How frequently is GUK1 LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How frequently is MORF4L1 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How frequently is MORF4L1 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How frequently is MORF4L1 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How frequently is MORF4L1 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How frequently is MYO3B LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How frequently is MYO3B LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How frequently is TENT5A LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How frequently is TENT5A LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How frequently is TENT5A LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How frequently is ZFAT LOH found in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How frequently is ZFAT LOH found in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How frequently is ZFAT LOH found in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+357,ZNF584,A211T,Sarcoma,How frequently is ZNF584 LOH found in Sarcoma?,freq_cnv_loss_or_gain
+358,ZNF584,A256T,Sarcoma,How frequently is ZNF584 LOH found in Sarcoma?,freq_cnv_loss_or_gain
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How frequently is LDOC1 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How frequently is PDGFC LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How frequently is MSANTD4 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How frequently is NPSR1 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How frequently is PHLPP1 LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How frequently is COL6A3 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How frequently is COL6A3 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How frequently is COL6A3 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How frequently is COL6A3 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How frequently is COL6A3 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How frequently is ADRA1A LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently is LAMB2 LOH found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+406,POC1B,I198T,Rectum Adenocarcinoma,How frequently is POC1B LOH found in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+407,POC1B,I286T,Rectum Adenocarcinoma,How frequently is POC1B LOH found in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+408,POC1B,I328T,Rectum Adenocarcinoma,How frequently is POC1B LOH found in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+409,POC1B,S79P,Rectum Adenocarcinoma,How frequently is POC1B LOH found in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How frequently is USH2A LOH found in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+414,AQP7,T110S,Rectum Adenocarcinoma,How frequently is AQP7 LOH found in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+415,AQP7,T166S,Rectum Adenocarcinoma,How frequently is AQP7 LOH found in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+416,AQP7,T167S,Rectum Adenocarcinoma,How frequently is AQP7 LOH found in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+417,AQP7,T75S,Rectum Adenocarcinoma,How frequently is AQP7 LOH found in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+430,DCN,R163C,Rectum Adenocarcinoma,How frequently is DCN LOH found in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+431,DCN,R203C,Rectum Adenocarcinoma,How frequently is DCN LOH found in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+432,DCN,R241C,Rectum Adenocarcinoma,How frequently is DCN LOH found in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+433,DCN,R350C,Rectum Adenocarcinoma,How frequently is DCN LOH found in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+434,DCN,R41C,Rectum Adenocarcinoma,How frequently is DCN LOH found in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How frequently is CPS1 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How frequently is CPS1 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How frequently is CPS1 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How frequently is FCGR2C LOH found in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How frequently is FCGR2C LOH found in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How frequently is GRM1 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+482,SGCZ,Q138H,Lung Adenocarcinoma,How frequently is SGCZ LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+483,SGCZ,Q91H,Lung Adenocarcinoma,How frequently is SGCZ LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+485,SMO,V15M,Stomach Adenocarcinoma,How frequently is SMO LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+486,SMO,V321M,Stomach Adenocarcinoma,How frequently is SMO LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+488,CHODL,G159E,Skin Cutaneous Melanoma,How frequently is CHODL LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+489,CHODL,G181E,Skin Cutaneous Melanoma,How frequently is CHODL LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+490,CHODL,G200E,Skin Cutaneous Melanoma,How frequently is CHODL LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+494,MYO16,P399H,Colon Adenocarcinoma,How frequently is MYO16 LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+495,MYO16,P421H,Colon Adenocarcinoma,How frequently is MYO16 LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+498,CXCR2,A98V,Stomach Adenocarcinoma,How frequently is CXCR2 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How frequently is TMEM225 LOH found in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How frequently is MAOB LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How frequently is GPRASP1 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How frequently is MRPL32 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How frequently is TYROBP LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+510,RAB40C,A111V,Lung Adenocarcinoma,How frequently is RAB40C LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+511,RAB40C,A143V,Lung Adenocarcinoma,How frequently is RAB40C LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+512,CTNNA2,S323R,Lung Adenocarcinoma,How frequently is CTNNA2 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+513,CTNNA2,S339R,Lung Adenocarcinoma,How frequently is CTNNA2 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+514,CTNNA2,S386R,Lung Adenocarcinoma,How frequently is CTNNA2 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+515,CTNNA2,S707R,Lung Adenocarcinoma,How frequently is CTNNA2 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How frequently is MYO15A LOH found in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How frequently is GIMAP2 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+532,KIF20B,N1160D,Glioblastoma Multiforme,How frequently is KIF20B LOH found in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+533,KIF20B,N1200D,Glioblastoma Multiforme,How frequently is KIF20B LOH found in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How frequently is ADAM17 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How frequently is BCAT1 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How frequently is BCAT1 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How frequently is BCAT1 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+540,ERCC6,R1053H,Colon Adenocarcinoma,How frequently is ERCC6 LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+541,DCC,R320W,Breast Invasive Carcinoma,How frequently is DCC LOH found in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+542,DCC,R363W,Breast Invasive Carcinoma,How frequently is DCC LOH found in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+543,DCC,R386W,Breast Invasive Carcinoma,How frequently is DCC LOH found in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+544,DCC,R41W,Breast Invasive Carcinoma,How frequently is DCC LOH found in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How frequently is FBXO15 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How frequently is FBXO15 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How frequently is GSTCD LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How frequently is GSTCD LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How frequently is OLFML3 LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How frequently is OLFML3 LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How frequently is OLFML3 LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How frequently is CFAP61 LOH found in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How frequently is CFAP61 LOH found in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How frequently is HLA-DQA2 LOH found in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How frequently is TENM2 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How frequently is TENM2 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How frequently is TENM2 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How frequently is ANKRD24 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How frequently is ANKRD24 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How frequently is ANKRD24 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How frequently is ZCCHC14 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How frequently is ZCCHC14 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How frequently is ZCCHC14 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How frequently is ZCCHC14 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+625,SIK2,I265M,Lung Adenocarcinoma,How frequently is SIK2 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How frequently is MYH11 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How frequently is MYH11 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How frequently is SLC6A4 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How frequently is SLC9C1 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How frequently is SLC9C1 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+644,OR2A12,A254T,Brain Lower Grade Glioma,How frequently is OR2A12 LOH found in Brain Lower Grade Glioma?,freq_cnv_loss_or_gain
+646,PYHIN1,T325K,Lung Adenocarcinoma,How frequently is PYHIN1 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+647,PYHIN1,T334K,Lung Adenocarcinoma,How frequently is PYHIN1 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+650,JAML,G191E,Skin Cutaneous Melanoma,How frequently is JAML LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+651,JAML,G219E,Skin Cutaneous Melanoma,How frequently is JAML LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+652,JAML,G220E,Skin Cutaneous Melanoma,How frequently is JAML LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+653,JAML,G230E,Skin Cutaneous Melanoma,How frequently is JAML LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+658,TYK2,H1146R,Stomach Adenocarcinoma,How frequently is TYK2 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+659,TYK2,H23R,Stomach Adenocarcinoma,How frequently is TYK2 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+660,TYK2,H961R,Stomach Adenocarcinoma,How frequently is TYK2 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How frequently is CTCFL LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How frequently is CTCFL LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How frequently is CTCFL LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How frequently is CTCFL LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How frequently is CEP20 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How frequently is CEP20 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How frequently is RIMS2 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How frequently is RIMS2 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How frequently is RIMS2 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How frequently is RIMS2 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How frequently is RIMS2 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How frequently is RIMS2 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How frequently is RIMS2 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How frequently is PIK3C2G LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How frequently is PIK3C2G LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+728,STK19,D341N,Colon Adenocarcinoma,How frequently is STK19 LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+729,STK19,D345N,Colon Adenocarcinoma,How frequently is STK19 LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+730,REXO4,P60A,Skin Cutaneous Melanoma,How frequently is REXO4 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How frequently is ZBTB34 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How frequently is ZBTB34 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How frequently is NCKAP5 LOH found in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is SORCS1 LOH found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is SORCS1 LOH found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is SORCS1 LOH found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is SORCS1 LOH found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How frequently is FGF8 LOH found in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How frequently is FGF8 LOH found in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How frequently is FGF8 LOH found in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How frequently is FGF8 LOH found in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How frequently is FGF8 LOH found in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How frequently is TENM3 LOH found in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,freq_cnv_loss_or_gain
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How frequently is AKT1 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently is CFAP298-TCP10L LOH found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+792,GLRB,E148D,Stomach Adenocarcinoma,How frequently is GLRB LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+793,TTN,F7636L,Colon Adenocarcinoma,How frequently is TTN LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+794,TTN,F8563L,Colon Adenocarcinoma,How frequently is TTN LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+795,TTN,F8880L,Colon Adenocarcinoma,How frequently is TTN LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How frequently is ANKRD30A LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How frequently is ANKRD30A LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How frequently is ANKRD30A LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+809,TRIM45,S177L,Colon Adenocarcinoma,How frequently is TRIM45 LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+810,TRIM45,S224L,Colon Adenocarcinoma,How frequently is TRIM45 LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+811,TRIM45,S281L,Colon Adenocarcinoma,How frequently is TRIM45 LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How frequently is CACNA1F LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How frequently is CACNA1F LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How frequently is CACNA1F LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+817,KL,R594C,Colon Adenocarcinoma,How frequently is KL LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How frequently is GUF1 LOH found in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+822,TAF1L,A539V,Colon Adenocarcinoma,How frequently is TAF1L LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How frequently is TASOR2 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How frequently is TASOR2 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How frequently is TASOR2 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How frequently is KDM5C LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How frequently is KDM5C LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How frequently is KDM5C LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How frequently is KDM5C LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently is IL5RA LOH found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+843,DHX16,A29V,Skin Cutaneous Melanoma,How frequently is DHX16 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+844,DHX16,A89V,Skin Cutaneous Melanoma,How frequently is DHX16 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+902,GPR158,A644V,Stomach Adenocarcinoma,How frequently is GPR158 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+903,GPR158,A723V,Stomach Adenocarcinoma,How frequently is GPR158 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is EIF2B4 LOH found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is EIF2B4 LOH found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is EIF2B4 LOH found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is EIF2B4 LOH found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is EIF2B4 LOH found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is EIF2B4 LOH found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How frequently is AUTS2 LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How frequently is AUTS2 LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How frequently is AUTS2 LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How frequently is AUTS2 LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How frequently is AUTS2 LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How frequently is AUTS2 LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How frequently is AUTS2 LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How frequently is AUTS2 LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How frequently is AUTS2 LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How frequently is AUTS2 LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is ACTL7B LOH found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How frequently is PCDHGA1 LOH found in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+954,TRAP1,R114W,Stomach Adenocarcinoma,How frequently is TRAP1 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+955,TRAP1,R61W,Stomach Adenocarcinoma,How frequently is TRAP1 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How frequently is PIK3C2A LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How frequently is KANSL1 LOH found in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How frequently is ANKRD52 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How frequently is PAPPA LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How frequently is B3GALNT1 LOH found in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+982,GABRA6,G115R,Lung Adenocarcinoma,How frequently is GABRA6 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+983,GABRA6,G122R,Lung Adenocarcinoma,How frequently is GABRA6 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+984,GABRA6,G165R,Lung Adenocarcinoma,How frequently is GABRA6 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+985,GABRA6,G175R,Lung Adenocarcinoma,How frequently is GABRA6 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+986,GABRA6,G70R,Lung Adenocarcinoma,How frequently is GABRA6 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How frequently is ZSCAN31 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is MED16 LOH found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is MED16 LOH found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How frequently is PTPRO LOH found in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How frequently is PTPRO LOH found in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How frequently is PTPRO LOH found in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How frequently is PTPRO LOH found in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How frequently is PTPRO LOH found in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How frequently is PTPRO LOH found in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How frequently is PTPRO LOH found in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How frequently is PTPRO LOH found in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How frequently is CHMP7 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1017,GPC3,I107N,Stomach Adenocarcinoma,How frequently is GPC3 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1018,GPC3,I161N,Stomach Adenocarcinoma,How frequently is GPC3 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently is TLK2 LOH found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently is TLK2 LOH found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently is TLK2 LOH found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently is TLK2 LOH found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently is TLK2 LOH found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How frequently is ZNF217 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1038,SYT9,V275L,Lung Adenocarcinoma,How frequently is SYT9 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1039,SYT9,V307L,Lung Adenocarcinoma,How frequently is SYT9 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How frequently is PKHD1L1 LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How frequently is MYO3A LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is VASN LOH found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How frequently is DNMT1 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How frequently is DNMT1 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How frequently is DNMT1 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1056,CA9,E402K,Colon Adenocarcinoma,How frequently is CA9 LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How frequently is TTC17 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How frequently is TTC17 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1065,PSG2,P43L,Breast Invasive Carcinoma,How frequently is PSG2 LOH found in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How frequently is RIPOR2 LOH found in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How frequently is RIPOR2 LOH found in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How frequently is RIPOR2 LOH found in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How frequently is RIPOR2 LOH found in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How frequently is DCLK3 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How frequently is DCLK3 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How frequently is MERTK LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How frequently is MERTK LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How frequently is MERTK LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How frequently is ZFP42 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How frequently is OR13C3 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How frequently is OR13C3 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How frequently is SPAG1 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How frequently is CDKN2AIP LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1093,PXN,H1016Y,Colon Adenocarcinoma,How frequently is PXN LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1094,PXN,H359Y,Colon Adenocarcinoma,How frequently is PXN LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1095,PXN,H492Y,Colon Adenocarcinoma,How frequently is PXN LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1096,PXN,H524Y,Colon Adenocarcinoma,How frequently is PXN LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1097,PXN,H526Y,Colon Adenocarcinoma,How frequently is PXN LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1098,PXN,H540Y,Colon Adenocarcinoma,How frequently is PXN LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How frequently is TTYH2 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How frequently is TTYH2 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How frequently is TMEM255A LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How frequently is TMEM255A LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How frequently is TMEM255A LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How frequently is TASOR2 LOH found in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How frequently is TASOR2 LOH found in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How frequently is ICE1 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1112,MYT1,A558E,Breast Invasive Carcinoma,How frequently is MYT1 LOH found in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1113,MYT1,A879E,Breast Invasive Carcinoma,How frequently is MYT1 LOH found in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1114,MYT1,A906E,Breast Invasive Carcinoma,How frequently is MYT1 LOH found in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How frequently is CX3CR1 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How frequently is CX3CR1 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How frequently is SPINDOC LOH found in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How frequently is ART3 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How frequently is ART3 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How frequently is CYP1A2 LOH found in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is ADRA1A LOH found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How frequently is CDH23 LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How frequently is CDH23 LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How frequently is KRT39 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How frequently is PDHA2 LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How frequently is SLC24A2 LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How frequently is PTPRN2 LOH found in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How frequently is PTPRN2 LOH found in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How frequently is PTPRN2 LOH found in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How frequently is PTPRN2 LOH found in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How frequently is PTPRN2 LOH found in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1188,SOX21,R55L,Lung Adenocarcinoma,How frequently is SOX21 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How frequently is CPA6 LOH found in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How frequently is GRM5 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is CASZ1 LOH found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How frequently is SGIP1 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How frequently is SGIP1 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How frequently is SGIP1 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How frequently is SGIP1 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How frequently is CARMIL1 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How frequently is CARMIL1 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How frequently is ZNF431 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How frequently is ZNF431 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1234,ZNF431,R128I,Lung Adenocarcinoma,How frequently is ZNF431 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How frequently is DNAH11 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How frequently is DNAH11 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How frequently is POLD1 LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How frequently is POLD1 LOH found in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1248,TTC12,D646H,Lung Adenocarcinoma,How frequently is TTC12 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1249,TTC12,D652H,Lung Adenocarcinoma,How frequently is TTC12 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How frequently is CNGB1 LOH found in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How frequently is CNGB1 LOH found in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1254,CTSC,E214V,Stomach Adenocarcinoma,How frequently is CTSC LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1255,CTSC,E291V,Stomach Adenocarcinoma,How frequently is CTSC LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1256,CTSC,E322V,Stomach Adenocarcinoma,How frequently is CTSC LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1257,CTSC,E324V,Stomach Adenocarcinoma,How frequently is CTSC LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1258,CTSC,E335V,Stomach Adenocarcinoma,How frequently is CTSC LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How frequently is PRSS8 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How frequently is PRSS8 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How frequently is ARHGEF40 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1264,ACTB,A138T,Rectum Adenocarcinoma,How frequently is ACTB LOH found in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1265,ACTB,A217T,Rectum Adenocarcinoma,How frequently is ACTB LOH found in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1266,ACTB,A244T,Rectum Adenocarcinoma,How frequently is ACTB LOH found in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1267,ACTB,A260T,Rectum Adenocarcinoma,How frequently is ACTB LOH found in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How frequently is YY1AP1 LOH found in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How frequently is YY1AP1 LOH found in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How frequently is YY1AP1 LOH found in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How frequently is YY1AP1 LOH found in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How frequently is YY1AP1 LOH found in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How frequently is YY1AP1 LOH found in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How frequently is YY1AP1 LOH found in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How frequently is FNDC7 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How frequently is FNDC7 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1299,TLCD5,G15V,Lung Adenocarcinoma,How frequently is TLCD5 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1300,TLCD5,G37V,Lung Adenocarcinoma,How frequently is TLCD5 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How frequently is POLR1G LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How frequently is POLR1G LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How frequently is DNAH14 LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How frequently is DNAH14 LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How frequently is DNAH14 LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How frequently is NEXN LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How frequently is CYB5R2 LOH found in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How frequently is CYB5R2 LOH found in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How frequently is NRAP LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How frequently is NRAP LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How frequently is NRAP LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How frequently is CCDC22 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How frequently is DCAF6 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How frequently is DCAF6 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How frequently is ZNF708 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How frequently is BFAR LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How frequently is MAST4 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How frequently is MAST4 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How frequently is MAST4 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How frequently is MAST4 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How frequently is MAST4 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How frequently is ARMC3 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How frequently is ARMC3 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How frequently is TET2 LOH found in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How frequently is TET2 LOH found in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How frequently is SERPINB10 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How frequently is STAT3 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How frequently is MIEF1 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How frequently is ACVR1B LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How frequently is ACVR1B LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How frequently is ACVR1B LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1393,EBF2,T104I,Stomach Adenocarcinoma,How frequently is EBF2 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1394,EBF2,T252I,Stomach Adenocarcinoma,How frequently is EBF2 LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How frequently is VPS26B LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is PGR LOH found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is PGR LOH found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently is PGR LOH found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How frequently is ACTA2 LOH found in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How frequently is THBS4 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How frequently is THBS4 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1413,PRSS1,S114T,Lung Adenocarcinoma,How frequently is PRSS1 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1414,PRSS1,S124T,Lung Adenocarcinoma,How frequently is PRSS1 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1415,PRSS1,S138T,Lung Adenocarcinoma,How frequently is PRSS1 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1416,PRSS1,S74T,Lung Adenocarcinoma,How frequently is PRSS1 LOH found in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1417,PGF,R126H,Stomach Adenocarcinoma,How frequently is PGF LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1418,PGF,R127H,Stomach Adenocarcinoma,How frequently is PGF LOH found in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How frequently is ITPRID2 LOH found in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How frequently is ITPRID2 LOH found in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How frequently is HBB LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How frequently is PCDHB2 LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How frequently is PCDHB2 LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How frequently is PCDHB2 LOH found in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How frequently is UBR2 LOH found in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How frequently is FBXO42 LOH found in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the distribution rate of TNS1 and RIPOR2 gain among Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the distribution rate of TNS1 and EVC2 gain among Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the distribution rate of TNS1 and KANSL1 gain among Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the distribution rate of TNS1 and ANP32E gain among Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the distribution rate of TNS1 and HLA-DQA2 gain among Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the distribution rate of TNS1 and ANKRD30A gain among Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the distribution rate of TNS1 and TASOR2 gain among Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the distribution rate of EVC2 and CTNNA2 gain among Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the distribution rate of EVC2 and WNT2 gain among Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of CR1 and CARMIL1 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of CR1 and DCC gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the distribution rate of TRPA1 and ADAM17 gain among Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the distribution rate of TRPA1 and ACTB gain among Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the distribution rate of TAF1C and MED16 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the distribution rate of TAF1C and SOX21 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the distribution rate of TAF1C and DGKD gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the distribution rate of TAF1C and ANKRD52 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the distribution rate of TAF1C and CTCFL gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of DPF3 and MAOB gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of DPF3 and FGF8 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of DPF3 and PAK3 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the distribution rate of OR2T4 and SPTAN1 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the distribution rate of OR2T4 and MED16 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the distribution rate of FBN1 and POC1B gain among Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the distribution rate of MAD1L1 and TTC17 gain among Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the distribution rate of MAD1L1 and DGKD gain among Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the distribution rate of MAD1L1 and CDH23 gain among Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the distribution rate of CCNG1 and PRSS1 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the distribution rate of ANP32E and MRPL32 gain among Kidney Renal Papillary Cell Carcinoma patients?,freq_cnv_loss_or_gain
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the distribution rate of ANP32E and PSG2 gain among Kidney Renal Papillary Cell Carcinoma patients?,freq_cnv_loss_or_gain
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the distribution rate of ANP32E and CHODL gain among Kidney Renal Papillary Cell Carcinoma patients?,freq_cnv_loss_or_gain
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the distribution rate of ANP32E and C7orf31 gain among Kidney Renal Papillary Cell Carcinoma patients?,freq_cnv_loss_or_gain
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the distribution rate of FRY and COL6A3 gain among Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the distribution rate of FRY and CARMIL1 gain among Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the distribution rate of FRY and CTSC gain among Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the distribution rate of FRY and RIMS2 gain among Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the distribution rate of PAK3 and ARMC3 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the distribution rate of PAK3 and ZFAT gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the distribution rate of PAK3 and GABRA6 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the distribution rate of PAK3 and CACNA1F gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the distribution rate of PAK3 and TMEM255A gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the distribution rate of MUC16 and DNAH14 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the distribution rate of ZFPM2 and MYH11 gain among Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the distribution rate of ZFPM2 and EBF2 gain among Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the distribution rate of PIK3C2B and ANKRD24 gain among Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the distribution rate of PIK3C2B and CR1 gain among Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the distribution rate of ZNF804A and SORCS1 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the distribution rate of RELN and POLR1G gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of EFCAB12 and HTR3B gain among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of EFCAB12 and ACVR1B gain among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the distribution rate of DEFB115 and GABRA6 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the distribution rate of ANKDD1A and ZNF431 gain among Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the distribution rate of ANKDD1A and OR2T4 gain among Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the distribution rate of ANKDD1A and DPF3 gain among Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of HTR3B and OR2T4 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of HTR3B and AUTS2 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of HTR3B and SMO gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the distribution rate of ABCC3 and FBN1 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of NOMO1 and DNMT1 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of NOMO1 and DCC gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the distribution rate of HYOU1 and SGCZ gain among Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the distribution rate of FMO4 and ITPRID2 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+140,BICC1,A372V,Exceptional Responders,What is the distribution rate of BICC1 and PTPRO gain among Exceptional Responders patients?,freq_cnv_loss_or_gain
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of ZMYM3 and NEXN gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of ZMYM3 and DCN gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of ZMYM3 and TAF1C gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of XKR4 and CTNNA2 gain among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the distribution rate of ABCC2 and BCAT1 gain among Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the distribution rate of OR8K5 and KL gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the distribution rate of SPTAN1 and PDGFC gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the distribution rate of SPTAN1 and POC1B gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the distribution rate of SYT10 and PDGFC gain among Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the distribution rate of HSPA5 and PRSS1 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the distribution rate of UNC5D and CFAP298-TCP10L gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the distribution rate of UNC5D and HYOU1 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the distribution rate of UNC5D and PRSS1 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the distribution rate of UNC5D and TASOR2 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the distribution rate of UNC5D and UNC5D gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the distribution rate of UNC5D and CARMIL1 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the distribution rate of DOCK2 and FRY gain among Kidney Renal Clear Cell Carcinoma patients?,freq_cnv_loss_or_gain
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the distribution rate of ZNF627 and TTN gain among Kidney Renal Clear Cell Carcinoma patients?,freq_cnv_loss_or_gain
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the distribution rate of CDC42BPA and DCN gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the distribution rate of MRPL55 and SYT10 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the distribution rate of MRPL55 and PRSS8 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the distribution rate of TMTC3 and GPR158 gain among Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the distribution rate of EPRS1 and ANKRD30A gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the distribution rate of EPRS1 and ARMC3 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the distribution rate of GRTP1 and WNT2 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the distribution rate of GRTP1 and ZNF217 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the distribution rate of TSHZ3 and PXN gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the distribution rate of TAS1R3 and KRT39 gain among HIV+ Tumor Molecular Characterization Project - Cervical Cancer patients?,freq_cnv_loss_or_gain
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the distribution rate of PIAS3 and HBB gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the distribution rate of PIAS3 and CEP20 gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the distribution rate of ZNF274 and PIK3C2A gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the distribution rate of SYNJ1 and GPRASP1 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the distribution rate of SYNJ1 and MORF4L1 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the distribution rate of SYNJ1 and GPR158 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the distribution rate of DSCAM and ACTA2 gain among Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the distribution rate of DSCAM and TMEM255A gain among Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the distribution rate of DSCAM and PIAS3 gain among Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+267,DGKD,R140H,Exceptional Responders,What is the distribution rate of DGKD and ANKRD30A gain among Exceptional Responders patients?,freq_cnv_loss_or_gain
+268,DGKD,R160H,Exceptional Responders,What is the distribution rate of DGKD and TYK2 gain among Exceptional Responders patients?,freq_cnv_loss_or_gain
+269,DGKD,R204H,Exceptional Responders,What is the distribution rate of DGKD and ACVR1B gain among Exceptional Responders patients?,freq_cnv_loss_or_gain
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the distribution rate of PLEKHG6 and TENM2 gain among Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the distribution rate of PLEKHG6 and ANKDD1A gain among Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the distribution rate of PLEKHG6 and TASOR2 gain among Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the distribution rate of WNT2 and ZNF274 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the distribution rate of GUCY2C and TENT5A gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of C7orf31 and MYH11 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of ZKSCAN7 and MORF4L1 gain among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+299,OR5D14,M210L,Neuroblastoma,What is the distribution rate of OR5D14 and ANKRD24 gain among Neuroblastoma patients?,freq_cnv_loss_or_gain
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of SPATA22 and LAMB2 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of SPATA22 and ART3 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of SPATA22 and UNC5D gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the distribution rate of LCN15 and MED16 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the distribution rate of DCAF4L2 and UNC5D gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the distribution rate of GUK1 and YY1AP1 gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the distribution rate of GUK1 and TTYH2 gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the distribution rate of GUK1 and C7orf31 gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the distribution rate of GUK1 and STAT3 gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the distribution rate of GUK1 and DGKD gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the distribution rate of MORF4L1 and KDM5C gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the distribution rate of MORF4L1 and HTR3B gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the distribution rate of MORF4L1 and YY1AP1 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the distribution rate of MORF4L1 and MIEF1 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the distribution rate of MYO3B and EBF2 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the distribution rate of MYO3B and EPRS1 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the distribution rate of TENT5A and DPF3 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the distribution rate of TENT5A and EBF2 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the distribution rate of TENT5A and ANKDD1A gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the distribution rate of ZFAT and DPF3 gain among Ovarian Serous Cystadenocarcinoma patients?,freq_cnv_loss_or_gain
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the distribution rate of ZFAT and EIF2B4 gain among Ovarian Serous Cystadenocarcinoma patients?,freq_cnv_loss_or_gain
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the distribution rate of ZFAT and RIMS2 gain among Ovarian Serous Cystadenocarcinoma patients?,freq_cnv_loss_or_gain
+357,ZNF584,A211T,Sarcoma,What is the distribution rate of ZNF584 and POC1B gain among Sarcoma patients?,freq_cnv_loss_or_gain
+358,ZNF584,A256T,Sarcoma,What is the distribution rate of ZNF584 and GUF1 gain among Sarcoma patients?,freq_cnv_loss_or_gain
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of LDOC1 and MYT1 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the distribution rate of PDGFC and ADRA1A gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of MSANTD4 and YY1AP1 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the distribution rate of NPSR1 and ZCCHC14 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the distribution rate of PHLPP1 and PRSS1 gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the distribution rate of COL6A3 and GUK1 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the distribution rate of COL6A3 and MRPL55 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the distribution rate of COL6A3 and DCC gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the distribution rate of COL6A3 and DNAH14 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the distribution rate of COL6A3 and FGF8 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the distribution rate of ADRA1A and ANKRD24 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the distribution rate of LAMB2 and PIAS3 gain among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the distribution rate of POC1B and TAF1L gain among Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the distribution rate of POC1B and TRPA1 gain among Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the distribution rate of POC1B and DOCK2 gain among Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the distribution rate of POC1B and EPRS1 gain among Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the distribution rate of USH2A and ADRA1A gain among Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the distribution rate of AQP7 and CTNNA2 gain among Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the distribution rate of AQP7 and CNGB1 gain among Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the distribution rate of AQP7 and AUTS2 gain among Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the distribution rate of AQP7 and MYO3B gain among Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+430,DCN,R163C,Rectum Adenocarcinoma,What is the distribution rate of DCN and MRPL32 gain among Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+431,DCN,R203C,Rectum Adenocarcinoma,What is the distribution rate of DCN and UBR2 gain among Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+432,DCN,R241C,Rectum Adenocarcinoma,What is the distribution rate of DCN and TENM2 gain among Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+433,DCN,R350C,Rectum Adenocarcinoma,What is the distribution rate of DCN and PCDHB2 gain among Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+434,DCN,R41C,Rectum Adenocarcinoma,What is the distribution rate of DCN and CYB5R2 gain among Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of CPS1 and DEFB115 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of CPS1 and SORCS1 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of CPS1 and MED16 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the distribution rate of FCGR2C and PGR gain among Kidney Renal Papillary Cell Carcinoma patients?,freq_cnv_loss_or_gain
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the distribution rate of FCGR2C and PXN gain among Kidney Renal Papillary Cell Carcinoma patients?,freq_cnv_loss_or_gain
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of GRM1 and ADRA1A gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the distribution rate of SGCZ and CHODL gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the distribution rate of SGCZ and BICC1 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+485,SMO,V15M,Stomach Adenocarcinoma,What is the distribution rate of SMO and PXN gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+486,SMO,V321M,Stomach Adenocarcinoma,What is the distribution rate of SMO and MAST4 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the distribution rate of CHODL and CPS1 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the distribution rate of CHODL and ERCC6 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the distribution rate of CHODL and DGKD gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+494,MYO16,P399H,Colon Adenocarcinoma,What is the distribution rate of MYO16 and THBS4 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+495,MYO16,P421H,Colon Adenocarcinoma,What is the distribution rate of MYO16 and FGF8 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the distribution rate of CXCR2 and FGF8 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the distribution rate of TMEM225 and PHLPP1 gain among Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of MAOB and MORF4L1 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of GPRASP1 and KDM5C gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of MRPL32 and PTPRN2 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of TYROBP and GRTP1 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the distribution rate of RAB40C and FBXO15 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the distribution rate of RAB40C and TRPA1 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the distribution rate of CTNNA2 and ACVR1B gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the distribution rate of CTNNA2 and SGCZ gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the distribution rate of CTNNA2 and UNC5D gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the distribution rate of CTNNA2 and CTSC gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the distribution rate of MYO15A and GPR158 gain among Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the distribution rate of GIMAP2 and HSPA5 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the distribution rate of KIF20B and DCN gain among Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the distribution rate of KIF20B and TMEM255A gain among Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of ADAM17 and B3GALNT1 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of BCAT1 and HYOU1 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of BCAT1 and SGIP1 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of BCAT1 and OR5D14 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the distribution rate of ERCC6 and MUC16 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+541,DCC,R320W,Breast Invasive Carcinoma,What is the distribution rate of DCC and TRAP1 gain among Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+542,DCC,R363W,Breast Invasive Carcinoma,What is the distribution rate of DCC and KL gain among Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+543,DCC,R386W,Breast Invasive Carcinoma,What is the distribution rate of DCC and EFCAB12 gain among Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+544,DCC,R41W,Breast Invasive Carcinoma,What is the distribution rate of DCC and YY1AP1 gain among Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the distribution rate of FBXO15 and FBXO15 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the distribution rate of FBXO15 and MYO16 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of GSTCD and RIPOR2 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of GSTCD and THBS4 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the distribution rate of OLFML3 and TRIM45 gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the distribution rate of OLFML3 and MERTK gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the distribution rate of OLFML3 and TRAP1 gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the distribution rate of CFAP61 and GABRA6 gain among Ovarian Serous Cystadenocarcinoma patients?,freq_cnv_loss_or_gain
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the distribution rate of CFAP61 and GRM1 gain among Ovarian Serous Cystadenocarcinoma patients?,freq_cnv_loss_or_gain
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the distribution rate of HLA-DQA2 and OR5D14 gain among Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the distribution rate of TENM2 and TYK2 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the distribution rate of TENM2 and ZKSCAN7 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the distribution rate of TENM2 and TNS1 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the distribution rate of ANKRD24 and ZFP42 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the distribution rate of ANKRD24 and SGIP1 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the distribution rate of ANKRD24 and CTSC gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the distribution rate of ZCCHC14 and ZNF217 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the distribution rate of ZCCHC14 and PTPRO gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the distribution rate of ZCCHC14 and SGIP1 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the distribution rate of ZCCHC14 and CX3CR1 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+625,SIK2,I265M,Lung Adenocarcinoma,What is the distribution rate of SIK2 and TLK2 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of MYH11 and GUK1 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of MYH11 and ANKRD30A gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the distribution rate of SLC6A4 and DGKD gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of SLC9C1 and GUK1 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of SLC9C1 and ZCCHC14 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the distribution rate of OR2A12 and DCN gain among Brain Lower Grade Glioma patients?,freq_cnv_loss_or_gain
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the distribution rate of PYHIN1 and ZFPM2 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the distribution rate of PYHIN1 and ZCCHC14 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the distribution rate of JAML and GUK1 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the distribution rate of JAML and POC1B gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the distribution rate of JAML and GPR158 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the distribution rate of JAML and EPRS1 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the distribution rate of TYK2 and PIAS3 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the distribution rate of TYK2 and YY1AP1 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the distribution rate of TYK2 and ART3 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of CTCFL and CARMIL1 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of CTCFL and ZBTB34 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of CTCFL and UNC5D gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of CTCFL and CACNA1F gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of CEP20 and RIMS2 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of CEP20 and SLC9C1 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the distribution rate of RIMS2 and PIK3C2G gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the distribution rate of RIMS2 and YY1AP1 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the distribution rate of RIMS2 and TET2 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the distribution rate of RIMS2 and OR2T4 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the distribution rate of RIMS2 and ANP32E gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the distribution rate of RIMS2 and COL6A3 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the distribution rate of RIMS2 and TASOR2 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the distribution rate of PIK3C2G and CFAP298-TCP10L gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the distribution rate of PIK3C2G and PDHA2 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+728,STK19,D341N,Colon Adenocarcinoma,What is the distribution rate of STK19 and PSG2 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+729,STK19,D345N,Colon Adenocarcinoma,What is the distribution rate of STK19 and TAF1C gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the distribution rate of REXO4 and PAK3 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of ZBTB34 and GUF1 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of ZBTB34 and CHMP7 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the distribution rate of NCKAP5 and CHMP7 gain among Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of SORCS1 and DNMT1 gain among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of SORCS1 and TTN gain among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of SORCS1 and CTSC gain among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of SORCS1 and EIF2B4 gain among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the distribution rate of FGF8 and THBS4 gain among Head and Neck Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the distribution rate of FGF8 and OR5D14 gain among Head and Neck Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the distribution rate of FGF8 and SPINDOC gain among Head and Neck Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the distribution rate of FGF8 and PRSS8 gain among Head and Neck Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the distribution rate of FGF8 and RIMS2 gain among Head and Neck Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the distribution rate of TENM3 and RIMS2 gain among Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia patients?,freq_cnv_loss_or_gain
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of AKT1 and TYK2 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the distribution rate of CFAP298-TCP10L and TASOR2 gain among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the distribution rate of GLRB and CPS1 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+793,TTN,F7636L,Colon Adenocarcinoma,What is the distribution rate of TTN and CR1 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+794,TTN,F8563L,Colon Adenocarcinoma,What is the distribution rate of TTN and MYO16 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+795,TTN,F8880L,Colon Adenocarcinoma,What is the distribution rate of TTN and ACVR1B gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the distribution rate of ANKRD30A and OR13C3 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the distribution rate of ANKRD30A and CXCR2 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the distribution rate of ANKRD30A and CTSC gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the distribution rate of TRIM45 and UNC5D gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the distribution rate of TRIM45 and PSG2 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the distribution rate of TRIM45 and COL6A3 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the distribution rate of CACNA1F and AUTS2 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the distribution rate of CACNA1F and AUTS2 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the distribution rate of CACNA1F and PGF gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+817,KL,R594C,Colon Adenocarcinoma,What is the distribution rate of KL and SPATA22 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the distribution rate of GUF1 and KRT39 gain among Kidney Renal Papillary Cell Carcinoma patients?,freq_cnv_loss_or_gain
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the distribution rate of TAF1L and DCLK3 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the distribution rate of TASOR2 and YY1AP1 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the distribution rate of TASOR2 and TMTC3 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the distribution rate of TASOR2 and CPS1 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the distribution rate of KDM5C and ZSCAN31 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the distribution rate of KDM5C and RIMS2 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the distribution rate of KDM5C and ANP32E gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the distribution rate of KDM5C and RAB40C gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the distribution rate of IL5RA and PTPRO gain among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the distribution rate of DHX16 and PLEKHG6 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the distribution rate of DHX16 and PCDHGA1 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the distribution rate of GPR158 and PDGFC gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the distribution rate of GPR158 and MUC16 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of EIF2B4 and CX3CR1 gain among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of EIF2B4 and EIF2B4 gain among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of EIF2B4 and PLEKHG6 gain among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of EIF2B4 and TNS1 gain among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of EIF2B4 and B3GALNT1 gain among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of EIF2B4 and PGF gain among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the distribution rate of AUTS2 and ANP32E gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the distribution rate of AUTS2 and SMO gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the distribution rate of AUTS2 and XKR4 gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the distribution rate of AUTS2 and TASOR2 gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the distribution rate of AUTS2 and FGF8 gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the distribution rate of AUTS2 and DSCAM gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the distribution rate of AUTS2 and DOCK2 gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the distribution rate of AUTS2 and TENM2 gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the distribution rate of AUTS2 and ACVR1B gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the distribution rate of AUTS2 and UNC5D gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of ACTL7B and UNC5D gain among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the distribution rate of PCDHGA1 and PRSS1 gain among Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the distribution rate of TRAP1 and GUK1 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the distribution rate of TRAP1 and DCC gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of PIK3C2A and EIF2B4 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the distribution rate of KANSL1 and ZFAT gain among Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the distribution rate of ANKRD52 and PTPRN2 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of PAPPA and FRY gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the distribution rate of B3GALNT1 and MORF4L1 gain among Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the distribution rate of GABRA6 and MRPL55 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the distribution rate of GABRA6 and FCGR2C gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the distribution rate of GABRA6 and TAF1L gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the distribution rate of GABRA6 and ANKRD24 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the distribution rate of GABRA6 and PRSS8 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the distribution rate of ZSCAN31 and COL6A3 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of MED16 and GUK1 gain among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of MED16 and RAB40C gain among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the distribution rate of PTPRO and CTCFL gain among Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the distribution rate of PTPRO and MORF4L1 gain among Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the distribution rate of PTPRO and ZFP42 gain among Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the distribution rate of PTPRO and SORCS1 gain among Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the distribution rate of PTPRO and HTR3B gain among Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the distribution rate of PTPRO and TENT5A gain among Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the distribution rate of PTPRO and CYB5R2 gain among Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the distribution rate of PTPRO and TTC12 gain among Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of CHMP7 and AQP7 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the distribution rate of GPC3 and CPS1 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the distribution rate of GPC3 and TLK2 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the distribution rate of TLK2 and MYO3B gain among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the distribution rate of TLK2 and MYO3B gain among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the distribution rate of TLK2 and CTSC gain among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the distribution rate of TLK2 and GSTCD gain among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the distribution rate of TLK2 and ACTB gain among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the distribution rate of ZNF217 and USH2A gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the distribution rate of SYT9 and JAML gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the distribution rate of SYT9 and CDC42BPA gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the distribution rate of PKHD1L1 and CYB5R2 gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the distribution rate of MYO3A and PXN gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of VASN and DCN gain among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of DNMT1 and ZNF708 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of DNMT1 and ACTA2 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of DNMT1 and ANKRD24 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1056,CA9,E402K,Colon Adenocarcinoma,What is the distribution rate of CA9 and PGR gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of TTC17 and YY1AP1 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of TTC17 and BCAT1 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the distribution rate of PSG2 and OLFML3 gain among Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the distribution rate of RIPOR2 and MAST4 gain among Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the distribution rate of RIPOR2 and CPS1 gain among Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the distribution rate of RIPOR2 and POC1B gain among Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the distribution rate of RIPOR2 and CNGB1 gain among Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of DCLK3 and MYO16 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of DCLK3 and NOMO1 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the distribution rate of MERTK and ANKDD1A gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the distribution rate of MERTK and SPATA22 gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the distribution rate of MERTK and MAOB gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the distribution rate of ZFP42 and NRAP gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the distribution rate of OR13C3 and ANKRD30A gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the distribution rate of OR13C3 and TMEM255A gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the distribution rate of SPAG1 and ABCC2 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of CDKN2AIP and DCC gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the distribution rate of PXN and GABRA6 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the distribution rate of PXN and TLCD5 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the distribution rate of PXN and PIK3C2G gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the distribution rate of PXN and SPAG1 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the distribution rate of PXN and CACNA1F gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the distribution rate of PXN and TTC17 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of TTYH2 and HTR3B gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of TTYH2 and RIMS2 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the distribution rate of TMEM255A and PSG2 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the distribution rate of TMEM255A and MORF4L1 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the distribution rate of TMEM255A and TRAP1 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the distribution rate of TASOR2 and FBXO42 gain among Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the distribution rate of TASOR2 and REXO4 gain among Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of ICE1 and ART3 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the distribution rate of MYT1 and TTC17 gain among Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the distribution rate of MYT1 and EPRS1 gain among Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the distribution rate of MYT1 and NRAP gain among Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of CX3CR1 and ZBTB34 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of CX3CR1 and TNS1 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the distribution rate of SPINDOC and TRIM45 gain among Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of ART3 and PRSS8 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of ART3 and TLK2 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the distribution rate of CYP1A2 and WNT2 gain among Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of ADRA1A and BCAT1 gain among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the distribution rate of CDH23 and MYH11 gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the distribution rate of CDH23 and FCGR2C gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the distribution rate of KRT39 and MYO3B gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the distribution rate of PDHA2 and COL6A3 gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the distribution rate of SLC24A2 and TTYH2 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the distribution rate of PTPRN2 and GRM5 gain among Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the distribution rate of PTPRN2 and CACNA1F gain among Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the distribution rate of PTPRN2 and KRT39 gain among Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the distribution rate of PTPRN2 and DNAH11 gain among Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the distribution rate of PTPRN2 and GABRA6 gain among Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the distribution rate of SOX21 and KL gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the distribution rate of CPA6 and YY1AP1 gain among Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the distribution rate of GRM5 and PIAS3 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of CASZ1 and YY1AP1 gain among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the distribution rate of SGIP1 and SLC9C1 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the distribution rate of SGIP1 and YY1AP1 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the distribution rate of SGIP1 and POC1B gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the distribution rate of SGIP1 and ZNF804A gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the distribution rate of CARMIL1 and PTPRO gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the distribution rate of CARMIL1 and PCDHGA1 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the distribution rate of ZNF431 and ZNF584 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the distribution rate of ZNF431 and PAK3 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the distribution rate of ZNF431 and CDH23 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the distribution rate of DNAH11 and COL6A3 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the distribution rate of DNAH11 and PXN gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the distribution rate of POLD1 and PIK3C2B gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the distribution rate of POLD1 and CPA6 gain among Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the distribution rate of TTC12 and EVC2 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the distribution rate of TTC12 and RIMS2 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the distribution rate of CNGB1 and GIMAP2 gain among Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the distribution rate of CNGB1 and MORF4L1 gain among Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the distribution rate of CTSC and LCN15 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the distribution rate of CTSC and GRTP1 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the distribution rate of CTSC and GPRASP1 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the distribution rate of CTSC and TASOR2 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the distribution rate of CTSC and ITPRID2 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of PRSS8 and POC1B gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of PRSS8 and PSG2 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the distribution rate of ARHGEF40 and OR13C3 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the distribution rate of ACTB and RIPOR2 gain among Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the distribution rate of ACTB and CPS1 gain among Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the distribution rate of ACTB and PCDHGA1 gain among Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the distribution rate of ACTB and HYOU1 gain among Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the distribution rate of YY1AP1 and CTSC gain among Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the distribution rate of YY1AP1 and EIF2B4 gain among Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the distribution rate of YY1AP1 and CACNA1F gain among Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the distribution rate of YY1AP1 and OLFML3 gain among Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the distribution rate of YY1AP1 and TENT5A gain among Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the distribution rate of YY1AP1 and POLR1G gain among Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the distribution rate of YY1AP1 and PTPRO gain among Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the distribution rate of FNDC7 and CA9 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the distribution rate of FNDC7 and THBS4 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the distribution rate of TLCD5 and EBF2 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the distribution rate of TLCD5 and TRIM45 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of POLR1G and MYO16 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of POLR1G and TASOR2 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the distribution rate of DNAH14 and GRM1 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the distribution rate of DNAH14 and NRAP gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the distribution rate of DNAH14 and TAF1C gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of NEXN and SPATA22 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the distribution rate of CYB5R2 and AQP7 gain among Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the distribution rate of CYB5R2 and ANP32E gain among Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of NRAP and TSHZ3 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of NRAP and ANKDD1A gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of NRAP and PYHIN1 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of CCDC22 and MORF4L1 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the distribution rate of DCAF6 and MYT1 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the distribution rate of DCAF6 and ACVR1B gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of ZNF708 and JAML gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of BFAR and PGR gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of MAST4 and MYH11 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of MAST4 and ACTB gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of MAST4 and MERTK gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of MAST4 and GRTP1 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of MAST4 and LDOC1 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the distribution rate of ARMC3 and EFCAB12 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the distribution rate of ARMC3 and GABRA6 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the distribution rate of TET2 and PLEKHG6 gain among Kidney Renal Clear Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the distribution rate of TET2 and NOMO1 gain among Kidney Renal Clear Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the distribution rate of SERPINB10 and THBS4 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of STAT3 and SORCS1 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of MIEF1 and TASOR2 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the distribution rate of ACVR1B and ANKRD30A gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the distribution rate of ACVR1B and GUK1 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the distribution rate of ACVR1B and SLC6A4 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the distribution rate of EBF2 and MERTK gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the distribution rate of EBF2 and JAML gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the distribution rate of VPS26B and CDC42BPA gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of PGR and GABRA6 gain among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of PGR and OR8K5 gain among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the distribution rate of PGR and PGF gain among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the distribution rate of ACTA2 and WNT2 gain among Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of THBS4 and DHX16 gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of THBS4 and SPINDOC gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the distribution rate of PRSS1 and SOX21 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the distribution rate of PRSS1 and CHMP7 gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the distribution rate of PRSS1 and HTR3B gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the distribution rate of PRSS1 and DCN gain among Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the distribution rate of PGF and TNS1 gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the distribution rate of PGF and DGKD gain among Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the distribution rate of ITPRID2 and DPF3 gain among Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the distribution rate of ITPRID2 and XKR4 gain among Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of HBB and ANKRD30A gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the distribution rate of PCDHB2 and SYNJ1 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the distribution rate of PCDHB2 and TRIM45 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the distribution rate of PCDHB2 and TMTC3 gain among Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the distribution rate of UBR2 and PTPRO gain among Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the distribution rate of FBXO42 and ACTB gain among Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1,TNS1,G1362V,Breast Invasive Carcinoma,How widespread is TNS1 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+2,TNS1,G1711V,Breast Invasive Carcinoma,How widespread is TNS1 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+3,TNS1,G1718V,Breast Invasive Carcinoma,How widespread is TNS1 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+4,TNS1,G1732V,Breast Invasive Carcinoma,How widespread is TNS1 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+5,TNS1,G1824V,Breast Invasive Carcinoma,How widespread is TNS1 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+6,TNS1,G1857V,Breast Invasive Carcinoma,How widespread is TNS1 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+7,TNS1,G843V,Breast Invasive Carcinoma,How widespread is TNS1 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How widespread is EVC2 LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How widespread is EVC2 LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How widespread is CR1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How widespread is CR1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+22,TRPA1,S295I,Rectum Adenocarcinoma,How widespread is TRPA1 LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+23,TRPA1,S443I,Rectum Adenocarcinoma,How widespread is TRPA1 LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+24,TAF1C,R299L,Lung Adenocarcinoma,How widespread is TAF1C LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+25,TAF1C,R396L,Lung Adenocarcinoma,How widespread is TAF1C LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+26,TAF1C,R634L,Lung Adenocarcinoma,How widespread is TAF1C LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+27,TAF1C,R702L,Lung Adenocarcinoma,How widespread is TAF1C LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+28,TAF1C,R728L,Lung Adenocarcinoma,How widespread is TAF1C LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How widespread is DPF3 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How widespread is DPF3 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How widespread is DPF3 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+42,OR2T4,P272H,Lung Adenocarcinoma,How widespread is OR2T4 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+43,OR2T4,P300H,Lung Adenocarcinoma,How widespread is OR2T4 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How widespread is FBN1 LOH in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How widespread is MAD1L1 LOH in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How widespread is MAD1L1 LOH in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How widespread is MAD1L1 LOH in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How widespread is CCNG1 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How widespread is ANP32E LOH in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How widespread is ANP32E LOH in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How widespread is ANP32E LOH in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How widespread is ANP32E LOH in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How widespread is FRY LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How widespread is FRY LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How widespread is FRY LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How widespread is FRY LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+70,PAK3,E318K,Skin Cutaneous Melanoma,How widespread is PAK3 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+71,PAK3,E319K,Skin Cutaneous Melanoma,How widespread is PAK3 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+72,PAK3,E334K,Skin Cutaneous Melanoma,How widespread is PAK3 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+73,PAK3,E340K,Skin Cutaneous Melanoma,How widespread is PAK3 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+74,PAK3,E355K,Skin Cutaneous Melanoma,How widespread is PAK3 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How widespread is MUC16 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How widespread is ZFPM2 LOH in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How widespread is ZFPM2 LOH in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How widespread is PIK3C2B LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How widespread is PIK3C2B LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How widespread is ZNF804A LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+116,RELN,A2371V,Stomach Adenocarcinoma,How widespread is RELN LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is EFCAB12 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is EFCAB12 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How widespread is DEFB115 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How widespread is ANKDD1A LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How widespread is ANKDD1A LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How widespread is ANKDD1A LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How widespread is HTR3B LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How widespread is HTR3B LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How widespread is HTR3B LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+129,ABCC3,R758W,Stomach Adenocarcinoma,How widespread is ABCC3 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How widespread is NOMO1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How widespread is NOMO1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How widespread is HYOU1 LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How widespread is FMO4 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+140,BICC1,A372V,Exceptional Responders,How widespread is BICC1 LOH in Exceptional Responders?,freq_cnv_loss_or_gain
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How widespread is ZMYM3 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How widespread is ZMYM3 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How widespread is ZMYM3 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is XKR4 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How widespread is ABCC2 LOH in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+157,OR8K5,R293G,Lung Adenocarcinoma,How widespread is OR8K5 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How widespread is SPTAN1 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How widespread is SPTAN1 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+164,SYT10,M484I,Rectum Adenocarcinoma,How widespread is SYT10 LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How widespread is HSPA5 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+175,UNC5D,L280V,Lung Adenocarcinoma,How widespread is UNC5D LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+176,UNC5D,L635V,Lung Adenocarcinoma,How widespread is UNC5D LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+177,UNC5D,L637V,Lung Adenocarcinoma,How widespread is UNC5D LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+178,UNC5D,L699V,Lung Adenocarcinoma,How widespread is UNC5D LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+179,UNC5D,L704V,Lung Adenocarcinoma,How widespread is UNC5D LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+180,UNC5D,L709V,Lung Adenocarcinoma,How widespread is UNC5D LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How widespread is DOCK2 LOH in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How widespread is ZNF627 LOH in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How widespread is CDC42BPA LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+193,MRPL55,H27Y,Colon Adenocarcinoma,How widespread is MRPL55 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+194,MRPL55,H63Y,Colon Adenocarcinoma,How widespread is MRPL55 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How widespread is TMTC3 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+198,EPRS1,K771I,Colon Adenocarcinoma,How widespread is EPRS1 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+199,EPRS1,K778I,Colon Adenocarcinoma,How widespread is EPRS1 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How widespread is GRTP1 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How widespread is GRTP1 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How widespread is TSHZ3 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How widespread is TAS1R3 LOH in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,freq_cnv_loss_or_gain
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How widespread is PIAS3 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How widespread is PIAS3 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+251,ZNF274,P13R,Stomach Adenocarcinoma,How widespread is ZNF274 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+253,SYNJ1,R795C,Colon Adenocarcinoma,How widespread is SYNJ1 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+254,SYNJ1,R800C,Colon Adenocarcinoma,How widespread is SYNJ1 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+255,SYNJ1,R839C,Colon Adenocarcinoma,How widespread is SYNJ1 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+261,DSCAM,V343M,Prostate Adenocarcinoma,How widespread is DSCAM LOH in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+262,DSCAM,V426M,Prostate Adenocarcinoma,How widespread is DSCAM LOH in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+263,DSCAM,V591M,Prostate Adenocarcinoma,How widespread is DSCAM LOH in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+267,DGKD,R140H,Exceptional Responders,How widespread is DGKD LOH in Exceptional Responders?,freq_cnv_loss_or_gain
+268,DGKD,R160H,Exceptional Responders,How widespread is DGKD LOH in Exceptional Responders?,freq_cnv_loss_or_gain
+269,DGKD,R204H,Exceptional Responders,How widespread is DGKD LOH in Exceptional Responders?,freq_cnv_loss_or_gain
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How widespread is PLEKHG6 LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How widespread is PLEKHG6 LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How widespread is PLEKHG6 LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+279,WNT2,D138N,Skin Cutaneous Melanoma,How widespread is WNT2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How widespread is GUCY2C LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How widespread is C7orf31 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is ZKSCAN7 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+299,OR5D14,M210L,Neuroblastoma,How widespread is OR5D14 LOH in Neuroblastoma?,freq_cnv_loss_or_gain
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How widespread is SPATA22 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How widespread is SPATA22 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How widespread is SPATA22 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+310,LCN15,E21V,Stomach Adenocarcinoma,How widespread is LCN15 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How widespread is DCAF4L2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How widespread is GUK1 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How widespread is GUK1 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How widespread is GUK1 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How widespread is GUK1 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How widespread is GUK1 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How widespread is MORF4L1 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How widespread is MORF4L1 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How widespread is MORF4L1 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How widespread is MORF4L1 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How widespread is MYO3B LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How widespread is MYO3B LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How widespread is TENT5A LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How widespread is TENT5A LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How widespread is TENT5A LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How widespread is ZFAT LOH in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How widespread is ZFAT LOH in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How widespread is ZFAT LOH in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+357,ZNF584,A211T,Sarcoma,How widespread is ZNF584 LOH in Sarcoma?,freq_cnv_loss_or_gain
+358,ZNF584,A256T,Sarcoma,How widespread is ZNF584 LOH in Sarcoma?,freq_cnv_loss_or_gain
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How widespread is LDOC1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How widespread is PDGFC LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How widespread is MSANTD4 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How widespread is NPSR1 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How widespread is PHLPP1 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How widespread is COL6A3 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How widespread is COL6A3 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How widespread is COL6A3 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How widespread is COL6A3 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How widespread is COL6A3 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How widespread is ADRA1A LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread is LAMB2 LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+406,POC1B,I198T,Rectum Adenocarcinoma,How widespread is POC1B LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+407,POC1B,I286T,Rectum Adenocarcinoma,How widespread is POC1B LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+408,POC1B,I328T,Rectum Adenocarcinoma,How widespread is POC1B LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+409,POC1B,S79P,Rectum Adenocarcinoma,How widespread is POC1B LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How widespread is USH2A LOH in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+414,AQP7,T110S,Rectum Adenocarcinoma,How widespread is AQP7 LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+415,AQP7,T166S,Rectum Adenocarcinoma,How widespread is AQP7 LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+416,AQP7,T167S,Rectum Adenocarcinoma,How widespread is AQP7 LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+417,AQP7,T75S,Rectum Adenocarcinoma,How widespread is AQP7 LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+430,DCN,R163C,Rectum Adenocarcinoma,How widespread is DCN LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+431,DCN,R203C,Rectum Adenocarcinoma,How widespread is DCN LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+432,DCN,R241C,Rectum Adenocarcinoma,How widespread is DCN LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+433,DCN,R350C,Rectum Adenocarcinoma,How widespread is DCN LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+434,DCN,R41C,Rectum Adenocarcinoma,How widespread is DCN LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How widespread is CPS1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How widespread is CPS1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How widespread is CPS1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How widespread is FCGR2C LOH in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How widespread is FCGR2C LOH in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How widespread is GRM1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+482,SGCZ,Q138H,Lung Adenocarcinoma,How widespread is SGCZ LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+483,SGCZ,Q91H,Lung Adenocarcinoma,How widespread is SGCZ LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+485,SMO,V15M,Stomach Adenocarcinoma,How widespread is SMO LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+486,SMO,V321M,Stomach Adenocarcinoma,How widespread is SMO LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+488,CHODL,G159E,Skin Cutaneous Melanoma,How widespread is CHODL LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+489,CHODL,G181E,Skin Cutaneous Melanoma,How widespread is CHODL LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+490,CHODL,G200E,Skin Cutaneous Melanoma,How widespread is CHODL LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+494,MYO16,P399H,Colon Adenocarcinoma,How widespread is MYO16 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+495,MYO16,P421H,Colon Adenocarcinoma,How widespread is MYO16 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+498,CXCR2,A98V,Stomach Adenocarcinoma,How widespread is CXCR2 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How widespread is TMEM225 LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How widespread is MAOB LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How widespread is GPRASP1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How widespread is MRPL32 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How widespread is TYROBP LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+510,RAB40C,A111V,Lung Adenocarcinoma,How widespread is RAB40C LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+511,RAB40C,A143V,Lung Adenocarcinoma,How widespread is RAB40C LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+512,CTNNA2,S323R,Lung Adenocarcinoma,How widespread is CTNNA2 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+513,CTNNA2,S339R,Lung Adenocarcinoma,How widespread is CTNNA2 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+514,CTNNA2,S386R,Lung Adenocarcinoma,How widespread is CTNNA2 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+515,CTNNA2,S707R,Lung Adenocarcinoma,How widespread is CTNNA2 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How widespread is MYO15A LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How widespread is GIMAP2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+532,KIF20B,N1160D,Glioblastoma Multiforme,How widespread is KIF20B LOH in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+533,KIF20B,N1200D,Glioblastoma Multiforme,How widespread is KIF20B LOH in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How widespread is ADAM17 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How widespread is BCAT1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How widespread is BCAT1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How widespread is BCAT1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+540,ERCC6,R1053H,Colon Adenocarcinoma,How widespread is ERCC6 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+541,DCC,R320W,Breast Invasive Carcinoma,How widespread is DCC LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+542,DCC,R363W,Breast Invasive Carcinoma,How widespread is DCC LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+543,DCC,R386W,Breast Invasive Carcinoma,How widespread is DCC LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+544,DCC,R41W,Breast Invasive Carcinoma,How widespread is DCC LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How widespread is FBXO15 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How widespread is FBXO15 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How widespread is GSTCD LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How widespread is GSTCD LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How widespread is OLFML3 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How widespread is OLFML3 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How widespread is OLFML3 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How widespread is CFAP61 LOH in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How widespread is CFAP61 LOH in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How widespread is HLA-DQA2 LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How widespread is TENM2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How widespread is TENM2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How widespread is TENM2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How widespread is ANKRD24 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How widespread is ANKRD24 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How widespread is ANKRD24 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How widespread is ZCCHC14 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How widespread is ZCCHC14 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How widespread is ZCCHC14 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How widespread is ZCCHC14 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+625,SIK2,I265M,Lung Adenocarcinoma,How widespread is SIK2 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How widespread is MYH11 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How widespread is MYH11 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How widespread is SLC6A4 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How widespread is SLC9C1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How widespread is SLC9C1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+644,OR2A12,A254T,Brain Lower Grade Glioma,How widespread is OR2A12 LOH in Brain Lower Grade Glioma?,freq_cnv_loss_or_gain
+646,PYHIN1,T325K,Lung Adenocarcinoma,How widespread is PYHIN1 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+647,PYHIN1,T334K,Lung Adenocarcinoma,How widespread is PYHIN1 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+650,JAML,G191E,Skin Cutaneous Melanoma,How widespread is JAML LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+651,JAML,G219E,Skin Cutaneous Melanoma,How widespread is JAML LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+652,JAML,G220E,Skin Cutaneous Melanoma,How widespread is JAML LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+653,JAML,G230E,Skin Cutaneous Melanoma,How widespread is JAML LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+658,TYK2,H1146R,Stomach Adenocarcinoma,How widespread is TYK2 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+659,TYK2,H23R,Stomach Adenocarcinoma,How widespread is TYK2 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+660,TYK2,H961R,Stomach Adenocarcinoma,How widespread is TYK2 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How widespread is CTCFL LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How widespread is CTCFL LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How widespread is CTCFL LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How widespread is CTCFL LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How widespread is CEP20 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How widespread is CEP20 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How widespread is RIMS2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How widespread is RIMS2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How widespread is RIMS2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How widespread is RIMS2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How widespread is RIMS2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How widespread is RIMS2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How widespread is RIMS2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How widespread is PIK3C2G LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How widespread is PIK3C2G LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+728,STK19,D341N,Colon Adenocarcinoma,How widespread is STK19 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+729,STK19,D345N,Colon Adenocarcinoma,How widespread is STK19 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+730,REXO4,P60A,Skin Cutaneous Melanoma,How widespread is REXO4 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How widespread is ZBTB34 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How widespread is ZBTB34 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How widespread is NCKAP5 LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is SORCS1 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is SORCS1 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is SORCS1 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is SORCS1 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How widespread is FGF8 LOH in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How widespread is FGF8 LOH in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How widespread is FGF8 LOH in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How widespread is FGF8 LOH in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How widespread is FGF8 LOH in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How widespread is TENM3 LOH in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,freq_cnv_loss_or_gain
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How widespread is AKT1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread is CFAP298-TCP10L LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+792,GLRB,E148D,Stomach Adenocarcinoma,How widespread is GLRB LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+793,TTN,F7636L,Colon Adenocarcinoma,How widespread is TTN LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+794,TTN,F8563L,Colon Adenocarcinoma,How widespread is TTN LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+795,TTN,F8880L,Colon Adenocarcinoma,How widespread is TTN LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How widespread is ANKRD30A LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How widespread is ANKRD30A LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How widespread is ANKRD30A LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+809,TRIM45,S177L,Colon Adenocarcinoma,How widespread is TRIM45 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+810,TRIM45,S224L,Colon Adenocarcinoma,How widespread is TRIM45 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+811,TRIM45,S281L,Colon Adenocarcinoma,How widespread is TRIM45 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How widespread is CACNA1F LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How widespread is CACNA1F LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How widespread is CACNA1F LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+817,KL,R594C,Colon Adenocarcinoma,How widespread is KL LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How widespread is GUF1 LOH in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+822,TAF1L,A539V,Colon Adenocarcinoma,How widespread is TAF1L LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How widespread is TASOR2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How widespread is TASOR2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How widespread is TASOR2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How widespread is KDM5C LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How widespread is KDM5C LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How widespread is KDM5C LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How widespread is KDM5C LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread is IL5RA LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+843,DHX16,A29V,Skin Cutaneous Melanoma,How widespread is DHX16 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+844,DHX16,A89V,Skin Cutaneous Melanoma,How widespread is DHX16 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+902,GPR158,A644V,Stomach Adenocarcinoma,How widespread is GPR158 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+903,GPR158,A723V,Stomach Adenocarcinoma,How widespread is GPR158 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is EIF2B4 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is EIF2B4 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is EIF2B4 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is EIF2B4 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is EIF2B4 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is EIF2B4 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How widespread is AUTS2 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How widespread is AUTS2 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How widespread is AUTS2 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How widespread is AUTS2 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How widespread is AUTS2 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How widespread is AUTS2 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How widespread is AUTS2 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How widespread is AUTS2 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How widespread is AUTS2 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How widespread is AUTS2 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is ACTL7B LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How widespread is PCDHGA1 LOH in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+954,TRAP1,R114W,Stomach Adenocarcinoma,How widespread is TRAP1 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+955,TRAP1,R61W,Stomach Adenocarcinoma,How widespread is TRAP1 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How widespread is PIK3C2A LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How widespread is KANSL1 LOH in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How widespread is ANKRD52 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How widespread is PAPPA LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How widespread is B3GALNT1 LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+982,GABRA6,G115R,Lung Adenocarcinoma,How widespread is GABRA6 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+983,GABRA6,G122R,Lung Adenocarcinoma,How widespread is GABRA6 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+984,GABRA6,G165R,Lung Adenocarcinoma,How widespread is GABRA6 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+985,GABRA6,G175R,Lung Adenocarcinoma,How widespread is GABRA6 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+986,GABRA6,G70R,Lung Adenocarcinoma,How widespread is GABRA6 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How widespread is ZSCAN31 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is MED16 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is MED16 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How widespread is PTPRO LOH in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How widespread is PTPRO LOH in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How widespread is PTPRO LOH in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How widespread is PTPRO LOH in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How widespread is PTPRO LOH in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How widespread is PTPRO LOH in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How widespread is PTPRO LOH in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How widespread is PTPRO LOH in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How widespread is CHMP7 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1017,GPC3,I107N,Stomach Adenocarcinoma,How widespread is GPC3 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1018,GPC3,I161N,Stomach Adenocarcinoma,How widespread is GPC3 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread is TLK2 LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread is TLK2 LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread is TLK2 LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread is TLK2 LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How widespread is TLK2 LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How widespread is ZNF217 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1038,SYT9,V275L,Lung Adenocarcinoma,How widespread is SYT9 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1039,SYT9,V307L,Lung Adenocarcinoma,How widespread is SYT9 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How widespread is PKHD1L1 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How widespread is MYO3A LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is VASN LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How widespread is DNMT1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How widespread is DNMT1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How widespread is DNMT1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1056,CA9,E402K,Colon Adenocarcinoma,How widespread is CA9 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How widespread is TTC17 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How widespread is TTC17 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1065,PSG2,P43L,Breast Invasive Carcinoma,How widespread is PSG2 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How widespread is RIPOR2 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How widespread is RIPOR2 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How widespread is RIPOR2 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How widespread is RIPOR2 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How widespread is DCLK3 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How widespread is DCLK3 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How widespread is MERTK LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How widespread is MERTK LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How widespread is MERTK LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How widespread is ZFP42 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How widespread is OR13C3 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How widespread is OR13C3 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How widespread is SPAG1 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How widespread is CDKN2AIP LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1093,PXN,H1016Y,Colon Adenocarcinoma,How widespread is PXN LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1094,PXN,H359Y,Colon Adenocarcinoma,How widespread is PXN LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1095,PXN,H492Y,Colon Adenocarcinoma,How widespread is PXN LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1096,PXN,H524Y,Colon Adenocarcinoma,How widespread is PXN LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1097,PXN,H526Y,Colon Adenocarcinoma,How widespread is PXN LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1098,PXN,H540Y,Colon Adenocarcinoma,How widespread is PXN LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How widespread is TTYH2 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How widespread is TTYH2 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How widespread is TMEM255A LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How widespread is TMEM255A LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How widespread is TMEM255A LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How widespread is TASOR2 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How widespread is TASOR2 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How widespread is ICE1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1112,MYT1,A558E,Breast Invasive Carcinoma,How widespread is MYT1 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1113,MYT1,A879E,Breast Invasive Carcinoma,How widespread is MYT1 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1114,MYT1,A906E,Breast Invasive Carcinoma,How widespread is MYT1 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How widespread is CX3CR1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How widespread is CX3CR1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How widespread is SPINDOC LOH in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How widespread is ART3 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How widespread is ART3 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How widespread is CYP1A2 LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is ADRA1A LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How widespread is CDH23 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How widespread is CDH23 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How widespread is KRT39 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How widespread is PDHA2 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How widespread is SLC24A2 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How widespread is PTPRN2 LOH in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How widespread is PTPRN2 LOH in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How widespread is PTPRN2 LOH in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How widespread is PTPRN2 LOH in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How widespread is PTPRN2 LOH in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1188,SOX21,R55L,Lung Adenocarcinoma,How widespread is SOX21 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How widespread is CPA6 LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How widespread is GRM5 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is CASZ1 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How widespread is SGIP1 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How widespread is SGIP1 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How widespread is SGIP1 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How widespread is SGIP1 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How widespread is CARMIL1 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How widespread is CARMIL1 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How widespread is ZNF431 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How widespread is ZNF431 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1234,ZNF431,R128I,Lung Adenocarcinoma,How widespread is ZNF431 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How widespread is DNAH11 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How widespread is DNAH11 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How widespread is POLD1 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How widespread is POLD1 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1248,TTC12,D646H,Lung Adenocarcinoma,How widespread is TTC12 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1249,TTC12,D652H,Lung Adenocarcinoma,How widespread is TTC12 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How widespread is CNGB1 LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How widespread is CNGB1 LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1254,CTSC,E214V,Stomach Adenocarcinoma,How widespread is CTSC LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1255,CTSC,E291V,Stomach Adenocarcinoma,How widespread is CTSC LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1256,CTSC,E322V,Stomach Adenocarcinoma,How widespread is CTSC LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1257,CTSC,E324V,Stomach Adenocarcinoma,How widespread is CTSC LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1258,CTSC,E335V,Stomach Adenocarcinoma,How widespread is CTSC LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How widespread is PRSS8 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How widespread is PRSS8 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How widespread is ARHGEF40 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1264,ACTB,A138T,Rectum Adenocarcinoma,How widespread is ACTB LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1265,ACTB,A217T,Rectum Adenocarcinoma,How widespread is ACTB LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1266,ACTB,A244T,Rectum Adenocarcinoma,How widespread is ACTB LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1267,ACTB,A260T,Rectum Adenocarcinoma,How widespread is ACTB LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How widespread is YY1AP1 LOH in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How widespread is YY1AP1 LOH in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How widespread is YY1AP1 LOH in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How widespread is YY1AP1 LOH in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How widespread is YY1AP1 LOH in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How widespread is YY1AP1 LOH in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How widespread is YY1AP1 LOH in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How widespread is FNDC7 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How widespread is FNDC7 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1299,TLCD5,G15V,Lung Adenocarcinoma,How widespread is TLCD5 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1300,TLCD5,G37V,Lung Adenocarcinoma,How widespread is TLCD5 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How widespread is POLR1G LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How widespread is POLR1G LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How widespread is DNAH14 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How widespread is DNAH14 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How widespread is DNAH14 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How widespread is NEXN LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How widespread is CYB5R2 LOH in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How widespread is CYB5R2 LOH in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How widespread is NRAP LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How widespread is NRAP LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How widespread is NRAP LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How widespread is CCDC22 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How widespread is DCAF6 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How widespread is DCAF6 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How widespread is ZNF708 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How widespread is BFAR LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How widespread is MAST4 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How widespread is MAST4 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How widespread is MAST4 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How widespread is MAST4 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How widespread is MAST4 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How widespread is ARMC3 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How widespread is ARMC3 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How widespread is TET2 LOH in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How widespread is TET2 LOH in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How widespread is SERPINB10 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How widespread is STAT3 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How widespread is MIEF1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How widespread is ACVR1B LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How widespread is ACVR1B LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How widespread is ACVR1B LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1393,EBF2,T104I,Stomach Adenocarcinoma,How widespread is EBF2 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1394,EBF2,T252I,Stomach Adenocarcinoma,How widespread is EBF2 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How widespread is VPS26B LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is PGR LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is PGR LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How widespread is PGR LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How widespread is ACTA2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How widespread is THBS4 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How widespread is THBS4 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1413,PRSS1,S114T,Lung Adenocarcinoma,How widespread is PRSS1 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1414,PRSS1,S124T,Lung Adenocarcinoma,How widespread is PRSS1 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1415,PRSS1,S138T,Lung Adenocarcinoma,How widespread is PRSS1 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1416,PRSS1,S74T,Lung Adenocarcinoma,How widespread is PRSS1 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1417,PGF,R126H,Stomach Adenocarcinoma,How widespread is PGF LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1418,PGF,R127H,Stomach Adenocarcinoma,How widespread is PGF LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How widespread is ITPRID2 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How widespread is ITPRID2 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How widespread is HBB LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How widespread is PCDHB2 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How widespread is PCDHB2 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How widespread is PCDHB2 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How widespread is UBR2 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How widespread is FBXO42 LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1,TNS1,G1362V,Breast Invasive Carcinoma,Can you tell me how prevalent TNS1 and FGF8 loss is in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+2,TNS1,G1711V,Breast Invasive Carcinoma,Can you tell me how prevalent TNS1 and CTNNA2 loss is in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+3,TNS1,G1718V,Breast Invasive Carcinoma,Can you tell me how prevalent TNS1 and PCDHB2 loss is in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+4,TNS1,G1732V,Breast Invasive Carcinoma,Can you tell me how prevalent TNS1 and OR2T4 loss is in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+5,TNS1,G1824V,Breast Invasive Carcinoma,Can you tell me how prevalent TNS1 and SGIP1 loss is in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+6,TNS1,G1857V,Breast Invasive Carcinoma,Can you tell me how prevalent TNS1 and UNC5D loss is in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+7,TNS1,G843V,Breast Invasive Carcinoma,Can you tell me how prevalent TNS1 and DHX16 loss is in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,Can you tell me how prevalent EVC2 and UNC5D loss is in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+15,EVC2,E987K,Bladder Urothelial Carcinoma,Can you tell me how prevalent EVC2 and PCDHB2 loss is in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent CR1 and CX3CR1 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent CR1 and OR13C3 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+22,TRPA1,S295I,Rectum Adenocarcinoma,Can you tell me how prevalent TRPA1 and SPINDOC loss is in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+23,TRPA1,S443I,Rectum Adenocarcinoma,Can you tell me how prevalent TRPA1 and PGF loss is in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+24,TAF1C,R299L,Lung Adenocarcinoma,Can you tell me how prevalent TAF1C and DCN loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+25,TAF1C,R396L,Lung Adenocarcinoma,Can you tell me how prevalent TAF1C and GUK1 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+26,TAF1C,R634L,Lung Adenocarcinoma,Can you tell me how prevalent TAF1C and TMEM255A loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+27,TAF1C,R702L,Lung Adenocarcinoma,Can you tell me how prevalent TAF1C and PAPPA loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+28,TAF1C,R728L,Lung Adenocarcinoma,Can you tell me how prevalent TAF1C and GIMAP2 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent DPF3 and ADAM17 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent DPF3 and MYO3B loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent DPF3 and GRTP1 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+42,OR2T4,P272H,Lung Adenocarcinoma,Can you tell me how prevalent OR2T4 and MORF4L1 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+43,OR2T4,P300H,Lung Adenocarcinoma,Can you tell me how prevalent OR2T4 and SGIP1 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,Can you tell me how prevalent FBN1 and CTSC loss is in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+45,MAD1L1,E396K,Prostate Adenocarcinoma,Can you tell me how prevalent MAD1L1 and MERTK loss is in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+46,MAD1L1,E488K,Prostate Adenocarcinoma,Can you tell me how prevalent MAD1L1 and ADAM17 loss is in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+47,MAD1L1,E78K,Prostate Adenocarcinoma,Can you tell me how prevalent MAD1L1 and SMO loss is in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+61,CCNG1,E22K,Skin Cutaneous Melanoma,Can you tell me how prevalent CCNG1 and DHX16 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,Can you tell me how prevalent ANP32E and PRSS8 loss is in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,Can you tell me how prevalent ANP32E and MYO3B loss is in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,Can you tell me how prevalent ANP32E and GPR158 loss is in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,Can you tell me how prevalent ANP32E and ACTA2 loss is in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+66,FRY,S1888A,Bladder Urothelial Carcinoma,Can you tell me how prevalent FRY and DCLK3 loss is in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+67,FRY,S1937A,Bladder Urothelial Carcinoma,Can you tell me how prevalent FRY and PIK3C2A loss is in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+68,FRY,S1938A,Bladder Urothelial Carcinoma,Can you tell me how prevalent FRY and NPSR1 loss is in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+69,FRY,S1983A,Bladder Urothelial Carcinoma,Can you tell me how prevalent FRY and GRM1 loss is in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+70,PAK3,E318K,Skin Cutaneous Melanoma,Can you tell me how prevalent PAK3 and TENT5A loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+71,PAK3,E319K,Skin Cutaneous Melanoma,Can you tell me how prevalent PAK3 and PIK3C2G loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+72,PAK3,E334K,Skin Cutaneous Melanoma,Can you tell me how prevalent PAK3 and GUK1 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+73,PAK3,E340K,Skin Cutaneous Melanoma,Can you tell me how prevalent PAK3 and PCDHB2 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+74,PAK3,E355K,Skin Cutaneous Melanoma,Can you tell me how prevalent PAK3 and DCC loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+80,MUC16,P7963L,Skin Cutaneous Melanoma,Can you tell me how prevalent MUC16 and SORCS1 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,Can you tell me how prevalent ZFPM2 and KDM5C loss is in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,Can you tell me how prevalent ZFPM2 and TENT5A loss is in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,Can you tell me how prevalent PIK3C2B and MERTK loss is in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,Can you tell me how prevalent PIK3C2B and MAST4 loss is in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+114,ZNF804A,S371Y,Colon Adenocarcinoma,Can you tell me how prevalent ZNF804A and DPF3 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+116,RELN,A2371V,Stomach Adenocarcinoma,Can you tell me how prevalent RELN and RIPOR2 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent EFCAB12 and EVC2 loss is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent EFCAB12 and YY1AP1 loss is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+120,DEFB115,E53K,Skin Cutaneous Melanoma,Can you tell me how prevalent DEFB115 and AUTS2 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,Can you tell me how prevalent ANKDD1A and AKT1 loss is in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,Can you tell me how prevalent ANKDD1A and PAK3 loss is in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,Can you tell me how prevalent ANKDD1A and EIF2B4 loss is in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent HTR3B and AUTS2 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent HTR3B and SYNJ1 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent HTR3B and CYB5R2 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+129,ABCC3,R758W,Stomach Adenocarcinoma,Can you tell me how prevalent ABCC3 and TASOR2 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent NOMO1 and MORF4L1 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent NOMO1 and TAF1C loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,Can you tell me how prevalent HYOU1 and HBB loss is in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+139,FMO4,R500Q,Skin Cutaneous Melanoma,Can you tell me how prevalent FMO4 and ANKRD30A loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+140,BICC1,A372V,Exceptional Responders,Can you tell me how prevalent BICC1 and AQP7 loss is in Exceptional Responders?,freq_cnv_loss_or_gain
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent ZMYM3 and MORF4L1 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent ZMYM3 and SMO loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent ZMYM3 and TLCD5 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent XKR4 and FCGR2C loss is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,Can you tell me how prevalent ABCC2 and MUC16 loss is in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+157,OR8K5,R293G,Lung Adenocarcinoma,Can you tell me how prevalent OR8K5 and PHLPP1 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,Can you tell me how prevalent SPTAN1 and ZNF627 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,Can you tell me how prevalent SPTAN1 and FGF8 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+164,SYT10,M484I,Rectum Adenocarcinoma,Can you tell me how prevalent SYT10 and CHODL loss is in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+174,HSPA5,N457K,Skin Cutaneous Melanoma,Can you tell me how prevalent HSPA5 and TSHZ3 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+175,UNC5D,L280V,Lung Adenocarcinoma,Can you tell me how prevalent UNC5D and PCDHB2 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+176,UNC5D,L635V,Lung Adenocarcinoma,Can you tell me how prevalent UNC5D and DNMT1 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+177,UNC5D,L637V,Lung Adenocarcinoma,Can you tell me how prevalent UNC5D and DNAH14 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+178,UNC5D,L699V,Lung Adenocarcinoma,Can you tell me how prevalent UNC5D and PXN loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+179,UNC5D,L704V,Lung Adenocarcinoma,Can you tell me how prevalent UNC5D and NEXN loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+180,UNC5D,L709V,Lung Adenocarcinoma,Can you tell me how prevalent UNC5D and DCLK3 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,Can you tell me how prevalent DOCK2 and DNAH11 loss is in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,Can you tell me how prevalent ZNF627 and PGR loss is in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,Can you tell me how prevalent CDC42BPA and DNAH14 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+193,MRPL55,H27Y,Colon Adenocarcinoma,Can you tell me how prevalent MRPL55 and HTR3B loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+194,MRPL55,H63Y,Colon Adenocarcinoma,Can you tell me how prevalent MRPL55 and CFAP61 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+197,TMTC3,Q749K,Breast Invasive Carcinoma,Can you tell me how prevalent TMTC3 and ZNF431 loss is in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+198,EPRS1,K771I,Colon Adenocarcinoma,Can you tell me how prevalent EPRS1 and LDOC1 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+199,EPRS1,K778I,Colon Adenocarcinoma,Can you tell me how prevalent EPRS1 and TAF1L loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+201,GRTP1,A110V,Skin Cutaneous Melanoma,Can you tell me how prevalent GRTP1 and PIK3C2B loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+202,GRTP1,A32V,Skin Cutaneous Melanoma,Can you tell me how prevalent GRTP1 and TASOR2 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,Can you tell me how prevalent TSHZ3 and ZSCAN31 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,Can you tell me how prevalent TAS1R3 and PYHIN1 loss is in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,freq_cnv_loss_or_gain
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,Can you tell me how prevalent PIAS3 and TENM2 loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,Can you tell me how prevalent PIAS3 and YY1AP1 loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+251,ZNF274,P13R,Stomach Adenocarcinoma,Can you tell me how prevalent ZNF274 and CNGB1 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+253,SYNJ1,R795C,Colon Adenocarcinoma,Can you tell me how prevalent SYNJ1 and DCLK3 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+254,SYNJ1,R800C,Colon Adenocarcinoma,Can you tell me how prevalent SYNJ1 and TAF1C loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+255,SYNJ1,R839C,Colon Adenocarcinoma,Can you tell me how prevalent SYNJ1 and POC1B loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+261,DSCAM,V343M,Prostate Adenocarcinoma,Can you tell me how prevalent DSCAM and AUTS2 loss is in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+262,DSCAM,V426M,Prostate Adenocarcinoma,Can you tell me how prevalent DSCAM and EBF2 loss is in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+263,DSCAM,V591M,Prostate Adenocarcinoma,Can you tell me how prevalent DSCAM and PTPRN2 loss is in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+267,DGKD,R140H,Exceptional Responders,Can you tell me how prevalent DGKD and AQP7 loss is in Exceptional Responders?,freq_cnv_loss_or_gain
+268,DGKD,R160H,Exceptional Responders,Can you tell me how prevalent DGKD and ZMYM3 loss is in Exceptional Responders?,freq_cnv_loss_or_gain
+269,DGKD,R204H,Exceptional Responders,Can you tell me how prevalent DGKD and HBB loss is in Exceptional Responders?,freq_cnv_loss_or_gain
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,Can you tell me how prevalent PLEKHG6 and FNDC7 loss is in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,Can you tell me how prevalent PLEKHG6 and MYO3B loss is in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,Can you tell me how prevalent PLEKHG6 and CXCR2 loss is in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+279,WNT2,D138N,Skin Cutaneous Melanoma,Can you tell me how prevalent WNT2 and LAMB2 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,Can you tell me how prevalent GUCY2C and RIPOR2 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent C7orf31 and ZNF274 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent ZKSCAN7 and SYT9 loss is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+299,OR5D14,M210L,Neuroblastoma,Can you tell me how prevalent OR5D14 and GABRA6 loss is in Neuroblastoma?,freq_cnv_loss_or_gain
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent SPATA22 and CTSC loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent SPATA22 and MYT1 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent SPATA22 and KDM5C loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+310,LCN15,E21V,Stomach Adenocarcinoma,Can you tell me how prevalent LCN15 and OR8K5 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,Can you tell me how prevalent DCAF4L2 and TLK2 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,Can you tell me how prevalent GUK1 and TTC17 loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,Can you tell me how prevalent GUK1 and TET2 loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,Can you tell me how prevalent GUK1 and FGF8 loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,Can you tell me how prevalent GUK1 and DCC loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,Can you tell me how prevalent GUK1 and SYT9 loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+328,MORF4L1,K29T,Stomach Adenocarcinoma,Can you tell me how prevalent MORF4L1 and EFCAB12 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+329,MORF4L1,K51T,Stomach Adenocarcinoma,Can you tell me how prevalent MORF4L1 and TNS1 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+330,MORF4L1,K61T,Stomach Adenocarcinoma,Can you tell me how prevalent MORF4L1 and PTPRN2 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+331,MORF4L1,K76T,Stomach Adenocarcinoma,Can you tell me how prevalent MORF4L1 and TENM2 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+335,MYO3B,F594L,Skin Cutaneous Melanoma,Can you tell me how prevalent MYO3B and SMO loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+336,MYO3B,F603L,Skin Cutaneous Melanoma,Can you tell me how prevalent MYO3B and CTNNA2 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+339,TENT5A,S320F,Skin Cutaneous Melanoma,Can you tell me how prevalent TENT5A and CTNNA2 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+340,TENT5A,S339F,Skin Cutaneous Melanoma,Can you tell me how prevalent TENT5A and SPTAN1 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+341,TENT5A,S401F,Skin Cutaneous Melanoma,Can you tell me how prevalent TENT5A and FCGR2C loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,Can you tell me how prevalent ZFAT and GABRA6 loss is in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,Can you tell me how prevalent ZFAT and TRPA1 loss is in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,Can you tell me how prevalent ZFAT and ZCCHC14 loss is in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+357,ZNF584,A211T,Sarcoma,Can you tell me how prevalent ZNF584 and DPF3 loss is in Sarcoma?,freq_cnv_loss_or_gain
+358,ZNF584,A256T,Sarcoma,Can you tell me how prevalent ZNF584 and TMTC3 loss is in Sarcoma?,freq_cnv_loss_or_gain
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent LDOC1 and FNDC7 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,Can you tell me how prevalent PDGFC and DNMT1 loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MSANTD4 and TENT5A loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+374,NPSR1,S123L,Skin Cutaneous Melanoma,Can you tell me how prevalent NPSR1 and AUTS2 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,Can you tell me how prevalent PHLPP1 and POC1B loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+385,COL6A3,G237S,Skin Cutaneous Melanoma,Can you tell me how prevalent COL6A3 and MSANTD4 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+386,COL6A3,G437S,Skin Cutaneous Melanoma,Can you tell me how prevalent COL6A3 and GPC3 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+387,COL6A3,G638S,Skin Cutaneous Melanoma,Can you tell me how prevalent COL6A3 and ZCCHC14 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+388,COL6A3,G644S,Skin Cutaneous Melanoma,Can you tell me how prevalent COL6A3 and PTPRO loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+389,COL6A3,G844S,Skin Cutaneous Melanoma,Can you tell me how prevalent COL6A3 and GUK1 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+395,ADRA1A,R348G,Stomach Adenocarcinoma,Can you tell me how prevalent ADRA1A and FGF8 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me how prevalent LAMB2 and STAT3 loss is in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+406,POC1B,I198T,Rectum Adenocarcinoma,Can you tell me how prevalent POC1B and GUF1 loss is in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+407,POC1B,I286T,Rectum Adenocarcinoma,Can you tell me how prevalent POC1B and DPF3 loss is in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+408,POC1B,I328T,Rectum Adenocarcinoma,Can you tell me how prevalent POC1B and DCN loss is in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+409,POC1B,S79P,Rectum Adenocarcinoma,Can you tell me how prevalent POC1B and ANP32E loss is in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,Can you tell me how prevalent USH2A and ACTA2 loss is in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+414,AQP7,T110S,Rectum Adenocarcinoma,Can you tell me how prevalent AQP7 and CFAP298-TCP10L loss is in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+415,AQP7,T166S,Rectum Adenocarcinoma,Can you tell me how prevalent AQP7 and LAMB2 loss is in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+416,AQP7,T167S,Rectum Adenocarcinoma,Can you tell me how prevalent AQP7 and KDM5C loss is in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+417,AQP7,T75S,Rectum Adenocarcinoma,Can you tell me how prevalent AQP7 and KDM5C loss is in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+430,DCN,R163C,Rectum Adenocarcinoma,Can you tell me how prevalent DCN and DNAH14 loss is in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+431,DCN,R203C,Rectum Adenocarcinoma,Can you tell me how prevalent DCN and DSCAM loss is in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+432,DCN,R241C,Rectum Adenocarcinoma,Can you tell me how prevalent DCN and CEP20 loss is in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+433,DCN,R350C,Rectum Adenocarcinoma,Can you tell me how prevalent DCN and ZNF217 loss is in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+434,DCN,R41C,Rectum Adenocarcinoma,Can you tell me how prevalent DCN and SORCS1 loss is in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent CPS1 and SPATA22 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent CPS1 and DCC loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent CPS1 and MSANTD4 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,Can you tell me how prevalent FCGR2C and ZFPM2 loss is in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,Can you tell me how prevalent FCGR2C and LDOC1 loss is in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent GRM1 and GABRA6 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+482,SGCZ,Q138H,Lung Adenocarcinoma,Can you tell me how prevalent SGCZ and MYO3B loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+483,SGCZ,Q91H,Lung Adenocarcinoma,Can you tell me how prevalent SGCZ and DSCAM loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+485,SMO,V15M,Stomach Adenocarcinoma,Can you tell me how prevalent SMO and TENT5A loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+486,SMO,V321M,Stomach Adenocarcinoma,Can you tell me how prevalent SMO and SORCS1 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+488,CHODL,G159E,Skin Cutaneous Melanoma,Can you tell me how prevalent CHODL and MYO16 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+489,CHODL,G181E,Skin Cutaneous Melanoma,Can you tell me how prevalent CHODL and UNC5D loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+490,CHODL,G200E,Skin Cutaneous Melanoma,Can you tell me how prevalent CHODL and YY1AP1 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+494,MYO16,P399H,Colon Adenocarcinoma,Can you tell me how prevalent MYO16 and PCDHGA1 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+495,MYO16,P421H,Colon Adenocarcinoma,Can you tell me how prevalent MYO16 and CTSC loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+498,CXCR2,A98V,Stomach Adenocarcinoma,Can you tell me how prevalent CXCR2 and PGF loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,Can you tell me how prevalent TMEM225 and SYNJ1 loss is in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MAOB and TET2 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent GPRASP1 and TLCD5 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MRPL32 and POLD1 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent TYROBP and ACTB loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+510,RAB40C,A111V,Lung Adenocarcinoma,Can you tell me how prevalent RAB40C and SORCS1 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+511,RAB40C,A143V,Lung Adenocarcinoma,Can you tell me how prevalent RAB40C and ANP32E loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+512,CTNNA2,S323R,Lung Adenocarcinoma,Can you tell me how prevalent CTNNA2 and PGR loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+513,CTNNA2,S339R,Lung Adenocarcinoma,Can you tell me how prevalent CTNNA2 and PTPRO loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+514,CTNNA2,S386R,Lung Adenocarcinoma,Can you tell me how prevalent CTNNA2 and FGF8 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+515,CTNNA2,S707R,Lung Adenocarcinoma,Can you tell me how prevalent CTNNA2 and TYK2 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,Can you tell me how prevalent MYO15A and ANP32E loss is in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,Can you tell me how prevalent GIMAP2 and KIF20B loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+532,KIF20B,N1160D,Glioblastoma Multiforme,Can you tell me how prevalent KIF20B and TENM3 loss is in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+533,KIF20B,N1200D,Glioblastoma Multiforme,Can you tell me how prevalent KIF20B and SGCZ loss is in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent ADAM17 and ACTA2 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent BCAT1 and DHX16 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent BCAT1 and SPTAN1 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent BCAT1 and GSTCD loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+540,ERCC6,R1053H,Colon Adenocarcinoma,Can you tell me how prevalent ERCC6 and PXN loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+541,DCC,R320W,Breast Invasive Carcinoma,Can you tell me how prevalent DCC and HYOU1 loss is in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+542,DCC,R363W,Breast Invasive Carcinoma,Can you tell me how prevalent DCC and RIMS2 loss is in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+543,DCC,R386W,Breast Invasive Carcinoma,Can you tell me how prevalent DCC and ZFPM2 loss is in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+544,DCC,R41W,Breast Invasive Carcinoma,Can you tell me how prevalent DCC and RIMS2 loss is in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+549,FBXO15,D417N,Skin Cutaneous Melanoma,Can you tell me how prevalent FBXO15 and ZMYM3 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+550,FBXO15,D86N,Skin Cutaneous Melanoma,Can you tell me how prevalent FBXO15 and ACVR1B loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent GSTCD and DHX16 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent GSTCD and CACNA1F loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,Can you tell me how prevalent OLFML3 and PHLPP1 loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,Can you tell me how prevalent OLFML3 and PRSS1 loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,Can you tell me how prevalent OLFML3 and FGF8 loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,Can you tell me how prevalent CFAP61 and AKT1 loss is in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,Can you tell me how prevalent CFAP61 and CCNG1 loss is in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,Can you tell me how prevalent HLA-DQA2 and POLR1G loss is in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+582,TENM2,H240Y,Skin Cutaneous Melanoma,Can you tell me how prevalent TENM2 and MAD1L1 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+583,TENM2,H351Y,Skin Cutaneous Melanoma,Can you tell me how prevalent TENM2 and FNDC7 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+584,TENM2,H472Y,Skin Cutaneous Melanoma,Can you tell me how prevalent TENM2 and AUTS2 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+600,ANKRD24,A465T,Stomach Adenocarcinoma,Can you tell me how prevalent ANKRD24 and ACTB loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+601,ANKRD24,A494T,Stomach Adenocarcinoma,Can you tell me how prevalent ANKRD24 and YY1AP1 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+602,ANKRD24,A584T,Stomach Adenocarcinoma,Can you tell me how prevalent ANKRD24 and PTPRN2 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,Can you tell me how prevalent ZCCHC14 and CXCR2 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,Can you tell me how prevalent ZCCHC14 and YY1AP1 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,Can you tell me how prevalent ZCCHC14 and ACTA2 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,Can you tell me how prevalent ZCCHC14 and UNC5D loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+625,SIK2,I265M,Lung Adenocarcinoma,Can you tell me how prevalent SIK2 and CYB5R2 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MYH11 and LCN15 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MYH11 and EFCAB12 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,Can you tell me how prevalent SLC6A4 and MRPL32 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent SLC9C1 and DPF3 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent SLC9C1 and CTSC loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+644,OR2A12,A254T,Brain Lower Grade Glioma,Can you tell me how prevalent OR2A12 and ZFAT loss is in Brain Lower Grade Glioma?,freq_cnv_loss_or_gain
+646,PYHIN1,T325K,Lung Adenocarcinoma,Can you tell me how prevalent PYHIN1 and NRAP loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+647,PYHIN1,T334K,Lung Adenocarcinoma,Can you tell me how prevalent PYHIN1 and MAST4 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+650,JAML,G191E,Skin Cutaneous Melanoma,Can you tell me how prevalent JAML and GUK1 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+651,JAML,G219E,Skin Cutaneous Melanoma,Can you tell me how prevalent JAML and TYK2 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+652,JAML,G220E,Skin Cutaneous Melanoma,Can you tell me how prevalent JAML and GUCY2C loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+653,JAML,G230E,Skin Cutaneous Melanoma,Can you tell me how prevalent JAML and ICE1 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+658,TYK2,H1146R,Stomach Adenocarcinoma,Can you tell me how prevalent TYK2 and ACVR1B loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+659,TYK2,H23R,Stomach Adenocarcinoma,Can you tell me how prevalent TYK2 and UNC5D loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+660,TYK2,H961R,Stomach Adenocarcinoma,Can you tell me how prevalent TYK2 and HBB loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent CTCFL and PTPRO loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent CTCFL and TLK2 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent CTCFL and TMTC3 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent CTCFL and TAF1C loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent CEP20 and CFAP61 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent CEP20 and CTSC loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+689,RIMS2,R25W,Skin Cutaneous Melanoma,Can you tell me how prevalent RIMS2 and CPS1 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+690,RIMS2,R393W,Skin Cutaneous Melanoma,Can you tell me how prevalent RIMS2 and NOMO1 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+691,RIMS2,R423W,Skin Cutaneous Melanoma,Can you tell me how prevalent RIMS2 and SLC9C1 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+692,RIMS2,R470W,Skin Cutaneous Melanoma,Can you tell me how prevalent RIMS2 and SORCS1 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+693,RIMS2,R615W,Skin Cutaneous Melanoma,Can you tell me how prevalent RIMS2 and YY1AP1 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+694,RIMS2,R619W,Skin Cutaneous Melanoma,Can you tell me how prevalent RIMS2 and ZNF627 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+695,RIMS2,R716W,Skin Cutaneous Melanoma,Can you tell me how prevalent RIMS2 and TTN loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,Can you tell me how prevalent PIK3C2G and JAML loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,Can you tell me how prevalent PIK3C2G and DCN loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+728,STK19,D341N,Colon Adenocarcinoma,Can you tell me how prevalent STK19 and PKHD1L1 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+729,STK19,D345N,Colon Adenocarcinoma,Can you tell me how prevalent STK19 and ZMYM3 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+730,REXO4,P60A,Skin Cutaneous Melanoma,Can you tell me how prevalent REXO4 and PXN loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent ZBTB34 and OLFML3 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent ZBTB34 and CTSC loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,Can you tell me how prevalent NCKAP5 and GRTP1 loss is in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent SORCS1 and ACVR1B loss is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent SORCS1 and TAF1C loss is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent SORCS1 and ACTB loss is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent SORCS1 and TYK2 loss is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,Can you tell me how prevalent FGF8 and DCN loss is in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,Can you tell me how prevalent FGF8 and AUTS2 loss is in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,Can you tell me how prevalent FGF8 and TASOR2 loss is in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,Can you tell me how prevalent FGF8 and BFAR loss is in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,Can you tell me how prevalent FGF8 and POC1B loss is in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,Can you tell me how prevalent TENM3 and GPR158 loss is in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,freq_cnv_loss_or_gain
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent AKT1 and PAK3 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me how prevalent CFAP298-TCP10L and DCN loss is in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+792,GLRB,E148D,Stomach Adenocarcinoma,Can you tell me how prevalent GLRB and SGIP1 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+793,TTN,F7636L,Colon Adenocarcinoma,Can you tell me how prevalent TTN and TLK2 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+794,TTN,F8563L,Colon Adenocarcinoma,Can you tell me how prevalent TTN and MIEF1 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+795,TTN,F8880L,Colon Adenocarcinoma,Can you tell me how prevalent TTN and YY1AP1 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+799,ANKRD30A,V798I,Colon Adenocarcinoma,Can you tell me how prevalent ANKRD30A and MORF4L1 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+800,ANKRD30A,V854I,Colon Adenocarcinoma,Can you tell me how prevalent ANKRD30A and MIEF1 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+801,ANKRD30A,V973I,Colon Adenocarcinoma,Can you tell me how prevalent ANKRD30A and ZMYM3 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+809,TRIM45,S177L,Colon Adenocarcinoma,Can you tell me how prevalent TRIM45 and TYK2 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+810,TRIM45,S224L,Colon Adenocarcinoma,Can you tell me how prevalent TRIM45 and YY1AP1 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+811,TRIM45,S281L,Colon Adenocarcinoma,Can you tell me how prevalent TRIM45 and ACVR1B loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+812,CACNA1F,G727V,Stomach Adenocarcinoma,Can you tell me how prevalent CACNA1F and RIMS2 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+813,CACNA1F,G781V,Stomach Adenocarcinoma,Can you tell me how prevalent CACNA1F and PGR loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+814,CACNA1F,G792V,Stomach Adenocarcinoma,Can you tell me how prevalent CACNA1F and FBXO15 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+817,KL,R594C,Colon Adenocarcinoma,Can you tell me how prevalent KL and PGF loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,Can you tell me how prevalent GUF1 and BCAT1 loss is in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+822,TAF1L,A539V,Colon Adenocarcinoma,Can you tell me how prevalent TAF1L and TYK2 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+823,TASOR2,S256F,Skin Cutaneous Melanoma,Can you tell me how prevalent TASOR2 and CTCFL loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+824,TASOR2,S36F,Skin Cutaneous Melanoma,Can you tell me how prevalent TASOR2 and ACTB loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+825,TASOR2,S471F,Skin Cutaneous Melanoma,Can you tell me how prevalent TASOR2 and GRM5 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,Can you tell me how prevalent KDM5C and SOX21 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,Can you tell me how prevalent KDM5C and NRAP loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,Can you tell me how prevalent KDM5C and MYO16 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,Can you tell me how prevalent KDM5C and AUTS2 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me how prevalent IL5RA and DCLK3 loss is in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+843,DHX16,A29V,Skin Cutaneous Melanoma,Can you tell me how prevalent DHX16 and PTPRN2 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+844,DHX16,A89V,Skin Cutaneous Melanoma,Can you tell me how prevalent DHX16 and USH2A loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+902,GPR158,A644V,Stomach Adenocarcinoma,Can you tell me how prevalent GPR158 and FRY loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+903,GPR158,A723V,Stomach Adenocarcinoma,Can you tell me how prevalent GPR158 and RIPOR2 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent EIF2B4 and SIK2 loss is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent EIF2B4 and AUTS2 loss is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent EIF2B4 and PIK3C2G loss is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent EIF2B4 and SLC9C1 loss is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent EIF2B4 and SLC9C1 loss is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent EIF2B4 and UNC5D loss is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,Can you tell me how prevalent AUTS2 and ZFAT loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,Can you tell me how prevalent AUTS2 and ANKDD1A loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,Can you tell me how prevalent AUTS2 and RIMS2 loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,Can you tell me how prevalent AUTS2 and CEP20 loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,Can you tell me how prevalent AUTS2 and TNS1 loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,Can you tell me how prevalent AUTS2 and LCN15 loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,Can you tell me how prevalent AUTS2 and DHX16 loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,Can you tell me how prevalent AUTS2 and KDM5C loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,Can you tell me how prevalent AUTS2 and ERCC6 loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,Can you tell me how prevalent AUTS2 and GRTP1 loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent ACTL7B and DNAH11 loss is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+952,PCDHGA1,R535W,Glioblastoma Multiforme,Can you tell me how prevalent PCDHGA1 and PTPRN2 loss is in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+954,TRAP1,R114W,Stomach Adenocarcinoma,Can you tell me how prevalent TRAP1 and DCN loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+955,TRAP1,R61W,Stomach Adenocarcinoma,Can you tell me how prevalent TRAP1 and RIPOR2 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent PIK3C2A and THBS4 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,Can you tell me how prevalent KANSL1 and FBXO15 loss is in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,Can you tell me how prevalent ANKRD52 and BCAT1 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent PAPPA and CTCFL loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,Can you tell me how prevalent B3GALNT1 and HTR3B loss is in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+982,GABRA6,G115R,Lung Adenocarcinoma,Can you tell me how prevalent GABRA6 and BFAR loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+983,GABRA6,G122R,Lung Adenocarcinoma,Can you tell me how prevalent GABRA6 and MYH11 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+984,GABRA6,G165R,Lung Adenocarcinoma,Can you tell me how prevalent GABRA6 and AUTS2 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+985,GABRA6,G175R,Lung Adenocarcinoma,Can you tell me how prevalent GABRA6 and USH2A loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+986,GABRA6,G70R,Lung Adenocarcinoma,Can you tell me how prevalent GABRA6 and TMEM255A loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,Can you tell me how prevalent ZSCAN31 and DSCAM loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent MED16 and DCC loss is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent MED16 and HTR3B loss is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,Can you tell me how prevalent PTPRO and YY1AP1 loss is in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,Can you tell me how prevalent PTPRO and ADRA1A loss is in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,Can you tell me how prevalent PTPRO and TENT5A loss is in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,Can you tell me how prevalent PTPRO and FGF8 loss is in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,Can you tell me how prevalent PTPRO and MAST4 loss is in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,Can you tell me how prevalent PTPRO and RIMS2 loss is in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,Can you tell me how prevalent PTPRO and MYO3A loss is in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,Can you tell me how prevalent PTPRO and TAF1C loss is in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent CHMP7 and ACVR1B loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1017,GPC3,I107N,Stomach Adenocarcinoma,Can you tell me how prevalent GPC3 and TLK2 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1018,GPC3,I161N,Stomach Adenocarcinoma,Can you tell me how prevalent GPC3 and SYNJ1 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me how prevalent TLK2 and PRSS1 loss is in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me how prevalent TLK2 and AUTS2 loss is in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me how prevalent TLK2 and CR1 loss is in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me how prevalent TLK2 and SGIP1 loss is in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me how prevalent TLK2 and RIPOR2 loss is in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1036,ZNF217,E209Q,Lung Adenocarcinoma,Can you tell me how prevalent ZNF217 and TENT5A loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1038,SYT9,V275L,Lung Adenocarcinoma,Can you tell me how prevalent SYT9 and TLK2 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1039,SYT9,V307L,Lung Adenocarcinoma,Can you tell me how prevalent SYT9 and SPATA22 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,Can you tell me how prevalent PKHD1L1 and MYT1 loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MYO3A and IL5RA loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent VASN and DNMT1 loss is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent DNMT1 and REXO4 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent DNMT1 and UNC5D loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent DNMT1 and ZNF431 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1056,CA9,E402K,Colon Adenocarcinoma,Can you tell me how prevalent CA9 and PLEKHG6 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent TTC17 and ANP32E loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent TTC17 and ZFPM2 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1065,PSG2,P43L,Breast Invasive Carcinoma,Can you tell me how prevalent PSG2 and KIF20B loss is in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,Can you tell me how prevalent RIPOR2 and GIMAP2 loss is in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,Can you tell me how prevalent RIPOR2 and PRSS1 loss is in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,Can you tell me how prevalent RIPOR2 and POC1B loss is in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,Can you tell me how prevalent RIPOR2 and TRPA1 loss is in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent DCLK3 and CHODL loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent DCLK3 and THBS4 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MERTK and DPF3 loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MERTK and PTPRO loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,Can you tell me how prevalent MERTK and HYOU1 loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,Can you tell me how prevalent ZFP42 and AUTS2 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,Can you tell me how prevalent OR13C3 and MED16 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,Can you tell me how prevalent OR13C3 and ANKDD1A loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1091,SPAG1,I917M,Stomach Adenocarcinoma,Can you tell me how prevalent SPAG1 and TMEM225 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent CDKN2AIP and PIK3C2G loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1093,PXN,H1016Y,Colon Adenocarcinoma,Can you tell me how prevalent PXN and TMEM255A loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1094,PXN,H359Y,Colon Adenocarcinoma,Can you tell me how prevalent PXN and MSANTD4 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1095,PXN,H492Y,Colon Adenocarcinoma,Can you tell me how prevalent PXN and DPF3 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1096,PXN,H524Y,Colon Adenocarcinoma,Can you tell me how prevalent PXN and PGF loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1097,PXN,H526Y,Colon Adenocarcinoma,Can you tell me how prevalent PXN and ZCCHC14 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1098,PXN,H540Y,Colon Adenocarcinoma,Can you tell me how prevalent PXN and MYO16 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent TTYH2 and ACTB loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent TTYH2 and PCDHGA1 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1106,TMEM255A,N205S,Colon Adenocarcinoma,Can you tell me how prevalent TMEM255A and TAF1C loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1107,TMEM255A,N229S,Colon Adenocarcinoma,Can you tell me how prevalent TMEM255A and RIMS2 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1108,TMEM255A,N65S,Colon Adenocarcinoma,Can you tell me how prevalent TMEM255A and ZFAT loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,Can you tell me how prevalent TASOR2 and CDH23 loss is in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,Can you tell me how prevalent TASOR2 and MYH11 loss is in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent ICE1 and TASOR2 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1112,MYT1,A558E,Breast Invasive Carcinoma,Can you tell me how prevalent MYT1 and DEFB115 loss is in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1113,MYT1,A879E,Breast Invasive Carcinoma,Can you tell me how prevalent MYT1 and COL6A3 loss is in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1114,MYT1,A906E,Breast Invasive Carcinoma,Can you tell me how prevalent MYT1 and CX3CR1 loss is in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent CX3CR1 and ZFPM2 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent CX3CR1 and FGF8 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,Can you tell me how prevalent SPINDOC and ZFPM2 loss is in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent ART3 and CHODL loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent ART3 and ZBTB34 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,Can you tell me how prevalent CYP1A2 and SPINDOC loss is in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent ADRA1A and TLK2 loss is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,Can you tell me how prevalent CDH23 and CTSC loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,Can you tell me how prevalent CDH23 and CTSC loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1148,KRT39,P137S,Skin Cutaneous Melanoma,Can you tell me how prevalent KRT39 and BCAT1 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,Can you tell me how prevalent PDHA2 and PTPRO loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,Can you tell me how prevalent SLC24A2 and CCDC22 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,Can you tell me how prevalent PTPRN2 and FBXO42 loss is in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,Can you tell me how prevalent PTPRN2 and SGIP1 loss is in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,Can you tell me how prevalent PTPRN2 and CACNA1F loss is in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,Can you tell me how prevalent PTPRN2 and PAK3 loss is in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,Can you tell me how prevalent PTPRN2 and DHX16 loss is in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1188,SOX21,R55L,Lung Adenocarcinoma,Can you tell me how prevalent SOX21 and MAST4 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,Can you tell me how prevalent CPA6 and POC1B loss is in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1206,GRM5,E14K,Skin Cutaneous Melanoma,Can you tell me how prevalent GRM5 and ACVR1B loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent CASZ1 and EIF2B4 loss is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1210,SGIP1,N122T,Stomach Adenocarcinoma,Can you tell me how prevalent SGIP1 and OR8K5 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1211,SGIP1,N420T,Stomach Adenocarcinoma,Can you tell me how prevalent SGIP1 and BFAR loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1212,SGIP1,N617T,Stomach Adenocarcinoma,Can you tell me how prevalent SGIP1 and JAML loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1213,SGIP1,N648T,Stomach Adenocarcinoma,Can you tell me how prevalent SGIP1 and SGCZ loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1227,CARMIL1,V549L,Lung Adenocarcinoma,Can you tell me how prevalent CARMIL1 and SPAG1 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1228,CARMIL1,V949L,Lung Adenocarcinoma,Can you tell me how prevalent CARMIL1 and ACTA2 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1232,ZNF431,D121Y,Lung Adenocarcinoma,Can you tell me how prevalent ZNF431 and PIK3C2G loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1233,ZNF431,D161Y,Lung Adenocarcinoma,Can you tell me how prevalent ZNF431 and PKHD1L1 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1234,ZNF431,R128I,Lung Adenocarcinoma,Can you tell me how prevalent ZNF431 and SLC9C1 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,Can you tell me how prevalent DNAH11 and SGIP1 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,Can you tell me how prevalent DNAH11 and SPATA22 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,Can you tell me how prevalent POLD1 and ANKDD1A loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,Can you tell me how prevalent POLD1 and PTPRO loss is in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1248,TTC12,D646H,Lung Adenocarcinoma,Can you tell me how prevalent TTC12 and RAB40C loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1249,TTC12,D652H,Lung Adenocarcinoma,Can you tell me how prevalent TTC12 and MYT1 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,Can you tell me how prevalent CNGB1 and PHLPP1 loss is in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,Can you tell me how prevalent CNGB1 and SPAG1 loss is in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1254,CTSC,E214V,Stomach Adenocarcinoma,Can you tell me how prevalent CTSC and GABRA6 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1255,CTSC,E291V,Stomach Adenocarcinoma,Can you tell me how prevalent CTSC and DNAH14 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1256,CTSC,E322V,Stomach Adenocarcinoma,Can you tell me how prevalent CTSC and VASN loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1257,CTSC,E324V,Stomach Adenocarcinoma,Can you tell me how prevalent CTSC and TYROBP loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1258,CTSC,E335V,Stomach Adenocarcinoma,Can you tell me how prevalent CTSC and TAF1C loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent PRSS8 and PTPRO loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent PRSS8 and SMO loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,Can you tell me how prevalent ARHGEF40 and MAST4 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1264,ACTB,A138T,Rectum Adenocarcinoma,Can you tell me how prevalent ACTB and CTNNA2 loss is in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1265,ACTB,A217T,Rectum Adenocarcinoma,Can you tell me how prevalent ACTB and SORCS1 loss is in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1266,ACTB,A244T,Rectum Adenocarcinoma,Can you tell me how prevalent ACTB and PIAS3 loss is in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1267,ACTB,A260T,Rectum Adenocarcinoma,Can you tell me how prevalent ACTB and POLD1 loss is in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1268,YY1AP1,V546D,Glioblastoma Multiforme,Can you tell me how prevalent YY1AP1 and COL6A3 loss is in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1269,YY1AP1,V557D,Glioblastoma Multiforme,Can you tell me how prevalent YY1AP1 and PTPRO loss is in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1270,YY1AP1,V566D,Glioblastoma Multiforme,Can you tell me how prevalent YY1AP1 and EIF2B4 loss is in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1271,YY1AP1,V577D,Glioblastoma Multiforme,Can you tell me how prevalent YY1AP1 and PTPRN2 loss is in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1272,YY1AP1,V623D,Glioblastoma Multiforme,Can you tell me how prevalent YY1AP1 and CARMIL1 loss is in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1273,YY1AP1,V695D,Glioblastoma Multiforme,Can you tell me how prevalent YY1AP1 and FBXO42 loss is in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1274,YY1AP1,V715D,Glioblastoma Multiforme,Can you tell me how prevalent YY1AP1 and TRIM45 loss is in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,Can you tell me how prevalent FNDC7 and MRPL55 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,Can you tell me how prevalent FNDC7 and XKR4 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1299,TLCD5,G15V,Lung Adenocarcinoma,Can you tell me how prevalent TLCD5 and FCGR2C loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1300,TLCD5,G37V,Lung Adenocarcinoma,Can you tell me how prevalent TLCD5 and RIMS2 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent POLR1G and TNS1 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent POLR1G and NRAP loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1308,DNAH14,N1186K,Colon Adenocarcinoma,Can you tell me how prevalent DNAH14 and RIMS2 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1309,DNAH14,N2657K,Colon Adenocarcinoma,Can you tell me how prevalent DNAH14 and CNGB1 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1310,DNAH14,N3460K,Colon Adenocarcinoma,Can you tell me how prevalent DNAH14 and TRIM45 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent NEXN and PXN loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,Can you tell me how prevalent CYB5R2 and SORCS1 loss is in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,Can you tell me how prevalent CYB5R2 and AQP7 loss is in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent NRAP and NPSR1 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent NRAP and DCLK3 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent NRAP and TLK2 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent CCDC22 and DCLK3 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,Can you tell me how prevalent DCAF6 and TLK2 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,Can you tell me how prevalent DCAF6 and TNS1 loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent ZNF708 and TLK2 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent BFAR and SORCS1 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MAST4 and ARMC3 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MAST4 and TNS1 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MAST4 and CTSC loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MAST4 and DNAH11 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MAST4 and CACNA1F loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1363,ARMC3,R169C,Stomach Adenocarcinoma,Can you tell me how prevalent ARMC3 and GUK1 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1364,ARMC3,R432C,Stomach Adenocarcinoma,Can you tell me how prevalent ARMC3 and GRTP1 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,Can you tell me how prevalent TET2 and GRTP1 loss is in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,Can you tell me how prevalent TET2 and ART3 loss is in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+1369,SERPINB10,A353P,Lung Adenocarcinoma,Can you tell me how prevalent SERPINB10 and MAST4 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent STAT3 and VASN loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent MIEF1 and DOCK2 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1381,ACVR1B,D397N,Colon Adenocarcinoma,Can you tell me how prevalent ACVR1B and SLC24A2 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1382,ACVR1B,D449N,Colon Adenocarcinoma,Can you tell me how prevalent ACVR1B and ACVR1B loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1383,ACVR1B,D490N,Colon Adenocarcinoma,Can you tell me how prevalent ACVR1B and FBN1 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1393,EBF2,T104I,Stomach Adenocarcinoma,Can you tell me how prevalent EBF2 and PLEKHG6 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1394,EBF2,T252I,Stomach Adenocarcinoma,Can you tell me how prevalent EBF2 and TAF1C loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1402,VPS26B,F266L,Stomach Adenocarcinoma,Can you tell me how prevalent VPS26B and SORCS1 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent PGR and CTSC loss is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent PGR and DNAH11 loss is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me how prevalent PGR and UNC5D loss is in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,Can you tell me how prevalent ACTA2 and TENT5A loss is in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent THBS4 and COL6A3 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent THBS4 and SORCS1 loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1413,PRSS1,S114T,Lung Adenocarcinoma,Can you tell me how prevalent PRSS1 and FBXO15 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1414,PRSS1,S124T,Lung Adenocarcinoma,Can you tell me how prevalent PRSS1 and FBXO42 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1415,PRSS1,S138T,Lung Adenocarcinoma,Can you tell me how prevalent PRSS1 and B3GALNT1 loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1416,PRSS1,S74T,Lung Adenocarcinoma,Can you tell me how prevalent PRSS1 and DGKD loss is in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1417,PGF,R126H,Stomach Adenocarcinoma,Can you tell me how prevalent PGF and CTNNA2 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1418,PGF,R127H,Stomach Adenocarcinoma,Can you tell me how prevalent PGF and GUK1 loss is in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,Can you tell me how prevalent ITPRID2 and SOX21 loss is in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,Can you tell me how prevalent ITPRID2 and DNAH14 loss is in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent HBB and MYO3B loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1441,PCDHB2,R158C,Colon Adenocarcinoma,Can you tell me how prevalent PCDHB2 and FGF8 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1442,PCDHB2,T15M,Colon Adenocarcinoma,Can you tell me how prevalent PCDHB2 and NRAP loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1443,PCDHB2,T26M,Colon Adenocarcinoma,Can you tell me how prevalent PCDHB2 and PIAS3 loss is in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,Can you tell me how prevalent UBR2 and CTSC loss is in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1452,FBXO42,A618D,Rectum Adenocarcinoma,Can you tell me how prevalent FBXO42 and CXCR2 loss is in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1,TNS1,G1362V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma are characterized by codeletion of TNS1 and VASN?,freq_cnv_loss_or_gain
+2,TNS1,G1711V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma are characterized by codeletion of TNS1 and COL6A3?,freq_cnv_loss_or_gain
+3,TNS1,G1718V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma are characterized by codeletion of TNS1 and CYP1A2?,freq_cnv_loss_or_gain
+4,TNS1,G1732V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma are characterized by codeletion of TNS1 and SYT10?,freq_cnv_loss_or_gain
+5,TNS1,G1824V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma are characterized by codeletion of TNS1 and ANKDD1A?,freq_cnv_loss_or_gain
+6,TNS1,G1857V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma are characterized by codeletion of TNS1 and DCAF6?,freq_cnv_loss_or_gain
+7,TNS1,G843V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma are characterized by codeletion of TNS1 and GUK1?,freq_cnv_loss_or_gain
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma are characterized by codeletion of EVC2 and JAML?,freq_cnv_loss_or_gain
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma are characterized by codeletion of EVC2 and TYROBP?,freq_cnv_loss_or_gain
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of CR1 and OR2T4?,freq_cnv_loss_or_gain
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of CR1 and AUTS2?,freq_cnv_loss_or_gain
+22,TRPA1,S295I,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma are characterized by codeletion of TRPA1 and USH2A?,freq_cnv_loss_or_gain
+23,TRPA1,S443I,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma are characterized by codeletion of TRPA1 and DCN?,freq_cnv_loss_or_gain
+24,TAF1C,R299L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of TAF1C and ACVR1B?,freq_cnv_loss_or_gain
+25,TAF1C,R396L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of TAF1C and TTN?,freq_cnv_loss_or_gain
+26,TAF1C,R634L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of TAF1C and B3GALNT1?,freq_cnv_loss_or_gain
+27,TAF1C,R702L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of TAF1C and CCNG1?,freq_cnv_loss_or_gain
+28,TAF1C,R728L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of TAF1C and ANKRD30A?,freq_cnv_loss_or_gain
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of DPF3 and CHODL?,freq_cnv_loss_or_gain
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of DPF3 and GLRB?,freq_cnv_loss_or_gain
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of DPF3 and UNC5D?,freq_cnv_loss_or_gain
+42,OR2T4,P272H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of OR2T4 and PRSS1?,freq_cnv_loss_or_gain
+43,OR2T4,P300H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of OR2T4 and HTR3B?,freq_cnv_loss_or_gain
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma are characterized by codeletion of FBN1 and UNC5D?,freq_cnv_loss_or_gain
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma are characterized by codeletion of MAD1L1 and NOMO1?,freq_cnv_loss_or_gain
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma are characterized by codeletion of MAD1L1 and GPR158?,freq_cnv_loss_or_gain
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma are characterized by codeletion of MAD1L1 and UNC5D?,freq_cnv_loss_or_gain
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of CCNG1 and OR2T4?,freq_cnv_loss_or_gain
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma are characterized by codeletion of ANP32E and PAK3?,freq_cnv_loss_or_gain
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma are characterized by codeletion of ANP32E and ANP32E?,freq_cnv_loss_or_gain
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma are characterized by codeletion of ANP32E and CHODL?,freq_cnv_loss_or_gain
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma are characterized by codeletion of ANP32E and CFAP61?,freq_cnv_loss_or_gain
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma are characterized by codeletion of FRY and PCDHB2?,freq_cnv_loss_or_gain
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma are characterized by codeletion of FRY and DGKD?,freq_cnv_loss_or_gain
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma are characterized by codeletion of FRY and AQP7?,freq_cnv_loss_or_gain
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma are characterized by codeletion of FRY and TLK2?,freq_cnv_loss_or_gain
+70,PAK3,E318K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of PAK3 and PYHIN1?,freq_cnv_loss_or_gain
+71,PAK3,E319K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of PAK3 and TTYH2?,freq_cnv_loss_or_gain
+72,PAK3,E334K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of PAK3 and YY1AP1?,freq_cnv_loss_or_gain
+73,PAK3,E340K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of PAK3 and PRSS8?,freq_cnv_loss_or_gain
+74,PAK3,E355K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of PAK3 and AQP7?,freq_cnv_loss_or_gain
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of MUC16 and SORCS1?,freq_cnv_loss_or_gain
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma are characterized by codeletion of ZFPM2 and TAF1C?,freq_cnv_loss_or_gain
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma are characterized by codeletion of ZFPM2 and ANKDD1A?,freq_cnv_loss_or_gain
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma are characterized by codeletion of PIK3C2B and PIK3C2B?,freq_cnv_loss_or_gain
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma are characterized by codeletion of PIK3C2B and RELN?,freq_cnv_loss_or_gain
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of ZNF804A and TASOR2?,freq_cnv_loss_or_gain
+116,RELN,A2371V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of RELN and CPS1?,freq_cnv_loss_or_gain
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus are characterized by codeletion of EFCAB12 and SYT9?",freq_cnv_loss_or_gain
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus are characterized by codeletion of EFCAB12 and GABRA6?",freq_cnv_loss_or_gain
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of DEFB115 and TAF1C?,freq_cnv_loss_or_gain
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma are characterized by codeletion of ANKDD1A and COL6A3?,freq_cnv_loss_or_gain
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma are characterized by codeletion of ANKDD1A and TMEM255A?,freq_cnv_loss_or_gain
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma are characterized by codeletion of ANKDD1A and MYO3B?,freq_cnv_loss_or_gain
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of HTR3B and NRAP?,freq_cnv_loss_or_gain
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of HTR3B and CDKN2AIP?,freq_cnv_loss_or_gain
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of HTR3B and DGKD?,freq_cnv_loss_or_gain
+129,ABCC3,R758W,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of ABCC3 and STK19?,freq_cnv_loss_or_gain
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of NOMO1 and NOMO1?,freq_cnv_loss_or_gain
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of NOMO1 and GUCY2C?,freq_cnv_loss_or_gain
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma are characterized by codeletion of HYOU1 and ANKRD24?,freq_cnv_loss_or_gain
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of FMO4 and TYK2?,freq_cnv_loss_or_gain
+140,BICC1,A372V,Exceptional Responders,What percentage of Exceptional Responders are characterized by codeletion of BICC1 and JAML?,freq_cnv_loss_or_gain
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of ZMYM3 and EIF2B4?,freq_cnv_loss_or_gain
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of ZMYM3 and TTC12?,freq_cnv_loss_or_gain
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of ZMYM3 and MORF4L1?,freq_cnv_loss_or_gain
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus are characterized by codeletion of XKR4 and AUTS2?",freq_cnv_loss_or_gain
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma are characterized by codeletion of ABCC2 and ERCC6?,freq_cnv_loss_or_gain
+157,OR8K5,R293G,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of OR8K5 and TTC12?,freq_cnv_loss_or_gain
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of SPTAN1 and LCN15?,freq_cnv_loss_or_gain
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of SPTAN1 and USH2A?,freq_cnv_loss_or_gain
+164,SYT10,M484I,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma are characterized by codeletion of SYT10 and TENM3?,freq_cnv_loss_or_gain
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of HSPA5 and ANKRD24?,freq_cnv_loss_or_gain
+175,UNC5D,L280V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of UNC5D and ANKDD1A?,freq_cnv_loss_or_gain
+176,UNC5D,L635V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of UNC5D and SYT9?,freq_cnv_loss_or_gain
+177,UNC5D,L637V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of UNC5D and HTR3B?,freq_cnv_loss_or_gain
+178,UNC5D,L699V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of UNC5D and TTC17?,freq_cnv_loss_or_gain
+179,UNC5D,L704V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of UNC5D and SYT10?,freq_cnv_loss_or_gain
+180,UNC5D,L709V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of UNC5D and EIF2B4?,freq_cnv_loss_or_gain
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma are characterized by codeletion of DOCK2 and OR8K5?,freq_cnv_loss_or_gain
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma are characterized by codeletion of ZNF627 and DCAF6?,freq_cnv_loss_or_gain
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of CDC42BPA and PIK3C2G?,freq_cnv_loss_or_gain
+193,MRPL55,H27Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of MRPL55 and MYH11?,freq_cnv_loss_or_gain
+194,MRPL55,H63Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of MRPL55 and RELN?,freq_cnv_loss_or_gain
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma are characterized by codeletion of TMTC3 and KDM5C?,freq_cnv_loss_or_gain
+198,EPRS1,K771I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of EPRS1 and HBB?,freq_cnv_loss_or_gain
+199,EPRS1,K778I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of EPRS1 and CR1?,freq_cnv_loss_or_gain
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of GRTP1 and COL6A3?,freq_cnv_loss_or_gain
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of GRTP1 and FNDC7?,freq_cnv_loss_or_gain
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of TSHZ3 and ZFAT?,freq_cnv_loss_or_gain
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What percentage of HIV+ Tumor Molecular Characterization Project - Cervical Cancer are characterized by codeletion of TAS1R3 and SPATA22?,freq_cnv_loss_or_gain
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of PIAS3 and UNC5D?,freq_cnv_loss_or_gain
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of PIAS3 and TTC12?,freq_cnv_loss_or_gain
+251,ZNF274,P13R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of ZNF274 and PCDHGA1?,freq_cnv_loss_or_gain
+253,SYNJ1,R795C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of SYNJ1 and BCAT1?,freq_cnv_loss_or_gain
+254,SYNJ1,R800C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of SYNJ1 and ACTB?,freq_cnv_loss_or_gain
+255,SYNJ1,R839C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of SYNJ1 and DPF3?,freq_cnv_loss_or_gain
+261,DSCAM,V343M,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma are characterized by codeletion of DSCAM and TENM3?,freq_cnv_loss_or_gain
+262,DSCAM,V426M,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma are characterized by codeletion of DSCAM and CA9?,freq_cnv_loss_or_gain
+263,DSCAM,V591M,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma are characterized by codeletion of DSCAM and EIF2B4?,freq_cnv_loss_or_gain
+267,DGKD,R140H,Exceptional Responders,What percentage of Exceptional Responders are characterized by codeletion of DGKD and SYNJ1?,freq_cnv_loss_or_gain
+268,DGKD,R160H,Exceptional Responders,What percentage of Exceptional Responders are characterized by codeletion of DGKD and JAML?,freq_cnv_loss_or_gain
+269,DGKD,R204H,Exceptional Responders,What percentage of Exceptional Responders are characterized by codeletion of DGKD and PTPRO?,freq_cnv_loss_or_gain
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma are characterized by codeletion of PLEKHG6 and GRTP1?,freq_cnv_loss_or_gain
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma are characterized by codeletion of PLEKHG6 and YY1AP1?,freq_cnv_loss_or_gain
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma are characterized by codeletion of PLEKHG6 and AUTS2?,freq_cnv_loss_or_gain
+279,WNT2,D138N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of WNT2 and PGR?,freq_cnv_loss_or_gain
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of GUCY2C and PKHD1L1?,freq_cnv_loss_or_gain
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of C7orf31 and TRIM45?,freq_cnv_loss_or_gain
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus are characterized by codeletion of ZKSCAN7 and NRAP?",freq_cnv_loss_or_gain
+299,OR5D14,M210L,Neuroblastoma,What percentage of Neuroblastoma are characterized by codeletion of OR5D14 and FNDC7?,freq_cnv_loss_or_gain
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of SPATA22 and JAML?,freq_cnv_loss_or_gain
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of SPATA22 and ANP32E?,freq_cnv_loss_or_gain
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of SPATA22 and POC1B?,freq_cnv_loss_or_gain
+310,LCN15,E21V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of LCN15 and PLEKHG6?,freq_cnv_loss_or_gain
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of DCAF4L2 and MORF4L1?,freq_cnv_loss_or_gain
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of GUK1 and MYO3B?,freq_cnv_loss_or_gain
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of GUK1 and FRY?,freq_cnv_loss_or_gain
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of GUK1 and UNC5D?,freq_cnv_loss_or_gain
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of GUK1 and DPF3?,freq_cnv_loss_or_gain
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of GUK1 and ANP32E?,freq_cnv_loss_or_gain
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of MORF4L1 and CTSC?,freq_cnv_loss_or_gain
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of MORF4L1 and CTNNA2?,freq_cnv_loss_or_gain
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of MORF4L1 and PXN?,freq_cnv_loss_or_gain
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of MORF4L1 and BFAR?,freq_cnv_loss_or_gain
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of MYO3B and SPAG1?,freq_cnv_loss_or_gain
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of MYO3B and CTCFL?,freq_cnv_loss_or_gain
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of TENT5A and GPR158?,freq_cnv_loss_or_gain
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of TENT5A and RIMS2?,freq_cnv_loss_or_gain
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of TENT5A and DCAF6?,freq_cnv_loss_or_gain
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma are characterized by codeletion of ZFAT and FBXO15?,freq_cnv_loss_or_gain
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma are characterized by codeletion of ZFAT and CTCFL?,freq_cnv_loss_or_gain
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma are characterized by codeletion of ZFAT and ICE1?,freq_cnv_loss_or_gain
+357,ZNF584,A211T,Sarcoma,What percentage of Sarcoma are characterized by codeletion of ZNF584 and YY1AP1?,freq_cnv_loss_or_gain
+358,ZNF584,A256T,Sarcoma,What percentage of Sarcoma are characterized by codeletion of ZNF584 and DPF3?,freq_cnv_loss_or_gain
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of LDOC1 and COL6A3?,freq_cnv_loss_or_gain
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of PDGFC and RIMS2?,freq_cnv_loss_or_gain
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of MSANTD4 and IL5RA?,freq_cnv_loss_or_gain
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of NPSR1 and REXO4?,freq_cnv_loss_or_gain
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of PHLPP1 and LAMB2?,freq_cnv_loss_or_gain
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of COL6A3 and OR2T4?,freq_cnv_loss_or_gain
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of COL6A3 and SLC9C1?,freq_cnv_loss_or_gain
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of COL6A3 and POC1B?,freq_cnv_loss_or_gain
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of COL6A3 and TYK2?,freq_cnv_loss_or_gain
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of COL6A3 and SGIP1?,freq_cnv_loss_or_gain
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of ADRA1A and PLEKHG6?,freq_cnv_loss_or_gain
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma are characterized by codeletion of LAMB2 and DNAH11?,freq_cnv_loss_or_gain
+406,POC1B,I198T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma are characterized by codeletion of POC1B and ZFP42?,freq_cnv_loss_or_gain
+407,POC1B,I286T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma are characterized by codeletion of POC1B and ANKRD52?,freq_cnv_loss_or_gain
+408,POC1B,I328T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma are characterized by codeletion of POC1B and ACTB?,freq_cnv_loss_or_gain
+409,POC1B,S79P,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma are characterized by codeletion of POC1B and YY1AP1?,freq_cnv_loss_or_gain
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma are characterized by codeletion of USH2A and FGF8?,freq_cnv_loss_or_gain
+414,AQP7,T110S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma are characterized by codeletion of AQP7 and EPRS1?,freq_cnv_loss_or_gain
+415,AQP7,T166S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma are characterized by codeletion of AQP7 and PTPRO?,freq_cnv_loss_or_gain
+416,AQP7,T167S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma are characterized by codeletion of AQP7 and EIF2B4?,freq_cnv_loss_or_gain
+417,AQP7,T75S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma are characterized by codeletion of AQP7 and CDH23?,freq_cnv_loss_or_gain
+430,DCN,R163C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma are characterized by codeletion of DCN and ZNF708?,freq_cnv_loss_or_gain
+431,DCN,R203C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma are characterized by codeletion of DCN and PYHIN1?,freq_cnv_loss_or_gain
+432,DCN,R241C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma are characterized by codeletion of DCN and SLC6A4?,freq_cnv_loss_or_gain
+433,DCN,R350C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma are characterized by codeletion of DCN and SLC9C1?,freq_cnv_loss_or_gain
+434,DCN,R41C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma are characterized by codeletion of DCN and PIK3C2B?,freq_cnv_loss_or_gain
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of CPS1 and PTPRO?,freq_cnv_loss_or_gain
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of CPS1 and TNS1?,freq_cnv_loss_or_gain
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of CPS1 and FNDC7?,freq_cnv_loss_or_gain
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma are characterized by codeletion of FCGR2C and TMEM255A?,freq_cnv_loss_or_gain
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma are characterized by codeletion of FCGR2C and UNC5D?,freq_cnv_loss_or_gain
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of GRM1 and MYO16?,freq_cnv_loss_or_gain
+482,SGCZ,Q138H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of SGCZ and PTPRN2?,freq_cnv_loss_or_gain
+483,SGCZ,Q91H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of SGCZ and PIAS3?,freq_cnv_loss_or_gain
+485,SMO,V15M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of SMO and CACNA1F?,freq_cnv_loss_or_gain
+486,SMO,V321M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of SMO and ITPRID2?,freq_cnv_loss_or_gain
+488,CHODL,G159E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of CHODL and CTSC?,freq_cnv_loss_or_gain
+489,CHODL,G181E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of CHODL and MORF4L1?,freq_cnv_loss_or_gain
+490,CHODL,G200E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of CHODL and VASN?,freq_cnv_loss_or_gain
+494,MYO16,P399H,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of MYO16 and ACVR1B?,freq_cnv_loss_or_gain
+495,MYO16,P421H,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of MYO16 and ZFPM2?,freq_cnv_loss_or_gain
+498,CXCR2,A98V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of CXCR2 and PCDHB2?,freq_cnv_loss_or_gain
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma are characterized by codeletion of TMEM225 and TASOR2?,freq_cnv_loss_or_gain
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of MAOB and CNGB1?,freq_cnv_loss_or_gain
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of GPRASP1 and GUK1?,freq_cnv_loss_or_gain
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of MRPL32 and OR13C3?,freq_cnv_loss_or_gain
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of TYROBP and MSANTD4?,freq_cnv_loss_or_gain
+510,RAB40C,A111V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of RAB40C and GRTP1?,freq_cnv_loss_or_gain
+511,RAB40C,A143V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of RAB40C and CTSC?,freq_cnv_loss_or_gain
+512,CTNNA2,S323R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of CTNNA2 and OLFML3?,freq_cnv_loss_or_gain
+513,CTNNA2,S339R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of CTNNA2 and GRM5?,freq_cnv_loss_or_gain
+514,CTNNA2,S386R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of CTNNA2 and CTNNA2?,freq_cnv_loss_or_gain
+515,CTNNA2,S707R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of CTNNA2 and MERTK?,freq_cnv_loss_or_gain
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma are characterized by codeletion of MYO15A and FBXO15?,freq_cnv_loss_or_gain
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of GIMAP2 and AQP7?,freq_cnv_loss_or_gain
+532,KIF20B,N1160D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme are characterized by codeletion of KIF20B and TYK2?,freq_cnv_loss_or_gain
+533,KIF20B,N1200D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme are characterized by codeletion of KIF20B and DSCAM?,freq_cnv_loss_or_gain
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of ADAM17 and CDH23?,freq_cnv_loss_or_gain
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of BCAT1 and COL6A3?,freq_cnv_loss_or_gain
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of BCAT1 and CYP1A2?,freq_cnv_loss_or_gain
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of BCAT1 and PTPRN2?,freq_cnv_loss_or_gain
+540,ERCC6,R1053H,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of ERCC6 and NEXN?,freq_cnv_loss_or_gain
+541,DCC,R320W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma are characterized by codeletion of DCC and TMTC3?,freq_cnv_loss_or_gain
+542,DCC,R363W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma are characterized by codeletion of DCC and MUC16?,freq_cnv_loss_or_gain
+543,DCC,R386W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma are characterized by codeletion of DCC and UNC5D?,freq_cnv_loss_or_gain
+544,DCC,R41W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma are characterized by codeletion of DCC and CFAP61?,freq_cnv_loss_or_gain
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of FBXO15 and GPC3?,freq_cnv_loss_or_gain
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of FBXO15 and SPATA22?,freq_cnv_loss_or_gain
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of GSTCD and ARHGEF40?,freq_cnv_loss_or_gain
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of GSTCD and TET2?,freq_cnv_loss_or_gain
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of OLFML3 and CPS1?,freq_cnv_loss_or_gain
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of OLFML3 and DNMT1?,freq_cnv_loss_or_gain
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of OLFML3 and TLK2?,freq_cnv_loss_or_gain
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma are characterized by codeletion of CFAP61 and FBXO42?,freq_cnv_loss_or_gain
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma are characterized by codeletion of CFAP61 and GRTP1?,freq_cnv_loss_or_gain
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma are characterized by codeletion of HLA-DQA2 and SORCS1?,freq_cnv_loss_or_gain
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of TENM2 and SPATA22?,freq_cnv_loss_or_gain
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of TENM2 and TAF1C?,freq_cnv_loss_or_gain
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of TENM2 and PHLPP1?,freq_cnv_loss_or_gain
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of ANKRD24 and AUTS2?,freq_cnv_loss_or_gain
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of ANKRD24 and SOX21?,freq_cnv_loss_or_gain
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of ANKRD24 and RIPOR2?,freq_cnv_loss_or_gain
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of ZCCHC14 and UNC5D?,freq_cnv_loss_or_gain
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of ZCCHC14 and ZMYM3?,freq_cnv_loss_or_gain
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of ZCCHC14 and PXN?,freq_cnv_loss_or_gain
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of ZCCHC14 and HLA-DQA2?,freq_cnv_loss_or_gain
+625,SIK2,I265M,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of SIK2 and YY1AP1?,freq_cnv_loss_or_gain
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of MYH11 and MRPL32?,freq_cnv_loss_or_gain
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of MYH11 and ZNF584?,freq_cnv_loss_or_gain
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of SLC6A4 and ZCCHC14?,freq_cnv_loss_or_gain
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of SLC9C1 and PCDHB2?,freq_cnv_loss_or_gain
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of SLC9C1 and HSPA5?,freq_cnv_loss_or_gain
+644,OR2A12,A254T,Brain Lower Grade Glioma,What percentage of Brain Lower Grade Glioma are characterized by codeletion of OR2A12 and MORF4L1?,freq_cnv_loss_or_gain
+646,PYHIN1,T325K,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of PYHIN1 and TTN?,freq_cnv_loss_or_gain
+647,PYHIN1,T334K,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of PYHIN1 and TNS1?,freq_cnv_loss_or_gain
+650,JAML,G191E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of JAML and TTN?,freq_cnv_loss_or_gain
+651,JAML,G219E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of JAML and PTPRO?,freq_cnv_loss_or_gain
+652,JAML,G220E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of JAML and DCN?,freq_cnv_loss_or_gain
+653,JAML,G230E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of JAML and RIPOR2?,freq_cnv_loss_or_gain
+658,TYK2,H1146R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of TYK2 and CTNNA2?,freq_cnv_loss_or_gain
+659,TYK2,H23R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of TYK2 and MERTK?,freq_cnv_loss_or_gain
+660,TYK2,H961R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of TYK2 and KIF20B?,freq_cnv_loss_or_gain
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of CTCFL and TLK2?,freq_cnv_loss_or_gain
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of CTCFL and GABRA6?,freq_cnv_loss_or_gain
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of CTCFL and CTNNA2?,freq_cnv_loss_or_gain
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of CTCFL and ZBTB34?,freq_cnv_loss_or_gain
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of CEP20 and ARMC3?,freq_cnv_loss_or_gain
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of CEP20 and FGF8?,freq_cnv_loss_or_gain
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of RIMS2 and TAF1L?,freq_cnv_loss_or_gain
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of RIMS2 and MORF4L1?,freq_cnv_loss_or_gain
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of RIMS2 and SORCS1?,freq_cnv_loss_or_gain
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of RIMS2 and STAT3?,freq_cnv_loss_or_gain
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of RIMS2 and MRPL32?,freq_cnv_loss_or_gain
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of RIMS2 and THBS4?,freq_cnv_loss_or_gain
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of RIMS2 and CDKN2AIP?,freq_cnv_loss_or_gain
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of PIK3C2G and LCN15?,freq_cnv_loss_or_gain
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of PIK3C2G and PRSS1?,freq_cnv_loss_or_gain
+728,STK19,D341N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of STK19 and NOMO1?,freq_cnv_loss_or_gain
+729,STK19,D345N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of STK19 and ERCC6?,freq_cnv_loss_or_gain
+730,REXO4,P60A,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of REXO4 and TLK2?,freq_cnv_loss_or_gain
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of ZBTB34 and PAK3?,freq_cnv_loss_or_gain
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of ZBTB34 and ANKRD30A?,freq_cnv_loss_or_gain
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma are characterized by codeletion of NCKAP5 and ARMC3?,freq_cnv_loss_or_gain
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus are characterized by codeletion of SORCS1 and SORCS1?",freq_cnv_loss_or_gain
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus are characterized by codeletion of SORCS1 and TTN?",freq_cnv_loss_or_gain
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus are characterized by codeletion of SORCS1 and WNT2?",freq_cnv_loss_or_gain
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus are characterized by codeletion of SORCS1 and MIEF1?",freq_cnv_loss_or_gain
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma are characterized by codeletion of FGF8 and MERTK?,freq_cnv_loss_or_gain
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma are characterized by codeletion of FGF8 and FBXO15?,freq_cnv_loss_or_gain
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma are characterized by codeletion of FGF8 and CHMP7?,freq_cnv_loss_or_gain
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma are characterized by codeletion of FGF8 and RIMS2?,freq_cnv_loss_or_gain
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma are characterized by codeletion of FGF8 and ANKRD30A?,freq_cnv_loss_or_gain
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What percentage of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia are characterized by codeletion of TENM3 and CXCR2?,freq_cnv_loss_or_gain
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of AKT1 and ZFAT?,freq_cnv_loss_or_gain
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma are characterized by codeletion of CFAP298-TCP10L and SMO?,freq_cnv_loss_or_gain
+792,GLRB,E148D,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of GLRB and ITPRID2?,freq_cnv_loss_or_gain
+793,TTN,F7636L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of TTN and ACVR1B?,freq_cnv_loss_or_gain
+794,TTN,F8563L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of TTN and MYO16?,freq_cnv_loss_or_gain
+795,TTN,F8880L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of TTN and DCN?,freq_cnv_loss_or_gain
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of ANKRD30A and KIF20B?,freq_cnv_loss_or_gain
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of ANKRD30A and CARMIL1?,freq_cnv_loss_or_gain
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of ANKRD30A and AQP7?,freq_cnv_loss_or_gain
+809,TRIM45,S177L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of TRIM45 and CTSC?,freq_cnv_loss_or_gain
+810,TRIM45,S224L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of TRIM45 and ACTB?,freq_cnv_loss_or_gain
+811,TRIM45,S281L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of TRIM45 and GUK1?,freq_cnv_loss_or_gain
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of CACNA1F and SORCS1?,freq_cnv_loss_or_gain
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of CACNA1F and GLRB?,freq_cnv_loss_or_gain
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of CACNA1F and ANKRD24?,freq_cnv_loss_or_gain
+817,KL,R594C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of KL and MYT1?,freq_cnv_loss_or_gain
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma are characterized by codeletion of GUF1 and PTPRO?,freq_cnv_loss_or_gain
+822,TAF1L,A539V,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of TAF1L and GUF1?,freq_cnv_loss_or_gain
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of TASOR2 and PAPPA?,freq_cnv_loss_or_gain
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of TASOR2 and YY1AP1?,freq_cnv_loss_or_gain
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of TASOR2 and HTR3B?,freq_cnv_loss_or_gain
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of KDM5C and DCLK3?,freq_cnv_loss_or_gain
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of KDM5C and PTPRN2?,freq_cnv_loss_or_gain
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of KDM5C and PGR?,freq_cnv_loss_or_gain
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of KDM5C and PKHD1L1?,freq_cnv_loss_or_gain
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma are characterized by codeletion of IL5RA and GPR158?,freq_cnv_loss_or_gain
+843,DHX16,A29V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of DHX16 and AUTS2?,freq_cnv_loss_or_gain
+844,DHX16,A89V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of DHX16 and RIMS2?,freq_cnv_loss_or_gain
+902,GPR158,A644V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of GPR158 and SYNJ1?,freq_cnv_loss_or_gain
+903,GPR158,A723V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of GPR158 and EIF2B4?,freq_cnv_loss_or_gain
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus are characterized by codeletion of EIF2B4 and ZBTB34?",freq_cnv_loss_or_gain
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus are characterized by codeletion of EIF2B4 and STAT3?",freq_cnv_loss_or_gain
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus are characterized by codeletion of EIF2B4 and PAPPA?",freq_cnv_loss_or_gain
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus are characterized by codeletion of EIF2B4 and OR2T4?",freq_cnv_loss_or_gain
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus are characterized by codeletion of EIF2B4 and MAOB?",freq_cnv_loss_or_gain
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus are characterized by codeletion of EIF2B4 and ACVR1B?",freq_cnv_loss_or_gain
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of AUTS2 and TTN?,freq_cnv_loss_or_gain
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of AUTS2 and PRSS1?,freq_cnv_loss_or_gain
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of AUTS2 and MAOB?,freq_cnv_loss_or_gain
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of AUTS2 and IL5RA?,freq_cnv_loss_or_gain
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of AUTS2 and CFAP61?,freq_cnv_loss_or_gain
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of AUTS2 and MYO3B?,freq_cnv_loss_or_gain
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of AUTS2 and MYO16?,freq_cnv_loss_or_gain
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of AUTS2 and MAST4?,freq_cnv_loss_or_gain
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of AUTS2 and ERCC6?,freq_cnv_loss_or_gain
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of AUTS2 and DEFB115?,freq_cnv_loss_or_gain
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus are characterized by codeletion of ACTL7B and CTCFL?",freq_cnv_loss_or_gain
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme are characterized by codeletion of PCDHGA1 and EFCAB12?,freq_cnv_loss_or_gain
+954,TRAP1,R114W,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of TRAP1 and PLEKHG6?,freq_cnv_loss_or_gain
+955,TRAP1,R61W,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of TRAP1 and PAK3?,freq_cnv_loss_or_gain
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of PIK3C2A and OR13C3?,freq_cnv_loss_or_gain
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma are characterized by codeletion of KANSL1 and MERTK?,freq_cnv_loss_or_gain
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of ANKRD52 and CTSC?,freq_cnv_loss_or_gain
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of PAPPA and ACVR1B?,freq_cnv_loss_or_gain
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma are characterized by codeletion of B3GALNT1 and ANKDD1A?,freq_cnv_loss_or_gain
+982,GABRA6,G115R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of GABRA6 and CA9?,freq_cnv_loss_or_gain
+983,GABRA6,G122R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of GABRA6 and SGIP1?,freq_cnv_loss_or_gain
+984,GABRA6,G165R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of GABRA6 and FRY?,freq_cnv_loss_or_gain
+985,GABRA6,G175R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of GABRA6 and PDHA2?,freq_cnv_loss_or_gain
+986,GABRA6,G70R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of GABRA6 and DCN?,freq_cnv_loss_or_gain
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of ZSCAN31 and MAOB?,freq_cnv_loss_or_gain
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus are characterized by codeletion of MED16 and UNC5D?",freq_cnv_loss_or_gain
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus are characterized by codeletion of MED16 and TTC17?",freq_cnv_loss_or_gain
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma are characterized by codeletion of PTPRO and CPS1?,freq_cnv_loss_or_gain
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma are characterized by codeletion of PTPRO and MAD1L1?,freq_cnv_loss_or_gain
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma are characterized by codeletion of PTPRO and KDM5C?,freq_cnv_loss_or_gain
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma are characterized by codeletion of PTPRO and TRPA1?,freq_cnv_loss_or_gain
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma are characterized by codeletion of PTPRO and PIK3C2B?,freq_cnv_loss_or_gain
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma are characterized by codeletion of PTPRO and PTPRO?,freq_cnv_loss_or_gain
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma are characterized by codeletion of PTPRO and ANP32E?,freq_cnv_loss_or_gain
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma are characterized by codeletion of PTPRO and TMTC3?,freq_cnv_loss_or_gain
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of CHMP7 and ANKRD24?,freq_cnv_loss_or_gain
+1017,GPC3,I107N,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of GPC3 and TNS1?,freq_cnv_loss_or_gain
+1018,GPC3,I161N,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of GPC3 and ARHGEF40?,freq_cnv_loss_or_gain
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma are characterized by codeletion of TLK2 and SGIP1?,freq_cnv_loss_or_gain
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma are characterized by codeletion of TLK2 and CACNA1F?,freq_cnv_loss_or_gain
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma are characterized by codeletion of TLK2 and CCDC22?,freq_cnv_loss_or_gain
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma are characterized by codeletion of TLK2 and NRAP?,freq_cnv_loss_or_gain
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma are characterized by codeletion of TLK2 and DNAH11?,freq_cnv_loss_or_gain
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of ZNF217 and SPTAN1?,freq_cnv_loss_or_gain
+1038,SYT9,V275L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of SYT9 and RIMS2?,freq_cnv_loss_or_gain
+1039,SYT9,V307L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of SYT9 and GPR158?,freq_cnv_loss_or_gain
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of PKHD1L1 and TASOR2?,freq_cnv_loss_or_gain
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of MYO3A and TRAP1?,freq_cnv_loss_or_gain
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus are characterized by codeletion of VASN and MAST4?",freq_cnv_loss_or_gain
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of DNMT1 and ZSCAN31?,freq_cnv_loss_or_gain
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of DNMT1 and TTYH2?,freq_cnv_loss_or_gain
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of DNMT1 and MED16?,freq_cnv_loss_or_gain
+1056,CA9,E402K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of CA9 and TLK2?,freq_cnv_loss_or_gain
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of TTC17 and TENM2?,freq_cnv_loss_or_gain
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of TTC17 and GIMAP2?,freq_cnv_loss_or_gain
+1065,PSG2,P43L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma are characterized by codeletion of PSG2 and CTSC?,freq_cnv_loss_or_gain
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma are characterized by codeletion of RIPOR2 and FRY?,freq_cnv_loss_or_gain
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma are characterized by codeletion of RIPOR2 and CTSC?,freq_cnv_loss_or_gain
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma are characterized by codeletion of RIPOR2 and TYK2?,freq_cnv_loss_or_gain
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma are characterized by codeletion of RIPOR2 and PRSS1?,freq_cnv_loss_or_gain
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of DCLK3 and CTSC?,freq_cnv_loss_or_gain
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of DCLK3 and NPSR1?,freq_cnv_loss_or_gain
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of MERTK and CCDC22?,freq_cnv_loss_or_gain
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of MERTK and GRM5?,freq_cnv_loss_or_gain
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of MERTK and PCDHGA1?,freq_cnv_loss_or_gain
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of ZFP42 and CTSC?,freq_cnv_loss_or_gain
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of OR13C3 and TRAP1?,freq_cnv_loss_or_gain
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of OR13C3 and STAT3?,freq_cnv_loss_or_gain
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of SPAG1 and PRSS8?,freq_cnv_loss_or_gain
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of CDKN2AIP and POLD1?,freq_cnv_loss_or_gain
+1093,PXN,H1016Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of PXN and SPTAN1?,freq_cnv_loss_or_gain
+1094,PXN,H359Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of PXN and KDM5C?,freq_cnv_loss_or_gain
+1095,PXN,H492Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of PXN and KANSL1?,freq_cnv_loss_or_gain
+1096,PXN,H524Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of PXN and AQP7?,freq_cnv_loss_or_gain
+1097,PXN,H526Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of PXN and CACNA1F?,freq_cnv_loss_or_gain
+1098,PXN,H540Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of PXN and MYT1?,freq_cnv_loss_or_gain
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of TTYH2 and ZMYM3?,freq_cnv_loss_or_gain
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of TTYH2 and CPS1?,freq_cnv_loss_or_gain
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of TMEM255A and PTPRN2?,freq_cnv_loss_or_gain
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of TMEM255A and SYNJ1?,freq_cnv_loss_or_gain
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of TMEM255A and ZNF584?,freq_cnv_loss_or_gain
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma are characterized by codeletion of TASOR2 and TYROBP?,freq_cnv_loss_or_gain
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma are characterized by codeletion of TASOR2 and TTC17?,freq_cnv_loss_or_gain
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of ICE1 and ACTB?,freq_cnv_loss_or_gain
+1112,MYT1,A558E,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma are characterized by codeletion of MYT1 and PIK3C2A?,freq_cnv_loss_or_gain
+1113,MYT1,A879E,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma are characterized by codeletion of MYT1 and SPINDOC?,freq_cnv_loss_or_gain
+1114,MYT1,A906E,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma are characterized by codeletion of MYT1 and TMEM225?,freq_cnv_loss_or_gain
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of CX3CR1 and PGR?,freq_cnv_loss_or_gain
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of CX3CR1 and ZNF584?,freq_cnv_loss_or_gain
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma are characterized by codeletion of SPINDOC and MYT1?,freq_cnv_loss_or_gain
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of ART3 and SGCZ?,freq_cnv_loss_or_gain
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of ART3 and CASZ1?,freq_cnv_loss_or_gain
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma are characterized by codeletion of CYP1A2 and RIMS2?,freq_cnv_loss_or_gain
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus are characterized by codeletion of ADRA1A and CHODL?",freq_cnv_loss_or_gain
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of CDH23 and TRAP1?,freq_cnv_loss_or_gain
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of CDH23 and KIF20B?,freq_cnv_loss_or_gain
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of KRT39 and POLD1?,freq_cnv_loss_or_gain
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of PDHA2 and VASN?,freq_cnv_loss_or_gain
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of SLC24A2 and TAF1C?,freq_cnv_loss_or_gain
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma are characterized by codeletion of PTPRN2 and PGR?,freq_cnv_loss_or_gain
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma are characterized by codeletion of PTPRN2 and OR2A12?,freq_cnv_loss_or_gain
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma are characterized by codeletion of PTPRN2 and DHX16?,freq_cnv_loss_or_gain
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma are characterized by codeletion of PTPRN2 and PTPRO?,freq_cnv_loss_or_gain
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma are characterized by codeletion of PTPRN2 and GUK1?,freq_cnv_loss_or_gain
+1188,SOX21,R55L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of SOX21 and CHODL?,freq_cnv_loss_or_gain
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma are characterized by codeletion of CPA6 and BCAT1?,freq_cnv_loss_or_gain
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of GRM5 and OR8K5?,freq_cnv_loss_or_gain
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus are characterized by codeletion of CASZ1 and DGKD?",freq_cnv_loss_or_gain
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of SGIP1 and SERPINB10?,freq_cnv_loss_or_gain
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of SGIP1 and POC1B?,freq_cnv_loss_or_gain
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of SGIP1 and TYK2?,freq_cnv_loss_or_gain
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of SGIP1 and TLCD5?,freq_cnv_loss_or_gain
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of CARMIL1 and FRY?,freq_cnv_loss_or_gain
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of CARMIL1 and KIF20B?,freq_cnv_loss_or_gain
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of ZNF431 and RIMS2?,freq_cnv_loss_or_gain
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of ZNF431 and ACTB?,freq_cnv_loss_or_gain
+1234,ZNF431,R128I,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of ZNF431 and TRAP1?,freq_cnv_loss_or_gain
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of DNAH11 and TMEM255A?,freq_cnv_loss_or_gain
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of DNAH11 and DCN?,freq_cnv_loss_or_gain
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of POLD1 and MYO3A?,freq_cnv_loss_or_gain
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma are characterized by codeletion of POLD1 and PXN?,freq_cnv_loss_or_gain
+1248,TTC12,D646H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of TTC12 and CCNG1?,freq_cnv_loss_or_gain
+1249,TTC12,D652H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of TTC12 and RELN?,freq_cnv_loss_or_gain
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma are characterized by codeletion of CNGB1 and TAF1C?,freq_cnv_loss_or_gain
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma are characterized by codeletion of CNGB1 and MYO3B?,freq_cnv_loss_or_gain
+1254,CTSC,E214V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of CTSC and ANKDD1A?,freq_cnv_loss_or_gain
+1255,CTSC,E291V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of CTSC and MIEF1?,freq_cnv_loss_or_gain
+1256,CTSC,E322V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of CTSC and PCDHGA1?,freq_cnv_loss_or_gain
+1257,CTSC,E324V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of CTSC and OR5D14?,freq_cnv_loss_or_gain
+1258,CTSC,E335V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of CTSC and LDOC1?,freq_cnv_loss_or_gain
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of PRSS8 and PCDHB2?,freq_cnv_loss_or_gain
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of PRSS8 and MAST4?,freq_cnv_loss_or_gain
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of ARHGEF40 and RIMS2?,freq_cnv_loss_or_gain
+1264,ACTB,A138T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma are characterized by codeletion of ACTB and EFCAB12?,freq_cnv_loss_or_gain
+1265,ACTB,A217T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma are characterized by codeletion of ACTB and SGIP1?,freq_cnv_loss_or_gain
+1266,ACTB,A244T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma are characterized by codeletion of ACTB and GRTP1?,freq_cnv_loss_or_gain
+1267,ACTB,A260T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma are characterized by codeletion of ACTB and ZNF217?,freq_cnv_loss_or_gain
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme are characterized by codeletion of YY1AP1 and POC1B?,freq_cnv_loss_or_gain
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme are characterized by codeletion of YY1AP1 and CTSC?,freq_cnv_loss_or_gain
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme are characterized by codeletion of YY1AP1 and SPATA22?,freq_cnv_loss_or_gain
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme are characterized by codeletion of YY1AP1 and ACTB?,freq_cnv_loss_or_gain
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme are characterized by codeletion of YY1AP1 and TENT5A?,freq_cnv_loss_or_gain
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme are characterized by codeletion of YY1AP1 and FRY?,freq_cnv_loss_or_gain
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme are characterized by codeletion of YY1AP1 and CFAP61?,freq_cnv_loss_or_gain
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of FNDC7 and CDH23?,freq_cnv_loss_or_gain
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of FNDC7 and ACTB?,freq_cnv_loss_or_gain
+1299,TLCD5,G15V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of TLCD5 and PLEKHG6?,freq_cnv_loss_or_gain
+1300,TLCD5,G37V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of TLCD5 and EIF2B4?,freq_cnv_loss_or_gain
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of POLR1G and ZCCHC14?,freq_cnv_loss_or_gain
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of POLR1G and KDM5C?,freq_cnv_loss_or_gain
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of DNAH14 and SPATA22?,freq_cnv_loss_or_gain
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of DNAH14 and CHMP7?,freq_cnv_loss_or_gain
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of DNAH14 and PIK3C2A?,freq_cnv_loss_or_gain
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of NEXN and KDM5C?,freq_cnv_loss_or_gain
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma are characterized by codeletion of CYB5R2 and HTR3B?,freq_cnv_loss_or_gain
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma are characterized by codeletion of CYB5R2 and PGR?,freq_cnv_loss_or_gain
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of NRAP and MAST4?,freq_cnv_loss_or_gain
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of NRAP and DCC?,freq_cnv_loss_or_gain
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of NRAP and TRIM45?,freq_cnv_loss_or_gain
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of CCDC22 and KDM5C?,freq_cnv_loss_or_gain
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of DCAF6 and CTSC?,freq_cnv_loss_or_gain
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of DCAF6 and RIMS2?,freq_cnv_loss_or_gain
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of ZNF708 and GPR158?,freq_cnv_loss_or_gain
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of BFAR and SYNJ1?,freq_cnv_loss_or_gain
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of MAST4 and MAST4?,freq_cnv_loss_or_gain
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of MAST4 and POLD1?,freq_cnv_loss_or_gain
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of MAST4 and DCC?,freq_cnv_loss_or_gain
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of MAST4 and PTPRO?,freq_cnv_loss_or_gain
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of MAST4 and FGF8?,freq_cnv_loss_or_gain
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of ARMC3 and PGR?,freq_cnv_loss_or_gain
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of ARMC3 and SORCS1?,freq_cnv_loss_or_gain
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma are characterized by codeletion of TET2 and DGKD?,freq_cnv_loss_or_gain
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma are characterized by codeletion of TET2 and DOCK2?,freq_cnv_loss_or_gain
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of SERPINB10 and MERTK?,freq_cnv_loss_or_gain
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of STAT3 and DSCAM?,freq_cnv_loss_or_gain
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of MIEF1 and TLK2?,freq_cnv_loss_or_gain
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of ACVR1B and DNAH14?,freq_cnv_loss_or_gain
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of ACVR1B and SYNJ1?,freq_cnv_loss_or_gain
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of ACVR1B and ACTB?,freq_cnv_loss_or_gain
+1393,EBF2,T104I,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of EBF2 and TASOR2?,freq_cnv_loss_or_gain
+1394,EBF2,T252I,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of EBF2 and PDHA2?,freq_cnv_loss_or_gain
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of VPS26B and MSANTD4?,freq_cnv_loss_or_gain
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus are characterized by codeletion of PGR and ANP32E?",freq_cnv_loss_or_gain
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus are characterized by codeletion of PGR and AQP7?",freq_cnv_loss_or_gain
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus are characterized by codeletion of PGR and PIK3C2B?",freq_cnv_loss_or_gain
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma are characterized by codeletion of ACTA2 and PXN?,freq_cnv_loss_or_gain
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of THBS4 and TNS1?,freq_cnv_loss_or_gain
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of THBS4 and PTPRO?,freq_cnv_loss_or_gain
+1413,PRSS1,S114T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of PRSS1 and SGIP1?,freq_cnv_loss_or_gain
+1414,PRSS1,S124T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of PRSS1 and POLD1?,freq_cnv_loss_or_gain
+1415,PRSS1,S138T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of PRSS1 and DCLK3?,freq_cnv_loss_or_gain
+1416,PRSS1,S74T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma are characterized by codeletion of PRSS1 and ZSCAN31?,freq_cnv_loss_or_gain
+1417,PGF,R126H,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of PGF and DCAF6?,freq_cnv_loss_or_gain
+1418,PGF,R127H,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma are characterized by codeletion of PGF and TRAP1?,freq_cnv_loss_or_gain
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma are characterized by codeletion of ITPRID2 and AUTS2?,freq_cnv_loss_or_gain
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma are characterized by codeletion of ITPRID2 and FBXO42?,freq_cnv_loss_or_gain
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of HBB and FRY?,freq_cnv_loss_or_gain
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of PCDHB2 and LDOC1?,freq_cnv_loss_or_gain
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of PCDHB2 and GABRA6?,freq_cnv_loss_or_gain
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma are characterized by codeletion of PCDHB2 and OLFML3?,freq_cnv_loss_or_gain
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma are characterized by codeletion of UBR2 and ARMC3?,freq_cnv_loss_or_gain
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma are characterized by codeletion of FBXO42 and GABRA6?,freq_cnv_loss_or_gain
+1,TNS1,G1362V,Breast Invasive Carcinoma,How common is DSCAM LOH in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+2,TNS1,G1711V,Breast Invasive Carcinoma,How common is FBXO15 LOH in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+3,TNS1,G1718V,Breast Invasive Carcinoma,How common is PXN LOH in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+4,TNS1,G1732V,Breast Invasive Carcinoma,How common is POC1B LOH in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+5,TNS1,G1824V,Breast Invasive Carcinoma,How common is PTPRN2 LOH in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+6,TNS1,G1857V,Breast Invasive Carcinoma,How common is ACVR1B LOH in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+7,TNS1,G843V,Breast Invasive Carcinoma,How common is ICE1 LOH in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How common is RIMS2 LOH in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How common is CYP1A2 LOH in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How common is YY1AP1 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How common is ZMYM3 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+22,TRPA1,S295I,Rectum Adenocarcinoma,How common is COL6A3 LOH in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+23,TRPA1,S443I,Rectum Adenocarcinoma,How common is RIPOR2 LOH in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+24,TAF1C,R299L,Lung Adenocarcinoma,How common is DNMT1 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+25,TAF1C,R396L,Lung Adenocarcinoma,How common is SORCS1 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+26,TAF1C,R634L,Lung Adenocarcinoma,How common is MAST4 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+27,TAF1C,R702L,Lung Adenocarcinoma,How common is MYO3B LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+28,TAF1C,R728L,Lung Adenocarcinoma,How common is DCN LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How common is TASOR2 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How common is PIK3C2G LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How common is ANKRD24 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+42,OR2T4,P272H,Lung Adenocarcinoma,How common is ABCC3 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+43,OR2T4,P300H,Lung Adenocarcinoma,How common is SORCS1 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How common is MUC16 LOH in Pancreatic Adenocarcinoma cases?,freq_cnv_loss_or_gain
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How common is COL6A3 LOH in Prostate Adenocarcinoma cases?,freq_cnv_loss_or_gain
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How common is CPS1 LOH in Prostate Adenocarcinoma cases?,freq_cnv_loss_or_gain
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How common is ZFAT LOH in Prostate Adenocarcinoma cases?,freq_cnv_loss_or_gain
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How common is NOMO1 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How common is DSCAM LOH in Kidney Renal Papillary Cell Carcinoma cases?,freq_cnv_loss_or_gain
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How common is AUTS2 LOH in Kidney Renal Papillary Cell Carcinoma cases?,freq_cnv_loss_or_gain
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How common is MYH11 LOH in Kidney Renal Papillary Cell Carcinoma cases?,freq_cnv_loss_or_gain
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How common is ANKRD24 LOH in Kidney Renal Papillary Cell Carcinoma cases?,freq_cnv_loss_or_gain
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How common is FCGR2C LOH in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How common is OR13C3 LOH in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How common is SGIP1 LOH in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How common is ANKRD52 LOH in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+70,PAK3,E318K,Skin Cutaneous Melanoma,How common is PRSS8 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+71,PAK3,E319K,Skin Cutaneous Melanoma,How common is TMTC3 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+72,PAK3,E334K,Skin Cutaneous Melanoma,How common is DPF3 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+73,PAK3,E340K,Skin Cutaneous Melanoma,How common is OLFML3 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+74,PAK3,E355K,Skin Cutaneous Melanoma,How common is REXO4 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How common is TLK2 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How common is HSPA5 LOH in Liver Hepatocellular Carcinoma cases?,freq_cnv_loss_or_gain
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How common is POC1B LOH in Liver Hepatocellular Carcinoma cases?,freq_cnv_loss_or_gain
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How common is LCN15 LOH in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How common is MYO16 LOH in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How common is TYROBP LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+116,RELN,A2371V,Stomach Adenocarcinoma,How common is GPC3 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is JAML LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is NRAP LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How common is POLR1G LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How common is PLEKHG6 LOH in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How common is REXO4 LOH in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How common is UNC5D LOH in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How common is ANKDD1A LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How common is MORF4L1 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How common is YY1AP1 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+129,ABCC3,R758W,Stomach Adenocarcinoma,How common is HBB LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How common is CHODL LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How common is GABRA6 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How common is PTPRN2 LOH in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How common is EIF2B4 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+140,BICC1,A372V,Exceptional Responders,How common is SLC9C1 LOH in Exceptional Responders cases?,freq_cnv_loss_or_gain
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How common is GABRA6 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How common is RIMS2 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How common is ZNF708 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is THBS4 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How common is EIF2B4 LOH in Liver Hepatocellular Carcinoma cases?,freq_cnv_loss_or_gain
+157,OR8K5,R293G,Lung Adenocarcinoma,How common is GRM1 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How common is RIPOR2 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How common is BCAT1 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+164,SYT10,M484I,Rectum Adenocarcinoma,How common is MAD1L1 LOH in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How common is PAPPA LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+175,UNC5D,L280V,Lung Adenocarcinoma,How common is ANKRD30A LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+176,UNC5D,L635V,Lung Adenocarcinoma,How common is PGR LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+177,UNC5D,L637V,Lung Adenocarcinoma,How common is MYO16 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+178,UNC5D,L699V,Lung Adenocarcinoma,How common is KDM5C LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+179,UNC5D,L704V,Lung Adenocarcinoma,How common is DPF3 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+180,UNC5D,L709V,Lung Adenocarcinoma,How common is PGR LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How common is TLK2 LOH in Kidney Renal Clear Cell Carcinoma cases?,freq_cnv_loss_or_gain
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How common is POC1B LOH in Kidney Renal Clear Cell Carcinoma cases?,freq_cnv_loss_or_gain
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How common is BCAT1 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+193,MRPL55,H27Y,Colon Adenocarcinoma,How common is CR1 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+194,MRPL55,H63Y,Colon Adenocarcinoma,How common is TTC17 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How common is TMEM225 LOH in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+198,EPRS1,K771I,Colon Adenocarcinoma,How common is PKHD1L1 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+199,EPRS1,K778I,Colon Adenocarcinoma,How common is DCAF6 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How common is BCAT1 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How common is PXN LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How common is POC1B LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How common is YY1AP1 LOH in HIV+ Tumor Molecular Characterization Project - Cervical Cancer cases?,freq_cnv_loss_or_gain
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How common is ANP32E LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How common is POLR1G LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+251,ZNF274,P13R,Stomach Adenocarcinoma,How common is TASOR2 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+253,SYNJ1,R795C,Colon Adenocarcinoma,How common is SORCS1 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+254,SYNJ1,R800C,Colon Adenocarcinoma,How common is PSG2 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+255,SYNJ1,R839C,Colon Adenocarcinoma,How common is CDKN2AIP LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+261,DSCAM,V343M,Prostate Adenocarcinoma,How common is ADAM17 LOH in Prostate Adenocarcinoma cases?,freq_cnv_loss_or_gain
+262,DSCAM,V426M,Prostate Adenocarcinoma,How common is KIF20B LOH in Prostate Adenocarcinoma cases?,freq_cnv_loss_or_gain
+263,DSCAM,V591M,Prostate Adenocarcinoma,How common is PTPRN2 LOH in Prostate Adenocarcinoma cases?,freq_cnv_loss_or_gain
+267,DGKD,R140H,Exceptional Responders,How common is TENM2 LOH in Exceptional Responders cases?,freq_cnv_loss_or_gain
+268,DGKD,R160H,Exceptional Responders,How common is CPS1 LOH in Exceptional Responders cases?,freq_cnv_loss_or_gain
+269,DGKD,R204H,Exceptional Responders,How common is MYT1 LOH in Exceptional Responders cases?,freq_cnv_loss_or_gain
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How common is PCDHGA1 LOH in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How common is SORCS1 LOH in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How common is ACTB LOH in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+279,WNT2,D138N,Skin Cutaneous Melanoma,How common is NOMO1 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How common is MED16 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How common is ABCC3 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MYO3B LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+299,OR5D14,M210L,Neuroblastoma,How common is GIMAP2 LOH in Neuroblastoma cases?,freq_cnv_loss_or_gain
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How common is TNS1 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How common is SORCS1 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How common is CDH23 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+310,LCN15,E21V,Stomach Adenocarcinoma,How common is PXN LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How common is TNS1 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How common is ACTL7B LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How common is SYT9 LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How common is TLCD5 LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How common is ACTL7B LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How common is FRY LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How common is RIMS2 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How common is PRSS8 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How common is CEP20 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How common is PTPRO LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How common is MYT1 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How common is DNAH11 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How common is KL LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How common is ABCC2 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How common is ZNF431 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How common is HTR3B LOH in Ovarian Serous Cystadenocarcinoma cases?,freq_cnv_loss_or_gain
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How common is DCC LOH in Ovarian Serous Cystadenocarcinoma cases?,freq_cnv_loss_or_gain
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How common is MAOB LOH in Ovarian Serous Cystadenocarcinoma cases?,freq_cnv_loss_or_gain
+357,ZNF584,A211T,Sarcoma,How common is RAB40C LOH in Sarcoma cases?,freq_cnv_loss_or_gain
+358,ZNF584,A256T,Sarcoma,How common is GUK1 LOH in Sarcoma cases?,freq_cnv_loss_or_gain
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How common is ZFPM2 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How common is SORCS1 LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How common is TRIM45 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How common is OR5D14 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How common is EPRS1 LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How common is KDM5C LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How common is GABRA6 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How common is OLFML3 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How common is OR5D14 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How common is ZNF804A LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How common is TET2 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is MYO3A LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,freq_cnv_loss_or_gain
+406,POC1B,I198T,Rectum Adenocarcinoma,How common is ZNF627 LOH in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+407,POC1B,I286T,Rectum Adenocarcinoma,How common is TENM3 LOH in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+408,POC1B,I328T,Rectum Adenocarcinoma,How common is ACTL7B LOH in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+409,POC1B,S79P,Rectum Adenocarcinoma,How common is AUTS2 LOH in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How common is EPRS1 LOH in Liver Hepatocellular Carcinoma cases?,freq_cnv_loss_or_gain
+414,AQP7,T110S,Rectum Adenocarcinoma,How common is COL6A3 LOH in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+415,AQP7,T166S,Rectum Adenocarcinoma,How common is TENT5A LOH in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+416,AQP7,T167S,Rectum Adenocarcinoma,How common is SPAG1 LOH in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+417,AQP7,T75S,Rectum Adenocarcinoma,How common is TTN LOH in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+430,DCN,R163C,Rectum Adenocarcinoma,How common is TLK2 LOH in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+431,DCN,R203C,Rectum Adenocarcinoma,How common is PXN LOH in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+432,DCN,R241C,Rectum Adenocarcinoma,How common is GUF1 LOH in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+433,DCN,R350C,Rectum Adenocarcinoma,How common is DCC LOH in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+434,DCN,R41C,Rectum Adenocarcinoma,How common is ICE1 LOH in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How common is GRM1 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How common is MERTK LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How common is RELN LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How common is ICE1 LOH in Kidney Renal Papillary Cell Carcinoma cases?,freq_cnv_loss_or_gain
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How common is DEFB115 LOH in Kidney Renal Papillary Cell Carcinoma cases?,freq_cnv_loss_or_gain
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How common is MED16 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+482,SGCZ,Q138H,Lung Adenocarcinoma,How common is DCN LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+483,SGCZ,Q91H,Lung Adenocarcinoma,How common is SOX21 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+485,SMO,V15M,Stomach Adenocarcinoma,How common is ZNF217 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+486,SMO,V321M,Stomach Adenocarcinoma,How common is TAF1C LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+488,CHODL,G159E,Skin Cutaneous Melanoma,How common is FRY LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+489,CHODL,G181E,Skin Cutaneous Melanoma,How common is GUK1 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+490,CHODL,G200E,Skin Cutaneous Melanoma,How common is OLFML3 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+494,MYO16,P399H,Colon Adenocarcinoma,How common is PTPRO LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+495,MYO16,P421H,Colon Adenocarcinoma,How common is KDM5C LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+498,CXCR2,A98V,Stomach Adenocarcinoma,How common is FBXO15 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How common is KDM5C LOH in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How common is ADRA1A LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How common is ANP32E LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How common is TAF1C LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How common is DPF3 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+510,RAB40C,A111V,Lung Adenocarcinoma,How common is AQP7 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+511,RAB40C,A143V,Lung Adenocarcinoma,How common is OR13C3 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+512,CTNNA2,S323R,Lung Adenocarcinoma,How common is PAPPA LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+513,CTNNA2,S339R,Lung Adenocarcinoma,How common is COL6A3 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+514,CTNNA2,S386R,Lung Adenocarcinoma,How common is RIMS2 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+515,CTNNA2,S707R,Lung Adenocarcinoma,How common is AUTS2 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How common is SLC9C1 LOH in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How common is MYO3B LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+532,KIF20B,N1160D,Glioblastoma Multiforme,How common is TENT5A LOH in Glioblastoma Multiforme cases?,freq_cnv_loss_or_gain
+533,KIF20B,N1200D,Glioblastoma Multiforme,How common is SYNJ1 LOH in Glioblastoma Multiforme cases?,freq_cnv_loss_or_gain
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How common is DNMT1 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How common is DNAH14 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How common is AQP7 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How common is TENT5A LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+540,ERCC6,R1053H,Colon Adenocarcinoma,How common is AUTS2 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+541,DCC,R320W,Breast Invasive Carcinoma,How common is ABCC3 LOH in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+542,DCC,R363W,Breast Invasive Carcinoma,How common is ZNF584 LOH in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+543,DCC,R386W,Breast Invasive Carcinoma,How common is FNDC7 LOH in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+544,DCC,R41W,Breast Invasive Carcinoma,How common is DNAH14 LOH in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How common is CNGB1 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How common is SPATA22 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How common is YY1AP1 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How common is MYH11 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How common is AQP7 LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How common is FGF8 LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How common is TENM2 LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How common is ZNF274 LOH in Ovarian Serous Cystadenocarcinoma cases?,freq_cnv_loss_or_gain
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How common is CYB5R2 LOH in Ovarian Serous Cystadenocarcinoma cases?,freq_cnv_loss_or_gain
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How common is AUTS2 LOH in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How common is PAK3 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How common is GABRA6 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How common is POLR1G LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How common is FBN1 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How common is MYT1 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How common is PIAS3 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How common is AUTS2 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How common is EFCAB12 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How common is CTCFL LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How common is COL6A3 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+625,SIK2,I265M,Lung Adenocarcinoma,How common is EIF2B4 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How common is EBF2 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How common is ZNF584 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How common is PRSS1 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How common is OR2A12 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How common is DGKD LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+644,OR2A12,A254T,Brain Lower Grade Glioma,How common is CTNNA2 LOH in Brain Lower Grade Glioma cases?,freq_cnv_loss_or_gain
+646,PYHIN1,T325K,Lung Adenocarcinoma,How common is FBN1 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+647,PYHIN1,T334K,Lung Adenocarcinoma,How common is FGF8 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+650,JAML,G191E,Skin Cutaneous Melanoma,How common is ACTA2 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+651,JAML,G219E,Skin Cutaneous Melanoma,How common is PCDHGA1 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+652,JAML,G220E,Skin Cutaneous Melanoma,How common is RIMS2 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+653,JAML,G230E,Skin Cutaneous Melanoma,How common is CPS1 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+658,TYK2,H1146R,Stomach Adenocarcinoma,How common is DCC LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+659,TYK2,H23R,Stomach Adenocarcinoma,How common is MAST4 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+660,TYK2,H961R,Stomach Adenocarcinoma,How common is UNC5D LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How common is ZFAT LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How common is CTSC LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How common is TENT5A LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How common is UNC5D LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How common is C7orf31 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How common is TRAP1 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How common is ANKRD52 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How common is TRPA1 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How common is DGKD LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How common is YY1AP1 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How common is ARMC3 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How common is GUK1 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How common is CTSC LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How common is ZNF431 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How common is DHX16 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+728,STK19,D341N,Colon Adenocarcinoma,How common is COL6A3 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+729,STK19,D345N,Colon Adenocarcinoma,How common is TNS1 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+730,REXO4,P60A,Skin Cutaneous Melanoma,How common is CTCFL LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How common is OLFML3 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How common is NRAP LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How common is SPINDOC LOH in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is KL LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is YY1AP1 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is DCLK3 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MAST4 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How common is TAF1C LOH in Head and Neck Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How common is SYNJ1 LOH in Head and Neck Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How common is DOCK2 LOH in Head and Neck Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How common is GPRASP1 LOH in Head and Neck Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How common is PIK3C2B LOH in Head and Neck Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How common is AUTS2 LOH in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia cases?,freq_cnv_loss_or_gain
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How common is CXCR2 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is FRY LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,freq_cnv_loss_or_gain
+792,GLRB,E148D,Stomach Adenocarcinoma,How common is RIMS2 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+793,TTN,F7636L,Colon Adenocarcinoma,How common is TNS1 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+794,TTN,F8563L,Colon Adenocarcinoma,How common is COL6A3 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+795,TTN,F8880L,Colon Adenocarcinoma,How common is PXN LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How common is SGIP1 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How common is TMEM255A LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How common is EIF2B4 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+809,TRIM45,S177L,Colon Adenocarcinoma,How common is ZSCAN31 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+810,TRIM45,S224L,Colon Adenocarcinoma,How common is RIPOR2 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+811,TRIM45,S281L,Colon Adenocarcinoma,How common is YY1AP1 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How common is DOCK2 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How common is SGIP1 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How common is FBN1 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+817,KL,R594C,Colon Adenocarcinoma,How common is MSANTD4 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How common is DNMT1 LOH in Kidney Renal Papillary Cell Carcinoma cases?,freq_cnv_loss_or_gain
+822,TAF1L,A539V,Colon Adenocarcinoma,How common is ANP32E LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How common is FBXO15 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How common is UNC5D LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How common is DSCAM LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How common is CDKN2AIP LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How common is OR2T4 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How common is SGCZ LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How common is PYHIN1 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is GLRB LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,freq_cnv_loss_or_gain
+843,DHX16,A29V,Skin Cutaneous Melanoma,How common is CACNA1F LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+844,DHX16,A89V,Skin Cutaneous Melanoma,How common is DCN LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+902,GPR158,A644V,Stomach Adenocarcinoma,How common is GPR158 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+903,GPR158,A723V,Stomach Adenocarcinoma,How common is COL6A3 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is YY1AP1 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is TSHZ3 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is ACVR1B LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is ANKRD24 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is XKR4 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is TYK2 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How common is DNAH11 LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How common is CHODL LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How common is AUTS2 LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How common is HYOU1 LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How common is POLR1G LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How common is BCAT1 LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How common is TNS1 LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How common is YY1AP1 LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How common is PTPRO LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How common is PRSS1 LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is TNS1 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How common is MERTK LOH in Glioblastoma Multiforme cases?,freq_cnv_loss_or_gain
+954,TRAP1,R114W,Stomach Adenocarcinoma,How common is ANKRD30A LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+955,TRAP1,R61W,Stomach Adenocarcinoma,How common is GUK1 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How common is PXN LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How common is AUTS2 LOH in Liver Hepatocellular Carcinoma cases?,freq_cnv_loss_or_gain
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How common is GUK1 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How common is ZNF584 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How common is LAMB2 LOH in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+982,GABRA6,G115R,Lung Adenocarcinoma,How common is SPINDOC LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+983,GABRA6,G122R,Lung Adenocarcinoma,How common is DCC LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+984,GABRA6,G165R,Lung Adenocarcinoma,How common is PTPRO LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+985,GABRA6,G175R,Lung Adenocarcinoma,How common is ANKDD1A LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+986,GABRA6,G70R,Lung Adenocarcinoma,How common is DCAF6 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How common is MED16 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is KDM5C LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is DNAH11 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How common is TRIM45 LOH in Pancreatic Adenocarcinoma cases?,freq_cnv_loss_or_gain
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How common is DPF3 LOH in Pancreatic Adenocarcinoma cases?,freq_cnv_loss_or_gain
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How common is TYROBP LOH in Pancreatic Adenocarcinoma cases?,freq_cnv_loss_or_gain
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How common is MAST4 LOH in Pancreatic Adenocarcinoma cases?,freq_cnv_loss_or_gain
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How common is CASZ1 LOH in Pancreatic Adenocarcinoma cases?,freq_cnv_loss_or_gain
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How common is PCDHGA1 LOH in Pancreatic Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How common is JAML LOH in Pancreatic Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How common is SGIP1 LOH in Pancreatic Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How common is TENT5A LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1017,GPC3,I107N,Stomach Adenocarcinoma,How common is AKT1 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1018,GPC3,I161N,Stomach Adenocarcinoma,How common is FRY LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is MYT1 LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is ARMC3 LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is KIF20B LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is BICC1 LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common is DNAH11 LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How common is PRSS1 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1038,SYT9,V275L,Lung Adenocarcinoma,How common is PIK3C2G LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1039,SYT9,V307L,Lung Adenocarcinoma,How common is TTN LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How common is PTPRN2 LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How common is TAF1C LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is PAK3 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How common is TTN LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How common is SYNJ1 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How common is TYROBP LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1056,CA9,E402K,Colon Adenocarcinoma,How common is ABCC2 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How common is AUTS2 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How common is USH2A LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1065,PSG2,P43L,Breast Invasive Carcinoma,How common is PAPPA LOH in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How common is TLK2 LOH in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How common is MRPL32 LOH in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How common is ZMYM3 LOH in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How common is POLR1G LOH in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How common is RIMS2 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How common is FNDC7 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How common is PHLPP1 LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How common is PTPRO LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How common is SYNJ1 LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How common is ARMC3 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How common is MAD1L1 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How common is PYHIN1 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How common is CACNA1F LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How common is PAK3 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1093,PXN,H1016Y,Colon Adenocarcinoma,How common is COL6A3 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1094,PXN,H359Y,Colon Adenocarcinoma,How common is AUTS2 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1095,PXN,H492Y,Colon Adenocarcinoma,How common is MORF4L1 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1096,PXN,H524Y,Colon Adenocarcinoma,How common is RIMS2 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1097,PXN,H526Y,Colon Adenocarcinoma,How common is MAST4 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1098,PXN,H540Y,Colon Adenocarcinoma,How common is DCAF6 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How common is DGKD LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How common is TSHZ3 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How common is TRIM45 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How common is PSG2 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How common is MAST4 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How common is IL5RA LOH in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How common is MYO16 LOH in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How common is COL6A3 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1112,MYT1,A558E,Breast Invasive Carcinoma,How common is PTPRO LOH in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+1113,MYT1,A879E,Breast Invasive Carcinoma,How common is DNAH11 LOH in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+1114,MYT1,A906E,Breast Invasive Carcinoma,How common is RIMS2 LOH in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How common is ANKRD30A LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How common is OLFML3 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How common is NOMO1 LOH in Liver Hepatocellular Carcinoma cases?,freq_cnv_loss_or_gain
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How common is CACNA1F LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How common is FMO4 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How common is RIPOR2 LOH in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is SPATA22 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How common is CHODL LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How common is AUTS2 LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How common is ZFPM2 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How common is ANKRD52 LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How common is KDM5C LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How common is AUTS2 LOH in Liver Hepatocellular Carcinoma cases?,freq_cnv_loss_or_gain
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How common is PXN LOH in Liver Hepatocellular Carcinoma cases?,freq_cnv_loss_or_gain
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How common is SGIP1 LOH in Liver Hepatocellular Carcinoma cases?,freq_cnv_loss_or_gain
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How common is ACVR1B LOH in Liver Hepatocellular Carcinoma cases?,freq_cnv_loss_or_gain
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How common is NCKAP5 LOH in Liver Hepatocellular Carcinoma cases?,freq_cnv_loss_or_gain
+1188,SOX21,R55L,Lung Adenocarcinoma,How common is SGIP1 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How common is MERTK LOH in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How common is PRSS8 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is MERTK LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How common is VASN LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How common is TAF1C LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How common is CDKN2AIP LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How common is TNS1 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How common is SORCS1 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How common is ANKRD30A LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How common is TYROBP LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How common is PGF LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1234,ZNF431,R128I,Lung Adenocarcinoma,How common is OLFML3 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How common is TYK2 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How common is HSPA5 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How common is SPATA22 LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How common is ANKDD1A LOH in Lung Squamous Cell Carcinoma cases?,freq_cnv_loss_or_gain
+1248,TTC12,D646H,Lung Adenocarcinoma,How common is TRPA1 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1249,TTC12,D652H,Lung Adenocarcinoma,How common is ZBTB34 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How common is MED16 LOH in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How common is ACTB LOH in Bladder Urothelial Carcinoma cases?,freq_cnv_loss_or_gain
+1254,CTSC,E214V,Stomach Adenocarcinoma,How common is TMTC3 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1255,CTSC,E291V,Stomach Adenocarcinoma,How common is MERTK LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1256,CTSC,E322V,Stomach Adenocarcinoma,How common is CARMIL1 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1257,CTSC,E324V,Stomach Adenocarcinoma,How common is SMO LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1258,CTSC,E335V,Stomach Adenocarcinoma,How common is JAML LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How common is CACNA1F LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How common is ACVR1B LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How common is LDOC1 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1264,ACTB,A138T,Rectum Adenocarcinoma,How common is AKT1 LOH in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1265,ACTB,A217T,Rectum Adenocarcinoma,How common is PGR LOH in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1266,ACTB,A244T,Rectum Adenocarcinoma,How common is PTPRO LOH in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1267,ACTB,A260T,Rectum Adenocarcinoma,How common is TTN LOH in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How common is GUF1 LOH in Glioblastoma Multiforme cases?,freq_cnv_loss_or_gain
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How common is SPATA22 LOH in Glioblastoma Multiforme cases?,freq_cnv_loss_or_gain
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How common is TAF1C LOH in Glioblastoma Multiforme cases?,freq_cnv_loss_or_gain
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How common is HTR3B LOH in Glioblastoma Multiforme cases?,freq_cnv_loss_or_gain
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How common is TLCD5 LOH in Glioblastoma Multiforme cases?,freq_cnv_loss_or_gain
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How common is LAMB2 LOH in Glioblastoma Multiforme cases?,freq_cnv_loss_or_gain
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How common is TNS1 LOH in Glioblastoma Multiforme cases?,freq_cnv_loss_or_gain
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How common is SMO LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How common is CNGB1 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+1299,TLCD5,G15V,Lung Adenocarcinoma,How common is NOMO1 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1300,TLCD5,G37V,Lung Adenocarcinoma,How common is ZFAT LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How common is TNS1 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How common is AUTS2 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How common is AUTS2 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How common is UNC5D LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How common is USH2A LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How common is MRPL32 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How common is GRM5 LOH in Prostate Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How common is SYNJ1 LOH in Prostate Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How common is SPAG1 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How common is DGKD LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How common is MAST4 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How common is POLD1 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How common is TYK2 LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How common is POC1B LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How common is PXN LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How common is ACVR1B LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How common is DCN LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How common is SPATA22 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How common is FRY LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How common is CCDC22 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How common is SGCZ LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How common is MAD1L1 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How common is TASOR2 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How common is TAS1R3 LOH in Kidney Renal Clear Cell Carcinoma cases?,freq_cnv_loss_or_gain
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How common is ART3 LOH in Kidney Renal Clear Cell Carcinoma cases?,freq_cnv_loss_or_gain
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How common is GUK1 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How common is PAK3 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How common is DNMT1 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How common is ANKDD1A LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How common is DGKD LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How common is ZFP42 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1393,EBF2,T104I,Stomach Adenocarcinoma,How common is TLK2 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1394,EBF2,T252I,Stomach Adenocarcinoma,How common is CA9 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How common is DCLK3 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is KDM5C LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is ACTL7B LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common is FNDC7 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",freq_cnv_loss_or_gain
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How common is MAOB LOH in Skin Cutaneous Melanoma cases?,freq_cnv_loss_or_gain
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How common is TTC12 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How common is DGKD LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1413,PRSS1,S114T,Lung Adenocarcinoma,How common is RIMS2 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1414,PRSS1,S124T,Lung Adenocarcinoma,How common is TNS1 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1415,PRSS1,S138T,Lung Adenocarcinoma,How common is PRSS1 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1416,PRSS1,S74T,Lung Adenocarcinoma,How common is AQP7 LOH in Lung Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1417,PGF,R126H,Stomach Adenocarcinoma,How common is TASOR2 LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1418,PGF,R127H,Stomach Adenocarcinoma,How common is MERTK LOH in Stomach Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How common is ERCC6 LOH in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How common is ZSCAN31 LOH in Breast Invasive Carcinoma cases?,freq_cnv_loss_or_gain
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How common is NOMO1 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How common is DNMT1 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How common is ZMYM3 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How common is ZKSCAN7 LOH in Colon Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How common is COL6A3 LOH in Uterine Corpus Endometrial Carcinoma cases?,freq_cnv_loss_or_gain
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How common is HTR3B LOH in Rectum Adenocarcinoma cases?,freq_cnv_loss_or_gain
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the rate of TNS1 LOH in Breast Invasive Carcinoma diagnoses?,freq_cnv_loss_or_gain
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the rate of TNS1 LOH in Breast Invasive Carcinoma diagnoses?,freq_cnv_loss_or_gain
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the rate of TNS1 LOH in Breast Invasive Carcinoma diagnoses?,freq_cnv_loss_or_gain
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the rate of TNS1 LOH in Breast Invasive Carcinoma diagnoses?,freq_cnv_loss_or_gain
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the rate of TNS1 LOH in Breast Invasive Carcinoma diagnoses?,freq_cnv_loss_or_gain
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the rate of TNS1 LOH in Breast Invasive Carcinoma diagnoses?,freq_cnv_loss_or_gain
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the rate of TNS1 LOH in Breast Invasive Carcinoma diagnoses?,freq_cnv_loss_or_gain
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the rate of EVC2 LOH in Bladder Urothelial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the rate of EVC2 LOH in Bladder Urothelial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the rate of CR1 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the rate of CR1 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the rate of TRPA1 LOH in Rectum Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the rate of TRPA1 LOH in Rectum Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the rate of TAF1C LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the rate of TAF1C LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the rate of TAF1C LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the rate of TAF1C LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the rate of TAF1C LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the rate of DPF3 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the rate of DPF3 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the rate of DPF3 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the rate of OR2T4 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the rate of OR2T4 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the rate of FBN1 LOH in Pancreatic Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the rate of MAD1L1 LOH in Prostate Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the rate of MAD1L1 LOH in Prostate Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the rate of MAD1L1 LOH in Prostate Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the rate of CCNG1 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the rate of ANP32E LOH in Kidney Renal Papillary Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the rate of ANP32E LOH in Kidney Renal Papillary Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the rate of ANP32E LOH in Kidney Renal Papillary Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the rate of ANP32E LOH in Kidney Renal Papillary Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the rate of FRY LOH in Bladder Urothelial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the rate of FRY LOH in Bladder Urothelial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the rate of FRY LOH in Bladder Urothelial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the rate of FRY LOH in Bladder Urothelial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the rate of PAK3 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the rate of PAK3 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the rate of PAK3 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the rate of PAK3 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the rate of PAK3 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the rate of MUC16 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the rate of ZFPM2 LOH in Liver Hepatocellular Carcinoma diagnoses?,freq_cnv_loss_or_gain
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the rate of ZFPM2 LOH in Liver Hepatocellular Carcinoma diagnoses?,freq_cnv_loss_or_gain
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the rate of PIK3C2B LOH in Breast Invasive Carcinoma diagnoses?,freq_cnv_loss_or_gain
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the rate of PIK3C2B LOH in Breast Invasive Carcinoma diagnoses?,freq_cnv_loss_or_gain
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the rate of ZNF804A LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the rate of RELN LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of EFCAB12 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",freq_cnv_loss_or_gain
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of EFCAB12 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",freq_cnv_loss_or_gain
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the rate of DEFB115 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the rate of ANKDD1A LOH in Bladder Urothelial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the rate of ANKDD1A LOH in Bladder Urothelial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the rate of ANKDD1A LOH in Bladder Urothelial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the rate of HTR3B LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the rate of HTR3B LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the rate of HTR3B LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the rate of ABCC3 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the rate of NOMO1 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the rate of NOMO1 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the rate of HYOU1 LOH in Bladder Urothelial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the rate of FMO4 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+140,BICC1,A372V,Exceptional Responders,What is the rate of BICC1 LOH in Exceptional Responders diagnoses?,freq_cnv_loss_or_gain
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the rate of ZMYM3 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the rate of ZMYM3 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the rate of ZMYM3 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of XKR4 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",freq_cnv_loss_or_gain
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the rate of ABCC2 LOH in Liver Hepatocellular Carcinoma diagnoses?,freq_cnv_loss_or_gain
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the rate of OR8K5 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the rate of SPTAN1 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the rate of SPTAN1 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the rate of SYT10 LOH in Rectum Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the rate of HSPA5 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the rate of UNC5D LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the rate of UNC5D LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the rate of UNC5D LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the rate of UNC5D LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the rate of UNC5D LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the rate of UNC5D LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the rate of DOCK2 LOH in Kidney Renal Clear Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the rate of ZNF627 LOH in Kidney Renal Clear Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the rate of CDC42BPA LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the rate of MRPL55 LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the rate of MRPL55 LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the rate of TMTC3 LOH in Breast Invasive Carcinoma diagnoses?,freq_cnv_loss_or_gain
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the rate of EPRS1 LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the rate of EPRS1 LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the rate of GRTP1 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the rate of GRTP1 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the rate of TSHZ3 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the rate of TAS1R3 LOH in HIV+ Tumor Molecular Characterization Project - Cervical Cancer diagnoses?,freq_cnv_loss_or_gain
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the rate of PIAS3 LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the rate of PIAS3 LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the rate of ZNF274 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the rate of SYNJ1 LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the rate of SYNJ1 LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the rate of SYNJ1 LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the rate of DSCAM LOH in Prostate Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the rate of DSCAM LOH in Prostate Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the rate of DSCAM LOH in Prostate Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+267,DGKD,R140H,Exceptional Responders,What is the rate of DGKD LOH in Exceptional Responders diagnoses?,freq_cnv_loss_or_gain
+268,DGKD,R160H,Exceptional Responders,What is the rate of DGKD LOH in Exceptional Responders diagnoses?,freq_cnv_loss_or_gain
+269,DGKD,R204H,Exceptional Responders,What is the rate of DGKD LOH in Exceptional Responders diagnoses?,freq_cnv_loss_or_gain
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the rate of PLEKHG6 LOH in Bladder Urothelial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the rate of PLEKHG6 LOH in Bladder Urothelial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the rate of PLEKHG6 LOH in Bladder Urothelial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the rate of WNT2 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the rate of GUCY2C LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the rate of C7orf31 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of ZKSCAN7 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",freq_cnv_loss_or_gain
+299,OR5D14,M210L,Neuroblastoma,What is the rate of OR5D14 LOH in Neuroblastoma diagnoses?,freq_cnv_loss_or_gain
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the rate of SPATA22 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the rate of SPATA22 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the rate of SPATA22 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the rate of LCN15 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the rate of DCAF4L2 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the rate of GUK1 LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the rate of GUK1 LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the rate of GUK1 LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the rate of GUK1 LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the rate of GUK1 LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the rate of MORF4L1 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the rate of MORF4L1 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the rate of MORF4L1 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the rate of MORF4L1 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the rate of MYO3B LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the rate of MYO3B LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the rate of TENT5A LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the rate of TENT5A LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the rate of TENT5A LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the rate of ZFAT LOH in Ovarian Serous Cystadenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the rate of ZFAT LOH in Ovarian Serous Cystadenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the rate of ZFAT LOH in Ovarian Serous Cystadenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+357,ZNF584,A211T,Sarcoma,What is the rate of ZNF584 LOH in Sarcoma diagnoses?,freq_cnv_loss_or_gain
+358,ZNF584,A256T,Sarcoma,What is the rate of ZNF584 LOH in Sarcoma diagnoses?,freq_cnv_loss_or_gain
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the rate of LDOC1 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the rate of PDGFC LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the rate of MSANTD4 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the rate of NPSR1 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the rate of PHLPP1 LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the rate of COL6A3 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the rate of COL6A3 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the rate of COL6A3 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the rate of COL6A3 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the rate of COL6A3 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the rate of ADRA1A LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of LAMB2 LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the rate of POC1B LOH in Rectum Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the rate of POC1B LOH in Rectum Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the rate of POC1B LOH in Rectum Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the rate of POC1B LOH in Rectum Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the rate of USH2A LOH in Liver Hepatocellular Carcinoma diagnoses?,freq_cnv_loss_or_gain
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the rate of AQP7 LOH in Rectum Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the rate of AQP7 LOH in Rectum Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the rate of AQP7 LOH in Rectum Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the rate of AQP7 LOH in Rectum Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+430,DCN,R163C,Rectum Adenocarcinoma,What is the rate of DCN LOH in Rectum Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+431,DCN,R203C,Rectum Adenocarcinoma,What is the rate of DCN LOH in Rectum Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+432,DCN,R241C,Rectum Adenocarcinoma,What is the rate of DCN LOH in Rectum Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+433,DCN,R350C,Rectum Adenocarcinoma,What is the rate of DCN LOH in Rectum Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+434,DCN,R41C,Rectum Adenocarcinoma,What is the rate of DCN LOH in Rectum Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the rate of CPS1 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the rate of CPS1 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the rate of CPS1 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the rate of FCGR2C LOH in Kidney Renal Papillary Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the rate of FCGR2C LOH in Kidney Renal Papillary Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the rate of GRM1 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the rate of SGCZ LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the rate of SGCZ LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+485,SMO,V15M,Stomach Adenocarcinoma,What is the rate of SMO LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+486,SMO,V321M,Stomach Adenocarcinoma,What is the rate of SMO LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the rate of CHODL LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the rate of CHODL LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the rate of CHODL LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+494,MYO16,P399H,Colon Adenocarcinoma,What is the rate of MYO16 LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+495,MYO16,P421H,Colon Adenocarcinoma,What is the rate of MYO16 LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the rate of CXCR2 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the rate of TMEM225 LOH in Bladder Urothelial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the rate of MAOB LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the rate of GPRASP1 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the rate of MRPL32 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the rate of TYROBP LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the rate of RAB40C LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the rate of RAB40C LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the rate of CTNNA2 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the rate of CTNNA2 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the rate of CTNNA2 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the rate of CTNNA2 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the rate of MYO15A LOH in Bladder Urothelial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the rate of GIMAP2 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the rate of KIF20B LOH in Glioblastoma Multiforme diagnoses?,freq_cnv_loss_or_gain
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the rate of KIF20B LOH in Glioblastoma Multiforme diagnoses?,freq_cnv_loss_or_gain
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the rate of ADAM17 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the rate of BCAT1 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the rate of BCAT1 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the rate of BCAT1 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the rate of ERCC6 LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+541,DCC,R320W,Breast Invasive Carcinoma,What is the rate of DCC LOH in Breast Invasive Carcinoma diagnoses?,freq_cnv_loss_or_gain
+542,DCC,R363W,Breast Invasive Carcinoma,What is the rate of DCC LOH in Breast Invasive Carcinoma diagnoses?,freq_cnv_loss_or_gain
+543,DCC,R386W,Breast Invasive Carcinoma,What is the rate of DCC LOH in Breast Invasive Carcinoma diagnoses?,freq_cnv_loss_or_gain
+544,DCC,R41W,Breast Invasive Carcinoma,What is the rate of DCC LOH in Breast Invasive Carcinoma diagnoses?,freq_cnv_loss_or_gain
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the rate of FBXO15 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the rate of FBXO15 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the rate of GSTCD LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the rate of GSTCD LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the rate of OLFML3 LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the rate of OLFML3 LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the rate of OLFML3 LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the rate of CFAP61 LOH in Ovarian Serous Cystadenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the rate of CFAP61 LOH in Ovarian Serous Cystadenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the rate of HLA-DQA2 LOH in Bladder Urothelial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the rate of TENM2 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the rate of TENM2 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the rate of TENM2 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the rate of ANKRD24 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the rate of ANKRD24 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the rate of ANKRD24 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the rate of ZCCHC14 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the rate of ZCCHC14 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the rate of ZCCHC14 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the rate of ZCCHC14 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+625,SIK2,I265M,Lung Adenocarcinoma,What is the rate of SIK2 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the rate of MYH11 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the rate of MYH11 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the rate of SLC6A4 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the rate of SLC9C1 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the rate of SLC9C1 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the rate of OR2A12 LOH in Brain Lower Grade Glioma diagnoses?,freq_cnv_loss_or_gain
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the rate of PYHIN1 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the rate of PYHIN1 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the rate of JAML LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the rate of JAML LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the rate of JAML LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the rate of JAML LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the rate of TYK2 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the rate of TYK2 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the rate of TYK2 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the rate of CTCFL LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the rate of CTCFL LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the rate of CTCFL LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the rate of CTCFL LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the rate of CEP20 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the rate of CEP20 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the rate of RIMS2 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the rate of RIMS2 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the rate of RIMS2 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the rate of RIMS2 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the rate of RIMS2 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the rate of RIMS2 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the rate of RIMS2 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the rate of PIK3C2G LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the rate of PIK3C2G LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+728,STK19,D341N,Colon Adenocarcinoma,What is the rate of STK19 LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+729,STK19,D345N,Colon Adenocarcinoma,What is the rate of STK19 LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the rate of REXO4 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the rate of ZBTB34 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the rate of ZBTB34 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the rate of NCKAP5 LOH in Bladder Urothelial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of SORCS1 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",freq_cnv_loss_or_gain
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of SORCS1 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",freq_cnv_loss_or_gain
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of SORCS1 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",freq_cnv_loss_or_gain
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of SORCS1 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",freq_cnv_loss_or_gain
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the rate of FGF8 LOH in Head and Neck Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the rate of FGF8 LOH in Head and Neck Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the rate of FGF8 LOH in Head and Neck Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the rate of FGF8 LOH in Head and Neck Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the rate of FGF8 LOH in Head and Neck Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the rate of TENM3 LOH in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia diagnoses?,freq_cnv_loss_or_gain
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the rate of AKT1 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of CFAP298-TCP10L LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the rate of GLRB LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+793,TTN,F7636L,Colon Adenocarcinoma,What is the rate of TTN LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+794,TTN,F8563L,Colon Adenocarcinoma,What is the rate of TTN LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+795,TTN,F8880L,Colon Adenocarcinoma,What is the rate of TTN LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the rate of ANKRD30A LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the rate of ANKRD30A LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the rate of ANKRD30A LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the rate of TRIM45 LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the rate of TRIM45 LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the rate of TRIM45 LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the rate of CACNA1F LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the rate of CACNA1F LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the rate of CACNA1F LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+817,KL,R594C,Colon Adenocarcinoma,What is the rate of KL LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the rate of GUF1 LOH in Kidney Renal Papillary Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the rate of TAF1L LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the rate of TASOR2 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the rate of TASOR2 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the rate of TASOR2 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the rate of KDM5C LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the rate of KDM5C LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the rate of KDM5C LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the rate of KDM5C LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of IL5RA LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the rate of DHX16 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the rate of DHX16 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the rate of GPR158 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the rate of GPR158 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of EIF2B4 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",freq_cnv_loss_or_gain
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of EIF2B4 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",freq_cnv_loss_or_gain
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of EIF2B4 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",freq_cnv_loss_or_gain
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of EIF2B4 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",freq_cnv_loss_or_gain
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of EIF2B4 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",freq_cnv_loss_or_gain
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of EIF2B4 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",freq_cnv_loss_or_gain
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the rate of AUTS2 LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the rate of AUTS2 LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the rate of AUTS2 LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the rate of AUTS2 LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the rate of AUTS2 LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the rate of AUTS2 LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the rate of AUTS2 LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the rate of AUTS2 LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the rate of AUTS2 LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the rate of AUTS2 LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of ACTL7B LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",freq_cnv_loss_or_gain
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the rate of PCDHGA1 LOH in Glioblastoma Multiforme diagnoses?,freq_cnv_loss_or_gain
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the rate of TRAP1 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the rate of TRAP1 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the rate of PIK3C2A LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the rate of KANSL1 LOH in Liver Hepatocellular Carcinoma diagnoses?,freq_cnv_loss_or_gain
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the rate of ANKRD52 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the rate of PAPPA LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the rate of B3GALNT1 LOH in Rectum Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the rate of GABRA6 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the rate of GABRA6 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the rate of GABRA6 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the rate of GABRA6 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the rate of GABRA6 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the rate of ZSCAN31 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of MED16 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",freq_cnv_loss_or_gain
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of MED16 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",freq_cnv_loss_or_gain
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the rate of PTPRO LOH in Pancreatic Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the rate of PTPRO LOH in Pancreatic Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the rate of PTPRO LOH in Pancreatic Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the rate of PTPRO LOH in Pancreatic Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the rate of PTPRO LOH in Pancreatic Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the rate of PTPRO LOH in Pancreatic Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the rate of PTPRO LOH in Pancreatic Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the rate of PTPRO LOH in Pancreatic Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the rate of CHMP7 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the rate of GPC3 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the rate of GPC3 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of TLK2 LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of TLK2 LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of TLK2 LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of TLK2 LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of TLK2 LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the rate of ZNF217 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the rate of SYT9 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the rate of SYT9 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the rate of PKHD1L1 LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the rate of MYO3A LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of VASN LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",freq_cnv_loss_or_gain
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the rate of DNMT1 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the rate of DNMT1 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the rate of DNMT1 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1056,CA9,E402K,Colon Adenocarcinoma,What is the rate of CA9 LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the rate of TTC17 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the rate of TTC17 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the rate of PSG2 LOH in Breast Invasive Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the rate of RIPOR2 LOH in Breast Invasive Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the rate of RIPOR2 LOH in Breast Invasive Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the rate of RIPOR2 LOH in Breast Invasive Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the rate of RIPOR2 LOH in Breast Invasive Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the rate of DCLK3 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the rate of DCLK3 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the rate of MERTK LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the rate of MERTK LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the rate of MERTK LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the rate of ZFP42 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the rate of OR13C3 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the rate of OR13C3 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the rate of SPAG1 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the rate of CDKN2AIP LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the rate of PXN LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the rate of PXN LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the rate of PXN LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the rate of PXN LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the rate of PXN LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the rate of PXN LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the rate of TTYH2 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the rate of TTYH2 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the rate of TMEM255A LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the rate of TMEM255A LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the rate of TMEM255A LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the rate of TASOR2 LOH in Breast Invasive Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the rate of TASOR2 LOH in Breast Invasive Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the rate of ICE1 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the rate of MYT1 LOH in Breast Invasive Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the rate of MYT1 LOH in Breast Invasive Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the rate of MYT1 LOH in Breast Invasive Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the rate of CX3CR1 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the rate of CX3CR1 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the rate of SPINDOC LOH in Liver Hepatocellular Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the rate of ART3 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the rate of ART3 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the rate of CYP1A2 LOH in Bladder Urothelial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of ADRA1A LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",freq_cnv_loss_or_gain
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the rate of CDH23 LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the rate of CDH23 LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the rate of KRT39 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the rate of PDHA2 LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the rate of SLC24A2 LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the rate of PTPRN2 LOH in Liver Hepatocellular Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the rate of PTPRN2 LOH in Liver Hepatocellular Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the rate of PTPRN2 LOH in Liver Hepatocellular Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the rate of PTPRN2 LOH in Liver Hepatocellular Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the rate of PTPRN2 LOH in Liver Hepatocellular Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the rate of SOX21 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the rate of CPA6 LOH in Bladder Urothelial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the rate of GRM5 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of CASZ1 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",freq_cnv_loss_or_gain
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the rate of SGIP1 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the rate of SGIP1 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the rate of SGIP1 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the rate of SGIP1 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the rate of CARMIL1 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the rate of CARMIL1 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the rate of ZNF431 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the rate of ZNF431 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the rate of ZNF431 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the rate of DNAH11 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the rate of DNAH11 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the rate of POLD1 LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the rate of POLD1 LOH in Lung Squamous Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the rate of TTC12 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the rate of TTC12 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the rate of CNGB1 LOH in Bladder Urothelial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the rate of CNGB1 LOH in Bladder Urothelial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the rate of CTSC LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the rate of CTSC LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the rate of CTSC LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the rate of CTSC LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the rate of CTSC LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the rate of PRSS8 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the rate of PRSS8 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the rate of ARHGEF40 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the rate of ACTB LOH in Rectum Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the rate of ACTB LOH in Rectum Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the rate of ACTB LOH in Rectum Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the rate of ACTB LOH in Rectum Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the rate of YY1AP1 LOH in Glioblastoma Multiforme diagnoses?,freq_cnv_loss_or_gain
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the rate of YY1AP1 LOH in Glioblastoma Multiforme diagnoses?,freq_cnv_loss_or_gain
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the rate of YY1AP1 LOH in Glioblastoma Multiforme diagnoses?,freq_cnv_loss_or_gain
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the rate of YY1AP1 LOH in Glioblastoma Multiforme diagnoses?,freq_cnv_loss_or_gain
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the rate of YY1AP1 LOH in Glioblastoma Multiforme diagnoses?,freq_cnv_loss_or_gain
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the rate of YY1AP1 LOH in Glioblastoma Multiforme diagnoses?,freq_cnv_loss_or_gain
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the rate of YY1AP1 LOH in Glioblastoma Multiforme diagnoses?,freq_cnv_loss_or_gain
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the rate of FNDC7 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the rate of FNDC7 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the rate of TLCD5 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the rate of TLCD5 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the rate of POLR1G LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the rate of POLR1G LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the rate of DNAH14 LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the rate of DNAH14 LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the rate of DNAH14 LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the rate of NEXN LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the rate of CYB5R2 LOH in Prostate Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the rate of CYB5R2 LOH in Prostate Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the rate of NRAP LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the rate of NRAP LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the rate of NRAP LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the rate of CCDC22 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the rate of DCAF6 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the rate of DCAF6 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the rate of ZNF708 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the rate of BFAR LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the rate of MAST4 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the rate of MAST4 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the rate of MAST4 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the rate of MAST4 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the rate of MAST4 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the rate of ARMC3 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the rate of ARMC3 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the rate of TET2 LOH in Kidney Renal Clear Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the rate of TET2 LOH in Kidney Renal Clear Cell Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the rate of SERPINB10 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the rate of STAT3 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the rate of MIEF1 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the rate of ACVR1B LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the rate of ACVR1B LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the rate of ACVR1B LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the rate of EBF2 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the rate of EBF2 LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the rate of VPS26B LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of PGR LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",freq_cnv_loss_or_gain
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of PGR LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",freq_cnv_loss_or_gain
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of PGR LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus diagnoses?",freq_cnv_loss_or_gain
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the rate of ACTA2 LOH in Skin Cutaneous Melanoma diagnoses?,freq_cnv_loss_or_gain
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the rate of THBS4 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the rate of THBS4 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the rate of PRSS1 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the rate of PRSS1 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the rate of PRSS1 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the rate of PRSS1 LOH in Lung Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the rate of PGF LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the rate of PGF LOH in Stomach Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the rate of ITPRID2 LOH in Breast Invasive Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the rate of ITPRID2 LOH in Breast Invasive Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the rate of HBB LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the rate of PCDHB2 LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the rate of PCDHB2 LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the rate of PCDHB2 LOH in Colon Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the rate of UBR2 LOH in Uterine Corpus Endometrial Carcinoma diagnoses?,freq_cnv_loss_or_gain
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the rate of FBXO42 LOH in Rectum Adenocarcinoma diagnoses?,freq_cnv_loss_or_gain
+1,TNS1,G1362V,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of PXN gain?",freq_cnv_loss_or_gain
+2,TNS1,G1711V,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of ZNF584 gain?",freq_cnv_loss_or_gain
+3,TNS1,G1718V,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of ANKRD24 gain?",freq_cnv_loss_or_gain
+4,TNS1,G1732V,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of GSTCD gain?",freq_cnv_loss_or_gain
+5,TNS1,G1824V,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of AUTS2 gain?",freq_cnv_loss_or_gain
+6,TNS1,G1857V,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of TENM2 gain?",freq_cnv_loss_or_gain
+7,TNS1,G843V,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of SLC24A2 gain?",freq_cnv_loss_or_gain
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of PCDHB2 gain?",freq_cnv_loss_or_gain
+15,EVC2,E987K,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of MAST4 gain?",freq_cnv_loss_or_gain
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of PTPRO gain?",freq_cnv_loss_or_gain
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of DSCAM gain?",freq_cnv_loss_or_gain
+22,TRPA1,S295I,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of ZCCHC14 gain?",freq_cnv_loss_or_gain
+23,TRPA1,S443I,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of CDH23 gain?",freq_cnv_loss_or_gain
+24,TAF1C,R299L,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of NPSR1 gain?",freq_cnv_loss_or_gain
+25,TAF1C,R396L,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of EIF2B4 gain?",freq_cnv_loss_or_gain
+26,TAF1C,R634L,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of FMO4 gain?",freq_cnv_loss_or_gain
+27,TAF1C,R702L,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of CTNNA2 gain?",freq_cnv_loss_or_gain
+28,TAF1C,R728L,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of USH2A gain?",freq_cnv_loss_or_gain
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of EIF2B4 gain?",freq_cnv_loss_or_gain
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of DCAF6 gain?",freq_cnv_loss_or_gain
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of JAML gain?",freq_cnv_loss_or_gain
+42,OR2T4,P272H,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of POLD1 gain?",freq_cnv_loss_or_gain
+43,OR2T4,P300H,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of TRIM45 gain?",freq_cnv_loss_or_gain
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,"Among Pancreatic Adenocarcinoma patients, what is the frequency of MRPL32 gain?",freq_cnv_loss_or_gain
+45,MAD1L1,E396K,Prostate Adenocarcinoma,"Among Prostate Adenocarcinoma patients, what is the frequency of GIMAP2 gain?",freq_cnv_loss_or_gain
+46,MAD1L1,E488K,Prostate Adenocarcinoma,"Among Prostate Adenocarcinoma patients, what is the frequency of POC1B gain?",freq_cnv_loss_or_gain
+47,MAD1L1,E78K,Prostate Adenocarcinoma,"Among Prostate Adenocarcinoma patients, what is the frequency of TMTC3 gain?",freq_cnv_loss_or_gain
+61,CCNG1,E22K,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of TNS1 gain?",freq_cnv_loss_or_gain
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,"Among Kidney Renal Papillary Cell Carcinoma patients, what is the frequency of ANKRD30A gain?",freq_cnv_loss_or_gain
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,"Among Kidney Renal Papillary Cell Carcinoma patients, what is the frequency of TYK2 gain?",freq_cnv_loss_or_gain
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,"Among Kidney Renal Papillary Cell Carcinoma patients, what is the frequency of JAML gain?",freq_cnv_loss_or_gain
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,"Among Kidney Renal Papillary Cell Carcinoma patients, what is the frequency of KIF20B gain?",freq_cnv_loss_or_gain
+66,FRY,S1888A,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of PGR gain?",freq_cnv_loss_or_gain
+67,FRY,S1937A,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of SYT9 gain?",freq_cnv_loss_or_gain
+68,FRY,S1938A,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of ZCCHC14 gain?",freq_cnv_loss_or_gain
+69,FRY,S1983A,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of DNAH11 gain?",freq_cnv_loss_or_gain
+70,PAK3,E318K,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of MAST4 gain?",freq_cnv_loss_or_gain
+71,PAK3,E319K,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of TAF1C gain?",freq_cnv_loss_or_gain
+72,PAK3,E334K,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of TNS1 gain?",freq_cnv_loss_or_gain
+73,PAK3,E340K,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of PCDHB2 gain?",freq_cnv_loss_or_gain
+74,PAK3,E355K,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of PTPRO gain?",freq_cnv_loss_or_gain
+80,MUC16,P7963L,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of CR1 gain?",freq_cnv_loss_or_gain
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,"Among Liver Hepatocellular Carcinoma patients, what is the frequency of COL6A3 gain?",freq_cnv_loss_or_gain
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,"Among Liver Hepatocellular Carcinoma patients, what is the frequency of PGF gain?",freq_cnv_loss_or_gain
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of NRAP gain?",freq_cnv_loss_or_gain
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of FNDC7 gain?",freq_cnv_loss_or_gain
+114,ZNF804A,S371Y,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of SPTAN1 gain?",freq_cnv_loss_or_gain
+116,RELN,A2371V,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of GUK1 gain?",freq_cnv_loss_or_gain
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of PTPRN2 gain?",freq_cnv_loss_or_gain
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of TYROBP gain?",freq_cnv_loss_or_gain
+120,DEFB115,E53K,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of DCN gain?",freq_cnv_loss_or_gain
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of OR8K5 gain?",freq_cnv_loss_or_gain
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of DPF3 gain?",freq_cnv_loss_or_gain
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of SLC24A2 gain?",freq_cnv_loss_or_gain
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of PXN gain?",freq_cnv_loss_or_gain
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of MERTK gain?",freq_cnv_loss_or_gain
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of WNT2 gain?",freq_cnv_loss_or_gain
+129,ABCC3,R758W,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of CHMP7 gain?",freq_cnv_loss_or_gain
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of FGF8 gain?",freq_cnv_loss_or_gain
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of TRPA1 gain?",freq_cnv_loss_or_gain
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of ZNF217 gain?",freq_cnv_loss_or_gain
+139,FMO4,R500Q,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of YY1AP1 gain?",freq_cnv_loss_or_gain
+140,BICC1,A372V,Exceptional Responders,"Among Exceptional Responders patients, what is the frequency of DPF3 gain?",freq_cnv_loss_or_gain
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of PGR gain?",freq_cnv_loss_or_gain
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of PRSS1 gain?",freq_cnv_loss_or_gain
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of NRAP gain?",freq_cnv_loss_or_gain
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of ANKRD30A gain?",freq_cnv_loss_or_gain
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,"Among Liver Hepatocellular Carcinoma patients, what is the frequency of ZNF274 gain?",freq_cnv_loss_or_gain
+157,OR8K5,R293G,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of EIF2B4 gain?",freq_cnv_loss_or_gain
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of GRTP1 gain?",freq_cnv_loss_or_gain
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of GPC3 gain?",freq_cnv_loss_or_gain
+164,SYT10,M484I,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of IL5RA gain?",freq_cnv_loss_or_gain
+174,HSPA5,N457K,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of JAML gain?",freq_cnv_loss_or_gain
+175,UNC5D,L280V,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of YY1AP1 gain?",freq_cnv_loss_or_gain
+176,UNC5D,L635V,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of PKHD1L1 gain?",freq_cnv_loss_or_gain
+177,UNC5D,L637V,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of PRSS1 gain?",freq_cnv_loss_or_gain
+178,UNC5D,L699V,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of HTR3B gain?",freq_cnv_loss_or_gain
+179,UNC5D,L704V,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of COL6A3 gain?",freq_cnv_loss_or_gain
+180,UNC5D,L709V,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of PXN gain?",freq_cnv_loss_or_gain
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,"Among Kidney Renal Clear Cell Carcinoma patients, what is the frequency of ANP32E gain?",freq_cnv_loss_or_gain
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,"Among Kidney Renal Clear Cell Carcinoma patients, what is the frequency of SOX21 gain?",freq_cnv_loss_or_gain
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of CTSC gain?",freq_cnv_loss_or_gain
+193,MRPL55,H27Y,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of PLEKHG6 gain?",freq_cnv_loss_or_gain
+194,MRPL55,H63Y,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of MAD1L1 gain?",freq_cnv_loss_or_gain
+197,TMTC3,Q749K,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of MAST4 gain?",freq_cnv_loss_or_gain
+198,EPRS1,K771I,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of SPINDOC gain?",freq_cnv_loss_or_gain
+199,EPRS1,K778I,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of TMEM255A gain?",freq_cnv_loss_or_gain
+201,GRTP1,A110V,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of ANKDD1A gain?",freq_cnv_loss_or_gain
+202,GRTP1,A32V,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of ZMYM3 gain?",freq_cnv_loss_or_gain
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of ADRA1A gain?",freq_cnv_loss_or_gain
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,"Among HIV+ Tumor Molecular Characterization Project - Cervical Cancer patients, what is the frequency of KL gain?",freq_cnv_loss_or_gain
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of ITPRID2 gain?",freq_cnv_loss_or_gain
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of ZCCHC14 gain?",freq_cnv_loss_or_gain
+251,ZNF274,P13R,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of CPS1 gain?",freq_cnv_loss_or_gain
+253,SYNJ1,R795C,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of DCAF6 gain?",freq_cnv_loss_or_gain
+254,SYNJ1,R800C,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of SPATA22 gain?",freq_cnv_loss_or_gain
+255,SYNJ1,R839C,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of UNC5D gain?",freq_cnv_loss_or_gain
+261,DSCAM,V343M,Prostate Adenocarcinoma,"Among Prostate Adenocarcinoma patients, what is the frequency of HTR3B gain?",freq_cnv_loss_or_gain
+262,DSCAM,V426M,Prostate Adenocarcinoma,"Among Prostate Adenocarcinoma patients, what is the frequency of JAML gain?",freq_cnv_loss_or_gain
+263,DSCAM,V591M,Prostate Adenocarcinoma,"Among Prostate Adenocarcinoma patients, what is the frequency of HTR3B gain?",freq_cnv_loss_or_gain
+267,DGKD,R140H,Exceptional Responders,"Among Exceptional Responders patients, what is the frequency of FNDC7 gain?",freq_cnv_loss_or_gain
+268,DGKD,R160H,Exceptional Responders,"Among Exceptional Responders patients, what is the frequency of DCC gain?",freq_cnv_loss_or_gain
+269,DGKD,R204H,Exceptional Responders,"Among Exceptional Responders patients, what is the frequency of ZFAT gain?",freq_cnv_loss_or_gain
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of B3GALNT1 gain?",freq_cnv_loss_or_gain
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of SGIP1 gain?",freq_cnv_loss_or_gain
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of SMO gain?",freq_cnv_loss_or_gain
+279,WNT2,D138N,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of TMEM255A gain?",freq_cnv_loss_or_gain
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of NEXN gain?",freq_cnv_loss_or_gain
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of PAK3 gain?",freq_cnv_loss_or_gain
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of RIPOR2 gain?",freq_cnv_loss_or_gain
+299,OR5D14,M210L,Neuroblastoma,"Among Neuroblastoma patients, what is the frequency of ACTL7B gain?",freq_cnv_loss_or_gain
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of SORCS1 gain?",freq_cnv_loss_or_gain
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of LAMB2 gain?",freq_cnv_loss_or_gain
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of TNS1 gain?",freq_cnv_loss_or_gain
+310,LCN15,E21V,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of COL6A3 gain?",freq_cnv_loss_or_gain
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of TTC17 gain?",freq_cnv_loss_or_gain
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of EIF2B4 gain?",freq_cnv_loss_or_gain
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of FRY gain?",freq_cnv_loss_or_gain
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of PIK3C2G gain?",freq_cnv_loss_or_gain
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of TLCD5 gain?",freq_cnv_loss_or_gain
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of JAML gain?",freq_cnv_loss_or_gain
+328,MORF4L1,K29T,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of SORCS1 gain?",freq_cnv_loss_or_gain
+329,MORF4L1,K51T,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of PAK3 gain?",freq_cnv_loss_or_gain
+330,MORF4L1,K61T,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of GABRA6 gain?",freq_cnv_loss_or_gain
+331,MORF4L1,K76T,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of MIEF1 gain?",freq_cnv_loss_or_gain
+335,MYO3B,F594L,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of B3GALNT1 gain?",freq_cnv_loss_or_gain
+336,MYO3B,F603L,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of MERTK gain?",freq_cnv_loss_or_gain
+339,TENT5A,S320F,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of TNS1 gain?",freq_cnv_loss_or_gain
+340,TENT5A,S339F,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of SPTAN1 gain?",freq_cnv_loss_or_gain
+341,TENT5A,S401F,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of POLD1 gain?",freq_cnv_loss_or_gain
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,"Among Ovarian Serous Cystadenocarcinoma patients, what is the frequency of COL6A3 gain?",freq_cnv_loss_or_gain
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,"Among Ovarian Serous Cystadenocarcinoma patients, what is the frequency of DOCK2 gain?",freq_cnv_loss_or_gain
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,"Among Ovarian Serous Cystadenocarcinoma patients, what is the frequency of SPATA22 gain?",freq_cnv_loss_or_gain
+357,ZNF584,A211T,Sarcoma,"Among Sarcoma patients, what is the frequency of AUTS2 gain?",freq_cnv_loss_or_gain
+358,ZNF584,A256T,Sarcoma,"Among Sarcoma patients, what is the frequency of CASZ1 gain?",freq_cnv_loss_or_gain
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of FBXO15 gain?",freq_cnv_loss_or_gain
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of BFAR gain?",freq_cnv_loss_or_gain
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of PLEKHG6 gain?",freq_cnv_loss_or_gain
+374,NPSR1,S123L,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of EIF2B4 gain?",freq_cnv_loss_or_gain
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of PGR gain?",freq_cnv_loss_or_gain
+385,COL6A3,G237S,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of SORCS1 gain?",freq_cnv_loss_or_gain
+386,COL6A3,G437S,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of CDC42BPA gain?",freq_cnv_loss_or_gain
+387,COL6A3,G638S,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of AQP7 gain?",freq_cnv_loss_or_gain
+388,COL6A3,G644S,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of XKR4 gain?",freq_cnv_loss_or_gain
+389,COL6A3,G844S,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of YY1AP1 gain?",freq_cnv_loss_or_gain
+395,ADRA1A,R348G,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of MYO3B gain?",freq_cnv_loss_or_gain
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"Among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients, what is the frequency of CCDC22 gain?",freq_cnv_loss_or_gain
+406,POC1B,I198T,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of POC1B gain?",freq_cnv_loss_or_gain
+407,POC1B,I286T,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of FCGR2C gain?",freq_cnv_loss_or_gain
+408,POC1B,I328T,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of CYB5R2 gain?",freq_cnv_loss_or_gain
+409,POC1B,S79P,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of CTNNA2 gain?",freq_cnv_loss_or_gain
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,"Among Liver Hepatocellular Carcinoma patients, what is the frequency of TLK2 gain?",freq_cnv_loss_or_gain
+414,AQP7,T110S,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of EIF2B4 gain?",freq_cnv_loss_or_gain
+415,AQP7,T166S,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of FBXO15 gain?",freq_cnv_loss_or_gain
+416,AQP7,T167S,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of OLFML3 gain?",freq_cnv_loss_or_gain
+417,AQP7,T75S,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of ZNF217 gain?",freq_cnv_loss_or_gain
+430,DCN,R163C,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of SIK2 gain?",freq_cnv_loss_or_gain
+431,DCN,R203C,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of ANKDD1A gain?",freq_cnv_loss_or_gain
+432,DCN,R241C,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of TTC12 gain?",freq_cnv_loss_or_gain
+433,DCN,R350C,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of TNS1 gain?",freq_cnv_loss_or_gain
+434,DCN,R41C,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of SPATA22 gain?",freq_cnv_loss_or_gain
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of UNC5D gain?",freq_cnv_loss_or_gain
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of TRPA1 gain?",freq_cnv_loss_or_gain
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of MYO3B gain?",freq_cnv_loss_or_gain
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,"Among Kidney Renal Papillary Cell Carcinoma patients, what is the frequency of ITPRID2 gain?",freq_cnv_loss_or_gain
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,"Among Kidney Renal Papillary Cell Carcinoma patients, what is the frequency of ACTA2 gain?",freq_cnv_loss_or_gain
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of TAF1C gain?",freq_cnv_loss_or_gain
+482,SGCZ,Q138H,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of CTNNA2 gain?",freq_cnv_loss_or_gain
+483,SGCZ,Q91H,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of TLK2 gain?",freq_cnv_loss_or_gain
+485,SMO,V15M,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of STAT3 gain?",freq_cnv_loss_or_gain
+486,SMO,V321M,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of PHLPP1 gain?",freq_cnv_loss_or_gain
+488,CHODL,G159E,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of HSPA5 gain?",freq_cnv_loss_or_gain
+489,CHODL,G181E,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of OR8K5 gain?",freq_cnv_loss_or_gain
+490,CHODL,G200E,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of ZNF431 gain?",freq_cnv_loss_or_gain
+494,MYO16,P399H,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of FNDC7 gain?",freq_cnv_loss_or_gain
+495,MYO16,P421H,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of DCC gain?",freq_cnv_loss_or_gain
+498,CXCR2,A98V,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of EIF2B4 gain?",freq_cnv_loss_or_gain
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of SGIP1 gain?",freq_cnv_loss_or_gain
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of TLK2 gain?",freq_cnv_loss_or_gain
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of FGF8 gain?",freq_cnv_loss_or_gain
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of MYO15A gain?",freq_cnv_loss_or_gain
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of EIF2B4 gain?",freq_cnv_loss_or_gain
+510,RAB40C,A111V,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of CDH23 gain?",freq_cnv_loss_or_gain
+511,RAB40C,A143V,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of UNC5D gain?",freq_cnv_loss_or_gain
+512,CTNNA2,S323R,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of MRPL55 gain?",freq_cnv_loss_or_gain
+513,CTNNA2,S339R,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of HLA-DQA2 gain?",freq_cnv_loss_or_gain
+514,CTNNA2,S386R,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of MYH11 gain?",freq_cnv_loss_or_gain
+515,CTNNA2,S707R,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of ANKRD30A gain?",freq_cnv_loss_or_gain
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of THBS4 gain?",freq_cnv_loss_or_gain
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of MYO3B gain?",freq_cnv_loss_or_gain
+532,KIF20B,N1160D,Glioblastoma Multiforme,"Among Glioblastoma Multiforme patients, what is the frequency of CASZ1 gain?",freq_cnv_loss_or_gain
+533,KIF20B,N1200D,Glioblastoma Multiforme,"Among Glioblastoma Multiforme patients, what is the frequency of TMEM255A gain?",freq_cnv_loss_or_gain
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of CPA6 gain?",freq_cnv_loss_or_gain
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of CHODL gain?",freq_cnv_loss_or_gain
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of TMEM255A gain?",freq_cnv_loss_or_gain
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of COL6A3 gain?",freq_cnv_loss_or_gain
+540,ERCC6,R1053H,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of ICE1 gain?",freq_cnv_loss_or_gain
+541,DCC,R320W,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of OR13C3 gain?",freq_cnv_loss_or_gain
+542,DCC,R363W,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of MERTK gain?",freq_cnv_loss_or_gain
+543,DCC,R386W,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of KIF20B gain?",freq_cnv_loss_or_gain
+544,DCC,R41W,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of ZNF431 gain?",freq_cnv_loss_or_gain
+549,FBXO15,D417N,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of PLEKHG6 gain?",freq_cnv_loss_or_gain
+550,FBXO15,D86N,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of ACVR1B gain?",freq_cnv_loss_or_gain
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of DNMT1 gain?",freq_cnv_loss_or_gain
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of FGF8 gain?",freq_cnv_loss_or_gain
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of SPAG1 gain?",freq_cnv_loss_or_gain
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of DCAF6 gain?",freq_cnv_loss_or_gain
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of FBN1 gain?",freq_cnv_loss_or_gain
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,"Among Ovarian Serous Cystadenocarcinoma patients, what is the frequency of XKR4 gain?",freq_cnv_loss_or_gain
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,"Among Ovarian Serous Cystadenocarcinoma patients, what is the frequency of HYOU1 gain?",freq_cnv_loss_or_gain
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of SYT10 gain?",freq_cnv_loss_or_gain
+582,TENM2,H240Y,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of JAML gain?",freq_cnv_loss_or_gain
+583,TENM2,H351Y,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of ARMC3 gain?",freq_cnv_loss_or_gain
+584,TENM2,H472Y,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of DCN gain?",freq_cnv_loss_or_gain
+600,ANKRD24,A465T,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of CA9 gain?",freq_cnv_loss_or_gain
+601,ANKRD24,A494T,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of ANKRD30A gain?",freq_cnv_loss_or_gain
+602,ANKRD24,A584T,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of TTC12 gain?",freq_cnv_loss_or_gain
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of ZMYM3 gain?",freq_cnv_loss_or_gain
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of POC1B gain?",freq_cnv_loss_or_gain
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of TYROBP gain?",freq_cnv_loss_or_gain
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of ACTB gain?",freq_cnv_loss_or_gain
+625,SIK2,I265M,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of TNS1 gain?",freq_cnv_loss_or_gain
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of TAF1L gain?",freq_cnv_loss_or_gain
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of NPSR1 gain?",freq_cnv_loss_or_gain
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of DCN gain?",freq_cnv_loss_or_gain
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of NOMO1 gain?",freq_cnv_loss_or_gain
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of PYHIN1 gain?",freq_cnv_loss_or_gain
+644,OR2A12,A254T,Brain Lower Grade Glioma,"Among Brain Lower Grade Glioma patients, what is the frequency of UNC5D gain?",freq_cnv_loss_or_gain
+646,PYHIN1,T325K,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of NRAP gain?",freq_cnv_loss_or_gain
+647,PYHIN1,T334K,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of TENT5A gain?",freq_cnv_loss_or_gain
+650,JAML,G191E,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of MERTK gain?",freq_cnv_loss_or_gain
+651,JAML,G219E,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of ART3 gain?",freq_cnv_loss_or_gain
+652,JAML,G220E,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of MED16 gain?",freq_cnv_loss_or_gain
+653,JAML,G230E,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of MAD1L1 gain?",freq_cnv_loss_or_gain
+658,TYK2,H1146R,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of AUTS2 gain?",freq_cnv_loss_or_gain
+659,TYK2,H23R,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of CHODL gain?",freq_cnv_loss_or_gain
+660,TYK2,H961R,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of MYT1 gain?",freq_cnv_loss_or_gain
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of TLK2 gain?",freq_cnv_loss_or_gain
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of ZNF584 gain?",freq_cnv_loss_or_gain
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of AUTS2 gain?",freq_cnv_loss_or_gain
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of CYB5R2 gain?",freq_cnv_loss_or_gain
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of ZBTB34 gain?",freq_cnv_loss_or_gain
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of ANKRD30A gain?",freq_cnv_loss_or_gain
+689,RIMS2,R25W,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of DNMT1 gain?",freq_cnv_loss_or_gain
+690,RIMS2,R393W,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of ICE1 gain?",freq_cnv_loss_or_gain
+691,RIMS2,R423W,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of MAST4 gain?",freq_cnv_loss_or_gain
+692,RIMS2,R470W,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of PRSS8 gain?",freq_cnv_loss_or_gain
+693,RIMS2,R615W,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of RIMS2 gain?",freq_cnv_loss_or_gain
+694,RIMS2,R619W,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of OR2T4 gain?",freq_cnv_loss_or_gain
+695,RIMS2,R716W,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of DNAH14 gain?",freq_cnv_loss_or_gain
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of EIF2B4 gain?",freq_cnv_loss_or_gain
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of MAST4 gain?",freq_cnv_loss_or_gain
+728,STK19,D341N,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of DOCK2 gain?",freq_cnv_loss_or_gain
+729,STK19,D345N,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of PLEKHG6 gain?",freq_cnv_loss_or_gain
+730,REXO4,P60A,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of ANP32E gain?",freq_cnv_loss_or_gain
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of UBR2 gain?",freq_cnv_loss_or_gain
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of TYROBP gain?",freq_cnv_loss_or_gain
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of MORF4L1 gain?",freq_cnv_loss_or_gain
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of KANSL1 gain?",freq_cnv_loss_or_gain
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of DCC gain?",freq_cnv_loss_or_gain
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of PRSS8 gain?",freq_cnv_loss_or_gain
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of ZFAT gain?",freq_cnv_loss_or_gain
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,"Among Head and Neck Squamous Cell Carcinoma patients, what is the frequency of PLEKHG6 gain?",freq_cnv_loss_or_gain
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,"Among Head and Neck Squamous Cell Carcinoma patients, what is the frequency of ADRA1A gain?",freq_cnv_loss_or_gain
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,"Among Head and Neck Squamous Cell Carcinoma patients, what is the frequency of POC1B gain?",freq_cnv_loss_or_gain
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,"Among Head and Neck Squamous Cell Carcinoma patients, what is the frequency of ABCC3 gain?",freq_cnv_loss_or_gain
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,"Among Head and Neck Squamous Cell Carcinoma patients, what is the frequency of STK19 gain?",freq_cnv_loss_or_gain
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,"Among Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia patients, what is the frequency of BCAT1 gain?",freq_cnv_loss_or_gain
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of JAML gain?",freq_cnv_loss_or_gain
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"Among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients, what is the frequency of AUTS2 gain?",freq_cnv_loss_or_gain
+792,GLRB,E148D,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of HLA-DQA2 gain?",freq_cnv_loss_or_gain
+793,TTN,F7636L,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of FGF8 gain?",freq_cnv_loss_or_gain
+794,TTN,F8563L,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of CCDC22 gain?",freq_cnv_loss_or_gain
+795,TTN,F8880L,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of GUCY2C gain?",freq_cnv_loss_or_gain
+799,ANKRD30A,V798I,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of ANKRD24 gain?",freq_cnv_loss_or_gain
+800,ANKRD30A,V854I,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of MORF4L1 gain?",freq_cnv_loss_or_gain
+801,ANKRD30A,V973I,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of SGIP1 gain?",freq_cnv_loss_or_gain
+809,TRIM45,S177L,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of ANKRD52 gain?",freq_cnv_loss_or_gain
+810,TRIM45,S224L,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of TYK2 gain?",freq_cnv_loss_or_gain
+811,TRIM45,S281L,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of DCC gain?",freq_cnv_loss_or_gain
+812,CACNA1F,G727V,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of PYHIN1 gain?",freq_cnv_loss_or_gain
+813,CACNA1F,G781V,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of SGCZ gain?",freq_cnv_loss_or_gain
+814,CACNA1F,G792V,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of TENT5A gain?",freq_cnv_loss_or_gain
+817,KL,R594C,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of SORCS1 gain?",freq_cnv_loss_or_gain
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,"Among Kidney Renal Papillary Cell Carcinoma patients, what is the frequency of CACNA1F gain?",freq_cnv_loss_or_gain
+822,TAF1L,A539V,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of PGR gain?",freq_cnv_loss_or_gain
+823,TASOR2,S256F,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of SPATA22 gain?",freq_cnv_loss_or_gain
+824,TASOR2,S36F,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of POLD1 gain?",freq_cnv_loss_or_gain
+825,TASOR2,S471F,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of OR13C3 gain?",freq_cnv_loss_or_gain
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of ACTB gain?",freq_cnv_loss_or_gain
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of PTPRO gain?",freq_cnv_loss_or_gain
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of PXN gain?",freq_cnv_loss_or_gain
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of TLCD5 gain?",freq_cnv_loss_or_gain
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"Among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients, what is the frequency of MYT1 gain?",freq_cnv_loss_or_gain
+843,DHX16,A29V,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of EBF2 gain?",freq_cnv_loss_or_gain
+844,DHX16,A89V,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of FBXO15 gain?",freq_cnv_loss_or_gain
+902,GPR158,A644V,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of OR2T4 gain?",freq_cnv_loss_or_gain
+903,GPR158,A723V,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of MORF4L1 gain?",freq_cnv_loss_or_gain
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of ERCC6 gain?",freq_cnv_loss_or_gain
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of DCN gain?",freq_cnv_loss_or_gain
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of CTCFL gain?",freq_cnv_loss_or_gain
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of RIMS2 gain?",freq_cnv_loss_or_gain
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of DNMT1 gain?",freq_cnv_loss_or_gain
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of DEFB115 gain?",freq_cnv_loss_or_gain
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of TRAP1 gain?",freq_cnv_loss_or_gain
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of GABRA6 gain?",freq_cnv_loss_or_gain
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of SORCS1 gain?",freq_cnv_loss_or_gain
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of GUF1 gain?",freq_cnv_loss_or_gain
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of TSHZ3 gain?",freq_cnv_loss_or_gain
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of MORF4L1 gain?",freq_cnv_loss_or_gain
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of ITPRID2 gain?",freq_cnv_loss_or_gain
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of CTSC gain?",freq_cnv_loss_or_gain
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of DSCAM gain?",freq_cnv_loss_or_gain
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of JAML gain?",freq_cnv_loss_or_gain
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of PIK3C2A gain?",freq_cnv_loss_or_gain
+952,PCDHGA1,R535W,Glioblastoma Multiforme,"Among Glioblastoma Multiforme patients, what is the frequency of TAF1C gain?",freq_cnv_loss_or_gain
+954,TRAP1,R114W,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of CASZ1 gain?",freq_cnv_loss_or_gain
+955,TRAP1,R61W,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of EVC2 gain?",freq_cnv_loss_or_gain
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of MERTK gain?",freq_cnv_loss_or_gain
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,"Among Liver Hepatocellular Carcinoma patients, what is the frequency of CYB5R2 gain?",freq_cnv_loss_or_gain
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of ZBTB34 gain?",freq_cnv_loss_or_gain
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of ACVR1B gain?",freq_cnv_loss_or_gain
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of ANKRD52 gain?",freq_cnv_loss_or_gain
+982,GABRA6,G115R,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of HYOU1 gain?",freq_cnv_loss_or_gain
+983,GABRA6,G122R,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of DCC gain?",freq_cnv_loss_or_gain
+984,GABRA6,G165R,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of DNMT1 gain?",freq_cnv_loss_or_gain
+985,GABRA6,G175R,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of YY1AP1 gain?",freq_cnv_loss_or_gain
+986,GABRA6,G70R,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of MYH11 gain?",freq_cnv_loss_or_gain
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of MYH11 gain?",freq_cnv_loss_or_gain
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of CTCFL gain?",freq_cnv_loss_or_gain
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of MORF4L1 gain?",freq_cnv_loss_or_gain
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,"Among Pancreatic Adenocarcinoma patients, what is the frequency of PTPRN2 gain?",freq_cnv_loss_or_gain
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,"Among Pancreatic Adenocarcinoma patients, what is the frequency of PIK3C2B gain?",freq_cnv_loss_or_gain
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,"Among Pancreatic Adenocarcinoma patients, what is the frequency of DCN gain?",freq_cnv_loss_or_gain
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,"Among Pancreatic Adenocarcinoma patients, what is the frequency of FMO4 gain?",freq_cnv_loss_or_gain
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,"Among Pancreatic Adenocarcinoma patients, what is the frequency of PRSS1 gain?",freq_cnv_loss_or_gain
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,"Among Pancreatic Adenocarcinoma patients, what is the frequency of EIF2B4 gain?",freq_cnv_loss_or_gain
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,"Among Pancreatic Adenocarcinoma patients, what is the frequency of COL6A3 gain?",freq_cnv_loss_or_gain
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,"Among Pancreatic Adenocarcinoma patients, what is the frequency of AUTS2 gain?",freq_cnv_loss_or_gain
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of CFAP61 gain?",freq_cnv_loss_or_gain
+1017,GPC3,I107N,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of CDH23 gain?",freq_cnv_loss_or_gain
+1018,GPC3,I161N,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of ANKRD30A gain?",freq_cnv_loss_or_gain
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"Among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients, what is the frequency of AUTS2 gain?",freq_cnv_loss_or_gain
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"Among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients, what is the frequency of CFAP61 gain?",freq_cnv_loss_or_gain
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"Among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients, what is the frequency of GSTCD gain?",freq_cnv_loss_or_gain
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"Among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients, what is the frequency of PTPRO gain?",freq_cnv_loss_or_gain
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"Among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients, what is the frequency of TTN gain?",freq_cnv_loss_or_gain
+1036,ZNF217,E209Q,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of TTN gain?",freq_cnv_loss_or_gain
+1038,SYT9,V275L,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of DEFB115 gain?",freq_cnv_loss_or_gain
+1039,SYT9,V307L,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of HYOU1 gain?",freq_cnv_loss_or_gain
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of CFAP61 gain?",freq_cnv_loss_or_gain
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of MYO3A gain?",freq_cnv_loss_or_gain
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of ZCCHC14 gain?",freq_cnv_loss_or_gain
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of ART3 gain?",freq_cnv_loss_or_gain
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of ZNF627 gain?",freq_cnv_loss_or_gain
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of DSCAM gain?",freq_cnv_loss_or_gain
+1056,CA9,E402K,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of TET2 gain?",freq_cnv_loss_or_gain
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of UNC5D gain?",freq_cnv_loss_or_gain
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of SYNJ1 gain?",freq_cnv_loss_or_gain
+1065,PSG2,P43L,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of ZFAT gain?",freq_cnv_loss_or_gain
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of ACVR1B gain?",freq_cnv_loss_or_gain
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of GABRA6 gain?",freq_cnv_loss_or_gain
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of TAF1C gain?",freq_cnv_loss_or_gain
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of MSANTD4 gain?",freq_cnv_loss_or_gain
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of GPRASP1 gain?",freq_cnv_loss_or_gain
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of EIF2B4 gain?",freq_cnv_loss_or_gain
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of RIMS2 gain?",freq_cnv_loss_or_gain
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of ZCCHC14 gain?",freq_cnv_loss_or_gain
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of ZCCHC14 gain?",freq_cnv_loss_or_gain
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of PTPRO gain?",freq_cnv_loss_or_gain
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of B3GALNT1 gain?",freq_cnv_loss_or_gain
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of GLRB gain?",freq_cnv_loss_or_gain
+1091,SPAG1,I917M,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of ABCC3 gain?",freq_cnv_loss_or_gain
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of SORCS1 gain?",freq_cnv_loss_or_gain
+1093,PXN,H1016Y,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of ANKDD1A gain?",freq_cnv_loss_or_gain
+1094,PXN,H359Y,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of ZNF584 gain?",freq_cnv_loss_or_gain
+1095,PXN,H492Y,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of COL6A3 gain?",freq_cnv_loss_or_gain
+1096,PXN,H524Y,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of CYB5R2 gain?",freq_cnv_loss_or_gain
+1097,PXN,H526Y,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of CHODL gain?",freq_cnv_loss_or_gain
+1098,PXN,H540Y,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of PTPRO gain?",freq_cnv_loss_or_gain
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of LDOC1 gain?",freq_cnv_loss_or_gain
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of KIF20B gain?",freq_cnv_loss_or_gain
+1106,TMEM255A,N205S,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of TET2 gain?",freq_cnv_loss_or_gain
+1107,TMEM255A,N229S,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of FGF8 gain?",freq_cnv_loss_or_gain
+1108,TMEM255A,N65S,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of PTPRO gain?",freq_cnv_loss_or_gain
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of FGF8 gain?",freq_cnv_loss_or_gain
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of POC1B gain?",freq_cnv_loss_or_gain
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of TNS1 gain?",freq_cnv_loss_or_gain
+1112,MYT1,A558E,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of ACVR1B gain?",freq_cnv_loss_or_gain
+1113,MYT1,A879E,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of SLC9C1 gain?",freq_cnv_loss_or_gain
+1114,MYT1,A906E,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of BCAT1 gain?",freq_cnv_loss_or_gain
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of YY1AP1 gain?",freq_cnv_loss_or_gain
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of ZBTB34 gain?",freq_cnv_loss_or_gain
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,"Among Liver Hepatocellular Carcinoma patients, what is the frequency of GSTCD gain?",freq_cnv_loss_or_gain
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of AQP7 gain?",freq_cnv_loss_or_gain
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of SPTAN1 gain?",freq_cnv_loss_or_gain
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of POLR1G gain?",freq_cnv_loss_or_gain
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of DNAH11 gain?",freq_cnv_loss_or_gain
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of GABRA6 gain?",freq_cnv_loss_or_gain
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of TAF1C gain?",freq_cnv_loss_or_gain
+1148,KRT39,P137S,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of MORF4L1 gain?",freq_cnv_loss_or_gain
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of SORCS1 gain?",freq_cnv_loss_or_gain
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of ZNF217 gain?",freq_cnv_loss_or_gain
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,"Among Liver Hepatocellular Carcinoma patients, what is the frequency of GPRASP1 gain?",freq_cnv_loss_or_gain
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,"Among Liver Hepatocellular Carcinoma patients, what is the frequency of CTSC gain?",freq_cnv_loss_or_gain
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,"Among Liver Hepatocellular Carcinoma patients, what is the frequency of DOCK2 gain?",freq_cnv_loss_or_gain
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,"Among Liver Hepatocellular Carcinoma patients, what is the frequency of SMO gain?",freq_cnv_loss_or_gain
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,"Among Liver Hepatocellular Carcinoma patients, what is the frequency of B3GALNT1 gain?",freq_cnv_loss_or_gain
+1188,SOX21,R55L,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of JAML gain?",freq_cnv_loss_or_gain
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of MYO3B gain?",freq_cnv_loss_or_gain
+1206,GRM5,E14K,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of FGF8 gain?",freq_cnv_loss_or_gain
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of AQP7 gain?",freq_cnv_loss_or_gain
+1210,SGIP1,N122T,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of SPINDOC gain?",freq_cnv_loss_or_gain
+1211,SGIP1,N420T,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of TASOR2 gain?",freq_cnv_loss_or_gain
+1212,SGIP1,N617T,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of TTC12 gain?",freq_cnv_loss_or_gain
+1213,SGIP1,N648T,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of ZNF584 gain?",freq_cnv_loss_or_gain
+1227,CARMIL1,V549L,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of POLR1G gain?",freq_cnv_loss_or_gain
+1228,CARMIL1,V949L,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of ITPRID2 gain?",freq_cnv_loss_or_gain
+1232,ZNF431,D121Y,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of ANKRD30A gain?",freq_cnv_loss_or_gain
+1233,ZNF431,D161Y,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of DNAH14 gain?",freq_cnv_loss_or_gain
+1234,ZNF431,R128I,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of AUTS2 gain?",freq_cnv_loss_or_gain
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of RIPOR2 gain?",freq_cnv_loss_or_gain
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of ZCCHC14 gain?",freq_cnv_loss_or_gain
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of TAF1C gain?",freq_cnv_loss_or_gain
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,"Among Lung Squamous Cell Carcinoma patients, what is the frequency of UNC5D gain?",freq_cnv_loss_or_gain
+1248,TTC12,D646H,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of ICE1 gain?",freq_cnv_loss_or_gain
+1249,TTC12,D652H,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of PTPRO gain?",freq_cnv_loss_or_gain
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of TASOR2 gain?",freq_cnv_loss_or_gain
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,"Among Bladder Urothelial Carcinoma patients, what is the frequency of TRAP1 gain?",freq_cnv_loss_or_gain
+1254,CTSC,E214V,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of RIPOR2 gain?",freq_cnv_loss_or_gain
+1255,CTSC,E291V,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of DHX16 gain?",freq_cnv_loss_or_gain
+1256,CTSC,E322V,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of CFAP298-TCP10L gain?",freq_cnv_loss_or_gain
+1257,CTSC,E324V,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of LCN15 gain?",freq_cnv_loss_or_gain
+1258,CTSC,E335V,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of UNC5D gain?",freq_cnv_loss_or_gain
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of KRT39 gain?",freq_cnv_loss_or_gain
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of PIAS3 gain?",freq_cnv_loss_or_gain
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of KDM5C gain?",freq_cnv_loss_or_gain
+1264,ACTB,A138T,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of TTC17 gain?",freq_cnv_loss_or_gain
+1265,ACTB,A217T,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of SERPINB10 gain?",freq_cnv_loss_or_gain
+1266,ACTB,A244T,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of MYO3A gain?",freq_cnv_loss_or_gain
+1267,ACTB,A260T,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of HTR3B gain?",freq_cnv_loss_or_gain
+1268,YY1AP1,V546D,Glioblastoma Multiforme,"Among Glioblastoma Multiforme patients, what is the frequency of KDM5C gain?",freq_cnv_loss_or_gain
+1269,YY1AP1,V557D,Glioblastoma Multiforme,"Among Glioblastoma Multiforme patients, what is the frequency of BCAT1 gain?",freq_cnv_loss_or_gain
+1270,YY1AP1,V566D,Glioblastoma Multiforme,"Among Glioblastoma Multiforme patients, what is the frequency of PAK3 gain?",freq_cnv_loss_or_gain
+1271,YY1AP1,V577D,Glioblastoma Multiforme,"Among Glioblastoma Multiforme patients, what is the frequency of OR8K5 gain?",freq_cnv_loss_or_gain
+1272,YY1AP1,V623D,Glioblastoma Multiforme,"Among Glioblastoma Multiforme patients, what is the frequency of PTPRN2 gain?",freq_cnv_loss_or_gain
+1273,YY1AP1,V695D,Glioblastoma Multiforme,"Among Glioblastoma Multiforme patients, what is the frequency of EIF2B4 gain?",freq_cnv_loss_or_gain
+1274,YY1AP1,V715D,Glioblastoma Multiforme,"Among Glioblastoma Multiforme patients, what is the frequency of COL6A3 gain?",freq_cnv_loss_or_gain
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of ACTL7B gain?",freq_cnv_loss_or_gain
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of COL6A3 gain?",freq_cnv_loss_or_gain
+1299,TLCD5,G15V,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of GRM5 gain?",freq_cnv_loss_or_gain
+1300,TLCD5,G37V,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of AQP7 gain?",freq_cnv_loss_or_gain
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of CNGB1 gain?",freq_cnv_loss_or_gain
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of CX3CR1 gain?",freq_cnv_loss_or_gain
+1308,DNAH14,N1186K,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of ADAM17 gain?",freq_cnv_loss_or_gain
+1309,DNAH14,N2657K,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of DCC gain?",freq_cnv_loss_or_gain
+1310,DNAH14,N3460K,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of CACNA1F gain?",freq_cnv_loss_or_gain
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of GIMAP2 gain?",freq_cnv_loss_or_gain
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,"Among Prostate Adenocarcinoma patients, what is the frequency of RIPOR2 gain?",freq_cnv_loss_or_gain
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,"Among Prostate Adenocarcinoma patients, what is the frequency of PCDHB2 gain?",freq_cnv_loss_or_gain
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of TTC17 gain?",freq_cnv_loss_or_gain
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of ZNF431 gain?",freq_cnv_loss_or_gain
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of TAF1C gain?",freq_cnv_loss_or_gain
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of SLC9C1 gain?",freq_cnv_loss_or_gain
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of AUTS2 gain?",freq_cnv_loss_or_gain
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of TNS1 gain?",freq_cnv_loss_or_gain
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of DCLK3 gain?",freq_cnv_loss_or_gain
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of HBB gain?",freq_cnv_loss_or_gain
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of NOMO1 gain?",freq_cnv_loss_or_gain
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of FRY gain?",freq_cnv_loss_or_gain
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of TTYH2 gain?",freq_cnv_loss_or_gain
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of COL6A3 gain?",freq_cnv_loss_or_gain
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of SORCS1 gain?",freq_cnv_loss_or_gain
+1363,ARMC3,R169C,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of TTYH2 gain?",freq_cnv_loss_or_gain
+1364,ARMC3,R432C,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of PLEKHG6 gain?",freq_cnv_loss_or_gain
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,"Among Kidney Renal Clear Cell Carcinoma patients, what is the frequency of PXN gain?",freq_cnv_loss_or_gain
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,"Among Kidney Renal Clear Cell Carcinoma patients, what is the frequency of YY1AP1 gain?",freq_cnv_loss_or_gain
+1369,SERPINB10,A353P,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of TAF1C gain?",freq_cnv_loss_or_gain
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of FNDC7 gain?",freq_cnv_loss_or_gain
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of ANKDD1A gain?",freq_cnv_loss_or_gain
+1381,ACVR1B,D397N,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of ERCC6 gain?",freq_cnv_loss_or_gain
+1382,ACVR1B,D449N,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of TRAP1 gain?",freq_cnv_loss_or_gain
+1383,ACVR1B,D490N,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of IL5RA gain?",freq_cnv_loss_or_gain
+1393,EBF2,T104I,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of CFAP61 gain?",freq_cnv_loss_or_gain
+1394,EBF2,T252I,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of GRTP1 gain?",freq_cnv_loss_or_gain
+1402,VPS26B,F266L,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of ZNF274 gain?",freq_cnv_loss_or_gain
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of ZNF274 gain?",freq_cnv_loss_or_gain
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of PKHD1L1 gain?",freq_cnv_loss_or_gain
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients, what is the frequency of CACNA1F gain?",freq_cnv_loss_or_gain
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,"Among Skin Cutaneous Melanoma patients, what is the frequency of SGIP1 gain?",freq_cnv_loss_or_gain
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of GPR158 gain?",freq_cnv_loss_or_gain
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of UNC5D gain?",freq_cnv_loss_or_gain
+1413,PRSS1,S114T,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of TTC17 gain?",freq_cnv_loss_or_gain
+1414,PRSS1,S124T,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of ANKDD1A gain?",freq_cnv_loss_or_gain
+1415,PRSS1,S138T,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of PLEKHG6 gain?",freq_cnv_loss_or_gain
+1416,PRSS1,S74T,Lung Adenocarcinoma,"Among Lung Adenocarcinoma patients, what is the frequency of SGIP1 gain?",freq_cnv_loss_or_gain
+1417,PGF,R126H,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of ACTB gain?",freq_cnv_loss_or_gain
+1418,PGF,R127H,Stomach Adenocarcinoma,"Among Stomach Adenocarcinoma patients, what is the frequency of RIMS2 gain?",freq_cnv_loss_or_gain
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of AUTS2 gain?",freq_cnv_loss_or_gain
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,"Among Breast Invasive Carcinoma patients, what is the frequency of EIF2B4 gain?",freq_cnv_loss_or_gain
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of CPS1 gain?",freq_cnv_loss_or_gain
+1441,PCDHB2,R158C,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of RIMS2 gain?",freq_cnv_loss_or_gain
+1442,PCDHB2,T15M,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of AUTS2 gain?",freq_cnv_loss_or_gain
+1443,PCDHB2,T26M,Colon Adenocarcinoma,"Among Colon Adenocarcinoma patients, what is the frequency of TYROBP gain?",freq_cnv_loss_or_gain
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,"Among Uterine Corpus Endometrial Carcinoma patients, what is the frequency of MAST4 gain?",freq_cnv_loss_or_gain
+1452,FBXO42,A618D,Rectum Adenocarcinoma,"Among Rectum Adenocarcinoma patients, what is the frequency of PTPRO gain?",freq_cnv_loss_or_gain
+1,TNS1,G1362V,Breast Invasive Carcinoma,How often does TNS1 loss occur in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+2,TNS1,G1711V,Breast Invasive Carcinoma,How often does TNS1 loss occur in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+3,TNS1,G1718V,Breast Invasive Carcinoma,How often does TNS1 loss occur in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+4,TNS1,G1732V,Breast Invasive Carcinoma,How often does TNS1 loss occur in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+5,TNS1,G1824V,Breast Invasive Carcinoma,How often does TNS1 loss occur in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+6,TNS1,G1857V,Breast Invasive Carcinoma,How often does TNS1 loss occur in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+7,TNS1,G843V,Breast Invasive Carcinoma,How often does TNS1 loss occur in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How often does EVC2 loss occur in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How often does EVC2 loss occur in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How often does CR1 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How often does CR1 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+22,TRPA1,S295I,Rectum Adenocarcinoma,How often does TRPA1 loss occur in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+23,TRPA1,S443I,Rectum Adenocarcinoma,How often does TRPA1 loss occur in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+24,TAF1C,R299L,Lung Adenocarcinoma,How often does TAF1C loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+25,TAF1C,R396L,Lung Adenocarcinoma,How often does TAF1C loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+26,TAF1C,R634L,Lung Adenocarcinoma,How often does TAF1C loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+27,TAF1C,R702L,Lung Adenocarcinoma,How often does TAF1C loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+28,TAF1C,R728L,Lung Adenocarcinoma,How often does TAF1C loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How often does DPF3 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How often does DPF3 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How often does DPF3 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+42,OR2T4,P272H,Lung Adenocarcinoma,How often does OR2T4 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+43,OR2T4,P300H,Lung Adenocarcinoma,How often does OR2T4 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How often does FBN1 loss occur in Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How often does MAD1L1 loss occur in Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How often does MAD1L1 loss occur in Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How often does MAD1L1 loss occur in Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How often does CCNG1 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How often does ANP32E loss occur in Kidney Renal Papillary Cell Carcinoma patients?,freq_cnv_loss_or_gain
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How often does ANP32E loss occur in Kidney Renal Papillary Cell Carcinoma patients?,freq_cnv_loss_or_gain
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How often does ANP32E loss occur in Kidney Renal Papillary Cell Carcinoma patients?,freq_cnv_loss_or_gain
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How often does ANP32E loss occur in Kidney Renal Papillary Cell Carcinoma patients?,freq_cnv_loss_or_gain
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How often does FRY loss occur in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How often does FRY loss occur in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How often does FRY loss occur in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How often does FRY loss occur in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+70,PAK3,E318K,Skin Cutaneous Melanoma,How often does PAK3 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+71,PAK3,E319K,Skin Cutaneous Melanoma,How often does PAK3 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+72,PAK3,E334K,Skin Cutaneous Melanoma,How often does PAK3 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+73,PAK3,E340K,Skin Cutaneous Melanoma,How often does PAK3 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+74,PAK3,E355K,Skin Cutaneous Melanoma,How often does PAK3 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How often does MUC16 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How often does ZFPM2 loss occur in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How often does ZFPM2 loss occur in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How often does PIK3C2B loss occur in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How often does PIK3C2B loss occur in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How often does ZNF804A loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+116,RELN,A2371V,Stomach Adenocarcinoma,How often does RELN loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does EFCAB12 loss occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does EFCAB12 loss occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How often does DEFB115 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How often does ANKDD1A loss occur in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How often does ANKDD1A loss occur in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How often does ANKDD1A loss occur in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How often does HTR3B loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How often does HTR3B loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How often does HTR3B loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+129,ABCC3,R758W,Stomach Adenocarcinoma,How often does ABCC3 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How often does NOMO1 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How often does NOMO1 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How often does HYOU1 loss occur in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How often does FMO4 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+140,BICC1,A372V,Exceptional Responders,How often does BICC1 loss occur in Exceptional Responders patients?,freq_cnv_loss_or_gain
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How often does ZMYM3 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How often does ZMYM3 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How often does ZMYM3 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does XKR4 loss occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How often does ABCC2 loss occur in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+157,OR8K5,R293G,Lung Adenocarcinoma,How often does OR8K5 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How often does SPTAN1 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How often does SPTAN1 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+164,SYT10,M484I,Rectum Adenocarcinoma,How often does SYT10 loss occur in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How often does HSPA5 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+175,UNC5D,L280V,Lung Adenocarcinoma,How often does UNC5D loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+176,UNC5D,L635V,Lung Adenocarcinoma,How often does UNC5D loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+177,UNC5D,L637V,Lung Adenocarcinoma,How often does UNC5D loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+178,UNC5D,L699V,Lung Adenocarcinoma,How often does UNC5D loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+179,UNC5D,L704V,Lung Adenocarcinoma,How often does UNC5D loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+180,UNC5D,L709V,Lung Adenocarcinoma,How often does UNC5D loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How often does DOCK2 loss occur in Kidney Renal Clear Cell Carcinoma patients?,freq_cnv_loss_or_gain
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How often does ZNF627 loss occur in Kidney Renal Clear Cell Carcinoma patients?,freq_cnv_loss_or_gain
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How often does CDC42BPA loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+193,MRPL55,H27Y,Colon Adenocarcinoma,How often does MRPL55 loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+194,MRPL55,H63Y,Colon Adenocarcinoma,How often does MRPL55 loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How often does TMTC3 loss occur in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+198,EPRS1,K771I,Colon Adenocarcinoma,How often does EPRS1 loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+199,EPRS1,K778I,Colon Adenocarcinoma,How often does EPRS1 loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How often does GRTP1 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How often does GRTP1 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How often does TSHZ3 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How often does TAS1R3 loss occur in HIV+ Tumor Molecular Characterization Project - Cervical Cancer patients?,freq_cnv_loss_or_gain
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How often does PIAS3 loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How often does PIAS3 loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+251,ZNF274,P13R,Stomach Adenocarcinoma,How often does ZNF274 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+253,SYNJ1,R795C,Colon Adenocarcinoma,How often does SYNJ1 loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+254,SYNJ1,R800C,Colon Adenocarcinoma,How often does SYNJ1 loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+255,SYNJ1,R839C,Colon Adenocarcinoma,How often does SYNJ1 loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+261,DSCAM,V343M,Prostate Adenocarcinoma,How often does DSCAM loss occur in Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+262,DSCAM,V426M,Prostate Adenocarcinoma,How often does DSCAM loss occur in Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+263,DSCAM,V591M,Prostate Adenocarcinoma,How often does DSCAM loss occur in Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+267,DGKD,R140H,Exceptional Responders,How often does DGKD loss occur in Exceptional Responders patients?,freq_cnv_loss_or_gain
+268,DGKD,R160H,Exceptional Responders,How often does DGKD loss occur in Exceptional Responders patients?,freq_cnv_loss_or_gain
+269,DGKD,R204H,Exceptional Responders,How often does DGKD loss occur in Exceptional Responders patients?,freq_cnv_loss_or_gain
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How often does PLEKHG6 loss occur in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How often does PLEKHG6 loss occur in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How often does PLEKHG6 loss occur in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+279,WNT2,D138N,Skin Cutaneous Melanoma,How often does WNT2 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How often does GUCY2C loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How often does C7orf31 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does ZKSCAN7 loss occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+299,OR5D14,M210L,Neuroblastoma,How often does OR5D14 loss occur in Neuroblastoma patients?,freq_cnv_loss_or_gain
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How often does SPATA22 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How often does SPATA22 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How often does SPATA22 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+310,LCN15,E21V,Stomach Adenocarcinoma,How often does LCN15 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How often does DCAF4L2 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How often does GUK1 loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How often does GUK1 loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How often does GUK1 loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How often does GUK1 loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How often does GUK1 loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How often does MORF4L1 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How often does MORF4L1 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How often does MORF4L1 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How often does MORF4L1 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How often does MYO3B loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How often does MYO3B loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How often does TENT5A loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How often does TENT5A loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How often does TENT5A loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How often does ZFAT loss occur in Ovarian Serous Cystadenocarcinoma patients?,freq_cnv_loss_or_gain
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How often does ZFAT loss occur in Ovarian Serous Cystadenocarcinoma patients?,freq_cnv_loss_or_gain
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How often does ZFAT loss occur in Ovarian Serous Cystadenocarcinoma patients?,freq_cnv_loss_or_gain
+357,ZNF584,A211T,Sarcoma,How often does ZNF584 loss occur in Sarcoma patients?,freq_cnv_loss_or_gain
+358,ZNF584,A256T,Sarcoma,How often does ZNF584 loss occur in Sarcoma patients?,freq_cnv_loss_or_gain
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How often does LDOC1 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How often does PDGFC loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How often does MSANTD4 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How often does NPSR1 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How often does PHLPP1 loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How often does COL6A3 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How often does COL6A3 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How often does COL6A3 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How often does COL6A3 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How often does COL6A3 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How often does ADRA1A loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often does LAMB2 loss occur in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+406,POC1B,I198T,Rectum Adenocarcinoma,How often does POC1B loss occur in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+407,POC1B,I286T,Rectum Adenocarcinoma,How often does POC1B loss occur in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+408,POC1B,I328T,Rectum Adenocarcinoma,How often does POC1B loss occur in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+409,POC1B,S79P,Rectum Adenocarcinoma,How often does POC1B loss occur in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How often does USH2A loss occur in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+414,AQP7,T110S,Rectum Adenocarcinoma,How often does AQP7 loss occur in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+415,AQP7,T166S,Rectum Adenocarcinoma,How often does AQP7 loss occur in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+416,AQP7,T167S,Rectum Adenocarcinoma,How often does AQP7 loss occur in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+417,AQP7,T75S,Rectum Adenocarcinoma,How often does AQP7 loss occur in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+430,DCN,R163C,Rectum Adenocarcinoma,How often does DCN loss occur in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+431,DCN,R203C,Rectum Adenocarcinoma,How often does DCN loss occur in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+432,DCN,R241C,Rectum Adenocarcinoma,How often does DCN loss occur in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+433,DCN,R350C,Rectum Adenocarcinoma,How often does DCN loss occur in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+434,DCN,R41C,Rectum Adenocarcinoma,How often does DCN loss occur in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How often does CPS1 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How often does CPS1 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How often does CPS1 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How often does FCGR2C loss occur in Kidney Renal Papillary Cell Carcinoma patients?,freq_cnv_loss_or_gain
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How often does FCGR2C loss occur in Kidney Renal Papillary Cell Carcinoma patients?,freq_cnv_loss_or_gain
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How often does GRM1 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+482,SGCZ,Q138H,Lung Adenocarcinoma,How often does SGCZ loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+483,SGCZ,Q91H,Lung Adenocarcinoma,How often does SGCZ loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+485,SMO,V15M,Stomach Adenocarcinoma,How often does SMO loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+486,SMO,V321M,Stomach Adenocarcinoma,How often does SMO loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+488,CHODL,G159E,Skin Cutaneous Melanoma,How often does CHODL loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+489,CHODL,G181E,Skin Cutaneous Melanoma,How often does CHODL loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+490,CHODL,G200E,Skin Cutaneous Melanoma,How often does CHODL loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+494,MYO16,P399H,Colon Adenocarcinoma,How often does MYO16 loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+495,MYO16,P421H,Colon Adenocarcinoma,How often does MYO16 loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+498,CXCR2,A98V,Stomach Adenocarcinoma,How often does CXCR2 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How often does TMEM225 loss occur in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How often does MAOB loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How often does GPRASP1 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How often does MRPL32 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How often does TYROBP loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+510,RAB40C,A111V,Lung Adenocarcinoma,How often does RAB40C loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+511,RAB40C,A143V,Lung Adenocarcinoma,How often does RAB40C loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+512,CTNNA2,S323R,Lung Adenocarcinoma,How often does CTNNA2 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+513,CTNNA2,S339R,Lung Adenocarcinoma,How often does CTNNA2 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+514,CTNNA2,S386R,Lung Adenocarcinoma,How often does CTNNA2 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+515,CTNNA2,S707R,Lung Adenocarcinoma,How often does CTNNA2 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How often does MYO15A loss occur in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How often does GIMAP2 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+532,KIF20B,N1160D,Glioblastoma Multiforme,How often does KIF20B loss occur in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+533,KIF20B,N1200D,Glioblastoma Multiforme,How often does KIF20B loss occur in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How often does ADAM17 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How often does BCAT1 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How often does BCAT1 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How often does BCAT1 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+540,ERCC6,R1053H,Colon Adenocarcinoma,How often does ERCC6 loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+541,DCC,R320W,Breast Invasive Carcinoma,How often does DCC loss occur in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+542,DCC,R363W,Breast Invasive Carcinoma,How often does DCC loss occur in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+543,DCC,R386W,Breast Invasive Carcinoma,How often does DCC loss occur in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+544,DCC,R41W,Breast Invasive Carcinoma,How often does DCC loss occur in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How often does FBXO15 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How often does FBXO15 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How often does GSTCD loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How often does GSTCD loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How often does OLFML3 loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How often does OLFML3 loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How often does OLFML3 loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How often does CFAP61 loss occur in Ovarian Serous Cystadenocarcinoma patients?,freq_cnv_loss_or_gain
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How often does CFAP61 loss occur in Ovarian Serous Cystadenocarcinoma patients?,freq_cnv_loss_or_gain
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How often does HLA-DQA2 loss occur in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How often does TENM2 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How often does TENM2 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How often does TENM2 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How often does ANKRD24 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How often does ANKRD24 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How often does ANKRD24 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How often does ZCCHC14 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How often does ZCCHC14 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How often does ZCCHC14 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How often does ZCCHC14 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+625,SIK2,I265M,Lung Adenocarcinoma,How often does SIK2 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How often does MYH11 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How often does MYH11 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How often does SLC6A4 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How often does SLC9C1 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How often does SLC9C1 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+644,OR2A12,A254T,Brain Lower Grade Glioma,How often does OR2A12 loss occur in Brain Lower Grade Glioma patients?,freq_cnv_loss_or_gain
+646,PYHIN1,T325K,Lung Adenocarcinoma,How often does PYHIN1 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+647,PYHIN1,T334K,Lung Adenocarcinoma,How often does PYHIN1 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+650,JAML,G191E,Skin Cutaneous Melanoma,How often does JAML loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+651,JAML,G219E,Skin Cutaneous Melanoma,How often does JAML loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+652,JAML,G220E,Skin Cutaneous Melanoma,How often does JAML loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+653,JAML,G230E,Skin Cutaneous Melanoma,How often does JAML loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+658,TYK2,H1146R,Stomach Adenocarcinoma,How often does TYK2 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+659,TYK2,H23R,Stomach Adenocarcinoma,How often does TYK2 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+660,TYK2,H961R,Stomach Adenocarcinoma,How often does TYK2 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How often does CTCFL loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How often does CTCFL loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How often does CTCFL loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How often does CTCFL loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How often does CEP20 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How often does CEP20 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How often does RIMS2 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How often does RIMS2 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How often does RIMS2 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How often does RIMS2 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How often does RIMS2 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How often does RIMS2 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How often does RIMS2 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How often does PIK3C2G loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How often does PIK3C2G loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+728,STK19,D341N,Colon Adenocarcinoma,How often does STK19 loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+729,STK19,D345N,Colon Adenocarcinoma,How often does STK19 loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+730,REXO4,P60A,Skin Cutaneous Melanoma,How often does REXO4 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How often does ZBTB34 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How often does ZBTB34 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How often does NCKAP5 loss occur in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does SORCS1 loss occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does SORCS1 loss occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does SORCS1 loss occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does SORCS1 loss occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How often does FGF8 loss occur in Head and Neck Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How often does FGF8 loss occur in Head and Neck Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How often does FGF8 loss occur in Head and Neck Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How often does FGF8 loss occur in Head and Neck Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How often does FGF8 loss occur in Head and Neck Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How often does TENM3 loss occur in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia patients?,freq_cnv_loss_or_gain
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How often does AKT1 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often does CFAP298-TCP10L loss occur in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+792,GLRB,E148D,Stomach Adenocarcinoma,How often does GLRB loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+793,TTN,F7636L,Colon Adenocarcinoma,How often does TTN loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+794,TTN,F8563L,Colon Adenocarcinoma,How often does TTN loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+795,TTN,F8880L,Colon Adenocarcinoma,How often does TTN loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How often does ANKRD30A loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How often does ANKRD30A loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How often does ANKRD30A loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+809,TRIM45,S177L,Colon Adenocarcinoma,How often does TRIM45 loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+810,TRIM45,S224L,Colon Adenocarcinoma,How often does TRIM45 loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+811,TRIM45,S281L,Colon Adenocarcinoma,How often does TRIM45 loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How often does CACNA1F loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How often does CACNA1F loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How often does CACNA1F loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+817,KL,R594C,Colon Adenocarcinoma,How often does KL loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How often does GUF1 loss occur in Kidney Renal Papillary Cell Carcinoma patients?,freq_cnv_loss_or_gain
+822,TAF1L,A539V,Colon Adenocarcinoma,How often does TAF1L loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How often does TASOR2 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How often does TASOR2 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How often does TASOR2 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How often does KDM5C loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How often does KDM5C loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How often does KDM5C loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How often does KDM5C loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often does IL5RA loss occur in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+843,DHX16,A29V,Skin Cutaneous Melanoma,How often does DHX16 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+844,DHX16,A89V,Skin Cutaneous Melanoma,How often does DHX16 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+902,GPR158,A644V,Stomach Adenocarcinoma,How often does GPR158 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+903,GPR158,A723V,Stomach Adenocarcinoma,How often does GPR158 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does EIF2B4 loss occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does EIF2B4 loss occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does EIF2B4 loss occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does EIF2B4 loss occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does EIF2B4 loss occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does EIF2B4 loss occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How often does AUTS2 loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How often does AUTS2 loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How often does AUTS2 loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How often does AUTS2 loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How often does AUTS2 loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How often does AUTS2 loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How often does AUTS2 loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How often does AUTS2 loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How often does AUTS2 loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How often does AUTS2 loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does ACTL7B loss occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How often does PCDHGA1 loss occur in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+954,TRAP1,R114W,Stomach Adenocarcinoma,How often does TRAP1 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+955,TRAP1,R61W,Stomach Adenocarcinoma,How often does TRAP1 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How often does PIK3C2A loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How often does KANSL1 loss occur in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How often does ANKRD52 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How often does PAPPA loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How often does B3GALNT1 loss occur in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+982,GABRA6,G115R,Lung Adenocarcinoma,How often does GABRA6 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+983,GABRA6,G122R,Lung Adenocarcinoma,How often does GABRA6 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+984,GABRA6,G165R,Lung Adenocarcinoma,How often does GABRA6 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+985,GABRA6,G175R,Lung Adenocarcinoma,How often does GABRA6 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+986,GABRA6,G70R,Lung Adenocarcinoma,How often does GABRA6 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How often does ZSCAN31 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does MED16 loss occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does MED16 loss occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How often does PTPRO loss occur in Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How often does PTPRO loss occur in Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How often does PTPRO loss occur in Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How often does PTPRO loss occur in Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How often does PTPRO loss occur in Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How often does PTPRO loss occur in Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How often does PTPRO loss occur in Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How often does PTPRO loss occur in Pancreatic Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How often does CHMP7 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1017,GPC3,I107N,Stomach Adenocarcinoma,How often does GPC3 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1018,GPC3,I161N,Stomach Adenocarcinoma,How often does GPC3 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often does TLK2 loss occur in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often does TLK2 loss occur in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often does TLK2 loss occur in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often does TLK2 loss occur in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often does TLK2 loss occur in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How often does ZNF217 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1038,SYT9,V275L,Lung Adenocarcinoma,How often does SYT9 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1039,SYT9,V307L,Lung Adenocarcinoma,How often does SYT9 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How often does PKHD1L1 loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How often does MYO3A loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does VASN loss occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How often does DNMT1 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How often does DNMT1 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How often does DNMT1 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1056,CA9,E402K,Colon Adenocarcinoma,How often does CA9 loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How often does TTC17 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How often does TTC17 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1065,PSG2,P43L,Breast Invasive Carcinoma,How often does PSG2 loss occur in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How often does RIPOR2 loss occur in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How often does RIPOR2 loss occur in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How often does RIPOR2 loss occur in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How often does RIPOR2 loss occur in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How often does DCLK3 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How often does DCLK3 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How often does MERTK loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How often does MERTK loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How often does MERTK loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How often does ZFP42 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How often does OR13C3 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How often does OR13C3 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How often does SPAG1 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How often does CDKN2AIP loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1093,PXN,H1016Y,Colon Adenocarcinoma,How often does PXN loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1094,PXN,H359Y,Colon Adenocarcinoma,How often does PXN loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1095,PXN,H492Y,Colon Adenocarcinoma,How often does PXN loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1096,PXN,H524Y,Colon Adenocarcinoma,How often does PXN loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1097,PXN,H526Y,Colon Adenocarcinoma,How often does PXN loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1098,PXN,H540Y,Colon Adenocarcinoma,How often does PXN loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How often does TTYH2 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How often does TTYH2 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How often does TMEM255A loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How often does TMEM255A loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How often does TMEM255A loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How often does TASOR2 loss occur in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How often does TASOR2 loss occur in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How often does ICE1 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1112,MYT1,A558E,Breast Invasive Carcinoma,How often does MYT1 loss occur in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1113,MYT1,A879E,Breast Invasive Carcinoma,How often does MYT1 loss occur in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1114,MYT1,A906E,Breast Invasive Carcinoma,How often does MYT1 loss occur in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How often does CX3CR1 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How often does CX3CR1 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How often does SPINDOC loss occur in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How often does ART3 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How often does ART3 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How often does CYP1A2 loss occur in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does ADRA1A loss occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How often does CDH23 loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How often does CDH23 loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How often does KRT39 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How often does PDHA2 loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How often does SLC24A2 loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How often does PTPRN2 loss occur in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How often does PTPRN2 loss occur in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How often does PTPRN2 loss occur in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How often does PTPRN2 loss occur in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How often does PTPRN2 loss occur in Liver Hepatocellular Carcinoma patients?,freq_cnv_loss_or_gain
+1188,SOX21,R55L,Lung Adenocarcinoma,How often does SOX21 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How often does CPA6 loss occur in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How often does GRM5 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does CASZ1 loss occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How often does SGIP1 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How often does SGIP1 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How often does SGIP1 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How often does SGIP1 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How often does CARMIL1 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How often does CARMIL1 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How often does ZNF431 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How often does ZNF431 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1234,ZNF431,R128I,Lung Adenocarcinoma,How often does ZNF431 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How often does DNAH11 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How often does DNAH11 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How often does POLD1 loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How often does POLD1 loss occur in Lung Squamous Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1248,TTC12,D646H,Lung Adenocarcinoma,How often does TTC12 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1249,TTC12,D652H,Lung Adenocarcinoma,How often does TTC12 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How often does CNGB1 loss occur in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How often does CNGB1 loss occur in Bladder Urothelial Carcinoma patients?,freq_cnv_loss_or_gain
+1254,CTSC,E214V,Stomach Adenocarcinoma,How often does CTSC loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1255,CTSC,E291V,Stomach Adenocarcinoma,How often does CTSC loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1256,CTSC,E322V,Stomach Adenocarcinoma,How often does CTSC loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1257,CTSC,E324V,Stomach Adenocarcinoma,How often does CTSC loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1258,CTSC,E335V,Stomach Adenocarcinoma,How often does CTSC loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How often does PRSS8 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How often does PRSS8 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How often does ARHGEF40 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1264,ACTB,A138T,Rectum Adenocarcinoma,How often does ACTB loss occur in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1265,ACTB,A217T,Rectum Adenocarcinoma,How often does ACTB loss occur in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1266,ACTB,A244T,Rectum Adenocarcinoma,How often does ACTB loss occur in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1267,ACTB,A260T,Rectum Adenocarcinoma,How often does ACTB loss occur in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How often does YY1AP1 loss occur in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How often does YY1AP1 loss occur in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How often does YY1AP1 loss occur in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How often does YY1AP1 loss occur in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How often does YY1AP1 loss occur in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How often does YY1AP1 loss occur in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How often does YY1AP1 loss occur in Glioblastoma Multiforme patients?,freq_cnv_loss_or_gain
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How often does FNDC7 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How often does FNDC7 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1299,TLCD5,G15V,Lung Adenocarcinoma,How often does TLCD5 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1300,TLCD5,G37V,Lung Adenocarcinoma,How often does TLCD5 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How often does POLR1G loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How often does POLR1G loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How often does DNAH14 loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How often does DNAH14 loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How often does DNAH14 loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How often does NEXN loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How often does CYB5R2 loss occur in Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How often does CYB5R2 loss occur in Prostate Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How often does NRAP loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How often does NRAP loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How often does NRAP loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How often does CCDC22 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How often does DCAF6 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How often does DCAF6 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How often does ZNF708 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How often does BFAR loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How often does MAST4 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How often does MAST4 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How often does MAST4 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How often does MAST4 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How often does MAST4 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How often does ARMC3 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How often does ARMC3 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How often does TET2 loss occur in Kidney Renal Clear Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How often does TET2 loss occur in Kidney Renal Clear Cell Carcinoma patients?,freq_cnv_loss_or_gain
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How often does SERPINB10 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How often does STAT3 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How often does MIEF1 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How often does ACVR1B loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How often does ACVR1B loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How often does ACVR1B loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1393,EBF2,T104I,Stomach Adenocarcinoma,How often does EBF2 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1394,EBF2,T252I,Stomach Adenocarcinoma,How often does EBF2 loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How often does VPS26B loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does PGR loss occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does PGR loss occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often does PGR loss occur in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",freq_cnv_loss_or_gain
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How often does ACTA2 loss occur in Skin Cutaneous Melanoma patients?,freq_cnv_loss_or_gain
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How often does THBS4 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How often does THBS4 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1413,PRSS1,S114T,Lung Adenocarcinoma,How often does PRSS1 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1414,PRSS1,S124T,Lung Adenocarcinoma,How often does PRSS1 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1415,PRSS1,S138T,Lung Adenocarcinoma,How often does PRSS1 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1416,PRSS1,S74T,Lung Adenocarcinoma,How often does PRSS1 loss occur in Lung Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1417,PGF,R126H,Stomach Adenocarcinoma,How often does PGF loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1418,PGF,R127H,Stomach Adenocarcinoma,How often does PGF loss occur in Stomach Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How often does ITPRID2 loss occur in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How often does ITPRID2 loss occur in Breast Invasive Carcinoma patients?,freq_cnv_loss_or_gain
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How often does HBB loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How often does PCDHB2 loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How often does PCDHB2 loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How often does PCDHB2 loss occur in Colon Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How often does UBR2 loss occur in Uterine Corpus Endometrial Carcinoma patients?,freq_cnv_loss_or_gain
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How often does FBXO42 loss occur in Rectum Adenocarcinoma patients?,freq_cnv_loss_or_gain
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the detection rate of TNS1 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the detection rate of TNS1 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the detection rate of TNS1 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the detection rate of TNS1 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the detection rate of TNS1 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the detection rate of TNS1 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the detection rate of TNS1 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the detection rate of EVC2 LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the detection rate of EVC2 LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the detection rate of CR1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the detection rate of CR1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the detection rate of TRPA1 LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the detection rate of TRPA1 LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the detection rate of TAF1C LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the detection rate of TAF1C LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the detection rate of TAF1C LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the detection rate of TAF1C LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the detection rate of TAF1C LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the detection rate of DPF3 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the detection rate of DPF3 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the detection rate of DPF3 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the detection rate of OR2T4 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the detection rate of OR2T4 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the detection rate of FBN1 LOH in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the detection rate of MAD1L1 LOH in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the detection rate of MAD1L1 LOH in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the detection rate of MAD1L1 LOH in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the detection rate of CCNG1 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the detection rate of ANP32E LOH in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the detection rate of ANP32E LOH in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the detection rate of ANP32E LOH in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the detection rate of ANP32E LOH in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the detection rate of FRY LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the detection rate of FRY LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the detection rate of FRY LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the detection rate of FRY LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the detection rate of PAK3 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the detection rate of PAK3 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the detection rate of PAK3 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the detection rate of PAK3 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the detection rate of PAK3 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the detection rate of MUC16 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the detection rate of ZFPM2 LOH in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the detection rate of ZFPM2 LOH in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the detection rate of PIK3C2B LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the detection rate of PIK3C2B LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the detection rate of ZNF804A LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the detection rate of RELN LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of EFCAB12 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of EFCAB12 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the detection rate of DEFB115 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the detection rate of ANKDD1A LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the detection rate of ANKDD1A LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the detection rate of ANKDD1A LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the detection rate of HTR3B LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the detection rate of HTR3B LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the detection rate of HTR3B LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the detection rate of ABCC3 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the detection rate of NOMO1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the detection rate of NOMO1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the detection rate of HYOU1 LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the detection rate of FMO4 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+140,BICC1,A372V,Exceptional Responders,What is the detection rate of BICC1 LOH in Exceptional Responders?,freq_cnv_loss_or_gain
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the detection rate of ZMYM3 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the detection rate of ZMYM3 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the detection rate of ZMYM3 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of XKR4 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the detection rate of ABCC2 LOH in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the detection rate of OR8K5 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the detection rate of SPTAN1 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the detection rate of SPTAN1 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the detection rate of SYT10 LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the detection rate of HSPA5 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the detection rate of UNC5D LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the detection rate of UNC5D LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the detection rate of UNC5D LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the detection rate of UNC5D LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the detection rate of UNC5D LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the detection rate of UNC5D LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the detection rate of DOCK2 LOH in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the detection rate of ZNF627 LOH in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the detection rate of CDC42BPA LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the detection rate of MRPL55 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the detection rate of MRPL55 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the detection rate of TMTC3 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the detection rate of EPRS1 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the detection rate of EPRS1 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the detection rate of GRTP1 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the detection rate of GRTP1 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the detection rate of TSHZ3 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the detection rate of TAS1R3 LOH in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,freq_cnv_loss_or_gain
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the detection rate of PIAS3 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the detection rate of PIAS3 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the detection rate of ZNF274 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the detection rate of SYNJ1 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the detection rate of SYNJ1 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the detection rate of SYNJ1 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the detection rate of DSCAM LOH in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the detection rate of DSCAM LOH in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the detection rate of DSCAM LOH in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+267,DGKD,R140H,Exceptional Responders,What is the detection rate of DGKD LOH in Exceptional Responders?,freq_cnv_loss_or_gain
+268,DGKD,R160H,Exceptional Responders,What is the detection rate of DGKD LOH in Exceptional Responders?,freq_cnv_loss_or_gain
+269,DGKD,R204H,Exceptional Responders,What is the detection rate of DGKD LOH in Exceptional Responders?,freq_cnv_loss_or_gain
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the detection rate of PLEKHG6 LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the detection rate of PLEKHG6 LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the detection rate of PLEKHG6 LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the detection rate of WNT2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the detection rate of GUCY2C LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the detection rate of C7orf31 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of ZKSCAN7 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+299,OR5D14,M210L,Neuroblastoma,What is the detection rate of OR5D14 LOH in Neuroblastoma?,freq_cnv_loss_or_gain
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the detection rate of SPATA22 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the detection rate of SPATA22 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the detection rate of SPATA22 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the detection rate of LCN15 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the detection rate of DCAF4L2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the detection rate of GUK1 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the detection rate of GUK1 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the detection rate of GUK1 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the detection rate of GUK1 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the detection rate of GUK1 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the detection rate of MORF4L1 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the detection rate of MORF4L1 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the detection rate of MORF4L1 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the detection rate of MORF4L1 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the detection rate of MYO3B LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the detection rate of MYO3B LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the detection rate of TENT5A LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the detection rate of TENT5A LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the detection rate of TENT5A LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the detection rate of ZFAT LOH in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the detection rate of ZFAT LOH in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the detection rate of ZFAT LOH in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+357,ZNF584,A211T,Sarcoma,What is the detection rate of ZNF584 LOH in Sarcoma?,freq_cnv_loss_or_gain
+358,ZNF584,A256T,Sarcoma,What is the detection rate of ZNF584 LOH in Sarcoma?,freq_cnv_loss_or_gain
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the detection rate of LDOC1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the detection rate of PDGFC LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the detection rate of MSANTD4 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the detection rate of NPSR1 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the detection rate of PHLPP1 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the detection rate of COL6A3 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the detection rate of COL6A3 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the detection rate of COL6A3 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the detection rate of COL6A3 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the detection rate of COL6A3 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the detection rate of ADRA1A LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the detection rate of LAMB2 LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the detection rate of POC1B LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the detection rate of POC1B LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the detection rate of POC1B LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the detection rate of POC1B LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the detection rate of USH2A LOH in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the detection rate of AQP7 LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the detection rate of AQP7 LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the detection rate of AQP7 LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the detection rate of AQP7 LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+430,DCN,R163C,Rectum Adenocarcinoma,What is the detection rate of DCN LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+431,DCN,R203C,Rectum Adenocarcinoma,What is the detection rate of DCN LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+432,DCN,R241C,Rectum Adenocarcinoma,What is the detection rate of DCN LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+433,DCN,R350C,Rectum Adenocarcinoma,What is the detection rate of DCN LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+434,DCN,R41C,Rectum Adenocarcinoma,What is the detection rate of DCN LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the detection rate of CPS1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the detection rate of CPS1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the detection rate of CPS1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the detection rate of FCGR2C LOH in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the detection rate of FCGR2C LOH in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the detection rate of GRM1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the detection rate of SGCZ LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the detection rate of SGCZ LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+485,SMO,V15M,Stomach Adenocarcinoma,What is the detection rate of SMO LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+486,SMO,V321M,Stomach Adenocarcinoma,What is the detection rate of SMO LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the detection rate of CHODL LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the detection rate of CHODL LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the detection rate of CHODL LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+494,MYO16,P399H,Colon Adenocarcinoma,What is the detection rate of MYO16 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+495,MYO16,P421H,Colon Adenocarcinoma,What is the detection rate of MYO16 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the detection rate of CXCR2 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the detection rate of TMEM225 LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the detection rate of MAOB LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the detection rate of GPRASP1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the detection rate of MRPL32 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the detection rate of TYROBP LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the detection rate of RAB40C LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the detection rate of RAB40C LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the detection rate of CTNNA2 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the detection rate of CTNNA2 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the detection rate of CTNNA2 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the detection rate of CTNNA2 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the detection rate of MYO15A LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the detection rate of GIMAP2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the detection rate of KIF20B LOH in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the detection rate of KIF20B LOH in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the detection rate of ADAM17 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the detection rate of BCAT1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the detection rate of BCAT1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the detection rate of BCAT1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the detection rate of ERCC6 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+541,DCC,R320W,Breast Invasive Carcinoma,What is the detection rate of DCC LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+542,DCC,R363W,Breast Invasive Carcinoma,What is the detection rate of DCC LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+543,DCC,R386W,Breast Invasive Carcinoma,What is the detection rate of DCC LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+544,DCC,R41W,Breast Invasive Carcinoma,What is the detection rate of DCC LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the detection rate of FBXO15 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the detection rate of FBXO15 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the detection rate of GSTCD LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the detection rate of GSTCD LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the detection rate of OLFML3 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the detection rate of OLFML3 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the detection rate of OLFML3 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the detection rate of CFAP61 LOH in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the detection rate of CFAP61 LOH in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the detection rate of HLA-DQA2 LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the detection rate of TENM2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the detection rate of TENM2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the detection rate of TENM2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the detection rate of ANKRD24 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the detection rate of ANKRD24 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the detection rate of ANKRD24 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the detection rate of ZCCHC14 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the detection rate of ZCCHC14 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the detection rate of ZCCHC14 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the detection rate of ZCCHC14 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+625,SIK2,I265M,Lung Adenocarcinoma,What is the detection rate of SIK2 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the detection rate of MYH11 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the detection rate of MYH11 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the detection rate of SLC6A4 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the detection rate of SLC9C1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the detection rate of SLC9C1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the detection rate of OR2A12 LOH in Brain Lower Grade Glioma?,freq_cnv_loss_or_gain
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the detection rate of PYHIN1 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the detection rate of PYHIN1 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the detection rate of JAML LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the detection rate of JAML LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the detection rate of JAML LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the detection rate of JAML LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the detection rate of TYK2 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the detection rate of TYK2 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the detection rate of TYK2 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the detection rate of CTCFL LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the detection rate of CTCFL LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the detection rate of CTCFL LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the detection rate of CTCFL LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the detection rate of CEP20 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the detection rate of CEP20 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the detection rate of RIMS2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the detection rate of RIMS2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the detection rate of RIMS2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the detection rate of RIMS2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the detection rate of RIMS2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the detection rate of RIMS2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the detection rate of RIMS2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the detection rate of PIK3C2G LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the detection rate of PIK3C2G LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+728,STK19,D341N,Colon Adenocarcinoma,What is the detection rate of STK19 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+729,STK19,D345N,Colon Adenocarcinoma,What is the detection rate of STK19 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the detection rate of REXO4 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the detection rate of ZBTB34 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the detection rate of ZBTB34 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the detection rate of NCKAP5 LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of SORCS1 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of SORCS1 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of SORCS1 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of SORCS1 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the detection rate of FGF8 LOH in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the detection rate of FGF8 LOH in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the detection rate of FGF8 LOH in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the detection rate of FGF8 LOH in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the detection rate of FGF8 LOH in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the detection rate of TENM3 LOH in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,freq_cnv_loss_or_gain
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the detection rate of AKT1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the detection rate of CFAP298-TCP10L LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the detection rate of GLRB LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+793,TTN,F7636L,Colon Adenocarcinoma,What is the detection rate of TTN LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+794,TTN,F8563L,Colon Adenocarcinoma,What is the detection rate of TTN LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+795,TTN,F8880L,Colon Adenocarcinoma,What is the detection rate of TTN LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the detection rate of ANKRD30A LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the detection rate of ANKRD30A LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the detection rate of ANKRD30A LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the detection rate of TRIM45 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the detection rate of TRIM45 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the detection rate of TRIM45 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the detection rate of CACNA1F LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the detection rate of CACNA1F LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the detection rate of CACNA1F LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+817,KL,R594C,Colon Adenocarcinoma,What is the detection rate of KL LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the detection rate of GUF1 LOH in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the detection rate of TAF1L LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the detection rate of TASOR2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the detection rate of TASOR2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the detection rate of TASOR2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the detection rate of KDM5C LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the detection rate of KDM5C LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the detection rate of KDM5C LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the detection rate of KDM5C LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the detection rate of IL5RA LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the detection rate of DHX16 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the detection rate of DHX16 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the detection rate of GPR158 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the detection rate of GPR158 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of EIF2B4 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of EIF2B4 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of EIF2B4 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of EIF2B4 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of EIF2B4 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of EIF2B4 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the detection rate of AUTS2 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the detection rate of AUTS2 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the detection rate of AUTS2 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the detection rate of AUTS2 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the detection rate of AUTS2 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the detection rate of AUTS2 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the detection rate of AUTS2 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the detection rate of AUTS2 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the detection rate of AUTS2 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the detection rate of AUTS2 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of ACTL7B LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the detection rate of PCDHGA1 LOH in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the detection rate of TRAP1 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the detection rate of TRAP1 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the detection rate of PIK3C2A LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the detection rate of KANSL1 LOH in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the detection rate of ANKRD52 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the detection rate of PAPPA LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the detection rate of B3GALNT1 LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the detection rate of GABRA6 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the detection rate of GABRA6 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the detection rate of GABRA6 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the detection rate of GABRA6 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the detection rate of GABRA6 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the detection rate of ZSCAN31 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of MED16 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of MED16 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the detection rate of PTPRO LOH in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the detection rate of PTPRO LOH in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the detection rate of PTPRO LOH in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the detection rate of PTPRO LOH in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the detection rate of PTPRO LOH in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the detection rate of PTPRO LOH in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the detection rate of PTPRO LOH in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the detection rate of PTPRO LOH in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the detection rate of CHMP7 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the detection rate of GPC3 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the detection rate of GPC3 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the detection rate of TLK2 LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the detection rate of TLK2 LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the detection rate of TLK2 LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the detection rate of TLK2 LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the detection rate of TLK2 LOH in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the detection rate of ZNF217 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the detection rate of SYT9 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the detection rate of SYT9 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the detection rate of PKHD1L1 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the detection rate of MYO3A LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of VASN LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the detection rate of DNMT1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the detection rate of DNMT1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the detection rate of DNMT1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1056,CA9,E402K,Colon Adenocarcinoma,What is the detection rate of CA9 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the detection rate of TTC17 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the detection rate of TTC17 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the detection rate of PSG2 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the detection rate of RIPOR2 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the detection rate of RIPOR2 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the detection rate of RIPOR2 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the detection rate of RIPOR2 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the detection rate of DCLK3 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the detection rate of DCLK3 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the detection rate of MERTK LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the detection rate of MERTK LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the detection rate of MERTK LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the detection rate of ZFP42 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the detection rate of OR13C3 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the detection rate of OR13C3 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the detection rate of SPAG1 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the detection rate of CDKN2AIP LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the detection rate of PXN LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the detection rate of PXN LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the detection rate of PXN LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the detection rate of PXN LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the detection rate of PXN LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the detection rate of PXN LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the detection rate of TTYH2 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the detection rate of TTYH2 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the detection rate of TMEM255A LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the detection rate of TMEM255A LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the detection rate of TMEM255A LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the detection rate of TASOR2 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the detection rate of TASOR2 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the detection rate of ICE1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the detection rate of MYT1 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the detection rate of MYT1 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the detection rate of MYT1 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the detection rate of CX3CR1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the detection rate of CX3CR1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the detection rate of SPINDOC LOH in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the detection rate of ART3 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the detection rate of ART3 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the detection rate of CYP1A2 LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of ADRA1A LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the detection rate of CDH23 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the detection rate of CDH23 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the detection rate of KRT39 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the detection rate of PDHA2 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the detection rate of SLC24A2 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the detection rate of PTPRN2 LOH in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the detection rate of PTPRN2 LOH in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the detection rate of PTPRN2 LOH in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the detection rate of PTPRN2 LOH in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the detection rate of PTPRN2 LOH in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the detection rate of SOX21 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the detection rate of CPA6 LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the detection rate of GRM5 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of CASZ1 LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the detection rate of SGIP1 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the detection rate of SGIP1 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the detection rate of SGIP1 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the detection rate of SGIP1 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the detection rate of CARMIL1 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the detection rate of CARMIL1 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the detection rate of ZNF431 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the detection rate of ZNF431 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the detection rate of ZNF431 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the detection rate of DNAH11 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the detection rate of DNAH11 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the detection rate of POLD1 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the detection rate of POLD1 LOH in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the detection rate of TTC12 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the detection rate of TTC12 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the detection rate of CNGB1 LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the detection rate of CNGB1 LOH in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the detection rate of CTSC LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the detection rate of CTSC LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the detection rate of CTSC LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the detection rate of CTSC LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the detection rate of CTSC LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the detection rate of PRSS8 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the detection rate of PRSS8 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the detection rate of ARHGEF40 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the detection rate of ACTB LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the detection rate of ACTB LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the detection rate of ACTB LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the detection rate of ACTB LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the detection rate of YY1AP1 LOH in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the detection rate of YY1AP1 LOH in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the detection rate of YY1AP1 LOH in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the detection rate of YY1AP1 LOH in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the detection rate of YY1AP1 LOH in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the detection rate of YY1AP1 LOH in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the detection rate of YY1AP1 LOH in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the detection rate of FNDC7 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the detection rate of FNDC7 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the detection rate of TLCD5 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the detection rate of TLCD5 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the detection rate of POLR1G LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the detection rate of POLR1G LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the detection rate of DNAH14 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the detection rate of DNAH14 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the detection rate of DNAH14 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the detection rate of NEXN LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the detection rate of CYB5R2 LOH in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the detection rate of CYB5R2 LOH in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the detection rate of NRAP LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the detection rate of NRAP LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the detection rate of NRAP LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the detection rate of CCDC22 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the detection rate of DCAF6 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the detection rate of DCAF6 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the detection rate of ZNF708 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the detection rate of BFAR LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the detection rate of MAST4 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the detection rate of MAST4 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the detection rate of MAST4 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the detection rate of MAST4 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the detection rate of MAST4 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the detection rate of ARMC3 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the detection rate of ARMC3 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the detection rate of TET2 LOH in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the detection rate of TET2 LOH in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the detection rate of SERPINB10 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the detection rate of STAT3 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the detection rate of MIEF1 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the detection rate of ACVR1B LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the detection rate of ACVR1B LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the detection rate of ACVR1B LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the detection rate of EBF2 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the detection rate of EBF2 LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the detection rate of VPS26B LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of PGR LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of PGR LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the detection rate of PGR LOH in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the detection rate of ACTA2 LOH in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the detection rate of THBS4 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the detection rate of THBS4 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the detection rate of PRSS1 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the detection rate of PRSS1 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the detection rate of PRSS1 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the detection rate of PRSS1 LOH in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the detection rate of PGF LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the detection rate of PGF LOH in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the detection rate of ITPRID2 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the detection rate of ITPRID2 LOH in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the detection rate of HBB LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the detection rate of PCDHB2 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the detection rate of PCDHB2 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the detection rate of PCDHB2 LOH in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the detection rate of UBR2 LOH in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the detection rate of FBXO42 LOH in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1,TNS1,G1362V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit cogains in TNS1 and ACTB?,freq_cnv_loss_or_gain
+2,TNS1,G1711V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit cogains in TNS1 and TRIM45?,freq_cnv_loss_or_gain
+3,TNS1,G1718V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit cogains in TNS1 and FRY?,freq_cnv_loss_or_gain
+4,TNS1,G1732V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit cogains in TNS1 and PGF?,freq_cnv_loss_or_gain
+5,TNS1,G1824V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit cogains in TNS1 and TENT5A?,freq_cnv_loss_or_gain
+6,TNS1,G1857V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit cogains in TNS1 and CTNNA2?,freq_cnv_loss_or_gain
+7,TNS1,G843V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit cogains in TNS1 and DNAH11?,freq_cnv_loss_or_gain
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit cogains in EVC2 and CNGB1?,freq_cnv_loss_or_gain
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit cogains in EVC2 and MYH11?,freq_cnv_loss_or_gain
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in CR1 and SMO?,freq_cnv_loss_or_gain
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in CR1 and CX3CR1?,freq_cnv_loss_or_gain
+22,TRPA1,S295I,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit cogains in TRPA1 and UNC5D?,freq_cnv_loss_or_gain
+23,TRPA1,S443I,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit cogains in TRPA1 and CFAP61?,freq_cnv_loss_or_gain
+24,TAF1C,R299L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in TAF1C and TLK2?,freq_cnv_loss_or_gain
+25,TAF1C,R396L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in TAF1C and ACTA2?,freq_cnv_loss_or_gain
+26,TAF1C,R634L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in TAF1C and MRPL55?,freq_cnv_loss_or_gain
+27,TAF1C,R702L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in TAF1C and ANP32E?,freq_cnv_loss_or_gain
+28,TAF1C,R728L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in TAF1C and TTYH2?,freq_cnv_loss_or_gain
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in DPF3 and EPRS1?,freq_cnv_loss_or_gain
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in DPF3 and ZNF431?,freq_cnv_loss_or_gain
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in DPF3 and CTNNA2?,freq_cnv_loss_or_gain
+42,OR2T4,P272H,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in OR2T4 and ADAM17?,freq_cnv_loss_or_gain
+43,OR2T4,P300H,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in OR2T4 and ZFPM2?,freq_cnv_loss_or_gain
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma patients exhibit cogains in FBN1 and TNS1?,freq_cnv_loss_or_gain
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma patients exhibit cogains in MAD1L1 and EPRS1?,freq_cnv_loss_or_gain
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma patients exhibit cogains in MAD1L1 and SPATA22?,freq_cnv_loss_or_gain
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma patients exhibit cogains in MAD1L1 and TRIM45?,freq_cnv_loss_or_gain
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in CCNG1 and TASOR2?,freq_cnv_loss_or_gain
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma patients exhibit cogains in ANP32E and CCDC22?,freq_cnv_loss_or_gain
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma patients exhibit cogains in ANP32E and TENM2?,freq_cnv_loss_or_gain
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma patients exhibit cogains in ANP32E and POLD1?,freq_cnv_loss_or_gain
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma patients exhibit cogains in ANP32E and ERCC6?,freq_cnv_loss_or_gain
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit cogains in FRY and ADRA1A?,freq_cnv_loss_or_gain
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit cogains in FRY and TLK2?,freq_cnv_loss_or_gain
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit cogains in FRY and PGF?,freq_cnv_loss_or_gain
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit cogains in FRY and AUTS2?,freq_cnv_loss_or_gain
+70,PAK3,E318K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in PAK3 and PKHD1L1?,freq_cnv_loss_or_gain
+71,PAK3,E319K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in PAK3 and ACTB?,freq_cnv_loss_or_gain
+72,PAK3,E334K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in PAK3 and PIK3C2A?,freq_cnv_loss_or_gain
+73,PAK3,E340K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in PAK3 and JAML?,freq_cnv_loss_or_gain
+74,PAK3,E355K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in PAK3 and MIEF1?,freq_cnv_loss_or_gain
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in MUC16 and PTPRO?,freq_cnv_loss_or_gain
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients exhibit cogains in ZFPM2 and PRSS1?,freq_cnv_loss_or_gain
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients exhibit cogains in ZFPM2 and MORF4L1?,freq_cnv_loss_or_gain
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit cogains in PIK3C2B and ZBTB34?,freq_cnv_loss_or_gain
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit cogains in PIK3C2B and SGIP1?,freq_cnv_loss_or_gain
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in ZNF804A and MYH11?,freq_cnv_loss_or_gain
+116,RELN,A2371V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in RELN and MYT1?,freq_cnv_loss_or_gain
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit cogains in EFCAB12 and CTCFL?",freq_cnv_loss_or_gain
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit cogains in EFCAB12 and DCN?",freq_cnv_loss_or_gain
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in DEFB115 and GUK1?,freq_cnv_loss_or_gain
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit cogains in ANKDD1A and TAF1C?,freq_cnv_loss_or_gain
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit cogains in ANKDD1A and MORF4L1?,freq_cnv_loss_or_gain
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit cogains in ANKDD1A and FCGR2C?,freq_cnv_loss_or_gain
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in HTR3B and SLC6A4?,freq_cnv_loss_or_gain
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in HTR3B and GRM5?,freq_cnv_loss_or_gain
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in HTR3B and FBN1?,freq_cnv_loss_or_gain
+129,ABCC3,R758W,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in ABCC3 and SPTAN1?,freq_cnv_loss_or_gain
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in NOMO1 and AUTS2?,freq_cnv_loss_or_gain
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in NOMO1 and MYO3B?,freq_cnv_loss_or_gain
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit cogains in HYOU1 and DSCAM?,freq_cnv_loss_or_gain
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in FMO4 and UBR2?,freq_cnv_loss_or_gain
+140,BICC1,A372V,Exceptional Responders,How many Exceptional Responders patients exhibit cogains in BICC1 and CTSC?,freq_cnv_loss_or_gain
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in ZMYM3 and AUTS2?,freq_cnv_loss_or_gain
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in ZMYM3 and ADRA1A?,freq_cnv_loss_or_gain
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in ZMYM3 and FBXO42?,freq_cnv_loss_or_gain
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit cogains in XKR4 and ZBTB34?",freq_cnv_loss_or_gain
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients exhibit cogains in ABCC2 and KL?,freq_cnv_loss_or_gain
+157,OR8K5,R293G,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in OR8K5 and ZMYM3?,freq_cnv_loss_or_gain
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in SPTAN1 and ANP32E?,freq_cnv_loss_or_gain
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in SPTAN1 and SGIP1?,freq_cnv_loss_or_gain
+164,SYT10,M484I,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit cogains in SYT10 and KL?,freq_cnv_loss_or_gain
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in HSPA5 and MORF4L1?,freq_cnv_loss_or_gain
+175,UNC5D,L280V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in UNC5D and TLK2?,freq_cnv_loss_or_gain
+176,UNC5D,L635V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in UNC5D and RAB40C?,freq_cnv_loss_or_gain
+177,UNC5D,L637V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in UNC5D and ACTL7B?,freq_cnv_loss_or_gain
+178,UNC5D,L699V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in UNC5D and SIK2?,freq_cnv_loss_or_gain
+179,UNC5D,L704V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in UNC5D and UNC5D?,freq_cnv_loss_or_gain
+180,UNC5D,L709V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in UNC5D and PTPRO?,freq_cnv_loss_or_gain
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How many Kidney Renal Clear Cell Carcinoma patients exhibit cogains in DOCK2 and OR5D14?,freq_cnv_loss_or_gain
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How many Kidney Renal Clear Cell Carcinoma patients exhibit cogains in ZNF627 and CA9?,freq_cnv_loss_or_gain
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in CDC42BPA and FGF8?,freq_cnv_loss_or_gain
+193,MRPL55,H27Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in MRPL55 and ANP32E?,freq_cnv_loss_or_gain
+194,MRPL55,H63Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in MRPL55 and PIK3C2B?,freq_cnv_loss_or_gain
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit cogains in TMTC3 and BCAT1?,freq_cnv_loss_or_gain
+198,EPRS1,K771I,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in EPRS1 and DCN?,freq_cnv_loss_or_gain
+199,EPRS1,K778I,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in EPRS1 and PAK3?,freq_cnv_loss_or_gain
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in GRTP1 and SPTAN1?,freq_cnv_loss_or_gain
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in GRTP1 and FGF8?,freq_cnv_loss_or_gain
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in TSHZ3 and GABRA6?,freq_cnv_loss_or_gain
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How many HIV+ Tumor Molecular Characterization Project - Cervical Cancer patients exhibit cogains in TAS1R3 and CHMP7?,freq_cnv_loss_or_gain
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in PIAS3 and AUTS2?,freq_cnv_loss_or_gain
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in PIAS3 and CR1?,freq_cnv_loss_or_gain
+251,ZNF274,P13R,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in ZNF274 and COL6A3?,freq_cnv_loss_or_gain
+253,SYNJ1,R795C,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in SYNJ1 and NRAP?,freq_cnv_loss_or_gain
+254,SYNJ1,R800C,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in SYNJ1 and AUTS2?,freq_cnv_loss_or_gain
+255,SYNJ1,R839C,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in SYNJ1 and NRAP?,freq_cnv_loss_or_gain
+261,DSCAM,V343M,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma patients exhibit cogains in DSCAM and TAF1C?,freq_cnv_loss_or_gain
+262,DSCAM,V426M,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma patients exhibit cogains in DSCAM and TTYH2?,freq_cnv_loss_or_gain
+263,DSCAM,V591M,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma patients exhibit cogains in DSCAM and PKHD1L1?,freq_cnv_loss_or_gain
+267,DGKD,R140H,Exceptional Responders,How many Exceptional Responders patients exhibit cogains in DGKD and MERTK?,freq_cnv_loss_or_gain
+268,DGKD,R160H,Exceptional Responders,How many Exceptional Responders patients exhibit cogains in DGKD and SORCS1?,freq_cnv_loss_or_gain
+269,DGKD,R204H,Exceptional Responders,How many Exceptional Responders patients exhibit cogains in DGKD and TNS1?,freq_cnv_loss_or_gain
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit cogains in PLEKHG6 and PHLPP1?,freq_cnv_loss_or_gain
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit cogains in PLEKHG6 and YY1AP1?,freq_cnv_loss_or_gain
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit cogains in PLEKHG6 and YY1AP1?,freq_cnv_loss_or_gain
+279,WNT2,D138N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in WNT2 and ACVR1B?,freq_cnv_loss_or_gain
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in GUCY2C and AKT1?,freq_cnv_loss_or_gain
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in C7orf31 and RIMS2?,freq_cnv_loss_or_gain
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit cogains in ZKSCAN7 and MAD1L1?",freq_cnv_loss_or_gain
+299,OR5D14,M210L,Neuroblastoma,How many Neuroblastoma patients exhibit cogains in OR5D14 and POC1B?,freq_cnv_loss_or_gain
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in SPATA22 and ANKDD1A?,freq_cnv_loss_or_gain
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in SPATA22 and MERTK?,freq_cnv_loss_or_gain
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in SPATA22 and ANKRD52?,freq_cnv_loss_or_gain
+310,LCN15,E21V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in LCN15 and TAF1C?,freq_cnv_loss_or_gain
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in DCAF4L2 and DGKD?,freq_cnv_loss_or_gain
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in GUK1 and BCAT1?,freq_cnv_loss_or_gain
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in GUK1 and CTCFL?,freq_cnv_loss_or_gain
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in GUK1 and FRY?,freq_cnv_loss_or_gain
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in GUK1 and LAMB2?,freq_cnv_loss_or_gain
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in GUK1 and SPATA22?,freq_cnv_loss_or_gain
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in MORF4L1 and PRSS1?,freq_cnv_loss_or_gain
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in MORF4L1 and TAF1C?,freq_cnv_loss_or_gain
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in MORF4L1 and FCGR2C?,freq_cnv_loss_or_gain
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in MORF4L1 and ZSCAN31?,freq_cnv_loss_or_gain
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in MYO3B and TTC17?,freq_cnv_loss_or_gain
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in MYO3B and CYB5R2?,freq_cnv_loss_or_gain
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in TENT5A and ANKRD30A?,freq_cnv_loss_or_gain
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in TENT5A and PTPRO?,freq_cnv_loss_or_gain
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in TENT5A and PXN?,freq_cnv_loss_or_gain
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How many Ovarian Serous Cystadenocarcinoma patients exhibit cogains in ZFAT and CX3CR1?,freq_cnv_loss_or_gain
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How many Ovarian Serous Cystadenocarcinoma patients exhibit cogains in ZFAT and RIMS2?,freq_cnv_loss_or_gain
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How many Ovarian Serous Cystadenocarcinoma patients exhibit cogains in ZFAT and GPC3?,freq_cnv_loss_or_gain
+357,ZNF584,A211T,Sarcoma,How many Sarcoma patients exhibit cogains in ZNF584 and MYO3B?,freq_cnv_loss_or_gain
+358,ZNF584,A256T,Sarcoma,How many Sarcoma patients exhibit cogains in ZNF584 and KDM5C?,freq_cnv_loss_or_gain
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in LDOC1 and EFCAB12?,freq_cnv_loss_or_gain
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in PDGFC and TYK2?,freq_cnv_loss_or_gain
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in MSANTD4 and EVC2?,freq_cnv_loss_or_gain
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in NPSR1 and MAD1L1?,freq_cnv_loss_or_gain
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in PHLPP1 and SOX21?,freq_cnv_loss_or_gain
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in COL6A3 and DNMT1?,freq_cnv_loss_or_gain
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in COL6A3 and PRSS1?,freq_cnv_loss_or_gain
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in COL6A3 and RAB40C?,freq_cnv_loss_or_gain
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in COL6A3 and ZNF627?,freq_cnv_loss_or_gain
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in COL6A3 and PGR?,freq_cnv_loss_or_gain
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in ADRA1A and ART3?,freq_cnv_loss_or_gain
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients exhibit cogains in LAMB2 and TAF1C?,freq_cnv_loss_or_gain
+406,POC1B,I198T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit cogains in POC1B and EVC2?,freq_cnv_loss_or_gain
+407,POC1B,I286T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit cogains in POC1B and YY1AP1?,freq_cnv_loss_or_gain
+408,POC1B,I328T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit cogains in POC1B and ABCC3?,freq_cnv_loss_or_gain
+409,POC1B,S79P,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit cogains in POC1B and FBXO15?,freq_cnv_loss_or_gain
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients exhibit cogains in USH2A and ARHGEF40?,freq_cnv_loss_or_gain
+414,AQP7,T110S,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit cogains in AQP7 and ZFAT?,freq_cnv_loss_or_gain
+415,AQP7,T166S,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit cogains in AQP7 and DCC?,freq_cnv_loss_or_gain
+416,AQP7,T167S,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit cogains in AQP7 and OR8K5?,freq_cnv_loss_or_gain
+417,AQP7,T75S,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit cogains in AQP7 and ZFAT?,freq_cnv_loss_or_gain
+430,DCN,R163C,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit cogains in DCN and MYT1?,freq_cnv_loss_or_gain
+431,DCN,R203C,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit cogains in DCN and CYP1A2?,freq_cnv_loss_or_gain
+432,DCN,R241C,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit cogains in DCN and YY1AP1?,freq_cnv_loss_or_gain
+433,DCN,R350C,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit cogains in DCN and JAML?,freq_cnv_loss_or_gain
+434,DCN,R41C,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit cogains in DCN and KDM5C?,freq_cnv_loss_or_gain
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in CPS1 and YY1AP1?,freq_cnv_loss_or_gain
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in CPS1 and ZFPM2?,freq_cnv_loss_or_gain
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in CPS1 and CYB5R2?,freq_cnv_loss_or_gain
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma patients exhibit cogains in FCGR2C and ICE1?,freq_cnv_loss_or_gain
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma patients exhibit cogains in FCGR2C and FRY?,freq_cnv_loss_or_gain
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in GRM1 and TYK2?,freq_cnv_loss_or_gain
+482,SGCZ,Q138H,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in SGCZ and MAST4?,freq_cnv_loss_or_gain
+483,SGCZ,Q91H,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in SGCZ and ARMC3?,freq_cnv_loss_or_gain
+485,SMO,V15M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in SMO and PDGFC?,freq_cnv_loss_or_gain
+486,SMO,V321M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in SMO and DNAH11?,freq_cnv_loss_or_gain
+488,CHODL,G159E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in CHODL and DCC?,freq_cnv_loss_or_gain
+489,CHODL,G181E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in CHODL and SORCS1?,freq_cnv_loss_or_gain
+490,CHODL,G200E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in CHODL and ANP32E?,freq_cnv_loss_or_gain
+494,MYO16,P399H,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in MYO16 and DNAH11?,freq_cnv_loss_or_gain
+495,MYO16,P421H,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in MYO16 and MRPL55?,freq_cnv_loss_or_gain
+498,CXCR2,A98V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in CXCR2 and TYROBP?,freq_cnv_loss_or_gain
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit cogains in TMEM225 and TENT5A?,freq_cnv_loss_or_gain
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in MAOB and HTR3B?,freq_cnv_loss_or_gain
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in GPRASP1 and HSPA5?,freq_cnv_loss_or_gain
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in MRPL32 and RIPOR2?,freq_cnv_loss_or_gain
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in TYROBP and ZFPM2?,freq_cnv_loss_or_gain
+510,RAB40C,A111V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in RAB40C and SPAG1?,freq_cnv_loss_or_gain
+511,RAB40C,A143V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in RAB40C and TLK2?,freq_cnv_loss_or_gain
+512,CTNNA2,S323R,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in CTNNA2 and TLCD5?,freq_cnv_loss_or_gain
+513,CTNNA2,S339R,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in CTNNA2 and KDM5C?,freq_cnv_loss_or_gain
+514,CTNNA2,S386R,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in CTNNA2 and ANKRD52?,freq_cnv_loss_or_gain
+515,CTNNA2,S707R,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in CTNNA2 and RIMS2?,freq_cnv_loss_or_gain
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit cogains in MYO15A and ANKRD30A?,freq_cnv_loss_or_gain
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in GIMAP2 and ZKSCAN7?,freq_cnv_loss_or_gain
+532,KIF20B,N1160D,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients exhibit cogains in KIF20B and SLC24A2?,freq_cnv_loss_or_gain
+533,KIF20B,N1200D,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients exhibit cogains in KIF20B and MYT1?,freq_cnv_loss_or_gain
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in ADAM17 and FGF8?,freq_cnv_loss_or_gain
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in BCAT1 and ZMYM3?,freq_cnv_loss_or_gain
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in BCAT1 and AUTS2?,freq_cnv_loss_or_gain
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in BCAT1 and AUTS2?,freq_cnv_loss_or_gain
+540,ERCC6,R1053H,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in ERCC6 and NRAP?,freq_cnv_loss_or_gain
+541,DCC,R320W,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit cogains in DCC and REXO4?,freq_cnv_loss_or_gain
+542,DCC,R363W,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit cogains in DCC and TRAP1?,freq_cnv_loss_or_gain
+543,DCC,R386W,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit cogains in DCC and PGR?,freq_cnv_loss_or_gain
+544,DCC,R41W,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit cogains in DCC and TYK2?,freq_cnv_loss_or_gain
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in FBXO15 and GUK1?,freq_cnv_loss_or_gain
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in FBXO15 and PAK3?,freq_cnv_loss_or_gain
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in GSTCD and SGIP1?,freq_cnv_loss_or_gain
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in GSTCD and NRAP?,freq_cnv_loss_or_gain
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in OLFML3 and OR8K5?,freq_cnv_loss_or_gain
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in OLFML3 and CR1?,freq_cnv_loss_or_gain
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in OLFML3 and ZNF804A?,freq_cnv_loss_or_gain
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How many Ovarian Serous Cystadenocarcinoma patients exhibit cogains in CFAP61 and ICE1?,freq_cnv_loss_or_gain
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How many Ovarian Serous Cystadenocarcinoma patients exhibit cogains in CFAP61 and ACVR1B?,freq_cnv_loss_or_gain
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit cogains in HLA-DQA2 and ACTB?,freq_cnv_loss_or_gain
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in TENM2 and CPS1?,freq_cnv_loss_or_gain
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in TENM2 and CPS1?,freq_cnv_loss_or_gain
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in TENM2 and TYK2?,freq_cnv_loss_or_gain
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in ANKRD24 and ARMC3?,freq_cnv_loss_or_gain
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in ANKRD24 and KDM5C?,freq_cnv_loss_or_gain
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in ANKRD24 and PTPRO?,freq_cnv_loss_or_gain
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in ZCCHC14 and RELN?,freq_cnv_loss_or_gain
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in ZCCHC14 and FBXO15?,freq_cnv_loss_or_gain
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in ZCCHC14 and ANKRD24?,freq_cnv_loss_or_gain
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in ZCCHC14 and PIK3C2G?,freq_cnv_loss_or_gain
+625,SIK2,I265M,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in SIK2 and PAPPA?,freq_cnv_loss_or_gain
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in MYH11 and FNDC7?,freq_cnv_loss_or_gain
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in MYH11 and PXN?,freq_cnv_loss_or_gain
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in SLC6A4 and TMEM255A?,freq_cnv_loss_or_gain
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in SLC9C1 and HSPA5?,freq_cnv_loss_or_gain
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in SLC9C1 and DCLK3?,freq_cnv_loss_or_gain
+644,OR2A12,A254T,Brain Lower Grade Glioma,How many Brain Lower Grade Glioma patients exhibit cogains in OR2A12 and ANKRD24?,freq_cnv_loss_or_gain
+646,PYHIN1,T325K,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in PYHIN1 and PSG2?,freq_cnv_loss_or_gain
+647,PYHIN1,T334K,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in PYHIN1 and CFAP298-TCP10L?,freq_cnv_loss_or_gain
+650,JAML,G191E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in JAML and RIMS2?,freq_cnv_loss_or_gain
+651,JAML,G219E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in JAML and OLFML3?,freq_cnv_loss_or_gain
+652,JAML,G220E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in JAML and PXN?,freq_cnv_loss_or_gain
+653,JAML,G230E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in JAML and ADRA1A?,freq_cnv_loss_or_gain
+658,TYK2,H1146R,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in TYK2 and RIMS2?,freq_cnv_loss_or_gain
+659,TYK2,H23R,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in TYK2 and ZFAT?,freq_cnv_loss_or_gain
+660,TYK2,H961R,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in TYK2 and TAF1C?,freq_cnv_loss_or_gain
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in CTCFL and PAK3?,freq_cnv_loss_or_gain
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in CTCFL and TAF1C?,freq_cnv_loss_or_gain
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in CTCFL and TAF1C?,freq_cnv_loss_or_gain
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in CTCFL and EPRS1?,freq_cnv_loss_or_gain
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in CEP20 and TTC12?,freq_cnv_loss_or_gain
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in CEP20 and UNC5D?,freq_cnv_loss_or_gain
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in RIMS2 and TNS1?,freq_cnv_loss_or_gain
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in RIMS2 and MYO15A?,freq_cnv_loss_or_gain
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in RIMS2 and SYNJ1?,freq_cnv_loss_or_gain
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in RIMS2 and FMO4?,freq_cnv_loss_or_gain
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in RIMS2 and JAML?,freq_cnv_loss_or_gain
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in RIMS2 and TLCD5?,freq_cnv_loss_or_gain
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in RIMS2 and OR13C3?,freq_cnv_loss_or_gain
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in PIK3C2G and FGF8?,freq_cnv_loss_or_gain
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in PIK3C2G and GPRASP1?,freq_cnv_loss_or_gain
+728,STK19,D341N,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in STK19 and ABCC3?,freq_cnv_loss_or_gain
+729,STK19,D345N,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in STK19 and OLFML3?,freq_cnv_loss_or_gain
+730,REXO4,P60A,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in REXO4 and FGF8?,freq_cnv_loss_or_gain
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in ZBTB34 and MYH11?,freq_cnv_loss_or_gain
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in ZBTB34 and PTPRO?,freq_cnv_loss_or_gain
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit cogains in NCKAP5 and CACNA1F?,freq_cnv_loss_or_gain
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit cogains in SORCS1 and ITPRID2?",freq_cnv_loss_or_gain
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit cogains in SORCS1 and FMO4?",freq_cnv_loss_or_gain
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit cogains in SORCS1 and PAK3?",freq_cnv_loss_or_gain
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit cogains in SORCS1 and TTC17?",freq_cnv_loss_or_gain
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How many Head and Neck Squamous Cell Carcinoma patients exhibit cogains in FGF8 and B3GALNT1?,freq_cnv_loss_or_gain
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How many Head and Neck Squamous Cell Carcinoma patients exhibit cogains in FGF8 and MRPL32?,freq_cnv_loss_or_gain
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How many Head and Neck Squamous Cell Carcinoma patients exhibit cogains in FGF8 and TASOR2?,freq_cnv_loss_or_gain
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How many Head and Neck Squamous Cell Carcinoma patients exhibit cogains in FGF8 and SOX21?,freq_cnv_loss_or_gain
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How many Head and Neck Squamous Cell Carcinoma patients exhibit cogains in FGF8 and TLK2?,freq_cnv_loss_or_gain
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How many Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia patients exhibit cogains in TENM3 and MYO16?,freq_cnv_loss_or_gain
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in AKT1 and ACTB?,freq_cnv_loss_or_gain
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients exhibit cogains in CFAP298-TCP10L and DCC?,freq_cnv_loss_or_gain
+792,GLRB,E148D,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in GLRB and FBN1?,freq_cnv_loss_or_gain
+793,TTN,F7636L,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in TTN and RIMS2?,freq_cnv_loss_or_gain
+794,TTN,F8563L,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in TTN and UNC5D?,freq_cnv_loss_or_gain
+795,TTN,F8880L,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in TTN and SLC9C1?,freq_cnv_loss_or_gain
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in ANKRD30A and PCDHB2?,freq_cnv_loss_or_gain
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in ANKRD30A and TENM2?,freq_cnv_loss_or_gain
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in ANKRD30A and UNC5D?,freq_cnv_loss_or_gain
+809,TRIM45,S177L,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in TRIM45 and PAPPA?,freq_cnv_loss_or_gain
+810,TRIM45,S224L,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in TRIM45 and CPS1?,freq_cnv_loss_or_gain
+811,TRIM45,S281L,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in TRIM45 and TRPA1?,freq_cnv_loss_or_gain
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in CACNA1F and KDM5C?,freq_cnv_loss_or_gain
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in CACNA1F and PGF?,freq_cnv_loss_or_gain
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in CACNA1F and TYK2?,freq_cnv_loss_or_gain
+817,KL,R594C,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in KL and ANP32E?,freq_cnv_loss_or_gain
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma patients exhibit cogains in GUF1 and RIMS2?,freq_cnv_loss_or_gain
+822,TAF1L,A539V,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in TAF1L and SGIP1?,freq_cnv_loss_or_gain
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in TASOR2 and TYK2?,freq_cnv_loss_or_gain
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in TASOR2 and OR8K5?,freq_cnv_loss_or_gain
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in TASOR2 and YY1AP1?,freq_cnv_loss_or_gain
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in KDM5C and ZNF431?,freq_cnv_loss_or_gain
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in KDM5C and TTN?,freq_cnv_loss_or_gain
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in KDM5C and PCDHB2?,freq_cnv_loss_or_gain
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in KDM5C and PTPRN2?,freq_cnv_loss_or_gain
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients exhibit cogains in IL5RA and PTPRN2?,freq_cnv_loss_or_gain
+843,DHX16,A29V,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in DHX16 and DGKD?,freq_cnv_loss_or_gain
+844,DHX16,A89V,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in DHX16 and CTSC?,freq_cnv_loss_or_gain
+902,GPR158,A644V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in GPR158 and POC1B?,freq_cnv_loss_or_gain
+903,GPR158,A723V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in GPR158 and CTSC?,freq_cnv_loss_or_gain
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit cogains in EIF2B4 and KL?",freq_cnv_loss_or_gain
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit cogains in EIF2B4 and TLK2?",freq_cnv_loss_or_gain
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit cogains in EIF2B4 and TRIM45?",freq_cnv_loss_or_gain
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit cogains in EIF2B4 and RIPOR2?",freq_cnv_loss_or_gain
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit cogains in EIF2B4 and SMO?",freq_cnv_loss_or_gain
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit cogains in EIF2B4 and ZMYM3?",freq_cnv_loss_or_gain
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in AUTS2 and ANKRD24?,freq_cnv_loss_or_gain
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in AUTS2 and POLD1?,freq_cnv_loss_or_gain
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in AUTS2 and HBB?,freq_cnv_loss_or_gain
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in AUTS2 and ANP32E?,freq_cnv_loss_or_gain
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in AUTS2 and CFAP61?,freq_cnv_loss_or_gain
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in AUTS2 and AQP7?,freq_cnv_loss_or_gain
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in AUTS2 and UNC5D?,freq_cnv_loss_or_gain
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in AUTS2 and TTC17?,freq_cnv_loss_or_gain
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in AUTS2 and ZNF431?,freq_cnv_loss_or_gain
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in AUTS2 and KIF20B?,freq_cnv_loss_or_gain
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit cogains in ACTL7B and STK19?",freq_cnv_loss_or_gain
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients exhibit cogains in PCDHGA1 and CR1?,freq_cnv_loss_or_gain
+954,TRAP1,R114W,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in TRAP1 and DSCAM?,freq_cnv_loss_or_gain
+955,TRAP1,R61W,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in TRAP1 and ADRA1A?,freq_cnv_loss_or_gain
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in PIK3C2A and MAST4?,freq_cnv_loss_or_gain
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients exhibit cogains in KANSL1 and CR1?,freq_cnv_loss_or_gain
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in ANKRD52 and SMO?,freq_cnv_loss_or_gain
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in PAPPA and CYB5R2?,freq_cnv_loss_or_gain
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit cogains in B3GALNT1 and MERTK?,freq_cnv_loss_or_gain
+982,GABRA6,G115R,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in GABRA6 and POC1B?,freq_cnv_loss_or_gain
+983,GABRA6,G122R,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in GABRA6 and PLEKHG6?,freq_cnv_loss_or_gain
+984,GABRA6,G165R,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in GABRA6 and PIAS3?,freq_cnv_loss_or_gain
+985,GABRA6,G175R,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in GABRA6 and TAF1C?,freq_cnv_loss_or_gain
+986,GABRA6,G70R,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in GABRA6 and GRM5?,freq_cnv_loss_or_gain
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in ZSCAN31 and ARMC3?,freq_cnv_loss_or_gain
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit cogains in MED16 and TTC12?",freq_cnv_loss_or_gain
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit cogains in MED16 and ZFPM2?",freq_cnv_loss_or_gain
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma patients exhibit cogains in PTPRO and ZFAT?,freq_cnv_loss_or_gain
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma patients exhibit cogains in PTPRO and DCLK3?,freq_cnv_loss_or_gain
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma patients exhibit cogains in PTPRO and SPAG1?,freq_cnv_loss_or_gain
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma patients exhibit cogains in PTPRO and TNS1?,freq_cnv_loss_or_gain
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma patients exhibit cogains in PTPRO and STK19?,freq_cnv_loss_or_gain
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma patients exhibit cogains in PTPRO and MAD1L1?,freq_cnv_loss_or_gain
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma patients exhibit cogains in PTPRO and ANKRD30A?,freq_cnv_loss_or_gain
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma patients exhibit cogains in PTPRO and PAPPA?,freq_cnv_loss_or_gain
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in CHMP7 and PCDHB2?,freq_cnv_loss_or_gain
+1017,GPC3,I107N,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in GPC3 and FMO4?,freq_cnv_loss_or_gain
+1018,GPC3,I161N,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in GPC3 and LCN15?,freq_cnv_loss_or_gain
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients exhibit cogains in TLK2 and DCC?,freq_cnv_loss_or_gain
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients exhibit cogains in TLK2 and BCAT1?,freq_cnv_loss_or_gain
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients exhibit cogains in TLK2 and DGKD?,freq_cnv_loss_or_gain
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients exhibit cogains in TLK2 and CPA6?,freq_cnv_loss_or_gain
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients exhibit cogains in TLK2 and DNAH11?,freq_cnv_loss_or_gain
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in ZNF217 and NRAP?,freq_cnv_loss_or_gain
+1038,SYT9,V275L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in SYT9 and KIF20B?,freq_cnv_loss_or_gain
+1039,SYT9,V307L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in SYT9 and ZMYM3?,freq_cnv_loss_or_gain
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in PKHD1L1 and TLCD5?,freq_cnv_loss_or_gain
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in MYO3A and CXCR2?,freq_cnv_loss_or_gain
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit cogains in VASN and ZNF708?",freq_cnv_loss_or_gain
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in DNMT1 and CTCFL?,freq_cnv_loss_or_gain
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in DNMT1 and TRAP1?,freq_cnv_loss_or_gain
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in DNMT1 and RIMS2?,freq_cnv_loss_or_gain
+1056,CA9,E402K,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in CA9 and JAML?,freq_cnv_loss_or_gain
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in TTC17 and NPSR1?,freq_cnv_loss_or_gain
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in TTC17 and POLR1G?,freq_cnv_loss_or_gain
+1065,PSG2,P43L,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit cogains in PSG2 and ABCC2?,freq_cnv_loss_or_gain
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit cogains in RIPOR2 and SMO?,freq_cnv_loss_or_gain
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit cogains in RIPOR2 and CACNA1F?,freq_cnv_loss_or_gain
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit cogains in RIPOR2 and AUTS2?,freq_cnv_loss_or_gain
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit cogains in RIPOR2 and NRAP?,freq_cnv_loss_or_gain
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in DCLK3 and CFAP61?,freq_cnv_loss_or_gain
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in DCLK3 and RIMS2?,freq_cnv_loss_or_gain
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in MERTK and TSHZ3?,freq_cnv_loss_or_gain
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in MERTK and ZNF584?,freq_cnv_loss_or_gain
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in MERTK and DOCK2?,freq_cnv_loss_or_gain
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in ZFP42 and PTPRO?,freq_cnv_loss_or_gain
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in OR13C3 and CACNA1F?,freq_cnv_loss_or_gain
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in OR13C3 and MYO3B?,freq_cnv_loss_or_gain
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in SPAG1 and ANP32E?,freq_cnv_loss_or_gain
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in CDKN2AIP and PYHIN1?,freq_cnv_loss_or_gain
+1093,PXN,H1016Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in PXN and ZCCHC14?,freq_cnv_loss_or_gain
+1094,PXN,H359Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in PXN and PIK3C2B?,freq_cnv_loss_or_gain
+1095,PXN,H492Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in PXN and AUTS2?,freq_cnv_loss_or_gain
+1096,PXN,H524Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in PXN and RAB40C?,freq_cnv_loss_or_gain
+1097,PXN,H526Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in PXN and NRAP?,freq_cnv_loss_or_gain
+1098,PXN,H540Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in PXN and MYT1?,freq_cnv_loss_or_gain
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in TTYH2 and FBXO15?,freq_cnv_loss_or_gain
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in TTYH2 and CNGB1?,freq_cnv_loss_or_gain
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in TMEM255A and BCAT1?,freq_cnv_loss_or_gain
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in TMEM255A and GPC3?,freq_cnv_loss_or_gain
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in TMEM255A and NOMO1?,freq_cnv_loss_or_gain
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit cogains in TASOR2 and OR13C3?,freq_cnv_loss_or_gain
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit cogains in TASOR2 and CPS1?,freq_cnv_loss_or_gain
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in ICE1 and SGCZ?,freq_cnv_loss_or_gain
+1112,MYT1,A558E,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit cogains in MYT1 and KL?,freq_cnv_loss_or_gain
+1113,MYT1,A879E,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit cogains in MYT1 and MAD1L1?,freq_cnv_loss_or_gain
+1114,MYT1,A906E,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit cogains in MYT1 and PXN?,freq_cnv_loss_or_gain
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in CX3CR1 and TENM2?,freq_cnv_loss_or_gain
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in CX3CR1 and CTCFL?,freq_cnv_loss_or_gain
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients exhibit cogains in SPINDOC and HTR3B?,freq_cnv_loss_or_gain
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in ART3 and OR2T4?,freq_cnv_loss_or_gain
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in ART3 and ANKRD24?,freq_cnv_loss_or_gain
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit cogains in CYP1A2 and TRIM45?,freq_cnv_loss_or_gain
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit cogains in ADRA1A and RIMS2?",freq_cnv_loss_or_gain
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in CDH23 and RIMS2?,freq_cnv_loss_or_gain
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in CDH23 and TTYH2?,freq_cnv_loss_or_gain
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in KRT39 and PTPRO?,freq_cnv_loss_or_gain
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in PDHA2 and ZFPM2?,freq_cnv_loss_or_gain
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in SLC24A2 and XKR4?,freq_cnv_loss_or_gain
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients exhibit cogains in PTPRN2 and HTR3B?,freq_cnv_loss_or_gain
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients exhibit cogains in PTPRN2 and TYROBP?,freq_cnv_loss_or_gain
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients exhibit cogains in PTPRN2 and ABCC2?,freq_cnv_loss_or_gain
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients exhibit cogains in PTPRN2 and PCDHB2?,freq_cnv_loss_or_gain
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients exhibit cogains in PTPRN2 and TRIM45?,freq_cnv_loss_or_gain
+1188,SOX21,R55L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in SOX21 and DCLK3?,freq_cnv_loss_or_gain
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit cogains in CPA6 and MRPL55?,freq_cnv_loss_or_gain
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in GRM5 and OLFML3?,freq_cnv_loss_or_gain
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit cogains in CASZ1 and CCNG1?",freq_cnv_loss_or_gain
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in SGIP1 and HBB?,freq_cnv_loss_or_gain
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in SGIP1 and SPATA22?,freq_cnv_loss_or_gain
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in SGIP1 and EFCAB12?,freq_cnv_loss_or_gain
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in SGIP1 and ADRA1A?,freq_cnv_loss_or_gain
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in CARMIL1 and FBXO15?,freq_cnv_loss_or_gain
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in CARMIL1 and CFAP61?,freq_cnv_loss_or_gain
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in ZNF431 and MYT1?,freq_cnv_loss_or_gain
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in ZNF431 and ACVR1B?,freq_cnv_loss_or_gain
+1234,ZNF431,R128I,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in ZNF431 and HYOU1?,freq_cnv_loss_or_gain
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in DNAH11 and FRY?,freq_cnv_loss_or_gain
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in DNAH11 and AUTS2?,freq_cnv_loss_or_gain
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in POLD1 and REXO4?,freq_cnv_loss_or_gain
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients exhibit cogains in POLD1 and GRTP1?,freq_cnv_loss_or_gain
+1248,TTC12,D646H,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in TTC12 and DHX16?,freq_cnv_loss_or_gain
+1249,TTC12,D652H,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in TTC12 and DCLK3?,freq_cnv_loss_or_gain
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit cogains in CNGB1 and KDM5C?,freq_cnv_loss_or_gain
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients exhibit cogains in CNGB1 and PTPRN2?,freq_cnv_loss_or_gain
+1254,CTSC,E214V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in CTSC and CTSC?,freq_cnv_loss_or_gain
+1255,CTSC,E291V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in CTSC and OR8K5?,freq_cnv_loss_or_gain
+1256,CTSC,E322V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in CTSC and FMO4?,freq_cnv_loss_or_gain
+1257,CTSC,E324V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in CTSC and MAST4?,freq_cnv_loss_or_gain
+1258,CTSC,E335V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in CTSC and ANKRD30A?,freq_cnv_loss_or_gain
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in PRSS8 and DCAF4L2?,freq_cnv_loss_or_gain
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in PRSS8 and TMEM255A?,freq_cnv_loss_or_gain
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in ARHGEF40 and MUC16?,freq_cnv_loss_or_gain
+1264,ACTB,A138T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit cogains in ACTB and FBN1?,freq_cnv_loss_or_gain
+1265,ACTB,A217T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit cogains in ACTB and DOCK2?,freq_cnv_loss_or_gain
+1266,ACTB,A244T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit cogains in ACTB and ZMYM3?,freq_cnv_loss_or_gain
+1267,ACTB,A260T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit cogains in ACTB and UNC5D?,freq_cnv_loss_or_gain
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients exhibit cogains in YY1AP1 and FRY?,freq_cnv_loss_or_gain
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients exhibit cogains in YY1AP1 and RIMS2?,freq_cnv_loss_or_gain
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients exhibit cogains in YY1AP1 and FBN1?,freq_cnv_loss_or_gain
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients exhibit cogains in YY1AP1 and TMTC3?,freq_cnv_loss_or_gain
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients exhibit cogains in YY1AP1 and ITPRID2?,freq_cnv_loss_or_gain
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients exhibit cogains in YY1AP1 and MED16?,freq_cnv_loss_or_gain
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients exhibit cogains in YY1AP1 and ZFAT?,freq_cnv_loss_or_gain
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in FNDC7 and PIK3C2B?,freq_cnv_loss_or_gain
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in FNDC7 and PGF?,freq_cnv_loss_or_gain
+1299,TLCD5,G15V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in TLCD5 and EIF2B4?,freq_cnv_loss_or_gain
+1300,TLCD5,G37V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in TLCD5 and TENM2?,freq_cnv_loss_or_gain
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in POLR1G and NOMO1?,freq_cnv_loss_or_gain
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in POLR1G and KDM5C?,freq_cnv_loss_or_gain
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in DNAH14 and RIMS2?,freq_cnv_loss_or_gain
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in DNAH14 and HSPA5?,freq_cnv_loss_or_gain
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in DNAH14 and MED16?,freq_cnv_loss_or_gain
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in NEXN and PGF?,freq_cnv_loss_or_gain
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma patients exhibit cogains in CYB5R2 and DCN?,freq_cnv_loss_or_gain
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma patients exhibit cogains in CYB5R2 and FBXO42?,freq_cnv_loss_or_gain
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in NRAP and PAK3?,freq_cnv_loss_or_gain
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in NRAP and POC1B?,freq_cnv_loss_or_gain
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in NRAP and BFAR?,freq_cnv_loss_or_gain
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in CCDC22 and PLEKHG6?,freq_cnv_loss_or_gain
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in DCAF6 and CPS1?,freq_cnv_loss_or_gain
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in DCAF6 and ANKRD24?,freq_cnv_loss_or_gain
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in ZNF708 and CTCFL?,freq_cnv_loss_or_gain
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in BFAR and PCDHB2?,freq_cnv_loss_or_gain
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in MAST4 and SGCZ?,freq_cnv_loss_or_gain
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in MAST4 and DEFB115?,freq_cnv_loss_or_gain
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in MAST4 and JAML?,freq_cnv_loss_or_gain
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in MAST4 and CR1?,freq_cnv_loss_or_gain
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in MAST4 and EPRS1?,freq_cnv_loss_or_gain
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in ARMC3 and ADRA1A?,freq_cnv_loss_or_gain
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in ARMC3 and TENT5A?,freq_cnv_loss_or_gain
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How many Kidney Renal Clear Cell Carcinoma patients exhibit cogains in TET2 and ACTL7B?,freq_cnv_loss_or_gain
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How many Kidney Renal Clear Cell Carcinoma patients exhibit cogains in TET2 and CTSC?,freq_cnv_loss_or_gain
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in SERPINB10 and MAST4?,freq_cnv_loss_or_gain
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in STAT3 and DCN?,freq_cnv_loss_or_gain
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in MIEF1 and ACVR1B?,freq_cnv_loss_or_gain
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in ACVR1B and CTSC?,freq_cnv_loss_or_gain
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in ACVR1B and DNAH11?,freq_cnv_loss_or_gain
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in ACVR1B and CPA6?,freq_cnv_loss_or_gain
+1393,EBF2,T104I,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in EBF2 and PXN?,freq_cnv_loss_or_gain
+1394,EBF2,T252I,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in EBF2 and RAB40C?,freq_cnv_loss_or_gain
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in VPS26B and THBS4?,freq_cnv_loss_or_gain
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit cogains in PGR and COL6A3?",freq_cnv_loss_or_gain
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit cogains in PGR and PAK3?",freq_cnv_loss_or_gain
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients exhibit cogains in PGR and HTR3B?",freq_cnv_loss_or_gain
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients exhibit cogains in ACTA2 and CHODL?,freq_cnv_loss_or_gain
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in THBS4 and PCDHB2?,freq_cnv_loss_or_gain
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in THBS4 and GPRASP1?,freq_cnv_loss_or_gain
+1413,PRSS1,S114T,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in PRSS1 and GABRA6?,freq_cnv_loss_or_gain
+1414,PRSS1,S124T,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in PRSS1 and ACTB?,freq_cnv_loss_or_gain
+1415,PRSS1,S138T,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in PRSS1 and PGF?,freq_cnv_loss_or_gain
+1416,PRSS1,S74T,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients exhibit cogains in PRSS1 and RIMS2?,freq_cnv_loss_or_gain
+1417,PGF,R126H,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in PGF and NRAP?,freq_cnv_loss_or_gain
+1418,PGF,R127H,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients exhibit cogains in PGF and LAMB2?,freq_cnv_loss_or_gain
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit cogains in ITPRID2 and GABRA6?,freq_cnv_loss_or_gain
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients exhibit cogains in ITPRID2 and GSTCD?,freq_cnv_loss_or_gain
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in HBB and DPF3?,freq_cnv_loss_or_gain
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in PCDHB2 and PRSS1?,freq_cnv_loss_or_gain
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in PCDHB2 and GABRA6?,freq_cnv_loss_or_gain
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients exhibit cogains in PCDHB2 and GPC3?,freq_cnv_loss_or_gain
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients exhibit cogains in UBR2 and DSCAM?,freq_cnv_loss_or_gain
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients exhibit cogains in FBXO42 and AUTS2?,freq_cnv_loss_or_gain
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the percentage occurrence of IL5RA loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the percentage occurrence of MED16 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the percentage occurrence of TAF1C loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the percentage occurrence of PXN loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the percentage occurrence of CTSC loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the percentage occurrence of LAMB2 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the percentage occurrence of DCN loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the percentage occurrence of SORCS1 loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the percentage occurrence of ANKDD1A loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of EIF2B4 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of CACNA1F loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the percentage occurrence of EIF2B4 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the percentage occurrence of PGF loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the percentage occurrence of TLK2 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the percentage occurrence of MYO15A loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the percentage occurrence of DOCK2 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the percentage occurrence of MIEF1 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the percentage occurrence of TMEM225 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of AUTS2 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of DGKD loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of GSTCD loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the percentage occurrence of UNC5D loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the percentage occurrence of CEP20 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the percentage occurrence of LAMB2 loss of heterozygosity in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the percentage occurrence of YY1AP1 loss of heterozygosity in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the percentage occurrence of OR13C3 loss of heterozygosity in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the percentage occurrence of DCC loss of heterozygosity in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the percentage occurrence of MAOB loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the percentage occurrence of NCKAP5 loss of heterozygosity in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the percentage occurrence of SORCS1 loss of heterozygosity in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the percentage occurrence of UNC5D loss of heterozygosity in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the percentage occurrence of GUK1 loss of heterozygosity in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the percentage occurrence of AUTS2 loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the percentage occurrence of THBS4 loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the percentage occurrence of PHLPP1 loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the percentage occurrence of ANKRD52 loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the percentage occurrence of CTNNA2 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the percentage occurrence of GIMAP2 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the percentage occurrence of CHODL loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the percentage occurrence of DGKD loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the percentage occurrence of GRTP1 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the percentage occurrence of ANKRD30A loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the percentage occurrence of TAF1C loss of heterozygosity in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the percentage occurrence of CDC42BPA loss of heterozygosity in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the percentage occurrence of PLEKHG6 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the percentage occurrence of DGKD loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the percentage occurrence of TTYH2 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the percentage occurrence of FCGR2C loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of DCC loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of GRM5 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the percentage occurrence of TAF1L loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the percentage occurrence of SYNJ1 loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the percentage occurrence of TTN loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the percentage occurrence of GRTP1 loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of COL6A3 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of FBN1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of SGCZ loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the percentage occurrence of DCN loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of TTN loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of GUK1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the percentage occurrence of PTPRN2 loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the percentage occurrence of ZNF584 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+140,BICC1,A372V,Exceptional Responders,What is the percentage occurrence of DCAF6 loss of heterozygosity in Exceptional Responders?,freq_cnv_loss_or_gain
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of PTPRO loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of TAF1C loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of GUK1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of TTC17 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the percentage occurrence of MRPL55 loss of heterozygosity in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the percentage occurrence of ACTA2 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the percentage occurrence of RIPOR2 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the percentage occurrence of ADRA1A loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the percentage occurrence of PTPRO loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the percentage occurrence of HYOU1 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the percentage occurrence of CFAP298-TCP10L loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the percentage occurrence of ERCC6 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the percentage occurrence of PLEKHG6 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the percentage occurrence of TENM2 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the percentage occurrence of ZSCAN31 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the percentage occurrence of ACVR1B loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the percentage occurrence of ARHGEF40 loss of heterozygosity in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the percentage occurrence of FBXO15 loss of heterozygosity in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the percentage occurrence of HYOU1 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the percentage occurrence of TAF1C loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the percentage occurrence of KANSL1 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the percentage occurrence of DNMT1 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the percentage occurrence of CFAP61 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the percentage occurrence of TYK2 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the percentage occurrence of GUK1 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the percentage occurrence of YY1AP1 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the percentage occurrence of CPS1 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the percentage occurrence of ZNF217 loss of heterozygosity in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,freq_cnv_loss_or_gain
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the percentage occurrence of TASOR2 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the percentage occurrence of PTPRN2 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the percentage occurrence of GRM5 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the percentage occurrence of GPR158 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the percentage occurrence of FGF8 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the percentage occurrence of TNS1 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the percentage occurrence of TTC12 loss of heterozygosity in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the percentage occurrence of ACTB loss of heterozygosity in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the percentage occurrence of PGR loss of heterozygosity in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+267,DGKD,R140H,Exceptional Responders,What is the percentage occurrence of HTR3B loss of heterozygosity in Exceptional Responders?,freq_cnv_loss_or_gain
+268,DGKD,R160H,Exceptional Responders,What is the percentage occurrence of JAML loss of heterozygosity in Exceptional Responders?,freq_cnv_loss_or_gain
+269,DGKD,R204H,Exceptional Responders,What is the percentage occurrence of SGCZ loss of heterozygosity in Exceptional Responders?,freq_cnv_loss_or_gain
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the percentage occurrence of JAML loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the percentage occurrence of POLR1G loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the percentage occurrence of MYO16 loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the percentage occurrence of EFCAB12 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the percentage occurrence of RIPOR2 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of DGKD loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of FNDC7 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+299,OR5D14,M210L,Neuroblastoma,What is the percentage occurrence of OLFML3 loss of heterozygosity in Neuroblastoma?,freq_cnv_loss_or_gain
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of TTN loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MRPL32 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of AQP7 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the percentage occurrence of MRPL55 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the percentage occurrence of LDOC1 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the percentage occurrence of SYNJ1 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the percentage occurrence of HYOU1 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the percentage occurrence of ICE1 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the percentage occurrence of PGR loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the percentage occurrence of SYT10 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the percentage occurrence of PXN loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the percentage occurrence of BFAR loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the percentage occurrence of AUTS2 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the percentage occurrence of PGF loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the percentage occurrence of TENM3 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the percentage occurrence of ABCC2 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the percentage occurrence of TMTC3 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the percentage occurrence of POC1B loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the percentage occurrence of POC1B loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the percentage occurrence of CACNA1F loss of heterozygosity in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the percentage occurrence of ZFAT loss of heterozygosity in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the percentage occurrence of PGR loss of heterozygosity in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+357,ZNF584,A211T,Sarcoma,What is the percentage occurrence of TRAP1 loss of heterozygosity in Sarcoma?,freq_cnv_loss_or_gain
+358,ZNF584,A256T,Sarcoma,What is the percentage occurrence of YY1AP1 loss of heterozygosity in Sarcoma?,freq_cnv_loss_or_gain
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of DNAH11 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the percentage occurrence of EIF2B4 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of TMEM255A loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the percentage occurrence of TLK2 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the percentage occurrence of ANKRD24 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the percentage occurrence of BICC1 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the percentage occurrence of SLC6A4 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the percentage occurrence of HTR3B loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the percentage occurrence of AUTS2 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the percentage occurrence of ACTB loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the percentage occurrence of STAT3 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the percentage occurrence of CYB5R2 loss of heterozygosity in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the percentage occurrence of GUCY2C loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the percentage occurrence of EVC2 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the percentage occurrence of ANKRD24 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the percentage occurrence of EPRS1 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the percentage occurrence of GPC3 loss of heterozygosity in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the percentage occurrence of PXN loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the percentage occurrence of EVC2 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the percentage occurrence of ZNF431 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the percentage occurrence of DCN loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+430,DCN,R163C,Rectum Adenocarcinoma,What is the percentage occurrence of CHODL loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+431,DCN,R203C,Rectum Adenocarcinoma,What is the percentage occurrence of MAD1L1 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+432,DCN,R241C,Rectum Adenocarcinoma,What is the percentage occurrence of ANP32E loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+433,DCN,R350C,Rectum Adenocarcinoma,What is the percentage occurrence of RIPOR2 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+434,DCN,R41C,Rectum Adenocarcinoma,What is the percentage occurrence of TNS1 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of ANKDD1A loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of TSHZ3 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of CYB5R2 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the percentage occurrence of CTNNA2 loss of heterozygosity in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the percentage occurrence of HLA-DQA2 loss of heterozygosity in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of SYT9 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the percentage occurrence of RIMS2 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the percentage occurrence of MAST4 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+485,SMO,V15M,Stomach Adenocarcinoma,What is the percentage occurrence of THBS4 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+486,SMO,V321M,Stomach Adenocarcinoma,What is the percentage occurrence of GPR158 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the percentage occurrence of EVC2 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the percentage occurrence of PTPRO loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the percentage occurrence of VASN loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+494,MYO16,P399H,Colon Adenocarcinoma,What is the percentage occurrence of SIK2 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+495,MYO16,P421H,Colon Adenocarcinoma,What is the percentage occurrence of TNS1 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the percentage occurrence of FRY loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the percentage occurrence of PXN loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of CYP1A2 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of EFCAB12 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of UNC5D loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of ACTA2 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the percentage occurrence of B3GALNT1 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the percentage occurrence of GUK1 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the percentage occurrence of MAD1L1 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the percentage occurrence of OR13C3 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the percentage occurrence of SYT9 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the percentage occurrence of JAML loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the percentage occurrence of FCGR2C loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the percentage occurrence of ZCCHC14 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the percentage occurrence of ZFPM2 loss of heterozygosity in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the percentage occurrence of VPS26B loss of heterozygosity in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of VASN loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MED16 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MAD1L1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of PKHD1L1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the percentage occurrence of CHMP7 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+541,DCC,R320W,Breast Invasive Carcinoma,What is the percentage occurrence of TYK2 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+542,DCC,R363W,Breast Invasive Carcinoma,What is the percentage occurrence of CTNNA2 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+543,DCC,R386W,Breast Invasive Carcinoma,What is the percentage occurrence of CPS1 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+544,DCC,R41W,Breast Invasive Carcinoma,What is the percentage occurrence of PTPRO loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the percentage occurrence of PLEKHG6 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the percentage occurrence of MAD1L1 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of TTYH2 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of NEXN loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the percentage occurrence of CHMP7 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the percentage occurrence of TENM2 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the percentage occurrence of SPAG1 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the percentage occurrence of AQP7 loss of heterozygosity in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the percentage occurrence of AUTS2 loss of heterozygosity in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the percentage occurrence of ARMC3 loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the percentage occurrence of SERPINB10 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the percentage occurrence of IL5RA loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the percentage occurrence of TYK2 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the percentage occurrence of ZCCHC14 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the percentage occurrence of EBF2 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the percentage occurrence of YY1AP1 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the percentage occurrence of GUK1 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the percentage occurrence of CTNNA2 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the percentage occurrence of PTPRN2 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the percentage occurrence of MED16 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+625,SIK2,I265M,Lung Adenocarcinoma,What is the percentage occurrence of MAST4 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of UNC5D loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of GUK1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the percentage occurrence of FRY loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of DEFB115 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of DHX16 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the percentage occurrence of MED16 loss of heterozygosity in Brain Lower Grade Glioma?,freq_cnv_loss_or_gain
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the percentage occurrence of SPATA22 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the percentage occurrence of ZNF431 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the percentage occurrence of MYO15A loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the percentage occurrence of OLFML3 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the percentage occurrence of IL5RA loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the percentage occurrence of FMO4 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the percentage occurrence of SYT9 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the percentage occurrence of EPRS1 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the percentage occurrence of PRSS1 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of DCAF6 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of HLA-DQA2 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of GABRA6 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of ZFAT loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of CTSC loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of RIMS2 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the percentage occurrence of TNS1 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the percentage occurrence of TTYH2 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the percentage occurrence of RIMS2 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the percentage occurrence of ANKRD24 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the percentage occurrence of ADRA1A loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the percentage occurrence of OR5D14 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the percentage occurrence of TRIM45 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the percentage occurrence of GUK1 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the percentage occurrence of FCGR2C loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+728,STK19,D341N,Colon Adenocarcinoma,What is the percentage occurrence of EIF2B4 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+729,STK19,D345N,Colon Adenocarcinoma,What is the percentage occurrence of ITPRID2 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the percentage occurrence of MRPL32 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of B3GALNT1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of AUTS2 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the percentage occurrence of PAK3 loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of DNAH14 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of TENT5A loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of DSCAM loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of ZNF431 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the percentage occurrence of GPC3 loss of heterozygosity in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the percentage occurrence of MYH11 loss of heterozygosity in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the percentage occurrence of DNMT1 loss of heterozygosity in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the percentage occurrence of MAOB loss of heterozygosity in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the percentage occurrence of MRPL55 loss of heterozygosity in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the percentage occurrence of SGCZ loss of heterozygosity in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,freq_cnv_loss_or_gain
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of AUTS2 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the percentage occurrence of AUTS2 loss of heterozygosity in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the percentage occurrence of MUC16 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+793,TTN,F7636L,Colon Adenocarcinoma,What is the percentage occurrence of CDH23 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+794,TTN,F8563L,Colon Adenocarcinoma,What is the percentage occurrence of MYO16 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+795,TTN,F8880L,Colon Adenocarcinoma,What is the percentage occurrence of FBXO15 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the percentage occurrence of PAK3 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the percentage occurrence of RIMS2 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the percentage occurrence of SYT9 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the percentage occurrence of PTPRO loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the percentage occurrence of EFCAB12 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the percentage occurrence of CR1 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the percentage occurrence of AUTS2 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the percentage occurrence of ZFAT loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the percentage occurrence of MERTK loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+817,KL,R594C,Colon Adenocarcinoma,What is the percentage occurrence of TAF1C loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the percentage occurrence of PIK3C2G loss of heterozygosity in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the percentage occurrence of THBS4 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the percentage occurrence of TTC12 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the percentage occurrence of PYHIN1 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the percentage occurrence of TTYH2 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the percentage occurrence of USH2A loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the percentage occurrence of PDHA2 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the percentage occurrence of PLEKHG6 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the percentage occurrence of DGKD loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the percentage occurrence of DCC loss of heterozygosity in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the percentage occurrence of COL6A3 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the percentage occurrence of PTPRO loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the percentage occurrence of DCN loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the percentage occurrence of AQP7 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of LDOC1 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of ZNF431 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of CR1 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of HBB loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of TNS1 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of GUCY2C loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the percentage occurrence of POC1B loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MRPL55 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the percentage occurrence of AUTS2 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the percentage occurrence of TYROBP loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the percentage occurrence of GABRA6 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the percentage occurrence of FBN1 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the percentage occurrence of SORCS1 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the percentage occurrence of POC1B loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the percentage occurrence of PIK3C2B loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the percentage occurrence of PXN loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of PDGFC loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the percentage occurrence of DNAH14 loss of heterozygosity in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the percentage occurrence of CACNA1F loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the percentage occurrence of ANKRD52 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of GABRA6 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the percentage occurrence of ABCC2 loss of heterozygosity in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the percentage occurrence of C7orf31 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of PTPRN2 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the percentage occurrence of POLD1 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the percentage occurrence of CACNA1F loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the percentage occurrence of TNS1 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the percentage occurrence of POC1B loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the percentage occurrence of TMEM255A loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the percentage occurrence of CTNNA2 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the percentage occurrence of PDGFC loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of TENM2 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of RIMS2 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the percentage occurrence of ITPRID2 loss of heterozygosity in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the percentage occurrence of GPR158 loss of heterozygosity in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the percentage occurrence of FGF8 loss of heterozygosity in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the percentage occurrence of OLFML3 loss of heterozygosity in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the percentage occurrence of RIMS2 loss of heterozygosity in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the percentage occurrence of GPC3 loss of heterozygosity in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the percentage occurrence of UNC5D loss of heterozygosity in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the percentage occurrence of EPRS1 loss of heterozygosity in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of NOMO1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the percentage occurrence of GABRA6 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the percentage occurrence of POC1B loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the percentage occurrence of CPA6 loss of heterozygosity in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the percentage occurrence of ACTL7B loss of heterozygosity in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the percentage occurrence of SPTAN1 loss of heterozygosity in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the percentage occurrence of UNC5D loss of heterozygosity in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the percentage occurrence of KL loss of heterozygosity in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the percentage occurrence of GUK1 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the percentage occurrence of EFCAB12 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the percentage occurrence of TAS1R3 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the percentage occurrence of DNAH11 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the percentage occurrence of SPTAN1 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of MYO3B loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of SLC24A2 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of DCN loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of TYK2 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1056,CA9,E402K,Colon Adenocarcinoma,What is the percentage occurrence of CNGB1 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of PKHD1L1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of PDHA2 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the percentage occurrence of PGF loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the percentage occurrence of BCAT1 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the percentage occurrence of GABRA6 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the percentage occurrence of BCAT1 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the percentage occurrence of KDM5C loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of ZCCHC14 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of CTSC loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the percentage occurrence of PAK3 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the percentage occurrence of CEP20 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the percentage occurrence of EVC2 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the percentage occurrence of ZKSCAN7 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the percentage occurrence of WNT2 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the percentage occurrence of FGF8 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the percentage occurrence of DHX16 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of DCC loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the percentage occurrence of PTPRO loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the percentage occurrence of CTCFL loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the percentage occurrence of NOMO1 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the percentage occurrence of MYO15A loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the percentage occurrence of POC1B loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the percentage occurrence of PCDHB2 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of FMO4 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of AUTS2 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the percentage occurrence of MAST4 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the percentage occurrence of DCC loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the percentage occurrence of PAPPA loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the percentage occurrence of TTC12 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the percentage occurrence of CFAP61 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of PRSS1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the percentage occurrence of ZFPM2 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the percentage occurrence of DNAH11 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the percentage occurrence of THBS4 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of RIPOR2 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MYO3B loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the percentage occurrence of TRIM45 loss of heterozygosity in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of OR2T4 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of SPATA22 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the percentage occurrence of AUTS2 loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of GABRA6 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the percentage occurrence of TTYH2 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the percentage occurrence of TTC12 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the percentage occurrence of KL loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the percentage occurrence of SGCZ loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the percentage occurrence of CEP20 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the percentage occurrence of MYO16 loss of heterozygosity in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the percentage occurrence of TRPA1 loss of heterozygosity in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the percentage occurrence of AUTS2 loss of heterozygosity in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the percentage occurrence of TENM3 loss of heterozygosity in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the percentage occurrence of DCAF6 loss of heterozygosity in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the percentage occurrence of PIAS3 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the percentage occurrence of KRT39 loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the percentage occurrence of DCC loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of DNAH11 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the percentage occurrence of ANKRD24 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the percentage occurrence of TAF1L loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the percentage occurrence of TET2 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the percentage occurrence of CHMP7 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the percentage occurrence of TAF1C loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the percentage occurrence of SPTAN1 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the percentage occurrence of CDH23 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the percentage occurrence of LAMB2 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the percentage occurrence of EPRS1 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the percentage occurrence of TTYH2 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the percentage occurrence of AUTS2 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the percentage occurrence of CHMP7 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the percentage occurrence of MORF4L1 loss of heterozygosity in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the percentage occurrence of DNAH14 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the percentage occurrence of AKT1 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the percentage occurrence of ADRA1A loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the percentage occurrence of SIK2 loss of heterozygosity in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the percentage occurrence of OLFML3 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the percentage occurrence of ZFP42 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the percentage occurrence of CCDC22 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the percentage occurrence of RIPOR2 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the percentage occurrence of REXO4 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of GUK1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of EFCAB12 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the percentage occurrence of CNGB1 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the percentage occurrence of DNAH14 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the percentage occurrence of ZNF627 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the percentage occurrence of UBR2 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the percentage occurrence of ZFP42 loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the percentage occurrence of HSPA5 loss of heterozygosity in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the percentage occurrence of GUK1 loss of heterozygosity in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the percentage occurrence of TENT5A loss of heterozygosity in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the percentage occurrence of MYO15A loss of heterozygosity in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the percentage occurrence of DHX16 loss of heterozygosity in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the percentage occurrence of GABRA6 loss of heterozygosity in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the percentage occurrence of TAF1C loss of heterozygosity in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the percentage occurrence of ANKRD52 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the percentage occurrence of MYO3B loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the percentage occurrence of GABRA6 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the percentage occurrence of DPF3 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of SGIP1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of PIK3C2A loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the percentage occurrence of CASZ1 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the percentage occurrence of VPS26B loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the percentage occurrence of ACVR1B loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of ZNF584 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the percentage occurrence of JAML loss of heterozygosity in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the percentage occurrence of DGKD loss of heterozygosity in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of UNC5D loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of TTN loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of UNC5D loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of SORCS1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the percentage occurrence of CHODL loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the percentage occurrence of ZMYM3 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of ARMC3 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of KDM5C loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of MYT1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of NRAP loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of ZNF217 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of CTCFL loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of ANKRD24 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the percentage occurrence of SYT10 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the percentage occurrence of ANKRD30A loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the percentage occurrence of MUC16 loss of heterozygosity in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the percentage occurrence of MED16 loss of heterozygosity in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the percentage occurrence of TASOR2 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of DGKD loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of GABRA6 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the percentage occurrence of ACTB loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the percentage occurrence of PGF loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the percentage occurrence of TTC17 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the percentage occurrence of FRY loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the percentage occurrence of SGIP1 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the percentage occurrence of MYO16 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of CX3CR1 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of GUK1 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the percentage occurrence of SPTAN1 loss of heterozygosity in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the percentage occurrence of PIAS3 loss of heterozygosity in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of PHLPP1 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of CDH23 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the percentage occurrence of PXN loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the percentage occurrence of ICE1 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the percentage occurrence of FRY loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the percentage occurrence of TENM2 loss of heterozygosity in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the percentage occurrence of TYK2 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the percentage occurrence of GRM1 loss of heterozygosity in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the percentage occurrence of PCDHGA1 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the percentage occurrence of PRSS1 loss of heterozygosity in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of TLK2 loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the percentage occurrence of CHMP7 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the percentage occurrence of ARMC3 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the percentage occurrence of CCDC22 loss of heterozygosity in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the percentage occurrence of ADRA1A loss of heterozygosity in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the percentage occurrence of ZFAT loss of heterozygosity in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1,TNS1,G1362V,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with KL loss of heterozygosity?,freq_cnv_loss_or_gain
+2,TNS1,G1711V,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with ACTB loss of heterozygosity?,freq_cnv_loss_or_gain
+3,TNS1,G1718V,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with MYO16 loss of heterozygosity?,freq_cnv_loss_or_gain
+4,TNS1,G1732V,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with MYO3B loss of heterozygosity?,freq_cnv_loss_or_gain
+5,TNS1,G1824V,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with YY1AP1 loss of heterozygosity?,freq_cnv_loss_or_gain
+6,TNS1,G1857V,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with LAMB2 loss of heterozygosity?,freq_cnv_loss_or_gain
+7,TNS1,G843V,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with ZCCHC14 loss of heterozygosity?,freq_cnv_loss_or_gain
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with ACVR1B loss of heterozygosity?,freq_cnv_loss_or_gain
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with TLK2 loss of heterozygosity?,freq_cnv_loss_or_gain
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with SGIP1 loss of heterozygosity?,freq_cnv_loss_or_gain
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with GSTCD loss of heterozygosity?,freq_cnv_loss_or_gain
+22,TRPA1,S295I,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with TTYH2 loss of heterozygosity?,freq_cnv_loss_or_gain
+23,TRPA1,S443I,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with GABRA6 loss of heterozygosity?,freq_cnv_loss_or_gain
+24,TAF1C,R299L,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with FGF8 loss of heterozygosity?,freq_cnv_loss_or_gain
+25,TAF1C,R396L,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with ZNF217 loss of heterozygosity?,freq_cnv_loss_or_gain
+26,TAF1C,R634L,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with YY1AP1 loss of heterozygosity?,freq_cnv_loss_or_gain
+27,TAF1C,R702L,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with CXCR2 loss of heterozygosity?,freq_cnv_loss_or_gain
+28,TAF1C,R728L,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with GUK1 loss of heterozygosity?,freq_cnv_loss_or_gain
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with PDHA2 loss of heterozygosity?,freq_cnv_loss_or_gain
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with PAK3 loss of heterozygosity?,freq_cnv_loss_or_gain
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with UNC5D loss of heterozygosity?,freq_cnv_loss_or_gain
+42,OR2T4,P272H,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with PRSS1 loss of heterozygosity?,freq_cnv_loss_or_gain
+43,OR2T4,P300H,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with THBS4 loss of heterozygosity?,freq_cnv_loss_or_gain
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How frequently do Pancreatic Adenocarcinoma patients present with ADRA1A loss of heterozygosity?,freq_cnv_loss_or_gain
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How frequently do Prostate Adenocarcinoma patients present with MAD1L1 loss of heterozygosity?,freq_cnv_loss_or_gain
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How frequently do Prostate Adenocarcinoma patients present with ZCCHC14 loss of heterozygosity?,freq_cnv_loss_or_gain
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How frequently do Prostate Adenocarcinoma patients present with PRSS1 loss of heterozygosity?,freq_cnv_loss_or_gain
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with CARMIL1 loss of heterozygosity?,freq_cnv_loss_or_gain
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How frequently do Kidney Renal Papillary Cell Carcinoma patients present with DCN loss of heterozygosity?,freq_cnv_loss_or_gain
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How frequently do Kidney Renal Papillary Cell Carcinoma patients present with HTR3B loss of heterozygosity?,freq_cnv_loss_or_gain
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How frequently do Kidney Renal Papillary Cell Carcinoma patients present with DSCAM loss of heterozygosity?,freq_cnv_loss_or_gain
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How frequently do Kidney Renal Papillary Cell Carcinoma patients present with PDHA2 loss of heterozygosity?,freq_cnv_loss_or_gain
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with MED16 loss of heterozygosity?,freq_cnv_loss_or_gain
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with RAB40C loss of heterozygosity?,freq_cnv_loss_or_gain
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with ZBTB34 loss of heterozygosity?,freq_cnv_loss_or_gain
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with DPF3 loss of heterozygosity?,freq_cnv_loss_or_gain
+70,PAK3,E318K,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with MYT1 loss of heterozygosity?,freq_cnv_loss_or_gain
+71,PAK3,E319K,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with AQP7 loss of heterozygosity?,freq_cnv_loss_or_gain
+72,PAK3,E334K,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with ZMYM3 loss of heterozygosity?,freq_cnv_loss_or_gain
+73,PAK3,E340K,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with ZNF274 loss of heterozygosity?,freq_cnv_loss_or_gain
+74,PAK3,E355K,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with PLEKHG6 loss of heterozygosity?,freq_cnv_loss_or_gain
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with OLFML3 loss of heterozygosity?,freq_cnv_loss_or_gain
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How frequently do Liver Hepatocellular Carcinoma patients present with PXN loss of heterozygosity?,freq_cnv_loss_or_gain
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How frequently do Liver Hepatocellular Carcinoma patients present with TAF1C loss of heterozygosity?,freq_cnv_loss_or_gain
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with AUTS2 loss of heterozygosity?,freq_cnv_loss_or_gain
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with DPF3 loss of heterozygosity?,freq_cnv_loss_or_gain
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with EIF2B4 loss of heterozygosity?,freq_cnv_loss_or_gain
+116,RELN,A2371V,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with RIMS2 loss of heterozygosity?,freq_cnv_loss_or_gain
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with RIPOR2 loss of heterozygosity?",freq_cnv_loss_or_gain
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with ZCCHC14 loss of heterozygosity?",freq_cnv_loss_or_gain
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with TAF1C loss of heterozygosity?,freq_cnv_loss_or_gain
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with UNC5D loss of heterozygosity?,freq_cnv_loss_or_gain
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with ZMYM3 loss of heterozygosity?,freq_cnv_loss_or_gain
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with SIK2 loss of heterozygosity?,freq_cnv_loss_or_gain
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with GPC3 loss of heterozygosity?,freq_cnv_loss_or_gain
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with UNC5D loss of heterozygosity?,freq_cnv_loss_or_gain
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with SLC6A4 loss of heterozygosity?,freq_cnv_loss_or_gain
+129,ABCC3,R758W,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with PTPRO loss of heterozygosity?,freq_cnv_loss_or_gain
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with UNC5D loss of heterozygosity?,freq_cnv_loss_or_gain
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with FGF8 loss of heterozygosity?,freq_cnv_loss_or_gain
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with UNC5D loss of heterozygosity?,freq_cnv_loss_or_gain
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with YY1AP1 loss of heterozygosity?,freq_cnv_loss_or_gain
+140,BICC1,A372V,Exceptional Responders,How frequently do Exceptional Responders patients present with KDM5C loss of heterozygosity?,freq_cnv_loss_or_gain
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with THBS4 loss of heterozygosity?,freq_cnv_loss_or_gain
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with MAD1L1 loss of heterozygosity?,freq_cnv_loss_or_gain
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with NOMO1 loss of heterozygosity?,freq_cnv_loss_or_gain
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with DGKD loss of heterozygosity?",freq_cnv_loss_or_gain
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How frequently do Liver Hepatocellular Carcinoma patients present with MORF4L1 loss of heterozygosity?,freq_cnv_loss_or_gain
+157,OR8K5,R293G,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with DCN loss of heterozygosity?,freq_cnv_loss_or_gain
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with FBN1 loss of heterozygosity?,freq_cnv_loss_or_gain
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with PLEKHG6 loss of heterozygosity?,freq_cnv_loss_or_gain
+164,SYT10,M484I,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with PXN loss of heterozygosity?,freq_cnv_loss_or_gain
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with CHODL loss of heterozygosity?,freq_cnv_loss_or_gain
+175,UNC5D,L280V,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with ACTB loss of heterozygosity?,freq_cnv_loss_or_gain
+176,UNC5D,L635V,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with PRSS1 loss of heterozygosity?,freq_cnv_loss_or_gain
+177,UNC5D,L637V,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with UNC5D loss of heterozygosity?,freq_cnv_loss_or_gain
+178,UNC5D,L699V,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with GABRA6 loss of heterozygosity?,freq_cnv_loss_or_gain
+179,UNC5D,L704V,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with YY1AP1 loss of heterozygosity?,freq_cnv_loss_or_gain
+180,UNC5D,L709V,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with FNDC7 loss of heterozygosity?,freq_cnv_loss_or_gain
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How frequently do Kidney Renal Clear Cell Carcinoma patients present with PXN loss of heterozygosity?,freq_cnv_loss_or_gain
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How frequently do Kidney Renal Clear Cell Carcinoma patients present with ARHGEF40 loss of heterozygosity?,freq_cnv_loss_or_gain
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with TTN loss of heterozygosity?,freq_cnv_loss_or_gain
+193,MRPL55,H27Y,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with EFCAB12 loss of heterozygosity?,freq_cnv_loss_or_gain
+194,MRPL55,H63Y,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with MRPL32 loss of heterozygosity?,freq_cnv_loss_or_gain
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with EFCAB12 loss of heterozygosity?,freq_cnv_loss_or_gain
+198,EPRS1,K771I,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with SYT9 loss of heterozygosity?,freq_cnv_loss_or_gain
+199,EPRS1,K778I,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with SYNJ1 loss of heterozygosity?,freq_cnv_loss_or_gain
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with GPC3 loss of heterozygosity?,freq_cnv_loss_or_gain
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with ZNF584 loss of heterozygosity?,freq_cnv_loss_or_gain
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with EBF2 loss of heterozygosity?,freq_cnv_loss_or_gain
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How frequently do HIV+ Tumor Molecular Characterization Project - Cervical Cancer patients present with PRSS1 loss of heterozygosity?,freq_cnv_loss_or_gain
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with DCAF4L2 loss of heterozygosity?,freq_cnv_loss_or_gain
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with PAK3 loss of heterozygosity?,freq_cnv_loss_or_gain
+251,ZNF274,P13R,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with PGF loss of heterozygosity?,freq_cnv_loss_or_gain
+253,SYNJ1,R795C,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with ICE1 loss of heterozygosity?,freq_cnv_loss_or_gain
+254,SYNJ1,R800C,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with TNS1 loss of heterozygosity?,freq_cnv_loss_or_gain
+255,SYNJ1,R839C,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with PIK3C2B loss of heterozygosity?,freq_cnv_loss_or_gain
+261,DSCAM,V343M,Prostate Adenocarcinoma,How frequently do Prostate Adenocarcinoma patients present with ZFPM2 loss of heterozygosity?,freq_cnv_loss_or_gain
+262,DSCAM,V426M,Prostate Adenocarcinoma,How frequently do Prostate Adenocarcinoma patients present with ZCCHC14 loss of heterozygosity?,freq_cnv_loss_or_gain
+263,DSCAM,V591M,Prostate Adenocarcinoma,How frequently do Prostate Adenocarcinoma patients present with CHODL loss of heterozygosity?,freq_cnv_loss_or_gain
+267,DGKD,R140H,Exceptional Responders,How frequently do Exceptional Responders patients present with ANP32E loss of heterozygosity?,freq_cnv_loss_or_gain
+268,DGKD,R160H,Exceptional Responders,How frequently do Exceptional Responders patients present with PIAS3 loss of heterozygosity?,freq_cnv_loss_or_gain
+269,DGKD,R204H,Exceptional Responders,How frequently do Exceptional Responders patients present with PAK3 loss of heterozygosity?,freq_cnv_loss_or_gain
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with PYHIN1 loss of heterozygosity?,freq_cnv_loss_or_gain
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with DNMT1 loss of heterozygosity?,freq_cnv_loss_or_gain
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with DNAH14 loss of heterozygosity?,freq_cnv_loss_or_gain
+279,WNT2,D138N,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with DPF3 loss of heterozygosity?,freq_cnv_loss_or_gain
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with PRSS1 loss of heterozygosity?,freq_cnv_loss_or_gain
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with MED16 loss of heterozygosity?,freq_cnv_loss_or_gain
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with ANP32E loss of heterozygosity?",freq_cnv_loss_or_gain
+299,OR5D14,M210L,Neuroblastoma,How frequently do Neuroblastoma patients present with TET2 loss of heterozygosity?,freq_cnv_loss_or_gain
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with POLD1 loss of heterozygosity?,freq_cnv_loss_or_gain
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with ZNF431 loss of heterozygosity?,freq_cnv_loss_or_gain
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with CTNNA2 loss of heterozygosity?,freq_cnv_loss_or_gain
+310,LCN15,E21V,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with DPF3 loss of heterozygosity?,freq_cnv_loss_or_gain
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with ZMYM3 loss of heterozygosity?,freq_cnv_loss_or_gain
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with UNC5D loss of heterozygosity?,freq_cnv_loss_or_gain
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with DNMT1 loss of heterozygosity?,freq_cnv_loss_or_gain
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with PRSS1 loss of heterozygosity?,freq_cnv_loss_or_gain
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with IL5RA loss of heterozygosity?,freq_cnv_loss_or_gain
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with ZCCHC14 loss of heterozygosity?,freq_cnv_loss_or_gain
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with GUK1 loss of heterozygosity?,freq_cnv_loss_or_gain
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with COL6A3 loss of heterozygosity?,freq_cnv_loss_or_gain
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with PRSS8 loss of heterozygosity?,freq_cnv_loss_or_gain
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with GUK1 loss of heterozygosity?,freq_cnv_loss_or_gain
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with CACNA1F loss of heterozygosity?,freq_cnv_loss_or_gain
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with MIEF1 loss of heterozygosity?,freq_cnv_loss_or_gain
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with ACTB loss of heterozygosity?,freq_cnv_loss_or_gain
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with RELN loss of heterozygosity?,freq_cnv_loss_or_gain
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with MYO3A loss of heterozygosity?,freq_cnv_loss_or_gain
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How frequently do Ovarian Serous Cystadenocarcinoma patients present with FCGR2C loss of heterozygosity?,freq_cnv_loss_or_gain
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How frequently do Ovarian Serous Cystadenocarcinoma patients present with CACNA1F loss of heterozygosity?,freq_cnv_loss_or_gain
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How frequently do Ovarian Serous Cystadenocarcinoma patients present with SYT9 loss of heterozygosity?,freq_cnv_loss_or_gain
+357,ZNF584,A211T,Sarcoma,How frequently do Sarcoma patients present with PYHIN1 loss of heterozygosity?,freq_cnv_loss_or_gain
+358,ZNF584,A256T,Sarcoma,How frequently do Sarcoma patients present with MED16 loss of heterozygosity?,freq_cnv_loss_or_gain
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with ABCC3 loss of heterozygosity?,freq_cnv_loss_or_gain
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with EPRS1 loss of heterozygosity?,freq_cnv_loss_or_gain
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with TAF1C loss of heterozygosity?,freq_cnv_loss_or_gain
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with PDGFC loss of heterozygosity?,freq_cnv_loss_or_gain
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with TMEM255A loss of heterozygosity?,freq_cnv_loss_or_gain
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with PLEKHG6 loss of heterozygosity?,freq_cnv_loss_or_gain
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with PTPRN2 loss of heterozygosity?,freq_cnv_loss_or_gain
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with ARMC3 loss of heterozygosity?,freq_cnv_loss_or_gain
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with PAK3 loss of heterozygosity?,freq_cnv_loss_or_gain
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with SPTAN1 loss of heterozygosity?,freq_cnv_loss_or_gain
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with ACTB loss of heterozygosity?,freq_cnv_loss_or_gain
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently do Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients present with GSTCD loss of heterozygosity?,freq_cnv_loss_or_gain
+406,POC1B,I198T,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with PCDHB2 loss of heterozygosity?,freq_cnv_loss_or_gain
+407,POC1B,I286T,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with COL6A3 loss of heterozygosity?,freq_cnv_loss_or_gain
+408,POC1B,I328T,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with CR1 loss of heterozygosity?,freq_cnv_loss_or_gain
+409,POC1B,S79P,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with PAK3 loss of heterozygosity?,freq_cnv_loss_or_gain
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How frequently do Liver Hepatocellular Carcinoma patients present with GABRA6 loss of heterozygosity?,freq_cnv_loss_or_gain
+414,AQP7,T110S,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with TNS1 loss of heterozygosity?,freq_cnv_loss_or_gain
+415,AQP7,T166S,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with DNAH11 loss of heterozygosity?,freq_cnv_loss_or_gain
+416,AQP7,T167S,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with KRT39 loss of heterozygosity?,freq_cnv_loss_or_gain
+417,AQP7,T75S,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with SIK2 loss of heterozygosity?,freq_cnv_loss_or_gain
+430,DCN,R163C,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with RAB40C loss of heterozygosity?,freq_cnv_loss_or_gain
+431,DCN,R203C,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with MYT1 loss of heterozygosity?,freq_cnv_loss_or_gain
+432,DCN,R241C,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with ZNF431 loss of heterozygosity?,freq_cnv_loss_or_gain
+433,DCN,R350C,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with CPS1 loss of heterozygosity?,freq_cnv_loss_or_gain
+434,DCN,R41C,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with PGR loss of heterozygosity?,freq_cnv_loss_or_gain
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with UNC5D loss of heterozygosity?,freq_cnv_loss_or_gain
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with SYNJ1 loss of heterozygosity?,freq_cnv_loss_or_gain
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with ANP32E loss of heterozygosity?,freq_cnv_loss_or_gain
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How frequently do Kidney Renal Papillary Cell Carcinoma patients present with TYK2 loss of heterozygosity?,freq_cnv_loss_or_gain
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How frequently do Kidney Renal Papillary Cell Carcinoma patients present with ACVR1B loss of heterozygosity?,freq_cnv_loss_or_gain
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with GUCY2C loss of heterozygosity?,freq_cnv_loss_or_gain
+482,SGCZ,Q138H,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with PXN loss of heterozygosity?,freq_cnv_loss_or_gain
+483,SGCZ,Q91H,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with ART3 loss of heterozygosity?,freq_cnv_loss_or_gain
+485,SMO,V15M,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with TENM2 loss of heterozygosity?,freq_cnv_loss_or_gain
+486,SMO,V321M,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with DGKD loss of heterozygosity?,freq_cnv_loss_or_gain
+488,CHODL,G159E,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with TNS1 loss of heterozygosity?,freq_cnv_loss_or_gain
+489,CHODL,G181E,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with ACVR1B loss of heterozygosity?,freq_cnv_loss_or_gain
+490,CHODL,G200E,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with PTPRO loss of heterozygosity?,freq_cnv_loss_or_gain
+494,MYO16,P399H,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with NRAP loss of heterozygosity?,freq_cnv_loss_or_gain
+495,MYO16,P421H,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with PGF loss of heterozygosity?,freq_cnv_loss_or_gain
+498,CXCR2,A98V,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with EBF2 loss of heterozygosity?,freq_cnv_loss_or_gain
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with ACVR1B loss of heterozygosity?,freq_cnv_loss_or_gain
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with PTPRO loss of heterozygosity?,freq_cnv_loss_or_gain
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with TENT5A loss of heterozygosity?,freq_cnv_loss_or_gain
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with MYO3A loss of heterozygosity?,freq_cnv_loss_or_gain
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with NCKAP5 loss of heterozygosity?,freq_cnv_loss_or_gain
+510,RAB40C,A111V,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with TENM2 loss of heterozygosity?,freq_cnv_loss_or_gain
+511,RAB40C,A143V,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with TENM2 loss of heterozygosity?,freq_cnv_loss_or_gain
+512,CTNNA2,S323R,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with EVC2 loss of heterozygosity?,freq_cnv_loss_or_gain
+513,CTNNA2,S339R,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with TLK2 loss of heterozygosity?,freq_cnv_loss_or_gain
+514,CTNNA2,S386R,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with ACTB loss of heterozygosity?,freq_cnv_loss_or_gain
+515,CTNNA2,S707R,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with PLEKHG6 loss of heterozygosity?,freq_cnv_loss_or_gain
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with XKR4 loss of heterozygosity?,freq_cnv_loss_or_gain
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with MERTK loss of heterozygosity?,freq_cnv_loss_or_gain
+532,KIF20B,N1160D,Glioblastoma Multiforme,How frequently do Glioblastoma Multiforme patients present with AQP7 loss of heterozygosity?,freq_cnv_loss_or_gain
+533,KIF20B,N1200D,Glioblastoma Multiforme,How frequently do Glioblastoma Multiforme patients present with PIAS3 loss of heterozygosity?,freq_cnv_loss_or_gain
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with STK19 loss of heterozygosity?,freq_cnv_loss_or_gain
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with CTCFL loss of heterozygosity?,freq_cnv_loss_or_gain
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with PTPRN2 loss of heterozygosity?,freq_cnv_loss_or_gain
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with USH2A loss of heterozygosity?,freq_cnv_loss_or_gain
+540,ERCC6,R1053H,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with DPF3 loss of heterozygosity?,freq_cnv_loss_or_gain
+541,DCC,R320W,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with ZMYM3 loss of heterozygosity?,freq_cnv_loss_or_gain
+542,DCC,R363W,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with DGKD loss of heterozygosity?,freq_cnv_loss_or_gain
+543,DCC,R386W,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with YY1AP1 loss of heterozygosity?,freq_cnv_loss_or_gain
+544,DCC,R41W,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with GUK1 loss of heterozygosity?,freq_cnv_loss_or_gain
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with CTNNA2 loss of heterozygosity?,freq_cnv_loss_or_gain
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with CCDC22 loss of heterozygosity?,freq_cnv_loss_or_gain
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with CNGB1 loss of heterozygosity?,freq_cnv_loss_or_gain
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with STK19 loss of heterozygosity?,freq_cnv_loss_or_gain
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with EIF2B4 loss of heterozygosity?,freq_cnv_loss_or_gain
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with EPRS1 loss of heterozygosity?,freq_cnv_loss_or_gain
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with DCC loss of heterozygosity?,freq_cnv_loss_or_gain
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How frequently do Ovarian Serous Cystadenocarcinoma patients present with CHODL loss of heterozygosity?,freq_cnv_loss_or_gain
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How frequently do Ovarian Serous Cystadenocarcinoma patients present with PIAS3 loss of heterozygosity?,freq_cnv_loss_or_gain
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with FGF8 loss of heterozygosity?,freq_cnv_loss_or_gain
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with POC1B loss of heterozygosity?,freq_cnv_loss_or_gain
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with FGF8 loss of heterozygosity?,freq_cnv_loss_or_gain
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with GRM1 loss of heterozygosity?,freq_cnv_loss_or_gain
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with TLCD5 loss of heterozygosity?,freq_cnv_loss_or_gain
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with MED16 loss of heterozygosity?,freq_cnv_loss_or_gain
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with ACVR1B loss of heterozygosity?,freq_cnv_loss_or_gain
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with PIK3C2B loss of heterozygosity?,freq_cnv_loss_or_gain
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with PCDHB2 loss of heterozygosity?,freq_cnv_loss_or_gain
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with CACNA1F loss of heterozygosity?,freq_cnv_loss_or_gain
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with ABCC3 loss of heterozygosity?,freq_cnv_loss_or_gain
+625,SIK2,I265M,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with MYO3B loss of heterozygosity?,freq_cnv_loss_or_gain
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with EVC2 loss of heterozygosity?,freq_cnv_loss_or_gain
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with OR13C3 loss of heterozygosity?,freq_cnv_loss_or_gain
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with PIAS3 loss of heterozygosity?,freq_cnv_loss_or_gain
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with TLCD5 loss of heterozygosity?,freq_cnv_loss_or_gain
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with ANKDD1A loss of heterozygosity?,freq_cnv_loss_or_gain
+644,OR2A12,A254T,Brain Lower Grade Glioma,How frequently do Brain Lower Grade Glioma patients present with MYO16 loss of heterozygosity?,freq_cnv_loss_or_gain
+646,PYHIN1,T325K,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with SPAG1 loss of heterozygosity?,freq_cnv_loss_or_gain
+647,PYHIN1,T334K,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with CCDC22 loss of heterozygosity?,freq_cnv_loss_or_gain
+650,JAML,G191E,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with CYB5R2 loss of heterozygosity?,freq_cnv_loss_or_gain
+651,JAML,G219E,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with ZNF708 loss of heterozygosity?,freq_cnv_loss_or_gain
+652,JAML,G220E,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with YY1AP1 loss of heterozygosity?,freq_cnv_loss_or_gain
+653,JAML,G230E,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with DPF3 loss of heterozygosity?,freq_cnv_loss_or_gain
+658,TYK2,H1146R,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with YY1AP1 loss of heterozygosity?,freq_cnv_loss_or_gain
+659,TYK2,H23R,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with PAK3 loss of heterozygosity?,freq_cnv_loss_or_gain
+660,TYK2,H961R,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with DCLK3 loss of heterozygosity?,freq_cnv_loss_or_gain
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with DCN loss of heterozygosity?,freq_cnv_loss_or_gain
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with TTC12 loss of heterozygosity?,freq_cnv_loss_or_gain
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with TNS1 loss of heterozygosity?,freq_cnv_loss_or_gain
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with ZNF274 loss of heterozygosity?,freq_cnv_loss_or_gain
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with GUK1 loss of heterozygosity?,freq_cnv_loss_or_gain
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with PDHA2 loss of heterozygosity?,freq_cnv_loss_or_gain
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with CX3CR1 loss of heterozygosity?,freq_cnv_loss_or_gain
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with CARMIL1 loss of heterozygosity?,freq_cnv_loss_or_gain
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with DGKD loss of heterozygosity?,freq_cnv_loss_or_gain
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with TTN loss of heterozygosity?,freq_cnv_loss_or_gain
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with TLK2 loss of heterozygosity?,freq_cnv_loss_or_gain
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with CYP1A2 loss of heterozygosity?,freq_cnv_loss_or_gain
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with GABRA6 loss of heterozygosity?,freq_cnv_loss_or_gain
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with PCDHB2 loss of heterozygosity?,freq_cnv_loss_or_gain
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with KDM5C loss of heterozygosity?,freq_cnv_loss_or_gain
+728,STK19,D341N,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with UNC5D loss of heterozygosity?,freq_cnv_loss_or_gain
+729,STK19,D345N,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with GUK1 loss of heterozygosity?,freq_cnv_loss_or_gain
+730,REXO4,P60A,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with RIMS2 loss of heterozygosity?,freq_cnv_loss_or_gain
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with PIK3C2G loss of heterozygosity?,freq_cnv_loss_or_gain
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with GUK1 loss of heterozygosity?,freq_cnv_loss_or_gain
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with SYNJ1 loss of heterozygosity?,freq_cnv_loss_or_gain
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with SORCS1 loss of heterozygosity?",freq_cnv_loss_or_gain
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with TAF1C loss of heterozygosity?",freq_cnv_loss_or_gain
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with MERTK loss of heterozygosity?",freq_cnv_loss_or_gain
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with DCN loss of heterozygosity?",freq_cnv_loss_or_gain
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How frequently do Head and Neck Squamous Cell Carcinoma patients present with DGKD loss of heterozygosity?,freq_cnv_loss_or_gain
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How frequently do Head and Neck Squamous Cell Carcinoma patients present with GPR158 loss of heterozygosity?,freq_cnv_loss_or_gain
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How frequently do Head and Neck Squamous Cell Carcinoma patients present with MUC16 loss of heterozygosity?,freq_cnv_loss_or_gain
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How frequently do Head and Neck Squamous Cell Carcinoma patients present with MAD1L1 loss of heterozygosity?,freq_cnv_loss_or_gain
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How frequently do Head and Neck Squamous Cell Carcinoma patients present with PTPRO loss of heterozygosity?,freq_cnv_loss_or_gain
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How frequently do Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia patients present with DCN loss of heterozygosity?,freq_cnv_loss_or_gain
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with FCGR2C loss of heterozygosity?,freq_cnv_loss_or_gain
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently do Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients present with DNMT1 loss of heterozygosity?,freq_cnv_loss_or_gain
+792,GLRB,E148D,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with ABCC3 loss of heterozygosity?,freq_cnv_loss_or_gain
+793,TTN,F7636L,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with PCDHB2 loss of heterozygosity?,freq_cnv_loss_or_gain
+794,TTN,F8563L,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with EVC2 loss of heterozygosity?,freq_cnv_loss_or_gain
+795,TTN,F8880L,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with DCC loss of heterozygosity?,freq_cnv_loss_or_gain
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with TENM2 loss of heterozygosity?,freq_cnv_loss_or_gain
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with BCAT1 loss of heterozygosity?,freq_cnv_loss_or_gain
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with DPF3 loss of heterozygosity?,freq_cnv_loss_or_gain
+809,TRIM45,S177L,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with ZFAT loss of heterozygosity?,freq_cnv_loss_or_gain
+810,TRIM45,S224L,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with TLK2 loss of heterozygosity?,freq_cnv_loss_or_gain
+811,TRIM45,S281L,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with CR1 loss of heterozygosity?,freq_cnv_loss_or_gain
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with MORF4L1 loss of heterozygosity?,freq_cnv_loss_or_gain
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with ACTA2 loss of heterozygosity?,freq_cnv_loss_or_gain
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with THBS4 loss of heterozygosity?,freq_cnv_loss_or_gain
+817,KL,R594C,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with ANKRD30A loss of heterozygosity?,freq_cnv_loss_or_gain
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How frequently do Kidney Renal Papillary Cell Carcinoma patients present with ZKSCAN7 loss of heterozygosity?,freq_cnv_loss_or_gain
+822,TAF1L,A539V,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with CTCFL loss of heterozygosity?,freq_cnv_loss_or_gain
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with KDM5C loss of heterozygosity?,freq_cnv_loss_or_gain
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with ZMYM3 loss of heterozygosity?,freq_cnv_loss_or_gain
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with TYK2 loss of heterozygosity?,freq_cnv_loss_or_gain
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with SPATA22 loss of heterozygosity?,freq_cnv_loss_or_gain
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with OR5D14 loss of heterozygosity?,freq_cnv_loss_or_gain
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with MAD1L1 loss of heterozygosity?,freq_cnv_loss_or_gain
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with FGF8 loss of heterozygosity?,freq_cnv_loss_or_gain
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently do Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients present with CYB5R2 loss of heterozygosity?,freq_cnv_loss_or_gain
+843,DHX16,A29V,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with RIPOR2 loss of heterozygosity?,freq_cnv_loss_or_gain
+844,DHX16,A89V,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with FRY loss of heterozygosity?,freq_cnv_loss_or_gain
+902,GPR158,A644V,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with FGF8 loss of heterozygosity?,freq_cnv_loss_or_gain
+903,GPR158,A723V,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with PIAS3 loss of heterozygosity?,freq_cnv_loss_or_gain
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with CTSC loss of heterozygosity?",freq_cnv_loss_or_gain
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with PIAS3 loss of heterozygosity?",freq_cnv_loss_or_gain
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with GUK1 loss of heterozygosity?",freq_cnv_loss_or_gain
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with ACTB loss of heterozygosity?",freq_cnv_loss_or_gain
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with DPF3 loss of heterozygosity?",freq_cnv_loss_or_gain
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with C7orf31 loss of heterozygosity?",freq_cnv_loss_or_gain
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with CTCFL loss of heterozygosity?,freq_cnv_loss_or_gain
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with TENT5A loss of heterozygosity?,freq_cnv_loss_or_gain
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with PRSS1 loss of heterozygosity?,freq_cnv_loss_or_gain
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with ZNF431 loss of heterozygosity?,freq_cnv_loss_or_gain
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with PTPRN2 loss of heterozygosity?,freq_cnv_loss_or_gain
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with ZFAT loss of heterozygosity?,freq_cnv_loss_or_gain
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with BCAT1 loss of heterozygosity?,freq_cnv_loss_or_gain
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with SORCS1 loss of heterozygosity?,freq_cnv_loss_or_gain
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with PCDHB2 loss of heterozygosity?,freq_cnv_loss_or_gain
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with PCDHB2 loss of heterozygosity?,freq_cnv_loss_or_gain
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with ACTA2 loss of heterozygosity?",freq_cnv_loss_or_gain
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How frequently do Glioblastoma Multiforme patients present with TLK2 loss of heterozygosity?,freq_cnv_loss_or_gain
+954,TRAP1,R114W,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with DCC loss of heterozygosity?,freq_cnv_loss_or_gain
+955,TRAP1,R61W,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with BCAT1 loss of heterozygosity?,freq_cnv_loss_or_gain
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with B3GALNT1 loss of heterozygosity?,freq_cnv_loss_or_gain
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How frequently do Liver Hepatocellular Carcinoma patients present with TENT5A loss of heterozygosity?,freq_cnv_loss_or_gain
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with KDM5C loss of heterozygosity?,freq_cnv_loss_or_gain
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with MAST4 loss of heterozygosity?,freq_cnv_loss_or_gain
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with PIAS3 loss of heterozygosity?,freq_cnv_loss_or_gain
+982,GABRA6,G115R,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with ZSCAN31 loss of heterozygosity?,freq_cnv_loss_or_gain
+983,GABRA6,G122R,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with GABRA6 loss of heterozygosity?,freq_cnv_loss_or_gain
+984,GABRA6,G165R,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with KDM5C loss of heterozygosity?,freq_cnv_loss_or_gain
+985,GABRA6,G175R,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with PCDHGA1 loss of heterozygosity?,freq_cnv_loss_or_gain
+986,GABRA6,G70R,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with TAF1L loss of heterozygosity?,freq_cnv_loss_or_gain
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with CTNNA2 loss of heterozygosity?,freq_cnv_loss_or_gain
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with ANKDD1A loss of heterozygosity?",freq_cnv_loss_or_gain
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with TYK2 loss of heterozygosity?",freq_cnv_loss_or_gain
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How frequently do Pancreatic Adenocarcinoma patients present with POC1B loss of heterozygosity?,freq_cnv_loss_or_gain
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How frequently do Pancreatic Adenocarcinoma patients present with DPF3 loss of heterozygosity?,freq_cnv_loss_or_gain
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How frequently do Pancreatic Adenocarcinoma patients present with GABRA6 loss of heterozygosity?,freq_cnv_loss_or_gain
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How frequently do Pancreatic Adenocarcinoma patients present with CFAP61 loss of heterozygosity?,freq_cnv_loss_or_gain
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How frequently do Pancreatic Adenocarcinoma patients present with B3GALNT1 loss of heterozygosity?,freq_cnv_loss_or_gain
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How frequently do Pancreatic Adenocarcinoma patients present with PYHIN1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How frequently do Pancreatic Adenocarcinoma patients present with TASOR2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How frequently do Pancreatic Adenocarcinoma patients present with KL loss of heterozygosity?,freq_cnv_loss_or_gain
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with TTC17 loss of heterozygosity?,freq_cnv_loss_or_gain
+1017,GPC3,I107N,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with SPINDOC loss of heterozygosity?,freq_cnv_loss_or_gain
+1018,GPC3,I161N,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with FGF8 loss of heterozygosity?,freq_cnv_loss_or_gain
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently do Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients present with CTNNA2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently do Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients present with TRIM45 loss of heterozygosity?,freq_cnv_loss_or_gain
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently do Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients present with DCAF6 loss of heterozygosity?,freq_cnv_loss_or_gain
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently do Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients present with ANKRD30A loss of heterozygosity?,freq_cnv_loss_or_gain
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently do Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients present with AUTS2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with DCC loss of heterozygosity?,freq_cnv_loss_or_gain
+1038,SYT9,V275L,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with POC1B loss of heterozygosity?,freq_cnv_loss_or_gain
+1039,SYT9,V307L,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with DCAF6 loss of heterozygosity?,freq_cnv_loss_or_gain
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with ARMC3 loss of heterozygosity?,freq_cnv_loss_or_gain
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with YY1AP1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with NOMO1 loss of heterozygosity?",freq_cnv_loss_or_gain
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with EPRS1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with EVC2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with UNC5D loss of heterozygosity?,freq_cnv_loss_or_gain
+1056,CA9,E402K,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with CACNA1F loss of heterozygosity?,freq_cnv_loss_or_gain
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with TNS1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with DCN loss of heterozygosity?,freq_cnv_loss_or_gain
+1065,PSG2,P43L,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with VPS26B loss of heterozygosity?,freq_cnv_loss_or_gain
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with ARMC3 loss of heterozygosity?,freq_cnv_loss_or_gain
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with ZCCHC14 loss of heterozygosity?,freq_cnv_loss_or_gain
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with GRM1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with TLK2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with MYT1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with RIMS2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with MAD1L1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with PCDHB2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with PYHIN1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with TNS1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with RIPOR2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with SPAG1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with PRSS8 loss of heterozygosity?,freq_cnv_loss_or_gain
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with DPF3 loss of heterozygosity?,freq_cnv_loss_or_gain
+1093,PXN,H1016Y,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with MAD1L1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1094,PXN,H359Y,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with DNAH11 loss of heterozygosity?,freq_cnv_loss_or_gain
+1095,PXN,H492Y,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with KIF20B loss of heterozygosity?,freq_cnv_loss_or_gain
+1096,PXN,H524Y,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with ANKRD52 loss of heterozygosity?,freq_cnv_loss_or_gain
+1097,PXN,H526Y,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with KDM5C loss of heterozygosity?,freq_cnv_loss_or_gain
+1098,PXN,H540Y,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with ANP32E loss of heterozygosity?,freq_cnv_loss_or_gain
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with HTR3B loss of heterozygosity?,freq_cnv_loss_or_gain
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with MAOB loss of heterozygosity?,freq_cnv_loss_or_gain
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with TET2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with TLCD5 loss of heterozygosity?,freq_cnv_loss_or_gain
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with FMO4 loss of heterozygosity?,freq_cnv_loss_or_gain
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with EPRS1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with NPSR1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with EIF2B4 loss of heterozygosity?,freq_cnv_loss_or_gain
+1112,MYT1,A558E,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with GRM5 loss of heterozygosity?,freq_cnv_loss_or_gain
+1113,MYT1,A879E,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with EPRS1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1114,MYT1,A906E,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with TRAP1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with MYO16 loss of heterozygosity?,freq_cnv_loss_or_gain
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with RIPOR2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How frequently do Liver Hepatocellular Carcinoma patients present with TASOR2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with GLRB loss of heterozygosity?,freq_cnv_loss_or_gain
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with COL6A3 loss of heterozygosity?,freq_cnv_loss_or_gain
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with EFCAB12 loss of heterozygosity?,freq_cnv_loss_or_gain
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with DCN loss of heterozygosity?",freq_cnv_loss_or_gain
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with RIMS2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with CYP1A2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with TRIM45 loss of heterozygosity?,freq_cnv_loss_or_gain
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with SGIP1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with STK19 loss of heterozygosity?,freq_cnv_loss_or_gain
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How frequently do Liver Hepatocellular Carcinoma patients present with ZFAT loss of heterozygosity?,freq_cnv_loss_or_gain
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How frequently do Liver Hepatocellular Carcinoma patients present with CFAP61 loss of heterozygosity?,freq_cnv_loss_or_gain
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How frequently do Liver Hepatocellular Carcinoma patients present with FBXO42 loss of heterozygosity?,freq_cnv_loss_or_gain
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How frequently do Liver Hepatocellular Carcinoma patients present with ACVR1B loss of heterozygosity?,freq_cnv_loss_or_gain
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How frequently do Liver Hepatocellular Carcinoma patients present with SGIP1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1188,SOX21,R55L,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with RIMS2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with ANP32E loss of heterozygosity?,freq_cnv_loss_or_gain
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with EIF2B4 loss of heterozygosity?,freq_cnv_loss_or_gain
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with GPRASP1 loss of heterozygosity?",freq_cnv_loss_or_gain
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with ACVR1B loss of heterozygosity?,freq_cnv_loss_or_gain
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with SPTAN1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with PXN loss of heterozygosity?,freq_cnv_loss_or_gain
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with SLC6A4 loss of heterozygosity?,freq_cnv_loss_or_gain
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with PTPRO loss of heterozygosity?,freq_cnv_loss_or_gain
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with CDH23 loss of heterozygosity?,freq_cnv_loss_or_gain
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with EIF2B4 loss of heterozygosity?,freq_cnv_loss_or_gain
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with NRAP loss of heterozygosity?,freq_cnv_loss_or_gain
+1234,ZNF431,R128I,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with DGKD loss of heterozygosity?,freq_cnv_loss_or_gain
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with ZFPM2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with LDOC1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with PAK3 loss of heterozygosity?,freq_cnv_loss_or_gain
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How frequently do Lung Squamous Cell Carcinoma patients present with GIMAP2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1248,TTC12,D646H,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with PIAS3 loss of heterozygosity?,freq_cnv_loss_or_gain
+1249,TTC12,D652H,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with NPSR1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with PIK3C2B loss of heterozygosity?,freq_cnv_loss_or_gain
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How frequently do Bladder Urothelial Carcinoma patients present with TTC17 loss of heterozygosity?,freq_cnv_loss_or_gain
+1254,CTSC,E214V,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with CTCFL loss of heterozygosity?,freq_cnv_loss_or_gain
+1255,CTSC,E291V,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with GSTCD loss of heterozygosity?,freq_cnv_loss_or_gain
+1256,CTSC,E322V,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with MAST4 loss of heterozygosity?,freq_cnv_loss_or_gain
+1257,CTSC,E324V,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with ACTA2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1258,CTSC,E335V,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with TET2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with ZCCHC14 loss of heterozygosity?,freq_cnv_loss_or_gain
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with CPS1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with AUTS2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1264,ACTB,A138T,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with ACTA2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1265,ACTB,A217T,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with DCAF6 loss of heterozygosity?,freq_cnv_loss_or_gain
+1266,ACTB,A244T,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with DNMT1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1267,ACTB,A260T,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with EVC2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How frequently do Glioblastoma Multiforme patients present with TTYH2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How frequently do Glioblastoma Multiforme patients present with ZNF217 loss of heterozygosity?,freq_cnv_loss_or_gain
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How frequently do Glioblastoma Multiforme patients present with PGR loss of heterozygosity?,freq_cnv_loss_or_gain
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How frequently do Glioblastoma Multiforme patients present with ANKRD30A loss of heterozygosity?,freq_cnv_loss_or_gain
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How frequently do Glioblastoma Multiforme patients present with KDM5C loss of heterozygosity?,freq_cnv_loss_or_gain
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How frequently do Glioblastoma Multiforme patients present with MAD1L1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How frequently do Glioblastoma Multiforme patients present with MYT1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with DNAH14 loss of heterozygosity?,freq_cnv_loss_or_gain
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with DGKD loss of heterozygosity?,freq_cnv_loss_or_gain
+1299,TLCD5,G15V,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with ARMC3 loss of heterozygosity?,freq_cnv_loss_or_gain
+1300,TLCD5,G37V,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with UNC5D loss of heterozygosity?,freq_cnv_loss_or_gain
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with PGR loss of heterozygosity?,freq_cnv_loss_or_gain
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with PGR loss of heterozygosity?,freq_cnv_loss_or_gain
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with AUTS2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with GUK1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with EIF2B4 loss of heterozygosity?,freq_cnv_loss_or_gain
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with OLFML3 loss of heterozygosity?,freq_cnv_loss_or_gain
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How frequently do Prostate Adenocarcinoma patients present with STK19 loss of heterozygosity?,freq_cnv_loss_or_gain
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How frequently do Prostate Adenocarcinoma patients present with DCN loss of heterozygosity?,freq_cnv_loss_or_gain
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with CACNA1F loss of heterozygosity?,freq_cnv_loss_or_gain
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with RIMS2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with OR2A12 loss of heterozygosity?,freq_cnv_loss_or_gain
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with LDOC1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with ANKDD1A loss of heterozygosity?,freq_cnv_loss_or_gain
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with TTC17 loss of heterozygosity?,freq_cnv_loss_or_gain
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with DCC loss of heterozygosity?,freq_cnv_loss_or_gain
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with MERTK loss of heterozygosity?,freq_cnv_loss_or_gain
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with PTPRO loss of heterozygosity?,freq_cnv_loss_or_gain
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with AQP7 loss of heterozygosity?,freq_cnv_loss_or_gain
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with YY1AP1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with RIPOR2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with GABRA6 loss of heterozygosity?,freq_cnv_loss_or_gain
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with MRPL55 loss of heterozygosity?,freq_cnv_loss_or_gain
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with PRSS1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How frequently do Kidney Renal Clear Cell Carcinoma patients present with MED16 loss of heterozygosity?,freq_cnv_loss_or_gain
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How frequently do Kidney Renal Clear Cell Carcinoma patients present with IL5RA loss of heterozygosity?,freq_cnv_loss_or_gain
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with DSCAM loss of heterozygosity?,freq_cnv_loss_or_gain
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with PXN loss of heterozygosity?,freq_cnv_loss_or_gain
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with RAB40C loss of heterozygosity?,freq_cnv_loss_or_gain
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with SGCZ loss of heterozygosity?,freq_cnv_loss_or_gain
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with ARMC3 loss of heterozygosity?,freq_cnv_loss_or_gain
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with RIMS2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1393,EBF2,T104I,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with SPATA22 loss of heterozygosity?,freq_cnv_loss_or_gain
+1394,EBF2,T252I,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with POC1B loss of heterozygosity?,freq_cnv_loss_or_gain
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with TNS1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with OR2T4 loss of heterozygosity?",freq_cnv_loss_or_gain
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with TMEM225 loss of heterozygosity?",freq_cnv_loss_or_gain
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients present with PLEKHG6 loss of heterozygosity?",freq_cnv_loss_or_gain
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How frequently do Skin Cutaneous Melanoma patients present with TMEM255A loss of heterozygosity?,freq_cnv_loss_or_gain
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with PTPRO loss of heterozygosity?,freq_cnv_loss_or_gain
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with DCN loss of heterozygosity?,freq_cnv_loss_or_gain
+1413,PRSS1,S114T,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with SYT9 loss of heterozygosity?,freq_cnv_loss_or_gain
+1414,PRSS1,S124T,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with GABRA6 loss of heterozygosity?,freq_cnv_loss_or_gain
+1415,PRSS1,S138T,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with GUK1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1416,PRSS1,S74T,Lung Adenocarcinoma,How frequently do Lung Adenocarcinoma patients present with COL6A3 loss of heterozygosity?,freq_cnv_loss_or_gain
+1417,PGF,R126H,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with TENM2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1418,PGF,R127H,Stomach Adenocarcinoma,How frequently do Stomach Adenocarcinoma patients present with ZCCHC14 loss of heterozygosity?,freq_cnv_loss_or_gain
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with MAST4 loss of heterozygosity?,freq_cnv_loss_or_gain
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How frequently do Breast Invasive Carcinoma patients present with ANKRD24 loss of heterozygosity?,freq_cnv_loss_or_gain
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with PDHA2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with TASOR2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with AUTS2 loss of heterozygosity?,freq_cnv_loss_or_gain
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How frequently do Colon Adenocarcinoma patients present with FCGR2C loss of heterozygosity?,freq_cnv_loss_or_gain
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How frequently do Uterine Corpus Endometrial Carcinoma patients present with UNC5D loss of heterozygosity?,freq_cnv_loss_or_gain
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How frequently do Rectum Adenocarcinoma patients present with SORCS1 loss of heterozygosity?,freq_cnv_loss_or_gain
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the proportion of AUTS2 and TNS1 codeletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the proportion of CR1 and TNS1 codeletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the proportion of TTYH2 and TNS1 codeletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the proportion of MAOB and TNS1 codeletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the proportion of PRSS8 and TNS1 codeletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the proportion of SERPINB10 and TNS1 codeletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the proportion of MORF4L1 and TNS1 codeletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the proportion of CPS1 and EVC2 codeletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the proportion of BFAR and EVC2 codeletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the proportion of CPS1 and CR1 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the proportion of MYO15A and CR1 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the proportion of MYT1 and TRPA1 codeletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the proportion of ZNF708 and TRPA1 codeletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the proportion of NPSR1 and TAF1C codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the proportion of GRM5 and TAF1C codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the proportion of CHODL and TAF1C codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the proportion of ANP32E and TAF1C codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the proportion of SPATA22 and TAF1C codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the proportion of PLEKHG6 and DPF3 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the proportion of PLEKHG6 and DPF3 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the proportion of PIK3C2A and DPF3 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the proportion of RIPOR2 and OR2T4 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the proportion of CHMP7 and OR2T4 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the proportion of AUTS2 and FBN1 codeletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the proportion of ZCCHC14 and MAD1L1 codeletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the proportion of ZNF431 and MAD1L1 codeletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the proportion of ARMC3 and MAD1L1 codeletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the proportion of DHX16 and CCNG1 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the proportion of GSTCD and ANP32E codeletion in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the proportion of TNS1 and ANP32E codeletion in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the proportion of DCN and ANP32E codeletion in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the proportion of COL6A3 and ANP32E codeletion in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the proportion of DCAF6 and FRY codeletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the proportion of TASOR2 and FRY codeletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the proportion of GIMAP2 and FRY codeletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the proportion of PCDHB2 and FRY codeletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the proportion of PHLPP1 and PAK3 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the proportion of FBN1 and PAK3 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the proportion of DCC and PAK3 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the proportion of ACTB and PAK3 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the proportion of PXN and PAK3 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the proportion of ZFPM2 and MUC16 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the proportion of DSCAM and ZFPM2 codeletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the proportion of TET2 and ZFPM2 codeletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the proportion of PSG2 and PIK3C2B codeletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the proportion of PXN and PIK3C2B codeletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the proportion of CFAP61 and ZNF804A codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the proportion of AUTS2 and RELN codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of CXCR2 and EFCAB12 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of MAD1L1 and EFCAB12 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the proportion of CYP1A2 and DEFB115 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the proportion of CACNA1F and ANKDD1A codeletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the proportion of KANSL1 and ANKDD1A codeletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the proportion of ZNF431 and ANKDD1A codeletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the proportion of SPATA22 and HTR3B codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the proportion of TLK2 and HTR3B codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the proportion of ARMC3 and HTR3B codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the proportion of GABRA6 and ABCC3 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the proportion of GABRA6 and NOMO1 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the proportion of ZFPM2 and NOMO1 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the proportion of MAST4 and HYOU1 codeletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the proportion of GPR158 and FMO4 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+140,BICC1,A372V,Exceptional Responders,What is the proportion of AKT1 and BICC1 codeletion in Exceptional Responders?,freq_cnv_loss_or_gain
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the proportion of OR8K5 and ZMYM3 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the proportion of EPRS1 and ZMYM3 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the proportion of PLEKHG6 and ZMYM3 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of NEXN and XKR4 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the proportion of GRM1 and ABCC2 codeletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the proportion of POLD1 and OR8K5 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the proportion of RIPOR2 and SPTAN1 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the proportion of RIMS2 and SPTAN1 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the proportion of AUTS2 and SYT10 codeletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the proportion of ZMYM3 and HSPA5 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the proportion of ZNF708 and UNC5D codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the proportion of MERTK and UNC5D codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the proportion of MAST4 and UNC5D codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the proportion of SPTAN1 and UNC5D codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the proportion of TAF1L and UNC5D codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the proportion of TLCD5 and UNC5D codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the proportion of KDM5C and DOCK2 codeletion in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the proportion of PGR and ZNF627 codeletion in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the proportion of MYT1 and CDC42BPA codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the proportion of TET2 and MRPL55 codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the proportion of OR2T4 and MRPL55 codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the proportion of ZKSCAN7 and TMTC3 codeletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the proportion of TTYH2 and EPRS1 codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the proportion of FBN1 and EPRS1 codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the proportion of GPRASP1 and GRTP1 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the proportion of GIMAP2 and GRTP1 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the proportion of AUTS2 and TSHZ3 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the proportion of PYHIN1 and TAS1R3 codeletion in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,freq_cnv_loss_or_gain
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the proportion of CPS1 and PIAS3 codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the proportion of TLCD5 and PIAS3 codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the proportion of TENM2 and ZNF274 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the proportion of OR8K5 and SYNJ1 codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the proportion of MERTK and SYNJ1 codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the proportion of DOCK2 and SYNJ1 codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the proportion of DCN and DSCAM codeletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the proportion of TRPA1 and DSCAM codeletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the proportion of FMO4 and DSCAM codeletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+267,DGKD,R140H,Exceptional Responders,What is the proportion of CFAP61 and DGKD codeletion in Exceptional Responders?,freq_cnv_loss_or_gain
+268,DGKD,R160H,Exceptional Responders,What is the proportion of DCAF6 and DGKD codeletion in Exceptional Responders?,freq_cnv_loss_or_gain
+269,DGKD,R204H,Exceptional Responders,What is the proportion of ITPRID2 and DGKD codeletion in Exceptional Responders?,freq_cnv_loss_or_gain
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the proportion of MAOB and PLEKHG6 codeletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the proportion of CDC42BPA and PLEKHG6 codeletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the proportion of CCDC22 and PLEKHG6 codeletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the proportion of GABRA6 and WNT2 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the proportion of CCNG1 and GUCY2C codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the proportion of FBN1 and C7orf31 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of CTNNA2 and ZKSCAN7 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+299,OR5D14,M210L,Neuroblastoma,What is the proportion of PXN and OR5D14 codeletion in Neuroblastoma?,freq_cnv_loss_or_gain
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the proportion of EIF2B4 and SPATA22 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the proportion of MYO15A and SPATA22 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the proportion of PRSS1 and SPATA22 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the proportion of TTYH2 and LCN15 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the proportion of POLD1 and DCAF4L2 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the proportion of GUK1 and GUK1 codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the proportion of GABRA6 and GUK1 codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the proportion of PCDHB2 and GUK1 codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the proportion of GABRA6 and GUK1 codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the proportion of ACTB and GUK1 codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the proportion of ACTB and MORF4L1 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the proportion of MAD1L1 and MORF4L1 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the proportion of DCAF6 and MORF4L1 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the proportion of SERPINB10 and MORF4L1 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the proportion of REXO4 and MYO3B codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the proportion of TTN and MYO3B codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the proportion of PLEKHG6 and TENT5A codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the proportion of PAK3 and TENT5A codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the proportion of SORCS1 and TENT5A codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the proportion of SYT9 and ZFAT codeletion in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the proportion of RELN and ZFAT codeletion in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the proportion of TASOR2 and ZFAT codeletion in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+357,ZNF584,A211T,Sarcoma,What is the proportion of TMEM225 and ZNF584 codeletion in Sarcoma?,freq_cnv_loss_or_gain
+358,ZNF584,A256T,Sarcoma,What is the proportion of FNDC7 and ZNF584 codeletion in Sarcoma?,freq_cnv_loss_or_gain
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the proportion of XKR4 and LDOC1 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the proportion of PYHIN1 and PDGFC codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the proportion of GPRASP1 and MSANTD4 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the proportion of AQP7 and NPSR1 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the proportion of DNMT1 and PHLPP1 codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the proportion of CTSC and COL6A3 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the proportion of ACVR1B and COL6A3 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the proportion of KL and COL6A3 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the proportion of EIF2B4 and COL6A3 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the proportion of GIMAP2 and COL6A3 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the proportion of MYO3B and ADRA1A codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the proportion of GRTP1 and LAMB2 codeletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the proportion of AUTS2 and POC1B codeletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the proportion of DCC and POC1B codeletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the proportion of CYP1A2 and POC1B codeletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the proportion of GRM1 and POC1B codeletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the proportion of POC1B and USH2A codeletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the proportion of TAF1C and AQP7 codeletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the proportion of PXN and AQP7 codeletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the proportion of ERCC6 and AQP7 codeletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the proportion of SOX21 and AQP7 codeletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+430,DCN,R163C,Rectum Adenocarcinoma,What is the proportion of ITPRID2 and DCN codeletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+431,DCN,R203C,Rectum Adenocarcinoma,What is the proportion of CPS1 and DCN codeletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+432,DCN,R241C,Rectum Adenocarcinoma,What is the proportion of PXN and DCN codeletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+433,DCN,R350C,Rectum Adenocarcinoma,What is the proportion of POC1B and DCN codeletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+434,DCN,R41C,Rectum Adenocarcinoma,What is the proportion of DEFB115 and DCN codeletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the proportion of CCNG1 and CPS1 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the proportion of ACVR1B and CPS1 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the proportion of PTPRO and CPS1 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the proportion of CPS1 and FCGR2C codeletion in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the proportion of DNAH14 and FCGR2C codeletion in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the proportion of TRPA1 and GRM1 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the proportion of ZCCHC14 and SGCZ codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the proportion of TAF1C and SGCZ codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+485,SMO,V15M,Stomach Adenocarcinoma,What is the proportion of GRM1 and SMO codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+486,SMO,V321M,Stomach Adenocarcinoma,What is the proportion of MORF4L1 and SMO codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the proportion of ZFAT and CHODL codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the proportion of MYH11 and CHODL codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the proportion of BCAT1 and CHODL codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+494,MYO16,P399H,Colon Adenocarcinoma,What is the proportion of SGIP1 and MYO16 codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+495,MYO16,P421H,Colon Adenocarcinoma,What is the proportion of PRSS1 and MYO16 codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the proportion of MAOB and CXCR2 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the proportion of ZBTB34 and TMEM225 codeletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the proportion of PIK3C2A and MAOB codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the proportion of PGR and GPRASP1 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the proportion of ZNF431 and MRPL32 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the proportion of MRPL32 and TYROBP codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the proportion of FGF8 and RAB40C codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the proportion of GPR158 and RAB40C codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the proportion of MED16 and CTNNA2 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the proportion of EIF2B4 and CTNNA2 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the proportion of AUTS2 and CTNNA2 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the proportion of SORCS1 and CTNNA2 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the proportion of SERPINB10 and MYO15A codeletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the proportion of ART3 and GIMAP2 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the proportion of ANKRD30A and KIF20B codeletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the proportion of ACVR1B and KIF20B codeletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the proportion of TTN and ADAM17 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the proportion of COL6A3 and BCAT1 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the proportion of FRY and BCAT1 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the proportion of TET2 and BCAT1 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the proportion of ACVR1B and ERCC6 codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+541,DCC,R320W,Breast Invasive Carcinoma,What is the proportion of ACVR1B and DCC codeletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+542,DCC,R363W,Breast Invasive Carcinoma,What is the proportion of PTPRO and DCC codeletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+543,DCC,R386W,Breast Invasive Carcinoma,What is the proportion of ICE1 and DCC codeletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+544,DCC,R41W,Breast Invasive Carcinoma,What is the proportion of ANP32E and DCC codeletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the proportion of DCN and FBXO15 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the proportion of TTN and FBXO15 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the proportion of IL5RA and GSTCD codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the proportion of MED16 and GSTCD codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the proportion of ZKSCAN7 and OLFML3 codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the proportion of MED16 and OLFML3 codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the proportion of VASN and OLFML3 codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the proportion of TENT5A and CFAP61 codeletion in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the proportion of PXN and CFAP61 codeletion in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the proportion of CTCFL and HLA-DQA2 codeletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the proportion of ACVR1B and TENM2 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the proportion of PIK3C2G and TENM2 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the proportion of ANKDD1A and TENM2 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the proportion of TLK2 and ANKRD24 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the proportion of CDC42BPA and ANKRD24 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the proportion of RIMS2 and ANKRD24 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the proportion of FRY and ZCCHC14 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the proportion of ZBTB34 and ZCCHC14 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the proportion of GABRA6 and ZCCHC14 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the proportion of VPS26B and ZCCHC14 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+625,SIK2,I265M,Lung Adenocarcinoma,What is the proportion of MORF4L1 and SIK2 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the proportion of VASN and MYH11 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the proportion of TASOR2 and MYH11 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the proportion of NRAP and SLC6A4 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the proportion of TLK2 and SLC9C1 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the proportion of AUTS2 and SLC9C1 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the proportion of PTPRN2 and OR2A12 codeletion in Brain Lower Grade Glioma?,freq_cnv_loss_or_gain
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the proportion of ADRA1A and PYHIN1 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the proportion of TRPA1 and PYHIN1 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the proportion of MORF4L1 and JAML codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the proportion of MAD1L1 and JAML codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the proportion of NOMO1 and JAML codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the proportion of FGF8 and JAML codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the proportion of HLA-DQA2 and TYK2 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the proportion of TRIM45 and TYK2 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the proportion of SYNJ1 and TYK2 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the proportion of DPF3 and CTCFL codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the proportion of GPR158 and CTCFL codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the proportion of DCLK3 and CTCFL codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the proportion of ZCCHC14 and CTCFL codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the proportion of LAMB2 and CEP20 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the proportion of ZSCAN31 and CEP20 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the proportion of GRM5 and RIMS2 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the proportion of EIF2B4 and RIMS2 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the proportion of SPATA22 and RIMS2 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the proportion of EIF2B4 and RIMS2 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the proportion of MORF4L1 and RIMS2 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the proportion of MERTK and RIMS2 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the proportion of MED16 and RIMS2 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the proportion of DCC and PIK3C2G codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the proportion of GPR158 and PIK3C2G codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+728,STK19,D341N,Colon Adenocarcinoma,What is the proportion of POLD1 and STK19 codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+729,STK19,D345N,Colon Adenocarcinoma,What is the proportion of ACVR1B and STK19 codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the proportion of PTPRO and REXO4 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the proportion of EIF2B4 and ZBTB34 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the proportion of CYB5R2 and ZBTB34 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the proportion of ACTA2 and NCKAP5 codeletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of EIF2B4 and SORCS1 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of CTSC and SORCS1 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of ZCCHC14 and SORCS1 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of TAF1C and SORCS1 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the proportion of DNMT1 and FGF8 codeletion in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the proportion of ACVR1B and FGF8 codeletion in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the proportion of TASOR2 and FGF8 codeletion in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the proportion of AUTS2 and FGF8 codeletion in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the proportion of PTPRO and FGF8 codeletion in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the proportion of CDKN2AIP and TENM3 codeletion in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,freq_cnv_loss_or_gain
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the proportion of CR1 and AKT1 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the proportion of TLK2 and CFAP298-TCP10L codeletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the proportion of CACNA1F and GLRB codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+793,TTN,F7636L,Colon Adenocarcinoma,What is the proportion of RAB40C and TTN codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+794,TTN,F8563L,Colon Adenocarcinoma,What is the proportion of PAPPA and TTN codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+795,TTN,F8880L,Colon Adenocarcinoma,What is the proportion of CDH23 and TTN codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the proportion of TASOR2 and ANKRD30A codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the proportion of TSHZ3 and ANKRD30A codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the proportion of FMO4 and ANKRD30A codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the proportion of CYB5R2 and TRIM45 codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the proportion of ANKRD52 and TRIM45 codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the proportion of OR13C3 and TRIM45 codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the proportion of ACVR1B and CACNA1F codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the proportion of POC1B and CACNA1F codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the proportion of KL and CACNA1F codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+817,KL,R594C,Colon Adenocarcinoma,What is the proportion of STK19 and KL codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the proportion of NOMO1 and GUF1 codeletion in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the proportion of TAS1R3 and TAF1L codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the proportion of ZNF431 and TASOR2 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the proportion of CDC42BPA and TASOR2 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the proportion of CEP20 and TASOR2 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the proportion of CPS1 and KDM5C codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the proportion of ARHGEF40 and KDM5C codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the proportion of CTNNA2 and KDM5C codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the proportion of POC1B and KDM5C codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the proportion of TLCD5 and IL5RA codeletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the proportion of KL and DHX16 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the proportion of AUTS2 and DHX16 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the proportion of PIK3C2B and GPR158 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the proportion of BCAT1 and GPR158 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of ERCC6 and EIF2B4 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of CHODL and EIF2B4 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of YY1AP1 and EIF2B4 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of AUTS2 and EIF2B4 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of TRPA1 and EIF2B4 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of PLEKHG6 and EIF2B4 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the proportion of DPF3 and AUTS2 codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the proportion of RAB40C and AUTS2 codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the proportion of TNS1 and AUTS2 codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the proportion of CHMP7 and AUTS2 codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the proportion of SPATA22 and AUTS2 codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the proportion of MAOB and AUTS2 codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the proportion of AKT1 and AUTS2 codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the proportion of AQP7 and AUTS2 codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the proportion of GABRA6 and AUTS2 codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the proportion of RIMS2 and AUTS2 codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of CPA6 and ACTL7B codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the proportion of DCC and PCDHGA1 codeletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the proportion of KRT39 and TRAP1 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the proportion of KRT39 and TRAP1 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the proportion of TYK2 and PIK3C2A codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the proportion of CDH23 and KANSL1 codeletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the proportion of ZBTB34 and ANKRD52 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the proportion of MSANTD4 and PAPPA codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the proportion of CTCFL and B3GALNT1 codeletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the proportion of ACTB and GABRA6 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the proportion of GRTP1 and GABRA6 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the proportion of POC1B and GABRA6 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the proportion of DNMT1 and GABRA6 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the proportion of DHX16 and GABRA6 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the proportion of SYT10 and ZSCAN31 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of GUK1 and MED16 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of GRM1 and MED16 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the proportion of RIMS2 and PTPRO codeletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the proportion of MYO3B and PTPRO codeletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the proportion of EIF2B4 and PTPRO codeletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the proportion of PRSS1 and PTPRO codeletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the proportion of SGCZ and PTPRO codeletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the proportion of SORCS1 and PTPRO codeletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the proportion of AQP7 and PTPRO codeletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the proportion of CASZ1 and PTPRO codeletion in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the proportion of DNAH14 and CHMP7 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the proportion of MORF4L1 and GPC3 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the proportion of DNAH14 and GPC3 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the proportion of AQP7 and TLK2 codeletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the proportion of EVC2 and TLK2 codeletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the proportion of ITPRID2 and TLK2 codeletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the proportion of TASOR2 and TLK2 codeletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the proportion of DCN and TLK2 codeletion in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the proportion of ZNF804A and ZNF217 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the proportion of MORF4L1 and SYT9 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the proportion of FGF8 and SYT9 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the proportion of POC1B and PKHD1L1 codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the proportion of CYB5R2 and MYO3A codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of SGIP1 and VASN codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the proportion of DCC and DNMT1 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the proportion of DCLK3 and DNMT1 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the proportion of PGF and DNMT1 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1056,CA9,E402K,Colon Adenocarcinoma,What is the proportion of BFAR and CA9 codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the proportion of ACTB and TTC17 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the proportion of EFCAB12 and TTC17 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the proportion of PTPRO and PSG2 codeletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the proportion of SYT9 and RIPOR2 codeletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the proportion of ANKRD52 and RIPOR2 codeletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the proportion of AUTS2 and RIPOR2 codeletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the proportion of PTPRN2 and RIPOR2 codeletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the proportion of EIF2B4 and DCLK3 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the proportion of DCAF6 and DCLK3 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the proportion of PIK3C2B and MERTK codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the proportion of C7orf31 and MERTK codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the proportion of PAK3 and MERTK codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the proportion of DNAH14 and ZFP42 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the proportion of SLC6A4 and OR13C3 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the proportion of CTSC and OR13C3 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the proportion of PAK3 and SPAG1 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the proportion of JAML and CDKN2AIP codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the proportion of PGF and PXN codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the proportion of BCAT1 and PXN codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the proportion of NRAP and PXN codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the proportion of SGCZ and PXN codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the proportion of MAD1L1 and PXN codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the proportion of MYT1 and PXN codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the proportion of SORCS1 and TTYH2 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the proportion of GUCY2C and TTYH2 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the proportion of POC1B and TMEM255A codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the proportion of DGKD and TMEM255A codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the proportion of FRY and TMEM255A codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the proportion of KIF20B and TASOR2 codeletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the proportion of UNC5D and TASOR2 codeletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the proportion of TAS1R3 and ICE1 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the proportion of NRAP and MYT1 codeletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the proportion of ARHGEF40 and MYT1 codeletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the proportion of MYO3B and MYT1 codeletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the proportion of SPTAN1 and CX3CR1 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the proportion of ADRA1A and CX3CR1 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the proportion of SYT10 and SPINDOC codeletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the proportion of CNGB1 and ART3 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the proportion of DNAH11 and ART3 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the proportion of ZFPM2 and CYP1A2 codeletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of RAB40C and ADRA1A codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the proportion of AUTS2 and CDH23 codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the proportion of PDHA2 and CDH23 codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the proportion of FBXO15 and KRT39 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the proportion of PIAS3 and PDHA2 codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the proportion of ZBTB34 and SLC24A2 codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the proportion of MED16 and PTPRN2 codeletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the proportion of SIK2 and PTPRN2 codeletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the proportion of PTPRN2 and PTPRN2 codeletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the proportion of CTCFL and PTPRN2 codeletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the proportion of GABRA6 and PTPRN2 codeletion in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the proportion of CFAP61 and SOX21 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the proportion of JAML and CPA6 codeletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the proportion of TRAP1 and GRM5 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of DNAH11 and CASZ1 codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the proportion of FRY and SGIP1 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the proportion of EPRS1 and SGIP1 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the proportion of FNDC7 and SGIP1 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the proportion of NPSR1 and SGIP1 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the proportion of CTSC and CARMIL1 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the proportion of ZNF804A and CARMIL1 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the proportion of FBXO15 and ZNF431 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the proportion of OLFML3 and ZNF431 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the proportion of UNC5D and ZNF431 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the proportion of RIMS2 and DNAH11 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the proportion of ZCCHC14 and DNAH11 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the proportion of CA9 and POLD1 codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the proportion of ARMC3 and POLD1 codeletion in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the proportion of TYK2 and TTC12 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the proportion of GRM1 and TTC12 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the proportion of TNS1 and CNGB1 codeletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the proportion of SMO and CNGB1 codeletion in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the proportion of SORCS1 and CTSC codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the proportion of CTSC and CTSC codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the proportion of SPTAN1 and CTSC codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the proportion of OR2T4 and CTSC codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the proportion of PKHD1L1 and CTSC codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the proportion of GABRA6 and PRSS8 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the proportion of KIF20B and PRSS8 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the proportion of PAK3 and ARHGEF40 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the proportion of KIF20B and ACTB codeletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the proportion of BFAR and ACTB codeletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the proportion of XKR4 and ACTB codeletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the proportion of DEFB115 and ACTB codeletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the proportion of OLFML3 and YY1AP1 codeletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the proportion of EFCAB12 and YY1AP1 codeletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the proportion of ERCC6 and YY1AP1 codeletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the proportion of COL6A3 and YY1AP1 codeletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the proportion of RIPOR2 and YY1AP1 codeletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the proportion of JAML and YY1AP1 codeletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the proportion of CA9 and YY1AP1 codeletion in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the proportion of CARMIL1 and FNDC7 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the proportion of ZCCHC14 and FNDC7 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the proportion of TAS1R3 and TLCD5 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the proportion of PLEKHG6 and TLCD5 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the proportion of RIMS2 and POLR1G codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the proportion of HTR3B and POLR1G codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the proportion of CTSC and DNAH14 codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the proportion of ANKRD52 and DNAH14 codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the proportion of TTC17 and DNAH14 codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the proportion of CTSC and NEXN codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the proportion of HYOU1 and CYB5R2 codeletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the proportion of NOMO1 and CYB5R2 codeletion in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the proportion of MAD1L1 and NRAP codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the proportion of JAML and NRAP codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the proportion of OLFML3 and NRAP codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the proportion of ARMC3 and CCDC22 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the proportion of TET2 and DCAF6 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the proportion of AUTS2 and DCAF6 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the proportion of UNC5D and ZNF708 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the proportion of ZFAT and BFAR codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the proportion of OR13C3 and MAST4 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the proportion of ACTB and MAST4 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the proportion of TTN and MAST4 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the proportion of MYO16 and MAST4 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the proportion of TLK2 and MAST4 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the proportion of AQP7 and ARMC3 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the proportion of JAML and ARMC3 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the proportion of SGIP1 and TET2 codeletion in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the proportion of AUTS2 and TET2 codeletion in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the proportion of DOCK2 and SERPINB10 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the proportion of CEP20 and STAT3 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the proportion of TMEM225 and MIEF1 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the proportion of PTPRO and ACVR1B codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the proportion of LCN15 and ACVR1B codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the proportion of DHX16 and ACVR1B codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the proportion of DHX16 and EBF2 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the proportion of RAB40C and EBF2 codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the proportion of EPRS1 and VPS26B codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of AUTS2 and PGR codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of CTSC and PGR codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of AUTS2 and PGR codeletion in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the proportion of FGF8 and ACTA2 codeletion in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the proportion of ACTB and THBS4 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the proportion of MERTK and THBS4 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the proportion of OR13C3 and PRSS1 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the proportion of BICC1 and PRSS1 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the proportion of SGCZ and PRSS1 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the proportion of ZMYM3 and PRSS1 codeletion in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the proportion of ACTB and PGF codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the proportion of FGF8 and PGF codeletion in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the proportion of TMEM255A and ITPRID2 codeletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the proportion of TMEM255A and ITPRID2 codeletion in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the proportion of ZKSCAN7 and HBB codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the proportion of ABCC2 and PCDHB2 codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the proportion of CTNNA2 and PCDHB2 codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the proportion of DNAH11 and PCDHB2 codeletion in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the proportion of GPR158 and UBR2 codeletion in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the proportion of CR1 and FBXO42 codeletion in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1,TNS1,G1362V,Breast Invasive Carcinoma,Can you share the incidence rate of TNS1 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+2,TNS1,G1711V,Breast Invasive Carcinoma,Can you share the incidence rate of TNS1 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+3,TNS1,G1718V,Breast Invasive Carcinoma,Can you share the incidence rate of TNS1 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+4,TNS1,G1732V,Breast Invasive Carcinoma,Can you share the incidence rate of TNS1 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+5,TNS1,G1824V,Breast Invasive Carcinoma,Can you share the incidence rate of TNS1 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+6,TNS1,G1857V,Breast Invasive Carcinoma,Can you share the incidence rate of TNS1 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+7,TNS1,G843V,Breast Invasive Carcinoma,Can you share the incidence rate of TNS1 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,Can you share the incidence rate of EVC2 loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+15,EVC2,E987K,Bladder Urothelial Carcinoma,Can you share the incidence rate of EVC2 loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of CR1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of CR1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+22,TRPA1,S295I,Rectum Adenocarcinoma,Can you share the incidence rate of TRPA1 loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+23,TRPA1,S443I,Rectum Adenocarcinoma,Can you share the incidence rate of TRPA1 loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+24,TAF1C,R299L,Lung Adenocarcinoma,Can you share the incidence rate of TAF1C loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+25,TAF1C,R396L,Lung Adenocarcinoma,Can you share the incidence rate of TAF1C loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+26,TAF1C,R634L,Lung Adenocarcinoma,Can you share the incidence rate of TAF1C loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+27,TAF1C,R702L,Lung Adenocarcinoma,Can you share the incidence rate of TAF1C loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+28,TAF1C,R728L,Lung Adenocarcinoma,Can you share the incidence rate of TAF1C loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of DPF3 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of DPF3 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of DPF3 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+42,OR2T4,P272H,Lung Adenocarcinoma,Can you share the incidence rate of OR2T4 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+43,OR2T4,P300H,Lung Adenocarcinoma,Can you share the incidence rate of OR2T4 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,Can you share the incidence rate of FBN1 loss in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+45,MAD1L1,E396K,Prostate Adenocarcinoma,Can you share the incidence rate of MAD1L1 loss in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+46,MAD1L1,E488K,Prostate Adenocarcinoma,Can you share the incidence rate of MAD1L1 loss in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+47,MAD1L1,E78K,Prostate Adenocarcinoma,Can you share the incidence rate of MAD1L1 loss in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+61,CCNG1,E22K,Skin Cutaneous Melanoma,Can you share the incidence rate of CCNG1 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,Can you share the incidence rate of ANP32E loss in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,Can you share the incidence rate of ANP32E loss in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,Can you share the incidence rate of ANP32E loss in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,Can you share the incidence rate of ANP32E loss in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+66,FRY,S1888A,Bladder Urothelial Carcinoma,Can you share the incidence rate of FRY loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+67,FRY,S1937A,Bladder Urothelial Carcinoma,Can you share the incidence rate of FRY loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+68,FRY,S1938A,Bladder Urothelial Carcinoma,Can you share the incidence rate of FRY loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+69,FRY,S1983A,Bladder Urothelial Carcinoma,Can you share the incidence rate of FRY loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+70,PAK3,E318K,Skin Cutaneous Melanoma,Can you share the incidence rate of PAK3 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+71,PAK3,E319K,Skin Cutaneous Melanoma,Can you share the incidence rate of PAK3 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+72,PAK3,E334K,Skin Cutaneous Melanoma,Can you share the incidence rate of PAK3 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+73,PAK3,E340K,Skin Cutaneous Melanoma,Can you share the incidence rate of PAK3 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+74,PAK3,E355K,Skin Cutaneous Melanoma,Can you share the incidence rate of PAK3 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+80,MUC16,P7963L,Skin Cutaneous Melanoma,Can you share the incidence rate of MUC16 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,Can you share the incidence rate of ZFPM2 loss in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,Can you share the incidence rate of ZFPM2 loss in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,Can you share the incidence rate of PIK3C2B loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,Can you share the incidence rate of PIK3C2B loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+114,ZNF804A,S371Y,Colon Adenocarcinoma,Can you share the incidence rate of ZNF804A loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+116,RELN,A2371V,Stomach Adenocarcinoma,Can you share the incidence rate of RELN loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of EFCAB12 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of EFCAB12 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+120,DEFB115,E53K,Skin Cutaneous Melanoma,Can you share the incidence rate of DEFB115 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,Can you share the incidence rate of ANKDD1A loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,Can you share the incidence rate of ANKDD1A loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,Can you share the incidence rate of ANKDD1A loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of HTR3B loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of HTR3B loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of HTR3B loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+129,ABCC3,R758W,Stomach Adenocarcinoma,Can you share the incidence rate of ABCC3 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of NOMO1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of NOMO1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,Can you share the incidence rate of HYOU1 loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+139,FMO4,R500Q,Skin Cutaneous Melanoma,Can you share the incidence rate of FMO4 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+140,BICC1,A372V,Exceptional Responders,Can you share the incidence rate of BICC1 loss in Exceptional Responders?,freq_cnv_loss_or_gain
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of ZMYM3 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of ZMYM3 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of ZMYM3 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of XKR4 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,Can you share the incidence rate of ABCC2 loss in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+157,OR8K5,R293G,Lung Adenocarcinoma,Can you share the incidence rate of OR8K5 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,Can you share the incidence rate of SPTAN1 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,Can you share the incidence rate of SPTAN1 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+164,SYT10,M484I,Rectum Adenocarcinoma,Can you share the incidence rate of SYT10 loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+174,HSPA5,N457K,Skin Cutaneous Melanoma,Can you share the incidence rate of HSPA5 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+175,UNC5D,L280V,Lung Adenocarcinoma,Can you share the incidence rate of UNC5D loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+176,UNC5D,L635V,Lung Adenocarcinoma,Can you share the incidence rate of UNC5D loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+177,UNC5D,L637V,Lung Adenocarcinoma,Can you share the incidence rate of UNC5D loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+178,UNC5D,L699V,Lung Adenocarcinoma,Can you share the incidence rate of UNC5D loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+179,UNC5D,L704V,Lung Adenocarcinoma,Can you share the incidence rate of UNC5D loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+180,UNC5D,L709V,Lung Adenocarcinoma,Can you share the incidence rate of UNC5D loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,Can you share the incidence rate of DOCK2 loss in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,Can you share the incidence rate of ZNF627 loss in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,Can you share the incidence rate of CDC42BPA loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+193,MRPL55,H27Y,Colon Adenocarcinoma,Can you share the incidence rate of MRPL55 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+194,MRPL55,H63Y,Colon Adenocarcinoma,Can you share the incidence rate of MRPL55 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+197,TMTC3,Q749K,Breast Invasive Carcinoma,Can you share the incidence rate of TMTC3 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+198,EPRS1,K771I,Colon Adenocarcinoma,Can you share the incidence rate of EPRS1 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+199,EPRS1,K778I,Colon Adenocarcinoma,Can you share the incidence rate of EPRS1 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+201,GRTP1,A110V,Skin Cutaneous Melanoma,Can you share the incidence rate of GRTP1 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+202,GRTP1,A32V,Skin Cutaneous Melanoma,Can you share the incidence rate of GRTP1 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,Can you share the incidence rate of TSHZ3 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,Can you share the incidence rate of TAS1R3 loss in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,freq_cnv_loss_or_gain
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,Can you share the incidence rate of PIAS3 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,Can you share the incidence rate of PIAS3 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+251,ZNF274,P13R,Stomach Adenocarcinoma,Can you share the incidence rate of ZNF274 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+253,SYNJ1,R795C,Colon Adenocarcinoma,Can you share the incidence rate of SYNJ1 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+254,SYNJ1,R800C,Colon Adenocarcinoma,Can you share the incidence rate of SYNJ1 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+255,SYNJ1,R839C,Colon Adenocarcinoma,Can you share the incidence rate of SYNJ1 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+261,DSCAM,V343M,Prostate Adenocarcinoma,Can you share the incidence rate of DSCAM loss in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+262,DSCAM,V426M,Prostate Adenocarcinoma,Can you share the incidence rate of DSCAM loss in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+263,DSCAM,V591M,Prostate Adenocarcinoma,Can you share the incidence rate of DSCAM loss in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+267,DGKD,R140H,Exceptional Responders,Can you share the incidence rate of DGKD loss in Exceptional Responders?,freq_cnv_loss_or_gain
+268,DGKD,R160H,Exceptional Responders,Can you share the incidence rate of DGKD loss in Exceptional Responders?,freq_cnv_loss_or_gain
+269,DGKD,R204H,Exceptional Responders,Can you share the incidence rate of DGKD loss in Exceptional Responders?,freq_cnv_loss_or_gain
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,Can you share the incidence rate of PLEKHG6 loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,Can you share the incidence rate of PLEKHG6 loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,Can you share the incidence rate of PLEKHG6 loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+279,WNT2,D138N,Skin Cutaneous Melanoma,Can you share the incidence rate of WNT2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,Can you share the incidence rate of GUCY2C loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of C7orf31 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of ZKSCAN7 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+299,OR5D14,M210L,Neuroblastoma,Can you share the incidence rate of OR5D14 loss in Neuroblastoma?,freq_cnv_loss_or_gain
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of SPATA22 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of SPATA22 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of SPATA22 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+310,LCN15,E21V,Stomach Adenocarcinoma,Can you share the incidence rate of LCN15 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,Can you share the incidence rate of DCAF4L2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,Can you share the incidence rate of GUK1 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,Can you share the incidence rate of GUK1 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,Can you share the incidence rate of GUK1 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,Can you share the incidence rate of GUK1 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,Can you share the incidence rate of GUK1 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+328,MORF4L1,K29T,Stomach Adenocarcinoma,Can you share the incidence rate of MORF4L1 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+329,MORF4L1,K51T,Stomach Adenocarcinoma,Can you share the incidence rate of MORF4L1 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+330,MORF4L1,K61T,Stomach Adenocarcinoma,Can you share the incidence rate of MORF4L1 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+331,MORF4L1,K76T,Stomach Adenocarcinoma,Can you share the incidence rate of MORF4L1 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+335,MYO3B,F594L,Skin Cutaneous Melanoma,Can you share the incidence rate of MYO3B loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+336,MYO3B,F603L,Skin Cutaneous Melanoma,Can you share the incidence rate of MYO3B loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+339,TENT5A,S320F,Skin Cutaneous Melanoma,Can you share the incidence rate of TENT5A loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+340,TENT5A,S339F,Skin Cutaneous Melanoma,Can you share the incidence rate of TENT5A loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+341,TENT5A,S401F,Skin Cutaneous Melanoma,Can you share the incidence rate of TENT5A loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,Can you share the incidence rate of ZFAT loss in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,Can you share the incidence rate of ZFAT loss in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,Can you share the incidence rate of ZFAT loss in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+357,ZNF584,A211T,Sarcoma,Can you share the incidence rate of ZNF584 loss in Sarcoma?,freq_cnv_loss_or_gain
+358,ZNF584,A256T,Sarcoma,Can you share the incidence rate of ZNF584 loss in Sarcoma?,freq_cnv_loss_or_gain
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of LDOC1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,Can you share the incidence rate of PDGFC loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of MSANTD4 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+374,NPSR1,S123L,Skin Cutaneous Melanoma,Can you share the incidence rate of NPSR1 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,Can you share the incidence rate of PHLPP1 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+385,COL6A3,G237S,Skin Cutaneous Melanoma,Can you share the incidence rate of COL6A3 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+386,COL6A3,G437S,Skin Cutaneous Melanoma,Can you share the incidence rate of COL6A3 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+387,COL6A3,G638S,Skin Cutaneous Melanoma,Can you share the incidence rate of COL6A3 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+388,COL6A3,G644S,Skin Cutaneous Melanoma,Can you share the incidence rate of COL6A3 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+389,COL6A3,G844S,Skin Cutaneous Melanoma,Can you share the incidence rate of COL6A3 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+395,ADRA1A,R348G,Stomach Adenocarcinoma,Can you share the incidence rate of ADRA1A loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you share the incidence rate of LAMB2 loss in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+406,POC1B,I198T,Rectum Adenocarcinoma,Can you share the incidence rate of POC1B loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+407,POC1B,I286T,Rectum Adenocarcinoma,Can you share the incidence rate of POC1B loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+408,POC1B,I328T,Rectum Adenocarcinoma,Can you share the incidence rate of POC1B loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+409,POC1B,S79P,Rectum Adenocarcinoma,Can you share the incidence rate of POC1B loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,Can you share the incidence rate of USH2A loss in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+414,AQP7,T110S,Rectum Adenocarcinoma,Can you share the incidence rate of AQP7 loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+415,AQP7,T166S,Rectum Adenocarcinoma,Can you share the incidence rate of AQP7 loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+416,AQP7,T167S,Rectum Adenocarcinoma,Can you share the incidence rate of AQP7 loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+417,AQP7,T75S,Rectum Adenocarcinoma,Can you share the incidence rate of AQP7 loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+430,DCN,R163C,Rectum Adenocarcinoma,Can you share the incidence rate of DCN loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+431,DCN,R203C,Rectum Adenocarcinoma,Can you share the incidence rate of DCN loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+432,DCN,R241C,Rectum Adenocarcinoma,Can you share the incidence rate of DCN loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+433,DCN,R350C,Rectum Adenocarcinoma,Can you share the incidence rate of DCN loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+434,DCN,R41C,Rectum Adenocarcinoma,Can you share the incidence rate of DCN loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of CPS1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of CPS1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of CPS1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,Can you share the incidence rate of FCGR2C loss in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,Can you share the incidence rate of FCGR2C loss in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of GRM1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+482,SGCZ,Q138H,Lung Adenocarcinoma,Can you share the incidence rate of SGCZ loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+483,SGCZ,Q91H,Lung Adenocarcinoma,Can you share the incidence rate of SGCZ loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+485,SMO,V15M,Stomach Adenocarcinoma,Can you share the incidence rate of SMO loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+486,SMO,V321M,Stomach Adenocarcinoma,Can you share the incidence rate of SMO loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+488,CHODL,G159E,Skin Cutaneous Melanoma,Can you share the incidence rate of CHODL loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+489,CHODL,G181E,Skin Cutaneous Melanoma,Can you share the incidence rate of CHODL loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+490,CHODL,G200E,Skin Cutaneous Melanoma,Can you share the incidence rate of CHODL loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+494,MYO16,P399H,Colon Adenocarcinoma,Can you share the incidence rate of MYO16 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+495,MYO16,P421H,Colon Adenocarcinoma,Can you share the incidence rate of MYO16 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+498,CXCR2,A98V,Stomach Adenocarcinoma,Can you share the incidence rate of CXCR2 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,Can you share the incidence rate of TMEM225 loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of MAOB loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of GPRASP1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of MRPL32 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of TYROBP loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+510,RAB40C,A111V,Lung Adenocarcinoma,Can you share the incidence rate of RAB40C loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+511,RAB40C,A143V,Lung Adenocarcinoma,Can you share the incidence rate of RAB40C loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+512,CTNNA2,S323R,Lung Adenocarcinoma,Can you share the incidence rate of CTNNA2 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+513,CTNNA2,S339R,Lung Adenocarcinoma,Can you share the incidence rate of CTNNA2 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+514,CTNNA2,S386R,Lung Adenocarcinoma,Can you share the incidence rate of CTNNA2 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+515,CTNNA2,S707R,Lung Adenocarcinoma,Can you share the incidence rate of CTNNA2 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,Can you share the incidence rate of MYO15A loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,Can you share the incidence rate of GIMAP2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+532,KIF20B,N1160D,Glioblastoma Multiforme,Can you share the incidence rate of KIF20B loss in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+533,KIF20B,N1200D,Glioblastoma Multiforme,Can you share the incidence rate of KIF20B loss in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of ADAM17 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of BCAT1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of BCAT1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of BCAT1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+540,ERCC6,R1053H,Colon Adenocarcinoma,Can you share the incidence rate of ERCC6 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+541,DCC,R320W,Breast Invasive Carcinoma,Can you share the incidence rate of DCC loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+542,DCC,R363W,Breast Invasive Carcinoma,Can you share the incidence rate of DCC loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+543,DCC,R386W,Breast Invasive Carcinoma,Can you share the incidence rate of DCC loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+544,DCC,R41W,Breast Invasive Carcinoma,Can you share the incidence rate of DCC loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+549,FBXO15,D417N,Skin Cutaneous Melanoma,Can you share the incidence rate of FBXO15 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+550,FBXO15,D86N,Skin Cutaneous Melanoma,Can you share the incidence rate of FBXO15 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of GSTCD loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of GSTCD loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,Can you share the incidence rate of OLFML3 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,Can you share the incidence rate of OLFML3 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,Can you share the incidence rate of OLFML3 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,Can you share the incidence rate of CFAP61 loss in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,Can you share the incidence rate of CFAP61 loss in Ovarian Serous Cystadenocarcinoma?,freq_cnv_loss_or_gain
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,Can you share the incidence rate of HLA-DQA2 loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+582,TENM2,H240Y,Skin Cutaneous Melanoma,Can you share the incidence rate of TENM2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+583,TENM2,H351Y,Skin Cutaneous Melanoma,Can you share the incidence rate of TENM2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+584,TENM2,H472Y,Skin Cutaneous Melanoma,Can you share the incidence rate of TENM2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+600,ANKRD24,A465T,Stomach Adenocarcinoma,Can you share the incidence rate of ANKRD24 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+601,ANKRD24,A494T,Stomach Adenocarcinoma,Can you share the incidence rate of ANKRD24 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+602,ANKRD24,A584T,Stomach Adenocarcinoma,Can you share the incidence rate of ANKRD24 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,Can you share the incidence rate of ZCCHC14 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,Can you share the incidence rate of ZCCHC14 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,Can you share the incidence rate of ZCCHC14 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,Can you share the incidence rate of ZCCHC14 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+625,SIK2,I265M,Lung Adenocarcinoma,Can you share the incidence rate of SIK2 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of MYH11 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of MYH11 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,Can you share the incidence rate of SLC6A4 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of SLC9C1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of SLC9C1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+644,OR2A12,A254T,Brain Lower Grade Glioma,Can you share the incidence rate of OR2A12 loss in Brain Lower Grade Glioma?,freq_cnv_loss_or_gain
+646,PYHIN1,T325K,Lung Adenocarcinoma,Can you share the incidence rate of PYHIN1 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+647,PYHIN1,T334K,Lung Adenocarcinoma,Can you share the incidence rate of PYHIN1 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+650,JAML,G191E,Skin Cutaneous Melanoma,Can you share the incidence rate of JAML loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+651,JAML,G219E,Skin Cutaneous Melanoma,Can you share the incidence rate of JAML loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+652,JAML,G220E,Skin Cutaneous Melanoma,Can you share the incidence rate of JAML loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+653,JAML,G230E,Skin Cutaneous Melanoma,Can you share the incidence rate of JAML loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+658,TYK2,H1146R,Stomach Adenocarcinoma,Can you share the incidence rate of TYK2 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+659,TYK2,H23R,Stomach Adenocarcinoma,Can you share the incidence rate of TYK2 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+660,TYK2,H961R,Stomach Adenocarcinoma,Can you share the incidence rate of TYK2 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of CTCFL loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of CTCFL loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of CTCFL loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of CTCFL loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of CEP20 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of CEP20 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+689,RIMS2,R25W,Skin Cutaneous Melanoma,Can you share the incidence rate of RIMS2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+690,RIMS2,R393W,Skin Cutaneous Melanoma,Can you share the incidence rate of RIMS2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+691,RIMS2,R423W,Skin Cutaneous Melanoma,Can you share the incidence rate of RIMS2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+692,RIMS2,R470W,Skin Cutaneous Melanoma,Can you share the incidence rate of RIMS2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+693,RIMS2,R615W,Skin Cutaneous Melanoma,Can you share the incidence rate of RIMS2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+694,RIMS2,R619W,Skin Cutaneous Melanoma,Can you share the incidence rate of RIMS2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+695,RIMS2,R716W,Skin Cutaneous Melanoma,Can you share the incidence rate of RIMS2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,Can you share the incidence rate of PIK3C2G loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,Can you share the incidence rate of PIK3C2G loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+728,STK19,D341N,Colon Adenocarcinoma,Can you share the incidence rate of STK19 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+729,STK19,D345N,Colon Adenocarcinoma,Can you share the incidence rate of STK19 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+730,REXO4,P60A,Skin Cutaneous Melanoma,Can you share the incidence rate of REXO4 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of ZBTB34 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of ZBTB34 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,Can you share the incidence rate of NCKAP5 loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of SORCS1 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of SORCS1 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of SORCS1 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of SORCS1 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,Can you share the incidence rate of FGF8 loss in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,Can you share the incidence rate of FGF8 loss in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,Can you share the incidence rate of FGF8 loss in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,Can you share the incidence rate of FGF8 loss in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,Can you share the incidence rate of FGF8 loss in Head and Neck Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,Can you share the incidence rate of TENM3 loss in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,freq_cnv_loss_or_gain
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of AKT1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you share the incidence rate of CFAP298-TCP10L loss in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+792,GLRB,E148D,Stomach Adenocarcinoma,Can you share the incidence rate of GLRB loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+793,TTN,F7636L,Colon Adenocarcinoma,Can you share the incidence rate of TTN loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+794,TTN,F8563L,Colon Adenocarcinoma,Can you share the incidence rate of TTN loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+795,TTN,F8880L,Colon Adenocarcinoma,Can you share the incidence rate of TTN loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+799,ANKRD30A,V798I,Colon Adenocarcinoma,Can you share the incidence rate of ANKRD30A loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+800,ANKRD30A,V854I,Colon Adenocarcinoma,Can you share the incidence rate of ANKRD30A loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+801,ANKRD30A,V973I,Colon Adenocarcinoma,Can you share the incidence rate of ANKRD30A loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+809,TRIM45,S177L,Colon Adenocarcinoma,Can you share the incidence rate of TRIM45 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+810,TRIM45,S224L,Colon Adenocarcinoma,Can you share the incidence rate of TRIM45 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+811,TRIM45,S281L,Colon Adenocarcinoma,Can you share the incidence rate of TRIM45 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+812,CACNA1F,G727V,Stomach Adenocarcinoma,Can you share the incidence rate of CACNA1F loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+813,CACNA1F,G781V,Stomach Adenocarcinoma,Can you share the incidence rate of CACNA1F loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+814,CACNA1F,G792V,Stomach Adenocarcinoma,Can you share the incidence rate of CACNA1F loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+817,KL,R594C,Colon Adenocarcinoma,Can you share the incidence rate of KL loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,Can you share the incidence rate of GUF1 loss in Kidney Renal Papillary Cell Carcinoma?,freq_cnv_loss_or_gain
+822,TAF1L,A539V,Colon Adenocarcinoma,Can you share the incidence rate of TAF1L loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+823,TASOR2,S256F,Skin Cutaneous Melanoma,Can you share the incidence rate of TASOR2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+824,TASOR2,S36F,Skin Cutaneous Melanoma,Can you share the incidence rate of TASOR2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+825,TASOR2,S471F,Skin Cutaneous Melanoma,Can you share the incidence rate of TASOR2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,Can you share the incidence rate of KDM5C loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,Can you share the incidence rate of KDM5C loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,Can you share the incidence rate of KDM5C loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,Can you share the incidence rate of KDM5C loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you share the incidence rate of IL5RA loss in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+843,DHX16,A29V,Skin Cutaneous Melanoma,Can you share the incidence rate of DHX16 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+844,DHX16,A89V,Skin Cutaneous Melanoma,Can you share the incidence rate of DHX16 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+902,GPR158,A644V,Stomach Adenocarcinoma,Can you share the incidence rate of GPR158 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+903,GPR158,A723V,Stomach Adenocarcinoma,Can you share the incidence rate of GPR158 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of EIF2B4 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of EIF2B4 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of EIF2B4 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of EIF2B4 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of EIF2B4 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of EIF2B4 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,Can you share the incidence rate of AUTS2 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,Can you share the incidence rate of AUTS2 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,Can you share the incidence rate of AUTS2 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,Can you share the incidence rate of AUTS2 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,Can you share the incidence rate of AUTS2 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,Can you share the incidence rate of AUTS2 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,Can you share the incidence rate of AUTS2 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,Can you share the incidence rate of AUTS2 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,Can you share the incidence rate of AUTS2 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,Can you share the incidence rate of AUTS2 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of ACTL7B loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+952,PCDHGA1,R535W,Glioblastoma Multiforme,Can you share the incidence rate of PCDHGA1 loss in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+954,TRAP1,R114W,Stomach Adenocarcinoma,Can you share the incidence rate of TRAP1 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+955,TRAP1,R61W,Stomach Adenocarcinoma,Can you share the incidence rate of TRAP1 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of PIK3C2A loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,Can you share the incidence rate of KANSL1 loss in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,Can you share the incidence rate of ANKRD52 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of PAPPA loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,Can you share the incidence rate of B3GALNT1 loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+982,GABRA6,G115R,Lung Adenocarcinoma,Can you share the incidence rate of GABRA6 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+983,GABRA6,G122R,Lung Adenocarcinoma,Can you share the incidence rate of GABRA6 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+984,GABRA6,G165R,Lung Adenocarcinoma,Can you share the incidence rate of GABRA6 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+985,GABRA6,G175R,Lung Adenocarcinoma,Can you share the incidence rate of GABRA6 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+986,GABRA6,G70R,Lung Adenocarcinoma,Can you share the incidence rate of GABRA6 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,Can you share the incidence rate of ZSCAN31 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of MED16 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of MED16 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,Can you share the incidence rate of PTPRO loss in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,Can you share the incidence rate of PTPRO loss in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,Can you share the incidence rate of PTPRO loss in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,Can you share the incidence rate of PTPRO loss in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,Can you share the incidence rate of PTPRO loss in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,Can you share the incidence rate of PTPRO loss in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,Can you share the incidence rate of PTPRO loss in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,Can you share the incidence rate of PTPRO loss in Pancreatic Adenocarcinoma?,freq_cnv_loss_or_gain
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of CHMP7 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1017,GPC3,I107N,Stomach Adenocarcinoma,Can you share the incidence rate of GPC3 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1018,GPC3,I161N,Stomach Adenocarcinoma,Can you share the incidence rate of GPC3 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you share the incidence rate of TLK2 loss in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you share the incidence rate of TLK2 loss in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you share the incidence rate of TLK2 loss in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you share the incidence rate of TLK2 loss in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you share the incidence rate of TLK2 loss in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,freq_cnv_loss_or_gain
+1036,ZNF217,E209Q,Lung Adenocarcinoma,Can you share the incidence rate of ZNF217 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1038,SYT9,V275L,Lung Adenocarcinoma,Can you share the incidence rate of SYT9 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1039,SYT9,V307L,Lung Adenocarcinoma,Can you share the incidence rate of SYT9 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,Can you share the incidence rate of PKHD1L1 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,Can you share the incidence rate of MYO3A loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of VASN loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of DNMT1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of DNMT1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of DNMT1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1056,CA9,E402K,Colon Adenocarcinoma,Can you share the incidence rate of CA9 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of TTC17 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of TTC17 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1065,PSG2,P43L,Breast Invasive Carcinoma,Can you share the incidence rate of PSG2 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,Can you share the incidence rate of RIPOR2 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,Can you share the incidence rate of RIPOR2 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,Can you share the incidence rate of RIPOR2 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,Can you share the incidence rate of RIPOR2 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of DCLK3 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of DCLK3 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,Can you share the incidence rate of MERTK loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,Can you share the incidence rate of MERTK loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,Can you share the incidence rate of MERTK loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,Can you share the incidence rate of ZFP42 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,Can you share the incidence rate of OR13C3 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,Can you share the incidence rate of OR13C3 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1091,SPAG1,I917M,Stomach Adenocarcinoma,Can you share the incidence rate of SPAG1 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of CDKN2AIP loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1093,PXN,H1016Y,Colon Adenocarcinoma,Can you share the incidence rate of PXN loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1094,PXN,H359Y,Colon Adenocarcinoma,Can you share the incidence rate of PXN loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1095,PXN,H492Y,Colon Adenocarcinoma,Can you share the incidence rate of PXN loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1096,PXN,H524Y,Colon Adenocarcinoma,Can you share the incidence rate of PXN loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1097,PXN,H526Y,Colon Adenocarcinoma,Can you share the incidence rate of PXN loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1098,PXN,H540Y,Colon Adenocarcinoma,Can you share the incidence rate of PXN loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of TTYH2 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of TTYH2 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1106,TMEM255A,N205S,Colon Adenocarcinoma,Can you share the incidence rate of TMEM255A loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1107,TMEM255A,N229S,Colon Adenocarcinoma,Can you share the incidence rate of TMEM255A loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1108,TMEM255A,N65S,Colon Adenocarcinoma,Can you share the incidence rate of TMEM255A loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,Can you share the incidence rate of TASOR2 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,Can you share the incidence rate of TASOR2 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of ICE1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1112,MYT1,A558E,Breast Invasive Carcinoma,Can you share the incidence rate of MYT1 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1113,MYT1,A879E,Breast Invasive Carcinoma,Can you share the incidence rate of MYT1 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1114,MYT1,A906E,Breast Invasive Carcinoma,Can you share the incidence rate of MYT1 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of CX3CR1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of CX3CR1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,Can you share the incidence rate of SPINDOC loss in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of ART3 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of ART3 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,Can you share the incidence rate of CYP1A2 loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of ADRA1A loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,Can you share the incidence rate of CDH23 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,Can you share the incidence rate of CDH23 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1148,KRT39,P137S,Skin Cutaneous Melanoma,Can you share the incidence rate of KRT39 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,Can you share the incidence rate of PDHA2 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,Can you share the incidence rate of SLC24A2 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,Can you share the incidence rate of PTPRN2 loss in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,Can you share the incidence rate of PTPRN2 loss in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,Can you share the incidence rate of PTPRN2 loss in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,Can you share the incidence rate of PTPRN2 loss in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,Can you share the incidence rate of PTPRN2 loss in Liver Hepatocellular Carcinoma?,freq_cnv_loss_or_gain
+1188,SOX21,R55L,Lung Adenocarcinoma,Can you share the incidence rate of SOX21 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,Can you share the incidence rate of CPA6 loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1206,GRM5,E14K,Skin Cutaneous Melanoma,Can you share the incidence rate of GRM5 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of CASZ1 loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1210,SGIP1,N122T,Stomach Adenocarcinoma,Can you share the incidence rate of SGIP1 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1211,SGIP1,N420T,Stomach Adenocarcinoma,Can you share the incidence rate of SGIP1 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1212,SGIP1,N617T,Stomach Adenocarcinoma,Can you share the incidence rate of SGIP1 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1213,SGIP1,N648T,Stomach Adenocarcinoma,Can you share the incidence rate of SGIP1 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1227,CARMIL1,V549L,Lung Adenocarcinoma,Can you share the incidence rate of CARMIL1 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1228,CARMIL1,V949L,Lung Adenocarcinoma,Can you share the incidence rate of CARMIL1 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1232,ZNF431,D121Y,Lung Adenocarcinoma,Can you share the incidence rate of ZNF431 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1233,ZNF431,D161Y,Lung Adenocarcinoma,Can you share the incidence rate of ZNF431 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1234,ZNF431,R128I,Lung Adenocarcinoma,Can you share the incidence rate of ZNF431 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,Can you share the incidence rate of DNAH11 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,Can you share the incidence rate of DNAH11 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,Can you share the incidence rate of POLD1 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,Can you share the incidence rate of POLD1 loss in Lung Squamous Cell Carcinoma?,freq_cnv_loss_or_gain
+1248,TTC12,D646H,Lung Adenocarcinoma,Can you share the incidence rate of TTC12 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1249,TTC12,D652H,Lung Adenocarcinoma,Can you share the incidence rate of TTC12 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,Can you share the incidence rate of CNGB1 loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,Can you share the incidence rate of CNGB1 loss in Bladder Urothelial Carcinoma?,freq_cnv_loss_or_gain
+1254,CTSC,E214V,Stomach Adenocarcinoma,Can you share the incidence rate of CTSC loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1255,CTSC,E291V,Stomach Adenocarcinoma,Can you share the incidence rate of CTSC loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1256,CTSC,E322V,Stomach Adenocarcinoma,Can you share the incidence rate of CTSC loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1257,CTSC,E324V,Stomach Adenocarcinoma,Can you share the incidence rate of CTSC loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1258,CTSC,E335V,Stomach Adenocarcinoma,Can you share the incidence rate of CTSC loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of PRSS8 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of PRSS8 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,Can you share the incidence rate of ARHGEF40 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1264,ACTB,A138T,Rectum Adenocarcinoma,Can you share the incidence rate of ACTB loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1265,ACTB,A217T,Rectum Adenocarcinoma,Can you share the incidence rate of ACTB loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1266,ACTB,A244T,Rectum Adenocarcinoma,Can you share the incidence rate of ACTB loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1267,ACTB,A260T,Rectum Adenocarcinoma,Can you share the incidence rate of ACTB loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1268,YY1AP1,V546D,Glioblastoma Multiforme,Can you share the incidence rate of YY1AP1 loss in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1269,YY1AP1,V557D,Glioblastoma Multiforme,Can you share the incidence rate of YY1AP1 loss in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1270,YY1AP1,V566D,Glioblastoma Multiforme,Can you share the incidence rate of YY1AP1 loss in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1271,YY1AP1,V577D,Glioblastoma Multiforme,Can you share the incidence rate of YY1AP1 loss in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1272,YY1AP1,V623D,Glioblastoma Multiforme,Can you share the incidence rate of YY1AP1 loss in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1273,YY1AP1,V695D,Glioblastoma Multiforme,Can you share the incidence rate of YY1AP1 loss in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1274,YY1AP1,V715D,Glioblastoma Multiforme,Can you share the incidence rate of YY1AP1 loss in Glioblastoma Multiforme?,freq_cnv_loss_or_gain
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,Can you share the incidence rate of FNDC7 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,Can you share the incidence rate of FNDC7 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1299,TLCD5,G15V,Lung Adenocarcinoma,Can you share the incidence rate of TLCD5 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1300,TLCD5,G37V,Lung Adenocarcinoma,Can you share the incidence rate of TLCD5 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of POLR1G loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of POLR1G loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1308,DNAH14,N1186K,Colon Adenocarcinoma,Can you share the incidence rate of DNAH14 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1309,DNAH14,N2657K,Colon Adenocarcinoma,Can you share the incidence rate of DNAH14 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1310,DNAH14,N3460K,Colon Adenocarcinoma,Can you share the incidence rate of DNAH14 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of NEXN loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,Can you share the incidence rate of CYB5R2 loss in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,Can you share the incidence rate of CYB5R2 loss in Prostate Adenocarcinoma?,freq_cnv_loss_or_gain
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of NRAP loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of NRAP loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of NRAP loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of CCDC22 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,Can you share the incidence rate of DCAF6 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,Can you share the incidence rate of DCAF6 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of ZNF708 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of BFAR loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of MAST4 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of MAST4 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of MAST4 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of MAST4 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of MAST4 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1363,ARMC3,R169C,Stomach Adenocarcinoma,Can you share the incidence rate of ARMC3 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1364,ARMC3,R432C,Stomach Adenocarcinoma,Can you share the incidence rate of ARMC3 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,Can you share the incidence rate of TET2 loss in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,Can you share the incidence rate of TET2 loss in Kidney Renal Clear Cell Carcinoma?,freq_cnv_loss_or_gain
+1369,SERPINB10,A353P,Lung Adenocarcinoma,Can you share the incidence rate of SERPINB10 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of STAT3 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of MIEF1 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1381,ACVR1B,D397N,Colon Adenocarcinoma,Can you share the incidence rate of ACVR1B loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1382,ACVR1B,D449N,Colon Adenocarcinoma,Can you share the incidence rate of ACVR1B loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1383,ACVR1B,D490N,Colon Adenocarcinoma,Can you share the incidence rate of ACVR1B loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1393,EBF2,T104I,Stomach Adenocarcinoma,Can you share the incidence rate of EBF2 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1394,EBF2,T252I,Stomach Adenocarcinoma,Can you share the incidence rate of EBF2 loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1402,VPS26B,F266L,Stomach Adenocarcinoma,Can you share the incidence rate of VPS26B loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of PGR loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of PGR loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you share the incidence rate of PGR loss in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",freq_cnv_loss_or_gain
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,Can you share the incidence rate of ACTA2 loss in Skin Cutaneous Melanoma?,freq_cnv_loss_or_gain
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of THBS4 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of THBS4 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1413,PRSS1,S114T,Lung Adenocarcinoma,Can you share the incidence rate of PRSS1 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1414,PRSS1,S124T,Lung Adenocarcinoma,Can you share the incidence rate of PRSS1 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1415,PRSS1,S138T,Lung Adenocarcinoma,Can you share the incidence rate of PRSS1 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1416,PRSS1,S74T,Lung Adenocarcinoma,Can you share the incidence rate of PRSS1 loss in Lung Adenocarcinoma?,freq_cnv_loss_or_gain
+1417,PGF,R126H,Stomach Adenocarcinoma,Can you share the incidence rate of PGF loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1418,PGF,R127H,Stomach Adenocarcinoma,Can you share the incidence rate of PGF loss in Stomach Adenocarcinoma?,freq_cnv_loss_or_gain
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,Can you share the incidence rate of ITPRID2 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,Can you share the incidence rate of ITPRID2 loss in Breast Invasive Carcinoma?,freq_cnv_loss_or_gain
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of HBB loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1441,PCDHB2,R158C,Colon Adenocarcinoma,Can you share the incidence rate of PCDHB2 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1442,PCDHB2,T15M,Colon Adenocarcinoma,Can you share the incidence rate of PCDHB2 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1443,PCDHB2,T26M,Colon Adenocarcinoma,Can you share the incidence rate of PCDHB2 loss in Colon Adenocarcinoma?,freq_cnv_loss_or_gain
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,Can you share the incidence rate of UBR2 loss in Uterine Corpus Endometrial Carcinoma?,freq_cnv_loss_or_gain
+1452,FBXO42,A618D,Rectum Adenocarcinoma,Can you share the incidence rate of FBXO42 loss in Rectum Adenocarcinoma?,freq_cnv_loss_or_gain
+1,TNS1,G1362V,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve TNS1 loss?,freq_cnv_loss_or_gain
+2,TNS1,G1711V,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve TNS1 loss?,freq_cnv_loss_or_gain
+3,TNS1,G1718V,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve TNS1 loss?,freq_cnv_loss_or_gain
+4,TNS1,G1732V,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve TNS1 loss?,freq_cnv_loss_or_gain
+5,TNS1,G1824V,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve TNS1 loss?,freq_cnv_loss_or_gain
+6,TNS1,G1857V,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve TNS1 loss?,freq_cnv_loss_or_gain
+7,TNS1,G843V,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve TNS1 loss?,freq_cnv_loss_or_gain
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve EVC2 loss?,freq_cnv_loss_or_gain
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve EVC2 loss?,freq_cnv_loss_or_gain
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve CR1 loss?,freq_cnv_loss_or_gain
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve CR1 loss?,freq_cnv_loss_or_gain
+22,TRPA1,S295I,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve TRPA1 loss?,freq_cnv_loss_or_gain
+23,TRPA1,S443I,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve TRPA1 loss?,freq_cnv_loss_or_gain
+24,TAF1C,R299L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve TAF1C loss?,freq_cnv_loss_or_gain
+25,TAF1C,R396L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve TAF1C loss?,freq_cnv_loss_or_gain
+26,TAF1C,R634L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve TAF1C loss?,freq_cnv_loss_or_gain
+27,TAF1C,R702L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve TAF1C loss?,freq_cnv_loss_or_gain
+28,TAF1C,R728L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve TAF1C loss?,freq_cnv_loss_or_gain
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve DPF3 loss?,freq_cnv_loss_or_gain
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve DPF3 loss?,freq_cnv_loss_or_gain
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve DPF3 loss?,freq_cnv_loss_or_gain
+42,OR2T4,P272H,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve OR2T4 loss?,freq_cnv_loss_or_gain
+43,OR2T4,P300H,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve OR2T4 loss?,freq_cnv_loss_or_gain
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma cases involve FBN1 loss?,freq_cnv_loss_or_gain
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma cases involve MAD1L1 loss?,freq_cnv_loss_or_gain
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma cases involve MAD1L1 loss?,freq_cnv_loss_or_gain
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma cases involve MAD1L1 loss?,freq_cnv_loss_or_gain
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve CCNG1 loss?,freq_cnv_loss_or_gain
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What fraction of Kidney Renal Papillary Cell Carcinoma cases involve ANP32E loss?,freq_cnv_loss_or_gain
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What fraction of Kidney Renal Papillary Cell Carcinoma cases involve ANP32E loss?,freq_cnv_loss_or_gain
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What fraction of Kidney Renal Papillary Cell Carcinoma cases involve ANP32E loss?,freq_cnv_loss_or_gain
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What fraction of Kidney Renal Papillary Cell Carcinoma cases involve ANP32E loss?,freq_cnv_loss_or_gain
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve FRY loss?,freq_cnv_loss_or_gain
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve FRY loss?,freq_cnv_loss_or_gain
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve FRY loss?,freq_cnv_loss_or_gain
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve FRY loss?,freq_cnv_loss_or_gain
+70,PAK3,E318K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve PAK3 loss?,freq_cnv_loss_or_gain
+71,PAK3,E319K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve PAK3 loss?,freq_cnv_loss_or_gain
+72,PAK3,E334K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve PAK3 loss?,freq_cnv_loss_or_gain
+73,PAK3,E340K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve PAK3 loss?,freq_cnv_loss_or_gain
+74,PAK3,E355K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve PAK3 loss?,freq_cnv_loss_or_gain
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve MUC16 loss?,freq_cnv_loss_or_gain
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases involve ZFPM2 loss?,freq_cnv_loss_or_gain
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases involve ZFPM2 loss?,freq_cnv_loss_or_gain
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve PIK3C2B loss?,freq_cnv_loss_or_gain
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve PIK3C2B loss?,freq_cnv_loss_or_gain
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve ZNF804A loss?,freq_cnv_loss_or_gain
+116,RELN,A2371V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve RELN loss?,freq_cnv_loss_or_gain
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve EFCAB12 loss?",freq_cnv_loss_or_gain
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve EFCAB12 loss?",freq_cnv_loss_or_gain
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve DEFB115 loss?,freq_cnv_loss_or_gain
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve ANKDD1A loss?,freq_cnv_loss_or_gain
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve ANKDD1A loss?,freq_cnv_loss_or_gain
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve ANKDD1A loss?,freq_cnv_loss_or_gain
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve HTR3B loss?,freq_cnv_loss_or_gain
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve HTR3B loss?,freq_cnv_loss_or_gain
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve HTR3B loss?,freq_cnv_loss_or_gain
+129,ABCC3,R758W,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve ABCC3 loss?,freq_cnv_loss_or_gain
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve NOMO1 loss?,freq_cnv_loss_or_gain
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve NOMO1 loss?,freq_cnv_loss_or_gain
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve HYOU1 loss?,freq_cnv_loss_or_gain
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve FMO4 loss?,freq_cnv_loss_or_gain
+140,BICC1,A372V,Exceptional Responders,What fraction of Exceptional Responders cases involve BICC1 loss?,freq_cnv_loss_or_gain
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve ZMYM3 loss?,freq_cnv_loss_or_gain
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve ZMYM3 loss?,freq_cnv_loss_or_gain
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve ZMYM3 loss?,freq_cnv_loss_or_gain
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve XKR4 loss?",freq_cnv_loss_or_gain
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases involve ABCC2 loss?,freq_cnv_loss_or_gain
+157,OR8K5,R293G,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve OR8K5 loss?,freq_cnv_loss_or_gain
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve SPTAN1 loss?,freq_cnv_loss_or_gain
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve SPTAN1 loss?,freq_cnv_loss_or_gain
+164,SYT10,M484I,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve SYT10 loss?,freq_cnv_loss_or_gain
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve HSPA5 loss?,freq_cnv_loss_or_gain
+175,UNC5D,L280V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve UNC5D loss?,freq_cnv_loss_or_gain
+176,UNC5D,L635V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve UNC5D loss?,freq_cnv_loss_or_gain
+177,UNC5D,L637V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve UNC5D loss?,freq_cnv_loss_or_gain
+178,UNC5D,L699V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve UNC5D loss?,freq_cnv_loss_or_gain
+179,UNC5D,L704V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve UNC5D loss?,freq_cnv_loss_or_gain
+180,UNC5D,L709V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve UNC5D loss?,freq_cnv_loss_or_gain
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What fraction of Kidney Renal Clear Cell Carcinoma cases involve DOCK2 loss?,freq_cnv_loss_or_gain
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What fraction of Kidney Renal Clear Cell Carcinoma cases involve ZNF627 loss?,freq_cnv_loss_or_gain
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve CDC42BPA loss?,freq_cnv_loss_or_gain
+193,MRPL55,H27Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve MRPL55 loss?,freq_cnv_loss_or_gain
+194,MRPL55,H63Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve MRPL55 loss?,freq_cnv_loss_or_gain
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve TMTC3 loss?,freq_cnv_loss_or_gain
+198,EPRS1,K771I,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve EPRS1 loss?,freq_cnv_loss_or_gain
+199,EPRS1,K778I,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve EPRS1 loss?,freq_cnv_loss_or_gain
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve GRTP1 loss?,freq_cnv_loss_or_gain
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve GRTP1 loss?,freq_cnv_loss_or_gain
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve TSHZ3 loss?,freq_cnv_loss_or_gain
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What fraction of HIV+ Tumor Molecular Characterization Project - Cervical Cancer cases involve TAS1R3 loss?,freq_cnv_loss_or_gain
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve PIAS3 loss?,freq_cnv_loss_or_gain
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve PIAS3 loss?,freq_cnv_loss_or_gain
+251,ZNF274,P13R,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve ZNF274 loss?,freq_cnv_loss_or_gain
+253,SYNJ1,R795C,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve SYNJ1 loss?,freq_cnv_loss_or_gain
+254,SYNJ1,R800C,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve SYNJ1 loss?,freq_cnv_loss_or_gain
+255,SYNJ1,R839C,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve SYNJ1 loss?,freq_cnv_loss_or_gain
+261,DSCAM,V343M,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma cases involve DSCAM loss?,freq_cnv_loss_or_gain
+262,DSCAM,V426M,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma cases involve DSCAM loss?,freq_cnv_loss_or_gain
+263,DSCAM,V591M,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma cases involve DSCAM loss?,freq_cnv_loss_or_gain
+267,DGKD,R140H,Exceptional Responders,What fraction of Exceptional Responders cases involve DGKD loss?,freq_cnv_loss_or_gain
+268,DGKD,R160H,Exceptional Responders,What fraction of Exceptional Responders cases involve DGKD loss?,freq_cnv_loss_or_gain
+269,DGKD,R204H,Exceptional Responders,What fraction of Exceptional Responders cases involve DGKD loss?,freq_cnv_loss_or_gain
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve PLEKHG6 loss?,freq_cnv_loss_or_gain
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve PLEKHG6 loss?,freq_cnv_loss_or_gain
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve PLEKHG6 loss?,freq_cnv_loss_or_gain
+279,WNT2,D138N,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve WNT2 loss?,freq_cnv_loss_or_gain
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve GUCY2C loss?,freq_cnv_loss_or_gain
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve C7orf31 loss?,freq_cnv_loss_or_gain
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve ZKSCAN7 loss?",freq_cnv_loss_or_gain
+299,OR5D14,M210L,Neuroblastoma,What fraction of Neuroblastoma cases involve OR5D14 loss?,freq_cnv_loss_or_gain
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve SPATA22 loss?,freq_cnv_loss_or_gain
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve SPATA22 loss?,freq_cnv_loss_or_gain
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve SPATA22 loss?,freq_cnv_loss_or_gain
+310,LCN15,E21V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve LCN15 loss?,freq_cnv_loss_or_gain
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve DCAF4L2 loss?,freq_cnv_loss_or_gain
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve GUK1 loss?,freq_cnv_loss_or_gain
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve GUK1 loss?,freq_cnv_loss_or_gain
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve GUK1 loss?,freq_cnv_loss_or_gain
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve GUK1 loss?,freq_cnv_loss_or_gain
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve GUK1 loss?,freq_cnv_loss_or_gain
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve MORF4L1 loss?,freq_cnv_loss_or_gain
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve MORF4L1 loss?,freq_cnv_loss_or_gain
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve MORF4L1 loss?,freq_cnv_loss_or_gain
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve MORF4L1 loss?,freq_cnv_loss_or_gain
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve MYO3B loss?,freq_cnv_loss_or_gain
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve MYO3B loss?,freq_cnv_loss_or_gain
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve TENT5A loss?,freq_cnv_loss_or_gain
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve TENT5A loss?,freq_cnv_loss_or_gain
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve TENT5A loss?,freq_cnv_loss_or_gain
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What fraction of Ovarian Serous Cystadenocarcinoma cases involve ZFAT loss?,freq_cnv_loss_or_gain
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What fraction of Ovarian Serous Cystadenocarcinoma cases involve ZFAT loss?,freq_cnv_loss_or_gain
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What fraction of Ovarian Serous Cystadenocarcinoma cases involve ZFAT loss?,freq_cnv_loss_or_gain
+357,ZNF584,A211T,Sarcoma,What fraction of Sarcoma cases involve ZNF584 loss?,freq_cnv_loss_or_gain
+358,ZNF584,A256T,Sarcoma,What fraction of Sarcoma cases involve ZNF584 loss?,freq_cnv_loss_or_gain
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve LDOC1 loss?,freq_cnv_loss_or_gain
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve PDGFC loss?,freq_cnv_loss_or_gain
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve MSANTD4 loss?,freq_cnv_loss_or_gain
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve NPSR1 loss?,freq_cnv_loss_or_gain
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve PHLPP1 loss?,freq_cnv_loss_or_gain
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve COL6A3 loss?,freq_cnv_loss_or_gain
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve COL6A3 loss?,freq_cnv_loss_or_gain
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve COL6A3 loss?,freq_cnv_loss_or_gain
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve COL6A3 loss?,freq_cnv_loss_or_gain
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve COL6A3 loss?,freq_cnv_loss_or_gain
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve ADRA1A loss?,freq_cnv_loss_or_gain
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases involve LAMB2 loss?,freq_cnv_loss_or_gain
+406,POC1B,I198T,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve POC1B loss?,freq_cnv_loss_or_gain
+407,POC1B,I286T,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve POC1B loss?,freq_cnv_loss_or_gain
+408,POC1B,I328T,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve POC1B loss?,freq_cnv_loss_or_gain
+409,POC1B,S79P,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve POC1B loss?,freq_cnv_loss_or_gain
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases involve USH2A loss?,freq_cnv_loss_or_gain
+414,AQP7,T110S,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve AQP7 loss?,freq_cnv_loss_or_gain
+415,AQP7,T166S,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve AQP7 loss?,freq_cnv_loss_or_gain
+416,AQP7,T167S,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve AQP7 loss?,freq_cnv_loss_or_gain
+417,AQP7,T75S,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve AQP7 loss?,freq_cnv_loss_or_gain
+430,DCN,R163C,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve DCN loss?,freq_cnv_loss_or_gain
+431,DCN,R203C,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve DCN loss?,freq_cnv_loss_or_gain
+432,DCN,R241C,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve DCN loss?,freq_cnv_loss_or_gain
+433,DCN,R350C,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve DCN loss?,freq_cnv_loss_or_gain
+434,DCN,R41C,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve DCN loss?,freq_cnv_loss_or_gain
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve CPS1 loss?,freq_cnv_loss_or_gain
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve CPS1 loss?,freq_cnv_loss_or_gain
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve CPS1 loss?,freq_cnv_loss_or_gain
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What fraction of Kidney Renal Papillary Cell Carcinoma cases involve FCGR2C loss?,freq_cnv_loss_or_gain
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What fraction of Kidney Renal Papillary Cell Carcinoma cases involve FCGR2C loss?,freq_cnv_loss_or_gain
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve GRM1 loss?,freq_cnv_loss_or_gain
+482,SGCZ,Q138H,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve SGCZ loss?,freq_cnv_loss_or_gain
+483,SGCZ,Q91H,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve SGCZ loss?,freq_cnv_loss_or_gain
+485,SMO,V15M,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve SMO loss?,freq_cnv_loss_or_gain
+486,SMO,V321M,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve SMO loss?,freq_cnv_loss_or_gain
+488,CHODL,G159E,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve CHODL loss?,freq_cnv_loss_or_gain
+489,CHODL,G181E,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve CHODL loss?,freq_cnv_loss_or_gain
+490,CHODL,G200E,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve CHODL loss?,freq_cnv_loss_or_gain
+494,MYO16,P399H,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve MYO16 loss?,freq_cnv_loss_or_gain
+495,MYO16,P421H,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve MYO16 loss?,freq_cnv_loss_or_gain
+498,CXCR2,A98V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve CXCR2 loss?,freq_cnv_loss_or_gain
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve TMEM225 loss?,freq_cnv_loss_or_gain
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve MAOB loss?,freq_cnv_loss_or_gain
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve GPRASP1 loss?,freq_cnv_loss_or_gain
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve MRPL32 loss?,freq_cnv_loss_or_gain
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve TYROBP loss?,freq_cnv_loss_or_gain
+510,RAB40C,A111V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve RAB40C loss?,freq_cnv_loss_or_gain
+511,RAB40C,A143V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve RAB40C loss?,freq_cnv_loss_or_gain
+512,CTNNA2,S323R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve CTNNA2 loss?,freq_cnv_loss_or_gain
+513,CTNNA2,S339R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve CTNNA2 loss?,freq_cnv_loss_or_gain
+514,CTNNA2,S386R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve CTNNA2 loss?,freq_cnv_loss_or_gain
+515,CTNNA2,S707R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve CTNNA2 loss?,freq_cnv_loss_or_gain
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve MYO15A loss?,freq_cnv_loss_or_gain
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve GIMAP2 loss?,freq_cnv_loss_or_gain
+532,KIF20B,N1160D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases involve KIF20B loss?,freq_cnv_loss_or_gain
+533,KIF20B,N1200D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases involve KIF20B loss?,freq_cnv_loss_or_gain
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve ADAM17 loss?,freq_cnv_loss_or_gain
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve BCAT1 loss?,freq_cnv_loss_or_gain
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve BCAT1 loss?,freq_cnv_loss_or_gain
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve BCAT1 loss?,freq_cnv_loss_or_gain
+540,ERCC6,R1053H,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve ERCC6 loss?,freq_cnv_loss_or_gain
+541,DCC,R320W,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve DCC loss?,freq_cnv_loss_or_gain
+542,DCC,R363W,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve DCC loss?,freq_cnv_loss_or_gain
+543,DCC,R386W,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve DCC loss?,freq_cnv_loss_or_gain
+544,DCC,R41W,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve DCC loss?,freq_cnv_loss_or_gain
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve FBXO15 loss?,freq_cnv_loss_or_gain
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve FBXO15 loss?,freq_cnv_loss_or_gain
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve GSTCD loss?,freq_cnv_loss_or_gain
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve GSTCD loss?,freq_cnv_loss_or_gain
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve OLFML3 loss?,freq_cnv_loss_or_gain
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve OLFML3 loss?,freq_cnv_loss_or_gain
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve OLFML3 loss?,freq_cnv_loss_or_gain
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What fraction of Ovarian Serous Cystadenocarcinoma cases involve CFAP61 loss?,freq_cnv_loss_or_gain
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What fraction of Ovarian Serous Cystadenocarcinoma cases involve CFAP61 loss?,freq_cnv_loss_or_gain
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve HLA-DQA2 loss?,freq_cnv_loss_or_gain
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve TENM2 loss?,freq_cnv_loss_or_gain
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve TENM2 loss?,freq_cnv_loss_or_gain
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve TENM2 loss?,freq_cnv_loss_or_gain
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve ANKRD24 loss?,freq_cnv_loss_or_gain
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve ANKRD24 loss?,freq_cnv_loss_or_gain
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve ANKRD24 loss?,freq_cnv_loss_or_gain
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve ZCCHC14 loss?,freq_cnv_loss_or_gain
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve ZCCHC14 loss?,freq_cnv_loss_or_gain
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve ZCCHC14 loss?,freq_cnv_loss_or_gain
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve ZCCHC14 loss?,freq_cnv_loss_or_gain
+625,SIK2,I265M,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve SIK2 loss?,freq_cnv_loss_or_gain
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve MYH11 loss?,freq_cnv_loss_or_gain
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve MYH11 loss?,freq_cnv_loss_or_gain
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve SLC6A4 loss?,freq_cnv_loss_or_gain
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve SLC9C1 loss?,freq_cnv_loss_or_gain
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve SLC9C1 loss?,freq_cnv_loss_or_gain
+644,OR2A12,A254T,Brain Lower Grade Glioma,What fraction of Brain Lower Grade Glioma cases involve OR2A12 loss?,freq_cnv_loss_or_gain
+646,PYHIN1,T325K,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve PYHIN1 loss?,freq_cnv_loss_or_gain
+647,PYHIN1,T334K,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve PYHIN1 loss?,freq_cnv_loss_or_gain
+650,JAML,G191E,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve JAML loss?,freq_cnv_loss_or_gain
+651,JAML,G219E,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve JAML loss?,freq_cnv_loss_or_gain
+652,JAML,G220E,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve JAML loss?,freq_cnv_loss_or_gain
+653,JAML,G230E,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve JAML loss?,freq_cnv_loss_or_gain
+658,TYK2,H1146R,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve TYK2 loss?,freq_cnv_loss_or_gain
+659,TYK2,H23R,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve TYK2 loss?,freq_cnv_loss_or_gain
+660,TYK2,H961R,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve TYK2 loss?,freq_cnv_loss_or_gain
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve CTCFL loss?,freq_cnv_loss_or_gain
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve CTCFL loss?,freq_cnv_loss_or_gain
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve CTCFL loss?,freq_cnv_loss_or_gain
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve CTCFL loss?,freq_cnv_loss_or_gain
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve CEP20 loss?,freq_cnv_loss_or_gain
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve CEP20 loss?,freq_cnv_loss_or_gain
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve RIMS2 loss?,freq_cnv_loss_or_gain
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve RIMS2 loss?,freq_cnv_loss_or_gain
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve RIMS2 loss?,freq_cnv_loss_or_gain
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve RIMS2 loss?,freq_cnv_loss_or_gain
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve RIMS2 loss?,freq_cnv_loss_or_gain
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve RIMS2 loss?,freq_cnv_loss_or_gain
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve RIMS2 loss?,freq_cnv_loss_or_gain
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve PIK3C2G loss?,freq_cnv_loss_or_gain
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve PIK3C2G loss?,freq_cnv_loss_or_gain
+728,STK19,D341N,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve STK19 loss?,freq_cnv_loss_or_gain
+729,STK19,D345N,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve STK19 loss?,freq_cnv_loss_or_gain
+730,REXO4,P60A,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve REXO4 loss?,freq_cnv_loss_or_gain
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve ZBTB34 loss?,freq_cnv_loss_or_gain
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve ZBTB34 loss?,freq_cnv_loss_or_gain
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve NCKAP5 loss?,freq_cnv_loss_or_gain
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve SORCS1 loss?",freq_cnv_loss_or_gain
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve SORCS1 loss?",freq_cnv_loss_or_gain
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve SORCS1 loss?",freq_cnv_loss_or_gain
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve SORCS1 loss?",freq_cnv_loss_or_gain
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What fraction of Head and Neck Squamous Cell Carcinoma cases involve FGF8 loss?,freq_cnv_loss_or_gain
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What fraction of Head and Neck Squamous Cell Carcinoma cases involve FGF8 loss?,freq_cnv_loss_or_gain
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What fraction of Head and Neck Squamous Cell Carcinoma cases involve FGF8 loss?,freq_cnv_loss_or_gain
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What fraction of Head and Neck Squamous Cell Carcinoma cases involve FGF8 loss?,freq_cnv_loss_or_gain
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What fraction of Head and Neck Squamous Cell Carcinoma cases involve FGF8 loss?,freq_cnv_loss_or_gain
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What fraction of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia cases involve TENM3 loss?,freq_cnv_loss_or_gain
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve AKT1 loss?,freq_cnv_loss_or_gain
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases involve CFAP298-TCP10L loss?,freq_cnv_loss_or_gain
+792,GLRB,E148D,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve GLRB loss?,freq_cnv_loss_or_gain
+793,TTN,F7636L,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve TTN loss?,freq_cnv_loss_or_gain
+794,TTN,F8563L,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve TTN loss?,freq_cnv_loss_or_gain
+795,TTN,F8880L,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve TTN loss?,freq_cnv_loss_or_gain
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve ANKRD30A loss?,freq_cnv_loss_or_gain
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve ANKRD30A loss?,freq_cnv_loss_or_gain
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve ANKRD30A loss?,freq_cnv_loss_or_gain
+809,TRIM45,S177L,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve TRIM45 loss?,freq_cnv_loss_or_gain
+810,TRIM45,S224L,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve TRIM45 loss?,freq_cnv_loss_or_gain
+811,TRIM45,S281L,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve TRIM45 loss?,freq_cnv_loss_or_gain
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve CACNA1F loss?,freq_cnv_loss_or_gain
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve CACNA1F loss?,freq_cnv_loss_or_gain
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve CACNA1F loss?,freq_cnv_loss_or_gain
+817,KL,R594C,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve KL loss?,freq_cnv_loss_or_gain
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What fraction of Kidney Renal Papillary Cell Carcinoma cases involve GUF1 loss?,freq_cnv_loss_or_gain
+822,TAF1L,A539V,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve TAF1L loss?,freq_cnv_loss_or_gain
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve TASOR2 loss?,freq_cnv_loss_or_gain
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve TASOR2 loss?,freq_cnv_loss_or_gain
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve TASOR2 loss?,freq_cnv_loss_or_gain
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve KDM5C loss?,freq_cnv_loss_or_gain
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve KDM5C loss?,freq_cnv_loss_or_gain
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve KDM5C loss?,freq_cnv_loss_or_gain
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve KDM5C loss?,freq_cnv_loss_or_gain
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases involve IL5RA loss?,freq_cnv_loss_or_gain
+843,DHX16,A29V,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve DHX16 loss?,freq_cnv_loss_or_gain
+844,DHX16,A89V,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve DHX16 loss?,freq_cnv_loss_or_gain
+902,GPR158,A644V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve GPR158 loss?,freq_cnv_loss_or_gain
+903,GPR158,A723V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve GPR158 loss?,freq_cnv_loss_or_gain
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve EIF2B4 loss?",freq_cnv_loss_or_gain
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve EIF2B4 loss?",freq_cnv_loss_or_gain
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve EIF2B4 loss?",freq_cnv_loss_or_gain
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve EIF2B4 loss?",freq_cnv_loss_or_gain
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve EIF2B4 loss?",freq_cnv_loss_or_gain
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve EIF2B4 loss?",freq_cnv_loss_or_gain
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve AUTS2 loss?,freq_cnv_loss_or_gain
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve AUTS2 loss?,freq_cnv_loss_or_gain
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve AUTS2 loss?,freq_cnv_loss_or_gain
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve AUTS2 loss?,freq_cnv_loss_or_gain
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve AUTS2 loss?,freq_cnv_loss_or_gain
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve AUTS2 loss?,freq_cnv_loss_or_gain
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve AUTS2 loss?,freq_cnv_loss_or_gain
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve AUTS2 loss?,freq_cnv_loss_or_gain
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve AUTS2 loss?,freq_cnv_loss_or_gain
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve AUTS2 loss?,freq_cnv_loss_or_gain
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve ACTL7B loss?",freq_cnv_loss_or_gain
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases involve PCDHGA1 loss?,freq_cnv_loss_or_gain
+954,TRAP1,R114W,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve TRAP1 loss?,freq_cnv_loss_or_gain
+955,TRAP1,R61W,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve TRAP1 loss?,freq_cnv_loss_or_gain
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve PIK3C2A loss?,freq_cnv_loss_or_gain
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases involve KANSL1 loss?,freq_cnv_loss_or_gain
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve ANKRD52 loss?,freq_cnv_loss_or_gain
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve PAPPA loss?,freq_cnv_loss_or_gain
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve B3GALNT1 loss?,freq_cnv_loss_or_gain
+982,GABRA6,G115R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve GABRA6 loss?,freq_cnv_loss_or_gain
+983,GABRA6,G122R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve GABRA6 loss?,freq_cnv_loss_or_gain
+984,GABRA6,G165R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve GABRA6 loss?,freq_cnv_loss_or_gain
+985,GABRA6,G175R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve GABRA6 loss?,freq_cnv_loss_or_gain
+986,GABRA6,G70R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve GABRA6 loss?,freq_cnv_loss_or_gain
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve ZSCAN31 loss?,freq_cnv_loss_or_gain
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve MED16 loss?",freq_cnv_loss_or_gain
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve MED16 loss?",freq_cnv_loss_or_gain
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma cases involve PTPRO loss?,freq_cnv_loss_or_gain
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma cases involve PTPRO loss?,freq_cnv_loss_or_gain
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma cases involve PTPRO loss?,freq_cnv_loss_or_gain
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma cases involve PTPRO loss?,freq_cnv_loss_or_gain
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma cases involve PTPRO loss?,freq_cnv_loss_or_gain
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma cases involve PTPRO loss?,freq_cnv_loss_or_gain
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma cases involve PTPRO loss?,freq_cnv_loss_or_gain
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma cases involve PTPRO loss?,freq_cnv_loss_or_gain
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve CHMP7 loss?,freq_cnv_loss_or_gain
+1017,GPC3,I107N,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve GPC3 loss?,freq_cnv_loss_or_gain
+1018,GPC3,I161N,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve GPC3 loss?,freq_cnv_loss_or_gain
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases involve TLK2 loss?,freq_cnv_loss_or_gain
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases involve TLK2 loss?,freq_cnv_loss_or_gain
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases involve TLK2 loss?,freq_cnv_loss_or_gain
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases involve TLK2 loss?,freq_cnv_loss_or_gain
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases involve TLK2 loss?,freq_cnv_loss_or_gain
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve ZNF217 loss?,freq_cnv_loss_or_gain
+1038,SYT9,V275L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve SYT9 loss?,freq_cnv_loss_or_gain
+1039,SYT9,V307L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve SYT9 loss?,freq_cnv_loss_or_gain
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve PKHD1L1 loss?,freq_cnv_loss_or_gain
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve MYO3A loss?,freq_cnv_loss_or_gain
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve VASN loss?",freq_cnv_loss_or_gain
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve DNMT1 loss?,freq_cnv_loss_or_gain
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve DNMT1 loss?,freq_cnv_loss_or_gain
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve DNMT1 loss?,freq_cnv_loss_or_gain
+1056,CA9,E402K,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve CA9 loss?,freq_cnv_loss_or_gain
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve TTC17 loss?,freq_cnv_loss_or_gain
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve TTC17 loss?,freq_cnv_loss_or_gain
+1065,PSG2,P43L,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve PSG2 loss?,freq_cnv_loss_or_gain
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve RIPOR2 loss?,freq_cnv_loss_or_gain
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve RIPOR2 loss?,freq_cnv_loss_or_gain
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve RIPOR2 loss?,freq_cnv_loss_or_gain
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve RIPOR2 loss?,freq_cnv_loss_or_gain
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve DCLK3 loss?,freq_cnv_loss_or_gain
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve DCLK3 loss?,freq_cnv_loss_or_gain
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve MERTK loss?,freq_cnv_loss_or_gain
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve MERTK loss?,freq_cnv_loss_or_gain
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve MERTK loss?,freq_cnv_loss_or_gain
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve ZFP42 loss?,freq_cnv_loss_or_gain
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve OR13C3 loss?,freq_cnv_loss_or_gain
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve OR13C3 loss?,freq_cnv_loss_or_gain
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve SPAG1 loss?,freq_cnv_loss_or_gain
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve CDKN2AIP loss?,freq_cnv_loss_or_gain
+1093,PXN,H1016Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve PXN loss?,freq_cnv_loss_or_gain
+1094,PXN,H359Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve PXN loss?,freq_cnv_loss_or_gain
+1095,PXN,H492Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve PXN loss?,freq_cnv_loss_or_gain
+1096,PXN,H524Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve PXN loss?,freq_cnv_loss_or_gain
+1097,PXN,H526Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve PXN loss?,freq_cnv_loss_or_gain
+1098,PXN,H540Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve PXN loss?,freq_cnv_loss_or_gain
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve TTYH2 loss?,freq_cnv_loss_or_gain
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve TTYH2 loss?,freq_cnv_loss_or_gain
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve TMEM255A loss?,freq_cnv_loss_or_gain
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve TMEM255A loss?,freq_cnv_loss_or_gain
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve TMEM255A loss?,freq_cnv_loss_or_gain
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve TASOR2 loss?,freq_cnv_loss_or_gain
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve TASOR2 loss?,freq_cnv_loss_or_gain
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve ICE1 loss?,freq_cnv_loss_or_gain
+1112,MYT1,A558E,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve MYT1 loss?,freq_cnv_loss_or_gain
+1113,MYT1,A879E,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve MYT1 loss?,freq_cnv_loss_or_gain
+1114,MYT1,A906E,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve MYT1 loss?,freq_cnv_loss_or_gain
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve CX3CR1 loss?,freq_cnv_loss_or_gain
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve CX3CR1 loss?,freq_cnv_loss_or_gain
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases involve SPINDOC loss?,freq_cnv_loss_or_gain
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve ART3 loss?,freq_cnv_loss_or_gain
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve ART3 loss?,freq_cnv_loss_or_gain
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve CYP1A2 loss?,freq_cnv_loss_or_gain
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve ADRA1A loss?",freq_cnv_loss_or_gain
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve CDH23 loss?,freq_cnv_loss_or_gain
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve CDH23 loss?,freq_cnv_loss_or_gain
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve KRT39 loss?,freq_cnv_loss_or_gain
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve PDHA2 loss?,freq_cnv_loss_or_gain
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve SLC24A2 loss?,freq_cnv_loss_or_gain
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases involve PTPRN2 loss?,freq_cnv_loss_or_gain
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases involve PTPRN2 loss?,freq_cnv_loss_or_gain
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases involve PTPRN2 loss?,freq_cnv_loss_or_gain
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases involve PTPRN2 loss?,freq_cnv_loss_or_gain
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases involve PTPRN2 loss?,freq_cnv_loss_or_gain
+1188,SOX21,R55L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve SOX21 loss?,freq_cnv_loss_or_gain
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve CPA6 loss?,freq_cnv_loss_or_gain
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve GRM5 loss?,freq_cnv_loss_or_gain
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve CASZ1 loss?",freq_cnv_loss_or_gain
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve SGIP1 loss?,freq_cnv_loss_or_gain
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve SGIP1 loss?,freq_cnv_loss_or_gain
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve SGIP1 loss?,freq_cnv_loss_or_gain
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve SGIP1 loss?,freq_cnv_loss_or_gain
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve CARMIL1 loss?,freq_cnv_loss_or_gain
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve CARMIL1 loss?,freq_cnv_loss_or_gain
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve ZNF431 loss?,freq_cnv_loss_or_gain
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve ZNF431 loss?,freq_cnv_loss_or_gain
+1234,ZNF431,R128I,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve ZNF431 loss?,freq_cnv_loss_or_gain
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve DNAH11 loss?,freq_cnv_loss_or_gain
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve DNAH11 loss?,freq_cnv_loss_or_gain
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve POLD1 loss?,freq_cnv_loss_or_gain
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases involve POLD1 loss?,freq_cnv_loss_or_gain
+1248,TTC12,D646H,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve TTC12 loss?,freq_cnv_loss_or_gain
+1249,TTC12,D652H,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve TTC12 loss?,freq_cnv_loss_or_gain
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve CNGB1 loss?,freq_cnv_loss_or_gain
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases involve CNGB1 loss?,freq_cnv_loss_or_gain
+1254,CTSC,E214V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve CTSC loss?,freq_cnv_loss_or_gain
+1255,CTSC,E291V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve CTSC loss?,freq_cnv_loss_or_gain
+1256,CTSC,E322V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve CTSC loss?,freq_cnv_loss_or_gain
+1257,CTSC,E324V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve CTSC loss?,freq_cnv_loss_or_gain
+1258,CTSC,E335V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve CTSC loss?,freq_cnv_loss_or_gain
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve PRSS8 loss?,freq_cnv_loss_or_gain
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve PRSS8 loss?,freq_cnv_loss_or_gain
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve ARHGEF40 loss?,freq_cnv_loss_or_gain
+1264,ACTB,A138T,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve ACTB loss?,freq_cnv_loss_or_gain
+1265,ACTB,A217T,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve ACTB loss?,freq_cnv_loss_or_gain
+1266,ACTB,A244T,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve ACTB loss?,freq_cnv_loss_or_gain
+1267,ACTB,A260T,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve ACTB loss?,freq_cnv_loss_or_gain
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases involve YY1AP1 loss?,freq_cnv_loss_or_gain
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases involve YY1AP1 loss?,freq_cnv_loss_or_gain
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases involve YY1AP1 loss?,freq_cnv_loss_or_gain
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases involve YY1AP1 loss?,freq_cnv_loss_or_gain
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases involve YY1AP1 loss?,freq_cnv_loss_or_gain
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases involve YY1AP1 loss?,freq_cnv_loss_or_gain
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases involve YY1AP1 loss?,freq_cnv_loss_or_gain
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve FNDC7 loss?,freq_cnv_loss_or_gain
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve FNDC7 loss?,freq_cnv_loss_or_gain
+1299,TLCD5,G15V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve TLCD5 loss?,freq_cnv_loss_or_gain
+1300,TLCD5,G37V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve TLCD5 loss?,freq_cnv_loss_or_gain
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve POLR1G loss?,freq_cnv_loss_or_gain
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve POLR1G loss?,freq_cnv_loss_or_gain
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve DNAH14 loss?,freq_cnv_loss_or_gain
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve DNAH14 loss?,freq_cnv_loss_or_gain
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve DNAH14 loss?,freq_cnv_loss_or_gain
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve NEXN loss?,freq_cnv_loss_or_gain
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma cases involve CYB5R2 loss?,freq_cnv_loss_or_gain
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma cases involve CYB5R2 loss?,freq_cnv_loss_or_gain
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve NRAP loss?,freq_cnv_loss_or_gain
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve NRAP loss?,freq_cnv_loss_or_gain
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve NRAP loss?,freq_cnv_loss_or_gain
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve CCDC22 loss?,freq_cnv_loss_or_gain
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve DCAF6 loss?,freq_cnv_loss_or_gain
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve DCAF6 loss?,freq_cnv_loss_or_gain
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve ZNF708 loss?,freq_cnv_loss_or_gain
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve BFAR loss?,freq_cnv_loss_or_gain
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve MAST4 loss?,freq_cnv_loss_or_gain
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve MAST4 loss?,freq_cnv_loss_or_gain
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve MAST4 loss?,freq_cnv_loss_or_gain
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve MAST4 loss?,freq_cnv_loss_or_gain
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve MAST4 loss?,freq_cnv_loss_or_gain
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve ARMC3 loss?,freq_cnv_loss_or_gain
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve ARMC3 loss?,freq_cnv_loss_or_gain
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What fraction of Kidney Renal Clear Cell Carcinoma cases involve TET2 loss?,freq_cnv_loss_or_gain
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What fraction of Kidney Renal Clear Cell Carcinoma cases involve TET2 loss?,freq_cnv_loss_or_gain
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve SERPINB10 loss?,freq_cnv_loss_or_gain
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve STAT3 loss?,freq_cnv_loss_or_gain
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve MIEF1 loss?,freq_cnv_loss_or_gain
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve ACVR1B loss?,freq_cnv_loss_or_gain
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve ACVR1B loss?,freq_cnv_loss_or_gain
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve ACVR1B loss?,freq_cnv_loss_or_gain
+1393,EBF2,T104I,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve EBF2 loss?,freq_cnv_loss_or_gain
+1394,EBF2,T252I,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve EBF2 loss?,freq_cnv_loss_or_gain
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve VPS26B loss?,freq_cnv_loss_or_gain
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve PGR loss?",freq_cnv_loss_or_gain
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve PGR loss?",freq_cnv_loss_or_gain
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases involve PGR loss?",freq_cnv_loss_or_gain
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases involve ACTA2 loss?,freq_cnv_loss_or_gain
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve THBS4 loss?,freq_cnv_loss_or_gain
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve THBS4 loss?,freq_cnv_loss_or_gain
+1413,PRSS1,S114T,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve PRSS1 loss?,freq_cnv_loss_or_gain
+1414,PRSS1,S124T,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve PRSS1 loss?,freq_cnv_loss_or_gain
+1415,PRSS1,S138T,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve PRSS1 loss?,freq_cnv_loss_or_gain
+1416,PRSS1,S74T,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases involve PRSS1 loss?,freq_cnv_loss_or_gain
+1417,PGF,R126H,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve PGF loss?,freq_cnv_loss_or_gain
+1418,PGF,R127H,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases involve PGF loss?,freq_cnv_loss_or_gain
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve ITPRID2 loss?,freq_cnv_loss_or_gain
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases involve ITPRID2 loss?,freq_cnv_loss_or_gain
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve HBB loss?,freq_cnv_loss_or_gain
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve PCDHB2 loss?,freq_cnv_loss_or_gain
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve PCDHB2 loss?,freq_cnv_loss_or_gain
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases involve PCDHB2 loss?,freq_cnv_loss_or_gain
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases involve UBR2 loss?,freq_cnv_loss_or_gain
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases involve FBXO42 loss?,freq_cnv_loss_or_gain
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the incidence of TNS1 or OR2T4 mutations in cases of Breast Invasive Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the incidence of TNS1 or SORCS1 mutations in cases of Breast Invasive Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the incidence of TNS1 or DCC mutations in cases of Breast Invasive Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the incidence of TNS1 or ZNF217 mutations in cases of Breast Invasive Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the incidence of TNS1 or CTSC mutations in cases of Breast Invasive Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the incidence of TNS1 or GSTCD mutations in cases of Breast Invasive Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the incidence of TNS1 or CEP20 mutations in cases of Breast Invasive Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the incidence of EVC2 or KDM5C mutations in cases of Bladder Urothelial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the incidence of EVC2 or MYO16 mutations in cases of Bladder Urothelial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the incidence of CR1 or GPC3 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the incidence of CR1 or UNC5D mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the incidence of TRPA1 or CTCFL mutations in cases of Rectum Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the incidence of TRPA1 or TASOR2 mutations in cases of Rectum Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the incidence of TAF1C or TNS1 mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the incidence of TAF1C or YY1AP1 mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the incidence of TAF1C or TLK2 mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the incidence of TAF1C or NRAP mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the incidence of TAF1C or FCGR2C mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the incidence of DPF3 or CYB5R2 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the incidence of DPF3 or DNAH14 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the incidence of DPF3 or CHODL mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the incidence of OR2T4 or CHODL mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the incidence of OR2T4 or CNGB1 mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the incidence of FBN1 or POC1B mutations in cases of Pancreatic Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the incidence of MAD1L1 or SLC9C1 mutations in cases of Prostate Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the incidence of MAD1L1 or DNAH14 mutations in cases of Prostate Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the incidence of MAD1L1 or ANP32E mutations in cases of Prostate Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the incidence of CCNG1 or HTR3B mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the incidence of ANP32E or UNC5D mutations in cases of Kidney Renal Papillary Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the incidence of ANP32E or RIPOR2 mutations in cases of Kidney Renal Papillary Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the incidence of ANP32E or EVC2 mutations in cases of Kidney Renal Papillary Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the incidence of ANP32E or AUTS2 mutations in cases of Kidney Renal Papillary Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the incidence of FRY or SORCS1 mutations in cases of Bladder Urothelial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the incidence of FRY or FNDC7 mutations in cases of Bladder Urothelial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the incidence of FRY or FGF8 mutations in cases of Bladder Urothelial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the incidence of FRY or NRAP mutations in cases of Bladder Urothelial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the incidence of PAK3 or SYT10 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the incidence of PAK3 or ANKRD30A mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the incidence of PAK3 or POC1B mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the incidence of PAK3 or ANKRD30A mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the incidence of PAK3 or HBB mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the incidence of MUC16 or ZMYM3 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the incidence of ZFPM2 or GSTCD mutations in cases of Liver Hepatocellular Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the incidence of ZFPM2 or EIF2B4 mutations in cases of Liver Hepatocellular Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the incidence of PIK3C2B or ANKRD24 mutations in cases of Breast Invasive Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the incidence of PIK3C2B or CPS1 mutations in cases of Breast Invasive Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the incidence of ZNF804A or ANP32E mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the incidence of RELN or SOX21 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of EFCAB12 or DHX16 mutations in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",top_cases_counts_by_genes
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of EFCAB12 or DNMT1 mutations in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",top_cases_counts_by_genes
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the incidence of DEFB115 or TTN mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the incidence of ANKDD1A or SPATA22 mutations in cases of Bladder Urothelial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the incidence of ANKDD1A or MYT1 mutations in cases of Bladder Urothelial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the incidence of ANKDD1A or PAK3 mutations in cases of Bladder Urothelial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the incidence of HTR3B or TTC12 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the incidence of HTR3B or YY1AP1 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the incidence of HTR3B or EBF2 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the incidence of ABCC3 or ANKRD30A mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the incidence of NOMO1 or FBN1 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the incidence of NOMO1 or FBXO15 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the incidence of HYOU1 or RIPOR2 mutations in cases of Bladder Urothelial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the incidence of FMO4 or RAB40C mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+140,BICC1,A372V,Exceptional Responders,What is the incidence of BICC1 or AUTS2 mutations in cases of Exceptional Responders in the genomic data commons?,top_cases_counts_by_genes
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the incidence of ZMYM3 or SYT9 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the incidence of ZMYM3 or ARMC3 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the incidence of ZMYM3 or CARMIL1 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of XKR4 or CTNNA2 mutations in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",top_cases_counts_by_genes
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the incidence of ABCC2 or FGF8 mutations in cases of Liver Hepatocellular Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the incidence of OR8K5 or TRIM45 mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the incidence of SPTAN1 or CCDC22 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the incidence of SPTAN1 or RIMS2 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the incidence of SYT10 or DNAH14 mutations in cases of Rectum Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the incidence of HSPA5 or STK19 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the incidence of UNC5D or RIMS2 mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the incidence of UNC5D or DSCAM mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the incidence of UNC5D or CPA6 mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the incidence of UNC5D or GUK1 mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the incidence of UNC5D or TLK2 mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the incidence of UNC5D or MAOB mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the incidence of DOCK2 or TAF1C mutations in cases of Kidney Renal Clear Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the incidence of ZNF627 or PTPRN2 mutations in cases of Kidney Renal Clear Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the incidence of CDC42BPA or CX3CR1 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the incidence of MRPL55 or TTYH2 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the incidence of MRPL55 or DNAH11 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the incidence of TMTC3 or YY1AP1 mutations in cases of Breast Invasive Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the incidence of EPRS1 or CACNA1F mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the incidence of EPRS1 or ZCCHC14 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the incidence of GRTP1 or MYT1 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the incidence of GRTP1 or DNMT1 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the incidence of TSHZ3 or UNC5D mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the incidence of TAS1R3 or CTNNA2 mutations in cases of HIV+ Tumor Molecular Characterization Project - Cervical Cancer in the genomic data commons?,top_cases_counts_by_genes
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the incidence of PIAS3 or RIPOR2 mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the incidence of PIAS3 or TENM2 mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the incidence of ZNF274 or TLCD5 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the incidence of SYNJ1 or TMEM225 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the incidence of SYNJ1 or SYT9 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the incidence of SYNJ1 or ZMYM3 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the incidence of DSCAM or CDKN2AIP mutations in cases of Prostate Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the incidence of DSCAM or EVC2 mutations in cases of Prostate Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the incidence of DSCAM or RIPOR2 mutations in cases of Prostate Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+267,DGKD,R140H,Exceptional Responders,What is the incidence of DGKD or KIF20B mutations in cases of Exceptional Responders in the genomic data commons?,top_cases_counts_by_genes
+268,DGKD,R160H,Exceptional Responders,What is the incidence of DGKD or CHODL mutations in cases of Exceptional Responders in the genomic data commons?,top_cases_counts_by_genes
+269,DGKD,R204H,Exceptional Responders,What is the incidence of DGKD or UNC5D mutations in cases of Exceptional Responders in the genomic data commons?,top_cases_counts_by_genes
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the incidence of PLEKHG6 or UNC5D mutations in cases of Bladder Urothelial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the incidence of PLEKHG6 or PTPRN2 mutations in cases of Bladder Urothelial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the incidence of PLEKHG6 or SYNJ1 mutations in cases of Bladder Urothelial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the incidence of WNT2 or CCDC22 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the incidence of GUCY2C or TLK2 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the incidence of C7orf31 or DCC mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of ZKSCAN7 or DSCAM mutations in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",top_cases_counts_by_genes
+299,OR5D14,M210L,Neuroblastoma,What is the incidence of OR5D14 or CR1 mutations in cases of Neuroblastoma in the genomic data commons?,top_cases_counts_by_genes
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the incidence of SPATA22 or MYH11 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the incidence of SPATA22 or PCDHGA1 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the incidence of SPATA22 or DSCAM mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the incidence of LCN15 or TASOR2 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the incidence of DCAF4L2 or MYO15A mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the incidence of GUK1 or MORF4L1 mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the incidence of GUK1 or REXO4 mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the incidence of GUK1 or NOMO1 mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the incidence of GUK1 or EIF2B4 mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the incidence of GUK1 or ZNF584 mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the incidence of MORF4L1 or GUK1 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the incidence of MORF4L1 or SIK2 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the incidence of MORF4L1 or CXCR2 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the incidence of MORF4L1 or RAB40C mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the incidence of MYO3B or ZFP42 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the incidence of MYO3B or GABRA6 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the incidence of TENT5A or PTPRO mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the incidence of TENT5A or DNAH14 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the incidence of TENT5A or PRSS8 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the incidence of ZFAT or PIK3C2G mutations in cases of Ovarian Serous Cystadenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the incidence of ZFAT or RAB40C mutations in cases of Ovarian Serous Cystadenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the incidence of ZFAT or FBXO15 mutations in cases of Ovarian Serous Cystadenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+357,ZNF584,A211T,Sarcoma,What is the incidence of ZNF584 or RIMS2 mutations in cases of Sarcoma in the genomic data commons?,top_cases_counts_by_genes
+358,ZNF584,A256T,Sarcoma,What is the incidence of ZNF584 or ZBTB34 mutations in cases of Sarcoma in the genomic data commons?,top_cases_counts_by_genes
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the incidence of LDOC1 or TMEM225 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the incidence of PDGFC or FRY mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSANTD4 or ADRA1A mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the incidence of NPSR1 or TTN mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the incidence of PHLPP1 or ACTB mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the incidence of COL6A3 or TTN mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the incidence of COL6A3 or CEP20 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the incidence of COL6A3 or MYO3A mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the incidence of COL6A3 or ACTL7B mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the incidence of COL6A3 or MAST4 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the incidence of ADRA1A or POLD1 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of LAMB2 or FGF8 mutations in cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the incidence of POC1B or MORF4L1 mutations in cases of Rectum Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the incidence of POC1B or POLD1 mutations in cases of Rectum Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the incidence of POC1B or MED16 mutations in cases of Rectum Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the incidence of POC1B or PGF mutations in cases of Rectum Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the incidence of USH2A or THBS4 mutations in cases of Liver Hepatocellular Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the incidence of AQP7 or TAF1C mutations in cases of Rectum Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the incidence of AQP7 or CACNA1F mutations in cases of Rectum Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the incidence of AQP7 or CEP20 mutations in cases of Rectum Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the incidence of AQP7 or CNGB1 mutations in cases of Rectum Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+430,DCN,R163C,Rectum Adenocarcinoma,What is the incidence of DCN or TTYH2 mutations in cases of Rectum Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+431,DCN,R203C,Rectum Adenocarcinoma,What is the incidence of DCN or PIAS3 mutations in cases of Rectum Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+432,DCN,R241C,Rectum Adenocarcinoma,What is the incidence of DCN or DCLK3 mutations in cases of Rectum Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+433,DCN,R350C,Rectum Adenocarcinoma,What is the incidence of DCN or YY1AP1 mutations in cases of Rectum Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+434,DCN,R41C,Rectum Adenocarcinoma,What is the incidence of DCN or GRM5 mutations in cases of Rectum Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the incidence of CPS1 or TTC17 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the incidence of CPS1 or CCNG1 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the incidence of CPS1 or CTSC mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the incidence of FCGR2C or TTN mutations in cases of Kidney Renal Papillary Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the incidence of FCGR2C or POLD1 mutations in cases of Kidney Renal Papillary Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the incidence of GRM1 or TAF1C mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the incidence of SGCZ or PRSS1 mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the incidence of SGCZ or CEP20 mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+485,SMO,V15M,Stomach Adenocarcinoma,What is the incidence of SMO or ZNF431 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+486,SMO,V321M,Stomach Adenocarcinoma,What is the incidence of SMO or PXN mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the incidence of CHODL or AUTS2 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the incidence of CHODL or GPC3 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the incidence of CHODL or HBB mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+494,MYO16,P399H,Colon Adenocarcinoma,What is the incidence of MYO16 or STK19 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+495,MYO16,P421H,Colon Adenocarcinoma,What is the incidence of MYO16 or CFAP298-TCP10L mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the incidence of CXCR2 or CTCFL mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the incidence of TMEM225 or PXN mutations in cases of Bladder Urothelial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the incidence of MAOB or BFAR mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the incidence of GPRASP1 or PAK3 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of MRPL32 or PRSS8 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the incidence of TYROBP or HTR3B mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the incidence of RAB40C or MAD1L1 mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the incidence of RAB40C or DCC mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the incidence of CTNNA2 or TNS1 mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the incidence of CTNNA2 or PCDHB2 mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the incidence of CTNNA2 or IL5RA mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the incidence of CTNNA2 or ZMYM3 mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the incidence of MYO15A or PIAS3 mutations in cases of Bladder Urothelial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the incidence of GIMAP2 or CFAP61 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the incidence of KIF20B or CX3CR1 mutations in cases of Glioblastoma Multiforme in the genomic data commons?,top_cases_counts_by_genes
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the incidence of KIF20B or DGKD mutations in cases of Glioblastoma Multiforme in the genomic data commons?,top_cases_counts_by_genes
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the incidence of ADAM17 or DCAF6 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the incidence of BCAT1 or MRPL55 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the incidence of BCAT1 or TTN mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the incidence of BCAT1 or TAF1C mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the incidence of ERCC6 or TTYH2 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+541,DCC,R320W,Breast Invasive Carcinoma,What is the incidence of DCC or PAK3 mutations in cases of Breast Invasive Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+542,DCC,R363W,Breast Invasive Carcinoma,What is the incidence of DCC or FNDC7 mutations in cases of Breast Invasive Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+543,DCC,R386W,Breast Invasive Carcinoma,What is the incidence of DCC or FGF8 mutations in cases of Breast Invasive Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+544,DCC,R41W,Breast Invasive Carcinoma,What is the incidence of DCC or PRSS1 mutations in cases of Breast Invasive Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the incidence of FBXO15 or STK19 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the incidence of FBXO15 or AUTS2 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the incidence of GSTCD or MIEF1 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the incidence of GSTCD or CTCFL mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the incidence of OLFML3 or ITPRID2 mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the incidence of OLFML3 or BCAT1 mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the incidence of OLFML3 or ZBTB34 mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the incidence of CFAP61 or TTYH2 mutations in cases of Ovarian Serous Cystadenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the incidence of CFAP61 or CR1 mutations in cases of Ovarian Serous Cystadenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the incidence of HLA-DQA2 or MYT1 mutations in cases of Bladder Urothelial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the incidence of TENM2 or ACVR1B mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the incidence of TENM2 or TYK2 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the incidence of TENM2 or COL6A3 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the incidence of ANKRD24 or PLEKHG6 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the incidence of ANKRD24 or MAST4 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the incidence of ANKRD24 or CHODL mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the incidence of ZCCHC14 or ART3 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the incidence of ZCCHC14 or ZBTB34 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the incidence of ZCCHC14 or NOMO1 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the incidence of ZCCHC14 or DSCAM mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+625,SIK2,I265M,Lung Adenocarcinoma,What is the incidence of SIK2 or PTPRO mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the incidence of MYH11 or TASOR2 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the incidence of MYH11 or GABRA6 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the incidence of SLC6A4 or EFCAB12 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the incidence of SLC9C1 or MORF4L1 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the incidence of SLC9C1 or SGCZ mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the incidence of OR2A12 or TYK2 mutations in cases of Brain Lower Grade Glioma in the genomic data commons?,top_cases_counts_by_genes
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the incidence of PYHIN1 or SYNJ1 mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the incidence of PYHIN1 or NOMO1 mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the incidence of JAML or TLK2 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the incidence of JAML or MERTK mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the incidence of JAML or PGF mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the incidence of JAML or CYB5R2 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the incidence of TYK2 or DGKD mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the incidence of TYK2 or RAB40C mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the incidence of TYK2 or GRM1 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the incidence of CTCFL or RIPOR2 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the incidence of CTCFL or DSCAM mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the incidence of CTCFL or ZNF627 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the incidence of CTCFL or CYB5R2 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of CEP20 or FMO4 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of CEP20 or CR1 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the incidence of RIMS2 or ZNF708 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the incidence of RIMS2 or GPC3 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the incidence of RIMS2 or EPRS1 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the incidence of RIMS2 or RIMS2 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the incidence of RIMS2 or PRSS1 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the incidence of RIMS2 or EVC2 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the incidence of RIMS2 or MAD1L1 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the incidence of PIK3C2G or PLEKHG6 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the incidence of PIK3C2G or FBXO15 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+728,STK19,D341N,Colon Adenocarcinoma,What is the incidence of STK19 or CTSC mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+729,STK19,D345N,Colon Adenocarcinoma,What is the incidence of STK19 or RIPOR2 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the incidence of REXO4 or TENM3 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the incidence of ZBTB34 or PYHIN1 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the incidence of ZBTB34 or ZNF627 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the incidence of NCKAP5 or TSHZ3 mutations in cases of Bladder Urothelial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of SORCS1 or AQP7 mutations in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",top_cases_counts_by_genes
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of SORCS1 or ANKRD52 mutations in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",top_cases_counts_by_genes
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of SORCS1 or OR2T4 mutations in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",top_cases_counts_by_genes
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of SORCS1 or SYT9 mutations in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",top_cases_counts_by_genes
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the incidence of FGF8 or KIF20B mutations in cases of Head and Neck Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the incidence of FGF8 or DCLK3 mutations in cases of Head and Neck Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the incidence of FGF8 or TLK2 mutations in cases of Head and Neck Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the incidence of FGF8 or AQP7 mutations in cases of Head and Neck Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the incidence of FGF8 or PAK3 mutations in cases of Head and Neck Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the incidence of TENM3 or ANKRD24 mutations in cases of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia in the genomic data commons?,top_cases_counts_by_genes
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the incidence of AKT1 or POC1B mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of CFAP298-TCP10L or ACTB mutations in cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the incidence of GLRB or SPAG1 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+793,TTN,F7636L,Colon Adenocarcinoma,What is the incidence of TTN or MERTK mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+794,TTN,F8563L,Colon Adenocarcinoma,What is the incidence of TTN or MORF4L1 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+795,TTN,F8880L,Colon Adenocarcinoma,What is the incidence of TTN or MRPL55 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the incidence of ANKRD30A or DGKD mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the incidence of ANKRD30A or DCC mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the incidence of ANKRD30A or ANKRD30A mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the incidence of TRIM45 or PRSS1 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the incidence of TRIM45 or CFAP61 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the incidence of TRIM45 or DCC mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the incidence of CACNA1F or ZMYM3 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the incidence of CACNA1F or TYK2 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the incidence of CACNA1F or SPINDOC mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+817,KL,R594C,Colon Adenocarcinoma,What is the incidence of KL or LAMB2 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the incidence of GUF1 or MYO16 mutations in cases of Kidney Renal Papillary Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the incidence of TAF1L or ZNF431 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the incidence of TASOR2 or POC1B mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the incidence of TASOR2 or GUK1 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the incidence of TASOR2 or ZNF584 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the incidence of KDM5C or AQP7 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the incidence of KDM5C or MYH11 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the incidence of KDM5C or ANP32E mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the incidence of KDM5C or BFAR mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of IL5RA or GPC3 mutations in cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the incidence of DHX16 or PYHIN1 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the incidence of DHX16 or ABCC2 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the incidence of GPR158 or CPS1 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the incidence of GPR158 or ART3 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of EIF2B4 or YY1AP1 mutations in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",top_cases_counts_by_genes
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of EIF2B4 or DPF3 mutations in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",top_cases_counts_by_genes
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of EIF2B4 or TASOR2 mutations in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",top_cases_counts_by_genes
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of EIF2B4 or GRM5 mutations in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",top_cases_counts_by_genes
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of EIF2B4 or SORCS1 mutations in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",top_cases_counts_by_genes
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of EIF2B4 or PGF mutations in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",top_cases_counts_by_genes
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 or TTYH2 mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 or DNAH14 mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 or GUK1 mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 or DCN mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 or MORF4L1 mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 or FGF8 mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 or TLCD5 mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 or OR2A12 mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 or ARMC3 mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 or PDHA2 mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of ACTL7B or SYT9 mutations in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",top_cases_counts_by_genes
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the incidence of PCDHGA1 or AUTS2 mutations in cases of Glioblastoma Multiforme in the genomic data commons?,top_cases_counts_by_genes
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the incidence of TRAP1 or MERTK mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the incidence of TRAP1 or TRIM45 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of PIK3C2A or ZFP42 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the incidence of KANSL1 or NPSR1 mutations in cases of Liver Hepatocellular Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the incidence of ANKRD52 or ANKRD52 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the incidence of PAPPA or CHODL mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the incidence of B3GALNT1 or SPTAN1 mutations in cases of Rectum Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the incidence of GABRA6 or POLD1 mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the incidence of GABRA6 or SGIP1 mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the incidence of GABRA6 or DPF3 mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the incidence of GABRA6 or MERTK mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the incidence of GABRA6 or UNC5D mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the incidence of ZSCAN31 or SPATA22 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of MED16 or EPRS1 mutations in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",top_cases_counts_by_genes
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of MED16 or CTNNA2 mutations in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",top_cases_counts_by_genes
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the incidence of PTPRO or PTPRN2 mutations in cases of Pancreatic Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the incidence of PTPRO or BFAR mutations in cases of Pancreatic Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the incidence of PTPRO or ANP32E mutations in cases of Pancreatic Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the incidence of PTPRO or ACTL7B mutations in cases of Pancreatic Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the incidence of PTPRO or EIF2B4 mutations in cases of Pancreatic Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the incidence of PTPRO or PXN mutations in cases of Pancreatic Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the incidence of PTPRO or OR13C3 mutations in cases of Pancreatic Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the incidence of PTPRO or ZFPM2 mutations in cases of Pancreatic Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the incidence of CHMP7 or GRM1 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the incidence of GPC3 or ZCCHC14 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the incidence of GPC3 or DCC mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of TLK2 or ZBTB34 mutations in cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of TLK2 or LCN15 mutations in cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of TLK2 or MYH11 mutations in cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of TLK2 or PCDHB2 mutations in cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of TLK2 or TNS1 mutations in cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the incidence of ZNF217 or AQP7 mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the incidence of SYT9 or POC1B mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the incidence of SYT9 or ANKRD30A mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the incidence of PKHD1L1 or STAT3 mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the incidence of MYO3A or TLCD5 mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of VASN or OR2A12 mutations in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",top_cases_counts_by_genes
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the incidence of DNMT1 or GABRA6 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the incidence of DNMT1 or MAD1L1 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the incidence of DNMT1 or SYNJ1 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1056,CA9,E402K,Colon Adenocarcinoma,What is the incidence of CA9 or TASOR2 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of TTC17 or TASOR2 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of TTC17 or DOCK2 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the incidence of PSG2 or ACTB mutations in cases of Breast Invasive Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the incidence of RIPOR2 or YY1AP1 mutations in cases of Breast Invasive Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the incidence of RIPOR2 or ZCCHC14 mutations in cases of Breast Invasive Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the incidence of RIPOR2 or MYO3A mutations in cases of Breast Invasive Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the incidence of RIPOR2 or TASOR2 mutations in cases of Breast Invasive Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the incidence of DCLK3 or MYO3A mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the incidence of DCLK3 or DCLK3 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the incidence of MERTK or ZNF708 mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the incidence of MERTK or TNS1 mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the incidence of MERTK or RIPOR2 mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the incidence of ZFP42 or EPRS1 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the incidence of OR13C3 or AQP7 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the incidence of OR13C3 or TLK2 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the incidence of SPAG1 or ZCCHC14 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the incidence of CDKN2AIP or CX3CR1 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the incidence of PXN or SORCS1 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the incidence of PXN or DPF3 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the incidence of PXN or PRSS1 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the incidence of PXN or OR5D14 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the incidence of PXN or OR2T4 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the incidence of PXN or MERTK mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the incidence of TTYH2 or OLFML3 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the incidence of TTYH2 or ZBTB34 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the incidence of TMEM255A or CFAP298-TCP10L mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the incidence of TMEM255A or EFCAB12 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the incidence of TMEM255A or CPS1 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the incidence of TASOR2 or ACTA2 mutations in cases of Breast Invasive Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the incidence of TASOR2 or TTN mutations in cases of Breast Invasive Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the incidence of ICE1 or SYNJ1 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the incidence of MYT1 or CPS1 mutations in cases of Breast Invasive Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the incidence of MYT1 or PRSS1 mutations in cases of Breast Invasive Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the incidence of MYT1 or ACTB mutations in cases of Breast Invasive Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the incidence of CX3CR1 or EVC2 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the incidence of CX3CR1 or TTC12 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the incidence of SPINDOC or FRY mutations in cases of Liver Hepatocellular Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the incidence of ART3 or ZNF708 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the incidence of ART3 or GUK1 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the incidence of CYP1A2 or TTC17 mutations in cases of Bladder Urothelial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of ADRA1A or CA9 mutations in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",top_cases_counts_by_genes
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the incidence of CDH23 or PIK3C2B mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the incidence of CDH23 or CR1 mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the incidence of KRT39 or PDHA2 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the incidence of PDHA2 or GUK1 mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the incidence of SLC24A2 or ADAM17 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the incidence of PTPRN2 or EBF2 mutations in cases of Liver Hepatocellular Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the incidence of PTPRN2 or ACTB mutations in cases of Liver Hepatocellular Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the incidence of PTPRN2 or PIK3C2A mutations in cases of Liver Hepatocellular Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the incidence of PTPRN2 or PXN mutations in cases of Liver Hepatocellular Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the incidence of PTPRN2 or IL5RA mutations in cases of Liver Hepatocellular Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the incidence of SOX21 or AKT1 mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the incidence of CPA6 or GUK1 mutations in cases of Bladder Urothelial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the incidence of GRM5 or YY1AP1 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of CASZ1 or FBXO42 mutations in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",top_cases_counts_by_genes
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the incidence of SGIP1 or MUC16 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the incidence of SGIP1 or UNC5D mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the incidence of SGIP1 or DHX16 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the incidence of SGIP1 or PIK3C2B mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the incidence of CARMIL1 or CTSC mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the incidence of CARMIL1 or CTCFL mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the incidence of ZNF431 or DNMT1 mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the incidence of ZNF431 or MYT1 mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the incidence of ZNF431 or TTN mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the incidence of DNAH11 or STK19 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the incidence of DNAH11 or CDH23 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the incidence of POLD1 or AUTS2 mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the incidence of POLD1 or SPTAN1 mutations in cases of Lung Squamous Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the incidence of TTC12 or CTCFL mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the incidence of TTC12 or TMEM255A mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the incidence of CNGB1 or CFAP61 mutations in cases of Bladder Urothelial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the incidence of CNGB1 or ZFP42 mutations in cases of Bladder Urothelial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the incidence of CTSC or SYT9 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the incidence of CTSC or CTNNA2 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the incidence of CTSC or STK19 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the incidence of CTSC or AKT1 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the incidence of CTSC or CX3CR1 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the incidence of PRSS8 or PTPRO mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the incidence of PRSS8 or ACTA2 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the incidence of ARHGEF40 or ADRA1A mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the incidence of ACTB or SGIP1 mutations in cases of Rectum Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the incidence of ACTB or CPA6 mutations in cases of Rectum Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the incidence of ACTB or TENT5A mutations in cases of Rectum Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the incidence of ACTB or PXN mutations in cases of Rectum Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the incidence of YY1AP1 or BCAT1 mutations in cases of Glioblastoma Multiforme in the genomic data commons?,top_cases_counts_by_genes
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the incidence of YY1AP1 or EIF2B4 mutations in cases of Glioblastoma Multiforme in the genomic data commons?,top_cases_counts_by_genes
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the incidence of YY1AP1 or RAB40C mutations in cases of Glioblastoma Multiforme in the genomic data commons?,top_cases_counts_by_genes
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the incidence of YY1AP1 or PAK3 mutations in cases of Glioblastoma Multiforme in the genomic data commons?,top_cases_counts_by_genes
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the incidence of YY1AP1 or CEP20 mutations in cases of Glioblastoma Multiforme in the genomic data commons?,top_cases_counts_by_genes
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the incidence of YY1AP1 or GPC3 mutations in cases of Glioblastoma Multiforme in the genomic data commons?,top_cases_counts_by_genes
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the incidence of YY1AP1 or OR8K5 mutations in cases of Glioblastoma Multiforme in the genomic data commons?,top_cases_counts_by_genes
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the incidence of FNDC7 or TLK2 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the incidence of FNDC7 or TASOR2 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the incidence of TLCD5 or DPF3 mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the incidence of TLCD5 or OR13C3 mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the incidence of POLR1G or SIK2 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the incidence of POLR1G or TNS1 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the incidence of DNAH14 or CTNNA2 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the incidence of DNAH14 or TAF1L mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the incidence of DNAH14 or SYT9 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the incidence of NEXN or PTPRN2 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the incidence of CYB5R2 or EBF2 mutations in cases of Prostate Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the incidence of CYB5R2 or CARMIL1 mutations in cases of Prostate Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the incidence of NRAP or CPA6 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the incidence of NRAP or ANP32E mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the incidence of NRAP or OR13C3 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the incidence of CCDC22 or ANKRD24 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the incidence of DCAF6 or MAD1L1 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the incidence of DCAF6 or PRSS8 mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the incidence of ZNF708 or TASOR2 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the incidence of BFAR or BCAT1 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the incidence of MAST4 or ZFAT mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the incidence of MAST4 or FBN1 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the incidence of MAST4 or TASOR2 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the incidence of MAST4 or DNMT1 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the incidence of MAST4 or CACNA1F mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the incidence of ARMC3 or CTCFL mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the incidence of ARMC3 or TRIM45 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the incidence of TET2 or SYT10 mutations in cases of Kidney Renal Clear Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the incidence of TET2 or DCN mutations in cases of Kidney Renal Clear Cell Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the incidence of SERPINB10 or SERPINB10 mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the incidence of STAT3 or TAF1C mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the incidence of MIEF1 or GSTCD mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the incidence of ACVR1B or GSTCD mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the incidence of ACVR1B or MYT1 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the incidence of ACVR1B or ZNF431 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the incidence of EBF2 or CTSC mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the incidence of EBF2 or ZNF431 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the incidence of VPS26B or SLC9C1 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of PGR or DCC mutations in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",top_cases_counts_by_genes
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of PGR or CTSC mutations in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",top_cases_counts_by_genes
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of PGR or RIMS2 mutations in cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",top_cases_counts_by_genes
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the incidence of ACTA2 or ADRA1A mutations in cases of Skin Cutaneous Melanoma in the genomic data commons?,top_cases_counts_by_genes
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the incidence of THBS4 or DCC mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the incidence of THBS4 or ZNF584 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the incidence of PRSS1 or TMEM255A mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the incidence of PRSS1 or PCDHB2 mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the incidence of PRSS1 or RIMS2 mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the incidence of PRSS1 or TENT5A mutations in cases of Lung Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the incidence of PGF or DNAH14 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the incidence of PGF or SYNJ1 mutations in cases of Stomach Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the incidence of ITPRID2 or AUTS2 mutations in cases of Breast Invasive Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the incidence of ITPRID2 or PSG2 mutations in cases of Breast Invasive Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the incidence of HBB or SYT9 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the incidence of PCDHB2 or TRAP1 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the incidence of PCDHB2 or FCGR2C mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the incidence of PCDHB2 or GUK1 mutations in cases of Colon Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the incidence of UBR2 or ANKRD24 mutations in cases of Uterine Corpus Endometrial Carcinoma in the genomic data commons?,top_cases_counts_by_genes
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the incidence of FBXO42 or CARMIL1 mutations in cases of Rectum Adenocarcinoma in the genomic data commons?,top_cases_counts_by_genes
+1,TNS1,G1362V,Breast Invasive Carcinoma,How frequently are TNS1 or ADRA1A mutations observed in Breast Invasive Carcinoma?,top_cases_counts_by_genes
+2,TNS1,G1711V,Breast Invasive Carcinoma,How frequently are TNS1 or FRY mutations observed in Breast Invasive Carcinoma?,top_cases_counts_by_genes
+3,TNS1,G1718V,Breast Invasive Carcinoma,How frequently are TNS1 or CTSC mutations observed in Breast Invasive Carcinoma?,top_cases_counts_by_genes
+4,TNS1,G1732V,Breast Invasive Carcinoma,How frequently are TNS1 or CDH23 mutations observed in Breast Invasive Carcinoma?,top_cases_counts_by_genes
+5,TNS1,G1824V,Breast Invasive Carcinoma,How frequently are TNS1 or ZFP42 mutations observed in Breast Invasive Carcinoma?,top_cases_counts_by_genes
+6,TNS1,G1857V,Breast Invasive Carcinoma,How frequently are TNS1 or MAST4 mutations observed in Breast Invasive Carcinoma?,top_cases_counts_by_genes
+7,TNS1,G843V,Breast Invasive Carcinoma,How frequently are TNS1 or AQP7 mutations observed in Breast Invasive Carcinoma?,top_cases_counts_by_genes
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How frequently are EVC2 or PIK3C2A mutations observed in Bladder Urothelial Carcinoma?,top_cases_counts_by_genes
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How frequently are EVC2 or FNDC7 mutations observed in Bladder Urothelial Carcinoma?,top_cases_counts_by_genes
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How frequently are CR1 or EIF2B4 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How frequently are CR1 or TET2 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+22,TRPA1,S295I,Rectum Adenocarcinoma,How frequently are TRPA1 or ANP32E mutations observed in Rectum Adenocarcinoma?,top_cases_counts_by_genes
+23,TRPA1,S443I,Rectum Adenocarcinoma,How frequently are TRPA1 or TRAP1 mutations observed in Rectum Adenocarcinoma?,top_cases_counts_by_genes
+24,TAF1C,R299L,Lung Adenocarcinoma,How frequently are TAF1C or ANKRD30A mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+25,TAF1C,R396L,Lung Adenocarcinoma,How frequently are TAF1C or GABRA6 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+26,TAF1C,R634L,Lung Adenocarcinoma,How frequently are TAF1C or NRAP mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+27,TAF1C,R702L,Lung Adenocarcinoma,How frequently are TAF1C or TTC12 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+28,TAF1C,R728L,Lung Adenocarcinoma,How frequently are TAF1C or TLK2 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How frequently are DPF3 or ITPRID2 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How frequently are DPF3 or JAML mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How frequently are DPF3 or PRSS1 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+42,OR2T4,P272H,Lung Adenocarcinoma,How frequently are OR2T4 or MAST4 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+43,OR2T4,P300H,Lung Adenocarcinoma,How frequently are OR2T4 or MAST4 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How frequently are FBN1 or CXCR2 mutations observed in Pancreatic Adenocarcinoma?,top_cases_counts_by_genes
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How frequently are MAD1L1 or CTCFL mutations observed in Prostate Adenocarcinoma?,top_cases_counts_by_genes
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How frequently are MAD1L1 or BCAT1 mutations observed in Prostate Adenocarcinoma?,top_cases_counts_by_genes
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How frequently are MAD1L1 or GSTCD mutations observed in Prostate Adenocarcinoma?,top_cases_counts_by_genes
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How frequently are CCNG1 or TET2 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How frequently are ANP32E or TTN mutations observed in Kidney Renal Papillary Cell Carcinoma?,top_cases_counts_by_genes
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How frequently are ANP32E or CTNNA2 mutations observed in Kidney Renal Papillary Cell Carcinoma?,top_cases_counts_by_genes
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How frequently are ANP32E or CTCFL mutations observed in Kidney Renal Papillary Cell Carcinoma?,top_cases_counts_by_genes
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How frequently are ANP32E or HTR3B mutations observed in Kidney Renal Papillary Cell Carcinoma?,top_cases_counts_by_genes
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How frequently are FRY or GRM1 mutations observed in Bladder Urothelial Carcinoma?,top_cases_counts_by_genes
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How frequently are FRY or CHODL mutations observed in Bladder Urothelial Carcinoma?,top_cases_counts_by_genes
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How frequently are FRY or TTN mutations observed in Bladder Urothelial Carcinoma?,top_cases_counts_by_genes
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How frequently are FRY or GABRA6 mutations observed in Bladder Urothelial Carcinoma?,top_cases_counts_by_genes
+70,PAK3,E318K,Skin Cutaneous Melanoma,How frequently are PAK3 or MYO16 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+71,PAK3,E319K,Skin Cutaneous Melanoma,How frequently are PAK3 or SPTAN1 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+72,PAK3,E334K,Skin Cutaneous Melanoma,How frequently are PAK3 or TET2 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+73,PAK3,E340K,Skin Cutaneous Melanoma,How frequently are PAK3 or ZNF274 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+74,PAK3,E355K,Skin Cutaneous Melanoma,How frequently are PAK3 or SPATA22 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How frequently are MUC16 or PDGFC mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How frequently are ZFPM2 or ANP32E mutations observed in Liver Hepatocellular Carcinoma?,top_cases_counts_by_genes
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How frequently are ZFPM2 or NPSR1 mutations observed in Liver Hepatocellular Carcinoma?,top_cases_counts_by_genes
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How frequently are PIK3C2B or COL6A3 mutations observed in Breast Invasive Carcinoma?,top_cases_counts_by_genes
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How frequently are PIK3C2B or OR2T4 mutations observed in Breast Invasive Carcinoma?,top_cases_counts_by_genes
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How frequently are ZNF804A or TTN mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+116,RELN,A2371V,Stomach Adenocarcinoma,How frequently are RELN or ICE1 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are EFCAB12 or TAS1R3 mutations observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",top_cases_counts_by_genes
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are EFCAB12 or PRSS1 mutations observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",top_cases_counts_by_genes
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How frequently are DEFB115 or PKHD1L1 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How frequently are ANKDD1A or ARHGEF40 mutations observed in Bladder Urothelial Carcinoma?,top_cases_counts_by_genes
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How frequently are ANKDD1A or DEFB115 mutations observed in Bladder Urothelial Carcinoma?,top_cases_counts_by_genes
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How frequently are ANKDD1A or NPSR1 mutations observed in Bladder Urothelial Carcinoma?,top_cases_counts_by_genes
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How frequently are HTR3B or CFAP61 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How frequently are HTR3B or PTPRO mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How frequently are HTR3B or AQP7 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+129,ABCC3,R758W,Stomach Adenocarcinoma,How frequently are ABCC3 or DCN mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How frequently are NOMO1 or UBR2 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How frequently are NOMO1 or POLR1G mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How frequently are HYOU1 or SPAG1 mutations observed in Bladder Urothelial Carcinoma?,top_cases_counts_by_genes
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How frequently are FMO4 or ERCC6 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+140,BICC1,A372V,Exceptional Responders,How frequently are BICC1 or EIF2B4 mutations observed in Exceptional Responders?,top_cases_counts_by_genes
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How frequently are ZMYM3 or SMO mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How frequently are ZMYM3 or B3GALNT1 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How frequently are ZMYM3 or AUTS2 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are XKR4 or CDKN2AIP mutations observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",top_cases_counts_by_genes
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How frequently are ABCC2 or TLK2 mutations observed in Liver Hepatocellular Carcinoma?,top_cases_counts_by_genes
+157,OR8K5,R293G,Lung Adenocarcinoma,How frequently are OR8K5 or RIMS2 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How frequently are SPTAN1 or GRTP1 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How frequently are SPTAN1 or ANP32E mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+164,SYT10,M484I,Rectum Adenocarcinoma,How frequently are SYT10 or GRTP1 mutations observed in Rectum Adenocarcinoma?,top_cases_counts_by_genes
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How frequently are HSPA5 or SGIP1 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+175,UNC5D,L280V,Lung Adenocarcinoma,How frequently are UNC5D or TTC17 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+176,UNC5D,L635V,Lung Adenocarcinoma,How frequently are UNC5D or FCGR2C mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+177,UNC5D,L637V,Lung Adenocarcinoma,How frequently are UNC5D or TNS1 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+178,UNC5D,L699V,Lung Adenocarcinoma,How frequently are UNC5D or PYHIN1 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+179,UNC5D,L704V,Lung Adenocarcinoma,How frequently are UNC5D or IL5RA mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+180,UNC5D,L709V,Lung Adenocarcinoma,How frequently are UNC5D or TASOR2 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How frequently are DOCK2 or UNC5D mutations observed in Kidney Renal Clear Cell Carcinoma?,top_cases_counts_by_genes
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How frequently are ZNF627 or KL mutations observed in Kidney Renal Clear Cell Carcinoma?,top_cases_counts_by_genes
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How frequently are CDC42BPA or ZNF627 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+193,MRPL55,H27Y,Colon Adenocarcinoma,How frequently are MRPL55 or AUTS2 mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+194,MRPL55,H63Y,Colon Adenocarcinoma,How frequently are MRPL55 or ADRA1A mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How frequently are TMTC3 or MIEF1 mutations observed in Breast Invasive Carcinoma?,top_cases_counts_by_genes
+198,EPRS1,K771I,Colon Adenocarcinoma,How frequently are EPRS1 or EVC2 mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+199,EPRS1,K778I,Colon Adenocarcinoma,How frequently are EPRS1 or PXN mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How frequently are GRTP1 or GUF1 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How frequently are GRTP1 or ZNF584 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How frequently are TSHZ3 or ZFP42 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How frequently are TAS1R3 or RIMS2 mutations observed in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,top_cases_counts_by_genes
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How frequently are PIAS3 or GSTCD mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How frequently are PIAS3 or MAST4 mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+251,ZNF274,P13R,Stomach Adenocarcinoma,How frequently are ZNF274 or MYO16 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+253,SYNJ1,R795C,Colon Adenocarcinoma,How frequently are SYNJ1 or COL6A3 mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+254,SYNJ1,R800C,Colon Adenocarcinoma,How frequently are SYNJ1 or FNDC7 mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+255,SYNJ1,R839C,Colon Adenocarcinoma,How frequently are SYNJ1 or GABRA6 mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+261,DSCAM,V343M,Prostate Adenocarcinoma,How frequently are DSCAM or ZNF431 mutations observed in Prostate Adenocarcinoma?,top_cases_counts_by_genes
+262,DSCAM,V426M,Prostate Adenocarcinoma,How frequently are DSCAM or ICE1 mutations observed in Prostate Adenocarcinoma?,top_cases_counts_by_genes
+263,DSCAM,V591M,Prostate Adenocarcinoma,How frequently are DSCAM or TAF1C mutations observed in Prostate Adenocarcinoma?,top_cases_counts_by_genes
+267,DGKD,R140H,Exceptional Responders,How frequently are DGKD or PKHD1L1 mutations observed in Exceptional Responders?,top_cases_counts_by_genes
+268,DGKD,R160H,Exceptional Responders,How frequently are DGKD or NRAP mutations observed in Exceptional Responders?,top_cases_counts_by_genes
+269,DGKD,R204H,Exceptional Responders,How frequently are DGKD or FGF8 mutations observed in Exceptional Responders?,top_cases_counts_by_genes
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How frequently are PLEKHG6 or KIF20B mutations observed in Bladder Urothelial Carcinoma?,top_cases_counts_by_genes
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How frequently are PLEKHG6 or TAS1R3 mutations observed in Bladder Urothelial Carcinoma?,top_cases_counts_by_genes
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How frequently are PLEKHG6 or TMEM255A mutations observed in Bladder Urothelial Carcinoma?,top_cases_counts_by_genes
+279,WNT2,D138N,Skin Cutaneous Melanoma,How frequently are WNT2 or ANP32E mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How frequently are GUCY2C or ZFP42 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How frequently are C7orf31 or MRPL32 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are ZKSCAN7 or ANKDD1A mutations observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",top_cases_counts_by_genes
+299,OR5D14,M210L,Neuroblastoma,How frequently are OR5D14 or ANP32E mutations observed in Neuroblastoma?,top_cases_counts_by_genes
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How frequently are SPATA22 or CTSC mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How frequently are SPATA22 or TTN mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How frequently are SPATA22 or OR5D14 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+310,LCN15,E21V,Stomach Adenocarcinoma,How frequently are LCN15 or MORF4L1 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How frequently are DCAF4L2 or CHMP7 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How frequently are GUK1 or AQP7 mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How frequently are GUK1 or DCC mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How frequently are GUK1 or CTNNA2 mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How frequently are GUK1 or MYT1 mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How frequently are GUK1 or ADRA1A mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How frequently are MORF4L1 or GABRA6 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How frequently are MORF4L1 or DNMT1 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How frequently are MORF4L1 or DSCAM mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How frequently are MORF4L1 or STAT3 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How frequently are MYO3B or COL6A3 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How frequently are MYO3B or PRSS8 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How frequently are TENT5A or SPATA22 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How frequently are TENT5A or ZBTB34 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How frequently are TENT5A or SGIP1 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How frequently are ZFAT or TENM2 mutations observed in Ovarian Serous Cystadenocarcinoma?,top_cases_counts_by_genes
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How frequently are ZFAT or CARMIL1 mutations observed in Ovarian Serous Cystadenocarcinoma?,top_cases_counts_by_genes
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How frequently are ZFAT or YY1AP1 mutations observed in Ovarian Serous Cystadenocarcinoma?,top_cases_counts_by_genes
+357,ZNF584,A211T,Sarcoma,How frequently are ZNF584 or DNMT1 mutations observed in Sarcoma?,top_cases_counts_by_genes
+358,ZNF584,A256T,Sarcoma,How frequently are ZNF584 or YY1AP1 mutations observed in Sarcoma?,top_cases_counts_by_genes
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How frequently are LDOC1 or CNGB1 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How frequently are PDGFC or SYT9 mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How frequently are MSANTD4 or PGR mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How frequently are NPSR1 or DNAH14 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How frequently are PHLPP1 or STK19 mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How frequently are COL6A3 or CHMP7 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How frequently are COL6A3 or PDGFC mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How frequently are COL6A3 or MYO3A mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How frequently are COL6A3 or FCGR2C mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How frequently are COL6A3 or PRSS1 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How frequently are ADRA1A or COL6A3 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently are LAMB2 or ZCCHC14 mutations observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,top_cases_counts_by_genes
+406,POC1B,I198T,Rectum Adenocarcinoma,How frequently are POC1B or ARHGEF40 mutations observed in Rectum Adenocarcinoma?,top_cases_counts_by_genes
+407,POC1B,I286T,Rectum Adenocarcinoma,How frequently are POC1B or PGR mutations observed in Rectum Adenocarcinoma?,top_cases_counts_by_genes
+408,POC1B,I328T,Rectum Adenocarcinoma,How frequently are POC1B or COL6A3 mutations observed in Rectum Adenocarcinoma?,top_cases_counts_by_genes
+409,POC1B,S79P,Rectum Adenocarcinoma,How frequently are POC1B or RIMS2 mutations observed in Rectum Adenocarcinoma?,top_cases_counts_by_genes
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How frequently are USH2A or ZMYM3 mutations observed in Liver Hepatocellular Carcinoma?,top_cases_counts_by_genes
+414,AQP7,T110S,Rectum Adenocarcinoma,How frequently are AQP7 or FRY mutations observed in Rectum Adenocarcinoma?,top_cases_counts_by_genes
+415,AQP7,T166S,Rectum Adenocarcinoma,How frequently are AQP7 or CNGB1 mutations observed in Rectum Adenocarcinoma?,top_cases_counts_by_genes
+416,AQP7,T167S,Rectum Adenocarcinoma,How frequently are AQP7 or CNGB1 mutations observed in Rectum Adenocarcinoma?,top_cases_counts_by_genes
+417,AQP7,T75S,Rectum Adenocarcinoma,How frequently are AQP7 or ZMYM3 mutations observed in Rectum Adenocarcinoma?,top_cases_counts_by_genes
+430,DCN,R163C,Rectum Adenocarcinoma,How frequently are DCN or PTPRO mutations observed in Rectum Adenocarcinoma?,top_cases_counts_by_genes
+431,DCN,R203C,Rectum Adenocarcinoma,How frequently are DCN or EIF2B4 mutations observed in Rectum Adenocarcinoma?,top_cases_counts_by_genes
+432,DCN,R241C,Rectum Adenocarcinoma,How frequently are DCN or PGF mutations observed in Rectum Adenocarcinoma?,top_cases_counts_by_genes
+433,DCN,R350C,Rectum Adenocarcinoma,How frequently are DCN or ANKDD1A mutations observed in Rectum Adenocarcinoma?,top_cases_counts_by_genes
+434,DCN,R41C,Rectum Adenocarcinoma,How frequently are DCN or TNS1 mutations observed in Rectum Adenocarcinoma?,top_cases_counts_by_genes
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How frequently are CPS1 or ZFAT mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How frequently are CPS1 or SPTAN1 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How frequently are CPS1 or TRIM45 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How frequently are FCGR2C or DPF3 mutations observed in Kidney Renal Papillary Cell Carcinoma?,top_cases_counts_by_genes
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How frequently are FCGR2C or AKT1 mutations observed in Kidney Renal Papillary Cell Carcinoma?,top_cases_counts_by_genes
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How frequently are GRM1 or SPAG1 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+482,SGCZ,Q138H,Lung Adenocarcinoma,How frequently are SGCZ or PLEKHG6 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+483,SGCZ,Q91H,Lung Adenocarcinoma,How frequently are SGCZ or SORCS1 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+485,SMO,V15M,Stomach Adenocarcinoma,How frequently are SMO or GABRA6 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+486,SMO,V321M,Stomach Adenocarcinoma,How frequently are SMO or CFAP61 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+488,CHODL,G159E,Skin Cutaneous Melanoma,How frequently are CHODL or FRY mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+489,CHODL,G181E,Skin Cutaneous Melanoma,How frequently are CHODL or TNS1 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+490,CHODL,G200E,Skin Cutaneous Melanoma,How frequently are CHODL or TTN mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+494,MYO16,P399H,Colon Adenocarcinoma,How frequently are MYO16 or COL6A3 mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+495,MYO16,P421H,Colon Adenocarcinoma,How frequently are MYO16 or ZFPM2 mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+498,CXCR2,A98V,Stomach Adenocarcinoma,How frequently are CXCR2 or MRPL55 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How frequently are TMEM225 or MORF4L1 mutations observed in Bladder Urothelial Carcinoma?,top_cases_counts_by_genes
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How frequently are MAOB or ACVR1B mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How frequently are GPRASP1 or BCAT1 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How frequently are MRPL32 or SOX21 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How frequently are TYROBP or GRM5 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+510,RAB40C,A111V,Lung Adenocarcinoma,How frequently are RAB40C or RELN mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+511,RAB40C,A143V,Lung Adenocarcinoma,How frequently are RAB40C or ACVR1B mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+512,CTNNA2,S323R,Lung Adenocarcinoma,How frequently are CTNNA2 or ACVR1B mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+513,CTNNA2,S339R,Lung Adenocarcinoma,How frequently are CTNNA2 or PTPRO mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+514,CTNNA2,S386R,Lung Adenocarcinoma,How frequently are CTNNA2 or TENT5A mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+515,CTNNA2,S707R,Lung Adenocarcinoma,How frequently are CTNNA2 or RIPOR2 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How frequently are MYO15A or PTPRO mutations observed in Bladder Urothelial Carcinoma?,top_cases_counts_by_genes
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How frequently are GIMAP2 or TNS1 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+532,KIF20B,N1160D,Glioblastoma Multiforme,How frequently are KIF20B or ANKDD1A mutations observed in Glioblastoma Multiforme?,top_cases_counts_by_genes
+533,KIF20B,N1200D,Glioblastoma Multiforme,How frequently are KIF20B or PLEKHG6 mutations observed in Glioblastoma Multiforme?,top_cases_counts_by_genes
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How frequently are ADAM17 or CTSC mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How frequently are BCAT1 or PXN mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How frequently are BCAT1 or POLD1 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How frequently are BCAT1 or STAT3 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+540,ERCC6,R1053H,Colon Adenocarcinoma,How frequently are ERCC6 or PTPRO mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+541,DCC,R320W,Breast Invasive Carcinoma,How frequently are DCC or PIK3C2B mutations observed in Breast Invasive Carcinoma?,top_cases_counts_by_genes
+542,DCC,R363W,Breast Invasive Carcinoma,How frequently are DCC or AQP7 mutations observed in Breast Invasive Carcinoma?,top_cases_counts_by_genes
+543,DCC,R386W,Breast Invasive Carcinoma,How frequently are DCC or IL5RA mutations observed in Breast Invasive Carcinoma?,top_cases_counts_by_genes
+544,DCC,R41W,Breast Invasive Carcinoma,How frequently are DCC or SPATA22 mutations observed in Breast Invasive Carcinoma?,top_cases_counts_by_genes
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How frequently are FBXO15 or CTSC mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How frequently are FBXO15 or WNT2 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How frequently are GSTCD or RIMS2 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How frequently are GSTCD or MORF4L1 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How frequently are OLFML3 or CTCFL mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How frequently are OLFML3 or GSTCD mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How frequently are OLFML3 or ANP32E mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How frequently are CFAP61 or FMO4 mutations observed in Ovarian Serous Cystadenocarcinoma?,top_cases_counts_by_genes
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How frequently are CFAP61 or GUK1 mutations observed in Ovarian Serous Cystadenocarcinoma?,top_cases_counts_by_genes
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How frequently are HLA-DQA2 or JAML mutations observed in Bladder Urothelial Carcinoma?,top_cases_counts_by_genes
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How frequently are TENM2 or UNC5D mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How frequently are TENM2 or MYO16 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How frequently are TENM2 or CEP20 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How frequently are ANKRD24 or CFAP61 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How frequently are ANKRD24 or TMEM255A mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How frequently are ANKRD24 or PTPRO mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How frequently are ZCCHC14 or UNC5D mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How frequently are ZCCHC14 or ACTB mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How frequently are ZCCHC14 or MYO3B mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How frequently are ZCCHC14 or AUTS2 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+625,SIK2,I265M,Lung Adenocarcinoma,How frequently are SIK2 or ZCCHC14 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How frequently are MYH11 or CTSC mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How frequently are MYH11 or ZCCHC14 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How frequently are SLC6A4 or SGIP1 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How frequently are SLC9C1 or YY1AP1 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How frequently are SLC9C1 or DPF3 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+644,OR2A12,A254T,Brain Lower Grade Glioma,How frequently are OR2A12 or KL mutations observed in Brain Lower Grade Glioma?,top_cases_counts_by_genes
+646,PYHIN1,T325K,Lung Adenocarcinoma,How frequently are PYHIN1 or CXCR2 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+647,PYHIN1,T334K,Lung Adenocarcinoma,How frequently are PYHIN1 or ZKSCAN7 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+650,JAML,G191E,Skin Cutaneous Melanoma,How frequently are JAML or CACNA1F mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+651,JAML,G219E,Skin Cutaneous Melanoma,How frequently are JAML or KDM5C mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+652,JAML,G220E,Skin Cutaneous Melanoma,How frequently are JAML or TAF1L mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+653,JAML,G230E,Skin Cutaneous Melanoma,How frequently are JAML or PXN mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+658,TYK2,H1146R,Stomach Adenocarcinoma,How frequently are TYK2 or AQP7 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+659,TYK2,H23R,Stomach Adenocarcinoma,How frequently are TYK2 or MED16 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+660,TYK2,H961R,Stomach Adenocarcinoma,How frequently are TYK2 or CPS1 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How frequently are CTCFL or ZNF217 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How frequently are CTCFL or KRT39 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How frequently are CTCFL or MIEF1 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How frequently are CTCFL or SGIP1 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How frequently are CEP20 or TMEM225 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How frequently are CEP20 or SPTAN1 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How frequently are RIMS2 or DNMT1 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How frequently are RIMS2 or SGIP1 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How frequently are RIMS2 or ICE1 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How frequently are RIMS2 or RIMS2 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How frequently are RIMS2 or CNGB1 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How frequently are RIMS2 or SPATA22 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How frequently are RIMS2 or OR13C3 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How frequently are PIK3C2G or GPR158 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How frequently are PIK3C2G or SORCS1 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+728,STK19,D341N,Colon Adenocarcinoma,How frequently are STK19 or ANKDD1A mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+729,STK19,D345N,Colon Adenocarcinoma,How frequently are STK19 or ANKRD30A mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+730,REXO4,P60A,Skin Cutaneous Melanoma,How frequently are REXO4 or TYK2 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How frequently are ZBTB34 or MRPL55 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How frequently are ZBTB34 or TNS1 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How frequently are NCKAP5 or EIF2B4 mutations observed in Bladder Urothelial Carcinoma?,top_cases_counts_by_genes
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are SORCS1 or MYO3B mutations observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",top_cases_counts_by_genes
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are SORCS1 or GIMAP2 mutations observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",top_cases_counts_by_genes
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are SORCS1 or EIF2B4 mutations observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",top_cases_counts_by_genes
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are SORCS1 or ZCCHC14 mutations observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",top_cases_counts_by_genes
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How frequently are FGF8 or CDKN2AIP mutations observed in Head and Neck Squamous Cell Carcinoma?,top_cases_counts_by_genes
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How frequently are FGF8 or CHMP7 mutations observed in Head and Neck Squamous Cell Carcinoma?,top_cases_counts_by_genes
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How frequently are FGF8 or YY1AP1 mutations observed in Head and Neck Squamous Cell Carcinoma?,top_cases_counts_by_genes
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How frequently are FGF8 or DCN mutations observed in Head and Neck Squamous Cell Carcinoma?,top_cases_counts_by_genes
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How frequently are FGF8 or OR13C3 mutations observed in Head and Neck Squamous Cell Carcinoma?,top_cases_counts_by_genes
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How frequently are TENM3 or TRIM45 mutations observed in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,top_cases_counts_by_genes
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How frequently are AKT1 or ANKRD30A mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently are CFAP298-TCP10L or CHMP7 mutations observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,top_cases_counts_by_genes
+792,GLRB,E148D,Stomach Adenocarcinoma,How frequently are GLRB or SORCS1 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+793,TTN,F7636L,Colon Adenocarcinoma,How frequently are TTN or GPR158 mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+794,TTN,F8563L,Colon Adenocarcinoma,How frequently are TTN or YY1AP1 mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+795,TTN,F8880L,Colon Adenocarcinoma,How frequently are TTN or CACNA1F mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How frequently are ANKRD30A or SLC24A2 mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How frequently are ANKRD30A or DCC mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How frequently are ANKRD30A or GABRA6 mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+809,TRIM45,S177L,Colon Adenocarcinoma,How frequently are TRIM45 or TENM2 mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+810,TRIM45,S224L,Colon Adenocarcinoma,How frequently are TRIM45 or PLEKHG6 mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+811,TRIM45,S281L,Colon Adenocarcinoma,How frequently are TRIM45 or PIK3C2A mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How frequently are CACNA1F or ANKRD30A mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How frequently are CACNA1F or CCNG1 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How frequently are CACNA1F or NRAP mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+817,KL,R594C,Colon Adenocarcinoma,How frequently are KL or TRIM45 mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How frequently are GUF1 or PTPRO mutations observed in Kidney Renal Papillary Cell Carcinoma?,top_cases_counts_by_genes
+822,TAF1L,A539V,Colon Adenocarcinoma,How frequently are TAF1L or SMO mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How frequently are TASOR2 or RIPOR2 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How frequently are TASOR2 or FCGR2C mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How frequently are TASOR2 or FBXO15 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How frequently are KDM5C or ANP32E mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How frequently are KDM5C or SORCS1 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How frequently are KDM5C or TRIM45 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How frequently are KDM5C or TTN mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently are IL5RA or FNDC7 mutations observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,top_cases_counts_by_genes
+843,DHX16,A29V,Skin Cutaneous Melanoma,How frequently are DHX16 or ADRA1A mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+844,DHX16,A89V,Skin Cutaneous Melanoma,How frequently are DHX16 or RIMS2 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+902,GPR158,A644V,Stomach Adenocarcinoma,How frequently are GPR158 or ZCCHC14 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+903,GPR158,A723V,Stomach Adenocarcinoma,How frequently are GPR158 or MERTK mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are EIF2B4 or ARMC3 mutations observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",top_cases_counts_by_genes
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are EIF2B4 or PIK3C2G mutations observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",top_cases_counts_by_genes
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are EIF2B4 or FBXO42 mutations observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",top_cases_counts_by_genes
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are EIF2B4 or MYO16 mutations observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",top_cases_counts_by_genes
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are EIF2B4 or AUTS2 mutations observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",top_cases_counts_by_genes
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are EIF2B4 or PRSS1 mutations observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",top_cases_counts_by_genes
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How frequently are AUTS2 or PIK3C2G mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How frequently are AUTS2 or AQP7 mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How frequently are AUTS2 or CTNNA2 mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How frequently are AUTS2 or ACTA2 mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How frequently are AUTS2 or DSCAM mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How frequently are AUTS2 or UNC5D mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How frequently are AUTS2 or FRY mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How frequently are AUTS2 or VASN mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How frequently are AUTS2 or GPR158 mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How frequently are AUTS2 or COL6A3 mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are ACTL7B or RIMS2 mutations observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",top_cases_counts_by_genes
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How frequently are PCDHGA1 or TMTC3 mutations observed in Glioblastoma Multiforme?,top_cases_counts_by_genes
+954,TRAP1,R114W,Stomach Adenocarcinoma,How frequently are TRAP1 or BICC1 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+955,TRAP1,R61W,Stomach Adenocarcinoma,How frequently are TRAP1 or ZNF627 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How frequently are PIK3C2A or ACTB mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How frequently are KANSL1 or GPR158 mutations observed in Liver Hepatocellular Carcinoma?,top_cases_counts_by_genes
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How frequently are ANKRD52 or PRSS8 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How frequently are PAPPA or CHODL mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How frequently are B3GALNT1 or DPF3 mutations observed in Rectum Adenocarcinoma?,top_cases_counts_by_genes
+982,GABRA6,G115R,Lung Adenocarcinoma,How frequently are GABRA6 or DNAH14 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+983,GABRA6,G122R,Lung Adenocarcinoma,How frequently are GABRA6 or SORCS1 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+984,GABRA6,G165R,Lung Adenocarcinoma,How frequently are GABRA6 or SPINDOC mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+985,GABRA6,G175R,Lung Adenocarcinoma,How frequently are GABRA6 or RAB40C mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+986,GABRA6,G70R,Lung Adenocarcinoma,How frequently are GABRA6 or ZFAT mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How frequently are ZSCAN31 or SMO mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are MED16 or ACVR1B mutations observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",top_cases_counts_by_genes
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are MED16 or EIF2B4 mutations observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",top_cases_counts_by_genes
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How frequently are PTPRO or PCDHB2 mutations observed in Pancreatic Adenocarcinoma?,top_cases_counts_by_genes
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How frequently are PTPRO or BCAT1 mutations observed in Pancreatic Adenocarcinoma?,top_cases_counts_by_genes
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How frequently are PTPRO or STK19 mutations observed in Pancreatic Adenocarcinoma?,top_cases_counts_by_genes
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How frequently are PTPRO or HTR3B mutations observed in Pancreatic Adenocarcinoma?,top_cases_counts_by_genes
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How frequently are PTPRO or ZNF708 mutations observed in Pancreatic Adenocarcinoma?,top_cases_counts_by_genes
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How frequently are PTPRO or MYH11 mutations observed in Pancreatic Adenocarcinoma?,top_cases_counts_by_genes
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How frequently are PTPRO or DGKD mutations observed in Pancreatic Adenocarcinoma?,top_cases_counts_by_genes
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How frequently are PTPRO or ERCC6 mutations observed in Pancreatic Adenocarcinoma?,top_cases_counts_by_genes
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How frequently are CHMP7 or CHODL mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1017,GPC3,I107N,Stomach Adenocarcinoma,How frequently are GPC3 or CTSC mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+1018,GPC3,I161N,Stomach Adenocarcinoma,How frequently are GPC3 or PKHD1L1 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently are TLK2 or CX3CR1 mutations observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,top_cases_counts_by_genes
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently are TLK2 or NEXN mutations observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,top_cases_counts_by_genes
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently are TLK2 or MYT1 mutations observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,top_cases_counts_by_genes
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently are TLK2 or ADRA1A mutations observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,top_cases_counts_by_genes
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently are TLK2 or GPC3 mutations observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,top_cases_counts_by_genes
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How frequently are ZNF217 or SGIP1 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+1038,SYT9,V275L,Lung Adenocarcinoma,How frequently are SYT9 or RIMS2 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+1039,SYT9,V307L,Lung Adenocarcinoma,How frequently are SYT9 or OLFML3 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How frequently are PKHD1L1 or ACTB mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How frequently are MYO3A or HTR3B mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are VASN or PIK3C2B mutations observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",top_cases_counts_by_genes
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How frequently are DNMT1 or ACTB mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How frequently are DNMT1 or SPINDOC mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How frequently are DNMT1 or DHX16 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1056,CA9,E402K,Colon Adenocarcinoma,How frequently are CA9 or OLFML3 mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How frequently are TTC17 or DGKD mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How frequently are TTC17 or EIF2B4 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1065,PSG2,P43L,Breast Invasive Carcinoma,How frequently are PSG2 or POC1B mutations observed in Breast Invasive Carcinoma?,top_cases_counts_by_genes
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How frequently are RIPOR2 or COL6A3 mutations observed in Breast Invasive Carcinoma?,top_cases_counts_by_genes
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How frequently are RIPOR2 or CDKN2AIP mutations observed in Breast Invasive Carcinoma?,top_cases_counts_by_genes
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How frequently are RIPOR2 or UBR2 mutations observed in Breast Invasive Carcinoma?,top_cases_counts_by_genes
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How frequently are RIPOR2 or PGF mutations observed in Breast Invasive Carcinoma?,top_cases_counts_by_genes
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How frequently are DCLK3 or DNAH14 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How frequently are DCLK3 or COL6A3 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How frequently are MERTK or TRAP1 mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How frequently are MERTK or MAD1L1 mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How frequently are MERTK or GUF1 mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How frequently are ZFP42 or POLD1 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How frequently are OR13C3 or MYT1 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How frequently are OR13C3 or PIAS3 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How frequently are SPAG1 or SYT9 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How frequently are CDKN2AIP or TLK2 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1093,PXN,H1016Y,Colon Adenocarcinoma,How frequently are PXN or CX3CR1 mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+1094,PXN,H359Y,Colon Adenocarcinoma,How frequently are PXN or CACNA1F mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+1095,PXN,H492Y,Colon Adenocarcinoma,How frequently are PXN or ADRA1A mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+1096,PXN,H524Y,Colon Adenocarcinoma,How frequently are PXN or TNS1 mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+1097,PXN,H526Y,Colon Adenocarcinoma,How frequently are PXN or TRAP1 mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+1098,PXN,H540Y,Colon Adenocarcinoma,How frequently are PXN or COL6A3 mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How frequently are TTYH2 or SMO mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How frequently are TTYH2 or CTSC mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How frequently are TMEM255A or OR5D14 mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How frequently are TMEM255A or CACNA1F mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How frequently are TMEM255A or SYNJ1 mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How frequently are TASOR2 or TASOR2 mutations observed in Breast Invasive Carcinoma?,top_cases_counts_by_genes
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How frequently are TASOR2 or PAK3 mutations observed in Breast Invasive Carcinoma?,top_cases_counts_by_genes
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How frequently are ICE1 or YY1AP1 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1112,MYT1,A558E,Breast Invasive Carcinoma,How frequently are MYT1 or ZNF584 mutations observed in Breast Invasive Carcinoma?,top_cases_counts_by_genes
+1113,MYT1,A879E,Breast Invasive Carcinoma,How frequently are MYT1 or KIF20B mutations observed in Breast Invasive Carcinoma?,top_cases_counts_by_genes
+1114,MYT1,A906E,Breast Invasive Carcinoma,How frequently are MYT1 or TNS1 mutations observed in Breast Invasive Carcinoma?,top_cases_counts_by_genes
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How frequently are CX3CR1 or RIMS2 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How frequently are CX3CR1 or DCC mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How frequently are SPINDOC or PLEKHG6 mutations observed in Liver Hepatocellular Carcinoma?,top_cases_counts_by_genes
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How frequently are ART3 or ANP32E mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How frequently are ART3 or CTNNA2 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How frequently are CYP1A2 or DCC mutations observed in Bladder Urothelial Carcinoma?,top_cases_counts_by_genes
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are ADRA1A or HSPA5 mutations observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",top_cases_counts_by_genes
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How frequently are CDH23 or KIF20B mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How frequently are CDH23 or TENT5A mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How frequently are KRT39 or RIPOR2 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How frequently are PDHA2 or CTSC mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How frequently are SLC24A2 or ACVR1B mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How frequently are PTPRN2 or EIF2B4 mutations observed in Liver Hepatocellular Carcinoma?,top_cases_counts_by_genes
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How frequently are PTPRN2 or DHX16 mutations observed in Liver Hepatocellular Carcinoma?,top_cases_counts_by_genes
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How frequently are PTPRN2 or MAOB mutations observed in Liver Hepatocellular Carcinoma?,top_cases_counts_by_genes
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How frequently are PTPRN2 or PGR mutations observed in Liver Hepatocellular Carcinoma?,top_cases_counts_by_genes
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How frequently are PTPRN2 or SGIP1 mutations observed in Liver Hepatocellular Carcinoma?,top_cases_counts_by_genes
+1188,SOX21,R55L,Lung Adenocarcinoma,How frequently are SOX21 or COL6A3 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How frequently are CPA6 or ZCCHC14 mutations observed in Bladder Urothelial Carcinoma?,top_cases_counts_by_genes
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How frequently are GRM5 or ZNF217 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are CASZ1 or DSCAM mutations observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",top_cases_counts_by_genes
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How frequently are SGIP1 or PTPRN2 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How frequently are SGIP1 or VASN mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How frequently are SGIP1 or KIF20B mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How frequently are SGIP1 or C7orf31 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How frequently are CARMIL1 or UBR2 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How frequently are CARMIL1 or PGF mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How frequently are ZNF431 or OR13C3 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How frequently are ZNF431 or MAST4 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+1234,ZNF431,R128I,Lung Adenocarcinoma,How frequently are ZNF431 or STAT3 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How frequently are DNAH11 or FGF8 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How frequently are DNAH11 or TMEM255A mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How frequently are POLD1 or GUK1 mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How frequently are POLD1 or GABRA6 mutations observed in Lung Squamous Cell Carcinoma?,top_cases_counts_by_genes
+1248,TTC12,D646H,Lung Adenocarcinoma,How frequently are TTC12 or ITPRID2 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+1249,TTC12,D652H,Lung Adenocarcinoma,How frequently are TTC12 or MED16 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How frequently are CNGB1 or ZFAT mutations observed in Bladder Urothelial Carcinoma?,top_cases_counts_by_genes
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How frequently are CNGB1 or PXN mutations observed in Bladder Urothelial Carcinoma?,top_cases_counts_by_genes
+1254,CTSC,E214V,Stomach Adenocarcinoma,How frequently are CTSC or TTYH2 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+1255,CTSC,E291V,Stomach Adenocarcinoma,How frequently are CTSC or JAML mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+1256,CTSC,E322V,Stomach Adenocarcinoma,How frequently are CTSC or CYP1A2 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+1257,CTSC,E324V,Stomach Adenocarcinoma,How frequently are CTSC or AUTS2 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+1258,CTSC,E335V,Stomach Adenocarcinoma,How frequently are CTSC or XKR4 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How frequently are PRSS8 or YY1AP1 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How frequently are PRSS8 or BCAT1 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How frequently are ARHGEF40 or MUC16 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+1264,ACTB,A138T,Rectum Adenocarcinoma,How frequently are ACTB or AKT1 mutations observed in Rectum Adenocarcinoma?,top_cases_counts_by_genes
+1265,ACTB,A217T,Rectum Adenocarcinoma,How frequently are ACTB or PTPRO mutations observed in Rectum Adenocarcinoma?,top_cases_counts_by_genes
+1266,ACTB,A244T,Rectum Adenocarcinoma,How frequently are ACTB or MYO3B mutations observed in Rectum Adenocarcinoma?,top_cases_counts_by_genes
+1267,ACTB,A260T,Rectum Adenocarcinoma,How frequently are ACTB or SPAG1 mutations observed in Rectum Adenocarcinoma?,top_cases_counts_by_genes
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How frequently are YY1AP1 or PCDHB2 mutations observed in Glioblastoma Multiforme?,top_cases_counts_by_genes
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How frequently are YY1AP1 or UNC5D mutations observed in Glioblastoma Multiforme?,top_cases_counts_by_genes
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How frequently are YY1AP1 or ZNF584 mutations observed in Glioblastoma Multiforme?,top_cases_counts_by_genes
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How frequently are YY1AP1 or RIPOR2 mutations observed in Glioblastoma Multiforme?,top_cases_counts_by_genes
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How frequently are YY1AP1 or STK19 mutations observed in Glioblastoma Multiforme?,top_cases_counts_by_genes
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How frequently are YY1AP1 or GABRA6 mutations observed in Glioblastoma Multiforme?,top_cases_counts_by_genes
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How frequently are YY1AP1 or TRPA1 mutations observed in Glioblastoma Multiforme?,top_cases_counts_by_genes
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How frequently are FNDC7 or CEP20 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How frequently are FNDC7 or ACVR1B mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+1299,TLCD5,G15V,Lung Adenocarcinoma,How frequently are TLCD5 or ABCC2 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+1300,TLCD5,G37V,Lung Adenocarcinoma,How frequently are TLCD5 or MYO16 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How frequently are POLR1G or GLRB mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How frequently are POLR1G or SYNJ1 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How frequently are DNAH14 or TET2 mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How frequently are DNAH14 or B3GALNT1 mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How frequently are DNAH14 or GRM1 mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How frequently are NEXN or ZCCHC14 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How frequently are CYB5R2 or PLEKHG6 mutations observed in Prostate Adenocarcinoma?,top_cases_counts_by_genes
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How frequently are CYB5R2 or CFAP298-TCP10L mutations observed in Prostate Adenocarcinoma?,top_cases_counts_by_genes
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How frequently are NRAP or PAPPA mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How frequently are NRAP or NRAP mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How frequently are NRAP or ZNF431 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How frequently are CCDC22 or PIK3C2G mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How frequently are DCAF6 or ANKRD30A mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How frequently are DCAF6 or ZMYM3 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How frequently are ZNF708 or ITPRID2 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How frequently are BFAR or TTN mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How frequently are MAST4 or ERCC6 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How frequently are MAST4 or DCAF6 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How frequently are MAST4 or ZFPM2 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How frequently are MAST4 or GRTP1 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How frequently are MAST4 or TTN mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How frequently are ARMC3 or AUTS2 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How frequently are ARMC3 or NPSR1 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How frequently are TET2 or HSPA5 mutations observed in Kidney Renal Clear Cell Carcinoma?,top_cases_counts_by_genes
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How frequently are TET2 or FNDC7 mutations observed in Kidney Renal Clear Cell Carcinoma?,top_cases_counts_by_genes
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How frequently are SERPINB10 or CFAP61 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How frequently are STAT3 or CXCR2 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How frequently are MIEF1 or SPTAN1 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How frequently are ACVR1B or ACTB mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How frequently are ACVR1B or CTNNA2 mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How frequently are ACVR1B or ADRA1A mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+1393,EBF2,T104I,Stomach Adenocarcinoma,How frequently are EBF2 or GPR158 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+1394,EBF2,T252I,Stomach Adenocarcinoma,How frequently are EBF2 or NRAP mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How frequently are VPS26B or DNMT1 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are PGR or PTPRO mutations observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",top_cases_counts_by_genes
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are PGR or UBR2 mutations observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",top_cases_counts_by_genes
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are PGR or PHLPP1 mutations observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",top_cases_counts_by_genes
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How frequently are ACTA2 or TRIM45 mutations observed in Skin Cutaneous Melanoma?,top_cases_counts_by_genes
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How frequently are THBS4 or POC1B mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How frequently are THBS4 or DNAH11 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1413,PRSS1,S114T,Lung Adenocarcinoma,How frequently are PRSS1 or GUK1 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+1414,PRSS1,S124T,Lung Adenocarcinoma,How frequently are PRSS1 or TENM2 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+1415,PRSS1,S138T,Lung Adenocarcinoma,How frequently are PRSS1 or JAML mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+1416,PRSS1,S74T,Lung Adenocarcinoma,How frequently are PRSS1 or CR1 mutations observed in Lung Adenocarcinoma?,top_cases_counts_by_genes
+1417,PGF,R126H,Stomach Adenocarcinoma,How frequently are PGF or KIF20B mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+1418,PGF,R127H,Stomach Adenocarcinoma,How frequently are PGF or DEFB115 mutations observed in Stomach Adenocarcinoma?,top_cases_counts_by_genes
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How frequently are ITPRID2 or SGIP1 mutations observed in Breast Invasive Carcinoma?,top_cases_counts_by_genes
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How frequently are ITPRID2 or DCN mutations observed in Breast Invasive Carcinoma?,top_cases_counts_by_genes
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How frequently are HBB or PGF mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How frequently are PCDHB2 or THBS4 mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How frequently are PCDHB2 or CACNA1F mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How frequently are PCDHB2 or MORF4L1 mutations observed in Colon Adenocarcinoma?,top_cases_counts_by_genes
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How frequently are UBR2 or SYNJ1 mutations observed in Uterine Corpus Endometrial Carcinoma?,top_cases_counts_by_genes
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How frequently are FBXO42 or AQP7 mutations observed in Rectum Adenocarcinoma?,top_cases_counts_by_genes
+1,TNS1,G1362V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases exhibit mutations in TNS1 genes?,top_cases_counts_by_genes
+2,TNS1,G1711V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases exhibit mutations in TNS1 genes?,top_cases_counts_by_genes
+3,TNS1,G1718V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases exhibit mutations in TNS1 genes?,top_cases_counts_by_genes
+4,TNS1,G1732V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases exhibit mutations in TNS1 genes?,top_cases_counts_by_genes
+5,TNS1,G1824V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases exhibit mutations in TNS1 genes?,top_cases_counts_by_genes
+6,TNS1,G1857V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases exhibit mutations in TNS1 genes?,top_cases_counts_by_genes
+7,TNS1,G843V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases exhibit mutations in TNS1 genes?,top_cases_counts_by_genes
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases exhibit mutations in EVC2 genes?,top_cases_counts_by_genes
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases exhibit mutations in EVC2 genes?,top_cases_counts_by_genes
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in CR1 genes?,top_cases_counts_by_genes
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in CR1 genes?,top_cases_counts_by_genes
+22,TRPA1,S295I,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases exhibit mutations in TRPA1 genes?,top_cases_counts_by_genes
+23,TRPA1,S443I,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases exhibit mutations in TRPA1 genes?,top_cases_counts_by_genes
+24,TAF1C,R299L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in TAF1C genes?,top_cases_counts_by_genes
+25,TAF1C,R396L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in TAF1C genes?,top_cases_counts_by_genes
+26,TAF1C,R634L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in TAF1C genes?,top_cases_counts_by_genes
+27,TAF1C,R702L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in TAF1C genes?,top_cases_counts_by_genes
+28,TAF1C,R728L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in TAF1C genes?,top_cases_counts_by_genes
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in DPF3 genes?,top_cases_counts_by_genes
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in DPF3 genes?,top_cases_counts_by_genes
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in DPF3 genes?,top_cases_counts_by_genes
+42,OR2T4,P272H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in OR2T4 genes?,top_cases_counts_by_genes
+43,OR2T4,P300H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in OR2T4 genes?,top_cases_counts_by_genes
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases exhibit mutations in FBN1 genes?,top_cases_counts_by_genes
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases exhibit mutations in MAD1L1 genes?,top_cases_counts_by_genes
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases exhibit mutations in MAD1L1 genes?,top_cases_counts_by_genes
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases exhibit mutations in MAD1L1 genes?,top_cases_counts_by_genes
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in CCNG1 genes?,top_cases_counts_by_genes
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases exhibit mutations in ANP32E genes?,top_cases_counts_by_genes
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases exhibit mutations in ANP32E genes?,top_cases_counts_by_genes
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases exhibit mutations in ANP32E genes?,top_cases_counts_by_genes
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases exhibit mutations in ANP32E genes?,top_cases_counts_by_genes
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases exhibit mutations in FRY genes?,top_cases_counts_by_genes
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases exhibit mutations in FRY genes?,top_cases_counts_by_genes
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases exhibit mutations in FRY genes?,top_cases_counts_by_genes
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases exhibit mutations in FRY genes?,top_cases_counts_by_genes
+70,PAK3,E318K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in PAK3 genes?,top_cases_counts_by_genes
+71,PAK3,E319K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in PAK3 genes?,top_cases_counts_by_genes
+72,PAK3,E334K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in PAK3 genes?,top_cases_counts_by_genes
+73,PAK3,E340K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in PAK3 genes?,top_cases_counts_by_genes
+74,PAK3,E355K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in PAK3 genes?,top_cases_counts_by_genes
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in MUC16 genes?,top_cases_counts_by_genes
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases exhibit mutations in ZFPM2 genes?,top_cases_counts_by_genes
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases exhibit mutations in ZFPM2 genes?,top_cases_counts_by_genes
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases exhibit mutations in PIK3C2B genes?,top_cases_counts_by_genes
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases exhibit mutations in PIK3C2B genes?,top_cases_counts_by_genes
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in ZNF804A genes?,top_cases_counts_by_genes
+116,RELN,A2371V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in RELN genes?,top_cases_counts_by_genes
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit mutations in EFCAB12 genes?",top_cases_counts_by_genes
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit mutations in EFCAB12 genes?",top_cases_counts_by_genes
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in DEFB115 genes?,top_cases_counts_by_genes
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases exhibit mutations in ANKDD1A genes?,top_cases_counts_by_genes
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases exhibit mutations in ANKDD1A genes?,top_cases_counts_by_genes
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases exhibit mutations in ANKDD1A genes?,top_cases_counts_by_genes
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in HTR3B genes?,top_cases_counts_by_genes
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in HTR3B genes?,top_cases_counts_by_genes
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in HTR3B genes?,top_cases_counts_by_genes
+129,ABCC3,R758W,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in ABCC3 genes?,top_cases_counts_by_genes
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in NOMO1 genes?,top_cases_counts_by_genes
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in NOMO1 genes?,top_cases_counts_by_genes
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases exhibit mutations in HYOU1 genes?,top_cases_counts_by_genes
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in FMO4 genes?,top_cases_counts_by_genes
+140,BICC1,A372V,Exceptional Responders,What percentage of Exceptional Responders cases exhibit mutations in BICC1 genes?,top_cases_counts_by_genes
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in ZMYM3 genes?,top_cases_counts_by_genes
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in ZMYM3 genes?,top_cases_counts_by_genes
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in ZMYM3 genes?,top_cases_counts_by_genes
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit mutations in XKR4 genes?",top_cases_counts_by_genes
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases exhibit mutations in ABCC2 genes?,top_cases_counts_by_genes
+157,OR8K5,R293G,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in OR8K5 genes?,top_cases_counts_by_genes
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in SPTAN1 genes?,top_cases_counts_by_genes
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in SPTAN1 genes?,top_cases_counts_by_genes
+164,SYT10,M484I,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases exhibit mutations in SYT10 genes?,top_cases_counts_by_genes
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in HSPA5 genes?,top_cases_counts_by_genes
+175,UNC5D,L280V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in UNC5D genes?,top_cases_counts_by_genes
+176,UNC5D,L635V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in UNC5D genes?,top_cases_counts_by_genes
+177,UNC5D,L637V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in UNC5D genes?,top_cases_counts_by_genes
+178,UNC5D,L699V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in UNC5D genes?,top_cases_counts_by_genes
+179,UNC5D,L704V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in UNC5D genes?,top_cases_counts_by_genes
+180,UNC5D,L709V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in UNC5D genes?,top_cases_counts_by_genes
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma cases exhibit mutations in DOCK2 genes?,top_cases_counts_by_genes
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma cases exhibit mutations in ZNF627 genes?,top_cases_counts_by_genes
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in CDC42BPA genes?,top_cases_counts_by_genes
+193,MRPL55,H27Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in MRPL55 genes?,top_cases_counts_by_genes
+194,MRPL55,H63Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in MRPL55 genes?,top_cases_counts_by_genes
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases exhibit mutations in TMTC3 genes?,top_cases_counts_by_genes
+198,EPRS1,K771I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in EPRS1 genes?,top_cases_counts_by_genes
+199,EPRS1,K778I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in EPRS1 genes?,top_cases_counts_by_genes
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in GRTP1 genes?,top_cases_counts_by_genes
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in GRTP1 genes?,top_cases_counts_by_genes
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in TSHZ3 genes?,top_cases_counts_by_genes
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What percentage of HIV+ Tumor Molecular Characterization Project - Cervical Cancer cases exhibit mutations in TAS1R3 genes?,top_cases_counts_by_genes
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in PIAS3 genes?,top_cases_counts_by_genes
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in PIAS3 genes?,top_cases_counts_by_genes
+251,ZNF274,P13R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in ZNF274 genes?,top_cases_counts_by_genes
+253,SYNJ1,R795C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in SYNJ1 genes?,top_cases_counts_by_genes
+254,SYNJ1,R800C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in SYNJ1 genes?,top_cases_counts_by_genes
+255,SYNJ1,R839C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in SYNJ1 genes?,top_cases_counts_by_genes
+261,DSCAM,V343M,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases exhibit mutations in DSCAM genes?,top_cases_counts_by_genes
+262,DSCAM,V426M,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases exhibit mutations in DSCAM genes?,top_cases_counts_by_genes
+263,DSCAM,V591M,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases exhibit mutations in DSCAM genes?,top_cases_counts_by_genes
+267,DGKD,R140H,Exceptional Responders,What percentage of Exceptional Responders cases exhibit mutations in DGKD genes?,top_cases_counts_by_genes
+268,DGKD,R160H,Exceptional Responders,What percentage of Exceptional Responders cases exhibit mutations in DGKD genes?,top_cases_counts_by_genes
+269,DGKD,R204H,Exceptional Responders,What percentage of Exceptional Responders cases exhibit mutations in DGKD genes?,top_cases_counts_by_genes
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases exhibit mutations in PLEKHG6 genes?,top_cases_counts_by_genes
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases exhibit mutations in PLEKHG6 genes?,top_cases_counts_by_genes
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases exhibit mutations in PLEKHG6 genes?,top_cases_counts_by_genes
+279,WNT2,D138N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in WNT2 genes?,top_cases_counts_by_genes
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in GUCY2C genes?,top_cases_counts_by_genes
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in C7orf31 genes?,top_cases_counts_by_genes
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit mutations in ZKSCAN7 genes?",top_cases_counts_by_genes
+299,OR5D14,M210L,Neuroblastoma,What percentage of Neuroblastoma cases exhibit mutations in OR5D14 genes?,top_cases_counts_by_genes
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in SPATA22 genes?,top_cases_counts_by_genes
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in SPATA22 genes?,top_cases_counts_by_genes
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in SPATA22 genes?,top_cases_counts_by_genes
+310,LCN15,E21V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in LCN15 genes?,top_cases_counts_by_genes
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in DCAF4L2 genes?,top_cases_counts_by_genes
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in GUK1 genes?,top_cases_counts_by_genes
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in GUK1 genes?,top_cases_counts_by_genes
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in GUK1 genes?,top_cases_counts_by_genes
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in GUK1 genes?,top_cases_counts_by_genes
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in GUK1 genes?,top_cases_counts_by_genes
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in MORF4L1 genes?,top_cases_counts_by_genes
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in MORF4L1 genes?,top_cases_counts_by_genes
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in MORF4L1 genes?,top_cases_counts_by_genes
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in MORF4L1 genes?,top_cases_counts_by_genes
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in MYO3B genes?,top_cases_counts_by_genes
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in MYO3B genes?,top_cases_counts_by_genes
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in TENT5A genes?,top_cases_counts_by_genes
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in TENT5A genes?,top_cases_counts_by_genes
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in TENT5A genes?,top_cases_counts_by_genes
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma cases exhibit mutations in ZFAT genes?,top_cases_counts_by_genes
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma cases exhibit mutations in ZFAT genes?,top_cases_counts_by_genes
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma cases exhibit mutations in ZFAT genes?,top_cases_counts_by_genes
+357,ZNF584,A211T,Sarcoma,What percentage of Sarcoma cases exhibit mutations in ZNF584 genes?,top_cases_counts_by_genes
+358,ZNF584,A256T,Sarcoma,What percentage of Sarcoma cases exhibit mutations in ZNF584 genes?,top_cases_counts_by_genes
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in LDOC1 genes?,top_cases_counts_by_genes
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in PDGFC genes?,top_cases_counts_by_genes
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in MSANTD4 genes?,top_cases_counts_by_genes
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in NPSR1 genes?,top_cases_counts_by_genes
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in PHLPP1 genes?,top_cases_counts_by_genes
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in COL6A3 genes?,top_cases_counts_by_genes
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in COL6A3 genes?,top_cases_counts_by_genes
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in COL6A3 genes?,top_cases_counts_by_genes
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in COL6A3 genes?,top_cases_counts_by_genes
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in COL6A3 genes?,top_cases_counts_by_genes
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in ADRA1A genes?,top_cases_counts_by_genes
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases exhibit mutations in LAMB2 genes?,top_cases_counts_by_genes
+406,POC1B,I198T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases exhibit mutations in POC1B genes?,top_cases_counts_by_genes
+407,POC1B,I286T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases exhibit mutations in POC1B genes?,top_cases_counts_by_genes
+408,POC1B,I328T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases exhibit mutations in POC1B genes?,top_cases_counts_by_genes
+409,POC1B,S79P,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases exhibit mutations in POC1B genes?,top_cases_counts_by_genes
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases exhibit mutations in USH2A genes?,top_cases_counts_by_genes
+414,AQP7,T110S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases exhibit mutations in AQP7 genes?,top_cases_counts_by_genes
+415,AQP7,T166S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases exhibit mutations in AQP7 genes?,top_cases_counts_by_genes
+416,AQP7,T167S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases exhibit mutations in AQP7 genes?,top_cases_counts_by_genes
+417,AQP7,T75S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases exhibit mutations in AQP7 genes?,top_cases_counts_by_genes
+430,DCN,R163C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases exhibit mutations in DCN genes?,top_cases_counts_by_genes
+431,DCN,R203C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases exhibit mutations in DCN genes?,top_cases_counts_by_genes
+432,DCN,R241C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases exhibit mutations in DCN genes?,top_cases_counts_by_genes
+433,DCN,R350C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases exhibit mutations in DCN genes?,top_cases_counts_by_genes
+434,DCN,R41C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases exhibit mutations in DCN genes?,top_cases_counts_by_genes
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in CPS1 genes?,top_cases_counts_by_genes
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in CPS1 genes?,top_cases_counts_by_genes
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in CPS1 genes?,top_cases_counts_by_genes
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases exhibit mutations in FCGR2C genes?,top_cases_counts_by_genes
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases exhibit mutations in FCGR2C genes?,top_cases_counts_by_genes
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in GRM1 genes?,top_cases_counts_by_genes
+482,SGCZ,Q138H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in SGCZ genes?,top_cases_counts_by_genes
+483,SGCZ,Q91H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in SGCZ genes?,top_cases_counts_by_genes
+485,SMO,V15M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in SMO genes?,top_cases_counts_by_genes
+486,SMO,V321M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in SMO genes?,top_cases_counts_by_genes
+488,CHODL,G159E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in CHODL genes?,top_cases_counts_by_genes
+489,CHODL,G181E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in CHODL genes?,top_cases_counts_by_genes
+490,CHODL,G200E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in CHODL genes?,top_cases_counts_by_genes
+494,MYO16,P399H,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in MYO16 genes?,top_cases_counts_by_genes
+495,MYO16,P421H,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in MYO16 genes?,top_cases_counts_by_genes
+498,CXCR2,A98V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in CXCR2 genes?,top_cases_counts_by_genes
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases exhibit mutations in TMEM225 genes?,top_cases_counts_by_genes
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in MAOB genes?,top_cases_counts_by_genes
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in GPRASP1 genes?,top_cases_counts_by_genes
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in MRPL32 genes?,top_cases_counts_by_genes
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in TYROBP genes?,top_cases_counts_by_genes
+510,RAB40C,A111V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in RAB40C genes?,top_cases_counts_by_genes
+511,RAB40C,A143V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in RAB40C genes?,top_cases_counts_by_genes
+512,CTNNA2,S323R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in CTNNA2 genes?,top_cases_counts_by_genes
+513,CTNNA2,S339R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in CTNNA2 genes?,top_cases_counts_by_genes
+514,CTNNA2,S386R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in CTNNA2 genes?,top_cases_counts_by_genes
+515,CTNNA2,S707R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in CTNNA2 genes?,top_cases_counts_by_genes
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases exhibit mutations in MYO15A genes?,top_cases_counts_by_genes
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in GIMAP2 genes?,top_cases_counts_by_genes
+532,KIF20B,N1160D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases exhibit mutations in KIF20B genes?,top_cases_counts_by_genes
+533,KIF20B,N1200D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases exhibit mutations in KIF20B genes?,top_cases_counts_by_genes
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in ADAM17 genes?,top_cases_counts_by_genes
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in BCAT1 genes?,top_cases_counts_by_genes
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in BCAT1 genes?,top_cases_counts_by_genes
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in BCAT1 genes?,top_cases_counts_by_genes
+540,ERCC6,R1053H,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in ERCC6 genes?,top_cases_counts_by_genes
+541,DCC,R320W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases exhibit mutations in DCC genes?,top_cases_counts_by_genes
+542,DCC,R363W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases exhibit mutations in DCC genes?,top_cases_counts_by_genes
+543,DCC,R386W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases exhibit mutations in DCC genes?,top_cases_counts_by_genes
+544,DCC,R41W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases exhibit mutations in DCC genes?,top_cases_counts_by_genes
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in FBXO15 genes?,top_cases_counts_by_genes
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in FBXO15 genes?,top_cases_counts_by_genes
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in GSTCD genes?,top_cases_counts_by_genes
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in GSTCD genes?,top_cases_counts_by_genes
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in OLFML3 genes?,top_cases_counts_by_genes
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in OLFML3 genes?,top_cases_counts_by_genes
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in OLFML3 genes?,top_cases_counts_by_genes
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma cases exhibit mutations in CFAP61 genes?,top_cases_counts_by_genes
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma cases exhibit mutations in CFAP61 genes?,top_cases_counts_by_genes
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases exhibit mutations in HLA-DQA2 genes?,top_cases_counts_by_genes
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in TENM2 genes?,top_cases_counts_by_genes
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in TENM2 genes?,top_cases_counts_by_genes
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in TENM2 genes?,top_cases_counts_by_genes
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in ANKRD24 genes?,top_cases_counts_by_genes
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in ANKRD24 genes?,top_cases_counts_by_genes
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in ANKRD24 genes?,top_cases_counts_by_genes
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in ZCCHC14 genes?,top_cases_counts_by_genes
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in ZCCHC14 genes?,top_cases_counts_by_genes
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in ZCCHC14 genes?,top_cases_counts_by_genes
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in ZCCHC14 genes?,top_cases_counts_by_genes
+625,SIK2,I265M,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in SIK2 genes?,top_cases_counts_by_genes
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in MYH11 genes?,top_cases_counts_by_genes
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in MYH11 genes?,top_cases_counts_by_genes
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in SLC6A4 genes?,top_cases_counts_by_genes
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in SLC9C1 genes?,top_cases_counts_by_genes
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in SLC9C1 genes?,top_cases_counts_by_genes
+644,OR2A12,A254T,Brain Lower Grade Glioma,What percentage of Brain Lower Grade Glioma cases exhibit mutations in OR2A12 genes?,top_cases_counts_by_genes
+646,PYHIN1,T325K,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in PYHIN1 genes?,top_cases_counts_by_genes
+647,PYHIN1,T334K,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in PYHIN1 genes?,top_cases_counts_by_genes
+650,JAML,G191E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in JAML genes?,top_cases_counts_by_genes
+651,JAML,G219E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in JAML genes?,top_cases_counts_by_genes
+652,JAML,G220E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in JAML genes?,top_cases_counts_by_genes
+653,JAML,G230E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in JAML genes?,top_cases_counts_by_genes
+658,TYK2,H1146R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in TYK2 genes?,top_cases_counts_by_genes
+659,TYK2,H23R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in TYK2 genes?,top_cases_counts_by_genes
+660,TYK2,H961R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in TYK2 genes?,top_cases_counts_by_genes
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in CTCFL genes?,top_cases_counts_by_genes
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in CTCFL genes?,top_cases_counts_by_genes
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in CTCFL genes?,top_cases_counts_by_genes
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in CTCFL genes?,top_cases_counts_by_genes
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in CEP20 genes?,top_cases_counts_by_genes
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in CEP20 genes?,top_cases_counts_by_genes
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in RIMS2 genes?,top_cases_counts_by_genes
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in RIMS2 genes?,top_cases_counts_by_genes
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in RIMS2 genes?,top_cases_counts_by_genes
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in RIMS2 genes?,top_cases_counts_by_genes
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in RIMS2 genes?,top_cases_counts_by_genes
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in RIMS2 genes?,top_cases_counts_by_genes
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in RIMS2 genes?,top_cases_counts_by_genes
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in PIK3C2G genes?,top_cases_counts_by_genes
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in PIK3C2G genes?,top_cases_counts_by_genes
+728,STK19,D341N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in STK19 genes?,top_cases_counts_by_genes
+729,STK19,D345N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in STK19 genes?,top_cases_counts_by_genes
+730,REXO4,P60A,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in REXO4 genes?,top_cases_counts_by_genes
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in ZBTB34 genes?,top_cases_counts_by_genes
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in ZBTB34 genes?,top_cases_counts_by_genes
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases exhibit mutations in NCKAP5 genes?,top_cases_counts_by_genes
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit mutations in SORCS1 genes?",top_cases_counts_by_genes
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit mutations in SORCS1 genes?",top_cases_counts_by_genes
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit mutations in SORCS1 genes?",top_cases_counts_by_genes
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit mutations in SORCS1 genes?",top_cases_counts_by_genes
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma cases exhibit mutations in FGF8 genes?,top_cases_counts_by_genes
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma cases exhibit mutations in FGF8 genes?,top_cases_counts_by_genes
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma cases exhibit mutations in FGF8 genes?,top_cases_counts_by_genes
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma cases exhibit mutations in FGF8 genes?,top_cases_counts_by_genes
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma cases exhibit mutations in FGF8 genes?,top_cases_counts_by_genes
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What percentage of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia cases exhibit mutations in TENM3 genes?,top_cases_counts_by_genes
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in AKT1 genes?,top_cases_counts_by_genes
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases exhibit mutations in CFAP298-TCP10L genes?,top_cases_counts_by_genes
+792,GLRB,E148D,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in GLRB genes?,top_cases_counts_by_genes
+793,TTN,F7636L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in TTN genes?,top_cases_counts_by_genes
+794,TTN,F8563L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in TTN genes?,top_cases_counts_by_genes
+795,TTN,F8880L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in TTN genes?,top_cases_counts_by_genes
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in ANKRD30A genes?,top_cases_counts_by_genes
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in ANKRD30A genes?,top_cases_counts_by_genes
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in ANKRD30A genes?,top_cases_counts_by_genes
+809,TRIM45,S177L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in TRIM45 genes?,top_cases_counts_by_genes
+810,TRIM45,S224L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in TRIM45 genes?,top_cases_counts_by_genes
+811,TRIM45,S281L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in TRIM45 genes?,top_cases_counts_by_genes
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in CACNA1F genes?,top_cases_counts_by_genes
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in CACNA1F genes?,top_cases_counts_by_genes
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in CACNA1F genes?,top_cases_counts_by_genes
+817,KL,R594C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in KL genes?,top_cases_counts_by_genes
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases exhibit mutations in GUF1 genes?,top_cases_counts_by_genes
+822,TAF1L,A539V,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in TAF1L genes?,top_cases_counts_by_genes
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in TASOR2 genes?,top_cases_counts_by_genes
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in TASOR2 genes?,top_cases_counts_by_genes
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in TASOR2 genes?,top_cases_counts_by_genes
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in KDM5C genes?,top_cases_counts_by_genes
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in KDM5C genes?,top_cases_counts_by_genes
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in KDM5C genes?,top_cases_counts_by_genes
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in KDM5C genes?,top_cases_counts_by_genes
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases exhibit mutations in IL5RA genes?,top_cases_counts_by_genes
+843,DHX16,A29V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in DHX16 genes?,top_cases_counts_by_genes
+844,DHX16,A89V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in DHX16 genes?,top_cases_counts_by_genes
+902,GPR158,A644V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in GPR158 genes?,top_cases_counts_by_genes
+903,GPR158,A723V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in GPR158 genes?,top_cases_counts_by_genes
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit mutations in EIF2B4 genes?",top_cases_counts_by_genes
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit mutations in EIF2B4 genes?",top_cases_counts_by_genes
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit mutations in EIF2B4 genes?",top_cases_counts_by_genes
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit mutations in EIF2B4 genes?",top_cases_counts_by_genes
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit mutations in EIF2B4 genes?",top_cases_counts_by_genes
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit mutations in EIF2B4 genes?",top_cases_counts_by_genes
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in AUTS2 genes?,top_cases_counts_by_genes
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in AUTS2 genes?,top_cases_counts_by_genes
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in AUTS2 genes?,top_cases_counts_by_genes
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in AUTS2 genes?,top_cases_counts_by_genes
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in AUTS2 genes?,top_cases_counts_by_genes
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in AUTS2 genes?,top_cases_counts_by_genes
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in AUTS2 genes?,top_cases_counts_by_genes
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in AUTS2 genes?,top_cases_counts_by_genes
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in AUTS2 genes?,top_cases_counts_by_genes
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in AUTS2 genes?,top_cases_counts_by_genes
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit mutations in ACTL7B genes?",top_cases_counts_by_genes
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases exhibit mutations in PCDHGA1 genes?,top_cases_counts_by_genes
+954,TRAP1,R114W,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in TRAP1 genes?,top_cases_counts_by_genes
+955,TRAP1,R61W,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in TRAP1 genes?,top_cases_counts_by_genes
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in PIK3C2A genes?,top_cases_counts_by_genes
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases exhibit mutations in KANSL1 genes?,top_cases_counts_by_genes
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in ANKRD52 genes?,top_cases_counts_by_genes
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in PAPPA genes?,top_cases_counts_by_genes
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases exhibit mutations in B3GALNT1 genes?,top_cases_counts_by_genes
+982,GABRA6,G115R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in GABRA6 genes?,top_cases_counts_by_genes
+983,GABRA6,G122R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in GABRA6 genes?,top_cases_counts_by_genes
+984,GABRA6,G165R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in GABRA6 genes?,top_cases_counts_by_genes
+985,GABRA6,G175R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in GABRA6 genes?,top_cases_counts_by_genes
+986,GABRA6,G70R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in GABRA6 genes?,top_cases_counts_by_genes
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in ZSCAN31 genes?,top_cases_counts_by_genes
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit mutations in MED16 genes?",top_cases_counts_by_genes
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit mutations in MED16 genes?",top_cases_counts_by_genes
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases exhibit mutations in PTPRO genes?,top_cases_counts_by_genes
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases exhibit mutations in PTPRO genes?,top_cases_counts_by_genes
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases exhibit mutations in PTPRO genes?,top_cases_counts_by_genes
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases exhibit mutations in PTPRO genes?,top_cases_counts_by_genes
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases exhibit mutations in PTPRO genes?,top_cases_counts_by_genes
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases exhibit mutations in PTPRO genes?,top_cases_counts_by_genes
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases exhibit mutations in PTPRO genes?,top_cases_counts_by_genes
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases exhibit mutations in PTPRO genes?,top_cases_counts_by_genes
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in CHMP7 genes?,top_cases_counts_by_genes
+1017,GPC3,I107N,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in GPC3 genes?,top_cases_counts_by_genes
+1018,GPC3,I161N,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in GPC3 genes?,top_cases_counts_by_genes
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases exhibit mutations in TLK2 genes?,top_cases_counts_by_genes
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases exhibit mutations in TLK2 genes?,top_cases_counts_by_genes
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases exhibit mutations in TLK2 genes?,top_cases_counts_by_genes
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases exhibit mutations in TLK2 genes?,top_cases_counts_by_genes
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases exhibit mutations in TLK2 genes?,top_cases_counts_by_genes
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in ZNF217 genes?,top_cases_counts_by_genes
+1038,SYT9,V275L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in SYT9 genes?,top_cases_counts_by_genes
+1039,SYT9,V307L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in SYT9 genes?,top_cases_counts_by_genes
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in PKHD1L1 genes?,top_cases_counts_by_genes
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in MYO3A genes?,top_cases_counts_by_genes
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit mutations in VASN genes?",top_cases_counts_by_genes
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in DNMT1 genes?,top_cases_counts_by_genes
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in DNMT1 genes?,top_cases_counts_by_genes
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in DNMT1 genes?,top_cases_counts_by_genes
+1056,CA9,E402K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in CA9 genes?,top_cases_counts_by_genes
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in TTC17 genes?,top_cases_counts_by_genes
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in TTC17 genes?,top_cases_counts_by_genes
+1065,PSG2,P43L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases exhibit mutations in PSG2 genes?,top_cases_counts_by_genes
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases exhibit mutations in RIPOR2 genes?,top_cases_counts_by_genes
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases exhibit mutations in RIPOR2 genes?,top_cases_counts_by_genes
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases exhibit mutations in RIPOR2 genes?,top_cases_counts_by_genes
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases exhibit mutations in RIPOR2 genes?,top_cases_counts_by_genes
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in DCLK3 genes?,top_cases_counts_by_genes
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in DCLK3 genes?,top_cases_counts_by_genes
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in MERTK genes?,top_cases_counts_by_genes
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in MERTK genes?,top_cases_counts_by_genes
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in MERTK genes?,top_cases_counts_by_genes
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in ZFP42 genes?,top_cases_counts_by_genes
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in OR13C3 genes?,top_cases_counts_by_genes
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in OR13C3 genes?,top_cases_counts_by_genes
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in SPAG1 genes?,top_cases_counts_by_genes
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in CDKN2AIP genes?,top_cases_counts_by_genes
+1093,PXN,H1016Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in PXN genes?,top_cases_counts_by_genes
+1094,PXN,H359Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in PXN genes?,top_cases_counts_by_genes
+1095,PXN,H492Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in PXN genes?,top_cases_counts_by_genes
+1096,PXN,H524Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in PXN genes?,top_cases_counts_by_genes
+1097,PXN,H526Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in PXN genes?,top_cases_counts_by_genes
+1098,PXN,H540Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in PXN genes?,top_cases_counts_by_genes
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in TTYH2 genes?,top_cases_counts_by_genes
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in TTYH2 genes?,top_cases_counts_by_genes
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in TMEM255A genes?,top_cases_counts_by_genes
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in TMEM255A genes?,top_cases_counts_by_genes
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in TMEM255A genes?,top_cases_counts_by_genes
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases exhibit mutations in TASOR2 genes?,top_cases_counts_by_genes
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases exhibit mutations in TASOR2 genes?,top_cases_counts_by_genes
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in ICE1 genes?,top_cases_counts_by_genes
+1112,MYT1,A558E,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases exhibit mutations in MYT1 genes?,top_cases_counts_by_genes
+1113,MYT1,A879E,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases exhibit mutations in MYT1 genes?,top_cases_counts_by_genes
+1114,MYT1,A906E,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases exhibit mutations in MYT1 genes?,top_cases_counts_by_genes
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in CX3CR1 genes?,top_cases_counts_by_genes
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in CX3CR1 genes?,top_cases_counts_by_genes
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases exhibit mutations in SPINDOC genes?,top_cases_counts_by_genes
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in ART3 genes?,top_cases_counts_by_genes
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in ART3 genes?,top_cases_counts_by_genes
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases exhibit mutations in CYP1A2 genes?,top_cases_counts_by_genes
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit mutations in ADRA1A genes?",top_cases_counts_by_genes
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in CDH23 genes?,top_cases_counts_by_genes
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in CDH23 genes?,top_cases_counts_by_genes
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in KRT39 genes?,top_cases_counts_by_genes
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in PDHA2 genes?,top_cases_counts_by_genes
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in SLC24A2 genes?,top_cases_counts_by_genes
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases exhibit mutations in PTPRN2 genes?,top_cases_counts_by_genes
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases exhibit mutations in PTPRN2 genes?,top_cases_counts_by_genes
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases exhibit mutations in PTPRN2 genes?,top_cases_counts_by_genes
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases exhibit mutations in PTPRN2 genes?,top_cases_counts_by_genes
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases exhibit mutations in PTPRN2 genes?,top_cases_counts_by_genes
+1188,SOX21,R55L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in SOX21 genes?,top_cases_counts_by_genes
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases exhibit mutations in CPA6 genes?,top_cases_counts_by_genes
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in GRM5 genes?,top_cases_counts_by_genes
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit mutations in CASZ1 genes?",top_cases_counts_by_genes
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in SGIP1 genes?,top_cases_counts_by_genes
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in SGIP1 genes?,top_cases_counts_by_genes
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in SGIP1 genes?,top_cases_counts_by_genes
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in SGIP1 genes?,top_cases_counts_by_genes
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in CARMIL1 genes?,top_cases_counts_by_genes
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in CARMIL1 genes?,top_cases_counts_by_genes
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in ZNF431 genes?,top_cases_counts_by_genes
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in ZNF431 genes?,top_cases_counts_by_genes
+1234,ZNF431,R128I,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in ZNF431 genes?,top_cases_counts_by_genes
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in DNAH11 genes?,top_cases_counts_by_genes
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in DNAH11 genes?,top_cases_counts_by_genes
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in POLD1 genes?,top_cases_counts_by_genes
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases exhibit mutations in POLD1 genes?,top_cases_counts_by_genes
+1248,TTC12,D646H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in TTC12 genes?,top_cases_counts_by_genes
+1249,TTC12,D652H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in TTC12 genes?,top_cases_counts_by_genes
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases exhibit mutations in CNGB1 genes?,top_cases_counts_by_genes
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases exhibit mutations in CNGB1 genes?,top_cases_counts_by_genes
+1254,CTSC,E214V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in CTSC genes?,top_cases_counts_by_genes
+1255,CTSC,E291V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in CTSC genes?,top_cases_counts_by_genes
+1256,CTSC,E322V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in CTSC genes?,top_cases_counts_by_genes
+1257,CTSC,E324V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in CTSC genes?,top_cases_counts_by_genes
+1258,CTSC,E335V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in CTSC genes?,top_cases_counts_by_genes
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in PRSS8 genes?,top_cases_counts_by_genes
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in PRSS8 genes?,top_cases_counts_by_genes
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in ARHGEF40 genes?,top_cases_counts_by_genes
+1264,ACTB,A138T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases exhibit mutations in ACTB genes?,top_cases_counts_by_genes
+1265,ACTB,A217T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases exhibit mutations in ACTB genes?,top_cases_counts_by_genes
+1266,ACTB,A244T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases exhibit mutations in ACTB genes?,top_cases_counts_by_genes
+1267,ACTB,A260T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases exhibit mutations in ACTB genes?,top_cases_counts_by_genes
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases exhibit mutations in YY1AP1 genes?,top_cases_counts_by_genes
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases exhibit mutations in YY1AP1 genes?,top_cases_counts_by_genes
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases exhibit mutations in YY1AP1 genes?,top_cases_counts_by_genes
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases exhibit mutations in YY1AP1 genes?,top_cases_counts_by_genes
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases exhibit mutations in YY1AP1 genes?,top_cases_counts_by_genes
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases exhibit mutations in YY1AP1 genes?,top_cases_counts_by_genes
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases exhibit mutations in YY1AP1 genes?,top_cases_counts_by_genes
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in FNDC7 genes?,top_cases_counts_by_genes
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in FNDC7 genes?,top_cases_counts_by_genes
+1299,TLCD5,G15V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in TLCD5 genes?,top_cases_counts_by_genes
+1300,TLCD5,G37V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in TLCD5 genes?,top_cases_counts_by_genes
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in POLR1G genes?,top_cases_counts_by_genes
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in POLR1G genes?,top_cases_counts_by_genes
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in DNAH14 genes?,top_cases_counts_by_genes
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in DNAH14 genes?,top_cases_counts_by_genes
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in DNAH14 genes?,top_cases_counts_by_genes
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in NEXN genes?,top_cases_counts_by_genes
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases exhibit mutations in CYB5R2 genes?,top_cases_counts_by_genes
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases exhibit mutations in CYB5R2 genes?,top_cases_counts_by_genes
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in NRAP genes?,top_cases_counts_by_genes
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in NRAP genes?,top_cases_counts_by_genes
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in NRAP genes?,top_cases_counts_by_genes
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in CCDC22 genes?,top_cases_counts_by_genes
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in DCAF6 genes?,top_cases_counts_by_genes
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in DCAF6 genes?,top_cases_counts_by_genes
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in ZNF708 genes?,top_cases_counts_by_genes
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in BFAR genes?,top_cases_counts_by_genes
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in MAST4 genes?,top_cases_counts_by_genes
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in MAST4 genes?,top_cases_counts_by_genes
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in MAST4 genes?,top_cases_counts_by_genes
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in MAST4 genes?,top_cases_counts_by_genes
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in MAST4 genes?,top_cases_counts_by_genes
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in ARMC3 genes?,top_cases_counts_by_genes
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in ARMC3 genes?,top_cases_counts_by_genes
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma cases exhibit mutations in TET2 genes?,top_cases_counts_by_genes
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma cases exhibit mutations in TET2 genes?,top_cases_counts_by_genes
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in SERPINB10 genes?,top_cases_counts_by_genes
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in STAT3 genes?,top_cases_counts_by_genes
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in MIEF1 genes?,top_cases_counts_by_genes
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in ACVR1B genes?,top_cases_counts_by_genes
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in ACVR1B genes?,top_cases_counts_by_genes
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in ACVR1B genes?,top_cases_counts_by_genes
+1393,EBF2,T104I,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in EBF2 genes?,top_cases_counts_by_genes
+1394,EBF2,T252I,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in EBF2 genes?,top_cases_counts_by_genes
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in VPS26B genes?,top_cases_counts_by_genes
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit mutations in PGR genes?",top_cases_counts_by_genes
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit mutations in PGR genes?",top_cases_counts_by_genes
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases exhibit mutations in PGR genes?",top_cases_counts_by_genes
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases exhibit mutations in ACTA2 genes?,top_cases_counts_by_genes
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in THBS4 genes?,top_cases_counts_by_genes
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in THBS4 genes?,top_cases_counts_by_genes
+1413,PRSS1,S114T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in PRSS1 genes?,top_cases_counts_by_genes
+1414,PRSS1,S124T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in PRSS1 genes?,top_cases_counts_by_genes
+1415,PRSS1,S138T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in PRSS1 genes?,top_cases_counts_by_genes
+1416,PRSS1,S74T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases exhibit mutations in PRSS1 genes?,top_cases_counts_by_genes
+1417,PGF,R126H,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in PGF genes?,top_cases_counts_by_genes
+1418,PGF,R127H,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases exhibit mutations in PGF genes?,top_cases_counts_by_genes
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases exhibit mutations in ITPRID2 genes?,top_cases_counts_by_genes
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases exhibit mutations in ITPRID2 genes?,top_cases_counts_by_genes
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in HBB genes?,top_cases_counts_by_genes
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in PCDHB2 genes?,top_cases_counts_by_genes
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in PCDHB2 genes?,top_cases_counts_by_genes
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases exhibit mutations in PCDHB2 genes?,top_cases_counts_by_genes
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases exhibit mutations in UBR2 genes?,top_cases_counts_by_genes
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases exhibit mutations in FBXO42 genes?,top_cases_counts_by_genes
+1,TNS1,G1362V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases have mutated TNS1 or FGF8?,top_cases_counts_by_genes
+2,TNS1,G1711V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases have mutated TNS1 or PDHA2?,top_cases_counts_by_genes
+3,TNS1,G1718V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases have mutated TNS1 or BFAR?,top_cases_counts_by_genes
+4,TNS1,G1732V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases have mutated TNS1 or CTSC?,top_cases_counts_by_genes
+5,TNS1,G1824V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases have mutated TNS1 or PGR?,top_cases_counts_by_genes
+6,TNS1,G1857V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases have mutated TNS1 or TTN?,top_cases_counts_by_genes
+7,TNS1,G843V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases have mutated TNS1 or CA9?,top_cases_counts_by_genes
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases have mutated EVC2 or SLC9C1?,top_cases_counts_by_genes
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases have mutated EVC2 or EIF2B4?,top_cases_counts_by_genes
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated CR1 or DPF3?,top_cases_counts_by_genes
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated CR1 or GUK1?,top_cases_counts_by_genes
+22,TRPA1,S295I,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases have mutated TRPA1 or NPSR1?,top_cases_counts_by_genes
+23,TRPA1,S443I,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases have mutated TRPA1 or PIK3C2B?,top_cases_counts_by_genes
+24,TAF1C,R299L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated TAF1C or PTPRN2?,top_cases_counts_by_genes
+25,TAF1C,R396L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated TAF1C or TLCD5?,top_cases_counts_by_genes
+26,TAF1C,R634L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated TAF1C or DCN?,top_cases_counts_by_genes
+27,TAF1C,R702L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated TAF1C or TLCD5?,top_cases_counts_by_genes
+28,TAF1C,R728L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated TAF1C or TNS1?,top_cases_counts_by_genes
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated DPF3 or DCLK3?,top_cases_counts_by_genes
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated DPF3 or JAML?,top_cases_counts_by_genes
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated DPF3 or ZCCHC14?,top_cases_counts_by_genes
+42,OR2T4,P272H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated OR2T4 or TAF1C?,top_cases_counts_by_genes
+43,OR2T4,P300H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated OR2T4 or GPRASP1?,top_cases_counts_by_genes
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma cases have mutated FBN1 or CFAP61?,top_cases_counts_by_genes
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma cases have mutated MAD1L1 or STAT3?,top_cases_counts_by_genes
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma cases have mutated MAD1L1 or ZFPM2?,top_cases_counts_by_genes
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma cases have mutated MAD1L1 or RIMS2?,top_cases_counts_by_genes
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated CCNG1 or ZCCHC14?,top_cases_counts_by_genes
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma cases have mutated ANP32E or ZMYM3?,top_cases_counts_by_genes
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma cases have mutated ANP32E or AUTS2?,top_cases_counts_by_genes
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma cases have mutated ANP32E or YY1AP1?,top_cases_counts_by_genes
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma cases have mutated ANP32E or DCC?,top_cases_counts_by_genes
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases have mutated FRY or RIMS2?,top_cases_counts_by_genes
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases have mutated FRY or ADRA1A?,top_cases_counts_by_genes
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases have mutated FRY or RIPOR2?,top_cases_counts_by_genes
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases have mutated FRY or MORF4L1?,top_cases_counts_by_genes
+70,PAK3,E318K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated PAK3 or THBS4?,top_cases_counts_by_genes
+71,PAK3,E319K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated PAK3 or CTCFL?,top_cases_counts_by_genes
+72,PAK3,E334K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated PAK3 or EPRS1?,top_cases_counts_by_genes
+73,PAK3,E340K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated PAK3 or ANKRD24?,top_cases_counts_by_genes
+74,PAK3,E355K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated PAK3 or TYK2?,top_cases_counts_by_genes
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated MUC16 or NRAP?,top_cases_counts_by_genes
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases have mutated ZFPM2 or MAST4?,top_cases_counts_by_genes
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases have mutated ZFPM2 or PAPPA?,top_cases_counts_by_genes
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases have mutated PIK3C2B or SOX21?,top_cases_counts_by_genes
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases have mutated PIK3C2B or PRSS8?,top_cases_counts_by_genes
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated ZNF804A or CHODL?,top_cases_counts_by_genes
+116,RELN,A2371V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated RELN or MAST4?,top_cases_counts_by_genes
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have mutated EFCAB12 or RELN?",top_cases_counts_by_genes
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have mutated EFCAB12 or TASOR2?",top_cases_counts_by_genes
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated DEFB115 or FRY?,top_cases_counts_by_genes
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases have mutated ANKDD1A or ART3?,top_cases_counts_by_genes
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases have mutated ANKDD1A or SGIP1?,top_cases_counts_by_genes
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases have mutated ANKDD1A or MAD1L1?,top_cases_counts_by_genes
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated HTR3B or PXN?,top_cases_counts_by_genes
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated HTR3B or CCDC22?,top_cases_counts_by_genes
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated HTR3B or PTPRN2?,top_cases_counts_by_genes
+129,ABCC3,R758W,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated ABCC3 or UNC5D?,top_cases_counts_by_genes
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated NOMO1 or FGF8?,top_cases_counts_by_genes
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated NOMO1 or TAF1L?,top_cases_counts_by_genes
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases have mutated HYOU1 or PLEKHG6?,top_cases_counts_by_genes
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated FMO4 or ARMC3?,top_cases_counts_by_genes
+140,BICC1,A372V,Exceptional Responders,What proportion of Exceptional Responders cases have mutated BICC1 or ANKDD1A?,top_cases_counts_by_genes
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated ZMYM3 or PTPRO?,top_cases_counts_by_genes
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated ZMYM3 or ZNF431?,top_cases_counts_by_genes
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated ZMYM3 or RIMS2?,top_cases_counts_by_genes
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have mutated XKR4 or PDHA2?",top_cases_counts_by_genes
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases have mutated ABCC2 or FBXO15?,top_cases_counts_by_genes
+157,OR8K5,R293G,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated OR8K5 or TMEM255A?,top_cases_counts_by_genes
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated SPTAN1 or PRSS1?,top_cases_counts_by_genes
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated SPTAN1 or DGKD?,top_cases_counts_by_genes
+164,SYT10,M484I,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases have mutated SYT10 or ITPRID2?,top_cases_counts_by_genes
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated HSPA5 or MYT1?,top_cases_counts_by_genes
+175,UNC5D,L280V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated UNC5D or DCC?,top_cases_counts_by_genes
+176,UNC5D,L635V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated UNC5D or POC1B?,top_cases_counts_by_genes
+177,UNC5D,L637V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated UNC5D or GPR158?,top_cases_counts_by_genes
+178,UNC5D,L699V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated UNC5D or CTSC?,top_cases_counts_by_genes
+179,UNC5D,L704V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated UNC5D or USH2A?,top_cases_counts_by_genes
+180,UNC5D,L709V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated UNC5D or B3GALNT1?,top_cases_counts_by_genes
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What proportion of Kidney Renal Clear Cell Carcinoma cases have mutated DOCK2 or ANP32E?,top_cases_counts_by_genes
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What proportion of Kidney Renal Clear Cell Carcinoma cases have mutated ZNF627 or SLC24A2?,top_cases_counts_by_genes
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated CDC42BPA or PAK3?,top_cases_counts_by_genes
+193,MRPL55,H27Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated MRPL55 or CEP20?,top_cases_counts_by_genes
+194,MRPL55,H63Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated MRPL55 or AUTS2?,top_cases_counts_by_genes
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases have mutated TMTC3 or PRSS1?,top_cases_counts_by_genes
+198,EPRS1,K771I,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated EPRS1 or NOMO1?,top_cases_counts_by_genes
+199,EPRS1,K778I,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated EPRS1 or SYNJ1?,top_cases_counts_by_genes
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated GRTP1 or EIF2B4?,top_cases_counts_by_genes
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated GRTP1 or POC1B?,top_cases_counts_by_genes
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated TSHZ3 or PCDHB2?,top_cases_counts_by_genes
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What proportion of HIV+ Tumor Molecular Characterization Project - Cervical Cancer cases have mutated TAS1R3 or ANP32E?,top_cases_counts_by_genes
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated PIAS3 or EIF2B4?,top_cases_counts_by_genes
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated PIAS3 or CCNG1?,top_cases_counts_by_genes
+251,ZNF274,P13R,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated ZNF274 or DCLK3?,top_cases_counts_by_genes
+253,SYNJ1,R795C,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated SYNJ1 or CDKN2AIP?,top_cases_counts_by_genes
+254,SYNJ1,R800C,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated SYNJ1 or TNS1?,top_cases_counts_by_genes
+255,SYNJ1,R839C,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated SYNJ1 or DGKD?,top_cases_counts_by_genes
+261,DSCAM,V343M,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma cases have mutated DSCAM or NOMO1?,top_cases_counts_by_genes
+262,DSCAM,V426M,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma cases have mutated DSCAM or CXCR2?,top_cases_counts_by_genes
+263,DSCAM,V591M,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma cases have mutated DSCAM or OR13C3?,top_cases_counts_by_genes
+267,DGKD,R140H,Exceptional Responders,What proportion of Exceptional Responders cases have mutated DGKD or B3GALNT1?,top_cases_counts_by_genes
+268,DGKD,R160H,Exceptional Responders,What proportion of Exceptional Responders cases have mutated DGKD or TMEM255A?,top_cases_counts_by_genes
+269,DGKD,R204H,Exceptional Responders,What proportion of Exceptional Responders cases have mutated DGKD or POC1B?,top_cases_counts_by_genes
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases have mutated PLEKHG6 or MAST4?,top_cases_counts_by_genes
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases have mutated PLEKHG6 or AQP7?,top_cases_counts_by_genes
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases have mutated PLEKHG6 or NRAP?,top_cases_counts_by_genes
+279,WNT2,D138N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated WNT2 or ARMC3?,top_cases_counts_by_genes
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated GUCY2C or MED16?,top_cases_counts_by_genes
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated C7orf31 or AUTS2?,top_cases_counts_by_genes
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have mutated ZKSCAN7 or AUTS2?",top_cases_counts_by_genes
+299,OR5D14,M210L,Neuroblastoma,What proportion of Neuroblastoma cases have mutated OR5D14 or POLR1G?,top_cases_counts_by_genes
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated SPATA22 or ANP32E?,top_cases_counts_by_genes
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated SPATA22 or TNS1?,top_cases_counts_by_genes
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated SPATA22 or CXCR2?,top_cases_counts_by_genes
+310,LCN15,E21V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated LCN15 or PGF?,top_cases_counts_by_genes
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated DCAF4L2 or AQP7?,top_cases_counts_by_genes
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated GUK1 or YY1AP1?,top_cases_counts_by_genes
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated GUK1 or MYO3A?,top_cases_counts_by_genes
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated GUK1 or GUK1?,top_cases_counts_by_genes
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated GUK1 or GUK1?,top_cases_counts_by_genes
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated GUK1 or MYO15A?,top_cases_counts_by_genes
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated MORF4L1 or RIMS2?,top_cases_counts_by_genes
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated MORF4L1 or SYNJ1?,top_cases_counts_by_genes
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated MORF4L1 or DEFB115?,top_cases_counts_by_genes
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated MORF4L1 or PRSS1?,top_cases_counts_by_genes
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated MYO3B or JAML?,top_cases_counts_by_genes
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated MYO3B or NCKAP5?,top_cases_counts_by_genes
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated TENT5A or DCN?,top_cases_counts_by_genes
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated TENT5A or PTPRN2?,top_cases_counts_by_genes
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated TENT5A or TLK2?,top_cases_counts_by_genes
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What proportion of Ovarian Serous Cystadenocarcinoma cases have mutated ZFAT or NOMO1?,top_cases_counts_by_genes
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What proportion of Ovarian Serous Cystadenocarcinoma cases have mutated ZFAT or DCC?,top_cases_counts_by_genes
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What proportion of Ovarian Serous Cystadenocarcinoma cases have mutated ZFAT or TMEM225?,top_cases_counts_by_genes
+357,ZNF584,A211T,Sarcoma,What proportion of Sarcoma cases have mutated ZNF584 or PTPRO?,top_cases_counts_by_genes
+358,ZNF584,A256T,Sarcoma,What proportion of Sarcoma cases have mutated ZNF584 or TAF1C?,top_cases_counts_by_genes
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated LDOC1 or DPF3?,top_cases_counts_by_genes
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated PDGFC or GUK1?,top_cases_counts_by_genes
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated MSANTD4 or TLK2?,top_cases_counts_by_genes
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated NPSR1 or ARMC3?,top_cases_counts_by_genes
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated PHLPP1 or ANKRD52?,top_cases_counts_by_genes
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated COL6A3 or GPRASP1?,top_cases_counts_by_genes
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated COL6A3 or CYB5R2?,top_cases_counts_by_genes
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated COL6A3 or GIMAP2?,top_cases_counts_by_genes
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated COL6A3 or CPA6?,top_cases_counts_by_genes
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated COL6A3 or AQP7?,top_cases_counts_by_genes
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated ADRA1A or PLEKHG6?,top_cases_counts_by_genes
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have mutated LAMB2 or PTPRO?,top_cases_counts_by_genes
+406,POC1B,I198T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases have mutated POC1B or THBS4?,top_cases_counts_by_genes
+407,POC1B,I286T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases have mutated POC1B or ANKRD24?,top_cases_counts_by_genes
+408,POC1B,I328T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases have mutated POC1B or EIF2B4?,top_cases_counts_by_genes
+409,POC1B,S79P,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases have mutated POC1B or LDOC1?,top_cases_counts_by_genes
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases have mutated USH2A or EPRS1?,top_cases_counts_by_genes
+414,AQP7,T110S,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases have mutated AQP7 or COL6A3?,top_cases_counts_by_genes
+415,AQP7,T166S,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases have mutated AQP7 or ZCCHC14?,top_cases_counts_by_genes
+416,AQP7,T167S,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases have mutated AQP7 or ANP32E?,top_cases_counts_by_genes
+417,AQP7,T75S,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases have mutated AQP7 or GPRASP1?,top_cases_counts_by_genes
+430,DCN,R163C,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases have mutated DCN or KDM5C?,top_cases_counts_by_genes
+431,DCN,R203C,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases have mutated DCN or CDC42BPA?,top_cases_counts_by_genes
+432,DCN,R241C,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases have mutated DCN or TTN?,top_cases_counts_by_genes
+433,DCN,R350C,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases have mutated DCN or MAST4?,top_cases_counts_by_genes
+434,DCN,R41C,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases have mutated DCN or FRY?,top_cases_counts_by_genes
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated CPS1 or ARMC3?,top_cases_counts_by_genes
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated CPS1 or UBR2?,top_cases_counts_by_genes
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated CPS1 or GRTP1?,top_cases_counts_by_genes
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma cases have mutated FCGR2C or GPC3?,top_cases_counts_by_genes
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma cases have mutated FCGR2C or MAST4?,top_cases_counts_by_genes
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated GRM1 or SORCS1?,top_cases_counts_by_genes
+482,SGCZ,Q138H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated SGCZ or CR1?,top_cases_counts_by_genes
+483,SGCZ,Q91H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated SGCZ or DNAH14?,top_cases_counts_by_genes
+485,SMO,V15M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated SMO or ACVR1B?,top_cases_counts_by_genes
+486,SMO,V321M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated SMO or MIEF1?,top_cases_counts_by_genes
+488,CHODL,G159E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated CHODL or GSTCD?,top_cases_counts_by_genes
+489,CHODL,G181E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated CHODL or STK19?,top_cases_counts_by_genes
+490,CHODL,G200E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated CHODL or ACVR1B?,top_cases_counts_by_genes
+494,MYO16,P399H,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated MYO16 or THBS4?,top_cases_counts_by_genes
+495,MYO16,P421H,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated MYO16 or CTSC?,top_cases_counts_by_genes
+498,CXCR2,A98V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated CXCR2 or CDH23?,top_cases_counts_by_genes
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases have mutated TMEM225 or FRY?,top_cases_counts_by_genes
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated MAOB or PDHA2?,top_cases_counts_by_genes
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated GPRASP1 or PTPRO?,top_cases_counts_by_genes
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated MRPL32 or TYK2?,top_cases_counts_by_genes
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated TYROBP or FMO4?,top_cases_counts_by_genes
+510,RAB40C,A111V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated RAB40C or YY1AP1?,top_cases_counts_by_genes
+511,RAB40C,A143V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated RAB40C or OLFML3?,top_cases_counts_by_genes
+512,CTNNA2,S323R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated CTNNA2 or MERTK?,top_cases_counts_by_genes
+513,CTNNA2,S339R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated CTNNA2 or SGIP1?,top_cases_counts_by_genes
+514,CTNNA2,S386R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated CTNNA2 or BCAT1?,top_cases_counts_by_genes
+515,CTNNA2,S707R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated CTNNA2 or ITPRID2?,top_cases_counts_by_genes
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases have mutated MYO15A or KANSL1?,top_cases_counts_by_genes
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated GIMAP2 or CXCR2?,top_cases_counts_by_genes
+532,KIF20B,N1160D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases have mutated KIF20B or PHLPP1?,top_cases_counts_by_genes
+533,KIF20B,N1200D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases have mutated KIF20B or PGF?,top_cases_counts_by_genes
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated ADAM17 or ZNF627?,top_cases_counts_by_genes
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated BCAT1 or EIF2B4?,top_cases_counts_by_genes
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated BCAT1 or MERTK?,top_cases_counts_by_genes
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated BCAT1 or CPA6?,top_cases_counts_by_genes
+540,ERCC6,R1053H,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated ERCC6 or DCC?,top_cases_counts_by_genes
+541,DCC,R320W,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases have mutated DCC or ZBTB34?,top_cases_counts_by_genes
+542,DCC,R363W,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases have mutated DCC or FBN1?,top_cases_counts_by_genes
+543,DCC,R386W,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases have mutated DCC or TASOR2?,top_cases_counts_by_genes
+544,DCC,R41W,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases have mutated DCC or DCN?,top_cases_counts_by_genes
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated FBXO15 or TET2?,top_cases_counts_by_genes
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated FBXO15 or TRAP1?,top_cases_counts_by_genes
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated GSTCD or CPS1?,top_cases_counts_by_genes
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated GSTCD or CTNNA2?,top_cases_counts_by_genes
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated OLFML3 or GUK1?,top_cases_counts_by_genes
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated OLFML3 or ANKRD24?,top_cases_counts_by_genes
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated OLFML3 or NPSR1?,top_cases_counts_by_genes
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What proportion of Ovarian Serous Cystadenocarcinoma cases have mutated CFAP61 or PSG2?,top_cases_counts_by_genes
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What proportion of Ovarian Serous Cystadenocarcinoma cases have mutated CFAP61 or EIF2B4?,top_cases_counts_by_genes
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases have mutated HLA-DQA2 or TENT5A?,top_cases_counts_by_genes
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated TENM2 or RIPOR2?,top_cases_counts_by_genes
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated TENM2 or EPRS1?,top_cases_counts_by_genes
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated TENM2 or ANKRD24?,top_cases_counts_by_genes
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated ANKRD24 or PIAS3?,top_cases_counts_by_genes
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated ANKRD24 or OR2T4?,top_cases_counts_by_genes
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated ANKRD24 or PTPRN2?,top_cases_counts_by_genes
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated ZCCHC14 or FBXO42?,top_cases_counts_by_genes
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated ZCCHC14 or SYT9?,top_cases_counts_by_genes
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated ZCCHC14 or CPS1?,top_cases_counts_by_genes
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated ZCCHC14 or FBXO15?,top_cases_counts_by_genes
+625,SIK2,I265M,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated SIK2 or ZMYM3?,top_cases_counts_by_genes
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated MYH11 or B3GALNT1?,top_cases_counts_by_genes
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated MYH11 or LCN15?,top_cases_counts_by_genes
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated SLC6A4 or VASN?,top_cases_counts_by_genes
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated SLC9C1 or HSPA5?,top_cases_counts_by_genes
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated SLC9C1 or CX3CR1?,top_cases_counts_by_genes
+644,OR2A12,A254T,Brain Lower Grade Glioma,What proportion of Brain Lower Grade Glioma cases have mutated OR2A12 or ZMYM3?,top_cases_counts_by_genes
+646,PYHIN1,T325K,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated PYHIN1 or MAST4?,top_cases_counts_by_genes
+647,PYHIN1,T334K,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated PYHIN1 or TNS1?,top_cases_counts_by_genes
+650,JAML,G191E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated JAML or CACNA1F?,top_cases_counts_by_genes
+651,JAML,G219E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated JAML or ARMC3?,top_cases_counts_by_genes
+652,JAML,G220E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated JAML or RIPOR2?,top_cases_counts_by_genes
+653,JAML,G230E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated JAML or DNAH11?,top_cases_counts_by_genes
+658,TYK2,H1146R,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated TYK2 or TENM2?,top_cases_counts_by_genes
+659,TYK2,H23R,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated TYK2 or PDHA2?,top_cases_counts_by_genes
+660,TYK2,H961R,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated TYK2 or ZBTB34?,top_cases_counts_by_genes
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated CTCFL or ZFP42?,top_cases_counts_by_genes
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated CTCFL or DCAF6?,top_cases_counts_by_genes
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated CTCFL or FNDC7?,top_cases_counts_by_genes
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated CTCFL or STK19?,top_cases_counts_by_genes
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated CEP20 or FMO4?,top_cases_counts_by_genes
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated CEP20 or PSG2?,top_cases_counts_by_genes
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated RIMS2 or POC1B?,top_cases_counts_by_genes
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated RIMS2 or TASOR2?,top_cases_counts_by_genes
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated RIMS2 or CDKN2AIP?,top_cases_counts_by_genes
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated RIMS2 or ZNF431?,top_cases_counts_by_genes
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated RIMS2 or ICE1?,top_cases_counts_by_genes
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated RIMS2 or EBF2?,top_cases_counts_by_genes
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated RIMS2 or OLFML3?,top_cases_counts_by_genes
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated PIK3C2G or CYB5R2?,top_cases_counts_by_genes
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated PIK3C2G or CFAP298-TCP10L?,top_cases_counts_by_genes
+728,STK19,D341N,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated STK19 or TET2?,top_cases_counts_by_genes
+729,STK19,D345N,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated STK19 or TRPA1?,top_cases_counts_by_genes
+730,REXO4,P60A,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated REXO4 or MORF4L1?,top_cases_counts_by_genes
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated ZBTB34 or RIMS2?,top_cases_counts_by_genes
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated ZBTB34 or GUK1?,top_cases_counts_by_genes
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases have mutated NCKAP5 or TNS1?,top_cases_counts_by_genes
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have mutated SORCS1 or TTC17?",top_cases_counts_by_genes
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have mutated SORCS1 or TENM2?",top_cases_counts_by_genes
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have mutated SORCS1 or ZMYM3?",top_cases_counts_by_genes
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have mutated SORCS1 or KDM5C?",top_cases_counts_by_genes
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What proportion of Head and Neck Squamous Cell Carcinoma cases have mutated FGF8 or RIMS2?,top_cases_counts_by_genes
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What proportion of Head and Neck Squamous Cell Carcinoma cases have mutated FGF8 or MAST4?,top_cases_counts_by_genes
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What proportion of Head and Neck Squamous Cell Carcinoma cases have mutated FGF8 or DNAH14?,top_cases_counts_by_genes
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What proportion of Head and Neck Squamous Cell Carcinoma cases have mutated FGF8 or YY1AP1?,top_cases_counts_by_genes
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What proportion of Head and Neck Squamous Cell Carcinoma cases have mutated FGF8 or GUCY2C?,top_cases_counts_by_genes
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What proportion of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia cases have mutated TENM3 or PRSS8?,top_cases_counts_by_genes
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated AKT1 or TLK2?,top_cases_counts_by_genes
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have mutated CFAP298-TCP10L or NEXN?,top_cases_counts_by_genes
+792,GLRB,E148D,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated GLRB or SYNJ1?,top_cases_counts_by_genes
+793,TTN,F7636L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated TTN or DHX16?,top_cases_counts_by_genes
+794,TTN,F8563L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated TTN or SYT10?,top_cases_counts_by_genes
+795,TTN,F8880L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated TTN or POC1B?,top_cases_counts_by_genes
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated ANKRD30A or PCDHB2?,top_cases_counts_by_genes
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated ANKRD30A or KL?,top_cases_counts_by_genes
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated ANKRD30A or TAF1C?,top_cases_counts_by_genes
+809,TRIM45,S177L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated TRIM45 or HTR3B?,top_cases_counts_by_genes
+810,TRIM45,S224L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated TRIM45 or SYT9?,top_cases_counts_by_genes
+811,TRIM45,S281L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated TRIM45 or MAD1L1?,top_cases_counts_by_genes
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated CACNA1F or OR5D14?,top_cases_counts_by_genes
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated CACNA1F or DCC?,top_cases_counts_by_genes
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated CACNA1F or TMEM255A?,top_cases_counts_by_genes
+817,KL,R594C,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated KL or PTPRN2?,top_cases_counts_by_genes
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma cases have mutated GUF1 or NPSR1?,top_cases_counts_by_genes
+822,TAF1L,A539V,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated TAF1L or EIF2B4?,top_cases_counts_by_genes
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated TASOR2 or DNMT1?,top_cases_counts_by_genes
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated TASOR2 or POC1B?,top_cases_counts_by_genes
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated TASOR2 or BCAT1?,top_cases_counts_by_genes
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated KDM5C or PTPRO?,top_cases_counts_by_genes
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated KDM5C or PTPRN2?,top_cases_counts_by_genes
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated KDM5C or PGF?,top_cases_counts_by_genes
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated KDM5C or AUTS2?,top_cases_counts_by_genes
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have mutated IL5RA or HTR3B?,top_cases_counts_by_genes
+843,DHX16,A29V,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated DHX16 or MAST4?,top_cases_counts_by_genes
+844,DHX16,A89V,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated DHX16 or FBXO15?,top_cases_counts_by_genes
+902,GPR158,A644V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated GPR158 or TYK2?,top_cases_counts_by_genes
+903,GPR158,A723V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated GPR158 or UNC5D?,top_cases_counts_by_genes
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have mutated EIF2B4 or CDC42BPA?",top_cases_counts_by_genes
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have mutated EIF2B4 or CFAP61?",top_cases_counts_by_genes
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have mutated EIF2B4 or CPS1?",top_cases_counts_by_genes
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have mutated EIF2B4 or OR2T4?",top_cases_counts_by_genes
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have mutated EIF2B4 or PGR?",top_cases_counts_by_genes
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have mutated EIF2B4 or PTPRO?",top_cases_counts_by_genes
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated AUTS2 or GRTP1?,top_cases_counts_by_genes
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated AUTS2 or GABRA6?,top_cases_counts_by_genes
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated AUTS2 or ERCC6?,top_cases_counts_by_genes
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated AUTS2 or FNDC7?,top_cases_counts_by_genes
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated AUTS2 or PTPRO?,top_cases_counts_by_genes
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated AUTS2 or YY1AP1?,top_cases_counts_by_genes
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated AUTS2 or DNMT1?,top_cases_counts_by_genes
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated AUTS2 or PGR?,top_cases_counts_by_genes
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated AUTS2 or ZNF431?,top_cases_counts_by_genes
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated AUTS2 or FBXO42?,top_cases_counts_by_genes
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have mutated ACTL7B or C7orf31?",top_cases_counts_by_genes
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases have mutated PCDHGA1 or COL6A3?,top_cases_counts_by_genes
+954,TRAP1,R114W,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated TRAP1 or ZNF217?,top_cases_counts_by_genes
+955,TRAP1,R61W,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated TRAP1 or ANKDD1A?,top_cases_counts_by_genes
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated PIK3C2A or TENT5A?,top_cases_counts_by_genes
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases have mutated KANSL1 or IL5RA?,top_cases_counts_by_genes
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated ANKRD52 or DGKD?,top_cases_counts_by_genes
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated PAPPA or ARHGEF40?,top_cases_counts_by_genes
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases have mutated B3GALNT1 or FBXO15?,top_cases_counts_by_genes
+982,GABRA6,G115R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated GABRA6 or ITPRID2?,top_cases_counts_by_genes
+983,GABRA6,G122R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated GABRA6 or PTPRN2?,top_cases_counts_by_genes
+984,GABRA6,G165R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated GABRA6 or AUTS2?,top_cases_counts_by_genes
+985,GABRA6,G175R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated GABRA6 or FNDC7?,top_cases_counts_by_genes
+986,GABRA6,G70R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated GABRA6 or ZCCHC14?,top_cases_counts_by_genes
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated ZSCAN31 or TTN?,top_cases_counts_by_genes
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have mutated MED16 or TRPA1?",top_cases_counts_by_genes
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have mutated MED16 or DNMT1?",top_cases_counts_by_genes
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma cases have mutated PTPRO or AUTS2?,top_cases_counts_by_genes
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma cases have mutated PTPRO or ANKDD1A?,top_cases_counts_by_genes
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma cases have mutated PTPRO or AQP7?,top_cases_counts_by_genes
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma cases have mutated PTPRO or THBS4?,top_cases_counts_by_genes
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma cases have mutated PTPRO or FRY?,top_cases_counts_by_genes
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma cases have mutated PTPRO or USH2A?,top_cases_counts_by_genes
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma cases have mutated PTPRO or HSPA5?,top_cases_counts_by_genes
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma cases have mutated PTPRO or EIF2B4?,top_cases_counts_by_genes
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated CHMP7 or ZFAT?,top_cases_counts_by_genes
+1017,GPC3,I107N,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated GPC3 or CXCR2?,top_cases_counts_by_genes
+1018,GPC3,I161N,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated GPC3 or ZFAT?,top_cases_counts_by_genes
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have mutated TLK2 or CCDC22?,top_cases_counts_by_genes
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have mutated TLK2 or TYK2?,top_cases_counts_by_genes
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have mutated TLK2 or FRY?,top_cases_counts_by_genes
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have mutated TLK2 or GRTP1?,top_cases_counts_by_genes
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have mutated TLK2 or UNC5D?,top_cases_counts_by_genes
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated ZNF217 or TAF1C?,top_cases_counts_by_genes
+1038,SYT9,V275L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated SYT9 or COL6A3?,top_cases_counts_by_genes
+1039,SYT9,V307L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated SYT9 or CHMP7?,top_cases_counts_by_genes
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated PKHD1L1 or PRSS1?,top_cases_counts_by_genes
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated MYO3A or ZFPM2?,top_cases_counts_by_genes
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have mutated VASN or SPATA22?",top_cases_counts_by_genes
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated DNMT1 or GUF1?,top_cases_counts_by_genes
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated DNMT1 or ANKDD1A?,top_cases_counts_by_genes
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated DNMT1 or GUF1?,top_cases_counts_by_genes
+1056,CA9,E402K,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated CA9 or DCLK3?,top_cases_counts_by_genes
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated TTC17 or SMO?,top_cases_counts_by_genes
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated TTC17 or MAST4?,top_cases_counts_by_genes
+1065,PSG2,P43L,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases have mutated PSG2 or PIAS3?,top_cases_counts_by_genes
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases have mutated RIPOR2 or TRAP1?,top_cases_counts_by_genes
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases have mutated RIPOR2 or CA9?,top_cases_counts_by_genes
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases have mutated RIPOR2 or DCN?,top_cases_counts_by_genes
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases have mutated RIPOR2 or PXN?,top_cases_counts_by_genes
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated DCLK3 or CARMIL1?,top_cases_counts_by_genes
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated DCLK3 or B3GALNT1?,top_cases_counts_by_genes
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated MERTK or EVC2?,top_cases_counts_by_genes
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated MERTK or TASOR2?,top_cases_counts_by_genes
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated MERTK or ARMC3?,top_cases_counts_by_genes
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated ZFP42 or TMEM255A?,top_cases_counts_by_genes
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated OR13C3 or CTNNA2?,top_cases_counts_by_genes
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated OR13C3 or CNGB1?,top_cases_counts_by_genes
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated SPAG1 or YY1AP1?,top_cases_counts_by_genes
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated CDKN2AIP or PAK3?,top_cases_counts_by_genes
+1093,PXN,H1016Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated PXN or RAB40C?,top_cases_counts_by_genes
+1094,PXN,H359Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated PXN or TRIM45?,top_cases_counts_by_genes
+1095,PXN,H492Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated PXN or MAOB?,top_cases_counts_by_genes
+1096,PXN,H524Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated PXN or NRAP?,top_cases_counts_by_genes
+1097,PXN,H526Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated PXN or SYNJ1?,top_cases_counts_by_genes
+1098,PXN,H540Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated PXN or DHX16?,top_cases_counts_by_genes
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated TTYH2 or ARMC3?,top_cases_counts_by_genes
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated TTYH2 or PRSS8?,top_cases_counts_by_genes
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated TMEM255A or TENT5A?,top_cases_counts_by_genes
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated TMEM255A or MYO16?,top_cases_counts_by_genes
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated TMEM255A or TMEM255A?,top_cases_counts_by_genes
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases have mutated TASOR2 or POC1B?,top_cases_counts_by_genes
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases have mutated TASOR2 or SLC24A2?,top_cases_counts_by_genes
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated ICE1 or TTC17?,top_cases_counts_by_genes
+1112,MYT1,A558E,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases have mutated MYT1 or ANKRD30A?,top_cases_counts_by_genes
+1113,MYT1,A879E,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases have mutated MYT1 or OR2A12?,top_cases_counts_by_genes
+1114,MYT1,A906E,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases have mutated MYT1 or KDM5C?,top_cases_counts_by_genes
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated CX3CR1 or RIMS2?,top_cases_counts_by_genes
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated CX3CR1 or MERTK?,top_cases_counts_by_genes
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases have mutated SPINDOC or MORF4L1?,top_cases_counts_by_genes
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated ART3 or PIK3C2B?,top_cases_counts_by_genes
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated ART3 or AQP7?,top_cases_counts_by_genes
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases have mutated CYP1A2 or DNAH11?,top_cases_counts_by_genes
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have mutated ADRA1A or EIF2B4?",top_cases_counts_by_genes
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated CDH23 or CTSC?,top_cases_counts_by_genes
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated CDH23 or DGKD?,top_cases_counts_by_genes
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated KRT39 or CEP20?,top_cases_counts_by_genes
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated PDHA2 or KIF20B?,top_cases_counts_by_genes
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated SLC24A2 or GPC3?,top_cases_counts_by_genes
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases have mutated PTPRN2 or ZCCHC14?,top_cases_counts_by_genes
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases have mutated PTPRN2 or KRT39?,top_cases_counts_by_genes
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases have mutated PTPRN2 or LAMB2?,top_cases_counts_by_genes
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases have mutated PTPRN2 or TENM3?,top_cases_counts_by_genes
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma cases have mutated PTPRN2 or FBXO42?,top_cases_counts_by_genes
+1188,SOX21,R55L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated SOX21 or OR2T4?,top_cases_counts_by_genes
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases have mutated CPA6 or EIF2B4?,top_cases_counts_by_genes
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated GRM5 or CCDC22?,top_cases_counts_by_genes
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have mutated CASZ1 or GUCY2C?",top_cases_counts_by_genes
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated SGIP1 or TTC12?,top_cases_counts_by_genes
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated SGIP1 or POLD1?,top_cases_counts_by_genes
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated SGIP1 or CDH23?,top_cases_counts_by_genes
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated SGIP1 or PCDHB2?,top_cases_counts_by_genes
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated CARMIL1 or SLC9C1?,top_cases_counts_by_genes
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated CARMIL1 or OR13C3?,top_cases_counts_by_genes
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated ZNF431 or BICC1?,top_cases_counts_by_genes
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated ZNF431 or PAK3?,top_cases_counts_by_genes
+1234,ZNF431,R128I,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated ZNF431 or ZNF431?,top_cases_counts_by_genes
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated DNAH11 or DCN?,top_cases_counts_by_genes
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated DNAH11 or KIF20B?,top_cases_counts_by_genes
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated POLD1 or CNGB1?,top_cases_counts_by_genes
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma cases have mutated POLD1 or EBF2?,top_cases_counts_by_genes
+1248,TTC12,D646H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated TTC12 or XKR4?,top_cases_counts_by_genes
+1249,TTC12,D652H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated TTC12 or POC1B?,top_cases_counts_by_genes
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases have mutated CNGB1 or COL6A3?,top_cases_counts_by_genes
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma cases have mutated CNGB1 or ZNF431?,top_cases_counts_by_genes
+1254,CTSC,E214V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated CTSC or KDM5C?,top_cases_counts_by_genes
+1255,CTSC,E291V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated CTSC or TTN?,top_cases_counts_by_genes
+1256,CTSC,E322V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated CTSC or MORF4L1?,top_cases_counts_by_genes
+1257,CTSC,E324V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated CTSC or PXN?,top_cases_counts_by_genes
+1258,CTSC,E335V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated CTSC or GIMAP2?,top_cases_counts_by_genes
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated PRSS8 or CHODL?,top_cases_counts_by_genes
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated PRSS8 or SPATA22?,top_cases_counts_by_genes
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated ARHGEF40 or CTSC?,top_cases_counts_by_genes
+1264,ACTB,A138T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases have mutated ACTB or OLFML3?,top_cases_counts_by_genes
+1265,ACTB,A217T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases have mutated ACTB or TENT5A?,top_cases_counts_by_genes
+1266,ACTB,A244T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases have mutated ACTB or PCDHB2?,top_cases_counts_by_genes
+1267,ACTB,A260T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases have mutated ACTB or DEFB115?,top_cases_counts_by_genes
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases have mutated YY1AP1 or MYH11?,top_cases_counts_by_genes
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases have mutated YY1AP1 or CDKN2AIP?,top_cases_counts_by_genes
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases have mutated YY1AP1 or SOX21?,top_cases_counts_by_genes
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases have mutated YY1AP1 or BCAT1?,top_cases_counts_by_genes
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases have mutated YY1AP1 or PTPRN2?,top_cases_counts_by_genes
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases have mutated YY1AP1 or TLK2?,top_cases_counts_by_genes
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme cases have mutated YY1AP1 or YY1AP1?,top_cases_counts_by_genes
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated FNDC7 or PIK3C2A?,top_cases_counts_by_genes
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated FNDC7 or PXN?,top_cases_counts_by_genes
+1299,TLCD5,G15V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated TLCD5 or ANKRD30A?,top_cases_counts_by_genes
+1300,TLCD5,G37V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated TLCD5 or GUK1?,top_cases_counts_by_genes
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated POLR1G or FRY?,top_cases_counts_by_genes
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated POLR1G or ACTL7B?,top_cases_counts_by_genes
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated DNAH14 or PTPRO?,top_cases_counts_by_genes
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated DNAH14 or EBF2?,top_cases_counts_by_genes
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated DNAH14 or SORCS1?,top_cases_counts_by_genes
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated NEXN or EIF2B4?,top_cases_counts_by_genes
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma cases have mutated CYB5R2 or TTN?,top_cases_counts_by_genes
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma cases have mutated CYB5R2 or SPAG1?,top_cases_counts_by_genes
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated NRAP or MUC16?,top_cases_counts_by_genes
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated NRAP or SGIP1?,top_cases_counts_by_genes
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated NRAP or ART3?,top_cases_counts_by_genes
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated CCDC22 or PDHA2?,top_cases_counts_by_genes
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated DCAF6 or DPF3?,top_cases_counts_by_genes
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated DCAF6 or BCAT1?,top_cases_counts_by_genes
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated ZNF708 or OR2T4?,top_cases_counts_by_genes
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated BFAR or MORF4L1?,top_cases_counts_by_genes
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated MAST4 or HTR3B?,top_cases_counts_by_genes
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated MAST4 or CA9?,top_cases_counts_by_genes
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated MAST4 or TASOR2?,top_cases_counts_by_genes
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated MAST4 or CASZ1?,top_cases_counts_by_genes
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated MAST4 or THBS4?,top_cases_counts_by_genes
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated ARMC3 or CACNA1F?,top_cases_counts_by_genes
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated ARMC3 or ACVR1B?,top_cases_counts_by_genes
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What proportion of Kidney Renal Clear Cell Carcinoma cases have mutated TET2 or YY1AP1?,top_cases_counts_by_genes
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What proportion of Kidney Renal Clear Cell Carcinoma cases have mutated TET2 or ANKRD30A?,top_cases_counts_by_genes
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated SERPINB10 or YY1AP1?,top_cases_counts_by_genes
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated STAT3 or DSCAM?,top_cases_counts_by_genes
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated MIEF1 or TAF1C?,top_cases_counts_by_genes
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated ACVR1B or TAS1R3?,top_cases_counts_by_genes
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated ACVR1B or RIPOR2?,top_cases_counts_by_genes
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated ACVR1B or DNMT1?,top_cases_counts_by_genes
+1393,EBF2,T104I,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated EBF2 or ADRA1A?,top_cases_counts_by_genes
+1394,EBF2,T252I,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated EBF2 or ZFPM2?,top_cases_counts_by_genes
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated VPS26B or DOCK2?,top_cases_counts_by_genes
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have mutated PGR or GPR158?",top_cases_counts_by_genes
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have mutated PGR or TRIM45?",top_cases_counts_by_genes
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have mutated PGR or FGF8?",top_cases_counts_by_genes
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma cases have mutated ACTA2 or JAML?,top_cases_counts_by_genes
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated THBS4 or MED16?,top_cases_counts_by_genes
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated THBS4 or DPF3?,top_cases_counts_by_genes
+1413,PRSS1,S114T,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated PRSS1 or NPSR1?,top_cases_counts_by_genes
+1414,PRSS1,S124T,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated PRSS1 or CTSC?,top_cases_counts_by_genes
+1415,PRSS1,S138T,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated PRSS1 or SYT9?,top_cases_counts_by_genes
+1416,PRSS1,S74T,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma cases have mutated PRSS1 or ANKRD30A?,top_cases_counts_by_genes
+1417,PGF,R126H,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated PGF or CR1?,top_cases_counts_by_genes
+1418,PGF,R127H,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma cases have mutated PGF or EIF2B4?,top_cases_counts_by_genes
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases have mutated ITPRID2 or HSPA5?,top_cases_counts_by_genes
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma cases have mutated ITPRID2 or MYT1?,top_cases_counts_by_genes
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated HBB or TAF1C?,top_cases_counts_by_genes
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated PCDHB2 or OR2T4?,top_cases_counts_by_genes
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated PCDHB2 or TYK2?,top_cases_counts_by_genes
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma cases have mutated PCDHB2 or SPINDOC?,top_cases_counts_by_genes
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma cases have mutated UBR2 or ZMYM3?,top_cases_counts_by_genes
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma cases have mutated FBXO42 or DCC?,top_cases_counts_by_genes
+1,TNS1,G1362V,Breast Invasive Carcinoma,How many patients with Breast Invasive Carcinoma carry mutations in either TNS1 or PYHIN1?,top_cases_counts_by_genes
+2,TNS1,G1711V,Breast Invasive Carcinoma,How many patients with Breast Invasive Carcinoma carry mutations in either TNS1 or DSCAM?,top_cases_counts_by_genes
+3,TNS1,G1718V,Breast Invasive Carcinoma,How many patients with Breast Invasive Carcinoma carry mutations in either TNS1 or CNGB1?,top_cases_counts_by_genes
+4,TNS1,G1732V,Breast Invasive Carcinoma,How many patients with Breast Invasive Carcinoma carry mutations in either TNS1 or SPAG1?,top_cases_counts_by_genes
+5,TNS1,G1824V,Breast Invasive Carcinoma,How many patients with Breast Invasive Carcinoma carry mutations in either TNS1 or SORCS1?,top_cases_counts_by_genes
+6,TNS1,G1857V,Breast Invasive Carcinoma,How many patients with Breast Invasive Carcinoma carry mutations in either TNS1 or PIAS3?,top_cases_counts_by_genes
+7,TNS1,G843V,Breast Invasive Carcinoma,How many patients with Breast Invasive Carcinoma carry mutations in either TNS1 or SORCS1?,top_cases_counts_by_genes
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How many patients with Bladder Urothelial Carcinoma carry mutations in either EVC2 or EFCAB12?,top_cases_counts_by_genes
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How many patients with Bladder Urothelial Carcinoma carry mutations in either EVC2 or RIPOR2?,top_cases_counts_by_genes
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either CR1 or SIK2?,top_cases_counts_by_genes
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either CR1 or TLK2?,top_cases_counts_by_genes
+22,TRPA1,S295I,Rectum Adenocarcinoma,How many patients with Rectum Adenocarcinoma carry mutations in either TRPA1 or MYH11?,top_cases_counts_by_genes
+23,TRPA1,S443I,Rectum Adenocarcinoma,How many patients with Rectum Adenocarcinoma carry mutations in either TRPA1 or CTCFL?,top_cases_counts_by_genes
+24,TAF1C,R299L,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either TAF1C or KANSL1?,top_cases_counts_by_genes
+25,TAF1C,R396L,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either TAF1C or TSHZ3?,top_cases_counts_by_genes
+26,TAF1C,R634L,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either TAF1C or CNGB1?,top_cases_counts_by_genes
+27,TAF1C,R702L,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either TAF1C or PAK3?,top_cases_counts_by_genes
+28,TAF1C,R728L,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either TAF1C or KANSL1?,top_cases_counts_by_genes
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either DPF3 or CFAP61?,top_cases_counts_by_genes
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either DPF3 or TYK2?,top_cases_counts_by_genes
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either DPF3 or TRIM45?,top_cases_counts_by_genes
+42,OR2T4,P272H,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either OR2T4 or OLFML3?,top_cases_counts_by_genes
+43,OR2T4,P300H,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either OR2T4 or TTC17?,top_cases_counts_by_genes
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How many patients with Pancreatic Adenocarcinoma carry mutations in either FBN1 or AUTS2?,top_cases_counts_by_genes
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How many patients with Prostate Adenocarcinoma carry mutations in either MAD1L1 or TENM3?,top_cases_counts_by_genes
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How many patients with Prostate Adenocarcinoma carry mutations in either MAD1L1 or DSCAM?,top_cases_counts_by_genes
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How many patients with Prostate Adenocarcinoma carry mutations in either MAD1L1 or JAML?,top_cases_counts_by_genes
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either CCNG1 or RIPOR2?,top_cases_counts_by_genes
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How many patients with Kidney Renal Papillary Cell Carcinoma carry mutations in either ANP32E or USH2A?,top_cases_counts_by_genes
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How many patients with Kidney Renal Papillary Cell Carcinoma carry mutations in either ANP32E or NRAP?,top_cases_counts_by_genes
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How many patients with Kidney Renal Papillary Cell Carcinoma carry mutations in either ANP32E or MERTK?,top_cases_counts_by_genes
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How many patients with Kidney Renal Papillary Cell Carcinoma carry mutations in either ANP32E or UNC5D?,top_cases_counts_by_genes
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How many patients with Bladder Urothelial Carcinoma carry mutations in either FRY or PIK3C2B?,top_cases_counts_by_genes
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How many patients with Bladder Urothelial Carcinoma carry mutations in either FRY or CACNA1F?,top_cases_counts_by_genes
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How many patients with Bladder Urothelial Carcinoma carry mutations in either FRY or ANKRD52?,top_cases_counts_by_genes
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How many patients with Bladder Urothelial Carcinoma carry mutations in either FRY or PCDHGA1?,top_cases_counts_by_genes
+70,PAK3,E318K,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either PAK3 or SYT10?,top_cases_counts_by_genes
+71,PAK3,E319K,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either PAK3 or SYNJ1?,top_cases_counts_by_genes
+72,PAK3,E334K,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either PAK3 or PRSS1?,top_cases_counts_by_genes
+73,PAK3,E340K,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either PAK3 or COL6A3?,top_cases_counts_by_genes
+74,PAK3,E355K,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either PAK3 or MAST4?,top_cases_counts_by_genes
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either MUC16 or PXN?,top_cases_counts_by_genes
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How many patients with Liver Hepatocellular Carcinoma carry mutations in either ZFPM2 or ZNF431?,top_cases_counts_by_genes
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How many patients with Liver Hepatocellular Carcinoma carry mutations in either ZFPM2 or PTPRO?,top_cases_counts_by_genes
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How many patients with Breast Invasive Carcinoma carry mutations in either PIK3C2B or PLEKHG6?,top_cases_counts_by_genes
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How many patients with Breast Invasive Carcinoma carry mutations in either PIK3C2B or BICC1?,top_cases_counts_by_genes
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either ZNF804A or SMO?,top_cases_counts_by_genes
+116,RELN,A2371V,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either RELN or POC1B?,top_cases_counts_by_genes
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus carry mutations in either EFCAB12 or CNGB1?",top_cases_counts_by_genes
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus carry mutations in either EFCAB12 or CTNNA2?",top_cases_counts_by_genes
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either DEFB115 or TTC12?,top_cases_counts_by_genes
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How many patients with Bladder Urothelial Carcinoma carry mutations in either ANKDD1A or TLCD5?,top_cases_counts_by_genes
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How many patients with Bladder Urothelial Carcinoma carry mutations in either ANKDD1A or TET2?,top_cases_counts_by_genes
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How many patients with Bladder Urothelial Carcinoma carry mutations in either ANKDD1A or SGIP1?,top_cases_counts_by_genes
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either HTR3B or TTN?,top_cases_counts_by_genes
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either HTR3B or TNS1?,top_cases_counts_by_genes
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either HTR3B or NOMO1?,top_cases_counts_by_genes
+129,ABCC3,R758W,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either ABCC3 or COL6A3?,top_cases_counts_by_genes
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either NOMO1 or GABRA6?,top_cases_counts_by_genes
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either NOMO1 or GPRASP1?,top_cases_counts_by_genes
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How many patients with Bladder Urothelial Carcinoma carry mutations in either HYOU1 or ZNF217?,top_cases_counts_by_genes
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either FMO4 or GRM5?,top_cases_counts_by_genes
+140,BICC1,A372V,Exceptional Responders,How many patients with Exceptional Responders carry mutations in either BICC1 or YY1AP1?,top_cases_counts_by_genes
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either ZMYM3 or GABRA6?,top_cases_counts_by_genes
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either ZMYM3 or KIF20B?,top_cases_counts_by_genes
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either ZMYM3 or PRSS1?,top_cases_counts_by_genes
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus carry mutations in either XKR4 or TMEM255A?",top_cases_counts_by_genes
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How many patients with Liver Hepatocellular Carcinoma carry mutations in either ABCC2 or ZFP42?,top_cases_counts_by_genes
+157,OR8K5,R293G,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either OR8K5 or SLC9C1?,top_cases_counts_by_genes
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either SPTAN1 or TASOR2?,top_cases_counts_by_genes
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either SPTAN1 or ANKRD30A?,top_cases_counts_by_genes
+164,SYT10,M484I,Rectum Adenocarcinoma,How many patients with Rectum Adenocarcinoma carry mutations in either SYT10 or ARMC3?,top_cases_counts_by_genes
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either HSPA5 or CYB5R2?,top_cases_counts_by_genes
+175,UNC5D,L280V,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either UNC5D or PRSS1?,top_cases_counts_by_genes
+176,UNC5D,L635V,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either UNC5D or COL6A3?,top_cases_counts_by_genes
+177,UNC5D,L637V,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either UNC5D or FBXO42?,top_cases_counts_by_genes
+178,UNC5D,L699V,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either UNC5D or ACTA2?,top_cases_counts_by_genes
+179,UNC5D,L704V,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either UNC5D or CTSC?,top_cases_counts_by_genes
+180,UNC5D,L709V,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either UNC5D or EBF2?,top_cases_counts_by_genes
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How many patients with Kidney Renal Clear Cell Carcinoma carry mutations in either DOCK2 or MED16?,top_cases_counts_by_genes
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How many patients with Kidney Renal Clear Cell Carcinoma carry mutations in either ZNF627 or TAF1C?,top_cases_counts_by_genes
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either CDC42BPA or GPC3?,top_cases_counts_by_genes
+193,MRPL55,H27Y,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either MRPL55 or ZNF584?,top_cases_counts_by_genes
+194,MRPL55,H63Y,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either MRPL55 or DPF3?,top_cases_counts_by_genes
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How many patients with Breast Invasive Carcinoma carry mutations in either TMTC3 or TRAP1?,top_cases_counts_by_genes
+198,EPRS1,K771I,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either EPRS1 or GPRASP1?,top_cases_counts_by_genes
+199,EPRS1,K778I,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either EPRS1 or OLFML3?,top_cases_counts_by_genes
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either GRTP1 or CHMP7?,top_cases_counts_by_genes
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either GRTP1 or ZMYM3?,top_cases_counts_by_genes
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either TSHZ3 or SGIP1?,top_cases_counts_by_genes
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How many patients with HIV+ Tumor Molecular Characterization Project - Cervical Cancer carry mutations in either TAS1R3 or FRY?,top_cases_counts_by_genes
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either PIAS3 or MUC16?,top_cases_counts_by_genes
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either PIAS3 or CPS1?,top_cases_counts_by_genes
+251,ZNF274,P13R,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either ZNF274 or RAB40C?,top_cases_counts_by_genes
+253,SYNJ1,R795C,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either SYNJ1 or ZCCHC14?,top_cases_counts_by_genes
+254,SYNJ1,R800C,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either SYNJ1 or CARMIL1?,top_cases_counts_by_genes
+255,SYNJ1,R839C,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either SYNJ1 or ACVR1B?,top_cases_counts_by_genes
+261,DSCAM,V343M,Prostate Adenocarcinoma,How many patients with Prostate Adenocarcinoma carry mutations in either DSCAM or MSANTD4?,top_cases_counts_by_genes
+262,DSCAM,V426M,Prostate Adenocarcinoma,How many patients with Prostate Adenocarcinoma carry mutations in either DSCAM or DCC?,top_cases_counts_by_genes
+263,DSCAM,V591M,Prostate Adenocarcinoma,How many patients with Prostate Adenocarcinoma carry mutations in either DSCAM or NOMO1?,top_cases_counts_by_genes
+267,DGKD,R140H,Exceptional Responders,How many patients with Exceptional Responders carry mutations in either DGKD or EPRS1?,top_cases_counts_by_genes
+268,DGKD,R160H,Exceptional Responders,How many patients with Exceptional Responders carry mutations in either DGKD or CFAP298-TCP10L?,top_cases_counts_by_genes
+269,DGKD,R204H,Exceptional Responders,How many patients with Exceptional Responders carry mutations in either DGKD or AUTS2?,top_cases_counts_by_genes
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How many patients with Bladder Urothelial Carcinoma carry mutations in either PLEKHG6 or GPR158?,top_cases_counts_by_genes
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How many patients with Bladder Urothelial Carcinoma carry mutations in either PLEKHG6 or EIF2B4?,top_cases_counts_by_genes
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How many patients with Bladder Urothelial Carcinoma carry mutations in either PLEKHG6 or GABRA6?,top_cases_counts_by_genes
+279,WNT2,D138N,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either WNT2 or CTCFL?,top_cases_counts_by_genes
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either GUCY2C or ANP32E?,top_cases_counts_by_genes
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either C7orf31 or GUF1?,top_cases_counts_by_genes
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus carry mutations in either ZKSCAN7 or POC1B?",top_cases_counts_by_genes
+299,OR5D14,M210L,Neuroblastoma,How many patients with Neuroblastoma carry mutations in either OR5D14 or MORF4L1?,top_cases_counts_by_genes
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either SPATA22 or TRAP1?,top_cases_counts_by_genes
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either SPATA22 or DHX16?,top_cases_counts_by_genes
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either SPATA22 or CYP1A2?,top_cases_counts_by_genes
+310,LCN15,E21V,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either LCN15 or HTR3B?,top_cases_counts_by_genes
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either DCAF4L2 or FNDC7?,top_cases_counts_by_genes
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either GUK1 or FGF8?,top_cases_counts_by_genes
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either GUK1 or CCNG1?,top_cases_counts_by_genes
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either GUK1 or NRAP?,top_cases_counts_by_genes
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either GUK1 or BICC1?,top_cases_counts_by_genes
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either GUK1 or TRIM45?,top_cases_counts_by_genes
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either MORF4L1 or ANKDD1A?,top_cases_counts_by_genes
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either MORF4L1 or CX3CR1?,top_cases_counts_by_genes
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either MORF4L1 or AUTS2?,top_cases_counts_by_genes
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either MORF4L1 or DCN?,top_cases_counts_by_genes
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either MYO3B or ICE1?,top_cases_counts_by_genes
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either MYO3B or PXN?,top_cases_counts_by_genes
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either TENT5A or GUK1?,top_cases_counts_by_genes
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either TENT5A or ACTA2?,top_cases_counts_by_genes
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either TENT5A or SORCS1?,top_cases_counts_by_genes
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How many patients with Ovarian Serous Cystadenocarcinoma carry mutations in either ZFAT or MERTK?,top_cases_counts_by_genes
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How many patients with Ovarian Serous Cystadenocarcinoma carry mutations in either ZFAT or RIPOR2?,top_cases_counts_by_genes
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How many patients with Ovarian Serous Cystadenocarcinoma carry mutations in either ZFAT or OR2A12?,top_cases_counts_by_genes
+357,ZNF584,A211T,Sarcoma,How many patients with Sarcoma carry mutations in either ZNF584 or SIK2?,top_cases_counts_by_genes
+358,ZNF584,A256T,Sarcoma,How many patients with Sarcoma carry mutations in either ZNF584 or MAST4?,top_cases_counts_by_genes
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either LDOC1 or ZNF274?,top_cases_counts_by_genes
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either PDGFC or SPTAN1?,top_cases_counts_by_genes
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either MSANTD4 or MAST4?,top_cases_counts_by_genes
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either NPSR1 or ANKDD1A?,top_cases_counts_by_genes
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either PHLPP1 or RIMS2?,top_cases_counts_by_genes
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either COL6A3 or GSTCD?,top_cases_counts_by_genes
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either COL6A3 or HYOU1?,top_cases_counts_by_genes
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either COL6A3 or TNS1?,top_cases_counts_by_genes
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either COL6A3 or DCN?,top_cases_counts_by_genes
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either COL6A3 or EIF2B4?,top_cases_counts_by_genes
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either ADRA1A or TTC12?,top_cases_counts_by_genes
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many patients with Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma carry mutations in either LAMB2 or PIK3C2B?,top_cases_counts_by_genes
+406,POC1B,I198T,Rectum Adenocarcinoma,How many patients with Rectum Adenocarcinoma carry mutations in either POC1B or PXN?,top_cases_counts_by_genes
+407,POC1B,I286T,Rectum Adenocarcinoma,How many patients with Rectum Adenocarcinoma carry mutations in either POC1B or RIMS2?,top_cases_counts_by_genes
+408,POC1B,I328T,Rectum Adenocarcinoma,How many patients with Rectum Adenocarcinoma carry mutations in either POC1B or ANKRD24?,top_cases_counts_by_genes
+409,POC1B,S79P,Rectum Adenocarcinoma,How many patients with Rectum Adenocarcinoma carry mutations in either POC1B or DCLK3?,top_cases_counts_by_genes
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How many patients with Liver Hepatocellular Carcinoma carry mutations in either USH2A or PIK3C2B?,top_cases_counts_by_genes
+414,AQP7,T110S,Rectum Adenocarcinoma,How many patients with Rectum Adenocarcinoma carry mutations in either AQP7 or ACTB?,top_cases_counts_by_genes
+415,AQP7,T166S,Rectum Adenocarcinoma,How many patients with Rectum Adenocarcinoma carry mutations in either AQP7 or DCAF6?,top_cases_counts_by_genes
+416,AQP7,T167S,Rectum Adenocarcinoma,How many patients with Rectum Adenocarcinoma carry mutations in either AQP7 or ARMC3?,top_cases_counts_by_genes
+417,AQP7,T75S,Rectum Adenocarcinoma,How many patients with Rectum Adenocarcinoma carry mutations in either AQP7 or GABRA6?,top_cases_counts_by_genes
+430,DCN,R163C,Rectum Adenocarcinoma,How many patients with Rectum Adenocarcinoma carry mutations in either DCN or ICE1?,top_cases_counts_by_genes
+431,DCN,R203C,Rectum Adenocarcinoma,How many patients with Rectum Adenocarcinoma carry mutations in either DCN or SPATA22?,top_cases_counts_by_genes
+432,DCN,R241C,Rectum Adenocarcinoma,How many patients with Rectum Adenocarcinoma carry mutations in either DCN or ABCC2?,top_cases_counts_by_genes
+433,DCN,R350C,Rectum Adenocarcinoma,How many patients with Rectum Adenocarcinoma carry mutations in either DCN or FBN1?,top_cases_counts_by_genes
+434,DCN,R41C,Rectum Adenocarcinoma,How many patients with Rectum Adenocarcinoma carry mutations in either DCN or EIF2B4?,top_cases_counts_by_genes
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either CPS1 or GUCY2C?,top_cases_counts_by_genes
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either CPS1 or EPRS1?,top_cases_counts_by_genes
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either CPS1 or PHLPP1?,top_cases_counts_by_genes
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How many patients with Kidney Renal Papillary Cell Carcinoma carry mutations in either FCGR2C or MRPL32?,top_cases_counts_by_genes
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How many patients with Kidney Renal Papillary Cell Carcinoma carry mutations in either FCGR2C or PGR?,top_cases_counts_by_genes
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either GRM1 or DNAH14?,top_cases_counts_by_genes
+482,SGCZ,Q138H,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either SGCZ or SORCS1?,top_cases_counts_by_genes
+483,SGCZ,Q91H,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either SGCZ or TSHZ3?,top_cases_counts_by_genes
+485,SMO,V15M,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either SMO or ZFAT?,top_cases_counts_by_genes
+486,SMO,V321M,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either SMO or DCC?,top_cases_counts_by_genes
+488,CHODL,G159E,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either CHODL or AUTS2?,top_cases_counts_by_genes
+489,CHODL,G181E,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either CHODL or CNGB1?,top_cases_counts_by_genes
+490,CHODL,G200E,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either CHODL or GUK1?,top_cases_counts_by_genes
+494,MYO16,P399H,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either MYO16 or MIEF1?,top_cases_counts_by_genes
+495,MYO16,P421H,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either MYO16 or TAF1C?,top_cases_counts_by_genes
+498,CXCR2,A98V,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either CXCR2 or ZFAT?,top_cases_counts_by_genes
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How many patients with Bladder Urothelial Carcinoma carry mutations in either TMEM225 or TAF1L?,top_cases_counts_by_genes
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either MAOB or YY1AP1?,top_cases_counts_by_genes
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either GPRASP1 or TMEM255A?,top_cases_counts_by_genes
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either MRPL32 or SMO?,top_cases_counts_by_genes
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either TYROBP or FGF8?,top_cases_counts_by_genes
+510,RAB40C,A111V,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either RAB40C or BCAT1?,top_cases_counts_by_genes
+511,RAB40C,A143V,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either RAB40C or PTPRN2?,top_cases_counts_by_genes
+512,CTNNA2,S323R,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either CTNNA2 or TASOR2?,top_cases_counts_by_genes
+513,CTNNA2,S339R,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either CTNNA2 or OR8K5?,top_cases_counts_by_genes
+514,CTNNA2,S386R,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either CTNNA2 or ZKSCAN7?,top_cases_counts_by_genes
+515,CTNNA2,S707R,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either CTNNA2 or POC1B?,top_cases_counts_by_genes
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How many patients with Bladder Urothelial Carcinoma carry mutations in either MYO15A or ZNF584?,top_cases_counts_by_genes
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either GIMAP2 or ARMC3?,top_cases_counts_by_genes
+532,KIF20B,N1160D,Glioblastoma Multiforme,How many patients with Glioblastoma Multiforme carry mutations in either KIF20B or TRAP1?,top_cases_counts_by_genes
+533,KIF20B,N1200D,Glioblastoma Multiforme,How many patients with Glioblastoma Multiforme carry mutations in either KIF20B or DCC?,top_cases_counts_by_genes
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either ADAM17 or DNAH11?,top_cases_counts_by_genes
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either BCAT1 or CHMP7?,top_cases_counts_by_genes
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either BCAT1 or FGF8?,top_cases_counts_by_genes
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either BCAT1 or SORCS1?,top_cases_counts_by_genes
+540,ERCC6,R1053H,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either ERCC6 or SORCS1?,top_cases_counts_by_genes
+541,DCC,R320W,Breast Invasive Carcinoma,How many patients with Breast Invasive Carcinoma carry mutations in either DCC or GPC3?,top_cases_counts_by_genes
+542,DCC,R363W,Breast Invasive Carcinoma,How many patients with Breast Invasive Carcinoma carry mutations in either DCC or CYB5R2?,top_cases_counts_by_genes
+543,DCC,R386W,Breast Invasive Carcinoma,How many patients with Breast Invasive Carcinoma carry mutations in either DCC or FRY?,top_cases_counts_by_genes
+544,DCC,R41W,Breast Invasive Carcinoma,How many patients with Breast Invasive Carcinoma carry mutations in either DCC or POC1B?,top_cases_counts_by_genes
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either FBXO15 or DOCK2?,top_cases_counts_by_genes
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either FBXO15 or EBF2?,top_cases_counts_by_genes
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either GSTCD or ADRA1A?,top_cases_counts_by_genes
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either GSTCD or FMO4?,top_cases_counts_by_genes
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either OLFML3 or STK19?,top_cases_counts_by_genes
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either OLFML3 or TTC12?,top_cases_counts_by_genes
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either OLFML3 or MIEF1?,top_cases_counts_by_genes
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How many patients with Ovarian Serous Cystadenocarcinoma carry mutations in either CFAP61 or MAD1L1?,top_cases_counts_by_genes
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How many patients with Ovarian Serous Cystadenocarcinoma carry mutations in either CFAP61 or CCDC22?,top_cases_counts_by_genes
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How many patients with Bladder Urothelial Carcinoma carry mutations in either HLA-DQA2 or ANKRD24?,top_cases_counts_by_genes
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either TENM2 or AUTS2?,top_cases_counts_by_genes
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either TENM2 or MAST4?,top_cases_counts_by_genes
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either TENM2 or PCDHB2?,top_cases_counts_by_genes
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either ANKRD24 or TTC12?,top_cases_counts_by_genes
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either ANKRD24 or ANP32E?,top_cases_counts_by_genes
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either ANKRD24 or PDHA2?,top_cases_counts_by_genes
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either ZCCHC14 or PTPRO?,top_cases_counts_by_genes
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either ZCCHC14 or SYNJ1?,top_cases_counts_by_genes
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either ZCCHC14 or HTR3B?,top_cases_counts_by_genes
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either ZCCHC14 or PXN?,top_cases_counts_by_genes
+625,SIK2,I265M,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either SIK2 or ZMYM3?,top_cases_counts_by_genes
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either MYH11 or CHMP7?,top_cases_counts_by_genes
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either MYH11 or AUTS2?,top_cases_counts_by_genes
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either SLC6A4 or TRIM45?,top_cases_counts_by_genes
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either SLC9C1 or FBN1?,top_cases_counts_by_genes
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either SLC9C1 or CFAP61?,top_cases_counts_by_genes
+644,OR2A12,A254T,Brain Lower Grade Glioma,How many patients with Brain Lower Grade Glioma carry mutations in either OR2A12 or ZCCHC14?,top_cases_counts_by_genes
+646,PYHIN1,T325K,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either PYHIN1 or MYT1?,top_cases_counts_by_genes
+647,PYHIN1,T334K,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either PYHIN1 or AQP7?,top_cases_counts_by_genes
+650,JAML,G191E,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either JAML or ICE1?,top_cases_counts_by_genes
+651,JAML,G219E,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either JAML or ANP32E?,top_cases_counts_by_genes
+652,JAML,G220E,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either JAML or FBXO15?,top_cases_counts_by_genes
+653,JAML,G230E,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either JAML or DNAH11?,top_cases_counts_by_genes
+658,TYK2,H1146R,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either TYK2 or RIPOR2?,top_cases_counts_by_genes
+659,TYK2,H23R,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either TYK2 or SPATA22?,top_cases_counts_by_genes
+660,TYK2,H961R,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either TYK2 or EBF2?,top_cases_counts_by_genes
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either CTCFL or PAK3?,top_cases_counts_by_genes
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either CTCFL or MORF4L1?,top_cases_counts_by_genes
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either CTCFL or FRY?,top_cases_counts_by_genes
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either CTCFL or OR8K5?,top_cases_counts_by_genes
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either CEP20 or AQP7?,top_cases_counts_by_genes
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either CEP20 or DSCAM?,top_cases_counts_by_genes
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either RIMS2 or PAK3?,top_cases_counts_by_genes
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either RIMS2 or FBXO42?,top_cases_counts_by_genes
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either RIMS2 or ZMYM3?,top_cases_counts_by_genes
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either RIMS2 or FCGR2C?,top_cases_counts_by_genes
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either RIMS2 or SYT10?,top_cases_counts_by_genes
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either RIMS2 or DCC?,top_cases_counts_by_genes
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either RIMS2 or NEXN?,top_cases_counts_by_genes
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either PIK3C2G or SPAG1?,top_cases_counts_by_genes
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either PIK3C2G or SPATA22?,top_cases_counts_by_genes
+728,STK19,D341N,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either STK19 or ACVR1B?,top_cases_counts_by_genes
+729,STK19,D345N,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either STK19 or CARMIL1?,top_cases_counts_by_genes
+730,REXO4,P60A,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either REXO4 or MYH11?,top_cases_counts_by_genes
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either ZBTB34 or PAK3?,top_cases_counts_by_genes
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either ZBTB34 or ANP32E?,top_cases_counts_by_genes
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How many patients with Bladder Urothelial Carcinoma carry mutations in either NCKAP5 or DPF3?,top_cases_counts_by_genes
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus carry mutations in either SORCS1 or DNAH11?",top_cases_counts_by_genes
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus carry mutations in either SORCS1 or FGF8?",top_cases_counts_by_genes
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus carry mutations in either SORCS1 or NRAP?",top_cases_counts_by_genes
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus carry mutations in either SORCS1 or TTN?",top_cases_counts_by_genes
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How many patients with Head and Neck Squamous Cell Carcinoma carry mutations in either FGF8 or MAD1L1?,top_cases_counts_by_genes
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How many patients with Head and Neck Squamous Cell Carcinoma carry mutations in either FGF8 or GABRA6?,top_cases_counts_by_genes
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How many patients with Head and Neck Squamous Cell Carcinoma carry mutations in either FGF8 or ZNF274?,top_cases_counts_by_genes
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How many patients with Head and Neck Squamous Cell Carcinoma carry mutations in either FGF8 or ANKRD30A?,top_cases_counts_by_genes
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How many patients with Head and Neck Squamous Cell Carcinoma carry mutations in either FGF8 or ACVR1B?,top_cases_counts_by_genes
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How many patients with Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia carry mutations in either TENM3 or CHODL?,top_cases_counts_by_genes
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either AKT1 or ANKRD30A?,top_cases_counts_by_genes
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many patients with Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma carry mutations in either CFAP298-TCP10L or MYT1?,top_cases_counts_by_genes
+792,GLRB,E148D,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either GLRB or COL6A3?,top_cases_counts_by_genes
+793,TTN,F7636L,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either TTN or DGKD?,top_cases_counts_by_genes
+794,TTN,F8563L,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either TTN or PTPRO?,top_cases_counts_by_genes
+795,TTN,F8880L,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either TTN or MAOB?,top_cases_counts_by_genes
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either ANKRD30A or TAF1C?,top_cases_counts_by_genes
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either ANKRD30A or PCDHB2?,top_cases_counts_by_genes
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either ANKRD30A or UBR2?,top_cases_counts_by_genes
+809,TRIM45,S177L,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either TRIM45 or TASOR2?,top_cases_counts_by_genes
+810,TRIM45,S224L,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either TRIM45 or EIF2B4?,top_cases_counts_by_genes
+811,TRIM45,S281L,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either TRIM45 or ZBTB34?,top_cases_counts_by_genes
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either CACNA1F or VPS26B?,top_cases_counts_by_genes
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either CACNA1F or ANP32E?,top_cases_counts_by_genes
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either CACNA1F or EBF2?,top_cases_counts_by_genes
+817,KL,R594C,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either KL or TMEM225?,top_cases_counts_by_genes
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How many patients with Kidney Renal Papillary Cell Carcinoma carry mutations in either GUF1 or DCN?,top_cases_counts_by_genes
+822,TAF1L,A539V,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either TAF1L or DGKD?,top_cases_counts_by_genes
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either TASOR2 or GSTCD?,top_cases_counts_by_genes
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either TASOR2 or USH2A?,top_cases_counts_by_genes
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either TASOR2 or FBXO15?,top_cases_counts_by_genes
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either KDM5C or EIF2B4?,top_cases_counts_by_genes
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either KDM5C or CHMP7?,top_cases_counts_by_genes
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either KDM5C or CPS1?,top_cases_counts_by_genes
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either KDM5C or CFAP61?,top_cases_counts_by_genes
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many patients with Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma carry mutations in either IL5RA or MRPL55?,top_cases_counts_by_genes
+843,DHX16,A29V,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either DHX16 or TTC17?,top_cases_counts_by_genes
+844,DHX16,A89V,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either DHX16 or EIF2B4?,top_cases_counts_by_genes
+902,GPR158,A644V,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either GPR158 or GPC3?,top_cases_counts_by_genes
+903,GPR158,A723V,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either GPR158 or TNS1?,top_cases_counts_by_genes
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus carry mutations in either EIF2B4 or CTNNA2?",top_cases_counts_by_genes
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus carry mutations in either EIF2B4 or GPC3?",top_cases_counts_by_genes
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus carry mutations in either EIF2B4 or FNDC7?",top_cases_counts_by_genes
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus carry mutations in either EIF2B4 or FCGR2C?",top_cases_counts_by_genes
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus carry mutations in either EIF2B4 or TRPA1?",top_cases_counts_by_genes
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus carry mutations in either EIF2B4 or JAML?",top_cases_counts_by_genes
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either AUTS2 or AUTS2?,top_cases_counts_by_genes
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either AUTS2 or GSTCD?,top_cases_counts_by_genes
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either AUTS2 or TLCD5?,top_cases_counts_by_genes
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either AUTS2 or SYNJ1?,top_cases_counts_by_genes
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either AUTS2 or ZSCAN31?,top_cases_counts_by_genes
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either AUTS2 or DCAF4L2?,top_cases_counts_by_genes
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either AUTS2 or PIAS3?,top_cases_counts_by_genes
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either AUTS2 or AUTS2?,top_cases_counts_by_genes
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either AUTS2 or DNAH11?,top_cases_counts_by_genes
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either AUTS2 or SPATA22?,top_cases_counts_by_genes
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus carry mutations in either ACTL7B or SPATA22?",top_cases_counts_by_genes
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How many patients with Glioblastoma Multiforme carry mutations in either PCDHGA1 or JAML?,top_cases_counts_by_genes
+954,TRAP1,R114W,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either TRAP1 or ANKDD1A?,top_cases_counts_by_genes
+955,TRAP1,R61W,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either TRAP1 or GUK1?,top_cases_counts_by_genes
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either PIK3C2A or LCN15?,top_cases_counts_by_genes
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How many patients with Liver Hepatocellular Carcinoma carry mutations in either KANSL1 or SGIP1?,top_cases_counts_by_genes
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either ANKRD52 or POC1B?,top_cases_counts_by_genes
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either PAPPA or TTYH2?,top_cases_counts_by_genes
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How many patients with Rectum Adenocarcinoma carry mutations in either B3GALNT1 or CTSC?,top_cases_counts_by_genes
+982,GABRA6,G115R,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either GABRA6 or PIAS3?,top_cases_counts_by_genes
+983,GABRA6,G122R,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either GABRA6 or TNS1?,top_cases_counts_by_genes
+984,GABRA6,G165R,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either GABRA6 or PLEKHG6?,top_cases_counts_by_genes
+985,GABRA6,G175R,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either GABRA6 or PAK3?,top_cases_counts_by_genes
+986,GABRA6,G70R,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either GABRA6 or PDGFC?,top_cases_counts_by_genes
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either ZSCAN31 or MYH11?,top_cases_counts_by_genes
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus carry mutations in either MED16 or MYO3B?",top_cases_counts_by_genes
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus carry mutations in either MED16 or HLA-DQA2?",top_cases_counts_by_genes
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How many patients with Pancreatic Adenocarcinoma carry mutations in either PTPRO or TAF1C?,top_cases_counts_by_genes
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How many patients with Pancreatic Adenocarcinoma carry mutations in either PTPRO or ADRA1A?,top_cases_counts_by_genes
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How many patients with Pancreatic Adenocarcinoma carry mutations in either PTPRO or ANKDD1A?,top_cases_counts_by_genes
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How many patients with Pancreatic Adenocarcinoma carry mutations in either PTPRO or DCN?,top_cases_counts_by_genes
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How many patients with Pancreatic Adenocarcinoma carry mutations in either PTPRO or GRTP1?,top_cases_counts_by_genes
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How many patients with Pancreatic Adenocarcinoma carry mutations in either PTPRO or DSCAM?,top_cases_counts_by_genes
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How many patients with Pancreatic Adenocarcinoma carry mutations in either PTPRO or EPRS1?,top_cases_counts_by_genes
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How many patients with Pancreatic Adenocarcinoma carry mutations in either PTPRO or CEP20?,top_cases_counts_by_genes
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either CHMP7 or EVC2?,top_cases_counts_by_genes
+1017,GPC3,I107N,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either GPC3 or GSTCD?,top_cases_counts_by_genes
+1018,GPC3,I161N,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either GPC3 or SLC9C1?,top_cases_counts_by_genes
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many patients with Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma carry mutations in either TLK2 or ACTB?,top_cases_counts_by_genes
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many patients with Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma carry mutations in either TLK2 or PGF?,top_cases_counts_by_genes
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many patients with Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma carry mutations in either TLK2 or TTC12?,top_cases_counts_by_genes
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many patients with Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma carry mutations in either TLK2 or POC1B?,top_cases_counts_by_genes
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many patients with Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma carry mutations in either TLK2 or POC1B?,top_cases_counts_by_genes
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either ZNF217 or TYK2?,top_cases_counts_by_genes
+1038,SYT9,V275L,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either SYT9 or PTPRO?,top_cases_counts_by_genes
+1039,SYT9,V307L,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either SYT9 or NOMO1?,top_cases_counts_by_genes
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either PKHD1L1 or CFAP298-TCP10L?,top_cases_counts_by_genes
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either MYO3A or DPF3?,top_cases_counts_by_genes
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus carry mutations in either VASN or UNC5D?",top_cases_counts_by_genes
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either DNMT1 or EIF2B4?,top_cases_counts_by_genes
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either DNMT1 or MUC16?,top_cases_counts_by_genes
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either DNMT1 or CCNG1?,top_cases_counts_by_genes
+1056,CA9,E402K,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either CA9 or OR2A12?,top_cases_counts_by_genes
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either TTC17 or TLK2?,top_cases_counts_by_genes
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either TTC17 or UNC5D?,top_cases_counts_by_genes
+1065,PSG2,P43L,Breast Invasive Carcinoma,How many patients with Breast Invasive Carcinoma carry mutations in either PSG2 or CR1?,top_cases_counts_by_genes
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How many patients with Breast Invasive Carcinoma carry mutations in either RIPOR2 or AQP7?,top_cases_counts_by_genes
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How many patients with Breast Invasive Carcinoma carry mutations in either RIPOR2 or RELN?,top_cases_counts_by_genes
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How many patients with Breast Invasive Carcinoma carry mutations in either RIPOR2 or ADRA1A?,top_cases_counts_by_genes
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How many patients with Breast Invasive Carcinoma carry mutations in either RIPOR2 or ACTL7B?,top_cases_counts_by_genes
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either DCLK3 or EVC2?,top_cases_counts_by_genes
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either DCLK3 or PDGFC?,top_cases_counts_by_genes
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either MERTK or SGCZ?,top_cases_counts_by_genes
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either MERTK or MAD1L1?,top_cases_counts_by_genes
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either MERTK or PAK3?,top_cases_counts_by_genes
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either ZFP42 or OR13C3?,top_cases_counts_by_genes
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either OR13C3 or TLK2?,top_cases_counts_by_genes
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either OR13C3 or GUK1?,top_cases_counts_by_genes
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either SPAG1 or PTPRO?,top_cases_counts_by_genes
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either CDKN2AIP or VPS26B?,top_cases_counts_by_genes
+1093,PXN,H1016Y,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either PXN or POC1B?,top_cases_counts_by_genes
+1094,PXN,H359Y,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either PXN or SGIP1?,top_cases_counts_by_genes
+1095,PXN,H492Y,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either PXN or PLEKHG6?,top_cases_counts_by_genes
+1096,PXN,H524Y,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either PXN or GPC3?,top_cases_counts_by_genes
+1097,PXN,H526Y,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either PXN or PTPRO?,top_cases_counts_by_genes
+1098,PXN,H540Y,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either PXN or FCGR2C?,top_cases_counts_by_genes
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either TTYH2 or EIF2B4?,top_cases_counts_by_genes
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either TTYH2 or TNS1?,top_cases_counts_by_genes
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either TMEM255A or ZFPM2?,top_cases_counts_by_genes
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either TMEM255A or REXO4?,top_cases_counts_by_genes
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either TMEM255A or TLK2?,top_cases_counts_by_genes
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How many patients with Breast Invasive Carcinoma carry mutations in either TASOR2 or CTCFL?,top_cases_counts_by_genes
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How many patients with Breast Invasive Carcinoma carry mutations in either TASOR2 or MYH11?,top_cases_counts_by_genes
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either ICE1 or AUTS2?,top_cases_counts_by_genes
+1112,MYT1,A558E,Breast Invasive Carcinoma,How many patients with Breast Invasive Carcinoma carry mutations in either MYT1 or CDH23?,top_cases_counts_by_genes
+1113,MYT1,A879E,Breast Invasive Carcinoma,How many patients with Breast Invasive Carcinoma carry mutations in either MYT1 or DSCAM?,top_cases_counts_by_genes
+1114,MYT1,A906E,Breast Invasive Carcinoma,How many patients with Breast Invasive Carcinoma carry mutations in either MYT1 or MAOB?,top_cases_counts_by_genes
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either CX3CR1 or HSPA5?,top_cases_counts_by_genes
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either CX3CR1 or ANP32E?,top_cases_counts_by_genes
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How many patients with Liver Hepatocellular Carcinoma carry mutations in either SPINDOC or PIK3C2A?,top_cases_counts_by_genes
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either ART3 or USH2A?,top_cases_counts_by_genes
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either ART3 or VASN?,top_cases_counts_by_genes
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How many patients with Bladder Urothelial Carcinoma carry mutations in either CYP1A2 or BCAT1?,top_cases_counts_by_genes
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus carry mutations in either ADRA1A or TAF1C?",top_cases_counts_by_genes
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either CDH23 or PXN?,top_cases_counts_by_genes
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either CDH23 or TLK2?,top_cases_counts_by_genes
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either KRT39 or UNC5D?,top_cases_counts_by_genes
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either PDHA2 or HSPA5?,top_cases_counts_by_genes
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either SLC24A2 or TYK2?,top_cases_counts_by_genes
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How many patients with Liver Hepatocellular Carcinoma carry mutations in either PTPRN2 or ZFPM2?,top_cases_counts_by_genes
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How many patients with Liver Hepatocellular Carcinoma carry mutations in either PTPRN2 or TTN?,top_cases_counts_by_genes
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How many patients with Liver Hepatocellular Carcinoma carry mutations in either PTPRN2 or TMEM255A?,top_cases_counts_by_genes
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How many patients with Liver Hepatocellular Carcinoma carry mutations in either PTPRN2 or GPC3?,top_cases_counts_by_genes
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How many patients with Liver Hepatocellular Carcinoma carry mutations in either PTPRN2 or DNMT1?,top_cases_counts_by_genes
+1188,SOX21,R55L,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either SOX21 or PGR?,top_cases_counts_by_genes
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How many patients with Bladder Urothelial Carcinoma carry mutations in either CPA6 or SLC6A4?,top_cases_counts_by_genes
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either GRM5 or SPATA22?,top_cases_counts_by_genes
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus carry mutations in either CASZ1 or SMO?",top_cases_counts_by_genes
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either SGIP1 or ZCCHC14?,top_cases_counts_by_genes
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either SGIP1 or MRPL55?,top_cases_counts_by_genes
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either SGIP1 or TNS1?,top_cases_counts_by_genes
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either SGIP1 or RELN?,top_cases_counts_by_genes
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either CARMIL1 or AUTS2?,top_cases_counts_by_genes
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either CARMIL1 or CR1?,top_cases_counts_by_genes
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either ZNF431 or GPR158?,top_cases_counts_by_genes
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either ZNF431 or TTN?,top_cases_counts_by_genes
+1234,ZNF431,R128I,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either ZNF431 or POLR1G?,top_cases_counts_by_genes
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either DNAH11 or COL6A3?,top_cases_counts_by_genes
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either DNAH11 or PXN?,top_cases_counts_by_genes
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either POLD1 or CARMIL1?,top_cases_counts_by_genes
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How many patients with Lung Squamous Cell Carcinoma carry mutations in either POLD1 or GSTCD?,top_cases_counts_by_genes
+1248,TTC12,D646H,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either TTC12 or MYT1?,top_cases_counts_by_genes
+1249,TTC12,D652H,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either TTC12 or PDHA2?,top_cases_counts_by_genes
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How many patients with Bladder Urothelial Carcinoma carry mutations in either CNGB1 or MRPL55?,top_cases_counts_by_genes
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How many patients with Bladder Urothelial Carcinoma carry mutations in either CNGB1 or ADRA1A?,top_cases_counts_by_genes
+1254,CTSC,E214V,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either CTSC or ACTB?,top_cases_counts_by_genes
+1255,CTSC,E291V,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either CTSC or PAK3?,top_cases_counts_by_genes
+1256,CTSC,E322V,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either CTSC or OR2A12?,top_cases_counts_by_genes
+1257,CTSC,E324V,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either CTSC or TMEM225?,top_cases_counts_by_genes
+1258,CTSC,E335V,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either CTSC or OR2T4?,top_cases_counts_by_genes
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either PRSS8 or RIPOR2?,top_cases_counts_by_genes
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either PRSS8 or RIMS2?,top_cases_counts_by_genes
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either ARHGEF40 or PTPRN2?,top_cases_counts_by_genes
+1264,ACTB,A138T,Rectum Adenocarcinoma,How many patients with Rectum Adenocarcinoma carry mutations in either ACTB or DCN?,top_cases_counts_by_genes
+1265,ACTB,A217T,Rectum Adenocarcinoma,How many patients with Rectum Adenocarcinoma carry mutations in either ACTB or RIMS2?,top_cases_counts_by_genes
+1266,ACTB,A244T,Rectum Adenocarcinoma,How many patients with Rectum Adenocarcinoma carry mutations in either ACTB or SLC24A2?,top_cases_counts_by_genes
+1267,ACTB,A260T,Rectum Adenocarcinoma,How many patients with Rectum Adenocarcinoma carry mutations in either ACTB or RIPOR2?,top_cases_counts_by_genes
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How many patients with Glioblastoma Multiforme carry mutations in either YY1AP1 or CHODL?,top_cases_counts_by_genes
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How many patients with Glioblastoma Multiforme carry mutations in either YY1AP1 or SIK2?,top_cases_counts_by_genes
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How many patients with Glioblastoma Multiforme carry mutations in either YY1AP1 or ACTA2?,top_cases_counts_by_genes
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How many patients with Glioblastoma Multiforme carry mutations in either YY1AP1 or ANKRD24?,top_cases_counts_by_genes
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How many patients with Glioblastoma Multiforme carry mutations in either YY1AP1 or YY1AP1?,top_cases_counts_by_genes
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How many patients with Glioblastoma Multiforme carry mutations in either YY1AP1 or AKT1?,top_cases_counts_by_genes
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How many patients with Glioblastoma Multiforme carry mutations in either YY1AP1 or ABCC3?,top_cases_counts_by_genes
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either FNDC7 or DSCAM?,top_cases_counts_by_genes
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either FNDC7 or PXN?,top_cases_counts_by_genes
+1299,TLCD5,G15V,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either TLCD5 or TTC12?,top_cases_counts_by_genes
+1300,TLCD5,G37V,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either TLCD5 or OLFML3?,top_cases_counts_by_genes
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either POLR1G or CYP1A2?,top_cases_counts_by_genes
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either POLR1G or EBF2?,top_cases_counts_by_genes
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either DNAH14 or ANP32E?,top_cases_counts_by_genes
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either DNAH14 or CYP1A2?,top_cases_counts_by_genes
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either DNAH14 or YY1AP1?,top_cases_counts_by_genes
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either NEXN or RIPOR2?,top_cases_counts_by_genes
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How many patients with Prostate Adenocarcinoma carry mutations in either CYB5R2 or FNDC7?,top_cases_counts_by_genes
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How many patients with Prostate Adenocarcinoma carry mutations in either CYB5R2 or GABRA6?,top_cases_counts_by_genes
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either NRAP or TNS1?,top_cases_counts_by_genes
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either NRAP or NOMO1?,top_cases_counts_by_genes
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either NRAP or CFAP61?,top_cases_counts_by_genes
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either CCDC22 or ZNF708?,top_cases_counts_by_genes
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either DCAF6 or PXN?,top_cases_counts_by_genes
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either DCAF6 or PTPRO?,top_cases_counts_by_genes
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either ZNF708 or CTSC?,top_cases_counts_by_genes
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either BFAR or AUTS2?,top_cases_counts_by_genes
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either MAST4 or DCAF4L2?,top_cases_counts_by_genes
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either MAST4 or UBR2?,top_cases_counts_by_genes
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either MAST4 or EVC2?,top_cases_counts_by_genes
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either MAST4 or AUTS2?,top_cases_counts_by_genes
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either MAST4 or CTSC?,top_cases_counts_by_genes
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either ARMC3 or RELN?,top_cases_counts_by_genes
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either ARMC3 or ZNF584?,top_cases_counts_by_genes
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How many patients with Kidney Renal Clear Cell Carcinoma carry mutations in either TET2 or TENT5A?,top_cases_counts_by_genes
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How many patients with Kidney Renal Clear Cell Carcinoma carry mutations in either TET2 or YY1AP1?,top_cases_counts_by_genes
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either SERPINB10 or RIMS2?,top_cases_counts_by_genes
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either STAT3 or NOMO1?,top_cases_counts_by_genes
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either MIEF1 or YY1AP1?,top_cases_counts_by_genes
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either ACVR1B or VASN?,top_cases_counts_by_genes
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either ACVR1B or PTPRN2?,top_cases_counts_by_genes
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either ACVR1B or TNS1?,top_cases_counts_by_genes
+1393,EBF2,T104I,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either EBF2 or ZCCHC14?,top_cases_counts_by_genes
+1394,EBF2,T252I,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either EBF2 or LCN15?,top_cases_counts_by_genes
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either VPS26B or SYNJ1?,top_cases_counts_by_genes
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus carry mutations in either PGR or PTPRO?",top_cases_counts_by_genes
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus carry mutations in either PGR or DCN?",top_cases_counts_by_genes
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus carry mutations in either PGR or TAF1L?",top_cases_counts_by_genes
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How many patients with Skin Cutaneous Melanoma carry mutations in either ACTA2 or TNS1?,top_cases_counts_by_genes
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either THBS4 or TAF1L?,top_cases_counts_by_genes
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either THBS4 or KDM5C?,top_cases_counts_by_genes
+1413,PRSS1,S114T,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either PRSS1 or WNT2?,top_cases_counts_by_genes
+1414,PRSS1,S124T,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either PRSS1 or SPTAN1?,top_cases_counts_by_genes
+1415,PRSS1,S138T,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either PRSS1 or PKHD1L1?,top_cases_counts_by_genes
+1416,PRSS1,S74T,Lung Adenocarcinoma,How many patients with Lung Adenocarcinoma carry mutations in either PRSS1 or GABRA6?,top_cases_counts_by_genes
+1417,PGF,R126H,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either PGF or MAST4?,top_cases_counts_by_genes
+1418,PGF,R127H,Stomach Adenocarcinoma,How many patients with Stomach Adenocarcinoma carry mutations in either PGF or DCN?,top_cases_counts_by_genes
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How many patients with Breast Invasive Carcinoma carry mutations in either ITPRID2 or POC1B?,top_cases_counts_by_genes
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How many patients with Breast Invasive Carcinoma carry mutations in either ITPRID2 or JAML?,top_cases_counts_by_genes
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either HBB or TRIM45?,top_cases_counts_by_genes
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either PCDHB2 or TAF1C?,top_cases_counts_by_genes
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either PCDHB2 or ITPRID2?,top_cases_counts_by_genes
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How many patients with Colon Adenocarcinoma carry mutations in either PCDHB2 or TNS1?,top_cases_counts_by_genes
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How many patients with Uterine Corpus Endometrial Carcinoma carry mutations in either UBR2 or DCN?,top_cases_counts_by_genes
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How many patients with Rectum Adenocarcinoma carry mutations in either FBXO42 or CA9?,top_cases_counts_by_genes
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the prevalence of mutations in TNS1 or ZNF431 among Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the prevalence of mutations in TNS1 or TNS1 among Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the prevalence of mutations in TNS1 or PRSS8 among Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the prevalence of mutations in TNS1 or TASOR2 among Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the prevalence of mutations in TNS1 or RIPOR2 among Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the prevalence of mutations in TNS1 or KL among Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the prevalence of mutations in TNS1 or DCAF6 among Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the prevalence of mutations in EVC2 or TENT5A among Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the prevalence of mutations in EVC2 or DNAH14 among Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in CR1 or MRPL55 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in CR1 or MERTK among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the prevalence of mutations in TRPA1 or CR1 among Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the prevalence of mutations in TRPA1 or GLRB among Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the prevalence of mutations in TAF1C or ZFP42 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the prevalence of mutations in TAF1C or ART3 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the prevalence of mutations in TAF1C or MAD1L1 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the prevalence of mutations in TAF1C or VPS26B among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the prevalence of mutations in TAF1C or FRY among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in DPF3 or C7orf31 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in DPF3 or SLC9C1 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in DPF3 or ANKRD24 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the prevalence of mutations in OR2T4 or TYK2 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the prevalence of mutations in OR2T4 or REXO4 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the prevalence of mutations in FBN1 or MIEF1 among Pancreatic Adenocarcinoma cases?,top_cases_counts_by_genes
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the prevalence of mutations in MAD1L1 or POLR1G among Prostate Adenocarcinoma cases?,top_cases_counts_by_genes
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the prevalence of mutations in MAD1L1 or TRIM45 among Prostate Adenocarcinoma cases?,top_cases_counts_by_genes
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the prevalence of mutations in MAD1L1 or DHX16 among Prostate Adenocarcinoma cases?,top_cases_counts_by_genes
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the prevalence of mutations in CCNG1 or TASOR2 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the prevalence of mutations in ANP32E or ACTB among Kidney Renal Papillary Cell Carcinoma cases?,top_cases_counts_by_genes
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the prevalence of mutations in ANP32E or TAF1C among Kidney Renal Papillary Cell Carcinoma cases?,top_cases_counts_by_genes
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the prevalence of mutations in ANP32E or CTCFL among Kidney Renal Papillary Cell Carcinoma cases?,top_cases_counts_by_genes
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the prevalence of mutations in ANP32E or ZKSCAN7 among Kidney Renal Papillary Cell Carcinoma cases?,top_cases_counts_by_genes
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the prevalence of mutations in FRY or ICE1 among Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the prevalence of mutations in FRY or SYT9 among Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the prevalence of mutations in FRY or PXN among Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the prevalence of mutations in FRY or RIMS2 among Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the prevalence of mutations in PAK3 or CYB5R2 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the prevalence of mutations in PAK3 or DSCAM among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the prevalence of mutations in PAK3 or SPAG1 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the prevalence of mutations in PAK3 or OR13C3 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the prevalence of mutations in PAK3 or HSPA5 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the prevalence of mutations in MUC16 or YY1AP1 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the prevalence of mutations in ZFPM2 or TLK2 among Liver Hepatocellular Carcinoma cases?,top_cases_counts_by_genes
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the prevalence of mutations in ZFPM2 or GRM1 among Liver Hepatocellular Carcinoma cases?,top_cases_counts_by_genes
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the prevalence of mutations in PIK3C2B or VPS26B among Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the prevalence of mutations in PIK3C2B or DCN among Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the prevalence of mutations in ZNF804A or CXCR2 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the prevalence of mutations in RELN or ADRA1A among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of mutations in EFCAB12 or GUK1 among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of mutations in EFCAB12 or AUTS2 among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the prevalence of mutations in DEFB115 or MAD1L1 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the prevalence of mutations in ANKDD1A or PIAS3 among Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the prevalence of mutations in ANKDD1A or MYO3B among Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the prevalence of mutations in ANKDD1A or TRPA1 among Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in HTR3B or CPS1 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in HTR3B or OR13C3 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in HTR3B or HLA-DQA2 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the prevalence of mutations in ABCC3 or GPR158 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in NOMO1 or AUTS2 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in NOMO1 or YY1AP1 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the prevalence of mutations in HYOU1 or SYNJ1 among Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the prevalence of mutations in FMO4 or TASOR2 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+140,BICC1,A372V,Exceptional Responders,What is the prevalence of mutations in BICC1 or EIF2B4 among Exceptional Responders cases?,top_cases_counts_by_genes
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in ZMYM3 or HYOU1 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in ZMYM3 or PTPRN2 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in ZMYM3 or ANP32E among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of mutations in XKR4 or KRT39 among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the prevalence of mutations in ABCC2 or DSCAM among Liver Hepatocellular Carcinoma cases?,top_cases_counts_by_genes
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the prevalence of mutations in OR8K5 or ARHGEF40 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the prevalence of mutations in SPTAN1 or ANKDD1A among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the prevalence of mutations in SPTAN1 or ZKSCAN7 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the prevalence of mutations in SYT10 or TASOR2 among Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the prevalence of mutations in HSPA5 or SORCS1 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the prevalence of mutations in UNC5D or TTC17 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the prevalence of mutations in UNC5D or SPAG1 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the prevalence of mutations in UNC5D or AUTS2 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the prevalence of mutations in UNC5D or MYO3B among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the prevalence of mutations in UNC5D or SLC6A4 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the prevalence of mutations in UNC5D or ZNF804A among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the prevalence of mutations in DOCK2 or FRY among Kidney Renal Clear Cell Carcinoma cases?,top_cases_counts_by_genes
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the prevalence of mutations in ZNF627 or DCC among Kidney Renal Clear Cell Carcinoma cases?,top_cases_counts_by_genes
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the prevalence of mutations in CDC42BPA or EFCAB12 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the prevalence of mutations in MRPL55 or CTCFL among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the prevalence of mutations in MRPL55 or PGF among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the prevalence of mutations in TMTC3 or TNS1 among Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the prevalence of mutations in EPRS1 or COL6A3 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the prevalence of mutations in EPRS1 or SLC6A4 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the prevalence of mutations in GRTP1 or FCGR2C among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the prevalence of mutations in GRTP1 or MYO16 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the prevalence of mutations in TSHZ3 or ACVR1B among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the prevalence of mutations in TAS1R3 or EBF2 among HIV+ Tumor Molecular Characterization Project - Cervical Cancer cases?,top_cases_counts_by_genes
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in PIAS3 or ITPRID2 among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in PIAS3 or GPC3 among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the prevalence of mutations in ZNF274 or TAS1R3 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the prevalence of mutations in SYNJ1 or KDM5C among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the prevalence of mutations in SYNJ1 or PXN among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the prevalence of mutations in SYNJ1 or RIMS2 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the prevalence of mutations in DSCAM or SGIP1 among Prostate Adenocarcinoma cases?,top_cases_counts_by_genes
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the prevalence of mutations in DSCAM or TAF1C among Prostate Adenocarcinoma cases?,top_cases_counts_by_genes
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the prevalence of mutations in DSCAM or GIMAP2 among Prostate Adenocarcinoma cases?,top_cases_counts_by_genes
+267,DGKD,R140H,Exceptional Responders,What is the prevalence of mutations in DGKD or PXN among Exceptional Responders cases?,top_cases_counts_by_genes
+268,DGKD,R160H,Exceptional Responders,What is the prevalence of mutations in DGKD or EIF2B4 among Exceptional Responders cases?,top_cases_counts_by_genes
+269,DGKD,R204H,Exceptional Responders,What is the prevalence of mutations in DGKD or TRPA1 among Exceptional Responders cases?,top_cases_counts_by_genes
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the prevalence of mutations in PLEKHG6 or CPS1 among Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the prevalence of mutations in PLEKHG6 or CASZ1 among Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the prevalence of mutations in PLEKHG6 or UNC5D among Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the prevalence of mutations in WNT2 or SGIP1 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the prevalence of mutations in GUCY2C or CEP20 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in C7orf31 or FGF8 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of mutations in ZKSCAN7 or GUK1 among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+299,OR5D14,M210L,Neuroblastoma,What is the prevalence of mutations in OR5D14 or YY1AP1 among Neuroblastoma cases?,top_cases_counts_by_genes
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in SPATA22 or DCAF6 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in SPATA22 or SYNJ1 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in SPATA22 or YY1AP1 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the prevalence of mutations in LCN15 or CFAP298-TCP10L among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the prevalence of mutations in DCAF4L2 or ZFPM2 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in GUK1 or ZNF708 among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in GUK1 or COL6A3 among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in GUK1 or SGIP1 among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in GUK1 or PGR among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in GUK1 or HTR3B among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the prevalence of mutations in MORF4L1 or FBXO42 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the prevalence of mutations in MORF4L1 or YY1AP1 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the prevalence of mutations in MORF4L1 or GABRA6 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the prevalence of mutations in MORF4L1 or CR1 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the prevalence of mutations in MYO3B or AQP7 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the prevalence of mutations in MYO3B or ABCC3 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the prevalence of mutations in TENT5A or VASN among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the prevalence of mutations in TENT5A or PRSS8 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the prevalence of mutations in TENT5A or MUC16 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the prevalence of mutations in ZFAT or CHODL among Ovarian Serous Cystadenocarcinoma cases?,top_cases_counts_by_genes
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the prevalence of mutations in ZFAT or GPC3 among Ovarian Serous Cystadenocarcinoma cases?,top_cases_counts_by_genes
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the prevalence of mutations in ZFAT or DPF3 among Ovarian Serous Cystadenocarcinoma cases?,top_cases_counts_by_genes
+357,ZNF584,A211T,Sarcoma,What is the prevalence of mutations in ZNF584 or ZMYM3 among Sarcoma cases?,top_cases_counts_by_genes
+358,ZNF584,A256T,Sarcoma,What is the prevalence of mutations in ZNF584 or IL5RA among Sarcoma cases?,top_cases_counts_by_genes
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in LDOC1 or ZNF431 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in PDGFC or GUCY2C among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in MSANTD4 or TAF1L among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the prevalence of mutations in NPSR1 or MYO3A among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in PHLPP1 or TNS1 among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the prevalence of mutations in COL6A3 or MRPL55 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the prevalence of mutations in COL6A3 or PIK3C2G among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the prevalence of mutations in COL6A3 or SGCZ among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the prevalence of mutations in COL6A3 or DPF3 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the prevalence of mutations in COL6A3 or CX3CR1 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the prevalence of mutations in ADRA1A or AQP7 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence of mutations in LAMB2 or PXN among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,top_cases_counts_by_genes
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the prevalence of mutations in POC1B or KIF20B among Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the prevalence of mutations in POC1B or CARMIL1 among Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the prevalence of mutations in POC1B or DCLK3 among Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the prevalence of mutations in POC1B or TASOR2 among Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the prevalence of mutations in USH2A or ANP32E among Liver Hepatocellular Carcinoma cases?,top_cases_counts_by_genes
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the prevalence of mutations in AQP7 or TNS1 among Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the prevalence of mutations in AQP7 or LDOC1 among Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the prevalence of mutations in AQP7 or ANP32E among Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the prevalence of mutations in AQP7 or ZCCHC14 among Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+430,DCN,R163C,Rectum Adenocarcinoma,What is the prevalence of mutations in DCN or POC1B among Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+431,DCN,R203C,Rectum Adenocarcinoma,What is the prevalence of mutations in DCN or TNS1 among Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+432,DCN,R241C,Rectum Adenocarcinoma,What is the prevalence of mutations in DCN or MYO3B among Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+433,DCN,R350C,Rectum Adenocarcinoma,What is the prevalence of mutations in DCN or PXN among Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+434,DCN,R41C,Rectum Adenocarcinoma,What is the prevalence of mutations in DCN or GPRASP1 among Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in CPS1 or DCC among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in CPS1 or CPS1 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in CPS1 or DGKD among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the prevalence of mutations in FCGR2C or DPF3 among Kidney Renal Papillary Cell Carcinoma cases?,top_cases_counts_by_genes
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the prevalence of mutations in FCGR2C or COL6A3 among Kidney Renal Papillary Cell Carcinoma cases?,top_cases_counts_by_genes
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in GRM1 or MED16 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the prevalence of mutations in SGCZ or SYT9 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the prevalence of mutations in SGCZ or RIMS2 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+485,SMO,V15M,Stomach Adenocarcinoma,What is the prevalence of mutations in SMO or SORCS1 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+486,SMO,V321M,Stomach Adenocarcinoma,What is the prevalence of mutations in SMO or KL among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the prevalence of mutations in CHODL or EIF2B4 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the prevalence of mutations in CHODL or HYOU1 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the prevalence of mutations in CHODL or HSPA5 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+494,MYO16,P399H,Colon Adenocarcinoma,What is the prevalence of mutations in MYO16 or PAK3 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+495,MYO16,P421H,Colon Adenocarcinoma,What is the prevalence of mutations in MYO16 or SPINDOC among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the prevalence of mutations in CXCR2 or ANKRD30A among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the prevalence of mutations in TMEM225 or MORF4L1 among Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in MAOB or MAST4 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in GPRASP1 or AQP7 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in MRPL32 or FRY among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in TYROBP or JAML among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the prevalence of mutations in RAB40C or AUTS2 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the prevalence of mutations in RAB40C or GRTP1 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the prevalence of mutations in CTNNA2 or PAK3 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the prevalence of mutations in CTNNA2 or TET2 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the prevalence of mutations in CTNNA2 or EFCAB12 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the prevalence of mutations in CTNNA2 or EIF2B4 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the prevalence of mutations in MYO15A or PYHIN1 among Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the prevalence of mutations in GIMAP2 or TNS1 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the prevalence of mutations in KIF20B or MORF4L1 among Glioblastoma Multiforme cases?,top_cases_counts_by_genes
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the prevalence of mutations in KIF20B or FRY among Glioblastoma Multiforme cases?,top_cases_counts_by_genes
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in ADAM17 or CR1 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in BCAT1 or SGCZ among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in BCAT1 or ACVR1B among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in BCAT1 or TTN among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the prevalence of mutations in ERCC6 or VPS26B among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+541,DCC,R320W,Breast Invasive Carcinoma,What is the prevalence of mutations in DCC or LAMB2 among Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+542,DCC,R363W,Breast Invasive Carcinoma,What is the prevalence of mutations in DCC or PLEKHG6 among Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+543,DCC,R386W,Breast Invasive Carcinoma,What is the prevalence of mutations in DCC or SGIP1 among Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+544,DCC,R41W,Breast Invasive Carcinoma,What is the prevalence of mutations in DCC or GRTP1 among Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the prevalence of mutations in FBXO15 or PAK3 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the prevalence of mutations in FBXO15 or KDM5C among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in GSTCD or TYROBP among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in GSTCD or PAK3 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in OLFML3 or ANKRD30A among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in OLFML3 or MAST4 among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in OLFML3 or TTN among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the prevalence of mutations in CFAP61 or ACTA2 among Ovarian Serous Cystadenocarcinoma cases?,top_cases_counts_by_genes
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the prevalence of mutations in CFAP61 or EBF2 among Ovarian Serous Cystadenocarcinoma cases?,top_cases_counts_by_genes
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the prevalence of mutations in HLA-DQA2 or DNMT1 among Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the prevalence of mutations in TENM2 or RIPOR2 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the prevalence of mutations in TENM2 or TAF1C among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the prevalence of mutations in TENM2 or PTPRO among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the prevalence of mutations in ANKRD24 or TET2 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the prevalence of mutations in ANKRD24 or TMEM255A among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the prevalence of mutations in ANKRD24 or ABCC3 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the prevalence of mutations in ZCCHC14 or DCC among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the prevalence of mutations in ZCCHC14 or MYO3B among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the prevalence of mutations in ZCCHC14 or CEP20 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the prevalence of mutations in ZCCHC14 or ITPRID2 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+625,SIK2,I265M,Lung Adenocarcinoma,What is the prevalence of mutations in SIK2 or YY1AP1 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in MYH11 or YY1AP1 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in MYH11 or CPS1 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the prevalence of mutations in SLC6A4 or ZSCAN31 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in SLC9C1 or CTSC among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in SLC9C1 or CX3CR1 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the prevalence of mutations in OR2A12 or BCAT1 among Brain Lower Grade Glioma cases?,top_cases_counts_by_genes
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the prevalence of mutations in PYHIN1 or CHODL among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the prevalence of mutations in PYHIN1 or DSCAM among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the prevalence of mutations in JAML or PXN among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the prevalence of mutations in JAML or TLCD5 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the prevalence of mutations in JAML or TET2 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the prevalence of mutations in JAML or GRTP1 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the prevalence of mutations in TYK2 or PIK3C2B among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the prevalence of mutations in TYK2 or SGIP1 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the prevalence of mutations in TYK2 or ZCCHC14 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in CTCFL or CPS1 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in CTCFL or ZNF431 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in CTCFL or KDM5C among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in CTCFL or POLD1 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in CEP20 or SYT9 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in CEP20 or ANKRD24 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the prevalence of mutations in RIMS2 or SLC9C1 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the prevalence of mutations in RIMS2 or TENM3 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the prevalence of mutations in RIMS2 or JAML among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the prevalence of mutations in RIMS2 or POC1B among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the prevalence of mutations in RIMS2 or OR2T4 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the prevalence of mutations in RIMS2 or RIPOR2 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the prevalence of mutations in RIMS2 or EIF2B4 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the prevalence of mutations in PIK3C2G or FGF8 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the prevalence of mutations in PIK3C2G or RIMS2 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+728,STK19,D341N,Colon Adenocarcinoma,What is the prevalence of mutations in STK19 or TRIM45 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+729,STK19,D345N,Colon Adenocarcinoma,What is the prevalence of mutations in STK19 or ACVR1B among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the prevalence of mutations in REXO4 or COL6A3 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in ZBTB34 or MORF4L1 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in ZBTB34 or CPS1 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the prevalence of mutations in NCKAP5 or CPS1 among Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of mutations in SORCS1 or HTR3B among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of mutations in SORCS1 or POLR1G among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of mutations in SORCS1 or FCGR2C among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of mutations in SORCS1 or JAML among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the prevalence of mutations in FGF8 or ANP32E among Head and Neck Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the prevalence of mutations in FGF8 or ARMC3 among Head and Neck Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the prevalence of mutations in FGF8 or MRPL55 among Head and Neck Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the prevalence of mutations in FGF8 or STAT3 among Head and Neck Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the prevalence of mutations in FGF8 or RAB40C among Head and Neck Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the prevalence of mutations in TENM3 or KDM5C among Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia cases?,top_cases_counts_by_genes
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in AKT1 or GLRB among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence of mutations in CFAP298-TCP10L or TYK2 among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,top_cases_counts_by_genes
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the prevalence of mutations in GLRB or OR13C3 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+793,TTN,F7636L,Colon Adenocarcinoma,What is the prevalence of mutations in TTN or PTPRN2 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+794,TTN,F8563L,Colon Adenocarcinoma,What is the prevalence of mutations in TTN or PTPRN2 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+795,TTN,F8880L,Colon Adenocarcinoma,What is the prevalence of mutations in TTN or PTPRO among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the prevalence of mutations in ANKRD30A or CTSC among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the prevalence of mutations in ANKRD30A or AQP7 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the prevalence of mutations in ANKRD30A or DCLK3 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the prevalence of mutations in TRIM45 or ZCCHC14 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the prevalence of mutations in TRIM45 or CTNNA2 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the prevalence of mutations in TRIM45 or GUK1 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the prevalence of mutations in CACNA1F or GRTP1 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the prevalence of mutations in CACNA1F or PKHD1L1 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the prevalence of mutations in CACNA1F or GUK1 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+817,KL,R594C,Colon Adenocarcinoma,What is the prevalence of mutations in KL or GPRASP1 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the prevalence of mutations in GUF1 or MAST4 among Kidney Renal Papillary Cell Carcinoma cases?,top_cases_counts_by_genes
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the prevalence of mutations in TAF1L or PLEKHG6 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the prevalence of mutations in TASOR2 or CTSC among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the prevalence of mutations in TASOR2 or GABRA6 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the prevalence of mutations in TASOR2 or SGCZ among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the prevalence of mutations in KDM5C or CARMIL1 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the prevalence of mutations in KDM5C or SYT9 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the prevalence of mutations in KDM5C or CARMIL1 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the prevalence of mutations in KDM5C or DNAH11 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence of mutations in IL5RA or ITPRID2 among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,top_cases_counts_by_genes
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the prevalence of mutations in DHX16 or MAST4 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the prevalence of mutations in DHX16 or AUTS2 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the prevalence of mutations in GPR158 or FRY among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the prevalence of mutations in GPR158 or UNC5D among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of mutations in EIF2B4 or MRPL32 among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of mutations in EIF2B4 or PGF among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of mutations in EIF2B4 or COL6A3 among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of mutations in EIF2B4 or PCDHGA1 among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of mutations in EIF2B4 or UNC5D among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of mutations in EIF2B4 or ANKDD1A among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in AUTS2 or DNMT1 among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in AUTS2 or RELN among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in AUTS2 or EVC2 among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in AUTS2 or ZFP42 among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in AUTS2 or ARMC3 among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in AUTS2 or HTR3B among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in AUTS2 or WNT2 among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in AUTS2 or OR2T4 among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in AUTS2 or GIMAP2 among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in AUTS2 or ZCCHC14 among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of mutations in ACTL7B or DNAH11 among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the prevalence of mutations in PCDHGA1 or OR5D14 among Glioblastoma Multiforme cases?,top_cases_counts_by_genes
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the prevalence of mutations in TRAP1 or GABRA6 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the prevalence of mutations in TRAP1 or GRM1 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in PIK3C2A or TLK2 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the prevalence of mutations in KANSL1 or PGF among Liver Hepatocellular Carcinoma cases?,top_cases_counts_by_genes
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the prevalence of mutations in ANKRD52 or PAK3 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in PAPPA or PRSS1 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the prevalence of mutations in B3GALNT1 or CTSC among Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the prevalence of mutations in GABRA6 or DCAF4L2 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the prevalence of mutations in GABRA6 or CYB5R2 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the prevalence of mutations in GABRA6 or PXN among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the prevalence of mutations in GABRA6 or MYO3A among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the prevalence of mutations in GABRA6 or CACNA1F among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the prevalence of mutations in ZSCAN31 or SPATA22 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of mutations in MED16 or HTR3B among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of mutations in MED16 or TTC12 among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the prevalence of mutations in PTPRO or TAS1R3 among Pancreatic Adenocarcinoma cases?,top_cases_counts_by_genes
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the prevalence of mutations in PTPRO or ANP32E among Pancreatic Adenocarcinoma cases?,top_cases_counts_by_genes
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the prevalence of mutations in PTPRO or JAML among Pancreatic Adenocarcinoma cases?,top_cases_counts_by_genes
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the prevalence of mutations in PTPRO or CTSC among Pancreatic Adenocarcinoma cases?,top_cases_counts_by_genes
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the prevalence of mutations in PTPRO or RIPOR2 among Pancreatic Adenocarcinoma cases?,top_cases_counts_by_genes
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the prevalence of mutations in PTPRO or ADRA1A among Pancreatic Adenocarcinoma cases?,top_cases_counts_by_genes
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the prevalence of mutations in PTPRO or PRSS1 among Pancreatic Adenocarcinoma cases?,top_cases_counts_by_genes
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the prevalence of mutations in PTPRO or AUTS2 among Pancreatic Adenocarcinoma cases?,top_cases_counts_by_genes
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in CHMP7 or SORCS1 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the prevalence of mutations in GPC3 or ACTA2 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the prevalence of mutations in GPC3 or MERTK among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence of mutations in TLK2 or KANSL1 among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,top_cases_counts_by_genes
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence of mutations in TLK2 or ACVR1B among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,top_cases_counts_by_genes
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence of mutations in TLK2 or UNC5D among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,top_cases_counts_by_genes
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence of mutations in TLK2 or CTNNA2 among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,top_cases_counts_by_genes
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence of mutations in TLK2 or CHODL among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,top_cases_counts_by_genes
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the prevalence of mutations in ZNF217 or FNDC7 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the prevalence of mutations in SYT9 or SGIP1 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the prevalence of mutations in SYT9 or TNS1 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in PKHD1L1 or RIMS2 among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in MYO3A or GSTCD among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of mutations in VASN or DCAF6 among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in DNMT1 or CARMIL1 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in DNMT1 or POLR1G among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in DNMT1 or POLD1 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1056,CA9,E402K,Colon Adenocarcinoma,What is the prevalence of mutations in CA9 or UNC5D among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in TTC17 or ANKRD52 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in TTC17 or GRM5 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the prevalence of mutations in PSG2 or PRSS8 among Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the prevalence of mutations in RIPOR2 or JAML among Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the prevalence of mutations in RIPOR2 or PGR among Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the prevalence of mutations in RIPOR2 or DNAH11 among Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the prevalence of mutations in RIPOR2 or ANKRD24 among Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in DCLK3 or CR1 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in DCLK3 or TASOR2 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in MERTK or CYB5R2 among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in MERTK or ITPRID2 among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in MERTK or EIF2B4 among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the prevalence of mutations in ZFP42 or STK19 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the prevalence of mutations in OR13C3 or MYT1 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the prevalence of mutations in OR13C3 or CR1 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the prevalence of mutations in SPAG1 or PYHIN1 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in CDKN2AIP or GUK1 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the prevalence of mutations in PXN or EIF2B4 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the prevalence of mutations in PXN or MYO3A among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the prevalence of mutations in PXN or SPATA22 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the prevalence of mutations in PXN or CTNNA2 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the prevalence of mutations in PXN or GABRA6 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the prevalence of mutations in PXN or PTPRN2 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in TTYH2 or PGF among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in TTYH2 or ZNF217 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the prevalence of mutations in TMEM255A or EIF2B4 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the prevalence of mutations in TMEM255A or ANKDD1A among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the prevalence of mutations in TMEM255A or DNAH14 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the prevalence of mutations in TASOR2 or MYH11 among Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the prevalence of mutations in TASOR2 or TAF1C among Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in ICE1 or PIK3C2A among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the prevalence of mutations in MYT1 or TRAP1 among Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the prevalence of mutations in MYT1 or ZFAT among Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the prevalence of mutations in MYT1 or TAF1C among Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in CX3CR1 or PGF among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in CX3CR1 or TTC17 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the prevalence of mutations in SPINDOC or MAD1L1 among Liver Hepatocellular Carcinoma cases?,top_cases_counts_by_genes
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in ART3 or CCDC22 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in ART3 or FGF8 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the prevalence of mutations in CYP1A2 or TLK2 among Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of mutations in ADRA1A or B3GALNT1 among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in CDH23 or ZBTB34 among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in CDH23 or DSCAM among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the prevalence of mutations in KRT39 or ZBTB34 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in PDHA2 or VASN among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the prevalence of mutations in SLC24A2 or TRIM45 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the prevalence of mutations in PTPRN2 or PYHIN1 among Liver Hepatocellular Carcinoma cases?,top_cases_counts_by_genes
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the prevalence of mutations in PTPRN2 or TAF1L among Liver Hepatocellular Carcinoma cases?,top_cases_counts_by_genes
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the prevalence of mutations in PTPRN2 or UNC5D among Liver Hepatocellular Carcinoma cases?,top_cases_counts_by_genes
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the prevalence of mutations in PTPRN2 or BCAT1 among Liver Hepatocellular Carcinoma cases?,top_cases_counts_by_genes
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the prevalence of mutations in PTPRN2 or LDOC1 among Liver Hepatocellular Carcinoma cases?,top_cases_counts_by_genes
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the prevalence of mutations in SOX21 or STK19 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the prevalence of mutations in CPA6 or PKHD1L1 among Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the prevalence of mutations in GRM5 or SORCS1 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of mutations in CASZ1 or UNC5D among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the prevalence of mutations in SGIP1 or ZNF584 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the prevalence of mutations in SGIP1 or COL6A3 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the prevalence of mutations in SGIP1 or EIF2B4 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the prevalence of mutations in SGIP1 or RIMS2 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the prevalence of mutations in CARMIL1 or YY1AP1 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the prevalence of mutations in CARMIL1 or RIPOR2 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the prevalence of mutations in ZNF431 or PYHIN1 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the prevalence of mutations in ZNF431 or ZNF217 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the prevalence of mutations in ZNF431 or YY1AP1 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the prevalence of mutations in DNAH11 or TENT5A among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the prevalence of mutations in DNAH11 or PTPRO among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in POLD1 or MYT1 among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the prevalence of mutations in POLD1 or MAD1L1 among Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the prevalence of mutations in TTC12 or B3GALNT1 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the prevalence of mutations in TTC12 or CDH23 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the prevalence of mutations in CNGB1 or TRAP1 among Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the prevalence of mutations in CNGB1 or AUTS2 among Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the prevalence of mutations in CTSC or DSCAM among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the prevalence of mutations in CTSC or NPSR1 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the prevalence of mutations in CTSC or TSHZ3 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the prevalence of mutations in CTSC or CPS1 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the prevalence of mutations in CTSC or AKT1 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in PRSS8 or EVC2 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in PRSS8 or PXN among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the prevalence of mutations in ARHGEF40 or ANKDD1A among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the prevalence of mutations in ACTB or ZCCHC14 among Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the prevalence of mutations in ACTB or NRAP among Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the prevalence of mutations in ACTB or PXN among Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the prevalence of mutations in ACTB or ZFAT among Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the prevalence of mutations in YY1AP1 or CHODL among Glioblastoma Multiforme cases?,top_cases_counts_by_genes
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the prevalence of mutations in YY1AP1 or PTPRN2 among Glioblastoma Multiforme cases?,top_cases_counts_by_genes
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the prevalence of mutations in YY1AP1 or EVC2 among Glioblastoma Multiforme cases?,top_cases_counts_by_genes
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the prevalence of mutations in YY1AP1 or NRAP among Glioblastoma Multiforme cases?,top_cases_counts_by_genes
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the prevalence of mutations in YY1AP1 or FCGR2C among Glioblastoma Multiforme cases?,top_cases_counts_by_genes
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the prevalence of mutations in YY1AP1 or SYT10 among Glioblastoma Multiforme cases?,top_cases_counts_by_genes
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the prevalence of mutations in YY1AP1 or DGKD among Glioblastoma Multiforme cases?,top_cases_counts_by_genes
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the prevalence of mutations in FNDC7 or SLC24A2 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the prevalence of mutations in FNDC7 or AUTS2 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the prevalence of mutations in TLCD5 or SGCZ among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the prevalence of mutations in TLCD5 or CACNA1F among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in POLR1G or POLR1G among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in POLR1G or EPRS1 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the prevalence of mutations in DNAH14 or NOMO1 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the prevalence of mutations in DNAH14 or AUTS2 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the prevalence of mutations in DNAH14 or TLK2 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in NEXN or THBS4 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the prevalence of mutations in CYB5R2 or CTCFL among Prostate Adenocarcinoma cases?,top_cases_counts_by_genes
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the prevalence of mutations in CYB5R2 or TENT5A among Prostate Adenocarcinoma cases?,top_cases_counts_by_genes
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in NRAP or NPSR1 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in NRAP or CTSC among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in NRAP or EFCAB12 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in CCDC22 or CDH23 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the prevalence of mutations in DCAF6 or FBXO15 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the prevalence of mutations in DCAF6 or REXO4 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in ZNF708 or PRSS1 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in BFAR or CTCFL among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in MAST4 or PTPRO among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in MAST4 or MORF4L1 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in MAST4 or SLC24A2 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in MAST4 or PXN among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in MAST4 or PIAS3 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the prevalence of mutations in ARMC3 or PIK3C2A among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the prevalence of mutations in ARMC3 or ZNF431 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the prevalence of mutations in TET2 or TENT5A among Kidney Renal Clear Cell Carcinoma cases?,top_cases_counts_by_genes
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the prevalence of mutations in TET2 or DNAH11 among Kidney Renal Clear Cell Carcinoma cases?,top_cases_counts_by_genes
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the prevalence of mutations in SERPINB10 or MYO3B among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in STAT3 or CTCFL among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in MIEF1 or PAK3 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the prevalence of mutations in ACVR1B or MORF4L1 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the prevalence of mutations in ACVR1B or MIEF1 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the prevalence of mutations in ACVR1B or OR2A12 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the prevalence of mutations in EBF2 or CTSC among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the prevalence of mutations in EBF2 or CX3CR1 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the prevalence of mutations in VPS26B or HLA-DQA2 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of mutations in PGR or SPAG1 among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of mutations in PGR or POC1B among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of mutations in PGR or TRAP1 among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the prevalence of mutations in ACTA2 or FGF8 among Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in THBS4 or ANKRD24 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in THBS4 or PRSS8 among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the prevalence of mutations in PRSS1 or PRSS8 among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the prevalence of mutations in PRSS1 or PXN among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the prevalence of mutations in PRSS1 or DCN among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the prevalence of mutations in PRSS1 or UNC5D among Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the prevalence of mutations in PGF or TTC12 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the prevalence of mutations in PGF or ANKRD24 among Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the prevalence of mutations in ITPRID2 or PTPRO among Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the prevalence of mutations in ITPRID2 or DSCAM among Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in HBB or BFAR among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the prevalence of mutations in PCDHB2 or TAF1L among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the prevalence of mutations in PCDHB2 or TMEM225 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the prevalence of mutations in PCDHB2 or MED16 among Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of mutations in UBR2 or PXN among Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the prevalence of mutations in FBXO42 or MAST4 among Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+1,TNS1,G1362V,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how many exhibit TNS1 mutations in the genomic data commons?",top_cases_counts_by_genes
+2,TNS1,G1711V,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how many exhibit TNS1 mutations in the genomic data commons?",top_cases_counts_by_genes
+3,TNS1,G1718V,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how many exhibit TNS1 mutations in the genomic data commons?",top_cases_counts_by_genes
+4,TNS1,G1732V,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how many exhibit TNS1 mutations in the genomic data commons?",top_cases_counts_by_genes
+5,TNS1,G1824V,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how many exhibit TNS1 mutations in the genomic data commons?",top_cases_counts_by_genes
+6,TNS1,G1857V,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how many exhibit TNS1 mutations in the genomic data commons?",top_cases_counts_by_genes
+7,TNS1,G843V,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how many exhibit TNS1 mutations in the genomic data commons?",top_cases_counts_by_genes
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how many exhibit EVC2 mutations in the genomic data commons?",top_cases_counts_by_genes
+15,EVC2,E987K,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how many exhibit EVC2 mutations in the genomic data commons?",top_cases_counts_by_genes
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit CR1 mutations in the genomic data commons?",top_cases_counts_by_genes
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit CR1 mutations in the genomic data commons?",top_cases_counts_by_genes
+22,TRPA1,S295I,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how many exhibit TRPA1 mutations in the genomic data commons?",top_cases_counts_by_genes
+23,TRPA1,S443I,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how many exhibit TRPA1 mutations in the genomic data commons?",top_cases_counts_by_genes
+24,TAF1C,R299L,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit TAF1C mutations in the genomic data commons?",top_cases_counts_by_genes
+25,TAF1C,R396L,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit TAF1C mutations in the genomic data commons?",top_cases_counts_by_genes
+26,TAF1C,R634L,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit TAF1C mutations in the genomic data commons?",top_cases_counts_by_genes
+27,TAF1C,R702L,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit TAF1C mutations in the genomic data commons?",top_cases_counts_by_genes
+28,TAF1C,R728L,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit TAF1C mutations in the genomic data commons?",top_cases_counts_by_genes
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit DPF3 mutations in the genomic data commons?",top_cases_counts_by_genes
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit DPF3 mutations in the genomic data commons?",top_cases_counts_by_genes
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit DPF3 mutations in the genomic data commons?",top_cases_counts_by_genes
+42,OR2T4,P272H,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit OR2T4 mutations in the genomic data commons?",top_cases_counts_by_genes
+43,OR2T4,P300H,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit OR2T4 mutations in the genomic data commons?",top_cases_counts_by_genes
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,"In cases of Pancreatic Adenocarcinoma, how many exhibit FBN1 mutations in the genomic data commons?",top_cases_counts_by_genes
+45,MAD1L1,E396K,Prostate Adenocarcinoma,"In cases of Prostate Adenocarcinoma, how many exhibit MAD1L1 mutations in the genomic data commons?",top_cases_counts_by_genes
+46,MAD1L1,E488K,Prostate Adenocarcinoma,"In cases of Prostate Adenocarcinoma, how many exhibit MAD1L1 mutations in the genomic data commons?",top_cases_counts_by_genes
+47,MAD1L1,E78K,Prostate Adenocarcinoma,"In cases of Prostate Adenocarcinoma, how many exhibit MAD1L1 mutations in the genomic data commons?",top_cases_counts_by_genes
+61,CCNG1,E22K,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit CCNG1 mutations in the genomic data commons?",top_cases_counts_by_genes
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,"In cases of Kidney Renal Papillary Cell Carcinoma, how many exhibit ANP32E mutations in the genomic data commons?",top_cases_counts_by_genes
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,"In cases of Kidney Renal Papillary Cell Carcinoma, how many exhibit ANP32E mutations in the genomic data commons?",top_cases_counts_by_genes
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,"In cases of Kidney Renal Papillary Cell Carcinoma, how many exhibit ANP32E mutations in the genomic data commons?",top_cases_counts_by_genes
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,"In cases of Kidney Renal Papillary Cell Carcinoma, how many exhibit ANP32E mutations in the genomic data commons?",top_cases_counts_by_genes
+66,FRY,S1888A,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how many exhibit FRY mutations in the genomic data commons?",top_cases_counts_by_genes
+67,FRY,S1937A,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how many exhibit FRY mutations in the genomic data commons?",top_cases_counts_by_genes
+68,FRY,S1938A,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how many exhibit FRY mutations in the genomic data commons?",top_cases_counts_by_genes
+69,FRY,S1983A,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how many exhibit FRY mutations in the genomic data commons?",top_cases_counts_by_genes
+70,PAK3,E318K,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit PAK3 mutations in the genomic data commons?",top_cases_counts_by_genes
+71,PAK3,E319K,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit PAK3 mutations in the genomic data commons?",top_cases_counts_by_genes
+72,PAK3,E334K,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit PAK3 mutations in the genomic data commons?",top_cases_counts_by_genes
+73,PAK3,E340K,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit PAK3 mutations in the genomic data commons?",top_cases_counts_by_genes
+74,PAK3,E355K,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit PAK3 mutations in the genomic data commons?",top_cases_counts_by_genes
+80,MUC16,P7963L,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit MUC16 mutations in the genomic data commons?",top_cases_counts_by_genes
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,"In cases of Liver Hepatocellular Carcinoma, how many exhibit ZFPM2 mutations in the genomic data commons?",top_cases_counts_by_genes
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,"In cases of Liver Hepatocellular Carcinoma, how many exhibit ZFPM2 mutations in the genomic data commons?",top_cases_counts_by_genes
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how many exhibit PIK3C2B mutations in the genomic data commons?",top_cases_counts_by_genes
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how many exhibit PIK3C2B mutations in the genomic data commons?",top_cases_counts_by_genes
+114,ZNF804A,S371Y,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit ZNF804A mutations in the genomic data commons?",top_cases_counts_by_genes
+116,RELN,A2371V,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit RELN mutations in the genomic data commons?",top_cases_counts_by_genes
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how many exhibit EFCAB12 mutations in the genomic data commons?",top_cases_counts_by_genes
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how many exhibit EFCAB12 mutations in the genomic data commons?",top_cases_counts_by_genes
+120,DEFB115,E53K,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit DEFB115 mutations in the genomic data commons?",top_cases_counts_by_genes
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how many exhibit ANKDD1A mutations in the genomic data commons?",top_cases_counts_by_genes
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how many exhibit ANKDD1A mutations in the genomic data commons?",top_cases_counts_by_genes
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how many exhibit ANKDD1A mutations in the genomic data commons?",top_cases_counts_by_genes
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit HTR3B mutations in the genomic data commons?",top_cases_counts_by_genes
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit HTR3B mutations in the genomic data commons?",top_cases_counts_by_genes
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit HTR3B mutations in the genomic data commons?",top_cases_counts_by_genes
+129,ABCC3,R758W,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit ABCC3 mutations in the genomic data commons?",top_cases_counts_by_genes
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit NOMO1 mutations in the genomic data commons?",top_cases_counts_by_genes
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit NOMO1 mutations in the genomic data commons?",top_cases_counts_by_genes
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how many exhibit HYOU1 mutations in the genomic data commons?",top_cases_counts_by_genes
+139,FMO4,R500Q,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit FMO4 mutations in the genomic data commons?",top_cases_counts_by_genes
+140,BICC1,A372V,Exceptional Responders,"In cases of Exceptional Responders, how many exhibit BICC1 mutations in the genomic data commons?",top_cases_counts_by_genes
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit ZMYM3 mutations in the genomic data commons?",top_cases_counts_by_genes
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit ZMYM3 mutations in the genomic data commons?",top_cases_counts_by_genes
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit ZMYM3 mutations in the genomic data commons?",top_cases_counts_by_genes
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how many exhibit XKR4 mutations in the genomic data commons?",top_cases_counts_by_genes
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,"In cases of Liver Hepatocellular Carcinoma, how many exhibit ABCC2 mutations in the genomic data commons?",top_cases_counts_by_genes
+157,OR8K5,R293G,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit OR8K5 mutations in the genomic data commons?",top_cases_counts_by_genes
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit SPTAN1 mutations in the genomic data commons?",top_cases_counts_by_genes
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit SPTAN1 mutations in the genomic data commons?",top_cases_counts_by_genes
+164,SYT10,M484I,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how many exhibit SYT10 mutations in the genomic data commons?",top_cases_counts_by_genes
+174,HSPA5,N457K,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit HSPA5 mutations in the genomic data commons?",top_cases_counts_by_genes
+175,UNC5D,L280V,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit UNC5D mutations in the genomic data commons?",top_cases_counts_by_genes
+176,UNC5D,L635V,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit UNC5D mutations in the genomic data commons?",top_cases_counts_by_genes
+177,UNC5D,L637V,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit UNC5D mutations in the genomic data commons?",top_cases_counts_by_genes
+178,UNC5D,L699V,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit UNC5D mutations in the genomic data commons?",top_cases_counts_by_genes
+179,UNC5D,L704V,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit UNC5D mutations in the genomic data commons?",top_cases_counts_by_genes
+180,UNC5D,L709V,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit UNC5D mutations in the genomic data commons?",top_cases_counts_by_genes
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,"In cases of Kidney Renal Clear Cell Carcinoma, how many exhibit DOCK2 mutations in the genomic data commons?",top_cases_counts_by_genes
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,"In cases of Kidney Renal Clear Cell Carcinoma, how many exhibit ZNF627 mutations in the genomic data commons?",top_cases_counts_by_genes
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit CDC42BPA mutations in the genomic data commons?",top_cases_counts_by_genes
+193,MRPL55,H27Y,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit MRPL55 mutations in the genomic data commons?",top_cases_counts_by_genes
+194,MRPL55,H63Y,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit MRPL55 mutations in the genomic data commons?",top_cases_counts_by_genes
+197,TMTC3,Q749K,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how many exhibit TMTC3 mutations in the genomic data commons?",top_cases_counts_by_genes
+198,EPRS1,K771I,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit EPRS1 mutations in the genomic data commons?",top_cases_counts_by_genes
+199,EPRS1,K778I,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit EPRS1 mutations in the genomic data commons?",top_cases_counts_by_genes
+201,GRTP1,A110V,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit GRTP1 mutations in the genomic data commons?",top_cases_counts_by_genes
+202,GRTP1,A32V,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit GRTP1 mutations in the genomic data commons?",top_cases_counts_by_genes
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit TSHZ3 mutations in the genomic data commons?",top_cases_counts_by_genes
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,"In cases of HIV+ Tumor Molecular Characterization Project - Cervical Cancer, how many exhibit TAS1R3 mutations in the genomic data commons?",top_cases_counts_by_genes
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit PIAS3 mutations in the genomic data commons?",top_cases_counts_by_genes
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit PIAS3 mutations in the genomic data commons?",top_cases_counts_by_genes
+251,ZNF274,P13R,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit ZNF274 mutations in the genomic data commons?",top_cases_counts_by_genes
+253,SYNJ1,R795C,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit SYNJ1 mutations in the genomic data commons?",top_cases_counts_by_genes
+254,SYNJ1,R800C,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit SYNJ1 mutations in the genomic data commons?",top_cases_counts_by_genes
+255,SYNJ1,R839C,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit SYNJ1 mutations in the genomic data commons?",top_cases_counts_by_genes
+261,DSCAM,V343M,Prostate Adenocarcinoma,"In cases of Prostate Adenocarcinoma, how many exhibit DSCAM mutations in the genomic data commons?",top_cases_counts_by_genes
+262,DSCAM,V426M,Prostate Adenocarcinoma,"In cases of Prostate Adenocarcinoma, how many exhibit DSCAM mutations in the genomic data commons?",top_cases_counts_by_genes
+263,DSCAM,V591M,Prostate Adenocarcinoma,"In cases of Prostate Adenocarcinoma, how many exhibit DSCAM mutations in the genomic data commons?",top_cases_counts_by_genes
+267,DGKD,R140H,Exceptional Responders,"In cases of Exceptional Responders, how many exhibit DGKD mutations in the genomic data commons?",top_cases_counts_by_genes
+268,DGKD,R160H,Exceptional Responders,"In cases of Exceptional Responders, how many exhibit DGKD mutations in the genomic data commons?",top_cases_counts_by_genes
+269,DGKD,R204H,Exceptional Responders,"In cases of Exceptional Responders, how many exhibit DGKD mutations in the genomic data commons?",top_cases_counts_by_genes
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how many exhibit PLEKHG6 mutations in the genomic data commons?",top_cases_counts_by_genes
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how many exhibit PLEKHG6 mutations in the genomic data commons?",top_cases_counts_by_genes
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how many exhibit PLEKHG6 mutations in the genomic data commons?",top_cases_counts_by_genes
+279,WNT2,D138N,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit WNT2 mutations in the genomic data commons?",top_cases_counts_by_genes
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit GUCY2C mutations in the genomic data commons?",top_cases_counts_by_genes
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit C7orf31 mutations in the genomic data commons?",top_cases_counts_by_genes
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how many exhibit ZKSCAN7 mutations in the genomic data commons?",top_cases_counts_by_genes
+299,OR5D14,M210L,Neuroblastoma,"In cases of Neuroblastoma, how many exhibit OR5D14 mutations in the genomic data commons?",top_cases_counts_by_genes
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit SPATA22 mutations in the genomic data commons?",top_cases_counts_by_genes
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit SPATA22 mutations in the genomic data commons?",top_cases_counts_by_genes
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit SPATA22 mutations in the genomic data commons?",top_cases_counts_by_genes
+310,LCN15,E21V,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit LCN15 mutations in the genomic data commons?",top_cases_counts_by_genes
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit DCAF4L2 mutations in the genomic data commons?",top_cases_counts_by_genes
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit GUK1 mutations in the genomic data commons?",top_cases_counts_by_genes
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit GUK1 mutations in the genomic data commons?",top_cases_counts_by_genes
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit GUK1 mutations in the genomic data commons?",top_cases_counts_by_genes
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit GUK1 mutations in the genomic data commons?",top_cases_counts_by_genes
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit GUK1 mutations in the genomic data commons?",top_cases_counts_by_genes
+328,MORF4L1,K29T,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit MORF4L1 mutations in the genomic data commons?",top_cases_counts_by_genes
+329,MORF4L1,K51T,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit MORF4L1 mutations in the genomic data commons?",top_cases_counts_by_genes
+330,MORF4L1,K61T,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit MORF4L1 mutations in the genomic data commons?",top_cases_counts_by_genes
+331,MORF4L1,K76T,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit MORF4L1 mutations in the genomic data commons?",top_cases_counts_by_genes
+335,MYO3B,F594L,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit MYO3B mutations in the genomic data commons?",top_cases_counts_by_genes
+336,MYO3B,F603L,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit MYO3B mutations in the genomic data commons?",top_cases_counts_by_genes
+339,TENT5A,S320F,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit TENT5A mutations in the genomic data commons?",top_cases_counts_by_genes
+340,TENT5A,S339F,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit TENT5A mutations in the genomic data commons?",top_cases_counts_by_genes
+341,TENT5A,S401F,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit TENT5A mutations in the genomic data commons?",top_cases_counts_by_genes
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,"In cases of Ovarian Serous Cystadenocarcinoma, how many exhibit ZFAT mutations in the genomic data commons?",top_cases_counts_by_genes
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,"In cases of Ovarian Serous Cystadenocarcinoma, how many exhibit ZFAT mutations in the genomic data commons?",top_cases_counts_by_genes
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,"In cases of Ovarian Serous Cystadenocarcinoma, how many exhibit ZFAT mutations in the genomic data commons?",top_cases_counts_by_genes
+357,ZNF584,A211T,Sarcoma,"In cases of Sarcoma, how many exhibit ZNF584 mutations in the genomic data commons?",top_cases_counts_by_genes
+358,ZNF584,A256T,Sarcoma,"In cases of Sarcoma, how many exhibit ZNF584 mutations in the genomic data commons?",top_cases_counts_by_genes
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit LDOC1 mutations in the genomic data commons?",top_cases_counts_by_genes
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit PDGFC mutations in the genomic data commons?",top_cases_counts_by_genes
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit MSANTD4 mutations in the genomic data commons?",top_cases_counts_by_genes
+374,NPSR1,S123L,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit NPSR1 mutations in the genomic data commons?",top_cases_counts_by_genes
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit PHLPP1 mutations in the genomic data commons?",top_cases_counts_by_genes
+385,COL6A3,G237S,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit COL6A3 mutations in the genomic data commons?",top_cases_counts_by_genes
+386,COL6A3,G437S,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit COL6A3 mutations in the genomic data commons?",top_cases_counts_by_genes
+387,COL6A3,G638S,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit COL6A3 mutations in the genomic data commons?",top_cases_counts_by_genes
+388,COL6A3,G644S,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit COL6A3 mutations in the genomic data commons?",top_cases_counts_by_genes
+389,COL6A3,G844S,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit COL6A3 mutations in the genomic data commons?",top_cases_counts_by_genes
+395,ADRA1A,R348G,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit ADRA1A mutations in the genomic data commons?",top_cases_counts_by_genes
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, how many exhibit LAMB2 mutations in the genomic data commons?",top_cases_counts_by_genes
+406,POC1B,I198T,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how many exhibit POC1B mutations in the genomic data commons?",top_cases_counts_by_genes
+407,POC1B,I286T,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how many exhibit POC1B mutations in the genomic data commons?",top_cases_counts_by_genes
+408,POC1B,I328T,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how many exhibit POC1B mutations in the genomic data commons?",top_cases_counts_by_genes
+409,POC1B,S79P,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how many exhibit POC1B mutations in the genomic data commons?",top_cases_counts_by_genes
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,"In cases of Liver Hepatocellular Carcinoma, how many exhibit USH2A mutations in the genomic data commons?",top_cases_counts_by_genes
+414,AQP7,T110S,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how many exhibit AQP7 mutations in the genomic data commons?",top_cases_counts_by_genes
+415,AQP7,T166S,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how many exhibit AQP7 mutations in the genomic data commons?",top_cases_counts_by_genes
+416,AQP7,T167S,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how many exhibit AQP7 mutations in the genomic data commons?",top_cases_counts_by_genes
+417,AQP7,T75S,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how many exhibit AQP7 mutations in the genomic data commons?",top_cases_counts_by_genes
+430,DCN,R163C,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how many exhibit DCN mutations in the genomic data commons?",top_cases_counts_by_genes
+431,DCN,R203C,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how many exhibit DCN mutations in the genomic data commons?",top_cases_counts_by_genes
+432,DCN,R241C,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how many exhibit DCN mutations in the genomic data commons?",top_cases_counts_by_genes
+433,DCN,R350C,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how many exhibit DCN mutations in the genomic data commons?",top_cases_counts_by_genes
+434,DCN,R41C,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how many exhibit DCN mutations in the genomic data commons?",top_cases_counts_by_genes
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit CPS1 mutations in the genomic data commons?",top_cases_counts_by_genes
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit CPS1 mutations in the genomic data commons?",top_cases_counts_by_genes
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit CPS1 mutations in the genomic data commons?",top_cases_counts_by_genes
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,"In cases of Kidney Renal Papillary Cell Carcinoma, how many exhibit FCGR2C mutations in the genomic data commons?",top_cases_counts_by_genes
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,"In cases of Kidney Renal Papillary Cell Carcinoma, how many exhibit FCGR2C mutations in the genomic data commons?",top_cases_counts_by_genes
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit GRM1 mutations in the genomic data commons?",top_cases_counts_by_genes
+482,SGCZ,Q138H,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit SGCZ mutations in the genomic data commons?",top_cases_counts_by_genes
+483,SGCZ,Q91H,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit SGCZ mutations in the genomic data commons?",top_cases_counts_by_genes
+485,SMO,V15M,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit SMO mutations in the genomic data commons?",top_cases_counts_by_genes
+486,SMO,V321M,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit SMO mutations in the genomic data commons?",top_cases_counts_by_genes
+488,CHODL,G159E,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit CHODL mutations in the genomic data commons?",top_cases_counts_by_genes
+489,CHODL,G181E,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit CHODL mutations in the genomic data commons?",top_cases_counts_by_genes
+490,CHODL,G200E,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit CHODL mutations in the genomic data commons?",top_cases_counts_by_genes
+494,MYO16,P399H,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit MYO16 mutations in the genomic data commons?",top_cases_counts_by_genes
+495,MYO16,P421H,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit MYO16 mutations in the genomic data commons?",top_cases_counts_by_genes
+498,CXCR2,A98V,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit CXCR2 mutations in the genomic data commons?",top_cases_counts_by_genes
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how many exhibit TMEM225 mutations in the genomic data commons?",top_cases_counts_by_genes
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit MAOB mutations in the genomic data commons?",top_cases_counts_by_genes
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit GPRASP1 mutations in the genomic data commons?",top_cases_counts_by_genes
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit MRPL32 mutations in the genomic data commons?",top_cases_counts_by_genes
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit TYROBP mutations in the genomic data commons?",top_cases_counts_by_genes
+510,RAB40C,A111V,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit RAB40C mutations in the genomic data commons?",top_cases_counts_by_genes
+511,RAB40C,A143V,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit RAB40C mutations in the genomic data commons?",top_cases_counts_by_genes
+512,CTNNA2,S323R,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit CTNNA2 mutations in the genomic data commons?",top_cases_counts_by_genes
+513,CTNNA2,S339R,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit CTNNA2 mutations in the genomic data commons?",top_cases_counts_by_genes
+514,CTNNA2,S386R,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit CTNNA2 mutations in the genomic data commons?",top_cases_counts_by_genes
+515,CTNNA2,S707R,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit CTNNA2 mutations in the genomic data commons?",top_cases_counts_by_genes
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how many exhibit MYO15A mutations in the genomic data commons?",top_cases_counts_by_genes
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit GIMAP2 mutations in the genomic data commons?",top_cases_counts_by_genes
+532,KIF20B,N1160D,Glioblastoma Multiforme,"In cases of Glioblastoma Multiforme, how many exhibit KIF20B mutations in the genomic data commons?",top_cases_counts_by_genes
+533,KIF20B,N1200D,Glioblastoma Multiforme,"In cases of Glioblastoma Multiforme, how many exhibit KIF20B mutations in the genomic data commons?",top_cases_counts_by_genes
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit ADAM17 mutations in the genomic data commons?",top_cases_counts_by_genes
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit BCAT1 mutations in the genomic data commons?",top_cases_counts_by_genes
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit BCAT1 mutations in the genomic data commons?",top_cases_counts_by_genes
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit BCAT1 mutations in the genomic data commons?",top_cases_counts_by_genes
+540,ERCC6,R1053H,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit ERCC6 mutations in the genomic data commons?",top_cases_counts_by_genes
+541,DCC,R320W,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how many exhibit DCC mutations in the genomic data commons?",top_cases_counts_by_genes
+542,DCC,R363W,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how many exhibit DCC mutations in the genomic data commons?",top_cases_counts_by_genes
+543,DCC,R386W,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how many exhibit DCC mutations in the genomic data commons?",top_cases_counts_by_genes
+544,DCC,R41W,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how many exhibit DCC mutations in the genomic data commons?",top_cases_counts_by_genes
+549,FBXO15,D417N,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit FBXO15 mutations in the genomic data commons?",top_cases_counts_by_genes
+550,FBXO15,D86N,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit FBXO15 mutations in the genomic data commons?",top_cases_counts_by_genes
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit GSTCD mutations in the genomic data commons?",top_cases_counts_by_genes
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit GSTCD mutations in the genomic data commons?",top_cases_counts_by_genes
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit OLFML3 mutations in the genomic data commons?",top_cases_counts_by_genes
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit OLFML3 mutations in the genomic data commons?",top_cases_counts_by_genes
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit OLFML3 mutations in the genomic data commons?",top_cases_counts_by_genes
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,"In cases of Ovarian Serous Cystadenocarcinoma, how many exhibit CFAP61 mutations in the genomic data commons?",top_cases_counts_by_genes
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,"In cases of Ovarian Serous Cystadenocarcinoma, how many exhibit CFAP61 mutations in the genomic data commons?",top_cases_counts_by_genes
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how many exhibit HLA-DQA2 mutations in the genomic data commons?",top_cases_counts_by_genes
+582,TENM2,H240Y,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit TENM2 mutations in the genomic data commons?",top_cases_counts_by_genes
+583,TENM2,H351Y,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit TENM2 mutations in the genomic data commons?",top_cases_counts_by_genes
+584,TENM2,H472Y,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit TENM2 mutations in the genomic data commons?",top_cases_counts_by_genes
+600,ANKRD24,A465T,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit ANKRD24 mutations in the genomic data commons?",top_cases_counts_by_genes
+601,ANKRD24,A494T,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit ANKRD24 mutations in the genomic data commons?",top_cases_counts_by_genes
+602,ANKRD24,A584T,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit ANKRD24 mutations in the genomic data commons?",top_cases_counts_by_genes
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit ZCCHC14 mutations in the genomic data commons?",top_cases_counts_by_genes
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit ZCCHC14 mutations in the genomic data commons?",top_cases_counts_by_genes
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit ZCCHC14 mutations in the genomic data commons?",top_cases_counts_by_genes
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit ZCCHC14 mutations in the genomic data commons?",top_cases_counts_by_genes
+625,SIK2,I265M,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit SIK2 mutations in the genomic data commons?",top_cases_counts_by_genes
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit MYH11 mutations in the genomic data commons?",top_cases_counts_by_genes
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit MYH11 mutations in the genomic data commons?",top_cases_counts_by_genes
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit SLC6A4 mutations in the genomic data commons?",top_cases_counts_by_genes
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit SLC9C1 mutations in the genomic data commons?",top_cases_counts_by_genes
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit SLC9C1 mutations in the genomic data commons?",top_cases_counts_by_genes
+644,OR2A12,A254T,Brain Lower Grade Glioma,"In cases of Brain Lower Grade Glioma, how many exhibit OR2A12 mutations in the genomic data commons?",top_cases_counts_by_genes
+646,PYHIN1,T325K,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit PYHIN1 mutations in the genomic data commons?",top_cases_counts_by_genes
+647,PYHIN1,T334K,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit PYHIN1 mutations in the genomic data commons?",top_cases_counts_by_genes
+650,JAML,G191E,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit JAML mutations in the genomic data commons?",top_cases_counts_by_genes
+651,JAML,G219E,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit JAML mutations in the genomic data commons?",top_cases_counts_by_genes
+652,JAML,G220E,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit JAML mutations in the genomic data commons?",top_cases_counts_by_genes
+653,JAML,G230E,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit JAML mutations in the genomic data commons?",top_cases_counts_by_genes
+658,TYK2,H1146R,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit TYK2 mutations in the genomic data commons?",top_cases_counts_by_genes
+659,TYK2,H23R,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit TYK2 mutations in the genomic data commons?",top_cases_counts_by_genes
+660,TYK2,H961R,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit TYK2 mutations in the genomic data commons?",top_cases_counts_by_genes
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit CTCFL mutations in the genomic data commons?",top_cases_counts_by_genes
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit CTCFL mutations in the genomic data commons?",top_cases_counts_by_genes
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit CTCFL mutations in the genomic data commons?",top_cases_counts_by_genes
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit CTCFL mutations in the genomic data commons?",top_cases_counts_by_genes
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit CEP20 mutations in the genomic data commons?",top_cases_counts_by_genes
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit CEP20 mutations in the genomic data commons?",top_cases_counts_by_genes
+689,RIMS2,R25W,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit RIMS2 mutations in the genomic data commons?",top_cases_counts_by_genes
+690,RIMS2,R393W,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit RIMS2 mutations in the genomic data commons?",top_cases_counts_by_genes
+691,RIMS2,R423W,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit RIMS2 mutations in the genomic data commons?",top_cases_counts_by_genes
+692,RIMS2,R470W,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit RIMS2 mutations in the genomic data commons?",top_cases_counts_by_genes
+693,RIMS2,R615W,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit RIMS2 mutations in the genomic data commons?",top_cases_counts_by_genes
+694,RIMS2,R619W,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit RIMS2 mutations in the genomic data commons?",top_cases_counts_by_genes
+695,RIMS2,R716W,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit RIMS2 mutations in the genomic data commons?",top_cases_counts_by_genes
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit PIK3C2G mutations in the genomic data commons?",top_cases_counts_by_genes
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit PIK3C2G mutations in the genomic data commons?",top_cases_counts_by_genes
+728,STK19,D341N,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit STK19 mutations in the genomic data commons?",top_cases_counts_by_genes
+729,STK19,D345N,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit STK19 mutations in the genomic data commons?",top_cases_counts_by_genes
+730,REXO4,P60A,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit REXO4 mutations in the genomic data commons?",top_cases_counts_by_genes
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit ZBTB34 mutations in the genomic data commons?",top_cases_counts_by_genes
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit ZBTB34 mutations in the genomic data commons?",top_cases_counts_by_genes
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how many exhibit NCKAP5 mutations in the genomic data commons?",top_cases_counts_by_genes
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how many exhibit SORCS1 mutations in the genomic data commons?",top_cases_counts_by_genes
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how many exhibit SORCS1 mutations in the genomic data commons?",top_cases_counts_by_genes
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how many exhibit SORCS1 mutations in the genomic data commons?",top_cases_counts_by_genes
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how many exhibit SORCS1 mutations in the genomic data commons?",top_cases_counts_by_genes
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,"In cases of Head and Neck Squamous Cell Carcinoma, how many exhibit FGF8 mutations in the genomic data commons?",top_cases_counts_by_genes
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,"In cases of Head and Neck Squamous Cell Carcinoma, how many exhibit FGF8 mutations in the genomic data commons?",top_cases_counts_by_genes
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,"In cases of Head and Neck Squamous Cell Carcinoma, how many exhibit FGF8 mutations in the genomic data commons?",top_cases_counts_by_genes
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,"In cases of Head and Neck Squamous Cell Carcinoma, how many exhibit FGF8 mutations in the genomic data commons?",top_cases_counts_by_genes
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,"In cases of Head and Neck Squamous Cell Carcinoma, how many exhibit FGF8 mutations in the genomic data commons?",top_cases_counts_by_genes
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,"In cases of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia, how many exhibit TENM3 mutations in the genomic data commons?",top_cases_counts_by_genes
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit AKT1 mutations in the genomic data commons?",top_cases_counts_by_genes
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, how many exhibit CFAP298-TCP10L mutations in the genomic data commons?",top_cases_counts_by_genes
+792,GLRB,E148D,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit GLRB mutations in the genomic data commons?",top_cases_counts_by_genes
+793,TTN,F7636L,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit TTN mutations in the genomic data commons?",top_cases_counts_by_genes
+794,TTN,F8563L,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit TTN mutations in the genomic data commons?",top_cases_counts_by_genes
+795,TTN,F8880L,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit TTN mutations in the genomic data commons?",top_cases_counts_by_genes
+799,ANKRD30A,V798I,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit ANKRD30A mutations in the genomic data commons?",top_cases_counts_by_genes
+800,ANKRD30A,V854I,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit ANKRD30A mutations in the genomic data commons?",top_cases_counts_by_genes
+801,ANKRD30A,V973I,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit ANKRD30A mutations in the genomic data commons?",top_cases_counts_by_genes
+809,TRIM45,S177L,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit TRIM45 mutations in the genomic data commons?",top_cases_counts_by_genes
+810,TRIM45,S224L,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit TRIM45 mutations in the genomic data commons?",top_cases_counts_by_genes
+811,TRIM45,S281L,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit TRIM45 mutations in the genomic data commons?",top_cases_counts_by_genes
+812,CACNA1F,G727V,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit CACNA1F mutations in the genomic data commons?",top_cases_counts_by_genes
+813,CACNA1F,G781V,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit CACNA1F mutations in the genomic data commons?",top_cases_counts_by_genes
+814,CACNA1F,G792V,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit CACNA1F mutations in the genomic data commons?",top_cases_counts_by_genes
+817,KL,R594C,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit KL mutations in the genomic data commons?",top_cases_counts_by_genes
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,"In cases of Kidney Renal Papillary Cell Carcinoma, how many exhibit GUF1 mutations in the genomic data commons?",top_cases_counts_by_genes
+822,TAF1L,A539V,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit TAF1L mutations in the genomic data commons?",top_cases_counts_by_genes
+823,TASOR2,S256F,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit TASOR2 mutations in the genomic data commons?",top_cases_counts_by_genes
+824,TASOR2,S36F,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit TASOR2 mutations in the genomic data commons?",top_cases_counts_by_genes
+825,TASOR2,S471F,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit TASOR2 mutations in the genomic data commons?",top_cases_counts_by_genes
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit KDM5C mutations in the genomic data commons?",top_cases_counts_by_genes
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit KDM5C mutations in the genomic data commons?",top_cases_counts_by_genes
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit KDM5C mutations in the genomic data commons?",top_cases_counts_by_genes
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit KDM5C mutations in the genomic data commons?",top_cases_counts_by_genes
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, how many exhibit IL5RA mutations in the genomic data commons?",top_cases_counts_by_genes
+843,DHX16,A29V,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit DHX16 mutations in the genomic data commons?",top_cases_counts_by_genes
+844,DHX16,A89V,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit DHX16 mutations in the genomic data commons?",top_cases_counts_by_genes
+902,GPR158,A644V,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit GPR158 mutations in the genomic data commons?",top_cases_counts_by_genes
+903,GPR158,A723V,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit GPR158 mutations in the genomic data commons?",top_cases_counts_by_genes
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how many exhibit EIF2B4 mutations in the genomic data commons?",top_cases_counts_by_genes
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how many exhibit EIF2B4 mutations in the genomic data commons?",top_cases_counts_by_genes
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how many exhibit EIF2B4 mutations in the genomic data commons?",top_cases_counts_by_genes
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how many exhibit EIF2B4 mutations in the genomic data commons?",top_cases_counts_by_genes
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how many exhibit EIF2B4 mutations in the genomic data commons?",top_cases_counts_by_genes
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how many exhibit EIF2B4 mutations in the genomic data commons?",top_cases_counts_by_genes
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit AUTS2 mutations in the genomic data commons?",top_cases_counts_by_genes
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit AUTS2 mutations in the genomic data commons?",top_cases_counts_by_genes
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit AUTS2 mutations in the genomic data commons?",top_cases_counts_by_genes
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit AUTS2 mutations in the genomic data commons?",top_cases_counts_by_genes
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit AUTS2 mutations in the genomic data commons?",top_cases_counts_by_genes
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit AUTS2 mutations in the genomic data commons?",top_cases_counts_by_genes
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit AUTS2 mutations in the genomic data commons?",top_cases_counts_by_genes
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit AUTS2 mutations in the genomic data commons?",top_cases_counts_by_genes
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit AUTS2 mutations in the genomic data commons?",top_cases_counts_by_genes
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit AUTS2 mutations in the genomic data commons?",top_cases_counts_by_genes
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how many exhibit ACTL7B mutations in the genomic data commons?",top_cases_counts_by_genes
+952,PCDHGA1,R535W,Glioblastoma Multiforme,"In cases of Glioblastoma Multiforme, how many exhibit PCDHGA1 mutations in the genomic data commons?",top_cases_counts_by_genes
+954,TRAP1,R114W,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit TRAP1 mutations in the genomic data commons?",top_cases_counts_by_genes
+955,TRAP1,R61W,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit TRAP1 mutations in the genomic data commons?",top_cases_counts_by_genes
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit PIK3C2A mutations in the genomic data commons?",top_cases_counts_by_genes
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,"In cases of Liver Hepatocellular Carcinoma, how many exhibit KANSL1 mutations in the genomic data commons?",top_cases_counts_by_genes
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit ANKRD52 mutations in the genomic data commons?",top_cases_counts_by_genes
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit PAPPA mutations in the genomic data commons?",top_cases_counts_by_genes
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how many exhibit B3GALNT1 mutations in the genomic data commons?",top_cases_counts_by_genes
+982,GABRA6,G115R,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit GABRA6 mutations in the genomic data commons?",top_cases_counts_by_genes
+983,GABRA6,G122R,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit GABRA6 mutations in the genomic data commons?",top_cases_counts_by_genes
+984,GABRA6,G165R,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit GABRA6 mutations in the genomic data commons?",top_cases_counts_by_genes
+985,GABRA6,G175R,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit GABRA6 mutations in the genomic data commons?",top_cases_counts_by_genes
+986,GABRA6,G70R,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit GABRA6 mutations in the genomic data commons?",top_cases_counts_by_genes
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit ZSCAN31 mutations in the genomic data commons?",top_cases_counts_by_genes
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how many exhibit MED16 mutations in the genomic data commons?",top_cases_counts_by_genes
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how many exhibit MED16 mutations in the genomic data commons?",top_cases_counts_by_genes
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,"In cases of Pancreatic Adenocarcinoma, how many exhibit PTPRO mutations in the genomic data commons?",top_cases_counts_by_genes
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,"In cases of Pancreatic Adenocarcinoma, how many exhibit PTPRO mutations in the genomic data commons?",top_cases_counts_by_genes
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,"In cases of Pancreatic Adenocarcinoma, how many exhibit PTPRO mutations in the genomic data commons?",top_cases_counts_by_genes
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,"In cases of Pancreatic Adenocarcinoma, how many exhibit PTPRO mutations in the genomic data commons?",top_cases_counts_by_genes
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,"In cases of Pancreatic Adenocarcinoma, how many exhibit PTPRO mutations in the genomic data commons?",top_cases_counts_by_genes
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,"In cases of Pancreatic Adenocarcinoma, how many exhibit PTPRO mutations in the genomic data commons?",top_cases_counts_by_genes
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,"In cases of Pancreatic Adenocarcinoma, how many exhibit PTPRO mutations in the genomic data commons?",top_cases_counts_by_genes
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,"In cases of Pancreatic Adenocarcinoma, how many exhibit PTPRO mutations in the genomic data commons?",top_cases_counts_by_genes
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit CHMP7 mutations in the genomic data commons?",top_cases_counts_by_genes
+1017,GPC3,I107N,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit GPC3 mutations in the genomic data commons?",top_cases_counts_by_genes
+1018,GPC3,I161N,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit GPC3 mutations in the genomic data commons?",top_cases_counts_by_genes
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, how many exhibit TLK2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, how many exhibit TLK2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, how many exhibit TLK2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, how many exhibit TLK2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, how many exhibit TLK2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1036,ZNF217,E209Q,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit ZNF217 mutations in the genomic data commons?",top_cases_counts_by_genes
+1038,SYT9,V275L,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit SYT9 mutations in the genomic data commons?",top_cases_counts_by_genes
+1039,SYT9,V307L,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit SYT9 mutations in the genomic data commons?",top_cases_counts_by_genes
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit PKHD1L1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit MYO3A mutations in the genomic data commons?",top_cases_counts_by_genes
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how many exhibit VASN mutations in the genomic data commons?",top_cases_counts_by_genes
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit DNMT1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit DNMT1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit DNMT1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1056,CA9,E402K,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit CA9 mutations in the genomic data commons?",top_cases_counts_by_genes
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit TTC17 mutations in the genomic data commons?",top_cases_counts_by_genes
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit TTC17 mutations in the genomic data commons?",top_cases_counts_by_genes
+1065,PSG2,P43L,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how many exhibit PSG2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how many exhibit RIPOR2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how many exhibit RIPOR2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how many exhibit RIPOR2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how many exhibit RIPOR2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit DCLK3 mutations in the genomic data commons?",top_cases_counts_by_genes
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit DCLK3 mutations in the genomic data commons?",top_cases_counts_by_genes
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit MERTK mutations in the genomic data commons?",top_cases_counts_by_genes
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit MERTK mutations in the genomic data commons?",top_cases_counts_by_genes
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit MERTK mutations in the genomic data commons?",top_cases_counts_by_genes
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit ZFP42 mutations in the genomic data commons?",top_cases_counts_by_genes
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit OR13C3 mutations in the genomic data commons?",top_cases_counts_by_genes
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit OR13C3 mutations in the genomic data commons?",top_cases_counts_by_genes
+1091,SPAG1,I917M,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit SPAG1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit CDKN2AIP mutations in the genomic data commons?",top_cases_counts_by_genes
+1093,PXN,H1016Y,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit PXN mutations in the genomic data commons?",top_cases_counts_by_genes
+1094,PXN,H359Y,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit PXN mutations in the genomic data commons?",top_cases_counts_by_genes
+1095,PXN,H492Y,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit PXN mutations in the genomic data commons?",top_cases_counts_by_genes
+1096,PXN,H524Y,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit PXN mutations in the genomic data commons?",top_cases_counts_by_genes
+1097,PXN,H526Y,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit PXN mutations in the genomic data commons?",top_cases_counts_by_genes
+1098,PXN,H540Y,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit PXN mutations in the genomic data commons?",top_cases_counts_by_genes
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit TTYH2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit TTYH2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1106,TMEM255A,N205S,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit TMEM255A mutations in the genomic data commons?",top_cases_counts_by_genes
+1107,TMEM255A,N229S,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit TMEM255A mutations in the genomic data commons?",top_cases_counts_by_genes
+1108,TMEM255A,N65S,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit TMEM255A mutations in the genomic data commons?",top_cases_counts_by_genes
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how many exhibit TASOR2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how many exhibit TASOR2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit ICE1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1112,MYT1,A558E,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how many exhibit MYT1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1113,MYT1,A879E,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how many exhibit MYT1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1114,MYT1,A906E,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how many exhibit MYT1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit CX3CR1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit CX3CR1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,"In cases of Liver Hepatocellular Carcinoma, how many exhibit SPINDOC mutations in the genomic data commons?",top_cases_counts_by_genes
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit ART3 mutations in the genomic data commons?",top_cases_counts_by_genes
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit ART3 mutations in the genomic data commons?",top_cases_counts_by_genes
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how many exhibit CYP1A2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how many exhibit ADRA1A mutations in the genomic data commons?",top_cases_counts_by_genes
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit CDH23 mutations in the genomic data commons?",top_cases_counts_by_genes
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit CDH23 mutations in the genomic data commons?",top_cases_counts_by_genes
+1148,KRT39,P137S,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit KRT39 mutations in the genomic data commons?",top_cases_counts_by_genes
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit PDHA2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit SLC24A2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,"In cases of Liver Hepatocellular Carcinoma, how many exhibit PTPRN2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,"In cases of Liver Hepatocellular Carcinoma, how many exhibit PTPRN2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,"In cases of Liver Hepatocellular Carcinoma, how many exhibit PTPRN2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,"In cases of Liver Hepatocellular Carcinoma, how many exhibit PTPRN2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,"In cases of Liver Hepatocellular Carcinoma, how many exhibit PTPRN2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1188,SOX21,R55L,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit SOX21 mutations in the genomic data commons?",top_cases_counts_by_genes
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how many exhibit CPA6 mutations in the genomic data commons?",top_cases_counts_by_genes
+1206,GRM5,E14K,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit GRM5 mutations in the genomic data commons?",top_cases_counts_by_genes
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how many exhibit CASZ1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1210,SGIP1,N122T,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit SGIP1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1211,SGIP1,N420T,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit SGIP1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1212,SGIP1,N617T,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit SGIP1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1213,SGIP1,N648T,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit SGIP1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1227,CARMIL1,V549L,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit CARMIL1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1228,CARMIL1,V949L,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit CARMIL1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1232,ZNF431,D121Y,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit ZNF431 mutations in the genomic data commons?",top_cases_counts_by_genes
+1233,ZNF431,D161Y,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit ZNF431 mutations in the genomic data commons?",top_cases_counts_by_genes
+1234,ZNF431,R128I,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit ZNF431 mutations in the genomic data commons?",top_cases_counts_by_genes
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit DNAH11 mutations in the genomic data commons?",top_cases_counts_by_genes
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit DNAH11 mutations in the genomic data commons?",top_cases_counts_by_genes
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit POLD1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how many exhibit POLD1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1248,TTC12,D646H,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit TTC12 mutations in the genomic data commons?",top_cases_counts_by_genes
+1249,TTC12,D652H,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit TTC12 mutations in the genomic data commons?",top_cases_counts_by_genes
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how many exhibit CNGB1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how many exhibit CNGB1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1254,CTSC,E214V,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit CTSC mutations in the genomic data commons?",top_cases_counts_by_genes
+1255,CTSC,E291V,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit CTSC mutations in the genomic data commons?",top_cases_counts_by_genes
+1256,CTSC,E322V,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit CTSC mutations in the genomic data commons?",top_cases_counts_by_genes
+1257,CTSC,E324V,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit CTSC mutations in the genomic data commons?",top_cases_counts_by_genes
+1258,CTSC,E335V,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit CTSC mutations in the genomic data commons?",top_cases_counts_by_genes
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit PRSS8 mutations in the genomic data commons?",top_cases_counts_by_genes
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit PRSS8 mutations in the genomic data commons?",top_cases_counts_by_genes
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit ARHGEF40 mutations in the genomic data commons?",top_cases_counts_by_genes
+1264,ACTB,A138T,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how many exhibit ACTB mutations in the genomic data commons?",top_cases_counts_by_genes
+1265,ACTB,A217T,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how many exhibit ACTB mutations in the genomic data commons?",top_cases_counts_by_genes
+1266,ACTB,A244T,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how many exhibit ACTB mutations in the genomic data commons?",top_cases_counts_by_genes
+1267,ACTB,A260T,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how many exhibit ACTB mutations in the genomic data commons?",top_cases_counts_by_genes
+1268,YY1AP1,V546D,Glioblastoma Multiforme,"In cases of Glioblastoma Multiforme, how many exhibit YY1AP1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1269,YY1AP1,V557D,Glioblastoma Multiforme,"In cases of Glioblastoma Multiforme, how many exhibit YY1AP1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1270,YY1AP1,V566D,Glioblastoma Multiforme,"In cases of Glioblastoma Multiforme, how many exhibit YY1AP1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1271,YY1AP1,V577D,Glioblastoma Multiforme,"In cases of Glioblastoma Multiforme, how many exhibit YY1AP1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1272,YY1AP1,V623D,Glioblastoma Multiforme,"In cases of Glioblastoma Multiforme, how many exhibit YY1AP1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1273,YY1AP1,V695D,Glioblastoma Multiforme,"In cases of Glioblastoma Multiforme, how many exhibit YY1AP1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1274,YY1AP1,V715D,Glioblastoma Multiforme,"In cases of Glioblastoma Multiforme, how many exhibit YY1AP1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit FNDC7 mutations in the genomic data commons?",top_cases_counts_by_genes
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit FNDC7 mutations in the genomic data commons?",top_cases_counts_by_genes
+1299,TLCD5,G15V,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit TLCD5 mutations in the genomic data commons?",top_cases_counts_by_genes
+1300,TLCD5,G37V,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit TLCD5 mutations in the genomic data commons?",top_cases_counts_by_genes
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit POLR1G mutations in the genomic data commons?",top_cases_counts_by_genes
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit POLR1G mutations in the genomic data commons?",top_cases_counts_by_genes
+1308,DNAH14,N1186K,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit DNAH14 mutations in the genomic data commons?",top_cases_counts_by_genes
+1309,DNAH14,N2657K,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit DNAH14 mutations in the genomic data commons?",top_cases_counts_by_genes
+1310,DNAH14,N3460K,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit DNAH14 mutations in the genomic data commons?",top_cases_counts_by_genes
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit NEXN mutations in the genomic data commons?",top_cases_counts_by_genes
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,"In cases of Prostate Adenocarcinoma, how many exhibit CYB5R2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,"In cases of Prostate Adenocarcinoma, how many exhibit CYB5R2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit NRAP mutations in the genomic data commons?",top_cases_counts_by_genes
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit NRAP mutations in the genomic data commons?",top_cases_counts_by_genes
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit NRAP mutations in the genomic data commons?",top_cases_counts_by_genes
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit CCDC22 mutations in the genomic data commons?",top_cases_counts_by_genes
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit DCAF6 mutations in the genomic data commons?",top_cases_counts_by_genes
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit DCAF6 mutations in the genomic data commons?",top_cases_counts_by_genes
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit ZNF708 mutations in the genomic data commons?",top_cases_counts_by_genes
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit BFAR mutations in the genomic data commons?",top_cases_counts_by_genes
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit MAST4 mutations in the genomic data commons?",top_cases_counts_by_genes
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit MAST4 mutations in the genomic data commons?",top_cases_counts_by_genes
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit MAST4 mutations in the genomic data commons?",top_cases_counts_by_genes
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit MAST4 mutations in the genomic data commons?",top_cases_counts_by_genes
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit MAST4 mutations in the genomic data commons?",top_cases_counts_by_genes
+1363,ARMC3,R169C,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit ARMC3 mutations in the genomic data commons?",top_cases_counts_by_genes
+1364,ARMC3,R432C,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit ARMC3 mutations in the genomic data commons?",top_cases_counts_by_genes
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,"In cases of Kidney Renal Clear Cell Carcinoma, how many exhibit TET2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,"In cases of Kidney Renal Clear Cell Carcinoma, how many exhibit TET2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1369,SERPINB10,A353P,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit SERPINB10 mutations in the genomic data commons?",top_cases_counts_by_genes
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit STAT3 mutations in the genomic data commons?",top_cases_counts_by_genes
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit MIEF1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1381,ACVR1B,D397N,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit ACVR1B mutations in the genomic data commons?",top_cases_counts_by_genes
+1382,ACVR1B,D449N,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit ACVR1B mutations in the genomic data commons?",top_cases_counts_by_genes
+1383,ACVR1B,D490N,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit ACVR1B mutations in the genomic data commons?",top_cases_counts_by_genes
+1393,EBF2,T104I,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit EBF2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1394,EBF2,T252I,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit EBF2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1402,VPS26B,F266L,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit VPS26B mutations in the genomic data commons?",top_cases_counts_by_genes
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how many exhibit PGR mutations in the genomic data commons?",top_cases_counts_by_genes
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how many exhibit PGR mutations in the genomic data commons?",top_cases_counts_by_genes
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how many exhibit PGR mutations in the genomic data commons?",top_cases_counts_by_genes
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how many exhibit ACTA2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit THBS4 mutations in the genomic data commons?",top_cases_counts_by_genes
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit THBS4 mutations in the genomic data commons?",top_cases_counts_by_genes
+1413,PRSS1,S114T,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit PRSS1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1414,PRSS1,S124T,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit PRSS1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1415,PRSS1,S138T,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit PRSS1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1416,PRSS1,S74T,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how many exhibit PRSS1 mutations in the genomic data commons?",top_cases_counts_by_genes
+1417,PGF,R126H,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit PGF mutations in the genomic data commons?",top_cases_counts_by_genes
+1418,PGF,R127H,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how many exhibit PGF mutations in the genomic data commons?",top_cases_counts_by_genes
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how many exhibit ITPRID2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how many exhibit ITPRID2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit HBB mutations in the genomic data commons?",top_cases_counts_by_genes
+1441,PCDHB2,R158C,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit PCDHB2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1442,PCDHB2,T15M,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit PCDHB2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1443,PCDHB2,T26M,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how many exhibit PCDHB2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how many exhibit UBR2 mutations in the genomic data commons?",top_cases_counts_by_genes
+1452,FBXO42,A618D,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how many exhibit FBXO42 mutations in the genomic data commons?",top_cases_counts_by_genes
+1,TNS1,G1362V,Breast Invasive Carcinoma,Are TNS1 or SGCZ mutations present in many Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+2,TNS1,G1711V,Breast Invasive Carcinoma,Are TNS1 or CARMIL1 mutations present in many Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+3,TNS1,G1718V,Breast Invasive Carcinoma,Are TNS1 or PRSS1 mutations present in many Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+4,TNS1,G1732V,Breast Invasive Carcinoma,Are TNS1 or EBF2 mutations present in many Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+5,TNS1,G1824V,Breast Invasive Carcinoma,Are TNS1 or GPR158 mutations present in many Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+6,TNS1,G1857V,Breast Invasive Carcinoma,Are TNS1 or TRIM45 mutations present in many Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+7,TNS1,G843V,Breast Invasive Carcinoma,Are TNS1 or ERCC6 mutations present in many Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,Are EVC2 or PTPRO mutations present in many Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+15,EVC2,E987K,Bladder Urothelial Carcinoma,Are EVC2 or ADAM17 mutations present in many Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,Are CR1 or POC1B mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,Are CR1 or HTR3B mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+22,TRPA1,S295I,Rectum Adenocarcinoma,Are TRPA1 or MAST4 mutations present in many Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+23,TRPA1,S443I,Rectum Adenocarcinoma,Are TRPA1 or ABCC2 mutations present in many Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+24,TAF1C,R299L,Lung Adenocarcinoma,Are TAF1C or PXN mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+25,TAF1C,R396L,Lung Adenocarcinoma,Are TAF1C or TENM2 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+26,TAF1C,R634L,Lung Adenocarcinoma,Are TAF1C or DPF3 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+27,TAF1C,R702L,Lung Adenocarcinoma,Are TAF1C or ZSCAN31 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+28,TAF1C,R728L,Lung Adenocarcinoma,Are TAF1C or TRPA1 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,Are DPF3 or CFAP61 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,Are DPF3 or PRSS8 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,Are DPF3 or MSANTD4 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+42,OR2T4,P272H,Lung Adenocarcinoma,Are OR2T4 or MORF4L1 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+43,OR2T4,P300H,Lung Adenocarcinoma,Are OR2T4 or EBF2 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,Are FBN1 or CA9 mutations present in many Pancreatic Adenocarcinoma cases?,top_cases_counts_by_genes
+45,MAD1L1,E396K,Prostate Adenocarcinoma,Are MAD1L1 or PRSS1 mutations present in many Prostate Adenocarcinoma cases?,top_cases_counts_by_genes
+46,MAD1L1,E488K,Prostate Adenocarcinoma,Are MAD1L1 or TNS1 mutations present in many Prostate Adenocarcinoma cases?,top_cases_counts_by_genes
+47,MAD1L1,E78K,Prostate Adenocarcinoma,Are MAD1L1 or COL6A3 mutations present in many Prostate Adenocarcinoma cases?,top_cases_counts_by_genes
+61,CCNG1,E22K,Skin Cutaneous Melanoma,Are CCNG1 or KDM5C mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,Are ANP32E or TLK2 mutations present in many Kidney Renal Papillary Cell Carcinoma cases?,top_cases_counts_by_genes
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,Are ANP32E or POC1B mutations present in many Kidney Renal Papillary Cell Carcinoma cases?,top_cases_counts_by_genes
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,Are ANP32E or DCC mutations present in many Kidney Renal Papillary Cell Carcinoma cases?,top_cases_counts_by_genes
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,Are ANP32E or MYO16 mutations present in many Kidney Renal Papillary Cell Carcinoma cases?,top_cases_counts_by_genes
+66,FRY,S1888A,Bladder Urothelial Carcinoma,Are FRY or POLD1 mutations present in many Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+67,FRY,S1937A,Bladder Urothelial Carcinoma,Are FRY or PXN mutations present in many Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+68,FRY,S1938A,Bladder Urothelial Carcinoma,Are FRY or AKT1 mutations present in many Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+69,FRY,S1983A,Bladder Urothelial Carcinoma,Are FRY or CARMIL1 mutations present in many Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+70,PAK3,E318K,Skin Cutaneous Melanoma,Are PAK3 or DEFB115 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+71,PAK3,E319K,Skin Cutaneous Melanoma,Are PAK3 or YY1AP1 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+72,PAK3,E334K,Skin Cutaneous Melanoma,Are PAK3 or AQP7 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+73,PAK3,E340K,Skin Cutaneous Melanoma,Are PAK3 or DCN mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+74,PAK3,E355K,Skin Cutaneous Melanoma,Are PAK3 or TTYH2 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+80,MUC16,P7963L,Skin Cutaneous Melanoma,Are MUC16 or RIMS2 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,Are ZFPM2 or OR13C3 mutations present in many Liver Hepatocellular Carcinoma cases?,top_cases_counts_by_genes
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,Are ZFPM2 or PRSS8 mutations present in many Liver Hepatocellular Carcinoma cases?,top_cases_counts_by_genes
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,Are PIK3C2B or PHLPP1 mutations present in many Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,Are PIK3C2B or PIK3C2A mutations present in many Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+114,ZNF804A,S371Y,Colon Adenocarcinoma,Are ZNF804A or GUK1 mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+116,RELN,A2371V,Stomach Adenocarcinoma,Are RELN or CTSC mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Are EFCAB12 or EBF2 mutations present in many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Are EFCAB12 or TYK2 mutations present in many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+120,DEFB115,E53K,Skin Cutaneous Melanoma,Are DEFB115 or GUK1 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,Are ANKDD1A or PGR mutations present in many Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,Are ANKDD1A or ZBTB34 mutations present in many Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,Are ANKDD1A or COL6A3 mutations present in many Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,Are HTR3B or YY1AP1 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,Are HTR3B or MYT1 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,Are HTR3B or DCC mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+129,ABCC3,R758W,Stomach Adenocarcinoma,Are ABCC3 or POLD1 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,Are NOMO1 or ANKRD30A mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,Are NOMO1 or RIPOR2 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,Are HYOU1 or SYT10 mutations present in many Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+139,FMO4,R500Q,Skin Cutaneous Melanoma,Are FMO4 or PXN mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+140,BICC1,A372V,Exceptional Responders,Are BICC1 or C7orf31 mutations present in many Exceptional Responders cases?,top_cases_counts_by_genes
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,Are ZMYM3 or PIK3C2A mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,Are ZMYM3 or ACTB mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,Are ZMYM3 or TRIM45 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Are XKR4 or TTC17 mutations present in many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,Are ABCC2 or DNAH11 mutations present in many Liver Hepatocellular Carcinoma cases?,top_cases_counts_by_genes
+157,OR8K5,R293G,Lung Adenocarcinoma,Are OR8K5 or NRAP mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,Are SPTAN1 or SGIP1 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,Are SPTAN1 or BFAR mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+164,SYT10,M484I,Rectum Adenocarcinoma,Are SYT10 or YY1AP1 mutations present in many Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+174,HSPA5,N457K,Skin Cutaneous Melanoma,Are HSPA5 or TNS1 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+175,UNC5D,L280V,Lung Adenocarcinoma,Are UNC5D or ZNF708 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+176,UNC5D,L635V,Lung Adenocarcinoma,Are UNC5D or FBN1 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+177,UNC5D,L637V,Lung Adenocarcinoma,Are UNC5D or CHODL mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+178,UNC5D,L699V,Lung Adenocarcinoma,Are UNC5D or PIK3C2G mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+179,UNC5D,L704V,Lung Adenocarcinoma,Are UNC5D or ZFAT mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+180,UNC5D,L709V,Lung Adenocarcinoma,Are UNC5D or BFAR mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,Are DOCK2 or PGF mutations present in many Kidney Renal Clear Cell Carcinoma cases?,top_cases_counts_by_genes
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,Are ZNF627 or TENT5A mutations present in many Kidney Renal Clear Cell Carcinoma cases?,top_cases_counts_by_genes
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,Are CDC42BPA or ZNF431 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+193,MRPL55,H27Y,Colon Adenocarcinoma,Are MRPL55 or UNC5D mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+194,MRPL55,H63Y,Colon Adenocarcinoma,Are MRPL55 or PGF mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+197,TMTC3,Q749K,Breast Invasive Carcinoma,Are TMTC3 or TET2 mutations present in many Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+198,EPRS1,K771I,Colon Adenocarcinoma,Are EPRS1 or MYO3B mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+199,EPRS1,K778I,Colon Adenocarcinoma,Are EPRS1 or SOX21 mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+201,GRTP1,A110V,Skin Cutaneous Melanoma,Are GRTP1 or CHODL mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+202,GRTP1,A32V,Skin Cutaneous Melanoma,Are GRTP1 or STK19 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,Are TSHZ3 or TYROBP mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,Are TAS1R3 or ITPRID2 mutations present in many HIV+ Tumor Molecular Characterization Project - Cervical Cancer cases?,top_cases_counts_by_genes
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,Are PIAS3 or CACNA1F mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,Are PIAS3 or CYB5R2 mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+251,ZNF274,P13R,Stomach Adenocarcinoma,Are ZNF274 or PRSS1 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+253,SYNJ1,R795C,Colon Adenocarcinoma,Are SYNJ1 or PIK3C2B mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+254,SYNJ1,R800C,Colon Adenocarcinoma,Are SYNJ1 or MAST4 mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+255,SYNJ1,R839C,Colon Adenocarcinoma,Are SYNJ1 or GUF1 mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+261,DSCAM,V343M,Prostate Adenocarcinoma,Are DSCAM or DNAH11 mutations present in many Prostate Adenocarcinoma cases?,top_cases_counts_by_genes
+262,DSCAM,V426M,Prostate Adenocarcinoma,Are DSCAM or RAB40C mutations present in many Prostate Adenocarcinoma cases?,top_cases_counts_by_genes
+263,DSCAM,V591M,Prostate Adenocarcinoma,Are DSCAM or SORCS1 mutations present in many Prostate Adenocarcinoma cases?,top_cases_counts_by_genes
+267,DGKD,R140H,Exceptional Responders,Are DGKD or GUK1 mutations present in many Exceptional Responders cases?,top_cases_counts_by_genes
+268,DGKD,R160H,Exceptional Responders,Are DGKD or BFAR mutations present in many Exceptional Responders cases?,top_cases_counts_by_genes
+269,DGKD,R204H,Exceptional Responders,Are DGKD or ZNF708 mutations present in many Exceptional Responders cases?,top_cases_counts_by_genes
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,Are PLEKHG6 or PXN mutations present in many Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,Are PLEKHG6 or PTPRO mutations present in many Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,Are PLEKHG6 or DGKD mutations present in many Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+279,WNT2,D138N,Skin Cutaneous Melanoma,Are WNT2 or B3GALNT1 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,Are GUCY2C or FCGR2C mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,Are C7orf31 or GRTP1 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Are ZKSCAN7 or SORCS1 mutations present in many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+299,OR5D14,M210L,Neuroblastoma,Are OR5D14 or MYO3A mutations present in many Neuroblastoma cases?,top_cases_counts_by_genes
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,Are SPATA22 or PDHA2 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,Are SPATA22 or GUK1 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,Are SPATA22 or KRT39 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+310,LCN15,E21V,Stomach Adenocarcinoma,Are LCN15 or NRAP mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,Are DCAF4L2 or CYB5R2 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,Are GUK1 or GUK1 mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,Are GUK1 or FRY mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,Are GUK1 or TRAP1 mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,Are GUK1 or SLC9C1 mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,Are GUK1 or PTPRO mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+328,MORF4L1,K29T,Stomach Adenocarcinoma,Are MORF4L1 or DGKD mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+329,MORF4L1,K51T,Stomach Adenocarcinoma,Are MORF4L1 or GRTP1 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+330,MORF4L1,K61T,Stomach Adenocarcinoma,Are MORF4L1 or COL6A3 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+331,MORF4L1,K76T,Stomach Adenocarcinoma,Are MORF4L1 or PCDHB2 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+335,MYO3B,F594L,Skin Cutaneous Melanoma,Are MYO3B or ANKRD30A mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+336,MYO3B,F603L,Skin Cutaneous Melanoma,Are MYO3B or SPATA22 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+339,TENT5A,S320F,Skin Cutaneous Melanoma,Are TENT5A or TMEM225 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+340,TENT5A,S339F,Skin Cutaneous Melanoma,Are TENT5A or TENT5A mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+341,TENT5A,S401F,Skin Cutaneous Melanoma,Are TENT5A or YY1AP1 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,Are ZFAT or DNMT1 mutations present in many Ovarian Serous Cystadenocarcinoma cases?,top_cases_counts_by_genes
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,Are ZFAT or TENM2 mutations present in many Ovarian Serous Cystadenocarcinoma cases?,top_cases_counts_by_genes
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,Are ZFAT or ADAM17 mutations present in many Ovarian Serous Cystadenocarcinoma cases?,top_cases_counts_by_genes
+357,ZNF584,A211T,Sarcoma,Are ZNF584 or POC1B mutations present in many Sarcoma cases?,top_cases_counts_by_genes
+358,ZNF584,A256T,Sarcoma,Are ZNF584 or GUK1 mutations present in many Sarcoma cases?,top_cases_counts_by_genes
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,Are LDOC1 or ZKSCAN7 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,Are PDGFC or GUK1 mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,Are MSANTD4 or CTNNA2 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+374,NPSR1,S123L,Skin Cutaneous Melanoma,Are NPSR1 or ZFPM2 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,Are PHLPP1 or FCGR2C mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+385,COL6A3,G237S,Skin Cutaneous Melanoma,Are COL6A3 or PGF mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+386,COL6A3,G437S,Skin Cutaneous Melanoma,Are COL6A3 or GABRA6 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+387,COL6A3,G638S,Skin Cutaneous Melanoma,Are COL6A3 or EFCAB12 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+388,COL6A3,G644S,Skin Cutaneous Melanoma,Are COL6A3 or ITPRID2 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+389,COL6A3,G844S,Skin Cutaneous Melanoma,Are COL6A3 or SYNJ1 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+395,ADRA1A,R348G,Stomach Adenocarcinoma,Are ADRA1A or EIF2B4 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Are LAMB2 or AKT1 mutations present in many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,top_cases_counts_by_genes
+406,POC1B,I198T,Rectum Adenocarcinoma,Are POC1B or BICC1 mutations present in many Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+407,POC1B,I286T,Rectum Adenocarcinoma,Are POC1B or TASOR2 mutations present in many Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+408,POC1B,I328T,Rectum Adenocarcinoma,Are POC1B or PLEKHG6 mutations present in many Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+409,POC1B,S79P,Rectum Adenocarcinoma,Are POC1B or ACTB mutations present in many Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,Are USH2A or HSPA5 mutations present in many Liver Hepatocellular Carcinoma cases?,top_cases_counts_by_genes
+414,AQP7,T110S,Rectum Adenocarcinoma,Are AQP7 or FBXO15 mutations present in many Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+415,AQP7,T166S,Rectum Adenocarcinoma,Are AQP7 or TTN mutations present in many Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+416,AQP7,T167S,Rectum Adenocarcinoma,Are AQP7 or ZFPM2 mutations present in many Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+417,AQP7,T75S,Rectum Adenocarcinoma,Are AQP7 or SGIP1 mutations present in many Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+430,DCN,R163C,Rectum Adenocarcinoma,Are DCN or CPS1 mutations present in many Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+431,DCN,R203C,Rectum Adenocarcinoma,Are DCN or VPS26B mutations present in many Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+432,DCN,R241C,Rectum Adenocarcinoma,Are DCN or MRPL55 mutations present in many Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+433,DCN,R350C,Rectum Adenocarcinoma,Are DCN or KIF20B mutations present in many Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+434,DCN,R41C,Rectum Adenocarcinoma,Are DCN or PXN mutations present in many Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,Are CPS1 or YY1AP1 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,Are CPS1 or BCAT1 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,Are CPS1 or PYHIN1 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,Are FCGR2C or DCN mutations present in many Kidney Renal Papillary Cell Carcinoma cases?,top_cases_counts_by_genes
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,Are FCGR2C or AQP7 mutations present in many Kidney Renal Papillary Cell Carcinoma cases?,top_cases_counts_by_genes
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,Are GRM1 or MAD1L1 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+482,SGCZ,Q138H,Lung Adenocarcinoma,Are SGCZ or FCGR2C mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+483,SGCZ,Q91H,Lung Adenocarcinoma,Are SGCZ or EIF2B4 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+485,SMO,V15M,Stomach Adenocarcinoma,Are SMO or PRSS8 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+486,SMO,V321M,Stomach Adenocarcinoma,Are SMO or RAB40C mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+488,CHODL,G159E,Skin Cutaneous Melanoma,Are CHODL or DCC mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+489,CHODL,G181E,Skin Cutaneous Melanoma,Are CHODL or POC1B mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+490,CHODL,G200E,Skin Cutaneous Melanoma,Are CHODL or PXN mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+494,MYO16,P399H,Colon Adenocarcinoma,Are MYO16 or UNC5D mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+495,MYO16,P421H,Colon Adenocarcinoma,Are MYO16 or IL5RA mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+498,CXCR2,A98V,Stomach Adenocarcinoma,Are CXCR2 or TASOR2 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,Are TMEM225 or CYP1A2 mutations present in many Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,Are MAOB or TTN mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,Are GPRASP1 or MORF4L1 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,Are MRPL32 or AQP7 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,Are TYROBP or KDM5C mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+510,RAB40C,A111V,Lung Adenocarcinoma,Are RAB40C or FGF8 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+511,RAB40C,A143V,Lung Adenocarcinoma,Are RAB40C or TNS1 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+512,CTNNA2,S323R,Lung Adenocarcinoma,Are CTNNA2 or TASOR2 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+513,CTNNA2,S339R,Lung Adenocarcinoma,Are CTNNA2 or KIF20B mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+514,CTNNA2,S386R,Lung Adenocarcinoma,Are CTNNA2 or PIK3C2G mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+515,CTNNA2,S707R,Lung Adenocarcinoma,Are CTNNA2 or ICE1 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,Are MYO15A or TENT5A mutations present in many Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,Are GIMAP2 or OR2A12 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+532,KIF20B,N1160D,Glioblastoma Multiforme,Are KIF20B or CFAP61 mutations present in many Glioblastoma Multiforme cases?,top_cases_counts_by_genes
+533,KIF20B,N1200D,Glioblastoma Multiforme,Are KIF20B or MAST4 mutations present in many Glioblastoma Multiforme cases?,top_cases_counts_by_genes
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,Are ADAM17 or LAMB2 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,Are BCAT1 or EBF2 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,Are BCAT1 or REXO4 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,Are BCAT1 or ANKRD30A mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+540,ERCC6,R1053H,Colon Adenocarcinoma,Are ERCC6 or MAST4 mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+541,DCC,R320W,Breast Invasive Carcinoma,Are DCC or AUTS2 mutations present in many Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+542,DCC,R363W,Breast Invasive Carcinoma,Are DCC or EPRS1 mutations present in many Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+543,DCC,R386W,Breast Invasive Carcinoma,Are DCC or MAST4 mutations present in many Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+544,DCC,R41W,Breast Invasive Carcinoma,Are DCC or PXN mutations present in many Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+549,FBXO15,D417N,Skin Cutaneous Melanoma,Are FBXO15 or TRPA1 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+550,FBXO15,D86N,Skin Cutaneous Melanoma,Are FBXO15 or POC1B mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,Are GSTCD or AKT1 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,Are GSTCD or LAMB2 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,Are OLFML3 or MORF4L1 mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,Are OLFML3 or IL5RA mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,Are OLFML3 or PYHIN1 mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,Are CFAP61 or FGF8 mutations present in many Ovarian Serous Cystadenocarcinoma cases?,top_cases_counts_by_genes
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,Are CFAP61 or TASOR2 mutations present in many Ovarian Serous Cystadenocarcinoma cases?,top_cases_counts_by_genes
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,Are HLA-DQA2 or PHLPP1 mutations present in many Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+582,TENM2,H240Y,Skin Cutaneous Melanoma,Are TENM2 or MERTK mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+583,TENM2,H351Y,Skin Cutaneous Melanoma,Are TENM2 or MAD1L1 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+584,TENM2,H472Y,Skin Cutaneous Melanoma,Are TENM2 or SYNJ1 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+600,ANKRD24,A465T,Stomach Adenocarcinoma,Are ANKRD24 or FBXO42 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+601,ANKRD24,A494T,Stomach Adenocarcinoma,Are ANKRD24 or MIEF1 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+602,ANKRD24,A584T,Stomach Adenocarcinoma,Are ANKRD24 or RIPOR2 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,Are ZCCHC14 or MYT1 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,Are ZCCHC14 or MYO3A mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,Are ZCCHC14 or SGCZ mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,Are ZCCHC14 or SYT9 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+625,SIK2,I265M,Lung Adenocarcinoma,Are SIK2 or JAML mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,Are MYH11 or FBXO42 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,Are MYH11 or KDM5C mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,Are SLC6A4 or MSANTD4 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,Are SLC9C1 or MRPL55 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,Are SLC9C1 or GRM5 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+644,OR2A12,A254T,Brain Lower Grade Glioma,Are OR2A12 or CASZ1 mutations present in many Brain Lower Grade Glioma cases?,top_cases_counts_by_genes
+646,PYHIN1,T325K,Lung Adenocarcinoma,Are PYHIN1 or ANKRD24 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+647,PYHIN1,T334K,Lung Adenocarcinoma,Are PYHIN1 or FGF8 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+650,JAML,G191E,Skin Cutaneous Melanoma,Are JAML or DGKD mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+651,JAML,G219E,Skin Cutaneous Melanoma,Are JAML or ACVR1B mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+652,JAML,G220E,Skin Cutaneous Melanoma,Are JAML or TYROBP mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+653,JAML,G230E,Skin Cutaneous Melanoma,Are JAML or TENM3 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+658,TYK2,H1146R,Stomach Adenocarcinoma,Are TYK2 or SPTAN1 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+659,TYK2,H23R,Stomach Adenocarcinoma,Are TYK2 or MYT1 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+660,TYK2,H961R,Stomach Adenocarcinoma,Are TYK2 or FCGR2C mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,Are CTCFL or EBF2 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,Are CTCFL or FNDC7 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,Are CTCFL or SORCS1 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,Are CTCFL or JAML mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,Are CEP20 or DCC mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,Are CEP20 or SERPINB10 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+689,RIMS2,R25W,Skin Cutaneous Melanoma,Are RIMS2 or YY1AP1 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+690,RIMS2,R393W,Skin Cutaneous Melanoma,Are RIMS2 or POC1B mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+691,RIMS2,R423W,Skin Cutaneous Melanoma,Are RIMS2 or TTN mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+692,RIMS2,R470W,Skin Cutaneous Melanoma,Are RIMS2 or ZMYM3 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+693,RIMS2,R615W,Skin Cutaneous Melanoma,Are RIMS2 or CDC42BPA mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+694,RIMS2,R619W,Skin Cutaneous Melanoma,Are RIMS2 or DCN mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+695,RIMS2,R716W,Skin Cutaneous Melanoma,Are RIMS2 or SMO mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,Are PIK3C2G or MAST4 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,Are PIK3C2G or TENT5A mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+728,STK19,D341N,Colon Adenocarcinoma,Are STK19 or ACTB mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+729,STK19,D345N,Colon Adenocarcinoma,Are STK19 or OR2T4 mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+730,REXO4,P60A,Skin Cutaneous Melanoma,Are REXO4 or RIMS2 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,Are ZBTB34 or YY1AP1 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,Are ZBTB34 or DCLK3 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,Are NCKAP5 or SMO mutations present in many Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Are SORCS1 or PTPRO mutations present in many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Are SORCS1 or PGF mutations present in many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Are SORCS1 or CPS1 mutations present in many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Are SORCS1 or PXN mutations present in many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,Are FGF8 or HTR3B mutations present in many Head and Neck Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,Are FGF8 or FBXO15 mutations present in many Head and Neck Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,Are FGF8 or UNC5D mutations present in many Head and Neck Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,Are FGF8 or MYH11 mutations present in many Head and Neck Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,Are FGF8 or MRPL32 mutations present in many Head and Neck Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,Are TENM3 or RIPOR2 mutations present in many Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia cases?,top_cases_counts_by_genes
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,Are AKT1 or YY1AP1 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Are CFAP298-TCP10L or DGKD mutations present in many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,top_cases_counts_by_genes
+792,GLRB,E148D,Stomach Adenocarcinoma,Are GLRB or POC1B mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+793,TTN,F7636L,Colon Adenocarcinoma,Are TTN or TAF1C mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+794,TTN,F8563L,Colon Adenocarcinoma,Are TTN or TTYH2 mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+795,TTN,F8880L,Colon Adenocarcinoma,Are TTN or DCC mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+799,ANKRD30A,V798I,Colon Adenocarcinoma,Are ANKRD30A or ZNF217 mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+800,ANKRD30A,V854I,Colon Adenocarcinoma,Are ANKRD30A or VPS26B mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+801,ANKRD30A,V973I,Colon Adenocarcinoma,Are ANKRD30A or ZNF627 mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+809,TRIM45,S177L,Colon Adenocarcinoma,Are TRIM45 or PKHD1L1 mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+810,TRIM45,S224L,Colon Adenocarcinoma,Are TRIM45 or LCN15 mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+811,TRIM45,S281L,Colon Adenocarcinoma,Are TRIM45 or CCNG1 mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+812,CACNA1F,G727V,Stomach Adenocarcinoma,Are CACNA1F or DCAF6 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+813,CACNA1F,G781V,Stomach Adenocarcinoma,Are CACNA1F or CDKN2AIP mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+814,CACNA1F,G792V,Stomach Adenocarcinoma,Are CACNA1F or UNC5D mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+817,KL,R594C,Colon Adenocarcinoma,Are KL or MAD1L1 mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,Are GUF1 or THBS4 mutations present in many Kidney Renal Papillary Cell Carcinoma cases?,top_cases_counts_by_genes
+822,TAF1L,A539V,Colon Adenocarcinoma,Are TAF1L or OLFML3 mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+823,TASOR2,S256F,Skin Cutaneous Melanoma,Are TASOR2 or KL mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+824,TASOR2,S36F,Skin Cutaneous Melanoma,Are TASOR2 or CARMIL1 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+825,TASOR2,S471F,Skin Cutaneous Melanoma,Are TASOR2 or ARMC3 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,Are KDM5C or ZCCHC14 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,Are KDM5C or TNS1 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,Are KDM5C or SGIP1 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,Are KDM5C or TRIM45 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Are IL5RA or MRPL55 mutations present in many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,top_cases_counts_by_genes
+843,DHX16,A29V,Skin Cutaneous Melanoma,Are DHX16 or KIF20B mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+844,DHX16,A89V,Skin Cutaneous Melanoma,Are DHX16 or PSG2 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+902,GPR158,A644V,Stomach Adenocarcinoma,Are GPR158 or PXN mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+903,GPR158,A723V,Stomach Adenocarcinoma,Are GPR158 or RIPOR2 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Are EIF2B4 or IL5RA mutations present in many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Are EIF2B4 or SGCZ mutations present in many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Are EIF2B4 or SGCZ mutations present in many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Are EIF2B4 or DCN mutations present in many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Are EIF2B4 or TYK2 mutations present in many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Are EIF2B4 or BCAT1 mutations present in many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,Are AUTS2 or CYB5R2 mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,Are AUTS2 or PXN mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,Are AUTS2 or SIK2 mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,Are AUTS2 or DSCAM mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,Are AUTS2 or YY1AP1 mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,Are AUTS2 or BCAT1 mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,Are AUTS2 or CFAP61 mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,Are AUTS2 or HTR3B mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,Are AUTS2 or KRT39 mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,Are AUTS2 or RIMS2 mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Are ACTL7B or DHX16 mutations present in many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+952,PCDHGA1,R535W,Glioblastoma Multiforme,Are PCDHGA1 or GRM5 mutations present in many Glioblastoma Multiforme cases?,top_cases_counts_by_genes
+954,TRAP1,R114W,Stomach Adenocarcinoma,Are TRAP1 or TTN mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+955,TRAP1,R61W,Stomach Adenocarcinoma,Are TRAP1 or HTR3B mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,Are PIK3C2A or GUK1 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,Are KANSL1 or UNC5D mutations present in many Liver Hepatocellular Carcinoma cases?,top_cases_counts_by_genes
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,Are ANKRD52 or KIF20B mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,Are PAPPA or CTSC mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,Are B3GALNT1 or PCDHB2 mutations present in many Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+982,GABRA6,G115R,Lung Adenocarcinoma,Are GABRA6 or TTYH2 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+983,GABRA6,G122R,Lung Adenocarcinoma,Are GABRA6 or HSPA5 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+984,GABRA6,G165R,Lung Adenocarcinoma,Are GABRA6 or ANKRD30A mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+985,GABRA6,G175R,Lung Adenocarcinoma,Are GABRA6 or ZBTB34 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+986,GABRA6,G70R,Lung Adenocarcinoma,Are GABRA6 or SLC9C1 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,Are ZSCAN31 or ANKRD30A mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Are MED16 or AQP7 mutations present in many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Are MED16 or MAOB mutations present in many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,Are PTPRO or PKHD1L1 mutations present in many Pancreatic Adenocarcinoma cases?,top_cases_counts_by_genes
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,Are PTPRO or TNS1 mutations present in many Pancreatic Adenocarcinoma cases?,top_cases_counts_by_genes
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,Are PTPRO or DCC mutations present in many Pancreatic Adenocarcinoma cases?,top_cases_counts_by_genes
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,Are PTPRO or AQP7 mutations present in many Pancreatic Adenocarcinoma cases?,top_cases_counts_by_genes
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,Are PTPRO or DEFB115 mutations present in many Pancreatic Adenocarcinoma cases?,top_cases_counts_by_genes
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,Are PTPRO or CHODL mutations present in many Pancreatic Adenocarcinoma cases?,top_cases_counts_by_genes
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,Are PTPRO or ZFPM2 mutations present in many Pancreatic Adenocarcinoma cases?,top_cases_counts_by_genes
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,Are PTPRO or CACNA1F mutations present in many Pancreatic Adenocarcinoma cases?,top_cases_counts_by_genes
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,Are CHMP7 or ZSCAN31 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1017,GPC3,I107N,Stomach Adenocarcinoma,Are GPC3 or OR8K5 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1018,GPC3,I161N,Stomach Adenocarcinoma,Are GPC3 or MORF4L1 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Are TLK2 or ZNF708 mutations present in many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,top_cases_counts_by_genes
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Are TLK2 or TLK2 mutations present in many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,top_cases_counts_by_genes
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Are TLK2 or PDGFC mutations present in many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,top_cases_counts_by_genes
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Are TLK2 or SORCS1 mutations present in many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,top_cases_counts_by_genes
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Are TLK2 or ZCCHC14 mutations present in many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,top_cases_counts_by_genes
+1036,ZNF217,E209Q,Lung Adenocarcinoma,Are ZNF217 or SPATA22 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1038,SYT9,V275L,Lung Adenocarcinoma,Are SYT9 or DNAH11 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1039,SYT9,V307L,Lung Adenocarcinoma,Are SYT9 or MAST4 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,Are PKHD1L1 or ANP32E mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,Are MYO3A or AUTS2 mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Are VASN or MERTK mutations present in many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,Are DNMT1 or CACNA1F mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,Are DNMT1 or DCC mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,Are DNMT1 or SGIP1 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1056,CA9,E402K,Colon Adenocarcinoma,Are CA9 or DGKD mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,Are TTC17 or MRPL32 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,Are TTC17 or ZCCHC14 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1065,PSG2,P43L,Breast Invasive Carcinoma,Are PSG2 or ACTB mutations present in many Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,Are RIPOR2 or OLFML3 mutations present in many Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,Are RIPOR2 or EBF2 mutations present in many Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,Are RIPOR2 or MYO16 mutations present in many Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,Are RIPOR2 or UNC5D mutations present in many Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,Are DCLK3 or PGF mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,Are DCLK3 or CFAP61 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,Are MERTK or PCDHGA1 mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,Are MERTK or CR1 mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,Are MERTK or KL mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,Are ZFP42 or AUTS2 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,Are OR13C3 or CHODL mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,Are OR13C3 or IL5RA mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+1091,SPAG1,I917M,Stomach Adenocarcinoma,Are SPAG1 or EFCAB12 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,Are CDKN2AIP or SPTAN1 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1093,PXN,H1016Y,Colon Adenocarcinoma,Are PXN or PTPRO mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1094,PXN,H359Y,Colon Adenocarcinoma,Are PXN or GABRA6 mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1095,PXN,H492Y,Colon Adenocarcinoma,Are PXN or PRSS1 mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1096,PXN,H524Y,Colon Adenocarcinoma,Are PXN or KIF20B mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1097,PXN,H526Y,Colon Adenocarcinoma,Are PXN or TTC17 mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1098,PXN,H540Y,Colon Adenocarcinoma,Are PXN or ACTA2 mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,Are TTYH2 or EIF2B4 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,Are TTYH2 or PCDHB2 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1106,TMEM255A,N205S,Colon Adenocarcinoma,Are TMEM255A or GRM1 mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1107,TMEM255A,N229S,Colon Adenocarcinoma,Are TMEM255A or CA9 mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1108,TMEM255A,N65S,Colon Adenocarcinoma,Are TMEM255A or PTPRN2 mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,Are TASOR2 or RAB40C mutations present in many Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,Are TASOR2 or EPRS1 mutations present in many Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,Are ICE1 or PCDHB2 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1112,MYT1,A558E,Breast Invasive Carcinoma,Are MYT1 or KL mutations present in many Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+1113,MYT1,A879E,Breast Invasive Carcinoma,Are MYT1 or DEFB115 mutations present in many Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+1114,MYT1,A906E,Breast Invasive Carcinoma,Are MYT1 or UNC5D mutations present in many Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,Are CX3CR1 or PAPPA mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,Are CX3CR1 or PGR mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,Are SPINDOC or ANP32E mutations present in many Liver Hepatocellular Carcinoma cases?,top_cases_counts_by_genes
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,Are ART3 or EFCAB12 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,Are ART3 or CHODL mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,Are CYP1A2 or ZFP42 mutations present in many Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Are ADRA1A or ACTB mutations present in many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,Are CDH23 or CNGB1 mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,Are CDH23 or COL6A3 mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+1148,KRT39,P137S,Skin Cutaneous Melanoma,Are KRT39 or CTSC mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,Are PDHA2 or VASN mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,Are SLC24A2 or KANSL1 mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,Are PTPRN2 or MAST4 mutations present in many Liver Hepatocellular Carcinoma cases?,top_cases_counts_by_genes
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,Are PTPRN2 or PDHA2 mutations present in many Liver Hepatocellular Carcinoma cases?,top_cases_counts_by_genes
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,Are PTPRN2 or OLFML3 mutations present in many Liver Hepatocellular Carcinoma cases?,top_cases_counts_by_genes
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,Are PTPRN2 or MORF4L1 mutations present in many Liver Hepatocellular Carcinoma cases?,top_cases_counts_by_genes
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,Are PTPRN2 or SYNJ1 mutations present in many Liver Hepatocellular Carcinoma cases?,top_cases_counts_by_genes
+1188,SOX21,R55L,Lung Adenocarcinoma,Are SOX21 or REXO4 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,Are CPA6 or CDC42BPA mutations present in many Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+1206,GRM5,E14K,Skin Cutaneous Melanoma,Are GRM5 or TASOR2 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Are CASZ1 or CTNNA2 mutations present in many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+1210,SGIP1,N122T,Stomach Adenocarcinoma,Are SGIP1 or TAF1C mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1211,SGIP1,N420T,Stomach Adenocarcinoma,Are SGIP1 or AUTS2 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1212,SGIP1,N617T,Stomach Adenocarcinoma,Are SGIP1 or PGR mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1213,SGIP1,N648T,Stomach Adenocarcinoma,Are SGIP1 or TTN mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1227,CARMIL1,V549L,Lung Adenocarcinoma,Are CARMIL1 or PRSS1 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1228,CARMIL1,V949L,Lung Adenocarcinoma,Are CARMIL1 or MYO3A mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1232,ZNF431,D121Y,Lung Adenocarcinoma,Are ZNF431 or EVC2 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1233,ZNF431,D161Y,Lung Adenocarcinoma,Are ZNF431 or DSCAM mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1234,ZNF431,R128I,Lung Adenocarcinoma,Are ZNF431 or DNAH11 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,Are DNAH11 or ZFPM2 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,Are DNAH11 or TRIM45 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,Are POLD1 or MORF4L1 mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,Are POLD1 or GUCY2C mutations present in many Lung Squamous Cell Carcinoma cases?,top_cases_counts_by_genes
+1248,TTC12,D646H,Lung Adenocarcinoma,Are TTC12 or YY1AP1 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1249,TTC12,D652H,Lung Adenocarcinoma,Are TTC12 or GPRASP1 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,Are CNGB1 or DHX16 mutations present in many Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,Are CNGB1 or PDGFC mutations present in many Bladder Urothelial Carcinoma cases?,top_cases_counts_by_genes
+1254,CTSC,E214V,Stomach Adenocarcinoma,Are CTSC or PAK3 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1255,CTSC,E291V,Stomach Adenocarcinoma,Are CTSC or UNC5D mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1256,CTSC,E322V,Stomach Adenocarcinoma,Are CTSC or COL6A3 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1257,CTSC,E324V,Stomach Adenocarcinoma,Are CTSC or EIF2B4 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1258,CTSC,E335V,Stomach Adenocarcinoma,Are CTSC or ANKRD30A mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,Are PRSS8 or DNMT1 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,Are PRSS8 or EVC2 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,Are ARHGEF40 or ZSCAN31 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1264,ACTB,A138T,Rectum Adenocarcinoma,Are ACTB or TAS1R3 mutations present in many Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+1265,ACTB,A217T,Rectum Adenocarcinoma,Are ACTB or MYT1 mutations present in many Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+1266,ACTB,A244T,Rectum Adenocarcinoma,Are ACTB or MAST4 mutations present in many Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+1267,ACTB,A260T,Rectum Adenocarcinoma,Are ACTB or PRSS1 mutations present in many Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+1268,YY1AP1,V546D,Glioblastoma Multiforme,Are YY1AP1 or ADRA1A mutations present in many Glioblastoma Multiforme cases?,top_cases_counts_by_genes
+1269,YY1AP1,V557D,Glioblastoma Multiforme,Are YY1AP1 or DSCAM mutations present in many Glioblastoma Multiforme cases?,top_cases_counts_by_genes
+1270,YY1AP1,V566D,Glioblastoma Multiforme,Are YY1AP1 or SYNJ1 mutations present in many Glioblastoma Multiforme cases?,top_cases_counts_by_genes
+1271,YY1AP1,V577D,Glioblastoma Multiforme,Are YY1AP1 or RELN mutations present in many Glioblastoma Multiforme cases?,top_cases_counts_by_genes
+1272,YY1AP1,V623D,Glioblastoma Multiforme,Are YY1AP1 or CFAP298-TCP10L mutations present in many Glioblastoma Multiforme cases?,top_cases_counts_by_genes
+1273,YY1AP1,V695D,Glioblastoma Multiforme,Are YY1AP1 or NOMO1 mutations present in many Glioblastoma Multiforme cases?,top_cases_counts_by_genes
+1274,YY1AP1,V715D,Glioblastoma Multiforme,Are YY1AP1 or SORCS1 mutations present in many Glioblastoma Multiforme cases?,top_cases_counts_by_genes
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,Are FNDC7 or TLCD5 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,Are FNDC7 or DGKD mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+1299,TLCD5,G15V,Lung Adenocarcinoma,Are TLCD5 or TNS1 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1300,TLCD5,G37V,Lung Adenocarcinoma,Are TLCD5 or AQP7 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,Are POLR1G or COL6A3 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,Are POLR1G or RAB40C mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1308,DNAH14,N1186K,Colon Adenocarcinoma,Are DNAH14 or MAST4 mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1309,DNAH14,N2657K,Colon Adenocarcinoma,Are DNAH14 or PRSS1 mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1310,DNAH14,N3460K,Colon Adenocarcinoma,Are DNAH14 or PIAS3 mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,Are NEXN or PRSS1 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,Are CYB5R2 or RELN mutations present in many Prostate Adenocarcinoma cases?,top_cases_counts_by_genes
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,Are CYB5R2 or TAF1C mutations present in many Prostate Adenocarcinoma cases?,top_cases_counts_by_genes
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,Are NRAP or SYT10 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,Are NRAP or ACTB mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,Are NRAP or TTC17 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,Are CCDC22 or ANKRD30A mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,Are DCAF6 or EFCAB12 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,Are DCAF6 or IL5RA mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,Are ZNF708 or MRPL32 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,Are BFAR or SLC6A4 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,Are MAST4 or DCAF6 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,Are MAST4 or CTNNA2 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,Are MAST4 or CCNG1 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,Are MAST4 or COL6A3 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,Are MAST4 or PTPRN2 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1363,ARMC3,R169C,Stomach Adenocarcinoma,Are ARMC3 or TLK2 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1364,ARMC3,R432C,Stomach Adenocarcinoma,Are ARMC3 or TLK2 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,Are TET2 or AQP7 mutations present in many Kidney Renal Clear Cell Carcinoma cases?,top_cases_counts_by_genes
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,Are TET2 or KL mutations present in many Kidney Renal Clear Cell Carcinoma cases?,top_cases_counts_by_genes
+1369,SERPINB10,A353P,Lung Adenocarcinoma,Are SERPINB10 or ZNF584 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,Are STAT3 or TASOR2 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,Are MIEF1 or ACVR1B mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1381,ACVR1B,D397N,Colon Adenocarcinoma,Are ACVR1B or TENM2 mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1382,ACVR1B,D449N,Colon Adenocarcinoma,Are ACVR1B or TLK2 mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1383,ACVR1B,D490N,Colon Adenocarcinoma,Are ACVR1B or FGF8 mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1393,EBF2,T104I,Stomach Adenocarcinoma,Are EBF2 or LCN15 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1394,EBF2,T252I,Stomach Adenocarcinoma,Are EBF2 or ANKRD30A mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1402,VPS26B,F266L,Stomach Adenocarcinoma,Are VPS26B or PAK3 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Are PGR or TLCD5 mutations present in many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Are PGR or MYT1 mutations present in many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Are PGR or TET2 mutations present in many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",top_cases_counts_by_genes
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,Are ACTA2 or COL6A3 mutations present in many Skin Cutaneous Melanoma cases?,top_cases_counts_by_genes
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,Are THBS4 or MAST4 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,Are THBS4 or PSG2 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1413,PRSS1,S114T,Lung Adenocarcinoma,Are PRSS1 or GPC3 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1414,PRSS1,S124T,Lung Adenocarcinoma,Are PRSS1 or PAK3 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1415,PRSS1,S138T,Lung Adenocarcinoma,Are PRSS1 or AUTS2 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1416,PRSS1,S74T,Lung Adenocarcinoma,Are PRSS1 or CX3CR1 mutations present in many Lung Adenocarcinoma cases?,top_cases_counts_by_genes
+1417,PGF,R126H,Stomach Adenocarcinoma,Are PGF or PRSS1 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1418,PGF,R127H,Stomach Adenocarcinoma,Are PGF or MSANTD4 mutations present in many Stomach Adenocarcinoma cases?,top_cases_counts_by_genes
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,Are ITPRID2 or DCAF6 mutations present in many Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,Are ITPRID2 or AQP7 mutations present in many Breast Invasive Carcinoma cases?,top_cases_counts_by_genes
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,Are HBB or PKHD1L1 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1441,PCDHB2,R158C,Colon Adenocarcinoma,Are PCDHB2 or UNC5D mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1442,PCDHB2,T15M,Colon Adenocarcinoma,Are PCDHB2 or DCC mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1443,PCDHB2,T26M,Colon Adenocarcinoma,Are PCDHB2 or MYO3B mutations present in many Colon Adenocarcinoma cases?,top_cases_counts_by_genes
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,Are UBR2 or CARMIL1 mutations present in many Uterine Corpus Endometrial Carcinoma cases?,top_cases_counts_by_genes
+1452,FBXO42,A618D,Rectum Adenocarcinoma,Are FBXO42 or MRPL55 mutations present in many Rectum Adenocarcinoma cases?,top_cases_counts_by_genes
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the rate of TNS1 mutations in Breast Invasive Carcinoma tumors?,top_cases_counts_by_genes
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the rate of TNS1 mutations in Breast Invasive Carcinoma tumors?,top_cases_counts_by_genes
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the rate of TNS1 mutations in Breast Invasive Carcinoma tumors?,top_cases_counts_by_genes
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the rate of TNS1 mutations in Breast Invasive Carcinoma tumors?,top_cases_counts_by_genes
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the rate of TNS1 mutations in Breast Invasive Carcinoma tumors?,top_cases_counts_by_genes
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the rate of TNS1 mutations in Breast Invasive Carcinoma tumors?,top_cases_counts_by_genes
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the rate of TNS1 mutations in Breast Invasive Carcinoma tumors?,top_cases_counts_by_genes
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the rate of EVC2 mutations in Bladder Urothelial Carcinoma tumors?,top_cases_counts_by_genes
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the rate of EVC2 mutations in Bladder Urothelial Carcinoma tumors?,top_cases_counts_by_genes
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the rate of CR1 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the rate of CR1 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the rate of TRPA1 mutations in Rectum Adenocarcinoma tumors?,top_cases_counts_by_genes
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the rate of TRPA1 mutations in Rectum Adenocarcinoma tumors?,top_cases_counts_by_genes
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the rate of TAF1C mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the rate of TAF1C mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the rate of TAF1C mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the rate of TAF1C mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the rate of TAF1C mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the rate of DPF3 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the rate of DPF3 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the rate of DPF3 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the rate of OR2T4 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the rate of OR2T4 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the rate of FBN1 mutations in Pancreatic Adenocarcinoma tumors?,top_cases_counts_by_genes
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the rate of MAD1L1 mutations in Prostate Adenocarcinoma tumors?,top_cases_counts_by_genes
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the rate of MAD1L1 mutations in Prostate Adenocarcinoma tumors?,top_cases_counts_by_genes
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the rate of MAD1L1 mutations in Prostate Adenocarcinoma tumors?,top_cases_counts_by_genes
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the rate of CCNG1 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the rate of ANP32E mutations in Kidney Renal Papillary Cell Carcinoma tumors?,top_cases_counts_by_genes
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the rate of ANP32E mutations in Kidney Renal Papillary Cell Carcinoma tumors?,top_cases_counts_by_genes
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the rate of ANP32E mutations in Kidney Renal Papillary Cell Carcinoma tumors?,top_cases_counts_by_genes
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the rate of ANP32E mutations in Kidney Renal Papillary Cell Carcinoma tumors?,top_cases_counts_by_genes
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the rate of FRY mutations in Bladder Urothelial Carcinoma tumors?,top_cases_counts_by_genes
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the rate of FRY mutations in Bladder Urothelial Carcinoma tumors?,top_cases_counts_by_genes
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the rate of FRY mutations in Bladder Urothelial Carcinoma tumors?,top_cases_counts_by_genes
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the rate of FRY mutations in Bladder Urothelial Carcinoma tumors?,top_cases_counts_by_genes
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the rate of PAK3 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the rate of PAK3 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the rate of PAK3 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the rate of PAK3 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the rate of PAK3 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the rate of MUC16 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the rate of ZFPM2 mutations in Liver Hepatocellular Carcinoma tumors?,top_cases_counts_by_genes
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the rate of ZFPM2 mutations in Liver Hepatocellular Carcinoma tumors?,top_cases_counts_by_genes
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the rate of PIK3C2B mutations in Breast Invasive Carcinoma tumors?,top_cases_counts_by_genes
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the rate of PIK3C2B mutations in Breast Invasive Carcinoma tumors?,top_cases_counts_by_genes
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the rate of ZNF804A mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the rate of RELN mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of EFCAB12 mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors?",top_cases_counts_by_genes
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of EFCAB12 mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors?",top_cases_counts_by_genes
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the rate of DEFB115 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the rate of ANKDD1A mutations in Bladder Urothelial Carcinoma tumors?,top_cases_counts_by_genes
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the rate of ANKDD1A mutations in Bladder Urothelial Carcinoma tumors?,top_cases_counts_by_genes
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the rate of ANKDD1A mutations in Bladder Urothelial Carcinoma tumors?,top_cases_counts_by_genes
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the rate of HTR3B mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the rate of HTR3B mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the rate of HTR3B mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the rate of ABCC3 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the rate of NOMO1 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the rate of NOMO1 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the rate of HYOU1 mutations in Bladder Urothelial Carcinoma tumors?,top_cases_counts_by_genes
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the rate of FMO4 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+140,BICC1,A372V,Exceptional Responders,What is the rate of BICC1 mutations in Exceptional Responders tumors?,top_cases_counts_by_genes
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the rate of ZMYM3 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the rate of ZMYM3 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the rate of ZMYM3 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of XKR4 mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors?",top_cases_counts_by_genes
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the rate of ABCC2 mutations in Liver Hepatocellular Carcinoma tumors?,top_cases_counts_by_genes
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the rate of OR8K5 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the rate of SPTAN1 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the rate of SPTAN1 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the rate of SYT10 mutations in Rectum Adenocarcinoma tumors?,top_cases_counts_by_genes
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the rate of HSPA5 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the rate of UNC5D mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the rate of UNC5D mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the rate of UNC5D mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the rate of UNC5D mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the rate of UNC5D mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the rate of UNC5D mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the rate of DOCK2 mutations in Kidney Renal Clear Cell Carcinoma tumors?,top_cases_counts_by_genes
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the rate of ZNF627 mutations in Kidney Renal Clear Cell Carcinoma tumors?,top_cases_counts_by_genes
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the rate of CDC42BPA mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the rate of MRPL55 mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the rate of MRPL55 mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the rate of TMTC3 mutations in Breast Invasive Carcinoma tumors?,top_cases_counts_by_genes
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the rate of EPRS1 mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the rate of EPRS1 mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the rate of GRTP1 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the rate of GRTP1 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the rate of TSHZ3 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the rate of TAS1R3 mutations in HIV+ Tumor Molecular Characterization Project - Cervical Cancer tumors?,top_cases_counts_by_genes
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the rate of PIAS3 mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the rate of PIAS3 mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the rate of ZNF274 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the rate of SYNJ1 mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the rate of SYNJ1 mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the rate of SYNJ1 mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the rate of DSCAM mutations in Prostate Adenocarcinoma tumors?,top_cases_counts_by_genes
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the rate of DSCAM mutations in Prostate Adenocarcinoma tumors?,top_cases_counts_by_genes
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the rate of DSCAM mutations in Prostate Adenocarcinoma tumors?,top_cases_counts_by_genes
+267,DGKD,R140H,Exceptional Responders,What is the rate of DGKD mutations in Exceptional Responders tumors?,top_cases_counts_by_genes
+268,DGKD,R160H,Exceptional Responders,What is the rate of DGKD mutations in Exceptional Responders tumors?,top_cases_counts_by_genes
+269,DGKD,R204H,Exceptional Responders,What is the rate of DGKD mutations in Exceptional Responders tumors?,top_cases_counts_by_genes
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the rate of PLEKHG6 mutations in Bladder Urothelial Carcinoma tumors?,top_cases_counts_by_genes
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the rate of PLEKHG6 mutations in Bladder Urothelial Carcinoma tumors?,top_cases_counts_by_genes
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the rate of PLEKHG6 mutations in Bladder Urothelial Carcinoma tumors?,top_cases_counts_by_genes
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the rate of WNT2 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the rate of GUCY2C mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the rate of C7orf31 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of ZKSCAN7 mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors?",top_cases_counts_by_genes
+299,OR5D14,M210L,Neuroblastoma,What is the rate of OR5D14 mutations in Neuroblastoma tumors?,top_cases_counts_by_genes
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the rate of SPATA22 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the rate of SPATA22 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the rate of SPATA22 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the rate of LCN15 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the rate of DCAF4L2 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the rate of GUK1 mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the rate of GUK1 mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the rate of GUK1 mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the rate of GUK1 mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the rate of GUK1 mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the rate of MORF4L1 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the rate of MORF4L1 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the rate of MORF4L1 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the rate of MORF4L1 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the rate of MYO3B mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the rate of MYO3B mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the rate of TENT5A mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the rate of TENT5A mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the rate of TENT5A mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the rate of ZFAT mutations in Ovarian Serous Cystadenocarcinoma tumors?,top_cases_counts_by_genes
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the rate of ZFAT mutations in Ovarian Serous Cystadenocarcinoma tumors?,top_cases_counts_by_genes
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the rate of ZFAT mutations in Ovarian Serous Cystadenocarcinoma tumors?,top_cases_counts_by_genes
+357,ZNF584,A211T,Sarcoma,What is the rate of ZNF584 mutations in Sarcoma tumors?,top_cases_counts_by_genes
+358,ZNF584,A256T,Sarcoma,What is the rate of ZNF584 mutations in Sarcoma tumors?,top_cases_counts_by_genes
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the rate of LDOC1 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the rate of PDGFC mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the rate of MSANTD4 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the rate of NPSR1 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the rate of PHLPP1 mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the rate of COL6A3 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the rate of COL6A3 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the rate of COL6A3 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the rate of COL6A3 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the rate of COL6A3 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the rate of ADRA1A mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of LAMB2 mutations in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma tumors?,top_cases_counts_by_genes
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the rate of POC1B mutations in Rectum Adenocarcinoma tumors?,top_cases_counts_by_genes
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the rate of POC1B mutations in Rectum Adenocarcinoma tumors?,top_cases_counts_by_genes
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the rate of POC1B mutations in Rectum Adenocarcinoma tumors?,top_cases_counts_by_genes
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the rate of POC1B mutations in Rectum Adenocarcinoma tumors?,top_cases_counts_by_genes
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the rate of USH2A mutations in Liver Hepatocellular Carcinoma tumors?,top_cases_counts_by_genes
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the rate of AQP7 mutations in Rectum Adenocarcinoma tumors?,top_cases_counts_by_genes
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the rate of AQP7 mutations in Rectum Adenocarcinoma tumors?,top_cases_counts_by_genes
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the rate of AQP7 mutations in Rectum Adenocarcinoma tumors?,top_cases_counts_by_genes
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the rate of AQP7 mutations in Rectum Adenocarcinoma tumors?,top_cases_counts_by_genes
+430,DCN,R163C,Rectum Adenocarcinoma,What is the rate of DCN mutations in Rectum Adenocarcinoma tumors?,top_cases_counts_by_genes
+431,DCN,R203C,Rectum Adenocarcinoma,What is the rate of DCN mutations in Rectum Adenocarcinoma tumors?,top_cases_counts_by_genes
+432,DCN,R241C,Rectum Adenocarcinoma,What is the rate of DCN mutations in Rectum Adenocarcinoma tumors?,top_cases_counts_by_genes
+433,DCN,R350C,Rectum Adenocarcinoma,What is the rate of DCN mutations in Rectum Adenocarcinoma tumors?,top_cases_counts_by_genes
+434,DCN,R41C,Rectum Adenocarcinoma,What is the rate of DCN mutations in Rectum Adenocarcinoma tumors?,top_cases_counts_by_genes
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the rate of CPS1 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the rate of CPS1 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the rate of CPS1 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the rate of FCGR2C mutations in Kidney Renal Papillary Cell Carcinoma tumors?,top_cases_counts_by_genes
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the rate of FCGR2C mutations in Kidney Renal Papillary Cell Carcinoma tumors?,top_cases_counts_by_genes
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the rate of GRM1 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the rate of SGCZ mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the rate of SGCZ mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+485,SMO,V15M,Stomach Adenocarcinoma,What is the rate of SMO mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+486,SMO,V321M,Stomach Adenocarcinoma,What is the rate of SMO mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the rate of CHODL mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the rate of CHODL mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the rate of CHODL mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+494,MYO16,P399H,Colon Adenocarcinoma,What is the rate of MYO16 mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+495,MYO16,P421H,Colon Adenocarcinoma,What is the rate of MYO16 mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the rate of CXCR2 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the rate of TMEM225 mutations in Bladder Urothelial Carcinoma tumors?,top_cases_counts_by_genes
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the rate of MAOB mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the rate of GPRASP1 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the rate of MRPL32 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the rate of TYROBP mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the rate of RAB40C mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the rate of RAB40C mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the rate of CTNNA2 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the rate of CTNNA2 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the rate of CTNNA2 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the rate of CTNNA2 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the rate of MYO15A mutations in Bladder Urothelial Carcinoma tumors?,top_cases_counts_by_genes
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the rate of GIMAP2 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the rate of KIF20B mutations in Glioblastoma Multiforme tumors?,top_cases_counts_by_genes
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the rate of KIF20B mutations in Glioblastoma Multiforme tumors?,top_cases_counts_by_genes
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the rate of ADAM17 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the rate of BCAT1 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the rate of BCAT1 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the rate of BCAT1 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the rate of ERCC6 mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+541,DCC,R320W,Breast Invasive Carcinoma,What is the rate of DCC mutations in Breast Invasive Carcinoma tumors?,top_cases_counts_by_genes
+542,DCC,R363W,Breast Invasive Carcinoma,What is the rate of DCC mutations in Breast Invasive Carcinoma tumors?,top_cases_counts_by_genes
+543,DCC,R386W,Breast Invasive Carcinoma,What is the rate of DCC mutations in Breast Invasive Carcinoma tumors?,top_cases_counts_by_genes
+544,DCC,R41W,Breast Invasive Carcinoma,What is the rate of DCC mutations in Breast Invasive Carcinoma tumors?,top_cases_counts_by_genes
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the rate of FBXO15 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the rate of FBXO15 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the rate of GSTCD mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the rate of GSTCD mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the rate of OLFML3 mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the rate of OLFML3 mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the rate of OLFML3 mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the rate of CFAP61 mutations in Ovarian Serous Cystadenocarcinoma tumors?,top_cases_counts_by_genes
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the rate of CFAP61 mutations in Ovarian Serous Cystadenocarcinoma tumors?,top_cases_counts_by_genes
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the rate of HLA-DQA2 mutations in Bladder Urothelial Carcinoma tumors?,top_cases_counts_by_genes
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the rate of TENM2 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the rate of TENM2 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the rate of TENM2 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the rate of ANKRD24 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the rate of ANKRD24 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the rate of ANKRD24 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the rate of ZCCHC14 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the rate of ZCCHC14 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the rate of ZCCHC14 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the rate of ZCCHC14 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+625,SIK2,I265M,Lung Adenocarcinoma,What is the rate of SIK2 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the rate of MYH11 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the rate of MYH11 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the rate of SLC6A4 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the rate of SLC9C1 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the rate of SLC9C1 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the rate of OR2A12 mutations in Brain Lower Grade Glioma tumors?,top_cases_counts_by_genes
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the rate of PYHIN1 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the rate of PYHIN1 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the rate of JAML mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the rate of JAML mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the rate of JAML mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the rate of JAML mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the rate of TYK2 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the rate of TYK2 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the rate of TYK2 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the rate of CTCFL mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the rate of CTCFL mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the rate of CTCFL mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the rate of CTCFL mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the rate of CEP20 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the rate of CEP20 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the rate of RIMS2 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the rate of RIMS2 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the rate of RIMS2 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the rate of RIMS2 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the rate of RIMS2 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the rate of RIMS2 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the rate of RIMS2 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the rate of PIK3C2G mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the rate of PIK3C2G mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+728,STK19,D341N,Colon Adenocarcinoma,What is the rate of STK19 mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+729,STK19,D345N,Colon Adenocarcinoma,What is the rate of STK19 mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the rate of REXO4 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the rate of ZBTB34 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the rate of ZBTB34 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the rate of NCKAP5 mutations in Bladder Urothelial Carcinoma tumors?,top_cases_counts_by_genes
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of SORCS1 mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors?",top_cases_counts_by_genes
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of SORCS1 mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors?",top_cases_counts_by_genes
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of SORCS1 mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors?",top_cases_counts_by_genes
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of SORCS1 mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors?",top_cases_counts_by_genes
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the rate of FGF8 mutations in Head and Neck Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the rate of FGF8 mutations in Head and Neck Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the rate of FGF8 mutations in Head and Neck Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the rate of FGF8 mutations in Head and Neck Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the rate of FGF8 mutations in Head and Neck Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the rate of TENM3 mutations in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia tumors?,top_cases_counts_by_genes
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the rate of AKT1 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of CFAP298-TCP10L mutations in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma tumors?,top_cases_counts_by_genes
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the rate of GLRB mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+793,TTN,F7636L,Colon Adenocarcinoma,What is the rate of TTN mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+794,TTN,F8563L,Colon Adenocarcinoma,What is the rate of TTN mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+795,TTN,F8880L,Colon Adenocarcinoma,What is the rate of TTN mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the rate of ANKRD30A mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the rate of ANKRD30A mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the rate of ANKRD30A mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the rate of TRIM45 mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the rate of TRIM45 mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the rate of TRIM45 mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the rate of CACNA1F mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the rate of CACNA1F mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the rate of CACNA1F mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+817,KL,R594C,Colon Adenocarcinoma,What is the rate of KL mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the rate of GUF1 mutations in Kidney Renal Papillary Cell Carcinoma tumors?,top_cases_counts_by_genes
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the rate of TAF1L mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the rate of TASOR2 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the rate of TASOR2 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the rate of TASOR2 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the rate of KDM5C mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the rate of KDM5C mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the rate of KDM5C mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the rate of KDM5C mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of IL5RA mutations in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma tumors?,top_cases_counts_by_genes
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the rate of DHX16 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the rate of DHX16 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the rate of GPR158 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the rate of GPR158 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of EIF2B4 mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors?",top_cases_counts_by_genes
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of EIF2B4 mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors?",top_cases_counts_by_genes
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of EIF2B4 mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors?",top_cases_counts_by_genes
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of EIF2B4 mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors?",top_cases_counts_by_genes
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of EIF2B4 mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors?",top_cases_counts_by_genes
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of EIF2B4 mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors?",top_cases_counts_by_genes
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the rate of AUTS2 mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the rate of AUTS2 mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the rate of AUTS2 mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the rate of AUTS2 mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the rate of AUTS2 mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the rate of AUTS2 mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the rate of AUTS2 mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the rate of AUTS2 mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the rate of AUTS2 mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the rate of AUTS2 mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of ACTL7B mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors?",top_cases_counts_by_genes
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the rate of PCDHGA1 mutations in Glioblastoma Multiforme tumors?,top_cases_counts_by_genes
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the rate of TRAP1 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the rate of TRAP1 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the rate of PIK3C2A mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the rate of KANSL1 mutations in Liver Hepatocellular Carcinoma tumors?,top_cases_counts_by_genes
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the rate of ANKRD52 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the rate of PAPPA mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the rate of B3GALNT1 mutations in Rectum Adenocarcinoma tumors?,top_cases_counts_by_genes
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the rate of GABRA6 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the rate of GABRA6 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the rate of GABRA6 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the rate of GABRA6 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the rate of GABRA6 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the rate of ZSCAN31 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of MED16 mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors?",top_cases_counts_by_genes
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of MED16 mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors?",top_cases_counts_by_genes
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the rate of PTPRO mutations in Pancreatic Adenocarcinoma tumors?,top_cases_counts_by_genes
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the rate of PTPRO mutations in Pancreatic Adenocarcinoma tumors?,top_cases_counts_by_genes
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the rate of PTPRO mutations in Pancreatic Adenocarcinoma tumors?,top_cases_counts_by_genes
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the rate of PTPRO mutations in Pancreatic Adenocarcinoma tumors?,top_cases_counts_by_genes
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the rate of PTPRO mutations in Pancreatic Adenocarcinoma tumors?,top_cases_counts_by_genes
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the rate of PTPRO mutations in Pancreatic Adenocarcinoma tumors?,top_cases_counts_by_genes
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the rate of PTPRO mutations in Pancreatic Adenocarcinoma tumors?,top_cases_counts_by_genes
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the rate of PTPRO mutations in Pancreatic Adenocarcinoma tumors?,top_cases_counts_by_genes
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the rate of CHMP7 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the rate of GPC3 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the rate of GPC3 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of TLK2 mutations in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma tumors?,top_cases_counts_by_genes
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of TLK2 mutations in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma tumors?,top_cases_counts_by_genes
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of TLK2 mutations in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma tumors?,top_cases_counts_by_genes
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of TLK2 mutations in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma tumors?,top_cases_counts_by_genes
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate of TLK2 mutations in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma tumors?,top_cases_counts_by_genes
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the rate of ZNF217 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the rate of SYT9 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the rate of SYT9 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the rate of PKHD1L1 mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the rate of MYO3A mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of VASN mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors?",top_cases_counts_by_genes
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the rate of DNMT1 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the rate of DNMT1 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the rate of DNMT1 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1056,CA9,E402K,Colon Adenocarcinoma,What is the rate of CA9 mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the rate of TTC17 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the rate of TTC17 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the rate of PSG2 mutations in Breast Invasive Carcinoma tumors?,top_cases_counts_by_genes
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the rate of RIPOR2 mutations in Breast Invasive Carcinoma tumors?,top_cases_counts_by_genes
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the rate of RIPOR2 mutations in Breast Invasive Carcinoma tumors?,top_cases_counts_by_genes
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the rate of RIPOR2 mutations in Breast Invasive Carcinoma tumors?,top_cases_counts_by_genes
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the rate of RIPOR2 mutations in Breast Invasive Carcinoma tumors?,top_cases_counts_by_genes
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the rate of DCLK3 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the rate of DCLK3 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the rate of MERTK mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the rate of MERTK mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the rate of MERTK mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the rate of ZFP42 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the rate of OR13C3 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the rate of OR13C3 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the rate of SPAG1 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the rate of CDKN2AIP mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the rate of PXN mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the rate of PXN mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the rate of PXN mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the rate of PXN mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the rate of PXN mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the rate of PXN mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the rate of TTYH2 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the rate of TTYH2 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the rate of TMEM255A mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the rate of TMEM255A mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the rate of TMEM255A mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the rate of TASOR2 mutations in Breast Invasive Carcinoma tumors?,top_cases_counts_by_genes
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the rate of TASOR2 mutations in Breast Invasive Carcinoma tumors?,top_cases_counts_by_genes
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the rate of ICE1 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the rate of MYT1 mutations in Breast Invasive Carcinoma tumors?,top_cases_counts_by_genes
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the rate of MYT1 mutations in Breast Invasive Carcinoma tumors?,top_cases_counts_by_genes
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the rate of MYT1 mutations in Breast Invasive Carcinoma tumors?,top_cases_counts_by_genes
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the rate of CX3CR1 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the rate of CX3CR1 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the rate of SPINDOC mutations in Liver Hepatocellular Carcinoma tumors?,top_cases_counts_by_genes
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the rate of ART3 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the rate of ART3 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the rate of CYP1A2 mutations in Bladder Urothelial Carcinoma tumors?,top_cases_counts_by_genes
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of ADRA1A mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors?",top_cases_counts_by_genes
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the rate of CDH23 mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the rate of CDH23 mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the rate of KRT39 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the rate of PDHA2 mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the rate of SLC24A2 mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the rate of PTPRN2 mutations in Liver Hepatocellular Carcinoma tumors?,top_cases_counts_by_genes
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the rate of PTPRN2 mutations in Liver Hepatocellular Carcinoma tumors?,top_cases_counts_by_genes
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the rate of PTPRN2 mutations in Liver Hepatocellular Carcinoma tumors?,top_cases_counts_by_genes
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the rate of PTPRN2 mutations in Liver Hepatocellular Carcinoma tumors?,top_cases_counts_by_genes
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the rate of PTPRN2 mutations in Liver Hepatocellular Carcinoma tumors?,top_cases_counts_by_genes
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the rate of SOX21 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the rate of CPA6 mutations in Bladder Urothelial Carcinoma tumors?,top_cases_counts_by_genes
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the rate of GRM5 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of CASZ1 mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors?",top_cases_counts_by_genes
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the rate of SGIP1 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the rate of SGIP1 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the rate of SGIP1 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the rate of SGIP1 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the rate of CARMIL1 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the rate of CARMIL1 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the rate of ZNF431 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the rate of ZNF431 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the rate of ZNF431 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the rate of DNAH11 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the rate of DNAH11 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the rate of POLD1 mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the rate of POLD1 mutations in Lung Squamous Cell Carcinoma tumors?,top_cases_counts_by_genes
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the rate of TTC12 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the rate of TTC12 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the rate of CNGB1 mutations in Bladder Urothelial Carcinoma tumors?,top_cases_counts_by_genes
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the rate of CNGB1 mutations in Bladder Urothelial Carcinoma tumors?,top_cases_counts_by_genes
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the rate of CTSC mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the rate of CTSC mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the rate of CTSC mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the rate of CTSC mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the rate of CTSC mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the rate of PRSS8 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the rate of PRSS8 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the rate of ARHGEF40 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the rate of ACTB mutations in Rectum Adenocarcinoma tumors?,top_cases_counts_by_genes
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the rate of ACTB mutations in Rectum Adenocarcinoma tumors?,top_cases_counts_by_genes
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the rate of ACTB mutations in Rectum Adenocarcinoma tumors?,top_cases_counts_by_genes
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the rate of ACTB mutations in Rectum Adenocarcinoma tumors?,top_cases_counts_by_genes
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the rate of YY1AP1 mutations in Glioblastoma Multiforme tumors?,top_cases_counts_by_genes
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the rate of YY1AP1 mutations in Glioblastoma Multiforme tumors?,top_cases_counts_by_genes
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the rate of YY1AP1 mutations in Glioblastoma Multiforme tumors?,top_cases_counts_by_genes
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the rate of YY1AP1 mutations in Glioblastoma Multiforme tumors?,top_cases_counts_by_genes
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the rate of YY1AP1 mutations in Glioblastoma Multiforme tumors?,top_cases_counts_by_genes
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the rate of YY1AP1 mutations in Glioblastoma Multiforme tumors?,top_cases_counts_by_genes
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the rate of YY1AP1 mutations in Glioblastoma Multiforme tumors?,top_cases_counts_by_genes
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the rate of FNDC7 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the rate of FNDC7 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the rate of TLCD5 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the rate of TLCD5 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the rate of POLR1G mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the rate of POLR1G mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the rate of DNAH14 mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the rate of DNAH14 mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the rate of DNAH14 mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the rate of NEXN mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the rate of CYB5R2 mutations in Prostate Adenocarcinoma tumors?,top_cases_counts_by_genes
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the rate of CYB5R2 mutations in Prostate Adenocarcinoma tumors?,top_cases_counts_by_genes
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the rate of NRAP mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the rate of NRAP mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the rate of NRAP mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the rate of CCDC22 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the rate of DCAF6 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the rate of DCAF6 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the rate of ZNF708 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the rate of BFAR mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the rate of MAST4 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the rate of MAST4 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the rate of MAST4 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the rate of MAST4 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the rate of MAST4 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the rate of ARMC3 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the rate of ARMC3 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the rate of TET2 mutations in Kidney Renal Clear Cell Carcinoma tumors?,top_cases_counts_by_genes
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the rate of TET2 mutations in Kidney Renal Clear Cell Carcinoma tumors?,top_cases_counts_by_genes
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the rate of SERPINB10 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the rate of STAT3 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the rate of MIEF1 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the rate of ACVR1B mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the rate of ACVR1B mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the rate of ACVR1B mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the rate of EBF2 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the rate of EBF2 mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the rate of VPS26B mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of PGR mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors?",top_cases_counts_by_genes
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of PGR mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors?",top_cases_counts_by_genes
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate of PGR mutations in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus tumors?",top_cases_counts_by_genes
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the rate of ACTA2 mutations in Skin Cutaneous Melanoma tumors?,top_cases_counts_by_genes
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the rate of THBS4 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the rate of THBS4 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the rate of PRSS1 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the rate of PRSS1 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the rate of PRSS1 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the rate of PRSS1 mutations in Lung Adenocarcinoma tumors?,top_cases_counts_by_genes
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the rate of PGF mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the rate of PGF mutations in Stomach Adenocarcinoma tumors?,top_cases_counts_by_genes
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the rate of ITPRID2 mutations in Breast Invasive Carcinoma tumors?,top_cases_counts_by_genes
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the rate of ITPRID2 mutations in Breast Invasive Carcinoma tumors?,top_cases_counts_by_genes
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the rate of HBB mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the rate of PCDHB2 mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the rate of PCDHB2 mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the rate of PCDHB2 mutations in Colon Adenocarcinoma tumors?,top_cases_counts_by_genes
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the rate of UBR2 mutations in Uterine Corpus Endometrial Carcinoma tumors?,top_cases_counts_by_genes
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the rate of FBXO42 mutations in Rectum Adenocarcinoma tumors?,top_cases_counts_by_genes
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the number of Breast Invasive Carcinoma cases without TNS1 and PGR mutations?,top_cases_counts_by_genes
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the number of Breast Invasive Carcinoma cases without TNS1 and DNMT1 mutations?,top_cases_counts_by_genes
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the number of Breast Invasive Carcinoma cases without TNS1 and UNC5D mutations?,top_cases_counts_by_genes
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the number of Breast Invasive Carcinoma cases without TNS1 and SPATA22 mutations?,top_cases_counts_by_genes
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the number of Breast Invasive Carcinoma cases without TNS1 and ZCCHC14 mutations?,top_cases_counts_by_genes
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the number of Breast Invasive Carcinoma cases without TNS1 and EIF2B4 mutations?,top_cases_counts_by_genes
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the number of Breast Invasive Carcinoma cases without TNS1 and TAS1R3 mutations?,top_cases_counts_by_genes
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the number of Bladder Urothelial Carcinoma cases without EVC2 and MYT1 mutations?,top_cases_counts_by_genes
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the number of Bladder Urothelial Carcinoma cases without EVC2 and COL6A3 mutations?,top_cases_counts_by_genes
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without CR1 and FCGR2C mutations?,top_cases_counts_by_genes
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without CR1 and TENM2 mutations?,top_cases_counts_by_genes
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the number of Rectum Adenocarcinoma cases without TRPA1 and PIK3C2G mutations?,top_cases_counts_by_genes
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the number of Rectum Adenocarcinoma cases without TRPA1 and OLFML3 mutations?,top_cases_counts_by_genes
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without TAF1C and ACTL7B mutations?,top_cases_counts_by_genes
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without TAF1C and ARMC3 mutations?,top_cases_counts_by_genes
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without TAF1C and MYT1 mutations?,top_cases_counts_by_genes
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without TAF1C and PGF mutations?,top_cases_counts_by_genes
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without TAF1C and VPS26B mutations?,top_cases_counts_by_genes
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without DPF3 and FGF8 mutations?,top_cases_counts_by_genes
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without DPF3 and TYK2 mutations?,top_cases_counts_by_genes
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without DPF3 and EIF2B4 mutations?,top_cases_counts_by_genes
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without OR2T4 and PRSS1 mutations?,top_cases_counts_by_genes
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without OR2T4 and CTCFL mutations?,top_cases_counts_by_genes
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the number of Pancreatic Adenocarcinoma cases without FBN1 and AUTS2 mutations?,top_cases_counts_by_genes
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the number of Prostate Adenocarcinoma cases without MAD1L1 and C7orf31 mutations?,top_cases_counts_by_genes
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the number of Prostate Adenocarcinoma cases without MAD1L1 and B3GALNT1 mutations?,top_cases_counts_by_genes
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the number of Prostate Adenocarcinoma cases without MAD1L1 and JAML mutations?,top_cases_counts_by_genes
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without CCNG1 and EPRS1 mutations?,top_cases_counts_by_genes
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the number of Kidney Renal Papillary Cell Carcinoma cases without ANP32E and RIMS2 mutations?,top_cases_counts_by_genes
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the number of Kidney Renal Papillary Cell Carcinoma cases without ANP32E and PHLPP1 mutations?,top_cases_counts_by_genes
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the number of Kidney Renal Papillary Cell Carcinoma cases without ANP32E and B3GALNT1 mutations?,top_cases_counts_by_genes
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the number of Kidney Renal Papillary Cell Carcinoma cases without ANP32E and RIMS2 mutations?,top_cases_counts_by_genes
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the number of Bladder Urothelial Carcinoma cases without FRY and CNGB1 mutations?,top_cases_counts_by_genes
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the number of Bladder Urothelial Carcinoma cases without FRY and GABRA6 mutations?,top_cases_counts_by_genes
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the number of Bladder Urothelial Carcinoma cases without FRY and FBXO42 mutations?,top_cases_counts_by_genes
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the number of Bladder Urothelial Carcinoma cases without FRY and PXN mutations?,top_cases_counts_by_genes
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without PAK3 and OLFML3 mutations?,top_cases_counts_by_genes
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without PAK3 and EPRS1 mutations?,top_cases_counts_by_genes
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without PAK3 and FGF8 mutations?,top_cases_counts_by_genes
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without PAK3 and TNS1 mutations?,top_cases_counts_by_genes
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without PAK3 and TENM2 mutations?,top_cases_counts_by_genes
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without MUC16 and ARMC3 mutations?,top_cases_counts_by_genes
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the number of Liver Hepatocellular Carcinoma cases without ZFPM2 and UNC5D mutations?,top_cases_counts_by_genes
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the number of Liver Hepatocellular Carcinoma cases without ZFPM2 and CYP1A2 mutations?,top_cases_counts_by_genes
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the number of Breast Invasive Carcinoma cases without PIK3C2B and ANKDD1A mutations?,top_cases_counts_by_genes
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the number of Breast Invasive Carcinoma cases without PIK3C2B and NRAP mutations?,top_cases_counts_by_genes
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without ZNF804A and TYK2 mutations?,top_cases_counts_by_genes
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without RELN and GUK1 mutations?,top_cases_counts_by_genes
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases without EFCAB12 and PIK3C2G mutations?",top_cases_counts_by_genes
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases without EFCAB12 and MAST4 mutations?",top_cases_counts_by_genes
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without DEFB115 and ZCCHC14 mutations?,top_cases_counts_by_genes
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the number of Bladder Urothelial Carcinoma cases without ANKDD1A and HTR3B mutations?,top_cases_counts_by_genes
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the number of Bladder Urothelial Carcinoma cases without ANKDD1A and COL6A3 mutations?,top_cases_counts_by_genes
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the number of Bladder Urothelial Carcinoma cases without ANKDD1A and PCDHB2 mutations?,top_cases_counts_by_genes
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without HTR3B and ZFAT mutations?,top_cases_counts_by_genes
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without HTR3B and TAF1C mutations?,top_cases_counts_by_genes
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without HTR3B and PAPPA mutations?,top_cases_counts_by_genes
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without ABCC3 and GUK1 mutations?,top_cases_counts_by_genes
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without NOMO1 and OR5D14 mutations?,top_cases_counts_by_genes
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without NOMO1 and GPR158 mutations?,top_cases_counts_by_genes
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the number of Bladder Urothelial Carcinoma cases without HYOU1 and MIEF1 mutations?,top_cases_counts_by_genes
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without FMO4 and ACVR1B mutations?,top_cases_counts_by_genes
+140,BICC1,A372V,Exceptional Responders,What is the number of Exceptional Responders cases without BICC1 and TRIM45 mutations?,top_cases_counts_by_genes
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without ZMYM3 and ART3 mutations?,top_cases_counts_by_genes
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without ZMYM3 and ZBTB34 mutations?,top_cases_counts_by_genes
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without ZMYM3 and KIF20B mutations?,top_cases_counts_by_genes
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases without XKR4 and TRIM45 mutations?",top_cases_counts_by_genes
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the number of Liver Hepatocellular Carcinoma cases without ABCC2 and CACNA1F mutations?,top_cases_counts_by_genes
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without OR8K5 and MERTK mutations?,top_cases_counts_by_genes
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without SPTAN1 and KANSL1 mutations?,top_cases_counts_by_genes
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without SPTAN1 and CFAP61 mutations?,top_cases_counts_by_genes
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the number of Rectum Adenocarcinoma cases without SYT10 and ADRA1A mutations?,top_cases_counts_by_genes
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without HSPA5 and HSPA5 mutations?,top_cases_counts_by_genes
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without UNC5D and THBS4 mutations?,top_cases_counts_by_genes
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without UNC5D and TENM2 mutations?,top_cases_counts_by_genes
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without UNC5D and TASOR2 mutations?,top_cases_counts_by_genes
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without UNC5D and YY1AP1 mutations?,top_cases_counts_by_genes
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without UNC5D and ZNF708 mutations?,top_cases_counts_by_genes
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without UNC5D and SORCS1 mutations?,top_cases_counts_by_genes
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the number of Kidney Renal Clear Cell Carcinoma cases without DOCK2 and DNMT1 mutations?,top_cases_counts_by_genes
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the number of Kidney Renal Clear Cell Carcinoma cases without ZNF627 and TAF1C mutations?,top_cases_counts_by_genes
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without CDC42BPA and GRTP1 mutations?,top_cases_counts_by_genes
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without MRPL55 and OR5D14 mutations?,top_cases_counts_by_genes
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without MRPL55 and OR2A12 mutations?,top_cases_counts_by_genes
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the number of Breast Invasive Carcinoma cases without TMTC3 and SORCS1 mutations?,top_cases_counts_by_genes
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without EPRS1 and MED16 mutations?,top_cases_counts_by_genes
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without EPRS1 and ICE1 mutations?,top_cases_counts_by_genes
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without GRTP1 and RIMS2 mutations?,top_cases_counts_by_genes
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without GRTP1 and MRPL32 mutations?,top_cases_counts_by_genes
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without TSHZ3 and DHX16 mutations?,top_cases_counts_by_genes
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the number of HIV+ Tumor Molecular Characterization Project - Cervical Cancer cases without TAS1R3 and AUTS2 mutations?,top_cases_counts_by_genes
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without PIAS3 and TLK2 mutations?,top_cases_counts_by_genes
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without PIAS3 and RIMS2 mutations?,top_cases_counts_by_genes
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without ZNF274 and TTC12 mutations?,top_cases_counts_by_genes
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without SYNJ1 and LDOC1 mutations?,top_cases_counts_by_genes
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without SYNJ1 and COL6A3 mutations?,top_cases_counts_by_genes
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without SYNJ1 and TLK2 mutations?,top_cases_counts_by_genes
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the number of Prostate Adenocarcinoma cases without DSCAM and COL6A3 mutations?,top_cases_counts_by_genes
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the number of Prostate Adenocarcinoma cases without DSCAM and CYB5R2 mutations?,top_cases_counts_by_genes
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the number of Prostate Adenocarcinoma cases without DSCAM and CHODL mutations?,top_cases_counts_by_genes
+267,DGKD,R140H,Exceptional Responders,What is the number of Exceptional Responders cases without DGKD and SPTAN1 mutations?,top_cases_counts_by_genes
+268,DGKD,R160H,Exceptional Responders,What is the number of Exceptional Responders cases without DGKD and CPS1 mutations?,top_cases_counts_by_genes
+269,DGKD,R204H,Exceptional Responders,What is the number of Exceptional Responders cases without DGKD and MYO3B mutations?,top_cases_counts_by_genes
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the number of Bladder Urothelial Carcinoma cases without PLEKHG6 and AUTS2 mutations?,top_cases_counts_by_genes
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the number of Bladder Urothelial Carcinoma cases without PLEKHG6 and TYK2 mutations?,top_cases_counts_by_genes
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the number of Bladder Urothelial Carcinoma cases without PLEKHG6 and ANKRD30A mutations?,top_cases_counts_by_genes
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without WNT2 and TTC12 mutations?,top_cases_counts_by_genes
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without GUCY2C and ZFP42 mutations?,top_cases_counts_by_genes
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without C7orf31 and GPR158 mutations?,top_cases_counts_by_genes
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases without ZKSCAN7 and CTSC mutations?",top_cases_counts_by_genes
+299,OR5D14,M210L,Neuroblastoma,What is the number of Neuroblastoma cases without OR5D14 and STK19 mutations?,top_cases_counts_by_genes
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without SPATA22 and NOMO1 mutations?,top_cases_counts_by_genes
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without SPATA22 and TNS1 mutations?,top_cases_counts_by_genes
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without SPATA22 and CNGB1 mutations?,top_cases_counts_by_genes
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without LCN15 and GUK1 mutations?,top_cases_counts_by_genes
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without DCAF4L2 and RIMS2 mutations?,top_cases_counts_by_genes
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without GUK1 and FGF8 mutations?,top_cases_counts_by_genes
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without GUK1 and DCN mutations?,top_cases_counts_by_genes
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without GUK1 and DCAF6 mutations?,top_cases_counts_by_genes
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without GUK1 and COL6A3 mutations?,top_cases_counts_by_genes
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without GUK1 and SYT9 mutations?,top_cases_counts_by_genes
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without MORF4L1 and PTPRN2 mutations?,top_cases_counts_by_genes
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without MORF4L1 and AUTS2 mutations?,top_cases_counts_by_genes
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without MORF4L1 and FBXO42 mutations?,top_cases_counts_by_genes
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without MORF4L1 and RIMS2 mutations?,top_cases_counts_by_genes
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without MYO3B and DEFB115 mutations?,top_cases_counts_by_genes
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without MYO3B and TMTC3 mutations?,top_cases_counts_by_genes
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without TENT5A and AUTS2 mutations?,top_cases_counts_by_genes
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without TENT5A and SGIP1 mutations?,top_cases_counts_by_genes
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without TENT5A and GUCY2C mutations?,top_cases_counts_by_genes
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the number of Ovarian Serous Cystadenocarcinoma cases without ZFAT and DCN mutations?,top_cases_counts_by_genes
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the number of Ovarian Serous Cystadenocarcinoma cases without ZFAT and OR2T4 mutations?,top_cases_counts_by_genes
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the number of Ovarian Serous Cystadenocarcinoma cases without ZFAT and ANKRD30A mutations?,top_cases_counts_by_genes
+357,ZNF584,A211T,Sarcoma,What is the number of Sarcoma cases without ZNF584 and TTC12 mutations?,top_cases_counts_by_genes
+358,ZNF584,A256T,Sarcoma,What is the number of Sarcoma cases without ZNF584 and PYHIN1 mutations?,top_cases_counts_by_genes
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without LDOC1 and ZFAT mutations?,top_cases_counts_by_genes
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without PDGFC and PTPRO mutations?,top_cases_counts_by_genes
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without MSANTD4 and ART3 mutations?,top_cases_counts_by_genes
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without NPSR1 and TRIM45 mutations?,top_cases_counts_by_genes
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without PHLPP1 and ZNF431 mutations?,top_cases_counts_by_genes
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without COL6A3 and REXO4 mutations?,top_cases_counts_by_genes
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without COL6A3 and RIPOR2 mutations?,top_cases_counts_by_genes
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without COL6A3 and PKHD1L1 mutations?,top_cases_counts_by_genes
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without COL6A3 and DCC mutations?,top_cases_counts_by_genes
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without COL6A3 and PRSS1 mutations?,top_cases_counts_by_genes
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without ADRA1A and TENT5A mutations?,top_cases_counts_by_genes
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the number of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases without LAMB2 and TNS1 mutations?,top_cases_counts_by_genes
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the number of Rectum Adenocarcinoma cases without POC1B and DOCK2 mutations?,top_cases_counts_by_genes
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the number of Rectum Adenocarcinoma cases without POC1B and PSG2 mutations?,top_cases_counts_by_genes
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the number of Rectum Adenocarcinoma cases without POC1B and FBXO15 mutations?,top_cases_counts_by_genes
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the number of Rectum Adenocarcinoma cases without POC1B and DCN mutations?,top_cases_counts_by_genes
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the number of Liver Hepatocellular Carcinoma cases without USH2A and DSCAM mutations?,top_cases_counts_by_genes
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the number of Rectum Adenocarcinoma cases without AQP7 and ZNF804A mutations?,top_cases_counts_by_genes
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the number of Rectum Adenocarcinoma cases without AQP7 and ZKSCAN7 mutations?,top_cases_counts_by_genes
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the number of Rectum Adenocarcinoma cases without AQP7 and UNC5D mutations?,top_cases_counts_by_genes
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the number of Rectum Adenocarcinoma cases without AQP7 and ARMC3 mutations?,top_cases_counts_by_genes
+430,DCN,R163C,Rectum Adenocarcinoma,What is the number of Rectum Adenocarcinoma cases without DCN and ADAM17 mutations?,top_cases_counts_by_genes
+431,DCN,R203C,Rectum Adenocarcinoma,What is the number of Rectum Adenocarcinoma cases without DCN and YY1AP1 mutations?,top_cases_counts_by_genes
+432,DCN,R241C,Rectum Adenocarcinoma,What is the number of Rectum Adenocarcinoma cases without DCN and CFAP61 mutations?,top_cases_counts_by_genes
+433,DCN,R350C,Rectum Adenocarcinoma,What is the number of Rectum Adenocarcinoma cases without DCN and PTPRO mutations?,top_cases_counts_by_genes
+434,DCN,R41C,Rectum Adenocarcinoma,What is the number of Rectum Adenocarcinoma cases without DCN and NPSR1 mutations?,top_cases_counts_by_genes
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without CPS1 and MERTK mutations?,top_cases_counts_by_genes
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without CPS1 and ANKRD24 mutations?,top_cases_counts_by_genes
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without CPS1 and TENM2 mutations?,top_cases_counts_by_genes
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the number of Kidney Renal Papillary Cell Carcinoma cases without FCGR2C and CTSC mutations?,top_cases_counts_by_genes
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the number of Kidney Renal Papillary Cell Carcinoma cases without FCGR2C and OLFML3 mutations?,top_cases_counts_by_genes
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without GRM1 and OLFML3 mutations?,top_cases_counts_by_genes
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without SGCZ and ANKRD24 mutations?,top_cases_counts_by_genes
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without SGCZ and NEXN mutations?,top_cases_counts_by_genes
+485,SMO,V15M,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without SMO and CASZ1 mutations?,top_cases_counts_by_genes
+486,SMO,V321M,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without SMO and HTR3B mutations?,top_cases_counts_by_genes
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without CHODL and GUK1 mutations?,top_cases_counts_by_genes
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without CHODL and AUTS2 mutations?,top_cases_counts_by_genes
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without CHODL and SGIP1 mutations?,top_cases_counts_by_genes
+494,MYO16,P399H,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without MYO16 and TAF1C mutations?,top_cases_counts_by_genes
+495,MYO16,P421H,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without MYO16 and MORF4L1 mutations?,top_cases_counts_by_genes
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without CXCR2 and FBXO15 mutations?,top_cases_counts_by_genes
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the number of Bladder Urothelial Carcinoma cases without TMEM225 and JAML mutations?,top_cases_counts_by_genes
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without MAOB and DSCAM mutations?,top_cases_counts_by_genes
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without GPRASP1 and ART3 mutations?,top_cases_counts_by_genes
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without MRPL32 and TSHZ3 mutations?,top_cases_counts_by_genes
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without TYROBP and FBXO15 mutations?,top_cases_counts_by_genes
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without RAB40C and CYP1A2 mutations?,top_cases_counts_by_genes
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without RAB40C and BFAR mutations?,top_cases_counts_by_genes
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without CTNNA2 and ACTB mutations?,top_cases_counts_by_genes
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without CTNNA2 and CA9 mutations?,top_cases_counts_by_genes
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without CTNNA2 and DCC mutations?,top_cases_counts_by_genes
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without CTNNA2 and PRSS1 mutations?,top_cases_counts_by_genes
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the number of Bladder Urothelial Carcinoma cases without MYO15A and PTPRN2 mutations?,top_cases_counts_by_genes
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without GIMAP2 and NOMO1 mutations?,top_cases_counts_by_genes
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the number of Glioblastoma Multiforme cases without KIF20B and DCN mutations?,top_cases_counts_by_genes
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the number of Glioblastoma Multiforme cases without KIF20B and EBF2 mutations?,top_cases_counts_by_genes
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without ADAM17 and CTNNA2 mutations?,top_cases_counts_by_genes
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without BCAT1 and MYO3B mutations?,top_cases_counts_by_genes
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without BCAT1 and MYT1 mutations?,top_cases_counts_by_genes
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without BCAT1 and ZNF708 mutations?,top_cases_counts_by_genes
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without ERCC6 and SPTAN1 mutations?,top_cases_counts_by_genes
+541,DCC,R320W,Breast Invasive Carcinoma,What is the number of Breast Invasive Carcinoma cases without DCC and ZBTB34 mutations?,top_cases_counts_by_genes
+542,DCC,R363W,Breast Invasive Carcinoma,What is the number of Breast Invasive Carcinoma cases without DCC and TMEM225 mutations?,top_cases_counts_by_genes
+543,DCC,R386W,Breast Invasive Carcinoma,What is the number of Breast Invasive Carcinoma cases without DCC and POC1B mutations?,top_cases_counts_by_genes
+544,DCC,R41W,Breast Invasive Carcinoma,What is the number of Breast Invasive Carcinoma cases without DCC and ACVR1B mutations?,top_cases_counts_by_genes
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without FBXO15 and PXN mutations?,top_cases_counts_by_genes
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without FBXO15 and TRPA1 mutations?,top_cases_counts_by_genes
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without GSTCD and PDHA2 mutations?,top_cases_counts_by_genes
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without GSTCD and TNS1 mutations?,top_cases_counts_by_genes
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without OLFML3 and NPSR1 mutations?,top_cases_counts_by_genes
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without OLFML3 and ART3 mutations?,top_cases_counts_by_genes
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without OLFML3 and OLFML3 mutations?,top_cases_counts_by_genes
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the number of Ovarian Serous Cystadenocarcinoma cases without CFAP61 and OR2A12 mutations?,top_cases_counts_by_genes
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the number of Ovarian Serous Cystadenocarcinoma cases without CFAP61 and ACVR1B mutations?,top_cases_counts_by_genes
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the number of Bladder Urothelial Carcinoma cases without HLA-DQA2 and TENM2 mutations?,top_cases_counts_by_genes
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without TENM2 and MYO15A mutations?,top_cases_counts_by_genes
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without TENM2 and MERTK mutations?,top_cases_counts_by_genes
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without TENM2 and ZNF431 mutations?,top_cases_counts_by_genes
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without ANKRD24 and TRIM45 mutations?,top_cases_counts_by_genes
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without ANKRD24 and ITPRID2 mutations?,top_cases_counts_by_genes
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without ANKRD24 and TLCD5 mutations?,top_cases_counts_by_genes
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without ZCCHC14 and FNDC7 mutations?,top_cases_counts_by_genes
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without ZCCHC14 and ACTA2 mutations?,top_cases_counts_by_genes
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without ZCCHC14 and ANP32E mutations?,top_cases_counts_by_genes
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without ZCCHC14 and CTCFL mutations?,top_cases_counts_by_genes
+625,SIK2,I265M,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without SIK2 and SLC9C1 mutations?,top_cases_counts_by_genes
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without MYH11 and POC1B mutations?,top_cases_counts_by_genes
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without MYH11 and KDM5C mutations?,top_cases_counts_by_genes
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without SLC6A4 and NEXN mutations?,top_cases_counts_by_genes
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without SLC9C1 and DCN mutations?,top_cases_counts_by_genes
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without SLC9C1 and TENM2 mutations?,top_cases_counts_by_genes
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the number of Brain Lower Grade Glioma cases without OR2A12 and ZFP42 mutations?,top_cases_counts_by_genes
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without PYHIN1 and STK19 mutations?,top_cases_counts_by_genes
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without PYHIN1 and FBXO42 mutations?,top_cases_counts_by_genes
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without JAML and OLFML3 mutations?,top_cases_counts_by_genes
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without JAML and GABRA6 mutations?,top_cases_counts_by_genes
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without JAML and HTR3B mutations?,top_cases_counts_by_genes
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without JAML and EIF2B4 mutations?,top_cases_counts_by_genes
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without TYK2 and PKHD1L1 mutations?,top_cases_counts_by_genes
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without TYK2 and TMEM225 mutations?,top_cases_counts_by_genes
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without TYK2 and GSTCD mutations?,top_cases_counts_by_genes
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without CTCFL and TAS1R3 mutations?,top_cases_counts_by_genes
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without CTCFL and SGCZ mutations?,top_cases_counts_by_genes
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without CTCFL and PYHIN1 mutations?,top_cases_counts_by_genes
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without CTCFL and POC1B mutations?,top_cases_counts_by_genes
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without CEP20 and PAK3 mutations?,top_cases_counts_by_genes
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without CEP20 and DNAH14 mutations?,top_cases_counts_by_genes
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without RIMS2 and LAMB2 mutations?,top_cases_counts_by_genes
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without RIMS2 and PTPRO mutations?,top_cases_counts_by_genes
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without RIMS2 and JAML mutations?,top_cases_counts_by_genes
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without RIMS2 and DCN mutations?,top_cases_counts_by_genes
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without RIMS2 and CTNNA2 mutations?,top_cases_counts_by_genes
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without RIMS2 and MERTK mutations?,top_cases_counts_by_genes
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without RIMS2 and PTPRO mutations?,top_cases_counts_by_genes
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without PIK3C2G and DSCAM mutations?,top_cases_counts_by_genes
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without PIK3C2G and ACTB mutations?,top_cases_counts_by_genes
+728,STK19,D341N,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without STK19 and KL mutations?,top_cases_counts_by_genes
+729,STK19,D345N,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without STK19 and TNS1 mutations?,top_cases_counts_by_genes
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without REXO4 and SYNJ1 mutations?,top_cases_counts_by_genes
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without ZBTB34 and GABRA6 mutations?,top_cases_counts_by_genes
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without ZBTB34 and CHODL mutations?,top_cases_counts_by_genes
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the number of Bladder Urothelial Carcinoma cases without NCKAP5 and MYO3B mutations?,top_cases_counts_by_genes
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases without SORCS1 and ZMYM3 mutations?",top_cases_counts_by_genes
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases without SORCS1 and SORCS1 mutations?",top_cases_counts_by_genes
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases without SORCS1 and MIEF1 mutations?",top_cases_counts_by_genes
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases without SORCS1 and LAMB2 mutations?",top_cases_counts_by_genes
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the number of Head and Neck Squamous Cell Carcinoma cases without FGF8 and ZCCHC14 mutations?,top_cases_counts_by_genes
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the number of Head and Neck Squamous Cell Carcinoma cases without FGF8 and CNGB1 mutations?,top_cases_counts_by_genes
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the number of Head and Neck Squamous Cell Carcinoma cases without FGF8 and B3GALNT1 mutations?,top_cases_counts_by_genes
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the number of Head and Neck Squamous Cell Carcinoma cases without FGF8 and GABRA6 mutations?,top_cases_counts_by_genes
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the number of Head and Neck Squamous Cell Carcinoma cases without FGF8 and TLK2 mutations?,top_cases_counts_by_genes
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the number of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia cases without TENM3 and PXN mutations?,top_cases_counts_by_genes
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without AKT1 and PTPRO mutations?,top_cases_counts_by_genes
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the number of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases without CFAP298-TCP10L and AUTS2 mutations?,top_cases_counts_by_genes
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without GLRB and TMEM225 mutations?,top_cases_counts_by_genes
+793,TTN,F7636L,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without TTN and KANSL1 mutations?,top_cases_counts_by_genes
+794,TTN,F8563L,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without TTN and ZSCAN31 mutations?,top_cases_counts_by_genes
+795,TTN,F8880L,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without TTN and COL6A3 mutations?,top_cases_counts_by_genes
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without ANKRD30A and GRTP1 mutations?,top_cases_counts_by_genes
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without ANKRD30A and ZBTB34 mutations?,top_cases_counts_by_genes
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without ANKRD30A and DNAH11 mutations?,top_cases_counts_by_genes
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without TRIM45 and AQP7 mutations?,top_cases_counts_by_genes
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without TRIM45 and PLEKHG6 mutations?,top_cases_counts_by_genes
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without TRIM45 and TNS1 mutations?,top_cases_counts_by_genes
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without CACNA1F and GPC3 mutations?,top_cases_counts_by_genes
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without CACNA1F and KANSL1 mutations?,top_cases_counts_by_genes
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without CACNA1F and PDHA2 mutations?,top_cases_counts_by_genes
+817,KL,R594C,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without KL and GABRA6 mutations?,top_cases_counts_by_genes
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the number of Kidney Renal Papillary Cell Carcinoma cases without GUF1 and ACVR1B mutations?,top_cases_counts_by_genes
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without TAF1L and PIK3C2B mutations?,top_cases_counts_by_genes
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without TASOR2 and CEP20 mutations?,top_cases_counts_by_genes
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without TASOR2 and RIMS2 mutations?,top_cases_counts_by_genes
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without TASOR2 and FMO4 mutations?,top_cases_counts_by_genes
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without KDM5C and FGF8 mutations?,top_cases_counts_by_genes
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without KDM5C and NOMO1 mutations?,top_cases_counts_by_genes
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without KDM5C and DCAF6 mutations?,top_cases_counts_by_genes
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without KDM5C and DCC mutations?,top_cases_counts_by_genes
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the number of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases without IL5RA and ZNF431 mutations?,top_cases_counts_by_genes
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without DHX16 and GABRA6 mutations?,top_cases_counts_by_genes
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without DHX16 and MAST4 mutations?,top_cases_counts_by_genes
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without GPR158 and TTN mutations?,top_cases_counts_by_genes
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without GPR158 and ANKDD1A mutations?,top_cases_counts_by_genes
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases without EIF2B4 and TNS1 mutations?",top_cases_counts_by_genes
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases without EIF2B4 and ZSCAN31 mutations?",top_cases_counts_by_genes
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases without EIF2B4 and CACNA1F mutations?",top_cases_counts_by_genes
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases without EIF2B4 and PCDHB2 mutations?",top_cases_counts_by_genes
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases without EIF2B4 and TRPA1 mutations?",top_cases_counts_by_genes
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases without EIF2B4 and CTNNA2 mutations?",top_cases_counts_by_genes
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without AUTS2 and TENT5A mutations?,top_cases_counts_by_genes
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without AUTS2 and ZBTB34 mutations?,top_cases_counts_by_genes
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without AUTS2 and PIK3C2B mutations?,top_cases_counts_by_genes
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without AUTS2 and EIF2B4 mutations?,top_cases_counts_by_genes
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without AUTS2 and CX3CR1 mutations?,top_cases_counts_by_genes
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without AUTS2 and SPAG1 mutations?,top_cases_counts_by_genes
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without AUTS2 and CR1 mutations?,top_cases_counts_by_genes
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without AUTS2 and TAF1C mutations?,top_cases_counts_by_genes
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without AUTS2 and MIEF1 mutations?,top_cases_counts_by_genes
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without AUTS2 and GUK1 mutations?,top_cases_counts_by_genes
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases without ACTL7B and CTNNA2 mutations?",top_cases_counts_by_genes
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the number of Glioblastoma Multiforme cases without PCDHGA1 and EIF2B4 mutations?,top_cases_counts_by_genes
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without TRAP1 and TAF1C mutations?,top_cases_counts_by_genes
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without TRAP1 and ACVR1B mutations?,top_cases_counts_by_genes
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without PIK3C2A and CNGB1 mutations?,top_cases_counts_by_genes
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the number of Liver Hepatocellular Carcinoma cases without KANSL1 and AUTS2 mutations?,top_cases_counts_by_genes
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without ANKRD52 and YY1AP1 mutations?,top_cases_counts_by_genes
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without PAPPA and GUK1 mutations?,top_cases_counts_by_genes
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the number of Rectum Adenocarcinoma cases without B3GALNT1 and ACVR1B mutations?,top_cases_counts_by_genes
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without GABRA6 and GABRA6 mutations?,top_cases_counts_by_genes
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without GABRA6 and SYT10 mutations?,top_cases_counts_by_genes
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without GABRA6 and TNS1 mutations?,top_cases_counts_by_genes
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without GABRA6 and PAK3 mutations?,top_cases_counts_by_genes
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without GABRA6 and CX3CR1 mutations?,top_cases_counts_by_genes
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without ZSCAN31 and TET2 mutations?,top_cases_counts_by_genes
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases without MED16 and BICC1 mutations?",top_cases_counts_by_genes
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases without MED16 and FRY mutations?",top_cases_counts_by_genes
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the number of Pancreatic Adenocarcinoma cases without PTPRO and NPSR1 mutations?,top_cases_counts_by_genes
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the number of Pancreatic Adenocarcinoma cases without PTPRO and CTSC mutations?,top_cases_counts_by_genes
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the number of Pancreatic Adenocarcinoma cases without PTPRO and ITPRID2 mutations?,top_cases_counts_by_genes
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the number of Pancreatic Adenocarcinoma cases without PTPRO and DGKD mutations?,top_cases_counts_by_genes
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the number of Pancreatic Adenocarcinoma cases without PTPRO and DCLK3 mutations?,top_cases_counts_by_genes
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the number of Pancreatic Adenocarcinoma cases without PTPRO and DCN mutations?,top_cases_counts_by_genes
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the number of Pancreatic Adenocarcinoma cases without PTPRO and PTPRO mutations?,top_cases_counts_by_genes
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the number of Pancreatic Adenocarcinoma cases without PTPRO and TRPA1 mutations?,top_cases_counts_by_genes
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without CHMP7 and DNAH14 mutations?,top_cases_counts_by_genes
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without GPC3 and HTR3B mutations?,top_cases_counts_by_genes
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without GPC3 and TTN mutations?,top_cases_counts_by_genes
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the number of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases without TLK2 and ACTB mutations?,top_cases_counts_by_genes
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the number of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases without TLK2 and EIF2B4 mutations?,top_cases_counts_by_genes
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the number of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases without TLK2 and ZFAT mutations?,top_cases_counts_by_genes
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the number of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases without TLK2 and TNS1 mutations?,top_cases_counts_by_genes
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the number of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases without TLK2 and PGR mutations?,top_cases_counts_by_genes
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without ZNF217 and ANKRD30A mutations?,top_cases_counts_by_genes
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without SYT9 and TET2 mutations?,top_cases_counts_by_genes
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without SYT9 and ZFP42 mutations?,top_cases_counts_by_genes
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without PKHD1L1 and BCAT1 mutations?,top_cases_counts_by_genes
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without MYO3A and PLEKHG6 mutations?,top_cases_counts_by_genes
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases without VASN and ANKRD24 mutations?",top_cases_counts_by_genes
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without DNMT1 and ZNF804A mutations?,top_cases_counts_by_genes
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without DNMT1 and DNAH11 mutations?,top_cases_counts_by_genes
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without DNMT1 and PRSS1 mutations?,top_cases_counts_by_genes
+1056,CA9,E402K,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without CA9 and SPAG1 mutations?,top_cases_counts_by_genes
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without TTC17 and ZMYM3 mutations?,top_cases_counts_by_genes
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without TTC17 and SYT10 mutations?,top_cases_counts_by_genes
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the number of Breast Invasive Carcinoma cases without PSG2 and TNS1 mutations?,top_cases_counts_by_genes
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the number of Breast Invasive Carcinoma cases without RIPOR2 and DEFB115 mutations?,top_cases_counts_by_genes
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the number of Breast Invasive Carcinoma cases without RIPOR2 and OR13C3 mutations?,top_cases_counts_by_genes
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the number of Breast Invasive Carcinoma cases without RIPOR2 and POLD1 mutations?,top_cases_counts_by_genes
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the number of Breast Invasive Carcinoma cases without RIPOR2 and DGKD mutations?,top_cases_counts_by_genes
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without DCLK3 and EPRS1 mutations?,top_cases_counts_by_genes
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without DCLK3 and RAB40C mutations?,top_cases_counts_by_genes
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without MERTK and AUTS2 mutations?,top_cases_counts_by_genes
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without MERTK and EIF2B4 mutations?,top_cases_counts_by_genes
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without MERTK and NRAP mutations?,top_cases_counts_by_genes
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without ZFP42 and TASOR2 mutations?,top_cases_counts_by_genes
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without OR13C3 and NRAP mutations?,top_cases_counts_by_genes
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without OR13C3 and BCAT1 mutations?,top_cases_counts_by_genes
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without SPAG1 and ZNF804A mutations?,top_cases_counts_by_genes
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without CDKN2AIP and ZFPM2 mutations?,top_cases_counts_by_genes
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without PXN and SORCS1 mutations?,top_cases_counts_by_genes
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without PXN and PYHIN1 mutations?,top_cases_counts_by_genes
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without PXN and ABCC3 mutations?,top_cases_counts_by_genes
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without PXN and TRAP1 mutations?,top_cases_counts_by_genes
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without PXN and CFAP61 mutations?,top_cases_counts_by_genes
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without PXN and NPSR1 mutations?,top_cases_counts_by_genes
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without TTYH2 and SORCS1 mutations?,top_cases_counts_by_genes
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without TTYH2 and TTC12 mutations?,top_cases_counts_by_genes
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without TMEM255A and CYB5R2 mutations?,top_cases_counts_by_genes
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without TMEM255A and PSG2 mutations?,top_cases_counts_by_genes
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without TMEM255A and PTPRO mutations?,top_cases_counts_by_genes
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the number of Breast Invasive Carcinoma cases without TASOR2 and TMEM255A mutations?,top_cases_counts_by_genes
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the number of Breast Invasive Carcinoma cases without TASOR2 and AUTS2 mutations?,top_cases_counts_by_genes
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without ICE1 and DCLK3 mutations?,top_cases_counts_by_genes
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the number of Breast Invasive Carcinoma cases without MYT1 and POC1B mutations?,top_cases_counts_by_genes
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the number of Breast Invasive Carcinoma cases without MYT1 and ZFAT mutations?,top_cases_counts_by_genes
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the number of Breast Invasive Carcinoma cases without MYT1 and XKR4 mutations?,top_cases_counts_by_genes
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without CX3CR1 and TTC12 mutations?,top_cases_counts_by_genes
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without CX3CR1 and DCLK3 mutations?,top_cases_counts_by_genes
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the number of Liver Hepatocellular Carcinoma cases without SPINDOC and AUTS2 mutations?,top_cases_counts_by_genes
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without ART3 and PTPRO mutations?,top_cases_counts_by_genes
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without ART3 and PIK3C2B mutations?,top_cases_counts_by_genes
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the number of Bladder Urothelial Carcinoma cases without CYP1A2 and RIMS2 mutations?,top_cases_counts_by_genes
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases without ADRA1A and RIMS2 mutations?",top_cases_counts_by_genes
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without CDH23 and AKT1 mutations?,top_cases_counts_by_genes
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without CDH23 and UNC5D mutations?,top_cases_counts_by_genes
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without KRT39 and GABRA6 mutations?,top_cases_counts_by_genes
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without PDHA2 and SLC24A2 mutations?,top_cases_counts_by_genes
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without SLC24A2 and TTN mutations?,top_cases_counts_by_genes
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the number of Liver Hepatocellular Carcinoma cases without PTPRN2 and GPR158 mutations?,top_cases_counts_by_genes
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the number of Liver Hepatocellular Carcinoma cases without PTPRN2 and TYROBP mutations?,top_cases_counts_by_genes
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the number of Liver Hepatocellular Carcinoma cases without PTPRN2 and CTSC mutations?,top_cases_counts_by_genes
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the number of Liver Hepatocellular Carcinoma cases without PTPRN2 and GPC3 mutations?,top_cases_counts_by_genes
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the number of Liver Hepatocellular Carcinoma cases without PTPRN2 and MYT1 mutations?,top_cases_counts_by_genes
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without SOX21 and CNGB1 mutations?,top_cases_counts_by_genes
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the number of Bladder Urothelial Carcinoma cases without CPA6 and MAST4 mutations?,top_cases_counts_by_genes
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without GRM5 and PTPRO mutations?,top_cases_counts_by_genes
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases without CASZ1 and ZBTB34 mutations?",top_cases_counts_by_genes
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without SGIP1 and GPC3 mutations?,top_cases_counts_by_genes
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without SGIP1 and CX3CR1 mutations?,top_cases_counts_by_genes
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without SGIP1 and TYROBP mutations?,top_cases_counts_by_genes
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without SGIP1 and UNC5D mutations?,top_cases_counts_by_genes
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without CARMIL1 and TTN mutations?,top_cases_counts_by_genes
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without CARMIL1 and MUC16 mutations?,top_cases_counts_by_genes
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without ZNF431 and PGR mutations?,top_cases_counts_by_genes
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without ZNF431 and DCLK3 mutations?,top_cases_counts_by_genes
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without ZNF431 and ZNF584 mutations?,top_cases_counts_by_genes
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without DNAH11 and TMTC3 mutations?,top_cases_counts_by_genes
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without DNAH11 and MRPL55 mutations?,top_cases_counts_by_genes
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without POLD1 and FRY mutations?,top_cases_counts_by_genes
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the number of Lung Squamous Cell Carcinoma cases without POLD1 and GABRA6 mutations?,top_cases_counts_by_genes
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without TTC12 and MSANTD4 mutations?,top_cases_counts_by_genes
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without TTC12 and PGR mutations?,top_cases_counts_by_genes
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the number of Bladder Urothelial Carcinoma cases without CNGB1 and CTSC mutations?,top_cases_counts_by_genes
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the number of Bladder Urothelial Carcinoma cases without CNGB1 and PIK3C2A mutations?,top_cases_counts_by_genes
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without CTSC and GRM1 mutations?,top_cases_counts_by_genes
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without CTSC and RIMS2 mutations?,top_cases_counts_by_genes
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without CTSC and MED16 mutations?,top_cases_counts_by_genes
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without CTSC and DCN mutations?,top_cases_counts_by_genes
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without CTSC and PXN mutations?,top_cases_counts_by_genes
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without PRSS8 and POLR1G mutations?,top_cases_counts_by_genes
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without PRSS8 and ZMYM3 mutations?,top_cases_counts_by_genes
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without ARHGEF40 and ZNF708 mutations?,top_cases_counts_by_genes
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the number of Rectum Adenocarcinoma cases without ACTB and TASOR2 mutations?,top_cases_counts_by_genes
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the number of Rectum Adenocarcinoma cases without ACTB and MRPL55 mutations?,top_cases_counts_by_genes
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the number of Rectum Adenocarcinoma cases without ACTB and JAML mutations?,top_cases_counts_by_genes
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the number of Rectum Adenocarcinoma cases without ACTB and TRAP1 mutations?,top_cases_counts_by_genes
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the number of Glioblastoma Multiforme cases without YY1AP1 and THBS4 mutations?,top_cases_counts_by_genes
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the number of Glioblastoma Multiforme cases without YY1AP1 and DOCK2 mutations?,top_cases_counts_by_genes
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the number of Glioblastoma Multiforme cases without YY1AP1 and DNMT1 mutations?,top_cases_counts_by_genes
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the number of Glioblastoma Multiforme cases without YY1AP1 and HYOU1 mutations?,top_cases_counts_by_genes
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the number of Glioblastoma Multiforme cases without YY1AP1 and UBR2 mutations?,top_cases_counts_by_genes
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the number of Glioblastoma Multiforme cases without YY1AP1 and TAS1R3 mutations?,top_cases_counts_by_genes
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the number of Glioblastoma Multiforme cases without YY1AP1 and GPRASP1 mutations?,top_cases_counts_by_genes
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without FNDC7 and PLEKHG6 mutations?,top_cases_counts_by_genes
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without FNDC7 and CNGB1 mutations?,top_cases_counts_by_genes
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without TLCD5 and DSCAM mutations?,top_cases_counts_by_genes
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without TLCD5 and MYH11 mutations?,top_cases_counts_by_genes
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without POLR1G and GABRA6 mutations?,top_cases_counts_by_genes
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without POLR1G and DCN mutations?,top_cases_counts_by_genes
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without DNAH14 and BICC1 mutations?,top_cases_counts_by_genes
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without DNAH14 and CDKN2AIP mutations?,top_cases_counts_by_genes
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without DNAH14 and DNAH11 mutations?,top_cases_counts_by_genes
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without NEXN and ACTB mutations?,top_cases_counts_by_genes
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the number of Prostate Adenocarcinoma cases without CYB5R2 and GUCY2C mutations?,top_cases_counts_by_genes
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the number of Prostate Adenocarcinoma cases without CYB5R2 and CHMP7 mutations?,top_cases_counts_by_genes
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without NRAP and ACTB mutations?,top_cases_counts_by_genes
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without NRAP and AUTS2 mutations?,top_cases_counts_by_genes
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without NRAP and RIMS2 mutations?,top_cases_counts_by_genes
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without CCDC22 and GPC3 mutations?,top_cases_counts_by_genes
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without DCAF6 and AKT1 mutations?,top_cases_counts_by_genes
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without DCAF6 and DGKD mutations?,top_cases_counts_by_genes
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without ZNF708 and TAS1R3 mutations?,top_cases_counts_by_genes
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without BFAR and UNC5D mutations?,top_cases_counts_by_genes
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without MAST4 and CDC42BPA mutations?,top_cases_counts_by_genes
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without MAST4 and FRY mutations?,top_cases_counts_by_genes
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without MAST4 and BFAR mutations?,top_cases_counts_by_genes
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without MAST4 and PRSS1 mutations?,top_cases_counts_by_genes
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without MAST4 and ZNF708 mutations?,top_cases_counts_by_genes
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without ARMC3 and TENT5A mutations?,top_cases_counts_by_genes
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without ARMC3 and LCN15 mutations?,top_cases_counts_by_genes
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the number of Kidney Renal Clear Cell Carcinoma cases without TET2 and ACTB mutations?,top_cases_counts_by_genes
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the number of Kidney Renal Clear Cell Carcinoma cases without TET2 and PXN mutations?,top_cases_counts_by_genes
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without SERPINB10 and SYT9 mutations?,top_cases_counts_by_genes
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without STAT3 and GRTP1 mutations?,top_cases_counts_by_genes
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without MIEF1 and PTPRN2 mutations?,top_cases_counts_by_genes
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without ACVR1B and ZBTB34 mutations?,top_cases_counts_by_genes
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without ACVR1B and TTYH2 mutations?,top_cases_counts_by_genes
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without ACVR1B and CPS1 mutations?,top_cases_counts_by_genes
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without EBF2 and GRM5 mutations?,top_cases_counts_by_genes
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without EBF2 and SYT9 mutations?,top_cases_counts_by_genes
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without VPS26B and SGCZ mutations?,top_cases_counts_by_genes
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases without PGR and CCDC22 mutations?",top_cases_counts_by_genes
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases without PGR and GABRA6 mutations?",top_cases_counts_by_genes
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases without PGR and SGCZ mutations?",top_cases_counts_by_genes
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the number of Skin Cutaneous Melanoma cases without ACTA2 and CPS1 mutations?,top_cases_counts_by_genes
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without THBS4 and FRY mutations?,top_cases_counts_by_genes
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without THBS4 and MAD1L1 mutations?,top_cases_counts_by_genes
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without PRSS1 and AUTS2 mutations?,top_cases_counts_by_genes
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without PRSS1 and ZFAT mutations?,top_cases_counts_by_genes
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without PRSS1 and ANKRD24 mutations?,top_cases_counts_by_genes
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the number of Lung Adenocarcinoma cases without PRSS1 and AUTS2 mutations?,top_cases_counts_by_genes
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without PGF and USH2A mutations?,top_cases_counts_by_genes
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the number of Stomach Adenocarcinoma cases without PGF and TTYH2 mutations?,top_cases_counts_by_genes
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the number of Breast Invasive Carcinoma cases without ITPRID2 and ANKRD30A mutations?,top_cases_counts_by_genes
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the number of Breast Invasive Carcinoma cases without ITPRID2 and MYO3A mutations?,top_cases_counts_by_genes
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without HBB and FCGR2C mutations?,top_cases_counts_by_genes
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without PCDHB2 and DHX16 mutations?,top_cases_counts_by_genes
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without PCDHB2 and GRTP1 mutations?,top_cases_counts_by_genes
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the number of Colon Adenocarcinoma cases without PCDHB2 and PTPRO mutations?,top_cases_counts_by_genes
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the number of Uterine Corpus Endometrial Carcinoma cases without UBR2 and ACVR1B mutations?,top_cases_counts_by_genes
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the number of Rectum Adenocarcinoma cases without FBXO42 and SPATA22 mutations?,top_cases_counts_by_genes
+1,TNS1,G1362V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients lack mutations in MYT1 in the genomic data commons?,top_cases_counts_by_genes
+2,TNS1,G1711V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients lack mutations in GPRASP1 in the genomic data commons?,top_cases_counts_by_genes
+3,TNS1,G1718V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients lack mutations in DSCAM in the genomic data commons?,top_cases_counts_by_genes
+4,TNS1,G1732V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients lack mutations in CARMIL1 in the genomic data commons?,top_cases_counts_by_genes
+5,TNS1,G1824V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients lack mutations in DHX16 in the genomic data commons?,top_cases_counts_by_genes
+6,TNS1,G1857V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients lack mutations in ABCC2 in the genomic data commons?,top_cases_counts_by_genes
+7,TNS1,G843V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients lack mutations in AKT1 in the genomic data commons?,top_cases_counts_by_genes
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients lack mutations in UNC5D in the genomic data commons?,top_cases_counts_by_genes
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients lack mutations in C7orf31 in the genomic data commons?,top_cases_counts_by_genes
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in PIK3C2G in the genomic data commons?,top_cases_counts_by_genes
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in CTNNA2 in the genomic data commons?,top_cases_counts_by_genes
+22,TRPA1,S295I,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients lack mutations in TENM2 in the genomic data commons?,top_cases_counts_by_genes
+23,TRPA1,S443I,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients lack mutations in ZFP42 in the genomic data commons?,top_cases_counts_by_genes
+24,TAF1C,R299L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in FBXO15 in the genomic data commons?,top_cases_counts_by_genes
+25,TAF1C,R396L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in THBS4 in the genomic data commons?,top_cases_counts_by_genes
+26,TAF1C,R634L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in YY1AP1 in the genomic data commons?,top_cases_counts_by_genes
+27,TAF1C,R702L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in RIPOR2 in the genomic data commons?,top_cases_counts_by_genes
+28,TAF1C,R728L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in GUK1 in the genomic data commons?,top_cases_counts_by_genes
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in PTPRO in the genomic data commons?,top_cases_counts_by_genes
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in NCKAP5 in the genomic data commons?,top_cases_counts_by_genes
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in ZFAT in the genomic data commons?,top_cases_counts_by_genes
+42,OR2T4,P272H,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in CPS1 in the genomic data commons?,top_cases_counts_by_genes
+43,OR2T4,P300H,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in CTSC in the genomic data commons?,top_cases_counts_by_genes
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma patients lack mutations in NOMO1 in the genomic data commons?,top_cases_counts_by_genes
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma patients lack mutations in ZMYM3 in the genomic data commons?,top_cases_counts_by_genes
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma patients lack mutations in SPTAN1 in the genomic data commons?,top_cases_counts_by_genes
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma patients lack mutations in TMEM255A in the genomic data commons?,top_cases_counts_by_genes
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in STK19 in the genomic data commons?,top_cases_counts_by_genes
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma patients lack mutations in REXO4 in the genomic data commons?,top_cases_counts_by_genes
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma patients lack mutations in MRPL55 in the genomic data commons?,top_cases_counts_by_genes
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma patients lack mutations in PIK3C2B in the genomic data commons?,top_cases_counts_by_genes
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma patients lack mutations in EIF2B4 in the genomic data commons?,top_cases_counts_by_genes
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients lack mutations in PAK3 in the genomic data commons?,top_cases_counts_by_genes
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients lack mutations in TENT5A in the genomic data commons?,top_cases_counts_by_genes
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients lack mutations in GABRA6 in the genomic data commons?,top_cases_counts_by_genes
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients lack mutations in UNC5D in the genomic data commons?,top_cases_counts_by_genes
+70,PAK3,E318K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in FCGR2C in the genomic data commons?,top_cases_counts_by_genes
+71,PAK3,E319K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in CHMP7 in the genomic data commons?,top_cases_counts_by_genes
+72,PAK3,E334K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in DNAH14 in the genomic data commons?,top_cases_counts_by_genes
+73,PAK3,E340K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in SPTAN1 in the genomic data commons?,top_cases_counts_by_genes
+74,PAK3,E355K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in SLC9C1 in the genomic data commons?,top_cases_counts_by_genes
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in TYK2 in the genomic data commons?,top_cases_counts_by_genes
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients lack mutations in EFCAB12 in the genomic data commons?,top_cases_counts_by_genes
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients lack mutations in MAST4 in the genomic data commons?,top_cases_counts_by_genes
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients lack mutations in ZCCHC14 in the genomic data commons?,top_cases_counts_by_genes
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients lack mutations in TLCD5 in the genomic data commons?,top_cases_counts_by_genes
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in JAML in the genomic data commons?,top_cases_counts_by_genes
+116,RELN,A2371V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in MORF4L1 in the genomic data commons?,top_cases_counts_by_genes
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients lack mutations in PXN in the genomic data commons?",top_cases_counts_by_genes
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients lack mutations in PTPRO in the genomic data commons?",top_cases_counts_by_genes
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in GPC3 in the genomic data commons?,top_cases_counts_by_genes
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients lack mutations in GUK1 in the genomic data commons?,top_cases_counts_by_genes
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients lack mutations in TAF1C in the genomic data commons?,top_cases_counts_by_genes
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients lack mutations in GUK1 in the genomic data commons?,top_cases_counts_by_genes
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in OR2A12 in the genomic data commons?,top_cases_counts_by_genes
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in AUTS2 in the genomic data commons?,top_cases_counts_by_genes
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in NRAP in the genomic data commons?,top_cases_counts_by_genes
+129,ABCC3,R758W,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in CTNNA2 in the genomic data commons?,top_cases_counts_by_genes
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in GRTP1 in the genomic data commons?,top_cases_counts_by_genes
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in CTNNA2 in the genomic data commons?,top_cases_counts_by_genes
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients lack mutations in OR8K5 in the genomic data commons?,top_cases_counts_by_genes
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in DOCK2 in the genomic data commons?,top_cases_counts_by_genes
+140,BICC1,A372V,Exceptional Responders,How many Exceptional Responders patients lack mutations in CYP1A2 in the genomic data commons?,top_cases_counts_by_genes
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in POLR1G in the genomic data commons?,top_cases_counts_by_genes
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in OLFML3 in the genomic data commons?,top_cases_counts_by_genes
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in PIK3C2B in the genomic data commons?,top_cases_counts_by_genes
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients lack mutations in SGIP1 in the genomic data commons?",top_cases_counts_by_genes
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients lack mutations in TNS1 in the genomic data commons?,top_cases_counts_by_genes
+157,OR8K5,R293G,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in OR2A12 in the genomic data commons?,top_cases_counts_by_genes
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in CYB5R2 in the genomic data commons?,top_cases_counts_by_genes
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in GSTCD in the genomic data commons?,top_cases_counts_by_genes
+164,SYT10,M484I,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients lack mutations in TRAP1 in the genomic data commons?,top_cases_counts_by_genes
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in DNAH11 in the genomic data commons?,top_cases_counts_by_genes
+175,UNC5D,L280V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in PTPRN2 in the genomic data commons?,top_cases_counts_by_genes
+176,UNC5D,L635V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in MORF4L1 in the genomic data commons?,top_cases_counts_by_genes
+177,UNC5D,L637V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in SYNJ1 in the genomic data commons?,top_cases_counts_by_genes
+178,UNC5D,L699V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in POLD1 in the genomic data commons?,top_cases_counts_by_genes
+179,UNC5D,L704V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in EIF2B4 in the genomic data commons?,top_cases_counts_by_genes
+180,UNC5D,L709V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in KDM5C in the genomic data commons?,top_cases_counts_by_genes
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How many Kidney Renal Clear Cell Carcinoma patients lack mutations in PTPRN2 in the genomic data commons?,top_cases_counts_by_genes
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How many Kidney Renal Clear Cell Carcinoma patients lack mutations in TENT5A in the genomic data commons?,top_cases_counts_by_genes
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in AQP7 in the genomic data commons?,top_cases_counts_by_genes
+193,MRPL55,H27Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in DCAF6 in the genomic data commons?,top_cases_counts_by_genes
+194,MRPL55,H63Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in ACTB in the genomic data commons?,top_cases_counts_by_genes
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients lack mutations in CCNG1 in the genomic data commons?,top_cases_counts_by_genes
+198,EPRS1,K771I,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in MAST4 in the genomic data commons?,top_cases_counts_by_genes
+199,EPRS1,K778I,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in PAK3 in the genomic data commons?,top_cases_counts_by_genes
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in DCC in the genomic data commons?,top_cases_counts_by_genes
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in THBS4 in the genomic data commons?,top_cases_counts_by_genes
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in TASOR2 in the genomic data commons?,top_cases_counts_by_genes
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How many HIV+ Tumor Molecular Characterization Project - Cervical Cancer patients lack mutations in CTSC in the genomic data commons?,top_cases_counts_by_genes
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in SYNJ1 in the genomic data commons?,top_cases_counts_by_genes
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in CX3CR1 in the genomic data commons?,top_cases_counts_by_genes
+251,ZNF274,P13R,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in TSHZ3 in the genomic data commons?,top_cases_counts_by_genes
+253,SYNJ1,R795C,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in AUTS2 in the genomic data commons?,top_cases_counts_by_genes
+254,SYNJ1,R800C,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in SYT9 in the genomic data commons?,top_cases_counts_by_genes
+255,SYNJ1,R839C,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in AUTS2 in the genomic data commons?,top_cases_counts_by_genes
+261,DSCAM,V343M,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma patients lack mutations in CTSC in the genomic data commons?,top_cases_counts_by_genes
+262,DSCAM,V426M,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma patients lack mutations in MYO16 in the genomic data commons?,top_cases_counts_by_genes
+263,DSCAM,V591M,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma patients lack mutations in TTC12 in the genomic data commons?,top_cases_counts_by_genes
+267,DGKD,R140H,Exceptional Responders,How many Exceptional Responders patients lack mutations in TTC12 in the genomic data commons?,top_cases_counts_by_genes
+268,DGKD,R160H,Exceptional Responders,How many Exceptional Responders patients lack mutations in MORF4L1 in the genomic data commons?,top_cases_counts_by_genes
+269,DGKD,R204H,Exceptional Responders,How many Exceptional Responders patients lack mutations in FBXO42 in the genomic data commons?,top_cases_counts_by_genes
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients lack mutations in JAML in the genomic data commons?,top_cases_counts_by_genes
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients lack mutations in ZCCHC14 in the genomic data commons?,top_cases_counts_by_genes
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients lack mutations in RIPOR2 in the genomic data commons?,top_cases_counts_by_genes
+279,WNT2,D138N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in TLCD5 in the genomic data commons?,top_cases_counts_by_genes
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in ANKDD1A in the genomic data commons?,top_cases_counts_by_genes
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in OR2T4 in the genomic data commons?,top_cases_counts_by_genes
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients lack mutations in FBXO15 in the genomic data commons?",top_cases_counts_by_genes
+299,OR5D14,M210L,Neuroblastoma,How many Neuroblastoma patients lack mutations in PTPRN2 in the genomic data commons?,top_cases_counts_by_genes
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in EPRS1 in the genomic data commons?,top_cases_counts_by_genes
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in KIF20B in the genomic data commons?,top_cases_counts_by_genes
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in OR5D14 in the genomic data commons?,top_cases_counts_by_genes
+310,LCN15,E21V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in PCDHB2 in the genomic data commons?,top_cases_counts_by_genes
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in TYK2 in the genomic data commons?,top_cases_counts_by_genes
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in AQP7 in the genomic data commons?,top_cases_counts_by_genes
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in TASOR2 in the genomic data commons?,top_cases_counts_by_genes
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in MRPL55 in the genomic data commons?,top_cases_counts_by_genes
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in JAML in the genomic data commons?,top_cases_counts_by_genes
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in SERPINB10 in the genomic data commons?,top_cases_counts_by_genes
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in KL in the genomic data commons?,top_cases_counts_by_genes
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in PTPRN2 in the genomic data commons?,top_cases_counts_by_genes
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in SGIP1 in the genomic data commons?,top_cases_counts_by_genes
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in MAD1L1 in the genomic data commons?,top_cases_counts_by_genes
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in ACVR1B in the genomic data commons?,top_cases_counts_by_genes
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in TENT5A in the genomic data commons?,top_cases_counts_by_genes
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in CARMIL1 in the genomic data commons?,top_cases_counts_by_genes
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in TNS1 in the genomic data commons?,top_cases_counts_by_genes
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in ARMC3 in the genomic data commons?,top_cases_counts_by_genes
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How many Ovarian Serous Cystadenocarcinoma patients lack mutations in CDKN2AIP in the genomic data commons?,top_cases_counts_by_genes
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How many Ovarian Serous Cystadenocarcinoma patients lack mutations in FGF8 in the genomic data commons?,top_cases_counts_by_genes
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How many Ovarian Serous Cystadenocarcinoma patients lack mutations in PSG2 in the genomic data commons?,top_cases_counts_by_genes
+357,ZNF584,A211T,Sarcoma,How many Sarcoma patients lack mutations in KRT39 in the genomic data commons?,top_cases_counts_by_genes
+358,ZNF584,A256T,Sarcoma,How many Sarcoma patients lack mutations in PIK3C2G in the genomic data commons?,top_cases_counts_by_genes
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in PRSS8 in the genomic data commons?,top_cases_counts_by_genes
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in AUTS2 in the genomic data commons?,top_cases_counts_by_genes
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in TLK2 in the genomic data commons?,top_cases_counts_by_genes
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in EPRS1 in the genomic data commons?,top_cases_counts_by_genes
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in TENM2 in the genomic data commons?,top_cases_counts_by_genes
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in AUTS2 in the genomic data commons?,top_cases_counts_by_genes
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in LDOC1 in the genomic data commons?,top_cases_counts_by_genes
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in TYK2 in the genomic data commons?,top_cases_counts_by_genes
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in HTR3B in the genomic data commons?,top_cases_counts_by_genes
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in PRSS1 in the genomic data commons?,top_cases_counts_by_genes
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in POLD1 in the genomic data commons?,top_cases_counts_by_genes
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients lack mutations in TRAP1 in the genomic data commons?,top_cases_counts_by_genes
+406,POC1B,I198T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients lack mutations in PAK3 in the genomic data commons?,top_cases_counts_by_genes
+407,POC1B,I286T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients lack mutations in PRSS1 in the genomic data commons?,top_cases_counts_by_genes
+408,POC1B,I328T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients lack mutations in ZBTB34 in the genomic data commons?,top_cases_counts_by_genes
+409,POC1B,S79P,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients lack mutations in ZNF431 in the genomic data commons?,top_cases_counts_by_genes
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients lack mutations in RIPOR2 in the genomic data commons?,top_cases_counts_by_genes
+414,AQP7,T110S,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients lack mutations in RIPOR2 in the genomic data commons?,top_cases_counts_by_genes
+415,AQP7,T166S,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients lack mutations in SGCZ in the genomic data commons?,top_cases_counts_by_genes
+416,AQP7,T167S,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients lack mutations in PLEKHG6 in the genomic data commons?,top_cases_counts_by_genes
+417,AQP7,T75S,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients lack mutations in AUTS2 in the genomic data commons?,top_cases_counts_by_genes
+430,DCN,R163C,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients lack mutations in CCNG1 in the genomic data commons?,top_cases_counts_by_genes
+431,DCN,R203C,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients lack mutations in CA9 in the genomic data commons?,top_cases_counts_by_genes
+432,DCN,R241C,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients lack mutations in CTSC in the genomic data commons?,top_cases_counts_by_genes
+433,DCN,R350C,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients lack mutations in JAML in the genomic data commons?,top_cases_counts_by_genes
+434,DCN,R41C,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients lack mutations in TENT5A in the genomic data commons?,top_cases_counts_by_genes
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in MED16 in the genomic data commons?,top_cases_counts_by_genes
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in EIF2B4 in the genomic data commons?,top_cases_counts_by_genes
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in PTPRO in the genomic data commons?,top_cases_counts_by_genes
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma patients lack mutations in RIMS2 in the genomic data commons?,top_cases_counts_by_genes
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma patients lack mutations in TNS1 in the genomic data commons?,top_cases_counts_by_genes
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in DNMT1 in the genomic data commons?,top_cases_counts_by_genes
+482,SGCZ,Q138H,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in ZSCAN31 in the genomic data commons?,top_cases_counts_by_genes
+483,SGCZ,Q91H,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in YY1AP1 in the genomic data commons?,top_cases_counts_by_genes
+485,SMO,V15M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in PTPRN2 in the genomic data commons?,top_cases_counts_by_genes
+486,SMO,V321M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in CEP20 in the genomic data commons?,top_cases_counts_by_genes
+488,CHODL,G159E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in CPA6 in the genomic data commons?,top_cases_counts_by_genes
+489,CHODL,G181E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in DNMT1 in the genomic data commons?,top_cases_counts_by_genes
+490,CHODL,G200E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in ACVR1B in the genomic data commons?,top_cases_counts_by_genes
+494,MYO16,P399H,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in TAF1C in the genomic data commons?,top_cases_counts_by_genes
+495,MYO16,P421H,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in DNAH11 in the genomic data commons?,top_cases_counts_by_genes
+498,CXCR2,A98V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in ANKDD1A in the genomic data commons?,top_cases_counts_by_genes
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients lack mutations in SORCS1 in the genomic data commons?,top_cases_counts_by_genes
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in SORCS1 in the genomic data commons?,top_cases_counts_by_genes
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in MAST4 in the genomic data commons?,top_cases_counts_by_genes
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in TLK2 in the genomic data commons?,top_cases_counts_by_genes
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in TAF1C in the genomic data commons?,top_cases_counts_by_genes
+510,RAB40C,A111V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in PYHIN1 in the genomic data commons?,top_cases_counts_by_genes
+511,RAB40C,A143V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in DPF3 in the genomic data commons?,top_cases_counts_by_genes
+512,CTNNA2,S323R,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in CTCFL in the genomic data commons?,top_cases_counts_by_genes
+513,CTNNA2,S339R,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in ZNF708 in the genomic data commons?,top_cases_counts_by_genes
+514,CTNNA2,S386R,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in ICE1 in the genomic data commons?,top_cases_counts_by_genes
+515,CTNNA2,S707R,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in TNS1 in the genomic data commons?,top_cases_counts_by_genes
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients lack mutations in CTNNA2 in the genomic data commons?,top_cases_counts_by_genes
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in JAML in the genomic data commons?,top_cases_counts_by_genes
+532,KIF20B,N1160D,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients lack mutations in TENT5A in the genomic data commons?,top_cases_counts_by_genes
+533,KIF20B,N1200D,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients lack mutations in RIPOR2 in the genomic data commons?,top_cases_counts_by_genes
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in CX3CR1 in the genomic data commons?,top_cases_counts_by_genes
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in CFAP61 in the genomic data commons?,top_cases_counts_by_genes
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in RIMS2 in the genomic data commons?,top_cases_counts_by_genes
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in AQP7 in the genomic data commons?,top_cases_counts_by_genes
+540,ERCC6,R1053H,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in PYHIN1 in the genomic data commons?,top_cases_counts_by_genes
+541,DCC,R320W,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients lack mutations in YY1AP1 in the genomic data commons?,top_cases_counts_by_genes
+542,DCC,R363W,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients lack mutations in TNS1 in the genomic data commons?,top_cases_counts_by_genes
+543,DCC,R386W,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients lack mutations in RIMS2 in the genomic data commons?,top_cases_counts_by_genes
+544,DCC,R41W,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients lack mutations in SOX21 in the genomic data commons?,top_cases_counts_by_genes
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in PTPRO in the genomic data commons?,top_cases_counts_by_genes
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in TTN in the genomic data commons?,top_cases_counts_by_genes
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in CTNNA2 in the genomic data commons?,top_cases_counts_by_genes
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in RIMS2 in the genomic data commons?,top_cases_counts_by_genes
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in PCDHB2 in the genomic data commons?,top_cases_counts_by_genes
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in RIMS2 in the genomic data commons?,top_cases_counts_by_genes
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in AQP7 in the genomic data commons?,top_cases_counts_by_genes
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How many Ovarian Serous Cystadenocarcinoma patients lack mutations in ADAM17 in the genomic data commons?,top_cases_counts_by_genes
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How many Ovarian Serous Cystadenocarcinoma patients lack mutations in UNC5D in the genomic data commons?,top_cases_counts_by_genes
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients lack mutations in FRY in the genomic data commons?,top_cases_counts_by_genes
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in CTCFL in the genomic data commons?,top_cases_counts_by_genes
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in SYNJ1 in the genomic data commons?,top_cases_counts_by_genes
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in MIEF1 in the genomic data commons?,top_cases_counts_by_genes
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in SIK2 in the genomic data commons?,top_cases_counts_by_genes
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in ART3 in the genomic data commons?,top_cases_counts_by_genes
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in GABRA6 in the genomic data commons?,top_cases_counts_by_genes
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in DPF3 in the genomic data commons?,top_cases_counts_by_genes
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in ZMYM3 in the genomic data commons?,top_cases_counts_by_genes
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in CX3CR1 in the genomic data commons?,top_cases_counts_by_genes
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in ZBTB34 in the genomic data commons?,top_cases_counts_by_genes
+625,SIK2,I265M,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in PCDHB2 in the genomic data commons?,top_cases_counts_by_genes
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in RIPOR2 in the genomic data commons?,top_cases_counts_by_genes
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in TTC12 in the genomic data commons?,top_cases_counts_by_genes
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in DCC in the genomic data commons?,top_cases_counts_by_genes
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in PTPRN2 in the genomic data commons?,top_cases_counts_by_genes
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in ZSCAN31 in the genomic data commons?,top_cases_counts_by_genes
+644,OR2A12,A254T,Brain Lower Grade Glioma,How many Brain Lower Grade Glioma patients lack mutations in PTPRO in the genomic data commons?,top_cases_counts_by_genes
+646,PYHIN1,T325K,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in VPS26B in the genomic data commons?,top_cases_counts_by_genes
+647,PYHIN1,T334K,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in OR2A12 in the genomic data commons?,top_cases_counts_by_genes
+650,JAML,G191E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in ZMYM3 in the genomic data commons?,top_cases_counts_by_genes
+651,JAML,G219E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in ZNF708 in the genomic data commons?,top_cases_counts_by_genes
+652,JAML,G220E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in ANKRD30A in the genomic data commons?,top_cases_counts_by_genes
+653,JAML,G230E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in SPTAN1 in the genomic data commons?,top_cases_counts_by_genes
+658,TYK2,H1146R,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in COL6A3 in the genomic data commons?,top_cases_counts_by_genes
+659,TYK2,H23R,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in AUTS2 in the genomic data commons?,top_cases_counts_by_genes
+660,TYK2,H961R,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in EIF2B4 in the genomic data commons?,top_cases_counts_by_genes
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in ANKDD1A in the genomic data commons?,top_cases_counts_by_genes
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in KDM5C in the genomic data commons?,top_cases_counts_by_genes
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in DCAF4L2 in the genomic data commons?,top_cases_counts_by_genes
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in AQP7 in the genomic data commons?,top_cases_counts_by_genes
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in MORF4L1 in the genomic data commons?,top_cases_counts_by_genes
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in DCC in the genomic data commons?,top_cases_counts_by_genes
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in NOMO1 in the genomic data commons?,top_cases_counts_by_genes
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in PRSS8 in the genomic data commons?,top_cases_counts_by_genes
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in TLK2 in the genomic data commons?,top_cases_counts_by_genes
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in ARMC3 in the genomic data commons?,top_cases_counts_by_genes
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in ZCCHC14 in the genomic data commons?,top_cases_counts_by_genes
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in TASOR2 in the genomic data commons?,top_cases_counts_by_genes
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in CNGB1 in the genomic data commons?,top_cases_counts_by_genes
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in EVC2 in the genomic data commons?,top_cases_counts_by_genes
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in KDM5C in the genomic data commons?,top_cases_counts_by_genes
+728,STK19,D341N,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in DCAF6 in the genomic data commons?,top_cases_counts_by_genes
+729,STK19,D345N,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in YY1AP1 in the genomic data commons?,top_cases_counts_by_genes
+730,REXO4,P60A,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in PIK3C2B in the genomic data commons?,top_cases_counts_by_genes
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in TAF1C in the genomic data commons?,top_cases_counts_by_genes
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in PGR in the genomic data commons?,top_cases_counts_by_genes
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients lack mutations in FRY in the genomic data commons?,top_cases_counts_by_genes
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients lack mutations in TSHZ3 in the genomic data commons?",top_cases_counts_by_genes
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients lack mutations in TENM2 in the genomic data commons?",top_cases_counts_by_genes
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients lack mutations in DPF3 in the genomic data commons?",top_cases_counts_by_genes
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients lack mutations in GLRB in the genomic data commons?",top_cases_counts_by_genes
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How many Head and Neck Squamous Cell Carcinoma patients lack mutations in BCAT1 in the genomic data commons?,top_cases_counts_by_genes
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How many Head and Neck Squamous Cell Carcinoma patients lack mutations in FNDC7 in the genomic data commons?,top_cases_counts_by_genes
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How many Head and Neck Squamous Cell Carcinoma patients lack mutations in PGF in the genomic data commons?,top_cases_counts_by_genes
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How many Head and Neck Squamous Cell Carcinoma patients lack mutations in RAB40C in the genomic data commons?,top_cases_counts_by_genes
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How many Head and Neck Squamous Cell Carcinoma patients lack mutations in AUTS2 in the genomic data commons?,top_cases_counts_by_genes
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How many Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia patients lack mutations in FGF8 in the genomic data commons?,top_cases_counts_by_genes
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in DSCAM in the genomic data commons?,top_cases_counts_by_genes
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients lack mutations in FRY in the genomic data commons?,top_cases_counts_by_genes
+792,GLRB,E148D,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in DGKD in the genomic data commons?,top_cases_counts_by_genes
+793,TTN,F7636L,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in ANP32E in the genomic data commons?,top_cases_counts_by_genes
+794,TTN,F8563L,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in MYO16 in the genomic data commons?,top_cases_counts_by_genes
+795,TTN,F8880L,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in HLA-DQA2 in the genomic data commons?,top_cases_counts_by_genes
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in ZNF431 in the genomic data commons?,top_cases_counts_by_genes
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in TENM2 in the genomic data commons?,top_cases_counts_by_genes
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in MED16 in the genomic data commons?,top_cases_counts_by_genes
+809,TRIM45,S177L,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in NPSR1 in the genomic data commons?,top_cases_counts_by_genes
+810,TRIM45,S224L,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in ZCCHC14 in the genomic data commons?,top_cases_counts_by_genes
+811,TRIM45,S281L,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in IL5RA in the genomic data commons?,top_cases_counts_by_genes
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in TENT5A in the genomic data commons?,top_cases_counts_by_genes
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in PXN in the genomic data commons?,top_cases_counts_by_genes
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in PIK3C2G in the genomic data commons?,top_cases_counts_by_genes
+817,KL,R594C,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in GPC3 in the genomic data commons?,top_cases_counts_by_genes
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma patients lack mutations in PCDHGA1 in the genomic data commons?,top_cases_counts_by_genes
+822,TAF1L,A539V,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in PTPRO in the genomic data commons?,top_cases_counts_by_genes
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in RAB40C in the genomic data commons?,top_cases_counts_by_genes
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in PGR in the genomic data commons?,top_cases_counts_by_genes
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in PRSS1 in the genomic data commons?,top_cases_counts_by_genes
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in DNAH11 in the genomic data commons?,top_cases_counts_by_genes
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in CTNNA2 in the genomic data commons?,top_cases_counts_by_genes
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in CR1 in the genomic data commons?,top_cases_counts_by_genes
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in EFCAB12 in the genomic data commons?,top_cases_counts_by_genes
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients lack mutations in PSG2 in the genomic data commons?,top_cases_counts_by_genes
+843,DHX16,A29V,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in POC1B in the genomic data commons?,top_cases_counts_by_genes
+844,DHX16,A89V,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in TNS1 in the genomic data commons?,top_cases_counts_by_genes
+902,GPR158,A644V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in DPF3 in the genomic data commons?,top_cases_counts_by_genes
+903,GPR158,A723V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in CDH23 in the genomic data commons?,top_cases_counts_by_genes
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients lack mutations in MYO15A in the genomic data commons?",top_cases_counts_by_genes
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients lack mutations in TRIM45 in the genomic data commons?",top_cases_counts_by_genes
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients lack mutations in PIK3C2B in the genomic data commons?",top_cases_counts_by_genes
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients lack mutations in DEFB115 in the genomic data commons?",top_cases_counts_by_genes
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients lack mutations in ACVR1B in the genomic data commons?",top_cases_counts_by_genes
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients lack mutations in FGF8 in the genomic data commons?",top_cases_counts_by_genes
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in TRPA1 in the genomic data commons?,top_cases_counts_by_genes
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in POLR1G in the genomic data commons?,top_cases_counts_by_genes
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in ANKDD1A in the genomic data commons?,top_cases_counts_by_genes
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in TASOR2 in the genomic data commons?,top_cases_counts_by_genes
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in TNS1 in the genomic data commons?,top_cases_counts_by_genes
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in TNS1 in the genomic data commons?,top_cases_counts_by_genes
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in GABRA6 in the genomic data commons?,top_cases_counts_by_genes
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in ANKDD1A in the genomic data commons?,top_cases_counts_by_genes
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in ITPRID2 in the genomic data commons?,top_cases_counts_by_genes
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in TET2 in the genomic data commons?,top_cases_counts_by_genes
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients lack mutations in CPS1 in the genomic data commons?",top_cases_counts_by_genes
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients lack mutations in CACNA1F in the genomic data commons?,top_cases_counts_by_genes
+954,TRAP1,R114W,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in MYO16 in the genomic data commons?,top_cases_counts_by_genes
+955,TRAP1,R61W,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in CDC42BPA in the genomic data commons?,top_cases_counts_by_genes
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in TAF1C in the genomic data commons?,top_cases_counts_by_genes
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients lack mutations in ANKRD52 in the genomic data commons?,top_cases_counts_by_genes
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in DCLK3 in the genomic data commons?,top_cases_counts_by_genes
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in PXN in the genomic data commons?,top_cases_counts_by_genes
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients lack mutations in RIMS2 in the genomic data commons?,top_cases_counts_by_genes
+982,GABRA6,G115R,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in MYH11 in the genomic data commons?,top_cases_counts_by_genes
+983,GABRA6,G122R,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in PIAS3 in the genomic data commons?,top_cases_counts_by_genes
+984,GABRA6,G165R,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in MAST4 in the genomic data commons?,top_cases_counts_by_genes
+985,GABRA6,G175R,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in POC1B in the genomic data commons?,top_cases_counts_by_genes
+986,GABRA6,G70R,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in COL6A3 in the genomic data commons?,top_cases_counts_by_genes
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in PIK3C2B in the genomic data commons?,top_cases_counts_by_genes
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients lack mutations in PRSS8 in the genomic data commons?",top_cases_counts_by_genes
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients lack mutations in FCGR2C in the genomic data commons?",top_cases_counts_by_genes
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma patients lack mutations in TLK2 in the genomic data commons?,top_cases_counts_by_genes
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma patients lack mutations in FBXO15 in the genomic data commons?,top_cases_counts_by_genes
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma patients lack mutations in HBB in the genomic data commons?,top_cases_counts_by_genes
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma patients lack mutations in TAS1R3 in the genomic data commons?,top_cases_counts_by_genes
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma patients lack mutations in CFAP61 in the genomic data commons?,top_cases_counts_by_genes
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma patients lack mutations in HSPA5 in the genomic data commons?,top_cases_counts_by_genes
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma patients lack mutations in POC1B in the genomic data commons?,top_cases_counts_by_genes
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma patients lack mutations in TTC17 in the genomic data commons?,top_cases_counts_by_genes
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in PXN in the genomic data commons?,top_cases_counts_by_genes
+1017,GPC3,I107N,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in SGIP1 in the genomic data commons?,top_cases_counts_by_genes
+1018,GPC3,I161N,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in SORCS1 in the genomic data commons?,top_cases_counts_by_genes
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients lack mutations in COL6A3 in the genomic data commons?,top_cases_counts_by_genes
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients lack mutations in EIF2B4 in the genomic data commons?,top_cases_counts_by_genes
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients lack mutations in SPAG1 in the genomic data commons?,top_cases_counts_by_genes
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients lack mutations in CA9 in the genomic data commons?,top_cases_counts_by_genes
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients lack mutations in AUTS2 in the genomic data commons?,top_cases_counts_by_genes
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in HLA-DQA2 in the genomic data commons?,top_cases_counts_by_genes
+1038,SYT9,V275L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in PKHD1L1 in the genomic data commons?,top_cases_counts_by_genes
+1039,SYT9,V307L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in CNGB1 in the genomic data commons?,top_cases_counts_by_genes
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in MYH11 in the genomic data commons?,top_cases_counts_by_genes
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in EPRS1 in the genomic data commons?,top_cases_counts_by_genes
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients lack mutations in ZFPM2 in the genomic data commons?",top_cases_counts_by_genes
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in DSCAM in the genomic data commons?,top_cases_counts_by_genes
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in RIMS2 in the genomic data commons?,top_cases_counts_by_genes
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in DCN in the genomic data commons?,top_cases_counts_by_genes
+1056,CA9,E402K,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in PTPRN2 in the genomic data commons?,top_cases_counts_by_genes
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in NEXN in the genomic data commons?,top_cases_counts_by_genes
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in ZNF804A in the genomic data commons?,top_cases_counts_by_genes
+1065,PSG2,P43L,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients lack mutations in TRIM45 in the genomic data commons?,top_cases_counts_by_genes
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients lack mutations in SORCS1 in the genomic data commons?,top_cases_counts_by_genes
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients lack mutations in PTPRN2 in the genomic data commons?,top_cases_counts_by_genes
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients lack mutations in ANKRD24 in the genomic data commons?,top_cases_counts_by_genes
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients lack mutations in MAD1L1 in the genomic data commons?,top_cases_counts_by_genes
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in TLK2 in the genomic data commons?,top_cases_counts_by_genes
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in DPF3 in the genomic data commons?,top_cases_counts_by_genes
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in TLK2 in the genomic data commons?,top_cases_counts_by_genes
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in RIMS2 in the genomic data commons?,top_cases_counts_by_genes
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in TAF1C in the genomic data commons?,top_cases_counts_by_genes
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in TTN in the genomic data commons?,top_cases_counts_by_genes
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in ANKDD1A in the genomic data commons?,top_cases_counts_by_genes
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in SORCS1 in the genomic data commons?,top_cases_counts_by_genes
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in MYH11 in the genomic data commons?,top_cases_counts_by_genes
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in FGF8 in the genomic data commons?,top_cases_counts_by_genes
+1093,PXN,H1016Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in PTPRO in the genomic data commons?,top_cases_counts_by_genes
+1094,PXN,H359Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in DNAH11 in the genomic data commons?,top_cases_counts_by_genes
+1095,PXN,H492Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in ZMYM3 in the genomic data commons?,top_cases_counts_by_genes
+1096,PXN,H524Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in CXCR2 in the genomic data commons?,top_cases_counts_by_genes
+1097,PXN,H526Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in GPR158 in the genomic data commons?,top_cases_counts_by_genes
+1098,PXN,H540Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in ACTB in the genomic data commons?,top_cases_counts_by_genes
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in IL5RA in the genomic data commons?,top_cases_counts_by_genes
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in MYO3B in the genomic data commons?,top_cases_counts_by_genes
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in AUTS2 in the genomic data commons?,top_cases_counts_by_genes
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in YY1AP1 in the genomic data commons?,top_cases_counts_by_genes
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in ZBTB34 in the genomic data commons?,top_cases_counts_by_genes
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients lack mutations in TENM3 in the genomic data commons?,top_cases_counts_by_genes
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients lack mutations in KDM5C in the genomic data commons?,top_cases_counts_by_genes
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in TYK2 in the genomic data commons?,top_cases_counts_by_genes
+1112,MYT1,A558E,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients lack mutations in TMTC3 in the genomic data commons?,top_cases_counts_by_genes
+1113,MYT1,A879E,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients lack mutations in CFAP61 in the genomic data commons?,top_cases_counts_by_genes
+1114,MYT1,A906E,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients lack mutations in PIK3C2B in the genomic data commons?,top_cases_counts_by_genes
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in YY1AP1 in the genomic data commons?,top_cases_counts_by_genes
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in KIF20B in the genomic data commons?,top_cases_counts_by_genes
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients lack mutations in EBF2 in the genomic data commons?,top_cases_counts_by_genes
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in FNDC7 in the genomic data commons?,top_cases_counts_by_genes
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in RIMS2 in the genomic data commons?,top_cases_counts_by_genes
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients lack mutations in SORCS1 in the genomic data commons?,top_cases_counts_by_genes
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients lack mutations in SYT9 in the genomic data commons?",top_cases_counts_by_genes
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in CTNNA2 in the genomic data commons?,top_cases_counts_by_genes
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in AUTS2 in the genomic data commons?,top_cases_counts_by_genes
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in FGF8 in the genomic data commons?,top_cases_counts_by_genes
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in MAST4 in the genomic data commons?,top_cases_counts_by_genes
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in SYNJ1 in the genomic data commons?,top_cases_counts_by_genes
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients lack mutations in COL6A3 in the genomic data commons?,top_cases_counts_by_genes
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients lack mutations in CEP20 in the genomic data commons?,top_cases_counts_by_genes
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients lack mutations in SGIP1 in the genomic data commons?,top_cases_counts_by_genes
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients lack mutations in TTYH2 in the genomic data commons?,top_cases_counts_by_genes
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma patients lack mutations in GRM5 in the genomic data commons?,top_cases_counts_by_genes
+1188,SOX21,R55L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in SPAG1 in the genomic data commons?,top_cases_counts_by_genes
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients lack mutations in SORCS1 in the genomic data commons?,top_cases_counts_by_genes
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in PTPRN2 in the genomic data commons?,top_cases_counts_by_genes
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients lack mutations in POC1B in the genomic data commons?",top_cases_counts_by_genes
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in ZCCHC14 in the genomic data commons?,top_cases_counts_by_genes
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in FCGR2C in the genomic data commons?,top_cases_counts_by_genes
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in NOMO1 in the genomic data commons?,top_cases_counts_by_genes
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in MAD1L1 in the genomic data commons?,top_cases_counts_by_genes
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in DNAH14 in the genomic data commons?,top_cases_counts_by_genes
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in EBF2 in the genomic data commons?,top_cases_counts_by_genes
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in RIMS2 in the genomic data commons?,top_cases_counts_by_genes
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in CARMIL1 in the genomic data commons?,top_cases_counts_by_genes
+1234,ZNF431,R128I,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in TAF1C in the genomic data commons?,top_cases_counts_by_genes
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in KDM5C in the genomic data commons?,top_cases_counts_by_genes
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in AUTS2 in the genomic data commons?,top_cases_counts_by_genes
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in PXN in the genomic data commons?,top_cases_counts_by_genes
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma patients lack mutations in AUTS2 in the genomic data commons?,top_cases_counts_by_genes
+1248,TTC12,D646H,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in CPA6 in the genomic data commons?,top_cases_counts_by_genes
+1249,TTC12,D652H,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in UNC5D in the genomic data commons?,top_cases_counts_by_genes
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients lack mutations in SIK2 in the genomic data commons?,top_cases_counts_by_genes
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma patients lack mutations in ZBTB34 in the genomic data commons?,top_cases_counts_by_genes
+1254,CTSC,E214V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in TYK2 in the genomic data commons?,top_cases_counts_by_genes
+1255,CTSC,E291V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in FBXO15 in the genomic data commons?,top_cases_counts_by_genes
+1256,CTSC,E322V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in ANKRD24 in the genomic data commons?,top_cases_counts_by_genes
+1257,CTSC,E324V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in TTC17 in the genomic data commons?,top_cases_counts_by_genes
+1258,CTSC,E335V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in EFCAB12 in the genomic data commons?,top_cases_counts_by_genes
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in PTPRN2 in the genomic data commons?,top_cases_counts_by_genes
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in CTNNA2 in the genomic data commons?,top_cases_counts_by_genes
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in JAML in the genomic data commons?,top_cases_counts_by_genes
+1264,ACTB,A138T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients lack mutations in SLC9C1 in the genomic data commons?,top_cases_counts_by_genes
+1265,ACTB,A217T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients lack mutations in ANKRD30A in the genomic data commons?,top_cases_counts_by_genes
+1266,ACTB,A244T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients lack mutations in CHODL in the genomic data commons?,top_cases_counts_by_genes
+1267,ACTB,A260T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients lack mutations in DGKD in the genomic data commons?,top_cases_counts_by_genes
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients lack mutations in BFAR in the genomic data commons?,top_cases_counts_by_genes
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients lack mutations in THBS4 in the genomic data commons?,top_cases_counts_by_genes
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients lack mutations in COL6A3 in the genomic data commons?,top_cases_counts_by_genes
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients lack mutations in SYT9 in the genomic data commons?,top_cases_counts_by_genes
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients lack mutations in PTPRO in the genomic data commons?,top_cases_counts_by_genes
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients lack mutations in BCAT1 in the genomic data commons?,top_cases_counts_by_genes
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How many Glioblastoma Multiforme patients lack mutations in RIMS2 in the genomic data commons?,top_cases_counts_by_genes
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in FNDC7 in the genomic data commons?,top_cases_counts_by_genes
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in CFAP61 in the genomic data commons?,top_cases_counts_by_genes
+1299,TLCD5,G15V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in YY1AP1 in the genomic data commons?,top_cases_counts_by_genes
+1300,TLCD5,G37V,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in TLK2 in the genomic data commons?,top_cases_counts_by_genes
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in TTN in the genomic data commons?,top_cases_counts_by_genes
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in ZFP42 in the genomic data commons?,top_cases_counts_by_genes
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in MERTK in the genomic data commons?,top_cases_counts_by_genes
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in FGF8 in the genomic data commons?,top_cases_counts_by_genes
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in PTPRO in the genomic data commons?,top_cases_counts_by_genes
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in ANKDD1A in the genomic data commons?,top_cases_counts_by_genes
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma patients lack mutations in PCDHGA1 in the genomic data commons?,top_cases_counts_by_genes
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma patients lack mutations in MYO3B in the genomic data commons?,top_cases_counts_by_genes
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in MORF4L1 in the genomic data commons?,top_cases_counts_by_genes
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in CNGB1 in the genomic data commons?,top_cases_counts_by_genes
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in SMO in the genomic data commons?,top_cases_counts_by_genes
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in ICE1 in the genomic data commons?,top_cases_counts_by_genes
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in TET2 in the genomic data commons?,top_cases_counts_by_genes
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in AQP7 in the genomic data commons?,top_cases_counts_by_genes
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in OR13C3 in the genomic data commons?,top_cases_counts_by_genes
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in AQP7 in the genomic data commons?,top_cases_counts_by_genes
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in DCN in the genomic data commons?,top_cases_counts_by_genes
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in GRTP1 in the genomic data commons?,top_cases_counts_by_genes
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in YY1AP1 in the genomic data commons?,top_cases_counts_by_genes
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in RIMS2 in the genomic data commons?,top_cases_counts_by_genes
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in OR2A12 in the genomic data commons?,top_cases_counts_by_genes
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in MED16 in the genomic data commons?,top_cases_counts_by_genes
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in MYO3B in the genomic data commons?,top_cases_counts_by_genes
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How many Kidney Renal Clear Cell Carcinoma patients lack mutations in GPC3 in the genomic data commons?,top_cases_counts_by_genes
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How many Kidney Renal Clear Cell Carcinoma patients lack mutations in SPAG1 in the genomic data commons?,top_cases_counts_by_genes
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in DNAH11 in the genomic data commons?,top_cases_counts_by_genes
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in PGF in the genomic data commons?,top_cases_counts_by_genes
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in CNGB1 in the genomic data commons?,top_cases_counts_by_genes
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in MED16 in the genomic data commons?,top_cases_counts_by_genes
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in FRY in the genomic data commons?,top_cases_counts_by_genes
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in TTYH2 in the genomic data commons?,top_cases_counts_by_genes
+1393,EBF2,T104I,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in TASOR2 in the genomic data commons?,top_cases_counts_by_genes
+1394,EBF2,T252I,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in TRAP1 in the genomic data commons?,top_cases_counts_by_genes
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in ANKRD30A in the genomic data commons?,top_cases_counts_by_genes
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients lack mutations in ZFAT in the genomic data commons?",top_cases_counts_by_genes
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients lack mutations in DGKD in the genomic data commons?",top_cases_counts_by_genes
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients lack mutations in ZNF584 in the genomic data commons?",top_cases_counts_by_genes
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma patients lack mutations in ANKRD24 in the genomic data commons?,top_cases_counts_by_genes
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in SERPINB10 in the genomic data commons?,top_cases_counts_by_genes
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in MAST4 in the genomic data commons?,top_cases_counts_by_genes
+1413,PRSS1,S114T,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in RIPOR2 in the genomic data commons?,top_cases_counts_by_genes
+1414,PRSS1,S124T,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in OR2A12 in the genomic data commons?,top_cases_counts_by_genes
+1415,PRSS1,S138T,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in AQP7 in the genomic data commons?,top_cases_counts_by_genes
+1416,PRSS1,S74T,Lung Adenocarcinoma,How many Lung Adenocarcinoma patients lack mutations in ZNF217 in the genomic data commons?,top_cases_counts_by_genes
+1417,PGF,R126H,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in SLC6A4 in the genomic data commons?,top_cases_counts_by_genes
+1418,PGF,R127H,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma patients lack mutations in DNAH14 in the genomic data commons?,top_cases_counts_by_genes
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients lack mutations in TNS1 in the genomic data commons?,top_cases_counts_by_genes
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma patients lack mutations in PRSS1 in the genomic data commons?,top_cases_counts_by_genes
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in OR13C3 in the genomic data commons?,top_cases_counts_by_genes
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in BCAT1 in the genomic data commons?,top_cases_counts_by_genes
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in TYK2 in the genomic data commons?,top_cases_counts_by_genes
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How many Colon Adenocarcinoma patients lack mutations in MYO3B in the genomic data commons?,top_cases_counts_by_genes
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma patients lack mutations in FGF8 in the genomic data commons?,top_cases_counts_by_genes
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma patients lack mutations in MORF4L1 in the genomic data commons?,top_cases_counts_by_genes
+1,TNS1,G1362V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma do not exhibit mutations in TNS1 and CNGB1?,top_cases_counts_by_genes
+2,TNS1,G1711V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma do not exhibit mutations in TNS1 and TYROBP?,top_cases_counts_by_genes
+3,TNS1,G1718V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma do not exhibit mutations in TNS1 and ANKRD30A?,top_cases_counts_by_genes
+4,TNS1,G1732V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma do not exhibit mutations in TNS1 and MRPL55?,top_cases_counts_by_genes
+5,TNS1,G1824V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma do not exhibit mutations in TNS1 and ACTB?,top_cases_counts_by_genes
+6,TNS1,G1857V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma do not exhibit mutations in TNS1 and ZMYM3?,top_cases_counts_by_genes
+7,TNS1,G843V,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma do not exhibit mutations in TNS1 and PIK3C2A?,top_cases_counts_by_genes
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma do not exhibit mutations in EVC2 and TASOR2?,top_cases_counts_by_genes
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma do not exhibit mutations in EVC2 and DCC?,top_cases_counts_by_genes
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in CR1 and YY1AP1?,top_cases_counts_by_genes
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in CR1 and LAMB2?,top_cases_counts_by_genes
+22,TRPA1,S295I,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma do not exhibit mutations in TRPA1 and PRSS1?,top_cases_counts_by_genes
+23,TRPA1,S443I,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma do not exhibit mutations in TRPA1 and PGR?,top_cases_counts_by_genes
+24,TAF1C,R299L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in TAF1C and TYK2?,top_cases_counts_by_genes
+25,TAF1C,R396L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in TAF1C and DHX16?,top_cases_counts_by_genes
+26,TAF1C,R634L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in TAF1C and YY1AP1?,top_cases_counts_by_genes
+27,TAF1C,R702L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in TAF1C and UNC5D?,top_cases_counts_by_genes
+28,TAF1C,R728L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in TAF1C and SPTAN1?,top_cases_counts_by_genes
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in DPF3 and POLD1?,top_cases_counts_by_genes
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in DPF3 and STK19?,top_cases_counts_by_genes
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in DPF3 and CDH23?,top_cases_counts_by_genes
+42,OR2T4,P272H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in OR2T4 and SGIP1?,top_cases_counts_by_genes
+43,OR2T4,P300H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in OR2T4 and GRTP1?,top_cases_counts_by_genes
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma do not exhibit mutations in FBN1 and AUTS2?,top_cases_counts_by_genes
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma do not exhibit mutations in MAD1L1 and RIMS2?,top_cases_counts_by_genes
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma do not exhibit mutations in MAD1L1 and MSANTD4?,top_cases_counts_by_genes
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma do not exhibit mutations in MAD1L1 and PTPRO?,top_cases_counts_by_genes
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in CCNG1 and RIMS2?,top_cases_counts_by_genes
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma do not exhibit mutations in ANP32E and TNS1?,top_cases_counts_by_genes
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma do not exhibit mutations in ANP32E and DCAF6?,top_cases_counts_by_genes
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma do not exhibit mutations in ANP32E and PTPRN2?,top_cases_counts_by_genes
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma do not exhibit mutations in ANP32E and LCN15?,top_cases_counts_by_genes
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma do not exhibit mutations in FRY and YY1AP1?,top_cases_counts_by_genes
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma do not exhibit mutations in FRY and DNAH14?,top_cases_counts_by_genes
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma do not exhibit mutations in FRY and REXO4?,top_cases_counts_by_genes
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma do not exhibit mutations in FRY and HTR3B?,top_cases_counts_by_genes
+70,PAK3,E318K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in PAK3 and PRSS1?,top_cases_counts_by_genes
+71,PAK3,E319K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in PAK3 and FGF8?,top_cases_counts_by_genes
+72,PAK3,E334K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in PAK3 and RIPOR2?,top_cases_counts_by_genes
+73,PAK3,E340K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in PAK3 and CPS1?,top_cases_counts_by_genes
+74,PAK3,E355K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in PAK3 and DGKD?,top_cases_counts_by_genes
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in MUC16 and PAK3?,top_cases_counts_by_genes
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma do not exhibit mutations in ZFPM2 and TTC17?,top_cases_counts_by_genes
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma do not exhibit mutations in ZFPM2 and NOMO1?,top_cases_counts_by_genes
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma do not exhibit mutations in PIK3C2B and NRAP?,top_cases_counts_by_genes
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma do not exhibit mutations in PIK3C2B and CFAP61?,top_cases_counts_by_genes
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in ZNF804A and ANP32E?,top_cases_counts_by_genes
+116,RELN,A2371V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in RELN and CFAP61?,top_cases_counts_by_genes
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus do not exhibit mutations in EFCAB12 and CEP20?",top_cases_counts_by_genes
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus do not exhibit mutations in EFCAB12 and KIF20B?",top_cases_counts_by_genes
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in DEFB115 and PRSS1?,top_cases_counts_by_genes
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma do not exhibit mutations in ANKDD1A and DCN?,top_cases_counts_by_genes
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma do not exhibit mutations in ANKDD1A and TAS1R3?,top_cases_counts_by_genes
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma do not exhibit mutations in ANKDD1A and CX3CR1?,top_cases_counts_by_genes
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in HTR3B and GABRA6?,top_cases_counts_by_genes
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in HTR3B and BCAT1?,top_cases_counts_by_genes
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in HTR3B and GRM5?,top_cases_counts_by_genes
+129,ABCC3,R758W,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in ABCC3 and RIMS2?,top_cases_counts_by_genes
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in NOMO1 and FGF8?,top_cases_counts_by_genes
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in NOMO1 and GUF1?,top_cases_counts_by_genes
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma do not exhibit mutations in HYOU1 and PIK3C2A?,top_cases_counts_by_genes
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in FMO4 and MORF4L1?,top_cases_counts_by_genes
+140,BICC1,A372V,Exceptional Responders,What proportion of Exceptional Responders do not exhibit mutations in BICC1 and DEFB115?,top_cases_counts_by_genes
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in ZMYM3 and CTNNA2?,top_cases_counts_by_genes
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in ZMYM3 and GABRA6?,top_cases_counts_by_genes
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in ZMYM3 and CDC42BPA?,top_cases_counts_by_genes
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus do not exhibit mutations in XKR4 and EFCAB12?",top_cases_counts_by_genes
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma do not exhibit mutations in ABCC2 and POC1B?,top_cases_counts_by_genes
+157,OR8K5,R293G,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in OR8K5 and TSHZ3?,top_cases_counts_by_genes
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in SPTAN1 and POLR1G?,top_cases_counts_by_genes
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in SPTAN1 and ZMYM3?,top_cases_counts_by_genes
+164,SYT10,M484I,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma do not exhibit mutations in SYT10 and EIF2B4?,top_cases_counts_by_genes
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in HSPA5 and DCAF6?,top_cases_counts_by_genes
+175,UNC5D,L280V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in UNC5D and DCC?,top_cases_counts_by_genes
+176,UNC5D,L635V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in UNC5D and PIK3C2G?,top_cases_counts_by_genes
+177,UNC5D,L637V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in UNC5D and HTR3B?,top_cases_counts_by_genes
+178,UNC5D,L699V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in UNC5D and PGF?,top_cases_counts_by_genes
+179,UNC5D,L704V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in UNC5D and PAK3?,top_cases_counts_by_genes
+180,UNC5D,L709V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in UNC5D and MORF4L1?,top_cases_counts_by_genes
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What proportion of Kidney Renal Clear Cell Carcinoma do not exhibit mutations in DOCK2 and STK19?,top_cases_counts_by_genes
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What proportion of Kidney Renal Clear Cell Carcinoma do not exhibit mutations in ZNF627 and ANKRD24?,top_cases_counts_by_genes
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in CDC42BPA and PTPRO?,top_cases_counts_by_genes
+193,MRPL55,H27Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in MRPL55 and CHMP7?,top_cases_counts_by_genes
+194,MRPL55,H63Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in MRPL55 and CXCR2?,top_cases_counts_by_genes
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma do not exhibit mutations in TMTC3 and CTNNA2?,top_cases_counts_by_genes
+198,EPRS1,K771I,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in EPRS1 and TLK2?,top_cases_counts_by_genes
+199,EPRS1,K778I,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in EPRS1 and TTYH2?,top_cases_counts_by_genes
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in GRTP1 and MYH11?,top_cases_counts_by_genes
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in GRTP1 and ZFAT?,top_cases_counts_by_genes
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in TSHZ3 and CEP20?,top_cases_counts_by_genes
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What proportion of HIV+ Tumor Molecular Characterization Project - Cervical Cancer do not exhibit mutations in TAS1R3 and FGF8?,top_cases_counts_by_genes
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in PIAS3 and RIPOR2?,top_cases_counts_by_genes
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in PIAS3 and DCAF6?,top_cases_counts_by_genes
+251,ZNF274,P13R,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in ZNF274 and TAF1C?,top_cases_counts_by_genes
+253,SYNJ1,R795C,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in SYNJ1 and PHLPP1?,top_cases_counts_by_genes
+254,SYNJ1,R800C,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in SYNJ1 and TMEM225?,top_cases_counts_by_genes
+255,SYNJ1,R839C,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in SYNJ1 and TET2?,top_cases_counts_by_genes
+261,DSCAM,V343M,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma do not exhibit mutations in DSCAM and GABRA6?,top_cases_counts_by_genes
+262,DSCAM,V426M,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma do not exhibit mutations in DSCAM and ACTL7B?,top_cases_counts_by_genes
+263,DSCAM,V591M,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma do not exhibit mutations in DSCAM and SGCZ?,top_cases_counts_by_genes
+267,DGKD,R140H,Exceptional Responders,What proportion of Exceptional Responders do not exhibit mutations in DGKD and DNAH11?,top_cases_counts_by_genes
+268,DGKD,R160H,Exceptional Responders,What proportion of Exceptional Responders do not exhibit mutations in DGKD and CYB5R2?,top_cases_counts_by_genes
+269,DGKD,R204H,Exceptional Responders,What proportion of Exceptional Responders do not exhibit mutations in DGKD and TENM2?,top_cases_counts_by_genes
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma do not exhibit mutations in PLEKHG6 and DCN?,top_cases_counts_by_genes
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma do not exhibit mutations in PLEKHG6 and TTN?,top_cases_counts_by_genes
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma do not exhibit mutations in PLEKHG6 and TLK2?,top_cases_counts_by_genes
+279,WNT2,D138N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in WNT2 and AUTS2?,top_cases_counts_by_genes
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in GUCY2C and NEXN?,top_cases_counts_by_genes
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in C7orf31 and DPF3?,top_cases_counts_by_genes
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus do not exhibit mutations in ZKSCAN7 and CYB5R2?",top_cases_counts_by_genes
+299,OR5D14,M210L,Neuroblastoma,What proportion of Neuroblastoma do not exhibit mutations in OR5D14 and YY1AP1?,top_cases_counts_by_genes
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in SPATA22 and ZFP42?,top_cases_counts_by_genes
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in SPATA22 and AQP7?,top_cases_counts_by_genes
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in SPATA22 and CXCR2?,top_cases_counts_by_genes
+310,LCN15,E21V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in LCN15 and CTSC?,top_cases_counts_by_genes
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in DCAF4L2 and DCLK3?,top_cases_counts_by_genes
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in GUK1 and AUTS2?,top_cases_counts_by_genes
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in GUK1 and ANKRD30A?,top_cases_counts_by_genes
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in GUK1 and USH2A?,top_cases_counts_by_genes
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in GUK1 and DSCAM?,top_cases_counts_by_genes
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in GUK1 and DCN?,top_cases_counts_by_genes
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in MORF4L1 and MAST4?,top_cases_counts_by_genes
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in MORF4L1 and ZMYM3?,top_cases_counts_by_genes
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in MORF4L1 and FGF8?,top_cases_counts_by_genes
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in MORF4L1 and ANKDD1A?,top_cases_counts_by_genes
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in MYO3B and GIMAP2?,top_cases_counts_by_genes
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in MYO3B and DCN?,top_cases_counts_by_genes
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in TENT5A and ZMYM3?,top_cases_counts_by_genes
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in TENT5A and YY1AP1?,top_cases_counts_by_genes
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in TENT5A and TNS1?,top_cases_counts_by_genes
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What proportion of Ovarian Serous Cystadenocarcinoma do not exhibit mutations in ZFAT and COL6A3?,top_cases_counts_by_genes
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What proportion of Ovarian Serous Cystadenocarcinoma do not exhibit mutations in ZFAT and GIMAP2?,top_cases_counts_by_genes
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What proportion of Ovarian Serous Cystadenocarcinoma do not exhibit mutations in ZFAT and AQP7?,top_cases_counts_by_genes
+357,ZNF584,A211T,Sarcoma,What proportion of Sarcoma do not exhibit mutations in ZNF584 and DCLK3?,top_cases_counts_by_genes
+358,ZNF584,A256T,Sarcoma,What proportion of Sarcoma do not exhibit mutations in ZNF584 and SPATA22?,top_cases_counts_by_genes
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in LDOC1 and ZNF431?,top_cases_counts_by_genes
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in PDGFC and KDM5C?,top_cases_counts_by_genes
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in MSANTD4 and EIF2B4?,top_cases_counts_by_genes
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in NPSR1 and SORCS1?,top_cases_counts_by_genes
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in PHLPP1 and YY1AP1?,top_cases_counts_by_genes
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in COL6A3 and ANKRD30A?,top_cases_counts_by_genes
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in COL6A3 and FCGR2C?,top_cases_counts_by_genes
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in COL6A3 and PXN?,top_cases_counts_by_genes
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in COL6A3 and DPF3?,top_cases_counts_by_genes
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in COL6A3 and CFAP61?,top_cases_counts_by_genes
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in ADRA1A and EBF2?,top_cases_counts_by_genes
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma do not exhibit mutations in LAMB2 and FGF8?,top_cases_counts_by_genes
+406,POC1B,I198T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma do not exhibit mutations in POC1B and FBXO15?,top_cases_counts_by_genes
+407,POC1B,I286T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma do not exhibit mutations in POC1B and MAD1L1?,top_cases_counts_by_genes
+408,POC1B,I328T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma do not exhibit mutations in POC1B and PLEKHG6?,top_cases_counts_by_genes
+409,POC1B,S79P,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma do not exhibit mutations in POC1B and TLCD5?,top_cases_counts_by_genes
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma do not exhibit mutations in USH2A and ARMC3?,top_cases_counts_by_genes
+414,AQP7,T110S,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma do not exhibit mutations in AQP7 and TENM2?,top_cases_counts_by_genes
+415,AQP7,T166S,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma do not exhibit mutations in AQP7 and TYK2?,top_cases_counts_by_genes
+416,AQP7,T167S,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma do not exhibit mutations in AQP7 and GUK1?,top_cases_counts_by_genes
+417,AQP7,T75S,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma do not exhibit mutations in AQP7 and CASZ1?,top_cases_counts_by_genes
+430,DCN,R163C,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma do not exhibit mutations in DCN and ZFAT?,top_cases_counts_by_genes
+431,DCN,R203C,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma do not exhibit mutations in DCN and MAST4?,top_cases_counts_by_genes
+432,DCN,R241C,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma do not exhibit mutations in DCN and GPRASP1?,top_cases_counts_by_genes
+433,DCN,R350C,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma do not exhibit mutations in DCN and PTPRN2?,top_cases_counts_by_genes
+434,DCN,R41C,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma do not exhibit mutations in DCN and UBR2?,top_cases_counts_by_genes
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in CPS1 and ABCC3?,top_cases_counts_by_genes
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in CPS1 and ANKDD1A?,top_cases_counts_by_genes
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in CPS1 and TNS1?,top_cases_counts_by_genes
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma do not exhibit mutations in FCGR2C and CTNNA2?,top_cases_counts_by_genes
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma do not exhibit mutations in FCGR2C and ACTA2?,top_cases_counts_by_genes
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in GRM1 and MYT1?,top_cases_counts_by_genes
+482,SGCZ,Q138H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in SGCZ and DHX16?,top_cases_counts_by_genes
+483,SGCZ,Q91H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in SGCZ and ZFP42?,top_cases_counts_by_genes
+485,SMO,V15M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in SMO and THBS4?,top_cases_counts_by_genes
+486,SMO,V321M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in SMO and CHODL?,top_cases_counts_by_genes
+488,CHODL,G159E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in CHODL and EIF2B4?,top_cases_counts_by_genes
+489,CHODL,G181E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in CHODL and SYT10?,top_cases_counts_by_genes
+490,CHODL,G200E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in CHODL and DOCK2?,top_cases_counts_by_genes
+494,MYO16,P399H,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in MYO16 and POC1B?,top_cases_counts_by_genes
+495,MYO16,P421H,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in MYO16 and ANP32E?,top_cases_counts_by_genes
+498,CXCR2,A98V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in CXCR2 and PGF?,top_cases_counts_by_genes
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma do not exhibit mutations in TMEM225 and SLC9C1?,top_cases_counts_by_genes
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in MAOB and AUTS2?,top_cases_counts_by_genes
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in GPRASP1 and PGF?,top_cases_counts_by_genes
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in MRPL32 and DCC?,top_cases_counts_by_genes
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in TYROBP and TNS1?,top_cases_counts_by_genes
+510,RAB40C,A111V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in RAB40C and JAML?,top_cases_counts_by_genes
+511,RAB40C,A143V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in RAB40C and LAMB2?,top_cases_counts_by_genes
+512,CTNNA2,S323R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in CTNNA2 and ACTA2?,top_cases_counts_by_genes
+513,CTNNA2,S339R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in CTNNA2 and TAF1C?,top_cases_counts_by_genes
+514,CTNNA2,S386R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in CTNNA2 and FRY?,top_cases_counts_by_genes
+515,CTNNA2,S707R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in CTNNA2 and DCAF6?,top_cases_counts_by_genes
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma do not exhibit mutations in MYO15A and EIF2B4?,top_cases_counts_by_genes
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in GIMAP2 and BCAT1?,top_cases_counts_by_genes
+532,KIF20B,N1160D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme do not exhibit mutations in KIF20B and PTPRN2?,top_cases_counts_by_genes
+533,KIF20B,N1200D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme do not exhibit mutations in KIF20B and ZNF584?,top_cases_counts_by_genes
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in ADAM17 and HTR3B?,top_cases_counts_by_genes
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in BCAT1 and GPR158?,top_cases_counts_by_genes
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in BCAT1 and UNC5D?,top_cases_counts_by_genes
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in BCAT1 and VASN?,top_cases_counts_by_genes
+540,ERCC6,R1053H,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in ERCC6 and OR13C3?,top_cases_counts_by_genes
+541,DCC,R320W,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma do not exhibit mutations in DCC and TENT5A?,top_cases_counts_by_genes
+542,DCC,R363W,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma do not exhibit mutations in DCC and ART3?,top_cases_counts_by_genes
+543,DCC,R386W,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma do not exhibit mutations in DCC and JAML?,top_cases_counts_by_genes
+544,DCC,R41W,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma do not exhibit mutations in DCC and SYT10?,top_cases_counts_by_genes
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in FBXO15 and PGF?,top_cases_counts_by_genes
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in FBXO15 and RAB40C?,top_cases_counts_by_genes
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in GSTCD and MRPL55?,top_cases_counts_by_genes
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in GSTCD and YY1AP1?,top_cases_counts_by_genes
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in OLFML3 and TET2?,top_cases_counts_by_genes
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in OLFML3 and TLCD5?,top_cases_counts_by_genes
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in OLFML3 and TLK2?,top_cases_counts_by_genes
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What proportion of Ovarian Serous Cystadenocarcinoma do not exhibit mutations in CFAP61 and DNAH14?,top_cases_counts_by_genes
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What proportion of Ovarian Serous Cystadenocarcinoma do not exhibit mutations in CFAP61 and SPINDOC?,top_cases_counts_by_genes
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma do not exhibit mutations in HLA-DQA2 and AQP7?,top_cases_counts_by_genes
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in TENM2 and ADAM17?,top_cases_counts_by_genes
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in TENM2 and MAOB?,top_cases_counts_by_genes
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in TENM2 and GUF1?,top_cases_counts_by_genes
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in ANKRD24 and FBXO15?,top_cases_counts_by_genes
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in ANKRD24 and TASOR2?,top_cases_counts_by_genes
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in ANKRD24 and PHLPP1?,top_cases_counts_by_genes
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in ZCCHC14 and CEP20?,top_cases_counts_by_genes
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in ZCCHC14 and KDM5C?,top_cases_counts_by_genes
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in ZCCHC14 and CACNA1F?,top_cases_counts_by_genes
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in ZCCHC14 and RIMS2?,top_cases_counts_by_genes
+625,SIK2,I265M,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in SIK2 and GUK1?,top_cases_counts_by_genes
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in MYH11 and PCDHGA1?,top_cases_counts_by_genes
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in MYH11 and PTPRN2?,top_cases_counts_by_genes
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in SLC6A4 and PAK3?,top_cases_counts_by_genes
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in SLC9C1 and MORF4L1?,top_cases_counts_by_genes
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in SLC9C1 and PAK3?,top_cases_counts_by_genes
+644,OR2A12,A254T,Brain Lower Grade Glioma,What proportion of Brain Lower Grade Glioma do not exhibit mutations in OR2A12 and SMO?,top_cases_counts_by_genes
+646,PYHIN1,T325K,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in PYHIN1 and CTNNA2?,top_cases_counts_by_genes
+647,PYHIN1,T334K,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in PYHIN1 and CNGB1?,top_cases_counts_by_genes
+650,JAML,G191E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in JAML and KANSL1?,top_cases_counts_by_genes
+651,JAML,G219E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in JAML and GRM1?,top_cases_counts_by_genes
+652,JAML,G220E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in JAML and ZMYM3?,top_cases_counts_by_genes
+653,JAML,G230E,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in JAML and CHMP7?,top_cases_counts_by_genes
+658,TYK2,H1146R,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in TYK2 and ZFAT?,top_cases_counts_by_genes
+659,TYK2,H23R,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in TYK2 and VASN?,top_cases_counts_by_genes
+660,TYK2,H961R,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in TYK2 and RIMS2?,top_cases_counts_by_genes
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in CTCFL and YY1AP1?,top_cases_counts_by_genes
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in CTCFL and OLFML3?,top_cases_counts_by_genes
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in CTCFL and TTC17?,top_cases_counts_by_genes
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in CTCFL and SGIP1?,top_cases_counts_by_genes
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in CEP20 and PXN?,top_cases_counts_by_genes
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in CEP20 and TASOR2?,top_cases_counts_by_genes
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in RIMS2 and ANKRD24?,top_cases_counts_by_genes
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in RIMS2 and FRY?,top_cases_counts_by_genes
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in RIMS2 and GRTP1?,top_cases_counts_by_genes
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in RIMS2 and PCDHGA1?,top_cases_counts_by_genes
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in RIMS2 and MAST4?,top_cases_counts_by_genes
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in RIMS2 and RIPOR2?,top_cases_counts_by_genes
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in RIMS2 and PGR?,top_cases_counts_by_genes
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in PIK3C2G and FGF8?,top_cases_counts_by_genes
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in PIK3C2G and TENM3?,top_cases_counts_by_genes
+728,STK19,D341N,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in STK19 and TTC17?,top_cases_counts_by_genes
+729,STK19,D345N,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in STK19 and TMEM255A?,top_cases_counts_by_genes
+730,REXO4,P60A,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in REXO4 and ANKDD1A?,top_cases_counts_by_genes
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in ZBTB34 and MAOB?,top_cases_counts_by_genes
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in ZBTB34 and TNS1?,top_cases_counts_by_genes
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma do not exhibit mutations in NCKAP5 and TYK2?,top_cases_counts_by_genes
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus do not exhibit mutations in SORCS1 and TRIM45?",top_cases_counts_by_genes
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus do not exhibit mutations in SORCS1 and PCDHGA1?",top_cases_counts_by_genes
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus do not exhibit mutations in SORCS1 and ZCCHC14?",top_cases_counts_by_genes
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus do not exhibit mutations in SORCS1 and MED16?",top_cases_counts_by_genes
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What proportion of Head and Neck Squamous Cell Carcinoma do not exhibit mutations in FGF8 and ACVR1B?,top_cases_counts_by_genes
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What proportion of Head and Neck Squamous Cell Carcinoma do not exhibit mutations in FGF8 and EBF2?,top_cases_counts_by_genes
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What proportion of Head and Neck Squamous Cell Carcinoma do not exhibit mutations in FGF8 and GUCY2C?,top_cases_counts_by_genes
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What proportion of Head and Neck Squamous Cell Carcinoma do not exhibit mutations in FGF8 and REXO4?,top_cases_counts_by_genes
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What proportion of Head and Neck Squamous Cell Carcinoma do not exhibit mutations in FGF8 and GSTCD?,top_cases_counts_by_genes
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What proportion of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia do not exhibit mutations in TENM3 and TENT5A?,top_cases_counts_by_genes
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in AKT1 and ZNF708?,top_cases_counts_by_genes
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma do not exhibit mutations in CFAP298-TCP10L and AUTS2?,top_cases_counts_by_genes
+792,GLRB,E148D,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in GLRB and RIPOR2?,top_cases_counts_by_genes
+793,TTN,F7636L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in TTN and PTPRO?,top_cases_counts_by_genes
+794,TTN,F8563L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in TTN and ZCCHC14?,top_cases_counts_by_genes
+795,TTN,F8880L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in TTN and ZFP42?,top_cases_counts_by_genes
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in ANKRD30A and MORF4L1?,top_cases_counts_by_genes
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in ANKRD30A and OR2T4?,top_cases_counts_by_genes
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in ANKRD30A and PLEKHG6?,top_cases_counts_by_genes
+809,TRIM45,S177L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in TRIM45 and AUTS2?,top_cases_counts_by_genes
+810,TRIM45,S224L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in TRIM45 and SGCZ?,top_cases_counts_by_genes
+811,TRIM45,S281L,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in TRIM45 and ANP32E?,top_cases_counts_by_genes
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in CACNA1F and PTPRO?,top_cases_counts_by_genes
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in CACNA1F and CTNNA2?,top_cases_counts_by_genes
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in CACNA1F and HLA-DQA2?,top_cases_counts_by_genes
+817,KL,R594C,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in KL and SORCS1?,top_cases_counts_by_genes
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What proportion of Kidney Renal Papillary Cell Carcinoma do not exhibit mutations in GUF1 and ADRA1A?,top_cases_counts_by_genes
+822,TAF1L,A539V,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in TAF1L and TASOR2?,top_cases_counts_by_genes
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in TASOR2 and CA9?,top_cases_counts_by_genes
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in TASOR2 and PXN?,top_cases_counts_by_genes
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in TASOR2 and CTCFL?,top_cases_counts_by_genes
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in KDM5C and PIK3C2G?,top_cases_counts_by_genes
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in KDM5C and RIMS2?,top_cases_counts_by_genes
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in KDM5C and ZCCHC14?,top_cases_counts_by_genes
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in KDM5C and EBF2?,top_cases_counts_by_genes
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma do not exhibit mutations in IL5RA and UNC5D?,top_cases_counts_by_genes
+843,DHX16,A29V,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in DHX16 and JAML?,top_cases_counts_by_genes
+844,DHX16,A89V,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in DHX16 and SGIP1?,top_cases_counts_by_genes
+902,GPR158,A644V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in GPR158 and SGIP1?,top_cases_counts_by_genes
+903,GPR158,A723V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in GPR158 and USH2A?,top_cases_counts_by_genes
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus do not exhibit mutations in EIF2B4 and GABRA6?",top_cases_counts_by_genes
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus do not exhibit mutations in EIF2B4 and EFCAB12?",top_cases_counts_by_genes
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus do not exhibit mutations in EIF2B4 and NOMO1?",top_cases_counts_by_genes
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus do not exhibit mutations in EIF2B4 and ANKRD24?",top_cases_counts_by_genes
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus do not exhibit mutations in EIF2B4 and CX3CR1?",top_cases_counts_by_genes
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus do not exhibit mutations in EIF2B4 and PIK3C2G?",top_cases_counts_by_genes
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in AUTS2 and ZFAT?,top_cases_counts_by_genes
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in AUTS2 and MYO3B?,top_cases_counts_by_genes
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in AUTS2 and TTC17?,top_cases_counts_by_genes
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in AUTS2 and DSCAM?,top_cases_counts_by_genes
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in AUTS2 and GABRA6?,top_cases_counts_by_genes
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in AUTS2 and SLC9C1?,top_cases_counts_by_genes
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in AUTS2 and POC1B?,top_cases_counts_by_genes
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in AUTS2 and CTNNA2?,top_cases_counts_by_genes
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in AUTS2 and CDH23?,top_cases_counts_by_genes
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in AUTS2 and AUTS2?,top_cases_counts_by_genes
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus do not exhibit mutations in ACTL7B and SLC6A4?",top_cases_counts_by_genes
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme do not exhibit mutations in PCDHGA1 and TENM2?,top_cases_counts_by_genes
+954,TRAP1,R114W,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in TRAP1 and CHODL?,top_cases_counts_by_genes
+955,TRAP1,R61W,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in TRAP1 and PAK3?,top_cases_counts_by_genes
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in PIK3C2A and PIK3C2G?,top_cases_counts_by_genes
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma do not exhibit mutations in KANSL1 and ACTB?,top_cases_counts_by_genes
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in ANKRD52 and GPRASP1?,top_cases_counts_by_genes
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in PAPPA and TTC17?,top_cases_counts_by_genes
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma do not exhibit mutations in B3GALNT1 and ZFPM2?,top_cases_counts_by_genes
+982,GABRA6,G115R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in GABRA6 and DHX16?,top_cases_counts_by_genes
+983,GABRA6,G122R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in GABRA6 and PRSS8?,top_cases_counts_by_genes
+984,GABRA6,G165R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in GABRA6 and WNT2?,top_cases_counts_by_genes
+985,GABRA6,G175R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in GABRA6 and KL?,top_cases_counts_by_genes
+986,GABRA6,G70R,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in GABRA6 and PTPRN2?,top_cases_counts_by_genes
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in ZSCAN31 and TAF1C?,top_cases_counts_by_genes
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus do not exhibit mutations in MED16 and LCN15?",top_cases_counts_by_genes
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus do not exhibit mutations in MED16 and TAF1C?",top_cases_counts_by_genes
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma do not exhibit mutations in PTPRO and ART3?,top_cases_counts_by_genes
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma do not exhibit mutations in PTPRO and FMO4?,top_cases_counts_by_genes
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma do not exhibit mutations in PTPRO and SIK2?,top_cases_counts_by_genes
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma do not exhibit mutations in PTPRO and TMEM255A?,top_cases_counts_by_genes
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma do not exhibit mutations in PTPRO and HBB?,top_cases_counts_by_genes
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma do not exhibit mutations in PTPRO and PTPRO?,top_cases_counts_by_genes
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma do not exhibit mutations in PTPRO and ZMYM3?,top_cases_counts_by_genes
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What proportion of Pancreatic Adenocarcinoma do not exhibit mutations in PTPRO and ZFAT?,top_cases_counts_by_genes
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in CHMP7 and DCLK3?,top_cases_counts_by_genes
+1017,GPC3,I107N,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in GPC3 and TRAP1?,top_cases_counts_by_genes
+1018,GPC3,I161N,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in GPC3 and MYO3A?,top_cases_counts_by_genes
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma do not exhibit mutations in TLK2 and ZBTB34?,top_cases_counts_by_genes
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma do not exhibit mutations in TLK2 and KDM5C?,top_cases_counts_by_genes
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma do not exhibit mutations in TLK2 and RIPOR2?,top_cases_counts_by_genes
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma do not exhibit mutations in TLK2 and GUCY2C?,top_cases_counts_by_genes
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma do not exhibit mutations in TLK2 and DNMT1?,top_cases_counts_by_genes
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in ZNF217 and SPTAN1?,top_cases_counts_by_genes
+1038,SYT9,V275L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in SYT9 and SYNJ1?,top_cases_counts_by_genes
+1039,SYT9,V307L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in SYT9 and PIAS3?,top_cases_counts_by_genes
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in PKHD1L1 and TLK2?,top_cases_counts_by_genes
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in MYO3A and TTN?,top_cases_counts_by_genes
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus do not exhibit mutations in VASN and ANKRD30A?",top_cases_counts_by_genes
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in DNMT1 and DCLK3?,top_cases_counts_by_genes
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in DNMT1 and UNC5D?,top_cases_counts_by_genes
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in DNMT1 and CFAP61?,top_cases_counts_by_genes
+1056,CA9,E402K,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in CA9 and RELN?,top_cases_counts_by_genes
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in TTC17 and DCLK3?,top_cases_counts_by_genes
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in TTC17 and CEP20?,top_cases_counts_by_genes
+1065,PSG2,P43L,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma do not exhibit mutations in PSG2 and JAML?,top_cases_counts_by_genes
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma do not exhibit mutations in RIPOR2 and MED16?,top_cases_counts_by_genes
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma do not exhibit mutations in RIPOR2 and ACVR1B?,top_cases_counts_by_genes
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma do not exhibit mutations in RIPOR2 and TENT5A?,top_cases_counts_by_genes
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma do not exhibit mutations in RIPOR2 and ACVR1B?,top_cases_counts_by_genes
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in DCLK3 and ZMYM3?,top_cases_counts_by_genes
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in DCLK3 and SORCS1?,top_cases_counts_by_genes
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in MERTK and POLR1G?,top_cases_counts_by_genes
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in MERTK and SMO?,top_cases_counts_by_genes
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in MERTK and JAML?,top_cases_counts_by_genes
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in ZFP42 and MYO16?,top_cases_counts_by_genes
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in OR13C3 and ARMC3?,top_cases_counts_by_genes
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in OR13C3 and PCDHB2?,top_cases_counts_by_genes
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in SPAG1 and GABRA6?,top_cases_counts_by_genes
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in CDKN2AIP and OR2A12?,top_cases_counts_by_genes
+1093,PXN,H1016Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in PXN and POLD1?,top_cases_counts_by_genes
+1094,PXN,H359Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in PXN and ICE1?,top_cases_counts_by_genes
+1095,PXN,H492Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in PXN and ITPRID2?,top_cases_counts_by_genes
+1096,PXN,H524Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in PXN and PXN?,top_cases_counts_by_genes
+1097,PXN,H526Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in PXN and TAS1R3?,top_cases_counts_by_genes
+1098,PXN,H540Y,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in PXN and FNDC7?,top_cases_counts_by_genes
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in TTYH2 and PXN?,top_cases_counts_by_genes
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in TTYH2 and ZCCHC14?,top_cases_counts_by_genes
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in TMEM255A and PXN?,top_cases_counts_by_genes
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in TMEM255A and AUTS2?,top_cases_counts_by_genes
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in TMEM255A and ANKRD30A?,top_cases_counts_by_genes
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma do not exhibit mutations in TASOR2 and MYT1?,top_cases_counts_by_genes
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma do not exhibit mutations in TASOR2 and MAD1L1?,top_cases_counts_by_genes
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in ICE1 and DCN?,top_cases_counts_by_genes
+1112,MYT1,A558E,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma do not exhibit mutations in MYT1 and UNC5D?,top_cases_counts_by_genes
+1113,MYT1,A879E,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma do not exhibit mutations in MYT1 and TNS1?,top_cases_counts_by_genes
+1114,MYT1,A906E,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma do not exhibit mutations in MYT1 and BCAT1?,top_cases_counts_by_genes
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in CX3CR1 and CDH23?,top_cases_counts_by_genes
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in CX3CR1 and NRAP?,top_cases_counts_by_genes
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma do not exhibit mutations in SPINDOC and TTYH2?,top_cases_counts_by_genes
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in ART3 and ZBTB34?,top_cases_counts_by_genes
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in ART3 and FRY?,top_cases_counts_by_genes
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma do not exhibit mutations in CYP1A2 and C7orf31?,top_cases_counts_by_genes
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus do not exhibit mutations in ADRA1A and PLEKHG6?",top_cases_counts_by_genes
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in CDH23 and PTPRO?,top_cases_counts_by_genes
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in CDH23 and FGF8?,top_cases_counts_by_genes
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in KRT39 and CACNA1F?,top_cases_counts_by_genes
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in PDHA2 and MUC16?,top_cases_counts_by_genes
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in SLC24A2 and MYO3B?,top_cases_counts_by_genes
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma do not exhibit mutations in PTPRN2 and UNC5D?,top_cases_counts_by_genes
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma do not exhibit mutations in PTPRN2 and AUTS2?,top_cases_counts_by_genes
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma do not exhibit mutations in PTPRN2 and SGCZ?,top_cases_counts_by_genes
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma do not exhibit mutations in PTPRN2 and AUTS2?,top_cases_counts_by_genes
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What proportion of Liver Hepatocellular Carcinoma do not exhibit mutations in PTPRN2 and TTC12?,top_cases_counts_by_genes
+1188,SOX21,R55L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in SOX21 and PGR?,top_cases_counts_by_genes
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma do not exhibit mutations in CPA6 and DGKD?,top_cases_counts_by_genes
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in GRM5 and ANP32E?,top_cases_counts_by_genes
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus do not exhibit mutations in CASZ1 and DCLK3?",top_cases_counts_by_genes
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in SGIP1 and PTPRN2?,top_cases_counts_by_genes
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in SGIP1 and DCLK3?,top_cases_counts_by_genes
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in SGIP1 and PIK3C2G?,top_cases_counts_by_genes
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in SGIP1 and CACNA1F?,top_cases_counts_by_genes
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in CARMIL1 and TENM2?,top_cases_counts_by_genes
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in CARMIL1 and GUCY2C?,top_cases_counts_by_genes
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in ZNF431 and ANKRD30A?,top_cases_counts_by_genes
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in ZNF431 and DCAF6?,top_cases_counts_by_genes
+1234,ZNF431,R128I,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in ZNF431 and PHLPP1?,top_cases_counts_by_genes
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in DNAH11 and KRT39?,top_cases_counts_by_genes
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in DNAH11 and PTPRN2?,top_cases_counts_by_genes
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in POLD1 and SYNJ1?,top_cases_counts_by_genes
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What proportion of Lung Squamous Cell Carcinoma do not exhibit mutations in POLD1 and POLD1?,top_cases_counts_by_genes
+1248,TTC12,D646H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in TTC12 and MYO3A?,top_cases_counts_by_genes
+1249,TTC12,D652H,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in TTC12 and JAML?,top_cases_counts_by_genes
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma do not exhibit mutations in CNGB1 and BCAT1?,top_cases_counts_by_genes
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What proportion of Bladder Urothelial Carcinoma do not exhibit mutations in CNGB1 and OR2T4?,top_cases_counts_by_genes
+1254,CTSC,E214V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in CTSC and UNC5D?,top_cases_counts_by_genes
+1255,CTSC,E291V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in CTSC and PRSS1?,top_cases_counts_by_genes
+1256,CTSC,E322V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in CTSC and FNDC7?,top_cases_counts_by_genes
+1257,CTSC,E324V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in CTSC and PIK3C2G?,top_cases_counts_by_genes
+1258,CTSC,E335V,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in CTSC and POLD1?,top_cases_counts_by_genes
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in PRSS8 and ZMYM3?,top_cases_counts_by_genes
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in PRSS8 and ACTA2?,top_cases_counts_by_genes
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in ARHGEF40 and PGR?,top_cases_counts_by_genes
+1264,ACTB,A138T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma do not exhibit mutations in ACTB and JAML?,top_cases_counts_by_genes
+1265,ACTB,A217T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma do not exhibit mutations in ACTB and SGIP1?,top_cases_counts_by_genes
+1266,ACTB,A244T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma do not exhibit mutations in ACTB and TAF1C?,top_cases_counts_by_genes
+1267,ACTB,A260T,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma do not exhibit mutations in ACTB and TMEM255A?,top_cases_counts_by_genes
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme do not exhibit mutations in YY1AP1 and ZFAT?,top_cases_counts_by_genes
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme do not exhibit mutations in YY1AP1 and CDKN2AIP?,top_cases_counts_by_genes
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme do not exhibit mutations in YY1AP1 and LDOC1?,top_cases_counts_by_genes
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme do not exhibit mutations in YY1AP1 and TTN?,top_cases_counts_by_genes
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme do not exhibit mutations in YY1AP1 and CTCFL?,top_cases_counts_by_genes
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme do not exhibit mutations in YY1AP1 and DCC?,top_cases_counts_by_genes
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What proportion of Glioblastoma Multiforme do not exhibit mutations in YY1AP1 and JAML?,top_cases_counts_by_genes
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in FNDC7 and MRPL32?,top_cases_counts_by_genes
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in FNDC7 and CTCFL?,top_cases_counts_by_genes
+1299,TLCD5,G15V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in TLCD5 and SPATA22?,top_cases_counts_by_genes
+1300,TLCD5,G37V,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in TLCD5 and GPC3?,top_cases_counts_by_genes
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in POLR1G and PLEKHG6?,top_cases_counts_by_genes
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in POLR1G and PTPRN2?,top_cases_counts_by_genes
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in DNAH14 and BICC1?,top_cases_counts_by_genes
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in DNAH14 and KIF20B?,top_cases_counts_by_genes
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in DNAH14 and TENT5A?,top_cases_counts_by_genes
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in NEXN and ANKDD1A?,top_cases_counts_by_genes
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma do not exhibit mutations in CYB5R2 and CACNA1F?,top_cases_counts_by_genes
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What proportion of Prostate Adenocarcinoma do not exhibit mutations in CYB5R2 and LCN15?,top_cases_counts_by_genes
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in NRAP and ANKDD1A?,top_cases_counts_by_genes
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in NRAP and ANKRD24?,top_cases_counts_by_genes
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in NRAP and CHODL?,top_cases_counts_by_genes
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in CCDC22 and PCDHGA1?,top_cases_counts_by_genes
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in DCAF6 and ACVR1B?,top_cases_counts_by_genes
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in DCAF6 and TNS1?,top_cases_counts_by_genes
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in ZNF708 and SPATA22?,top_cases_counts_by_genes
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in BFAR and OR13C3?,top_cases_counts_by_genes
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in MAST4 and ANKRD24?,top_cases_counts_by_genes
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in MAST4 and ZNF627?,top_cases_counts_by_genes
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in MAST4 and PTPRO?,top_cases_counts_by_genes
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in MAST4 and TYK2?,top_cases_counts_by_genes
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in MAST4 and GLRB?,top_cases_counts_by_genes
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in ARMC3 and ZFPM2?,top_cases_counts_by_genes
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in ARMC3 and ACVR1B?,top_cases_counts_by_genes
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What proportion of Kidney Renal Clear Cell Carcinoma do not exhibit mutations in TET2 and POLR1G?,top_cases_counts_by_genes
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What proportion of Kidney Renal Clear Cell Carcinoma do not exhibit mutations in TET2 and POC1B?,top_cases_counts_by_genes
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in SERPINB10 and POLR1G?,top_cases_counts_by_genes
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in STAT3 and KDM5C?,top_cases_counts_by_genes
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in MIEF1 and DCC?,top_cases_counts_by_genes
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in ACVR1B and PTPRN2?,top_cases_counts_by_genes
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in ACVR1B and POC1B?,top_cases_counts_by_genes
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in ACVR1B and DCN?,top_cases_counts_by_genes
+1393,EBF2,T104I,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in EBF2 and MORF4L1?,top_cases_counts_by_genes
+1394,EBF2,T252I,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in EBF2 and TLK2?,top_cases_counts_by_genes
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in VPS26B and BCAT1?,top_cases_counts_by_genes
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus do not exhibit mutations in PGR and DCC?",top_cases_counts_by_genes
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus do not exhibit mutations in PGR and PXN?",top_cases_counts_by_genes
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus do not exhibit mutations in PGR and ANP32E?",top_cases_counts_by_genes
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What proportion of Skin Cutaneous Melanoma do not exhibit mutations in ACTA2 and ADRA1A?,top_cases_counts_by_genes
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in THBS4 and ABCC2?,top_cases_counts_by_genes
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in THBS4 and RIPOR2?,top_cases_counts_by_genes
+1413,PRSS1,S114T,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in PRSS1 and RIPOR2?,top_cases_counts_by_genes
+1414,PRSS1,S124T,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in PRSS1 and GABRA6?,top_cases_counts_by_genes
+1415,PRSS1,S138T,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in PRSS1 and ADRA1A?,top_cases_counts_by_genes
+1416,PRSS1,S74T,Lung Adenocarcinoma,What proportion of Lung Adenocarcinoma do not exhibit mutations in PRSS1 and MYO15A?,top_cases_counts_by_genes
+1417,PGF,R126H,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in PGF and JAML?,top_cases_counts_by_genes
+1418,PGF,R127H,Stomach Adenocarcinoma,What proportion of Stomach Adenocarcinoma do not exhibit mutations in PGF and TASOR2?,top_cases_counts_by_genes
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma do not exhibit mutations in ITPRID2 and CA9?,top_cases_counts_by_genes
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What proportion of Breast Invasive Carcinoma do not exhibit mutations in ITPRID2 and MED16?,top_cases_counts_by_genes
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in HBB and PLEKHG6?,top_cases_counts_by_genes
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in PCDHB2 and AUTS2?,top_cases_counts_by_genes
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in PCDHB2 and EIF2B4?,top_cases_counts_by_genes
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What proportion of Colon Adenocarcinoma do not exhibit mutations in PCDHB2 and MAST4?,top_cases_counts_by_genes
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What proportion of Uterine Corpus Endometrial Carcinoma do not exhibit mutations in UBR2 and TAF1C?,top_cases_counts_by_genes
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What proportion of Rectum Adenocarcinoma do not exhibit mutations in FBXO42 and GABRA6?,top_cases_counts_by_genes
+1,TNS1,G1362V,Breast Invasive Carcinoma,How frequently are Breast Invasive Carcinoma without TNS1 mutations observed?,top_cases_counts_by_genes
+2,TNS1,G1711V,Breast Invasive Carcinoma,How frequently are Breast Invasive Carcinoma without TNS1 mutations observed?,top_cases_counts_by_genes
+3,TNS1,G1718V,Breast Invasive Carcinoma,How frequently are Breast Invasive Carcinoma without TNS1 mutations observed?,top_cases_counts_by_genes
+4,TNS1,G1732V,Breast Invasive Carcinoma,How frequently are Breast Invasive Carcinoma without TNS1 mutations observed?,top_cases_counts_by_genes
+5,TNS1,G1824V,Breast Invasive Carcinoma,How frequently are Breast Invasive Carcinoma without TNS1 mutations observed?,top_cases_counts_by_genes
+6,TNS1,G1857V,Breast Invasive Carcinoma,How frequently are Breast Invasive Carcinoma without TNS1 mutations observed?,top_cases_counts_by_genes
+7,TNS1,G843V,Breast Invasive Carcinoma,How frequently are Breast Invasive Carcinoma without TNS1 mutations observed?,top_cases_counts_by_genes
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How frequently are Bladder Urothelial Carcinoma without EVC2 mutations observed?,top_cases_counts_by_genes
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How frequently are Bladder Urothelial Carcinoma without EVC2 mutations observed?,top_cases_counts_by_genes
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without CR1 mutations observed?,top_cases_counts_by_genes
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without CR1 mutations observed?,top_cases_counts_by_genes
+22,TRPA1,S295I,Rectum Adenocarcinoma,How frequently are Rectum Adenocarcinoma without TRPA1 mutations observed?,top_cases_counts_by_genes
+23,TRPA1,S443I,Rectum Adenocarcinoma,How frequently are Rectum Adenocarcinoma without TRPA1 mutations observed?,top_cases_counts_by_genes
+24,TAF1C,R299L,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without TAF1C mutations observed?,top_cases_counts_by_genes
+25,TAF1C,R396L,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without TAF1C mutations observed?,top_cases_counts_by_genes
+26,TAF1C,R634L,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without TAF1C mutations observed?,top_cases_counts_by_genes
+27,TAF1C,R702L,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without TAF1C mutations observed?,top_cases_counts_by_genes
+28,TAF1C,R728L,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without TAF1C mutations observed?,top_cases_counts_by_genes
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without DPF3 mutations observed?,top_cases_counts_by_genes
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without DPF3 mutations observed?,top_cases_counts_by_genes
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without DPF3 mutations observed?,top_cases_counts_by_genes
+42,OR2T4,P272H,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without OR2T4 mutations observed?,top_cases_counts_by_genes
+43,OR2T4,P300H,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without OR2T4 mutations observed?,top_cases_counts_by_genes
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How frequently are Pancreatic Adenocarcinoma without FBN1 mutations observed?,top_cases_counts_by_genes
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How frequently are Prostate Adenocarcinoma without MAD1L1 mutations observed?,top_cases_counts_by_genes
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How frequently are Prostate Adenocarcinoma without MAD1L1 mutations observed?,top_cases_counts_by_genes
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How frequently are Prostate Adenocarcinoma without MAD1L1 mutations observed?,top_cases_counts_by_genes
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without CCNG1 mutations observed?,top_cases_counts_by_genes
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How frequently are Kidney Renal Papillary Cell Carcinoma without ANP32E mutations observed?,top_cases_counts_by_genes
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How frequently are Kidney Renal Papillary Cell Carcinoma without ANP32E mutations observed?,top_cases_counts_by_genes
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How frequently are Kidney Renal Papillary Cell Carcinoma without ANP32E mutations observed?,top_cases_counts_by_genes
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How frequently are Kidney Renal Papillary Cell Carcinoma without ANP32E mutations observed?,top_cases_counts_by_genes
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How frequently are Bladder Urothelial Carcinoma without FRY mutations observed?,top_cases_counts_by_genes
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How frequently are Bladder Urothelial Carcinoma without FRY mutations observed?,top_cases_counts_by_genes
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How frequently are Bladder Urothelial Carcinoma without FRY mutations observed?,top_cases_counts_by_genes
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How frequently are Bladder Urothelial Carcinoma without FRY mutations observed?,top_cases_counts_by_genes
+70,PAK3,E318K,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without PAK3 mutations observed?,top_cases_counts_by_genes
+71,PAK3,E319K,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without PAK3 mutations observed?,top_cases_counts_by_genes
+72,PAK3,E334K,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without PAK3 mutations observed?,top_cases_counts_by_genes
+73,PAK3,E340K,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without PAK3 mutations observed?,top_cases_counts_by_genes
+74,PAK3,E355K,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without PAK3 mutations observed?,top_cases_counts_by_genes
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without MUC16 mutations observed?,top_cases_counts_by_genes
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How frequently are Liver Hepatocellular Carcinoma without ZFPM2 mutations observed?,top_cases_counts_by_genes
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How frequently are Liver Hepatocellular Carcinoma without ZFPM2 mutations observed?,top_cases_counts_by_genes
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How frequently are Breast Invasive Carcinoma without PIK3C2B mutations observed?,top_cases_counts_by_genes
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How frequently are Breast Invasive Carcinoma without PIK3C2B mutations observed?,top_cases_counts_by_genes
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without ZNF804A mutations observed?,top_cases_counts_by_genes
+116,RELN,A2371V,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without RELN mutations observed?,top_cases_counts_by_genes
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without EFCAB12 mutations observed?",top_cases_counts_by_genes
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without EFCAB12 mutations observed?",top_cases_counts_by_genes
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without DEFB115 mutations observed?,top_cases_counts_by_genes
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How frequently are Bladder Urothelial Carcinoma without ANKDD1A mutations observed?,top_cases_counts_by_genes
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How frequently are Bladder Urothelial Carcinoma without ANKDD1A mutations observed?,top_cases_counts_by_genes
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How frequently are Bladder Urothelial Carcinoma without ANKDD1A mutations observed?,top_cases_counts_by_genes
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without HTR3B mutations observed?,top_cases_counts_by_genes
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without HTR3B mutations observed?,top_cases_counts_by_genes
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without HTR3B mutations observed?,top_cases_counts_by_genes
+129,ABCC3,R758W,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without ABCC3 mutations observed?,top_cases_counts_by_genes
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without NOMO1 mutations observed?,top_cases_counts_by_genes
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without NOMO1 mutations observed?,top_cases_counts_by_genes
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How frequently are Bladder Urothelial Carcinoma without HYOU1 mutations observed?,top_cases_counts_by_genes
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without FMO4 mutations observed?,top_cases_counts_by_genes
+140,BICC1,A372V,Exceptional Responders,How frequently are Exceptional Responders without BICC1 mutations observed?,top_cases_counts_by_genes
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without ZMYM3 mutations observed?,top_cases_counts_by_genes
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without ZMYM3 mutations observed?,top_cases_counts_by_genes
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without ZMYM3 mutations observed?,top_cases_counts_by_genes
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without XKR4 mutations observed?",top_cases_counts_by_genes
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How frequently are Liver Hepatocellular Carcinoma without ABCC2 mutations observed?,top_cases_counts_by_genes
+157,OR8K5,R293G,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without OR8K5 mutations observed?,top_cases_counts_by_genes
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without SPTAN1 mutations observed?,top_cases_counts_by_genes
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without SPTAN1 mutations observed?,top_cases_counts_by_genes
+164,SYT10,M484I,Rectum Adenocarcinoma,How frequently are Rectum Adenocarcinoma without SYT10 mutations observed?,top_cases_counts_by_genes
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without HSPA5 mutations observed?,top_cases_counts_by_genes
+175,UNC5D,L280V,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without UNC5D mutations observed?,top_cases_counts_by_genes
+176,UNC5D,L635V,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without UNC5D mutations observed?,top_cases_counts_by_genes
+177,UNC5D,L637V,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without UNC5D mutations observed?,top_cases_counts_by_genes
+178,UNC5D,L699V,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without UNC5D mutations observed?,top_cases_counts_by_genes
+179,UNC5D,L704V,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without UNC5D mutations observed?,top_cases_counts_by_genes
+180,UNC5D,L709V,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without UNC5D mutations observed?,top_cases_counts_by_genes
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How frequently are Kidney Renal Clear Cell Carcinoma without DOCK2 mutations observed?,top_cases_counts_by_genes
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How frequently are Kidney Renal Clear Cell Carcinoma without ZNF627 mutations observed?,top_cases_counts_by_genes
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without CDC42BPA mutations observed?,top_cases_counts_by_genes
+193,MRPL55,H27Y,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without MRPL55 mutations observed?,top_cases_counts_by_genes
+194,MRPL55,H63Y,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without MRPL55 mutations observed?,top_cases_counts_by_genes
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How frequently are Breast Invasive Carcinoma without TMTC3 mutations observed?,top_cases_counts_by_genes
+198,EPRS1,K771I,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without EPRS1 mutations observed?,top_cases_counts_by_genes
+199,EPRS1,K778I,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without EPRS1 mutations observed?,top_cases_counts_by_genes
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without GRTP1 mutations observed?,top_cases_counts_by_genes
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without GRTP1 mutations observed?,top_cases_counts_by_genes
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without TSHZ3 mutations observed?,top_cases_counts_by_genes
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How frequently are HIV+ Tumor Molecular Characterization Project - Cervical Cancer without TAS1R3 mutations observed?,top_cases_counts_by_genes
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without PIAS3 mutations observed?,top_cases_counts_by_genes
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without PIAS3 mutations observed?,top_cases_counts_by_genes
+251,ZNF274,P13R,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without ZNF274 mutations observed?,top_cases_counts_by_genes
+253,SYNJ1,R795C,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without SYNJ1 mutations observed?,top_cases_counts_by_genes
+254,SYNJ1,R800C,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without SYNJ1 mutations observed?,top_cases_counts_by_genes
+255,SYNJ1,R839C,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without SYNJ1 mutations observed?,top_cases_counts_by_genes
+261,DSCAM,V343M,Prostate Adenocarcinoma,How frequently are Prostate Adenocarcinoma without DSCAM mutations observed?,top_cases_counts_by_genes
+262,DSCAM,V426M,Prostate Adenocarcinoma,How frequently are Prostate Adenocarcinoma without DSCAM mutations observed?,top_cases_counts_by_genes
+263,DSCAM,V591M,Prostate Adenocarcinoma,How frequently are Prostate Adenocarcinoma without DSCAM mutations observed?,top_cases_counts_by_genes
+267,DGKD,R140H,Exceptional Responders,How frequently are Exceptional Responders without DGKD mutations observed?,top_cases_counts_by_genes
+268,DGKD,R160H,Exceptional Responders,How frequently are Exceptional Responders without DGKD mutations observed?,top_cases_counts_by_genes
+269,DGKD,R204H,Exceptional Responders,How frequently are Exceptional Responders without DGKD mutations observed?,top_cases_counts_by_genes
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How frequently are Bladder Urothelial Carcinoma without PLEKHG6 mutations observed?,top_cases_counts_by_genes
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How frequently are Bladder Urothelial Carcinoma without PLEKHG6 mutations observed?,top_cases_counts_by_genes
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How frequently are Bladder Urothelial Carcinoma without PLEKHG6 mutations observed?,top_cases_counts_by_genes
+279,WNT2,D138N,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without WNT2 mutations observed?,top_cases_counts_by_genes
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without GUCY2C mutations observed?,top_cases_counts_by_genes
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without C7orf31 mutations observed?,top_cases_counts_by_genes
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without ZKSCAN7 mutations observed?",top_cases_counts_by_genes
+299,OR5D14,M210L,Neuroblastoma,How frequently are Neuroblastoma without OR5D14 mutations observed?,top_cases_counts_by_genes
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without SPATA22 mutations observed?,top_cases_counts_by_genes
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without SPATA22 mutations observed?,top_cases_counts_by_genes
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without SPATA22 mutations observed?,top_cases_counts_by_genes
+310,LCN15,E21V,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without LCN15 mutations observed?,top_cases_counts_by_genes
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without DCAF4L2 mutations observed?,top_cases_counts_by_genes
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without GUK1 mutations observed?,top_cases_counts_by_genes
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without GUK1 mutations observed?,top_cases_counts_by_genes
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without GUK1 mutations observed?,top_cases_counts_by_genes
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without GUK1 mutations observed?,top_cases_counts_by_genes
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without GUK1 mutations observed?,top_cases_counts_by_genes
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without MORF4L1 mutations observed?,top_cases_counts_by_genes
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without MORF4L1 mutations observed?,top_cases_counts_by_genes
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without MORF4L1 mutations observed?,top_cases_counts_by_genes
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without MORF4L1 mutations observed?,top_cases_counts_by_genes
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without MYO3B mutations observed?,top_cases_counts_by_genes
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without MYO3B mutations observed?,top_cases_counts_by_genes
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without TENT5A mutations observed?,top_cases_counts_by_genes
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without TENT5A mutations observed?,top_cases_counts_by_genes
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without TENT5A mutations observed?,top_cases_counts_by_genes
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How frequently are Ovarian Serous Cystadenocarcinoma without ZFAT mutations observed?,top_cases_counts_by_genes
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How frequently are Ovarian Serous Cystadenocarcinoma without ZFAT mutations observed?,top_cases_counts_by_genes
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How frequently are Ovarian Serous Cystadenocarcinoma without ZFAT mutations observed?,top_cases_counts_by_genes
+357,ZNF584,A211T,Sarcoma,How frequently are Sarcoma without ZNF584 mutations observed?,top_cases_counts_by_genes
+358,ZNF584,A256T,Sarcoma,How frequently are Sarcoma without ZNF584 mutations observed?,top_cases_counts_by_genes
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without LDOC1 mutations observed?,top_cases_counts_by_genes
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without PDGFC mutations observed?,top_cases_counts_by_genes
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without MSANTD4 mutations observed?,top_cases_counts_by_genes
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without NPSR1 mutations observed?,top_cases_counts_by_genes
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without PHLPP1 mutations observed?,top_cases_counts_by_genes
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without COL6A3 mutations observed?,top_cases_counts_by_genes
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without COL6A3 mutations observed?,top_cases_counts_by_genes
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without COL6A3 mutations observed?,top_cases_counts_by_genes
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without COL6A3 mutations observed?,top_cases_counts_by_genes
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without COL6A3 mutations observed?,top_cases_counts_by_genes
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without ADRA1A mutations observed?,top_cases_counts_by_genes
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently are Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma without LAMB2 mutations observed?,top_cases_counts_by_genes
+406,POC1B,I198T,Rectum Adenocarcinoma,How frequently are Rectum Adenocarcinoma without POC1B mutations observed?,top_cases_counts_by_genes
+407,POC1B,I286T,Rectum Adenocarcinoma,How frequently are Rectum Adenocarcinoma without POC1B mutations observed?,top_cases_counts_by_genes
+408,POC1B,I328T,Rectum Adenocarcinoma,How frequently are Rectum Adenocarcinoma without POC1B mutations observed?,top_cases_counts_by_genes
+409,POC1B,S79P,Rectum Adenocarcinoma,How frequently are Rectum Adenocarcinoma without POC1B mutations observed?,top_cases_counts_by_genes
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How frequently are Liver Hepatocellular Carcinoma without USH2A mutations observed?,top_cases_counts_by_genes
+414,AQP7,T110S,Rectum Adenocarcinoma,How frequently are Rectum Adenocarcinoma without AQP7 mutations observed?,top_cases_counts_by_genes
+415,AQP7,T166S,Rectum Adenocarcinoma,How frequently are Rectum Adenocarcinoma without AQP7 mutations observed?,top_cases_counts_by_genes
+416,AQP7,T167S,Rectum Adenocarcinoma,How frequently are Rectum Adenocarcinoma without AQP7 mutations observed?,top_cases_counts_by_genes
+417,AQP7,T75S,Rectum Adenocarcinoma,How frequently are Rectum Adenocarcinoma without AQP7 mutations observed?,top_cases_counts_by_genes
+430,DCN,R163C,Rectum Adenocarcinoma,How frequently are Rectum Adenocarcinoma without DCN mutations observed?,top_cases_counts_by_genes
+431,DCN,R203C,Rectum Adenocarcinoma,How frequently are Rectum Adenocarcinoma without DCN mutations observed?,top_cases_counts_by_genes
+432,DCN,R241C,Rectum Adenocarcinoma,How frequently are Rectum Adenocarcinoma without DCN mutations observed?,top_cases_counts_by_genes
+433,DCN,R350C,Rectum Adenocarcinoma,How frequently are Rectum Adenocarcinoma without DCN mutations observed?,top_cases_counts_by_genes
+434,DCN,R41C,Rectum Adenocarcinoma,How frequently are Rectum Adenocarcinoma without DCN mutations observed?,top_cases_counts_by_genes
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without CPS1 mutations observed?,top_cases_counts_by_genes
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without CPS1 mutations observed?,top_cases_counts_by_genes
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without CPS1 mutations observed?,top_cases_counts_by_genes
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How frequently are Kidney Renal Papillary Cell Carcinoma without FCGR2C mutations observed?,top_cases_counts_by_genes
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How frequently are Kidney Renal Papillary Cell Carcinoma without FCGR2C mutations observed?,top_cases_counts_by_genes
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without GRM1 mutations observed?,top_cases_counts_by_genes
+482,SGCZ,Q138H,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without SGCZ mutations observed?,top_cases_counts_by_genes
+483,SGCZ,Q91H,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without SGCZ mutations observed?,top_cases_counts_by_genes
+485,SMO,V15M,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without SMO mutations observed?,top_cases_counts_by_genes
+486,SMO,V321M,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without SMO mutations observed?,top_cases_counts_by_genes
+488,CHODL,G159E,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without CHODL mutations observed?,top_cases_counts_by_genes
+489,CHODL,G181E,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without CHODL mutations observed?,top_cases_counts_by_genes
+490,CHODL,G200E,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without CHODL mutations observed?,top_cases_counts_by_genes
+494,MYO16,P399H,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without MYO16 mutations observed?,top_cases_counts_by_genes
+495,MYO16,P421H,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without MYO16 mutations observed?,top_cases_counts_by_genes
+498,CXCR2,A98V,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without CXCR2 mutations observed?,top_cases_counts_by_genes
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How frequently are Bladder Urothelial Carcinoma without TMEM225 mutations observed?,top_cases_counts_by_genes
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without MAOB mutations observed?,top_cases_counts_by_genes
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without GPRASP1 mutations observed?,top_cases_counts_by_genes
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without MRPL32 mutations observed?,top_cases_counts_by_genes
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without TYROBP mutations observed?,top_cases_counts_by_genes
+510,RAB40C,A111V,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without RAB40C mutations observed?,top_cases_counts_by_genes
+511,RAB40C,A143V,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without RAB40C mutations observed?,top_cases_counts_by_genes
+512,CTNNA2,S323R,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without CTNNA2 mutations observed?,top_cases_counts_by_genes
+513,CTNNA2,S339R,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without CTNNA2 mutations observed?,top_cases_counts_by_genes
+514,CTNNA2,S386R,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without CTNNA2 mutations observed?,top_cases_counts_by_genes
+515,CTNNA2,S707R,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without CTNNA2 mutations observed?,top_cases_counts_by_genes
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How frequently are Bladder Urothelial Carcinoma without MYO15A mutations observed?,top_cases_counts_by_genes
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without GIMAP2 mutations observed?,top_cases_counts_by_genes
+532,KIF20B,N1160D,Glioblastoma Multiforme,How frequently are Glioblastoma Multiforme without KIF20B mutations observed?,top_cases_counts_by_genes
+533,KIF20B,N1200D,Glioblastoma Multiforme,How frequently are Glioblastoma Multiforme without KIF20B mutations observed?,top_cases_counts_by_genes
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without ADAM17 mutations observed?,top_cases_counts_by_genes
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without BCAT1 mutations observed?,top_cases_counts_by_genes
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without BCAT1 mutations observed?,top_cases_counts_by_genes
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without BCAT1 mutations observed?,top_cases_counts_by_genes
+540,ERCC6,R1053H,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without ERCC6 mutations observed?,top_cases_counts_by_genes
+541,DCC,R320W,Breast Invasive Carcinoma,How frequently are Breast Invasive Carcinoma without DCC mutations observed?,top_cases_counts_by_genes
+542,DCC,R363W,Breast Invasive Carcinoma,How frequently are Breast Invasive Carcinoma without DCC mutations observed?,top_cases_counts_by_genes
+543,DCC,R386W,Breast Invasive Carcinoma,How frequently are Breast Invasive Carcinoma without DCC mutations observed?,top_cases_counts_by_genes
+544,DCC,R41W,Breast Invasive Carcinoma,How frequently are Breast Invasive Carcinoma without DCC mutations observed?,top_cases_counts_by_genes
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without FBXO15 mutations observed?,top_cases_counts_by_genes
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without FBXO15 mutations observed?,top_cases_counts_by_genes
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without GSTCD mutations observed?,top_cases_counts_by_genes
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without GSTCD mutations observed?,top_cases_counts_by_genes
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without OLFML3 mutations observed?,top_cases_counts_by_genes
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without OLFML3 mutations observed?,top_cases_counts_by_genes
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without OLFML3 mutations observed?,top_cases_counts_by_genes
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How frequently are Ovarian Serous Cystadenocarcinoma without CFAP61 mutations observed?,top_cases_counts_by_genes
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How frequently are Ovarian Serous Cystadenocarcinoma without CFAP61 mutations observed?,top_cases_counts_by_genes
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How frequently are Bladder Urothelial Carcinoma without HLA-DQA2 mutations observed?,top_cases_counts_by_genes
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without TENM2 mutations observed?,top_cases_counts_by_genes
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without TENM2 mutations observed?,top_cases_counts_by_genes
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without TENM2 mutations observed?,top_cases_counts_by_genes
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without ANKRD24 mutations observed?,top_cases_counts_by_genes
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without ANKRD24 mutations observed?,top_cases_counts_by_genes
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without ANKRD24 mutations observed?,top_cases_counts_by_genes
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without ZCCHC14 mutations observed?,top_cases_counts_by_genes
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without ZCCHC14 mutations observed?,top_cases_counts_by_genes
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without ZCCHC14 mutations observed?,top_cases_counts_by_genes
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without ZCCHC14 mutations observed?,top_cases_counts_by_genes
+625,SIK2,I265M,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without SIK2 mutations observed?,top_cases_counts_by_genes
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without MYH11 mutations observed?,top_cases_counts_by_genes
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without MYH11 mutations observed?,top_cases_counts_by_genes
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without SLC6A4 mutations observed?,top_cases_counts_by_genes
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without SLC9C1 mutations observed?,top_cases_counts_by_genes
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without SLC9C1 mutations observed?,top_cases_counts_by_genes
+644,OR2A12,A254T,Brain Lower Grade Glioma,How frequently are Brain Lower Grade Glioma without OR2A12 mutations observed?,top_cases_counts_by_genes
+646,PYHIN1,T325K,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without PYHIN1 mutations observed?,top_cases_counts_by_genes
+647,PYHIN1,T334K,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without PYHIN1 mutations observed?,top_cases_counts_by_genes
+650,JAML,G191E,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without JAML mutations observed?,top_cases_counts_by_genes
+651,JAML,G219E,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without JAML mutations observed?,top_cases_counts_by_genes
+652,JAML,G220E,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without JAML mutations observed?,top_cases_counts_by_genes
+653,JAML,G230E,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without JAML mutations observed?,top_cases_counts_by_genes
+658,TYK2,H1146R,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without TYK2 mutations observed?,top_cases_counts_by_genes
+659,TYK2,H23R,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without TYK2 mutations observed?,top_cases_counts_by_genes
+660,TYK2,H961R,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without TYK2 mutations observed?,top_cases_counts_by_genes
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without CTCFL mutations observed?,top_cases_counts_by_genes
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without CTCFL mutations observed?,top_cases_counts_by_genes
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without CTCFL mutations observed?,top_cases_counts_by_genes
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without CTCFL mutations observed?,top_cases_counts_by_genes
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without CEP20 mutations observed?,top_cases_counts_by_genes
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without CEP20 mutations observed?,top_cases_counts_by_genes
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without RIMS2 mutations observed?,top_cases_counts_by_genes
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without RIMS2 mutations observed?,top_cases_counts_by_genes
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without RIMS2 mutations observed?,top_cases_counts_by_genes
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without RIMS2 mutations observed?,top_cases_counts_by_genes
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without RIMS2 mutations observed?,top_cases_counts_by_genes
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without RIMS2 mutations observed?,top_cases_counts_by_genes
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without RIMS2 mutations observed?,top_cases_counts_by_genes
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without PIK3C2G mutations observed?,top_cases_counts_by_genes
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without PIK3C2G mutations observed?,top_cases_counts_by_genes
+728,STK19,D341N,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without STK19 mutations observed?,top_cases_counts_by_genes
+729,STK19,D345N,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without STK19 mutations observed?,top_cases_counts_by_genes
+730,REXO4,P60A,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without REXO4 mutations observed?,top_cases_counts_by_genes
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without ZBTB34 mutations observed?,top_cases_counts_by_genes
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without ZBTB34 mutations observed?,top_cases_counts_by_genes
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How frequently are Bladder Urothelial Carcinoma without NCKAP5 mutations observed?,top_cases_counts_by_genes
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without SORCS1 mutations observed?",top_cases_counts_by_genes
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without SORCS1 mutations observed?",top_cases_counts_by_genes
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without SORCS1 mutations observed?",top_cases_counts_by_genes
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without SORCS1 mutations observed?",top_cases_counts_by_genes
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How frequently are Head and Neck Squamous Cell Carcinoma without FGF8 mutations observed?,top_cases_counts_by_genes
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How frequently are Head and Neck Squamous Cell Carcinoma without FGF8 mutations observed?,top_cases_counts_by_genes
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How frequently are Head and Neck Squamous Cell Carcinoma without FGF8 mutations observed?,top_cases_counts_by_genes
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How frequently are Head and Neck Squamous Cell Carcinoma without FGF8 mutations observed?,top_cases_counts_by_genes
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How frequently are Head and Neck Squamous Cell Carcinoma without FGF8 mutations observed?,top_cases_counts_by_genes
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How frequently are Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia without TENM3 mutations observed?,top_cases_counts_by_genes
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without AKT1 mutations observed?,top_cases_counts_by_genes
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently are Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma without CFAP298-TCP10L mutations observed?,top_cases_counts_by_genes
+792,GLRB,E148D,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without GLRB mutations observed?,top_cases_counts_by_genes
+793,TTN,F7636L,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without TTN mutations observed?,top_cases_counts_by_genes
+794,TTN,F8563L,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without TTN mutations observed?,top_cases_counts_by_genes
+795,TTN,F8880L,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without TTN mutations observed?,top_cases_counts_by_genes
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without ANKRD30A mutations observed?,top_cases_counts_by_genes
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without ANKRD30A mutations observed?,top_cases_counts_by_genes
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without ANKRD30A mutations observed?,top_cases_counts_by_genes
+809,TRIM45,S177L,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without TRIM45 mutations observed?,top_cases_counts_by_genes
+810,TRIM45,S224L,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without TRIM45 mutations observed?,top_cases_counts_by_genes
+811,TRIM45,S281L,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without TRIM45 mutations observed?,top_cases_counts_by_genes
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without CACNA1F mutations observed?,top_cases_counts_by_genes
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without CACNA1F mutations observed?,top_cases_counts_by_genes
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without CACNA1F mutations observed?,top_cases_counts_by_genes
+817,KL,R594C,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without KL mutations observed?,top_cases_counts_by_genes
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How frequently are Kidney Renal Papillary Cell Carcinoma without GUF1 mutations observed?,top_cases_counts_by_genes
+822,TAF1L,A539V,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without TAF1L mutations observed?,top_cases_counts_by_genes
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without TASOR2 mutations observed?,top_cases_counts_by_genes
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without TASOR2 mutations observed?,top_cases_counts_by_genes
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without TASOR2 mutations observed?,top_cases_counts_by_genes
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without KDM5C mutations observed?,top_cases_counts_by_genes
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without KDM5C mutations observed?,top_cases_counts_by_genes
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without KDM5C mutations observed?,top_cases_counts_by_genes
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without KDM5C mutations observed?,top_cases_counts_by_genes
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently are Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma without IL5RA mutations observed?,top_cases_counts_by_genes
+843,DHX16,A29V,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without DHX16 mutations observed?,top_cases_counts_by_genes
+844,DHX16,A89V,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without DHX16 mutations observed?,top_cases_counts_by_genes
+902,GPR158,A644V,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without GPR158 mutations observed?,top_cases_counts_by_genes
+903,GPR158,A723V,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without GPR158 mutations observed?,top_cases_counts_by_genes
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without EIF2B4 mutations observed?",top_cases_counts_by_genes
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without EIF2B4 mutations observed?",top_cases_counts_by_genes
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without EIF2B4 mutations observed?",top_cases_counts_by_genes
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without EIF2B4 mutations observed?",top_cases_counts_by_genes
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without EIF2B4 mutations observed?",top_cases_counts_by_genes
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without EIF2B4 mutations observed?",top_cases_counts_by_genes
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without AUTS2 mutations observed?,top_cases_counts_by_genes
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without AUTS2 mutations observed?,top_cases_counts_by_genes
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without AUTS2 mutations observed?,top_cases_counts_by_genes
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without AUTS2 mutations observed?,top_cases_counts_by_genes
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without AUTS2 mutations observed?,top_cases_counts_by_genes
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without AUTS2 mutations observed?,top_cases_counts_by_genes
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without AUTS2 mutations observed?,top_cases_counts_by_genes
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without AUTS2 mutations observed?,top_cases_counts_by_genes
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without AUTS2 mutations observed?,top_cases_counts_by_genes
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without AUTS2 mutations observed?,top_cases_counts_by_genes
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without ACTL7B mutations observed?",top_cases_counts_by_genes
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How frequently are Glioblastoma Multiforme without PCDHGA1 mutations observed?,top_cases_counts_by_genes
+954,TRAP1,R114W,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without TRAP1 mutations observed?,top_cases_counts_by_genes
+955,TRAP1,R61W,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without TRAP1 mutations observed?,top_cases_counts_by_genes
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without PIK3C2A mutations observed?,top_cases_counts_by_genes
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How frequently are Liver Hepatocellular Carcinoma without KANSL1 mutations observed?,top_cases_counts_by_genes
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without ANKRD52 mutations observed?,top_cases_counts_by_genes
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without PAPPA mutations observed?,top_cases_counts_by_genes
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How frequently are Rectum Adenocarcinoma without B3GALNT1 mutations observed?,top_cases_counts_by_genes
+982,GABRA6,G115R,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without GABRA6 mutations observed?,top_cases_counts_by_genes
+983,GABRA6,G122R,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without GABRA6 mutations observed?,top_cases_counts_by_genes
+984,GABRA6,G165R,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without GABRA6 mutations observed?,top_cases_counts_by_genes
+985,GABRA6,G175R,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without GABRA6 mutations observed?,top_cases_counts_by_genes
+986,GABRA6,G70R,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without GABRA6 mutations observed?,top_cases_counts_by_genes
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without ZSCAN31 mutations observed?,top_cases_counts_by_genes
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without MED16 mutations observed?",top_cases_counts_by_genes
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without MED16 mutations observed?",top_cases_counts_by_genes
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How frequently are Pancreatic Adenocarcinoma without PTPRO mutations observed?,top_cases_counts_by_genes
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How frequently are Pancreatic Adenocarcinoma without PTPRO mutations observed?,top_cases_counts_by_genes
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How frequently are Pancreatic Adenocarcinoma without PTPRO mutations observed?,top_cases_counts_by_genes
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How frequently are Pancreatic Adenocarcinoma without PTPRO mutations observed?,top_cases_counts_by_genes
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How frequently are Pancreatic Adenocarcinoma without PTPRO mutations observed?,top_cases_counts_by_genes
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How frequently are Pancreatic Adenocarcinoma without PTPRO mutations observed?,top_cases_counts_by_genes
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How frequently are Pancreatic Adenocarcinoma without PTPRO mutations observed?,top_cases_counts_by_genes
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How frequently are Pancreatic Adenocarcinoma without PTPRO mutations observed?,top_cases_counts_by_genes
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without CHMP7 mutations observed?,top_cases_counts_by_genes
+1017,GPC3,I107N,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without GPC3 mutations observed?,top_cases_counts_by_genes
+1018,GPC3,I161N,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without GPC3 mutations observed?,top_cases_counts_by_genes
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently are Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma without TLK2 mutations observed?,top_cases_counts_by_genes
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently are Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma without TLK2 mutations observed?,top_cases_counts_by_genes
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently are Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma without TLK2 mutations observed?,top_cases_counts_by_genes
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently are Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma without TLK2 mutations observed?,top_cases_counts_by_genes
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently are Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma without TLK2 mutations observed?,top_cases_counts_by_genes
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without ZNF217 mutations observed?,top_cases_counts_by_genes
+1038,SYT9,V275L,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without SYT9 mutations observed?,top_cases_counts_by_genes
+1039,SYT9,V307L,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without SYT9 mutations observed?,top_cases_counts_by_genes
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without PKHD1L1 mutations observed?,top_cases_counts_by_genes
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without MYO3A mutations observed?,top_cases_counts_by_genes
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without VASN mutations observed?",top_cases_counts_by_genes
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without DNMT1 mutations observed?,top_cases_counts_by_genes
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without DNMT1 mutations observed?,top_cases_counts_by_genes
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without DNMT1 mutations observed?,top_cases_counts_by_genes
+1056,CA9,E402K,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without CA9 mutations observed?,top_cases_counts_by_genes
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without TTC17 mutations observed?,top_cases_counts_by_genes
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without TTC17 mutations observed?,top_cases_counts_by_genes
+1065,PSG2,P43L,Breast Invasive Carcinoma,How frequently are Breast Invasive Carcinoma without PSG2 mutations observed?,top_cases_counts_by_genes
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How frequently are Breast Invasive Carcinoma without RIPOR2 mutations observed?,top_cases_counts_by_genes
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How frequently are Breast Invasive Carcinoma without RIPOR2 mutations observed?,top_cases_counts_by_genes
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How frequently are Breast Invasive Carcinoma without RIPOR2 mutations observed?,top_cases_counts_by_genes
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How frequently are Breast Invasive Carcinoma without RIPOR2 mutations observed?,top_cases_counts_by_genes
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without DCLK3 mutations observed?,top_cases_counts_by_genes
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without DCLK3 mutations observed?,top_cases_counts_by_genes
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without MERTK mutations observed?,top_cases_counts_by_genes
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without MERTK mutations observed?,top_cases_counts_by_genes
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without MERTK mutations observed?,top_cases_counts_by_genes
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without ZFP42 mutations observed?,top_cases_counts_by_genes
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without OR13C3 mutations observed?,top_cases_counts_by_genes
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without OR13C3 mutations observed?,top_cases_counts_by_genes
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without SPAG1 mutations observed?,top_cases_counts_by_genes
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without CDKN2AIP mutations observed?,top_cases_counts_by_genes
+1093,PXN,H1016Y,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without PXN mutations observed?,top_cases_counts_by_genes
+1094,PXN,H359Y,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without PXN mutations observed?,top_cases_counts_by_genes
+1095,PXN,H492Y,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without PXN mutations observed?,top_cases_counts_by_genes
+1096,PXN,H524Y,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without PXN mutations observed?,top_cases_counts_by_genes
+1097,PXN,H526Y,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without PXN mutations observed?,top_cases_counts_by_genes
+1098,PXN,H540Y,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without PXN mutations observed?,top_cases_counts_by_genes
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without TTYH2 mutations observed?,top_cases_counts_by_genes
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without TTYH2 mutations observed?,top_cases_counts_by_genes
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without TMEM255A mutations observed?,top_cases_counts_by_genes
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without TMEM255A mutations observed?,top_cases_counts_by_genes
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without TMEM255A mutations observed?,top_cases_counts_by_genes
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How frequently are Breast Invasive Carcinoma without TASOR2 mutations observed?,top_cases_counts_by_genes
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How frequently are Breast Invasive Carcinoma without TASOR2 mutations observed?,top_cases_counts_by_genes
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without ICE1 mutations observed?,top_cases_counts_by_genes
+1112,MYT1,A558E,Breast Invasive Carcinoma,How frequently are Breast Invasive Carcinoma without MYT1 mutations observed?,top_cases_counts_by_genes
+1113,MYT1,A879E,Breast Invasive Carcinoma,How frequently are Breast Invasive Carcinoma without MYT1 mutations observed?,top_cases_counts_by_genes
+1114,MYT1,A906E,Breast Invasive Carcinoma,How frequently are Breast Invasive Carcinoma without MYT1 mutations observed?,top_cases_counts_by_genes
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without CX3CR1 mutations observed?,top_cases_counts_by_genes
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without CX3CR1 mutations observed?,top_cases_counts_by_genes
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How frequently are Liver Hepatocellular Carcinoma without SPINDOC mutations observed?,top_cases_counts_by_genes
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without ART3 mutations observed?,top_cases_counts_by_genes
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without ART3 mutations observed?,top_cases_counts_by_genes
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How frequently are Bladder Urothelial Carcinoma without CYP1A2 mutations observed?,top_cases_counts_by_genes
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without ADRA1A mutations observed?",top_cases_counts_by_genes
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without CDH23 mutations observed?,top_cases_counts_by_genes
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without CDH23 mutations observed?,top_cases_counts_by_genes
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without KRT39 mutations observed?,top_cases_counts_by_genes
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without PDHA2 mutations observed?,top_cases_counts_by_genes
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without SLC24A2 mutations observed?,top_cases_counts_by_genes
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How frequently are Liver Hepatocellular Carcinoma without PTPRN2 mutations observed?,top_cases_counts_by_genes
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How frequently are Liver Hepatocellular Carcinoma without PTPRN2 mutations observed?,top_cases_counts_by_genes
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How frequently are Liver Hepatocellular Carcinoma without PTPRN2 mutations observed?,top_cases_counts_by_genes
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How frequently are Liver Hepatocellular Carcinoma without PTPRN2 mutations observed?,top_cases_counts_by_genes
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How frequently are Liver Hepatocellular Carcinoma without PTPRN2 mutations observed?,top_cases_counts_by_genes
+1188,SOX21,R55L,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without SOX21 mutations observed?,top_cases_counts_by_genes
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How frequently are Bladder Urothelial Carcinoma without CPA6 mutations observed?,top_cases_counts_by_genes
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without GRM5 mutations observed?,top_cases_counts_by_genes
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without CASZ1 mutations observed?",top_cases_counts_by_genes
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without SGIP1 mutations observed?,top_cases_counts_by_genes
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without SGIP1 mutations observed?,top_cases_counts_by_genes
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without SGIP1 mutations observed?,top_cases_counts_by_genes
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without SGIP1 mutations observed?,top_cases_counts_by_genes
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without CARMIL1 mutations observed?,top_cases_counts_by_genes
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without CARMIL1 mutations observed?,top_cases_counts_by_genes
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without ZNF431 mutations observed?,top_cases_counts_by_genes
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without ZNF431 mutations observed?,top_cases_counts_by_genes
+1234,ZNF431,R128I,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without ZNF431 mutations observed?,top_cases_counts_by_genes
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without DNAH11 mutations observed?,top_cases_counts_by_genes
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without DNAH11 mutations observed?,top_cases_counts_by_genes
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without POLD1 mutations observed?,top_cases_counts_by_genes
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How frequently are Lung Squamous Cell Carcinoma without POLD1 mutations observed?,top_cases_counts_by_genes
+1248,TTC12,D646H,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without TTC12 mutations observed?,top_cases_counts_by_genes
+1249,TTC12,D652H,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without TTC12 mutations observed?,top_cases_counts_by_genes
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How frequently are Bladder Urothelial Carcinoma without CNGB1 mutations observed?,top_cases_counts_by_genes
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How frequently are Bladder Urothelial Carcinoma without CNGB1 mutations observed?,top_cases_counts_by_genes
+1254,CTSC,E214V,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without CTSC mutations observed?,top_cases_counts_by_genes
+1255,CTSC,E291V,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without CTSC mutations observed?,top_cases_counts_by_genes
+1256,CTSC,E322V,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without CTSC mutations observed?,top_cases_counts_by_genes
+1257,CTSC,E324V,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without CTSC mutations observed?,top_cases_counts_by_genes
+1258,CTSC,E335V,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without CTSC mutations observed?,top_cases_counts_by_genes
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without PRSS8 mutations observed?,top_cases_counts_by_genes
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without PRSS8 mutations observed?,top_cases_counts_by_genes
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without ARHGEF40 mutations observed?,top_cases_counts_by_genes
+1264,ACTB,A138T,Rectum Adenocarcinoma,How frequently are Rectum Adenocarcinoma without ACTB mutations observed?,top_cases_counts_by_genes
+1265,ACTB,A217T,Rectum Adenocarcinoma,How frequently are Rectum Adenocarcinoma without ACTB mutations observed?,top_cases_counts_by_genes
+1266,ACTB,A244T,Rectum Adenocarcinoma,How frequently are Rectum Adenocarcinoma without ACTB mutations observed?,top_cases_counts_by_genes
+1267,ACTB,A260T,Rectum Adenocarcinoma,How frequently are Rectum Adenocarcinoma without ACTB mutations observed?,top_cases_counts_by_genes
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How frequently are Glioblastoma Multiforme without YY1AP1 mutations observed?,top_cases_counts_by_genes
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How frequently are Glioblastoma Multiforme without YY1AP1 mutations observed?,top_cases_counts_by_genes
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How frequently are Glioblastoma Multiforme without YY1AP1 mutations observed?,top_cases_counts_by_genes
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How frequently are Glioblastoma Multiforme without YY1AP1 mutations observed?,top_cases_counts_by_genes
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How frequently are Glioblastoma Multiforme without YY1AP1 mutations observed?,top_cases_counts_by_genes
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How frequently are Glioblastoma Multiforme without YY1AP1 mutations observed?,top_cases_counts_by_genes
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How frequently are Glioblastoma Multiforme without YY1AP1 mutations observed?,top_cases_counts_by_genes
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without FNDC7 mutations observed?,top_cases_counts_by_genes
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without FNDC7 mutations observed?,top_cases_counts_by_genes
+1299,TLCD5,G15V,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without TLCD5 mutations observed?,top_cases_counts_by_genes
+1300,TLCD5,G37V,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without TLCD5 mutations observed?,top_cases_counts_by_genes
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without POLR1G mutations observed?,top_cases_counts_by_genes
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without POLR1G mutations observed?,top_cases_counts_by_genes
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without DNAH14 mutations observed?,top_cases_counts_by_genes
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without DNAH14 mutations observed?,top_cases_counts_by_genes
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without DNAH14 mutations observed?,top_cases_counts_by_genes
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without NEXN mutations observed?,top_cases_counts_by_genes
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How frequently are Prostate Adenocarcinoma without CYB5R2 mutations observed?,top_cases_counts_by_genes
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How frequently are Prostate Adenocarcinoma without CYB5R2 mutations observed?,top_cases_counts_by_genes
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without NRAP mutations observed?,top_cases_counts_by_genes
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without NRAP mutations observed?,top_cases_counts_by_genes
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without NRAP mutations observed?,top_cases_counts_by_genes
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without CCDC22 mutations observed?,top_cases_counts_by_genes
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without DCAF6 mutations observed?,top_cases_counts_by_genes
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without DCAF6 mutations observed?,top_cases_counts_by_genes
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without ZNF708 mutations observed?,top_cases_counts_by_genes
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without BFAR mutations observed?,top_cases_counts_by_genes
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without MAST4 mutations observed?,top_cases_counts_by_genes
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without MAST4 mutations observed?,top_cases_counts_by_genes
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without MAST4 mutations observed?,top_cases_counts_by_genes
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without MAST4 mutations observed?,top_cases_counts_by_genes
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without MAST4 mutations observed?,top_cases_counts_by_genes
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without ARMC3 mutations observed?,top_cases_counts_by_genes
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without ARMC3 mutations observed?,top_cases_counts_by_genes
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How frequently are Kidney Renal Clear Cell Carcinoma without TET2 mutations observed?,top_cases_counts_by_genes
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How frequently are Kidney Renal Clear Cell Carcinoma without TET2 mutations observed?,top_cases_counts_by_genes
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without SERPINB10 mutations observed?,top_cases_counts_by_genes
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without STAT3 mutations observed?,top_cases_counts_by_genes
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without MIEF1 mutations observed?,top_cases_counts_by_genes
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without ACVR1B mutations observed?,top_cases_counts_by_genes
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without ACVR1B mutations observed?,top_cases_counts_by_genes
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without ACVR1B mutations observed?,top_cases_counts_by_genes
+1393,EBF2,T104I,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without EBF2 mutations observed?,top_cases_counts_by_genes
+1394,EBF2,T252I,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without EBF2 mutations observed?,top_cases_counts_by_genes
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without VPS26B mutations observed?,top_cases_counts_by_genes
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without PGR mutations observed?",top_cases_counts_by_genes
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without PGR mutations observed?",top_cases_counts_by_genes
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without PGR mutations observed?",top_cases_counts_by_genes
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How frequently are Skin Cutaneous Melanoma without ACTA2 mutations observed?,top_cases_counts_by_genes
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without THBS4 mutations observed?,top_cases_counts_by_genes
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without THBS4 mutations observed?,top_cases_counts_by_genes
+1413,PRSS1,S114T,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without PRSS1 mutations observed?,top_cases_counts_by_genes
+1414,PRSS1,S124T,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without PRSS1 mutations observed?,top_cases_counts_by_genes
+1415,PRSS1,S138T,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without PRSS1 mutations observed?,top_cases_counts_by_genes
+1416,PRSS1,S74T,Lung Adenocarcinoma,How frequently are Lung Adenocarcinoma without PRSS1 mutations observed?,top_cases_counts_by_genes
+1417,PGF,R126H,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without PGF mutations observed?,top_cases_counts_by_genes
+1418,PGF,R127H,Stomach Adenocarcinoma,How frequently are Stomach Adenocarcinoma without PGF mutations observed?,top_cases_counts_by_genes
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How frequently are Breast Invasive Carcinoma without ITPRID2 mutations observed?,top_cases_counts_by_genes
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How frequently are Breast Invasive Carcinoma without ITPRID2 mutations observed?,top_cases_counts_by_genes
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without HBB mutations observed?,top_cases_counts_by_genes
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without PCDHB2 mutations observed?,top_cases_counts_by_genes
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without PCDHB2 mutations observed?,top_cases_counts_by_genes
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How frequently are Colon Adenocarcinoma without PCDHB2 mutations observed?,top_cases_counts_by_genes
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How frequently are Uterine Corpus Endometrial Carcinoma without UBR2 mutations observed?,top_cases_counts_by_genes
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How frequently are Rectum Adenocarcinoma without FBXO42 mutations observed?,top_cases_counts_by_genes
+1,TNS1,G1362V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases do not have FRY mutations?,top_cases_counts_by_genes
+2,TNS1,G1711V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases do not have NRAP mutations?,top_cases_counts_by_genes
+3,TNS1,G1718V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases do not have SMO mutations?,top_cases_counts_by_genes
+4,TNS1,G1732V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases do not have ABCC2 mutations?,top_cases_counts_by_genes
+5,TNS1,G1824V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases do not have ACVR1B mutations?,top_cases_counts_by_genes
+6,TNS1,G1857V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases do not have OR5D14 mutations?,top_cases_counts_by_genes
+7,TNS1,G843V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases do not have POLD1 mutations?,top_cases_counts_by_genes
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases do not have GLRB mutations?,top_cases_counts_by_genes
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases do not have DCC mutations?,top_cases_counts_by_genes
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have SORCS1 mutations?,top_cases_counts_by_genes
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have SPAG1 mutations?,top_cases_counts_by_genes
+22,TRPA1,S295I,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases do not have ZCCHC14 mutations?,top_cases_counts_by_genes
+23,TRPA1,S443I,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases do not have UNC5D mutations?,top_cases_counts_by_genes
+24,TAF1C,R299L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have POC1B mutations?,top_cases_counts_by_genes
+25,TAF1C,R396L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have MAD1L1 mutations?,top_cases_counts_by_genes
+26,TAF1C,R634L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have MYT1 mutations?,top_cases_counts_by_genes
+27,TAF1C,R702L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have CDH23 mutations?,top_cases_counts_by_genes
+28,TAF1C,R728L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have PGF mutations?,top_cases_counts_by_genes
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have TAF1C mutations?,top_cases_counts_by_genes
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have EIF2B4 mutations?,top_cases_counts_by_genes
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have FNDC7 mutations?,top_cases_counts_by_genes
+42,OR2T4,P272H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have PXN mutations?,top_cases_counts_by_genes
+43,OR2T4,P300H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have ARHGEF40 mutations?,top_cases_counts_by_genes
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases do not have TASOR2 mutations?,top_cases_counts_by_genes
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases do not have PRSS8 mutations?,top_cases_counts_by_genes
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases do not have DNAH11 mutations?,top_cases_counts_by_genes
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases do not have PXN mutations?,top_cases_counts_by_genes
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have YY1AP1 mutations?,top_cases_counts_by_genes
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases do not have DNMT1 mutations?,top_cases_counts_by_genes
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases do not have EVC2 mutations?,top_cases_counts_by_genes
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases do not have PRSS1 mutations?,top_cases_counts_by_genes
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases do not have CHMP7 mutations?,top_cases_counts_by_genes
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases do not have SLC24A2 mutations?,top_cases_counts_by_genes
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases do not have SLC24A2 mutations?,top_cases_counts_by_genes
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases do not have MYO15A mutations?,top_cases_counts_by_genes
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases do not have TNS1 mutations?,top_cases_counts_by_genes
+70,PAK3,E318K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have TLK2 mutations?,top_cases_counts_by_genes
+71,PAK3,E319K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have PGF mutations?,top_cases_counts_by_genes
+72,PAK3,E334K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have MORF4L1 mutations?,top_cases_counts_by_genes
+73,PAK3,E340K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have TTN mutations?,top_cases_counts_by_genes
+74,PAK3,E355K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have THBS4 mutations?,top_cases_counts_by_genes
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have PYHIN1 mutations?,top_cases_counts_by_genes
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases do not have PHLPP1 mutations?,top_cases_counts_by_genes
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases do not have SLC9C1 mutations?,top_cases_counts_by_genes
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases do not have OR5D14 mutations?,top_cases_counts_by_genes
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases do not have AUTS2 mutations?,top_cases_counts_by_genes
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have ZFP42 mutations?,top_cases_counts_by_genes
+116,RELN,A2371V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have CYP1A2 mutations?,top_cases_counts_by_genes
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not have EPRS1 mutations?",top_cases_counts_by_genes
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not have TTN mutations?",top_cases_counts_by_genes
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have RAB40C mutations?,top_cases_counts_by_genes
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases do not have ANKRD30A mutations?,top_cases_counts_by_genes
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases do not have ZFAT mutations?,top_cases_counts_by_genes
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases do not have XKR4 mutations?,top_cases_counts_by_genes
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have MSANTD4 mutations?,top_cases_counts_by_genes
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have STK19 mutations?,top_cases_counts_by_genes
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have TASOR2 mutations?,top_cases_counts_by_genes
+129,ABCC3,R758W,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have PTPRO mutations?,top_cases_counts_by_genes
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have POC1B mutations?,top_cases_counts_by_genes
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have TASOR2 mutations?,top_cases_counts_by_genes
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases do not have XKR4 mutations?,top_cases_counts_by_genes
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have FBXO15 mutations?,top_cases_counts_by_genes
+140,BICC1,A372V,Exceptional Responders,What percentage of Exceptional Responders cases do not have TAF1C mutations?,top_cases_counts_by_genes
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have TNS1 mutations?,top_cases_counts_by_genes
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have TLK2 mutations?,top_cases_counts_by_genes
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have DCLK3 mutations?,top_cases_counts_by_genes
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not have LDOC1 mutations?",top_cases_counts_by_genes
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases do not have PIK3C2B mutations?,top_cases_counts_by_genes
+157,OR8K5,R293G,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have PKHD1L1 mutations?,top_cases_counts_by_genes
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have PRSS1 mutations?,top_cases_counts_by_genes
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have AUTS2 mutations?,top_cases_counts_by_genes
+164,SYT10,M484I,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases do not have TTC12 mutations?,top_cases_counts_by_genes
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have SYNJ1 mutations?,top_cases_counts_by_genes
+175,UNC5D,L280V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have CFAP298-TCP10L mutations?,top_cases_counts_by_genes
+176,UNC5D,L635V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have CTCFL mutations?,top_cases_counts_by_genes
+177,UNC5D,L637V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have SORCS1 mutations?,top_cases_counts_by_genes
+178,UNC5D,L699V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have MAOB mutations?,top_cases_counts_by_genes
+179,UNC5D,L704V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have PAPPA mutations?,top_cases_counts_by_genes
+180,UNC5D,L709V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have TNS1 mutations?,top_cases_counts_by_genes
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma cases do not have DPF3 mutations?,top_cases_counts_by_genes
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma cases do not have CYP1A2 mutations?,top_cases_counts_by_genes
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have PCDHB2 mutations?,top_cases_counts_by_genes
+193,MRPL55,H27Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have KDM5C mutations?,top_cases_counts_by_genes
+194,MRPL55,H63Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have STAT3 mutations?,top_cases_counts_by_genes
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases do not have FCGR2C mutations?,top_cases_counts_by_genes
+198,EPRS1,K771I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have GABRA6 mutations?,top_cases_counts_by_genes
+199,EPRS1,K778I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have COL6A3 mutations?,top_cases_counts_by_genes
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have PIK3C2B mutations?,top_cases_counts_by_genes
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have PGR mutations?,top_cases_counts_by_genes
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have PXN mutations?,top_cases_counts_by_genes
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What percentage of HIV+ Tumor Molecular Characterization Project - Cervical Cancer cases do not have ACTL7B mutations?,top_cases_counts_by_genes
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have GIMAP2 mutations?,top_cases_counts_by_genes
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have EBF2 mutations?,top_cases_counts_by_genes
+251,ZNF274,P13R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have KANSL1 mutations?,top_cases_counts_by_genes
+253,SYNJ1,R795C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have ZCCHC14 mutations?,top_cases_counts_by_genes
+254,SYNJ1,R800C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have CCNG1 mutations?,top_cases_counts_by_genes
+255,SYNJ1,R839C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have HTR3B mutations?,top_cases_counts_by_genes
+261,DSCAM,V343M,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases do not have MERTK mutations?,top_cases_counts_by_genes
+262,DSCAM,V426M,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases do not have YY1AP1 mutations?,top_cases_counts_by_genes
+263,DSCAM,V591M,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases do not have ZNF431 mutations?,top_cases_counts_by_genes
+267,DGKD,R140H,Exceptional Responders,What percentage of Exceptional Responders cases do not have CTCFL mutations?,top_cases_counts_by_genes
+268,DGKD,R160H,Exceptional Responders,What percentage of Exceptional Responders cases do not have LCN15 mutations?,top_cases_counts_by_genes
+269,DGKD,R204H,Exceptional Responders,What percentage of Exceptional Responders cases do not have C7orf31 mutations?,top_cases_counts_by_genes
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases do not have RELN mutations?,top_cases_counts_by_genes
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases do not have EVC2 mutations?,top_cases_counts_by_genes
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases do not have TASOR2 mutations?,top_cases_counts_by_genes
+279,WNT2,D138N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have DCN mutations?,top_cases_counts_by_genes
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have TENT5A mutations?,top_cases_counts_by_genes
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have SGIP1 mutations?,top_cases_counts_by_genes
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not have LDOC1 mutations?",top_cases_counts_by_genes
+299,OR5D14,M210L,Neuroblastoma,What percentage of Neuroblastoma cases do not have EPRS1 mutations?,top_cases_counts_by_genes
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have MYH11 mutations?,top_cases_counts_by_genes
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have DCC mutations?,top_cases_counts_by_genes
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have ITPRID2 mutations?,top_cases_counts_by_genes
+310,LCN15,E21V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have NRAP mutations?,top_cases_counts_by_genes
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have SGIP1 mutations?,top_cases_counts_by_genes
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have TLK2 mutations?,top_cases_counts_by_genes
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have CARMIL1 mutations?,top_cases_counts_by_genes
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have JAML mutations?,top_cases_counts_by_genes
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have POLD1 mutations?,top_cases_counts_by_genes
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have FRY mutations?,top_cases_counts_by_genes
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have DEFB115 mutations?,top_cases_counts_by_genes
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have OLFML3 mutations?,top_cases_counts_by_genes
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have PTPRO mutations?,top_cases_counts_by_genes
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have PRSS8 mutations?,top_cases_counts_by_genes
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have DCN mutations?,top_cases_counts_by_genes
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have PTPRN2 mutations?,top_cases_counts_by_genes
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have ANKRD24 mutations?,top_cases_counts_by_genes
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have FBXO15 mutations?,top_cases_counts_by_genes
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have TRIM45 mutations?,top_cases_counts_by_genes
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma cases do not have RIMS2 mutations?,top_cases_counts_by_genes
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma cases do not have MYO3B mutations?,top_cases_counts_by_genes
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma cases do not have ZFAT mutations?,top_cases_counts_by_genes
+357,ZNF584,A211T,Sarcoma,What percentage of Sarcoma cases do not have TET2 mutations?,top_cases_counts_by_genes
+358,ZNF584,A256T,Sarcoma,What percentage of Sarcoma cases do not have RIPOR2 mutations?,top_cases_counts_by_genes
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have MORF4L1 mutations?,top_cases_counts_by_genes
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have KDM5C mutations?,top_cases_counts_by_genes
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have TTC17 mutations?,top_cases_counts_by_genes
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have PIK3C2G mutations?,top_cases_counts_by_genes
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have BCAT1 mutations?,top_cases_counts_by_genes
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have ZNF584 mutations?,top_cases_counts_by_genes
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have COL6A3 mutations?,top_cases_counts_by_genes
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have TRIM45 mutations?,top_cases_counts_by_genes
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have GPR158 mutations?,top_cases_counts_by_genes
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have ACTB mutations?,top_cases_counts_by_genes
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have RIPOR2 mutations?,top_cases_counts_by_genes
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases do not have TAS1R3 mutations?,top_cases_counts_by_genes
+406,POC1B,I198T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases do not have ZFPM2 mutations?,top_cases_counts_by_genes
+407,POC1B,I286T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases do not have MAD1L1 mutations?,top_cases_counts_by_genes
+408,POC1B,I328T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases do not have RIPOR2 mutations?,top_cases_counts_by_genes
+409,POC1B,S79P,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases do not have VPS26B mutations?,top_cases_counts_by_genes
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases do not have OR13C3 mutations?,top_cases_counts_by_genes
+414,AQP7,T110S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases do not have MAST4 mutations?,top_cases_counts_by_genes
+415,AQP7,T166S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases do not have EIF2B4 mutations?,top_cases_counts_by_genes
+416,AQP7,T167S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases do not have MYH11 mutations?,top_cases_counts_by_genes
+417,AQP7,T75S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases do not have MAST4 mutations?,top_cases_counts_by_genes
+430,DCN,R163C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases do not have ZNF217 mutations?,top_cases_counts_by_genes
+431,DCN,R203C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases do not have DSCAM mutations?,top_cases_counts_by_genes
+432,DCN,R241C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases do not have PSG2 mutations?,top_cases_counts_by_genes
+433,DCN,R350C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases do not have CDKN2AIP mutations?,top_cases_counts_by_genes
+434,DCN,R41C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases do not have FRY mutations?,top_cases_counts_by_genes
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have ZCCHC14 mutations?,top_cases_counts_by_genes
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have POC1B mutations?,top_cases_counts_by_genes
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have YY1AP1 mutations?,top_cases_counts_by_genes
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases do not have ANKRD30A mutations?,top_cases_counts_by_genes
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases do not have CTCFL mutations?,top_cases_counts_by_genes
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have ZCCHC14 mutations?,top_cases_counts_by_genes
+482,SGCZ,Q138H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have SOX21 mutations?,top_cases_counts_by_genes
+483,SGCZ,Q91H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have ICE1 mutations?,top_cases_counts_by_genes
+485,SMO,V15M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have YY1AP1 mutations?,top_cases_counts_by_genes
+486,SMO,V321M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have DHX16 mutations?,top_cases_counts_by_genes
+488,CHODL,G159E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have PTPRO mutations?,top_cases_counts_by_genes
+489,CHODL,G181E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have TLK2 mutations?,top_cases_counts_by_genes
+490,CHODL,G200E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have RIPOR2 mutations?,top_cases_counts_by_genes
+494,MYO16,P399H,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have CTNNA2 mutations?,top_cases_counts_by_genes
+495,MYO16,P421H,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have COL6A3 mutations?,top_cases_counts_by_genes
+498,CXCR2,A98V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have PAK3 mutations?,top_cases_counts_by_genes
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases do not have TLCD5 mutations?,top_cases_counts_by_genes
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have FRY mutations?,top_cases_counts_by_genes
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have ACTL7B mutations?,top_cases_counts_by_genes
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have CTNNA2 mutations?,top_cases_counts_by_genes
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have CXCR2 mutations?,top_cases_counts_by_genes
+510,RAB40C,A111V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have DGKD mutations?,top_cases_counts_by_genes
+511,RAB40C,A143V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have DCLK3 mutations?,top_cases_counts_by_genes
+512,CTNNA2,S323R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have ERCC6 mutations?,top_cases_counts_by_genes
+513,CTNNA2,S339R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have GABRA6 mutations?,top_cases_counts_by_genes
+514,CTNNA2,S386R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have TTYH2 mutations?,top_cases_counts_by_genes
+515,CTNNA2,S707R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have AQP7 mutations?,top_cases_counts_by_genes
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases do not have ANP32E mutations?,top_cases_counts_by_genes
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have PRSS1 mutations?,top_cases_counts_by_genes
+532,KIF20B,N1160D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases do not have PTPRO mutations?,top_cases_counts_by_genes
+533,KIF20B,N1200D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases do not have ZNF708 mutations?,top_cases_counts_by_genes
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have YY1AP1 mutations?,top_cases_counts_by_genes
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have GABRA6 mutations?,top_cases_counts_by_genes
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have CHODL mutations?,top_cases_counts_by_genes
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have YY1AP1 mutations?,top_cases_counts_by_genes
+540,ERCC6,R1053H,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have PTPRO mutations?,top_cases_counts_by_genes
+541,DCC,R320W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases do not have FNDC7 mutations?,top_cases_counts_by_genes
+542,DCC,R363W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases do not have SORCS1 mutations?,top_cases_counts_by_genes
+543,DCC,R386W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases do not have ADAM17 mutations?,top_cases_counts_by_genes
+544,DCC,R41W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases do not have TYK2 mutations?,top_cases_counts_by_genes
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have PGR mutations?,top_cases_counts_by_genes
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have ANKRD30A mutations?,top_cases_counts_by_genes
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have ZMYM3 mutations?,top_cases_counts_by_genes
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have OLFML3 mutations?,top_cases_counts_by_genes
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have MYO15A mutations?,top_cases_counts_by_genes
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have CR1 mutations?,top_cases_counts_by_genes
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have CHMP7 mutations?,top_cases_counts_by_genes
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma cases do not have AUTS2 mutations?,top_cases_counts_by_genes
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma cases do not have YY1AP1 mutations?,top_cases_counts_by_genes
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases do not have TSHZ3 mutations?,top_cases_counts_by_genes
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have UNC5D mutations?,top_cases_counts_by_genes
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have LCN15 mutations?,top_cases_counts_by_genes
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have FGF8 mutations?,top_cases_counts_by_genes
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have SPAG1 mutations?,top_cases_counts_by_genes
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have ANKRD24 mutations?,top_cases_counts_by_genes
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have TAS1R3 mutations?,top_cases_counts_by_genes
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have DCN mutations?,top_cases_counts_by_genes
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have GABRA6 mutations?,top_cases_counts_by_genes
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have TNS1 mutations?,top_cases_counts_by_genes
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have HTR3B mutations?,top_cases_counts_by_genes
+625,SIK2,I265M,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have EFCAB12 mutations?,top_cases_counts_by_genes
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have TASOR2 mutations?,top_cases_counts_by_genes
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have PTPRN2 mutations?,top_cases_counts_by_genes
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have CHODL mutations?,top_cases_counts_by_genes
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have BICC1 mutations?,top_cases_counts_by_genes
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have ACVR1B mutations?,top_cases_counts_by_genes
+644,OR2A12,A254T,Brain Lower Grade Glioma,What percentage of Brain Lower Grade Glioma cases do not have TENM3 mutations?,top_cases_counts_by_genes
+646,PYHIN1,T325K,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have GUCY2C mutations?,top_cases_counts_by_genes
+647,PYHIN1,T334K,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have GABRA6 mutations?,top_cases_counts_by_genes
+650,JAML,G191E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have ZCCHC14 mutations?,top_cases_counts_by_genes
+651,JAML,G219E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have TET2 mutations?,top_cases_counts_by_genes
+652,JAML,G220E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have SMO mutations?,top_cases_counts_by_genes
+653,JAML,G230E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have RELN mutations?,top_cases_counts_by_genes
+658,TYK2,H1146R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have COL6A3 mutations?,top_cases_counts_by_genes
+659,TYK2,H23R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have POC1B mutations?,top_cases_counts_by_genes
+660,TYK2,H961R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have DCAF6 mutations?,top_cases_counts_by_genes
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have HLA-DQA2 mutations?,top_cases_counts_by_genes
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have VASN mutations?,top_cases_counts_by_genes
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have FBXO42 mutations?,top_cases_counts_by_genes
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have CTNNA2 mutations?,top_cases_counts_by_genes
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have THBS4 mutations?,top_cases_counts_by_genes
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have MERTK mutations?,top_cases_counts_by_genes
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have MYO3B mutations?,top_cases_counts_by_genes
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have PTPRO mutations?,top_cases_counts_by_genes
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have ANKRD24 mutations?,top_cases_counts_by_genes
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have ZCCHC14 mutations?,top_cases_counts_by_genes
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have DNMT1 mutations?,top_cases_counts_by_genes
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have FCGR2C mutations?,top_cases_counts_by_genes
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have OLFML3 mutations?,top_cases_counts_by_genes
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have PIK3C2G mutations?,top_cases_counts_by_genes
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have SYNJ1 mutations?,top_cases_counts_by_genes
+728,STK19,D341N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have PIK3C2G mutations?,top_cases_counts_by_genes
+729,STK19,D345N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have GUK1 mutations?,top_cases_counts_by_genes
+730,REXO4,P60A,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have CARMIL1 mutations?,top_cases_counts_by_genes
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have MIEF1 mutations?,top_cases_counts_by_genes
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have MORF4L1 mutations?,top_cases_counts_by_genes
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases do not have ARMC3 mutations?,top_cases_counts_by_genes
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not have ANKRD30A mutations?",top_cases_counts_by_genes
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not have TNS1 mutations?",top_cases_counts_by_genes
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not have AUTS2 mutations?",top_cases_counts_by_genes
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not have ACTB mutations?",top_cases_counts_by_genes
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma cases do not have NPSR1 mutations?,top_cases_counts_by_genes
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma cases do not have ARMC3 mutations?,top_cases_counts_by_genes
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma cases do not have DCC mutations?,top_cases_counts_by_genes
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma cases do not have PIK3C2G mutations?,top_cases_counts_by_genes
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma cases do not have LCN15 mutations?,top_cases_counts_by_genes
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What percentage of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia cases do not have EIF2B4 mutations?,top_cases_counts_by_genes
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have ARMC3 mutations?,top_cases_counts_by_genes
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases do not have VPS26B mutations?,top_cases_counts_by_genes
+792,GLRB,E148D,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have FRY mutations?,top_cases_counts_by_genes
+793,TTN,F7636L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have ARMC3 mutations?,top_cases_counts_by_genes
+794,TTN,F8563L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have TLK2 mutations?,top_cases_counts_by_genes
+795,TTN,F8880L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have EFCAB12 mutations?,top_cases_counts_by_genes
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have AQP7 mutations?,top_cases_counts_by_genes
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have UNC5D mutations?,top_cases_counts_by_genes
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have FGF8 mutations?,top_cases_counts_by_genes
+809,TRIM45,S177L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have NEXN mutations?,top_cases_counts_by_genes
+810,TRIM45,S224L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have GUK1 mutations?,top_cases_counts_by_genes
+811,TRIM45,S281L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have DSCAM mutations?,top_cases_counts_by_genes
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have YY1AP1 mutations?,top_cases_counts_by_genes
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have MAD1L1 mutations?,top_cases_counts_by_genes
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have FBN1 mutations?,top_cases_counts_by_genes
+817,KL,R594C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have SYNJ1 mutations?,top_cases_counts_by_genes
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases do not have ABCC2 mutations?,top_cases_counts_by_genes
+822,TAF1L,A539V,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have FNDC7 mutations?,top_cases_counts_by_genes
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have BICC1 mutations?,top_cases_counts_by_genes
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have GPR158 mutations?,top_cases_counts_by_genes
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have ZFPM2 mutations?,top_cases_counts_by_genes
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have SMO mutations?,top_cases_counts_by_genes
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have PGR mutations?,top_cases_counts_by_genes
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have PTPRO mutations?,top_cases_counts_by_genes
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have PTPRN2 mutations?,top_cases_counts_by_genes
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases do not have SGIP1 mutations?,top_cases_counts_by_genes
+843,DHX16,A29V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have CCNG1 mutations?,top_cases_counts_by_genes
+844,DHX16,A89V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have MYT1 mutations?,top_cases_counts_by_genes
+902,GPR158,A644V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have AQP7 mutations?,top_cases_counts_by_genes
+903,GPR158,A723V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have GUK1 mutations?,top_cases_counts_by_genes
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not have HBB mutations?",top_cases_counts_by_genes
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not have JAML mutations?",top_cases_counts_by_genes
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not have MYH11 mutations?",top_cases_counts_by_genes
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not have DEFB115 mutations?",top_cases_counts_by_genes
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not have CDH23 mutations?",top_cases_counts_by_genes
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not have SLC24A2 mutations?",top_cases_counts_by_genes
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have PGF mutations?,top_cases_counts_by_genes
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have TNS1 mutations?,top_cases_counts_by_genes
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have PCDHGA1 mutations?,top_cases_counts_by_genes
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have MYT1 mutations?,top_cases_counts_by_genes
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have TAF1C mutations?,top_cases_counts_by_genes
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have PCDHB2 mutations?,top_cases_counts_by_genes
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have GUCY2C mutations?,top_cases_counts_by_genes
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have PAPPA mutations?,top_cases_counts_by_genes
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have TYK2 mutations?,top_cases_counts_by_genes
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have CPS1 mutations?,top_cases_counts_by_genes
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not have GPC3 mutations?",top_cases_counts_by_genes
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases do not have CHODL mutations?,top_cases_counts_by_genes
+954,TRAP1,R114W,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have CTNNA2 mutations?,top_cases_counts_by_genes
+955,TRAP1,R61W,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have KDM5C mutations?,top_cases_counts_by_genes
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have MYO16 mutations?,top_cases_counts_by_genes
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases do not have NRAP mutations?,top_cases_counts_by_genes
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have DNMT1 mutations?,top_cases_counts_by_genes
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have SYNJ1 mutations?,top_cases_counts_by_genes
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases do not have DCAF4L2 mutations?,top_cases_counts_by_genes
+982,GABRA6,G115R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have TRPA1 mutations?,top_cases_counts_by_genes
+983,GABRA6,G122R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have YY1AP1 mutations?,top_cases_counts_by_genes
+984,GABRA6,G165R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have PIK3C2B mutations?,top_cases_counts_by_genes
+985,GABRA6,G175R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have KL mutations?,top_cases_counts_by_genes
+986,GABRA6,G70R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have CEP20 mutations?,top_cases_counts_by_genes
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have EPRS1 mutations?,top_cases_counts_by_genes
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not have CDH23 mutations?",top_cases_counts_by_genes
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not have GUK1 mutations?",top_cases_counts_by_genes
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases do not have SIK2 mutations?,top_cases_counts_by_genes
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases do not have ACVR1B mutations?,top_cases_counts_by_genes
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases do not have PDGFC mutations?,top_cases_counts_by_genes
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases do not have VPS26B mutations?,top_cases_counts_by_genes
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases do not have MAST4 mutations?,top_cases_counts_by_genes
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases do not have DCN mutations?,top_cases_counts_by_genes
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases do not have STK19 mutations?,top_cases_counts_by_genes
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases do not have FNDC7 mutations?,top_cases_counts_by_genes
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have TENT5A mutations?,top_cases_counts_by_genes
+1017,GPC3,I107N,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have ZNF217 mutations?,top_cases_counts_by_genes
+1018,GPC3,I161N,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have GABRA6 mutations?,top_cases_counts_by_genes
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases do not have MYO3B mutations?,top_cases_counts_by_genes
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases do not have SMO mutations?,top_cases_counts_by_genes
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases do not have MORF4L1 mutations?,top_cases_counts_by_genes
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases do not have ZFP42 mutations?,top_cases_counts_by_genes
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases do not have TTC17 mutations?,top_cases_counts_by_genes
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have GABRA6 mutations?,top_cases_counts_by_genes
+1038,SYT9,V275L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have ABCC3 mutations?,top_cases_counts_by_genes
+1039,SYT9,V307L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have FRY mutations?,top_cases_counts_by_genes
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have ACVR1B mutations?,top_cases_counts_by_genes
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have EFCAB12 mutations?,top_cases_counts_by_genes
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not have MUC16 mutations?",top_cases_counts_by_genes
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have SYNJ1 mutations?,top_cases_counts_by_genes
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have ACVR1B mutations?,top_cases_counts_by_genes
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have TNS1 mutations?,top_cases_counts_by_genes
+1056,CA9,E402K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have ZNF274 mutations?,top_cases_counts_by_genes
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have NRAP mutations?,top_cases_counts_by_genes
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have CTCFL mutations?,top_cases_counts_by_genes
+1065,PSG2,P43L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases do not have WNT2 mutations?,top_cases_counts_by_genes
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases do not have MERTK mutations?,top_cases_counts_by_genes
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases do not have DGKD mutations?,top_cases_counts_by_genes
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases do not have DNAH11 mutations?,top_cases_counts_by_genes
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases do not have ZSCAN31 mutations?,top_cases_counts_by_genes
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have CA9 mutations?,top_cases_counts_by_genes
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have GPC3 mutations?,top_cases_counts_by_genes
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have PRSS8 mutations?,top_cases_counts_by_genes
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have ZFP42 mutations?,top_cases_counts_by_genes
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have OR5D14 mutations?,top_cases_counts_by_genes
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have FRY mutations?,top_cases_counts_by_genes
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have CACNA1F mutations?,top_cases_counts_by_genes
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have KL mutations?,top_cases_counts_by_genes
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have DSCAM mutations?,top_cases_counts_by_genes
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have DGKD mutations?,top_cases_counts_by_genes
+1093,PXN,H1016Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have CX3CR1 mutations?,top_cases_counts_by_genes
+1094,PXN,H359Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have ANKDD1A mutations?,top_cases_counts_by_genes
+1095,PXN,H492Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have PYHIN1 mutations?,top_cases_counts_by_genes
+1096,PXN,H524Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have TRAP1 mutations?,top_cases_counts_by_genes
+1097,PXN,H526Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have LDOC1 mutations?,top_cases_counts_by_genes
+1098,PXN,H540Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have SORCS1 mutations?,top_cases_counts_by_genes
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have EIF2B4 mutations?,top_cases_counts_by_genes
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have OR5D14 mutations?,top_cases_counts_by_genes
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have PXN mutations?,top_cases_counts_by_genes
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have EVC2 mutations?,top_cases_counts_by_genes
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have RELN mutations?,top_cases_counts_by_genes
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases do not have GABRA6 mutations?,top_cases_counts_by_genes
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases do not have PCDHGA1 mutations?,top_cases_counts_by_genes
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have ITPRID2 mutations?,top_cases_counts_by_genes
+1112,MYT1,A558E,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases do not have OR5D14 mutations?,top_cases_counts_by_genes
+1113,MYT1,A879E,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases do not have TENT5A mutations?,top_cases_counts_by_genes
+1114,MYT1,A906E,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases do not have ZFAT mutations?,top_cases_counts_by_genes
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have UBR2 mutations?,top_cases_counts_by_genes
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have AUTS2 mutations?,top_cases_counts_by_genes
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases do not have PTPRN2 mutations?,top_cases_counts_by_genes
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have MRPL55 mutations?,top_cases_counts_by_genes
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have MYO15A mutations?,top_cases_counts_by_genes
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases do not have MED16 mutations?,top_cases_counts_by_genes
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not have DCN mutations?",top_cases_counts_by_genes
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have ZNF627 mutations?,top_cases_counts_by_genes
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have CTCFL mutations?,top_cases_counts_by_genes
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have EIF2B4 mutations?,top_cases_counts_by_genes
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have DNMT1 mutations?,top_cases_counts_by_genes
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have FBXO15 mutations?,top_cases_counts_by_genes
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases do not have HYOU1 mutations?,top_cases_counts_by_genes
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases do not have EIF2B4 mutations?,top_cases_counts_by_genes
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases do not have TMTC3 mutations?,top_cases_counts_by_genes
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases do not have ZFPM2 mutations?,top_cases_counts_by_genes
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases do not have PXN mutations?,top_cases_counts_by_genes
+1188,SOX21,R55L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have WNT2 mutations?,top_cases_counts_by_genes
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases do not have IL5RA mutations?,top_cases_counts_by_genes
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have AUTS2 mutations?,top_cases_counts_by_genes
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not have RIMS2 mutations?",top_cases_counts_by_genes
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have RIMS2 mutations?,top_cases_counts_by_genes
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have GABRA6 mutations?,top_cases_counts_by_genes
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have TENM2 mutations?,top_cases_counts_by_genes
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have THBS4 mutations?,top_cases_counts_by_genes
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have PSG2 mutations?,top_cases_counts_by_genes
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have UNC5D mutations?,top_cases_counts_by_genes
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have DPF3 mutations?,top_cases_counts_by_genes
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have FRY mutations?,top_cases_counts_by_genes
+1234,ZNF431,R128I,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have TENM3 mutations?,top_cases_counts_by_genes
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have CTNNA2 mutations?,top_cases_counts_by_genes
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have CYB5R2 mutations?,top_cases_counts_by_genes
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have TTYH2 mutations?,top_cases_counts_by_genes
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases do not have MORF4L1 mutations?,top_cases_counts_by_genes
+1248,TTC12,D646H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have BCAT1 mutations?,top_cases_counts_by_genes
+1249,TTC12,D652H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have CR1 mutations?,top_cases_counts_by_genes
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases do not have CHMP7 mutations?,top_cases_counts_by_genes
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases do not have DCLK3 mutations?,top_cases_counts_by_genes
+1254,CTSC,E214V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have ART3 mutations?,top_cases_counts_by_genes
+1255,CTSC,E291V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have TRIM45 mutations?,top_cases_counts_by_genes
+1256,CTSC,E322V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have TTN mutations?,top_cases_counts_by_genes
+1257,CTSC,E324V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have CYB5R2 mutations?,top_cases_counts_by_genes
+1258,CTSC,E335V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have EIF2B4 mutations?,top_cases_counts_by_genes
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have OLFML3 mutations?,top_cases_counts_by_genes
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have CCNG1 mutations?,top_cases_counts_by_genes
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have TRAP1 mutations?,top_cases_counts_by_genes
+1264,ACTB,A138T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases do not have TASOR2 mutations?,top_cases_counts_by_genes
+1265,ACTB,A217T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases do not have CPS1 mutations?,top_cases_counts_by_genes
+1266,ACTB,A244T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases do not have CDH23 mutations?,top_cases_counts_by_genes
+1267,ACTB,A260T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases do not have HSPA5 mutations?,top_cases_counts_by_genes
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases do not have ZNF804A mutations?,top_cases_counts_by_genes
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases do not have SERPINB10 mutations?,top_cases_counts_by_genes
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases do not have KIF20B mutations?,top_cases_counts_by_genes
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases do not have PTPRO mutations?,top_cases_counts_by_genes
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases do not have POC1B mutations?,top_cases_counts_by_genes
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases do not have TAF1C mutations?,top_cases_counts_by_genes
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases do not have GRTP1 mutations?,top_cases_counts_by_genes
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have ANKDD1A mutations?,top_cases_counts_by_genes
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have BCAT1 mutations?,top_cases_counts_by_genes
+1299,TLCD5,G15V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have PTPRO mutations?,top_cases_counts_by_genes
+1300,TLCD5,G37V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have GABRA6 mutations?,top_cases_counts_by_genes
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have TNS1 mutations?,top_cases_counts_by_genes
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have ARMC3 mutations?,top_cases_counts_by_genes
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have PGR mutations?,top_cases_counts_by_genes
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have KRT39 mutations?,top_cases_counts_by_genes
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have DCAF4L2 mutations?,top_cases_counts_by_genes
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have MYH11 mutations?,top_cases_counts_by_genes
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases do not have SGCZ mutations?,top_cases_counts_by_genes
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases do not have TYK2 mutations?,top_cases_counts_by_genes
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have CTSC mutations?,top_cases_counts_by_genes
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have MYO16 mutations?,top_cases_counts_by_genes
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have GRM1 mutations?,top_cases_counts_by_genes
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have POC1B mutations?,top_cases_counts_by_genes
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have MERTK mutations?,top_cases_counts_by_genes
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have PXN mutations?,top_cases_counts_by_genes
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have AUTS2 mutations?,top_cases_counts_by_genes
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have PGF mutations?,top_cases_counts_by_genes
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have ZNF274 mutations?,top_cases_counts_by_genes
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have TRPA1 mutations?,top_cases_counts_by_genes
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have CHODL mutations?,top_cases_counts_by_genes
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have MAST4 mutations?,top_cases_counts_by_genes
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have FRY mutations?,top_cases_counts_by_genes
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have PLEKHG6 mutations?,top_cases_counts_by_genes
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have TAF1C mutations?,top_cases_counts_by_genes
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma cases do not have UNC5D mutations?,top_cases_counts_by_genes
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma cases do not have MRPL32 mutations?,top_cases_counts_by_genes
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have EIF2B4 mutations?,top_cases_counts_by_genes
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have TRIM45 mutations?,top_cases_counts_by_genes
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have MYT1 mutations?,top_cases_counts_by_genes
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have EIF2B4 mutations?,top_cases_counts_by_genes
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have ANP32E mutations?,top_cases_counts_by_genes
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have PTPRO mutations?,top_cases_counts_by_genes
+1393,EBF2,T104I,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have PRSS1 mutations?,top_cases_counts_by_genes
+1394,EBF2,T252I,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have MYO16 mutations?,top_cases_counts_by_genes
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have DSCAM mutations?,top_cases_counts_by_genes
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not have RIPOR2 mutations?",top_cases_counts_by_genes
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not have DSCAM mutations?",top_cases_counts_by_genes
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not have GIMAP2 mutations?",top_cases_counts_by_genes
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases do not have DCLK3 mutations?,top_cases_counts_by_genes
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have TLCD5 mutations?,top_cases_counts_by_genes
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have MYH11 mutations?,top_cases_counts_by_genes
+1413,PRSS1,S114T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have TLK2 mutations?,top_cases_counts_by_genes
+1414,PRSS1,S124T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have SYNJ1 mutations?,top_cases_counts_by_genes
+1415,PRSS1,S138T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have YY1AP1 mutations?,top_cases_counts_by_genes
+1416,PRSS1,S74T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases do not have DCLK3 mutations?,top_cases_counts_by_genes
+1417,PGF,R126H,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have RIMS2 mutations?,top_cases_counts_by_genes
+1418,PGF,R127H,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases do not have RIMS2 mutations?,top_cases_counts_by_genes
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases do not have PLEKHG6 mutations?,top_cases_counts_by_genes
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases do not have FGF8 mutations?,top_cases_counts_by_genes
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have CPS1 mutations?,top_cases_counts_by_genes
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have CNGB1 mutations?,top_cases_counts_by_genes
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have TRPA1 mutations?,top_cases_counts_by_genes
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases do not have POC1B mutations?,top_cases_counts_by_genes
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases do not have ZFP42 mutations?,top_cases_counts_by_genes
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases do not have KDM5C mutations?,top_cases_counts_by_genes
+1,TNS1,G1362V,Breast Invasive Carcinoma,How rare is it to find Breast Invasive Carcinoma without mutations in TNS1 and AQP7?,top_cases_counts_by_genes
+2,TNS1,G1711V,Breast Invasive Carcinoma,How rare is it to find Breast Invasive Carcinoma without mutations in TNS1 and RIMS2?,top_cases_counts_by_genes
+3,TNS1,G1718V,Breast Invasive Carcinoma,How rare is it to find Breast Invasive Carcinoma without mutations in TNS1 and CHODL?,top_cases_counts_by_genes
+4,TNS1,G1732V,Breast Invasive Carcinoma,How rare is it to find Breast Invasive Carcinoma without mutations in TNS1 and DNAH14?,top_cases_counts_by_genes
+5,TNS1,G1824V,Breast Invasive Carcinoma,How rare is it to find Breast Invasive Carcinoma without mutations in TNS1 and MYT1?,top_cases_counts_by_genes
+6,TNS1,G1857V,Breast Invasive Carcinoma,How rare is it to find Breast Invasive Carcinoma without mutations in TNS1 and STK19?,top_cases_counts_by_genes
+7,TNS1,G843V,Breast Invasive Carcinoma,How rare is it to find Breast Invasive Carcinoma without mutations in TNS1 and PAPPA?,top_cases_counts_by_genes
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How rare is it to find Bladder Urothelial Carcinoma without mutations in EVC2 and CYB5R2?,top_cases_counts_by_genes
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How rare is it to find Bladder Urothelial Carcinoma without mutations in EVC2 and PIK3C2G?,top_cases_counts_by_genes
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in CR1 and TLK2?,top_cases_counts_by_genes
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in CR1 and GUK1?,top_cases_counts_by_genes
+22,TRPA1,S295I,Rectum Adenocarcinoma,How rare is it to find Rectum Adenocarcinoma without mutations in TRPA1 and PXN?,top_cases_counts_by_genes
+23,TRPA1,S443I,Rectum Adenocarcinoma,How rare is it to find Rectum Adenocarcinoma without mutations in TRPA1 and PTPRN2?,top_cases_counts_by_genes
+24,TAF1C,R299L,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in TAF1C and ANP32E?,top_cases_counts_by_genes
+25,TAF1C,R396L,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in TAF1C and PAK3?,top_cases_counts_by_genes
+26,TAF1C,R634L,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in TAF1C and TTC17?,top_cases_counts_by_genes
+27,TAF1C,R702L,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in TAF1C and ZFAT?,top_cases_counts_by_genes
+28,TAF1C,R728L,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in TAF1C and PIAS3?,top_cases_counts_by_genes
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in DPF3 and DEFB115?,top_cases_counts_by_genes
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in DPF3 and TNS1?,top_cases_counts_by_genes
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in DPF3 and GUK1?,top_cases_counts_by_genes
+42,OR2T4,P272H,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in OR2T4 and FGF8?,top_cases_counts_by_genes
+43,OR2T4,P300H,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in OR2T4 and RIMS2?,top_cases_counts_by_genes
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How rare is it to find Pancreatic Adenocarcinoma without mutations in FBN1 and GRM1?,top_cases_counts_by_genes
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How rare is it to find Prostate Adenocarcinoma without mutations in MAD1L1 and GUK1?,top_cases_counts_by_genes
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How rare is it to find Prostate Adenocarcinoma without mutations in MAD1L1 and MERTK?,top_cases_counts_by_genes
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How rare is it to find Prostate Adenocarcinoma without mutations in MAD1L1 and DCN?,top_cases_counts_by_genes
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in CCNG1 and TNS1?,top_cases_counts_by_genes
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How rare is it to find Kidney Renal Papillary Cell Carcinoma without mutations in ANP32E and YY1AP1?,top_cases_counts_by_genes
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How rare is it to find Kidney Renal Papillary Cell Carcinoma without mutations in ANP32E and C7orf31?,top_cases_counts_by_genes
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How rare is it to find Kidney Renal Papillary Cell Carcinoma without mutations in ANP32E and RIPOR2?,top_cases_counts_by_genes
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How rare is it to find Kidney Renal Papillary Cell Carcinoma without mutations in ANP32E and TASOR2?,top_cases_counts_by_genes
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How rare is it to find Bladder Urothelial Carcinoma without mutations in FRY and JAML?,top_cases_counts_by_genes
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How rare is it to find Bladder Urothelial Carcinoma without mutations in FRY and SMO?,top_cases_counts_by_genes
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How rare is it to find Bladder Urothelial Carcinoma without mutations in FRY and FRY?,top_cases_counts_by_genes
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How rare is it to find Bladder Urothelial Carcinoma without mutations in FRY and PTPRO?,top_cases_counts_by_genes
+70,PAK3,E318K,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in PAK3 and SLC9C1?,top_cases_counts_by_genes
+71,PAK3,E319K,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in PAK3 and ZMYM3?,top_cases_counts_by_genes
+72,PAK3,E334K,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in PAK3 and TNS1?,top_cases_counts_by_genes
+73,PAK3,E340K,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in PAK3 and ART3?,top_cases_counts_by_genes
+74,PAK3,E355K,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in PAK3 and RAB40C?,top_cases_counts_by_genes
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in MUC16 and TET2?,top_cases_counts_by_genes
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How rare is it to find Liver Hepatocellular Carcinoma without mutations in ZFPM2 and EFCAB12?,top_cases_counts_by_genes
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How rare is it to find Liver Hepatocellular Carcinoma without mutations in ZFPM2 and EPRS1?,top_cases_counts_by_genes
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How rare is it to find Breast Invasive Carcinoma without mutations in PIK3C2B and SYNJ1?,top_cases_counts_by_genes
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How rare is it to find Breast Invasive Carcinoma without mutations in PIK3C2B and DCAF6?,top_cases_counts_by_genes
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in ZNF804A and VPS26B?,top_cases_counts_by_genes
+116,RELN,A2371V,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in RELN and DPF3?,top_cases_counts_by_genes
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How rare is it to find CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without mutations in EFCAB12 and POLR1G?",top_cases_counts_by_genes
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How rare is it to find CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without mutations in EFCAB12 and POC1B?",top_cases_counts_by_genes
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in DEFB115 and BCAT1?,top_cases_counts_by_genes
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How rare is it to find Bladder Urothelial Carcinoma without mutations in ANKDD1A and ZNF431?,top_cases_counts_by_genes
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How rare is it to find Bladder Urothelial Carcinoma without mutations in ANKDD1A and SLC24A2?,top_cases_counts_by_genes
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How rare is it to find Bladder Urothelial Carcinoma without mutations in ANKDD1A and EBF2?,top_cases_counts_by_genes
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in HTR3B and BFAR?,top_cases_counts_by_genes
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in HTR3B and ANP32E?,top_cases_counts_by_genes
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in HTR3B and CPA6?,top_cases_counts_by_genes
+129,ABCC3,R758W,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in ABCC3 and ACTA2?,top_cases_counts_by_genes
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in NOMO1 and COL6A3?,top_cases_counts_by_genes
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in NOMO1 and ANKRD30A?,top_cases_counts_by_genes
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How rare is it to find Bladder Urothelial Carcinoma without mutations in HYOU1 and KANSL1?,top_cases_counts_by_genes
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in FMO4 and ZCCHC14?,top_cases_counts_by_genes
+140,BICC1,A372V,Exceptional Responders,How rare is it to find Exceptional Responders without mutations in BICC1 and CTNNA2?,top_cases_counts_by_genes
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in ZMYM3 and EPRS1?,top_cases_counts_by_genes
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in ZMYM3 and PCDHB2?,top_cases_counts_by_genes
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in ZMYM3 and CTSC?,top_cases_counts_by_genes
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How rare is it to find CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without mutations in XKR4 and NRAP?",top_cases_counts_by_genes
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How rare is it to find Liver Hepatocellular Carcinoma without mutations in ABCC2 and FNDC7?,top_cases_counts_by_genes
+157,OR8K5,R293G,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in OR8K5 and FGF8?,top_cases_counts_by_genes
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in SPTAN1 and DNAH11?,top_cases_counts_by_genes
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in SPTAN1 and PXN?,top_cases_counts_by_genes
+164,SYT10,M484I,Rectum Adenocarcinoma,How rare is it to find Rectum Adenocarcinoma without mutations in SYT10 and PTPRO?,top_cases_counts_by_genes
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in HSPA5 and FBXO15?,top_cases_counts_by_genes
+175,UNC5D,L280V,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in UNC5D and SYNJ1?,top_cases_counts_by_genes
+176,UNC5D,L635V,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in UNC5D and SYNJ1?,top_cases_counts_by_genes
+177,UNC5D,L637V,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in UNC5D and PIK3C2B?,top_cases_counts_by_genes
+178,UNC5D,L699V,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in UNC5D and NOMO1?,top_cases_counts_by_genes
+179,UNC5D,L704V,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in UNC5D and ZNF431?,top_cases_counts_by_genes
+180,UNC5D,L709V,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in UNC5D and MAST4?,top_cases_counts_by_genes
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How rare is it to find Kidney Renal Clear Cell Carcinoma without mutations in DOCK2 and SGIP1?,top_cases_counts_by_genes
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How rare is it to find Kidney Renal Clear Cell Carcinoma without mutations in ZNF627 and BCAT1?,top_cases_counts_by_genes
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in CDC42BPA and USH2A?,top_cases_counts_by_genes
+193,MRPL55,H27Y,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in MRPL55 and RIMS2?,top_cases_counts_by_genes
+194,MRPL55,H63Y,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in MRPL55 and TRPA1?,top_cases_counts_by_genes
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How rare is it to find Breast Invasive Carcinoma without mutations in TMTC3 and ANKRD24?,top_cases_counts_by_genes
+198,EPRS1,K771I,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in EPRS1 and THBS4?,top_cases_counts_by_genes
+199,EPRS1,K778I,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in EPRS1 and HTR3B?,top_cases_counts_by_genes
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in GRTP1 and TENT5A?,top_cases_counts_by_genes
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in GRTP1 and TYK2?,top_cases_counts_by_genes
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in TSHZ3 and TAS1R3?,top_cases_counts_by_genes
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How rare is it to find HIV+ Tumor Molecular Characterization Project - Cervical Cancer without mutations in TAS1R3 and CFAP61?,top_cases_counts_by_genes
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in PIAS3 and HTR3B?,top_cases_counts_by_genes
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in PIAS3 and MYT1?,top_cases_counts_by_genes
+251,ZNF274,P13R,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in ZNF274 and TAF1C?,top_cases_counts_by_genes
+253,SYNJ1,R795C,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in SYNJ1 and TMEM255A?,top_cases_counts_by_genes
+254,SYNJ1,R800C,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in SYNJ1 and EPRS1?,top_cases_counts_by_genes
+255,SYNJ1,R839C,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in SYNJ1 and TMEM225?,top_cases_counts_by_genes
+261,DSCAM,V343M,Prostate Adenocarcinoma,How rare is it to find Prostate Adenocarcinoma without mutations in DSCAM and BCAT1?,top_cases_counts_by_genes
+262,DSCAM,V426M,Prostate Adenocarcinoma,How rare is it to find Prostate Adenocarcinoma without mutations in DSCAM and KDM5C?,top_cases_counts_by_genes
+263,DSCAM,V591M,Prostate Adenocarcinoma,How rare is it to find Prostate Adenocarcinoma without mutations in DSCAM and CTCFL?,top_cases_counts_by_genes
+267,DGKD,R140H,Exceptional Responders,How rare is it to find Exceptional Responders without mutations in DGKD and POC1B?,top_cases_counts_by_genes
+268,DGKD,R160H,Exceptional Responders,How rare is it to find Exceptional Responders without mutations in DGKD and TNS1?,top_cases_counts_by_genes
+269,DGKD,R204H,Exceptional Responders,How rare is it to find Exceptional Responders without mutations in DGKD and FBXO15?,top_cases_counts_by_genes
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How rare is it to find Bladder Urothelial Carcinoma without mutations in PLEKHG6 and SIK2?,top_cases_counts_by_genes
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How rare is it to find Bladder Urothelial Carcinoma without mutations in PLEKHG6 and AUTS2?,top_cases_counts_by_genes
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How rare is it to find Bladder Urothelial Carcinoma without mutations in PLEKHG6 and MYH11?,top_cases_counts_by_genes
+279,WNT2,D138N,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in WNT2 and MSANTD4?,top_cases_counts_by_genes
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in GUCY2C and LDOC1?,top_cases_counts_by_genes
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in C7orf31 and FCGR2C?,top_cases_counts_by_genes
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How rare is it to find CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without mutations in ZKSCAN7 and AUTS2?",top_cases_counts_by_genes
+299,OR5D14,M210L,Neuroblastoma,How rare is it to find Neuroblastoma without mutations in OR5D14 and CR1?,top_cases_counts_by_genes
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in SPATA22 and CNGB1?,top_cases_counts_by_genes
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in SPATA22 and ZFP42?,top_cases_counts_by_genes
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in SPATA22 and TTN?,top_cases_counts_by_genes
+310,LCN15,E21V,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in LCN15 and ZFAT?,top_cases_counts_by_genes
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in DCAF4L2 and PGR?,top_cases_counts_by_genes
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in GUK1 and ZMYM3?,top_cases_counts_by_genes
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in GUK1 and ACTL7B?,top_cases_counts_by_genes
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in GUK1 and SPAG1?,top_cases_counts_by_genes
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in GUK1 and ZBTB34?,top_cases_counts_by_genes
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in GUK1 and TENM2?,top_cases_counts_by_genes
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in MORF4L1 and FRY?,top_cases_counts_by_genes
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in MORF4L1 and TENM2?,top_cases_counts_by_genes
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in MORF4L1 and TASOR2?,top_cases_counts_by_genes
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in MORF4L1 and SOX21?,top_cases_counts_by_genes
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in MYO3B and PLEKHG6?,top_cases_counts_by_genes
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in MYO3B and YY1AP1?,top_cases_counts_by_genes
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in TENT5A and RAB40C?,top_cases_counts_by_genes
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in TENT5A and PCDHB2?,top_cases_counts_by_genes
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in TENT5A and EPRS1?,top_cases_counts_by_genes
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How rare is it to find Ovarian Serous Cystadenocarcinoma without mutations in ZFAT and THBS4?,top_cases_counts_by_genes
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How rare is it to find Ovarian Serous Cystadenocarcinoma without mutations in ZFAT and GABRA6?,top_cases_counts_by_genes
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How rare is it to find Ovarian Serous Cystadenocarcinoma without mutations in ZFAT and TTC17?,top_cases_counts_by_genes
+357,ZNF584,A211T,Sarcoma,How rare is it to find Sarcoma without mutations in ZNF584 and EFCAB12?,top_cases_counts_by_genes
+358,ZNF584,A256T,Sarcoma,How rare is it to find Sarcoma without mutations in ZNF584 and DCN?,top_cases_counts_by_genes
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in LDOC1 and TTC12?,top_cases_counts_by_genes
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in PDGFC and SPTAN1?,top_cases_counts_by_genes
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in MSANTD4 and PXN?,top_cases_counts_by_genes
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in NPSR1 and DCC?,top_cases_counts_by_genes
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in PHLPP1 and DCN?,top_cases_counts_by_genes
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in COL6A3 and TASOR2?,top_cases_counts_by_genes
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in COL6A3 and OLFML3?,top_cases_counts_by_genes
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in COL6A3 and GLRB?,top_cases_counts_by_genes
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in COL6A3 and PAK3?,top_cases_counts_by_genes
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in COL6A3 and PXN?,top_cases_counts_by_genes
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in ADRA1A and JAML?,top_cases_counts_by_genes
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How rare is it to find Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma without mutations in LAMB2 and AQP7?,top_cases_counts_by_genes
+406,POC1B,I198T,Rectum Adenocarcinoma,How rare is it to find Rectum Adenocarcinoma without mutations in POC1B and CPS1?,top_cases_counts_by_genes
+407,POC1B,I286T,Rectum Adenocarcinoma,How rare is it to find Rectum Adenocarcinoma without mutations in POC1B and TYROBP?,top_cases_counts_by_genes
+408,POC1B,I328T,Rectum Adenocarcinoma,How rare is it to find Rectum Adenocarcinoma without mutations in POC1B and UNC5D?,top_cases_counts_by_genes
+409,POC1B,S79P,Rectum Adenocarcinoma,How rare is it to find Rectum Adenocarcinoma without mutations in POC1B and EIF2B4?,top_cases_counts_by_genes
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How rare is it to find Liver Hepatocellular Carcinoma without mutations in USH2A and SGIP1?,top_cases_counts_by_genes
+414,AQP7,T110S,Rectum Adenocarcinoma,How rare is it to find Rectum Adenocarcinoma without mutations in AQP7 and IL5RA?,top_cases_counts_by_genes
+415,AQP7,T166S,Rectum Adenocarcinoma,How rare is it to find Rectum Adenocarcinoma without mutations in AQP7 and ART3?,top_cases_counts_by_genes
+416,AQP7,T167S,Rectum Adenocarcinoma,How rare is it to find Rectum Adenocarcinoma without mutations in AQP7 and YY1AP1?,top_cases_counts_by_genes
+417,AQP7,T75S,Rectum Adenocarcinoma,How rare is it to find Rectum Adenocarcinoma without mutations in AQP7 and DCN?,top_cases_counts_by_genes
+430,DCN,R163C,Rectum Adenocarcinoma,How rare is it to find Rectum Adenocarcinoma without mutations in DCN and PIK3C2G?,top_cases_counts_by_genes
+431,DCN,R203C,Rectum Adenocarcinoma,How rare is it to find Rectum Adenocarcinoma without mutations in DCN and ZFAT?,top_cases_counts_by_genes
+432,DCN,R241C,Rectum Adenocarcinoma,How rare is it to find Rectum Adenocarcinoma without mutations in DCN and COL6A3?,top_cases_counts_by_genes
+433,DCN,R350C,Rectum Adenocarcinoma,How rare is it to find Rectum Adenocarcinoma without mutations in DCN and ZNF274?,top_cases_counts_by_genes
+434,DCN,R41C,Rectum Adenocarcinoma,How rare is it to find Rectum Adenocarcinoma without mutations in DCN and ABCC3?,top_cases_counts_by_genes
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in CPS1 and RIMS2?,top_cases_counts_by_genes
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in CPS1 and TNS1?,top_cases_counts_by_genes
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in CPS1 and CTCFL?,top_cases_counts_by_genes
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How rare is it to find Kidney Renal Papillary Cell Carcinoma without mutations in FCGR2C and EIF2B4?,top_cases_counts_by_genes
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How rare is it to find Kidney Renal Papillary Cell Carcinoma without mutations in FCGR2C and SORCS1?,top_cases_counts_by_genes
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in GRM1 and AUTS2?,top_cases_counts_by_genes
+482,SGCZ,Q138H,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in SGCZ and DCC?,top_cases_counts_by_genes
+483,SGCZ,Q91H,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in SGCZ and PTPRO?,top_cases_counts_by_genes
+485,SMO,V15M,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in SMO and ACVR1B?,top_cases_counts_by_genes
+486,SMO,V321M,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in SMO and DNAH14?,top_cases_counts_by_genes
+488,CHODL,G159E,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in CHODL and SYT10?,top_cases_counts_by_genes
+489,CHODL,G181E,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in CHODL and KDM5C?,top_cases_counts_by_genes
+490,CHODL,G200E,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in CHODL and COL6A3?,top_cases_counts_by_genes
+494,MYO16,P399H,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in MYO16 and SLC6A4?,top_cases_counts_by_genes
+495,MYO16,P421H,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in MYO16 and MYO15A?,top_cases_counts_by_genes
+498,CXCR2,A98V,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in CXCR2 and TTC12?,top_cases_counts_by_genes
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How rare is it to find Bladder Urothelial Carcinoma without mutations in TMEM225 and SGCZ?,top_cases_counts_by_genes
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in MAOB and TYK2?,top_cases_counts_by_genes
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in GPRASP1 and MYH11?,top_cases_counts_by_genes
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in MRPL32 and MERTK?,top_cases_counts_by_genes
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in TYROBP and TENT5A?,top_cases_counts_by_genes
+510,RAB40C,A111V,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in RAB40C and ANKRD24?,top_cases_counts_by_genes
+511,RAB40C,A143V,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in RAB40C and ZMYM3?,top_cases_counts_by_genes
+512,CTNNA2,S323R,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in CTNNA2 and POLR1G?,top_cases_counts_by_genes
+513,CTNNA2,S339R,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in CTNNA2 and CXCR2?,top_cases_counts_by_genes
+514,CTNNA2,S386R,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in CTNNA2 and ZCCHC14?,top_cases_counts_by_genes
+515,CTNNA2,S707R,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in CTNNA2 and PIK3C2G?,top_cases_counts_by_genes
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How rare is it to find Bladder Urothelial Carcinoma without mutations in MYO15A and RIPOR2?,top_cases_counts_by_genes
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in GIMAP2 and MAD1L1?,top_cases_counts_by_genes
+532,KIF20B,N1160D,Glioblastoma Multiforme,How rare is it to find Glioblastoma Multiforme without mutations in KIF20B and HTR3B?,top_cases_counts_by_genes
+533,KIF20B,N1200D,Glioblastoma Multiforme,How rare is it to find Glioblastoma Multiforme without mutations in KIF20B and ZNF431?,top_cases_counts_by_genes
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in ADAM17 and POLR1G?,top_cases_counts_by_genes
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in BCAT1 and TAF1C?,top_cases_counts_by_genes
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in BCAT1 and GABRA6?,top_cases_counts_by_genes
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in BCAT1 and CXCR2?,top_cases_counts_by_genes
+540,ERCC6,R1053H,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in ERCC6 and KRT39?,top_cases_counts_by_genes
+541,DCC,R320W,Breast Invasive Carcinoma,How rare is it to find Breast Invasive Carcinoma without mutations in DCC and RAB40C?,top_cases_counts_by_genes
+542,DCC,R363W,Breast Invasive Carcinoma,How rare is it to find Breast Invasive Carcinoma without mutations in DCC and CTCFL?,top_cases_counts_by_genes
+543,DCC,R386W,Breast Invasive Carcinoma,How rare is it to find Breast Invasive Carcinoma without mutations in DCC and CPS1?,top_cases_counts_by_genes
+544,DCC,R41W,Breast Invasive Carcinoma,How rare is it to find Breast Invasive Carcinoma without mutations in DCC and CHODL?,top_cases_counts_by_genes
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in FBXO15 and CTNNA2?,top_cases_counts_by_genes
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in FBXO15 and TAF1C?,top_cases_counts_by_genes
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in GSTCD and FRY?,top_cases_counts_by_genes
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in GSTCD and ZBTB34?,top_cases_counts_by_genes
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in OLFML3 and ZNF217?,top_cases_counts_by_genes
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in OLFML3 and COL6A3?,top_cases_counts_by_genes
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in OLFML3 and TLCD5?,top_cases_counts_by_genes
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How rare is it to find Ovarian Serous Cystadenocarcinoma without mutations in CFAP61 and AQP7?,top_cases_counts_by_genes
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How rare is it to find Ovarian Serous Cystadenocarcinoma without mutations in CFAP61 and CDH23?,top_cases_counts_by_genes
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How rare is it to find Bladder Urothelial Carcinoma without mutations in HLA-DQA2 and POC1B?,top_cases_counts_by_genes
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in TENM2 and ACTB?,top_cases_counts_by_genes
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in TENM2 and MORF4L1?,top_cases_counts_by_genes
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in TENM2 and PRSS1?,top_cases_counts_by_genes
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in ANKRD24 and FNDC7?,top_cases_counts_by_genes
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in ANKRD24 and MIEF1?,top_cases_counts_by_genes
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in ANKRD24 and GRM1?,top_cases_counts_by_genes
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in ZCCHC14 and DNMT1?,top_cases_counts_by_genes
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in ZCCHC14 and ZNF627?,top_cases_counts_by_genes
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in ZCCHC14 and GPRASP1?,top_cases_counts_by_genes
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in ZCCHC14 and TLCD5?,top_cases_counts_by_genes
+625,SIK2,I265M,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in SIK2 and PIK3C2B?,top_cases_counts_by_genes
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in MYH11 and TAF1L?,top_cases_counts_by_genes
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in MYH11 and MERTK?,top_cases_counts_by_genes
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in SLC6A4 and C7orf31?,top_cases_counts_by_genes
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in SLC9C1 and AUTS2?,top_cases_counts_by_genes
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in SLC9C1 and TMEM225?,top_cases_counts_by_genes
+644,OR2A12,A254T,Brain Lower Grade Glioma,How rare is it to find Brain Lower Grade Glioma without mutations in OR2A12 and AUTS2?,top_cases_counts_by_genes
+646,PYHIN1,T325K,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in PYHIN1 and PRSS1?,top_cases_counts_by_genes
+647,PYHIN1,T334K,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in PYHIN1 and HTR3B?,top_cases_counts_by_genes
+650,JAML,G191E,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in JAML and YY1AP1?,top_cases_counts_by_genes
+651,JAML,G219E,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in JAML and NRAP?,top_cases_counts_by_genes
+652,JAML,G220E,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in JAML and POLD1?,top_cases_counts_by_genes
+653,JAML,G230E,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in JAML and MAST4?,top_cases_counts_by_genes
+658,TYK2,H1146R,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in TYK2 and NRAP?,top_cases_counts_by_genes
+659,TYK2,H23R,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in TYK2 and MYH11?,top_cases_counts_by_genes
+660,TYK2,H961R,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in TYK2 and RIMS2?,top_cases_counts_by_genes
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in CTCFL and ZMYM3?,top_cases_counts_by_genes
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in CTCFL and RIMS2?,top_cases_counts_by_genes
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in CTCFL and PGR?,top_cases_counts_by_genes
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in CTCFL and CYB5R2?,top_cases_counts_by_genes
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in CEP20 and GLRB?,top_cases_counts_by_genes
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in CEP20 and MYO16?,top_cases_counts_by_genes
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in RIMS2 and TRPA1?,top_cases_counts_by_genes
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in RIMS2 and AUTS2?,top_cases_counts_by_genes
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in RIMS2 and MYO16?,top_cases_counts_by_genes
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in RIMS2 and TNS1?,top_cases_counts_by_genes
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in RIMS2 and TTYH2?,top_cases_counts_by_genes
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in RIMS2 and STK19?,top_cases_counts_by_genes
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in RIMS2 and TASOR2?,top_cases_counts_by_genes
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in PIK3C2G and ZCCHC14?,top_cases_counts_by_genes
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in PIK3C2G and DNAH14?,top_cases_counts_by_genes
+728,STK19,D341N,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in STK19 and RIMS2?,top_cases_counts_by_genes
+729,STK19,D345N,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in STK19 and AUTS2?,top_cases_counts_by_genes
+730,REXO4,P60A,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in REXO4 and DGKD?,top_cases_counts_by_genes
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in ZBTB34 and DCLK3?,top_cases_counts_by_genes
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in ZBTB34 and UNC5D?,top_cases_counts_by_genes
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How rare is it to find Bladder Urothelial Carcinoma without mutations in NCKAP5 and AQP7?,top_cases_counts_by_genes
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How rare is it to find CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without mutations in SORCS1 and SGIP1?",top_cases_counts_by_genes
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How rare is it to find CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without mutations in SORCS1 and AUTS2?",top_cases_counts_by_genes
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How rare is it to find CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without mutations in SORCS1 and POLD1?",top_cases_counts_by_genes
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How rare is it to find CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without mutations in SORCS1 and GUK1?",top_cases_counts_by_genes
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How rare is it to find Head and Neck Squamous Cell Carcinoma without mutations in FGF8 and ZFAT?,top_cases_counts_by_genes
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How rare is it to find Head and Neck Squamous Cell Carcinoma without mutations in FGF8 and OLFML3?,top_cases_counts_by_genes
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How rare is it to find Head and Neck Squamous Cell Carcinoma without mutations in FGF8 and TENM2?,top_cases_counts_by_genes
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How rare is it to find Head and Neck Squamous Cell Carcinoma without mutations in FGF8 and ABCC3?,top_cases_counts_by_genes
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How rare is it to find Head and Neck Squamous Cell Carcinoma without mutations in FGF8 and OR5D14?,top_cases_counts_by_genes
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How rare is it to find Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia without mutations in TENM3 and SYNJ1?,top_cases_counts_by_genes
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in AKT1 and EBF2?,top_cases_counts_by_genes
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How rare is it to find Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma without mutations in CFAP298-TCP10L and MORF4L1?,top_cases_counts_by_genes
+792,GLRB,E148D,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in GLRB and GABRA6?,top_cases_counts_by_genes
+793,TTN,F7636L,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in TTN and MAD1L1?,top_cases_counts_by_genes
+794,TTN,F8563L,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in TTN and GUK1?,top_cases_counts_by_genes
+795,TTN,F8880L,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in TTN and MYH11?,top_cases_counts_by_genes
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in ANKRD30A and TLK2?,top_cases_counts_by_genes
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in ANKRD30A and PTPRO?,top_cases_counts_by_genes
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in ANKRD30A and TLCD5?,top_cases_counts_by_genes
+809,TRIM45,S177L,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in TRIM45 and SPAG1?,top_cases_counts_by_genes
+810,TRIM45,S224L,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in TRIM45 and UNC5D?,top_cases_counts_by_genes
+811,TRIM45,S281L,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in TRIM45 and TMTC3?,top_cases_counts_by_genes
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in CACNA1F and ZMYM3?,top_cases_counts_by_genes
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in CACNA1F and TENT5A?,top_cases_counts_by_genes
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in CACNA1F and PGR?,top_cases_counts_by_genes
+817,KL,R594C,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in KL and UNC5D?,top_cases_counts_by_genes
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How rare is it to find Kidney Renal Papillary Cell Carcinoma without mutations in GUF1 and CYB5R2?,top_cases_counts_by_genes
+822,TAF1L,A539V,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in TAF1L and TENT5A?,top_cases_counts_by_genes
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in TASOR2 and TENM3?,top_cases_counts_by_genes
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in TASOR2 and SORCS1?,top_cases_counts_by_genes
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in TASOR2 and PIK3C2G?,top_cases_counts_by_genes
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in KDM5C and ANP32E?,top_cases_counts_by_genes
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in KDM5C and POC1B?,top_cases_counts_by_genes
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in KDM5C and SLC9C1?,top_cases_counts_by_genes
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in KDM5C and NOMO1?,top_cases_counts_by_genes
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How rare is it to find Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma without mutations in IL5RA and LCN15?,top_cases_counts_by_genes
+843,DHX16,A29V,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in DHX16 and OLFML3?,top_cases_counts_by_genes
+844,DHX16,A89V,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in DHX16 and SPTAN1?,top_cases_counts_by_genes
+902,GPR158,A644V,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in GPR158 and PIK3C2G?,top_cases_counts_by_genes
+903,GPR158,A723V,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in GPR158 and CXCR2?,top_cases_counts_by_genes
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How rare is it to find CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without mutations in EIF2B4 and MAST4?",top_cases_counts_by_genes
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How rare is it to find CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without mutations in EIF2B4 and GUK1?",top_cases_counts_by_genes
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How rare is it to find CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without mutations in EIF2B4 and GUK1?",top_cases_counts_by_genes
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How rare is it to find CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without mutations in EIF2B4 and GPR158?",top_cases_counts_by_genes
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How rare is it to find CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without mutations in EIF2B4 and COL6A3?",top_cases_counts_by_genes
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How rare is it to find CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without mutations in EIF2B4 and YY1AP1?",top_cases_counts_by_genes
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in AUTS2 and PCDHB2?,top_cases_counts_by_genes
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in AUTS2 and GUCY2C?,top_cases_counts_by_genes
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in AUTS2 and TLK2?,top_cases_counts_by_genes
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in AUTS2 and MAST4?,top_cases_counts_by_genes
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in AUTS2 and TRPA1?,top_cases_counts_by_genes
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in AUTS2 and MSANTD4?,top_cases_counts_by_genes
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in AUTS2 and POC1B?,top_cases_counts_by_genes
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in AUTS2 and MERTK?,top_cases_counts_by_genes
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in AUTS2 and PXN?,top_cases_counts_by_genes
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in AUTS2 and CCNG1?,top_cases_counts_by_genes
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How rare is it to find CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without mutations in ACTL7B and ADRA1A?",top_cases_counts_by_genes
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How rare is it to find Glioblastoma Multiforme without mutations in PCDHGA1 and GPR158?,top_cases_counts_by_genes
+954,TRAP1,R114W,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in TRAP1 and GPC3?,top_cases_counts_by_genes
+955,TRAP1,R61W,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in TRAP1 and TYK2?,top_cases_counts_by_genes
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in PIK3C2A and VPS26B?,top_cases_counts_by_genes
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How rare is it to find Liver Hepatocellular Carcinoma without mutations in KANSL1 and GPR158?,top_cases_counts_by_genes
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in ANKRD52 and AKT1?,top_cases_counts_by_genes
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in PAPPA and PRSS1?,top_cases_counts_by_genes
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How rare is it to find Rectum Adenocarcinoma without mutations in B3GALNT1 and CXCR2?,top_cases_counts_by_genes
+982,GABRA6,G115R,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in GABRA6 and PCDHB2?,top_cases_counts_by_genes
+983,GABRA6,G122R,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in GABRA6 and DNMT1?,top_cases_counts_by_genes
+984,GABRA6,G165R,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in GABRA6 and ZNF708?,top_cases_counts_by_genes
+985,GABRA6,G175R,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in GABRA6 and DHX16?,top_cases_counts_by_genes
+986,GABRA6,G70R,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in GABRA6 and TASOR2?,top_cases_counts_by_genes
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in ZSCAN31 and ANP32E?,top_cases_counts_by_genes
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How rare is it to find CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without mutations in MED16 and PTPRO?",top_cases_counts_by_genes
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How rare is it to find CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without mutations in MED16 and TNS1?",top_cases_counts_by_genes
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How rare is it to find Pancreatic Adenocarcinoma without mutations in PTPRO and SPATA22?,top_cases_counts_by_genes
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How rare is it to find Pancreatic Adenocarcinoma without mutations in PTPRO and AUTS2?,top_cases_counts_by_genes
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How rare is it to find Pancreatic Adenocarcinoma without mutations in PTPRO and POC1B?,top_cases_counts_by_genes
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How rare is it to find Pancreatic Adenocarcinoma without mutations in PTPRO and EIF2B4?,top_cases_counts_by_genes
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How rare is it to find Pancreatic Adenocarcinoma without mutations in PTPRO and PIK3C2B?,top_cases_counts_by_genes
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How rare is it to find Pancreatic Adenocarcinoma without mutations in PTPRO and ZFPM2?,top_cases_counts_by_genes
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How rare is it to find Pancreatic Adenocarcinoma without mutations in PTPRO and POC1B?,top_cases_counts_by_genes
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How rare is it to find Pancreatic Adenocarcinoma without mutations in PTPRO and ZNF584?,top_cases_counts_by_genes
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in CHMP7 and EPRS1?,top_cases_counts_by_genes
+1017,GPC3,I107N,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in GPC3 and THBS4?,top_cases_counts_by_genes
+1018,GPC3,I161N,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in GPC3 and MYT1?,top_cases_counts_by_genes
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How rare is it to find Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma without mutations in TLK2 and ANKDD1A?,top_cases_counts_by_genes
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How rare is it to find Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma without mutations in TLK2 and SIK2?,top_cases_counts_by_genes
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How rare is it to find Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma without mutations in TLK2 and ZCCHC14?,top_cases_counts_by_genes
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How rare is it to find Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma without mutations in TLK2 and TMEM255A?,top_cases_counts_by_genes
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How rare is it to find Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma without mutations in TLK2 and EPRS1?,top_cases_counts_by_genes
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in ZNF217 and POLD1?,top_cases_counts_by_genes
+1038,SYT9,V275L,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in SYT9 and DGKD?,top_cases_counts_by_genes
+1039,SYT9,V307L,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in SYT9 and MAD1L1?,top_cases_counts_by_genes
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in PKHD1L1 and PIK3C2B?,top_cases_counts_by_genes
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in MYO3A and PGR?,top_cases_counts_by_genes
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How rare is it to find CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without mutations in VASN and FNDC7?",top_cases_counts_by_genes
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in DNMT1 and CA9?,top_cases_counts_by_genes
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in DNMT1 and MRPL32?,top_cases_counts_by_genes
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in DNMT1 and ZCCHC14?,top_cases_counts_by_genes
+1056,CA9,E402K,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in CA9 and KRT39?,top_cases_counts_by_genes
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in TTC17 and ACTB?,top_cases_counts_by_genes
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in TTC17 and AUTS2?,top_cases_counts_by_genes
+1065,PSG2,P43L,Breast Invasive Carcinoma,How rare is it to find Breast Invasive Carcinoma without mutations in PSG2 and PAK3?,top_cases_counts_by_genes
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How rare is it to find Breast Invasive Carcinoma without mutations in RIPOR2 and CACNA1F?,top_cases_counts_by_genes
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How rare is it to find Breast Invasive Carcinoma without mutations in RIPOR2 and POLR1G?,top_cases_counts_by_genes
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How rare is it to find Breast Invasive Carcinoma without mutations in RIPOR2 and TTC17?,top_cases_counts_by_genes
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How rare is it to find Breast Invasive Carcinoma without mutations in RIPOR2 and DCAF6?,top_cases_counts_by_genes
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in DCLK3 and SYNJ1?,top_cases_counts_by_genes
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in DCLK3 and ACVR1B?,top_cases_counts_by_genes
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in MERTK and PTPRN2?,top_cases_counts_by_genes
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in MERTK and RIPOR2?,top_cases_counts_by_genes
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in MERTK and PAK3?,top_cases_counts_by_genes
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in ZFP42 and ANKRD30A?,top_cases_counts_by_genes
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in OR13C3 and CTSC?,top_cases_counts_by_genes
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in OR13C3 and SPATA22?,top_cases_counts_by_genes
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in SPAG1 and MYO3A?,top_cases_counts_by_genes
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in CDKN2AIP and DCC?,top_cases_counts_by_genes
+1093,PXN,H1016Y,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in PXN and TTYH2?,top_cases_counts_by_genes
+1094,PXN,H359Y,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in PXN and MAST4?,top_cases_counts_by_genes
+1095,PXN,H492Y,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in PXN and SORCS1?,top_cases_counts_by_genes
+1096,PXN,H524Y,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in PXN and DCLK3?,top_cases_counts_by_genes
+1097,PXN,H526Y,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in PXN and TAF1L?,top_cases_counts_by_genes
+1098,PXN,H540Y,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in PXN and THBS4?,top_cases_counts_by_genes
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in TTYH2 and DPF3?,top_cases_counts_by_genes
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in TTYH2 and RIMS2?,top_cases_counts_by_genes
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in TMEM255A and BICC1?,top_cases_counts_by_genes
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in TMEM255A and AUTS2?,top_cases_counts_by_genes
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in TMEM255A and PXN?,top_cases_counts_by_genes
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How rare is it to find Breast Invasive Carcinoma without mutations in TASOR2 and DCN?,top_cases_counts_by_genes
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How rare is it to find Breast Invasive Carcinoma without mutations in TASOR2 and TASOR2?,top_cases_counts_by_genes
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in ICE1 and DSCAM?,top_cases_counts_by_genes
+1112,MYT1,A558E,Breast Invasive Carcinoma,How rare is it to find Breast Invasive Carcinoma without mutations in MYT1 and FNDC7?,top_cases_counts_by_genes
+1113,MYT1,A879E,Breast Invasive Carcinoma,How rare is it to find Breast Invasive Carcinoma without mutations in MYT1 and PXN?,top_cases_counts_by_genes
+1114,MYT1,A906E,Breast Invasive Carcinoma,How rare is it to find Breast Invasive Carcinoma without mutations in MYT1 and OLFML3?,top_cases_counts_by_genes
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in CX3CR1 and DGKD?,top_cases_counts_by_genes
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in CX3CR1 and TENM2?,top_cases_counts_by_genes
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How rare is it to find Liver Hepatocellular Carcinoma without mutations in SPINDOC and EVC2?,top_cases_counts_by_genes
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in ART3 and MAST4?,top_cases_counts_by_genes
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in ART3 and THBS4?,top_cases_counts_by_genes
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How rare is it to find Bladder Urothelial Carcinoma without mutations in CYP1A2 and FBXO15?,top_cases_counts_by_genes
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How rare is it to find CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without mutations in ADRA1A and FGF8?",top_cases_counts_by_genes
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in CDH23 and EBF2?,top_cases_counts_by_genes
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in CDH23 and CTCFL?,top_cases_counts_by_genes
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in KRT39 and KRT39?,top_cases_counts_by_genes
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in PDHA2 and GUF1?,top_cases_counts_by_genes
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in SLC24A2 and CDH23?,top_cases_counts_by_genes
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How rare is it to find Liver Hepatocellular Carcinoma without mutations in PTPRN2 and CPS1?,top_cases_counts_by_genes
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How rare is it to find Liver Hepatocellular Carcinoma without mutations in PTPRN2 and CHODL?,top_cases_counts_by_genes
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How rare is it to find Liver Hepatocellular Carcinoma without mutations in PTPRN2 and PCDHB2?,top_cases_counts_by_genes
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How rare is it to find Liver Hepatocellular Carcinoma without mutations in PTPRN2 and TRAP1?,top_cases_counts_by_genes
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How rare is it to find Liver Hepatocellular Carcinoma without mutations in PTPRN2 and EPRS1?,top_cases_counts_by_genes
+1188,SOX21,R55L,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in SOX21 and DGKD?,top_cases_counts_by_genes
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How rare is it to find Bladder Urothelial Carcinoma without mutations in CPA6 and GUK1?,top_cases_counts_by_genes
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in GRM5 and AQP7?,top_cases_counts_by_genes
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How rare is it to find CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without mutations in CASZ1 and ERCC6?",top_cases_counts_by_genes
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in SGIP1 and PCDHB2?,top_cases_counts_by_genes
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in SGIP1 and SYNJ1?,top_cases_counts_by_genes
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in SGIP1 and DCC?,top_cases_counts_by_genes
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in SGIP1 and YY1AP1?,top_cases_counts_by_genes
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in CARMIL1 and CCDC22?,top_cases_counts_by_genes
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in CARMIL1 and CDH23?,top_cases_counts_by_genes
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in ZNF431 and KDM5C?,top_cases_counts_by_genes
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in ZNF431 and TENM2?,top_cases_counts_by_genes
+1234,ZNF431,R128I,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in ZNF431 and CFAP298-TCP10L?,top_cases_counts_by_genes
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in DNAH11 and ZFPM2?,top_cases_counts_by_genes
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in DNAH11 and DHX16?,top_cases_counts_by_genes
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in POLD1 and SLC24A2?,top_cases_counts_by_genes
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How rare is it to find Lung Squamous Cell Carcinoma without mutations in POLD1 and PLEKHG6?,top_cases_counts_by_genes
+1248,TTC12,D646H,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in TTC12 and CTNNA2?,top_cases_counts_by_genes
+1249,TTC12,D652H,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in TTC12 and TNS1?,top_cases_counts_by_genes
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How rare is it to find Bladder Urothelial Carcinoma without mutations in CNGB1 and DCAF4L2?,top_cases_counts_by_genes
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How rare is it to find Bladder Urothelial Carcinoma without mutations in CNGB1 and PLEKHG6?,top_cases_counts_by_genes
+1254,CTSC,E214V,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in CTSC and LCN15?,top_cases_counts_by_genes
+1255,CTSC,E291V,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in CTSC and MORF4L1?,top_cases_counts_by_genes
+1256,CTSC,E322V,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in CTSC and TTN?,top_cases_counts_by_genes
+1257,CTSC,E324V,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in CTSC and LAMB2?,top_cases_counts_by_genes
+1258,CTSC,E335V,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in CTSC and TAF1C?,top_cases_counts_by_genes
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in PRSS8 and SORCS1?,top_cases_counts_by_genes
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in PRSS8 and PAK3?,top_cases_counts_by_genes
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in ARHGEF40 and TTN?,top_cases_counts_by_genes
+1264,ACTB,A138T,Rectum Adenocarcinoma,How rare is it to find Rectum Adenocarcinoma without mutations in ACTB and SYNJ1?,top_cases_counts_by_genes
+1265,ACTB,A217T,Rectum Adenocarcinoma,How rare is it to find Rectum Adenocarcinoma without mutations in ACTB and USH2A?,top_cases_counts_by_genes
+1266,ACTB,A244T,Rectum Adenocarcinoma,How rare is it to find Rectum Adenocarcinoma without mutations in ACTB and ACTL7B?,top_cases_counts_by_genes
+1267,ACTB,A260T,Rectum Adenocarcinoma,How rare is it to find Rectum Adenocarcinoma without mutations in ACTB and TMEM255A?,top_cases_counts_by_genes
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How rare is it to find Glioblastoma Multiforme without mutations in YY1AP1 and GPC3?,top_cases_counts_by_genes
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How rare is it to find Glioblastoma Multiforme without mutations in YY1AP1 and FBXO42?,top_cases_counts_by_genes
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How rare is it to find Glioblastoma Multiforme without mutations in YY1AP1 and RIMS2?,top_cases_counts_by_genes
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How rare is it to find Glioblastoma Multiforme without mutations in YY1AP1 and ACTA2?,top_cases_counts_by_genes
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How rare is it to find Glioblastoma Multiforme without mutations in YY1AP1 and FRY?,top_cases_counts_by_genes
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How rare is it to find Glioblastoma Multiforme without mutations in YY1AP1 and ARMC3?,top_cases_counts_by_genes
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How rare is it to find Glioblastoma Multiforme without mutations in YY1AP1 and MORF4L1?,top_cases_counts_by_genes
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in FNDC7 and SYT9?,top_cases_counts_by_genes
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in FNDC7 and ANP32E?,top_cases_counts_by_genes
+1299,TLCD5,G15V,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in TLCD5 and DGKD?,top_cases_counts_by_genes
+1300,TLCD5,G37V,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in TLCD5 and DOCK2?,top_cases_counts_by_genes
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in POLR1G and CPS1?,top_cases_counts_by_genes
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in POLR1G and SGCZ?,top_cases_counts_by_genes
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in DNAH14 and PIK3C2G?,top_cases_counts_by_genes
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in DNAH14 and PXN?,top_cases_counts_by_genes
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in DNAH14 and XKR4?,top_cases_counts_by_genes
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in NEXN and AQP7?,top_cases_counts_by_genes
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How rare is it to find Prostate Adenocarcinoma without mutations in CYB5R2 and ZNF584?,top_cases_counts_by_genes
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How rare is it to find Prostate Adenocarcinoma without mutations in CYB5R2 and ZNF431?,top_cases_counts_by_genes
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in NRAP and ANKRD30A?,top_cases_counts_by_genes
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in NRAP and DCLK3?,top_cases_counts_by_genes
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in NRAP and DCN?,top_cases_counts_by_genes
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in CCDC22 and ANKDD1A?,top_cases_counts_by_genes
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in DCAF6 and ZNF274?,top_cases_counts_by_genes
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in DCAF6 and NCKAP5?,top_cases_counts_by_genes
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in ZNF708 and PTPRO?,top_cases_counts_by_genes
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in BFAR and GRM5?,top_cases_counts_by_genes
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in MAST4 and ZCCHC14?,top_cases_counts_by_genes
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in MAST4 and FMO4?,top_cases_counts_by_genes
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in MAST4 and PRSS1?,top_cases_counts_by_genes
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in MAST4 and YY1AP1?,top_cases_counts_by_genes
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in MAST4 and RIPOR2?,top_cases_counts_by_genes
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in ARMC3 and DGKD?,top_cases_counts_by_genes
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in ARMC3 and MYH11?,top_cases_counts_by_genes
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How rare is it to find Kidney Renal Clear Cell Carcinoma without mutations in TET2 and DCC?,top_cases_counts_by_genes
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How rare is it to find Kidney Renal Clear Cell Carcinoma without mutations in TET2 and TENT5A?,top_cases_counts_by_genes
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in SERPINB10 and PTPRN2?,top_cases_counts_by_genes
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in STAT3 and DCN?,top_cases_counts_by_genes
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in MIEF1 and UNC5D?,top_cases_counts_by_genes
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in ACVR1B and GUK1?,top_cases_counts_by_genes
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in ACVR1B and TAF1C?,top_cases_counts_by_genes
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in ACVR1B and SGCZ?,top_cases_counts_by_genes
+1393,EBF2,T104I,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in EBF2 and SYNJ1?,top_cases_counts_by_genes
+1394,EBF2,T252I,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in EBF2 and TENM2?,top_cases_counts_by_genes
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in VPS26B and GRM1?,top_cases_counts_by_genes
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How rare is it to find CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without mutations in PGR and PTPRO?",top_cases_counts_by_genes
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How rare is it to find CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without mutations in PGR and AUTS2?",top_cases_counts_by_genes
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How rare is it to find CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus without mutations in PGR and ANP32E?",top_cases_counts_by_genes
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How rare is it to find Skin Cutaneous Melanoma without mutations in ACTA2 and DCC?,top_cases_counts_by_genes
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in THBS4 and DPF3?,top_cases_counts_by_genes
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in THBS4 and TENT5A?,top_cases_counts_by_genes
+1413,PRSS1,S114T,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in PRSS1 and FRY?,top_cases_counts_by_genes
+1414,PRSS1,S124T,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in PRSS1 and PTPRO?,top_cases_counts_by_genes
+1415,PRSS1,S138T,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in PRSS1 and MERTK?,top_cases_counts_by_genes
+1416,PRSS1,S74T,Lung Adenocarcinoma,How rare is it to find Lung Adenocarcinoma without mutations in PRSS1 and TENM2?,top_cases_counts_by_genes
+1417,PGF,R126H,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in PGF and ERCC6?,top_cases_counts_by_genes
+1418,PGF,R127H,Stomach Adenocarcinoma,How rare is it to find Stomach Adenocarcinoma without mutations in PGF and ANP32E?,top_cases_counts_by_genes
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How rare is it to find Breast Invasive Carcinoma without mutations in ITPRID2 and TNS1?,top_cases_counts_by_genes
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How rare is it to find Breast Invasive Carcinoma without mutations in ITPRID2 and SLC6A4?,top_cases_counts_by_genes
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in HBB and TLCD5?,top_cases_counts_by_genes
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in PCDHB2 and ANKRD24?,top_cases_counts_by_genes
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in PCDHB2 and MORF4L1?,top_cases_counts_by_genes
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How rare is it to find Colon Adenocarcinoma without mutations in PCDHB2 and TRIM45?,top_cases_counts_by_genes
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How rare is it to find Uterine Corpus Endometrial Carcinoma without mutations in UBR2 and REXO4?,top_cases_counts_by_genes
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How rare is it to find Rectum Adenocarcinoma without mutations in FBXO42 and LAMB2?,top_cases_counts_by_genes
+1,TNS1,G1362V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases lack TNS1 and CYB5R2 gene mutations?,top_cases_counts_by_genes
+2,TNS1,G1711V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases lack TNS1 and TENM2 gene mutations?,top_cases_counts_by_genes
+3,TNS1,G1718V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases lack TNS1 and DSCAM gene mutations?,top_cases_counts_by_genes
+4,TNS1,G1732V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases lack TNS1 and FCGR2C gene mutations?,top_cases_counts_by_genes
+5,TNS1,G1824V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases lack TNS1 and MYO3B gene mutations?,top_cases_counts_by_genes
+6,TNS1,G1857V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases lack TNS1 and PIK3C2B gene mutations?,top_cases_counts_by_genes
+7,TNS1,G843V,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases lack TNS1 and TRAP1 gene mutations?,top_cases_counts_by_genes
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases lack EVC2 and TASOR2 gene mutations?,top_cases_counts_by_genes
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases lack EVC2 and ZFP42 gene mutations?,top_cases_counts_by_genes
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack CR1 and TRIM45 gene mutations?,top_cases_counts_by_genes
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack CR1 and MAOB gene mutations?,top_cases_counts_by_genes
+22,TRPA1,S295I,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases lack TRPA1 and CHODL gene mutations?,top_cases_counts_by_genes
+23,TRPA1,S443I,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases lack TRPA1 and C7orf31 gene mutations?,top_cases_counts_by_genes
+24,TAF1C,R299L,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack TAF1C and TET2 gene mutations?,top_cases_counts_by_genes
+25,TAF1C,R396L,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack TAF1C and TRIM45 gene mutations?,top_cases_counts_by_genes
+26,TAF1C,R634L,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack TAF1C and CARMIL1 gene mutations?,top_cases_counts_by_genes
+27,TAF1C,R702L,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack TAF1C and PGR gene mutations?,top_cases_counts_by_genes
+28,TAF1C,R728L,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack TAF1C and PTPRO gene mutations?,top_cases_counts_by_genes
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack DPF3 and ZCCHC14 gene mutations?,top_cases_counts_by_genes
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack DPF3 and MORF4L1 gene mutations?,top_cases_counts_by_genes
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack DPF3 and SPTAN1 gene mutations?,top_cases_counts_by_genes
+42,OR2T4,P272H,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack OR2T4 and NOMO1 gene mutations?,top_cases_counts_by_genes
+43,OR2T4,P300H,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack OR2T4 and ZSCAN31 gene mutations?,top_cases_counts_by_genes
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma cases lack FBN1 and PGR gene mutations?,top_cases_counts_by_genes
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma cases lack MAD1L1 and CPS1 gene mutations?,top_cases_counts_by_genes
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma cases lack MAD1L1 and NRAP gene mutations?,top_cases_counts_by_genes
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma cases lack MAD1L1 and DCAF4L2 gene mutations?,top_cases_counts_by_genes
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack CCNG1 and SGIP1 gene mutations?,top_cases_counts_by_genes
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma cases lack ANP32E and ZMYM3 gene mutations?,top_cases_counts_by_genes
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma cases lack ANP32E and CDC42BPA gene mutations?,top_cases_counts_by_genes
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma cases lack ANP32E and CR1 gene mutations?,top_cases_counts_by_genes
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma cases lack ANP32E and ZNF431 gene mutations?,top_cases_counts_by_genes
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases lack FRY and PTPRO gene mutations?,top_cases_counts_by_genes
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases lack FRY and OR2T4 gene mutations?,top_cases_counts_by_genes
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases lack FRY and MYO3A gene mutations?,top_cases_counts_by_genes
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases lack FRY and GUK1 gene mutations?,top_cases_counts_by_genes
+70,PAK3,E318K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack PAK3 and DGKD gene mutations?,top_cases_counts_by_genes
+71,PAK3,E319K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack PAK3 and TTN gene mutations?,top_cases_counts_by_genes
+72,PAK3,E334K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack PAK3 and MYO16 gene mutations?,top_cases_counts_by_genes
+73,PAK3,E340K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack PAK3 and POLD1 gene mutations?,top_cases_counts_by_genes
+74,PAK3,E355K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack PAK3 and TAF1C gene mutations?,top_cases_counts_by_genes
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack MUC16 and OR13C3 gene mutations?,top_cases_counts_by_genes
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma cases lack ZFPM2 and MORF4L1 gene mutations?,top_cases_counts_by_genes
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma cases lack ZFPM2 and TAF1C gene mutations?,top_cases_counts_by_genes
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases lack PIK3C2B and EVC2 gene mutations?,top_cases_counts_by_genes
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases lack PIK3C2B and ITPRID2 gene mutations?,top_cases_counts_by_genes
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack ZNF804A and MYO16 gene mutations?,top_cases_counts_by_genes
+116,RELN,A2371V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack RELN and MORF4L1 gene mutations?,top_cases_counts_by_genes
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases lack EFCAB12 and MIEF1 gene mutations?",top_cases_counts_by_genes
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases lack EFCAB12 and SYNJ1 gene mutations?",top_cases_counts_by_genes
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack DEFB115 and ACTB gene mutations?,top_cases_counts_by_genes
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases lack ANKDD1A and VPS26B gene mutations?,top_cases_counts_by_genes
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases lack ANKDD1A and DPF3 gene mutations?,top_cases_counts_by_genes
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases lack ANKDD1A and AUTS2 gene mutations?,top_cases_counts_by_genes
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack HTR3B and DNMT1 gene mutations?,top_cases_counts_by_genes
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack HTR3B and GUK1 gene mutations?,top_cases_counts_by_genes
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack HTR3B and CACNA1F gene mutations?,top_cases_counts_by_genes
+129,ABCC3,R758W,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack ABCC3 and YY1AP1 gene mutations?,top_cases_counts_by_genes
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack NOMO1 and PRSS1 gene mutations?,top_cases_counts_by_genes
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack NOMO1 and BICC1 gene mutations?,top_cases_counts_by_genes
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases lack HYOU1 and AUTS2 gene mutations?,top_cases_counts_by_genes
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack FMO4 and RIMS2 gene mutations?,top_cases_counts_by_genes
+140,BICC1,A372V,Exceptional Responders,How many Exceptional Responders cases lack BICC1 and SLC9C1 gene mutations?,top_cases_counts_by_genes
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack ZMYM3 and SLC24A2 gene mutations?,top_cases_counts_by_genes
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack ZMYM3 and ANP32E gene mutations?,top_cases_counts_by_genes
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack ZMYM3 and ZMYM3 gene mutations?,top_cases_counts_by_genes
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases lack XKR4 and EVC2 gene mutations?",top_cases_counts_by_genes
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma cases lack ABCC2 and ACTB gene mutations?,top_cases_counts_by_genes
+157,OR8K5,R293G,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack OR8K5 and COL6A3 gene mutations?,top_cases_counts_by_genes
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack SPTAN1 and CTNNA2 gene mutations?,top_cases_counts_by_genes
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack SPTAN1 and ZCCHC14 gene mutations?,top_cases_counts_by_genes
+164,SYT10,M484I,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases lack SYT10 and GPRASP1 gene mutations?,top_cases_counts_by_genes
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack HSPA5 and FGF8 gene mutations?,top_cases_counts_by_genes
+175,UNC5D,L280V,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack UNC5D and POC1B gene mutations?,top_cases_counts_by_genes
+176,UNC5D,L635V,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack UNC5D and POC1B gene mutations?,top_cases_counts_by_genes
+177,UNC5D,L637V,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack UNC5D and EPRS1 gene mutations?,top_cases_counts_by_genes
+178,UNC5D,L699V,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack UNC5D and MYO16 gene mutations?,top_cases_counts_by_genes
+179,UNC5D,L704V,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack UNC5D and PTPRO gene mutations?,top_cases_counts_by_genes
+180,UNC5D,L709V,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack UNC5D and MAST4 gene mutations?,top_cases_counts_by_genes
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How many Kidney Renal Clear Cell Carcinoma cases lack DOCK2 and ZNF708 gene mutations?,top_cases_counts_by_genes
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How many Kidney Renal Clear Cell Carcinoma cases lack ZNF627 and ANKDD1A gene mutations?,top_cases_counts_by_genes
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack CDC42BPA and CTNNA2 gene mutations?,top_cases_counts_by_genes
+193,MRPL55,H27Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack MRPL55 and B3GALNT1 gene mutations?,top_cases_counts_by_genes
+194,MRPL55,H63Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack MRPL55 and DNAH14 gene mutations?,top_cases_counts_by_genes
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases lack TMTC3 and UNC5D gene mutations?,top_cases_counts_by_genes
+198,EPRS1,K771I,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack EPRS1 and PIAS3 gene mutations?,top_cases_counts_by_genes
+199,EPRS1,K778I,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack EPRS1 and NCKAP5 gene mutations?,top_cases_counts_by_genes
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack GRTP1 and ZCCHC14 gene mutations?,top_cases_counts_by_genes
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack GRTP1 and JAML gene mutations?,top_cases_counts_by_genes
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack TSHZ3 and PAK3 gene mutations?,top_cases_counts_by_genes
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How many HIV+ Tumor Molecular Characterization Project - Cervical Cancer cases lack TAS1R3 and TENM2 gene mutations?,top_cases_counts_by_genes
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack PIAS3 and GPR158 gene mutations?,top_cases_counts_by_genes
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack PIAS3 and DPF3 gene mutations?,top_cases_counts_by_genes
+251,ZNF274,P13R,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack ZNF274 and NCKAP5 gene mutations?,top_cases_counts_by_genes
+253,SYNJ1,R795C,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack SYNJ1 and MAST4 gene mutations?,top_cases_counts_by_genes
+254,SYNJ1,R800C,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack SYNJ1 and FRY gene mutations?,top_cases_counts_by_genes
+255,SYNJ1,R839C,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack SYNJ1 and PXN gene mutations?,top_cases_counts_by_genes
+261,DSCAM,V343M,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma cases lack DSCAM and CNGB1 gene mutations?,top_cases_counts_by_genes
+262,DSCAM,V426M,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma cases lack DSCAM and PIK3C2G gene mutations?,top_cases_counts_by_genes
+263,DSCAM,V591M,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma cases lack DSCAM and CACNA1F gene mutations?,top_cases_counts_by_genes
+267,DGKD,R140H,Exceptional Responders,How many Exceptional Responders cases lack DGKD and ANP32E gene mutations?,top_cases_counts_by_genes
+268,DGKD,R160H,Exceptional Responders,How many Exceptional Responders cases lack DGKD and HLA-DQA2 gene mutations?,top_cases_counts_by_genes
+269,DGKD,R204H,Exceptional Responders,How many Exceptional Responders cases lack DGKD and SYT10 gene mutations?,top_cases_counts_by_genes
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases lack PLEKHG6 and CACNA1F gene mutations?,top_cases_counts_by_genes
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases lack PLEKHG6 and ZNF584 gene mutations?,top_cases_counts_by_genes
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases lack PLEKHG6 and EIF2B4 gene mutations?,top_cases_counts_by_genes
+279,WNT2,D138N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack WNT2 and SGIP1 gene mutations?,top_cases_counts_by_genes
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack GUCY2C and UNC5D gene mutations?,top_cases_counts_by_genes
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack C7orf31 and MAST4 gene mutations?,top_cases_counts_by_genes
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases lack ZKSCAN7 and FGF8 gene mutations?",top_cases_counts_by_genes
+299,OR5D14,M210L,Neuroblastoma,How many Neuroblastoma cases lack OR5D14 and CFAP61 gene mutations?,top_cases_counts_by_genes
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack SPATA22 and SORCS1 gene mutations?,top_cases_counts_by_genes
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack SPATA22 and SYT9 gene mutations?,top_cases_counts_by_genes
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack SPATA22 and SPATA22 gene mutations?,top_cases_counts_by_genes
+310,LCN15,E21V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack LCN15 and ANKRD24 gene mutations?,top_cases_counts_by_genes
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack DCAF4L2 and COL6A3 gene mutations?,top_cases_counts_by_genes
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack GUK1 and PTPRO gene mutations?,top_cases_counts_by_genes
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack GUK1 and PAPPA gene mutations?,top_cases_counts_by_genes
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack GUK1 and NCKAP5 gene mutations?,top_cases_counts_by_genes
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack GUK1 and TET2 gene mutations?,top_cases_counts_by_genes
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack GUK1 and DNAH11 gene mutations?,top_cases_counts_by_genes
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack MORF4L1 and FBN1 gene mutations?,top_cases_counts_by_genes
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack MORF4L1 and TYROBP gene mutations?,top_cases_counts_by_genes
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack MORF4L1 and SLC9C1 gene mutations?,top_cases_counts_by_genes
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack MORF4L1 and DHX16 gene mutations?,top_cases_counts_by_genes
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack MYO3B and DSCAM gene mutations?,top_cases_counts_by_genes
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack MYO3B and TLCD5 gene mutations?,top_cases_counts_by_genes
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack TENT5A and DPF3 gene mutations?,top_cases_counts_by_genes
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack TENT5A and TMEM255A gene mutations?,top_cases_counts_by_genes
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack TENT5A and MYO3B gene mutations?,top_cases_counts_by_genes
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How many Ovarian Serous Cystadenocarcinoma cases lack ZFAT and EVC2 gene mutations?,top_cases_counts_by_genes
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How many Ovarian Serous Cystadenocarcinoma cases lack ZFAT and ZFPM2 gene mutations?,top_cases_counts_by_genes
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How many Ovarian Serous Cystadenocarcinoma cases lack ZFAT and NRAP gene mutations?,top_cases_counts_by_genes
+357,ZNF584,A211T,Sarcoma,How many Sarcoma cases lack ZNF584 and ZFAT gene mutations?,top_cases_counts_by_genes
+358,ZNF584,A256T,Sarcoma,How many Sarcoma cases lack ZNF584 and FGF8 gene mutations?,top_cases_counts_by_genes
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack LDOC1 and PLEKHG6 gene mutations?,top_cases_counts_by_genes
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack PDGFC and ANKRD30A gene mutations?,top_cases_counts_by_genes
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack MSANTD4 and EFCAB12 gene mutations?,top_cases_counts_by_genes
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack NPSR1 and CX3CR1 gene mutations?,top_cases_counts_by_genes
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack PHLPP1 and CYP1A2 gene mutations?,top_cases_counts_by_genes
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack COL6A3 and CHODL gene mutations?,top_cases_counts_by_genes
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack COL6A3 and OLFML3 gene mutations?,top_cases_counts_by_genes
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack COL6A3 and COL6A3 gene mutations?,top_cases_counts_by_genes
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack COL6A3 and MYO3A gene mutations?,top_cases_counts_by_genes
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack COL6A3 and YY1AP1 gene mutations?,top_cases_counts_by_genes
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack ADRA1A and TMEM255A gene mutations?,top_cases_counts_by_genes
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases lack LAMB2 and DNMT1 gene mutations?,top_cases_counts_by_genes
+406,POC1B,I198T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases lack POC1B and DOCK2 gene mutations?,top_cases_counts_by_genes
+407,POC1B,I286T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases lack POC1B and RIMS2 gene mutations?,top_cases_counts_by_genes
+408,POC1B,I328T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases lack POC1B and ACVR1B gene mutations?,top_cases_counts_by_genes
+409,POC1B,S79P,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases lack POC1B and CTCFL gene mutations?,top_cases_counts_by_genes
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma cases lack USH2A and FMO4 gene mutations?,top_cases_counts_by_genes
+414,AQP7,T110S,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases lack AQP7 and CASZ1 gene mutations?,top_cases_counts_by_genes
+415,AQP7,T166S,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases lack AQP7 and DCAF4L2 gene mutations?,top_cases_counts_by_genes
+416,AQP7,T167S,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases lack AQP7 and MAD1L1 gene mutations?,top_cases_counts_by_genes
+417,AQP7,T75S,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases lack AQP7 and MYO3B gene mutations?,top_cases_counts_by_genes
+430,DCN,R163C,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases lack DCN and AKT1 gene mutations?,top_cases_counts_by_genes
+431,DCN,R203C,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases lack DCN and MAOB gene mutations?,top_cases_counts_by_genes
+432,DCN,R241C,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases lack DCN and ACVR1B gene mutations?,top_cases_counts_by_genes
+433,DCN,R350C,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases lack DCN and TTC17 gene mutations?,top_cases_counts_by_genes
+434,DCN,R41C,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases lack DCN and ZBTB34 gene mutations?,top_cases_counts_by_genes
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack CPS1 and RIPOR2 gene mutations?,top_cases_counts_by_genes
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack CPS1 and DCN gene mutations?,top_cases_counts_by_genes
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack CPS1 and CTSC gene mutations?,top_cases_counts_by_genes
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma cases lack FCGR2C and PCDHGA1 gene mutations?,top_cases_counts_by_genes
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma cases lack FCGR2C and RAB40C gene mutations?,top_cases_counts_by_genes
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack GRM1 and ZBTB34 gene mutations?,top_cases_counts_by_genes
+482,SGCZ,Q138H,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack SGCZ and ANP32E gene mutations?,top_cases_counts_by_genes
+483,SGCZ,Q91H,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack SGCZ and JAML gene mutations?,top_cases_counts_by_genes
+485,SMO,V15M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack SMO and PCDHB2 gene mutations?,top_cases_counts_by_genes
+486,SMO,V321M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack SMO and CACNA1F gene mutations?,top_cases_counts_by_genes
+488,CHODL,G159E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack CHODL and ZFAT gene mutations?,top_cases_counts_by_genes
+489,CHODL,G181E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack CHODL and YY1AP1 gene mutations?,top_cases_counts_by_genes
+490,CHODL,G200E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack CHODL and ZNF431 gene mutations?,top_cases_counts_by_genes
+494,MYO16,P399H,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack MYO16 and TTN gene mutations?,top_cases_counts_by_genes
+495,MYO16,P421H,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack MYO16 and PCDHGA1 gene mutations?,top_cases_counts_by_genes
+498,CXCR2,A98V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack CXCR2 and TTC12 gene mutations?,top_cases_counts_by_genes
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases lack TMEM225 and TENT5A gene mutations?,top_cases_counts_by_genes
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack MAOB and PGR gene mutations?,top_cases_counts_by_genes
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack GPRASP1 and DCAF4L2 gene mutations?,top_cases_counts_by_genes
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack MRPL32 and AQP7 gene mutations?,top_cases_counts_by_genes
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack TYROBP and FNDC7 gene mutations?,top_cases_counts_by_genes
+510,RAB40C,A111V,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack RAB40C and NCKAP5 gene mutations?,top_cases_counts_by_genes
+511,RAB40C,A143V,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack RAB40C and PCDHB2 gene mutations?,top_cases_counts_by_genes
+512,CTNNA2,S323R,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack CTNNA2 and NOMO1 gene mutations?,top_cases_counts_by_genes
+513,CTNNA2,S339R,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack CTNNA2 and GPR158 gene mutations?,top_cases_counts_by_genes
+514,CTNNA2,S386R,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack CTNNA2 and SGIP1 gene mutations?,top_cases_counts_by_genes
+515,CTNNA2,S707R,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack CTNNA2 and CR1 gene mutations?,top_cases_counts_by_genes
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases lack MYO15A and CDKN2AIP gene mutations?,top_cases_counts_by_genes
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack GIMAP2 and UNC5D gene mutations?,top_cases_counts_by_genes
+532,KIF20B,N1160D,Glioblastoma Multiforme,How many Glioblastoma Multiforme cases lack KIF20B and GPRASP1 gene mutations?,top_cases_counts_by_genes
+533,KIF20B,N1200D,Glioblastoma Multiforme,How many Glioblastoma Multiforme cases lack KIF20B and MAOB gene mutations?,top_cases_counts_by_genes
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack ADAM17 and TLK2 gene mutations?,top_cases_counts_by_genes
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack BCAT1 and ZFAT gene mutations?,top_cases_counts_by_genes
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack BCAT1 and CACNA1F gene mutations?,top_cases_counts_by_genes
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack BCAT1 and TAF1C gene mutations?,top_cases_counts_by_genes
+540,ERCC6,R1053H,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack ERCC6 and SYT9 gene mutations?,top_cases_counts_by_genes
+541,DCC,R320W,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases lack DCC and TRAP1 gene mutations?,top_cases_counts_by_genes
+542,DCC,R363W,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases lack DCC and REXO4 gene mutations?,top_cases_counts_by_genes
+543,DCC,R386W,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases lack DCC and AKT1 gene mutations?,top_cases_counts_by_genes
+544,DCC,R41W,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases lack DCC and TAF1C gene mutations?,top_cases_counts_by_genes
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack FBXO15 and CHODL gene mutations?,top_cases_counts_by_genes
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack FBXO15 and PTPRO gene mutations?,top_cases_counts_by_genes
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack GSTCD and FBXO15 gene mutations?,top_cases_counts_by_genes
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack GSTCD and HTR3B gene mutations?,top_cases_counts_by_genes
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack OLFML3 and MIEF1 gene mutations?,top_cases_counts_by_genes
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack OLFML3 and CCNG1 gene mutations?,top_cases_counts_by_genes
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack OLFML3 and MYH11 gene mutations?,top_cases_counts_by_genes
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How many Ovarian Serous Cystadenocarcinoma cases lack CFAP61 and FNDC7 gene mutations?,top_cases_counts_by_genes
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How many Ovarian Serous Cystadenocarcinoma cases lack CFAP61 and THBS4 gene mutations?,top_cases_counts_by_genes
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases lack HLA-DQA2 and ZNF584 gene mutations?,top_cases_counts_by_genes
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack TENM2 and MRPL32 gene mutations?,top_cases_counts_by_genes
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack TENM2 and PAPPA gene mutations?,top_cases_counts_by_genes
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack TENM2 and OLFML3 gene mutations?,top_cases_counts_by_genes
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack ANKRD24 and PCDHB2 gene mutations?,top_cases_counts_by_genes
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack ANKRD24 and GUK1 gene mutations?,top_cases_counts_by_genes
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack ANKRD24 and ACTB gene mutations?,top_cases_counts_by_genes
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack ZCCHC14 and ZNF584 gene mutations?,top_cases_counts_by_genes
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack ZCCHC14 and DCN gene mutations?,top_cases_counts_by_genes
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack ZCCHC14 and COL6A3 gene mutations?,top_cases_counts_by_genes
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack ZCCHC14 and DHX16 gene mutations?,top_cases_counts_by_genes
+625,SIK2,I265M,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack SIK2 and TENM2 gene mutations?,top_cases_counts_by_genes
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack MYH11 and KDM5C gene mutations?,top_cases_counts_by_genes
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack MYH11 and TTN gene mutations?,top_cases_counts_by_genes
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack SLC6A4 and SGIP1 gene mutations?,top_cases_counts_by_genes
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack SLC9C1 and GABRA6 gene mutations?,top_cases_counts_by_genes
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack SLC9C1 and SERPINB10 gene mutations?,top_cases_counts_by_genes
+644,OR2A12,A254T,Brain Lower Grade Glioma,How many Brain Lower Grade Glioma cases lack OR2A12 and CDC42BPA gene mutations?,top_cases_counts_by_genes
+646,PYHIN1,T325K,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack PYHIN1 and AKT1 gene mutations?,top_cases_counts_by_genes
+647,PYHIN1,T334K,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack PYHIN1 and EFCAB12 gene mutations?,top_cases_counts_by_genes
+650,JAML,G191E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack JAML and CFAP298-TCP10L gene mutations?,top_cases_counts_by_genes
+651,JAML,G219E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack JAML and DNAH14 gene mutations?,top_cases_counts_by_genes
+652,JAML,G220E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack JAML and DSCAM gene mutations?,top_cases_counts_by_genes
+653,JAML,G230E,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack JAML and DNMT1 gene mutations?,top_cases_counts_by_genes
+658,TYK2,H1146R,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack TYK2 and DNAH11 gene mutations?,top_cases_counts_by_genes
+659,TYK2,H23R,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack TYK2 and PTPRN2 gene mutations?,top_cases_counts_by_genes
+660,TYK2,H961R,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack TYK2 and GABRA6 gene mutations?,top_cases_counts_by_genes
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack CTCFL and ZFAT gene mutations?,top_cases_counts_by_genes
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack CTCFL and SYT9 gene mutations?,top_cases_counts_by_genes
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack CTCFL and CFAP61 gene mutations?,top_cases_counts_by_genes
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack CTCFL and ZMYM3 gene mutations?,top_cases_counts_by_genes
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack CEP20 and CTNNA2 gene mutations?,top_cases_counts_by_genes
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack CEP20 and PAK3 gene mutations?,top_cases_counts_by_genes
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack RIMS2 and CYB5R2 gene mutations?,top_cases_counts_by_genes
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack RIMS2 and MYO3B gene mutations?,top_cases_counts_by_genes
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack RIMS2 and DCC gene mutations?,top_cases_counts_by_genes
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack RIMS2 and TENM3 gene mutations?,top_cases_counts_by_genes
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack RIMS2 and PGR gene mutations?,top_cases_counts_by_genes
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack RIMS2 and TASOR2 gene mutations?,top_cases_counts_by_genes
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack RIMS2 and PCDHB2 gene mutations?,top_cases_counts_by_genes
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack PIK3C2G and ANKDD1A gene mutations?,top_cases_counts_by_genes
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack PIK3C2G and AUTS2 gene mutations?,top_cases_counts_by_genes
+728,STK19,D341N,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack STK19 and ACTB gene mutations?,top_cases_counts_by_genes
+729,STK19,D345N,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack STK19 and ZSCAN31 gene mutations?,top_cases_counts_by_genes
+730,REXO4,P60A,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack REXO4 and CR1 gene mutations?,top_cases_counts_by_genes
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack ZBTB34 and MERTK gene mutations?,top_cases_counts_by_genes
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack ZBTB34 and TASOR2 gene mutations?,top_cases_counts_by_genes
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases lack NCKAP5 and COL6A3 gene mutations?,top_cases_counts_by_genes
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases lack SORCS1 and ZFP42 gene mutations?",top_cases_counts_by_genes
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases lack SORCS1 and PLEKHG6 gene mutations?",top_cases_counts_by_genes
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases lack SORCS1 and STAT3 gene mutations?",top_cases_counts_by_genes
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases lack SORCS1 and COL6A3 gene mutations?",top_cases_counts_by_genes
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How many Head and Neck Squamous Cell Carcinoma cases lack FGF8 and ADRA1A gene mutations?,top_cases_counts_by_genes
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How many Head and Neck Squamous Cell Carcinoma cases lack FGF8 and ZBTB34 gene mutations?,top_cases_counts_by_genes
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How many Head and Neck Squamous Cell Carcinoma cases lack FGF8 and PTPRN2 gene mutations?,top_cases_counts_by_genes
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How many Head and Neck Squamous Cell Carcinoma cases lack FGF8 and TTYH2 gene mutations?,top_cases_counts_by_genes
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How many Head and Neck Squamous Cell Carcinoma cases lack FGF8 and FBN1 gene mutations?,top_cases_counts_by_genes
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How many Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia cases lack TENM3 and ANP32E gene mutations?,top_cases_counts_by_genes
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack AKT1 and PRSS8 gene mutations?,top_cases_counts_by_genes
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases lack CFAP298-TCP10L and ZCCHC14 gene mutations?,top_cases_counts_by_genes
+792,GLRB,E148D,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack GLRB and ART3 gene mutations?,top_cases_counts_by_genes
+793,TTN,F7636L,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack TTN and POC1B gene mutations?,top_cases_counts_by_genes
+794,TTN,F8563L,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack TTN and SPATA22 gene mutations?,top_cases_counts_by_genes
+795,TTN,F8880L,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack TTN and GRM1 gene mutations?,top_cases_counts_by_genes
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack ANKRD30A and KL gene mutations?,top_cases_counts_by_genes
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack ANKRD30A and THBS4 gene mutations?,top_cases_counts_by_genes
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack ANKRD30A and TYK2 gene mutations?,top_cases_counts_by_genes
+809,TRIM45,S177L,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack TRIM45 and PAK3 gene mutations?,top_cases_counts_by_genes
+810,TRIM45,S224L,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack TRIM45 and EPRS1 gene mutations?,top_cases_counts_by_genes
+811,TRIM45,S281L,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack TRIM45 and STK19 gene mutations?,top_cases_counts_by_genes
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack CACNA1F and ZNF584 gene mutations?,top_cases_counts_by_genes
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack CACNA1F and ARHGEF40 gene mutations?,top_cases_counts_by_genes
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack CACNA1F and DOCK2 gene mutations?,top_cases_counts_by_genes
+817,KL,R594C,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack KL and GUK1 gene mutations?,top_cases_counts_by_genes
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How many Kidney Renal Papillary Cell Carcinoma cases lack GUF1 and ZNF627 gene mutations?,top_cases_counts_by_genes
+822,TAF1L,A539V,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack TAF1L and FNDC7 gene mutations?,top_cases_counts_by_genes
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack TASOR2 and DGKD gene mutations?,top_cases_counts_by_genes
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack TASOR2 and DNAH11 gene mutations?,top_cases_counts_by_genes
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack TASOR2 and ANKRD24 gene mutations?,top_cases_counts_by_genes
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack KDM5C and MED16 gene mutations?,top_cases_counts_by_genes
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack KDM5C and RIPOR2 gene mutations?,top_cases_counts_by_genes
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack KDM5C and OR5D14 gene mutations?,top_cases_counts_by_genes
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack KDM5C and RIMS2 gene mutations?,top_cases_counts_by_genes
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases lack IL5RA and GABRA6 gene mutations?,top_cases_counts_by_genes
+843,DHX16,A29V,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack DHX16 and GUK1 gene mutations?,top_cases_counts_by_genes
+844,DHX16,A89V,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack DHX16 and MAD1L1 gene mutations?,top_cases_counts_by_genes
+902,GPR158,A644V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack GPR158 and TASOR2 gene mutations?,top_cases_counts_by_genes
+903,GPR158,A723V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack GPR158 and AUTS2 gene mutations?,top_cases_counts_by_genes
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases lack EIF2B4 and ACVR1B gene mutations?",top_cases_counts_by_genes
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases lack EIF2B4 and PYHIN1 gene mutations?",top_cases_counts_by_genes
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases lack EIF2B4 and POLD1 gene mutations?",top_cases_counts_by_genes
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases lack EIF2B4 and CTNNA2 gene mutations?",top_cases_counts_by_genes
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases lack EIF2B4 and MORF4L1 gene mutations?",top_cases_counts_by_genes
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases lack EIF2B4 and GUK1 gene mutations?",top_cases_counts_by_genes
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack AUTS2 and PIK3C2B gene mutations?,top_cases_counts_by_genes
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack AUTS2 and B3GALNT1 gene mutations?,top_cases_counts_by_genes
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack AUTS2 and AUTS2 gene mutations?,top_cases_counts_by_genes
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack AUTS2 and GRM5 gene mutations?,top_cases_counts_by_genes
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack AUTS2 and PIK3C2G gene mutations?,top_cases_counts_by_genes
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack AUTS2 and CYB5R2 gene mutations?,top_cases_counts_by_genes
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack AUTS2 and TMEM255A gene mutations?,top_cases_counts_by_genes
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack AUTS2 and MORF4L1 gene mutations?,top_cases_counts_by_genes
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack AUTS2 and SYT9 gene mutations?,top_cases_counts_by_genes
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack AUTS2 and POC1B gene mutations?,top_cases_counts_by_genes
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases lack ACTL7B and GPC3 gene mutations?",top_cases_counts_by_genes
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How many Glioblastoma Multiforme cases lack PCDHGA1 and CTSC gene mutations?,top_cases_counts_by_genes
+954,TRAP1,R114W,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack TRAP1 and POLR1G gene mutations?,top_cases_counts_by_genes
+955,TRAP1,R61W,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack TRAP1 and HTR3B gene mutations?,top_cases_counts_by_genes
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack PIK3C2A and FGF8 gene mutations?,top_cases_counts_by_genes
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma cases lack KANSL1 and ZCCHC14 gene mutations?,top_cases_counts_by_genes
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack ANKRD52 and DSCAM gene mutations?,top_cases_counts_by_genes
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack PAPPA and DNAH14 gene mutations?,top_cases_counts_by_genes
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases lack B3GALNT1 and CX3CR1 gene mutations?,top_cases_counts_by_genes
+982,GABRA6,G115R,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack GABRA6 and GPC3 gene mutations?,top_cases_counts_by_genes
+983,GABRA6,G122R,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack GABRA6 and EFCAB12 gene mutations?,top_cases_counts_by_genes
+984,GABRA6,G165R,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack GABRA6 and FBXO15 gene mutations?,top_cases_counts_by_genes
+985,GABRA6,G175R,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack GABRA6 and DCN gene mutations?,top_cases_counts_by_genes
+986,GABRA6,G70R,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack GABRA6 and ZNF274 gene mutations?,top_cases_counts_by_genes
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack ZSCAN31 and JAML gene mutations?,top_cases_counts_by_genes
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases lack MED16 and MIEF1 gene mutations?",top_cases_counts_by_genes
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases lack MED16 and CFAP61 gene mutations?",top_cases_counts_by_genes
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma cases lack PTPRO and ZBTB34 gene mutations?,top_cases_counts_by_genes
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma cases lack PTPRO and PRSS1 gene mutations?,top_cases_counts_by_genes
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma cases lack PTPRO and MAD1L1 gene mutations?,top_cases_counts_by_genes
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma cases lack PTPRO and ZFP42 gene mutations?,top_cases_counts_by_genes
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma cases lack PTPRO and ZCCHC14 gene mutations?,top_cases_counts_by_genes
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma cases lack PTPRO and MAST4 gene mutations?,top_cases_counts_by_genes
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma cases lack PTPRO and ZNF217 gene mutations?,top_cases_counts_by_genes
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How many Pancreatic Adenocarcinoma cases lack PTPRO and AQP7 gene mutations?,top_cases_counts_by_genes
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack CHMP7 and PIK3C2G gene mutations?,top_cases_counts_by_genes
+1017,GPC3,I107N,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack GPC3 and FRY gene mutations?,top_cases_counts_by_genes
+1018,GPC3,I161N,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack GPC3 and CFAP61 gene mutations?,top_cases_counts_by_genes
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases lack TLK2 and ACTA2 gene mutations?,top_cases_counts_by_genes
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases lack TLK2 and TASOR2 gene mutations?,top_cases_counts_by_genes
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases lack TLK2 and PLEKHG6 gene mutations?,top_cases_counts_by_genes
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases lack TLK2 and JAML gene mutations?,top_cases_counts_by_genes
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How many Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases lack TLK2 and FGF8 gene mutations?,top_cases_counts_by_genes
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack ZNF217 and PTPRO gene mutations?,top_cases_counts_by_genes
+1038,SYT9,V275L,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack SYT9 and SORCS1 gene mutations?,top_cases_counts_by_genes
+1039,SYT9,V307L,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack SYT9 and ZCCHC14 gene mutations?,top_cases_counts_by_genes
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack PKHD1L1 and HLA-DQA2 gene mutations?,top_cases_counts_by_genes
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack MYO3A and FRY gene mutations?,top_cases_counts_by_genes
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases lack VASN and PGR gene mutations?",top_cases_counts_by_genes
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack DNMT1 and MYO15A gene mutations?,top_cases_counts_by_genes
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack DNMT1 and STK19 gene mutations?,top_cases_counts_by_genes
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack DNMT1 and PTPRO gene mutations?,top_cases_counts_by_genes
+1056,CA9,E402K,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack CA9 and YY1AP1 gene mutations?,top_cases_counts_by_genes
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack TTC17 and GPR158 gene mutations?,top_cases_counts_by_genes
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack TTC17 and YY1AP1 gene mutations?,top_cases_counts_by_genes
+1065,PSG2,P43L,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases lack PSG2 and ACVR1B gene mutations?,top_cases_counts_by_genes
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases lack RIPOR2 and TLK2 gene mutations?,top_cases_counts_by_genes
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases lack RIPOR2 and MYT1 gene mutations?,top_cases_counts_by_genes
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases lack RIPOR2 and MERTK gene mutations?,top_cases_counts_by_genes
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases lack RIPOR2 and DCN gene mutations?,top_cases_counts_by_genes
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack DCLK3 and YY1AP1 gene mutations?,top_cases_counts_by_genes
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack DCLK3 and SGIP1 gene mutations?,top_cases_counts_by_genes
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack MERTK and CFAP61 gene mutations?,top_cases_counts_by_genes
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack MERTK and DOCK2 gene mutations?,top_cases_counts_by_genes
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack MERTK and FNDC7 gene mutations?,top_cases_counts_by_genes
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack ZFP42 and AUTS2 gene mutations?,top_cases_counts_by_genes
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack OR13C3 and OR13C3 gene mutations?,top_cases_counts_by_genes
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack OR13C3 and CX3CR1 gene mutations?,top_cases_counts_by_genes
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack SPAG1 and TTN gene mutations?,top_cases_counts_by_genes
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack CDKN2AIP and AQP7 gene mutations?,top_cases_counts_by_genes
+1093,PXN,H1016Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack PXN and ZNF431 gene mutations?,top_cases_counts_by_genes
+1094,PXN,H359Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack PXN and CTCFL gene mutations?,top_cases_counts_by_genes
+1095,PXN,H492Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack PXN and TYK2 gene mutations?,top_cases_counts_by_genes
+1096,PXN,H524Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack PXN and CTNNA2 gene mutations?,top_cases_counts_by_genes
+1097,PXN,H526Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack PXN and SYNJ1 gene mutations?,top_cases_counts_by_genes
+1098,PXN,H540Y,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack PXN and TNS1 gene mutations?,top_cases_counts_by_genes
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack TTYH2 and HLA-DQA2 gene mutations?,top_cases_counts_by_genes
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack TTYH2 and GABRA6 gene mutations?,top_cases_counts_by_genes
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack TMEM255A and DNAH14 gene mutations?,top_cases_counts_by_genes
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack TMEM255A and STAT3 gene mutations?,top_cases_counts_by_genes
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack TMEM255A and GUK1 gene mutations?,top_cases_counts_by_genes
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases lack TASOR2 and NRAP gene mutations?,top_cases_counts_by_genes
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases lack TASOR2 and TAF1C gene mutations?,top_cases_counts_by_genes
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack ICE1 and DPF3 gene mutations?,top_cases_counts_by_genes
+1112,MYT1,A558E,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases lack MYT1 and CACNA1F gene mutations?,top_cases_counts_by_genes
+1113,MYT1,A879E,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases lack MYT1 and WNT2 gene mutations?,top_cases_counts_by_genes
+1114,MYT1,A906E,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases lack MYT1 and RAB40C gene mutations?,top_cases_counts_by_genes
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack CX3CR1 and TAF1C gene mutations?,top_cases_counts_by_genes
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack CX3CR1 and UNC5D gene mutations?,top_cases_counts_by_genes
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma cases lack SPINDOC and TLK2 gene mutations?,top_cases_counts_by_genes
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack ART3 and KIF20B gene mutations?,top_cases_counts_by_genes
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack ART3 and CPS1 gene mutations?,top_cases_counts_by_genes
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases lack CYP1A2 and PXN gene mutations?,top_cases_counts_by_genes
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases lack ADRA1A and DEFB115 gene mutations?",top_cases_counts_by_genes
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack CDH23 and SPTAN1 gene mutations?,top_cases_counts_by_genes
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack CDH23 and TTC17 gene mutations?,top_cases_counts_by_genes
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack KRT39 and PRSS8 gene mutations?,top_cases_counts_by_genes
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack PDHA2 and ZFPM2 gene mutations?,top_cases_counts_by_genes
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack SLC24A2 and ZFPM2 gene mutations?,top_cases_counts_by_genes
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma cases lack PTPRN2 and TASOR2 gene mutations?,top_cases_counts_by_genes
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma cases lack PTPRN2 and DSCAM gene mutations?,top_cases_counts_by_genes
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma cases lack PTPRN2 and ZFPM2 gene mutations?,top_cases_counts_by_genes
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma cases lack PTPRN2 and PDGFC gene mutations?,top_cases_counts_by_genes
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How many Liver Hepatocellular Carcinoma cases lack PTPRN2 and CTCFL gene mutations?,top_cases_counts_by_genes
+1188,SOX21,R55L,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack SOX21 and SMO gene mutations?,top_cases_counts_by_genes
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases lack CPA6 and FGF8 gene mutations?,top_cases_counts_by_genes
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack GRM5 and OLFML3 gene mutations?,top_cases_counts_by_genes
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases lack CASZ1 and GABRA6 gene mutations?",top_cases_counts_by_genes
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack SGIP1 and AUTS2 gene mutations?,top_cases_counts_by_genes
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack SGIP1 and TTYH2 gene mutations?,top_cases_counts_by_genes
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack SGIP1 and SGCZ gene mutations?,top_cases_counts_by_genes
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack SGIP1 and CDH23 gene mutations?,top_cases_counts_by_genes
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack CARMIL1 and SPAG1 gene mutations?,top_cases_counts_by_genes
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack CARMIL1 and POC1B gene mutations?,top_cases_counts_by_genes
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack ZNF431 and PIAS3 gene mutations?,top_cases_counts_by_genes
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack ZNF431 and GUK1 gene mutations?,top_cases_counts_by_genes
+1234,ZNF431,R128I,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack ZNF431 and DPF3 gene mutations?,top_cases_counts_by_genes
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack DNAH11 and PTPRN2 gene mutations?,top_cases_counts_by_genes
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack DNAH11 and KDM5C gene mutations?,top_cases_counts_by_genes
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack POLD1 and CARMIL1 gene mutations?,top_cases_counts_by_genes
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How many Lung Squamous Cell Carcinoma cases lack POLD1 and MORF4L1 gene mutations?,top_cases_counts_by_genes
+1248,TTC12,D646H,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack TTC12 and MED16 gene mutations?,top_cases_counts_by_genes
+1249,TTC12,D652H,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack TTC12 and PSG2 gene mutations?,top_cases_counts_by_genes
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases lack CNGB1 and DCN gene mutations?,top_cases_counts_by_genes
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How many Bladder Urothelial Carcinoma cases lack CNGB1 and TLK2 gene mutations?,top_cases_counts_by_genes
+1254,CTSC,E214V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack CTSC and PGF gene mutations?,top_cases_counts_by_genes
+1255,CTSC,E291V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack CTSC and CTCFL gene mutations?,top_cases_counts_by_genes
+1256,CTSC,E322V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack CTSC and FRY gene mutations?,top_cases_counts_by_genes
+1257,CTSC,E324V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack CTSC and DCAF4L2 gene mutations?,top_cases_counts_by_genes
+1258,CTSC,E335V,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack CTSC and CASZ1 gene mutations?,top_cases_counts_by_genes
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack PRSS8 and EFCAB12 gene mutations?,top_cases_counts_by_genes
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack PRSS8 and MYO3B gene mutations?,top_cases_counts_by_genes
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack ARHGEF40 and DPF3 gene mutations?,top_cases_counts_by_genes
+1264,ACTB,A138T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases lack ACTB and ZMYM3 gene mutations?,top_cases_counts_by_genes
+1265,ACTB,A217T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases lack ACTB and PRSS8 gene mutations?,top_cases_counts_by_genes
+1266,ACTB,A244T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases lack ACTB and GABRA6 gene mutations?,top_cases_counts_by_genes
+1267,ACTB,A260T,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases lack ACTB and TRIM45 gene mutations?,top_cases_counts_by_genes
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How many Glioblastoma Multiforme cases lack YY1AP1 and TTN gene mutations?,top_cases_counts_by_genes
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How many Glioblastoma Multiforme cases lack YY1AP1 and FRY gene mutations?,top_cases_counts_by_genes
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How many Glioblastoma Multiforme cases lack YY1AP1 and ANKRD24 gene mutations?,top_cases_counts_by_genes
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How many Glioblastoma Multiforme cases lack YY1AP1 and UNC5D gene mutations?,top_cases_counts_by_genes
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How many Glioblastoma Multiforme cases lack YY1AP1 and TRAP1 gene mutations?,top_cases_counts_by_genes
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How many Glioblastoma Multiforme cases lack YY1AP1 and TAF1C gene mutations?,top_cases_counts_by_genes
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How many Glioblastoma Multiforme cases lack YY1AP1 and DGKD gene mutations?,top_cases_counts_by_genes
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack FNDC7 and PRSS1 gene mutations?,top_cases_counts_by_genes
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack FNDC7 and CDH23 gene mutations?,top_cases_counts_by_genes
+1299,TLCD5,G15V,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack TLCD5 and GSTCD gene mutations?,top_cases_counts_by_genes
+1300,TLCD5,G37V,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack TLCD5 and SLC24A2 gene mutations?,top_cases_counts_by_genes
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack POLR1G and POC1B gene mutations?,top_cases_counts_by_genes
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack POLR1G and ZMYM3 gene mutations?,top_cases_counts_by_genes
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack DNAH14 and MAD1L1 gene mutations?,top_cases_counts_by_genes
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack DNAH14 and SLC24A2 gene mutations?,top_cases_counts_by_genes
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack DNAH14 and GUK1 gene mutations?,top_cases_counts_by_genes
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack NEXN and POC1B gene mutations?,top_cases_counts_by_genes
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma cases lack CYB5R2 and REXO4 gene mutations?,top_cases_counts_by_genes
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How many Prostate Adenocarcinoma cases lack CYB5R2 and WNT2 gene mutations?,top_cases_counts_by_genes
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack NRAP and C7orf31 gene mutations?,top_cases_counts_by_genes
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack NRAP and GSTCD gene mutations?,top_cases_counts_by_genes
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack NRAP and SGIP1 gene mutations?,top_cases_counts_by_genes
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack CCDC22 and MAST4 gene mutations?,top_cases_counts_by_genes
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack DCAF6 and FGF8 gene mutations?,top_cases_counts_by_genes
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack DCAF6 and DNAH14 gene mutations?,top_cases_counts_by_genes
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack ZNF708 and BCAT1 gene mutations?,top_cases_counts_by_genes
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack BFAR and PAK3 gene mutations?,top_cases_counts_by_genes
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack MAST4 and CFAP61 gene mutations?,top_cases_counts_by_genes
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack MAST4 and WNT2 gene mutations?,top_cases_counts_by_genes
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack MAST4 and ANP32E gene mutations?,top_cases_counts_by_genes
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack MAST4 and PTPRN2 gene mutations?,top_cases_counts_by_genes
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack MAST4 and FCGR2C gene mutations?,top_cases_counts_by_genes
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack ARMC3 and ADAM17 gene mutations?,top_cases_counts_by_genes
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack ARMC3 and GLRB gene mutations?,top_cases_counts_by_genes
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How many Kidney Renal Clear Cell Carcinoma cases lack TET2 and KDM5C gene mutations?,top_cases_counts_by_genes
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How many Kidney Renal Clear Cell Carcinoma cases lack TET2 and CHODL gene mutations?,top_cases_counts_by_genes
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack SERPINB10 and CPS1 gene mutations?,top_cases_counts_by_genes
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack STAT3 and DNAH14 gene mutations?,top_cases_counts_by_genes
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack MIEF1 and DNAH11 gene mutations?,top_cases_counts_by_genes
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack ACVR1B and RIPOR2 gene mutations?,top_cases_counts_by_genes
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack ACVR1B and HTR3B gene mutations?,top_cases_counts_by_genes
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack ACVR1B and HTR3B gene mutations?,top_cases_counts_by_genes
+1393,EBF2,T104I,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack EBF2 and FRY gene mutations?,top_cases_counts_by_genes
+1394,EBF2,T252I,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack EBF2 and PTPRN2 gene mutations?,top_cases_counts_by_genes
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack VPS26B and PTPRO gene mutations?,top_cases_counts_by_genes
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases lack PGR and RIPOR2 gene mutations?",top_cases_counts_by_genes
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases lack PGR and TYK2 gene mutations?",top_cases_counts_by_genes
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How many CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases lack PGR and ANP32E gene mutations?",top_cases_counts_by_genes
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How many Skin Cutaneous Melanoma cases lack ACTA2 and CPA6 gene mutations?,top_cases_counts_by_genes
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack THBS4 and ZNF708 gene mutations?,top_cases_counts_by_genes
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack THBS4 and EBF2 gene mutations?,top_cases_counts_by_genes
+1413,PRSS1,S114T,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack PRSS1 and ART3 gene mutations?,top_cases_counts_by_genes
+1414,PRSS1,S124T,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack PRSS1 and FRY gene mutations?,top_cases_counts_by_genes
+1415,PRSS1,S138T,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack PRSS1 and PAPPA gene mutations?,top_cases_counts_by_genes
+1416,PRSS1,S74T,Lung Adenocarcinoma,How many Lung Adenocarcinoma cases lack PRSS1 and NOMO1 gene mutations?,top_cases_counts_by_genes
+1417,PGF,R126H,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack PGF and DNMT1 gene mutations?,top_cases_counts_by_genes
+1418,PGF,R127H,Stomach Adenocarcinoma,How many Stomach Adenocarcinoma cases lack PGF and CHODL gene mutations?,top_cases_counts_by_genes
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases lack ITPRID2 and SPAG1 gene mutations?,top_cases_counts_by_genes
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How many Breast Invasive Carcinoma cases lack ITPRID2 and RIMS2 gene mutations?,top_cases_counts_by_genes
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack HBB and MED16 gene mutations?,top_cases_counts_by_genes
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack PCDHB2 and DCC gene mutations?,top_cases_counts_by_genes
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack PCDHB2 and KANSL1 gene mutations?,top_cases_counts_by_genes
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How many Colon Adenocarcinoma cases lack PCDHB2 and PTPRN2 gene mutations?,top_cases_counts_by_genes
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How many Uterine Corpus Endometrial Carcinoma cases lack UBR2 and PIK3C2G gene mutations?,top_cases_counts_by_genes
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How many Rectum Adenocarcinoma cases lack FBXO42 and PRSS1 gene mutations?,top_cases_counts_by_genes
+1,TNS1,G1362V,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases do not possess mutations in TNS1 and PAK3?,top_cases_counts_by_genes
+2,TNS1,G1711V,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases do not possess mutations in TNS1 and PIAS3?,top_cases_counts_by_genes
+3,TNS1,G1718V,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases do not possess mutations in TNS1 and ABCC3?,top_cases_counts_by_genes
+4,TNS1,G1732V,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases do not possess mutations in TNS1 and PTPRO?,top_cases_counts_by_genes
+5,TNS1,G1824V,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases do not possess mutations in TNS1 and ANKRD30A?,top_cases_counts_by_genes
+6,TNS1,G1857V,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases do not possess mutations in TNS1 and SPINDOC?,top_cases_counts_by_genes
+7,TNS1,G843V,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases do not possess mutations in TNS1 and TMTC3?,top_cases_counts_by_genes
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases do not possess mutations in EVC2 and TLK2?,top_cases_counts_by_genes
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases do not possess mutations in EVC2 and PAPPA?,top_cases_counts_by_genes
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in CR1 and RIPOR2?,top_cases_counts_by_genes
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in CR1 and PTPRN2?,top_cases_counts_by_genes
+22,TRPA1,S295I,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases do not possess mutations in TRPA1 and TLK2?,top_cases_counts_by_genes
+23,TRPA1,S443I,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases do not possess mutations in TRPA1 and TTYH2?,top_cases_counts_by_genes
+24,TAF1C,R299L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in TAF1C and CACNA1F?,top_cases_counts_by_genes
+25,TAF1C,R396L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in TAF1C and TASOR2?,top_cases_counts_by_genes
+26,TAF1C,R634L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in TAF1C and EIF2B4?,top_cases_counts_by_genes
+27,TAF1C,R702L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in TAF1C and FBXO15?,top_cases_counts_by_genes
+28,TAF1C,R728L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in TAF1C and DPF3?,top_cases_counts_by_genes
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in DPF3 and FBXO15?,top_cases_counts_by_genes
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in DPF3 and POLD1?,top_cases_counts_by_genes
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in DPF3 and ANKRD30A?,top_cases_counts_by_genes
+42,OR2T4,P272H,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in OR2T4 and TMEM255A?,top_cases_counts_by_genes
+43,OR2T4,P300H,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in OR2T4 and PGR?,top_cases_counts_by_genes
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma cases do not possess mutations in FBN1 and TNS1?,top_cases_counts_by_genes
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma cases do not possess mutations in MAD1L1 and CEP20?,top_cases_counts_by_genes
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma cases do not possess mutations in MAD1L1 and TYK2?,top_cases_counts_by_genes
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma cases do not possess mutations in MAD1L1 and PHLPP1?,top_cases_counts_by_genes
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in CCNG1 and LDOC1?,top_cases_counts_by_genes
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What fraction of Kidney Renal Papillary Cell Carcinoma cases do not possess mutations in ANP32E and CHODL?,top_cases_counts_by_genes
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What fraction of Kidney Renal Papillary Cell Carcinoma cases do not possess mutations in ANP32E and STAT3?,top_cases_counts_by_genes
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What fraction of Kidney Renal Papillary Cell Carcinoma cases do not possess mutations in ANP32E and ACTB?,top_cases_counts_by_genes
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What fraction of Kidney Renal Papillary Cell Carcinoma cases do not possess mutations in ANP32E and ABCC2?,top_cases_counts_by_genes
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases do not possess mutations in FRY and PAK3?,top_cases_counts_by_genes
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases do not possess mutations in FRY and TYK2?,top_cases_counts_by_genes
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases do not possess mutations in FRY and GUK1?,top_cases_counts_by_genes
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases do not possess mutations in FRY and GUK1?,top_cases_counts_by_genes
+70,PAK3,E318K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in PAK3 and DOCK2?,top_cases_counts_by_genes
+71,PAK3,E319K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in PAK3 and UNC5D?,top_cases_counts_by_genes
+72,PAK3,E334K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in PAK3 and PDHA2?,top_cases_counts_by_genes
+73,PAK3,E340K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in PAK3 and ACVR1B?,top_cases_counts_by_genes
+74,PAK3,E355K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in PAK3 and TYK2?,top_cases_counts_by_genes
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in MUC16 and B3GALNT1?,top_cases_counts_by_genes
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases do not possess mutations in ZFPM2 and CFAP298-TCP10L?,top_cases_counts_by_genes
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases do not possess mutations in ZFPM2 and PCDHB2?,top_cases_counts_by_genes
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases do not possess mutations in PIK3C2B and GSTCD?,top_cases_counts_by_genes
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases do not possess mutations in PIK3C2B and GRM1?,top_cases_counts_by_genes
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in ZNF804A and DGKD?,top_cases_counts_by_genes
+116,RELN,A2371V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in RELN and ZFAT?,top_cases_counts_by_genes
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not possess mutations in EFCAB12 and TLK2?",top_cases_counts_by_genes
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not possess mutations in EFCAB12 and COL6A3?",top_cases_counts_by_genes
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in DEFB115 and AQP7?,top_cases_counts_by_genes
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases do not possess mutations in ANKDD1A and ZBTB34?,top_cases_counts_by_genes
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases do not possess mutations in ANKDD1A and DSCAM?,top_cases_counts_by_genes
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases do not possess mutations in ANKDD1A and GABRA6?,top_cases_counts_by_genes
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in HTR3B and GUK1?,top_cases_counts_by_genes
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in HTR3B and OR8K5?,top_cases_counts_by_genes
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in HTR3B and SPINDOC?,top_cases_counts_by_genes
+129,ABCC3,R758W,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in ABCC3 and DCC?,top_cases_counts_by_genes
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in NOMO1 and PTPRN2?,top_cases_counts_by_genes
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in NOMO1 and SLC6A4?,top_cases_counts_by_genes
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases do not possess mutations in HYOU1 and CTNNA2?,top_cases_counts_by_genes
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in FMO4 and CR1?,top_cases_counts_by_genes
+140,BICC1,A372V,Exceptional Responders,What fraction of Exceptional Responders cases do not possess mutations in BICC1 and HLA-DQA2?,top_cases_counts_by_genes
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in ZMYM3 and FMO4?,top_cases_counts_by_genes
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in ZMYM3 and AQP7?,top_cases_counts_by_genes
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in ZMYM3 and DGKD?,top_cases_counts_by_genes
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not possess mutations in XKR4 and TENM2?",top_cases_counts_by_genes
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases do not possess mutations in ABCC2 and PIK3C2B?,top_cases_counts_by_genes
+157,OR8K5,R293G,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in OR8K5 and DSCAM?,top_cases_counts_by_genes
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in SPTAN1 and SIK2?,top_cases_counts_by_genes
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in SPTAN1 and ITPRID2?,top_cases_counts_by_genes
+164,SYT10,M484I,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases do not possess mutations in SYT10 and MUC16?,top_cases_counts_by_genes
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in HSPA5 and DHX16?,top_cases_counts_by_genes
+175,UNC5D,L280V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in UNC5D and NOMO1?,top_cases_counts_by_genes
+176,UNC5D,L635V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in UNC5D and SLC24A2?,top_cases_counts_by_genes
+177,UNC5D,L637V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in UNC5D and CDKN2AIP?,top_cases_counts_by_genes
+178,UNC5D,L699V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in UNC5D and PRSS1?,top_cases_counts_by_genes
+179,UNC5D,L704V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in UNC5D and FRY?,top_cases_counts_by_genes
+180,UNC5D,L709V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in UNC5D and KDM5C?,top_cases_counts_by_genes
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What fraction of Kidney Renal Clear Cell Carcinoma cases do not possess mutations in DOCK2 and ACVR1B?,top_cases_counts_by_genes
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What fraction of Kidney Renal Clear Cell Carcinoma cases do not possess mutations in ZNF627 and PIK3C2G?,top_cases_counts_by_genes
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in CDC42BPA and VASN?,top_cases_counts_by_genes
+193,MRPL55,H27Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in MRPL55 and PTPRO?,top_cases_counts_by_genes
+194,MRPL55,H63Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in MRPL55 and AUTS2?,top_cases_counts_by_genes
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases do not possess mutations in TMTC3 and CHODL?,top_cases_counts_by_genes
+198,EPRS1,K771I,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in EPRS1 and ITPRID2?,top_cases_counts_by_genes
+199,EPRS1,K778I,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in EPRS1 and TNS1?,top_cases_counts_by_genes
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in GRTP1 and ITPRID2?,top_cases_counts_by_genes
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in GRTP1 and ADRA1A?,top_cases_counts_by_genes
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in TSHZ3 and TLK2?,top_cases_counts_by_genes
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What fraction of HIV+ Tumor Molecular Characterization Project - Cervical Cancer cases do not possess mutations in TAS1R3 and GPR158?,top_cases_counts_by_genes
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in PIAS3 and RIMS2?,top_cases_counts_by_genes
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in PIAS3 and TRAP1?,top_cases_counts_by_genes
+251,ZNF274,P13R,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in ZNF274 and ZSCAN31?,top_cases_counts_by_genes
+253,SYNJ1,R795C,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in SYNJ1 and PTPRO?,top_cases_counts_by_genes
+254,SYNJ1,R800C,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in SYNJ1 and PIK3C2B?,top_cases_counts_by_genes
+255,SYNJ1,R839C,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in SYNJ1 and CCDC22?,top_cases_counts_by_genes
+261,DSCAM,V343M,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma cases do not possess mutations in DSCAM and MYO3A?,top_cases_counts_by_genes
+262,DSCAM,V426M,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma cases do not possess mutations in DSCAM and CHMP7?,top_cases_counts_by_genes
+263,DSCAM,V591M,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma cases do not possess mutations in DSCAM and AUTS2?,top_cases_counts_by_genes
+267,DGKD,R140H,Exceptional Responders,What fraction of Exceptional Responders cases do not possess mutations in DGKD and TRPA1?,top_cases_counts_by_genes
+268,DGKD,R160H,Exceptional Responders,What fraction of Exceptional Responders cases do not possess mutations in DGKD and GABRA6?,top_cases_counts_by_genes
+269,DGKD,R204H,Exceptional Responders,What fraction of Exceptional Responders cases do not possess mutations in DGKD and ERCC6?,top_cases_counts_by_genes
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases do not possess mutations in PLEKHG6 and SYNJ1?,top_cases_counts_by_genes
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases do not possess mutations in PLEKHG6 and ZKSCAN7?,top_cases_counts_by_genes
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases do not possess mutations in PLEKHG6 and ACVR1B?,top_cases_counts_by_genes
+279,WNT2,D138N,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in WNT2 and CACNA1F?,top_cases_counts_by_genes
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in GUCY2C and DCC?,top_cases_counts_by_genes
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in C7orf31 and GABRA6?,top_cases_counts_by_genes
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not possess mutations in ZKSCAN7 and DCLK3?",top_cases_counts_by_genes
+299,OR5D14,M210L,Neuroblastoma,What fraction of Neuroblastoma cases do not possess mutations in OR5D14 and NEXN?,top_cases_counts_by_genes
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in SPATA22 and SPTAN1?,top_cases_counts_by_genes
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in SPATA22 and RELN?,top_cases_counts_by_genes
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in SPATA22 and OR13C3?,top_cases_counts_by_genes
+310,LCN15,E21V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in LCN15 and ZNF804A?,top_cases_counts_by_genes
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in DCAF4L2 and OR8K5?,top_cases_counts_by_genes
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in GUK1 and CYB5R2?,top_cases_counts_by_genes
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in GUK1 and CFAP298-TCP10L?,top_cases_counts_by_genes
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in GUK1 and EIF2B4?,top_cases_counts_by_genes
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in GUK1 and ARMC3?,top_cases_counts_by_genes
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in GUK1 and DCN?,top_cases_counts_by_genes
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in MORF4L1 and OR2T4?,top_cases_counts_by_genes
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in MORF4L1 and RAB40C?,top_cases_counts_by_genes
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in MORF4L1 and CX3CR1?,top_cases_counts_by_genes
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in MORF4L1 and TAF1C?,top_cases_counts_by_genes
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in MYO3B and RAB40C?,top_cases_counts_by_genes
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in MYO3B and EIF2B4?,top_cases_counts_by_genes
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in TENT5A and ACVR1B?,top_cases_counts_by_genes
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in TENT5A and TMEM255A?,top_cases_counts_by_genes
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in TENT5A and EBF2?,top_cases_counts_by_genes
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What fraction of Ovarian Serous Cystadenocarcinoma cases do not possess mutations in ZFAT and MORF4L1?,top_cases_counts_by_genes
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What fraction of Ovarian Serous Cystadenocarcinoma cases do not possess mutations in ZFAT and CTCFL?,top_cases_counts_by_genes
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What fraction of Ovarian Serous Cystadenocarcinoma cases do not possess mutations in ZFAT and PIAS3?,top_cases_counts_by_genes
+357,ZNF584,A211T,Sarcoma,What fraction of Sarcoma cases do not possess mutations in ZNF584 and ZMYM3?,top_cases_counts_by_genes
+358,ZNF584,A256T,Sarcoma,What fraction of Sarcoma cases do not possess mutations in ZNF584 and CPS1?,top_cases_counts_by_genes
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in LDOC1 and SORCS1?,top_cases_counts_by_genes
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in PDGFC and MAST4?,top_cases_counts_by_genes
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in MSANTD4 and DCN?,top_cases_counts_by_genes
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in NPSR1 and TLCD5?,top_cases_counts_by_genes
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in PHLPP1 and CHODL?,top_cases_counts_by_genes
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in COL6A3 and AUTS2?,top_cases_counts_by_genes
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in COL6A3 and MYT1?,top_cases_counts_by_genes
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in COL6A3 and HLA-DQA2?,top_cases_counts_by_genes
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in COL6A3 and FCGR2C?,top_cases_counts_by_genes
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in COL6A3 and MAST4?,top_cases_counts_by_genes
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in ADRA1A and PHLPP1?,top_cases_counts_by_genes
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases do not possess mutations in LAMB2 and ZSCAN31?,top_cases_counts_by_genes
+406,POC1B,I198T,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases do not possess mutations in POC1B and ZFPM2?,top_cases_counts_by_genes
+407,POC1B,I286T,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases do not possess mutations in POC1B and ZCCHC14?,top_cases_counts_by_genes
+408,POC1B,I328T,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases do not possess mutations in POC1B and EIF2B4?,top_cases_counts_by_genes
+409,POC1B,S79P,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases do not possess mutations in POC1B and OLFML3?,top_cases_counts_by_genes
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases do not possess mutations in USH2A and PCDHB2?,top_cases_counts_by_genes
+414,AQP7,T110S,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases do not possess mutations in AQP7 and DNMT1?,top_cases_counts_by_genes
+415,AQP7,T166S,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases do not possess mutations in AQP7 and TTYH2?,top_cases_counts_by_genes
+416,AQP7,T167S,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases do not possess mutations in AQP7 and CTSC?,top_cases_counts_by_genes
+417,AQP7,T75S,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases do not possess mutations in AQP7 and THBS4?,top_cases_counts_by_genes
+430,DCN,R163C,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases do not possess mutations in DCN and PCDHGA1?,top_cases_counts_by_genes
+431,DCN,R203C,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases do not possess mutations in DCN and ZNF431?,top_cases_counts_by_genes
+432,DCN,R241C,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases do not possess mutations in DCN and PAPPA?,top_cases_counts_by_genes
+433,DCN,R350C,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases do not possess mutations in DCN and PKHD1L1?,top_cases_counts_by_genes
+434,DCN,R41C,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases do not possess mutations in DCN and PTPRN2?,top_cases_counts_by_genes
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in CPS1 and MYT1?,top_cases_counts_by_genes
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in CPS1 and PIK3C2G?,top_cases_counts_by_genes
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in CPS1 and CHODL?,top_cases_counts_by_genes
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What fraction of Kidney Renal Papillary Cell Carcinoma cases do not possess mutations in FCGR2C and ACTL7B?,top_cases_counts_by_genes
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What fraction of Kidney Renal Papillary Cell Carcinoma cases do not possess mutations in FCGR2C and TENM3?,top_cases_counts_by_genes
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in GRM1 and THBS4?,top_cases_counts_by_genes
+482,SGCZ,Q138H,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in SGCZ and CCNG1?,top_cases_counts_by_genes
+483,SGCZ,Q91H,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in SGCZ and AUTS2?,top_cases_counts_by_genes
+485,SMO,V15M,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in SMO and DNMT1?,top_cases_counts_by_genes
+486,SMO,V321M,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in SMO and ZCCHC14?,top_cases_counts_by_genes
+488,CHODL,G159E,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in CHODL and KDM5C?,top_cases_counts_by_genes
+489,CHODL,G181E,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in CHODL and YY1AP1?,top_cases_counts_by_genes
+490,CHODL,G200E,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in CHODL and SLC6A4?,top_cases_counts_by_genes
+494,MYO16,P399H,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in MYO16 and FBN1?,top_cases_counts_by_genes
+495,MYO16,P421H,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in MYO16 and MAST4?,top_cases_counts_by_genes
+498,CXCR2,A98V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in CXCR2 and PLEKHG6?,top_cases_counts_by_genes
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases do not possess mutations in TMEM225 and DNMT1?,top_cases_counts_by_genes
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in MAOB and SORCS1?,top_cases_counts_by_genes
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in GPRASP1 and PRSS8?,top_cases_counts_by_genes
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in MRPL32 and DNAH11?,top_cases_counts_by_genes
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in TYROBP and TLCD5?,top_cases_counts_by_genes
+510,RAB40C,A111V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in RAB40C and PAK3?,top_cases_counts_by_genes
+511,RAB40C,A143V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in RAB40C and JAML?,top_cases_counts_by_genes
+512,CTNNA2,S323R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in CTNNA2 and AUTS2?,top_cases_counts_by_genes
+513,CTNNA2,S339R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in CTNNA2 and AUTS2?,top_cases_counts_by_genes
+514,CTNNA2,S386R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in CTNNA2 and FRY?,top_cases_counts_by_genes
+515,CTNNA2,S707R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in CTNNA2 and ABCC2?,top_cases_counts_by_genes
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases do not possess mutations in MYO15A and CHODL?,top_cases_counts_by_genes
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in GIMAP2 and PXN?,top_cases_counts_by_genes
+532,KIF20B,N1160D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases do not possess mutations in KIF20B and UNC5D?,top_cases_counts_by_genes
+533,KIF20B,N1200D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases do not possess mutations in KIF20B and CACNA1F?,top_cases_counts_by_genes
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in ADAM17 and DCN?,top_cases_counts_by_genes
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in BCAT1 and PGR?,top_cases_counts_by_genes
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in BCAT1 and JAML?,top_cases_counts_by_genes
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in BCAT1 and RELN?,top_cases_counts_by_genes
+540,ERCC6,R1053H,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in ERCC6 and ANKRD30A?,top_cases_counts_by_genes
+541,DCC,R320W,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases do not possess mutations in DCC and OR2T4?,top_cases_counts_by_genes
+542,DCC,R363W,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases do not possess mutations in DCC and ZNF804A?,top_cases_counts_by_genes
+543,DCC,R386W,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases do not possess mutations in DCC and JAML?,top_cases_counts_by_genes
+544,DCC,R41W,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases do not possess mutations in DCC and GLRB?,top_cases_counts_by_genes
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in FBXO15 and DGKD?,top_cases_counts_by_genes
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in FBXO15 and UBR2?,top_cases_counts_by_genes
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in GSTCD and TASOR2?,top_cases_counts_by_genes
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in GSTCD and TTC17?,top_cases_counts_by_genes
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in OLFML3 and MERTK?,top_cases_counts_by_genes
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in OLFML3 and OLFML3?,top_cases_counts_by_genes
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in OLFML3 and ZNF274?,top_cases_counts_by_genes
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What fraction of Ovarian Serous Cystadenocarcinoma cases do not possess mutations in CFAP61 and GUK1?,top_cases_counts_by_genes
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What fraction of Ovarian Serous Cystadenocarcinoma cases do not possess mutations in CFAP61 and ANKRD24?,top_cases_counts_by_genes
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases do not possess mutations in HLA-DQA2 and ANKRD30A?,top_cases_counts_by_genes
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in TENM2 and DPF3?,top_cases_counts_by_genes
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in TENM2 and ANP32E?,top_cases_counts_by_genes
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in TENM2 and TAF1C?,top_cases_counts_by_genes
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in ANKRD24 and BCAT1?,top_cases_counts_by_genes
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in ANKRD24 and BICC1?,top_cases_counts_by_genes
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in ANKRD24 and TLK2?,top_cases_counts_by_genes
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in ZCCHC14 and CEP20?,top_cases_counts_by_genes
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in ZCCHC14 and KDM5C?,top_cases_counts_by_genes
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in ZCCHC14 and RIMS2?,top_cases_counts_by_genes
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in ZCCHC14 and YY1AP1?,top_cases_counts_by_genes
+625,SIK2,I265M,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in SIK2 and OR8K5?,top_cases_counts_by_genes
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in MYH11 and RELN?,top_cases_counts_by_genes
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in MYH11 and PTPRN2?,top_cases_counts_by_genes
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in SLC6A4 and TTN?,top_cases_counts_by_genes
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in SLC9C1 and OR13C3?,top_cases_counts_by_genes
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in SLC9C1 and ADRA1A?,top_cases_counts_by_genes
+644,OR2A12,A254T,Brain Lower Grade Glioma,What fraction of Brain Lower Grade Glioma cases do not possess mutations in OR2A12 and PIK3C2A?,top_cases_counts_by_genes
+646,PYHIN1,T325K,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in PYHIN1 and AQP7?,top_cases_counts_by_genes
+647,PYHIN1,T334K,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in PYHIN1 and GABRA6?,top_cases_counts_by_genes
+650,JAML,G191E,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in JAML and CYB5R2?,top_cases_counts_by_genes
+651,JAML,G219E,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in JAML and AUTS2?,top_cases_counts_by_genes
+652,JAML,G220E,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in JAML and CYB5R2?,top_cases_counts_by_genes
+653,JAML,G230E,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in JAML and DCN?,top_cases_counts_by_genes
+658,TYK2,H1146R,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in TYK2 and PKHD1L1?,top_cases_counts_by_genes
+659,TYK2,H23R,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in TYK2 and NRAP?,top_cases_counts_by_genes
+660,TYK2,H961R,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in TYK2 and RELN?,top_cases_counts_by_genes
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in CTCFL and FBXO15?,top_cases_counts_by_genes
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in CTCFL and HTR3B?,top_cases_counts_by_genes
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in CTCFL and ZFAT?,top_cases_counts_by_genes
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in CTCFL and MERTK?,top_cases_counts_by_genes
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in CEP20 and AUTS2?,top_cases_counts_by_genes
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in CEP20 and PTPRO?,top_cases_counts_by_genes
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in RIMS2 and RAB40C?,top_cases_counts_by_genes
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in RIMS2 and EVC2?,top_cases_counts_by_genes
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in RIMS2 and JAML?,top_cases_counts_by_genes
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in RIMS2 and MYH11?,top_cases_counts_by_genes
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in RIMS2 and TASOR2?,top_cases_counts_by_genes
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in RIMS2 and COL6A3?,top_cases_counts_by_genes
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in RIMS2 and BCAT1?,top_cases_counts_by_genes
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in PIK3C2G and CDH23?,top_cases_counts_by_genes
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in PIK3C2G and CX3CR1?,top_cases_counts_by_genes
+728,STK19,D341N,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in STK19 and TYK2?,top_cases_counts_by_genes
+729,STK19,D345N,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in STK19 and PRSS1?,top_cases_counts_by_genes
+730,REXO4,P60A,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in REXO4 and TTC12?,top_cases_counts_by_genes
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in ZBTB34 and FRY?,top_cases_counts_by_genes
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in ZBTB34 and ZNF804A?,top_cases_counts_by_genes
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases do not possess mutations in NCKAP5 and SOX21?,top_cases_counts_by_genes
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not possess mutations in SORCS1 and PXN?",top_cases_counts_by_genes
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not possess mutations in SORCS1 and ZFPM2?",top_cases_counts_by_genes
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not possess mutations in SORCS1 and DCAF6?",top_cases_counts_by_genes
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not possess mutations in SORCS1 and ANP32E?",top_cases_counts_by_genes
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What fraction of Head and Neck Squamous Cell Carcinoma cases do not possess mutations in FGF8 and SORCS1?,top_cases_counts_by_genes
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What fraction of Head and Neck Squamous Cell Carcinoma cases do not possess mutations in FGF8 and MAST4?,top_cases_counts_by_genes
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What fraction of Head and Neck Squamous Cell Carcinoma cases do not possess mutations in FGF8 and CYP1A2?,top_cases_counts_by_genes
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What fraction of Head and Neck Squamous Cell Carcinoma cases do not possess mutations in FGF8 and RIPOR2?,top_cases_counts_by_genes
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What fraction of Head and Neck Squamous Cell Carcinoma cases do not possess mutations in FGF8 and WNT2?,top_cases_counts_by_genes
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What fraction of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia cases do not possess mutations in TENM3 and PRSS1?,top_cases_counts_by_genes
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in AKT1 and SGIP1?,top_cases_counts_by_genes
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases do not possess mutations in CFAP298-TCP10L and REXO4?,top_cases_counts_by_genes
+792,GLRB,E148D,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in GLRB and DNAH11?,top_cases_counts_by_genes
+793,TTN,F7636L,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in TTN and ACTL7B?,top_cases_counts_by_genes
+794,TTN,F8563L,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in TTN and CR1?,top_cases_counts_by_genes
+795,TTN,F8880L,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in TTN and DSCAM?,top_cases_counts_by_genes
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in ANKRD30A and ZFPM2?,top_cases_counts_by_genes
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in ANKRD30A and DSCAM?,top_cases_counts_by_genes
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in ANKRD30A and TENT5A?,top_cases_counts_by_genes
+809,TRIM45,S177L,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in TRIM45 and AUTS2?,top_cases_counts_by_genes
+810,TRIM45,S224L,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in TRIM45 and CDH23?,top_cases_counts_by_genes
+811,TRIM45,S281L,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in TRIM45 and SLC9C1?,top_cases_counts_by_genes
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in CACNA1F and FGF8?,top_cases_counts_by_genes
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in CACNA1F and RIMS2?,top_cases_counts_by_genes
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in CACNA1F and LCN15?,top_cases_counts_by_genes
+817,KL,R594C,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in KL and KDM5C?,top_cases_counts_by_genes
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What fraction of Kidney Renal Papillary Cell Carcinoma cases do not possess mutations in GUF1 and TMEM225?,top_cases_counts_by_genes
+822,TAF1L,A539V,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in TAF1L and SGIP1?,top_cases_counts_by_genes
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in TASOR2 and TENM2?,top_cases_counts_by_genes
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in TASOR2 and SORCS1?,top_cases_counts_by_genes
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in TASOR2 and EIF2B4?,top_cases_counts_by_genes
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in KDM5C and PXN?,top_cases_counts_by_genes
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in KDM5C and CACNA1F?,top_cases_counts_by_genes
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in KDM5C and MYO3B?,top_cases_counts_by_genes
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in KDM5C and PYHIN1?,top_cases_counts_by_genes
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases do not possess mutations in IL5RA and FNDC7?,top_cases_counts_by_genes
+843,DHX16,A29V,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in DHX16 and POLR1G?,top_cases_counts_by_genes
+844,DHX16,A89V,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in DHX16 and YY1AP1?,top_cases_counts_by_genes
+902,GPR158,A644V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in GPR158 and SLC9C1?,top_cases_counts_by_genes
+903,GPR158,A723V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in GPR158 and MRPL55?,top_cases_counts_by_genes
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not possess mutations in EIF2B4 and ACTL7B?",top_cases_counts_by_genes
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not possess mutations in EIF2B4 and TLK2?",top_cases_counts_by_genes
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not possess mutations in EIF2B4 and ANKRD30A?",top_cases_counts_by_genes
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not possess mutations in EIF2B4 and ABCC3?",top_cases_counts_by_genes
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not possess mutations in EIF2B4 and JAML?",top_cases_counts_by_genes
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not possess mutations in EIF2B4 and FBXO15?",top_cases_counts_by_genes
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in AUTS2 and MUC16?,top_cases_counts_by_genes
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in AUTS2 and ZMYM3?,top_cases_counts_by_genes
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in AUTS2 and C7orf31?,top_cases_counts_by_genes
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in AUTS2 and CHODL?,top_cases_counts_by_genes
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in AUTS2 and BCAT1?,top_cases_counts_by_genes
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in AUTS2 and TLCD5?,top_cases_counts_by_genes
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in AUTS2 and TTC17?,top_cases_counts_by_genes
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in AUTS2 and DPF3?,top_cases_counts_by_genes
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in AUTS2 and ADAM17?,top_cases_counts_by_genes
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in AUTS2 and BICC1?,top_cases_counts_by_genes
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not possess mutations in ACTL7B and OR8K5?",top_cases_counts_by_genes
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases do not possess mutations in PCDHGA1 and EPRS1?,top_cases_counts_by_genes
+954,TRAP1,R114W,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in TRAP1 and TENM2?,top_cases_counts_by_genes
+955,TRAP1,R61W,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in TRAP1 and SLC9C1?,top_cases_counts_by_genes
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in PIK3C2A and GSTCD?,top_cases_counts_by_genes
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases do not possess mutations in KANSL1 and DNAH11?,top_cases_counts_by_genes
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in ANKRD52 and SGIP1?,top_cases_counts_by_genes
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in PAPPA and PTPRO?,top_cases_counts_by_genes
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases do not possess mutations in B3GALNT1 and DCN?,top_cases_counts_by_genes
+982,GABRA6,G115R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in GABRA6 and TAS1R3?,top_cases_counts_by_genes
+983,GABRA6,G122R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in GABRA6 and FCGR2C?,top_cases_counts_by_genes
+984,GABRA6,G165R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in GABRA6 and MED16?,top_cases_counts_by_genes
+985,GABRA6,G175R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in GABRA6 and LCN15?,top_cases_counts_by_genes
+986,GABRA6,G70R,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in GABRA6 and ZFPM2?,top_cases_counts_by_genes
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in ZSCAN31 and MERTK?,top_cases_counts_by_genes
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not possess mutations in MED16 and YY1AP1?",top_cases_counts_by_genes
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not possess mutations in MED16 and TET2?",top_cases_counts_by_genes
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma cases do not possess mutations in PTPRO and MORF4L1?,top_cases_counts_by_genes
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma cases do not possess mutations in PTPRO and FBN1?,top_cases_counts_by_genes
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma cases do not possess mutations in PTPRO and ANP32E?,top_cases_counts_by_genes
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma cases do not possess mutations in PTPRO and POC1B?,top_cases_counts_by_genes
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma cases do not possess mutations in PTPRO and TASOR2?,top_cases_counts_by_genes
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma cases do not possess mutations in PTPRO and RAB40C?,top_cases_counts_by_genes
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma cases do not possess mutations in PTPRO and AUTS2?,top_cases_counts_by_genes
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What fraction of Pancreatic Adenocarcinoma cases do not possess mutations in PTPRO and AUTS2?,top_cases_counts_by_genes
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in CHMP7 and YY1AP1?,top_cases_counts_by_genes
+1017,GPC3,I107N,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in GPC3 and ACTB?,top_cases_counts_by_genes
+1018,GPC3,I161N,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in GPC3 and POC1B?,top_cases_counts_by_genes
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases do not possess mutations in TLK2 and ZSCAN31?,top_cases_counts_by_genes
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases do not possess mutations in TLK2 and CTNNA2?,top_cases_counts_by_genes
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases do not possess mutations in TLK2 and HTR3B?,top_cases_counts_by_genes
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases do not possess mutations in TLK2 and ARHGEF40?,top_cases_counts_by_genes
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What fraction of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases do not possess mutations in TLK2 and EIF2B4?,top_cases_counts_by_genes
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in ZNF217 and CFAP61?,top_cases_counts_by_genes
+1038,SYT9,V275L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in SYT9 and FGF8?,top_cases_counts_by_genes
+1039,SYT9,V307L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in SYT9 and PAK3?,top_cases_counts_by_genes
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in PKHD1L1 and PXN?,top_cases_counts_by_genes
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in MYO3A and CTSC?,top_cases_counts_by_genes
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not possess mutations in VASN and SGIP1?",top_cases_counts_by_genes
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in DNMT1 and GRM1?,top_cases_counts_by_genes
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in DNMT1 and DCN?,top_cases_counts_by_genes
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in DNMT1 and HBB?,top_cases_counts_by_genes
+1056,CA9,E402K,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in CA9 and OLFML3?,top_cases_counts_by_genes
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in TTC17 and FNDC7?,top_cases_counts_by_genes
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in TTC17 and DGKD?,top_cases_counts_by_genes
+1065,PSG2,P43L,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases do not possess mutations in PSG2 and OR8K5?,top_cases_counts_by_genes
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases do not possess mutations in RIPOR2 and HTR3B?,top_cases_counts_by_genes
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases do not possess mutations in RIPOR2 and TRIM45?,top_cases_counts_by_genes
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases do not possess mutations in RIPOR2 and MORF4L1?,top_cases_counts_by_genes
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases do not possess mutations in RIPOR2 and PTPRN2?,top_cases_counts_by_genes
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in DCLK3 and ANP32E?,top_cases_counts_by_genes
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in DCLK3 and ACTB?,top_cases_counts_by_genes
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in MERTK and TTN?,top_cases_counts_by_genes
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in MERTK and EFCAB12?,top_cases_counts_by_genes
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in MERTK and MED16?,top_cases_counts_by_genes
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in ZFP42 and SMO?,top_cases_counts_by_genes
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in OR13C3 and PDGFC?,top_cases_counts_by_genes
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in OR13C3 and ANKDD1A?,top_cases_counts_by_genes
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in SPAG1 and DHX16?,top_cases_counts_by_genes
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in CDKN2AIP and YY1AP1?,top_cases_counts_by_genes
+1093,PXN,H1016Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in PXN and ZCCHC14?,top_cases_counts_by_genes
+1094,PXN,H359Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in PXN and RIMS2?,top_cases_counts_by_genes
+1095,PXN,H492Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in PXN and NOMO1?,top_cases_counts_by_genes
+1096,PXN,H524Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in PXN and ZCCHC14?,top_cases_counts_by_genes
+1097,PXN,H526Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in PXN and ABCC2?,top_cases_counts_by_genes
+1098,PXN,H540Y,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in PXN and ZBTB34?,top_cases_counts_by_genes
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in TTYH2 and CCNG1?,top_cases_counts_by_genes
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in TTYH2 and SGIP1?,top_cases_counts_by_genes
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in TMEM255A and DNMT1?,top_cases_counts_by_genes
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in TMEM255A and DPF3?,top_cases_counts_by_genes
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in TMEM255A and CHODL?,top_cases_counts_by_genes
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases do not possess mutations in TASOR2 and TLK2?,top_cases_counts_by_genes
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases do not possess mutations in TASOR2 and TAF1L?,top_cases_counts_by_genes
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in ICE1 and PRSS8?,top_cases_counts_by_genes
+1112,MYT1,A558E,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases do not possess mutations in MYT1 and CDC42BPA?,top_cases_counts_by_genes
+1113,MYT1,A879E,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases do not possess mutations in MYT1 and ZNF217?,top_cases_counts_by_genes
+1114,MYT1,A906E,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases do not possess mutations in MYT1 and ZKSCAN7?,top_cases_counts_by_genes
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in CX3CR1 and CPS1?,top_cases_counts_by_genes
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in CX3CR1 and CYB5R2?,top_cases_counts_by_genes
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases do not possess mutations in SPINDOC and MAST4?,top_cases_counts_by_genes
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in ART3 and FRY?,top_cases_counts_by_genes
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in ART3 and ANP32E?,top_cases_counts_by_genes
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases do not possess mutations in CYP1A2 and ZCCHC14?,top_cases_counts_by_genes
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not possess mutations in ADRA1A and GPC3?",top_cases_counts_by_genes
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in CDH23 and SMO?,top_cases_counts_by_genes
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in CDH23 and IL5RA?,top_cases_counts_by_genes
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in KRT39 and PSG2?,top_cases_counts_by_genes
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in PDHA2 and MYT1?,top_cases_counts_by_genes
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in SLC24A2 and AUTS2?,top_cases_counts_by_genes
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases do not possess mutations in PTPRN2 and WNT2?,top_cases_counts_by_genes
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases do not possess mutations in PTPRN2 and TENT5A?,top_cases_counts_by_genes
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases do not possess mutations in PTPRN2 and HLA-DQA2?,top_cases_counts_by_genes
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases do not possess mutations in PTPRN2 and HSPA5?,top_cases_counts_by_genes
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What fraction of Liver Hepatocellular Carcinoma cases do not possess mutations in PTPRN2 and MORF4L1?,top_cases_counts_by_genes
+1188,SOX21,R55L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in SOX21 and PAK3?,top_cases_counts_by_genes
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases do not possess mutations in CPA6 and DCC?,top_cases_counts_by_genes
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in GRM5 and CPA6?,top_cases_counts_by_genes
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not possess mutations in CASZ1 and SORCS1?",top_cases_counts_by_genes
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in SGIP1 and ZCCHC14?,top_cases_counts_by_genes
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in SGIP1 and CYP1A2?,top_cases_counts_by_genes
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in SGIP1 and MAST4?,top_cases_counts_by_genes
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in SGIP1 and YY1AP1?,top_cases_counts_by_genes
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in CARMIL1 and PGR?,top_cases_counts_by_genes
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in CARMIL1 and GUK1?,top_cases_counts_by_genes
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in ZNF431 and CX3CR1?,top_cases_counts_by_genes
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in ZNF431 and TLK2?,top_cases_counts_by_genes
+1234,ZNF431,R128I,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in ZNF431 and TRPA1?,top_cases_counts_by_genes
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in DNAH11 and EIF2B4?,top_cases_counts_by_genes
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in DNAH11 and GRTP1?,top_cases_counts_by_genes
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in POLD1 and SORCS1?,top_cases_counts_by_genes
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What fraction of Lung Squamous Cell Carcinoma cases do not possess mutations in POLD1 and MYT1?,top_cases_counts_by_genes
+1248,TTC12,D646H,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in TTC12 and RIMS2?,top_cases_counts_by_genes
+1249,TTC12,D652H,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in TTC12 and CTNNA2?,top_cases_counts_by_genes
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases do not possess mutations in CNGB1 and NOMO1?,top_cases_counts_by_genes
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What fraction of Bladder Urothelial Carcinoma cases do not possess mutations in CNGB1 and STK19?,top_cases_counts_by_genes
+1254,CTSC,E214V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in CTSC and OLFML3?,top_cases_counts_by_genes
+1255,CTSC,E291V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in CTSC and OR13C3?,top_cases_counts_by_genes
+1256,CTSC,E322V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in CTSC and SYT9?,top_cases_counts_by_genes
+1257,CTSC,E324V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in CTSC and PRSS8?,top_cases_counts_by_genes
+1258,CTSC,E335V,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in CTSC and GRM1?,top_cases_counts_by_genes
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in PRSS8 and CACNA1F?,top_cases_counts_by_genes
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in PRSS8 and OR13C3?,top_cases_counts_by_genes
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in ARHGEF40 and TRAP1?,top_cases_counts_by_genes
+1264,ACTB,A138T,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases do not possess mutations in ACTB and TMEM255A?,top_cases_counts_by_genes
+1265,ACTB,A217T,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases do not possess mutations in ACTB and MAD1L1?,top_cases_counts_by_genes
+1266,ACTB,A244T,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases do not possess mutations in ACTB and DPF3?,top_cases_counts_by_genes
+1267,ACTB,A260T,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases do not possess mutations in ACTB and PAK3?,top_cases_counts_by_genes
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases do not possess mutations in YY1AP1 and EIF2B4?,top_cases_counts_by_genes
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases do not possess mutations in YY1AP1 and GABRA6?,top_cases_counts_by_genes
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases do not possess mutations in YY1AP1 and DNAH14?,top_cases_counts_by_genes
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases do not possess mutations in YY1AP1 and TLCD5?,top_cases_counts_by_genes
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases do not possess mutations in YY1AP1 and GUCY2C?,top_cases_counts_by_genes
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases do not possess mutations in YY1AP1 and PHLPP1?,top_cases_counts_by_genes
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What fraction of Glioblastoma Multiforme cases do not possess mutations in YY1AP1 and ANKDD1A?,top_cases_counts_by_genes
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in FNDC7 and CACNA1F?,top_cases_counts_by_genes
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in FNDC7 and ACTL7B?,top_cases_counts_by_genes
+1299,TLCD5,G15V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in TLCD5 and KDM5C?,top_cases_counts_by_genes
+1300,TLCD5,G37V,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in TLCD5 and TMTC3?,top_cases_counts_by_genes
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in POLR1G and OR2T4?,top_cases_counts_by_genes
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in POLR1G and FMO4?,top_cases_counts_by_genes
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in DNAH14 and TRIM45?,top_cases_counts_by_genes
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in DNAH14 and ABCC3?,top_cases_counts_by_genes
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in DNAH14 and PRSS1?,top_cases_counts_by_genes
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in NEXN and DSCAM?,top_cases_counts_by_genes
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma cases do not possess mutations in CYB5R2 and ZKSCAN7?,top_cases_counts_by_genes
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What fraction of Prostate Adenocarcinoma cases do not possess mutations in CYB5R2 and TTYH2?,top_cases_counts_by_genes
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in NRAP and TASOR2?,top_cases_counts_by_genes
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in NRAP and DCLK3?,top_cases_counts_by_genes
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in NRAP and KIF20B?,top_cases_counts_by_genes
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in CCDC22 and PAK3?,top_cases_counts_by_genes
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in DCAF6 and PYHIN1?,top_cases_counts_by_genes
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in DCAF6 and SGIP1?,top_cases_counts_by_genes
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in ZNF708 and CHODL?,top_cases_counts_by_genes
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in BFAR and CTCFL?,top_cases_counts_by_genes
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in MAST4 and TET2?,top_cases_counts_by_genes
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in MAST4 and AQP7?,top_cases_counts_by_genes
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in MAST4 and CACNA1F?,top_cases_counts_by_genes
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in MAST4 and ACVR1B?,top_cases_counts_by_genes
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in MAST4 and SORCS1?,top_cases_counts_by_genes
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in ARMC3 and EIF2B4?,top_cases_counts_by_genes
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in ARMC3 and GUF1?,top_cases_counts_by_genes
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What fraction of Kidney Renal Clear Cell Carcinoma cases do not possess mutations in TET2 and PAK3?,top_cases_counts_by_genes
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What fraction of Kidney Renal Clear Cell Carcinoma cases do not possess mutations in TET2 and ZSCAN31?,top_cases_counts_by_genes
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in SERPINB10 and USH2A?,top_cases_counts_by_genes
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in STAT3 and ZFPM2?,top_cases_counts_by_genes
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in MIEF1 and SMO?,top_cases_counts_by_genes
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in ACVR1B and EBF2?,top_cases_counts_by_genes
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in ACVR1B and SGIP1?,top_cases_counts_by_genes
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in ACVR1B and CTSC?,top_cases_counts_by_genes
+1393,EBF2,T104I,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in EBF2 and TRAP1?,top_cases_counts_by_genes
+1394,EBF2,T252I,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in EBF2 and SLC9C1?,top_cases_counts_by_genes
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in VPS26B and TRPA1?,top_cases_counts_by_genes
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not possess mutations in PGR and AUTS2?",top_cases_counts_by_genes
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not possess mutations in PGR and ARMC3?",top_cases_counts_by_genes
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What fraction of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases do not possess mutations in PGR and GSTCD?",top_cases_counts_by_genes
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What fraction of Skin Cutaneous Melanoma cases do not possess mutations in ACTA2 and SGCZ?,top_cases_counts_by_genes
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in THBS4 and KIF20B?,top_cases_counts_by_genes
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in THBS4 and SGIP1?,top_cases_counts_by_genes
+1413,PRSS1,S114T,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in PRSS1 and RIMS2?,top_cases_counts_by_genes
+1414,PRSS1,S124T,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in PRSS1 and PTPRN2?,top_cases_counts_by_genes
+1415,PRSS1,S138T,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in PRSS1 and ARHGEF40?,top_cases_counts_by_genes
+1416,PRSS1,S74T,Lung Adenocarcinoma,What fraction of Lung Adenocarcinoma cases do not possess mutations in PRSS1 and PTPRO?,top_cases_counts_by_genes
+1417,PGF,R126H,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in PGF and PCDHB2?,top_cases_counts_by_genes
+1418,PGF,R127H,Stomach Adenocarcinoma,What fraction of Stomach Adenocarcinoma cases do not possess mutations in PGF and TRIM45?,top_cases_counts_by_genes
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases do not possess mutations in ITPRID2 and DNMT1?,top_cases_counts_by_genes
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What fraction of Breast Invasive Carcinoma cases do not possess mutations in ITPRID2 and LAMB2?,top_cases_counts_by_genes
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in HBB and ART3?,top_cases_counts_by_genes
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in PCDHB2 and PYHIN1?,top_cases_counts_by_genes
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in PCDHB2 and CR1?,top_cases_counts_by_genes
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What fraction of Colon Adenocarcinoma cases do not possess mutations in PCDHB2 and ZFPM2?,top_cases_counts_by_genes
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What fraction of Uterine Corpus Endometrial Carcinoma cases do not possess mutations in UBR2 and ACVR1B?,top_cases_counts_by_genes
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What fraction of Rectum Adenocarcinoma cases do not possess mutations in FBXO42 and FBN1?,top_cases_counts_by_genes
+1,TNS1,G1362V,Breast Invasive Carcinoma,Do a substantial number of Breast Invasive Carcinoma not have TNS1 and SGIP1 mutations?,top_cases_counts_by_genes
+2,TNS1,G1711V,Breast Invasive Carcinoma,Do a substantial number of Breast Invasive Carcinoma not have TNS1 and ANKRD30A mutations?,top_cases_counts_by_genes
+3,TNS1,G1718V,Breast Invasive Carcinoma,Do a substantial number of Breast Invasive Carcinoma not have TNS1 and PXN mutations?,top_cases_counts_by_genes
+4,TNS1,G1732V,Breast Invasive Carcinoma,Do a substantial number of Breast Invasive Carcinoma not have TNS1 and NPSR1 mutations?,top_cases_counts_by_genes
+5,TNS1,G1824V,Breast Invasive Carcinoma,Do a substantial number of Breast Invasive Carcinoma not have TNS1 and CTSC mutations?,top_cases_counts_by_genes
+6,TNS1,G1857V,Breast Invasive Carcinoma,Do a substantial number of Breast Invasive Carcinoma not have TNS1 and FRY mutations?,top_cases_counts_by_genes
+7,TNS1,G843V,Breast Invasive Carcinoma,Do a substantial number of Breast Invasive Carcinoma not have TNS1 and PAK3 mutations?,top_cases_counts_by_genes
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,Do a substantial number of Bladder Urothelial Carcinoma not have EVC2 and TRPA1 mutations?,top_cases_counts_by_genes
+15,EVC2,E987K,Bladder Urothelial Carcinoma,Do a substantial number of Bladder Urothelial Carcinoma not have EVC2 and SORCS1 mutations?,top_cases_counts_by_genes
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have CR1 and PTPRO mutations?,top_cases_counts_by_genes
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have CR1 and TNS1 mutations?,top_cases_counts_by_genes
+22,TRPA1,S295I,Rectum Adenocarcinoma,Do a substantial number of Rectum Adenocarcinoma not have TRPA1 and CACNA1F mutations?,top_cases_counts_by_genes
+23,TRPA1,S443I,Rectum Adenocarcinoma,Do a substantial number of Rectum Adenocarcinoma not have TRPA1 and SOX21 mutations?,top_cases_counts_by_genes
+24,TAF1C,R299L,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have TAF1C and AUTS2 mutations?,top_cases_counts_by_genes
+25,TAF1C,R396L,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have TAF1C and MYT1 mutations?,top_cases_counts_by_genes
+26,TAF1C,R634L,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have TAF1C and DEFB115 mutations?,top_cases_counts_by_genes
+27,TAF1C,R702L,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have TAF1C and RAB40C mutations?,top_cases_counts_by_genes
+28,TAF1C,R728L,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have TAF1C and ABCC3 mutations?,top_cases_counts_by_genes
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have DPF3 and SGCZ mutations?,top_cases_counts_by_genes
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have DPF3 and UNC5D mutations?,top_cases_counts_by_genes
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have DPF3 and RIMS2 mutations?,top_cases_counts_by_genes
+42,OR2T4,P272H,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have OR2T4 and CTNNA2 mutations?,top_cases_counts_by_genes
+43,OR2T4,P300H,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have OR2T4 and COL6A3 mutations?,top_cases_counts_by_genes
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,Do a substantial number of Pancreatic Adenocarcinoma not have FBN1 and ACTA2 mutations?,top_cases_counts_by_genes
+45,MAD1L1,E396K,Prostate Adenocarcinoma,Do a substantial number of Prostate Adenocarcinoma not have MAD1L1 and GPRASP1 mutations?,top_cases_counts_by_genes
+46,MAD1L1,E488K,Prostate Adenocarcinoma,Do a substantial number of Prostate Adenocarcinoma not have MAD1L1 and MYO3B mutations?,top_cases_counts_by_genes
+47,MAD1L1,E78K,Prostate Adenocarcinoma,Do a substantial number of Prostate Adenocarcinoma not have MAD1L1 and ACVR1B mutations?,top_cases_counts_by_genes
+61,CCNG1,E22K,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have CCNG1 and FNDC7 mutations?,top_cases_counts_by_genes
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,Do a substantial number of Kidney Renal Papillary Cell Carcinoma not have ANP32E and YY1AP1 mutations?,top_cases_counts_by_genes
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,Do a substantial number of Kidney Renal Papillary Cell Carcinoma not have ANP32E and RELN mutations?,top_cases_counts_by_genes
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,Do a substantial number of Kidney Renal Papillary Cell Carcinoma not have ANP32E and ZNF217 mutations?,top_cases_counts_by_genes
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,Do a substantial number of Kidney Renal Papillary Cell Carcinoma not have ANP32E and MIEF1 mutations?,top_cases_counts_by_genes
+66,FRY,S1888A,Bladder Urothelial Carcinoma,Do a substantial number of Bladder Urothelial Carcinoma not have FRY and PAK3 mutations?,top_cases_counts_by_genes
+67,FRY,S1937A,Bladder Urothelial Carcinoma,Do a substantial number of Bladder Urothelial Carcinoma not have FRY and REXO4 mutations?,top_cases_counts_by_genes
+68,FRY,S1938A,Bladder Urothelial Carcinoma,Do a substantial number of Bladder Urothelial Carcinoma not have FRY and BCAT1 mutations?,top_cases_counts_by_genes
+69,FRY,S1983A,Bladder Urothelial Carcinoma,Do a substantial number of Bladder Urothelial Carcinoma not have FRY and ERCC6 mutations?,top_cases_counts_by_genes
+70,PAK3,E318K,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have PAK3 and ZNF584 mutations?,top_cases_counts_by_genes
+71,PAK3,E319K,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have PAK3 and EPRS1 mutations?,top_cases_counts_by_genes
+72,PAK3,E334K,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have PAK3 and AUTS2 mutations?,top_cases_counts_by_genes
+73,PAK3,E340K,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have PAK3 and MSANTD4 mutations?,top_cases_counts_by_genes
+74,PAK3,E355K,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have PAK3 and ZNF431 mutations?,top_cases_counts_by_genes
+80,MUC16,P7963L,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have MUC16 and OR2T4 mutations?,top_cases_counts_by_genes
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,Do a substantial number of Liver Hepatocellular Carcinoma not have ZFPM2 and JAML mutations?,top_cases_counts_by_genes
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,Do a substantial number of Liver Hepatocellular Carcinoma not have ZFPM2 and IL5RA mutations?,top_cases_counts_by_genes
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,Do a substantial number of Breast Invasive Carcinoma not have PIK3C2B and ANKDD1A mutations?,top_cases_counts_by_genes
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,Do a substantial number of Breast Invasive Carcinoma not have PIK3C2B and SPATA22 mutations?,top_cases_counts_by_genes
+114,ZNF804A,S371Y,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have ZNF804A and RIPOR2 mutations?,top_cases_counts_by_genes
+116,RELN,A2371V,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have RELN and TASOR2 mutations?,top_cases_counts_by_genes
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Do a substantial number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus not have EFCAB12 and ERCC6 mutations?",top_cases_counts_by_genes
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Do a substantial number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus not have EFCAB12 and EPRS1 mutations?",top_cases_counts_by_genes
+120,DEFB115,E53K,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have DEFB115 and GPRASP1 mutations?,top_cases_counts_by_genes
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,Do a substantial number of Bladder Urothelial Carcinoma not have ANKDD1A and MYO15A mutations?,top_cases_counts_by_genes
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,Do a substantial number of Bladder Urothelial Carcinoma not have ANKDD1A and ZFAT mutations?,top_cases_counts_by_genes
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,Do a substantial number of Bladder Urothelial Carcinoma not have ANKDD1A and HTR3B mutations?,top_cases_counts_by_genes
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have HTR3B and SORCS1 mutations?,top_cases_counts_by_genes
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have HTR3B and TRPA1 mutations?,top_cases_counts_by_genes
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have HTR3B and DGKD mutations?,top_cases_counts_by_genes
+129,ABCC3,R758W,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have ABCC3 and TAF1C mutations?,top_cases_counts_by_genes
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have NOMO1 and DNAH14 mutations?,top_cases_counts_by_genes
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have NOMO1 and DCN mutations?,top_cases_counts_by_genes
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,Do a substantial number of Bladder Urothelial Carcinoma not have HYOU1 and DGKD mutations?,top_cases_counts_by_genes
+139,FMO4,R500Q,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have FMO4 and SYT9 mutations?,top_cases_counts_by_genes
+140,BICC1,A372V,Exceptional Responders,Do a substantial number of Exceptional Responders not have BICC1 and NCKAP5 mutations?,top_cases_counts_by_genes
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have ZMYM3 and PKHD1L1 mutations?,top_cases_counts_by_genes
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have ZMYM3 and CHODL mutations?,top_cases_counts_by_genes
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have ZMYM3 and DEFB115 mutations?,top_cases_counts_by_genes
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Do a substantial number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus not have XKR4 and SPTAN1 mutations?",top_cases_counts_by_genes
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,Do a substantial number of Liver Hepatocellular Carcinoma not have ABCC2 and TLCD5 mutations?,top_cases_counts_by_genes
+157,OR8K5,R293G,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have OR8K5 and GIMAP2 mutations?,top_cases_counts_by_genes
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have SPTAN1 and ZBTB34 mutations?,top_cases_counts_by_genes
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have SPTAN1 and TET2 mutations?,top_cases_counts_by_genes
+164,SYT10,M484I,Rectum Adenocarcinoma,Do a substantial number of Rectum Adenocarcinoma not have SYT10 and PAK3 mutations?,top_cases_counts_by_genes
+174,HSPA5,N457K,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have HSPA5 and CPA6 mutations?,top_cases_counts_by_genes
+175,UNC5D,L280V,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have UNC5D and MORF4L1 mutations?,top_cases_counts_by_genes
+176,UNC5D,L635V,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have UNC5D and PAK3 mutations?,top_cases_counts_by_genes
+177,UNC5D,L637V,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have UNC5D and STK19 mutations?,top_cases_counts_by_genes
+178,UNC5D,L699V,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have UNC5D and PRSS1 mutations?,top_cases_counts_by_genes
+179,UNC5D,L704V,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have UNC5D and ABCC2 mutations?,top_cases_counts_by_genes
+180,UNC5D,L709V,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have UNC5D and SGIP1 mutations?,top_cases_counts_by_genes
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,Do a substantial number of Kidney Renal Clear Cell Carcinoma not have DOCK2 and RELN mutations?,top_cases_counts_by_genes
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,Do a substantial number of Kidney Renal Clear Cell Carcinoma not have ZNF627 and PXN mutations?,top_cases_counts_by_genes
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have CDC42BPA and CNGB1 mutations?,top_cases_counts_by_genes
+193,MRPL55,H27Y,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have MRPL55 and YY1AP1 mutations?,top_cases_counts_by_genes
+194,MRPL55,H63Y,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have MRPL55 and KDM5C mutations?,top_cases_counts_by_genes
+197,TMTC3,Q749K,Breast Invasive Carcinoma,Do a substantial number of Breast Invasive Carcinoma not have TMTC3 and AKT1 mutations?,top_cases_counts_by_genes
+198,EPRS1,K771I,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have EPRS1 and RIPOR2 mutations?,top_cases_counts_by_genes
+199,EPRS1,K778I,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have EPRS1 and PCDHB2 mutations?,top_cases_counts_by_genes
+201,GRTP1,A110V,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have GRTP1 and PAK3 mutations?,top_cases_counts_by_genes
+202,GRTP1,A32V,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have GRTP1 and ANKRD24 mutations?,top_cases_counts_by_genes
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have TSHZ3 and MYT1 mutations?,top_cases_counts_by_genes
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,Do a substantial number of HIV+ Tumor Molecular Characterization Project - Cervical Cancer not have TAS1R3 and ZMYM3 mutations?,top_cases_counts_by_genes
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have PIAS3 and MYH11 mutations?,top_cases_counts_by_genes
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have PIAS3 and TET2 mutations?,top_cases_counts_by_genes
+251,ZNF274,P13R,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have ZNF274 and ANKRD30A mutations?,top_cases_counts_by_genes
+253,SYNJ1,R795C,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have SYNJ1 and OR5D14 mutations?,top_cases_counts_by_genes
+254,SYNJ1,R800C,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have SYNJ1 and KIF20B mutations?,top_cases_counts_by_genes
+255,SYNJ1,R839C,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have SYNJ1 and OLFML3 mutations?,top_cases_counts_by_genes
+261,DSCAM,V343M,Prostate Adenocarcinoma,Do a substantial number of Prostate Adenocarcinoma not have DSCAM and AUTS2 mutations?,top_cases_counts_by_genes
+262,DSCAM,V426M,Prostate Adenocarcinoma,Do a substantial number of Prostate Adenocarcinoma not have DSCAM and CR1 mutations?,top_cases_counts_by_genes
+263,DSCAM,V591M,Prostate Adenocarcinoma,Do a substantial number of Prostate Adenocarcinoma not have DSCAM and CHODL mutations?,top_cases_counts_by_genes
+267,DGKD,R140H,Exceptional Responders,Do a substantial number of Exceptional Responders not have DGKD and ABCC2 mutations?,top_cases_counts_by_genes
+268,DGKD,R160H,Exceptional Responders,Do a substantial number of Exceptional Responders not have DGKD and TRIM45 mutations?,top_cases_counts_by_genes
+269,DGKD,R204H,Exceptional Responders,Do a substantial number of Exceptional Responders not have DGKD and GIMAP2 mutations?,top_cases_counts_by_genes
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,Do a substantial number of Bladder Urothelial Carcinoma not have PLEKHG6 and MYO3A mutations?,top_cases_counts_by_genes
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,Do a substantial number of Bladder Urothelial Carcinoma not have PLEKHG6 and UNC5D mutations?,top_cases_counts_by_genes
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,Do a substantial number of Bladder Urothelial Carcinoma not have PLEKHG6 and PTPRN2 mutations?,top_cases_counts_by_genes
+279,WNT2,D138N,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have WNT2 and TLK2 mutations?,top_cases_counts_by_genes
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have GUCY2C and DGKD mutations?,top_cases_counts_by_genes
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have C7orf31 and TTC17 mutations?,top_cases_counts_by_genes
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Do a substantial number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus not have ZKSCAN7 and PAK3 mutations?",top_cases_counts_by_genes
+299,OR5D14,M210L,Neuroblastoma,Do a substantial number of Neuroblastoma not have OR5D14 and GUF1 mutations?,top_cases_counts_by_genes
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have SPATA22 and ZBTB34 mutations?,top_cases_counts_by_genes
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have SPATA22 and TAF1C mutations?,top_cases_counts_by_genes
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have SPATA22 and PHLPP1 mutations?,top_cases_counts_by_genes
+310,LCN15,E21V,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have LCN15 and PRSS1 mutations?,top_cases_counts_by_genes
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have DCAF4L2 and DSCAM mutations?,top_cases_counts_by_genes
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have GUK1 and MAD1L1 mutations?,top_cases_counts_by_genes
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have GUK1 and ZSCAN31 mutations?,top_cases_counts_by_genes
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have GUK1 and DPF3 mutations?,top_cases_counts_by_genes
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have GUK1 and MRPL32 mutations?,top_cases_counts_by_genes
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have GUK1 and ANKDD1A mutations?,top_cases_counts_by_genes
+328,MORF4L1,K29T,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have MORF4L1 and TTN mutations?,top_cases_counts_by_genes
+329,MORF4L1,K51T,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have MORF4L1 and DOCK2 mutations?,top_cases_counts_by_genes
+330,MORF4L1,K61T,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have MORF4L1 and TTN mutations?,top_cases_counts_by_genes
+331,MORF4L1,K76T,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have MORF4L1 and PIAS3 mutations?,top_cases_counts_by_genes
+335,MYO3B,F594L,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have MYO3B and JAML mutations?,top_cases_counts_by_genes
+336,MYO3B,F603L,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have MYO3B and CTCFL mutations?,top_cases_counts_by_genes
+339,TENT5A,S320F,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have TENT5A and DCLK3 mutations?,top_cases_counts_by_genes
+340,TENT5A,S339F,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have TENT5A and PHLPP1 mutations?,top_cases_counts_by_genes
+341,TENT5A,S401F,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have TENT5A and MYH11 mutations?,top_cases_counts_by_genes
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,Do a substantial number of Ovarian Serous Cystadenocarcinoma not have ZFAT and DNMT1 mutations?,top_cases_counts_by_genes
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,Do a substantial number of Ovarian Serous Cystadenocarcinoma not have ZFAT and SGIP1 mutations?,top_cases_counts_by_genes
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,Do a substantial number of Ovarian Serous Cystadenocarcinoma not have ZFAT and OR13C3 mutations?,top_cases_counts_by_genes
+357,ZNF584,A211T,Sarcoma,Do a substantial number of Sarcoma not have ZNF584 and SGIP1 mutations?,top_cases_counts_by_genes
+358,ZNF584,A256T,Sarcoma,Do a substantial number of Sarcoma not have ZNF584 and TLK2 mutations?,top_cases_counts_by_genes
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have LDOC1 and THBS4 mutations?,top_cases_counts_by_genes
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have PDGFC and PHLPP1 mutations?,top_cases_counts_by_genes
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have MSANTD4 and GABRA6 mutations?,top_cases_counts_by_genes
+374,NPSR1,S123L,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have NPSR1 and PDGFC mutations?,top_cases_counts_by_genes
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have PHLPP1 and XKR4 mutations?,top_cases_counts_by_genes
+385,COL6A3,G237S,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have COL6A3 and ERCC6 mutations?,top_cases_counts_by_genes
+386,COL6A3,G437S,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have COL6A3 and DNMT1 mutations?,top_cases_counts_by_genes
+387,COL6A3,G638S,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have COL6A3 and TLCD5 mutations?,top_cases_counts_by_genes
+388,COL6A3,G644S,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have COL6A3 and ZFAT mutations?,top_cases_counts_by_genes
+389,COL6A3,G844S,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have COL6A3 and CEP20 mutations?,top_cases_counts_by_genes
+395,ADRA1A,R348G,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have ADRA1A and MORF4L1 mutations?,top_cases_counts_by_genes
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Do a substantial number of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma not have LAMB2 and EPRS1 mutations?,top_cases_counts_by_genes
+406,POC1B,I198T,Rectum Adenocarcinoma,Do a substantial number of Rectum Adenocarcinoma not have POC1B and GPC3 mutations?,top_cases_counts_by_genes
+407,POC1B,I286T,Rectum Adenocarcinoma,Do a substantial number of Rectum Adenocarcinoma not have POC1B and KDM5C mutations?,top_cases_counts_by_genes
+408,POC1B,I328T,Rectum Adenocarcinoma,Do a substantial number of Rectum Adenocarcinoma not have POC1B and CPS1 mutations?,top_cases_counts_by_genes
+409,POC1B,S79P,Rectum Adenocarcinoma,Do a substantial number of Rectum Adenocarcinoma not have POC1B and PYHIN1 mutations?,top_cases_counts_by_genes
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,Do a substantial number of Liver Hepatocellular Carcinoma not have USH2A and PCDHB2 mutations?,top_cases_counts_by_genes
+414,AQP7,T110S,Rectum Adenocarcinoma,Do a substantial number of Rectum Adenocarcinoma not have AQP7 and TASOR2 mutations?,top_cases_counts_by_genes
+415,AQP7,T166S,Rectum Adenocarcinoma,Do a substantial number of Rectum Adenocarcinoma not have AQP7 and RIPOR2 mutations?,top_cases_counts_by_genes
+416,AQP7,T167S,Rectum Adenocarcinoma,Do a substantial number of Rectum Adenocarcinoma not have AQP7 and ZNF431 mutations?,top_cases_counts_by_genes
+417,AQP7,T75S,Rectum Adenocarcinoma,Do a substantial number of Rectum Adenocarcinoma not have AQP7 and DSCAM mutations?,top_cases_counts_by_genes
+430,DCN,R163C,Rectum Adenocarcinoma,Do a substantial number of Rectum Adenocarcinoma not have DCN and COL6A3 mutations?,top_cases_counts_by_genes
+431,DCN,R203C,Rectum Adenocarcinoma,Do a substantial number of Rectum Adenocarcinoma not have DCN and PCDHB2 mutations?,top_cases_counts_by_genes
+432,DCN,R241C,Rectum Adenocarcinoma,Do a substantial number of Rectum Adenocarcinoma not have DCN and TLK2 mutations?,top_cases_counts_by_genes
+433,DCN,R350C,Rectum Adenocarcinoma,Do a substantial number of Rectum Adenocarcinoma not have DCN and GRM5 mutations?,top_cases_counts_by_genes
+434,DCN,R41C,Rectum Adenocarcinoma,Do a substantial number of Rectum Adenocarcinoma not have DCN and SGIP1 mutations?,top_cases_counts_by_genes
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have CPS1 and SGIP1 mutations?,top_cases_counts_by_genes
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have CPS1 and NRAP mutations?,top_cases_counts_by_genes
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have CPS1 and JAML mutations?,top_cases_counts_by_genes
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,Do a substantial number of Kidney Renal Papillary Cell Carcinoma not have FCGR2C and ADRA1A mutations?,top_cases_counts_by_genes
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,Do a substantial number of Kidney Renal Papillary Cell Carcinoma not have FCGR2C and SYT10 mutations?,top_cases_counts_by_genes
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have GRM1 and ZNF431 mutations?,top_cases_counts_by_genes
+482,SGCZ,Q138H,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have SGCZ and MYO3B mutations?,top_cases_counts_by_genes
+483,SGCZ,Q91H,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have SGCZ and ACTB mutations?,top_cases_counts_by_genes
+485,SMO,V15M,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have SMO and TRAP1 mutations?,top_cases_counts_by_genes
+486,SMO,V321M,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have SMO and GRTP1 mutations?,top_cases_counts_by_genes
+488,CHODL,G159E,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have CHODL and CARMIL1 mutations?,top_cases_counts_by_genes
+489,CHODL,G181E,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have CHODL and TNS1 mutations?,top_cases_counts_by_genes
+490,CHODL,G200E,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have CHODL and CPS1 mutations?,top_cases_counts_by_genes
+494,MYO16,P399H,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have MYO16 and PTPRN2 mutations?,top_cases_counts_by_genes
+495,MYO16,P421H,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have MYO16 and DHX16 mutations?,top_cases_counts_by_genes
+498,CXCR2,A98V,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have CXCR2 and PTPRN2 mutations?,top_cases_counts_by_genes
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,Do a substantial number of Bladder Urothelial Carcinoma not have TMEM225 and FNDC7 mutations?,top_cases_counts_by_genes
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have MAOB and PAK3 mutations?,top_cases_counts_by_genes
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have GPRASP1 and PTPRO mutations?,top_cases_counts_by_genes
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have MRPL32 and SORCS1 mutations?,top_cases_counts_by_genes
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have TYROBP and DPF3 mutations?,top_cases_counts_by_genes
+510,RAB40C,A111V,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have RAB40C and RIPOR2 mutations?,top_cases_counts_by_genes
+511,RAB40C,A143V,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have RAB40C and PYHIN1 mutations?,top_cases_counts_by_genes
+512,CTNNA2,S323R,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have CTNNA2 and MORF4L1 mutations?,top_cases_counts_by_genes
+513,CTNNA2,S339R,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have CTNNA2 and ZFAT mutations?,top_cases_counts_by_genes
+514,CTNNA2,S386R,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have CTNNA2 and ABCC2 mutations?,top_cases_counts_by_genes
+515,CTNNA2,S707R,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have CTNNA2 and DCN mutations?,top_cases_counts_by_genes
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,Do a substantial number of Bladder Urothelial Carcinoma not have MYO15A and CDC42BPA mutations?,top_cases_counts_by_genes
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have GIMAP2 and ACVR1B mutations?,top_cases_counts_by_genes
+532,KIF20B,N1160D,Glioblastoma Multiforme,Do a substantial number of Glioblastoma Multiforme not have KIF20B and THBS4 mutations?,top_cases_counts_by_genes
+533,KIF20B,N1200D,Glioblastoma Multiforme,Do a substantial number of Glioblastoma Multiforme not have KIF20B and TRIM45 mutations?,top_cases_counts_by_genes
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have ADAM17 and TAF1C mutations?,top_cases_counts_by_genes
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have BCAT1 and MYO3B mutations?,top_cases_counts_by_genes
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have BCAT1 and DHX16 mutations?,top_cases_counts_by_genes
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have BCAT1 and TMEM255A mutations?,top_cases_counts_by_genes
+540,ERCC6,R1053H,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have ERCC6 and OLFML3 mutations?,top_cases_counts_by_genes
+541,DCC,R320W,Breast Invasive Carcinoma,Do a substantial number of Breast Invasive Carcinoma not have DCC and POC1B mutations?,top_cases_counts_by_genes
+542,DCC,R363W,Breast Invasive Carcinoma,Do a substantial number of Breast Invasive Carcinoma not have DCC and AKT1 mutations?,top_cases_counts_by_genes
+543,DCC,R386W,Breast Invasive Carcinoma,Do a substantial number of Breast Invasive Carcinoma not have DCC and PLEKHG6 mutations?,top_cases_counts_by_genes
+544,DCC,R41W,Breast Invasive Carcinoma,Do a substantial number of Breast Invasive Carcinoma not have DCC and TRAP1 mutations?,top_cases_counts_by_genes
+549,FBXO15,D417N,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have FBXO15 and ZNF584 mutations?,top_cases_counts_by_genes
+550,FBXO15,D86N,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have FBXO15 and SORCS1 mutations?,top_cases_counts_by_genes
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have GSTCD and PXN mutations?,top_cases_counts_by_genes
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have GSTCD and MRPL32 mutations?,top_cases_counts_by_genes
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have OLFML3 and JAML mutations?,top_cases_counts_by_genes
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have OLFML3 and PXN mutations?,top_cases_counts_by_genes
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have OLFML3 and PIAS3 mutations?,top_cases_counts_by_genes
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,Do a substantial number of Ovarian Serous Cystadenocarcinoma not have CFAP61 and TENT5A mutations?,top_cases_counts_by_genes
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,Do a substantial number of Ovarian Serous Cystadenocarcinoma not have CFAP61 and CTNNA2 mutations?,top_cases_counts_by_genes
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,Do a substantial number of Bladder Urothelial Carcinoma not have HLA-DQA2 and DOCK2 mutations?,top_cases_counts_by_genes
+582,TENM2,H240Y,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have TENM2 and SPATA22 mutations?,top_cases_counts_by_genes
+583,TENM2,H351Y,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have TENM2 and BICC1 mutations?,top_cases_counts_by_genes
+584,TENM2,H472Y,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have TENM2 and SLC9C1 mutations?,top_cases_counts_by_genes
+600,ANKRD24,A465T,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have ANKRD24 and RIPOR2 mutations?,top_cases_counts_by_genes
+601,ANKRD24,A494T,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have ANKRD24 and TTN mutations?,top_cases_counts_by_genes
+602,ANKRD24,A584T,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have ANKRD24 and COL6A3 mutations?,top_cases_counts_by_genes
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have ZCCHC14 and SGIP1 mutations?,top_cases_counts_by_genes
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have ZCCHC14 and POLR1G mutations?,top_cases_counts_by_genes
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have ZCCHC14 and STK19 mutations?,top_cases_counts_by_genes
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have ZCCHC14 and YY1AP1 mutations?,top_cases_counts_by_genes
+625,SIK2,I265M,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have SIK2 and PTPRN2 mutations?,top_cases_counts_by_genes
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have MYH11 and BFAR mutations?,top_cases_counts_by_genes
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have MYH11 and SYT10 mutations?,top_cases_counts_by_genes
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have SLC6A4 and SLC9C1 mutations?,top_cases_counts_by_genes
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have SLC9C1 and PTPRN2 mutations?,top_cases_counts_by_genes
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have SLC9C1 and TLK2 mutations?,top_cases_counts_by_genes
+644,OR2A12,A254T,Brain Lower Grade Glioma,Do a substantial number of Brain Lower Grade Glioma not have OR2A12 and HTR3B mutations?,top_cases_counts_by_genes
+646,PYHIN1,T325K,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have PYHIN1 and AUTS2 mutations?,top_cases_counts_by_genes
+647,PYHIN1,T334K,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have PYHIN1 and DNAH11 mutations?,top_cases_counts_by_genes
+650,JAML,G191E,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have JAML and KRT39 mutations?,top_cases_counts_by_genes
+651,JAML,G219E,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have JAML and HTR3B mutations?,top_cases_counts_by_genes
+652,JAML,G220E,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have JAML and AUTS2 mutations?,top_cases_counts_by_genes
+653,JAML,G230E,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have JAML and FNDC7 mutations?,top_cases_counts_by_genes
+658,TYK2,H1146R,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have TYK2 and DCC mutations?,top_cases_counts_by_genes
+659,TYK2,H23R,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have TYK2 and GUF1 mutations?,top_cases_counts_by_genes
+660,TYK2,H961R,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have TYK2 and YY1AP1 mutations?,top_cases_counts_by_genes
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have CTCFL and C7orf31 mutations?,top_cases_counts_by_genes
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have CTCFL and OR2T4 mutations?,top_cases_counts_by_genes
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have CTCFL and RIMS2 mutations?,top_cases_counts_by_genes
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have CTCFL and TRIM45 mutations?,top_cases_counts_by_genes
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have CEP20 and DEFB115 mutations?,top_cases_counts_by_genes
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have CEP20 and ZMYM3 mutations?,top_cases_counts_by_genes
+689,RIMS2,R25W,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have RIMS2 and MYO3A mutations?,top_cases_counts_by_genes
+690,RIMS2,R393W,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have RIMS2 and DCC mutations?,top_cases_counts_by_genes
+691,RIMS2,R423W,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have RIMS2 and CCNG1 mutations?,top_cases_counts_by_genes
+692,RIMS2,R470W,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have RIMS2 and PTPRO mutations?,top_cases_counts_by_genes
+693,RIMS2,R615W,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have RIMS2 and BCAT1 mutations?,top_cases_counts_by_genes
+694,RIMS2,R619W,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have RIMS2 and ANKRD24 mutations?,top_cases_counts_by_genes
+695,RIMS2,R716W,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have RIMS2 and EPRS1 mutations?,top_cases_counts_by_genes
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have PIK3C2G and TTN mutations?,top_cases_counts_by_genes
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have PIK3C2G and AUTS2 mutations?,top_cases_counts_by_genes
+728,STK19,D341N,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have STK19 and PGF mutations?,top_cases_counts_by_genes
+729,STK19,D345N,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have STK19 and PTPRN2 mutations?,top_cases_counts_by_genes
+730,REXO4,P60A,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have REXO4 and GLRB mutations?,top_cases_counts_by_genes
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have ZBTB34 and GABRA6 mutations?,top_cases_counts_by_genes
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have ZBTB34 and ANKRD24 mutations?,top_cases_counts_by_genes
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,Do a substantial number of Bladder Urothelial Carcinoma not have NCKAP5 and EIF2B4 mutations?,top_cases_counts_by_genes
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Do a substantial number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus not have SORCS1 and FCGR2C mutations?",top_cases_counts_by_genes
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Do a substantial number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus not have SORCS1 and MAST4 mutations?",top_cases_counts_by_genes
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Do a substantial number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus not have SORCS1 and PYHIN1 mutations?",top_cases_counts_by_genes
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Do a substantial number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus not have SORCS1 and PHLPP1 mutations?",top_cases_counts_by_genes
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,Do a substantial number of Head and Neck Squamous Cell Carcinoma not have FGF8 and MSANTD4 mutations?,top_cases_counts_by_genes
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,Do a substantial number of Head and Neck Squamous Cell Carcinoma not have FGF8 and DHX16 mutations?,top_cases_counts_by_genes
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,Do a substantial number of Head and Neck Squamous Cell Carcinoma not have FGF8 and COL6A3 mutations?,top_cases_counts_by_genes
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,Do a substantial number of Head and Neck Squamous Cell Carcinoma not have FGF8 and GUCY2C mutations?,top_cases_counts_by_genes
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,Do a substantial number of Head and Neck Squamous Cell Carcinoma not have FGF8 and CX3CR1 mutations?,top_cases_counts_by_genes
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,Do a substantial number of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia not have TENM3 and MRPL32 mutations?,top_cases_counts_by_genes
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have AKT1 and THBS4 mutations?,top_cases_counts_by_genes
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Do a substantial number of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma not have CFAP298-TCP10L and EFCAB12 mutations?,top_cases_counts_by_genes
+792,GLRB,E148D,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have GLRB and ZFAT mutations?,top_cases_counts_by_genes
+793,TTN,F7636L,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have TTN and SGCZ mutations?,top_cases_counts_by_genes
+794,TTN,F8563L,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have TTN and EFCAB12 mutations?,top_cases_counts_by_genes
+795,TTN,F8880L,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have TTN and AQP7 mutations?,top_cases_counts_by_genes
+799,ANKRD30A,V798I,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have ANKRD30A and THBS4 mutations?,top_cases_counts_by_genes
+800,ANKRD30A,V854I,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have ANKRD30A and UNC5D mutations?,top_cases_counts_by_genes
+801,ANKRD30A,V973I,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have ANKRD30A and TLCD5 mutations?,top_cases_counts_by_genes
+809,TRIM45,S177L,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have TRIM45 and MYT1 mutations?,top_cases_counts_by_genes
+810,TRIM45,S224L,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have TRIM45 and UNC5D mutations?,top_cases_counts_by_genes
+811,TRIM45,S281L,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have TRIM45 and DHX16 mutations?,top_cases_counts_by_genes
+812,CACNA1F,G727V,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have CACNA1F and YY1AP1 mutations?,top_cases_counts_by_genes
+813,CACNA1F,G781V,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have CACNA1F and DHX16 mutations?,top_cases_counts_by_genes
+814,CACNA1F,G792V,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have CACNA1F and ZFP42 mutations?,top_cases_counts_by_genes
+817,KL,R594C,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have KL and PCDHB2 mutations?,top_cases_counts_by_genes
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,Do a substantial number of Kidney Renal Papillary Cell Carcinoma not have GUF1 and MAST4 mutations?,top_cases_counts_by_genes
+822,TAF1L,A539V,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have TAF1L and RIMS2 mutations?,top_cases_counts_by_genes
+823,TASOR2,S256F,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have TASOR2 and UNC5D mutations?,top_cases_counts_by_genes
+824,TASOR2,S36F,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have TASOR2 and PRSS1 mutations?,top_cases_counts_by_genes
+825,TASOR2,S471F,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have TASOR2 and MYT1 mutations?,top_cases_counts_by_genes
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have KDM5C and GUK1 mutations?,top_cases_counts_by_genes
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have KDM5C and PLEKHG6 mutations?,top_cases_counts_by_genes
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have KDM5C and JAML mutations?,top_cases_counts_by_genes
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have KDM5C and ZCCHC14 mutations?,top_cases_counts_by_genes
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Do a substantial number of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma not have IL5RA and DCN mutations?,top_cases_counts_by_genes
+843,DHX16,A29V,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have DHX16 and OR5D14 mutations?,top_cases_counts_by_genes
+844,DHX16,A89V,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have DHX16 and DCC mutations?,top_cases_counts_by_genes
+902,GPR158,A644V,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have GPR158 and KL mutations?,top_cases_counts_by_genes
+903,GPR158,A723V,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have GPR158 and DSCAM mutations?,top_cases_counts_by_genes
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Do a substantial number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus not have EIF2B4 and ZCCHC14 mutations?",top_cases_counts_by_genes
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Do a substantial number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus not have EIF2B4 and DCC mutations?",top_cases_counts_by_genes
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Do a substantial number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus not have EIF2B4 and PXN mutations?",top_cases_counts_by_genes
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Do a substantial number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus not have EIF2B4 and CFAP61 mutations?",top_cases_counts_by_genes
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Do a substantial number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus not have EIF2B4 and FGF8 mutations?",top_cases_counts_by_genes
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Do a substantial number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus not have EIF2B4 and CASZ1 mutations?",top_cases_counts_by_genes
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have AUTS2 and TENT5A mutations?,top_cases_counts_by_genes
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have AUTS2 and MORF4L1 mutations?,top_cases_counts_by_genes
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have AUTS2 and SYNJ1 mutations?,top_cases_counts_by_genes
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have AUTS2 and KIF20B mutations?,top_cases_counts_by_genes
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have AUTS2 and CA9 mutations?,top_cases_counts_by_genes
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have AUTS2 and MAST4 mutations?,top_cases_counts_by_genes
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have AUTS2 and TYK2 mutations?,top_cases_counts_by_genes
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have AUTS2 and CDKN2AIP mutations?,top_cases_counts_by_genes
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have AUTS2 and FBXO15 mutations?,top_cases_counts_by_genes
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have AUTS2 and OR8K5 mutations?,top_cases_counts_by_genes
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Do a substantial number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus not have ACTL7B and HTR3B mutations?",top_cases_counts_by_genes
+952,PCDHGA1,R535W,Glioblastoma Multiforme,Do a substantial number of Glioblastoma Multiforme not have PCDHGA1 and SIK2 mutations?,top_cases_counts_by_genes
+954,TRAP1,R114W,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have TRAP1 and POC1B mutations?,top_cases_counts_by_genes
+955,TRAP1,R61W,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have TRAP1 and TENM2 mutations?,top_cases_counts_by_genes
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have PIK3C2A and SLC6A4 mutations?,top_cases_counts_by_genes
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,Do a substantial number of Liver Hepatocellular Carcinoma not have KANSL1 and GUK1 mutations?,top_cases_counts_by_genes
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have ANKRD52 and CTSC mutations?,top_cases_counts_by_genes
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have PAPPA and PCDHB2 mutations?,top_cases_counts_by_genes
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,Do a substantial number of Rectum Adenocarcinoma not have B3GALNT1 and ZNF708 mutations?,top_cases_counts_by_genes
+982,GABRA6,G115R,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have GABRA6 and YY1AP1 mutations?,top_cases_counts_by_genes
+983,GABRA6,G122R,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have GABRA6 and PAK3 mutations?,top_cases_counts_by_genes
+984,GABRA6,G165R,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have GABRA6 and PAPPA mutations?,top_cases_counts_by_genes
+985,GABRA6,G175R,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have GABRA6 and ACTB mutations?,top_cases_counts_by_genes
+986,GABRA6,G70R,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have GABRA6 and CEP20 mutations?,top_cases_counts_by_genes
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have ZSCAN31 and FCGR2C mutations?,top_cases_counts_by_genes
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Do a substantial number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus not have MED16 and SPINDOC mutations?",top_cases_counts_by_genes
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Do a substantial number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus not have MED16 and OR13C3 mutations?",top_cases_counts_by_genes
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,Do a substantial number of Pancreatic Adenocarcinoma not have PTPRO and ZFAT mutations?,top_cases_counts_by_genes
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,Do a substantial number of Pancreatic Adenocarcinoma not have PTPRO and CFAP61 mutations?,top_cases_counts_by_genes
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,Do a substantial number of Pancreatic Adenocarcinoma not have PTPRO and PGF mutations?,top_cases_counts_by_genes
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,Do a substantial number of Pancreatic Adenocarcinoma not have PTPRO and TRIM45 mutations?,top_cases_counts_by_genes
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,Do a substantial number of Pancreatic Adenocarcinoma not have PTPRO and MRPL55 mutations?,top_cases_counts_by_genes
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,Do a substantial number of Pancreatic Adenocarcinoma not have PTPRO and COL6A3 mutations?,top_cases_counts_by_genes
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,Do a substantial number of Pancreatic Adenocarcinoma not have PTPRO and RAB40C mutations?,top_cases_counts_by_genes
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,Do a substantial number of Pancreatic Adenocarcinoma not have PTPRO and SGCZ mutations?,top_cases_counts_by_genes
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have CHMP7 and POLD1 mutations?,top_cases_counts_by_genes
+1017,GPC3,I107N,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have GPC3 and ACTB mutations?,top_cases_counts_by_genes
+1018,GPC3,I161N,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have GPC3 and DCN mutations?,top_cases_counts_by_genes
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Do a substantial number of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma not have TLK2 and MYH11 mutations?,top_cases_counts_by_genes
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Do a substantial number of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma not have TLK2 and TTN mutations?,top_cases_counts_by_genes
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Do a substantial number of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma not have TLK2 and PIAS3 mutations?,top_cases_counts_by_genes
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Do a substantial number of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma not have TLK2 and KDM5C mutations?,top_cases_counts_by_genes
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Do a substantial number of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma not have TLK2 and CACNA1F mutations?,top_cases_counts_by_genes
+1036,ZNF217,E209Q,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have ZNF217 and BICC1 mutations?,top_cases_counts_by_genes
+1038,SYT9,V275L,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have SYT9 and CASZ1 mutations?,top_cases_counts_by_genes
+1039,SYT9,V307L,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have SYT9 and COL6A3 mutations?,top_cases_counts_by_genes
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have PKHD1L1 and ACTB mutations?,top_cases_counts_by_genes
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have MYO3A and CYB5R2 mutations?,top_cases_counts_by_genes
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Do a substantial number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus not have VASN and POC1B mutations?",top_cases_counts_by_genes
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have DNMT1 and POLD1 mutations?,top_cases_counts_by_genes
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have DNMT1 and PDHA2 mutations?,top_cases_counts_by_genes
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have DNMT1 and HLA-DQA2 mutations?,top_cases_counts_by_genes
+1056,CA9,E402K,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have CA9 and GUK1 mutations?,top_cases_counts_by_genes
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have TTC17 and CTSC mutations?,top_cases_counts_by_genes
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have TTC17 and PCDHB2 mutations?,top_cases_counts_by_genes
+1065,PSG2,P43L,Breast Invasive Carcinoma,Do a substantial number of Breast Invasive Carcinoma not have PSG2 and ZCCHC14 mutations?,top_cases_counts_by_genes
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,Do a substantial number of Breast Invasive Carcinoma not have RIPOR2 and MYH11 mutations?,top_cases_counts_by_genes
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,Do a substantial number of Breast Invasive Carcinoma not have RIPOR2 and TTN mutations?,top_cases_counts_by_genes
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,Do a substantial number of Breast Invasive Carcinoma not have RIPOR2 and AUTS2 mutations?,top_cases_counts_by_genes
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,Do a substantial number of Breast Invasive Carcinoma not have RIPOR2 and AUTS2 mutations?,top_cases_counts_by_genes
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have DCLK3 and TNS1 mutations?,top_cases_counts_by_genes
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have DCLK3 and UNC5D mutations?,top_cases_counts_by_genes
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have MERTK and GPC3 mutations?,top_cases_counts_by_genes
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have MERTK and AKT1 mutations?,top_cases_counts_by_genes
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have MERTK and KDM5C mutations?,top_cases_counts_by_genes
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have ZFP42 and SYNJ1 mutations?,top_cases_counts_by_genes
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have OR13C3 and MAD1L1 mutations?,top_cases_counts_by_genes
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have OR13C3 and MAST4 mutations?,top_cases_counts_by_genes
+1091,SPAG1,I917M,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have SPAG1 and PAK3 mutations?,top_cases_counts_by_genes
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have CDKN2AIP and ACTA2 mutations?,top_cases_counts_by_genes
+1093,PXN,H1016Y,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have PXN and ZSCAN31 mutations?,top_cases_counts_by_genes
+1094,PXN,H359Y,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have PXN and VASN mutations?,top_cases_counts_by_genes
+1095,PXN,H492Y,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have PXN and CACNA1F mutations?,top_cases_counts_by_genes
+1096,PXN,H524Y,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have PXN and EFCAB12 mutations?,top_cases_counts_by_genes
+1097,PXN,H526Y,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have PXN and SLC6A4 mutations?,top_cases_counts_by_genes
+1098,PXN,H540Y,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have PXN and TAF1C mutations?,top_cases_counts_by_genes
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have TTYH2 and DPF3 mutations?,top_cases_counts_by_genes
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have TTYH2 and DCN mutations?,top_cases_counts_by_genes
+1106,TMEM255A,N205S,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have TMEM255A and POLR1G mutations?,top_cases_counts_by_genes
+1107,TMEM255A,N229S,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have TMEM255A and PYHIN1 mutations?,top_cases_counts_by_genes
+1108,TMEM255A,N65S,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have TMEM255A and RIPOR2 mutations?,top_cases_counts_by_genes
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,Do a substantial number of Breast Invasive Carcinoma not have TASOR2 and SPINDOC mutations?,top_cases_counts_by_genes
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,Do a substantial number of Breast Invasive Carcinoma not have TASOR2 and TAF1C mutations?,top_cases_counts_by_genes
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have ICE1 and KDM5C mutations?,top_cases_counts_by_genes
+1112,MYT1,A558E,Breast Invasive Carcinoma,Do a substantial number of Breast Invasive Carcinoma not have MYT1 and SGIP1 mutations?,top_cases_counts_by_genes
+1113,MYT1,A879E,Breast Invasive Carcinoma,Do a substantial number of Breast Invasive Carcinoma not have MYT1 and FNDC7 mutations?,top_cases_counts_by_genes
+1114,MYT1,A906E,Breast Invasive Carcinoma,Do a substantial number of Breast Invasive Carcinoma not have MYT1 and EPRS1 mutations?,top_cases_counts_by_genes
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have CX3CR1 and ZNF431 mutations?,top_cases_counts_by_genes
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have CX3CR1 and XKR4 mutations?,top_cases_counts_by_genes
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,Do a substantial number of Liver Hepatocellular Carcinoma not have SPINDOC and MAST4 mutations?,top_cases_counts_by_genes
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have ART3 and TSHZ3 mutations?,top_cases_counts_by_genes
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have ART3 and KRT39 mutations?,top_cases_counts_by_genes
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,Do a substantial number of Bladder Urothelial Carcinoma not have CYP1A2 and ACTA2 mutations?,top_cases_counts_by_genes
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Do a substantial number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus not have ADRA1A and PIK3C2G mutations?",top_cases_counts_by_genes
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have CDH23 and DCAF6 mutations?,top_cases_counts_by_genes
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have CDH23 and PTPRO mutations?,top_cases_counts_by_genes
+1148,KRT39,P137S,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have KRT39 and MYT1 mutations?,top_cases_counts_by_genes
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have PDHA2 and PTPRO mutations?,top_cases_counts_by_genes
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have SLC24A2 and TLCD5 mutations?,top_cases_counts_by_genes
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,Do a substantial number of Liver Hepatocellular Carcinoma not have PTPRN2 and FGF8 mutations?,top_cases_counts_by_genes
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,Do a substantial number of Liver Hepatocellular Carcinoma not have PTPRN2 and AUTS2 mutations?,top_cases_counts_by_genes
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,Do a substantial number of Liver Hepatocellular Carcinoma not have PTPRN2 and POC1B mutations?,top_cases_counts_by_genes
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,Do a substantial number of Liver Hepatocellular Carcinoma not have PTPRN2 and FGF8 mutations?,top_cases_counts_by_genes
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,Do a substantial number of Liver Hepatocellular Carcinoma not have PTPRN2 and GRM1 mutations?,top_cases_counts_by_genes
+1188,SOX21,R55L,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have SOX21 and RIMS2 mutations?,top_cases_counts_by_genes
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,Do a substantial number of Bladder Urothelial Carcinoma not have CPA6 and TET2 mutations?,top_cases_counts_by_genes
+1206,GRM5,E14K,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have GRM5 and PLEKHG6 mutations?,top_cases_counts_by_genes
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Do a substantial number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus not have CASZ1 and UNC5D mutations?",top_cases_counts_by_genes
+1210,SGIP1,N122T,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have SGIP1 and POC1B mutations?,top_cases_counts_by_genes
+1211,SGIP1,N420T,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have SGIP1 and GABRA6 mutations?,top_cases_counts_by_genes
+1212,SGIP1,N617T,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have SGIP1 and TMEM225 mutations?,top_cases_counts_by_genes
+1213,SGIP1,N648T,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have SGIP1 and CTSC mutations?,top_cases_counts_by_genes
+1227,CARMIL1,V549L,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have CARMIL1 and HTR3B mutations?,top_cases_counts_by_genes
+1228,CARMIL1,V949L,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have CARMIL1 and DCN mutations?,top_cases_counts_by_genes
+1232,ZNF431,D121Y,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have ZNF431 and CPA6 mutations?,top_cases_counts_by_genes
+1233,ZNF431,D161Y,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have ZNF431 and PAPPA mutations?,top_cases_counts_by_genes
+1234,ZNF431,R128I,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have ZNF431 and MAD1L1 mutations?,top_cases_counts_by_genes
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have DNAH11 and ITPRID2 mutations?,top_cases_counts_by_genes
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have DNAH11 and YY1AP1 mutations?,top_cases_counts_by_genes
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have POLD1 and RIPOR2 mutations?,top_cases_counts_by_genes
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,Do a substantial number of Lung Squamous Cell Carcinoma not have POLD1 and PIK3C2B mutations?,top_cases_counts_by_genes
+1248,TTC12,D646H,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have TTC12 and SORCS1 mutations?,top_cases_counts_by_genes
+1249,TTC12,D652H,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have TTC12 and PRSS1 mutations?,top_cases_counts_by_genes
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,Do a substantial number of Bladder Urothelial Carcinoma not have CNGB1 and GPC3 mutations?,top_cases_counts_by_genes
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,Do a substantial number of Bladder Urothelial Carcinoma not have CNGB1 and SLC24A2 mutations?,top_cases_counts_by_genes
+1254,CTSC,E214V,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have CTSC and EBF2 mutations?,top_cases_counts_by_genes
+1255,CTSC,E291V,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have CTSC and MYO3B mutations?,top_cases_counts_by_genes
+1256,CTSC,E322V,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have CTSC and ANKDD1A mutations?,top_cases_counts_by_genes
+1257,CTSC,E324V,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have CTSC and POC1B mutations?,top_cases_counts_by_genes
+1258,CTSC,E335V,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have CTSC and TLK2 mutations?,top_cases_counts_by_genes
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have PRSS8 and TENT5A mutations?,top_cases_counts_by_genes
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have PRSS8 and ZMYM3 mutations?,top_cases_counts_by_genes
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have ARHGEF40 and TTN mutations?,top_cases_counts_by_genes
+1264,ACTB,A138T,Rectum Adenocarcinoma,Do a substantial number of Rectum Adenocarcinoma not have ACTB and TRPA1 mutations?,top_cases_counts_by_genes
+1265,ACTB,A217T,Rectum Adenocarcinoma,Do a substantial number of Rectum Adenocarcinoma not have ACTB and MRPL55 mutations?,top_cases_counts_by_genes
+1266,ACTB,A244T,Rectum Adenocarcinoma,Do a substantial number of Rectum Adenocarcinoma not have ACTB and AUTS2 mutations?,top_cases_counts_by_genes
+1267,ACTB,A260T,Rectum Adenocarcinoma,Do a substantial number of Rectum Adenocarcinoma not have ACTB and EIF2B4 mutations?,top_cases_counts_by_genes
+1268,YY1AP1,V546D,Glioblastoma Multiforme,Do a substantial number of Glioblastoma Multiforme not have YY1AP1 and MAST4 mutations?,top_cases_counts_by_genes
+1269,YY1AP1,V557D,Glioblastoma Multiforme,Do a substantial number of Glioblastoma Multiforme not have YY1AP1 and FMO4 mutations?,top_cases_counts_by_genes
+1270,YY1AP1,V566D,Glioblastoma Multiforme,Do a substantial number of Glioblastoma Multiforme not have YY1AP1 and DCC mutations?,top_cases_counts_by_genes
+1271,YY1AP1,V577D,Glioblastoma Multiforme,Do a substantial number of Glioblastoma Multiforme not have YY1AP1 and ZNF708 mutations?,top_cases_counts_by_genes
+1272,YY1AP1,V623D,Glioblastoma Multiforme,Do a substantial number of Glioblastoma Multiforme not have YY1AP1 and SMO mutations?,top_cases_counts_by_genes
+1273,YY1AP1,V695D,Glioblastoma Multiforme,Do a substantial number of Glioblastoma Multiforme not have YY1AP1 and PRSS1 mutations?,top_cases_counts_by_genes
+1274,YY1AP1,V715D,Glioblastoma Multiforme,Do a substantial number of Glioblastoma Multiforme not have YY1AP1 and OR13C3 mutations?,top_cases_counts_by_genes
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have FNDC7 and ZNF431 mutations?,top_cases_counts_by_genes
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have FNDC7 and RIMS2 mutations?,top_cases_counts_by_genes
+1299,TLCD5,G15V,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have TLCD5 and FGF8 mutations?,top_cases_counts_by_genes
+1300,TLCD5,G37V,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have TLCD5 and DNMT1 mutations?,top_cases_counts_by_genes
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have POLR1G and ZCCHC14 mutations?,top_cases_counts_by_genes
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have POLR1G and PTPRN2 mutations?,top_cases_counts_by_genes
+1308,DNAH14,N1186K,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have DNAH14 and GPC3 mutations?,top_cases_counts_by_genes
+1309,DNAH14,N2657K,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have DNAH14 and ZCCHC14 mutations?,top_cases_counts_by_genes
+1310,DNAH14,N3460K,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have DNAH14 and RIMS2 mutations?,top_cases_counts_by_genes
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have NEXN and MIEF1 mutations?,top_cases_counts_by_genes
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,Do a substantial number of Prostate Adenocarcinoma not have CYB5R2 and TRAP1 mutations?,top_cases_counts_by_genes
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,Do a substantial number of Prostate Adenocarcinoma not have CYB5R2 and DCAF4L2 mutations?,top_cases_counts_by_genes
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have NRAP and ZCCHC14 mutations?,top_cases_counts_by_genes
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have NRAP and MIEF1 mutations?,top_cases_counts_by_genes
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have NRAP and ANKRD24 mutations?,top_cases_counts_by_genes
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have CCDC22 and PTPRO mutations?,top_cases_counts_by_genes
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have DCAF6 and TRAP1 mutations?,top_cases_counts_by_genes
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have DCAF6 and ANKDD1A mutations?,top_cases_counts_by_genes
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have ZNF708 and TLK2 mutations?,top_cases_counts_by_genes
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have BFAR and PYHIN1 mutations?,top_cases_counts_by_genes
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have MAST4 and CFAP61 mutations?,top_cases_counts_by_genes
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have MAST4 and MERTK mutations?,top_cases_counts_by_genes
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have MAST4 and DCN mutations?,top_cases_counts_by_genes
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have MAST4 and ANKRD52 mutations?,top_cases_counts_by_genes
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have MAST4 and DGKD mutations?,top_cases_counts_by_genes
+1363,ARMC3,R169C,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have ARMC3 and ICE1 mutations?,top_cases_counts_by_genes
+1364,ARMC3,R432C,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have ARMC3 and ANKRD30A mutations?,top_cases_counts_by_genes
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,Do a substantial number of Kidney Renal Clear Cell Carcinoma not have TET2 and CPA6 mutations?,top_cases_counts_by_genes
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,Do a substantial number of Kidney Renal Clear Cell Carcinoma not have TET2 and DCN mutations?,top_cases_counts_by_genes
+1369,SERPINB10,A353P,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have SERPINB10 and ANKRD52 mutations?,top_cases_counts_by_genes
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have STAT3 and PTPRN2 mutations?,top_cases_counts_by_genes
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have MIEF1 and PTPRN2 mutations?,top_cases_counts_by_genes
+1381,ACVR1B,D397N,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have ACVR1B and POC1B mutations?,top_cases_counts_by_genes
+1382,ACVR1B,D449N,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have ACVR1B and MORF4L1 mutations?,top_cases_counts_by_genes
+1383,ACVR1B,D490N,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have ACVR1B and ACVR1B mutations?,top_cases_counts_by_genes
+1393,EBF2,T104I,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have EBF2 and MYO15A mutations?,top_cases_counts_by_genes
+1394,EBF2,T252I,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have EBF2 and CCDC22 mutations?,top_cases_counts_by_genes
+1402,VPS26B,F266L,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have VPS26B and ANP32E mutations?,top_cases_counts_by_genes
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Do a substantial number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus not have PGR and PGF mutations?",top_cases_counts_by_genes
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Do a substantial number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus not have PGR and SPTAN1 mutations?",top_cases_counts_by_genes
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Do a substantial number of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus not have PGR and MYO16 mutations?",top_cases_counts_by_genes
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,Do a substantial number of Skin Cutaneous Melanoma not have ACTA2 and EPRS1 mutations?,top_cases_counts_by_genes
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have THBS4 and ANKDD1A mutations?,top_cases_counts_by_genes
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have THBS4 and TTN mutations?,top_cases_counts_by_genes
+1413,PRSS1,S114T,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have PRSS1 and OR8K5 mutations?,top_cases_counts_by_genes
+1414,PRSS1,S124T,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have PRSS1 and OR5D14 mutations?,top_cases_counts_by_genes
+1415,PRSS1,S138T,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have PRSS1 and PTPRO mutations?,top_cases_counts_by_genes
+1416,PRSS1,S74T,Lung Adenocarcinoma,Do a substantial number of Lung Adenocarcinoma not have PRSS1 and CHMP7 mutations?,top_cases_counts_by_genes
+1417,PGF,R126H,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have PGF and RIMS2 mutations?,top_cases_counts_by_genes
+1418,PGF,R127H,Stomach Adenocarcinoma,Do a substantial number of Stomach Adenocarcinoma not have PGF and ZBTB34 mutations?,top_cases_counts_by_genes
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,Do a substantial number of Breast Invasive Carcinoma not have ITPRID2 and ZFAT mutations?,top_cases_counts_by_genes
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,Do a substantial number of Breast Invasive Carcinoma not have ITPRID2 and TENM2 mutations?,top_cases_counts_by_genes
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have HBB and MYH11 mutations?,top_cases_counts_by_genes
+1441,PCDHB2,R158C,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have PCDHB2 and TLK2 mutations?,top_cases_counts_by_genes
+1442,PCDHB2,T15M,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have PCDHB2 and SYT9 mutations?,top_cases_counts_by_genes
+1443,PCDHB2,T26M,Colon Adenocarcinoma,Do a substantial number of Colon Adenocarcinoma not have PCDHB2 and SGCZ mutations?,top_cases_counts_by_genes
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,Do a substantial number of Uterine Corpus Endometrial Carcinoma not have UBR2 and MYO15A mutations?,top_cases_counts_by_genes
+1452,FBXO42,A618D,Rectum Adenocarcinoma,Do a substantial number of Rectum Adenocarcinoma not have FBXO42 and ABCC2 mutations?,top_cases_counts_by_genes
+1,TNS1,G1362V,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases is without TNS1 and ANKRD30A mutations?,top_cases_counts_by_genes
+2,TNS1,G1711V,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases is without TNS1 and KL mutations?,top_cases_counts_by_genes
+3,TNS1,G1718V,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases is without TNS1 and MYH11 mutations?,top_cases_counts_by_genes
+4,TNS1,G1732V,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases is without TNS1 and MYH11 mutations?,top_cases_counts_by_genes
+5,TNS1,G1824V,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases is without TNS1 and EVC2 mutations?,top_cases_counts_by_genes
+6,TNS1,G1857V,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases is without TNS1 and TNS1 mutations?,top_cases_counts_by_genes
+7,TNS1,G843V,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases is without TNS1 and TAF1C mutations?,top_cases_counts_by_genes
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases is without EVC2 and GRTP1 mutations?,top_cases_counts_by_genes
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases is without EVC2 and TASOR2 mutations?,top_cases_counts_by_genes
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without CR1 and MYO3B mutations?,top_cases_counts_by_genes
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without CR1 and PGR mutations?,top_cases_counts_by_genes
+22,TRPA1,S295I,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases is without TRPA1 and GPC3 mutations?,top_cases_counts_by_genes
+23,TRPA1,S443I,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases is without TRPA1 and PTPRO mutations?,top_cases_counts_by_genes
+24,TAF1C,R299L,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without TAF1C and ART3 mutations?,top_cases_counts_by_genes
+25,TAF1C,R396L,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without TAF1C and TTC12 mutations?,top_cases_counts_by_genes
+26,TAF1C,R634L,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without TAF1C and MAST4 mutations?,top_cases_counts_by_genes
+27,TAF1C,R702L,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without TAF1C and AKT1 mutations?,top_cases_counts_by_genes
+28,TAF1C,R728L,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without TAF1C and GLRB mutations?,top_cases_counts_by_genes
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without DPF3 and HYOU1 mutations?,top_cases_counts_by_genes
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without DPF3 and MYT1 mutations?,top_cases_counts_by_genes
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without DPF3 and SYNJ1 mutations?,top_cases_counts_by_genes
+42,OR2T4,P272H,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without OR2T4 and ADRA1A mutations?,top_cases_counts_by_genes
+43,OR2T4,P300H,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without OR2T4 and AQP7 mutations?,top_cases_counts_by_genes
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What share of Pancreatic Adenocarcinoma cases is without FBN1 and CA9 mutations?,top_cases_counts_by_genes
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What share of Prostate Adenocarcinoma cases is without MAD1L1 and ITPRID2 mutations?,top_cases_counts_by_genes
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What share of Prostate Adenocarcinoma cases is without MAD1L1 and CYB5R2 mutations?,top_cases_counts_by_genes
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What share of Prostate Adenocarcinoma cases is without MAD1L1 and GPC3 mutations?,top_cases_counts_by_genes
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without CCNG1 and PTPRO mutations?,top_cases_counts_by_genes
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What share of Kidney Renal Papillary Cell Carcinoma cases is without ANP32E and UBR2 mutations?,top_cases_counts_by_genes
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What share of Kidney Renal Papillary Cell Carcinoma cases is without ANP32E and PDGFC mutations?,top_cases_counts_by_genes
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What share of Kidney Renal Papillary Cell Carcinoma cases is without ANP32E and PLEKHG6 mutations?,top_cases_counts_by_genes
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What share of Kidney Renal Papillary Cell Carcinoma cases is without ANP32E and DOCK2 mutations?,top_cases_counts_by_genes
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases is without FRY and ZFAT mutations?,top_cases_counts_by_genes
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases is without FRY and PDGFC mutations?,top_cases_counts_by_genes
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases is without FRY and KRT39 mutations?,top_cases_counts_by_genes
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases is without FRY and PGF mutations?,top_cases_counts_by_genes
+70,PAK3,E318K,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without PAK3 and MRPL55 mutations?,top_cases_counts_by_genes
+71,PAK3,E319K,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without PAK3 and PSG2 mutations?,top_cases_counts_by_genes
+72,PAK3,E334K,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without PAK3 and JAML mutations?,top_cases_counts_by_genes
+73,PAK3,E340K,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without PAK3 and NOMO1 mutations?,top_cases_counts_by_genes
+74,PAK3,E355K,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without PAK3 and EBF2 mutations?,top_cases_counts_by_genes
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without MUC16 and PTPRO mutations?,top_cases_counts_by_genes
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What share of Liver Hepatocellular Carcinoma cases is without ZFPM2 and C7orf31 mutations?,top_cases_counts_by_genes
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What share of Liver Hepatocellular Carcinoma cases is without ZFPM2 and RIMS2 mutations?,top_cases_counts_by_genes
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases is without PIK3C2B and POC1B mutations?,top_cases_counts_by_genes
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases is without PIK3C2B and RAB40C mutations?,top_cases_counts_by_genes
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without ZNF804A and GSTCD mutations?,top_cases_counts_by_genes
+116,RELN,A2371V,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without RELN and GUK1 mutations?,top_cases_counts_by_genes
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases is without EFCAB12 and PXN mutations?",top_cases_counts_by_genes
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases is without EFCAB12 and JAML mutations?",top_cases_counts_by_genes
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without DEFB115 and PGF mutations?,top_cases_counts_by_genes
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases is without ANKDD1A and OLFML3 mutations?,top_cases_counts_by_genes
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases is without ANKDD1A and PIK3C2B mutations?,top_cases_counts_by_genes
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases is without ANKDD1A and KDM5C mutations?,top_cases_counts_by_genes
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without HTR3B and TLK2 mutations?,top_cases_counts_by_genes
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without HTR3B and TASOR2 mutations?,top_cases_counts_by_genes
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without HTR3B and CHMP7 mutations?,top_cases_counts_by_genes
+129,ABCC3,R758W,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without ABCC3 and SPAG1 mutations?,top_cases_counts_by_genes
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without NOMO1 and CHODL mutations?,top_cases_counts_by_genes
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without NOMO1 and GUK1 mutations?,top_cases_counts_by_genes
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases is without HYOU1 and TASOR2 mutations?,top_cases_counts_by_genes
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without FMO4 and UNC5D mutations?,top_cases_counts_by_genes
+140,BICC1,A372V,Exceptional Responders,What share of Exceptional Responders cases is without BICC1 and ANKRD24 mutations?,top_cases_counts_by_genes
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without ZMYM3 and TRIM45 mutations?,top_cases_counts_by_genes
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without ZMYM3 and EIF2B4 mutations?,top_cases_counts_by_genes
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without ZMYM3 and EFCAB12 mutations?,top_cases_counts_by_genes
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases is without XKR4 and XKR4 mutations?",top_cases_counts_by_genes
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What share of Liver Hepatocellular Carcinoma cases is without ABCC2 and EIF2B4 mutations?,top_cases_counts_by_genes
+157,OR8K5,R293G,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without OR8K5 and PCDHB2 mutations?,top_cases_counts_by_genes
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without SPTAN1 and GRTP1 mutations?,top_cases_counts_by_genes
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without SPTAN1 and PAK3 mutations?,top_cases_counts_by_genes
+164,SYT10,M484I,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases is without SYT10 and PTPRO mutations?,top_cases_counts_by_genes
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without HSPA5 and FGF8 mutations?,top_cases_counts_by_genes
+175,UNC5D,L280V,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without UNC5D and DSCAM mutations?,top_cases_counts_by_genes
+176,UNC5D,L635V,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without UNC5D and TTC12 mutations?,top_cases_counts_by_genes
+177,UNC5D,L637V,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without UNC5D and TTYH2 mutations?,top_cases_counts_by_genes
+178,UNC5D,L699V,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without UNC5D and TENT5A mutations?,top_cases_counts_by_genes
+179,UNC5D,L704V,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without UNC5D and ZNF804A mutations?,top_cases_counts_by_genes
+180,UNC5D,L709V,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without UNC5D and GABRA6 mutations?,top_cases_counts_by_genes
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What share of Kidney Renal Clear Cell Carcinoma cases is without DOCK2 and TYROBP mutations?,top_cases_counts_by_genes
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What share of Kidney Renal Clear Cell Carcinoma cases is without ZNF627 and MAD1L1 mutations?,top_cases_counts_by_genes
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without CDC42BPA and PTPRO mutations?,top_cases_counts_by_genes
+193,MRPL55,H27Y,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without MRPL55 and ITPRID2 mutations?,top_cases_counts_by_genes
+194,MRPL55,H63Y,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without MRPL55 and PTPRN2 mutations?,top_cases_counts_by_genes
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases is without TMTC3 and KDM5C mutations?,top_cases_counts_by_genes
+198,EPRS1,K771I,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without EPRS1 and SORCS1 mutations?,top_cases_counts_by_genes
+199,EPRS1,K778I,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without EPRS1 and ZSCAN31 mutations?,top_cases_counts_by_genes
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without GRTP1 and IL5RA mutations?,top_cases_counts_by_genes
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without GRTP1 and PTPRO mutations?,top_cases_counts_by_genes
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without TSHZ3 and ANP32E mutations?,top_cases_counts_by_genes
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What share of HIV+ Tumor Molecular Characterization Project - Cervical Cancer cases is without TAS1R3 and SPATA22 mutations?,top_cases_counts_by_genes
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without PIAS3 and MRPL55 mutations?,top_cases_counts_by_genes
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without PIAS3 and PTPRO mutations?,top_cases_counts_by_genes
+251,ZNF274,P13R,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without ZNF274 and TLK2 mutations?,top_cases_counts_by_genes
+253,SYNJ1,R795C,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without SYNJ1 and FCGR2C mutations?,top_cases_counts_by_genes
+254,SYNJ1,R800C,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without SYNJ1 and TENT5A mutations?,top_cases_counts_by_genes
+255,SYNJ1,R839C,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without SYNJ1 and TAS1R3 mutations?,top_cases_counts_by_genes
+261,DSCAM,V343M,Prostate Adenocarcinoma,What share of Prostate Adenocarcinoma cases is without DSCAM and MERTK mutations?,top_cases_counts_by_genes
+262,DSCAM,V426M,Prostate Adenocarcinoma,What share of Prostate Adenocarcinoma cases is without DSCAM and MAD1L1 mutations?,top_cases_counts_by_genes
+263,DSCAM,V591M,Prostate Adenocarcinoma,What share of Prostate Adenocarcinoma cases is without DSCAM and SPTAN1 mutations?,top_cases_counts_by_genes
+267,DGKD,R140H,Exceptional Responders,What share of Exceptional Responders cases is without DGKD and KDM5C mutations?,top_cases_counts_by_genes
+268,DGKD,R160H,Exceptional Responders,What share of Exceptional Responders cases is without DGKD and ANKRD24 mutations?,top_cases_counts_by_genes
+269,DGKD,R204H,Exceptional Responders,What share of Exceptional Responders cases is without DGKD and DCAF6 mutations?,top_cases_counts_by_genes
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases is without PLEKHG6 and EIF2B4 mutations?,top_cases_counts_by_genes
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases is without PLEKHG6 and TENM2 mutations?,top_cases_counts_by_genes
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases is without PLEKHG6 and KDM5C mutations?,top_cases_counts_by_genes
+279,WNT2,D138N,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without WNT2 and EIF2B4 mutations?,top_cases_counts_by_genes
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without GUCY2C and GRM1 mutations?,top_cases_counts_by_genes
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without C7orf31 and CYB5R2 mutations?,top_cases_counts_by_genes
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases is without ZKSCAN7 and TNS1 mutations?",top_cases_counts_by_genes
+299,OR5D14,M210L,Neuroblastoma,What share of Neuroblastoma cases is without OR5D14 and CTCFL mutations?,top_cases_counts_by_genes
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without SPATA22 and ART3 mutations?,top_cases_counts_by_genes
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without SPATA22 and ZCCHC14 mutations?,top_cases_counts_by_genes
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without SPATA22 and EVC2 mutations?,top_cases_counts_by_genes
+310,LCN15,E21V,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without LCN15 and RIMS2 mutations?,top_cases_counts_by_genes
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without DCAF4L2 and PAK3 mutations?,top_cases_counts_by_genes
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without GUK1 and CNGB1 mutations?,top_cases_counts_by_genes
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without GUK1 and NPSR1 mutations?,top_cases_counts_by_genes
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without GUK1 and GUK1 mutations?,top_cases_counts_by_genes
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without GUK1 and GABRA6 mutations?,top_cases_counts_by_genes
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without GUK1 and CHMP7 mutations?,top_cases_counts_by_genes
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without MORF4L1 and PGR mutations?,top_cases_counts_by_genes
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without MORF4L1 and ZMYM3 mutations?,top_cases_counts_by_genes
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without MORF4L1 and MYO15A mutations?,top_cases_counts_by_genes
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without MORF4L1 and MYO16 mutations?,top_cases_counts_by_genes
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without MYO3B and NOMO1 mutations?,top_cases_counts_by_genes
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without MYO3B and GUCY2C mutations?,top_cases_counts_by_genes
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without TENT5A and HSPA5 mutations?,top_cases_counts_by_genes
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without TENT5A and CACNA1F mutations?,top_cases_counts_by_genes
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without TENT5A and WNT2 mutations?,top_cases_counts_by_genes
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What share of Ovarian Serous Cystadenocarcinoma cases is without ZFAT and CDC42BPA mutations?,top_cases_counts_by_genes
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What share of Ovarian Serous Cystadenocarcinoma cases is without ZFAT and KDM5C mutations?,top_cases_counts_by_genes
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What share of Ovarian Serous Cystadenocarcinoma cases is without ZFAT and RIMS2 mutations?,top_cases_counts_by_genes
+357,ZNF584,A211T,Sarcoma,What share of Sarcoma cases is without ZNF584 and BCAT1 mutations?,top_cases_counts_by_genes
+358,ZNF584,A256T,Sarcoma,What share of Sarcoma cases is without ZNF584 and TRPA1 mutations?,top_cases_counts_by_genes
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without LDOC1 and TTN mutations?,top_cases_counts_by_genes
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without PDGFC and SMO mutations?,top_cases_counts_by_genes
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without MSANTD4 and SORCS1 mutations?,top_cases_counts_by_genes
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without NPSR1 and PTPRO mutations?,top_cases_counts_by_genes
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without PHLPP1 and KANSL1 mutations?,top_cases_counts_by_genes
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without COL6A3 and GUK1 mutations?,top_cases_counts_by_genes
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without COL6A3 and WNT2 mutations?,top_cases_counts_by_genes
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without COL6A3 and TASOR2 mutations?,top_cases_counts_by_genes
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without COL6A3 and OR2T4 mutations?,top_cases_counts_by_genes
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without COL6A3 and PRSS1 mutations?,top_cases_counts_by_genes
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without ADRA1A and ACTB mutations?,top_cases_counts_by_genes
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What share of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases is without LAMB2 and ANKRD30A mutations?,top_cases_counts_by_genes
+406,POC1B,I198T,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases is without POC1B and UNC5D mutations?,top_cases_counts_by_genes
+407,POC1B,I286T,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases is without POC1B and PYHIN1 mutations?,top_cases_counts_by_genes
+408,POC1B,I328T,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases is without POC1B and PIK3C2B mutations?,top_cases_counts_by_genes
+409,POC1B,S79P,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases is without POC1B and TENT5A mutations?,top_cases_counts_by_genes
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What share of Liver Hepatocellular Carcinoma cases is without USH2A and ZNF584 mutations?,top_cases_counts_by_genes
+414,AQP7,T110S,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases is without AQP7 and RIPOR2 mutations?,top_cases_counts_by_genes
+415,AQP7,T166S,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases is without AQP7 and FNDC7 mutations?,top_cases_counts_by_genes
+416,AQP7,T167S,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases is without AQP7 and CTCFL mutations?,top_cases_counts_by_genes
+417,AQP7,T75S,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases is without AQP7 and COL6A3 mutations?,top_cases_counts_by_genes
+430,DCN,R163C,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases is without DCN and GSTCD mutations?,top_cases_counts_by_genes
+431,DCN,R203C,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases is without DCN and ANP32E mutations?,top_cases_counts_by_genes
+432,DCN,R241C,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases is without DCN and PIK3C2B mutations?,top_cases_counts_by_genes
+433,DCN,R350C,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases is without DCN and AQP7 mutations?,top_cases_counts_by_genes
+434,DCN,R41C,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases is without DCN and TTN mutations?,top_cases_counts_by_genes
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without CPS1 and SLC9C1 mutations?,top_cases_counts_by_genes
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without CPS1 and CTSC mutations?,top_cases_counts_by_genes
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without CPS1 and MYO3B mutations?,top_cases_counts_by_genes
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What share of Kidney Renal Papillary Cell Carcinoma cases is without FCGR2C and CX3CR1 mutations?,top_cases_counts_by_genes
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What share of Kidney Renal Papillary Cell Carcinoma cases is without FCGR2C and MYO3B mutations?,top_cases_counts_by_genes
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without GRM1 and TENT5A mutations?,top_cases_counts_by_genes
+482,SGCZ,Q138H,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without SGCZ and DNAH11 mutations?,top_cases_counts_by_genes
+483,SGCZ,Q91H,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without SGCZ and TTYH2 mutations?,top_cases_counts_by_genes
+485,SMO,V15M,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without SMO and PCDHB2 mutations?,top_cases_counts_by_genes
+486,SMO,V321M,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without SMO and TLCD5 mutations?,top_cases_counts_by_genes
+488,CHODL,G159E,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without CHODL and GABRA6 mutations?,top_cases_counts_by_genes
+489,CHODL,G181E,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without CHODL and MERTK mutations?,top_cases_counts_by_genes
+490,CHODL,G200E,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without CHODL and TMEM255A mutations?,top_cases_counts_by_genes
+494,MYO16,P399H,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without MYO16 and POLD1 mutations?,top_cases_counts_by_genes
+495,MYO16,P421H,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without MYO16 and TTC17 mutations?,top_cases_counts_by_genes
+498,CXCR2,A98V,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without CXCR2 and PTPRO mutations?,top_cases_counts_by_genes
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases is without TMEM225 and GRTP1 mutations?,top_cases_counts_by_genes
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without MAOB and ZCCHC14 mutations?,top_cases_counts_by_genes
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without GPRASP1 and SGCZ mutations?,top_cases_counts_by_genes
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without MRPL32 and ZCCHC14 mutations?,top_cases_counts_by_genes
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without TYROBP and SMO mutations?,top_cases_counts_by_genes
+510,RAB40C,A111V,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without RAB40C and TRAP1 mutations?,top_cases_counts_by_genes
+511,RAB40C,A143V,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without RAB40C and STK19 mutations?,top_cases_counts_by_genes
+512,CTNNA2,S323R,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without CTNNA2 and UBR2 mutations?,top_cases_counts_by_genes
+513,CTNNA2,S339R,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without CTNNA2 and ARHGEF40 mutations?,top_cases_counts_by_genes
+514,CTNNA2,S386R,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without CTNNA2 and FGF8 mutations?,top_cases_counts_by_genes
+515,CTNNA2,S707R,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without CTNNA2 and MSANTD4 mutations?,top_cases_counts_by_genes
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases is without MYO15A and ZFAT mutations?,top_cases_counts_by_genes
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without GIMAP2 and TTC17 mutations?,top_cases_counts_by_genes
+532,KIF20B,N1160D,Glioblastoma Multiforme,What share of Glioblastoma Multiforme cases is without KIF20B and SGIP1 mutations?,top_cases_counts_by_genes
+533,KIF20B,N1200D,Glioblastoma Multiforme,What share of Glioblastoma Multiforme cases is without KIF20B and AUTS2 mutations?,top_cases_counts_by_genes
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without ADAM17 and CTNNA2 mutations?,top_cases_counts_by_genes
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without BCAT1 and OR2T4 mutations?,top_cases_counts_by_genes
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without BCAT1 and ANP32E mutations?,top_cases_counts_by_genes
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without BCAT1 and ANKRD24 mutations?,top_cases_counts_by_genes
+540,ERCC6,R1053H,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without ERCC6 and TASOR2 mutations?,top_cases_counts_by_genes
+541,DCC,R320W,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases is without DCC and CTSC mutations?,top_cases_counts_by_genes
+542,DCC,R363W,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases is without DCC and ZNF431 mutations?,top_cases_counts_by_genes
+543,DCC,R386W,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases is without DCC and PGR mutations?,top_cases_counts_by_genes
+544,DCC,R41W,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases is without DCC and CX3CR1 mutations?,top_cases_counts_by_genes
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without FBXO15 and USH2A mutations?,top_cases_counts_by_genes
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without FBXO15 and PIK3C2B mutations?,top_cases_counts_by_genes
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without GSTCD and ACTL7B mutations?,top_cases_counts_by_genes
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without GSTCD and TRAP1 mutations?,top_cases_counts_by_genes
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without OLFML3 and MAD1L1 mutations?,top_cases_counts_by_genes
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without OLFML3 and PIAS3 mutations?,top_cases_counts_by_genes
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without OLFML3 and PXN mutations?,top_cases_counts_by_genes
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What share of Ovarian Serous Cystadenocarcinoma cases is without CFAP61 and PGR mutations?,top_cases_counts_by_genes
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What share of Ovarian Serous Cystadenocarcinoma cases is without CFAP61 and NRAP mutations?,top_cases_counts_by_genes
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases is without HLA-DQA2 and AKT1 mutations?,top_cases_counts_by_genes
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without TENM2 and PSG2 mutations?,top_cases_counts_by_genes
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without TENM2 and SGIP1 mutations?,top_cases_counts_by_genes
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without TENM2 and DNMT1 mutations?,top_cases_counts_by_genes
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without ANKRD24 and GRTP1 mutations?,top_cases_counts_by_genes
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without ANKRD24 and CXCR2 mutations?,top_cases_counts_by_genes
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without ANKRD24 and PIK3C2A mutations?,top_cases_counts_by_genes
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without ZCCHC14 and NCKAP5 mutations?,top_cases_counts_by_genes
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without ZCCHC14 and SPTAN1 mutations?,top_cases_counts_by_genes
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without ZCCHC14 and PXN mutations?,top_cases_counts_by_genes
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without ZCCHC14 and GRTP1 mutations?,top_cases_counts_by_genes
+625,SIK2,I265M,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without SIK2 and UNC5D mutations?,top_cases_counts_by_genes
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without MYH11 and ANP32E mutations?,top_cases_counts_by_genes
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without MYH11 and CR1 mutations?,top_cases_counts_by_genes
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without SLC6A4 and AQP7 mutations?,top_cases_counts_by_genes
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without SLC9C1 and PLEKHG6 mutations?,top_cases_counts_by_genes
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without SLC9C1 and HYOU1 mutations?,top_cases_counts_by_genes
+644,OR2A12,A254T,Brain Lower Grade Glioma,What share of Brain Lower Grade Glioma cases is without OR2A12 and ANP32E mutations?,top_cases_counts_by_genes
+646,PYHIN1,T325K,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without PYHIN1 and TAS1R3 mutations?,top_cases_counts_by_genes
+647,PYHIN1,T334K,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without PYHIN1 and PTPRN2 mutations?,top_cases_counts_by_genes
+650,JAML,G191E,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without JAML and RIPOR2 mutations?,top_cases_counts_by_genes
+651,JAML,G219E,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without JAML and TRPA1 mutations?,top_cases_counts_by_genes
+652,JAML,G220E,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without JAML and GRTP1 mutations?,top_cases_counts_by_genes
+653,JAML,G230E,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without JAML and AUTS2 mutations?,top_cases_counts_by_genes
+658,TYK2,H1146R,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without TYK2 and SLC9C1 mutations?,top_cases_counts_by_genes
+659,TYK2,H23R,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without TYK2 and HYOU1 mutations?,top_cases_counts_by_genes
+660,TYK2,H961R,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without TYK2 and JAML mutations?,top_cases_counts_by_genes
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without CTCFL and EPRS1 mutations?,top_cases_counts_by_genes
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without CTCFL and FMO4 mutations?,top_cases_counts_by_genes
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without CTCFL and UNC5D mutations?,top_cases_counts_by_genes
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without CTCFL and CPS1 mutations?,top_cases_counts_by_genes
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without CEP20 and MYH11 mutations?,top_cases_counts_by_genes
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without CEP20 and AUTS2 mutations?,top_cases_counts_by_genes
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without RIMS2 and GUCY2C mutations?,top_cases_counts_by_genes
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without RIMS2 and MED16 mutations?,top_cases_counts_by_genes
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without RIMS2 and SGIP1 mutations?,top_cases_counts_by_genes
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without RIMS2 and ANKRD52 mutations?,top_cases_counts_by_genes
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without RIMS2 and GPR158 mutations?,top_cases_counts_by_genes
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without RIMS2 and THBS4 mutations?,top_cases_counts_by_genes
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without RIMS2 and TLK2 mutations?,top_cases_counts_by_genes
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without PIK3C2G and DCN mutations?,top_cases_counts_by_genes
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without PIK3C2G and PXN mutations?,top_cases_counts_by_genes
+728,STK19,D341N,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without STK19 and ANP32E mutations?,top_cases_counts_by_genes
+729,STK19,D345N,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without STK19 and MED16 mutations?,top_cases_counts_by_genes
+730,REXO4,P60A,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without REXO4 and PIK3C2B mutations?,top_cases_counts_by_genes
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without ZBTB34 and RIPOR2 mutations?,top_cases_counts_by_genes
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without ZBTB34 and UBR2 mutations?,top_cases_counts_by_genes
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases is without NCKAP5 and CTCFL mutations?,top_cases_counts_by_genes
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases is without SORCS1 and PTPRO mutations?",top_cases_counts_by_genes
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases is without SORCS1 and STK19 mutations?",top_cases_counts_by_genes
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases is without SORCS1 and RIMS2 mutations?",top_cases_counts_by_genes
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases is without SORCS1 and SGIP1 mutations?",top_cases_counts_by_genes
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What share of Head and Neck Squamous Cell Carcinoma cases is without FGF8 and TAF1C mutations?,top_cases_counts_by_genes
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What share of Head and Neck Squamous Cell Carcinoma cases is without FGF8 and MED16 mutations?,top_cases_counts_by_genes
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What share of Head and Neck Squamous Cell Carcinoma cases is without FGF8 and ICE1 mutations?,top_cases_counts_by_genes
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What share of Head and Neck Squamous Cell Carcinoma cases is without FGF8 and CACNA1F mutations?,top_cases_counts_by_genes
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What share of Head and Neck Squamous Cell Carcinoma cases is without FGF8 and SPTAN1 mutations?,top_cases_counts_by_genes
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What share of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia cases is without TENM3 and CYB5R2 mutations?,top_cases_counts_by_genes
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without AKT1 and PYHIN1 mutations?,top_cases_counts_by_genes
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What share of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases is without CFAP298-TCP10L and JAML mutations?,top_cases_counts_by_genes
+792,GLRB,E148D,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without GLRB and TTC12 mutations?,top_cases_counts_by_genes
+793,TTN,F7636L,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without TTN and OR5D14 mutations?,top_cases_counts_by_genes
+794,TTN,F8563L,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without TTN and FMO4 mutations?,top_cases_counts_by_genes
+795,TTN,F8880L,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without TTN and NRAP mutations?,top_cases_counts_by_genes
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without ANKRD30A and GUK1 mutations?,top_cases_counts_by_genes
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without ANKRD30A and ZNF708 mutations?,top_cases_counts_by_genes
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without ANKRD30A and CTSC mutations?,top_cases_counts_by_genes
+809,TRIM45,S177L,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without TRIM45 and JAML mutations?,top_cases_counts_by_genes
+810,TRIM45,S224L,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without TRIM45 and MYH11 mutations?,top_cases_counts_by_genes
+811,TRIM45,S281L,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without TRIM45 and IL5RA mutations?,top_cases_counts_by_genes
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without CACNA1F and ANKRD52 mutations?,top_cases_counts_by_genes
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without CACNA1F and SLC9C1 mutations?,top_cases_counts_by_genes
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without CACNA1F and DSCAM mutations?,top_cases_counts_by_genes
+817,KL,R594C,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without KL and CHODL mutations?,top_cases_counts_by_genes
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What share of Kidney Renal Papillary Cell Carcinoma cases is without GUF1 and CYB5R2 mutations?,top_cases_counts_by_genes
+822,TAF1L,A539V,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without TAF1L and PIAS3 mutations?,top_cases_counts_by_genes
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without TASOR2 and DGKD mutations?,top_cases_counts_by_genes
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without TASOR2 and SMO mutations?,top_cases_counts_by_genes
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without TASOR2 and ACTB mutations?,top_cases_counts_by_genes
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without KDM5C and CTCFL mutations?,top_cases_counts_by_genes
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without KDM5C and REXO4 mutations?,top_cases_counts_by_genes
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without KDM5C and YY1AP1 mutations?,top_cases_counts_by_genes
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without KDM5C and PTPRO mutations?,top_cases_counts_by_genes
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What share of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases is without IL5RA and TASOR2 mutations?,top_cases_counts_by_genes
+843,DHX16,A29V,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without DHX16 and ITPRID2 mutations?,top_cases_counts_by_genes
+844,DHX16,A89V,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without DHX16 and ABCC3 mutations?,top_cases_counts_by_genes
+902,GPR158,A644V,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without GPR158 and MRPL32 mutations?,top_cases_counts_by_genes
+903,GPR158,A723V,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without GPR158 and RIPOR2 mutations?,top_cases_counts_by_genes
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases is without EIF2B4 and PAK3 mutations?",top_cases_counts_by_genes
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases is without EIF2B4 and PGR mutations?",top_cases_counts_by_genes
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases is without EIF2B4 and DGKD mutations?",top_cases_counts_by_genes
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases is without EIF2B4 and TASOR2 mutations?",top_cases_counts_by_genes
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases is without EIF2B4 and DHX16 mutations?",top_cases_counts_by_genes
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases is without EIF2B4 and SORCS1 mutations?",top_cases_counts_by_genes
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without AUTS2 and TLK2 mutations?,top_cases_counts_by_genes
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without AUTS2 and MYO3B mutations?,top_cases_counts_by_genes
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without AUTS2 and FRY mutations?,top_cases_counts_by_genes
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without AUTS2 and PTPRN2 mutations?,top_cases_counts_by_genes
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without AUTS2 and AUTS2 mutations?,top_cases_counts_by_genes
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without AUTS2 and ANKDD1A mutations?,top_cases_counts_by_genes
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without AUTS2 and TENM3 mutations?,top_cases_counts_by_genes
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without AUTS2 and SOX21 mutations?,top_cases_counts_by_genes
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without AUTS2 and ZCCHC14 mutations?,top_cases_counts_by_genes
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without AUTS2 and DNAH14 mutations?,top_cases_counts_by_genes
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases is without ACTL7B and YY1AP1 mutations?",top_cases_counts_by_genes
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What share of Glioblastoma Multiforme cases is without PCDHGA1 and JAML mutations?,top_cases_counts_by_genes
+954,TRAP1,R114W,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without TRAP1 and COL6A3 mutations?,top_cases_counts_by_genes
+955,TRAP1,R61W,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without TRAP1 and TNS1 mutations?,top_cases_counts_by_genes
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without PIK3C2A and HYOU1 mutations?,top_cases_counts_by_genes
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What share of Liver Hepatocellular Carcinoma cases is without KANSL1 and DCN mutations?,top_cases_counts_by_genes
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without ANKRD52 and DNMT1 mutations?,top_cases_counts_by_genes
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without PAPPA and FRY mutations?,top_cases_counts_by_genes
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases is without B3GALNT1 and SGCZ mutations?,top_cases_counts_by_genes
+982,GABRA6,G115R,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without GABRA6 and YY1AP1 mutations?,top_cases_counts_by_genes
+983,GABRA6,G122R,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without GABRA6 and PHLPP1 mutations?,top_cases_counts_by_genes
+984,GABRA6,G165R,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without GABRA6 and ABCC3 mutations?,top_cases_counts_by_genes
+985,GABRA6,G175R,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without GABRA6 and ANKRD24 mutations?,top_cases_counts_by_genes
+986,GABRA6,G70R,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without GABRA6 and AQP7 mutations?,top_cases_counts_by_genes
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without ZSCAN31 and NRAP mutations?,top_cases_counts_by_genes
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases is without MED16 and PAK3 mutations?",top_cases_counts_by_genes
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases is without MED16 and CTNNA2 mutations?",top_cases_counts_by_genes
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What share of Pancreatic Adenocarcinoma cases is without PTPRO and SPAG1 mutations?,top_cases_counts_by_genes
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What share of Pancreatic Adenocarcinoma cases is without PTPRO and DCLK3 mutations?,top_cases_counts_by_genes
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What share of Pancreatic Adenocarcinoma cases is without PTPRO and CDH23 mutations?,top_cases_counts_by_genes
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What share of Pancreatic Adenocarcinoma cases is without PTPRO and TTC17 mutations?,top_cases_counts_by_genes
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What share of Pancreatic Adenocarcinoma cases is without PTPRO and OLFML3 mutations?,top_cases_counts_by_genes
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What share of Pancreatic Adenocarcinoma cases is without PTPRO and CTCFL mutations?,top_cases_counts_by_genes
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What share of Pancreatic Adenocarcinoma cases is without PTPRO and DCN mutations?,top_cases_counts_by_genes
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What share of Pancreatic Adenocarcinoma cases is without PTPRO and GUF1 mutations?,top_cases_counts_by_genes
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without CHMP7 and AUTS2 mutations?,top_cases_counts_by_genes
+1017,GPC3,I107N,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without GPC3 and TTC17 mutations?,top_cases_counts_by_genes
+1018,GPC3,I161N,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without GPC3 and FBXO15 mutations?,top_cases_counts_by_genes
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What share of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases is without TLK2 and KIF20B mutations?,top_cases_counts_by_genes
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What share of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases is without TLK2 and POC1B mutations?,top_cases_counts_by_genes
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What share of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases is without TLK2 and ABCC3 mutations?,top_cases_counts_by_genes
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What share of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases is without TLK2 and PGF mutations?,top_cases_counts_by_genes
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What share of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases is without TLK2 and ZMYM3 mutations?,top_cases_counts_by_genes
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without ZNF217 and CTCFL mutations?,top_cases_counts_by_genes
+1038,SYT9,V275L,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without SYT9 and PCDHB2 mutations?,top_cases_counts_by_genes
+1039,SYT9,V307L,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without SYT9 and CTCFL mutations?,top_cases_counts_by_genes
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without PKHD1L1 and PIK3C2A mutations?,top_cases_counts_by_genes
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without MYO3A and HSPA5 mutations?,top_cases_counts_by_genes
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases is without VASN and MERTK mutations?",top_cases_counts_by_genes
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without DNMT1 and CCNG1 mutations?,top_cases_counts_by_genes
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without DNMT1 and OLFML3 mutations?,top_cases_counts_by_genes
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without DNMT1 and EVC2 mutations?,top_cases_counts_by_genes
+1056,CA9,E402K,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without CA9 and CYB5R2 mutations?,top_cases_counts_by_genes
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without TTC17 and UNC5D mutations?,top_cases_counts_by_genes
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without TTC17 and ANP32E mutations?,top_cases_counts_by_genes
+1065,PSG2,P43L,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases is without PSG2 and SGIP1 mutations?,top_cases_counts_by_genes
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases is without RIPOR2 and FBXO15 mutations?,top_cases_counts_by_genes
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases is without RIPOR2 and ANKRD24 mutations?,top_cases_counts_by_genes
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases is without RIPOR2 and TENM2 mutations?,top_cases_counts_by_genes
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases is without RIPOR2 and SGIP1 mutations?,top_cases_counts_by_genes
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without DCLK3 and JAML mutations?,top_cases_counts_by_genes
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without DCLK3 and PKHD1L1 mutations?,top_cases_counts_by_genes
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without MERTK and ANP32E mutations?,top_cases_counts_by_genes
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without MERTK and ACTB mutations?,top_cases_counts_by_genes
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without MERTK and ZFAT mutations?,top_cases_counts_by_genes
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without ZFP42 and LAMB2 mutations?,top_cases_counts_by_genes
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without OR13C3 and FMO4 mutations?,top_cases_counts_by_genes
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without OR13C3 and HBB mutations?,top_cases_counts_by_genes
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without SPAG1 and TTC17 mutations?,top_cases_counts_by_genes
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without CDKN2AIP and SLC9C1 mutations?,top_cases_counts_by_genes
+1093,PXN,H1016Y,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without PXN and DCLK3 mutations?,top_cases_counts_by_genes
+1094,PXN,H359Y,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without PXN and ADRA1A mutations?,top_cases_counts_by_genes
+1095,PXN,H492Y,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without PXN and ADRA1A mutations?,top_cases_counts_by_genes
+1096,PXN,H524Y,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without PXN and GRM1 mutations?,top_cases_counts_by_genes
+1097,PXN,H526Y,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without PXN and ACTA2 mutations?,top_cases_counts_by_genes
+1098,PXN,H540Y,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without PXN and PLEKHG6 mutations?,top_cases_counts_by_genes
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without TTYH2 and TNS1 mutations?,top_cases_counts_by_genes
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without TTYH2 and MYO3B mutations?,top_cases_counts_by_genes
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without TMEM255A and C7orf31 mutations?,top_cases_counts_by_genes
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without TMEM255A and SGCZ mutations?,top_cases_counts_by_genes
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without TMEM255A and ARMC3 mutations?,top_cases_counts_by_genes
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases is without TASOR2 and ZNF431 mutations?,top_cases_counts_by_genes
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases is without TASOR2 and GSTCD mutations?,top_cases_counts_by_genes
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without ICE1 and YY1AP1 mutations?,top_cases_counts_by_genes
+1112,MYT1,A558E,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases is without MYT1 and TAF1C mutations?,top_cases_counts_by_genes
+1113,MYT1,A879E,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases is without MYT1 and FBXO15 mutations?,top_cases_counts_by_genes
+1114,MYT1,A906E,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases is without MYT1 and RIPOR2 mutations?,top_cases_counts_by_genes
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without CX3CR1 and JAML mutations?,top_cases_counts_by_genes
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without CX3CR1 and PIK3C2A mutations?,top_cases_counts_by_genes
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What share of Liver Hepatocellular Carcinoma cases is without SPINDOC and KDM5C mutations?,top_cases_counts_by_genes
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without ART3 and PTPRO mutations?,top_cases_counts_by_genes
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without ART3 and ABCC3 mutations?,top_cases_counts_by_genes
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases is without CYP1A2 and PSG2 mutations?,top_cases_counts_by_genes
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases is without ADRA1A and CASZ1 mutations?",top_cases_counts_by_genes
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without CDH23 and PTPRO mutations?,top_cases_counts_by_genes
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without CDH23 and CR1 mutations?,top_cases_counts_by_genes
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without KRT39 and PDGFC mutations?,top_cases_counts_by_genes
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without PDHA2 and BFAR mutations?,top_cases_counts_by_genes
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without SLC24A2 and SMO mutations?,top_cases_counts_by_genes
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What share of Liver Hepatocellular Carcinoma cases is without PTPRN2 and KIF20B mutations?,top_cases_counts_by_genes
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What share of Liver Hepatocellular Carcinoma cases is without PTPRN2 and YY1AP1 mutations?,top_cases_counts_by_genes
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What share of Liver Hepatocellular Carcinoma cases is without PTPRN2 and UNC5D mutations?,top_cases_counts_by_genes
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What share of Liver Hepatocellular Carcinoma cases is without PTPRN2 and JAML mutations?,top_cases_counts_by_genes
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What share of Liver Hepatocellular Carcinoma cases is without PTPRN2 and GUK1 mutations?,top_cases_counts_by_genes
+1188,SOX21,R55L,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without SOX21 and SPATA22 mutations?,top_cases_counts_by_genes
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases is without CPA6 and TTC12 mutations?,top_cases_counts_by_genes
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without GRM5 and TTC17 mutations?,top_cases_counts_by_genes
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases is without CASZ1 and MORF4L1 mutations?",top_cases_counts_by_genes
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without SGIP1 and OLFML3 mutations?,top_cases_counts_by_genes
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without SGIP1 and TMEM255A mutations?,top_cases_counts_by_genes
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without SGIP1 and SPATA22 mutations?,top_cases_counts_by_genes
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without SGIP1 and CYP1A2 mutations?,top_cases_counts_by_genes
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without CARMIL1 and DGKD mutations?,top_cases_counts_by_genes
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without CARMIL1 and RIMS2 mutations?,top_cases_counts_by_genes
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without ZNF431 and PSG2 mutations?,top_cases_counts_by_genes
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without ZNF431 and ANKRD24 mutations?,top_cases_counts_by_genes
+1234,ZNF431,R128I,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without ZNF431 and PRSS1 mutations?,top_cases_counts_by_genes
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without DNAH11 and MAST4 mutations?,top_cases_counts_by_genes
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without DNAH11 and AQP7 mutations?,top_cases_counts_by_genes
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without POLD1 and TASOR2 mutations?,top_cases_counts_by_genes
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases is without POLD1 and AUTS2 mutations?,top_cases_counts_by_genes
+1248,TTC12,D646H,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without TTC12 and TTN mutations?,top_cases_counts_by_genes
+1249,TTC12,D652H,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without TTC12 and AUTS2 mutations?,top_cases_counts_by_genes
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases is without CNGB1 and KDM5C mutations?,top_cases_counts_by_genes
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases is without CNGB1 and MED16 mutations?,top_cases_counts_by_genes
+1254,CTSC,E214V,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without CTSC and JAML mutations?,top_cases_counts_by_genes
+1255,CTSC,E291V,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without CTSC and PCDHB2 mutations?,top_cases_counts_by_genes
+1256,CTSC,E322V,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without CTSC and HLA-DQA2 mutations?,top_cases_counts_by_genes
+1257,CTSC,E324V,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without CTSC and GSTCD mutations?,top_cases_counts_by_genes
+1258,CTSC,E335V,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without CTSC and ANKRD24 mutations?,top_cases_counts_by_genes
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without PRSS8 and CACNA1F mutations?,top_cases_counts_by_genes
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without PRSS8 and SPAG1 mutations?,top_cases_counts_by_genes
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without ARHGEF40 and SLC9C1 mutations?,top_cases_counts_by_genes
+1264,ACTB,A138T,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases is without ACTB and POLR1G mutations?,top_cases_counts_by_genes
+1265,ACTB,A217T,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases is without ACTB and TENT5A mutations?,top_cases_counts_by_genes
+1266,ACTB,A244T,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases is without ACTB and PXN mutations?,top_cases_counts_by_genes
+1267,ACTB,A260T,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases is without ACTB and STK19 mutations?,top_cases_counts_by_genes
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What share of Glioblastoma Multiforme cases is without YY1AP1 and AKT1 mutations?,top_cases_counts_by_genes
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What share of Glioblastoma Multiforme cases is without YY1AP1 and BCAT1 mutations?,top_cases_counts_by_genes
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What share of Glioblastoma Multiforme cases is without YY1AP1 and SERPINB10 mutations?,top_cases_counts_by_genes
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What share of Glioblastoma Multiforme cases is without YY1AP1 and BICC1 mutations?,top_cases_counts_by_genes
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What share of Glioblastoma Multiforme cases is without YY1AP1 and DGKD mutations?,top_cases_counts_by_genes
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What share of Glioblastoma Multiforme cases is without YY1AP1 and ZCCHC14 mutations?,top_cases_counts_by_genes
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What share of Glioblastoma Multiforme cases is without YY1AP1 and NOMO1 mutations?,top_cases_counts_by_genes
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without FNDC7 and ZCCHC14 mutations?,top_cases_counts_by_genes
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without FNDC7 and FRY mutations?,top_cases_counts_by_genes
+1299,TLCD5,G15V,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without TLCD5 and CHODL mutations?,top_cases_counts_by_genes
+1300,TLCD5,G37V,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without TLCD5 and ZCCHC14 mutations?,top_cases_counts_by_genes
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without POLR1G and CACNA1F mutations?,top_cases_counts_by_genes
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without POLR1G and PIK3C2B mutations?,top_cases_counts_by_genes
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without DNAH14 and FGF8 mutations?,top_cases_counts_by_genes
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without DNAH14 and DCN mutations?,top_cases_counts_by_genes
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without DNAH14 and SPTAN1 mutations?,top_cases_counts_by_genes
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without NEXN and ITPRID2 mutations?,top_cases_counts_by_genes
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What share of Prostate Adenocarcinoma cases is without CYB5R2 and TNS1 mutations?,top_cases_counts_by_genes
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What share of Prostate Adenocarcinoma cases is without CYB5R2 and FNDC7 mutations?,top_cases_counts_by_genes
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without NRAP and DCLK3 mutations?,top_cases_counts_by_genes
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without NRAP and PSG2 mutations?,top_cases_counts_by_genes
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without NRAP and PTPRN2 mutations?,top_cases_counts_by_genes
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without CCDC22 and CA9 mutations?,top_cases_counts_by_genes
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without DCAF6 and CTSC mutations?,top_cases_counts_by_genes
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without DCAF6 and ZNF627 mutations?,top_cases_counts_by_genes
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without ZNF708 and UNC5D mutations?,top_cases_counts_by_genes
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without BFAR and TSHZ3 mutations?,top_cases_counts_by_genes
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without MAST4 and WNT2 mutations?,top_cases_counts_by_genes
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without MAST4 and PTPRN2 mutations?,top_cases_counts_by_genes
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without MAST4 and MYO16 mutations?,top_cases_counts_by_genes
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without MAST4 and SGIP1 mutations?,top_cases_counts_by_genes
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without MAST4 and GPC3 mutations?,top_cases_counts_by_genes
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without ARMC3 and DSCAM mutations?,top_cases_counts_by_genes
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without ARMC3 and EIF2B4 mutations?,top_cases_counts_by_genes
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What share of Kidney Renal Clear Cell Carcinoma cases is without TET2 and MRPL55 mutations?,top_cases_counts_by_genes
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What share of Kidney Renal Clear Cell Carcinoma cases is without TET2 and PAPPA mutations?,top_cases_counts_by_genes
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without SERPINB10 and CPA6 mutations?,top_cases_counts_by_genes
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without STAT3 and MERTK mutations?,top_cases_counts_by_genes
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without MIEF1 and ZFAT mutations?,top_cases_counts_by_genes
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without ACVR1B and YY1AP1 mutations?,top_cases_counts_by_genes
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without ACVR1B and RIMS2 mutations?,top_cases_counts_by_genes
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without ACVR1B and BCAT1 mutations?,top_cases_counts_by_genes
+1393,EBF2,T104I,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without EBF2 and HTR3B mutations?,top_cases_counts_by_genes
+1394,EBF2,T252I,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without EBF2 and TAF1C mutations?,top_cases_counts_by_genes
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without VPS26B and TTYH2 mutations?,top_cases_counts_by_genes
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases is without PGR and TTC17 mutations?",top_cases_counts_by_genes
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases is without PGR and SYNJ1 mutations?",top_cases_counts_by_genes
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases is without PGR and SYNJ1 mutations?",top_cases_counts_by_genes
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases is without ACTA2 and PTPRO mutations?,top_cases_counts_by_genes
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without THBS4 and PRSS1 mutations?,top_cases_counts_by_genes
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without THBS4 and SLC6A4 mutations?,top_cases_counts_by_genes
+1413,PRSS1,S114T,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without PRSS1 and POLD1 mutations?,top_cases_counts_by_genes
+1414,PRSS1,S124T,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without PRSS1 and SYNJ1 mutations?,top_cases_counts_by_genes
+1415,PRSS1,S138T,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without PRSS1 and KL mutations?,top_cases_counts_by_genes
+1416,PRSS1,S74T,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases is without PRSS1 and TENT5A mutations?,top_cases_counts_by_genes
+1417,PGF,R126H,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without PGF and PSG2 mutations?,top_cases_counts_by_genes
+1418,PGF,R127H,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases is without PGF and FBXO15 mutations?,top_cases_counts_by_genes
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases is without ITPRID2 and TLK2 mutations?,top_cases_counts_by_genes
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases is without ITPRID2 and THBS4 mutations?,top_cases_counts_by_genes
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without HBB and SYT10 mutations?,top_cases_counts_by_genes
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without PCDHB2 and PRSS1 mutations?,top_cases_counts_by_genes
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without PCDHB2 and AUTS2 mutations?,top_cases_counts_by_genes
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases is without PCDHB2 and GUK1 mutations?,top_cases_counts_by_genes
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases is without UBR2 and TASOR2 mutations?,top_cases_counts_by_genes
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases is without FBXO42 and LAMB2 mutations?,top_cases_counts_by_genes
+1,TNS1,G1362V,Breast Invasive Carcinoma,what is the frequency of cases with somatic mutations in TNS1 and amplifications in PTPRN2 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+2,TNS1,G1711V,Breast Invasive Carcinoma,what is the frequency of cases with somatic mutations in TNS1 and amplifications in PYHIN1 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+3,TNS1,G1718V,Breast Invasive Carcinoma,what is the frequency of cases with somatic mutations in TNS1 and amplifications in ANKRD30A in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+4,TNS1,G1732V,Breast Invasive Carcinoma,what is the frequency of cases with somatic mutations in TNS1 and amplifications in TTN in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+5,TNS1,G1824V,Breast Invasive Carcinoma,what is the frequency of cases with somatic mutations in TNS1 and amplifications in MAST4 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+6,TNS1,G1857V,Breast Invasive Carcinoma,what is the frequency of cases with somatic mutations in TNS1 and amplifications in ZFP42 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+7,TNS1,G843V,Breast Invasive Carcinoma,what is the frequency of cases with somatic mutations in TNS1 and amplifications in PTPRO in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,what is the frequency of cases with somatic mutations in EVC2 and amplifications in UNC5D in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+15,EVC2,E987K,Bladder Urothelial Carcinoma,what is the frequency of cases with somatic mutations in EVC2 and amplifications in PCDHB2 in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in CR1 and amplifications in TRIM45 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in CR1 and amplifications in TRPA1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+22,TRPA1,S295I,Rectum Adenocarcinoma,what is the frequency of cases with somatic mutations in TRPA1 and amplifications in EIF2B4 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+23,TRPA1,S443I,Rectum Adenocarcinoma,what is the frequency of cases with somatic mutations in TRPA1 and amplifications in ZNF627 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+24,TAF1C,R299L,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in TAF1C and amplifications in SYT9 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+25,TAF1C,R396L,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in TAF1C and amplifications in DCN in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+26,TAF1C,R634L,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in TAF1C and amplifications in ANP32E in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+27,TAF1C,R702L,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in TAF1C and amplifications in GSTCD in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+28,TAF1C,R728L,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in TAF1C and amplifications in CTNNA2 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in DPF3 and amplifications in DSCAM in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in DPF3 and amplifications in IL5RA in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in DPF3 and amplifications in MYO16 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+42,OR2T4,P272H,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in OR2T4 and amplifications in NRAP in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+43,OR2T4,P300H,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in OR2T4 and amplifications in TMEM255A in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,what is the frequency of cases with somatic mutations in FBN1 and amplifications in TASOR2 in Pancreatic Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+45,MAD1L1,E396K,Prostate Adenocarcinoma,what is the frequency of cases with somatic mutations in MAD1L1 and amplifications in MAST4 in Prostate Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+46,MAD1L1,E488K,Prostate Adenocarcinoma,what is the frequency of cases with somatic mutations in MAD1L1 and amplifications in RIPOR2 in Prostate Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+47,MAD1L1,E78K,Prostate Adenocarcinoma,what is the frequency of cases with somatic mutations in MAD1L1 and amplifications in PTPRO in Prostate Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+61,CCNG1,E22K,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in CCNG1 and amplifications in TNS1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,what is the frequency of cases with somatic mutations in ANP32E and amplifications in PSG2 in Kidney Renal Papillary Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,what is the frequency of cases with somatic mutations in ANP32E and amplifications in PLEKHG6 in Kidney Renal Papillary Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,what is the frequency of cases with somatic mutations in ANP32E and amplifications in CYP1A2 in Kidney Renal Papillary Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,what is the frequency of cases with somatic mutations in ANP32E and amplifications in RIPOR2 in Kidney Renal Papillary Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+66,FRY,S1888A,Bladder Urothelial Carcinoma,what is the frequency of cases with somatic mutations in FRY and amplifications in ACTB in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+67,FRY,S1937A,Bladder Urothelial Carcinoma,what is the frequency of cases with somatic mutations in FRY and amplifications in ART3 in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+68,FRY,S1938A,Bladder Urothelial Carcinoma,what is the frequency of cases with somatic mutations in FRY and amplifications in MYO3B in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+69,FRY,S1983A,Bladder Urothelial Carcinoma,what is the frequency of cases with somatic mutations in FRY and amplifications in PIK3C2B in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+70,PAK3,E318K,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in PAK3 and amplifications in PRSS1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+71,PAK3,E319K,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in PAK3 and amplifications in BCAT1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+72,PAK3,E334K,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in PAK3 and amplifications in ANKRD24 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+73,PAK3,E340K,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in PAK3 and amplifications in SIK2 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+74,PAK3,E355K,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in PAK3 and amplifications in EPRS1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+80,MUC16,P7963L,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in MUC16 and amplifications in TAF1C in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,what is the frequency of cases with somatic mutations in ZFPM2 and amplifications in HYOU1 in Liver Hepatocellular Carcinoma in the genomic data commons?,cnv_and_ssm
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,what is the frequency of cases with somatic mutations in ZFPM2 and amplifications in MYH11 in Liver Hepatocellular Carcinoma in the genomic data commons?,cnv_and_ssm
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,what is the frequency of cases with somatic mutations in PIK3C2B and amplifications in COL6A3 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,what is the frequency of cases with somatic mutations in PIK3C2B and amplifications in KDM5C in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+114,ZNF804A,S371Y,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in ZNF804A and amplifications in DCC in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+116,RELN,A2371V,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in RELN and amplifications in CPS1 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with somatic mutations in EFCAB12 and amplifications in MAST4 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with somatic mutations in EFCAB12 and amplifications in COL6A3 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+120,DEFB115,E53K,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in DEFB115 and amplifications in ARMC3 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,what is the frequency of cases with somatic mutations in ANKDD1A and amplifications in GABRA6 in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,what is the frequency of cases with somatic mutations in ANKDD1A and amplifications in SLC6A4 in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,what is the frequency of cases with somatic mutations in ANKDD1A and amplifications in CDKN2AIP in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in HTR3B and amplifications in SORCS1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in HTR3B and amplifications in TASOR2 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in HTR3B and amplifications in ANKRD24 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+129,ABCC3,R758W,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in ABCC3 and amplifications in MUC16 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in NOMO1 and amplifications in RAB40C in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in NOMO1 and amplifications in FGF8 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,what is the frequency of cases with somatic mutations in HYOU1 and amplifications in MYO16 in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+139,FMO4,R500Q,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in FMO4 and amplifications in PTPRO in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+140,BICC1,A372V,Exceptional Responders,what is the frequency of cases with somatic mutations in BICC1 and amplifications in ADRA1A in Exceptional Responders in the genomic data commons?,cnv_and_ssm
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in ZMYM3 and amplifications in ITPRID2 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in ZMYM3 and amplifications in SYT9 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in ZMYM3 and amplifications in TAF1L in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with somatic mutations in XKR4 and amplifications in SYT9 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,what is the frequency of cases with somatic mutations in ABCC2 and amplifications in TLCD5 in Liver Hepatocellular Carcinoma in the genomic data commons?,cnv_and_ssm
+157,OR8K5,R293G,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in OR8K5 and amplifications in CDH23 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in SPTAN1 and amplifications in TET2 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in SPTAN1 and amplifications in ACTB in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+164,SYT10,M484I,Rectum Adenocarcinoma,what is the frequency of cases with somatic mutations in SYT10 and amplifications in ZFAT in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+174,HSPA5,N457K,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in HSPA5 and amplifications in NEXN in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+175,UNC5D,L280V,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in UNC5D and amplifications in AUTS2 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+176,UNC5D,L635V,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in UNC5D and amplifications in SGCZ in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+177,UNC5D,L637V,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in UNC5D and amplifications in PHLPP1 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+178,UNC5D,L699V,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in UNC5D and amplifications in PGR in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+179,UNC5D,L704V,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in UNC5D and amplifications in OLFML3 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+180,UNC5D,L709V,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in UNC5D and amplifications in OLFML3 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,what is the frequency of cases with somatic mutations in DOCK2 and amplifications in ACVR1B in Kidney Renal Clear Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,what is the frequency of cases with somatic mutations in ZNF627 and amplifications in TMEM225 in Kidney Renal Clear Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in CDC42BPA and amplifications in SGCZ in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+193,MRPL55,H27Y,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in MRPL55 and amplifications in TTC12 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+194,MRPL55,H63Y,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in MRPL55 and amplifications in PDGFC in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+197,TMTC3,Q749K,Breast Invasive Carcinoma,what is the frequency of cases with somatic mutations in TMTC3 and amplifications in PTPRN2 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+198,EPRS1,K771I,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in EPRS1 and amplifications in KIF20B in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+199,EPRS1,K778I,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in EPRS1 and amplifications in TTN in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+201,GRTP1,A110V,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in GRTP1 and amplifications in EVC2 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+202,GRTP1,A32V,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in GRTP1 and amplifications in DCAF4L2 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in TSHZ3 and amplifications in PCDHGA1 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,what is the frequency of cases with somatic mutations in TAS1R3 and amplifications in TASOR2 in HIV+ Tumor Molecular Characterization Project - Cervical Cancer in the genomic data commons?,cnv_and_ssm
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in PIAS3 and amplifications in EFCAB12 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in PIAS3 and amplifications in MYO16 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+251,ZNF274,P13R,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in ZNF274 and amplifications in AQP7 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+253,SYNJ1,R795C,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in SYNJ1 and amplifications in DNMT1 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+254,SYNJ1,R800C,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in SYNJ1 and amplifications in PTPRO in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+255,SYNJ1,R839C,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in SYNJ1 and amplifications in AUTS2 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+261,DSCAM,V343M,Prostate Adenocarcinoma,what is the frequency of cases with somatic mutations in DSCAM and amplifications in CYB5R2 in Prostate Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+262,DSCAM,V426M,Prostate Adenocarcinoma,what is the frequency of cases with somatic mutations in DSCAM and amplifications in TNS1 in Prostate Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+263,DSCAM,V591M,Prostate Adenocarcinoma,what is the frequency of cases with somatic mutations in DSCAM and amplifications in PAK3 in Prostate Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+267,DGKD,R140H,Exceptional Responders,what is the frequency of cases with somatic mutations in DGKD and amplifications in GABRA6 in Exceptional Responders in the genomic data commons?,cnv_and_ssm
+268,DGKD,R160H,Exceptional Responders,what is the frequency of cases with somatic mutations in DGKD and amplifications in TRIM45 in Exceptional Responders in the genomic data commons?,cnv_and_ssm
+269,DGKD,R204H,Exceptional Responders,what is the frequency of cases with somatic mutations in DGKD and amplifications in AUTS2 in Exceptional Responders in the genomic data commons?,cnv_and_ssm
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,what is the frequency of cases with somatic mutations in PLEKHG6 and amplifications in TET2 in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,what is the frequency of cases with somatic mutations in PLEKHG6 and amplifications in NOMO1 in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,what is the frequency of cases with somatic mutations in PLEKHG6 and amplifications in AUTS2 in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+279,WNT2,D138N,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in WNT2 and amplifications in CASZ1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in GUCY2C and amplifications in TYK2 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in C7orf31 and amplifications in SYT9 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with somatic mutations in ZKSCAN7 and amplifications in GSTCD in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+299,OR5D14,M210L,Neuroblastoma,what is the frequency of cases with somatic mutations in OR5D14 and amplifications in CFAP61 in Neuroblastoma in the genomic data commons?,cnv_and_ssm
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in SPATA22 and amplifications in TMEM255A in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in SPATA22 and amplifications in MRPL55 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in SPATA22 and amplifications in ZNF627 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+310,LCN15,E21V,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in LCN15 and amplifications in FRY in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in DCAF4L2 and amplifications in TRAP1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in GUK1 and amplifications in MSANTD4 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in GUK1 and amplifications in SYT9 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in GUK1 and amplifications in CPS1 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in GUK1 and amplifications in ART3 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in GUK1 and amplifications in OR13C3 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+328,MORF4L1,K29T,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in MORF4L1 and amplifications in GABRA6 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+329,MORF4L1,K51T,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in MORF4L1 and amplifications in MYH11 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+330,MORF4L1,K61T,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in MORF4L1 and amplifications in DHX16 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+331,MORF4L1,K76T,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in MORF4L1 and amplifications in KDM5C in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+335,MYO3B,F594L,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in MYO3B and amplifications in SLC24A2 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+336,MYO3B,F603L,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in MYO3B and amplifications in RIMS2 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+339,TENT5A,S320F,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in TENT5A and amplifications in SPATA22 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+340,TENT5A,S339F,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in TENT5A and amplifications in GIMAP2 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+341,TENT5A,S401F,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in TENT5A and amplifications in CTCFL in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,what is the frequency of cases with somatic mutations in ZFAT and amplifications in KANSL1 in Ovarian Serous Cystadenocarcinoma in the genomic data commons?,cnv_and_ssm
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,what is the frequency of cases with somatic mutations in ZFAT and amplifications in POC1B in Ovarian Serous Cystadenocarcinoma in the genomic data commons?,cnv_and_ssm
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,what is the frequency of cases with somatic mutations in ZFAT and amplifications in MRPL32 in Ovarian Serous Cystadenocarcinoma in the genomic data commons?,cnv_and_ssm
+357,ZNF584,A211T,Sarcoma,what is the frequency of cases with somatic mutations in ZNF584 and amplifications in YY1AP1 in Sarcoma in the genomic data commons?,cnv_and_ssm
+358,ZNF584,A256T,Sarcoma,what is the frequency of cases with somatic mutations in ZNF584 and amplifications in COL6A3 in Sarcoma in the genomic data commons?,cnv_and_ssm
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in LDOC1 and amplifications in GUK1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in PDGFC and amplifications in ART3 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in MSANTD4 and amplifications in ADAM17 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+374,NPSR1,S123L,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in NPSR1 and amplifications in GPC3 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in PHLPP1 and amplifications in CTSC in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+385,COL6A3,G237S,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in COL6A3 and amplifications in TRIM45 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+386,COL6A3,G437S,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in COL6A3 and amplifications in GABRA6 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+387,COL6A3,G638S,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in COL6A3 and amplifications in TENT5A in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+388,COL6A3,G644S,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in COL6A3 and amplifications in PLEKHG6 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+389,COL6A3,G844S,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in COL6A3 and amplifications in COL6A3 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+395,ADRA1A,R348G,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in ADRA1A and amplifications in TLK2 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what is the frequency of cases with somatic mutations in LAMB2 and amplifications in TYROBP in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+406,POC1B,I198T,Rectum Adenocarcinoma,what is the frequency of cases with somatic mutations in POC1B and amplifications in NRAP in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+407,POC1B,I286T,Rectum Adenocarcinoma,what is the frequency of cases with somatic mutations in POC1B and amplifications in PTPRN2 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+408,POC1B,I328T,Rectum Adenocarcinoma,what is the frequency of cases with somatic mutations in POC1B and amplifications in TAF1C in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+409,POC1B,S79P,Rectum Adenocarcinoma,what is the frequency of cases with somatic mutations in POC1B and amplifications in CYB5R2 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,what is the frequency of cases with somatic mutations in USH2A and amplifications in DPF3 in Liver Hepatocellular Carcinoma in the genomic data commons?,cnv_and_ssm
+414,AQP7,T110S,Rectum Adenocarcinoma,what is the frequency of cases with somatic mutations in AQP7 and amplifications in TYK2 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+415,AQP7,T166S,Rectum Adenocarcinoma,what is the frequency of cases with somatic mutations in AQP7 and amplifications in EIF2B4 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+416,AQP7,T167S,Rectum Adenocarcinoma,what is the frequency of cases with somatic mutations in AQP7 and amplifications in PAK3 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+417,AQP7,T75S,Rectum Adenocarcinoma,what is the frequency of cases with somatic mutations in AQP7 and amplifications in GABRA6 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+430,DCN,R163C,Rectum Adenocarcinoma,what is the frequency of cases with somatic mutations in DCN and amplifications in FGF8 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+431,DCN,R203C,Rectum Adenocarcinoma,what is the frequency of cases with somatic mutations in DCN and amplifications in PRSS1 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+432,DCN,R241C,Rectum Adenocarcinoma,what is the frequency of cases with somatic mutations in DCN and amplifications in LDOC1 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+433,DCN,R350C,Rectum Adenocarcinoma,what is the frequency of cases with somatic mutations in DCN and amplifications in SLC6A4 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+434,DCN,R41C,Rectum Adenocarcinoma,what is the frequency of cases with somatic mutations in DCN and amplifications in KDM5C in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in CPS1 and amplifications in STK19 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in CPS1 and amplifications in MAOB in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in CPS1 and amplifications in PGF in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,what is the frequency of cases with somatic mutations in FCGR2C and amplifications in TNS1 in Kidney Renal Papillary Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,what is the frequency of cases with somatic mutations in FCGR2C and amplifications in PTPRO in Kidney Renal Papillary Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in GRM1 and amplifications in ANKRD24 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+482,SGCZ,Q138H,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in SGCZ and amplifications in GLRB in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+483,SGCZ,Q91H,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in SGCZ and amplifications in FGF8 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+485,SMO,V15M,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in SMO and amplifications in IL5RA in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+486,SMO,V321M,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in SMO and amplifications in CTSC in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+488,CHODL,G159E,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in CHODL and amplifications in FGF8 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+489,CHODL,G181E,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in CHODL and amplifications in EPRS1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+490,CHODL,G200E,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in CHODL and amplifications in COL6A3 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+494,MYO16,P399H,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in MYO16 and amplifications in PRSS1 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+495,MYO16,P421H,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in MYO16 and amplifications in MYT1 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+498,CXCR2,A98V,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in CXCR2 and amplifications in MED16 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,what is the frequency of cases with somatic mutations in TMEM225 and amplifications in AKT1 in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in MAOB and amplifications in MRPL32 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in GPRASP1 and amplifications in PCDHB2 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in MRPL32 and amplifications in PKHD1L1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in TYROBP and amplifications in SYT10 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+510,RAB40C,A111V,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in RAB40C and amplifications in CDC42BPA in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+511,RAB40C,A143V,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in RAB40C and amplifications in SOX21 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+512,CTNNA2,S323R,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in CTNNA2 and amplifications in ZMYM3 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+513,CTNNA2,S339R,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in CTNNA2 and amplifications in CACNA1F in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+514,CTNNA2,S386R,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in CTNNA2 and amplifications in TYK2 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+515,CTNNA2,S707R,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in CTNNA2 and amplifications in TASOR2 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,what is the frequency of cases with somatic mutations in MYO15A and amplifications in SERPINB10 in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in GIMAP2 and amplifications in TLK2 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+532,KIF20B,N1160D,Glioblastoma Multiforme,what is the frequency of cases with somatic mutations in KIF20B and amplifications in TRAP1 in Glioblastoma Multiforme in the genomic data commons?,cnv_and_ssm
+533,KIF20B,N1200D,Glioblastoma Multiforme,what is the frequency of cases with somatic mutations in KIF20B and amplifications in ICE1 in Glioblastoma Multiforme in the genomic data commons?,cnv_and_ssm
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in ADAM17 and amplifications in ZBTB34 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in BCAT1 and amplifications in ACTB in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in BCAT1 and amplifications in OLFML3 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in BCAT1 and amplifications in TLCD5 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+540,ERCC6,R1053H,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in ERCC6 and amplifications in TYK2 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+541,DCC,R320W,Breast Invasive Carcinoma,what is the frequency of cases with somatic mutations in DCC and amplifications in FNDC7 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+542,DCC,R363W,Breast Invasive Carcinoma,what is the frequency of cases with somatic mutations in DCC and amplifications in RIPOR2 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+543,DCC,R386W,Breast Invasive Carcinoma,what is the frequency of cases with somatic mutations in DCC and amplifications in POLR1G in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+544,DCC,R41W,Breast Invasive Carcinoma,what is the frequency of cases with somatic mutations in DCC and amplifications in VPS26B in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+549,FBXO15,D417N,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in FBXO15 and amplifications in CPS1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+550,FBXO15,D86N,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in FBXO15 and amplifications in OR8K5 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in GSTCD and amplifications in ITPRID2 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in GSTCD and amplifications in PGR in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in OLFML3 and amplifications in TAF1C in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in OLFML3 and amplifications in SLC24A2 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in OLFML3 and amplifications in IL5RA in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,what is the frequency of cases with somatic mutations in CFAP61 and amplifications in MYH11 in Ovarian Serous Cystadenocarcinoma in the genomic data commons?,cnv_and_ssm
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,what is the frequency of cases with somatic mutations in CFAP61 and amplifications in TLK2 in Ovarian Serous Cystadenocarcinoma in the genomic data commons?,cnv_and_ssm
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,what is the frequency of cases with somatic mutations in HLA-DQA2 and amplifications in RIMS2 in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+582,TENM2,H240Y,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in TENM2 and amplifications in OR2A12 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+583,TENM2,H351Y,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in TENM2 and amplifications in PTPRO in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+584,TENM2,H472Y,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in TENM2 and amplifications in DCC in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+600,ANKRD24,A465T,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in ANKRD24 and amplifications in MAST4 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+601,ANKRD24,A494T,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in ANKRD24 and amplifications in ZNF274 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+602,ANKRD24,A584T,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in ANKRD24 and amplifications in ZNF804A in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in ZCCHC14 and amplifications in AUTS2 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in ZCCHC14 and amplifications in NRAP in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in ZCCHC14 and amplifications in ANKDD1A in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in ZCCHC14 and amplifications in ANKRD30A in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+625,SIK2,I265M,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in SIK2 and amplifications in PTPRO in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in MYH11 and amplifications in GRTP1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in MYH11 and amplifications in PRSS1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in SLC6A4 and amplifications in STK19 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in SLC9C1 and amplifications in PTPRO in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in SLC9C1 and amplifications in DNAH14 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+644,OR2A12,A254T,Brain Lower Grade Glioma,what is the frequency of cases with somatic mutations in OR2A12 and amplifications in NCKAP5 in Brain Lower Grade Glioma in the genomic data commons?,cnv_and_ssm
+646,PYHIN1,T325K,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in PYHIN1 and amplifications in YY1AP1 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+647,PYHIN1,T334K,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in PYHIN1 and amplifications in PGR in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+650,JAML,G191E,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in JAML and amplifications in COL6A3 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+651,JAML,G219E,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in JAML and amplifications in PTPRO in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+652,JAML,G220E,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in JAML and amplifications in ICE1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+653,JAML,G230E,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in JAML and amplifications in TENT5A in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+658,TYK2,H1146R,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in TYK2 and amplifications in SLC9C1 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+659,TYK2,H23R,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in TYK2 and amplifications in PGR in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+660,TYK2,H961R,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in TYK2 and amplifications in DGKD in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in CTCFL and amplifications in MORF4L1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in CTCFL and amplifications in CACNA1F in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in CTCFL and amplifications in PXN in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in CTCFL and amplifications in CYB5R2 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in CEP20 and amplifications in ICE1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in CEP20 and amplifications in EFCAB12 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+689,RIMS2,R25W,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in RIMS2 and amplifications in SGCZ in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+690,RIMS2,R393W,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in RIMS2 and amplifications in ACTB in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+691,RIMS2,R423W,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in RIMS2 and amplifications in SPAG1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+692,RIMS2,R470W,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in RIMS2 and amplifications in FGF8 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+693,RIMS2,R615W,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in RIMS2 and amplifications in PTPRO in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+694,RIMS2,R619W,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in RIMS2 and amplifications in MERTK in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+695,RIMS2,R716W,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in RIMS2 and amplifications in NCKAP5 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in PIK3C2G and amplifications in TMEM255A in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in PIK3C2G and amplifications in HTR3B in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+728,STK19,D341N,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in STK19 and amplifications in OR8K5 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+729,STK19,D345N,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in STK19 and amplifications in SPINDOC in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+730,REXO4,P60A,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in REXO4 and amplifications in RIMS2 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in ZBTB34 and amplifications in HYOU1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in ZBTB34 and amplifications in PTPRN2 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,what is the frequency of cases with somatic mutations in NCKAP5 and amplifications in CHODL in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with somatic mutations in SORCS1 and amplifications in DSCAM in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with somatic mutations in SORCS1 and amplifications in DPF3 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with somatic mutations in SORCS1 and amplifications in TYK2 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with somatic mutations in SORCS1 and amplifications in RAB40C in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in FGF8 and amplifications in CTCFL in Head and Neck Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in FGF8 and amplifications in DCC in Head and Neck Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in FGF8 and amplifications in CACNA1F in Head and Neck Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in FGF8 and amplifications in MYO15A in Head and Neck Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in FGF8 and amplifications in CDC42BPA in Head and Neck Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,what is the frequency of cases with somatic mutations in TENM3 and amplifications in TNS1 in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia in the genomic data commons?,cnv_and_ssm
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in AKT1 and amplifications in SPATA22 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what is the frequency of cases with somatic mutations in CFAP298-TCP10L and amplifications in TRIM45 in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+792,GLRB,E148D,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in GLRB and amplifications in ZNF431 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+793,TTN,F7636L,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in TTN and amplifications in PIK3C2G in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+794,TTN,F8563L,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in TTN and amplifications in CTNNA2 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+795,TTN,F8880L,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in TTN and amplifications in ANKDD1A in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+799,ANKRD30A,V798I,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in ANKRD30A and amplifications in PRSS1 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+800,ANKRD30A,V854I,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in ANKRD30A and amplifications in JAML in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+801,ANKRD30A,V973I,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in ANKRD30A and amplifications in CX3CR1 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+809,TRIM45,S177L,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in TRIM45 and amplifications in FGF8 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+810,TRIM45,S224L,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in TRIM45 and amplifications in TMEM255A in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+811,TRIM45,S281L,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in TRIM45 and amplifications in UNC5D in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+812,CACNA1F,G727V,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in CACNA1F and amplifications in PGR in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+813,CACNA1F,G781V,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in CACNA1F and amplifications in PGR in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+814,CACNA1F,G792V,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in CACNA1F and amplifications in ANKRD24 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+817,KL,R594C,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in KL and amplifications in PIK3C2G in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,what is the frequency of cases with somatic mutations in GUF1 and amplifications in GPRASP1 in Kidney Renal Papillary Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+822,TAF1L,A539V,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in TAF1L and amplifications in ZNF274 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+823,TASOR2,S256F,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in TASOR2 and amplifications in C7orf31 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+824,TASOR2,S36F,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in TASOR2 and amplifications in GUK1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+825,TASOR2,S471F,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in TASOR2 and amplifications in OR8K5 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in KDM5C and amplifications in SLC6A4 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in KDM5C and amplifications in SORCS1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in KDM5C and amplifications in CTSC in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in KDM5C and amplifications in CTNNA2 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what is the frequency of cases with somatic mutations in IL5RA and amplifications in ACTB in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+843,DHX16,A29V,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in DHX16 and amplifications in TENT5A in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+844,DHX16,A89V,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in DHX16 and amplifications in STAT3 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+902,GPR158,A644V,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in GPR158 and amplifications in COL6A3 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+903,GPR158,A723V,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in GPR158 and amplifications in TMTC3 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with somatic mutations in EIF2B4 and amplifications in CTSC in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with somatic mutations in EIF2B4 and amplifications in GPC3 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with somatic mutations in EIF2B4 and amplifications in OR2A12 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with somatic mutations in EIF2B4 and amplifications in ACTA2 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with somatic mutations in EIF2B4 and amplifications in TYROBP in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with somatic mutations in EIF2B4 and amplifications in PAK3 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in AUTS2 and amplifications in RIPOR2 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in AUTS2 and amplifications in MAST4 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in AUTS2 and amplifications in DGKD in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in AUTS2 and amplifications in AUTS2 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in AUTS2 and amplifications in MED16 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in AUTS2 and amplifications in ZNF584 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in AUTS2 and amplifications in PTPRO in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in AUTS2 and amplifications in DCN in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in AUTS2 and amplifications in TENM2 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in AUTS2 and amplifications in USH2A in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with somatic mutations in ACTL7B and amplifications in AQP7 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+952,PCDHGA1,R535W,Glioblastoma Multiforme,what is the frequency of cases with somatic mutations in PCDHGA1 and amplifications in MERTK in Glioblastoma Multiforme in the genomic data commons?,cnv_and_ssm
+954,TRAP1,R114W,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in TRAP1 and amplifications in RIMS2 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+955,TRAP1,R61W,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in TRAP1 and amplifications in SORCS1 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in PIK3C2A and amplifications in MYO16 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,what is the frequency of cases with somatic mutations in KANSL1 and amplifications in TENM2 in Liver Hepatocellular Carcinoma in the genomic data commons?,cnv_and_ssm
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in ANKRD52 and amplifications in TTYH2 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in PAPPA and amplifications in MERTK in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,what is the frequency of cases with somatic mutations in B3GALNT1 and amplifications in TRPA1 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+982,GABRA6,G115R,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in GABRA6 and amplifications in PXN in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+983,GABRA6,G122R,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in GABRA6 and amplifications in TRIM45 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+984,GABRA6,G165R,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in GABRA6 and amplifications in ARHGEF40 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+985,GABRA6,G175R,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in GABRA6 and amplifications in ZMYM3 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+986,GABRA6,G70R,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in GABRA6 and amplifications in PCDHB2 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in ZSCAN31 and amplifications in SLC9C1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with somatic mutations in MED16 and amplifications in PIK3C2G in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with somatic mutations in MED16 and amplifications in LAMB2 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,what is the frequency of cases with somatic mutations in PTPRO and amplifications in NCKAP5 in Pancreatic Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,what is the frequency of cases with somatic mutations in PTPRO and amplifications in CPS1 in Pancreatic Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,what is the frequency of cases with somatic mutations in PTPRO and amplifications in CEP20 in Pancreatic Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,what is the frequency of cases with somatic mutations in PTPRO and amplifications in PTPRO in Pancreatic Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,what is the frequency of cases with somatic mutations in PTPRO and amplifications in PAPPA in Pancreatic Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,what is the frequency of cases with somatic mutations in PTPRO and amplifications in EBF2 in Pancreatic Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,what is the frequency of cases with somatic mutations in PTPRO and amplifications in PTPRO in Pancreatic Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,what is the frequency of cases with somatic mutations in PTPRO and amplifications in TMEM255A in Pancreatic Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in CHMP7 and amplifications in PIK3C2B in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1017,GPC3,I107N,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in GPC3 and amplifications in YY1AP1 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1018,GPC3,I161N,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in GPC3 and amplifications in RIPOR2 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what is the frequency of cases with somatic mutations in TLK2 and amplifications in BICC1 in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what is the frequency of cases with somatic mutations in TLK2 and amplifications in ZNF431 in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what is the frequency of cases with somatic mutations in TLK2 and amplifications in GUK1 in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what is the frequency of cases with somatic mutations in TLK2 and amplifications in BICC1 in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what is the frequency of cases with somatic mutations in TLK2 and amplifications in RAB40C in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1036,ZNF217,E209Q,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in ZNF217 and amplifications in TASOR2 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1038,SYT9,V275L,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in SYT9 and amplifications in ANP32E in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1039,SYT9,V307L,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in SYT9 and amplifications in CACNA1F in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in PKHD1L1 and amplifications in KDM5C in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in MYO3A and amplifications in RIMS2 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with somatic mutations in VASN and amplifications in PGF in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in DNMT1 and amplifications in MAST4 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in DNMT1 and amplifications in ZMYM3 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in DNMT1 and amplifications in BCAT1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1056,CA9,E402K,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in CA9 and amplifications in YY1AP1 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in TTC17 and amplifications in AUTS2 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in TTC17 and amplifications in MAOB in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1065,PSG2,P43L,Breast Invasive Carcinoma,what is the frequency of cases with somatic mutations in PSG2 and amplifications in FMO4 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,what is the frequency of cases with somatic mutations in RIPOR2 and amplifications in PAK3 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,what is the frequency of cases with somatic mutations in RIPOR2 and amplifications in POLR1G in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,what is the frequency of cases with somatic mutations in RIPOR2 and amplifications in SIK2 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,what is the frequency of cases with somatic mutations in RIPOR2 and amplifications in PRSS1 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in DCLK3 and amplifications in FCGR2C in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in DCLK3 and amplifications in MERTK in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in MERTK and amplifications in CDC42BPA in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in MERTK and amplifications in CDH23 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in MERTK and amplifications in EVC2 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in ZFP42 and amplifications in YY1AP1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in OR13C3 and amplifications in PYHIN1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in OR13C3 and amplifications in SGCZ in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+1091,SPAG1,I917M,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in SPAG1 and amplifications in TRIM45 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in CDKN2AIP and amplifications in NRAP in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1093,PXN,H1016Y,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in PXN and amplifications in EFCAB12 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1094,PXN,H359Y,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in PXN and amplifications in MRPL55 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1095,PXN,H492Y,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in PXN and amplifications in TASOR2 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1096,PXN,H524Y,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in PXN and amplifications in TLK2 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1097,PXN,H526Y,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in PXN and amplifications in ZNF274 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1098,PXN,H540Y,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in PXN and amplifications in ZFAT in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in TTYH2 and amplifications in RIMS2 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in TTYH2 and amplifications in KIF20B in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1106,TMEM255A,N205S,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in TMEM255A and amplifications in KDM5C in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1107,TMEM255A,N229S,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in TMEM255A and amplifications in NEXN in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1108,TMEM255A,N65S,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in TMEM255A and amplifications in FGF8 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,what is the frequency of cases with somatic mutations in TASOR2 and amplifications in ITPRID2 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,what is the frequency of cases with somatic mutations in TASOR2 and amplifications in XKR4 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in ICE1 and amplifications in TAF1C in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1112,MYT1,A558E,Breast Invasive Carcinoma,what is the frequency of cases with somatic mutations in MYT1 and amplifications in CFAP61 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+1113,MYT1,A879E,Breast Invasive Carcinoma,what is the frequency of cases with somatic mutations in MYT1 and amplifications in PAPPA in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+1114,MYT1,A906E,Breast Invasive Carcinoma,what is the frequency of cases with somatic mutations in MYT1 and amplifications in KIF20B in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in CX3CR1 and amplifications in ABCC2 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in CX3CR1 and amplifications in MRPL55 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,what is the frequency of cases with somatic mutations in SPINDOC and amplifications in CTNNA2 in Liver Hepatocellular Carcinoma in the genomic data commons?,cnv_and_ssm
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in ART3 and amplifications in FRY in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in ART3 and amplifications in PTPRO in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,what is the frequency of cases with somatic mutations in CYP1A2 and amplifications in PTPRN2 in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with somatic mutations in ADRA1A and amplifications in YY1AP1 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in CDH23 and amplifications in DCC in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in CDH23 and amplifications in OR13C3 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+1148,KRT39,P137S,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in KRT39 and amplifications in DNAH11 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in PDHA2 and amplifications in POLR1G in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in SLC24A2 and amplifications in POLR1G in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,what is the frequency of cases with somatic mutations in PTPRN2 and amplifications in PTPRN2 in Liver Hepatocellular Carcinoma in the genomic data commons?,cnv_and_ssm
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,what is the frequency of cases with somatic mutations in PTPRN2 and amplifications in GUK1 in Liver Hepatocellular Carcinoma in the genomic data commons?,cnv_and_ssm
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,what is the frequency of cases with somatic mutations in PTPRN2 and amplifications in DCC in Liver Hepatocellular Carcinoma in the genomic data commons?,cnv_and_ssm
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,what is the frequency of cases with somatic mutations in PTPRN2 and amplifications in BCAT1 in Liver Hepatocellular Carcinoma in the genomic data commons?,cnv_and_ssm
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,what is the frequency of cases with somatic mutations in PTPRN2 and amplifications in TASOR2 in Liver Hepatocellular Carcinoma in the genomic data commons?,cnv_and_ssm
+1188,SOX21,R55L,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in SOX21 and amplifications in GUK1 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,what is the frequency of cases with somatic mutations in CPA6 and amplifications in SGIP1 in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+1206,GRM5,E14K,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in GRM5 and amplifications in GABRA6 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with somatic mutations in CASZ1 and amplifications in TTC17 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+1210,SGIP1,N122T,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in SGIP1 and amplifications in GABRA6 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1211,SGIP1,N420T,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in SGIP1 and amplifications in CEP20 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1212,SGIP1,N617T,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in SGIP1 and amplifications in C7orf31 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1213,SGIP1,N648T,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in SGIP1 and amplifications in ABCC2 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1227,CARMIL1,V549L,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in CARMIL1 and amplifications in DPF3 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1228,CARMIL1,V949L,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in CARMIL1 and amplifications in CNGB1 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1232,ZNF431,D121Y,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in ZNF431 and amplifications in PDGFC in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1233,ZNF431,D161Y,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in ZNF431 and amplifications in SMO in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1234,ZNF431,R128I,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in ZNF431 and amplifications in THBS4 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in DNAH11 and amplifications in ART3 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in DNAH11 and amplifications in STK19 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in POLD1 and amplifications in TRAP1 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,what is the frequency of cases with somatic mutations in POLD1 and amplifications in COL6A3 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+1248,TTC12,D646H,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in TTC12 and amplifications in COL6A3 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1249,TTC12,D652H,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in TTC12 and amplifications in FMO4 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,what is the frequency of cases with somatic mutations in CNGB1 and amplifications in SGCZ in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,what is the frequency of cases with somatic mutations in CNGB1 and amplifications in PXN in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+1254,CTSC,E214V,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in CTSC and amplifications in DCAF6 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1255,CTSC,E291V,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in CTSC and amplifications in PTPRN2 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1256,CTSC,E322V,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in CTSC and amplifications in NRAP in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1257,CTSC,E324V,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in CTSC and amplifications in YY1AP1 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1258,CTSC,E335V,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in CTSC and amplifications in OR2T4 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in PRSS8 and amplifications in GPC3 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in PRSS8 and amplifications in GSTCD in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in ARHGEF40 and amplifications in ANKDD1A in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1264,ACTB,A138T,Rectum Adenocarcinoma,what is the frequency of cases with somatic mutations in ACTB and amplifications in CPA6 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1265,ACTB,A217T,Rectum Adenocarcinoma,what is the frequency of cases with somatic mutations in ACTB and amplifications in ZSCAN31 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1266,ACTB,A244T,Rectum Adenocarcinoma,what is the frequency of cases with somatic mutations in ACTB and amplifications in ZBTB34 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1267,ACTB,A260T,Rectum Adenocarcinoma,what is the frequency of cases with somatic mutations in ACTB and amplifications in ACTB in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1268,YY1AP1,V546D,Glioblastoma Multiforme,what is the frequency of cases with somatic mutations in YY1AP1 and amplifications in PTPRO in Glioblastoma Multiforme in the genomic data commons?,cnv_and_ssm
+1269,YY1AP1,V557D,Glioblastoma Multiforme,what is the frequency of cases with somatic mutations in YY1AP1 and amplifications in ZCCHC14 in Glioblastoma Multiforme in the genomic data commons?,cnv_and_ssm
+1270,YY1AP1,V566D,Glioblastoma Multiforme,what is the frequency of cases with somatic mutations in YY1AP1 and amplifications in JAML in Glioblastoma Multiforme in the genomic data commons?,cnv_and_ssm
+1271,YY1AP1,V577D,Glioblastoma Multiforme,what is the frequency of cases with somatic mutations in YY1AP1 and amplifications in ABCC2 in Glioblastoma Multiforme in the genomic data commons?,cnv_and_ssm
+1272,YY1AP1,V623D,Glioblastoma Multiforme,what is the frequency of cases with somatic mutations in YY1AP1 and amplifications in XKR4 in Glioblastoma Multiforme in the genomic data commons?,cnv_and_ssm
+1273,YY1AP1,V695D,Glioblastoma Multiforme,what is the frequency of cases with somatic mutations in YY1AP1 and amplifications in EFCAB12 in Glioblastoma Multiforme in the genomic data commons?,cnv_and_ssm
+1274,YY1AP1,V715D,Glioblastoma Multiforme,what is the frequency of cases with somatic mutations in YY1AP1 and amplifications in TLK2 in Glioblastoma Multiforme in the genomic data commons?,cnv_and_ssm
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in FNDC7 and amplifications in TAF1C in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in FNDC7 and amplifications in TYK2 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+1299,TLCD5,G15V,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in TLCD5 and amplifications in ZCCHC14 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1300,TLCD5,G37V,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in TLCD5 and amplifications in DCC in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in POLR1G and amplifications in PXN in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in POLR1G and amplifications in AUTS2 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1308,DNAH14,N1186K,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in DNAH14 and amplifications in TENM2 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1309,DNAH14,N2657K,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in DNAH14 and amplifications in GUK1 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1310,DNAH14,N3460K,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in DNAH14 and amplifications in CTCFL in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in NEXN and amplifications in TENT5A in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,what is the frequency of cases with somatic mutations in CYB5R2 and amplifications in POLD1 in Prostate Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,what is the frequency of cases with somatic mutations in CYB5R2 and amplifications in SYNJ1 in Prostate Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in NRAP and amplifications in TMTC3 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in NRAP and amplifications in SGIP1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in NRAP and amplifications in DCC in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in CCDC22 and amplifications in TENM3 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in DCAF6 and amplifications in BCAT1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in DCAF6 and amplifications in TRIM45 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in ZNF708 and amplifications in PGR in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in BFAR and amplifications in TENT5A in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in MAST4 and amplifications in TENM2 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in MAST4 and amplifications in ZKSCAN7 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in MAST4 and amplifications in RAB40C in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in MAST4 and amplifications in POLR1G in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in MAST4 and amplifications in COL6A3 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1363,ARMC3,R169C,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in ARMC3 and amplifications in EIF2B4 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1364,ARMC3,R432C,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in ARMC3 and amplifications in CARMIL1 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,what is the frequency of cases with somatic mutations in TET2 and amplifications in ITPRID2 in Kidney Renal Clear Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,what is the frequency of cases with somatic mutations in TET2 and amplifications in TRIM45 in Kidney Renal Clear Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+1369,SERPINB10,A353P,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in SERPINB10 and amplifications in ITPRID2 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in STAT3 and amplifications in YY1AP1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in MIEF1 and amplifications in AUTS2 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1381,ACVR1B,D397N,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in ACVR1B and amplifications in AQP7 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1382,ACVR1B,D449N,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in ACVR1B and amplifications in TNS1 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1383,ACVR1B,D490N,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in ACVR1B and amplifications in TENT5A in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1393,EBF2,T104I,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in EBF2 and amplifications in KIF20B in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1394,EBF2,T252I,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in EBF2 and amplifications in DCC in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1402,VPS26B,F266L,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in VPS26B and amplifications in DCN in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with somatic mutations in PGR and amplifications in HTR3B in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with somatic mutations in PGR and amplifications in ACTB in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with somatic mutations in PGR and amplifications in PGR in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,what is the frequency of cases with somatic mutations in ACTA2 and amplifications in FBXO15 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in THBS4 and amplifications in EFCAB12 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in THBS4 and amplifications in UNC5D in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1413,PRSS1,S114T,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in PRSS1 and amplifications in PGR in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1414,PRSS1,S124T,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in PRSS1 and amplifications in GUK1 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1415,PRSS1,S138T,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in PRSS1 and amplifications in MYO16 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1416,PRSS1,S74T,Lung Adenocarcinoma,what is the frequency of cases with somatic mutations in PRSS1 and amplifications in COL6A3 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1417,PGF,R126H,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in PGF and amplifications in CDKN2AIP in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1418,PGF,R127H,Stomach Adenocarcinoma,what is the frequency of cases with somatic mutations in PGF and amplifications in GUK1 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,what is the frequency of cases with somatic mutations in ITPRID2 and amplifications in STK19 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,what is the frequency of cases with somatic mutations in ITPRID2 and amplifications in AUTS2 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in HBB and amplifications in CX3CR1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1441,PCDHB2,R158C,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in PCDHB2 and amplifications in ACVR1B in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1442,PCDHB2,T15M,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in PCDHB2 and amplifications in PGF in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1443,PCDHB2,T26M,Colon Adenocarcinoma,what is the frequency of cases with somatic mutations in PCDHB2 and amplifications in PIK3C2G in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with somatic mutations in UBR2 and amplifications in KDM5C in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1452,FBXO42,A618D,Rectum Adenocarcinoma,what is the frequency of cases with somatic mutations in FBXO42 and amplifications in TASOR2 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1,TNS1,G1362V,Breast Invasive Carcinoma,what is the frequency of cases with amplifications in TNS1 and mutations in CEP20 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+2,TNS1,G1711V,Breast Invasive Carcinoma,what is the frequency of cases with amplifications in TNS1 and mutations in KDM5C in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+3,TNS1,G1718V,Breast Invasive Carcinoma,what is the frequency of cases with amplifications in TNS1 and mutations in CTCFL in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+4,TNS1,G1732V,Breast Invasive Carcinoma,what is the frequency of cases with amplifications in TNS1 and mutations in GLRB in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+5,TNS1,G1824V,Breast Invasive Carcinoma,what is the frequency of cases with amplifications in TNS1 and mutations in TMTC3 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+6,TNS1,G1857V,Breast Invasive Carcinoma,what is the frequency of cases with amplifications in TNS1 and mutations in EPRS1 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+7,TNS1,G843V,Breast Invasive Carcinoma,what is the frequency of cases with amplifications in TNS1 and mutations in TAF1C in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,what is the frequency of cases with amplifications in EVC2 and mutations in PHLPP1 in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+15,EVC2,E987K,Bladder Urothelial Carcinoma,what is the frequency of cases with amplifications in EVC2 and mutations in AUTS2 in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in CR1 and mutations in PYHIN1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in CR1 and mutations in ZKSCAN7 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+22,TRPA1,S295I,Rectum Adenocarcinoma,what is the frequency of cases with amplifications in TRPA1 and mutations in KDM5C in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+23,TRPA1,S443I,Rectum Adenocarcinoma,what is the frequency of cases with amplifications in TRPA1 and mutations in TNS1 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+24,TAF1C,R299L,Lung Adenocarcinoma,what is the frequency of cases with amplifications in TAF1C and mutations in PRSS8 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+25,TAF1C,R396L,Lung Adenocarcinoma,what is the frequency of cases with amplifications in TAF1C and mutations in PXN in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+26,TAF1C,R634L,Lung Adenocarcinoma,what is the frequency of cases with amplifications in TAF1C and mutations in ZCCHC14 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+27,TAF1C,R702L,Lung Adenocarcinoma,what is the frequency of cases with amplifications in TAF1C and mutations in KDM5C in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+28,TAF1C,R728L,Lung Adenocarcinoma,what is the frequency of cases with amplifications in TAF1C and mutations in ACTB in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in DPF3 and mutations in ZFPM2 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in DPF3 and mutations in ZMYM3 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in DPF3 and mutations in ICE1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+42,OR2T4,P272H,Lung Adenocarcinoma,what is the frequency of cases with amplifications in OR2T4 and mutations in LAMB2 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+43,OR2T4,P300H,Lung Adenocarcinoma,what is the frequency of cases with amplifications in OR2T4 and mutations in TENT5A in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,what is the frequency of cases with amplifications in FBN1 and mutations in ANKRD30A in Pancreatic Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+45,MAD1L1,E396K,Prostate Adenocarcinoma,what is the frequency of cases with amplifications in MAD1L1 and mutations in RIMS2 in Prostate Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+46,MAD1L1,E488K,Prostate Adenocarcinoma,what is the frequency of cases with amplifications in MAD1L1 and mutations in POLD1 in Prostate Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+47,MAD1L1,E78K,Prostate Adenocarcinoma,what is the frequency of cases with amplifications in MAD1L1 and mutations in NCKAP5 in Prostate Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+61,CCNG1,E22K,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in CCNG1 and mutations in SPATA22 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,what is the frequency of cases with amplifications in ANP32E and mutations in CR1 in Kidney Renal Papillary Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,what is the frequency of cases with amplifications in ANP32E and mutations in PGR in Kidney Renal Papillary Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,what is the frequency of cases with amplifications in ANP32E and mutations in CPS1 in Kidney Renal Papillary Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,what is the frequency of cases with amplifications in ANP32E and mutations in ZMYM3 in Kidney Renal Papillary Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+66,FRY,S1888A,Bladder Urothelial Carcinoma,what is the frequency of cases with amplifications in FRY and mutations in PXN in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+67,FRY,S1937A,Bladder Urothelial Carcinoma,what is the frequency of cases with amplifications in FRY and mutations in CNGB1 in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+68,FRY,S1938A,Bladder Urothelial Carcinoma,what is the frequency of cases with amplifications in FRY and mutations in ACTB in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+69,FRY,S1983A,Bladder Urothelial Carcinoma,what is the frequency of cases with amplifications in FRY and mutations in CEP20 in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+70,PAK3,E318K,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in PAK3 and mutations in AUTS2 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+71,PAK3,E319K,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in PAK3 and mutations in TRAP1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+72,PAK3,E334K,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in PAK3 and mutations in FBXO15 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+73,PAK3,E340K,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in PAK3 and mutations in RIMS2 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+74,PAK3,E355K,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in PAK3 and mutations in ACTB in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+80,MUC16,P7963L,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in MUC16 and mutations in GPR158 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,what is the frequency of cases with amplifications in ZFPM2 and mutations in CTSC in Liver Hepatocellular Carcinoma in the genomic data commons?,cnv_and_ssm
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,what is the frequency of cases with amplifications in ZFPM2 and mutations in AUTS2 in Liver Hepatocellular Carcinoma in the genomic data commons?,cnv_and_ssm
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,what is the frequency of cases with amplifications in PIK3C2B and mutations in OR2T4 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,what is the frequency of cases with amplifications in PIK3C2B and mutations in TLK2 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+114,ZNF804A,S371Y,Colon Adenocarcinoma,what is the frequency of cases with amplifications in ZNF804A and mutations in AUTS2 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+116,RELN,A2371V,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in RELN and mutations in POLR1G in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with amplifications in EFCAB12 and mutations in TNS1 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with amplifications in EFCAB12 and mutations in PIK3C2B in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+120,DEFB115,E53K,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in DEFB115 and mutations in GABRA6 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,what is the frequency of cases with amplifications in ANKDD1A and mutations in USH2A in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,what is the frequency of cases with amplifications in ANKDD1A and mutations in HTR3B in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,what is the frequency of cases with amplifications in ANKDD1A and mutations in SOX21 in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in HTR3B and mutations in GUF1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in HTR3B and mutations in ANP32E in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in HTR3B and mutations in DPF3 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+129,ABCC3,R758W,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in ABCC3 and mutations in STK19 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in NOMO1 and mutations in DGKD in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in NOMO1 and mutations in ACTB in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,what is the frequency of cases with amplifications in HYOU1 and mutations in MAOB in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+139,FMO4,R500Q,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in FMO4 and mutations in CPS1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+140,BICC1,A372V,Exceptional Responders,what is the frequency of cases with amplifications in BICC1 and mutations in TENT5A in Exceptional Responders in the genomic data commons?,cnv_and_ssm
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in ZMYM3 and mutations in EVC2 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in ZMYM3 and mutations in RIMS2 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in ZMYM3 and mutations in ANP32E in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with amplifications in XKR4 and mutations in GABRA6 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,what is the frequency of cases with amplifications in ABCC2 and mutations in PTPRN2 in Liver Hepatocellular Carcinoma in the genomic data commons?,cnv_and_ssm
+157,OR8K5,R293G,Lung Adenocarcinoma,what is the frequency of cases with amplifications in OR8K5 and mutations in PTPRO in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in SPTAN1 and mutations in CFAP298-TCP10L in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in SPTAN1 and mutations in ZMYM3 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+164,SYT10,M484I,Rectum Adenocarcinoma,what is the frequency of cases with amplifications in SYT10 and mutations in UNC5D in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+174,HSPA5,N457K,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in HSPA5 and mutations in CASZ1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+175,UNC5D,L280V,Lung Adenocarcinoma,what is the frequency of cases with amplifications in UNC5D and mutations in DSCAM in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+176,UNC5D,L635V,Lung Adenocarcinoma,what is the frequency of cases with amplifications in UNC5D and mutations in IL5RA in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+177,UNC5D,L637V,Lung Adenocarcinoma,what is the frequency of cases with amplifications in UNC5D and mutations in TASOR2 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+178,UNC5D,L699V,Lung Adenocarcinoma,what is the frequency of cases with amplifications in UNC5D and mutations in CPS1 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+179,UNC5D,L704V,Lung Adenocarcinoma,what is the frequency of cases with amplifications in UNC5D and mutations in OLFML3 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+180,UNC5D,L709V,Lung Adenocarcinoma,what is the frequency of cases with amplifications in UNC5D and mutations in VPS26B in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,what is the frequency of cases with amplifications in DOCK2 and mutations in PRSS1 in Kidney Renal Clear Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,what is the frequency of cases with amplifications in ZNF627 and mutations in ACTA2 in Kidney Renal Clear Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in CDC42BPA and mutations in ZMYM3 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+193,MRPL55,H27Y,Colon Adenocarcinoma,what is the frequency of cases with amplifications in MRPL55 and mutations in EIF2B4 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+194,MRPL55,H63Y,Colon Adenocarcinoma,what is the frequency of cases with amplifications in MRPL55 and mutations in DCN in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+197,TMTC3,Q749K,Breast Invasive Carcinoma,what is the frequency of cases with amplifications in TMTC3 and mutations in DOCK2 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+198,EPRS1,K771I,Colon Adenocarcinoma,what is the frequency of cases with amplifications in EPRS1 and mutations in SORCS1 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+199,EPRS1,K778I,Colon Adenocarcinoma,what is the frequency of cases with amplifications in EPRS1 and mutations in ITPRID2 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+201,GRTP1,A110V,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in GRTP1 and mutations in RIMS2 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+202,GRTP1,A32V,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in GRTP1 and mutations in GRTP1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in TSHZ3 and mutations in FBN1 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,what is the frequency of cases with amplifications in TAS1R3 and mutations in DCAF4L2 in HIV+ Tumor Molecular Characterization Project - Cervical Cancer in the genomic data commons?,cnv_and_ssm
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in PIAS3 and mutations in ZNF431 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in PIAS3 and mutations in TAF1L in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+251,ZNF274,P13R,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in ZNF274 and mutations in PGF in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+253,SYNJ1,R795C,Colon Adenocarcinoma,what is the frequency of cases with amplifications in SYNJ1 and mutations in PTPRN2 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+254,SYNJ1,R800C,Colon Adenocarcinoma,what is the frequency of cases with amplifications in SYNJ1 and mutations in GABRA6 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+255,SYNJ1,R839C,Colon Adenocarcinoma,what is the frequency of cases with amplifications in SYNJ1 and mutations in GUCY2C in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+261,DSCAM,V343M,Prostate Adenocarcinoma,what is the frequency of cases with amplifications in DSCAM and mutations in PCDHB2 in Prostate Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+262,DSCAM,V426M,Prostate Adenocarcinoma,what is the frequency of cases with amplifications in DSCAM and mutations in ANKRD30A in Prostate Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+263,DSCAM,V591M,Prostate Adenocarcinoma,what is the frequency of cases with amplifications in DSCAM and mutations in PAK3 in Prostate Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+267,DGKD,R140H,Exceptional Responders,what is the frequency of cases with amplifications in DGKD and mutations in SYT9 in Exceptional Responders in the genomic data commons?,cnv_and_ssm
+268,DGKD,R160H,Exceptional Responders,what is the frequency of cases with amplifications in DGKD and mutations in GABRA6 in Exceptional Responders in the genomic data commons?,cnv_and_ssm
+269,DGKD,R204H,Exceptional Responders,what is the frequency of cases with amplifications in DGKD and mutations in BICC1 in Exceptional Responders in the genomic data commons?,cnv_and_ssm
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,what is the frequency of cases with amplifications in PLEKHG6 and mutations in FGF8 in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,what is the frequency of cases with amplifications in PLEKHG6 and mutations in YY1AP1 in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,what is the frequency of cases with amplifications in PLEKHG6 and mutations in DPF3 in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+279,WNT2,D138N,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in WNT2 and mutations in RIPOR2 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in GUCY2C and mutations in GPRASP1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in C7orf31 and mutations in DCC in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with amplifications in ZKSCAN7 and mutations in GABRA6 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+299,OR5D14,M210L,Neuroblastoma,what is the frequency of cases with amplifications in OR5D14 and mutations in PGR in Neuroblastoma in the genomic data commons?,cnv_and_ssm
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in SPATA22 and mutations in YY1AP1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in SPATA22 and mutations in AQP7 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in SPATA22 and mutations in LCN15 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+310,LCN15,E21V,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in LCN15 and mutations in ACTB in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in DCAF4L2 and mutations in THBS4 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in GUK1 and mutations in PTPRN2 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in GUK1 and mutations in MRPL55 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in GUK1 and mutations in CARMIL1 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in GUK1 and mutations in ABCC2 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in GUK1 and mutations in POLR1G in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+328,MORF4L1,K29T,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in MORF4L1 and mutations in ANKRD24 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+329,MORF4L1,K51T,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in MORF4L1 and mutations in CPS1 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+330,MORF4L1,K61T,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in MORF4L1 and mutations in GRTP1 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+331,MORF4L1,K76T,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in MORF4L1 and mutations in PAK3 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+335,MYO3B,F594L,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in MYO3B and mutations in LAMB2 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+336,MYO3B,F603L,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in MYO3B and mutations in PCDHB2 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+339,TENT5A,S320F,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in TENT5A and mutations in ARMC3 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+340,TENT5A,S339F,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in TENT5A and mutations in STK19 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+341,TENT5A,S401F,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in TENT5A and mutations in ZNF804A in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,what is the frequency of cases with amplifications in ZFAT and mutations in RIMS2 in Ovarian Serous Cystadenocarcinoma in the genomic data commons?,cnv_and_ssm
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,what is the frequency of cases with amplifications in ZFAT and mutations in AUTS2 in Ovarian Serous Cystadenocarcinoma in the genomic data commons?,cnv_and_ssm
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,what is the frequency of cases with amplifications in ZFAT and mutations in THBS4 in Ovarian Serous Cystadenocarcinoma in the genomic data commons?,cnv_and_ssm
+357,ZNF584,A211T,Sarcoma,what is the frequency of cases with amplifications in ZNF584 and mutations in DNAH11 in Sarcoma in the genomic data commons?,cnv_and_ssm
+358,ZNF584,A256T,Sarcoma,what is the frequency of cases with amplifications in ZNF584 and mutations in POC1B in Sarcoma in the genomic data commons?,cnv_and_ssm
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in LDOC1 and mutations in EPRS1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in PDGFC and mutations in GUK1 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in MSANTD4 and mutations in CDC42BPA in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+374,NPSR1,S123L,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in NPSR1 and mutations in MAST4 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in PHLPP1 and mutations in DCN in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+385,COL6A3,G237S,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in COL6A3 and mutations in RAB40C in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+386,COL6A3,G437S,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in COL6A3 and mutations in KDM5C in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+387,COL6A3,G638S,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in COL6A3 and mutations in POLD1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+388,COL6A3,G644S,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in COL6A3 and mutations in TMTC3 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+389,COL6A3,G844S,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in COL6A3 and mutations in GABRA6 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+395,ADRA1A,R348G,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in ADRA1A and mutations in TTC17 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what is the frequency of cases with amplifications in LAMB2 and mutations in CNGB1 in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+406,POC1B,I198T,Rectum Adenocarcinoma,what is the frequency of cases with amplifications in POC1B and mutations in CPS1 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+407,POC1B,I286T,Rectum Adenocarcinoma,what is the frequency of cases with amplifications in POC1B and mutations in PTPRN2 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+408,POC1B,I328T,Rectum Adenocarcinoma,what is the frequency of cases with amplifications in POC1B and mutations in RIMS2 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+409,POC1B,S79P,Rectum Adenocarcinoma,what is the frequency of cases with amplifications in POC1B and mutations in BCAT1 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,what is the frequency of cases with amplifications in USH2A and mutations in MRPL55 in Liver Hepatocellular Carcinoma in the genomic data commons?,cnv_and_ssm
+414,AQP7,T110S,Rectum Adenocarcinoma,what is the frequency of cases with amplifications in AQP7 and mutations in MYT1 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+415,AQP7,T166S,Rectum Adenocarcinoma,what is the frequency of cases with amplifications in AQP7 and mutations in EIF2B4 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+416,AQP7,T167S,Rectum Adenocarcinoma,what is the frequency of cases with amplifications in AQP7 and mutations in AQP7 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+417,AQP7,T75S,Rectum Adenocarcinoma,what is the frequency of cases with amplifications in AQP7 and mutations in GUK1 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+430,DCN,R163C,Rectum Adenocarcinoma,what is the frequency of cases with amplifications in DCN and mutations in CDH23 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+431,DCN,R203C,Rectum Adenocarcinoma,what is the frequency of cases with amplifications in DCN and mutations in SMO in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+432,DCN,R241C,Rectum Adenocarcinoma,what is the frequency of cases with amplifications in DCN and mutations in RAB40C in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+433,DCN,R350C,Rectum Adenocarcinoma,what is the frequency of cases with amplifications in DCN and mutations in MIEF1 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+434,DCN,R41C,Rectum Adenocarcinoma,what is the frequency of cases with amplifications in DCN and mutations in DCC in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in CPS1 and mutations in DNMT1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in CPS1 and mutations in BFAR in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in CPS1 and mutations in YY1AP1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,what is the frequency of cases with amplifications in FCGR2C and mutations in CTSC in Kidney Renal Papillary Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,what is the frequency of cases with amplifications in FCGR2C and mutations in CYB5R2 in Kidney Renal Papillary Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in GRM1 and mutations in VASN in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+482,SGCZ,Q138H,Lung Adenocarcinoma,what is the frequency of cases with amplifications in SGCZ and mutations in MYO16 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+483,SGCZ,Q91H,Lung Adenocarcinoma,what is the frequency of cases with amplifications in SGCZ and mutations in TRIM45 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+485,SMO,V15M,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in SMO and mutations in PKHD1L1 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+486,SMO,V321M,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in SMO and mutations in ZCCHC14 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+488,CHODL,G159E,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in CHODL and mutations in EBF2 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+489,CHODL,G181E,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in CHODL and mutations in MYH11 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+490,CHODL,G200E,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in CHODL and mutations in TTN in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+494,MYO16,P399H,Colon Adenocarcinoma,what is the frequency of cases with amplifications in MYO16 and mutations in MYH11 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+495,MYO16,P421H,Colon Adenocarcinoma,what is the frequency of cases with amplifications in MYO16 and mutations in EVC2 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+498,CXCR2,A98V,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in CXCR2 and mutations in EFCAB12 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,what is the frequency of cases with amplifications in TMEM225 and mutations in TAF1C in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in MAOB and mutations in ZFAT in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in GPRASP1 and mutations in CEP20 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in MRPL32 and mutations in COL6A3 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in TYROBP and mutations in CR1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+510,RAB40C,A111V,Lung Adenocarcinoma,what is the frequency of cases with amplifications in RAB40C and mutations in DGKD in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+511,RAB40C,A143V,Lung Adenocarcinoma,what is the frequency of cases with amplifications in RAB40C and mutations in STAT3 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+512,CTNNA2,S323R,Lung Adenocarcinoma,what is the frequency of cases with amplifications in CTNNA2 and mutations in ANKRD30A in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+513,CTNNA2,S339R,Lung Adenocarcinoma,what is the frequency of cases with amplifications in CTNNA2 and mutations in SPINDOC in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+514,CTNNA2,S386R,Lung Adenocarcinoma,what is the frequency of cases with amplifications in CTNNA2 and mutations in SLC9C1 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+515,CTNNA2,S707R,Lung Adenocarcinoma,what is the frequency of cases with amplifications in CTNNA2 and mutations in DNAH11 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,what is the frequency of cases with amplifications in MYO15A and mutations in PGR in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in GIMAP2 and mutations in GUK1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+532,KIF20B,N1160D,Glioblastoma Multiforme,what is the frequency of cases with amplifications in KIF20B and mutations in TNS1 in Glioblastoma Multiforme in the genomic data commons?,cnv_and_ssm
+533,KIF20B,N1200D,Glioblastoma Multiforme,what is the frequency of cases with amplifications in KIF20B and mutations in PCDHB2 in Glioblastoma Multiforme in the genomic data commons?,cnv_and_ssm
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in ADAM17 and mutations in GUK1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in BCAT1 and mutations in HTR3B in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in BCAT1 and mutations in SLC6A4 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in BCAT1 and mutations in TMEM255A in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+540,ERCC6,R1053H,Colon Adenocarcinoma,what is the frequency of cases with amplifications in ERCC6 and mutations in JAML in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+541,DCC,R320W,Breast Invasive Carcinoma,what is the frequency of cases with amplifications in DCC and mutations in ZNF431 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+542,DCC,R363W,Breast Invasive Carcinoma,what is the frequency of cases with amplifications in DCC and mutations in OR13C3 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+543,DCC,R386W,Breast Invasive Carcinoma,what is the frequency of cases with amplifications in DCC and mutations in REXO4 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+544,DCC,R41W,Breast Invasive Carcinoma,what is the frequency of cases with amplifications in DCC and mutations in TNS1 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+549,FBXO15,D417N,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in FBXO15 and mutations in AUTS2 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+550,FBXO15,D86N,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in FBXO15 and mutations in DHX16 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in GSTCD and mutations in EFCAB12 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in GSTCD and mutations in CTSC in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in OLFML3 and mutations in AUTS2 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in OLFML3 and mutations in TAF1C in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in OLFML3 and mutations in KIF20B in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,what is the frequency of cases with amplifications in CFAP61 and mutations in POC1B in Ovarian Serous Cystadenocarcinoma in the genomic data commons?,cnv_and_ssm
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,what is the frequency of cases with amplifications in CFAP61 and mutations in SGIP1 in Ovarian Serous Cystadenocarcinoma in the genomic data commons?,cnv_and_ssm
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,what is the frequency of cases with amplifications in HLA-DQA2 and mutations in SPATA22 in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+582,TENM2,H240Y,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in TENM2 and mutations in ACVR1B in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+583,TENM2,H351Y,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in TENM2 and mutations in PAK3 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+584,TENM2,H472Y,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in TENM2 and mutations in ADRA1A in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+600,ANKRD24,A465T,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in ANKRD24 and mutations in ANKDD1A in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+601,ANKRD24,A494T,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in ANKRD24 and mutations in SPINDOC in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+602,ANKRD24,A584T,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in ANKRD24 and mutations in GPRASP1 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in ZCCHC14 and mutations in MRPL55 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in ZCCHC14 and mutations in EPRS1 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in ZCCHC14 and mutations in FBXO15 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in ZCCHC14 and mutations in POLD1 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+625,SIK2,I265M,Lung Adenocarcinoma,what is the frequency of cases with amplifications in SIK2 and mutations in TTN in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in MYH11 and mutations in PRSS1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in MYH11 and mutations in THBS4 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in SLC6A4 and mutations in ANKDD1A in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in SLC9C1 and mutations in PCDHGA1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in SLC9C1 and mutations in TAS1R3 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+644,OR2A12,A254T,Brain Lower Grade Glioma,what is the frequency of cases with amplifications in OR2A12 and mutations in TNS1 in Brain Lower Grade Glioma in the genomic data commons?,cnv_and_ssm
+646,PYHIN1,T325K,Lung Adenocarcinoma,what is the frequency of cases with amplifications in PYHIN1 and mutations in PIK3C2B in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+647,PYHIN1,T334K,Lung Adenocarcinoma,what is the frequency of cases with amplifications in PYHIN1 and mutations in POC1B in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+650,JAML,G191E,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in JAML and mutations in PTPRO in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+651,JAML,G219E,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in JAML and mutations in DEFB115 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+652,JAML,G220E,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in JAML and mutations in THBS4 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+653,JAML,G230E,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in JAML and mutations in PTPRO in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+658,TYK2,H1146R,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in TYK2 and mutations in ACVR1B in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+659,TYK2,H23R,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in TYK2 and mutations in TLK2 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+660,TYK2,H961R,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in TYK2 and mutations in PXN in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in CTCFL and mutations in ZCCHC14 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in CTCFL and mutations in ARMC3 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in CTCFL and mutations in ABCC2 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in CTCFL and mutations in CTSC in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in CEP20 and mutations in SPATA22 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in CEP20 and mutations in CPS1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+689,RIMS2,R25W,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in RIMS2 and mutations in TMEM225 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+690,RIMS2,R393W,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in RIMS2 and mutations in KDM5C in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+691,RIMS2,R423W,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in RIMS2 and mutations in BCAT1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+692,RIMS2,R470W,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in RIMS2 and mutations in MYO15A in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+693,RIMS2,R615W,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in RIMS2 and mutations in EPRS1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+694,RIMS2,R619W,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in RIMS2 and mutations in PAK3 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+695,RIMS2,R716W,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in RIMS2 and mutations in HBB in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in PIK3C2G and mutations in PTPRN2 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in PIK3C2G and mutations in TASOR2 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+728,STK19,D341N,Colon Adenocarcinoma,what is the frequency of cases with amplifications in STK19 and mutations in PAK3 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+729,STK19,D345N,Colon Adenocarcinoma,what is the frequency of cases with amplifications in STK19 and mutations in DCN in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+730,REXO4,P60A,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in REXO4 and mutations in DNMT1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in ZBTB34 and mutations in DCAF6 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in ZBTB34 and mutations in MORF4L1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,what is the frequency of cases with amplifications in NCKAP5 and mutations in GABRA6 in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with amplifications in SORCS1 and mutations in YY1AP1 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with amplifications in SORCS1 and mutations in HTR3B in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with amplifications in SORCS1 and mutations in SLC9C1 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with amplifications in SORCS1 and mutations in CTSC in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,what is the frequency of cases with amplifications in FGF8 and mutations in MYT1 in Head and Neck Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,what is the frequency of cases with amplifications in FGF8 and mutations in ABCC2 in Head and Neck Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,what is the frequency of cases with amplifications in FGF8 and mutations in TNS1 in Head and Neck Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,what is the frequency of cases with amplifications in FGF8 and mutations in COL6A3 in Head and Neck Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,what is the frequency of cases with amplifications in FGF8 and mutations in OR8K5 in Head and Neck Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,what is the frequency of cases with amplifications in TENM3 and mutations in GABRA6 in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia in the genomic data commons?,cnv_and_ssm
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in AKT1 and mutations in MORF4L1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what is the frequency of cases with amplifications in CFAP298-TCP10L and mutations in PGR in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+792,GLRB,E148D,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in GLRB and mutations in DHX16 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+793,TTN,F7636L,Colon Adenocarcinoma,what is the frequency of cases with amplifications in TTN and mutations in TENM2 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+794,TTN,F8563L,Colon Adenocarcinoma,what is the frequency of cases with amplifications in TTN and mutations in PAK3 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+795,TTN,F8880L,Colon Adenocarcinoma,what is the frequency of cases with amplifications in TTN and mutations in WNT2 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+799,ANKRD30A,V798I,Colon Adenocarcinoma,what is the frequency of cases with amplifications in ANKRD30A and mutations in LAMB2 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+800,ANKRD30A,V854I,Colon Adenocarcinoma,what is the frequency of cases with amplifications in ANKRD30A and mutations in DNAH14 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+801,ANKRD30A,V973I,Colon Adenocarcinoma,what is the frequency of cases with amplifications in ANKRD30A and mutations in SGCZ in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+809,TRIM45,S177L,Colon Adenocarcinoma,what is the frequency of cases with amplifications in TRIM45 and mutations in UNC5D in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+810,TRIM45,S224L,Colon Adenocarcinoma,what is the frequency of cases with amplifications in TRIM45 and mutations in SORCS1 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+811,TRIM45,S281L,Colon Adenocarcinoma,what is the frequency of cases with amplifications in TRIM45 and mutations in SLC6A4 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+812,CACNA1F,G727V,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in CACNA1F and mutations in BFAR in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+813,CACNA1F,G781V,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in CACNA1F and mutations in PTPRO in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+814,CACNA1F,G792V,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in CACNA1F and mutations in FGF8 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+817,KL,R594C,Colon Adenocarcinoma,what is the frequency of cases with amplifications in KL and mutations in CTCFL in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,what is the frequency of cases with amplifications in GUF1 and mutations in NCKAP5 in Kidney Renal Papillary Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+822,TAF1L,A539V,Colon Adenocarcinoma,what is the frequency of cases with amplifications in TAF1L and mutations in ADRA1A in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+823,TASOR2,S256F,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in TASOR2 and mutations in ADRA1A in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+824,TASOR2,S36F,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in TASOR2 and mutations in SYNJ1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+825,TASOR2,S471F,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in TASOR2 and mutations in TAF1C in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in KDM5C and mutations in ACTB in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in KDM5C and mutations in ANP32E in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in KDM5C and mutations in TASOR2 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in KDM5C and mutations in GIMAP2 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what is the frequency of cases with amplifications in IL5RA and mutations in B3GALNT1 in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+843,DHX16,A29V,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in DHX16 and mutations in POLD1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+844,DHX16,A89V,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in DHX16 and mutations in ANP32E in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+902,GPR158,A644V,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in GPR158 and mutations in OLFML3 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+903,GPR158,A723V,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in GPR158 and mutations in DSCAM in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with amplifications in EIF2B4 and mutations in CYB5R2 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with amplifications in EIF2B4 and mutations in UNC5D in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with amplifications in EIF2B4 and mutations in PTPRO in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with amplifications in EIF2B4 and mutations in GUCY2C in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with amplifications in EIF2B4 and mutations in OLFML3 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with amplifications in EIF2B4 and mutations in SYT10 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in AUTS2 and mutations in ZFAT in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in AUTS2 and mutations in WNT2 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in AUTS2 and mutations in PCDHB2 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in AUTS2 and mutations in AUTS2 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in AUTS2 and mutations in MAD1L1 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in AUTS2 and mutations in MYO3B in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in AUTS2 and mutations in ARHGEF40 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in AUTS2 and mutations in SIK2 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in AUTS2 and mutations in RIPOR2 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in AUTS2 and mutations in ACTL7B in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with amplifications in ACTL7B and mutations in CX3CR1 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+952,PCDHGA1,R535W,Glioblastoma Multiforme,what is the frequency of cases with amplifications in PCDHGA1 and mutations in GABRA6 in Glioblastoma Multiforme in the genomic data commons?,cnv_and_ssm
+954,TRAP1,R114W,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in TRAP1 and mutations in CX3CR1 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+955,TRAP1,R61W,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in TRAP1 and mutations in GABRA6 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in PIK3C2A and mutations in ZNF584 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,what is the frequency of cases with amplifications in KANSL1 and mutations in FRY in Liver Hepatocellular Carcinoma in the genomic data commons?,cnv_and_ssm
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in ANKRD52 and mutations in ACVR1B in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in PAPPA and mutations in TENM3 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,what is the frequency of cases with amplifications in B3GALNT1 and mutations in UNC5D in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+982,GABRA6,G115R,Lung Adenocarcinoma,what is the frequency of cases with amplifications in GABRA6 and mutations in UNC5D in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+983,GABRA6,G122R,Lung Adenocarcinoma,what is the frequency of cases with amplifications in GABRA6 and mutations in SGIP1 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+984,GABRA6,G165R,Lung Adenocarcinoma,what is the frequency of cases with amplifications in GABRA6 and mutations in UBR2 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+985,GABRA6,G175R,Lung Adenocarcinoma,what is the frequency of cases with amplifications in GABRA6 and mutations in GRM1 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+986,GABRA6,G70R,Lung Adenocarcinoma,what is the frequency of cases with amplifications in GABRA6 and mutations in ACVR1B in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in ZSCAN31 and mutations in TTC12 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with amplifications in MED16 and mutations in MAST4 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with amplifications in MED16 and mutations in ARHGEF40 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,what is the frequency of cases with amplifications in PTPRO and mutations in PGR in Pancreatic Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,what is the frequency of cases with amplifications in PTPRO and mutations in MAST4 in Pancreatic Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,what is the frequency of cases with amplifications in PTPRO and mutations in TSHZ3 in Pancreatic Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,what is the frequency of cases with amplifications in PTPRO and mutations in TAF1C in Pancreatic Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,what is the frequency of cases with amplifications in PTPRO and mutations in DSCAM in Pancreatic Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,what is the frequency of cases with amplifications in PTPRO and mutations in CDH23 in Pancreatic Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,what is the frequency of cases with amplifications in PTPRO and mutations in PTPRN2 in Pancreatic Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,what is the frequency of cases with amplifications in PTPRO and mutations in SGIP1 in Pancreatic Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in CHMP7 and mutations in CEP20 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1017,GPC3,I107N,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in GPC3 and mutations in TMEM255A in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1018,GPC3,I161N,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in GPC3 and mutations in TAF1C in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what is the frequency of cases with amplifications in TLK2 and mutations in ACTB in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what is the frequency of cases with amplifications in TLK2 and mutations in GUK1 in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what is the frequency of cases with amplifications in TLK2 and mutations in MED16 in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what is the frequency of cases with amplifications in TLK2 and mutations in PTPRO in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,what is the frequency of cases with amplifications in TLK2 and mutations in AUTS2 in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1036,ZNF217,E209Q,Lung Adenocarcinoma,what is the frequency of cases with amplifications in ZNF217 and mutations in TENT5A in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1038,SYT9,V275L,Lung Adenocarcinoma,what is the frequency of cases with amplifications in SYT9 and mutations in TAF1C in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1039,SYT9,V307L,Lung Adenocarcinoma,what is the frequency of cases with amplifications in SYT9 and mutations in CEP20 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in PKHD1L1 and mutations in CFAP298-TCP10L in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in MYO3A and mutations in SYNJ1 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with amplifications in VASN and mutations in RIPOR2 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in DNMT1 and mutations in CFAP61 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in DNMT1 and mutations in HBB in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in DNMT1 and mutations in RIPOR2 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1056,CA9,E402K,Colon Adenocarcinoma,what is the frequency of cases with amplifications in CA9 and mutations in TTC17 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in TTC17 and mutations in ACVR1B in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in TTC17 and mutations in BCAT1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1065,PSG2,P43L,Breast Invasive Carcinoma,what is the frequency of cases with amplifications in PSG2 and mutations in AUTS2 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,what is the frequency of cases with amplifications in RIPOR2 and mutations in PTPRO in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,what is the frequency of cases with amplifications in RIPOR2 and mutations in FGF8 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,what is the frequency of cases with amplifications in RIPOR2 and mutations in SOX21 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,what is the frequency of cases with amplifications in RIPOR2 and mutations in NEXN in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in DCLK3 and mutations in SLC6A4 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in DCLK3 and mutations in ICE1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in MERTK and mutations in RELN in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in MERTK and mutations in DCN in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in MERTK and mutations in PCDHGA1 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in ZFP42 and mutations in CPS1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in OR13C3 and mutations in SYNJ1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in OR13C3 and mutations in PIK3C2B in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+1091,SPAG1,I917M,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in SPAG1 and mutations in CTNNA2 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in CDKN2AIP and mutations in WNT2 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1093,PXN,H1016Y,Colon Adenocarcinoma,what is the frequency of cases with amplifications in PXN and mutations in FCGR2C in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1094,PXN,H359Y,Colon Adenocarcinoma,what is the frequency of cases with amplifications in PXN and mutations in EVC2 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1095,PXN,H492Y,Colon Adenocarcinoma,what is the frequency of cases with amplifications in PXN and mutations in FGF8 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1096,PXN,H524Y,Colon Adenocarcinoma,what is the frequency of cases with amplifications in PXN and mutations in DCN in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1097,PXN,H526Y,Colon Adenocarcinoma,what is the frequency of cases with amplifications in PXN and mutations in GUK1 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1098,PXN,H540Y,Colon Adenocarcinoma,what is the frequency of cases with amplifications in PXN and mutations in DCN in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in TTYH2 and mutations in FGF8 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in TTYH2 and mutations in REXO4 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1106,TMEM255A,N205S,Colon Adenocarcinoma,what is the frequency of cases with amplifications in TMEM255A and mutations in BICC1 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1107,TMEM255A,N229S,Colon Adenocarcinoma,what is the frequency of cases with amplifications in TMEM255A and mutations in LDOC1 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1108,TMEM255A,N65S,Colon Adenocarcinoma,what is the frequency of cases with amplifications in TMEM255A and mutations in ZFP42 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,what is the frequency of cases with amplifications in TASOR2 and mutations in ANKRD52 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,what is the frequency of cases with amplifications in TASOR2 and mutations in PRSS1 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in ICE1 and mutations in TAF1C in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1112,MYT1,A558E,Breast Invasive Carcinoma,what is the frequency of cases with amplifications in MYT1 and mutations in KDM5C in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+1113,MYT1,A879E,Breast Invasive Carcinoma,what is the frequency of cases with amplifications in MYT1 and mutations in TTC17 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+1114,MYT1,A906E,Breast Invasive Carcinoma,what is the frequency of cases with amplifications in MYT1 and mutations in CFAP61 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in CX3CR1 and mutations in TENT5A in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in CX3CR1 and mutations in MERTK in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,what is the frequency of cases with amplifications in SPINDOC and mutations in RIMS2 in Liver Hepatocellular Carcinoma in the genomic data commons?,cnv_and_ssm
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in ART3 and mutations in SLC9C1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in ART3 and mutations in ACVR1B in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,what is the frequency of cases with amplifications in CYP1A2 and mutations in PAK3 in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with amplifications in ADRA1A and mutations in TLK2 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in CDH23 and mutations in CDKN2AIP in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in CDH23 and mutations in CHODL in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+1148,KRT39,P137S,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in KRT39 and mutations in FRY in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in PDHA2 and mutations in AUTS2 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,what is the frequency of cases with amplifications in SLC24A2 and mutations in HTR3B in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,what is the frequency of cases with amplifications in PTPRN2 and mutations in GUF1 in Liver Hepatocellular Carcinoma in the genomic data commons?,cnv_and_ssm
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,what is the frequency of cases with amplifications in PTPRN2 and mutations in TYROBP in Liver Hepatocellular Carcinoma in the genomic data commons?,cnv_and_ssm
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,what is the frequency of cases with amplifications in PTPRN2 and mutations in POC1B in Liver Hepatocellular Carcinoma in the genomic data commons?,cnv_and_ssm
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,what is the frequency of cases with amplifications in PTPRN2 and mutations in TENT5A in Liver Hepatocellular Carcinoma in the genomic data commons?,cnv_and_ssm
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,what is the frequency of cases with amplifications in PTPRN2 and mutations in OR13C3 in Liver Hepatocellular Carcinoma in the genomic data commons?,cnv_and_ssm
+1188,SOX21,R55L,Lung Adenocarcinoma,what is the frequency of cases with amplifications in SOX21 and mutations in TNS1 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,what is the frequency of cases with amplifications in CPA6 and mutations in FBXO15 in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+1206,GRM5,E14K,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in GRM5 and mutations in SMO in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with amplifications in CASZ1 and mutations in SGCZ in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+1210,SGIP1,N122T,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in SGIP1 and mutations in DPF3 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1211,SGIP1,N420T,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in SGIP1 and mutations in LCN15 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1212,SGIP1,N617T,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in SGIP1 and mutations in ART3 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1213,SGIP1,N648T,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in SGIP1 and mutations in SERPINB10 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1227,CARMIL1,V549L,Lung Adenocarcinoma,what is the frequency of cases with amplifications in CARMIL1 and mutations in ACTA2 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1228,CARMIL1,V949L,Lung Adenocarcinoma,what is the frequency of cases with amplifications in CARMIL1 and mutations in YY1AP1 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1232,ZNF431,D121Y,Lung Adenocarcinoma,what is the frequency of cases with amplifications in ZNF431 and mutations in FGF8 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1233,ZNF431,D161Y,Lung Adenocarcinoma,what is the frequency of cases with amplifications in ZNF431 and mutations in AQP7 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1234,ZNF431,R128I,Lung Adenocarcinoma,what is the frequency of cases with amplifications in ZNF431 and mutations in PLEKHG6 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in DNAH11 and mutations in SGIP1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in DNAH11 and mutations in MAST4 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in POLD1 and mutations in SPTAN1 in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,what is the frequency of cases with amplifications in POLD1 and mutations in CTCFL in Lung Squamous Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+1248,TTC12,D646H,Lung Adenocarcinoma,what is the frequency of cases with amplifications in TTC12 and mutations in MYT1 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1249,TTC12,D652H,Lung Adenocarcinoma,what is the frequency of cases with amplifications in TTC12 and mutations in PTPRO in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,what is the frequency of cases with amplifications in CNGB1 and mutations in SYT10 in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,what is the frequency of cases with amplifications in CNGB1 and mutations in PGF in Bladder Urothelial Carcinoma in the genomic data commons?,cnv_and_ssm
+1254,CTSC,E214V,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in CTSC and mutations in AQP7 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1255,CTSC,E291V,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in CTSC and mutations in ADRA1A in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1256,CTSC,E322V,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in CTSC and mutations in BCAT1 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1257,CTSC,E324V,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in CTSC and mutations in TYK2 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1258,CTSC,E335V,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in CTSC and mutations in PAK3 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in PRSS8 and mutations in MYH11 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in PRSS8 and mutations in TTYH2 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,what is the frequency of cases with amplifications in ARHGEF40 and mutations in ACTB in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1264,ACTB,A138T,Rectum Adenocarcinoma,what is the frequency of cases with amplifications in ACTB and mutations in PXN in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1265,ACTB,A217T,Rectum Adenocarcinoma,what is the frequency of cases with amplifications in ACTB and mutations in TMEM255A in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1266,ACTB,A244T,Rectum Adenocarcinoma,what is the frequency of cases with amplifications in ACTB and mutations in COL6A3 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1267,ACTB,A260T,Rectum Adenocarcinoma,what is the frequency of cases with amplifications in ACTB and mutations in CCDC22 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1268,YY1AP1,V546D,Glioblastoma Multiforme,what is the frequency of cases with amplifications in YY1AP1 and mutations in RIMS2 in Glioblastoma Multiforme in the genomic data commons?,cnv_and_ssm
+1269,YY1AP1,V557D,Glioblastoma Multiforme,what is the frequency of cases with amplifications in YY1AP1 and mutations in LCN15 in Glioblastoma Multiforme in the genomic data commons?,cnv_and_ssm
+1270,YY1AP1,V566D,Glioblastoma Multiforme,what is the frequency of cases with amplifications in YY1AP1 and mutations in DGKD in Glioblastoma Multiforme in the genomic data commons?,cnv_and_ssm
+1271,YY1AP1,V577D,Glioblastoma Multiforme,what is the frequency of cases with amplifications in YY1AP1 and mutations in MAST4 in Glioblastoma Multiforme in the genomic data commons?,cnv_and_ssm
+1272,YY1AP1,V623D,Glioblastoma Multiforme,what is the frequency of cases with amplifications in YY1AP1 and mutations in PRSS8 in Glioblastoma Multiforme in the genomic data commons?,cnv_and_ssm
+1273,YY1AP1,V695D,Glioblastoma Multiforme,what is the frequency of cases with amplifications in YY1AP1 and mutations in GUK1 in Glioblastoma Multiforme in the genomic data commons?,cnv_and_ssm
+1274,YY1AP1,V715D,Glioblastoma Multiforme,what is the frequency of cases with amplifications in YY1AP1 and mutations in SPTAN1 in Glioblastoma Multiforme in the genomic data commons?,cnv_and_ssm
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in FNDC7 and mutations in PLEKHG6 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in FNDC7 and mutations in CNGB1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+1299,TLCD5,G15V,Lung Adenocarcinoma,what is the frequency of cases with amplifications in TLCD5 and mutations in ZNF708 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1300,TLCD5,G37V,Lung Adenocarcinoma,what is the frequency of cases with amplifications in TLCD5 and mutations in ZFPM2 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in POLR1G and mutations in FRY in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in POLR1G and mutations in RIMS2 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1308,DNAH14,N1186K,Colon Adenocarcinoma,what is the frequency of cases with amplifications in DNAH14 and mutations in SMO in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1309,DNAH14,N2657K,Colon Adenocarcinoma,what is the frequency of cases with amplifications in DNAH14 and mutations in OR2T4 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1310,DNAH14,N3460K,Colon Adenocarcinoma,what is the frequency of cases with amplifications in DNAH14 and mutations in DGKD in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in NEXN and mutations in ZFAT in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,what is the frequency of cases with amplifications in CYB5R2 and mutations in PTPRN2 in Prostate Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,what is the frequency of cases with amplifications in CYB5R2 and mutations in PAPPA in Prostate Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in NRAP and mutations in PCDHGA1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in NRAP and mutations in ANP32E in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in NRAP and mutations in PIAS3 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in CCDC22 and mutations in PXN in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in DCAF6 and mutations in BCAT1 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in DCAF6 and mutations in SYT9 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in ZNF708 and mutations in PXN in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in BFAR and mutations in KL in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in MAST4 and mutations in FNDC7 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in MAST4 and mutations in DCN in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in MAST4 and mutations in UNC5D in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in MAST4 and mutations in CX3CR1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in MAST4 and mutations in NOMO1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1363,ARMC3,R169C,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in ARMC3 and mutations in COL6A3 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1364,ARMC3,R432C,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in ARMC3 and mutations in EIF2B4 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,what is the frequency of cases with amplifications in TET2 and mutations in TLK2 in Kidney Renal Clear Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,what is the frequency of cases with amplifications in TET2 and mutations in CTCFL in Kidney Renal Clear Cell Carcinoma in the genomic data commons?,cnv_and_ssm
+1369,SERPINB10,A353P,Lung Adenocarcinoma,what is the frequency of cases with amplifications in SERPINB10 and mutations in HLA-DQA2 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in STAT3 and mutations in PTPRO in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in MIEF1 and mutations in ZCCHC14 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1381,ACVR1B,D397N,Colon Adenocarcinoma,what is the frequency of cases with amplifications in ACVR1B and mutations in CNGB1 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1382,ACVR1B,D449N,Colon Adenocarcinoma,what is the frequency of cases with amplifications in ACVR1B and mutations in CPA6 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1383,ACVR1B,D490N,Colon Adenocarcinoma,what is the frequency of cases with amplifications in ACVR1B and mutations in PTPRO in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1393,EBF2,T104I,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in EBF2 and mutations in MORF4L1 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1394,EBF2,T252I,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in EBF2 and mutations in SGCZ in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1402,VPS26B,F266L,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in VPS26B and mutations in CACNA1F in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with amplifications in PGR and mutations in MAST4 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with amplifications in PGR and mutations in ITPRID2 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","what is the frequency of cases with amplifications in PGR and mutations in EBF2 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus in the genomic data commons?",cnv_and_ssm
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,what is the frequency of cases with amplifications in ACTA2 and mutations in DEFB115 in Skin Cutaneous Melanoma in the genomic data commons?,cnv_and_ssm
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in THBS4 and mutations in ANKRD52 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in THBS4 and mutations in EVC2 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1413,PRSS1,S114T,Lung Adenocarcinoma,what is the frequency of cases with amplifications in PRSS1 and mutations in ZNF627 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1414,PRSS1,S124T,Lung Adenocarcinoma,what is the frequency of cases with amplifications in PRSS1 and mutations in CTCFL in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1415,PRSS1,S138T,Lung Adenocarcinoma,what is the frequency of cases with amplifications in PRSS1 and mutations in GSTCD in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1416,PRSS1,S74T,Lung Adenocarcinoma,what is the frequency of cases with amplifications in PRSS1 and mutations in ZFPM2 in Lung Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1417,PGF,R126H,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in PGF and mutations in GRTP1 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1418,PGF,R127H,Stomach Adenocarcinoma,what is the frequency of cases with amplifications in PGF and mutations in YY1AP1 in Stomach Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,what is the frequency of cases with amplifications in ITPRID2 and mutations in CNGB1 in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,what is the frequency of cases with amplifications in ITPRID2 and mutations in BFAR in Breast Invasive Carcinoma in the genomic data commons?,cnv_and_ssm
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in HBB and mutations in SORCS1 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1441,PCDHB2,R158C,Colon Adenocarcinoma,what is the frequency of cases with amplifications in PCDHB2 and mutations in ARMC3 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1442,PCDHB2,T15M,Colon Adenocarcinoma,what is the frequency of cases with amplifications in PCDHB2 and mutations in FGF8 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1443,PCDHB2,T26M,Colon Adenocarcinoma,what is the frequency of cases with amplifications in PCDHB2 and mutations in AUTS2 in Colon Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,what is the frequency of cases with amplifications in UBR2 and mutations in GIMAP2 in Uterine Corpus Endometrial Carcinoma in the genomic data commons?,cnv_and_ssm
+1452,FBXO42,A618D,Rectum Adenocarcinoma,what is the frequency of cases with amplifications in FBXO42 and mutations in RIMS2 in Rectum Adenocarcinoma in the genomic data commons?,cnv_and_ssm
+1,TNS1,G1362V,Breast Invasive Carcinoma,How often do cases of Breast Invasive Carcinoma exhibit mutations in TNS1 and homozyous deletions in TMEM255A?,cnv_and_ssm
+2,TNS1,G1711V,Breast Invasive Carcinoma,How often do cases of Breast Invasive Carcinoma exhibit mutations in TNS1 and homozyous deletions in TYK2?,cnv_and_ssm
+3,TNS1,G1718V,Breast Invasive Carcinoma,How often do cases of Breast Invasive Carcinoma exhibit mutations in TNS1 and homozyous deletions in GIMAP2?,cnv_and_ssm
+4,TNS1,G1732V,Breast Invasive Carcinoma,How often do cases of Breast Invasive Carcinoma exhibit mutations in TNS1 and homozyous deletions in MAST4?,cnv_and_ssm
+5,TNS1,G1824V,Breast Invasive Carcinoma,How often do cases of Breast Invasive Carcinoma exhibit mutations in TNS1 and homozyous deletions in FCGR2C?,cnv_and_ssm
+6,TNS1,G1857V,Breast Invasive Carcinoma,How often do cases of Breast Invasive Carcinoma exhibit mutations in TNS1 and homozyous deletions in SYNJ1?,cnv_and_ssm
+7,TNS1,G843V,Breast Invasive Carcinoma,How often do cases of Breast Invasive Carcinoma exhibit mutations in TNS1 and homozyous deletions in ZBTB34?,cnv_and_ssm
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How often do cases of Bladder Urothelial Carcinoma exhibit mutations in EVC2 and homozyous deletions in FGF8?,cnv_and_ssm
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How often do cases of Bladder Urothelial Carcinoma exhibit mutations in EVC2 and homozyous deletions in POLR1G?,cnv_and_ssm
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in CR1 and homozyous deletions in EBF2?,cnv_and_ssm
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in CR1 and homozyous deletions in RIPOR2?,cnv_and_ssm
+22,TRPA1,S295I,Rectum Adenocarcinoma,How often do cases of Rectum Adenocarcinoma exhibit mutations in TRPA1 and homozyous deletions in POLR1G?,cnv_and_ssm
+23,TRPA1,S443I,Rectum Adenocarcinoma,How often do cases of Rectum Adenocarcinoma exhibit mutations in TRPA1 and homozyous deletions in ACTB?,cnv_and_ssm
+24,TAF1C,R299L,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in TAF1C and homozyous deletions in SLC9C1?,cnv_and_ssm
+25,TAF1C,R396L,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in TAF1C and homozyous deletions in BCAT1?,cnv_and_ssm
+26,TAF1C,R634L,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in TAF1C and homozyous deletions in DHX16?,cnv_and_ssm
+27,TAF1C,R702L,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in TAF1C and homozyous deletions in DPF3?,cnv_and_ssm
+28,TAF1C,R728L,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in TAF1C and homozyous deletions in SGCZ?,cnv_and_ssm
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in DPF3 and homozyous deletions in PIK3C2G?,cnv_and_ssm
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in DPF3 and homozyous deletions in DNMT1?,cnv_and_ssm
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in DPF3 and homozyous deletions in BCAT1?,cnv_and_ssm
+42,OR2T4,P272H,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in OR2T4 and homozyous deletions in OR2T4?,cnv_and_ssm
+43,OR2T4,P300H,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in OR2T4 and homozyous deletions in YY1AP1?,cnv_and_ssm
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How often do cases of Pancreatic Adenocarcinoma exhibit mutations in FBN1 and homozyous deletions in CDKN2AIP?,cnv_and_ssm
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How often do cases of Prostate Adenocarcinoma exhibit mutations in MAD1L1 and homozyous deletions in BCAT1?,cnv_and_ssm
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How often do cases of Prostate Adenocarcinoma exhibit mutations in MAD1L1 and homozyous deletions in ANKDD1A?,cnv_and_ssm
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How often do cases of Prostate Adenocarcinoma exhibit mutations in MAD1L1 and homozyous deletions in HYOU1?,cnv_and_ssm
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in CCNG1 and homozyous deletions in PAPPA?,cnv_and_ssm
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How often do cases of Kidney Renal Papillary Cell Carcinoma exhibit mutations in ANP32E and homozyous deletions in TSHZ3?,cnv_and_ssm
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How often do cases of Kidney Renal Papillary Cell Carcinoma exhibit mutations in ANP32E and homozyous deletions in CDH23?,cnv_and_ssm
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How often do cases of Kidney Renal Papillary Cell Carcinoma exhibit mutations in ANP32E and homozyous deletions in TENT5A?,cnv_and_ssm
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How often do cases of Kidney Renal Papillary Cell Carcinoma exhibit mutations in ANP32E and homozyous deletions in ART3?,cnv_and_ssm
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How often do cases of Bladder Urothelial Carcinoma exhibit mutations in FRY and homozyous deletions in GUCY2C?,cnv_and_ssm
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How often do cases of Bladder Urothelial Carcinoma exhibit mutations in FRY and homozyous deletions in PGR?,cnv_and_ssm
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How often do cases of Bladder Urothelial Carcinoma exhibit mutations in FRY and homozyous deletions in RIPOR2?,cnv_and_ssm
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How often do cases of Bladder Urothelial Carcinoma exhibit mutations in FRY and homozyous deletions in MAD1L1?,cnv_and_ssm
+70,PAK3,E318K,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in PAK3 and homozyous deletions in CNGB1?,cnv_and_ssm
+71,PAK3,E319K,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in PAK3 and homozyous deletions in EIF2B4?,cnv_and_ssm
+72,PAK3,E334K,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in PAK3 and homozyous deletions in OR2T4?,cnv_and_ssm
+73,PAK3,E340K,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in PAK3 and homozyous deletions in UNC5D?,cnv_and_ssm
+74,PAK3,E355K,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in PAK3 and homozyous deletions in ACVR1B?,cnv_and_ssm
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in MUC16 and homozyous deletions in CTSC?,cnv_and_ssm
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How often do cases of Liver Hepatocellular Carcinoma exhibit mutations in ZFPM2 and homozyous deletions in PGR?,cnv_and_ssm
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How often do cases of Liver Hepatocellular Carcinoma exhibit mutations in ZFPM2 and homozyous deletions in PIK3C2B?,cnv_and_ssm
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How often do cases of Breast Invasive Carcinoma exhibit mutations in PIK3C2B and homozyous deletions in TLCD5?,cnv_and_ssm
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How often do cases of Breast Invasive Carcinoma exhibit mutations in PIK3C2B and homozyous deletions in TMEM255A?,cnv_and_ssm
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in ZNF804A and homozyous deletions in TNS1?,cnv_and_ssm
+116,RELN,A2371V,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in RELN and homozyous deletions in THBS4?,cnv_and_ssm
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often do cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus exhibit mutations in EFCAB12 and homozyous deletions in SMO?",cnv_and_ssm
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often do cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus exhibit mutations in EFCAB12 and homozyous deletions in CPS1?",cnv_and_ssm
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in DEFB115 and homozyous deletions in CNGB1?,cnv_and_ssm
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How often do cases of Bladder Urothelial Carcinoma exhibit mutations in ANKDD1A and homozyous deletions in JAML?,cnv_and_ssm
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How often do cases of Bladder Urothelial Carcinoma exhibit mutations in ANKDD1A and homozyous deletions in CDH23?,cnv_and_ssm
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How often do cases of Bladder Urothelial Carcinoma exhibit mutations in ANKDD1A and homozyous deletions in FRY?,cnv_and_ssm
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in HTR3B and homozyous deletions in TMEM255A?,cnv_and_ssm
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in HTR3B and homozyous deletions in MYT1?,cnv_and_ssm
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in HTR3B and homozyous deletions in RIMS2?,cnv_and_ssm
+129,ABCC3,R758W,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in ABCC3 and homozyous deletions in CHMP7?,cnv_and_ssm
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in NOMO1 and homozyous deletions in CR1?,cnv_and_ssm
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in NOMO1 and homozyous deletions in TTN?,cnv_and_ssm
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How often do cases of Bladder Urothelial Carcinoma exhibit mutations in HYOU1 and homozyous deletions in OR2A12?,cnv_and_ssm
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in FMO4 and homozyous deletions in DNAH14?,cnv_and_ssm
+140,BICC1,A372V,Exceptional Responders,How often do cases of Exceptional Responders exhibit mutations in BICC1 and homozyous deletions in CEP20?,cnv_and_ssm
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in ZMYM3 and homozyous deletions in SPATA22?,cnv_and_ssm
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in ZMYM3 and homozyous deletions in PAK3?,cnv_and_ssm
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in ZMYM3 and homozyous deletions in MAD1L1?,cnv_and_ssm
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often do cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus exhibit mutations in XKR4 and homozyous deletions in CTSC?",cnv_and_ssm
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How often do cases of Liver Hepatocellular Carcinoma exhibit mutations in ABCC2 and homozyous deletions in FBXO15?,cnv_and_ssm
+157,OR8K5,R293G,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in OR8K5 and homozyous deletions in FRY?,cnv_and_ssm
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in SPTAN1 and homozyous deletions in FGF8?,cnv_and_ssm
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in SPTAN1 and homozyous deletions in ART3?,cnv_and_ssm
+164,SYT10,M484I,Rectum Adenocarcinoma,How often do cases of Rectum Adenocarcinoma exhibit mutations in SYT10 and homozyous deletions in MUC16?,cnv_and_ssm
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in HSPA5 and homozyous deletions in TRIM45?,cnv_and_ssm
+175,UNC5D,L280V,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in UNC5D and homozyous deletions in HBB?,cnv_and_ssm
+176,UNC5D,L635V,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in UNC5D and homozyous deletions in MAD1L1?,cnv_and_ssm
+177,UNC5D,L637V,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in UNC5D and homozyous deletions in SORCS1?,cnv_and_ssm
+178,UNC5D,L699V,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in UNC5D and homozyous deletions in PXN?,cnv_and_ssm
+179,UNC5D,L704V,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in UNC5D and homozyous deletions in CYB5R2?,cnv_and_ssm
+180,UNC5D,L709V,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in UNC5D and homozyous deletions in DCC?,cnv_and_ssm
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How often do cases of Kidney Renal Clear Cell Carcinoma exhibit mutations in DOCK2 and homozyous deletions in CFAP61?,cnv_and_ssm
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How often do cases of Kidney Renal Clear Cell Carcinoma exhibit mutations in ZNF627 and homozyous deletions in MSANTD4?,cnv_and_ssm
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in CDC42BPA and homozyous deletions in CFAP298-TCP10L?,cnv_and_ssm
+193,MRPL55,H27Y,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in MRPL55 and homozyous deletions in FCGR2C?,cnv_and_ssm
+194,MRPL55,H63Y,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in MRPL55 and homozyous deletions in DSCAM?,cnv_and_ssm
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How often do cases of Breast Invasive Carcinoma exhibit mutations in TMTC3 and homozyous deletions in MRPL55?,cnv_and_ssm
+198,EPRS1,K771I,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in EPRS1 and homozyous deletions in PGF?,cnv_and_ssm
+199,EPRS1,K778I,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in EPRS1 and homozyous deletions in NRAP?,cnv_and_ssm
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in GRTP1 and homozyous deletions in AQP7?,cnv_and_ssm
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in GRTP1 and homozyous deletions in AUTS2?,cnv_and_ssm
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in TSHZ3 and homozyous deletions in GRM1?,cnv_and_ssm
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How often do cases of HIV+ Tumor Molecular Characterization Project - Cervical Cancer exhibit mutations in TAS1R3 and homozyous deletions in ZCCHC14?,cnv_and_ssm
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in PIAS3 and homozyous deletions in RIMS2?,cnv_and_ssm
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in PIAS3 and homozyous deletions in GRTP1?,cnv_and_ssm
+251,ZNF274,P13R,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in ZNF274 and homozyous deletions in GABRA6?,cnv_and_ssm
+253,SYNJ1,R795C,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in SYNJ1 and homozyous deletions in POC1B?,cnv_and_ssm
+254,SYNJ1,R800C,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in SYNJ1 and homozyous deletions in MYH11?,cnv_and_ssm
+255,SYNJ1,R839C,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in SYNJ1 and homozyous deletions in MAST4?,cnv_and_ssm
+261,DSCAM,V343M,Prostate Adenocarcinoma,How often do cases of Prostate Adenocarcinoma exhibit mutations in DSCAM and homozyous deletions in PXN?,cnv_and_ssm
+262,DSCAM,V426M,Prostate Adenocarcinoma,How often do cases of Prostate Adenocarcinoma exhibit mutations in DSCAM and homozyous deletions in DCN?,cnv_and_ssm
+263,DSCAM,V591M,Prostate Adenocarcinoma,How often do cases of Prostate Adenocarcinoma exhibit mutations in DSCAM and homozyous deletions in AUTS2?,cnv_and_ssm
+267,DGKD,R140H,Exceptional Responders,How often do cases of Exceptional Responders exhibit mutations in DGKD and homozyous deletions in EIF2B4?,cnv_and_ssm
+268,DGKD,R160H,Exceptional Responders,How often do cases of Exceptional Responders exhibit mutations in DGKD and homozyous deletions in ZNF431?,cnv_and_ssm
+269,DGKD,R204H,Exceptional Responders,How often do cases of Exceptional Responders exhibit mutations in DGKD and homozyous deletions in ACTB?,cnv_and_ssm
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How often do cases of Bladder Urothelial Carcinoma exhibit mutations in PLEKHG6 and homozyous deletions in ZCCHC14?,cnv_and_ssm
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How often do cases of Bladder Urothelial Carcinoma exhibit mutations in PLEKHG6 and homozyous deletions in MAST4?,cnv_and_ssm
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How often do cases of Bladder Urothelial Carcinoma exhibit mutations in PLEKHG6 and homozyous deletions in DNAH14?,cnv_and_ssm
+279,WNT2,D138N,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in WNT2 and homozyous deletions in CR1?,cnv_and_ssm
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in GUCY2C and homozyous deletions in B3GALNT1?,cnv_and_ssm
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in C7orf31 and homozyous deletions in DGKD?,cnv_and_ssm
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often do cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus exhibit mutations in ZKSCAN7 and homozyous deletions in PTPRO?",cnv_and_ssm
+299,OR5D14,M210L,Neuroblastoma,How often do cases of Neuroblastoma exhibit mutations in OR5D14 and homozyous deletions in EIF2B4?,cnv_and_ssm
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in SPATA22 and homozyous deletions in SPATA22?,cnv_and_ssm
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in SPATA22 and homozyous deletions in CNGB1?,cnv_and_ssm
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in SPATA22 and homozyous deletions in TMEM255A?,cnv_and_ssm
+310,LCN15,E21V,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in LCN15 and homozyous deletions in ARMC3?,cnv_and_ssm
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in DCAF4L2 and homozyous deletions in ZNF431?,cnv_and_ssm
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in GUK1 and homozyous deletions in COL6A3?,cnv_and_ssm
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in GUK1 and homozyous deletions in MERTK?,cnv_and_ssm
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in GUK1 and homozyous deletions in TRPA1?,cnv_and_ssm
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in GUK1 and homozyous deletions in CTCFL?,cnv_and_ssm
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in GUK1 and homozyous deletions in KDM5C?,cnv_and_ssm
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in MORF4L1 and homozyous deletions in TNS1?,cnv_and_ssm
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in MORF4L1 and homozyous deletions in YY1AP1?,cnv_and_ssm
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in MORF4L1 and homozyous deletions in TTC12?,cnv_and_ssm
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in MORF4L1 and homozyous deletions in SPTAN1?,cnv_and_ssm
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in MYO3B and homozyous deletions in TRAP1?,cnv_and_ssm
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in MYO3B and homozyous deletions in CCNG1?,cnv_and_ssm
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in TENT5A and homozyous deletions in POLD1?,cnv_and_ssm
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in TENT5A and homozyous deletions in FCGR2C?,cnv_and_ssm
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in TENT5A and homozyous deletions in CTSC?,cnv_and_ssm
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How often do cases of Ovarian Serous Cystadenocarcinoma exhibit mutations in ZFAT and homozyous deletions in CNGB1?,cnv_and_ssm
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How often do cases of Ovarian Serous Cystadenocarcinoma exhibit mutations in ZFAT and homozyous deletions in KANSL1?,cnv_and_ssm
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How often do cases of Ovarian Serous Cystadenocarcinoma exhibit mutations in ZFAT and homozyous deletions in SPAG1?,cnv_and_ssm
+357,ZNF584,A211T,Sarcoma,How often do cases of Sarcoma exhibit mutations in ZNF584 and homozyous deletions in PHLPP1?,cnv_and_ssm
+358,ZNF584,A256T,Sarcoma,How often do cases of Sarcoma exhibit mutations in ZNF584 and homozyous deletions in TTYH2?,cnv_and_ssm
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in LDOC1 and homozyous deletions in EPRS1?,cnv_and_ssm
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in PDGFC and homozyous deletions in PTPRO?,cnv_and_ssm
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in MSANTD4 and homozyous deletions in CTNNA2?,cnv_and_ssm
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in NPSR1 and homozyous deletions in ABCC3?,cnv_and_ssm
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in PHLPP1 and homozyous deletions in CPS1?,cnv_and_ssm
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in COL6A3 and homozyous deletions in TENT5A?,cnv_and_ssm
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in COL6A3 and homozyous deletions in TENM2?,cnv_and_ssm
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in COL6A3 and homozyous deletions in TLK2?,cnv_and_ssm
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in COL6A3 and homozyous deletions in CXCR2?,cnv_and_ssm
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in COL6A3 and homozyous deletions in TASOR2?,cnv_and_ssm
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in ADRA1A and homozyous deletions in POLR1G?,cnv_and_ssm
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often do cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma exhibit mutations in LAMB2 and homozyous deletions in CPS1?,cnv_and_ssm
+406,POC1B,I198T,Rectum Adenocarcinoma,How often do cases of Rectum Adenocarcinoma exhibit mutations in POC1B and homozyous deletions in FGF8?,cnv_and_ssm
+407,POC1B,I286T,Rectum Adenocarcinoma,How often do cases of Rectum Adenocarcinoma exhibit mutations in POC1B and homozyous deletions in NRAP?,cnv_and_ssm
+408,POC1B,I328T,Rectum Adenocarcinoma,How often do cases of Rectum Adenocarcinoma exhibit mutations in POC1B and homozyous deletions in DCC?,cnv_and_ssm
+409,POC1B,S79P,Rectum Adenocarcinoma,How often do cases of Rectum Adenocarcinoma exhibit mutations in POC1B and homozyous deletions in TAF1C?,cnv_and_ssm
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How often do cases of Liver Hepatocellular Carcinoma exhibit mutations in USH2A and homozyous deletions in PAK3?,cnv_and_ssm
+414,AQP7,T110S,Rectum Adenocarcinoma,How often do cases of Rectum Adenocarcinoma exhibit mutations in AQP7 and homozyous deletions in ACTB?,cnv_and_ssm
+415,AQP7,T166S,Rectum Adenocarcinoma,How often do cases of Rectum Adenocarcinoma exhibit mutations in AQP7 and homozyous deletions in EIF2B4?,cnv_and_ssm
+416,AQP7,T167S,Rectum Adenocarcinoma,How often do cases of Rectum Adenocarcinoma exhibit mutations in AQP7 and homozyous deletions in POC1B?,cnv_and_ssm
+417,AQP7,T75S,Rectum Adenocarcinoma,How often do cases of Rectum Adenocarcinoma exhibit mutations in AQP7 and homozyous deletions in ZNF274?,cnv_and_ssm
+430,DCN,R163C,Rectum Adenocarcinoma,How often do cases of Rectum Adenocarcinoma exhibit mutations in DCN and homozyous deletions in DCLK3?,cnv_and_ssm
+431,DCN,R203C,Rectum Adenocarcinoma,How often do cases of Rectum Adenocarcinoma exhibit mutations in DCN and homozyous deletions in DCAF6?,cnv_and_ssm
+432,DCN,R241C,Rectum Adenocarcinoma,How often do cases of Rectum Adenocarcinoma exhibit mutations in DCN and homozyous deletions in MAOB?,cnv_and_ssm
+433,DCN,R350C,Rectum Adenocarcinoma,How often do cases of Rectum Adenocarcinoma exhibit mutations in DCN and homozyous deletions in CTCFL?,cnv_and_ssm
+434,DCN,R41C,Rectum Adenocarcinoma,How often do cases of Rectum Adenocarcinoma exhibit mutations in DCN and homozyous deletions in MERTK?,cnv_and_ssm
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in CPS1 and homozyous deletions in JAML?,cnv_and_ssm
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in CPS1 and homozyous deletions in POC1B?,cnv_and_ssm
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in CPS1 and homozyous deletions in YY1AP1?,cnv_and_ssm
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How often do cases of Kidney Renal Papillary Cell Carcinoma exhibit mutations in FCGR2C and homozyous deletions in PRSS1?,cnv_and_ssm
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How often do cases of Kidney Renal Papillary Cell Carcinoma exhibit mutations in FCGR2C and homozyous deletions in POLD1?,cnv_and_ssm
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in GRM1 and homozyous deletions in CARMIL1?,cnv_and_ssm
+482,SGCZ,Q138H,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in SGCZ and homozyous deletions in ZFPM2?,cnv_and_ssm
+483,SGCZ,Q91H,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in SGCZ and homozyous deletions in PIK3C2B?,cnv_and_ssm
+485,SMO,V15M,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in SMO and homozyous deletions in RIMS2?,cnv_and_ssm
+486,SMO,V321M,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in SMO and homozyous deletions in FRY?,cnv_and_ssm
+488,CHODL,G159E,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in CHODL and homozyous deletions in GABRA6?,cnv_and_ssm
+489,CHODL,G181E,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in CHODL and homozyous deletions in KDM5C?,cnv_and_ssm
+490,CHODL,G200E,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in CHODL and homozyous deletions in RIMS2?,cnv_and_ssm
+494,MYO16,P399H,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in MYO16 and homozyous deletions in TTN?,cnv_and_ssm
+495,MYO16,P421H,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in MYO16 and homozyous deletions in GPR158?,cnv_and_ssm
+498,CXCR2,A98V,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in CXCR2 and homozyous deletions in TENM3?,cnv_and_ssm
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How often do cases of Bladder Urothelial Carcinoma exhibit mutations in TMEM225 and homozyous deletions in TNS1?,cnv_and_ssm
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in MAOB and homozyous deletions in TRAP1?,cnv_and_ssm
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in GPRASP1 and homozyous deletions in GUK1?,cnv_and_ssm
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in MRPL32 and homozyous deletions in NRAP?,cnv_and_ssm
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in TYROBP and homozyous deletions in JAML?,cnv_and_ssm
+510,RAB40C,A111V,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in RAB40C and homozyous deletions in DPF3?,cnv_and_ssm
+511,RAB40C,A143V,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in RAB40C and homozyous deletions in JAML?,cnv_and_ssm
+512,CTNNA2,S323R,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in CTNNA2 and homozyous deletions in FCGR2C?,cnv_and_ssm
+513,CTNNA2,S339R,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in CTNNA2 and homozyous deletions in MYO16?,cnv_and_ssm
+514,CTNNA2,S386R,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in CTNNA2 and homozyous deletions in ANKDD1A?,cnv_and_ssm
+515,CTNNA2,S707R,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in CTNNA2 and homozyous deletions in OR2T4?,cnv_and_ssm
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How often do cases of Bladder Urothelial Carcinoma exhibit mutations in MYO15A and homozyous deletions in GABRA6?,cnv_and_ssm
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in GIMAP2 and homozyous deletions in ZNF431?,cnv_and_ssm
+532,KIF20B,N1160D,Glioblastoma Multiforme,How often do cases of Glioblastoma Multiforme exhibit mutations in KIF20B and homozyous deletions in SPAG1?,cnv_and_ssm
+533,KIF20B,N1200D,Glioblastoma Multiforme,How often do cases of Glioblastoma Multiforme exhibit mutations in KIF20B and homozyous deletions in ACTB?,cnv_and_ssm
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in ADAM17 and homozyous deletions in MORF4L1?,cnv_and_ssm
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in BCAT1 and homozyous deletions in ANP32E?,cnv_and_ssm
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in BCAT1 and homozyous deletions in PXN?,cnv_and_ssm
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in BCAT1 and homozyous deletions in FNDC7?,cnv_and_ssm
+540,ERCC6,R1053H,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in ERCC6 and homozyous deletions in PXN?,cnv_and_ssm
+541,DCC,R320W,Breast Invasive Carcinoma,How often do cases of Breast Invasive Carcinoma exhibit mutations in DCC and homozyous deletions in MYO3B?,cnv_and_ssm
+542,DCC,R363W,Breast Invasive Carcinoma,How often do cases of Breast Invasive Carcinoma exhibit mutations in DCC and homozyous deletions in MSANTD4?,cnv_and_ssm
+543,DCC,R386W,Breast Invasive Carcinoma,How often do cases of Breast Invasive Carcinoma exhibit mutations in DCC and homozyous deletions in COL6A3?,cnv_and_ssm
+544,DCC,R41W,Breast Invasive Carcinoma,How often do cases of Breast Invasive Carcinoma exhibit mutations in DCC and homozyous deletions in TRAP1?,cnv_and_ssm
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in FBXO15 and homozyous deletions in DHX16?,cnv_and_ssm
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in FBXO15 and homozyous deletions in ANKDD1A?,cnv_and_ssm
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in GSTCD and homozyous deletions in SORCS1?,cnv_and_ssm
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in GSTCD and homozyous deletions in SOX21?,cnv_and_ssm
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in OLFML3 and homozyous deletions in EFCAB12?,cnv_and_ssm
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in OLFML3 and homozyous deletions in MYH11?,cnv_and_ssm
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in OLFML3 and homozyous deletions in CARMIL1?,cnv_and_ssm
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How often do cases of Ovarian Serous Cystadenocarcinoma exhibit mutations in CFAP61 and homozyous deletions in TRAP1?,cnv_and_ssm
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How often do cases of Ovarian Serous Cystadenocarcinoma exhibit mutations in CFAP61 and homozyous deletions in GIMAP2?,cnv_and_ssm
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How often do cases of Bladder Urothelial Carcinoma exhibit mutations in HLA-DQA2 and homozyous deletions in CA9?,cnv_and_ssm
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in TENM2 and homozyous deletions in CYB5R2?,cnv_and_ssm
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in TENM2 and homozyous deletions in SERPINB10?,cnv_and_ssm
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in TENM2 and homozyous deletions in YY1AP1?,cnv_and_ssm
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in ANKRD24 and homozyous deletions in CCNG1?,cnv_and_ssm
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in ANKRD24 and homozyous deletions in EIF2B4?,cnv_and_ssm
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in ANKRD24 and homozyous deletions in MRPL55?,cnv_and_ssm
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in ZCCHC14 and homozyous deletions in TMEM225?,cnv_and_ssm
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in ZCCHC14 and homozyous deletions in GUK1?,cnv_and_ssm
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in ZCCHC14 and homozyous deletions in SORCS1?,cnv_and_ssm
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in ZCCHC14 and homozyous deletions in ANKRD24?,cnv_and_ssm
+625,SIK2,I265M,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in SIK2 and homozyous deletions in ABCC3?,cnv_and_ssm
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in MYH11 and homozyous deletions in SGIP1?,cnv_and_ssm
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in MYH11 and homozyous deletions in PLEKHG6?,cnv_and_ssm
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in SLC6A4 and homozyous deletions in ZNF708?,cnv_and_ssm
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in SLC9C1 and homozyous deletions in MYO3A?,cnv_and_ssm
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in SLC9C1 and homozyous deletions in MERTK?,cnv_and_ssm
+644,OR2A12,A254T,Brain Lower Grade Glioma,How often do cases of Brain Lower Grade Glioma exhibit mutations in OR2A12 and homozyous deletions in GIMAP2?,cnv_and_ssm
+646,PYHIN1,T325K,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in PYHIN1 and homozyous deletions in TRIM45?,cnv_and_ssm
+647,PYHIN1,T334K,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in PYHIN1 and homozyous deletions in SLC9C1?,cnv_and_ssm
+650,JAML,G191E,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in JAML and homozyous deletions in GUK1?,cnv_and_ssm
+651,JAML,G219E,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in JAML and homozyous deletions in RIPOR2?,cnv_and_ssm
+652,JAML,G220E,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in JAML and homozyous deletions in MAOB?,cnv_and_ssm
+653,JAML,G230E,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in JAML and homozyous deletions in OLFML3?,cnv_and_ssm
+658,TYK2,H1146R,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in TYK2 and homozyous deletions in AQP7?,cnv_and_ssm
+659,TYK2,H23R,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in TYK2 and homozyous deletions in MORF4L1?,cnv_and_ssm
+660,TYK2,H961R,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in TYK2 and homozyous deletions in PXN?,cnv_and_ssm
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in CTCFL and homozyous deletions in DCC?,cnv_and_ssm
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in CTCFL and homozyous deletions in RIMS2?,cnv_and_ssm
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in CTCFL and homozyous deletions in ZMYM3?,cnv_and_ssm
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in CTCFL and homozyous deletions in POLD1?,cnv_and_ssm
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in CEP20 and homozyous deletions in KDM5C?,cnv_and_ssm
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in CEP20 and homozyous deletions in SGIP1?,cnv_and_ssm
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in RIMS2 and homozyous deletions in JAML?,cnv_and_ssm
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in RIMS2 and homozyous deletions in GRM5?,cnv_and_ssm
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in RIMS2 and homozyous deletions in GPRASP1?,cnv_and_ssm
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in RIMS2 and homozyous deletions in DCN?,cnv_and_ssm
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in RIMS2 and homozyous deletions in ANKDD1A?,cnv_and_ssm
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in RIMS2 and homozyous deletions in TNS1?,cnv_and_ssm
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in RIMS2 and homozyous deletions in PIK3C2B?,cnv_and_ssm
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in PIK3C2G and homozyous deletions in EIF2B4?,cnv_and_ssm
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in PIK3C2G and homozyous deletions in OR8K5?,cnv_and_ssm
+728,STK19,D341N,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in STK19 and homozyous deletions in SGIP1?,cnv_and_ssm
+729,STK19,D345N,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in STK19 and homozyous deletions in PIK3C2G?,cnv_and_ssm
+730,REXO4,P60A,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in REXO4 and homozyous deletions in MAD1L1?,cnv_and_ssm
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in ZBTB34 and homozyous deletions in ANKDD1A?,cnv_and_ssm
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in ZBTB34 and homozyous deletions in TET2?,cnv_and_ssm
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How often do cases of Bladder Urothelial Carcinoma exhibit mutations in NCKAP5 and homozyous deletions in ANP32E?,cnv_and_ssm
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often do cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus exhibit mutations in SORCS1 and homozyous deletions in GPRASP1?",cnv_and_ssm
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often do cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus exhibit mutations in SORCS1 and homozyous deletions in TNS1?",cnv_and_ssm
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often do cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus exhibit mutations in SORCS1 and homozyous deletions in GABRA6?",cnv_and_ssm
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often do cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus exhibit mutations in SORCS1 and homozyous deletions in AQP7?",cnv_and_ssm
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How often do cases of Head and Neck Squamous Cell Carcinoma exhibit mutations in FGF8 and homozyous deletions in GABRA6?,cnv_and_ssm
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How often do cases of Head and Neck Squamous Cell Carcinoma exhibit mutations in FGF8 and homozyous deletions in SMO?,cnv_and_ssm
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How often do cases of Head and Neck Squamous Cell Carcinoma exhibit mutations in FGF8 and homozyous deletions in TAF1C?,cnv_and_ssm
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How often do cases of Head and Neck Squamous Cell Carcinoma exhibit mutations in FGF8 and homozyous deletions in PIAS3?,cnv_and_ssm
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How often do cases of Head and Neck Squamous Cell Carcinoma exhibit mutations in FGF8 and homozyous deletions in AQP7?,cnv_and_ssm
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How often do cases of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia exhibit mutations in TENM3 and homozyous deletions in TAF1C?,cnv_and_ssm
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in AKT1 and homozyous deletions in DCLK3?,cnv_and_ssm
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often do cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma exhibit mutations in CFAP298-TCP10L and homozyous deletions in NRAP?,cnv_and_ssm
+792,GLRB,E148D,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in GLRB and homozyous deletions in COL6A3?,cnv_and_ssm
+793,TTN,F7636L,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in TTN and homozyous deletions in CCDC22?,cnv_and_ssm
+794,TTN,F8563L,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in TTN and homozyous deletions in GUK1?,cnv_and_ssm
+795,TTN,F8880L,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in TTN and homozyous deletions in TRPA1?,cnv_and_ssm
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in ANKRD30A and homozyous deletions in TLCD5?,cnv_and_ssm
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in ANKRD30A and homozyous deletions in DCC?,cnv_and_ssm
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in ANKRD30A and homozyous deletions in ZKSCAN7?,cnv_and_ssm
+809,TRIM45,S177L,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in TRIM45 and homozyous deletions in ACTL7B?,cnv_and_ssm
+810,TRIM45,S224L,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in TRIM45 and homozyous deletions in CCDC22?,cnv_and_ssm
+811,TRIM45,S281L,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in TRIM45 and homozyous deletions in DCAF6?,cnv_and_ssm
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in CACNA1F and homozyous deletions in CTCFL?,cnv_and_ssm
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in CACNA1F and homozyous deletions in SOX21?,cnv_and_ssm
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in CACNA1F and homozyous deletions in AUTS2?,cnv_and_ssm
+817,KL,R594C,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in KL and homozyous deletions in GPR158?,cnv_and_ssm
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How often do cases of Kidney Renal Papillary Cell Carcinoma exhibit mutations in GUF1 and homozyous deletions in DSCAM?,cnv_and_ssm
+822,TAF1L,A539V,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in TAF1L and homozyous deletions in SYT9?,cnv_and_ssm
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in TASOR2 and homozyous deletions in FBXO15?,cnv_and_ssm
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in TASOR2 and homozyous deletions in PTPRN2?,cnv_and_ssm
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in TASOR2 and homozyous deletions in ZNF274?,cnv_and_ssm
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in KDM5C and homozyous deletions in OR8K5?,cnv_and_ssm
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in KDM5C and homozyous deletions in TASOR2?,cnv_and_ssm
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in KDM5C and homozyous deletions in CYB5R2?,cnv_and_ssm
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in KDM5C and homozyous deletions in PHLPP1?,cnv_and_ssm
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often do cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma exhibit mutations in IL5RA and homozyous deletions in POC1B?,cnv_and_ssm
+843,DHX16,A29V,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in DHX16 and homozyous deletions in PAPPA?,cnv_and_ssm
+844,DHX16,A89V,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in DHX16 and homozyous deletions in SORCS1?,cnv_and_ssm
+902,GPR158,A644V,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in GPR158 and homozyous deletions in GPR158?,cnv_and_ssm
+903,GPR158,A723V,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in GPR158 and homozyous deletions in AUTS2?,cnv_and_ssm
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often do cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus exhibit mutations in EIF2B4 and homozyous deletions in DSCAM?",cnv_and_ssm
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often do cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus exhibit mutations in EIF2B4 and homozyous deletions in GSTCD?",cnv_and_ssm
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often do cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus exhibit mutations in EIF2B4 and homozyous deletions in MYO15A?",cnv_and_ssm
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often do cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus exhibit mutations in EIF2B4 and homozyous deletions in ZNF804A?",cnv_and_ssm
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often do cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus exhibit mutations in EIF2B4 and homozyous deletions in TNS1?",cnv_and_ssm
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often do cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus exhibit mutations in EIF2B4 and homozyous deletions in UNC5D?",cnv_and_ssm
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in AUTS2 and homozyous deletions in CPA6?,cnv_and_ssm
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in AUTS2 and homozyous deletions in DCLK3?,cnv_and_ssm
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in AUTS2 and homozyous deletions in FNDC7?,cnv_and_ssm
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in AUTS2 and homozyous deletions in CTCFL?,cnv_and_ssm
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in AUTS2 and homozyous deletions in EIF2B4?,cnv_and_ssm
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in AUTS2 and homozyous deletions in PAK3?,cnv_and_ssm
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in AUTS2 and homozyous deletions in TASOR2?,cnv_and_ssm
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in AUTS2 and homozyous deletions in TAF1L?,cnv_and_ssm
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in AUTS2 and homozyous deletions in PSG2?,cnv_and_ssm
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in AUTS2 and homozyous deletions in OR13C3?,cnv_and_ssm
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often do cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus exhibit mutations in ACTL7B and homozyous deletions in TNS1?",cnv_and_ssm
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How often do cases of Glioblastoma Multiforme exhibit mutations in PCDHGA1 and homozyous deletions in TNS1?,cnv_and_ssm
+954,TRAP1,R114W,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in TRAP1 and homozyous deletions in CX3CR1?,cnv_and_ssm
+955,TRAP1,R61W,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in TRAP1 and homozyous deletions in FRY?,cnv_and_ssm
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in PIK3C2A and homozyous deletions in GUK1?,cnv_and_ssm
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How often do cases of Liver Hepatocellular Carcinoma exhibit mutations in KANSL1 and homozyous deletions in CTSC?,cnv_and_ssm
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in ANKRD52 and homozyous deletions in GABRA6?,cnv_and_ssm
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in PAPPA and homozyous deletions in GSTCD?,cnv_and_ssm
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How often do cases of Rectum Adenocarcinoma exhibit mutations in B3GALNT1 and homozyous deletions in TTYH2?,cnv_and_ssm
+982,GABRA6,G115R,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in GABRA6 and homozyous deletions in FMO4?,cnv_and_ssm
+983,GABRA6,G122R,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in GABRA6 and homozyous deletions in ADAM17?,cnv_and_ssm
+984,GABRA6,G165R,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in GABRA6 and homozyous deletions in TYK2?,cnv_and_ssm
+985,GABRA6,G175R,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in GABRA6 and homozyous deletions in SYNJ1?,cnv_and_ssm
+986,GABRA6,G70R,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in GABRA6 and homozyous deletions in POC1B?,cnv_and_ssm
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in ZSCAN31 and homozyous deletions in TLCD5?,cnv_and_ssm
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often do cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus exhibit mutations in MED16 and homozyous deletions in ACTA2?",cnv_and_ssm
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often do cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus exhibit mutations in MED16 and homozyous deletions in MUC16?",cnv_and_ssm
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How often do cases of Pancreatic Adenocarcinoma exhibit mutations in PTPRO and homozyous deletions in DNMT1?,cnv_and_ssm
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How often do cases of Pancreatic Adenocarcinoma exhibit mutations in PTPRO and homozyous deletions in YY1AP1?,cnv_and_ssm
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How often do cases of Pancreatic Adenocarcinoma exhibit mutations in PTPRO and homozyous deletions in RIPOR2?,cnv_and_ssm
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How often do cases of Pancreatic Adenocarcinoma exhibit mutations in PTPRO and homozyous deletions in PYHIN1?,cnv_and_ssm
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How often do cases of Pancreatic Adenocarcinoma exhibit mutations in PTPRO and homozyous deletions in EFCAB12?,cnv_and_ssm
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How often do cases of Pancreatic Adenocarcinoma exhibit mutations in PTPRO and homozyous deletions in SORCS1?,cnv_and_ssm
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How often do cases of Pancreatic Adenocarcinoma exhibit mutations in PTPRO and homozyous deletions in MORF4L1?,cnv_and_ssm
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How often do cases of Pancreatic Adenocarcinoma exhibit mutations in PTPRO and homozyous deletions in CTNNA2?,cnv_and_ssm
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in CHMP7 and homozyous deletions in PTPRN2?,cnv_and_ssm
+1017,GPC3,I107N,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in GPC3 and homozyous deletions in ACTB?,cnv_and_ssm
+1018,GPC3,I161N,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in GPC3 and homozyous deletions in SGIP1?,cnv_and_ssm
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often do cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma exhibit mutations in TLK2 and homozyous deletions in MAST4?,cnv_and_ssm
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often do cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma exhibit mutations in TLK2 and homozyous deletions in NRAP?,cnv_and_ssm
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often do cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma exhibit mutations in TLK2 and homozyous deletions in GRTP1?,cnv_and_ssm
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often do cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma exhibit mutations in TLK2 and homozyous deletions in MYT1?,cnv_and_ssm
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often do cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma exhibit mutations in TLK2 and homozyous deletions in DCN?,cnv_and_ssm
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in ZNF217 and homozyous deletions in MSANTD4?,cnv_and_ssm
+1038,SYT9,V275L,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in SYT9 and homozyous deletions in ERCC6?,cnv_and_ssm
+1039,SYT9,V307L,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in SYT9 and homozyous deletions in RIPOR2?,cnv_and_ssm
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in PKHD1L1 and homozyous deletions in MERTK?,cnv_and_ssm
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in MYO3A and homozyous deletions in KDM5C?,cnv_and_ssm
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often do cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus exhibit mutations in VASN and homozyous deletions in CTSC?",cnv_and_ssm
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in DNMT1 and homozyous deletions in CHODL?,cnv_and_ssm
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in DNMT1 and homozyous deletions in AUTS2?,cnv_and_ssm
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in DNMT1 and homozyous deletions in ACVR1B?,cnv_and_ssm
+1056,CA9,E402K,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in CA9 and homozyous deletions in CDH23?,cnv_and_ssm
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in TTC17 and homozyous deletions in ZFAT?,cnv_and_ssm
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in TTC17 and homozyous deletions in PTPRO?,cnv_and_ssm
+1065,PSG2,P43L,Breast Invasive Carcinoma,How often do cases of Breast Invasive Carcinoma exhibit mutations in PSG2 and homozyous deletions in TYK2?,cnv_and_ssm
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How often do cases of Breast Invasive Carcinoma exhibit mutations in RIPOR2 and homozyous deletions in PXN?,cnv_and_ssm
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How often do cases of Breast Invasive Carcinoma exhibit mutations in RIPOR2 and homozyous deletions in TSHZ3?,cnv_and_ssm
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How often do cases of Breast Invasive Carcinoma exhibit mutations in RIPOR2 and homozyous deletions in TENM2?,cnv_and_ssm
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How often do cases of Breast Invasive Carcinoma exhibit mutations in RIPOR2 and homozyous deletions in CHMP7?,cnv_and_ssm
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in DCLK3 and homozyous deletions in PXN?,cnv_and_ssm
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in DCLK3 and homozyous deletions in EPRS1?,cnv_and_ssm
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in MERTK and homozyous deletions in CPA6?,cnv_and_ssm
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in MERTK and homozyous deletions in COL6A3?,cnv_and_ssm
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in MERTK and homozyous deletions in CTSC?,cnv_and_ssm
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in ZFP42 and homozyous deletions in FGF8?,cnv_and_ssm
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in OR13C3 and homozyous deletions in TYK2?,cnv_and_ssm
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in OR13C3 and homozyous deletions in PAK3?,cnv_and_ssm
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in SPAG1 and homozyous deletions in CHODL?,cnv_and_ssm
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in CDKN2AIP and homozyous deletions in UNC5D?,cnv_and_ssm
+1093,PXN,H1016Y,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in PXN and homozyous deletions in DGKD?,cnv_and_ssm
+1094,PXN,H359Y,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in PXN and homozyous deletions in ANP32E?,cnv_and_ssm
+1095,PXN,H492Y,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in PXN and homozyous deletions in ANKRD30A?,cnv_and_ssm
+1096,PXN,H524Y,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in PXN and homozyous deletions in CYP1A2?,cnv_and_ssm
+1097,PXN,H526Y,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in PXN and homozyous deletions in EBF2?,cnv_and_ssm
+1098,PXN,H540Y,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in PXN and homozyous deletions in RIMS2?,cnv_and_ssm
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in TTYH2 and homozyous deletions in TLK2?,cnv_and_ssm
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in TTYH2 and homozyous deletions in SPTAN1?,cnv_and_ssm
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in TMEM255A and homozyous deletions in ABCC3?,cnv_and_ssm
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in TMEM255A and homozyous deletions in ZFPM2?,cnv_and_ssm
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in TMEM255A and homozyous deletions in HSPA5?,cnv_and_ssm
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How often do cases of Breast Invasive Carcinoma exhibit mutations in TASOR2 and homozyous deletions in OLFML3?,cnv_and_ssm
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How often do cases of Breast Invasive Carcinoma exhibit mutations in TASOR2 and homozyous deletions in MORF4L1?,cnv_and_ssm
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in ICE1 and homozyous deletions in MRPL55?,cnv_and_ssm
+1112,MYT1,A558E,Breast Invasive Carcinoma,How often do cases of Breast Invasive Carcinoma exhibit mutations in MYT1 and homozyous deletions in PIK3C2B?,cnv_and_ssm
+1113,MYT1,A879E,Breast Invasive Carcinoma,How often do cases of Breast Invasive Carcinoma exhibit mutations in MYT1 and homozyous deletions in PRSS8?,cnv_and_ssm
+1114,MYT1,A906E,Breast Invasive Carcinoma,How often do cases of Breast Invasive Carcinoma exhibit mutations in MYT1 and homozyous deletions in NOMO1?,cnv_and_ssm
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in CX3CR1 and homozyous deletions in UNC5D?,cnv_and_ssm
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in CX3CR1 and homozyous deletions in PGR?,cnv_and_ssm
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How often do cases of Liver Hepatocellular Carcinoma exhibit mutations in SPINDOC and homozyous deletions in TTC17?,cnv_and_ssm
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in ART3 and homozyous deletions in CARMIL1?,cnv_and_ssm
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in ART3 and homozyous deletions in MAST4?,cnv_and_ssm
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How often do cases of Bladder Urothelial Carcinoma exhibit mutations in CYP1A2 and homozyous deletions in ADAM17?,cnv_and_ssm
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often do cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus exhibit mutations in ADRA1A and homozyous deletions in DNMT1?",cnv_and_ssm
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in CDH23 and homozyous deletions in COL6A3?,cnv_and_ssm
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in CDH23 and homozyous deletions in BFAR?,cnv_and_ssm
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in KRT39 and homozyous deletions in ACTL7B?,cnv_and_ssm
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in PDHA2 and homozyous deletions in DCC?,cnv_and_ssm
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in SLC24A2 and homozyous deletions in DCN?,cnv_and_ssm
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How often do cases of Liver Hepatocellular Carcinoma exhibit mutations in PTPRN2 and homozyous deletions in SGCZ?,cnv_and_ssm
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How often do cases of Liver Hepatocellular Carcinoma exhibit mutations in PTPRN2 and homozyous deletions in BFAR?,cnv_and_ssm
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How often do cases of Liver Hepatocellular Carcinoma exhibit mutations in PTPRN2 and homozyous deletions in AQP7?,cnv_and_ssm
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How often do cases of Liver Hepatocellular Carcinoma exhibit mutations in PTPRN2 and homozyous deletions in PCDHB2?,cnv_and_ssm
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How often do cases of Liver Hepatocellular Carcinoma exhibit mutations in PTPRN2 and homozyous deletions in RIMS2?,cnv_and_ssm
+1188,SOX21,R55L,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in SOX21 and homozyous deletions in PHLPP1?,cnv_and_ssm
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How often do cases of Bladder Urothelial Carcinoma exhibit mutations in CPA6 and homozyous deletions in TASOR2?,cnv_and_ssm
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in GRM5 and homozyous deletions in ZFAT?,cnv_and_ssm
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often do cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus exhibit mutations in CASZ1 and homozyous deletions in MED16?",cnv_and_ssm
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in SGIP1 and homozyous deletions in DOCK2?,cnv_and_ssm
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in SGIP1 and homozyous deletions in TAF1C?,cnv_and_ssm
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in SGIP1 and homozyous deletions in TAF1C?,cnv_and_ssm
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in SGIP1 and homozyous deletions in ZMYM3?,cnv_and_ssm
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in CARMIL1 and homozyous deletions in TNS1?,cnv_and_ssm
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in CARMIL1 and homozyous deletions in PXN?,cnv_and_ssm
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in ZNF431 and homozyous deletions in TTC12?,cnv_and_ssm
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in ZNF431 and homozyous deletions in UNC5D?,cnv_and_ssm
+1234,ZNF431,R128I,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in ZNF431 and homozyous deletions in KIF20B?,cnv_and_ssm
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in DNAH11 and homozyous deletions in MAOB?,cnv_and_ssm
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in DNAH11 and homozyous deletions in CFAP61?,cnv_and_ssm
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in POLD1 and homozyous deletions in PTPRO?,cnv_and_ssm
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How often do cases of Lung Squamous Cell Carcinoma exhibit mutations in POLD1 and homozyous deletions in TNS1?,cnv_and_ssm
+1248,TTC12,D646H,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in TTC12 and homozyous deletions in CARMIL1?,cnv_and_ssm
+1249,TTC12,D652H,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in TTC12 and homozyous deletions in SPTAN1?,cnv_and_ssm
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How often do cases of Bladder Urothelial Carcinoma exhibit mutations in CNGB1 and homozyous deletions in AUTS2?,cnv_and_ssm
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How often do cases of Bladder Urothelial Carcinoma exhibit mutations in CNGB1 and homozyous deletions in ACVR1B?,cnv_and_ssm
+1254,CTSC,E214V,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in CTSC and homozyous deletions in CTSC?,cnv_and_ssm
+1255,CTSC,E291V,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in CTSC and homozyous deletions in MORF4L1?,cnv_and_ssm
+1256,CTSC,E322V,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in CTSC and homozyous deletions in CDH23?,cnv_and_ssm
+1257,CTSC,E324V,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in CTSC and homozyous deletions in AQP7?,cnv_and_ssm
+1258,CTSC,E335V,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in CTSC and homozyous deletions in POLD1?,cnv_and_ssm
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in PRSS8 and homozyous deletions in ZFAT?,cnv_and_ssm
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in PRSS8 and homozyous deletions in MYH11?,cnv_and_ssm
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in ARHGEF40 and homozyous deletions in PXN?,cnv_and_ssm
+1264,ACTB,A138T,Rectum Adenocarcinoma,How often do cases of Rectum Adenocarcinoma exhibit mutations in ACTB and homozyous deletions in PTPRN2?,cnv_and_ssm
+1265,ACTB,A217T,Rectum Adenocarcinoma,How often do cases of Rectum Adenocarcinoma exhibit mutations in ACTB and homozyous deletions in GPC3?,cnv_and_ssm
+1266,ACTB,A244T,Rectum Adenocarcinoma,How often do cases of Rectum Adenocarcinoma exhibit mutations in ACTB and homozyous deletions in KANSL1?,cnv_and_ssm
+1267,ACTB,A260T,Rectum Adenocarcinoma,How often do cases of Rectum Adenocarcinoma exhibit mutations in ACTB and homozyous deletions in PTPRN2?,cnv_and_ssm
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How often do cases of Glioblastoma Multiforme exhibit mutations in YY1AP1 and homozyous deletions in RIPOR2?,cnv_and_ssm
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How often do cases of Glioblastoma Multiforme exhibit mutations in YY1AP1 and homozyous deletions in GRTP1?,cnv_and_ssm
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How often do cases of Glioblastoma Multiforme exhibit mutations in YY1AP1 and homozyous deletions in ADRA1A?,cnv_and_ssm
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How often do cases of Glioblastoma Multiforme exhibit mutations in YY1AP1 and homozyous deletions in UNC5D?,cnv_and_ssm
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How often do cases of Glioblastoma Multiforme exhibit mutations in YY1AP1 and homozyous deletions in POLD1?,cnv_and_ssm
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How often do cases of Glioblastoma Multiforme exhibit mutations in YY1AP1 and homozyous deletions in FGF8?,cnv_and_ssm
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How often do cases of Glioblastoma Multiforme exhibit mutations in YY1AP1 and homozyous deletions in CNGB1?,cnv_and_ssm
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in FNDC7 and homozyous deletions in ZNF431?,cnv_and_ssm
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in FNDC7 and homozyous deletions in TNS1?,cnv_and_ssm
+1299,TLCD5,G15V,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in TLCD5 and homozyous deletions in FBN1?,cnv_and_ssm
+1300,TLCD5,G37V,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in TLCD5 and homozyous deletions in ANP32E?,cnv_and_ssm
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in POLR1G and homozyous deletions in PGR?,cnv_and_ssm
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in POLR1G and homozyous deletions in GRTP1?,cnv_and_ssm
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in DNAH14 and homozyous deletions in RIMS2?,cnv_and_ssm
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in DNAH14 and homozyous deletions in POC1B?,cnv_and_ssm
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in DNAH14 and homozyous deletions in AQP7?,cnv_and_ssm
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in NEXN and homozyous deletions in MORF4L1?,cnv_and_ssm
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How often do cases of Prostate Adenocarcinoma exhibit mutations in CYB5R2 and homozyous deletions in DCN?,cnv_and_ssm
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How often do cases of Prostate Adenocarcinoma exhibit mutations in CYB5R2 and homozyous deletions in FGF8?,cnv_and_ssm
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in NRAP and homozyous deletions in ARMC3?,cnv_and_ssm
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in NRAP and homozyous deletions in DCLK3?,cnv_and_ssm
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in NRAP and homozyous deletions in PXN?,cnv_and_ssm
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in CCDC22 and homozyous deletions in AQP7?,cnv_and_ssm
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in DCAF6 and homozyous deletions in PDHA2?,cnv_and_ssm
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in DCAF6 and homozyous deletions in CEP20?,cnv_and_ssm
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in ZNF708 and homozyous deletions in ACTB?,cnv_and_ssm
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in BFAR and homozyous deletions in CTSC?,cnv_and_ssm
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in MAST4 and homozyous deletions in MORF4L1?,cnv_and_ssm
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in MAST4 and homozyous deletions in JAML?,cnv_and_ssm
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in MAST4 and homozyous deletions in TLK2?,cnv_and_ssm
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in MAST4 and homozyous deletions in DSCAM?,cnv_and_ssm
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in MAST4 and homozyous deletions in DCC?,cnv_and_ssm
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in ARMC3 and homozyous deletions in TTC12?,cnv_and_ssm
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in ARMC3 and homozyous deletions in TMEM255A?,cnv_and_ssm
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How often do cases of Kidney Renal Clear Cell Carcinoma exhibit mutations in TET2 and homozyous deletions in CFAP61?,cnv_and_ssm
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How often do cases of Kidney Renal Clear Cell Carcinoma exhibit mutations in TET2 and homozyous deletions in STAT3?,cnv_and_ssm
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in SERPINB10 and homozyous deletions in ACTB?,cnv_and_ssm
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in STAT3 and homozyous deletions in SIK2?,cnv_and_ssm
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in MIEF1 and homozyous deletions in YY1AP1?,cnv_and_ssm
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in ACVR1B and homozyous deletions in PTPRN2?,cnv_and_ssm
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in ACVR1B and homozyous deletions in ANKRD30A?,cnv_and_ssm
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in ACVR1B and homozyous deletions in TAF1C?,cnv_and_ssm
+1393,EBF2,T104I,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in EBF2 and homozyous deletions in ZNF431?,cnv_and_ssm
+1394,EBF2,T252I,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in EBF2 and homozyous deletions in ANKDD1A?,cnv_and_ssm
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in VPS26B and homozyous deletions in MRPL32?,cnv_and_ssm
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often do cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus exhibit mutations in PGR and homozyous deletions in AQP7?",cnv_and_ssm
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often do cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus exhibit mutations in PGR and homozyous deletions in FRY?",cnv_and_ssm
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often do cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus exhibit mutations in PGR and homozyous deletions in HTR3B?",cnv_and_ssm
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How often do cases of Skin Cutaneous Melanoma exhibit mutations in ACTA2 and homozyous deletions in PRSS1?,cnv_and_ssm
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in THBS4 and homozyous deletions in PXN?,cnv_and_ssm
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in THBS4 and homozyous deletions in TENT5A?,cnv_and_ssm
+1413,PRSS1,S114T,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in PRSS1 and homozyous deletions in AUTS2?,cnv_and_ssm
+1414,PRSS1,S124T,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in PRSS1 and homozyous deletions in SMO?,cnv_and_ssm
+1415,PRSS1,S138T,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in PRSS1 and homozyous deletions in TASOR2?,cnv_and_ssm
+1416,PRSS1,S74T,Lung Adenocarcinoma,How often do cases of Lung Adenocarcinoma exhibit mutations in PRSS1 and homozyous deletions in DNAH11?,cnv_and_ssm
+1417,PGF,R126H,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in PGF and homozyous deletions in TLK2?,cnv_and_ssm
+1418,PGF,R127H,Stomach Adenocarcinoma,How often do cases of Stomach Adenocarcinoma exhibit mutations in PGF and homozyous deletions in ZNF804A?,cnv_and_ssm
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How often do cases of Breast Invasive Carcinoma exhibit mutations in ITPRID2 and homozyous deletions in RIMS2?,cnv_and_ssm
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How often do cases of Breast Invasive Carcinoma exhibit mutations in ITPRID2 and homozyous deletions in MIEF1?,cnv_and_ssm
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in HBB and homozyous deletions in CFAP61?,cnv_and_ssm
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in PCDHB2 and homozyous deletions in KRT39?,cnv_and_ssm
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in PCDHB2 and homozyous deletions in DCAF6?,cnv_and_ssm
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How often do cases of Colon Adenocarcinoma exhibit mutations in PCDHB2 and homozyous deletions in TAF1C?,cnv_and_ssm
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How often do cases of Uterine Corpus Endometrial Carcinoma exhibit mutations in UBR2 and homozyous deletions in ACVR1B?,cnv_and_ssm
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How often do cases of Rectum Adenocarcinoma exhibit mutations in FBXO42 and homozyous deletions in IL5RA?,cnv_and_ssm
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the prevalence of TNS1 somatic mutations and TASOR2 heterozygous deletions in Breast Invasive Carcinoma cases?,cnv_and_ssm
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the prevalence of TNS1 somatic mutations and PTPRN2 heterozygous deletions in Breast Invasive Carcinoma cases?,cnv_and_ssm
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the prevalence of TNS1 somatic mutations and GIMAP2 heterozygous deletions in Breast Invasive Carcinoma cases?,cnv_and_ssm
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the prevalence of TNS1 somatic mutations and FNDC7 heterozygous deletions in Breast Invasive Carcinoma cases?,cnv_and_ssm
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the prevalence of TNS1 somatic mutations and PXN heterozygous deletions in Breast Invasive Carcinoma cases?,cnv_and_ssm
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the prevalence of TNS1 somatic mutations and YY1AP1 heterozygous deletions in Breast Invasive Carcinoma cases?,cnv_and_ssm
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the prevalence of TNS1 somatic mutations and TAF1C heterozygous deletions in Breast Invasive Carcinoma cases?,cnv_and_ssm
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the prevalence of EVC2 somatic mutations and AUTS2 heterozygous deletions in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the prevalence of EVC2 somatic mutations and MYT1 heterozygous deletions in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CR1 somatic mutations and GRM1 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CR1 somatic mutations and GUK1 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the prevalence of TRPA1 somatic mutations and TLK2 heterozygous deletions in Rectum Adenocarcinoma cases?,cnv_and_ssm
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the prevalence of TRPA1 somatic mutations and RIMS2 heterozygous deletions in Rectum Adenocarcinoma cases?,cnv_and_ssm
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the prevalence of TAF1C somatic mutations and OR13C3 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the prevalence of TAF1C somatic mutations and CCNG1 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the prevalence of TAF1C somatic mutations and ACTB heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the prevalence of TAF1C somatic mutations and TTC12 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the prevalence of TAF1C somatic mutations and PGF heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the prevalence of DPF3 somatic mutations and SGIP1 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the prevalence of DPF3 somatic mutations and DCC heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the prevalence of DPF3 somatic mutations and SGIP1 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the prevalence of OR2T4 somatic mutations and PXN heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the prevalence of OR2T4 somatic mutations and TLK2 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the prevalence of FBN1 somatic mutations and PAK3 heterozygous deletions in Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the prevalence of MAD1L1 somatic mutations and ZBTB34 heterozygous deletions in Prostate Adenocarcinoma cases?,cnv_and_ssm
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the prevalence of MAD1L1 somatic mutations and EFCAB12 heterozygous deletions in Prostate Adenocarcinoma cases?,cnv_and_ssm
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the prevalence of MAD1L1 somatic mutations and GUK1 heterozygous deletions in Prostate Adenocarcinoma cases?,cnv_and_ssm
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the prevalence of CCNG1 somatic mutations and ZFP42 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the prevalence of ANP32E somatic mutations and SORCS1 heterozygous deletions in Kidney Renal Papillary Cell Carcinoma cases?,cnv_and_ssm
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the prevalence of ANP32E somatic mutations and YY1AP1 heterozygous deletions in Kidney Renal Papillary Cell Carcinoma cases?,cnv_and_ssm
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the prevalence of ANP32E somatic mutations and ARHGEF40 heterozygous deletions in Kidney Renal Papillary Cell Carcinoma cases?,cnv_and_ssm
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the prevalence of ANP32E somatic mutations and CPA6 heterozygous deletions in Kidney Renal Papillary Cell Carcinoma cases?,cnv_and_ssm
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the prevalence of FRY somatic mutations and POLR1G heterozygous deletions in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the prevalence of FRY somatic mutations and TLK2 heterozygous deletions in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the prevalence of FRY somatic mutations and TAF1C heterozygous deletions in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the prevalence of FRY somatic mutations and OLFML3 heterozygous deletions in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the prevalence of PAK3 somatic mutations and AUTS2 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the prevalence of PAK3 somatic mutations and POC1B heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the prevalence of PAK3 somatic mutations and EIF2B4 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the prevalence of PAK3 somatic mutations and HTR3B heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the prevalence of PAK3 somatic mutations and DOCK2 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the prevalence of MUC16 somatic mutations and CARMIL1 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the prevalence of ZFPM2 somatic mutations and THBS4 heterozygous deletions in Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the prevalence of ZFPM2 somatic mutations and LCN15 heterozygous deletions in Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the prevalence of PIK3C2B somatic mutations and SLC24A2 heterozygous deletions in Breast Invasive Carcinoma cases?,cnv_and_ssm
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the prevalence of PIK3C2B somatic mutations and ADRA1A heterozygous deletions in Breast Invasive Carcinoma cases?,cnv_and_ssm
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the prevalence of ZNF804A somatic mutations and GRTP1 heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the prevalence of RELN somatic mutations and PTPRO heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of EFCAB12 somatic mutations and PTPRN2 heterozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of EFCAB12 somatic mutations and COL6A3 heterozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the prevalence of DEFB115 somatic mutations and PGF heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the prevalence of ANKDD1A somatic mutations and RIMS2 heterozygous deletions in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the prevalence of ANKDD1A somatic mutations and ADRA1A heterozygous deletions in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the prevalence of ANKDD1A somatic mutations and POC1B heterozygous deletions in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the prevalence of HTR3B somatic mutations and LDOC1 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the prevalence of HTR3B somatic mutations and TRAP1 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the prevalence of HTR3B somatic mutations and ZSCAN31 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the prevalence of ABCC3 somatic mutations and TNS1 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the prevalence of NOMO1 somatic mutations and KDM5C heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the prevalence of NOMO1 somatic mutations and MERTK heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the prevalence of HYOU1 somatic mutations and ZSCAN31 heterozygous deletions in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the prevalence of FMO4 somatic mutations and STAT3 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+140,BICC1,A372V,Exceptional Responders,What is the prevalence of BICC1 somatic mutations and CTCFL heterozygous deletions in Exceptional Responders cases?,cnv_and_ssm
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the prevalence of ZMYM3 somatic mutations and TAF1C heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the prevalence of ZMYM3 somatic mutations and DEFB115 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the prevalence of ZMYM3 somatic mutations and PTPRN2 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of XKR4 somatic mutations and GPR158 heterozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the prevalence of ABCC2 somatic mutations and HTR3B heterozygous deletions in Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the prevalence of OR8K5 somatic mutations and CPS1 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the prevalence of SPTAN1 somatic mutations and ACVR1B heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the prevalence of SPTAN1 somatic mutations and GABRA6 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the prevalence of SYT10 somatic mutations and TMEM225 heterozygous deletions in Rectum Adenocarcinoma cases?,cnv_and_ssm
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the prevalence of HSPA5 somatic mutations and DNAH14 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the prevalence of UNC5D somatic mutations and UNC5D heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the prevalence of UNC5D somatic mutations and RIMS2 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the prevalence of UNC5D somatic mutations and DPF3 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the prevalence of UNC5D somatic mutations and ZFPM2 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the prevalence of UNC5D somatic mutations and THBS4 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the prevalence of UNC5D somatic mutations and EIF2B4 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the prevalence of DOCK2 somatic mutations and PCDHGA1 heterozygous deletions in Kidney Renal Clear Cell Carcinoma cases?,cnv_and_ssm
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the prevalence of ZNF627 somatic mutations and DCN heterozygous deletions in Kidney Renal Clear Cell Carcinoma cases?,cnv_and_ssm
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the prevalence of CDC42BPA somatic mutations and TAS1R3 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the prevalence of MRPL55 somatic mutations and JAML heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the prevalence of MRPL55 somatic mutations and FBXO15 heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the prevalence of TMTC3 somatic mutations and WNT2 heterozygous deletions in Breast Invasive Carcinoma cases?,cnv_and_ssm
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the prevalence of EPRS1 somatic mutations and ART3 heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the prevalence of EPRS1 somatic mutations and AUTS2 heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the prevalence of GRTP1 somatic mutations and GABRA6 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the prevalence of GRTP1 somatic mutations and STAT3 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the prevalence of TSHZ3 somatic mutations and MRPL32 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the prevalence of TAS1R3 somatic mutations and AKT1 heterozygous deletions in HIV+ Tumor Molecular Characterization Project - Cervical Cancer cases?,cnv_and_ssm
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the prevalence of PIAS3 somatic mutations and ITPRID2 heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the prevalence of PIAS3 somatic mutations and ANP32E heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the prevalence of ZNF274 somatic mutations and UNC5D heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the prevalence of SYNJ1 somatic mutations and SYT10 heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the prevalence of SYNJ1 somatic mutations and SPTAN1 heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the prevalence of SYNJ1 somatic mutations and DCN heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the prevalence of DSCAM somatic mutations and PCDHB2 heterozygous deletions in Prostate Adenocarcinoma cases?,cnv_and_ssm
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the prevalence of DSCAM somatic mutations and PYHIN1 heterozygous deletions in Prostate Adenocarcinoma cases?,cnv_and_ssm
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the prevalence of DSCAM somatic mutations and ABCC2 heterozygous deletions in Prostate Adenocarcinoma cases?,cnv_and_ssm
+267,DGKD,R140H,Exceptional Responders,What is the prevalence of DGKD somatic mutations and ACTB heterozygous deletions in Exceptional Responders cases?,cnv_and_ssm
+268,DGKD,R160H,Exceptional Responders,What is the prevalence of DGKD somatic mutations and TYK2 heterozygous deletions in Exceptional Responders cases?,cnv_and_ssm
+269,DGKD,R204H,Exceptional Responders,What is the prevalence of DGKD somatic mutations and TLCD5 heterozygous deletions in Exceptional Responders cases?,cnv_and_ssm
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the prevalence of PLEKHG6 somatic mutations and CPS1 heterozygous deletions in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the prevalence of PLEKHG6 somatic mutations and CDH23 heterozygous deletions in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the prevalence of PLEKHG6 somatic mutations and RIPOR2 heterozygous deletions in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the prevalence of WNT2 somatic mutations and SPINDOC heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the prevalence of GUCY2C somatic mutations and SORCS1 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the prevalence of C7orf31 somatic mutations and ZCCHC14 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of ZKSCAN7 somatic mutations and TTYH2 heterozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+299,OR5D14,M210L,Neuroblastoma,What is the prevalence of OR5D14 somatic mutations and NCKAP5 heterozygous deletions in Neuroblastoma cases?,cnv_and_ssm
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the prevalence of SPATA22 somatic mutations and ACTL7B heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the prevalence of SPATA22 somatic mutations and AQP7 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the prevalence of SPATA22 somatic mutations and POC1B heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the prevalence of LCN15 somatic mutations and YY1AP1 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the prevalence of DCAF4L2 somatic mutations and TRAP1 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the prevalence of GUK1 somatic mutations and CHODL heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the prevalence of GUK1 somatic mutations and MERTK heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the prevalence of GUK1 somatic mutations and PRSS1 heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the prevalence of GUK1 somatic mutations and TRIM45 heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the prevalence of GUK1 somatic mutations and TLK2 heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the prevalence of MORF4L1 somatic mutations and PGF heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the prevalence of MORF4L1 somatic mutations and PAK3 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the prevalence of MORF4L1 somatic mutations and DCN heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the prevalence of MORF4L1 somatic mutations and DNMT1 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the prevalence of MYO3B somatic mutations and MORF4L1 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the prevalence of MYO3B somatic mutations and UNC5D heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the prevalence of TENT5A somatic mutations and PIK3C2G heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the prevalence of TENT5A somatic mutations and FRY heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the prevalence of TENT5A somatic mutations and SPTAN1 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the prevalence of ZFAT somatic mutations and PTPRN2 heterozygous deletions in Ovarian Serous Cystadenocarcinoma cases?,cnv_and_ssm
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the prevalence of ZFAT somatic mutations and FRY heterozygous deletions in Ovarian Serous Cystadenocarcinoma cases?,cnv_and_ssm
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the prevalence of ZFAT somatic mutations and FRY heterozygous deletions in Ovarian Serous Cystadenocarcinoma cases?,cnv_and_ssm
+357,ZNF584,A211T,Sarcoma,What is the prevalence of ZNF584 somatic mutations and TNS1 heterozygous deletions in Sarcoma cases?,cnv_and_ssm
+358,ZNF584,A256T,Sarcoma,What is the prevalence of ZNF584 somatic mutations and CEP20 heterozygous deletions in Sarcoma cases?,cnv_and_ssm
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the prevalence of LDOC1 somatic mutations and OR13C3 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the prevalence of PDGFC somatic mutations and PTPRO heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the prevalence of MSANTD4 somatic mutations and CTSC heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the prevalence of NPSR1 somatic mutations and B3GALNT1 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the prevalence of PHLPP1 somatic mutations and RIMS2 heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the prevalence of COL6A3 somatic mutations and TTYH2 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the prevalence of COL6A3 somatic mutations and TLK2 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the prevalence of COL6A3 somatic mutations and GIMAP2 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the prevalence of COL6A3 somatic mutations and TAF1C heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the prevalence of COL6A3 somatic mutations and YY1AP1 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the prevalence of ADRA1A somatic mutations and PXN heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence of LAMB2 somatic mutations and RIMS2 heterozygous deletions in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the prevalence of POC1B somatic mutations and CPA6 heterozygous deletions in Rectum Adenocarcinoma cases?,cnv_and_ssm
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the prevalence of POC1B somatic mutations and PXN heterozygous deletions in Rectum Adenocarcinoma cases?,cnv_and_ssm
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the prevalence of POC1B somatic mutations and SPATA22 heterozygous deletions in Rectum Adenocarcinoma cases?,cnv_and_ssm
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the prevalence of POC1B somatic mutations and WNT2 heterozygous deletions in Rectum Adenocarcinoma cases?,cnv_and_ssm
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the prevalence of USH2A somatic mutations and PTPRN2 heterozygous deletions in Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the prevalence of AQP7 somatic mutations and RIPOR2 heterozygous deletions in Rectum Adenocarcinoma cases?,cnv_and_ssm
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the prevalence of AQP7 somatic mutations and SMO heterozygous deletions in Rectum Adenocarcinoma cases?,cnv_and_ssm
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the prevalence of AQP7 somatic mutations and DGKD heterozygous deletions in Rectum Adenocarcinoma cases?,cnv_and_ssm
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the prevalence of AQP7 somatic mutations and ACVR1B heterozygous deletions in Rectum Adenocarcinoma cases?,cnv_and_ssm
+430,DCN,R163C,Rectum Adenocarcinoma,What is the prevalence of DCN somatic mutations and AKT1 heterozygous deletions in Rectum Adenocarcinoma cases?,cnv_and_ssm
+431,DCN,R203C,Rectum Adenocarcinoma,What is the prevalence of DCN somatic mutations and TTN heterozygous deletions in Rectum Adenocarcinoma cases?,cnv_and_ssm
+432,DCN,R241C,Rectum Adenocarcinoma,What is the prevalence of DCN somatic mutations and PHLPP1 heterozygous deletions in Rectum Adenocarcinoma cases?,cnv_and_ssm
+433,DCN,R350C,Rectum Adenocarcinoma,What is the prevalence of DCN somatic mutations and OR2A12 heterozygous deletions in Rectum Adenocarcinoma cases?,cnv_and_ssm
+434,DCN,R41C,Rectum Adenocarcinoma,What is the prevalence of DCN somatic mutations and CXCR2 heterozygous deletions in Rectum Adenocarcinoma cases?,cnv_and_ssm
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CPS1 somatic mutations and NCKAP5 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CPS1 somatic mutations and ABCC3 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CPS1 somatic mutations and RIMS2 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the prevalence of FCGR2C somatic mutations and AUTS2 heterozygous deletions in Kidney Renal Papillary Cell Carcinoma cases?,cnv_and_ssm
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the prevalence of FCGR2C somatic mutations and PTPRO heterozygous deletions in Kidney Renal Papillary Cell Carcinoma cases?,cnv_and_ssm
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the prevalence of GRM1 somatic mutations and SPATA22 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the prevalence of SGCZ somatic mutations and GLRB heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the prevalence of SGCZ somatic mutations and CPS1 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+485,SMO,V15M,Stomach Adenocarcinoma,What is the prevalence of SMO somatic mutations and DEFB115 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+486,SMO,V321M,Stomach Adenocarcinoma,What is the prevalence of SMO somatic mutations and CFAP61 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the prevalence of CHODL somatic mutations and CACNA1F heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the prevalence of CHODL somatic mutations and ARHGEF40 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the prevalence of CHODL somatic mutations and CPS1 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+494,MYO16,P399H,Colon Adenocarcinoma,What is the prevalence of MYO16 somatic mutations and RIMS2 heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+495,MYO16,P421H,Colon Adenocarcinoma,What is the prevalence of MYO16 somatic mutations and UNC5D heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the prevalence of CXCR2 somatic mutations and GSTCD heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the prevalence of TMEM225 somatic mutations and DCC heterozygous deletions in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the prevalence of MAOB somatic mutations and CPS1 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of GPRASP1 somatic mutations and SGIP1 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence of MRPL32 somatic mutations and DHX16 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the prevalence of TYROBP somatic mutations and DNMT1 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the prevalence of RAB40C somatic mutations and MORF4L1 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the prevalence of RAB40C somatic mutations and RIMS2 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the prevalence of CTNNA2 somatic mutations and ZFP42 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the prevalence of CTNNA2 somatic mutations and TYROBP heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the prevalence of CTNNA2 somatic mutations and CPS1 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the prevalence of CTNNA2 somatic mutations and KDM5C heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the prevalence of MYO15A somatic mutations and RIPOR2 heterozygous deletions in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the prevalence of GIMAP2 somatic mutations and ARHGEF40 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the prevalence of KIF20B somatic mutations and CHODL heterozygous deletions in Glioblastoma Multiforme cases?,cnv_and_ssm
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the prevalence of KIF20B somatic mutations and ZCCHC14 heterozygous deletions in Glioblastoma Multiforme cases?,cnv_and_ssm
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the prevalence of ADAM17 somatic mutations and RIMS2 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the prevalence of BCAT1 somatic mutations and TTN heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the prevalence of BCAT1 somatic mutations and TLK2 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the prevalence of BCAT1 somatic mutations and CR1 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the prevalence of ERCC6 somatic mutations and CFAP61 heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+541,DCC,R320W,Breast Invasive Carcinoma,What is the prevalence of DCC somatic mutations and MYT1 heterozygous deletions in Breast Invasive Carcinoma cases?,cnv_and_ssm
+542,DCC,R363W,Breast Invasive Carcinoma,What is the prevalence of DCC somatic mutations and DNMT1 heterozygous deletions in Breast Invasive Carcinoma cases?,cnv_and_ssm
+543,DCC,R386W,Breast Invasive Carcinoma,What is the prevalence of DCC somatic mutations and POLD1 heterozygous deletions in Breast Invasive Carcinoma cases?,cnv_and_ssm
+544,DCC,R41W,Breast Invasive Carcinoma,What is the prevalence of DCC somatic mutations and MAST4 heterozygous deletions in Breast Invasive Carcinoma cases?,cnv_and_ssm
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the prevalence of FBXO15 somatic mutations and RIMS2 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the prevalence of FBXO15 somatic mutations and SGCZ heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the prevalence of GSTCD somatic mutations and DNAH14 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the prevalence of GSTCD somatic mutations and KL heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the prevalence of OLFML3 somatic mutations and CYB5R2 heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the prevalence of OLFML3 somatic mutations and CTSC heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the prevalence of OLFML3 somatic mutations and MERTK heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the prevalence of CFAP61 somatic mutations and FGF8 heterozygous deletions in Ovarian Serous Cystadenocarcinoma cases?,cnv_and_ssm
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the prevalence of CFAP61 somatic mutations and ZSCAN31 heterozygous deletions in Ovarian Serous Cystadenocarcinoma cases?,cnv_and_ssm
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the prevalence of HLA-DQA2 somatic mutations and PRSS1 heterozygous deletions in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the prevalence of TENM2 somatic mutations and LCN15 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the prevalence of TENM2 somatic mutations and PGR heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the prevalence of TENM2 somatic mutations and CPS1 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the prevalence of ANKRD24 somatic mutations and EIF2B4 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the prevalence of ANKRD24 somatic mutations and PIAS3 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the prevalence of ANKRD24 somatic mutations and DNAH14 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the prevalence of ZCCHC14 somatic mutations and ACTB heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the prevalence of ZCCHC14 somatic mutations and OLFML3 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the prevalence of ZCCHC14 somatic mutations and ADAM17 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the prevalence of ZCCHC14 somatic mutations and SORCS1 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+625,SIK2,I265M,Lung Adenocarcinoma,What is the prevalence of SIK2 somatic mutations and CHODL heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the prevalence of MYH11 somatic mutations and DCC heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the prevalence of MYH11 somatic mutations and GPC3 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the prevalence of SLC6A4 somatic mutations and EPRS1 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the prevalence of SLC9C1 somatic mutations and AUTS2 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the prevalence of SLC9C1 somatic mutations and TMEM225 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the prevalence of OR2A12 somatic mutations and DNAH14 heterozygous deletions in Brain Lower Grade Glioma cases?,cnv_and_ssm
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the prevalence of PYHIN1 somatic mutations and COL6A3 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the prevalence of PYHIN1 somatic mutations and STK19 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the prevalence of JAML somatic mutations and PTPRO heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the prevalence of JAML somatic mutations and BCAT1 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the prevalence of JAML somatic mutations and PAPPA heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the prevalence of JAML somatic mutations and POC1B heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the prevalence of TYK2 somatic mutations and CARMIL1 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the prevalence of TYK2 somatic mutations and TLK2 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the prevalence of TYK2 somatic mutations and RELN heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CTCFL somatic mutations and YY1AP1 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CTCFL somatic mutations and TRIM45 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CTCFL somatic mutations and TNS1 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CTCFL somatic mutations and CTNNA2 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CEP20 somatic mutations and COL6A3 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CEP20 somatic mutations and ANKRD30A heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the prevalence of RIMS2 somatic mutations and FRY heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the prevalence of RIMS2 somatic mutations and SGCZ heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the prevalence of RIMS2 somatic mutations and DPF3 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the prevalence of RIMS2 somatic mutations and CFAP298-TCP10L heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the prevalence of RIMS2 somatic mutations and GPR158 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the prevalence of RIMS2 somatic mutations and GUK1 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the prevalence of RIMS2 somatic mutations and ADRA1A heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the prevalence of PIK3C2G somatic mutations and ZNF274 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the prevalence of PIK3C2G somatic mutations and MYO15A heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+728,STK19,D341N,Colon Adenocarcinoma,What is the prevalence of STK19 somatic mutations and NOMO1 heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+729,STK19,D345N,Colon Adenocarcinoma,What is the prevalence of STK19 somatic mutations and CFAP61 heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the prevalence of REXO4 somatic mutations and TNS1 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of ZBTB34 somatic mutations and TET2 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of ZBTB34 somatic mutations and ZCCHC14 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the prevalence of NCKAP5 somatic mutations and POLR1G heterozygous deletions in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of SORCS1 somatic mutations and GPRASP1 heterozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of SORCS1 somatic mutations and YY1AP1 heterozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of SORCS1 somatic mutations and ZFAT heterozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of SORCS1 somatic mutations and KIF20B heterozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the prevalence of FGF8 somatic mutations and OLFML3 heterozygous deletions in Head and Neck Squamous Cell Carcinoma cases?,cnv_and_ssm
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the prevalence of FGF8 somatic mutations and ACTB heterozygous deletions in Head and Neck Squamous Cell Carcinoma cases?,cnv_and_ssm
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the prevalence of FGF8 somatic mutations and EIF2B4 heterozygous deletions in Head and Neck Squamous Cell Carcinoma cases?,cnv_and_ssm
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the prevalence of FGF8 somatic mutations and NCKAP5 heterozygous deletions in Head and Neck Squamous Cell Carcinoma cases?,cnv_and_ssm
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the prevalence of FGF8 somatic mutations and ANKRD30A heterozygous deletions in Head and Neck Squamous Cell Carcinoma cases?,cnv_and_ssm
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the prevalence of TENM3 somatic mutations and RELN heterozygous deletions in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia cases?,cnv_and_ssm
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the prevalence of AKT1 somatic mutations and GRM1 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence of CFAP298-TCP10L somatic mutations and ANKDD1A heterozygous deletions in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the prevalence of GLRB somatic mutations and HTR3B heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+793,TTN,F7636L,Colon Adenocarcinoma,What is the prevalence of TTN somatic mutations and POC1B heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+794,TTN,F8563L,Colon Adenocarcinoma,What is the prevalence of TTN somatic mutations and PIK3C2B heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+795,TTN,F8880L,Colon Adenocarcinoma,What is the prevalence of TTN somatic mutations and CDH23 heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the prevalence of ANKRD30A somatic mutations and DCN heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the prevalence of ANKRD30A somatic mutations and SERPINB10 heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the prevalence of ANKRD30A somatic mutations and PIK3C2B heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the prevalence of TRIM45 somatic mutations and PIK3C2G heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the prevalence of TRIM45 somatic mutations and TAS1R3 heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the prevalence of TRIM45 somatic mutations and TMEM255A heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the prevalence of CACNA1F somatic mutations and SPTAN1 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the prevalence of CACNA1F somatic mutations and THBS4 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the prevalence of CACNA1F somatic mutations and MYT1 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+817,KL,R594C,Colon Adenocarcinoma,What is the prevalence of KL somatic mutations and AQP7 heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the prevalence of GUF1 somatic mutations and OLFML3 heterozygous deletions in Kidney Renal Papillary Cell Carcinoma cases?,cnv_and_ssm
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the prevalence of TAF1L somatic mutations and CDH23 heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the prevalence of TASOR2 somatic mutations and PTPRN2 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the prevalence of TASOR2 somatic mutations and PRSS1 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the prevalence of TASOR2 somatic mutations and DCC heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the prevalence of KDM5C somatic mutations and OR2A12 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the prevalence of KDM5C somatic mutations and FBXO15 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the prevalence of KDM5C somatic mutations and ZMYM3 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the prevalence of KDM5C somatic mutations and DCLK3 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence of IL5RA somatic mutations and RIPOR2 heterozygous deletions in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the prevalence of DHX16 somatic mutations and AQP7 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the prevalence of DHX16 somatic mutations and NRAP heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the prevalence of GPR158 somatic mutations and MYO16 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the prevalence of GPR158 somatic mutations and CARMIL1 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of EIF2B4 somatic mutations and RIPOR2 heterozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of EIF2B4 somatic mutations and EPRS1 heterozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of EIF2B4 somatic mutations and ADRA1A heterozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of EIF2B4 somatic mutations and GUK1 heterozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of EIF2B4 somatic mutations and ANKRD24 heterozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of EIF2B4 somatic mutations and EIF2B4 heterozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the prevalence of AUTS2 somatic mutations and EIF2B4 heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the prevalence of AUTS2 somatic mutations and DPF3 heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the prevalence of AUTS2 somatic mutations and POC1B heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the prevalence of AUTS2 somatic mutations and ZCCHC14 heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the prevalence of AUTS2 somatic mutations and EIF2B4 heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the prevalence of AUTS2 somatic mutations and EBF2 heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the prevalence of AUTS2 somatic mutations and SMO heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the prevalence of AUTS2 somatic mutations and PDHA2 heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the prevalence of AUTS2 somatic mutations and DNAH14 heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the prevalence of AUTS2 somatic mutations and CTSC heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of ACTL7B somatic mutations and TYK2 heterozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the prevalence of PCDHGA1 somatic mutations and OR2A12 heterozygous deletions in Glioblastoma Multiforme cases?,cnv_and_ssm
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the prevalence of TRAP1 somatic mutations and CNGB1 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the prevalence of TRAP1 somatic mutations and PRSS1 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence of PIK3C2A somatic mutations and ANKRD30A heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the prevalence of KANSL1 somatic mutations and TENT5A heterozygous deletions in Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the prevalence of ANKRD52 somatic mutations and ANKRD52 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of PAPPA somatic mutations and PCDHB2 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the prevalence of B3GALNT1 somatic mutations and TTN heterozygous deletions in Rectum Adenocarcinoma cases?,cnv_and_ssm
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the prevalence of GABRA6 somatic mutations and SORCS1 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the prevalence of GABRA6 somatic mutations and TAF1C heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the prevalence of GABRA6 somatic mutations and PRSS1 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the prevalence of GABRA6 somatic mutations and CYB5R2 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the prevalence of GABRA6 somatic mutations and TAF1C heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the prevalence of ZSCAN31 somatic mutations and UNC5D heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of MED16 somatic mutations and MSANTD4 heterozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of MED16 somatic mutations and ICE1 heterozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the prevalence of PTPRO somatic mutations and GPC3 heterozygous deletions in Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the prevalence of PTPRO somatic mutations and PTPRO heterozygous deletions in Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the prevalence of PTPRO somatic mutations and SOX21 heterozygous deletions in Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the prevalence of PTPRO somatic mutations and AUTS2 heterozygous deletions in Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the prevalence of PTPRO somatic mutations and OLFML3 heterozygous deletions in Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the prevalence of PTPRO somatic mutations and NOMO1 heterozygous deletions in Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the prevalence of PTPRO somatic mutations and TTC17 heterozygous deletions in Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the prevalence of PTPRO somatic mutations and YY1AP1 heterozygous deletions in Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CHMP7 somatic mutations and MYO15A heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the prevalence of GPC3 somatic mutations and PTPRN2 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the prevalence of GPC3 somatic mutations and ACTB heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence of TLK2 somatic mutations and DSCAM heterozygous deletions in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence of TLK2 somatic mutations and TTC12 heterozygous deletions in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence of TLK2 somatic mutations and ANP32E heterozygous deletions in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence of TLK2 somatic mutations and YY1AP1 heterozygous deletions in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the prevalence of TLK2 somatic mutations and SERPINB10 heterozygous deletions in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the prevalence of ZNF217 somatic mutations and BCAT1 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the prevalence of SYT9 somatic mutations and SPAG1 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the prevalence of SYT9 somatic mutations and NRAP heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the prevalence of PKHD1L1 somatic mutations and SPINDOC heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the prevalence of MYO3A somatic mutations and RIMS2 heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of VASN somatic mutations and SGIP1 heterozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the prevalence of DNMT1 somatic mutations and DCC heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the prevalence of DNMT1 somatic mutations and ANP32E heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the prevalence of DNMT1 somatic mutations and TTC17 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1056,CA9,E402K,Colon Adenocarcinoma,What is the prevalence of CA9 somatic mutations and OLFML3 heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence of TTC17 somatic mutations and PIAS3 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the prevalence of TTC17 somatic mutations and PTPRN2 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the prevalence of PSG2 somatic mutations and PTPRN2 heterozygous deletions in Breast Invasive Carcinoma cases?,cnv_and_ssm
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the prevalence of RIPOR2 somatic mutations and RIMS2 heterozygous deletions in Breast Invasive Carcinoma cases?,cnv_and_ssm
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the prevalence of RIPOR2 somatic mutations and DSCAM heterozygous deletions in Breast Invasive Carcinoma cases?,cnv_and_ssm
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the prevalence of RIPOR2 somatic mutations and MORF4L1 heterozygous deletions in Breast Invasive Carcinoma cases?,cnv_and_ssm
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the prevalence of RIPOR2 somatic mutations and SPATA22 heterozygous deletions in Breast Invasive Carcinoma cases?,cnv_and_ssm
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the prevalence of DCLK3 somatic mutations and TTC17 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the prevalence of DCLK3 somatic mutations and DCC heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the prevalence of MERTK somatic mutations and HYOU1 heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the prevalence of MERTK somatic mutations and SPINDOC heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the prevalence of MERTK somatic mutations and ART3 heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the prevalence of ZFP42 somatic mutations and ZNF804A heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the prevalence of OR13C3 somatic mutations and ANP32E heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the prevalence of OR13C3 somatic mutations and TNS1 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the prevalence of SPAG1 somatic mutations and POC1B heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CDKN2AIP somatic mutations and FRY heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the prevalence of PXN somatic mutations and COL6A3 heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the prevalence of PXN somatic mutations and PTPRN2 heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the prevalence of PXN somatic mutations and ANP32E heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the prevalence of PXN somatic mutations and CHODL heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the prevalence of PXN somatic mutations and GSTCD heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the prevalence of PXN somatic mutations and THBS4 heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the prevalence of TTYH2 somatic mutations and TENM2 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the prevalence of TTYH2 somatic mutations and KIF20B heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the prevalence of TMEM255A somatic mutations and ANKRD30A heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the prevalence of TMEM255A somatic mutations and MED16 heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the prevalence of TMEM255A somatic mutations and FNDC7 heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the prevalence of TASOR2 somatic mutations and B3GALNT1 heterozygous deletions in Breast Invasive Carcinoma cases?,cnv_and_ssm
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the prevalence of TASOR2 somatic mutations and CDH23 heterozygous deletions in Breast Invasive Carcinoma cases?,cnv_and_ssm
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the prevalence of ICE1 somatic mutations and ANKRD30A heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the prevalence of MYT1 somatic mutations and ABCC2 heterozygous deletions in Breast Invasive Carcinoma cases?,cnv_and_ssm
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the prevalence of MYT1 somatic mutations and EBF2 heterozygous deletions in Breast Invasive Carcinoma cases?,cnv_and_ssm
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the prevalence of MYT1 somatic mutations and MAST4 heterozygous deletions in Breast Invasive Carcinoma cases?,cnv_and_ssm
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CX3CR1 somatic mutations and TMEM225 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CX3CR1 somatic mutations and SLC9C1 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the prevalence of SPINDOC somatic mutations and MERTK heterozygous deletions in Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the prevalence of ART3 somatic mutations and PTPRO heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the prevalence of ART3 somatic mutations and TENM2 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the prevalence of CYP1A2 somatic mutations and SYNJ1 heterozygous deletions in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of ADRA1A somatic mutations and SPATA22 heterozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the prevalence of CDH23 somatic mutations and REXO4 heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the prevalence of CDH23 somatic mutations and MYO16 heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the prevalence of KRT39 somatic mutations and PYHIN1 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the prevalence of PDHA2 somatic mutations and ITPRID2 heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the prevalence of SLC24A2 somatic mutations and CTNNA2 heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the prevalence of PTPRN2 somatic mutations and TTC17 heterozygous deletions in Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the prevalence of PTPRN2 somatic mutations and ACTB heterozygous deletions in Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the prevalence of PTPRN2 somatic mutations and TTC17 heterozygous deletions in Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the prevalence of PTPRN2 somatic mutations and MAST4 heterozygous deletions in Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the prevalence of PTPRN2 somatic mutations and ZNF804A heterozygous deletions in Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the prevalence of SOX21 somatic mutations and TRIM45 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the prevalence of CPA6 somatic mutations and SLC6A4 heterozygous deletions in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the prevalence of GRM5 somatic mutations and NOMO1 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of CASZ1 somatic mutations and CACNA1F heterozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the prevalence of SGIP1 somatic mutations and HSPA5 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the prevalence of SGIP1 somatic mutations and SIK2 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the prevalence of SGIP1 somatic mutations and TASOR2 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the prevalence of SGIP1 somatic mutations and AQP7 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the prevalence of CARMIL1 somatic mutations and KDM5C heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the prevalence of CARMIL1 somatic mutations and TAF1L heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the prevalence of ZNF431 somatic mutations and TRIM45 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the prevalence of ZNF431 somatic mutations and MERTK heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the prevalence of ZNF431 somatic mutations and PLEKHG6 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the prevalence of DNAH11 somatic mutations and AUTS2 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the prevalence of DNAH11 somatic mutations and PCDHB2 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the prevalence of POLD1 somatic mutations and EVC2 heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the prevalence of POLD1 somatic mutations and PGR heterozygous deletions in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the prevalence of TTC12 somatic mutations and PSG2 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the prevalence of TTC12 somatic mutations and MAOB heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the prevalence of CNGB1 somatic mutations and SERPINB10 heterozygous deletions in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the prevalence of CNGB1 somatic mutations and DCN heterozygous deletions in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the prevalence of CTSC somatic mutations and PIK3C2G heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the prevalence of CTSC somatic mutations and ZCCHC14 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the prevalence of CTSC somatic mutations and TRPA1 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the prevalence of CTSC somatic mutations and MERTK heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the prevalence of CTSC somatic mutations and ZBTB34 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the prevalence of PRSS8 somatic mutations and CDC42BPA heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the prevalence of PRSS8 somatic mutations and CFAP61 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the prevalence of ARHGEF40 somatic mutations and TLK2 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the prevalence of ACTB somatic mutations and CX3CR1 heterozygous deletions in Rectum Adenocarcinoma cases?,cnv_and_ssm
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the prevalence of ACTB somatic mutations and EFCAB12 heterozygous deletions in Rectum Adenocarcinoma cases?,cnv_and_ssm
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the prevalence of ACTB somatic mutations and EIF2B4 heterozygous deletions in Rectum Adenocarcinoma cases?,cnv_and_ssm
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the prevalence of ACTB somatic mutations and SOX21 heterozygous deletions in Rectum Adenocarcinoma cases?,cnv_and_ssm
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the prevalence of YY1AP1 somatic mutations and PIK3C2A heterozygous deletions in Glioblastoma Multiforme cases?,cnv_and_ssm
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the prevalence of YY1AP1 somatic mutations and CR1 heterozygous deletions in Glioblastoma Multiforme cases?,cnv_and_ssm
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the prevalence of YY1AP1 somatic mutations and OLFML3 heterozygous deletions in Glioblastoma Multiforme cases?,cnv_and_ssm
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the prevalence of YY1AP1 somatic mutations and DNAH11 heterozygous deletions in Glioblastoma Multiforme cases?,cnv_and_ssm
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the prevalence of YY1AP1 somatic mutations and DCN heterozygous deletions in Glioblastoma Multiforme cases?,cnv_and_ssm
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the prevalence of YY1AP1 somatic mutations and PLEKHG6 heterozygous deletions in Glioblastoma Multiforme cases?,cnv_and_ssm
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the prevalence of YY1AP1 somatic mutations and ACTA2 heterozygous deletions in Glioblastoma Multiforme cases?,cnv_and_ssm
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the prevalence of FNDC7 somatic mutations and SGCZ heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the prevalence of FNDC7 somatic mutations and CPS1 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the prevalence of TLCD5 somatic mutations and ACTL7B heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the prevalence of TLCD5 somatic mutations and CX3CR1 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the prevalence of POLR1G somatic mutations and FCGR2C heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the prevalence of POLR1G somatic mutations and MAD1L1 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the prevalence of DNAH14 somatic mutations and TASOR2 heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the prevalence of DNAH14 somatic mutations and AQP7 heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the prevalence of DNAH14 somatic mutations and KL heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the prevalence of NEXN somatic mutations and TLCD5 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the prevalence of CYB5R2 somatic mutations and GABRA6 heterozygous deletions in Prostate Adenocarcinoma cases?,cnv_and_ssm
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the prevalence of CYB5R2 somatic mutations and PTPRO heterozygous deletions in Prostate Adenocarcinoma cases?,cnv_and_ssm
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the prevalence of NRAP somatic mutations and MAD1L1 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the prevalence of NRAP somatic mutations and DCAF6 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the prevalence of NRAP somatic mutations and TNS1 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the prevalence of CCDC22 somatic mutations and DNAH14 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the prevalence of DCAF6 somatic mutations and POC1B heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the prevalence of DCAF6 somatic mutations and EPRS1 heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the prevalence of ZNF708 somatic mutations and ZCCHC14 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the prevalence of BFAR somatic mutations and OLFML3 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of MAST4 somatic mutations and PKHD1L1 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of MAST4 somatic mutations and ACTB heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of MAST4 somatic mutations and CARMIL1 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of MAST4 somatic mutations and KDM5C heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of MAST4 somatic mutations and PAK3 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the prevalence of ARMC3 somatic mutations and VASN heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the prevalence of ARMC3 somatic mutations and CNGB1 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the prevalence of TET2 somatic mutations and ZFAT heterozygous deletions in Kidney Renal Clear Cell Carcinoma cases?,cnv_and_ssm
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the prevalence of TET2 somatic mutations and ZNF431 heterozygous deletions in Kidney Renal Clear Cell Carcinoma cases?,cnv_and_ssm
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the prevalence of SERPINB10 somatic mutations and PSG2 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the prevalence of STAT3 somatic mutations and FGF8 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the prevalence of MIEF1 somatic mutations and AQP7 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the prevalence of ACVR1B somatic mutations and DCAF6 heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the prevalence of ACVR1B somatic mutations and GSTCD heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the prevalence of ACVR1B somatic mutations and MAD1L1 heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the prevalence of EBF2 somatic mutations and YY1AP1 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the prevalence of EBF2 somatic mutations and SPATA22 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the prevalence of VPS26B somatic mutations and NPSR1 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of PGR somatic mutations and CR1 heterozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of PGR somatic mutations and TTN heterozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the prevalence of PGR somatic mutations and MYH11 heterozygous deletions in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the prevalence of ACTA2 somatic mutations and DCC heterozygous deletions in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the prevalence of THBS4 somatic mutations and OR2A12 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the prevalence of THBS4 somatic mutations and B3GALNT1 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the prevalence of PRSS1 somatic mutations and ART3 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the prevalence of PRSS1 somatic mutations and ANKDD1A heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the prevalence of PRSS1 somatic mutations and DNMT1 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the prevalence of PRSS1 somatic mutations and TMTC3 heterozygous deletions in Lung Adenocarcinoma cases?,cnv_and_ssm
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the prevalence of PGF somatic mutations and ANKRD24 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the prevalence of PGF somatic mutations and CXCR2 heterozygous deletions in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the prevalence of ITPRID2 somatic mutations and ANP32E heterozygous deletions in Breast Invasive Carcinoma cases?,cnv_and_ssm
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the prevalence of ITPRID2 somatic mutations and EBF2 heterozygous deletions in Breast Invasive Carcinoma cases?,cnv_and_ssm
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the prevalence of HBB somatic mutations and NRAP heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the prevalence of PCDHB2 somatic mutations and ITPRID2 heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the prevalence of PCDHB2 somatic mutations and ZKSCAN7 heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the prevalence of PCDHB2 somatic mutations and FRY heterozygous deletions in Colon Adenocarcinoma cases?,cnv_and_ssm
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the prevalence of UBR2 somatic mutations and OLFML3 heterozygous deletions in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the prevalence of FBXO42 somatic mutations and ZNF804A heterozygous deletions in Rectum Adenocarcinoma cases?,cnv_and_ssm
+1,TNS1,G1362V,Breast Invasive Carcinoma,Can you tell me the frequency of TNS1 mutations co-occurring with RIMS2 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+2,TNS1,G1711V,Breast Invasive Carcinoma,Can you tell me the frequency of TNS1 mutations co-occurring with OR2A12 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+3,TNS1,G1718V,Breast Invasive Carcinoma,Can you tell me the frequency of TNS1 mutations co-occurring with EIF2B4 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+4,TNS1,G1732V,Breast Invasive Carcinoma,Can you tell me the frequency of TNS1 mutations co-occurring with SGCZ amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+5,TNS1,G1824V,Breast Invasive Carcinoma,Can you tell me the frequency of TNS1 mutations co-occurring with TRPA1 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+6,TNS1,G1857V,Breast Invasive Carcinoma,Can you tell me the frequency of TNS1 mutations co-occurring with CHMP7 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+7,TNS1,G843V,Breast Invasive Carcinoma,Can you tell me the frequency of TNS1 mutations co-occurring with RIMS2 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,Can you tell me the frequency of EVC2 mutations co-occurring with PRSS1 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+15,EVC2,E987K,Bladder Urothelial Carcinoma,Can you tell me the frequency of EVC2 mutations co-occurring with AUTS2 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of CR1 mutations co-occurring with DNAH14 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of CR1 mutations co-occurring with PXN amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+22,TRPA1,S295I,Rectum Adenocarcinoma,Can you tell me the frequency of TRPA1 mutations co-occurring with RELN amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+23,TRPA1,S443I,Rectum Adenocarcinoma,Can you tell me the frequency of TRPA1 mutations co-occurring with GPC3 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+24,TAF1C,R299L,Lung Adenocarcinoma,Can you tell me the frequency of TAF1C mutations co-occurring with ZNF431 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+25,TAF1C,R396L,Lung Adenocarcinoma,Can you tell me the frequency of TAF1C mutations co-occurring with TASOR2 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+26,TAF1C,R634L,Lung Adenocarcinoma,Can you tell me the frequency of TAF1C mutations co-occurring with SYNJ1 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+27,TAF1C,R702L,Lung Adenocarcinoma,Can you tell me the frequency of TAF1C mutations co-occurring with HBB amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+28,TAF1C,R728L,Lung Adenocarcinoma,Can you tell me the frequency of TAF1C mutations co-occurring with ANP32E amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of DPF3 mutations co-occurring with SGIP1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of DPF3 mutations co-occurring with RIMS2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of DPF3 mutations co-occurring with RIMS2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+42,OR2T4,P272H,Lung Adenocarcinoma,Can you tell me the frequency of OR2T4 mutations co-occurring with TRPA1 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+43,OR2T4,P300H,Lung Adenocarcinoma,Can you tell me the frequency of OR2T4 mutations co-occurring with EIF2B4 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,Can you tell me the frequency of FBN1 mutations co-occurring with POLD1 amplifications in Pancreatic Adenocarcinoma?,cnv_and_ssm
+45,MAD1L1,E396K,Prostate Adenocarcinoma,Can you tell me the frequency of MAD1L1 mutations co-occurring with CYP1A2 amplifications in Prostate Adenocarcinoma?,cnv_and_ssm
+46,MAD1L1,E488K,Prostate Adenocarcinoma,Can you tell me the frequency of MAD1L1 mutations co-occurring with STK19 amplifications in Prostate Adenocarcinoma?,cnv_and_ssm
+47,MAD1L1,E78K,Prostate Adenocarcinoma,Can you tell me the frequency of MAD1L1 mutations co-occurring with PLEKHG6 amplifications in Prostate Adenocarcinoma?,cnv_and_ssm
+61,CCNG1,E22K,Skin Cutaneous Melanoma,Can you tell me the frequency of CCNG1 mutations co-occurring with TASOR2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,Can you tell me the frequency of ANP32E mutations co-occurring with ACVR1B amplifications in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,Can you tell me the frequency of ANP32E mutations co-occurring with HLA-DQA2 amplifications in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,Can you tell me the frequency of ANP32E mutations co-occurring with STK19 amplifications in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,Can you tell me the frequency of ANP32E mutations co-occurring with LDOC1 amplifications in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+66,FRY,S1888A,Bladder Urothelial Carcinoma,Can you tell me the frequency of FRY mutations co-occurring with CDKN2AIP amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+67,FRY,S1937A,Bladder Urothelial Carcinoma,Can you tell me the frequency of FRY mutations co-occurring with FRY amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+68,FRY,S1938A,Bladder Urothelial Carcinoma,Can you tell me the frequency of FRY mutations co-occurring with CHODL amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+69,FRY,S1983A,Bladder Urothelial Carcinoma,Can you tell me the frequency of FRY mutations co-occurring with TLK2 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+70,PAK3,E318K,Skin Cutaneous Melanoma,Can you tell me the frequency of PAK3 mutations co-occurring with SPAG1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+71,PAK3,E319K,Skin Cutaneous Melanoma,Can you tell me the frequency of PAK3 mutations co-occurring with PRSS1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+72,PAK3,E334K,Skin Cutaneous Melanoma,Can you tell me the frequency of PAK3 mutations co-occurring with POC1B amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+73,PAK3,E340K,Skin Cutaneous Melanoma,Can you tell me the frequency of PAK3 mutations co-occurring with AUTS2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+74,PAK3,E355K,Skin Cutaneous Melanoma,Can you tell me the frequency of PAK3 mutations co-occurring with PYHIN1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+80,MUC16,P7963L,Skin Cutaneous Melanoma,Can you tell me the frequency of MUC16 mutations co-occurring with UNC5D amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,Can you tell me the frequency of ZFPM2 mutations co-occurring with DCAF6 amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,Can you tell me the frequency of ZFPM2 mutations co-occurring with PTPRO amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,Can you tell me the frequency of PIK3C2B mutations co-occurring with DNAH11 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,Can you tell me the frequency of PIK3C2B mutations co-occurring with UNC5D amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+114,ZNF804A,S371Y,Colon Adenocarcinoma,Can you tell me the frequency of ZNF804A mutations co-occurring with ACTB amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+116,RELN,A2371V,Stomach Adenocarcinoma,Can you tell me the frequency of RELN mutations co-occurring with SYNJ1 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the frequency of EFCAB12 mutations co-occurring with SORCS1 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the frequency of EFCAB12 mutations co-occurring with ARMC3 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+120,DEFB115,E53K,Skin Cutaneous Melanoma,Can you tell me the frequency of DEFB115 mutations co-occurring with TNS1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,Can you tell me the frequency of ANKDD1A mutations co-occurring with FNDC7 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,Can you tell me the frequency of ANKDD1A mutations co-occurring with TLK2 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,Can you tell me the frequency of ANKDD1A mutations co-occurring with DCN amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of HTR3B mutations co-occurring with TASOR2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of HTR3B mutations co-occurring with ACTB amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of HTR3B mutations co-occurring with UBR2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+129,ABCC3,R758W,Stomach Adenocarcinoma,Can you tell me the frequency of ABCC3 mutations co-occurring with ACTB amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of NOMO1 mutations co-occurring with MUC16 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of NOMO1 mutations co-occurring with ANP32E amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,Can you tell me the frequency of HYOU1 mutations co-occurring with EVC2 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+139,FMO4,R500Q,Skin Cutaneous Melanoma,Can you tell me the frequency of FMO4 mutations co-occurring with MYH11 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+140,BICC1,A372V,Exceptional Responders,Can you tell me the frequency of BICC1 mutations co-occurring with PLEKHG6 amplifications in Exceptional Responders?,cnv_and_ssm
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of ZMYM3 mutations co-occurring with PTPRN2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of ZMYM3 mutations co-occurring with DCN amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of ZMYM3 mutations co-occurring with TMTC3 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the frequency of XKR4 mutations co-occurring with PXN amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,Can you tell me the frequency of ABCC2 mutations co-occurring with PTPRO amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+157,OR8K5,R293G,Lung Adenocarcinoma,Can you tell me the frequency of OR8K5 mutations co-occurring with PRSS1 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,Can you tell me the frequency of SPTAN1 mutations co-occurring with SPAG1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,Can you tell me the frequency of SPTAN1 mutations co-occurring with SERPINB10 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+164,SYT10,M484I,Rectum Adenocarcinoma,Can you tell me the frequency of SYT10 mutations co-occurring with UNC5D amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+174,HSPA5,N457K,Skin Cutaneous Melanoma,Can you tell me the frequency of HSPA5 mutations co-occurring with GRTP1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+175,UNC5D,L280V,Lung Adenocarcinoma,Can you tell me the frequency of UNC5D mutations co-occurring with JAML amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+176,UNC5D,L635V,Lung Adenocarcinoma,Can you tell me the frequency of UNC5D mutations co-occurring with TNS1 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+177,UNC5D,L637V,Lung Adenocarcinoma,Can you tell me the frequency of UNC5D mutations co-occurring with DCLK3 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+178,UNC5D,L699V,Lung Adenocarcinoma,Can you tell me the frequency of UNC5D mutations co-occurring with MYO15A amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+179,UNC5D,L704V,Lung Adenocarcinoma,Can you tell me the frequency of UNC5D mutations co-occurring with GABRA6 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+180,UNC5D,L709V,Lung Adenocarcinoma,Can you tell me the frequency of UNC5D mutations co-occurring with OR13C3 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,Can you tell me the frequency of DOCK2 mutations co-occurring with PAPPA amplifications in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,Can you tell me the frequency of ZNF627 mutations co-occurring with PTPRN2 amplifications in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,Can you tell me the frequency of CDC42BPA mutations co-occurring with SGIP1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+193,MRPL55,H27Y,Colon Adenocarcinoma,Can you tell me the frequency of MRPL55 mutations co-occurring with FGF8 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+194,MRPL55,H63Y,Colon Adenocarcinoma,Can you tell me the frequency of MRPL55 mutations co-occurring with ANP32E amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+197,TMTC3,Q749K,Breast Invasive Carcinoma,Can you tell me the frequency of TMTC3 mutations co-occurring with ANKRD24 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+198,EPRS1,K771I,Colon Adenocarcinoma,Can you tell me the frequency of EPRS1 mutations co-occurring with STAT3 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+199,EPRS1,K778I,Colon Adenocarcinoma,Can you tell me the frequency of EPRS1 mutations co-occurring with AUTS2 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+201,GRTP1,A110V,Skin Cutaneous Melanoma,Can you tell me the frequency of GRTP1 mutations co-occurring with EVC2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+202,GRTP1,A32V,Skin Cutaneous Melanoma,Can you tell me the frequency of GRTP1 mutations co-occurring with CTNNA2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,Can you tell me the frequency of TSHZ3 mutations co-occurring with PXN amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,Can you tell me the frequency of TAS1R3 mutations co-occurring with ANKRD30A amplifications in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,cnv_and_ssm
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,Can you tell me the frequency of PIAS3 mutations co-occurring with CARMIL1 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,Can you tell me the frequency of PIAS3 mutations co-occurring with CCNG1 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+251,ZNF274,P13R,Stomach Adenocarcinoma,Can you tell me the frequency of ZNF274 mutations co-occurring with DPF3 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+253,SYNJ1,R795C,Colon Adenocarcinoma,Can you tell me the frequency of SYNJ1 mutations co-occurring with COL6A3 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+254,SYNJ1,R800C,Colon Adenocarcinoma,Can you tell me the frequency of SYNJ1 mutations co-occurring with DCAF4L2 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+255,SYNJ1,R839C,Colon Adenocarcinoma,Can you tell me the frequency of SYNJ1 mutations co-occurring with PTPRO amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+261,DSCAM,V343M,Prostate Adenocarcinoma,Can you tell me the frequency of DSCAM mutations co-occurring with DSCAM amplifications in Prostate Adenocarcinoma?,cnv_and_ssm
+262,DSCAM,V426M,Prostate Adenocarcinoma,Can you tell me the frequency of DSCAM mutations co-occurring with ANKRD30A amplifications in Prostate Adenocarcinoma?,cnv_and_ssm
+263,DSCAM,V591M,Prostate Adenocarcinoma,Can you tell me the frequency of DSCAM mutations co-occurring with GIMAP2 amplifications in Prostate Adenocarcinoma?,cnv_and_ssm
+267,DGKD,R140H,Exceptional Responders,Can you tell me the frequency of DGKD mutations co-occurring with PTPRO amplifications in Exceptional Responders?,cnv_and_ssm
+268,DGKD,R160H,Exceptional Responders,Can you tell me the frequency of DGKD mutations co-occurring with ITPRID2 amplifications in Exceptional Responders?,cnv_and_ssm
+269,DGKD,R204H,Exceptional Responders,Can you tell me the frequency of DGKD mutations co-occurring with AUTS2 amplifications in Exceptional Responders?,cnv_and_ssm
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,Can you tell me the frequency of PLEKHG6 mutations co-occurring with EIF2B4 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,Can you tell me the frequency of PLEKHG6 mutations co-occurring with AQP7 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,Can you tell me the frequency of PLEKHG6 mutations co-occurring with MORF4L1 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+279,WNT2,D138N,Skin Cutaneous Melanoma,Can you tell me the frequency of WNT2 mutations co-occurring with CTNNA2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,Can you tell me the frequency of GUCY2C mutations co-occurring with OR2T4 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of C7orf31 mutations co-occurring with ARHGEF40 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the frequency of ZKSCAN7 mutations co-occurring with MYO3B amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+299,OR5D14,M210L,Neuroblastoma,Can you tell me the frequency of OR5D14 mutations co-occurring with CDH23 amplifications in Neuroblastoma?,cnv_and_ssm
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of SPATA22 mutations co-occurring with FRY amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of SPATA22 mutations co-occurring with GPR158 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of SPATA22 mutations co-occurring with EFCAB12 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+310,LCN15,E21V,Stomach Adenocarcinoma,Can you tell me the frequency of LCN15 mutations co-occurring with MUC16 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,Can you tell me the frequency of DCAF4L2 mutations co-occurring with NRAP amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,Can you tell me the frequency of GUK1 mutations co-occurring with DNMT1 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,Can you tell me the frequency of GUK1 mutations co-occurring with RAB40C amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,Can you tell me the frequency of GUK1 mutations co-occurring with KDM5C amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,Can you tell me the frequency of GUK1 mutations co-occurring with ZFP42 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,Can you tell me the frequency of GUK1 mutations co-occurring with PAK3 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+328,MORF4L1,K29T,Stomach Adenocarcinoma,Can you tell me the frequency of MORF4L1 mutations co-occurring with OLFML3 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+329,MORF4L1,K51T,Stomach Adenocarcinoma,Can you tell me the frequency of MORF4L1 mutations co-occurring with GABRA6 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+330,MORF4L1,K61T,Stomach Adenocarcinoma,Can you tell me the frequency of MORF4L1 mutations co-occurring with MERTK amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+331,MORF4L1,K76T,Stomach Adenocarcinoma,Can you tell me the frequency of MORF4L1 mutations co-occurring with TYK2 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+335,MYO3B,F594L,Skin Cutaneous Melanoma,Can you tell me the frequency of MYO3B mutations co-occurring with UNC5D amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+336,MYO3B,F603L,Skin Cutaneous Melanoma,Can you tell me the frequency of MYO3B mutations co-occurring with NOMO1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+339,TENT5A,S320F,Skin Cutaneous Melanoma,Can you tell me the frequency of TENT5A mutations co-occurring with FBN1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+340,TENT5A,S339F,Skin Cutaneous Melanoma,Can you tell me the frequency of TENT5A mutations co-occurring with UNC5D amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+341,TENT5A,S401F,Skin Cutaneous Melanoma,Can you tell me the frequency of TENT5A mutations co-occurring with SYNJ1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,Can you tell me the frequency of ZFAT mutations co-occurring with ART3 amplifications in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,Can you tell me the frequency of ZFAT mutations co-occurring with HTR3B amplifications in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,Can you tell me the frequency of ZFAT mutations co-occurring with CX3CR1 amplifications in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+357,ZNF584,A211T,Sarcoma,Can you tell me the frequency of ZNF584 mutations co-occurring with TNS1 amplifications in Sarcoma?,cnv_and_ssm
+358,ZNF584,A256T,Sarcoma,Can you tell me the frequency of ZNF584 mutations co-occurring with PIK3C2A amplifications in Sarcoma?,cnv_and_ssm
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of LDOC1 mutations co-occurring with MYT1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,Can you tell me the frequency of PDGFC mutations co-occurring with AUTS2 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of MSANTD4 mutations co-occurring with OR13C3 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+374,NPSR1,S123L,Skin Cutaneous Melanoma,Can you tell me the frequency of NPSR1 mutations co-occurring with GRM1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,Can you tell me the frequency of PHLPP1 mutations co-occurring with ZFPM2 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+385,COL6A3,G237S,Skin Cutaneous Melanoma,Can you tell me the frequency of COL6A3 mutations co-occurring with PLEKHG6 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+386,COL6A3,G437S,Skin Cutaneous Melanoma,Can you tell me the frequency of COL6A3 mutations co-occurring with RIMS2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+387,COL6A3,G638S,Skin Cutaneous Melanoma,Can you tell me the frequency of COL6A3 mutations co-occurring with ACVR1B amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+388,COL6A3,G644S,Skin Cutaneous Melanoma,Can you tell me the frequency of COL6A3 mutations co-occurring with RIPOR2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+389,COL6A3,G844S,Skin Cutaneous Melanoma,Can you tell me the frequency of COL6A3 mutations co-occurring with GRTP1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+395,ADRA1A,R348G,Stomach Adenocarcinoma,Can you tell me the frequency of ADRA1A mutations co-occurring with GUK1 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me the frequency of LAMB2 mutations co-occurring with TRAP1 amplifications in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+406,POC1B,I198T,Rectum Adenocarcinoma,Can you tell me the frequency of POC1B mutations co-occurring with PIK3C2G amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+407,POC1B,I286T,Rectum Adenocarcinoma,Can you tell me the frequency of POC1B mutations co-occurring with PGR amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+408,POC1B,I328T,Rectum Adenocarcinoma,Can you tell me the frequency of POC1B mutations co-occurring with BCAT1 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+409,POC1B,S79P,Rectum Adenocarcinoma,Can you tell me the frequency of POC1B mutations co-occurring with PRSS1 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,Can you tell me the frequency of USH2A mutations co-occurring with DEFB115 amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+414,AQP7,T110S,Rectum Adenocarcinoma,Can you tell me the frequency of AQP7 mutations co-occurring with DPF3 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+415,AQP7,T166S,Rectum Adenocarcinoma,Can you tell me the frequency of AQP7 mutations co-occurring with PIK3C2B amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+416,AQP7,T167S,Rectum Adenocarcinoma,Can you tell me the frequency of AQP7 mutations co-occurring with ZNF431 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+417,AQP7,T75S,Rectum Adenocarcinoma,Can you tell me the frequency of AQP7 mutations co-occurring with TMTC3 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+430,DCN,R163C,Rectum Adenocarcinoma,Can you tell me the frequency of DCN mutations co-occurring with TTC12 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+431,DCN,R203C,Rectum Adenocarcinoma,Can you tell me the frequency of DCN mutations co-occurring with STK19 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+432,DCN,R241C,Rectum Adenocarcinoma,Can you tell me the frequency of DCN mutations co-occurring with PXN amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+433,DCN,R350C,Rectum Adenocarcinoma,Can you tell me the frequency of DCN mutations co-occurring with ZKSCAN7 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+434,DCN,R41C,Rectum Adenocarcinoma,Can you tell me the frequency of DCN mutations co-occurring with ART3 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of CPS1 mutations co-occurring with ANKDD1A amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of CPS1 mutations co-occurring with KIF20B amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of CPS1 mutations co-occurring with CDC42BPA amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,Can you tell me the frequency of FCGR2C mutations co-occurring with SLC9C1 amplifications in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,Can you tell me the frequency of FCGR2C mutations co-occurring with EPRS1 amplifications in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of GRM1 mutations co-occurring with YY1AP1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+482,SGCZ,Q138H,Lung Adenocarcinoma,Can you tell me the frequency of SGCZ mutations co-occurring with TYROBP amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+483,SGCZ,Q91H,Lung Adenocarcinoma,Can you tell me the frequency of SGCZ mutations co-occurring with CPA6 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+485,SMO,V15M,Stomach Adenocarcinoma,Can you tell me the frequency of SMO mutations co-occurring with MIEF1 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+486,SMO,V321M,Stomach Adenocarcinoma,Can you tell me the frequency of SMO mutations co-occurring with SYT10 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+488,CHODL,G159E,Skin Cutaneous Melanoma,Can you tell me the frequency of CHODL mutations co-occurring with CHODL amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+489,CHODL,G181E,Skin Cutaneous Melanoma,Can you tell me the frequency of CHODL mutations co-occurring with GRTP1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+490,CHODL,G200E,Skin Cutaneous Melanoma,Can you tell me the frequency of CHODL mutations co-occurring with PRSS1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+494,MYO16,P399H,Colon Adenocarcinoma,Can you tell me the frequency of MYO16 mutations co-occurring with CR1 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+495,MYO16,P421H,Colon Adenocarcinoma,Can you tell me the frequency of MYO16 mutations co-occurring with AQP7 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+498,CXCR2,A98V,Stomach Adenocarcinoma,Can you tell me the frequency of CXCR2 mutations co-occurring with TTN amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,Can you tell me the frequency of TMEM225 mutations co-occurring with PIK3C2B amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of MAOB mutations co-occurring with PXN amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of GPRASP1 mutations co-occurring with SPTAN1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of MRPL32 mutations co-occurring with CEP20 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of TYROBP mutations co-occurring with TET2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+510,RAB40C,A111V,Lung Adenocarcinoma,Can you tell me the frequency of RAB40C mutations co-occurring with CTSC amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+511,RAB40C,A143V,Lung Adenocarcinoma,Can you tell me the frequency of RAB40C mutations co-occurring with MERTK amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+512,CTNNA2,S323R,Lung Adenocarcinoma,Can you tell me the frequency of CTNNA2 mutations co-occurring with ANKRD24 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+513,CTNNA2,S339R,Lung Adenocarcinoma,Can you tell me the frequency of CTNNA2 mutations co-occurring with ACVR1B amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+514,CTNNA2,S386R,Lung Adenocarcinoma,Can you tell me the frequency of CTNNA2 mutations co-occurring with ZNF627 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+515,CTNNA2,S707R,Lung Adenocarcinoma,Can you tell me the frequency of CTNNA2 mutations co-occurring with MYO3B amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,Can you tell me the frequency of MYO15A mutations co-occurring with ANKRD24 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,Can you tell me the frequency of GIMAP2 mutations co-occurring with FGF8 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+532,KIF20B,N1160D,Glioblastoma Multiforme,Can you tell me the frequency of KIF20B mutations co-occurring with PIAS3 amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+533,KIF20B,N1200D,Glioblastoma Multiforme,Can you tell me the frequency of KIF20B mutations co-occurring with PRSS1 amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of ADAM17 mutations co-occurring with SYT10 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of BCAT1 mutations co-occurring with EVC2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of BCAT1 mutations co-occurring with MYO3A amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of BCAT1 mutations co-occurring with DGKD amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+540,ERCC6,R1053H,Colon Adenocarcinoma,Can you tell me the frequency of ERCC6 mutations co-occurring with AUTS2 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+541,DCC,R320W,Breast Invasive Carcinoma,Can you tell me the frequency of DCC mutations co-occurring with SGIP1 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+542,DCC,R363W,Breast Invasive Carcinoma,Can you tell me the frequency of DCC mutations co-occurring with TAF1C amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+543,DCC,R386W,Breast Invasive Carcinoma,Can you tell me the frequency of DCC mutations co-occurring with EIF2B4 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+544,DCC,R41W,Breast Invasive Carcinoma,Can you tell me the frequency of DCC mutations co-occurring with CTNNA2 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+549,FBXO15,D417N,Skin Cutaneous Melanoma,Can you tell me the frequency of FBXO15 mutations co-occurring with AQP7 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+550,FBXO15,D86N,Skin Cutaneous Melanoma,Can you tell me the frequency of FBXO15 mutations co-occurring with SYT9 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of GSTCD mutations co-occurring with SORCS1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of GSTCD mutations co-occurring with SPAG1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,Can you tell me the frequency of OLFML3 mutations co-occurring with EIF2B4 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,Can you tell me the frequency of OLFML3 mutations co-occurring with RIPOR2 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,Can you tell me the frequency of OLFML3 mutations co-occurring with TYK2 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,Can you tell me the frequency of CFAP61 mutations co-occurring with TTN amplifications in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,Can you tell me the frequency of CFAP61 mutations co-occurring with DEFB115 amplifications in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,Can you tell me the frequency of HLA-DQA2 mutations co-occurring with GUK1 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+582,TENM2,H240Y,Skin Cutaneous Melanoma,Can you tell me the frequency of TENM2 mutations co-occurring with POC1B amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+583,TENM2,H351Y,Skin Cutaneous Melanoma,Can you tell me the frequency of TENM2 mutations co-occurring with RIMS2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+584,TENM2,H472Y,Skin Cutaneous Melanoma,Can you tell me the frequency of TENM2 mutations co-occurring with BFAR amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+600,ANKRD24,A465T,Stomach Adenocarcinoma,Can you tell me the frequency of ANKRD24 mutations co-occurring with PTPRN2 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+601,ANKRD24,A494T,Stomach Adenocarcinoma,Can you tell me the frequency of ANKRD24 mutations co-occurring with SMO amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+602,ANKRD24,A584T,Stomach Adenocarcinoma,Can you tell me the frequency of ANKRD24 mutations co-occurring with RIMS2 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,Can you tell me the frequency of ZCCHC14 mutations co-occurring with PRSS8 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,Can you tell me the frequency of ZCCHC14 mutations co-occurring with ZBTB34 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,Can you tell me the frequency of ZCCHC14 mutations co-occurring with COL6A3 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,Can you tell me the frequency of ZCCHC14 mutations co-occurring with ANP32E amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+625,SIK2,I265M,Lung Adenocarcinoma,Can you tell me the frequency of SIK2 mutations co-occurring with MED16 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of MYH11 mutations co-occurring with PIK3C2G amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of MYH11 mutations co-occurring with TENT5A amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,Can you tell me the frequency of SLC6A4 mutations co-occurring with TRAP1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of SLC9C1 mutations co-occurring with MRPL55 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of SLC9C1 mutations co-occurring with FGF8 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+644,OR2A12,A254T,Brain Lower Grade Glioma,Can you tell me the frequency of OR2A12 mutations co-occurring with HBB amplifications in Brain Lower Grade Glioma?,cnv_and_ssm
+646,PYHIN1,T325K,Lung Adenocarcinoma,Can you tell me the frequency of PYHIN1 mutations co-occurring with PTPRN2 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+647,PYHIN1,T334K,Lung Adenocarcinoma,Can you tell me the frequency of PYHIN1 mutations co-occurring with HTR3B amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+650,JAML,G191E,Skin Cutaneous Melanoma,Can you tell me the frequency of JAML mutations co-occurring with TMTC3 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+651,JAML,G219E,Skin Cutaneous Melanoma,Can you tell me the frequency of JAML mutations co-occurring with SYT9 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+652,JAML,G220E,Skin Cutaneous Melanoma,Can you tell me the frequency of JAML mutations co-occurring with TYK2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+653,JAML,G230E,Skin Cutaneous Melanoma,Can you tell me the frequency of JAML mutations co-occurring with DCC amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+658,TYK2,H1146R,Stomach Adenocarcinoma,Can you tell me the frequency of TYK2 mutations co-occurring with POC1B amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+659,TYK2,H23R,Stomach Adenocarcinoma,Can you tell me the frequency of TYK2 mutations co-occurring with BICC1 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+660,TYK2,H961R,Stomach Adenocarcinoma,Can you tell me the frequency of TYK2 mutations co-occurring with CCDC22 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of CTCFL mutations co-occurring with DCAF6 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of CTCFL mutations co-occurring with MAST4 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of CTCFL mutations co-occurring with PSG2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of CTCFL mutations co-occurring with MYO16 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of CEP20 mutations co-occurring with DSCAM amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of CEP20 mutations co-occurring with DOCK2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+689,RIMS2,R25W,Skin Cutaneous Melanoma,Can you tell me the frequency of RIMS2 mutations co-occurring with TTC17 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+690,RIMS2,R393W,Skin Cutaneous Melanoma,Can you tell me the frequency of RIMS2 mutations co-occurring with PTPRO amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+691,RIMS2,R423W,Skin Cutaneous Melanoma,Can you tell me the frequency of RIMS2 mutations co-occurring with AUTS2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+692,RIMS2,R470W,Skin Cutaneous Melanoma,Can you tell me the frequency of RIMS2 mutations co-occurring with SGCZ amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+693,RIMS2,R615W,Skin Cutaneous Melanoma,Can you tell me the frequency of RIMS2 mutations co-occurring with GABRA6 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+694,RIMS2,R619W,Skin Cutaneous Melanoma,Can you tell me the frequency of RIMS2 mutations co-occurring with CHMP7 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+695,RIMS2,R716W,Skin Cutaneous Melanoma,Can you tell me the frequency of RIMS2 mutations co-occurring with ADRA1A amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,Can you tell me the frequency of PIK3C2G mutations co-occurring with PLEKHG6 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,Can you tell me the frequency of PIK3C2G mutations co-occurring with AQP7 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+728,STK19,D341N,Colon Adenocarcinoma,Can you tell me the frequency of STK19 mutations co-occurring with XKR4 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+729,STK19,D345N,Colon Adenocarcinoma,Can you tell me the frequency of STK19 mutations co-occurring with BICC1 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+730,REXO4,P60A,Skin Cutaneous Melanoma,Can you tell me the frequency of REXO4 mutations co-occurring with CACNA1F amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of ZBTB34 mutations co-occurring with MRPL55 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of ZBTB34 mutations co-occurring with DOCK2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,Can you tell me the frequency of NCKAP5 mutations co-occurring with DOCK2 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the frequency of SORCS1 mutations co-occurring with CPS1 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the frequency of SORCS1 mutations co-occurring with ADRA1A amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the frequency of SORCS1 mutations co-occurring with TMEM255A amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the frequency of SORCS1 mutations co-occurring with GIMAP2 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,Can you tell me the frequency of FGF8 mutations co-occurring with CTSC amplifications in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,Can you tell me the frequency of FGF8 mutations co-occurring with ART3 amplifications in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,Can you tell me the frequency of FGF8 mutations co-occurring with CARMIL1 amplifications in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,Can you tell me the frequency of FGF8 mutations co-occurring with KIF20B amplifications in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,Can you tell me the frequency of FGF8 mutations co-occurring with SGIP1 amplifications in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,Can you tell me the frequency of TENM3 mutations co-occurring with CPS1 amplifications in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,cnv_and_ssm
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of AKT1 mutations co-occurring with SOX21 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me the frequency of CFAP298-TCP10L mutations co-occurring with PXN amplifications in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+792,GLRB,E148D,Stomach Adenocarcinoma,Can you tell me the frequency of GLRB mutations co-occurring with MYO16 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+793,TTN,F7636L,Colon Adenocarcinoma,Can you tell me the frequency of TTN mutations co-occurring with TYK2 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+794,TTN,F8563L,Colon Adenocarcinoma,Can you tell me the frequency of TTN mutations co-occurring with EIF2B4 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+795,TTN,F8880L,Colon Adenocarcinoma,Can you tell me the frequency of TTN mutations co-occurring with TNS1 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+799,ANKRD30A,V798I,Colon Adenocarcinoma,Can you tell me the frequency of ANKRD30A mutations co-occurring with FCGR2C amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+800,ANKRD30A,V854I,Colon Adenocarcinoma,Can you tell me the frequency of ANKRD30A mutations co-occurring with ICE1 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+801,ANKRD30A,V973I,Colon Adenocarcinoma,Can you tell me the frequency of ANKRD30A mutations co-occurring with GPR158 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+809,TRIM45,S177L,Colon Adenocarcinoma,Can you tell me the frequency of TRIM45 mutations co-occurring with RAB40C amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+810,TRIM45,S224L,Colon Adenocarcinoma,Can you tell me the frequency of TRIM45 mutations co-occurring with CDH23 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+811,TRIM45,S281L,Colon Adenocarcinoma,Can you tell me the frequency of TRIM45 mutations co-occurring with TTN amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+812,CACNA1F,G727V,Stomach Adenocarcinoma,Can you tell me the frequency of CACNA1F mutations co-occurring with FBXO42 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+813,CACNA1F,G781V,Stomach Adenocarcinoma,Can you tell me the frequency of CACNA1F mutations co-occurring with TNS1 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+814,CACNA1F,G792V,Stomach Adenocarcinoma,Can you tell me the frequency of CACNA1F mutations co-occurring with OLFML3 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+817,KL,R594C,Colon Adenocarcinoma,Can you tell me the frequency of KL mutations co-occurring with MIEF1 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,Can you tell me the frequency of GUF1 mutations co-occurring with CTNNA2 amplifications in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+822,TAF1L,A539V,Colon Adenocarcinoma,Can you tell me the frequency of TAF1L mutations co-occurring with ANKRD24 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+823,TASOR2,S256F,Skin Cutaneous Melanoma,Can you tell me the frequency of TASOR2 mutations co-occurring with OR2T4 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+824,TASOR2,S36F,Skin Cutaneous Melanoma,Can you tell me the frequency of TASOR2 mutations co-occurring with RIMS2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+825,TASOR2,S471F,Skin Cutaneous Melanoma,Can you tell me the frequency of TASOR2 mutations co-occurring with CDC42BPA amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,Can you tell me the frequency of KDM5C mutations co-occurring with UNC5D amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,Can you tell me the frequency of KDM5C mutations co-occurring with MAD1L1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,Can you tell me the frequency of KDM5C mutations co-occurring with FGF8 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,Can you tell me the frequency of KDM5C mutations co-occurring with DGKD amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me the frequency of IL5RA mutations co-occurring with OR2T4 amplifications in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+843,DHX16,A29V,Skin Cutaneous Melanoma,Can you tell me the frequency of DHX16 mutations co-occurring with OR13C3 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+844,DHX16,A89V,Skin Cutaneous Melanoma,Can you tell me the frequency of DHX16 mutations co-occurring with OR13C3 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+902,GPR158,A644V,Stomach Adenocarcinoma,Can you tell me the frequency of GPR158 mutations co-occurring with PDHA2 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+903,GPR158,A723V,Stomach Adenocarcinoma,Can you tell me the frequency of GPR158 mutations co-occurring with PCDHB2 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the frequency of EIF2B4 mutations co-occurring with MYO3B amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the frequency of EIF2B4 mutations co-occurring with MAST4 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the frequency of EIF2B4 mutations co-occurring with COL6A3 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the frequency of EIF2B4 mutations co-occurring with SORCS1 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the frequency of EIF2B4 mutations co-occurring with FGF8 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the frequency of EIF2B4 mutations co-occurring with DGKD amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,Can you tell me the frequency of AUTS2 mutations co-occurring with YY1AP1 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,Can you tell me the frequency of AUTS2 mutations co-occurring with DCN amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,Can you tell me the frequency of AUTS2 mutations co-occurring with SPATA22 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,Can you tell me the frequency of AUTS2 mutations co-occurring with TAF1C amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,Can you tell me the frequency of AUTS2 mutations co-occurring with AQP7 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,Can you tell me the frequency of AUTS2 mutations co-occurring with CHMP7 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,Can you tell me the frequency of AUTS2 mutations co-occurring with UNC5D amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,Can you tell me the frequency of AUTS2 mutations co-occurring with ZNF431 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,Can you tell me the frequency of AUTS2 mutations co-occurring with RIPOR2 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,Can you tell me the frequency of AUTS2 mutations co-occurring with ZCCHC14 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the frequency of ACTL7B mutations co-occurring with CHODL amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+952,PCDHGA1,R535W,Glioblastoma Multiforme,Can you tell me the frequency of PCDHGA1 mutations co-occurring with PXN amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+954,TRAP1,R114W,Stomach Adenocarcinoma,Can you tell me the frequency of TRAP1 mutations co-occurring with TET2 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+955,TRAP1,R61W,Stomach Adenocarcinoma,Can you tell me the frequency of TRAP1 mutations co-occurring with PGR amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of PIK3C2A mutations co-occurring with MORF4L1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,Can you tell me the frequency of KANSL1 mutations co-occurring with FGF8 amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,Can you tell me the frequency of ANKRD52 mutations co-occurring with TAF1C amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of PAPPA mutations co-occurring with PIAS3 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,Can you tell me the frequency of B3GALNT1 mutations co-occurring with CTNNA2 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+982,GABRA6,G115R,Lung Adenocarcinoma,Can you tell me the frequency of GABRA6 mutations co-occurring with PXN amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+983,GABRA6,G122R,Lung Adenocarcinoma,Can you tell me the frequency of GABRA6 mutations co-occurring with MYO15A amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+984,GABRA6,G165R,Lung Adenocarcinoma,Can you tell me the frequency of GABRA6 mutations co-occurring with ACTB amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+985,GABRA6,G175R,Lung Adenocarcinoma,Can you tell me the frequency of GABRA6 mutations co-occurring with ZNF274 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+986,GABRA6,G70R,Lung Adenocarcinoma,Can you tell me the frequency of GABRA6 mutations co-occurring with SOX21 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,Can you tell me the frequency of ZSCAN31 mutations co-occurring with TLCD5 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the frequency of MED16 mutations co-occurring with AUTS2 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the frequency of MED16 mutations co-occurring with CDKN2AIP amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,Can you tell me the frequency of PTPRO mutations co-occurring with ZFAT amplifications in Pancreatic Adenocarcinoma?,cnv_and_ssm
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,Can you tell me the frequency of PTPRO mutations co-occurring with ZBTB34 amplifications in Pancreatic Adenocarcinoma?,cnv_and_ssm
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,Can you tell me the frequency of PTPRO mutations co-occurring with SYT10 amplifications in Pancreatic Adenocarcinoma?,cnv_and_ssm
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,Can you tell me the frequency of PTPRO mutations co-occurring with MAST4 amplifications in Pancreatic Adenocarcinoma?,cnv_and_ssm
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,Can you tell me the frequency of PTPRO mutations co-occurring with FBXO15 amplifications in Pancreatic Adenocarcinoma?,cnv_and_ssm
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,Can you tell me the frequency of PTPRO mutations co-occurring with AUTS2 amplifications in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,Can you tell me the frequency of PTPRO mutations co-occurring with MYT1 amplifications in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,Can you tell me the frequency of PTPRO mutations co-occurring with PYHIN1 amplifications in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of CHMP7 mutations co-occurring with NCKAP5 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1017,GPC3,I107N,Stomach Adenocarcinoma,Can you tell me the frequency of GPC3 mutations co-occurring with PIAS3 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1018,GPC3,I161N,Stomach Adenocarcinoma,Can you tell me the frequency of GPC3 mutations co-occurring with LDOC1 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me the frequency of TLK2 mutations co-occurring with PXN amplifications in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me the frequency of TLK2 mutations co-occurring with HSPA5 amplifications in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me the frequency of TLK2 mutations co-occurring with TMEM255A amplifications in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me the frequency of TLK2 mutations co-occurring with FRY amplifications in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you tell me the frequency of TLK2 mutations co-occurring with PTPRO amplifications in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1036,ZNF217,E209Q,Lung Adenocarcinoma,Can you tell me the frequency of ZNF217 mutations co-occurring with HSPA5 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1038,SYT9,V275L,Lung Adenocarcinoma,Can you tell me the frequency of SYT9 mutations co-occurring with ERCC6 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1039,SYT9,V307L,Lung Adenocarcinoma,Can you tell me the frequency of SYT9 mutations co-occurring with VPS26B amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,Can you tell me the frequency of PKHD1L1 mutations co-occurring with MRPL55 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,Can you tell me the frequency of MYO3A mutations co-occurring with OLFML3 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the frequency of VASN mutations co-occurring with ZCCHC14 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of DNMT1 mutations co-occurring with CXCR2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of DNMT1 mutations co-occurring with PXN amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of DNMT1 mutations co-occurring with MED16 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1056,CA9,E402K,Colon Adenocarcinoma,Can you tell me the frequency of CA9 mutations co-occurring with GUK1 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of TTC17 mutations co-occurring with GUK1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of TTC17 mutations co-occurring with GSTCD amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1065,PSG2,P43L,Breast Invasive Carcinoma,Can you tell me the frequency of PSG2 mutations co-occurring with TASOR2 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,Can you tell me the frequency of RIPOR2 mutations co-occurring with MED16 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,Can you tell me the frequency of RIPOR2 mutations co-occurring with PDHA2 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,Can you tell me the frequency of RIPOR2 mutations co-occurring with RIMS2 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,Can you tell me the frequency of RIPOR2 mutations co-occurring with ANKRD24 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of DCLK3 mutations co-occurring with GRM1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of DCLK3 mutations co-occurring with ITPRID2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,Can you tell me the frequency of MERTK mutations co-occurring with OLFML3 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,Can you tell me the frequency of MERTK mutations co-occurring with MAST4 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,Can you tell me the frequency of MERTK mutations co-occurring with PAK3 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,Can you tell me the frequency of ZFP42 mutations co-occurring with TAF1C amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,Can you tell me the frequency of OR13C3 mutations co-occurring with AQP7 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,Can you tell me the frequency of OR13C3 mutations co-occurring with B3GALNT1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1091,SPAG1,I917M,Stomach Adenocarcinoma,Can you tell me the frequency of SPAG1 mutations co-occurring with EIF2B4 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of CDKN2AIP mutations co-occurring with VPS26B amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1093,PXN,H1016Y,Colon Adenocarcinoma,Can you tell me the frequency of PXN mutations co-occurring with DGKD amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1094,PXN,H359Y,Colon Adenocarcinoma,Can you tell me the frequency of PXN mutations co-occurring with SYNJ1 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1095,PXN,H492Y,Colon Adenocarcinoma,Can you tell me the frequency of PXN mutations co-occurring with CXCR2 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1096,PXN,H524Y,Colon Adenocarcinoma,Can you tell me the frequency of PXN mutations co-occurring with FRY amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1097,PXN,H526Y,Colon Adenocarcinoma,Can you tell me the frequency of PXN mutations co-occurring with PCDHB2 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1098,PXN,H540Y,Colon Adenocarcinoma,Can you tell me the frequency of PXN mutations co-occurring with PTPRO amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of TTYH2 mutations co-occurring with CEP20 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of TTYH2 mutations co-occurring with MAD1L1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1106,TMEM255A,N205S,Colon Adenocarcinoma,Can you tell me the frequency of TMEM255A mutations co-occurring with FBXO15 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1107,TMEM255A,N229S,Colon Adenocarcinoma,Can you tell me the frequency of TMEM255A mutations co-occurring with CARMIL1 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1108,TMEM255A,N65S,Colon Adenocarcinoma,Can you tell me the frequency of TMEM255A mutations co-occurring with MAST4 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,Can you tell me the frequency of TASOR2 mutations co-occurring with MAST4 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,Can you tell me the frequency of TASOR2 mutations co-occurring with SGCZ amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of ICE1 mutations co-occurring with OR8K5 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1112,MYT1,A558E,Breast Invasive Carcinoma,Can you tell me the frequency of MYT1 mutations co-occurring with PTPRN2 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1113,MYT1,A879E,Breast Invasive Carcinoma,Can you tell me the frequency of MYT1 mutations co-occurring with BCAT1 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1114,MYT1,A906E,Breast Invasive Carcinoma,Can you tell me the frequency of MYT1 mutations co-occurring with TASOR2 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of CX3CR1 mutations co-occurring with ANKRD30A amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of CX3CR1 mutations co-occurring with DCC amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,Can you tell me the frequency of SPINDOC mutations co-occurring with GUK1 amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of ART3 mutations co-occurring with PGF amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of ART3 mutations co-occurring with CXCR2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,Can you tell me the frequency of CYP1A2 mutations co-occurring with PGF amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the frequency of ADRA1A mutations co-occurring with MYO16 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,Can you tell me the frequency of CDH23 mutations co-occurring with UNC5D amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,Can you tell me the frequency of CDH23 mutations co-occurring with CX3CR1 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1148,KRT39,P137S,Skin Cutaneous Melanoma,Can you tell me the frequency of KRT39 mutations co-occurring with PRSS1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,Can you tell me the frequency of PDHA2 mutations co-occurring with GUK1 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,Can you tell me the frequency of SLC24A2 mutations co-occurring with GIMAP2 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,Can you tell me the frequency of PTPRN2 mutations co-occurring with CTSC amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,Can you tell me the frequency of PTPRN2 mutations co-occurring with TASOR2 amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,Can you tell me the frequency of PTPRN2 mutations co-occurring with TYK2 amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,Can you tell me the frequency of PTPRN2 mutations co-occurring with OLFML3 amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,Can you tell me the frequency of PTPRN2 mutations co-occurring with GRM5 amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1188,SOX21,R55L,Lung Adenocarcinoma,Can you tell me the frequency of SOX21 mutations co-occurring with MAD1L1 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,Can you tell me the frequency of CPA6 mutations co-occurring with CTSC amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1206,GRM5,E14K,Skin Cutaneous Melanoma,Can you tell me the frequency of GRM5 mutations co-occurring with TLK2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the frequency of CASZ1 mutations co-occurring with SPAG1 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1210,SGIP1,N122T,Stomach Adenocarcinoma,Can you tell me the frequency of SGIP1 mutations co-occurring with KIF20B amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1211,SGIP1,N420T,Stomach Adenocarcinoma,Can you tell me the frequency of SGIP1 mutations co-occurring with CDC42BPA amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1212,SGIP1,N617T,Stomach Adenocarcinoma,Can you tell me the frequency of SGIP1 mutations co-occurring with ZNF431 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1213,SGIP1,N648T,Stomach Adenocarcinoma,Can you tell me the frequency of SGIP1 mutations co-occurring with KL amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1227,CARMIL1,V549L,Lung Adenocarcinoma,Can you tell me the frequency of CARMIL1 mutations co-occurring with ICE1 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1228,CARMIL1,V949L,Lung Adenocarcinoma,Can you tell me the frequency of CARMIL1 mutations co-occurring with TTN amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1232,ZNF431,D121Y,Lung Adenocarcinoma,Can you tell me the frequency of ZNF431 mutations co-occurring with SGIP1 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1233,ZNF431,D161Y,Lung Adenocarcinoma,Can you tell me the frequency of ZNF431 mutations co-occurring with PTPRO amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1234,ZNF431,R128I,Lung Adenocarcinoma,Can you tell me the frequency of ZNF431 mutations co-occurring with BCAT1 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,Can you tell me the frequency of DNAH11 mutations co-occurring with CNGB1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,Can you tell me the frequency of DNAH11 mutations co-occurring with SPAG1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,Can you tell me the frequency of POLD1 mutations co-occurring with ACVR1B amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,Can you tell me the frequency of POLD1 mutations co-occurring with YY1AP1 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1248,TTC12,D646H,Lung Adenocarcinoma,Can you tell me the frequency of TTC12 mutations co-occurring with KANSL1 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1249,TTC12,D652H,Lung Adenocarcinoma,Can you tell me the frequency of TTC12 mutations co-occurring with ACTB amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,Can you tell me the frequency of CNGB1 mutations co-occurring with SMO amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,Can you tell me the frequency of CNGB1 mutations co-occurring with ZCCHC14 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1254,CTSC,E214V,Stomach Adenocarcinoma,Can you tell me the frequency of CTSC mutations co-occurring with TET2 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1255,CTSC,E291V,Stomach Adenocarcinoma,Can you tell me the frequency of CTSC mutations co-occurring with PGR amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1256,CTSC,E322V,Stomach Adenocarcinoma,Can you tell me the frequency of CTSC mutations co-occurring with OLFML3 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1257,CTSC,E324V,Stomach Adenocarcinoma,Can you tell me the frequency of CTSC mutations co-occurring with CR1 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1258,CTSC,E335V,Stomach Adenocarcinoma,Can you tell me the frequency of CTSC mutations co-occurring with MORF4L1 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of PRSS8 mutations co-occurring with AUTS2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of PRSS8 mutations co-occurring with NOMO1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,Can you tell me the frequency of ARHGEF40 mutations co-occurring with SGIP1 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1264,ACTB,A138T,Rectum Adenocarcinoma,Can you tell me the frequency of ACTB mutations co-occurring with GUK1 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+1265,ACTB,A217T,Rectum Adenocarcinoma,Can you tell me the frequency of ACTB mutations co-occurring with CFAP61 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+1266,ACTB,A244T,Rectum Adenocarcinoma,Can you tell me the frequency of ACTB mutations co-occurring with CTNNA2 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+1267,ACTB,A260T,Rectum Adenocarcinoma,Can you tell me the frequency of ACTB mutations co-occurring with CTCFL amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+1268,YY1AP1,V546D,Glioblastoma Multiforme,Can you tell me the frequency of YY1AP1 mutations co-occurring with TENM2 amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+1269,YY1AP1,V557D,Glioblastoma Multiforme,Can you tell me the frequency of YY1AP1 mutations co-occurring with GUCY2C amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+1270,YY1AP1,V566D,Glioblastoma Multiforme,Can you tell me the frequency of YY1AP1 mutations co-occurring with DSCAM amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+1271,YY1AP1,V577D,Glioblastoma Multiforme,Can you tell me the frequency of YY1AP1 mutations co-occurring with CTNNA2 amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+1272,YY1AP1,V623D,Glioblastoma Multiforme,Can you tell me the frequency of YY1AP1 mutations co-occurring with GRM1 amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+1273,YY1AP1,V695D,Glioblastoma Multiforme,Can you tell me the frequency of YY1AP1 mutations co-occurring with MYO16 amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+1274,YY1AP1,V715D,Glioblastoma Multiforme,Can you tell me the frequency of YY1AP1 mutations co-occurring with YY1AP1 amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,Can you tell me the frequency of FNDC7 mutations co-occurring with ITPRID2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,Can you tell me the frequency of FNDC7 mutations co-occurring with PTPRO amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1299,TLCD5,G15V,Lung Adenocarcinoma,Can you tell me the frequency of TLCD5 mutations co-occurring with COL6A3 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1300,TLCD5,G37V,Lung Adenocarcinoma,Can you tell me the frequency of TLCD5 mutations co-occurring with TLK2 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of POLR1G mutations co-occurring with DGKD amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of POLR1G mutations co-occurring with CTNNA2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1308,DNAH14,N1186K,Colon Adenocarcinoma,Can you tell me the frequency of DNAH14 mutations co-occurring with OR2T4 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1309,DNAH14,N2657K,Colon Adenocarcinoma,Can you tell me the frequency of DNAH14 mutations co-occurring with DCAF6 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1310,DNAH14,N3460K,Colon Adenocarcinoma,Can you tell me the frequency of DNAH14 mutations co-occurring with SGIP1 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of NEXN mutations co-occurring with BCAT1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,Can you tell me the frequency of CYB5R2 mutations co-occurring with NOMO1 amplifications in Prostate Adenocarcinoma?,cnv_and_ssm
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,Can you tell me the frequency of CYB5R2 mutations co-occurring with ZFPM2 amplifications in Prostate Adenocarcinoma?,cnv_and_ssm
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of NRAP mutations co-occurring with GPRASP1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of NRAP mutations co-occurring with DNMT1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of NRAP mutations co-occurring with HTR3B amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of CCDC22 mutations co-occurring with ACVR1B amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,Can you tell me the frequency of DCAF6 mutations co-occurring with FGF8 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,Can you tell me the frequency of DCAF6 mutations co-occurring with AUTS2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of ZNF708 mutations co-occurring with PTPRO amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of BFAR mutations co-occurring with TNS1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of MAST4 mutations co-occurring with IL5RA amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of MAST4 mutations co-occurring with NRAP amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of MAST4 mutations co-occurring with YY1AP1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of MAST4 mutations co-occurring with DCAF4L2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of MAST4 mutations co-occurring with ANKDD1A amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1363,ARMC3,R169C,Stomach Adenocarcinoma,Can you tell me the frequency of ARMC3 mutations co-occurring with SYNJ1 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1364,ARMC3,R432C,Stomach Adenocarcinoma,Can you tell me the frequency of ARMC3 mutations co-occurring with MUC16 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,Can you tell me the frequency of TET2 mutations co-occurring with EPRS1 amplifications in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,Can you tell me the frequency of TET2 mutations co-occurring with GLRB amplifications in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+1369,SERPINB10,A353P,Lung Adenocarcinoma,Can you tell me the frequency of SERPINB10 mutations co-occurring with DPF3 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of STAT3 mutations co-occurring with JAML amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of MIEF1 mutations co-occurring with DCC amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1381,ACVR1B,D397N,Colon Adenocarcinoma,Can you tell me the frequency of ACVR1B mutations co-occurring with BFAR amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1382,ACVR1B,D449N,Colon Adenocarcinoma,Can you tell me the frequency of ACVR1B mutations co-occurring with CXCR2 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1383,ACVR1B,D490N,Colon Adenocarcinoma,Can you tell me the frequency of ACVR1B mutations co-occurring with MAD1L1 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1393,EBF2,T104I,Stomach Adenocarcinoma,Can you tell me the frequency of EBF2 mutations co-occurring with PGF amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1394,EBF2,T252I,Stomach Adenocarcinoma,Can you tell me the frequency of EBF2 mutations co-occurring with ARMC3 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1402,VPS26B,F266L,Stomach Adenocarcinoma,Can you tell me the frequency of VPS26B mutations co-occurring with ACTB amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the frequency of PGR mutations co-occurring with CDH23 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the frequency of PGR mutations co-occurring with USH2A amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you tell me the frequency of PGR mutations co-occurring with NEXN amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,Can you tell me the frequency of ACTA2 mutations co-occurring with UNC5D amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of THBS4 mutations co-occurring with ACVR1B amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of THBS4 mutations co-occurring with CTSC amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1413,PRSS1,S114T,Lung Adenocarcinoma,Can you tell me the frequency of PRSS1 mutations co-occurring with DNAH14 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1414,PRSS1,S124T,Lung Adenocarcinoma,Can you tell me the frequency of PRSS1 mutations co-occurring with TLCD5 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1415,PRSS1,S138T,Lung Adenocarcinoma,Can you tell me the frequency of PRSS1 mutations co-occurring with CA9 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1416,PRSS1,S74T,Lung Adenocarcinoma,Can you tell me the frequency of PRSS1 mutations co-occurring with ANKRD52 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1417,PGF,R126H,Stomach Adenocarcinoma,Can you tell me the frequency of PGF mutations co-occurring with ARMC3 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1418,PGF,R127H,Stomach Adenocarcinoma,Can you tell me the frequency of PGF mutations co-occurring with CTSC amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,Can you tell me the frequency of ITPRID2 mutations co-occurring with PRSS1 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,Can you tell me the frequency of ITPRID2 mutations co-occurring with COL6A3 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of HBB mutations co-occurring with DOCK2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1441,PCDHB2,R158C,Colon Adenocarcinoma,Can you tell me the frequency of PCDHB2 mutations co-occurring with CHODL amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1442,PCDHB2,T15M,Colon Adenocarcinoma,Can you tell me the frequency of PCDHB2 mutations co-occurring with DCAF4L2 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1443,PCDHB2,T26M,Colon Adenocarcinoma,Can you tell me the frequency of PCDHB2 mutations co-occurring with ZBTB34 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,Can you tell me the frequency of UBR2 mutations co-occurring with POC1B amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1452,FBXO42,A618D,Rectum Adenocarcinoma,Can you tell me the frequency of FBXO42 mutations co-occurring with MED16 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+1,TNS1,G1362V,Breast Invasive Carcinoma,How common are mutations in TNS1 and amplifications in CNGB1 among patients with Breast Invasive Carcinoma?,cnv_and_ssm
+2,TNS1,G1711V,Breast Invasive Carcinoma,How common are mutations in TNS1 and amplifications in RIMS2 among patients with Breast Invasive Carcinoma?,cnv_and_ssm
+3,TNS1,G1718V,Breast Invasive Carcinoma,How common are mutations in TNS1 and amplifications in TMEM255A among patients with Breast Invasive Carcinoma?,cnv_and_ssm
+4,TNS1,G1732V,Breast Invasive Carcinoma,How common are mutations in TNS1 and amplifications in PTPRO among patients with Breast Invasive Carcinoma?,cnv_and_ssm
+5,TNS1,G1824V,Breast Invasive Carcinoma,How common are mutations in TNS1 and amplifications in YY1AP1 among patients with Breast Invasive Carcinoma?,cnv_and_ssm
+6,TNS1,G1857V,Breast Invasive Carcinoma,How common are mutations in TNS1 and amplifications in ZFPM2 among patients with Breast Invasive Carcinoma?,cnv_and_ssm
+7,TNS1,G843V,Breast Invasive Carcinoma,How common are mutations in TNS1 and amplifications in CARMIL1 among patients with Breast Invasive Carcinoma?,cnv_and_ssm
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How common are mutations in EVC2 and amplifications in EFCAB12 among patients with Bladder Urothelial Carcinoma?,cnv_and_ssm
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How common are mutations in EVC2 and amplifications in TYROBP among patients with Bladder Urothelial Carcinoma?,cnv_and_ssm
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How common are mutations in CR1 and amplifications in TAF1C among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How common are mutations in CR1 and amplifications in OR2A12 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+22,TRPA1,S295I,Rectum Adenocarcinoma,How common are mutations in TRPA1 and amplifications in MAD1L1 among patients with Rectum Adenocarcinoma?,cnv_and_ssm
+23,TRPA1,S443I,Rectum Adenocarcinoma,How common are mutations in TRPA1 and amplifications in LAMB2 among patients with Rectum Adenocarcinoma?,cnv_and_ssm
+24,TAF1C,R299L,Lung Adenocarcinoma,How common are mutations in TAF1C and amplifications in MYT1 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+25,TAF1C,R396L,Lung Adenocarcinoma,How common are mutations in TAF1C and amplifications in PIAS3 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+26,TAF1C,R634L,Lung Adenocarcinoma,How common are mutations in TAF1C and amplifications in MAD1L1 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+27,TAF1C,R702L,Lung Adenocarcinoma,How common are mutations in TAF1C and amplifications in DCAF6 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+28,TAF1C,R728L,Lung Adenocarcinoma,How common are mutations in TAF1C and amplifications in PRSS1 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How common are mutations in DPF3 and amplifications in XKR4 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How common are mutations in DPF3 and amplifications in ZKSCAN7 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How common are mutations in DPF3 and amplifications in CYB5R2 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+42,OR2T4,P272H,Lung Adenocarcinoma,How common are mutations in OR2T4 and amplifications in FGF8 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+43,OR2T4,P300H,Lung Adenocarcinoma,How common are mutations in OR2T4 and amplifications in PTPRO among patients with Lung Adenocarcinoma?,cnv_and_ssm
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How common are mutations in FBN1 and amplifications in PRSS1 among patients with Pancreatic Adenocarcinoma?,cnv_and_ssm
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How common are mutations in MAD1L1 and amplifications in LCN15 among patients with Prostate Adenocarcinoma?,cnv_and_ssm
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How common are mutations in MAD1L1 and amplifications in GIMAP2 among patients with Prostate Adenocarcinoma?,cnv_and_ssm
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How common are mutations in MAD1L1 and amplifications in MSANTD4 among patients with Prostate Adenocarcinoma?,cnv_and_ssm
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How common are mutations in CCNG1 and amplifications in CHODL among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How common are mutations in ANP32E and amplifications in TASOR2 among patients with Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How common are mutations in ANP32E and amplifications in DNMT1 among patients with Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How common are mutations in ANP32E and amplifications in OLFML3 among patients with Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How common are mutations in ANP32E and amplifications in ZSCAN31 among patients with Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How common are mutations in FRY and amplifications in ITPRID2 among patients with Bladder Urothelial Carcinoma?,cnv_and_ssm
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How common are mutations in FRY and amplifications in DNAH14 among patients with Bladder Urothelial Carcinoma?,cnv_and_ssm
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How common are mutations in FRY and amplifications in PKHD1L1 among patients with Bladder Urothelial Carcinoma?,cnv_and_ssm
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How common are mutations in FRY and amplifications in PDHA2 among patients with Bladder Urothelial Carcinoma?,cnv_and_ssm
+70,PAK3,E318K,Skin Cutaneous Melanoma,How common are mutations in PAK3 and amplifications in TTN among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+71,PAK3,E319K,Skin Cutaneous Melanoma,How common are mutations in PAK3 and amplifications in MAD1L1 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+72,PAK3,E334K,Skin Cutaneous Melanoma,How common are mutations in PAK3 and amplifications in PXN among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+73,PAK3,E340K,Skin Cutaneous Melanoma,How common are mutations in PAK3 and amplifications in CHODL among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+74,PAK3,E355K,Skin Cutaneous Melanoma,How common are mutations in PAK3 and amplifications in NPSR1 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How common are mutations in MUC16 and amplifications in MYO15A among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How common are mutations in ZFPM2 and amplifications in PKHD1L1 among patients with Liver Hepatocellular Carcinoma?,cnv_and_ssm
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How common are mutations in ZFPM2 and amplifications in THBS4 among patients with Liver Hepatocellular Carcinoma?,cnv_and_ssm
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How common are mutations in PIK3C2B and amplifications in MAST4 among patients with Breast Invasive Carcinoma?,cnv_and_ssm
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How common are mutations in PIK3C2B and amplifications in MORF4L1 among patients with Breast Invasive Carcinoma?,cnv_and_ssm
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How common are mutations in ZNF804A and amplifications in YY1AP1 among patients with Colon Adenocarcinoma?,cnv_and_ssm
+116,RELN,A2371V,Stomach Adenocarcinoma,How common are mutations in RELN and amplifications in EIF2B4 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are mutations in EFCAB12 and amplifications in RIPOR2 among patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are mutations in EFCAB12 and amplifications in DGKD among patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How common are mutations in DEFB115 and amplifications in IL5RA among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How common are mutations in ANKDD1A and amplifications in FCGR2C among patients with Bladder Urothelial Carcinoma?,cnv_and_ssm
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How common are mutations in ANKDD1A and amplifications in SLC6A4 among patients with Bladder Urothelial Carcinoma?,cnv_and_ssm
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How common are mutations in ANKDD1A and amplifications in CNGB1 among patients with Bladder Urothelial Carcinoma?,cnv_and_ssm
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How common are mutations in HTR3B and amplifications in MAOB among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How common are mutations in HTR3B and amplifications in PRSS1 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How common are mutations in HTR3B and amplifications in CTNNA2 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+129,ABCC3,R758W,Stomach Adenocarcinoma,How common are mutations in ABCC3 and amplifications in TMEM255A among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How common are mutations in NOMO1 and amplifications in ADAM17 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How common are mutations in NOMO1 and amplifications in ADAM17 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How common are mutations in HYOU1 and amplifications in DGKD among patients with Bladder Urothelial Carcinoma?,cnv_and_ssm
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How common are mutations in FMO4 and amplifications in VASN among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+140,BICC1,A372V,Exceptional Responders,How common are mutations in BICC1 and amplifications in DNAH14 among patients with Exceptional Responders?,cnv_and_ssm
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How common are mutations in ZMYM3 and amplifications in DNMT1 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How common are mutations in ZMYM3 and amplifications in JAML among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How common are mutations in ZMYM3 and amplifications in AQP7 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are mutations in XKR4 and amplifications in EFCAB12 among patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How common are mutations in ABCC2 and amplifications in EFCAB12 among patients with Liver Hepatocellular Carcinoma?,cnv_and_ssm
+157,OR8K5,R293G,Lung Adenocarcinoma,How common are mutations in OR8K5 and amplifications in MAD1L1 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How common are mutations in SPTAN1 and amplifications in PGR among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How common are mutations in SPTAN1 and amplifications in SYT9 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+164,SYT10,M484I,Rectum Adenocarcinoma,How common are mutations in SYT10 and amplifications in PHLPP1 among patients with Rectum Adenocarcinoma?,cnv_and_ssm
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How common are mutations in HSPA5 and amplifications in SORCS1 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+175,UNC5D,L280V,Lung Adenocarcinoma,How common are mutations in UNC5D and amplifications in PKHD1L1 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+176,UNC5D,L635V,Lung Adenocarcinoma,How common are mutations in UNC5D and amplifications in TET2 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+177,UNC5D,L637V,Lung Adenocarcinoma,How common are mutations in UNC5D and amplifications in RIMS2 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+178,UNC5D,L699V,Lung Adenocarcinoma,How common are mutations in UNC5D and amplifications in DNMT1 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+179,UNC5D,L704V,Lung Adenocarcinoma,How common are mutations in UNC5D and amplifications in COL6A3 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+180,UNC5D,L709V,Lung Adenocarcinoma,How common are mutations in UNC5D and amplifications in TENT5A among patients with Lung Adenocarcinoma?,cnv_and_ssm
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How common are mutations in DOCK2 and amplifications in ZBTB34 among patients with Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How common are mutations in ZNF627 and amplifications in ADRA1A among patients with Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How common are mutations in CDC42BPA and amplifications in DNAH14 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+193,MRPL55,H27Y,Colon Adenocarcinoma,How common are mutations in MRPL55 and amplifications in ZMYM3 among patients with Colon Adenocarcinoma?,cnv_and_ssm
+194,MRPL55,H63Y,Colon Adenocarcinoma,How common are mutations in MRPL55 and amplifications in DNAH11 among patients with Colon Adenocarcinoma?,cnv_and_ssm
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How common are mutations in TMTC3 and amplifications in STAT3 among patients with Breast Invasive Carcinoma?,cnv_and_ssm
+198,EPRS1,K771I,Colon Adenocarcinoma,How common are mutations in EPRS1 and amplifications in DCN among patients with Colon Adenocarcinoma?,cnv_and_ssm
+199,EPRS1,K778I,Colon Adenocarcinoma,How common are mutations in EPRS1 and amplifications in MYO3B among patients with Colon Adenocarcinoma?,cnv_and_ssm
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How common are mutations in GRTP1 and amplifications in JAML among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How common are mutations in GRTP1 and amplifications in DNMT1 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How common are mutations in TSHZ3 and amplifications in SYNJ1 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How common are mutations in TAS1R3 and amplifications in TTN among patients with HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,cnv_and_ssm
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How common are mutations in PIAS3 and amplifications in ZNF431 among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How common are mutations in PIAS3 and amplifications in TNS1 among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+251,ZNF274,P13R,Stomach Adenocarcinoma,How common are mutations in ZNF274 and amplifications in PXN among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+253,SYNJ1,R795C,Colon Adenocarcinoma,How common are mutations in SYNJ1 and amplifications in DOCK2 among patients with Colon Adenocarcinoma?,cnv_and_ssm
+254,SYNJ1,R800C,Colon Adenocarcinoma,How common are mutations in SYNJ1 and amplifications in ACTA2 among patients with Colon Adenocarcinoma?,cnv_and_ssm
+255,SYNJ1,R839C,Colon Adenocarcinoma,How common are mutations in SYNJ1 and amplifications in OR13C3 among patients with Colon Adenocarcinoma?,cnv_and_ssm
+261,DSCAM,V343M,Prostate Adenocarcinoma,How common are mutations in DSCAM and amplifications in MSANTD4 among patients with Prostate Adenocarcinoma?,cnv_and_ssm
+262,DSCAM,V426M,Prostate Adenocarcinoma,How common are mutations in DSCAM and amplifications in TMEM255A among patients with Prostate Adenocarcinoma?,cnv_and_ssm
+263,DSCAM,V591M,Prostate Adenocarcinoma,How common are mutations in DSCAM and amplifications in PIAS3 among patients with Prostate Adenocarcinoma?,cnv_and_ssm
+267,DGKD,R140H,Exceptional Responders,How common are mutations in DGKD and amplifications in GRTP1 among patients with Exceptional Responders?,cnv_and_ssm
+268,DGKD,R160H,Exceptional Responders,How common are mutations in DGKD and amplifications in ZNF431 among patients with Exceptional Responders?,cnv_and_ssm
+269,DGKD,R204H,Exceptional Responders,How common are mutations in DGKD and amplifications in ANKDD1A among patients with Exceptional Responders?,cnv_and_ssm
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How common are mutations in PLEKHG6 and amplifications in MRPL32 among patients with Bladder Urothelial Carcinoma?,cnv_and_ssm
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How common are mutations in PLEKHG6 and amplifications in ZNF431 among patients with Bladder Urothelial Carcinoma?,cnv_and_ssm
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How common are mutations in PLEKHG6 and amplifications in LCN15 among patients with Bladder Urothelial Carcinoma?,cnv_and_ssm
+279,WNT2,D138N,Skin Cutaneous Melanoma,How common are mutations in WNT2 and amplifications in EPRS1 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How common are mutations in GUCY2C and amplifications in EBF2 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How common are mutations in C7orf31 and amplifications in EVC2 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are mutations in ZKSCAN7 and amplifications in PTPRN2 among patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+299,OR5D14,M210L,Neuroblastoma,How common are mutations in OR5D14 and amplifications in SOX21 among patients with Neuroblastoma?,cnv_and_ssm
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How common are mutations in SPATA22 and amplifications in GPR158 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How common are mutations in SPATA22 and amplifications in PTPRO among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How common are mutations in SPATA22 and amplifications in ABCC2 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+310,LCN15,E21V,Stomach Adenocarcinoma,How common are mutations in LCN15 and amplifications in CFAP61 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How common are mutations in DCAF4L2 and amplifications in OR2T4 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How common are mutations in GUK1 and amplifications in NEXN among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How common are mutations in GUK1 and amplifications in KDM5C among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How common are mutations in GUK1 and amplifications in TYK2 among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How common are mutations in GUK1 and amplifications in HLA-DQA2 among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How common are mutations in GUK1 and amplifications in NRAP among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How common are mutations in MORF4L1 and amplifications in PIAS3 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How common are mutations in MORF4L1 and amplifications in UBR2 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How common are mutations in MORF4L1 and amplifications in PXN among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How common are mutations in MORF4L1 and amplifications in SPATA22 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How common are mutations in MYO3B and amplifications in MERTK among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How common are mutations in MYO3B and amplifications in CTSC among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How common are mutations in TENT5A and amplifications in MAST4 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How common are mutations in TENT5A and amplifications in ANP32E among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How common are mutations in TENT5A and amplifications in MERTK among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How common are mutations in ZFAT and amplifications in TLK2 among patients with Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How common are mutations in ZFAT and amplifications in SORCS1 among patients with Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How common are mutations in ZFAT and amplifications in DCC among patients with Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+357,ZNF584,A211T,Sarcoma,How common are mutations in ZNF584 and amplifications in YY1AP1 among patients with Sarcoma?,cnv_and_ssm
+358,ZNF584,A256T,Sarcoma,How common are mutations in ZNF584 and amplifications in CTCFL among patients with Sarcoma?,cnv_and_ssm
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How common are mutations in LDOC1 and amplifications in ANKDD1A among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How common are mutations in PDGFC and amplifications in TMEM255A among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How common are mutations in MSANTD4 and amplifications in TTC17 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How common are mutations in NPSR1 and amplifications in MRPL55 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How common are mutations in PHLPP1 and amplifications in YY1AP1 among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How common are mutations in COL6A3 and amplifications in LDOC1 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How common are mutations in COL6A3 and amplifications in AUTS2 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How common are mutations in COL6A3 and amplifications in POC1B among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How common are mutations in COL6A3 and amplifications in GSTCD among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How common are mutations in COL6A3 and amplifications in GPR158 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How common are mutations in ADRA1A and amplifications in CCDC22 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common are mutations in LAMB2 and amplifications in PAK3 among patients with Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+406,POC1B,I198T,Rectum Adenocarcinoma,How common are mutations in POC1B and amplifications in DGKD among patients with Rectum Adenocarcinoma?,cnv_and_ssm
+407,POC1B,I286T,Rectum Adenocarcinoma,How common are mutations in POC1B and amplifications in PTPRN2 among patients with Rectum Adenocarcinoma?,cnv_and_ssm
+408,POC1B,I328T,Rectum Adenocarcinoma,How common are mutations in POC1B and amplifications in SMO among patients with Rectum Adenocarcinoma?,cnv_and_ssm
+409,POC1B,S79P,Rectum Adenocarcinoma,How common are mutations in POC1B and amplifications in PRSS1 among patients with Rectum Adenocarcinoma?,cnv_and_ssm
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How common are mutations in USH2A and amplifications in PGR among patients with Liver Hepatocellular Carcinoma?,cnv_and_ssm
+414,AQP7,T110S,Rectum Adenocarcinoma,How common are mutations in AQP7 and amplifications in LAMB2 among patients with Rectum Adenocarcinoma?,cnv_and_ssm
+415,AQP7,T166S,Rectum Adenocarcinoma,How common are mutations in AQP7 and amplifications in MERTK among patients with Rectum Adenocarcinoma?,cnv_and_ssm
+416,AQP7,T167S,Rectum Adenocarcinoma,How common are mutations in AQP7 and amplifications in ANP32E among patients with Rectum Adenocarcinoma?,cnv_and_ssm
+417,AQP7,T75S,Rectum Adenocarcinoma,How common are mutations in AQP7 and amplifications in RIMS2 among patients with Rectum Adenocarcinoma?,cnv_and_ssm
+430,DCN,R163C,Rectum Adenocarcinoma,How common are mutations in DCN and amplifications in DHX16 among patients with Rectum Adenocarcinoma?,cnv_and_ssm
+431,DCN,R203C,Rectum Adenocarcinoma,How common are mutations in DCN and amplifications in PTPRO among patients with Rectum Adenocarcinoma?,cnv_and_ssm
+432,DCN,R241C,Rectum Adenocarcinoma,How common are mutations in DCN and amplifications in KIF20B among patients with Rectum Adenocarcinoma?,cnv_and_ssm
+433,DCN,R350C,Rectum Adenocarcinoma,How common are mutations in DCN and amplifications in DCLK3 among patients with Rectum Adenocarcinoma?,cnv_and_ssm
+434,DCN,R41C,Rectum Adenocarcinoma,How common are mutations in DCN and amplifications in ANKRD52 among patients with Rectum Adenocarcinoma?,cnv_and_ssm
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How common are mutations in CPS1 and amplifications in MERTK among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How common are mutations in CPS1 and amplifications in MAST4 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How common are mutations in CPS1 and amplifications in PTPRN2 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How common are mutations in FCGR2C and amplifications in ZNF431 among patients with Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How common are mutations in FCGR2C and amplifications in PTPRN2 among patients with Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How common are mutations in GRM1 and amplifications in DNMT1 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+482,SGCZ,Q138H,Lung Adenocarcinoma,How common are mutations in SGCZ and amplifications in GSTCD among patients with Lung Adenocarcinoma?,cnv_and_ssm
+483,SGCZ,Q91H,Lung Adenocarcinoma,How common are mutations in SGCZ and amplifications in ABCC3 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+485,SMO,V15M,Stomach Adenocarcinoma,How common are mutations in SMO and amplifications in ARMC3 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+486,SMO,V321M,Stomach Adenocarcinoma,How common are mutations in SMO and amplifications in ACTB among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+488,CHODL,G159E,Skin Cutaneous Melanoma,How common are mutations in CHODL and amplifications in STK19 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+489,CHODL,G181E,Skin Cutaneous Melanoma,How common are mutations in CHODL and amplifications in MYO3B among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+490,CHODL,G200E,Skin Cutaneous Melanoma,How common are mutations in CHODL and amplifications in SGIP1 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+494,MYO16,P399H,Colon Adenocarcinoma,How common are mutations in MYO16 and amplifications in SIK2 among patients with Colon Adenocarcinoma?,cnv_and_ssm
+495,MYO16,P421H,Colon Adenocarcinoma,How common are mutations in MYO16 and amplifications in EBF2 among patients with Colon Adenocarcinoma?,cnv_and_ssm
+498,CXCR2,A98V,Stomach Adenocarcinoma,How common are mutations in CXCR2 and amplifications in ARMC3 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How common are mutations in TMEM225 and amplifications in C7orf31 among patients with Bladder Urothelial Carcinoma?,cnv_and_ssm
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How common are mutations in MAOB and amplifications in EIF2B4 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How common are mutations in GPRASP1 and amplifications in HBB among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How common are mutations in MRPL32 and amplifications in TRPA1 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How common are mutations in TYROBP and amplifications in GABRA6 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+510,RAB40C,A111V,Lung Adenocarcinoma,How common are mutations in RAB40C and amplifications in ZBTB34 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+511,RAB40C,A143V,Lung Adenocarcinoma,How common are mutations in RAB40C and amplifications in MUC16 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+512,CTNNA2,S323R,Lung Adenocarcinoma,How common are mutations in CTNNA2 and amplifications in AKT1 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+513,CTNNA2,S339R,Lung Adenocarcinoma,How common are mutations in CTNNA2 and amplifications in PRSS1 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+514,CTNNA2,S386R,Lung Adenocarcinoma,How common are mutations in CTNNA2 and amplifications in AUTS2 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+515,CTNNA2,S707R,Lung Adenocarcinoma,How common are mutations in CTNNA2 and amplifications in UBR2 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How common are mutations in MYO15A and amplifications in OLFML3 among patients with Bladder Urothelial Carcinoma?,cnv_and_ssm
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How common are mutations in GIMAP2 and amplifications in KDM5C among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+532,KIF20B,N1160D,Glioblastoma Multiforme,How common are mutations in KIF20B and amplifications in POC1B among patients with Glioblastoma Multiforme?,cnv_and_ssm
+533,KIF20B,N1200D,Glioblastoma Multiforme,How common are mutations in KIF20B and amplifications in COL6A3 among patients with Glioblastoma Multiforme?,cnv_and_ssm
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How common are mutations in ADAM17 and amplifications in MYO16 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How common are mutations in BCAT1 and amplifications in SYT9 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How common are mutations in BCAT1 and amplifications in CHMP7 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How common are mutations in BCAT1 and amplifications in DSCAM among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+540,ERCC6,R1053H,Colon Adenocarcinoma,How common are mutations in ERCC6 and amplifications in CTCFL among patients with Colon Adenocarcinoma?,cnv_and_ssm
+541,DCC,R320W,Breast Invasive Carcinoma,How common are mutations in DCC and amplifications in YY1AP1 among patients with Breast Invasive Carcinoma?,cnv_and_ssm
+542,DCC,R363W,Breast Invasive Carcinoma,How common are mutations in DCC and amplifications in GUK1 among patients with Breast Invasive Carcinoma?,cnv_and_ssm
+543,DCC,R386W,Breast Invasive Carcinoma,How common are mutations in DCC and amplifications in PRSS8 among patients with Breast Invasive Carcinoma?,cnv_and_ssm
+544,DCC,R41W,Breast Invasive Carcinoma,How common are mutations in DCC and amplifications in SLC9C1 among patients with Breast Invasive Carcinoma?,cnv_and_ssm
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How common are mutations in FBXO15 and amplifications in CTNNA2 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How common are mutations in FBXO15 and amplifications in CPS1 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How common are mutations in GSTCD and amplifications in ADRA1A among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How common are mutations in GSTCD and amplifications in MYO16 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How common are mutations in OLFML3 and amplifications in AUTS2 among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How common are mutations in OLFML3 and amplifications in FBXO15 among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How common are mutations in OLFML3 and amplifications in TTC12 among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How common are mutations in CFAP61 and amplifications in TRIM45 among patients with Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How common are mutations in CFAP61 and amplifications in AQP7 among patients with Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How common are mutations in HLA-DQA2 and amplifications in TSHZ3 among patients with Bladder Urothelial Carcinoma?,cnv_and_ssm
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How common are mutations in TENM2 and amplifications in UBR2 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How common are mutations in TENM2 and amplifications in PRSS1 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How common are mutations in TENM2 and amplifications in GIMAP2 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How common are mutations in ANKRD24 and amplifications in PTPRO among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How common are mutations in ANKRD24 and amplifications in GPC3 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How common are mutations in ANKRD24 and amplifications in ZNF431 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How common are mutations in ZCCHC14 and amplifications in TNS1 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How common are mutations in ZCCHC14 and amplifications in FGF8 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How common are mutations in ZCCHC14 and amplifications in RIPOR2 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How common are mutations in ZCCHC14 and amplifications in COL6A3 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+625,SIK2,I265M,Lung Adenocarcinoma,How common are mutations in SIK2 and amplifications in SPTAN1 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How common are mutations in MYH11 and amplifications in GPC3 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How common are mutations in MYH11 and amplifications in CX3CR1 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How common are mutations in SLC6A4 and amplifications in JAML among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How common are mutations in SLC9C1 and amplifications in PHLPP1 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How common are mutations in SLC9C1 and amplifications in PIK3C2G among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+644,OR2A12,A254T,Brain Lower Grade Glioma,How common are mutations in OR2A12 and amplifications in CA9 among patients with Brain Lower Grade Glioma?,cnv_and_ssm
+646,PYHIN1,T325K,Lung Adenocarcinoma,How common are mutations in PYHIN1 and amplifications in SYT10 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+647,PYHIN1,T334K,Lung Adenocarcinoma,How common are mutations in PYHIN1 and amplifications in PIAS3 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+650,JAML,G191E,Skin Cutaneous Melanoma,How common are mutations in JAML and amplifications in SYNJ1 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+651,JAML,G219E,Skin Cutaneous Melanoma,How common are mutations in JAML and amplifications in ZCCHC14 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+652,JAML,G220E,Skin Cutaneous Melanoma,How common are mutations in JAML and amplifications in RIMS2 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+653,JAML,G230E,Skin Cutaneous Melanoma,How common are mutations in JAML and amplifications in FGF8 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+658,TYK2,H1146R,Stomach Adenocarcinoma,How common are mutations in TYK2 and amplifications in CTSC among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+659,TYK2,H23R,Stomach Adenocarcinoma,How common are mutations in TYK2 and amplifications in ADAM17 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+660,TYK2,H961R,Stomach Adenocarcinoma,How common are mutations in TYK2 and amplifications in RAB40C among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How common are mutations in CTCFL and amplifications in PRSS1 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How common are mutations in CTCFL and amplifications in PTPRO among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How common are mutations in CTCFL and amplifications in DEFB115 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How common are mutations in CTCFL and amplifications in ABCC2 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How common are mutations in CEP20 and amplifications in TET2 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How common are mutations in CEP20 and amplifications in GRTP1 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How common are mutations in RIMS2 and amplifications in ANKDD1A among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How common are mutations in RIMS2 and amplifications in TSHZ3 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How common are mutations in RIMS2 and amplifications in YY1AP1 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How common are mutations in RIMS2 and amplifications in RIPOR2 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How common are mutations in RIMS2 and amplifications in ICE1 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How common are mutations in RIMS2 and amplifications in ANP32E among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How common are mutations in RIMS2 and amplifications in DCN among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How common are mutations in PIK3C2G and amplifications in ANKDD1A among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How common are mutations in PIK3C2G and amplifications in DCN among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+728,STK19,D341N,Colon Adenocarcinoma,How common are mutations in STK19 and amplifications in PXN among patients with Colon Adenocarcinoma?,cnv_and_ssm
+729,STK19,D345N,Colon Adenocarcinoma,How common are mutations in STK19 and amplifications in CACNA1F among patients with Colon Adenocarcinoma?,cnv_and_ssm
+730,REXO4,P60A,Skin Cutaneous Melanoma,How common are mutations in REXO4 and amplifications in TLK2 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How common are mutations in ZBTB34 and amplifications in MIEF1 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How common are mutations in ZBTB34 and amplifications in CFAP298-TCP10L among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How common are mutations in NCKAP5 and amplifications in LAMB2 among patients with Bladder Urothelial Carcinoma?,cnv_and_ssm
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are mutations in SORCS1 and amplifications in RAB40C among patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are mutations in SORCS1 and amplifications in YY1AP1 among patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are mutations in SORCS1 and amplifications in PCDHB2 among patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are mutations in SORCS1 and amplifications in PTPRO among patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How common are mutations in FGF8 and amplifications in GPR158 among patients with Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How common are mutations in FGF8 and amplifications in MYO3A among patients with Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How common are mutations in FGF8 and amplifications in CTSC among patients with Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How common are mutations in FGF8 and amplifications in EFCAB12 among patients with Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How common are mutations in FGF8 and amplifications in PIAS3 among patients with Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How common are mutations in TENM3 and amplifications in AQP7 among patients with Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,cnv_and_ssm
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How common are mutations in AKT1 and amplifications in PIK3C2B among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common are mutations in CFAP298-TCP10L and amplifications in ZBTB34 among patients with Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+792,GLRB,E148D,Stomach Adenocarcinoma,How common are mutations in GLRB and amplifications in PGR among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+793,TTN,F7636L,Colon Adenocarcinoma,How common are mutations in TTN and amplifications in ZKSCAN7 among patients with Colon Adenocarcinoma?,cnv_and_ssm
+794,TTN,F8563L,Colon Adenocarcinoma,How common are mutations in TTN and amplifications in GPR158 among patients with Colon Adenocarcinoma?,cnv_and_ssm
+795,TTN,F8880L,Colon Adenocarcinoma,How common are mutations in TTN and amplifications in CTSC among patients with Colon Adenocarcinoma?,cnv_and_ssm
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How common are mutations in ANKRD30A and amplifications in USH2A among patients with Colon Adenocarcinoma?,cnv_and_ssm
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How common are mutations in ANKRD30A and amplifications in MERTK among patients with Colon Adenocarcinoma?,cnv_and_ssm
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How common are mutations in ANKRD30A and amplifications in SOX21 among patients with Colon Adenocarcinoma?,cnv_and_ssm
+809,TRIM45,S177L,Colon Adenocarcinoma,How common are mutations in TRIM45 and amplifications in PYHIN1 among patients with Colon Adenocarcinoma?,cnv_and_ssm
+810,TRIM45,S224L,Colon Adenocarcinoma,How common are mutations in TRIM45 and amplifications in ICE1 among patients with Colon Adenocarcinoma?,cnv_and_ssm
+811,TRIM45,S281L,Colon Adenocarcinoma,How common are mutations in TRIM45 and amplifications in CTCFL among patients with Colon Adenocarcinoma?,cnv_and_ssm
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How common are mutations in CACNA1F and amplifications in ANKRD30A among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How common are mutations in CACNA1F and amplifications in MAST4 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How common are mutations in CACNA1F and amplifications in TENM3 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+817,KL,R594C,Colon Adenocarcinoma,How common are mutations in KL and amplifications in PIK3C2A among patients with Colon Adenocarcinoma?,cnv_and_ssm
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How common are mutations in GUF1 and amplifications in ARHGEF40 among patients with Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+822,TAF1L,A539V,Colon Adenocarcinoma,How common are mutations in TAF1L and amplifications in MAD1L1 among patients with Colon Adenocarcinoma?,cnv_and_ssm
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How common are mutations in TASOR2 and amplifications in CHODL among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How common are mutations in TASOR2 and amplifications in AUTS2 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How common are mutations in TASOR2 and amplifications in RIMS2 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How common are mutations in KDM5C and amplifications in OR5D14 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How common are mutations in KDM5C and amplifications in CPS1 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How common are mutations in KDM5C and amplifications in SIK2 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How common are mutations in KDM5C and amplifications in KRT39 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common are mutations in IL5RA and amplifications in FNDC7 among patients with Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+843,DHX16,A29V,Skin Cutaneous Melanoma,How common are mutations in DHX16 and amplifications in IL5RA among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+844,DHX16,A89V,Skin Cutaneous Melanoma,How common are mutations in DHX16 and amplifications in GLRB among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+902,GPR158,A644V,Stomach Adenocarcinoma,How common are mutations in GPR158 and amplifications in ZFAT among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+903,GPR158,A723V,Stomach Adenocarcinoma,How common are mutations in GPR158 and amplifications in ACTB among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are mutations in EIF2B4 and amplifications in POC1B among patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are mutations in EIF2B4 and amplifications in CACNA1F among patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are mutations in EIF2B4 and amplifications in CNGB1 among patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are mutations in EIF2B4 and amplifications in EPRS1 among patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are mutations in EIF2B4 and amplifications in ICE1 among patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are mutations in EIF2B4 and amplifications in PGR among patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How common are mutations in AUTS2 and amplifications in EPRS1 among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How common are mutations in AUTS2 and amplifications in GPR158 among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How common are mutations in AUTS2 and amplifications in HYOU1 among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How common are mutations in AUTS2 and amplifications in ACTB among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How common are mutations in AUTS2 and amplifications in SPATA22 among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How common are mutations in AUTS2 and amplifications in XKR4 among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How common are mutations in AUTS2 and amplifications in CASZ1 among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How common are mutations in AUTS2 and amplifications in C7orf31 among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How common are mutations in AUTS2 and amplifications in TMEM255A among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How common are mutations in AUTS2 and amplifications in GUK1 among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are mutations in ACTL7B and amplifications in GRM1 among patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How common are mutations in PCDHGA1 and amplifications in TYK2 among patients with Glioblastoma Multiforme?,cnv_and_ssm
+954,TRAP1,R114W,Stomach Adenocarcinoma,How common are mutations in TRAP1 and amplifications in DCLK3 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+955,TRAP1,R61W,Stomach Adenocarcinoma,How common are mutations in TRAP1 and amplifications in ZNF804A among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How common are mutations in PIK3C2A and amplifications in DCN among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How common are mutations in KANSL1 and amplifications in ICE1 among patients with Liver Hepatocellular Carcinoma?,cnv_and_ssm
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How common are mutations in ANKRD52 and amplifications in ACTB among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How common are mutations in PAPPA and amplifications in PAK3 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How common are mutations in B3GALNT1 and amplifications in EFCAB12 among patients with Rectum Adenocarcinoma?,cnv_and_ssm
+982,GABRA6,G115R,Lung Adenocarcinoma,How common are mutations in GABRA6 and amplifications in CX3CR1 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+983,GABRA6,G122R,Lung Adenocarcinoma,How common are mutations in GABRA6 and amplifications in DNAH11 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+984,GABRA6,G165R,Lung Adenocarcinoma,How common are mutations in GABRA6 and amplifications in GABRA6 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+985,GABRA6,G175R,Lung Adenocarcinoma,How common are mutations in GABRA6 and amplifications in FBXO15 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+986,GABRA6,G70R,Lung Adenocarcinoma,How common are mutations in GABRA6 and amplifications in GUK1 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How common are mutations in ZSCAN31 and amplifications in GABRA6 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are mutations in MED16 and amplifications in COL6A3 among patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are mutations in MED16 and amplifications in TAF1C among patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How common are mutations in PTPRO and amplifications in MRPL32 among patients with Pancreatic Adenocarcinoma?,cnv_and_ssm
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How common are mutations in PTPRO and amplifications in YY1AP1 among patients with Pancreatic Adenocarcinoma?,cnv_and_ssm
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How common are mutations in PTPRO and amplifications in UNC5D among patients with Pancreatic Adenocarcinoma?,cnv_and_ssm
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How common are mutations in PTPRO and amplifications in KIF20B among patients with Pancreatic Adenocarcinoma?,cnv_and_ssm
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How common are mutations in PTPRO and amplifications in SPATA22 among patients with Pancreatic Adenocarcinoma?,cnv_and_ssm
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How common are mutations in PTPRO and amplifications in ANP32E among patients with Pancreatic Adenocarcinoma?,cnv_and_ssm
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How common are mutations in PTPRO and amplifications in YY1AP1 among patients with Pancreatic Adenocarcinoma?,cnv_and_ssm
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How common are mutations in PTPRO and amplifications in FCGR2C among patients with Pancreatic Adenocarcinoma?,cnv_and_ssm
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How common are mutations in CHMP7 and amplifications in TAF1C among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1017,GPC3,I107N,Stomach Adenocarcinoma,How common are mutations in GPC3 and amplifications in MYO15A among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+1018,GPC3,I161N,Stomach Adenocarcinoma,How common are mutations in GPC3 and amplifications in OR2T4 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common are mutations in TLK2 and amplifications in PIK3C2G among patients with Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common are mutations in TLK2 and amplifications in OR5D14 among patients with Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common are mutations in TLK2 and amplifications in TRAP1 among patients with Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common are mutations in TLK2 and amplifications in SORCS1 among patients with Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common are mutations in TLK2 and amplifications in TLCD5 among patients with Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How common are mutations in ZNF217 and amplifications in OR8K5 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+1038,SYT9,V275L,Lung Adenocarcinoma,How common are mutations in SYT9 and amplifications in SPATA22 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+1039,SYT9,V307L,Lung Adenocarcinoma,How common are mutations in SYT9 and amplifications in GUK1 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How common are mutations in PKHD1L1 and amplifications in CTSC among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How common are mutations in MYO3A and amplifications in CX3CR1 among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are mutations in VASN and amplifications in GUK1 among patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How common are mutations in DNMT1 and amplifications in AUTS2 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How common are mutations in DNMT1 and amplifications in NRAP among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How common are mutations in DNMT1 and amplifications in TASOR2 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1056,CA9,E402K,Colon Adenocarcinoma,How common are mutations in CA9 and amplifications in YY1AP1 among patients with Colon Adenocarcinoma?,cnv_and_ssm
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How common are mutations in TTC17 and amplifications in CFAP61 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How common are mutations in TTC17 and amplifications in ZNF431 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1065,PSG2,P43L,Breast Invasive Carcinoma,How common are mutations in PSG2 and amplifications in PTPRN2 among patients with Breast Invasive Carcinoma?,cnv_and_ssm
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How common are mutations in RIPOR2 and amplifications in DNMT1 among patients with Breast Invasive Carcinoma?,cnv_and_ssm
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How common are mutations in RIPOR2 and amplifications in CTCFL among patients with Breast Invasive Carcinoma?,cnv_and_ssm
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How common are mutations in RIPOR2 and amplifications in MYT1 among patients with Breast Invasive Carcinoma?,cnv_and_ssm
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How common are mutations in RIPOR2 and amplifications in PAK3 among patients with Breast Invasive Carcinoma?,cnv_and_ssm
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How common are mutations in DCLK3 and amplifications in TMEM255A among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How common are mutations in DCLK3 and amplifications in PGF among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How common are mutations in MERTK and amplifications in TNS1 among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How common are mutations in MERTK and amplifications in ZNF708 among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How common are mutations in MERTK and amplifications in ERCC6 among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How common are mutations in ZFP42 and amplifications in CDH23 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How common are mutations in OR13C3 and amplifications in ZFP42 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How common are mutations in OR13C3 and amplifications in AQP7 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How common are mutations in SPAG1 and amplifications in TET2 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How common are mutations in CDKN2AIP and amplifications in PTPRN2 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1093,PXN,H1016Y,Colon Adenocarcinoma,How common are mutations in PXN and amplifications in SLC24A2 among patients with Colon Adenocarcinoma?,cnv_and_ssm
+1094,PXN,H359Y,Colon Adenocarcinoma,How common are mutations in PXN and amplifications in THBS4 among patients with Colon Adenocarcinoma?,cnv_and_ssm
+1095,PXN,H492Y,Colon Adenocarcinoma,How common are mutations in PXN and amplifications in ACTB among patients with Colon Adenocarcinoma?,cnv_and_ssm
+1096,PXN,H524Y,Colon Adenocarcinoma,How common are mutations in PXN and amplifications in CARMIL1 among patients with Colon Adenocarcinoma?,cnv_and_ssm
+1097,PXN,H526Y,Colon Adenocarcinoma,How common are mutations in PXN and amplifications in YY1AP1 among patients with Colon Adenocarcinoma?,cnv_and_ssm
+1098,PXN,H540Y,Colon Adenocarcinoma,How common are mutations in PXN and amplifications in XKR4 among patients with Colon Adenocarcinoma?,cnv_and_ssm
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How common are mutations in TTYH2 and amplifications in DCLK3 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How common are mutations in TTYH2 and amplifications in JAML among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How common are mutations in TMEM255A and amplifications in TAS1R3 among patients with Colon Adenocarcinoma?,cnv_and_ssm
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How common are mutations in TMEM255A and amplifications in ZFPM2 among patients with Colon Adenocarcinoma?,cnv_and_ssm
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How common are mutations in TMEM255A and amplifications in UNC5D among patients with Colon Adenocarcinoma?,cnv_and_ssm
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How common are mutations in TASOR2 and amplifications in SORCS1 among patients with Breast Invasive Carcinoma?,cnv_and_ssm
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How common are mutations in TASOR2 and amplifications in CYP1A2 among patients with Breast Invasive Carcinoma?,cnv_and_ssm
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How common are mutations in ICE1 and amplifications in POC1B among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1112,MYT1,A558E,Breast Invasive Carcinoma,How common are mutations in MYT1 and amplifications in GABRA6 among patients with Breast Invasive Carcinoma?,cnv_and_ssm
+1113,MYT1,A879E,Breast Invasive Carcinoma,How common are mutations in MYT1 and amplifications in TET2 among patients with Breast Invasive Carcinoma?,cnv_and_ssm
+1114,MYT1,A906E,Breast Invasive Carcinoma,How common are mutations in MYT1 and amplifications in PYHIN1 among patients with Breast Invasive Carcinoma?,cnv_and_ssm
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How common are mutations in CX3CR1 and amplifications in AUTS2 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How common are mutations in CX3CR1 and amplifications in HLA-DQA2 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How common are mutations in SPINDOC and amplifications in AQP7 among patients with Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How common are mutations in ART3 and amplifications in OR2A12 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How common are mutations in ART3 and amplifications in SLC6A4 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How common are mutations in CYP1A2 and amplifications in BCAT1 among patients with Bladder Urothelial Carcinoma?,cnv_and_ssm
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are mutations in ADRA1A and amplifications in TRIM45 among patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How common are mutations in CDH23 and amplifications in MED16 among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How common are mutations in CDH23 and amplifications in MAD1L1 among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How common are mutations in KRT39 and amplifications in SYT9 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How common are mutations in PDHA2 and amplifications in RIMS2 among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How common are mutations in SLC24A2 and amplifications in TASOR2 among patients with Colon Adenocarcinoma?,cnv_and_ssm
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How common are mutations in PTPRN2 and amplifications in AQP7 among patients with Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How common are mutations in PTPRN2 and amplifications in TAF1C among patients with Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How common are mutations in PTPRN2 and amplifications in MSANTD4 among patients with Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How common are mutations in PTPRN2 and amplifications in ZCCHC14 among patients with Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How common are mutations in PTPRN2 and amplifications in GPC3 among patients with Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1188,SOX21,R55L,Lung Adenocarcinoma,How common are mutations in SOX21 and amplifications in FRY among patients with Lung Adenocarcinoma?,cnv_and_ssm
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How common are mutations in CPA6 and amplifications in OLFML3 among patients with Bladder Urothelial Carcinoma?,cnv_and_ssm
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How common are mutations in GRM5 and amplifications in PDHA2 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are mutations in CASZ1 and amplifications in ITPRID2 among patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How common are mutations in SGIP1 and amplifications in MERTK among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How common are mutations in SGIP1 and amplifications in GPR158 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How common are mutations in SGIP1 and amplifications in STK19 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How common are mutations in SGIP1 and amplifications in FRY among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How common are mutations in CARMIL1 and amplifications in ZFAT among patients with Lung Adenocarcinoma?,cnv_and_ssm
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How common are mutations in CARMIL1 and amplifications in GPRASP1 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How common are mutations in ZNF431 and amplifications in ADRA1A among patients with Lung Adenocarcinoma?,cnv_and_ssm
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How common are mutations in ZNF431 and amplifications in OLFML3 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+1234,ZNF431,R128I,Lung Adenocarcinoma,How common are mutations in ZNF431 and amplifications in TENM2 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How common are mutations in DNAH11 and amplifications in DCN among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How common are mutations in DNAH11 and amplifications in AQP7 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How common are mutations in POLD1 and amplifications in CFAP298-TCP10L among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How common are mutations in POLD1 and amplifications in GPR158 among patients with Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1248,TTC12,D646H,Lung Adenocarcinoma,How common are mutations in TTC12 and amplifications in PIAS3 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+1249,TTC12,D652H,Lung Adenocarcinoma,How common are mutations in TTC12 and amplifications in DPF3 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How common are mutations in CNGB1 and amplifications in SERPINB10 among patients with Bladder Urothelial Carcinoma?,cnv_and_ssm
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How common are mutations in CNGB1 and amplifications in KIF20B among patients with Bladder Urothelial Carcinoma?,cnv_and_ssm
+1254,CTSC,E214V,Stomach Adenocarcinoma,How common are mutations in CTSC and amplifications in AQP7 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+1255,CTSC,E291V,Stomach Adenocarcinoma,How common are mutations in CTSC and amplifications in DCN among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+1256,CTSC,E322V,Stomach Adenocarcinoma,How common are mutations in CTSC and amplifications in SYNJ1 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+1257,CTSC,E324V,Stomach Adenocarcinoma,How common are mutations in CTSC and amplifications in SPTAN1 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+1258,CTSC,E335V,Stomach Adenocarcinoma,How common are mutations in CTSC and amplifications in CCNG1 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How common are mutations in PRSS8 and amplifications in TTN among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How common are mutations in PRSS8 and amplifications in TAF1C among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How common are mutations in ARHGEF40 and amplifications in JAML among patients with Lung Adenocarcinoma?,cnv_and_ssm
+1264,ACTB,A138T,Rectum Adenocarcinoma,How common are mutations in ACTB and amplifications in ADRA1A among patients with Rectum Adenocarcinoma?,cnv_and_ssm
+1265,ACTB,A217T,Rectum Adenocarcinoma,How common are mutations in ACTB and amplifications in ZCCHC14 among patients with Rectum Adenocarcinoma?,cnv_and_ssm
+1266,ACTB,A244T,Rectum Adenocarcinoma,How common are mutations in ACTB and amplifications in TLK2 among patients with Rectum Adenocarcinoma?,cnv_and_ssm
+1267,ACTB,A260T,Rectum Adenocarcinoma,How common are mutations in ACTB and amplifications in TNS1 among patients with Rectum Adenocarcinoma?,cnv_and_ssm
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How common are mutations in YY1AP1 and amplifications in USH2A among patients with Glioblastoma Multiforme?,cnv_and_ssm
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How common are mutations in YY1AP1 and amplifications in COL6A3 among patients with Glioblastoma Multiforme?,cnv_and_ssm
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How common are mutations in YY1AP1 and amplifications in SPTAN1 among patients with Glioblastoma Multiforme?,cnv_and_ssm
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How common are mutations in YY1AP1 and amplifications in GLRB among patients with Glioblastoma Multiforme?,cnv_and_ssm
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How common are mutations in YY1AP1 and amplifications in PTPRN2 among patients with Glioblastoma Multiforme?,cnv_and_ssm
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How common are mutations in YY1AP1 and amplifications in MAD1L1 among patients with Glioblastoma Multiforme?,cnv_and_ssm
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How common are mutations in YY1AP1 and amplifications in YY1AP1 among patients with Glioblastoma Multiforme?,cnv_and_ssm
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How common are mutations in FNDC7 and amplifications in ADRA1A among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How common are mutations in FNDC7 and amplifications in FRY among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+1299,TLCD5,G15V,Lung Adenocarcinoma,How common are mutations in TLCD5 and amplifications in LAMB2 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+1300,TLCD5,G37V,Lung Adenocarcinoma,How common are mutations in TLCD5 and amplifications in CYP1A2 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How common are mutations in POLR1G and amplifications in EIF2B4 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How common are mutations in POLR1G and amplifications in DCN among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How common are mutations in DNAH14 and amplifications in POLD1 among patients with Colon Adenocarcinoma?,cnv_and_ssm
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How common are mutations in DNAH14 and amplifications in RIMS2 among patients with Colon Adenocarcinoma?,cnv_and_ssm
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How common are mutations in DNAH14 and amplifications in THBS4 among patients with Colon Adenocarcinoma?,cnv_and_ssm
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How common are mutations in NEXN and amplifications in PSG2 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How common are mutations in CYB5R2 and amplifications in RIMS2 among patients with Prostate Adenocarcinoma?,cnv_and_ssm
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How common are mutations in CYB5R2 and amplifications in TTYH2 among patients with Prostate Adenocarcinoma?,cnv_and_ssm
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How common are mutations in NRAP and amplifications in GABRA6 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How common are mutations in NRAP and amplifications in GUK1 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How common are mutations in NRAP and amplifications in MRPL55 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How common are mutations in CCDC22 and amplifications in MED16 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How common are mutations in DCAF6 and amplifications in PYHIN1 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How common are mutations in DCAF6 and amplifications in TASOR2 among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How common are mutations in ZNF708 and amplifications in AUTS2 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How common are mutations in BFAR and amplifications in AUTS2 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How common are mutations in MAST4 and amplifications in EIF2B4 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How common are mutations in MAST4 and amplifications in CX3CR1 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How common are mutations in MAST4 and amplifications in KDM5C among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How common are mutations in MAST4 and amplifications in DNMT1 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How common are mutations in MAST4 and amplifications in MAST4 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How common are mutations in ARMC3 and amplifications in DNAH14 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How common are mutations in ARMC3 and amplifications in PGF among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How common are mutations in TET2 and amplifications in LAMB2 among patients with Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How common are mutations in TET2 and amplifications in CDH23 among patients with Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How common are mutations in SERPINB10 and amplifications in TASOR2 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How common are mutations in STAT3 and amplifications in MERTK among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How common are mutations in MIEF1 and amplifications in MYO16 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How common are mutations in ACVR1B and amplifications in NEXN among patients with Colon Adenocarcinoma?,cnv_and_ssm
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How common are mutations in ACVR1B and amplifications in SYNJ1 among patients with Colon Adenocarcinoma?,cnv_and_ssm
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How common are mutations in ACVR1B and amplifications in CTSC among patients with Colon Adenocarcinoma?,cnv_and_ssm
+1393,EBF2,T104I,Stomach Adenocarcinoma,How common are mutations in EBF2 and amplifications in PGR among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+1394,EBF2,T252I,Stomach Adenocarcinoma,How common are mutations in EBF2 and amplifications in GABRA6 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How common are mutations in VPS26B and amplifications in ZNF217 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are mutations in PGR and amplifications in AUTS2 among patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are mutations in PGR and amplifications in EIF2B4 among patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are mutations in PGR and amplifications in GUCY2C among patients with CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How common are mutations in ACTA2 and amplifications in CDC42BPA among patients with Skin Cutaneous Melanoma?,cnv_and_ssm
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How common are mutations in THBS4 and amplifications in CTNNA2 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How common are mutations in THBS4 and amplifications in PTPRO among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1413,PRSS1,S114T,Lung Adenocarcinoma,How common are mutations in PRSS1 and amplifications in TSHZ3 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+1414,PRSS1,S124T,Lung Adenocarcinoma,How common are mutations in PRSS1 and amplifications in COL6A3 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+1415,PRSS1,S138T,Lung Adenocarcinoma,How common are mutations in PRSS1 and amplifications in RIMS2 among patients with Lung Adenocarcinoma?,cnv_and_ssm
+1416,PRSS1,S74T,Lung Adenocarcinoma,How common are mutations in PRSS1 and amplifications in PGF among patients with Lung Adenocarcinoma?,cnv_and_ssm
+1417,PGF,R126H,Stomach Adenocarcinoma,How common are mutations in PGF and amplifications in GPC3 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+1418,PGF,R127H,Stomach Adenocarcinoma,How common are mutations in PGF and amplifications in SORCS1 among patients with Stomach Adenocarcinoma?,cnv_and_ssm
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How common are mutations in ITPRID2 and amplifications in RIPOR2 among patients with Breast Invasive Carcinoma?,cnv_and_ssm
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How common are mutations in ITPRID2 and amplifications in CTCFL among patients with Breast Invasive Carcinoma?,cnv_and_ssm
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How common are mutations in HBB and amplifications in FGF8 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How common are mutations in PCDHB2 and amplifications in TNS1 among patients with Colon Adenocarcinoma?,cnv_and_ssm
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How common are mutations in PCDHB2 and amplifications in CTCFL among patients with Colon Adenocarcinoma?,cnv_and_ssm
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How common are mutations in PCDHB2 and amplifications in CEP20 among patients with Colon Adenocarcinoma?,cnv_and_ssm
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How common are mutations in UBR2 and amplifications in SGIP1 among patients with Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How common are mutations in FBXO42 and amplifications in MYO3A among patients with Rectum Adenocarcinoma?,cnv_and_ssm
+1,TNS1,G1362V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases present with mutations in TNS1 and somatic homozygous deletions in PIK3C2G?,cnv_and_ssm
+2,TNS1,G1711V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases present with mutations in TNS1 and somatic homozygous deletions in JAML?,cnv_and_ssm
+3,TNS1,G1718V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases present with mutations in TNS1 and somatic homozygous deletions in KDM5C?,cnv_and_ssm
+4,TNS1,G1732V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases present with mutations in TNS1 and somatic homozygous deletions in GSTCD?,cnv_and_ssm
+5,TNS1,G1824V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases present with mutations in TNS1 and somatic homozygous deletions in ACVR1B?,cnv_and_ssm
+6,TNS1,G1857V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases present with mutations in TNS1 and somatic homozygous deletions in ZNF274?,cnv_and_ssm
+7,TNS1,G843V,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases present with mutations in TNS1 and somatic homozygous deletions in LCN15?,cnv_and_ssm
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases present with mutations in EVC2 and somatic homozygous deletions in RAB40C?,cnv_and_ssm
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases present with mutations in EVC2 and somatic homozygous deletions in MORF4L1?,cnv_and_ssm
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in CR1 and somatic homozygous deletions in GLRB?,cnv_and_ssm
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in CR1 and somatic homozygous deletions in ZNF431?,cnv_and_ssm
+22,TRPA1,S295I,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases present with mutations in TRPA1 and somatic homozygous deletions in ZKSCAN7?,cnv_and_ssm
+23,TRPA1,S443I,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases present with mutations in TRPA1 and somatic homozygous deletions in TNS1?,cnv_and_ssm
+24,TAF1C,R299L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in TAF1C and somatic homozygous deletions in ZCCHC14?,cnv_and_ssm
+25,TAF1C,R396L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in TAF1C and somatic homozygous deletions in ANKRD24?,cnv_and_ssm
+26,TAF1C,R634L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in TAF1C and somatic homozygous deletions in ADAM17?,cnv_and_ssm
+27,TAF1C,R702L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in TAF1C and somatic homozygous deletions in PIAS3?,cnv_and_ssm
+28,TAF1C,R728L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in TAF1C and somatic homozygous deletions in FBXO42?,cnv_and_ssm
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in DPF3 and somatic homozygous deletions in CHMP7?,cnv_and_ssm
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in DPF3 and somatic homozygous deletions in SGIP1?,cnv_and_ssm
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in DPF3 and somatic homozygous deletions in SPATA22?,cnv_and_ssm
+42,OR2T4,P272H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in OR2T4 and somatic homozygous deletions in ZFAT?,cnv_and_ssm
+43,OR2T4,P300H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in OR2T4 and somatic homozygous deletions in CPS1?,cnv_and_ssm
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases present with mutations in FBN1 and somatic homozygous deletions in TAF1C?,cnv_and_ssm
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases present with mutations in MAD1L1 and somatic homozygous deletions in RIMS2?,cnv_and_ssm
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases present with mutations in MAD1L1 and somatic homozygous deletions in PIAS3?,cnv_and_ssm
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases present with mutations in MAD1L1 and somatic homozygous deletions in PDGFC?,cnv_and_ssm
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in CCNG1 and somatic homozygous deletions in FGF8?,cnv_and_ssm
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases present with mutations in ANP32E and somatic homozygous deletions in COL6A3?,cnv_and_ssm
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases present with mutations in ANP32E and somatic homozygous deletions in PAK3?,cnv_and_ssm
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases present with mutations in ANP32E and somatic homozygous deletions in MYO3B?,cnv_and_ssm
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases present with mutations in ANP32E and somatic homozygous deletions in GRM1?,cnv_and_ssm
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases present with mutations in FRY and somatic homozygous deletions in TET2?,cnv_and_ssm
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases present with mutations in FRY and somatic homozygous deletions in DNAH11?,cnv_and_ssm
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases present with mutations in FRY and somatic homozygous deletions in SLC6A4?,cnv_and_ssm
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases present with mutations in FRY and somatic homozygous deletions in REXO4?,cnv_and_ssm
+70,PAK3,E318K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in PAK3 and somatic homozygous deletions in FNDC7?,cnv_and_ssm
+71,PAK3,E319K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in PAK3 and somatic homozygous deletions in B3GALNT1?,cnv_and_ssm
+72,PAK3,E334K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in PAK3 and somatic homozygous deletions in PYHIN1?,cnv_and_ssm
+73,PAK3,E340K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in PAK3 and somatic homozygous deletions in MYT1?,cnv_and_ssm
+74,PAK3,E355K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in PAK3 and somatic homozygous deletions in ZFAT?,cnv_and_ssm
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in MUC16 and somatic homozygous deletions in TRIM45?,cnv_and_ssm
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases present with mutations in ZFPM2 and somatic homozygous deletions in OLFML3?,cnv_and_ssm
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases present with mutations in ZFPM2 and somatic homozygous deletions in MYH11?,cnv_and_ssm
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases present with mutations in PIK3C2B and somatic homozygous deletions in ZFAT?,cnv_and_ssm
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases present with mutations in PIK3C2B and somatic homozygous deletions in FMO4?,cnv_and_ssm
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in ZNF804A and somatic homozygous deletions in TLK2?,cnv_and_ssm
+116,RELN,A2371V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in RELN and somatic homozygous deletions in EBF2?,cnv_and_ssm
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases present with mutations in EFCAB12 and somatic homozygous deletions in COL6A3?",cnv_and_ssm
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases present with mutations in EFCAB12 and somatic homozygous deletions in MYO15A?",cnv_and_ssm
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in DEFB115 and somatic homozygous deletions in PCDHB2?,cnv_and_ssm
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases present with mutations in ANKDD1A and somatic homozygous deletions in ANKRD30A?,cnv_and_ssm
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases present with mutations in ANKDD1A and somatic homozygous deletions in MYO3B?,cnv_and_ssm
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases present with mutations in ANKDD1A and somatic homozygous deletions in SPTAN1?,cnv_and_ssm
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in HTR3B and somatic homozygous deletions in CTSC?,cnv_and_ssm
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in HTR3B and somatic homozygous deletions in UNC5D?,cnv_and_ssm
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in HTR3B and somatic homozygous deletions in COL6A3?,cnv_and_ssm
+129,ABCC3,R758W,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in ABCC3 and somatic homozygous deletions in TAS1R3?,cnv_and_ssm
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in NOMO1 and somatic homozygous deletions in GRM1?,cnv_and_ssm
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in NOMO1 and somatic homozygous deletions in PDHA2?,cnv_and_ssm
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases present with mutations in HYOU1 and somatic homozygous deletions in PLEKHG6?,cnv_and_ssm
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in FMO4 and somatic homozygous deletions in CPS1?,cnv_and_ssm
+140,BICC1,A372V,Exceptional Responders,What percentage of Exceptional Responders cases present with mutations in BICC1 and somatic homozygous deletions in KL?,cnv_and_ssm
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in ZMYM3 and somatic homozygous deletions in MAD1L1?,cnv_and_ssm
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in ZMYM3 and somatic homozygous deletions in TLK2?,cnv_and_ssm
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in ZMYM3 and somatic homozygous deletions in DCLK3?,cnv_and_ssm
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases present with mutations in XKR4 and somatic homozygous deletions in CHODL?",cnv_and_ssm
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases present with mutations in ABCC2 and somatic homozygous deletions in DCLK3?,cnv_and_ssm
+157,OR8K5,R293G,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in OR8K5 and somatic homozygous deletions in CX3CR1?,cnv_and_ssm
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in SPTAN1 and somatic homozygous deletions in ANKDD1A?,cnv_and_ssm
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in SPTAN1 and somatic homozygous deletions in PCDHB2?,cnv_and_ssm
+164,SYT10,M484I,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases present with mutations in SYT10 and somatic homozygous deletions in MRPL55?,cnv_and_ssm
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in HSPA5 and somatic homozygous deletions in ACTB?,cnv_and_ssm
+175,UNC5D,L280V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in UNC5D and somatic homozygous deletions in TENM2?,cnv_and_ssm
+176,UNC5D,L635V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in UNC5D and somatic homozygous deletions in TLK2?,cnv_and_ssm
+177,UNC5D,L637V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in UNC5D and somatic homozygous deletions in CDC42BPA?,cnv_and_ssm
+178,UNC5D,L699V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in UNC5D and somatic homozygous deletions in ZFAT?,cnv_and_ssm
+179,UNC5D,L704V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in UNC5D and somatic homozygous deletions in DSCAM?,cnv_and_ssm
+180,UNC5D,L709V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in UNC5D and somatic homozygous deletions in MYH11?,cnv_and_ssm
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma cases present with mutations in DOCK2 and somatic homozygous deletions in COL6A3?,cnv_and_ssm
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma cases present with mutations in ZNF627 and somatic homozygous deletions in TNS1?,cnv_and_ssm
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in CDC42BPA and somatic homozygous deletions in COL6A3?,cnv_and_ssm
+193,MRPL55,H27Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in MRPL55 and somatic homozygous deletions in PAK3?,cnv_and_ssm
+194,MRPL55,H63Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in MRPL55 and somatic homozygous deletions in YY1AP1?,cnv_and_ssm
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases present with mutations in TMTC3 and somatic homozygous deletions in ZCCHC14?,cnv_and_ssm
+198,EPRS1,K771I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in EPRS1 and somatic homozygous deletions in FCGR2C?,cnv_and_ssm
+199,EPRS1,K778I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in EPRS1 and somatic homozygous deletions in TAF1C?,cnv_and_ssm
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in GRTP1 and somatic homozygous deletions in MORF4L1?,cnv_and_ssm
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in GRTP1 and somatic homozygous deletions in STAT3?,cnv_and_ssm
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in TSHZ3 and somatic homozygous deletions in SGIP1?,cnv_and_ssm
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What percentage of HIV+ Tumor Molecular Characterization Project - Cervical Cancer cases present with mutations in TAS1R3 and somatic homozygous deletions in SYT9?,cnv_and_ssm
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in PIAS3 and somatic homozygous deletions in FRY?,cnv_and_ssm
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in PIAS3 and somatic homozygous deletions in SGIP1?,cnv_and_ssm
+251,ZNF274,P13R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in ZNF274 and somatic homozygous deletions in MYO3B?,cnv_and_ssm
+253,SYNJ1,R795C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in SYNJ1 and somatic homozygous deletions in ZFAT?,cnv_and_ssm
+254,SYNJ1,R800C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in SYNJ1 and somatic homozygous deletions in SGIP1?,cnv_and_ssm
+255,SYNJ1,R839C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in SYNJ1 and somatic homozygous deletions in ANKDD1A?,cnv_and_ssm
+261,DSCAM,V343M,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases present with mutations in DSCAM and somatic homozygous deletions in DNAH11?,cnv_and_ssm
+262,DSCAM,V426M,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases present with mutations in DSCAM and somatic homozygous deletions in NCKAP5?,cnv_and_ssm
+263,DSCAM,V591M,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases present with mutations in DSCAM and somatic homozygous deletions in TAF1C?,cnv_and_ssm
+267,DGKD,R140H,Exceptional Responders,What percentage of Exceptional Responders cases present with mutations in DGKD and somatic homozygous deletions in FGF8?,cnv_and_ssm
+268,DGKD,R160H,Exceptional Responders,What percentage of Exceptional Responders cases present with mutations in DGKD and somatic homozygous deletions in TTN?,cnv_and_ssm
+269,DGKD,R204H,Exceptional Responders,What percentage of Exceptional Responders cases present with mutations in DGKD and somatic homozygous deletions in YY1AP1?,cnv_and_ssm
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases present with mutations in PLEKHG6 and somatic homozygous deletions in CYB5R2?,cnv_and_ssm
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases present with mutations in PLEKHG6 and somatic homozygous deletions in TAF1C?,cnv_and_ssm
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases present with mutations in PLEKHG6 and somatic homozygous deletions in ZNF708?,cnv_and_ssm
+279,WNT2,D138N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in WNT2 and somatic homozygous deletions in TMEM225?,cnv_and_ssm
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in GUCY2C and somatic homozygous deletions in TNS1?,cnv_and_ssm
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in C7orf31 and somatic homozygous deletions in SIK2?,cnv_and_ssm
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases present with mutations in ZKSCAN7 and somatic homozygous deletions in GABRA6?",cnv_and_ssm
+299,OR5D14,M210L,Neuroblastoma,What percentage of Neuroblastoma cases present with mutations in OR5D14 and somatic homozygous deletions in NRAP?,cnv_and_ssm
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in SPATA22 and somatic homozygous deletions in DHX16?,cnv_and_ssm
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in SPATA22 and somatic homozygous deletions in TRAP1?,cnv_and_ssm
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in SPATA22 and somatic homozygous deletions in NRAP?,cnv_and_ssm
+310,LCN15,E21V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in LCN15 and somatic homozygous deletions in SGIP1?,cnv_and_ssm
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in DCAF4L2 and somatic homozygous deletions in BFAR?,cnv_and_ssm
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in GUK1 and somatic homozygous deletions in CR1?,cnv_and_ssm
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in GUK1 and somatic homozygous deletions in SGIP1?,cnv_and_ssm
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in GUK1 and somatic homozygous deletions in DCLK3?,cnv_and_ssm
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in GUK1 and somatic homozygous deletions in TASOR2?,cnv_and_ssm
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in GUK1 and somatic homozygous deletions in TLK2?,cnv_and_ssm
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in MORF4L1 and somatic homozygous deletions in PHLPP1?,cnv_and_ssm
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in MORF4L1 and somatic homozygous deletions in C7orf31?,cnv_and_ssm
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in MORF4L1 and somatic homozygous deletions in CTNNA2?,cnv_and_ssm
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in MORF4L1 and somatic homozygous deletions in ZSCAN31?,cnv_and_ssm
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in MYO3B and somatic homozygous deletions in GPC3?,cnv_and_ssm
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in MYO3B and somatic homozygous deletions in ZCCHC14?,cnv_and_ssm
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in TENT5A and somatic homozygous deletions in CPS1?,cnv_and_ssm
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in TENT5A and somatic homozygous deletions in TENT5A?,cnv_and_ssm
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in TENT5A and somatic homozygous deletions in ZSCAN31?,cnv_and_ssm
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma cases present with mutations in ZFAT and somatic homozygous deletions in BFAR?,cnv_and_ssm
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma cases present with mutations in ZFAT and somatic homozygous deletions in ACTA2?,cnv_and_ssm
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma cases present with mutations in ZFAT and somatic homozygous deletions in AUTS2?,cnv_and_ssm
+357,ZNF584,A211T,Sarcoma,What percentage of Sarcoma cases present with mutations in ZNF584 and somatic homozygous deletions in DCLK3?,cnv_and_ssm
+358,ZNF584,A256T,Sarcoma,What percentage of Sarcoma cases present with mutations in ZNF584 and somatic homozygous deletions in MORF4L1?,cnv_and_ssm
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in LDOC1 and somatic homozygous deletions in DCN?,cnv_and_ssm
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in PDGFC and somatic homozygous deletions in CPS1?,cnv_and_ssm
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in MSANTD4 and somatic homozygous deletions in GSTCD?,cnv_and_ssm
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in NPSR1 and somatic homozygous deletions in DCLK3?,cnv_and_ssm
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in PHLPP1 and somatic homozygous deletions in PXN?,cnv_and_ssm
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in COL6A3 and somatic homozygous deletions in EPRS1?,cnv_and_ssm
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in COL6A3 and somatic homozygous deletions in CTNNA2?,cnv_and_ssm
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in COL6A3 and somatic homozygous deletions in YY1AP1?,cnv_and_ssm
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in COL6A3 and somatic homozygous deletions in MAD1L1?,cnv_and_ssm
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in COL6A3 and somatic homozygous deletions in PTPRN2?,cnv_and_ssm
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in ADRA1A and somatic homozygous deletions in FBXO42?,cnv_and_ssm
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases present with mutations in LAMB2 and somatic homozygous deletions in DOCK2?,cnv_and_ssm
+406,POC1B,I198T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases present with mutations in POC1B and somatic homozygous deletions in TASOR2?,cnv_and_ssm
+407,POC1B,I286T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases present with mutations in POC1B and somatic homozygous deletions in BCAT1?,cnv_and_ssm
+408,POC1B,I328T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases present with mutations in POC1B and somatic homozygous deletions in ITPRID2?,cnv_and_ssm
+409,POC1B,S79P,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases present with mutations in POC1B and somatic homozygous deletions in TTN?,cnv_and_ssm
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases present with mutations in USH2A and somatic homozygous deletions in GABRA6?,cnv_and_ssm
+414,AQP7,T110S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases present with mutations in AQP7 and somatic homozygous deletions in UNC5D?,cnv_and_ssm
+415,AQP7,T166S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases present with mutations in AQP7 and somatic homozygous deletions in TASOR2?,cnv_and_ssm
+416,AQP7,T167S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases present with mutations in AQP7 and somatic homozygous deletions in GABRA6?,cnv_and_ssm
+417,AQP7,T75S,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases present with mutations in AQP7 and somatic homozygous deletions in PIK3C2G?,cnv_and_ssm
+430,DCN,R163C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases present with mutations in DCN and somatic homozygous deletions in SGCZ?,cnv_and_ssm
+431,DCN,R203C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases present with mutations in DCN and somatic homozygous deletions in MORF4L1?,cnv_and_ssm
+432,DCN,R241C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases present with mutations in DCN and somatic homozygous deletions in SLC9C1?,cnv_and_ssm
+433,DCN,R350C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases present with mutations in DCN and somatic homozygous deletions in SPINDOC?,cnv_and_ssm
+434,DCN,R41C,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases present with mutations in DCN and somatic homozygous deletions in TYK2?,cnv_and_ssm
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in CPS1 and somatic homozygous deletions in ZCCHC14?,cnv_and_ssm
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in CPS1 and somatic homozygous deletions in ZMYM3?,cnv_and_ssm
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in CPS1 and somatic homozygous deletions in TMEM255A?,cnv_and_ssm
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases present with mutations in FCGR2C and somatic homozygous deletions in MERTK?,cnv_and_ssm
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases present with mutations in FCGR2C and somatic homozygous deletions in KIF20B?,cnv_and_ssm
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in GRM1 and somatic homozygous deletions in CTCFL?,cnv_and_ssm
+482,SGCZ,Q138H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in SGCZ and somatic homozygous deletions in FRY?,cnv_and_ssm
+483,SGCZ,Q91H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in SGCZ and somatic homozygous deletions in UNC5D?,cnv_and_ssm
+485,SMO,V15M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in SMO and somatic homozygous deletions in NRAP?,cnv_and_ssm
+486,SMO,V321M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in SMO and somatic homozygous deletions in MORF4L1?,cnv_and_ssm
+488,CHODL,G159E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in CHODL and somatic homozygous deletions in MAD1L1?,cnv_and_ssm
+489,CHODL,G181E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in CHODL and somatic homozygous deletions in DCLK3?,cnv_and_ssm
+490,CHODL,G200E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in CHODL and somatic homozygous deletions in SGIP1?,cnv_and_ssm
+494,MYO16,P399H,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in MYO16 and somatic homozygous deletions in TTC12?,cnv_and_ssm
+495,MYO16,P421H,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in MYO16 and somatic homozygous deletions in SIK2?,cnv_and_ssm
+498,CXCR2,A98V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in CXCR2 and somatic homozygous deletions in PAK3?,cnv_and_ssm
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases present with mutations in TMEM225 and somatic homozygous deletions in TTC12?,cnv_and_ssm
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in MAOB and somatic homozygous deletions in DNMT1?,cnv_and_ssm
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in GPRASP1 and somatic homozygous deletions in MRPL55?,cnv_and_ssm
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in MRPL32 and somatic homozygous deletions in CEP20?,cnv_and_ssm
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in TYROBP and somatic homozygous deletions in TAF1C?,cnv_and_ssm
+510,RAB40C,A111V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in RAB40C and somatic homozygous deletions in CPS1?,cnv_and_ssm
+511,RAB40C,A143V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in RAB40C and somatic homozygous deletions in ZBTB34?,cnv_and_ssm
+512,CTNNA2,S323R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in CTNNA2 and somatic homozygous deletions in JAML?,cnv_and_ssm
+513,CTNNA2,S339R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in CTNNA2 and somatic homozygous deletions in PSG2?,cnv_and_ssm
+514,CTNNA2,S386R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in CTNNA2 and somatic homozygous deletions in GIMAP2?,cnv_and_ssm
+515,CTNNA2,S707R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in CTNNA2 and somatic homozygous deletions in COL6A3?,cnv_and_ssm
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases present with mutations in MYO15A and somatic homozygous deletions in COL6A3?,cnv_and_ssm
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in GIMAP2 and somatic homozygous deletions in GABRA6?,cnv_and_ssm
+532,KIF20B,N1160D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases present with mutations in KIF20B and somatic homozygous deletions in SLC9C1?,cnv_and_ssm
+533,KIF20B,N1200D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases present with mutations in KIF20B and somatic homozygous deletions in CX3CR1?,cnv_and_ssm
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in ADAM17 and somatic homozygous deletions in DCC?,cnv_and_ssm
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in BCAT1 and somatic homozygous deletions in TLCD5?,cnv_and_ssm
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in BCAT1 and somatic homozygous deletions in KIF20B?,cnv_and_ssm
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in BCAT1 and somatic homozygous deletions in MIEF1?,cnv_and_ssm
+540,ERCC6,R1053H,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in ERCC6 and somatic homozygous deletions in GUK1?,cnv_and_ssm
+541,DCC,R320W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases present with mutations in DCC and somatic homozygous deletions in FGF8?,cnv_and_ssm
+542,DCC,R363W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases present with mutations in DCC and somatic homozygous deletions in RIPOR2?,cnv_and_ssm
+543,DCC,R386W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases present with mutations in DCC and somatic homozygous deletions in KDM5C?,cnv_and_ssm
+544,DCC,R41W,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases present with mutations in DCC and somatic homozygous deletions in DGKD?,cnv_and_ssm
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in FBXO15 and somatic homozygous deletions in SOX21?,cnv_and_ssm
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in FBXO15 and somatic homozygous deletions in FGF8?,cnv_and_ssm
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in GSTCD and somatic homozygous deletions in TENM3?,cnv_and_ssm
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in GSTCD and somatic homozygous deletions in POC1B?,cnv_and_ssm
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in OLFML3 and somatic homozygous deletions in TASOR2?,cnv_and_ssm
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in OLFML3 and somatic homozygous deletions in FGF8?,cnv_and_ssm
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in OLFML3 and somatic homozygous deletions in DHX16?,cnv_and_ssm
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma cases present with mutations in CFAP61 and somatic homozygous deletions in GUK1?,cnv_and_ssm
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What percentage of Ovarian Serous Cystadenocarcinoma cases present with mutations in CFAP61 and somatic homozygous deletions in ARHGEF40?,cnv_and_ssm
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases present with mutations in HLA-DQA2 and somatic homozygous deletions in PHLPP1?,cnv_and_ssm
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in TENM2 and somatic homozygous deletions in ZNF431?,cnv_and_ssm
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in TENM2 and somatic homozygous deletions in CARMIL1?,cnv_and_ssm
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in TENM2 and somatic homozygous deletions in FRY?,cnv_and_ssm
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in ANKRD24 and somatic homozygous deletions in OR2T4?,cnv_and_ssm
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in ANKRD24 and somatic homozygous deletions in TENM2?,cnv_and_ssm
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in ANKRD24 and somatic homozygous deletions in TASOR2?,cnv_and_ssm
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in ZCCHC14 and somatic homozygous deletions in TAF1C?,cnv_and_ssm
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in ZCCHC14 and somatic homozygous deletions in ANKDD1A?,cnv_and_ssm
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in ZCCHC14 and somatic homozygous deletions in REXO4?,cnv_and_ssm
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in ZCCHC14 and somatic homozygous deletions in ZFAT?,cnv_and_ssm
+625,SIK2,I265M,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in SIK2 and somatic homozygous deletions in CDKN2AIP?,cnv_and_ssm
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in MYH11 and somatic homozygous deletions in GABRA6?,cnv_and_ssm
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in MYH11 and somatic homozygous deletions in DSCAM?,cnv_and_ssm
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in SLC6A4 and somatic homozygous deletions in PIK3C2G?,cnv_and_ssm
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in SLC9C1 and somatic homozygous deletions in YY1AP1?,cnv_and_ssm
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in SLC9C1 and somatic homozygous deletions in PTPRO?,cnv_and_ssm
+644,OR2A12,A254T,Brain Lower Grade Glioma,What percentage of Brain Lower Grade Glioma cases present with mutations in OR2A12 and somatic homozygous deletions in GRM1?,cnv_and_ssm
+646,PYHIN1,T325K,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in PYHIN1 and somatic homozygous deletions in EFCAB12?,cnv_and_ssm
+647,PYHIN1,T334K,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in PYHIN1 and somatic homozygous deletions in GABRA6?,cnv_and_ssm
+650,JAML,G191E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in JAML and somatic homozygous deletions in PRSS1?,cnv_and_ssm
+651,JAML,G219E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in JAML and somatic homozygous deletions in ZNF627?,cnv_and_ssm
+652,JAML,G220E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in JAML and somatic homozygous deletions in ITPRID2?,cnv_and_ssm
+653,JAML,G230E,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in JAML and somatic homozygous deletions in DNAH11?,cnv_and_ssm
+658,TYK2,H1146R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in TYK2 and somatic homozygous deletions in EPRS1?,cnv_and_ssm
+659,TYK2,H23R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in TYK2 and somatic homozygous deletions in EVC2?,cnv_and_ssm
+660,TYK2,H961R,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in TYK2 and somatic homozygous deletions in PRSS1?,cnv_and_ssm
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in CTCFL and somatic homozygous deletions in TYK2?,cnv_and_ssm
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in CTCFL and somatic homozygous deletions in CYP1A2?,cnv_and_ssm
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in CTCFL and somatic homozygous deletions in TNS1?,cnv_and_ssm
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in CTCFL and somatic homozygous deletions in CHODL?,cnv_and_ssm
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in CEP20 and somatic homozygous deletions in UNC5D?,cnv_and_ssm
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in CEP20 and somatic homozygous deletions in GRTP1?,cnv_and_ssm
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in RIMS2 and somatic homozygous deletions in MAOB?,cnv_and_ssm
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in RIMS2 and somatic homozygous deletions in CFAP298-TCP10L?,cnv_and_ssm
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in RIMS2 and somatic homozygous deletions in RIMS2?,cnv_and_ssm
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in RIMS2 and somatic homozygous deletions in FBN1?,cnv_and_ssm
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in RIMS2 and somatic homozygous deletions in PHLPP1?,cnv_and_ssm
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in RIMS2 and somatic homozygous deletions in PAK3?,cnv_and_ssm
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in RIMS2 and somatic homozygous deletions in SYT9?,cnv_and_ssm
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in PIK3C2G and somatic homozygous deletions in C7orf31?,cnv_and_ssm
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in PIK3C2G and somatic homozygous deletions in BICC1?,cnv_and_ssm
+728,STK19,D341N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in STK19 and somatic homozygous deletions in OR8K5?,cnv_and_ssm
+729,STK19,D345N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in STK19 and somatic homozygous deletions in TASOR2?,cnv_and_ssm
+730,REXO4,P60A,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in REXO4 and somatic homozygous deletions in DSCAM?,cnv_and_ssm
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in ZBTB34 and somatic homozygous deletions in PLEKHG6?,cnv_and_ssm
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in ZBTB34 and somatic homozygous deletions in SGCZ?,cnv_and_ssm
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases present with mutations in NCKAP5 and somatic homozygous deletions in GUK1?,cnv_and_ssm
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases present with mutations in SORCS1 and somatic homozygous deletions in FGF8?",cnv_and_ssm
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases present with mutations in SORCS1 and somatic homozygous deletions in ACTB?",cnv_and_ssm
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases present with mutations in SORCS1 and somatic homozygous deletions in JAML?",cnv_and_ssm
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases present with mutations in SORCS1 and somatic homozygous deletions in TTC12?",cnv_and_ssm
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma cases present with mutations in FGF8 and somatic homozygous deletions in PAPPA?,cnv_and_ssm
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma cases present with mutations in FGF8 and somatic homozygous deletions in PYHIN1?,cnv_and_ssm
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma cases present with mutations in FGF8 and somatic homozygous deletions in PDGFC?,cnv_and_ssm
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma cases present with mutations in FGF8 and somatic homozygous deletions in CTNNA2?,cnv_and_ssm
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What percentage of Head and Neck Squamous Cell Carcinoma cases present with mutations in FGF8 and somatic homozygous deletions in ANP32E?,cnv_and_ssm
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What percentage of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia cases present with mutations in TENM3 and somatic homozygous deletions in COL6A3?,cnv_and_ssm
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in AKT1 and somatic homozygous deletions in COL6A3?,cnv_and_ssm
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases present with mutations in CFAP298-TCP10L and somatic homozygous deletions in SPATA22?,cnv_and_ssm
+792,GLRB,E148D,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in GLRB and somatic homozygous deletions in TMEM255A?,cnv_and_ssm
+793,TTN,F7636L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in TTN and somatic homozygous deletions in CHMP7?,cnv_and_ssm
+794,TTN,F8563L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in TTN and somatic homozygous deletions in PDHA2?,cnv_and_ssm
+795,TTN,F8880L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in TTN and somatic homozygous deletions in PGR?,cnv_and_ssm
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in ANKRD30A and somatic homozygous deletions in CPA6?,cnv_and_ssm
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in ANKRD30A and somatic homozygous deletions in PDGFC?,cnv_and_ssm
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in ANKRD30A and somatic homozygous deletions in GRM5?,cnv_and_ssm
+809,TRIM45,S177L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in TRIM45 and somatic homozygous deletions in DCN?,cnv_and_ssm
+810,TRIM45,S224L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in TRIM45 and somatic homozygous deletions in SGIP1?,cnv_and_ssm
+811,TRIM45,S281L,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in TRIM45 and somatic homozygous deletions in EPRS1?,cnv_and_ssm
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in CACNA1F and somatic homozygous deletions in DCC?,cnv_and_ssm
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in CACNA1F and somatic homozygous deletions in GUK1?,cnv_and_ssm
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in CACNA1F and somatic homozygous deletions in COL6A3?,cnv_and_ssm
+817,KL,R594C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in KL and somatic homozygous deletions in ZNF217?,cnv_and_ssm
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What percentage of Kidney Renal Papillary Cell Carcinoma cases present with mutations in GUF1 and somatic homozygous deletions in MYH11?,cnv_and_ssm
+822,TAF1L,A539V,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in TAF1L and somatic homozygous deletions in C7orf31?,cnv_and_ssm
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in TASOR2 and somatic homozygous deletions in GABRA6?,cnv_and_ssm
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in TASOR2 and somatic homozygous deletions in TTYH2?,cnv_and_ssm
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in TASOR2 and somatic homozygous deletions in RAB40C?,cnv_and_ssm
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in KDM5C and somatic homozygous deletions in PSG2?,cnv_and_ssm
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in KDM5C and somatic homozygous deletions in NPSR1?,cnv_and_ssm
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in KDM5C and somatic homozygous deletions in YY1AP1?,cnv_and_ssm
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in KDM5C and somatic homozygous deletions in TRIM45?,cnv_and_ssm
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases present with mutations in IL5RA and somatic homozygous deletions in ZNF584?,cnv_and_ssm
+843,DHX16,A29V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in DHX16 and somatic homozygous deletions in THBS4?,cnv_and_ssm
+844,DHX16,A89V,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in DHX16 and somatic homozygous deletions in TLK2?,cnv_and_ssm
+902,GPR158,A644V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in GPR158 and somatic homozygous deletions in CFAP61?,cnv_and_ssm
+903,GPR158,A723V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in GPR158 and somatic homozygous deletions in CXCR2?,cnv_and_ssm
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases present with mutations in EIF2B4 and somatic homozygous deletions in ACTB?",cnv_and_ssm
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases present with mutations in EIF2B4 and somatic homozygous deletions in MYO16?",cnv_and_ssm
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases present with mutations in EIF2B4 and somatic homozygous deletions in ZFAT?",cnv_and_ssm
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases present with mutations in EIF2B4 and somatic homozygous deletions in RAB40C?",cnv_and_ssm
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases present with mutations in EIF2B4 and somatic homozygous deletions in ANP32E?",cnv_and_ssm
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases present with mutations in EIF2B4 and somatic homozygous deletions in CCNG1?",cnv_and_ssm
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in AUTS2 and somatic homozygous deletions in ITPRID2?,cnv_and_ssm
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in AUTS2 and somatic homozygous deletions in TMEM225?,cnv_and_ssm
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in AUTS2 and somatic homozygous deletions in PHLPP1?,cnv_and_ssm
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in AUTS2 and somatic homozygous deletions in TRIM45?,cnv_and_ssm
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in AUTS2 and somatic homozygous deletions in FNDC7?,cnv_and_ssm
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in AUTS2 and somatic homozygous deletions in AUTS2?,cnv_and_ssm
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in AUTS2 and somatic homozygous deletions in PCDHB2?,cnv_and_ssm
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in AUTS2 and somatic homozygous deletions in POLD1?,cnv_and_ssm
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in AUTS2 and somatic homozygous deletions in GRTP1?,cnv_and_ssm
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in AUTS2 and somatic homozygous deletions in PRSS1?,cnv_and_ssm
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases present with mutations in ACTL7B and somatic homozygous deletions in ZMYM3?",cnv_and_ssm
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases present with mutations in PCDHGA1 and somatic homozygous deletions in TENM2?,cnv_and_ssm
+954,TRAP1,R114W,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in TRAP1 and somatic homozygous deletions in SYNJ1?,cnv_and_ssm
+955,TRAP1,R61W,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in TRAP1 and somatic homozygous deletions in AUTS2?,cnv_and_ssm
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in PIK3C2A and somatic homozygous deletions in RIPOR2?,cnv_and_ssm
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases present with mutations in KANSL1 and somatic homozygous deletions in GPC3?,cnv_and_ssm
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in ANKRD52 and somatic homozygous deletions in TMEM255A?,cnv_and_ssm
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in PAPPA and somatic homozygous deletions in CTSC?,cnv_and_ssm
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases present with mutations in B3GALNT1 and somatic homozygous deletions in ACTB?,cnv_and_ssm
+982,GABRA6,G115R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in GABRA6 and somatic homozygous deletions in ARMC3?,cnv_and_ssm
+983,GABRA6,G122R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in GABRA6 and somatic homozygous deletions in MERTK?,cnv_and_ssm
+984,GABRA6,G165R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in GABRA6 and somatic homozygous deletions in RAB40C?,cnv_and_ssm
+985,GABRA6,G175R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in GABRA6 and somatic homozygous deletions in DSCAM?,cnv_and_ssm
+986,GABRA6,G70R,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in GABRA6 and somatic homozygous deletions in GIMAP2?,cnv_and_ssm
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in ZSCAN31 and somatic homozygous deletions in PAPPA?,cnv_and_ssm
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases present with mutations in MED16 and somatic homozygous deletions in DCN?",cnv_and_ssm
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases present with mutations in MED16 and somatic homozygous deletions in GUCY2C?",cnv_and_ssm
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases present with mutations in PTPRO and somatic homozygous deletions in ACVR1B?,cnv_and_ssm
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases present with mutations in PTPRO and somatic homozygous deletions in MAST4?,cnv_and_ssm
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases present with mutations in PTPRO and somatic homozygous deletions in DPF3?,cnv_and_ssm
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases present with mutations in PTPRO and somatic homozygous deletions in MAST4?,cnv_and_ssm
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases present with mutations in PTPRO and somatic homozygous deletions in KANSL1?,cnv_and_ssm
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases present with mutations in PTPRO and somatic homozygous deletions in POLR1G?,cnv_and_ssm
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases present with mutations in PTPRO and somatic homozygous deletions in PRSS1?,cnv_and_ssm
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What percentage of Pancreatic Adenocarcinoma cases present with mutations in PTPRO and somatic homozygous deletions in FBXO15?,cnv_and_ssm
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in CHMP7 and somatic homozygous deletions in ACTL7B?,cnv_and_ssm
+1017,GPC3,I107N,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in GPC3 and somatic homozygous deletions in ACVR1B?,cnv_and_ssm
+1018,GPC3,I161N,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in GPC3 and somatic homozygous deletions in TMEM255A?,cnv_and_ssm
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases present with mutations in TLK2 and somatic homozygous deletions in MSANTD4?,cnv_and_ssm
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases present with mutations in TLK2 and somatic homozygous deletions in UNC5D?,cnv_and_ssm
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases present with mutations in TLK2 and somatic homozygous deletions in FGF8?,cnv_and_ssm
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases present with mutations in TLK2 and somatic homozygous deletions in MED16?,cnv_and_ssm
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What percentage of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases present with mutations in TLK2 and somatic homozygous deletions in TNS1?,cnv_and_ssm
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in ZNF217 and somatic homozygous deletions in AQP7?,cnv_and_ssm
+1038,SYT9,V275L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in SYT9 and somatic homozygous deletions in DNMT1?,cnv_and_ssm
+1039,SYT9,V307L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in SYT9 and somatic homozygous deletions in AUTS2?,cnv_and_ssm
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in PKHD1L1 and somatic homozygous deletions in DSCAM?,cnv_and_ssm
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in MYO3A and somatic homozygous deletions in NRAP?,cnv_and_ssm
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases present with mutations in VASN and somatic homozygous deletions in TTC17?",cnv_and_ssm
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in DNMT1 and somatic homozygous deletions in ZFPM2?,cnv_and_ssm
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in DNMT1 and somatic homozygous deletions in ACVR1B?,cnv_and_ssm
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in DNMT1 and somatic homozygous deletions in CTNNA2?,cnv_and_ssm
+1056,CA9,E402K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in CA9 and somatic homozygous deletions in GSTCD?,cnv_and_ssm
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in TTC17 and somatic homozygous deletions in NPSR1?,cnv_and_ssm
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in TTC17 and somatic homozygous deletions in ZFPM2?,cnv_and_ssm
+1065,PSG2,P43L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases present with mutations in PSG2 and somatic homozygous deletions in MYO16?,cnv_and_ssm
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases present with mutations in RIPOR2 and somatic homozygous deletions in THBS4?,cnv_and_ssm
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases present with mutations in RIPOR2 and somatic homozygous deletions in DCAF4L2?,cnv_and_ssm
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases present with mutations in RIPOR2 and somatic homozygous deletions in VASN?,cnv_and_ssm
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases present with mutations in RIPOR2 and somatic homozygous deletions in TRIM45?,cnv_and_ssm
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in DCLK3 and somatic homozygous deletions in CNGB1?,cnv_and_ssm
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in DCLK3 and somatic homozygous deletions in PTPRN2?,cnv_and_ssm
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in MERTK and somatic homozygous deletions in PIK3C2G?,cnv_and_ssm
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in MERTK and somatic homozygous deletions in LDOC1?,cnv_and_ssm
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in MERTK and somatic homozygous deletions in GLRB?,cnv_and_ssm
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in ZFP42 and somatic homozygous deletions in CPS1?,cnv_and_ssm
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in OR13C3 and somatic homozygous deletions in YY1AP1?,cnv_and_ssm
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in OR13C3 and somatic homozygous deletions in MORF4L1?,cnv_and_ssm
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in SPAG1 and somatic homozygous deletions in SORCS1?,cnv_and_ssm
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in CDKN2AIP and somatic homozygous deletions in RIMS2?,cnv_and_ssm
+1093,PXN,H1016Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in PXN and somatic homozygous deletions in ZNF431?,cnv_and_ssm
+1094,PXN,H359Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in PXN and somatic homozygous deletions in PAK3?,cnv_and_ssm
+1095,PXN,H492Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in PXN and somatic homozygous deletions in VPS26B?,cnv_and_ssm
+1096,PXN,H524Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in PXN and somatic homozygous deletions in TTYH2?,cnv_and_ssm
+1097,PXN,H526Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in PXN and somatic homozygous deletions in CPS1?,cnv_and_ssm
+1098,PXN,H540Y,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in PXN and somatic homozygous deletions in DCLK3?,cnv_and_ssm
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in TTYH2 and somatic homozygous deletions in PAK3?,cnv_and_ssm
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in TTYH2 and somatic homozygous deletions in GUK1?,cnv_and_ssm
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in TMEM255A and somatic homozygous deletions in OR2T4?,cnv_and_ssm
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in TMEM255A and somatic homozygous deletions in ANKDD1A?,cnv_and_ssm
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in TMEM255A and somatic homozygous deletions in NRAP?,cnv_and_ssm
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases present with mutations in TASOR2 and somatic homozygous deletions in PTPRN2?,cnv_and_ssm
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases present with mutations in TASOR2 and somatic homozygous deletions in GABRA6?,cnv_and_ssm
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in ICE1 and somatic homozygous deletions in GPC3?,cnv_and_ssm
+1112,MYT1,A558E,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases present with mutations in MYT1 and somatic homozygous deletions in PXN?,cnv_and_ssm
+1113,MYT1,A879E,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases present with mutations in MYT1 and somatic homozygous deletions in ACTL7B?,cnv_and_ssm
+1114,MYT1,A906E,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases present with mutations in MYT1 and somatic homozygous deletions in CTNNA2?,cnv_and_ssm
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in CX3CR1 and somatic homozygous deletions in ZNF274?,cnv_and_ssm
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in CX3CR1 and somatic homozygous deletions in ANP32E?,cnv_and_ssm
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases present with mutations in SPINDOC and somatic homozygous deletions in MRPL55?,cnv_and_ssm
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in ART3 and somatic homozygous deletions in FGF8?,cnv_and_ssm
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in ART3 and somatic homozygous deletions in CTNNA2?,cnv_and_ssm
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases present with mutations in CYP1A2 and somatic homozygous deletions in NEXN?,cnv_and_ssm
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases present with mutations in ADRA1A and somatic homozygous deletions in TYROBP?",cnv_and_ssm
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in CDH23 and somatic homozygous deletions in MYH11?,cnv_and_ssm
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in CDH23 and somatic homozygous deletions in CARMIL1?,cnv_and_ssm
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in KRT39 and somatic homozygous deletions in ANKRD30A?,cnv_and_ssm
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in PDHA2 and somatic homozygous deletions in SLC6A4?,cnv_and_ssm
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in SLC24A2 and somatic homozygous deletions in PTPRO?,cnv_and_ssm
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases present with mutations in PTPRN2 and somatic homozygous deletions in GABRA6?,cnv_and_ssm
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases present with mutations in PTPRN2 and somatic homozygous deletions in COL6A3?,cnv_and_ssm
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases present with mutations in PTPRN2 and somatic homozygous deletions in AUTS2?,cnv_and_ssm
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases present with mutations in PTPRN2 and somatic homozygous deletions in DSCAM?,cnv_and_ssm
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What percentage of Liver Hepatocellular Carcinoma cases present with mutations in PTPRN2 and somatic homozygous deletions in ANKRD30A?,cnv_and_ssm
+1188,SOX21,R55L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in SOX21 and somatic homozygous deletions in EPRS1?,cnv_and_ssm
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases present with mutations in CPA6 and somatic homozygous deletions in ABCC3?,cnv_and_ssm
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in GRM5 and somatic homozygous deletions in ZFAT?,cnv_and_ssm
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases present with mutations in CASZ1 and somatic homozygous deletions in FBN1?",cnv_and_ssm
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in SGIP1 and somatic homozygous deletions in DPF3?,cnv_and_ssm
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in SGIP1 and somatic homozygous deletions in MIEF1?,cnv_and_ssm
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in SGIP1 and somatic homozygous deletions in CEP20?,cnv_and_ssm
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in SGIP1 and somatic homozygous deletions in TLK2?,cnv_and_ssm
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in CARMIL1 and somatic homozygous deletions in CFAP61?,cnv_and_ssm
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in CARMIL1 and somatic homozygous deletions in ADAM17?,cnv_and_ssm
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in ZNF431 and somatic homozygous deletions in DPF3?,cnv_and_ssm
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in ZNF431 and somatic homozygous deletions in ZFAT?,cnv_and_ssm
+1234,ZNF431,R128I,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in ZNF431 and somatic homozygous deletions in PXN?,cnv_and_ssm
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in DNAH11 and somatic homozygous deletions in TENM2?,cnv_and_ssm
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in DNAH11 and somatic homozygous deletions in TAF1C?,cnv_and_ssm
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in POLD1 and somatic homozygous deletions in NEXN?,cnv_and_ssm
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What percentage of Lung Squamous Cell Carcinoma cases present with mutations in POLD1 and somatic homozygous deletions in MORF4L1?,cnv_and_ssm
+1248,TTC12,D646H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in TTC12 and somatic homozygous deletions in TRPA1?,cnv_and_ssm
+1249,TTC12,D652H,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in TTC12 and somatic homozygous deletions in CTCFL?,cnv_and_ssm
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases present with mutations in CNGB1 and somatic homozygous deletions in TYK2?,cnv_and_ssm
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What percentage of Bladder Urothelial Carcinoma cases present with mutations in CNGB1 and somatic homozygous deletions in CTCFL?,cnv_and_ssm
+1254,CTSC,E214V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in CTSC and somatic homozygous deletions in STAT3?,cnv_and_ssm
+1255,CTSC,E291V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in CTSC and somatic homozygous deletions in BCAT1?,cnv_and_ssm
+1256,CTSC,E322V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in CTSC and somatic homozygous deletions in KDM5C?,cnv_and_ssm
+1257,CTSC,E324V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in CTSC and somatic homozygous deletions in KANSL1?,cnv_and_ssm
+1258,CTSC,E335V,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in CTSC and somatic homozygous deletions in TYK2?,cnv_and_ssm
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in PRSS8 and somatic homozygous deletions in TRPA1?,cnv_and_ssm
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in PRSS8 and somatic homozygous deletions in POLR1G?,cnv_and_ssm
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in ARHGEF40 and somatic homozygous deletions in ANP32E?,cnv_and_ssm
+1264,ACTB,A138T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases present with mutations in ACTB and somatic homozygous deletions in USH2A?,cnv_and_ssm
+1265,ACTB,A217T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases present with mutations in ACTB and somatic homozygous deletions in AUTS2?,cnv_and_ssm
+1266,ACTB,A244T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases present with mutations in ACTB and somatic homozygous deletions in CACNA1F?,cnv_and_ssm
+1267,ACTB,A260T,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases present with mutations in ACTB and somatic homozygous deletions in NPSR1?,cnv_and_ssm
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases present with mutations in YY1AP1 and somatic homozygous deletions in COL6A3?,cnv_and_ssm
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases present with mutations in YY1AP1 and somatic homozygous deletions in GPRASP1?,cnv_and_ssm
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases present with mutations in YY1AP1 and somatic homozygous deletions in ZNF274?,cnv_and_ssm
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases present with mutations in YY1AP1 and somatic homozygous deletions in KANSL1?,cnv_and_ssm
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases present with mutations in YY1AP1 and somatic homozygous deletions in HTR3B?,cnv_and_ssm
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases present with mutations in YY1AP1 and somatic homozygous deletions in SGIP1?,cnv_and_ssm
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What percentage of Glioblastoma Multiforme cases present with mutations in YY1AP1 and somatic homozygous deletions in RIPOR2?,cnv_and_ssm
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in FNDC7 and somatic homozygous deletions in POC1B?,cnv_and_ssm
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in FNDC7 and somatic homozygous deletions in PIK3C2G?,cnv_and_ssm
+1299,TLCD5,G15V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in TLCD5 and somatic homozygous deletions in CTSC?,cnv_and_ssm
+1300,TLCD5,G37V,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in TLCD5 and somatic homozygous deletions in BICC1?,cnv_and_ssm
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in POLR1G and somatic homozygous deletions in ITPRID2?,cnv_and_ssm
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in POLR1G and somatic homozygous deletions in TMEM255A?,cnv_and_ssm
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in DNAH14 and somatic homozygous deletions in DCLK3?,cnv_and_ssm
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in DNAH14 and somatic homozygous deletions in SYT9?,cnv_and_ssm
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in DNAH14 and somatic homozygous deletions in PHLPP1?,cnv_and_ssm
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in NEXN and somatic homozygous deletions in CTNNA2?,cnv_and_ssm
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases present with mutations in CYB5R2 and somatic homozygous deletions in FBXO42?,cnv_and_ssm
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What percentage of Prostate Adenocarcinoma cases present with mutations in CYB5R2 and somatic homozygous deletions in UNC5D?,cnv_and_ssm
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in NRAP and somatic homozygous deletions in PRSS1?,cnv_and_ssm
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in NRAP and somatic homozygous deletions in YY1AP1?,cnv_and_ssm
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in NRAP and somatic homozygous deletions in HTR3B?,cnv_and_ssm
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in CCDC22 and somatic homozygous deletions in TMTC3?,cnv_and_ssm
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in DCAF6 and somatic homozygous deletions in CARMIL1?,cnv_and_ssm
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in DCAF6 and somatic homozygous deletions in BCAT1?,cnv_and_ssm
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in ZNF708 and somatic homozygous deletions in CACNA1F?,cnv_and_ssm
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in BFAR and somatic homozygous deletions in STK19?,cnv_and_ssm
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in MAST4 and somatic homozygous deletions in TET2?,cnv_and_ssm
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in MAST4 and somatic homozygous deletions in GUF1?,cnv_and_ssm
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in MAST4 and somatic homozygous deletions in CR1?,cnv_and_ssm
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in MAST4 and somatic homozygous deletions in PIK3C2G?,cnv_and_ssm
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in MAST4 and somatic homozygous deletions in DHX16?,cnv_and_ssm
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in ARMC3 and somatic homozygous deletions in RIPOR2?,cnv_and_ssm
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in ARMC3 and somatic homozygous deletions in TRIM45?,cnv_and_ssm
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma cases present with mutations in TET2 and somatic homozygous deletions in ZBTB34?,cnv_and_ssm
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What percentage of Kidney Renal Clear Cell Carcinoma cases present with mutations in TET2 and somatic homozygous deletions in DGKD?,cnv_and_ssm
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in SERPINB10 and somatic homozygous deletions in CDH23?,cnv_and_ssm
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in STAT3 and somatic homozygous deletions in CCDC22?,cnv_and_ssm
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in MIEF1 and somatic homozygous deletions in DCC?,cnv_and_ssm
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in ACVR1B and somatic homozygous deletions in GABRA6?,cnv_and_ssm
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in ACVR1B and somatic homozygous deletions in CHODL?,cnv_and_ssm
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in ACVR1B and somatic homozygous deletions in ADRA1A?,cnv_and_ssm
+1393,EBF2,T104I,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in EBF2 and somatic homozygous deletions in JAML?,cnv_and_ssm
+1394,EBF2,T252I,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in EBF2 and somatic homozygous deletions in EPRS1?,cnv_and_ssm
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in VPS26B and somatic homozygous deletions in SLC24A2?,cnv_and_ssm
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases present with mutations in PGR and somatic homozygous deletions in DNMT1?",cnv_and_ssm
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases present with mutations in PGR and somatic homozygous deletions in TTYH2?",cnv_and_ssm
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What percentage of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases present with mutations in PGR and somatic homozygous deletions in MRPL55?",cnv_and_ssm
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What percentage of Skin Cutaneous Melanoma cases present with mutations in ACTA2 and somatic homozygous deletions in PTPRN2?,cnv_and_ssm
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in THBS4 and somatic homozygous deletions in TAF1L?,cnv_and_ssm
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in THBS4 and somatic homozygous deletions in PAK3?,cnv_and_ssm
+1413,PRSS1,S114T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in PRSS1 and somatic homozygous deletions in ANKDD1A?,cnv_and_ssm
+1414,PRSS1,S124T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in PRSS1 and somatic homozygous deletions in AUTS2?,cnv_and_ssm
+1415,PRSS1,S138T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in PRSS1 and somatic homozygous deletions in MERTK?,cnv_and_ssm
+1416,PRSS1,S74T,Lung Adenocarcinoma,What percentage of Lung Adenocarcinoma cases present with mutations in PRSS1 and somatic homozygous deletions in PXN?,cnv_and_ssm
+1417,PGF,R126H,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in PGF and somatic homozygous deletions in GPR158?,cnv_and_ssm
+1418,PGF,R127H,Stomach Adenocarcinoma,What percentage of Stomach Adenocarcinoma cases present with mutations in PGF and somatic homozygous deletions in GABRA6?,cnv_and_ssm
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases present with mutations in ITPRID2 and somatic homozygous deletions in ZCCHC14?,cnv_and_ssm
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What percentage of Breast Invasive Carcinoma cases present with mutations in ITPRID2 and somatic homozygous deletions in BCAT1?,cnv_and_ssm
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in HBB and somatic homozygous deletions in OR2T4?,cnv_and_ssm
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in PCDHB2 and somatic homozygous deletions in MYO3B?,cnv_and_ssm
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in PCDHB2 and somatic homozygous deletions in ANP32E?,cnv_and_ssm
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What percentage of Colon Adenocarcinoma cases present with mutations in PCDHB2 and somatic homozygous deletions in CA9?,cnv_and_ssm
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What percentage of Uterine Corpus Endometrial Carcinoma cases present with mutations in UBR2 and somatic homozygous deletions in SGIP1?,cnv_and_ssm
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What percentage of Rectum Adenocarcinoma cases present with mutations in FBXO42 and somatic homozygous deletions in YY1AP1?,cnv_and_ssm
+1,TNS1,G1362V,Breast Invasive Carcinoma,To what extent do Breast Invasive Carcinoma cases show somatic mutations in TNS1 along with somatic amplifications in MAST4?,cnv_and_ssm
+2,TNS1,G1711V,Breast Invasive Carcinoma,To what extent do Breast Invasive Carcinoma cases show somatic mutations in TNS1 along with somatic amplifications in SYT10?,cnv_and_ssm
+3,TNS1,G1718V,Breast Invasive Carcinoma,To what extent do Breast Invasive Carcinoma cases show somatic mutations in TNS1 along with somatic amplifications in AUTS2?,cnv_and_ssm
+4,TNS1,G1732V,Breast Invasive Carcinoma,To what extent do Breast Invasive Carcinoma cases show somatic mutations in TNS1 along with somatic amplifications in PYHIN1?,cnv_and_ssm
+5,TNS1,G1824V,Breast Invasive Carcinoma,To what extent do Breast Invasive Carcinoma cases show somatic mutations in TNS1 along with somatic amplifications in HTR3B?,cnv_and_ssm
+6,TNS1,G1857V,Breast Invasive Carcinoma,To what extent do Breast Invasive Carcinoma cases show somatic mutations in TNS1 along with somatic amplifications in ARHGEF40?,cnv_and_ssm
+7,TNS1,G843V,Breast Invasive Carcinoma,To what extent do Breast Invasive Carcinoma cases show somatic mutations in TNS1 along with somatic amplifications in SPATA22?,cnv_and_ssm
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,To what extent do Bladder Urothelial Carcinoma cases show somatic mutations in EVC2 along with somatic amplifications in PTPRO?,cnv_and_ssm
+15,EVC2,E987K,Bladder Urothelial Carcinoma,To what extent do Bladder Urothelial Carcinoma cases show somatic mutations in EVC2 along with somatic amplifications in CEP20?,cnv_and_ssm
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in CR1 along with somatic amplifications in TMEM255A?,cnv_and_ssm
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in CR1 along with somatic amplifications in RIPOR2?,cnv_and_ssm
+22,TRPA1,S295I,Rectum Adenocarcinoma,To what extent do Rectum Adenocarcinoma cases show somatic mutations in TRPA1 along with somatic amplifications in CNGB1?,cnv_and_ssm
+23,TRPA1,S443I,Rectum Adenocarcinoma,To what extent do Rectum Adenocarcinoma cases show somatic mutations in TRPA1 along with somatic amplifications in PGR?,cnv_and_ssm
+24,TAF1C,R299L,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in TAF1C along with somatic amplifications in PAK3?,cnv_and_ssm
+25,TAF1C,R396L,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in TAF1C along with somatic amplifications in CHODL?,cnv_and_ssm
+26,TAF1C,R634L,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in TAF1C along with somatic amplifications in MAST4?,cnv_and_ssm
+27,TAF1C,R702L,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in TAF1C along with somatic amplifications in DNAH11?,cnv_and_ssm
+28,TAF1C,R728L,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in TAF1C along with somatic amplifications in PTPRO?,cnv_and_ssm
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in DPF3 along with somatic amplifications in ZMYM3?,cnv_and_ssm
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in DPF3 along with somatic amplifications in SPTAN1?,cnv_and_ssm
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in DPF3 along with somatic amplifications in MAOB?,cnv_and_ssm
+42,OR2T4,P272H,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in OR2T4 along with somatic amplifications in RIMS2?,cnv_and_ssm
+43,OR2T4,P300H,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in OR2T4 along with somatic amplifications in CTNNA2?,cnv_and_ssm
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,To what extent do Pancreatic Adenocarcinoma cases show somatic mutations in FBN1 along with somatic amplifications in CNGB1?,cnv_and_ssm
+45,MAD1L1,E396K,Prostate Adenocarcinoma,To what extent do Prostate Adenocarcinoma cases show somatic mutations in MAD1L1 along with somatic amplifications in UBR2?,cnv_and_ssm
+46,MAD1L1,E488K,Prostate Adenocarcinoma,To what extent do Prostate Adenocarcinoma cases show somatic mutations in MAD1L1 along with somatic amplifications in DEFB115?,cnv_and_ssm
+47,MAD1L1,E78K,Prostate Adenocarcinoma,To what extent do Prostate Adenocarcinoma cases show somatic mutations in MAD1L1 along with somatic amplifications in MAD1L1?,cnv_and_ssm
+61,CCNG1,E22K,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in CCNG1 along with somatic amplifications in SGIP1?,cnv_and_ssm
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,To what extent do Kidney Renal Papillary Cell Carcinoma cases show somatic mutations in ANP32E along with somatic amplifications in TNS1?,cnv_and_ssm
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,To what extent do Kidney Renal Papillary Cell Carcinoma cases show somatic mutations in ANP32E along with somatic amplifications in TRPA1?,cnv_and_ssm
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,To what extent do Kidney Renal Papillary Cell Carcinoma cases show somatic mutations in ANP32E along with somatic amplifications in PTPRO?,cnv_and_ssm
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,To what extent do Kidney Renal Papillary Cell Carcinoma cases show somatic mutations in ANP32E along with somatic amplifications in AUTS2?,cnv_and_ssm
+66,FRY,S1888A,Bladder Urothelial Carcinoma,To what extent do Bladder Urothelial Carcinoma cases show somatic mutations in FRY along with somatic amplifications in TTYH2?,cnv_and_ssm
+67,FRY,S1937A,Bladder Urothelial Carcinoma,To what extent do Bladder Urothelial Carcinoma cases show somatic mutations in FRY along with somatic amplifications in ACTB?,cnv_and_ssm
+68,FRY,S1938A,Bladder Urothelial Carcinoma,To what extent do Bladder Urothelial Carcinoma cases show somatic mutations in FRY along with somatic amplifications in ART3?,cnv_and_ssm
+69,FRY,S1983A,Bladder Urothelial Carcinoma,To what extent do Bladder Urothelial Carcinoma cases show somatic mutations in FRY along with somatic amplifications in MYT1?,cnv_and_ssm
+70,PAK3,E318K,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in PAK3 along with somatic amplifications in B3GALNT1?,cnv_and_ssm
+71,PAK3,E319K,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in PAK3 along with somatic amplifications in SMO?,cnv_and_ssm
+72,PAK3,E334K,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in PAK3 along with somatic amplifications in ART3?,cnv_and_ssm
+73,PAK3,E340K,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in PAK3 along with somatic amplifications in GABRA6?,cnv_and_ssm
+74,PAK3,E355K,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in PAK3 along with somatic amplifications in CX3CR1?,cnv_and_ssm
+80,MUC16,P7963L,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in MUC16 along with somatic amplifications in AUTS2?,cnv_and_ssm
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,To what extent do Liver Hepatocellular Carcinoma cases show somatic mutations in ZFPM2 along with somatic amplifications in KDM5C?,cnv_and_ssm
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,To what extent do Liver Hepatocellular Carcinoma cases show somatic mutations in ZFPM2 along with somatic amplifications in AQP7?,cnv_and_ssm
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,To what extent do Breast Invasive Carcinoma cases show somatic mutations in PIK3C2B along with somatic amplifications in CPS1?,cnv_and_ssm
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,To what extent do Breast Invasive Carcinoma cases show somatic mutations in PIK3C2B along with somatic amplifications in EIF2B4?,cnv_and_ssm
+114,ZNF804A,S371Y,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in ZNF804A along with somatic amplifications in AQP7?,cnv_and_ssm
+116,RELN,A2371V,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in RELN along with somatic amplifications in CTSC?,cnv_and_ssm
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","To what extent do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases show somatic mutations in EFCAB12 along with somatic amplifications in BCAT1?",cnv_and_ssm
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","To what extent do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases show somatic mutations in EFCAB12 along with somatic amplifications in ZCCHC14?",cnv_and_ssm
+120,DEFB115,E53K,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in DEFB115 along with somatic amplifications in ANKDD1A?,cnv_and_ssm
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,To what extent do Bladder Urothelial Carcinoma cases show somatic mutations in ANKDD1A along with somatic amplifications in JAML?,cnv_and_ssm
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,To what extent do Bladder Urothelial Carcinoma cases show somatic mutations in ANKDD1A along with somatic amplifications in RIMS2?,cnv_and_ssm
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,To what extent do Bladder Urothelial Carcinoma cases show somatic mutations in ANKDD1A along with somatic amplifications in GABRA6?,cnv_and_ssm
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in HTR3B along with somatic amplifications in GRTP1?,cnv_and_ssm
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in HTR3B along with somatic amplifications in PTPRN2?,cnv_and_ssm
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in HTR3B along with somatic amplifications in ZCCHC14?,cnv_and_ssm
+129,ABCC3,R758W,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in ABCC3 along with somatic amplifications in MAST4?,cnv_and_ssm
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in NOMO1 along with somatic amplifications in DNAH11?,cnv_and_ssm
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in NOMO1 along with somatic amplifications in TENT5A?,cnv_and_ssm
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,To what extent do Bladder Urothelial Carcinoma cases show somatic mutations in HYOU1 along with somatic amplifications in MAST4?,cnv_and_ssm
+139,FMO4,R500Q,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in FMO4 along with somatic amplifications in ABCC3?,cnv_and_ssm
+140,BICC1,A372V,Exceptional Responders,To what extent do Exceptional Responders cases show somatic mutations in BICC1 along with somatic amplifications in OR2A12?,cnv_and_ssm
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in ZMYM3 along with somatic amplifications in ZFAT?,cnv_and_ssm
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in ZMYM3 along with somatic amplifications in ICE1?,cnv_and_ssm
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in ZMYM3 along with somatic amplifications in ANKRD24?,cnv_and_ssm
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","To what extent do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases show somatic mutations in XKR4 along with somatic amplifications in ADAM17?",cnv_and_ssm
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,To what extent do Liver Hepatocellular Carcinoma cases show somatic mutations in ABCC2 along with somatic amplifications in ACTB?,cnv_and_ssm
+157,OR8K5,R293G,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in OR8K5 along with somatic amplifications in YY1AP1?,cnv_and_ssm
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in SPTAN1 along with somatic amplifications in SGIP1?,cnv_and_ssm
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in SPTAN1 along with somatic amplifications in YY1AP1?,cnv_and_ssm
+164,SYT10,M484I,Rectum Adenocarcinoma,To what extent do Rectum Adenocarcinoma cases show somatic mutations in SYT10 along with somatic amplifications in RAB40C?,cnv_and_ssm
+174,HSPA5,N457K,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in HSPA5 along with somatic amplifications in CFAP298-TCP10L?,cnv_and_ssm
+175,UNC5D,L280V,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in UNC5D along with somatic amplifications in CHODL?,cnv_and_ssm
+176,UNC5D,L635V,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in UNC5D along with somatic amplifications in CTCFL?,cnv_and_ssm
+177,UNC5D,L637V,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in UNC5D along with somatic amplifications in DCLK3?,cnv_and_ssm
+178,UNC5D,L699V,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in UNC5D along with somatic amplifications in TYROBP?,cnv_and_ssm
+179,UNC5D,L704V,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in UNC5D along with somatic amplifications in PRSS1?,cnv_and_ssm
+180,UNC5D,L709V,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in UNC5D along with somatic amplifications in GUK1?,cnv_and_ssm
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,To what extent do Kidney Renal Clear Cell Carcinoma cases show somatic mutations in DOCK2 along with somatic amplifications in TENM2?,cnv_and_ssm
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,To what extent do Kidney Renal Clear Cell Carcinoma cases show somatic mutations in ZNF627 along with somatic amplifications in GPC3?,cnv_and_ssm
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in CDC42BPA along with somatic amplifications in CARMIL1?,cnv_and_ssm
+193,MRPL55,H27Y,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in MRPL55 along with somatic amplifications in RIMS2?,cnv_and_ssm
+194,MRPL55,H63Y,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in MRPL55 along with somatic amplifications in PCDHB2?,cnv_and_ssm
+197,TMTC3,Q749K,Breast Invasive Carcinoma,To what extent do Breast Invasive Carcinoma cases show somatic mutations in TMTC3 along with somatic amplifications in COL6A3?,cnv_and_ssm
+198,EPRS1,K771I,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in EPRS1 along with somatic amplifications in DNAH14?,cnv_and_ssm
+199,EPRS1,K778I,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in EPRS1 along with somatic amplifications in AUTS2?,cnv_and_ssm
+201,GRTP1,A110V,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in GRTP1 along with somatic amplifications in ITPRID2?,cnv_and_ssm
+202,GRTP1,A32V,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in GRTP1 along with somatic amplifications in SYNJ1?,cnv_and_ssm
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in TSHZ3 along with somatic amplifications in GUF1?,cnv_and_ssm
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,To what extent do HIV+ Tumor Molecular Characterization Project - Cervical Cancer cases show somatic mutations in TAS1R3 along with somatic amplifications in YY1AP1?,cnv_and_ssm
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in PIAS3 along with somatic amplifications in DNAH14?,cnv_and_ssm
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in PIAS3 along with somatic amplifications in GABRA6?,cnv_and_ssm
+251,ZNF274,P13R,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in ZNF274 along with somatic amplifications in PKHD1L1?,cnv_and_ssm
+253,SYNJ1,R795C,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in SYNJ1 along with somatic amplifications in TASOR2?,cnv_and_ssm
+254,SYNJ1,R800C,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in SYNJ1 along with somatic amplifications in ZCCHC14?,cnv_and_ssm
+255,SYNJ1,R839C,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in SYNJ1 along with somatic amplifications in POLR1G?,cnv_and_ssm
+261,DSCAM,V343M,Prostate Adenocarcinoma,To what extent do Prostate Adenocarcinoma cases show somatic mutations in DSCAM along with somatic amplifications in REXO4?,cnv_and_ssm
+262,DSCAM,V426M,Prostate Adenocarcinoma,To what extent do Prostate Adenocarcinoma cases show somatic mutations in DSCAM along with somatic amplifications in ANKDD1A?,cnv_and_ssm
+263,DSCAM,V591M,Prostate Adenocarcinoma,To what extent do Prostate Adenocarcinoma cases show somatic mutations in DSCAM along with somatic amplifications in CNGB1?,cnv_and_ssm
+267,DGKD,R140H,Exceptional Responders,To what extent do Exceptional Responders cases show somatic mutations in DGKD along with somatic amplifications in CARMIL1?,cnv_and_ssm
+268,DGKD,R160H,Exceptional Responders,To what extent do Exceptional Responders cases show somatic mutations in DGKD along with somatic amplifications in CTSC?,cnv_and_ssm
+269,DGKD,R204H,Exceptional Responders,To what extent do Exceptional Responders cases show somatic mutations in DGKD along with somatic amplifications in CTNNA2?,cnv_and_ssm
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,To what extent do Bladder Urothelial Carcinoma cases show somatic mutations in PLEKHG6 along with somatic amplifications in THBS4?,cnv_and_ssm
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,To what extent do Bladder Urothelial Carcinoma cases show somatic mutations in PLEKHG6 along with somatic amplifications in ACTA2?,cnv_and_ssm
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,To what extent do Bladder Urothelial Carcinoma cases show somatic mutations in PLEKHG6 along with somatic amplifications in CHODL?,cnv_and_ssm
+279,WNT2,D138N,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in WNT2 along with somatic amplifications in GUCY2C?,cnv_and_ssm
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in GUCY2C along with somatic amplifications in GUF1?,cnv_and_ssm
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in C7orf31 along with somatic amplifications in PTPRO?,cnv_and_ssm
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","To what extent do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases show somatic mutations in ZKSCAN7 along with somatic amplifications in CTNNA2?",cnv_and_ssm
+299,OR5D14,M210L,Neuroblastoma,To what extent do Neuroblastoma cases show somatic mutations in OR5D14 along with somatic amplifications in TAF1C?,cnv_and_ssm
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in SPATA22 along with somatic amplifications in ZSCAN31?,cnv_and_ssm
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in SPATA22 along with somatic amplifications in GRTP1?,cnv_and_ssm
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in SPATA22 along with somatic amplifications in HBB?,cnv_and_ssm
+310,LCN15,E21V,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in LCN15 along with somatic amplifications in ZNF431?,cnv_and_ssm
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in DCAF4L2 along with somatic amplifications in EBF2?,cnv_and_ssm
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in GUK1 along with somatic amplifications in ZNF217?,cnv_and_ssm
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in GUK1 along with somatic amplifications in SLC6A4?,cnv_and_ssm
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in GUK1 along with somatic amplifications in CFAP298-TCP10L?,cnv_and_ssm
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in GUK1 along with somatic amplifications in GABRA6?,cnv_and_ssm
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in GUK1 along with somatic amplifications in CYB5R2?,cnv_and_ssm
+328,MORF4L1,K29T,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in MORF4L1 along with somatic amplifications in ANP32E?,cnv_and_ssm
+329,MORF4L1,K51T,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in MORF4L1 along with somatic amplifications in TRPA1?,cnv_and_ssm
+330,MORF4L1,K61T,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in MORF4L1 along with somatic amplifications in GABRA6?,cnv_and_ssm
+331,MORF4L1,K76T,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in MORF4L1 along with somatic amplifications in MYO3B?,cnv_and_ssm
+335,MYO3B,F594L,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in MYO3B along with somatic amplifications in TAF1C?,cnv_and_ssm
+336,MYO3B,F603L,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in MYO3B along with somatic amplifications in CTSC?,cnv_and_ssm
+339,TENT5A,S320F,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in TENT5A along with somatic amplifications in ADRA1A?,cnv_and_ssm
+340,TENT5A,S339F,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in TENT5A along with somatic amplifications in POC1B?,cnv_and_ssm
+341,TENT5A,S401F,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in TENT5A along with somatic amplifications in TAF1C?,cnv_and_ssm
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,To what extent do Ovarian Serous Cystadenocarcinoma cases show somatic mutations in ZFAT along with somatic amplifications in FCGR2C?,cnv_and_ssm
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,To what extent do Ovarian Serous Cystadenocarcinoma cases show somatic mutations in ZFAT along with somatic amplifications in FGF8?,cnv_and_ssm
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,To what extent do Ovarian Serous Cystadenocarcinoma cases show somatic mutations in ZFAT along with somatic amplifications in ANKRD30A?,cnv_and_ssm
+357,ZNF584,A211T,Sarcoma,To what extent do Sarcoma cases show somatic mutations in ZNF584 along with somatic amplifications in DNMT1?,cnv_and_ssm
+358,ZNF584,A256T,Sarcoma,To what extent do Sarcoma cases show somatic mutations in ZNF584 along with somatic amplifications in MAST4?,cnv_and_ssm
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in LDOC1 along with somatic amplifications in FBXO15?,cnv_and_ssm
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in PDGFC along with somatic amplifications in PRSS1?,cnv_and_ssm
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in MSANTD4 along with somatic amplifications in AUTS2?,cnv_and_ssm
+374,NPSR1,S123L,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in NPSR1 along with somatic amplifications in SYT9?,cnv_and_ssm
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in PHLPP1 along with somatic amplifications in RIMS2?,cnv_and_ssm
+385,COL6A3,G237S,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in COL6A3 along with somatic amplifications in TENM2?,cnv_and_ssm
+386,COL6A3,G437S,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in COL6A3 along with somatic amplifications in COL6A3?,cnv_and_ssm
+387,COL6A3,G638S,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in COL6A3 along with somatic amplifications in CHODL?,cnv_and_ssm
+388,COL6A3,G644S,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in COL6A3 along with somatic amplifications in DNAH14?,cnv_and_ssm
+389,COL6A3,G844S,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in COL6A3 along with somatic amplifications in DNMT1?,cnv_and_ssm
+395,ADRA1A,R348G,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in ADRA1A along with somatic amplifications in MYO3A?,cnv_and_ssm
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,To what extent do Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases show somatic mutations in LAMB2 along with somatic amplifications in SGCZ?,cnv_and_ssm
+406,POC1B,I198T,Rectum Adenocarcinoma,To what extent do Rectum Adenocarcinoma cases show somatic mutations in POC1B along with somatic amplifications in UNC5D?,cnv_and_ssm
+407,POC1B,I286T,Rectum Adenocarcinoma,To what extent do Rectum Adenocarcinoma cases show somatic mutations in POC1B along with somatic amplifications in KDM5C?,cnv_and_ssm
+408,POC1B,I328T,Rectum Adenocarcinoma,To what extent do Rectum Adenocarcinoma cases show somatic mutations in POC1B along with somatic amplifications in HSPA5?,cnv_and_ssm
+409,POC1B,S79P,Rectum Adenocarcinoma,To what extent do Rectum Adenocarcinoma cases show somatic mutations in POC1B along with somatic amplifications in MAD1L1?,cnv_and_ssm
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,To what extent do Liver Hepatocellular Carcinoma cases show somatic mutations in USH2A along with somatic amplifications in ZFAT?,cnv_and_ssm
+414,AQP7,T110S,Rectum Adenocarcinoma,To what extent do Rectum Adenocarcinoma cases show somatic mutations in AQP7 along with somatic amplifications in IL5RA?,cnv_and_ssm
+415,AQP7,T166S,Rectum Adenocarcinoma,To what extent do Rectum Adenocarcinoma cases show somatic mutations in AQP7 along with somatic amplifications in TENM2?,cnv_and_ssm
+416,AQP7,T167S,Rectum Adenocarcinoma,To what extent do Rectum Adenocarcinoma cases show somatic mutations in AQP7 along with somatic amplifications in TNS1?,cnv_and_ssm
+417,AQP7,T75S,Rectum Adenocarcinoma,To what extent do Rectum Adenocarcinoma cases show somatic mutations in AQP7 along with somatic amplifications in UNC5D?,cnv_and_ssm
+430,DCN,R163C,Rectum Adenocarcinoma,To what extent do Rectum Adenocarcinoma cases show somatic mutations in DCN along with somatic amplifications in MIEF1?,cnv_and_ssm
+431,DCN,R203C,Rectum Adenocarcinoma,To what extent do Rectum Adenocarcinoma cases show somatic mutations in DCN along with somatic amplifications in CNGB1?,cnv_and_ssm
+432,DCN,R241C,Rectum Adenocarcinoma,To what extent do Rectum Adenocarcinoma cases show somatic mutations in DCN along with somatic amplifications in RAB40C?,cnv_and_ssm
+433,DCN,R350C,Rectum Adenocarcinoma,To what extent do Rectum Adenocarcinoma cases show somatic mutations in DCN along with somatic amplifications in DCN?,cnv_and_ssm
+434,DCN,R41C,Rectum Adenocarcinoma,To what extent do Rectum Adenocarcinoma cases show somatic mutations in DCN along with somatic amplifications in OR13C3?,cnv_and_ssm
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in CPS1 along with somatic amplifications in PAK3?,cnv_and_ssm
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in CPS1 along with somatic amplifications in USH2A?,cnv_and_ssm
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in CPS1 along with somatic amplifications in PTPRO?,cnv_and_ssm
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,To what extent do Kidney Renal Papillary Cell Carcinoma cases show somatic mutations in FCGR2C along with somatic amplifications in SLC6A4?,cnv_and_ssm
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,To what extent do Kidney Renal Papillary Cell Carcinoma cases show somatic mutations in FCGR2C along with somatic amplifications in TASOR2?,cnv_and_ssm
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in GRM1 along with somatic amplifications in AUTS2?,cnv_and_ssm
+482,SGCZ,Q138H,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in SGCZ along with somatic amplifications in ZNF431?,cnv_and_ssm
+483,SGCZ,Q91H,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in SGCZ along with somatic amplifications in DNMT1?,cnv_and_ssm
+485,SMO,V15M,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in SMO along with somatic amplifications in ANP32E?,cnv_and_ssm
+486,SMO,V321M,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in SMO along with somatic amplifications in TET2?,cnv_and_ssm
+488,CHODL,G159E,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in CHODL along with somatic amplifications in TNS1?,cnv_and_ssm
+489,CHODL,G181E,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in CHODL along with somatic amplifications in DCAF6?,cnv_and_ssm
+490,CHODL,G200E,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in CHODL along with somatic amplifications in GABRA6?,cnv_and_ssm
+494,MYO16,P399H,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in MYO16 along with somatic amplifications in RIMS2?,cnv_and_ssm
+495,MYO16,P421H,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in MYO16 along with somatic amplifications in TAF1C?,cnv_and_ssm
+498,CXCR2,A98V,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in CXCR2 along with somatic amplifications in POLD1?,cnv_and_ssm
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,To what extent do Bladder Urothelial Carcinoma cases show somatic mutations in TMEM225 along with somatic amplifications in TTN?,cnv_and_ssm
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in MAOB along with somatic amplifications in EIF2B4?,cnv_and_ssm
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in GPRASP1 along with somatic amplifications in RELN?,cnv_and_ssm
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in MRPL32 along with somatic amplifications in CXCR2?,cnv_and_ssm
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in TYROBP along with somatic amplifications in MSANTD4?,cnv_and_ssm
+510,RAB40C,A111V,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in RAB40C along with somatic amplifications in FBN1?,cnv_and_ssm
+511,RAB40C,A143V,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in RAB40C along with somatic amplifications in JAML?,cnv_and_ssm
+512,CTNNA2,S323R,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in CTNNA2 along with somatic amplifications in TASOR2?,cnv_and_ssm
+513,CTNNA2,S339R,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in CTNNA2 along with somatic amplifications in AUTS2?,cnv_and_ssm
+514,CTNNA2,S386R,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in CTNNA2 along with somatic amplifications in GSTCD?,cnv_and_ssm
+515,CTNNA2,S707R,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in CTNNA2 along with somatic amplifications in AUTS2?,cnv_and_ssm
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,To what extent do Bladder Urothelial Carcinoma cases show somatic mutations in MYO15A along with somatic amplifications in KDM5C?,cnv_and_ssm
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in GIMAP2 along with somatic amplifications in XKR4?,cnv_and_ssm
+532,KIF20B,N1160D,Glioblastoma Multiforme,To what extent do Glioblastoma Multiforme cases show somatic mutations in KIF20B along with somatic amplifications in TENM2?,cnv_and_ssm
+533,KIF20B,N1200D,Glioblastoma Multiforme,To what extent do Glioblastoma Multiforme cases show somatic mutations in KIF20B along with somatic amplifications in ZNF431?,cnv_and_ssm
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in ADAM17 along with somatic amplifications in ACVR1B?,cnv_and_ssm
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in BCAT1 along with somatic amplifications in DOCK2?,cnv_and_ssm
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in BCAT1 along with somatic amplifications in AUTS2?,cnv_and_ssm
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in BCAT1 along with somatic amplifications in KRT39?,cnv_and_ssm
+540,ERCC6,R1053H,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in ERCC6 along with somatic amplifications in POLR1G?,cnv_and_ssm
+541,DCC,R320W,Breast Invasive Carcinoma,To what extent do Breast Invasive Carcinoma cases show somatic mutations in DCC along with somatic amplifications in ZNF627?,cnv_and_ssm
+542,DCC,R363W,Breast Invasive Carcinoma,To what extent do Breast Invasive Carcinoma cases show somatic mutations in DCC along with somatic amplifications in CFAP298-TCP10L?,cnv_and_ssm
+543,DCC,R386W,Breast Invasive Carcinoma,To what extent do Breast Invasive Carcinoma cases show somatic mutations in DCC along with somatic amplifications in ACTB?,cnv_and_ssm
+544,DCC,R41W,Breast Invasive Carcinoma,To what extent do Breast Invasive Carcinoma cases show somatic mutations in DCC along with somatic amplifications in SLC9C1?,cnv_and_ssm
+549,FBXO15,D417N,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in FBXO15 along with somatic amplifications in PCDHGA1?,cnv_and_ssm
+550,FBXO15,D86N,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in FBXO15 along with somatic amplifications in WNT2?,cnv_and_ssm
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in GSTCD along with somatic amplifications in STAT3?,cnv_and_ssm
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in GSTCD along with somatic amplifications in GRTP1?,cnv_and_ssm
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in OLFML3 along with somatic amplifications in MAST4?,cnv_and_ssm
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in OLFML3 along with somatic amplifications in SLC6A4?,cnv_and_ssm
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in OLFML3 along with somatic amplifications in ZSCAN31?,cnv_and_ssm
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,To what extent do Ovarian Serous Cystadenocarcinoma cases show somatic mutations in CFAP61 along with somatic amplifications in ITPRID2?,cnv_and_ssm
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,To what extent do Ovarian Serous Cystadenocarcinoma cases show somatic mutations in CFAP61 along with somatic amplifications in CTNNA2?,cnv_and_ssm
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,To what extent do Bladder Urothelial Carcinoma cases show somatic mutations in HLA-DQA2 along with somatic amplifications in PAK3?,cnv_and_ssm
+582,TENM2,H240Y,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in TENM2 along with somatic amplifications in CDC42BPA?,cnv_and_ssm
+583,TENM2,H351Y,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in TENM2 along with somatic amplifications in STK19?,cnv_and_ssm
+584,TENM2,H472Y,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in TENM2 along with somatic amplifications in FCGR2C?,cnv_and_ssm
+600,ANKRD24,A465T,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in ANKRD24 along with somatic amplifications in PCDHB2?,cnv_and_ssm
+601,ANKRD24,A494T,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in ANKRD24 along with somatic amplifications in ZCCHC14?,cnv_and_ssm
+602,ANKRD24,A584T,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in ANKRD24 along with somatic amplifications in TTC12?,cnv_and_ssm
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in ZCCHC14 along with somatic amplifications in CTSC?,cnv_and_ssm
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in ZCCHC14 along with somatic amplifications in RAB40C?,cnv_and_ssm
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in ZCCHC14 along with somatic amplifications in CARMIL1?,cnv_and_ssm
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in ZCCHC14 along with somatic amplifications in PXN?,cnv_and_ssm
+625,SIK2,I265M,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in SIK2 along with somatic amplifications in ZFPM2?,cnv_and_ssm
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in MYH11 along with somatic amplifications in ART3?,cnv_and_ssm
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in MYH11 along with somatic amplifications in CTNNA2?,cnv_and_ssm
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in SLC6A4 along with somatic amplifications in AUTS2?,cnv_and_ssm
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in SLC9C1 along with somatic amplifications in CACNA1F?,cnv_and_ssm
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in SLC9C1 along with somatic amplifications in FRY?,cnv_and_ssm
+644,OR2A12,A254T,Brain Lower Grade Glioma,To what extent do Brain Lower Grade Glioma cases show somatic mutations in OR2A12 along with somatic amplifications in SPAG1?,cnv_and_ssm
+646,PYHIN1,T325K,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in PYHIN1 along with somatic amplifications in PTPRN2?,cnv_and_ssm
+647,PYHIN1,T334K,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in PYHIN1 along with somatic amplifications in LDOC1?,cnv_and_ssm
+650,JAML,G191E,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in JAML along with somatic amplifications in CX3CR1?,cnv_and_ssm
+651,JAML,G219E,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in JAML along with somatic amplifications in CHMP7?,cnv_and_ssm
+652,JAML,G220E,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in JAML along with somatic amplifications in ZSCAN31?,cnv_and_ssm
+653,JAML,G230E,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in JAML along with somatic amplifications in AQP7?,cnv_and_ssm
+658,TYK2,H1146R,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in TYK2 along with somatic amplifications in ART3?,cnv_and_ssm
+659,TYK2,H23R,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in TYK2 along with somatic amplifications in SOX21?,cnv_and_ssm
+660,TYK2,H961R,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in TYK2 along with somatic amplifications in FGF8?,cnv_and_ssm
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in CTCFL along with somatic amplifications in AUTS2?,cnv_and_ssm
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in CTCFL along with somatic amplifications in SPTAN1?,cnv_and_ssm
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in CTCFL along with somatic amplifications in GPR158?,cnv_and_ssm
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in CTCFL along with somatic amplifications in NOMO1?,cnv_and_ssm
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in CEP20 along with somatic amplifications in CTSC?,cnv_and_ssm
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in CEP20 along with somatic amplifications in AUTS2?,cnv_and_ssm
+689,RIMS2,R25W,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in RIMS2 along with somatic amplifications in COL6A3?,cnv_and_ssm
+690,RIMS2,R393W,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in RIMS2 along with somatic amplifications in CHMP7?,cnv_and_ssm
+691,RIMS2,R423W,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in RIMS2 along with somatic amplifications in TYK2?,cnv_and_ssm
+692,RIMS2,R470W,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in RIMS2 along with somatic amplifications in TENT5A?,cnv_and_ssm
+693,RIMS2,R615W,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in RIMS2 along with somatic amplifications in JAML?,cnv_and_ssm
+694,RIMS2,R619W,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in RIMS2 along with somatic amplifications in MYO16?,cnv_and_ssm
+695,RIMS2,R716W,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in RIMS2 along with somatic amplifications in GABRA6?,cnv_and_ssm
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in PIK3C2G along with somatic amplifications in ANKDD1A?,cnv_and_ssm
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in PIK3C2G along with somatic amplifications in HTR3B?,cnv_and_ssm
+728,STK19,D341N,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in STK19 along with somatic amplifications in ANP32E?,cnv_and_ssm
+729,STK19,D345N,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in STK19 along with somatic amplifications in OR8K5?,cnv_and_ssm
+730,REXO4,P60A,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in REXO4 along with somatic amplifications in PXN?,cnv_and_ssm
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in ZBTB34 along with somatic amplifications in ANKDD1A?,cnv_and_ssm
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in ZBTB34 along with somatic amplifications in TASOR2?,cnv_and_ssm
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,To what extent do Bladder Urothelial Carcinoma cases show somatic mutations in NCKAP5 along with somatic amplifications in ZNF584?,cnv_and_ssm
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","To what extent do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases show somatic mutations in SORCS1 along with somatic amplifications in OLFML3?",cnv_and_ssm
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","To what extent do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases show somatic mutations in SORCS1 along with somatic amplifications in YY1AP1?",cnv_and_ssm
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","To what extent do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases show somatic mutations in SORCS1 along with somatic amplifications in SLC24A2?",cnv_and_ssm
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","To what extent do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases show somatic mutations in SORCS1 along with somatic amplifications in MYH11?",cnv_and_ssm
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,To what extent do Head and Neck Squamous Cell Carcinoma cases show somatic mutations in FGF8 along with somatic amplifications in DPF3?,cnv_and_ssm
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,To what extent do Head and Neck Squamous Cell Carcinoma cases show somatic mutations in FGF8 along with somatic amplifications in CTCFL?,cnv_and_ssm
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,To what extent do Head and Neck Squamous Cell Carcinoma cases show somatic mutations in FGF8 along with somatic amplifications in PAK3?,cnv_and_ssm
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,To what extent do Head and Neck Squamous Cell Carcinoma cases show somatic mutations in FGF8 along with somatic amplifications in TAF1C?,cnv_and_ssm
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,To what extent do Head and Neck Squamous Cell Carcinoma cases show somatic mutations in FGF8 along with somatic amplifications in AUTS2?,cnv_and_ssm
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,To what extent do Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia cases show somatic mutations in TENM3 along with somatic amplifications in GRTP1?,cnv_and_ssm
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in AKT1 along with somatic amplifications in CTNNA2?,cnv_and_ssm
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,To what extent do Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases show somatic mutations in CFAP298-TCP10L along with somatic amplifications in GUK1?,cnv_and_ssm
+792,GLRB,E148D,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in GLRB along with somatic amplifications in LAMB2?,cnv_and_ssm
+793,TTN,F7636L,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in TTN along with somatic amplifications in CNGB1?,cnv_and_ssm
+794,TTN,F8563L,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in TTN along with somatic amplifications in TASOR2?,cnv_and_ssm
+795,TTN,F8880L,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in TTN along with somatic amplifications in RIPOR2?,cnv_and_ssm
+799,ANKRD30A,V798I,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in ANKRD30A along with somatic amplifications in SLC9C1?,cnv_and_ssm
+800,ANKRD30A,V854I,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in ANKRD30A along with somatic amplifications in EIF2B4?,cnv_and_ssm
+801,ANKRD30A,V973I,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in ANKRD30A along with somatic amplifications in ZFAT?,cnv_and_ssm
+809,TRIM45,S177L,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in TRIM45 along with somatic amplifications in ANKRD52?,cnv_and_ssm
+810,TRIM45,S224L,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in TRIM45 along with somatic amplifications in GPC3?,cnv_and_ssm
+811,TRIM45,S281L,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in TRIM45 along with somatic amplifications in JAML?,cnv_and_ssm
+812,CACNA1F,G727V,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in CACNA1F along with somatic amplifications in THBS4?,cnv_and_ssm
+813,CACNA1F,G781V,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in CACNA1F along with somatic amplifications in TTC17?,cnv_and_ssm
+814,CACNA1F,G792V,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in CACNA1F along with somatic amplifications in ZFPM2?,cnv_and_ssm
+817,KL,R594C,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in KL along with somatic amplifications in TASOR2?,cnv_and_ssm
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,To what extent do Kidney Renal Papillary Cell Carcinoma cases show somatic mutations in GUF1 along with somatic amplifications in EIF2B4?,cnv_and_ssm
+822,TAF1L,A539V,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in TAF1L along with somatic amplifications in DNMT1?,cnv_and_ssm
+823,TASOR2,S256F,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in TASOR2 along with somatic amplifications in MYH11?,cnv_and_ssm
+824,TASOR2,S36F,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in TASOR2 along with somatic amplifications in EIF2B4?,cnv_and_ssm
+825,TASOR2,S471F,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in TASOR2 along with somatic amplifications in KANSL1?,cnv_and_ssm
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in KDM5C along with somatic amplifications in GUK1?,cnv_and_ssm
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in KDM5C along with somatic amplifications in GSTCD?,cnv_and_ssm
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in KDM5C along with somatic amplifications in OR5D14?,cnv_and_ssm
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in KDM5C along with somatic amplifications in EIF2B4?,cnv_and_ssm
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,To what extent do Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases show somatic mutations in IL5RA along with somatic amplifications in ACTB?,cnv_and_ssm
+843,DHX16,A29V,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in DHX16 along with somatic amplifications in C7orf31?,cnv_and_ssm
+844,DHX16,A89V,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in DHX16 along with somatic amplifications in CARMIL1?,cnv_and_ssm
+902,GPR158,A644V,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in GPR158 along with somatic amplifications in TNS1?,cnv_and_ssm
+903,GPR158,A723V,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in GPR158 along with somatic amplifications in DGKD?,cnv_and_ssm
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","To what extent do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases show somatic mutations in EIF2B4 along with somatic amplifications in TAF1C?",cnv_and_ssm
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","To what extent do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases show somatic mutations in EIF2B4 along with somatic amplifications in ANKRD24?",cnv_and_ssm
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","To what extent do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases show somatic mutations in EIF2B4 along with somatic amplifications in ZBTB34?",cnv_and_ssm
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","To what extent do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases show somatic mutations in EIF2B4 along with somatic amplifications in HLA-DQA2?",cnv_and_ssm
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","To what extent do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases show somatic mutations in EIF2B4 along with somatic amplifications in SGCZ?",cnv_and_ssm
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","To what extent do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases show somatic mutations in EIF2B4 along with somatic amplifications in BICC1?",cnv_and_ssm
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in AUTS2 along with somatic amplifications in AUTS2?,cnv_and_ssm
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in AUTS2 along with somatic amplifications in SPTAN1?,cnv_and_ssm
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in AUTS2 along with somatic amplifications in UNC5D?,cnv_and_ssm
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in AUTS2 along with somatic amplifications in ANKDD1A?,cnv_and_ssm
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in AUTS2 along with somatic amplifications in PTPRO?,cnv_and_ssm
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in AUTS2 along with somatic amplifications in TNS1?,cnv_and_ssm
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in AUTS2 along with somatic amplifications in PIK3C2B?,cnv_and_ssm
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in AUTS2 along with somatic amplifications in CHMP7?,cnv_and_ssm
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in AUTS2 along with somatic amplifications in PIAS3?,cnv_and_ssm
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in AUTS2 along with somatic amplifications in BFAR?,cnv_and_ssm
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","To what extent do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases show somatic mutations in ACTL7B along with somatic amplifications in GUK1?",cnv_and_ssm
+952,PCDHGA1,R535W,Glioblastoma Multiforme,To what extent do Glioblastoma Multiforme cases show somatic mutations in PCDHGA1 along with somatic amplifications in ZFP42?,cnv_and_ssm
+954,TRAP1,R114W,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in TRAP1 along with somatic amplifications in POC1B?,cnv_and_ssm
+955,TRAP1,R61W,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in TRAP1 along with somatic amplifications in CTCFL?,cnv_and_ssm
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in PIK3C2A along with somatic amplifications in HTR3B?,cnv_and_ssm
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,To what extent do Liver Hepatocellular Carcinoma cases show somatic mutations in KANSL1 along with somatic amplifications in FGF8?,cnv_and_ssm
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in ANKRD52 along with somatic amplifications in PIK3C2B?,cnv_and_ssm
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in PAPPA along with somatic amplifications in AUTS2?,cnv_and_ssm
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,To what extent do Rectum Adenocarcinoma cases show somatic mutations in B3GALNT1 along with somatic amplifications in PSG2?,cnv_and_ssm
+982,GABRA6,G115R,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in GABRA6 along with somatic amplifications in MYO15A?,cnv_and_ssm
+983,GABRA6,G122R,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in GABRA6 along with somatic amplifications in GABRA6?,cnv_and_ssm
+984,GABRA6,G165R,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in GABRA6 along with somatic amplifications in MAD1L1?,cnv_and_ssm
+985,GABRA6,G175R,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in GABRA6 along with somatic amplifications in TNS1?,cnv_and_ssm
+986,GABRA6,G70R,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in GABRA6 along with somatic amplifications in PTPRO?,cnv_and_ssm
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in ZSCAN31 along with somatic amplifications in PXN?,cnv_and_ssm
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","To what extent do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases show somatic mutations in MED16 along with somatic amplifications in PIK3C2G?",cnv_and_ssm
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","To what extent do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases show somatic mutations in MED16 along with somatic amplifications in YY1AP1?",cnv_and_ssm
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,To what extent do Pancreatic Adenocarcinoma cases show somatic mutations in PTPRO along with somatic amplifications in MRPL32?,cnv_and_ssm
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,To what extent do Pancreatic Adenocarcinoma cases show somatic mutations in PTPRO along with somatic amplifications in RIMS2?,cnv_and_ssm
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,To what extent do Pancreatic Adenocarcinoma cases show somatic mutations in PTPRO along with somatic amplifications in PTPRO?,cnv_and_ssm
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,To what extent do Pancreatic Adenocarcinoma cases show somatic mutations in PTPRO along with somatic amplifications in GUK1?,cnv_and_ssm
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,To what extent do Pancreatic Adenocarcinoma cases show somatic mutations in PTPRO along with somatic amplifications in DPF3?,cnv_and_ssm
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,To what extent do Pancreatic Adenocarcinoma cases show somatic mutations in PTPRO along with somatic amplifications in ANKDD1A?,cnv_and_ssm
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,To what extent do Pancreatic Adenocarcinoma cases show somatic mutations in PTPRO along with somatic amplifications in DSCAM?,cnv_and_ssm
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,To what extent do Pancreatic Adenocarcinoma cases show somatic mutations in PTPRO along with somatic amplifications in SYT9?,cnv_and_ssm
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in CHMP7 along with somatic amplifications in DGKD?,cnv_and_ssm
+1017,GPC3,I107N,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in GPC3 along with somatic amplifications in AQP7?,cnv_and_ssm
+1018,GPC3,I161N,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in GPC3 along with somatic amplifications in TTYH2?,cnv_and_ssm
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,To what extent do Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases show somatic mutations in TLK2 along with somatic amplifications in TRAP1?,cnv_and_ssm
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,To what extent do Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases show somatic mutations in TLK2 along with somatic amplifications in KIF20B?,cnv_and_ssm
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,To what extent do Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases show somatic mutations in TLK2 along with somatic amplifications in CPS1?,cnv_and_ssm
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,To what extent do Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases show somatic mutations in TLK2 along with somatic amplifications in SPAG1?,cnv_and_ssm
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,To what extent do Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases show somatic mutations in TLK2 along with somatic amplifications in ACVR1B?,cnv_and_ssm
+1036,ZNF217,E209Q,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in ZNF217 along with somatic amplifications in ZMYM3?,cnv_and_ssm
+1038,SYT9,V275L,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in SYT9 along with somatic amplifications in ANKDD1A?,cnv_and_ssm
+1039,SYT9,V307L,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in SYT9 along with somatic amplifications in AUTS2?,cnv_and_ssm
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in PKHD1L1 along with somatic amplifications in TSHZ3?,cnv_and_ssm
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in MYO3A along with somatic amplifications in PHLPP1?,cnv_and_ssm
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","To what extent do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases show somatic mutations in VASN along with somatic amplifications in TAF1C?",cnv_and_ssm
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in DNMT1 along with somatic amplifications in GPR158?,cnv_and_ssm
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in DNMT1 along with somatic amplifications in TRPA1?,cnv_and_ssm
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in DNMT1 along with somatic amplifications in MYH11?,cnv_and_ssm
+1056,CA9,E402K,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in CA9 along with somatic amplifications in GABRA6?,cnv_and_ssm
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in TTC17 along with somatic amplifications in EIF2B4?,cnv_and_ssm
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in TTC17 along with somatic amplifications in YY1AP1?,cnv_and_ssm
+1065,PSG2,P43L,Breast Invasive Carcinoma,To what extent do Breast Invasive Carcinoma cases show somatic mutations in PSG2 along with somatic amplifications in FNDC7?,cnv_and_ssm
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,To what extent do Breast Invasive Carcinoma cases show somatic mutations in RIPOR2 along with somatic amplifications in RIMS2?,cnv_and_ssm
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,To what extent do Breast Invasive Carcinoma cases show somatic mutations in RIPOR2 along with somatic amplifications in PRSS1?,cnv_and_ssm
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,To what extent do Breast Invasive Carcinoma cases show somatic mutations in RIPOR2 along with somatic amplifications in ANKRD30A?,cnv_and_ssm
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,To what extent do Breast Invasive Carcinoma cases show somatic mutations in RIPOR2 along with somatic amplifications in MAST4?,cnv_and_ssm
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in DCLK3 along with somatic amplifications in DCAF4L2?,cnv_and_ssm
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in DCLK3 along with somatic amplifications in PAK3?,cnv_and_ssm
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in MERTK along with somatic amplifications in NRAP?,cnv_and_ssm
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in MERTK along with somatic amplifications in PXN?,cnv_and_ssm
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in MERTK along with somatic amplifications in PTPRN2?,cnv_and_ssm
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in ZFP42 along with somatic amplifications in DGKD?,cnv_and_ssm
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in OR13C3 along with somatic amplifications in SYNJ1?,cnv_and_ssm
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in OR13C3 along with somatic amplifications in SPTAN1?,cnv_and_ssm
+1091,SPAG1,I917M,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in SPAG1 along with somatic amplifications in ZNF431?,cnv_and_ssm
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in CDKN2AIP along with somatic amplifications in PRSS1?,cnv_and_ssm
+1093,PXN,H1016Y,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in PXN along with somatic amplifications in SYNJ1?,cnv_and_ssm
+1094,PXN,H359Y,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in PXN along with somatic amplifications in PAPPA?,cnv_and_ssm
+1095,PXN,H492Y,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in PXN along with somatic amplifications in RIPOR2?,cnv_and_ssm
+1096,PXN,H524Y,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in PXN along with somatic amplifications in RIMS2?,cnv_and_ssm
+1097,PXN,H526Y,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in PXN along with somatic amplifications in GLRB?,cnv_and_ssm
+1098,PXN,H540Y,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in PXN along with somatic amplifications in MYT1?,cnv_and_ssm
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in TTYH2 along with somatic amplifications in CTNNA2?,cnv_and_ssm
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in TTYH2 along with somatic amplifications in MYO16?,cnv_and_ssm
+1106,TMEM255A,N205S,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in TMEM255A along with somatic amplifications in CTCFL?,cnv_and_ssm
+1107,TMEM255A,N229S,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in TMEM255A along with somatic amplifications in GRTP1?,cnv_and_ssm
+1108,TMEM255A,N65S,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in TMEM255A along with somatic amplifications in YY1AP1?,cnv_and_ssm
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,To what extent do Breast Invasive Carcinoma cases show somatic mutations in TASOR2 along with somatic amplifications in TTC12?,cnv_and_ssm
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,To what extent do Breast Invasive Carcinoma cases show somatic mutations in TASOR2 along with somatic amplifications in SPAG1?,cnv_and_ssm
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in ICE1 along with somatic amplifications in AQP7?,cnv_and_ssm
+1112,MYT1,A558E,Breast Invasive Carcinoma,To what extent do Breast Invasive Carcinoma cases show somatic mutations in MYT1 along with somatic amplifications in ZNF431?,cnv_and_ssm
+1113,MYT1,A879E,Breast Invasive Carcinoma,To what extent do Breast Invasive Carcinoma cases show somatic mutations in MYT1 along with somatic amplifications in ZFPM2?,cnv_and_ssm
+1114,MYT1,A906E,Breast Invasive Carcinoma,To what extent do Breast Invasive Carcinoma cases show somatic mutations in MYT1 along with somatic amplifications in CTCFL?,cnv_and_ssm
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in CX3CR1 along with somatic amplifications in TAF1C?,cnv_and_ssm
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in CX3CR1 along with somatic amplifications in CCNG1?,cnv_and_ssm
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,To what extent do Liver Hepatocellular Carcinoma cases show somatic mutations in SPINDOC along with somatic amplifications in PDGFC?,cnv_and_ssm
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in ART3 along with somatic amplifications in EIF2B4?,cnv_and_ssm
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in ART3 along with somatic amplifications in HTR3B?,cnv_and_ssm
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,To what extent do Bladder Urothelial Carcinoma cases show somatic mutations in CYP1A2 along with somatic amplifications in ZNF431?,cnv_and_ssm
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","To what extent do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases show somatic mutations in ADRA1A along with somatic amplifications in DSCAM?",cnv_and_ssm
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in CDH23 along with somatic amplifications in CEP20?,cnv_and_ssm
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in CDH23 along with somatic amplifications in ZNF708?,cnv_and_ssm
+1148,KRT39,P137S,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in KRT39 along with somatic amplifications in PYHIN1?,cnv_and_ssm
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in PDHA2 along with somatic amplifications in LCN15?,cnv_and_ssm
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in SLC24A2 along with somatic amplifications in DGKD?,cnv_and_ssm
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,To what extent do Liver Hepatocellular Carcinoma cases show somatic mutations in PTPRN2 along with somatic amplifications in PTPRO?,cnv_and_ssm
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,To what extent do Liver Hepatocellular Carcinoma cases show somatic mutations in PTPRN2 along with somatic amplifications in PAK3?,cnv_and_ssm
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,To what extent do Liver Hepatocellular Carcinoma cases show somatic mutations in PTPRN2 along with somatic amplifications in PIAS3?,cnv_and_ssm
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,To what extent do Liver Hepatocellular Carcinoma cases show somatic mutations in PTPRN2 along with somatic amplifications in COL6A3?,cnv_and_ssm
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,To what extent do Liver Hepatocellular Carcinoma cases show somatic mutations in PTPRN2 along with somatic amplifications in SPATA22?,cnv_and_ssm
+1188,SOX21,R55L,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in SOX21 along with somatic amplifications in MAST4?,cnv_and_ssm
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,To what extent do Bladder Urothelial Carcinoma cases show somatic mutations in CPA6 along with somatic amplifications in TYK2?,cnv_and_ssm
+1206,GRM5,E14K,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in GRM5 along with somatic amplifications in ART3?,cnv_and_ssm
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","To what extent do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases show somatic mutations in CASZ1 along with somatic amplifications in NPSR1?",cnv_and_ssm
+1210,SGIP1,N122T,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in SGIP1 along with somatic amplifications in PIAS3?,cnv_and_ssm
+1211,SGIP1,N420T,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in SGIP1 along with somatic amplifications in MAOB?,cnv_and_ssm
+1212,SGIP1,N617T,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in SGIP1 along with somatic amplifications in FCGR2C?,cnv_and_ssm
+1213,SGIP1,N648T,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in SGIP1 along with somatic amplifications in MYH11?,cnv_and_ssm
+1227,CARMIL1,V549L,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in CARMIL1 along with somatic amplifications in SPATA22?,cnv_and_ssm
+1228,CARMIL1,V949L,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in CARMIL1 along with somatic amplifications in SYT10?,cnv_and_ssm
+1232,ZNF431,D121Y,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in ZNF431 along with somatic amplifications in BCAT1?,cnv_and_ssm
+1233,ZNF431,D161Y,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in ZNF431 along with somatic amplifications in DNAH11?,cnv_and_ssm
+1234,ZNF431,R128I,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in ZNF431 along with somatic amplifications in DSCAM?,cnv_and_ssm
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in DNAH11 along with somatic amplifications in NRAP?,cnv_and_ssm
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in DNAH11 along with somatic amplifications in ANKDD1A?,cnv_and_ssm
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in POLD1 along with somatic amplifications in AUTS2?,cnv_and_ssm
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,To what extent do Lung Squamous Cell Carcinoma cases show somatic mutations in POLD1 along with somatic amplifications in CPA6?,cnv_and_ssm
+1248,TTC12,D646H,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in TTC12 along with somatic amplifications in GIMAP2?,cnv_and_ssm
+1249,TTC12,D652H,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in TTC12 along with somatic amplifications in CTSC?,cnv_and_ssm
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,To what extent do Bladder Urothelial Carcinoma cases show somatic mutations in CNGB1 along with somatic amplifications in EPRS1?,cnv_and_ssm
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,To what extent do Bladder Urothelial Carcinoma cases show somatic mutations in CNGB1 along with somatic amplifications in ANKDD1A?,cnv_and_ssm
+1254,CTSC,E214V,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in CTSC along with somatic amplifications in CARMIL1?,cnv_and_ssm
+1255,CTSC,E291V,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in CTSC along with somatic amplifications in GPC3?,cnv_and_ssm
+1256,CTSC,E322V,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in CTSC along with somatic amplifications in POLD1?,cnv_and_ssm
+1257,CTSC,E324V,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in CTSC along with somatic amplifications in TMTC3?,cnv_and_ssm
+1258,CTSC,E335V,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in CTSC along with somatic amplifications in PAK3?,cnv_and_ssm
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in PRSS8 along with somatic amplifications in TTC12?,cnv_and_ssm
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in PRSS8 along with somatic amplifications in PXN?,cnv_and_ssm
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in ARHGEF40 along with somatic amplifications in FGF8?,cnv_and_ssm
+1264,ACTB,A138T,Rectum Adenocarcinoma,To what extent do Rectum Adenocarcinoma cases show somatic mutations in ACTB along with somatic amplifications in TNS1?,cnv_and_ssm
+1265,ACTB,A217T,Rectum Adenocarcinoma,To what extent do Rectum Adenocarcinoma cases show somatic mutations in ACTB along with somatic amplifications in ACTB?,cnv_and_ssm
+1266,ACTB,A244T,Rectum Adenocarcinoma,To what extent do Rectum Adenocarcinoma cases show somatic mutations in ACTB along with somatic amplifications in TLK2?,cnv_and_ssm
+1267,ACTB,A260T,Rectum Adenocarcinoma,To what extent do Rectum Adenocarcinoma cases show somatic mutations in ACTB along with somatic amplifications in TTYH2?,cnv_and_ssm
+1268,YY1AP1,V546D,Glioblastoma Multiforme,To what extent do Glioblastoma Multiforme cases show somatic mutations in YY1AP1 along with somatic amplifications in CACNA1F?,cnv_and_ssm
+1269,YY1AP1,V557D,Glioblastoma Multiforme,To what extent do Glioblastoma Multiforme cases show somatic mutations in YY1AP1 along with somatic amplifications in TRIM45?,cnv_and_ssm
+1270,YY1AP1,V566D,Glioblastoma Multiforme,To what extent do Glioblastoma Multiforme cases show somatic mutations in YY1AP1 along with somatic amplifications in ANKRD24?,cnv_and_ssm
+1271,YY1AP1,V577D,Glioblastoma Multiforme,To what extent do Glioblastoma Multiforme cases show somatic mutations in YY1AP1 along with somatic amplifications in AUTS2?,cnv_and_ssm
+1272,YY1AP1,V623D,Glioblastoma Multiforme,To what extent do Glioblastoma Multiforme cases show somatic mutations in YY1AP1 along with somatic amplifications in ZNF431?,cnv_and_ssm
+1273,YY1AP1,V695D,Glioblastoma Multiforme,To what extent do Glioblastoma Multiforme cases show somatic mutations in YY1AP1 along with somatic amplifications in TNS1?,cnv_and_ssm
+1274,YY1AP1,V715D,Glioblastoma Multiforme,To what extent do Glioblastoma Multiforme cases show somatic mutations in YY1AP1 along with somatic amplifications in SYNJ1?,cnv_and_ssm
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in FNDC7 along with somatic amplifications in TASOR2?,cnv_and_ssm
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in FNDC7 along with somatic amplifications in ZNF627?,cnv_and_ssm
+1299,TLCD5,G15V,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in TLCD5 along with somatic amplifications in HYOU1?,cnv_and_ssm
+1300,TLCD5,G37V,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in TLCD5 along with somatic amplifications in TENT5A?,cnv_and_ssm
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in POLR1G along with somatic amplifications in PTPRO?,cnv_and_ssm
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in POLR1G along with somatic amplifications in YY1AP1?,cnv_and_ssm
+1308,DNAH14,N1186K,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in DNAH14 along with somatic amplifications in PDGFC?,cnv_and_ssm
+1309,DNAH14,N2657K,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in DNAH14 along with somatic amplifications in TRIM45?,cnv_and_ssm
+1310,DNAH14,N3460K,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in DNAH14 along with somatic amplifications in GIMAP2?,cnv_and_ssm
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in NEXN along with somatic amplifications in PGR?,cnv_and_ssm
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,To what extent do Prostate Adenocarcinoma cases show somatic mutations in CYB5R2 along with somatic amplifications in GUK1?,cnv_and_ssm
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,To what extent do Prostate Adenocarcinoma cases show somatic mutations in CYB5R2 along with somatic amplifications in CASZ1?,cnv_and_ssm
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in NRAP along with somatic amplifications in CR1?,cnv_and_ssm
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in NRAP along with somatic amplifications in RIMS2?,cnv_and_ssm
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in NRAP along with somatic amplifications in ZFPM2?,cnv_and_ssm
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in CCDC22 along with somatic amplifications in ZNF217?,cnv_and_ssm
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in DCAF6 along with somatic amplifications in TYK2?,cnv_and_ssm
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in DCAF6 along with somatic amplifications in RIPOR2?,cnv_and_ssm
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in ZNF708 along with somatic amplifications in MYO3B?,cnv_and_ssm
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in BFAR along with somatic amplifications in BICC1?,cnv_and_ssm
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in MAST4 along with somatic amplifications in CCDC22?,cnv_and_ssm
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in MAST4 along with somatic amplifications in VASN?,cnv_and_ssm
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in MAST4 along with somatic amplifications in AUTS2?,cnv_and_ssm
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in MAST4 along with somatic amplifications in PTPRO?,cnv_and_ssm
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in MAST4 along with somatic amplifications in FNDC7?,cnv_and_ssm
+1363,ARMC3,R169C,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in ARMC3 along with somatic amplifications in PRSS8?,cnv_and_ssm
+1364,ARMC3,R432C,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in ARMC3 along with somatic amplifications in DCC?,cnv_and_ssm
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,To what extent do Kidney Renal Clear Cell Carcinoma cases show somatic mutations in TET2 along with somatic amplifications in AUTS2?,cnv_and_ssm
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,To what extent do Kidney Renal Clear Cell Carcinoma cases show somatic mutations in TET2 along with somatic amplifications in ITPRID2?,cnv_and_ssm
+1369,SERPINB10,A353P,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in SERPINB10 along with somatic amplifications in NCKAP5?,cnv_and_ssm
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in STAT3 along with somatic amplifications in FGF8?,cnv_and_ssm
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in MIEF1 along with somatic amplifications in STAT3?,cnv_and_ssm
+1381,ACVR1B,D397N,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in ACVR1B along with somatic amplifications in GRTP1?,cnv_and_ssm
+1382,ACVR1B,D449N,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in ACVR1B along with somatic amplifications in DHX16?,cnv_and_ssm
+1383,ACVR1B,D490N,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in ACVR1B along with somatic amplifications in DEFB115?,cnv_and_ssm
+1393,EBF2,T104I,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in EBF2 along with somatic amplifications in CHODL?,cnv_and_ssm
+1394,EBF2,T252I,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in EBF2 along with somatic amplifications in TENM2?,cnv_and_ssm
+1402,VPS26B,F266L,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in VPS26B along with somatic amplifications in ANKRD30A?,cnv_and_ssm
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","To what extent do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases show somatic mutations in PGR along with somatic amplifications in NPSR1?",cnv_and_ssm
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","To what extent do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases show somatic mutations in PGR along with somatic amplifications in SORCS1?",cnv_and_ssm
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","To what extent do CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases show somatic mutations in PGR along with somatic amplifications in PIK3C2G?",cnv_and_ssm
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,To what extent do Skin Cutaneous Melanoma cases show somatic mutations in ACTA2 along with somatic amplifications in YY1AP1?,cnv_and_ssm
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in THBS4 along with somatic amplifications in SORCS1?,cnv_and_ssm
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in THBS4 along with somatic amplifications in SOX21?,cnv_and_ssm
+1413,PRSS1,S114T,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in PRSS1 along with somatic amplifications in MAOB?,cnv_and_ssm
+1414,PRSS1,S124T,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in PRSS1 along with somatic amplifications in ADRA1A?,cnv_and_ssm
+1415,PRSS1,S138T,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in PRSS1 along with somatic amplifications in PYHIN1?,cnv_and_ssm
+1416,PRSS1,S74T,Lung Adenocarcinoma,To what extent do Lung Adenocarcinoma cases show somatic mutations in PRSS1 along with somatic amplifications in ANKDD1A?,cnv_and_ssm
+1417,PGF,R126H,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in PGF along with somatic amplifications in SPTAN1?,cnv_and_ssm
+1418,PGF,R127H,Stomach Adenocarcinoma,To what extent do Stomach Adenocarcinoma cases show somatic mutations in PGF along with somatic amplifications in DHX16?,cnv_and_ssm
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,To what extent do Breast Invasive Carcinoma cases show somatic mutations in ITPRID2 along with somatic amplifications in ANKRD24?,cnv_and_ssm
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,To what extent do Breast Invasive Carcinoma cases show somatic mutations in ITPRID2 along with somatic amplifications in EIF2B4?,cnv_and_ssm
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in HBB along with somatic amplifications in PTPRO?,cnv_and_ssm
+1441,PCDHB2,R158C,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in PCDHB2 along with somatic amplifications in VPS26B?,cnv_and_ssm
+1442,PCDHB2,T15M,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in PCDHB2 along with somatic amplifications in ART3?,cnv_and_ssm
+1443,PCDHB2,T26M,Colon Adenocarcinoma,To what extent do Colon Adenocarcinoma cases show somatic mutations in PCDHB2 along with somatic amplifications in HSPA5?,cnv_and_ssm
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,To what extent do Uterine Corpus Endometrial Carcinoma cases show somatic mutations in UBR2 along with somatic amplifications in NCKAP5?,cnv_and_ssm
+1452,FBXO42,A618D,Rectum Adenocarcinoma,To what extent do Rectum Adenocarcinoma cases show somatic mutations in FBXO42 along with somatic amplifications in CASZ1?,cnv_and_ssm
+1,TNS1,G1362V,Breast Invasive Carcinoma,How frequently are TNS1 somatic mutations and somatic THBS4 amplifications found in Breast Invasive Carcinoma patients?,cnv_and_ssm
+2,TNS1,G1711V,Breast Invasive Carcinoma,How frequently are TNS1 somatic mutations and somatic AUTS2 amplifications found in Breast Invasive Carcinoma patients?,cnv_and_ssm
+3,TNS1,G1718V,Breast Invasive Carcinoma,How frequently are TNS1 somatic mutations and somatic TNS1 amplifications found in Breast Invasive Carcinoma patients?,cnv_and_ssm
+4,TNS1,G1732V,Breast Invasive Carcinoma,How frequently are TNS1 somatic mutations and somatic DSCAM amplifications found in Breast Invasive Carcinoma patients?,cnv_and_ssm
+5,TNS1,G1824V,Breast Invasive Carcinoma,How frequently are TNS1 somatic mutations and somatic EIF2B4 amplifications found in Breast Invasive Carcinoma patients?,cnv_and_ssm
+6,TNS1,G1857V,Breast Invasive Carcinoma,How frequently are TNS1 somatic mutations and somatic EIF2B4 amplifications found in Breast Invasive Carcinoma patients?,cnv_and_ssm
+7,TNS1,G843V,Breast Invasive Carcinoma,How frequently are TNS1 somatic mutations and somatic TASOR2 amplifications found in Breast Invasive Carcinoma patients?,cnv_and_ssm
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How frequently are EVC2 somatic mutations and somatic PCDHB2 amplifications found in Bladder Urothelial Carcinoma patients?,cnv_and_ssm
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How frequently are EVC2 somatic mutations and somatic MERTK amplifications found in Bladder Urothelial Carcinoma patients?,cnv_and_ssm
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How frequently are CR1 somatic mutations and somatic SYT10 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How frequently are CR1 somatic mutations and somatic MAST4 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+22,TRPA1,S295I,Rectum Adenocarcinoma,How frequently are TRPA1 somatic mutations and somatic LDOC1 amplifications found in Rectum Adenocarcinoma patients?,cnv_and_ssm
+23,TRPA1,S443I,Rectum Adenocarcinoma,How frequently are TRPA1 somatic mutations and somatic ZFAT amplifications found in Rectum Adenocarcinoma patients?,cnv_and_ssm
+24,TAF1C,R299L,Lung Adenocarcinoma,How frequently are TAF1C somatic mutations and somatic CNGB1 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+25,TAF1C,R396L,Lung Adenocarcinoma,How frequently are TAF1C somatic mutations and somatic DCN amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+26,TAF1C,R634L,Lung Adenocarcinoma,How frequently are TAF1C somatic mutations and somatic DNMT1 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+27,TAF1C,R702L,Lung Adenocarcinoma,How frequently are TAF1C somatic mutations and somatic TNS1 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+28,TAF1C,R728L,Lung Adenocarcinoma,How frequently are TAF1C somatic mutations and somatic GRTP1 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How frequently are DPF3 somatic mutations and somatic PRSS1 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How frequently are DPF3 somatic mutations and somatic TTC12 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How frequently are DPF3 somatic mutations and somatic TTC12 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+42,OR2T4,P272H,Lung Adenocarcinoma,How frequently are OR2T4 somatic mutations and somatic YY1AP1 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+43,OR2T4,P300H,Lung Adenocarcinoma,How frequently are OR2T4 somatic mutations and somatic SOX21 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How frequently are FBN1 somatic mutations and somatic SPTAN1 amplifications found in Pancreatic Adenocarcinoma patients?,cnv_and_ssm
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How frequently are MAD1L1 somatic mutations and somatic OR2A12 amplifications found in Prostate Adenocarcinoma patients?,cnv_and_ssm
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How frequently are MAD1L1 somatic mutations and somatic NPSR1 amplifications found in Prostate Adenocarcinoma patients?,cnv_and_ssm
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How frequently are MAD1L1 somatic mutations and somatic MERTK amplifications found in Prostate Adenocarcinoma patients?,cnv_and_ssm
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How frequently are CCNG1 somatic mutations and somatic DCAF6 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How frequently are ANP32E somatic mutations and somatic PRSS1 amplifications found in Kidney Renal Papillary Cell Carcinoma patients?,cnv_and_ssm
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How frequently are ANP32E somatic mutations and somatic ZCCHC14 amplifications found in Kidney Renal Papillary Cell Carcinoma patients?,cnv_and_ssm
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How frequently are ANP32E somatic mutations and somatic DCC amplifications found in Kidney Renal Papillary Cell Carcinoma patients?,cnv_and_ssm
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How frequently are ANP32E somatic mutations and somatic LCN15 amplifications found in Kidney Renal Papillary Cell Carcinoma patients?,cnv_and_ssm
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How frequently are FRY somatic mutations and somatic YY1AP1 amplifications found in Bladder Urothelial Carcinoma patients?,cnv_and_ssm
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How frequently are FRY somatic mutations and somatic CPS1 amplifications found in Bladder Urothelial Carcinoma patients?,cnv_and_ssm
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How frequently are FRY somatic mutations and somatic CTSC amplifications found in Bladder Urothelial Carcinoma patients?,cnv_and_ssm
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How frequently are FRY somatic mutations and somatic PRSS1 amplifications found in Bladder Urothelial Carcinoma patients?,cnv_and_ssm
+70,PAK3,E318K,Skin Cutaneous Melanoma,How frequently are PAK3 somatic mutations and somatic COL6A3 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+71,PAK3,E319K,Skin Cutaneous Melanoma,How frequently are PAK3 somatic mutations and somatic PRSS1 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+72,PAK3,E334K,Skin Cutaneous Melanoma,How frequently are PAK3 somatic mutations and somatic PAK3 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+73,PAK3,E340K,Skin Cutaneous Melanoma,How frequently are PAK3 somatic mutations and somatic GPC3 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+74,PAK3,E355K,Skin Cutaneous Melanoma,How frequently are PAK3 somatic mutations and somatic ACTA2 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How frequently are MUC16 somatic mutations and somatic PTPRO amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How frequently are ZFPM2 somatic mutations and somatic TRAP1 amplifications found in Liver Hepatocellular Carcinoma patients?,cnv_and_ssm
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How frequently are ZFPM2 somatic mutations and somatic CYB5R2 amplifications found in Liver Hepatocellular Carcinoma patients?,cnv_and_ssm
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How frequently are PIK3C2B somatic mutations and somatic SPTAN1 amplifications found in Breast Invasive Carcinoma patients?,cnv_and_ssm
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How frequently are PIK3C2B somatic mutations and somatic CTSC amplifications found in Breast Invasive Carcinoma patients?,cnv_and_ssm
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How frequently are ZNF804A somatic mutations and somatic CYP1A2 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+116,RELN,A2371V,Stomach Adenocarcinoma,How frequently are RELN somatic mutations and somatic MAOB amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are EFCAB12 somatic mutations and somatic ZCCHC14 amplifications found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",cnv_and_ssm
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are EFCAB12 somatic mutations and somatic ZFPM2 amplifications found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",cnv_and_ssm
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How frequently are DEFB115 somatic mutations and somatic OR13C3 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How frequently are ANKDD1A somatic mutations and somatic PRSS8 amplifications found in Bladder Urothelial Carcinoma patients?,cnv_and_ssm
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How frequently are ANKDD1A somatic mutations and somatic SGCZ amplifications found in Bladder Urothelial Carcinoma patients?,cnv_and_ssm
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How frequently are ANKDD1A somatic mutations and somatic EBF2 amplifications found in Bladder Urothelial Carcinoma patients?,cnv_and_ssm
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How frequently are HTR3B somatic mutations and somatic ZFAT amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How frequently are HTR3B somatic mutations and somatic CR1 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How frequently are HTR3B somatic mutations and somatic DEFB115 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+129,ABCC3,R758W,Stomach Adenocarcinoma,How frequently are ABCC3 somatic mutations and somatic MAST4 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How frequently are NOMO1 somatic mutations and somatic GPC3 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How frequently are NOMO1 somatic mutations and somatic GABRA6 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How frequently are HYOU1 somatic mutations and somatic ZMYM3 amplifications found in Bladder Urothelial Carcinoma patients?,cnv_and_ssm
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How frequently are FMO4 somatic mutations and somatic LDOC1 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+140,BICC1,A372V,Exceptional Responders,How frequently are BICC1 somatic mutations and somatic CCNG1 amplifications found in Exceptional Responders patients?,cnv_and_ssm
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How frequently are ZMYM3 somatic mutations and somatic EVC2 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How frequently are ZMYM3 somatic mutations and somatic GABRA6 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How frequently are ZMYM3 somatic mutations and somatic DOCK2 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are XKR4 somatic mutations and somatic CHODL amplifications found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",cnv_and_ssm
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How frequently are ABCC2 somatic mutations and somatic TENT5A amplifications found in Liver Hepatocellular Carcinoma patients?,cnv_and_ssm
+157,OR8K5,R293G,Lung Adenocarcinoma,How frequently are OR8K5 somatic mutations and somatic AKT1 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How frequently are SPTAN1 somatic mutations and somatic PGF amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How frequently are SPTAN1 somatic mutations and somatic PYHIN1 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+164,SYT10,M484I,Rectum Adenocarcinoma,How frequently are SYT10 somatic mutations and somatic MSANTD4 amplifications found in Rectum Adenocarcinoma patients?,cnv_and_ssm
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How frequently are HSPA5 somatic mutations and somatic COL6A3 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+175,UNC5D,L280V,Lung Adenocarcinoma,How frequently are UNC5D somatic mutations and somatic DNMT1 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+176,UNC5D,L635V,Lung Adenocarcinoma,How frequently are UNC5D somatic mutations and somatic ZSCAN31 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+177,UNC5D,L637V,Lung Adenocarcinoma,How frequently are UNC5D somatic mutations and somatic ANKRD52 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+178,UNC5D,L699V,Lung Adenocarcinoma,How frequently are UNC5D somatic mutations and somatic POLD1 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+179,UNC5D,L704V,Lung Adenocarcinoma,How frequently are UNC5D somatic mutations and somatic TRPA1 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+180,UNC5D,L709V,Lung Adenocarcinoma,How frequently are UNC5D somatic mutations and somatic MUC16 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How frequently are DOCK2 somatic mutations and somatic ANKRD30A amplifications found in Kidney Renal Clear Cell Carcinoma patients?,cnv_and_ssm
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How frequently are ZNF627 somatic mutations and somatic TTYH2 amplifications found in Kidney Renal Clear Cell Carcinoma patients?,cnv_and_ssm
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How frequently are CDC42BPA somatic mutations and somatic CNGB1 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+193,MRPL55,H27Y,Colon Adenocarcinoma,How frequently are MRPL55 somatic mutations and somatic KIF20B amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+194,MRPL55,H63Y,Colon Adenocarcinoma,How frequently are MRPL55 somatic mutations and somatic OR5D14 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How frequently are TMTC3 somatic mutations and somatic PTPRN2 amplifications found in Breast Invasive Carcinoma patients?,cnv_and_ssm
+198,EPRS1,K771I,Colon Adenocarcinoma,How frequently are EPRS1 somatic mutations and somatic PCDHB2 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+199,EPRS1,K778I,Colon Adenocarcinoma,How frequently are EPRS1 somatic mutations and somatic KIF20B amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How frequently are GRTP1 somatic mutations and somatic PHLPP1 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How frequently are GRTP1 somatic mutations and somatic CFAP298-TCP10L amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How frequently are TSHZ3 somatic mutations and somatic ZBTB34 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How frequently are TAS1R3 somatic mutations and somatic DGKD amplifications found in HIV+ Tumor Molecular Characterization Project - Cervical Cancer patients?,cnv_and_ssm
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How frequently are PIAS3 somatic mutations and somatic ART3 amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How frequently are PIAS3 somatic mutations and somatic MAD1L1 amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+251,ZNF274,P13R,Stomach Adenocarcinoma,How frequently are ZNF274 somatic mutations and somatic SOX21 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+253,SYNJ1,R795C,Colon Adenocarcinoma,How frequently are SYNJ1 somatic mutations and somatic FGF8 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+254,SYNJ1,R800C,Colon Adenocarcinoma,How frequently are SYNJ1 somatic mutations and somatic FMO4 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+255,SYNJ1,R839C,Colon Adenocarcinoma,How frequently are SYNJ1 somatic mutations and somatic CARMIL1 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+261,DSCAM,V343M,Prostate Adenocarcinoma,How frequently are DSCAM somatic mutations and somatic GSTCD amplifications found in Prostate Adenocarcinoma patients?,cnv_and_ssm
+262,DSCAM,V426M,Prostate Adenocarcinoma,How frequently are DSCAM somatic mutations and somatic CYP1A2 amplifications found in Prostate Adenocarcinoma patients?,cnv_and_ssm
+263,DSCAM,V591M,Prostate Adenocarcinoma,How frequently are DSCAM somatic mutations and somatic TNS1 amplifications found in Prostate Adenocarcinoma patients?,cnv_and_ssm
+267,DGKD,R140H,Exceptional Responders,How frequently are DGKD somatic mutations and somatic DCAF4L2 amplifications found in Exceptional Responders patients?,cnv_and_ssm
+268,DGKD,R160H,Exceptional Responders,How frequently are DGKD somatic mutations and somatic TAF1C amplifications found in Exceptional Responders patients?,cnv_and_ssm
+269,DGKD,R204H,Exceptional Responders,How frequently are DGKD somatic mutations and somatic TTN amplifications found in Exceptional Responders patients?,cnv_and_ssm
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How frequently are PLEKHG6 somatic mutations and somatic PCDHB2 amplifications found in Bladder Urothelial Carcinoma patients?,cnv_and_ssm
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How frequently are PLEKHG6 somatic mutations and somatic TLK2 amplifications found in Bladder Urothelial Carcinoma patients?,cnv_and_ssm
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How frequently are PLEKHG6 somatic mutations and somatic SPTAN1 amplifications found in Bladder Urothelial Carcinoma patients?,cnv_and_ssm
+279,WNT2,D138N,Skin Cutaneous Melanoma,How frequently are WNT2 somatic mutations and somatic PRSS8 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How frequently are GUCY2C somatic mutations and somatic RAB40C amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How frequently are C7orf31 somatic mutations and somatic KANSL1 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are ZKSCAN7 somatic mutations and somatic REXO4 amplifications found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",cnv_and_ssm
+299,OR5D14,M210L,Neuroblastoma,How frequently are OR5D14 somatic mutations and somatic STK19 amplifications found in Neuroblastoma patients?,cnv_and_ssm
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How frequently are SPATA22 somatic mutations and somatic AUTS2 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How frequently are SPATA22 somatic mutations and somatic SGIP1 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How frequently are SPATA22 somatic mutations and somatic PIK3C2A amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+310,LCN15,E21V,Stomach Adenocarcinoma,How frequently are LCN15 somatic mutations and somatic PYHIN1 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How frequently are DCAF4L2 somatic mutations and somatic MORF4L1 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How frequently are GUK1 somatic mutations and somatic OR8K5 amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How frequently are GUK1 somatic mutations and somatic MYO16 amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How frequently are GUK1 somatic mutations and somatic TNS1 amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How frequently are GUK1 somatic mutations and somatic YY1AP1 amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How frequently are GUK1 somatic mutations and somatic DSCAM amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How frequently are MORF4L1 somatic mutations and somatic TTC17 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How frequently are MORF4L1 somatic mutations and somatic KDM5C amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How frequently are MORF4L1 somatic mutations and somatic KL amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How frequently are MORF4L1 somatic mutations and somatic TAF1C amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How frequently are MYO3B somatic mutations and somatic TNS1 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How frequently are MYO3B somatic mutations and somatic DCC amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How frequently are TENT5A somatic mutations and somatic CTSC amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How frequently are TENT5A somatic mutations and somatic AUTS2 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How frequently are TENT5A somatic mutations and somatic ANKRD24 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How frequently are ZFAT somatic mutations and somatic TTN amplifications found in Ovarian Serous Cystadenocarcinoma patients?,cnv_and_ssm
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How frequently are ZFAT somatic mutations and somatic CDH23 amplifications found in Ovarian Serous Cystadenocarcinoma patients?,cnv_and_ssm
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How frequently are ZFAT somatic mutations and somatic SGCZ amplifications found in Ovarian Serous Cystadenocarcinoma patients?,cnv_and_ssm
+357,ZNF584,A211T,Sarcoma,How frequently are ZNF584 somatic mutations and somatic POC1B amplifications found in Sarcoma patients?,cnv_and_ssm
+358,ZNF584,A256T,Sarcoma,How frequently are ZNF584 somatic mutations and somatic ZNF584 amplifications found in Sarcoma patients?,cnv_and_ssm
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How frequently are LDOC1 somatic mutations and somatic CTSC amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How frequently are PDGFC somatic mutations and somatic GPC3 amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How frequently are MSANTD4 somatic mutations and somatic FCGR2C amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How frequently are NPSR1 somatic mutations and somatic DCLK3 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How frequently are PHLPP1 somatic mutations and somatic EIF2B4 amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How frequently are COL6A3 somatic mutations and somatic CASZ1 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How frequently are COL6A3 somatic mutations and somatic POLD1 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How frequently are COL6A3 somatic mutations and somatic TAF1C amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How frequently are COL6A3 somatic mutations and somatic SORCS1 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How frequently are COL6A3 somatic mutations and somatic MYT1 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How frequently are ADRA1A somatic mutations and somatic PCDHB2 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently are LAMB2 somatic mutations and somatic SLC24A2 amplifications found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,cnv_and_ssm
+406,POC1B,I198T,Rectum Adenocarcinoma,How frequently are POC1B somatic mutations and somatic SYT9 amplifications found in Rectum Adenocarcinoma patients?,cnv_and_ssm
+407,POC1B,I286T,Rectum Adenocarcinoma,How frequently are POC1B somatic mutations and somatic TTC12 amplifications found in Rectum Adenocarcinoma patients?,cnv_and_ssm
+408,POC1B,I328T,Rectum Adenocarcinoma,How frequently are POC1B somatic mutations and somatic SPTAN1 amplifications found in Rectum Adenocarcinoma patients?,cnv_and_ssm
+409,POC1B,S79P,Rectum Adenocarcinoma,How frequently are POC1B somatic mutations and somatic MYH11 amplifications found in Rectum Adenocarcinoma patients?,cnv_and_ssm
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How frequently are USH2A somatic mutations and somatic CARMIL1 amplifications found in Liver Hepatocellular Carcinoma patients?,cnv_and_ssm
+414,AQP7,T110S,Rectum Adenocarcinoma,How frequently are AQP7 somatic mutations and somatic EVC2 amplifications found in Rectum Adenocarcinoma patients?,cnv_and_ssm
+415,AQP7,T166S,Rectum Adenocarcinoma,How frequently are AQP7 somatic mutations and somatic ZFAT amplifications found in Rectum Adenocarcinoma patients?,cnv_and_ssm
+416,AQP7,T167S,Rectum Adenocarcinoma,How frequently are AQP7 somatic mutations and somatic BICC1 amplifications found in Rectum Adenocarcinoma patients?,cnv_and_ssm
+417,AQP7,T75S,Rectum Adenocarcinoma,How frequently are AQP7 somatic mutations and somatic MAST4 amplifications found in Rectum Adenocarcinoma patients?,cnv_and_ssm
+430,DCN,R163C,Rectum Adenocarcinoma,How frequently are DCN somatic mutations and somatic FMO4 amplifications found in Rectum Adenocarcinoma patients?,cnv_and_ssm
+431,DCN,R203C,Rectum Adenocarcinoma,How frequently are DCN somatic mutations and somatic ACVR1B amplifications found in Rectum Adenocarcinoma patients?,cnv_and_ssm
+432,DCN,R241C,Rectum Adenocarcinoma,How frequently are DCN somatic mutations and somatic ZKSCAN7 amplifications found in Rectum Adenocarcinoma patients?,cnv_and_ssm
+433,DCN,R350C,Rectum Adenocarcinoma,How frequently are DCN somatic mutations and somatic POLR1G amplifications found in Rectum Adenocarcinoma patients?,cnv_and_ssm
+434,DCN,R41C,Rectum Adenocarcinoma,How frequently are DCN somatic mutations and somatic SPATA22 amplifications found in Rectum Adenocarcinoma patients?,cnv_and_ssm
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How frequently are CPS1 somatic mutations and somatic GABRA6 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How frequently are CPS1 somatic mutations and somatic POLD1 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How frequently are CPS1 somatic mutations and somatic RIMS2 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How frequently are FCGR2C somatic mutations and somatic BCAT1 amplifications found in Kidney Renal Papillary Cell Carcinoma patients?,cnv_and_ssm
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How frequently are FCGR2C somatic mutations and somatic DPF3 amplifications found in Kidney Renal Papillary Cell Carcinoma patients?,cnv_and_ssm
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How frequently are GRM1 somatic mutations and somatic DNAH11 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+482,SGCZ,Q138H,Lung Adenocarcinoma,How frequently are SGCZ somatic mutations and somatic KANSL1 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+483,SGCZ,Q91H,Lung Adenocarcinoma,How frequently are SGCZ somatic mutations and somatic TLK2 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+485,SMO,V15M,Stomach Adenocarcinoma,How frequently are SMO somatic mutations and somatic SOX21 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+486,SMO,V321M,Stomach Adenocarcinoma,How frequently are SMO somatic mutations and somatic COL6A3 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+488,CHODL,G159E,Skin Cutaneous Melanoma,How frequently are CHODL somatic mutations and somatic LAMB2 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+489,CHODL,G181E,Skin Cutaneous Melanoma,How frequently are CHODL somatic mutations and somatic ABCC3 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+490,CHODL,G200E,Skin Cutaneous Melanoma,How frequently are CHODL somatic mutations and somatic CASZ1 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+494,MYO16,P399H,Colon Adenocarcinoma,How frequently are MYO16 somatic mutations and somatic SPATA22 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+495,MYO16,P421H,Colon Adenocarcinoma,How frequently are MYO16 somatic mutations and somatic TTC12 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+498,CXCR2,A98V,Stomach Adenocarcinoma,How frequently are CXCR2 somatic mutations and somatic GPC3 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How frequently are TMEM225 somatic mutations and somatic TYK2 amplifications found in Bladder Urothelial Carcinoma patients?,cnv_and_ssm
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How frequently are MAOB somatic mutations and somatic PLEKHG6 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How frequently are GPRASP1 somatic mutations and somatic TRAP1 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How frequently are MRPL32 somatic mutations and somatic HYOU1 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How frequently are TYROBP somatic mutations and somatic PRSS1 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+510,RAB40C,A111V,Lung Adenocarcinoma,How frequently are RAB40C somatic mutations and somatic ZNF708 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+511,RAB40C,A143V,Lung Adenocarcinoma,How frequently are RAB40C somatic mutations and somatic GUK1 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+512,CTNNA2,S323R,Lung Adenocarcinoma,How frequently are CTNNA2 somatic mutations and somatic DSCAM amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+513,CTNNA2,S339R,Lung Adenocarcinoma,How frequently are CTNNA2 somatic mutations and somatic DNMT1 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+514,CTNNA2,S386R,Lung Adenocarcinoma,How frequently are CTNNA2 somatic mutations and somatic TENM2 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+515,CTNNA2,S707R,Lung Adenocarcinoma,How frequently are CTNNA2 somatic mutations and somatic TTC17 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How frequently are MYO15A somatic mutations and somatic DHX16 amplifications found in Bladder Urothelial Carcinoma patients?,cnv_and_ssm
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How frequently are GIMAP2 somatic mutations and somatic RIMS2 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+532,KIF20B,N1160D,Glioblastoma Multiforme,How frequently are KIF20B somatic mutations and somatic TASOR2 amplifications found in Glioblastoma Multiforme patients?,cnv_and_ssm
+533,KIF20B,N1200D,Glioblastoma Multiforme,How frequently are KIF20B somatic mutations and somatic AUTS2 amplifications found in Glioblastoma Multiforme patients?,cnv_and_ssm
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How frequently are ADAM17 somatic mutations and somatic DCN amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How frequently are BCAT1 somatic mutations and somatic FBXO15 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How frequently are BCAT1 somatic mutations and somatic GSTCD amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How frequently are BCAT1 somatic mutations and somatic BCAT1 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+540,ERCC6,R1053H,Colon Adenocarcinoma,How frequently are ERCC6 somatic mutations and somatic NCKAP5 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+541,DCC,R320W,Breast Invasive Carcinoma,How frequently are DCC somatic mutations and somatic TNS1 amplifications found in Breast Invasive Carcinoma patients?,cnv_and_ssm
+542,DCC,R363W,Breast Invasive Carcinoma,How frequently are DCC somatic mutations and somatic DSCAM amplifications found in Breast Invasive Carcinoma patients?,cnv_and_ssm
+543,DCC,R386W,Breast Invasive Carcinoma,How frequently are DCC somatic mutations and somatic DCN amplifications found in Breast Invasive Carcinoma patients?,cnv_and_ssm
+544,DCC,R41W,Breast Invasive Carcinoma,How frequently are DCC somatic mutations and somatic MAST4 amplifications found in Breast Invasive Carcinoma patients?,cnv_and_ssm
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How frequently are FBXO15 somatic mutations and somatic MORF4L1 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How frequently are FBXO15 somatic mutations and somatic FRY amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How frequently are GSTCD somatic mutations and somatic GUF1 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How frequently are GSTCD somatic mutations and somatic MAST4 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How frequently are OLFML3 somatic mutations and somatic PLEKHG6 amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How frequently are OLFML3 somatic mutations and somatic ZNF274 amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How frequently are OLFML3 somatic mutations and somatic ZNF627 amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How frequently are CFAP61 somatic mutations and somatic KRT39 amplifications found in Ovarian Serous Cystadenocarcinoma patients?,cnv_and_ssm
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How frequently are CFAP61 somatic mutations and somatic ART3 amplifications found in Ovarian Serous Cystadenocarcinoma patients?,cnv_and_ssm
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How frequently are HLA-DQA2 somatic mutations and somatic OLFML3 amplifications found in Bladder Urothelial Carcinoma patients?,cnv_and_ssm
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How frequently are TENM2 somatic mutations and somatic TYK2 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How frequently are TENM2 somatic mutations and somatic CX3CR1 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How frequently are TENM2 somatic mutations and somatic GABRA6 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How frequently are ANKRD24 somatic mutations and somatic CEP20 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How frequently are ANKRD24 somatic mutations and somatic TYROBP amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How frequently are ANKRD24 somatic mutations and somatic TYROBP amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How frequently are ZCCHC14 somatic mutations and somatic SPTAN1 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How frequently are ZCCHC14 somatic mutations and somatic B3GALNT1 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How frequently are ZCCHC14 somatic mutations and somatic PTPRO amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How frequently are ZCCHC14 somatic mutations and somatic ZNF584 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+625,SIK2,I265M,Lung Adenocarcinoma,How frequently are SIK2 somatic mutations and somatic NRAP amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How frequently are MYH11 somatic mutations and somatic TNS1 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How frequently are MYH11 somatic mutations and somatic EIF2B4 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How frequently are SLC6A4 somatic mutations and somatic MYO3B amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How frequently are SLC9C1 somatic mutations and somatic GABRA6 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How frequently are SLC9C1 somatic mutations and somatic RIPOR2 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+644,OR2A12,A254T,Brain Lower Grade Glioma,How frequently are OR2A12 somatic mutations and somatic MUC16 amplifications found in Brain Lower Grade Glioma patients?,cnv_and_ssm
+646,PYHIN1,T325K,Lung Adenocarcinoma,How frequently are PYHIN1 somatic mutations and somatic ZNF584 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+647,PYHIN1,T334K,Lung Adenocarcinoma,How frequently are PYHIN1 somatic mutations and somatic CTSC amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+650,JAML,G191E,Skin Cutaneous Melanoma,How frequently are JAML somatic mutations and somatic SPATA22 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+651,JAML,G219E,Skin Cutaneous Melanoma,How frequently are JAML somatic mutations and somatic GPRASP1 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+652,JAML,G220E,Skin Cutaneous Melanoma,How frequently are JAML somatic mutations and somatic AQP7 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+653,JAML,G230E,Skin Cutaneous Melanoma,How frequently are JAML somatic mutations and somatic GPR158 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+658,TYK2,H1146R,Stomach Adenocarcinoma,How frequently are TYK2 somatic mutations and somatic TTN amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+659,TYK2,H23R,Stomach Adenocarcinoma,How frequently are TYK2 somatic mutations and somatic GUCY2C amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+660,TYK2,H961R,Stomach Adenocarcinoma,How frequently are TYK2 somatic mutations and somatic CTCFL amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How frequently are CTCFL somatic mutations and somatic GLRB amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How frequently are CTCFL somatic mutations and somatic FGF8 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How frequently are CTCFL somatic mutations and somatic CHODL amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How frequently are CTCFL somatic mutations and somatic GPC3 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How frequently are CEP20 somatic mutations and somatic CTNNA2 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How frequently are CEP20 somatic mutations and somatic GPC3 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How frequently are RIMS2 somatic mutations and somatic SPAG1 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How frequently are RIMS2 somatic mutations and somatic CFAP298-TCP10L amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How frequently are RIMS2 somatic mutations and somatic DCN amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How frequently are RIMS2 somatic mutations and somatic CTSC amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How frequently are RIMS2 somatic mutations and somatic TLK2 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How frequently are RIMS2 somatic mutations and somatic RIMS2 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How frequently are RIMS2 somatic mutations and somatic FNDC7 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How frequently are PIK3C2G somatic mutations and somatic PRSS1 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How frequently are PIK3C2G somatic mutations and somatic RIMS2 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+728,STK19,D341N,Colon Adenocarcinoma,How frequently are STK19 somatic mutations and somatic RIMS2 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+729,STK19,D345N,Colon Adenocarcinoma,How frequently are STK19 somatic mutations and somatic YY1AP1 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+730,REXO4,P60A,Skin Cutaneous Melanoma,How frequently are REXO4 somatic mutations and somatic TYK2 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How frequently are ZBTB34 somatic mutations and somatic COL6A3 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How frequently are ZBTB34 somatic mutations and somatic NPSR1 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How frequently are NCKAP5 somatic mutations and somatic YY1AP1 amplifications found in Bladder Urothelial Carcinoma patients?,cnv_and_ssm
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are SORCS1 somatic mutations and somatic ANP32E amplifications found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",cnv_and_ssm
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are SORCS1 somatic mutations and somatic CFAP61 amplifications found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",cnv_and_ssm
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are SORCS1 somatic mutations and somatic DCAF6 amplifications found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",cnv_and_ssm
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are SORCS1 somatic mutations and somatic OLFML3 amplifications found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",cnv_and_ssm
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How frequently are FGF8 somatic mutations and somatic CTSC amplifications found in Head and Neck Squamous Cell Carcinoma patients?,cnv_and_ssm
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How frequently are FGF8 somatic mutations and somatic CACNA1F amplifications found in Head and Neck Squamous Cell Carcinoma patients?,cnv_and_ssm
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How frequently are FGF8 somatic mutations and somatic TAS1R3 amplifications found in Head and Neck Squamous Cell Carcinoma patients?,cnv_and_ssm
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How frequently are FGF8 somatic mutations and somatic CCNG1 amplifications found in Head and Neck Squamous Cell Carcinoma patients?,cnv_and_ssm
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How frequently are FGF8 somatic mutations and somatic NCKAP5 amplifications found in Head and Neck Squamous Cell Carcinoma patients?,cnv_and_ssm
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How frequently are TENM3 somatic mutations and somatic CHMP7 amplifications found in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia patients?,cnv_and_ssm
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How frequently are AKT1 somatic mutations and somatic CTNNA2 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently are CFAP298-TCP10L somatic mutations and somatic ZNF431 amplifications found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,cnv_and_ssm
+792,GLRB,E148D,Stomach Adenocarcinoma,How frequently are GLRB somatic mutations and somatic AUTS2 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+793,TTN,F7636L,Colon Adenocarcinoma,How frequently are TTN somatic mutations and somatic FNDC7 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+794,TTN,F8563L,Colon Adenocarcinoma,How frequently are TTN somatic mutations and somatic SGCZ amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+795,TTN,F8880L,Colon Adenocarcinoma,How frequently are TTN somatic mutations and somatic PTPRO amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How frequently are ANKRD30A somatic mutations and somatic BFAR amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How frequently are ANKRD30A somatic mutations and somatic DNAH14 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How frequently are ANKRD30A somatic mutations and somatic CTCFL amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+809,TRIM45,S177L,Colon Adenocarcinoma,How frequently are TRIM45 somatic mutations and somatic KDM5C amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+810,TRIM45,S224L,Colon Adenocarcinoma,How frequently are TRIM45 somatic mutations and somatic CTSC amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+811,TRIM45,S281L,Colon Adenocarcinoma,How frequently are TRIM45 somatic mutations and somatic GABRA6 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How frequently are CACNA1F somatic mutations and somatic YY1AP1 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How frequently are CACNA1F somatic mutations and somatic GUK1 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How frequently are CACNA1F somatic mutations and somatic DCAF4L2 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+817,KL,R594C,Colon Adenocarcinoma,How frequently are KL somatic mutations and somatic TRAP1 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How frequently are GUF1 somatic mutations and somatic JAML amplifications found in Kidney Renal Papillary Cell Carcinoma patients?,cnv_and_ssm
+822,TAF1L,A539V,Colon Adenocarcinoma,How frequently are TAF1L somatic mutations and somatic PTPRN2 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How frequently are TASOR2 somatic mutations and somatic OR13C3 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How frequently are TASOR2 somatic mutations and somatic REXO4 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How frequently are TASOR2 somatic mutations and somatic PGF amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How frequently are KDM5C somatic mutations and somatic VPS26B amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How frequently are KDM5C somatic mutations and somatic TENM3 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How frequently are KDM5C somatic mutations and somatic ZFPM2 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How frequently are KDM5C somatic mutations and somatic MRPL32 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently are IL5RA somatic mutations and somatic POLD1 amplifications found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,cnv_and_ssm
+843,DHX16,A29V,Skin Cutaneous Melanoma,How frequently are DHX16 somatic mutations and somatic LAMB2 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+844,DHX16,A89V,Skin Cutaneous Melanoma,How frequently are DHX16 somatic mutations and somatic PAK3 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+902,GPR158,A644V,Stomach Adenocarcinoma,How frequently are GPR158 somatic mutations and somatic ZMYM3 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+903,GPR158,A723V,Stomach Adenocarcinoma,How frequently are GPR158 somatic mutations and somatic TTN amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are EIF2B4 somatic mutations and somatic KANSL1 amplifications found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",cnv_and_ssm
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are EIF2B4 somatic mutations and somatic SGIP1 amplifications found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",cnv_and_ssm
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are EIF2B4 somatic mutations and somatic ANKRD24 amplifications found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",cnv_and_ssm
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are EIF2B4 somatic mutations and somatic GABRA6 amplifications found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",cnv_and_ssm
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are EIF2B4 somatic mutations and somatic RIMS2 amplifications found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",cnv_and_ssm
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are EIF2B4 somatic mutations and somatic GABRA6 amplifications found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",cnv_and_ssm
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How frequently are AUTS2 somatic mutations and somatic DCC amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How frequently are AUTS2 somatic mutations and somatic MYT1 amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How frequently are AUTS2 somatic mutations and somatic AQP7 amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How frequently are AUTS2 somatic mutations and somatic ZNF708 amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How frequently are AUTS2 somatic mutations and somatic CYP1A2 amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How frequently are AUTS2 somatic mutations and somatic CFAP298-TCP10L amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How frequently are AUTS2 somatic mutations and somatic POC1B amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How frequently are AUTS2 somatic mutations and somatic JAML amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How frequently are AUTS2 somatic mutations and somatic GPR158 amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How frequently are AUTS2 somatic mutations and somatic TRIM45 amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are ACTL7B somatic mutations and somatic PIK3C2B amplifications found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",cnv_and_ssm
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How frequently are PCDHGA1 somatic mutations and somatic DNAH11 amplifications found in Glioblastoma Multiforme patients?,cnv_and_ssm
+954,TRAP1,R114W,Stomach Adenocarcinoma,How frequently are TRAP1 somatic mutations and somatic TSHZ3 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+955,TRAP1,R61W,Stomach Adenocarcinoma,How frequently are TRAP1 somatic mutations and somatic MYO16 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How frequently are PIK3C2A somatic mutations and somatic GABRA6 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How frequently are KANSL1 somatic mutations and somatic CTNNA2 amplifications found in Liver Hepatocellular Carcinoma patients?,cnv_and_ssm
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How frequently are ANKRD52 somatic mutations and somatic PTPRO amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How frequently are PAPPA somatic mutations and somatic DNAH11 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How frequently are B3GALNT1 somatic mutations and somatic EIF2B4 amplifications found in Rectum Adenocarcinoma patients?,cnv_and_ssm
+982,GABRA6,G115R,Lung Adenocarcinoma,How frequently are GABRA6 somatic mutations and somatic ANP32E amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+983,GABRA6,G122R,Lung Adenocarcinoma,How frequently are GABRA6 somatic mutations and somatic TLK2 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+984,GABRA6,G165R,Lung Adenocarcinoma,How frequently are GABRA6 somatic mutations and somatic SPTAN1 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+985,GABRA6,G175R,Lung Adenocarcinoma,How frequently are GABRA6 somatic mutations and somatic AUTS2 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+986,GABRA6,G70R,Lung Adenocarcinoma,How frequently are GABRA6 somatic mutations and somatic CFAP61 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How frequently are ZSCAN31 somatic mutations and somatic TTC12 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are MED16 somatic mutations and somatic NOMO1 amplifications found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",cnv_and_ssm
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are MED16 somatic mutations and somatic SPTAN1 amplifications found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",cnv_and_ssm
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How frequently are PTPRO somatic mutations and somatic DGKD amplifications found in Pancreatic Adenocarcinoma patients?,cnv_and_ssm
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How frequently are PTPRO somatic mutations and somatic MYT1 amplifications found in Pancreatic Adenocarcinoma patients?,cnv_and_ssm
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How frequently are PTPRO somatic mutations and somatic ADAM17 amplifications found in Pancreatic Adenocarcinoma patients?,cnv_and_ssm
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How frequently are PTPRO somatic mutations and somatic CTSC amplifications found in Pancreatic Adenocarcinoma patients?,cnv_and_ssm
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How frequently are PTPRO somatic mutations and somatic THBS4 amplifications found in Pancreatic Adenocarcinoma patients?,cnv_and_ssm
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How frequently are PTPRO somatic mutations and somatic SYT9 amplifications found in Pancreatic Adenocarcinoma patients?,cnv_and_ssm
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How frequently are PTPRO somatic mutations and somatic SMO amplifications found in Pancreatic Adenocarcinoma patients?,cnv_and_ssm
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How frequently are PTPRO somatic mutations and somatic DHX16 amplifications found in Pancreatic Adenocarcinoma patients?,cnv_and_ssm
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How frequently are CHMP7 somatic mutations and somatic YY1AP1 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1017,GPC3,I107N,Stomach Adenocarcinoma,How frequently are GPC3 somatic mutations and somatic RAB40C amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+1018,GPC3,I161N,Stomach Adenocarcinoma,How frequently are GPC3 somatic mutations and somatic FRY amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently are TLK2 somatic mutations and somatic TTC12 amplifications found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,cnv_and_ssm
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently are TLK2 somatic mutations and somatic SPTAN1 amplifications found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,cnv_and_ssm
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently are TLK2 somatic mutations and somatic PGR amplifications found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,cnv_and_ssm
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently are TLK2 somatic mutations and somatic TTYH2 amplifications found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,cnv_and_ssm
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently are TLK2 somatic mutations and somatic DNAH11 amplifications found in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma patients?,cnv_and_ssm
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How frequently are ZNF217 somatic mutations and somatic CHODL amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+1038,SYT9,V275L,Lung Adenocarcinoma,How frequently are SYT9 somatic mutations and somatic GPC3 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+1039,SYT9,V307L,Lung Adenocarcinoma,How frequently are SYT9 somatic mutations and somatic PRSS8 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How frequently are PKHD1L1 somatic mutations and somatic ANKRD24 amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How frequently are MYO3A somatic mutations and somatic GPR158 amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are VASN somatic mutations and somatic DGKD amplifications found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",cnv_and_ssm
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How frequently are DNMT1 somatic mutations and somatic NOMO1 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How frequently are DNMT1 somatic mutations and somatic PRSS1 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How frequently are DNMT1 somatic mutations and somatic EIF2B4 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1056,CA9,E402K,Colon Adenocarcinoma,How frequently are CA9 somatic mutations and somatic DPF3 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How frequently are TTC17 somatic mutations and somatic UNC5D amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How frequently are TTC17 somatic mutations and somatic POC1B amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1065,PSG2,P43L,Breast Invasive Carcinoma,How frequently are PSG2 somatic mutations and somatic MYT1 amplifications found in Breast Invasive Carcinoma patients?,cnv_and_ssm
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How frequently are RIPOR2 somatic mutations and somatic GPR158 amplifications found in Breast Invasive Carcinoma patients?,cnv_and_ssm
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How frequently are RIPOR2 somatic mutations and somatic CPS1 amplifications found in Breast Invasive Carcinoma patients?,cnv_and_ssm
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How frequently are RIPOR2 somatic mutations and somatic FNDC7 amplifications found in Breast Invasive Carcinoma patients?,cnv_and_ssm
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How frequently are RIPOR2 somatic mutations and somatic PCDHB2 amplifications found in Breast Invasive Carcinoma patients?,cnv_and_ssm
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How frequently are DCLK3 somatic mutations and somatic RIMS2 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How frequently are DCLK3 somatic mutations and somatic FRY amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How frequently are MERTK somatic mutations and somatic PTPRO amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How frequently are MERTK somatic mutations and somatic ZNF274 amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How frequently are MERTK somatic mutations and somatic CTNNA2 amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How frequently are ZFP42 somatic mutations and somatic SGIP1 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How frequently are OR13C3 somatic mutations and somatic ARMC3 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How frequently are OR13C3 somatic mutations and somatic ZCCHC14 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How frequently are SPAG1 somatic mutations and somatic SMO amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How frequently are CDKN2AIP somatic mutations and somatic STK19 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1093,PXN,H1016Y,Colon Adenocarcinoma,How frequently are PXN somatic mutations and somatic CASZ1 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+1094,PXN,H359Y,Colon Adenocarcinoma,How frequently are PXN somatic mutations and somatic MYO3B amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+1095,PXN,H492Y,Colon Adenocarcinoma,How frequently are PXN somatic mutations and somatic SORCS1 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+1096,PXN,H524Y,Colon Adenocarcinoma,How frequently are PXN somatic mutations and somatic PYHIN1 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+1097,PXN,H526Y,Colon Adenocarcinoma,How frequently are PXN somatic mutations and somatic DCAF6 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+1098,PXN,H540Y,Colon Adenocarcinoma,How frequently are PXN somatic mutations and somatic PAK3 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How frequently are TTYH2 somatic mutations and somatic PTPRN2 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How frequently are TTYH2 somatic mutations and somatic RIMS2 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How frequently are TMEM255A somatic mutations and somatic DSCAM amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How frequently are TMEM255A somatic mutations and somatic GRTP1 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How frequently are TMEM255A somatic mutations and somatic SYT10 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How frequently are TASOR2 somatic mutations and somatic TASOR2 amplifications found in Breast Invasive Carcinoma patients?,cnv_and_ssm
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How frequently are TASOR2 somatic mutations and somatic TENM2 amplifications found in Breast Invasive Carcinoma patients?,cnv_and_ssm
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How frequently are ICE1 somatic mutations and somatic TNS1 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1112,MYT1,A558E,Breast Invasive Carcinoma,How frequently are MYT1 somatic mutations and somatic ART3 amplifications found in Breast Invasive Carcinoma patients?,cnv_and_ssm
+1113,MYT1,A879E,Breast Invasive Carcinoma,How frequently are MYT1 somatic mutations and somatic YY1AP1 amplifications found in Breast Invasive Carcinoma patients?,cnv_and_ssm
+1114,MYT1,A906E,Breast Invasive Carcinoma,How frequently are MYT1 somatic mutations and somatic AQP7 amplifications found in Breast Invasive Carcinoma patients?,cnv_and_ssm
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How frequently are CX3CR1 somatic mutations and somatic TMEM255A amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How frequently are CX3CR1 somatic mutations and somatic PXN amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How frequently are SPINDOC somatic mutations and somatic DCC amplifications found in Liver Hepatocellular Carcinoma patients?,cnv_and_ssm
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How frequently are ART3 somatic mutations and somatic MYT1 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How frequently are ART3 somatic mutations and somatic DCN amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How frequently are CYP1A2 somatic mutations and somatic ZBTB34 amplifications found in Bladder Urothelial Carcinoma patients?,cnv_and_ssm
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are ADRA1A somatic mutations and somatic TRPA1 amplifications found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",cnv_and_ssm
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How frequently are CDH23 somatic mutations and somatic ACTB amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How frequently are CDH23 somatic mutations and somatic GSTCD amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How frequently are KRT39 somatic mutations and somatic ZNF431 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How frequently are PDHA2 somatic mutations and somatic MAST4 amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How frequently are SLC24A2 somatic mutations and somatic TNS1 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How frequently are PTPRN2 somatic mutations and somatic ZMYM3 amplifications found in Liver Hepatocellular Carcinoma patients?,cnv_and_ssm
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How frequently are PTPRN2 somatic mutations and somatic RIMS2 amplifications found in Liver Hepatocellular Carcinoma patients?,cnv_and_ssm
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How frequently are PTPRN2 somatic mutations and somatic RIMS2 amplifications found in Liver Hepatocellular Carcinoma patients?,cnv_and_ssm
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How frequently are PTPRN2 somatic mutations and somatic MRPL55 amplifications found in Liver Hepatocellular Carcinoma patients?,cnv_and_ssm
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How frequently are PTPRN2 somatic mutations and somatic DNAH14 amplifications found in Liver Hepatocellular Carcinoma patients?,cnv_and_ssm
+1188,SOX21,R55L,Lung Adenocarcinoma,How frequently are SOX21 somatic mutations and somatic PTPRO amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How frequently are CPA6 somatic mutations and somatic ZNF804A amplifications found in Bladder Urothelial Carcinoma patients?,cnv_and_ssm
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How frequently are GRM5 somatic mutations and somatic PRSS1 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are CASZ1 somatic mutations and somatic HBB amplifications found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",cnv_and_ssm
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How frequently are SGIP1 somatic mutations and somatic DCN amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How frequently are SGIP1 somatic mutations and somatic MYT1 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How frequently are SGIP1 somatic mutations and somatic MAOB amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How frequently are SGIP1 somatic mutations and somatic ZFP42 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How frequently are CARMIL1 somatic mutations and somatic RIMS2 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How frequently are CARMIL1 somatic mutations and somatic MED16 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How frequently are ZNF431 somatic mutations and somatic SPAG1 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How frequently are ZNF431 somatic mutations and somatic MYO3B amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+1234,ZNF431,R128I,Lung Adenocarcinoma,How frequently are ZNF431 somatic mutations and somatic DCN amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How frequently are DNAH11 somatic mutations and somatic TTC12 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How frequently are DNAH11 somatic mutations and somatic POC1B amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How frequently are POLD1 somatic mutations and somatic CYP1A2 amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How frequently are POLD1 somatic mutations and somatic WNT2 amplifications found in Lung Squamous Cell Carcinoma patients?,cnv_and_ssm
+1248,TTC12,D646H,Lung Adenocarcinoma,How frequently are TTC12 somatic mutations and somatic TNS1 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+1249,TTC12,D652H,Lung Adenocarcinoma,How frequently are TTC12 somatic mutations and somatic COL6A3 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How frequently are CNGB1 somatic mutations and somatic DCN amplifications found in Bladder Urothelial Carcinoma patients?,cnv_and_ssm
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How frequently are CNGB1 somatic mutations and somatic PXN amplifications found in Bladder Urothelial Carcinoma patients?,cnv_and_ssm
+1254,CTSC,E214V,Stomach Adenocarcinoma,How frequently are CTSC somatic mutations and somatic POLD1 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+1255,CTSC,E291V,Stomach Adenocarcinoma,How frequently are CTSC somatic mutations and somatic SGIP1 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+1256,CTSC,E322V,Stomach Adenocarcinoma,How frequently are CTSC somatic mutations and somatic AKT1 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+1257,CTSC,E324V,Stomach Adenocarcinoma,How frequently are CTSC somatic mutations and somatic LDOC1 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+1258,CTSC,E335V,Stomach Adenocarcinoma,How frequently are CTSC somatic mutations and somatic POLD1 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How frequently are PRSS8 somatic mutations and somatic CYB5R2 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How frequently are PRSS8 somatic mutations and somatic CCDC22 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How frequently are ARHGEF40 somatic mutations and somatic CTNNA2 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+1264,ACTB,A138T,Rectum Adenocarcinoma,How frequently are ACTB somatic mutations and somatic SYT9 amplifications found in Rectum Adenocarcinoma patients?,cnv_and_ssm
+1265,ACTB,A217T,Rectum Adenocarcinoma,How frequently are ACTB somatic mutations and somatic AUTS2 amplifications found in Rectum Adenocarcinoma patients?,cnv_and_ssm
+1266,ACTB,A244T,Rectum Adenocarcinoma,How frequently are ACTB somatic mutations and somatic PXN amplifications found in Rectum Adenocarcinoma patients?,cnv_and_ssm
+1267,ACTB,A260T,Rectum Adenocarcinoma,How frequently are ACTB somatic mutations and somatic AUTS2 amplifications found in Rectum Adenocarcinoma patients?,cnv_and_ssm
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How frequently are YY1AP1 somatic mutations and somatic CNGB1 amplifications found in Glioblastoma Multiforme patients?,cnv_and_ssm
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How frequently are YY1AP1 somatic mutations and somatic TMEM255A amplifications found in Glioblastoma Multiforme patients?,cnv_and_ssm
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How frequently are YY1AP1 somatic mutations and somatic DCLK3 amplifications found in Glioblastoma Multiforme patients?,cnv_and_ssm
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How frequently are YY1AP1 somatic mutations and somatic MAST4 amplifications found in Glioblastoma Multiforme patients?,cnv_and_ssm
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How frequently are YY1AP1 somatic mutations and somatic UNC5D amplifications found in Glioblastoma Multiforme patients?,cnv_and_ssm
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How frequently are YY1AP1 somatic mutations and somatic PCDHB2 amplifications found in Glioblastoma Multiforme patients?,cnv_and_ssm
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How frequently are YY1AP1 somatic mutations and somatic DCAF4L2 amplifications found in Glioblastoma Multiforme patients?,cnv_and_ssm
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How frequently are FNDC7 somatic mutations and somatic EIF2B4 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How frequently are FNDC7 somatic mutations and somatic CTSC amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+1299,TLCD5,G15V,Lung Adenocarcinoma,How frequently are TLCD5 somatic mutations and somatic TLK2 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+1300,TLCD5,G37V,Lung Adenocarcinoma,How frequently are TLCD5 somatic mutations and somatic JAML amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How frequently are POLR1G somatic mutations and somatic SYNJ1 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How frequently are POLR1G somatic mutations and somatic ACTB amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How frequently are DNAH14 somatic mutations and somatic STK19 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How frequently are DNAH14 somatic mutations and somatic FMO4 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How frequently are DNAH14 somatic mutations and somatic MED16 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How frequently are NEXN somatic mutations and somatic GUK1 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How frequently are CYB5R2 somatic mutations and somatic EIF2B4 amplifications found in Prostate Adenocarcinoma patients?,cnv_and_ssm
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How frequently are CYB5R2 somatic mutations and somatic TSHZ3 amplifications found in Prostate Adenocarcinoma patients?,cnv_and_ssm
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How frequently are NRAP somatic mutations and somatic DCLK3 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How frequently are NRAP somatic mutations and somatic POC1B amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How frequently are NRAP somatic mutations and somatic TRIM45 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How frequently are CCDC22 somatic mutations and somatic MYO3B amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How frequently are DCAF6 somatic mutations and somatic SORCS1 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How frequently are DCAF6 somatic mutations and somatic GUK1 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How frequently are ZNF708 somatic mutations and somatic PHLPP1 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How frequently are BFAR somatic mutations and somatic CTSC amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How frequently are MAST4 somatic mutations and somatic SGIP1 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How frequently are MAST4 somatic mutations and somatic KIF20B amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How frequently are MAST4 somatic mutations and somatic CA9 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How frequently are MAST4 somatic mutations and somatic CTSC amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How frequently are MAST4 somatic mutations and somatic TNS1 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How frequently are ARMC3 somatic mutations and somatic CXCR2 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How frequently are ARMC3 somatic mutations and somatic DCN amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How frequently are TET2 somatic mutations and somatic CHMP7 amplifications found in Kidney Renal Clear Cell Carcinoma patients?,cnv_and_ssm
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How frequently are TET2 somatic mutations and somatic GABRA6 amplifications found in Kidney Renal Clear Cell Carcinoma patients?,cnv_and_ssm
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How frequently are SERPINB10 somatic mutations and somatic FNDC7 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How frequently are STAT3 somatic mutations and somatic GSTCD amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How frequently are MIEF1 somatic mutations and somatic RIMS2 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How frequently are ACVR1B somatic mutations and somatic PRSS1 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How frequently are ACVR1B somatic mutations and somatic ANKDD1A amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How frequently are ACVR1B somatic mutations and somatic REXO4 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+1393,EBF2,T104I,Stomach Adenocarcinoma,How frequently are EBF2 somatic mutations and somatic TMEM255A amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+1394,EBF2,T252I,Stomach Adenocarcinoma,How frequently are EBF2 somatic mutations and somatic UNC5D amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How frequently are VPS26B somatic mutations and somatic NPSR1 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are PGR somatic mutations and somatic EIF2B4 amplifications found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",cnv_and_ssm
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are PGR somatic mutations and somatic PIK3C2G amplifications found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",cnv_and_ssm
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently are PGR somatic mutations and somatic FMO4 amplifications found in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus patients?",cnv_and_ssm
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How frequently are ACTA2 somatic mutations and somatic AUTS2 amplifications found in Skin Cutaneous Melanoma patients?,cnv_and_ssm
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How frequently are THBS4 somatic mutations and somatic JAML amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How frequently are THBS4 somatic mutations and somatic TLK2 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1413,PRSS1,S114T,Lung Adenocarcinoma,How frequently are PRSS1 somatic mutations and somatic NCKAP5 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+1414,PRSS1,S124T,Lung Adenocarcinoma,How frequently are PRSS1 somatic mutations and somatic PGR amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+1415,PRSS1,S138T,Lung Adenocarcinoma,How frequently are PRSS1 somatic mutations and somatic PXN amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+1416,PRSS1,S74T,Lung Adenocarcinoma,How frequently are PRSS1 somatic mutations and somatic OR8K5 amplifications found in Lung Adenocarcinoma patients?,cnv_and_ssm
+1417,PGF,R126H,Stomach Adenocarcinoma,How frequently are PGF somatic mutations and somatic PCDHB2 amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+1418,PGF,R127H,Stomach Adenocarcinoma,How frequently are PGF somatic mutations and somatic PIK3C2B amplifications found in Stomach Adenocarcinoma patients?,cnv_and_ssm
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How frequently are ITPRID2 somatic mutations and somatic ZCCHC14 amplifications found in Breast Invasive Carcinoma patients?,cnv_and_ssm
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How frequently are ITPRID2 somatic mutations and somatic PGF amplifications found in Breast Invasive Carcinoma patients?,cnv_and_ssm
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How frequently are HBB somatic mutations and somatic MAST4 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How frequently are PCDHB2 somatic mutations and somatic CA9 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How frequently are PCDHB2 somatic mutations and somatic MAD1L1 amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How frequently are PCDHB2 somatic mutations and somatic PTPRO amplifications found in Colon Adenocarcinoma patients?,cnv_and_ssm
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How frequently are UBR2 somatic mutations and somatic SYT9 amplifications found in Uterine Corpus Endometrial Carcinoma patients?,cnv_and_ssm
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How frequently are FBXO42 somatic mutations and somatic PXN amplifications found in Rectum Adenocarcinoma patients?,cnv_and_ssm
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the incidence rate of mutations in TNS1 paired with somatic heterozygous deletions in TAF1C in Breast Invasive Carcinoma?,cnv_and_ssm
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the incidence rate of mutations in TNS1 paired with somatic heterozygous deletions in UBR2 in Breast Invasive Carcinoma?,cnv_and_ssm
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the incidence rate of mutations in TNS1 paired with somatic heterozygous deletions in B3GALNT1 in Breast Invasive Carcinoma?,cnv_and_ssm
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the incidence rate of mutations in TNS1 paired with somatic heterozygous deletions in KRT39 in Breast Invasive Carcinoma?,cnv_and_ssm
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the incidence rate of mutations in TNS1 paired with somatic heterozygous deletions in PCDHGA1 in Breast Invasive Carcinoma?,cnv_and_ssm
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the incidence rate of mutations in TNS1 paired with somatic heterozygous deletions in PTPRO in Breast Invasive Carcinoma?,cnv_and_ssm
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the incidence rate of mutations in TNS1 paired with somatic heterozygous deletions in MRPL32 in Breast Invasive Carcinoma?,cnv_and_ssm
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the incidence rate of mutations in EVC2 paired with somatic heterozygous deletions in ANKDD1A in Bladder Urothelial Carcinoma?,cnv_and_ssm
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the incidence rate of mutations in EVC2 paired with somatic heterozygous deletions in TENT5A in Bladder Urothelial Carcinoma?,cnv_and_ssm
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in CR1 paired with somatic heterozygous deletions in TNS1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in CR1 paired with somatic heterozygous deletions in FMO4 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the incidence rate of mutations in TRPA1 paired with somatic heterozygous deletions in GRM1 in Rectum Adenocarcinoma?,cnv_and_ssm
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the incidence rate of mutations in TRPA1 paired with somatic heterozygous deletions in HTR3B in Rectum Adenocarcinoma?,cnv_and_ssm
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the incidence rate of mutations in TAF1C paired with somatic heterozygous deletions in MYO3B in Lung Adenocarcinoma?,cnv_and_ssm
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the incidence rate of mutations in TAF1C paired with somatic heterozygous deletions in CTSC in Lung Adenocarcinoma?,cnv_and_ssm
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the incidence rate of mutations in TAF1C paired with somatic heterozygous deletions in DCN in Lung Adenocarcinoma?,cnv_and_ssm
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the incidence rate of mutations in TAF1C paired with somatic heterozygous deletions in TENT5A in Lung Adenocarcinoma?,cnv_and_ssm
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the incidence rate of mutations in TAF1C paired with somatic heterozygous deletions in JAML in Lung Adenocarcinoma?,cnv_and_ssm
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in DPF3 paired with somatic heterozygous deletions in DCN in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in DPF3 paired with somatic heterozygous deletions in ZFPM2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in DPF3 paired with somatic heterozygous deletions in DCN in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the incidence rate of mutations in OR2T4 paired with somatic heterozygous deletions in PGF in Lung Adenocarcinoma?,cnv_and_ssm
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the incidence rate of mutations in OR2T4 paired with somatic heterozygous deletions in TET2 in Lung Adenocarcinoma?,cnv_and_ssm
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the incidence rate of mutations in FBN1 paired with somatic heterozygous deletions in PGF in Pancreatic Adenocarcinoma?,cnv_and_ssm
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the incidence rate of mutations in MAD1L1 paired with somatic heterozygous deletions in COL6A3 in Prostate Adenocarcinoma?,cnv_and_ssm
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the incidence rate of mutations in MAD1L1 paired with somatic heterozygous deletions in RELN in Prostate Adenocarcinoma?,cnv_and_ssm
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the incidence rate of mutations in MAD1L1 paired with somatic heterozygous deletions in CNGB1 in Prostate Adenocarcinoma?,cnv_and_ssm
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the incidence rate of mutations in CCNG1 paired with somatic heterozygous deletions in ADRA1A in Skin Cutaneous Melanoma?,cnv_and_ssm
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the incidence rate of mutations in ANP32E paired with somatic heterozygous deletions in TNS1 in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the incidence rate of mutations in ANP32E paired with somatic heterozygous deletions in ARMC3 in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the incidence rate of mutations in ANP32E paired with somatic heterozygous deletions in MYT1 in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the incidence rate of mutations in ANP32E paired with somatic heterozygous deletions in ZCCHC14 in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the incidence rate of mutations in FRY paired with somatic heterozygous deletions in NRAP in Bladder Urothelial Carcinoma?,cnv_and_ssm
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the incidence rate of mutations in FRY paired with somatic heterozygous deletions in TLK2 in Bladder Urothelial Carcinoma?,cnv_and_ssm
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the incidence rate of mutations in FRY paired with somatic heterozygous deletions in PXN in Bladder Urothelial Carcinoma?,cnv_and_ssm
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the incidence rate of mutations in FRY paired with somatic heterozygous deletions in AUTS2 in Bladder Urothelial Carcinoma?,cnv_and_ssm
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the incidence rate of mutations in PAK3 paired with somatic heterozygous deletions in SGIP1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the incidence rate of mutations in PAK3 paired with somatic heterozygous deletions in ADRA1A in Skin Cutaneous Melanoma?,cnv_and_ssm
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the incidence rate of mutations in PAK3 paired with somatic heterozygous deletions in ABCC2 in Skin Cutaneous Melanoma?,cnv_and_ssm
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the incidence rate of mutations in PAK3 paired with somatic heterozygous deletions in ANP32E in Skin Cutaneous Melanoma?,cnv_and_ssm
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the incidence rate of mutations in PAK3 paired with somatic heterozygous deletions in OR5D14 in Skin Cutaneous Melanoma?,cnv_and_ssm
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the incidence rate of mutations in MUC16 paired with somatic heterozygous deletions in SGCZ in Skin Cutaneous Melanoma?,cnv_and_ssm
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the incidence rate of mutations in ZFPM2 paired with somatic heterozygous deletions in TTYH2 in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the incidence rate of mutations in ZFPM2 paired with somatic heterozygous deletions in ZFAT in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the incidence rate of mutations in PIK3C2B paired with somatic heterozygous deletions in CACNA1F in Breast Invasive Carcinoma?,cnv_and_ssm
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the incidence rate of mutations in PIK3C2B paired with somatic heterozygous deletions in SLC9C1 in Breast Invasive Carcinoma?,cnv_and_ssm
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the incidence rate of mutations in ZNF804A paired with somatic heterozygous deletions in EIF2B4 in Colon Adenocarcinoma?,cnv_and_ssm
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the incidence rate of mutations in RELN paired with somatic heterozygous deletions in CXCR2 in Stomach Adenocarcinoma?,cnv_and_ssm
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence rate of mutations in EFCAB12 paired with somatic heterozygous deletions in TRPA1 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence rate of mutations in EFCAB12 paired with somatic heterozygous deletions in TTC17 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the incidence rate of mutations in DEFB115 paired with somatic heterozygous deletions in PYHIN1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the incidence rate of mutations in ANKDD1A paired with somatic heterozygous deletions in BCAT1 in Bladder Urothelial Carcinoma?,cnv_and_ssm
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the incidence rate of mutations in ANKDD1A paired with somatic heterozygous deletions in BCAT1 in Bladder Urothelial Carcinoma?,cnv_and_ssm
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the incidence rate of mutations in ANKDD1A paired with somatic heterozygous deletions in DCC in Bladder Urothelial Carcinoma?,cnv_and_ssm
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in HTR3B paired with somatic heterozygous deletions in ZNF627 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in HTR3B paired with somatic heterozygous deletions in KANSL1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in HTR3B paired with somatic heterozygous deletions in DSCAM in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the incidence rate of mutations in ABCC3 paired with somatic heterozygous deletions in PIAS3 in Stomach Adenocarcinoma?,cnv_and_ssm
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in NOMO1 paired with somatic heterozygous deletions in TENM2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in NOMO1 paired with somatic heterozygous deletions in DSCAM in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the incidence rate of mutations in HYOU1 paired with somatic heterozygous deletions in CDKN2AIP in Bladder Urothelial Carcinoma?,cnv_and_ssm
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the incidence rate of mutations in FMO4 paired with somatic heterozygous deletions in EVC2 in Skin Cutaneous Melanoma?,cnv_and_ssm
+140,BICC1,A372V,Exceptional Responders,What is the incidence rate of mutations in BICC1 paired with somatic heterozygous deletions in VASN in Exceptional Responders?,cnv_and_ssm
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in ZMYM3 paired with somatic heterozygous deletions in ZBTB34 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in ZMYM3 paired with somatic heterozygous deletions in ANKRD52 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in ZMYM3 paired with somatic heterozygous deletions in SPTAN1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence rate of mutations in XKR4 paired with somatic heterozygous deletions in TASOR2 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the incidence rate of mutations in ABCC2 paired with somatic heterozygous deletions in RAB40C in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the incidence rate of mutations in OR8K5 paired with somatic heterozygous deletions in KDM5C in Lung Adenocarcinoma?,cnv_and_ssm
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the incidence rate of mutations in SPTAN1 paired with somatic heterozygous deletions in GABRA6 in Skin Cutaneous Melanoma?,cnv_and_ssm
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the incidence rate of mutations in SPTAN1 paired with somatic heterozygous deletions in ANKRD30A in Skin Cutaneous Melanoma?,cnv_and_ssm
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the incidence rate of mutations in SYT10 paired with somatic heterozygous deletions in CEP20 in Rectum Adenocarcinoma?,cnv_and_ssm
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the incidence rate of mutations in HSPA5 paired with somatic heterozygous deletions in PCDHB2 in Skin Cutaneous Melanoma?,cnv_and_ssm
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the incidence rate of mutations in UNC5D paired with somatic heterozygous deletions in PTPRO in Lung Adenocarcinoma?,cnv_and_ssm
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the incidence rate of mutations in UNC5D paired with somatic heterozygous deletions in ITPRID2 in Lung Adenocarcinoma?,cnv_and_ssm
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the incidence rate of mutations in UNC5D paired with somatic heterozygous deletions in GIMAP2 in Lung Adenocarcinoma?,cnv_and_ssm
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the incidence rate of mutations in UNC5D paired with somatic heterozygous deletions in CR1 in Lung Adenocarcinoma?,cnv_and_ssm
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the incidence rate of mutations in UNC5D paired with somatic heterozygous deletions in TASOR2 in Lung Adenocarcinoma?,cnv_and_ssm
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the incidence rate of mutations in UNC5D paired with somatic heterozygous deletions in PGF in Lung Adenocarcinoma?,cnv_and_ssm
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the incidence rate of mutations in DOCK2 paired with somatic heterozygous deletions in ZFPM2 in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the incidence rate of mutations in ZNF627 paired with somatic heterozygous deletions in TENT5A in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the incidence rate of mutations in CDC42BPA paired with somatic heterozygous deletions in EVC2 in Skin Cutaneous Melanoma?,cnv_and_ssm
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the incidence rate of mutations in MRPL55 paired with somatic heterozygous deletions in GUK1 in Colon Adenocarcinoma?,cnv_and_ssm
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the incidence rate of mutations in MRPL55 paired with somatic heterozygous deletions in CCDC22 in Colon Adenocarcinoma?,cnv_and_ssm
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the incidence rate of mutations in TMTC3 paired with somatic heterozygous deletions in UNC5D in Breast Invasive Carcinoma?,cnv_and_ssm
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the incidence rate of mutations in EPRS1 paired with somatic heterozygous deletions in DNMT1 in Colon Adenocarcinoma?,cnv_and_ssm
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the incidence rate of mutations in EPRS1 paired with somatic heterozygous deletions in MYT1 in Colon Adenocarcinoma?,cnv_and_ssm
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the incidence rate of mutations in GRTP1 paired with somatic heterozygous deletions in DCN in Skin Cutaneous Melanoma?,cnv_and_ssm
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the incidence rate of mutations in GRTP1 paired with somatic heterozygous deletions in ACTB in Skin Cutaneous Melanoma?,cnv_and_ssm
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the incidence rate of mutations in TSHZ3 paired with somatic heterozygous deletions in TMEM255A in Stomach Adenocarcinoma?,cnv_and_ssm
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the incidence rate of mutations in TAS1R3 paired with somatic heterozygous deletions in DCLK3 in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,cnv_and_ssm
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in PIAS3 paired with somatic heterozygous deletions in FGF8 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in PIAS3 paired with somatic heterozygous deletions in TAF1L in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the incidence rate of mutations in ZNF274 paired with somatic heterozygous deletions in ABCC2 in Stomach Adenocarcinoma?,cnv_and_ssm
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the incidence rate of mutations in SYNJ1 paired with somatic heterozygous deletions in DCC in Colon Adenocarcinoma?,cnv_and_ssm
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the incidence rate of mutations in SYNJ1 paired with somatic heterozygous deletions in CNGB1 in Colon Adenocarcinoma?,cnv_and_ssm
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the incidence rate of mutations in SYNJ1 paired with somatic heterozygous deletions in PXN in Colon Adenocarcinoma?,cnv_and_ssm
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the incidence rate of mutations in DSCAM paired with somatic heterozygous deletions in TLCD5 in Prostate Adenocarcinoma?,cnv_and_ssm
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the incidence rate of mutations in DSCAM paired with somatic heterozygous deletions in ARHGEF40 in Prostate Adenocarcinoma?,cnv_and_ssm
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the incidence rate of mutations in DSCAM paired with somatic heterozygous deletions in PRSS1 in Prostate Adenocarcinoma?,cnv_and_ssm
+267,DGKD,R140H,Exceptional Responders,What is the incidence rate of mutations in DGKD paired with somatic heterozygous deletions in PGR in Exceptional Responders?,cnv_and_ssm
+268,DGKD,R160H,Exceptional Responders,What is the incidence rate of mutations in DGKD paired with somatic heterozygous deletions in FRY in Exceptional Responders?,cnv_and_ssm
+269,DGKD,R204H,Exceptional Responders,What is the incidence rate of mutations in DGKD paired with somatic heterozygous deletions in OLFML3 in Exceptional Responders?,cnv_and_ssm
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the incidence rate of mutations in PLEKHG6 paired with somatic heterozygous deletions in ABCC3 in Bladder Urothelial Carcinoma?,cnv_and_ssm
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the incidence rate of mutations in PLEKHG6 paired with somatic heterozygous deletions in MYH11 in Bladder Urothelial Carcinoma?,cnv_and_ssm
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the incidence rate of mutations in PLEKHG6 paired with somatic heterozygous deletions in ACVR1B in Bladder Urothelial Carcinoma?,cnv_and_ssm
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the incidence rate of mutations in WNT2 paired with somatic heterozygous deletions in ACTL7B in Skin Cutaneous Melanoma?,cnv_and_ssm
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the incidence rate of mutations in GUCY2C paired with somatic heterozygous deletions in CCDC22 in Skin Cutaneous Melanoma?,cnv_and_ssm
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in C7orf31 paired with somatic heterozygous deletions in PXN in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence rate of mutations in ZKSCAN7 paired with somatic heterozygous deletions in SYNJ1 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+299,OR5D14,M210L,Neuroblastoma,What is the incidence rate of mutations in OR5D14 paired with somatic heterozygous deletions in PDGFC in Neuroblastoma?,cnv_and_ssm
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in SPATA22 paired with somatic heterozygous deletions in ANP32E in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in SPATA22 paired with somatic heterozygous deletions in PGR in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in SPATA22 paired with somatic heterozygous deletions in SORCS1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the incidence rate of mutations in LCN15 paired with somatic heterozygous deletions in CXCR2 in Stomach Adenocarcinoma?,cnv_and_ssm
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the incidence rate of mutations in DCAF4L2 paired with somatic heterozygous deletions in DPF3 in Skin Cutaneous Melanoma?,cnv_and_ssm
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in GUK1 paired with somatic heterozygous deletions in TENM2 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in GUK1 paired with somatic heterozygous deletions in BCAT1 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in GUK1 paired with somatic heterozygous deletions in GLRB in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in GUK1 paired with somatic heterozygous deletions in POC1B in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in GUK1 paired with somatic heterozygous deletions in PAPPA in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the incidence rate of mutations in MORF4L1 paired with somatic heterozygous deletions in LAMB2 in Stomach Adenocarcinoma?,cnv_and_ssm
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the incidence rate of mutations in MORF4L1 paired with somatic heterozygous deletions in TAF1C in Stomach Adenocarcinoma?,cnv_and_ssm
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the incidence rate of mutations in MORF4L1 paired with somatic heterozygous deletions in CHODL in Stomach Adenocarcinoma?,cnv_and_ssm
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the incidence rate of mutations in MORF4L1 paired with somatic heterozygous deletions in ANKDD1A in Stomach Adenocarcinoma?,cnv_and_ssm
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the incidence rate of mutations in MYO3B paired with somatic heterozygous deletions in BCAT1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the incidence rate of mutations in MYO3B paired with somatic heterozygous deletions in TASOR2 in Skin Cutaneous Melanoma?,cnv_and_ssm
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the incidence rate of mutations in TENT5A paired with somatic heterozygous deletions in PTPRO in Skin Cutaneous Melanoma?,cnv_and_ssm
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the incidence rate of mutations in TENT5A paired with somatic heterozygous deletions in TLK2 in Skin Cutaneous Melanoma?,cnv_and_ssm
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the incidence rate of mutations in TENT5A paired with somatic heterozygous deletions in EIF2B4 in Skin Cutaneous Melanoma?,cnv_and_ssm
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the incidence rate of mutations in ZFAT paired with somatic heterozygous deletions in RIPOR2 in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the incidence rate of mutations in ZFAT paired with somatic heterozygous deletions in KIF20B in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the incidence rate of mutations in ZFAT paired with somatic heterozygous deletions in TTYH2 in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+357,ZNF584,A211T,Sarcoma,What is the incidence rate of mutations in ZNF584 paired with somatic heterozygous deletions in ZNF217 in Sarcoma?,cnv_and_ssm
+358,ZNF584,A256T,Sarcoma,What is the incidence rate of mutations in ZNF584 paired with somatic heterozygous deletions in PKHD1L1 in Sarcoma?,cnv_and_ssm
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in LDOC1 paired with somatic heterozygous deletions in FGF8 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in PDGFC paired with somatic heterozygous deletions in ZNF431 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in MSANTD4 paired with somatic heterozygous deletions in MYO3B in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the incidence rate of mutations in NPSR1 paired with somatic heterozygous deletions in ACTA2 in Skin Cutaneous Melanoma?,cnv_and_ssm
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in PHLPP1 paired with somatic heterozygous deletions in ZFPM2 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the incidence rate of mutations in COL6A3 paired with somatic heterozygous deletions in ABCC2 in Skin Cutaneous Melanoma?,cnv_and_ssm
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the incidence rate of mutations in COL6A3 paired with somatic heterozygous deletions in DCC in Skin Cutaneous Melanoma?,cnv_and_ssm
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the incidence rate of mutations in COL6A3 paired with somatic heterozygous deletions in CARMIL1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the incidence rate of mutations in COL6A3 paired with somatic heterozygous deletions in SOX21 in Skin Cutaneous Melanoma?,cnv_and_ssm
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the incidence rate of mutations in COL6A3 paired with somatic heterozygous deletions in RAB40C in Skin Cutaneous Melanoma?,cnv_and_ssm
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the incidence rate of mutations in ADRA1A paired with somatic heterozygous deletions in MYO3B in Stomach Adenocarcinoma?,cnv_and_ssm
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence rate of mutations in LAMB2 paired with somatic heterozygous deletions in MYO15A in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the incidence rate of mutations in POC1B paired with somatic heterozygous deletions in ITPRID2 in Rectum Adenocarcinoma?,cnv_and_ssm
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the incidence rate of mutations in POC1B paired with somatic heterozygous deletions in GPR158 in Rectum Adenocarcinoma?,cnv_and_ssm
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the incidence rate of mutations in POC1B paired with somatic heterozygous deletions in DCN in Rectum Adenocarcinoma?,cnv_and_ssm
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the incidence rate of mutations in POC1B paired with somatic heterozygous deletions in TNS1 in Rectum Adenocarcinoma?,cnv_and_ssm
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the incidence rate of mutations in USH2A paired with somatic heterozygous deletions in DGKD in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the incidence rate of mutations in AQP7 paired with somatic heterozygous deletions in CFAP61 in Rectum Adenocarcinoma?,cnv_and_ssm
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the incidence rate of mutations in AQP7 paired with somatic heterozygous deletions in SLC6A4 in Rectum Adenocarcinoma?,cnv_and_ssm
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the incidence rate of mutations in AQP7 paired with somatic heterozygous deletions in RAB40C in Rectum Adenocarcinoma?,cnv_and_ssm
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the incidence rate of mutations in AQP7 paired with somatic heterozygous deletions in ZFPM2 in Rectum Adenocarcinoma?,cnv_and_ssm
+430,DCN,R163C,Rectum Adenocarcinoma,What is the incidence rate of mutations in DCN paired with somatic heterozygous deletions in TENM2 in Rectum Adenocarcinoma?,cnv_and_ssm
+431,DCN,R203C,Rectum Adenocarcinoma,What is the incidence rate of mutations in DCN paired with somatic heterozygous deletions in PKHD1L1 in Rectum Adenocarcinoma?,cnv_and_ssm
+432,DCN,R241C,Rectum Adenocarcinoma,What is the incidence rate of mutations in DCN paired with somatic heterozygous deletions in ZCCHC14 in Rectum Adenocarcinoma?,cnv_and_ssm
+433,DCN,R350C,Rectum Adenocarcinoma,What is the incidence rate of mutations in DCN paired with somatic heterozygous deletions in AUTS2 in Rectum Adenocarcinoma?,cnv_and_ssm
+434,DCN,R41C,Rectum Adenocarcinoma,What is the incidence rate of mutations in DCN paired with somatic heterozygous deletions in CPA6 in Rectum Adenocarcinoma?,cnv_and_ssm
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in CPS1 paired with somatic heterozygous deletions in GABRA6 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in CPS1 paired with somatic heterozygous deletions in CTCFL in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in CPS1 paired with somatic heterozygous deletions in EPRS1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the incidence rate of mutations in FCGR2C paired with somatic heterozygous deletions in MAD1L1 in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the incidence rate of mutations in FCGR2C paired with somatic heterozygous deletions in PAK3 in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in GRM1 paired with somatic heterozygous deletions in ITPRID2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the incidence rate of mutations in SGCZ paired with somatic heterozygous deletions in PAK3 in Lung Adenocarcinoma?,cnv_and_ssm
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the incidence rate of mutations in SGCZ paired with somatic heterozygous deletions in SPATA22 in Lung Adenocarcinoma?,cnv_and_ssm
+485,SMO,V15M,Stomach Adenocarcinoma,What is the incidence rate of mutations in SMO paired with somatic heterozygous deletions in TYK2 in Stomach Adenocarcinoma?,cnv_and_ssm
+486,SMO,V321M,Stomach Adenocarcinoma,What is the incidence rate of mutations in SMO paired with somatic heterozygous deletions in NOMO1 in Stomach Adenocarcinoma?,cnv_and_ssm
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the incidence rate of mutations in CHODL paired with somatic heterozygous deletions in TRPA1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the incidence rate of mutations in CHODL paired with somatic heterozygous deletions in CTNNA2 in Skin Cutaneous Melanoma?,cnv_and_ssm
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the incidence rate of mutations in CHODL paired with somatic heterozygous deletions in PKHD1L1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+494,MYO16,P399H,Colon Adenocarcinoma,What is the incidence rate of mutations in MYO16 paired with somatic heterozygous deletions in CCNG1 in Colon Adenocarcinoma?,cnv_and_ssm
+495,MYO16,P421H,Colon Adenocarcinoma,What is the incidence rate of mutations in MYO16 paired with somatic heterozygous deletions in ACVR1B in Colon Adenocarcinoma?,cnv_and_ssm
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the incidence rate of mutations in CXCR2 paired with somatic heterozygous deletions in CTNNA2 in Stomach Adenocarcinoma?,cnv_and_ssm
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the incidence rate of mutations in TMEM225 paired with somatic heterozygous deletions in PIK3C2A in Bladder Urothelial Carcinoma?,cnv_and_ssm
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in MAOB paired with somatic heterozygous deletions in MAST4 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in GPRASP1 paired with somatic heterozygous deletions in GABRA6 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in MRPL32 paired with somatic heterozygous deletions in SPAG1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in TYROBP paired with somatic heterozygous deletions in GSTCD in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the incidence rate of mutations in RAB40C paired with somatic heterozygous deletions in KDM5C in Lung Adenocarcinoma?,cnv_and_ssm
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the incidence rate of mutations in RAB40C paired with somatic heterozygous deletions in ZCCHC14 in Lung Adenocarcinoma?,cnv_and_ssm
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the incidence rate of mutations in CTNNA2 paired with somatic heterozygous deletions in PCDHB2 in Lung Adenocarcinoma?,cnv_and_ssm
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the incidence rate of mutations in CTNNA2 paired with somatic heterozygous deletions in CHODL in Lung Adenocarcinoma?,cnv_and_ssm
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the incidence rate of mutations in CTNNA2 paired with somatic heterozygous deletions in OR13C3 in Lung Adenocarcinoma?,cnv_and_ssm
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the incidence rate of mutations in CTNNA2 paired with somatic heterozygous deletions in TASOR2 in Lung Adenocarcinoma?,cnv_and_ssm
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the incidence rate of mutations in MYO15A paired with somatic heterozygous deletions in PTPRN2 in Bladder Urothelial Carcinoma?,cnv_and_ssm
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the incidence rate of mutations in GIMAP2 paired with somatic heterozygous deletions in TET2 in Skin Cutaneous Melanoma?,cnv_and_ssm
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the incidence rate of mutations in KIF20B paired with somatic heterozygous deletions in RAB40C in Glioblastoma Multiforme?,cnv_and_ssm
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the incidence rate of mutations in KIF20B paired with somatic heterozygous deletions in CDH23 in Glioblastoma Multiforme?,cnv_and_ssm
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in ADAM17 paired with somatic heterozygous deletions in COL6A3 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in BCAT1 paired with somatic heterozygous deletions in FNDC7 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in BCAT1 paired with somatic heterozygous deletions in KRT39 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in BCAT1 paired with somatic heterozygous deletions in ANKRD24 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the incidence rate of mutations in ERCC6 paired with somatic heterozygous deletions in SLC9C1 in Colon Adenocarcinoma?,cnv_and_ssm
+541,DCC,R320W,Breast Invasive Carcinoma,What is the incidence rate of mutations in DCC paired with somatic heterozygous deletions in PTPRO in Breast Invasive Carcinoma?,cnv_and_ssm
+542,DCC,R363W,Breast Invasive Carcinoma,What is the incidence rate of mutations in DCC paired with somatic heterozygous deletions in ZFAT in Breast Invasive Carcinoma?,cnv_and_ssm
+543,DCC,R386W,Breast Invasive Carcinoma,What is the incidence rate of mutations in DCC paired with somatic heterozygous deletions in IL5RA in Breast Invasive Carcinoma?,cnv_and_ssm
+544,DCC,R41W,Breast Invasive Carcinoma,What is the incidence rate of mutations in DCC paired with somatic heterozygous deletions in KRT39 in Breast Invasive Carcinoma?,cnv_and_ssm
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the incidence rate of mutations in FBXO15 paired with somatic heterozygous deletions in PIK3C2G in Skin Cutaneous Melanoma?,cnv_and_ssm
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the incidence rate of mutations in FBXO15 paired with somatic heterozygous deletions in KIF20B in Skin Cutaneous Melanoma?,cnv_and_ssm
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in GSTCD paired with somatic heterozygous deletions in POLD1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in GSTCD paired with somatic heterozygous deletions in GPC3 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in OLFML3 paired with somatic heterozygous deletions in SYNJ1 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in OLFML3 paired with somatic heterozygous deletions in COL6A3 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in OLFML3 paired with somatic heterozygous deletions in DNMT1 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the incidence rate of mutations in CFAP61 paired with somatic heterozygous deletions in KL in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the incidence rate of mutations in CFAP61 paired with somatic heterozygous deletions in ZNF431 in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the incidence rate of mutations in HLA-DQA2 paired with somatic heterozygous deletions in TMEM255A in Bladder Urothelial Carcinoma?,cnv_and_ssm
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the incidence rate of mutations in TENM2 paired with somatic heterozygous deletions in FGF8 in Skin Cutaneous Melanoma?,cnv_and_ssm
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the incidence rate of mutations in TENM2 paired with somatic heterozygous deletions in OR8K5 in Skin Cutaneous Melanoma?,cnv_and_ssm
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the incidence rate of mutations in TENM2 paired with somatic heterozygous deletions in CTCFL in Skin Cutaneous Melanoma?,cnv_and_ssm
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the incidence rate of mutations in ANKRD24 paired with somatic heterozygous deletions in SORCS1 in Stomach Adenocarcinoma?,cnv_and_ssm
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the incidence rate of mutations in ANKRD24 paired with somatic heterozygous deletions in PIK3C2G in Stomach Adenocarcinoma?,cnv_and_ssm
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the incidence rate of mutations in ANKRD24 paired with somatic heterozygous deletions in SPATA22 in Stomach Adenocarcinoma?,cnv_and_ssm
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the incidence rate of mutations in ZCCHC14 paired with somatic heterozygous deletions in PTPRO in Stomach Adenocarcinoma?,cnv_and_ssm
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the incidence rate of mutations in ZCCHC14 paired with somatic heterozygous deletions in DCLK3 in Stomach Adenocarcinoma?,cnv_and_ssm
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the incidence rate of mutations in ZCCHC14 paired with somatic heterozygous deletions in PGR in Stomach Adenocarcinoma?,cnv_and_ssm
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the incidence rate of mutations in ZCCHC14 paired with somatic heterozygous deletions in STK19 in Stomach Adenocarcinoma?,cnv_and_ssm
+625,SIK2,I265M,Lung Adenocarcinoma,What is the incidence rate of mutations in SIK2 paired with somatic heterozygous deletions in MAST4 in Lung Adenocarcinoma?,cnv_and_ssm
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in MYH11 paired with somatic heterozygous deletions in ZNF708 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in MYH11 paired with somatic heterozygous deletions in DCAF4L2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the incidence rate of mutations in SLC6A4 paired with somatic heterozygous deletions in ZCCHC14 in Skin Cutaneous Melanoma?,cnv_and_ssm
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in SLC9C1 paired with somatic heterozygous deletions in CYP1A2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in SLC9C1 paired with somatic heterozygous deletions in UNC5D in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the incidence rate of mutations in OR2A12 paired with somatic heterozygous deletions in AUTS2 in Brain Lower Grade Glioma?,cnv_and_ssm
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the incidence rate of mutations in PYHIN1 paired with somatic heterozygous deletions in TRIM45 in Lung Adenocarcinoma?,cnv_and_ssm
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the incidence rate of mutations in PYHIN1 paired with somatic heterozygous deletions in TYK2 in Lung Adenocarcinoma?,cnv_and_ssm
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the incidence rate of mutations in JAML paired with somatic heterozygous deletions in TTN in Skin Cutaneous Melanoma?,cnv_and_ssm
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the incidence rate of mutations in JAML paired with somatic heterozygous deletions in THBS4 in Skin Cutaneous Melanoma?,cnv_and_ssm
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the incidence rate of mutations in JAML paired with somatic heterozygous deletions in MAST4 in Skin Cutaneous Melanoma?,cnv_and_ssm
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the incidence rate of mutations in JAML paired with somatic heterozygous deletions in TYK2 in Skin Cutaneous Melanoma?,cnv_and_ssm
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the incidence rate of mutations in TYK2 paired with somatic heterozygous deletions in GIMAP2 in Stomach Adenocarcinoma?,cnv_and_ssm
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the incidence rate of mutations in TYK2 paired with somatic heterozygous deletions in SMO in Stomach Adenocarcinoma?,cnv_and_ssm
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the incidence rate of mutations in TYK2 paired with somatic heterozygous deletions in ARHGEF40 in Stomach Adenocarcinoma?,cnv_and_ssm
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in CTCFL paired with somatic heterozygous deletions in NEXN in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in CTCFL paired with somatic heterozygous deletions in DPF3 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in CTCFL paired with somatic heterozygous deletions in EFCAB12 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in CTCFL paired with somatic heterozygous deletions in CEP20 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in CEP20 paired with somatic heterozygous deletions in ANKRD24 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in CEP20 paired with somatic heterozygous deletions in ADAM17 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the incidence rate of mutations in RIMS2 paired with somatic heterozygous deletions in FGF8 in Skin Cutaneous Melanoma?,cnv_and_ssm
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the incidence rate of mutations in RIMS2 paired with somatic heterozygous deletions in CPS1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the incidence rate of mutations in RIMS2 paired with somatic heterozygous deletions in UNC5D in Skin Cutaneous Melanoma?,cnv_and_ssm
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the incidence rate of mutations in RIMS2 paired with somatic heterozygous deletions in FRY in Skin Cutaneous Melanoma?,cnv_and_ssm
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the incidence rate of mutations in RIMS2 paired with somatic heterozygous deletions in CFAP61 in Skin Cutaneous Melanoma?,cnv_and_ssm
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the incidence rate of mutations in RIMS2 paired with somatic heterozygous deletions in ANKRD30A in Skin Cutaneous Melanoma?,cnv_and_ssm
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the incidence rate of mutations in RIMS2 paired with somatic heterozygous deletions in TENM2 in Skin Cutaneous Melanoma?,cnv_and_ssm
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the incidence rate of mutations in PIK3C2G paired with somatic heterozygous deletions in ADAM17 in Skin Cutaneous Melanoma?,cnv_and_ssm
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the incidence rate of mutations in PIK3C2G paired with somatic heterozygous deletions in ANP32E in Skin Cutaneous Melanoma?,cnv_and_ssm
+728,STK19,D341N,Colon Adenocarcinoma,What is the incidence rate of mutations in STK19 paired with somatic heterozygous deletions in PHLPP1 in Colon Adenocarcinoma?,cnv_and_ssm
+729,STK19,D345N,Colon Adenocarcinoma,What is the incidence rate of mutations in STK19 paired with somatic heterozygous deletions in EPRS1 in Colon Adenocarcinoma?,cnv_and_ssm
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the incidence rate of mutations in REXO4 paired with somatic heterozygous deletions in AQP7 in Skin Cutaneous Melanoma?,cnv_and_ssm
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in ZBTB34 paired with somatic heterozygous deletions in UNC5D in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in ZBTB34 paired with somatic heterozygous deletions in JAML in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the incidence rate of mutations in NCKAP5 paired with somatic heterozygous deletions in RELN in Bladder Urothelial Carcinoma?,cnv_and_ssm
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence rate of mutations in SORCS1 paired with somatic heterozygous deletions in TASOR2 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence rate of mutations in SORCS1 paired with somatic heterozygous deletions in TNS1 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence rate of mutations in SORCS1 paired with somatic heterozygous deletions in PRSS8 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence rate of mutations in SORCS1 paired with somatic heterozygous deletions in PTPRO in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the incidence rate of mutations in FGF8 paired with somatic heterozygous deletions in DCN in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the incidence rate of mutations in FGF8 paired with somatic heterozygous deletions in PIK3C2B in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the incidence rate of mutations in FGF8 paired with somatic heterozygous deletions in NOMO1 in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the incidence rate of mutations in FGF8 paired with somatic heterozygous deletions in WNT2 in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the incidence rate of mutations in FGF8 paired with somatic heterozygous deletions in ARMC3 in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the incidence rate of mutations in TENM3 paired with somatic heterozygous deletions in RIPOR2 in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,cnv_and_ssm
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in AKT1 paired with somatic heterozygous deletions in GRTP1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence rate of mutations in CFAP298-TCP10L paired with somatic heterozygous deletions in DCAF6 in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the incidence rate of mutations in GLRB paired with somatic heterozygous deletions in TLCD5 in Stomach Adenocarcinoma?,cnv_and_ssm
+793,TTN,F7636L,Colon Adenocarcinoma,What is the incidence rate of mutations in TTN paired with somatic heterozygous deletions in PIAS3 in Colon Adenocarcinoma?,cnv_and_ssm
+794,TTN,F8563L,Colon Adenocarcinoma,What is the incidence rate of mutations in TTN paired with somatic heterozygous deletions in UNC5D in Colon Adenocarcinoma?,cnv_and_ssm
+795,TTN,F8880L,Colon Adenocarcinoma,What is the incidence rate of mutations in TTN paired with somatic heterozygous deletions in STK19 in Colon Adenocarcinoma?,cnv_and_ssm
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the incidence rate of mutations in ANKRD30A paired with somatic heterozygous deletions in PCDHB2 in Colon Adenocarcinoma?,cnv_and_ssm
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the incidence rate of mutations in ANKRD30A paired with somatic heterozygous deletions in EIF2B4 in Colon Adenocarcinoma?,cnv_and_ssm
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the incidence rate of mutations in ANKRD30A paired with somatic heterozygous deletions in ZFPM2 in Colon Adenocarcinoma?,cnv_and_ssm
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the incidence rate of mutations in TRIM45 paired with somatic heterozygous deletions in MERTK in Colon Adenocarcinoma?,cnv_and_ssm
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the incidence rate of mutations in TRIM45 paired with somatic heterozygous deletions in CEP20 in Colon Adenocarcinoma?,cnv_and_ssm
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the incidence rate of mutations in TRIM45 paired with somatic heterozygous deletions in PRSS8 in Colon Adenocarcinoma?,cnv_and_ssm
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the incidence rate of mutations in CACNA1F paired with somatic heterozygous deletions in OR5D14 in Stomach Adenocarcinoma?,cnv_and_ssm
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the incidence rate of mutations in CACNA1F paired with somatic heterozygous deletions in SLC9C1 in Stomach Adenocarcinoma?,cnv_and_ssm
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the incidence rate of mutations in CACNA1F paired with somatic heterozygous deletions in CYB5R2 in Stomach Adenocarcinoma?,cnv_and_ssm
+817,KL,R594C,Colon Adenocarcinoma,What is the incidence rate of mutations in KL paired with somatic heterozygous deletions in KIF20B in Colon Adenocarcinoma?,cnv_and_ssm
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the incidence rate of mutations in GUF1 paired with somatic heterozygous deletions in OR5D14 in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the incidence rate of mutations in TAF1L paired with somatic heterozygous deletions in PTPRN2 in Colon Adenocarcinoma?,cnv_and_ssm
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the incidence rate of mutations in TASOR2 paired with somatic heterozygous deletions in YY1AP1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the incidence rate of mutations in TASOR2 paired with somatic heterozygous deletions in AUTS2 in Skin Cutaneous Melanoma?,cnv_and_ssm
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the incidence rate of mutations in TASOR2 paired with somatic heterozygous deletions in CTCFL in Skin Cutaneous Melanoma?,cnv_and_ssm
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the incidence rate of mutations in KDM5C paired with somatic heterozygous deletions in MAD1L1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the incidence rate of mutations in KDM5C paired with somatic heterozygous deletions in XKR4 in Skin Cutaneous Melanoma?,cnv_and_ssm
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the incidence rate of mutations in KDM5C paired with somatic heterozygous deletions in KDM5C in Skin Cutaneous Melanoma?,cnv_and_ssm
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the incidence rate of mutations in KDM5C paired with somatic heterozygous deletions in POC1B in Skin Cutaneous Melanoma?,cnv_and_ssm
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence rate of mutations in IL5RA paired with somatic heterozygous deletions in FGF8 in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the incidence rate of mutations in DHX16 paired with somatic heterozygous deletions in STK19 in Skin Cutaneous Melanoma?,cnv_and_ssm
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the incidence rate of mutations in DHX16 paired with somatic heterozygous deletions in MYH11 in Skin Cutaneous Melanoma?,cnv_and_ssm
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the incidence rate of mutations in GPR158 paired with somatic heterozygous deletions in RIMS2 in Stomach Adenocarcinoma?,cnv_and_ssm
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the incidence rate of mutations in GPR158 paired with somatic heterozygous deletions in CHODL in Stomach Adenocarcinoma?,cnv_and_ssm
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence rate of mutations in EIF2B4 paired with somatic heterozygous deletions in MYT1 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence rate of mutations in EIF2B4 paired with somatic heterozygous deletions in MRPL55 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence rate of mutations in EIF2B4 paired with somatic heterozygous deletions in PTPRN2 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence rate of mutations in EIF2B4 paired with somatic heterozygous deletions in CPS1 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence rate of mutations in EIF2B4 paired with somatic heterozygous deletions in ANP32E in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence rate of mutations in EIF2B4 paired with somatic heterozygous deletions in TENM2 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in AUTS2 paired with somatic heterozygous deletions in CHODL in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in AUTS2 paired with somatic heterozygous deletions in NCKAP5 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in AUTS2 paired with somatic heterozygous deletions in PTPRN2 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in AUTS2 paired with somatic heterozygous deletions in AQP7 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in AUTS2 paired with somatic heterozygous deletions in MUC16 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in AUTS2 paired with somatic heterozygous deletions in AUTS2 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in AUTS2 paired with somatic heterozygous deletions in SGIP1 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in AUTS2 paired with somatic heterozygous deletions in ZCCHC14 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in AUTS2 paired with somatic heterozygous deletions in SIK2 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in AUTS2 paired with somatic heterozygous deletions in DHX16 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence rate of mutations in ACTL7B paired with somatic heterozygous deletions in PTPRN2 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the incidence rate of mutations in PCDHGA1 paired with somatic heterozygous deletions in GUK1 in Glioblastoma Multiforme?,cnv_and_ssm
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the incidence rate of mutations in TRAP1 paired with somatic heterozygous deletions in MRPL55 in Stomach Adenocarcinoma?,cnv_and_ssm
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the incidence rate of mutations in TRAP1 paired with somatic heterozygous deletions in TENT5A in Stomach Adenocarcinoma?,cnv_and_ssm
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in PIK3C2A paired with somatic heterozygous deletions in ICE1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the incidence rate of mutations in KANSL1 paired with somatic heterozygous deletions in FBN1 in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the incidence rate of mutations in ANKRD52 paired with somatic heterozygous deletions in FGF8 in Stomach Adenocarcinoma?,cnv_and_ssm
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in PAPPA paired with somatic heterozygous deletions in PTPRO in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the incidence rate of mutations in B3GALNT1 paired with somatic heterozygous deletions in MYO16 in Rectum Adenocarcinoma?,cnv_and_ssm
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the incidence rate of mutations in GABRA6 paired with somatic heterozygous deletions in PHLPP1 in Lung Adenocarcinoma?,cnv_and_ssm
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the incidence rate of mutations in GABRA6 paired with somatic heterozygous deletions in TNS1 in Lung Adenocarcinoma?,cnv_and_ssm
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the incidence rate of mutations in GABRA6 paired with somatic heterozygous deletions in RIMS2 in Lung Adenocarcinoma?,cnv_and_ssm
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the incidence rate of mutations in GABRA6 paired with somatic heterozygous deletions in CHODL in Lung Adenocarcinoma?,cnv_and_ssm
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the incidence rate of mutations in GABRA6 paired with somatic heterozygous deletions in AUTS2 in Lung Adenocarcinoma?,cnv_and_ssm
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the incidence rate of mutations in ZSCAN31 paired with somatic heterozygous deletions in UNC5D in Skin Cutaneous Melanoma?,cnv_and_ssm
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence rate of mutations in MED16 paired with somatic heterozygous deletions in UBR2 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence rate of mutations in MED16 paired with somatic heterozygous deletions in ANKDD1A in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the incidence rate of mutations in PTPRO paired with somatic heterozygous deletions in KDM5C in Pancreatic Adenocarcinoma?,cnv_and_ssm
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the incidence rate of mutations in PTPRO paired with somatic heterozygous deletions in TASOR2 in Pancreatic Adenocarcinoma?,cnv_and_ssm
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the incidence rate of mutations in PTPRO paired with somatic heterozygous deletions in TNS1 in Pancreatic Adenocarcinoma?,cnv_and_ssm
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the incidence rate of mutations in PTPRO paired with somatic heterozygous deletions in CHMP7 in Pancreatic Adenocarcinoma?,cnv_and_ssm
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the incidence rate of mutations in PTPRO paired with somatic heterozygous deletions in TSHZ3 in Pancreatic Adenocarcinoma?,cnv_and_ssm
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the incidence rate of mutations in PTPRO paired with somatic heterozygous deletions in TTYH2 in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the incidence rate of mutations in PTPRO paired with somatic heterozygous deletions in TMEM225 in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the incidence rate of mutations in PTPRO paired with somatic heterozygous deletions in PTPRO in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in CHMP7 paired with somatic heterozygous deletions in PTPRO in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the incidence rate of mutations in GPC3 paired with somatic heterozygous deletions in MYO3B in Stomach Adenocarcinoma?,cnv_and_ssm
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the incidence rate of mutations in GPC3 paired with somatic heterozygous deletions in GPRASP1 in Stomach Adenocarcinoma?,cnv_and_ssm
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence rate of mutations in TLK2 paired with somatic heterozygous deletions in CDH23 in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence rate of mutations in TLK2 paired with somatic heterozygous deletions in TASOR2 in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence rate of mutations in TLK2 paired with somatic heterozygous deletions in CTNNA2 in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence rate of mutations in TLK2 paired with somatic heterozygous deletions in GSTCD in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence rate of mutations in TLK2 paired with somatic heterozygous deletions in FCGR2C in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the incidence rate of mutations in ZNF217 paired with somatic heterozygous deletions in THBS4 in Lung Adenocarcinoma?,cnv_and_ssm
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the incidence rate of mutations in SYT9 paired with somatic heterozygous deletions in FRY in Lung Adenocarcinoma?,cnv_and_ssm
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the incidence rate of mutations in SYT9 paired with somatic heterozygous deletions in PAK3 in Lung Adenocarcinoma?,cnv_and_ssm
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in PKHD1L1 paired with somatic heterozygous deletions in CPS1 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in MYO3A paired with somatic heterozygous deletions in SGCZ in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence rate of mutations in VASN paired with somatic heterozygous deletions in CTSC in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in DNMT1 paired with somatic heterozygous deletions in SMO in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in DNMT1 paired with somatic heterozygous deletions in DSCAM in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in DNMT1 paired with somatic heterozygous deletions in PRSS8 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1056,CA9,E402K,Colon Adenocarcinoma,What is the incidence rate of mutations in CA9 paired with somatic heterozygous deletions in THBS4 in Colon Adenocarcinoma?,cnv_and_ssm
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in TTC17 paired with somatic heterozygous deletions in DGKD in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in TTC17 paired with somatic heterozygous deletions in FRY in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the incidence rate of mutations in PSG2 paired with somatic heterozygous deletions in FBXO15 in Breast Invasive Carcinoma?,cnv_and_ssm
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the incidence rate of mutations in RIPOR2 paired with somatic heterozygous deletions in MAST4 in Breast Invasive Carcinoma?,cnv_and_ssm
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the incidence rate of mutations in RIPOR2 paired with somatic heterozygous deletions in EIF2B4 in Breast Invasive Carcinoma?,cnv_and_ssm
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the incidence rate of mutations in RIPOR2 paired with somatic heterozygous deletions in MERTK in Breast Invasive Carcinoma?,cnv_and_ssm
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the incidence rate of mutations in RIPOR2 paired with somatic heterozygous deletions in ZNF217 in Breast Invasive Carcinoma?,cnv_and_ssm
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in DCLK3 paired with somatic heterozygous deletions in TRPA1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in DCLK3 paired with somatic heterozygous deletions in EVC2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in MERTK paired with somatic heterozygous deletions in PYHIN1 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in MERTK paired with somatic heterozygous deletions in GPR158 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in MERTK paired with somatic heterozygous deletions in OR13C3 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the incidence rate of mutations in ZFP42 paired with somatic heterozygous deletions in SORCS1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the incidence rate of mutations in OR13C3 paired with somatic heterozygous deletions in SGCZ in Skin Cutaneous Melanoma?,cnv_and_ssm
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the incidence rate of mutations in OR13C3 paired with somatic heterozygous deletions in MAST4 in Skin Cutaneous Melanoma?,cnv_and_ssm
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the incidence rate of mutations in SPAG1 paired with somatic heterozygous deletions in SGCZ in Stomach Adenocarcinoma?,cnv_and_ssm
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in CDKN2AIP paired with somatic heterozygous deletions in TAF1L in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the incidence rate of mutations in PXN paired with somatic heterozygous deletions in ZFPM2 in Colon Adenocarcinoma?,cnv_and_ssm
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the incidence rate of mutations in PXN paired with somatic heterozygous deletions in TTYH2 in Colon Adenocarcinoma?,cnv_and_ssm
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the incidence rate of mutations in PXN paired with somatic heterozygous deletions in PIK3C2B in Colon Adenocarcinoma?,cnv_and_ssm
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the incidence rate of mutations in PXN paired with somatic heterozygous deletions in GRTP1 in Colon Adenocarcinoma?,cnv_and_ssm
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the incidence rate of mutations in PXN paired with somatic heterozygous deletions in GPC3 in Colon Adenocarcinoma?,cnv_and_ssm
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the incidence rate of mutations in PXN paired with somatic heterozygous deletions in STK19 in Colon Adenocarcinoma?,cnv_and_ssm
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in TTYH2 paired with somatic heterozygous deletions in ANKRD24 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in TTYH2 paired with somatic heterozygous deletions in ITPRID2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the incidence rate of mutations in TMEM255A paired with somatic heterozygous deletions in TENM2 in Colon Adenocarcinoma?,cnv_and_ssm
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the incidence rate of mutations in TMEM255A paired with somatic heterozygous deletions in KIF20B in Colon Adenocarcinoma?,cnv_and_ssm
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the incidence rate of mutations in TMEM255A paired with somatic heterozygous deletions in DCC in Colon Adenocarcinoma?,cnv_and_ssm
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the incidence rate of mutations in TASOR2 paired with somatic heterozygous deletions in TMEM255A in Breast Invasive Carcinoma?,cnv_and_ssm
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the incidence rate of mutations in TASOR2 paired with somatic heterozygous deletions in ZMYM3 in Breast Invasive Carcinoma?,cnv_and_ssm
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in ICE1 paired with somatic heterozygous deletions in MORF4L1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the incidence rate of mutations in MYT1 paired with somatic heterozygous deletions in DEFB115 in Breast Invasive Carcinoma?,cnv_and_ssm
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the incidence rate of mutations in MYT1 paired with somatic heterozygous deletions in STK19 in Breast Invasive Carcinoma?,cnv_and_ssm
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the incidence rate of mutations in MYT1 paired with somatic heterozygous deletions in SGCZ in Breast Invasive Carcinoma?,cnv_and_ssm
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in CX3CR1 paired with somatic heterozygous deletions in SGIP1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in CX3CR1 paired with somatic heterozygous deletions in ITPRID2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the incidence rate of mutations in SPINDOC paired with somatic heterozygous deletions in DCLK3 in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in ART3 paired with somatic heterozygous deletions in FNDC7 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in ART3 paired with somatic heterozygous deletions in TNS1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the incidence rate of mutations in CYP1A2 paired with somatic heterozygous deletions in MAST4 in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence rate of mutations in ADRA1A paired with somatic heterozygous deletions in AQP7 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in CDH23 paired with somatic heterozygous deletions in BCAT1 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in CDH23 paired with somatic heterozygous deletions in OLFML3 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the incidence rate of mutations in KRT39 paired with somatic heterozygous deletions in EIF2B4 in Skin Cutaneous Melanoma?,cnv_and_ssm
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in PDHA2 paired with somatic heterozygous deletions in FBXO15 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the incidence rate of mutations in SLC24A2 paired with somatic heterozygous deletions in UBR2 in Colon Adenocarcinoma?,cnv_and_ssm
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the incidence rate of mutations in PTPRN2 paired with somatic heterozygous deletions in MYH11 in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the incidence rate of mutations in PTPRN2 paired with somatic heterozygous deletions in MAST4 in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the incidence rate of mutations in PTPRN2 paired with somatic heterozygous deletions in REXO4 in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the incidence rate of mutations in PTPRN2 paired with somatic heterozygous deletions in SLC24A2 in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the incidence rate of mutations in PTPRN2 paired with somatic heterozygous deletions in PLEKHG6 in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the incidence rate of mutations in SOX21 paired with somatic heterozygous deletions in POC1B in Lung Adenocarcinoma?,cnv_and_ssm
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the incidence rate of mutations in CPA6 paired with somatic heterozygous deletions in EFCAB12 in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the incidence rate of mutations in GRM5 paired with somatic heterozygous deletions in PYHIN1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence rate of mutations in CASZ1 paired with somatic heterozygous deletions in ZNF584 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the incidence rate of mutations in SGIP1 paired with somatic heterozygous deletions in TRPA1 in Stomach Adenocarcinoma?,cnv_and_ssm
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the incidence rate of mutations in SGIP1 paired with somatic heterozygous deletions in CXCR2 in Stomach Adenocarcinoma?,cnv_and_ssm
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the incidence rate of mutations in SGIP1 paired with somatic heterozygous deletions in TMEM225 in Stomach Adenocarcinoma?,cnv_and_ssm
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the incidence rate of mutations in SGIP1 paired with somatic heterozygous deletions in MRPL55 in Stomach Adenocarcinoma?,cnv_and_ssm
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the incidence rate of mutations in CARMIL1 paired with somatic heterozygous deletions in UNC5D in Lung Adenocarcinoma?,cnv_and_ssm
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the incidence rate of mutations in CARMIL1 paired with somatic heterozygous deletions in JAML in Lung Adenocarcinoma?,cnv_and_ssm
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the incidence rate of mutations in ZNF431 paired with somatic heterozygous deletions in PAK3 in Lung Adenocarcinoma?,cnv_and_ssm
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the incidence rate of mutations in ZNF431 paired with somatic heterozygous deletions in PTPRO in Lung Adenocarcinoma?,cnv_and_ssm
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the incidence rate of mutations in ZNF431 paired with somatic heterozygous deletions in CTSC in Lung Adenocarcinoma?,cnv_and_ssm
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the incidence rate of mutations in DNAH11 paired with somatic heterozygous deletions in MYO3B in Skin Cutaneous Melanoma?,cnv_and_ssm
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the incidence rate of mutations in DNAH11 paired with somatic heterozygous deletions in TTN in Skin Cutaneous Melanoma?,cnv_and_ssm
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in POLD1 paired with somatic heterozygous deletions in POC1B in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the incidence rate of mutations in POLD1 paired with somatic heterozygous deletions in ART3 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the incidence rate of mutations in TTC12 paired with somatic heterozygous deletions in OR8K5 in Lung Adenocarcinoma?,cnv_and_ssm
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the incidence rate of mutations in TTC12 paired with somatic heterozygous deletions in ZFPM2 in Lung Adenocarcinoma?,cnv_and_ssm
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the incidence rate of mutations in CNGB1 paired with somatic heterozygous deletions in PXN in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the incidence rate of mutations in CNGB1 paired with somatic heterozygous deletions in ART3 in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the incidence rate of mutations in CTSC paired with somatic heterozygous deletions in RIMS2 in Stomach Adenocarcinoma?,cnv_and_ssm
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the incidence rate of mutations in CTSC paired with somatic heterozygous deletions in PTPRO in Stomach Adenocarcinoma?,cnv_and_ssm
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the incidence rate of mutations in CTSC paired with somatic heterozygous deletions in AUTS2 in Stomach Adenocarcinoma?,cnv_and_ssm
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the incidence rate of mutations in CTSC paired with somatic heterozygous deletions in ZFAT in Stomach Adenocarcinoma?,cnv_and_ssm
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the incidence rate of mutations in CTSC paired with somatic heterozygous deletions in MYT1 in Stomach Adenocarcinoma?,cnv_and_ssm
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in PRSS8 paired with somatic heterozygous deletions in PTPRN2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in PRSS8 paired with somatic heterozygous deletions in USH2A in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the incidence rate of mutations in ARHGEF40 paired with somatic heterozygous deletions in XKR4 in Lung Adenocarcinoma?,cnv_and_ssm
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the incidence rate of mutations in ACTB paired with somatic heterozygous deletions in MUC16 in Rectum Adenocarcinoma?,cnv_and_ssm
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the incidence rate of mutations in ACTB paired with somatic heterozygous deletions in ADRA1A in Rectum Adenocarcinoma?,cnv_and_ssm
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the incidence rate of mutations in ACTB paired with somatic heterozygous deletions in TSHZ3 in Rectum Adenocarcinoma?,cnv_and_ssm
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the incidence rate of mutations in ACTB paired with somatic heterozygous deletions in PAK3 in Rectum Adenocarcinoma?,cnv_and_ssm
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the incidence rate of mutations in YY1AP1 paired with somatic heterozygous deletions in ACTA2 in Glioblastoma Multiforme?,cnv_and_ssm
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the incidence rate of mutations in YY1AP1 paired with somatic heterozygous deletions in PCDHB2 in Glioblastoma Multiforme?,cnv_and_ssm
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the incidence rate of mutations in YY1AP1 paired with somatic heterozygous deletions in CHMP7 in Glioblastoma Multiforme?,cnv_and_ssm
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the incidence rate of mutations in YY1AP1 paired with somatic heterozygous deletions in PTPRO in Glioblastoma Multiforme?,cnv_and_ssm
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the incidence rate of mutations in YY1AP1 paired with somatic heterozygous deletions in DCC in Glioblastoma Multiforme?,cnv_and_ssm
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the incidence rate of mutations in YY1AP1 paired with somatic heterozygous deletions in CTCFL in Glioblastoma Multiforme?,cnv_and_ssm
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the incidence rate of mutations in YY1AP1 paired with somatic heterozygous deletions in XKR4 in Glioblastoma Multiforme?,cnv_and_ssm
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the incidence rate of mutations in FNDC7 paired with somatic heterozygous deletions in LCN15 in Skin Cutaneous Melanoma?,cnv_and_ssm
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the incidence rate of mutations in FNDC7 paired with somatic heterozygous deletions in EVC2 in Skin Cutaneous Melanoma?,cnv_and_ssm
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the incidence rate of mutations in TLCD5 paired with somatic heterozygous deletions in ZNF431 in Lung Adenocarcinoma?,cnv_and_ssm
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the incidence rate of mutations in TLCD5 paired with somatic heterozygous deletions in EIF2B4 in Lung Adenocarcinoma?,cnv_and_ssm
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in POLR1G paired with somatic heterozygous deletions in CDC42BPA in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in POLR1G paired with somatic heterozygous deletions in TENM2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the incidence rate of mutations in DNAH14 paired with somatic heterozygous deletions in CTNNA2 in Colon Adenocarcinoma?,cnv_and_ssm
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the incidence rate of mutations in DNAH14 paired with somatic heterozygous deletions in DGKD in Colon Adenocarcinoma?,cnv_and_ssm
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the incidence rate of mutations in DNAH14 paired with somatic heterozygous deletions in EVC2 in Colon Adenocarcinoma?,cnv_and_ssm
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in NEXN paired with somatic heterozygous deletions in DCAF6 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the incidence rate of mutations in CYB5R2 paired with somatic heterozygous deletions in EPRS1 in Prostate Adenocarcinoma?,cnv_and_ssm
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the incidence rate of mutations in CYB5R2 paired with somatic heterozygous deletions in PTPRN2 in Prostate Adenocarcinoma?,cnv_and_ssm
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in NRAP paired with somatic heterozygous deletions in MYT1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in NRAP paired with somatic heterozygous deletions in DOCK2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in NRAP paired with somatic heterozygous deletions in POLD1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in CCDC22 paired with somatic heterozygous deletions in TENM3 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the incidence rate of mutations in DCAF6 paired with somatic heterozygous deletions in BCAT1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the incidence rate of mutations in DCAF6 paired with somatic heterozygous deletions in CPS1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in ZNF708 paired with somatic heterozygous deletions in HYOU1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in BFAR paired with somatic heterozygous deletions in FBXO15 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in MAST4 paired with somatic heterozygous deletions in FRY in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in MAST4 paired with somatic heterozygous deletions in PTPRN2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in MAST4 paired with somatic heterozygous deletions in TNS1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in MAST4 paired with somatic heterozygous deletions in EIF2B4 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in MAST4 paired with somatic heterozygous deletions in GABRA6 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the incidence rate of mutations in ARMC3 paired with somatic heterozygous deletions in SLC9C1 in Stomach Adenocarcinoma?,cnv_and_ssm
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the incidence rate of mutations in ARMC3 paired with somatic heterozygous deletions in ZCCHC14 in Stomach Adenocarcinoma?,cnv_and_ssm
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the incidence rate of mutations in TET2 paired with somatic heterozygous deletions in PGR in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the incidence rate of mutations in TET2 paired with somatic heterozygous deletions in DNAH14 in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the incidence rate of mutations in SERPINB10 paired with somatic heterozygous deletions in GUK1 in Lung Adenocarcinoma?,cnv_and_ssm
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in STAT3 paired with somatic heterozygous deletions in SGIP1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in MIEF1 paired with somatic heterozygous deletions in CXCR2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the incidence rate of mutations in ACVR1B paired with somatic heterozygous deletions in TAF1C in Colon Adenocarcinoma?,cnv_and_ssm
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the incidence rate of mutations in ACVR1B paired with somatic heterozygous deletions in ZFAT in Colon Adenocarcinoma?,cnv_and_ssm
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the incidence rate of mutations in ACVR1B paired with somatic heterozygous deletions in CHMP7 in Colon Adenocarcinoma?,cnv_and_ssm
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the incidence rate of mutations in EBF2 paired with somatic heterozygous deletions in PIK3C2G in Stomach Adenocarcinoma?,cnv_and_ssm
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the incidence rate of mutations in EBF2 paired with somatic heterozygous deletions in MYH11 in Stomach Adenocarcinoma?,cnv_and_ssm
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the incidence rate of mutations in VPS26B paired with somatic heterozygous deletions in TASOR2 in Stomach Adenocarcinoma?,cnv_and_ssm
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence rate of mutations in PGR paired with somatic heterozygous deletions in ZCCHC14 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence rate of mutations in PGR paired with somatic heterozygous deletions in ITPRID2 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence rate of mutations in PGR paired with somatic heterozygous deletions in PXN in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the incidence rate of mutations in ACTA2 paired with somatic heterozygous deletions in GABRA6 in Skin Cutaneous Melanoma?,cnv_and_ssm
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in THBS4 paired with somatic heterozygous deletions in UNC5D in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in THBS4 paired with somatic heterozygous deletions in CACNA1F in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the incidence rate of mutations in PRSS1 paired with somatic heterozygous deletions in NOMO1 in Lung Adenocarcinoma?,cnv_and_ssm
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the incidence rate of mutations in PRSS1 paired with somatic heterozygous deletions in TENM2 in Lung Adenocarcinoma?,cnv_and_ssm
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the incidence rate of mutations in PRSS1 paired with somatic heterozygous deletions in MYO15A in Lung Adenocarcinoma?,cnv_and_ssm
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the incidence rate of mutations in PRSS1 paired with somatic heterozygous deletions in PCDHGA1 in Lung Adenocarcinoma?,cnv_and_ssm
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the incidence rate of mutations in PGF paired with somatic heterozygous deletions in MRPL55 in Stomach Adenocarcinoma?,cnv_and_ssm
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the incidence rate of mutations in PGF paired with somatic heterozygous deletions in MYH11 in Stomach Adenocarcinoma?,cnv_and_ssm
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the incidence rate of mutations in ITPRID2 paired with somatic heterozygous deletions in NEXN in Breast Invasive Carcinoma?,cnv_and_ssm
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the incidence rate of mutations in ITPRID2 paired with somatic heterozygous deletions in MAST4 in Breast Invasive Carcinoma?,cnv_and_ssm
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in HBB paired with somatic heterozygous deletions in MED16 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the incidence rate of mutations in PCDHB2 paired with somatic heterozygous deletions in MYO16 in Colon Adenocarcinoma?,cnv_and_ssm
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the incidence rate of mutations in PCDHB2 paired with somatic heterozygous deletions in CTSC in Colon Adenocarcinoma?,cnv_and_ssm
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the incidence rate of mutations in PCDHB2 paired with somatic heterozygous deletions in AUTS2 in Colon Adenocarcinoma?,cnv_and_ssm
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the incidence rate of mutations in UBR2 paired with somatic heterozygous deletions in GUK1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the incidence rate of mutations in FBXO42 paired with somatic heterozygous deletions in PCDHB2 in Rectum Adenocarcinoma?,cnv_and_ssm
+1,TNS1,G1362V,Breast Invasive Carcinoma,What portion of Breast Invasive Carcinoma cases have both TNS1 mutations and ANKRD30A gains?,cnv_and_ssm
+2,TNS1,G1711V,Breast Invasive Carcinoma,What portion of Breast Invasive Carcinoma cases have both TNS1 mutations and SPTAN1 gains?,cnv_and_ssm
+3,TNS1,G1718V,Breast Invasive Carcinoma,What portion of Breast Invasive Carcinoma cases have both TNS1 mutations and DCC gains?,cnv_and_ssm
+4,TNS1,G1732V,Breast Invasive Carcinoma,What portion of Breast Invasive Carcinoma cases have both TNS1 mutations and ANP32E gains?,cnv_and_ssm
+5,TNS1,G1824V,Breast Invasive Carcinoma,What portion of Breast Invasive Carcinoma cases have both TNS1 mutations and DSCAM gains?,cnv_and_ssm
+6,TNS1,G1857V,Breast Invasive Carcinoma,What portion of Breast Invasive Carcinoma cases have both TNS1 mutations and ANP32E gains?,cnv_and_ssm
+7,TNS1,G843V,Breast Invasive Carcinoma,What portion of Breast Invasive Carcinoma cases have both TNS1 mutations and CASZ1 gains?,cnv_and_ssm
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What portion of Bladder Urothelial Carcinoma cases have both EVC2 mutations and FGF8 gains?,cnv_and_ssm
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What portion of Bladder Urothelial Carcinoma cases have both EVC2 mutations and MAOB gains?,cnv_and_ssm
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both CR1 mutations and JAML gains?,cnv_and_ssm
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both CR1 mutations and COL6A3 gains?,cnv_and_ssm
+22,TRPA1,S295I,Rectum Adenocarcinoma,What portion of Rectum Adenocarcinoma cases have both TRPA1 mutations and TSHZ3 gains?,cnv_and_ssm
+23,TRPA1,S443I,Rectum Adenocarcinoma,What portion of Rectum Adenocarcinoma cases have both TRPA1 mutations and MORF4L1 gains?,cnv_and_ssm
+24,TAF1C,R299L,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both TAF1C mutations and ITPRID2 gains?,cnv_and_ssm
+25,TAF1C,R396L,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both TAF1C mutations and ERCC6 gains?,cnv_and_ssm
+26,TAF1C,R634L,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both TAF1C mutations and ADAM17 gains?,cnv_and_ssm
+27,TAF1C,R702L,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both TAF1C mutations and SLC9C1 gains?,cnv_and_ssm
+28,TAF1C,R728L,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both TAF1C mutations and ACTB gains?,cnv_and_ssm
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both DPF3 mutations and TENT5A gains?,cnv_and_ssm
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both DPF3 mutations and SGIP1 gains?,cnv_and_ssm
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both DPF3 mutations and UNC5D gains?,cnv_and_ssm
+42,OR2T4,P272H,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both OR2T4 mutations and YY1AP1 gains?,cnv_and_ssm
+43,OR2T4,P300H,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both OR2T4 mutations and KRT39 gains?,cnv_and_ssm
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What portion of Pancreatic Adenocarcinoma cases have both FBN1 mutations and MYT1 gains?,cnv_and_ssm
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What portion of Prostate Adenocarcinoma cases have both MAD1L1 mutations and EFCAB12 gains?,cnv_and_ssm
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What portion of Prostate Adenocarcinoma cases have both MAD1L1 mutations and ADRA1A gains?,cnv_and_ssm
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What portion of Prostate Adenocarcinoma cases have both MAD1L1 mutations and SPATA22 gains?,cnv_and_ssm
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both CCNG1 mutations and ZBTB34 gains?,cnv_and_ssm
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What portion of Kidney Renal Papillary Cell Carcinoma cases have both ANP32E mutations and XKR4 gains?,cnv_and_ssm
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What portion of Kidney Renal Papillary Cell Carcinoma cases have both ANP32E mutations and ACVR1B gains?,cnv_and_ssm
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What portion of Kidney Renal Papillary Cell Carcinoma cases have both ANP32E mutations and DCAF6 gains?,cnv_and_ssm
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What portion of Kidney Renal Papillary Cell Carcinoma cases have both ANP32E mutations and ANP32E gains?,cnv_and_ssm
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What portion of Bladder Urothelial Carcinoma cases have both FRY mutations and CR1 gains?,cnv_and_ssm
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What portion of Bladder Urothelial Carcinoma cases have both FRY mutations and THBS4 gains?,cnv_and_ssm
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What portion of Bladder Urothelial Carcinoma cases have both FRY mutations and DOCK2 gains?,cnv_and_ssm
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What portion of Bladder Urothelial Carcinoma cases have both FRY mutations and PTPRN2 gains?,cnv_and_ssm
+70,PAK3,E318K,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both PAK3 mutations and HLA-DQA2 gains?,cnv_and_ssm
+71,PAK3,E319K,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both PAK3 mutations and ACTL7B gains?,cnv_and_ssm
+72,PAK3,E334K,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both PAK3 mutations and TET2 gains?,cnv_and_ssm
+73,PAK3,E340K,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both PAK3 mutations and TLCD5 gains?,cnv_and_ssm
+74,PAK3,E355K,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both PAK3 mutations and TYROBP gains?,cnv_and_ssm
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both MUC16 mutations and DOCK2 gains?,cnv_and_ssm
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What portion of Liver Hepatocellular Carcinoma cases have both ZFPM2 mutations and HTR3B gains?,cnv_and_ssm
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What portion of Liver Hepatocellular Carcinoma cases have both ZFPM2 mutations and ANP32E gains?,cnv_and_ssm
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What portion of Breast Invasive Carcinoma cases have both PIK3C2B mutations and PAPPA gains?,cnv_and_ssm
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What portion of Breast Invasive Carcinoma cases have both PIK3C2B mutations and FRY gains?,cnv_and_ssm
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both ZNF804A mutations and EBF2 gains?,cnv_and_ssm
+116,RELN,A2371V,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both RELN mutations and EIF2B4 gains?,cnv_and_ssm
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What portion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have both EFCAB12 mutations and EIF2B4 gains?",cnv_and_ssm
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What portion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have both EFCAB12 mutations and CDKN2AIP gains?",cnv_and_ssm
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both DEFB115 mutations and PXN gains?,cnv_and_ssm
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What portion of Bladder Urothelial Carcinoma cases have both ANKDD1A mutations and LCN15 gains?,cnv_and_ssm
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What portion of Bladder Urothelial Carcinoma cases have both ANKDD1A mutations and CEP20 gains?,cnv_and_ssm
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What portion of Bladder Urothelial Carcinoma cases have both ANKDD1A mutations and TASOR2 gains?,cnv_and_ssm
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both HTR3B mutations and TTC17 gains?,cnv_and_ssm
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both HTR3B mutations and PCDHB2 gains?,cnv_and_ssm
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both HTR3B mutations and SPAG1 gains?,cnv_and_ssm
+129,ABCC3,R758W,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both ABCC3 mutations and PKHD1L1 gains?,cnv_and_ssm
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both NOMO1 mutations and DNMT1 gains?,cnv_and_ssm
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both NOMO1 mutations and RIPOR2 gains?,cnv_and_ssm
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What portion of Bladder Urothelial Carcinoma cases have both HYOU1 mutations and JAML gains?,cnv_and_ssm
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both FMO4 mutations and SYNJ1 gains?,cnv_and_ssm
+140,BICC1,A372V,Exceptional Responders,What portion of Exceptional Responders cases have both BICC1 mutations and MRPL55 gains?,cnv_and_ssm
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both ZMYM3 mutations and PRSS8 gains?,cnv_and_ssm
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both ZMYM3 mutations and ABCC2 gains?,cnv_and_ssm
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both ZMYM3 mutations and MED16 gains?,cnv_and_ssm
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What portion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have both XKR4 mutations and AKT1 gains?",cnv_and_ssm
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What portion of Liver Hepatocellular Carcinoma cases have both ABCC2 mutations and SPATA22 gains?,cnv_and_ssm
+157,OR8K5,R293G,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both OR8K5 mutations and ANKDD1A gains?,cnv_and_ssm
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both SPTAN1 mutations and PRSS1 gains?,cnv_and_ssm
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both SPTAN1 mutations and TTC12 gains?,cnv_and_ssm
+164,SYT10,M484I,Rectum Adenocarcinoma,What portion of Rectum Adenocarcinoma cases have both SYT10 mutations and HSPA5 gains?,cnv_and_ssm
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both HSPA5 mutations and GIMAP2 gains?,cnv_and_ssm
+175,UNC5D,L280V,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both UNC5D mutations and ZNF708 gains?,cnv_and_ssm
+176,UNC5D,L635V,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both UNC5D mutations and GABRA6 gains?,cnv_and_ssm
+177,UNC5D,L637V,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both UNC5D mutations and PCDHB2 gains?,cnv_and_ssm
+178,UNC5D,L699V,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both UNC5D mutations and SPATA22 gains?,cnv_and_ssm
+179,UNC5D,L704V,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both UNC5D mutations and JAML gains?,cnv_and_ssm
+180,UNC5D,L709V,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both UNC5D mutations and BCAT1 gains?,cnv_and_ssm
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What portion of Kidney Renal Clear Cell Carcinoma cases have both DOCK2 mutations and SLC24A2 gains?,cnv_and_ssm
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What portion of Kidney Renal Clear Cell Carcinoma cases have both ZNF627 mutations and SMO gains?,cnv_and_ssm
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both CDC42BPA mutations and OR2A12 gains?,cnv_and_ssm
+193,MRPL55,H27Y,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both MRPL55 mutations and SIK2 gains?,cnv_and_ssm
+194,MRPL55,H63Y,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both MRPL55 mutations and DHX16 gains?,cnv_and_ssm
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What portion of Breast Invasive Carcinoma cases have both TMTC3 mutations and ZNF708 gains?,cnv_and_ssm
+198,EPRS1,K771I,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both EPRS1 mutations and DCN gains?,cnv_and_ssm
+199,EPRS1,K778I,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both EPRS1 mutations and ANKRD24 gains?,cnv_and_ssm
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both GRTP1 mutations and PTPRO gains?,cnv_and_ssm
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both GRTP1 mutations and EIF2B4 gains?,cnv_and_ssm
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both TSHZ3 mutations and FGF8 gains?,cnv_and_ssm
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What portion of HIV+ Tumor Molecular Characterization Project - Cervical Cancer cases have both TAS1R3 mutations and GPR158 gains?,cnv_and_ssm
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both PIAS3 mutations and SORCS1 gains?,cnv_and_ssm
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both PIAS3 mutations and CR1 gains?,cnv_and_ssm
+251,ZNF274,P13R,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both ZNF274 mutations and CEP20 gains?,cnv_and_ssm
+253,SYNJ1,R795C,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both SYNJ1 mutations and FRY gains?,cnv_and_ssm
+254,SYNJ1,R800C,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both SYNJ1 mutations and CXCR2 gains?,cnv_and_ssm
+255,SYNJ1,R839C,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both SYNJ1 mutations and DSCAM gains?,cnv_and_ssm
+261,DSCAM,V343M,Prostate Adenocarcinoma,What portion of Prostate Adenocarcinoma cases have both DSCAM mutations and MAD1L1 gains?,cnv_and_ssm
+262,DSCAM,V426M,Prostate Adenocarcinoma,What portion of Prostate Adenocarcinoma cases have both DSCAM mutations and POC1B gains?,cnv_and_ssm
+263,DSCAM,V591M,Prostate Adenocarcinoma,What portion of Prostate Adenocarcinoma cases have both DSCAM mutations and CTSC gains?,cnv_and_ssm
+267,DGKD,R140H,Exceptional Responders,What portion of Exceptional Responders cases have both DGKD mutations and HSPA5 gains?,cnv_and_ssm
+268,DGKD,R160H,Exceptional Responders,What portion of Exceptional Responders cases have both DGKD mutations and HLA-DQA2 gains?,cnv_and_ssm
+269,DGKD,R204H,Exceptional Responders,What portion of Exceptional Responders cases have both DGKD mutations and POLD1 gains?,cnv_and_ssm
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What portion of Bladder Urothelial Carcinoma cases have both PLEKHG6 mutations and ZNF431 gains?,cnv_and_ssm
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What portion of Bladder Urothelial Carcinoma cases have both PLEKHG6 mutations and PIK3C2G gains?,cnv_and_ssm
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What portion of Bladder Urothelial Carcinoma cases have both PLEKHG6 mutations and SPATA22 gains?,cnv_and_ssm
+279,WNT2,D138N,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both WNT2 mutations and PCDHB2 gains?,cnv_and_ssm
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both GUCY2C mutations and MYH11 gains?,cnv_and_ssm
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both C7orf31 mutations and OLFML3 gains?,cnv_and_ssm
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What portion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have both ZKSCAN7 mutations and ARMC3 gains?",cnv_and_ssm
+299,OR5D14,M210L,Neuroblastoma,What portion of Neuroblastoma cases have both OR5D14 mutations and OR13C3 gains?,cnv_and_ssm
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both SPATA22 mutations and PXN gains?,cnv_and_ssm
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both SPATA22 mutations and PTPRO gains?,cnv_and_ssm
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both SPATA22 mutations and PCDHGA1 gains?,cnv_and_ssm
+310,LCN15,E21V,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both LCN15 mutations and MYO16 gains?,cnv_and_ssm
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both DCAF4L2 mutations and GUF1 gains?,cnv_and_ssm
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both GUK1 mutations and HTR3B gains?,cnv_and_ssm
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both GUK1 mutations and CCNG1 gains?,cnv_and_ssm
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both GUK1 mutations and OR2T4 gains?,cnv_and_ssm
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both GUK1 mutations and PGR gains?,cnv_and_ssm
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both GUK1 mutations and CPS1 gains?,cnv_and_ssm
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both MORF4L1 mutations and PAK3 gains?,cnv_and_ssm
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both MORF4L1 mutations and ANKRD24 gains?,cnv_and_ssm
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both MORF4L1 mutations and FNDC7 gains?,cnv_and_ssm
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both MORF4L1 mutations and HTR3B gains?,cnv_and_ssm
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both MYO3B mutations and TMEM255A gains?,cnv_and_ssm
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both MYO3B mutations and ICE1 gains?,cnv_and_ssm
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both TENT5A mutations and MYH11 gains?,cnv_and_ssm
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both TENT5A mutations and YY1AP1 gains?,cnv_and_ssm
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both TENT5A mutations and MYT1 gains?,cnv_and_ssm
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What portion of Ovarian Serous Cystadenocarcinoma cases have both ZFAT mutations and EIF2B4 gains?,cnv_and_ssm
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What portion of Ovarian Serous Cystadenocarcinoma cases have both ZFAT mutations and B3GALNT1 gains?,cnv_and_ssm
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What portion of Ovarian Serous Cystadenocarcinoma cases have both ZFAT mutations and PRSS8 gains?,cnv_and_ssm
+357,ZNF584,A211T,Sarcoma,What portion of Sarcoma cases have both ZNF584 mutations and FCGR2C gains?,cnv_and_ssm
+358,ZNF584,A256T,Sarcoma,What portion of Sarcoma cases have both ZNF584 mutations and KDM5C gains?,cnv_and_ssm
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both LDOC1 mutations and TNS1 gains?,cnv_and_ssm
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both PDGFC mutations and CHODL gains?,cnv_and_ssm
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both MSANTD4 mutations and CDC42BPA gains?,cnv_and_ssm
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both NPSR1 mutations and OR2T4 gains?,cnv_and_ssm
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both PHLPP1 mutations and DNMT1 gains?,cnv_and_ssm
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both COL6A3 mutations and EVC2 gains?,cnv_and_ssm
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both COL6A3 mutations and MORF4L1 gains?,cnv_and_ssm
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both COL6A3 mutations and MYO3B gains?,cnv_and_ssm
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both COL6A3 mutations and CTNNA2 gains?,cnv_and_ssm
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both COL6A3 mutations and ZCCHC14 gains?,cnv_and_ssm
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both ADRA1A mutations and DHX16 gains?,cnv_and_ssm
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What portion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have both LAMB2 mutations and ANKRD24 gains?,cnv_and_ssm
+406,POC1B,I198T,Rectum Adenocarcinoma,What portion of Rectum Adenocarcinoma cases have both POC1B mutations and XKR4 gains?,cnv_and_ssm
+407,POC1B,I286T,Rectum Adenocarcinoma,What portion of Rectum Adenocarcinoma cases have both POC1B mutations and PTPRO gains?,cnv_and_ssm
+408,POC1B,I328T,Rectum Adenocarcinoma,What portion of Rectum Adenocarcinoma cases have both POC1B mutations and CFAP61 gains?,cnv_and_ssm
+409,POC1B,S79P,Rectum Adenocarcinoma,What portion of Rectum Adenocarcinoma cases have both POC1B mutations and EIF2B4 gains?,cnv_and_ssm
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What portion of Liver Hepatocellular Carcinoma cases have both USH2A mutations and ACTL7B gains?,cnv_and_ssm
+414,AQP7,T110S,Rectum Adenocarcinoma,What portion of Rectum Adenocarcinoma cases have both AQP7 mutations and C7orf31 gains?,cnv_and_ssm
+415,AQP7,T166S,Rectum Adenocarcinoma,What portion of Rectum Adenocarcinoma cases have both AQP7 mutations and RIMS2 gains?,cnv_and_ssm
+416,AQP7,T167S,Rectum Adenocarcinoma,What portion of Rectum Adenocarcinoma cases have both AQP7 mutations and NOMO1 gains?,cnv_and_ssm
+417,AQP7,T75S,Rectum Adenocarcinoma,What portion of Rectum Adenocarcinoma cases have both AQP7 mutations and GABRA6 gains?,cnv_and_ssm
+430,DCN,R163C,Rectum Adenocarcinoma,What portion of Rectum Adenocarcinoma cases have both DCN mutations and DGKD gains?,cnv_and_ssm
+431,DCN,R203C,Rectum Adenocarcinoma,What portion of Rectum Adenocarcinoma cases have both DCN mutations and SPATA22 gains?,cnv_and_ssm
+432,DCN,R241C,Rectum Adenocarcinoma,What portion of Rectum Adenocarcinoma cases have both DCN mutations and TYK2 gains?,cnv_and_ssm
+433,DCN,R350C,Rectum Adenocarcinoma,What portion of Rectum Adenocarcinoma cases have both DCN mutations and ANKRD24 gains?,cnv_and_ssm
+434,DCN,R41C,Rectum Adenocarcinoma,What portion of Rectum Adenocarcinoma cases have both DCN mutations and GSTCD gains?,cnv_and_ssm
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both CPS1 mutations and ZNF804A gains?,cnv_and_ssm
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both CPS1 mutations and OR13C3 gains?,cnv_and_ssm
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both CPS1 mutations and TASOR2 gains?,cnv_and_ssm
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What portion of Kidney Renal Papillary Cell Carcinoma cases have both FCGR2C mutations and HTR3B gains?,cnv_and_ssm
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What portion of Kidney Renal Papillary Cell Carcinoma cases have both FCGR2C mutations and PAK3 gains?,cnv_and_ssm
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both GRM1 mutations and SLC9C1 gains?,cnv_and_ssm
+482,SGCZ,Q138H,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both SGCZ mutations and PRSS8 gains?,cnv_and_ssm
+483,SGCZ,Q91H,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both SGCZ mutations and PAK3 gains?,cnv_and_ssm
+485,SMO,V15M,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both SMO mutations and AQP7 gains?,cnv_and_ssm
+486,SMO,V321M,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both SMO mutations and ACTB gains?,cnv_and_ssm
+488,CHODL,G159E,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both CHODL mutations and PTPRO gains?,cnv_and_ssm
+489,CHODL,G181E,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both CHODL mutations and TAF1C gains?,cnv_and_ssm
+490,CHODL,G200E,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both CHODL mutations and ANP32E gains?,cnv_and_ssm
+494,MYO16,P399H,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both MYO16 mutations and AUTS2 gains?,cnv_and_ssm
+495,MYO16,P421H,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both MYO16 mutations and DGKD gains?,cnv_and_ssm
+498,CXCR2,A98V,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both CXCR2 mutations and SYNJ1 gains?,cnv_and_ssm
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What portion of Bladder Urothelial Carcinoma cases have both TMEM225 mutations and UNC5D gains?,cnv_and_ssm
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both MAOB mutations and CPS1 gains?,cnv_and_ssm
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both GPRASP1 mutations and MYO3B gains?,cnv_and_ssm
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both MRPL32 mutations and ACTB gains?,cnv_and_ssm
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both TYROBP mutations and SYT9 gains?,cnv_and_ssm
+510,RAB40C,A111V,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both RAB40C mutations and UNC5D gains?,cnv_and_ssm
+511,RAB40C,A143V,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both RAB40C mutations and GUK1 gains?,cnv_and_ssm
+512,CTNNA2,S323R,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both CTNNA2 mutations and RIMS2 gains?,cnv_and_ssm
+513,CTNNA2,S339R,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both CTNNA2 mutations and GPC3 gains?,cnv_and_ssm
+514,CTNNA2,S386R,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both CTNNA2 mutations and FGF8 gains?,cnv_and_ssm
+515,CTNNA2,S707R,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both CTNNA2 mutations and TTC12 gains?,cnv_and_ssm
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What portion of Bladder Urothelial Carcinoma cases have both MYO15A mutations and PXN gains?,cnv_and_ssm
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both GIMAP2 mutations and ACTB gains?,cnv_and_ssm
+532,KIF20B,N1160D,Glioblastoma Multiforme,What portion of Glioblastoma Multiforme cases have both KIF20B mutations and TAF1C gains?,cnv_and_ssm
+533,KIF20B,N1200D,Glioblastoma Multiforme,What portion of Glioblastoma Multiforme cases have both KIF20B mutations and ABCC3 gains?,cnv_and_ssm
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both ADAM17 mutations and BCAT1 gains?,cnv_and_ssm
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both BCAT1 mutations and OR13C3 gains?,cnv_and_ssm
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both BCAT1 mutations and HLA-DQA2 gains?,cnv_and_ssm
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both BCAT1 mutations and GRTP1 gains?,cnv_and_ssm
+540,ERCC6,R1053H,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both ERCC6 mutations and XKR4 gains?,cnv_and_ssm
+541,DCC,R320W,Breast Invasive Carcinoma,What portion of Breast Invasive Carcinoma cases have both DCC mutations and TENM2 gains?,cnv_and_ssm
+542,DCC,R363W,Breast Invasive Carcinoma,What portion of Breast Invasive Carcinoma cases have both DCC mutations and OLFML3 gains?,cnv_and_ssm
+543,DCC,R386W,Breast Invasive Carcinoma,What portion of Breast Invasive Carcinoma cases have both DCC mutations and OLFML3 gains?,cnv_and_ssm
+544,DCC,R41W,Breast Invasive Carcinoma,What portion of Breast Invasive Carcinoma cases have both DCC mutations and PXN gains?,cnv_and_ssm
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both FBXO15 mutations and TASOR2 gains?,cnv_and_ssm
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both FBXO15 mutations and PRSS1 gains?,cnv_and_ssm
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both GSTCD mutations and ZNF274 gains?,cnv_and_ssm
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both GSTCD mutations and TENM2 gains?,cnv_and_ssm
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both OLFML3 mutations and PTPRN2 gains?,cnv_and_ssm
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both OLFML3 mutations and JAML gains?,cnv_and_ssm
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both OLFML3 mutations and ANKRD30A gains?,cnv_and_ssm
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What portion of Ovarian Serous Cystadenocarcinoma cases have both CFAP61 mutations and ZCCHC14 gains?,cnv_and_ssm
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What portion of Ovarian Serous Cystadenocarcinoma cases have both CFAP61 mutations and PTPRO gains?,cnv_and_ssm
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What portion of Bladder Urothelial Carcinoma cases have both HLA-DQA2 mutations and KDM5C gains?,cnv_and_ssm
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both TENM2 mutations and CTNNA2 gains?,cnv_and_ssm
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both TENM2 mutations and NOMO1 gains?,cnv_and_ssm
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both TENM2 mutations and SGIP1 gains?,cnv_and_ssm
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both ANKRD24 mutations and TRIM45 gains?,cnv_and_ssm
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both ANKRD24 mutations and MAD1L1 gains?,cnv_and_ssm
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both ANKRD24 mutations and ANKDD1A gains?,cnv_and_ssm
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both ZCCHC14 mutations and ANKDD1A gains?,cnv_and_ssm
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both ZCCHC14 mutations and MORF4L1 gains?,cnv_and_ssm
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both ZCCHC14 mutations and SPINDOC gains?,cnv_and_ssm
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both ZCCHC14 mutations and ZFAT gains?,cnv_and_ssm
+625,SIK2,I265M,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both SIK2 mutations and TAS1R3 gains?,cnv_and_ssm
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both MYH11 mutations and POC1B gains?,cnv_and_ssm
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both MYH11 mutations and MORF4L1 gains?,cnv_and_ssm
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both SLC6A4 mutations and ACVR1B gains?,cnv_and_ssm
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both SLC9C1 mutations and TENM2 gains?,cnv_and_ssm
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both SLC9C1 mutations and PAK3 gains?,cnv_and_ssm
+644,OR2A12,A254T,Brain Lower Grade Glioma,What portion of Brain Lower Grade Glioma cases have both OR2A12 mutations and ABCC3 gains?,cnv_and_ssm
+646,PYHIN1,T325K,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both PYHIN1 mutations and RIPOR2 gains?,cnv_and_ssm
+647,PYHIN1,T334K,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both PYHIN1 mutations and KDM5C gains?,cnv_and_ssm
+650,JAML,G191E,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both JAML mutations and GSTCD gains?,cnv_and_ssm
+651,JAML,G219E,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both JAML mutations and PYHIN1 gains?,cnv_and_ssm
+652,JAML,G220E,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both JAML mutations and HTR3B gains?,cnv_and_ssm
+653,JAML,G230E,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both JAML mutations and YY1AP1 gains?,cnv_and_ssm
+658,TYK2,H1146R,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both TYK2 mutations and HLA-DQA2 gains?,cnv_and_ssm
+659,TYK2,H23R,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both TYK2 mutations and EVC2 gains?,cnv_and_ssm
+660,TYK2,H961R,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both TYK2 mutations and NEXN gains?,cnv_and_ssm
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both CTCFL mutations and PYHIN1 gains?,cnv_and_ssm
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both CTCFL mutations and DSCAM gains?,cnv_and_ssm
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both CTCFL mutations and CHMP7 gains?,cnv_and_ssm
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both CTCFL mutations and CX3CR1 gains?,cnv_and_ssm
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both CEP20 mutations and ACTA2 gains?,cnv_and_ssm
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both CEP20 mutations and PTPRO gains?,cnv_and_ssm
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both RIMS2 mutations and PXN gains?,cnv_and_ssm
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both RIMS2 mutations and CDH23 gains?,cnv_and_ssm
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both RIMS2 mutations and PIK3C2B gains?,cnv_and_ssm
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both RIMS2 mutations and GUK1 gains?,cnv_and_ssm
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both RIMS2 mutations and PAK3 gains?,cnv_and_ssm
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both RIMS2 mutations and ANKDD1A gains?,cnv_and_ssm
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both RIMS2 mutations and DCLK3 gains?,cnv_and_ssm
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both PIK3C2G mutations and TTC12 gains?,cnv_and_ssm
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both PIK3C2G mutations and TTN gains?,cnv_and_ssm
+728,STK19,D341N,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both STK19 mutations and DCN gains?,cnv_and_ssm
+729,STK19,D345N,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both STK19 mutations and RELN gains?,cnv_and_ssm
+730,REXO4,P60A,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both REXO4 mutations and DSCAM gains?,cnv_and_ssm
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both ZBTB34 mutations and HTR3B gains?,cnv_and_ssm
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both ZBTB34 mutations and TRPA1 gains?,cnv_and_ssm
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What portion of Bladder Urothelial Carcinoma cases have both NCKAP5 mutations and CACNA1F gains?,cnv_and_ssm
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What portion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have both SORCS1 mutations and THBS4 gains?",cnv_and_ssm
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What portion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have both SORCS1 mutations and ZKSCAN7 gains?",cnv_and_ssm
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What portion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have both SORCS1 mutations and KL gains?",cnv_and_ssm
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What portion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have both SORCS1 mutations and GIMAP2 gains?",cnv_and_ssm
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What portion of Head and Neck Squamous Cell Carcinoma cases have both FGF8 mutations and TYK2 gains?,cnv_and_ssm
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What portion of Head and Neck Squamous Cell Carcinoma cases have both FGF8 mutations and KRT39 gains?,cnv_and_ssm
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What portion of Head and Neck Squamous Cell Carcinoma cases have both FGF8 mutations and DEFB115 gains?,cnv_and_ssm
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What portion of Head and Neck Squamous Cell Carcinoma cases have both FGF8 mutations and ZCCHC14 gains?,cnv_and_ssm
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What portion of Head and Neck Squamous Cell Carcinoma cases have both FGF8 mutations and DCN gains?,cnv_and_ssm
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What portion of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia cases have both TENM3 mutations and TSHZ3 gains?,cnv_and_ssm
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both AKT1 mutations and PXN gains?,cnv_and_ssm
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What portion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have both CFAP298-TCP10L mutations and GRTP1 gains?,cnv_and_ssm
+792,GLRB,E148D,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both GLRB mutations and TMEM225 gains?,cnv_and_ssm
+793,TTN,F7636L,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both TTN mutations and PTPRN2 gains?,cnv_and_ssm
+794,TTN,F8563L,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both TTN mutations and CARMIL1 gains?,cnv_and_ssm
+795,TTN,F8880L,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both TTN mutations and FRY gains?,cnv_and_ssm
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both ANKRD30A mutations and TRAP1 gains?,cnv_and_ssm
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both ANKRD30A mutations and BICC1 gains?,cnv_and_ssm
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both ANKRD30A mutations and PXN gains?,cnv_and_ssm
+809,TRIM45,S177L,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both TRIM45 mutations and SPTAN1 gains?,cnv_and_ssm
+810,TRIM45,S224L,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both TRIM45 mutations and AUTS2 gains?,cnv_and_ssm
+811,TRIM45,S281L,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both TRIM45 mutations and THBS4 gains?,cnv_and_ssm
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both CACNA1F mutations and DNAH11 gains?,cnv_and_ssm
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both CACNA1F mutations and SYT9 gains?,cnv_and_ssm
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both CACNA1F mutations and B3GALNT1 gains?,cnv_and_ssm
+817,KL,R594C,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both KL mutations and OLFML3 gains?,cnv_and_ssm
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What portion of Kidney Renal Papillary Cell Carcinoma cases have both GUF1 mutations and CYB5R2 gains?,cnv_and_ssm
+822,TAF1L,A539V,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both TAF1L mutations and PTPRO gains?,cnv_and_ssm
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both TASOR2 mutations and AQP7 gains?,cnv_and_ssm
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both TASOR2 mutations and MYO3B gains?,cnv_and_ssm
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both TASOR2 mutations and CDKN2AIP gains?,cnv_and_ssm
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both KDM5C mutations and DCLK3 gains?,cnv_and_ssm
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both KDM5C mutations and SLC24A2 gains?,cnv_and_ssm
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both KDM5C mutations and PRSS8 gains?,cnv_and_ssm
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both KDM5C mutations and UBR2 gains?,cnv_and_ssm
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What portion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have both IL5RA mutations and GSTCD gains?,cnv_and_ssm
+843,DHX16,A29V,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both DHX16 mutations and CPA6 gains?,cnv_and_ssm
+844,DHX16,A89V,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both DHX16 mutations and TNS1 gains?,cnv_and_ssm
+902,GPR158,A644V,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both GPR158 mutations and CDH23 gains?,cnv_and_ssm
+903,GPR158,A723V,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both GPR158 mutations and AQP7 gains?,cnv_and_ssm
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What portion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have both EIF2B4 mutations and HTR3B gains?",cnv_and_ssm
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What portion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have both EIF2B4 mutations and ACTB gains?",cnv_and_ssm
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What portion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have both EIF2B4 mutations and AQP7 gains?",cnv_and_ssm
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What portion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have both EIF2B4 mutations and DPF3 gains?",cnv_and_ssm
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What portion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have both EIF2B4 mutations and SPATA22 gains?",cnv_and_ssm
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What portion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have both EIF2B4 mutations and CXCR2 gains?",cnv_and_ssm
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both AUTS2 mutations and MAD1L1 gains?,cnv_and_ssm
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both AUTS2 mutations and RIMS2 gains?,cnv_and_ssm
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both AUTS2 mutations and COL6A3 gains?,cnv_and_ssm
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both AUTS2 mutations and DNAH14 gains?,cnv_and_ssm
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both AUTS2 mutations and YY1AP1 gains?,cnv_and_ssm
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both AUTS2 mutations and PAK3 gains?,cnv_and_ssm
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both AUTS2 mutations and TENT5A gains?,cnv_and_ssm
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both AUTS2 mutations and OR2A12 gains?,cnv_and_ssm
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both AUTS2 mutations and POLR1G gains?,cnv_and_ssm
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both AUTS2 mutations and DNAH11 gains?,cnv_and_ssm
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What portion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have both ACTL7B mutations and OR13C3 gains?",cnv_and_ssm
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What portion of Glioblastoma Multiforme cases have both PCDHGA1 mutations and CTCFL gains?,cnv_and_ssm
+954,TRAP1,R114W,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both TRAP1 mutations and ITPRID2 gains?,cnv_and_ssm
+955,TRAP1,R61W,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both TRAP1 mutations and JAML gains?,cnv_and_ssm
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both PIK3C2A mutations and SIK2 gains?,cnv_and_ssm
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What portion of Liver Hepatocellular Carcinoma cases have both KANSL1 mutations and ANKRD30A gains?,cnv_and_ssm
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both ANKRD52 mutations and FGF8 gains?,cnv_and_ssm
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both PAPPA mutations and ART3 gains?,cnv_and_ssm
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What portion of Rectum Adenocarcinoma cases have both B3GALNT1 mutations and ZNF431 gains?,cnv_and_ssm
+982,GABRA6,G115R,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both GABRA6 mutations and SPATA22 gains?,cnv_and_ssm
+983,GABRA6,G122R,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both GABRA6 mutations and FGF8 gains?,cnv_and_ssm
+984,GABRA6,G165R,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both GABRA6 mutations and CFAP61 gains?,cnv_and_ssm
+985,GABRA6,G175R,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both GABRA6 mutations and SYT9 gains?,cnv_and_ssm
+986,GABRA6,G70R,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both GABRA6 mutations and CTSC gains?,cnv_and_ssm
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both ZSCAN31 mutations and KDM5C gains?,cnv_and_ssm
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What portion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have both MED16 mutations and MYO15A gains?",cnv_and_ssm
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What portion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have both MED16 mutations and ITPRID2 gains?",cnv_and_ssm
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What portion of Pancreatic Adenocarcinoma cases have both PTPRO mutations and ZFP42 gains?,cnv_and_ssm
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What portion of Pancreatic Adenocarcinoma cases have both PTPRO mutations and GRTP1 gains?,cnv_and_ssm
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What portion of Pancreatic Adenocarcinoma cases have both PTPRO mutations and KIF20B gains?,cnv_and_ssm
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What portion of Pancreatic Adenocarcinoma cases have both PTPRO mutations and POC1B gains?,cnv_and_ssm
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What portion of Pancreatic Adenocarcinoma cases have both PTPRO mutations and TENM2 gains?,cnv_and_ssm
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What portion of Pancreatic Adenocarcinoma cases have both PTPRO mutations and TLCD5 gains?,cnv_and_ssm
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What portion of Pancreatic Adenocarcinoma cases have both PTPRO mutations and TENT5A gains?,cnv_and_ssm
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What portion of Pancreatic Adenocarcinoma cases have both PTPRO mutations and GRTP1 gains?,cnv_and_ssm
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both CHMP7 mutations and ABCC2 gains?,cnv_and_ssm
+1017,GPC3,I107N,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both GPC3 mutations and PRSS8 gains?,cnv_and_ssm
+1018,GPC3,I161N,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both GPC3 mutations and ARHGEF40 gains?,cnv_and_ssm
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What portion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have both TLK2 mutations and KDM5C gains?,cnv_and_ssm
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What portion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have both TLK2 mutations and GUK1 gains?,cnv_and_ssm
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What portion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have both TLK2 mutations and RAB40C gains?,cnv_and_ssm
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What portion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have both TLK2 mutations and DGKD gains?,cnv_and_ssm
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What portion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases have both TLK2 mutations and ANKRD24 gains?,cnv_and_ssm
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both ZNF217 mutations and JAML gains?,cnv_and_ssm
+1038,SYT9,V275L,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both SYT9 mutations and DGKD gains?,cnv_and_ssm
+1039,SYT9,V307L,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both SYT9 mutations and PTPRN2 gains?,cnv_and_ssm
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both PKHD1L1 mutations and SYNJ1 gains?,cnv_and_ssm
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both MYO3A mutations and DNAH14 gains?,cnv_and_ssm
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What portion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have both VASN mutations and GRM5 gains?",cnv_and_ssm
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both DNMT1 mutations and FGF8 gains?,cnv_and_ssm
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both DNMT1 mutations and RIMS2 gains?,cnv_and_ssm
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both DNMT1 mutations and KDM5C gains?,cnv_and_ssm
+1056,CA9,E402K,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both CA9 mutations and ZFAT gains?,cnv_and_ssm
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both TTC17 mutations and ZMYM3 gains?,cnv_and_ssm
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both TTC17 mutations and DPF3 gains?,cnv_and_ssm
+1065,PSG2,P43L,Breast Invasive Carcinoma,What portion of Breast Invasive Carcinoma cases have both PSG2 mutations and PTPRN2 gains?,cnv_and_ssm
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What portion of Breast Invasive Carcinoma cases have both RIPOR2 mutations and ACTB gains?,cnv_and_ssm
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What portion of Breast Invasive Carcinoma cases have both RIPOR2 mutations and AUTS2 gains?,cnv_and_ssm
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What portion of Breast Invasive Carcinoma cases have both RIPOR2 mutations and GRM1 gains?,cnv_and_ssm
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What portion of Breast Invasive Carcinoma cases have both RIPOR2 mutations and ANKRD30A gains?,cnv_and_ssm
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both DCLK3 mutations and TRIM45 gains?,cnv_and_ssm
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both DCLK3 mutations and ANP32E gains?,cnv_and_ssm
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both MERTK mutations and ADRA1A gains?,cnv_and_ssm
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both MERTK mutations and RIMS2 gains?,cnv_and_ssm
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both MERTK mutations and ZNF584 gains?,cnv_and_ssm
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both ZFP42 mutations and STK19 gains?,cnv_and_ssm
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both OR13C3 mutations and TSHZ3 gains?,cnv_and_ssm
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both OR13C3 mutations and DCLK3 gains?,cnv_and_ssm
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both SPAG1 mutations and PKHD1L1 gains?,cnv_and_ssm
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both CDKN2AIP mutations and POLD1 gains?,cnv_and_ssm
+1093,PXN,H1016Y,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both PXN mutations and NRAP gains?,cnv_and_ssm
+1094,PXN,H359Y,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both PXN mutations and ZCCHC14 gains?,cnv_and_ssm
+1095,PXN,H492Y,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both PXN mutations and ANP32E gains?,cnv_and_ssm
+1096,PXN,H524Y,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both PXN mutations and AQP7 gains?,cnv_and_ssm
+1097,PXN,H526Y,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both PXN mutations and ARMC3 gains?,cnv_and_ssm
+1098,PXN,H540Y,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both PXN mutations and CHODL gains?,cnv_and_ssm
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both TTYH2 mutations and PTPRO gains?,cnv_and_ssm
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both TTYH2 mutations and CEP20 gains?,cnv_and_ssm
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both TMEM255A mutations and TNS1 gains?,cnv_and_ssm
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both TMEM255A mutations and FBN1 gains?,cnv_and_ssm
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both TMEM255A mutations and PDGFC gains?,cnv_and_ssm
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What portion of Breast Invasive Carcinoma cases have both TASOR2 mutations and POLD1 gains?,cnv_and_ssm
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What portion of Breast Invasive Carcinoma cases have both TASOR2 mutations and EPRS1 gains?,cnv_and_ssm
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both ICE1 mutations and USH2A gains?,cnv_and_ssm
+1112,MYT1,A558E,Breast Invasive Carcinoma,What portion of Breast Invasive Carcinoma cases have both MYT1 mutations and FGF8 gains?,cnv_and_ssm
+1113,MYT1,A879E,Breast Invasive Carcinoma,What portion of Breast Invasive Carcinoma cases have both MYT1 mutations and SYT9 gains?,cnv_and_ssm
+1114,MYT1,A906E,Breast Invasive Carcinoma,What portion of Breast Invasive Carcinoma cases have both MYT1 mutations and GUCY2C gains?,cnv_and_ssm
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both CX3CR1 mutations and ACVR1B gains?,cnv_and_ssm
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both CX3CR1 mutations and ZFAT gains?,cnv_and_ssm
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What portion of Liver Hepatocellular Carcinoma cases have both SPINDOC mutations and MED16 gains?,cnv_and_ssm
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both ART3 mutations and OR2T4 gains?,cnv_and_ssm
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both ART3 mutations and ARMC3 gains?,cnv_and_ssm
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What portion of Bladder Urothelial Carcinoma cases have both CYP1A2 mutations and PYHIN1 gains?,cnv_and_ssm
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What portion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have both ADRA1A mutations and PIK3C2B gains?",cnv_and_ssm
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both CDH23 mutations and YY1AP1 gains?,cnv_and_ssm
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both CDH23 mutations and CXCR2 gains?,cnv_and_ssm
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both KRT39 mutations and DGKD gains?,cnv_and_ssm
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both PDHA2 mutations and FRY gains?,cnv_and_ssm
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both SLC24A2 mutations and FGF8 gains?,cnv_and_ssm
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What portion of Liver Hepatocellular Carcinoma cases have both PTPRN2 mutations and ZNF217 gains?,cnv_and_ssm
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What portion of Liver Hepatocellular Carcinoma cases have both PTPRN2 mutations and SLC6A4 gains?,cnv_and_ssm
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What portion of Liver Hepatocellular Carcinoma cases have both PTPRN2 mutations and MYT1 gains?,cnv_and_ssm
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What portion of Liver Hepatocellular Carcinoma cases have both PTPRN2 mutations and GRTP1 gains?,cnv_and_ssm
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What portion of Liver Hepatocellular Carcinoma cases have both PTPRN2 mutations and KIF20B gains?,cnv_and_ssm
+1188,SOX21,R55L,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both SOX21 mutations and EIF2B4 gains?,cnv_and_ssm
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What portion of Bladder Urothelial Carcinoma cases have both CPA6 mutations and MYO16 gains?,cnv_and_ssm
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both GRM5 mutations and AUTS2 gains?,cnv_and_ssm
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What portion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have both CASZ1 mutations and JAML gains?",cnv_and_ssm
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both SGIP1 mutations and ACTB gains?,cnv_and_ssm
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both SGIP1 mutations and TENM2 gains?,cnv_and_ssm
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both SGIP1 mutations and MYH11 gains?,cnv_and_ssm
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both SGIP1 mutations and PTPRN2 gains?,cnv_and_ssm
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both CARMIL1 mutations and DCN gains?,cnv_and_ssm
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both CARMIL1 mutations and TNS1 gains?,cnv_and_ssm
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both ZNF431 mutations and PDGFC gains?,cnv_and_ssm
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both ZNF431 mutations and EFCAB12 gains?,cnv_and_ssm
+1234,ZNF431,R128I,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both ZNF431 mutations and ZNF804A gains?,cnv_and_ssm
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both DNAH11 mutations and DNAH14 gains?,cnv_and_ssm
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both DNAH11 mutations and ICE1 gains?,cnv_and_ssm
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both POLD1 mutations and MORF4L1 gains?,cnv_and_ssm
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What portion of Lung Squamous Cell Carcinoma cases have both POLD1 mutations and BICC1 gains?,cnv_and_ssm
+1248,TTC12,D646H,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both TTC12 mutations and OR8K5 gains?,cnv_and_ssm
+1249,TTC12,D652H,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both TTC12 mutations and AQP7 gains?,cnv_and_ssm
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What portion of Bladder Urothelial Carcinoma cases have both CNGB1 mutations and OR2T4 gains?,cnv_and_ssm
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What portion of Bladder Urothelial Carcinoma cases have both CNGB1 mutations and DCC gains?,cnv_and_ssm
+1254,CTSC,E214V,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both CTSC mutations and PXN gains?,cnv_and_ssm
+1255,CTSC,E291V,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both CTSC mutations and FGF8 gains?,cnv_and_ssm
+1256,CTSC,E322V,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both CTSC mutations and ZMYM3 gains?,cnv_and_ssm
+1257,CTSC,E324V,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both CTSC mutations and OR5D14 gains?,cnv_and_ssm
+1258,CTSC,E335V,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both CTSC mutations and PYHIN1 gains?,cnv_and_ssm
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both PRSS8 mutations and PCDHGA1 gains?,cnv_and_ssm
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both PRSS8 mutations and DCAF6 gains?,cnv_and_ssm
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both ARHGEF40 mutations and CX3CR1 gains?,cnv_and_ssm
+1264,ACTB,A138T,Rectum Adenocarcinoma,What portion of Rectum Adenocarcinoma cases have both ACTB mutations and MERTK gains?,cnv_and_ssm
+1265,ACTB,A217T,Rectum Adenocarcinoma,What portion of Rectum Adenocarcinoma cases have both ACTB mutations and EVC2 gains?,cnv_and_ssm
+1266,ACTB,A244T,Rectum Adenocarcinoma,What portion of Rectum Adenocarcinoma cases have both ACTB mutations and ZNF584 gains?,cnv_and_ssm
+1267,ACTB,A260T,Rectum Adenocarcinoma,What portion of Rectum Adenocarcinoma cases have both ACTB mutations and TET2 gains?,cnv_and_ssm
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What portion of Glioblastoma Multiforme cases have both YY1AP1 mutations and ACTB gains?,cnv_and_ssm
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What portion of Glioblastoma Multiforme cases have both YY1AP1 mutations and TTC17 gains?,cnv_and_ssm
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What portion of Glioblastoma Multiforme cases have both YY1AP1 mutations and POC1B gains?,cnv_and_ssm
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What portion of Glioblastoma Multiforme cases have both YY1AP1 mutations and COL6A3 gains?,cnv_and_ssm
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What portion of Glioblastoma Multiforme cases have both YY1AP1 mutations and TTC17 gains?,cnv_and_ssm
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What portion of Glioblastoma Multiforme cases have both YY1AP1 mutations and PCDHB2 gains?,cnv_and_ssm
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What portion of Glioblastoma Multiforme cases have both YY1AP1 mutations and AUTS2 gains?,cnv_and_ssm
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both FNDC7 mutations and RIMS2 gains?,cnv_and_ssm
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both FNDC7 mutations and PTPRN2 gains?,cnv_and_ssm
+1299,TLCD5,G15V,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both TLCD5 mutations and TNS1 gains?,cnv_and_ssm
+1300,TLCD5,G37V,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both TLCD5 mutations and ZFAT gains?,cnv_and_ssm
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both POLR1G mutations and AUTS2 gains?,cnv_and_ssm
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both POLR1G mutations and FGF8 gains?,cnv_and_ssm
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both DNAH14 mutations and LCN15 gains?,cnv_and_ssm
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both DNAH14 mutations and MYO16 gains?,cnv_and_ssm
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both DNAH14 mutations and CTNNA2 gains?,cnv_and_ssm
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both NEXN mutations and TMEM225 gains?,cnv_and_ssm
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What portion of Prostate Adenocarcinoma cases have both CYB5R2 mutations and NRAP gains?,cnv_and_ssm
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What portion of Prostate Adenocarcinoma cases have both CYB5R2 mutations and DSCAM gains?,cnv_and_ssm
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both NRAP mutations and TSHZ3 gains?,cnv_and_ssm
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both NRAP mutations and PTPRN2 gains?,cnv_and_ssm
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both NRAP mutations and CEP20 gains?,cnv_and_ssm
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both CCDC22 mutations and ANKRD24 gains?,cnv_and_ssm
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both DCAF6 mutations and CARMIL1 gains?,cnv_and_ssm
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both DCAF6 mutations and DSCAM gains?,cnv_and_ssm
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both ZNF708 mutations and KIF20B gains?,cnv_and_ssm
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both BFAR mutations and DOCK2 gains?,cnv_and_ssm
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both MAST4 mutations and GPC3 gains?,cnv_and_ssm
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both MAST4 mutations and NEXN gains?,cnv_and_ssm
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both MAST4 mutations and HYOU1 gains?,cnv_and_ssm
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both MAST4 mutations and MED16 gains?,cnv_and_ssm
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both MAST4 mutations and SGIP1 gains?,cnv_and_ssm
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both ARMC3 mutations and COL6A3 gains?,cnv_and_ssm
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both ARMC3 mutations and ICE1 gains?,cnv_and_ssm
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What portion of Kidney Renal Clear Cell Carcinoma cases have both TET2 mutations and AUTS2 gains?,cnv_and_ssm
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What portion of Kidney Renal Clear Cell Carcinoma cases have both TET2 mutations and FRY gains?,cnv_and_ssm
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both SERPINB10 mutations and ZNF431 gains?,cnv_and_ssm
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both STAT3 mutations and PCDHB2 gains?,cnv_and_ssm
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both MIEF1 mutations and DHX16 gains?,cnv_and_ssm
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both ACVR1B mutations and PXN gains?,cnv_and_ssm
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both ACVR1B mutations and MYO16 gains?,cnv_and_ssm
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both ACVR1B mutations and ZMYM3 gains?,cnv_and_ssm
+1393,EBF2,T104I,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both EBF2 mutations and DCAF4L2 gains?,cnv_and_ssm
+1394,EBF2,T252I,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both EBF2 mutations and MYO15A gains?,cnv_and_ssm
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both VPS26B mutations and HTR3B gains?,cnv_and_ssm
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What portion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have both PGR mutations and EIF2B4 gains?",cnv_and_ssm
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What portion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have both PGR mutations and BCAT1 gains?",cnv_and_ssm
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What portion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases have both PGR mutations and JAML gains?",cnv_and_ssm
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What portion of Skin Cutaneous Melanoma cases have both ACTA2 mutations and NOMO1 gains?,cnv_and_ssm
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both THBS4 mutations and FRY gains?,cnv_and_ssm
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both THBS4 mutations and ZNF627 gains?,cnv_and_ssm
+1413,PRSS1,S114T,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both PRSS1 mutations and YY1AP1 gains?,cnv_and_ssm
+1414,PRSS1,S124T,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both PRSS1 mutations and NCKAP5 gains?,cnv_and_ssm
+1415,PRSS1,S138T,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both PRSS1 mutations and GABRA6 gains?,cnv_and_ssm
+1416,PRSS1,S74T,Lung Adenocarcinoma,What portion of Lung Adenocarcinoma cases have both PRSS1 mutations and PRSS1 gains?,cnv_and_ssm
+1417,PGF,R126H,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both PGF mutations and GUK1 gains?,cnv_and_ssm
+1418,PGF,R127H,Stomach Adenocarcinoma,What portion of Stomach Adenocarcinoma cases have both PGF mutations and ZFAT gains?,cnv_and_ssm
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What portion of Breast Invasive Carcinoma cases have both ITPRID2 mutations and PLEKHG6 gains?,cnv_and_ssm
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What portion of Breast Invasive Carcinoma cases have both ITPRID2 mutations and PTPRO gains?,cnv_and_ssm
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both HBB mutations and TNS1 gains?,cnv_and_ssm
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both PCDHB2 mutations and DCN gains?,cnv_and_ssm
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both PCDHB2 mutations and TLK2 gains?,cnv_and_ssm
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What portion of Colon Adenocarcinoma cases have both PCDHB2 mutations and SPATA22 gains?,cnv_and_ssm
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What portion of Uterine Corpus Endometrial Carcinoma cases have both UBR2 mutations and TTC12 gains?,cnv_and_ssm
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What portion of Rectum Adenocarcinoma cases have both FBXO42 mutations and TET2 gains?,cnv_and_ssm
+1,TNS1,G1362V,Breast Invasive Carcinoma,How prevalent are simultaneous mutations in TNS1 and gains in DCN in Breast Invasive Carcinoma?,cnv_and_ssm
+2,TNS1,G1711V,Breast Invasive Carcinoma,How prevalent are simultaneous mutations in TNS1 and gains in MYO3B in Breast Invasive Carcinoma?,cnv_and_ssm
+3,TNS1,G1718V,Breast Invasive Carcinoma,How prevalent are simultaneous mutations in TNS1 and gains in DNAH14 in Breast Invasive Carcinoma?,cnv_and_ssm
+4,TNS1,G1732V,Breast Invasive Carcinoma,How prevalent are simultaneous mutations in TNS1 and gains in ADRA1A in Breast Invasive Carcinoma?,cnv_and_ssm
+5,TNS1,G1824V,Breast Invasive Carcinoma,How prevalent are simultaneous mutations in TNS1 and gains in FGF8 in Breast Invasive Carcinoma?,cnv_and_ssm
+6,TNS1,G1857V,Breast Invasive Carcinoma,How prevalent are simultaneous mutations in TNS1 and gains in OR2T4 in Breast Invasive Carcinoma?,cnv_and_ssm
+7,TNS1,G843V,Breast Invasive Carcinoma,How prevalent are simultaneous mutations in TNS1 and gains in ANKRD24 in Breast Invasive Carcinoma?,cnv_and_ssm
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How prevalent are simultaneous mutations in EVC2 and gains in PAK3 in Bladder Urothelial Carcinoma?,cnv_and_ssm
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How prevalent are simultaneous mutations in EVC2 and gains in NRAP in Bladder Urothelial Carcinoma?,cnv_and_ssm
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in CR1 and gains in SMO in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in CR1 and gains in ZBTB34 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+22,TRPA1,S295I,Rectum Adenocarcinoma,How prevalent are simultaneous mutations in TRPA1 and gains in TMEM255A in Rectum Adenocarcinoma?,cnv_and_ssm
+23,TRPA1,S443I,Rectum Adenocarcinoma,How prevalent are simultaneous mutations in TRPA1 and gains in TNS1 in Rectum Adenocarcinoma?,cnv_and_ssm
+24,TAF1C,R299L,Lung Adenocarcinoma,How prevalent are simultaneous mutations in TAF1C and gains in IL5RA in Lung Adenocarcinoma?,cnv_and_ssm
+25,TAF1C,R396L,Lung Adenocarcinoma,How prevalent are simultaneous mutations in TAF1C and gains in EIF2B4 in Lung Adenocarcinoma?,cnv_and_ssm
+26,TAF1C,R634L,Lung Adenocarcinoma,How prevalent are simultaneous mutations in TAF1C and gains in RIPOR2 in Lung Adenocarcinoma?,cnv_and_ssm
+27,TAF1C,R702L,Lung Adenocarcinoma,How prevalent are simultaneous mutations in TAF1C and gains in CTNNA2 in Lung Adenocarcinoma?,cnv_and_ssm
+28,TAF1C,R728L,Lung Adenocarcinoma,How prevalent are simultaneous mutations in TAF1C and gains in TMEM255A in Lung Adenocarcinoma?,cnv_and_ssm
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in DPF3 and gains in TTC17 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in DPF3 and gains in IL5RA in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in DPF3 and gains in DNAH14 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+42,OR2T4,P272H,Lung Adenocarcinoma,How prevalent are simultaneous mutations in OR2T4 and gains in ARMC3 in Lung Adenocarcinoma?,cnv_and_ssm
+43,OR2T4,P300H,Lung Adenocarcinoma,How prevalent are simultaneous mutations in OR2T4 and gains in EVC2 in Lung Adenocarcinoma?,cnv_and_ssm
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How prevalent are simultaneous mutations in FBN1 and gains in RIMS2 in Pancreatic Adenocarcinoma?,cnv_and_ssm
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How prevalent are simultaneous mutations in MAD1L1 and gains in FGF8 in Prostate Adenocarcinoma?,cnv_and_ssm
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How prevalent are simultaneous mutations in MAD1L1 and gains in ZFP42 in Prostate Adenocarcinoma?,cnv_and_ssm
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How prevalent are simultaneous mutations in MAD1L1 and gains in OLFML3 in Prostate Adenocarcinoma?,cnv_and_ssm
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in CCNG1 and gains in CYP1A2 in Skin Cutaneous Melanoma?,cnv_and_ssm
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How prevalent are simultaneous mutations in ANP32E and gains in PYHIN1 in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How prevalent are simultaneous mutations in ANP32E and gains in DCLK3 in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How prevalent are simultaneous mutations in ANP32E and gains in DNAH14 in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How prevalent are simultaneous mutations in ANP32E and gains in PRSS1 in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How prevalent are simultaneous mutations in FRY and gains in ARHGEF40 in Bladder Urothelial Carcinoma?,cnv_and_ssm
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How prevalent are simultaneous mutations in FRY and gains in AUTS2 in Bladder Urothelial Carcinoma?,cnv_and_ssm
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How prevalent are simultaneous mutations in FRY and gains in CARMIL1 in Bladder Urothelial Carcinoma?,cnv_and_ssm
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How prevalent are simultaneous mutations in FRY and gains in ANP32E in Bladder Urothelial Carcinoma?,cnv_and_ssm
+70,PAK3,E318K,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in PAK3 and gains in FGF8 in Skin Cutaneous Melanoma?,cnv_and_ssm
+71,PAK3,E319K,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in PAK3 and gains in EIF2B4 in Skin Cutaneous Melanoma?,cnv_and_ssm
+72,PAK3,E334K,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in PAK3 and gains in DCC in Skin Cutaneous Melanoma?,cnv_and_ssm
+73,PAK3,E340K,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in PAK3 and gains in KL in Skin Cutaneous Melanoma?,cnv_and_ssm
+74,PAK3,E355K,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in PAK3 and gains in KIF20B in Skin Cutaneous Melanoma?,cnv_and_ssm
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in MUC16 and gains in TTYH2 in Skin Cutaneous Melanoma?,cnv_and_ssm
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How prevalent are simultaneous mutations in ZFPM2 and gains in EFCAB12 in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How prevalent are simultaneous mutations in ZFPM2 and gains in DHX16 in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How prevalent are simultaneous mutations in PIK3C2B and gains in TNS1 in Breast Invasive Carcinoma?,cnv_and_ssm
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How prevalent are simultaneous mutations in PIK3C2B and gains in UBR2 in Breast Invasive Carcinoma?,cnv_and_ssm
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How prevalent are simultaneous mutations in ZNF804A and gains in UNC5D in Colon Adenocarcinoma?,cnv_and_ssm
+116,RELN,A2371V,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in RELN and gains in ANKDD1A in Stomach Adenocarcinoma?,cnv_and_ssm
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent are simultaneous mutations in EFCAB12 and gains in MAST4 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent are simultaneous mutations in EFCAB12 and gains in DPF3 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in DEFB115 and gains in ZBTB34 in Skin Cutaneous Melanoma?,cnv_and_ssm
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How prevalent are simultaneous mutations in ANKDD1A and gains in MYO16 in Bladder Urothelial Carcinoma?,cnv_and_ssm
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How prevalent are simultaneous mutations in ANKDD1A and gains in RIMS2 in Bladder Urothelial Carcinoma?,cnv_and_ssm
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How prevalent are simultaneous mutations in ANKDD1A and gains in GRM5 in Bladder Urothelial Carcinoma?,cnv_and_ssm
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in HTR3B and gains in PRSS1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in HTR3B and gains in CXCR2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in HTR3B and gains in PIAS3 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+129,ABCC3,R758W,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in ABCC3 and gains in PTPRN2 in Stomach Adenocarcinoma?,cnv_and_ssm
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in NOMO1 and gains in ZNF584 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in NOMO1 and gains in PXN in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How prevalent are simultaneous mutations in HYOU1 and gains in DCC in Bladder Urothelial Carcinoma?,cnv_and_ssm
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in FMO4 and gains in CX3CR1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+140,BICC1,A372V,Exceptional Responders,How prevalent are simultaneous mutations in BICC1 and gains in SIK2 in Exceptional Responders?,cnv_and_ssm
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in ZMYM3 and gains in TNS1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in ZMYM3 and gains in ZCCHC14 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in ZMYM3 and gains in TRIM45 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent are simultaneous mutations in XKR4 and gains in SYT9 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How prevalent are simultaneous mutations in ABCC2 and gains in DHX16 in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+157,OR8K5,R293G,Lung Adenocarcinoma,How prevalent are simultaneous mutations in OR8K5 and gains in GUF1 in Lung Adenocarcinoma?,cnv_and_ssm
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in SPTAN1 and gains in WNT2 in Skin Cutaneous Melanoma?,cnv_and_ssm
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in SPTAN1 and gains in SYT9 in Skin Cutaneous Melanoma?,cnv_and_ssm
+164,SYT10,M484I,Rectum Adenocarcinoma,How prevalent are simultaneous mutations in SYT10 and gains in UNC5D in Rectum Adenocarcinoma?,cnv_and_ssm
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in HSPA5 and gains in CARMIL1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+175,UNC5D,L280V,Lung Adenocarcinoma,How prevalent are simultaneous mutations in UNC5D and gains in AKT1 in Lung Adenocarcinoma?,cnv_and_ssm
+176,UNC5D,L635V,Lung Adenocarcinoma,How prevalent are simultaneous mutations in UNC5D and gains in TLK2 in Lung Adenocarcinoma?,cnv_and_ssm
+177,UNC5D,L637V,Lung Adenocarcinoma,How prevalent are simultaneous mutations in UNC5D and gains in PKHD1L1 in Lung Adenocarcinoma?,cnv_and_ssm
+178,UNC5D,L699V,Lung Adenocarcinoma,How prevalent are simultaneous mutations in UNC5D and gains in MED16 in Lung Adenocarcinoma?,cnv_and_ssm
+179,UNC5D,L704V,Lung Adenocarcinoma,How prevalent are simultaneous mutations in UNC5D and gains in RAB40C in Lung Adenocarcinoma?,cnv_and_ssm
+180,UNC5D,L709V,Lung Adenocarcinoma,How prevalent are simultaneous mutations in UNC5D and gains in RIMS2 in Lung Adenocarcinoma?,cnv_and_ssm
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How prevalent are simultaneous mutations in DOCK2 and gains in TNS1 in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How prevalent are simultaneous mutations in ZNF627 and gains in FRY in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in CDC42BPA and gains in PRSS1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+193,MRPL55,H27Y,Colon Adenocarcinoma,How prevalent are simultaneous mutations in MRPL55 and gains in DSCAM in Colon Adenocarcinoma?,cnv_and_ssm
+194,MRPL55,H63Y,Colon Adenocarcinoma,How prevalent are simultaneous mutations in MRPL55 and gains in TNS1 in Colon Adenocarcinoma?,cnv_and_ssm
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How prevalent are simultaneous mutations in TMTC3 and gains in TTN in Breast Invasive Carcinoma?,cnv_and_ssm
+198,EPRS1,K771I,Colon Adenocarcinoma,How prevalent are simultaneous mutations in EPRS1 and gains in CNGB1 in Colon Adenocarcinoma?,cnv_and_ssm
+199,EPRS1,K778I,Colon Adenocarcinoma,How prevalent are simultaneous mutations in EPRS1 and gains in CTCFL in Colon Adenocarcinoma?,cnv_and_ssm
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in GRTP1 and gains in FBXO42 in Skin Cutaneous Melanoma?,cnv_and_ssm
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in GRTP1 and gains in TAF1C in Skin Cutaneous Melanoma?,cnv_and_ssm
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in TSHZ3 and gains in DCLK3 in Stomach Adenocarcinoma?,cnv_and_ssm
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How prevalent are simultaneous mutations in TAS1R3 and gains in EIF2B4 in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,cnv_and_ssm
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in PIAS3 and gains in HTR3B in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in PIAS3 and gains in GABRA6 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+251,ZNF274,P13R,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in ZNF274 and gains in CPS1 in Stomach Adenocarcinoma?,cnv_and_ssm
+253,SYNJ1,R795C,Colon Adenocarcinoma,How prevalent are simultaneous mutations in SYNJ1 and gains in FCGR2C in Colon Adenocarcinoma?,cnv_and_ssm
+254,SYNJ1,R800C,Colon Adenocarcinoma,How prevalent are simultaneous mutations in SYNJ1 and gains in FGF8 in Colon Adenocarcinoma?,cnv_and_ssm
+255,SYNJ1,R839C,Colon Adenocarcinoma,How prevalent are simultaneous mutations in SYNJ1 and gains in ZMYM3 in Colon Adenocarcinoma?,cnv_and_ssm
+261,DSCAM,V343M,Prostate Adenocarcinoma,How prevalent are simultaneous mutations in DSCAM and gains in TAS1R3 in Prostate Adenocarcinoma?,cnv_and_ssm
+262,DSCAM,V426M,Prostate Adenocarcinoma,How prevalent are simultaneous mutations in DSCAM and gains in TMTC3 in Prostate Adenocarcinoma?,cnv_and_ssm
+263,DSCAM,V591M,Prostate Adenocarcinoma,How prevalent are simultaneous mutations in DSCAM and gains in GSTCD in Prostate Adenocarcinoma?,cnv_and_ssm
+267,DGKD,R140H,Exceptional Responders,How prevalent are simultaneous mutations in DGKD and gains in GPRASP1 in Exceptional Responders?,cnv_and_ssm
+268,DGKD,R160H,Exceptional Responders,How prevalent are simultaneous mutations in DGKD and gains in ZCCHC14 in Exceptional Responders?,cnv_and_ssm
+269,DGKD,R204H,Exceptional Responders,How prevalent are simultaneous mutations in DGKD and gains in CPS1 in Exceptional Responders?,cnv_and_ssm
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How prevalent are simultaneous mutations in PLEKHG6 and gains in RAB40C in Bladder Urothelial Carcinoma?,cnv_and_ssm
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How prevalent are simultaneous mutations in PLEKHG6 and gains in ZFP42 in Bladder Urothelial Carcinoma?,cnv_and_ssm
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How prevalent are simultaneous mutations in PLEKHG6 and gains in UNC5D in Bladder Urothelial Carcinoma?,cnv_and_ssm
+279,WNT2,D138N,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in WNT2 and gains in CTNNA2 in Skin Cutaneous Melanoma?,cnv_and_ssm
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in GUCY2C and gains in NRAP in Skin Cutaneous Melanoma?,cnv_and_ssm
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in C7orf31 and gains in NOMO1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent are simultaneous mutations in ZKSCAN7 and gains in PTPRO in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+299,OR5D14,M210L,Neuroblastoma,How prevalent are simultaneous mutations in OR5D14 and gains in MRPL32 in Neuroblastoma?,cnv_and_ssm
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in SPATA22 and gains in TAF1C in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in SPATA22 and gains in ZMYM3 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in SPATA22 and gains in RAB40C in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+310,LCN15,E21V,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in LCN15 and gains in SORCS1 in Stomach Adenocarcinoma?,cnv_and_ssm
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in DCAF4L2 and gains in FGF8 in Skin Cutaneous Melanoma?,cnv_and_ssm
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in GUK1 and gains in ANP32E in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in GUK1 and gains in TLCD5 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in GUK1 and gains in CTNNA2 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in GUK1 and gains in UNC5D in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in GUK1 and gains in PIK3C2G in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in MORF4L1 and gains in ZNF217 in Stomach Adenocarcinoma?,cnv_and_ssm
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in MORF4L1 and gains in GPR158 in Stomach Adenocarcinoma?,cnv_and_ssm
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in MORF4L1 and gains in AUTS2 in Stomach Adenocarcinoma?,cnv_and_ssm
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in MORF4L1 and gains in PXN in Stomach Adenocarcinoma?,cnv_and_ssm
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in MYO3B and gains in ZFPM2 in Skin Cutaneous Melanoma?,cnv_and_ssm
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in MYO3B and gains in YY1AP1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in TENT5A and gains in B3GALNT1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in TENT5A and gains in SLC9C1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in TENT5A and gains in MERTK in Skin Cutaneous Melanoma?,cnv_and_ssm
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How prevalent are simultaneous mutations in ZFAT and gains in POLR1G in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How prevalent are simultaneous mutations in ZFAT and gains in CFAP61 in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How prevalent are simultaneous mutations in ZFAT and gains in TENM3 in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+357,ZNF584,A211T,Sarcoma,How prevalent are simultaneous mutations in ZNF584 and gains in PRSS1 in Sarcoma?,cnv_and_ssm
+358,ZNF584,A256T,Sarcoma,How prevalent are simultaneous mutations in ZNF584 and gains in TAF1C in Sarcoma?,cnv_and_ssm
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in LDOC1 and gains in MED16 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in PDGFC and gains in DCN in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in MSANTD4 and gains in CDKN2AIP in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in NPSR1 and gains in MORF4L1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in PHLPP1 and gains in GIMAP2 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in COL6A3 and gains in FGF8 in Skin Cutaneous Melanoma?,cnv_and_ssm
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in COL6A3 and gains in YY1AP1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in COL6A3 and gains in TRAP1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in COL6A3 and gains in TAF1C in Skin Cutaneous Melanoma?,cnv_and_ssm
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in COL6A3 and gains in GRM5 in Skin Cutaneous Melanoma?,cnv_and_ssm
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in ADRA1A and gains in ZNF708 in Stomach Adenocarcinoma?,cnv_and_ssm
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent are simultaneous mutations in LAMB2 and gains in ZCCHC14 in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+406,POC1B,I198T,Rectum Adenocarcinoma,How prevalent are simultaneous mutations in POC1B and gains in ZBTB34 in Rectum Adenocarcinoma?,cnv_and_ssm
+407,POC1B,I286T,Rectum Adenocarcinoma,How prevalent are simultaneous mutations in POC1B and gains in RIPOR2 in Rectum Adenocarcinoma?,cnv_and_ssm
+408,POC1B,I328T,Rectum Adenocarcinoma,How prevalent are simultaneous mutations in POC1B and gains in ZNF584 in Rectum Adenocarcinoma?,cnv_and_ssm
+409,POC1B,S79P,Rectum Adenocarcinoma,How prevalent are simultaneous mutations in POC1B and gains in KRT39 in Rectum Adenocarcinoma?,cnv_and_ssm
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How prevalent are simultaneous mutations in USH2A and gains in CDH23 in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+414,AQP7,T110S,Rectum Adenocarcinoma,How prevalent are simultaneous mutations in AQP7 and gains in ABCC3 in Rectum Adenocarcinoma?,cnv_and_ssm
+415,AQP7,T166S,Rectum Adenocarcinoma,How prevalent are simultaneous mutations in AQP7 and gains in CFAP61 in Rectum Adenocarcinoma?,cnv_and_ssm
+416,AQP7,T167S,Rectum Adenocarcinoma,How prevalent are simultaneous mutations in AQP7 and gains in LAMB2 in Rectum Adenocarcinoma?,cnv_and_ssm
+417,AQP7,T75S,Rectum Adenocarcinoma,How prevalent are simultaneous mutations in AQP7 and gains in YY1AP1 in Rectum Adenocarcinoma?,cnv_and_ssm
+430,DCN,R163C,Rectum Adenocarcinoma,How prevalent are simultaneous mutations in DCN and gains in ACTL7B in Rectum Adenocarcinoma?,cnv_and_ssm
+431,DCN,R203C,Rectum Adenocarcinoma,How prevalent are simultaneous mutations in DCN and gains in CYP1A2 in Rectum Adenocarcinoma?,cnv_and_ssm
+432,DCN,R241C,Rectum Adenocarcinoma,How prevalent are simultaneous mutations in DCN and gains in PAK3 in Rectum Adenocarcinoma?,cnv_and_ssm
+433,DCN,R350C,Rectum Adenocarcinoma,How prevalent are simultaneous mutations in DCN and gains in FGF8 in Rectum Adenocarcinoma?,cnv_and_ssm
+434,DCN,R41C,Rectum Adenocarcinoma,How prevalent are simultaneous mutations in DCN and gains in AQP7 in Rectum Adenocarcinoma?,cnv_and_ssm
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in CPS1 and gains in RAB40C in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in CPS1 and gains in FBN1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in CPS1 and gains in DNAH11 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How prevalent are simultaneous mutations in FCGR2C and gains in CARMIL1 in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How prevalent are simultaneous mutations in FCGR2C and gains in RIPOR2 in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in GRM1 and gains in GPC3 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+482,SGCZ,Q138H,Lung Adenocarcinoma,How prevalent are simultaneous mutations in SGCZ and gains in WNT2 in Lung Adenocarcinoma?,cnv_and_ssm
+483,SGCZ,Q91H,Lung Adenocarcinoma,How prevalent are simultaneous mutations in SGCZ and gains in USH2A in Lung Adenocarcinoma?,cnv_and_ssm
+485,SMO,V15M,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in SMO and gains in PIK3C2G in Stomach Adenocarcinoma?,cnv_and_ssm
+486,SMO,V321M,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in SMO and gains in MERTK in Stomach Adenocarcinoma?,cnv_and_ssm
+488,CHODL,G159E,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in CHODL and gains in AKT1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+489,CHODL,G181E,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in CHODL and gains in ZFAT in Skin Cutaneous Melanoma?,cnv_and_ssm
+490,CHODL,G200E,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in CHODL and gains in MAD1L1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+494,MYO16,P399H,Colon Adenocarcinoma,How prevalent are simultaneous mutations in MYO16 and gains in SYT10 in Colon Adenocarcinoma?,cnv_and_ssm
+495,MYO16,P421H,Colon Adenocarcinoma,How prevalent are simultaneous mutations in MYO16 and gains in CACNA1F in Colon Adenocarcinoma?,cnv_and_ssm
+498,CXCR2,A98V,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in CXCR2 and gains in CASZ1 in Stomach Adenocarcinoma?,cnv_and_ssm
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How prevalent are simultaneous mutations in TMEM225 and gains in TAF1C in Bladder Urothelial Carcinoma?,cnv_and_ssm
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in MAOB and gains in CPA6 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in GPRASP1 and gains in VPS26B in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in MRPL32 and gains in MAOB in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in TYROBP and gains in EVC2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+510,RAB40C,A111V,Lung Adenocarcinoma,How prevalent are simultaneous mutations in RAB40C and gains in CX3CR1 in Lung Adenocarcinoma?,cnv_and_ssm
+511,RAB40C,A143V,Lung Adenocarcinoma,How prevalent are simultaneous mutations in RAB40C and gains in SPTAN1 in Lung Adenocarcinoma?,cnv_and_ssm
+512,CTNNA2,S323R,Lung Adenocarcinoma,How prevalent are simultaneous mutations in CTNNA2 and gains in RIMS2 in Lung Adenocarcinoma?,cnv_and_ssm
+513,CTNNA2,S339R,Lung Adenocarcinoma,How prevalent are simultaneous mutations in CTNNA2 and gains in GRM5 in Lung Adenocarcinoma?,cnv_and_ssm
+514,CTNNA2,S386R,Lung Adenocarcinoma,How prevalent are simultaneous mutations in CTNNA2 and gains in ZSCAN31 in Lung Adenocarcinoma?,cnv_and_ssm
+515,CTNNA2,S707R,Lung Adenocarcinoma,How prevalent are simultaneous mutations in CTNNA2 and gains in PXN in Lung Adenocarcinoma?,cnv_and_ssm
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How prevalent are simultaneous mutations in MYO15A and gains in CDC42BPA in Bladder Urothelial Carcinoma?,cnv_and_ssm
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in GIMAP2 and gains in PXN in Skin Cutaneous Melanoma?,cnv_and_ssm
+532,KIF20B,N1160D,Glioblastoma Multiforme,How prevalent are simultaneous mutations in KIF20B and gains in SPATA22 in Glioblastoma Multiforme?,cnv_and_ssm
+533,KIF20B,N1200D,Glioblastoma Multiforme,How prevalent are simultaneous mutations in KIF20B and gains in DCAF4L2 in Glioblastoma Multiforme?,cnv_and_ssm
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in ADAM17 and gains in TLK2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in BCAT1 and gains in RIMS2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in BCAT1 and gains in DOCK2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in BCAT1 and gains in DGKD in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+540,ERCC6,R1053H,Colon Adenocarcinoma,How prevalent are simultaneous mutations in ERCC6 and gains in FNDC7 in Colon Adenocarcinoma?,cnv_and_ssm
+541,DCC,R320W,Breast Invasive Carcinoma,How prevalent are simultaneous mutations in DCC and gains in ACTA2 in Breast Invasive Carcinoma?,cnv_and_ssm
+542,DCC,R363W,Breast Invasive Carcinoma,How prevalent are simultaneous mutations in DCC and gains in AUTS2 in Breast Invasive Carcinoma?,cnv_and_ssm
+543,DCC,R386W,Breast Invasive Carcinoma,How prevalent are simultaneous mutations in DCC and gains in DCN in Breast Invasive Carcinoma?,cnv_and_ssm
+544,DCC,R41W,Breast Invasive Carcinoma,How prevalent are simultaneous mutations in DCC and gains in TRIM45 in Breast Invasive Carcinoma?,cnv_and_ssm
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in FBXO15 and gains in FNDC7 in Skin Cutaneous Melanoma?,cnv_and_ssm
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in FBXO15 and gains in MAOB in Skin Cutaneous Melanoma?,cnv_and_ssm
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in GSTCD and gains in STK19 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in GSTCD and gains in TNS1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in OLFML3 and gains in MAD1L1 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in OLFML3 and gains in RELN in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in OLFML3 and gains in TRIM45 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How prevalent are simultaneous mutations in CFAP61 and gains in ZNF274 in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How prevalent are simultaneous mutations in CFAP61 and gains in ANKDD1A in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How prevalent are simultaneous mutations in HLA-DQA2 and gains in PRSS8 in Bladder Urothelial Carcinoma?,cnv_and_ssm
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in TENM2 and gains in RIMS2 in Skin Cutaneous Melanoma?,cnv_and_ssm
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in TENM2 and gains in PRSS1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in TENM2 and gains in DCAF4L2 in Skin Cutaneous Melanoma?,cnv_and_ssm
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in ANKRD24 and gains in MYO15A in Stomach Adenocarcinoma?,cnv_and_ssm
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in ANKRD24 and gains in GUK1 in Stomach Adenocarcinoma?,cnv_and_ssm
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in ANKRD24 and gains in PGF in Stomach Adenocarcinoma?,cnv_and_ssm
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in ZCCHC14 and gains in TTN in Stomach Adenocarcinoma?,cnv_and_ssm
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in ZCCHC14 and gains in GSTCD in Stomach Adenocarcinoma?,cnv_and_ssm
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in ZCCHC14 and gains in GUCY2C in Stomach Adenocarcinoma?,cnv_and_ssm
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in ZCCHC14 and gains in MRPL55 in Stomach Adenocarcinoma?,cnv_and_ssm
+625,SIK2,I265M,Lung Adenocarcinoma,How prevalent are simultaneous mutations in SIK2 and gains in PTPRN2 in Lung Adenocarcinoma?,cnv_and_ssm
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in MYH11 and gains in SPATA22 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in MYH11 and gains in RIPOR2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in SLC6A4 and gains in VPS26B in Skin Cutaneous Melanoma?,cnv_and_ssm
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in SLC9C1 and gains in DCAF4L2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in SLC9C1 and gains in PGR in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+644,OR2A12,A254T,Brain Lower Grade Glioma,How prevalent are simultaneous mutations in OR2A12 and gains in DNAH11 in Brain Lower Grade Glioma?,cnv_and_ssm
+646,PYHIN1,T325K,Lung Adenocarcinoma,How prevalent are simultaneous mutations in PYHIN1 and gains in AQP7 in Lung Adenocarcinoma?,cnv_and_ssm
+647,PYHIN1,T334K,Lung Adenocarcinoma,How prevalent are simultaneous mutations in PYHIN1 and gains in PAK3 in Lung Adenocarcinoma?,cnv_and_ssm
+650,JAML,G191E,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in JAML and gains in TTC12 in Skin Cutaneous Melanoma?,cnv_and_ssm
+651,JAML,G219E,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in JAML and gains in ANKRD24 in Skin Cutaneous Melanoma?,cnv_and_ssm
+652,JAML,G220E,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in JAML and gains in CNGB1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+653,JAML,G230E,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in JAML and gains in PXN in Skin Cutaneous Melanoma?,cnv_and_ssm
+658,TYK2,H1146R,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in TYK2 and gains in HTR3B in Stomach Adenocarcinoma?,cnv_and_ssm
+659,TYK2,H23R,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in TYK2 and gains in CTSC in Stomach Adenocarcinoma?,cnv_and_ssm
+660,TYK2,H961R,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in TYK2 and gains in POC1B in Stomach Adenocarcinoma?,cnv_and_ssm
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in CTCFL and gains in MAST4 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in CTCFL and gains in RIMS2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in CTCFL and gains in FNDC7 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in CTCFL and gains in DSCAM in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in CEP20 and gains in PRSS1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in CEP20 and gains in SYNJ1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in RIMS2 and gains in AUTS2 in Skin Cutaneous Melanoma?,cnv_and_ssm
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in RIMS2 and gains in WNT2 in Skin Cutaneous Melanoma?,cnv_and_ssm
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in RIMS2 and gains in PKHD1L1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in RIMS2 and gains in EBF2 in Skin Cutaneous Melanoma?,cnv_and_ssm
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in RIMS2 and gains in FRY in Skin Cutaneous Melanoma?,cnv_and_ssm
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in RIMS2 and gains in TAF1C in Skin Cutaneous Melanoma?,cnv_and_ssm
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in RIMS2 and gains in SIK2 in Skin Cutaneous Melanoma?,cnv_and_ssm
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in PIK3C2G and gains in ZNF708 in Skin Cutaneous Melanoma?,cnv_and_ssm
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in PIK3C2G and gains in PIAS3 in Skin Cutaneous Melanoma?,cnv_and_ssm
+728,STK19,D341N,Colon Adenocarcinoma,How prevalent are simultaneous mutations in STK19 and gains in TENM3 in Colon Adenocarcinoma?,cnv_and_ssm
+729,STK19,D345N,Colon Adenocarcinoma,How prevalent are simultaneous mutations in STK19 and gains in ACTB in Colon Adenocarcinoma?,cnv_and_ssm
+730,REXO4,P60A,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in REXO4 and gains in PAK3 in Skin Cutaneous Melanoma?,cnv_and_ssm
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in ZBTB34 and gains in ZFAT in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in ZBTB34 and gains in CASZ1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How prevalent are simultaneous mutations in NCKAP5 and gains in UBR2 in Bladder Urothelial Carcinoma?,cnv_and_ssm
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent are simultaneous mutations in SORCS1 and gains in TMEM225 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent are simultaneous mutations in SORCS1 and gains in POC1B in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent are simultaneous mutations in SORCS1 and gains in OR13C3 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent are simultaneous mutations in SORCS1 and gains in CNGB1 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How prevalent are simultaneous mutations in FGF8 and gains in DHX16 in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How prevalent are simultaneous mutations in FGF8 and gains in CX3CR1 in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How prevalent are simultaneous mutations in FGF8 and gains in EFCAB12 in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How prevalent are simultaneous mutations in FGF8 and gains in ZNF431 in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How prevalent are simultaneous mutations in FGF8 and gains in KL in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How prevalent are simultaneous mutations in TENM3 and gains in CX3CR1 in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,cnv_and_ssm
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in AKT1 and gains in MAD1L1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent are simultaneous mutations in CFAP298-TCP10L and gains in ZFPM2 in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+792,GLRB,E148D,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in GLRB and gains in ANKDD1A in Stomach Adenocarcinoma?,cnv_and_ssm
+793,TTN,F7636L,Colon Adenocarcinoma,How prevalent are simultaneous mutations in TTN and gains in TRPA1 in Colon Adenocarcinoma?,cnv_and_ssm
+794,TTN,F8563L,Colon Adenocarcinoma,How prevalent are simultaneous mutations in TTN and gains in ANKRD30A in Colon Adenocarcinoma?,cnv_and_ssm
+795,TTN,F8880L,Colon Adenocarcinoma,How prevalent are simultaneous mutations in TTN and gains in ITPRID2 in Colon Adenocarcinoma?,cnv_and_ssm
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How prevalent are simultaneous mutations in ANKRD30A and gains in PXN in Colon Adenocarcinoma?,cnv_and_ssm
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How prevalent are simultaneous mutations in ANKRD30A and gains in TLCD5 in Colon Adenocarcinoma?,cnv_and_ssm
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How prevalent are simultaneous mutations in ANKRD30A and gains in ICE1 in Colon Adenocarcinoma?,cnv_and_ssm
+809,TRIM45,S177L,Colon Adenocarcinoma,How prevalent are simultaneous mutations in TRIM45 and gains in MAD1L1 in Colon Adenocarcinoma?,cnv_and_ssm
+810,TRIM45,S224L,Colon Adenocarcinoma,How prevalent are simultaneous mutations in TRIM45 and gains in VASN in Colon Adenocarcinoma?,cnv_and_ssm
+811,TRIM45,S281L,Colon Adenocarcinoma,How prevalent are simultaneous mutations in TRIM45 and gains in PLEKHG6 in Colon Adenocarcinoma?,cnv_and_ssm
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in CACNA1F and gains in ZCCHC14 in Stomach Adenocarcinoma?,cnv_and_ssm
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in CACNA1F and gains in ZFPM2 in Stomach Adenocarcinoma?,cnv_and_ssm
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in CACNA1F and gains in C7orf31 in Stomach Adenocarcinoma?,cnv_and_ssm
+817,KL,R594C,Colon Adenocarcinoma,How prevalent are simultaneous mutations in KL and gains in TNS1 in Colon Adenocarcinoma?,cnv_and_ssm
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How prevalent are simultaneous mutations in GUF1 and gains in AUTS2 in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+822,TAF1L,A539V,Colon Adenocarcinoma,How prevalent are simultaneous mutations in TAF1L and gains in RIPOR2 in Colon Adenocarcinoma?,cnv_and_ssm
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in TASOR2 and gains in DNMT1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in TASOR2 and gains in TSHZ3 in Skin Cutaneous Melanoma?,cnv_and_ssm
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in TASOR2 and gains in TASOR2 in Skin Cutaneous Melanoma?,cnv_and_ssm
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in KDM5C and gains in TAF1C in Skin Cutaneous Melanoma?,cnv_and_ssm
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in KDM5C and gains in FRY in Skin Cutaneous Melanoma?,cnv_and_ssm
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in KDM5C and gains in SMO in Skin Cutaneous Melanoma?,cnv_and_ssm
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in KDM5C and gains in CTSC in Skin Cutaneous Melanoma?,cnv_and_ssm
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent are simultaneous mutations in IL5RA and gains in DEFB115 in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+843,DHX16,A29V,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in DHX16 and gains in MAD1L1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+844,DHX16,A89V,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in DHX16 and gains in DGKD in Skin Cutaneous Melanoma?,cnv_and_ssm
+902,GPR158,A644V,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in GPR158 and gains in ACTB in Stomach Adenocarcinoma?,cnv_and_ssm
+903,GPR158,A723V,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in GPR158 and gains in RELN in Stomach Adenocarcinoma?,cnv_and_ssm
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent are simultaneous mutations in EIF2B4 and gains in PGF in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent are simultaneous mutations in EIF2B4 and gains in FGF8 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent are simultaneous mutations in EIF2B4 and gains in ART3 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent are simultaneous mutations in EIF2B4 and gains in SPATA22 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent are simultaneous mutations in EIF2B4 and gains in RIMS2 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent are simultaneous mutations in EIF2B4 and gains in PDHA2 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in AUTS2 and gains in DNMT1 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in AUTS2 and gains in GIMAP2 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in AUTS2 and gains in CTSC in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in AUTS2 and gains in TYK2 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in AUTS2 and gains in GRTP1 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in AUTS2 and gains in UNC5D in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in AUTS2 and gains in MRPL55 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in AUTS2 and gains in ABCC2 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in AUTS2 and gains in EBF2 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in AUTS2 and gains in TENM3 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent are simultaneous mutations in ACTL7B and gains in MERTK in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How prevalent are simultaneous mutations in PCDHGA1 and gains in TNS1 in Glioblastoma Multiforme?,cnv_and_ssm
+954,TRAP1,R114W,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in TRAP1 and gains in CPS1 in Stomach Adenocarcinoma?,cnv_and_ssm
+955,TRAP1,R61W,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in TRAP1 and gains in TMEM255A in Stomach Adenocarcinoma?,cnv_and_ssm
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in PIK3C2A and gains in TYK2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How prevalent are simultaneous mutations in KANSL1 and gains in PRSS8 in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in ANKRD52 and gains in AUTS2 in Stomach Adenocarcinoma?,cnv_and_ssm
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in PAPPA and gains in AUTS2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How prevalent are simultaneous mutations in B3GALNT1 and gains in GSTCD in Rectum Adenocarcinoma?,cnv_and_ssm
+982,GABRA6,G115R,Lung Adenocarcinoma,How prevalent are simultaneous mutations in GABRA6 and gains in JAML in Lung Adenocarcinoma?,cnv_and_ssm
+983,GABRA6,G122R,Lung Adenocarcinoma,How prevalent are simultaneous mutations in GABRA6 and gains in SYNJ1 in Lung Adenocarcinoma?,cnv_and_ssm
+984,GABRA6,G165R,Lung Adenocarcinoma,How prevalent are simultaneous mutations in GABRA6 and gains in POC1B in Lung Adenocarcinoma?,cnv_and_ssm
+985,GABRA6,G175R,Lung Adenocarcinoma,How prevalent are simultaneous mutations in GABRA6 and gains in MRPL32 in Lung Adenocarcinoma?,cnv_and_ssm
+986,GABRA6,G70R,Lung Adenocarcinoma,How prevalent are simultaneous mutations in GABRA6 and gains in DNAH14 in Lung Adenocarcinoma?,cnv_and_ssm
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in ZSCAN31 and gains in YY1AP1 in Skin Cutaneous Melanoma?,cnv_and_ssm
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent are simultaneous mutations in MED16 and gains in ZNF274 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent are simultaneous mutations in MED16 and gains in ANKRD24 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How prevalent are simultaneous mutations in PTPRO and gains in ZSCAN31 in Pancreatic Adenocarcinoma?,cnv_and_ssm
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How prevalent are simultaneous mutations in PTPRO and gains in TASOR2 in Pancreatic Adenocarcinoma?,cnv_and_ssm
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How prevalent are simultaneous mutations in PTPRO and gains in EBF2 in Pancreatic Adenocarcinoma?,cnv_and_ssm
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How prevalent are simultaneous mutations in PTPRO and gains in ADAM17 in Pancreatic Adenocarcinoma?,cnv_and_ssm
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How prevalent are simultaneous mutations in PTPRO and gains in SIK2 in Pancreatic Adenocarcinoma?,cnv_and_ssm
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How prevalent are simultaneous mutations in PTPRO and gains in AUTS2 in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How prevalent are simultaneous mutations in PTPRO and gains in TET2 in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How prevalent are simultaneous mutations in PTPRO and gains in SLC9C1 in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in CHMP7 and gains in MORF4L1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1017,GPC3,I107N,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in GPC3 and gains in NRAP in Stomach Adenocarcinoma?,cnv_and_ssm
+1018,GPC3,I161N,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in GPC3 and gains in SGIP1 in Stomach Adenocarcinoma?,cnv_and_ssm
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent are simultaneous mutations in TLK2 and gains in GABRA6 in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent are simultaneous mutations in TLK2 and gains in RIMS2 in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent are simultaneous mutations in TLK2 and gains in SORCS1 in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent are simultaneous mutations in TLK2 and gains in ZBTB34 in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent are simultaneous mutations in TLK2 and gains in FNDC7 in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How prevalent are simultaneous mutations in ZNF217 and gains in CTSC in Lung Adenocarcinoma?,cnv_and_ssm
+1038,SYT9,V275L,Lung Adenocarcinoma,How prevalent are simultaneous mutations in SYT9 and gains in SLC9C1 in Lung Adenocarcinoma?,cnv_and_ssm
+1039,SYT9,V307L,Lung Adenocarcinoma,How prevalent are simultaneous mutations in SYT9 and gains in GRM1 in Lung Adenocarcinoma?,cnv_and_ssm
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in PKHD1L1 and gains in TET2 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in MYO3A and gains in CTNNA2 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent are simultaneous mutations in VASN and gains in UNC5D in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in DNMT1 and gains in PIK3C2G in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in DNMT1 and gains in CEP20 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in DNMT1 and gains in NRAP in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1056,CA9,E402K,Colon Adenocarcinoma,How prevalent are simultaneous mutations in CA9 and gains in LAMB2 in Colon Adenocarcinoma?,cnv_and_ssm
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in TTC17 and gains in CEP20 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in TTC17 and gains in TTN in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1065,PSG2,P43L,Breast Invasive Carcinoma,How prevalent are simultaneous mutations in PSG2 and gains in NRAP in Breast Invasive Carcinoma?,cnv_and_ssm
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How prevalent are simultaneous mutations in RIPOR2 and gains in DCC in Breast Invasive Carcinoma?,cnv_and_ssm
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How prevalent are simultaneous mutations in RIPOR2 and gains in KIF20B in Breast Invasive Carcinoma?,cnv_and_ssm
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How prevalent are simultaneous mutations in RIPOR2 and gains in ZNF804A in Breast Invasive Carcinoma?,cnv_and_ssm
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How prevalent are simultaneous mutations in RIPOR2 and gains in PAK3 in Breast Invasive Carcinoma?,cnv_and_ssm
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in DCLK3 and gains in TASOR2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in DCLK3 and gains in MYO3B in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in MERTK and gains in NEXN in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in MERTK and gains in PRSS1 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in MERTK and gains in UNC5D in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in ZFP42 and gains in GABRA6 in Skin Cutaneous Melanoma?,cnv_and_ssm
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in OR13C3 and gains in RIPOR2 in Skin Cutaneous Melanoma?,cnv_and_ssm
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in OR13C3 and gains in TTN in Skin Cutaneous Melanoma?,cnv_and_ssm
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in SPAG1 and gains in SLC9C1 in Stomach Adenocarcinoma?,cnv_and_ssm
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in CDKN2AIP and gains in HTR3B in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1093,PXN,H1016Y,Colon Adenocarcinoma,How prevalent are simultaneous mutations in PXN and gains in TET2 in Colon Adenocarcinoma?,cnv_and_ssm
+1094,PXN,H359Y,Colon Adenocarcinoma,How prevalent are simultaneous mutations in PXN and gains in FNDC7 in Colon Adenocarcinoma?,cnv_and_ssm
+1095,PXN,H492Y,Colon Adenocarcinoma,How prevalent are simultaneous mutations in PXN and gains in AUTS2 in Colon Adenocarcinoma?,cnv_and_ssm
+1096,PXN,H524Y,Colon Adenocarcinoma,How prevalent are simultaneous mutations in PXN and gains in GSTCD in Colon Adenocarcinoma?,cnv_and_ssm
+1097,PXN,H526Y,Colon Adenocarcinoma,How prevalent are simultaneous mutations in PXN and gains in CEP20 in Colon Adenocarcinoma?,cnv_and_ssm
+1098,PXN,H540Y,Colon Adenocarcinoma,How prevalent are simultaneous mutations in PXN and gains in ZBTB34 in Colon Adenocarcinoma?,cnv_and_ssm
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in TTYH2 and gains in ZBTB34 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in TTYH2 and gains in SGIP1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How prevalent are simultaneous mutations in TMEM255A and gains in ZKSCAN7 in Colon Adenocarcinoma?,cnv_and_ssm
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How prevalent are simultaneous mutations in TMEM255A and gains in POLD1 in Colon Adenocarcinoma?,cnv_and_ssm
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How prevalent are simultaneous mutations in TMEM255A and gains in NCKAP5 in Colon Adenocarcinoma?,cnv_and_ssm
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How prevalent are simultaneous mutations in TASOR2 and gains in TTC17 in Breast Invasive Carcinoma?,cnv_and_ssm
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How prevalent are simultaneous mutations in TASOR2 and gains in TRIM45 in Breast Invasive Carcinoma?,cnv_and_ssm
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in ICE1 and gains in ITPRID2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1112,MYT1,A558E,Breast Invasive Carcinoma,How prevalent are simultaneous mutations in MYT1 and gains in YY1AP1 in Breast Invasive Carcinoma?,cnv_and_ssm
+1113,MYT1,A879E,Breast Invasive Carcinoma,How prevalent are simultaneous mutations in MYT1 and gains in ZNF217 in Breast Invasive Carcinoma?,cnv_and_ssm
+1114,MYT1,A906E,Breast Invasive Carcinoma,How prevalent are simultaneous mutations in MYT1 and gains in ABCC2 in Breast Invasive Carcinoma?,cnv_and_ssm
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in CX3CR1 and gains in DNAH14 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in CX3CR1 and gains in CEP20 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How prevalent are simultaneous mutations in SPINDOC and gains in ARMC3 in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in ART3 and gains in RIPOR2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in ART3 and gains in PTPRO in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How prevalent are simultaneous mutations in CYP1A2 and gains in AUTS2 in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent are simultaneous mutations in ADRA1A and gains in ZFP42 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in CDH23 and gains in POLR1G in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in CDH23 and gains in SPATA22 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in KRT39 and gains in MYO3B in Skin Cutaneous Melanoma?,cnv_and_ssm
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in PDHA2 and gains in TASOR2 in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How prevalent are simultaneous mutations in SLC24A2 and gains in VASN in Colon Adenocarcinoma?,cnv_and_ssm
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How prevalent are simultaneous mutations in PTPRN2 and gains in PXN in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How prevalent are simultaneous mutations in PTPRN2 and gains in HTR3B in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How prevalent are simultaneous mutations in PTPRN2 and gains in ANKRD30A in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How prevalent are simultaneous mutations in PTPRN2 and gains in EIF2B4 in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How prevalent are simultaneous mutations in PTPRN2 and gains in HTR3B in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1188,SOX21,R55L,Lung Adenocarcinoma,How prevalent are simultaneous mutations in SOX21 and gains in UNC5D in Lung Adenocarcinoma?,cnv_and_ssm
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How prevalent are simultaneous mutations in CPA6 and gains in TLK2 in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in GRM5 and gains in OLFML3 in Skin Cutaneous Melanoma?,cnv_and_ssm
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent are simultaneous mutations in CASZ1 and gains in OLFML3 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in SGIP1 and gains in OR13C3 in Stomach Adenocarcinoma?,cnv_and_ssm
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in SGIP1 and gains in DCN in Stomach Adenocarcinoma?,cnv_and_ssm
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in SGIP1 and gains in DHX16 in Stomach Adenocarcinoma?,cnv_and_ssm
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in SGIP1 and gains in CPA6 in Stomach Adenocarcinoma?,cnv_and_ssm
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How prevalent are simultaneous mutations in CARMIL1 and gains in UNC5D in Lung Adenocarcinoma?,cnv_and_ssm
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How prevalent are simultaneous mutations in CARMIL1 and gains in GRM5 in Lung Adenocarcinoma?,cnv_and_ssm
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How prevalent are simultaneous mutations in ZNF431 and gains in PGF in Lung Adenocarcinoma?,cnv_and_ssm
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How prevalent are simultaneous mutations in ZNF431 and gains in HSPA5 in Lung Adenocarcinoma?,cnv_and_ssm
+1234,ZNF431,R128I,Lung Adenocarcinoma,How prevalent are simultaneous mutations in ZNF431 and gains in THBS4 in Lung Adenocarcinoma?,cnv_and_ssm
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in DNAH11 and gains in TLCD5 in Skin Cutaneous Melanoma?,cnv_and_ssm
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in DNAH11 and gains in GPC3 in Skin Cutaneous Melanoma?,cnv_and_ssm
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in POLD1 and gains in DCC in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How prevalent are simultaneous mutations in POLD1 and gains in MYO15A in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1248,TTC12,D646H,Lung Adenocarcinoma,How prevalent are simultaneous mutations in TTC12 and gains in DGKD in Lung Adenocarcinoma?,cnv_and_ssm
+1249,TTC12,D652H,Lung Adenocarcinoma,How prevalent are simultaneous mutations in TTC12 and gains in PAK3 in Lung Adenocarcinoma?,cnv_and_ssm
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How prevalent are simultaneous mutations in CNGB1 and gains in TASOR2 in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How prevalent are simultaneous mutations in CNGB1 and gains in SYT9 in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1254,CTSC,E214V,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in CTSC and gains in ACTB in Stomach Adenocarcinoma?,cnv_and_ssm
+1255,CTSC,E291V,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in CTSC and gains in MAD1L1 in Stomach Adenocarcinoma?,cnv_and_ssm
+1256,CTSC,E322V,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in CTSC and gains in DGKD in Stomach Adenocarcinoma?,cnv_and_ssm
+1257,CTSC,E324V,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in CTSC and gains in TMEM225 in Stomach Adenocarcinoma?,cnv_and_ssm
+1258,CTSC,E335V,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in CTSC and gains in XKR4 in Stomach Adenocarcinoma?,cnv_and_ssm
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in PRSS8 and gains in HLA-DQA2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in PRSS8 and gains in TAF1C in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How prevalent are simultaneous mutations in ARHGEF40 and gains in TAF1C in Lung Adenocarcinoma?,cnv_and_ssm
+1264,ACTB,A138T,Rectum Adenocarcinoma,How prevalent are simultaneous mutations in ACTB and gains in MYO3A in Rectum Adenocarcinoma?,cnv_and_ssm
+1265,ACTB,A217T,Rectum Adenocarcinoma,How prevalent are simultaneous mutations in ACTB and gains in TTC17 in Rectum Adenocarcinoma?,cnv_and_ssm
+1266,ACTB,A244T,Rectum Adenocarcinoma,How prevalent are simultaneous mutations in ACTB and gains in TYK2 in Rectum Adenocarcinoma?,cnv_and_ssm
+1267,ACTB,A260T,Rectum Adenocarcinoma,How prevalent are simultaneous mutations in ACTB and gains in EIF2B4 in Rectum Adenocarcinoma?,cnv_and_ssm
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How prevalent are simultaneous mutations in YY1AP1 and gains in TMEM255A in Glioblastoma Multiforme?,cnv_and_ssm
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How prevalent are simultaneous mutations in YY1AP1 and gains in UNC5D in Glioblastoma Multiforme?,cnv_and_ssm
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How prevalent are simultaneous mutations in YY1AP1 and gains in ZNF584 in Glioblastoma Multiforme?,cnv_and_ssm
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How prevalent are simultaneous mutations in YY1AP1 and gains in TAF1C in Glioblastoma Multiforme?,cnv_and_ssm
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How prevalent are simultaneous mutations in YY1AP1 and gains in ACVR1B in Glioblastoma Multiforme?,cnv_and_ssm
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How prevalent are simultaneous mutations in YY1AP1 and gains in GUK1 in Glioblastoma Multiforme?,cnv_and_ssm
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How prevalent are simultaneous mutations in YY1AP1 and gains in MAST4 in Glioblastoma Multiforme?,cnv_and_ssm
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in FNDC7 and gains in POLR1G in Skin Cutaneous Melanoma?,cnv_and_ssm
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in FNDC7 and gains in FBXO42 in Skin Cutaneous Melanoma?,cnv_and_ssm
+1299,TLCD5,G15V,Lung Adenocarcinoma,How prevalent are simultaneous mutations in TLCD5 and gains in TAF1C in Lung Adenocarcinoma?,cnv_and_ssm
+1300,TLCD5,G37V,Lung Adenocarcinoma,How prevalent are simultaneous mutations in TLCD5 and gains in SPTAN1 in Lung Adenocarcinoma?,cnv_and_ssm
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in POLR1G and gains in CPA6 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in POLR1G and gains in NRAP in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How prevalent are simultaneous mutations in DNAH14 and gains in MAST4 in Colon Adenocarcinoma?,cnv_and_ssm
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How prevalent are simultaneous mutations in DNAH14 and gains in YY1AP1 in Colon Adenocarcinoma?,cnv_and_ssm
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How prevalent are simultaneous mutations in DNAH14 and gains in DNMT1 in Colon Adenocarcinoma?,cnv_and_ssm
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in NEXN and gains in MYO3A in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How prevalent are simultaneous mutations in CYB5R2 and gains in UNC5D in Prostate Adenocarcinoma?,cnv_and_ssm
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How prevalent are simultaneous mutations in CYB5R2 and gains in TYK2 in Prostate Adenocarcinoma?,cnv_and_ssm
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in NRAP and gains in BCAT1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in NRAP and gains in RIPOR2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in NRAP and gains in TRIM45 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in CCDC22 and gains in FRY in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in DCAF6 and gains in MYO16 in Skin Cutaneous Melanoma?,cnv_and_ssm
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in DCAF6 and gains in ZCCHC14 in Skin Cutaneous Melanoma?,cnv_and_ssm
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in ZNF708 and gains in KL in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in BFAR and gains in ACTB in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in MAST4 and gains in ART3 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in MAST4 and gains in CR1 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in MAST4 and gains in MAST4 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in MAST4 and gains in TASOR2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in MAST4 and gains in PRSS8 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in ARMC3 and gains in ADAM17 in Stomach Adenocarcinoma?,cnv_and_ssm
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in ARMC3 and gains in ANKDD1A in Stomach Adenocarcinoma?,cnv_and_ssm
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How prevalent are simultaneous mutations in TET2 and gains in SYT9 in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How prevalent are simultaneous mutations in TET2 and gains in TMEM255A in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How prevalent are simultaneous mutations in SERPINB10 and gains in ANP32E in Lung Adenocarcinoma?,cnv_and_ssm
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in STAT3 and gains in PTPRO in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in MIEF1 and gains in PAPPA in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How prevalent are simultaneous mutations in ACVR1B and gains in CCDC22 in Colon Adenocarcinoma?,cnv_and_ssm
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How prevalent are simultaneous mutations in ACVR1B and gains in MYH11 in Colon Adenocarcinoma?,cnv_and_ssm
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How prevalent are simultaneous mutations in ACVR1B and gains in TTC12 in Colon Adenocarcinoma?,cnv_and_ssm
+1393,EBF2,T104I,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in EBF2 and gains in PAPPA in Stomach Adenocarcinoma?,cnv_and_ssm
+1394,EBF2,T252I,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in EBF2 and gains in MYH11 in Stomach Adenocarcinoma?,cnv_and_ssm
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in VPS26B and gains in OR8K5 in Stomach Adenocarcinoma?,cnv_and_ssm
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent are simultaneous mutations in PGR and gains in PTPRN2 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent are simultaneous mutations in PGR and gains in TRIM45 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent are simultaneous mutations in PGR and gains in CTCFL in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How prevalent are simultaneous mutations in ACTA2 and gains in TSHZ3 in Skin Cutaneous Melanoma?,cnv_and_ssm
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in THBS4 and gains in ACTA2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in THBS4 and gains in AUTS2 in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1413,PRSS1,S114T,Lung Adenocarcinoma,How prevalent are simultaneous mutations in PRSS1 and gains in PTPRN2 in Lung Adenocarcinoma?,cnv_and_ssm
+1414,PRSS1,S124T,Lung Adenocarcinoma,How prevalent are simultaneous mutations in PRSS1 and gains in SGIP1 in Lung Adenocarcinoma?,cnv_and_ssm
+1415,PRSS1,S138T,Lung Adenocarcinoma,How prevalent are simultaneous mutations in PRSS1 and gains in MYO3B in Lung Adenocarcinoma?,cnv_and_ssm
+1416,PRSS1,S74T,Lung Adenocarcinoma,How prevalent are simultaneous mutations in PRSS1 and gains in EIF2B4 in Lung Adenocarcinoma?,cnv_and_ssm
+1417,PGF,R126H,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in PGF and gains in TTC17 in Stomach Adenocarcinoma?,cnv_and_ssm
+1418,PGF,R127H,Stomach Adenocarcinoma,How prevalent are simultaneous mutations in PGF and gains in ACTB in Stomach Adenocarcinoma?,cnv_and_ssm
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How prevalent are simultaneous mutations in ITPRID2 and gains in EFCAB12 in Breast Invasive Carcinoma?,cnv_and_ssm
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How prevalent are simultaneous mutations in ITPRID2 and gains in ZNF217 in Breast Invasive Carcinoma?,cnv_and_ssm
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in HBB and gains in MYO3A in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How prevalent are simultaneous mutations in PCDHB2 and gains in SLC6A4 in Colon Adenocarcinoma?,cnv_and_ssm
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How prevalent are simultaneous mutations in PCDHB2 and gains in MAOB in Colon Adenocarcinoma?,cnv_and_ssm
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How prevalent are simultaneous mutations in PCDHB2 and gains in SORCS1 in Colon Adenocarcinoma?,cnv_and_ssm
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How prevalent are simultaneous mutations in UBR2 and gains in PIK3C2B in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How prevalent are simultaneous mutations in FBXO42 and gains in DSCAM in Rectum Adenocarcinoma?,cnv_and_ssm
+1,TNS1,G1362V,Breast Invasive Carcinoma,Could you provide the rate of TNS1 mutations and FMO4 deletions among Breast Invasive Carcinoma cases?,cnv_and_ssm
+2,TNS1,G1711V,Breast Invasive Carcinoma,Could you provide the rate of TNS1 mutations and LCN15 deletions among Breast Invasive Carcinoma cases?,cnv_and_ssm
+3,TNS1,G1718V,Breast Invasive Carcinoma,Could you provide the rate of TNS1 mutations and PRSS1 deletions among Breast Invasive Carcinoma cases?,cnv_and_ssm
+4,TNS1,G1732V,Breast Invasive Carcinoma,Could you provide the rate of TNS1 mutations and TRAP1 deletions among Breast Invasive Carcinoma cases?,cnv_and_ssm
+5,TNS1,G1824V,Breast Invasive Carcinoma,Could you provide the rate of TNS1 mutations and TLCD5 deletions among Breast Invasive Carcinoma cases?,cnv_and_ssm
+6,TNS1,G1857V,Breast Invasive Carcinoma,Could you provide the rate of TNS1 mutations and CPA6 deletions among Breast Invasive Carcinoma cases?,cnv_and_ssm
+7,TNS1,G843V,Breast Invasive Carcinoma,Could you provide the rate of TNS1 mutations and DNAH14 deletions among Breast Invasive Carcinoma cases?,cnv_and_ssm
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,Could you provide the rate of EVC2 mutations and EFCAB12 deletions among Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+15,EVC2,E987K,Bladder Urothelial Carcinoma,Could you provide the rate of EVC2 mutations and ACTB deletions among Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of CR1 mutations and PXN deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of CR1 mutations and SYNJ1 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+22,TRPA1,S295I,Rectum Adenocarcinoma,Could you provide the rate of TRPA1 mutations and HTR3B deletions among Rectum Adenocarcinoma cases?,cnv_and_ssm
+23,TRPA1,S443I,Rectum Adenocarcinoma,Could you provide the rate of TRPA1 mutations and CARMIL1 deletions among Rectum Adenocarcinoma cases?,cnv_and_ssm
+24,TAF1C,R299L,Lung Adenocarcinoma,Could you provide the rate of TAF1C mutations and SYNJ1 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+25,TAF1C,R396L,Lung Adenocarcinoma,Could you provide the rate of TAF1C mutations and MAD1L1 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+26,TAF1C,R634L,Lung Adenocarcinoma,Could you provide the rate of TAF1C mutations and CTSC deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+27,TAF1C,R702L,Lung Adenocarcinoma,Could you provide the rate of TAF1C mutations and AUTS2 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+28,TAF1C,R728L,Lung Adenocarcinoma,Could you provide the rate of TAF1C mutations and ANKDD1A deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of DPF3 mutations and SPATA22 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of DPF3 mutations and ZFP42 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of DPF3 mutations and MRPL32 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+42,OR2T4,P272H,Lung Adenocarcinoma,Could you provide the rate of OR2T4 mutations and DCN deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+43,OR2T4,P300H,Lung Adenocarcinoma,Could you provide the rate of OR2T4 mutations and CTCFL deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,Could you provide the rate of FBN1 mutations and EBF2 deletions among Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+45,MAD1L1,E396K,Prostate Adenocarcinoma,Could you provide the rate of MAD1L1 mutations and PTPRN2 deletions among Prostate Adenocarcinoma cases?,cnv_and_ssm
+46,MAD1L1,E488K,Prostate Adenocarcinoma,Could you provide the rate of MAD1L1 mutations and SLC9C1 deletions among Prostate Adenocarcinoma cases?,cnv_and_ssm
+47,MAD1L1,E78K,Prostate Adenocarcinoma,Could you provide the rate of MAD1L1 mutations and DCLK3 deletions among Prostate Adenocarcinoma cases?,cnv_and_ssm
+61,CCNG1,E22K,Skin Cutaneous Melanoma,Could you provide the rate of CCNG1 mutations and MAD1L1 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,Could you provide the rate of ANP32E mutations and PLEKHG6 deletions among Kidney Renal Papillary Cell Carcinoma cases?,cnv_and_ssm
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,Could you provide the rate of ANP32E mutations and SLC9C1 deletions among Kidney Renal Papillary Cell Carcinoma cases?,cnv_and_ssm
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,Could you provide the rate of ANP32E mutations and BFAR deletions among Kidney Renal Papillary Cell Carcinoma cases?,cnv_and_ssm
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,Could you provide the rate of ANP32E mutations and TAF1L deletions among Kidney Renal Papillary Cell Carcinoma cases?,cnv_and_ssm
+66,FRY,S1888A,Bladder Urothelial Carcinoma,Could you provide the rate of FRY mutations and ZNF804A deletions among Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+67,FRY,S1937A,Bladder Urothelial Carcinoma,Could you provide the rate of FRY mutations and GUK1 deletions among Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+68,FRY,S1938A,Bladder Urothelial Carcinoma,Could you provide the rate of FRY mutations and MAOB deletions among Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+69,FRY,S1983A,Bladder Urothelial Carcinoma,Could you provide the rate of FRY mutations and KDM5C deletions among Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+70,PAK3,E318K,Skin Cutaneous Melanoma,Could you provide the rate of PAK3 mutations and GPR158 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+71,PAK3,E319K,Skin Cutaneous Melanoma,Could you provide the rate of PAK3 mutations and DNAH14 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+72,PAK3,E334K,Skin Cutaneous Melanoma,Could you provide the rate of PAK3 mutations and FRY deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+73,PAK3,E340K,Skin Cutaneous Melanoma,Could you provide the rate of PAK3 mutations and GIMAP2 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+74,PAK3,E355K,Skin Cutaneous Melanoma,Could you provide the rate of PAK3 mutations and AUTS2 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+80,MUC16,P7963L,Skin Cutaneous Melanoma,Could you provide the rate of MUC16 mutations and PTPRO deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,Could you provide the rate of ZFPM2 mutations and FBXO15 deletions among Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,Could you provide the rate of ZFPM2 mutations and GRTP1 deletions among Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,Could you provide the rate of PIK3C2B mutations and GABRA6 deletions among Breast Invasive Carcinoma cases?,cnv_and_ssm
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,Could you provide the rate of PIK3C2B mutations and MED16 deletions among Breast Invasive Carcinoma cases?,cnv_and_ssm
+114,ZNF804A,S371Y,Colon Adenocarcinoma,Could you provide the rate of ZNF804A mutations and KIF20B deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+116,RELN,A2371V,Stomach Adenocarcinoma,Could you provide the rate of RELN mutations and MAD1L1 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Could you provide the rate of EFCAB12 mutations and CPS1 deletions among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Could you provide the rate of EFCAB12 mutations and DCN deletions among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+120,DEFB115,E53K,Skin Cutaneous Melanoma,Could you provide the rate of DEFB115 mutations and CCNG1 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,Could you provide the rate of ANKDD1A mutations and TYK2 deletions among Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,Could you provide the rate of ANKDD1A mutations and AUTS2 deletions among Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,Could you provide the rate of ANKDD1A mutations and LAMB2 deletions among Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of HTR3B mutations and AUTS2 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of HTR3B mutations and TNS1 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of HTR3B mutations and FRY deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+129,ABCC3,R758W,Stomach Adenocarcinoma,Could you provide the rate of ABCC3 mutations and ITPRID2 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of NOMO1 mutations and TYK2 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of NOMO1 mutations and OR2T4 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,Could you provide the rate of HYOU1 mutations and PRSS1 deletions among Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+139,FMO4,R500Q,Skin Cutaneous Melanoma,Could you provide the rate of FMO4 mutations and TLK2 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+140,BICC1,A372V,Exceptional Responders,Could you provide the rate of BICC1 mutations and DCLK3 deletions among Exceptional Responders cases?,cnv_and_ssm
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of ZMYM3 mutations and IL5RA deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of ZMYM3 mutations and GUK1 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of ZMYM3 mutations and PIK3C2G deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Could you provide the rate of XKR4 mutations and DGKD deletions among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,Could you provide the rate of ABCC2 mutations and TTC17 deletions among Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+157,OR8K5,R293G,Lung Adenocarcinoma,Could you provide the rate of OR8K5 mutations and SYT10 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,Could you provide the rate of SPTAN1 mutations and PTPRO deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,Could you provide the rate of SPTAN1 mutations and STK19 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+164,SYT10,M484I,Rectum Adenocarcinoma,Could you provide the rate of SYT10 mutations and PRSS1 deletions among Rectum Adenocarcinoma cases?,cnv_and_ssm
+174,HSPA5,N457K,Skin Cutaneous Melanoma,Could you provide the rate of HSPA5 mutations and ADAM17 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+175,UNC5D,L280V,Lung Adenocarcinoma,Could you provide the rate of UNC5D mutations and DNMT1 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+176,UNC5D,L635V,Lung Adenocarcinoma,Could you provide the rate of UNC5D mutations and ANP32E deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+177,UNC5D,L637V,Lung Adenocarcinoma,Could you provide the rate of UNC5D mutations and FRY deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+178,UNC5D,L699V,Lung Adenocarcinoma,Could you provide the rate of UNC5D mutations and SYT9 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+179,UNC5D,L704V,Lung Adenocarcinoma,Could you provide the rate of UNC5D mutations and PCDHB2 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+180,UNC5D,L709V,Lung Adenocarcinoma,Could you provide the rate of UNC5D mutations and ZSCAN31 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,Could you provide the rate of DOCK2 mutations and PLEKHG6 deletions among Kidney Renal Clear Cell Carcinoma cases?,cnv_and_ssm
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,Could you provide the rate of ZNF627 mutations and PXN deletions among Kidney Renal Clear Cell Carcinoma cases?,cnv_and_ssm
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,Could you provide the rate of CDC42BPA mutations and CASZ1 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+193,MRPL55,H27Y,Colon Adenocarcinoma,Could you provide the rate of MRPL55 mutations and CTCFL deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+194,MRPL55,H63Y,Colon Adenocarcinoma,Could you provide the rate of MRPL55 mutations and GUK1 deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+197,TMTC3,Q749K,Breast Invasive Carcinoma,Could you provide the rate of TMTC3 mutations and AUTS2 deletions among Breast Invasive Carcinoma cases?,cnv_and_ssm
+198,EPRS1,K771I,Colon Adenocarcinoma,Could you provide the rate of EPRS1 mutations and AKT1 deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+199,EPRS1,K778I,Colon Adenocarcinoma,Could you provide the rate of EPRS1 mutations and SIK2 deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+201,GRTP1,A110V,Skin Cutaneous Melanoma,Could you provide the rate of GRTP1 mutations and AQP7 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+202,GRTP1,A32V,Skin Cutaneous Melanoma,Could you provide the rate of GRTP1 mutations and TENM2 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,Could you provide the rate of TSHZ3 mutations and DGKD deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,Could you provide the rate of TAS1R3 mutations and ZNF708 deletions among HIV+ Tumor Molecular Characterization Project - Cervical Cancer cases?,cnv_and_ssm
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,Could you provide the rate of PIAS3 mutations and TENM2 deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,Could you provide the rate of PIAS3 mutations and DNAH11 deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+251,ZNF274,P13R,Stomach Adenocarcinoma,Could you provide the rate of ZNF274 mutations and ERCC6 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+253,SYNJ1,R795C,Colon Adenocarcinoma,Could you provide the rate of SYNJ1 mutations and SPTAN1 deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+254,SYNJ1,R800C,Colon Adenocarcinoma,Could you provide the rate of SYNJ1 mutations and POLD1 deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+255,SYNJ1,R839C,Colon Adenocarcinoma,Could you provide the rate of SYNJ1 mutations and PAK3 deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+261,DSCAM,V343M,Prostate Adenocarcinoma,Could you provide the rate of DSCAM mutations and ANKRD30A deletions among Prostate Adenocarcinoma cases?,cnv_and_ssm
+262,DSCAM,V426M,Prostate Adenocarcinoma,Could you provide the rate of DSCAM mutations and CDH23 deletions among Prostate Adenocarcinoma cases?,cnv_and_ssm
+263,DSCAM,V591M,Prostate Adenocarcinoma,Could you provide the rate of DSCAM mutations and PGR deletions among Prostate Adenocarcinoma cases?,cnv_and_ssm
+267,DGKD,R140H,Exceptional Responders,Could you provide the rate of DGKD mutations and TRIM45 deletions among Exceptional Responders cases?,cnv_and_ssm
+268,DGKD,R160H,Exceptional Responders,Could you provide the rate of DGKD mutations and DGKD deletions among Exceptional Responders cases?,cnv_and_ssm
+269,DGKD,R204H,Exceptional Responders,Could you provide the rate of DGKD mutations and USH2A deletions among Exceptional Responders cases?,cnv_and_ssm
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,Could you provide the rate of PLEKHG6 mutations and FBXO42 deletions among Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,Could you provide the rate of PLEKHG6 mutations and ARHGEF40 deletions among Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,Could you provide the rate of PLEKHG6 mutations and GABRA6 deletions among Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+279,WNT2,D138N,Skin Cutaneous Melanoma,Could you provide the rate of WNT2 mutations and PIK3C2G deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,Could you provide the rate of GUCY2C mutations and ART3 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of C7orf31 mutations and EIF2B4 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Could you provide the rate of ZKSCAN7 mutations and TMEM255A deletions among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+299,OR5D14,M210L,Neuroblastoma,Could you provide the rate of OR5D14 mutations and PTPRO deletions among Neuroblastoma cases?,cnv_and_ssm
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of SPATA22 mutations and TTC12 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of SPATA22 mutations and FRY deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of SPATA22 mutations and HSPA5 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+310,LCN15,E21V,Stomach Adenocarcinoma,Could you provide the rate of LCN15 mutations and NEXN deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,Could you provide the rate of DCAF4L2 mutations and TENM2 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,Could you provide the rate of GUK1 mutations and GLRB deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,Could you provide the rate of GUK1 mutations and DCC deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,Could you provide the rate of GUK1 mutations and CTNNA2 deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,Could you provide the rate of GUK1 mutations and JAML deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,Could you provide the rate of GUK1 mutations and ANP32E deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+328,MORF4L1,K29T,Stomach Adenocarcinoma,Could you provide the rate of MORF4L1 mutations and TLCD5 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+329,MORF4L1,K51T,Stomach Adenocarcinoma,Could you provide the rate of MORF4L1 mutations and SPATA22 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+330,MORF4L1,K61T,Stomach Adenocarcinoma,Could you provide the rate of MORF4L1 mutations and DNAH14 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+331,MORF4L1,K76T,Stomach Adenocarcinoma,Could you provide the rate of MORF4L1 mutations and KANSL1 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+335,MYO3B,F594L,Skin Cutaneous Melanoma,Could you provide the rate of MYO3B mutations and SGIP1 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+336,MYO3B,F603L,Skin Cutaneous Melanoma,Could you provide the rate of MYO3B mutations and TRAP1 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+339,TENT5A,S320F,Skin Cutaneous Melanoma,Could you provide the rate of TENT5A mutations and ADAM17 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+340,TENT5A,S339F,Skin Cutaneous Melanoma,Could you provide the rate of TENT5A mutations and PIK3C2B deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+341,TENT5A,S401F,Skin Cutaneous Melanoma,Could you provide the rate of TENT5A mutations and UNC5D deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,Could you provide the rate of ZFAT mutations and TENT5A deletions among Ovarian Serous Cystadenocarcinoma cases?,cnv_and_ssm
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,Could you provide the rate of ZFAT mutations and DCAF4L2 deletions among Ovarian Serous Cystadenocarcinoma cases?,cnv_and_ssm
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,Could you provide the rate of ZFAT mutations and DNAH11 deletions among Ovarian Serous Cystadenocarcinoma cases?,cnv_and_ssm
+357,ZNF584,A211T,Sarcoma,Could you provide the rate of ZNF584 mutations and TYK2 deletions among Sarcoma cases?,cnv_and_ssm
+358,ZNF584,A256T,Sarcoma,Could you provide the rate of ZNF584 mutations and RAB40C deletions among Sarcoma cases?,cnv_and_ssm
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of LDOC1 mutations and ZMYM3 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,Could you provide the rate of PDGFC mutations and EIF2B4 deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of MSANTD4 mutations and SLC6A4 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+374,NPSR1,S123L,Skin Cutaneous Melanoma,Could you provide the rate of NPSR1 mutations and AUTS2 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,Could you provide the rate of PHLPP1 mutations and MED16 deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+385,COL6A3,G237S,Skin Cutaneous Melanoma,Could you provide the rate of COL6A3 mutations and TENT5A deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+386,COL6A3,G437S,Skin Cutaneous Melanoma,Could you provide the rate of COL6A3 mutations and PYHIN1 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+387,COL6A3,G638S,Skin Cutaneous Melanoma,Could you provide the rate of COL6A3 mutations and TLK2 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+388,COL6A3,G644S,Skin Cutaneous Melanoma,Could you provide the rate of COL6A3 mutations and TET2 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+389,COL6A3,G844S,Skin Cutaneous Melanoma,Could you provide the rate of COL6A3 mutations and CARMIL1 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+395,ADRA1A,R348G,Stomach Adenocarcinoma,Could you provide the rate of ADRA1A mutations and ACVR1B deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Could you provide the rate of LAMB2 mutations and SGIP1 deletions among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+406,POC1B,I198T,Rectum Adenocarcinoma,Could you provide the rate of POC1B mutations and GABRA6 deletions among Rectum Adenocarcinoma cases?,cnv_and_ssm
+407,POC1B,I286T,Rectum Adenocarcinoma,Could you provide the rate of POC1B mutations and UNC5D deletions among Rectum Adenocarcinoma cases?,cnv_and_ssm
+408,POC1B,I328T,Rectum Adenocarcinoma,Could you provide the rate of POC1B mutations and TTN deletions among Rectum Adenocarcinoma cases?,cnv_and_ssm
+409,POC1B,S79P,Rectum Adenocarcinoma,Could you provide the rate of POC1B mutations and PRSS8 deletions among Rectum Adenocarcinoma cases?,cnv_and_ssm
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,Could you provide the rate of USH2A mutations and CFAP61 deletions among Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+414,AQP7,T110S,Rectum Adenocarcinoma,Could you provide the rate of AQP7 mutations and C7orf31 deletions among Rectum Adenocarcinoma cases?,cnv_and_ssm
+415,AQP7,T166S,Rectum Adenocarcinoma,Could you provide the rate of AQP7 mutations and TENM2 deletions among Rectum Adenocarcinoma cases?,cnv_and_ssm
+416,AQP7,T167S,Rectum Adenocarcinoma,Could you provide the rate of AQP7 mutations and CNGB1 deletions among Rectum Adenocarcinoma cases?,cnv_and_ssm
+417,AQP7,T75S,Rectum Adenocarcinoma,Could you provide the rate of AQP7 mutations and GIMAP2 deletions among Rectum Adenocarcinoma cases?,cnv_and_ssm
+430,DCN,R163C,Rectum Adenocarcinoma,Could you provide the rate of DCN mutations and UNC5D deletions among Rectum Adenocarcinoma cases?,cnv_and_ssm
+431,DCN,R203C,Rectum Adenocarcinoma,Could you provide the rate of DCN mutations and STAT3 deletions among Rectum Adenocarcinoma cases?,cnv_and_ssm
+432,DCN,R241C,Rectum Adenocarcinoma,Could you provide the rate of DCN mutations and THBS4 deletions among Rectum Adenocarcinoma cases?,cnv_and_ssm
+433,DCN,R350C,Rectum Adenocarcinoma,Could you provide the rate of DCN mutations and OR2A12 deletions among Rectum Adenocarcinoma cases?,cnv_and_ssm
+434,DCN,R41C,Rectum Adenocarcinoma,Could you provide the rate of DCN mutations and MAST4 deletions among Rectum Adenocarcinoma cases?,cnv_and_ssm
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of CPS1 mutations and AUTS2 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of CPS1 mutations and PSG2 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of CPS1 mutations and SGCZ deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,Could you provide the rate of FCGR2C mutations and HBB deletions among Kidney Renal Papillary Cell Carcinoma cases?,cnv_and_ssm
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,Could you provide the rate of FCGR2C mutations and TENM3 deletions among Kidney Renal Papillary Cell Carcinoma cases?,cnv_and_ssm
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of GRM1 mutations and PLEKHG6 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+482,SGCZ,Q138H,Lung Adenocarcinoma,Could you provide the rate of SGCZ mutations and CR1 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+483,SGCZ,Q91H,Lung Adenocarcinoma,Could you provide the rate of SGCZ mutations and SYNJ1 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+485,SMO,V15M,Stomach Adenocarcinoma,Could you provide the rate of SMO mutations and EBF2 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+486,SMO,V321M,Stomach Adenocarcinoma,Could you provide the rate of SMO mutations and DCLK3 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+488,CHODL,G159E,Skin Cutaneous Melanoma,Could you provide the rate of CHODL mutations and DHX16 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+489,CHODL,G181E,Skin Cutaneous Melanoma,Could you provide the rate of CHODL mutations and PIAS3 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+490,CHODL,G200E,Skin Cutaneous Melanoma,Could you provide the rate of CHODL mutations and PGF deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+494,MYO16,P399H,Colon Adenocarcinoma,Could you provide the rate of MYO16 mutations and SORCS1 deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+495,MYO16,P421H,Colon Adenocarcinoma,Could you provide the rate of MYO16 mutations and TAF1L deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+498,CXCR2,A98V,Stomach Adenocarcinoma,Could you provide the rate of CXCR2 mutations and FRY deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,Could you provide the rate of TMEM225 mutations and DEFB115 deletions among Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of MAOB mutations and MYH11 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of GPRASP1 mutations and TTN deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of MRPL32 mutations and PDGFC deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of TYROBP mutations and IL5RA deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+510,RAB40C,A111V,Lung Adenocarcinoma,Could you provide the rate of RAB40C mutations and PDGFC deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+511,RAB40C,A143V,Lung Adenocarcinoma,Could you provide the rate of RAB40C mutations and PCDHGA1 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+512,CTNNA2,S323R,Lung Adenocarcinoma,Could you provide the rate of CTNNA2 mutations and ACTB deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+513,CTNNA2,S339R,Lung Adenocarcinoma,Could you provide the rate of CTNNA2 mutations and TYK2 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+514,CTNNA2,S386R,Lung Adenocarcinoma,Could you provide the rate of CTNNA2 mutations and SGIP1 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+515,CTNNA2,S707R,Lung Adenocarcinoma,Could you provide the rate of CTNNA2 mutations and POLR1G deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,Could you provide the rate of MYO15A mutations and TMEM255A deletions among Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,Could you provide the rate of GIMAP2 mutations and JAML deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+532,KIF20B,N1160D,Glioblastoma Multiforme,Could you provide the rate of KIF20B mutations and TYROBP deletions among Glioblastoma Multiforme cases?,cnv_and_ssm
+533,KIF20B,N1200D,Glioblastoma Multiforme,Could you provide the rate of KIF20B mutations and SPATA22 deletions among Glioblastoma Multiforme cases?,cnv_and_ssm
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of ADAM17 mutations and MAOB deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of BCAT1 mutations and PRSS1 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of BCAT1 mutations and EIF2B4 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of BCAT1 mutations and TMEM255A deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+540,ERCC6,R1053H,Colon Adenocarcinoma,Could you provide the rate of ERCC6 mutations and MAD1L1 deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+541,DCC,R320W,Breast Invasive Carcinoma,Could you provide the rate of DCC mutations and YY1AP1 deletions among Breast Invasive Carcinoma cases?,cnv_and_ssm
+542,DCC,R363W,Breast Invasive Carcinoma,Could you provide the rate of DCC mutations and CDC42BPA deletions among Breast Invasive Carcinoma cases?,cnv_and_ssm
+543,DCC,R386W,Breast Invasive Carcinoma,Could you provide the rate of DCC mutations and PRSS1 deletions among Breast Invasive Carcinoma cases?,cnv_and_ssm
+544,DCC,R41W,Breast Invasive Carcinoma,Could you provide the rate of DCC mutations and TNS1 deletions among Breast Invasive Carcinoma cases?,cnv_and_ssm
+549,FBXO15,D417N,Skin Cutaneous Melanoma,Could you provide the rate of FBXO15 mutations and PLEKHG6 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+550,FBXO15,D86N,Skin Cutaneous Melanoma,Could you provide the rate of FBXO15 mutations and RIPOR2 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of GSTCD mutations and HTR3B deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of GSTCD mutations and ABCC3 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,Could you provide the rate of OLFML3 mutations and PYHIN1 deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,Could you provide the rate of OLFML3 mutations and JAML deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,Could you provide the rate of OLFML3 mutations and HTR3B deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,Could you provide the rate of CFAP61 mutations and GUCY2C deletions among Ovarian Serous Cystadenocarcinoma cases?,cnv_and_ssm
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,Could you provide the rate of CFAP61 mutations and HTR3B deletions among Ovarian Serous Cystadenocarcinoma cases?,cnv_and_ssm
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,Could you provide the rate of HLA-DQA2 mutations and TAF1C deletions among Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+582,TENM2,H240Y,Skin Cutaneous Melanoma,Could you provide the rate of TENM2 mutations and ACTB deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+583,TENM2,H351Y,Skin Cutaneous Melanoma,Could you provide the rate of TENM2 mutations and HYOU1 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+584,TENM2,H472Y,Skin Cutaneous Melanoma,Could you provide the rate of TENM2 mutations and PAK3 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+600,ANKRD24,A465T,Stomach Adenocarcinoma,Could you provide the rate of ANKRD24 mutations and FGF8 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+601,ANKRD24,A494T,Stomach Adenocarcinoma,Could you provide the rate of ANKRD24 mutations and GPR158 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+602,ANKRD24,A584T,Stomach Adenocarcinoma,Could you provide the rate of ANKRD24 mutations and TTYH2 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,Could you provide the rate of ZCCHC14 mutations and CYB5R2 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,Could you provide the rate of ZCCHC14 mutations and TLCD5 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,Could you provide the rate of ZCCHC14 mutations and EIF2B4 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,Could you provide the rate of ZCCHC14 mutations and ARHGEF40 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+625,SIK2,I265M,Lung Adenocarcinoma,Could you provide the rate of SIK2 mutations and DNAH14 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of MYH11 mutations and FNDC7 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of MYH11 mutations and PXN deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,Could you provide the rate of SLC6A4 mutations and AUTS2 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of SLC9C1 mutations and ZNF584 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of SLC9C1 mutations and B3GALNT1 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+644,OR2A12,A254T,Brain Lower Grade Glioma,Could you provide the rate of OR2A12 mutations and ANKDD1A deletions among Brain Lower Grade Glioma cases?,cnv_and_ssm
+646,PYHIN1,T325K,Lung Adenocarcinoma,Could you provide the rate of PYHIN1 mutations and ACVR1B deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+647,PYHIN1,T334K,Lung Adenocarcinoma,Could you provide the rate of PYHIN1 mutations and OR2A12 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+650,JAML,G191E,Skin Cutaneous Melanoma,Could you provide the rate of JAML mutations and POC1B deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+651,JAML,G219E,Skin Cutaneous Melanoma,Could you provide the rate of JAML mutations and PTPRO deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+652,JAML,G220E,Skin Cutaneous Melanoma,Could you provide the rate of JAML mutations and GPR158 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+653,JAML,G230E,Skin Cutaneous Melanoma,Could you provide the rate of JAML mutations and ACTB deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+658,TYK2,H1146R,Stomach Adenocarcinoma,Could you provide the rate of TYK2 mutations and SGIP1 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+659,TYK2,H23R,Stomach Adenocarcinoma,Could you provide the rate of TYK2 mutations and FBXO42 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+660,TYK2,H961R,Stomach Adenocarcinoma,Could you provide the rate of TYK2 mutations and DCAF6 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of CTCFL mutations and DCC deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of CTCFL mutations and CARMIL1 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of CTCFL mutations and PYHIN1 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of CTCFL mutations and AUTS2 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of CEP20 mutations and ARHGEF40 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of CEP20 mutations and TYK2 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+689,RIMS2,R25W,Skin Cutaneous Melanoma,Could you provide the rate of RIMS2 mutations and TAF1C deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+690,RIMS2,R393W,Skin Cutaneous Melanoma,Could you provide the rate of RIMS2 mutations and PDHA2 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+691,RIMS2,R423W,Skin Cutaneous Melanoma,Could you provide the rate of RIMS2 mutations and ACTB deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+692,RIMS2,R470W,Skin Cutaneous Melanoma,Could you provide the rate of RIMS2 mutations and GSTCD deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+693,RIMS2,R615W,Skin Cutaneous Melanoma,Could you provide the rate of RIMS2 mutations and MED16 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+694,RIMS2,R619W,Skin Cutaneous Melanoma,Could you provide the rate of RIMS2 mutations and TRIM45 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+695,RIMS2,R716W,Skin Cutaneous Melanoma,Could you provide the rate of RIMS2 mutations and FBXO15 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,Could you provide the rate of PIK3C2G mutations and FRY deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,Could you provide the rate of PIK3C2G mutations and DSCAM deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+728,STK19,D341N,Colon Adenocarcinoma,Could you provide the rate of STK19 mutations and EVC2 deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+729,STK19,D345N,Colon Adenocarcinoma,Could you provide the rate of STK19 mutations and ANKRD30A deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+730,REXO4,P60A,Skin Cutaneous Melanoma,Could you provide the rate of REXO4 mutations and TET2 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of ZBTB34 mutations and DGKD deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of ZBTB34 mutations and TNS1 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,Could you provide the rate of NCKAP5 mutations and MORF4L1 deletions among Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Could you provide the rate of SORCS1 mutations and POLD1 deletions among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Could you provide the rate of SORCS1 mutations and FRY deletions among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Could you provide the rate of SORCS1 mutations and COL6A3 deletions among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Could you provide the rate of SORCS1 mutations and TENT5A deletions among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,Could you provide the rate of FGF8 mutations and PTPRO deletions among Head and Neck Squamous Cell Carcinoma cases?,cnv_and_ssm
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,Could you provide the rate of FGF8 mutations and UNC5D deletions among Head and Neck Squamous Cell Carcinoma cases?,cnv_and_ssm
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,Could you provide the rate of FGF8 mutations and MERTK deletions among Head and Neck Squamous Cell Carcinoma cases?,cnv_and_ssm
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,Could you provide the rate of FGF8 mutations and CYB5R2 deletions among Head and Neck Squamous Cell Carcinoma cases?,cnv_and_ssm
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,Could you provide the rate of FGF8 mutations and AQP7 deletions among Head and Neck Squamous Cell Carcinoma cases?,cnv_and_ssm
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,Could you provide the rate of TENM3 mutations and ZFPM2 deletions among Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia cases?,cnv_and_ssm
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of AKT1 mutations and TLK2 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Could you provide the rate of CFAP298-TCP10L mutations and MAST4 deletions among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+792,GLRB,E148D,Stomach Adenocarcinoma,Could you provide the rate of GLRB mutations and PTPRO deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+793,TTN,F7636L,Colon Adenocarcinoma,Could you provide the rate of TTN mutations and YY1AP1 deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+794,TTN,F8563L,Colon Adenocarcinoma,Could you provide the rate of TTN mutations and GUCY2C deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+795,TTN,F8880L,Colon Adenocarcinoma,Could you provide the rate of TTN mutations and TLK2 deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+799,ANKRD30A,V798I,Colon Adenocarcinoma,Could you provide the rate of ANKRD30A mutations and FRY deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+800,ANKRD30A,V854I,Colon Adenocarcinoma,Could you provide the rate of ANKRD30A mutations and GUK1 deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+801,ANKRD30A,V973I,Colon Adenocarcinoma,Could you provide the rate of ANKRD30A mutations and PTPRO deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+809,TRIM45,S177L,Colon Adenocarcinoma,Could you provide the rate of TRIM45 mutations and PIK3C2A deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+810,TRIM45,S224L,Colon Adenocarcinoma,Could you provide the rate of TRIM45 mutations and PDHA2 deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+811,TRIM45,S281L,Colon Adenocarcinoma,Could you provide the rate of TRIM45 mutations and DNAH11 deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+812,CACNA1F,G727V,Stomach Adenocarcinoma,Could you provide the rate of CACNA1F mutations and ARHGEF40 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+813,CACNA1F,G781V,Stomach Adenocarcinoma,Could you provide the rate of CACNA1F mutations and ZNF584 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+814,CACNA1F,G792V,Stomach Adenocarcinoma,Could you provide the rate of CACNA1F mutations and MRPL32 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+817,KL,R594C,Colon Adenocarcinoma,Could you provide the rate of KL mutations and AUTS2 deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,Could you provide the rate of GUF1 mutations and RIMS2 deletions among Kidney Renal Papillary Cell Carcinoma cases?,cnv_and_ssm
+822,TAF1L,A539V,Colon Adenocarcinoma,Could you provide the rate of TAF1L mutations and MORF4L1 deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+823,TASOR2,S256F,Skin Cutaneous Melanoma,Could you provide the rate of TASOR2 mutations and SMO deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+824,TASOR2,S36F,Skin Cutaneous Melanoma,Could you provide the rate of TASOR2 mutations and POC1B deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+825,TASOR2,S471F,Skin Cutaneous Melanoma,Could you provide the rate of TASOR2 mutations and ZFAT deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,Could you provide the rate of KDM5C mutations and GSTCD deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,Could you provide the rate of KDM5C mutations and FBXO15 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,Could you provide the rate of KDM5C mutations and STK19 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,Could you provide the rate of KDM5C mutations and PHLPP1 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Could you provide the rate of IL5RA mutations and TENT5A deletions among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+843,DHX16,A29V,Skin Cutaneous Melanoma,Could you provide the rate of DHX16 mutations and ANKRD24 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+844,DHX16,A89V,Skin Cutaneous Melanoma,Could you provide the rate of DHX16 mutations and MORF4L1 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+902,GPR158,A644V,Stomach Adenocarcinoma,Could you provide the rate of GPR158 mutations and MYO15A deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+903,GPR158,A723V,Stomach Adenocarcinoma,Could you provide the rate of GPR158 mutations and ANKRD30A deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Could you provide the rate of EIF2B4 mutations and TRPA1 deletions among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Could you provide the rate of EIF2B4 mutations and MYH11 deletions among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Could you provide the rate of EIF2B4 mutations and ADRA1A deletions among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Could you provide the rate of EIF2B4 mutations and COL6A3 deletions among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Could you provide the rate of EIF2B4 mutations and PGR deletions among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Could you provide the rate of EIF2B4 mutations and UNC5D deletions among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,Could you provide the rate of AUTS2 mutations and BCAT1 deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,Could you provide the rate of AUTS2 mutations and GUK1 deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,Could you provide the rate of AUTS2 mutations and PXN deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,Could you provide the rate of AUTS2 mutations and IL5RA deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,Could you provide the rate of AUTS2 mutations and DHX16 deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,Could you provide the rate of AUTS2 mutations and CARMIL1 deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,Could you provide the rate of AUTS2 mutations and FRY deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,Could you provide the rate of AUTS2 mutations and TENM2 deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,Could you provide the rate of AUTS2 mutations and MYO3B deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,Could you provide the rate of AUTS2 mutations and GUK1 deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Could you provide the rate of ACTL7B mutations and CFAP61 deletions among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+952,PCDHGA1,R535W,Glioblastoma Multiforme,Could you provide the rate of PCDHGA1 mutations and KANSL1 deletions among Glioblastoma Multiforme cases?,cnv_and_ssm
+954,TRAP1,R114W,Stomach Adenocarcinoma,Could you provide the rate of TRAP1 mutations and RELN deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+955,TRAP1,R61W,Stomach Adenocarcinoma,Could you provide the rate of TRAP1 mutations and ZNF708 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of PIK3C2A mutations and MYT1 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,Could you provide the rate of KANSL1 mutations and OR13C3 deletions among Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,Could you provide the rate of ANKRD52 mutations and TTC12 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of PAPPA mutations and ACTB deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,Could you provide the rate of B3GALNT1 mutations and YY1AP1 deletions among Rectum Adenocarcinoma cases?,cnv_and_ssm
+982,GABRA6,G115R,Lung Adenocarcinoma,Could you provide the rate of GABRA6 mutations and ANKDD1A deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+983,GABRA6,G122R,Lung Adenocarcinoma,Could you provide the rate of GABRA6 mutations and GRTP1 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+984,GABRA6,G165R,Lung Adenocarcinoma,Could you provide the rate of GABRA6 mutations and SERPINB10 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+985,GABRA6,G175R,Lung Adenocarcinoma,Could you provide the rate of GABRA6 mutations and AQP7 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+986,GABRA6,G70R,Lung Adenocarcinoma,Could you provide the rate of GABRA6 mutations and DNAH11 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,Could you provide the rate of ZSCAN31 mutations and PGR deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Could you provide the rate of MED16 mutations and OLFML3 deletions among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Could you provide the rate of MED16 mutations and TTC12 deletions among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,Could you provide the rate of PTPRO mutations and SYT9 deletions among Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,Could you provide the rate of PTPRO mutations and KDM5C deletions among Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,Could you provide the rate of PTPRO mutations and SLC9C1 deletions among Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,Could you provide the rate of PTPRO mutations and TYK2 deletions among Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,Could you provide the rate of PTPRO mutations and TRIM45 deletions among Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,Could you provide the rate of PTPRO mutations and MIEF1 deletions among Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,Could you provide the rate of PTPRO mutations and ZKSCAN7 deletions among Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,Could you provide the rate of PTPRO mutations and TAS1R3 deletions among Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of CHMP7 mutations and DGKD deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1017,GPC3,I107N,Stomach Adenocarcinoma,Could you provide the rate of GPC3 mutations and PRSS8 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+1018,GPC3,I161N,Stomach Adenocarcinoma,Could you provide the rate of GPC3 mutations and OR2T4 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Could you provide the rate of TLK2 mutations and DCC deletions among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Could you provide the rate of TLK2 mutations and ANKRD24 deletions among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Could you provide the rate of TLK2 mutations and YY1AP1 deletions among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Could you provide the rate of TLK2 mutations and TLCD5 deletions among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Could you provide the rate of TLK2 mutations and DSCAM deletions among Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+1036,ZNF217,E209Q,Lung Adenocarcinoma,Could you provide the rate of ZNF217 mutations and MORF4L1 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+1038,SYT9,V275L,Lung Adenocarcinoma,Could you provide the rate of SYT9 mutations and ANKDD1A deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+1039,SYT9,V307L,Lung Adenocarcinoma,Could you provide the rate of SYT9 mutations and MSANTD4 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,Could you provide the rate of PKHD1L1 mutations and DSCAM deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,Could you provide the rate of MYO3A mutations and LDOC1 deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Could you provide the rate of VASN mutations and FGF8 deletions among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of DNMT1 mutations and ANKRD24 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of DNMT1 mutations and OR13C3 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of DNMT1 mutations and ZNF431 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1056,CA9,E402K,Colon Adenocarcinoma,Could you provide the rate of CA9 mutations and RAB40C deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of TTC17 mutations and PIK3C2B deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of TTC17 mutations and YY1AP1 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1065,PSG2,P43L,Breast Invasive Carcinoma,Could you provide the rate of PSG2 mutations and TYROBP deletions among Breast Invasive Carcinoma cases?,cnv_and_ssm
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,Could you provide the rate of RIPOR2 mutations and AQP7 deletions among Breast Invasive Carcinoma cases?,cnv_and_ssm
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,Could you provide the rate of RIPOR2 mutations and TENT5A deletions among Breast Invasive Carcinoma cases?,cnv_and_ssm
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,Could you provide the rate of RIPOR2 mutations and TASOR2 deletions among Breast Invasive Carcinoma cases?,cnv_and_ssm
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,Could you provide the rate of RIPOR2 mutations and CTSC deletions among Breast Invasive Carcinoma cases?,cnv_and_ssm
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of DCLK3 mutations and SYNJ1 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of DCLK3 mutations and ARHGEF40 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,Could you provide the rate of MERTK mutations and STAT3 deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,Could you provide the rate of MERTK mutations and FRY deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,Could you provide the rate of MERTK mutations and DCC deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,Could you provide the rate of ZFP42 mutations and ACTB deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,Could you provide the rate of OR13C3 mutations and ANP32E deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,Could you provide the rate of OR13C3 mutations and JAML deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1091,SPAG1,I917M,Stomach Adenocarcinoma,Could you provide the rate of SPAG1 mutations and TNS1 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of CDKN2AIP mutations and MYT1 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1093,PXN,H1016Y,Colon Adenocarcinoma,Could you provide the rate of PXN mutations and JAML deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+1094,PXN,H359Y,Colon Adenocarcinoma,Could you provide the rate of PXN mutations and DCN deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+1095,PXN,H492Y,Colon Adenocarcinoma,Could you provide the rate of PXN mutations and GABRA6 deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+1096,PXN,H524Y,Colon Adenocarcinoma,Could you provide the rate of PXN mutations and COL6A3 deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+1097,PXN,H526Y,Colon Adenocarcinoma,Could you provide the rate of PXN mutations and LCN15 deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+1098,PXN,H540Y,Colon Adenocarcinoma,Could you provide the rate of PXN mutations and AUTS2 deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of TTYH2 mutations and ZMYM3 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of TTYH2 mutations and TASOR2 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1106,TMEM255A,N205S,Colon Adenocarcinoma,Could you provide the rate of TMEM255A mutations and TLK2 deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+1107,TMEM255A,N229S,Colon Adenocarcinoma,Could you provide the rate of TMEM255A mutations and PTPRO deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+1108,TMEM255A,N65S,Colon Adenocarcinoma,Could you provide the rate of TMEM255A mutations and AUTS2 deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,Could you provide the rate of TASOR2 mutations and ANKRD52 deletions among Breast Invasive Carcinoma cases?,cnv_and_ssm
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,Could you provide the rate of TASOR2 mutations and PIAS3 deletions among Breast Invasive Carcinoma cases?,cnv_and_ssm
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of ICE1 mutations and CTNNA2 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1112,MYT1,A558E,Breast Invasive Carcinoma,Could you provide the rate of MYT1 mutations and PIAS3 deletions among Breast Invasive Carcinoma cases?,cnv_and_ssm
+1113,MYT1,A879E,Breast Invasive Carcinoma,Could you provide the rate of MYT1 mutations and FBXO15 deletions among Breast Invasive Carcinoma cases?,cnv_and_ssm
+1114,MYT1,A906E,Breast Invasive Carcinoma,Could you provide the rate of MYT1 mutations and PTPRO deletions among Breast Invasive Carcinoma cases?,cnv_and_ssm
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of CX3CR1 mutations and KIF20B deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of CX3CR1 mutations and GUK1 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,Could you provide the rate of SPINDOC mutations and PTPRO deletions among Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of ART3 mutations and RAB40C deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of ART3 mutations and PTPRO deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,Could you provide the rate of CYP1A2 mutations and TYK2 deletions among Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Could you provide the rate of ADRA1A mutations and RIMS2 deletions among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,Could you provide the rate of CDH23 mutations and CYB5R2 deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,Could you provide the rate of CDH23 mutations and YY1AP1 deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1148,KRT39,P137S,Skin Cutaneous Melanoma,Could you provide the rate of KRT39 mutations and CYB5R2 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,Could you provide the rate of PDHA2 mutations and KIF20B deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,Could you provide the rate of SLC24A2 mutations and OR13C3 deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,Could you provide the rate of PTPRN2 mutations and TAS1R3 deletions among Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,Could you provide the rate of PTPRN2 mutations and TLK2 deletions among Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,Could you provide the rate of PTPRN2 mutations and TASOR2 deletions among Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,Could you provide the rate of PTPRN2 mutations and THBS4 deletions among Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,Could you provide the rate of PTPRN2 mutations and PSG2 deletions among Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+1188,SOX21,R55L,Lung Adenocarcinoma,Could you provide the rate of SOX21 mutations and TNS1 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,Could you provide the rate of CPA6 mutations and REXO4 deletions among Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+1206,GRM5,E14K,Skin Cutaneous Melanoma,Could you provide the rate of GRM5 mutations and MAD1L1 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Could you provide the rate of CASZ1 mutations and PTPRO deletions among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+1210,SGIP1,N122T,Stomach Adenocarcinoma,Could you provide the rate of SGIP1 mutations and RIMS2 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+1211,SGIP1,N420T,Stomach Adenocarcinoma,Could you provide the rate of SGIP1 mutations and TTN deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+1212,SGIP1,N617T,Stomach Adenocarcinoma,Could you provide the rate of SGIP1 mutations and RIMS2 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+1213,SGIP1,N648T,Stomach Adenocarcinoma,Could you provide the rate of SGIP1 mutations and CFAP298-TCP10L deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+1227,CARMIL1,V549L,Lung Adenocarcinoma,Could you provide the rate of CARMIL1 mutations and DNAH14 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+1228,CARMIL1,V949L,Lung Adenocarcinoma,Could you provide the rate of CARMIL1 mutations and FRY deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+1232,ZNF431,D121Y,Lung Adenocarcinoma,Could you provide the rate of ZNF431 mutations and FBXO42 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+1233,ZNF431,D161Y,Lung Adenocarcinoma,Could you provide the rate of ZNF431 mutations and MYO3B deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+1234,ZNF431,R128I,Lung Adenocarcinoma,Could you provide the rate of ZNF431 mutations and MAST4 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,Could you provide the rate of DNAH11 mutations and CYP1A2 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,Could you provide the rate of DNAH11 mutations and ACTB deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,Could you provide the rate of POLD1 mutations and LAMB2 deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,Could you provide the rate of POLD1 mutations and MYT1 deletions among Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1248,TTC12,D646H,Lung Adenocarcinoma,Could you provide the rate of TTC12 mutations and STK19 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+1249,TTC12,D652H,Lung Adenocarcinoma,Could you provide the rate of TTC12 mutations and FBXO15 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,Could you provide the rate of CNGB1 mutations and HTR3B deletions among Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,Could you provide the rate of CNGB1 mutations and FGF8 deletions among Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+1254,CTSC,E214V,Stomach Adenocarcinoma,Could you provide the rate of CTSC mutations and SGIP1 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+1255,CTSC,E291V,Stomach Adenocarcinoma,Could you provide the rate of CTSC mutations and JAML deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+1256,CTSC,E322V,Stomach Adenocarcinoma,Could you provide the rate of CTSC mutations and PCDHB2 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+1257,CTSC,E324V,Stomach Adenocarcinoma,Could you provide the rate of CTSC mutations and EIF2B4 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+1258,CTSC,E335V,Stomach Adenocarcinoma,Could you provide the rate of CTSC mutations and EBF2 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of PRSS8 mutations and ZBTB34 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of PRSS8 mutations and TASOR2 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,Could you provide the rate of ARHGEF40 mutations and ZNF274 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+1264,ACTB,A138T,Rectum Adenocarcinoma,Could you provide the rate of ACTB mutations and GIMAP2 deletions among Rectum Adenocarcinoma cases?,cnv_and_ssm
+1265,ACTB,A217T,Rectum Adenocarcinoma,Could you provide the rate of ACTB mutations and CACNA1F deletions among Rectum Adenocarcinoma cases?,cnv_and_ssm
+1266,ACTB,A244T,Rectum Adenocarcinoma,Could you provide the rate of ACTB mutations and POLD1 deletions among Rectum Adenocarcinoma cases?,cnv_and_ssm
+1267,ACTB,A260T,Rectum Adenocarcinoma,Could you provide the rate of ACTB mutations and CPS1 deletions among Rectum Adenocarcinoma cases?,cnv_and_ssm
+1268,YY1AP1,V546D,Glioblastoma Multiforme,Could you provide the rate of YY1AP1 mutations and DCC deletions among Glioblastoma Multiforme cases?,cnv_and_ssm
+1269,YY1AP1,V557D,Glioblastoma Multiforme,Could you provide the rate of YY1AP1 mutations and EPRS1 deletions among Glioblastoma Multiforme cases?,cnv_and_ssm
+1270,YY1AP1,V566D,Glioblastoma Multiforme,Could you provide the rate of YY1AP1 mutations and TNS1 deletions among Glioblastoma Multiforme cases?,cnv_and_ssm
+1271,YY1AP1,V577D,Glioblastoma Multiforme,Could you provide the rate of YY1AP1 mutations and PTPRN2 deletions among Glioblastoma Multiforme cases?,cnv_and_ssm
+1272,YY1AP1,V623D,Glioblastoma Multiforme,Could you provide the rate of YY1AP1 mutations and ZNF584 deletions among Glioblastoma Multiforme cases?,cnv_and_ssm
+1273,YY1AP1,V695D,Glioblastoma Multiforme,Could you provide the rate of YY1AP1 mutations and AQP7 deletions among Glioblastoma Multiforme cases?,cnv_and_ssm
+1274,YY1AP1,V715D,Glioblastoma Multiforme,Could you provide the rate of YY1AP1 mutations and SLC9C1 deletions among Glioblastoma Multiforme cases?,cnv_and_ssm
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,Could you provide the rate of FNDC7 mutations and AQP7 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,Could you provide the rate of FNDC7 mutations and ACVR1B deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1299,TLCD5,G15V,Lung Adenocarcinoma,Could you provide the rate of TLCD5 mutations and CFAP298-TCP10L deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+1300,TLCD5,G37V,Lung Adenocarcinoma,Could you provide the rate of TLCD5 mutations and KL deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of POLR1G mutations and AQP7 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of POLR1G mutations and FBN1 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1308,DNAH14,N1186K,Colon Adenocarcinoma,Could you provide the rate of DNAH14 mutations and FBXO42 deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+1309,DNAH14,N2657K,Colon Adenocarcinoma,Could you provide the rate of DNAH14 mutations and HTR3B deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+1310,DNAH14,N3460K,Colon Adenocarcinoma,Could you provide the rate of DNAH14 mutations and CFAP298-TCP10L deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of NEXN mutations and UNC5D deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,Could you provide the rate of CYB5R2 mutations and USH2A deletions among Prostate Adenocarcinoma cases?,cnv_and_ssm
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,Could you provide the rate of CYB5R2 mutations and ARHGEF40 deletions among Prostate Adenocarcinoma cases?,cnv_and_ssm
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of NRAP mutations and POLR1G deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of NRAP mutations and PIAS3 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of NRAP mutations and FGF8 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of CCDC22 mutations and ITPRID2 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,Could you provide the rate of DCAF6 mutations and DNAH11 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,Could you provide the rate of DCAF6 mutations and ZMYM3 deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of ZNF708 mutations and MAD1L1 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of BFAR mutations and CEP20 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of MAST4 mutations and SORCS1 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of MAST4 mutations and PRSS8 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of MAST4 mutations and STK19 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of MAST4 mutations and CTCFL deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of MAST4 mutations and OLFML3 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1363,ARMC3,R169C,Stomach Adenocarcinoma,Could you provide the rate of ARMC3 mutations and TYK2 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+1364,ARMC3,R432C,Stomach Adenocarcinoma,Could you provide the rate of ARMC3 mutations and SGIP1 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,Could you provide the rate of TET2 mutations and PCDHGA1 deletions among Kidney Renal Clear Cell Carcinoma cases?,cnv_and_ssm
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,Could you provide the rate of TET2 mutations and MORF4L1 deletions among Kidney Renal Clear Cell Carcinoma cases?,cnv_and_ssm
+1369,SERPINB10,A353P,Lung Adenocarcinoma,Could you provide the rate of SERPINB10 mutations and ZNF708 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of STAT3 mutations and SMO deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of MIEF1 mutations and TENM2 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1381,ACVR1B,D397N,Colon Adenocarcinoma,Could you provide the rate of ACVR1B mutations and BICC1 deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+1382,ACVR1B,D449N,Colon Adenocarcinoma,Could you provide the rate of ACVR1B mutations and SLC24A2 deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+1383,ACVR1B,D490N,Colon Adenocarcinoma,Could you provide the rate of ACVR1B mutations and TET2 deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+1393,EBF2,T104I,Stomach Adenocarcinoma,Could you provide the rate of EBF2 mutations and GSTCD deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+1394,EBF2,T252I,Stomach Adenocarcinoma,Could you provide the rate of EBF2 mutations and CHODL deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+1402,VPS26B,F266L,Stomach Adenocarcinoma,Could you provide the rate of VPS26B mutations and MERTK deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Could you provide the rate of PGR mutations and SLC9C1 deletions among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Could you provide the rate of PGR mutations and FCGR2C deletions among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Could you provide the rate of PGR mutations and HLA-DQA2 deletions among CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,Could you provide the rate of ACTA2 mutations and TYROBP deletions among Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of THBS4 mutations and UNC5D deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of THBS4 mutations and PTPRN2 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1413,PRSS1,S114T,Lung Adenocarcinoma,Could you provide the rate of PRSS1 mutations and CDKN2AIP deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+1414,PRSS1,S124T,Lung Adenocarcinoma,Could you provide the rate of PRSS1 mutations and DCAF6 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+1415,PRSS1,S138T,Lung Adenocarcinoma,Could you provide the rate of PRSS1 mutations and TNS1 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+1416,PRSS1,S74T,Lung Adenocarcinoma,Could you provide the rate of PRSS1 mutations and FBXO15 deletions among Lung Adenocarcinoma cases?,cnv_and_ssm
+1417,PGF,R126H,Stomach Adenocarcinoma,Could you provide the rate of PGF mutations and BCAT1 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+1418,PGF,R127H,Stomach Adenocarcinoma,Could you provide the rate of PGF mutations and TENM2 deletions among Stomach Adenocarcinoma cases?,cnv_and_ssm
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,Could you provide the rate of ITPRID2 mutations and STK19 deletions among Breast Invasive Carcinoma cases?,cnv_and_ssm
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,Could you provide the rate of ITPRID2 mutations and FRY deletions among Breast Invasive Carcinoma cases?,cnv_and_ssm
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of HBB mutations and NRAP deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1441,PCDHB2,R158C,Colon Adenocarcinoma,Could you provide the rate of PCDHB2 mutations and EFCAB12 deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+1442,PCDHB2,T15M,Colon Adenocarcinoma,Could you provide the rate of PCDHB2 mutations and ZFP42 deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+1443,PCDHB2,T26M,Colon Adenocarcinoma,Could you provide the rate of PCDHB2 mutations and ZFAT deletions among Colon Adenocarcinoma cases?,cnv_and_ssm
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,Could you provide the rate of UBR2 mutations and FNDC7 deletions among Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1452,FBXO42,A618D,Rectum Adenocarcinoma,Could you provide the rate of FBXO42 mutations and CA9 deletions among Rectum Adenocarcinoma cases?,cnv_and_ssm
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the occurrence of TNS1 mutations alongside CPS1 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the occurrence of TNS1 mutations alongside DGKD amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the occurrence of TNS1 mutations alongside HSPA5 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the occurrence of TNS1 mutations alongside FNDC7 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the occurrence of TNS1 mutations alongside FRY amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the occurrence of TNS1 mutations alongside FGF8 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the occurrence of TNS1 mutations alongside CARMIL1 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the occurrence of EVC2 mutations alongside TYK2 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the occurrence of EVC2 mutations alongside AKT1 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CR1 mutations alongside DCN amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CR1 mutations alongside CXCR2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the occurrence of TRPA1 mutations alongside PRSS1 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the occurrence of TRPA1 mutations alongside SGIP1 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the occurrence of TAF1C mutations alongside MRPL32 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the occurrence of TAF1C mutations alongside ABCC2 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the occurrence of TAF1C mutations alongside OR13C3 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the occurrence of TAF1C mutations alongside ANKRD24 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the occurrence of TAF1C mutations alongside MYT1 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the occurrence of DPF3 mutations alongside GABRA6 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the occurrence of DPF3 mutations alongside STAT3 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the occurrence of DPF3 mutations alongside PGR amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the occurrence of OR2T4 mutations alongside PTPRO amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the occurrence of OR2T4 mutations alongside TENM2 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the occurrence of FBN1 mutations alongside AQP7 amplifications in Pancreatic Adenocarcinoma?,cnv_and_ssm
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the occurrence of MAD1L1 mutations alongside TLCD5 amplifications in Prostate Adenocarcinoma?,cnv_and_ssm
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the occurrence of MAD1L1 mutations alongside DCAF6 amplifications in Prostate Adenocarcinoma?,cnv_and_ssm
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the occurrence of MAD1L1 mutations alongside CPS1 amplifications in Prostate Adenocarcinoma?,cnv_and_ssm
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the occurrence of CCNG1 mutations alongside CHODL amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the occurrence of ANP32E mutations alongside MAD1L1 amplifications in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the occurrence of ANP32E mutations alongside PAK3 amplifications in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the occurrence of ANP32E mutations alongside DCN amplifications in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the occurrence of ANP32E mutations alongside SMO amplifications in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the occurrence of FRY mutations alongside DCN amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the occurrence of FRY mutations alongside ZNF804A amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the occurrence of FRY mutations alongside EIF2B4 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the occurrence of FRY mutations alongside TLCD5 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the occurrence of PAK3 mutations alongside XKR4 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the occurrence of PAK3 mutations alongside TET2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the occurrence of PAK3 mutations alongside SPINDOC amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the occurrence of PAK3 mutations alongside PRSS8 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the occurrence of PAK3 mutations alongside PIK3C2B amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the occurrence of MUC16 mutations alongside SGIP1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the occurrence of ZFPM2 mutations alongside OR13C3 amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the occurrence of ZFPM2 mutations alongside CX3CR1 amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the occurrence of PIK3C2B mutations alongside ANP32E amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the occurrence of PIK3C2B mutations alongside DEFB115 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the occurrence of ZNF804A mutations alongside RIMS2 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the occurrence of RELN mutations alongside MSANTD4 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of EFCAB12 mutations alongside NOMO1 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of EFCAB12 mutations alongside GABRA6 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the occurrence of DEFB115 mutations alongside CR1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the occurrence of ANKDD1A mutations alongside EBF2 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the occurrence of ANKDD1A mutations alongside BCAT1 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the occurrence of ANKDD1A mutations alongside TRIM45 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the occurrence of HTR3B mutations alongside MORF4L1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the occurrence of HTR3B mutations alongside SYNJ1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the occurrence of HTR3B mutations alongside ITPRID2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the occurrence of ABCC3 mutations alongside HBB amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the occurrence of NOMO1 mutations alongside FRY amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the occurrence of NOMO1 mutations alongside TNS1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the occurrence of HYOU1 mutations alongside AUTS2 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the occurrence of FMO4 mutations alongside GUK1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+140,BICC1,A372V,Exceptional Responders,What is the occurrence of BICC1 mutations alongside UNC5D amplifications in Exceptional Responders?,cnv_and_ssm
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the occurrence of ZMYM3 mutations alongside PKHD1L1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the occurrence of ZMYM3 mutations alongside MORF4L1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the occurrence of ZMYM3 mutations alongside CR1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of XKR4 mutations alongside NEXN amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the occurrence of ABCC2 mutations alongside EBF2 amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the occurrence of OR8K5 mutations alongside DCAF6 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the occurrence of SPTAN1 mutations alongside CPS1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the occurrence of SPTAN1 mutations alongside ZNF431 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the occurrence of SYT10 mutations alongside FBN1 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the occurrence of HSPA5 mutations alongside ZSCAN31 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the occurrence of UNC5D mutations alongside TET2 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the occurrence of UNC5D mutations alongside TNS1 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the occurrence of UNC5D mutations alongside ZNF274 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the occurrence of UNC5D mutations alongside EIF2B4 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the occurrence of UNC5D mutations alongside SGCZ amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the occurrence of UNC5D mutations alongside MSANTD4 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the occurrence of DOCK2 mutations alongside TLK2 amplifications in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the occurrence of ZNF627 mutations alongside RIMS2 amplifications in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the occurrence of CDC42BPA mutations alongside PLEKHG6 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the occurrence of MRPL55 mutations alongside MYO3B amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the occurrence of MRPL55 mutations alongside DNMT1 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the occurrence of TMTC3 mutations alongside KANSL1 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the occurrence of EPRS1 mutations alongside HSPA5 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the occurrence of EPRS1 mutations alongside TTC12 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the occurrence of GRTP1 mutations alongside SYNJ1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the occurrence of GRTP1 mutations alongside ANKRD30A amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the occurrence of TSHZ3 mutations alongside ANKRD24 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the occurrence of TAS1R3 mutations alongside SLC9C1 amplifications in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,cnv_and_ssm
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the occurrence of PIAS3 mutations alongside ZFPM2 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the occurrence of PIAS3 mutations alongside STK19 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the occurrence of ZNF274 mutations alongside TAF1C amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the occurrence of SYNJ1 mutations alongside KDM5C amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the occurrence of SYNJ1 mutations alongside PHLPP1 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the occurrence of SYNJ1 mutations alongside TAF1C amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the occurrence of DSCAM mutations alongside ZFAT amplifications in Prostate Adenocarcinoma?,cnv_and_ssm
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the occurrence of DSCAM mutations alongside TNS1 amplifications in Prostate Adenocarcinoma?,cnv_and_ssm
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the occurrence of DSCAM mutations alongside FGF8 amplifications in Prostate Adenocarcinoma?,cnv_and_ssm
+267,DGKD,R140H,Exceptional Responders,What is the occurrence of DGKD mutations alongside CACNA1F amplifications in Exceptional Responders?,cnv_and_ssm
+268,DGKD,R160H,Exceptional Responders,What is the occurrence of DGKD mutations alongside CX3CR1 amplifications in Exceptional Responders?,cnv_and_ssm
+269,DGKD,R204H,Exceptional Responders,What is the occurrence of DGKD mutations alongside BCAT1 amplifications in Exceptional Responders?,cnv_and_ssm
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the occurrence of PLEKHG6 mutations alongside PTPRN2 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the occurrence of PLEKHG6 mutations alongside PDHA2 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the occurrence of PLEKHG6 mutations alongside DHX16 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the occurrence of WNT2 mutations alongside MED16 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the occurrence of GUCY2C mutations alongside CTSC amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the occurrence of C7orf31 mutations alongside ANKRD24 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of ZKSCAN7 mutations alongside CTCFL amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+299,OR5D14,M210L,Neuroblastoma,What is the occurrence of OR5D14 mutations alongside VASN amplifications in Neuroblastoma?,cnv_and_ssm
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the occurrence of SPATA22 mutations alongside TAF1C amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the occurrence of SPATA22 mutations alongside TTC17 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the occurrence of SPATA22 mutations alongside PIK3C2B amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the occurrence of LCN15 mutations alongside PIK3C2B amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the occurrence of DCAF4L2 mutations alongside ITPRID2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the occurrence of GUK1 mutations alongside CFAP61 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the occurrence of GUK1 mutations alongside PRSS1 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the occurrence of GUK1 mutations alongside TASOR2 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the occurrence of GUK1 mutations alongside TAS1R3 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the occurrence of GUK1 mutations alongside FBXO15 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the occurrence of MORF4L1 mutations alongside FCGR2C amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the occurrence of MORF4L1 mutations alongside OR13C3 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the occurrence of MORF4L1 mutations alongside ZFAT amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the occurrence of MORF4L1 mutations alongside RIMS2 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the occurrence of MYO3B mutations alongside ANP32E amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the occurrence of MYO3B mutations alongside BCAT1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the occurrence of TENT5A mutations alongside DPF3 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the occurrence of TENT5A mutations alongside PIK3C2A amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the occurrence of TENT5A mutations alongside CDH23 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the occurrence of ZFAT mutations alongside FBN1 amplifications in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the occurrence of ZFAT mutations alongside TENT5A amplifications in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the occurrence of ZFAT mutations alongside NEXN amplifications in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+357,ZNF584,A211T,Sarcoma,What is the occurrence of ZNF584 mutations alongside PGF amplifications in Sarcoma?,cnv_and_ssm
+358,ZNF584,A256T,Sarcoma,What is the occurrence of ZNF584 mutations alongside CYP1A2 amplifications in Sarcoma?,cnv_and_ssm
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the occurrence of LDOC1 mutations alongside ABCC2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the occurrence of PDGFC mutations alongside MYO3A amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the occurrence of MSANTD4 mutations alongside EPRS1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the occurrence of NPSR1 mutations alongside TENM2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the occurrence of PHLPP1 mutations alongside PIK3C2G amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the occurrence of COL6A3 mutations alongside FRY amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the occurrence of COL6A3 mutations alongside ANP32E amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the occurrence of COL6A3 mutations alongside CACNA1F amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the occurrence of COL6A3 mutations alongside TMEM225 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the occurrence of COL6A3 mutations alongside DNAH14 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the occurrence of ADRA1A mutations alongside MED16 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the occurrence of LAMB2 mutations alongside GABRA6 amplifications in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the occurrence of POC1B mutations alongside PGF amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the occurrence of POC1B mutations alongside TYK2 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the occurrence of POC1B mutations alongside JAML amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the occurrence of POC1B mutations alongside TRPA1 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the occurrence of USH2A mutations alongside FMO4 amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the occurrence of AQP7 mutations alongside MUC16 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the occurrence of AQP7 mutations alongside DCN amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the occurrence of AQP7 mutations alongside DHX16 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the occurrence of AQP7 mutations alongside SGIP1 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+430,DCN,R163C,Rectum Adenocarcinoma,What is the occurrence of DCN mutations alongside ANP32E amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+431,DCN,R203C,Rectum Adenocarcinoma,What is the occurrence of DCN mutations alongside DGKD amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+432,DCN,R241C,Rectum Adenocarcinoma,What is the occurrence of DCN mutations alongside POC1B amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+433,DCN,R350C,Rectum Adenocarcinoma,What is the occurrence of DCN mutations alongside GPR158 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+434,DCN,R41C,Rectum Adenocarcinoma,What is the occurrence of DCN mutations alongside CFAP61 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CPS1 mutations alongside GPRASP1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CPS1 mutations alongside ZNF217 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CPS1 mutations alongside MRPL32 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the occurrence of FCGR2C mutations alongside EIF2B4 amplifications in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the occurrence of FCGR2C mutations alongside LCN15 amplifications in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the occurrence of GRM1 mutations alongside PGR amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the occurrence of SGCZ mutations alongside UBR2 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the occurrence of SGCZ mutations alongside SLC9C1 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+485,SMO,V15M,Stomach Adenocarcinoma,What is the occurrence of SMO mutations alongside OR13C3 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+486,SMO,V321M,Stomach Adenocarcinoma,What is the occurrence of SMO mutations alongside SIK2 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the occurrence of CHODL mutations alongside TASOR2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the occurrence of CHODL mutations alongside YY1AP1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the occurrence of CHODL mutations alongside TENT5A amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+494,MYO16,P399H,Colon Adenocarcinoma,What is the occurrence of MYO16 mutations alongside CDH23 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+495,MYO16,P421H,Colon Adenocarcinoma,What is the occurrence of MYO16 mutations alongside CARMIL1 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the occurrence of CXCR2 mutations alongside MRPL55 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the occurrence of TMEM225 mutations alongside EFCAB12 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the occurrence of MAOB mutations alongside VPS26B amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the occurrence of GPRASP1 mutations alongside PCDHB2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the occurrence of MRPL32 mutations alongside HTR3B amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the occurrence of TYROBP mutations alongside PRSS8 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the occurrence of RAB40C mutations alongside SGCZ amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the occurrence of RAB40C mutations alongside FNDC7 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the occurrence of CTNNA2 mutations alongside SGCZ amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the occurrence of CTNNA2 mutations alongside GUK1 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the occurrence of CTNNA2 mutations alongside ZNF804A amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the occurrence of CTNNA2 mutations alongside DPF3 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the occurrence of MYO15A mutations alongside AQP7 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the occurrence of GIMAP2 mutations alongside TENM2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the occurrence of KIF20B mutations alongside GABRA6 amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the occurrence of KIF20B mutations alongside TMEM225 amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the occurrence of ADAM17 mutations alongside DPF3 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the occurrence of BCAT1 mutations alongside SPATA22 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the occurrence of BCAT1 mutations alongside DGKD amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the occurrence of BCAT1 mutations alongside YY1AP1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the occurrence of ERCC6 mutations alongside ACTB amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+541,DCC,R320W,Breast Invasive Carcinoma,What is the occurrence of DCC mutations alongside PIK3C2B amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+542,DCC,R363W,Breast Invasive Carcinoma,What is the occurrence of DCC mutations alongside GUK1 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+543,DCC,R386W,Breast Invasive Carcinoma,What is the occurrence of DCC mutations alongside PIK3C2G amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+544,DCC,R41W,Breast Invasive Carcinoma,What is the occurrence of DCC mutations alongside DNAH14 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the occurrence of FBXO15 mutations alongside EVC2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the occurrence of FBXO15 mutations alongside SERPINB10 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the occurrence of GSTCD mutations alongside FRY amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the occurrence of GSTCD mutations alongside FBN1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the occurrence of OLFML3 mutations alongside SGIP1 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the occurrence of OLFML3 mutations alongside ACTL7B amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the occurrence of OLFML3 mutations alongside ACTL7B amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the occurrence of CFAP61 mutations alongside GPR158 amplifications in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the occurrence of CFAP61 mutations alongside HTR3B amplifications in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the occurrence of HLA-DQA2 mutations alongside MRPL32 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the occurrence of TENM2 mutations alongside DHX16 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the occurrence of TENM2 mutations alongside ZCCHC14 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the occurrence of TENM2 mutations alongside TMEM225 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the occurrence of ANKRD24 mutations alongside DNAH14 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the occurrence of ANKRD24 mutations alongside CACNA1F amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the occurrence of ANKRD24 mutations alongside GPRASP1 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the occurrence of ZCCHC14 mutations alongside TRIM45 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the occurrence of ZCCHC14 mutations alongside TRIM45 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the occurrence of ZCCHC14 mutations alongside ACTA2 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the occurrence of ZCCHC14 mutations alongside EVC2 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+625,SIK2,I265M,Lung Adenocarcinoma,What is the occurrence of SIK2 mutations alongside TAS1R3 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the occurrence of MYH11 mutations alongside UNC5D amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the occurrence of MYH11 mutations alongside PIAS3 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the occurrence of SLC6A4 mutations alongside UNC5D amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the occurrence of SLC9C1 mutations alongside MYH11 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the occurrence of SLC9C1 mutations alongside ZNF708 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the occurrence of OR2A12 mutations alongside CPS1 amplifications in Brain Lower Grade Glioma?,cnv_and_ssm
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the occurrence of PYHIN1 mutations alongside SMO amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the occurrence of PYHIN1 mutations alongside CTCFL amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the occurrence of JAML mutations alongside AUTS2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the occurrence of JAML mutations alongside SYT9 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the occurrence of JAML mutations alongside LAMB2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the occurrence of JAML mutations alongside MERTK amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the occurrence of TYK2 mutations alongside MYO16 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the occurrence of TYK2 mutations alongside PIAS3 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the occurrence of TYK2 mutations alongside CHMP7 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CTCFL mutations alongside DCLK3 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CTCFL mutations alongside CNGB1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CTCFL mutations alongside CDKN2AIP amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CTCFL mutations alongside OR13C3 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CEP20 mutations alongside CPA6 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CEP20 mutations alongside ANKRD30A amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the occurrence of RIMS2 mutations alongside GRTP1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the occurrence of RIMS2 mutations alongside AUTS2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the occurrence of RIMS2 mutations alongside SYT9 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the occurrence of RIMS2 mutations alongside TSHZ3 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the occurrence of RIMS2 mutations alongside ZFAT amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the occurrence of RIMS2 mutations alongside PIK3C2B amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the occurrence of RIMS2 mutations alongside TASOR2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the occurrence of PIK3C2G mutations alongside RIMS2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the occurrence of PIK3C2G mutations alongside TRIM45 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+728,STK19,D341N,Colon Adenocarcinoma,What is the occurrence of STK19 mutations alongside DSCAM amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+729,STK19,D345N,Colon Adenocarcinoma,What is the occurrence of STK19 mutations alongside PTPRO amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the occurrence of REXO4 mutations alongside FGF8 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the occurrence of ZBTB34 mutations alongside REXO4 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the occurrence of ZBTB34 mutations alongside CHODL amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the occurrence of NCKAP5 mutations alongside CARMIL1 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of SORCS1 mutations alongside UNC5D amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of SORCS1 mutations alongside STAT3 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of SORCS1 mutations alongside MERTK amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of SORCS1 mutations alongside TASOR2 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the occurrence of FGF8 mutations alongside TET2 amplifications in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the occurrence of FGF8 mutations alongside MYO16 amplifications in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the occurrence of FGF8 mutations alongside TNS1 amplifications in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the occurrence of FGF8 mutations alongside HTR3B amplifications in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the occurrence of FGF8 mutations alongside RIPOR2 amplifications in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the occurrence of TENM3 mutations alongside MYT1 amplifications in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,cnv_and_ssm
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the occurrence of AKT1 mutations alongside KIF20B amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the occurrence of CFAP298-TCP10L mutations alongside TTN amplifications in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the occurrence of GLRB mutations alongside TMEM255A amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+793,TTN,F7636L,Colon Adenocarcinoma,What is the occurrence of TTN mutations alongside KRT39 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+794,TTN,F8563L,Colon Adenocarcinoma,What is the occurrence of TTN mutations alongside MIEF1 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+795,TTN,F8880L,Colon Adenocarcinoma,What is the occurrence of TTN mutations alongside ZCCHC14 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the occurrence of ANKRD30A mutations alongside KRT39 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the occurrence of ANKRD30A mutations alongside ZNF431 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the occurrence of ANKRD30A mutations alongside PXN amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the occurrence of TRIM45 mutations alongside ANP32E amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the occurrence of TRIM45 mutations alongside DCN amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the occurrence of TRIM45 mutations alongside BCAT1 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the occurrence of CACNA1F mutations alongside PGR amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the occurrence of CACNA1F mutations alongside DCC amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the occurrence of CACNA1F mutations alongside SGIP1 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+817,KL,R594C,Colon Adenocarcinoma,What is the occurrence of KL mutations alongside CTSC amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the occurrence of GUF1 mutations alongside TENM2 amplifications in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the occurrence of TAF1L mutations alongside TTYH2 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the occurrence of TASOR2 mutations alongside PAPPA amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the occurrence of TASOR2 mutations alongside PTPRN2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the occurrence of TASOR2 mutations alongside ANKRD24 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the occurrence of KDM5C mutations alongside XKR4 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the occurrence of KDM5C mutations alongside AUTS2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the occurrence of KDM5C mutations alongside CDH23 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the occurrence of KDM5C mutations alongside ZNF431 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the occurrence of IL5RA mutations alongside JAML amplifications in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the occurrence of DHX16 mutations alongside TET2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the occurrence of DHX16 mutations alongside DSCAM amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the occurrence of GPR158 mutations alongside ABCC2 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the occurrence of GPR158 mutations alongside BFAR amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of EIF2B4 mutations alongside KDM5C amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of EIF2B4 mutations alongside RIMS2 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of EIF2B4 mutations alongside GUF1 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of EIF2B4 mutations alongside RIPOR2 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of EIF2B4 mutations alongside TTC12 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of EIF2B4 mutations alongside ANKDD1A amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the occurrence of AUTS2 mutations alongside MORF4L1 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the occurrence of AUTS2 mutations alongside SGIP1 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the occurrence of AUTS2 mutations alongside GPR158 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the occurrence of AUTS2 mutations alongside SPTAN1 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the occurrence of AUTS2 mutations alongside AUTS2 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the occurrence of AUTS2 mutations alongside TASOR2 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the occurrence of AUTS2 mutations alongside AQP7 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the occurrence of AUTS2 mutations alongside LDOC1 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the occurrence of AUTS2 mutations alongside MRPL32 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the occurrence of AUTS2 mutations alongside RIPOR2 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of ACTL7B mutations alongside ACTB amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the occurrence of PCDHGA1 mutations alongside STK19 amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the occurrence of TRAP1 mutations alongside CHODL amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the occurrence of TRAP1 mutations alongside DCN amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the occurrence of PIK3C2A mutations alongside TMEM255A amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the occurrence of KANSL1 mutations alongside TYK2 amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the occurrence of ANKRD52 mutations alongside EIF2B4 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the occurrence of PAPPA mutations alongside MYO3B amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the occurrence of B3GALNT1 mutations alongside PTPRO amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the occurrence of GABRA6 mutations alongside RIMS2 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the occurrence of GABRA6 mutations alongside KDM5C amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the occurrence of GABRA6 mutations alongside ANKRD30A amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the occurrence of GABRA6 mutations alongside ARHGEF40 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the occurrence of GABRA6 mutations alongside COL6A3 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the occurrence of ZSCAN31 mutations alongside AUTS2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of MED16 mutations alongside BCAT1 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of MED16 mutations alongside MORF4L1 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the occurrence of PTPRO mutations alongside AUTS2 amplifications in Pancreatic Adenocarcinoma?,cnv_and_ssm
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the occurrence of PTPRO mutations alongside ERCC6 amplifications in Pancreatic Adenocarcinoma?,cnv_and_ssm
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the occurrence of PTPRO mutations alongside RELN amplifications in Pancreatic Adenocarcinoma?,cnv_and_ssm
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the occurrence of PTPRO mutations alongside TLK2 amplifications in Pancreatic Adenocarcinoma?,cnv_and_ssm
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the occurrence of PTPRO mutations alongside DNMT1 amplifications in Pancreatic Adenocarcinoma?,cnv_and_ssm
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the occurrence of PTPRO mutations alongside SGCZ amplifications in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the occurrence of PTPRO mutations alongside MRPL55 amplifications in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the occurrence of PTPRO mutations alongside SPATA22 amplifications in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CHMP7 mutations alongside RELN amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the occurrence of GPC3 mutations alongside CPA6 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the occurrence of GPC3 mutations alongside ANP32E amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the occurrence of TLK2 mutations alongside PIAS3 amplifications in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the occurrence of TLK2 mutations alongside DNAH14 amplifications in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the occurrence of TLK2 mutations alongside DNMT1 amplifications in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the occurrence of TLK2 mutations alongside ACVR1B amplifications in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the occurrence of TLK2 mutations alongside IL5RA amplifications in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the occurrence of ZNF217 mutations alongside ABCC3 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the occurrence of SYT9 mutations alongside AQP7 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the occurrence of SYT9 mutations alongside AUTS2 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the occurrence of PKHD1L1 mutations alongside MYH11 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the occurrence of MYO3A mutations alongside TASOR2 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of VASN mutations alongside TRPA1 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the occurrence of DNMT1 mutations alongside PIK3C2B amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the occurrence of DNMT1 mutations alongside CDC42BPA amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the occurrence of DNMT1 mutations alongside ZBTB34 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1056,CA9,E402K,Colon Adenocarcinoma,What is the occurrence of CA9 mutations alongside KANSL1 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the occurrence of TTC17 mutations alongside ANKRD24 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the occurrence of TTC17 mutations alongside KDM5C amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the occurrence of PSG2 mutations alongside PRSS1 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the occurrence of RIPOR2 mutations alongside RIPOR2 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the occurrence of RIPOR2 mutations alongside CX3CR1 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the occurrence of RIPOR2 mutations alongside COL6A3 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the occurrence of RIPOR2 mutations alongside RIPOR2 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the occurrence of DCLK3 mutations alongside HTR3B amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the occurrence of DCLK3 mutations alongside GSTCD amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the occurrence of MERTK mutations alongside MYT1 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the occurrence of MERTK mutations alongside PIK3C2G amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the occurrence of MERTK mutations alongside CDH23 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the occurrence of ZFP42 mutations alongside EIF2B4 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the occurrence of OR13C3 mutations alongside ART3 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the occurrence of OR13C3 mutations alongside DGKD amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the occurrence of SPAG1 mutations alongside PXN amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CDKN2AIP mutations alongside MERTK amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the occurrence of PXN mutations alongside CHODL amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the occurrence of PXN mutations alongside LDOC1 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the occurrence of PXN mutations alongside ZFP42 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the occurrence of PXN mutations alongside ANP32E amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the occurrence of PXN mutations alongside DNMT1 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the occurrence of PXN mutations alongside ANP32E amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the occurrence of TTYH2 mutations alongside COL6A3 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the occurrence of TTYH2 mutations alongside CDH23 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the occurrence of TMEM255A mutations alongside CPS1 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the occurrence of TMEM255A mutations alongside AQP7 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the occurrence of TMEM255A mutations alongside DCC amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the occurrence of TASOR2 mutations alongside PRSS8 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the occurrence of TASOR2 mutations alongside HLA-DQA2 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the occurrence of ICE1 mutations alongside PHLPP1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the occurrence of MYT1 mutations alongside STK19 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the occurrence of MYT1 mutations alongside CTSC amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the occurrence of MYT1 mutations alongside GABRA6 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CX3CR1 mutations alongside CHODL amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CX3CR1 mutations alongside PYHIN1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the occurrence of SPINDOC mutations alongside ZNF431 amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the occurrence of ART3 mutations alongside PTPRO amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the occurrence of ART3 mutations alongside CFAP298-TCP10L amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the occurrence of CYP1A2 mutations alongside TENM2 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of ADRA1A mutations alongside PTPRO amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the occurrence of CDH23 mutations alongside MYO3B amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the occurrence of CDH23 mutations alongside ANKRD24 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the occurrence of KRT39 mutations alongside GRM5 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the occurrence of PDHA2 mutations alongside DSCAM amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the occurrence of SLC24A2 mutations alongside DNMT1 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the occurrence of PTPRN2 mutations alongside PXN amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the occurrence of PTPRN2 mutations alongside PGR amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the occurrence of PTPRN2 mutations alongside PGR amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the occurrence of PTPRN2 mutations alongside TENT5A amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the occurrence of PTPRN2 mutations alongside BCAT1 amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the occurrence of SOX21 mutations alongside UNC5D amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the occurrence of CPA6 mutations alongside PAK3 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the occurrence of GRM5 mutations alongside DSCAM amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of CASZ1 mutations alongside ITPRID2 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the occurrence of SGIP1 mutations alongside CFAP298-TCP10L amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the occurrence of SGIP1 mutations alongside PGF amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the occurrence of SGIP1 mutations alongside AUTS2 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the occurrence of SGIP1 mutations alongside SORCS1 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the occurrence of CARMIL1 mutations alongside TLK2 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the occurrence of CARMIL1 mutations alongside PAK3 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the occurrence of ZNF431 mutations alongside TMEM255A amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the occurrence of ZNF431 mutations alongside EBF2 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the occurrence of ZNF431 mutations alongside DCN amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the occurrence of DNAH11 mutations alongside PTPRN2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the occurrence of DNAH11 mutations alongside PCDHB2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the occurrence of POLD1 mutations alongside RIMS2 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the occurrence of POLD1 mutations alongside CEP20 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the occurrence of TTC12 mutations alongside FRY amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the occurrence of TTC12 mutations alongside POC1B amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the occurrence of CNGB1 mutations alongside TRIM45 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the occurrence of CNGB1 mutations alongside DCLK3 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the occurrence of CTSC mutations alongside TASOR2 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the occurrence of CTSC mutations alongside EVC2 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the occurrence of CTSC mutations alongside PDGFC amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the occurrence of CTSC mutations alongside PTPRO amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the occurrence of CTSC mutations alongside ZMYM3 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the occurrence of PRSS8 mutations alongside RIMS2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the occurrence of PRSS8 mutations alongside MAD1L1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the occurrence of ARHGEF40 mutations alongside EFCAB12 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the occurrence of ACTB mutations alongside EIF2B4 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the occurrence of ACTB mutations alongside EIF2B4 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the occurrence of ACTB mutations alongside CTSC amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the occurrence of ACTB mutations alongside ZMYM3 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the occurrence of YY1AP1 mutations alongside POLR1G amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the occurrence of YY1AP1 mutations alongside AUTS2 amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the occurrence of YY1AP1 mutations alongside DNMT1 amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the occurrence of YY1AP1 mutations alongside ZCCHC14 amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the occurrence of YY1AP1 mutations alongside SMO amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the occurrence of YY1AP1 mutations alongside POLD1 amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the occurrence of YY1AP1 mutations alongside ZNF584 amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the occurrence of FNDC7 mutations alongside ZNF627 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the occurrence of FNDC7 mutations alongside TMEM255A amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the occurrence of TLCD5 mutations alongside ACTB amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the occurrence of TLCD5 mutations alongside MYO3A amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the occurrence of POLR1G mutations alongside SYT9 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the occurrence of POLR1G mutations alongside MERTK amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the occurrence of DNAH14 mutations alongside TNS1 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the occurrence of DNAH14 mutations alongside STK19 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the occurrence of DNAH14 mutations alongside KRT39 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the occurrence of NEXN mutations alongside FNDC7 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the occurrence of CYB5R2 mutations alongside SMO amplifications in Prostate Adenocarcinoma?,cnv_and_ssm
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the occurrence of CYB5R2 mutations alongside ZBTB34 amplifications in Prostate Adenocarcinoma?,cnv_and_ssm
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the occurrence of NRAP mutations alongside TLK2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the occurrence of NRAP mutations alongside VASN amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the occurrence of NRAP mutations alongside AKT1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the occurrence of CCDC22 mutations alongside ADAM17 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the occurrence of DCAF6 mutations alongside CHODL amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the occurrence of DCAF6 mutations alongside CTCFL amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the occurrence of ZNF708 mutations alongside PGF amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the occurrence of BFAR mutations alongside SORCS1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the occurrence of MAST4 mutations alongside ERCC6 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the occurrence of MAST4 mutations alongside ZBTB34 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the occurrence of MAST4 mutations alongside CACNA1F amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the occurrence of MAST4 mutations alongside TNS1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the occurrence of MAST4 mutations alongside TLCD5 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the occurrence of ARMC3 mutations alongside FCGR2C amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the occurrence of ARMC3 mutations alongside RIPOR2 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the occurrence of TET2 mutations alongside DNAH14 amplifications in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the occurrence of TET2 mutations alongside SGCZ amplifications in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the occurrence of SERPINB10 mutations alongside ADRA1A amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the occurrence of STAT3 mutations alongside POLR1G amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the occurrence of MIEF1 mutations alongside CTNNA2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the occurrence of ACVR1B mutations alongside GRM1 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the occurrence of ACVR1B mutations alongside MERTK amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the occurrence of ACVR1B mutations alongside PTPRN2 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the occurrence of EBF2 mutations alongside DPF3 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the occurrence of EBF2 mutations alongside AUTS2 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the occurrence of VPS26B mutations alongside KIF20B amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of PGR mutations alongside MERTK amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of PGR mutations alongside CPS1 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the occurrence of PGR mutations alongside KIF20B amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the occurrence of ACTA2 mutations alongside POC1B amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the occurrence of THBS4 mutations alongside CTSC amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the occurrence of THBS4 mutations alongside POC1B amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the occurrence of PRSS1 mutations alongside POLD1 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the occurrence of PRSS1 mutations alongside ZNF627 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the occurrence of PRSS1 mutations alongside RIMS2 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the occurrence of PRSS1 mutations alongside ACVR1B amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the occurrence of PGF mutations alongside TTN amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the occurrence of PGF mutations alongside PIAS3 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the occurrence of ITPRID2 mutations alongside ZNF217 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the occurrence of ITPRID2 mutations alongside XKR4 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the occurrence of HBB mutations alongside PGR amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the occurrence of PCDHB2 mutations alongside FCGR2C amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the occurrence of PCDHB2 mutations alongside PDGFC amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the occurrence of PCDHB2 mutations alongside ZCCHC14 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the occurrence of UBR2 mutations alongside MYT1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the occurrence of FBXO42 mutations alongside ACVR1B amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+1,TNS1,G1362V,Breast Invasive Carcinoma,How often are concurrent somatic mutations in TNS1 and deletions in ADRA1A observed in Breast Invasive Carcinoma?,cnv_and_ssm
+2,TNS1,G1711V,Breast Invasive Carcinoma,How often are concurrent somatic mutations in TNS1 and deletions in TTC12 observed in Breast Invasive Carcinoma?,cnv_and_ssm
+3,TNS1,G1718V,Breast Invasive Carcinoma,How often are concurrent somatic mutations in TNS1 and deletions in RELN observed in Breast Invasive Carcinoma?,cnv_and_ssm
+4,TNS1,G1732V,Breast Invasive Carcinoma,How often are concurrent somatic mutations in TNS1 and deletions in SYT10 observed in Breast Invasive Carcinoma?,cnv_and_ssm
+5,TNS1,G1824V,Breast Invasive Carcinoma,How often are concurrent somatic mutations in TNS1 and deletions in TENM2 observed in Breast Invasive Carcinoma?,cnv_and_ssm
+6,TNS1,G1857V,Breast Invasive Carcinoma,How often are concurrent somatic mutations in TNS1 and deletions in ZFAT observed in Breast Invasive Carcinoma?,cnv_and_ssm
+7,TNS1,G843V,Breast Invasive Carcinoma,How often are concurrent somatic mutations in TNS1 and deletions in GABRA6 observed in Breast Invasive Carcinoma?,cnv_and_ssm
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How often are concurrent somatic mutations in EVC2 and deletions in RAB40C observed in Bladder Urothelial Carcinoma?,cnv_and_ssm
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How often are concurrent somatic mutations in EVC2 and deletions in JAML observed in Bladder Urothelial Carcinoma?,cnv_and_ssm
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in CR1 and deletions in CCDC22 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in CR1 and deletions in PSG2 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+22,TRPA1,S295I,Rectum Adenocarcinoma,How often are concurrent somatic mutations in TRPA1 and deletions in CASZ1 observed in Rectum Adenocarcinoma?,cnv_and_ssm
+23,TRPA1,S443I,Rectum Adenocarcinoma,How often are concurrent somatic mutations in TRPA1 and deletions in DPF3 observed in Rectum Adenocarcinoma?,cnv_and_ssm
+24,TAF1C,R299L,Lung Adenocarcinoma,How often are concurrent somatic mutations in TAF1C and deletions in POLR1G observed in Lung Adenocarcinoma?,cnv_and_ssm
+25,TAF1C,R396L,Lung Adenocarcinoma,How often are concurrent somatic mutations in TAF1C and deletions in CARMIL1 observed in Lung Adenocarcinoma?,cnv_and_ssm
+26,TAF1C,R634L,Lung Adenocarcinoma,How often are concurrent somatic mutations in TAF1C and deletions in OR8K5 observed in Lung Adenocarcinoma?,cnv_and_ssm
+27,TAF1C,R702L,Lung Adenocarcinoma,How often are concurrent somatic mutations in TAF1C and deletions in TMEM255A observed in Lung Adenocarcinoma?,cnv_and_ssm
+28,TAF1C,R728L,Lung Adenocarcinoma,How often are concurrent somatic mutations in TAF1C and deletions in CDKN2AIP observed in Lung Adenocarcinoma?,cnv_and_ssm
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in DPF3 and deletions in ABCC2 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in DPF3 and deletions in MED16 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in DPF3 and deletions in TNS1 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+42,OR2T4,P272H,Lung Adenocarcinoma,How often are concurrent somatic mutations in OR2T4 and deletions in ACTB observed in Lung Adenocarcinoma?,cnv_and_ssm
+43,OR2T4,P300H,Lung Adenocarcinoma,How often are concurrent somatic mutations in OR2T4 and deletions in ADRA1A observed in Lung Adenocarcinoma?,cnv_and_ssm
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How often are concurrent somatic mutations in FBN1 and deletions in FNDC7 observed in Pancreatic Adenocarcinoma?,cnv_and_ssm
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How often are concurrent somatic mutations in MAD1L1 and deletions in TTN observed in Prostate Adenocarcinoma?,cnv_and_ssm
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How often are concurrent somatic mutations in MAD1L1 and deletions in GUK1 observed in Prostate Adenocarcinoma?,cnv_and_ssm
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How often are concurrent somatic mutations in MAD1L1 and deletions in SORCS1 observed in Prostate Adenocarcinoma?,cnv_and_ssm
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in CCNG1 and deletions in AUTS2 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How often are concurrent somatic mutations in ANP32E and deletions in PTPRO observed in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How often are concurrent somatic mutations in ANP32E and deletions in JAML observed in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How often are concurrent somatic mutations in ANP32E and deletions in DPF3 observed in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How often are concurrent somatic mutations in ANP32E and deletions in YY1AP1 observed in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How often are concurrent somatic mutations in FRY and deletions in PRSS8 observed in Bladder Urothelial Carcinoma?,cnv_and_ssm
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How often are concurrent somatic mutations in FRY and deletions in PAK3 observed in Bladder Urothelial Carcinoma?,cnv_and_ssm
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How often are concurrent somatic mutations in FRY and deletions in FNDC7 observed in Bladder Urothelial Carcinoma?,cnv_and_ssm
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How often are concurrent somatic mutations in FRY and deletions in CFAP61 observed in Bladder Urothelial Carcinoma?,cnv_and_ssm
+70,PAK3,E318K,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in PAK3 and deletions in BCAT1 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+71,PAK3,E319K,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in PAK3 and deletions in ANKRD30A observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+72,PAK3,E334K,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in PAK3 and deletions in PKHD1L1 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+73,PAK3,E340K,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in PAK3 and deletions in DCAF6 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+74,PAK3,E355K,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in PAK3 and deletions in IL5RA observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in MUC16 and deletions in DPF3 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How often are concurrent somatic mutations in ZFPM2 and deletions in TNS1 observed in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How often are concurrent somatic mutations in ZFPM2 and deletions in DPF3 observed in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How often are concurrent somatic mutations in PIK3C2B and deletions in HLA-DQA2 observed in Breast Invasive Carcinoma?,cnv_and_ssm
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How often are concurrent somatic mutations in PIK3C2B and deletions in PTPRO observed in Breast Invasive Carcinoma?,cnv_and_ssm
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How often are concurrent somatic mutations in ZNF804A and deletions in ACTB observed in Colon Adenocarcinoma?,cnv_and_ssm
+116,RELN,A2371V,Stomach Adenocarcinoma,How often are concurrent somatic mutations in RELN and deletions in ZCCHC14 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often are concurrent somatic mutations in EFCAB12 and deletions in RIMS2 observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often are concurrent somatic mutations in EFCAB12 and deletions in SGIP1 observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in DEFB115 and deletions in EIF2B4 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How often are concurrent somatic mutations in ANKDD1A and deletions in SPINDOC observed in Bladder Urothelial Carcinoma?,cnv_and_ssm
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How often are concurrent somatic mutations in ANKDD1A and deletions in PGR observed in Bladder Urothelial Carcinoma?,cnv_and_ssm
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How often are concurrent somatic mutations in ANKDD1A and deletions in EIF2B4 observed in Bladder Urothelial Carcinoma?,cnv_and_ssm
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in HTR3B and deletions in RIPOR2 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in HTR3B and deletions in TENM2 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in HTR3B and deletions in MYT1 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+129,ABCC3,R758W,Stomach Adenocarcinoma,How often are concurrent somatic mutations in ABCC3 and deletions in TTN observed in Stomach Adenocarcinoma?,cnv_and_ssm
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in NOMO1 and deletions in TTN observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in NOMO1 and deletions in CEP20 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How often are concurrent somatic mutations in HYOU1 and deletions in AUTS2 observed in Bladder Urothelial Carcinoma?,cnv_and_ssm
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in FMO4 and deletions in PXN observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+140,BICC1,A372V,Exceptional Responders,How often are concurrent somatic mutations in BICC1 and deletions in FBXO15 observed in Exceptional Responders?,cnv_and_ssm
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in ZMYM3 and deletions in JAML observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in ZMYM3 and deletions in KRT39 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in ZMYM3 and deletions in CTSC observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often are concurrent somatic mutations in XKR4 and deletions in MYO15A observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How often are concurrent somatic mutations in ABCC2 and deletions in FBN1 observed in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+157,OR8K5,R293G,Lung Adenocarcinoma,How often are concurrent somatic mutations in OR8K5 and deletions in TTYH2 observed in Lung Adenocarcinoma?,cnv_and_ssm
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in SPTAN1 and deletions in PLEKHG6 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in SPTAN1 and deletions in MRPL55 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+164,SYT10,M484I,Rectum Adenocarcinoma,How often are concurrent somatic mutations in SYT10 and deletions in RIPOR2 observed in Rectum Adenocarcinoma?,cnv_and_ssm
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in HSPA5 and deletions in NCKAP5 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+175,UNC5D,L280V,Lung Adenocarcinoma,How often are concurrent somatic mutations in UNC5D and deletions in ZKSCAN7 observed in Lung Adenocarcinoma?,cnv_and_ssm
+176,UNC5D,L635V,Lung Adenocarcinoma,How often are concurrent somatic mutations in UNC5D and deletions in FNDC7 observed in Lung Adenocarcinoma?,cnv_and_ssm
+177,UNC5D,L637V,Lung Adenocarcinoma,How often are concurrent somatic mutations in UNC5D and deletions in ZFPM2 observed in Lung Adenocarcinoma?,cnv_and_ssm
+178,UNC5D,L699V,Lung Adenocarcinoma,How often are concurrent somatic mutations in UNC5D and deletions in RIPOR2 observed in Lung Adenocarcinoma?,cnv_and_ssm
+179,UNC5D,L704V,Lung Adenocarcinoma,How often are concurrent somatic mutations in UNC5D and deletions in EIF2B4 observed in Lung Adenocarcinoma?,cnv_and_ssm
+180,UNC5D,L709V,Lung Adenocarcinoma,How often are concurrent somatic mutations in UNC5D and deletions in KDM5C observed in Lung Adenocarcinoma?,cnv_and_ssm
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How often are concurrent somatic mutations in DOCK2 and deletions in ACTB observed in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How often are concurrent somatic mutations in ZNF627 and deletions in TNS1 observed in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in CDC42BPA and deletions in PXN observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+193,MRPL55,H27Y,Colon Adenocarcinoma,How often are concurrent somatic mutations in MRPL55 and deletions in SYT9 observed in Colon Adenocarcinoma?,cnv_and_ssm
+194,MRPL55,H63Y,Colon Adenocarcinoma,How often are concurrent somatic mutations in MRPL55 and deletions in BFAR observed in Colon Adenocarcinoma?,cnv_and_ssm
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How often are concurrent somatic mutations in TMTC3 and deletions in ANP32E observed in Breast Invasive Carcinoma?,cnv_and_ssm
+198,EPRS1,K771I,Colon Adenocarcinoma,How often are concurrent somatic mutations in EPRS1 and deletions in SIK2 observed in Colon Adenocarcinoma?,cnv_and_ssm
+199,EPRS1,K778I,Colon Adenocarcinoma,How often are concurrent somatic mutations in EPRS1 and deletions in DNAH11 observed in Colon Adenocarcinoma?,cnv_and_ssm
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in GRTP1 and deletions in BCAT1 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in GRTP1 and deletions in AUTS2 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How often are concurrent somatic mutations in TSHZ3 and deletions in UNC5D observed in Stomach Adenocarcinoma?,cnv_and_ssm
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How often are concurrent somatic mutations in TAS1R3 and deletions in SLC9C1 observed in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,cnv_and_ssm
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in PIAS3 and deletions in CNGB1 observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in PIAS3 and deletions in TYK2 observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+251,ZNF274,P13R,Stomach Adenocarcinoma,How often are concurrent somatic mutations in ZNF274 and deletions in POC1B observed in Stomach Adenocarcinoma?,cnv_and_ssm
+253,SYNJ1,R795C,Colon Adenocarcinoma,How often are concurrent somatic mutations in SYNJ1 and deletions in COL6A3 observed in Colon Adenocarcinoma?,cnv_and_ssm
+254,SYNJ1,R800C,Colon Adenocarcinoma,How often are concurrent somatic mutations in SYNJ1 and deletions in ZFP42 observed in Colon Adenocarcinoma?,cnv_and_ssm
+255,SYNJ1,R839C,Colon Adenocarcinoma,How often are concurrent somatic mutations in SYNJ1 and deletions in TTYH2 observed in Colon Adenocarcinoma?,cnv_and_ssm
+261,DSCAM,V343M,Prostate Adenocarcinoma,How often are concurrent somatic mutations in DSCAM and deletions in SPTAN1 observed in Prostate Adenocarcinoma?,cnv_and_ssm
+262,DSCAM,V426M,Prostate Adenocarcinoma,How often are concurrent somatic mutations in DSCAM and deletions in PGR observed in Prostate Adenocarcinoma?,cnv_and_ssm
+263,DSCAM,V591M,Prostate Adenocarcinoma,How often are concurrent somatic mutations in DSCAM and deletions in COL6A3 observed in Prostate Adenocarcinoma?,cnv_and_ssm
+267,DGKD,R140H,Exceptional Responders,How often are concurrent somatic mutations in DGKD and deletions in COL6A3 observed in Exceptional Responders?,cnv_and_ssm
+268,DGKD,R160H,Exceptional Responders,How often are concurrent somatic mutations in DGKD and deletions in ARMC3 observed in Exceptional Responders?,cnv_and_ssm
+269,DGKD,R204H,Exceptional Responders,How often are concurrent somatic mutations in DGKD and deletions in ZKSCAN7 observed in Exceptional Responders?,cnv_and_ssm
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How often are concurrent somatic mutations in PLEKHG6 and deletions in HYOU1 observed in Bladder Urothelial Carcinoma?,cnv_and_ssm
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How often are concurrent somatic mutations in PLEKHG6 and deletions in TYK2 observed in Bladder Urothelial Carcinoma?,cnv_and_ssm
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How often are concurrent somatic mutations in PLEKHG6 and deletions in OR13C3 observed in Bladder Urothelial Carcinoma?,cnv_and_ssm
+279,WNT2,D138N,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in WNT2 and deletions in AUTS2 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in GUCY2C and deletions in FMO4 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in C7orf31 and deletions in TENM2 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often are concurrent somatic mutations in ZKSCAN7 and deletions in AUTS2 observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+299,OR5D14,M210L,Neuroblastoma,How often are concurrent somatic mutations in OR5D14 and deletions in ACTA2 observed in Neuroblastoma?,cnv_and_ssm
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in SPATA22 and deletions in ZFAT observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in SPATA22 and deletions in C7orf31 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in SPATA22 and deletions in DCC observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+310,LCN15,E21V,Stomach Adenocarcinoma,How often are concurrent somatic mutations in LCN15 and deletions in HTR3B observed in Stomach Adenocarcinoma?,cnv_and_ssm
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in DCAF4L2 and deletions in PGR observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in GUK1 and deletions in PTPRO observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in GUK1 and deletions in KDM5C observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in GUK1 and deletions in MORF4L1 observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in GUK1 and deletions in MYH11 observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in GUK1 and deletions in RIPOR2 observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How often are concurrent somatic mutations in MORF4L1 and deletions in TMEM255A observed in Stomach Adenocarcinoma?,cnv_and_ssm
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How often are concurrent somatic mutations in MORF4L1 and deletions in ZFAT observed in Stomach Adenocarcinoma?,cnv_and_ssm
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How often are concurrent somatic mutations in MORF4L1 and deletions in GIMAP2 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How often are concurrent somatic mutations in MORF4L1 and deletions in EIF2B4 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in MYO3B and deletions in CTSC observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in MYO3B and deletions in CTNNA2 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in TENT5A and deletions in NRAP observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in TENT5A and deletions in PRSS1 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in TENT5A and deletions in B3GALNT1 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How often are concurrent somatic mutations in ZFAT and deletions in ICE1 observed in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How often are concurrent somatic mutations in ZFAT and deletions in DGKD observed in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How often are concurrent somatic mutations in ZFAT and deletions in CTSC observed in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+357,ZNF584,A211T,Sarcoma,How often are concurrent somatic mutations in ZNF584 and deletions in TMTC3 observed in Sarcoma?,cnv_and_ssm
+358,ZNF584,A256T,Sarcoma,How often are concurrent somatic mutations in ZNF584 and deletions in ANKDD1A observed in Sarcoma?,cnv_and_ssm
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in LDOC1 and deletions in CTSC observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in PDGFC and deletions in SYNJ1 observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in MSANTD4 and deletions in JAML observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in NPSR1 and deletions in TYK2 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in PHLPP1 and deletions in HTR3B observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in COL6A3 and deletions in MAST4 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in COL6A3 and deletions in TASOR2 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in COL6A3 and deletions in JAML observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in COL6A3 and deletions in MORF4L1 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in COL6A3 and deletions in ACVR1B observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How often are concurrent somatic mutations in ADRA1A and deletions in CPA6 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often are concurrent somatic mutations in LAMB2 and deletions in MAOB observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+406,POC1B,I198T,Rectum Adenocarcinoma,How often are concurrent somatic mutations in POC1B and deletions in GSTCD observed in Rectum Adenocarcinoma?,cnv_and_ssm
+407,POC1B,I286T,Rectum Adenocarcinoma,How often are concurrent somatic mutations in POC1B and deletions in CPA6 observed in Rectum Adenocarcinoma?,cnv_and_ssm
+408,POC1B,I328T,Rectum Adenocarcinoma,How often are concurrent somatic mutations in POC1B and deletions in AUTS2 observed in Rectum Adenocarcinoma?,cnv_and_ssm
+409,POC1B,S79P,Rectum Adenocarcinoma,How often are concurrent somatic mutations in POC1B and deletions in TASOR2 observed in Rectum Adenocarcinoma?,cnv_and_ssm
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How often are concurrent somatic mutations in USH2A and deletions in FNDC7 observed in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+414,AQP7,T110S,Rectum Adenocarcinoma,How often are concurrent somatic mutations in AQP7 and deletions in FBXO42 observed in Rectum Adenocarcinoma?,cnv_and_ssm
+415,AQP7,T166S,Rectum Adenocarcinoma,How often are concurrent somatic mutations in AQP7 and deletions in TNS1 observed in Rectum Adenocarcinoma?,cnv_and_ssm
+416,AQP7,T167S,Rectum Adenocarcinoma,How often are concurrent somatic mutations in AQP7 and deletions in TTC17 observed in Rectum Adenocarcinoma?,cnv_and_ssm
+417,AQP7,T75S,Rectum Adenocarcinoma,How often are concurrent somatic mutations in AQP7 and deletions in PAK3 observed in Rectum Adenocarcinoma?,cnv_and_ssm
+430,DCN,R163C,Rectum Adenocarcinoma,How often are concurrent somatic mutations in DCN and deletions in CYB5R2 observed in Rectum Adenocarcinoma?,cnv_and_ssm
+431,DCN,R203C,Rectum Adenocarcinoma,How often are concurrent somatic mutations in DCN and deletions in TENT5A observed in Rectum Adenocarcinoma?,cnv_and_ssm
+432,DCN,R241C,Rectum Adenocarcinoma,How often are concurrent somatic mutations in DCN and deletions in STK19 observed in Rectum Adenocarcinoma?,cnv_and_ssm
+433,DCN,R350C,Rectum Adenocarcinoma,How often are concurrent somatic mutations in DCN and deletions in WNT2 observed in Rectum Adenocarcinoma?,cnv_and_ssm
+434,DCN,R41C,Rectum Adenocarcinoma,How often are concurrent somatic mutations in DCN and deletions in OR13C3 observed in Rectum Adenocarcinoma?,cnv_and_ssm
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in CPS1 and deletions in CASZ1 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in CPS1 and deletions in RIPOR2 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in CPS1 and deletions in MORF4L1 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How often are concurrent somatic mutations in FCGR2C and deletions in SORCS1 observed in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How often are concurrent somatic mutations in FCGR2C and deletions in PRSS8 observed in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in GRM1 and deletions in TET2 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+482,SGCZ,Q138H,Lung Adenocarcinoma,How often are concurrent somatic mutations in SGCZ and deletions in STAT3 observed in Lung Adenocarcinoma?,cnv_and_ssm
+483,SGCZ,Q91H,Lung Adenocarcinoma,How often are concurrent somatic mutations in SGCZ and deletions in ACTB observed in Lung Adenocarcinoma?,cnv_and_ssm
+485,SMO,V15M,Stomach Adenocarcinoma,How often are concurrent somatic mutations in SMO and deletions in TRIM45 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+486,SMO,V321M,Stomach Adenocarcinoma,How often are concurrent somatic mutations in SMO and deletions in CYB5R2 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+488,CHODL,G159E,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in CHODL and deletions in TTN observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+489,CHODL,G181E,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in CHODL and deletions in STAT3 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+490,CHODL,G200E,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in CHODL and deletions in MAOB observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+494,MYO16,P399H,Colon Adenocarcinoma,How often are concurrent somatic mutations in MYO16 and deletions in PRSS1 observed in Colon Adenocarcinoma?,cnv_and_ssm
+495,MYO16,P421H,Colon Adenocarcinoma,How often are concurrent somatic mutations in MYO16 and deletions in AUTS2 observed in Colon Adenocarcinoma?,cnv_and_ssm
+498,CXCR2,A98V,Stomach Adenocarcinoma,How often are concurrent somatic mutations in CXCR2 and deletions in PCDHB2 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How often are concurrent somatic mutations in TMEM225 and deletions in GUK1 observed in Bladder Urothelial Carcinoma?,cnv_and_ssm
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in MAOB and deletions in MERTK observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in GPRASP1 and deletions in SYNJ1 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in MRPL32 and deletions in CHODL observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in TYROBP and deletions in PIAS3 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+510,RAB40C,A111V,Lung Adenocarcinoma,How often are concurrent somatic mutations in RAB40C and deletions in SYT10 observed in Lung Adenocarcinoma?,cnv_and_ssm
+511,RAB40C,A143V,Lung Adenocarcinoma,How often are concurrent somatic mutations in RAB40C and deletions in CTNNA2 observed in Lung Adenocarcinoma?,cnv_and_ssm
+512,CTNNA2,S323R,Lung Adenocarcinoma,How often are concurrent somatic mutations in CTNNA2 and deletions in STK19 observed in Lung Adenocarcinoma?,cnv_and_ssm
+513,CTNNA2,S339R,Lung Adenocarcinoma,How often are concurrent somatic mutations in CTNNA2 and deletions in TRIM45 observed in Lung Adenocarcinoma?,cnv_and_ssm
+514,CTNNA2,S386R,Lung Adenocarcinoma,How often are concurrent somatic mutations in CTNNA2 and deletions in TASOR2 observed in Lung Adenocarcinoma?,cnv_and_ssm
+515,CTNNA2,S707R,Lung Adenocarcinoma,How often are concurrent somatic mutations in CTNNA2 and deletions in ARHGEF40 observed in Lung Adenocarcinoma?,cnv_and_ssm
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How often are concurrent somatic mutations in MYO15A and deletions in PTPRN2 observed in Bladder Urothelial Carcinoma?,cnv_and_ssm
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in GIMAP2 and deletions in TASOR2 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+532,KIF20B,N1160D,Glioblastoma Multiforme,How often are concurrent somatic mutations in KIF20B and deletions in MIEF1 observed in Glioblastoma Multiforme?,cnv_and_ssm
+533,KIF20B,N1200D,Glioblastoma Multiforme,How often are concurrent somatic mutations in KIF20B and deletions in MAD1L1 observed in Glioblastoma Multiforme?,cnv_and_ssm
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in ADAM17 and deletions in PXN observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in BCAT1 and deletions in GPR158 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in BCAT1 and deletions in UNC5D observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in BCAT1 and deletions in DCN observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+540,ERCC6,R1053H,Colon Adenocarcinoma,How often are concurrent somatic mutations in ERCC6 and deletions in MRPL55 observed in Colon Adenocarcinoma?,cnv_and_ssm
+541,DCC,R320W,Breast Invasive Carcinoma,How often are concurrent somatic mutations in DCC and deletions in DGKD observed in Breast Invasive Carcinoma?,cnv_and_ssm
+542,DCC,R363W,Breast Invasive Carcinoma,How often are concurrent somatic mutations in DCC and deletions in MYO3A observed in Breast Invasive Carcinoma?,cnv_and_ssm
+543,DCC,R386W,Breast Invasive Carcinoma,How often are concurrent somatic mutations in DCC and deletions in STAT3 observed in Breast Invasive Carcinoma?,cnv_and_ssm
+544,DCC,R41W,Breast Invasive Carcinoma,How often are concurrent somatic mutations in DCC and deletions in ZFP42 observed in Breast Invasive Carcinoma?,cnv_and_ssm
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in FBXO15 and deletions in UNC5D observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in FBXO15 and deletions in DCN observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in GSTCD and deletions in PCDHGA1 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in GSTCD and deletions in MAST4 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in OLFML3 and deletions in GPC3 observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in OLFML3 and deletions in DPF3 observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in OLFML3 and deletions in AQP7 observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How often are concurrent somatic mutations in CFAP61 and deletions in CYB5R2 observed in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How often are concurrent somatic mutations in CFAP61 and deletions in TASOR2 observed in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How often are concurrent somatic mutations in HLA-DQA2 and deletions in PRSS1 observed in Bladder Urothelial Carcinoma?,cnv_and_ssm
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in TENM2 and deletions in DSCAM observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in TENM2 and deletions in CDH23 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in TENM2 and deletions in HLA-DQA2 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How often are concurrent somatic mutations in ANKRD24 and deletions in ACTB observed in Stomach Adenocarcinoma?,cnv_and_ssm
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How often are concurrent somatic mutations in ANKRD24 and deletions in ZKSCAN7 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How often are concurrent somatic mutations in ANKRD24 and deletions in DOCK2 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How often are concurrent somatic mutations in ZCCHC14 and deletions in FGF8 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How often are concurrent somatic mutations in ZCCHC14 and deletions in STK19 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How often are concurrent somatic mutations in ZCCHC14 and deletions in ANKRD52 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How often are concurrent somatic mutations in ZCCHC14 and deletions in SORCS1 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+625,SIK2,I265M,Lung Adenocarcinoma,How often are concurrent somatic mutations in SIK2 and deletions in HTR3B observed in Lung Adenocarcinoma?,cnv_and_ssm
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in MYH11 and deletions in KIF20B observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in MYH11 and deletions in POLR1G observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in SLC6A4 and deletions in ERCC6 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in SLC9C1 and deletions in GUK1 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in SLC9C1 and deletions in DPF3 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+644,OR2A12,A254T,Brain Lower Grade Glioma,How often are concurrent somatic mutations in OR2A12 and deletions in ANP32E observed in Brain Lower Grade Glioma?,cnv_and_ssm
+646,PYHIN1,T325K,Lung Adenocarcinoma,How often are concurrent somatic mutations in PYHIN1 and deletions in ANP32E observed in Lung Adenocarcinoma?,cnv_and_ssm
+647,PYHIN1,T334K,Lung Adenocarcinoma,How often are concurrent somatic mutations in PYHIN1 and deletions in MERTK observed in Lung Adenocarcinoma?,cnv_and_ssm
+650,JAML,G191E,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in JAML and deletions in UNC5D observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+651,JAML,G219E,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in JAML and deletions in PTPRO observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+652,JAML,G220E,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in JAML and deletions in TRAP1 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+653,JAML,G230E,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in JAML and deletions in YY1AP1 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+658,TYK2,H1146R,Stomach Adenocarcinoma,How often are concurrent somatic mutations in TYK2 and deletions in PIK3C2B observed in Stomach Adenocarcinoma?,cnv_and_ssm
+659,TYK2,H23R,Stomach Adenocarcinoma,How often are concurrent somatic mutations in TYK2 and deletions in OLFML3 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+660,TYK2,H961R,Stomach Adenocarcinoma,How often are concurrent somatic mutations in TYK2 and deletions in PCDHB2 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in CTCFL and deletions in STAT3 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in CTCFL and deletions in ZNF217 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in CTCFL and deletions in TLCD5 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in CTCFL and deletions in MYT1 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in CEP20 and deletions in CDKN2AIP observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in CEP20 and deletions in FBXO15 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in RIMS2 and deletions in TYK2 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in RIMS2 and deletions in EPRS1 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in RIMS2 and deletions in ART3 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in RIMS2 and deletions in YY1AP1 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in RIMS2 and deletions in YY1AP1 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in RIMS2 and deletions in RAB40C observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in RIMS2 and deletions in ANP32E observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in PIK3C2G and deletions in OLFML3 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in PIK3C2G and deletions in PGR observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+728,STK19,D341N,Colon Adenocarcinoma,How often are concurrent somatic mutations in STK19 and deletions in HTR3B observed in Colon Adenocarcinoma?,cnv_and_ssm
+729,STK19,D345N,Colon Adenocarcinoma,How often are concurrent somatic mutations in STK19 and deletions in FGF8 observed in Colon Adenocarcinoma?,cnv_and_ssm
+730,REXO4,P60A,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in REXO4 and deletions in TASOR2 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in ZBTB34 and deletions in TLCD5 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in ZBTB34 and deletions in PXN observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How often are concurrent somatic mutations in NCKAP5 and deletions in ZFP42 observed in Bladder Urothelial Carcinoma?,cnv_and_ssm
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often are concurrent somatic mutations in SORCS1 and deletions in CTNNA2 observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often are concurrent somatic mutations in SORCS1 and deletions in DCLK3 observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often are concurrent somatic mutations in SORCS1 and deletions in TLK2 observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often are concurrent somatic mutations in SORCS1 and deletions in CCDC22 observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How often are concurrent somatic mutations in FGF8 and deletions in PRSS1 observed in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How often are concurrent somatic mutations in FGF8 and deletions in COL6A3 observed in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How often are concurrent somatic mutations in FGF8 and deletions in MERTK observed in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How often are concurrent somatic mutations in FGF8 and deletions in SGCZ observed in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How often are concurrent somatic mutations in FGF8 and deletions in ITPRID2 observed in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How often are concurrent somatic mutations in TENM3 and deletions in EIF2B4 observed in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,cnv_and_ssm
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in AKT1 and deletions in CTSC observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often are concurrent somatic mutations in CFAP298-TCP10L and deletions in NOMO1 observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+792,GLRB,E148D,Stomach Adenocarcinoma,How often are concurrent somatic mutations in GLRB and deletions in STAT3 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+793,TTN,F7636L,Colon Adenocarcinoma,How often are concurrent somatic mutations in TTN and deletions in TMEM255A observed in Colon Adenocarcinoma?,cnv_and_ssm
+794,TTN,F8563L,Colon Adenocarcinoma,How often are concurrent somatic mutations in TTN and deletions in CPS1 observed in Colon Adenocarcinoma?,cnv_and_ssm
+795,TTN,F8880L,Colon Adenocarcinoma,How often are concurrent somatic mutations in TTN and deletions in NPSR1 observed in Colon Adenocarcinoma?,cnv_and_ssm
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How often are concurrent somatic mutations in ANKRD30A and deletions in DCAF6 observed in Colon Adenocarcinoma?,cnv_and_ssm
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How often are concurrent somatic mutations in ANKRD30A and deletions in EIF2B4 observed in Colon Adenocarcinoma?,cnv_and_ssm
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How often are concurrent somatic mutations in ANKRD30A and deletions in ANKRD24 observed in Colon Adenocarcinoma?,cnv_and_ssm
+809,TRIM45,S177L,Colon Adenocarcinoma,How often are concurrent somatic mutations in TRIM45 and deletions in MYT1 observed in Colon Adenocarcinoma?,cnv_and_ssm
+810,TRIM45,S224L,Colon Adenocarcinoma,How often are concurrent somatic mutations in TRIM45 and deletions in PCDHB2 observed in Colon Adenocarcinoma?,cnv_and_ssm
+811,TRIM45,S281L,Colon Adenocarcinoma,How often are concurrent somatic mutations in TRIM45 and deletions in CHODL observed in Colon Adenocarcinoma?,cnv_and_ssm
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How often are concurrent somatic mutations in CACNA1F and deletions in TRPA1 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How often are concurrent somatic mutations in CACNA1F and deletions in PRSS1 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How often are concurrent somatic mutations in CACNA1F and deletions in TNS1 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+817,KL,R594C,Colon Adenocarcinoma,How often are concurrent somatic mutations in KL and deletions in SYNJ1 observed in Colon Adenocarcinoma?,cnv_and_ssm
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How often are concurrent somatic mutations in GUF1 and deletions in RIMS2 observed in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+822,TAF1L,A539V,Colon Adenocarcinoma,How often are concurrent somatic mutations in TAF1L and deletions in OR8K5 observed in Colon Adenocarcinoma?,cnv_and_ssm
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in TASOR2 and deletions in PYHIN1 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in TASOR2 and deletions in DOCK2 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in TASOR2 and deletions in ZNF217 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in KDM5C and deletions in KDM5C observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in KDM5C and deletions in SPATA22 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in KDM5C and deletions in SYT9 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in KDM5C and deletions in SYNJ1 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often are concurrent somatic mutations in IL5RA and deletions in TAS1R3 observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+843,DHX16,A29V,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in DHX16 and deletions in FNDC7 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+844,DHX16,A89V,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in DHX16 and deletions in RIMS2 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+902,GPR158,A644V,Stomach Adenocarcinoma,How often are concurrent somatic mutations in GPR158 and deletions in SGIP1 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+903,GPR158,A723V,Stomach Adenocarcinoma,How often are concurrent somatic mutations in GPR158 and deletions in SYNJ1 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often are concurrent somatic mutations in EIF2B4 and deletions in ANP32E observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often are concurrent somatic mutations in EIF2B4 and deletions in DCN observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often are concurrent somatic mutations in EIF2B4 and deletions in ZKSCAN7 observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often are concurrent somatic mutations in EIF2B4 and deletions in PXN observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often are concurrent somatic mutations in EIF2B4 and deletions in ADAM17 observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often are concurrent somatic mutations in EIF2B4 and deletions in SGCZ observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in AUTS2 and deletions in KIF20B observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in AUTS2 and deletions in CEP20 observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in AUTS2 and deletions in DSCAM observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in AUTS2 and deletions in CASZ1 observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in AUTS2 and deletions in SYT9 observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in AUTS2 and deletions in SORCS1 observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in AUTS2 and deletions in PXN observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in AUTS2 and deletions in DNAH14 observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in AUTS2 and deletions in TLK2 observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in AUTS2 and deletions in TMTC3 observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often are concurrent somatic mutations in ACTL7B and deletions in MAST4 observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How often are concurrent somatic mutations in PCDHGA1 and deletions in DGKD observed in Glioblastoma Multiforme?,cnv_and_ssm
+954,TRAP1,R114W,Stomach Adenocarcinoma,How often are concurrent somatic mutations in TRAP1 and deletions in FBXO15 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+955,TRAP1,R61W,Stomach Adenocarcinoma,How often are concurrent somatic mutations in TRAP1 and deletions in ZCCHC14 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in PIK3C2A and deletions in SPATA22 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How often are concurrent somatic mutations in KANSL1 and deletions in RAB40C observed in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How often are concurrent somatic mutations in ANKRD52 and deletions in TNS1 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in PAPPA and deletions in CCDC22 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How often are concurrent somatic mutations in B3GALNT1 and deletions in TLK2 observed in Rectum Adenocarcinoma?,cnv_and_ssm
+982,GABRA6,G115R,Lung Adenocarcinoma,How often are concurrent somatic mutations in GABRA6 and deletions in CYP1A2 observed in Lung Adenocarcinoma?,cnv_and_ssm
+983,GABRA6,G122R,Lung Adenocarcinoma,How often are concurrent somatic mutations in GABRA6 and deletions in TNS1 observed in Lung Adenocarcinoma?,cnv_and_ssm
+984,GABRA6,G165R,Lung Adenocarcinoma,How often are concurrent somatic mutations in GABRA6 and deletions in PGR observed in Lung Adenocarcinoma?,cnv_and_ssm
+985,GABRA6,G175R,Lung Adenocarcinoma,How often are concurrent somatic mutations in GABRA6 and deletions in MAST4 observed in Lung Adenocarcinoma?,cnv_and_ssm
+986,GABRA6,G70R,Lung Adenocarcinoma,How often are concurrent somatic mutations in GABRA6 and deletions in ARMC3 observed in Lung Adenocarcinoma?,cnv_and_ssm
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in ZSCAN31 and deletions in POLD1 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often are concurrent somatic mutations in MED16 and deletions in CTCFL observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often are concurrent somatic mutations in MED16 and deletions in YY1AP1 observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How often are concurrent somatic mutations in PTPRO and deletions in OR5D14 observed in Pancreatic Adenocarcinoma?,cnv_and_ssm
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How often are concurrent somatic mutations in PTPRO and deletions in MAD1L1 observed in Pancreatic Adenocarcinoma?,cnv_and_ssm
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How often are concurrent somatic mutations in PTPRO and deletions in PAK3 observed in Pancreatic Adenocarcinoma?,cnv_and_ssm
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How often are concurrent somatic mutations in PTPRO and deletions in DGKD observed in Pancreatic Adenocarcinoma?,cnv_and_ssm
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How often are concurrent somatic mutations in PTPRO and deletions in GABRA6 observed in Pancreatic Adenocarcinoma?,cnv_and_ssm
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How often are concurrent somatic mutations in PTPRO and deletions in EVC2 observed in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How often are concurrent somatic mutations in PTPRO and deletions in PAK3 observed in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How often are concurrent somatic mutations in PTPRO and deletions in RIMS2 observed in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in CHMP7 and deletions in POC1B observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1017,GPC3,I107N,Stomach Adenocarcinoma,How often are concurrent somatic mutations in GPC3 and deletions in TLK2 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+1018,GPC3,I161N,Stomach Adenocarcinoma,How often are concurrent somatic mutations in GPC3 and deletions in TNS1 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often are concurrent somatic mutations in TLK2 and deletions in TLK2 observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often are concurrent somatic mutations in TLK2 and deletions in SPTAN1 observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often are concurrent somatic mutations in TLK2 and deletions in KIF20B observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often are concurrent somatic mutations in TLK2 and deletions in TMTC3 observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How often are concurrent somatic mutations in TLK2 and deletions in CTNNA2 observed in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How often are concurrent somatic mutations in ZNF217 and deletions in MYO3A observed in Lung Adenocarcinoma?,cnv_and_ssm
+1038,SYT9,V275L,Lung Adenocarcinoma,How often are concurrent somatic mutations in SYT9 and deletions in EFCAB12 observed in Lung Adenocarcinoma?,cnv_and_ssm
+1039,SYT9,V307L,Lung Adenocarcinoma,How often are concurrent somatic mutations in SYT9 and deletions in ZNF584 observed in Lung Adenocarcinoma?,cnv_and_ssm
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in PKHD1L1 and deletions in CFAP61 observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in MYO3A and deletions in GUK1 observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often are concurrent somatic mutations in VASN and deletions in OR8K5 observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in DNMT1 and deletions in TLCD5 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in DNMT1 and deletions in TRPA1 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in DNMT1 and deletions in MAST4 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1056,CA9,E402K,Colon Adenocarcinoma,How often are concurrent somatic mutations in CA9 and deletions in GABRA6 observed in Colon Adenocarcinoma?,cnv_and_ssm
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in TTC17 and deletions in SPTAN1 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in TTC17 and deletions in TTC12 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1065,PSG2,P43L,Breast Invasive Carcinoma,How often are concurrent somatic mutations in PSG2 and deletions in ANKRD24 observed in Breast Invasive Carcinoma?,cnv_and_ssm
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How often are concurrent somatic mutations in RIPOR2 and deletions in TET2 observed in Breast Invasive Carcinoma?,cnv_and_ssm
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How often are concurrent somatic mutations in RIPOR2 and deletions in THBS4 observed in Breast Invasive Carcinoma?,cnv_and_ssm
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How often are concurrent somatic mutations in RIPOR2 and deletions in SORCS1 observed in Breast Invasive Carcinoma?,cnv_and_ssm
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How often are concurrent somatic mutations in RIPOR2 and deletions in ANKDD1A observed in Breast Invasive Carcinoma?,cnv_and_ssm
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in DCLK3 and deletions in AUTS2 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in DCLK3 and deletions in RIPOR2 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in MERTK and deletions in SYT9 observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in MERTK and deletions in NRAP observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in MERTK and deletions in PGR observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in ZFP42 and deletions in PGR observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in OR13C3 and deletions in CX3CR1 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in OR13C3 and deletions in FGF8 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How often are concurrent somatic mutations in SPAG1 and deletions in C7orf31 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in CDKN2AIP and deletions in DCLK3 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1093,PXN,H1016Y,Colon Adenocarcinoma,How often are concurrent somatic mutations in PXN and deletions in CTSC observed in Colon Adenocarcinoma?,cnv_and_ssm
+1094,PXN,H359Y,Colon Adenocarcinoma,How often are concurrent somatic mutations in PXN and deletions in UNC5D observed in Colon Adenocarcinoma?,cnv_and_ssm
+1095,PXN,H492Y,Colon Adenocarcinoma,How often are concurrent somatic mutations in PXN and deletions in GUK1 observed in Colon Adenocarcinoma?,cnv_and_ssm
+1096,PXN,H524Y,Colon Adenocarcinoma,How often are concurrent somatic mutations in PXN and deletions in ANP32E observed in Colon Adenocarcinoma?,cnv_and_ssm
+1097,PXN,H526Y,Colon Adenocarcinoma,How often are concurrent somatic mutations in PXN and deletions in YY1AP1 observed in Colon Adenocarcinoma?,cnv_and_ssm
+1098,PXN,H540Y,Colon Adenocarcinoma,How often are concurrent somatic mutations in PXN and deletions in RIMS2 observed in Colon Adenocarcinoma?,cnv_and_ssm
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in TTYH2 and deletions in TAS1R3 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in TTYH2 and deletions in GSTCD observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How often are concurrent somatic mutations in TMEM255A and deletions in CTNNA2 observed in Colon Adenocarcinoma?,cnv_and_ssm
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How often are concurrent somatic mutations in TMEM255A and deletions in PLEKHG6 observed in Colon Adenocarcinoma?,cnv_and_ssm
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How often are concurrent somatic mutations in TMEM255A and deletions in SIK2 observed in Colon Adenocarcinoma?,cnv_and_ssm
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How often are concurrent somatic mutations in TASOR2 and deletions in TMEM225 observed in Breast Invasive Carcinoma?,cnv_and_ssm
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How often are concurrent somatic mutations in TASOR2 and deletions in TTYH2 observed in Breast Invasive Carcinoma?,cnv_and_ssm
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in ICE1 and deletions in PTPRO observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1112,MYT1,A558E,Breast Invasive Carcinoma,How often are concurrent somatic mutations in MYT1 and deletions in DSCAM observed in Breast Invasive Carcinoma?,cnv_and_ssm
+1113,MYT1,A879E,Breast Invasive Carcinoma,How often are concurrent somatic mutations in MYT1 and deletions in MRPL55 observed in Breast Invasive Carcinoma?,cnv_and_ssm
+1114,MYT1,A906E,Breast Invasive Carcinoma,How often are concurrent somatic mutations in MYT1 and deletions in PGR observed in Breast Invasive Carcinoma?,cnv_and_ssm
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in CX3CR1 and deletions in AQP7 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in CX3CR1 and deletions in FBXO42 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How often are concurrent somatic mutations in SPINDOC and deletions in TYK2 observed in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in ART3 and deletions in ANP32E observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in ART3 and deletions in PHLPP1 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How often are concurrent somatic mutations in CYP1A2 and deletions in GUF1 observed in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often are concurrent somatic mutations in ADRA1A and deletions in MORF4L1 observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in CDH23 and deletions in CTCFL observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in CDH23 and deletions in PCDHB2 observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in KRT39 and deletions in MYT1 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in PDHA2 and deletions in FGF8 observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How often are concurrent somatic mutations in SLC24A2 and deletions in MAST4 observed in Colon Adenocarcinoma?,cnv_and_ssm
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How often are concurrent somatic mutations in PTPRN2 and deletions in ERCC6 observed in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How often are concurrent somatic mutations in PTPRN2 and deletions in MED16 observed in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How often are concurrent somatic mutations in PTPRN2 and deletions in ANKRD52 observed in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How often are concurrent somatic mutations in PTPRN2 and deletions in OR5D14 observed in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How often are concurrent somatic mutations in PTPRN2 and deletions in CPA6 observed in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1188,SOX21,R55L,Lung Adenocarcinoma,How often are concurrent somatic mutations in SOX21 and deletions in MYH11 observed in Lung Adenocarcinoma?,cnv_and_ssm
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How often are concurrent somatic mutations in CPA6 and deletions in SORCS1 observed in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in GRM5 and deletions in ANKRD24 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often are concurrent somatic mutations in CASZ1 and deletions in PIAS3 observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How often are concurrent somatic mutations in SGIP1 and deletions in SLC9C1 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How often are concurrent somatic mutations in SGIP1 and deletions in SPINDOC observed in Stomach Adenocarcinoma?,cnv_and_ssm
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How often are concurrent somatic mutations in SGIP1 and deletions in AKT1 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How often are concurrent somatic mutations in SGIP1 and deletions in SLC24A2 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How often are concurrent somatic mutations in CARMIL1 and deletions in ZBTB34 observed in Lung Adenocarcinoma?,cnv_and_ssm
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How often are concurrent somatic mutations in CARMIL1 and deletions in ACVR1B observed in Lung Adenocarcinoma?,cnv_and_ssm
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How often are concurrent somatic mutations in ZNF431 and deletions in MRPL32 observed in Lung Adenocarcinoma?,cnv_and_ssm
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How often are concurrent somatic mutations in ZNF431 and deletions in ZNF708 observed in Lung Adenocarcinoma?,cnv_and_ssm
+1234,ZNF431,R128I,Lung Adenocarcinoma,How often are concurrent somatic mutations in ZNF431 and deletions in TTC17 observed in Lung Adenocarcinoma?,cnv_and_ssm
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in DNAH11 and deletions in ACTB observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in DNAH11 and deletions in PXN observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in POLD1 and deletions in CTSC observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How often are concurrent somatic mutations in POLD1 and deletions in NOMO1 observed in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1248,TTC12,D646H,Lung Adenocarcinoma,How often are concurrent somatic mutations in TTC12 and deletions in UNC5D observed in Lung Adenocarcinoma?,cnv_and_ssm
+1249,TTC12,D652H,Lung Adenocarcinoma,How often are concurrent somatic mutations in TTC12 and deletions in SYNJ1 observed in Lung Adenocarcinoma?,cnv_and_ssm
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How often are concurrent somatic mutations in CNGB1 and deletions in SGIP1 observed in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How often are concurrent somatic mutations in CNGB1 and deletions in DGKD observed in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1254,CTSC,E214V,Stomach Adenocarcinoma,How often are concurrent somatic mutations in CTSC and deletions in DNMT1 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+1255,CTSC,E291V,Stomach Adenocarcinoma,How often are concurrent somatic mutations in CTSC and deletions in EIF2B4 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+1256,CTSC,E322V,Stomach Adenocarcinoma,How often are concurrent somatic mutations in CTSC and deletions in AQP7 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+1257,CTSC,E324V,Stomach Adenocarcinoma,How often are concurrent somatic mutations in CTSC and deletions in RIPOR2 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+1258,CTSC,E335V,Stomach Adenocarcinoma,How often are concurrent somatic mutations in CTSC and deletions in GLRB observed in Stomach Adenocarcinoma?,cnv_and_ssm
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in PRSS8 and deletions in TASOR2 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in PRSS8 and deletions in AQP7 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How often are concurrent somatic mutations in ARHGEF40 and deletions in GRM5 observed in Lung Adenocarcinoma?,cnv_and_ssm
+1264,ACTB,A138T,Rectum Adenocarcinoma,How often are concurrent somatic mutations in ACTB and deletions in TENM2 observed in Rectum Adenocarcinoma?,cnv_and_ssm
+1265,ACTB,A217T,Rectum Adenocarcinoma,How often are concurrent somatic mutations in ACTB and deletions in SYNJ1 observed in Rectum Adenocarcinoma?,cnv_and_ssm
+1266,ACTB,A244T,Rectum Adenocarcinoma,How often are concurrent somatic mutations in ACTB and deletions in TRPA1 observed in Rectum Adenocarcinoma?,cnv_and_ssm
+1267,ACTB,A260T,Rectum Adenocarcinoma,How often are concurrent somatic mutations in ACTB and deletions in DNAH11 observed in Rectum Adenocarcinoma?,cnv_and_ssm
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How often are concurrent somatic mutations in YY1AP1 and deletions in WNT2 observed in Glioblastoma Multiforme?,cnv_and_ssm
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How often are concurrent somatic mutations in YY1AP1 and deletions in ZFP42 observed in Glioblastoma Multiforme?,cnv_and_ssm
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How often are concurrent somatic mutations in YY1AP1 and deletions in HLA-DQA2 observed in Glioblastoma Multiforme?,cnv_and_ssm
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How often are concurrent somatic mutations in YY1AP1 and deletions in ART3 observed in Glioblastoma Multiforme?,cnv_and_ssm
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How often are concurrent somatic mutations in YY1AP1 and deletions in KDM5C observed in Glioblastoma Multiforme?,cnv_and_ssm
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How often are concurrent somatic mutations in YY1AP1 and deletions in FGF8 observed in Glioblastoma Multiforme?,cnv_and_ssm
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How often are concurrent somatic mutations in YY1AP1 and deletions in MAD1L1 observed in Glioblastoma Multiforme?,cnv_and_ssm
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in FNDC7 and deletions in CACNA1F observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in FNDC7 and deletions in ICE1 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+1299,TLCD5,G15V,Lung Adenocarcinoma,How often are concurrent somatic mutations in TLCD5 and deletions in ANP32E observed in Lung Adenocarcinoma?,cnv_and_ssm
+1300,TLCD5,G37V,Lung Adenocarcinoma,How often are concurrent somatic mutations in TLCD5 and deletions in CTNNA2 observed in Lung Adenocarcinoma?,cnv_and_ssm
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in POLR1G and deletions in LCN15 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in POLR1G and deletions in PKHD1L1 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How often are concurrent somatic mutations in DNAH14 and deletions in GRM5 observed in Colon Adenocarcinoma?,cnv_and_ssm
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How often are concurrent somatic mutations in DNAH14 and deletions in TAF1C observed in Colon Adenocarcinoma?,cnv_and_ssm
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How often are concurrent somatic mutations in DNAH14 and deletions in DNAH14 observed in Colon Adenocarcinoma?,cnv_and_ssm
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in NEXN and deletions in TMTC3 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How often are concurrent somatic mutations in CYB5R2 and deletions in B3GALNT1 observed in Prostate Adenocarcinoma?,cnv_and_ssm
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How often are concurrent somatic mutations in CYB5R2 and deletions in REXO4 observed in Prostate Adenocarcinoma?,cnv_and_ssm
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in NRAP and deletions in ANKRD52 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in NRAP and deletions in CCNG1 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in NRAP and deletions in TAF1C observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in CCDC22 and deletions in AUTS2 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in DCAF6 and deletions in MSANTD4 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in DCAF6 and deletions in HBB observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in ZNF708 and deletions in IL5RA observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in BFAR and deletions in GABRA6 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in MAST4 and deletions in ZCCHC14 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in MAST4 and deletions in UNC5D observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in MAST4 and deletions in TTYH2 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in MAST4 and deletions in SYT9 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in MAST4 and deletions in SLC9C1 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How often are concurrent somatic mutations in ARMC3 and deletions in HLA-DQA2 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How often are concurrent somatic mutations in ARMC3 and deletions in PGR observed in Stomach Adenocarcinoma?,cnv_and_ssm
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How often are concurrent somatic mutations in TET2 and deletions in ZFP42 observed in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How often are concurrent somatic mutations in TET2 and deletions in NOMO1 observed in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How often are concurrent somatic mutations in SERPINB10 and deletions in PRSS1 observed in Lung Adenocarcinoma?,cnv_and_ssm
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in STAT3 and deletions in RAB40C observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in MIEF1 and deletions in BCAT1 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How often are concurrent somatic mutations in ACVR1B and deletions in EIF2B4 observed in Colon Adenocarcinoma?,cnv_and_ssm
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How often are concurrent somatic mutations in ACVR1B and deletions in TENM3 observed in Colon Adenocarcinoma?,cnv_and_ssm
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How often are concurrent somatic mutations in ACVR1B and deletions in OR13C3 observed in Colon Adenocarcinoma?,cnv_and_ssm
+1393,EBF2,T104I,Stomach Adenocarcinoma,How often are concurrent somatic mutations in EBF2 and deletions in TTC17 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+1394,EBF2,T252I,Stomach Adenocarcinoma,How often are concurrent somatic mutations in EBF2 and deletions in ARMC3 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How often are concurrent somatic mutations in VPS26B and deletions in AUTS2 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often are concurrent somatic mutations in PGR and deletions in SMO observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often are concurrent somatic mutations in PGR and deletions in OR2A12 observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How often are concurrent somatic mutations in PGR and deletions in PAK3 observed in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How often are concurrent somatic mutations in ACTA2 and deletions in ANKRD52 observed in Skin Cutaneous Melanoma?,cnv_and_ssm
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in THBS4 and deletions in PTPRN2 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in THBS4 and deletions in DGKD observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1413,PRSS1,S114T,Lung Adenocarcinoma,How often are concurrent somatic mutations in PRSS1 and deletions in EPRS1 observed in Lung Adenocarcinoma?,cnv_and_ssm
+1414,PRSS1,S124T,Lung Adenocarcinoma,How often are concurrent somatic mutations in PRSS1 and deletions in CNGB1 observed in Lung Adenocarcinoma?,cnv_and_ssm
+1415,PRSS1,S138T,Lung Adenocarcinoma,How often are concurrent somatic mutations in PRSS1 and deletions in ZNF584 observed in Lung Adenocarcinoma?,cnv_and_ssm
+1416,PRSS1,S74T,Lung Adenocarcinoma,How often are concurrent somatic mutations in PRSS1 and deletions in PGR observed in Lung Adenocarcinoma?,cnv_and_ssm
+1417,PGF,R126H,Stomach Adenocarcinoma,How often are concurrent somatic mutations in PGF and deletions in FRY observed in Stomach Adenocarcinoma?,cnv_and_ssm
+1418,PGF,R127H,Stomach Adenocarcinoma,How often are concurrent somatic mutations in PGF and deletions in AUTS2 observed in Stomach Adenocarcinoma?,cnv_and_ssm
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How often are concurrent somatic mutations in ITPRID2 and deletions in TNS1 observed in Breast Invasive Carcinoma?,cnv_and_ssm
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How often are concurrent somatic mutations in ITPRID2 and deletions in OLFML3 observed in Breast Invasive Carcinoma?,cnv_and_ssm
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in HBB and deletions in RIPOR2 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How often are concurrent somatic mutations in PCDHB2 and deletions in EIF2B4 observed in Colon Adenocarcinoma?,cnv_and_ssm
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How often are concurrent somatic mutations in PCDHB2 and deletions in YY1AP1 observed in Colon Adenocarcinoma?,cnv_and_ssm
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How often are concurrent somatic mutations in PCDHB2 and deletions in TAS1R3 observed in Colon Adenocarcinoma?,cnv_and_ssm
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How often are concurrent somatic mutations in UBR2 and deletions in DNMT1 observed in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How often are concurrent somatic mutations in FBXO42 and deletions in PAK3 observed in Rectum Adenocarcinoma?,cnv_and_ssm
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the proportion of Breast Invasive Carcinoma cases with both TNS1 mutations and UNC5D amplifications?,cnv_and_ssm
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the proportion of Breast Invasive Carcinoma cases with both TNS1 mutations and CXCR2 amplifications?,cnv_and_ssm
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the proportion of Breast Invasive Carcinoma cases with both TNS1 mutations and DCC amplifications?,cnv_and_ssm
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the proportion of Breast Invasive Carcinoma cases with both TNS1 mutations and CPS1 amplifications?,cnv_and_ssm
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the proportion of Breast Invasive Carcinoma cases with both TNS1 mutations and MYT1 amplifications?,cnv_and_ssm
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the proportion of Breast Invasive Carcinoma cases with both TNS1 mutations and FRY amplifications?,cnv_and_ssm
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the proportion of Breast Invasive Carcinoma cases with both TNS1 mutations and KIF20B amplifications?,cnv_and_ssm
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the proportion of Bladder Urothelial Carcinoma cases with both EVC2 mutations and MERTK amplifications?,cnv_and_ssm
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the proportion of Bladder Urothelial Carcinoma cases with both EVC2 mutations and VPS26B amplifications?,cnv_and_ssm
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both CR1 mutations and TAF1C amplifications?,cnv_and_ssm
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both CR1 mutations and ANKRD30A amplifications?,cnv_and_ssm
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the proportion of Rectum Adenocarcinoma cases with both TRPA1 mutations and OLFML3 amplifications?,cnv_and_ssm
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the proportion of Rectum Adenocarcinoma cases with both TRPA1 mutations and AUTS2 amplifications?,cnv_and_ssm
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both TAF1C mutations and RIPOR2 amplifications?,cnv_and_ssm
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both TAF1C mutations and SERPINB10 amplifications?,cnv_and_ssm
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both TAF1C mutations and EBF2 amplifications?,cnv_and_ssm
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both TAF1C mutations and SPATA22 amplifications?,cnv_and_ssm
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both TAF1C mutations and DPF3 amplifications?,cnv_and_ssm
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both DPF3 mutations and JAML amplifications?,cnv_and_ssm
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both DPF3 mutations and CYP1A2 amplifications?,cnv_and_ssm
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both DPF3 mutations and ZCCHC14 amplifications?,cnv_and_ssm
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both OR2T4 mutations and MYO16 amplifications?,cnv_and_ssm
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both OR2T4 mutations and TLCD5 amplifications?,cnv_and_ssm
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the proportion of Pancreatic Adenocarcinoma cases with both FBN1 mutations and DPF3 amplifications?,cnv_and_ssm
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the proportion of Prostate Adenocarcinoma cases with both MAD1L1 mutations and CX3CR1 amplifications?,cnv_and_ssm
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the proportion of Prostate Adenocarcinoma cases with both MAD1L1 mutations and KIF20B amplifications?,cnv_and_ssm
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the proportion of Prostate Adenocarcinoma cases with both MAD1L1 mutations and DCN amplifications?,cnv_and_ssm
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both CCNG1 mutations and CARMIL1 amplifications?,cnv_and_ssm
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the proportion of Kidney Renal Papillary Cell Carcinoma cases with both ANP32E mutations and TRPA1 amplifications?,cnv_and_ssm
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the proportion of Kidney Renal Papillary Cell Carcinoma cases with both ANP32E mutations and TENM3 amplifications?,cnv_and_ssm
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the proportion of Kidney Renal Papillary Cell Carcinoma cases with both ANP32E mutations and EVC2 amplifications?,cnv_and_ssm
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the proportion of Kidney Renal Papillary Cell Carcinoma cases with both ANP32E mutations and DCN amplifications?,cnv_and_ssm
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the proportion of Bladder Urothelial Carcinoma cases with both FRY mutations and ANKRD24 amplifications?,cnv_and_ssm
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the proportion of Bladder Urothelial Carcinoma cases with both FRY mutations and FBN1 amplifications?,cnv_and_ssm
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the proportion of Bladder Urothelial Carcinoma cases with both FRY mutations and EBF2 amplifications?,cnv_and_ssm
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the proportion of Bladder Urothelial Carcinoma cases with both FRY mutations and PYHIN1 amplifications?,cnv_and_ssm
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both PAK3 mutations and DCN amplifications?,cnv_and_ssm
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both PAK3 mutations and AUTS2 amplifications?,cnv_and_ssm
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both PAK3 mutations and TTC17 amplifications?,cnv_and_ssm
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both PAK3 mutations and CPS1 amplifications?,cnv_and_ssm
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both PAK3 mutations and TMEM255A amplifications?,cnv_and_ssm
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both MUC16 mutations and SPINDOC amplifications?,cnv_and_ssm
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the proportion of Liver Hepatocellular Carcinoma cases with both ZFPM2 mutations and PRSS8 amplifications?,cnv_and_ssm
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the proportion of Liver Hepatocellular Carcinoma cases with both ZFPM2 mutations and TET2 amplifications?,cnv_and_ssm
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the proportion of Breast Invasive Carcinoma cases with both PIK3C2B mutations and HBB amplifications?,cnv_and_ssm
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the proportion of Breast Invasive Carcinoma cases with both PIK3C2B mutations and ANKRD24 amplifications?,cnv_and_ssm
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both ZNF804A mutations and PXN amplifications?,cnv_and_ssm
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both RELN mutations and DHX16 amplifications?,cnv_and_ssm
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases with both EFCAB12 mutations and ZMYM3 amplifications?",cnv_and_ssm
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases with both EFCAB12 mutations and PYHIN1 amplifications?",cnv_and_ssm
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both DEFB115 mutations and FGF8 amplifications?,cnv_and_ssm
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the proportion of Bladder Urothelial Carcinoma cases with both ANKDD1A mutations and RAB40C amplifications?,cnv_and_ssm
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the proportion of Bladder Urothelial Carcinoma cases with both ANKDD1A mutations and FBXO15 amplifications?,cnv_and_ssm
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the proportion of Bladder Urothelial Carcinoma cases with both ANKDD1A mutations and NRAP amplifications?,cnv_and_ssm
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both HTR3B mutations and STK19 amplifications?,cnv_and_ssm
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both HTR3B mutations and CARMIL1 amplifications?,cnv_and_ssm
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both HTR3B mutations and PXN amplifications?,cnv_and_ssm
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both ABCC3 mutations and CR1 amplifications?,cnv_and_ssm
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both NOMO1 mutations and PIK3C2A amplifications?,cnv_and_ssm
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both NOMO1 mutations and TYROBP amplifications?,cnv_and_ssm
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the proportion of Bladder Urothelial Carcinoma cases with both HYOU1 mutations and CHODL amplifications?,cnv_and_ssm
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both FMO4 mutations and PIK3C2B amplifications?,cnv_and_ssm
+140,BICC1,A372V,Exceptional Responders,What is the proportion of Exceptional Responders cases with both BICC1 mutations and DCN amplifications?,cnv_and_ssm
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both ZMYM3 mutations and CCNG1 amplifications?,cnv_and_ssm
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both ZMYM3 mutations and RIPOR2 amplifications?,cnv_and_ssm
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both ZMYM3 mutations and PTPRO amplifications?,cnv_and_ssm
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases with both XKR4 mutations and ZMYM3 amplifications?",cnv_and_ssm
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the proportion of Liver Hepatocellular Carcinoma cases with both ABCC2 mutations and SGIP1 amplifications?,cnv_and_ssm
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both OR8K5 mutations and DPF3 amplifications?,cnv_and_ssm
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both SPTAN1 mutations and CPS1 amplifications?,cnv_and_ssm
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both SPTAN1 mutations and MORF4L1 amplifications?,cnv_and_ssm
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the proportion of Rectum Adenocarcinoma cases with both SYT10 mutations and BFAR amplifications?,cnv_and_ssm
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both HSPA5 mutations and COL6A3 amplifications?,cnv_and_ssm
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both UNC5D mutations and CR1 amplifications?,cnv_and_ssm
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both UNC5D mutations and ANP32E amplifications?,cnv_and_ssm
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both UNC5D mutations and PRSS1 amplifications?,cnv_and_ssm
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both UNC5D mutations and TTN amplifications?,cnv_and_ssm
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both UNC5D mutations and TLCD5 amplifications?,cnv_and_ssm
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both UNC5D mutations and CTSC amplifications?,cnv_and_ssm
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the proportion of Kidney Renal Clear Cell Carcinoma cases with both DOCK2 mutations and UNC5D amplifications?,cnv_and_ssm
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the proportion of Kidney Renal Clear Cell Carcinoma cases with both ZNF627 mutations and ADRA1A amplifications?,cnv_and_ssm
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both CDC42BPA mutations and FGF8 amplifications?,cnv_and_ssm
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both MRPL55 mutations and CYB5R2 amplifications?,cnv_and_ssm
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both MRPL55 mutations and EIF2B4 amplifications?,cnv_and_ssm
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the proportion of Breast Invasive Carcinoma cases with both TMTC3 mutations and ANP32E amplifications?,cnv_and_ssm
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both EPRS1 mutations and DOCK2 amplifications?,cnv_and_ssm
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both EPRS1 mutations and TYK2 amplifications?,cnv_and_ssm
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both GRTP1 mutations and TET2 amplifications?,cnv_and_ssm
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both GRTP1 mutations and SGIP1 amplifications?,cnv_and_ssm
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both TSHZ3 mutations and AUTS2 amplifications?,cnv_and_ssm
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the proportion of HIV+ Tumor Molecular Characterization Project - Cervical Cancer cases with both TAS1R3 mutations and TASOR2 amplifications?,cnv_and_ssm
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both PIAS3 mutations and RAB40C amplifications?,cnv_and_ssm
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both PIAS3 mutations and ZKSCAN7 amplifications?,cnv_and_ssm
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both ZNF274 mutations and ADRA1A amplifications?,cnv_and_ssm
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both SYNJ1 mutations and TASOR2 amplifications?,cnv_and_ssm
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both SYNJ1 mutations and ACVR1B amplifications?,cnv_and_ssm
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both SYNJ1 mutations and PGF amplifications?,cnv_and_ssm
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the proportion of Prostate Adenocarcinoma cases with both DSCAM mutations and FRY amplifications?,cnv_and_ssm
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the proportion of Prostate Adenocarcinoma cases with both DSCAM mutations and PRSS8 amplifications?,cnv_and_ssm
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the proportion of Prostate Adenocarcinoma cases with both DSCAM mutations and TENM2 amplifications?,cnv_and_ssm
+267,DGKD,R140H,Exceptional Responders,What is the proportion of Exceptional Responders cases with both DGKD mutations and NRAP amplifications?,cnv_and_ssm
+268,DGKD,R160H,Exceptional Responders,What is the proportion of Exceptional Responders cases with both DGKD mutations and PTPRO amplifications?,cnv_and_ssm
+269,DGKD,R204H,Exceptional Responders,What is the proportion of Exceptional Responders cases with both DGKD mutations and POC1B amplifications?,cnv_and_ssm
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the proportion of Bladder Urothelial Carcinoma cases with both PLEKHG6 mutations and GUK1 amplifications?,cnv_and_ssm
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the proportion of Bladder Urothelial Carcinoma cases with both PLEKHG6 mutations and TENM2 amplifications?,cnv_and_ssm
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the proportion of Bladder Urothelial Carcinoma cases with both PLEKHG6 mutations and SLC9C1 amplifications?,cnv_and_ssm
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both WNT2 mutations and MORF4L1 amplifications?,cnv_and_ssm
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both GUCY2C mutations and MORF4L1 amplifications?,cnv_and_ssm
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both C7orf31 mutations and MORF4L1 amplifications?,cnv_and_ssm
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases with both ZKSCAN7 mutations and DCN amplifications?",cnv_and_ssm
+299,OR5D14,M210L,Neuroblastoma,What is the proportion of Neuroblastoma cases with both OR5D14 mutations and ADRA1A amplifications?,cnv_and_ssm
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both SPATA22 mutations and TRPA1 amplifications?,cnv_and_ssm
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both SPATA22 mutations and PRSS1 amplifications?,cnv_and_ssm
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both SPATA22 mutations and ANKDD1A amplifications?,cnv_and_ssm
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both LCN15 mutations and MSANTD4 amplifications?,cnv_and_ssm
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both DCAF4L2 mutations and GUK1 amplifications?,cnv_and_ssm
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both GUK1 mutations and DCN amplifications?,cnv_and_ssm
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both GUK1 mutations and SYT9 amplifications?,cnv_and_ssm
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both GUK1 mutations and DCN amplifications?,cnv_and_ssm
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both GUK1 mutations and PGR amplifications?,cnv_and_ssm
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both GUK1 mutations and PIK3C2G amplifications?,cnv_and_ssm
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both MORF4L1 mutations and MAD1L1 amplifications?,cnv_and_ssm
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both MORF4L1 mutations and DCN amplifications?,cnv_and_ssm
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both MORF4L1 mutations and PTPRO amplifications?,cnv_and_ssm
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both MORF4L1 mutations and PRSS1 amplifications?,cnv_and_ssm
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both MYO3B mutations and TYK2 amplifications?,cnv_and_ssm
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both MYO3B mutations and ZMYM3 amplifications?,cnv_and_ssm
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both TENT5A mutations and NRAP amplifications?,cnv_and_ssm
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both TENT5A mutations and ZNF431 amplifications?,cnv_and_ssm
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both TENT5A mutations and SORCS1 amplifications?,cnv_and_ssm
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the proportion of Ovarian Serous Cystadenocarcinoma cases with both ZFAT mutations and OLFML3 amplifications?,cnv_and_ssm
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the proportion of Ovarian Serous Cystadenocarcinoma cases with both ZFAT mutations and PSG2 amplifications?,cnv_and_ssm
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the proportion of Ovarian Serous Cystadenocarcinoma cases with both ZFAT mutations and OR13C3 amplifications?,cnv_and_ssm
+357,ZNF584,A211T,Sarcoma,What is the proportion of Sarcoma cases with both ZNF584 mutations and MAD1L1 amplifications?,cnv_and_ssm
+358,ZNF584,A256T,Sarcoma,What is the proportion of Sarcoma cases with both ZNF584 mutations and POC1B amplifications?,cnv_and_ssm
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both LDOC1 mutations and CASZ1 amplifications?,cnv_and_ssm
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both PDGFC mutations and HTR3B amplifications?,cnv_and_ssm
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both MSANTD4 mutations and KL amplifications?,cnv_and_ssm
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both NPSR1 mutations and CTSC amplifications?,cnv_and_ssm
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both PHLPP1 mutations and UBR2 amplifications?,cnv_and_ssm
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both COL6A3 mutations and NRAP amplifications?,cnv_and_ssm
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both COL6A3 mutations and POLD1 amplifications?,cnv_and_ssm
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both COL6A3 mutations and POLR1G amplifications?,cnv_and_ssm
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both COL6A3 mutations and MYO3A amplifications?,cnv_and_ssm
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both COL6A3 mutations and ZNF584 amplifications?,cnv_and_ssm
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both ADRA1A mutations and SMO amplifications?,cnv_and_ssm
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases with both LAMB2 mutations and SGIP1 amplifications?,cnv_and_ssm
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the proportion of Rectum Adenocarcinoma cases with both POC1B mutations and AQP7 amplifications?,cnv_and_ssm
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the proportion of Rectum Adenocarcinoma cases with both POC1B mutations and EVC2 amplifications?,cnv_and_ssm
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the proportion of Rectum Adenocarcinoma cases with both POC1B mutations and TENM2 amplifications?,cnv_and_ssm
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the proportion of Rectum Adenocarcinoma cases with both POC1B mutations and POLR1G amplifications?,cnv_and_ssm
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the proportion of Liver Hepatocellular Carcinoma cases with both USH2A mutations and CYB5R2 amplifications?,cnv_and_ssm
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the proportion of Rectum Adenocarcinoma cases with both AQP7 mutations and PIAS3 amplifications?,cnv_and_ssm
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the proportion of Rectum Adenocarcinoma cases with both AQP7 mutations and TSHZ3 amplifications?,cnv_and_ssm
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the proportion of Rectum Adenocarcinoma cases with both AQP7 mutations and CFAP298-TCP10L amplifications?,cnv_and_ssm
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the proportion of Rectum Adenocarcinoma cases with both AQP7 mutations and MED16 amplifications?,cnv_and_ssm
+430,DCN,R163C,Rectum Adenocarcinoma,What is the proportion of Rectum Adenocarcinoma cases with both DCN mutations and CEP20 amplifications?,cnv_and_ssm
+431,DCN,R203C,Rectum Adenocarcinoma,What is the proportion of Rectum Adenocarcinoma cases with both DCN mutations and GRTP1 amplifications?,cnv_and_ssm
+432,DCN,R241C,Rectum Adenocarcinoma,What is the proportion of Rectum Adenocarcinoma cases with both DCN mutations and PAK3 amplifications?,cnv_and_ssm
+433,DCN,R350C,Rectum Adenocarcinoma,What is the proportion of Rectum Adenocarcinoma cases with both DCN mutations and GUK1 amplifications?,cnv_and_ssm
+434,DCN,R41C,Rectum Adenocarcinoma,What is the proportion of Rectum Adenocarcinoma cases with both DCN mutations and ACTA2 amplifications?,cnv_and_ssm
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both CPS1 mutations and POC1B amplifications?,cnv_and_ssm
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both CPS1 mutations and TMEM255A amplifications?,cnv_and_ssm
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both CPS1 mutations and ZNF804A amplifications?,cnv_and_ssm
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the proportion of Kidney Renal Papillary Cell Carcinoma cases with both FCGR2C mutations and CARMIL1 amplifications?,cnv_and_ssm
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the proportion of Kidney Renal Papillary Cell Carcinoma cases with both FCGR2C mutations and NRAP amplifications?,cnv_and_ssm
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both GRM1 mutations and MYO3B amplifications?,cnv_and_ssm
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both SGCZ mutations and CTCFL amplifications?,cnv_and_ssm
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both SGCZ mutations and ZFAT amplifications?,cnv_and_ssm
+485,SMO,V15M,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both SMO mutations and FGF8 amplifications?,cnv_and_ssm
+486,SMO,V321M,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both SMO mutations and DCN amplifications?,cnv_and_ssm
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both CHODL mutations and TASOR2 amplifications?,cnv_and_ssm
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both CHODL mutations and UNC5D amplifications?,cnv_and_ssm
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both CHODL mutations and NCKAP5 amplifications?,cnv_and_ssm
+494,MYO16,P399H,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both MYO16 mutations and ZMYM3 amplifications?,cnv_and_ssm
+495,MYO16,P421H,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both MYO16 mutations and HTR3B amplifications?,cnv_and_ssm
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both CXCR2 mutations and SMO amplifications?,cnv_and_ssm
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the proportion of Bladder Urothelial Carcinoma cases with both TMEM225 mutations and RIPOR2 amplifications?,cnv_and_ssm
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both MAOB mutations and NPSR1 amplifications?,cnv_and_ssm
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both GPRASP1 mutations and GPRASP1 amplifications?,cnv_and_ssm
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both MRPL32 mutations and VASN amplifications?,cnv_and_ssm
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both TYROBP mutations and TTN amplifications?,cnv_and_ssm
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both RAB40C mutations and JAML amplifications?,cnv_and_ssm
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both RAB40C mutations and RIMS2 amplifications?,cnv_and_ssm
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both CTNNA2 mutations and TNS1 amplifications?,cnv_and_ssm
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both CTNNA2 mutations and AKT1 amplifications?,cnv_and_ssm
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both CTNNA2 mutations and DNMT1 amplifications?,cnv_and_ssm
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both CTNNA2 mutations and ZCCHC14 amplifications?,cnv_and_ssm
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the proportion of Bladder Urothelial Carcinoma cases with both MYO15A mutations and TMEM255A amplifications?,cnv_and_ssm
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both GIMAP2 mutations and PTPRO amplifications?,cnv_and_ssm
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the proportion of Glioblastoma Multiforme cases with both KIF20B mutations and POLD1 amplifications?,cnv_and_ssm
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the proportion of Glioblastoma Multiforme cases with both KIF20B mutations and CX3CR1 amplifications?,cnv_and_ssm
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both ADAM17 mutations and JAML amplifications?,cnv_and_ssm
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both BCAT1 mutations and PYHIN1 amplifications?,cnv_and_ssm
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both BCAT1 mutations and RIPOR2 amplifications?,cnv_and_ssm
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both BCAT1 mutations and PRSS1 amplifications?,cnv_and_ssm
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both ERCC6 mutations and POC1B amplifications?,cnv_and_ssm
+541,DCC,R320W,Breast Invasive Carcinoma,What is the proportion of Breast Invasive Carcinoma cases with both DCC mutations and EVC2 amplifications?,cnv_and_ssm
+542,DCC,R363W,Breast Invasive Carcinoma,What is the proportion of Breast Invasive Carcinoma cases with both DCC mutations and CX3CR1 amplifications?,cnv_and_ssm
+543,DCC,R386W,Breast Invasive Carcinoma,What is the proportion of Breast Invasive Carcinoma cases with both DCC mutations and ZNF627 amplifications?,cnv_and_ssm
+544,DCC,R41W,Breast Invasive Carcinoma,What is the proportion of Breast Invasive Carcinoma cases with both DCC mutations and HTR3B amplifications?,cnv_and_ssm
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both FBXO15 mutations and SORCS1 amplifications?,cnv_and_ssm
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both FBXO15 mutations and AUTS2 amplifications?,cnv_and_ssm
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both GSTCD mutations and DCAF6 amplifications?,cnv_and_ssm
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both GSTCD mutations and EVC2 amplifications?,cnv_and_ssm
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both OLFML3 mutations and AUTS2 amplifications?,cnv_and_ssm
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both OLFML3 mutations and PAK3 amplifications?,cnv_and_ssm
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both OLFML3 mutations and ZBTB34 amplifications?,cnv_and_ssm
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the proportion of Ovarian Serous Cystadenocarcinoma cases with both CFAP61 mutations and ZNF431 amplifications?,cnv_and_ssm
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the proportion of Ovarian Serous Cystadenocarcinoma cases with both CFAP61 mutations and RIPOR2 amplifications?,cnv_and_ssm
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the proportion of Bladder Urothelial Carcinoma cases with both HLA-DQA2 mutations and CX3CR1 amplifications?,cnv_and_ssm
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both TENM2 mutations and FRY amplifications?,cnv_and_ssm
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both TENM2 mutations and SYNJ1 amplifications?,cnv_and_ssm
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both TENM2 mutations and PXN amplifications?,cnv_and_ssm
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both ANKRD24 mutations and CTSC amplifications?,cnv_and_ssm
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both ANKRD24 mutations and AQP7 amplifications?,cnv_and_ssm
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both ANKRD24 mutations and CYB5R2 amplifications?,cnv_and_ssm
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both ZCCHC14 mutations and PRSS1 amplifications?,cnv_and_ssm
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both ZCCHC14 mutations and TNS1 amplifications?,cnv_and_ssm
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both ZCCHC14 mutations and FGF8 amplifications?,cnv_and_ssm
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both ZCCHC14 mutations and ZNF217 amplifications?,cnv_and_ssm
+625,SIK2,I265M,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both SIK2 mutations and CHODL amplifications?,cnv_and_ssm
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both MYH11 mutations and OLFML3 amplifications?,cnv_and_ssm
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both MYH11 mutations and MED16 amplifications?,cnv_and_ssm
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both SLC6A4 mutations and FRY amplifications?,cnv_and_ssm
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both SLC9C1 mutations and GSTCD amplifications?,cnv_and_ssm
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both SLC9C1 mutations and FCGR2C amplifications?,cnv_and_ssm
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the proportion of Brain Lower Grade Glioma cases with both OR2A12 mutations and PTPRN2 amplifications?,cnv_and_ssm
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both PYHIN1 mutations and TLCD5 amplifications?,cnv_and_ssm
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both PYHIN1 mutations and RELN amplifications?,cnv_and_ssm
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both JAML mutations and SYT9 amplifications?,cnv_and_ssm
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both JAML mutations and DCC amplifications?,cnv_and_ssm
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both JAML mutations and PRSS1 amplifications?,cnv_and_ssm
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both JAML mutations and STAT3 amplifications?,cnv_and_ssm
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both TYK2 mutations and TTN amplifications?,cnv_and_ssm
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both TYK2 mutations and MYT1 amplifications?,cnv_and_ssm
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both TYK2 mutations and SPTAN1 amplifications?,cnv_and_ssm
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both CTCFL mutations and YY1AP1 amplifications?,cnv_and_ssm
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both CTCFL mutations and SOX21 amplifications?,cnv_and_ssm
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both CTCFL mutations and ANKRD24 amplifications?,cnv_and_ssm
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both CTCFL mutations and GIMAP2 amplifications?,cnv_and_ssm
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both CEP20 mutations and GPRASP1 amplifications?,cnv_and_ssm
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both CEP20 mutations and TASOR2 amplifications?,cnv_and_ssm
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both RIMS2 mutations and TRPA1 amplifications?,cnv_and_ssm
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both RIMS2 mutations and DGKD amplifications?,cnv_and_ssm
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both RIMS2 mutations and DPF3 amplifications?,cnv_and_ssm
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both RIMS2 mutations and RIPOR2 amplifications?,cnv_and_ssm
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both RIMS2 mutations and POLD1 amplifications?,cnv_and_ssm
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both RIMS2 mutations and GABRA6 amplifications?,cnv_and_ssm
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both RIMS2 mutations and ZNF584 amplifications?,cnv_and_ssm
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both PIK3C2G mutations and PXN amplifications?,cnv_and_ssm
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both PIK3C2G mutations and CEP20 amplifications?,cnv_and_ssm
+728,STK19,D341N,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both STK19 mutations and SLC6A4 amplifications?,cnv_and_ssm
+729,STK19,D345N,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both STK19 mutations and DCLK3 amplifications?,cnv_and_ssm
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both REXO4 mutations and DNAH14 amplifications?,cnv_and_ssm
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both ZBTB34 mutations and DGKD amplifications?,cnv_and_ssm
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both ZBTB34 mutations and DCN amplifications?,cnv_and_ssm
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the proportion of Bladder Urothelial Carcinoma cases with both NCKAP5 mutations and NRAP amplifications?,cnv_and_ssm
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases with both SORCS1 mutations and UNC5D amplifications?",cnv_and_ssm
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases with both SORCS1 mutations and C7orf31 amplifications?",cnv_and_ssm
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases with both SORCS1 mutations and CA9 amplifications?",cnv_and_ssm
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases with both SORCS1 mutations and PTPRO amplifications?",cnv_and_ssm
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the proportion of Head and Neck Squamous Cell Carcinoma cases with both FGF8 mutations and ACVR1B amplifications?,cnv_and_ssm
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the proportion of Head and Neck Squamous Cell Carcinoma cases with both FGF8 mutations and CACNA1F amplifications?,cnv_and_ssm
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the proportion of Head and Neck Squamous Cell Carcinoma cases with both FGF8 mutations and PRSS1 amplifications?,cnv_and_ssm
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the proportion of Head and Neck Squamous Cell Carcinoma cases with both FGF8 mutations and SGIP1 amplifications?,cnv_and_ssm
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the proportion of Head and Neck Squamous Cell Carcinoma cases with both FGF8 mutations and YY1AP1 amplifications?,cnv_and_ssm
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the proportion of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia cases with both TENM3 mutations and FGF8 amplifications?,cnv_and_ssm
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both AKT1 mutations and CTNNA2 amplifications?,cnv_and_ssm
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases with both CFAP298-TCP10L mutations and TLK2 amplifications?,cnv_and_ssm
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both GLRB mutations and SOX21 amplifications?,cnv_and_ssm
+793,TTN,F7636L,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both TTN mutations and CHODL amplifications?,cnv_and_ssm
+794,TTN,F8563L,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both TTN mutations and PTPRO amplifications?,cnv_and_ssm
+795,TTN,F8880L,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both TTN mutations and PXN amplifications?,cnv_and_ssm
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both ANKRD30A mutations and GRTP1 amplifications?,cnv_and_ssm
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both ANKRD30A mutations and PTPRO amplifications?,cnv_and_ssm
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both ANKRD30A mutations and DNMT1 amplifications?,cnv_and_ssm
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both TRIM45 mutations and PYHIN1 amplifications?,cnv_and_ssm
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both TRIM45 mutations and ACVR1B amplifications?,cnv_and_ssm
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both TRIM45 mutations and CTCFL amplifications?,cnv_and_ssm
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both CACNA1F mutations and CX3CR1 amplifications?,cnv_and_ssm
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both CACNA1F mutations and HBB amplifications?,cnv_and_ssm
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both CACNA1F mutations and TRIM45 amplifications?,cnv_and_ssm
+817,KL,R594C,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both KL mutations and TSHZ3 amplifications?,cnv_and_ssm
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the proportion of Kidney Renal Papillary Cell Carcinoma cases with both GUF1 mutations and AQP7 amplifications?,cnv_and_ssm
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both TAF1L mutations and CTSC amplifications?,cnv_and_ssm
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both TASOR2 mutations and MAD1L1 amplifications?,cnv_and_ssm
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both TASOR2 mutations and UBR2 amplifications?,cnv_and_ssm
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both TASOR2 mutations and TLK2 amplifications?,cnv_and_ssm
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both KDM5C mutations and VASN amplifications?,cnv_and_ssm
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both KDM5C mutations and TTC12 amplifications?,cnv_and_ssm
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both KDM5C mutations and STK19 amplifications?,cnv_and_ssm
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both KDM5C mutations and PXN amplifications?,cnv_and_ssm
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases with both IL5RA mutations and FGF8 amplifications?,cnv_and_ssm
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both DHX16 mutations and CTNNA2 amplifications?,cnv_and_ssm
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both DHX16 mutations and EBF2 amplifications?,cnv_and_ssm
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both GPR158 mutations and PRSS8 amplifications?,cnv_and_ssm
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both GPR158 mutations and GUF1 amplifications?,cnv_and_ssm
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases with both EIF2B4 mutations and ZFAT amplifications?",cnv_and_ssm
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases with both EIF2B4 mutations and HSPA5 amplifications?",cnv_and_ssm
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases with both EIF2B4 mutations and OLFML3 amplifications?",cnv_and_ssm
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases with both EIF2B4 mutations and CR1 amplifications?",cnv_and_ssm
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases with both EIF2B4 mutations and TENM3 amplifications?",cnv_and_ssm
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases with both EIF2B4 mutations and TTYH2 amplifications?",cnv_and_ssm
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both AUTS2 mutations and PXN amplifications?,cnv_and_ssm
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both AUTS2 mutations and KDM5C amplifications?,cnv_and_ssm
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both AUTS2 mutations and POC1B amplifications?,cnv_and_ssm
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both AUTS2 mutations and FBXO15 amplifications?,cnv_and_ssm
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both AUTS2 mutations and CASZ1 amplifications?,cnv_and_ssm
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both AUTS2 mutations and MAD1L1 amplifications?,cnv_and_ssm
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both AUTS2 mutations and TNS1 amplifications?,cnv_and_ssm
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both AUTS2 mutations and ZNF431 amplifications?,cnv_and_ssm
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both AUTS2 mutations and DCN amplifications?,cnv_and_ssm
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both AUTS2 mutations and MRPL55 amplifications?,cnv_and_ssm
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases with both ACTL7B mutations and ZCCHC14 amplifications?",cnv_and_ssm
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the proportion of Glioblastoma Multiforme cases with both PCDHGA1 mutations and FRY amplifications?,cnv_and_ssm
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both TRAP1 mutations and TRIM45 amplifications?,cnv_and_ssm
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both TRAP1 mutations and EIF2B4 amplifications?,cnv_and_ssm
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both PIK3C2A mutations and GSTCD amplifications?,cnv_and_ssm
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the proportion of Liver Hepatocellular Carcinoma cases with both KANSL1 mutations and TNS1 amplifications?,cnv_and_ssm
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both ANKRD52 mutations and EIF2B4 amplifications?,cnv_and_ssm
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both PAPPA mutations and COL6A3 amplifications?,cnv_and_ssm
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the proportion of Rectum Adenocarcinoma cases with both B3GALNT1 mutations and ANP32E amplifications?,cnv_and_ssm
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both GABRA6 mutations and HYOU1 amplifications?,cnv_and_ssm
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both GABRA6 mutations and MORF4L1 amplifications?,cnv_and_ssm
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both GABRA6 mutations and CDKN2AIP amplifications?,cnv_and_ssm
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both GABRA6 mutations and ABCC2 amplifications?,cnv_and_ssm
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both GABRA6 mutations and MAOB amplifications?,cnv_and_ssm
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both ZSCAN31 mutations and MYT1 amplifications?,cnv_and_ssm
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases with both MED16 mutations and SGCZ amplifications?",cnv_and_ssm
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases with both MED16 mutations and CACNA1F amplifications?",cnv_and_ssm
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the proportion of Pancreatic Adenocarcinoma cases with both PTPRO mutations and AUTS2 amplifications?,cnv_and_ssm
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the proportion of Pancreatic Adenocarcinoma cases with both PTPRO mutations and YY1AP1 amplifications?,cnv_and_ssm
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the proportion of Pancreatic Adenocarcinoma cases with both PTPRO mutations and SYNJ1 amplifications?,cnv_and_ssm
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the proportion of Pancreatic Adenocarcinoma cases with both PTPRO mutations and YY1AP1 amplifications?,cnv_and_ssm
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the proportion of Pancreatic Adenocarcinoma cases with both PTPRO mutations and AUTS2 amplifications?,cnv_and_ssm
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the proportion of Pancreatic Adenocarcinoma cases with both PTPRO mutations and EIF2B4 amplifications?,cnv_and_ssm
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the proportion of Pancreatic Adenocarcinoma cases with both PTPRO mutations and POC1B amplifications?,cnv_and_ssm
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the proportion of Pancreatic Adenocarcinoma cases with both PTPRO mutations and RIPOR2 amplifications?,cnv_and_ssm
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both CHMP7 mutations and COL6A3 amplifications?,cnv_and_ssm
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both GPC3 mutations and PXN amplifications?,cnv_and_ssm
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both GPC3 mutations and TMEM255A amplifications?,cnv_and_ssm
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases with both TLK2 mutations and TNS1 amplifications?,cnv_and_ssm
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases with both TLK2 mutations and ACTB amplifications?,cnv_and_ssm
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases with both TLK2 mutations and TSHZ3 amplifications?,cnv_and_ssm
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases with both TLK2 mutations and TNS1 amplifications?,cnv_and_ssm
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the proportion of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases with both TLK2 mutations and DOCK2 amplifications?,cnv_and_ssm
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both ZNF217 mutations and MYT1 amplifications?,cnv_and_ssm
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both SYT9 mutations and PGR amplifications?,cnv_and_ssm
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both SYT9 mutations and DGKD amplifications?,cnv_and_ssm
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both PKHD1L1 mutations and KL amplifications?,cnv_and_ssm
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both MYO3A mutations and VASN amplifications?,cnv_and_ssm
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases with both VASN mutations and AQP7 amplifications?",cnv_and_ssm
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both DNMT1 mutations and SORCS1 amplifications?,cnv_and_ssm
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both DNMT1 mutations and YY1AP1 amplifications?,cnv_and_ssm
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both DNMT1 mutations and DHX16 amplifications?,cnv_and_ssm
+1056,CA9,E402K,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both CA9 mutations and SIK2 amplifications?,cnv_and_ssm
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both TTC17 mutations and OLFML3 amplifications?,cnv_and_ssm
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both TTC17 mutations and ANP32E amplifications?,cnv_and_ssm
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the proportion of Breast Invasive Carcinoma cases with both PSG2 mutations and WNT2 amplifications?,cnv_and_ssm
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the proportion of Breast Invasive Carcinoma cases with both RIPOR2 mutations and ZMYM3 amplifications?,cnv_and_ssm
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the proportion of Breast Invasive Carcinoma cases with both RIPOR2 mutations and TYK2 amplifications?,cnv_and_ssm
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the proportion of Breast Invasive Carcinoma cases with both RIPOR2 mutations and THBS4 amplifications?,cnv_and_ssm
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the proportion of Breast Invasive Carcinoma cases with both RIPOR2 mutations and CHODL amplifications?,cnv_and_ssm
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both DCLK3 mutations and ZSCAN31 amplifications?,cnv_and_ssm
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both DCLK3 mutations and PTPRN2 amplifications?,cnv_and_ssm
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both MERTK mutations and AUTS2 amplifications?,cnv_and_ssm
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both MERTK mutations and CYP1A2 amplifications?,cnv_and_ssm
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both MERTK mutations and UNC5D amplifications?,cnv_and_ssm
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both ZFP42 mutations and SPATA22 amplifications?,cnv_and_ssm
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both OR13C3 mutations and ZNF627 amplifications?,cnv_and_ssm
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both OR13C3 mutations and ZNF584 amplifications?,cnv_and_ssm
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both SPAG1 mutations and PGF amplifications?,cnv_and_ssm
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both CDKN2AIP mutations and DSCAM amplifications?,cnv_and_ssm
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both PXN mutations and ZNF804A amplifications?,cnv_and_ssm
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both PXN mutations and GUK1 amplifications?,cnv_and_ssm
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both PXN mutations and DCAF4L2 amplifications?,cnv_and_ssm
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both PXN mutations and AUTS2 amplifications?,cnv_and_ssm
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both PXN mutations and TTC12 amplifications?,cnv_and_ssm
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both PXN mutations and PGR amplifications?,cnv_and_ssm
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both TTYH2 mutations and COL6A3 amplifications?,cnv_and_ssm
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both TTYH2 mutations and ZBTB34 amplifications?,cnv_and_ssm
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both TMEM255A mutations and CACNA1F amplifications?,cnv_and_ssm
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both TMEM255A mutations and TAS1R3 amplifications?,cnv_and_ssm
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both TMEM255A mutations and TYK2 amplifications?,cnv_and_ssm
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the proportion of Breast Invasive Carcinoma cases with both TASOR2 mutations and BCAT1 amplifications?,cnv_and_ssm
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the proportion of Breast Invasive Carcinoma cases with both TASOR2 mutations and GRTP1 amplifications?,cnv_and_ssm
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both ICE1 mutations and TRPA1 amplifications?,cnv_and_ssm
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the proportion of Breast Invasive Carcinoma cases with both MYT1 mutations and PAK3 amplifications?,cnv_and_ssm
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the proportion of Breast Invasive Carcinoma cases with both MYT1 mutations and ABCC3 amplifications?,cnv_and_ssm
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the proportion of Breast Invasive Carcinoma cases with both MYT1 mutations and RIMS2 amplifications?,cnv_and_ssm
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both CX3CR1 mutations and MRPL55 amplifications?,cnv_and_ssm
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both CX3CR1 mutations and ANP32E amplifications?,cnv_and_ssm
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the proportion of Liver Hepatocellular Carcinoma cases with both SPINDOC mutations and SYT10 amplifications?,cnv_and_ssm
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both ART3 mutations and SGCZ amplifications?,cnv_and_ssm
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both ART3 mutations and RELN amplifications?,cnv_and_ssm
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the proportion of Bladder Urothelial Carcinoma cases with both CYP1A2 mutations and NRAP amplifications?,cnv_and_ssm
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases with both ADRA1A mutations and RAB40C amplifications?",cnv_and_ssm
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both CDH23 mutations and CTSC amplifications?,cnv_and_ssm
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both CDH23 mutations and STK19 amplifications?,cnv_and_ssm
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both KRT39 mutations and PAK3 amplifications?,cnv_and_ssm
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both PDHA2 mutations and MRPL55 amplifications?,cnv_and_ssm
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both SLC24A2 mutations and AUTS2 amplifications?,cnv_and_ssm
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the proportion of Liver Hepatocellular Carcinoma cases with both PTPRN2 mutations and TASOR2 amplifications?,cnv_and_ssm
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the proportion of Liver Hepatocellular Carcinoma cases with both PTPRN2 mutations and POLD1 amplifications?,cnv_and_ssm
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the proportion of Liver Hepatocellular Carcinoma cases with both PTPRN2 mutations and PTPRN2 amplifications?,cnv_and_ssm
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the proportion of Liver Hepatocellular Carcinoma cases with both PTPRN2 mutations and ANKRD52 amplifications?,cnv_and_ssm
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the proportion of Liver Hepatocellular Carcinoma cases with both PTPRN2 mutations and PGR amplifications?,cnv_and_ssm
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both SOX21 mutations and PYHIN1 amplifications?,cnv_and_ssm
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the proportion of Bladder Urothelial Carcinoma cases with both CPA6 mutations and GIMAP2 amplifications?,cnv_and_ssm
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both GRM5 mutations and AUTS2 amplifications?,cnv_and_ssm
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases with both CASZ1 mutations and TET2 amplifications?",cnv_and_ssm
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both SGIP1 mutations and TRIM45 amplifications?,cnv_and_ssm
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both SGIP1 mutations and YY1AP1 amplifications?,cnv_and_ssm
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both SGIP1 mutations and PSG2 amplifications?,cnv_and_ssm
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both SGIP1 mutations and ZSCAN31 amplifications?,cnv_and_ssm
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both CARMIL1 mutations and PGR amplifications?,cnv_and_ssm
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both CARMIL1 mutations and ZCCHC14 amplifications?,cnv_and_ssm
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both ZNF431 mutations and TRAP1 amplifications?,cnv_and_ssm
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both ZNF431 mutations and ZFPM2 amplifications?,cnv_and_ssm
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both ZNF431 mutations and PGF amplifications?,cnv_and_ssm
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both DNAH11 mutations and TMEM255A amplifications?,cnv_and_ssm
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both DNAH11 mutations and PXN amplifications?,cnv_and_ssm
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both POLD1 mutations and ANKRD24 amplifications?,cnv_and_ssm
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the proportion of Lung Squamous Cell Carcinoma cases with both POLD1 mutations and GSTCD amplifications?,cnv_and_ssm
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both TTC12 mutations and TENM3 amplifications?,cnv_and_ssm
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both TTC12 mutations and MAD1L1 amplifications?,cnv_and_ssm
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the proportion of Bladder Urothelial Carcinoma cases with both CNGB1 mutations and EIF2B4 amplifications?,cnv_and_ssm
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the proportion of Bladder Urothelial Carcinoma cases with both CNGB1 mutations and FMO4 amplifications?,cnv_and_ssm
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both CTSC mutations and ZCCHC14 amplifications?,cnv_and_ssm
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both CTSC mutations and SGIP1 amplifications?,cnv_and_ssm
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both CTSC mutations and TYK2 amplifications?,cnv_and_ssm
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both CTSC mutations and ACVR1B amplifications?,cnv_and_ssm
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both CTSC mutations and XKR4 amplifications?,cnv_and_ssm
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both PRSS8 mutations and TNS1 amplifications?,cnv_and_ssm
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both PRSS8 mutations and TRAP1 amplifications?,cnv_and_ssm
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both ARHGEF40 mutations and POC1B amplifications?,cnv_and_ssm
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the proportion of Rectum Adenocarcinoma cases with both ACTB mutations and TNS1 amplifications?,cnv_and_ssm
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the proportion of Rectum Adenocarcinoma cases with both ACTB mutations and CTCFL amplifications?,cnv_and_ssm
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the proportion of Rectum Adenocarcinoma cases with both ACTB mutations and PAK3 amplifications?,cnv_and_ssm
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the proportion of Rectum Adenocarcinoma cases with both ACTB mutations and OR2A12 amplifications?,cnv_and_ssm
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the proportion of Glioblastoma Multiforme cases with both YY1AP1 mutations and SMO amplifications?,cnv_and_ssm
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the proportion of Glioblastoma Multiforme cases with both YY1AP1 mutations and TTYH2 amplifications?,cnv_and_ssm
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the proportion of Glioblastoma Multiforme cases with both YY1AP1 mutations and TNS1 amplifications?,cnv_and_ssm
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the proportion of Glioblastoma Multiforme cases with both YY1AP1 mutations and MYO3B amplifications?,cnv_and_ssm
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the proportion of Glioblastoma Multiforme cases with both YY1AP1 mutations and HTR3B amplifications?,cnv_and_ssm
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the proportion of Glioblastoma Multiforme cases with both YY1AP1 mutations and FBN1 amplifications?,cnv_and_ssm
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the proportion of Glioblastoma Multiforme cases with both YY1AP1 mutations and CTNNA2 amplifications?,cnv_and_ssm
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both FNDC7 mutations and PGR amplifications?,cnv_and_ssm
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both FNDC7 mutations and PGF amplifications?,cnv_and_ssm
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both TLCD5 mutations and VPS26B amplifications?,cnv_and_ssm
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both TLCD5 mutations and ANKRD24 amplifications?,cnv_and_ssm
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both POLR1G mutations and MYH11 amplifications?,cnv_and_ssm
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both POLR1G mutations and OLFML3 amplifications?,cnv_and_ssm
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both DNAH14 mutations and JAML amplifications?,cnv_and_ssm
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both DNAH14 mutations and PRSS1 amplifications?,cnv_and_ssm
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both DNAH14 mutations and FRY amplifications?,cnv_and_ssm
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both NEXN mutations and PCDHB2 amplifications?,cnv_and_ssm
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the proportion of Prostate Adenocarcinoma cases with both CYB5R2 mutations and TENM3 amplifications?,cnv_and_ssm
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the proportion of Prostate Adenocarcinoma cases with both CYB5R2 mutations and TTYH2 amplifications?,cnv_and_ssm
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both NRAP mutations and HBB amplifications?,cnv_and_ssm
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both NRAP mutations and UNC5D amplifications?,cnv_and_ssm
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both NRAP mutations and DPF3 amplifications?,cnv_and_ssm
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both CCDC22 mutations and HLA-DQA2 amplifications?,cnv_and_ssm
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both DCAF6 mutations and KDM5C amplifications?,cnv_and_ssm
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both DCAF6 mutations and NCKAP5 amplifications?,cnv_and_ssm
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both ZNF708 mutations and CYB5R2 amplifications?,cnv_and_ssm
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both BFAR mutations and COL6A3 amplifications?,cnv_and_ssm
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both MAST4 mutations and GABRA6 amplifications?,cnv_and_ssm
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both MAST4 mutations and FBXO15 amplifications?,cnv_and_ssm
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both MAST4 mutations and RIMS2 amplifications?,cnv_and_ssm
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both MAST4 mutations and CEP20 amplifications?,cnv_and_ssm
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both MAST4 mutations and EVC2 amplifications?,cnv_and_ssm
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both ARMC3 mutations and VPS26B amplifications?,cnv_and_ssm
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both ARMC3 mutations and UBR2 amplifications?,cnv_and_ssm
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the proportion of Kidney Renal Clear Cell Carcinoma cases with both TET2 mutations and PIK3C2G amplifications?,cnv_and_ssm
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the proportion of Kidney Renal Clear Cell Carcinoma cases with both TET2 mutations and STAT3 amplifications?,cnv_and_ssm
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both SERPINB10 mutations and GUK1 amplifications?,cnv_and_ssm
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both STAT3 mutations and UNC5D amplifications?,cnv_and_ssm
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both MIEF1 mutations and ACTA2 amplifications?,cnv_and_ssm
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both ACVR1B mutations and TAF1C amplifications?,cnv_and_ssm
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both ACVR1B mutations and PCDHB2 amplifications?,cnv_and_ssm
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both ACVR1B mutations and ANKRD30A amplifications?,cnv_and_ssm
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both EBF2 mutations and MAD1L1 amplifications?,cnv_and_ssm
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both EBF2 mutations and ZNF217 amplifications?,cnv_and_ssm
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both VPS26B mutations and PKHD1L1 amplifications?,cnv_and_ssm
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases with both PGR mutations and TNS1 amplifications?",cnv_and_ssm
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases with both PGR mutations and JAML amplifications?",cnv_and_ssm
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the proportion of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases with both PGR mutations and CTCFL amplifications?",cnv_and_ssm
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the proportion of Skin Cutaneous Melanoma cases with both ACTA2 mutations and PGR amplifications?,cnv_and_ssm
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both THBS4 mutations and PXN amplifications?,cnv_and_ssm
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both THBS4 mutations and TMEM255A amplifications?,cnv_and_ssm
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both PRSS1 mutations and GABRA6 amplifications?,cnv_and_ssm
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both PRSS1 mutations and GPRASP1 amplifications?,cnv_and_ssm
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both PRSS1 mutations and TTC12 amplifications?,cnv_and_ssm
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the proportion of Lung Adenocarcinoma cases with both PRSS1 mutations and AQP7 amplifications?,cnv_and_ssm
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both PGF mutations and RIMS2 amplifications?,cnv_and_ssm
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the proportion of Stomach Adenocarcinoma cases with both PGF mutations and SPATA22 amplifications?,cnv_and_ssm
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the proportion of Breast Invasive Carcinoma cases with both ITPRID2 mutations and ARMC3 amplifications?,cnv_and_ssm
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the proportion of Breast Invasive Carcinoma cases with both ITPRID2 mutations and CTSC amplifications?,cnv_and_ssm
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both HBB mutations and MRPL55 amplifications?,cnv_and_ssm
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both PCDHB2 mutations and BFAR amplifications?,cnv_and_ssm
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both PCDHB2 mutations and ZCCHC14 amplifications?,cnv_and_ssm
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the proportion of Colon Adenocarcinoma cases with both PCDHB2 mutations and CPS1 amplifications?,cnv_and_ssm
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the proportion of Uterine Corpus Endometrial Carcinoma cases with both UBR2 mutations and TNS1 amplifications?,cnv_and_ssm
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the proportion of Rectum Adenocarcinoma cases with both FBXO42 mutations and FGF8 amplifications?,cnv_and_ssm
+1,TNS1,G1362V,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how common are mutations in TNS1 and amplifications in ZNF431?",cnv_and_ssm
+2,TNS1,G1711V,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how common are mutations in TNS1 and amplifications in SPINDOC?",cnv_and_ssm
+3,TNS1,G1718V,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how common are mutations in TNS1 and amplifications in ZBTB34?",cnv_and_ssm
+4,TNS1,G1732V,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how common are mutations in TNS1 and amplifications in CACNA1F?",cnv_and_ssm
+5,TNS1,G1824V,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how common are mutations in TNS1 and amplifications in CTNNA2?",cnv_and_ssm
+6,TNS1,G1857V,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how common are mutations in TNS1 and amplifications in ZMYM3?",cnv_and_ssm
+7,TNS1,G843V,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how common are mutations in TNS1 and amplifications in TASOR2?",cnv_and_ssm
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how common are mutations in EVC2 and amplifications in DHX16?",cnv_and_ssm
+15,EVC2,E987K,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how common are mutations in EVC2 and amplifications in MORF4L1?",cnv_and_ssm
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in CR1 and amplifications in CDH23?",cnv_and_ssm
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in CR1 and amplifications in EIF2B4?",cnv_and_ssm
+22,TRPA1,S295I,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how common are mutations in TRPA1 and amplifications in TLCD5?",cnv_and_ssm
+23,TRPA1,S443I,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how common are mutations in TRPA1 and amplifications in PTPRO?",cnv_and_ssm
+24,TAF1C,R299L,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in TAF1C and amplifications in OR13C3?",cnv_and_ssm
+25,TAF1C,R396L,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in TAF1C and amplifications in ZBTB34?",cnv_and_ssm
+26,TAF1C,R634L,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in TAF1C and amplifications in CFAP61?",cnv_and_ssm
+27,TAF1C,R702L,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in TAF1C and amplifications in RIPOR2?",cnv_and_ssm
+28,TAF1C,R728L,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in TAF1C and amplifications in MAST4?",cnv_and_ssm
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in DPF3 and amplifications in KDM5C?",cnv_and_ssm
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in DPF3 and amplifications in GSTCD?",cnv_and_ssm
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in DPF3 and amplifications in MORF4L1?",cnv_and_ssm
+42,OR2T4,P272H,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in OR2T4 and amplifications in AKT1?",cnv_and_ssm
+43,OR2T4,P300H,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in OR2T4 and amplifications in RAB40C?",cnv_and_ssm
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,"In cases of Pancreatic Adenocarcinoma, how common are mutations in FBN1 and amplifications in SPATA22?",cnv_and_ssm
+45,MAD1L1,E396K,Prostate Adenocarcinoma,"In cases of Prostate Adenocarcinoma, how common are mutations in MAD1L1 and amplifications in CNGB1?",cnv_and_ssm
+46,MAD1L1,E488K,Prostate Adenocarcinoma,"In cases of Prostate Adenocarcinoma, how common are mutations in MAD1L1 and amplifications in FCGR2C?",cnv_and_ssm
+47,MAD1L1,E78K,Prostate Adenocarcinoma,"In cases of Prostate Adenocarcinoma, how common are mutations in MAD1L1 and amplifications in AUTS2?",cnv_and_ssm
+61,CCNG1,E22K,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in CCNG1 and amplifications in ZKSCAN7?",cnv_and_ssm
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,"In cases of Kidney Renal Papillary Cell Carcinoma, how common are mutations in ANP32E and amplifications in MYH11?",cnv_and_ssm
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,"In cases of Kidney Renal Papillary Cell Carcinoma, how common are mutations in ANP32E and amplifications in MAD1L1?",cnv_and_ssm
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,"In cases of Kidney Renal Papillary Cell Carcinoma, how common are mutations in ANP32E and amplifications in PIK3C2B?",cnv_and_ssm
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,"In cases of Kidney Renal Papillary Cell Carcinoma, how common are mutations in ANP32E and amplifications in PLEKHG6?",cnv_and_ssm
+66,FRY,S1888A,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how common are mutations in FRY and amplifications in MRPL32?",cnv_and_ssm
+67,FRY,S1937A,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how common are mutations in FRY and amplifications in TYROBP?",cnv_and_ssm
+68,FRY,S1938A,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how common are mutations in FRY and amplifications in DNMT1?",cnv_and_ssm
+69,FRY,S1983A,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how common are mutations in FRY and amplifications in TNS1?",cnv_and_ssm
+70,PAK3,E318K,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in PAK3 and amplifications in SMO?",cnv_and_ssm
+71,PAK3,E319K,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in PAK3 and amplifications in KDM5C?",cnv_and_ssm
+72,PAK3,E334K,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in PAK3 and amplifications in FRY?",cnv_and_ssm
+73,PAK3,E340K,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in PAK3 and amplifications in PAPPA?",cnv_and_ssm
+74,PAK3,E355K,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in PAK3 and amplifications in EIF2B4?",cnv_and_ssm
+80,MUC16,P7963L,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in MUC16 and amplifications in PYHIN1?",cnv_and_ssm
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,"In cases of Liver Hepatocellular Carcinoma, how common are mutations in ZFPM2 and amplifications in USH2A?",cnv_and_ssm
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,"In cases of Liver Hepatocellular Carcinoma, how common are mutations in ZFPM2 and amplifications in TYROBP?",cnv_and_ssm
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how common are mutations in PIK3C2B and amplifications in YY1AP1?",cnv_and_ssm
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how common are mutations in PIK3C2B and amplifications in POLR1G?",cnv_and_ssm
+114,ZNF804A,S371Y,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in ZNF804A and amplifications in CPS1?",cnv_and_ssm
+116,RELN,A2371V,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in RELN and amplifications in ANKRD24?",cnv_and_ssm
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how common are mutations in EFCAB12 and amplifications in TRIM45?",cnv_and_ssm
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how common are mutations in EFCAB12 and amplifications in ZCCHC14?",cnv_and_ssm
+120,DEFB115,E53K,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in DEFB115 and amplifications in EIF2B4?",cnv_and_ssm
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how common are mutations in ANKDD1A and amplifications in AUTS2?",cnv_and_ssm
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how common are mutations in ANKDD1A and amplifications in TNS1?",cnv_and_ssm
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how common are mutations in ANKDD1A and amplifications in ANKDD1A?",cnv_and_ssm
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in HTR3B and amplifications in EPRS1?",cnv_and_ssm
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in HTR3B and amplifications in KRT39?",cnv_and_ssm
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in HTR3B and amplifications in DCC?",cnv_and_ssm
+129,ABCC3,R758W,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in ABCC3 and amplifications in FRY?",cnv_and_ssm
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in NOMO1 and amplifications in GLRB?",cnv_and_ssm
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in NOMO1 and amplifications in TENM3?",cnv_and_ssm
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how common are mutations in HYOU1 and amplifications in CTCFL?",cnv_and_ssm
+139,FMO4,R500Q,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in FMO4 and amplifications in GRM5?",cnv_and_ssm
+140,BICC1,A372V,Exceptional Responders,"In cases of Exceptional Responders, how common are mutations in BICC1 and amplifications in PAK3?",cnv_and_ssm
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in ZMYM3 and amplifications in TLCD5?",cnv_and_ssm
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in ZMYM3 and amplifications in MSANTD4?",cnv_and_ssm
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in ZMYM3 and amplifications in PSG2?",cnv_and_ssm
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how common are mutations in XKR4 and amplifications in PGF?",cnv_and_ssm
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,"In cases of Liver Hepatocellular Carcinoma, how common are mutations in ABCC2 and amplifications in ANKRD24?",cnv_and_ssm
+157,OR8K5,R293G,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in OR8K5 and amplifications in PDGFC?",cnv_and_ssm
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in SPTAN1 and amplifications in ANKRD24?",cnv_and_ssm
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in SPTAN1 and amplifications in NRAP?",cnv_and_ssm
+164,SYT10,M484I,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how common are mutations in SYT10 and amplifications in POC1B?",cnv_and_ssm
+174,HSPA5,N457K,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in HSPA5 and amplifications in OR8K5?",cnv_and_ssm
+175,UNC5D,L280V,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in UNC5D and amplifications in PRSS8?",cnv_and_ssm
+176,UNC5D,L635V,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in UNC5D and amplifications in FGF8?",cnv_and_ssm
+177,UNC5D,L637V,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in UNC5D and amplifications in WNT2?",cnv_and_ssm
+178,UNC5D,L699V,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in UNC5D and amplifications in RIMS2?",cnv_and_ssm
+179,UNC5D,L704V,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in UNC5D and amplifications in DSCAM?",cnv_and_ssm
+180,UNC5D,L709V,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in UNC5D and amplifications in PXN?",cnv_and_ssm
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,"In cases of Kidney Renal Clear Cell Carcinoma, how common are mutations in DOCK2 and amplifications in ZCCHC14?",cnv_and_ssm
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,"In cases of Kidney Renal Clear Cell Carcinoma, how common are mutations in ZNF627 and amplifications in DNMT1?",cnv_and_ssm
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in CDC42BPA and amplifications in UNC5D?",cnv_and_ssm
+193,MRPL55,H27Y,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in MRPL55 and amplifications in LDOC1?",cnv_and_ssm
+194,MRPL55,H63Y,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in MRPL55 and amplifications in PIK3C2A?",cnv_and_ssm
+197,TMTC3,Q749K,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how common are mutations in TMTC3 and amplifications in YY1AP1?",cnv_and_ssm
+198,EPRS1,K771I,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in EPRS1 and amplifications in BICC1?",cnv_and_ssm
+199,EPRS1,K778I,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in EPRS1 and amplifications in AUTS2?",cnv_and_ssm
+201,GRTP1,A110V,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in GRTP1 and amplifications in STK19?",cnv_and_ssm
+202,GRTP1,A32V,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in GRTP1 and amplifications in YY1AP1?",cnv_and_ssm
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in TSHZ3 and amplifications in TNS1?",cnv_and_ssm
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,"In cases of HIV+ Tumor Molecular Characterization Project - Cervical Cancer, how common are mutations in TAS1R3 and amplifications in TENT5A?",cnv_and_ssm
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in PIAS3 and amplifications in ARHGEF40?",cnv_and_ssm
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in PIAS3 and amplifications in DPF3?",cnv_and_ssm
+251,ZNF274,P13R,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in ZNF274 and amplifications in RAB40C?",cnv_and_ssm
+253,SYNJ1,R795C,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in SYNJ1 and amplifications in TENM2?",cnv_and_ssm
+254,SYNJ1,R800C,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in SYNJ1 and amplifications in EIF2B4?",cnv_and_ssm
+255,SYNJ1,R839C,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in SYNJ1 and amplifications in NRAP?",cnv_and_ssm
+261,DSCAM,V343M,Prostate Adenocarcinoma,"In cases of Prostate Adenocarcinoma, how common are mutations in DSCAM and amplifications in FGF8?",cnv_and_ssm
+262,DSCAM,V426M,Prostate Adenocarcinoma,"In cases of Prostate Adenocarcinoma, how common are mutations in DSCAM and amplifications in UNC5D?",cnv_and_ssm
+263,DSCAM,V591M,Prostate Adenocarcinoma,"In cases of Prostate Adenocarcinoma, how common are mutations in DSCAM and amplifications in TAF1C?",cnv_and_ssm
+267,DGKD,R140H,Exceptional Responders,"In cases of Exceptional Responders, how common are mutations in DGKD and amplifications in DCC?",cnv_and_ssm
+268,DGKD,R160H,Exceptional Responders,"In cases of Exceptional Responders, how common are mutations in DGKD and amplifications in MYO16?",cnv_and_ssm
+269,DGKD,R204H,Exceptional Responders,"In cases of Exceptional Responders, how common are mutations in DGKD and amplifications in CX3CR1?",cnv_and_ssm
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how common are mutations in PLEKHG6 and amplifications in AUTS2?",cnv_and_ssm
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how common are mutations in PLEKHG6 and amplifications in KIF20B?",cnv_and_ssm
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how common are mutations in PLEKHG6 and amplifications in PCDHB2?",cnv_and_ssm
+279,WNT2,D138N,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in WNT2 and amplifications in FGF8?",cnv_and_ssm
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in GUCY2C and amplifications in FRY?",cnv_and_ssm
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in C7orf31 and amplifications in FBXO15?",cnv_and_ssm
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how common are mutations in ZKSCAN7 and amplifications in PRSS8?",cnv_and_ssm
+299,OR5D14,M210L,Neuroblastoma,"In cases of Neuroblastoma, how common are mutations in OR5D14 and amplifications in KDM5C?",cnv_and_ssm
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in SPATA22 and amplifications in CTCFL?",cnv_and_ssm
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in SPATA22 and amplifications in TTYH2?",cnv_and_ssm
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in SPATA22 and amplifications in CPA6?",cnv_and_ssm
+310,LCN15,E21V,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in LCN15 and amplifications in ZNF584?",cnv_and_ssm
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in DCAF4L2 and amplifications in MAST4?",cnv_and_ssm
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in GUK1 and amplifications in ZFPM2?",cnv_and_ssm
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in GUK1 and amplifications in RELN?",cnv_and_ssm
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in GUK1 and amplifications in MAD1L1?",cnv_and_ssm
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in GUK1 and amplifications in DNAH11?",cnv_and_ssm
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in GUK1 and amplifications in ART3?",cnv_and_ssm
+328,MORF4L1,K29T,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in MORF4L1 and amplifications in TLCD5?",cnv_and_ssm
+329,MORF4L1,K51T,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in MORF4L1 and amplifications in FCGR2C?",cnv_and_ssm
+330,MORF4L1,K61T,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in MORF4L1 and amplifications in DNMT1?",cnv_and_ssm
+331,MORF4L1,K76T,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in MORF4L1 and amplifications in TENM3?",cnv_and_ssm
+335,MYO3B,F594L,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in MYO3B and amplifications in PKHD1L1?",cnv_and_ssm
+336,MYO3B,F603L,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in MYO3B and amplifications in CFAP61?",cnv_and_ssm
+339,TENT5A,S320F,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in TENT5A and amplifications in PKHD1L1?",cnv_and_ssm
+340,TENT5A,S339F,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in TENT5A and amplifications in TNS1?",cnv_and_ssm
+341,TENT5A,S401F,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in TENT5A and amplifications in TAF1L?",cnv_and_ssm
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,"In cases of Ovarian Serous Cystadenocarcinoma, how common are mutations in ZFAT and amplifications in KDM5C?",cnv_and_ssm
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,"In cases of Ovarian Serous Cystadenocarcinoma, how common are mutations in ZFAT and amplifications in ZNF431?",cnv_and_ssm
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,"In cases of Ovarian Serous Cystadenocarcinoma, how common are mutations in ZFAT and amplifications in NOMO1?",cnv_and_ssm
+357,ZNF584,A211T,Sarcoma,"In cases of Sarcoma, how common are mutations in ZNF584 and amplifications in DSCAM?",cnv_and_ssm
+358,ZNF584,A256T,Sarcoma,"In cases of Sarcoma, how common are mutations in ZNF584 and amplifications in ACTB?",cnv_and_ssm
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in LDOC1 and amplifications in PIK3C2G?",cnv_and_ssm
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in PDGFC and amplifications in PTPRO?",cnv_and_ssm
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in MSANTD4 and amplifications in CNGB1?",cnv_and_ssm
+374,NPSR1,S123L,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in NPSR1 and amplifications in PTPRN2?",cnv_and_ssm
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in PHLPP1 and amplifications in BFAR?",cnv_and_ssm
+385,COL6A3,G237S,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in COL6A3 and amplifications in SPATA22?",cnv_and_ssm
+386,COL6A3,G437S,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in COL6A3 and amplifications in PIK3C2B?",cnv_and_ssm
+387,COL6A3,G638S,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in COL6A3 and amplifications in SPTAN1?",cnv_and_ssm
+388,COL6A3,G644S,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in COL6A3 and amplifications in PTPRN2?",cnv_and_ssm
+389,COL6A3,G844S,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in COL6A3 and amplifications in XKR4?",cnv_and_ssm
+395,ADRA1A,R348G,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in ADRA1A and amplifications in MYO16?",cnv_and_ssm
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, how common are mutations in LAMB2 and amplifications in GUCY2C?",cnv_and_ssm
+406,POC1B,I198T,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how common are mutations in POC1B and amplifications in TTN?",cnv_and_ssm
+407,POC1B,I286T,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how common are mutations in POC1B and amplifications in DCLK3?",cnv_and_ssm
+408,POC1B,I328T,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how common are mutations in POC1B and amplifications in ADAM17?",cnv_and_ssm
+409,POC1B,S79P,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how common are mutations in POC1B and amplifications in LAMB2?",cnv_and_ssm
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,"In cases of Liver Hepatocellular Carcinoma, how common are mutations in USH2A and amplifications in TNS1?",cnv_and_ssm
+414,AQP7,T110S,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how common are mutations in AQP7 and amplifications in CDC42BPA?",cnv_and_ssm
+415,AQP7,T166S,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how common are mutations in AQP7 and amplifications in KIF20B?",cnv_and_ssm
+416,AQP7,T167S,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how common are mutations in AQP7 and amplifications in TMEM255A?",cnv_and_ssm
+417,AQP7,T75S,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how common are mutations in AQP7 and amplifications in CHODL?",cnv_and_ssm
+430,DCN,R163C,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how common are mutations in DCN and amplifications in PDHA2?",cnv_and_ssm
+431,DCN,R203C,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how common are mutations in DCN and amplifications in FCGR2C?",cnv_and_ssm
+432,DCN,R241C,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how common are mutations in DCN and amplifications in EIF2B4?",cnv_and_ssm
+433,DCN,R350C,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how common are mutations in DCN and amplifications in CPS1?",cnv_and_ssm
+434,DCN,R41C,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how common are mutations in DCN and amplifications in DCC?",cnv_and_ssm
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in CPS1 and amplifications in ZCCHC14?",cnv_and_ssm
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in CPS1 and amplifications in FGF8?",cnv_and_ssm
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in CPS1 and amplifications in PTPRN2?",cnv_and_ssm
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,"In cases of Kidney Renal Papillary Cell Carcinoma, how common are mutations in FCGR2C and amplifications in ANKRD30A?",cnv_and_ssm
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,"In cases of Kidney Renal Papillary Cell Carcinoma, how common are mutations in FCGR2C and amplifications in MYH11?",cnv_and_ssm
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in GRM1 and amplifications in PGR?",cnv_and_ssm
+482,SGCZ,Q138H,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in SGCZ and amplifications in OR2T4?",cnv_and_ssm
+483,SGCZ,Q91H,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in SGCZ and amplifications in TTC12?",cnv_and_ssm
+485,SMO,V15M,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in SMO and amplifications in ARMC3?",cnv_and_ssm
+486,SMO,V321M,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in SMO and amplifications in FGF8?",cnv_and_ssm
+488,CHODL,G159E,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in CHODL and amplifications in LAMB2?",cnv_and_ssm
+489,CHODL,G181E,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in CHODL and amplifications in SOX21?",cnv_and_ssm
+490,CHODL,G200E,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in CHODL and amplifications in DCC?",cnv_and_ssm
+494,MYO16,P399H,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in MYO16 and amplifications in DNAH11?",cnv_and_ssm
+495,MYO16,P421H,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in MYO16 and amplifications in EIF2B4?",cnv_and_ssm
+498,CXCR2,A98V,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in CXCR2 and amplifications in ZNF804A?",cnv_and_ssm
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how common are mutations in TMEM225 and amplifications in CX3CR1?",cnv_and_ssm
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in MAOB and amplifications in ERCC6?",cnv_and_ssm
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in GPRASP1 and amplifications in ARMC3?",cnv_and_ssm
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in MRPL32 and amplifications in RIMS2?",cnv_and_ssm
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in TYROBP and amplifications in KDM5C?",cnv_and_ssm
+510,RAB40C,A111V,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in RAB40C and amplifications in DCC?",cnv_and_ssm
+511,RAB40C,A143V,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in RAB40C and amplifications in DHX16?",cnv_and_ssm
+512,CTNNA2,S323R,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in CTNNA2 and amplifications in GABRA6?",cnv_and_ssm
+513,CTNNA2,S339R,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in CTNNA2 and amplifications in BCAT1?",cnv_and_ssm
+514,CTNNA2,S386R,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in CTNNA2 and amplifications in CDH23?",cnv_and_ssm
+515,CTNNA2,S707R,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in CTNNA2 and amplifications in TAF1C?",cnv_and_ssm
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how common are mutations in MYO15A and amplifications in SGIP1?",cnv_and_ssm
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in GIMAP2 and amplifications in TLK2?",cnv_and_ssm
+532,KIF20B,N1160D,Glioblastoma Multiforme,"In cases of Glioblastoma Multiforme, how common are mutations in KIF20B and amplifications in SLC9C1?",cnv_and_ssm
+533,KIF20B,N1200D,Glioblastoma Multiforme,"In cases of Glioblastoma Multiforme, how common are mutations in KIF20B and amplifications in PTPRO?",cnv_and_ssm
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in ADAM17 and amplifications in MYT1?",cnv_and_ssm
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in BCAT1 and amplifications in ICE1?",cnv_and_ssm
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in BCAT1 and amplifications in GIMAP2?",cnv_and_ssm
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in BCAT1 and amplifications in TAF1L?",cnv_and_ssm
+540,ERCC6,R1053H,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in ERCC6 and amplifications in PRSS1?",cnv_and_ssm
+541,DCC,R320W,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how common are mutations in DCC and amplifications in BICC1?",cnv_and_ssm
+542,DCC,R363W,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how common are mutations in DCC and amplifications in USH2A?",cnv_and_ssm
+543,DCC,R386W,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how common are mutations in DCC and amplifications in HTR3B?",cnv_and_ssm
+544,DCC,R41W,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how common are mutations in DCC and amplifications in CTSC?",cnv_and_ssm
+549,FBXO15,D417N,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in FBXO15 and amplifications in ZFP42?",cnv_and_ssm
+550,FBXO15,D86N,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in FBXO15 and amplifications in JAML?",cnv_and_ssm
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in GSTCD and amplifications in PTPRO?",cnv_and_ssm
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in GSTCD and amplifications in CTCFL?",cnv_and_ssm
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in OLFML3 and amplifications in UNC5D?",cnv_and_ssm
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in OLFML3 and amplifications in TTC12?",cnv_and_ssm
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in OLFML3 and amplifications in LAMB2?",cnv_and_ssm
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,"In cases of Ovarian Serous Cystadenocarcinoma, how common are mutations in CFAP61 and amplifications in ZCCHC14?",cnv_and_ssm
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,"In cases of Ovarian Serous Cystadenocarcinoma, how common are mutations in CFAP61 and amplifications in TTC12?",cnv_and_ssm
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how common are mutations in HLA-DQA2 and amplifications in THBS4?",cnv_and_ssm
+582,TENM2,H240Y,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in TENM2 and amplifications in UNC5D?",cnv_and_ssm
+583,TENM2,H351Y,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in TENM2 and amplifications in UNC5D?",cnv_and_ssm
+584,TENM2,H472Y,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in TENM2 and amplifications in EIF2B4?",cnv_and_ssm
+600,ANKRD24,A465T,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in ANKRD24 and amplifications in AUTS2?",cnv_and_ssm
+601,ANKRD24,A494T,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in ANKRD24 and amplifications in PXN?",cnv_and_ssm
+602,ANKRD24,A584T,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in ANKRD24 and amplifications in PAPPA?",cnv_and_ssm
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in ZCCHC14 and amplifications in STK19?",cnv_and_ssm
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in ZCCHC14 and amplifications in MAST4?",cnv_and_ssm
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in ZCCHC14 and amplifications in RELN?",cnv_and_ssm
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in ZCCHC14 and amplifications in TNS1?",cnv_and_ssm
+625,SIK2,I265M,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in SIK2 and amplifications in THBS4?",cnv_and_ssm
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in MYH11 and amplifications in MYO15A?",cnv_and_ssm
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in MYH11 and amplifications in PIAS3?",cnv_and_ssm
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in SLC6A4 and amplifications in ART3?",cnv_and_ssm
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in SLC9C1 and amplifications in GRM1?",cnv_and_ssm
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in SLC9C1 and amplifications in CYB5R2?",cnv_and_ssm
+644,OR2A12,A254T,Brain Lower Grade Glioma,"In cases of Brain Lower Grade Glioma, how common are mutations in OR2A12 and amplifications in GUK1?",cnv_and_ssm
+646,PYHIN1,T325K,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in PYHIN1 and amplifications in TNS1?",cnv_and_ssm
+647,PYHIN1,T334K,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in PYHIN1 and amplifications in MAD1L1?",cnv_and_ssm
+650,JAML,G191E,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in JAML and amplifications in TTC12?",cnv_and_ssm
+651,JAML,G219E,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in JAML and amplifications in CARMIL1?",cnv_and_ssm
+652,JAML,G220E,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in JAML and amplifications in SMO?",cnv_and_ssm
+653,JAML,G230E,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in JAML and amplifications in YY1AP1?",cnv_and_ssm
+658,TYK2,H1146R,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in TYK2 and amplifications in MYO3A?",cnv_and_ssm
+659,TYK2,H23R,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in TYK2 and amplifications in AQP7?",cnv_and_ssm
+660,TYK2,H961R,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in TYK2 and amplifications in GUCY2C?",cnv_and_ssm
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in CTCFL and amplifications in USH2A?",cnv_and_ssm
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in CTCFL and amplifications in GPR158?",cnv_and_ssm
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in CTCFL and amplifications in COL6A3?",cnv_and_ssm
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in CTCFL and amplifications in ART3?",cnv_and_ssm
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in CEP20 and amplifications in MAD1L1?",cnv_and_ssm
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in CEP20 and amplifications in ZBTB34?",cnv_and_ssm
+689,RIMS2,R25W,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in RIMS2 and amplifications in PIK3C2B?",cnv_and_ssm
+690,RIMS2,R393W,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in RIMS2 and amplifications in SGCZ?",cnv_and_ssm
+691,RIMS2,R423W,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in RIMS2 and amplifications in DCAF6?",cnv_and_ssm
+692,RIMS2,R470W,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in RIMS2 and amplifications in CTCFL?",cnv_and_ssm
+693,RIMS2,R615W,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in RIMS2 and amplifications in PCDHB2?",cnv_and_ssm
+694,RIMS2,R619W,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in RIMS2 and amplifications in EFCAB12?",cnv_and_ssm
+695,RIMS2,R716W,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in RIMS2 and amplifications in MYT1?",cnv_and_ssm
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in PIK3C2G and amplifications in MRPL55?",cnv_and_ssm
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in PIK3C2G and amplifications in UNC5D?",cnv_and_ssm
+728,STK19,D341N,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in STK19 and amplifications in ZFAT?",cnv_and_ssm
+729,STK19,D345N,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in STK19 and amplifications in CPA6?",cnv_and_ssm
+730,REXO4,P60A,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in REXO4 and amplifications in VPS26B?",cnv_and_ssm
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in ZBTB34 and amplifications in ADAM17?",cnv_and_ssm
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in ZBTB34 and amplifications in AUTS2?",cnv_and_ssm
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how common are mutations in NCKAP5 and amplifications in TLK2?",cnv_and_ssm
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how common are mutations in SORCS1 and amplifications in UNC5D?",cnv_and_ssm
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how common are mutations in SORCS1 and amplifications in PRSS1?",cnv_and_ssm
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how common are mutations in SORCS1 and amplifications in KDM5C?",cnv_and_ssm
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how common are mutations in SORCS1 and amplifications in EIF2B4?",cnv_and_ssm
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,"In cases of Head and Neck Squamous Cell Carcinoma, how common are mutations in FGF8 and amplifications in AUTS2?",cnv_and_ssm
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,"In cases of Head and Neck Squamous Cell Carcinoma, how common are mutations in FGF8 and amplifications in ANP32E?",cnv_and_ssm
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,"In cases of Head and Neck Squamous Cell Carcinoma, how common are mutations in FGF8 and amplifications in ERCC6?",cnv_and_ssm
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,"In cases of Head and Neck Squamous Cell Carcinoma, how common are mutations in FGF8 and amplifications in MAD1L1?",cnv_and_ssm
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,"In cases of Head and Neck Squamous Cell Carcinoma, how common are mutations in FGF8 and amplifications in PIK3C2G?",cnv_and_ssm
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,"In cases of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia, how common are mutations in TENM3 and amplifications in ANKRD24?",cnv_and_ssm
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in AKT1 and amplifications in HSPA5?",cnv_and_ssm
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, how common are mutations in CFAP298-TCP10L and amplifications in CPS1?",cnv_and_ssm
+792,GLRB,E148D,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in GLRB and amplifications in CCNG1?",cnv_and_ssm
+793,TTN,F7636L,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in TTN and amplifications in ZNF274?",cnv_and_ssm
+794,TTN,F8563L,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in TTN and amplifications in CR1?",cnv_and_ssm
+795,TTN,F8880L,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in TTN and amplifications in OR5D14?",cnv_and_ssm
+799,ANKRD30A,V798I,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in ANKRD30A and amplifications in CTCFL?",cnv_and_ssm
+800,ANKRD30A,V854I,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in ANKRD30A and amplifications in AUTS2?",cnv_and_ssm
+801,ANKRD30A,V973I,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in ANKRD30A and amplifications in NEXN?",cnv_and_ssm
+809,TRIM45,S177L,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in TRIM45 and amplifications in MAD1L1?",cnv_and_ssm
+810,TRIM45,S224L,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in TRIM45 and amplifications in PRSS1?",cnv_and_ssm
+811,TRIM45,S281L,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in TRIM45 and amplifications in PTPRN2?",cnv_and_ssm
+812,CACNA1F,G727V,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in CACNA1F and amplifications in SYNJ1?",cnv_and_ssm
+813,CACNA1F,G781V,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in CACNA1F and amplifications in PAPPA?",cnv_and_ssm
+814,CACNA1F,G792V,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in CACNA1F and amplifications in ANKRD30A?",cnv_and_ssm
+817,KL,R594C,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in KL and amplifications in SORCS1?",cnv_and_ssm
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,"In cases of Kidney Renal Papillary Cell Carcinoma, how common are mutations in GUF1 and amplifications in CNGB1?",cnv_and_ssm
+822,TAF1L,A539V,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in TAF1L and amplifications in TLK2?",cnv_and_ssm
+823,TASOR2,S256F,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in TASOR2 and amplifications in MYH11?",cnv_and_ssm
+824,TASOR2,S36F,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in TASOR2 and amplifications in EPRS1?",cnv_and_ssm
+825,TASOR2,S471F,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in TASOR2 and amplifications in HBB?",cnv_and_ssm
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in KDM5C and amplifications in COL6A3?",cnv_and_ssm
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in KDM5C and amplifications in CTNNA2?",cnv_and_ssm
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in KDM5C and amplifications in EIF2B4?",cnv_and_ssm
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in KDM5C and amplifications in TLK2?",cnv_and_ssm
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, how common are mutations in IL5RA and amplifications in TLK2?",cnv_and_ssm
+843,DHX16,A29V,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in DHX16 and amplifications in DNAH11?",cnv_and_ssm
+844,DHX16,A89V,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in DHX16 and amplifications in PRSS8?",cnv_and_ssm
+902,GPR158,A644V,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in GPR158 and amplifications in CTNNA2?",cnv_and_ssm
+903,GPR158,A723V,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in GPR158 and amplifications in SORCS1?",cnv_and_ssm
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how common are mutations in EIF2B4 and amplifications in POLD1?",cnv_and_ssm
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how common are mutations in EIF2B4 and amplifications in RIMS2?",cnv_and_ssm
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how common are mutations in EIF2B4 and amplifications in CYB5R2?",cnv_and_ssm
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how common are mutations in EIF2B4 and amplifications in KIF20B?",cnv_and_ssm
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how common are mutations in EIF2B4 and amplifications in TNS1?",cnv_and_ssm
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how common are mutations in EIF2B4 and amplifications in IL5RA?",cnv_and_ssm
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in AUTS2 and amplifications in COL6A3?",cnv_and_ssm
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in AUTS2 and amplifications in POC1B?",cnv_and_ssm
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in AUTS2 and amplifications in TNS1?",cnv_and_ssm
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in AUTS2 and amplifications in SPTAN1?",cnv_and_ssm
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in AUTS2 and amplifications in PIK3C2G?",cnv_and_ssm
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in AUTS2 and amplifications in MED16?",cnv_and_ssm
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in AUTS2 and amplifications in TRPA1?",cnv_and_ssm
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in AUTS2 and amplifications in MAD1L1?",cnv_and_ssm
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in AUTS2 and amplifications in B3GALNT1?",cnv_and_ssm
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in AUTS2 and amplifications in FCGR2C?",cnv_and_ssm
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how common are mutations in ACTL7B and amplifications in STK19?",cnv_and_ssm
+952,PCDHGA1,R535W,Glioblastoma Multiforme,"In cases of Glioblastoma Multiforme, how common are mutations in PCDHGA1 and amplifications in ACTB?",cnv_and_ssm
+954,TRAP1,R114W,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in TRAP1 and amplifications in SGIP1?",cnv_and_ssm
+955,TRAP1,R61W,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in TRAP1 and amplifications in PXN?",cnv_and_ssm
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in PIK3C2A and amplifications in POC1B?",cnv_and_ssm
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,"In cases of Liver Hepatocellular Carcinoma, how common are mutations in KANSL1 and amplifications in MORF4L1?",cnv_and_ssm
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in ANKRD52 and amplifications in MERTK?",cnv_and_ssm
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in PAPPA and amplifications in UBR2?",cnv_and_ssm
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how common are mutations in B3GALNT1 and amplifications in CCDC22?",cnv_and_ssm
+982,GABRA6,G115R,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in GABRA6 and amplifications in SORCS1?",cnv_and_ssm
+983,GABRA6,G122R,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in GABRA6 and amplifications in PDHA2?",cnv_and_ssm
+984,GABRA6,G165R,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in GABRA6 and amplifications in CFAP298-TCP10L?",cnv_and_ssm
+985,GABRA6,G175R,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in GABRA6 and amplifications in POC1B?",cnv_and_ssm
+986,GABRA6,G70R,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in GABRA6 and amplifications in EBF2?",cnv_and_ssm
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in ZSCAN31 and amplifications in MYO3A?",cnv_and_ssm
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how common are mutations in MED16 and amplifications in BCAT1?",cnv_and_ssm
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how common are mutations in MED16 and amplifications in POLD1?",cnv_and_ssm
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,"In cases of Pancreatic Adenocarcinoma, how common are mutations in PTPRO and amplifications in AUTS2?",cnv_and_ssm
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,"In cases of Pancreatic Adenocarcinoma, how common are mutations in PTPRO and amplifications in ANP32E?",cnv_and_ssm
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,"In cases of Pancreatic Adenocarcinoma, how common are mutations in PTPRO and amplifications in ANKRD24?",cnv_and_ssm
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,"In cases of Pancreatic Adenocarcinoma, how common are mutations in PTPRO and amplifications in ZBTB34?",cnv_and_ssm
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,"In cases of Pancreatic Adenocarcinoma, how common are mutations in PTPRO and amplifications in CFAP61?",cnv_and_ssm
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,"In cases of Pancreatic Adenocarcinoma, how common are mutations in PTPRO and amplifications in ACVR1B?",cnv_and_ssm
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,"In cases of Pancreatic Adenocarcinoma, how common are mutations in PTPRO and amplifications in DCC?",cnv_and_ssm
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,"In cases of Pancreatic Adenocarcinoma, how common are mutations in PTPRO and amplifications in MERTK?",cnv_and_ssm
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in CHMP7 and amplifications in TTC17?",cnv_and_ssm
+1017,GPC3,I107N,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in GPC3 and amplifications in BCAT1?",cnv_and_ssm
+1018,GPC3,I161N,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in GPC3 and amplifications in PAK3?",cnv_and_ssm
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, how common are mutations in TLK2 and amplifications in VPS26B?",cnv_and_ssm
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, how common are mutations in TLK2 and amplifications in SGIP1?",cnv_and_ssm
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, how common are mutations in TLK2 and amplifications in CTSC?",cnv_and_ssm
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, how common are mutations in TLK2 and amplifications in TYK2?",cnv_and_ssm
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,"In cases of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma, how common are mutations in TLK2 and amplifications in KL?",cnv_and_ssm
+1036,ZNF217,E209Q,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in ZNF217 and amplifications in PTPRO?",cnv_and_ssm
+1038,SYT9,V275L,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in SYT9 and amplifications in KIF20B?",cnv_and_ssm
+1039,SYT9,V307L,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in SYT9 and amplifications in SGIP1?",cnv_and_ssm
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in PKHD1L1 and amplifications in ACTB?",cnv_and_ssm
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in MYO3A and amplifications in TTC17?",cnv_and_ssm
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how common are mutations in VASN and amplifications in MRPL55?",cnv_and_ssm
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in DNMT1 and amplifications in C7orf31?",cnv_and_ssm
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in DNMT1 and amplifications in CDKN2AIP?",cnv_and_ssm
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in DNMT1 and amplifications in DCN?",cnv_and_ssm
+1056,CA9,E402K,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in CA9 and amplifications in SERPINB10?",cnv_and_ssm
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in TTC17 and amplifications in COL6A3?",cnv_and_ssm
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in TTC17 and amplifications in ZBTB34?",cnv_and_ssm
+1065,PSG2,P43L,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how common are mutations in PSG2 and amplifications in TTYH2?",cnv_and_ssm
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how common are mutations in RIPOR2 and amplifications in SYT9?",cnv_and_ssm
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how common are mutations in RIPOR2 and amplifications in THBS4?",cnv_and_ssm
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how common are mutations in RIPOR2 and amplifications in MERTK?",cnv_and_ssm
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how common are mutations in RIPOR2 and amplifications in UNC5D?",cnv_and_ssm
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in DCLK3 and amplifications in PXN?",cnv_and_ssm
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in DCLK3 and amplifications in TENT5A?",cnv_and_ssm
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in MERTK and amplifications in CTCFL?",cnv_and_ssm
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in MERTK and amplifications in GRTP1?",cnv_and_ssm
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in MERTK and amplifications in PLEKHG6?",cnv_and_ssm
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in ZFP42 and amplifications in EPRS1?",cnv_and_ssm
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in OR13C3 and amplifications in RIMS2?",cnv_and_ssm
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in OR13C3 and amplifications in ANKRD52?",cnv_and_ssm
+1091,SPAG1,I917M,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in SPAG1 and amplifications in RIMS2?",cnv_and_ssm
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in CDKN2AIP and amplifications in GUK1?",cnv_and_ssm
+1093,PXN,H1016Y,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in PXN and amplifications in ACVR1B?",cnv_and_ssm
+1094,PXN,H359Y,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in PXN and amplifications in COL6A3?",cnv_and_ssm
+1095,PXN,H492Y,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in PXN and amplifications in CTSC?",cnv_and_ssm
+1096,PXN,H524Y,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in PXN and amplifications in CDKN2AIP?",cnv_and_ssm
+1097,PXN,H526Y,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in PXN and amplifications in FGF8?",cnv_and_ssm
+1098,PXN,H540Y,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in PXN and amplifications in TAF1C?",cnv_and_ssm
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in TTYH2 and amplifications in C7orf31?",cnv_and_ssm
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in TTYH2 and amplifications in FBXO15?",cnv_and_ssm
+1106,TMEM255A,N205S,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in TMEM255A and amplifications in MUC16?",cnv_and_ssm
+1107,TMEM255A,N229S,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in TMEM255A and amplifications in UNC5D?",cnv_and_ssm
+1108,TMEM255A,N65S,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in TMEM255A and amplifications in PCDHB2?",cnv_and_ssm
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how common are mutations in TASOR2 and amplifications in AQP7?",cnv_and_ssm
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how common are mutations in TASOR2 and amplifications in DPF3?",cnv_and_ssm
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in ICE1 and amplifications in DNAH11?",cnv_and_ssm
+1112,MYT1,A558E,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how common are mutations in MYT1 and amplifications in SYT9?",cnv_and_ssm
+1113,MYT1,A879E,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how common are mutations in MYT1 and amplifications in AUTS2?",cnv_and_ssm
+1114,MYT1,A906E,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how common are mutations in MYT1 and amplifications in VASN?",cnv_and_ssm
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in CX3CR1 and amplifications in MED16?",cnv_and_ssm
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in CX3CR1 and amplifications in GABRA6?",cnv_and_ssm
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,"In cases of Liver Hepatocellular Carcinoma, how common are mutations in SPINDOC and amplifications in PCDHB2?",cnv_and_ssm
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in ART3 and amplifications in OR8K5?",cnv_and_ssm
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in ART3 and amplifications in HTR3B?",cnv_and_ssm
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how common are mutations in CYP1A2 and amplifications in GUK1?",cnv_and_ssm
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how common are mutations in ADRA1A and amplifications in CTCFL?",cnv_and_ssm
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in CDH23 and amplifications in RAB40C?",cnv_and_ssm
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in CDH23 and amplifications in CASZ1?",cnv_and_ssm
+1148,KRT39,P137S,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in KRT39 and amplifications in ITPRID2?",cnv_and_ssm
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in PDHA2 and amplifications in ADAM17?",cnv_and_ssm
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in SLC24A2 and amplifications in GPR158?",cnv_and_ssm
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,"In cases of Liver Hepatocellular Carcinoma, how common are mutations in PTPRN2 and amplifications in CARMIL1?",cnv_and_ssm
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,"In cases of Liver Hepatocellular Carcinoma, how common are mutations in PTPRN2 and amplifications in BCAT1?",cnv_and_ssm
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,"In cases of Liver Hepatocellular Carcinoma, how common are mutations in PTPRN2 and amplifications in EFCAB12?",cnv_and_ssm
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,"In cases of Liver Hepatocellular Carcinoma, how common are mutations in PTPRN2 and amplifications in JAML?",cnv_and_ssm
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,"In cases of Liver Hepatocellular Carcinoma, how common are mutations in PTPRN2 and amplifications in CTSC?",cnv_and_ssm
+1188,SOX21,R55L,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in SOX21 and amplifications in GSTCD?",cnv_and_ssm
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how common are mutations in CPA6 and amplifications in OLFML3?",cnv_and_ssm
+1206,GRM5,E14K,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in GRM5 and amplifications in ANP32E?",cnv_and_ssm
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how common are mutations in CASZ1 and amplifications in AKT1?",cnv_and_ssm
+1210,SGIP1,N122T,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in SGIP1 and amplifications in ZNF804A?",cnv_and_ssm
+1211,SGIP1,N420T,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in SGIP1 and amplifications in CTSC?",cnv_and_ssm
+1212,SGIP1,N617T,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in SGIP1 and amplifications in PLEKHG6?",cnv_and_ssm
+1213,SGIP1,N648T,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in SGIP1 and amplifications in CASZ1?",cnv_and_ssm
+1227,CARMIL1,V549L,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in CARMIL1 and amplifications in EIF2B4?",cnv_and_ssm
+1228,CARMIL1,V949L,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in CARMIL1 and amplifications in ACTA2?",cnv_and_ssm
+1232,ZNF431,D121Y,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in ZNF431 and amplifications in TENM3?",cnv_and_ssm
+1233,ZNF431,D161Y,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in ZNF431 and amplifications in PTPRO?",cnv_and_ssm
+1234,ZNF431,R128I,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in ZNF431 and amplifications in LAMB2?",cnv_and_ssm
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in DNAH11 and amplifications in PIK3C2G?",cnv_and_ssm
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in DNAH11 and amplifications in DGKD?",cnv_and_ssm
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in POLD1 and amplifications in DNAH14?",cnv_and_ssm
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,"In cases of Lung Squamous Cell Carcinoma, how common are mutations in POLD1 and amplifications in ZMYM3?",cnv_and_ssm
+1248,TTC12,D646H,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in TTC12 and amplifications in FMO4?",cnv_and_ssm
+1249,TTC12,D652H,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in TTC12 and amplifications in UNC5D?",cnv_and_ssm
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how common are mutations in CNGB1 and amplifications in ARMC3?",cnv_and_ssm
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,"In cases of Bladder Urothelial Carcinoma, how common are mutations in CNGB1 and amplifications in COL6A3?",cnv_and_ssm
+1254,CTSC,E214V,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in CTSC and amplifications in ZNF804A?",cnv_and_ssm
+1255,CTSC,E291V,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in CTSC and amplifications in RIMS2?",cnv_and_ssm
+1256,CTSC,E322V,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in CTSC and amplifications in MYH11?",cnv_and_ssm
+1257,CTSC,E324V,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in CTSC and amplifications in ZMYM3?",cnv_and_ssm
+1258,CTSC,E335V,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in CTSC and amplifications in PYHIN1?",cnv_and_ssm
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in PRSS8 and amplifications in SPTAN1?",cnv_and_ssm
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in PRSS8 and amplifications in JAML?",cnv_and_ssm
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in ARHGEF40 and amplifications in GPRASP1?",cnv_and_ssm
+1264,ACTB,A138T,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how common are mutations in ACTB and amplifications in CHODL?",cnv_and_ssm
+1265,ACTB,A217T,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how common are mutations in ACTB and amplifications in CTCFL?",cnv_and_ssm
+1266,ACTB,A244T,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how common are mutations in ACTB and amplifications in SPAG1?",cnv_and_ssm
+1267,ACTB,A260T,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how common are mutations in ACTB and amplifications in DNAH14?",cnv_and_ssm
+1268,YY1AP1,V546D,Glioblastoma Multiforme,"In cases of Glioblastoma Multiforme, how common are mutations in YY1AP1 and amplifications in DGKD?",cnv_and_ssm
+1269,YY1AP1,V557D,Glioblastoma Multiforme,"In cases of Glioblastoma Multiforme, how common are mutations in YY1AP1 and amplifications in KANSL1?",cnv_and_ssm
+1270,YY1AP1,V566D,Glioblastoma Multiforme,"In cases of Glioblastoma Multiforme, how common are mutations in YY1AP1 and amplifications in POLD1?",cnv_and_ssm
+1271,YY1AP1,V577D,Glioblastoma Multiforme,"In cases of Glioblastoma Multiforme, how common are mutations in YY1AP1 and amplifications in ANKDD1A?",cnv_and_ssm
+1272,YY1AP1,V623D,Glioblastoma Multiforme,"In cases of Glioblastoma Multiforme, how common are mutations in YY1AP1 and amplifications in MRPL55?",cnv_and_ssm
+1273,YY1AP1,V695D,Glioblastoma Multiforme,"In cases of Glioblastoma Multiforme, how common are mutations in YY1AP1 and amplifications in TAF1C?",cnv_and_ssm
+1274,YY1AP1,V715D,Glioblastoma Multiforme,"In cases of Glioblastoma Multiforme, how common are mutations in YY1AP1 and amplifications in DNAH14?",cnv_and_ssm
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in FNDC7 and amplifications in ZFP42?",cnv_and_ssm
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in FNDC7 and amplifications in TET2?",cnv_and_ssm
+1299,TLCD5,G15V,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in TLCD5 and amplifications in SIK2?",cnv_and_ssm
+1300,TLCD5,G37V,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in TLCD5 and amplifications in PAK3?",cnv_and_ssm
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in POLR1G and amplifications in MYO16?",cnv_and_ssm
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in POLR1G and amplifications in KANSL1?",cnv_and_ssm
+1308,DNAH14,N1186K,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in DNAH14 and amplifications in UNC5D?",cnv_and_ssm
+1309,DNAH14,N2657K,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in DNAH14 and amplifications in ZNF584?",cnv_and_ssm
+1310,DNAH14,N3460K,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in DNAH14 and amplifications in HTR3B?",cnv_and_ssm
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in NEXN and amplifications in PGR?",cnv_and_ssm
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,"In cases of Prostate Adenocarcinoma, how common are mutations in CYB5R2 and amplifications in SGIP1?",cnv_and_ssm
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,"In cases of Prostate Adenocarcinoma, how common are mutations in CYB5R2 and amplifications in ABCC2?",cnv_and_ssm
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in NRAP and amplifications in PTPRN2?",cnv_and_ssm
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in NRAP and amplifications in EFCAB12?",cnv_and_ssm
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in NRAP and amplifications in ZNF804A?",cnv_and_ssm
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in CCDC22 and amplifications in CHODL?",cnv_and_ssm
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in DCAF6 and amplifications in ADAM17?",cnv_and_ssm
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in DCAF6 and amplifications in TSHZ3?",cnv_and_ssm
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in ZNF708 and amplifications in CCNG1?",cnv_and_ssm
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in BFAR and amplifications in GPR158?",cnv_and_ssm
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in MAST4 and amplifications in MSANTD4?",cnv_and_ssm
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in MAST4 and amplifications in PRSS8?",cnv_and_ssm
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in MAST4 and amplifications in TNS1?",cnv_and_ssm
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in MAST4 and amplifications in DPF3?",cnv_and_ssm
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in MAST4 and amplifications in EBF2?",cnv_and_ssm
+1363,ARMC3,R169C,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in ARMC3 and amplifications in CHODL?",cnv_and_ssm
+1364,ARMC3,R432C,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in ARMC3 and amplifications in ACTL7B?",cnv_and_ssm
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,"In cases of Kidney Renal Clear Cell Carcinoma, how common are mutations in TET2 and amplifications in CTSC?",cnv_and_ssm
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,"In cases of Kidney Renal Clear Cell Carcinoma, how common are mutations in TET2 and amplifications in ANKRD30A?",cnv_and_ssm
+1369,SERPINB10,A353P,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in SERPINB10 and amplifications in ANKDD1A?",cnv_and_ssm
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in STAT3 and amplifications in ACTB?",cnv_and_ssm
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in MIEF1 and amplifications in MYO3B?",cnv_and_ssm
+1381,ACVR1B,D397N,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in ACVR1B and amplifications in TENM3?",cnv_and_ssm
+1382,ACVR1B,D449N,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in ACVR1B and amplifications in TAF1C?",cnv_and_ssm
+1383,ACVR1B,D490N,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in ACVR1B and amplifications in YY1AP1?",cnv_and_ssm
+1393,EBF2,T104I,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in EBF2 and amplifications in TAF1C?",cnv_and_ssm
+1394,EBF2,T252I,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in EBF2 and amplifications in DNMT1?",cnv_and_ssm
+1402,VPS26B,F266L,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in VPS26B and amplifications in OR8K5?",cnv_and_ssm
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how common are mutations in PGR and amplifications in MUC16?",cnv_and_ssm
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how common are mutations in PGR and amplifications in CX3CR1?",cnv_and_ssm
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","In cases of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus, how common are mutations in PGR and amplifications in FNDC7?",cnv_and_ssm
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,"In cases of Skin Cutaneous Melanoma, how common are mutations in ACTA2 and amplifications in RAB40C?",cnv_and_ssm
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in THBS4 and amplifications in ANKRD30A?",cnv_and_ssm
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in THBS4 and amplifications in AUTS2?",cnv_and_ssm
+1413,PRSS1,S114T,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in PRSS1 and amplifications in RELN?",cnv_and_ssm
+1414,PRSS1,S124T,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in PRSS1 and amplifications in PIK3C2B?",cnv_and_ssm
+1415,PRSS1,S138T,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in PRSS1 and amplifications in JAML?",cnv_and_ssm
+1416,PRSS1,S74T,Lung Adenocarcinoma,"In cases of Lung Adenocarcinoma, how common are mutations in PRSS1 and amplifications in TAF1C?",cnv_and_ssm
+1417,PGF,R126H,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in PGF and amplifications in HTR3B?",cnv_and_ssm
+1418,PGF,R127H,Stomach Adenocarcinoma,"In cases of Stomach Adenocarcinoma, how common are mutations in PGF and amplifications in ZNF627?",cnv_and_ssm
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how common are mutations in ITPRID2 and amplifications in OR13C3?",cnv_and_ssm
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,"In cases of Breast Invasive Carcinoma, how common are mutations in ITPRID2 and amplifications in TAF1C?",cnv_and_ssm
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in HBB and amplifications in CTCFL?",cnv_and_ssm
+1441,PCDHB2,R158C,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in PCDHB2 and amplifications in TYK2?",cnv_and_ssm
+1442,PCDHB2,T15M,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in PCDHB2 and amplifications in GUK1?",cnv_and_ssm
+1443,PCDHB2,T26M,Colon Adenocarcinoma,"In cases of Colon Adenocarcinoma, how common are mutations in PCDHB2 and amplifications in MAST4?",cnv_and_ssm
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,"In cases of Uterine Corpus Endometrial Carcinoma, how common are mutations in UBR2 and amplifications in MORF4L1?",cnv_and_ssm
+1452,FBXO42,A618D,Rectum Adenocarcinoma,"In cases of Rectum Adenocarcinoma, how common are mutations in FBXO42 and amplifications in POLR1G?",cnv_and_ssm
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the rate at which TNS1 somatic mutations and somatic AUTS2 homozygous deletions coincide in Breast Invasive Carcinoma?,cnv_and_ssm
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the rate at which TNS1 somatic mutations and somatic RIMS2 homozygous deletions coincide in Breast Invasive Carcinoma?,cnv_and_ssm
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the rate at which TNS1 somatic mutations and somatic ANKDD1A homozygous deletions coincide in Breast Invasive Carcinoma?,cnv_and_ssm
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the rate at which TNS1 somatic mutations and somatic TTYH2 homozygous deletions coincide in Breast Invasive Carcinoma?,cnv_and_ssm
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the rate at which TNS1 somatic mutations and somatic SPTAN1 homozygous deletions coincide in Breast Invasive Carcinoma?,cnv_and_ssm
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the rate at which TNS1 somatic mutations and somatic COL6A3 homozygous deletions coincide in Breast Invasive Carcinoma?,cnv_and_ssm
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the rate at which TNS1 somatic mutations and somatic DCC homozygous deletions coincide in Breast Invasive Carcinoma?,cnv_and_ssm
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the rate at which EVC2 somatic mutations and somatic COL6A3 homozygous deletions coincide in Bladder Urothelial Carcinoma?,cnv_and_ssm
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the rate at which EVC2 somatic mutations and somatic TLCD5 homozygous deletions coincide in Bladder Urothelial Carcinoma?,cnv_and_ssm
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the rate at which CR1 somatic mutations and somatic ARMC3 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the rate at which CR1 somatic mutations and somatic DGKD homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the rate at which TRPA1 somatic mutations and somatic UNC5D homozygous deletions coincide in Rectum Adenocarcinoma?,cnv_and_ssm
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the rate at which TRPA1 somatic mutations and somatic POC1B homozygous deletions coincide in Rectum Adenocarcinoma?,cnv_and_ssm
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the rate at which TAF1C somatic mutations and somatic MORF4L1 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the rate at which TAF1C somatic mutations and somatic AUTS2 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the rate at which TAF1C somatic mutations and somatic MRPL55 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the rate at which TAF1C somatic mutations and somatic YY1AP1 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the rate at which TAF1C somatic mutations and somatic FNDC7 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the rate at which DPF3 somatic mutations and somatic ZNF431 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the rate at which DPF3 somatic mutations and somatic LDOC1 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the rate at which DPF3 somatic mutations and somatic ZCCHC14 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the rate at which OR2T4 somatic mutations and somatic CTSC homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the rate at which OR2T4 somatic mutations and somatic TTC17 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the rate at which FBN1 somatic mutations and somatic PCDHB2 homozygous deletions coincide in Pancreatic Adenocarcinoma?,cnv_and_ssm
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the rate at which MAD1L1 somatic mutations and somatic MERTK homozygous deletions coincide in Prostate Adenocarcinoma?,cnv_and_ssm
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the rate at which MAD1L1 somatic mutations and somatic ARHGEF40 homozygous deletions coincide in Prostate Adenocarcinoma?,cnv_and_ssm
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the rate at which MAD1L1 somatic mutations and somatic CPS1 homozygous deletions coincide in Prostate Adenocarcinoma?,cnv_and_ssm
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the rate at which CCNG1 somatic mutations and somatic TTC12 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the rate at which ANP32E somatic mutations and somatic MERTK homozygous deletions coincide in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the rate at which ANP32E somatic mutations and somatic B3GALNT1 homozygous deletions coincide in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the rate at which ANP32E somatic mutations and somatic BCAT1 homozygous deletions coincide in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the rate at which ANP32E somatic mutations and somatic MERTK homozygous deletions coincide in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the rate at which FRY somatic mutations and somatic STK19 homozygous deletions coincide in Bladder Urothelial Carcinoma?,cnv_and_ssm
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the rate at which FRY somatic mutations and somatic CACNA1F homozygous deletions coincide in Bladder Urothelial Carcinoma?,cnv_and_ssm
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the rate at which FRY somatic mutations and somatic AUTS2 homozygous deletions coincide in Bladder Urothelial Carcinoma?,cnv_and_ssm
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the rate at which FRY somatic mutations and somatic SMO homozygous deletions coincide in Bladder Urothelial Carcinoma?,cnv_and_ssm
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the rate at which PAK3 somatic mutations and somatic RIPOR2 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the rate at which PAK3 somatic mutations and somatic PLEKHG6 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the rate at which PAK3 somatic mutations and somatic DCN homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the rate at which PAK3 somatic mutations and somatic ANKDD1A homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the rate at which PAK3 somatic mutations and somatic FBXO15 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the rate at which MUC16 somatic mutations and somatic CR1 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the rate at which ZFPM2 somatic mutations and somatic HYOU1 homozygous deletions coincide in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the rate at which ZFPM2 somatic mutations and somatic COL6A3 homozygous deletions coincide in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the rate at which PIK3C2B somatic mutations and somatic DNMT1 homozygous deletions coincide in Breast Invasive Carcinoma?,cnv_and_ssm
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the rate at which PIK3C2B somatic mutations and somatic PXN homozygous deletions coincide in Breast Invasive Carcinoma?,cnv_and_ssm
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the rate at which ZNF804A somatic mutations and somatic ABCC2 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the rate at which RELN somatic mutations and somatic TMEM255A homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate at which EFCAB12 somatic mutations and somatic NEXN homozygous deletions coincide in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate at which EFCAB12 somatic mutations and somatic VASN homozygous deletions coincide in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the rate at which DEFB115 somatic mutations and somatic OR2T4 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the rate at which ANKDD1A somatic mutations and somatic STK19 homozygous deletions coincide in Bladder Urothelial Carcinoma?,cnv_and_ssm
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the rate at which ANKDD1A somatic mutations and somatic TYK2 homozygous deletions coincide in Bladder Urothelial Carcinoma?,cnv_and_ssm
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the rate at which ANKDD1A somatic mutations and somatic CTCFL homozygous deletions coincide in Bladder Urothelial Carcinoma?,cnv_and_ssm
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the rate at which HTR3B somatic mutations and somatic TTC17 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the rate at which HTR3B somatic mutations and somatic MYT1 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the rate at which HTR3B somatic mutations and somatic PXN homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the rate at which ABCC3 somatic mutations and somatic DCN homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the rate at which NOMO1 somatic mutations and somatic ART3 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the rate at which NOMO1 somatic mutations and somatic PTPRO homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the rate at which HYOU1 somatic mutations and somatic LCN15 homozygous deletions coincide in Bladder Urothelial Carcinoma?,cnv_and_ssm
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the rate at which FMO4 somatic mutations and somatic SYNJ1 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+140,BICC1,A372V,Exceptional Responders,What is the rate at which BICC1 somatic mutations and somatic GRM1 homozygous deletions coincide in Exceptional Responders?,cnv_and_ssm
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the rate at which ZMYM3 somatic mutations and somatic PIK3C2G homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the rate at which ZMYM3 somatic mutations and somatic PRSS8 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the rate at which ZMYM3 somatic mutations and somatic PGF homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate at which XKR4 somatic mutations and somatic ACVR1B homozygous deletions coincide in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the rate at which ABCC2 somatic mutations and somatic CNGB1 homozygous deletions coincide in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the rate at which OR8K5 somatic mutations and somatic FGF8 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the rate at which SPTAN1 somatic mutations and somatic YY1AP1 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the rate at which SPTAN1 somatic mutations and somatic TMEM255A homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the rate at which SYT10 somatic mutations and somatic RIMS2 homozygous deletions coincide in Rectum Adenocarcinoma?,cnv_and_ssm
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the rate at which HSPA5 somatic mutations and somatic FCGR2C homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the rate at which UNC5D somatic mutations and somatic ANP32E homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the rate at which UNC5D somatic mutations and somatic CARMIL1 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the rate at which UNC5D somatic mutations and somatic COL6A3 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the rate at which UNC5D somatic mutations and somatic PLEKHG6 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the rate at which UNC5D somatic mutations and somatic ANKRD24 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the rate at which UNC5D somatic mutations and somatic ART3 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the rate at which DOCK2 somatic mutations and somatic PRSS1 homozygous deletions coincide in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the rate at which ZNF627 somatic mutations and somatic ZFAT homozygous deletions coincide in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the rate at which CDC42BPA somatic mutations and somatic GUK1 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the rate at which MRPL55 somatic mutations and somatic ANKDD1A homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the rate at which MRPL55 somatic mutations and somatic PTPRO homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the rate at which TMTC3 somatic mutations and somatic TLK2 homozygous deletions coincide in Breast Invasive Carcinoma?,cnv_and_ssm
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the rate at which EPRS1 somatic mutations and somatic DOCK2 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the rate at which EPRS1 somatic mutations and somatic GIMAP2 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the rate at which GRTP1 somatic mutations and somatic DNAH14 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the rate at which GRTP1 somatic mutations and somatic GLRB homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the rate at which TSHZ3 somatic mutations and somatic EIF2B4 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the rate at which TAS1R3 somatic mutations and somatic ANKDD1A homozygous deletions coincide in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,cnv_and_ssm
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the rate at which PIAS3 somatic mutations and somatic PTPRO homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the rate at which PIAS3 somatic mutations and somatic EPRS1 homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the rate at which ZNF274 somatic mutations and somatic ACTB homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the rate at which SYNJ1 somatic mutations and somatic KL homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the rate at which SYNJ1 somatic mutations and somatic TTC17 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the rate at which SYNJ1 somatic mutations and somatic PDHA2 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the rate at which DSCAM somatic mutations and somatic PTPRO homozygous deletions coincide in Prostate Adenocarcinoma?,cnv_and_ssm
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the rate at which DSCAM somatic mutations and somatic AUTS2 homozygous deletions coincide in Prostate Adenocarcinoma?,cnv_and_ssm
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the rate at which DSCAM somatic mutations and somatic YY1AP1 homozygous deletions coincide in Prostate Adenocarcinoma?,cnv_and_ssm
+267,DGKD,R140H,Exceptional Responders,What is the rate at which DGKD somatic mutations and somatic POC1B homozygous deletions coincide in Exceptional Responders?,cnv_and_ssm
+268,DGKD,R160H,Exceptional Responders,What is the rate at which DGKD somatic mutations and somatic PTPRN2 homozygous deletions coincide in Exceptional Responders?,cnv_and_ssm
+269,DGKD,R204H,Exceptional Responders,What is the rate at which DGKD somatic mutations and somatic ZNF584 homozygous deletions coincide in Exceptional Responders?,cnv_and_ssm
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the rate at which PLEKHG6 somatic mutations and somatic PRSS8 homozygous deletions coincide in Bladder Urothelial Carcinoma?,cnv_and_ssm
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the rate at which PLEKHG6 somatic mutations and somatic LAMB2 homozygous deletions coincide in Bladder Urothelial Carcinoma?,cnv_and_ssm
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the rate at which PLEKHG6 somatic mutations and somatic DSCAM homozygous deletions coincide in Bladder Urothelial Carcinoma?,cnv_and_ssm
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the rate at which WNT2 somatic mutations and somatic TTC17 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the rate at which GUCY2C somatic mutations and somatic SORCS1 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the rate at which C7orf31 somatic mutations and somatic ACTB homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate at which ZKSCAN7 somatic mutations and somatic DPF3 homozygous deletions coincide in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+299,OR5D14,M210L,Neuroblastoma,What is the rate at which OR5D14 somatic mutations and somatic TAF1L homozygous deletions coincide in Neuroblastoma?,cnv_and_ssm
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the rate at which SPATA22 somatic mutations and somatic PRSS1 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the rate at which SPATA22 somatic mutations and somatic ZCCHC14 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the rate at which SPATA22 somatic mutations and somatic OR13C3 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the rate at which LCN15 somatic mutations and somatic ANKRD24 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the rate at which DCAF4L2 somatic mutations and somatic ZNF627 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the rate at which GUK1 somatic mutations and somatic PIK3C2B homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the rate at which GUK1 somatic mutations and somatic TNS1 homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the rate at which GUK1 somatic mutations and somatic GUF1 homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the rate at which GUK1 somatic mutations and somatic TYK2 homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the rate at which GUK1 somatic mutations and somatic AUTS2 homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the rate at which MORF4L1 somatic mutations and somatic TLK2 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the rate at which MORF4L1 somatic mutations and somatic ZNF804A homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the rate at which MORF4L1 somatic mutations and somatic FBXO15 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the rate at which MORF4L1 somatic mutations and somatic TET2 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the rate at which MYO3B somatic mutations and somatic DCN homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the rate at which MYO3B somatic mutations and somatic COL6A3 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the rate at which TENT5A somatic mutations and somatic TTYH2 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the rate at which TENT5A somatic mutations and somatic PYHIN1 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the rate at which TENT5A somatic mutations and somatic KIF20B homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the rate at which ZFAT somatic mutations and somatic GRM5 homozygous deletions coincide in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the rate at which ZFAT somatic mutations and somatic DHX16 homozygous deletions coincide in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the rate at which ZFAT somatic mutations and somatic ADAM17 homozygous deletions coincide in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+357,ZNF584,A211T,Sarcoma,What is the rate at which ZNF584 somatic mutations and somatic ACVR1B homozygous deletions coincide in Sarcoma?,cnv_and_ssm
+358,ZNF584,A256T,Sarcoma,What is the rate at which ZNF584 somatic mutations and somatic FBN1 homozygous deletions coincide in Sarcoma?,cnv_and_ssm
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the rate at which LDOC1 somatic mutations and somatic MRPL55 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the rate at which PDGFC somatic mutations and somatic GUF1 homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the rate at which MSANTD4 somatic mutations and somatic DNAH14 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the rate at which NPSR1 somatic mutations and somatic STK19 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the rate at which PHLPP1 somatic mutations and somatic DNAH11 homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the rate at which COL6A3 somatic mutations and somatic EIF2B4 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the rate at which COL6A3 somatic mutations and somatic GABRA6 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the rate at which COL6A3 somatic mutations and somatic PRSS1 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the rate at which COL6A3 somatic mutations and somatic MYT1 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the rate at which COL6A3 somatic mutations and somatic PTPRN2 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the rate at which ADRA1A somatic mutations and somatic MORF4L1 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate at which LAMB2 somatic mutations and somatic EFCAB12 homozygous deletions coincide in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the rate at which POC1B somatic mutations and somatic MAST4 homozygous deletions coincide in Rectum Adenocarcinoma?,cnv_and_ssm
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the rate at which POC1B somatic mutations and somatic ADRA1A homozygous deletions coincide in Rectum Adenocarcinoma?,cnv_and_ssm
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the rate at which POC1B somatic mutations and somatic OR2A12 homozygous deletions coincide in Rectum Adenocarcinoma?,cnv_and_ssm
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the rate at which POC1B somatic mutations and somatic TSHZ3 homozygous deletions coincide in Rectum Adenocarcinoma?,cnv_and_ssm
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the rate at which USH2A somatic mutations and somatic PTPRN2 homozygous deletions coincide in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the rate at which AQP7 somatic mutations and somatic SORCS1 homozygous deletions coincide in Rectum Adenocarcinoma?,cnv_and_ssm
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the rate at which AQP7 somatic mutations and somatic TTC17 homozygous deletions coincide in Rectum Adenocarcinoma?,cnv_and_ssm
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the rate at which AQP7 somatic mutations and somatic GLRB homozygous deletions coincide in Rectum Adenocarcinoma?,cnv_and_ssm
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the rate at which AQP7 somatic mutations and somatic UNC5D homozygous deletions coincide in Rectum Adenocarcinoma?,cnv_and_ssm
+430,DCN,R163C,Rectum Adenocarcinoma,What is the rate at which DCN somatic mutations and somatic JAML homozygous deletions coincide in Rectum Adenocarcinoma?,cnv_and_ssm
+431,DCN,R203C,Rectum Adenocarcinoma,What is the rate at which DCN somatic mutations and somatic VASN homozygous deletions coincide in Rectum Adenocarcinoma?,cnv_and_ssm
+432,DCN,R241C,Rectum Adenocarcinoma,What is the rate at which DCN somatic mutations and somatic FRY homozygous deletions coincide in Rectum Adenocarcinoma?,cnv_and_ssm
+433,DCN,R350C,Rectum Adenocarcinoma,What is the rate at which DCN somatic mutations and somatic FGF8 homozygous deletions coincide in Rectum Adenocarcinoma?,cnv_and_ssm
+434,DCN,R41C,Rectum Adenocarcinoma,What is the rate at which DCN somatic mutations and somatic PTPRN2 homozygous deletions coincide in Rectum Adenocarcinoma?,cnv_and_ssm
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the rate at which CPS1 somatic mutations and somatic COL6A3 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the rate at which CPS1 somatic mutations and somatic SLC9C1 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the rate at which CPS1 somatic mutations and somatic B3GALNT1 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the rate at which FCGR2C somatic mutations and somatic UNC5D homozygous deletions coincide in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the rate at which FCGR2C somatic mutations and somatic ANKRD24 homozygous deletions coincide in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the rate at which GRM1 somatic mutations and somatic DCN homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the rate at which SGCZ somatic mutations and somatic CDC42BPA homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the rate at which SGCZ somatic mutations and somatic MERTK homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+485,SMO,V15M,Stomach Adenocarcinoma,What is the rate at which SMO somatic mutations and somatic SPATA22 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+486,SMO,V321M,Stomach Adenocarcinoma,What is the rate at which SMO somatic mutations and somatic FGF8 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the rate at which CHODL somatic mutations and somatic CTCFL homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the rate at which CHODL somatic mutations and somatic EIF2B4 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the rate at which CHODL somatic mutations and somatic PTPRO homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+494,MYO16,P399H,Colon Adenocarcinoma,What is the rate at which MYO16 somatic mutations and somatic ITPRID2 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+495,MYO16,P421H,Colon Adenocarcinoma,What is the rate at which MYO16 somatic mutations and somatic GIMAP2 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the rate at which CXCR2 somatic mutations and somatic TNS1 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the rate at which TMEM225 somatic mutations and somatic PHLPP1 homozygous deletions coincide in Bladder Urothelial Carcinoma?,cnv_and_ssm
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the rate at which MAOB somatic mutations and somatic PKHD1L1 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the rate at which GPRASP1 somatic mutations and somatic CHODL homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the rate at which MRPL32 somatic mutations and somatic TASOR2 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the rate at which TYROBP somatic mutations and somatic MIEF1 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the rate at which RAB40C somatic mutations and somatic PIK3C2B homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the rate at which RAB40C somatic mutations and somatic TNS1 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the rate at which CTNNA2 somatic mutations and somatic OR2T4 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the rate at which CTNNA2 somatic mutations and somatic TNS1 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the rate at which CTNNA2 somatic mutations and somatic SLC24A2 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the rate at which CTNNA2 somatic mutations and somatic AUTS2 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the rate at which MYO15A somatic mutations and somatic RAB40C homozygous deletions coincide in Bladder Urothelial Carcinoma?,cnv_and_ssm
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the rate at which GIMAP2 somatic mutations and somatic NRAP homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the rate at which KIF20B somatic mutations and somatic ANKDD1A homozygous deletions coincide in Glioblastoma Multiforme?,cnv_and_ssm
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the rate at which KIF20B somatic mutations and somatic GSTCD homozygous deletions coincide in Glioblastoma Multiforme?,cnv_and_ssm
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the rate at which ADAM17 somatic mutations and somatic EIF2B4 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the rate at which BCAT1 somatic mutations and somatic ZNF431 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the rate at which BCAT1 somatic mutations and somatic TLK2 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the rate at which BCAT1 somatic mutations and somatic TASOR2 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the rate at which ERCC6 somatic mutations and somatic BCAT1 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+541,DCC,R320W,Breast Invasive Carcinoma,What is the rate at which DCC somatic mutations and somatic ZFAT homozygous deletions coincide in Breast Invasive Carcinoma?,cnv_and_ssm
+542,DCC,R363W,Breast Invasive Carcinoma,What is the rate at which DCC somatic mutations and somatic JAML homozygous deletions coincide in Breast Invasive Carcinoma?,cnv_and_ssm
+543,DCC,R386W,Breast Invasive Carcinoma,What is the rate at which DCC somatic mutations and somatic ACTB homozygous deletions coincide in Breast Invasive Carcinoma?,cnv_and_ssm
+544,DCC,R41W,Breast Invasive Carcinoma,What is the rate at which DCC somatic mutations and somatic HLA-DQA2 homozygous deletions coincide in Breast Invasive Carcinoma?,cnv_and_ssm
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the rate at which FBXO15 somatic mutations and somatic ANP32E homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the rate at which FBXO15 somatic mutations and somatic KIF20B homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the rate at which GSTCD somatic mutations and somatic AUTS2 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the rate at which GSTCD somatic mutations and somatic DCN homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the rate at which OLFML3 somatic mutations and somatic ANKRD24 homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the rate at which OLFML3 somatic mutations and somatic ZNF804A homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the rate at which OLFML3 somatic mutations and somatic AUTS2 homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the rate at which CFAP61 somatic mutations and somatic AUTS2 homozygous deletions coincide in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the rate at which CFAP61 somatic mutations and somatic POC1B homozygous deletions coincide in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the rate at which HLA-DQA2 somatic mutations and somatic PLEKHG6 homozygous deletions coincide in Bladder Urothelial Carcinoma?,cnv_and_ssm
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the rate at which TENM2 somatic mutations and somatic TYROBP homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the rate at which TENM2 somatic mutations and somatic SGIP1 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the rate at which TENM2 somatic mutations and somatic DCC homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the rate at which ANKRD24 somatic mutations and somatic ANKRD52 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the rate at which ANKRD24 somatic mutations and somatic PYHIN1 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the rate at which ANKRD24 somatic mutations and somatic ACTL7B homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the rate at which ZCCHC14 somatic mutations and somatic PCDHB2 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the rate at which ZCCHC14 somatic mutations and somatic YY1AP1 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the rate at which ZCCHC14 somatic mutations and somatic ACTA2 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the rate at which ZCCHC14 somatic mutations and somatic RIMS2 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+625,SIK2,I265M,Lung Adenocarcinoma,What is the rate at which SIK2 somatic mutations and somatic POC1B homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the rate at which MYH11 somatic mutations and somatic ADAM17 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the rate at which MYH11 somatic mutations and somatic HTR3B homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the rate at which SLC6A4 somatic mutations and somatic AUTS2 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the rate at which SLC9C1 somatic mutations and somatic EFCAB12 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the rate at which SLC9C1 somatic mutations and somatic MAST4 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the rate at which OR2A12 somatic mutations and somatic TLK2 homozygous deletions coincide in Brain Lower Grade Glioma?,cnv_and_ssm
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the rate at which PYHIN1 somatic mutations and somatic TASOR2 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the rate at which PYHIN1 somatic mutations and somatic KANSL1 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the rate at which JAML somatic mutations and somatic MYO3B homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the rate at which JAML somatic mutations and somatic GRTP1 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the rate at which JAML somatic mutations and somatic ZCCHC14 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the rate at which JAML somatic mutations and somatic ZMYM3 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the rate at which TYK2 somatic mutations and somatic SMO homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the rate at which TYK2 somatic mutations and somatic DNMT1 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the rate at which TYK2 somatic mutations and somatic KRT39 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the rate at which CTCFL somatic mutations and somatic MAST4 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the rate at which CTCFL somatic mutations and somatic YY1AP1 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the rate at which CTCFL somatic mutations and somatic KL homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the rate at which CTCFL somatic mutations and somatic FGF8 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the rate at which CEP20 somatic mutations and somatic TAF1C homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the rate at which CEP20 somatic mutations and somatic PTPRO homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the rate at which RIMS2 somatic mutations and somatic ZFPM2 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the rate at which RIMS2 somatic mutations and somatic COL6A3 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the rate at which RIMS2 somatic mutations and somatic TAF1C homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the rate at which RIMS2 somatic mutations and somatic PGR homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the rate at which RIMS2 somatic mutations and somatic PCDHB2 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the rate at which RIMS2 somatic mutations and somatic RIMS2 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the rate at which RIMS2 somatic mutations and somatic PTPRO homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the rate at which PIK3C2G somatic mutations and somatic OLFML3 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the rate at which PIK3C2G somatic mutations and somatic TNS1 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+728,STK19,D341N,Colon Adenocarcinoma,What is the rate at which STK19 somatic mutations and somatic PTPRO homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+729,STK19,D345N,Colon Adenocarcinoma,What is the rate at which STK19 somatic mutations and somatic AQP7 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the rate at which REXO4 somatic mutations and somatic CDC42BPA homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the rate at which ZBTB34 somatic mutations and somatic PCDHGA1 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the rate at which ZBTB34 somatic mutations and somatic PIK3C2A homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the rate at which NCKAP5 somatic mutations and somatic SPATA22 homozygous deletions coincide in Bladder Urothelial Carcinoma?,cnv_and_ssm
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate at which SORCS1 somatic mutations and somatic NRAP homozygous deletions coincide in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate at which SORCS1 somatic mutations and somatic GABRA6 homozygous deletions coincide in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate at which SORCS1 somatic mutations and somatic SYT9 homozygous deletions coincide in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate at which SORCS1 somatic mutations and somatic TTN homozygous deletions coincide in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the rate at which FGF8 somatic mutations and somatic ART3 homozygous deletions coincide in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the rate at which FGF8 somatic mutations and somatic TAF1C homozygous deletions coincide in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the rate at which FGF8 somatic mutations and somatic TENM3 homozygous deletions coincide in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the rate at which FGF8 somatic mutations and somatic DCC homozygous deletions coincide in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the rate at which FGF8 somatic mutations and somatic TAF1C homozygous deletions coincide in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the rate at which TENM3 somatic mutations and somatic DPF3 homozygous deletions coincide in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,cnv_and_ssm
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the rate at which AKT1 somatic mutations and somatic MYT1 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate at which CFAP298-TCP10L somatic mutations and somatic EIF2B4 homozygous deletions coincide in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the rate at which GLRB somatic mutations and somatic GUK1 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+793,TTN,F7636L,Colon Adenocarcinoma,What is the rate at which TTN somatic mutations and somatic PRSS1 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+794,TTN,F8563L,Colon Adenocarcinoma,What is the rate at which TTN somatic mutations and somatic GUCY2C homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+795,TTN,F8880L,Colon Adenocarcinoma,What is the rate at which TTN somatic mutations and somatic CTNNA2 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the rate at which ANKRD30A somatic mutations and somatic TYK2 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the rate at which ANKRD30A somatic mutations and somatic SLC24A2 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the rate at which ANKRD30A somatic mutations and somatic DSCAM homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the rate at which TRIM45 somatic mutations and somatic PTPRN2 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the rate at which TRIM45 somatic mutations and somatic HLA-DQA2 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the rate at which TRIM45 somatic mutations and somatic ZSCAN31 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the rate at which CACNA1F somatic mutations and somatic UNC5D homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the rate at which CACNA1F somatic mutations and somatic ICE1 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the rate at which CACNA1F somatic mutations and somatic ANP32E homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+817,KL,R594C,Colon Adenocarcinoma,What is the rate at which KL somatic mutations and somatic CYB5R2 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the rate at which GUF1 somatic mutations and somatic EVC2 homozygous deletions coincide in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the rate at which TAF1L somatic mutations and somatic PXN homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the rate at which TASOR2 somatic mutations and somatic OR2A12 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the rate at which TASOR2 somatic mutations and somatic COL6A3 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the rate at which TASOR2 somatic mutations and somatic SERPINB10 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the rate at which KDM5C somatic mutations and somatic CXCR2 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the rate at which KDM5C somatic mutations and somatic PIK3C2B homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the rate at which KDM5C somatic mutations and somatic ART3 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the rate at which KDM5C somatic mutations and somatic ANP32E homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate at which IL5RA somatic mutations and somatic TYK2 homozygous deletions coincide in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the rate at which DHX16 somatic mutations and somatic AUTS2 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the rate at which DHX16 somatic mutations and somatic GPC3 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the rate at which GPR158 somatic mutations and somatic SPATA22 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the rate at which GPR158 somatic mutations and somatic CPS1 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate at which EIF2B4 somatic mutations and somatic RIPOR2 homozygous deletions coincide in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate at which EIF2B4 somatic mutations and somatic TENM2 homozygous deletions coincide in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate at which EIF2B4 somatic mutations and somatic MYH11 homozygous deletions coincide in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate at which EIF2B4 somatic mutations and somatic RIMS2 homozygous deletions coincide in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate at which EIF2B4 somatic mutations and somatic DSCAM homozygous deletions coincide in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate at which EIF2B4 somatic mutations and somatic RELN homozygous deletions coincide in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the rate at which AUTS2 somatic mutations and somatic JAML homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the rate at which AUTS2 somatic mutations and somatic SGIP1 homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the rate at which AUTS2 somatic mutations and somatic POLD1 homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the rate at which AUTS2 somatic mutations and somatic TASOR2 homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the rate at which AUTS2 somatic mutations and somatic ACTB homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the rate at which AUTS2 somatic mutations and somatic DNMT1 homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the rate at which AUTS2 somatic mutations and somatic FMO4 homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the rate at which AUTS2 somatic mutations and somatic GPC3 homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the rate at which AUTS2 somatic mutations and somatic TLCD5 homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the rate at which AUTS2 somatic mutations and somatic PCDHB2 homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate at which ACTL7B somatic mutations and somatic DEFB115 homozygous deletions coincide in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the rate at which PCDHGA1 somatic mutations and somatic HSPA5 homozygous deletions coincide in Glioblastoma Multiforme?,cnv_and_ssm
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the rate at which TRAP1 somatic mutations and somatic GRTP1 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the rate at which TRAP1 somatic mutations and somatic NCKAP5 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the rate at which PIK3C2A somatic mutations and somatic AQP7 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the rate at which KANSL1 somatic mutations and somatic YY1AP1 homozygous deletions coincide in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the rate at which ANKRD52 somatic mutations and somatic DSCAM homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the rate at which PAPPA somatic mutations and somatic MYO16 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the rate at which B3GALNT1 somatic mutations and somatic ANKRD30A homozygous deletions coincide in Rectum Adenocarcinoma?,cnv_and_ssm
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the rate at which GABRA6 somatic mutations and somatic GUK1 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the rate at which GABRA6 somatic mutations and somatic ZMYM3 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the rate at which GABRA6 somatic mutations and somatic JAML homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the rate at which GABRA6 somatic mutations and somatic HYOU1 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the rate at which GABRA6 somatic mutations and somatic TRAP1 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the rate at which ZSCAN31 somatic mutations and somatic TLK2 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate at which MED16 somatic mutations and somatic ANKRD30A homozygous deletions coincide in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate at which MED16 somatic mutations and somatic FBXO15 homozygous deletions coincide in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the rate at which PTPRO somatic mutations and somatic MRPL32 homozygous deletions coincide in Pancreatic Adenocarcinoma?,cnv_and_ssm
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the rate at which PTPRO somatic mutations and somatic MRPL32 homozygous deletions coincide in Pancreatic Adenocarcinoma?,cnv_and_ssm
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the rate at which PTPRO somatic mutations and somatic WNT2 homozygous deletions coincide in Pancreatic Adenocarcinoma?,cnv_and_ssm
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the rate at which PTPRO somatic mutations and somatic CYB5R2 homozygous deletions coincide in Pancreatic Adenocarcinoma?,cnv_and_ssm
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the rate at which PTPRO somatic mutations and somatic RIPOR2 homozygous deletions coincide in Pancreatic Adenocarcinoma?,cnv_and_ssm
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the rate at which PTPRO somatic mutations and somatic CTNNA2 homozygous deletions coincide in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the rate at which PTPRO somatic mutations and somatic MYO15A homozygous deletions coincide in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the rate at which PTPRO somatic mutations and somatic PXN homozygous deletions coincide in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the rate at which CHMP7 somatic mutations and somatic GPC3 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the rate at which GPC3 somatic mutations and somatic SGIP1 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the rate at which GPC3 somatic mutations and somatic DNMT1 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate at which TLK2 somatic mutations and somatic POC1B homozygous deletions coincide in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate at which TLK2 somatic mutations and somatic AUTS2 homozygous deletions coincide in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate at which TLK2 somatic mutations and somatic LAMB2 homozygous deletions coincide in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate at which TLK2 somatic mutations and somatic ZFAT homozygous deletions coincide in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the rate at which TLK2 somatic mutations and somatic SYNJ1 homozygous deletions coincide in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the rate at which ZNF217 somatic mutations and somatic CTSC homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the rate at which SYT9 somatic mutations and somatic RIMS2 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the rate at which SYT9 somatic mutations and somatic EIF2B4 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the rate at which PKHD1L1 somatic mutations and somatic CTCFL homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the rate at which MYO3A somatic mutations and somatic TTN homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate at which VASN somatic mutations and somatic UNC5D homozygous deletions coincide in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the rate at which DNMT1 somatic mutations and somatic GPR158 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the rate at which DNMT1 somatic mutations and somatic ACVR1B homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the rate at which DNMT1 somatic mutations and somatic FGF8 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1056,CA9,E402K,Colon Adenocarcinoma,What is the rate at which CA9 somatic mutations and somatic YY1AP1 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the rate at which TTC17 somatic mutations and somatic FCGR2C homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the rate at which TTC17 somatic mutations and somatic DOCK2 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the rate at which PSG2 somatic mutations and somatic TNS1 homozygous deletions coincide in Breast Invasive Carcinoma?,cnv_and_ssm
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the rate at which RIPOR2 somatic mutations and somatic AUTS2 homozygous deletions coincide in Breast Invasive Carcinoma?,cnv_and_ssm
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the rate at which RIPOR2 somatic mutations and somatic SPTAN1 homozygous deletions coincide in Breast Invasive Carcinoma?,cnv_and_ssm
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the rate at which RIPOR2 somatic mutations and somatic MAST4 homozygous deletions coincide in Breast Invasive Carcinoma?,cnv_and_ssm
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the rate at which RIPOR2 somatic mutations and somatic CFAP61 homozygous deletions coincide in Breast Invasive Carcinoma?,cnv_and_ssm
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the rate at which DCLK3 somatic mutations and somatic DCN homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the rate at which DCLK3 somatic mutations and somatic DCN homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the rate at which MERTK somatic mutations and somatic PRSS1 homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the rate at which MERTK somatic mutations and somatic ANKRD30A homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the rate at which MERTK somatic mutations and somatic GABRA6 homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the rate at which ZFP42 somatic mutations and somatic CDC42BPA homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the rate at which OR13C3 somatic mutations and somatic RIPOR2 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the rate at which OR13C3 somatic mutations and somatic DPF3 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the rate at which SPAG1 somatic mutations and somatic HTR3B homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the rate at which CDKN2AIP somatic mutations and somatic ANKRD24 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the rate at which PXN somatic mutations and somatic POLD1 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the rate at which PXN somatic mutations and somatic TRAP1 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the rate at which PXN somatic mutations and somatic ZNF431 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the rate at which PXN somatic mutations and somatic DNAH14 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the rate at which PXN somatic mutations and somatic TAF1C homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the rate at which PXN somatic mutations and somatic CX3CR1 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the rate at which TTYH2 somatic mutations and somatic HBB homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the rate at which TTYH2 somatic mutations and somatic HLA-DQA2 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the rate at which TMEM255A somatic mutations and somatic SORCS1 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the rate at which TMEM255A somatic mutations and somatic UBR2 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the rate at which TMEM255A somatic mutations and somatic OLFML3 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the rate at which TASOR2 somatic mutations and somatic DCLK3 homozygous deletions coincide in Breast Invasive Carcinoma?,cnv_and_ssm
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the rate at which TASOR2 somatic mutations and somatic ANKRD24 homozygous deletions coincide in Breast Invasive Carcinoma?,cnv_and_ssm
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the rate at which ICE1 somatic mutations and somatic AUTS2 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the rate at which MYT1 somatic mutations and somatic YY1AP1 homozygous deletions coincide in Breast Invasive Carcinoma?,cnv_and_ssm
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the rate at which MYT1 somatic mutations and somatic PDHA2 homozygous deletions coincide in Breast Invasive Carcinoma?,cnv_and_ssm
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the rate at which MYT1 somatic mutations and somatic OR2T4 homozygous deletions coincide in Breast Invasive Carcinoma?,cnv_and_ssm
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the rate at which CX3CR1 somatic mutations and somatic PIAS3 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the rate at which CX3CR1 somatic mutations and somatic PIK3C2G homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the rate at which SPINDOC somatic mutations and somatic PRSS1 homozygous deletions coincide in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the rate at which ART3 somatic mutations and somatic THBS4 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the rate at which ART3 somatic mutations and somatic DSCAM homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the rate at which CYP1A2 somatic mutations and somatic CTCFL homozygous deletions coincide in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate at which ADRA1A somatic mutations and somatic HTR3B homozygous deletions coincide in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the rate at which CDH23 somatic mutations and somatic VASN homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the rate at which CDH23 somatic mutations and somatic PCDHB2 homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the rate at which KRT39 somatic mutations and somatic NRAP homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the rate at which PDHA2 somatic mutations and somatic ANKDD1A homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the rate at which SLC24A2 somatic mutations and somatic EBF2 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the rate at which PTPRN2 somatic mutations and somatic TMEM255A homozygous deletions coincide in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the rate at which PTPRN2 somatic mutations and somatic TNS1 homozygous deletions coincide in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the rate at which PTPRN2 somatic mutations and somatic FNDC7 homozygous deletions coincide in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the rate at which PTPRN2 somatic mutations and somatic TTN homozygous deletions coincide in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the rate at which PTPRN2 somatic mutations and somatic POC1B homozygous deletions coincide in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the rate at which SOX21 somatic mutations and somatic DGKD homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the rate at which CPA6 somatic mutations and somatic SYNJ1 homozygous deletions coincide in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the rate at which GRM5 somatic mutations and somatic TTYH2 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate at which CASZ1 somatic mutations and somatic MRPL32 homozygous deletions coincide in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the rate at which SGIP1 somatic mutations and somatic DCLK3 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the rate at which SGIP1 somatic mutations and somatic TTC17 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the rate at which SGIP1 somatic mutations and somatic PTPRO homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the rate at which SGIP1 somatic mutations and somatic MERTK homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the rate at which CARMIL1 somatic mutations and somatic FRY homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the rate at which CARMIL1 somatic mutations and somatic TENT5A homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the rate at which ZNF431 somatic mutations and somatic GABRA6 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the rate at which ZNF431 somatic mutations and somatic GUK1 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the rate at which ZNF431 somatic mutations and somatic SYT9 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the rate at which DNAH11 somatic mutations and somatic RIPOR2 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the rate at which DNAH11 somatic mutations and somatic AQP7 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the rate at which POLD1 somatic mutations and somatic DCC homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the rate at which POLD1 somatic mutations and somatic ZCCHC14 homozygous deletions coincide in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the rate at which TTC12 somatic mutations and somatic EBF2 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the rate at which TTC12 somatic mutations and somatic TNS1 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the rate at which CNGB1 somatic mutations and somatic MYO3B homozygous deletions coincide in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the rate at which CNGB1 somatic mutations and somatic DNAH11 homozygous deletions coincide in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the rate at which CTSC somatic mutations and somatic FGF8 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the rate at which CTSC somatic mutations and somatic ZCCHC14 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the rate at which CTSC somatic mutations and somatic FRY homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the rate at which CTSC somatic mutations and somatic SGCZ homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the rate at which CTSC somatic mutations and somatic YY1AP1 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the rate at which PRSS8 somatic mutations and somatic TNS1 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the rate at which PRSS8 somatic mutations and somatic ANP32E homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the rate at which ARHGEF40 somatic mutations and somatic DNMT1 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the rate at which ACTB somatic mutations and somatic ANKDD1A homozygous deletions coincide in Rectum Adenocarcinoma?,cnv_and_ssm
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the rate at which ACTB somatic mutations and somatic RIMS2 homozygous deletions coincide in Rectum Adenocarcinoma?,cnv_and_ssm
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the rate at which ACTB somatic mutations and somatic DCAF4L2 homozygous deletions coincide in Rectum Adenocarcinoma?,cnv_and_ssm
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the rate at which ACTB somatic mutations and somatic PLEKHG6 homozygous deletions coincide in Rectum Adenocarcinoma?,cnv_and_ssm
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the rate at which YY1AP1 somatic mutations and somatic ART3 homozygous deletions coincide in Glioblastoma Multiforme?,cnv_and_ssm
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the rate at which YY1AP1 somatic mutations and somatic ZNF584 homozygous deletions coincide in Glioblastoma Multiforme?,cnv_and_ssm
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the rate at which YY1AP1 somatic mutations and somatic TENM2 homozygous deletions coincide in Glioblastoma Multiforme?,cnv_and_ssm
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the rate at which YY1AP1 somatic mutations and somatic TAF1L homozygous deletions coincide in Glioblastoma Multiforme?,cnv_and_ssm
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the rate at which YY1AP1 somatic mutations and somatic MORF4L1 homozygous deletions coincide in Glioblastoma Multiforme?,cnv_and_ssm
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the rate at which YY1AP1 somatic mutations and somatic JAML homozygous deletions coincide in Glioblastoma Multiforme?,cnv_and_ssm
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the rate at which YY1AP1 somatic mutations and somatic TMEM255A homozygous deletions coincide in Glioblastoma Multiforme?,cnv_and_ssm
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the rate at which FNDC7 somatic mutations and somatic GRM1 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the rate at which FNDC7 somatic mutations and somatic CARMIL1 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the rate at which TLCD5 somatic mutations and somatic ANKDD1A homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the rate at which TLCD5 somatic mutations and somatic SYNJ1 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the rate at which POLR1G somatic mutations and somatic ZCCHC14 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the rate at which POLR1G somatic mutations and somatic SORCS1 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the rate at which DNAH14 somatic mutations and somatic WNT2 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the rate at which DNAH14 somatic mutations and somatic ZCCHC14 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the rate at which DNAH14 somatic mutations and somatic PIK3C2G homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the rate at which NEXN somatic mutations and somatic TENT5A homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the rate at which CYB5R2 somatic mutations and somatic FRY homozygous deletions coincide in Prostate Adenocarcinoma?,cnv_and_ssm
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the rate at which CYB5R2 somatic mutations and somatic MERTK homozygous deletions coincide in Prostate Adenocarcinoma?,cnv_and_ssm
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the rate at which NRAP somatic mutations and somatic DCN homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the rate at which NRAP somatic mutations and somatic RELN homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the rate at which NRAP somatic mutations and somatic CACNA1F homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the rate at which CCDC22 somatic mutations and somatic ZNF274 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the rate at which DCAF6 somatic mutations and somatic PTPRN2 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the rate at which DCAF6 somatic mutations and somatic UBR2 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the rate at which ZNF708 somatic mutations and somatic GUCY2C homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the rate at which BFAR somatic mutations and somatic CTNNA2 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the rate at which MAST4 somatic mutations and somatic PRSS1 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the rate at which MAST4 somatic mutations and somatic MUC16 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the rate at which MAST4 somatic mutations and somatic ZCCHC14 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the rate at which MAST4 somatic mutations and somatic NCKAP5 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the rate at which MAST4 somatic mutations and somatic RAB40C homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the rate at which ARMC3 somatic mutations and somatic YY1AP1 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the rate at which ARMC3 somatic mutations and somatic ANP32E homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the rate at which TET2 somatic mutations and somatic PTPRO homozygous deletions coincide in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the rate at which TET2 somatic mutations and somatic CHODL homozygous deletions coincide in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the rate at which SERPINB10 somatic mutations and somatic PHLPP1 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the rate at which STAT3 somatic mutations and somatic SMO homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the rate at which MIEF1 somatic mutations and somatic GABRA6 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the rate at which ACVR1B somatic mutations and somatic PXN homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the rate at which ACVR1B somatic mutations and somatic MORF4L1 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the rate at which ACVR1B somatic mutations and somatic RAB40C homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the rate at which EBF2 somatic mutations and somatic OR2A12 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the rate at which EBF2 somatic mutations and somatic FBXO42 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the rate at which VPS26B somatic mutations and somatic CNGB1 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate at which PGR somatic mutations and somatic CARMIL1 homozygous deletions coincide in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate at which PGR somatic mutations and somatic TRAP1 homozygous deletions coincide in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the rate at which PGR somatic mutations and somatic NCKAP5 homozygous deletions coincide in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the rate at which ACTA2 somatic mutations and somatic OR13C3 homozygous deletions coincide in Skin Cutaneous Melanoma?,cnv_and_ssm
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the rate at which THBS4 somatic mutations and somatic ANP32E homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the rate at which THBS4 somatic mutations and somatic CYB5R2 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the rate at which PRSS1 somatic mutations and somatic POC1B homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the rate at which PRSS1 somatic mutations and somatic ZBTB34 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the rate at which PRSS1 somatic mutations and somatic STK19 homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the rate at which PRSS1 somatic mutations and somatic JAML homozygous deletions coincide in Lung Adenocarcinoma?,cnv_and_ssm
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the rate at which PGF somatic mutations and somatic DHX16 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the rate at which PGF somatic mutations and somatic AUTS2 homozygous deletions coincide in Stomach Adenocarcinoma?,cnv_and_ssm
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the rate at which ITPRID2 somatic mutations and somatic ACTB homozygous deletions coincide in Breast Invasive Carcinoma?,cnv_and_ssm
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the rate at which ITPRID2 somatic mutations and somatic TMEM255A homozygous deletions coincide in Breast Invasive Carcinoma?,cnv_and_ssm
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the rate at which HBB somatic mutations and somatic PGR homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the rate at which PCDHB2 somatic mutations and somatic EIF2B4 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the rate at which PCDHB2 somatic mutations and somatic LDOC1 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the rate at which PCDHB2 somatic mutations and somatic MYO16 homozygous deletions coincide in Colon Adenocarcinoma?,cnv_and_ssm
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the rate at which UBR2 somatic mutations and somatic RIPOR2 homozygous deletions coincide in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the rate at which FBXO42 somatic mutations and somatic ACTB homozygous deletions coincide in Rectum Adenocarcinoma?,cnv_and_ssm
+1,TNS1,G1362V,Breast Invasive Carcinoma,How frequently do TNS1 mutations and YY1AP1 amplifications occur together in Breast Invasive Carcinoma cases?,cnv_and_ssm
+2,TNS1,G1711V,Breast Invasive Carcinoma,How frequently do TNS1 mutations and SYT10 amplifications occur together in Breast Invasive Carcinoma cases?,cnv_and_ssm
+3,TNS1,G1718V,Breast Invasive Carcinoma,How frequently do TNS1 mutations and EIF2B4 amplifications occur together in Breast Invasive Carcinoma cases?,cnv_and_ssm
+4,TNS1,G1732V,Breast Invasive Carcinoma,How frequently do TNS1 mutations and TLK2 amplifications occur together in Breast Invasive Carcinoma cases?,cnv_and_ssm
+5,TNS1,G1824V,Breast Invasive Carcinoma,How frequently do TNS1 mutations and CDH23 amplifications occur together in Breast Invasive Carcinoma cases?,cnv_and_ssm
+6,TNS1,G1857V,Breast Invasive Carcinoma,How frequently do TNS1 mutations and PDGFC amplifications occur together in Breast Invasive Carcinoma cases?,cnv_and_ssm
+7,TNS1,G843V,Breast Invasive Carcinoma,How frequently do TNS1 mutations and MAST4 amplifications occur together in Breast Invasive Carcinoma cases?,cnv_and_ssm
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How frequently do EVC2 mutations and ACTL7B amplifications occur together in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How frequently do EVC2 mutations and PIK3C2A amplifications occur together in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How frequently do CR1 mutations and MORF4L1 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How frequently do CR1 mutations and PRSS8 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+22,TRPA1,S295I,Rectum Adenocarcinoma,How frequently do TRPA1 mutations and CHODL amplifications occur together in Rectum Adenocarcinoma cases?,cnv_and_ssm
+23,TRPA1,S443I,Rectum Adenocarcinoma,How frequently do TRPA1 mutations and NRAP amplifications occur together in Rectum Adenocarcinoma cases?,cnv_and_ssm
+24,TAF1C,R299L,Lung Adenocarcinoma,How frequently do TAF1C mutations and SYNJ1 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+25,TAF1C,R396L,Lung Adenocarcinoma,How frequently do TAF1C mutations and SPATA22 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+26,TAF1C,R634L,Lung Adenocarcinoma,How frequently do TAF1C mutations and THBS4 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+27,TAF1C,R702L,Lung Adenocarcinoma,How frequently do TAF1C mutations and IL5RA amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+28,TAF1C,R728L,Lung Adenocarcinoma,How frequently do TAF1C mutations and ZFAT amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How frequently do DPF3 mutations and PHLPP1 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How frequently do DPF3 mutations and FRY amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How frequently do DPF3 mutations and DPF3 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+42,OR2T4,P272H,Lung Adenocarcinoma,How frequently do OR2T4 mutations and CNGB1 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+43,OR2T4,P300H,Lung Adenocarcinoma,How frequently do OR2T4 mutations and NPSR1 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How frequently do FBN1 mutations and WNT2 amplifications occur together in Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How frequently do MAD1L1 mutations and NPSR1 amplifications occur together in Prostate Adenocarcinoma cases?,cnv_and_ssm
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How frequently do MAD1L1 mutations and ZNF431 amplifications occur together in Prostate Adenocarcinoma cases?,cnv_and_ssm
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How frequently do MAD1L1 mutations and DSCAM amplifications occur together in Prostate Adenocarcinoma cases?,cnv_and_ssm
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How frequently do CCNG1 mutations and CFAP61 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How frequently do ANP32E mutations and PCDHB2 amplifications occur together in Kidney Renal Papillary Cell Carcinoma cases?,cnv_and_ssm
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How frequently do ANP32E mutations and AUTS2 amplifications occur together in Kidney Renal Papillary Cell Carcinoma cases?,cnv_and_ssm
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How frequently do ANP32E mutations and TASOR2 amplifications occur together in Kidney Renal Papillary Cell Carcinoma cases?,cnv_and_ssm
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How frequently do ANP32E mutations and TYK2 amplifications occur together in Kidney Renal Papillary Cell Carcinoma cases?,cnv_and_ssm
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How frequently do FRY mutations and DSCAM amplifications occur together in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How frequently do FRY mutations and GRTP1 amplifications occur together in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How frequently do FRY mutations and DNMT1 amplifications occur together in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How frequently do FRY mutations and TENM2 amplifications occur together in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+70,PAK3,E318K,Skin Cutaneous Melanoma,How frequently do PAK3 mutations and PIAS3 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+71,PAK3,E319K,Skin Cutaneous Melanoma,How frequently do PAK3 mutations and SOX21 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+72,PAK3,E334K,Skin Cutaneous Melanoma,How frequently do PAK3 mutations and TASOR2 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+73,PAK3,E340K,Skin Cutaneous Melanoma,How frequently do PAK3 mutations and SPTAN1 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+74,PAK3,E355K,Skin Cutaneous Melanoma,How frequently do PAK3 mutations and PYHIN1 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How frequently do MUC16 mutations and PTPRN2 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How frequently do ZFPM2 mutations and REXO4 amplifications occur together in Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How frequently do ZFPM2 mutations and VPS26B amplifications occur together in Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How frequently do PIK3C2B mutations and BICC1 amplifications occur together in Breast Invasive Carcinoma cases?,cnv_and_ssm
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How frequently do PIK3C2B mutations and GLRB amplifications occur together in Breast Invasive Carcinoma cases?,cnv_and_ssm
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How frequently do ZNF804A mutations and DNMT1 amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+116,RELN,A2371V,Stomach Adenocarcinoma,How frequently do RELN mutations and RIPOR2 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do EFCAB12 mutations and PRSS1 amplifications occur together in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do EFCAB12 mutations and DCLK3 amplifications occur together in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How frequently do DEFB115 mutations and CTCFL amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How frequently do ANKDD1A mutations and PDHA2 amplifications occur together in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How frequently do ANKDD1A mutations and GSTCD amplifications occur together in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How frequently do ANKDD1A mutations and MYO3A amplifications occur together in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How frequently do HTR3B mutations and CTCFL amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How frequently do HTR3B mutations and HBB amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How frequently do HTR3B mutations and TAF1C amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+129,ABCC3,R758W,Stomach Adenocarcinoma,How frequently do ABCC3 mutations and PGR amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How frequently do NOMO1 mutations and PGR amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How frequently do NOMO1 mutations and FBN1 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How frequently do HYOU1 mutations and PIK3C2B amplifications occur together in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How frequently do FMO4 mutations and FGF8 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+140,BICC1,A372V,Exceptional Responders,How frequently do BICC1 mutations and CTSC amplifications occur together in Exceptional Responders cases?,cnv_and_ssm
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How frequently do ZMYM3 mutations and KDM5C amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How frequently do ZMYM3 mutations and PAK3 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How frequently do ZMYM3 mutations and FGF8 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do XKR4 mutations and MYT1 amplifications occur together in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How frequently do ABCC2 mutations and ANKRD24 amplifications occur together in Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+157,OR8K5,R293G,Lung Adenocarcinoma,How frequently do OR8K5 mutations and MAST4 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How frequently do SPTAN1 mutations and TAF1C amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How frequently do SPTAN1 mutations and PGF amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+164,SYT10,M484I,Rectum Adenocarcinoma,How frequently do SYT10 mutations and CX3CR1 amplifications occur together in Rectum Adenocarcinoma cases?,cnv_and_ssm
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How frequently do HSPA5 mutations and CASZ1 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+175,UNC5D,L280V,Lung Adenocarcinoma,How frequently do UNC5D mutations and NEXN amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+176,UNC5D,L635V,Lung Adenocarcinoma,How frequently do UNC5D mutations and PTPRO amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+177,UNC5D,L637V,Lung Adenocarcinoma,How frequently do UNC5D mutations and FBXO15 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+178,UNC5D,L699V,Lung Adenocarcinoma,How frequently do UNC5D mutations and PAK3 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+179,UNC5D,L704V,Lung Adenocarcinoma,How frequently do UNC5D mutations and FGF8 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+180,UNC5D,L709V,Lung Adenocarcinoma,How frequently do UNC5D mutations and ICE1 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How frequently do DOCK2 mutations and DNAH11 amplifications occur together in Kidney Renal Clear Cell Carcinoma cases?,cnv_and_ssm
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How frequently do ZNF627 mutations and HSPA5 amplifications occur together in Kidney Renal Clear Cell Carcinoma cases?,cnv_and_ssm
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How frequently do CDC42BPA mutations and FRY amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+193,MRPL55,H27Y,Colon Adenocarcinoma,How frequently do MRPL55 mutations and ZMYM3 amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+194,MRPL55,H63Y,Colon Adenocarcinoma,How frequently do MRPL55 mutations and CHODL amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How frequently do TMTC3 mutations and FRY amplifications occur together in Breast Invasive Carcinoma cases?,cnv_and_ssm
+198,EPRS1,K771I,Colon Adenocarcinoma,How frequently do EPRS1 mutations and ANP32E amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+199,EPRS1,K778I,Colon Adenocarcinoma,How frequently do EPRS1 mutations and FNDC7 amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How frequently do GRTP1 mutations and MRPL32 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How frequently do GRTP1 mutations and ZNF431 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How frequently do TSHZ3 mutations and ZNF217 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How frequently do TAS1R3 mutations and ZFAT amplifications occur together in HIV+ Tumor Molecular Characterization Project - Cervical Cancer cases?,cnv_and_ssm
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How frequently do PIAS3 mutations and RAB40C amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How frequently do PIAS3 mutations and FRY amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+251,ZNF274,P13R,Stomach Adenocarcinoma,How frequently do ZNF274 mutations and ITPRID2 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+253,SYNJ1,R795C,Colon Adenocarcinoma,How frequently do SYNJ1 mutations and ZFP42 amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+254,SYNJ1,R800C,Colon Adenocarcinoma,How frequently do SYNJ1 mutations and GABRA6 amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+255,SYNJ1,R839C,Colon Adenocarcinoma,How frequently do SYNJ1 mutations and RIMS2 amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+261,DSCAM,V343M,Prostate Adenocarcinoma,How frequently do DSCAM mutations and DSCAM amplifications occur together in Prostate Adenocarcinoma cases?,cnv_and_ssm
+262,DSCAM,V426M,Prostate Adenocarcinoma,How frequently do DSCAM mutations and UNC5D amplifications occur together in Prostate Adenocarcinoma cases?,cnv_and_ssm
+263,DSCAM,V591M,Prostate Adenocarcinoma,How frequently do DSCAM mutations and TSHZ3 amplifications occur together in Prostate Adenocarcinoma cases?,cnv_and_ssm
+267,DGKD,R140H,Exceptional Responders,How frequently do DGKD mutations and TLK2 amplifications occur together in Exceptional Responders cases?,cnv_and_ssm
+268,DGKD,R160H,Exceptional Responders,How frequently do DGKD mutations and CHODL amplifications occur together in Exceptional Responders cases?,cnv_and_ssm
+269,DGKD,R204H,Exceptional Responders,How frequently do DGKD mutations and ANKRD24 amplifications occur together in Exceptional Responders cases?,cnv_and_ssm
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How frequently do PLEKHG6 mutations and GABRA6 amplifications occur together in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How frequently do PLEKHG6 mutations and DCAF6 amplifications occur together in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How frequently do PLEKHG6 mutations and RIMS2 amplifications occur together in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+279,WNT2,D138N,Skin Cutaneous Melanoma,How frequently do WNT2 mutations and CTSC amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How frequently do GUCY2C mutations and PTPRO amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How frequently do C7orf31 mutations and PLEKHG6 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do ZKSCAN7 mutations and EIF2B4 amplifications occur together in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+299,OR5D14,M210L,Neuroblastoma,How frequently do OR5D14 mutations and PHLPP1 amplifications occur together in Neuroblastoma cases?,cnv_and_ssm
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How frequently do SPATA22 mutations and AUTS2 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How frequently do SPATA22 mutations and DCN amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How frequently do SPATA22 mutations and MYH11 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+310,LCN15,E21V,Stomach Adenocarcinoma,How frequently do LCN15 mutations and CTSC amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How frequently do DCAF4L2 mutations and GPR158 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How frequently do GUK1 mutations and STK19 amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How frequently do GUK1 mutations and COL6A3 amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How frequently do GUK1 mutations and HBB amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How frequently do GUK1 mutations and DSCAM amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How frequently do GUK1 mutations and TMEM255A amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How frequently do MORF4L1 mutations and UNC5D amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How frequently do MORF4L1 mutations and TMEM255A amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How frequently do MORF4L1 mutations and TLK2 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How frequently do MORF4L1 mutations and PTPRN2 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How frequently do MYO3B mutations and ART3 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How frequently do MYO3B mutations and PAPPA amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How frequently do TENT5A mutations and DCN amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How frequently do TENT5A mutations and LAMB2 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How frequently do TENT5A mutations and ZNF274 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How frequently do ZFAT mutations and UNC5D amplifications occur together in Ovarian Serous Cystadenocarcinoma cases?,cnv_and_ssm
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How frequently do ZFAT mutations and MUC16 amplifications occur together in Ovarian Serous Cystadenocarcinoma cases?,cnv_and_ssm
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How frequently do ZFAT mutations and ZNF627 amplifications occur together in Ovarian Serous Cystadenocarcinoma cases?,cnv_and_ssm
+357,ZNF584,A211T,Sarcoma,How frequently do ZNF584 mutations and MORF4L1 amplifications occur together in Sarcoma cases?,cnv_and_ssm
+358,ZNF584,A256T,Sarcoma,How frequently do ZNF584 mutations and FNDC7 amplifications occur together in Sarcoma cases?,cnv_and_ssm
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How frequently do LDOC1 mutations and ZFAT amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How frequently do PDGFC mutations and DSCAM amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How frequently do MSANTD4 mutations and CTSC amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How frequently do NPSR1 mutations and PLEKHG6 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How frequently do PHLPP1 mutations and PAK3 amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How frequently do COL6A3 mutations and TASOR2 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How frequently do COL6A3 mutations and ART3 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How frequently do COL6A3 mutations and ABCC2 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How frequently do COL6A3 mutations and USH2A amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How frequently do COL6A3 mutations and CTSC amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How frequently do ADRA1A mutations and CTCFL amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently do LAMB2 mutations and DCAF6 amplifications occur together in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+406,POC1B,I198T,Rectum Adenocarcinoma,How frequently do POC1B mutations and C7orf31 amplifications occur together in Rectum Adenocarcinoma cases?,cnv_and_ssm
+407,POC1B,I286T,Rectum Adenocarcinoma,How frequently do POC1B mutations and GSTCD amplifications occur together in Rectum Adenocarcinoma cases?,cnv_and_ssm
+408,POC1B,I328T,Rectum Adenocarcinoma,How frequently do POC1B mutations and STK19 amplifications occur together in Rectum Adenocarcinoma cases?,cnv_and_ssm
+409,POC1B,S79P,Rectum Adenocarcinoma,How frequently do POC1B mutations and ACTB amplifications occur together in Rectum Adenocarcinoma cases?,cnv_and_ssm
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How frequently do USH2A mutations and UNC5D amplifications occur together in Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+414,AQP7,T110S,Rectum Adenocarcinoma,How frequently do AQP7 mutations and TTC17 amplifications occur together in Rectum Adenocarcinoma cases?,cnv_and_ssm
+415,AQP7,T166S,Rectum Adenocarcinoma,How frequently do AQP7 mutations and RIPOR2 amplifications occur together in Rectum Adenocarcinoma cases?,cnv_and_ssm
+416,AQP7,T167S,Rectum Adenocarcinoma,How frequently do AQP7 mutations and CACNA1F amplifications occur together in Rectum Adenocarcinoma cases?,cnv_and_ssm
+417,AQP7,T75S,Rectum Adenocarcinoma,How frequently do AQP7 mutations and AUTS2 amplifications occur together in Rectum Adenocarcinoma cases?,cnv_and_ssm
+430,DCN,R163C,Rectum Adenocarcinoma,How frequently do DCN mutations and FRY amplifications occur together in Rectum Adenocarcinoma cases?,cnv_and_ssm
+431,DCN,R203C,Rectum Adenocarcinoma,How frequently do DCN mutations and GPRASP1 amplifications occur together in Rectum Adenocarcinoma cases?,cnv_and_ssm
+432,DCN,R241C,Rectum Adenocarcinoma,How frequently do DCN mutations and MYH11 amplifications occur together in Rectum Adenocarcinoma cases?,cnv_and_ssm
+433,DCN,R350C,Rectum Adenocarcinoma,How frequently do DCN mutations and DCAF6 amplifications occur together in Rectum Adenocarcinoma cases?,cnv_and_ssm
+434,DCN,R41C,Rectum Adenocarcinoma,How frequently do DCN mutations and YY1AP1 amplifications occur together in Rectum Adenocarcinoma cases?,cnv_and_ssm
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How frequently do CPS1 mutations and KDM5C amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How frequently do CPS1 mutations and DNAH14 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How frequently do CPS1 mutations and OR2T4 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How frequently do FCGR2C mutations and DCC amplifications occur together in Kidney Renal Papillary Cell Carcinoma cases?,cnv_and_ssm
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How frequently do FCGR2C mutations and SGIP1 amplifications occur together in Kidney Renal Papillary Cell Carcinoma cases?,cnv_and_ssm
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How frequently do GRM1 mutations and CXCR2 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+482,SGCZ,Q138H,Lung Adenocarcinoma,How frequently do SGCZ mutations and MYO16 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+483,SGCZ,Q91H,Lung Adenocarcinoma,How frequently do SGCZ mutations and CDKN2AIP amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+485,SMO,V15M,Stomach Adenocarcinoma,How frequently do SMO mutations and CTSC amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+486,SMO,V321M,Stomach Adenocarcinoma,How frequently do SMO mutations and SYNJ1 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+488,CHODL,G159E,Skin Cutaneous Melanoma,How frequently do CHODL mutations and PTPRN2 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+489,CHODL,G181E,Skin Cutaneous Melanoma,How frequently do CHODL mutations and STK19 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+490,CHODL,G200E,Skin Cutaneous Melanoma,How frequently do CHODL mutations and JAML amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+494,MYO16,P399H,Colon Adenocarcinoma,How frequently do MYO16 mutations and DNMT1 amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+495,MYO16,P421H,Colon Adenocarcinoma,How frequently do MYO16 mutations and ANKRD30A amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+498,CXCR2,A98V,Stomach Adenocarcinoma,How frequently do CXCR2 mutations and PXN amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How frequently do TMEM225 mutations and UNC5D amplifications occur together in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How frequently do MAOB mutations and SGIP1 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How frequently do GPRASP1 mutations and AKT1 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How frequently do MRPL32 mutations and RIMS2 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How frequently do TYROBP mutations and UNC5D amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+510,RAB40C,A111V,Lung Adenocarcinoma,How frequently do RAB40C mutations and AQP7 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+511,RAB40C,A143V,Lung Adenocarcinoma,How frequently do RAB40C mutations and BCAT1 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+512,CTNNA2,S323R,Lung Adenocarcinoma,How frequently do CTNNA2 mutations and CASZ1 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+513,CTNNA2,S339R,Lung Adenocarcinoma,How frequently do CTNNA2 mutations and FGF8 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+514,CTNNA2,S386R,Lung Adenocarcinoma,How frequently do CTNNA2 mutations and AUTS2 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+515,CTNNA2,S707R,Lung Adenocarcinoma,How frequently do CTNNA2 mutations and PRSS1 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How frequently do MYO15A mutations and MYH11 amplifications occur together in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How frequently do GIMAP2 mutations and RIPOR2 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+532,KIF20B,N1160D,Glioblastoma Multiforme,How frequently do KIF20B mutations and TTN amplifications occur together in Glioblastoma Multiforme cases?,cnv_and_ssm
+533,KIF20B,N1200D,Glioblastoma Multiforme,How frequently do KIF20B mutations and OR13C3 amplifications occur together in Glioblastoma Multiforme cases?,cnv_and_ssm
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How frequently do ADAM17 mutations and CEP20 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How frequently do BCAT1 mutations and TAF1C amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How frequently do BCAT1 mutations and CX3CR1 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How frequently do BCAT1 mutations and CNGB1 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+540,ERCC6,R1053H,Colon Adenocarcinoma,How frequently do ERCC6 mutations and ACVR1B amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+541,DCC,R320W,Breast Invasive Carcinoma,How frequently do DCC mutations and COL6A3 amplifications occur together in Breast Invasive Carcinoma cases?,cnv_and_ssm
+542,DCC,R363W,Breast Invasive Carcinoma,How frequently do DCC mutations and OLFML3 amplifications occur together in Breast Invasive Carcinoma cases?,cnv_and_ssm
+543,DCC,R386W,Breast Invasive Carcinoma,How frequently do DCC mutations and TTN amplifications occur together in Breast Invasive Carcinoma cases?,cnv_and_ssm
+544,DCC,R41W,Breast Invasive Carcinoma,How frequently do DCC mutations and MAOB amplifications occur together in Breast Invasive Carcinoma cases?,cnv_and_ssm
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How frequently do FBXO15 mutations and EVC2 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How frequently do FBXO15 mutations and THBS4 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How frequently do GSTCD mutations and TENT5A amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How frequently do GSTCD mutations and DCN amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How frequently do OLFML3 mutations and JAML amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How frequently do OLFML3 mutations and GPC3 amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How frequently do OLFML3 mutations and PCDHB2 amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How frequently do CFAP61 mutations and CR1 amplifications occur together in Ovarian Serous Cystadenocarcinoma cases?,cnv_and_ssm
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How frequently do CFAP61 mutations and ZFAT amplifications occur together in Ovarian Serous Cystadenocarcinoma cases?,cnv_and_ssm
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How frequently do HLA-DQA2 mutations and SYT9 amplifications occur together in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How frequently do TENM2 mutations and ADRA1A amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How frequently do TENM2 mutations and DNAH14 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How frequently do TENM2 mutations and EFCAB12 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How frequently do ANKRD24 mutations and IL5RA amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How frequently do ANKRD24 mutations and PXN amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How frequently do ANKRD24 mutations and PTPRN2 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How frequently do ZCCHC14 mutations and ACVR1B amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How frequently do ZCCHC14 mutations and YY1AP1 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How frequently do ZCCHC14 mutations and PTPRO amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How frequently do ZCCHC14 mutations and FGF8 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+625,SIK2,I265M,Lung Adenocarcinoma,How frequently do SIK2 mutations and POC1B amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How frequently do MYH11 mutations and ACVR1B amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How frequently do MYH11 mutations and FBXO15 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How frequently do SLC6A4 mutations and EPRS1 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How frequently do SLC9C1 mutations and MAOB amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How frequently do SLC9C1 mutations and CTNNA2 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+644,OR2A12,A254T,Brain Lower Grade Glioma,How frequently do OR2A12 mutations and RIMS2 amplifications occur together in Brain Lower Grade Glioma cases?,cnv_and_ssm
+646,PYHIN1,T325K,Lung Adenocarcinoma,How frequently do PYHIN1 mutations and ZNF804A amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+647,PYHIN1,T334K,Lung Adenocarcinoma,How frequently do PYHIN1 mutations and PRSS1 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+650,JAML,G191E,Skin Cutaneous Melanoma,How frequently do JAML mutations and GABRA6 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+651,JAML,G219E,Skin Cutaneous Melanoma,How frequently do JAML mutations and TAF1C amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+652,JAML,G220E,Skin Cutaneous Melanoma,How frequently do JAML mutations and RAB40C amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+653,JAML,G230E,Skin Cutaneous Melanoma,How frequently do JAML mutations and MSANTD4 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+658,TYK2,H1146R,Stomach Adenocarcinoma,How frequently do TYK2 mutations and STK19 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+659,TYK2,H23R,Stomach Adenocarcinoma,How frequently do TYK2 mutations and RIPOR2 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+660,TYK2,H961R,Stomach Adenocarcinoma,How frequently do TYK2 mutations and KIF20B amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How frequently do CTCFL mutations and GRM1 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How frequently do CTCFL mutations and CASZ1 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How frequently do CTCFL mutations and MRPL32 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How frequently do CTCFL mutations and DSCAM amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How frequently do CEP20 mutations and BFAR amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How frequently do CEP20 mutations and MYO3B amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How frequently do RIMS2 mutations and UNC5D amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How frequently do RIMS2 mutations and KDM5C amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How frequently do RIMS2 mutations and MYT1 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How frequently do RIMS2 mutations and AUTS2 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How frequently do RIMS2 mutations and AQP7 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How frequently do RIMS2 mutations and CTNNA2 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How frequently do RIMS2 mutations and ZKSCAN7 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How frequently do PIK3C2G mutations and FGF8 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How frequently do PIK3C2G mutations and ADRA1A amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+728,STK19,D341N,Colon Adenocarcinoma,How frequently do STK19 mutations and COL6A3 amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+729,STK19,D345N,Colon Adenocarcinoma,How frequently do STK19 mutations and PRSS8 amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+730,REXO4,P60A,Skin Cutaneous Melanoma,How frequently do REXO4 mutations and PHLPP1 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How frequently do ZBTB34 mutations and ANKRD30A amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How frequently do ZBTB34 mutations and NEXN amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How frequently do NCKAP5 mutations and PRSS8 amplifications occur together in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do SORCS1 mutations and SPTAN1 amplifications occur together in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do SORCS1 mutations and DNAH11 amplifications occur together in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do SORCS1 mutations and FCGR2C amplifications occur together in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do SORCS1 mutations and PTPRN2 amplifications occur together in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How frequently do FGF8 mutations and MERTK amplifications occur together in Head and Neck Squamous Cell Carcinoma cases?,cnv_and_ssm
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How frequently do FGF8 mutations and ZFPM2 amplifications occur together in Head and Neck Squamous Cell Carcinoma cases?,cnv_and_ssm
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How frequently do FGF8 mutations and MYO16 amplifications occur together in Head and Neck Squamous Cell Carcinoma cases?,cnv_and_ssm
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How frequently do FGF8 mutations and ADRA1A amplifications occur together in Head and Neck Squamous Cell Carcinoma cases?,cnv_and_ssm
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How frequently do FGF8 mutations and TENM2 amplifications occur together in Head and Neck Squamous Cell Carcinoma cases?,cnv_and_ssm
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How frequently do TENM3 mutations and PIAS3 amplifications occur together in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia cases?,cnv_and_ssm
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How frequently do AKT1 mutations and DCC amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently do CFAP298-TCP10L mutations and SYT9 amplifications occur together in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+792,GLRB,E148D,Stomach Adenocarcinoma,How frequently do GLRB mutations and GIMAP2 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+793,TTN,F7636L,Colon Adenocarcinoma,How frequently do TTN mutations and DCN amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+794,TTN,F8563L,Colon Adenocarcinoma,How frequently do TTN mutations and FRY amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+795,TTN,F8880L,Colon Adenocarcinoma,How frequently do TTN mutations and VASN amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How frequently do ANKRD30A mutations and FGF8 amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How frequently do ANKRD30A mutations and PYHIN1 amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How frequently do ANKRD30A mutations and PAK3 amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+809,TRIM45,S177L,Colon Adenocarcinoma,How frequently do TRIM45 mutations and CR1 amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+810,TRIM45,S224L,Colon Adenocarcinoma,How frequently do TRIM45 mutations and DGKD amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+811,TRIM45,S281L,Colon Adenocarcinoma,How frequently do TRIM45 mutations and POLR1G amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How frequently do CACNA1F mutations and NCKAP5 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How frequently do CACNA1F mutations and NRAP amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How frequently do CACNA1F mutations and CX3CR1 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+817,KL,R594C,Colon Adenocarcinoma,How frequently do KL mutations and DNAH14 amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How frequently do GUF1 mutations and AUTS2 amplifications occur together in Kidney Renal Papillary Cell Carcinoma cases?,cnv_and_ssm
+822,TAF1L,A539V,Colon Adenocarcinoma,How frequently do TAF1L mutations and CX3CR1 amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How frequently do TASOR2 mutations and AUTS2 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How frequently do TASOR2 mutations and YY1AP1 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How frequently do TASOR2 mutations and PGR amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How frequently do KDM5C mutations and ZNF627 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How frequently do KDM5C mutations and ANKRD52 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How frequently do KDM5C mutations and TYK2 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How frequently do KDM5C mutations and OLFML3 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently do IL5RA mutations and MED16 amplifications occur together in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+843,DHX16,A29V,Skin Cutaneous Melanoma,How frequently do DHX16 mutations and ZNF708 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+844,DHX16,A89V,Skin Cutaneous Melanoma,How frequently do DHX16 mutations and ANP32E amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+902,GPR158,A644V,Stomach Adenocarcinoma,How frequently do GPR158 mutations and YY1AP1 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+903,GPR158,A723V,Stomach Adenocarcinoma,How frequently do GPR158 mutations and MORF4L1 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do EIF2B4 mutations and EVC2 amplifications occur together in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do EIF2B4 mutations and CEP20 amplifications occur together in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do EIF2B4 mutations and DNAH14 amplifications occur together in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do EIF2B4 mutations and OR8K5 amplifications occur together in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do EIF2B4 mutations and FNDC7 amplifications occur together in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do EIF2B4 mutations and PXN amplifications occur together in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How frequently do AUTS2 mutations and GUK1 amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How frequently do AUTS2 mutations and SYNJ1 amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How frequently do AUTS2 mutations and TTC17 amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How frequently do AUTS2 mutations and CTCFL amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How frequently do AUTS2 mutations and ZCCHC14 amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How frequently do AUTS2 mutations and DPF3 amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How frequently do AUTS2 mutations and JAML amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How frequently do AUTS2 mutations and SMO amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How frequently do AUTS2 mutations and DEFB115 amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How frequently do AUTS2 mutations and C7orf31 amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do ACTL7B mutations and DGKD amplifications occur together in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How frequently do PCDHGA1 mutations and PTPRO amplifications occur together in Glioblastoma Multiforme cases?,cnv_and_ssm
+954,TRAP1,R114W,Stomach Adenocarcinoma,How frequently do TRAP1 mutations and ZNF431 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+955,TRAP1,R61W,Stomach Adenocarcinoma,How frequently do TRAP1 mutations and GSTCD amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How frequently do PIK3C2A mutations and ANKDD1A amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How frequently do KANSL1 mutations and SOX21 amplifications occur together in Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How frequently do ANKRD52 mutations and PTPRN2 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How frequently do PAPPA mutations and ANKRD24 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How frequently do B3GALNT1 mutations and PIAS3 amplifications occur together in Rectum Adenocarcinoma cases?,cnv_and_ssm
+982,GABRA6,G115R,Lung Adenocarcinoma,How frequently do GABRA6 mutations and TENM2 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+983,GABRA6,G122R,Lung Adenocarcinoma,How frequently do GABRA6 mutations and AQP7 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+984,GABRA6,G165R,Lung Adenocarcinoma,How frequently do GABRA6 mutations and ZNF584 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+985,GABRA6,G175R,Lung Adenocarcinoma,How frequently do GABRA6 mutations and BCAT1 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+986,GABRA6,G70R,Lung Adenocarcinoma,How frequently do GABRA6 mutations and TENT5A amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How frequently do ZSCAN31 mutations and ZFAT amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do MED16 mutations and ZMYM3 amplifications occur together in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do MED16 mutations and RIMS2 amplifications occur together in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How frequently do PTPRO mutations and CDKN2AIP amplifications occur together in Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How frequently do PTPRO mutations and DPF3 amplifications occur together in Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How frequently do PTPRO mutations and ZFAT amplifications occur together in Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How frequently do PTPRO mutations and PGF amplifications occur together in Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How frequently do PTPRO mutations and ANKDD1A amplifications occur together in Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How frequently do PTPRO mutations and DSCAM amplifications occur together in Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How frequently do PTPRO mutations and PAK3 amplifications occur together in Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How frequently do PTPRO mutations and BCAT1 amplifications occur together in Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How frequently do CHMP7 mutations and PTPRO amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1017,GPC3,I107N,Stomach Adenocarcinoma,How frequently do GPC3 mutations and STK19 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1018,GPC3,I161N,Stomach Adenocarcinoma,How frequently do GPC3 mutations and PXN amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently do TLK2 mutations and SORCS1 amplifications occur together in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently do TLK2 mutations and CFAP61 amplifications occur together in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently do TLK2 mutations and AQP7 amplifications occur together in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently do TLK2 mutations and PLEKHG6 amplifications occur together in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How frequently do TLK2 mutations and TMEM255A amplifications occur together in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How frequently do ZNF217 mutations and CHODL amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+1038,SYT9,V275L,Lung Adenocarcinoma,How frequently do SYT9 mutations and AKT1 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+1039,SYT9,V307L,Lung Adenocarcinoma,How frequently do SYT9 mutations and GUK1 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How frequently do PKHD1L1 mutations and DCC amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How frequently do MYO3A mutations and GPR158 amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do VASN mutations and GABRA6 amplifications occur together in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How frequently do DNMT1 mutations and GIMAP2 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How frequently do DNMT1 mutations and AUTS2 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How frequently do DNMT1 mutations and THBS4 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1056,CA9,E402K,Colon Adenocarcinoma,How frequently do CA9 mutations and TMEM255A amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How frequently do TTC17 mutations and TRIM45 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How frequently do TTC17 mutations and ACTB amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1065,PSG2,P43L,Breast Invasive Carcinoma,How frequently do PSG2 mutations and CCDC22 amplifications occur together in Breast Invasive Carcinoma cases?,cnv_and_ssm
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How frequently do RIPOR2 mutations and RIMS2 amplifications occur together in Breast Invasive Carcinoma cases?,cnv_and_ssm
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How frequently do RIPOR2 mutations and NRAP amplifications occur together in Breast Invasive Carcinoma cases?,cnv_and_ssm
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How frequently do RIPOR2 mutations and CACNA1F amplifications occur together in Breast Invasive Carcinoma cases?,cnv_and_ssm
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How frequently do RIPOR2 mutations and GSTCD amplifications occur together in Breast Invasive Carcinoma cases?,cnv_and_ssm
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How frequently do DCLK3 mutations and FRY amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How frequently do DCLK3 mutations and SORCS1 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How frequently do MERTK mutations and MERTK amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How frequently do MERTK mutations and PCDHB2 amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How frequently do MERTK mutations and RIMS2 amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How frequently do ZFP42 mutations and PAK3 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How frequently do OR13C3 mutations and NRAP amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How frequently do OR13C3 mutations and ZCCHC14 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How frequently do SPAG1 mutations and MAD1L1 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How frequently do CDKN2AIP mutations and MED16 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1093,PXN,H1016Y,Colon Adenocarcinoma,How frequently do PXN mutations and MIEF1 amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+1094,PXN,H359Y,Colon Adenocarcinoma,How frequently do PXN mutations and USH2A amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+1095,PXN,H492Y,Colon Adenocarcinoma,How frequently do PXN mutations and MAOB amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+1096,PXN,H524Y,Colon Adenocarcinoma,How frequently do PXN mutations and MAST4 amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+1097,PXN,H526Y,Colon Adenocarcinoma,How frequently do PXN mutations and AQP7 amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+1098,PXN,H540Y,Colon Adenocarcinoma,How frequently do PXN mutations and SPINDOC amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How frequently do TTYH2 mutations and ITPRID2 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How frequently do TTYH2 mutations and CARMIL1 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How frequently do TMEM255A mutations and GPR158 amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How frequently do TMEM255A mutations and ACTA2 amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How frequently do TMEM255A mutations and TNS1 amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How frequently do TASOR2 mutations and FNDC7 amplifications occur together in Breast Invasive Carcinoma cases?,cnv_and_ssm
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How frequently do TASOR2 mutations and DNAH11 amplifications occur together in Breast Invasive Carcinoma cases?,cnv_and_ssm
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How frequently do ICE1 mutations and FRY amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1112,MYT1,A558E,Breast Invasive Carcinoma,How frequently do MYT1 mutations and ZMYM3 amplifications occur together in Breast Invasive Carcinoma cases?,cnv_and_ssm
+1113,MYT1,A879E,Breast Invasive Carcinoma,How frequently do MYT1 mutations and TENM2 amplifications occur together in Breast Invasive Carcinoma cases?,cnv_and_ssm
+1114,MYT1,A906E,Breast Invasive Carcinoma,How frequently do MYT1 mutations and PLEKHG6 amplifications occur together in Breast Invasive Carcinoma cases?,cnv_and_ssm
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How frequently do CX3CR1 mutations and ZNF274 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How frequently do CX3CR1 mutations and PGF amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How frequently do SPINDOC mutations and RIPOR2 amplifications occur together in Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How frequently do ART3 mutations and ANKRD24 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How frequently do ART3 mutations and EVC2 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How frequently do CYP1A2 mutations and RAB40C amplifications occur together in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do ADRA1A mutations and PXN amplifications occur together in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How frequently do CDH23 mutations and CEP20 amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How frequently do CDH23 mutations and PTPRO amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How frequently do KRT39 mutations and UBR2 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How frequently do PDHA2 mutations and GSTCD amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How frequently do SLC24A2 mutations and PXN amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How frequently do PTPRN2 mutations and ZNF431 amplifications occur together in Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How frequently do PTPRN2 mutations and POLR1G amplifications occur together in Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How frequently do PTPRN2 mutations and PCDHB2 amplifications occur together in Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How frequently do PTPRN2 mutations and LAMB2 amplifications occur together in Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How frequently do PTPRN2 mutations and UNC5D amplifications occur together in Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+1188,SOX21,R55L,Lung Adenocarcinoma,How frequently do SOX21 mutations and TMEM225 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How frequently do CPA6 mutations and ZFAT amplifications occur together in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How frequently do GRM5 mutations and DPF3 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do CASZ1 mutations and CHODL amplifications occur together in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How frequently do SGIP1 mutations and OR2T4 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How frequently do SGIP1 mutations and EPRS1 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How frequently do SGIP1 mutations and GPRASP1 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How frequently do SGIP1 mutations and TLK2 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How frequently do CARMIL1 mutations and PAK3 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How frequently do CARMIL1 mutations and GUK1 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How frequently do ZNF431 mutations and MYH11 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How frequently do ZNF431 mutations and GABRA6 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+1234,ZNF431,R128I,Lung Adenocarcinoma,How frequently do ZNF431 mutations and PGR amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How frequently do DNAH11 mutations and ZNF431 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How frequently do DNAH11 mutations and ZFP42 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How frequently do POLD1 mutations and PDHA2 amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How frequently do POLD1 mutations and EVC2 amplifications occur together in Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1248,TTC12,D646H,Lung Adenocarcinoma,How frequently do TTC12 mutations and MORF4L1 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+1249,TTC12,D652H,Lung Adenocarcinoma,How frequently do TTC12 mutations and AUTS2 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How frequently do CNGB1 mutations and ANP32E amplifications occur together in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How frequently do CNGB1 mutations and WNT2 amplifications occur together in Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+1254,CTSC,E214V,Stomach Adenocarcinoma,How frequently do CTSC mutations and CHODL amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1255,CTSC,E291V,Stomach Adenocarcinoma,How frequently do CTSC mutations and HTR3B amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1256,CTSC,E322V,Stomach Adenocarcinoma,How frequently do CTSC mutations and RIMS2 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1257,CTSC,E324V,Stomach Adenocarcinoma,How frequently do CTSC mutations and GPR158 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1258,CTSC,E335V,Stomach Adenocarcinoma,How frequently do CTSC mutations and ANKDD1A amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How frequently do PRSS8 mutations and GUK1 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How frequently do PRSS8 mutations and DCN amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How frequently do ARHGEF40 mutations and NPSR1 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+1264,ACTB,A138T,Rectum Adenocarcinoma,How frequently do ACTB mutations and GABRA6 amplifications occur together in Rectum Adenocarcinoma cases?,cnv_and_ssm
+1265,ACTB,A217T,Rectum Adenocarcinoma,How frequently do ACTB mutations and UBR2 amplifications occur together in Rectum Adenocarcinoma cases?,cnv_and_ssm
+1266,ACTB,A244T,Rectum Adenocarcinoma,How frequently do ACTB mutations and CDH23 amplifications occur together in Rectum Adenocarcinoma cases?,cnv_and_ssm
+1267,ACTB,A260T,Rectum Adenocarcinoma,How frequently do ACTB mutations and EBF2 amplifications occur together in Rectum Adenocarcinoma cases?,cnv_and_ssm
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How frequently do YY1AP1 mutations and POLR1G amplifications occur together in Glioblastoma Multiforme cases?,cnv_and_ssm
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How frequently do YY1AP1 mutations and MYO15A amplifications occur together in Glioblastoma Multiforme cases?,cnv_and_ssm
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How frequently do YY1AP1 mutations and CPS1 amplifications occur together in Glioblastoma Multiforme cases?,cnv_and_ssm
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How frequently do YY1AP1 mutations and HLA-DQA2 amplifications occur together in Glioblastoma Multiforme cases?,cnv_and_ssm
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How frequently do YY1AP1 mutations and ZNF708 amplifications occur together in Glioblastoma Multiforme cases?,cnv_and_ssm
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How frequently do YY1AP1 mutations and PTPRN2 amplifications occur together in Glioblastoma Multiforme cases?,cnv_and_ssm
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How frequently do YY1AP1 mutations and ACTB amplifications occur together in Glioblastoma Multiforme cases?,cnv_and_ssm
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How frequently do FNDC7 mutations and DNAH14 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How frequently do FNDC7 mutations and ZFPM2 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1299,TLCD5,G15V,Lung Adenocarcinoma,How frequently do TLCD5 mutations and EVC2 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+1300,TLCD5,G37V,Lung Adenocarcinoma,How frequently do TLCD5 mutations and CHMP7 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How frequently do POLR1G mutations and FGF8 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How frequently do POLR1G mutations and DPF3 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How frequently do DNAH14 mutations and EVC2 amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How frequently do DNAH14 mutations and CTNNA2 amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How frequently do DNAH14 mutations and MRPL32 amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How frequently do NEXN mutations and PTPRN2 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How frequently do CYB5R2 mutations and GLRB amplifications occur together in Prostate Adenocarcinoma cases?,cnv_and_ssm
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How frequently do CYB5R2 mutations and MORF4L1 amplifications occur together in Prostate Adenocarcinoma cases?,cnv_and_ssm
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How frequently do NRAP mutations and ACVR1B amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How frequently do NRAP mutations and FMO4 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How frequently do NRAP mutations and TAF1C amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How frequently do CCDC22 mutations and CYP1A2 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How frequently do DCAF6 mutations and TMTC3 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How frequently do DCAF6 mutations and HTR3B amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How frequently do ZNF708 mutations and SERPINB10 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How frequently do BFAR mutations and STK19 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How frequently do MAST4 mutations and SYNJ1 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How frequently do MAST4 mutations and FRY amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How frequently do MAST4 mutations and TNS1 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How frequently do MAST4 mutations and DCC amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How frequently do MAST4 mutations and RIMS2 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How frequently do ARMC3 mutations and SPAG1 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How frequently do ARMC3 mutations and KDM5C amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How frequently do TET2 mutations and RIMS2 amplifications occur together in Kidney Renal Clear Cell Carcinoma cases?,cnv_and_ssm
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How frequently do TET2 mutations and NRAP amplifications occur together in Kidney Renal Clear Cell Carcinoma cases?,cnv_and_ssm
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How frequently do SERPINB10 mutations and ANP32E amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How frequently do STAT3 mutations and AUTS2 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How frequently do MIEF1 mutations and CDC42BPA amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How frequently do ACVR1B mutations and ACTL7B amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How frequently do ACVR1B mutations and GABRA6 amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How frequently do ACVR1B mutations and GPC3 amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+1393,EBF2,T104I,Stomach Adenocarcinoma,How frequently do EBF2 mutations and GUK1 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1394,EBF2,T252I,Stomach Adenocarcinoma,How frequently do EBF2 mutations and CX3CR1 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How frequently do VPS26B mutations and GUK1 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do PGR mutations and CCNG1 amplifications occur together in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do PGR mutations and GRM5 amplifications occur together in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How frequently do PGR mutations and EVC2 amplifications occur together in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How frequently do ACTA2 mutations and EVC2 amplifications occur together in Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How frequently do THBS4 mutations and DGKD amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How frequently do THBS4 mutations and ACVR1B amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1413,PRSS1,S114T,Lung Adenocarcinoma,How frequently do PRSS1 mutations and ZNF627 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+1414,PRSS1,S124T,Lung Adenocarcinoma,How frequently do PRSS1 mutations and FBXO42 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+1415,PRSS1,S138T,Lung Adenocarcinoma,How frequently do PRSS1 mutations and PLEKHG6 amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+1416,PRSS1,S74T,Lung Adenocarcinoma,How frequently do PRSS1 mutations and USH2A amplifications occur together in Lung Adenocarcinoma cases?,cnv_and_ssm
+1417,PGF,R126H,Stomach Adenocarcinoma,How frequently do PGF mutations and PXN amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1418,PGF,R127H,Stomach Adenocarcinoma,How frequently do PGF mutations and PSG2 amplifications occur together in Stomach Adenocarcinoma cases?,cnv_and_ssm
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How frequently do ITPRID2 mutations and RAB40C amplifications occur together in Breast Invasive Carcinoma cases?,cnv_and_ssm
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How frequently do ITPRID2 mutations and FRY amplifications occur together in Breast Invasive Carcinoma cases?,cnv_and_ssm
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How frequently do HBB mutations and MYO16 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How frequently do PCDHB2 mutations and SORCS1 amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How frequently do PCDHB2 mutations and RIMS2 amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How frequently do PCDHB2 mutations and EPRS1 amplifications occur together in Colon Adenocarcinoma cases?,cnv_and_ssm
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How frequently do UBR2 mutations and TYK2 amplifications occur together in Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How frequently do FBXO42 mutations and POC1B amplifications occur together in Rectum Adenocarcinoma cases?,cnv_and_ssm
+1,TNS1,G1362V,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases display both somatic TNS1 mutations and somatic HTR3B losses?,cnv_and_ssm
+2,TNS1,G1711V,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases display both somatic TNS1 mutations and somatic GSTCD losses?,cnv_and_ssm
+3,TNS1,G1718V,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases display both somatic TNS1 mutations and somatic STAT3 losses?,cnv_and_ssm
+4,TNS1,G1732V,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases display both somatic TNS1 mutations and somatic TLCD5 losses?,cnv_and_ssm
+5,TNS1,G1824V,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases display both somatic TNS1 mutations and somatic IL5RA losses?,cnv_and_ssm
+6,TNS1,G1857V,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases display both somatic TNS1 mutations and somatic DSCAM losses?,cnv_and_ssm
+7,TNS1,G843V,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases display both somatic TNS1 mutations and somatic FRY losses?,cnv_and_ssm
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases display both somatic EVC2 mutations and somatic PTPRO losses?,cnv_and_ssm
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases display both somatic EVC2 mutations and somatic AUTS2 losses?,cnv_and_ssm
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic CR1 mutations and somatic PGR losses?,cnv_and_ssm
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic CR1 mutations and somatic GUK1 losses?,cnv_and_ssm
+22,TRPA1,S295I,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases display both somatic TRPA1 mutations and somatic AQP7 losses?,cnv_and_ssm
+23,TRPA1,S443I,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases display both somatic TRPA1 mutations and somatic ACVR1B losses?,cnv_and_ssm
+24,TAF1C,R299L,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic TAF1C mutations and somatic FRY losses?,cnv_and_ssm
+25,TAF1C,R396L,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic TAF1C mutations and somatic MAST4 losses?,cnv_and_ssm
+26,TAF1C,R634L,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic TAF1C mutations and somatic UNC5D losses?,cnv_and_ssm
+27,TAF1C,R702L,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic TAF1C mutations and somatic CHODL losses?,cnv_and_ssm
+28,TAF1C,R728L,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic TAF1C mutations and somatic SPINDOC losses?,cnv_and_ssm
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic DPF3 mutations and somatic CTCFL losses?,cnv_and_ssm
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic DPF3 mutations and somatic RIMS2 losses?,cnv_and_ssm
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic DPF3 mutations and somatic ACTB losses?,cnv_and_ssm
+42,OR2T4,P272H,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic OR2T4 mutations and somatic EBF2 losses?,cnv_and_ssm
+43,OR2T4,P300H,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic OR2T4 mutations and somatic MRPL55 losses?,cnv_and_ssm
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What share of Pancreatic Adenocarcinoma cases display both somatic FBN1 mutations and somatic PHLPP1 losses?,cnv_and_ssm
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What share of Prostate Adenocarcinoma cases display both somatic MAD1L1 mutations and somatic PIK3C2G losses?,cnv_and_ssm
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What share of Prostate Adenocarcinoma cases display both somatic MAD1L1 mutations and somatic CPS1 losses?,cnv_and_ssm
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What share of Prostate Adenocarcinoma cases display both somatic MAD1L1 mutations and somatic DSCAM losses?,cnv_and_ssm
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic CCNG1 mutations and somatic ZFPM2 losses?,cnv_and_ssm
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What share of Kidney Renal Papillary Cell Carcinoma cases display both somatic ANP32E mutations and somatic DNMT1 losses?,cnv_and_ssm
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What share of Kidney Renal Papillary Cell Carcinoma cases display both somatic ANP32E mutations and somatic KDM5C losses?,cnv_and_ssm
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What share of Kidney Renal Papillary Cell Carcinoma cases display both somatic ANP32E mutations and somatic TET2 losses?,cnv_and_ssm
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What share of Kidney Renal Papillary Cell Carcinoma cases display both somatic ANP32E mutations and somatic SYT9 losses?,cnv_and_ssm
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases display both somatic FRY mutations and somatic FBXO15 losses?,cnv_and_ssm
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases display both somatic FRY mutations and somatic DCC losses?,cnv_and_ssm
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases display both somatic FRY mutations and somatic UNC5D losses?,cnv_and_ssm
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases display both somatic FRY mutations and somatic CHODL losses?,cnv_and_ssm
+70,PAK3,E318K,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic PAK3 mutations and somatic CTCFL losses?,cnv_and_ssm
+71,PAK3,E319K,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic PAK3 mutations and somatic ADAM17 losses?,cnv_and_ssm
+72,PAK3,E334K,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic PAK3 mutations and somatic OR2A12 losses?,cnv_and_ssm
+73,PAK3,E340K,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic PAK3 mutations and somatic CTSC losses?,cnv_and_ssm
+74,PAK3,E355K,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic PAK3 mutations and somatic THBS4 losses?,cnv_and_ssm
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic MUC16 mutations and somatic GUK1 losses?,cnv_and_ssm
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What share of Liver Hepatocellular Carcinoma cases display both somatic ZFPM2 mutations and somatic BICC1 losses?,cnv_and_ssm
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What share of Liver Hepatocellular Carcinoma cases display both somatic ZFPM2 mutations and somatic ACVR1B losses?,cnv_and_ssm
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases display both somatic PIK3C2B mutations and somatic SGIP1 losses?,cnv_and_ssm
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases display both somatic PIK3C2B mutations and somatic CTCFL losses?,cnv_and_ssm
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic ZNF804A mutations and somatic KIF20B losses?,cnv_and_ssm
+116,RELN,A2371V,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic RELN mutations and somatic GLRB losses?,cnv_and_ssm
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases display both somatic EFCAB12 mutations and somatic OR5D14 losses?",cnv_and_ssm
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases display both somatic EFCAB12 mutations and somatic OLFML3 losses?",cnv_and_ssm
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic DEFB115 mutations and somatic TNS1 losses?,cnv_and_ssm
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases display both somatic ANKDD1A mutations and somatic ANKRD24 losses?,cnv_and_ssm
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases display both somatic ANKDD1A mutations and somatic RAB40C losses?,cnv_and_ssm
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases display both somatic ANKDD1A mutations and somatic PIK3C2A losses?,cnv_and_ssm
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic HTR3B mutations and somatic AUTS2 losses?,cnv_and_ssm
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic HTR3B mutations and somatic PAPPA losses?,cnv_and_ssm
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic HTR3B mutations and somatic GUK1 losses?,cnv_and_ssm
+129,ABCC3,R758W,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic ABCC3 mutations and somatic SPATA22 losses?,cnv_and_ssm
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic NOMO1 mutations and somatic TASOR2 losses?,cnv_and_ssm
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic NOMO1 mutations and somatic ANP32E losses?,cnv_and_ssm
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases display both somatic HYOU1 mutations and somatic PLEKHG6 losses?,cnv_and_ssm
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic FMO4 mutations and somatic DCC losses?,cnv_and_ssm
+140,BICC1,A372V,Exceptional Responders,What share of Exceptional Responders cases display both somatic BICC1 mutations and somatic STK19 losses?,cnv_and_ssm
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic ZMYM3 mutations and somatic FGF8 losses?,cnv_and_ssm
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic ZMYM3 mutations and somatic PAK3 losses?,cnv_and_ssm
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic ZMYM3 mutations and somatic GRTP1 losses?,cnv_and_ssm
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases display both somatic XKR4 mutations and somatic TRIM45 losses?",cnv_and_ssm
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What share of Liver Hepatocellular Carcinoma cases display both somatic ABCC2 mutations and somatic MAD1L1 losses?,cnv_and_ssm
+157,OR8K5,R293G,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic OR8K5 mutations and somatic CTNNA2 losses?,cnv_and_ssm
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic SPTAN1 mutations and somatic SPATA22 losses?,cnv_and_ssm
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic SPTAN1 mutations and somatic PTPRO losses?,cnv_and_ssm
+164,SYT10,M484I,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases display both somatic SYT10 mutations and somatic ADRA1A losses?,cnv_and_ssm
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic HSPA5 mutations and somatic GABRA6 losses?,cnv_and_ssm
+175,UNC5D,L280V,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic UNC5D mutations and somatic TASOR2 losses?,cnv_and_ssm
+176,UNC5D,L635V,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic UNC5D mutations and somatic PAK3 losses?,cnv_and_ssm
+177,UNC5D,L637V,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic UNC5D mutations and somatic ZCCHC14 losses?,cnv_and_ssm
+178,UNC5D,L699V,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic UNC5D mutations and somatic CACNA1F losses?,cnv_and_ssm
+179,UNC5D,L704V,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic UNC5D mutations and somatic YY1AP1 losses?,cnv_and_ssm
+180,UNC5D,L709V,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic UNC5D mutations and somatic SGIP1 losses?,cnv_and_ssm
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What share of Kidney Renal Clear Cell Carcinoma cases display both somatic DOCK2 mutations and somatic THBS4 losses?,cnv_and_ssm
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What share of Kidney Renal Clear Cell Carcinoma cases display both somatic ZNF627 mutations and somatic JAML losses?,cnv_and_ssm
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic CDC42BPA mutations and somatic YY1AP1 losses?,cnv_and_ssm
+193,MRPL55,H27Y,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic MRPL55 mutations and somatic CYP1A2 losses?,cnv_and_ssm
+194,MRPL55,H63Y,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic MRPL55 mutations and somatic TENM3 losses?,cnv_and_ssm
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases display both somatic TMTC3 mutations and somatic SYNJ1 losses?,cnv_and_ssm
+198,EPRS1,K771I,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic EPRS1 mutations and somatic GABRA6 losses?,cnv_and_ssm
+199,EPRS1,K778I,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic EPRS1 mutations and somatic POLR1G losses?,cnv_and_ssm
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic GRTP1 mutations and somatic ERCC6 losses?,cnv_and_ssm
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic GRTP1 mutations and somatic UNC5D losses?,cnv_and_ssm
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic TSHZ3 mutations and somatic RIMS2 losses?,cnv_and_ssm
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What share of HIV+ Tumor Molecular Characterization Project - Cervical Cancer cases display both somatic TAS1R3 mutations and somatic DCC losses?,cnv_and_ssm
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic PIAS3 mutations and somatic POC1B losses?,cnv_and_ssm
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic PIAS3 mutations and somatic PRSS1 losses?,cnv_and_ssm
+251,ZNF274,P13R,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic ZNF274 mutations and somatic MAST4 losses?,cnv_and_ssm
+253,SYNJ1,R795C,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic SYNJ1 mutations and somatic NCKAP5 losses?,cnv_and_ssm
+254,SYNJ1,R800C,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic SYNJ1 mutations and somatic MYO3A losses?,cnv_and_ssm
+255,SYNJ1,R839C,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic SYNJ1 mutations and somatic REXO4 losses?,cnv_and_ssm
+261,DSCAM,V343M,Prostate Adenocarcinoma,What share of Prostate Adenocarcinoma cases display both somatic DSCAM mutations and somatic SGCZ losses?,cnv_and_ssm
+262,DSCAM,V426M,Prostate Adenocarcinoma,What share of Prostate Adenocarcinoma cases display both somatic DSCAM mutations and somatic NEXN losses?,cnv_and_ssm
+263,DSCAM,V591M,Prostate Adenocarcinoma,What share of Prostate Adenocarcinoma cases display both somatic DSCAM mutations and somatic MERTK losses?,cnv_and_ssm
+267,DGKD,R140H,Exceptional Responders,What share of Exceptional Responders cases display both somatic DGKD mutations and somatic CTSC losses?,cnv_and_ssm
+268,DGKD,R160H,Exceptional Responders,What share of Exceptional Responders cases display both somatic DGKD mutations and somatic ACTB losses?,cnv_and_ssm
+269,DGKD,R204H,Exceptional Responders,What share of Exceptional Responders cases display both somatic DGKD mutations and somatic DCC losses?,cnv_and_ssm
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases display both somatic PLEKHG6 mutations and somatic PKHD1L1 losses?,cnv_and_ssm
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases display both somatic PLEKHG6 mutations and somatic ACVR1B losses?,cnv_and_ssm
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases display both somatic PLEKHG6 mutations and somatic SORCS1 losses?,cnv_and_ssm
+279,WNT2,D138N,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic WNT2 mutations and somatic TTC17 losses?,cnv_and_ssm
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic GUCY2C mutations and somatic TASOR2 losses?,cnv_and_ssm
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic C7orf31 mutations and somatic CDC42BPA losses?,cnv_and_ssm
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases display both somatic ZKSCAN7 mutations and somatic EIF2B4 losses?",cnv_and_ssm
+299,OR5D14,M210L,Neuroblastoma,What share of Neuroblastoma cases display both somatic OR5D14 mutations and somatic ARMC3 losses?,cnv_and_ssm
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic SPATA22 mutations and somatic RIMS2 losses?,cnv_and_ssm
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic SPATA22 mutations and somatic PIK3C2G losses?,cnv_and_ssm
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic SPATA22 mutations and somatic DCN losses?,cnv_and_ssm
+310,LCN15,E21V,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic LCN15 mutations and somatic TRAP1 losses?,cnv_and_ssm
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic DCAF4L2 mutations and somatic TTC12 losses?,cnv_and_ssm
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic GUK1 mutations and somatic CX3CR1 losses?,cnv_and_ssm
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic GUK1 mutations and somatic TNS1 losses?,cnv_and_ssm
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic GUK1 mutations and somatic ZNF804A losses?,cnv_and_ssm
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic GUK1 mutations and somatic CNGB1 losses?,cnv_and_ssm
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic GUK1 mutations and somatic HBB losses?,cnv_and_ssm
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic MORF4L1 mutations and somatic TTYH2 losses?,cnv_and_ssm
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic MORF4L1 mutations and somatic YY1AP1 losses?,cnv_and_ssm
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic MORF4L1 mutations and somatic FGF8 losses?,cnv_and_ssm
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic MORF4L1 mutations and somatic CDH23 losses?,cnv_and_ssm
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic MYO3B mutations and somatic TTC17 losses?,cnv_and_ssm
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic MYO3B mutations and somatic POLR1G losses?,cnv_and_ssm
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic TENT5A mutations and somatic ANKRD30A losses?,cnv_and_ssm
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic TENT5A mutations and somatic HTR3B losses?,cnv_and_ssm
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic TENT5A mutations and somatic FBXO42 losses?,cnv_and_ssm
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What share of Ovarian Serous Cystadenocarcinoma cases display both somatic ZFAT mutations and somatic RAB40C losses?,cnv_and_ssm
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What share of Ovarian Serous Cystadenocarcinoma cases display both somatic ZFAT mutations and somatic GSTCD losses?,cnv_and_ssm
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What share of Ovarian Serous Cystadenocarcinoma cases display both somatic ZFAT mutations and somatic TLK2 losses?,cnv_and_ssm
+357,ZNF584,A211T,Sarcoma,What share of Sarcoma cases display both somatic ZNF584 mutations and somatic AUTS2 losses?,cnv_and_ssm
+358,ZNF584,A256T,Sarcoma,What share of Sarcoma cases display both somatic ZNF584 mutations and somatic MSANTD4 losses?,cnv_and_ssm
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic LDOC1 mutations and somatic DNAH14 losses?,cnv_and_ssm
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic PDGFC mutations and somatic CARMIL1 losses?,cnv_and_ssm
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic MSANTD4 mutations and somatic AUTS2 losses?,cnv_and_ssm
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic NPSR1 mutations and somatic DNAH11 losses?,cnv_and_ssm
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic PHLPP1 mutations and somatic PTPRO losses?,cnv_and_ssm
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic COL6A3 mutations and somatic MORF4L1 losses?,cnv_and_ssm
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic COL6A3 mutations and somatic PTPRN2 losses?,cnv_and_ssm
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic COL6A3 mutations and somatic YY1AP1 losses?,cnv_and_ssm
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic COL6A3 mutations and somatic ACVR1B losses?,cnv_and_ssm
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic COL6A3 mutations and somatic HTR3B losses?,cnv_and_ssm
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic ADRA1A mutations and somatic POC1B losses?,cnv_and_ssm
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What share of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases display both somatic LAMB2 mutations and somatic ZFPM2 losses?,cnv_and_ssm
+406,POC1B,I198T,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases display both somatic POC1B mutations and somatic PRSS1 losses?,cnv_and_ssm
+407,POC1B,I286T,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases display both somatic POC1B mutations and somatic DGKD losses?,cnv_and_ssm
+408,POC1B,I328T,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases display both somatic POC1B mutations and somatic STK19 losses?,cnv_and_ssm
+409,POC1B,S79P,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases display both somatic POC1B mutations and somatic SYNJ1 losses?,cnv_and_ssm
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What share of Liver Hepatocellular Carcinoma cases display both somatic USH2A mutations and somatic FGF8 losses?,cnv_and_ssm
+414,AQP7,T110S,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases display both somatic AQP7 mutations and somatic RAB40C losses?,cnv_and_ssm
+415,AQP7,T166S,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases display both somatic AQP7 mutations and somatic PRSS8 losses?,cnv_and_ssm
+416,AQP7,T167S,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases display both somatic AQP7 mutations and somatic NEXN losses?,cnv_and_ssm
+417,AQP7,T75S,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases display both somatic AQP7 mutations and somatic PYHIN1 losses?,cnv_and_ssm
+430,DCN,R163C,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases display both somatic DCN mutations and somatic SYT9 losses?,cnv_and_ssm
+431,DCN,R203C,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases display both somatic DCN mutations and somatic BCAT1 losses?,cnv_and_ssm
+432,DCN,R241C,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases display both somatic DCN mutations and somatic SMO losses?,cnv_and_ssm
+433,DCN,R350C,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases display both somatic DCN mutations and somatic CEP20 losses?,cnv_and_ssm
+434,DCN,R41C,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases display both somatic DCN mutations and somatic DCLK3 losses?,cnv_and_ssm
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic CPS1 mutations and somatic GUK1 losses?,cnv_and_ssm
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic CPS1 mutations and somatic PRSS8 losses?,cnv_and_ssm
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic CPS1 mutations and somatic PLEKHG6 losses?,cnv_and_ssm
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What share of Kidney Renal Papillary Cell Carcinoma cases display both somatic FCGR2C mutations and somatic GIMAP2 losses?,cnv_and_ssm
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What share of Kidney Renal Papillary Cell Carcinoma cases display both somatic FCGR2C mutations and somatic JAML losses?,cnv_and_ssm
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic GRM1 mutations and somatic TRIM45 losses?,cnv_and_ssm
+482,SGCZ,Q138H,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic SGCZ mutations and somatic PRSS1 losses?,cnv_and_ssm
+483,SGCZ,Q91H,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic SGCZ mutations and somatic TAF1C losses?,cnv_and_ssm
+485,SMO,V15M,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic SMO mutations and somatic PRSS8 losses?,cnv_and_ssm
+486,SMO,V321M,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic SMO mutations and somatic YY1AP1 losses?,cnv_and_ssm
+488,CHODL,G159E,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic CHODL mutations and somatic KDM5C losses?,cnv_and_ssm
+489,CHODL,G181E,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic CHODL mutations and somatic SIK2 losses?,cnv_and_ssm
+490,CHODL,G200E,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic CHODL mutations and somatic MAST4 losses?,cnv_and_ssm
+494,MYO16,P399H,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic MYO16 mutations and somatic GPC3 losses?,cnv_and_ssm
+495,MYO16,P421H,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic MYO16 mutations and somatic TYK2 losses?,cnv_and_ssm
+498,CXCR2,A98V,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic CXCR2 mutations and somatic GUK1 losses?,cnv_and_ssm
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases display both somatic TMEM225 mutations and somatic NPSR1 losses?,cnv_and_ssm
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic MAOB mutations and somatic CXCR2 losses?,cnv_and_ssm
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic GPRASP1 mutations and somatic TNS1 losses?,cnv_and_ssm
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic MRPL32 mutations and somatic UBR2 losses?,cnv_and_ssm
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic TYROBP mutations and somatic KANSL1 losses?,cnv_and_ssm
+510,RAB40C,A111V,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic RAB40C mutations and somatic ZFPM2 losses?,cnv_and_ssm
+511,RAB40C,A143V,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic RAB40C mutations and somatic TAF1C losses?,cnv_and_ssm
+512,CTNNA2,S323R,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic CTNNA2 mutations and somatic MORF4L1 losses?,cnv_and_ssm
+513,CTNNA2,S339R,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic CTNNA2 mutations and somatic ZBTB34 losses?,cnv_and_ssm
+514,CTNNA2,S386R,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic CTNNA2 mutations and somatic MAST4 losses?,cnv_and_ssm
+515,CTNNA2,S707R,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic CTNNA2 mutations and somatic CYB5R2 losses?,cnv_and_ssm
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases display both somatic MYO15A mutations and somatic NOMO1 losses?,cnv_and_ssm
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic GIMAP2 mutations and somatic RIPOR2 losses?,cnv_and_ssm
+532,KIF20B,N1160D,Glioblastoma Multiforme,What share of Glioblastoma Multiforme cases display both somatic KIF20B mutations and somatic PTPRO losses?,cnv_and_ssm
+533,KIF20B,N1200D,Glioblastoma Multiforme,What share of Glioblastoma Multiforme cases display both somatic KIF20B mutations and somatic TASOR2 losses?,cnv_and_ssm
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic ADAM17 mutations and somatic TTC12 losses?,cnv_and_ssm
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic BCAT1 mutations and somatic MRPL55 losses?,cnv_and_ssm
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic BCAT1 mutations and somatic DCN losses?,cnv_and_ssm
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic BCAT1 mutations and somatic DHX16 losses?,cnv_and_ssm
+540,ERCC6,R1053H,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic ERCC6 mutations and somatic TYK2 losses?,cnv_and_ssm
+541,DCC,R320W,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases display both somatic DCC mutations and somatic CX3CR1 losses?,cnv_and_ssm
+542,DCC,R363W,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases display both somatic DCC mutations and somatic ANKDD1A losses?,cnv_and_ssm
+543,DCC,R386W,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases display both somatic DCC mutations and somatic GIMAP2 losses?,cnv_and_ssm
+544,DCC,R41W,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases display both somatic DCC mutations and somatic HTR3B losses?,cnv_and_ssm
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic FBXO15 mutations and somatic TRPA1 losses?,cnv_and_ssm
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic FBXO15 mutations and somatic RIMS2 losses?,cnv_and_ssm
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic GSTCD mutations and somatic TTC12 losses?,cnv_and_ssm
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic GSTCD mutations and somatic TNS1 losses?,cnv_and_ssm
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic OLFML3 mutations and somatic CNGB1 losses?,cnv_and_ssm
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic OLFML3 mutations and somatic SORCS1 losses?,cnv_and_ssm
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic OLFML3 mutations and somatic PTPRN2 losses?,cnv_and_ssm
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What share of Ovarian Serous Cystadenocarcinoma cases display both somatic CFAP61 mutations and somatic OR2T4 losses?,cnv_and_ssm
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What share of Ovarian Serous Cystadenocarcinoma cases display both somatic CFAP61 mutations and somatic TMEM255A losses?,cnv_and_ssm
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases display both somatic HLA-DQA2 mutations and somatic HTR3B losses?,cnv_and_ssm
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic TENM2 mutations and somatic RELN losses?,cnv_and_ssm
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic TENM2 mutations and somatic EVC2 losses?,cnv_and_ssm
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic TENM2 mutations and somatic CNGB1 losses?,cnv_and_ssm
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic ANKRD24 mutations and somatic B3GALNT1 losses?,cnv_and_ssm
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic ANKRD24 mutations and somatic RIMS2 losses?,cnv_and_ssm
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic ANKRD24 mutations and somatic FGF8 losses?,cnv_and_ssm
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic ZCCHC14 mutations and somatic CFAP298-TCP10L losses?,cnv_and_ssm
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic ZCCHC14 mutations and somatic RIMS2 losses?,cnv_and_ssm
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic ZCCHC14 mutations and somatic CDKN2AIP losses?,cnv_and_ssm
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic ZCCHC14 mutations and somatic TRPA1 losses?,cnv_and_ssm
+625,SIK2,I265M,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic SIK2 mutations and somatic PYHIN1 losses?,cnv_and_ssm
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic MYH11 mutations and somatic ACVR1B losses?,cnv_and_ssm
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic MYH11 mutations and somatic MYO3A losses?,cnv_and_ssm
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic SLC6A4 mutations and somatic MYH11 losses?,cnv_and_ssm
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic SLC9C1 mutations and somatic GUK1 losses?,cnv_and_ssm
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic SLC9C1 mutations and somatic PTPRO losses?,cnv_and_ssm
+644,OR2A12,A254T,Brain Lower Grade Glioma,What share of Brain Lower Grade Glioma cases display both somatic OR2A12 mutations and somatic STK19 losses?,cnv_and_ssm
+646,PYHIN1,T325K,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic PYHIN1 mutations and somatic AUTS2 losses?,cnv_and_ssm
+647,PYHIN1,T334K,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic PYHIN1 mutations and somatic HLA-DQA2 losses?,cnv_and_ssm
+650,JAML,G191E,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic JAML mutations and somatic THBS4 losses?,cnv_and_ssm
+651,JAML,G219E,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic JAML mutations and somatic CPA6 losses?,cnv_and_ssm
+652,JAML,G220E,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic JAML mutations and somatic TYROBP losses?,cnv_and_ssm
+653,JAML,G230E,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic JAML mutations and somatic MAST4 losses?,cnv_and_ssm
+658,TYK2,H1146R,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic TYK2 mutations and somatic RIPOR2 losses?,cnv_and_ssm
+659,TYK2,H23R,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic TYK2 mutations and somatic DNAH14 losses?,cnv_and_ssm
+660,TYK2,H961R,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic TYK2 mutations and somatic FBN1 losses?,cnv_and_ssm
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic CTCFL mutations and somatic EFCAB12 losses?,cnv_and_ssm
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic CTCFL mutations and somatic POC1B losses?,cnv_and_ssm
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic CTCFL mutations and somatic ZFAT losses?,cnv_and_ssm
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic CTCFL mutations and somatic PAK3 losses?,cnv_and_ssm
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic CEP20 mutations and somatic EIF2B4 losses?,cnv_and_ssm
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic CEP20 mutations and somatic PAK3 losses?,cnv_and_ssm
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic RIMS2 mutations and somatic SGCZ losses?,cnv_and_ssm
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic RIMS2 mutations and somatic USH2A losses?,cnv_and_ssm
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic RIMS2 mutations and somatic USH2A losses?,cnv_and_ssm
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic RIMS2 mutations and somatic ACTA2 losses?,cnv_and_ssm
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic RIMS2 mutations and somatic TAF1C losses?,cnv_and_ssm
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic RIMS2 mutations and somatic FBXO42 losses?,cnv_and_ssm
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic RIMS2 mutations and somatic TRPA1 losses?,cnv_and_ssm
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic PIK3C2G mutations and somatic PYHIN1 losses?,cnv_and_ssm
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic PIK3C2G mutations and somatic TNS1 losses?,cnv_and_ssm
+728,STK19,D341N,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic STK19 mutations and somatic POC1B losses?,cnv_and_ssm
+729,STK19,D345N,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic STK19 mutations and somatic TRPA1 losses?,cnv_and_ssm
+730,REXO4,P60A,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic REXO4 mutations and somatic TLK2 losses?,cnv_and_ssm
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic ZBTB34 mutations and somatic YY1AP1 losses?,cnv_and_ssm
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic ZBTB34 mutations and somatic BCAT1 losses?,cnv_and_ssm
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases display both somatic NCKAP5 mutations and somatic YY1AP1 losses?,cnv_and_ssm
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases display both somatic SORCS1 mutations and somatic GRTP1 losses?",cnv_and_ssm
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases display both somatic SORCS1 mutations and somatic ANKDD1A losses?",cnv_and_ssm
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases display both somatic SORCS1 mutations and somatic GRTP1 losses?",cnv_and_ssm
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases display both somatic SORCS1 mutations and somatic PCDHB2 losses?",cnv_and_ssm
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What share of Head and Neck Squamous Cell Carcinoma cases display both somatic FGF8 mutations and somatic EIF2B4 losses?,cnv_and_ssm
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What share of Head and Neck Squamous Cell Carcinoma cases display both somatic FGF8 mutations and somatic GSTCD losses?,cnv_and_ssm
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What share of Head and Neck Squamous Cell Carcinoma cases display both somatic FGF8 mutations and somatic TET2 losses?,cnv_and_ssm
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What share of Head and Neck Squamous Cell Carcinoma cases display both somatic FGF8 mutations and somatic DCN losses?,cnv_and_ssm
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What share of Head and Neck Squamous Cell Carcinoma cases display both somatic FGF8 mutations and somatic PAK3 losses?,cnv_and_ssm
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What share of Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia cases display both somatic TENM3 mutations and somatic DPF3 losses?,cnv_and_ssm
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic AKT1 mutations and somatic PRSS1 losses?,cnv_and_ssm
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What share of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases display both somatic CFAP298-TCP10L mutations and somatic MRPL32 losses?,cnv_and_ssm
+792,GLRB,E148D,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic GLRB mutations and somatic MYH11 losses?,cnv_and_ssm
+793,TTN,F7636L,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic TTN mutations and somatic DNMT1 losses?,cnv_and_ssm
+794,TTN,F8563L,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic TTN mutations and somatic CARMIL1 losses?,cnv_and_ssm
+795,TTN,F8880L,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic TTN mutations and somatic TENT5A losses?,cnv_and_ssm
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic ANKRD30A mutations and somatic RIMS2 losses?,cnv_and_ssm
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic ANKRD30A mutations and somatic GLRB losses?,cnv_and_ssm
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic ANKRD30A mutations and somatic EIF2B4 losses?,cnv_and_ssm
+809,TRIM45,S177L,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic TRIM45 mutations and somatic FRY losses?,cnv_and_ssm
+810,TRIM45,S224L,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic TRIM45 mutations and somatic AQP7 losses?,cnv_and_ssm
+811,TRIM45,S281L,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic TRIM45 mutations and somatic PRSS8 losses?,cnv_and_ssm
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic CACNA1F mutations and somatic GUK1 losses?,cnv_and_ssm
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic CACNA1F mutations and somatic ZMYM3 losses?,cnv_and_ssm
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic CACNA1F mutations and somatic ARHGEF40 losses?,cnv_and_ssm
+817,KL,R594C,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic KL mutations and somatic FCGR2C losses?,cnv_and_ssm
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What share of Kidney Renal Papillary Cell Carcinoma cases display both somatic GUF1 mutations and somatic ZNF431 losses?,cnv_and_ssm
+822,TAF1L,A539V,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic TAF1L mutations and somatic DNAH14 losses?,cnv_and_ssm
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic TASOR2 mutations and somatic RIPOR2 losses?,cnv_and_ssm
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic TASOR2 mutations and somatic MYO3B losses?,cnv_and_ssm
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic TASOR2 mutations and somatic CHODL losses?,cnv_and_ssm
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic KDM5C mutations and somatic CHODL losses?,cnv_and_ssm
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic KDM5C mutations and somatic ZNF627 losses?,cnv_and_ssm
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic KDM5C mutations and somatic SGIP1 losses?,cnv_and_ssm
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic KDM5C mutations and somatic CR1 losses?,cnv_and_ssm
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What share of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases display both somatic IL5RA mutations and somatic TENM2 losses?,cnv_and_ssm
+843,DHX16,A29V,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic DHX16 mutations and somatic GABRA6 losses?,cnv_and_ssm
+844,DHX16,A89V,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic DHX16 mutations and somatic PGR losses?,cnv_and_ssm
+902,GPR158,A644V,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic GPR158 mutations and somatic GRM5 losses?,cnv_and_ssm
+903,GPR158,A723V,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic GPR158 mutations and somatic DCC losses?,cnv_and_ssm
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases display both somatic EIF2B4 mutations and somatic GABRA6 losses?",cnv_and_ssm
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases display both somatic EIF2B4 mutations and somatic PDGFC losses?",cnv_and_ssm
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases display both somatic EIF2B4 mutations and somatic GABRA6 losses?",cnv_and_ssm
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases display both somatic EIF2B4 mutations and somatic CFAP61 losses?",cnv_and_ssm
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases display both somatic EIF2B4 mutations and somatic TAF1C losses?",cnv_and_ssm
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases display both somatic EIF2B4 mutations and somatic SGIP1 losses?",cnv_and_ssm
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic AUTS2 mutations and somatic ZFP42 losses?,cnv_and_ssm
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic AUTS2 mutations and somatic GIMAP2 losses?,cnv_and_ssm
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic AUTS2 mutations and somatic SLC9C1 losses?,cnv_and_ssm
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic AUTS2 mutations and somatic OLFML3 losses?,cnv_and_ssm
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic AUTS2 mutations and somatic EPRS1 losses?,cnv_and_ssm
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic AUTS2 mutations and somatic TET2 losses?,cnv_and_ssm
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic AUTS2 mutations and somatic PXN losses?,cnv_and_ssm
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic AUTS2 mutations and somatic ZFAT losses?,cnv_and_ssm
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic AUTS2 mutations and somatic DNAH11 losses?,cnv_and_ssm
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic AUTS2 mutations and somatic POLD1 losses?,cnv_and_ssm
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases display both somatic ACTL7B mutations and somatic TASOR2 losses?",cnv_and_ssm
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What share of Glioblastoma Multiforme cases display both somatic PCDHGA1 mutations and somatic PHLPP1 losses?,cnv_and_ssm
+954,TRAP1,R114W,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic TRAP1 mutations and somatic DNAH14 losses?,cnv_and_ssm
+955,TRAP1,R61W,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic TRAP1 mutations and somatic HSPA5 losses?,cnv_and_ssm
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic PIK3C2A mutations and somatic ACTA2 losses?,cnv_and_ssm
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What share of Liver Hepatocellular Carcinoma cases display both somatic KANSL1 mutations and somatic AUTS2 losses?,cnv_and_ssm
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic ANKRD52 mutations and somatic RIMS2 losses?,cnv_and_ssm
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic PAPPA mutations and somatic PRSS1 losses?,cnv_and_ssm
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases display both somatic B3GALNT1 mutations and somatic ZFPM2 losses?,cnv_and_ssm
+982,GABRA6,G115R,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic GABRA6 mutations and somatic DPF3 losses?,cnv_and_ssm
+983,GABRA6,G122R,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic GABRA6 mutations and somatic THBS4 losses?,cnv_and_ssm
+984,GABRA6,G165R,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic GABRA6 mutations and somatic ZNF584 losses?,cnv_and_ssm
+985,GABRA6,G175R,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic GABRA6 mutations and somatic ZCCHC14 losses?,cnv_and_ssm
+986,GABRA6,G70R,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic GABRA6 mutations and somatic FGF8 losses?,cnv_and_ssm
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic ZSCAN31 mutations and somatic ZFAT losses?,cnv_and_ssm
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases display both somatic MED16 mutations and somatic ANP32E losses?",cnv_and_ssm
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases display both somatic MED16 mutations and somatic PRSS8 losses?",cnv_and_ssm
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What share of Pancreatic Adenocarcinoma cases display both somatic PTPRO mutations and somatic PRSS8 losses?,cnv_and_ssm
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What share of Pancreatic Adenocarcinoma cases display both somatic PTPRO mutations and somatic PGF losses?,cnv_and_ssm
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What share of Pancreatic Adenocarcinoma cases display both somatic PTPRO mutations and somatic SPATA22 losses?,cnv_and_ssm
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What share of Pancreatic Adenocarcinoma cases display both somatic PTPRO mutations and somatic KDM5C losses?,cnv_and_ssm
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What share of Pancreatic Adenocarcinoma cases display both somatic PTPRO mutations and somatic EFCAB12 losses?,cnv_and_ssm
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What share of Pancreatic Adenocarcinoma cases display both somatic PTPRO mutations and somatic AUTS2 losses?,cnv_and_ssm
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What share of Pancreatic Adenocarcinoma cases display both somatic PTPRO mutations and somatic TTC17 losses?,cnv_and_ssm
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What share of Pancreatic Adenocarcinoma cases display both somatic PTPRO mutations and somatic TET2 losses?,cnv_and_ssm
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic CHMP7 mutations and somatic BICC1 losses?,cnv_and_ssm
+1017,GPC3,I107N,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic GPC3 mutations and somatic RIPOR2 losses?,cnv_and_ssm
+1018,GPC3,I161N,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic GPC3 mutations and somatic TYK2 losses?,cnv_and_ssm
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What share of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases display both somatic TLK2 mutations and somatic ZFP42 losses?,cnv_and_ssm
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What share of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases display both somatic TLK2 mutations and somatic SPATA22 losses?,cnv_and_ssm
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What share of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases display both somatic TLK2 mutations and somatic PIK3C2A losses?,cnv_and_ssm
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What share of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases display both somatic TLK2 mutations and somatic GPRASP1 losses?,cnv_and_ssm
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What share of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases display both somatic TLK2 mutations and somatic PDHA2 losses?,cnv_and_ssm
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic ZNF217 mutations and somatic KL losses?,cnv_and_ssm
+1038,SYT9,V275L,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic SYT9 mutations and somatic FGF8 losses?,cnv_and_ssm
+1039,SYT9,V307L,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic SYT9 mutations and somatic ZFPM2 losses?,cnv_and_ssm
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic PKHD1L1 mutations and somatic ERCC6 losses?,cnv_and_ssm
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic MYO3A mutations and somatic PSG2 losses?,cnv_and_ssm
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases display both somatic VASN mutations and somatic FGF8 losses?",cnv_and_ssm
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic DNMT1 mutations and somatic EIF2B4 losses?,cnv_and_ssm
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic DNMT1 mutations and somatic CDKN2AIP losses?,cnv_and_ssm
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic DNMT1 mutations and somatic YY1AP1 losses?,cnv_and_ssm
+1056,CA9,E402K,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic CA9 mutations and somatic DGKD losses?,cnv_and_ssm
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic TTC17 mutations and somatic CASZ1 losses?,cnv_and_ssm
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic TTC17 mutations and somatic SYT10 losses?,cnv_and_ssm
+1065,PSG2,P43L,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases display both somatic PSG2 mutations and somatic TLK2 losses?,cnv_and_ssm
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases display both somatic RIPOR2 mutations and somatic TASOR2 losses?,cnv_and_ssm
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases display both somatic RIPOR2 mutations and somatic IL5RA losses?,cnv_and_ssm
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases display both somatic RIPOR2 mutations and somatic ZBTB34 losses?,cnv_and_ssm
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases display both somatic RIPOR2 mutations and somatic CHMP7 losses?,cnv_and_ssm
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic DCLK3 mutations and somatic JAML losses?,cnv_and_ssm
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic DCLK3 mutations and somatic OR5D14 losses?,cnv_and_ssm
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic MERTK mutations and somatic CYP1A2 losses?,cnv_and_ssm
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic MERTK mutations and somatic PTPRO losses?,cnv_and_ssm
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic MERTK mutations and somatic GPRASP1 losses?,cnv_and_ssm
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic ZFP42 mutations and somatic CR1 losses?,cnv_and_ssm
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic OR13C3 mutations and somatic CTSC losses?,cnv_and_ssm
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic OR13C3 mutations and somatic GABRA6 losses?,cnv_and_ssm
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic SPAG1 mutations and somatic USH2A losses?,cnv_and_ssm
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic CDKN2AIP mutations and somatic FGF8 losses?,cnv_and_ssm
+1093,PXN,H1016Y,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic PXN mutations and somatic SPINDOC losses?,cnv_and_ssm
+1094,PXN,H359Y,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic PXN mutations and somatic PIK3C2G losses?,cnv_and_ssm
+1095,PXN,H492Y,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic PXN mutations and somatic DEFB115 losses?,cnv_and_ssm
+1096,PXN,H524Y,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic PXN mutations and somatic SYT9 losses?,cnv_and_ssm
+1097,PXN,H526Y,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic PXN mutations and somatic MERTK losses?,cnv_and_ssm
+1098,PXN,H540Y,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic PXN mutations and somatic GUK1 losses?,cnv_and_ssm
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic TTYH2 mutations and somatic DNAH14 losses?,cnv_and_ssm
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic TTYH2 mutations and somatic AQP7 losses?,cnv_and_ssm
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic TMEM255A mutations and somatic WNT2 losses?,cnv_and_ssm
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic TMEM255A mutations and somatic CFAP61 losses?,cnv_and_ssm
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic TMEM255A mutations and somatic ACTB losses?,cnv_and_ssm
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases display both somatic TASOR2 mutations and somatic MSANTD4 losses?,cnv_and_ssm
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases display both somatic TASOR2 mutations and somatic TENT5A losses?,cnv_and_ssm
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic ICE1 mutations and somatic NOMO1 losses?,cnv_and_ssm
+1112,MYT1,A558E,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases display both somatic MYT1 mutations and somatic PDHA2 losses?,cnv_and_ssm
+1113,MYT1,A879E,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases display both somatic MYT1 mutations and somatic SPTAN1 losses?,cnv_and_ssm
+1114,MYT1,A906E,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases display both somatic MYT1 mutations and somatic CEP20 losses?,cnv_and_ssm
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic CX3CR1 mutations and somatic OLFML3 losses?,cnv_and_ssm
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic CX3CR1 mutations and somatic MAD1L1 losses?,cnv_and_ssm
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What share of Liver Hepatocellular Carcinoma cases display both somatic SPINDOC mutations and somatic TASOR2 losses?,cnv_and_ssm
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic ART3 mutations and somatic EIF2B4 losses?,cnv_and_ssm
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic ART3 mutations and somatic GUK1 losses?,cnv_and_ssm
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases display both somatic CYP1A2 mutations and somatic FNDC7 losses?,cnv_and_ssm
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases display both somatic ADRA1A mutations and somatic PYHIN1 losses?",cnv_and_ssm
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic CDH23 mutations and somatic GABRA6 losses?,cnv_and_ssm
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic CDH23 mutations and somatic AUTS2 losses?,cnv_and_ssm
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic KRT39 mutations and somatic SORCS1 losses?,cnv_and_ssm
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic PDHA2 mutations and somatic FRY losses?,cnv_and_ssm
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic SLC24A2 mutations and somatic MAST4 losses?,cnv_and_ssm
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What share of Liver Hepatocellular Carcinoma cases display both somatic PTPRN2 mutations and somatic CDKN2AIP losses?,cnv_and_ssm
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What share of Liver Hepatocellular Carcinoma cases display both somatic PTPRN2 mutations and somatic DGKD losses?,cnv_and_ssm
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What share of Liver Hepatocellular Carcinoma cases display both somatic PTPRN2 mutations and somatic GABRA6 losses?,cnv_and_ssm
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What share of Liver Hepatocellular Carcinoma cases display both somatic PTPRN2 mutations and somatic SYT9 losses?,cnv_and_ssm
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What share of Liver Hepatocellular Carcinoma cases display both somatic PTPRN2 mutations and somatic GPR158 losses?,cnv_and_ssm
+1188,SOX21,R55L,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic SOX21 mutations and somatic PRSS1 losses?,cnv_and_ssm
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases display both somatic CPA6 mutations and somatic MED16 losses?,cnv_and_ssm
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic GRM5 mutations and somatic ACTL7B losses?,cnv_and_ssm
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases display both somatic CASZ1 mutations and somatic ANKRD30A losses?",cnv_and_ssm
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic SGIP1 mutations and somatic TRAP1 losses?,cnv_and_ssm
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic SGIP1 mutations and somatic MAD1L1 losses?,cnv_and_ssm
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic SGIP1 mutations and somatic PSG2 losses?,cnv_and_ssm
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic SGIP1 mutations and somatic ANKRD24 losses?,cnv_and_ssm
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic CARMIL1 mutations and somatic NEXN losses?,cnv_and_ssm
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic CARMIL1 mutations and somatic DCN losses?,cnv_and_ssm
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic ZNF431 mutations and somatic CDC42BPA losses?,cnv_and_ssm
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic ZNF431 mutations and somatic DCN losses?,cnv_and_ssm
+1234,ZNF431,R128I,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic ZNF431 mutations and somatic PDHA2 losses?,cnv_and_ssm
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic DNAH11 mutations and somatic DCC losses?,cnv_and_ssm
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic DNAH11 mutations and somatic GUK1 losses?,cnv_and_ssm
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic POLD1 mutations and somatic MYO16 losses?,cnv_and_ssm
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What share of Lung Squamous Cell Carcinoma cases display both somatic POLD1 mutations and somatic LAMB2 losses?,cnv_and_ssm
+1248,TTC12,D646H,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic TTC12 mutations and somatic AUTS2 losses?,cnv_and_ssm
+1249,TTC12,D652H,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic TTC12 mutations and somatic PHLPP1 losses?,cnv_and_ssm
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases display both somatic CNGB1 mutations and somatic ADAM17 losses?,cnv_and_ssm
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What share of Bladder Urothelial Carcinoma cases display both somatic CNGB1 mutations and somatic EIF2B4 losses?,cnv_and_ssm
+1254,CTSC,E214V,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic CTSC mutations and somatic MRPL55 losses?,cnv_and_ssm
+1255,CTSC,E291V,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic CTSC mutations and somatic POC1B losses?,cnv_and_ssm
+1256,CTSC,E322V,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic CTSC mutations and somatic OLFML3 losses?,cnv_and_ssm
+1257,CTSC,E324V,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic CTSC mutations and somatic ANKDD1A losses?,cnv_and_ssm
+1258,CTSC,E335V,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic CTSC mutations and somatic SLC9C1 losses?,cnv_and_ssm
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic PRSS8 mutations and somatic AUTS2 losses?,cnv_and_ssm
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic PRSS8 mutations and somatic TLK2 losses?,cnv_and_ssm
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic ARHGEF40 mutations and somatic ACVR1B losses?,cnv_and_ssm
+1264,ACTB,A138T,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases display both somatic ACTB mutations and somatic ZCCHC14 losses?,cnv_and_ssm
+1265,ACTB,A217T,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases display both somatic ACTB mutations and somatic CEP20 losses?,cnv_and_ssm
+1266,ACTB,A244T,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases display both somatic ACTB mutations and somatic YY1AP1 losses?,cnv_and_ssm
+1267,ACTB,A260T,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases display both somatic ACTB mutations and somatic CTCFL losses?,cnv_and_ssm
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What share of Glioblastoma Multiforme cases display both somatic YY1AP1 mutations and somatic DNAH14 losses?,cnv_and_ssm
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What share of Glioblastoma Multiforme cases display both somatic YY1AP1 mutations and somatic OR2T4 losses?,cnv_and_ssm
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What share of Glioblastoma Multiforme cases display both somatic YY1AP1 mutations and somatic TTYH2 losses?,cnv_and_ssm
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What share of Glioblastoma Multiforme cases display both somatic YY1AP1 mutations and somatic PGR losses?,cnv_and_ssm
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What share of Glioblastoma Multiforme cases display both somatic YY1AP1 mutations and somatic BCAT1 losses?,cnv_and_ssm
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What share of Glioblastoma Multiforme cases display both somatic YY1AP1 mutations and somatic PRSS1 losses?,cnv_and_ssm
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What share of Glioblastoma Multiforme cases display both somatic YY1AP1 mutations and somatic AUTS2 losses?,cnv_and_ssm
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic FNDC7 mutations and somatic MYO3B losses?,cnv_and_ssm
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic FNDC7 mutations and somatic GABRA6 losses?,cnv_and_ssm
+1299,TLCD5,G15V,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic TLCD5 mutations and somatic SGIP1 losses?,cnv_and_ssm
+1300,TLCD5,G37V,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic TLCD5 mutations and somatic AQP7 losses?,cnv_and_ssm
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic POLR1G mutations and somatic CPS1 losses?,cnv_and_ssm
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic POLR1G mutations and somatic OR13C3 losses?,cnv_and_ssm
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic DNAH14 mutations and somatic EIF2B4 losses?,cnv_and_ssm
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic DNAH14 mutations and somatic ZBTB34 losses?,cnv_and_ssm
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic DNAH14 mutations and somatic CYB5R2 losses?,cnv_and_ssm
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic NEXN mutations and somatic MAD1L1 losses?,cnv_and_ssm
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What share of Prostate Adenocarcinoma cases display both somatic CYB5R2 mutations and somatic POLD1 losses?,cnv_and_ssm
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What share of Prostate Adenocarcinoma cases display both somatic CYB5R2 mutations and somatic ADRA1A losses?,cnv_and_ssm
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic NRAP mutations and somatic PRSS1 losses?,cnv_and_ssm
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic NRAP mutations and somatic SPATA22 losses?,cnv_and_ssm
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic NRAP mutations and somatic CARMIL1 losses?,cnv_and_ssm
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic CCDC22 mutations and somatic CACNA1F losses?,cnv_and_ssm
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic DCAF6 mutations and somatic TAF1C losses?,cnv_and_ssm
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic DCAF6 mutations and somatic ZFPM2 losses?,cnv_and_ssm
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic ZNF708 mutations and somatic CDH23 losses?,cnv_and_ssm
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic BFAR mutations and somatic RIPOR2 losses?,cnv_and_ssm
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic MAST4 mutations and somatic DGKD losses?,cnv_and_ssm
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic MAST4 mutations and somatic DCAF4L2 losses?,cnv_and_ssm
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic MAST4 mutations and somatic CTSC losses?,cnv_and_ssm
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic MAST4 mutations and somatic COL6A3 losses?,cnv_and_ssm
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic MAST4 mutations and somatic AUTS2 losses?,cnv_and_ssm
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic ARMC3 mutations and somatic YY1AP1 losses?,cnv_and_ssm
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic ARMC3 mutations and somatic TRPA1 losses?,cnv_and_ssm
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What share of Kidney Renal Clear Cell Carcinoma cases display both somatic TET2 mutations and somatic UNC5D losses?,cnv_and_ssm
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What share of Kidney Renal Clear Cell Carcinoma cases display both somatic TET2 mutations and somatic GRTP1 losses?,cnv_and_ssm
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic SERPINB10 mutations and somatic ZKSCAN7 losses?,cnv_and_ssm
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic STAT3 mutations and somatic RIMS2 losses?,cnv_and_ssm
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic MIEF1 mutations and somatic CA9 losses?,cnv_and_ssm
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic ACVR1B mutations and somatic CR1 losses?,cnv_and_ssm
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic ACVR1B mutations and somatic THBS4 losses?,cnv_and_ssm
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic ACVR1B mutations and somatic PYHIN1 losses?,cnv_and_ssm
+1393,EBF2,T104I,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic EBF2 mutations and somatic FGF8 losses?,cnv_and_ssm
+1394,EBF2,T252I,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic EBF2 mutations and somatic BFAR losses?,cnv_and_ssm
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic VPS26B mutations and somatic TRIM45 losses?,cnv_and_ssm
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases display both somatic PGR mutations and somatic RIMS2 losses?",cnv_and_ssm
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases display both somatic PGR mutations and somatic CHODL losses?",cnv_and_ssm
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What share of CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases display both somatic PGR mutations and somatic ANKDD1A losses?",cnv_and_ssm
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What share of Skin Cutaneous Melanoma cases display both somatic ACTA2 mutations and somatic OR2A12 losses?,cnv_and_ssm
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic THBS4 mutations and somatic PTPRO losses?,cnv_and_ssm
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic THBS4 mutations and somatic DSCAM losses?,cnv_and_ssm
+1413,PRSS1,S114T,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic PRSS1 mutations and somatic ANKDD1A losses?,cnv_and_ssm
+1414,PRSS1,S124T,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic PRSS1 mutations and somatic CTNNA2 losses?,cnv_and_ssm
+1415,PRSS1,S138T,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic PRSS1 mutations and somatic PYHIN1 losses?,cnv_and_ssm
+1416,PRSS1,S74T,Lung Adenocarcinoma,What share of Lung Adenocarcinoma cases display both somatic PRSS1 mutations and somatic GRTP1 losses?,cnv_and_ssm
+1417,PGF,R126H,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic PGF mutations and somatic ANKRD24 losses?,cnv_and_ssm
+1418,PGF,R127H,Stomach Adenocarcinoma,What share of Stomach Adenocarcinoma cases display both somatic PGF mutations and somatic PTPRN2 losses?,cnv_and_ssm
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases display both somatic ITPRID2 mutations and somatic SYT10 losses?,cnv_and_ssm
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What share of Breast Invasive Carcinoma cases display both somatic ITPRID2 mutations and somatic HTR3B losses?,cnv_and_ssm
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic HBB mutations and somatic KIF20B losses?,cnv_and_ssm
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic PCDHB2 mutations and somatic CTCFL losses?,cnv_and_ssm
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic PCDHB2 mutations and somatic POC1B losses?,cnv_and_ssm
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What share of Colon Adenocarcinoma cases display both somatic PCDHB2 mutations and somatic TTC17 losses?,cnv_and_ssm
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What share of Uterine Corpus Endometrial Carcinoma cases display both somatic UBR2 mutations and somatic EIF2B4 losses?,cnv_and_ssm
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What share of Rectum Adenocarcinoma cases display both somatic FBXO42 mutations and somatic HYOU1 losses?,cnv_and_ssm
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the joint frequency of somatic TNS1 mutations and PLEKHG6 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the joint frequency of somatic TNS1 mutations and MAD1L1 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the joint frequency of somatic TNS1 mutations and C7orf31 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the joint frequency of somatic TNS1 mutations and MYO16 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the joint frequency of somatic TNS1 mutations and STK19 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the joint frequency of somatic TNS1 mutations and STK19 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the joint frequency of somatic TNS1 mutations and SPAG1 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the joint frequency of somatic EVC2 mutations and CPS1 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the joint frequency of somatic EVC2 mutations and RIMS2 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CR1 mutations and KDM5C losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CR1 mutations and MAD1L1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the joint frequency of somatic TRPA1 mutations and AUTS2 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the joint frequency of somatic TRPA1 mutations and PIAS3 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the joint frequency of somatic TAF1C mutations and TLK2 losses in Lung Adenocarcinoma?,cnv_and_ssm
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the joint frequency of somatic TAF1C mutations and JAML losses in Lung Adenocarcinoma?,cnv_and_ssm
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the joint frequency of somatic TAF1C mutations and BCAT1 losses in Lung Adenocarcinoma?,cnv_and_ssm
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the joint frequency of somatic TAF1C mutations and YY1AP1 losses in Lung Adenocarcinoma?,cnv_and_ssm
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the joint frequency of somatic TAF1C mutations and MORF4L1 losses in Lung Adenocarcinoma?,cnv_and_ssm
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic DPF3 mutations and KIF20B losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic DPF3 mutations and GPR158 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic DPF3 mutations and MAD1L1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the joint frequency of somatic OR2T4 mutations and TNS1 losses in Lung Adenocarcinoma?,cnv_and_ssm
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the joint frequency of somatic OR2T4 mutations and SYT9 losses in Lung Adenocarcinoma?,cnv_and_ssm
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the joint frequency of somatic FBN1 mutations and OR13C3 losses in Pancreatic Adenocarcinoma?,cnv_and_ssm
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the joint frequency of somatic MAD1L1 mutations and DNMT1 losses in Prostate Adenocarcinoma?,cnv_and_ssm
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the joint frequency of somatic MAD1L1 mutations and B3GALNT1 losses in Prostate Adenocarcinoma?,cnv_and_ssm
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the joint frequency of somatic MAD1L1 mutations and ZBTB34 losses in Prostate Adenocarcinoma?,cnv_and_ssm
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the joint frequency of somatic CCNG1 mutations and TYROBP losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the joint frequency of somatic ANP32E mutations and CXCR2 losses in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the joint frequency of somatic ANP32E mutations and MORF4L1 losses in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the joint frequency of somatic ANP32E mutations and POLD1 losses in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the joint frequency of somatic ANP32E mutations and ACVR1B losses in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the joint frequency of somatic FRY mutations and THBS4 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the joint frequency of somatic FRY mutations and CTSC losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the joint frequency of somatic FRY mutations and TRIM45 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the joint frequency of somatic FRY mutations and MAST4 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the joint frequency of somatic PAK3 mutations and MED16 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the joint frequency of somatic PAK3 mutations and ART3 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the joint frequency of somatic PAK3 mutations and GPC3 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the joint frequency of somatic PAK3 mutations and TLK2 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the joint frequency of somatic PAK3 mutations and TLCD5 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the joint frequency of somatic MUC16 mutations and PXN losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the joint frequency of somatic ZFPM2 mutations and TAF1C losses in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the joint frequency of somatic ZFPM2 mutations and HTR3B losses in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the joint frequency of somatic PIK3C2B mutations and ZNF584 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the joint frequency of somatic PIK3C2B mutations and MAOB losses in Breast Invasive Carcinoma?,cnv_and_ssm
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the joint frequency of somatic ZNF804A mutations and KRT39 losses in Colon Adenocarcinoma?,cnv_and_ssm
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the joint frequency of somatic RELN mutations and OR5D14 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic EFCAB12 mutations and TASOR2 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic EFCAB12 mutations and CTNNA2 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the joint frequency of somatic DEFB115 mutations and DCN losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the joint frequency of somatic ANKDD1A mutations and TRIM45 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the joint frequency of somatic ANKDD1A mutations and CTNNA2 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the joint frequency of somatic ANKDD1A mutations and MIEF1 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic HTR3B mutations and CX3CR1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic HTR3B mutations and MYH11 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic HTR3B mutations and STK19 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the joint frequency of somatic ABCC3 mutations and HYOU1 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic NOMO1 mutations and EIF2B4 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic NOMO1 mutations and DCN losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the joint frequency of somatic HYOU1 mutations and TYK2 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the joint frequency of somatic FMO4 mutations and PRSS8 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+140,BICC1,A372V,Exceptional Responders,What is the joint frequency of somatic BICC1 mutations and PCDHB2 losses in Exceptional Responders?,cnv_and_ssm
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic ZMYM3 mutations and CR1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic ZMYM3 mutations and ABCC3 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic ZMYM3 mutations and TMEM225 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic XKR4 mutations and TTN losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the joint frequency of somatic ABCC2 mutations and GSTCD losses in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the joint frequency of somatic OR8K5 mutations and ANP32E losses in Lung Adenocarcinoma?,cnv_and_ssm
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the joint frequency of somatic SPTAN1 mutations and DCC losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the joint frequency of somatic SPTAN1 mutations and MAST4 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the joint frequency of somatic SYT10 mutations and SORCS1 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the joint frequency of somatic HSPA5 mutations and STK19 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the joint frequency of somatic UNC5D mutations and FCGR2C losses in Lung Adenocarcinoma?,cnv_and_ssm
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the joint frequency of somatic UNC5D mutations and SLC6A4 losses in Lung Adenocarcinoma?,cnv_and_ssm
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the joint frequency of somatic UNC5D mutations and COL6A3 losses in Lung Adenocarcinoma?,cnv_and_ssm
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the joint frequency of somatic UNC5D mutations and OR2T4 losses in Lung Adenocarcinoma?,cnv_and_ssm
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the joint frequency of somatic UNC5D mutations and TASOR2 losses in Lung Adenocarcinoma?,cnv_and_ssm
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the joint frequency of somatic UNC5D mutations and PTPRN2 losses in Lung Adenocarcinoma?,cnv_and_ssm
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the joint frequency of somatic DOCK2 mutations and CNGB1 losses in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the joint frequency of somatic ZNF627 mutations and TMTC3 losses in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the joint frequency of somatic CDC42BPA mutations and RELN losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the joint frequency of somatic MRPL55 mutations and YY1AP1 losses in Colon Adenocarcinoma?,cnv_and_ssm
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the joint frequency of somatic MRPL55 mutations and CARMIL1 losses in Colon Adenocarcinoma?,cnv_and_ssm
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the joint frequency of somatic TMTC3 mutations and NRAP losses in Breast Invasive Carcinoma?,cnv_and_ssm
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the joint frequency of somatic EPRS1 mutations and GABRA6 losses in Colon Adenocarcinoma?,cnv_and_ssm
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the joint frequency of somatic EPRS1 mutations and KDM5C losses in Colon Adenocarcinoma?,cnv_and_ssm
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the joint frequency of somatic GRTP1 mutations and CPA6 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the joint frequency of somatic GRTP1 mutations and ANKRD30A losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the joint frequency of somatic TSHZ3 mutations and ANKRD30A losses in Stomach Adenocarcinoma?,cnv_and_ssm
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the joint frequency of somatic TAS1R3 mutations and MRPL55 losses in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,cnv_and_ssm
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic PIAS3 mutations and PTPRN2 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic PIAS3 mutations and CEP20 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the joint frequency of somatic ZNF274 mutations and OR8K5 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the joint frequency of somatic SYNJ1 mutations and SORCS1 losses in Colon Adenocarcinoma?,cnv_and_ssm
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the joint frequency of somatic SYNJ1 mutations and POLD1 losses in Colon Adenocarcinoma?,cnv_and_ssm
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the joint frequency of somatic SYNJ1 mutations and POLD1 losses in Colon Adenocarcinoma?,cnv_and_ssm
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the joint frequency of somatic DSCAM mutations and TYROBP losses in Prostate Adenocarcinoma?,cnv_and_ssm
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the joint frequency of somatic DSCAM mutations and DHX16 losses in Prostate Adenocarcinoma?,cnv_and_ssm
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the joint frequency of somatic DSCAM mutations and TTC12 losses in Prostate Adenocarcinoma?,cnv_and_ssm
+267,DGKD,R140H,Exceptional Responders,What is the joint frequency of somatic DGKD mutations and SERPINB10 losses in Exceptional Responders?,cnv_and_ssm
+268,DGKD,R160H,Exceptional Responders,What is the joint frequency of somatic DGKD mutations and BICC1 losses in Exceptional Responders?,cnv_and_ssm
+269,DGKD,R204H,Exceptional Responders,What is the joint frequency of somatic DGKD mutations and FBXO15 losses in Exceptional Responders?,cnv_and_ssm
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the joint frequency of somatic PLEKHG6 mutations and PCDHB2 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the joint frequency of somatic PLEKHG6 mutations and MIEF1 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the joint frequency of somatic PLEKHG6 mutations and ZFPM2 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the joint frequency of somatic WNT2 mutations and CTSC losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the joint frequency of somatic GUCY2C mutations and PLEKHG6 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic C7orf31 mutations and CX3CR1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic ZKSCAN7 mutations and ADAM17 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+299,OR5D14,M210L,Neuroblastoma,What is the joint frequency of somatic OR5D14 mutations and CPS1 losses in Neuroblastoma?,cnv_and_ssm
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic SPATA22 mutations and JAML losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic SPATA22 mutations and ANKDD1A losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic SPATA22 mutations and PTPRO losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the joint frequency of somatic LCN15 mutations and PYHIN1 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the joint frequency of somatic DCAF4L2 mutations and CEP20 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic GUK1 mutations and GUK1 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic GUK1 mutations and PCDHB2 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic GUK1 mutations and PCDHB2 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic GUK1 mutations and SGIP1 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic GUK1 mutations and TSHZ3 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the joint frequency of somatic MORF4L1 mutations and KDM5C losses in Stomach Adenocarcinoma?,cnv_and_ssm
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the joint frequency of somatic MORF4L1 mutations and OR8K5 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the joint frequency of somatic MORF4L1 mutations and RIPOR2 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the joint frequency of somatic MORF4L1 mutations and PYHIN1 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the joint frequency of somatic MYO3B mutations and PGR losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the joint frequency of somatic MYO3B mutations and TRAP1 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the joint frequency of somatic TENT5A mutations and DGKD losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the joint frequency of somatic TENT5A mutations and SGIP1 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the joint frequency of somatic TENT5A mutations and EFCAB12 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the joint frequency of somatic ZFAT mutations and YY1AP1 losses in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the joint frequency of somatic ZFAT mutations and MED16 losses in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the joint frequency of somatic ZFAT mutations and ZMYM3 losses in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+357,ZNF584,A211T,Sarcoma,What is the joint frequency of somatic ZNF584 mutations and TMEM225 losses in Sarcoma?,cnv_and_ssm
+358,ZNF584,A256T,Sarcoma,What is the joint frequency of somatic ZNF584 mutations and ARMC3 losses in Sarcoma?,cnv_and_ssm
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic LDOC1 mutations and TNS1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic PDGFC mutations and TRIM45 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic MSANTD4 mutations and GUK1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the joint frequency of somatic NPSR1 mutations and CPS1 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic PHLPP1 mutations and ZNF804A losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the joint frequency of somatic COL6A3 mutations and TTC12 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the joint frequency of somatic COL6A3 mutations and CDH23 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the joint frequency of somatic COL6A3 mutations and REXO4 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the joint frequency of somatic COL6A3 mutations and TENM2 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the joint frequency of somatic COL6A3 mutations and ANKRD52 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the joint frequency of somatic ADRA1A mutations and PTPRN2 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the joint frequency of somatic LAMB2 mutations and STK19 losses in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the joint frequency of somatic POC1B mutations and TTC17 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the joint frequency of somatic POC1B mutations and CYB5R2 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the joint frequency of somatic POC1B mutations and PGF losses in Rectum Adenocarcinoma?,cnv_and_ssm
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the joint frequency of somatic POC1B mutations and ANKRD30A losses in Rectum Adenocarcinoma?,cnv_and_ssm
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the joint frequency of somatic USH2A mutations and TRPA1 losses in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the joint frequency of somatic AQP7 mutations and DNMT1 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the joint frequency of somatic AQP7 mutations and ZBTB34 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the joint frequency of somatic AQP7 mutations and TASOR2 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the joint frequency of somatic AQP7 mutations and PTPRN2 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+430,DCN,R163C,Rectum Adenocarcinoma,What is the joint frequency of somatic DCN mutations and AUTS2 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+431,DCN,R203C,Rectum Adenocarcinoma,What is the joint frequency of somatic DCN mutations and WNT2 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+432,DCN,R241C,Rectum Adenocarcinoma,What is the joint frequency of somatic DCN mutations and PCDHGA1 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+433,DCN,R350C,Rectum Adenocarcinoma,What is the joint frequency of somatic DCN mutations and PIK3C2A losses in Rectum Adenocarcinoma?,cnv_and_ssm
+434,DCN,R41C,Rectum Adenocarcinoma,What is the joint frequency of somatic DCN mutations and XKR4 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CPS1 mutations and CTCFL losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CPS1 mutations and PTPRO losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CPS1 mutations and FMO4 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the joint frequency of somatic FCGR2C mutations and FBN1 losses in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the joint frequency of somatic FCGR2C mutations and MRPL55 losses in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic GRM1 mutations and DCN losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the joint frequency of somatic SGCZ mutations and TAS1R3 losses in Lung Adenocarcinoma?,cnv_and_ssm
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the joint frequency of somatic SGCZ mutations and SYNJ1 losses in Lung Adenocarcinoma?,cnv_and_ssm
+485,SMO,V15M,Stomach Adenocarcinoma,What is the joint frequency of somatic SMO mutations and YY1AP1 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+486,SMO,V321M,Stomach Adenocarcinoma,What is the joint frequency of somatic SMO mutations and FBXO15 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the joint frequency of somatic CHODL mutations and FGF8 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the joint frequency of somatic CHODL mutations and KDM5C losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the joint frequency of somatic CHODL mutations and OLFML3 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+494,MYO16,P399H,Colon Adenocarcinoma,What is the joint frequency of somatic MYO16 mutations and PRSS8 losses in Colon Adenocarcinoma?,cnv_and_ssm
+495,MYO16,P421H,Colon Adenocarcinoma,What is the joint frequency of somatic MYO16 mutations and MYH11 losses in Colon Adenocarcinoma?,cnv_and_ssm
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the joint frequency of somatic CXCR2 mutations and TASOR2 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the joint frequency of somatic TMEM225 mutations and TTC12 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic MAOB mutations and GSTCD losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic GPRASP1 mutations and TYK2 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic MRPL32 mutations and SGCZ losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic TYROBP mutations and TRPA1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the joint frequency of somatic RAB40C mutations and PGF losses in Lung Adenocarcinoma?,cnv_and_ssm
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the joint frequency of somatic RAB40C mutations and DCLK3 losses in Lung Adenocarcinoma?,cnv_and_ssm
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the joint frequency of somatic CTNNA2 mutations and TLCD5 losses in Lung Adenocarcinoma?,cnv_and_ssm
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the joint frequency of somatic CTNNA2 mutations and MAOB losses in Lung Adenocarcinoma?,cnv_and_ssm
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the joint frequency of somatic CTNNA2 mutations and EIF2B4 losses in Lung Adenocarcinoma?,cnv_and_ssm
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the joint frequency of somatic CTNNA2 mutations and PCDHB2 losses in Lung Adenocarcinoma?,cnv_and_ssm
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the joint frequency of somatic MYO15A mutations and SYNJ1 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the joint frequency of somatic GIMAP2 mutations and C7orf31 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the joint frequency of somatic KIF20B mutations and VPS26B losses in Glioblastoma Multiforme?,cnv_and_ssm
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the joint frequency of somatic KIF20B mutations and MYH11 losses in Glioblastoma Multiforme?,cnv_and_ssm
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic ADAM17 mutations and OR8K5 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic BCAT1 mutations and CYB5R2 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic BCAT1 mutations and GPRASP1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic BCAT1 mutations and BFAR losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the joint frequency of somatic ERCC6 mutations and TNS1 losses in Colon Adenocarcinoma?,cnv_and_ssm
+541,DCC,R320W,Breast Invasive Carcinoma,What is the joint frequency of somatic DCC mutations and CFAP61 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+542,DCC,R363W,Breast Invasive Carcinoma,What is the joint frequency of somatic DCC mutations and PYHIN1 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+543,DCC,R386W,Breast Invasive Carcinoma,What is the joint frequency of somatic DCC mutations and ACTB losses in Breast Invasive Carcinoma?,cnv_and_ssm
+544,DCC,R41W,Breast Invasive Carcinoma,What is the joint frequency of somatic DCC mutations and CTSC losses in Breast Invasive Carcinoma?,cnv_and_ssm
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the joint frequency of somatic FBXO15 mutations and AUTS2 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the joint frequency of somatic FBXO15 mutations and PCDHB2 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic GSTCD mutations and ACTA2 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic GSTCD mutations and CHODL losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic OLFML3 mutations and FBXO15 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic OLFML3 mutations and SORCS1 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic OLFML3 mutations and TENM3 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the joint frequency of somatic CFAP61 mutations and PIK3C2G losses in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the joint frequency of somatic CFAP61 mutations and SMO losses in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the joint frequency of somatic HLA-DQA2 mutations and PIK3C2B losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the joint frequency of somatic TENM2 mutations and GABRA6 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the joint frequency of somatic TENM2 mutations and MYO15A losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the joint frequency of somatic TENM2 mutations and POC1B losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the joint frequency of somatic ANKRD24 mutations and FGF8 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the joint frequency of somatic ANKRD24 mutations and FGF8 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the joint frequency of somatic ANKRD24 mutations and MYT1 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the joint frequency of somatic ZCCHC14 mutations and COL6A3 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the joint frequency of somatic ZCCHC14 mutations and TRIM45 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the joint frequency of somatic ZCCHC14 mutations and JAML losses in Stomach Adenocarcinoma?,cnv_and_ssm
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the joint frequency of somatic ZCCHC14 mutations and USH2A losses in Stomach Adenocarcinoma?,cnv_and_ssm
+625,SIK2,I265M,Lung Adenocarcinoma,What is the joint frequency of somatic SIK2 mutations and PIK3C2B losses in Lung Adenocarcinoma?,cnv_and_ssm
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic MYH11 mutations and AQP7 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic MYH11 mutations and HSPA5 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the joint frequency of somatic SLC6A4 mutations and CTNNA2 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic SLC9C1 mutations and TNS1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic SLC9C1 mutations and PRSS1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the joint frequency of somatic OR2A12 mutations and JAML losses in Brain Lower Grade Glioma?,cnv_and_ssm
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the joint frequency of somatic PYHIN1 mutations and MERTK losses in Lung Adenocarcinoma?,cnv_and_ssm
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the joint frequency of somatic PYHIN1 mutations and UNC5D losses in Lung Adenocarcinoma?,cnv_and_ssm
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the joint frequency of somatic JAML mutations and PRSS8 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the joint frequency of somatic JAML mutations and CTSC losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the joint frequency of somatic JAML mutations and MAST4 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the joint frequency of somatic JAML mutations and TLK2 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the joint frequency of somatic TYK2 mutations and GABRA6 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the joint frequency of somatic TYK2 mutations and DNAH11 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the joint frequency of somatic TYK2 mutations and PIAS3 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CTCFL mutations and TRAP1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CTCFL mutations and EPRS1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CTCFL mutations and POC1B losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CTCFL mutations and CPS1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CEP20 mutations and GUF1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CEP20 mutations and DHX16 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the joint frequency of somatic RIMS2 mutations and PTPRO losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the joint frequency of somatic RIMS2 mutations and FNDC7 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the joint frequency of somatic RIMS2 mutations and MERTK losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the joint frequency of somatic RIMS2 mutations and TAF1C losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the joint frequency of somatic RIMS2 mutations and YY1AP1 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the joint frequency of somatic RIMS2 mutations and SORCS1 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the joint frequency of somatic RIMS2 mutations and MORF4L1 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the joint frequency of somatic PIK3C2G mutations and SPTAN1 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the joint frequency of somatic PIK3C2G mutations and MAST4 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+728,STK19,D341N,Colon Adenocarcinoma,What is the joint frequency of somatic STK19 mutations and MYH11 losses in Colon Adenocarcinoma?,cnv_and_ssm
+729,STK19,D345N,Colon Adenocarcinoma,What is the joint frequency of somatic STK19 mutations and GPRASP1 losses in Colon Adenocarcinoma?,cnv_and_ssm
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the joint frequency of somatic REXO4 mutations and PLEKHG6 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic ZBTB34 mutations and MAD1L1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic ZBTB34 mutations and GABRA6 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the joint frequency of somatic NCKAP5 mutations and PIK3C2G losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic SORCS1 mutations and SMO losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic SORCS1 mutations and ADAM17 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic SORCS1 mutations and PRSS8 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic SORCS1 mutations and STK19 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the joint frequency of somatic FGF8 mutations and MYH11 losses in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the joint frequency of somatic FGF8 mutations and SPATA22 losses in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the joint frequency of somatic FGF8 mutations and ZNF431 losses in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the joint frequency of somatic FGF8 mutations and TENM2 losses in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the joint frequency of somatic FGF8 mutations and MAOB losses in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the joint frequency of somatic TENM3 mutations and ACVR1B losses in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,cnv_and_ssm
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic AKT1 mutations and OR13C3 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the joint frequency of somatic CFAP298-TCP10L mutations and MAD1L1 losses in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the joint frequency of somatic GLRB mutations and HLA-DQA2 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+793,TTN,F7636L,Colon Adenocarcinoma,What is the joint frequency of somatic TTN mutations and DCN losses in Colon Adenocarcinoma?,cnv_and_ssm
+794,TTN,F8563L,Colon Adenocarcinoma,What is the joint frequency of somatic TTN mutations and ZNF584 losses in Colon Adenocarcinoma?,cnv_and_ssm
+795,TTN,F8880L,Colon Adenocarcinoma,What is the joint frequency of somatic TTN mutations and TTC17 losses in Colon Adenocarcinoma?,cnv_and_ssm
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the joint frequency of somatic ANKRD30A mutations and STK19 losses in Colon Adenocarcinoma?,cnv_and_ssm
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the joint frequency of somatic ANKRD30A mutations and POLR1G losses in Colon Adenocarcinoma?,cnv_and_ssm
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the joint frequency of somatic ANKRD30A mutations and ZFAT losses in Colon Adenocarcinoma?,cnv_and_ssm
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the joint frequency of somatic TRIM45 mutations and GRTP1 losses in Colon Adenocarcinoma?,cnv_and_ssm
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the joint frequency of somatic TRIM45 mutations and MORF4L1 losses in Colon Adenocarcinoma?,cnv_and_ssm
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the joint frequency of somatic TRIM45 mutations and EIF2B4 losses in Colon Adenocarcinoma?,cnv_and_ssm
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the joint frequency of somatic CACNA1F mutations and ZNF431 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the joint frequency of somatic CACNA1F mutations and DSCAM losses in Stomach Adenocarcinoma?,cnv_and_ssm
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the joint frequency of somatic CACNA1F mutations and TTN losses in Stomach Adenocarcinoma?,cnv_and_ssm
+817,KL,R594C,Colon Adenocarcinoma,What is the joint frequency of somatic KL mutations and LDOC1 losses in Colon Adenocarcinoma?,cnv_and_ssm
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the joint frequency of somatic GUF1 mutations and EPRS1 losses in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the joint frequency of somatic TAF1L mutations and SLC9C1 losses in Colon Adenocarcinoma?,cnv_and_ssm
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the joint frequency of somatic TASOR2 mutations and RIMS2 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the joint frequency of somatic TASOR2 mutations and AUTS2 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the joint frequency of somatic TASOR2 mutations and PTPRN2 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the joint frequency of somatic KDM5C mutations and XKR4 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the joint frequency of somatic KDM5C mutations and TET2 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the joint frequency of somatic KDM5C mutations and TENM2 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the joint frequency of somatic KDM5C mutations and CHODL losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the joint frequency of somatic IL5RA mutations and BFAR losses in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the joint frequency of somatic DHX16 mutations and ZNF584 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the joint frequency of somatic DHX16 mutations and RIMS2 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the joint frequency of somatic GPR158 mutations and FBXO15 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the joint frequency of somatic GPR158 mutations and KDM5C losses in Stomach Adenocarcinoma?,cnv_and_ssm
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic EIF2B4 mutations and PRSS1 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic EIF2B4 mutations and CHODL losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic EIF2B4 mutations and BCAT1 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic EIF2B4 mutations and RAB40C losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic EIF2B4 mutations and SGCZ losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic EIF2B4 mutations and DNAH14 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic AUTS2 mutations and ADRA1A losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic AUTS2 mutations and ANP32E losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic AUTS2 mutations and PRSS1 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic AUTS2 mutations and UNC5D losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic AUTS2 mutations and DCN losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic AUTS2 mutations and NRAP losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic AUTS2 mutations and ANKDD1A losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic AUTS2 mutations and TTN losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic AUTS2 mutations and ZCCHC14 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic AUTS2 mutations and TNS1 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic ACTL7B mutations and TYK2 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the joint frequency of somatic PCDHGA1 mutations and ZBTB34 losses in Glioblastoma Multiforme?,cnv_and_ssm
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the joint frequency of somatic TRAP1 mutations and RAB40C losses in Stomach Adenocarcinoma?,cnv_and_ssm
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the joint frequency of somatic TRAP1 mutations and DNAH14 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic PIK3C2A mutations and TASOR2 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the joint frequency of somatic KANSL1 mutations and TASOR2 losses in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the joint frequency of somatic ANKRD52 mutations and JAML losses in Stomach Adenocarcinoma?,cnv_and_ssm
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic PAPPA mutations and SORCS1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the joint frequency of somatic B3GALNT1 mutations and CX3CR1 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the joint frequency of somatic GABRA6 mutations and CTSC losses in Lung Adenocarcinoma?,cnv_and_ssm
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the joint frequency of somatic GABRA6 mutations and CEP20 losses in Lung Adenocarcinoma?,cnv_and_ssm
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the joint frequency of somatic GABRA6 mutations and DPF3 losses in Lung Adenocarcinoma?,cnv_and_ssm
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the joint frequency of somatic GABRA6 mutations and DCAF4L2 losses in Lung Adenocarcinoma?,cnv_and_ssm
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the joint frequency of somatic GABRA6 mutations and ZNF708 losses in Lung Adenocarcinoma?,cnv_and_ssm
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the joint frequency of somatic ZSCAN31 mutations and FGF8 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic MED16 mutations and MORF4L1 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic MED16 mutations and ZFP42 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the joint frequency of somatic PTPRO mutations and OLFML3 losses in Pancreatic Adenocarcinoma?,cnv_and_ssm
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the joint frequency of somatic PTPRO mutations and OR8K5 losses in Pancreatic Adenocarcinoma?,cnv_and_ssm
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the joint frequency of somatic PTPRO mutations and ANKRD24 losses in Pancreatic Adenocarcinoma?,cnv_and_ssm
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the joint frequency of somatic PTPRO mutations and MORF4L1 losses in Pancreatic Adenocarcinoma?,cnv_and_ssm
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the joint frequency of somatic PTPRO mutations and AUTS2 losses in Pancreatic Adenocarcinoma?,cnv_and_ssm
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the joint frequency of somatic PTPRO mutations and CPS1 losses in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the joint frequency of somatic PTPRO mutations and DHX16 losses in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the joint frequency of somatic PTPRO mutations and DSCAM losses in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CHMP7 mutations and ARMC3 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the joint frequency of somatic GPC3 mutations and DCN losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the joint frequency of somatic GPC3 mutations and RIPOR2 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the joint frequency of somatic TLK2 mutations and TSHZ3 losses in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the joint frequency of somatic TLK2 mutations and RIMS2 losses in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the joint frequency of somatic TLK2 mutations and SPATA22 losses in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the joint frequency of somatic TLK2 mutations and MYO16 losses in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the joint frequency of somatic TLK2 mutations and TYK2 losses in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the joint frequency of somatic ZNF217 mutations and FRY losses in Lung Adenocarcinoma?,cnv_and_ssm
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the joint frequency of somatic SYT9 mutations and RIMS2 losses in Lung Adenocarcinoma?,cnv_and_ssm
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the joint frequency of somatic SYT9 mutations and TYK2 losses in Lung Adenocarcinoma?,cnv_and_ssm
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic PKHD1L1 mutations and PKHD1L1 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic MYO3A mutations and SORCS1 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic VASN mutations and FGF8 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic DNMT1 mutations and PTPRO losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic DNMT1 mutations and TYK2 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic DNMT1 mutations and CTCFL losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1056,CA9,E402K,Colon Adenocarcinoma,What is the joint frequency of somatic CA9 mutations and DCC losses in Colon Adenocarcinoma?,cnv_and_ssm
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic TTC17 mutations and PYHIN1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic TTC17 mutations and DCN losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the joint frequency of somatic PSG2 mutations and PGR losses in Breast Invasive Carcinoma?,cnv_and_ssm
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the joint frequency of somatic RIPOR2 mutations and GUK1 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the joint frequency of somatic RIPOR2 mutations and CYB5R2 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the joint frequency of somatic RIPOR2 mutations and TTC12 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the joint frequency of somatic RIPOR2 mutations and ZFPM2 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic DCLK3 mutations and CTCFL losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic DCLK3 mutations and IL5RA losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic MERTK mutations and ICE1 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic MERTK mutations and EIF2B4 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic MERTK mutations and EIF2B4 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the joint frequency of somatic ZFP42 mutations and CPS1 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the joint frequency of somatic OR13C3 mutations and NCKAP5 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the joint frequency of somatic OR13C3 mutations and ART3 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the joint frequency of somatic SPAG1 mutations and CTSC losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CDKN2AIP mutations and ZFAT losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the joint frequency of somatic PXN mutations and TYROBP losses in Colon Adenocarcinoma?,cnv_and_ssm
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the joint frequency of somatic PXN mutations and TNS1 losses in Colon Adenocarcinoma?,cnv_and_ssm
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the joint frequency of somatic PXN mutations and DHX16 losses in Colon Adenocarcinoma?,cnv_and_ssm
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the joint frequency of somatic PXN mutations and DNAH14 losses in Colon Adenocarcinoma?,cnv_and_ssm
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the joint frequency of somatic PXN mutations and DNAH14 losses in Colon Adenocarcinoma?,cnv_and_ssm
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the joint frequency of somatic PXN mutations and CPA6 losses in Colon Adenocarcinoma?,cnv_and_ssm
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic TTYH2 mutations and EFCAB12 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic TTYH2 mutations and YY1AP1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the joint frequency of somatic TMEM255A mutations and PAK3 losses in Colon Adenocarcinoma?,cnv_and_ssm
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the joint frequency of somatic TMEM255A mutations and YY1AP1 losses in Colon Adenocarcinoma?,cnv_and_ssm
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the joint frequency of somatic TMEM255A mutations and ZFAT losses in Colon Adenocarcinoma?,cnv_and_ssm
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the joint frequency of somatic TASOR2 mutations and ZCCHC14 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the joint frequency of somatic TASOR2 mutations and DCN losses in Breast Invasive Carcinoma?,cnv_and_ssm
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic ICE1 mutations and GPC3 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the joint frequency of somatic MYT1 mutations and MAST4 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the joint frequency of somatic MYT1 mutations and POC1B losses in Breast Invasive Carcinoma?,cnv_and_ssm
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the joint frequency of somatic MYT1 mutations and MYO3B losses in Breast Invasive Carcinoma?,cnv_and_ssm
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CX3CR1 mutations and AUTS2 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CX3CR1 mutations and GUK1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the joint frequency of somatic SPINDOC mutations and CTNNA2 losses in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic ART3 mutations and NRAP losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic ART3 mutations and YY1AP1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the joint frequency of somatic CYP1A2 mutations and GUK1 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic ADRA1A mutations and CTCFL losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic CDH23 mutations and EVC2 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic CDH23 mutations and CHODL losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the joint frequency of somatic KRT39 mutations and ACVR1B losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic PDHA2 mutations and REXO4 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the joint frequency of somatic SLC24A2 mutations and ACTB losses in Colon Adenocarcinoma?,cnv_and_ssm
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the joint frequency of somatic PTPRN2 mutations and MRPL55 losses in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the joint frequency of somatic PTPRN2 mutations and MRPL55 losses in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the joint frequency of somatic PTPRN2 mutations and PLEKHG6 losses in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the joint frequency of somatic PTPRN2 mutations and PTPRO losses in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the joint frequency of somatic PTPRN2 mutations and ARHGEF40 losses in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the joint frequency of somatic SOX21 mutations and JAML losses in Lung Adenocarcinoma?,cnv_and_ssm
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the joint frequency of somatic CPA6 mutations and CACNA1F losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the joint frequency of somatic GRM5 mutations and CTCFL losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic CASZ1 mutations and DNAH14 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the joint frequency of somatic SGIP1 mutations and DNAH11 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the joint frequency of somatic SGIP1 mutations and TYK2 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the joint frequency of somatic SGIP1 mutations and TENT5A losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the joint frequency of somatic SGIP1 mutations and ACTL7B losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the joint frequency of somatic CARMIL1 mutations and TAF1C losses in Lung Adenocarcinoma?,cnv_and_ssm
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the joint frequency of somatic CARMIL1 mutations and FCGR2C losses in Lung Adenocarcinoma?,cnv_and_ssm
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the joint frequency of somatic ZNF431 mutations and GABRA6 losses in Lung Adenocarcinoma?,cnv_and_ssm
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the joint frequency of somatic ZNF431 mutations and GABRA6 losses in Lung Adenocarcinoma?,cnv_and_ssm
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the joint frequency of somatic ZNF431 mutations and RIPOR2 losses in Lung Adenocarcinoma?,cnv_and_ssm
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the joint frequency of somatic DNAH11 mutations and CTSC losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the joint frequency of somatic DNAH11 mutations and AUTS2 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic POLD1 mutations and RIPOR2 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the joint frequency of somatic POLD1 mutations and ANKRD30A losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the joint frequency of somatic TTC12 mutations and ZBTB34 losses in Lung Adenocarcinoma?,cnv_and_ssm
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the joint frequency of somatic TTC12 mutations and TENM3 losses in Lung Adenocarcinoma?,cnv_and_ssm
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the joint frequency of somatic CNGB1 mutations and PYHIN1 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the joint frequency of somatic CNGB1 mutations and ZNF431 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the joint frequency of somatic CTSC mutations and TAF1C losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the joint frequency of somatic CTSC mutations and HSPA5 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the joint frequency of somatic CTSC mutations and TMEM255A losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the joint frequency of somatic CTSC mutations and ACTB losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the joint frequency of somatic CTSC mutations and DSCAM losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic PRSS8 mutations and SPAG1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic PRSS8 mutations and NOMO1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the joint frequency of somatic ARHGEF40 mutations and TENM2 losses in Lung Adenocarcinoma?,cnv_and_ssm
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the joint frequency of somatic ACTB mutations and TENM2 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the joint frequency of somatic ACTB mutations and CTCFL losses in Rectum Adenocarcinoma?,cnv_and_ssm
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the joint frequency of somatic ACTB mutations and DCC losses in Rectum Adenocarcinoma?,cnv_and_ssm
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the joint frequency of somatic ACTB mutations and AUTS2 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the joint frequency of somatic YY1AP1 mutations and CCNG1 losses in Glioblastoma Multiforme?,cnv_and_ssm
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the joint frequency of somatic YY1AP1 mutations and NRAP losses in Glioblastoma Multiforme?,cnv_and_ssm
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the joint frequency of somatic YY1AP1 mutations and JAML losses in Glioblastoma Multiforme?,cnv_and_ssm
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the joint frequency of somatic YY1AP1 mutations and DCN losses in Glioblastoma Multiforme?,cnv_and_ssm
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the joint frequency of somatic YY1AP1 mutations and EFCAB12 losses in Glioblastoma Multiforme?,cnv_and_ssm
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the joint frequency of somatic YY1AP1 mutations and SLC9C1 losses in Glioblastoma Multiforme?,cnv_and_ssm
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the joint frequency of somatic YY1AP1 mutations and CA9 losses in Glioblastoma Multiforme?,cnv_and_ssm
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the joint frequency of somatic FNDC7 mutations and NOMO1 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the joint frequency of somatic FNDC7 mutations and RIPOR2 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the joint frequency of somatic TLCD5 mutations and DPF3 losses in Lung Adenocarcinoma?,cnv_and_ssm
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the joint frequency of somatic TLCD5 mutations and RIMS2 losses in Lung Adenocarcinoma?,cnv_and_ssm
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic POLR1G mutations and TMEM225 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic POLR1G mutations and TNS1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the joint frequency of somatic DNAH14 mutations and FNDC7 losses in Colon Adenocarcinoma?,cnv_and_ssm
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the joint frequency of somatic DNAH14 mutations and EFCAB12 losses in Colon Adenocarcinoma?,cnv_and_ssm
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the joint frequency of somatic DNAH14 mutations and SPTAN1 losses in Colon Adenocarcinoma?,cnv_and_ssm
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic NEXN mutations and EFCAB12 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the joint frequency of somatic CYB5R2 mutations and AUTS2 losses in Prostate Adenocarcinoma?,cnv_and_ssm
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the joint frequency of somatic CYB5R2 mutations and TENT5A losses in Prostate Adenocarcinoma?,cnv_and_ssm
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic NRAP mutations and DPF3 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic NRAP mutations and AUTS2 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic NRAP mutations and ZFAT losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic CCDC22 mutations and KDM5C losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the joint frequency of somatic DCAF6 mutations and TLK2 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the joint frequency of somatic DCAF6 mutations and DNAH14 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic ZNF708 mutations and GABRA6 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic BFAR mutations and MORF4L1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic MAST4 mutations and SLC9C1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic MAST4 mutations and GUCY2C losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic MAST4 mutations and TTN losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic MAST4 mutations and RAB40C losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic MAST4 mutations and DGKD losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the joint frequency of somatic ARMC3 mutations and GUK1 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the joint frequency of somatic ARMC3 mutations and PGR losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the joint frequency of somatic TET2 mutations and RIMS2 losses in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the joint frequency of somatic TET2 mutations and OLFML3 losses in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the joint frequency of somatic SERPINB10 mutations and GRM5 losses in Lung Adenocarcinoma?,cnv_and_ssm
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic STAT3 mutations and ANKRD30A losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic MIEF1 mutations and ACVR1B losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the joint frequency of somatic ACVR1B mutations and ARHGEF40 losses in Colon Adenocarcinoma?,cnv_and_ssm
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the joint frequency of somatic ACVR1B mutations and MAST4 losses in Colon Adenocarcinoma?,cnv_and_ssm
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the joint frequency of somatic ACVR1B mutations and FBXO15 losses in Colon Adenocarcinoma?,cnv_and_ssm
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the joint frequency of somatic EBF2 mutations and PDHA2 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the joint frequency of somatic EBF2 mutations and TMTC3 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the joint frequency of somatic VPS26B mutations and OLFML3 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic PGR mutations and MAST4 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic PGR mutations and TLCD5 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the joint frequency of somatic PGR mutations and RIMS2 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the joint frequency of somatic ACTA2 mutations and FGF8 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic THBS4 mutations and FGF8 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic THBS4 mutations and PTPRO losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the joint frequency of somatic PRSS1 mutations and COL6A3 losses in Lung Adenocarcinoma?,cnv_and_ssm
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the joint frequency of somatic PRSS1 mutations and TYK2 losses in Lung Adenocarcinoma?,cnv_and_ssm
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the joint frequency of somatic PRSS1 mutations and AQP7 losses in Lung Adenocarcinoma?,cnv_and_ssm
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the joint frequency of somatic PRSS1 mutations and CNGB1 losses in Lung Adenocarcinoma?,cnv_and_ssm
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the joint frequency of somatic PGF mutations and TENT5A losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the joint frequency of somatic PGF mutations and TLCD5 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the joint frequency of somatic ITPRID2 mutations and PAK3 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the joint frequency of somatic ITPRID2 mutations and ANKDD1A losses in Breast Invasive Carcinoma?,cnv_and_ssm
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic HBB mutations and PIK3C2G losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the joint frequency of somatic PCDHB2 mutations and ANKDD1A losses in Colon Adenocarcinoma?,cnv_and_ssm
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the joint frequency of somatic PCDHB2 mutations and RELN losses in Colon Adenocarcinoma?,cnv_and_ssm
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the joint frequency of somatic PCDHB2 mutations and XKR4 losses in Colon Adenocarcinoma?,cnv_and_ssm
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the joint frequency of somatic UBR2 mutations and NEXN losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the joint frequency of somatic FBXO42 mutations and FNDC7 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+1,TNS1,G1362V,Breast Invasive Carcinoma,How prevalent is the co-occurrence of TNS1 mutations and RIMS2 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+2,TNS1,G1711V,Breast Invasive Carcinoma,How prevalent is the co-occurrence of TNS1 mutations and TTN amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+3,TNS1,G1718V,Breast Invasive Carcinoma,How prevalent is the co-occurrence of TNS1 mutations and TNS1 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+4,TNS1,G1732V,Breast Invasive Carcinoma,How prevalent is the co-occurrence of TNS1 mutations and DSCAM amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+5,TNS1,G1824V,Breast Invasive Carcinoma,How prevalent is the co-occurrence of TNS1 mutations and PIK3C2G amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+6,TNS1,G1857V,Breast Invasive Carcinoma,How prevalent is the co-occurrence of TNS1 mutations and SMO amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+7,TNS1,G843V,Breast Invasive Carcinoma,How prevalent is the co-occurrence of TNS1 mutations and PTPRO amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How prevalent is the co-occurrence of EVC2 mutations and PRSS8 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How prevalent is the co-occurrence of EVC2 mutations and ACVR1B amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of CR1 mutations and PTPRO amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of CR1 mutations and TASOR2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+22,TRPA1,S295I,Rectum Adenocarcinoma,How prevalent is the co-occurrence of TRPA1 mutations and EIF2B4 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+23,TRPA1,S443I,Rectum Adenocarcinoma,How prevalent is the co-occurrence of TRPA1 mutations and AUTS2 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+24,TAF1C,R299L,Lung Adenocarcinoma,How prevalent is the co-occurrence of TAF1C mutations and PYHIN1 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+25,TAF1C,R396L,Lung Adenocarcinoma,How prevalent is the co-occurrence of TAF1C mutations and PLEKHG6 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+26,TAF1C,R634L,Lung Adenocarcinoma,How prevalent is the co-occurrence of TAF1C mutations and UNC5D amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+27,TAF1C,R702L,Lung Adenocarcinoma,How prevalent is the co-occurrence of TAF1C mutations and PTPRN2 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+28,TAF1C,R728L,Lung Adenocarcinoma,How prevalent is the co-occurrence of TAF1C mutations and AUTS2 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of DPF3 mutations and PCDHB2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of DPF3 mutations and ZNF431 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of DPF3 mutations and FMO4 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+42,OR2T4,P272H,Lung Adenocarcinoma,How prevalent is the co-occurrence of OR2T4 mutations and PCDHB2 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+43,OR2T4,P300H,Lung Adenocarcinoma,How prevalent is the co-occurrence of OR2T4 mutations and TTC17 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How prevalent is the co-occurrence of FBN1 mutations and DEFB115 amplifications in Pancreatic Adenocarcinoma?,cnv_and_ssm
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How prevalent is the co-occurrence of MAD1L1 mutations and SPTAN1 amplifications in Prostate Adenocarcinoma?,cnv_and_ssm
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How prevalent is the co-occurrence of MAD1L1 mutations and ABCC3 amplifications in Prostate Adenocarcinoma?,cnv_and_ssm
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How prevalent is the co-occurrence of MAD1L1 mutations and TTN amplifications in Prostate Adenocarcinoma?,cnv_and_ssm
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of CCNG1 mutations and DCAF6 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How prevalent is the co-occurrence of ANP32E mutations and PRSS1 amplifications in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How prevalent is the co-occurrence of ANP32E mutations and TASOR2 amplifications in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How prevalent is the co-occurrence of ANP32E mutations and FBXO42 amplifications in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How prevalent is the co-occurrence of ANP32E mutations and FCGR2C amplifications in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How prevalent is the co-occurrence of FRY mutations and DCN amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How prevalent is the co-occurrence of FRY mutations and TLCD5 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How prevalent is the co-occurrence of FRY mutations and ZNF804A amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How prevalent is the co-occurrence of FRY mutations and SOX21 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+70,PAK3,E318K,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of PAK3 mutations and MYH11 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+71,PAK3,E319K,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of PAK3 mutations and ZNF584 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+72,PAK3,E334K,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of PAK3 mutations and ANKRD24 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+73,PAK3,E340K,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of PAK3 mutations and TENM3 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+74,PAK3,E355K,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of PAK3 mutations and TMEM255A amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of MUC16 mutations and PTPRO amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How prevalent is the co-occurrence of ZFPM2 mutations and TAS1R3 amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How prevalent is the co-occurrence of ZFPM2 mutations and DCAF6 amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How prevalent is the co-occurrence of PIK3C2B mutations and PRSS1 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How prevalent is the co-occurrence of PIK3C2B mutations and YY1AP1 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How prevalent is the co-occurrence of ZNF804A mutations and CYP1A2 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+116,RELN,A2371V,Stomach Adenocarcinoma,How prevalent is the co-occurrence of RELN mutations and FRY amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the co-occurrence of EFCAB12 mutations and GSTCD amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the co-occurrence of EFCAB12 mutations and RIMS2 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of DEFB115 mutations and DCAF4L2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How prevalent is the co-occurrence of ANKDD1A mutations and ACVR1B amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How prevalent is the co-occurrence of ANKDD1A mutations and KIF20B amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How prevalent is the co-occurrence of ANKDD1A mutations and ANKRD24 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of HTR3B mutations and EBF2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of HTR3B mutations and CHODL amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of HTR3B mutations and OR5D14 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+129,ABCC3,R758W,Stomach Adenocarcinoma,How prevalent is the co-occurrence of ABCC3 mutations and MAD1L1 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of NOMO1 mutations and TLK2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of NOMO1 mutations and DCAF6 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How prevalent is the co-occurrence of HYOU1 mutations and CARMIL1 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of FMO4 mutations and PLEKHG6 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+140,BICC1,A372V,Exceptional Responders,How prevalent is the co-occurrence of BICC1 mutations and TNS1 amplifications in Exceptional Responders?,cnv_and_ssm
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of ZMYM3 mutations and CFAP61 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of ZMYM3 mutations and SYNJ1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of ZMYM3 mutations and TENM3 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the co-occurrence of XKR4 mutations and YY1AP1 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How prevalent is the co-occurrence of ABCC2 mutations and SYT10 amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+157,OR8K5,R293G,Lung Adenocarcinoma,How prevalent is the co-occurrence of OR8K5 mutations and ANP32E amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of SPTAN1 mutations and CPS1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of SPTAN1 mutations and PTPRO amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+164,SYT10,M484I,Rectum Adenocarcinoma,How prevalent is the co-occurrence of SYT10 mutations and TMEM255A amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of HSPA5 mutations and ABCC3 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+175,UNC5D,L280V,Lung Adenocarcinoma,How prevalent is the co-occurrence of UNC5D mutations and SLC9C1 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+176,UNC5D,L635V,Lung Adenocarcinoma,How prevalent is the co-occurrence of UNC5D mutations and ANP32E amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+177,UNC5D,L637V,Lung Adenocarcinoma,How prevalent is the co-occurrence of UNC5D mutations and THBS4 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+178,UNC5D,L699V,Lung Adenocarcinoma,How prevalent is the co-occurrence of UNC5D mutations and MYO15A amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+179,UNC5D,L704V,Lung Adenocarcinoma,How prevalent is the co-occurrence of UNC5D mutations and TNS1 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+180,UNC5D,L709V,Lung Adenocarcinoma,How prevalent is the co-occurrence of UNC5D mutations and BCAT1 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How prevalent is the co-occurrence of DOCK2 mutations and RAB40C amplifications in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How prevalent is the co-occurrence of ZNF627 mutations and DCLK3 amplifications in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of CDC42BPA mutations and TTN amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+193,MRPL55,H27Y,Colon Adenocarcinoma,How prevalent is the co-occurrence of MRPL55 mutations and JAML amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+194,MRPL55,H63Y,Colon Adenocarcinoma,How prevalent is the co-occurrence of MRPL55 mutations and MED16 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How prevalent is the co-occurrence of TMTC3 mutations and FCGR2C amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+198,EPRS1,K771I,Colon Adenocarcinoma,How prevalent is the co-occurrence of EPRS1 mutations and PIK3C2B amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+199,EPRS1,K778I,Colon Adenocarcinoma,How prevalent is the co-occurrence of EPRS1 mutations and SMO amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of GRTP1 mutations and DCN amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of GRTP1 mutations and CTCFL amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How prevalent is the co-occurrence of TSHZ3 mutations and PGR amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How prevalent is the co-occurrence of TAS1R3 mutations and TYK2 amplifications in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,cnv_and_ssm
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of PIAS3 mutations and ANKRD30A amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of PIAS3 mutations and TNS1 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+251,ZNF274,P13R,Stomach Adenocarcinoma,How prevalent is the co-occurrence of ZNF274 mutations and KDM5C amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+253,SYNJ1,R795C,Colon Adenocarcinoma,How prevalent is the co-occurrence of SYNJ1 mutations and TLK2 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+254,SYNJ1,R800C,Colon Adenocarcinoma,How prevalent is the co-occurrence of SYNJ1 mutations and PRSS1 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+255,SYNJ1,R839C,Colon Adenocarcinoma,How prevalent is the co-occurrence of SYNJ1 mutations and CYB5R2 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+261,DSCAM,V343M,Prostate Adenocarcinoma,How prevalent is the co-occurrence of DSCAM mutations and FBN1 amplifications in Prostate Adenocarcinoma?,cnv_and_ssm
+262,DSCAM,V426M,Prostate Adenocarcinoma,How prevalent is the co-occurrence of DSCAM mutations and KDM5C amplifications in Prostate Adenocarcinoma?,cnv_and_ssm
+263,DSCAM,V591M,Prostate Adenocarcinoma,How prevalent is the co-occurrence of DSCAM mutations and NRAP amplifications in Prostate Adenocarcinoma?,cnv_and_ssm
+267,DGKD,R140H,Exceptional Responders,How prevalent is the co-occurrence of DGKD mutations and DNAH14 amplifications in Exceptional Responders?,cnv_and_ssm
+268,DGKD,R160H,Exceptional Responders,How prevalent is the co-occurrence of DGKD mutations and SLC24A2 amplifications in Exceptional Responders?,cnv_and_ssm
+269,DGKD,R204H,Exceptional Responders,How prevalent is the co-occurrence of DGKD mutations and TNS1 amplifications in Exceptional Responders?,cnv_and_ssm
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How prevalent is the co-occurrence of PLEKHG6 mutations and PAK3 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How prevalent is the co-occurrence of PLEKHG6 mutations and ITPRID2 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How prevalent is the co-occurrence of PLEKHG6 mutations and CHMP7 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+279,WNT2,D138N,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of WNT2 mutations and GPC3 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of GUCY2C mutations and TRIM45 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of C7orf31 mutations and MYO15A amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the co-occurrence of ZKSCAN7 mutations and MYH11 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+299,OR5D14,M210L,Neuroblastoma,How prevalent is the co-occurrence of OR5D14 mutations and CA9 amplifications in Neuroblastoma?,cnv_and_ssm
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of SPATA22 mutations and FNDC7 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of SPATA22 mutations and UNC5D amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of SPATA22 mutations and MORF4L1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+310,LCN15,E21V,Stomach Adenocarcinoma,How prevalent is the co-occurrence of LCN15 mutations and JAML amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of DCAF4L2 mutations and MAST4 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of GUK1 mutations and TRIM45 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of GUK1 mutations and CDC42BPA amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of GUK1 mutations and KDM5C amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of GUK1 mutations and DCC amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of GUK1 mutations and HTR3B amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How prevalent is the co-occurrence of MORF4L1 mutations and CTNNA2 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How prevalent is the co-occurrence of MORF4L1 mutations and PXN amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How prevalent is the co-occurrence of MORF4L1 mutations and ANKRD30A amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How prevalent is the co-occurrence of MORF4L1 mutations and NRAP amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of MYO3B mutations and DSCAM amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of MYO3B mutations and CNGB1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of TENT5A mutations and LDOC1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of TENT5A mutations and ZNF431 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of TENT5A mutations and STK19 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How prevalent is the co-occurrence of ZFAT mutations and TRIM45 amplifications in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How prevalent is the co-occurrence of ZFAT mutations and FBXO42 amplifications in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How prevalent is the co-occurrence of ZFAT mutations and GUCY2C amplifications in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+357,ZNF584,A211T,Sarcoma,How prevalent is the co-occurrence of ZNF584 mutations and CACNA1F amplifications in Sarcoma?,cnv_and_ssm
+358,ZNF584,A256T,Sarcoma,How prevalent is the co-occurrence of ZNF584 mutations and CEP20 amplifications in Sarcoma?,cnv_and_ssm
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of LDOC1 mutations and CHODL amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of PDGFC mutations and TAF1C amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of MSANTD4 mutations and DSCAM amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of NPSR1 mutations and EVC2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of PHLPP1 mutations and SPTAN1 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of COL6A3 mutations and OR2T4 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of COL6A3 mutations and JAML amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of COL6A3 mutations and EPRS1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of COL6A3 mutations and TENM3 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of COL6A3 mutations and TRPA1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How prevalent is the co-occurrence of ADRA1A mutations and PXN amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is the co-occurrence of LAMB2 mutations and LDOC1 amplifications in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+406,POC1B,I198T,Rectum Adenocarcinoma,How prevalent is the co-occurrence of POC1B mutations and DHX16 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+407,POC1B,I286T,Rectum Adenocarcinoma,How prevalent is the co-occurrence of POC1B mutations and AUTS2 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+408,POC1B,I328T,Rectum Adenocarcinoma,How prevalent is the co-occurrence of POC1B mutations and CACNA1F amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+409,POC1B,S79P,Rectum Adenocarcinoma,How prevalent is the co-occurrence of POC1B mutations and TAS1R3 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How prevalent is the co-occurrence of USH2A mutations and SPTAN1 amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+414,AQP7,T110S,Rectum Adenocarcinoma,How prevalent is the co-occurrence of AQP7 mutations and VPS26B amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+415,AQP7,T166S,Rectum Adenocarcinoma,How prevalent is the co-occurrence of AQP7 mutations and AQP7 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+416,AQP7,T167S,Rectum Adenocarcinoma,How prevalent is the co-occurrence of AQP7 mutations and DCLK3 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+417,AQP7,T75S,Rectum Adenocarcinoma,How prevalent is the co-occurrence of AQP7 mutations and EIF2B4 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+430,DCN,R163C,Rectum Adenocarcinoma,How prevalent is the co-occurrence of DCN mutations and RIMS2 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+431,DCN,R203C,Rectum Adenocarcinoma,How prevalent is the co-occurrence of DCN mutations and TASOR2 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+432,DCN,R241C,Rectum Adenocarcinoma,How prevalent is the co-occurrence of DCN mutations and ANKDD1A amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+433,DCN,R350C,Rectum Adenocarcinoma,How prevalent is the co-occurrence of DCN mutations and RIMS2 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+434,DCN,R41C,Rectum Adenocarcinoma,How prevalent is the co-occurrence of DCN mutations and TENM2 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of CPS1 mutations and CTNNA2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of CPS1 mutations and GSTCD amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of CPS1 mutations and KDM5C amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How prevalent is the co-occurrence of FCGR2C mutations and C7orf31 amplifications in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How prevalent is the co-occurrence of FCGR2C mutations and ANP32E amplifications in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of GRM1 mutations and AQP7 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+482,SGCZ,Q138H,Lung Adenocarcinoma,How prevalent is the co-occurrence of SGCZ mutations and ACTB amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+483,SGCZ,Q91H,Lung Adenocarcinoma,How prevalent is the co-occurrence of SGCZ mutations and KDM5C amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+485,SMO,V15M,Stomach Adenocarcinoma,How prevalent is the co-occurrence of SMO mutations and THBS4 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+486,SMO,V321M,Stomach Adenocarcinoma,How prevalent is the co-occurrence of SMO mutations and TMTC3 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+488,CHODL,G159E,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of CHODL mutations and COL6A3 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+489,CHODL,G181E,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of CHODL mutations and ZKSCAN7 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+490,CHODL,G200E,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of CHODL mutations and ANP32E amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+494,MYO16,P399H,Colon Adenocarcinoma,How prevalent is the co-occurrence of MYO16 mutations and EVC2 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+495,MYO16,P421H,Colon Adenocarcinoma,How prevalent is the co-occurrence of MYO16 mutations and UNC5D amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+498,CXCR2,A98V,Stomach Adenocarcinoma,How prevalent is the co-occurrence of CXCR2 mutations and DCC amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How prevalent is the co-occurrence of TMEM225 mutations and HSPA5 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of MAOB mutations and POC1B amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of GPRASP1 mutations and SOX21 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of MRPL32 mutations and PCDHB2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of TYROBP mutations and ZNF217 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+510,RAB40C,A111V,Lung Adenocarcinoma,How prevalent is the co-occurrence of RAB40C mutations and ZCCHC14 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+511,RAB40C,A143V,Lung Adenocarcinoma,How prevalent is the co-occurrence of RAB40C mutations and CR1 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+512,CTNNA2,S323R,Lung Adenocarcinoma,How prevalent is the co-occurrence of CTNNA2 mutations and TNS1 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+513,CTNNA2,S339R,Lung Adenocarcinoma,How prevalent is the co-occurrence of CTNNA2 mutations and MERTK amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+514,CTNNA2,S386R,Lung Adenocarcinoma,How prevalent is the co-occurrence of CTNNA2 mutations and PAK3 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+515,CTNNA2,S707R,Lung Adenocarcinoma,How prevalent is the co-occurrence of CTNNA2 mutations and TTC17 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How prevalent is the co-occurrence of MYO15A mutations and ZNF431 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of GIMAP2 mutations and GABRA6 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+532,KIF20B,N1160D,Glioblastoma Multiforme,How prevalent is the co-occurrence of KIF20B mutations and ZFAT amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+533,KIF20B,N1200D,Glioblastoma Multiforme,How prevalent is the co-occurrence of KIF20B mutations and AKT1 amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of ADAM17 mutations and YY1AP1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of BCAT1 mutations and ZNF431 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of BCAT1 mutations and KRT39 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of BCAT1 mutations and PTPRN2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+540,ERCC6,R1053H,Colon Adenocarcinoma,How prevalent is the co-occurrence of ERCC6 mutations and CCDC22 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+541,DCC,R320W,Breast Invasive Carcinoma,How prevalent is the co-occurrence of DCC mutations and C7orf31 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+542,DCC,R363W,Breast Invasive Carcinoma,How prevalent is the co-occurrence of DCC mutations and GSTCD amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+543,DCC,R386W,Breast Invasive Carcinoma,How prevalent is the co-occurrence of DCC mutations and DHX16 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+544,DCC,R41W,Breast Invasive Carcinoma,How prevalent is the co-occurrence of DCC mutations and TRAP1 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of FBXO15 mutations and PTPRN2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of FBXO15 mutations and PTPRO amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of GSTCD mutations and EIF2B4 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of GSTCD mutations and MERTK amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of OLFML3 mutations and PHLPP1 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of OLFML3 mutations and LDOC1 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of OLFML3 mutations and TAF1L amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How prevalent is the co-occurrence of CFAP61 mutations and ANP32E amplifications in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How prevalent is the co-occurrence of CFAP61 mutations and MSANTD4 amplifications in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How prevalent is the co-occurrence of HLA-DQA2 mutations and PYHIN1 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of TENM2 mutations and ANKRD24 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of TENM2 mutations and FCGR2C amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of TENM2 mutations and TASOR2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How prevalent is the co-occurrence of ANKRD24 mutations and FMO4 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How prevalent is the co-occurrence of ANKRD24 mutations and FBXO15 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How prevalent is the co-occurrence of ANKRD24 mutations and EIF2B4 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How prevalent is the co-occurrence of ZCCHC14 mutations and ZNF584 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How prevalent is the co-occurrence of ZCCHC14 mutations and MYO15A amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How prevalent is the co-occurrence of ZCCHC14 mutations and ACTB amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How prevalent is the co-occurrence of ZCCHC14 mutations and SORCS1 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+625,SIK2,I265M,Lung Adenocarcinoma,How prevalent is the co-occurrence of SIK2 mutations and KIF20B amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of MYH11 mutations and SGCZ amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of MYH11 mutations and PLEKHG6 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of SLC6A4 mutations and PAK3 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of SLC9C1 mutations and TAF1L amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of SLC9C1 mutations and SGIP1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+644,OR2A12,A254T,Brain Lower Grade Glioma,How prevalent is the co-occurrence of OR2A12 mutations and ART3 amplifications in Brain Lower Grade Glioma?,cnv_and_ssm
+646,PYHIN1,T325K,Lung Adenocarcinoma,How prevalent is the co-occurrence of PYHIN1 mutations and FBXO42 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+647,PYHIN1,T334K,Lung Adenocarcinoma,How prevalent is the co-occurrence of PYHIN1 mutations and MYO3A amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+650,JAML,G191E,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of JAML mutations and GPC3 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+651,JAML,G219E,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of JAML mutations and HSPA5 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+652,JAML,G220E,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of JAML mutations and PXN amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+653,JAML,G230E,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of JAML mutations and TMEM255A amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+658,TYK2,H1146R,Stomach Adenocarcinoma,How prevalent is the co-occurrence of TYK2 mutations and ZMYM3 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+659,TYK2,H23R,Stomach Adenocarcinoma,How prevalent is the co-occurrence of TYK2 mutations and MORF4L1 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+660,TYK2,H961R,Stomach Adenocarcinoma,How prevalent is the co-occurrence of TYK2 mutations and CTCFL amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of CTCFL mutations and TNS1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of CTCFL mutations and SPAG1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of CTCFL mutations and ANKRD30A amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of CTCFL mutations and MAD1L1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of CEP20 mutations and JAML amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of CEP20 mutations and PIK3C2G amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of RIMS2 mutations and ZNF584 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of RIMS2 mutations and MIEF1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of RIMS2 mutations and TTN amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of RIMS2 mutations and PGR amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of RIMS2 mutations and PRSS1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of RIMS2 mutations and UNC5D amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of RIMS2 mutations and PIAS3 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of PIK3C2G mutations and MRPL55 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of PIK3C2G mutations and DCN amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+728,STK19,D341N,Colon Adenocarcinoma,How prevalent is the co-occurrence of STK19 mutations and ZNF708 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+729,STK19,D345N,Colon Adenocarcinoma,How prevalent is the co-occurrence of STK19 mutations and DCAF6 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+730,REXO4,P60A,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of REXO4 mutations and DPF3 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of ZBTB34 mutations and PRSS1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of ZBTB34 mutations and TASOR2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How prevalent is the co-occurrence of NCKAP5 mutations and TTN amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the co-occurrence of SORCS1 mutations and GRTP1 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the co-occurrence of SORCS1 mutations and TENT5A amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the co-occurrence of SORCS1 mutations and CASZ1 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the co-occurrence of SORCS1 mutations and ANKDD1A amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How prevalent is the co-occurrence of FGF8 mutations and ITPRID2 amplifications in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How prevalent is the co-occurrence of FGF8 mutations and KANSL1 amplifications in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How prevalent is the co-occurrence of FGF8 mutations and PTPRO amplifications in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How prevalent is the co-occurrence of FGF8 mutations and GSTCD amplifications in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How prevalent is the co-occurrence of FGF8 mutations and EPRS1 amplifications in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How prevalent is the co-occurrence of TENM3 mutations and GPRASP1 amplifications in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,cnv_and_ssm
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of AKT1 mutations and ANP32E amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is the co-occurrence of CFAP298-TCP10L mutations and ZNF431 amplifications in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+792,GLRB,E148D,Stomach Adenocarcinoma,How prevalent is the co-occurrence of GLRB mutations and EVC2 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+793,TTN,F7636L,Colon Adenocarcinoma,How prevalent is the co-occurrence of TTN mutations and PGF amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+794,TTN,F8563L,Colon Adenocarcinoma,How prevalent is the co-occurrence of TTN mutations and PHLPP1 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+795,TTN,F8880L,Colon Adenocarcinoma,How prevalent is the co-occurrence of TTN mutations and DSCAM amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How prevalent is the co-occurrence of ANKRD30A mutations and KL amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How prevalent is the co-occurrence of ANKRD30A mutations and EVC2 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How prevalent is the co-occurrence of ANKRD30A mutations and PAPPA amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+809,TRIM45,S177L,Colon Adenocarcinoma,How prevalent is the co-occurrence of TRIM45 mutations and PGF amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+810,TRIM45,S224L,Colon Adenocarcinoma,How prevalent is the co-occurrence of TRIM45 mutations and POC1B amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+811,TRIM45,S281L,Colon Adenocarcinoma,How prevalent is the co-occurrence of TRIM45 mutations and TAF1C amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How prevalent is the co-occurrence of CACNA1F mutations and HLA-DQA2 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How prevalent is the co-occurrence of CACNA1F mutations and TMEM255A amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How prevalent is the co-occurrence of CACNA1F mutations and HLA-DQA2 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+817,KL,R594C,Colon Adenocarcinoma,How prevalent is the co-occurrence of KL mutations and DCLK3 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How prevalent is the co-occurrence of GUF1 mutations and GABRA6 amplifications in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+822,TAF1L,A539V,Colon Adenocarcinoma,How prevalent is the co-occurrence of TAF1L mutations and PLEKHG6 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of TASOR2 mutations and EVC2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of TASOR2 mutations and NRAP amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of TASOR2 mutations and PTPRO amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of KDM5C mutations and XKR4 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of KDM5C mutations and CTSC amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of KDM5C mutations and MERTK amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of KDM5C mutations and CTNNA2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is the co-occurrence of IL5RA mutations and ANKDD1A amplifications in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+843,DHX16,A29V,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of DHX16 mutations and PXN amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+844,DHX16,A89V,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of DHX16 mutations and CACNA1F amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+902,GPR158,A644V,Stomach Adenocarcinoma,How prevalent is the co-occurrence of GPR158 mutations and UNC5D amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+903,GPR158,A723V,Stomach Adenocarcinoma,How prevalent is the co-occurrence of GPR158 mutations and BCAT1 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the co-occurrence of EIF2B4 mutations and TTC12 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the co-occurrence of EIF2B4 mutations and PTPRO amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the co-occurrence of EIF2B4 mutations and PAPPA amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the co-occurrence of EIF2B4 mutations and TTC17 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the co-occurrence of EIF2B4 mutations and GPRASP1 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the co-occurrence of EIF2B4 mutations and SLC9C1 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of AUTS2 mutations and TASOR2 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of AUTS2 mutations and TRPA1 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of AUTS2 mutations and MYT1 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of AUTS2 mutations and ZFP42 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of AUTS2 mutations and YY1AP1 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of AUTS2 mutations and GUF1 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of AUTS2 mutations and CR1 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of AUTS2 mutations and EFCAB12 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of AUTS2 mutations and OLFML3 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of AUTS2 mutations and FBXO42 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the co-occurrence of ACTL7B mutations and TMEM225 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How prevalent is the co-occurrence of PCDHGA1 mutations and SLC6A4 amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+954,TRAP1,R114W,Stomach Adenocarcinoma,How prevalent is the co-occurrence of TRAP1 mutations and HYOU1 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+955,TRAP1,R61W,Stomach Adenocarcinoma,How prevalent is the co-occurrence of TRAP1 mutations and CDH23 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of PIK3C2A mutations and ACVR1B amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How prevalent is the co-occurrence of KANSL1 mutations and FNDC7 amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How prevalent is the co-occurrence of ANKRD52 mutations and ACVR1B amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of PAPPA mutations and MAD1L1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How prevalent is the co-occurrence of B3GALNT1 mutations and MERTK amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+982,GABRA6,G115R,Lung Adenocarcinoma,How prevalent is the co-occurrence of GABRA6 mutations and TAF1C amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+983,GABRA6,G122R,Lung Adenocarcinoma,How prevalent is the co-occurrence of GABRA6 mutations and CX3CR1 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+984,GABRA6,G165R,Lung Adenocarcinoma,How prevalent is the co-occurrence of GABRA6 mutations and ZNF431 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+985,GABRA6,G175R,Lung Adenocarcinoma,How prevalent is the co-occurrence of GABRA6 mutations and ANKRD24 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+986,GABRA6,G70R,Lung Adenocarcinoma,How prevalent is the co-occurrence of GABRA6 mutations and MAST4 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of ZSCAN31 mutations and SGCZ amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the co-occurrence of MED16 mutations and GIMAP2 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the co-occurrence of MED16 mutations and ZKSCAN7 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How prevalent is the co-occurrence of PTPRO mutations and CFAP61 amplifications in Pancreatic Adenocarcinoma?,cnv_and_ssm
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How prevalent is the co-occurrence of PTPRO mutations and ADRA1A amplifications in Pancreatic Adenocarcinoma?,cnv_and_ssm
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How prevalent is the co-occurrence of PTPRO mutations and PAPPA amplifications in Pancreatic Adenocarcinoma?,cnv_and_ssm
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How prevalent is the co-occurrence of PTPRO mutations and OLFML3 amplifications in Pancreatic Adenocarcinoma?,cnv_and_ssm
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How prevalent is the co-occurrence of PTPRO mutations and ZNF431 amplifications in Pancreatic Adenocarcinoma?,cnv_and_ssm
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How prevalent is the co-occurrence of PTPRO mutations and POLR1G amplifications in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How prevalent is the co-occurrence of PTPRO mutations and ARMC3 amplifications in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How prevalent is the co-occurrence of PTPRO mutations and ANKRD24 amplifications in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of CHMP7 mutations and PLEKHG6 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1017,GPC3,I107N,Stomach Adenocarcinoma,How prevalent is the co-occurrence of GPC3 mutations and DNAH14 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1018,GPC3,I161N,Stomach Adenocarcinoma,How prevalent is the co-occurrence of GPC3 mutations and DCN amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is the co-occurrence of TLK2 mutations and CX3CR1 amplifications in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is the co-occurrence of TLK2 mutations and AUTS2 amplifications in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is the co-occurrence of TLK2 mutations and CFAP61 amplifications in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is the co-occurrence of TLK2 mutations and YY1AP1 amplifications in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How prevalent is the co-occurrence of TLK2 mutations and ZNF804A amplifications in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How prevalent is the co-occurrence of ZNF217 mutations and TRPA1 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1038,SYT9,V275L,Lung Adenocarcinoma,How prevalent is the co-occurrence of SYT9 mutations and FBXO15 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1039,SYT9,V307L,Lung Adenocarcinoma,How prevalent is the co-occurrence of SYT9 mutations and MAST4 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of PKHD1L1 mutations and FGF8 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of MYO3A mutations and DCN amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the co-occurrence of VASN mutations and FRY amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of DNMT1 mutations and ACTA2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of DNMT1 mutations and JAML amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of DNMT1 mutations and FNDC7 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1056,CA9,E402K,Colon Adenocarcinoma,How prevalent is the co-occurrence of CA9 mutations and ANKRD30A amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of TTC17 mutations and ACTB amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of TTC17 mutations and TNS1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1065,PSG2,P43L,Breast Invasive Carcinoma,How prevalent is the co-occurrence of PSG2 mutations and DCC amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How prevalent is the co-occurrence of RIPOR2 mutations and DHX16 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How prevalent is the co-occurrence of RIPOR2 mutations and PXN amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How prevalent is the co-occurrence of RIPOR2 mutations and PLEKHG6 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How prevalent is the co-occurrence of RIPOR2 mutations and DNAH14 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of DCLK3 mutations and YY1AP1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of DCLK3 mutations and USH2A amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of MERTK mutations and FGF8 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of MERTK mutations and NRAP amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of MERTK mutations and TET2 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of ZFP42 mutations and CTSC amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of OR13C3 mutations and MAST4 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of OR13C3 mutations and CTSC amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How prevalent is the co-occurrence of SPAG1 mutations and FCGR2C amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of CDKN2AIP mutations and SYNJ1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1093,PXN,H1016Y,Colon Adenocarcinoma,How prevalent is the co-occurrence of PXN mutations and ACTB amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1094,PXN,H359Y,Colon Adenocarcinoma,How prevalent is the co-occurrence of PXN mutations and TRIM45 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1095,PXN,H492Y,Colon Adenocarcinoma,How prevalent is the co-occurrence of PXN mutations and CARMIL1 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1096,PXN,H524Y,Colon Adenocarcinoma,How prevalent is the co-occurrence of PXN mutations and MAST4 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1097,PXN,H526Y,Colon Adenocarcinoma,How prevalent is the co-occurrence of PXN mutations and DGKD amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1098,PXN,H540Y,Colon Adenocarcinoma,How prevalent is the co-occurrence of PXN mutations and ZSCAN31 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of TTYH2 mutations and ANP32E amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of TTYH2 mutations and UNC5D amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How prevalent is the co-occurrence of TMEM255A mutations and AUTS2 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How prevalent is the co-occurrence of TMEM255A mutations and CFAP61 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How prevalent is the co-occurrence of TMEM255A mutations and TASOR2 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How prevalent is the co-occurrence of TASOR2 mutations and PIK3C2G amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How prevalent is the co-occurrence of TASOR2 mutations and TET2 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of ICE1 mutations and TLK2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1112,MYT1,A558E,Breast Invasive Carcinoma,How prevalent is the co-occurrence of MYT1 mutations and SOX21 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1113,MYT1,A879E,Breast Invasive Carcinoma,How prevalent is the co-occurrence of MYT1 mutations and CDC42BPA amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1114,MYT1,A906E,Breast Invasive Carcinoma,How prevalent is the co-occurrence of MYT1 mutations and AUTS2 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of CX3CR1 mutations and YY1AP1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of CX3CR1 mutations and MYO16 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How prevalent is the co-occurrence of SPINDOC mutations and CCNG1 amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of ART3 mutations and GPC3 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of ART3 mutations and TLK2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How prevalent is the co-occurrence of CYP1A2 mutations and ZSCAN31 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the co-occurrence of ADRA1A mutations and TTYH2 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of CDH23 mutations and TSHZ3 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of CDH23 mutations and ZFPM2 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of KRT39 mutations and BICC1 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of PDHA2 mutations and PXN amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How prevalent is the co-occurrence of SLC24A2 mutations and IL5RA amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How prevalent is the co-occurrence of PTPRN2 mutations and POC1B amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How prevalent is the co-occurrence of PTPRN2 mutations and SYT10 amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How prevalent is the co-occurrence of PTPRN2 mutations and CDH23 amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How prevalent is the co-occurrence of PTPRN2 mutations and CTCFL amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How prevalent is the co-occurrence of PTPRN2 mutations and HTR3B amplifications in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1188,SOX21,R55L,Lung Adenocarcinoma,How prevalent is the co-occurrence of SOX21 mutations and FRY amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How prevalent is the co-occurrence of CPA6 mutations and DEFB115 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of GRM5 mutations and PIK3C2A amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the co-occurrence of CASZ1 mutations and ANKRD24 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How prevalent is the co-occurrence of SGIP1 mutations and NEXN amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How prevalent is the co-occurrence of SGIP1 mutations and PIK3C2G amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How prevalent is the co-occurrence of SGIP1 mutations and GABRA6 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How prevalent is the co-occurrence of SGIP1 mutations and ANKRD30A amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How prevalent is the co-occurrence of CARMIL1 mutations and TLK2 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How prevalent is the co-occurrence of CARMIL1 mutations and FGF8 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How prevalent is the co-occurrence of ZNF431 mutations and SLC24A2 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How prevalent is the co-occurrence of ZNF431 mutations and NRAP amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1234,ZNF431,R128I,Lung Adenocarcinoma,How prevalent is the co-occurrence of ZNF431 mutations and TENM2 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of DNAH11 mutations and VASN amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of DNAH11 mutations and AUTS2 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of POLD1 mutations and PTPRN2 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How prevalent is the co-occurrence of POLD1 mutations and OLFML3 amplifications in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1248,TTC12,D646H,Lung Adenocarcinoma,How prevalent is the co-occurrence of TTC12 mutations and KIF20B amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1249,TTC12,D652H,Lung Adenocarcinoma,How prevalent is the co-occurrence of TTC12 mutations and FRY amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How prevalent is the co-occurrence of CNGB1 mutations and DCC amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How prevalent is the co-occurrence of CNGB1 mutations and ZNF274 amplifications in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1254,CTSC,E214V,Stomach Adenocarcinoma,How prevalent is the co-occurrence of CTSC mutations and TRPA1 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1255,CTSC,E291V,Stomach Adenocarcinoma,How prevalent is the co-occurrence of CTSC mutations and NRAP amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1256,CTSC,E322V,Stomach Adenocarcinoma,How prevalent is the co-occurrence of CTSC mutations and SYNJ1 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1257,CTSC,E324V,Stomach Adenocarcinoma,How prevalent is the co-occurrence of CTSC mutations and CPS1 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1258,CTSC,E335V,Stomach Adenocarcinoma,How prevalent is the co-occurrence of CTSC mutations and GUK1 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of PRSS8 mutations and TASOR2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of PRSS8 mutations and DNMT1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How prevalent is the co-occurrence of ARHGEF40 mutations and ANKRD30A amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1264,ACTB,A138T,Rectum Adenocarcinoma,How prevalent is the co-occurrence of ACTB mutations and BCAT1 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+1265,ACTB,A217T,Rectum Adenocarcinoma,How prevalent is the co-occurrence of ACTB mutations and SPTAN1 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+1266,ACTB,A244T,Rectum Adenocarcinoma,How prevalent is the co-occurrence of ACTB mutations and ARMC3 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+1267,ACTB,A260T,Rectum Adenocarcinoma,How prevalent is the co-occurrence of ACTB mutations and CR1 amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How prevalent is the co-occurrence of YY1AP1 mutations and TAF1C amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How prevalent is the co-occurrence of YY1AP1 mutations and TLK2 amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How prevalent is the co-occurrence of YY1AP1 mutations and STK19 amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How prevalent is the co-occurrence of YY1AP1 mutations and FBXO15 amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How prevalent is the co-occurrence of YY1AP1 mutations and IL5RA amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How prevalent is the co-occurrence of YY1AP1 mutations and PXN amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How prevalent is the co-occurrence of YY1AP1 mutations and SLC6A4 amplifications in Glioblastoma Multiforme?,cnv_and_ssm
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of FNDC7 mutations and MED16 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of FNDC7 mutations and OR2T4 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1299,TLCD5,G15V,Lung Adenocarcinoma,How prevalent is the co-occurrence of TLCD5 mutations and POLR1G amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1300,TLCD5,G37V,Lung Adenocarcinoma,How prevalent is the co-occurrence of TLCD5 mutations and GRM5 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of POLR1G mutations and TNS1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of POLR1G mutations and ANP32E amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How prevalent is the co-occurrence of DNAH14 mutations and TASOR2 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How prevalent is the co-occurrence of DNAH14 mutations and DCC amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How prevalent is the co-occurrence of DNAH14 mutations and TNS1 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of NEXN mutations and MAST4 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How prevalent is the co-occurrence of CYB5R2 mutations and PIK3C2B amplifications in Prostate Adenocarcinoma?,cnv_and_ssm
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How prevalent is the co-occurrence of CYB5R2 mutations and EBF2 amplifications in Prostate Adenocarcinoma?,cnv_and_ssm
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of NRAP mutations and FRY amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of NRAP mutations and ZNF431 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of NRAP mutations and POLD1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of CCDC22 mutations and MRPL55 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of DCAF6 mutations and FMO4 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of DCAF6 mutations and EIF2B4 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of ZNF708 mutations and PXN amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of BFAR mutations and TNS1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of MAST4 mutations and TYROBP amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of MAST4 mutations and MAST4 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of MAST4 mutations and CTSC amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of MAST4 mutations and POC1B amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of MAST4 mutations and DCC amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How prevalent is the co-occurrence of ARMC3 mutations and EIF2B4 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How prevalent is the co-occurrence of ARMC3 mutations and ADRA1A amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How prevalent is the co-occurrence of TET2 mutations and TASOR2 amplifications in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How prevalent is the co-occurrence of TET2 mutations and PKHD1L1 amplifications in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How prevalent is the co-occurrence of SERPINB10 mutations and ANKDD1A amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of STAT3 mutations and AQP7 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of MIEF1 mutations and GRM1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How prevalent is the co-occurrence of ACVR1B mutations and ANKRD24 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How prevalent is the co-occurrence of ACVR1B mutations and PTPRO amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How prevalent is the co-occurrence of ACVR1B mutations and MORF4L1 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1393,EBF2,T104I,Stomach Adenocarcinoma,How prevalent is the co-occurrence of EBF2 mutations and PLEKHG6 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1394,EBF2,T252I,Stomach Adenocarcinoma,How prevalent is the co-occurrence of EBF2 mutations and OLFML3 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How prevalent is the co-occurrence of VPS26B mutations and TENM2 amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the co-occurrence of PGR mutations and RIMS2 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the co-occurrence of PGR mutations and HYOU1 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How prevalent is the co-occurrence of PGR mutations and FGF8 amplifications in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How prevalent is the co-occurrence of ACTA2 mutations and PLEKHG6 amplifications in Skin Cutaneous Melanoma?,cnv_and_ssm
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of THBS4 mutations and PCDHGA1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of THBS4 mutations and DCN amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1413,PRSS1,S114T,Lung Adenocarcinoma,How prevalent is the co-occurrence of PRSS1 mutations and PIK3C2A amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1414,PRSS1,S124T,Lung Adenocarcinoma,How prevalent is the co-occurrence of PRSS1 mutations and ACTB amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1415,PRSS1,S138T,Lung Adenocarcinoma,How prevalent is the co-occurrence of PRSS1 mutations and ANKRD30A amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1416,PRSS1,S74T,Lung Adenocarcinoma,How prevalent is the co-occurrence of PRSS1 mutations and GRTP1 amplifications in Lung Adenocarcinoma?,cnv_and_ssm
+1417,PGF,R126H,Stomach Adenocarcinoma,How prevalent is the co-occurrence of PGF mutations and DCC amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1418,PGF,R127H,Stomach Adenocarcinoma,How prevalent is the co-occurrence of PGF mutations and VASN amplifications in Stomach Adenocarcinoma?,cnv_and_ssm
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How prevalent is the co-occurrence of ITPRID2 mutations and ANKRD30A amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How prevalent is the co-occurrence of ITPRID2 mutations and FBXO42 amplifications in Breast Invasive Carcinoma?,cnv_and_ssm
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of HBB mutations and CNGB1 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How prevalent is the co-occurrence of PCDHB2 mutations and EIF2B4 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How prevalent is the co-occurrence of PCDHB2 mutations and DEFB115 amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How prevalent is the co-occurrence of PCDHB2 mutations and MAOB amplifications in Colon Adenocarcinoma?,cnv_and_ssm
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How prevalent is the co-occurrence of UBR2 mutations and TASOR2 amplifications in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How prevalent is the co-occurrence of FBXO42 mutations and PGF amplifications in Rectum Adenocarcinoma?,cnv_and_ssm
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the frequency of mutations in TNS1 coupled with gains in FBN1 in Breast Invasive Carcinoma?How often do mutations in TNS1 and amplifications in FBN1 happen in Breast Invasive Carcinoma?,cnv_and_ssm
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the frequency of mutations in TNS1 coupled with gains in GPRASP1 in Breast Invasive Carcinoma?How often do mutations in TNS1 and amplifications in GPRASP1 happen in Breast Invasive Carcinoma?,cnv_and_ssm
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the frequency of mutations in TNS1 coupled with gains in BFAR in Breast Invasive Carcinoma?How often do mutations in TNS1 and amplifications in BFAR happen in Breast Invasive Carcinoma?,cnv_and_ssm
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the frequency of mutations in TNS1 coupled with gains in ZMYM3 in Breast Invasive Carcinoma?How often do mutations in TNS1 and amplifications in ZMYM3 happen in Breast Invasive Carcinoma?,cnv_and_ssm
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the frequency of mutations in TNS1 coupled with gains in DNAH11 in Breast Invasive Carcinoma?How often do mutations in TNS1 and amplifications in DNAH11 happen in Breast Invasive Carcinoma?,cnv_and_ssm
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the frequency of mutations in TNS1 coupled with gains in IL5RA in Breast Invasive Carcinoma?How often do mutations in TNS1 and amplifications in IL5RA happen in Breast Invasive Carcinoma?,cnv_and_ssm
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the frequency of mutations in TNS1 coupled with gains in DEFB115 in Breast Invasive Carcinoma?How often do mutations in TNS1 and amplifications in DEFB115 happen in Breast Invasive Carcinoma?,cnv_and_ssm
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the frequency of mutations in EVC2 coupled with gains in CDH23 in Bladder Urothelial Carcinoma?How often do mutations in EVC2 and amplifications in CDH23 happen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the frequency of mutations in EVC2 coupled with gains in ADAM17 in Bladder Urothelial Carcinoma?How often do mutations in EVC2 and amplifications in ADAM17 happen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in CR1 coupled with gains in TASOR2 in Uterine Corpus Endometrial Carcinoma?How often do mutations in CR1 and amplifications in TASOR2 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in CR1 coupled with gains in ZMYM3 in Uterine Corpus Endometrial Carcinoma?How often do mutations in CR1 and amplifications in ZMYM3 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the frequency of mutations in TRPA1 coupled with gains in PDHA2 in Rectum Adenocarcinoma?How often do mutations in TRPA1 and amplifications in PDHA2 happen in Rectum Adenocarcinoma?,cnv_and_ssm
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the frequency of mutations in TRPA1 coupled with gains in DCLK3 in Rectum Adenocarcinoma?How often do mutations in TRPA1 and amplifications in DCLK3 happen in Rectum Adenocarcinoma?,cnv_and_ssm
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the frequency of mutations in TAF1C coupled with gains in SMO in Lung Adenocarcinoma?How often do mutations in TAF1C and amplifications in SMO happen in Lung Adenocarcinoma?,cnv_and_ssm
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the frequency of mutations in TAF1C coupled with gains in COL6A3 in Lung Adenocarcinoma?How often do mutations in TAF1C and amplifications in COL6A3 happen in Lung Adenocarcinoma?,cnv_and_ssm
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the frequency of mutations in TAF1C coupled with gains in FCGR2C in Lung Adenocarcinoma?How often do mutations in TAF1C and amplifications in FCGR2C happen in Lung Adenocarcinoma?,cnv_and_ssm
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the frequency of mutations in TAF1C coupled with gains in UNC5D in Lung Adenocarcinoma?How often do mutations in TAF1C and amplifications in UNC5D happen in Lung Adenocarcinoma?,cnv_and_ssm
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the frequency of mutations in TAF1C coupled with gains in MED16 in Lung Adenocarcinoma?How often do mutations in TAF1C and amplifications in MED16 happen in Lung Adenocarcinoma?,cnv_and_ssm
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in DPF3 coupled with gains in POLD1 in Uterine Corpus Endometrial Carcinoma?How often do mutations in DPF3 and amplifications in POLD1 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in DPF3 coupled with gains in CHMP7 in Uterine Corpus Endometrial Carcinoma?How often do mutations in DPF3 and amplifications in CHMP7 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in DPF3 coupled with gains in CACNA1F in Uterine Corpus Endometrial Carcinoma?How often do mutations in DPF3 and amplifications in CACNA1F happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the frequency of mutations in OR2T4 coupled with gains in AUTS2 in Lung Adenocarcinoma?How often do mutations in OR2T4 and amplifications in AUTS2 happen in Lung Adenocarcinoma?,cnv_and_ssm
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the frequency of mutations in OR2T4 coupled with gains in AUTS2 in Lung Adenocarcinoma?How often do mutations in OR2T4 and amplifications in AUTS2 happen in Lung Adenocarcinoma?,cnv_and_ssm
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the frequency of mutations in FBN1 coupled with gains in POLD1 in Pancreatic Adenocarcinoma?How often do mutations in FBN1 and amplifications in POLD1 happen in Pancreatic Adenocarcinoma?,cnv_and_ssm
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the frequency of mutations in MAD1L1 coupled with gains in CDH23 in Prostate Adenocarcinoma?How often do mutations in MAD1L1 and amplifications in CDH23 happen in Prostate Adenocarcinoma?,cnv_and_ssm
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the frequency of mutations in MAD1L1 coupled with gains in PGF in Prostate Adenocarcinoma?How often do mutations in MAD1L1 and amplifications in PGF happen in Prostate Adenocarcinoma?,cnv_and_ssm
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the frequency of mutations in MAD1L1 coupled with gains in SYT10 in Prostate Adenocarcinoma?How often do mutations in MAD1L1 and amplifications in SYT10 happen in Prostate Adenocarcinoma?,cnv_and_ssm
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the frequency of mutations in CCNG1 coupled with gains in ACVR1B in Skin Cutaneous Melanoma?How often do mutations in CCNG1 and amplifications in ACVR1B happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of mutations in ANP32E coupled with gains in TAF1C in Kidney Renal Papillary Cell Carcinoma?How often do mutations in ANP32E and amplifications in TAF1C happen in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of mutations in ANP32E coupled with gains in JAML in Kidney Renal Papillary Cell Carcinoma?How often do mutations in ANP32E and amplifications in JAML happen in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of mutations in ANP32E coupled with gains in PGF in Kidney Renal Papillary Cell Carcinoma?How often do mutations in ANP32E and amplifications in PGF happen in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of mutations in ANP32E coupled with gains in JAML in Kidney Renal Papillary Cell Carcinoma?How often do mutations in ANP32E and amplifications in JAML happen in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the frequency of mutations in FRY coupled with gains in TYK2 in Bladder Urothelial Carcinoma?How often do mutations in FRY and amplifications in TYK2 happen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the frequency of mutations in FRY coupled with gains in NRAP in Bladder Urothelial Carcinoma?How often do mutations in FRY and amplifications in NRAP happen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the frequency of mutations in FRY coupled with gains in ADAM17 in Bladder Urothelial Carcinoma?How often do mutations in FRY and amplifications in ADAM17 happen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the frequency of mutations in FRY coupled with gains in RIMS2 in Bladder Urothelial Carcinoma?How often do mutations in FRY and amplifications in RIMS2 happen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the frequency of mutations in PAK3 coupled with gains in UNC5D in Skin Cutaneous Melanoma?How often do mutations in PAK3 and amplifications in UNC5D happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the frequency of mutations in PAK3 coupled with gains in MED16 in Skin Cutaneous Melanoma?How often do mutations in PAK3 and amplifications in MED16 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the frequency of mutations in PAK3 coupled with gains in ZFP42 in Skin Cutaneous Melanoma?How often do mutations in PAK3 and amplifications in ZFP42 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the frequency of mutations in PAK3 coupled with gains in EFCAB12 in Skin Cutaneous Melanoma?How often do mutations in PAK3 and amplifications in EFCAB12 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the frequency of mutations in PAK3 coupled with gains in TET2 in Skin Cutaneous Melanoma?How often do mutations in PAK3 and amplifications in TET2 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the frequency of mutations in MUC16 coupled with gains in CNGB1 in Skin Cutaneous Melanoma?How often do mutations in MUC16 and amplifications in CNGB1 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the frequency of mutations in ZFPM2 coupled with gains in PTPRN2 in Liver Hepatocellular Carcinoma?How often do mutations in ZFPM2 and amplifications in PTPRN2 happen in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the frequency of mutations in ZFPM2 coupled with gains in TMEM255A in Liver Hepatocellular Carcinoma?How often do mutations in ZFPM2 and amplifications in TMEM255A happen in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the frequency of mutations in PIK3C2B coupled with gains in MAD1L1 in Breast Invasive Carcinoma?How often do mutations in PIK3C2B and amplifications in MAD1L1 happen in Breast Invasive Carcinoma?,cnv_and_ssm
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the frequency of mutations in PIK3C2B coupled with gains in SGCZ in Breast Invasive Carcinoma?How often do mutations in PIK3C2B and amplifications in SGCZ happen in Breast Invasive Carcinoma?,cnv_and_ssm
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the frequency of mutations in ZNF804A coupled with gains in STK19 in Colon Adenocarcinoma?How often do mutations in ZNF804A and amplifications in STK19 happen in Colon Adenocarcinoma?,cnv_and_ssm
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the frequency of mutations in RELN coupled with gains in STK19 in Stomach Adenocarcinoma?How often do mutations in RELN and amplifications in STK19 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of mutations in EFCAB12 coupled with gains in ACVR1B in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?How often do mutations in EFCAB12 and amplifications in ACVR1B happen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of mutations in EFCAB12 coupled with gains in DCN in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?How often do mutations in EFCAB12 and amplifications in DCN happen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the frequency of mutations in DEFB115 coupled with gains in ACTB in Skin Cutaneous Melanoma?How often do mutations in DEFB115 and amplifications in ACTB happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the frequency of mutations in ANKDD1A coupled with gains in GRM1 in Bladder Urothelial Carcinoma?How often do mutations in ANKDD1A and amplifications in GRM1 happen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the frequency of mutations in ANKDD1A coupled with gains in DCN in Bladder Urothelial Carcinoma?How often do mutations in ANKDD1A and amplifications in DCN happen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the frequency of mutations in ANKDD1A coupled with gains in TNS1 in Bladder Urothelial Carcinoma?How often do mutations in ANKDD1A and amplifications in TNS1 happen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in HTR3B coupled with gains in PRSS1 in Uterine Corpus Endometrial Carcinoma?How often do mutations in HTR3B and amplifications in PRSS1 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in HTR3B coupled with gains in SMO in Uterine Corpus Endometrial Carcinoma?How often do mutations in HTR3B and amplifications in SMO happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in HTR3B coupled with gains in MYO15A in Uterine Corpus Endometrial Carcinoma?How often do mutations in HTR3B and amplifications in MYO15A happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the frequency of mutations in ABCC3 coupled with gains in TNS1 in Stomach Adenocarcinoma?How often do mutations in ABCC3 and amplifications in TNS1 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in NOMO1 coupled with gains in FMO4 in Uterine Corpus Endometrial Carcinoma?How often do mutations in NOMO1 and amplifications in FMO4 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in NOMO1 coupled with gains in CA9 in Uterine Corpus Endometrial Carcinoma?How often do mutations in NOMO1 and amplifications in CA9 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the frequency of mutations in HYOU1 coupled with gains in PIK3C2G in Bladder Urothelial Carcinoma?How often do mutations in HYOU1 and amplifications in PIK3C2G happen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the frequency of mutations in FMO4 coupled with gains in TMEM255A in Skin Cutaneous Melanoma?How often do mutations in FMO4 and amplifications in TMEM255A happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+140,BICC1,A372V,Exceptional Responders,What is the frequency of mutations in BICC1 coupled with gains in UNC5D in Exceptional Responders?How often do mutations in BICC1 and amplifications in UNC5D happen in Exceptional Responders?,cnv_and_ssm
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in ZMYM3 coupled with gains in SORCS1 in Uterine Corpus Endometrial Carcinoma?How often do mutations in ZMYM3 and amplifications in SORCS1 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in ZMYM3 coupled with gains in GABRA6 in Uterine Corpus Endometrial Carcinoma?How often do mutations in ZMYM3 and amplifications in GABRA6 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in ZMYM3 coupled with gains in PCDHB2 in Uterine Corpus Endometrial Carcinoma?How often do mutations in ZMYM3 and amplifications in PCDHB2 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of mutations in XKR4 coupled with gains in DNMT1 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?How often do mutations in XKR4 and amplifications in DNMT1 happen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the frequency of mutations in ABCC2 coupled with gains in CPS1 in Liver Hepatocellular Carcinoma?How often do mutations in ABCC2 and amplifications in CPS1 happen in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the frequency of mutations in OR8K5 coupled with gains in ZFAT in Lung Adenocarcinoma?How often do mutations in OR8K5 and amplifications in ZFAT happen in Lung Adenocarcinoma?,cnv_and_ssm
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the frequency of mutations in SPTAN1 coupled with gains in TRIM45 in Skin Cutaneous Melanoma?How often do mutations in SPTAN1 and amplifications in TRIM45 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the frequency of mutations in SPTAN1 coupled with gains in ABCC2 in Skin Cutaneous Melanoma?How often do mutations in SPTAN1 and amplifications in ABCC2 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the frequency of mutations in SYT10 coupled with gains in PXN in Rectum Adenocarcinoma?How often do mutations in SYT10 and amplifications in PXN happen in Rectum Adenocarcinoma?,cnv_and_ssm
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the frequency of mutations in HSPA5 coupled with gains in AQP7 in Skin Cutaneous Melanoma?How often do mutations in HSPA5 and amplifications in AQP7 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the frequency of mutations in UNC5D coupled with gains in NOMO1 in Lung Adenocarcinoma?How often do mutations in UNC5D and amplifications in NOMO1 happen in Lung Adenocarcinoma?,cnv_and_ssm
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the frequency of mutations in UNC5D coupled with gains in GUK1 in Lung Adenocarcinoma?How often do mutations in UNC5D and amplifications in GUK1 happen in Lung Adenocarcinoma?,cnv_and_ssm
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the frequency of mutations in UNC5D coupled with gains in PLEKHG6 in Lung Adenocarcinoma?How often do mutations in UNC5D and amplifications in PLEKHG6 happen in Lung Adenocarcinoma?,cnv_and_ssm
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the frequency of mutations in UNC5D coupled with gains in ACVR1B in Lung Adenocarcinoma?How often do mutations in UNC5D and amplifications in ACVR1B happen in Lung Adenocarcinoma?,cnv_and_ssm
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the frequency of mutations in UNC5D coupled with gains in CTCFL in Lung Adenocarcinoma?How often do mutations in UNC5D and amplifications in CTCFL happen in Lung Adenocarcinoma?,cnv_and_ssm
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the frequency of mutations in UNC5D coupled with gains in TAS1R3 in Lung Adenocarcinoma?How often do mutations in UNC5D and amplifications in TAS1R3 happen in Lung Adenocarcinoma?,cnv_and_ssm
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the frequency of mutations in DOCK2 coupled with gains in TTC12 in Kidney Renal Clear Cell Carcinoma?How often do mutations in DOCK2 and amplifications in TTC12 happen in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the frequency of mutations in ZNF627 coupled with gains in CYB5R2 in Kidney Renal Clear Cell Carcinoma?How often do mutations in ZNF627 and amplifications in CYB5R2 happen in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the frequency of mutations in CDC42BPA coupled with gains in DSCAM in Skin Cutaneous Melanoma?How often do mutations in CDC42BPA and amplifications in DSCAM happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the frequency of mutations in MRPL55 coupled with gains in SORCS1 in Colon Adenocarcinoma?How often do mutations in MRPL55 and amplifications in SORCS1 happen in Colon Adenocarcinoma?,cnv_and_ssm
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the frequency of mutations in MRPL55 coupled with gains in PTPRO in Colon Adenocarcinoma?How often do mutations in MRPL55 and amplifications in PTPRO happen in Colon Adenocarcinoma?,cnv_and_ssm
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the frequency of mutations in TMTC3 coupled with gains in DPF3 in Breast Invasive Carcinoma?How often do mutations in TMTC3 and amplifications in DPF3 happen in Breast Invasive Carcinoma?,cnv_and_ssm
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the frequency of mutations in EPRS1 coupled with gains in PAK3 in Colon Adenocarcinoma?How often do mutations in EPRS1 and amplifications in PAK3 happen in Colon Adenocarcinoma?,cnv_and_ssm
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the frequency of mutations in EPRS1 coupled with gains in HBB in Colon Adenocarcinoma?How often do mutations in EPRS1 and amplifications in HBB happen in Colon Adenocarcinoma?,cnv_and_ssm
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the frequency of mutations in GRTP1 coupled with gains in MYO3B in Skin Cutaneous Melanoma?How often do mutations in GRTP1 and amplifications in MYO3B happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the frequency of mutations in GRTP1 coupled with gains in CDH23 in Skin Cutaneous Melanoma?How often do mutations in GRTP1 and amplifications in CDH23 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the frequency of mutations in TSHZ3 coupled with gains in TMEM225 in Stomach Adenocarcinoma?How often do mutations in TSHZ3 and amplifications in TMEM225 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the frequency of mutations in TAS1R3 coupled with gains in HTR3B in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?How often do mutations in TAS1R3 and amplifications in HTR3B happen in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,cnv_and_ssm
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the frequency of mutations in PIAS3 coupled with gains in MAD1L1 in Lung Squamous Cell Carcinoma?How often do mutations in PIAS3 and amplifications in MAD1L1 happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the frequency of mutations in PIAS3 coupled with gains in SPINDOC in Lung Squamous Cell Carcinoma?How often do mutations in PIAS3 and amplifications in SPINDOC happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the frequency of mutations in ZNF274 coupled with gains in PAK3 in Stomach Adenocarcinoma?How often do mutations in ZNF274 and amplifications in PAK3 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the frequency of mutations in SYNJ1 coupled with gains in KL in Colon Adenocarcinoma?How often do mutations in SYNJ1 and amplifications in KL happen in Colon Adenocarcinoma?,cnv_and_ssm
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the frequency of mutations in SYNJ1 coupled with gains in DCLK3 in Colon Adenocarcinoma?How often do mutations in SYNJ1 and amplifications in DCLK3 happen in Colon Adenocarcinoma?,cnv_and_ssm
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the frequency of mutations in SYNJ1 coupled with gains in PTPRN2 in Colon Adenocarcinoma?How often do mutations in SYNJ1 and amplifications in PTPRN2 happen in Colon Adenocarcinoma?,cnv_and_ssm
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the frequency of mutations in DSCAM coupled with gains in PYHIN1 in Prostate Adenocarcinoma?How often do mutations in DSCAM and amplifications in PYHIN1 happen in Prostate Adenocarcinoma?,cnv_and_ssm
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the frequency of mutations in DSCAM coupled with gains in TASOR2 in Prostate Adenocarcinoma?How often do mutations in DSCAM and amplifications in TASOR2 happen in Prostate Adenocarcinoma?,cnv_and_ssm
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the frequency of mutations in DSCAM coupled with gains in ZNF431 in Prostate Adenocarcinoma?How often do mutations in DSCAM and amplifications in ZNF431 happen in Prostate Adenocarcinoma?,cnv_and_ssm
+267,DGKD,R140H,Exceptional Responders,What is the frequency of mutations in DGKD coupled with gains in DGKD in Exceptional Responders?How often do mutations in DGKD and amplifications in DGKD happen in Exceptional Responders?,cnv_and_ssm
+268,DGKD,R160H,Exceptional Responders,What is the frequency of mutations in DGKD coupled with gains in AQP7 in Exceptional Responders?How often do mutations in DGKD and amplifications in AQP7 happen in Exceptional Responders?,cnv_and_ssm
+269,DGKD,R204H,Exceptional Responders,What is the frequency of mutations in DGKD coupled with gains in CTSC in Exceptional Responders?How often do mutations in DGKD and amplifications in CTSC happen in Exceptional Responders?,cnv_and_ssm
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the frequency of mutations in PLEKHG6 coupled with gains in B3GALNT1 in Bladder Urothelial Carcinoma?How often do mutations in PLEKHG6 and amplifications in B3GALNT1 happen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the frequency of mutations in PLEKHG6 coupled with gains in PIK3C2B in Bladder Urothelial Carcinoma?How often do mutations in PLEKHG6 and amplifications in PIK3C2B happen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the frequency of mutations in PLEKHG6 coupled with gains in POLR1G in Bladder Urothelial Carcinoma?How often do mutations in PLEKHG6 and amplifications in POLR1G happen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the frequency of mutations in WNT2 coupled with gains in GPRASP1 in Skin Cutaneous Melanoma?How often do mutations in WNT2 and amplifications in GPRASP1 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the frequency of mutations in GUCY2C coupled with gains in HBB in Skin Cutaneous Melanoma?How often do mutations in GUCY2C and amplifications in HBB happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in C7orf31 coupled with gains in PXN in Uterine Corpus Endometrial Carcinoma?How often do mutations in C7orf31 and amplifications in PXN happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of mutations in ZKSCAN7 coupled with gains in MIEF1 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?How often do mutations in ZKSCAN7 and amplifications in MIEF1 happen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+299,OR5D14,M210L,Neuroblastoma,What is the frequency of mutations in OR5D14 coupled with gains in PTPRO in Neuroblastoma?How often do mutations in OR5D14 and amplifications in PTPRO happen in Neuroblastoma?,cnv_and_ssm
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in SPATA22 coupled with gains in COL6A3 in Uterine Corpus Endometrial Carcinoma?How often do mutations in SPATA22 and amplifications in COL6A3 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in SPATA22 coupled with gains in ANKDD1A in Uterine Corpus Endometrial Carcinoma?How often do mutations in SPATA22 and amplifications in ANKDD1A happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in SPATA22 coupled with gains in RIMS2 in Uterine Corpus Endometrial Carcinoma?How often do mutations in SPATA22 and amplifications in RIMS2 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the frequency of mutations in LCN15 coupled with gains in OLFML3 in Stomach Adenocarcinoma?How often do mutations in LCN15 and amplifications in OLFML3 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the frequency of mutations in DCAF4L2 coupled with gains in ZNF804A in Skin Cutaneous Melanoma?How often do mutations in DCAF4L2 and amplifications in ZNF804A happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the frequency of mutations in GUK1 coupled with gains in ZFPM2 in Lung Squamous Cell Carcinoma?How often do mutations in GUK1 and amplifications in ZFPM2 happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the frequency of mutations in GUK1 coupled with gains in TTYH2 in Lung Squamous Cell Carcinoma?How often do mutations in GUK1 and amplifications in TTYH2 happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the frequency of mutations in GUK1 coupled with gains in AQP7 in Lung Squamous Cell Carcinoma?How often do mutations in GUK1 and amplifications in AQP7 happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the frequency of mutations in GUK1 coupled with gains in KDM5C in Lung Squamous Cell Carcinoma?How often do mutations in GUK1 and amplifications in KDM5C happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the frequency of mutations in GUK1 coupled with gains in CACNA1F in Lung Squamous Cell Carcinoma?How often do mutations in GUK1 and amplifications in CACNA1F happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the frequency of mutations in MORF4L1 coupled with gains in PLEKHG6 in Stomach Adenocarcinoma?How often do mutations in MORF4L1 and amplifications in PLEKHG6 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the frequency of mutations in MORF4L1 coupled with gains in CASZ1 in Stomach Adenocarcinoma?How often do mutations in MORF4L1 and amplifications in CASZ1 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the frequency of mutations in MORF4L1 coupled with gains in LAMB2 in Stomach Adenocarcinoma?How often do mutations in MORF4L1 and amplifications in LAMB2 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the frequency of mutations in MORF4L1 coupled with gains in EIF2B4 in Stomach Adenocarcinoma?How often do mutations in MORF4L1 and amplifications in EIF2B4 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the frequency of mutations in MYO3B coupled with gains in EPRS1 in Skin Cutaneous Melanoma?How often do mutations in MYO3B and amplifications in EPRS1 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the frequency of mutations in MYO3B coupled with gains in DCLK3 in Skin Cutaneous Melanoma?How often do mutations in MYO3B and amplifications in DCLK3 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the frequency of mutations in TENT5A coupled with gains in POLR1G in Skin Cutaneous Melanoma?How often do mutations in TENT5A and amplifications in POLR1G happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the frequency of mutations in TENT5A coupled with gains in ANKRD30A in Skin Cutaneous Melanoma?How often do mutations in TENT5A and amplifications in ANKRD30A happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the frequency of mutations in TENT5A coupled with gains in DNAH14 in Skin Cutaneous Melanoma?How often do mutations in TENT5A and amplifications in DNAH14 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the frequency of mutations in ZFAT coupled with gains in SYT9 in Ovarian Serous Cystadenocarcinoma?How often do mutations in ZFAT and amplifications in SYT9 happen in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the frequency of mutations in ZFAT coupled with gains in PGF in Ovarian Serous Cystadenocarcinoma?How often do mutations in ZFAT and amplifications in PGF happen in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the frequency of mutations in ZFAT coupled with gains in DGKD in Ovarian Serous Cystadenocarcinoma?How often do mutations in ZFAT and amplifications in DGKD happen in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+357,ZNF584,A211T,Sarcoma,What is the frequency of mutations in ZNF584 coupled with gains in STK19 in Sarcoma?How often do mutations in ZNF584 and amplifications in STK19 happen in Sarcoma?,cnv_and_ssm
+358,ZNF584,A256T,Sarcoma,What is the frequency of mutations in ZNF584 coupled with gains in DEFB115 in Sarcoma?How often do mutations in ZNF584 and amplifications in DEFB115 happen in Sarcoma?,cnv_and_ssm
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in LDOC1 coupled with gains in CACNA1F in Uterine Corpus Endometrial Carcinoma?How often do mutations in LDOC1 and amplifications in CACNA1F happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the frequency of mutations in PDGFC coupled with gains in ARHGEF40 in Lung Squamous Cell Carcinoma?How often do mutations in PDGFC and amplifications in ARHGEF40 happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in MSANTD4 coupled with gains in PXN in Uterine Corpus Endometrial Carcinoma?How often do mutations in MSANTD4 and amplifications in PXN happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the frequency of mutations in NPSR1 coupled with gains in PXN in Skin Cutaneous Melanoma?How often do mutations in NPSR1 and amplifications in PXN happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the frequency of mutations in PHLPP1 coupled with gains in TYROBP in Lung Squamous Cell Carcinoma?How often do mutations in PHLPP1 and amplifications in TYROBP happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the frequency of mutations in COL6A3 coupled with gains in FBXO15 in Skin Cutaneous Melanoma?How often do mutations in COL6A3 and amplifications in FBXO15 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the frequency of mutations in COL6A3 coupled with gains in GUK1 in Skin Cutaneous Melanoma?How often do mutations in COL6A3 and amplifications in GUK1 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the frequency of mutations in COL6A3 coupled with gains in CYB5R2 in Skin Cutaneous Melanoma?How often do mutations in COL6A3 and amplifications in CYB5R2 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the frequency of mutations in COL6A3 coupled with gains in CDH23 in Skin Cutaneous Melanoma?How often do mutations in COL6A3 and amplifications in CDH23 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the frequency of mutations in COL6A3 coupled with gains in PTPRN2 in Skin Cutaneous Melanoma?How often do mutations in COL6A3 and amplifications in PTPRN2 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the frequency of mutations in ADRA1A coupled with gains in PTPRN2 in Stomach Adenocarcinoma?How often do mutations in ADRA1A and amplifications in PTPRN2 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of mutations in LAMB2 coupled with gains in ICE1 in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?How often do mutations in LAMB2 and amplifications in ICE1 happen in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the frequency of mutations in POC1B coupled with gains in EPRS1 in Rectum Adenocarcinoma?How often do mutations in POC1B and amplifications in EPRS1 happen in Rectum Adenocarcinoma?,cnv_and_ssm
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the frequency of mutations in POC1B coupled with gains in ZFAT in Rectum Adenocarcinoma?How often do mutations in POC1B and amplifications in ZFAT happen in Rectum Adenocarcinoma?,cnv_and_ssm
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the frequency of mutations in POC1B coupled with gains in ADAM17 in Rectum Adenocarcinoma?How often do mutations in POC1B and amplifications in ADAM17 happen in Rectum Adenocarcinoma?,cnv_and_ssm
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the frequency of mutations in POC1B coupled with gains in RIMS2 in Rectum Adenocarcinoma?How often do mutations in POC1B and amplifications in RIMS2 happen in Rectum Adenocarcinoma?,cnv_and_ssm
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the frequency of mutations in USH2A coupled with gains in TENM2 in Liver Hepatocellular Carcinoma?How often do mutations in USH2A and amplifications in TENM2 happen in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the frequency of mutations in AQP7 coupled with gains in POC1B in Rectum Adenocarcinoma?How often do mutations in AQP7 and amplifications in POC1B happen in Rectum Adenocarcinoma?,cnv_and_ssm
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the frequency of mutations in AQP7 coupled with gains in ACTB in Rectum Adenocarcinoma?How often do mutations in AQP7 and amplifications in ACTB happen in Rectum Adenocarcinoma?,cnv_and_ssm
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the frequency of mutations in AQP7 coupled with gains in DCAF6 in Rectum Adenocarcinoma?How often do mutations in AQP7 and amplifications in DCAF6 happen in Rectum Adenocarcinoma?,cnv_and_ssm
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the frequency of mutations in AQP7 coupled with gains in RAB40C in Rectum Adenocarcinoma?How often do mutations in AQP7 and amplifications in RAB40C happen in Rectum Adenocarcinoma?,cnv_and_ssm
+430,DCN,R163C,Rectum Adenocarcinoma,What is the frequency of mutations in DCN coupled with gains in NCKAP5 in Rectum Adenocarcinoma?How often do mutations in DCN and amplifications in NCKAP5 happen in Rectum Adenocarcinoma?,cnv_and_ssm
+431,DCN,R203C,Rectum Adenocarcinoma,What is the frequency of mutations in DCN coupled with gains in PHLPP1 in Rectum Adenocarcinoma?How often do mutations in DCN and amplifications in PHLPP1 happen in Rectum Adenocarcinoma?,cnv_and_ssm
+432,DCN,R241C,Rectum Adenocarcinoma,What is the frequency of mutations in DCN coupled with gains in OLFML3 in Rectum Adenocarcinoma?How often do mutations in DCN and amplifications in OLFML3 happen in Rectum Adenocarcinoma?,cnv_and_ssm
+433,DCN,R350C,Rectum Adenocarcinoma,What is the frequency of mutations in DCN coupled with gains in COL6A3 in Rectum Adenocarcinoma?How often do mutations in DCN and amplifications in COL6A3 happen in Rectum Adenocarcinoma?,cnv_and_ssm
+434,DCN,R41C,Rectum Adenocarcinoma,What is the frequency of mutations in DCN coupled with gains in AUTS2 in Rectum Adenocarcinoma?How often do mutations in DCN and amplifications in AUTS2 happen in Rectum Adenocarcinoma?,cnv_and_ssm
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in CPS1 coupled with gains in GSTCD in Uterine Corpus Endometrial Carcinoma?How often do mutations in CPS1 and amplifications in GSTCD happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in CPS1 coupled with gains in ZFAT in Uterine Corpus Endometrial Carcinoma?How often do mutations in CPS1 and amplifications in ZFAT happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in CPS1 coupled with gains in CDH23 in Uterine Corpus Endometrial Carcinoma?How often do mutations in CPS1 and amplifications in CDH23 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the frequency of mutations in FCGR2C coupled with gains in CDKN2AIP in Kidney Renal Papillary Cell Carcinoma?How often do mutations in FCGR2C and amplifications in CDKN2AIP happen in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the frequency of mutations in FCGR2C coupled with gains in SYT10 in Kidney Renal Papillary Cell Carcinoma?How often do mutations in FCGR2C and amplifications in SYT10 happen in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in GRM1 coupled with gains in CA9 in Uterine Corpus Endometrial Carcinoma?How often do mutations in GRM1 and amplifications in CA9 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the frequency of mutations in SGCZ coupled with gains in CTNNA2 in Lung Adenocarcinoma?How often do mutations in SGCZ and amplifications in CTNNA2 happen in Lung Adenocarcinoma?,cnv_and_ssm
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the frequency of mutations in SGCZ coupled with gains in CFAP61 in Lung Adenocarcinoma?How often do mutations in SGCZ and amplifications in CFAP61 happen in Lung Adenocarcinoma?,cnv_and_ssm
+485,SMO,V15M,Stomach Adenocarcinoma,What is the frequency of mutations in SMO coupled with gains in DSCAM in Stomach Adenocarcinoma?How often do mutations in SMO and amplifications in DSCAM happen in Stomach Adenocarcinoma?,cnv_and_ssm
+486,SMO,V321M,Stomach Adenocarcinoma,What is the frequency of mutations in SMO coupled with gains in TTC12 in Stomach Adenocarcinoma?How often do mutations in SMO and amplifications in TTC12 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the frequency of mutations in CHODL coupled with gains in ACTL7B in Skin Cutaneous Melanoma?How often do mutations in CHODL and amplifications in ACTL7B happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the frequency of mutations in CHODL coupled with gains in TRIM45 in Skin Cutaneous Melanoma?How often do mutations in CHODL and amplifications in TRIM45 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the frequency of mutations in CHODL coupled with gains in TRPA1 in Skin Cutaneous Melanoma?How often do mutations in CHODL and amplifications in TRPA1 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+494,MYO16,P399H,Colon Adenocarcinoma,What is the frequency of mutations in MYO16 coupled with gains in CARMIL1 in Colon Adenocarcinoma?How often do mutations in MYO16 and amplifications in CARMIL1 happen in Colon Adenocarcinoma?,cnv_and_ssm
+495,MYO16,P421H,Colon Adenocarcinoma,What is the frequency of mutations in MYO16 coupled with gains in MYH11 in Colon Adenocarcinoma?How often do mutations in MYO16 and amplifications in MYH11 happen in Colon Adenocarcinoma?,cnv_and_ssm
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the frequency of mutations in CXCR2 coupled with gains in PSG2 in Stomach Adenocarcinoma?How often do mutations in CXCR2 and amplifications in PSG2 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the frequency of mutations in TMEM225 coupled with gains in AQP7 in Bladder Urothelial Carcinoma?How often do mutations in TMEM225 and amplifications in AQP7 happen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in MAOB coupled with gains in SOX21 in Uterine Corpus Endometrial Carcinoma?How often do mutations in MAOB and amplifications in SOX21 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in GPRASP1 coupled with gains in ZNF274 in Uterine Corpus Endometrial Carcinoma?How often do mutations in GPRASP1 and amplifications in ZNF274 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in MRPL32 coupled with gains in ANP32E in Uterine Corpus Endometrial Carcinoma?How often do mutations in MRPL32 and amplifications in ANP32E happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in TYROBP coupled with gains in SGIP1 in Uterine Corpus Endometrial Carcinoma?How often do mutations in TYROBP and amplifications in SGIP1 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the frequency of mutations in RAB40C coupled with gains in COL6A3 in Lung Adenocarcinoma?How often do mutations in RAB40C and amplifications in COL6A3 happen in Lung Adenocarcinoma?,cnv_and_ssm
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the frequency of mutations in RAB40C coupled with gains in PIK3C2B in Lung Adenocarcinoma?How often do mutations in RAB40C and amplifications in PIK3C2B happen in Lung Adenocarcinoma?,cnv_and_ssm
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the frequency of mutations in CTNNA2 coupled with gains in DNAH14 in Lung Adenocarcinoma?How often do mutations in CTNNA2 and amplifications in DNAH14 happen in Lung Adenocarcinoma?,cnv_and_ssm
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the frequency of mutations in CTNNA2 coupled with gains in DPF3 in Lung Adenocarcinoma?How often do mutations in CTNNA2 and amplifications in DPF3 happen in Lung Adenocarcinoma?,cnv_and_ssm
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the frequency of mutations in CTNNA2 coupled with gains in USH2A in Lung Adenocarcinoma?How often do mutations in CTNNA2 and amplifications in USH2A happen in Lung Adenocarcinoma?,cnv_and_ssm
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the frequency of mutations in CTNNA2 coupled with gains in CEP20 in Lung Adenocarcinoma?How often do mutations in CTNNA2 and amplifications in CEP20 happen in Lung Adenocarcinoma?,cnv_and_ssm
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the frequency of mutations in MYO15A coupled with gains in TTN in Bladder Urothelial Carcinoma?How often do mutations in MYO15A and amplifications in TTN happen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the frequency of mutations in GIMAP2 coupled with gains in AUTS2 in Skin Cutaneous Melanoma?How often do mutations in GIMAP2 and amplifications in AUTS2 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the frequency of mutations in KIF20B coupled with gains in TNS1 in Glioblastoma Multiforme?How often do mutations in KIF20B and amplifications in TNS1 happen in Glioblastoma Multiforme?,cnv_and_ssm
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the frequency of mutations in KIF20B coupled with gains in SPINDOC in Glioblastoma Multiforme?How often do mutations in KIF20B and amplifications in SPINDOC happen in Glioblastoma Multiforme?,cnv_and_ssm
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in ADAM17 coupled with gains in SORCS1 in Uterine Corpus Endometrial Carcinoma?How often do mutations in ADAM17 and amplifications in SORCS1 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in BCAT1 coupled with gains in ADRA1A in Uterine Corpus Endometrial Carcinoma?How often do mutations in BCAT1 and amplifications in ADRA1A happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in BCAT1 coupled with gains in CR1 in Uterine Corpus Endometrial Carcinoma?How often do mutations in BCAT1 and amplifications in CR1 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in BCAT1 coupled with gains in SORCS1 in Uterine Corpus Endometrial Carcinoma?How often do mutations in BCAT1 and amplifications in SORCS1 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the frequency of mutations in ERCC6 coupled with gains in SYNJ1 in Colon Adenocarcinoma?How often do mutations in ERCC6 and amplifications in SYNJ1 happen in Colon Adenocarcinoma?,cnv_and_ssm
+541,DCC,R320W,Breast Invasive Carcinoma,What is the frequency of mutations in DCC coupled with gains in DNMT1 in Breast Invasive Carcinoma?How often do mutations in DCC and amplifications in DNMT1 happen in Breast Invasive Carcinoma?,cnv_and_ssm
+542,DCC,R363W,Breast Invasive Carcinoma,What is the frequency of mutations in DCC coupled with gains in ITPRID2 in Breast Invasive Carcinoma?How often do mutations in DCC and amplifications in ITPRID2 happen in Breast Invasive Carcinoma?,cnv_and_ssm
+543,DCC,R386W,Breast Invasive Carcinoma,What is the frequency of mutations in DCC coupled with gains in ANKRD24 in Breast Invasive Carcinoma?How often do mutations in DCC and amplifications in ANKRD24 happen in Breast Invasive Carcinoma?,cnv_and_ssm
+544,DCC,R41W,Breast Invasive Carcinoma,What is the frequency of mutations in DCC coupled with gains in ANP32E in Breast Invasive Carcinoma?How often do mutations in DCC and amplifications in ANP32E happen in Breast Invasive Carcinoma?,cnv_and_ssm
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the frequency of mutations in FBXO15 coupled with gains in FRY in Skin Cutaneous Melanoma?How often do mutations in FBXO15 and amplifications in FRY happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the frequency of mutations in FBXO15 coupled with gains in DGKD in Skin Cutaneous Melanoma?How often do mutations in FBXO15 and amplifications in DGKD happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in GSTCD coupled with gains in AUTS2 in Uterine Corpus Endometrial Carcinoma?How often do mutations in GSTCD and amplifications in AUTS2 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in GSTCD coupled with gains in TLK2 in Uterine Corpus Endometrial Carcinoma?How often do mutations in GSTCD and amplifications in TLK2 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the frequency of mutations in OLFML3 coupled with gains in CA9 in Lung Squamous Cell Carcinoma?How often do mutations in OLFML3 and amplifications in CA9 happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the frequency of mutations in OLFML3 coupled with gains in PGF in Lung Squamous Cell Carcinoma?How often do mutations in OLFML3 and amplifications in PGF happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the frequency of mutations in OLFML3 coupled with gains in YY1AP1 in Lung Squamous Cell Carcinoma?How often do mutations in OLFML3 and amplifications in YY1AP1 happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the frequency of mutations in CFAP61 coupled with gains in SYNJ1 in Ovarian Serous Cystadenocarcinoma?How often do mutations in CFAP61 and amplifications in SYNJ1 happen in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the frequency of mutations in CFAP61 coupled with gains in BICC1 in Ovarian Serous Cystadenocarcinoma?How often do mutations in CFAP61 and amplifications in BICC1 happen in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the frequency of mutations in HLA-DQA2 coupled with gains in PYHIN1 in Bladder Urothelial Carcinoma?How often do mutations in HLA-DQA2 and amplifications in PYHIN1 happen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the frequency of mutations in TENM2 coupled with gains in DSCAM in Skin Cutaneous Melanoma?How often do mutations in TENM2 and amplifications in DSCAM happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the frequency of mutations in TENM2 coupled with gains in SORCS1 in Skin Cutaneous Melanoma?How often do mutations in TENM2 and amplifications in SORCS1 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the frequency of mutations in TENM2 coupled with gains in CEP20 in Skin Cutaneous Melanoma?How often do mutations in TENM2 and amplifications in CEP20 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the frequency of mutations in ANKRD24 coupled with gains in VASN in Stomach Adenocarcinoma?How often do mutations in ANKRD24 and amplifications in VASN happen in Stomach Adenocarcinoma?,cnv_and_ssm
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the frequency of mutations in ANKRD24 coupled with gains in ANP32E in Stomach Adenocarcinoma?How often do mutations in ANKRD24 and amplifications in ANP32E happen in Stomach Adenocarcinoma?,cnv_and_ssm
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the frequency of mutations in ANKRD24 coupled with gains in SPATA22 in Stomach Adenocarcinoma?How often do mutations in ANKRD24 and amplifications in SPATA22 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the frequency of mutations in ZCCHC14 coupled with gains in TASOR2 in Stomach Adenocarcinoma?How often do mutations in ZCCHC14 and amplifications in TASOR2 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the frequency of mutations in ZCCHC14 coupled with gains in CCNG1 in Stomach Adenocarcinoma?How often do mutations in ZCCHC14 and amplifications in CCNG1 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the frequency of mutations in ZCCHC14 coupled with gains in ZMYM3 in Stomach Adenocarcinoma?How often do mutations in ZCCHC14 and amplifications in ZMYM3 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the frequency of mutations in ZCCHC14 coupled with gains in POC1B in Stomach Adenocarcinoma?How often do mutations in ZCCHC14 and amplifications in POC1B happen in Stomach Adenocarcinoma?,cnv_and_ssm
+625,SIK2,I265M,Lung Adenocarcinoma,What is the frequency of mutations in SIK2 coupled with gains in TENM2 in Lung Adenocarcinoma?How often do mutations in SIK2 and amplifications in TENM2 happen in Lung Adenocarcinoma?,cnv_and_ssm
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in MYH11 coupled with gains in MRPL32 in Uterine Corpus Endometrial Carcinoma?How often do mutations in MYH11 and amplifications in MRPL32 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in MYH11 coupled with gains in DNMT1 in Uterine Corpus Endometrial Carcinoma?How often do mutations in MYH11 and amplifications in DNMT1 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the frequency of mutations in SLC6A4 coupled with gains in SOX21 in Skin Cutaneous Melanoma?How often do mutations in SLC6A4 and amplifications in SOX21 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in SLC9C1 coupled with gains in NRAP in Uterine Corpus Endometrial Carcinoma?How often do mutations in SLC9C1 and amplifications in NRAP happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in SLC9C1 coupled with gains in TMTC3 in Uterine Corpus Endometrial Carcinoma?How often do mutations in SLC9C1 and amplifications in TMTC3 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the frequency of mutations in OR2A12 coupled with gains in CHODL in Brain Lower Grade Glioma?How often do mutations in OR2A12 and amplifications in CHODL happen in Brain Lower Grade Glioma?,cnv_and_ssm
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the frequency of mutations in PYHIN1 coupled with gains in CTCFL in Lung Adenocarcinoma?How often do mutations in PYHIN1 and amplifications in CTCFL happen in Lung Adenocarcinoma?,cnv_and_ssm
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the frequency of mutations in PYHIN1 coupled with gains in SMO in Lung Adenocarcinoma?How often do mutations in PYHIN1 and amplifications in SMO happen in Lung Adenocarcinoma?,cnv_and_ssm
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the frequency of mutations in JAML coupled with gains in DHX16 in Skin Cutaneous Melanoma?How often do mutations in JAML and amplifications in DHX16 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the frequency of mutations in JAML coupled with gains in ZNF431 in Skin Cutaneous Melanoma?How often do mutations in JAML and amplifications in ZNF431 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the frequency of mutations in JAML coupled with gains in MRPL32 in Skin Cutaneous Melanoma?How often do mutations in JAML and amplifications in MRPL32 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the frequency of mutations in JAML coupled with gains in ACTL7B in Skin Cutaneous Melanoma?How often do mutations in JAML and amplifications in ACTL7B happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the frequency of mutations in TYK2 coupled with gains in ERCC6 in Stomach Adenocarcinoma?How often do mutations in TYK2 and amplifications in ERCC6 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the frequency of mutations in TYK2 coupled with gains in PSG2 in Stomach Adenocarcinoma?How often do mutations in TYK2 and amplifications in PSG2 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the frequency of mutations in TYK2 coupled with gains in COL6A3 in Stomach Adenocarcinoma?How often do mutations in TYK2 and amplifications in COL6A3 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in CTCFL coupled with gains in GSTCD in Uterine Corpus Endometrial Carcinoma?How often do mutations in CTCFL and amplifications in GSTCD happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in CTCFL coupled with gains in DSCAM in Uterine Corpus Endometrial Carcinoma?How often do mutations in CTCFL and amplifications in DSCAM happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in CTCFL coupled with gains in FGF8 in Uterine Corpus Endometrial Carcinoma?How often do mutations in CTCFL and amplifications in FGF8 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in CTCFL coupled with gains in ANKRD24 in Uterine Corpus Endometrial Carcinoma?How often do mutations in CTCFL and amplifications in ANKRD24 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in CEP20 coupled with gains in SPTAN1 in Uterine Corpus Endometrial Carcinoma?How often do mutations in CEP20 and amplifications in SPTAN1 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in CEP20 coupled with gains in PRSS8 in Uterine Corpus Endometrial Carcinoma?How often do mutations in CEP20 and amplifications in PRSS8 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the frequency of mutations in RIMS2 coupled with gains in FRY in Skin Cutaneous Melanoma?How often do mutations in RIMS2 and amplifications in FRY happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the frequency of mutations in RIMS2 coupled with gains in FGF8 in Skin Cutaneous Melanoma?How often do mutations in RIMS2 and amplifications in FGF8 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the frequency of mutations in RIMS2 coupled with gains in CASZ1 in Skin Cutaneous Melanoma?How often do mutations in RIMS2 and amplifications in CASZ1 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the frequency of mutations in RIMS2 coupled with gains in ACTB in Skin Cutaneous Melanoma?How often do mutations in RIMS2 and amplifications in ACTB happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the frequency of mutations in RIMS2 coupled with gains in NOMO1 in Skin Cutaneous Melanoma?How often do mutations in RIMS2 and amplifications in NOMO1 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the frequency of mutations in RIMS2 coupled with gains in GRM1 in Skin Cutaneous Melanoma?How often do mutations in RIMS2 and amplifications in GRM1 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the frequency of mutations in RIMS2 coupled with gains in LAMB2 in Skin Cutaneous Melanoma?How often do mutations in RIMS2 and amplifications in LAMB2 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the frequency of mutations in PIK3C2G coupled with gains in MYO16 in Skin Cutaneous Melanoma?How often do mutations in PIK3C2G and amplifications in MYO16 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the frequency of mutations in PIK3C2G coupled with gains in ARHGEF40 in Skin Cutaneous Melanoma?How often do mutations in PIK3C2G and amplifications in ARHGEF40 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+728,STK19,D341N,Colon Adenocarcinoma,What is the frequency of mutations in STK19 coupled with gains in FRY in Colon Adenocarcinoma?How often do mutations in STK19 and amplifications in FRY happen in Colon Adenocarcinoma?,cnv_and_ssm
+729,STK19,D345N,Colon Adenocarcinoma,What is the frequency of mutations in STK19 coupled with gains in CNGB1 in Colon Adenocarcinoma?How often do mutations in STK19 and amplifications in CNGB1 happen in Colon Adenocarcinoma?,cnv_and_ssm
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the frequency of mutations in REXO4 coupled with gains in AUTS2 in Skin Cutaneous Melanoma?How often do mutations in REXO4 and amplifications in AUTS2 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in ZBTB34 coupled with gains in ANP32E in Uterine Corpus Endometrial Carcinoma?How often do mutations in ZBTB34 and amplifications in ANP32E happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in ZBTB34 coupled with gains in CTSC in Uterine Corpus Endometrial Carcinoma?How often do mutations in ZBTB34 and amplifications in CTSC happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the frequency of mutations in NCKAP5 coupled with gains in PCDHB2 in Bladder Urothelial Carcinoma?How often do mutations in NCKAP5 and amplifications in PCDHB2 happen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of mutations in SORCS1 coupled with gains in PAK3 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?How often do mutations in SORCS1 and amplifications in PAK3 happen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of mutations in SORCS1 coupled with gains in VASN in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?How often do mutations in SORCS1 and amplifications in VASN happen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of mutations in SORCS1 coupled with gains in TENT5A in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?How often do mutations in SORCS1 and amplifications in TENT5A happen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of mutations in SORCS1 coupled with gains in PXN in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?How often do mutations in SORCS1 and amplifications in PXN happen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the frequency of mutations in FGF8 coupled with gains in CEP20 in Head and Neck Squamous Cell Carcinoma?How often do mutations in FGF8 and amplifications in CEP20 happen in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the frequency of mutations in FGF8 coupled with gains in DCLK3 in Head and Neck Squamous Cell Carcinoma?How often do mutations in FGF8 and amplifications in DCLK3 happen in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the frequency of mutations in FGF8 coupled with gains in ITPRID2 in Head and Neck Squamous Cell Carcinoma?How often do mutations in FGF8 and amplifications in ITPRID2 happen in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the frequency of mutations in FGF8 coupled with gains in ZCCHC14 in Head and Neck Squamous Cell Carcinoma?How often do mutations in FGF8 and amplifications in ZCCHC14 happen in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the frequency of mutations in FGF8 coupled with gains in COL6A3 in Head and Neck Squamous Cell Carcinoma?How often do mutations in FGF8 and amplifications in COL6A3 happen in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the frequency of mutations in TENM3 coupled with gains in PTPRO in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?How often do mutations in TENM3 and amplifications in PTPRO happen in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,cnv_and_ssm
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in AKT1 coupled with gains in COL6A3 in Uterine Corpus Endometrial Carcinoma?How often do mutations in AKT1 and amplifications in COL6A3 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of mutations in CFAP298-TCP10L coupled with gains in DSCAM in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?How often do mutations in CFAP298-TCP10L and amplifications in DSCAM happen in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the frequency of mutations in GLRB coupled with gains in COL6A3 in Stomach Adenocarcinoma?How often do mutations in GLRB and amplifications in COL6A3 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+793,TTN,F7636L,Colon Adenocarcinoma,What is the frequency of mutations in TTN coupled with gains in PIK3C2B in Colon Adenocarcinoma?How often do mutations in TTN and amplifications in PIK3C2B happen in Colon Adenocarcinoma?,cnv_and_ssm
+794,TTN,F8563L,Colon Adenocarcinoma,What is the frequency of mutations in TTN coupled with gains in MUC16 in Colon Adenocarcinoma?How often do mutations in TTN and amplifications in MUC16 happen in Colon Adenocarcinoma?,cnv_and_ssm
+795,TTN,F8880L,Colon Adenocarcinoma,What is the frequency of mutations in TTN coupled with gains in SYNJ1 in Colon Adenocarcinoma?How often do mutations in TTN and amplifications in SYNJ1 happen in Colon Adenocarcinoma?,cnv_and_ssm
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the frequency of mutations in ANKRD30A coupled with gains in CHODL in Colon Adenocarcinoma?How often do mutations in ANKRD30A and amplifications in CHODL happen in Colon Adenocarcinoma?,cnv_and_ssm
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the frequency of mutations in ANKRD30A coupled with gains in AUTS2 in Colon Adenocarcinoma?How often do mutations in ANKRD30A and amplifications in AUTS2 happen in Colon Adenocarcinoma?,cnv_and_ssm
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the frequency of mutations in ANKRD30A coupled with gains in TAF1C in Colon Adenocarcinoma?How often do mutations in ANKRD30A and amplifications in TAF1C happen in Colon Adenocarcinoma?,cnv_and_ssm
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the frequency of mutations in TRIM45 coupled with gains in KDM5C in Colon Adenocarcinoma?How often do mutations in TRIM45 and amplifications in KDM5C happen in Colon Adenocarcinoma?,cnv_and_ssm
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the frequency of mutations in TRIM45 coupled with gains in KDM5C in Colon Adenocarcinoma?How often do mutations in TRIM45 and amplifications in KDM5C happen in Colon Adenocarcinoma?,cnv_and_ssm
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the frequency of mutations in TRIM45 coupled with gains in EBF2 in Colon Adenocarcinoma?How often do mutations in TRIM45 and amplifications in EBF2 happen in Colon Adenocarcinoma?,cnv_and_ssm
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the frequency of mutations in CACNA1F coupled with gains in SYNJ1 in Stomach Adenocarcinoma?How often do mutations in CACNA1F and amplifications in SYNJ1 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the frequency of mutations in CACNA1F coupled with gains in SGIP1 in Stomach Adenocarcinoma?How often do mutations in CACNA1F and amplifications in SGIP1 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the frequency of mutations in CACNA1F coupled with gains in PIK3C2B in Stomach Adenocarcinoma?How often do mutations in CACNA1F and amplifications in PIK3C2B happen in Stomach Adenocarcinoma?,cnv_and_ssm
+817,KL,R594C,Colon Adenocarcinoma,What is the frequency of mutations in KL coupled with gains in DCLK3 in Colon Adenocarcinoma?How often do mutations in KL and amplifications in DCLK3 happen in Colon Adenocarcinoma?,cnv_and_ssm
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the frequency of mutations in GUF1 coupled with gains in PIAS3 in Kidney Renal Papillary Cell Carcinoma?How often do mutations in GUF1 and amplifications in PIAS3 happen in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the frequency of mutations in TAF1L coupled with gains in CX3CR1 in Colon Adenocarcinoma?How often do mutations in TAF1L and amplifications in CX3CR1 happen in Colon Adenocarcinoma?,cnv_and_ssm
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the frequency of mutations in TASOR2 coupled with gains in TTC17 in Skin Cutaneous Melanoma?How often do mutations in TASOR2 and amplifications in TTC17 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the frequency of mutations in TASOR2 coupled with gains in SERPINB10 in Skin Cutaneous Melanoma?How often do mutations in TASOR2 and amplifications in SERPINB10 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the frequency of mutations in TASOR2 coupled with gains in MYO3B in Skin Cutaneous Melanoma?How often do mutations in TASOR2 and amplifications in MYO3B happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the frequency of mutations in KDM5C coupled with gains in PKHD1L1 in Skin Cutaneous Melanoma?How often do mutations in KDM5C and amplifications in PKHD1L1 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the frequency of mutations in KDM5C coupled with gains in CFAP61 in Skin Cutaneous Melanoma?How often do mutations in KDM5C and amplifications in CFAP61 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the frequency of mutations in KDM5C coupled with gains in TAF1C in Skin Cutaneous Melanoma?How often do mutations in KDM5C and amplifications in TAF1C happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the frequency of mutations in KDM5C coupled with gains in EIF2B4 in Skin Cutaneous Melanoma?How often do mutations in KDM5C and amplifications in EIF2B4 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of mutations in IL5RA coupled with gains in DHX16 in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?How often do mutations in IL5RA and amplifications in DHX16 happen in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the frequency of mutations in DHX16 coupled with gains in RIMS2 in Skin Cutaneous Melanoma?How often do mutations in DHX16 and amplifications in RIMS2 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the frequency of mutations in DHX16 coupled with gains in TTN in Skin Cutaneous Melanoma?How often do mutations in DHX16 and amplifications in TTN happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the frequency of mutations in GPR158 coupled with gains in NPSR1 in Stomach Adenocarcinoma?How often do mutations in GPR158 and amplifications in NPSR1 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the frequency of mutations in GPR158 coupled with gains in ACTB in Stomach Adenocarcinoma?How often do mutations in GPR158 and amplifications in ACTB happen in Stomach Adenocarcinoma?,cnv_and_ssm
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of mutations in EIF2B4 coupled with gains in HYOU1 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?How often do mutations in EIF2B4 and amplifications in HYOU1 happen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of mutations in EIF2B4 coupled with gains in CTNNA2 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?How often do mutations in EIF2B4 and amplifications in CTNNA2 happen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of mutations in EIF2B4 coupled with gains in YY1AP1 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?How often do mutations in EIF2B4 and amplifications in YY1AP1 happen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of mutations in EIF2B4 coupled with gains in TMEM255A in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?How often do mutations in EIF2B4 and amplifications in TMEM255A happen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of mutations in EIF2B4 coupled with gains in OLFML3 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?How often do mutations in EIF2B4 and amplifications in OLFML3 happen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of mutations in EIF2B4 coupled with gains in NEXN in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?How often do mutations in EIF2B4 and amplifications in NEXN happen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the frequency of mutations in AUTS2 coupled with gains in CDKN2AIP in Lung Squamous Cell Carcinoma?How often do mutations in AUTS2 and amplifications in CDKN2AIP happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the frequency of mutations in AUTS2 coupled with gains in DHX16 in Lung Squamous Cell Carcinoma?How often do mutations in AUTS2 and amplifications in DHX16 happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the frequency of mutations in AUTS2 coupled with gains in TNS1 in Lung Squamous Cell Carcinoma?How often do mutations in AUTS2 and amplifications in TNS1 happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the frequency of mutations in AUTS2 coupled with gains in SGIP1 in Lung Squamous Cell Carcinoma?How often do mutations in AUTS2 and amplifications in SGIP1 happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the frequency of mutations in AUTS2 coupled with gains in MYT1 in Lung Squamous Cell Carcinoma?How often do mutations in AUTS2 and amplifications in MYT1 happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the frequency of mutations in AUTS2 coupled with gains in CTCFL in Lung Squamous Cell Carcinoma?How often do mutations in AUTS2 and amplifications in CTCFL happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the frequency of mutations in AUTS2 coupled with gains in TLK2 in Lung Squamous Cell Carcinoma?How often do mutations in AUTS2 and amplifications in TLK2 happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the frequency of mutations in AUTS2 coupled with gains in TENT5A in Lung Squamous Cell Carcinoma?How often do mutations in AUTS2 and amplifications in TENT5A happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the frequency of mutations in AUTS2 coupled with gains in AUTS2 in Lung Squamous Cell Carcinoma?How often do mutations in AUTS2 and amplifications in AUTS2 happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the frequency of mutations in AUTS2 coupled with gains in MAST4 in Lung Squamous Cell Carcinoma?How often do mutations in AUTS2 and amplifications in MAST4 happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of mutations in ACTL7B coupled with gains in ZNF274 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?How often do mutations in ACTL7B and amplifications in ZNF274 happen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the frequency of mutations in PCDHGA1 coupled with gains in TLK2 in Glioblastoma Multiforme?How often do mutations in PCDHGA1 and amplifications in TLK2 happen in Glioblastoma Multiforme?,cnv_and_ssm
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the frequency of mutations in TRAP1 coupled with gains in ICE1 in Stomach Adenocarcinoma?How often do mutations in TRAP1 and amplifications in ICE1 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the frequency of mutations in TRAP1 coupled with gains in TAF1C in Stomach Adenocarcinoma?How often do mutations in TRAP1 and amplifications in TAF1C happen in Stomach Adenocarcinoma?,cnv_and_ssm
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in PIK3C2A coupled with gains in GABRA6 in Uterine Corpus Endometrial Carcinoma?How often do mutations in PIK3C2A and amplifications in GABRA6 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the frequency of mutations in KANSL1 coupled with gains in CYP1A2 in Liver Hepatocellular Carcinoma?How often do mutations in KANSL1 and amplifications in CYP1A2 happen in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the frequency of mutations in ANKRD52 coupled with gains in CDKN2AIP in Stomach Adenocarcinoma?How often do mutations in ANKRD52 and amplifications in CDKN2AIP happen in Stomach Adenocarcinoma?,cnv_and_ssm
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in PAPPA coupled with gains in PXN in Uterine Corpus Endometrial Carcinoma?How often do mutations in PAPPA and amplifications in PXN happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the frequency of mutations in B3GALNT1 coupled with gains in AQP7 in Rectum Adenocarcinoma?How often do mutations in B3GALNT1 and amplifications in AQP7 happen in Rectum Adenocarcinoma?,cnv_and_ssm
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the frequency of mutations in GABRA6 coupled with gains in SGIP1 in Lung Adenocarcinoma?How often do mutations in GABRA6 and amplifications in SGIP1 happen in Lung Adenocarcinoma?,cnv_and_ssm
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the frequency of mutations in GABRA6 coupled with gains in USH2A in Lung Adenocarcinoma?How often do mutations in GABRA6 and amplifications in USH2A happen in Lung Adenocarcinoma?,cnv_and_ssm
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the frequency of mutations in GABRA6 coupled with gains in BCAT1 in Lung Adenocarcinoma?How often do mutations in GABRA6 and amplifications in BCAT1 happen in Lung Adenocarcinoma?,cnv_and_ssm
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the frequency of mutations in GABRA6 coupled with gains in TYROBP in Lung Adenocarcinoma?How often do mutations in GABRA6 and amplifications in TYROBP happen in Lung Adenocarcinoma?,cnv_and_ssm
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the frequency of mutations in GABRA6 coupled with gains in DNAH14 in Lung Adenocarcinoma?How often do mutations in GABRA6 and amplifications in DNAH14 happen in Lung Adenocarcinoma?,cnv_and_ssm
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the frequency of mutations in ZSCAN31 coupled with gains in AKT1 in Skin Cutaneous Melanoma?How often do mutations in ZSCAN31 and amplifications in AKT1 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of mutations in MED16 coupled with gains in ZCCHC14 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?How often do mutations in MED16 and amplifications in ZCCHC14 happen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of mutations in MED16 coupled with gains in GRM5 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?How often do mutations in MED16 and amplifications in GRM5 happen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the frequency of mutations in PTPRO coupled with gains in ANKDD1A in Pancreatic Adenocarcinoma?How often do mutations in PTPRO and amplifications in ANKDD1A happen in Pancreatic Adenocarcinoma?,cnv_and_ssm
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the frequency of mutations in PTPRO coupled with gains in DCC in Pancreatic Adenocarcinoma?How often do mutations in PTPRO and amplifications in DCC happen in Pancreatic Adenocarcinoma?,cnv_and_ssm
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the frequency of mutations in PTPRO coupled with gains in DNAH14 in Pancreatic Adenocarcinoma?How often do mutations in PTPRO and amplifications in DNAH14 happen in Pancreatic Adenocarcinoma?,cnv_and_ssm
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the frequency of mutations in PTPRO coupled with gains in OR13C3 in Pancreatic Adenocarcinoma?How often do mutations in PTPRO and amplifications in OR13C3 happen in Pancreatic Adenocarcinoma?,cnv_and_ssm
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the frequency of mutations in PTPRO coupled with gains in CARMIL1 in Pancreatic Adenocarcinoma?How often do mutations in PTPRO and amplifications in CARMIL1 happen in Pancreatic Adenocarcinoma?,cnv_and_ssm
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the frequency of mutations in PTPRO coupled with gains in CTSC in Pancreatic Adenocarcinoma?How often do mutations in PTPRO and amplifications in CTSC happen in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the frequency of mutations in PTPRO coupled with gains in TAF1C in Pancreatic Adenocarcinoma?How often do mutations in PTPRO and amplifications in TAF1C happen in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the frequency of mutations in PTPRO coupled with gains in SYT9 in Pancreatic Adenocarcinoma?How often do mutations in PTPRO and amplifications in SYT9 happen in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in CHMP7 coupled with gains in TNS1 in Uterine Corpus Endometrial Carcinoma?How often do mutations in CHMP7 and amplifications in TNS1 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the frequency of mutations in GPC3 coupled with gains in GUK1 in Stomach Adenocarcinoma?How often do mutations in GPC3 and amplifications in GUK1 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the frequency of mutations in GPC3 coupled with gains in OLFML3 in Stomach Adenocarcinoma?How often do mutations in GPC3 and amplifications in OLFML3 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of mutations in TLK2 coupled with gains in TNS1 in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?How often do mutations in TLK2 and amplifications in TNS1 happen in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of mutations in TLK2 coupled with gains in TNS1 in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?How often do mutations in TLK2 and amplifications in TNS1 happen in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of mutations in TLK2 coupled with gains in PTPRO in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?How often do mutations in TLK2 and amplifications in PTPRO happen in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of mutations in TLK2 coupled with gains in ANP32E in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?How often do mutations in TLK2 and amplifications in ANP32E happen in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the frequency of mutations in TLK2 coupled with gains in POLR1G in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?How often do mutations in TLK2 and amplifications in POLR1G happen in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the frequency of mutations in ZNF217 coupled with gains in PTPRN2 in Lung Adenocarcinoma?How often do mutations in ZNF217 and amplifications in PTPRN2 happen in Lung Adenocarcinoma?,cnv_and_ssm
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the frequency of mutations in SYT9 coupled with gains in ANKRD24 in Lung Adenocarcinoma?How often do mutations in SYT9 and amplifications in ANKRD24 happen in Lung Adenocarcinoma?,cnv_and_ssm
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the frequency of mutations in SYT9 coupled with gains in CTSC in Lung Adenocarcinoma?How often do mutations in SYT9 and amplifications in CTSC happen in Lung Adenocarcinoma?,cnv_and_ssm
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the frequency of mutations in PKHD1L1 coupled with gains in KDM5C in Lung Squamous Cell Carcinoma?How often do mutations in PKHD1L1 and amplifications in KDM5C happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the frequency of mutations in MYO3A coupled with gains in PIAS3 in Lung Squamous Cell Carcinoma?How often do mutations in MYO3A and amplifications in PIAS3 happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of mutations in VASN coupled with gains in STAT3 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?How often do mutations in VASN and amplifications in STAT3 happen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in DNMT1 coupled with gains in RIMS2 in Uterine Corpus Endometrial Carcinoma?How often do mutations in DNMT1 and amplifications in RIMS2 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in DNMT1 coupled with gains in NOMO1 in Uterine Corpus Endometrial Carcinoma?How often do mutations in DNMT1 and amplifications in NOMO1 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in DNMT1 coupled with gains in AQP7 in Uterine Corpus Endometrial Carcinoma?How often do mutations in DNMT1 and amplifications in AQP7 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1056,CA9,E402K,Colon Adenocarcinoma,What is the frequency of mutations in CA9 coupled with gains in EPRS1 in Colon Adenocarcinoma?How often do mutations in CA9 and amplifications in EPRS1 happen in Colon Adenocarcinoma?,cnv_and_ssm
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in TTC17 coupled with gains in CR1 in Uterine Corpus Endometrial Carcinoma?How often do mutations in TTC17 and amplifications in CR1 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in TTC17 coupled with gains in EVC2 in Uterine Corpus Endometrial Carcinoma?How often do mutations in TTC17 and amplifications in EVC2 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the frequency of mutations in PSG2 coupled with gains in SLC6A4 in Breast Invasive Carcinoma?How often do mutations in PSG2 and amplifications in SLC6A4 happen in Breast Invasive Carcinoma?,cnv_and_ssm
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the frequency of mutations in RIPOR2 coupled with gains in TLK2 in Breast Invasive Carcinoma?How often do mutations in RIPOR2 and amplifications in TLK2 happen in Breast Invasive Carcinoma?,cnv_and_ssm
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the frequency of mutations in RIPOR2 coupled with gains in AUTS2 in Breast Invasive Carcinoma?How often do mutations in RIPOR2 and amplifications in AUTS2 happen in Breast Invasive Carcinoma?,cnv_and_ssm
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the frequency of mutations in RIPOR2 coupled with gains in KDM5C in Breast Invasive Carcinoma?How often do mutations in RIPOR2 and amplifications in KDM5C happen in Breast Invasive Carcinoma?,cnv_and_ssm
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the frequency of mutations in RIPOR2 coupled with gains in CARMIL1 in Breast Invasive Carcinoma?How often do mutations in RIPOR2 and amplifications in CARMIL1 happen in Breast Invasive Carcinoma?,cnv_and_ssm
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in DCLK3 coupled with gains in GRM5 in Uterine Corpus Endometrial Carcinoma?How often do mutations in DCLK3 and amplifications in GRM5 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in DCLK3 coupled with gains in TASOR2 in Uterine Corpus Endometrial Carcinoma?How often do mutations in DCLK3 and amplifications in TASOR2 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the frequency of mutations in MERTK coupled with gains in TET2 in Lung Squamous Cell Carcinoma?How often do mutations in MERTK and amplifications in TET2 happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the frequency of mutations in MERTK coupled with gains in CNGB1 in Lung Squamous Cell Carcinoma?How often do mutations in MERTK and amplifications in CNGB1 happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the frequency of mutations in MERTK coupled with gains in OR2T4 in Lung Squamous Cell Carcinoma?How often do mutations in MERTK and amplifications in OR2T4 happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the frequency of mutations in ZFP42 coupled with gains in EIF2B4 in Skin Cutaneous Melanoma?How often do mutations in ZFP42 and amplifications in EIF2B4 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the frequency of mutations in OR13C3 coupled with gains in UNC5D in Skin Cutaneous Melanoma?How often do mutations in OR13C3 and amplifications in UNC5D happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the frequency of mutations in OR13C3 coupled with gains in TTN in Skin Cutaneous Melanoma?How often do mutations in OR13C3 and amplifications in TTN happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the frequency of mutations in SPAG1 coupled with gains in ZSCAN31 in Stomach Adenocarcinoma?How often do mutations in SPAG1 and amplifications in ZSCAN31 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in CDKN2AIP coupled with gains in PRSS8 in Uterine Corpus Endometrial Carcinoma?How often do mutations in CDKN2AIP and amplifications in PRSS8 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the frequency of mutations in PXN coupled with gains in MED16 in Colon Adenocarcinoma?How often do mutations in PXN and amplifications in MED16 happen in Colon Adenocarcinoma?,cnv_and_ssm
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the frequency of mutations in PXN coupled with gains in MAST4 in Colon Adenocarcinoma?How often do mutations in PXN and amplifications in MAST4 happen in Colon Adenocarcinoma?,cnv_and_ssm
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the frequency of mutations in PXN coupled with gains in MYH11 in Colon Adenocarcinoma?How often do mutations in PXN and amplifications in MYH11 happen in Colon Adenocarcinoma?,cnv_and_ssm
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the frequency of mutations in PXN coupled with gains in NRAP in Colon Adenocarcinoma?How often do mutations in PXN and amplifications in NRAP happen in Colon Adenocarcinoma?,cnv_and_ssm
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the frequency of mutations in PXN coupled with gains in RIPOR2 in Colon Adenocarcinoma?How often do mutations in PXN and amplifications in RIPOR2 happen in Colon Adenocarcinoma?,cnv_and_ssm
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the frequency of mutations in PXN coupled with gains in AUTS2 in Colon Adenocarcinoma?How often do mutations in PXN and amplifications in AUTS2 happen in Colon Adenocarcinoma?,cnv_and_ssm
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in TTYH2 coupled with gains in SYNJ1 in Uterine Corpus Endometrial Carcinoma?How often do mutations in TTYH2 and amplifications in SYNJ1 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in TTYH2 coupled with gains in PTPRN2 in Uterine Corpus Endometrial Carcinoma?How often do mutations in TTYH2 and amplifications in PTPRN2 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the frequency of mutations in TMEM255A coupled with gains in ANKRD24 in Colon Adenocarcinoma?How often do mutations in TMEM255A and amplifications in ANKRD24 happen in Colon Adenocarcinoma?,cnv_and_ssm
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the frequency of mutations in TMEM255A coupled with gains in TRIM45 in Colon Adenocarcinoma?How often do mutations in TMEM255A and amplifications in TRIM45 happen in Colon Adenocarcinoma?,cnv_and_ssm
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the frequency of mutations in TMEM255A coupled with gains in DPF3 in Colon Adenocarcinoma?How often do mutations in TMEM255A and amplifications in DPF3 happen in Colon Adenocarcinoma?,cnv_and_ssm
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the frequency of mutations in TASOR2 coupled with gains in ZNF627 in Breast Invasive Carcinoma?How often do mutations in TASOR2 and amplifications in ZNF627 happen in Breast Invasive Carcinoma?,cnv_and_ssm
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the frequency of mutations in TASOR2 coupled with gains in HYOU1 in Breast Invasive Carcinoma?How often do mutations in TASOR2 and amplifications in HYOU1 happen in Breast Invasive Carcinoma?,cnv_and_ssm
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in ICE1 coupled with gains in ZNF217 in Uterine Corpus Endometrial Carcinoma?How often do mutations in ICE1 and amplifications in ZNF217 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the frequency of mutations in MYT1 coupled with gains in POC1B in Breast Invasive Carcinoma?How often do mutations in MYT1 and amplifications in POC1B happen in Breast Invasive Carcinoma?,cnv_and_ssm
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the frequency of mutations in MYT1 coupled with gains in ZNF431 in Breast Invasive Carcinoma?How often do mutations in MYT1 and amplifications in ZNF431 happen in Breast Invasive Carcinoma?,cnv_and_ssm
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the frequency of mutations in MYT1 coupled with gains in CPA6 in Breast Invasive Carcinoma?How often do mutations in MYT1 and amplifications in CPA6 happen in Breast Invasive Carcinoma?,cnv_and_ssm
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in CX3CR1 coupled with gains in CPS1 in Uterine Corpus Endometrial Carcinoma?How often do mutations in CX3CR1 and amplifications in CPS1 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in CX3CR1 coupled with gains in YY1AP1 in Uterine Corpus Endometrial Carcinoma?How often do mutations in CX3CR1 and amplifications in YY1AP1 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the frequency of mutations in SPINDOC coupled with gains in ICE1 in Liver Hepatocellular Carcinoma?How often do mutations in SPINDOC and amplifications in ICE1 happen in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in ART3 coupled with gains in MIEF1 in Uterine Corpus Endometrial Carcinoma?How often do mutations in ART3 and amplifications in MIEF1 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in ART3 coupled with gains in SGIP1 in Uterine Corpus Endometrial Carcinoma?How often do mutations in ART3 and amplifications in SGIP1 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the frequency of mutations in CYP1A2 coupled with gains in ANKRD52 in Bladder Urothelial Carcinoma?How often do mutations in CYP1A2 and amplifications in ANKRD52 happen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of mutations in ADRA1A coupled with gains in SYT9 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?How often do mutations in ADRA1A and amplifications in SYT9 happen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the frequency of mutations in CDH23 coupled with gains in FRY in Lung Squamous Cell Carcinoma?How often do mutations in CDH23 and amplifications in FRY happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the frequency of mutations in CDH23 coupled with gains in PCDHGA1 in Lung Squamous Cell Carcinoma?How often do mutations in CDH23 and amplifications in PCDHGA1 happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the frequency of mutations in KRT39 coupled with gains in PIK3C2B in Skin Cutaneous Melanoma?How often do mutations in KRT39 and amplifications in PIK3C2B happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the frequency of mutations in PDHA2 coupled with gains in NRAP in Lung Squamous Cell Carcinoma?How often do mutations in PDHA2 and amplifications in NRAP happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the frequency of mutations in SLC24A2 coupled with gains in DNMT1 in Colon Adenocarcinoma?How often do mutations in SLC24A2 and amplifications in DNMT1 happen in Colon Adenocarcinoma?,cnv_and_ssm
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the frequency of mutations in PTPRN2 coupled with gains in PIK3C2G in Liver Hepatocellular Carcinoma?How often do mutations in PTPRN2 and amplifications in PIK3C2G happen in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the frequency of mutations in PTPRN2 coupled with gains in KRT39 in Liver Hepatocellular Carcinoma?How often do mutations in PTPRN2 and amplifications in KRT39 happen in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the frequency of mutations in PTPRN2 coupled with gains in MYH11 in Liver Hepatocellular Carcinoma?How often do mutations in PTPRN2 and amplifications in MYH11 happen in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the frequency of mutations in PTPRN2 coupled with gains in UNC5D in Liver Hepatocellular Carcinoma?How often do mutations in PTPRN2 and amplifications in UNC5D happen in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the frequency of mutations in PTPRN2 coupled with gains in CARMIL1 in Liver Hepatocellular Carcinoma?How often do mutations in PTPRN2 and amplifications in CARMIL1 happen in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the frequency of mutations in SOX21 coupled with gains in CDH23 in Lung Adenocarcinoma?How often do mutations in SOX21 and amplifications in CDH23 happen in Lung Adenocarcinoma?,cnv_and_ssm
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the frequency of mutations in CPA6 coupled with gains in YY1AP1 in Bladder Urothelial Carcinoma?How often do mutations in CPA6 and amplifications in YY1AP1 happen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the frequency of mutations in GRM5 coupled with gains in DCC in Skin Cutaneous Melanoma?How often do mutations in GRM5 and amplifications in DCC happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of mutations in CASZ1 coupled with gains in DCC in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?How often do mutations in CASZ1 and amplifications in DCC happen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the frequency of mutations in SGIP1 coupled with gains in MSANTD4 in Stomach Adenocarcinoma?How often do mutations in SGIP1 and amplifications in MSANTD4 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the frequency of mutations in SGIP1 coupled with gains in DCN in Stomach Adenocarcinoma?How often do mutations in SGIP1 and amplifications in DCN happen in Stomach Adenocarcinoma?,cnv_and_ssm
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the frequency of mutations in SGIP1 coupled with gains in ZKSCAN7 in Stomach Adenocarcinoma?How often do mutations in SGIP1 and amplifications in ZKSCAN7 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the frequency of mutations in SGIP1 coupled with gains in NOMO1 in Stomach Adenocarcinoma?How often do mutations in SGIP1 and amplifications in NOMO1 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the frequency of mutations in CARMIL1 coupled with gains in ADRA1A in Lung Adenocarcinoma?How often do mutations in CARMIL1 and amplifications in ADRA1A happen in Lung Adenocarcinoma?,cnv_and_ssm
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the frequency of mutations in CARMIL1 coupled with gains in SPATA22 in Lung Adenocarcinoma?How often do mutations in CARMIL1 and amplifications in SPATA22 happen in Lung Adenocarcinoma?,cnv_and_ssm
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the frequency of mutations in ZNF431 coupled with gains in TENM2 in Lung Adenocarcinoma?How often do mutations in ZNF431 and amplifications in TENM2 happen in Lung Adenocarcinoma?,cnv_and_ssm
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the frequency of mutations in ZNF431 coupled with gains in ANKDD1A in Lung Adenocarcinoma?How often do mutations in ZNF431 and amplifications in ANKDD1A happen in Lung Adenocarcinoma?,cnv_and_ssm
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the frequency of mutations in ZNF431 coupled with gains in YY1AP1 in Lung Adenocarcinoma?How often do mutations in ZNF431 and amplifications in YY1AP1 happen in Lung Adenocarcinoma?,cnv_and_ssm
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the frequency of mutations in DNAH11 coupled with gains in SGCZ in Skin Cutaneous Melanoma?How often do mutations in DNAH11 and amplifications in SGCZ happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the frequency of mutations in DNAH11 coupled with gains in AUTS2 in Skin Cutaneous Melanoma?How often do mutations in DNAH11 and amplifications in AUTS2 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the frequency of mutations in POLD1 coupled with gains in TTC12 in Lung Squamous Cell Carcinoma?How often do mutations in POLD1 and amplifications in TTC12 happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the frequency of mutations in POLD1 coupled with gains in TAF1L in Lung Squamous Cell Carcinoma?How often do mutations in POLD1 and amplifications in TAF1L happen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the frequency of mutations in TTC12 coupled with gains in CFAP61 in Lung Adenocarcinoma?How often do mutations in TTC12 and amplifications in CFAP61 happen in Lung Adenocarcinoma?,cnv_and_ssm
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the frequency of mutations in TTC12 coupled with gains in PXN in Lung Adenocarcinoma?How often do mutations in TTC12 and amplifications in PXN happen in Lung Adenocarcinoma?,cnv_and_ssm
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the frequency of mutations in CNGB1 coupled with gains in HSPA5 in Bladder Urothelial Carcinoma?How often do mutations in CNGB1 and amplifications in HSPA5 happen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the frequency of mutations in CNGB1 coupled with gains in TASOR2 in Bladder Urothelial Carcinoma?How often do mutations in CNGB1 and amplifications in TASOR2 happen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the frequency of mutations in CTSC coupled with gains in POC1B in Stomach Adenocarcinoma?How often do mutations in CTSC and amplifications in POC1B happen in Stomach Adenocarcinoma?,cnv_and_ssm
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the frequency of mutations in CTSC coupled with gains in PAK3 in Stomach Adenocarcinoma?How often do mutations in CTSC and amplifications in PAK3 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the frequency of mutations in CTSC coupled with gains in ANP32E in Stomach Adenocarcinoma?How often do mutations in CTSC and amplifications in ANP32E happen in Stomach Adenocarcinoma?,cnv_and_ssm
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the frequency of mutations in CTSC coupled with gains in OLFML3 in Stomach Adenocarcinoma?How often do mutations in CTSC and amplifications in OLFML3 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the frequency of mutations in CTSC coupled with gains in POLR1G in Stomach Adenocarcinoma?How often do mutations in CTSC and amplifications in POLR1G happen in Stomach Adenocarcinoma?,cnv_and_ssm
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in PRSS8 coupled with gains in MED16 in Uterine Corpus Endometrial Carcinoma?How often do mutations in PRSS8 and amplifications in MED16 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in PRSS8 coupled with gains in CNGB1 in Uterine Corpus Endometrial Carcinoma?How often do mutations in PRSS8 and amplifications in CNGB1 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the frequency of mutations in ARHGEF40 coupled with gains in FNDC7 in Lung Adenocarcinoma?How often do mutations in ARHGEF40 and amplifications in FNDC7 happen in Lung Adenocarcinoma?,cnv_and_ssm
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the frequency of mutations in ACTB coupled with gains in OR5D14 in Rectum Adenocarcinoma?How often do mutations in ACTB and amplifications in OR5D14 happen in Rectum Adenocarcinoma?,cnv_and_ssm
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the frequency of mutations in ACTB coupled with gains in GUK1 in Rectum Adenocarcinoma?How often do mutations in ACTB and amplifications in GUK1 happen in Rectum Adenocarcinoma?,cnv_and_ssm
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the frequency of mutations in ACTB coupled with gains in CASZ1 in Rectum Adenocarcinoma?How often do mutations in ACTB and amplifications in CASZ1 happen in Rectum Adenocarcinoma?,cnv_and_ssm
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the frequency of mutations in ACTB coupled with gains in DCC in Rectum Adenocarcinoma?How often do mutations in ACTB and amplifications in DCC happen in Rectum Adenocarcinoma?,cnv_and_ssm
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the frequency of mutations in YY1AP1 coupled with gains in KDM5C in Glioblastoma Multiforme?How often do mutations in YY1AP1 and amplifications in KDM5C happen in Glioblastoma Multiforme?,cnv_and_ssm
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the frequency of mutations in YY1AP1 coupled with gains in PAK3 in Glioblastoma Multiforme?How often do mutations in YY1AP1 and amplifications in PAK3 happen in Glioblastoma Multiforme?,cnv_and_ssm
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the frequency of mutations in YY1AP1 coupled with gains in FGF8 in Glioblastoma Multiforme?How often do mutations in YY1AP1 and amplifications in FGF8 happen in Glioblastoma Multiforme?,cnv_and_ssm
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the frequency of mutations in YY1AP1 coupled with gains in FNDC7 in Glioblastoma Multiforme?How often do mutations in YY1AP1 and amplifications in FNDC7 happen in Glioblastoma Multiforme?,cnv_and_ssm
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the frequency of mutations in YY1AP1 coupled with gains in PCDHB2 in Glioblastoma Multiforme?How often do mutations in YY1AP1 and amplifications in PCDHB2 happen in Glioblastoma Multiforme?,cnv_and_ssm
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the frequency of mutations in YY1AP1 coupled with gains in RIPOR2 in Glioblastoma Multiforme?How often do mutations in YY1AP1 and amplifications in RIPOR2 happen in Glioblastoma Multiforme?,cnv_and_ssm
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the frequency of mutations in YY1AP1 coupled with gains in TRIM45 in Glioblastoma Multiforme?How often do mutations in YY1AP1 and amplifications in TRIM45 happen in Glioblastoma Multiforme?,cnv_and_ssm
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the frequency of mutations in FNDC7 coupled with gains in EIF2B4 in Skin Cutaneous Melanoma?How often do mutations in FNDC7 and amplifications in EIF2B4 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the frequency of mutations in FNDC7 coupled with gains in RIMS2 in Skin Cutaneous Melanoma?How often do mutations in FNDC7 and amplifications in RIMS2 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the frequency of mutations in TLCD5 coupled with gains in GIMAP2 in Lung Adenocarcinoma?How often do mutations in TLCD5 and amplifications in GIMAP2 happen in Lung Adenocarcinoma?,cnv_and_ssm
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the frequency of mutations in TLCD5 coupled with gains in CTSC in Lung Adenocarcinoma?How often do mutations in TLCD5 and amplifications in CTSC happen in Lung Adenocarcinoma?,cnv_and_ssm
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in POLR1G coupled with gains in DCLK3 in Uterine Corpus Endometrial Carcinoma?How often do mutations in POLR1G and amplifications in DCLK3 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in POLR1G coupled with gains in ARMC3 in Uterine Corpus Endometrial Carcinoma?How often do mutations in POLR1G and amplifications in ARMC3 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the frequency of mutations in DNAH14 coupled with gains in GPR158 in Colon Adenocarcinoma?How often do mutations in DNAH14 and amplifications in GPR158 happen in Colon Adenocarcinoma?,cnv_and_ssm
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the frequency of mutations in DNAH14 coupled with gains in YY1AP1 in Colon Adenocarcinoma?How often do mutations in DNAH14 and amplifications in YY1AP1 happen in Colon Adenocarcinoma?,cnv_and_ssm
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the frequency of mutations in DNAH14 coupled with gains in TET2 in Colon Adenocarcinoma?How often do mutations in DNAH14 and amplifications in TET2 happen in Colon Adenocarcinoma?,cnv_and_ssm
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in NEXN coupled with gains in EIF2B4 in Uterine Corpus Endometrial Carcinoma?How often do mutations in NEXN and amplifications in EIF2B4 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the frequency of mutations in CYB5R2 coupled with gains in CNGB1 in Prostate Adenocarcinoma?How often do mutations in CYB5R2 and amplifications in CNGB1 happen in Prostate Adenocarcinoma?,cnv_and_ssm
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the frequency of mutations in CYB5R2 coupled with gains in PTPRN2 in Prostate Adenocarcinoma?How often do mutations in CYB5R2 and amplifications in PTPRN2 happen in Prostate Adenocarcinoma?,cnv_and_ssm
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in NRAP coupled with gains in MRPL32 in Uterine Corpus Endometrial Carcinoma?How often do mutations in NRAP and amplifications in MRPL32 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in NRAP coupled with gains in DCLK3 in Uterine Corpus Endometrial Carcinoma?How often do mutations in NRAP and amplifications in DCLK3 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in NRAP coupled with gains in ANKRD30A in Uterine Corpus Endometrial Carcinoma?How often do mutations in NRAP and amplifications in ANKRD30A happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in CCDC22 coupled with gains in ZFAT in Uterine Corpus Endometrial Carcinoma?How often do mutations in CCDC22 and amplifications in ZFAT happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the frequency of mutations in DCAF6 coupled with gains in PTPRN2 in Skin Cutaneous Melanoma?How often do mutations in DCAF6 and amplifications in PTPRN2 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the frequency of mutations in DCAF6 coupled with gains in CASZ1 in Skin Cutaneous Melanoma?How often do mutations in DCAF6 and amplifications in CASZ1 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in ZNF708 coupled with gains in PCDHB2 in Uterine Corpus Endometrial Carcinoma?How often do mutations in ZNF708 and amplifications in PCDHB2 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in BFAR coupled with gains in OR2A12 in Uterine Corpus Endometrial Carcinoma?How often do mutations in BFAR and amplifications in OR2A12 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in MAST4 coupled with gains in CDH23 in Uterine Corpus Endometrial Carcinoma?How often do mutations in MAST4 and amplifications in CDH23 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in MAST4 coupled with gains in POC1B in Uterine Corpus Endometrial Carcinoma?How often do mutations in MAST4 and amplifications in POC1B happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in MAST4 coupled with gains in MAST4 in Uterine Corpus Endometrial Carcinoma?How often do mutations in MAST4 and amplifications in MAST4 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in MAST4 coupled with gains in GABRA6 in Uterine Corpus Endometrial Carcinoma?How often do mutations in MAST4 and amplifications in GABRA6 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in MAST4 coupled with gains in KIF20B in Uterine Corpus Endometrial Carcinoma?How often do mutations in MAST4 and amplifications in KIF20B happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the frequency of mutations in ARMC3 coupled with gains in DCN in Stomach Adenocarcinoma?How often do mutations in ARMC3 and amplifications in DCN happen in Stomach Adenocarcinoma?,cnv_and_ssm
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the frequency of mutations in ARMC3 coupled with gains in DCC in Stomach Adenocarcinoma?How often do mutations in ARMC3 and amplifications in DCC happen in Stomach Adenocarcinoma?,cnv_and_ssm
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the frequency of mutations in TET2 coupled with gains in MORF4L1 in Kidney Renal Clear Cell Carcinoma?How often do mutations in TET2 and amplifications in MORF4L1 happen in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the frequency of mutations in TET2 coupled with gains in VPS26B in Kidney Renal Clear Cell Carcinoma?How often do mutations in TET2 and amplifications in VPS26B happen in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the frequency of mutations in SERPINB10 coupled with gains in ZNF804A in Lung Adenocarcinoma?How often do mutations in SERPINB10 and amplifications in ZNF804A happen in Lung Adenocarcinoma?,cnv_and_ssm
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in STAT3 coupled with gains in CHODL in Uterine Corpus Endometrial Carcinoma?How often do mutations in STAT3 and amplifications in CHODL happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in MIEF1 coupled with gains in TLK2 in Uterine Corpus Endometrial Carcinoma?How often do mutations in MIEF1 and amplifications in TLK2 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the frequency of mutations in ACVR1B coupled with gains in CFAP61 in Colon Adenocarcinoma?How often do mutations in ACVR1B and amplifications in CFAP61 happen in Colon Adenocarcinoma?,cnv_and_ssm
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the frequency of mutations in ACVR1B coupled with gains in DCC in Colon Adenocarcinoma?How often do mutations in ACVR1B and amplifications in DCC happen in Colon Adenocarcinoma?,cnv_and_ssm
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the frequency of mutations in ACVR1B coupled with gains in CTCFL in Colon Adenocarcinoma?How often do mutations in ACVR1B and amplifications in CTCFL happen in Colon Adenocarcinoma?,cnv_and_ssm
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the frequency of mutations in EBF2 coupled with gains in TASOR2 in Stomach Adenocarcinoma?How often do mutations in EBF2 and amplifications in TASOR2 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the frequency of mutations in EBF2 coupled with gains in SORCS1 in Stomach Adenocarcinoma?How often do mutations in EBF2 and amplifications in SORCS1 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the frequency of mutations in VPS26B coupled with gains in MERTK in Stomach Adenocarcinoma?How often do mutations in VPS26B and amplifications in MERTK happen in Stomach Adenocarcinoma?,cnv_and_ssm
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of mutations in PGR coupled with gains in CTCFL in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?How often do mutations in PGR and amplifications in CTCFL happen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of mutations in PGR coupled with gains in CTSC in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?How often do mutations in PGR and amplifications in CTSC happen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the frequency of mutations in PGR coupled with gains in TRIM45 in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?How often do mutations in PGR and amplifications in TRIM45 happen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the frequency of mutations in ACTA2 coupled with gains in FGF8 in Skin Cutaneous Melanoma?How often do mutations in ACTA2 and amplifications in FGF8 happen in Skin Cutaneous Melanoma?,cnv_and_ssm
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in THBS4 coupled with gains in CACNA1F in Uterine Corpus Endometrial Carcinoma?How often do mutations in THBS4 and amplifications in CACNA1F happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in THBS4 coupled with gains in SIK2 in Uterine Corpus Endometrial Carcinoma?How often do mutations in THBS4 and amplifications in SIK2 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the frequency of mutations in PRSS1 coupled with gains in ANKRD30A in Lung Adenocarcinoma?How often do mutations in PRSS1 and amplifications in ANKRD30A happen in Lung Adenocarcinoma?,cnv_and_ssm
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the frequency of mutations in PRSS1 coupled with gains in BICC1 in Lung Adenocarcinoma?How often do mutations in PRSS1 and amplifications in BICC1 happen in Lung Adenocarcinoma?,cnv_and_ssm
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the frequency of mutations in PRSS1 coupled with gains in FGF8 in Lung Adenocarcinoma?How often do mutations in PRSS1 and amplifications in FGF8 happen in Lung Adenocarcinoma?,cnv_and_ssm
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the frequency of mutations in PRSS1 coupled with gains in SYNJ1 in Lung Adenocarcinoma?How often do mutations in PRSS1 and amplifications in SYNJ1 happen in Lung Adenocarcinoma?,cnv_and_ssm
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the frequency of mutations in PGF coupled with gains in POLR1G in Stomach Adenocarcinoma?How often do mutations in PGF and amplifications in POLR1G happen in Stomach Adenocarcinoma?,cnv_and_ssm
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the frequency of mutations in PGF coupled with gains in MORF4L1 in Stomach Adenocarcinoma?How often do mutations in PGF and amplifications in MORF4L1 happen in Stomach Adenocarcinoma?,cnv_and_ssm
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the frequency of mutations in ITPRID2 coupled with gains in COL6A3 in Breast Invasive Carcinoma?How often do mutations in ITPRID2 and amplifications in COL6A3 happen in Breast Invasive Carcinoma?,cnv_and_ssm
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the frequency of mutations in ITPRID2 coupled with gains in HYOU1 in Breast Invasive Carcinoma?How often do mutations in ITPRID2 and amplifications in HYOU1 happen in Breast Invasive Carcinoma?,cnv_and_ssm
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in HBB coupled with gains in NEXN in Uterine Corpus Endometrial Carcinoma?How often do mutations in HBB and amplifications in NEXN happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the frequency of mutations in PCDHB2 coupled with gains in ACVR1B in Colon Adenocarcinoma?How often do mutations in PCDHB2 and amplifications in ACVR1B happen in Colon Adenocarcinoma?,cnv_and_ssm
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the frequency of mutations in PCDHB2 coupled with gains in PCDHGA1 in Colon Adenocarcinoma?How often do mutations in PCDHB2 and amplifications in PCDHGA1 happen in Colon Adenocarcinoma?,cnv_and_ssm
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the frequency of mutations in PCDHB2 coupled with gains in ARMC3 in Colon Adenocarcinoma?How often do mutations in PCDHB2 and amplifications in ARMC3 happen in Colon Adenocarcinoma?,cnv_and_ssm
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the frequency of mutations in UBR2 coupled with gains in ARMC3 in Uterine Corpus Endometrial Carcinoma?How often do mutations in UBR2 and amplifications in ARMC3 happen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the frequency of mutations in FBXO42 coupled with gains in RIPOR2 in Rectum Adenocarcinoma?How often do mutations in FBXO42 and amplifications in RIPOR2 happen in Rectum Adenocarcinoma?,cnv_and_ssm
+1,TNS1,G1362V,Breast Invasive Carcinoma,What is the incidence of TNS1 mutations along with RIPOR2 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+2,TNS1,G1711V,Breast Invasive Carcinoma,What is the incidence of TNS1 mutations along with NOMO1 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+3,TNS1,G1718V,Breast Invasive Carcinoma,What is the incidence of TNS1 mutations along with PHLPP1 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+4,TNS1,G1732V,Breast Invasive Carcinoma,What is the incidence of TNS1 mutations along with PYHIN1 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+5,TNS1,G1824V,Breast Invasive Carcinoma,What is the incidence of TNS1 mutations along with TENT5A losses in Breast Invasive Carcinoma?,cnv_and_ssm
+6,TNS1,G1857V,Breast Invasive Carcinoma,What is the incidence of TNS1 mutations along with DEFB115 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+7,TNS1,G843V,Breast Invasive Carcinoma,What is the incidence of TNS1 mutations along with FRY losses in Breast Invasive Carcinoma?,cnv_and_ssm
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,What is the incidence of EVC2 mutations along with RIPOR2 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+15,EVC2,E987K,Bladder Urothelial Carcinoma,What is the incidence of EVC2 mutations along with WNT2 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,What is the incidence of CR1 mutations along with GABRA6 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,What is the incidence of CR1 mutations along with CDH23 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+22,TRPA1,S295I,Rectum Adenocarcinoma,What is the incidence of TRPA1 mutations along with SLC9C1 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+23,TRPA1,S443I,Rectum Adenocarcinoma,What is the incidence of TRPA1 mutations along with REXO4 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+24,TAF1C,R299L,Lung Adenocarcinoma,What is the incidence of TAF1C mutations along with TRPA1 losses in Lung Adenocarcinoma?,cnv_and_ssm
+25,TAF1C,R396L,Lung Adenocarcinoma,What is the incidence of TAF1C mutations along with AQP7 losses in Lung Adenocarcinoma?,cnv_and_ssm
+26,TAF1C,R634L,Lung Adenocarcinoma,What is the incidence of TAF1C mutations along with COL6A3 losses in Lung Adenocarcinoma?,cnv_and_ssm
+27,TAF1C,R702L,Lung Adenocarcinoma,What is the incidence of TAF1C mutations along with ABCC2 losses in Lung Adenocarcinoma?,cnv_and_ssm
+28,TAF1C,R728L,Lung Adenocarcinoma,What is the incidence of TAF1C mutations along with TTC17 losses in Lung Adenocarcinoma?,cnv_and_ssm
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,What is the incidence of DPF3 mutations along with SPTAN1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,What is the incidence of DPF3 mutations along with JAML losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,What is the incidence of DPF3 mutations along with SGIP1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+42,OR2T4,P272H,Lung Adenocarcinoma,What is the incidence of OR2T4 mutations along with ANP32E losses in Lung Adenocarcinoma?,cnv_and_ssm
+43,OR2T4,P300H,Lung Adenocarcinoma,What is the incidence of OR2T4 mutations along with SLC24A2 losses in Lung Adenocarcinoma?,cnv_and_ssm
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,What is the incidence of FBN1 mutations along with TNS1 losses in Pancreatic Adenocarcinoma?,cnv_and_ssm
+45,MAD1L1,E396K,Prostate Adenocarcinoma,What is the incidence of MAD1L1 mutations along with GRTP1 losses in Prostate Adenocarcinoma?,cnv_and_ssm
+46,MAD1L1,E488K,Prostate Adenocarcinoma,What is the incidence of MAD1L1 mutations along with ANKRD30A losses in Prostate Adenocarcinoma?,cnv_and_ssm
+47,MAD1L1,E78K,Prostate Adenocarcinoma,What is the incidence of MAD1L1 mutations along with CACNA1F losses in Prostate Adenocarcinoma?,cnv_and_ssm
+61,CCNG1,E22K,Skin Cutaneous Melanoma,What is the incidence of CCNG1 mutations along with SGCZ losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,What is the incidence of ANP32E mutations along with CDH23 losses in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,What is the incidence of ANP32E mutations along with FNDC7 losses in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,What is the incidence of ANP32E mutations along with PGF losses in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,What is the incidence of ANP32E mutations along with DCC losses in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+66,FRY,S1888A,Bladder Urothelial Carcinoma,What is the incidence of FRY mutations along with SPAG1 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+67,FRY,S1937A,Bladder Urothelial Carcinoma,What is the incidence of FRY mutations along with AUTS2 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+68,FRY,S1938A,Bladder Urothelial Carcinoma,What is the incidence of FRY mutations along with AQP7 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+69,FRY,S1983A,Bladder Urothelial Carcinoma,What is the incidence of FRY mutations along with OLFML3 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+70,PAK3,E318K,Skin Cutaneous Melanoma,What is the incidence of PAK3 mutations along with TENT5A losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+71,PAK3,E319K,Skin Cutaneous Melanoma,What is the incidence of PAK3 mutations along with ACTB losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+72,PAK3,E334K,Skin Cutaneous Melanoma,What is the incidence of PAK3 mutations along with FCGR2C losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+73,PAK3,E340K,Skin Cutaneous Melanoma,What is the incidence of PAK3 mutations along with EIF2B4 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+74,PAK3,E355K,Skin Cutaneous Melanoma,What is the incidence of PAK3 mutations along with PTPRO losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+80,MUC16,P7963L,Skin Cutaneous Melanoma,What is the incidence of MUC16 mutations along with MAD1L1 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,What is the incidence of ZFPM2 mutations along with MYO3A losses in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,What is the incidence of ZFPM2 mutations along with COL6A3 losses in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,What is the incidence of PIK3C2B mutations along with JAML losses in Breast Invasive Carcinoma?,cnv_and_ssm
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,What is the incidence of PIK3C2B mutations along with SYT9 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+114,ZNF804A,S371Y,Colon Adenocarcinoma,What is the incidence of ZNF804A mutations along with NEXN losses in Colon Adenocarcinoma?,cnv_and_ssm
+116,RELN,A2371V,Stomach Adenocarcinoma,What is the incidence of RELN mutations along with ZFAT losses in Stomach Adenocarcinoma?,cnv_and_ssm
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of EFCAB12 mutations along with TMTC3 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of EFCAB12 mutations along with MIEF1 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+120,DEFB115,E53K,Skin Cutaneous Melanoma,What is the incidence of DEFB115 mutations along with JAML losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,What is the incidence of ANKDD1A mutations along with FCGR2C losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,What is the incidence of ANKDD1A mutations along with DNAH11 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,What is the incidence of ANKDD1A mutations along with CR1 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,What is the incidence of HTR3B mutations along with PIAS3 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,What is the incidence of HTR3B mutations along with MYO3A losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,What is the incidence of HTR3B mutations along with MAST4 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+129,ABCC3,R758W,Stomach Adenocarcinoma,What is the incidence of ABCC3 mutations along with TMEM255A losses in Stomach Adenocarcinoma?,cnv_and_ssm
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,What is the incidence of NOMO1 mutations along with CYB5R2 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,What is the incidence of NOMO1 mutations along with WNT2 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,What is the incidence of HYOU1 mutations along with DPF3 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+139,FMO4,R500Q,Skin Cutaneous Melanoma,What is the incidence of FMO4 mutations along with GPR158 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+140,BICC1,A372V,Exceptional Responders,What is the incidence of BICC1 mutations along with GPRASP1 losses in Exceptional Responders?,cnv_and_ssm
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,What is the incidence of ZMYM3 mutations along with YY1AP1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,What is the incidence of ZMYM3 mutations along with CARMIL1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,What is the incidence of ZMYM3 mutations along with CTNNA2 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of XKR4 mutations along with PXN losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,What is the incidence of ABCC2 mutations along with DSCAM losses in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+157,OR8K5,R293G,Lung Adenocarcinoma,What is the incidence of OR8K5 mutations along with CNGB1 losses in Lung Adenocarcinoma?,cnv_and_ssm
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,What is the incidence of SPTAN1 mutations along with MORF4L1 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,What is the incidence of SPTAN1 mutations along with CARMIL1 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+164,SYT10,M484I,Rectum Adenocarcinoma,What is the incidence of SYT10 mutations along with MYO16 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+174,HSPA5,N457K,Skin Cutaneous Melanoma,What is the incidence of HSPA5 mutations along with TTC17 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+175,UNC5D,L280V,Lung Adenocarcinoma,What is the incidence of UNC5D mutations along with FGF8 losses in Lung Adenocarcinoma?,cnv_and_ssm
+176,UNC5D,L635V,Lung Adenocarcinoma,What is the incidence of UNC5D mutations along with SYT10 losses in Lung Adenocarcinoma?,cnv_and_ssm
+177,UNC5D,L637V,Lung Adenocarcinoma,What is the incidence of UNC5D mutations along with SYT9 losses in Lung Adenocarcinoma?,cnv_and_ssm
+178,UNC5D,L699V,Lung Adenocarcinoma,What is the incidence of UNC5D mutations along with CDH23 losses in Lung Adenocarcinoma?,cnv_and_ssm
+179,UNC5D,L704V,Lung Adenocarcinoma,What is the incidence of UNC5D mutations along with RIMS2 losses in Lung Adenocarcinoma?,cnv_and_ssm
+180,UNC5D,L709V,Lung Adenocarcinoma,What is the incidence of UNC5D mutations along with ANKRD30A losses in Lung Adenocarcinoma?,cnv_and_ssm
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,What is the incidence of DOCK2 mutations along with GUCY2C losses in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,What is the incidence of ZNF627 mutations along with REXO4 losses in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,What is the incidence of CDC42BPA mutations along with UNC5D losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+193,MRPL55,H27Y,Colon Adenocarcinoma,What is the incidence of MRPL55 mutations along with CA9 losses in Colon Adenocarcinoma?,cnv_and_ssm
+194,MRPL55,H63Y,Colon Adenocarcinoma,What is the incidence of MRPL55 mutations along with ADRA1A losses in Colon Adenocarcinoma?,cnv_and_ssm
+197,TMTC3,Q749K,Breast Invasive Carcinoma,What is the incidence of TMTC3 mutations along with PKHD1L1 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+198,EPRS1,K771I,Colon Adenocarcinoma,What is the incidence of EPRS1 mutations along with PLEKHG6 losses in Colon Adenocarcinoma?,cnv_and_ssm
+199,EPRS1,K778I,Colon Adenocarcinoma,What is the incidence of EPRS1 mutations along with GPR158 losses in Colon Adenocarcinoma?,cnv_and_ssm
+201,GRTP1,A110V,Skin Cutaneous Melanoma,What is the incidence of GRTP1 mutations along with PLEKHG6 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+202,GRTP1,A32V,Skin Cutaneous Melanoma,What is the incidence of GRTP1 mutations along with SPATA22 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,What is the incidence of TSHZ3 mutations along with DNMT1 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,What is the incidence of TAS1R3 mutations along with CDKN2AIP losses in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,cnv_and_ssm
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,What is the incidence of PIAS3 mutations along with RIPOR2 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,What is the incidence of PIAS3 mutations along with PTPRO losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+251,ZNF274,P13R,Stomach Adenocarcinoma,What is the incidence of ZNF274 mutations along with PTPRO losses in Stomach Adenocarcinoma?,cnv_and_ssm
+253,SYNJ1,R795C,Colon Adenocarcinoma,What is the incidence of SYNJ1 mutations along with YY1AP1 losses in Colon Adenocarcinoma?,cnv_and_ssm
+254,SYNJ1,R800C,Colon Adenocarcinoma,What is the incidence of SYNJ1 mutations along with PYHIN1 losses in Colon Adenocarcinoma?,cnv_and_ssm
+255,SYNJ1,R839C,Colon Adenocarcinoma,What is the incidence of SYNJ1 mutations along with PLEKHG6 losses in Colon Adenocarcinoma?,cnv_and_ssm
+261,DSCAM,V343M,Prostate Adenocarcinoma,What is the incidence of DSCAM mutations along with REXO4 losses in Prostate Adenocarcinoma?,cnv_and_ssm
+262,DSCAM,V426M,Prostate Adenocarcinoma,What is the incidence of DSCAM mutations along with TTC17 losses in Prostate Adenocarcinoma?,cnv_and_ssm
+263,DSCAM,V591M,Prostate Adenocarcinoma,What is the incidence of DSCAM mutations along with REXO4 losses in Prostate Adenocarcinoma?,cnv_and_ssm
+267,DGKD,R140H,Exceptional Responders,What is the incidence of DGKD mutations along with MAD1L1 losses in Exceptional Responders?,cnv_and_ssm
+268,DGKD,R160H,Exceptional Responders,What is the incidence of DGKD mutations along with PLEKHG6 losses in Exceptional Responders?,cnv_and_ssm
+269,DGKD,R204H,Exceptional Responders,What is the incidence of DGKD mutations along with STK19 losses in Exceptional Responders?,cnv_and_ssm
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,What is the incidence of PLEKHG6 mutations along with TRPA1 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,What is the incidence of PLEKHG6 mutations along with POC1B losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,What is the incidence of PLEKHG6 mutations along with SGIP1 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+279,WNT2,D138N,Skin Cutaneous Melanoma,What is the incidence of WNT2 mutations along with MAST4 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,What is the incidence of GUCY2C mutations along with SPATA22 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,What is the incidence of C7orf31 mutations along with PIK3C2G losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of ZKSCAN7 mutations along with KDM5C losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+299,OR5D14,M210L,Neuroblastoma,What is the incidence of OR5D14 mutations along with CTCFL losses in Neuroblastoma?,cnv_and_ssm
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,What is the incidence of SPATA22 mutations along with MERTK losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,What is the incidence of SPATA22 mutations along with OR2A12 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,What is the incidence of SPATA22 mutations along with PTPRN2 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+310,LCN15,E21V,Stomach Adenocarcinoma,What is the incidence of LCN15 mutations along with NRAP losses in Stomach Adenocarcinoma?,cnv_and_ssm
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,What is the incidence of DCAF4L2 mutations along with SERPINB10 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,What is the incidence of GUK1 mutations along with PIAS3 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,What is the incidence of GUK1 mutations along with DCAF6 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,What is the incidence of GUK1 mutations along with PIK3C2B losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,What is the incidence of GUK1 mutations along with AQP7 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,What is the incidence of GUK1 mutations along with CTNNA2 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+328,MORF4L1,K29T,Stomach Adenocarcinoma,What is the incidence of MORF4L1 mutations along with ZNF708 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+329,MORF4L1,K51T,Stomach Adenocarcinoma,What is the incidence of MORF4L1 mutations along with DCC losses in Stomach Adenocarcinoma?,cnv_and_ssm
+330,MORF4L1,K61T,Stomach Adenocarcinoma,What is the incidence of MORF4L1 mutations along with KANSL1 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+331,MORF4L1,K76T,Stomach Adenocarcinoma,What is the incidence of MORF4L1 mutations along with DCC losses in Stomach Adenocarcinoma?,cnv_and_ssm
+335,MYO3B,F594L,Skin Cutaneous Melanoma,What is the incidence of MYO3B mutations along with MED16 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+336,MYO3B,F603L,Skin Cutaneous Melanoma,What is the incidence of MYO3B mutations along with DCC losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+339,TENT5A,S320F,Skin Cutaneous Melanoma,What is the incidence of TENT5A mutations along with ZNF804A losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+340,TENT5A,S339F,Skin Cutaneous Melanoma,What is the incidence of TENT5A mutations along with NCKAP5 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+341,TENT5A,S401F,Skin Cutaneous Melanoma,What is the incidence of TENT5A mutations along with PIK3C2G losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,What is the incidence of ZFAT mutations along with SPATA22 losses in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,What is the incidence of ZFAT mutations along with TENT5A losses in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,What is the incidence of ZFAT mutations along with ZSCAN31 losses in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+357,ZNF584,A211T,Sarcoma,What is the incidence of ZNF584 mutations along with TNS1 losses in Sarcoma?,cnv_and_ssm
+358,ZNF584,A256T,Sarcoma,What is the incidence of ZNF584 mutations along with BCAT1 losses in Sarcoma?,cnv_and_ssm
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,What is the incidence of LDOC1 mutations along with POC1B losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,What is the incidence of PDGFC mutations along with MRPL32 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,What is the incidence of MSANTD4 mutations along with PTPRO losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+374,NPSR1,S123L,Skin Cutaneous Melanoma,What is the incidence of NPSR1 mutations along with TAF1C losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,What is the incidence of PHLPP1 mutations along with DGKD losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+385,COL6A3,G237S,Skin Cutaneous Melanoma,What is the incidence of COL6A3 mutations along with RIPOR2 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+386,COL6A3,G437S,Skin Cutaneous Melanoma,What is the incidence of COL6A3 mutations along with ITPRID2 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+387,COL6A3,G638S,Skin Cutaneous Melanoma,What is the incidence of COL6A3 mutations along with PXN losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+388,COL6A3,G644S,Skin Cutaneous Melanoma,What is the incidence of COL6A3 mutations along with DHX16 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+389,COL6A3,G844S,Skin Cutaneous Melanoma,What is the incidence of COL6A3 mutations along with TAF1C losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+395,ADRA1A,R348G,Stomach Adenocarcinoma,What is the incidence of ADRA1A mutations along with EIF2B4 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of LAMB2 mutations along with YY1AP1 losses in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+406,POC1B,I198T,Rectum Adenocarcinoma,What is the incidence of POC1B mutations along with DCN losses in Rectum Adenocarcinoma?,cnv_and_ssm
+407,POC1B,I286T,Rectum Adenocarcinoma,What is the incidence of POC1B mutations along with KL losses in Rectum Adenocarcinoma?,cnv_and_ssm
+408,POC1B,I328T,Rectum Adenocarcinoma,What is the incidence of POC1B mutations along with ZNF804A losses in Rectum Adenocarcinoma?,cnv_and_ssm
+409,POC1B,S79P,Rectum Adenocarcinoma,What is the incidence of POC1B mutations along with DCAF4L2 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,What is the incidence of USH2A mutations along with KDM5C losses in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+414,AQP7,T110S,Rectum Adenocarcinoma,What is the incidence of AQP7 mutations along with ZBTB34 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+415,AQP7,T166S,Rectum Adenocarcinoma,What is the incidence of AQP7 mutations along with ART3 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+416,AQP7,T167S,Rectum Adenocarcinoma,What is the incidence of AQP7 mutations along with SPATA22 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+417,AQP7,T75S,Rectum Adenocarcinoma,What is the incidence of AQP7 mutations along with ARMC3 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+430,DCN,R163C,Rectum Adenocarcinoma,What is the incidence of DCN mutations along with RIMS2 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+431,DCN,R203C,Rectum Adenocarcinoma,What is the incidence of DCN mutations along with PRSS1 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+432,DCN,R241C,Rectum Adenocarcinoma,What is the incidence of DCN mutations along with YY1AP1 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+433,DCN,R350C,Rectum Adenocarcinoma,What is the incidence of DCN mutations along with KIF20B losses in Rectum Adenocarcinoma?,cnv_and_ssm
+434,DCN,R41C,Rectum Adenocarcinoma,What is the incidence of DCN mutations along with DOCK2 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,What is the incidence of CPS1 mutations along with ITPRID2 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,What is the incidence of CPS1 mutations along with GPC3 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,What is the incidence of CPS1 mutations along with TTN losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,What is the incidence of FCGR2C mutations along with GABRA6 losses in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,What is the incidence of FCGR2C mutations along with MYO15A losses in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,What is the incidence of GRM1 mutations along with SGCZ losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+482,SGCZ,Q138H,Lung Adenocarcinoma,What is the incidence of SGCZ mutations along with PHLPP1 losses in Lung Adenocarcinoma?,cnv_and_ssm
+483,SGCZ,Q91H,Lung Adenocarcinoma,What is the incidence of SGCZ mutations along with TTN losses in Lung Adenocarcinoma?,cnv_and_ssm
+485,SMO,V15M,Stomach Adenocarcinoma,What is the incidence of SMO mutations along with MORF4L1 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+486,SMO,V321M,Stomach Adenocarcinoma,What is the incidence of SMO mutations along with ITPRID2 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+488,CHODL,G159E,Skin Cutaneous Melanoma,What is the incidence of CHODL mutations along with GPR158 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+489,CHODL,G181E,Skin Cutaneous Melanoma,What is the incidence of CHODL mutations along with TENM3 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+490,CHODL,G200E,Skin Cutaneous Melanoma,What is the incidence of CHODL mutations along with MORF4L1 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+494,MYO16,P399H,Colon Adenocarcinoma,What is the incidence of MYO16 mutations along with ANKRD30A losses in Colon Adenocarcinoma?,cnv_and_ssm
+495,MYO16,P421H,Colon Adenocarcinoma,What is the incidence of MYO16 mutations along with ZNF627 losses in Colon Adenocarcinoma?,cnv_and_ssm
+498,CXCR2,A98V,Stomach Adenocarcinoma,What is the incidence of CXCR2 mutations along with ZCCHC14 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,What is the incidence of TMEM225 mutations along with EBF2 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,What is the incidence of MAOB mutations along with CHMP7 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,What is the incidence of GPRASP1 mutations along with TASOR2 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of MRPL32 mutations along with YY1AP1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,What is the incidence of TYROBP mutations along with EFCAB12 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+510,RAB40C,A111V,Lung Adenocarcinoma,What is the incidence of RAB40C mutations along with PTPRO losses in Lung Adenocarcinoma?,cnv_and_ssm
+511,RAB40C,A143V,Lung Adenocarcinoma,What is the incidence of RAB40C mutations along with TET2 losses in Lung Adenocarcinoma?,cnv_and_ssm
+512,CTNNA2,S323R,Lung Adenocarcinoma,What is the incidence of CTNNA2 mutations along with SLC9C1 losses in Lung Adenocarcinoma?,cnv_and_ssm
+513,CTNNA2,S339R,Lung Adenocarcinoma,What is the incidence of CTNNA2 mutations along with CTCFL losses in Lung Adenocarcinoma?,cnv_and_ssm
+514,CTNNA2,S386R,Lung Adenocarcinoma,What is the incidence of CTNNA2 mutations along with DNMT1 losses in Lung Adenocarcinoma?,cnv_and_ssm
+515,CTNNA2,S707R,Lung Adenocarcinoma,What is the incidence of CTNNA2 mutations along with UNC5D losses in Lung Adenocarcinoma?,cnv_and_ssm
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,What is the incidence of MYO15A mutations along with TAF1C losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,What is the incidence of GIMAP2 mutations along with DNMT1 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+532,KIF20B,N1160D,Glioblastoma Multiforme,What is the incidence of KIF20B mutations along with TASOR2 losses in Glioblastoma Multiforme?,cnv_and_ssm
+533,KIF20B,N1200D,Glioblastoma Multiforme,What is the incidence of KIF20B mutations along with GUK1 losses in Glioblastoma Multiforme?,cnv_and_ssm
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,What is the incidence of ADAM17 mutations along with YY1AP1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,What is the incidence of BCAT1 mutations along with PAK3 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,What is the incidence of BCAT1 mutations along with TET2 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,What is the incidence of BCAT1 mutations along with USH2A losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+540,ERCC6,R1053H,Colon Adenocarcinoma,What is the incidence of ERCC6 mutations along with TENM2 losses in Colon Adenocarcinoma?,cnv_and_ssm
+541,DCC,R320W,Breast Invasive Carcinoma,What is the incidence of DCC mutations along with CTCFL losses in Breast Invasive Carcinoma?,cnv_and_ssm
+542,DCC,R363W,Breast Invasive Carcinoma,What is the incidence of DCC mutations along with PYHIN1 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+543,DCC,R386W,Breast Invasive Carcinoma,What is the incidence of DCC mutations along with ANKRD30A losses in Breast Invasive Carcinoma?,cnv_and_ssm
+544,DCC,R41W,Breast Invasive Carcinoma,What is the incidence of DCC mutations along with SORCS1 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+549,FBXO15,D417N,Skin Cutaneous Melanoma,What is the incidence of FBXO15 mutations along with CFAP61 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+550,FBXO15,D86N,Skin Cutaneous Melanoma,What is the incidence of FBXO15 mutations along with CR1 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,What is the incidence of GSTCD mutations along with DHX16 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,What is the incidence of GSTCD mutations along with TMEM225 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,What is the incidence of OLFML3 mutations along with DNAH14 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,What is the incidence of OLFML3 mutations along with AUTS2 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,What is the incidence of OLFML3 mutations along with PGF losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,What is the incidence of CFAP61 mutations along with TNS1 losses in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,What is the incidence of CFAP61 mutations along with PTPRO losses in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,What is the incidence of HLA-DQA2 mutations along with PIK3C2G losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+582,TENM2,H240Y,Skin Cutaneous Melanoma,What is the incidence of TENM2 mutations along with SORCS1 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+583,TENM2,H351Y,Skin Cutaneous Melanoma,What is the incidence of TENM2 mutations along with AKT1 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+584,TENM2,H472Y,Skin Cutaneous Melanoma,What is the incidence of TENM2 mutations along with KIF20B losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+600,ANKRD24,A465T,Stomach Adenocarcinoma,What is the incidence of ANKRD24 mutations along with OR2T4 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+601,ANKRD24,A494T,Stomach Adenocarcinoma,What is the incidence of ANKRD24 mutations along with SLC6A4 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+602,ANKRD24,A584T,Stomach Adenocarcinoma,What is the incidence of ANKRD24 mutations along with DOCK2 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,What is the incidence of ZCCHC14 mutations along with CDKN2AIP losses in Stomach Adenocarcinoma?,cnv_and_ssm
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,What is the incidence of ZCCHC14 mutations along with TSHZ3 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,What is the incidence of ZCCHC14 mutations along with RIMS2 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,What is the incidence of ZCCHC14 mutations along with KANSL1 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+625,SIK2,I265M,Lung Adenocarcinoma,What is the incidence of SIK2 mutations along with UNC5D losses in Lung Adenocarcinoma?,cnv_and_ssm
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,What is the incidence of MYH11 mutations along with PTPRN2 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,What is the incidence of MYH11 mutations along with GPC3 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,What is the incidence of SLC6A4 mutations along with TTYH2 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,What is the incidence of SLC9C1 mutations along with PXN losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,What is the incidence of SLC9C1 mutations along with SGIP1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+644,OR2A12,A254T,Brain Lower Grade Glioma,What is the incidence of OR2A12 mutations along with SLC24A2 losses in Brain Lower Grade Glioma?,cnv_and_ssm
+646,PYHIN1,T325K,Lung Adenocarcinoma,What is the incidence of PYHIN1 mutations along with GUF1 losses in Lung Adenocarcinoma?,cnv_and_ssm
+647,PYHIN1,T334K,Lung Adenocarcinoma,What is the incidence of PYHIN1 mutations along with FGF8 losses in Lung Adenocarcinoma?,cnv_and_ssm
+650,JAML,G191E,Skin Cutaneous Melanoma,What is the incidence of JAML mutations along with ZFP42 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+651,JAML,G219E,Skin Cutaneous Melanoma,What is the incidence of JAML mutations along with GUK1 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+652,JAML,G220E,Skin Cutaneous Melanoma,What is the incidence of JAML mutations along with CPS1 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+653,JAML,G230E,Skin Cutaneous Melanoma,What is the incidence of JAML mutations along with HSPA5 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+658,TYK2,H1146R,Stomach Adenocarcinoma,What is the incidence of TYK2 mutations along with CX3CR1 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+659,TYK2,H23R,Stomach Adenocarcinoma,What is the incidence of TYK2 mutations along with TMEM255A losses in Stomach Adenocarcinoma?,cnv_and_ssm
+660,TYK2,H961R,Stomach Adenocarcinoma,What is the incidence of TYK2 mutations along with SORCS1 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,What is the incidence of CTCFL mutations along with PTPRO losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,What is the incidence of CTCFL mutations along with ZNF431 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,What is the incidence of CTCFL mutations along with OLFML3 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,What is the incidence of CTCFL mutations along with SPAG1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of CEP20 mutations along with TRAP1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of CEP20 mutations along with PGR losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+689,RIMS2,R25W,Skin Cutaneous Melanoma,What is the incidence of RIMS2 mutations along with TAF1C losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+690,RIMS2,R393W,Skin Cutaneous Melanoma,What is the incidence of RIMS2 mutations along with PGR losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+691,RIMS2,R423W,Skin Cutaneous Melanoma,What is the incidence of RIMS2 mutations along with YY1AP1 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+692,RIMS2,R470W,Skin Cutaneous Melanoma,What is the incidence of RIMS2 mutations along with EFCAB12 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+693,RIMS2,R615W,Skin Cutaneous Melanoma,What is the incidence of RIMS2 mutations along with PIK3C2A losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+694,RIMS2,R619W,Skin Cutaneous Melanoma,What is the incidence of RIMS2 mutations along with RIMS2 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+695,RIMS2,R716W,Skin Cutaneous Melanoma,What is the incidence of RIMS2 mutations along with CEP20 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,What is the incidence of PIK3C2G mutations along with FGF8 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,What is the incidence of PIK3C2G mutations along with CACNA1F losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+728,STK19,D341N,Colon Adenocarcinoma,What is the incidence of STK19 mutations along with GIMAP2 losses in Colon Adenocarcinoma?,cnv_and_ssm
+729,STK19,D345N,Colon Adenocarcinoma,What is the incidence of STK19 mutations along with ZNF584 losses in Colon Adenocarcinoma?,cnv_and_ssm
+730,REXO4,P60A,Skin Cutaneous Melanoma,What is the incidence of REXO4 mutations along with TTC12 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,What is the incidence of ZBTB34 mutations along with CARMIL1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,What is the incidence of ZBTB34 mutations along with ZNF217 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,What is the incidence of NCKAP5 mutations along with OLFML3 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of SORCS1 mutations along with GABRA6 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of SORCS1 mutations along with COL6A3 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of SORCS1 mutations along with TTN losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of SORCS1 mutations along with MAD1L1 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,What is the incidence of FGF8 mutations along with GUK1 losses in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,What is the incidence of FGF8 mutations along with SPAG1 losses in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,What is the incidence of FGF8 mutations along with PTPRN2 losses in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,What is the incidence of FGF8 mutations along with ZNF804A losses in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,What is the incidence of FGF8 mutations along with DCN losses in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,What is the incidence of TENM3 mutations along with ANKRD30A losses in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,cnv_and_ssm
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,What is the incidence of AKT1 mutations along with DSCAM losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of CFAP298-TCP10L mutations along with OLFML3 losses in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+792,GLRB,E148D,Stomach Adenocarcinoma,What is the incidence of GLRB mutations along with CTSC losses in Stomach Adenocarcinoma?,cnv_and_ssm
+793,TTN,F7636L,Colon Adenocarcinoma,What is the incidence of TTN mutations along with XKR4 losses in Colon Adenocarcinoma?,cnv_and_ssm
+794,TTN,F8563L,Colon Adenocarcinoma,What is the incidence of TTN mutations along with DCN losses in Colon Adenocarcinoma?,cnv_and_ssm
+795,TTN,F8880L,Colon Adenocarcinoma,What is the incidence of TTN mutations along with SYNJ1 losses in Colon Adenocarcinoma?,cnv_and_ssm
+799,ANKRD30A,V798I,Colon Adenocarcinoma,What is the incidence of ANKRD30A mutations along with BCAT1 losses in Colon Adenocarcinoma?,cnv_and_ssm
+800,ANKRD30A,V854I,Colon Adenocarcinoma,What is the incidence of ANKRD30A mutations along with DGKD losses in Colon Adenocarcinoma?,cnv_and_ssm
+801,ANKRD30A,V973I,Colon Adenocarcinoma,What is the incidence of ANKRD30A mutations along with SGIP1 losses in Colon Adenocarcinoma?,cnv_and_ssm
+809,TRIM45,S177L,Colon Adenocarcinoma,What is the incidence of TRIM45 mutations along with FRY losses in Colon Adenocarcinoma?,cnv_and_ssm
+810,TRIM45,S224L,Colon Adenocarcinoma,What is the incidence of TRIM45 mutations along with ACVR1B losses in Colon Adenocarcinoma?,cnv_and_ssm
+811,TRIM45,S281L,Colon Adenocarcinoma,What is the incidence of TRIM45 mutations along with ANKRD30A losses in Colon Adenocarcinoma?,cnv_and_ssm
+812,CACNA1F,G727V,Stomach Adenocarcinoma,What is the incidence of CACNA1F mutations along with OLFML3 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+813,CACNA1F,G781V,Stomach Adenocarcinoma,What is the incidence of CACNA1F mutations along with RAB40C losses in Stomach Adenocarcinoma?,cnv_and_ssm
+814,CACNA1F,G792V,Stomach Adenocarcinoma,What is the incidence of CACNA1F mutations along with CNGB1 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+817,KL,R594C,Colon Adenocarcinoma,What is the incidence of KL mutations along with TYK2 losses in Colon Adenocarcinoma?,cnv_and_ssm
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,What is the incidence of GUF1 mutations along with EPRS1 losses in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+822,TAF1L,A539V,Colon Adenocarcinoma,What is the incidence of TAF1L mutations along with ZCCHC14 losses in Colon Adenocarcinoma?,cnv_and_ssm
+823,TASOR2,S256F,Skin Cutaneous Melanoma,What is the incidence of TASOR2 mutations along with DPF3 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+824,TASOR2,S36F,Skin Cutaneous Melanoma,What is the incidence of TASOR2 mutations along with PTPRO losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+825,TASOR2,S471F,Skin Cutaneous Melanoma,What is the incidence of TASOR2 mutations along with COL6A3 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,What is the incidence of KDM5C mutations along with HTR3B losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,What is the incidence of KDM5C mutations along with COL6A3 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,What is the incidence of KDM5C mutations along with PDGFC losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,What is the incidence of KDM5C mutations along with ZCCHC14 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of IL5RA mutations along with PCDHGA1 losses in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+843,DHX16,A29V,Skin Cutaneous Melanoma,What is the incidence of DHX16 mutations along with RIMS2 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+844,DHX16,A89V,Skin Cutaneous Melanoma,What is the incidence of DHX16 mutations along with PYHIN1 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+902,GPR158,A644V,Stomach Adenocarcinoma,What is the incidence of GPR158 mutations along with EPRS1 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+903,GPR158,A723V,Stomach Adenocarcinoma,What is the incidence of GPR158 mutations along with JAML losses in Stomach Adenocarcinoma?,cnv_and_ssm
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of EIF2B4 mutations along with MIEF1 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of EIF2B4 mutations along with OLFML3 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of EIF2B4 mutations along with HLA-DQA2 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of EIF2B4 mutations along with FCGR2C losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of EIF2B4 mutations along with DGKD losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of EIF2B4 mutations along with PRSS1 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 mutations along with PXN losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 mutations along with TASOR2 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 mutations along with TTYH2 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 mutations along with ZMYM3 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 mutations along with TMEM255A losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 mutations along with MYO3B losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 mutations along with KDM5C losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 mutations along with ARMC3 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 mutations along with TNS1 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,What is the incidence of AUTS2 mutations along with KIF20B losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of ACTL7B mutations along with MAD1L1 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+952,PCDHGA1,R535W,Glioblastoma Multiforme,What is the incidence of PCDHGA1 mutations along with CTNNA2 losses in Glioblastoma Multiforme?,cnv_and_ssm
+954,TRAP1,R114W,Stomach Adenocarcinoma,What is the incidence of TRAP1 mutations along with SYT9 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+955,TRAP1,R61W,Stomach Adenocarcinoma,What is the incidence of TRAP1 mutations along with GUK1 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of PIK3C2A mutations along with HLA-DQA2 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,What is the incidence of KANSL1 mutations along with PAPPA losses in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,What is the incidence of ANKRD52 mutations along with GPR158 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,What is the incidence of PAPPA mutations along with EIF2B4 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,What is the incidence of B3GALNT1 mutations along with DCLK3 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+982,GABRA6,G115R,Lung Adenocarcinoma,What is the incidence of GABRA6 mutations along with PCDHB2 losses in Lung Adenocarcinoma?,cnv_and_ssm
+983,GABRA6,G122R,Lung Adenocarcinoma,What is the incidence of GABRA6 mutations along with GPC3 losses in Lung Adenocarcinoma?,cnv_and_ssm
+984,GABRA6,G165R,Lung Adenocarcinoma,What is the incidence of GABRA6 mutations along with MAST4 losses in Lung Adenocarcinoma?,cnv_and_ssm
+985,GABRA6,G175R,Lung Adenocarcinoma,What is the incidence of GABRA6 mutations along with PIAS3 losses in Lung Adenocarcinoma?,cnv_and_ssm
+986,GABRA6,G70R,Lung Adenocarcinoma,What is the incidence of GABRA6 mutations along with COL6A3 losses in Lung Adenocarcinoma?,cnv_and_ssm
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,What is the incidence of ZSCAN31 mutations along with PIK3C2G losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of MED16 mutations along with TTYH2 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of MED16 mutations along with RAB40C losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,What is the incidence of PTPRO mutations along with ZNF431 losses in Pancreatic Adenocarcinoma?,cnv_and_ssm
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,What is the incidence of PTPRO mutations along with CEP20 losses in Pancreatic Adenocarcinoma?,cnv_and_ssm
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,What is the incidence of PTPRO mutations along with ARHGEF40 losses in Pancreatic Adenocarcinoma?,cnv_and_ssm
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,What is the incidence of PTPRO mutations along with SGIP1 losses in Pancreatic Adenocarcinoma?,cnv_and_ssm
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,What is the incidence of PTPRO mutations along with PYHIN1 losses in Pancreatic Adenocarcinoma?,cnv_and_ssm
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,What is the incidence of PTPRO mutations along with ANKDD1A losses in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,What is the incidence of PTPRO mutations along with GRM5 losses in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,What is the incidence of PTPRO mutations along with CYP1A2 losses in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,What is the incidence of CHMP7 mutations along with ABCC2 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1017,GPC3,I107N,Stomach Adenocarcinoma,What is the incidence of GPC3 mutations along with FBXO15 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1018,GPC3,I161N,Stomach Adenocarcinoma,What is the incidence of GPC3 mutations along with FGF8 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of TLK2 mutations along with TAS1R3 losses in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of TLK2 mutations along with CHMP7 losses in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of TLK2 mutations along with TNS1 losses in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of TLK2 mutations along with DGKD losses in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,What is the incidence of TLK2 mutations along with ANKRD30A losses in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1036,ZNF217,E209Q,Lung Adenocarcinoma,What is the incidence of ZNF217 mutations along with SYT9 losses in Lung Adenocarcinoma?,cnv_and_ssm
+1038,SYT9,V275L,Lung Adenocarcinoma,What is the incidence of SYT9 mutations along with YY1AP1 losses in Lung Adenocarcinoma?,cnv_and_ssm
+1039,SYT9,V307L,Lung Adenocarcinoma,What is the incidence of SYT9 mutations along with ANKRD24 losses in Lung Adenocarcinoma?,cnv_and_ssm
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,What is the incidence of PKHD1L1 mutations along with ARMC3 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,What is the incidence of MYO3A mutations along with TASOR2 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of VASN mutations along with CNGB1 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,What is the incidence of DNMT1 mutations along with TLCD5 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,What is the incidence of DNMT1 mutations along with DCAF6 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,What is the incidence of DNMT1 mutations along with ANP32E losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1056,CA9,E402K,Colon Adenocarcinoma,What is the incidence of CA9 mutations along with HBB losses in Colon Adenocarcinoma?,cnv_and_ssm
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of TTC17 mutations along with SERPINB10 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,What is the incidence of TTC17 mutations along with TNS1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1065,PSG2,P43L,Breast Invasive Carcinoma,What is the incidence of PSG2 mutations along with NCKAP5 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,What is the incidence of RIPOR2 mutations along with OR8K5 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,What is the incidence of RIPOR2 mutations along with MYT1 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,What is the incidence of RIPOR2 mutations along with PLEKHG6 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,What is the incidence of RIPOR2 mutations along with DNMT1 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,What is the incidence of DCLK3 mutations along with ERCC6 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,What is the incidence of DCLK3 mutations along with UBR2 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,What is the incidence of MERTK mutations along with TRAP1 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,What is the incidence of MERTK mutations along with STAT3 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,What is the incidence of MERTK mutations along with GUCY2C losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,What is the incidence of ZFP42 mutations along with CX3CR1 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,What is the incidence of OR13C3 mutations along with PYHIN1 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,What is the incidence of OR13C3 mutations along with PGF losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+1091,SPAG1,I917M,Stomach Adenocarcinoma,What is the incidence of SPAG1 mutations along with SLC6A4 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,What is the incidence of CDKN2AIP mutations along with CCDC22 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1093,PXN,H1016Y,Colon Adenocarcinoma,What is the incidence of PXN mutations along with PGR losses in Colon Adenocarcinoma?,cnv_and_ssm
+1094,PXN,H359Y,Colon Adenocarcinoma,What is the incidence of PXN mutations along with CCDC22 losses in Colon Adenocarcinoma?,cnv_and_ssm
+1095,PXN,H492Y,Colon Adenocarcinoma,What is the incidence of PXN mutations along with CTSC losses in Colon Adenocarcinoma?,cnv_and_ssm
+1096,PXN,H524Y,Colon Adenocarcinoma,What is the incidence of PXN mutations along with EBF2 losses in Colon Adenocarcinoma?,cnv_and_ssm
+1097,PXN,H526Y,Colon Adenocarcinoma,What is the incidence of PXN mutations along with ZBTB34 losses in Colon Adenocarcinoma?,cnv_and_ssm
+1098,PXN,H540Y,Colon Adenocarcinoma,What is the incidence of PXN mutations along with EBF2 losses in Colon Adenocarcinoma?,cnv_and_ssm
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,What is the incidence of TTYH2 mutations along with ANKRD30A losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,What is the incidence of TTYH2 mutations along with COL6A3 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1106,TMEM255A,N205S,Colon Adenocarcinoma,What is the incidence of TMEM255A mutations along with ZNF584 losses in Colon Adenocarcinoma?,cnv_and_ssm
+1107,TMEM255A,N229S,Colon Adenocarcinoma,What is the incidence of TMEM255A mutations along with PAPPA losses in Colon Adenocarcinoma?,cnv_and_ssm
+1108,TMEM255A,N65S,Colon Adenocarcinoma,What is the incidence of TMEM255A mutations along with MYO3B losses in Colon Adenocarcinoma?,cnv_and_ssm
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,What is the incidence of TASOR2 mutations along with EIF2B4 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,What is the incidence of TASOR2 mutations along with FBXO15 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,What is the incidence of ICE1 mutations along with PTPRN2 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1112,MYT1,A558E,Breast Invasive Carcinoma,What is the incidence of MYT1 mutations along with ANP32E losses in Breast Invasive Carcinoma?,cnv_and_ssm
+1113,MYT1,A879E,Breast Invasive Carcinoma,What is the incidence of MYT1 mutations along with KDM5C losses in Breast Invasive Carcinoma?,cnv_and_ssm
+1114,MYT1,A906E,Breast Invasive Carcinoma,What is the incidence of MYT1 mutations along with PTPRO losses in Breast Invasive Carcinoma?,cnv_and_ssm
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,What is the incidence of CX3CR1 mutations along with CACNA1F losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,What is the incidence of CX3CR1 mutations along with EIF2B4 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,What is the incidence of SPINDOC mutations along with CASZ1 losses in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,What is the incidence of ART3 mutations along with DNAH14 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,What is the incidence of ART3 mutations along with YY1AP1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,What is the incidence of CYP1A2 mutations along with DGKD losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of ADRA1A mutations along with SPINDOC losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,What is the incidence of CDH23 mutations along with OR2A12 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,What is the incidence of CDH23 mutations along with AUTS2 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1148,KRT39,P137S,Skin Cutaneous Melanoma,What is the incidence of KRT39 mutations along with TYK2 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,What is the incidence of PDHA2 mutations along with ZCCHC14 losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,What is the incidence of SLC24A2 mutations along with TNS1 losses in Colon Adenocarcinoma?,cnv_and_ssm
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,What is the incidence of PTPRN2 mutations along with ITPRID2 losses in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,What is the incidence of PTPRN2 mutations along with PLEKHG6 losses in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,What is the incidence of PTPRN2 mutations along with FBXO15 losses in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,What is the incidence of PTPRN2 mutations along with ZNF431 losses in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,What is the incidence of PTPRN2 mutations along with TMEM255A losses in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1188,SOX21,R55L,Lung Adenocarcinoma,What is the incidence of SOX21 mutations along with TAF1L losses in Lung Adenocarcinoma?,cnv_and_ssm
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,What is the incidence of CPA6 mutations along with DCLK3 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1206,GRM5,E14K,Skin Cutaneous Melanoma,What is the incidence of GRM5 mutations along with MAST4 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of CASZ1 mutations along with ABCC2 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1210,SGIP1,N122T,Stomach Adenocarcinoma,What is the incidence of SGIP1 mutations along with ART3 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1211,SGIP1,N420T,Stomach Adenocarcinoma,What is the incidence of SGIP1 mutations along with MYO3A losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1212,SGIP1,N617T,Stomach Adenocarcinoma,What is the incidence of SGIP1 mutations along with COL6A3 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1213,SGIP1,N648T,Stomach Adenocarcinoma,What is the incidence of SGIP1 mutations along with CX3CR1 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1227,CARMIL1,V549L,Lung Adenocarcinoma,What is the incidence of CARMIL1 mutations along with EIF2B4 losses in Lung Adenocarcinoma?,cnv_and_ssm
+1228,CARMIL1,V949L,Lung Adenocarcinoma,What is the incidence of CARMIL1 mutations along with ZBTB34 losses in Lung Adenocarcinoma?,cnv_and_ssm
+1232,ZNF431,D121Y,Lung Adenocarcinoma,What is the incidence of ZNF431 mutations along with HTR3B losses in Lung Adenocarcinoma?,cnv_and_ssm
+1233,ZNF431,D161Y,Lung Adenocarcinoma,What is the incidence of ZNF431 mutations along with PXN losses in Lung Adenocarcinoma?,cnv_and_ssm
+1234,ZNF431,R128I,Lung Adenocarcinoma,What is the incidence of ZNF431 mutations along with ANKRD30A losses in Lung Adenocarcinoma?,cnv_and_ssm
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,What is the incidence of DNAH11 mutations along with BCAT1 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,What is the incidence of DNAH11 mutations along with BCAT1 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,What is the incidence of POLD1 mutations along with UNC5D losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,What is the incidence of POLD1 mutations along with TAF1C losses in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1248,TTC12,D646H,Lung Adenocarcinoma,What is the incidence of TTC12 mutations along with TLCD5 losses in Lung Adenocarcinoma?,cnv_and_ssm
+1249,TTC12,D652H,Lung Adenocarcinoma,What is the incidence of TTC12 mutations along with SGIP1 losses in Lung Adenocarcinoma?,cnv_and_ssm
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,What is the incidence of CNGB1 mutations along with ARMC3 losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,What is the incidence of CNGB1 mutations along with DCC losses in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1254,CTSC,E214V,Stomach Adenocarcinoma,What is the incidence of CTSC mutations along with OR5D14 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1255,CTSC,E291V,Stomach Adenocarcinoma,What is the incidence of CTSC mutations along with MIEF1 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1256,CTSC,E322V,Stomach Adenocarcinoma,What is the incidence of CTSC mutations along with OR2T4 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1257,CTSC,E324V,Stomach Adenocarcinoma,What is the incidence of CTSC mutations along with CYB5R2 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1258,CTSC,E335V,Stomach Adenocarcinoma,What is the incidence of CTSC mutations along with MERTK losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,What is the incidence of PRSS8 mutations along with THBS4 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,What is the incidence of PRSS8 mutations along with EPRS1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,What is the incidence of ARHGEF40 mutations along with PIAS3 losses in Lung Adenocarcinoma?,cnv_and_ssm
+1264,ACTB,A138T,Rectum Adenocarcinoma,What is the incidence of ACTB mutations along with TLCD5 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+1265,ACTB,A217T,Rectum Adenocarcinoma,What is the incidence of ACTB mutations along with ANP32E losses in Rectum Adenocarcinoma?,cnv_and_ssm
+1266,ACTB,A244T,Rectum Adenocarcinoma,What is the incidence of ACTB mutations along with AQP7 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+1267,ACTB,A260T,Rectum Adenocarcinoma,What is the incidence of ACTB mutations along with RAB40C losses in Rectum Adenocarcinoma?,cnv_and_ssm
+1268,YY1AP1,V546D,Glioblastoma Multiforme,What is the incidence of YY1AP1 mutations along with ABCC3 losses in Glioblastoma Multiforme?,cnv_and_ssm
+1269,YY1AP1,V557D,Glioblastoma Multiforme,What is the incidence of YY1AP1 mutations along with TAF1C losses in Glioblastoma Multiforme?,cnv_and_ssm
+1270,YY1AP1,V566D,Glioblastoma Multiforme,What is the incidence of YY1AP1 mutations along with DCN losses in Glioblastoma Multiforme?,cnv_and_ssm
+1271,YY1AP1,V577D,Glioblastoma Multiforme,What is the incidence of YY1AP1 mutations along with TNS1 losses in Glioblastoma Multiforme?,cnv_and_ssm
+1272,YY1AP1,V623D,Glioblastoma Multiforme,What is the incidence of YY1AP1 mutations along with DCAF6 losses in Glioblastoma Multiforme?,cnv_and_ssm
+1273,YY1AP1,V695D,Glioblastoma Multiforme,What is the incidence of YY1AP1 mutations along with MAST4 losses in Glioblastoma Multiforme?,cnv_and_ssm
+1274,YY1AP1,V715D,Glioblastoma Multiforme,What is the incidence of YY1AP1 mutations along with TYK2 losses in Glioblastoma Multiforme?,cnv_and_ssm
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,What is the incidence of FNDC7 mutations along with JAML losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,What is the incidence of FNDC7 mutations along with GRM5 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+1299,TLCD5,G15V,Lung Adenocarcinoma,What is the incidence of TLCD5 mutations along with TRAP1 losses in Lung Adenocarcinoma?,cnv_and_ssm
+1300,TLCD5,G37V,Lung Adenocarcinoma,What is the incidence of TLCD5 mutations along with PXN losses in Lung Adenocarcinoma?,cnv_and_ssm
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,What is the incidence of POLR1G mutations along with ZNF627 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,What is the incidence of POLR1G mutations along with TLK2 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1308,DNAH14,N1186K,Colon Adenocarcinoma,What is the incidence of DNAH14 mutations along with TLK2 losses in Colon Adenocarcinoma?,cnv_and_ssm
+1309,DNAH14,N2657K,Colon Adenocarcinoma,What is the incidence of DNAH14 mutations along with MAST4 losses in Colon Adenocarcinoma?,cnv_and_ssm
+1310,DNAH14,N3460K,Colon Adenocarcinoma,What is the incidence of DNAH14 mutations along with CASZ1 losses in Colon Adenocarcinoma?,cnv_and_ssm
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,What is the incidence of NEXN mutations along with CTNNA2 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,What is the incidence of CYB5R2 mutations along with COL6A3 losses in Prostate Adenocarcinoma?,cnv_and_ssm
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,What is the incidence of CYB5R2 mutations along with ZNF584 losses in Prostate Adenocarcinoma?,cnv_and_ssm
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,What is the incidence of NRAP mutations along with DCN losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,What is the incidence of NRAP mutations along with UNC5D losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,What is the incidence of NRAP mutations along with EIF2B4 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,What is the incidence of CCDC22 mutations along with RIMS2 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,What is the incidence of DCAF6 mutations along with SERPINB10 losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,What is the incidence of DCAF6 mutations along with PTPRO losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,What is the incidence of ZNF708 mutations along with AUTS2 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,What is the incidence of BFAR mutations along with POC1B losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,What is the incidence of MAST4 mutations along with ACTB losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,What is the incidence of MAST4 mutations along with DNMT1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,What is the incidence of MAST4 mutations along with YY1AP1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,What is the incidence of MAST4 mutations along with DCAF4L2 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,What is the incidence of MAST4 mutations along with GRM1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1363,ARMC3,R169C,Stomach Adenocarcinoma,What is the incidence of ARMC3 mutations along with DNAH11 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1364,ARMC3,R432C,Stomach Adenocarcinoma,What is the incidence of ARMC3 mutations along with COL6A3 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,What is the incidence of TET2 mutations along with CYP1A2 losses in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,What is the incidence of TET2 mutations along with CPA6 losses in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+1369,SERPINB10,A353P,Lung Adenocarcinoma,What is the incidence of SERPINB10 mutations along with GUK1 losses in Lung Adenocarcinoma?,cnv_and_ssm
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,What is the incidence of STAT3 mutations along with PGF losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,What is the incidence of MIEF1 mutations along with ZNF431 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1381,ACVR1B,D397N,Colon Adenocarcinoma,What is the incidence of ACVR1B mutations along with POLD1 losses in Colon Adenocarcinoma?,cnv_and_ssm
+1382,ACVR1B,D449N,Colon Adenocarcinoma,What is the incidence of ACVR1B mutations along with SORCS1 losses in Colon Adenocarcinoma?,cnv_and_ssm
+1383,ACVR1B,D490N,Colon Adenocarcinoma,What is the incidence of ACVR1B mutations along with ZFAT losses in Colon Adenocarcinoma?,cnv_and_ssm
+1393,EBF2,T104I,Stomach Adenocarcinoma,What is the incidence of EBF2 mutations along with SOX21 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1394,EBF2,T252I,Stomach Adenocarcinoma,What is the incidence of EBF2 mutations along with OR2A12 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1402,VPS26B,F266L,Stomach Adenocarcinoma,What is the incidence of VPS26B mutations along with PIK3C2A losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of PGR mutations along with TRIM45 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of PGR mutations along with TYROBP losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","What is the incidence of PGR mutations along with STK19 losses in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,What is the incidence of ACTA2 mutations along with TENT5A losses in Skin Cutaneous Melanoma?,cnv_and_ssm
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,What is the incidence of THBS4 mutations along with JAML losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,What is the incidence of THBS4 mutations along with GRM1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1413,PRSS1,S114T,Lung Adenocarcinoma,What is the incidence of PRSS1 mutations along with IL5RA losses in Lung Adenocarcinoma?,cnv_and_ssm
+1414,PRSS1,S124T,Lung Adenocarcinoma,What is the incidence of PRSS1 mutations along with SPINDOC losses in Lung Adenocarcinoma?,cnv_and_ssm
+1415,PRSS1,S138T,Lung Adenocarcinoma,What is the incidence of PRSS1 mutations along with RIMS2 losses in Lung Adenocarcinoma?,cnv_and_ssm
+1416,PRSS1,S74T,Lung Adenocarcinoma,What is the incidence of PRSS1 mutations along with MSANTD4 losses in Lung Adenocarcinoma?,cnv_and_ssm
+1417,PGF,R126H,Stomach Adenocarcinoma,What is the incidence of PGF mutations along with PRSS1 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1418,PGF,R127H,Stomach Adenocarcinoma,What is the incidence of PGF mutations along with TLK2 losses in Stomach Adenocarcinoma?,cnv_and_ssm
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,What is the incidence of ITPRID2 mutations along with DGKD losses in Breast Invasive Carcinoma?,cnv_and_ssm
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,What is the incidence of ITPRID2 mutations along with ZNF431 losses in Breast Invasive Carcinoma?,cnv_and_ssm
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,What is the incidence of HBB mutations along with YY1AP1 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1441,PCDHB2,R158C,Colon Adenocarcinoma,What is the incidence of PCDHB2 mutations along with TLK2 losses in Colon Adenocarcinoma?,cnv_and_ssm
+1442,PCDHB2,T15M,Colon Adenocarcinoma,What is the incidence of PCDHB2 mutations along with PIK3C2B losses in Colon Adenocarcinoma?,cnv_and_ssm
+1443,PCDHB2,T26M,Colon Adenocarcinoma,What is the incidence of PCDHB2 mutations along with ZCCHC14 losses in Colon Adenocarcinoma?,cnv_and_ssm
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,What is the incidence of UBR2 mutations along with GABRA6 losses in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1452,FBXO42,A618D,Rectum Adenocarcinoma,What is the incidence of FBXO42 mutations along with PSG2 losses in Rectum Adenocarcinoma?,cnv_and_ssm
+1,TNS1,G1362V,Breast Invasive Carcinoma,How common are both TNS1 mutations and PSG2 amplifications within Breast Invasive Carcinoma cases?,cnv_and_ssm
+2,TNS1,G1711V,Breast Invasive Carcinoma,How common are both TNS1 mutations and TASOR2 amplifications within Breast Invasive Carcinoma cases?,cnv_and_ssm
+3,TNS1,G1718V,Breast Invasive Carcinoma,How common are both TNS1 mutations and SPATA22 amplifications within Breast Invasive Carcinoma cases?,cnv_and_ssm
+4,TNS1,G1732V,Breast Invasive Carcinoma,How common are both TNS1 mutations and HLA-DQA2 amplifications within Breast Invasive Carcinoma cases?,cnv_and_ssm
+5,TNS1,G1824V,Breast Invasive Carcinoma,How common are both TNS1 mutations and COL6A3 amplifications within Breast Invasive Carcinoma cases?,cnv_and_ssm
+6,TNS1,G1857V,Breast Invasive Carcinoma,How common are both TNS1 mutations and MAST4 amplifications within Breast Invasive Carcinoma cases?,cnv_and_ssm
+7,TNS1,G843V,Breast Invasive Carcinoma,How common are both TNS1 mutations and CPS1 amplifications within Breast Invasive Carcinoma cases?,cnv_and_ssm
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,How common are both EVC2 mutations and ZNF431 amplifications within Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+15,EVC2,E987K,Bladder Urothelial Carcinoma,How common are both EVC2 mutations and MYT1 amplifications within Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,How common are both CR1 mutations and PTPRN2 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,How common are both CR1 mutations and MYT1 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+22,TRPA1,S295I,Rectum Adenocarcinoma,How common are both TRPA1 mutations and TMEM225 amplifications within Rectum Adenocarcinoma cases?,cnv_and_ssm
+23,TRPA1,S443I,Rectum Adenocarcinoma,How common are both TRPA1 mutations and RIPOR2 amplifications within Rectum Adenocarcinoma cases?,cnv_and_ssm
+24,TAF1C,R299L,Lung Adenocarcinoma,How common are both TAF1C mutations and TNS1 amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+25,TAF1C,R396L,Lung Adenocarcinoma,How common are both TAF1C mutations and SOX21 amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+26,TAF1C,R634L,Lung Adenocarcinoma,How common are both TAF1C mutations and ANKDD1A amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+27,TAF1C,R702L,Lung Adenocarcinoma,How common are both TAF1C mutations and UBR2 amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+28,TAF1C,R728L,Lung Adenocarcinoma,How common are both TAF1C mutations and TNS1 amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,How common are both DPF3 mutations and PAK3 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,How common are both DPF3 mutations and SGCZ amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,How common are both DPF3 mutations and TAF1C amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+42,OR2T4,P272H,Lung Adenocarcinoma,How common are both OR2T4 mutations and MAST4 amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+43,OR2T4,P300H,Lung Adenocarcinoma,How common are both OR2T4 mutations and MYO3B amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,How common are both FBN1 mutations and ZFAT amplifications within Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+45,MAD1L1,E396K,Prostate Adenocarcinoma,How common are both MAD1L1 mutations and COL6A3 amplifications within Prostate Adenocarcinoma cases?,cnv_and_ssm
+46,MAD1L1,E488K,Prostate Adenocarcinoma,How common are both MAD1L1 mutations and CTCFL amplifications within Prostate Adenocarcinoma cases?,cnv_and_ssm
+47,MAD1L1,E78K,Prostate Adenocarcinoma,How common are both MAD1L1 mutations and DCC amplifications within Prostate Adenocarcinoma cases?,cnv_and_ssm
+61,CCNG1,E22K,Skin Cutaneous Melanoma,How common are both CCNG1 mutations and TAF1C amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,How common are both ANP32E mutations and DEFB115 amplifications within Kidney Renal Papillary Cell Carcinoma cases?,cnv_and_ssm
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,How common are both ANP32E mutations and FBN1 amplifications within Kidney Renal Papillary Cell Carcinoma cases?,cnv_and_ssm
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,How common are both ANP32E mutations and ANP32E amplifications within Kidney Renal Papillary Cell Carcinoma cases?,cnv_and_ssm
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,How common are both ANP32E mutations and ZCCHC14 amplifications within Kidney Renal Papillary Cell Carcinoma cases?,cnv_and_ssm
+66,FRY,S1888A,Bladder Urothelial Carcinoma,How common are both FRY mutations and SYNJ1 amplifications within Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+67,FRY,S1937A,Bladder Urothelial Carcinoma,How common are both FRY mutations and MRPL32 amplifications within Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+68,FRY,S1938A,Bladder Urothelial Carcinoma,How common are both FRY mutations and GPRASP1 amplifications within Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+69,FRY,S1983A,Bladder Urothelial Carcinoma,How common are both FRY mutations and MYO16 amplifications within Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+70,PAK3,E318K,Skin Cutaneous Melanoma,How common are both PAK3 mutations and PXN amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+71,PAK3,E319K,Skin Cutaneous Melanoma,How common are both PAK3 mutations and PHLPP1 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+72,PAK3,E334K,Skin Cutaneous Melanoma,How common are both PAK3 mutations and EIF2B4 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+73,PAK3,E340K,Skin Cutaneous Melanoma,How common are both PAK3 mutations and JAML amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+74,PAK3,E355K,Skin Cutaneous Melanoma,How common are both PAK3 mutations and SMO amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+80,MUC16,P7963L,Skin Cutaneous Melanoma,How common are both MUC16 mutations and SYT9 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,How common are both ZFPM2 mutations and RIPOR2 amplifications within Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,How common are both ZFPM2 mutations and PGF amplifications within Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,How common are both PIK3C2B mutations and ZBTB34 amplifications within Breast Invasive Carcinoma cases?,cnv_and_ssm
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,How common are both PIK3C2B mutations and SORCS1 amplifications within Breast Invasive Carcinoma cases?,cnv_and_ssm
+114,ZNF804A,S371Y,Colon Adenocarcinoma,How common are both ZNF804A mutations and GSTCD amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+116,RELN,A2371V,Stomach Adenocarcinoma,How common are both RELN mutations and DGKD amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are both EFCAB12 mutations and PGF amplifications within CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are both EFCAB12 mutations and CTNNA2 amplifications within CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+120,DEFB115,E53K,Skin Cutaneous Melanoma,How common are both DEFB115 mutations and KIF20B amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,How common are both ANKDD1A mutations and FGF8 amplifications within Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,How common are both ANKDD1A mutations and XKR4 amplifications within Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,How common are both ANKDD1A mutations and CNGB1 amplifications within Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,How common are both HTR3B mutations and TLK2 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,How common are both HTR3B mutations and RIMS2 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,How common are both HTR3B mutations and ZNF804A amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+129,ABCC3,R758W,Stomach Adenocarcinoma,How common are both ABCC3 mutations and TMEM255A amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,How common are both NOMO1 mutations and RIMS2 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,How common are both NOMO1 mutations and CA9 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,How common are both HYOU1 mutations and BCAT1 amplifications within Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+139,FMO4,R500Q,Skin Cutaneous Melanoma,How common are both FMO4 mutations and MAOB amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+140,BICC1,A372V,Exceptional Responders,How common are both BICC1 mutations and FGF8 amplifications within Exceptional Responders cases?,cnv_and_ssm
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,How common are both ZMYM3 mutations and DNAH14 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,How common are both ZMYM3 mutations and TNS1 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,How common are both ZMYM3 mutations and MERTK amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are both XKR4 mutations and ART3 amplifications within CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,How common are both ABCC2 mutations and TENT5A amplifications within Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+157,OR8K5,R293G,Lung Adenocarcinoma,How common are both OR8K5 mutations and MYO15A amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,How common are both SPTAN1 mutations and GRM1 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,How common are both SPTAN1 mutations and RIMS2 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+164,SYT10,M484I,Rectum Adenocarcinoma,How common are both SYT10 mutations and PRSS8 amplifications within Rectum Adenocarcinoma cases?,cnv_and_ssm
+174,HSPA5,N457K,Skin Cutaneous Melanoma,How common are both HSPA5 mutations and FRY amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+175,UNC5D,L280V,Lung Adenocarcinoma,How common are both UNC5D mutations and ANKRD30A amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+176,UNC5D,L635V,Lung Adenocarcinoma,How common are both UNC5D mutations and MYO15A amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+177,UNC5D,L637V,Lung Adenocarcinoma,How common are both UNC5D mutations and ABCC2 amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+178,UNC5D,L699V,Lung Adenocarcinoma,How common are both UNC5D mutations and CX3CR1 amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+179,UNC5D,L704V,Lung Adenocarcinoma,How common are both UNC5D mutations and EFCAB12 amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+180,UNC5D,L709V,Lung Adenocarcinoma,How common are both UNC5D mutations and OLFML3 amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,How common are both DOCK2 mutations and TYK2 amplifications within Kidney Renal Clear Cell Carcinoma cases?,cnv_and_ssm
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,How common are both ZNF627 mutations and HBB amplifications within Kidney Renal Clear Cell Carcinoma cases?,cnv_and_ssm
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,How common are both CDC42BPA mutations and STK19 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+193,MRPL55,H27Y,Colon Adenocarcinoma,How common are both MRPL55 mutations and FNDC7 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+194,MRPL55,H63Y,Colon Adenocarcinoma,How common are both MRPL55 mutations and EPRS1 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+197,TMTC3,Q749K,Breast Invasive Carcinoma,How common are both TMTC3 mutations and DSCAM amplifications within Breast Invasive Carcinoma cases?,cnv_and_ssm
+198,EPRS1,K771I,Colon Adenocarcinoma,How common are both EPRS1 mutations and TENM3 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+199,EPRS1,K778I,Colon Adenocarcinoma,How common are both EPRS1 mutations and PXN amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+201,GRTP1,A110V,Skin Cutaneous Melanoma,How common are both GRTP1 mutations and CASZ1 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+202,GRTP1,A32V,Skin Cutaneous Melanoma,How common are both GRTP1 mutations and PXN amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,How common are both TSHZ3 mutations and CHODL amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,How common are both TAS1R3 mutations and AUTS2 amplifications within HIV+ Tumor Molecular Characterization Project - Cervical Cancer cases?,cnv_and_ssm
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,How common are both PIAS3 mutations and CFAP298-TCP10L amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,How common are both PIAS3 mutations and JAML amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+251,ZNF274,P13R,Stomach Adenocarcinoma,How common are both ZNF274 mutations and SYT9 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+253,SYNJ1,R795C,Colon Adenocarcinoma,How common are both SYNJ1 mutations and DNMT1 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+254,SYNJ1,R800C,Colon Adenocarcinoma,How common are both SYNJ1 mutations and THBS4 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+255,SYNJ1,R839C,Colon Adenocarcinoma,How common are both SYNJ1 mutations and MUC16 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+261,DSCAM,V343M,Prostate Adenocarcinoma,How common are both DSCAM mutations and ACTB amplifications within Prostate Adenocarcinoma cases?,cnv_and_ssm
+262,DSCAM,V426M,Prostate Adenocarcinoma,How common are both DSCAM mutations and NEXN amplifications within Prostate Adenocarcinoma cases?,cnv_and_ssm
+263,DSCAM,V591M,Prostate Adenocarcinoma,How common are both DSCAM mutations and RIMS2 amplifications within Prostate Adenocarcinoma cases?,cnv_and_ssm
+267,DGKD,R140H,Exceptional Responders,How common are both DGKD mutations and OLFML3 amplifications within Exceptional Responders cases?,cnv_and_ssm
+268,DGKD,R160H,Exceptional Responders,How common are both DGKD mutations and LDOC1 amplifications within Exceptional Responders cases?,cnv_and_ssm
+269,DGKD,R204H,Exceptional Responders,How common are both DGKD mutations and POLD1 amplifications within Exceptional Responders cases?,cnv_and_ssm
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,How common are both PLEKHG6 mutations and TET2 amplifications within Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,How common are both PLEKHG6 mutations and ART3 amplifications within Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,How common are both PLEKHG6 mutations and CPS1 amplifications within Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+279,WNT2,D138N,Skin Cutaneous Melanoma,How common are both WNT2 mutations and TTC17 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,How common are both GUCY2C mutations and ABCC2 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,How common are both C7orf31 mutations and TYROBP amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are both ZKSCAN7 mutations and SORCS1 amplifications within CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+299,OR5D14,M210L,Neuroblastoma,How common are both OR5D14 mutations and PTPRO amplifications within Neuroblastoma cases?,cnv_and_ssm
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,How common are both SPATA22 mutations and DPF3 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,How common are both SPATA22 mutations and TENT5A amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,How common are both SPATA22 mutations and DGKD amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+310,LCN15,E21V,Stomach Adenocarcinoma,How common are both LCN15 mutations and PIK3C2A amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,How common are both DCAF4L2 mutations and TRAP1 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,How common are both GUK1 mutations and CNGB1 amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,How common are both GUK1 mutations and TNS1 amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,How common are both GUK1 mutations and CTSC amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,How common are both GUK1 mutations and DNMT1 amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,How common are both GUK1 mutations and DCAF6 amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+328,MORF4L1,K29T,Stomach Adenocarcinoma,How common are both MORF4L1 mutations and PIAS3 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+329,MORF4L1,K51T,Stomach Adenocarcinoma,How common are both MORF4L1 mutations and PHLPP1 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+330,MORF4L1,K61T,Stomach Adenocarcinoma,How common are both MORF4L1 mutations and SLC9C1 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+331,MORF4L1,K76T,Stomach Adenocarcinoma,How common are both MORF4L1 mutations and AQP7 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+335,MYO3B,F594L,Skin Cutaneous Melanoma,How common are both MYO3B mutations and DCC amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+336,MYO3B,F603L,Skin Cutaneous Melanoma,How common are both MYO3B mutations and TNS1 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+339,TENT5A,S320F,Skin Cutaneous Melanoma,How common are both TENT5A mutations and TAF1C amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+340,TENT5A,S339F,Skin Cutaneous Melanoma,How common are both TENT5A mutations and KIF20B amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+341,TENT5A,S401F,Skin Cutaneous Melanoma,How common are both TENT5A mutations and GABRA6 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,How common are both ZFAT mutations and MAD1L1 amplifications within Ovarian Serous Cystadenocarcinoma cases?,cnv_and_ssm
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,How common are both ZFAT mutations and AUTS2 amplifications within Ovarian Serous Cystadenocarcinoma cases?,cnv_and_ssm
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,How common are both ZFAT mutations and DCAF6 amplifications within Ovarian Serous Cystadenocarcinoma cases?,cnv_and_ssm
+357,ZNF584,A211T,Sarcoma,How common are both ZNF584 mutations and ZNF708 amplifications within Sarcoma cases?,cnv_and_ssm
+358,ZNF584,A256T,Sarcoma,How common are both ZNF584 mutations and GABRA6 amplifications within Sarcoma cases?,cnv_and_ssm
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,How common are both LDOC1 mutations and MAD1L1 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,How common are both PDGFC mutations and PDGFC amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,How common are both MSANTD4 mutations and ITPRID2 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+374,NPSR1,S123L,Skin Cutaneous Melanoma,How common are both NPSR1 mutations and CDKN2AIP amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,How common are both PHLPP1 mutations and DNAH11 amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+385,COL6A3,G237S,Skin Cutaneous Melanoma,How common are both COL6A3 mutations and POLD1 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+386,COL6A3,G437S,Skin Cutaneous Melanoma,How common are both COL6A3 mutations and CX3CR1 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+387,COL6A3,G638S,Skin Cutaneous Melanoma,How common are both COL6A3 mutations and MAST4 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+388,COL6A3,G644S,Skin Cutaneous Melanoma,How common are both COL6A3 mutations and NEXN amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+389,COL6A3,G844S,Skin Cutaneous Melanoma,How common are both COL6A3 mutations and TRAP1 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+395,ADRA1A,R348G,Stomach Adenocarcinoma,How common are both ADRA1A mutations and TMTC3 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common are both LAMB2 mutations and CARMIL1 amplifications within Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+406,POC1B,I198T,Rectum Adenocarcinoma,How common are both POC1B mutations and DCAF6 amplifications within Rectum Adenocarcinoma cases?,cnv_and_ssm
+407,POC1B,I286T,Rectum Adenocarcinoma,How common are both POC1B mutations and SMO amplifications within Rectum Adenocarcinoma cases?,cnv_and_ssm
+408,POC1B,I328T,Rectum Adenocarcinoma,How common are both POC1B mutations and POC1B amplifications within Rectum Adenocarcinoma cases?,cnv_and_ssm
+409,POC1B,S79P,Rectum Adenocarcinoma,How common are both POC1B mutations and PCDHB2 amplifications within Rectum Adenocarcinoma cases?,cnv_and_ssm
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,How common are both USH2A mutations and MAST4 amplifications within Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+414,AQP7,T110S,Rectum Adenocarcinoma,How common are both AQP7 mutations and CDH23 amplifications within Rectum Adenocarcinoma cases?,cnv_and_ssm
+415,AQP7,T166S,Rectum Adenocarcinoma,How common are both AQP7 mutations and TNS1 amplifications within Rectum Adenocarcinoma cases?,cnv_and_ssm
+416,AQP7,T167S,Rectum Adenocarcinoma,How common are both AQP7 mutations and GUK1 amplifications within Rectum Adenocarcinoma cases?,cnv_and_ssm
+417,AQP7,T75S,Rectum Adenocarcinoma,How common are both AQP7 mutations and C7orf31 amplifications within Rectum Adenocarcinoma cases?,cnv_and_ssm
+430,DCN,R163C,Rectum Adenocarcinoma,How common are both DCN mutations and CDH23 amplifications within Rectum Adenocarcinoma cases?,cnv_and_ssm
+431,DCN,R203C,Rectum Adenocarcinoma,How common are both DCN mutations and MYH11 amplifications within Rectum Adenocarcinoma cases?,cnv_and_ssm
+432,DCN,R241C,Rectum Adenocarcinoma,How common are both DCN mutations and PXN amplifications within Rectum Adenocarcinoma cases?,cnv_and_ssm
+433,DCN,R350C,Rectum Adenocarcinoma,How common are both DCN mutations and TASOR2 amplifications within Rectum Adenocarcinoma cases?,cnv_and_ssm
+434,DCN,R41C,Rectum Adenocarcinoma,How common are both DCN mutations and BICC1 amplifications within Rectum Adenocarcinoma cases?,cnv_and_ssm
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,How common are both CPS1 mutations and UNC5D amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,How common are both CPS1 mutations and DGKD amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,How common are both CPS1 mutations and MED16 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,How common are both FCGR2C mutations and MERTK amplifications within Kidney Renal Papillary Cell Carcinoma cases?,cnv_and_ssm
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,How common are both FCGR2C mutations and FBXO15 amplifications within Kidney Renal Papillary Cell Carcinoma cases?,cnv_and_ssm
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,How common are both GRM1 mutations and ZMYM3 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+482,SGCZ,Q138H,Lung Adenocarcinoma,How common are both SGCZ mutations and ZCCHC14 amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+483,SGCZ,Q91H,Lung Adenocarcinoma,How common are both SGCZ mutations and PIAS3 amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+485,SMO,V15M,Stomach Adenocarcinoma,How common are both SMO mutations and POLR1G amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+486,SMO,V321M,Stomach Adenocarcinoma,How common are both SMO mutations and TLCD5 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+488,CHODL,G159E,Skin Cutaneous Melanoma,How common are both CHODL mutations and PTPRO amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+489,CHODL,G181E,Skin Cutaneous Melanoma,How common are both CHODL mutations and HTR3B amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+490,CHODL,G200E,Skin Cutaneous Melanoma,How common are both CHODL mutations and EIF2B4 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+494,MYO16,P399H,Colon Adenocarcinoma,How common are both MYO16 mutations and FRY amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+495,MYO16,P421H,Colon Adenocarcinoma,How common are both MYO16 mutations and ZNF431 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+498,CXCR2,A98V,Stomach Adenocarcinoma,How common are both CXCR2 mutations and PAK3 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,How common are both TMEM225 mutations and ZNF627 amplifications within Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,How common are both MAOB mutations and ARHGEF40 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,How common are both GPRASP1 mutations and EVC2 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,How common are both MRPL32 mutations and DNAH11 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,How common are both TYROBP mutations and AUTS2 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+510,RAB40C,A111V,Lung Adenocarcinoma,How common are both RAB40C mutations and DCC amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+511,RAB40C,A143V,Lung Adenocarcinoma,How common are both RAB40C mutations and FCGR2C amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+512,CTNNA2,S323R,Lung Adenocarcinoma,How common are both CTNNA2 mutations and SGCZ amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+513,CTNNA2,S339R,Lung Adenocarcinoma,How common are both CTNNA2 mutations and DCLK3 amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+514,CTNNA2,S386R,Lung Adenocarcinoma,How common are both CTNNA2 mutations and NEXN amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+515,CTNNA2,S707R,Lung Adenocarcinoma,How common are both CTNNA2 mutations and PTPRO amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,How common are both MYO15A mutations and TRPA1 amplifications within Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,How common are both GIMAP2 mutations and FGF8 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+532,KIF20B,N1160D,Glioblastoma Multiforme,How common are both KIF20B mutations and ANKRD24 amplifications within Glioblastoma Multiforme cases?,cnv_and_ssm
+533,KIF20B,N1200D,Glioblastoma Multiforme,How common are both KIF20B mutations and TENM2 amplifications within Glioblastoma Multiforme cases?,cnv_and_ssm
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,How common are both ADAM17 mutations and COL6A3 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,How common are both BCAT1 mutations and OR13C3 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,How common are both BCAT1 mutations and RIMS2 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,How common are both BCAT1 mutations and DSCAM amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+540,ERCC6,R1053H,Colon Adenocarcinoma,How common are both ERCC6 mutations and TASOR2 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+541,DCC,R320W,Breast Invasive Carcinoma,How common are both DCC mutations and ANKRD24 amplifications within Breast Invasive Carcinoma cases?,cnv_and_ssm
+542,DCC,R363W,Breast Invasive Carcinoma,How common are both DCC mutations and FBXO42 amplifications within Breast Invasive Carcinoma cases?,cnv_and_ssm
+543,DCC,R386W,Breast Invasive Carcinoma,How common are both DCC mutations and CTNNA2 amplifications within Breast Invasive Carcinoma cases?,cnv_and_ssm
+544,DCC,R41W,Breast Invasive Carcinoma,How common are both DCC mutations and DNAH11 amplifications within Breast Invasive Carcinoma cases?,cnv_and_ssm
+549,FBXO15,D417N,Skin Cutaneous Melanoma,How common are both FBXO15 mutations and ZNF584 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+550,FBXO15,D86N,Skin Cutaneous Melanoma,How common are both FBXO15 mutations and GPR158 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,How common are both GSTCD mutations and RIMS2 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,How common are both GSTCD mutations and PAPPA amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,How common are both OLFML3 mutations and POC1B amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,How common are both OLFML3 mutations and ACTL7B amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,How common are both OLFML3 mutations and FGF8 amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,How common are both CFAP61 mutations and MYO3A amplifications within Ovarian Serous Cystadenocarcinoma cases?,cnv_and_ssm
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,How common are both CFAP61 mutations and ANKRD30A amplifications within Ovarian Serous Cystadenocarcinoma cases?,cnv_and_ssm
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,How common are both HLA-DQA2 mutations and EFCAB12 amplifications within Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+582,TENM2,H240Y,Skin Cutaneous Melanoma,How common are both TENM2 mutations and ZNF708 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+583,TENM2,H351Y,Skin Cutaneous Melanoma,How common are both TENM2 mutations and ZFPM2 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+584,TENM2,H472Y,Skin Cutaneous Melanoma,How common are both TENM2 mutations and HTR3B amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+600,ANKRD24,A465T,Stomach Adenocarcinoma,How common are both ANKRD24 mutations and ZKSCAN7 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+601,ANKRD24,A494T,Stomach Adenocarcinoma,How common are both ANKRD24 mutations and MUC16 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+602,ANKRD24,A584T,Stomach Adenocarcinoma,How common are both ANKRD24 mutations and GSTCD amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,How common are both ZCCHC14 mutations and SOX21 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,How common are both ZCCHC14 mutations and PGF amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,How common are both ZCCHC14 mutations and CHODL amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,How common are both ZCCHC14 mutations and TENT5A amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+625,SIK2,I265M,Lung Adenocarcinoma,How common are both SIK2 mutations and SYT9 amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,How common are both MYH11 mutations and MAD1L1 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,How common are both MYH11 mutations and AUTS2 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,How common are both SLC6A4 mutations and TAF1C amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,How common are both SLC9C1 mutations and DCAF4L2 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,How common are both SLC9C1 mutations and TNS1 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+644,OR2A12,A254T,Brain Lower Grade Glioma,How common are both OR2A12 mutations and SPATA22 amplifications within Brain Lower Grade Glioma cases?,cnv_and_ssm
+646,PYHIN1,T325K,Lung Adenocarcinoma,How common are both PYHIN1 mutations and TAS1R3 amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+647,PYHIN1,T334K,Lung Adenocarcinoma,How common are both PYHIN1 mutations and KIF20B amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+650,JAML,G191E,Skin Cutaneous Melanoma,How common are both JAML mutations and FGF8 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+651,JAML,G219E,Skin Cutaneous Melanoma,How common are both JAML mutations and RIPOR2 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+652,JAML,G220E,Skin Cutaneous Melanoma,How common are both JAML mutations and DNAH14 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+653,JAML,G230E,Skin Cutaneous Melanoma,How common are both JAML mutations and BFAR amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+658,TYK2,H1146R,Stomach Adenocarcinoma,How common are both TYK2 mutations and TTYH2 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+659,TYK2,H23R,Stomach Adenocarcinoma,How common are both TYK2 mutations and CYP1A2 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+660,TYK2,H961R,Stomach Adenocarcinoma,How common are both TYK2 mutations and RIMS2 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,How common are both CTCFL mutations and TLK2 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,How common are both CTCFL mutations and ZFPM2 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,How common are both CTCFL mutations and PCDHB2 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,How common are both CTCFL mutations and SPATA22 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,How common are both CEP20 mutations and MAD1L1 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,How common are both CEP20 mutations and MED16 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+689,RIMS2,R25W,Skin Cutaneous Melanoma,How common are both RIMS2 mutations and PYHIN1 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+690,RIMS2,R393W,Skin Cutaneous Melanoma,How common are both RIMS2 mutations and RAB40C amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+691,RIMS2,R423W,Skin Cutaneous Melanoma,How common are both RIMS2 mutations and ANP32E amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+692,RIMS2,R470W,Skin Cutaneous Melanoma,How common are both RIMS2 mutations and DSCAM amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+693,RIMS2,R615W,Skin Cutaneous Melanoma,How common are both RIMS2 mutations and MORF4L1 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+694,RIMS2,R619W,Skin Cutaneous Melanoma,How common are both RIMS2 mutations and SPTAN1 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+695,RIMS2,R716W,Skin Cutaneous Melanoma,How common are both RIMS2 mutations and CTSC amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,How common are both PIK3C2G mutations and GLRB amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,How common are both PIK3C2G mutations and ZNF804A amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+728,STK19,D341N,Colon Adenocarcinoma,How common are both STK19 mutations and TENM3 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+729,STK19,D345N,Colon Adenocarcinoma,How common are both STK19 mutations and LDOC1 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+730,REXO4,P60A,Skin Cutaneous Melanoma,How common are both REXO4 mutations and CARMIL1 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,How common are both ZBTB34 mutations and OR2T4 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,How common are both ZBTB34 mutations and DCC amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,How common are both NCKAP5 mutations and PTPRN2 amplifications within Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are both SORCS1 mutations and ANKDD1A amplifications within CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are both SORCS1 mutations and TTN amplifications within CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are both SORCS1 mutations and PGR amplifications within CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are both SORCS1 mutations and FRY amplifications within CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,How common are both FGF8 mutations and SLC6A4 amplifications within Head and Neck Squamous Cell Carcinoma cases?,cnv_and_ssm
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,How common are both FGF8 mutations and PIAS3 amplifications within Head and Neck Squamous Cell Carcinoma cases?,cnv_and_ssm
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,How common are both FGF8 mutations and GRM1 amplifications within Head and Neck Squamous Cell Carcinoma cases?,cnv_and_ssm
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,How common are both FGF8 mutations and SLC9C1 amplifications within Head and Neck Squamous Cell Carcinoma cases?,cnv_and_ssm
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,How common are both FGF8 mutations and GPRASP1 amplifications within Head and Neck Squamous Cell Carcinoma cases?,cnv_and_ssm
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,How common are both TENM3 mutations and ANKRD52 amplifications within Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia cases?,cnv_and_ssm
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,How common are both AKT1 mutations and DGKD amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common are both CFAP298-TCP10L mutations and MED16 amplifications within Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+792,GLRB,E148D,Stomach Adenocarcinoma,How common are both GLRB mutations and HBB amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+793,TTN,F7636L,Colon Adenocarcinoma,How common are both TTN mutations and ARMC3 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+794,TTN,F8563L,Colon Adenocarcinoma,How common are both TTN mutations and PCDHB2 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+795,TTN,F8880L,Colon Adenocarcinoma,How common are both TTN mutations and GRM5 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+799,ANKRD30A,V798I,Colon Adenocarcinoma,How common are both ANKRD30A mutations and TNS1 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+800,ANKRD30A,V854I,Colon Adenocarcinoma,How common are both ANKRD30A mutations and DNAH11 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+801,ANKRD30A,V973I,Colon Adenocarcinoma,How common are both ANKRD30A mutations and ZFPM2 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+809,TRIM45,S177L,Colon Adenocarcinoma,How common are both TRIM45 mutations and POC1B amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+810,TRIM45,S224L,Colon Adenocarcinoma,How common are both TRIM45 mutations and CPA6 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+811,TRIM45,S281L,Colon Adenocarcinoma,How common are both TRIM45 mutations and TTYH2 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+812,CACNA1F,G727V,Stomach Adenocarcinoma,How common are both CACNA1F mutations and CHMP7 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+813,CACNA1F,G781V,Stomach Adenocarcinoma,How common are both CACNA1F mutations and PAK3 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+814,CACNA1F,G792V,Stomach Adenocarcinoma,How common are both CACNA1F mutations and PIK3C2G amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+817,KL,R594C,Colon Adenocarcinoma,How common are both KL mutations and SYNJ1 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,How common are both GUF1 mutations and SPATA22 amplifications within Kidney Renal Papillary Cell Carcinoma cases?,cnv_and_ssm
+822,TAF1L,A539V,Colon Adenocarcinoma,How common are both TAF1L mutations and FNDC7 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+823,TASOR2,S256F,Skin Cutaneous Melanoma,How common are both TASOR2 mutations and TENT5A amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+824,TASOR2,S36F,Skin Cutaneous Melanoma,How common are both TASOR2 mutations and FRY amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+825,TASOR2,S471F,Skin Cutaneous Melanoma,How common are both TASOR2 mutations and TTC12 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,How common are both KDM5C mutations and SPAG1 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,How common are both KDM5C mutations and TRIM45 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,How common are both KDM5C mutations and CHODL amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,How common are both KDM5C mutations and SERPINB10 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common are both IL5RA mutations and FRY amplifications within Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+843,DHX16,A29V,Skin Cutaneous Melanoma,How common are both DHX16 mutations and FNDC7 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+844,DHX16,A89V,Skin Cutaneous Melanoma,How common are both DHX16 mutations and MORF4L1 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+902,GPR158,A644V,Stomach Adenocarcinoma,How common are both GPR158 mutations and CNGB1 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+903,GPR158,A723V,Stomach Adenocarcinoma,How common are both GPR158 mutations and MYO16 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are both EIF2B4 mutations and PTPRO amplifications within CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are both EIF2B4 mutations and PTPRN2 amplifications within CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are both EIF2B4 mutations and MAST4 amplifications within CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are both EIF2B4 mutations and SLC6A4 amplifications within CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are both EIF2B4 mutations and CTSC amplifications within CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are both EIF2B4 mutations and DGKD amplifications within CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,How common are both AUTS2 mutations and AQP7 amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,How common are both AUTS2 mutations and AUTS2 amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,How common are both AUTS2 mutations and NRAP amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,How common are both AUTS2 mutations and OR5D14 amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,How common are both AUTS2 mutations and AQP7 amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,How common are both AUTS2 mutations and EIF2B4 amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,How common are both AUTS2 mutations and CHMP7 amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,How common are both AUTS2 mutations and UNC5D amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,How common are both AUTS2 mutations and THBS4 amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,How common are both AUTS2 mutations and CHODL amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are both ACTL7B mutations and BFAR amplifications within CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+952,PCDHGA1,R535W,Glioblastoma Multiforme,How common are both PCDHGA1 mutations and ANKRD30A amplifications within Glioblastoma Multiforme cases?,cnv_and_ssm
+954,TRAP1,R114W,Stomach Adenocarcinoma,How common are both TRAP1 mutations and SYT9 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+955,TRAP1,R61W,Stomach Adenocarcinoma,How common are both TRAP1 mutations and TNS1 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,How common are both PIK3C2A mutations and PIK3C2A amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,How common are both KANSL1 mutations and TTYH2 amplifications within Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,How common are both ANKRD52 mutations and DHX16 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,How common are both PAPPA mutations and ADAM17 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,How common are both B3GALNT1 mutations and YY1AP1 amplifications within Rectum Adenocarcinoma cases?,cnv_and_ssm
+982,GABRA6,G115R,Lung Adenocarcinoma,How common are both GABRA6 mutations and KDM5C amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+983,GABRA6,G122R,Lung Adenocarcinoma,How common are both GABRA6 mutations and ARMC3 amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+984,GABRA6,G165R,Lung Adenocarcinoma,How common are both GABRA6 mutations and GSTCD amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+985,GABRA6,G175R,Lung Adenocarcinoma,How common are both GABRA6 mutations and DGKD amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+986,GABRA6,G70R,Lung Adenocarcinoma,How common are both GABRA6 mutations and PIAS3 amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,How common are both ZSCAN31 mutations and CYP1A2 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are both MED16 mutations and BICC1 amplifications within CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are both MED16 mutations and ACTB amplifications within CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,How common are both PTPRO mutations and YY1AP1 amplifications within Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,How common are both PTPRO mutations and PXN amplifications within Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,How common are both PTPRO mutations and CARMIL1 amplifications within Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,How common are both PTPRO mutations and ZCCHC14 amplifications within Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,How common are both PTPRO mutations and DEFB115 amplifications within Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,How common are both PTPRO mutations and SGIP1 amplifications within Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,How common are both PTPRO mutations and XKR4 amplifications within Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,How common are both PTPRO mutations and AQP7 amplifications within Pancreatic Adenocarcinoma cases?,cnv_and_ssm
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,How common are both CHMP7 mutations and JAML amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1017,GPC3,I107N,Stomach Adenocarcinoma,How common are both GPC3 mutations and PKHD1L1 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+1018,GPC3,I161N,Stomach Adenocarcinoma,How common are both GPC3 mutations and OR13C3 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common are both TLK2 mutations and MYO3B amplifications within Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common are both TLK2 mutations and PXN amplifications within Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common are both TLK2 mutations and DEFB115 amplifications within Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common are both TLK2 mutations and YY1AP1 amplifications within Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,How common are both TLK2 mutations and TMEM255A amplifications within Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cases?,cnv_and_ssm
+1036,ZNF217,E209Q,Lung Adenocarcinoma,How common are both ZNF217 mutations and THBS4 amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+1038,SYT9,V275L,Lung Adenocarcinoma,How common are both SYT9 mutations and YY1AP1 amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+1039,SYT9,V307L,Lung Adenocarcinoma,How common are both SYT9 mutations and PXN amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,How common are both PKHD1L1 mutations and TLK2 amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,How common are both MYO3A mutations and MAD1L1 amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are both VASN mutations and MYO3B amplifications within CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,How common are both DNMT1 mutations and DGKD amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,How common are both DNMT1 mutations and TENT5A amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,How common are both DNMT1 mutations and GABRA6 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1056,CA9,E402K,Colon Adenocarcinoma,How common are both CA9 mutations and PGR amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,How common are both TTC17 mutations and ZFPM2 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,How common are both TTC17 mutations and RAB40C amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1065,PSG2,P43L,Breast Invasive Carcinoma,How common are both PSG2 mutations and TASOR2 amplifications within Breast Invasive Carcinoma cases?,cnv_and_ssm
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,How common are both RIPOR2 mutations and ZBTB34 amplifications within Breast Invasive Carcinoma cases?,cnv_and_ssm
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,How common are both RIPOR2 mutations and TASOR2 amplifications within Breast Invasive Carcinoma cases?,cnv_and_ssm
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,How common are both RIPOR2 mutations and OR13C3 amplifications within Breast Invasive Carcinoma cases?,cnv_and_ssm
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,How common are both RIPOR2 mutations and TRAP1 amplifications within Breast Invasive Carcinoma cases?,cnv_and_ssm
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,How common are both DCLK3 mutations and USH2A amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,How common are both DCLK3 mutations and CTCFL amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,How common are both MERTK mutations and ACVR1B amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,How common are both MERTK mutations and ICE1 amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,How common are both MERTK mutations and RIPOR2 amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,How common are both ZFP42 mutations and AKT1 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,How common are both OR13C3 mutations and MYH11 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,How common are both OR13C3 mutations and ADRA1A amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1091,SPAG1,I917M,Stomach Adenocarcinoma,How common are both SPAG1 mutations and SOX21 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,How common are both CDKN2AIP mutations and CNGB1 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1093,PXN,H1016Y,Colon Adenocarcinoma,How common are both PXN mutations and CTNNA2 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+1094,PXN,H359Y,Colon Adenocarcinoma,How common are both PXN mutations and DCAF6 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+1095,PXN,H492Y,Colon Adenocarcinoma,How common are both PXN mutations and TET2 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+1096,PXN,H524Y,Colon Adenocarcinoma,How common are both PXN mutations and POC1B amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+1097,PXN,H526Y,Colon Adenocarcinoma,How common are both PXN mutations and KL amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+1098,PXN,H540Y,Colon Adenocarcinoma,How common are both PXN mutations and EVC2 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,How common are both TTYH2 mutations and TRIM45 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,How common are both TTYH2 mutations and POC1B amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1106,TMEM255A,N205S,Colon Adenocarcinoma,How common are both TMEM255A mutations and TASOR2 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+1107,TMEM255A,N229S,Colon Adenocarcinoma,How common are both TMEM255A mutations and MAOB amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+1108,TMEM255A,N65S,Colon Adenocarcinoma,How common are both TMEM255A mutations and REXO4 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,How common are both TASOR2 mutations and PRSS1 amplifications within Breast Invasive Carcinoma cases?,cnv_and_ssm
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,How common are both TASOR2 mutations and TRPA1 amplifications within Breast Invasive Carcinoma cases?,cnv_and_ssm
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,How common are both ICE1 mutations and GUK1 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1112,MYT1,A558E,Breast Invasive Carcinoma,How common are both MYT1 mutations and TAF1C amplifications within Breast Invasive Carcinoma cases?,cnv_and_ssm
+1113,MYT1,A879E,Breast Invasive Carcinoma,How common are both MYT1 mutations and WNT2 amplifications within Breast Invasive Carcinoma cases?,cnv_and_ssm
+1114,MYT1,A906E,Breast Invasive Carcinoma,How common are both MYT1 mutations and ANKDD1A amplifications within Breast Invasive Carcinoma cases?,cnv_and_ssm
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,How common are both CX3CR1 mutations and AUTS2 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,How common are both CX3CR1 mutations and AUTS2 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,How common are both SPINDOC mutations and PYHIN1 amplifications within Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,How common are both ART3 mutations and POC1B amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,How common are both ART3 mutations and GSTCD amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,How common are both CYP1A2 mutations and NOMO1 amplifications within Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are both ADRA1A mutations and DNMT1 amplifications within CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,How common are both CDH23 mutations and JAML amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,How common are both CDH23 mutations and ANKRD30A amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1148,KRT39,P137S,Skin Cutaneous Melanoma,How common are both KRT39 mutations and PTPRN2 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,How common are both PDHA2 mutations and RIMS2 amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,How common are both SLC24A2 mutations and ANKDD1A amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,How common are both PTPRN2 mutations and PLEKHG6 amplifications within Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,How common are both PTPRN2 mutations and FCGR2C amplifications within Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,How common are both PTPRN2 mutations and FGF8 amplifications within Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,How common are both PTPRN2 mutations and PRSS8 amplifications within Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,How common are both PTPRN2 mutations and UNC5D amplifications within Liver Hepatocellular Carcinoma cases?,cnv_and_ssm
+1188,SOX21,R55L,Lung Adenocarcinoma,How common are both SOX21 mutations and ABCC2 amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,How common are both CPA6 mutations and KDM5C amplifications within Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+1206,GRM5,E14K,Skin Cutaneous Melanoma,How common are both GRM5 mutations and PXN amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are both CASZ1 mutations and CDH23 amplifications within CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+1210,SGIP1,N122T,Stomach Adenocarcinoma,How common are both SGIP1 mutations and ADRA1A amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+1211,SGIP1,N420T,Stomach Adenocarcinoma,How common are both SGIP1 mutations and TTC12 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+1212,SGIP1,N617T,Stomach Adenocarcinoma,How common are both SGIP1 mutations and PTPRN2 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+1213,SGIP1,N648T,Stomach Adenocarcinoma,How common are both SGIP1 mutations and THBS4 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+1227,CARMIL1,V549L,Lung Adenocarcinoma,How common are both CARMIL1 mutations and GABRA6 amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+1228,CARMIL1,V949L,Lung Adenocarcinoma,How common are both CARMIL1 mutations and OR2T4 amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+1232,ZNF431,D121Y,Lung Adenocarcinoma,How common are both ZNF431 mutations and TENT5A amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+1233,ZNF431,D161Y,Lung Adenocarcinoma,How common are both ZNF431 mutations and YY1AP1 amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+1234,ZNF431,R128I,Lung Adenocarcinoma,How common are both ZNF431 mutations and EIF2B4 amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,How common are both DNAH11 mutations and ANKDD1A amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,How common are both DNAH11 mutations and STAT3 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,How common are both POLD1 mutations and TRIM45 amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,How common are both POLD1 mutations and HTR3B amplifications within Lung Squamous Cell Carcinoma cases?,cnv_and_ssm
+1248,TTC12,D646H,Lung Adenocarcinoma,How common are both TTC12 mutations and ANP32E amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+1249,TTC12,D652H,Lung Adenocarcinoma,How common are both TTC12 mutations and SIK2 amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,How common are both CNGB1 mutations and ANKRD30A amplifications within Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,How common are both CNGB1 mutations and IL5RA amplifications within Bladder Urothelial Carcinoma cases?,cnv_and_ssm
+1254,CTSC,E214V,Stomach Adenocarcinoma,How common are both CTSC mutations and MYH11 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+1255,CTSC,E291V,Stomach Adenocarcinoma,How common are both CTSC mutations and AQP7 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+1256,CTSC,E322V,Stomach Adenocarcinoma,How common are both CTSC mutations and RIPOR2 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+1257,CTSC,E324V,Stomach Adenocarcinoma,How common are both CTSC mutations and SGCZ amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+1258,CTSC,E335V,Stomach Adenocarcinoma,How common are both CTSC mutations and CYB5R2 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,How common are both PRSS8 mutations and ANP32E amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,How common are both PRSS8 mutations and TTC12 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,How common are both ARHGEF40 mutations and CTSC amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+1264,ACTB,A138T,Rectum Adenocarcinoma,How common are both ACTB mutations and SLC9C1 amplifications within Rectum Adenocarcinoma cases?,cnv_and_ssm
+1265,ACTB,A217T,Rectum Adenocarcinoma,How common are both ACTB mutations and CFAP298-TCP10L amplifications within Rectum Adenocarcinoma cases?,cnv_and_ssm
+1266,ACTB,A244T,Rectum Adenocarcinoma,How common are both ACTB mutations and DGKD amplifications within Rectum Adenocarcinoma cases?,cnv_and_ssm
+1267,ACTB,A260T,Rectum Adenocarcinoma,How common are both ACTB mutations and TLCD5 amplifications within Rectum Adenocarcinoma cases?,cnv_and_ssm
+1268,YY1AP1,V546D,Glioblastoma Multiforme,How common are both YY1AP1 mutations and SYNJ1 amplifications within Glioblastoma Multiforme cases?,cnv_and_ssm
+1269,YY1AP1,V557D,Glioblastoma Multiforme,How common are both YY1AP1 mutations and MAD1L1 amplifications within Glioblastoma Multiforme cases?,cnv_and_ssm
+1270,YY1AP1,V566D,Glioblastoma Multiforme,How common are both YY1AP1 mutations and GUK1 amplifications within Glioblastoma Multiforme cases?,cnv_and_ssm
+1271,YY1AP1,V577D,Glioblastoma Multiforme,How common are both YY1AP1 mutations and TLK2 amplifications within Glioblastoma Multiforme cases?,cnv_and_ssm
+1272,YY1AP1,V623D,Glioblastoma Multiforme,How common are both YY1AP1 mutations and MAD1L1 amplifications within Glioblastoma Multiforme cases?,cnv_and_ssm
+1273,YY1AP1,V695D,Glioblastoma Multiforme,How common are both YY1AP1 mutations and RELN amplifications within Glioblastoma Multiforme cases?,cnv_and_ssm
+1274,YY1AP1,V715D,Glioblastoma Multiforme,How common are both YY1AP1 mutations and CTCFL amplifications within Glioblastoma Multiforme cases?,cnv_and_ssm
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,How common are both FNDC7 mutations and VPS26B amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,How common are both FNDC7 mutations and ZCCHC14 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1299,TLCD5,G15V,Lung Adenocarcinoma,How common are both TLCD5 mutations and KDM5C amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+1300,TLCD5,G37V,Lung Adenocarcinoma,How common are both TLCD5 mutations and CDC42BPA amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,How common are both POLR1G mutations and RIMS2 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,How common are both POLR1G mutations and TLCD5 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1308,DNAH14,N1186K,Colon Adenocarcinoma,How common are both DNAH14 mutations and CTSC amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+1309,DNAH14,N2657K,Colon Adenocarcinoma,How common are both DNAH14 mutations and ZNF431 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+1310,DNAH14,N3460K,Colon Adenocarcinoma,How common are both DNAH14 mutations and POLD1 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,How common are both NEXN mutations and PXN amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,How common are both CYB5R2 mutations and ZMYM3 amplifications within Prostate Adenocarcinoma cases?,cnv_and_ssm
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,How common are both CYB5R2 mutations and DNAH11 amplifications within Prostate Adenocarcinoma cases?,cnv_and_ssm
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,How common are both NRAP mutations and RIMS2 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,How common are both NRAP mutations and ZFAT amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,How common are both NRAP mutations and PXN amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,How common are both CCDC22 mutations and EIF2B4 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,How common are both DCAF6 mutations and PRSS1 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,How common are both DCAF6 mutations and TAF1C amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,How common are both ZNF708 mutations and PXN amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,How common are both BFAR mutations and RIMS2 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,How common are both MAST4 mutations and AUTS2 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,How common are both MAST4 mutations and UNC5D amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,How common are both MAST4 mutations and BCAT1 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,How common are both MAST4 mutations and COL6A3 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,How common are both MAST4 mutations and SPAG1 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1363,ARMC3,R169C,Stomach Adenocarcinoma,How common are both ARMC3 mutations and MYT1 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+1364,ARMC3,R432C,Stomach Adenocarcinoma,How common are both ARMC3 mutations and SLC6A4 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,How common are both TET2 mutations and CTSC amplifications within Kidney Renal Clear Cell Carcinoma cases?,cnv_and_ssm
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,How common are both TET2 mutations and CNGB1 amplifications within Kidney Renal Clear Cell Carcinoma cases?,cnv_and_ssm
+1369,SERPINB10,A353P,Lung Adenocarcinoma,How common are both SERPINB10 mutations and NRAP amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,How common are both STAT3 mutations and SMO amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,How common are both MIEF1 mutations and ITPRID2 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1381,ACVR1B,D397N,Colon Adenocarcinoma,How common are both ACVR1B mutations and TAS1R3 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+1382,ACVR1B,D449N,Colon Adenocarcinoma,How common are both ACVR1B mutations and CFAP61 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+1383,ACVR1B,D490N,Colon Adenocarcinoma,How common are both ACVR1B mutations and TRPA1 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+1393,EBF2,T104I,Stomach Adenocarcinoma,How common are both EBF2 mutations and GRTP1 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+1394,EBF2,T252I,Stomach Adenocarcinoma,How common are both EBF2 mutations and PCDHB2 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+1402,VPS26B,F266L,Stomach Adenocarcinoma,How common are both VPS26B mutations and CTNNA2 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are both PGR mutations and AUTS2 amplifications within CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are both PGR mutations and TENT5A amplifications within CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","How common are both PGR mutations and MAST4 amplifications within CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus cases?",cnv_and_ssm
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,How common are both ACTA2 mutations and PRSS8 amplifications within Skin Cutaneous Melanoma cases?,cnv_and_ssm
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,How common are both THBS4 mutations and TSHZ3 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,How common are both THBS4 mutations and GLRB amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1413,PRSS1,S114T,Lung Adenocarcinoma,How common are both PRSS1 mutations and NOMO1 amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+1414,PRSS1,S124T,Lung Adenocarcinoma,How common are both PRSS1 mutations and ANKRD24 amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+1415,PRSS1,S138T,Lung Adenocarcinoma,How common are both PRSS1 mutations and PAPPA amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+1416,PRSS1,S74T,Lung Adenocarcinoma,How common are both PRSS1 mutations and KDM5C amplifications within Lung Adenocarcinoma cases?,cnv_and_ssm
+1417,PGF,R126H,Stomach Adenocarcinoma,How common are both PGF mutations and GIMAP2 amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+1418,PGF,R127H,Stomach Adenocarcinoma,How common are both PGF mutations and MYO15A amplifications within Stomach Adenocarcinoma cases?,cnv_and_ssm
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,How common are both ITPRID2 mutations and MERTK amplifications within Breast Invasive Carcinoma cases?,cnv_and_ssm
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,How common are both ITPRID2 mutations and RIPOR2 amplifications within Breast Invasive Carcinoma cases?,cnv_and_ssm
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,How common are both HBB mutations and PTPRN2 amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1441,PCDHB2,R158C,Colon Adenocarcinoma,How common are both PCDHB2 mutations and CACNA1F amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+1442,PCDHB2,T15M,Colon Adenocarcinoma,How common are both PCDHB2 mutations and COL6A3 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+1443,PCDHB2,T26M,Colon Adenocarcinoma,How common are both PCDHB2 mutations and CR1 amplifications within Colon Adenocarcinoma cases?,cnv_and_ssm
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,How common are both UBR2 mutations and FCGR2C amplifications within Uterine Corpus Endometrial Carcinoma cases?,cnv_and_ssm
+1452,FBXO42,A618D,Rectum Adenocarcinoma,How common are both FBXO42 mutations and MRPL32 amplifications within Rectum Adenocarcinoma cases?,cnv_and_ssm
+1,TNS1,G1362V,Breast Invasive Carcinoma,Can you specify the frequency at which TNS1 mutations and PLEKHG6 gains are seen in Breast Invasive Carcinoma?,cnv_and_ssm
+2,TNS1,G1711V,Breast Invasive Carcinoma,Can you specify the frequency at which TNS1 mutations and PXN gains are seen in Breast Invasive Carcinoma?,cnv_and_ssm
+3,TNS1,G1718V,Breast Invasive Carcinoma,Can you specify the frequency at which TNS1 mutations and RIMS2 gains are seen in Breast Invasive Carcinoma?,cnv_and_ssm
+4,TNS1,G1732V,Breast Invasive Carcinoma,Can you specify the frequency at which TNS1 mutations and FGF8 gains are seen in Breast Invasive Carcinoma?,cnv_and_ssm
+5,TNS1,G1824V,Breast Invasive Carcinoma,Can you specify the frequency at which TNS1 mutations and ART3 gains are seen in Breast Invasive Carcinoma?,cnv_and_ssm
+6,TNS1,G1857V,Breast Invasive Carcinoma,Can you specify the frequency at which TNS1 mutations and POLR1G gains are seen in Breast Invasive Carcinoma?,cnv_and_ssm
+7,TNS1,G843V,Breast Invasive Carcinoma,Can you specify the frequency at which TNS1 mutations and AQP7 gains are seen in Breast Invasive Carcinoma?,cnv_and_ssm
+14,EVC2,E1067K,Bladder Urothelial Carcinoma,Can you specify the frequency at which EVC2 mutations and TNS1 gains are seen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+15,EVC2,E987K,Bladder Urothelial Carcinoma,Can you specify the frequency at which EVC2 mutations and ACTB gains are seen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+18,CR1,V1108G,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which CR1 mutations and MERTK gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+19,CR1,V1558G,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which CR1 mutations and DCN gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+22,TRPA1,S295I,Rectum Adenocarcinoma,Can you specify the frequency at which TRPA1 mutations and TENT5A gains are seen in Rectum Adenocarcinoma?,cnv_and_ssm
+23,TRPA1,S443I,Rectum Adenocarcinoma,Can you specify the frequency at which TRPA1 mutations and DNAH14 gains are seen in Rectum Adenocarcinoma?,cnv_and_ssm
+24,TAF1C,R299L,Lung Adenocarcinoma,Can you specify the frequency at which TAF1C mutations and GSTCD gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+25,TAF1C,R396L,Lung Adenocarcinoma,Can you specify the frequency at which TAF1C mutations and GPR158 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+26,TAF1C,R634L,Lung Adenocarcinoma,Can you specify the frequency at which TAF1C mutations and MERTK gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+27,TAF1C,R702L,Lung Adenocarcinoma,Can you specify the frequency at which TAF1C mutations and DSCAM gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+28,TAF1C,R728L,Lung Adenocarcinoma,Can you specify the frequency at which TAF1C mutations and SGIP1 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+31,DPF3,R104W,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which DPF3 mutations and DNMT1 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+32,DPF3,R149W,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which DPF3 mutations and DCN gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+33,DPF3,R94W,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which DPF3 mutations and GRTP1 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+42,OR2T4,P272H,Lung Adenocarcinoma,Can you specify the frequency at which OR2T4 mutations and REXO4 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+43,OR2T4,P300H,Lung Adenocarcinoma,Can you specify the frequency at which OR2T4 mutations and DCC gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+44,FBN1,E2667K,Pancreatic Adenocarcinoma,Can you specify the frequency at which FBN1 mutations and PIAS3 gains are seen in Pancreatic Adenocarcinoma?,cnv_and_ssm
+45,MAD1L1,E396K,Prostate Adenocarcinoma,Can you specify the frequency at which MAD1L1 mutations and SORCS1 gains are seen in Prostate Adenocarcinoma?,cnv_and_ssm
+46,MAD1L1,E488K,Prostate Adenocarcinoma,Can you specify the frequency at which MAD1L1 mutations and GUK1 gains are seen in Prostate Adenocarcinoma?,cnv_and_ssm
+47,MAD1L1,E78K,Prostate Adenocarcinoma,Can you specify the frequency at which MAD1L1 mutations and NPSR1 gains are seen in Prostate Adenocarcinoma?,cnv_and_ssm
+61,CCNG1,E22K,Skin Cutaneous Melanoma,Can you specify the frequency at which CCNG1 mutations and TRAP1 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+62,ANP32E,N114T,Kidney Renal Papillary Cell Carcinoma,Can you specify the frequency at which ANP32E mutations and YY1AP1 gains are seen in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+63,ANP32E,N64T,Kidney Renal Papillary Cell Carcinoma,Can you specify the frequency at which ANP32E mutations and ANKRD24 gains are seen in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+64,ANP32E,N66T,Kidney Renal Papillary Cell Carcinoma,Can you specify the frequency at which ANP32E mutations and MUC16 gains are seen in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+65,ANP32E,N73T,Kidney Renal Papillary Cell Carcinoma,Can you specify the frequency at which ANP32E mutations and RIMS2 gains are seen in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+66,FRY,S1888A,Bladder Urothelial Carcinoma,Can you specify the frequency at which FRY mutations and BFAR gains are seen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+67,FRY,S1937A,Bladder Urothelial Carcinoma,Can you specify the frequency at which FRY mutations and XKR4 gains are seen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+68,FRY,S1938A,Bladder Urothelial Carcinoma,Can you specify the frequency at which FRY mutations and GUCY2C gains are seen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+69,FRY,S1983A,Bladder Urothelial Carcinoma,Can you specify the frequency at which FRY mutations and SGCZ gains are seen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+70,PAK3,E318K,Skin Cutaneous Melanoma,Can you specify the frequency at which PAK3 mutations and FGF8 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+71,PAK3,E319K,Skin Cutaneous Melanoma,Can you specify the frequency at which PAK3 mutations and MAST4 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+72,PAK3,E334K,Skin Cutaneous Melanoma,Can you specify the frequency at which PAK3 mutations and PTPRO gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+73,PAK3,E340K,Skin Cutaneous Melanoma,Can you specify the frequency at which PAK3 mutations and PGF gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+74,PAK3,E355K,Skin Cutaneous Melanoma,Can you specify the frequency at which PAK3 mutations and MORF4L1 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+80,MUC16,P7963L,Skin Cutaneous Melanoma,Can you specify the frequency at which MUC16 mutations and BICC1 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+84,ZFPM2,T498I,Liver Hepatocellular Carcinoma,Can you specify the frequency at which ZFPM2 mutations and MED16 gains are seen in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+85,ZFPM2,T630I,Liver Hepatocellular Carcinoma,Can you specify the frequency at which ZFPM2 mutations and UNC5D gains are seen in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+86,PIK3C2B,S1328C,Breast Invasive Carcinoma,Can you specify the frequency at which PIK3C2B mutations and CTCFL gains are seen in Breast Invasive Carcinoma?,cnv_and_ssm
+87,PIK3C2B,S1356C,Breast Invasive Carcinoma,Can you specify the frequency at which PIK3C2B mutations and EBF2 gains are seen in Breast Invasive Carcinoma?,cnv_and_ssm
+114,ZNF804A,S371Y,Colon Adenocarcinoma,Can you specify the frequency at which ZNF804A mutations and TRIM45 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+116,RELN,A2371V,Stomach Adenocarcinoma,Can you specify the frequency at which RELN mutations and ABCC2 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+117,EFCAB12,R173C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you specify the frequency at which EFCAB12 mutations and FRY gains are seen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+118,EFCAB12,R23C,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you specify the frequency at which EFCAB12 mutations and ANKRD30A gains are seen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+120,DEFB115,E53K,Skin Cutaneous Melanoma,Can you specify the frequency at which DEFB115 mutations and MYT1 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+121,ANKDD1A,S290F,Bladder Urothelial Carcinoma,Can you specify the frequency at which ANKDD1A mutations and GUK1 gains are seen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+122,ANKDD1A,S322F,Bladder Urothelial Carcinoma,Can you specify the frequency at which ANKDD1A mutations and SORCS1 gains are seen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+123,ANKDD1A,S413F,Bladder Urothelial Carcinoma,Can you specify the frequency at which ANKDD1A mutations and PAK3 gains are seen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+126,HTR3B,S146I,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which HTR3B mutations and MORF4L1 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+127,HTR3B,S206I,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which HTR3B mutations and CTSC gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+128,HTR3B,S217I,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which HTR3B mutations and POC1B gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+129,ABCC3,R758W,Stomach Adenocarcinoma,Can you specify the frequency at which ABCC3 mutations and UNC5D gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+133,NOMO1,T204I,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which NOMO1 mutations and OR2T4 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+134,NOMO1,T371I,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which NOMO1 mutations and FBXO15 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+137,HYOU1,D298H,Bladder Urothelial Carcinoma,Can you specify the frequency at which HYOU1 mutations and CTSC gains are seen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+139,FMO4,R500Q,Skin Cutaneous Melanoma,Can you specify the frequency at which FMO4 mutations and FNDC7 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+140,BICC1,A372V,Exceptional Responders,Can you specify the frequency at which BICC1 mutations and COL6A3 gains are seen in Exceptional Responders?,cnv_and_ssm
+150,ZMYM3,I920V,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which ZMYM3 mutations and OLFML3 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+151,ZMYM3,I932V,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which ZMYM3 mutations and SGCZ gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+152,ZMYM3,I934V,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which ZMYM3 mutations and GRTP1 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+153,XKR4,R547W,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you specify the frequency at which XKR4 mutations and CHODL gains are seen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+156,ABCC2,V239L,Liver Hepatocellular Carcinoma,Can you specify the frequency at which ABCC2 mutations and PAK3 gains are seen in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+157,OR8K5,R293G,Lung Adenocarcinoma,Can you specify the frequency at which OR8K5 mutations and NOMO1 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+160,SPTAN1,S1503F,Skin Cutaneous Melanoma,Can you specify the frequency at which SPTAN1 mutations and DNAH14 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+161,SPTAN1,S1523F,Skin Cutaneous Melanoma,Can you specify the frequency at which SPTAN1 mutations and TNS1 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+164,SYT10,M484I,Rectum Adenocarcinoma,Can you specify the frequency at which SYT10 mutations and GRM5 gains are seen in Rectum Adenocarcinoma?,cnv_and_ssm
+174,HSPA5,N457K,Skin Cutaneous Melanoma,Can you specify the frequency at which HSPA5 mutations and TRAP1 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+175,UNC5D,L280V,Lung Adenocarcinoma,Can you specify the frequency at which UNC5D mutations and DCAF6 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+176,UNC5D,L635V,Lung Adenocarcinoma,Can you specify the frequency at which UNC5D mutations and PLEKHG6 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+177,UNC5D,L637V,Lung Adenocarcinoma,Can you specify the frequency at which UNC5D mutations and GRTP1 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+178,UNC5D,L699V,Lung Adenocarcinoma,Can you specify the frequency at which UNC5D mutations and CTCFL gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+179,UNC5D,L704V,Lung Adenocarcinoma,Can you specify the frequency at which UNC5D mutations and GABRA6 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+180,UNC5D,L709V,Lung Adenocarcinoma,Can you specify the frequency at which UNC5D mutations and SPINDOC gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+187,DOCK2,L1527H,Kidney Renal Clear Cell Carcinoma,Can you specify the frequency at which DOCK2 mutations and DGKD gains are seen in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+190,ZNF627,A5V,Kidney Renal Clear Cell Carcinoma,Can you specify the frequency at which ZNF627 mutations and RIMS2 gains are seen in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+191,CDC42BPA,L823F,Skin Cutaneous Melanoma,Can you specify the frequency at which CDC42BPA mutations and ACTB gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+193,MRPL55,H27Y,Colon Adenocarcinoma,Can you specify the frequency at which MRPL55 mutations and BCAT1 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+194,MRPL55,H63Y,Colon Adenocarcinoma,Can you specify the frequency at which MRPL55 mutations and MRPL55 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+197,TMTC3,Q749K,Breast Invasive Carcinoma,Can you specify the frequency at which TMTC3 mutations and TAF1C gains are seen in Breast Invasive Carcinoma?,cnv_and_ssm
+198,EPRS1,K771I,Colon Adenocarcinoma,Can you specify the frequency at which EPRS1 mutations and ZNF217 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+199,EPRS1,K778I,Colon Adenocarcinoma,Can you specify the frequency at which EPRS1 mutations and IL5RA gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+201,GRTP1,A110V,Skin Cutaneous Melanoma,Can you specify the frequency at which GRTP1 mutations and TRIM45 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+202,GRTP1,A32V,Skin Cutaneous Melanoma,Can you specify the frequency at which GRTP1 mutations and SPAG1 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+216,TSHZ3,Q538K,Stomach Adenocarcinoma,Can you specify the frequency at which TSHZ3 mutations and CFAP298-TCP10L gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+224,TAS1R3,Q326H,HIV+ Tumor Molecular Characterization Project - Cervical Cancer,Can you specify the frequency at which TAS1R3 mutations and CTSC gains are seen in HIV+ Tumor Molecular Characterization Project - Cervical Cancer?,cnv_and_ssm
+234,PIAS3,S238C,Lung Squamous Cell Carcinoma,Can you specify the frequency at which PIAS3 mutations and ARHGEF40 gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+235,PIAS3,S273C,Lung Squamous Cell Carcinoma,Can you specify the frequency at which PIAS3 mutations and PDGFC gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+251,ZNF274,P13R,Stomach Adenocarcinoma,Can you specify the frequency at which ZNF274 mutations and MYH11 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+253,SYNJ1,R795C,Colon Adenocarcinoma,Can you specify the frequency at which SYNJ1 mutations and TLK2 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+254,SYNJ1,R800C,Colon Adenocarcinoma,Can you specify the frequency at which SYNJ1 mutations and MRPL55 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+255,SYNJ1,R839C,Colon Adenocarcinoma,Can you specify the frequency at which SYNJ1 mutations and PLEKHG6 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+261,DSCAM,V343M,Prostate Adenocarcinoma,Can you specify the frequency at which DSCAM mutations and FNDC7 gains are seen in Prostate Adenocarcinoma?,cnv_and_ssm
+262,DSCAM,V426M,Prostate Adenocarcinoma,Can you specify the frequency at which DSCAM mutations and DCN gains are seen in Prostate Adenocarcinoma?,cnv_and_ssm
+263,DSCAM,V591M,Prostate Adenocarcinoma,Can you specify the frequency at which DSCAM mutations and CACNA1F gains are seen in Prostate Adenocarcinoma?,cnv_and_ssm
+267,DGKD,R140H,Exceptional Responders,Can you specify the frequency at which DGKD mutations and DCC gains are seen in Exceptional Responders?,cnv_and_ssm
+268,DGKD,R160H,Exceptional Responders,Can you specify the frequency at which DGKD mutations and DSCAM gains are seen in Exceptional Responders?,cnv_and_ssm
+269,DGKD,R204H,Exceptional Responders,Can you specify the frequency at which DGKD mutations and NRAP gains are seen in Exceptional Responders?,cnv_and_ssm
+270,PLEKHG6,D105Y,Bladder Urothelial Carcinoma,Can you specify the frequency at which PLEKHG6 mutations and AQP7 gains are seen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+271,PLEKHG6,D543Y,Bladder Urothelial Carcinoma,Can you specify the frequency at which PLEKHG6 mutations and KDM5C gains are seen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+272,PLEKHG6,D575Y,Bladder Urothelial Carcinoma,Can you specify the frequency at which PLEKHG6 mutations and ZMYM3 gains are seen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+279,WNT2,D138N,Skin Cutaneous Melanoma,Can you specify the frequency at which WNT2 mutations and GUK1 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+293,GUCY2C,G667R,Skin Cutaneous Melanoma,Can you specify the frequency at which GUCY2C mutations and ART3 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+294,C7orf31,P244H,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which C7orf31 mutations and FRY gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+297,ZKSCAN7,E64K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you specify the frequency at which ZKSCAN7 mutations and PIK3C2G gains are seen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+299,OR5D14,M210L,Neuroblastoma,Can you specify the frequency at which OR5D14 mutations and GUK1 gains are seen in Neuroblastoma?,cnv_and_ssm
+307,SPATA22,K279E,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which SPATA22 mutations and GUK1 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+308,SPATA22,K306E,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which SPATA22 mutations and TLK2 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+309,SPATA22,K322E,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which SPATA22 mutations and PTPRO gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+310,LCN15,E21V,Stomach Adenocarcinoma,Can you specify the frequency at which LCN15 mutations and CTSC gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+311,DCAF4L2,S129F,Skin Cutaneous Melanoma,Can you specify the frequency at which DCAF4L2 mutations and PXN gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+312,GUK1,R135P,Lung Squamous Cell Carcinoma,Can you specify the frequency at which GUK1 mutations and GSTCD gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+313,GUK1,R137P,Lung Squamous Cell Carcinoma,Can you specify the frequency at which GUK1 mutations and FGF8 gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+314,GUK1,R139P,Lung Squamous Cell Carcinoma,Can you specify the frequency at which GUK1 mutations and TTC12 gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+315,GUK1,R158P,Lung Squamous Cell Carcinoma,Can you specify the frequency at which GUK1 mutations and ANKRD24 gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+316,GUK1,R203P,Lung Squamous Cell Carcinoma,Can you specify the frequency at which GUK1 mutations and FRY gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+328,MORF4L1,K29T,Stomach Adenocarcinoma,Can you specify the frequency at which MORF4L1 mutations and OR13C3 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+329,MORF4L1,K51T,Stomach Adenocarcinoma,Can you specify the frequency at which MORF4L1 mutations and RIMS2 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+330,MORF4L1,K61T,Stomach Adenocarcinoma,Can you specify the frequency at which MORF4L1 mutations and AQP7 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+331,MORF4L1,K76T,Stomach Adenocarcinoma,Can you specify the frequency at which MORF4L1 mutations and PIK3C2B gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+335,MYO3B,F594L,Skin Cutaneous Melanoma,Can you specify the frequency at which MYO3B mutations and PGR gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+336,MYO3B,F603L,Skin Cutaneous Melanoma,Can you specify the frequency at which MYO3B mutations and TET2 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+339,TENT5A,S320F,Skin Cutaneous Melanoma,Can you specify the frequency at which TENT5A mutations and TENM2 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+340,TENT5A,S339F,Skin Cutaneous Melanoma,Can you specify the frequency at which TENT5A mutations and DCC gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+341,TENT5A,S401F,Skin Cutaneous Melanoma,Can you specify the frequency at which TENT5A mutations and CYB5R2 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+351,ZFAT,S614L,Ovarian Serous Cystadenocarcinoma,Can you specify the frequency at which ZFAT mutations and SPAG1 gains are seen in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+352,ZFAT,S664L,Ovarian Serous Cystadenocarcinoma,Can you specify the frequency at which ZFAT mutations and DGKD gains are seen in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+353,ZFAT,S676L,Ovarian Serous Cystadenocarcinoma,Can you specify the frequency at which ZFAT mutations and SLC9C1 gains are seen in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+357,ZNF584,A211T,Sarcoma,Can you specify the frequency at which ZNF584 mutations and GRM1 gains are seen in Sarcoma?,cnv_and_ssm
+358,ZNF584,A256T,Sarcoma,Can you specify the frequency at which ZNF584 mutations and EFCAB12 gains are seen in Sarcoma?,cnv_and_ssm
+361,LDOC1,R63W,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which LDOC1 mutations and TYK2 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+364,PDGFC,R201G,Lung Squamous Cell Carcinoma,Can you specify the frequency at which PDGFC mutations and DSCAM gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+365,MSANTD4,R304C,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which MSANTD4 mutations and TMTC3 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+374,NPSR1,S123L,Skin Cutaneous Melanoma,Can you specify the frequency at which NPSR1 mutations and AQP7 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+382,PHLPP1,K1317E,Lung Squamous Cell Carcinoma,Can you specify the frequency at which PHLPP1 mutations and PIK3C2G gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+385,COL6A3,G237S,Skin Cutaneous Melanoma,Can you specify the frequency at which COL6A3 mutations and GUK1 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+386,COL6A3,G437S,Skin Cutaneous Melanoma,Can you specify the frequency at which COL6A3 mutations and TLCD5 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+387,COL6A3,G638S,Skin Cutaneous Melanoma,Can you specify the frequency at which COL6A3 mutations and SPTAN1 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+388,COL6A3,G644S,Skin Cutaneous Melanoma,Can you specify the frequency at which COL6A3 mutations and ZBTB34 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+389,COL6A3,G844S,Skin Cutaneous Melanoma,Can you specify the frequency at which COL6A3 mutations and TAS1R3 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+395,ADRA1A,R348G,Stomach Adenocarcinoma,Can you specify the frequency at which ADRA1A mutations and FNDC7 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+405,LAMB2,S1254F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you specify the frequency at which LAMB2 mutations and IL5RA gains are seen in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+406,POC1B,I198T,Rectum Adenocarcinoma,Can you specify the frequency at which POC1B mutations and JAML gains are seen in Rectum Adenocarcinoma?,cnv_and_ssm
+407,POC1B,I286T,Rectum Adenocarcinoma,Can you specify the frequency at which POC1B mutations and AUTS2 gains are seen in Rectum Adenocarcinoma?,cnv_and_ssm
+408,POC1B,I328T,Rectum Adenocarcinoma,Can you specify the frequency at which POC1B mutations and CHODL gains are seen in Rectum Adenocarcinoma?,cnv_and_ssm
+409,POC1B,S79P,Rectum Adenocarcinoma,Can you specify the frequency at which POC1B mutations and C7orf31 gains are seen in Rectum Adenocarcinoma?,cnv_and_ssm
+411,USH2A,G1451C,Liver Hepatocellular Carcinoma,Can you specify the frequency at which USH2A mutations and AUTS2 gains are seen in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+414,AQP7,T110S,Rectum Adenocarcinoma,Can you specify the frequency at which AQP7 mutations and RIPOR2 gains are seen in Rectum Adenocarcinoma?,cnv_and_ssm
+415,AQP7,T166S,Rectum Adenocarcinoma,Can you specify the frequency at which AQP7 mutations and TTC17 gains are seen in Rectum Adenocarcinoma?,cnv_and_ssm
+416,AQP7,T167S,Rectum Adenocarcinoma,Can you specify the frequency at which AQP7 mutations and AUTS2 gains are seen in Rectum Adenocarcinoma?,cnv_and_ssm
+417,AQP7,T75S,Rectum Adenocarcinoma,Can you specify the frequency at which AQP7 mutations and AUTS2 gains are seen in Rectum Adenocarcinoma?,cnv_and_ssm
+430,DCN,R163C,Rectum Adenocarcinoma,Can you specify the frequency at which DCN mutations and TLK2 gains are seen in Rectum Adenocarcinoma?,cnv_and_ssm
+431,DCN,R203C,Rectum Adenocarcinoma,Can you specify the frequency at which DCN mutations and STK19 gains are seen in Rectum Adenocarcinoma?,cnv_and_ssm
+432,DCN,R241C,Rectum Adenocarcinoma,Can you specify the frequency at which DCN mutations and EIF2B4 gains are seen in Rectum Adenocarcinoma?,cnv_and_ssm
+433,DCN,R350C,Rectum Adenocarcinoma,Can you specify the frequency at which DCN mutations and PTPRO gains are seen in Rectum Adenocarcinoma?,cnv_and_ssm
+434,DCN,R41C,Rectum Adenocarcinoma,Can you specify the frequency at which DCN mutations and TENM3 gains are seen in Rectum Adenocarcinoma?,cnv_and_ssm
+465,CPS1,K1269N,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which CPS1 mutations and AUTS2 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+466,CPS1,K1275N,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which CPS1 mutations and PXN gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+467,CPS1,K818N,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which CPS1 mutations and POC1B gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+477,FCGR2C,P122S,Kidney Renal Papillary Cell Carcinoma,Can you specify the frequency at which FCGR2C mutations and TMEM225 gains are seen in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+478,FCGR2C,P123S,Kidney Renal Papillary Cell Carcinoma,Can you specify the frequency at which FCGR2C mutations and ACTB gains are seen in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+480,GRM1,R280M,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which GRM1 mutations and ABCC3 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+482,SGCZ,Q138H,Lung Adenocarcinoma,Can you specify the frequency at which SGCZ mutations and PXN gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+483,SGCZ,Q91H,Lung Adenocarcinoma,Can you specify the frequency at which SGCZ mutations and CR1 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+485,SMO,V15M,Stomach Adenocarcinoma,Can you specify the frequency at which SMO mutations and GUK1 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+486,SMO,V321M,Stomach Adenocarcinoma,Can you specify the frequency at which SMO mutations and ANKRD30A gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+488,CHODL,G159E,Skin Cutaneous Melanoma,Can you specify the frequency at which CHODL mutations and FGF8 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+489,CHODL,G181E,Skin Cutaneous Melanoma,Can you specify the frequency at which CHODL mutations and CYP1A2 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+490,CHODL,G200E,Skin Cutaneous Melanoma,Can you specify the frequency at which CHODL mutations and SORCS1 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+494,MYO16,P399H,Colon Adenocarcinoma,Can you specify the frequency at which MYO16 mutations and UNC5D gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+495,MYO16,P421H,Colon Adenocarcinoma,Can you specify the frequency at which MYO16 mutations and TTYH2 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+498,CXCR2,A98V,Stomach Adenocarcinoma,Can you specify the frequency at which CXCR2 mutations and GABRA6 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+499,TMEM225,L212V,Bladder Urothelial Carcinoma,Can you specify the frequency at which TMEM225 mutations and SPTAN1 gains are seen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+500,MAOB,N251T,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which MAOB mutations and PIK3C2G gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+501,GPRASP1,F580S,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which GPRASP1 mutations and FGF8 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+506,MRPL32,R181Q,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which MRPL32 mutations and PAK3 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+508,TYROBP,A29T,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which TYROBP mutations and DCC gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+510,RAB40C,A111V,Lung Adenocarcinoma,Can you specify the frequency at which RAB40C mutations and MAST4 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+511,RAB40C,A143V,Lung Adenocarcinoma,Can you specify the frequency at which RAB40C mutations and RIMS2 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+512,CTNNA2,S323R,Lung Adenocarcinoma,Can you specify the frequency at which CTNNA2 mutations and CTCFL gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+513,CTNNA2,S339R,Lung Adenocarcinoma,Can you specify the frequency at which CTNNA2 mutations and ACVR1B gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+514,CTNNA2,S386R,Lung Adenocarcinoma,Can you specify the frequency at which CTNNA2 mutations and OLFML3 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+515,CTNNA2,S707R,Lung Adenocarcinoma,Can you specify the frequency at which CTNNA2 mutations and EBF2 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+528,MYO15A,S268R,Bladder Urothelial Carcinoma,Can you specify the frequency at which MYO15A mutations and MAD1L1 gains are seen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+529,GIMAP2,A167T,Skin Cutaneous Melanoma,Can you specify the frequency at which GIMAP2 mutations and TMTC3 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+532,KIF20B,N1160D,Glioblastoma Multiforme,Can you specify the frequency at which KIF20B mutations and PXN gains are seen in Glioblastoma Multiforme?,cnv_and_ssm
+533,KIF20B,N1200D,Glioblastoma Multiforme,Can you specify the frequency at which KIF20B mutations and CDKN2AIP gains are seen in Glioblastoma Multiforme?,cnv_and_ssm
+536,ADAM17,E583K,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which ADAM17 mutations and GUK1 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+537,BCAT1,G16R,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which BCAT1 mutations and RIMS2 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+538,BCAT1,G17R,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which BCAT1 mutations and TENM2 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+539,BCAT1,G29R,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which BCAT1 mutations and SPAG1 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+540,ERCC6,R1053H,Colon Adenocarcinoma,Can you specify the frequency at which ERCC6 mutations and DCC gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+541,DCC,R320W,Breast Invasive Carcinoma,Can you specify the frequency at which DCC mutations and TLK2 gains are seen in Breast Invasive Carcinoma?,cnv_and_ssm
+542,DCC,R363W,Breast Invasive Carcinoma,Can you specify the frequency at which DCC mutations and ZFP42 gains are seen in Breast Invasive Carcinoma?,cnv_and_ssm
+543,DCC,R386W,Breast Invasive Carcinoma,Can you specify the frequency at which DCC mutations and PXN gains are seen in Breast Invasive Carcinoma?,cnv_and_ssm
+544,DCC,R41W,Breast Invasive Carcinoma,Can you specify the frequency at which DCC mutations and CDH23 gains are seen in Breast Invasive Carcinoma?,cnv_and_ssm
+549,FBXO15,D417N,Skin Cutaneous Melanoma,Can you specify the frequency at which FBXO15 mutations and GSTCD gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+550,FBXO15,D86N,Skin Cutaneous Melanoma,Can you specify the frequency at which FBXO15 mutations and DSCAM gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+553,GSTCD,S528F,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which GSTCD mutations and AUTS2 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+554,GSTCD,S615F,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which GSTCD mutations and ZFP42 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+561,OLFML3,P296S,Lung Squamous Cell Carcinoma,Can you specify the frequency at which OLFML3 mutations and GUK1 gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+562,OLFML3,P337S,Lung Squamous Cell Carcinoma,Can you specify the frequency at which OLFML3 mutations and GLRB gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+563,OLFML3,P357S,Lung Squamous Cell Carcinoma,Can you specify the frequency at which OLFML3 mutations and MYT1 gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+567,CFAP61,E173V,Ovarian Serous Cystadenocarcinoma,Can you specify the frequency at which CFAP61 mutations and THBS4 gains are seen in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+568,CFAP61,E817V,Ovarian Serous Cystadenocarcinoma,Can you specify the frequency at which CFAP61 mutations and PXN gains are seen in Ovarian Serous Cystadenocarcinoma?,cnv_and_ssm
+569,HLA-DQA2,E51K,Bladder Urothelial Carcinoma,Can you specify the frequency at which HLA-DQA2 mutations and KDM5C gains are seen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+582,TENM2,H240Y,Skin Cutaneous Melanoma,Can you specify the frequency at which TENM2 mutations and TAF1C gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+583,TENM2,H351Y,Skin Cutaneous Melanoma,Can you specify the frequency at which TENM2 mutations and EFCAB12 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+584,TENM2,H472Y,Skin Cutaneous Melanoma,Can you specify the frequency at which TENM2 mutations and ZNF627 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+600,ANKRD24,A465T,Stomach Adenocarcinoma,Can you specify the frequency at which ANKRD24 mutations and SLC9C1 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+601,ANKRD24,A494T,Stomach Adenocarcinoma,Can you specify the frequency at which ANKRD24 mutations and PGF gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+602,ANKRD24,A584T,Stomach Adenocarcinoma,Can you specify the frequency at which ANKRD24 mutations and PIK3C2B gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+611,ZCCHC14,V549M,Stomach Adenocarcinoma,Can you specify the frequency at which ZCCHC14 mutations and HLA-DQA2 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+612,ZCCHC14,V665M,Stomach Adenocarcinoma,Can you specify the frequency at which ZCCHC14 mutations and SPATA22 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+613,ZCCHC14,V676M,Stomach Adenocarcinoma,Can you specify the frequency at which ZCCHC14 mutations and MAST4 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+614,ZCCHC14,V802M,Stomach Adenocarcinoma,Can you specify the frequency at which ZCCHC14 mutations and C7orf31 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+625,SIK2,I265M,Lung Adenocarcinoma,Can you specify the frequency at which SIK2 mutations and MRPL55 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+632,MYH11,T1336M,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which MYH11 mutations and GUK1 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+633,MYH11,T1343M,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which MYH11 mutations and AUTS2 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+636,SLC6A4,S174F,Skin Cutaneous Melanoma,Can you specify the frequency at which SLC6A4 mutations and TSHZ3 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+642,SLC9C1,K102N,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which SLC9C1 mutations and DGKD gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+643,SLC9C1,K29N,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which SLC9C1 mutations and COL6A3 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+644,OR2A12,A254T,Brain Lower Grade Glioma,Can you specify the frequency at which OR2A12 mutations and DNAH11 gains are seen in Brain Lower Grade Glioma?,cnv_and_ssm
+646,PYHIN1,T325K,Lung Adenocarcinoma,Can you specify the frequency at which PYHIN1 mutations and ADRA1A gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+647,PYHIN1,T334K,Lung Adenocarcinoma,Can you specify the frequency at which PYHIN1 mutations and MORF4L1 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+650,JAML,G191E,Skin Cutaneous Melanoma,Can you specify the frequency at which JAML mutations and TYK2 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+651,JAML,G219E,Skin Cutaneous Melanoma,Can you specify the frequency at which JAML mutations and EVC2 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+652,JAML,G220E,Skin Cutaneous Melanoma,Can you specify the frequency at which JAML mutations and MAST4 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+653,JAML,G230E,Skin Cutaneous Melanoma,Can you specify the frequency at which JAML mutations and TNS1 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+658,TYK2,H1146R,Stomach Adenocarcinoma,Can you specify the frequency at which TYK2 mutations and CDH23 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+659,TYK2,H23R,Stomach Adenocarcinoma,Can you specify the frequency at which TYK2 mutations and DGKD gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+660,TYK2,H961R,Stomach Adenocarcinoma,Can you specify the frequency at which TYK2 mutations and PKHD1L1 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+662,CTCFL,R208C,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which CTCFL mutations and TNS1 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+663,CTCFL,R265C,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which CTCFL mutations and OR5D14 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+664,CTCFL,R420C,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which CTCFL mutations and RIMS2 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+665,CTCFL,R470C,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which CTCFL mutations and GUCY2C gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+687,CEP20,R31Q,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which CEP20 mutations and KDM5C gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+688,CEP20,R58Q,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which CEP20 mutations and YY1AP1 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+689,RIMS2,R25W,Skin Cutaneous Melanoma,Can you specify the frequency at which RIMS2 mutations and CNGB1 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+690,RIMS2,R393W,Skin Cutaneous Melanoma,Can you specify the frequency at which RIMS2 mutations and MORF4L1 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+691,RIMS2,R423W,Skin Cutaneous Melanoma,Can you specify the frequency at which RIMS2 mutations and CPA6 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+692,RIMS2,R470W,Skin Cutaneous Melanoma,Can you specify the frequency at which RIMS2 mutations and PRSS1 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+693,RIMS2,R615W,Skin Cutaneous Melanoma,Can you specify the frequency at which RIMS2 mutations and RIMS2 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+694,RIMS2,R619W,Skin Cutaneous Melanoma,Can you specify the frequency at which RIMS2 mutations and PYHIN1 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+695,RIMS2,R716W,Skin Cutaneous Melanoma,Can you specify the frequency at which RIMS2 mutations and CYB5R2 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+724,PIK3C2G,S551L,Skin Cutaneous Melanoma,Can you specify the frequency at which PIK3C2G mutations and DCAF6 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+725,PIK3C2G,S592L,Skin Cutaneous Melanoma,Can you specify the frequency at which PIK3C2G mutations and DCN gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+728,STK19,D341N,Colon Adenocarcinoma,Can you specify the frequency at which STK19 mutations and EVC2 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+729,STK19,D345N,Colon Adenocarcinoma,Can you specify the frequency at which STK19 mutations and ART3 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+730,REXO4,P60A,Skin Cutaneous Melanoma,Can you specify the frequency at which REXO4 mutations and EVC2 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+735,ZBTB34,P160S,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which ZBTB34 mutations and LAMB2 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+736,ZBTB34,P164S,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which ZBTB34 mutations and PTPRN2 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+737,NCKAP5,E148K,Bladder Urothelial Carcinoma,Can you specify the frequency at which NCKAP5 mutations and OR8K5 gains are seen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+759,SORCS1,D1052Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you specify the frequency at which SORCS1 mutations and CTSC gains are seen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+760,SORCS1,D587Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you specify the frequency at which SORCS1 mutations and TASOR2 gains are seen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+761,SORCS1,D67Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you specify the frequency at which SORCS1 mutations and ZFP42 gains are seen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+762,SORCS1,D810Y,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you specify the frequency at which SORCS1 mutations and RIPOR2 gains are seen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+767,FGF8,T154M,Head and Neck Squamous Cell Carcinoma,Can you specify the frequency at which FGF8 mutations and PAK3 gains are seen in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+768,FGF8,T165M,Head and Neck Squamous Cell Carcinoma,Can you specify the frequency at which FGF8 mutations and PXN gains are seen in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+769,FGF8,T183M,Head and Neck Squamous Cell Carcinoma,Can you specify the frequency at which FGF8 mutations and UNC5D gains are seen in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+770,FGF8,T194M,Head and Neck Squamous Cell Carcinoma,Can you specify the frequency at which FGF8 mutations and CX3CR1 gains are seen in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+771,FGF8,T90M,Head and Neck Squamous Cell Carcinoma,Can you specify the frequency at which FGF8 mutations and DHX16 gains are seen in Head and Neck Squamous Cell Carcinoma?,cnv_and_ssm
+785,TENM3,R1877W,Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia,Can you specify the frequency at which TENM3 mutations and PIK3C2G gains are seen in Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia?,cnv_and_ssm
+787,AKT1,D44N,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which AKT1 mutations and EFCAB12 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+788,CFAP298-TCP10L,E11Q,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you specify the frequency at which CFAP298-TCP10L mutations and OR5D14 gains are seen in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+792,GLRB,E148D,Stomach Adenocarcinoma,Can you specify the frequency at which GLRB mutations and GUK1 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+793,TTN,F7636L,Colon Adenocarcinoma,Can you specify the frequency at which TTN mutations and SGIP1 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+794,TTN,F8563L,Colon Adenocarcinoma,Can you specify the frequency at which TTN mutations and TLK2 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+795,TTN,F8880L,Colon Adenocarcinoma,Can you specify the frequency at which TTN mutations and DCC gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+799,ANKRD30A,V798I,Colon Adenocarcinoma,Can you specify the frequency at which ANKRD30A mutations and AUTS2 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+800,ANKRD30A,V854I,Colon Adenocarcinoma,Can you specify the frequency at which ANKRD30A mutations and CPS1 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+801,ANKRD30A,V973I,Colon Adenocarcinoma,Can you specify the frequency at which ANKRD30A mutations and UNC5D gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+809,TRIM45,S177L,Colon Adenocarcinoma,Can you specify the frequency at which TRIM45 mutations and PYHIN1 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+810,TRIM45,S224L,Colon Adenocarcinoma,Can you specify the frequency at which TRIM45 mutations and REXO4 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+811,TRIM45,S281L,Colon Adenocarcinoma,Can you specify the frequency at which TRIM45 mutations and PTPRN2 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+812,CACNA1F,G727V,Stomach Adenocarcinoma,Can you specify the frequency at which CACNA1F mutations and TAS1R3 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+813,CACNA1F,G781V,Stomach Adenocarcinoma,Can you specify the frequency at which CACNA1F mutations and RELN gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+814,CACNA1F,G792V,Stomach Adenocarcinoma,Can you specify the frequency at which CACNA1F mutations and MYT1 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+817,KL,R594C,Colon Adenocarcinoma,Can you specify the frequency at which KL mutations and ANKRD30A gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+821,GUF1,I243T,Kidney Renal Papillary Cell Carcinoma,Can you specify the frequency at which GUF1 mutations and CASZ1 gains are seen in Kidney Renal Papillary Cell Carcinoma?,cnv_and_ssm
+822,TAF1L,A539V,Colon Adenocarcinoma,Can you specify the frequency at which TAF1L mutations and PLEKHG6 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+823,TASOR2,S256F,Skin Cutaneous Melanoma,Can you specify the frequency at which TASOR2 mutations and DPF3 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+824,TASOR2,S36F,Skin Cutaneous Melanoma,Can you specify the frequency at which TASOR2 mutations and GUK1 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+825,TASOR2,S471F,Skin Cutaneous Melanoma,Can you specify the frequency at which TASOR2 mutations and DCC gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+829,KDM5C,R1151C,Skin Cutaneous Melanoma,Can you specify the frequency at which KDM5C mutations and CNGB1 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+830,KDM5C,R1177C,Skin Cutaneous Melanoma,Can you specify the frequency at which KDM5C mutations and CASZ1 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+831,KDM5C,R1217C,Skin Cutaneous Melanoma,Can you specify the frequency at which KDM5C mutations and CEP20 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+832,KDM5C,R1218C,Skin Cutaneous Melanoma,Can you specify the frequency at which KDM5C mutations and ANKRD30A gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+841,IL5RA,L153F,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you specify the frequency at which IL5RA mutations and ABCC3 gains are seen in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+843,DHX16,A29V,Skin Cutaneous Melanoma,Can you specify the frequency at which DHX16 mutations and TYK2 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+844,DHX16,A89V,Skin Cutaneous Melanoma,Can you specify the frequency at which DHX16 mutations and FRY gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+902,GPR158,A644V,Stomach Adenocarcinoma,Can you specify the frequency at which GPR158 mutations and ANP32E gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+903,GPR158,A723V,Stomach Adenocarcinoma,Can you specify the frequency at which GPR158 mutations and ADRA1A gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+904,EIF2B4,E108K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you specify the frequency at which EIF2B4 mutations and PTPRO gains are seen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+905,EIF2B4,E110K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you specify the frequency at which EIF2B4 mutations and SGCZ gains are seen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+906,EIF2B4,E111K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you specify the frequency at which EIF2B4 mutations and KIF20B gains are seen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+907,EIF2B4,E131K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you specify the frequency at which EIF2B4 mutations and CPA6 gains are seen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+908,EIF2B4,E132K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you specify the frequency at which EIF2B4 mutations and MAOB gains are seen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+909,EIF2B4,E96K,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you specify the frequency at which EIF2B4 mutations and PGF gains are seen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+928,AUTS2,P136S,Lung Squamous Cell Carcinoma,Can you specify the frequency at which AUTS2 mutations and ART3 gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+929,AUTS2,P218S,Lung Squamous Cell Carcinoma,Can you specify the frequency at which AUTS2 mutations and CTCFL gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+930,AUTS2,P233S,Lung Squamous Cell Carcinoma,Can you specify the frequency at which AUTS2 mutations and DSCAM gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+931,AUTS2,P313S,Lung Squamous Cell Carcinoma,Can you specify the frequency at which AUTS2 mutations and ZCCHC14 gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+932,AUTS2,P419S,Lung Squamous Cell Carcinoma,Can you specify the frequency at which AUTS2 mutations and TAF1C gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+933,AUTS2,P443S,Lung Squamous Cell Carcinoma,Can you specify the frequency at which AUTS2 mutations and PHLPP1 gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+934,AUTS2,P56S,Lung Squamous Cell Carcinoma,Can you specify the frequency at which AUTS2 mutations and POC1B gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+935,AUTS2,P667S,Lung Squamous Cell Carcinoma,Can you specify the frequency at which AUTS2 mutations and POLR1G gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+936,AUTS2,P690S,Lung Squamous Cell Carcinoma,Can you specify the frequency at which AUTS2 mutations and PGR gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+937,AUTS2,P691S,Lung Squamous Cell Carcinoma,Can you specify the frequency at which AUTS2 mutations and MRPL32 gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+942,ACTL7B,D223N,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you specify the frequency at which ACTL7B mutations and MYO15A gains are seen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+952,PCDHGA1,R535W,Glioblastoma Multiforme,Can you specify the frequency at which PCDHGA1 mutations and EBF2 gains are seen in Glioblastoma Multiforme?,cnv_and_ssm
+954,TRAP1,R114W,Stomach Adenocarcinoma,Can you specify the frequency at which TRAP1 mutations and KDM5C gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+955,TRAP1,R61W,Stomach Adenocarcinoma,Can you specify the frequency at which TRAP1 mutations and POC1B gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+956,PIK3C2A,R1570Q,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which PIK3C2A mutations and TLCD5 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+977,KANSL1,R139G,Liver Hepatocellular Carcinoma,Can you specify the frequency at which KANSL1 mutations and SYT9 gains are seen in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+979,ANKRD52,Y594C,Stomach Adenocarcinoma,Can you specify the frequency at which ANKRD52 mutations and POC1B gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+980,PAPPA,G1580S,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which PAPPA mutations and PTPRN2 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+981,B3GALNT1,V270A,Rectum Adenocarcinoma,Can you specify the frequency at which B3GALNT1 mutations and PRSS8 gains are seen in Rectum Adenocarcinoma?,cnv_and_ssm
+982,GABRA6,G115R,Lung Adenocarcinoma,Can you specify the frequency at which GABRA6 mutations and SMO gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+983,GABRA6,G122R,Lung Adenocarcinoma,Can you specify the frequency at which GABRA6 mutations and AUTS2 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+984,GABRA6,G165R,Lung Adenocarcinoma,Can you specify the frequency at which GABRA6 mutations and TRPA1 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+985,GABRA6,G175R,Lung Adenocarcinoma,Can you specify the frequency at which GABRA6 mutations and FBN1 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+986,GABRA6,G70R,Lung Adenocarcinoma,Can you specify the frequency at which GABRA6 mutations and CEP20 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+987,ZSCAN31,D9N,Skin Cutaneous Melanoma,Can you specify the frequency at which ZSCAN31 mutations and KRT39 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+991,MED16,L126P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you specify the frequency at which MED16 mutations and GIMAP2 gains are seen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+992,MED16,L868P,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you specify the frequency at which MED16 mutations and GPRASP1 gains are seen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+994,PTPRO,E1060K,Pancreatic Adenocarcinoma,Can you specify the frequency at which PTPRO mutations and TTN gains are seen in Pancreatic Adenocarcinoma?,cnv_and_ssm
+995,PTPRO,E1088K,Pancreatic Adenocarcinoma,Can you specify the frequency at which PTPRO mutations and ANKRD30A gains are seen in Pancreatic Adenocarcinoma?,cnv_and_ssm
+996,PTPRO,E249K,Pancreatic Adenocarcinoma,Can you specify the frequency at which PTPRO mutations and CFAP61 gains are seen in Pancreatic Adenocarcinoma?,cnv_and_ssm
+997,PTPRO,E265K,Pancreatic Adenocarcinoma,Can you specify the frequency at which PTPRO mutations and ZCCHC14 gains are seen in Pancreatic Adenocarcinoma?,cnv_and_ssm
+998,PTPRO,E277K,Pancreatic Adenocarcinoma,Can you specify the frequency at which PTPRO mutations and EFCAB12 gains are seen in Pancreatic Adenocarcinoma?,cnv_and_ssm
+999,PTPRO,E67K,Pancreatic Adenocarcinoma,Can you specify the frequency at which PTPRO mutations and DNAH11 gains are seen in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1000,PTPRO,E923K,Pancreatic Adenocarcinoma,Can you specify the frequency at which PTPRO mutations and TASOR2 gains are seen in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1001,PTPRO,E940K,Pancreatic Adenocarcinoma,Can you specify the frequency at which PTPRO mutations and CTSC gains are seen in Pancreatic Adenocarcinoma?,cnv_and_ssm
+1010,CHMP7,D397N,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which CHMP7 mutations and CNGB1 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1017,GPC3,I107N,Stomach Adenocarcinoma,Can you specify the frequency at which GPC3 mutations and SORCS1 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+1018,GPC3,I161N,Stomach Adenocarcinoma,Can you specify the frequency at which GPC3 mutations and PDGFC gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+1021,TLK2,V430L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you specify the frequency at which TLK2 mutations and STK19 gains are seen in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1022,TLK2,V515L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you specify the frequency at which TLK2 mutations and GUK1 gains are seen in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1023,TLK2,V547L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you specify the frequency at which TLK2 mutations and DPF3 gains are seen in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1024,TLK2,V579L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you specify the frequency at which TLK2 mutations and FGF8 gains are seen in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1025,TLK2,V601L,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Can you specify the frequency at which TLK2 mutations and ACTB gains are seen in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma?,cnv_and_ssm
+1036,ZNF217,E209Q,Lung Adenocarcinoma,Can you specify the frequency at which ZNF217 mutations and CTSC gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+1038,SYT9,V275L,Lung Adenocarcinoma,Can you specify the frequency at which SYT9 mutations and TLCD5 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+1039,SYT9,V307L,Lung Adenocarcinoma,Can you specify the frequency at which SYT9 mutations and TAS1R3 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+1042,PKHD1L1,S2830N,Lung Squamous Cell Carcinoma,Can you specify the frequency at which PKHD1L1 mutations and TET2 gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1044,MYO3A,Y1295C,Lung Squamous Cell Carcinoma,Can you specify the frequency at which MYO3A mutations and PTPRO gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1045,VASN,V318I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you specify the frequency at which VASN mutations and ACTL7B gains are seen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1047,DNMT1,A1037T,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which DNMT1 mutations and SPINDOC gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1048,DNMT1,A1053T,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which DNMT1 mutations and PCDHB2 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1049,DNMT1,A934T,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which DNMT1 mutations and PXN gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1056,CA9,E402K,Colon Adenocarcinoma,Can you specify the frequency at which CA9 mutations and DHX16 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+1059,TTC17,R808Q,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which TTC17 mutations and DOCK2 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1060,TTC17,R865Q,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which TTC17 mutations and ANKRD24 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1065,PSG2,P43L,Breast Invasive Carcinoma,Can you specify the frequency at which PSG2 mutations and FBXO15 gains are seen in Breast Invasive Carcinoma?,cnv_and_ssm
+1067,RIPOR2,R470L,Breast Invasive Carcinoma,Can you specify the frequency at which RIPOR2 mutations and PTPRN2 gains are seen in Breast Invasive Carcinoma?,cnv_and_ssm
+1068,RIPOR2,R499L,Breast Invasive Carcinoma,Can you specify the frequency at which RIPOR2 mutations and TENT5A gains are seen in Breast Invasive Carcinoma?,cnv_and_ssm
+1069,RIPOR2,R504L,Breast Invasive Carcinoma,Can you specify the frequency at which RIPOR2 mutations and CTCFL gains are seen in Breast Invasive Carcinoma?,cnv_and_ssm
+1070,RIPOR2,R520L,Breast Invasive Carcinoma,Can you specify the frequency at which RIPOR2 mutations and DCC gains are seen in Breast Invasive Carcinoma?,cnv_and_ssm
+1083,DCLK3,V520I,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which DCLK3 mutations and TYROBP gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1084,DCLK3,V689I,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which DCLK3 mutations and RIMS2 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1085,MERTK,G257A,Lung Squamous Cell Carcinoma,Can you specify the frequency at which MERTK mutations and STAT3 gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1086,MERTK,G757A,Lung Squamous Cell Carcinoma,Can you specify the frequency at which MERTK mutations and EFCAB12 gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1087,MERTK,G933A,Lung Squamous Cell Carcinoma,Can you specify the frequency at which MERTK mutations and MYO16 gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1088,ZFP42,R206K,Skin Cutaneous Melanoma,Can you specify the frequency at which ZFP42 mutations and GPC3 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+1089,OR13C3,M117I,Skin Cutaneous Melanoma,Can you specify the frequency at which OR13C3 mutations and TRAP1 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+1090,OR13C3,M147I,Skin Cutaneous Melanoma,Can you specify the frequency at which OR13C3 mutations and DOCK2 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+1091,SPAG1,I917M,Stomach Adenocarcinoma,Can you specify the frequency at which SPAG1 mutations and TNS1 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+1092,CDKN2AIP,Y92H,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which CDKN2AIP mutations and SORCS1 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1093,PXN,H1016Y,Colon Adenocarcinoma,Can you specify the frequency at which PXN mutations and ACVR1B gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+1094,PXN,H359Y,Colon Adenocarcinoma,Can you specify the frequency at which PXN mutations and TTYH2 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+1095,PXN,H492Y,Colon Adenocarcinoma,Can you specify the frequency at which PXN mutations and ANKRD30A gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+1096,PXN,H524Y,Colon Adenocarcinoma,Can you specify the frequency at which PXN mutations and NCKAP5 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+1097,PXN,H526Y,Colon Adenocarcinoma,Can you specify the frequency at which PXN mutations and PTPRO gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+1098,PXN,H540Y,Colon Adenocarcinoma,Can you specify the frequency at which PXN mutations and TLK2 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+1101,TTYH2,S23L,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which TTYH2 mutations and THBS4 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1102,TTYH2,S44L,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which TTYH2 mutations and ARHGEF40 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1106,TMEM255A,N205S,Colon Adenocarcinoma,Can you specify the frequency at which TMEM255A mutations and GUK1 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+1107,TMEM255A,N229S,Colon Adenocarcinoma,Can you specify the frequency at which TMEM255A mutations and ARMC3 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+1108,TMEM255A,N65S,Colon Adenocarcinoma,Can you specify the frequency at which TMEM255A mutations and COL6A3 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+1109,TASOR2,H2271D,Breast Invasive Carcinoma,Can you specify the frequency at which TASOR2 mutations and ZMYM3 gains are seen in Breast Invasive Carcinoma?,cnv_and_ssm
+1110,TASOR2,H2486D,Breast Invasive Carcinoma,Can you specify the frequency at which TASOR2 mutations and CNGB1 gains are seen in Breast Invasive Carcinoma?,cnv_and_ssm
+1111,ICE1,T1839M,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which ICE1 mutations and ANKRD24 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1112,MYT1,A558E,Breast Invasive Carcinoma,Can you specify the frequency at which MYT1 mutations and PCDHGA1 gains are seen in Breast Invasive Carcinoma?,cnv_and_ssm
+1113,MYT1,A879E,Breast Invasive Carcinoma,Can you specify the frequency at which MYT1 mutations and KDM5C gains are seen in Breast Invasive Carcinoma?,cnv_and_ssm
+1114,MYT1,A906E,Breast Invasive Carcinoma,Can you specify the frequency at which MYT1 mutations and KIF20B gains are seen in Breast Invasive Carcinoma?,cnv_and_ssm
+1121,CX3CR1,P203L,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which CX3CR1 mutations and DNMT1 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1122,CX3CR1,P235L,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which CX3CR1 mutations and TTC12 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1125,SPINDOC,R197C,Liver Hepatocellular Carcinoma,Can you specify the frequency at which SPINDOC mutations and MYH11 gains are seen in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1126,ART3,C251Y,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which ART3 mutations and TTN gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1127,ART3,C3Y,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which ART3 mutations and AQP7 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1138,CYP1A2,R243G,Bladder Urothelial Carcinoma,Can you specify the frequency at which CYP1A2 mutations and ANKDD1A gains are seen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1139,ADRA1A,G279S,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you specify the frequency at which ADRA1A mutations and SORCS1 gains are seen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1146,CDH23,P2523R,Lung Squamous Cell Carcinoma,Can you specify the frequency at which CDH23 mutations and MYO3B gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1147,CDH23,P283R,Lung Squamous Cell Carcinoma,Can you specify the frequency at which CDH23 mutations and MED16 gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1148,KRT39,P137S,Skin Cutaneous Melanoma,Can you specify the frequency at which KRT39 mutations and FBXO15 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+1149,PDHA2,S7F,Lung Squamous Cell Carcinoma,Can you specify the frequency at which PDHA2 mutations and MSANTD4 gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1151,SLC24A2,H200Q,Colon Adenocarcinoma,Can you specify the frequency at which SLC24A2 mutations and PTPRO gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+1153,PTPRN2,F153L,Liver Hepatocellular Carcinoma,Can you specify the frequency at which PTPRN2 mutations and MUC16 gains are seen in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1154,PTPRN2,F847L,Liver Hepatocellular Carcinoma,Can you specify the frequency at which PTPRN2 mutations and PAK3 gains are seen in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1155,PTPRN2,F856L,Liver Hepatocellular Carcinoma,Can you specify the frequency at which PTPRN2 mutations and COL6A3 gains are seen in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1156,PTPRN2,F868L,Liver Hepatocellular Carcinoma,Can you specify the frequency at which PTPRN2 mutations and MERTK gains are seen in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1157,PTPRN2,F885L,Liver Hepatocellular Carcinoma,Can you specify the frequency at which PTPRN2 mutations and COL6A3 gains are seen in Liver Hepatocellular Carcinoma?,cnv_and_ssm
+1188,SOX21,R55L,Lung Adenocarcinoma,Can you specify the frequency at which SOX21 mutations and RIMS2 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+1189,CPA6,G166E,Bladder Urothelial Carcinoma,Can you specify the frequency at which CPA6 mutations and PRSS8 gains are seen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1206,GRM5,E14K,Skin Cutaneous Melanoma,Can you specify the frequency at which GRM5 mutations and MYT1 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+1209,CASZ1,R233Q,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you specify the frequency at which CASZ1 mutations and WNT2 gains are seen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1210,SGIP1,N122T,Stomach Adenocarcinoma,Can you specify the frequency at which SGIP1 mutations and FMO4 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+1211,SGIP1,N420T,Stomach Adenocarcinoma,Can you specify the frequency at which SGIP1 mutations and ZCCHC14 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+1212,SGIP1,N617T,Stomach Adenocarcinoma,Can you specify the frequency at which SGIP1 mutations and DNMT1 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+1213,SGIP1,N648T,Stomach Adenocarcinoma,Can you specify the frequency at which SGIP1 mutations and TRPA1 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+1227,CARMIL1,V549L,Lung Adenocarcinoma,Can you specify the frequency at which CARMIL1 mutations and TTC17 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+1228,CARMIL1,V949L,Lung Adenocarcinoma,Can you specify the frequency at which CARMIL1 mutations and ARHGEF40 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+1232,ZNF431,D121Y,Lung Adenocarcinoma,Can you specify the frequency at which ZNF431 mutations and GUCY2C gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+1233,ZNF431,D161Y,Lung Adenocarcinoma,Can you specify the frequency at which ZNF431 mutations and ART3 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+1234,ZNF431,R128I,Lung Adenocarcinoma,Can you specify the frequency at which ZNF431 mutations and FGF8 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+1235,DNAH11,P2987S,Skin Cutaneous Melanoma,Can you specify the frequency at which DNAH11 mutations and COL6A3 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+1236,DNAH11,P2994S,Skin Cutaneous Melanoma,Can you specify the frequency at which DNAH11 mutations and PTPRO gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+1244,POLD1,Q461L,Lung Squamous Cell Carcinoma,Can you specify the frequency at which POLD1 mutations and MYO3A gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1245,POLD1,Q85L,Lung Squamous Cell Carcinoma,Can you specify the frequency at which POLD1 mutations and RIMS2 gains are seen in Lung Squamous Cell Carcinoma?,cnv_and_ssm
+1248,TTC12,D646H,Lung Adenocarcinoma,Can you specify the frequency at which TTC12 mutations and TAF1C gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+1249,TTC12,D652H,Lung Adenocarcinoma,Can you specify the frequency at which TTC12 mutations and PGR gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+1252,CNGB1,D967N,Bladder Urothelial Carcinoma,Can you specify the frequency at which CNGB1 mutations and OLFML3 gains are seen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1253,CNGB1,D973N,Bladder Urothelial Carcinoma,Can you specify the frequency at which CNGB1 mutations and FRY gains are seen in Bladder Urothelial Carcinoma?,cnv_and_ssm
+1254,CTSC,E214V,Stomach Adenocarcinoma,Can you specify the frequency at which CTSC mutations and PTPRO gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+1255,CTSC,E291V,Stomach Adenocarcinoma,Can you specify the frequency at which CTSC mutations and CTNNA2 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+1256,CTSC,E322V,Stomach Adenocarcinoma,Can you specify the frequency at which CTSC mutations and PTPRO gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+1257,CTSC,E324V,Stomach Adenocarcinoma,Can you specify the frequency at which CTSC mutations and CACNA1F gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+1258,CTSC,E335V,Stomach Adenocarcinoma,Can you specify the frequency at which CTSC mutations and STK19 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+1260,PRSS8,A179T,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which PRSS8 mutations and PDGFC gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1261,PRSS8,A233T,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which PRSS8 mutations and GRM5 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1263,ARHGEF40,V864F,Lung Adenocarcinoma,Can you specify the frequency at which ARHGEF40 mutations and CEP20 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+1264,ACTB,A138T,Rectum Adenocarcinoma,Can you specify the frequency at which ACTB mutations and MYO16 gains are seen in Rectum Adenocarcinoma?,cnv_and_ssm
+1265,ACTB,A217T,Rectum Adenocarcinoma,Can you specify the frequency at which ACTB mutations and DNAH11 gains are seen in Rectum Adenocarcinoma?,cnv_and_ssm
+1266,ACTB,A244T,Rectum Adenocarcinoma,Can you specify the frequency at which ACTB mutations and PRSS1 gains are seen in Rectum Adenocarcinoma?,cnv_and_ssm
+1267,ACTB,A260T,Rectum Adenocarcinoma,Can you specify the frequency at which ACTB mutations and SPATA22 gains are seen in Rectum Adenocarcinoma?,cnv_and_ssm
+1268,YY1AP1,V546D,Glioblastoma Multiforme,Can you specify the frequency at which YY1AP1 mutations and TLK2 gains are seen in Glioblastoma Multiforme?,cnv_and_ssm
+1269,YY1AP1,V557D,Glioblastoma Multiforme,Can you specify the frequency at which YY1AP1 mutations and PDHA2 gains are seen in Glioblastoma Multiforme?,cnv_and_ssm
+1270,YY1AP1,V566D,Glioblastoma Multiforme,Can you specify the frequency at which YY1AP1 mutations and DCAF6 gains are seen in Glioblastoma Multiforme?,cnv_and_ssm
+1271,YY1AP1,V577D,Glioblastoma Multiforme,Can you specify the frequency at which YY1AP1 mutations and CX3CR1 gains are seen in Glioblastoma Multiforme?,cnv_and_ssm
+1272,YY1AP1,V623D,Glioblastoma Multiforme,Can you specify the frequency at which YY1AP1 mutations and AUTS2 gains are seen in Glioblastoma Multiforme?,cnv_and_ssm
+1273,YY1AP1,V695D,Glioblastoma Multiforme,Can you specify the frequency at which YY1AP1 mutations and TLK2 gains are seen in Glioblastoma Multiforme?,cnv_and_ssm
+1274,YY1AP1,V715D,Glioblastoma Multiforme,Can you specify the frequency at which YY1AP1 mutations and WNT2 gains are seen in Glioblastoma Multiforme?,cnv_and_ssm
+1292,FNDC7,D323N,Skin Cutaneous Melanoma,Can you specify the frequency at which FNDC7 mutations and PXN gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+1293,FNDC7,D99N,Skin Cutaneous Melanoma,Can you specify the frequency at which FNDC7 mutations and MED16 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+1299,TLCD5,G15V,Lung Adenocarcinoma,Can you specify the frequency at which TLCD5 mutations and ANKDD1A gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+1300,TLCD5,G37V,Lung Adenocarcinoma,Can you specify the frequency at which TLCD5 mutations and TNS1 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+1306,POLR1G,R498W,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which POLR1G mutations and GUK1 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1307,POLR1G,R500W,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which POLR1G mutations and UNC5D gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1308,DNAH14,N1186K,Colon Adenocarcinoma,Can you specify the frequency at which DNAH14 mutations and UNC5D gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+1309,DNAH14,N2657K,Colon Adenocarcinoma,Can you specify the frequency at which DNAH14 mutations and DCAF4L2 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+1310,DNAH14,N3460K,Colon Adenocarcinoma,Can you specify the frequency at which DNAH14 mutations and TNS1 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+1314,NEXN,E73D,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which NEXN mutations and PGF gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1321,CYB5R2,G112R,Prostate Adenocarcinoma,Can you specify the frequency at which CYB5R2 mutations and PTPRO gains are seen in Prostate Adenocarcinoma?,cnv_and_ssm
+1322,CYB5R2,G172R,Prostate Adenocarcinoma,Can you specify the frequency at which CYB5R2 mutations and MYT1 gains are seen in Prostate Adenocarcinoma?,cnv_and_ssm
+1326,NRAP,S808L,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which NRAP mutations and TAF1L gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1327,NRAP,S816L,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which NRAP mutations and AUTS2 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1328,NRAP,S843L,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which NRAP mutations and MORF4L1 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1329,CCDC22,E179D,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which CCDC22 mutations and ANKRD30A gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1331,DCAF6,S402F,Skin Cutaneous Melanoma,Can you specify the frequency at which DCAF6 mutations and MRPL55 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+1332,DCAF6,S433F,Skin Cutaneous Melanoma,Can you specify the frequency at which DCAF6 mutations and PGR gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+1335,ZNF708,E389D,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which ZNF708 mutations and CACNA1F gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1337,BFAR,T103M,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which BFAR mutations and DCLK3 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1346,MAST4,P1237S,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which MAST4 mutations and OLFML3 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1347,MAST4,P1986S,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which MAST4 mutations and PIK3C2A gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1348,MAST4,P1991S,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which MAST4 mutations and MRPL55 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1349,MAST4,P2001S,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which MAST4 mutations and GUK1 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1350,MAST4,P2180S,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which MAST4 mutations and ANKDD1A gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1363,ARMC3,R169C,Stomach Adenocarcinoma,Can you specify the frequency at which ARMC3 mutations and GPC3 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+1364,ARMC3,R432C,Stomach Adenocarcinoma,Can you specify the frequency at which ARMC3 mutations and TTC12 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+1367,TET2,L757V,Kidney Renal Clear Cell Carcinoma,Can you specify the frequency at which TET2 mutations and MRPL55 gains are seen in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+1368,TET2,L778V,Kidney Renal Clear Cell Carcinoma,Can you specify the frequency at which TET2 mutations and PTPRN2 gains are seen in Kidney Renal Clear Cell Carcinoma?,cnv_and_ssm
+1369,SERPINB10,A353P,Lung Adenocarcinoma,Can you specify the frequency at which SERPINB10 mutations and KANSL1 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+1370,STAT3,Y22H,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which STAT3 mutations and SLC9C1 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1372,MIEF1,A42T,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which MIEF1 mutations and PTPRN2 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1381,ACVR1B,D397N,Colon Adenocarcinoma,Can you specify the frequency at which ACVR1B mutations and NEXN gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+1382,ACVR1B,D449N,Colon Adenocarcinoma,Can you specify the frequency at which ACVR1B mutations and ANP32E gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+1383,ACVR1B,D490N,Colon Adenocarcinoma,Can you specify the frequency at which ACVR1B mutations and TRAP1 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+1393,EBF2,T104I,Stomach Adenocarcinoma,Can you specify the frequency at which EBF2 mutations and CHODL gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+1394,EBF2,T252I,Stomach Adenocarcinoma,Can you specify the frequency at which EBF2 mutations and GABRA6 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+1402,VPS26B,F266L,Stomach Adenocarcinoma,Can you specify the frequency at which VPS26B mutations and CDC42BPA gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+1403,PGR,M106I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you specify the frequency at which PGR mutations and MYO3A gains are seen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1404,PGR,M38I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you specify the frequency at which PGR mutations and KIF20B gains are seen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1405,PGR,M632I,"CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus","Can you specify the frequency at which PGR mutations and PSG2 gains are seen in CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus?",cnv_and_ssm
+1409,ACTA2,P334L,Skin Cutaneous Melanoma,Can you specify the frequency at which ACTA2 mutations and ZNF217 gains are seen in Skin Cutaneous Melanoma?,cnv_and_ssm
+1411,THBS4,T852I,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which THBS4 mutations and SPTAN1 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1412,THBS4,T943I,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which THBS4 mutations and DCLK3 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1413,PRSS1,S114T,Lung Adenocarcinoma,Can you specify the frequency at which PRSS1 mutations and CDKN2AIP gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+1414,PRSS1,S124T,Lung Adenocarcinoma,Can you specify the frequency at which PRSS1 mutations and AUTS2 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+1415,PRSS1,S138T,Lung Adenocarcinoma,Can you specify the frequency at which PRSS1 mutations and ICE1 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+1416,PRSS1,S74T,Lung Adenocarcinoma,Can you specify the frequency at which PRSS1 mutations and ZNF708 gains are seen in Lung Adenocarcinoma?,cnv_and_ssm
+1417,PGF,R126H,Stomach Adenocarcinoma,Can you specify the frequency at which PGF mutations and ZFP42 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+1418,PGF,R127H,Stomach Adenocarcinoma,Can you specify the frequency at which PGF mutations and GRTP1 gains are seen in Stomach Adenocarcinoma?,cnv_and_ssm
+1430,ITPRID2,S351C,Breast Invasive Carcinoma,Can you specify the frequency at which ITPRID2 mutations and SYT9 gains are seen in Breast Invasive Carcinoma?,cnv_and_ssm
+1431,ITPRID2,S842C,Breast Invasive Carcinoma,Can you specify the frequency at which ITPRID2 mutations and STK19 gains are seen in Breast Invasive Carcinoma?,cnv_and_ssm
+1434,HBB,E8D,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which HBB mutations and TLK2 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1441,PCDHB2,R158C,Colon Adenocarcinoma,Can you specify the frequency at which PCDHB2 mutations and MRPL32 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+1442,PCDHB2,T15M,Colon Adenocarcinoma,Can you specify the frequency at which PCDHB2 mutations and ZNF431 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+1443,PCDHB2,T26M,Colon Adenocarcinoma,Can you specify the frequency at which PCDHB2 mutations and DCAF6 gains are seen in Colon Adenocarcinoma?,cnv_and_ssm
+1451,UBR2,P1594S,Uterine Corpus Endometrial Carcinoma,Can you specify the frequency at which UBR2 mutations and HLA-DQA2 gains are seen in Uterine Corpus Endometrial Carcinoma?,cnv_and_ssm
+1452,FBXO42,A618D,Rectum Adenocarcinoma,Can you specify the frequency at which FBXO42 mutations and CXCR2 gains are seen in Rectum Adenocarcinoma?,cnv_and_ssm